You are on page 1of 1898

APPROVED

DRUG
PRODUCTS
WITH

THERAPEUTIC
EQUIVALENCE
EVALUATIONS
43rd EDITION

THE PRODUCTS IN THIS LIST HAVE BEEN APPROVED UNDER


SECTION 505 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT.

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES


FOOD AND DRUG ADMINISTRATION
OFFICE OF MEDICAL PRODUCTS AND TOBACCO
CENTER FOR DRUG EVALUATION AND RESEARCH
OFFICE OF GENERIC DRUGS
OFFICE OF GENERIC DRUG POLICY

2023
APPROVED DRUG PRODUCTS
with
THERAPEUTIC EQUIVALENCE EVALUATIONS

The products in this list have been approved under section 505 of the
Federal Food, Drug, and Cosmetic Act. This volume is current through
December 31, 2022.

43rd EDITION

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES


FOOD AND DRUG ADMINISTRATION
OFFICE OF MEDICAL PRODUCTS AND TOBACCO
CENTER FOR DRUG EVALUATION AND RESEARCH
OFFICE OF GENERIC DRUGS
OFFICE OF GENERIC DRUG POLICY

2023
FOOD AND DRUG ADMINISTRATION
CENTER FOR DRUG EVALUATION AND RESEARCH

APPROVED DRUG PRODUCTS


With
Therapeutic Equivalence Evaluations

CONTENTS
PAGE

PREFACE TO FORTY THIRD EDITION………………...……………………….…..…........ iv

1.0 INTRODUCTION ..................................................................................................................vi


1.1 Content and Exclusion......................................................................................................vi
1.2 Therapeutic Equivalence-Related Terms ........................................................................vii
1.3 Further Guidance on Bioequivalence ...............................................................................ix
1.4 Reference Listed Drug and Reference Standard ............................................................. x
1.5 General Policies and Legal Status ...................................................................................xi
1.6 Practitioner/User Responsibilities.....................................................................................xi
1.7 Therapeutic Equivalence Evaluations Codes ..................................................................xii
1.8 Description of Certain Special Situations ........................................................................xx
1.9 Therapeutic Equivalence Code Change for a Drug Entity............................................ xxiii
1.10 Change of the Therapeutic Equivalence Evaluation for a Single Product .................... xxiii
1.11 Discontinued Section.................................................................................................... xxiv
1.12 Changes to the Orange Book ....................................................................................... xxiv
1.13 Availability of the Edition................................................................................................xxv

2.0 HOW TO USE THE DRUG PRODUCTS LISTS .............................................................2-1


2.1 Key Sections for Using the Drug Product Lists ……………….…….….………………......2-1
2.2 Drug Product Illustration ………………………………………….…..….…………….……..2-3
2.3 Therapeutic Equivalence Evaluations Illustration …………….…….….…………..………2-4

DRUG PRODUCT LISTS


Prescription Drug Product List ……………………………………….…………….………………...3-1
OTC Drug Product List ……………………………………………….…………….…………………4-1
Drug Products with Approval under Section 505 of the FD&C Act Administered
by the Center for Biologics Evaluation and Research List ...……….…….………………...5-1
Discontinued Drug Product List .…………………………………………….…….………………....6-1
Orphan Products Designations and Approvals List …………….………….…….………………..7-1
Drug Products Which Must Demonstrate in vivo Bioavailability
Only if Product Fails to Achieve Adequate Dissolution …………………..………………………..8-1

APPENDICES
A. Product Name Index ……….…...………………………….………..……………………A-1
B. Product Name Index Listed by Applicant ………………….……..……………………..B-1
C. Uniform Terms …………………………………………….………..…………...………...C-1

PATENT AND EXCLUSIVITY INFORMATION ADDENDUM ……….……..………………..........AD1


A. Patent and Exclusivity Lists …………………………….…..……..……………..……ADA1
B. Patent and Exclusivity Terms ...……………………….….………...…………………ADB1
FOOD AND DRUG ADMINISTRATION
CENTER FOR DRUG EVALUATION AND RESEARCH

APPROVED DRUG PRODUCTS


With
Therapeutic Equivalence Evaluations

PREFACE TO FORTY THIRD EDITION


The publication, Approved Drug Products With Therapeutic Equivalence
Evaluations (the List, commonly known as the Orange Book), identifies drug
products approved on the basis of safety and effectiveness by the Food and
Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the
FD&C Act). The main criterion for the inclusion of any product is that the
product is the subject of an application with an approval that has not been
withdrawn for safety or effectiveness reasons. Inclusion of products in the
Orange Book is independent of any current regulatory action being taken
administratively or judicially against a drug product. In addition, the
Orange Book contains therapeutic equivalence evaluations for approved
multisource prescription drug products. These evaluations have been prepared
to serve as public information and advice to state health agencies,
prescribers, and pharmacists to promote public education in the area of drug
product selection and to foster containment of health care costs.
Therapeutic equivalence evaluations in this publication are not official FDA
actions affecting the legal status of products under the FD&C Act.

Background of the Publication. To contain drug costs, virtually every


state has adopted laws and/or regulations that encourage the substitution of
drug products. These state laws generally require either that substitution
be limited to drugs on a specific list (the positive formulary approach) or
that it be permitted for all drugs except those prohibited by a particular
list (the negative formulary approach). Because of the number of requests in
the late 1970s for FDA assistance in preparing both positive and negative
formularies, it became apparent that FDA could not serve the needs of each
state on an individual basis. The Agency also recognized that providing a
single list based on common criteria would be preferable to evaluating drug
products on the basis of differing definitions and criteria in various state
laws. As a result, on May 31, 1978, the Commissioner of the Food and Drug
Administration sent a letter to officials of each state announcing FDA's
intent to provide a list of all prescription drug products that are approved
by FDA for safety and effectiveness, along with therapeutic equivalence
determinations for multisource prescription products.

The Orange Book was distributed as a proposal in January 1979. It


included only currently marketed prescription drug products approved by FDA
through new drug applications (NDAs) and abbreviated new drug applications
(ANDAs) under the provisions of Section 505 of the FD&C Act and FDA
regulations at that time.

The therapeutic equivalence evaluations in the Orange Book reflect FDA's


application of specific criteria to the multisource prescription drug
products listed in the Orange Book and approved under Section 505 of the FD&C
Act. These evaluations are presented in the form of code letters that
indicate the basis for the evaluation made. An explanation of the codes
appears in the Introduction.

iv
A complete discussion of the background and basis of FDA's therapeutic
equivalence evaluation policy was published in the Federal Register on
January 12, 1979 (44 FR 2932). The final rule, which includes FDA's
responses to the public comments on the proposal, was published in the
Federal Register on October 31, 1980 (45 FR 72582). The first publication of
the Orange Book in October 1980, concurrent with finalization of the rule,
incorporated appropriate revisions. Each subsequent edition has included new
approvals and made appropriate changes in data.

On September 24, 1984, the President signed into law the Drug Price
Competition and Patent Term Restoration Act of 1984 (Hatch-Waxman
Amendments). The Hatch-Waxman Amendments amended the FD&C Act to establish,
among other things, the 505(b)(2) and 505(j) approval pathways. The Hatch-
Waxman Amendments require that FDA, among other things, make publicly
available a list of approved drug products with monthly supplements. The
Orange Book and its monthly Cumulative Supplements satisfy this requirement.
The Addendum to this publication identifies drugs that have qualified under
the FD&C Act for periods of exclusivity and provides patent information
concerning the approved drug products in the Orange Book. The Addendum also
provides additional information that may be helpful to those submitting an
NDA under section 505(b) of the FD&C Act or an ANDA under section 505(j) of
the FD&C Act to the Agency.

The Agency intends to use this publication to further its objective of


obtaining input and comment on the publication itself and related Agency
procedures. Therefore, if you have comments on how the publication can be
improved, please send them to the Central Document Room, Attn: Director,
Division of Orange Book Publication and Regulatory Assessment (DOBPRA),
Office of Generic Drug Policy, Center for Drug Evaluation and Research, Food
and Drug Administration, 5901-B Ammendale Rd., Beltsville, MD 20705-1266.
Comments received are publicly available to the extent allowable under the
Freedom of Information Act and FDA regulations.

v
1.0 INTRODUCTION

1.1 Content and Exclusion

The Orange Book is composed of four parts: (1) approved prescription drug
products with therapeutic equivalence evaluations; (2) approved over-the-
counter (OTC) drug products for those drugs that may not be marketed without
NDAs or ANDAs because they are not covered under existing OTC monographs; (3)
drug products with approval under Section 505 of the FD&C Act administered by
the Center for Biologics Evaluation and Research; and (4) a cumulative list
of approved products that have never been marketed, are for exportation, are
for military use, have been discontinued from marketing and we have not
determined that they were withdrawn from sale for safety or effectiveness
reasons, or have had their approvals withdrawn for other than safety or
effectiveness reasons subsequent to being discontinued from marketing. 1 This
publication also includes indices of prescription and OTC drug products by
proprietary name (brand name or trade name) or, if no proprietary name
exists, established name of the active ingredient and by applicant name,
which have been abbreviated for this publication. Established names for
active ingredients generally conform to compendial names or United States
Adopted Names (USAN) as described in 21 CFR 299.4(e). A list of uniform
terms is provided in Appendix C.

The Addendum contains patent and exclusivity information for the


Prescription, OTC, Discontinued Drug Product Lists, and for the Drug Products
with Approval under Section 505 of the FD&C Act Administered by the Center
for Biologics Evaluation and Research. The publication may include
additional information that the Agency deems appropriate to disseminate.

Prior to the 6th Edition, the publication had excluded OTC drug products
and drug products with approval under Section 505 of the FD&C Act
administered by the Center for Biologics Evaluation and Research. The Hatch-
Waxman Amendments required the Agency to begin publishing an up-to-date list
of all marketed drug products, OTC as well as prescription, that have been
approved for safety and effectiveness and for which NDAs are required.

Under the FD&C Act, some drug products are given tentative approvals. The
Agency will not include drug products with tentative approvals in the Orange
Book because a drug product that is granted tentative approval is not an
approved drug product. Tentative approval lists by month are available on
FDA’s website Drugs@FDA. When the tentative approval becomes a final
approval through a subsequent action letter to the applicant, the Agency will
list the drug product and the date of approval in the appropriate approved
drug product list. In addition, we note that Section 505(x) of the FD&C Act
affects the date of approval for certain drug products subject to scheduling
under the Controlled Substances Act. For these drug products subject to
scheduling, the Agency will list the drug product on FDA’s website Drugs@FDA
upon approval under section 505(c) of the FD&C Act, and will list the drug
product in the Orange Book upon the date of approval as determined under
Section 505(x).

1
Generally, newly approved products are added to the Active Section of the Orange Book (i.e.,
the Prescription Drug Product List or the Over-the-Counter Drug Product List), depending on the
dispensing requirements (prescription or OTC) or approval authority, unless the Division of
Orange Book Publication and Regulatory Assessment is otherwise notified before publication. See
Section 1.12.

vi
The Orange Book identifies the application holder of a drug product and
does not identify distributors or repackagers.

1.2 Therapeutic Equivalence-Related Terms

Pharmaceutical Equivalents. Pharmaceutical equivalents are drug products


in identical dosage forms and route(s) of administration that contain
identical amounts of the identical active drug ingredient, i.e., the same
salt or ester of the same therapeutic moiety, or, in the case of modified-
release dosage forms that require a reservoir or overage or such forms as
prefilled syringes where the residual volume may vary, that deliver identical
amounts of the active drug ingredient over the identical dosing period; do
not necessarily contain the same inactive ingredients; and meet the identical
compendial or other applicable standard of identity, strength, quality, and
purity, including potency and, where applicable, content uniformity,
disintegration times, and/or dissolution rates. 2 They may differ in
characteristics such as shape, scoring configuration, release mechanisms,
packaging, excipients (including colors, flavors, preservatives), expiration
date/time, and, within certain limits, labeling.

Pharmaceutical Alternatives. Pharmaceutical alternatives are drug


products that contain the identical therapeutic moiety, or its precursor, but
not necessarily in the same amount or dosage form, or the same salt or ester
(e.g., tetracycline hydrochloride, 250 mg capsules vs. tetracycline phosphate
complex, 250 mg capsules; quinidine sulfate, 200 mg tablets vs. quinidine
sulfate, 200 mg capsules). 3 Each such drug product individually meets either
the identical or its own respective compendial or other applicable standard
of identity, strength, quality, and purity, including potency and, where
applicable, content uniformity, disintegration times, and/or dissolution
rates. 4 Different dosage forms and strengths within a product line by a
single manufacturer are pharmaceutical alternatives, as are extended-release
products when compared with immediate-release or standard-release
formulations of the same active ingredient.

Therapeutic Equivalents. Approved drug products are considered to be


therapeutic equivalents if they are pharmaceutical equivalents for which
bioequivalence has been demonstrated, and they can be expected to have the
same clinical effect and safety profile when administered to patients under
the conditions specified in the labeling. 5

FDA classifies as therapeutically equivalent those drug products that meet


the following general criteria: (1) they are approved as safe and effective;
(2) they are pharmaceutical equivalents in that they (a) contain identical
amounts of the identical active drug ingredient in the identical dosage form
and route of administration, and (b) meet compendial or other applicable
standards of strength, quality, purity, and identity; (3) they are
bioequivalent in that (a) they do not present a known or potential
bioequivalence problem, and they meet an acceptable in vitro standard, or (b)
if they do present such a known or potential problem, they are shown to meet
an appropriate bioequivalence standard; (4) they are adequately labeled; and
(5) they are manufactured in compliance with Current Good Manufacturing
Practice regulations. The concept of therapeutic equivalence applies only to
drug products containing the identical active ingredient(s) and does not
encompass a comparison of different therapeutic agents used for the same

2
21 CFR 314.3(b).
3
See 21 CFR 314.3(b).
4
21 CFR 314.3(b).
5
21 CFR 314.3(b).
vii
condition (e.g., meperidine hydrochloride vs. morphine sulfate for the
treatment of pain). Any drug product in the Orange Book repackaged and/or
distributed by other than the applicant is considered to be therapeutically
equivalent to the applicant’s drug product even if the applicant’s drug
product is single source or coded as non-equivalent (e.g., BN). Distributors
or repackagers of an applicant’s drug product are not identified in the
Orange Book.

FDA considers drug products to be therapeutically equivalent if they meet


the criteria outlined above, even though they may differ in certain other
characteristics such as shape, scoring configuration, release mechanisms,
packaging, excipients (including colors, flavors, preservatives), expiration
date/time, certain aspects of labeling (e.g., the presence of specific
pharmacokinetic information), and storage conditions. When such differences
are important in the care of a particular patient, it may be appropriate for
the prescribing physician to require that a specific product be dispensed as
a medical necessity. With this limitation, however, FDA believes that
products classified as therapeutically equivalent can be substituted with the
full expectation that the substituted product can be expected to have the
same clinical effect and safety profile as the prescribed product when
administered to patients under the conditions specified in the labeling.

Strength. Strength refers to the amount of drug substance contained in,


delivered, or deliverable from a drug product, which includes: (1)(a) the
total quantity of drug substance in mass or units of activity in a dosage
unit or container closure (e.g., weight/unit dose, weight/volume or
weight/weight in a container closure, or units/volume or units/weight in a
container closure); and/or, as applicable, (b) the concentration of the drug
substance in mass or units of activity per unit volume or mass (e.g., weight/
weight, weight/volume, or units/volume); or (2) such other criteria the
Agency establishes for determining the amount of drug substance contained in,
delivered, or deliverable from a drug product if the weights and measures
described in clause (1)(a) do not apply (e.g., certain drug-device
combination products for which the amount of drug substance is emitted per
use or unit time). 6 Note that if the criteria the Agency establishes for
determining and expressing the amount of drug substance in a product evolves
over time, the Agency generally does not intend to revise the expressions of
strength for drug products already included in the Orange Book, but rather
intends to apply the criteria prospectively to drug products added to the
Orange Book.

Although the strength of drug products in the Orange Book is generally


expressed in terms of the amount of drug substance (active ingredient) in the
drug product, it is sometimes expressed in terms of the amount of the active
moiety. 7 For example, certain drug products included in the Orange Book
include a designation of “EQ” next to their expression of strength. This
“EQ” designation generally is used in connection with salt drug products to
indicate that the strength of such drug product is being expressed in terms
of the equivalent strength of the active moiety (e.g., “EQ 200 MG BASE”),
rather than in terms of the strength of the active ingredient.

Bioavailability. Bioavailability is the rate and extent to which the


active ingredient or active moiety is absorbed from a drug product and
becomes available at the site of drug action. For drug products that are not
intended to be absorbed into the bloodstream, bioavailability may be assessed

6
21 CFR 314.3(b).
7
Active moiety is the molecule or ion, excluding those appended portions of the molecule that
cause the drug to be an ester, salt (including a salt with hydrogen or coordination bonds), or
other noncovalent bonds (such as a complex, chelate, or clathrate) of the molecule, responsible
for the physiological or pharmacological action of the drug substance. 21 CFR 314.3(b).
viii
by scientifically valid measurements intended to reflect the rate and extent
to which the active ingredient or active moiety becomes available at the site
of drug action. 8

Bioequivalence. Bioequivalence is the absence of a significant difference


in the rate and extent to which the active ingredient or active moiety in
pharmaceutical equivalents or pharmaceutical alternatives becomes available
at the site of drug action when administered at the same molar dose under
similar conditions in an appropriately designed study. 9 Section 505(j)(8)(B)
of the FD&C Act describes certain conditions under which a test drug and
reference listed drug (RLD)(see Section 1.4) shall be considered
bioequivalent:

(i) the rate and extent of absorption of the [test] drug do not show a
significant difference from the rate and extent of absorption of
the [reference] listed drug when administered at the same molar
dose of the therapeutic ingredient under similar experimental
conditions in either a single dose or multiple doses; or

(ii) the extent of absorption of the [test] drug does not show a
significant difference from the extent of absorption of the
[reference] listed drug when administered at the same molar dose
of the therapeutic ingredient under similar experimental
conditions in either a single dose or multiple doses and the
difference from the [reference] listed drug in the rate of
absorption of the drug is intentional, is reflected in its
proposed labeling, is not essential to the attainment of
effective body drug concentrations on chronic use, and is
considered medically insignificant for the drug.

Where these above methods are not applicable (e.g., for drug products that
are not intended to be absorbed into the bloodstream), other scientifically
valid in vivo or in vitro test methods to demonstrate bioequivalence may be
appropriate.

For example, bioequivalence may sometimes be demonstrated using an in


vitro bioequivalence standard, especially when such an in vitro test has been
correlated with human in vivo bioavailability data. In other situations,
bioequivalence may sometimes be demonstrated through comparative clinical
trials or pharmacodynamic studies. 10

1.3 Further Guidance on Bioequivalence

FDA’s regulations and guidance documents provide additional information


regarding bioequivalence and bioavailability, including methodologies and
statistical criteria used to establish the bioequivalence of drug products. 11

8
21 CFR 314.3(b).
9
21 CFR 314.3(b).
10
21 CFR 320.24.
11
We note that prior to the 36th edition of the Orange Book, the Preface to the Orange Book
included a section entitled “Statistical Criteria for Bioequivalence.” Please see FDA’s
regulations and guidance documents for additional information regarding bioequivalence and
bioavailability. See generally 21 CFR part 320. See FDA Drugs guidance Web page at
https://www.fda.gov/drugs/guidance-compliance-regulatory-information/guidances-drugs and FDA
Drugs guidance (Product-Specific Guidances for Generic Drug Development) Web page at
https://www.fda.gov/drugs/guidances-drugs/product-specific-guidances-generic-drug-development.
ix
1.4 Reference Listed Drug and Reference Standard

A reference listed drug is the listed drug 12 identified by FDA as the drug
product upon which an applicant relies in seeking approval of its ANDA. 13
FDA’s general practice is to designate as RLDs drug products that have been
approved for safety and effectiveness under section 505(c) of the FD&C Act.
For an ANDA based on an approved suitability petition (a petitioned ANDA),
the reference listed drug generally is the listed drug referenced in the
approved suitability petition. 14

A reference standard is the drug product selected by FDA that an applicant


seeking approval of an ANDA must use in conducting an in vivo bioequivalence
study required for approval. 15 FDA generally selects a single reference
standard that ANDA applicants must use in in vivo bioequivalence testing.
Ordinarily, FDA will select the reference listed drug as the reference
standard. However, in some instances, the reference listed drug and the
reference standard may be different. For example, where the reference listed
drug has been withdrawn from sale for reasons other than safety or
effectiveness, FDA may select an ANDA that is therapeutically equivalent to
this reference listed drug as the reference standard.

FDA identifies reference listed drugs in the Prescription Drug Product,


OTC Drug Product, and Discontinued Drug Product Lists. Listed drugs
identified as reference listed drugs represent drug products upon which an
applicant can rely in seeking approval of an ANDA. FDA intends to update
periodically the reference listed drugs identified in the Prescription Drug
Product, OTC Drug Product, and Discontinued Drug Product Lists, as
appropriate.

If FDA has not designated a reference listed drug for a drug product the
applicant intends to duplicate, the potential applicant may submit a
controlled correspondence to the Office of Generic Drugs to ask FDA to
designate a reference listed drug for that drug product. Section 1.7,
Therapeutic Equivalence Evaluations Codes (products meeting necessary
bioequivalence requirements) explains the character coding system (e.g., AB,
AB1, AB2, AB3...) for multisource prescription drug products listed under the
same heading with two or more reference listed drugs.

FDA also identifies reference standards in the Prescription Drug Product


and OTC Drug Product Lists. Listed drugs identified as reference standards
represent FDA’s best judgment at this time as to the appropriate comparator
for purposes of conducting any in vivo bioequivalence studies required for
approval.

A potential applicant should consult Agency guidance related to


referencing approved drug products in ANDA submissions for information on
submitting a request for selection of a reference standard. FDA may, on its
own initiative, select a new reference standard when doing so will help to
ensure that applications for generic drugs may be submitted and evaluated,
e.g., in the event that the listed drug currently selected as the reference
standard has been withdrawn from sale.

12
A “listed drug” is a new drug product that has been approved under section 505(c) of the FD&C
Act for safety and effectiveness or under section 505(j) of the FD&C Act, which has not been
withdrawn or suspended under section 505(e)(1) through (5) or section 505(j)(6) of the FD&C Act,
and which has not been withdrawn from sale for what FDA has determined are reasons of safety or
effectiveness. Listed drug status is evidenced by the drug product's identification in the
current edition of FDA’s “Approved Drug Products With Therapeutic Equivalence Evaluations” (the
list) as an approved drug. A drug product is deemed to be a listed drug on the date of approval
for the NDA or ANDA for that drug product (21 CFR 314.3(b)).
13
21 CFR 314.3(b).
14
21 CFR 314.94(a)(3)(i).
15
21 CFR 314.3(b).
x
If an applicant has a question related to the appropriate reference
standard, it is recommended that an applicant planning to conduct an in vivo
bioequivalence study submit a controlled correspondence to the Office of
Generic Drugs.

1.5 General Policies and Legal Status

The Orange Book contains public information and advice. It does not
mandate the drug products that are purchased, prescribed, dispensed, or
substituted for one another, nor does it, conversely, mandate the products
that should be avoided. To the extent that the Orange Book sets forth FDA's
evaluations of the therapeutic equivalence of drug products that have been
approved, it contains FDA's advice to the public, to practitioners, and to
the states regarding drug product selection. These evaluations do not
constitute determinations that any product is in violation of the FD&C Act or
that any product is preferable to any other. Therapeutic equivalence
evaluations are a scientific judgment based upon evidence, while generic
substitution may involve social and economic policy administered by the
states, e.g., reducing the cost of drugs to consumers. To the extent that
the Orange Book identifies drug products approved under Section 505 of the
FD&C Act, it sets forth information that the Agency is required to publish
and that the public is entitled to under the Freedom of Information Act.
Exclusion of a drug product from the Orange Book does not necessarily mean
that the drug product is in violation of Section 505 of the FD&C Act, that
such a product is not safe or effective, or that such a product is not
therapeutically equivalent to other drug products. Rather, the exclusion may
be based on the fact that FDA has not evaluated the safety, effectiveness,
and quality of the drug product.

1.6 Practitioner/User Responsibilities

Professional care and judgment should be exercised in using the Orange


Book. Evaluations of therapeutic equivalence for prescription drugs are based
on scientific and medical evaluations by FDA. Products evaluated as
therapeutically equivalent can be expected, in the judgment of FDA, to have
the same clinical effect and safety profile when administered to patients
under the conditions specified in the labeling. However, these products may
differ in other characteristics that are not required by statute or
regulation to be the same, such as shape, scoring configuration, release
mechanisms, packaging, excipients (including colors, flavors, preservatives),
expiration date/time, and, in some instances, labeling. If products with
such differences are substituted for each other, there is a potential for
patient confusion, e.g., due to differences in color or shape of tablets,
inability to provide a given dose using a partial tablet if the proper
scoring configuration is not available, or decreased patient acceptance of
certain products because of flavor. There may also be patient-specific
allergic reactions in rare cases due to a coloring or a preservative
ingredient.

FDA evaluation of therapeutic equivalence in no way relieves practitioners


of their professional responsibilities in prescribing and dispensing such
products with due care and with appropriate information to individual
patients. In those circumstances where the characteristics of a specific
product, other than its active ingredient, are important in the therapy of a
particular patient, the practitioner's prescribing of that product may be
appropriate. Pharmacists must also be familiar with the different
characteristics of therapeutically equivalent products, e.g., expiration
dates/times and labeling directions for storage of the different products
xi
(particularly for reconstituted products), so they can properly advise
patients when one product is substituted for another.

Multisource and single-source drug products. In the Orange Book, FDA has
evaluated for therapeutic equivalence only multisource prescription drug
products approved under Section 505 of the FD&C Act, which in most instances
means those pharmaceutical equivalents available (i.e., not on the
Discontinued Drug Product list) from more than one manufacturer. For such
products, a therapeutic equivalence code generally is included and product
information is highlighted in bold face and underlined. Those products with
approved applications that are single source (i.e., there is only one
approved product available for that active ingredient, dosage form, route of
administration, and strength) are also included in the Orange Book, but no
therapeutic equivalence code is included with such products. Any drug
product in the Orange Book repackaged and/or distributed by the applicant or
some other person authorized by the applicant (e.g., an authorized generic)
is considered to be therapeutically equivalent to the applicant’s drug
product even if the applicant’s drug product is single source or coded as
non-equivalent (e.g., BN). Distributors or repackagers of an applicant’s
drug product are not identified in the Orange Book. The details of
therapeutic equivalence codes and the policies underlying them are discussed
in Section 1.7, Therapeutic Equivalence Evaluations Codes.

Products in the Orange Book are identified by the names of the holders of
approved applications (applicants) who may not necessarily be the
manufacturer of the product. There are numerous entities other than the
applicant that may be involved in the development, manufacturing, and/or
marketing of a product. Products listed in the Orange Book are identified by
the applicant’s name (firm name on the Form FDA 356h in the
application). Where the applicant’s name does not appear on the label, a
person wishing to relate a specific product to the applicant name in the
Orange Book may refer to FDA’s NDC Directory 16 and match its search terms to
information on the label, such as the NDC Code if available.

Every product in the Orange Book is subject at all times to regulatory


action. From time to time, approved products may be found in violation of one
or more provisions of the FD&C Act. In such circumstances, the Agency may
commence appropriate enforcement action to correct the violation, if
necessary, by securing removal of the product from the market by voluntary
recall, seizure, or other enforcement actions. Such regulatory actions are,
however, independent of the inclusion of a product in the Orange Book. The
main criterion for inclusion of a product is that it has an NDA or ANDA that
has been approved and that has not been withdrawn for safety or effectiveness
reasons. FDA believes that retention of a violative product in the Orange
Book will not have any significant adverse health consequences, because other
legal mechanisms are available to the Agency to prevent the product's actual
marketing. FDA may, however, change a product's therapeutic equivalence
rating if the circumstances giving rise to the violation change or otherwise
call into question the Agency's assessment of whether a product meets the
criteria for therapeutic equivalence.

1.7 Therapeutic Equivalence Evaluations Codes

Generally, prescription drug products that the Agency considers


multisource have been assigned a therapeutic equivalence code. The coding
system for therapeutic equivalence evaluations is designed to allow users to
determine quickly whether the Agency has evaluated a particular approved

16 https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory.
xii
prescription drug product (e.g., a particular strength of an approved drug
that is not on the Discontinued Drug Product list) as therapeutically
equivalent to other pharmaceutically equivalent prescription drug products
(first letter) and to provide additional information on the basis of FDA's
evaluations (second letter). With some exceptions (e.g., therapeutic
equivalence evaluations for certain 505(b)(2) applications), the therapeutic
equivalence evaluation date is the same as the approval date.

The two basic categories into which multisource drugs have been placed are
indicated by the first letter of the relevant therapeutic equivalence code as
follows:

A Drug products that FDA considers to be therapeutically equivalent to


other pharmaceutically equivalent products, i.e., drug products for which:

(1) there are no known or suspected bioequivalence problems. These are


designated AA, AN, AO, AP, or AT, depending on the dosage form; or

(2) actual or potential bioequivalence problems have been resolved with


adequate in vivo and/or in vitro evidence supporting
bioequivalence. These are designated AB.

B Drug products that FDA at this time, considers not to be


therapeutically equivalent to other pharmaceutically equivalent products,
i.e.,

drug products for which actual or potential bioequivalence problems


have not been resolved by adequate evidence of bioequivalence. Often
the problem is with specific dosage forms rather than with the active
ingredients. These are designated BC, BD, BE, BN, BP, BR, BS, BT, BX,
or B*.

Individual drug products have been evaluated as therapeutically equivalent


to the reference product in accordance with the definitions and policies
outlined below:

"A" CODES
Drug products that are considered to be therapeutically equivalent to other pharmaceutically
equivalent products.

"A" products are those for which there are no known or suspected
bioequivalence problems or for which actual or potential bioequivalence
problems have been resolved with adequate in vivo and/or in vitro evidence
supporting bioequivalence. Drug products designated with an "A" code fall
under one of two main policies:

(1) for those active ingredients or dosage forms for which no in vivo
bioequivalence issue is known or suspected, the information necessary to
show bioequivalence between pharmaceutically equivalent products is
either presumed and considered self-evident (based on other information
in the application for some dosage forms (e.g., solutions)), or satisfied
by a showing that an acceptable in vitro approach is met. A
therapeutically equivalent rating is assigned such products so long as
they are manufactured in accordance with Current Good Manufacturing
Practice regulations and meet the other requirements of their approved
applications (these are designated AA, AN, AO, AP, or AT, depending on
the dosage form, as described below); or

xiii
(2) for those Drug Efficacy Study Implementation (DESI) drug products
containing active ingredients or dosage forms that have been identified
by FDA as having actual or potential bioequivalence problems, and for
post-1962 drug products presenting a potential bioequivalence problem,
an evaluation of therapeutic equivalence is assigned to pharmaceutical
equivalents only if the approved application contains adequate
scientific evidence establishing through in vivo and/or in vitro studies
the bioequivalence of the product to a selected reference product (these
products are designated as AB).

There are some general principles that may affect the substitution of
pharmaceutically equivalent products in specific cases. Prescribers and
dispensers of drugs should be alert to these principles so as to deal
appropriately with situations that require professional judgment and
discretion.

There may be labeling differences among pharmaceutically equivalent


products that require attention on the part of the health professional (e.g.,
pharmaceutically equivalent powders to be reconstituted for administration as
oral or injectable liquids may vary with respect to their expiration time or
storage conditions after reconstitution). FDA’s determination that such
products are therapeutically equivalent is applicable only when each product
is reconstituted, stored, and used under the conditions specified in its
labeling.

The Agency may use notes in this publication to point out special
situations, such as potential differences between two drug products that have
been evaluated as bioequivalent and otherwise therapeutically equivalent,
when they should be brought to the attention of health professionals. These
notes are contained in Section 1.8, Description of Certain Special
Situations. For example, in certain instances, there may be variations among
therapeutically equivalent products in their use or in conditions of
administration. When such variations may, in the Agency's opinion, affect
prescribing or substitution decisions by health professionals, a note may be
added to Section 1.8.

For example, occasionally a situation may arise in which changes in a


listed drug product after its approval (for example, a change in dosing
interval) may have an impact on the substitutability of already approved
generic versions of that product that were rated by the Agency as
therapeutically equivalent to the listed product. When such changes in the
listed drug product are considered by the Agency to have a significant impact
on therapeutic equivalence, the Agency will change the therapeutic
equivalence ratings for other versions of the drug product unless the
manufacturers of those other versions of the product provide additional
information to assure equivalence under the changed conditions. Pending
receipt of the additional data, the Agency may add a note to Section 1.8, or,
in rare cases, may even change the therapeutic equivalence rating.

In some cases (e.g., Isolyte® S w/ Dextrose 5% in Plastic Container and


Plasma-Lyte® 148 and Dextrose 5% in Plastic Container), closely related
products are listed as containing the same active ingredients, but in
somewhat different amounts. In determining which of these products are
pharmaceutically equivalent, generally the Agency has considered products to
be pharmaceutically equivalent with labeled strengths of an ingredient that
do not vary by more than 1%.

Different salts, esters or other noncovalent derivatives (such as a


complex, chelate, or clathrate) of the same active moiety are regarded as
different active ingredients. For the purpose of this publication, products
containing such different active ingredients are considered pharmaceutical
xiv
alternatives and, thus, not therapeutically equivalent. Anhydrous and
hydrated entities, as well as different polymorphs, are considered to be the
same active ingredient and are expected to meet the same standards for
identity to be considered pharmaceutical equivalents and therapeutic
equivalents.

The codes in this book are not intended to preclude health care
professionals from converting pharmaceutically different concentrations into
pharmaceutical equivalents using accepted professional practice.

Where package size variations have therapeutic implications, products so


packaged have not been considered pharmaceutically equivalent. For example,
some oral contraceptives are supplied in 21-tablet and 28-tablet packets; the
28-tablet packets contain 7 placebo or iron tablets. These two packaging
configurations are not regarded as pharmaceutically equivalent; thus, they
are not designated as therapeutically equivalent.

Preservatives and other inactive ingredients may differ among some


therapeutically equivalent drug products. These differences do not affect
FDA's evaluation of therapeutic equivalence except in cases where these
components may influence bioequivalence or routes of administration.

The specific sub-codes for those drugs evaluated as therapeutically


equivalent and the policies underlying these sub-codes follow:

AA Products in conventional dosage forms not presenting bioequivalence problems

Multisource drug products coded as AA contain active ingredients and are


in dosage forms that are not regarded as presenting either actual or
potential bioequivalence problems or drug quality or standards issues.
However, all oral dosage forms must, nonetheless, meet an appropriate in
vitro bioequivalence standard that is acceptable to the Agency in order to
be approved.

AB, AB1, AB2, AB3... Products meeting necessary bioequivalence requirements

Multisource drug products listed under the same heading (i.e., identical
active ingredients(s), dosage form, and route(s) of administration) and
having the same strength (see Section 1.2, Therapeutic Equivalence-Related
Terms, Strength) generally will be coded AB if data and information are
submitted demonstrating bioequivalence.

In certain instances, a number is added to the end of the AB code to make


a three character code (i.e., AB1, AB2, AB3, etc.). Three-character codes
generally are assigned only in situations when more than one reference
listed drug of the same strength has been designated under the same
heading. If a study is submitted that demonstrates bioequivalence to a
reference listed drug product, the generic product will be given the same
three-character code as the reference listed drug it was compared against.
For example, Adalat® CC and Procardia XL®, extended-release tablets, are
listed under the active ingredient nifedipine. These drug products, listed
under the same heading, are not bioequivalent to each other. Adalat® CC
and Procardia XL® have been assigned ratings of AB1 and AB2, respectively.
Generic drug products deemed by FDA to be bioequivalent to Adalat® CC and
Procardia XL® have been approved. As a result, the generic drug products
bioequivalent to Adalat® CC have been assigned a rating of AB1 and those
bioequivalent to Procardia XL® have been assigned a rating of AB2. (The
assignment of an AB1 or AB2 rating to a specific product does not imply
product preference.) Even though drug products of distributors and/or
repackagers are not included in the Orange Book, they are considered
xv
therapeutically equivalent to the applicant’s drug product if the
applicant’s drug product is rated either with an AB or three-character
code or is single source in the Orange Book. Drugs coded as AB under a
heading are considered therapeutically equivalent only to other drugs
coded as AB under that heading. Drugs coded with a three-character code
under a heading are considered therapeutically equivalent only to other
drugs coded with the same three-character code under that heading.

AN Solutions and powders for aerosolization

Uncertainty regarding the therapeutic equivalence of aerosolized products


arises primarily because of differences in the drug delivery system.
Solutions and powders intended for aerosolization that are marketed for
use in general-use delivery systems are considered to be pharmaceutically
and therapeutically equivalent and are coded AN. Those products that are
compatible only with a specific delivery system or those products that are
packaged in and with a specific delivery system are coded BN, unless they
have met an appropriate bioequivalence standard and are otherwise
determined to be therapeutically equivalent. Solutions or suspensions in
a specific delivery system will be coded AN if the bioequivalence standard
is based upon in vitro methodology. If bioequivalence needs to be
demonstrated by in vivo methodology, then the drug products will be coded
AB.

AO Injectable oil solutions

The absorption of drugs in injectable (parenteral) oil solutions may vary


substantially with the type of oil employed as a vehicle and the
concentration of the active ingredient. Injectable oil solutions are
therefore considered to be pharmaceutically and therapeutically equivalent
only when the active ingredient, its concentration, and the type of oil
used as a vehicle are all identical.

AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous


solutions

It should be noted that even though injectable (parenteral) products under


a specific listing may be evaluated as therapeutically equivalent, there
may be important differences among the products in the general category,
Injectable; Injection. For example, historically some injectable products
that are rated therapeutically equivalent are labeled for different routes
of administration. In addition, some products evaluated as
therapeutically equivalent may have different preservatives or no
preservatives at all. Injectable products available as dry powders for
reconstitution, concentrated sterile solutions for dilution, or sterile
solutions ready for injection are pharmaceutical alternative drug
products. They are not rated as therapeutically equivalent (AP) to each
other even if these pharmaceutical alternative drug products are designed
to produce the same concentration prior to injection and are similarly
labeled. Consistent with accepted professional practice, it is the
responsibility of the prescriber, dispenser, or individual administering
the product to be familiar with a product's labeling to assure that it is
given only by the route(s) of administration stated in the labeling.

Certain commonly used large volume intravenous products in glass


containers are not included in the Orange Book (e.g., dextrose injection
5%, dextrose injection 10%, sodium chloride injection 0.9%) since these

xvi
products are on the market without FDA approval and FDA has not published
conditions for marketing such parenteral products under approved NDAs.
When packaged in plastic containers, however, FDA regulations require
approved applications prior to marketing. Approval then depends on, among
other things, the extent of the available safety data involving the
specific plastic component of the product. All large volume parenteral
products are manufactured under similar standards, regardless of whether
they are packaged in glass or plastic. Thus, FDA has no reason to believe
that the packaging container of large volume parenteral drug products that
are pharmaceutically equivalent would have any effect on their therapeutic
equivalence.

Consistent with the definition of strength included in Section 1.2,


Therapeutic Equivalence-Related Terms, the strength of parenteral drug
products generally is identified by both the total drug content and the
concentration of drug substance in a container approved by FDA. 17 In the
past, the strength of liquid parenteral drug products in the Orange Book
has not been fully displayed. Rather, the strength of liquid parenteral
drug products in the Orange Book has been displayed in terms of
concentration, expressed as x mg/mL. Generally, the amount of dry powder
or lyophilized powder in a container is identified as the strength,
expressed as x mg/vial.

However, FDA subsequently realized that the format of the Orange Book with
respect to parenteral solutions should be changed to reflect that each
strength of a drug is considered to be a separate listed drug. The Orange
Book generally displays the strength of new approvals of parenteral
solutions. Previously (i.e., prior to 2003), we would have displayed only
the concentration of an approved parenteral solution, e.g. 1 mg/mL. For
example, if this application had a 125 mL and 250 mL container approved,
we would now display two product strengths, listing both total drug
content and concentration of drug substance in the relevant approved
container, e.g. 125 mg/125 mL (1 mg/mL) and 250 mg/250 mL (1 mg/mL).

AT Topical products

There are a variety of topical dosage forms available for dermatologic,


ophthalmic, otic, rectal, and vaginal administration, including creams,
gels, lotions, oils, ointments, pastes, solutions, sprays, suppositories,
and inserts. Even though different topical dosage forms may contain the
same active ingredient and potency, these dosage forms are not considered
pharmaceutically equivalent. Therefore, they are not considered
therapeutically equivalent. All solutions and DESI drug products
containing the same active ingredient in the same topical dosage form for
which a waiver of in vivo bioequivalence has been granted, or the
application contains adequate scientific evidence establishing through an
in vitro approach the bioequivalence of the product to a selected
reference product, and for which chemistry and manufacturing processes are
adequate to demonstrate bioequivalence, are considered therapeutically
equivalent and coded AT. Pharmaceutically equivalent topical products
that raise questions of bioequivalence and for which a waiver of in vivo
bioequivalence has not been granted, including all post-1962 non-solution
topical drug products, are coded AB when supported by adequate in vivo
bioequivalence data, and BT in the absence of such data.

17
The strengths of certain parenteral drug products, including contrast agents, may be expressed
as a percentage.
xvii
"B" CODES

Drug products that FDA, at this time, considers not to be therapeutically equivalent to other
pharmaceutically equivalent products.

"B" products, for which actual or potential bioequivalence problems have


not been resolved by adequate evidence of bioequivalence, often have a
problem with specific dosage forms rather than with the active ingredients.
Drug products designated with a "B" code fall under one of three main
policies:

(1) the drug products contain active ingredients or are manufactured in


dosage forms that have been identified by the Agency as having
documented bioequivalence problems or a significant potential for
such problems and for which no adequate studies demonstrating
bioequivalence have been submitted to FDA; or

(2) the quality standards are inadequate or FDA has an insufficient basis
to determine therapeutic equivalence; or

(3) the drug products are under regulatory review.

The specific coding definitions and policies for the "B" sub-codes are as
follows:

B* Drug products requiring further FDA investigation and review to determine therapeutic
equivalence

The code B* is assigned to products previously assigned an A or B code


when FDA receives new information that raises a significant question
regarding therapeutic equivalence that can be resolved only through
further Agency investigation and/or review of data and information
submitted by the applicant. The B* code signifies that the Agency will
take no position regarding the therapeutic equivalence of the product
until the Agency completes its investigation and review.

BC Extended-release dosage forms (capsules, injectables and tablets)

Extended-release tablets are formulated in such a manner as to make the


contained drug substance available over an extended period of time
following ingestion.

Although bioavailability studies have been conducted on these dosage


forms, they may be subject to bioavailability differences, primarily
because applicants developing extended-release products for the same
active ingredient rarely employ the same formulation approach. FDA,
therefore, does not consider different extended-release dosage forms
containing the same active ingredient in equal strength to be
therapeutically equivalent unless equivalence between individual products
in both rate and extent has been specifically demonstrated through
appropriate bioequivalence studies. Extended-release products for which
such bioequivalence data have not been submitted are coded BC, while those
for which such data are available have been coded AB.

BD Active ingredients and dosage forms with documented bioequivalence problems

The BD code denotes products containing active ingredients with known


bioequivalence problems and for which adequate studies have not been
xviii
submitted to FDA demonstrating bioequivalence. Where studies showing
bioequivalence have been submitted, the product has been coded AB.

BE Delayed-release oral dosage forms

Where the drug may be destroyed or inactivated by the gastric juice or


where it may irritate the gastric mucosa, the use of “enteric” coatings is
indicated. Such coatings are intended to delay the release of the
medication until the tablet has passed through the stomach. Drug products
in delayed-release dosage forms containing the same active ingredients are
subject to significant differences in absorption. Unless otherwise
specifically noted, the Agency considers different delayed-release
products containing the same active ingredients as presenting a potential
bioequivalence problem and codes these products BE in the absence of
in vivo studies showing bioequivalence. If adequate in vivo studies have
demonstrated the bioequivalence of specific delayed-release products, such
products are coded AB.

BN Products in aerosol-nebulizer drug delivery systems

This code applies to drug solutions or powders that are marketed only as a
component of, or as compatible with, a specific drug delivery system.
There may, for example, be significant differences in the dose of drug and
particle size delivered by different products of this type. Therefore,
the Agency does not consider different metered aerosol dosage forms
containing the same active ingredient(s) in equal strengths to be
therapeutically equivalent unless the drug products meet an appropriate
bioequivalence standard; such products are coded AB.

BP Active ingredients and dosage forms with potential bioequivalence problems

FDA's bioequivalence regulations (21 CFR 320.33) contain criteria and


procedures for determining whether a specific active ingredient in a
specific dosage form has a potential for causing a bioequivalence problem.
It is FDA's policy to consider an ingredient meeting these criteria as
having a potential bioequivalence problem even in the absence of positive
data demonstrating inequivalence. Pharmaceutically equivalent products
containing these ingredients in oral dosage forms are coded BP until
adequate bioequivalence data are submitted, after which such products are
coded AB. Injectable suspensions containing an active ingredient
suspended in an aqueous or oleaginous vehicle have also been coded BP.
Injectable suspensions are subject to bioequivalence problems because
differences in particle size, polymorphic structure of the suspended
active ingredient, or the suspension formulation can significantly affect
the rate of release and absorption. FDA does not consider pharmaceutical
equivalents of these products bioequivalent without adequate evidence of
bioequivalence; such products would be coded AB.

BR Suppositories or enemas that deliver drugs for systemic absorption

The absorption of active ingredients from suppositories or enemas that are


intended to have a systemic effect (as distinct from suppositories
administered for local effect) can vary significantly from product to
product. Therefore, FDA considers pharmaceutically equivalent systemic
suppositories or enemas bioequivalent only if in vivo evidence of
bioequivalence is available. In those cases where in vivo evidence is

xix
available, the products are coded AB. If such evidence is not available,
the products are coded BR.

BS Products having drug standard deficiencies

If the drug standards for an active ingredient in a particular dosage form


are found by FDA to be deficient so as to prevent an FDA evaluation of
either pharmaceutical or therapeutic equivalence, all drug products
containing that active ingredient in that dosage form are coded BS. For
example, if the standards permit a wide variation in pharmacologically
active components of the active ingredient such that pharmaceutical
equivalence is in question, all products containing that active ingredient
in that dosage form are coded BS.

BT Topical products with bioequivalence issues

This code applies mainly to post-1962 dermatologic, ophthalmic, otic,


rectal, and vaginal products for topical administration, including creams,
gels, lotions, oils, ointments, pastes, solutions, sprays, suppositories,
and inserts not intended for systemic drug absorption. Topical products
evaluated as having acceptable clinical performance, but that are not
bioequivalent to other pharmaceutically equivalent products or that lack
sufficient evidence of bioequivalence, will be coded BT.

BX Drug products for which the data are insufficient to determine therapeutic equivalence

The code BX is assigned to specific drug products for which the data that
have been reviewed by the Agency are insufficient to determine therapeutic
equivalence under the policies stated in this document. In these
situations, the drug products are presumed to be therapeutically
inequivalent until the Agency has determined that there is adequate
information to make a full evaluation of therapeutic equivalence.

1.8 Description of Certain Special Situations

Certain drugs listed in the Orange Book present special situations that
merit further discussion. The following are descriptions of certain examples
of those special situations:

Amino Acid and Protein Hydrolysate Injections. These products differ in


the amount and kinds of amino acids they contain and, therefore, are not
considered pharmaceutical equivalents. For this reason, these products are
not considered therapeutically equivalent. At the same time, the Agency
believes that it is appropriate to point out that where nitrogen balance is
the sole therapeutic objective and individual amino acid content is not a
consideration, pharmaceutical alternatives with the same total amount of
nitrogen content may be expected to have the same clinical effect and safety
profile when administered to patients under the conditions specified in the
labeling.

Gaviscon®. Gaviscon® is an OTC product that has been marketed since


September 1970. The active ingredients in this product, aluminum hydroxide
and magnesium trisilicate, were reviewed by the Agency's OTC Antacid Panel
and were considered to be safe and effective ingredients (Category I) by that
Panel. However, the tablet failed to pass the antacid test that is required
of all antacid products. The Agency, therefore, placed the tablet in
Category III for lack of effectiveness. A full NDA with clinical studies was
xx
submitted by Marion Laboratories, Inc., and approved by FDA on December 9,
1983. Gaviscon®’s activity in treating reflux acidity is made possible by
the physical-chemical properties of the inactive ingredients, sodium
bicarbonate and alginic acid. Therefore, all ANDAs that cite Gaviscon®
tablets as the reference listed drug must contain the inactive ingredients
sodium bicarbonate and alginic acid. A full NDA will be required to support
the effectiveness of the drug product if different inactive ingredients are
to be substituted for sodium bicarbonate or alginic acid or if different
proportions of these ingredients are to be used.

Levothyroxine Sodium. 18 Because there are multiple reference listed drugs


for levothyroxine sodium tablets and some reference listed drugs' sponsors
have conducted studies to establish their drugs' therapeutic equivalence to
other reference listed drugs, FDA has determined that its usual practice of
assigning two or three character therapeutic equivalence codes may be
potentially confusing and inadequate for these drug products. Looking at the
Orange Book listing alone for a product identified as a reference listed drug
or reference standard, it may be difficult to determine to which therapeutic
equivalence code the reference listed drugs and/or reference standard
designation corresponds. For example, Unithroid 0.3 mg strength has been
assigned the therapeutic equivalence codes AB1, AB2, and AB3 and it is
identified as the reference listed drug and reference standard, but it is
unclear that the reference listed drug and reference standard designations
are associated with the AB1 therapeutic equivalence code.

Accordingly, FDA provides the following chart, which identifies (1) a


reference listed drug for each therapeutic equivalence code in the Orange
Book and (2) and the reference standard products in the Active Section of the
Orange Book. 19

• Therapeutic equivalence has been established between products that have


the same AB+number therapeutic equivalence code (i.e. AB1, AB2, AB3 or
AB4).

• More than one therapeutic equivalence code may apply to some products.
One common therapeutic equivalence code indicates therapeutic
equivalence between products. For example, Unithroid has been assigned
therapeutic equivalence codes AB1, AB2, and AB3, and therefore,
Unithroid tablets are considered therapeutically equivalent to other
levothyroxine sodium products of the same strength with these
therapeutic equivalence codes.

Appl
TE Code Proprietary Name Applicant Strength RLD RS
No
AB1 UNITHROID STEVENS J 0.3 MG N021210 RLD RS

AB2 SYNTHROID ABBVIE 0.3 MG N021402 RLD RS

18
In previous editions of the Orange Book, FDA provided a chart outlining therapeutic equivalence
codes for all 0.025 mg levothyroxine sodium drug products in the Active Section of the Orange
Book. FDA has decided, for ease of review, to revise the chart to identify the NDAs for the
reference listed drugs for each therapeutic equivalence code (i.e., AB1, AB2, AB3, and AB4), and
their corresponding reference standards, which are identified in 0.2 and 0.3 mg strengths.
19
The chart is current as of the date of publication of the annual edition. See the most current
monthly cumulative supplement for updates to this information available at
https://www.fda.gov/media/72973/download. Please consult the Active Section for information on
other strengths.

xxi
AB3 LEVOXYL KING PHARMS 0.2 MG N021301 RLD RS

AB4 THYRO-TABS ALVOGEN INC 0.3 MG N021116 RLD −

LEVOTHYROXINE
AB4 MYLAN 0.3 MG A076187 − RS
SODIUM 20

Patent Certification(s) and Reference Standard for ANDAs Duplicating a


Drug Product Approved in a Petitioned ANDA. To submit an ANDA for a generic
drug that is not the same as its reference listed drug because it has one
different active ingredient in a fixed-combination drug product, or has a
different route of administration, dosage form, or strength than that of the
reference listed drug, an applicant first must obtain permission from FDA
through what is known as a suitability petition pursuant to Section
505(j)(2)(C) of the FD&C Act. A petitioned ANDA relies on the reference
listed drug described in the suitability petition. An ANDA seeking approval
of a drug that is the same as a drug product approved in a petitioned ANDA
should use as its reference listed drug, the reference listed drug that
served as the basis for the approved suitability petition, and use the drug
product approved in the petitioned ANDA as its reference standard for
conducting an in vivo bioequivalence study required for approval. However,
the reference listed drug for any such ANDA is generally the listed drug
referenced in the approved suitability petition. The ANDA must include
appropriate patent certification(s) and an exclusivity statement with respect
to the reference listed drug that served as the basis for the approved
suitability petition. 21 (This concept also generally applies to an ANDA
applicant that utilizes a reference standard that is not a reference listed
drug, as such an application must include appropriate patent certification(s)
and an exclusivity statement with respect to the reference listed drug.)

Waived exclusivity. If an NDA submitted under Section 505(b) of the FD&C


Act qualifies for exclusivity under the FD&C Act, the exclusivity is
generally listed in the Patent and Exclusivity Section of the Orange Book.
If a drug product has received this exclusivity, FDA will not accept for
review and/or will not approve, as applicable, other applications blocked by
the relevant exclusivity. If the listed drug is also protected by one or more
patents, the approval date for an ANDA or 505(b)(2) application that relies
on the listed drug will be determined based on an analysis of the applicant’s
patent certification(s) or statement(s) for each relevant patent and the
effect of relevant exclusivity listed in the Orange Book. However, the

20
Alvogen, Inc’s tablets (NDA 021116) (previously known as Levothroid) previously was listed in
the Discontinued Drug Product List section of the Orange Book. It is the RLD for therapeutic
equivalents identified with the AB4 code. During this time, Mylan’s levothyroxine product (ANDA
076187) was selected as the reference standard for ANDA applicants to use to establish
bioequivalence to Thyro-Tabs. It remains the reference standard for ANDA applicants to use to
establish bioequivalence to Thyro-Tabs. If an ANDA that uses Mylan’s levothyroxine product as
its reference standard is approved, the ANDA will receive an AB4 rating. The ANDA applicant also
may obtain an AB rating for its product to the other reference listed drugs (i.e., Unithroid,
Synthroid, and Levoxyl) by submitting supplements that demonstrate that the generic product is
bioequivalent to these other reference listed drugs and satisfies all other therapeutic
equivalence criteria with respect to these reference listed drugs. See Letter from Janet
Woodcock, M.D., Director, Center for Drug Evaluation and Research, FDA to Teri Nataline,
Principal Consultant, Lachman Consultant Services, Inc., Docket No. FDA-2015-P-0403 (May 27,
2016).
21
If after approval of a suitability petition and before approval of an ANDA submitted pursuant
to the approved petition, a drug product is approved in an NDA for the change described in the
petition, the suitability petition and the listed drug identified in the petition can no longer
be the basis of submission for such ANDA. Under these circumstances, an applicant seeking
approval for a drug product with the change approved in the suitability petition must submit a
new ANDA that identifies the drug product approved under such NDA as the RLD and comply with
applicable regulatory requirements. See 21 CFR 314.93(f)(2).
xxii
holder of the NDA may waive its exclusivity as to any or all applications
that might otherwise be blocked by such exclusivity. If an NDA holder waives
its exclusivity, qualified applications may be accepted for review and/or
approved, as applicable. An NDA for which the holder has waived its
exclusivity as to all applications will be coded with a “W” in the Patent and
Exclusivity Section of the Orange Book. The applicant whose product might
otherwise be blocked by this exclusivity should indicate in the exclusivity
statement in its application that the holder of the listed drug has waived
its exclusivity.

1.9 Therapeutic Equivalence Code Change for a Category of Multisource Drug Products

The Agency will use the following procedures when, in response to a


petition or on its own initiative, it is considering a change in the
therapeutic equivalence code for approved multisource drug products. Such
changes will generally occur when the Agency becomes aware of new scientific
information affecting the therapeutic equivalence of an entire category of
multisource drug products in the Orange Book (e.g., information concerning
the active ingredient or the dosage form), rather than information concerning
a single drug product within the category. These procedures will be used
when a change in therapeutic equivalence code is under consideration for all
drug products found in the Prescription Drug Product List under a specific
active ingredient and dosage form. The change may be from the code
signifying that the drug does not present a bioequivalence problem (e.g., AA)
to a code signifying an actual or potential bioequivalence problem (e.g.,
BP), or vice versa. This procedure does not apply to a change of a
particular product code (e.g., a change from BP to AB or from AB to BX).

Before making a change in a therapeutic equivalence code for an entire


category of multisource drug products as described above, the Agency will
announce in the Introduction to the Cumulative Supplement that it is
considering the change and will invite comments. Comments, along with
scientific data, may be sent to the Director, Office of Bioequivalence,
Office of Generic Drugs, Center for Drug Evaluation and Research, Food and
Drug Administration, Central Document Room, 5901-B Ammendale Rd., Beltsville,
MD 20705-1266.

The comment period will generally be 60 days in length, and the closing
date for comments will be listed in the description of the proposed change
for each drug entity.

The most useful type of scientific data submitted to support comments is


generally an in vivo bioavailability/bioequivalence study conducted on
batches of the subject drug products. Comments including scientific data
from an in vivo bioavailability/bioequivalence study should present a full
description of the analytical procedures and equipment used, a validation of
the analytical methodology, including the standard curve, a description of
the method of calculating results, and a description of the pharmacokinetic
and statistical models used in analyzing the data. Anecdotal or testimonial
information is the least useful to the Agency, and submission of comments
based on such information is discouraged. However, when there is supporting
published or unpublished scientific literature, copies should be submitted
with comments.

1.10 Change of the Therapeutic Equivalence Evaluation for a Single Product

The procedure described in Section 1.9 does not apply to a change in a


single drug product code. For example, a change in a single drug product's

xxiii
code from BP to AB as a result of the submission of an acceptable
bioequivalence study ordinarily will not be the subject of notice and comment
in the Cumulative Supplement. Likewise, a change in a single drug product's
code from AB to BX (e.g., as a result of new information raising a
significant question as to bioequivalence) does not require notice and
comment. The Agency's responsibility to provide the public with the Agency's
most current information related to therapeutic equivalence may require a
change in a drug product's code prior to any formal notice and opportunity
for the applicant to be heard. The publication in the Federal Register of a
proposal to withdraw approval of a drug product will ordinarily result in a
change in a product's code from AB to BX if this action has not already been
taken.

We recognize that certain drug products approved in 505(b)(2) applications


may not have therapeutic equivalence codes, and that FDA may undertake
therapeutic equivalence evaluations with respect to such drug products. A
person seeking to have a therapeutic equivalence rating for a drug product
approved in a 505(b)(2) application may petition the Agency through the
citizen petition procedure (see 21 CFR 10.25(a) and 21 CFR 10.30).

1.11 Discontinued Section

Those drug products in the discontinued section of the Orange Book


(Discontinued Drug Product List) for which a determination has been made that
the products were not withdrawn for safety or effectiveness reasons have been
annotated with a footnote following the product strength: “**Federal Register
determination that product was not discontinued or withdrawn for safety or
effectiveness reasons**”. The determinations listed in the Orange Book are
only reflective of determinations made since 1995 and published in the
Federal Register. The identification of these drug products in the
Discontinued Drug Product List should avoid the submission of multiple
citizen petitions requesting a determination for the same drug product.

Generally, approved products are added to the Discontinued Drug Product


List when the applicant notifies the Division of Orange Book Publication and
Regulatory Assessment (DOBPRA) of the products’ not-marketed status.
Products may also be added to the Discontinued Drug Product List if annual
reports or other submissions to the Agency indicate the product is not being
marketed or as a result of other Agency administrative actions. 22 Changes to
the Orange Book are not affected by the drug registration and listing
requirements of Section 510 of the FD&C Act.

1.12 Changes to the Orange Book

Every effort is made to ensure the Annual Edition is current and


accurate. Applicants are requested to inform DOBPRA of any changes or
corrections, including any change in ownership or a product’s marketing
status that would result in the product being moved to the Discontinued Drug
Product List. FDA notes that under Section 506I(a) of the FD&C Act,
application holders must notify the Agency in writing 180 days prior to
withdrawing a drug product from sale, or if 180 days is not practicable, not
later than the date of withdrawal from sale. Furthermore, Section 506I(b) of
the FD&C Act requires that application holders notify the Agency in writing
within 180 days of approval of a drug product if such drug product will not
be available for sale within 180 days of approval. A request to include a
newly approved product in the Discontinued Drug Product List, rather than
parts 1 or 2 of the Orange Book (as discussed in Section 1.1), must be

22
See, e.g., Section 506I(d) of the FD&C Act.
xxiv
submitted to DOBPRA by the end of the month in which the product is approved
to ensure that the product is not included in the “Active Section” of the
next published Orange Book update. The Prescription Drug Product List and the
Over-the-Counter (OTC) Drug Product List are collectively referred to as the
“Active Section.”

In addition, DOBPRA generally will act on requests to change a


proprietary name for a listed drug only after approval of a supplement for
the relevant change in proprietary name. To the extent that conventions for
describing product identification information (i.e., active ingredients,
dosage forms, routes of administration, product names, applicants, strengths)
evolve over time, the Agency generally does not intend to revise such
information for drug products already listed in the Orange Book, but rather
intends to apply the change prospectively to drug products as they are added
to the Orange Book.

You can contact DOBPRA by email at orangebook@fda.hhs.gov.

1.13 Availability of the Edition

The Annual Edition and current monthly Cumulative Supplement are


available in a Portable Document Format (PDF) at the Orange Book home page by
clicking on Publications. An annual subscription of the PDF format may be
obtained from the U.S. Government Publishing Office, https://www.gpo.gov/.

xxv
2.0 HOW TO USE THE DRUG PRODUCT LISTS

2.1 Key Sections for Using the Drug Product Lists

This publication contains illustrations, along with Drug Product Lists,


indices, and lists of abbreviations and terms which facilitate their use.

Illustrations. The annotated Drug Product Illustration (see Section 2.2)


and the Therapeutic Equivalence Evaluations Illustration (see Section 2.3)
are offered to provide further clarification. These depict the format found
in the Prescription Drug Product List (the only list in which therapeutic
equivalence evaluation codes are displayed).

Drug Product Lists. The Prescription and OTC Drug Product Lists,
arranged alphabetically by active ingredient(s), contain product
identification information (active ingredients, dosage forms, routes of
administration, product names, applicants, strengths) for single and multiple
ingredient drug products. Also shown are the application number and drug
product number (FDA internal computer data use only) and approval dates for
those drug products approved on or after January 1, 1982. The application
number preceded by “N” is a New Drug Application (NDA or commonly the
innovator). The application number preceded by an “A” is an Abbreviated New
Drug Application (ANDA or commonly the generic).

The Discontinued Drug Product List, arranged alphabetically by active


ingredient(s), contains product identification information (active
ingredients, dosage forms, routes of administration, product names,
applicants, strengths).

If a prescription drug product is available from more than one source


(multisource), a therapeutic equivalence code will appear in front of the
applicant's name. If a product is therapeutically equivalent to one or more
products or to an appropriate reference, it will be designated with a code
beginning with "A" and the entry will be underlined and printed in bold font
for emphasis.

Active ingredient headings for multiple ingredient (combination) drug


products are arranged alphabetically. For purposes of this publication, this
alphabetical sort takes precedence over United States Pharmacopeia official
monograph order (i.e., Reserpine, Hydralazine Hydrochloride,
Hydrochlorothiazide). For example, product information labeled as Reserpine,
Hydrochlorothiazide and Hydralazine Hydrochloride appears under the active
ingredient heading Hydralazine Hydrochloride; Hydrochlorothiazide; Reserpine.
A cross-reference to the product information (for prescription and OTC
products) appears for each additional active ingredient in the product. For
combination drug products, the ingredient strengths are separated by
semicolons and appear in the same relative sequence as the ingredients in the
heading. Available strengths of the dosage form from an applicant appear on
separate lines.

To use the Drug Product Lists, determine by alphabetical order the


ingredient under which the product information is listed, using the Product
Name Index, if necessary. Then, find the ingredient in the applicable Drug
Product List. Proceed to the dosage form and route of administration and

2-1
compare products within that ingredient heading only. Therapeutic
equivalence or inequivalence for prescription products is determined on the
basis of the therapeutic equivalence codes provided within that specific
dosage form and route heading. The OTC Drug Product List, Discontinued Drug
Product List, and Drug Products with Approval under Section 505 of the Act
Administered by the Center for Biologics Evaluation and Research List have
their data arranged similarly.

The Discontinued Drug Product List contains approved products that have
never been marketed, have been discontinued from marketing and we have not
determined that they were withdrawn for safety or effectiveness reasons, are
for military use, or have had their approvals withdrawn for other than safety
or efficacy reasons subsequent to being discontinued from marketing. All
products having a "@" in the December Cumulative Supplement of the previous
Edition List have been added to the Discontinued Drug Product List appearing
in this Edition. In addition, approved drug products that are not in the
commercial distribution channel e.g., approved drug products in applications
for export only are also listed in the Discontinued Drug Product List.

Product Name Index (Prescription and OTC Drug Product Lists). This is an
index of drug products by trade name or established name of the active
ingredient, if no trade name exists. The second term of each entry indicates
the active ingredient name under which product information can be found in
the appropriate Drug Product List. For those drug products with multiple
active ingredients, only the first active ingredient (in alphabetical order)
will appear. OTC products are so designated.

Product Name Index Listed by Applicant (Prescription and OTC Drug Product
Lists). This is an index that cross-references applicants to drug products.
The bolded and underlined entry represents the applicant name abbreviation
used in this publication. Each complete applicant name that is represented
by the abbreviated name is marked with an asterisk (*). Listed under each
complete applicant name is the first alphabetically arranged ingredient under
which product information can be found in the appropriate Drug Product List.
OTC products are so designated. To use the Drug Product Lists, determine by
alphabetical order the ingredient under which the product information is
listed, using the Product Name Index, if appropriate.

Uniform Terms. To improve readability, uniform terms are used to


designate dosage forms, routes of administration, and abbreviations used to
express strengths. These terms are listed in Appendix C. In some cases, the
terms used may differ from those used in product labels and other labeling.

2-2
2.2 DRUG PRODUCT ILLUSTRATION
SINGLE INGREDIENT

ACTIVE INGREDIENT MEPERIDINE HYDROCHLORIDE

DOSAGE FORM; ROUTE OF ADMINISTRATION INJECTABLE;INJECTION


HEXANON
TRADE OR GENERIC NAMES
AP +! PAGE PHARMA 25MG/ML N013111 001 AUG 22, 1983
REFERENCE LISTED DRUG* (+) AP +! 50MG/ML N013111 002 AUG 22, 1983
REFERENCE STANDARD * (!) AP +! 75MG/ML N013111 003 AUG 22, 1983
AP +! 100MG/ML N013111 004 JAN 04, 1989

MEPERIDINE HCL
AP DAVIS PHARM 25MG/ML A064890 001 FEB 29, 1987
THERAPEUTIC EQUIVALENCE (TE) AP 50MG/ML A064890 002 FEB 29, 1987
CODE FOR MULTISOURCE PRODUCT AP 75MG/ML A064890 003 FEB 29, 1987
AP 100MG/ML A064890 004 MAR 08, 1992

SINGLE SOURCE PRODUCT (NO TE CODE) ! TIMOKIM LLC 10MG/ML A099225 001 DEC 12, 1995
AP JOHNSON MED 25MG/ML A099226 001 NOV 27, 1993
! KENDRA PHARM 150MG/ML A079444 001 OCT 31, 1999

APPLICANT

AVAILABLE STRENGTH(S) OF A PRODUCT

APPLICATION NUMBER
PRODUCT NUMBER IS FOR FDA INTERNAL COMPUTER DATA USE ONLY

APPROVAL DATE

*NOTE: REFERENCE LISTED DRUG AND REFERENCE STANDARD ARE DISCUSSED IN THE PREFACE SECTION 1.4

MULTIPLE INGREDIENTS WITH PRODUCT INFORMATION

ALPHABETICALLY SORTED BY
ACTIVE INGREDIENT HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE

TABLET;ORAL
PRODUCT INFORMATION HYDROCHLOROTHIAZIDE, RESERPINE AND HYDRALAZINE HCL
REINWALD LABS 25MG;15MG;0.1MG A069808 001 JAN 18, 1982

THIS EXAMPLE IS FOR PURPOSE OF ILLUSTRATION ONLY. IT DOES NOT REPRESENT ACTUAL PRODUCTS FROM THE
PRESCRIPTION DRUG PRODUCT LIST.

2-3
2.3 THERAPEUTIC EQUIVALENCE EVALUATIONS ILLUSTRATION
DRUG PRODUCTS CODED AB (OR ANY CODE BEGINNING WITH AN "A") UNDER AN INGREDIENT AND DOSAGE FORM HEADING
ARE CONSIDERED THERAPEUTICALLY EQUIVALENT ONLY TO OTHER PRODUCTS CODED AB (OR ANY CODE BEGINNING WITH AN
“A") AND NOT TO THOSE CODED BP (OR ANY CODE BEGINNING WITH "B") AND ANY PRODUCTS NOT LISTED. DRUG
PRODUCTS CODED BP (OR ANY CODE BEGINNING WITH A "B") ARE NOT CONSIDERED THERAPEUTICALLY EQUIVALENT TO
ANY OTHER PRODUCT. FOR A COMPLETE EXPLANATION OF THE TE CODES REFER TO SECTION 1.7 OF THE INTRODUCTION.

SULFASALAZINE

TABLET; ORAL

FAZINE

AB PARKLAND 500MG A042999 001

PRODUCTS CONSIDERED THERAPEUTICALLY SULAZINE

EQUIVALENT TO EACH OTHER AB URSA 500MG A042222 001

SULFASALAZINE

PRODUCTS CONSIDERED NOT THERAPEUTICALLY BP BROWN 500MG A041297 001

EQUIVALENT TO ANY OTHER PRODUCTS LISTED

SULFASALAZINE

TABLET; ORAL
FAZINE
AB PARKLAND 500MG A042999 001

PRODUCTS CONSIDERED NOT THERAPEUTICALLY SULFASALAZINE

EQUIVALENT TO EACH OTHER BP BROWN 500MG A041297 001

SOUTH 500MG A067627 001

NOTE: BOLD FONT AND UNDERLINING DENOTES MULTISOURCE PRODUCTS WHICH ARE CONSIDERED THERAPEUTICALLY
EQUIVALENT.

THIS EXAMPLE IS FOR PURPOSES OF ILLUSTRATION ONLY. IT DOES NOT REPRESENT ACTUAL PRODUCTS FROM THE
PRESCRIPTION DRUG PRODUCT LIST.

2-4
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-1(of 474)

ABACAVIR SULFATE
SOLUTION;ORAL
ABACAVIR SULFATE
AA AUROBINDO PHARMA EQ 20MG BASE/ML A077950 001 Mar 14, 2018
LTD
AA HETERO LABS LTD III EQ 20MG BASE/ML A201107 001 Sep 26, 2016
ZIAGEN
AA +! VIIV HLTHCARE EQ 20MG BASE/ML N020978 001 Dec 17, 1998
TABLET;ORAL
ABACAVIR SULFATE
AB AUROBINDO PHARMA EQ 300MG BASE A077844 001 Dec 17, 2012
LTD
AB CIPLA EQ 300MG BASE A078119 001 Nov 21, 2017
AB HETERO LABS LTD III EQ 300MG BASE A091560 001 Sep 13, 2013
AB MYLAN PHARMS INC EQ 300MG BASE A091294 001 Jun 18, 2012
AB STRIDES PHARMA EQ 300MG BASE A091050 001 Oct 28, 2016
ZIAGEN
AB +! VIIV HLTHCARE EQ 300MG BASE N020977 001 Dec 17, 1998
ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
TABLET;ORAL
TRIUMEQ
+! VIIV HLTHCARE EQ 600MG BASE;EQ 50MG BASE;300MG N205551 001 Aug 22, 2014
TABLET, FOR SUSPENSION;ORAL
TRIUMEQ PD
+! VIIV HLTHCARE EQ 60MG BASE;EQ 5MG BASE;30MG N215413 001 Mar 30, 2022
ABACAVIR SULFATE; LAMIVUDINE
TABLET;ORAL
ABACAVIR SULFATE AND LAMIVUDINE
AB AUROBINDO PHARMA EQ 600MG BASE;300MG A090159 001 Nov 15, 2018
LTD
AB CIPLA EQ 600MG BASE;300MG A091144 001 Mar 28, 2017
AB LAURUS EQ 600MG BASE;300MG A216332 001 Jul 25, 2022
AB LUPIN LTD EQ 600MG BASE;300MG A204990 001 Mar 28, 2017
EPZICOM
AB +! VIIV HLTHCARE EQ 600MG BASE;300MG N021652 001 Aug 02, 2004
ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE
TABLET;ORAL
ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
AB LUPIN LTD EQ 300MG BASE;150MG;300MG A202912 001 Dec 05, 2013
TRIZIVIR
AB +! VIIV HLTHCARE EQ 300MG BASE;150MG;300MG N021205 001 Nov 14, 2000
ABALOPARATIDE
SOLUTION;SUBCUTANEOUS
TYMLOS
+! RADIUS HEALTH INC 3.12MG/1.56ML (2MG/ML) N208743 001 Apr 28, 2017
ABEMACICLIB
TABLET;ORAL
VERZENIO
+ ELI LILLY AND CO 50MG N208716 001 Sep 28, 2017
+ 100MG N208716 002 Sep 28, 2017
+ 150MG N208716 003 Sep 28, 2017
+! 200MG N208716 004 Sep 28, 2017
ABIRATERONE ACETATE
TABLET;ORAL
ABIRATERONE ACETATE
AB AMNEAL PHARMS 250MG A208327 001 Jan 07, 2019
AB 500MG A208327 002 Dec 23, 2020
AB APOTEX 250MG A208453 001 Oct 31, 2018
AB DR REDDYS 250MG A208416 001 May 18, 2020
AB GLENMARK PHARMS 250MG A209227 001 Oct 16, 2019
AB 500MG A209227 002 May 19, 2022
AB HIKMA 250MG A208339 001 Oct 31, 2018
AB MSN 250MG A210686 001 Jul 10, 2019
AB MYLAN 250MG A208446 001 Oct 31, 2018
AB 500MG A208446 002 Dec 14, 2020
AB NOVUGEN 250MG A215947 001 Jan 05, 2022
AB 500MG A215947 002 Jan 05, 2022
AB QILU 250MG A212462 001 Sep 27, 2019
AB 500MG A212462 002 Jun 25, 2021
AB RISING 250MG A208371 001 Feb 25, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-2(of 474)

ABIRATERONE ACETATE
TABLET;ORAL
ABIRATERONE ACETATE
AB TEVA PHARMS USA 250MG A208432 001 Oct 31, 2018
AB WOCKHARDT BIO AG 250MG A208380 001 Feb 27, 2019
ZYTIGA
AB + JANSSEN BIOTECH 250MG N202379 001 Apr 28, 2011
AB +! 500MG N202379 002 Apr 14, 2017
YONSA
+! SUN PHARM 125MG N210308 001 May 22, 2018
ABROCITINIB
TABLET;ORAL
CIBINQO
+ PFIZER 50MG N213871 001 Jan 14, 2022
+ 100MG N213871 002 Jan 14, 2022
+! 200MG N213871 003 Jan 14, 2022
ACALABRUTINIB
CAPSULE;ORAL
CALQUENCE
+! ASTRAZENECA 100MG N210259 001 Oct 31, 2017
ACALABRUTINIB MALEATE
TABLET;ORAL
CALQUENCE
+! ASTRAZENECA EQ 100MG BASE N216387 001 Aug 03, 2022
ACAMPROSATE CALCIUM
TABLET, DELAYED RELEASE;ORAL
ACAMPROSATE CALCIUM
AB ! GLENMARK GENERICS 333MG A202229 001 Jul 16, 2013
AB MYLAN 333MG A200142 001 Mar 11, 2014
AB ZYDUS PHARMS 333MG A205995 001 May 26, 2017
ACARBOSE
TABLET;ORAL
ACARBOSE
AB EMCURE PHARMS LTD 25MG A202271 001 Feb 07, 2012
AB 50MG A202271 002 Feb 07, 2012
AB 100MG A202271 003 Feb 07, 2012
AB HIKMA 25MG A078470 001 May 07, 2008
AB 50MG A078470 002 May 07, 2008
AB 100MG A078470 003 May 07, 2008
AB IMPAX LABS 25MG A078441 001 May 14, 2009
AB 50MG A078441 002 May 14, 2009
AB 100MG A078441 003 May 14, 2009
AB ! STRIDES PHARMA 25MG A090912 001 Jul 27, 2011
AB 50MG A090912 002 Jul 27, 2011
AB 100MG A090912 003 Jul 27, 2011
AB VIRTUS PHARM 25MG A091343 001 Oct 17, 2013
AB 50MG A091343 002 Oct 17, 2013
AB 100MG A091343 003 Oct 17, 2013
AB WATSON LABS 25MG A077532 001 May 07, 2008
AB 50MG A077532 002 May 07, 2008
AB 100MG A077532 003 May 07, 2008
ACEBUTOLOL HYDROCHLORIDE
CAPSULE;ORAL
ACEBUTOLOL HYDROCHLORIDE
AB ! AMNEAL PHARM EQ 200MG BASE A075047 001 Dec 30, 1999
AB ! EQ 400MG BASE A075047 002 Dec 30, 1999
AB ANI PHARMS EQ 200MG BASE A074007 001 Oct 18, 1995
AB EQ 400MG BASE A074007 002 Oct 18, 1995
ACETAMINOPHEN
SOLUTION;INTRAVENOUS
ACETAMINOPHEN
AP ASPIRO 1GM/100ML (10MG/ML) A216617 001 Jul 27, 2022
AP BAXTER HLTHCARE 1GM/100ML (10MG/ML) A214331 001 Sep 17, 2021
CORP
AP EUGIA PHARMA 1GM/100ML (10MG/ML) A210969 001 Oct 21, 2020
AP HIKMA 1GM/100ML (10MG/ML) A202605 001 Jun 13, 2016
AP MYLAN 1GM/100ML (10MG/ML) A213255 001 Aug 07, 2020
AP ! SANDOZ INC 1GM/100ML (10MG/ML) A204052 001 Mar 22, 2016
AP ZYDUS PHARMS 1GM/100ML (10MG/ML) A216467 001 Oct 25, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-3(of 474)

ACETAMINOPHEN
SOLUTION;INTRAVENOUS
ACETAMINOPHEN
+! B BRAUN MEDICAL INC 500MG/50ML (10MG/ML) N204957 001 Feb 18, 2021
+! 1GM/100ML (10MG/ML) N204957 002 Feb 18, 2021
FRESENIUS KABI USA 1GM/100ML (10MG/ML) N204767 001 Oct 28, 2015
+! HIKMA 1GM/100ML (10MG/ML) N206968 001 Jun 03, 2022
ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE
TABLET;ORAL
APADAZ
+ KVK TECH INC 325MG;EQ 4.08MG BASE N208653 002 Jan 04, 2019
+ 325MG;EQ 6.12MG BASE N208653 001 Feb 23, 2018
+! 325MG;EQ 8.16MG BASE N208653 003 Jan 04, 2019
ACETAMINOPHEN; BUTALBITAL
CAPSULE;ORAL
BUTALBITAL AND ACETAMINOPHEN
AA GRANULES 300MG;50MG A213115 001 Nov 22, 2019
AA ! MAYNE PHARMA INC 300MG;50MG A207313 001 Dec 27, 2017
TABLET;ORAL
ALLZITAL
AA ! LARKEN LABS INC 325MG;25MG A203484 001 Dec 04, 2015
BUTALBITAL AND ACETAMINOPHEN
AA AACE PHARMS 300MG;50MG A214955 001 Aug 16, 2022
AA ALVOGEN 300MG;50MG A207635 001 Jun 05, 2017
AA LARKEN LABS INC 325MG;50MG A203484 002 Dec 04, 2015
AA ! LGM PHARMA 300MG;50MG A090956 001 Aug 23, 2011
AA MIKART 300MG;50MG A207386 001 Nov 15, 2016
AA RISE PHARMA 300MG;50MG A214088 001 Apr 07, 2022
AA 325MG;25MG A214088 002 Apr 07, 2022
AA 325MG;50MG A214088 003 Apr 07, 2022
BUTAPAP
AA ! MIKART 325MG;50MG A089987 001 Oct 26, 1992
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
CAPSULE;ORAL
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
AA AUROLIFE PHARMA LLC 325MG;50MG;40MG A204733 001 Sep 26, 2018
AA GRANULES 300MG;50MG;40MG A213321 001 Apr 08, 2020
AA LANNETT CO INC 300MG;50MG;40MG A212082 001 Dec 17, 2019
AA 325MG;50MG;40MG A212083 001 Dec 17, 2019
AA ! LGM PHARMA 300MG;50MG;40MG A040885 001 Nov 16, 2009
AA MAYNE PHARMA INC 300MG;50MG;40MG A210817 001 Dec 17, 2019
AA ! 325MG;50MG;40MG A089007 001 Mar 17, 1986
AA NOVAST LABS 300MG;50MG;40MG A215047 001 Nov 17, 2021
AA NUVO PHARMS INC 300MG;50MG;40MG A207118 001 Oct 28, 2016
AA SENORES PHARMS 300MG;50MG;40MG A214087 001 Aug 13, 2021
AA 325MG;50MG;40MG A214087 002 Aug 13, 2021
AA TARO PHARM INDS LTD 300MG;50MG;40MG A213046 001 Jul 01, 2020
AA XSPIRE PHARMA 300MG;50MG;40MG A206615 001 Aug 04, 2017
SOLUTION;ORAL
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
! MIKART 325MG/15ML;50MG/15ML;40MG/15ML A040387 001 Jan 31, 2003
TABLET;ORAL
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
AA ABHAI LLC 325MG;50MG;40MG A211106 001 Sep 26, 2018
AA + ACTAVIS LABS UT INC 325MG;50MG;40MG A088616 001 Nov 09, 1984
AA GRANULES 325MG;50MG;40MG A040864 001 Dec 01, 2008
AA LANNETT CO INC 325MG;50MG;40MG A200243 001 Sep 13, 2012
AA LGM PHARMA 325MG;50MG;40MG A209587 001 Oct 31, 2018
AA MIKART 325MG;50MG;40MG A089175 001 Jan 21, 1987
AA ! STRIDES PHARMA 325MG;50MG;40MG A040511 001 Aug 27, 2003
AA 325MG;50MG;40MG A203647 001 Sep 21, 2020
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
CAPSULE;ORAL
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
AB HIKMA 300MG;50MG;40MG;30MG A215138 002 Jan 26, 2022
AB 325MG;50MG;40MG;30MG A215138 001 Jan 26, 2022
AB LGM PHARMA 300MG;50MG;40MG;30MG A076560 002 Jul 19, 2012
AB 325MG;50MG;40MG;30MG A076560 001 Jun 10, 2004
AB NOSTRUM LABS INC 325MG;50MG;40MG;30MG A075929 001 Apr 22, 2002
AB STRIDES PHARMA 325MG;50MG;40MG;30MG A204649 001 Jul 08, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-4(of 474)

ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE


CAPSULE;ORAL
FIORICET W/ CODEINE
AB +! ACTAVIS LABS UT INC 325MG;50MG;40MG;30MG N020232 001 Jul 30, 1992
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
CAPSULE;ORAL
TREZIX
XSPIRE PHARMA 320.5MG;30MG;16MG A204785 001 Nov 26, 2014
TABLET;ORAL
ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE
LARKEN LABS INC 325MG;30MG;16MG A204209 001 Sep 30, 2016
ACETAMINOPHEN; CODEINE PHOSPHATE
SOLUTION;ORAL
ACETAMINOPHEN AND CODEINE PHOSPHATE
AA AKORN 120MG/5ML;12MG/5ML A040119 001 Apr 26, 1996
AA CHARTWELL 120MG/5ML;12MG/5ML A089450 001 Oct 27, 1992
AA ! PHARM ASSOC 120MG/5ML;12MG/5ML A087508 001
TABLET;ORAL
ACETAMINOPHEN AND CODEINE PHOSPHATE
AA AMNEAL PHARMS NY 300MG;30MG A040779 001 May 29, 2008
AA AUROLIFE PHARMA LLC 300MG;15MG A202800 001 Apr 15, 2013
AA 300MG;30MG A202800 002 Apr 15, 2013
AA 300MG;60MG A202800 003 Apr 15, 2013
AA ELITE LABS INC 300MG;15MG A212418 001 Sep 10, 2019
AA 300MG;30MG A212418 002 Sep 10, 2019
AA 300MG;60MG A212418 003 Sep 10, 2019
AA EYWA 300MG;15MG A211610 001 Jun 27, 2019
AA 300MG;30MG A211610 002 Jun 27, 2019
AA 300MG;60MG A211610 003 Jun 27, 2019
AA NOSTRUM LABS INC 300MG;15MG A088629 002 Mar 06, 1985
AA 300MG;30MG A088629 003 Mar 06, 1985
AA +! 300MG;60MG A088629 001 Mar 06, 1985
AA ! SPECGX LLC 300MG;15MG A040419 001 May 31, 2001
AA ! 300MG;30MG A040419 002 May 31, 2001
AA 300MG;60MG A040419 003 May 31, 2001
AA SUN PHARM INDS LTD 300MG;30MG A085868 001
AA 300MG;60MG A087083 001
ACETAMINOPHEN; HYDROCODONE BITARTRATE
SOLUTION;ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
AA ! CHARTWELL 325MG/15ML;7.5MG/15ML A040482 001 Sep 25, 2003
AA EYWA 325MG/15ML;7.5MG/15ML A211023 001 Mar 08, 2019
AA GENUS 325MG/15ML;7.5MG/15ML A040894 001 Jul 19, 2011
AA PHARM ASSOC 325MG/15ML;7.5MG/15ML A040838 001 May 10, 2013
AA VISTAPHARM 325MG/15ML;7.5MG/15ML A200343 001 Jan 25, 2012
! MIKART 300MG/15ML;10MG/15ML A040881 001 Feb 25, 2010
! PHARM ASSOC 325MG/15ML;10MG/15ML A040834 001 Apr 18, 2008
TABLET;ORAL
ANEXSIA 5/325
AA ! SPECGX LLC 325MG;5MG A040409 001 Oct 20, 2000
ANEXSIA 7.5/325
AA ! SPECGX LLC 325MG;7.5MG A040405 001 Sep 08, 2000
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
AA ABHAI LLC 300MG;5MG A209036 001 Jun 21, 2017
AA 300MG;7.5MG A209036 002 Jun 21, 2017
AA 300MG;10MG A209036 003 Jun 21, 2017
AA 325MG;5MG A209037 001 Jun 21, 2017
AA 325MG;7.5MG A209037 002 Jun 21, 2017
AA 325MG;10MG A209037 003 Jun 21, 2017
AA AMNEAL PHARMS 300MG;10MG A207137 001 Nov 29, 2016
AA AMNEAL PHARMS NY 300MG;5MG A206869 001 Jun 23, 2017
AA 325MG;5MG A040736 001 Aug 25, 2006
AA 325MG;7.5MG A040746 002 May 10, 2016
AA 325MG;10MG A040746 001 Aug 25, 2006
AA ASCENT PHARMS INC 325MG;5MG A211487 002 Nov 07, 2018
AA 325MG;7.5MG A211487 003 Nov 07, 2018
AA 325MG;10MG A211487 004 Nov 07, 2018
AA AUROLIFE PHARMA LLC 300MG;5MG A207709 001 Sep 13, 2018
AA 300MG;7.5MG A207709 002 Sep 13, 2018
AA 300MG;10MG A207709 003 Sep 13, 2018
AA 325MG;5MG A201013 001 Apr 11, 2012
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-5(of 474)

ACETAMINOPHEN; HYDROCODONE BITARTRATE


TABLET;ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
AA 325MG;7.5MG A201013 002 Apr 11, 2012
AA 325MG;10MG A201013 003 Apr 11, 2012
AA ! CHARTWELL 300MG;5MG A040658 001 Jan 19, 2006
AA ! 300MG;7.5MG A040658 002 Mar 24, 2006
AA ! 300MG;10MG A040658 003 Jun 23, 2004
AA 325MG;7.5MG A040432 001 Jan 22, 2003
AA EPIC PHARMA LLC 325MG;5MG A203863 001 Mar 30, 2018
AA 325MG;7.5MG A203863 002 Mar 30, 2018
AA 325MG;10MG A203863 003 Mar 30, 2018
AA NOVEL LABS INC 300MG;5MG A206142 001 Nov 14, 2016
AA 300MG;7.5MG A206142 002 Nov 14, 2016
AA 300MG;10MG A206142 003 Nov 14, 2016
AA 325MG;5MG A206245 001 Dec 01, 2016
AA 325MG;7.5MG A206245 002 Dec 01, 2016
AA 325MG;10MG A206245 003 Dec 01, 2016
AA PRINSTON INC 325MG;5MG A214928 001 Dec 30, 2021
AA 325MG;7.5MG A214928 002 Dec 30, 2021
AA 325MG;10MG A214928 003 Dec 30, 2021
AA RHODES PHARMS 300MG;5MG A207808 001 Mar 30, 2018
AA 300MG;7.5MG A207808 002 Mar 30, 2018
AA 300MG;10MG A207808 003 Mar 30, 2018
AA 325MG;5MG A202991 001 Apr 12, 2016
AA 325MG;7.5MG A202991 002 Apr 12, 2016
AA 325MG;10MG A202991 003 Apr 12, 2016
AA SPECGX LLC 300MG;5MG A206718 001 Mar 31, 2017
AA 300MG;7.5MG A206718 002 Mar 31, 2017
AA 300MG;10MG A206718 003 Mar 31, 2017
AA ! 325MG;10MG A040400 001 Jul 26, 2000
AA STRIDES PHARMA 325MG;5MG A040655 001 Jan 19, 2006
AA 325MG;5MG A202935 002 Jun 15, 2016
AA 325MG;7.5MG A040656 001 Jan 19, 2006
AA 325MG;7.5MG A202935 003 Jun 15, 2016
AA 325MG;10MG A040355 001 May 31, 2000
AA 325MG;10MG A202935 004 Jun 15, 2016
AA SUN PHARM INDS INC 325MG;5MG A090118 001 Dec 23, 2008
AA 325MG;7.5MG A090118 002 Dec 23, 2008
AA 325MG;10MG A090118 003 Dec 23, 2008
AA TRIS PHARMA INC 300MG;5MG A202214 004 Mar 15, 2016
AA 300MG;7.5MG A202214 005 Mar 15, 2016
AA 300MG;10MG A202214 006 Mar 15, 2016
AA 325MG;5MG A202214 001 Mar 27, 2013
AA 325MG;7.5MG A202214 002 Mar 27, 2013
AA 325MG;10MG A202214 003 Mar 27, 2013
AA WES PHARMA INC 300MG;5MG A207509 001 Oct 29, 2018
AA 300MG;7.5MG A207509 002 Oct 29, 2018
AA 300MG;10MG A207509 003 Oct 29, 2018
AA 325MG;5MG A210211 001 Oct 30, 2017
AA 325MG;7.5MG A210211 002 Oct 30, 2017
AA 325MG;10MG A210211 003 Oct 30, 2017
! ASCENT PHARMS INC 325MG;2.5MG A211487 001 Nov 07, 2018
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
SOLUTION;ORAL
OXYCODONE AND ACETAMINOPHEN
AA ! ABHAI LLC 325MG/5ML;5MG/5ML A211499 001 Dec 31, 2018
AA NOSTRUM LABS INC 325MG/5ML;5MG/5ML A201448 001 Aug 26, 2021
MIKART 300MG/5ML;10MG/5ML A202142 001 Nov 27, 2018
TABLET;ORAL
OXYCET
AA SPECGX LLC 325MG;5MG A087463 001 Dec 07, 1983
OXYCODONE AND ACETAMINOPHEN
AA ABHAI LLC 325MG;2.5MG A210644 001 Feb 09, 2018
AA 325MG;5MG A210644 002 Feb 09, 2018
AA 325MG;7.5MG A210644 003 Feb 09, 2018
AA 325MG;10MG A210644 004 Feb 09, 2018
AA ACTAVIS ELIZABETH 325MG;2.5MG A201447 001 Apr 12, 2013
AA 325MG;5MG A201447 002 Apr 12, 2013
AA 325MG;7.5MG A201447 003 Apr 12, 2013
AA 325MG;10MG A201447 004 Apr 12, 2013
AA ALVOGEN 325MG;5MG A202677 003 Mar 08, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-6(of 474)

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE


TABLET;ORAL
OXYCODONE AND ACETAMINOPHEN
AA 325MG;7.5MG A202677 001 Jul 26, 2012
AA 325MG;10MG A202677 002 Jul 26, 2012
AA AMNEAL PHARMS 325MG;5MG A040777 001 Nov 27, 2007
AA AMNEAL PHARMS NY 325MG;7.5MG A040778 002 Jun 27, 2014
AA 325MG;10MG A040778 001 Nov 27, 2007
AA ASCENT PHARMS INC 325MG;2.5MG A207419 001 Mar 22, 2017
AA 325MG;5MG A207419 002 Mar 22, 2017
AA 325MG;7.5MG A207419 003 Mar 22, 2017
AA 325MG;10MG A207419 004 Mar 22, 2017
AA AUROLIFE PHARMA LLC 325MG;2.5MG A201972 001 Jul 15, 2013
AA 325MG;5MG A201972 002 Jul 15, 2013
AA 325MG;7.5MG A201972 003 Jul 15, 2013
AA 325MG;10MG A201972 004 Jul 15, 2013
AA CHARTWELL 325MG;5MG A207834 001 Aug 15, 2019
AA 325MG;7.5MG A207834 002 Aug 15, 2019
AA 325MG;10MG A207834 003 Aug 15, 2019
AA EPIC PHARMA LLC 325MG;5MG A203864 001 Jul 02, 2018
AA 325MG;7.5MG A203864 002 Jul 02, 2018
AA 325MG;10MG A203864 003 Jul 02, 2018
AA MAYNE PHARMA INC 325MG;2.5MG A090177 001 Oct 20, 2008
AA 325MG;5MG A090177 002 Oct 20, 2008
AA 325MG;7.5MG A090177 003 Oct 20, 2008
AA 325MG;10MG A090177 004 Oct 20, 2008
AA NOVEL LABS INC 325MG;2.5MG A204407 001 Feb 24, 2017
AA 325MG;5MG A204407 002 Feb 24, 2017
AA 325MG;7.5MG A204407 003 Feb 24, 2017
AA 325MG;10MG A204407 004 Feb 24, 2017
AA RHODES PHARMS 325MG;5MG A201278 001 Aug 28, 2014
AA 325MG;7.5MG A201278 002 Aug 28, 2014
AA 325MG;10MG A201278 003 Aug 28, 2014
AA SPECGX LLC 325MG;7.5MG A040545 001 Jun 30, 2004
AA 325MG;10MG A040545 002 Jun 30, 2004
AA SUN PHARM INDS INC 325MG;2.5MG A090535 001 Dec 26, 2013
AA 325MG;5MG A090535 002 Dec 26, 2013
AA 325MG;7.5MG A090535 003 Dec 26, 2013
AA 325MG;10MG A090535 004 Dec 26, 2013
AA WES PHARMA INC 325MG;5MG A207510 001 Mar 21, 2018
AA 325MG;7.5MG A207510 002 Mar 21, 2018
AA 325MG;10MG A207510 003 Mar 21, 2018
PERCOCET
AA ! VINTAGE PHARMS LLC 325MG;2.5MG A040330 001 Jun 25, 1999
AA ! 325MG;5MG A040330 002 Jun 25, 1999
AA ! 325MG;7.5MG A040330 003 Nov 23, 2001
AA ! 325MG;10MG A040330 004 Nov 23, 2001
OXYCODONE AND ACETAMINOPHEN
! MIKART 300MG;2.5MG A040608 001 Dec 30, 2005
! 300MG;5MG A040608 002 Dec 30, 2005
! 300MG;7.5MG A040608 003 Dec 30, 2005
! 300MG;10MG A040608 004 Dec 30, 2005
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
TABLET;ORAL
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN
AB ALKEM LABS LTD 325MG;37.5MG A202076 001 Mar 30, 2012
AB AMNEAL PHARMS 325MG;37.5MG A090485 001 Dec 09, 2009
AB AUROBINDO PHARMA 325MG;37.5MG A207152 001 Mar 22, 2017
AB MICRO LABS LTD 325MG;37.5MG A201952 001 Dec 14, 2012
INDIA
AB RISING 325MG;37.5MG A077858 001 Sep 26, 2008
AB SUN PHARM INDS INC 325MG;37.5MG A077184 001 Dec 16, 2005
AB ZYDUS PHARMS USA 325MG;37.5MG A090460 001 Sep 06, 2012
INC
ULTRACET
AB +! JANSSEN PHARMS 325MG;37.5MG N021123 001 Aug 15, 2001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-7(of 474)

ACETAZOLAMIDE
CAPSULE, EXTENDED RELEASE;ORAL
ACETAZOLAMIDE
AB ACCORD HLTHCARE 500MG A207659 001 Oct 18, 2018
AB ALEMBIC PHARMS 500MG A210423 001 Feb 19, 2019
AB ! CADILA 500MG A205301 001 Jan 16, 2019
AB HERITAGE PHARMA 500MG A040904 001 Dec 10, 2008
AB MICRO LABS LTD 500MG A207401 001 Oct 01, 2020
INDIA
AB NOSTRUM LABS INC 500MG A204691 001 Mar 29, 2016
AB NOVAST LABS 500MG A203434 001 Sep 30, 2016
TABLET;ORAL
ACETAZOLAMIDE
AB APPCO 125MG A211372 001 Feb 22, 2021
AB 250MG A211372 002 Feb 22, 2021
AB BRECKENRIDGE 125MG A207503 001 Apr 30, 2020
AB 250MG A207503 002 Apr 30, 2020
AB CHARTWELL MOLECULAR 250MG A084840 001
AB EYWA PHARMA 125MG A211556 001 Oct 18, 2019
AB 250MG A211556 002 Oct 18, 2019
AB HERITAGE PHARMA 125MG A205530 001 Oct 27, 2016
AB 250MG A205530 002 Oct 27, 2016
AB MANKIND PHARMA 125MG A214282 001 Oct 07, 2020
AB 250MG A214282 002 Oct 07, 2020
AB NOVITIUM PHARMA 125MG A210588 001 Oct 17, 2019
AB 250MG A210588 002 Oct 17, 2019
AB RUBICON 125MG A215101 001 Aug 19, 2021
AB 250MG A215101 002 Aug 19, 2021
AB STRIDES PHARMA 125MG A209734 001 Nov 20, 2017
AB 250MG A209734 002 Nov 20, 2017
AB TARO 125MG A040195 001 May 28, 1997
AB ! 250MG A040195 002 May 28, 1997
ACETAZOLAMIDE SODIUM
INJECTABLE;INJECTION
ACETAZOLAMIDE SODIUM
AP EMCURE PHARMS LTD EQ 500MG BASE/VIAL A202693 001 Dec 19, 2014
AP HIKMA EQ 500MG BASE/VIAL A040089 001 Feb 28, 1995
AP MYLAN ASI EQ 500MG BASE/VIAL A200880 001 May 09, 2012
AP ! XGEN PHARMS EQ 500MG BASE/VIAL A040784 001 Dec 10, 2008
AP ZYDUS PHARMS EQ 500MG BASE/VIAL A206533 001 Apr 15, 2019
ACETIC ACID, GLACIAL
SOLUTION;IRRIGATION, URETHRAL
ACETIC ACID 0.25% IN PLASTIC CONTAINER
AT B BRAUN 250MG/100ML N018161 001
AT BAXTER HLTHCARE 250MG/100ML N018523 001 Feb 19, 1982
AT +! ICU MEDICAL INC 250MG/100ML N017656 001
SOLUTION/DROPS;OTIC
ACETIC ACID
AT RISING 2% A207280 001 Mar 09, 2018
AT SAPTALIS PHARMS 2% A040607 001 Feb 24, 2005
AT TARO 2% A088638 001 Sep 06, 1984
VOSOL
AT ! AKORN 2% N012179 001
ACETIC ACID, GLACIAL; HYDROCORTISONE
SOLUTION/DROPS;OTIC
HYDROCORTISONE AND ACETIC ACID
AT COSETTE 2%;1% A040609 001 Feb 06, 2006
AT TARO PHARM INDS LTD 2%;1% A088759 001 Mar 04, 1985
VOSOL HC
AT +! AKORN 2%;1% N012770 001
ACETOHYDROXAMIC ACID
TABLET;ORAL
LITHOSTAT
+! MISSION PHARMA 250MG N018749 001 May 31, 1983
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-8(of 474)

ACETYLCHOLINE CHLORIDE
FOR SOLUTION;OPHTHALMIC
MIOCHOL-E
+! BAUSCH AND LOMB 20MG/VIAL N020213 001 Sep 22, 1993
ACETYLCYSTEINE
INJECTABLE;INTRAVENOUS
ACETADOTE
AP +! CUMBERLAND PHARMS 6GM/30ML (200MG/ML) N021539 001 Jan 23, 2004
ACETYLCYSTEINE
AP AKORN 6GM/30ML (200MG/ML) A203173 001 Mar 24, 2015
AP ASPEN 6GM/30ML (200MG/ML) A213693 001 Feb 03, 2022
AP EUGIA PHARMA 6GM/30ML (200MG/ML) A207358 001 Feb 29, 2016
AP FRESENIUS KABI USA 6GM/30ML (200MG/ML) A200644 001 Nov 07, 2012
AP INDOCO 6GM/30ML (200MG/ML) A215620 001 Feb 23, 2022
AP SAGENT PHARMS INC 6GM/30ML (200MG/ML) A091684 001 Oct 31, 2017
AP ZYDUS PHARMS 6GM/30ML (200MG/ML) A208166 001 Jul 20, 2018
SOLUTION;INHALATION, ORAL
ACETYLCYSTEINE
AN ALVOGEN 10% A204674 001 Feb 11, 2014
AN 20% A203853 001 Jun 21, 2012
AN ! AM REGENT 10% A072489 001 Jul 28, 1995
AN ! 20% A072547 001 Jul 28, 1995
AN HOSPIRA 10% A073664 001 Aug 30, 1994
AN 20% A074037 001 Aug 30, 1994
ACITRETIN
CAPSULE;ORAL
ACITRETIN
AB BARR LABS INC 10MG A091455 001 Apr 04, 2013
AB 25MG A091455 002 Apr 04, 2013
AB IMPAX LABS INC 10MG A202552 001 Dec 23, 2015
AB 17.5MG A202552 002 Dec 23, 2015
AB 22.5MG A202552 003 Dec 23, 2015
AB 25MG A202552 004 Dec 23, 2015
AB MYLAN 10MG A202148 001 Sep 10, 2015
AB 25MG A202148 002 Sep 10, 2015
AB SIGMAPHARM LABS LLC 10MG A204633 001 May 22, 2015
AB 17.5MG A204633 002 May 22, 2015
AB 22.5MG A204633 003 May 22, 2015
AB ! 25MG A204633 004 May 22, 2015
AB TEVA PHARMS USA 17.5MG A202897 001 Apr 04, 2013
AB 22.5MG A202897 002 Apr 04, 2013
ACLIDINIUM BROMIDE
POWDER, METERED;INHALATION
TUDORZA PRESSAIR
+! COVIS 0.4MG/INH N202450 001 Jul 23, 2012
ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE
POWDER, METERED;INHALATION
DUAKLIR PRESSAIR
+! COVIS 0.4MG/INH;0.012MG/INH N210595 001 Mar 29, 2019
ACYCLOVIR
CAPSULE;ORAL
ACYCLOVIR
AB ! APOTEX 200MG A075677 001 Sep 28, 2005
AB CADILA 200MG A204313 001 Mar 25, 2016
AB CADILA PHARMS LTD 200MG A201445 001 Mar 06, 2014
AB CARLSBAD TECHNOLOGY 200MG A206261 001 Aug 16, 2017
AB HERITAGE PHARMS 200MG A074889 001 Oct 31, 1997
AB KENTON 200MG A075090 001 Jan 26, 1999
AB TEVA 200MG A074578 001 Apr 22, 1997
AB YILING 200MG A212173 001 Sep 14, 2020
CREAM;TOPICAL
ACYCLOVIR
AB AMNEAL 5% A208766 001 Nov 09, 2020
AB ! PADAGIS ISRAEL 5% A208702 001 Feb 04, 2019
ZOVIRAX
AB + BAUSCH 5% N021478 001 Dec 30, 2002
OINTMENT;TOPICAL
ACYCLOVIR
AB ALEMBIC PHARMS 5% A209000 001 Apr 06, 2018
AB AMNEAL PHARMS 5% A204605 001 Jun 18, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-9(of 474)

ACYCLOVIR
OINTMENT;TOPICAL
ACYCLOVIR
AB APOTEX 5% A210774 001 Sep 06, 2019
AB CADILA 5% A205974 001 Mar 15, 2019
AB CHARTWELL RX 5% A212495 001 Apr 07, 2020
AB CIPLA 5% A211794 001 Jan 18, 2019
AB COSETTE 5% A205591 001 Nov 13, 2017
AB FOUGERA PHARMS INC 5% A206633 001 May 11, 2016
AB GLENMARK PHARMS SA 5% A205510 001 Jul 31, 2017
AB MACLEODS PHARMS LTD 5% A212444 001 May 19, 2021
AB MYLAN PHARMS INC 5% A202459 001 Apr 03, 2013
AB TARO 5% A205469 001 Dec 21, 2016
AB TORRENT 5% A209971 001 Jan 11, 2019
AB XIROMED 5% A201501 001 Jan 29, 2020
ZOVIRAX
AB +! BAUSCH 5% N018604 001 Mar 29, 1982
SUSPENSION;ORAL
ACYCLOVIR
AB ACTAVIS MID 200MG/5ML A074738 001 Apr 28, 1997
ATLANTIC
AB AKORN 200MG/5ML A077026 001 Jun 07, 2005
AB HERITAGE PHARMS INC 200MG/5ML A212718 001 Apr 23, 2020
AB HETERO LABS LTD III 200MG/5ML A215669 001 Jul 01, 2022
AB NOVITIUM PHARMA 200MG/5ML A212252 001 Jul 10, 2020
AB RUBICON 200MG/5ML A215724 001 Aug 18, 2022
AB VISTAPHARM 200MG/5ML A213951 001 Jan 11, 2021
ZOVIRAX
AB +! MYLAN 200MG/5ML N019909 001 Dec 22, 1989
TABLET;BUCCAL
SITAVIG
+! EPI HLTH 50MG N203791 001 Apr 12, 2013
TABLET;ORAL
ACYCLOVIR
AB APOTEX INC 400MG A077309 001 Sep 29, 2005
AB 800MG A077309 002 Sep 29, 2005
AB CADILA PHARMS LTD 400MG A202168 001 Nov 15, 2013
AB 800MG A202168 002 Nov 15, 2013
AB CARLSBAD 400MG A075382 001 Apr 30, 1999
AB 800MG A075382 002 Apr 30, 1999
AB HERITAGE PHARMS 400MG A074891 001 Oct 31, 1997
AB 800MG A074891 002 Oct 31, 1997
AB HETERO LABS LTD V 400MG A203834 001 Oct 29, 2013
AB ! 800MG A203834 002 Oct 29, 2013
AB SQUARE PHARMS 400MG A209366 001 Oct 07, 2019
AB 800MG A209366 002 Oct 07, 2019
AB STRIDES PHARMA 400MG A074946 001 Nov 19, 1997
AB 800MG A074946 002 Nov 19, 1997
AB TEVA 400MG A074556 002 Apr 22, 1997
AB 800MG A074556 003 Apr 22, 1997
AB YILING 400MG A210401 001 Mar 07, 2018
AB 800MG A210401 002 Mar 07, 2018
AB ZYDUS PHARMS 400MG A204314 001 Aug 19, 2014
AB 800MG A204314 002 Aug 19, 2014
ACYCLOVIR SODIUM
INJECTABLE;INJECTION
ACYCLOVIR SODIUM
AP EUGIA PHARMA EQ 50MG BASE/ML A203701 001 Oct 11, 2013
AP ! FRESENIUS KABI USA EQ 50MG BASE/ML A074930 001 May 13, 1998
AP ZYDUS PHARMS EQ 50MG BASE/ML A206535 001 Aug 31, 2018
ACYCLOVIR; HYDROCORTISONE
CREAM;TOPICAL
XERESE
+! BAUSCH 5%;1% N022436 001 Jul 31, 2009
ADAGRASIB
TABLET;ORAL
KRAZATI
+! MIRATI THERAPS 200MG N216340 001 Dec 12, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-10(of 474)

ADAPALENE
CREAM;TOPICAL
ADAPALENE
AB FOUGERA PHARMS 0.1% A090824 001 Jun 30, 2010
DIFFERIN
AB +! GALDERMA LABS LP 0.1% N020748 001 May 26, 2000
GEL;TOPICAL
ADAPALENE
AB ACTAVIS MID 0.3% A201000 001 Oct 27, 2014
ATLANTIC
AB ALEOR 0.3% A213508 001 Jun 18, 2020
DERMACEUTICALS
AB TARO 0.3% A208322 001 Jun 23, 2016
DIFFERIN
AB +! GALDERMA LABS LP 0.3% N021753 001 Jun 19, 2007
LOTION;TOPICAL
DIFFERIN
+! GALDERMA LABS LP 0.1% N022502 001 Mar 17, 2010
SOLUTION;TOPICAL
ADAPALENE
AB CALL INC 0.1% A203981 001 Sep 23, 2016
AB 0.1% A204593 001 Jan 05, 2016
ADAPALENE; BENZOYL PEROXIDE
GEL;TOPICAL
ADAPALENE AND BENZOYL PEROXIDE
AB ACTAVIS LABS UT INC 0.3%;2.5% A209641 001 Jun 22, 2022
AB ALEOR 0.3%;2.5% A214185 001 Aug 04, 2022
DERMACEUTICALS
AB GLENMARK PHARMS LTD 0.1%;2.5% A208108 001 Nov 08, 2019
AB PADAGIS ISRAEL 0.1%;2.5% A205033 001 Jan 23, 2018
AB 0.3%;2.5% A212464 001 May 31, 2022
AB TARO 0.1%;2.5% A206959 001 Jan 24, 2018
AB 0.3%;2.5% A209148 001 Oct 17, 2018
AB ZYDUS PHARMS 0.3%;2.5% A214553 001 Jun 03, 2022
EPIDUO
AB +! GALDERMA LABS LP 0.1%;2.5% N022320 001 Dec 08, 2008
EPIDUO FORTE
AB +! GALDERMA LABS 0.3%;2.5% N207917 001 Jul 15, 2015
ADEFOVIR DIPIVOXIL
TABLET;ORAL
ADEFOVIR DIPIVOXIL
AB APOTEX 10MG A205459 001 Jul 06, 2018
AB SIGMAPHARM LABS LLC 10MG A202051 001 Aug 29, 2013
HEPSERA
AB +! GILEAD 10MG N021449 001 Sep 20, 2002
ADENOSINE
INJECTABLE;INJECTION
ADENOSINE
AP ! AKORN 3MG/ML A078076 001 Oct 31, 2008
AP FRESENIUS KABI USA 3MG/ML A077133 001 Apr 27, 2005
AP 3MG/ML A205568 001 Apr 16, 2018
AP GLAND PHARMA LTD 3MG/ML A077283 001 Jun 14, 2007
AP 3MG/ML A206778 001 Feb 16, 2018
AP HIKMA 3MG/ML A076404 001 Jun 16, 2004
AP 3MG/ML A076500 001 Jun 16, 2004
AP MYLAN LABS LTD 3MG/ML A078686 001 May 13, 2009
SOLUTION;INTRAVENOUS
ADENOSINE
AP AKORN 60MG/20ML (3MG/ML) A090450 001 Oct 02, 2014
AP 90MG/30ML (3MG/ML) A090450 002 Oct 02, 2014
AP EMCURE PHARMS LTD 60MG/20ML (3MG/ML) A202313 001 Sep 15, 2014
AP 90MG/30ML (3MG/ML) A202313 002 Sep 15, 2014
AP EUGIA PHARMA 60MG/20ML (3MG/ML) A205331 001 Nov 02, 2017
AP 90MG/30ML (3MG/ML) A205331 002 Nov 02, 2017
AP FRESENIUS KABI USA 60MG/20ML (3MG/ML) A077897 001 Nov 27, 2017
AP 90MG/30ML (3MG/ML) A077897 002 Nov 27, 2017
AP HOSPIRA 60MG/20ML (3MG/ML) A203883 001 Mar 24, 2014
AP 90MG/30ML (3MG/ML) A203883 002 Mar 24, 2014
AP MYLAN ASI 60MG/20ML (3MG/ML) A090212 001 Mar 28, 2014
AP 90MG/30ML (3MG/ML) A090212 002 Mar 28, 2014
AP ! TEVA PHARMS USA 60MG/20ML (3MG/ML) A077425 001 Aug 29, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-11(of 474)

ADENOSINE
SOLUTION;INTRAVENOUS
ADENOSINE
AP ! 90MG/30ML (3MG/ML) A077425 002 Aug 29, 2013
AFAMELANOTIDE
IMPLANT;SUBCUTANEOUS
SCENESSE
+! CLIVUNEL INC 16MG N210797 001 Oct 08, 2019
AFATINIB DIMALEATE
TABLET;ORAL
GILOTRIF
+ BOEHRINGER EQ 20MG BASE N201292 001 Jul 12, 2013
INGELHEIM
+ EQ 30MG BASE N201292 002 Jul 12, 2013
+! EQ 40MG BASE N201292 003 Jul 12, 2013
AIR POLYMER-TYPE A
FOAM;INTRAUTERINE
EXEM FOAM KIT
+! GISKIT 10ML N212279 001 Nov 07, 2019
ALBENDAZOLE
TABLET;ORAL
ALBENDAZOLE
AB ACTAVIS ELIZABETH 200MG A208094 001 May 20, 2019
AB CIPLA LTD 200MG A210434 001 Sep 21, 2018
AB ! DR REDDYS 200MG A211034 001 Jan 26, 2021
AB EDENBRIDGE PHARMS 200MG A211117 001 May 14, 2019
AB MSN 200MG A213435 001 Jan 21, 2021
AB STRIDES PHARMA 200MG A210011 001 Dec 07, 2018
AB ZYDUS PHARMS 200MG A208979 001 Dec 14, 2018
ALBUMIN HUMAN
INJECTABLE;INJECTION
OPTISON
+! GE HEALTHCARE 10MG/ML N020899 001 Dec 31, 1997
ALBUTEROL SULFATE
AEROSOL, METERED;INHALATION
ALBUTEROL SULFATE
AB1 CIPLA EQ 0.09MG BASE/INH A209959 001 Apr 08, 2020
AB1 SANDOZ INC EQ 0.09MG BASE/INH A207085 001 Jun 01, 2021
PROVENTIL-HFA
AB1 +! KINDEVA EQ 0.09MG BASE/INH N020503 001 Aug 15, 1996
ALBUTEROL SULFATE
AB2 LUPIN EQ 0.09MG BASE/INH A209954 001 Aug 24, 2020
PROAIR HFA
AB2 +! TEVA BRANDED PHARM EQ 0.09MG BASE/INH N021457 001 Oct 29, 2004
VENTOLIN HFA
BX +! GLAXOSMITHKLINE EQ 0.09MG BASE/INH N020983 001 Apr 19, 2001
POWDER, METERED;INHALATION
PROAIR DIGIHALER
+ TEVA BRANDED PHARM EQ 0.09MG BASE/INH N205636 002 Dec 21, 2018
PROAIR RESPICLICK
+! TEVA BRANDED PHARM EQ 0.09MG BASE/INH N205636 001 Mar 31, 2015
SOLUTION;INHALATION
ACCUNEB
AN +! MYLAN SPECIALITY LP EQ 0.021% BASE N020949 002 Apr 30, 2001
ALBUTEROL SULFATE
AN AKORN EQ 0.5% BASE A074543 001 Jan 15, 1998
AN LUOXIN AUROVITAS EQ 0.083% BASE A206224 001 Oct 17, 2017
AN NEPHRON EQ 0.021% BASE A076355 002 Mar 31, 2010
AN ! EQ 0.042% BASE A076355 001 Jun 28, 2004
AN ! EQ 0.083% BASE A074880 001 Sep 17, 1997
AN ! EQ 0.5% BASE A075664 001 Jun 26, 2001
AN RITEDOSE CORP EQ 0.021% BASE A214531 001 Dec 28, 2021
AN EQ 0.042% BASE A214531 002 Dec 28, 2021
AN EQ 0.083% BASE A077839 001 Dec 16, 2008
AN SUN PHARM EQ 0.083% BASE A207857 001 Jul 21, 2017
AN WATSON LABS EQ 0.021% BASE A077772 001 Sep 25, 2007
AN EQ 0.042% BASE A077772 002 Sep 25, 2007
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-12(of 474)

ALBUTEROL SULFATE
SYRUP;ORAL
ALBUTEROL SULFATE
AA AKORN EQ 2MG BASE/5ML A074749 001 Jan 30, 1998
AA AMNEAL PHARMS EQ 2MG BASE/5ML A079241 001 May 12, 2010
AA CHARTWELL MOLECULAR EQ 2MG BASE/5ML A078105 001 Dec 27, 2006
AA CHARTWELL RX EQ 2MG BASE/5ML A077788 001 Jun 26, 2007
AA COSETTE EQ 2MG BASE/5ML A074454 001 Sep 25, 1995
AA QUAGEN EQ 2MG BASE/5ML A212197 001 Sep 06, 2019
AA ! TEVA EQ 2MG BASE/5ML A073419 001 Mar 30, 1992
TABLET;ORAL
ALBUTEROL SULFATE
AB AIZANT EQ 2MG BASE A210948 001 Mar 15, 2019
AB EQ 4MG BASE A210948 002 Mar 15, 2019
AB AMNEAL PHARMS CO EQ 2MG BASE A208804 001 May 21, 2018
AB EQ 4MG BASE A208804 002 May 21, 2018
AB MYLAN EQ 2MG BASE A072894 002 Jan 17, 1991
AB ! EQ 4MG BASE A072894 001 Jan 17, 1991
AB RISING EQ 2MG BASE A207046 001 Jun 29, 2018
AB EQ 4MG BASE A207046 002 Jun 29, 2018
AB SUN PHARM EQ 2MG BASE A072637 002 Dec 05, 1989
INDUSTRIES
AB EQ 4MG BASE A072637 001 Dec 05, 1989
AB VIRTUS PHARM EQ 2MG BASE A211397 001 Oct 26, 2018
AB EQ 4MG BASE A211397 002 Oct 26, 2018
AB ZYDUS PHARMS EQ 2MG BASE A208884 001 Oct 22, 2020
AB EQ 4MG BASE A208884 002 Oct 22, 2020
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE
SOLUTION;INHALATION
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
AN CIPLA EQ 0.083% BASE;0.017% A077559 001 Dec 31, 2007
AN ! NEPHRON EQ 0.083% BASE;0.017% A076749 001 Dec 31, 2007
AN RITEDOSE CORP EQ 0.083% BASE;0.017% A202496 001 Oct 01, 2012
AN SUN PHARM EQ 0.083% BASE;0.017% A207875 001 Aug 07, 2017
SPRAY, METERED;INHALATION
COMBIVENT RESPIMAT
+! BOEHRINGER EQ 0.1MG BASE/INH;0.02MG/INH N021747 001 Oct 07, 2011
INGELHEIM
ALCLOMETASONE DIPROPIONATE
CREAM;TOPICAL
ALCLOMETASONE DIPROPIONATE
AB ! FOUGERA PHARMS 0.05% A076973 001 Jul 12, 2005
AB GLENMARK GENERICS 0.05% A079061 001 Jun 23, 2009
AB TARO 0.05% A076587 001 Sep 15, 2005
OINTMENT;TOPICAL
ALCLOMETASONE DIPROPIONATE
AB ! FOUGERA PHARMS 0.05% A076884 001 Jul 18, 2005
AB GLENMARK GENERICS 0.05% A079227 001 Jul 30, 2009
AB TARO 0.05% A076730 001 Jul 29, 2004
ALCOHOL
SOLUTION;INTRA-ARTERIAL
ABLYSINOL
+ BPI LABS 99% (1ML) N207987 001 Jun 21, 2018
+! 99% (5ML) N207987 002 Jun 21, 2018
ALECTINIB HYDROCHLORIDE
CAPSULE;ORAL
ALECENSA
+! HOFFMANN-LA ROCHE EQ 150MG BASE N208434 001 Dec 11, 2015
ALENDRONATE SODIUM
SOLUTION;ORAL
ALENDRONATE SODIUM
! HIKMA EQ 70MG BASE/75ML A090520 001 Feb 25, 2013
TABLET;ORAL
ALENDRONATE SODIUM
AB APOTEX EQ 5MG BASE A077982 001 Aug 04, 2008
AB EQ 10MG BASE A077982 002 Aug 04, 2008
AB EQ 35MG BASE A077982 003 Aug 04, 2008
AB EQ 70MG BASE A077982 004 Aug 04, 2008
AB AUROBINDO PHARMA EQ 10MG BASE A090124 001 Aug 04, 2008
AB EQ 35MG BASE A090124 002 Aug 04, 2008
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-13(of 474)

ALENDRONATE SODIUM
TABLET;ORAL
ALENDRONATE SODIUM
AB EQ 70MG BASE A090124 003 Aug 04, 2008
AB CIPLA EQ 5MG BASE A076768 001 Aug 04, 2008
AB EQ 10MG BASE A076768 002 Aug 04, 2008
AB EQ 35MG BASE A076768 003 Aug 04, 2008
AB EQ 40MG BASE A076768 004 Aug 04, 2008
AB EQ 70MG BASE A076768 005 Aug 04, 2008
AB HANGZHOU BINJIANG EQ 5MG BASE A090258 001 Sep 24, 2009
AB EQ 10MG BASE A090258 002 Sep 24, 2009
AB EQ 35MG BASE A090258 003 Sep 24, 2009
AB EQ 70MG BASE A090258 004 Sep 24, 2009
AB SUN PHARM EQ 5MG BASE A090022 001 Sep 10, 2008
AB EQ 10MG BASE A090022 002 Sep 10, 2008
AB EQ 35MG BASE A090022 003 Sep 10, 2008
AB EQ 70MG BASE A090022 004 Sep 10, 2008
AB WATSON LABS EQ 35MG BASE A076984 001 Aug 04, 2008
AB EQ 40MG BASE A076984 002 Aug 04, 2008
AB EQ 70MG BASE A076984 003 Aug 04, 2008
FOSAMAX
AB +! ORGANON EQ 70MG BASE N020560 005 Oct 20, 2000
TABLET, EFFERVESCENT;ORAL
BINOSTO
+! ASCEND THERAPS US EQ 70MG BASE N202344 001 Mar 12, 2012
ALENDRONATE SODIUM; CHOLECALCIFEROL
TABLET;ORAL
FOSAMAX PLUS D
+ ORGANON LLC EQ 70MG BASE;2,800 IU N021762 001 Apr 07, 2005
+! EQ 70MG BASE;5,600 IU N021762 002 Apr 26, 2007
ALFENTANIL HYDROCHLORIDE
INJECTABLE;INJECTION
ALFENTA
AP +! AKORN EQ 0.5MG BASE/ML N019353 001 Dec 29, 1986
ALFENTANIL
AP HOSPIRA EQ 0.5MG BASE/ML A075221 001 Oct 28, 1999
ALFUZOSIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
ALFUZOSIN HYDROCHLORIDE
AB APOTEX INC 10MG A079013 001 Jul 18, 2011
AB AUROBINDO PHARMA 10MG A079060 001 Aug 30, 2012
LTD
AB INVAGEN PHARMS 10MG A090284 001 Jan 17, 2012
AB SUN PHARM 10MG A079057 001 Jul 18, 2011
AB UNICHEM 10MG A203192 001 Jan 28, 2016
UROXATRAL
AB +! CONCORDIA 10MG N021287 001 Jun 12, 2003
ALISKIREN HEMIFUMARATE
TABLET;ORAL
ALISKIREN HEMIFUMARATE
AB ANCHEN PHARMS EQ 150MG BASE A206665 001 Mar 22, 2019
AB EQ 300MG BASE A206665 002 Mar 22, 2019
TEKTURNA
AB + NODEN PHARMA EQ 150MG BASE N021985 001 Mar 05, 2007
AB +! EQ 300MG BASE N021985 002 Mar 05, 2007
ALITRETINOIN
GEL;TOPICAL
PANRETIN
+! CONCORDIA EQ 0.1% BASE N020886 001 Feb 02, 1999
ALLOPURINOL
TABLET;ORAL
ALLOPURINOL
AB ACCORD HLTHCARE 100MG A203154 001 May 06, 2013
AB ! 300MG A203154 002 May 06, 2013
AB CHARTWELL 100MG A077353 001 Sep 08, 2005
AB 300MG A077353 002 Sep 08, 2005
AB HARMAN FINOCHEM 100MG A214443 001 Mar 07, 2022
AB 300MG A214443 002 Mar 07, 2022
AB INDOCO 100MG A204467 001 Jul 28, 2016
AB 300MG A204467 002 Jul 28, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-14(of 474)

ALLOPURINOL
TABLET;ORAL
ALLOPURINOL
AB IPCA LABS LTD 100MG A090637 001 Mar 16, 2011
AB 300MG A090637 002 Mar 16, 2011
AB MYLAN 100MG A018659 001 Oct 24, 1986
AB 300MG A018659 002 Oct 24, 1986
AB NORTHSTAR HLTHCARE 100MG A078253 001 Sep 11, 2007
AB 300MG A078253 002 Sep 11, 2007
AB SUN PHARM 100MG A071450 002 Jan 09, 1987
INDUSTRIES
AB 300MG A071450 001 Jan 09, 1987
AB UNICHEM 100MG A211820 001 Mar 12, 2019
AB 300MG A211820 002 Mar 12, 2019
AB VINTAGE PHARMS 100MG A075798 001 Jun 27, 2003
AB 300MG A075798 002 Jun 27, 2003
AB WATSON LABS 100MG N018832 002 Sep 28, 1984
AB 300MG N018877 001 Sep 28, 1984
AB ZYDUS PHARMS 100MG A210117 001 Oct 12, 2017
AB 300MG A210117 002 Oct 12, 2017
LOPURIN
AB DR REDDYS LA 100MG A071586 001 Apr 02, 1987
AB 300MG A071587 001 Apr 02, 1987
ZYLOPRIM
AB + CASPER PHARMA LLC 100MG N016084 001
AB + 300MG N016084 002
+ 200MG N016084 003 Aug 04, 2022
ALLOPURINOL SODIUM
INJECTABLE;INJECTION
ALLOPURINOL SODIUM
AP GLAND PHARMA LTD EQ 500MG BASE/VIAL A212363 001 Jan 26, 2022
AP HIKMA EQ 500MG BASE/VIAL A076870 001 Aug 26, 2004
ALOPRIM
AP +! MYLAN EQ 500MG BASE/VIAL N020298 001 May 17, 1996
ALMOTRIPTAN MALATE
TABLET;ORAL
ALMOTRIPTAN MALATE
AB AJANTA PHARMA LTD EQ 6.25MG BASE A205523 001 Mar 03, 2016
AB ! EQ 12.5MG BASE A205523 002 Mar 03, 2016
AB MYLAN EQ 6.25MG BASE A205171 001 Nov 09, 2015
AB EQ 12.5MG BASE A205171 002 Nov 09, 2015
AB TEVA PHARMS USA EQ 6.25MG BASE A078027 001 Jul 07, 2015
AB EQ 12.5MG BASE A078027 002 Jul 07, 2015
ALOGLIPTIN BENZOATE
TABLET;ORAL
NESINA
+ TAKEDA PHARMS USA EQ 6.25MG BASE N022271 001 Jan 25, 2013
+ EQ 12.5MG BASE N022271 002 Jan 25, 2013
+! EQ 25MG BASE N022271 003 Jan 25, 2013
ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE
TABLET;ORAL
KAZANO
+ TAKEDA PHARMS USA EQ 12.5MG BASE;500MG N203414 001 Jan 25, 2013
+! EQ 12.5MG BASE;1GM N203414 002 Jan 25, 2013
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
TABLET;ORAL
OSENI
+ TAKEDA PHARMS USA EQ 12.5MG BASE;EQ 30MG BASE N022426 005 Jan 25, 2013
+ EQ 25MG BASE;EQ 15MG BASE N022426 001 Jan 25, 2013
+ EQ 25MG BASE;EQ 30MG BASE N022426 002 Jan 25, 2013
+! EQ 25MG BASE;EQ 45MG BASE N022426 003 Jan 25, 2013
ALOSETRON HYDROCHLORIDE
TABLET;ORAL
ALOSETRON HYDROCHLORIDE
AB AMNEAL PHARMS EQ 0.5MG BASE A206647 001 Dec 22, 2016
AB EQ 1MG BASE A206647 002 Dec 22, 2016
AB HIKMA EQ 0.5MG BASE A200652 001 May 04, 2015
AB EQ 1MG BASE A200652 002 May 04, 2015
AB MANKIND PHARMA EQ 0.5MG BASE A213614 001 Sep 09, 2020
AB EQ 1MG BASE A213614 002 Sep 09, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-15(of 474)

ALOSETRON HYDROCHLORIDE
TABLET;ORAL
ALOSETRON HYDROCHLORIDE
AB RISING EQ 0.5MG BASE A209180 001 Jan 14, 2019
AB EQ 1MG BASE A209180 002 Jan 14, 2019
LOTRONEX
AB + SEBELA IRELAND LTD EQ 0.5MG BASE N021107 002 Dec 23, 2003
AB +! EQ 1MG BASE N021107 001 Feb 09, 2000
ALPELISIB
TABLET;ORAL
PIQRAY
+ NOVARTIS 50MG N212526 001 May 24, 2019
+ 150MG N212526 002 May 24, 2019
+! 200MG N212526 003 May 24, 2019
VIJOICE
+ NOVARTIS 50MG N215039 001 Apr 05, 2022
+ 125MG N215039 002 Apr 05, 2022
+! 200MG N215039 003 Apr 05, 2022
ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL;
FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE
HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K
SOLUTION;INTRAVENOUS
INFUVITE ADULT
+! SANDOZ CANADA INC 2 IU/ML;40MG/ML;12MCG/ML;40 N021163 001 May 18, 2000
IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1
.2MG/ML;0.72MG/ML;1.2MG/ML;660
IU/ML;0.03MG/ML
+! 2 IU/ML;40MG/ML;12MCG/ML;40 N021163 002 Jun 16, 2003
IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1
.2MG/ML;0.72MG/ML;1.2MG/ML;660
IU/ML;30MCG/ML
ALPRAZOLAM
CONCENTRATE;ORAL
ALPRAZOLAM
! HIKMA 1MG/ML A074312 001 Oct 31, 1993
TABLET;ORAL
ALPRAZOLAM
AB ACTAVIS ELIZABETH 0.25MG A074342 001 Oct 31, 1993
AB 0.5MG A074342 002 Oct 31, 1993
AB 1MG A074342 003 Oct 31, 1993
AB 2MG A074342 004 Oct 31, 1993
AB APOTEX INC 0.25MG A077741 001 Jan 19, 2007
AB 0.5MG A077741 002 Jan 19, 2007
AB 1MG A077741 003 Jan 19, 2007
AB 2MG A077741 004 Jan 19, 2007
AB AUROBINDO PHARMA 0.25MG A203346 001 Jul 31, 2015
AB 0.5MG A203346 002 Jul 31, 2015
AB 1MG A203346 003 Jul 31, 2015
AB 2MG A203346 004 Jul 31, 2015
AB BRECKENRIDGE 0.25MG A207507 001 Jul 09, 2018
AB 0.5MG A207507 002 Jul 09, 2018
AB 1MG A207507 003 Jul 09, 2018
AB 2MG A207507 004 Jul 09, 2018
AB NATCO 0.25MG A200739 001 Apr 15, 2015
AB 0.5MG A200739 002 Apr 15, 2015
AB 1MG A200739 003 Apr 15, 2015
AB 2MG A200739 004 Apr 15, 2015
AB NOVITIUM PHARMA 0.25MG A074174 001 Oct 19, 1993
AB 0.5MG A074174 002 Oct 19, 1993
AB 1MG A074174 003 Oct 19, 1993
AB 2MG A074174 004 Oct 19, 1993
AB SANDOZ 0.25MG A074112 001 Dec 29, 1995
AB 0.5MG A074112 002 Dec 29, 1995
AB 1MG A074112 003 Dec 29, 1995
AB 2MG A074909 001 Mar 25, 1998
AB STRIDES PHARMA 0.25MG A090248 001 Sep 17, 2010
AB 0.5MG A090248 002 Sep 17, 2010
AB 1MG A090248 003 Sep 17, 2010
AB 2MG A090248 004 Sep 17, 2010
AB SUN PHARM 0.25MG A090082 001 Jun 17, 2010
AB 0.5MG A090082 002 Jun 17, 2010
AB 1MG A090082 003 Jun 17, 2010
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-16(of 474)

ALPRAZOLAM
TABLET;ORAL
ALPRAZOLAM
AB 2MG A090082 004 Jun 17, 2010
XANAX
AB + UPJOHN 0.25MG N018276 001
AB + 0.5MG N018276 002
AB +! 1MG N018276 003
AB + 2MG N018276 004 Nov 27, 1985
TABLET, EXTENDED RELEASE;ORAL
ALPRAZOLAM
AB ACTAVIS ELIZABETH 0.5MG A078056 001 Feb 13, 2007
AB 1MG A078056 002 Feb 13, 2007
AB 2MG A078056 003 Feb 13, 2007
AB 3MG A078056 004 Feb 13, 2007
AB AMNEAL PHARMS NY 0.5MG A078387 001 May 30, 2008
AB 1MG A078387 002 May 30, 2008
AB 2MG A078387 003 May 30, 2008
AB 3MG A078387 004 May 30, 2008
AB ANCHEN PHARMS 0.5MG A078469 001 Sep 29, 2011
AB 1MG A078469 002 Sep 29, 2011
AB 2MG A078469 003 Sep 29, 2011
AB 3MG A078469 004 Sep 29, 2011
AB APOTEX INC 0.5MG A078449 001 Nov 12, 2008
AB 1MG A078449 004 Dec 23, 2015
AB 2MG A078449 002 Nov 12, 2008
AB 3MG A078449 003 Nov 12, 2008
AB AUROBINDO PHARMA 0.5MG A090871 001 Jun 07, 2011
AB 1MG A090871 002 Jun 07, 2011
AB 2MG A090871 003 Jun 07, 2011
AB 3MG A090871 004 Jun 07, 2011
XANAX XR
AB + UPJOHN 0.5MG N021434 001 Jan 17, 2003
AB + 1MG N021434 002 Jan 17, 2003
AB + 2MG N021434 003 Jan 17, 2003
AB +! 3MG N021434 004 Jan 17, 2003
TABLET, ORALLY DISINTEGRATING;ORAL
ALPRAZOLAM
AB ACTAVIS ELIZABETH 0.25MG A078561 001 Mar 16, 2010
AB 0.5MG A078561 002 Mar 16, 2010
AB 1MG A078561 003 Mar 16, 2010
AB 2MG A078561 004 Mar 16, 2010
AB PAR PHARM 0.25MG A078088 001 Jan 09, 2009
AB 0.5MG A078088 002 Jan 09, 2009
AB ! 1MG A078088 003 Jan 09, 2009
AB 2MG A078088 004 Jan 09, 2009
ALPROSTADIL
INJECTABLE;INJECTION
ALPROSTADIL
AP HIKMA 0.5MG/ML A074815 001 Jan 20, 1998
AP TEVA PHARMS USA 0.5MG/ML A075196 001 Apr 30, 1999
CAVERJECT
AP + PFIZER 0.01MG/VIAL N020379 001 Jul 06, 1995
AP +! 0.02MG/VIAL N020379 002 Jul 06, 1995
AP +! 0.04MG/VIAL N020379 004 May 19, 1997
EDEX
AP + AUXILIUM PHARMS LLC 0.01MG/VIAL N020649 002 Jun 12, 1997
AP + 0.02MG/VIAL N020649 003 Jun 12, 1997
AP +! 0.04MG/VIAL N020649 004 Jun 12, 1997
PROSTIN VR PEDIATRIC
AP +! PFIZER 0.5MG/ML N018484 001
CAVERJECT IMPULSE
PFIZER 0.01MG/VIAL N021212 001 Jun 11, 2002
0.02MG/VIAL N021212 002 Jun 11, 2002
EDEX
+! AUXILIUM PHARMS LLC 0.01MG/VIAL N020649 005 Jul 30, 1998
+! 0.02MG/VIAL N020649 006 Jul 30, 1998
+! 0.04MG/VIAL N020649 007 Jul 30, 1998
SUPPOSITORY;URETHRAL
MUSE
+! MYLAN SPECIALITY LP 0.25MG N020700 002 Nov 19, 1996
+! 0.5MG N020700 003 Nov 19, 1996
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-17(of 474)

ALPROSTADIL
SUPPOSITORY;URETHRAL
MUSE
+! 1MG N020700 004 Nov 19, 1996
ALVIMOPAN
CAPSULE;ORAL
ALVIMOPAN
AB WATSON LABS TEVA 12MG A208295 001 Dec 19, 2019
ENTEREG
AB +! CUBIST PHARMS 12MG N021775 001 May 20, 2008
AMANTADINE HYDROCHLORIDE
CAPSULE;ORAL
AMANTADINE HYDROCHLORIDE
AB ALEMBIC PHARMS 100MG A208966 001 Jun 21, 2017
AB ! BIONPHARMA INC 100MG A078720 001 May 29, 2008
AB HERITAGE PHARMA 100MG A209171 001 Jun 12, 2017
AB HUMANWELL PURACAP 100MG A214580 001 Dec 20, 2022
AB NOVELGENIX THERAPS 100MG A210129 001 Mar 02, 2020
AB RUBICON 100MG A212044 001 May 21, 2020
AB SANDOZ 100MG A071293 001 Feb 18, 1987
AB STRIDES PHARMA 100MG A211354 001 Feb 18, 2022
AB UPSHER SMITH LABS 100MG A070589 001 Aug 05, 1986
AB ZYDUS PHARMS 100MG A208278 001 May 31, 2016
BX STRIDES PHARMA 100MG A209047 001 Jun 07, 2017
CAPSULE, EXTENDED RELEASE;ORAL
GOCOVRI
+ ADAMAS OPERATIONS EQ 68.5MG BASE N208944 001 Aug 24, 2017
+! EQ 137MG BASE N208944 002 Aug 24, 2017
SYRUP;ORAL
AMANTADINE HYDROCHLORIDE
AA ! AKORN 50MG/5ML A074170 001 Oct 28, 1994
AA ! CHARTWELL RX 50MG/5ML A074028 001 Jun 28, 1993
AA ! CMP PHARMA INC 50MG/5ML A075819 001 Sep 11, 2002
AA NOVELGENIX THERAPS 50MG/5ML A214178 001 Aug 20, 2021
AA ! PHARM ASSOC 50MG/5ML A074509 001 Jul 17, 1995
TABLET;ORAL
AMANTADINE HYDROCHLORIDE
AB ALEMBIC PHARMS 100MG A214284 001 Oct 15, 2020
AB NOVELGENIX THERAPS 100MG A210215 001 Mar 10, 2020
AB ! UPSHER SMITH LABS 100MG A076186 001 Dec 16, 2002
AB WATSON LABS INC 100MG A208096 001 Dec 15, 2016
BX STRIDES PHARMA 100MG A209035 001 Jun 09, 2017
TABLET, EXTENDED RELEASE;ORAL
OSMOLEX ER
+ ADAMAS OPERATIONS EQ 129MG BASE N209410 001 Feb 16, 2018
+ EQ 193MG BASE N209410 002 Feb 16, 2018
AMBRISENTAN
TABLET;ORAL
AMBRISENTAN
AB APOTEX 5MG A210701 001 May 19, 2022
AB 10MG A210701 002 May 19, 2022
AB AUROBINDO PHARMA 5MG A216531 001 Jul 21, 2022
AB 10MG A216531 002 Jul 21, 2022
AB CIPLA 5MG A210715 001 Apr 26, 2019
AB 10MG A210715 002 Apr 26, 2019
AB MYLAN 5MG A208441 001 Mar 28, 2019
AB 10MG A208441 002 Mar 28, 2019
AB PAR PHARM INC 5MG A209509 001 Apr 10, 2019
AB 10MG A209509 002 Apr 10, 2019
AB SIGMAPHARM LABS LLC 5MG A208354 001 Apr 10, 2019
AB 10MG A208354 002 Apr 10, 2019
AB SUN PHARM 5MG A210784 001 Mar 28, 2019
AB 10MG A210784 002 Mar 28, 2019
AB WATSON LABS INC 5MG A208252 001 Mar 28, 2019
AB 10MG A208252 002 Mar 28, 2019
AB ZYDUS PHARMS 5MG A210058 001 Mar 28, 2019
AB 10MG A210058 002 Mar 28, 2019
LETAIRIS
AB + GILEAD 5MG N022081 001 Jun 15, 2007
AB +! 10MG N022081 002 Jun 15, 2007
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-18(of 474)

AMCINONIDE
CREAM;TOPICAL
AMCINONIDE
AB ! GENUS LIFESCIENCES 0.1% A076065 001 May 15, 2003
AB TARO PHARM INDS 0.1% A076229 001 May 31, 2002
LOTION;TOPICAL
AMCINONIDE
! ANDA REPOSITORY 0.1% A076329 001 Nov 06, 2002
OINTMENT;TOPICAL
AMCINONIDE
AB ! ANDA REPOSITORY 0.1% A076096 001 Nov 19, 2002
AB TARO PHARM INDS 0.1% A076367 001 Mar 19, 2003
AMIFAMPRIDINE PHOSPHATE
TABLET;ORAL
FIRDAPSE
+! CATALYST PHARMS EQ 10MG BASE N208078 001 Nov 28, 2018
AMIFOSTINE
INJECTABLE;INJECTION
AMIFOSTINE
AP SUN PHARM 500MG/VIAL A077126 001 Mar 14, 2008
ETHYOL
AP +! CLINIGEN 500MG/VIAL N020221 001 Dec 08, 1995
AMIKACIN SULFATE
INJECTABLE;INJECTION
AMIKACIN SULFATE
AP ! EMCURE PHARMS LTD EQ 250MG BASE/ML A204040 001 Dec 12, 2013
AP FRESENIUS KABI USA EQ 50MG BASE/ML A205605 001 Dec 09, 2015
AP EQ 250MG BASE/ML A205604 001 Dec 09, 2015
AP ! HIKMA EQ 50MG BASE/ML A063313 001 Apr 11, 1994
AP EQ 250MG BASE/ML A063315 001 Apr 11, 1994
AP SAGENT PHARMS INC EQ 250MG BASE/ML A203323 001 May 12, 2016
AP TEVA PHARMS USA EQ 250MG BASE/ML A064045 002 Sep 28, 1993
SUSPENSION, LIPOSOMAL;INHALATION
ARIKAYCE KIT
+! INSMED INC EQ 590MG BASE/8.4ML N207356 001 Sep 28, 2018
AMILORIDE HYDROCHLORIDE
TABLET;ORAL
AMILORIDE HYDROCHLORIDE
AB ! PAR PHARM 5MG A070346 001 Jan 22, 1986
AB SIGMAPHARM LABS LLC 5MG A079133 001 Jan 30, 2009
MIDAMOR
AB + PADAGIS US 5MG N018200 001
AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
TABLET;ORAL
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
AB BARR EQ 5MG ANHYDROUS;50MG A071111 001 May 10, 1988
AB ! RISING EQ 5MG ANHYDROUS;50MG A073209 001 Oct 31, 1991
AMINO ACIDS
INJECTABLE;INJECTION
AMINO ACIDS
B BRAUN 15%(150GM/1000ML) A091112 001 Apr 13, 2012
15%(300GM/2000ML) A091112 002 Apr 13, 2012
AMINOSYN II 10% IN PLASTIC CONTAINER
ICU MEDICAL INC 10% (10GM/100ML) N020015 001 Dec 19, 1991
AMINOSYN II 15% IN PLASTIC CONTAINER
ICU MEDICAL INC 15% (15GM/100ML) N020041 001 Dec 19, 1991
AMINOSYN-PF 10%
ICU MEDICAL INC 10% (10GM/100ML) N019492 002 Oct 17, 1986
AMINOSYN-PF 7%
ICU MEDICAL INC 7% (7GM/100ML) N019398 001 Sep 06, 1985
CLINISOL 15% SULFITE FREE IN PLASTIC CONTAINER
BAXTER HLTHCARE 15% (15GM/100ML) A020512 001 Aug 30, 1996
FREAMINE HBC 6.9%
B BRAUN 6.9% (6.9GM/100ML) N016822 006 May 17, 1983
FREAMINE III 10%
B BRAUN 10% (10GM/100ML) N016822 005
FREAMINE III 8.5%
B BRAUN 8.5% (8.5GM/100ML) N016822 004
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-19(of 474)

AMINO ACIDS
INJECTABLE;INJECTION
HEPATAMINE 8%
B BRAUN 8% (8GM/100ML) N018676 001 Aug 03, 1982
PREMASOL 10% IN PLASTIC CONTAINER
BAXTER HLTHCARE 10% (10GM/100ML) A075880 002 Jun 19, 2003
PREMASOL 6% IN PLASTIC CONTAINER
BAXTER HLTHCARE 6% (6GM/100ML) A075880 001 Jun 19, 2003
PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 20% (20GM/100ML) N020849 001 Aug 26, 1998
TRAVASOL 10% IN PLASTIC CONTAINER
BAXTER HLTHCARE 10% (10MG/100ML) N018931 003 Aug 23, 1984
TRAVASOL 5.5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 5.5% (5.5GM/100ML) N018931 001 Aug 23, 1984
TRAVASOL 8.5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 8.5% (8.5GM/100ML) N018931 002 Aug 23, 1984
TROPHAMINE
+! B BRAUN 6% (6GM/100ML) N019018 001 Jul 20, 1984
TROPHAMINE 10%
+! B BRAUN 10% (10GM/100ML) N019018 003 Sep 07, 1988
AMINO ACIDS; CALCIUM ACETATE; GLYCERIN; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE;
SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
PROCALAMINE
B BRAUN 3%;26MG/100ML;3GM/100ML;54MG/100ML;41MG N018582 001 May 08, 1982
/100ML;150MG/100ML;200MG/100ML;120MG/10
0ML
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM
ACETATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
CLINIMIX E 2.75/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 2.75%;33MG/100ML;10GM/100ML;51MG/100ML; N020678 002 Mar 26, 1997
261MG/100ML;217MG/100ML;112MG/100ML
CLINIMIX E 2.75/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 2.75%;33MG/100ML;25GM/100ML;51MG/100ML; N020678 005 Mar 26, 1997
261MG/100ML;217MG/100ML;112MG/100ML
CLINIMIX E 2.75/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 2.75%;33MG/100ML;5GM/100ML;51MG/100ML;2 N020678 001 Mar 26, 1997
61MG/100ML;217MG/100ML;112MG/100ML
CLINIMIX E 4.25/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 4.25%;33MG/100ML;10GM/100ML;51MG/100ML; N020678 009 Mar 26, 1997
261MG/100ML;297MG/100ML;77MG/100ML
CLINIMIX E 4.25/20 SULFITE FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 4.25%;33MG/100ML;20GM/100ML;51MG/100ML; N020678 011 Mar 26, 1997
261MG/100ML;297MG/100ML;77MG/100ML
CLINIMIX E 4.25/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 4.25%;33MG/100ML;25GM/100ML;51MG/100ML; N020678 012 Mar 26, 1997
261MG/100ML;297MG/100ML;77MG/100ML
CLINIMIX E 4.25/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 4.25%;33MG/100ML;5GM/100ML;51MG/100ML;2 N020678 008 Mar 26, 1997
61MG/100ML;297MG/100ML;77MG/100ML
CLINIMIX E 5/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 5%;33MG/100ML;10GM/100ML;51MG/100ML;261 N020678 016 Mar 26, 1997
MG/100ML;340MG/100ML;59MG/100ML
CLINIMIX E 5/15 SULFITE FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 5%;33MG/100ML;15GM/100ML;51MG/100ML;261 N020678 017 Mar 26, 1997
MG/100ML;340MG/100ML;59MG/100ML
CLINIMIX E 5/20 SULFITE FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 5%;33MG/100ML;20GM/100ML;51MG/100ML;261 N020678 018 Mar 26, 1997
MG/100ML;340MG/100ML;59MG/100ML
CLINIMIX E 5/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 5%;33MG/100ML;25GM/100ML;51MG/100ML;261 N020678 019 Mar 26, 1997
MG/100ML;340MG/100ML;59MG/100ML
CLINIMIX E 5/35 SULFITE FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 5%;33MG/100ML;35GM/100ML;51MG/100ML;261 N020678 021 Mar 26, 1997
MG/100ML;340MG/100ML;59MG/100ML
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE;
SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL
EMULSION;INTRAVENOUS
KABIVEN IN PLASTIC CONTAINER
+ FRESENIUS KABI USA 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML; N200656 004 Aug 25, 2014
174MG/100ML;239MG/100ML
;147MG/100ML;3.9GM/100ML (1026ML)
+ 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML; N200656 005 Aug 25, 2014
174MG/100ML;239MG/100ML;147MG/100ML;3.9
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-20(of 474)

AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE;
SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL
EMULSION;INTRAVENOUS
KABIVEN IN PLASTIC CONTAINER
GM/100ML (1540ML)
+ 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML; N200656 006 Aug 25, 2014
174MG/100ML;239MG/100ML;147MG/100ML;3.9
GM/100ML (2053ML)
+! 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML; N200656 007 Aug 25, 2014
174MG/100ML;239MG/100ML;147MG/100ML;3.9
GM/100ML (2566ML)
PERIKABIVEN IN PLASTIC CONTAINER
+ FRESENIUS KABI USA 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML; N200656 001 Aug 25, 2014
124MG/100ML;170MG/100ML;105MG/100ML;3.5
GM/100ML (1440ML)
+ 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML; N200656 002 Aug 25, 2014
124MG/100ML;170MG/100ML;105MG/100ML;3.5
GM/100ML (1920ML)
+! 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML; N200656 003 Aug 25, 2014
124MG/100ML;170MG/100ML
;105MG/100ML;3.5GM/100ML (2400ML)
AMINO ACIDS; DEXTROSE
INJECTABLE;INJECTION
CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER
BAXTER HLTHCARE 2.75%;10GM/100ML N020734 002 Sep 29, 1997
CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER
BAXTER HLTHCARE 2.75%;25GM/100ML N020734 005 Sep 29, 1997
CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 2.75%;5GM/100ML N020734 001 Sep 29, 1997
CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4.25%;10GM/100ML N020734 008 Sep 29, 1997
CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4.25%;20GM/100ML N020734 010 Sep 29, 1997
CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4.25%;25GM/100ML N020734 011 Sep 29, 1997
CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4.25%;5GM/100ML N020734 007 Sep 29, 1997
CLINIMIX 5/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER
BAXTER HLTHCARE 5%;10GM/100ML N020734 014 Sep 29, 1997
CLINIMIX 5/15 SULFITE FREE IN DEXTROSE 15% IN PLASTIC CONTAINER
BAXTER HLTHCARE 5%;15GM/100ML N020734 015 Sep 29, 1997
CLINIMIX 5/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER
BAXTER HLTHCARE 5%;20GM/100ML N020734 016 Sep 29, 1997
CLINIMIX 5/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER
BAXTER HLTHCARE 5%;25GM/100ML N020734 017 Sep 29, 1997
CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER
BAXTER HLTHCARE 5%;35GM/100ML N020734 018 Sep 29, 1997
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM
ACETATE
INJECTABLE;INJECTION
FREAMINE III 8.5% W/ ELECTROLYTES
B BRAUN 8.5%;110MG/100ML;230MG/100ML;10MG/100ML N016822 007 Jul 01, 1988
;440MG/100ML;690MG/100ML
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM
CHLORIDE
INJECTABLE;INJECTION
FREAMINE III 3% W/ ELECTROLYTES
B BRAUN 3%;54MG/100ML;40MG/100ML;150MG/100ML;20 N016822 003
0MG/100ML;120MG/100ML
AMINOCAPROIC ACID
INJECTABLE;INJECTION
AMINOCAPROIC ACID
AP LUITPOLD 250MG/ML A071192 001 Dec 01, 1987
AMINOCAPROIC ACID IN PLASTIC CONTAINER
AP ! HOSPIRA 250MG/ML A070010 001 Mar 09, 1987
SOLUTION;ORAL
AMICAR
AA +! AKORN 0.25GM/ML N015230 002
AMINOCAPROIC ACID
AA AMNEAL 0.25GM/ML A212780 001 Aug 23, 2019
AA ANNORA PHARMA 0.25GM/ML A216464 001 Nov 04, 2022
AA AUROBINDO PHARMA 0.25GM/ML A216804 001 Sep 26, 2022
AA BELCHER 0.25GM/ML A213825 001 Apr 08, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-21(of 474)

AMINOCAPROIC ACID
SOLUTION;ORAL
AMINOCAPROIC ACID
AA CARNEGIE 0.25GM/ML A214140 001 Jan 26, 2021
AA FLORIDA 0.25GM/ML A215510 001 Mar 23, 2022
AA TULEX PHARMS INC 0.25GM/ML A212494 001 Aug 11, 2020
AA VISTAPHARM 0.25GM/ML A212814 001 Feb 26, 2020
TABLET;ORAL
AMICAR
AB + AKORN 500MG N015197 001
AB + 1GM N015197 002 Jun 24, 2004
AMINOCAPROIC ACID
AB AMNEAL 500MG A212492 001 Nov 26, 2019
AB ANI PHARMS 500MG A211629 001 Dec 14, 2020
AB CARNEGIE 500MG A213928 001 Feb 12, 2021
AB 1GM A213928 002 Feb 12, 2021
AB MSN 500MG A212938 001 Nov 06, 2020
AB OPTIMUS 500MG A213944 001 Sep 14, 2022
AB 1GM A213944 002 Sep 14, 2022
AB SUNNY 500MG A209060 001 Nov 27, 2018
AB ! 1GM A209060 002 Nov 27, 2018
AMINOLEVULINIC ACID HYDROCHLORIDE
FOR SOLUTION;ORAL
GLEOLAN
+! NXDC 1.5GM/VIAL N208630 001 Jun 06, 2017
GEL;TOPICAL
AMELUZ
+! BIOFRONTERA 10% N208081 001 May 10, 2016
SOLUTION;TOPICAL
LEVULAN
+! DUSA 20% N020965 001 Dec 03, 1999
AMINOPHYLLINE
INJECTABLE;INJECTION
AMINOPHYLLINE
! HOSPIRA 25MG/ML A087242 001 Oct 26, 1983
AMINOSALICYLIC ACID
GRANULE, DELAYED RELEASE;ORAL
PASER
! EUROCEPT PHARMS 4GM/PACKET A074346 001 Jun 30, 1994
AMIODARONE HYDROCHLORIDE
INJECTABLE;INJECTION
AMIODARONE HYDROCHLORIDE
AP ACELLA 50MG/ML A077610 001 Oct 30, 2008
AP 50MG/ML A077834 001 Oct 30, 2008
AP ! FRESENIUS KABI USA 50MG/ML A075761 001 Oct 15, 2002
AP ! GLAND PHARMA LTD 50MG/ML A077161 001 Apr 20, 2005
AP HIKMA FARMACEUTICA 50MG/ML A077234 001 Feb 25, 2008
AP HOSPIRA 50MG/ML A203884 001 Nov 25, 2013
AP ! MYLAN INSTITUTIONAL 50MG/ML A076217 001 Oct 15, 2002
NEXTERONE
+! BAXTER HLTHCARE 150MG/100ML (1.5MG/ML) N022325 002 Nov 16, 2010
+! 360MG/200ML (1.8MG/ML) N022325 003 Nov 16, 2010
TABLET;ORAL
AMIODARONE HYDROCHLORIDE
AB AUROBINDO PHARMA 200MG A204742 001 Jun 03, 2016
LTD
AB MAYNE PHARMA INC 100MG A075389 002 Dec 28, 2017
AB 200MG A075389 001 Jan 25, 2001
AB 400MG A075389 003 Dec 28, 2017
AB MURTY PHARMS 100MG A077069 003 Oct 04, 2016
AB 200MG A077069 001 Apr 08, 2005
AB 400MG A077069 002 Apr 08, 2005
AB RUBICON 100MG A078578 002 Feb 26, 2021
AB 200MG A078578 001 Nov 06, 2008
AB 400MG A078578 003 Feb 26, 2021
AB TARO 100MG A075424 002 Dec 18, 2002
AB ! 200MG A075424 001 Mar 30, 2001
AB 400MG A076362 001 Nov 29, 2002
AB TEVA PHARMS 200MG A074739 001 Nov 30, 1998
AB UNICHEM 200MG A213446 001 Jul 21, 2020
AB ZYDUS PHARMS USA 100MG A079029 002 Jan 06, 2023
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-22(of 474)

AMIODARONE HYDROCHLORIDE
TABLET;ORAL
AMIODARONE HYDROCHLORIDE
INC
AB 200MG A079029 001 Sep 16, 2008
AB 400MG A079029 003 Jan 06, 2023
PACERONE
AB UPSHER SMITH LABS 100MG A075135 002 Apr 12, 2005
AB 200MG A075135 001 Apr 30, 1998
AB 400MG A075135 003 Jul 02, 2020
AMIODARONE HYDROCHLORIDE
TARO 300MG A076362 002 Dec 02, 2003
AMISULPRIDE
SOLUTION;INTRAVENOUS
BARHEMSYS
+! ACACIA 5MG/2ML (2.5MG/ML) N209510 001 Feb 26, 2020
+! 10MG/4ML (2.5MG/ML) N209510 002 Sep 01, 2020
AMITRIPTYLINE HYDROCHLORIDE
TABLET;ORAL
AMITRIPTYLINE HYDROCHLORIDE
AB ACCORD HLTHCARE 10MG A202446 001 Jun 04, 2014
AB 25MG A202446 002 Jun 04, 2014
AB 50MG A202446 003 Jun 04, 2014
AB 75MG A202446 004 Jun 04, 2014
AB 100MG A202446 005 Jun 04, 2014
AB 150MG A202446 006 Jun 04, 2014
AB LEADING 10MG A216243 001 Jun 06, 2022
AB 25MG A216243 002 Jun 06, 2022
AB 50MG A216243 003 Jun 06, 2022
AB 75MG A216243 004 Jun 06, 2022
AB 100MG A216243 005 Jun 06, 2022
AB 150MG A216243 006 Jun 06, 2022
AB MANKIND PHARMA 10MG A213999 001 Feb 19, 2021
AB 25MG A213999 002 Feb 19, 2021
AB 50MG A213999 003 Feb 19, 2021
AB 75MG A213999 004 Feb 19, 2021
AB 100MG A213999 005 Feb 19, 2021
AB 150MG A213999 006 Feb 19, 2021
AB + SANDOZ 10MG A085968 004
AB +! 25MG A085968 002
AB + 50MG A085968 001
AB + 75MG A085968 006
AB + 100MG A085968 003
AB + 150MG A085968 005
AB SUN PHARM INDS INC 10MG A089399 002 Jul 14, 1987
AB 25MG A089399 001 Jul 14, 1987
AB 50MG A089399 003 Jul 14, 1987
AB 75MG A089399 004 Jul 14, 1987
AB 100MG A089399 005 Jul 14, 1987
AB 150MG A089399 006 Jul 14, 1987
AB UNICHEM 10MG A214548 001 May 19, 2021
AB 25MG A214548 002 May 19, 2021
AB 50MG A214548 003 May 19, 2021
AB 75MG A214548 004 May 19, 2021
AB 100MG A214548 005 May 19, 2021
AB 150MG A214548 006 May 19, 2021
AB ZYDUS PHARMS 10MG A210086 001 Oct 06, 2017
AB 25MG A210086 002 Oct 06, 2017
AB 50MG A210086 003 Oct 06, 2017
AB 75MG A210086 004 Oct 06, 2017
AB 100MG A210086 005 Oct 06, 2017
AB 150MG A210086 006 Oct 06, 2017
AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE
TABLET;ORAL
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE
AB MICRO LABS EQ 12.5MG BASE;5MG A211925 001 Feb 02, 2022
AB EQ 25MG BASE;10MG A211925 002 Feb 02, 2022
AB MYLAN PHARMS INC EQ 12.5MG BASE;5MG A071297 002 Dec 10, 1986
AB ! EQ 25MG BASE;10MG A071297 001 Dec 10, 1986
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-23(of 474)

AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE


TABLET;ORAL
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
MYLAN 10MG;2MG A071443 002 Nov 10, 1988
10MG;4MG A071443 003 Nov 10, 1988
! 25MG;2MG A071443 004 Nov 10, 1988
! 25MG;4MG A071443 005 Nov 10, 1988
! 50MG;4MG A071443 001 Nov 10, 1988
AMLODIPINE BENZOATE
SUSPENSION;ORAL
KATERZIA
+! AZURITY EQ 1MG BASE/ML N211340 001 Jul 08, 2019
AMLODIPINE BESYLATE
SOLUTION;ORAL
NORLIQVA
+! CMP DEV LLC EQ 1MG BASE/ML N214439 001 Feb 24, 2022
TABLET;ORAL
AMLODIPINE BESYLATE
AB ACCORD HLTHCARE EQ 2.5MG BASE A202553 001 Apr 29, 2013
AB EQ 5MG BASE A202553 002 Apr 29, 2013
AB EQ 10MG BASE A202553 003 Apr 29, 2013
AB ALKEM EQ 2.5MG BASE A078925 001 May 04, 2009
AB EQ 5MG BASE A078925 002 May 04, 2009
AB EQ 10MG BASE A078925 003 May 04, 2009
AB APOTEX EQ 2.5MG BASE A076719 001 May 23, 2007
AB EQ 5MG BASE A076719 002 May 23, 2007
AB EQ 10MG BASE A076719 003 May 23, 2007
AB AUROBINDO PHARMA EQ 2.5MG BASE A078021 001 Jul 17, 2007
AB EQ 5MG BASE A078021 002 Jul 17, 2007
AB EQ 10MG BASE A078021 003 Jul 17, 2007
AB CHARTWELL RX EQ 2.5MG BASE A076692 001 Jul 20, 2007
AB EQ 5MG BASE A076692 002 Jul 20, 2007
AB EQ 10MG BASE A076692 003 Jul 20, 2007
AB CHINA RESOURCES EQ 2.5MG BASE A090752 003 May 16, 2016
AB EQ 5MG BASE A090752 001 Apr 15, 2011
AB EQ 10MG BASE A090752 002 Apr 15, 2011
AB CIPLA EQ 2.5MG BASE A077073 001 Sep 26, 2007
AB EQ 5MG BASE A077073 002 Sep 26, 2007
AB EQ 10MG BASE A077073 003 Sep 26, 2007
AB EPIC PHARMA LLC EQ 2.5MG BASE A078552 001 Apr 08, 2009
AB EQ 5MG BASE A078552 002 Apr 08, 2009
AB EQ 10MG BASE A078552 003 Apr 08, 2009
AB INVAGEN PHARMS EQ 2.5MG BASE A077955 001 Aug 28, 2007
AB EQ 2.5MG BASE A206367 001 Dec 10, 2015
AB EQ 5MG BASE A077955 002 Aug 28, 2007
AB EQ 5MG BASE A206367 002 Dec 10, 2015
AB EQ 10MG BASE A077955 003 Aug 28, 2007
AB EQ 10MG BASE A206367 003 Dec 10, 2015
AB LUPIN EQ 2.5MG BASE A078043 001 Jul 12, 2007
AB EQ 5MG BASE A078043 002 Jul 12, 2007
AB EQ 10MG BASE A078043 003 Jul 12, 2007
AB ORBION PHARMS EQ 2.5MG BASE A078453 001 Jul 02, 2009
AB EQ 5MG BASE A078453 002 Jul 02, 2009
AB EQ 10MG BASE A078453 003 Jul 02, 2009
AB OXFORD PHARMS EQ 2.5MG BASE A078414 001 Apr 07, 2010
AB EQ 5MG BASE A078414 002 Apr 07, 2010
AB EQ 10MG BASE A078414 003 Apr 07, 2010
AB POLYGEN PHARMS EQ 2.5MG BASE A207821 001 Jul 11, 2016
AB EQ 5MG BASE A207821 002 Jul 11, 2016
AB EQ 10MG BASE A207821 003 Jul 11, 2016
AB STRIDES PHARMA EQ 2.5MG BASE A077516 001 Jul 11, 2007
AB EQ 5MG BASE A077516 002 Jul 11, 2007
AB EQ 10MG BASE A077516 003 Jul 11, 2007
AB SUN PHARM INDS LTD EQ 2.5MG BASE A077974 001 Jul 09, 2007
AB EQ 5MG BASE A077974 002 Jul 09, 2007
AB EQ 10MG BASE A077974 003 Jul 09, 2007
AB TEVA EQ 2.5MG BASE A076846 001 Jun 28, 2007
AB EQ 5MG BASE A076846 002 Jun 28, 2007
AB EQ 10MG BASE A076846 003 Jun 28, 2007
AB UNICHEM EQ 2.5MG BASE A203245 001 Oct 21, 2013
AB EQ 5MG BASE A203245 002 Oct 21, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-24(of 474)

AMLODIPINE BESYLATE
TABLET;ORAL
AMLODIPINE BESYLATE
AB EQ 10MG BASE A203245 003 Oct 21, 2013
AB ZYDUS PHARMS USA EQ 2.5MG BASE A078226 001 Jul 09, 2007
AB EQ 5MG BASE A078226 002 Jul 09, 2007
AB EQ 10MG BASE A078226 003 Jul 09, 2007
NORVASC
AB + VIATRIS EQ 2.5MG BASE N019787 001 Jul 31, 1992
AB + EQ 5MG BASE N019787 002 Jul 31, 1992
AB +! EQ 10MG BASE N019787 003 Jul 31, 1992
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM
TABLET;ORAL
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
AB APOTEX EQ 5MG BASE;EQ 10MG BASE A205199 001 Nov 18, 2019
AB EQ 5MG BASE;EQ 20MG BASE A205199 002 Nov 18, 2019
AB EQ 5MG BASE;EQ 40MG BASE A205199 003 Nov 18, 2019
AB EQ 5MG BASE;EQ 80MG BASE A205199 004 Nov 18, 2019
AB EQ 10MG BASE;EQ 10MG BASE A205199 005 Nov 18, 2019
AB EQ 10MG BASE;EQ 20MG BASE A205199 006 Nov 18, 2019
AB EQ 10MG BASE;EQ 40MG BASE A205199 007 Nov 18, 2019
AB EQ 10MG BASE;EQ 80MG BASE A205199 008 Nov 18, 2019
AB DR REDDYS EQ 2.5MG BASE;EQ 10MG BASE A203874 001 Mar 07, 2014
AB EQ 2.5MG BASE;EQ 20MG BASE A203874 002 Mar 07, 2014
AB EQ 2.5MG BASE;EQ 40MG BASE A203874 003 Mar 07, 2014
AB EQ 5MG BASE;EQ 10MG BASE A203874 004 Mar 07, 2014
AB EQ 5MG BASE;EQ 20MG BASE A203874 005 Mar 07, 2014
AB EQ 5MG BASE;EQ 40MG BASE A203874 006 Mar 07, 2014
AB EQ 5MG BASE;EQ 80MG BASE A203874 007 Mar 07, 2014
AB EQ 10MG BASE;EQ 10MG BASE A203874 008 Mar 07, 2014
AB EQ 10MG BASE;EQ 20MG BASE A203874 009 Mar 07, 2014
AB EQ 10MG BASE;EQ 40MG BASE A203874 010 Mar 07, 2014
AB EQ 10MG BASE;EQ 80MG BASE A203874 011 Mar 07, 2014
AB MYLAN EQ 5MG BASE;EQ 10MG BASE A200465 004 Nov 29, 2013
AB EQ 5MG BASE;EQ 20MG BASE A200465 005 Nov 29, 2013
AB EQ 5MG BASE;EQ 40MG BASE A200465 006 Nov 29, 2013
AB EQ 5MG BASE;EQ 80MG BASE A200465 007 Nov 29, 2013
AB EQ 10MG BASE;EQ 10MG BASE A200465 008 Nov 29, 2013
AB EQ 10MG BASE;EQ 20MG BASE A200465 009 Nov 29, 2013
AB EQ 10MG BASE;EQ 40MG BASE A200465 010 Nov 29, 2013
AB EQ 10MG BASE;EQ 80MG BASE A200465 011 Nov 29, 2013
AB ZYDUS PHARMS EQ 2.5MG BASE;EQ 10MG BASE A207762 001 Jan 11, 2019
AB EQ 2.5MG BASE;EQ 20MG BASE A207762 002 Jan 11, 2019
AB EQ 2.5MG BASE;EQ 40MG BASE A207762 003 Jan 11, 2019
AB EQ 5MG BASE;EQ 10MG BASE A207762 004 Jan 11, 2019
AB EQ 5MG BASE;EQ 20MG BASE A207762 005 Jan 11, 2019
AB EQ 5MG BASE;EQ 40MG BASE A207762 006 Jan 11, 2019
AB EQ 5MG BASE;EQ 80MG BASE A207762 007 Jan 11, 2019
AB EQ 10MG BASE;EQ 10MG BASE A207762 008 Jan 11, 2019
AB EQ 10MG BASE;EQ 20MG BASE A207762 009 Jan 11, 2019
AB EQ 10MG BASE;EQ 40MG BASE A207762 010 Jan 11, 2019
AB EQ 10MG BASE;EQ 80MG BASE A207762 011 Jan 11, 2019
CADUET
AB + PHARMACIA EQ 2.5MG BASE;EQ 10MG BASE N021540 009 Jul 29, 2004
AB + EQ 2.5MG BASE;EQ 20MG BASE N021540 010 Jul 29, 2004
AB + EQ 2.5MG BASE;EQ 40MG BASE N021540 011 Jul 29, 2004
AB + EQ 5MG BASE;EQ 10MG BASE N021540 001 Jan 30, 2004
AB + EQ 5MG BASE;EQ 20MG BASE N021540 002 Jan 30, 2004
AB + EQ 5MG BASE;EQ 40MG BASE N021540 003 Jan 30, 2004
AB + EQ 5MG BASE;EQ 80MG BASE N021540 004 Jan 30, 2004
AB + EQ 10MG BASE;EQ 10MG BASE N021540 005 Jan 30, 2004
AB + EQ 10MG BASE;EQ 20MG BASE N021540 006 Jan 30, 2004
AB + EQ 10MG BASE;EQ 40MG BASE N021540 007 Jan 30, 2004
AB +! EQ 10MG BASE;EQ 80MG BASE N021540 008 Jan 30, 2004
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
CAPSULE;ORAL
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
AB APOTEX EQ 2.5MG BASE;10MG A091431 001 Dec 30, 2013
AB EQ 5MG BASE;10MG A091431 002 Dec 30, 2013
AB EQ 5MG BASE;20MG A091431 003 Dec 30, 2013
AB EQ 5MG BASE;40MG A091431 004 Dec 30, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-25(of 474)

AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE


CAPSULE;ORAL
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
AB EQ 10MG BASE;20MG A091431 005 Dec 30, 2013
AB EQ 10MG BASE;40MG A091431 006 Dec 30, 2013
AB AUROBINDO PHARMA EQ 2.5MG BASE;10MG A202239 001 Sep 05, 2012
LTD
AB EQ 5MG BASE;10MG A202239 002 Sep 05, 2012
AB EQ 5MG BASE;20MG A202239 003 Sep 05, 2012
AB EQ 5MG BASE;40MG A202239 004 Sep 05, 2012
AB EQ 10MG BASE;20MG A202239 005 Sep 05, 2012
AB EQ 10MG BASE;40MG A202239 006 Sep 05, 2012
AB DR REDDYS LABS INC EQ 2.5MG BASE;10MG A077183 001 Apr 15, 2010
AB EQ 5MG BASE;10MG A077183 002 Apr 15, 2010
AB EQ 5MG BASE;20MG A077183 003 Apr 15, 2010
AB EQ 5MG BASE;40MG A090149 001 Jul 05, 2011
AB EQ 10MG BASE;20MG A077183 004 Apr 15, 2010
AB EQ 10MG BASE;40MG A090149 002 Jul 05, 2011
AB LUPIN PHARMS EQ 2.5MG BASE;10MG A078466 001 Feb 05, 2010
AB EQ 5MG BASE;10MG A078466 002 Feb 05, 2010
AB EQ 5MG BASE;20MG A078466 003 Feb 05, 2010
AB EQ 5MG BASE;40MG A078466 005 Jul 05, 2011
AB EQ 10MG BASE;20MG A078466 004 Feb 05, 2010
AB EQ 10MG BASE;40MG A078466 006 Jul 05, 2011
AB WATSON LABS EQ 2.5MG BASE;10MG A077890 001 Oct 14, 2010
AB EQ 5MG BASE;10MG A077890 002 Oct 14, 2010
AB EQ 5MG BASE;20MG A077890 003 Oct 14, 2010
AB EQ 10MG BASE;20MG A077890 004 Oct 14, 2010
AB WATSON LABS INC EQ 5MG BASE;40MG A090364 001 Jul 05, 2011
AB EQ 10MG BASE;40MG A090364 002 Jul 05, 2011
LOTREL
AB + NOVARTIS EQ 2.5MG BASE;10MG N020364 002 Mar 03, 1995
AB + EQ 5MG BASE;10MG N020364 003 Mar 03, 1995
AB + EQ 5MG BASE;20MG N020364 004 Mar 03, 1995
AB + EQ 5MG BASE;40MG N020364 007 Apr 11, 2006
AB + EQ 10MG BASE;20MG N020364 005 Jun 20, 2002
AB +! EQ 10MG BASE;40MG N020364 006 Apr 11, 2006
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
TABLET;ORAL
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
AB PAR PHARM INC EQ 5MG BASE;12.5MG;20MG A206137 001 Oct 26, 2016
AB EQ 5MG BASE;12.5MG;40MG A206137 002 Oct 26, 2016
AB EQ 5MG BASE;25MG;40MG A206137 003 Oct 26, 2016
AB EQ 10MG BASE;12.5MG;40MG A206137 004 Oct 26, 2016
AB EQ 10MG BASE;25MG;40MG A206137 005 Oct 26, 2016
AB TEVA PHARMS USA EQ 5MG BASE;12.5MG;20MG A202491 001 Nov 03, 2016
AB EQ 5MG BASE;12.5MG;40MG A202491 002 Nov 03, 2016
AB EQ 5MG BASE;25MG;40MG A202491 003 Nov 03, 2016
AB EQ 10MG BASE;12.5MG;40MG A202491 004 Nov 03, 2016
AB EQ 10MG BASE;25MG;40MG A202491 005 Nov 03, 2016
AB TORRENT EQ 5MG BASE;12.5MG;20MG A203580 001 Oct 26, 2016
AB EQ 5MG BASE;12.5MG;40MG A203580 002 Oct 26, 2016
AB EQ 5MG BASE;25MG;40MG A203580 003 Oct 26, 2016
AB EQ 10MG BASE;12.5MG;40MG A203580 004 Oct 26, 2016
AB EQ 10MG BASE;25MG;40MG A203580 005 Oct 26, 2016
TRIBENZOR
AB + COSETTE EQ 5MG BASE;12.5MG;20MG N200175 001 Jul 23, 2010
AB + EQ 5MG BASE;12.5MG;40MG N200175 002 Jul 23, 2010
AB + EQ 5MG BASE;25MG;40MG N200175 003 Jul 23, 2010
AB + EQ 10MG BASE;12.5MG;40MG N200175 004 Jul 23, 2010
AB +! EQ 10MG BASE;25MG;40MG N200175 005 Jul 23, 2010
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN
TABLET;ORAL
AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE
AB AUROBINDO PHARMA EQ 5MG BASE;12.5MG;160MG A206180 001 Dec 19, 2017
AB EQ 5MG BASE;25MG;160MG A206180 002 Dec 19, 2017
AB EQ 10MG BASE;12.5MG;160MG A206180 003 Dec 19, 2017
AB EQ 10MG BASE;25MG;160MG A206180 004 Dec 19, 2017
AB EQ 10MG BASE;25MG;320MG A206180 005 Dec 19, 2017
AB LUPIN LTD EQ 5MG BASE;12.5MG;160MG A200797 001 Jun 03, 2015
AB EQ 5MG BASE;25MG;160MG A200797 002 Jun 03, 2015
AB EQ 10MG BASE;12.5MG;160MG A200797 003 Jun 03, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-26(of 474)

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN


TABLET;ORAL
AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE
AB EQ 10MG BASE;25MG;160MG A200797 004 Jun 03, 2015
AB EQ 10MG BASE;25MG;320MG A200797 005 Jun 03, 2015
AB STRIDES PHARMA EQ 5MG BASE;12.5MG;160MG A201087 001 Jun 01, 2015
AB EQ 5MG BASE;25MG;160MG A201087 002 Jun 01, 2015
AB EQ 10MG BASE;12.5MG;160MG A201087 003 Jun 01, 2015
AB EQ 10MG BASE;25MG;160MG A201087 004 Jun 01, 2015
AB EQ 10MG BASE;25MG;320MG A201087 005 Jun 01, 2015
EXFORGE HCT
AB + NOVARTIS EQ 5MG BASE;12.5MG;160MG N022314 001 Apr 30, 2009
AB + EQ 5MG BASE;25MG;160MG N022314 002 Apr 30, 2009
AB + EQ 10MG BASE;12.5MG;160MG N022314 003 Apr 30, 2009
AB + EQ 10MG BASE;25MG;160MG N022314 004 Apr 30, 2009
AB +! EQ 10MG BASE;25MG;320MG N022314 005 Apr 30, 2009
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
TABLET;ORAL
AMLODIPINE AND OLMESARTAN MEDOXOMIL
AB AJANTA PHARMA LTD EQ 5MG BASE;20MG A207216 001 Oct 28, 2016
AB EQ 5MG BASE;40MG A207216 002 Oct 28, 2016
AB EQ 10MG BASE;20MG A207216 003 Oct 28, 2016
AB EQ 10MG BASE;40MG A207216 004 Oct 28, 2016
AB ALEMBIC PHARMS EQ 5MG BASE;20MG A207073 001 Jul 17, 2017
AB EQ 5MG BASE;40MG A207073 002 Jul 17, 2017
AB EQ 10MG BASE;20MG A207073 003 Jul 17, 2017
AB EQ 10MG BASE;40MG A207073 004 Jul 17, 2017
AB ALKEM LABS LTD EQ 5MG BASE;20MG A209042 001 Aug 14, 2017
AB EQ 5MG BASE;40MG A209042 002 Aug 14, 2017
AB EQ 10MG BASE;20MG A209042 003 Aug 14, 2017
AB EQ 10MG BASE;40MG A209042 004 Aug 14, 2017
AB AUROBINDO PHARMA EQ 5MG BASE;20MG A206906 001 May 15, 2017
AB EQ 5MG BASE;40MG A206906 002 May 15, 2017
AB EQ 10MG BASE;20MG A206906 003 May 15, 2017
AB EQ 10MG BASE;40MG A206906 004 May 15, 2017
AB GLENMARK PHARMS LTD EQ 5MG BASE;20MG A207807 001 Jul 05, 2017
AB EQ 5MG BASE;40MG A207807 002 Jul 05, 2017
AB EQ 10MG BASE;20MG A207807 003 Jul 05, 2017
AB EQ 10MG BASE;40MG A207807 004 Jul 05, 2017
AB MACLEODS PHARMS LTD EQ 5MG BASE;20MG A206884 001 Oct 26, 2016
AB EQ 5MG BASE;40MG A206884 003 Oct 26, 2016
AB EQ 10MG BASE;20MG A206884 002 Oct 26, 2016
AB EQ 10MG BASE;40MG A206884 004 Oct 26, 2016
AB MICRO LABS EQ 5MG BASE;20MG A207435 001 Nov 02, 2017
AB EQ 5MG BASE;40MG A207435 002 Nov 02, 2017
AB EQ 10MG BASE;20MG A207435 003 Nov 02, 2017
AB EQ 10MG BASE;40MG A207435 004 Nov 02, 2017
AB ZYDUS PHARMS EQ 5MG BASE;20MG A207771 001 Sep 22, 2017
AB EQ 5MG BASE;40MG A207771 002 Sep 22, 2017
AB EQ 10MG BASE;20MG A207771 003 Sep 22, 2017
AB EQ 10MG BASE;40MG A207771 004 Sep 22, 2017
AZOR
AB + COSETTE EQ 5MG BASE;20MG N022100 001 Sep 26, 2007
AB + EQ 5MG BASE;40MG N022100 002 Sep 26, 2007
AB + EQ 10MG BASE;20MG N022100 003 Sep 26, 2007
AB +! EQ 10MG BASE;40MG N022100 004 Sep 26, 2007
AMLODIPINE BESYLATE; PERINDOPRIL ARGININE
TABLET;ORAL
PRESTALIA
+ ADHERA EQ 2.5MG BASE;3.5MG N205003 001 Jan 21, 2015
+ EQ 5MG BASE;7MG N205003 002 Jan 21, 2015
+! EQ 10MG BASE;14MG N205003 003 Jan 21, 2015
AMLODIPINE BESYLATE; TELMISARTAN
TABLET;ORAL
TELMISARTAN AND AMLODIPINE
AB LUPIN LTD EQ 5MG BASE;40MG A201586 001 Jan 08, 2014
AB EQ 5MG BASE;80MG A201586 003 Jan 08, 2014
AB EQ 10MG BASE;40MG A201586 002 Jan 08, 2014
AB EQ 10MG BASE;80MG A201586 004 Jan 08, 2014
AB MYLAN EQ 5MG BASE;40MG A202516 001 Aug 26, 2014
AB EQ 5MG BASE;80MG A202516 003 Aug 26, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-27(of 474)

AMLODIPINE BESYLATE; TELMISARTAN


TABLET;ORAL
TELMISARTAN AND AMLODIPINE
AB EQ 10MG BASE;40MG A202516 002 Aug 26, 2014
AB ! EQ 10MG BASE;80MG A202516 004 Aug 26, 2014
AMLODIPINE BESYLATE; VALSARTAN
TABLET;ORAL
AMLODIPINE BESYLATE AND VALSARTAN
AB ALEMBIC PHARMS EQ 5MG BASE;160MG A202713 001 Apr 03, 2015
AB EQ 5MG BASE;320MG A202713 003 Apr 03, 2015
AB EQ 10MG BASE;160MG A202713 002 Apr 03, 2015
AB EQ 10MG BASE;320MG A202713 004 Apr 03, 2015
AB AUROBINDO PHARMA EQ 5MG BASE;160MG A206512 001 Apr 22, 2016
AB EQ 5MG BASE;320MG A206512 002 Apr 22, 2016
AB EQ 10MG BASE;160MG A206512 003 Apr 22, 2016
AB EQ 10MG BASE;320MG A206512 004 Apr 22, 2016
AB HETERO LABS EQ 5MG BASE;160MG A205137 001 Sep 16, 2016
AB EQ 5MG BASE;320MG A205137 003 Sep 16, 2016
AB EQ 10MG BASE;160MG A205137 002 Sep 16, 2016
AB EQ 10MG BASE;320MG A205137 004 Sep 16, 2016
AB LUPIN EQ 5MG BASE;160MG A090245 001 Mar 30, 2015
AB EQ 5MG BASE;320MG A090245 003 Mar 30, 2015
AB EQ 10MG BASE;160MG A090245 002 Mar 30, 2015
AB EQ 10MG BASE;320MG A090245 004 Mar 30, 2015
AB MYLAN EQ 5MG BASE;160MG A090483 001 Mar 30, 2015
AB EQ 5MG BASE;320MG A090483 003 Mar 30, 2015
AB EQ 10MG BASE;160MG A090483 002 Mar 30, 2015
AB EQ 10MG BASE;320MG A090483 004 Mar 30, 2015
AB NOVEL LABS INC EQ 5MG BASE;160MG A202829 001 Mar 30, 2015
AB EQ 5MG BASE;320MG A202829 003 Mar 30, 2015
AB EQ 10MG BASE;160MG A202829 002 Mar 30, 2015
AB EQ 10MG BASE;320MG A202829 004 Mar 30, 2015
AB STRIDES PHARMA EQ 5MG BASE;160MG A090011 001 Mar 28, 2013
AB EQ 5MG BASE;320MG A090011 003 Mar 28, 2013
AB EQ 10MG BASE;160MG A090011 002 Mar 28, 2013
AB EQ 10MG BASE;320MG A090011 004 Mar 28, 2013
EXFORGE
AB + NOVARTIS EQ 5MG BASE;160MG N021990 002 Jun 20, 2007
AB + EQ 5MG BASE;320MG N021990 004 Jun 20, 2007
AB +! EQ 10MG BASE;160MG N021990 003 Jun 20, 2007
AB +! EQ 10MG BASE;320MG N021990 005 Jun 20, 2007
AMMONIA N-13
INJECTABLE;INTRAVENOUS
AMMONIA N 13
AP 3D IMAGING DRUG 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A203779 001 Oct 19, 2015
AP BIOMEDCL RES FDN 48.75mCi-487.5mCi/13ML (3.75- A204352 001 May 01, 2015
37.5mCi/ML)
AP BRIGHAM WOMENS HOSP 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A203783 001 Oct 30, 2014
AP CARDINAL HLTH 414 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A203700 001 Feb 25, 2013
AP DECATUR 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A204465 001 Oct 23, 2014
AP ESSENTIAL ISOTOPES 3.75mCi-260mCi/ML A205687 001 Dec 17, 2015
AP +! FEINSTEIN 30mCi-300mCi/8ML (3.75-37.5mCi/ML) N022119 001 Aug 23, 2007
AP GEN HOSP 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A207025 001 Feb 03, 2016
AP IONETIX 22.5mCi-225mCi/6ML (3.75-37.5mCi/ML) A210524 001 Dec 21, 2018
AP JOHNS HOPKINS UNIV 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A204514 001 Aug 19, 2014
AP KREITCHMAN PET CTR 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A203938 001 Dec 09, 2013
AP MCPRF 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A203321 001 Feb 25, 2013
AP METHODIST 3.75mCi-260mCi/ML A215083 001 Jul 09, 2021
AP MIDWEST MEDCL 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A204457 001 Nov 18, 2015
AP MIPS CRF 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A204535 001 Nov 20, 2014
AP NCM USA BRONX LLC 3.75mCi-260mCi/ML A204515 001 Feb 04, 2015
AP NUKEMED 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A204455 001 Apr 23, 2015
AP PETNET 30mCi-300mCi (3.75-37.5mCi/ML) A204510 001 Nov 02, 2015
AP PRECISION NUCLEAR 3.75mCi-260mCi/ML A204547 001 Aug 14, 2015
AP SHERTECH LABS LLC 3.75mCi-260mCi/ML A204366 001 Sep 19, 2014
AP SOFIE 18.8mCi-188mCi/5ML (3.75-37.5mCi/ML) A204667 001 Apr 22, 2015
AP ! 3.75mCi-260mCi/ML A203543 001 Dec 14, 2012
AP UCLA BIOMEDICAL 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A203812 001 Jun 27, 2013
AP UCSF RODIOPHARM 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A204496 001 Mar 28, 2014
AP UNIV ALAHAMA BIRM 15mCi-150mCi/4ML (3.75-37.5mCi/ML) A211698 001 Nov 03, 2022
AP UNIV TX SW MEDCTR 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A209507 001 Nov 01, 2019
AP UNIV WISCONSIN 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A211740 001 Sep 09, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-28(of 474)

AMMONIA N-13
INJECTABLE;INTRAVENOUS
AMMONIA N 13
AP WA UNIV SCH MED 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A204506 001 Feb 07, 2014
AP WISCONSIN 3.75mCi-260mCi/ML A204356 001 Dec 18, 2014
AMMONIUM CHLORIDE
INJECTABLE;INJECTION
AMMONIUM CHLORIDE IN PLASTIC CONTAINER
! HOSPIRA 5MEQ/ML A088366 001 Jun 13, 1984
AMMONIUM LACTATE
CREAM;TOPICAL
AMMONIUM LACTATE
AB ! PADAGIS ISRAEL EQ 12% BASE A075774 001 May 01, 2002
AB TARO EQ 12% BASE A075883 001 Apr 10, 2003
LOTION;TOPICAL
AMMONIUM LACTATE
AB ! PADAGIS ISRAEL EQ 12% BASE A075570 001 Jun 23, 2004
AB TARO EQ 12% BASE A076216 001 May 28, 2004
AMOXAPINE
TABLET;ORAL
AMOXAPINE
WATSON LABS 25MG A072691 002 Aug 28, 1992
50MG A072691 003 Aug 28, 1992
100MG A072691 004 Aug 28, 1992
! 150MG A072691 001 Aug 28, 1992
AMOXICILLIN
CAPSULE;ORAL
AMOXICILLIN
AB AUROBINDO 250MG A065271 001 Nov 09, 2005
AB 500MG A065271 002 Nov 09, 2005
AB CHARTWELL 250MG A062058 001
AB 500MG A062058 002
AB HIKMA PHARMS 250MG A065291 001 Feb 05, 2007
AB 500MG A065291 002 Feb 05, 2007
AB MICRO LABS 250MG A207471 001 Jun 24, 2022
AB 500MG A207471 002 Jun 24, 2022
AB SANDOZ 250MG A064076 001 Sep 30, 1994
AB 500MG A064076 002 Sep 30, 1994
AB TEVA 250MG A061926 001
AB ! 500MG A061926 003
AMOXIL
AB US ANTIBIOTICS 250MG A062216 001
AB 500MG A062216 004
FOR SUSPENSION;ORAL
AMOXICILLIN
AB AUROBINDO 200MG/5ML A065334 001 Dec 28, 2006
AB 400MG/5ML A065334 002 Dec 28, 2006
AB AUROBINDO PHARMA 125MG/5ML A204030 001 Sep 15, 2014
LTD
AB 250MG/5ML A204030 002 Sep 15, 2014
AB DAVA PHARMS INC 125MG/5ML A062927 001 Nov 25, 1988
AB 250MG/5ML A062927 002 Nov 25, 1988
AB HIKMA 125MG/5ML A065322 002 Jun 19, 2006
AB 200MG/5ML A065325 002 Jun 19, 2006
AB 250MG/5ML A065322 001 Jun 19, 2006
AB 400MG/5ML A065325 001 Jun 19, 2006
AB SANDOZ 125MG/5ML A065387 001 Mar 26, 2007
AB 200MG/5ML A065378 001 Mar 26, 2007
AB 250MG/5ML A065387 002 Mar 26, 2007
AB 400MG/5ML A065378 002 Mar 26, 2007
AB TEVA 200MG/5ML A065119 001 Dec 04, 2002
AB ! 250MG/5ML A061931 002
AB ! 400MG/5ML A065119 002 Dec 04, 2002
AB WOCKHARDT BIO AG 400MG/5ML A065319 002 Jun 18, 2007
AMOXICILLIN PEDIATRIC
AB TEVA 50MG/ML A061931 003 Dec 01, 1982
AMOXIL
AB US ANTIBIOTICS 50MG/ML A062226 005
AB 125MG/5ML A062226 001
AB 250MG/5ML A062226 002
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-29(of 474)

AMOXICILLIN
FOR SUSPENSION;ORAL
LAROTID
AB US ANTIBIOTICS 125MG/5ML A062226 003
AB 250MG/5ML A062226 004
TABLET;ORAL
AMOXICILLIN
AB AUROBINDO 500MG A065256 001 Nov 09, 2005
AB 875MG A065256 002 Nov 09, 2005
AB HIKMA 875MG A065255 001 Mar 29, 2006
AB SANDOZ 500MG A065228 001 Jul 13, 2005
AB 875MG A065228 002 Jul 13, 2005
AB TEVA 500MG A065056 001 Sep 18, 2000
AB ! 875MG A065056 002 Sep 18, 2000
TABLET, CHEWABLE;ORAL
AMOXICILLIN
TEVA 125MG A064013 002 Sep 11, 1995
! 250MG A064013 001 Dec 22, 1992
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE
CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED)
AB ! RISING 500MG;500MG;30MG A206006 001 Oct 07, 2016
AB SANDOZ INC 500MG;500MG;30MG A202588 001 Mar 04, 2014
AMOXICILLIN; CLAVULANATE POTASSIUM
FOR SUSPENSION;ORAL
AMOXICILLIN AND CLAVULANATE POTASSIUM
AB AUROBINDO PHARMA 125MG/5ML;EQ 31.25MG BASE/5ML A209371 001 Apr 19, 2019
AB 250MG/5ML;EQ 62.5MG BASE/5ML A209371 002 Apr 19, 2019
AB AUROBINDO PHARMA 200MG/5ML;EQ 28.5MG BASE/5ML A201090 001 Dec 20, 2011
LTD
AB 400MG/5ML;EQ 57MG BASE/5ML A201090 002 Dec 20, 2011
AB 600MG/5ML;EQ 42.9MG BASE/5ML A201091 001 Dec 20, 2011
AB HIKMA PHARMS 200MG/5ML;EQ 28.5MG BASE/5ML A065191 002 Jan 25, 2005
AB 400MG/5ML;EQ 57MG BASE/5ML A065191 001 Jan 25, 2005
AB 600MG/5ML;EQ 42.9MG BASE/5ML A065373 001 Nov 09, 2007
AB MICRO LABS LTD 200MG/5ML;EQ 28.5MG BASE/5ML A205187 001 May 21, 2021
INDIA
AB 400MG/5ML;EQ 57MG BASE/5ML A205187 002 May 21, 2021
AB SANDOZ 200MG/5ML;EQ 28.5MG BASE/5ML A065066 001 Jun 05, 2002
AB 400MG/5ML;EQ 57MG BASE/5ML A065066 002 Jun 05, 2002
AB SANDOZ INC 200MG/5ML;EQ 28.5MG BASE/5ML A065098 001 Dec 16, 2002
AB 400MG/5ML;EQ 57MG BASE/5ML A065098 002 Dec 16, 2002
AB 600MG/5ML;EQ 42.9MG BASE/5ML A065358 001 Aug 13, 2007
AB TEVA 200MG/5ML;EQ 28.5MG BASE/5ML A065089 001 May 25, 2004
AB ! 400MG/5ML;EQ 57MG BASE/5ML A065089 002 May 25, 2004
AB ! 600MG/5ML;EQ 42.9MG BASE/5ML A065162 001 Mar 12, 2004
AB WOCKHARDT BIO AG 250MG/5ML;EQ 62.5MG BASE/5ML A065431 001 Nov 25, 2008
AB 600MG/5ML;EQ 42.9MG BASE/5ML A065420 001 Dec 02, 2013
AUGMENTIN '125'
AB + US ANTIBIOTICS 125MG/5ML;EQ 31.25MG BASE/5ML N050575 001 Aug 06, 1984
AUGMENTIN '250'
AB +! US ANTIBIOTICS 250MG/5ML;EQ 62.5MG BASE/5ML N050575 002 Aug 06, 1984
AUGMENTIN ES-600
AB + US ANTIBIOTICS 600MG/5ML;EQ 42.9MG BASE/5ML N050755 001 Jun 22, 2001
TABLET;ORAL
AMOXICILLIN AND CLAVULANATE POTASSIUM
AB AUROBINDO PHARMA 250MG;EQ 125MG BASE A091569 001 Jan 20, 2012
LTD
AB 500MG;EQ 125MG BASE A091569 002 Jan 20, 2012
AB 875MG;EQ 125MG BASE A091568 001 Jan 20, 2012
AB HIKMA PHARMS 875MG;EQ 125MG BASE A203824 001 Aug 23, 2016
AB MICRO LABS LTD 250MG;EQ 125MG BASE A205707 001 Dec 30, 2016
INDIA
AB 500MG;EQ 125MG BASE A205707 002 Dec 30, 2016
AB 875MG;EQ 125MG BASE A204755 003 Dec 30, 2016
AB ! SANDOZ 250MG;EQ 125MG BASE A065189 001 Aug 23, 2005
AB 500MG;EQ 125MG BASE A065064 001 Mar 15, 2002
AB ! 875MG;EQ 125MG BASE A065063 001 Mar 14, 2002
AB ! SANDOZ INC 500MG;EQ 125MG BASE A065117 001 Nov 27, 2002
AB 875MG;EQ 125MG BASE A065093 001 Nov 21, 2002
AB TEVA 500MG;EQ 125MG BASE A065101 001 Oct 30, 2002
AB TEVA PHARMS USA 875MG;EQ 125MG BASE A065096 001 Oct 29, 2002
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-30(of 474)

AMOXICILLIN; CLAVULANATE POTASSIUM


TABLET;ORAL
AUGMENTIN '875'
AB + US ANTIBIOTICS 875MG;EQ 125MG BASE N050720 001 Feb 13, 1996
TABLET, CHEWABLE;ORAL
AMOXICILLIN AND CLAVULANATE POTASSIUM
TEVA 200MG;EQ 28.5MG BASE A065205 001 Feb 09, 2005
! 400MG;EQ 57MG BASE A065205 002 Feb 09, 2005
TABLET, EXTENDED RELEASE;ORAL
AMOXICILLIN AND CLAVULANATE POTASSIUM
! SANDOZ 1GM;EQ 62.5MG BASE A090227 001 Apr 21, 2010
AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN
CAPSULE, DELAYED RELEASE;ORAL
TALICIA
+! REDHILL 250MG;EQ 10MG BASE;12.5MG N213004 001 Nov 01, 2019
AMPHETAMINE
TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
ADZENYS XR-ODT
+ NEOS THERAPS EQ 3.1MG BASE N204326 001 Jan 27, 2016
+ EQ 6.3MG BASE N204326 002 Jan 27, 2016
+ EQ 9.4MG BASE N204326 003 Jan 27, 2016
+ EQ 12.5MG BASE N204326 004 Jan 27, 2016
+ EQ 15.7MG BASE N204326 005 Jan 27, 2016
+! EQ 18.8MG BASE N204326 006 Jan 27, 2016
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE
SULFATE
CAPSULE, EXTENDED RELEASE;ORAL
ADDERALL XR 10
AB + TAKEDA PHARMS USA 2.5MG;2.5MG;2.5MG;2.5MG N021303 001 Oct 11, 2001
ADDERALL XR 15
AB + TAKEDA PHARMS USA 3.75MG;3.75MG;3.75MG;3.75MG N021303 006 May 22, 2002
ADDERALL XR 20
AB + TAKEDA PHARMS USA 5MG;5MG;5MG;5MG N021303 002 Oct 11, 2001
ADDERALL XR 25
AB + TAKEDA PHARMS USA 6.25MG;6.25MG;6.25MG;6.25MG N021303 004 May 22, 2002
ADDERALL XR 30
AB +! TAKEDA PHARMS USA 7.5MG;7.5MG;7.5MG;7.5MG N021303 003 Oct 11, 2001
ADDERALL XR 5
AB + TAKEDA PHARMS USA 1.25MG;1.25MG;1.25MG;1.25MG N021303 005 May 22, 2002
DETROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
AB ASCENT PHARMS INC 1.25MG;1.25MG;1.25MG;1.25MG A214959 001 Sep 29, 2021
AB 2.5MG;2.5MG;2.5MG;2.5MG A214959 002 Sep 29, 2021
AB 3.75MG;3.75MG;3.75MG;3.75MG A214959 003 Sep 29, 2021
AB 5MG;5MG;5MG;5MG A214959 004 Sep 29, 2021
AB 6.25MG;6.25MG;6.25MG;6.25MG A214959 005 Sep 29, 2021
AB 7.5MG;7.5MG;7.5MG;7.5MG A214959 006 Sep 29, 2021
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
AB ACTAVIS ELIZABETH 1.25MG;1.25MG;1.25MG;1.25MG A077302 001 Jun 22, 2012
AB 2.5MG;2.5MG;2.5MG;2.5MG A077302 002 Jun 22, 2012
AB 3.75MG;3.75MG;3.75MG;3.75MG A077302 003 Jun 22, 2012
AB 5MG;5MG;5MG;5MG A077302 004 Jun 22, 2012
AB 6.25MG;6.25MG;6.25MG;6.25MG A077302 005 Jun 22, 2012
AB 7.5MG;7.5MG;7.5MG;7.5MG A077302 006 Jun 22, 2012
AB ANI PHARMS 1.25MG;1.25MG;1.25MG;1.25MG A205401 001 Jan 22, 2019
AB 3.75MG;3.75MG;3.75MG;3.75MG A205401 003 Jan 22, 2019
AB 5MG;5MG;5MG;5MG A205401 004 Jan 22, 2019
AB 6.25MG;6.25MG;6.25MG;6.25MG A205401 005 Jan 22, 2019
AB 7.5MG;7.5MG;7.5MG;7.5MG A205401 006 Jan 22, 2019
AB ELITE LABS INC 1.25MG;1.25MG;1.25MG;1.25MG A212037 001 Dec 11, 2019
AB 2.5MG;2.5MG;2.5MG;2.5MG A212037 002 Dec 11, 2019
AB 3.75MG;3.75MG;3.75MG;3.75MG A212037 003 Dec 11, 2019
AB 5MG;5MG;5MG;5MG A212037 004 Dec 11, 2019
AB 6.25MG;6.25MG;6.25MG;6.25MG A212037 005 Dec 11, 2019
AB 7.5MG;7.5MG;7.5MG;7.5MG A212037 006 Dec 11, 2019
AB IMPAX LABS 1.25MG;1.25MG;1.25MG;1.25MG A076852 001 Feb 16, 2016
AB 2.5MG;2.5MG;2.5MG;2.5MG A076852 002 Feb 16, 2016
AB 3.75MG;3.75MG;3.75MG;3.75MG A076852 003 Feb 16, 2016
AB 5MG;5MG;5MG;5MG A076852 004 Feb 16, 2016
AB 6.25MG;6.25MG;6.25MG;6.25MG A076852 005 Feb 16, 2016
AB 7.5MG;7.5MG;7.5MG;7.5MG A076852 006 Feb 16, 2016
AB RHODES PHARMS 1.25MG;1.25MG;1.25MG;1.25MG A210651 001 May 17, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-31(of 474)

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE


SULFATE
CAPSULE, EXTENDED RELEASE;ORAL
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
AB 2.5MG;2.5MG;2.5MG;2.5MG A210651 002 May 17, 2019
AB 3.75MG;3.75MG;3.75MG;3.75MG A210651 003 May 17, 2019
AB 5MG;5MG;5MG;5MG A210651 004 May 17, 2019
AB 6.25MG;6.25MG;6.25MG;6.25MG A210651 005 May 17, 2019
AB 7.5MG;7.5MG;7.5MG;7.5MG A210651 006 May 17, 2019
AB SPECGX LLC 1.25MG;1.25MG;1.25MG;1.25MG A211547 001 Apr 22, 2019
AB 2.5MG;2.5MG;2.5MG;2.5MG A211547 002 Apr 22, 2019
AB 3.75MG;3.75MG;3.75MG;3.75MG A211547 003 Apr 22, 2019
AB 5MG;5MG;5MG;5MG A211547 004 Apr 22, 2019
AB 6.25MG;6.25MG;6.25MG;6.25MG A211547 005 Apr 22, 2019
AB 7.5MG;7.5MG;7.5MG;7.5MG A211547 006 Apr 22, 2019
AB SUN PHARM 1.25MG;1.25MG;1.25MG;1.25MG A211715 001 May 17, 2019
INDUSTRIES
AB 2.5MG;2.5MG;2.5MG;2.5MG A211715 002 May 17, 2019
AB 3.75MG;3.75MG;3.75MG;3.75MG A211715 003 May 17, 2019
AB 5MG;5MG;5MG;5MG A211715 004 May 17, 2019
AB 6.25MG;6.25MG;6.25MG;6.25MG A211715 005 May 17, 2019
AB 7.5MG;7.5MG;7.5MG;7.5MG A211715 006 May 17, 2019
MYDAYIS
+ TAKEDA PHARMS USA 3.125MG;3.125MG;3.125MG;3.125MG N022063 001 Jun 20, 2017
+ 6.25MG;6.25MG;6.25MG;6.25MG N022063 002 Jun 20, 2017
+ 9.375MG;9.375MG;9.375MG;9.375MG N022063 003 Jun 20, 2017
+! 12.5MG;12.5MG;12.5MG;12.5MG N022063 004 Jun 20, 2017
TABLET;ORAL
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
AB ACTAVIS ELIZABETH 1.25MG;1.25MG;1.25MG;1.25MG A206340 001 Feb 05, 2016
AB 1.875MG;1.875MG;1.875MG;1.875MG A206340 002 Feb 05, 2016
AB 2.5MG;2.5MG;2.5MG;2.5MG A206340 003 Feb 05, 2016
AB 3.125MG;3.125MG;3.125MG;3.125MG A206340 004 Feb 05, 2016
AB 3.75MG;3.75MG;3.75MG;3.75MG A206340 005 Feb 05, 2016
AB 5MG;5MG;5MG;5MG A206340 006 Feb 05, 2016
AB 7.5MG;7.5MG;7.5MG;7.5MG A206340 007 Feb 05, 2016
AB ALVOGEN 1.25MG;1.25MG;1.25MG;1.25MG A207388 001 Jul 28, 2017
AB 1.875MG;1.875MG;1.875MG;1.875MG A207388 002 Jul 28, 2017
AB 2.5MG;2.5MG;2.5MG;2.5MG A207388 003 Jul 28, 2017
AB 3.125MG;3.125MG;3.125MG;3.125MG A207388 004 Jul 28, 2017
AB 3.75MG;3.75MG;3.75MG;3.75MG A207388 005 Jul 28, 2017
AB 5MG;5MG;5MG;5MG A207388 006 Jul 28, 2017
AB 7.5MG;7.5MG;7.5MG;7.5MG A207388 007 Jul 28, 2017
AB ASCENT PHARMS INC 1.25MG;1.25MG;1.25MG;1.25MG A213709 001 Apr 22, 2021
AB 1.875MG;1.875MG;1.875MG;1.875MG A213709 002 Apr 22, 2021
AB 2.5MG;2.5MG;2.5MG;2.5MG A213709 003 Apr 22, 2021
AB 3.125MG;3.125MG;3.125MG;3.125MG A213709 004 Apr 22, 2021
AB 3.75MG;3.75MG;3.75MG;3.75MG A213709 005 Apr 22, 2021
AB 5MG;5MG;5MG;5MG A213709 006 Apr 22, 2021
AB 7.5MG;7.5MG;7.5MG;7.5MG A213709 007 Apr 22, 2021
AB AUROLIFE PHARMA LLC 1.25MG;1.25MG;1.25MG;1.25MG A202424 001 Nov 27, 2013
AB 1.875MG;1.875MG;1.875MG;1.875MG A202424 002 Nov 27, 2013
AB 2.5MG;2.5MG;2.5MG;2.5MG A202424 003 Nov 27, 2013
AB 3.125MG;3.125MG;3.125MG;3.125MG A202424 004 Nov 27, 2013
AB 3.75MG;3.75MG;3.75MG;3.75MG A202424 005 Nov 27, 2013
AB 5MG;5MG;5MG;5MG A202424 006 Nov 27, 2013
AB 7.5MG;7.5MG;7.5MG;7.5MG A202424 007 Nov 27, 2013
AB BARR 1.25MG;1.25MG;1.25MG;1.25MG A040422 001 Feb 11, 2002
AB 1.875MG;1.875MG;1.875MG;1.875MG A040422 005 Mar 19, 2003
AB 2.5MG;2.5MG;2.5MG;2.5MG A040422 002 Feb 11, 2002
AB 3.125MG;3.125MG;3.125MG;3.125MG A040422 006 Mar 19, 2003
AB 3.75MG;3.75MG;3.75MG;3.75MG A040422 007 Mar 19, 2003
AB 5MG;5MG;5MG;5MG A040422 003 Feb 11, 2002
AB ! 7.5MG;7.5MG;7.5MG;7.5MG A040422 004 Feb 11, 2002
AB ELITE LABS INC 1.25MG;1.25MG;1.25MG;1.25MG A211352 001 Dec 07, 2018
AB 1.875MG;1.875MG;1.875MG;1.875MG A211352 002 Dec 07, 2018
AB 2.5MG;2.5MG;2.5MG;2.5MG A211352 003 Dec 07, 2018
AB 3.125MG;3.125MG;3.125MG;3.125MG A211352 004 Dec 07, 2018
AB 3.75MG;3.75MG;3.75MG;3.75MG A211352 005 Dec 07, 2018
AB 5MG;5MG;5MG;5MG A211352 006 Dec 07, 2018
AB 7.5MG;7.5MG;7.5MG;7.5MG A211352 007 Dec 07, 2018
AB EPIC PHARMA LLC 1.25MG;1.25MG;1.25MG;1.25MG A040444 001 Jun 19, 2002
AB 1.875MG;1.875MG;1.875MG;1.875MG A040444 005 Nov 03, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-32(of 474)

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE


SULFATE
TABLET;ORAL
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
AB 2.5MG;2.5MG;2.5MG;2.5MG A040444 002 Jun 19, 2002
AB 3.125MG;3.125MG;3.125MG;3.125MG A040444 006 Nov 03, 2014
AB 3.75MG;3.75MG;3.75MG;3.75MG A040444 007 Nov 03, 2014
AB 5MG;5MG;5MG;5MG A040444 003 Jun 19, 2002
AB 7.5MG;7.5MG;7.5MG;7.5MG A040444 004 Jun 19, 2002
AB GRANULES 1.25MG;1.25MG;1.25MG;1.25MG A215771 001 Dec 28, 2021
AB 1.875MG;1.875MG;1.875MG;1.875MG A215771 002 Dec 28, 2021
AB 2.5MG;2.5MG;2.5MG;2.5MG A215771 003 Dec 28, 2021
AB 3.125MG;3.125MG;3.125MG;3.125MG A215771 004 Dec 28, 2021
AB 3.75MG;3.75MG;3.75MG;3.75MG A215771 005 Dec 28, 2021
AB 5MG;5MG;5MG;5MG A215771 006 Dec 28, 2021
AB 7.5MG;7.5MG;7.5MG;7.5MG A215771 007 Dec 28, 2021
AB NUVO PHARM 1.25MG;1.25MG;1.25MG;1.25MG A209799 001 Dec 28, 2017
AB 1.875MG;1.875MG;1.875MG;1.875MG A209799 002 Dec 28, 2017
AB 2.5MG;2.5MG;2.5MG;2.5MG A209799 003 Dec 28, 2017
AB 3.125MG;3.125MG;3.125MG;3.125MG A209799 004 Dec 28, 2017
AB 3.75MG;3.75MG;3.75MG;3.75MG A209799 005 Dec 28, 2017
AB 5MG;5MG;5MG;5MG A209799 006 Dec 28, 2017
AB 7.5MG;7.5MG;7.5MG;7.5MG A209799 007 Dec 28, 2017
AB RHODES PHARMS 1.25MG;1.25MG;1.25MG;1.25MG A213111 001 Jan 13, 2021
AB 1.875MG;1.875MG;1.875MG;1.875MG A213111 002 Jan 13, 2021
AB 2.5MG;2.5MG;2.5MG;2.5MG A213111 003 Jan 13, 2021
AB 3.125MG;3.125MG;3.125MG;3.125MG A213111 004 Jan 13, 2021
AB 3.75MG;3.75MG;3.75MG;3.75MG A213111 005 Jan 13, 2021
AB 5MG;5MG;5MG;5MG A213111 006 Jan 13, 2021
AB 7.5MG;7.5MG;7.5MG;7.5MG A213111 007 Jan 13, 2021
AB SANDOZ 1.25MG;1.25MG;1.25MG;1.25MG A040439 004 Sep 27, 2002
AB 2.5MG;2.5MG;2.5MG;2.5MG A040439 001 Jun 14, 2002
AB 5MG;5MG;5MG;5MG A040439 002 Jun 14, 2002
AB 7.5MG;7.5MG;7.5MG;7.5MG A040439 003 Jun 14, 2002
AB SPECGX LLC 1.25MG;1.25MG;1.25MG;1.25MG A040440 001 Oct 07, 2003
AB 1.875MG;1.875MG;1.875MG;1.875MG A040440 002 Oct 07, 2003
AB 2.5MG;2.5MG;2.5MG;2.5MG A040440 003 Oct 07, 2003
AB 3.125MG;3.125MG;3.125MG;3.125MG A040440 004 Oct 07, 2003
AB 3.75MG;3.75MG;3.75MG;3.75MG A040440 005 Oct 07, 2003
AB 5MG;5MG;5MG;5MG A040440 006 Oct 07, 2003
AB 7.5MG;7.5MG;7.5MG;7.5MG A040440 007 Oct 07, 2003
AB SUN PHARM 1.25MG;1.25MG;1.25MG;1.25MG A040480 001 Sep 09, 2003
INDUSTRIES
AB 1.875MG;1.875MG;1.875MG;1.875MG A040480 002 Sep 09, 2003
AB 2.5MG;2.5MG;2.5MG;2.5MG A040480 003 Sep 09, 2003
AB 3.125MG;3.125MG;3.125MG;3.125MG A040480 004 Sep 09, 2003
AB 3.75MG;3.75MG;3.75MG;3.75MG A040480 005 Sep 09, 2003
AB 5MG;5MG;5MG;5MG A040480 006 Sep 09, 2003
AB 7.5MG;7.5MG;7.5MG;7.5MG A040480 007 Sep 09, 2003
AB USPHARMA WINDLAS 1.25MG;1.25MG;1.25MG;1.25MG A210293 001 Apr 03, 2020
AB 1.875MG;1.875MG;1.875MG;1.875MG A210293 002 Apr 03, 2020
AB 2.5MG;2.5MG;2.5MG;2.5MG A210293 003 Apr 03, 2020
AB 3.75MG;3.75MG;3.75MG;3.75MG A210293 004 Apr 03, 2020
AB 5MG;5MG;5MG;5MG A210293 005 Apr 03, 2020
AB 7.5MG;7.5MG;7.5MG;7.5MG A210293 006 Apr 03, 2020
AB ZYDUS PHARMS 1.25MG;1.25MG;1.25MG;1.25MG A207340 001 Oct 31, 2017
AB 1.875MG;1.875MG;1.875MG;1.875MG A207340 002 Oct 31, 2017
AB 2.5MG;2.5MG;2.5MG;2.5MG A207340 003 Oct 31, 2017
AB 3.125MG;3.125MG;3.125MG;3.125MG A207340 004 Oct 31, 2017
AB 3.75MG;3.75MG;3.75MG;3.75MG A207340 005 Oct 31, 2017
AB 5MG;5MG;5MG;5MG A207340 006 Oct 31, 2017
AB 7.5MG;7.5MG;7.5MG;7.5MG A207340 007 Oct 31, 2017
AMPHETAMINE SULFATE
TABLET;ORAL
AMPHETAMINE SULFATE
AA ALKEM LABS LTD 5MG A213720 001 Oct 27, 2020
AA 10MG A213720 002 Oct 27, 2020
AA AMNEAL PHARMS 5MG A211139 001 Sep 26, 2018
AA 10MG A211139 002 Sep 26, 2018
AA AUROLIFE PHARMA LLC 5MG A211639 001 Apr 17, 2019
AA 10MG A211639 002 Apr 17, 2019
AA BIONPHARMA INC 5MG A212919 001 Nov 22, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-33(of 474)

AMPHETAMINE SULFATE
TABLET;ORAL
AMPHETAMINE SULFATE
AA 10MG A212919 002 Nov 22, 2019
AA CEROVENE INC 5MG A212582 001 Feb 04, 2020
AA 10MG A212582 002 Feb 04, 2020
AA EPIC PHARMA LLC 5MG A213980 001 Oct 27, 2020
AA 10MG A213980 002 Oct 27, 2020
AA GRANULES 5MG A212619 001 Aug 05, 2019
AA 10MG A212619 002 Aug 05, 2019
AA PRINSTON INC 5MG A211861 001 Mar 11, 2020
AA 10MG A211861 002 Mar 11, 2020
AA RHODES PHARMS 5MG A213852 001 Sep 07, 2021
AA 10MG A213852 002 Sep 07, 2021
AA RISE PHARMA 5MG A212901 001 May 22, 2020
AA 10MG A212901 002 May 22, 2020
AA SPECGX LLC 5MG A213583 001 Jan 22, 2021
AA 10MG A213583 002 Jan 22, 2021
AA SUN PHARM INDS INC 5MG A214574 001 Jan 27, 2021
AA 10MG A214574 002 Jan 27, 2021
EVEKEO
AA ARBOR PHARMS LLC 5MG A200166 001 Aug 09, 2012
AA ! 10MG A200166 002 Aug 09, 2012
TABLET, ORALLY DISINTEGRATING;ORAL
EVEKEO ODT
+ AZURITY 5MG N209905 001 Jan 30, 2019
+ 10MG N209905 002 Jan 30, 2019
+ 15MG N209905 003 Jan 30, 2019
+! 20MG N209905 004 Jan 30, 2019
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
SUSPENSION, EXTENDED RELEASE;ORAL
DYANAVEL XR
+! TRIS PHARMA INC 2MG/ML;EQ 0.5MG BASE/ML N208147 001 Oct 19, 2015
TABLET, EXTENDED RELEASE;ORAL
DYANAVEL XR 10
+ TRIS PHARMA INC 8MG;EQ 2MG BASE N210526 002 Nov 04, 2021
DYANAVEL XR 15
+ TRIS PHARMA INC 12MG;EQ 3MG BASE N210526 003 Nov 04, 2021
DYANAVEL XR 20
+! TRIS PHARMA INC 16MG;EQ 4MG BASE N210526 004 Nov 04, 2021
DYANAVEL XR 5
+ TRIS PHARMA INC 4MG;EQ 1MG BASE N210526 001 Nov 04, 2021
AMPHOTERICIN B
INJECTABLE;INJECTION
AMPHOTERICIN B
! XGEN PHARMS 50MG/VIAL A063206 001 Apr 29, 1992
INJECTABLE, LIPID COMPLEX;INJECTION
ABELCET
+! LEADIANT BIOSCI INC 5MG/ML N050724 001 Nov 20, 1995
INJECTABLE, LIPOSOMAL;INJECTION
AMBISOME
AB +! ASTELLAS 50MG/VIAL N050740 001 Aug 11, 1997
AMPHOTERICIN B
AB EUGIA PHARMA 50MG/VIAL A214010 001 Nov 17, 2022
AB SPIL 50MG/VIAL A212514 001 Dec 14, 2021
AMPICILLIN SODIUM
INJECTABLE;INJECTION
AMPICILLIN SODIUM
AP ACS DOBFAR SPA EQ 10GM BASE/VIAL A090889 001 Apr 03, 2013
AP ANTIBIOTICE EQ 250MG BASE/VIAL A090354 001 Dec 28, 2009
AP EQ 500MG BASE/VIAL A090354 002 Dec 28, 2009
AP EQ 1GM BASE/VIAL A090354 003 Dec 28, 2009
AP EQ 2GM BASE/VIAL A090354 004 Dec 28, 2009
AP EUGIA PHARMA EQ 250MG BASE/VIAL A065499 002 Aug 17, 2010
SPECLTS
AP EQ 500MG BASE/VIAL A065499 003 Aug 17, 2010
AP EQ 1GM BASE/VIAL A065499 004 Aug 17, 2010
AP EQ 2GM BASE/VIAL A065499 005 Aug 17, 2010
AP EQ 10GM BASE/VIAL A065493 001 Aug 17, 2010
AP HQ SPECLT PHARMA EQ 250MG BASE/VIAL A062772 006 Apr 15, 1993
AP EQ 500MG BASE/VIAL A062772 007 Apr 15, 1993
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-34(of 474)

AMPICILLIN SODIUM
INJECTABLE;INJECTION
AMPICILLIN SODIUM
AP EQ 1GM BASE/VIAL A062772 001 Apr 15, 1993
AP EQ 2GM BASE/VIAL A062772 003 Apr 15, 1993
AP EQ 10GM BASE/VIAL A063142 001 Apr 15, 1993
AP ISTITUTO BIO ITA EQ 10GM BASE/VIAL A201404 001 Dec 20, 2013
SPA
AP EQ 250MG BASE/VIAL A062719 001 May 12, 1987
AP EQ 500MG BASE/VIAL A062719 003 May 12, 1987
AP EQ 1GM BASE/VIAL A062719 002 May 12, 1987
AP EQ 2GM BASE/VIAL A062797 002 Jul 12, 1993
AP MYLAN LABS LTD EQ 1GM BASE/VIAL A201025 003 Apr 09, 2014
AP EQ 2GM BASE/VIAL A201025 004 Apr 09, 2014
AP EQ 10GM BASE/VIAL A202198 001 Apr 07, 2014
AP SAGENT PHARMS INC EQ 125MG BASE/VIAL A090583 001 Nov 27, 2015
AP EQ 250MG BASE/VIAL A090583 002 Nov 27, 2015
AP EQ 500MG BASE/VIAL A090583 003 Nov 27, 2015
AP EQ 1GM BASE/VIAL A090583 004 Nov 27, 2015
AP EQ 2GM BASE/VIAL A090583 005 Nov 27, 2015
AP EQ 10GM BASE/VIAL A090581 001 Oct 20, 2015
AP ! SANDOZ EQ 125MG BASE/VIAL A061395 001
AP ! EQ 250MG BASE/VIAL A061395 002
AP ! EQ 500MG BASE/VIAL A061395 003
AP ! EQ 1GM BASE/VIAL A061395 004
AP ! EQ 2GM BASE/VIAL A061395 005
AP ! EQ 10GM BASE/VIAL A061395 006
POWDER;INTRAVENOUS
AMPICILLIN SODIUM
AP ! SANDOZ EQ 1GM BASE/VIAL A062738 001 Feb 19, 1987
AP ! EQ 2GM BASE/VIAL A062738 002 Feb 19, 1987
AMPICILLIN SODIUM; SULBACTAM SODIUM
INJECTABLE;INJECTION
AMPICILLIN AND SULBACTAM
AP ACS DOBFAR EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL A065406 001 Dec 22, 2009
AP EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL A065406 002 Dec 22, 2009
AP EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL A065403 001 Dec 23, 2009
AP ANTIBIOTICE EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL A201406 001 Dec 07, 2015
AP EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL A201406 002 Dec 07, 2015
AP ASTRAL EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL A090579 001 Jan 08, 2016
AP EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL A090579 002 Jan 08, 2016
AP EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL A090578 001 Jan 11, 2016
AP EUGIA PHARMA EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL A090349 001 Sep 20, 2010
SPECLTS
AP EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL A090349 002 Sep 20, 2010
AP EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL A090339 001 Sep 20, 2010
AP HIKMA EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL A065074 001 Mar 19, 2002
AP EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL A065074 002 Mar 19, 2002
AP EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL A065076 001 Mar 19, 2002
AP HQ SPECLT PHARMA EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL A065176 001 Nov 30, 2005
AP EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL A065176 002 Nov 30, 2005
AP EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL A065188 001 Nov 25, 2005
AP ISTITUTO BIO ITA EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL A065222 001 Nov 29, 2005
SPA
AP EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL A065222 002 Nov 29, 2005
AP EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL A065314 001 Nov 27, 2006
AP MYLAN LABS LTD EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL A201024 001 Apr 07, 2014
AP EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL A201024 002 Apr 07, 2014
AP EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL A202197 001 Apr 07, 2014
AP SANDOZ EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL A065241 001 Jul 25, 2006
AP EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL A065310 001 Jul 25, 2006
AP EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL A065241 002 Jul 25, 2006
AP EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL A065310 002 Jul 25, 2006
AP EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL A065240 001 Jul 25, 2006
UNASYN
AP ! PFIZER EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL A062901 002 Feb 27, 1992
AP ! EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL A062901 001 Nov 23, 1988
AP +! EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL N050608 002 Dec 31, 1986
AP +! EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL N050608 001 Dec 31, 1986
AP +! EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL N050608 005 Dec 10, 1993
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-35(of 474)

AMPICILLIN/AMPICILLIN TRIHYDRATE
CAPSULE;ORAL
AMPICILLIN TRIHYDRATE
! SANDOZ EQ 500MG BASE A064082 002 Aug 29, 1995
ANAGRELIDE HYDROCHLORIDE
CAPSULE;ORAL
AGRYLIN
AB TAKEDA PHARMS USA EQ 0.5MG BASE N020333 001 Mar 14, 1997
ANAGRELIDE HYDROCHLORIDE
AB IMPAX LABS EQ 0.5MG BASE A076910 001 Apr 18, 2005
AB EQ 1MG BASE A076910 002 Apr 18, 2005
AB IVAX SUB TEVA EQ 0.5MG BASE A076468 001 Apr 18, 2005
PHARMS
AB ! EQ 1MG BASE A076468 002 Apr 18, 2005
AB TORRENT EQ 0.5MG BASE A209151 001 Jun 30, 2017
AB EQ 1MG BASE A209151 002 Jun 30, 2017
ANASTROZOLE
TABLET;ORAL
ANASTROZOLE
AB ACCORD HLTHCARE 1MG A090568 001 Jun 28, 2010
AB BEIJING YILING 1MG A206037 001 Nov 09, 2018
AB CIPLA 1MG A091164 001 Jun 28, 2010
AB EUGIA PHARMA 1MG A212434 001 Jul 24, 2020
AB KENTON 1MG A078944 001 Jun 28, 2010
AB NATCO PHARMA LTD 1MG A079220 001 Jun 28, 2010
AB TEVA PHARMS 1MG A078058 001 Jun 28, 2010
AB ZYDUS PHARMS USA 1MG A078921 001 Jun 28, 2010
INC
ARIMIDEX
AB +! ANI PHARMS 1MG N020541 001 Dec 27, 1995
ANGIOTENSIN II ACETATE
SOLUTION;INTRAVENOUS
GIAPREZA
+! LA JOLLA PHARMA EQ 0.5MG BASE/ML (EQ 0.5MG BASE/ML) N209360 003 Dec 23, 2021
+! EQ 2.5MG BASE/ML (EQ 2.5MG BASE/ML) N209360 001 Dec 21, 2017
ANIDULAFUNGIN
POWDER;INTRAVENOUS
ERAXIS
+! VICURON HOLDINGS 50MG/VIAL N021632 001 Feb 17, 2006
+! 100MG/VIAL N021632 002 Nov 14, 2006
APALUTAMIDE
TABLET;ORAL
ERLEADA
+! JANSSEN BIOTECH 60MG N210951 001 Feb 14, 2018
APIXABAN
TABLET;ORAL
APIXABAN
AB ACCORD HLTHCARE 2.5MG A210180 001 Jul 28, 2020
AB 5MG A210180 002 Jul 28, 2020
AB INDOCO 2.5MG A209898 001 Sep 11, 2020
AB 5MG A209898 002 Sep 11, 2020
ELIQUIS
AB + BRISTOL MYERS 2.5MG N202155 001 Dec 28, 2012
SQUIBB
AB +! 5MG N202155 002 Dec 28, 2012
APOMORPHINE HYDROCHLORIDE
FILM;SUBLINGUAL
KYNMOBI
+ SUNOVION PHARMS INC 10MG N210875 001 May 21, 2020
+ 15MG N210875 002 May 21, 2020
+ 20MG N210875 003 May 21, 2020
+ 25MG N210875 004 May 21, 2020
+! 30MG N210875 005 May 21, 2020
INJECTABLE;SUBCUTANEOUS
APOKYN
AP +! MDD US 30MG/3ML (10MG/ML) N021264 002 Apr 20, 2004
APOMORPHINE HYDROCHLORIDE
AP SAGE CHEMS 30MG/3ML (10MG/ML) A212025 001 Feb 23, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-36(of 474)

APRACLONIDINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
APRACLONIDINE HYDROCHLORIDE
AT AKORN EQ 0.5% BASE A077764 001 Mar 12, 2009
IOPIDINE
AT +! IMPRIMIS PHARMS USA EQ 0.5% BASE N020258 001 Jul 30, 1993
+! EQ 1% BASE N019779 001 Dec 31, 1987
APREMILAST
TABLET;ORAL
APREMILAST
AB ALKEM LABS LTD 10MG A211761 001 Sep 21, 2021
AB 20MG A211761 002 Sep 21, 2021
AB 30MG A211761 003 Sep 21, 2021
AB TEVA PHARMS USA INC 10MG A211897 001 Aug 18, 2022
AB 20MG A211897 002 Aug 18, 2022
AB 30MG A211897 003 Aug 18, 2022
OTEZLA
AB + AMGEN INC 10MG N205437 001 Mar 21, 2014
AB + 20MG N205437 002 Mar 21, 2014
AB +! 30MG N205437 003 Mar 21, 2014
APREPITANT
CAPSULE;ORAL
APREPITANT
AB GLENMARK PHARMS SA 40MG A207777 001 Oct 12, 2017
AB 80MG A207777 002 Oct 12, 2017
AB 125MG A207777 003 Oct 12, 2017
AB SANDOZ 40MG A090999 001 Sep 24, 2012
AB 80MG A090999 002 Sep 24, 2012
AB 125MG A090999 003 Sep 24, 2012
AB TORRENT 40MG A211835 001 Oct 21, 2020
AB 80MG A211835 002 Oct 21, 2020
AB 125MG A211835 003 Oct 21, 2020
EMEND
AB + MERCK 80MG N021549 001 Mar 26, 2003
AB +! 125MG N021549 002 Mar 26, 2003
EMULSION;INTRAVENOUS
APONVIE
+! HERON THERAPS INC 32MG/4.4ML (7.2MG/ML) N216457 001 Sep 16, 2022
CINVANTI
+! HERON THERAPS INC 130MG/18ML (7.2MG/ML) N209296 001 Nov 09, 2017
FOR SUSPENSION;ORAL
EMEND
+! MSD MERCK CO 125MG/KIT N207865 001 Dec 17, 2015
ARFORMOTEROL TARTRATE
SOLUTION;INHALATION
ARFORMOTEROL TARTRATE
AN ALEMBIC PHARMS EQ 0.015MG BASE/2ML A214779 001 May 10, 2022
AN CIPLA EQ 0.015MG BASE/2ML A207306 001 Jun 22, 2021
AN LUPIN EQ 0.015MG BASE/2ML A213068 001 Feb 07, 2022
AN MANKIND PHARMA EQ 0.015MG BASE/2ML A216128 001 Nov 15, 2022
AN SLATE RUN PHARMA EQ 0.015MG BASE/2ML A213762 001 Jun 22, 2021
AN SLAYBACK PHARMA LLC EQ 0.015MG BASE/2ML A216815 001 Nov 25, 2022
AN SUN PHARM EQ 0.015MG BASE/2ML A215385 001 May 26, 2022
AN TEVA PHARMS USA EQ 0.015MG BASE/2ML A200293 001 Nov 09, 2021
BROVANA
AN +! LUPIN EQ 0.015MG BASE/2ML N021912 001 Oct 06, 2006
ARGATROBAN
INJECTABLE;INJECTION
ARGATROBAN
AP AMNEAL PHARMS CO 250MG/2.5ML (100MG/ML) A206698 001 Jan 26, 2018
AP CAPLIN 50MG/50ML (1MG/ML) A214235 001 Jan 21, 2021
AP FRESENIUS KABI USA 250MG/2.5ML (100MG/ML) N201811 001 Mar 23, 2015
AP +! HIKMA PHARM CO LTD 50MG/50ML (1MG/ML) N203049 002 Sep 30, 2016
AP +! 250MG/2.5ML (100MG/ML) N203049 001 Jan 05, 2012
AP HOSPIRA 250MG/2.5ML (100MG/ML) A204120 001 Sep 21, 2016
AP MYLAN INSTITUTIONAL 250MG/2.5ML (100MG/ML) A202626 001 Jun 30, 2014
AP +! NOVARTIS 250MG/2.5ML (100MG/ML) N020883 001 Jun 30, 2000
AP PAR STERILE 250MG/2.5ML (100MG/ML) A091665 001 Jun 30, 2014
PRODUCTS
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-37(of 474)

ARGATROBAN
INJECTABLE;INTRAVENOUS
ARGATROBAN IN SODIUM CHLORIDE
AP GLAND PHARMA LTD 125MG/125ML (1MG/ML) A205570 001 May 22, 2017
AP +! SANDOZ 125MG/125ML (1MG/ML) N022485 001 May 09, 2011
SOLUTION;INTRAVENOUS
ARGATROBAN IN SODIUM CHLORIDE
+! ACCORD HLTHCARE 50MG/50ML (1MG/ML) N212035 001 Jun 07, 2021
EUGIA PHARMA 50MG/50ML (1MG/ML) N209552 001 Nov 27, 2018
SPECLTS
ARGININE HYDROCHLORIDE
INJECTABLE;INJECTION
R-GENE 10
+! PHARMACIA AND 10GM/100ML N016931 001
UPJOHN
ARIPIPRAZOLE
FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
ABILIFY MAINTENA KIT
+ OTSUKA PHARM CO LTD 300MG/VIAL N202971 001 Feb 28, 2013
+ 300MG N202971 003 Sep 29, 2014
+! 400MG/VIAL N202971 002 Feb 28, 2013
+ 400MG N202971 004 Sep 29, 2014
SOLUTION;ORAL
ARIPIPRAZOLE
AA ! AMNEAL PHARMS 1MG/ML A203906 001 Aug 14, 2015
AA APOTEX INC 1MG/ML A204094 001 Sep 30, 2015
AA AUROBINDO PHARMA 1MG/ML A210479 001 Jan 29, 2019
LTD
AA GLASSHOUSE PHARMS 1MG/ML A215595 001 Oct 25, 2022
AA LANNETT CO INC 1MG/ML A204171 001 Aug 14, 2015
AA RUBICON 1MG/ML A216351 001 Oct 27, 2022
AA VISTAPHARM 1MG/ML A212870 001 Dec 26, 2019
TABLET;ORAL
ABILIFY
AB + OTSUKA 2MG N021436 006 Nov 15, 2002
AB + 5MG N021436 005 Nov 15, 2002
AB +! 10MG N021436 001 Nov 15, 2002
AB + 15MG N021436 002 Nov 15, 2002
AB + 20MG N021436 003 Nov 15, 2002
AB + 30MG N021436 004 Nov 15, 2002
ARIPIPRAZOLE
AB ACCORD HLTHCARE 2MG A206251 001 Dec 07, 2016
AB 5MG A206251 002 Dec 07, 2016
AB 10MG A206251 003 Dec 07, 2016
AB 15MG A206251 004 Dec 07, 2016
AB 20MG A206251 005 Dec 07, 2016
AB 30MG A206251 006 Dec 07, 2016
AB AJANTA PHARMA LTD 2MG A206174 001 Sep 12, 2016
AB 5MG A206174 002 Sep 12, 2016
AB 10MG A206174 003 Sep 12, 2016
AB 15MG A206174 004 Sep 12, 2016
AB 20MG A206174 005 Sep 12, 2016
AB 30MG A206174 006 Sep 12, 2016
AB ALEMBIC PHARMS 2MG A202101 001 Apr 28, 2015
AB 5MG A202101 002 Apr 28, 2015
AB 10MG A202101 003 Apr 28, 2015
AB 15MG A202101 004 Apr 28, 2015
AB 20MG A202101 005 Apr 28, 2015
AB 30MG A202101 006 Apr 28, 2015
AB ALKEM LABS LTD 2MG A207105 001 Feb 21, 2019
AB 5MG A207105 002 Feb 21, 2019
AB 10MG A207105 003 Feb 21, 2019
AB 15MG A207105 004 Feb 21, 2019
AB 20MG A207105 005 Feb 21, 2019
AB 30MG A207105 006 Feb 21, 2019
AB AMNEAL PHARMS 2MG A204838 001 Jun 17, 2016
AB 5MG A204838 002 Jun 17, 2016
AB 10MG A204838 003 Jun 17, 2016
AB 15MG A204838 004 Jun 17, 2016
AB 20MG A204838 005 Jun 17, 2016
AB 30MG A204838 006 Jun 17, 2016
AB APOTEX INC 2MG A078583 001 Jul 24, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-38(of 474)

ARIPIPRAZOLE
TABLET;ORAL
ARIPIPRAZOLE
AB 5MG A078583 002 Jul 24, 2015
AB 10MG A078583 003 Jul 24, 2015
AB 15MG A078583 004 Jul 24, 2015
AB 20MG A078583 005 Jul 24, 2015
AB 30MG A078583 006 Jul 24, 2015
AB AUROBINDO PHARMA 2MG A203908 001 Oct 08, 2015
AB 5MG A203908 002 Oct 08, 2015
AB 10MG A203908 003 Oct 08, 2015
AB 15MG A203908 004 Oct 08, 2015
AB 20MG A203908 005 Oct 08, 2015
AB 30MG A203908 006 Oct 08, 2015
AB BOSCOGEN 2MG A091279 001 Jan 09, 2017
AB 5MG A091279 002 Jan 09, 2017
AB 10MG A091279 003 Jan 09, 2017
AB 15MG A091279 004 Jan 09, 2017
AB 20MG A091279 005 Jan 09, 2017
AB 30MG A091279 006 Jan 09, 2017
AB HETERO LABS LTD V 2MG A205064 001 Apr 28, 2015
AB 5MG A205064 002 Apr 28, 2015
AB 10MG A205064 003 Apr 28, 2015
AB 15MG A205064 004 Apr 28, 2015
AB 20MG A205064 005 Apr 28, 2015
AB 30MG A205064 006 Apr 28, 2015
AB MACLEODS PHARMS LTD 2MG A204111 001 Oct 07, 2016
AB 5MG A204111 002 Oct 07, 2016
AB 10MG A204111 003 Oct 07, 2016
AB 15MG A204111 004 Oct 07, 2016
AB 20MG A204111 005 Oct 07, 2016
AB 30MG A204111 006 Oct 07, 2016
AB ORBION PHARMS 2MG A202683 001 May 23, 2017
AB 5MG A202683 002 May 23, 2017
AB 10MG A202683 003 May 23, 2017
AB 15MG A202683 004 May 23, 2017
AB 20MG A202683 005 May 23, 2017
AB 30MG A202683 006 May 23, 2017
AB PRINSTON INC 2MG A205363 001 Dec 04, 2017
AB 5MG A205363 002 Dec 04, 2017
AB 10MG A205363 003 Dec 04, 2017
AB 15MG A205363 004 Dec 04, 2017
AB 20MG A205363 005 Dec 04, 2017
AB 30MG A205363 006 Dec 04, 2017
AB SCIEGEN PHARMS INC 2MG A206383 001 Sep 29, 2016
AB 5MG A206383 002 Sep 29, 2016
AB 10MG A206383 003 Sep 29, 2016
AB 15MG A206383 004 Sep 29, 2016
AB 20MG A206383 005 Sep 29, 2016
AB 30MG A206383 006 Sep 29, 2016
AB TORRENT 2MG A201519 001 Apr 28, 2015
AB 10MG A201519 003 Apr 28, 2015
AB 5MG A201519 002 Apr 28, 2015
AB 15MG A201519 004 Apr 28, 2015
AB 20MG A201519 005 Apr 28, 2015
AB 30MG A201519 006 Apr 28, 2015
AB UNICHEM 2MG A203025 001 Dec 01, 2021
AB 5MG A203025 002 Dec 01, 2021
AB 10MG A203025 003 Dec 01, 2021
AB 15MG A203025 004 Dec 01, 2021
AB 20MG A203025 005 Dec 01, 2021
AB 30MG A203025 006 Dec 01, 2021
ABILIFY MYCITE KIT
+ OTSUKA 2MG N207202 001 Nov 13, 2017
+! 5MG N207202 002 Nov 13, 2017
+ 10MG N207202 003 Nov 13, 2017
+ 15MG N207202 004 Nov 13, 2017
+ 20MG N207202 005 Nov 13, 2017
+ 30MG N207202 006 Nov 13, 2017
TABLET, ORALLY DISINTEGRATING;ORAL
ARIPIPRAZOLE
AB ! ALEMBIC PHARMS 10MG A202102 001 Apr 28, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-39(of 474)

ARIPIPRAZOLE
TABLET, ORALLY DISINTEGRATING;ORAL
ARIPIPRAZOLE
AB 15MG A202102 002 Apr 28, 2015
AB ORBION PHARMS 10MG A202547 001 Dec 11, 2017
AB 15MG A202547 002 Dec 11, 2017
AB SCIEGEN PHARMS INC 10MG A207240 001 Apr 18, 2018
AB 15MG A207240 002 Apr 18, 2018
AB SQUARE PHARMS 10MG A090165 001 Aug 28, 2018
AB 15MG A090165 002 Aug 28, 2018
20MG A090165 003 Aug 28, 2018
30MG A090165 004 Aug 28, 2018
ARIPIPRAZOLE LAUROXIL
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
ARISTADA
+ ALKERMES INC 441MG/1.6ML (275.63MG/ML) N207533 001 Oct 05, 2015
+ 662MG/2.4ML (275.83MG/ML) N207533 002 Oct 05, 2015
+! 882MG/3.2ML (275.63MG/ML) N207533 003 Oct 05, 2015
+ 1064MG/3.9ML (272.82MG/ML) N207533 004 Jun 05, 2017
ARISTADA INITIO KIT
+ ALKERMES INC 675MG/2.4ML N209830 001 Jun 29, 2018
ARMODAFINIL
TABLET;ORAL
ARMODAFINIL
AB AUROBINDO PHARMA 50MG A206069 001 Mar 06, 2018
LTD
AB 150MG A206069 002 Mar 06, 2018
AB 200MG A206069 004 Dec 07, 2018
AB 250MG A206069 003 Mar 06, 2018
AB LUPIN LTD 50MG A200751 001 Nov 28, 2016
AB 150MG A200751 003 Nov 28, 2016
AB 200MG A200751 004 Nov 28, 2016
AB 250MG A200751 005 Nov 28, 2016
AB MYLAN PHARMS INC 50MG A200043 001 Jun 01, 2012
AB 100MG A200043 004 May 09, 2019
AB 150MG A200043 002 Jun 01, 2012
AB 200MG A200043 005 May 09, 2019
AB 250MG A200043 003 Jun 01, 2012
AB NATCO PHARMA LTD 50MG A202768 001 Nov 28, 2016
AB 100MG A202768 004 Sep 28, 2017
AB 150MG A202768 002 Nov 28, 2016
AB 200MG A202768 005 Sep 28, 2017
AB 250MG A202768 003 Nov 28, 2016
NUVIGIL
AB + CEPHALON 50MG N021875 001 Jun 15, 2007
AB + 150MG N021875 003 Jun 15, 2007
AB + 200MG N021875 005 Mar 26, 2009
AB +! 250MG N021875 004 Jun 15, 2007
ARSENIC TRIOXIDE
INJECTABLE;INJECTION
ARSENIC TRIOXIDE
AP AMNEAL 1MG/ML A210739 001 Jan 25, 2021
AP 2MG/ML A210739 002 Aug 19, 2021
AP AMRING PHARMS 1MG/ML A210802 001 Nov 13, 2018
AP EUGIA PHARMA 2MG/ML A214011 001 Oct 15, 2021
AP ! FRESENIUS KABI USA 1MG/ML A208231 001 Aug 31, 2018
AP GLAND PHARMA LTD 1MG/ML A215059 002 Apr 22, 2022
AP 2MG/ML A215059 001 Oct 07, 2021
AP INGENUS PHARMS LLC 1MG/ML A209315 001 Nov 15, 2018
AP NEXUS PHARMS 1MG/ML A209780 001 Nov 15, 2018
AP SANDOZ INC 2MG/ML A215359 001 Dec 02, 2021
AP STI PHARMA LLC 1MG/ML A209873 001 May 06, 2019
AP ZYDUS PHARMS 1MG/ML A206228 001 Nov 13, 2018
AP 2MG/ML A206228 002 Aug 30, 2019
TRISENOX
AP +! CEPHALON 2MG/ML N021248 002 Oct 13, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-40(of 474)

ARTEMETHER; LUMEFANTRINE
TABLET;ORAL
COARTEM
+! NOVARTIS 20MG;120MG N022268 001 Apr 07, 2009
ARTESUNATE
POWDER;INTRAVENOUS
ARTESUNATE
+! AMIVAS 110MG/VIAL N213036 001 May 26, 2020
ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
INJECTABLE;INJECTION
ORABLOC
+ PIERREL 4%;EQ 0.009MG BASE/1.8ML (EQ 0.005MG N022466 001 Feb 26, 2010
BASE/ML)
+! 4%;EQ 0.018MG BASE/1.8ML (EQ 0.01MG N022466 002 Feb 26, 2010
BASE/ML)
SEPTOCAINE
+! DEPROCO 4%; EQ 0.0085MG BASE/1.7ML (4%; EQ N020971 002 Mar 30, 2006
0.005MG BASE/ML)
+! 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG N020971 001 Apr 03, 2000
BASE/ML)
ASCIMINIB HYDROCHLORIDE
TABLET;ORAL
SCEMBLIX
+ NOVARTIS EQ 20MG BASE N215358 001 Oct 29, 2021
+! EQ 40MG BASE N215358 002 Oct 29, 2021
ASCORBIC ACID
SOLUTION;INTRAVENOUS
ASCOR
+! MCGUFF 25,000MG/50ML (500MG/ML) N209112 001 Oct 02, 2017
ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE;
PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K
INJECTABLE;INTRAVENOUS
INFUVITE PEDIATRIC
+! SANDOZ CANADA INC 80MG/VIAL;0.02MG/VIAL;400 N021265 001 Feb 21, 2001
IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VI
AL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/
VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL
INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)
+! SANDOZ CANADA INC 80MG/VIAL;0.02MG/VIAL;400 N021265 002 Jan 29, 2004
IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VI
AL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/
VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL
ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE;
SODIUM SULFATE
FOR SOLUTION;ORAL
MOVIPREP
AA +! SALIX PHARMS 4.7GM;100GM;1.015GM;5.9GM;2.691GM;7.5GM N021881 001 Aug 02, 2006
PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC
AA NOVEL LABS INC 4.7GM;100GM;1.015GM;5.9GM;2.691GM;7.5GM A090145 001 Jan 25, 2012
PLENVU
+! SALIX 7.54GM;140GM;2.2GM;48.11GM;5.2GM;9GM N209381 001 May 04, 2018
ASENAPINE
SYSTEM;TRANSDERMAL
SECUADO
+! HISAMITSU 3.8MG/24HR N212268 001 Oct 11, 2019
+ 5.7MG/24HR N212268 002 Oct 11, 2019
+ 7.6MG/24HR N212268 003 Oct 11, 2019
ASENAPINE MALEATE
TABLET;SUBLINGUAL
ASENAPINE MALEATE
AB ALEMBIC PHARMS EQ 2.5MG BASE A206098 003 Jul 19, 2021
AB EQ 5MG BASE A206098 001 Dec 10, 2020
AB EQ 10MG BASE A206098 002 Dec 10, 2020
AB BRECKENRIDGE EQ 2.5MG BASE A205960 001 Dec 10, 2020
AB EQ 5MG BASE A205960 003 Mar 08, 2021
AB EQ 10MG BASE A205960 002 Dec 10, 2020
AB SIGMAPHARM LABS LLC EQ 5MG BASE A206107 001 Dec 10, 2020
AB EQ 10MG BASE A206107 002 Dec 10, 2020
SAPHRIS
AB + ALLERGAN EQ 2.5MG BASE N022117 003 Mar 12, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-41(of 474)

ASENAPINE MALEATE
TABLET;SUBLINGUAL
SAPHRIS
AB + EQ 5MG BASE N022117 001 Aug 13, 2009
AB +! EQ 10MG BASE N022117 002 Aug 13, 2009
ASPIRIN
CAPSULE, EXTENDED RELEASE;ORAL
DURLAZA
+! ESPERO 162.5MG N200671 001 Sep 04, 2015
ASPIRIN; BUTALBITAL; CAFFEINE
CAPSULE;ORAL
BUTALBITAL, ASPIRIN AND CAFFEINE
AA NOSTRUM LABS INC 325MG;50MG;40MG A078149 001 Jun 13, 2007
LANORINAL
AA ! LANNETT 325MG;50MG;40MG A086996 002 Oct 11, 1985
TABLET;ORAL
BUTALBITAL, ASPIRIN AND CAFFEINE
! STRIDES PHARMA 325MG;50MG;40MG A204195 001 Sep 22, 2016
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
CAPSULE;ORAL
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
AB LGM PHARMA 325MG;50MG;40MG;30MG A075231 001 Nov 30, 2001
AB ! STEVENS J 325MG;50MG;40MG;30MG A074951 001 Aug 31, 1998
ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
TABLET;ORAL
ORPHENGESIC
GALT PHARMS 385MG;30MG;25MG A075141 001 May 29, 1998
ORPHENGESIC FORTE
! GALT PHARMS 770MG;60MG;50MG A075141 002 May 29, 1998
ASPIRIN; DIPYRIDAMOLE
CAPSULE, EXTENDED RELEASE;ORAL
ASPIRIN AND DIPYRIDAMOLE
AB AMNEAL PHARMS 25MG;200MG A206392 001 Mar 08, 2016
AB BARR 25MG;200MG A078804 001 Aug 14, 2009
AB DR REDDYS 25MG;200MG A209048 001 Oct 10, 2018
AB ! GLENMARK PHARMS SA 25MG;200MG A210318 001 May 24, 2019
AB MICRO LABS 25MG;200MG A209929 001 Aug 11, 2021
AB PAR PHARM INC 25MG;200MG A207944 001 Jan 18, 2017
AB SANDOZ INC 25MG;200MG A206739 001 Jan 18, 2017
AB ZYDUS PHARMS 25MG;200MG A206753 001 Aug 29, 2017
ASPIRIN; HYDROCODONE BITARTRATE
TABLET;ORAL
HYDROCODONE BITARTRATE AND ASPIRIN
! LGM PHARMA 500MG;5MG A205479 001 May 28, 2021
ASPIRIN; OXYCODONE HYDROCHLORIDE
TABLET;ORAL
OXYCODONE AND ASPIRIN
AA EPIC PHARMA LLC 325MG;4.8355MG A040910 001 Jul 16, 2020
PERCODAN
AA +! ENDO PHARMS 325MG;4.8355MG N007337 007 Aug 05, 2005
ATAZANAVIR SULFATE
CAPSULE;ORAL
ATAZANAVIR SULFATE
AB AMNEAL EQ 150MG BASE A209717 002 Jun 01, 2020
AB EQ 200MG BASE A209717 003 Jun 01, 2020
AB EQ 300MG BASE A209717 004 Jun 01, 2020
AB AUROBINDO PHARMA EQ 100MG BASE A204806 001 Jun 25, 2018
AB EQ 150MG BASE A204806 002 Jun 25, 2018
AB EQ 200MG BASE A204806 003 Jun 25, 2018
AB EQ 300MG BASE A204806 004 Jun 25, 2018
AB CIPLA EQ 100MG BASE A200626 001 Aug 09, 2018
AB EQ 150MG BASE A200626 002 Aug 09, 2018
AB EQ 200MG BASE A200626 003 Aug 09, 2018
AB EQ 300MG BASE A200626 004 Aug 09, 2018
AB HETERO LABS LTD III EQ 150MG BASE A212278 001 Feb 02, 2022
AB EQ 200MG BASE A212278 002 Feb 02, 2022
AB EQ 300MG BASE A212278 003 Feb 02, 2022
AB LAURUS EQ 150MG BASE A212579 001 Apr 30, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-42(of 474)

ATAZANAVIR SULFATE
CAPSULE;ORAL
ATAZANAVIR SULFATE
AB EQ 200MG BASE A212579 002 Apr 30, 2021
AB EQ 300MG BASE A212579 003 Apr 30, 2021
AB TEVA PHARMS USA EQ 100MG BASE A091673 001 Apr 22, 2014
AB EQ 150MG BASE A091673 002 Apr 22, 2014
AB EQ 200MG BASE A091673 003 Apr 22, 2014
AB EQ 300MG BASE A091673 004 Apr 22, 2014
REYATAZ
AB + BRISTOL MYERS EQ 200MG BASE N021567 003 Jun 20, 2003
SQUIBB
AB +! EQ 300MG BASE N021567 004 Oct 16, 2006
POWDER;ORAL
REYATAZ
+! BRISTOL MYERS EQ 50MG BASE/PACKET N206352 001 Jun 02, 2014
SQUIBB
ATAZANAVIR SULFATE; COBICISTAT
TABLET;ORAL
EVOTAZ
+! BRISTOL EQ 300MG BASE;150MG N206353 001 Jan 29, 2015
ATENOLOL
TABLET;ORAL
ATENOLOL
AB ALVOGEN 25MG A072304 002 Jul 31, 1992
AB 50MG A072304 003 Jul 18, 1988
AB 100MG A072304 001 Jul 15, 1988
AB AUROBINDO PHARMA 25MG A078512 001 Oct 31, 2007
AB 50MG A078512 002 Oct 31, 2007
AB 100MG A078512 003 Oct 31, 2007
AB HLTHCARE 25MG A073026 002 May 01, 1992
AB 50MG A073026 003 Sep 17, 1991
AB 100MG A073026 001 Sep 17, 1991
AB IPCA LABS LTD 25MG A077877 001 Dec 27, 2006
AB 50MG A077877 002 Dec 27, 2006
AB 100MG A077877 003 Dec 27, 2006
AB MYLAN 25MG A073457 002 Apr 26, 1999
AB 50MG A073457 003 Jan 24, 1992
AB 100MG A073457 001 Jan 24, 1992
AB TEVA 25MG A074056 003 Jul 19, 2004
AB 50MG A074056 001 Jan 18, 1995
AB 100MG A074056 002 Jan 18, 1995
AB UNICHEM 25MG A213136 001 Nov 21, 2019
AB 50MG A213136 002 Nov 21, 2019
AB 100MG A213136 003 Nov 21, 2019
AB UNIQUE 25MG A077443 001 Sep 13, 2006
AB 50MG A077443 002 Sep 13, 2006
AB 100MG A077443 003 Sep 13, 2006
AB ZYDUS PHARMS USA 25MG A076900 001 Jan 28, 2005
AB 50MG A076900 002 Jan 28, 2005
AB 100MG A076900 003 Jan 28, 2005
TENORMIN
AB + ALMATICA 25MG N018240 004 Apr 09, 1990
AB + 50MG N018240 001
AB +! 100MG N018240 002
ATENOLOL; CHLORTHALIDONE
TABLET;ORAL
ATENOLOL AND CHLORTHALIDONE
AB ALVOGEN 50MG;25MG A072302 002 May 31, 1990
AB 100MG;25MG A072302 001 May 31, 1990
AB NOVITIUM PHARMA 50MG;25MG A215560 001 Oct 25, 2021
AB 100MG;25MG A215560 002 Oct 25, 2021
AB UNICHEM 50MG;25MG A213302 001 Nov 25, 2020
AB 100MG;25MG A213302 002 Nov 25, 2020
AB WATSON LABS 50MG;25MG A073665 001 Jul 02, 1992
AB 100MG;25MG A073665 002 Jul 02, 1992
AB ZYDUS PHARMS 50MG;25MG A210028 001 Mar 08, 2019
AB 100MG;25MG A210028 002 Mar 08, 2019
TENORETIC 100
AB +! ALMATICA 100MG;25MG N018760 001 Jun 08, 1984
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-43(of 474)

ATENOLOL; CHLORTHALIDONE
TABLET;ORAL
TENORETIC 50
AB + ALMATICA 50MG;25MG N018760 002 Jun 08, 1984
ATOGEPANT
TABLET;ORAL
QULIPTA
+ ABBVIE INC 10MG N215206 001 Sep 28, 2021
+ 30MG N215206 002 Sep 28, 2021
+! 60MG N215206 003 Sep 28, 2021
ATOMOXETINE HYDROCHLORIDE
CAPSULE;ORAL
ATOMOXETINE HYDROCHLORIDE
AB APOTEX 10MG A078983 001 May 30, 2017
AB 18MG A078983 002 May 30, 2017
AB 25MG A078983 003 May 30, 2017
AB 40MG A078983 004 May 30, 2017
AB 60MG A078983 005 May 30, 2017
AB 80MG A078983 006 May 30, 2017
AB 100MG A078983 007 May 30, 2017
AB AUROBINDO PHARMA 10MG A079016 001 May 30, 2017
AB 18MG A079016 002 May 30, 2017
AB 25MG A079016 003 May 30, 2017
AB 40MG A079016 004 May 30, 2017
AB 60MG A079016 005 May 30, 2017
AB 80MG A079016 006 May 30, 2017
AB 100MG A079016 007 May 30, 2017
AB DR REDDYS 10MG A090609 001 Feb 23, 2018
AB 18MG A090609 002 Feb 23, 2018
AB 25MG A090609 003 Feb 23, 2018
AB 40MG A090609 004 Feb 23, 2018
AB 60MG A090609 005 Feb 23, 2018
AB 80MG A090609 006 Feb 23, 2018
AB 100MG A090609 007 Feb 23, 2018
AB GLENMARK PHARMS LTD 10MG A079019 001 May 30, 2017
AB 18MG A079019 002 May 30, 2017
AB 25MG A079019 003 May 30, 2017
AB 40MG A079019 004 May 30, 2017
AB 60MG A079019 005 May 30, 2017
AB 80MG A079019 006 May 30, 2017
AB 100MG A079019 007 May 30, 2017
AB HETERO LABS LTD V 10MG A202682 001 Mar 11, 2021
AB 18MG A202682 002 Mar 11, 2021
AB 25MG A202682 003 Mar 11, 2021
AB 40MG A202682 004 Mar 11, 2021
AB 60MG A202682 005 Mar 11, 2021
AB 80MG A202682 006 Mar 11, 2021
AB 100MG A202682 007 Mar 11, 2021
AB TEVA PHARMS USA 10MG A079022 001 May 30, 2017
AB 18MG A079022 002 May 30, 2017
AB 25MG A079022 003 May 30, 2017
AB 40MG A079022 004 May 30, 2017
AB 60MG A079022 005 May 30, 2017
AB 80MG A079022 006 May 30, 2017
AB 100MG A079022 007 May 30, 2017
AB ZYDUS PHARMS USA 18MG A079017 001 Sep 17, 2010
INC
AB 25MG A079017 002 Sep 17, 2010
AB 40MG A079017 003 Sep 17, 2010
AB 60MG A079017 004 Sep 17, 2010
AB 80MG A079017 005 Sep 17, 2010
AB 100MG A079017 006 Sep 17, 2010
STRATTERA
AB + LILLY 10MG N021411 002 Nov 26, 2002
AB + 18MG N021411 003 Nov 26, 2002
AB + 25MG N021411 004 Nov 26, 2002
AB + 40MG N021411 005 Nov 26, 2002
AB +! 60MG N021411 006 Nov 26, 2002
AB + 80MG N021411 007 Feb 14, 2005
AB + 100MG N021411 008 Feb 14, 2005
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-44(of 474)

ATORVASTATIN CALCIUM
TABLET;ORAL
ATORVASTATIN CALCIUM
AB ACCORD HLTHCARE EQ 10MG BASE A207687 001 Mar 30, 2018
AB EQ 20MG BASE A207687 002 Mar 30, 2018
AB EQ 40MG BASE A207687 003 Mar 30, 2018
AB EQ 80MG BASE A207687 004 Mar 30, 2018
AB AGNITIO EQ 10MG BASE A214969 001 Sep 02, 2021
AB EQ 20MG BASE A214969 002 Sep 02, 2021
AB EQ 40MG BASE A214969 003 Sep 02, 2021
AB EQ 80MG BASE A214969 004 Sep 02, 2021
AB ALKEM LABS LTD EQ 10MG BASE A209288 001 Dec 21, 2018
AB EQ 20MG BASE A209288 002 Dec 21, 2018
AB EQ 40MG BASE A209288 003 Dec 21, 2018
AB EQ 80MG BASE A209288 004 Dec 21, 2018
AB APOTEX INC EQ 10MG BASE A090548 001 May 29, 2012
AB EQ 20MG BASE A090548 002 May 29, 2012
AB EQ 40MG BASE A090548 003 May 29, 2012
AB EQ 80MG BASE A090548 004 May 29, 2012
AB BIOCON PHARMA EQ 10MG BASE A216436 001 Nov 23, 2022
AB EQ 20MG BASE A216436 002 Nov 23, 2022
AB EQ 40MG BASE A216436 003 Nov 23, 2022
AB EQ 80MG BASE A216436 004 Nov 23, 2022
AB DR REDDYS EQ 10MG BASE A214659 001 Jul 14, 2021
AB EQ 20MG BASE A214659 002 Jul 14, 2021
AB EQ 40MG BASE A214659 003 Jul 14, 2021
AB EQ 80MG BASE A214659 004 Jul 14, 2021
AB DR REDDYS LABS LTD EQ 10MG BASE A091650 001 Jul 17, 2012
AB EQ 20MG BASE A091650 002 Jul 17, 2012
AB EQ 40MG BASE A091650 003 Jul 17, 2012
AB EQ 80MG BASE A202357 001 Jul 17, 2012
AB GRAVITI PHARMS EQ 10MG BASE A209912 001 Jun 18, 2018
AB EQ 20MG BASE A209912 002 Jun 18, 2018
AB EQ 40MG BASE A209912 003 Jun 18, 2018
AB EQ 80MG BASE A209912 004 Jun 18, 2018
AB INVAGEN PHARMS EQ 10MG BASE A204846 001 Jan 09, 2017
AB EQ 20MG BASE A204846 002 Jan 09, 2017
AB EQ 40MG BASE A204846 003 Jan 09, 2017
AB EQ 80MG BASE A204846 004 Jan 09, 2017
AB LANNETT CO INC EQ 10MG BASE A091624 001 Apr 05, 2013
AB EQ 20MG BASE A091624 002 Apr 05, 2013
AB EQ 40MG BASE A091624 003 Apr 05, 2013
AB EQ 80MG BASE A091624 004 Apr 05, 2013
AB LEPU PHARM EQ 10MG BASE A216848 001 Nov 03, 2022
AB EQ 20MG BASE A216848 002 Nov 03, 2022
AB EQ 40MG BASE A216848 003 Nov 03, 2022
AB EQ 80MG BASE A216848 004 Nov 03, 2022
AB LUPIN LTD EQ 10MG BASE A204991 001 Mar 06, 2019
AB EQ 20MG BASE A204991 002 Mar 06, 2019
AB EQ 40MG BASE A204991 003 Mar 06, 2019
AB EQ 80MG BASE A204991 004 Mar 06, 2019
AB MICRO LABS LTD EQ 10MG BASE A205945 001 Nov 07, 2019
INDIA
AB EQ 20MG BASE A205945 002 Nov 07, 2019
AB EQ 40MG BASE A205945 003 Nov 07, 2019
AB EQ 80MG BASE A205945 004 Nov 07, 2019
AB MSN EQ 10MG BASE A211933 001 Feb 08, 2019
AB EQ 20MG BASE A211933 002 Feb 08, 2019
AB EQ 40MG BASE A211933 003 Feb 08, 2019
AB EQ 80MG BASE A211933 004 Feb 08, 2019
AB MYLAN PHARMS INC EQ 10MG BASE A091226 001 May 29, 2012
AB EQ 20MG BASE A091226 002 May 29, 2012
AB EQ 40MG BASE A091226 003 May 29, 2012
AB EQ 80MG BASE A091226 004 May 29, 2012
AB SANDOZ INC EQ 10MG BASE A077575 001 May 29, 2012
AB EQ 20MG BASE A077575 002 May 29, 2012
AB EQ 40MG BASE A077575 003 May 29, 2012
AB EQ 80MG BASE A077575 004 May 29, 2012
AB SCIEGEN PHARMS INC EQ 10MG BASE A205519 001 May 19, 2016
AB EQ 20MG BASE A205519 002 May 19, 2016
AB EQ 40MG BASE A205519 003 May 19, 2016
AB EQ 80MG BASE A205519 004 May 19, 2016
AB SUN PHARM INDS LTD EQ 10MG BASE A076477 001 Nov 30, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-45(of 474)

ATORVASTATIN CALCIUM
TABLET;ORAL
ATORVASTATIN CALCIUM
AB EQ 20MG BASE A076477 002 Nov 30, 2011
AB EQ 40MG BASE A076477 003 Nov 30, 2011
AB EQ 80MG BASE A076477 004 Nov 30, 2011
AB TEVA PHARMS USA EQ 10MG BASE A205300 001 Mar 27, 2017
AB EQ 20MG BASE A205300 002 Mar 27, 2017
AB EQ 40MG BASE A205300 003 Mar 27, 2017
AB EQ 80MG BASE A205300 004 Mar 27, 2017
AB UMEDICA LABS PVT EQ 10MG BASE A213853 001 Aug 19, 2020
LTD
AB EQ 20MG BASE A213853 002 Aug 19, 2020
AB EQ 40MG BASE A213853 003 Aug 19, 2020
AB EQ 80MG BASE A213853 004 Aug 19, 2020
AB ZYDUS PHARMS EQ 10MG BASE A206536 001 Nov 20, 2018
AB EQ 20MG BASE A206536 002 Nov 20, 2018
AB EQ 40MG BASE A206536 003 Nov 20, 2018
AB EQ 80MG BASE A206536 004 Nov 20, 2018
LIPITOR
AB + UPJOHN EQ 10MG BASE N020702 001 Dec 17, 1996
AB + EQ 20MG BASE N020702 002 Dec 17, 1996
AB + EQ 40MG BASE N020702 003 Dec 17, 1996
AB +! EQ 80MG BASE N020702 004 Apr 07, 2000
ATORVASTATIN CALCIUM; EZETIMIBE
TABLET;ORAL
LYPQOZET
SCOV3 EQ 10MG BASE;10MG A206084 001 Apr 26, 2017
EQ 20MG BASE;10MG A206084 002 Apr 26, 2017
EQ 40MG BASE;10MG A206084 003 Apr 26, 2017
! EQ 80MG BASE;10MG A206084 004 Apr 26, 2017
ATOVAQUONE
SUSPENSION;ORAL
ATOVAQUONE
AB ABHAI LLC 750MG/5ML A210510 001 May 31, 2019
AB ABON PHARMS LLC 750MG/5ML A214272 001 Oct 25, 2021
AB AMNEAL PHARMS 750MG/5ML A202960 001 Mar 18, 2014
AB APOTEX 750MG/5ML A209750 001 Oct 11, 2017
AB BIONPHARMA INC 750MG/5ML A212918 001 Mar 30, 2021
AB CHARTWELL RX 750MG/5ML A207833 001 Apr 28, 2017
AB GLENMARK PHARMS 750MG/5ML A209685 001 Nov 21, 2018
AB HETERO LABS LTD III 750MG/5ML A210692 001 Oct 11, 2018
AB LUPIN LTD 750MG/5ML A209105 001 Sep 11, 2018
MEPRON
AB +! GLAXOSMITHKLINE LLC 750MG/5ML N020500 001 Feb 08, 1995
ATOVAQUONE; PROGUANIL HYDROCHLORIDE
TABLET;ORAL
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
AB GLENMARK GENERICS 62.5MG;25MG A091211 002 Apr 06, 2015
AB 250MG;100MG A091211 001 Jan 12, 2011
AB MYLAN 62.5MG;25MG A202362 001 May 27, 2014
AB 250MG;100MG A202362 002 May 27, 2014
MALARONE
AB +! GLAXOSMITHKLINE 250MG;100MG N021078 001 Jul 14, 2000
MALARONE PEDIATRIC
AB + GLAXOSMITHKLINE 62.5MG;25MG N021078 002 Jul 14, 2000
ATRACURIUM BESYLATE
INJECTABLE;INJECTION
ATRACURIUM BESYLATE
AP EUGIA PHARMA 10MG/ML A206011 001 Apr 08, 2015
AP ! HIKMA 10MG/ML A074901 001 Jul 18, 1997
AP HOSPIRA INC 10MG/ML A090761 001 Oct 18, 2012
AP MEITHEAL 10MG/ML A091489 001 Feb 17, 2012
ATRACURIUM BESYLATE PRESERVATIVE FREE
AP EUGIA PHARMA 10MG/ML A206010 001 Apr 08, 2015
AP ! HIKMA 10MG/ML A074900 001 Jul 18, 1997
AP HOSPIRA INC 10MG/ML A090782 001 Oct 18, 2012
AP MEITHEAL 10MG/ML A091488 001 Feb 17, 2012
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-46(of 474)

ATROPINE
SOLUTION;INTRAMUSCULAR
ATROPEN
+! MMT EQ 0.25MG SULFATE/0.3ML N017106 004 Sep 17, 2004
+! EQ 0.5MG SULFATE/0.7ML N017106 003 Jun 19, 2003
+! EQ 1MG SULFATE/0.7ML N017106 002 Jun 19, 2003
+! EQ 2MG SULFATE/0.7ML N017106 001
ATROPINE SULFATE
SOLUTION;INTRAVENOUS
ATROPINE SULFATE
AP ACCORD HLTHCARE 0.25MG/5ML (0.05MG/ML) A212868 001 Jul 26, 2021
AP +! 0.4MG/ML (0.4MG/ML) N214652 001 Sep 29, 2020
AP 0.5MG/5ML (0.1MG/ML) A212868 002 Jul 26, 2021
AP 1MG/10ML (0.1MG/ML) A212868 003 Jul 26, 2021
AP +! 1MG/ML (1MG/ML) N214652 002 Sep 29, 2020
AP AM REGENT 0.4MG/ML (0.4MG/ML) A216120 001 May 26, 2022
AP 1MG/ML (1MG/ML) A216120 002 May 26, 2022
AP AMNEAL 0.5MG/5ML (0.1MG/ML) A215342 001 Jan 26, 2022
AP +! HOSPIRA 0.25MG/5ML (0.05MG/ML) N021146 002 Jul 09, 2001
AP +! 0.5MG/5ML (0.1MG/ML) N021146 001 Jul 09, 2001
AP +! 1MG/10ML (0.1MG/ML) N021146 003 Jul 09, 2001
AP INTL MEDICATION SYS 1MG/10ML (0.1MG/ML) A212461 001 Oct 05, 2020
AP MEDEFIL INC 1MG/10ML (0.1MG/ML) A214970 001 Nov 04, 2022
SOLUTION;INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAOSSEOUS, ENDOTRACHEAL
ATROPINE SULFATE
AP ACCORD HLTHCARE 8MG/20ML (0.4MG/ML) A213424 001 Mar 19, 2021
AP +! FRESENIUS KABI USA 8MG/20ML (0.4MG/ML) N209260 001 Jan 26, 2018
AP HIKMA 8MG/20ML (0.4MG/ML) A213561 001 Dec 01, 2021
SOLUTION/DROPS;OPHTHALMIC
ATROPINE SULFATE
AT +! AKORN 1% N206289 001 Jul 18, 2014
AT AMNEAL 1% A214752 001 Jul 14, 2022
AT APOTEX INC 1% A215624 001 Nov 26, 2021
+! BAUSCH AND LOMB INC 1% N213581 001 Mar 15, 2022
ISOPTO ATROPINE
+! ALCON LABS INC 1% N208151 001 Dec 01, 2016
ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE
TABLET;ORAL
MOTOFEN
+! SEBELA IRELAND LTD 0.025MG;1MG N017744 002
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE
SOLUTION;ORAL
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
! HIKMA 0.025MG/5ML;2.5MG/5ML A087708 001 May 03, 1982
TABLET;ORAL
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
AA ANI PHARMS 0.025MG;2.5MG A086727 001
AA BAYSHORE PHARMS LLC 0.025MG;2.5MG A210819 001 Nov 13, 2018
AA CHARTWELL RX 0.025MG;2.5MG A207128 001 Oct 21, 2020
AA LANNETT 0.025MG;2.5MG A085372 001
AA LEADING 0.025MG;2.5MG A213413 001 Feb 20, 2020
AA MYLAN 0.025MG;2.5MG A085762 001
AA SPECGX LLC 0.025MG;2.5MG A213335 001 Oct 06, 2020
AA UPSHER SMITH LABS 0.025MG;2.5MG A210571 001 Aug 31, 2018
AA WINDER LABS LLC 0.025MG;2.5MG A211362 001 Jan 27, 2021
LOMOTIL
AA +! PFIZER 0.025MG;2.5MG N012462 001
ATROPINE; PRALIDOXIME CHLORIDE
INJECTABLE;INTRAMUSCULAR
DUODOTE
+! MMT 2.1MG/0.7ML;600MG/2ML N021983 001 Sep 28, 2006
AURANOFIN
CAPSULE;ORAL
RIDAURA
+! SEBELA IRELAND LTD 3MG N018689 001 May 24, 1985
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-47(of 474)

AVACOPAN
CAPSULE;ORAL
TAVNEOS
+! CHEMOCENTRYX 10MG N214487 001 Oct 07, 2021
AVANAFIL
TABLET;ORAL
STENDRA
+ METUCHEN PHARMS 50MG N202276 001 Apr 27, 2012
+ 100MG N202276 002 Apr 27, 2012
+! 200MG N202276 003 Apr 27, 2012
AVAPRITINIB
TABLET;ORAL
AYVAKIT
+ BLUEPRINT MEDICINES 25MG N212608 004 Jun 16, 2021
+ 50MG N212608 005 Jun 16, 2021
+ 100MG N212608 001 Jan 09, 2020
+ 200MG N212608 002 Jan 09, 2020
+! 300MG N212608 003 Jan 09, 2020
AVATROMBOPAG MALEATE
TABLET;ORAL
DOPTELET
+! AKARX INC EQ 20MG BASE N210238 001 May 21, 2018
AVIBACTAM SODIUM; CEFTAZIDIME
POWDER;INTRAVENOUS
AVYCAZ
+! ALLERGAN EQ 0.5GM BASE;2GM/VIAL N206494 001 Feb 25, 2015
AXITINIB
TABLET;ORAL
INLYTA
+ PF PRISM CV 1MG N202324 001 Jan 27, 2012
+! 5MG N202324 002 Jan 27, 2012
AZACITIDINE
POWDER;INTRAVENOUS, SUBCUTANEOUS
AZACITIDINE
AP ACCORD HLTHCARE 100MG/VIAL A207475 001 Jul 02, 2018
AP ACTAVIS LLC 100MG/VIAL N208216 001 Apr 29, 2016
AP AMNEAL 100MG/VIAL A211549 001 Feb 03, 2022
AP CIPLA 100MG/VIAL A209540 001 May 04, 2018
AP DR REDDYS 100MG/VIAL A201537 001 Sep 16, 2013
AP EUGIA PHARMA 100MG/VIAL A215066 001 Dec 30, 2022
AP EUROHLTH INTL SARL 100MG/VIAL A209337 001 Jun 08, 2020
AP MEITHEAL 100MG/VIAL A212128 001 Nov 02, 2020
AP NATCO PHARMA LTD 100MG/VIAL A207234 001 Jun 23, 2017
AP SHILPA MEDICARE 100MG/VIAL A207518 001 Sep 29, 2016
VIDAZA
AP +! BRISTOL-MYERS 100MG/VIAL N050794 001 May 19, 2004
TABLET;ORAL
ONUREG
+ BRISTOL 200MG N214120 001 Sep 01, 2020
+! 300MG N214120 002 Sep 01, 2020
AZATHIOPRINE
TABLET;ORAL
AZASAN
AB AAIPHARMA LLC 25MG A075252 002 Feb 03, 2003
AB 50MG A075252 001 Jun 07, 1999
AB 75MG A075252 003 Feb 03, 2003
AB 100MG A075252 004 Feb 03, 2003
AZATHIOPRINE
AB ALKEM LABS LTD 25MG A208687 001 Mar 27, 2020
AB 50MG A208687 002 Mar 27, 2020
AB 75MG A208687 003 Mar 27, 2020
AB 100MG A208687 004 Mar 27, 2020
AB AMNEAL 50MG A074069 001 Feb 16, 1996
AB 75MG A074069 002 Nov 02, 2021
AB 100MG A074069 003 Nov 02, 2021
AB RISING 50MG A075568 001 Dec 13, 1999
AB ZYDUS PHARMS USA 25MG A077621 002 Sep 05, 2008
AB 50MG A077621 001 Mar 15, 2007
AB 75MG A077621 003 Sep 05, 2008
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-48(of 474)

AZATHIOPRINE
TABLET;ORAL
AZATHIOPRINE
AB 100MG A077621 004 Sep 05, 2008
IMURAN
AB +! SEBELA IRELAND LTD 50MG N016324 001
AZATHIOPRINE SODIUM
INJECTABLE;INJECTION
AZATHIOPRINE SODIUM
! HIKMA EQ 100MG BASE/VIAL A074419 001 Mar 31, 1995
AZELAIC ACID
AEROSOL, FOAM;TOPICAL
FINACEA
AB +! LEO PHARMA AS 15% N207071 001 Jul 29, 2015
CREAM;TOPICAL
AZELEX
+! ALMIRALL 20% N020428 001 Sep 13, 1995
GEL;TOPICAL
AZELAIC ACID
AB ACTAVIS LABS UT INC 15% A208011 001 Nov 19, 2018
AB ENCUBE 15% A208724 001 Nov 19, 2018
AB GLENMARK PHARMS 15% A204637 001 Nov 19, 2018
AB TARO 15% A210549 001 Aug 23, 2019
FINACEA
AB +! LEO PHARMA AS 15% N021470 001 Dec 24, 2002
AZELASTINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
AZELASTINE HYDROCHLORIDE
AT ALEMBIC PHARMS 0.05% A209620 001 Mar 20, 2019
AT APOTEX INC 0.05% A078621 001 Aug 03, 2009
AT GLAND PHARMA LTD 0.05% A210092 001 Feb 25, 2020
AT ! SANDOZ INC 0.05% A202305 001 May 31, 2012
AT SOMERSET THERAPS 0.05% A207411 001 Mar 29, 2019
LLC
AT SUN PHARM 0.05% A078738 001 Jun 21, 2010
SPRAY, METERED;NASAL
AZELASTINE HYDROCHLORIDE
AB AKORN 0.137MG/SPRAY A207610 001 May 17, 2019
AB ALKEM LABS LTD 0.137MG/SPRAY A208156 001 Aug 18, 2017
AB AMNEAL 0.137MG/SPRAY A204660 001 Aug 28, 2017
AB ! APOTEX INC 0.137MG/SPRAY A077954 001 Apr 30, 2009
AB AUROBINDO PHARMA 0.137MG/SPRAY A212289 001 May 08, 2020
LTD
AB BRECKENRIDGE 0.137MG/SPRAY A090176 001 Jul 28, 2015
AB HIKMA 0.137MG/SPRAY A091444 001 Oct 24, 2014
AB PADAGIS ISRAEL 0.2055MG/SPRAY A202743 001 May 08, 2014
AB SUN PHARM 0.137MG/SPRAY A090423 001 May 23, 2012
AB UPSHER SMITH LABS 0.137MG/SPRAY A202609 001 Mar 17, 2017
AB ZYDUS PHARMS 0.137MG/SPRAY A091409 001 Aug 14, 2017
AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE
SPRAY, METERED;NASAL
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
AB APOTEX 0.137MG/SPRAY;0.05MG/SPRAY A207712 001 Apr 28, 2017
AB PADAGIS ISRAEL 0.137MG/SPRAY;0.05MG/SPRAY A208111 001 Feb 18, 2021
DYMISTA
AB +! MYLAN SPECIALITY LP 0.137MG/SPRAY;0.05MG/SPRAY N202236 001 May 01, 2012
AZILSARTAN KAMEDOXOMIL
TABLET;ORAL
EDARBI
+ AZURITY EQ 40MG MEDOXOMIL N200796 001 Feb 25, 2011
+! EQ 80MG MEDOXOMIL N200796 002 Feb 25, 2011
AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
TABLET;ORAL
EDARBYCLOR
+ AZURITY EQ 40MG MEDOXOMIL;12.5MG N202331 001 Dec 20, 2011
+! EQ 40MG MEDOXOMIL;25MG N202331 002 Dec 20, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-49(of 474)

AZITHROMYCIN
FOR SUSPENSION;ORAL
AZITHROMYCIN
AB AMNEAL EQ 100MG BASE/5ML A205666 001 Jul 19, 2018
AB EQ 200MG BASE/5ML A205666 002 Jul 19, 2018
AB AUROBINDO PHARMA EQ 100MG BASE/5ML A209201 001 Oct 09, 2018
LTD
AB EQ 200MG BASE/5ML A209201 002 Oct 09, 2018
AB EPIC PHARMA LLC EQ 100MG BASE/5ML A207531 001 Apr 09, 2018
AB EQ 200MG BASE/5ML A207531 002 Apr 09, 2018
AB PLIVA EQ 100MG BASE/5ML A065246 002 Jul 05, 2006
AB EQ 200MG BASE/5ML A065246 001 Jul 05, 2006
AB ZYDUS EQ 100MG BASE/5ML A211147 001 Jul 31, 2018
AB EQ 200MG BASE/5ML A211147 002 Jul 31, 2018
ZITHROMAX
AB + PFIZER EQ 100MG BASE/5ML N050710 001 Oct 19, 1995
AB +! EQ 200MG BASE/5ML N050710 002 Oct 19, 1995
+! EQ 1GM BASE/PACKET N050693 001 Sep 28, 1994
INJECTABLE;INJECTION
AZITHROMYCIN
AP EUGIA PHARMA EQ 500MG BASE/VIAL A203294 001 Jun 19, 2015
AP FRESENIUS KABI USA EQ 500MG BASE/VIAL A065179 001 Dec 13, 2005
AP GLAND PHARMA LTD EQ 500MG BASE/VIAL A065501 001 Nov 09, 2009
AP HAINAN POLY PHARM EQ 500MG BASE/VIAL A203412 001 Oct 09, 2018
AP HOSPIRA EQ 500MG BASE/VIAL A065500 001 Jun 26, 2009
AP EQ 500MG BASE/VIAL A065511 001 Jun 26, 2009
AP SUN PHARM INDS LTD EQ 500MG BASE/VIAL A090923 001 Apr 02, 2013
ZITHROMAX
AP +! PFIZER EQ 500MG BASE/VIAL N050733 001 Jan 30, 1997
SOLUTION/DROPS;OPHTHALMIC
AZASITE
+! THEA PHARMA 1% N050810 001 Apr 27, 2007
TABLET;ORAL
AZITHROMYCIN
AB ACI EQ 250MG BASE A215772 001 Jul 15, 2022
AB EQ 500MG BASE A215773 001 Jul 12, 2022
AB ALEMBIC PHARMS EQ 250MG BASE A211791 001 Jan 28, 2020
AB EQ 500MG BASE A211792 001 Jan 28, 2020
AB EQ 600MG BASE A211793 001 Jan 27, 2020
AB AUROBINDO PHARMA EQ 250MG BASE A207370 001 Jul 05, 2018
LTD
AB EQ 500MG BASE A207398 001 Jul 05, 2018
AB BIONPHARMA INC EQ 250MG BASE A210000 001 Feb 26, 2019
AB EQ 500MG BASE A210001 001 Feb 26, 2019
AB EQ 600MG BASE A209999 001 Dec 26, 2018
AB CHARTWELL RX EQ 250MG BASE A065404 001 Feb 11, 2008
AB EQ 500MG BASE A065405 001 Feb 11, 2008
AB EQ 600MG BASE A065302 003 Feb 11, 2008
AB CSPC OUYI EQ 250MG BASE A208250 001 Apr 17, 2019
AB EQ 500MG BASE A208249 001 Oct 25, 2018
AB EQ 600MG BASE A207566 001 Sep 24, 2018
AB LUPIN LTD EQ 250MG BASE A065398 001 May 15, 2015
AB EQ 500MG BASE A065399 001 May 15, 2015
AB EQ 600MG BASE A065400 001 May 15, 2015
AB PLIVA EQ 250MG BASE A065225 001 Nov 14, 2005
AB EQ 500MG BASE A065223 001 Nov 14, 2005
AB ! EQ 600MG BASE A065218 001 Nov 14, 2005
AB SANDOZ EQ 250MG BASE A065211 001 Nov 14, 2005
AB EQ 500MG BASE A065212 001 Nov 14, 2005
AB EQ 600MG BASE A065209 001 Nov 14, 2005
AB SUNSHINE EQ 250MG BASE A209045 001 Dec 07, 2018
AB EQ 500MG BASE A209044 001 Dec 07, 2018
AB EQ 600MG BASE A209043 001 Dec 06, 2018
AB TEVA EQ 500MG BASE A065193 001 Nov 14, 2005
AB YUNG SHIN PHARM EQ 250MG BASE A211317 001 Jul 26, 2022
AB EQ 600MG BASE A211068 001 May 08, 2020
ZITHROMAX
AB + PFIZER EQ 250MG BASE N050711 001 Jul 18, 1996
AB + EQ 500MG BASE N050784 001 May 24, 2002
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-50(of 474)

AZTREONAM
FOR SOLUTION;INHALATION
CAYSTON
+! GILEAD 75MG/VIAL N050814 001 Feb 22, 2010
INJECTABLE;INJECTION
AZACTAM
AP +! BRISTOL MYERS 1GM/VIAL N050580 002 Dec 31, 1986
SQUIBB
AP +! 2GM/VIAL N050580 003 Dec 31, 1986
AZTREONAM
AP FRESENIUS KABI USA 1GM/VIAL A065439 002 Jun 18, 2010
AP 2GM/VIAL A065439 003 Jun 18, 2010
AP HOSPIRA 1GM/VIAL A206517 001 Nov 08, 2021
AP 2GM/VIAL A206517 002 Nov 08, 2021
FRESENIUS KABI USA 500MG/VIAL A065439 001 Jun 18, 2010
BACITRACIN
OINTMENT;OPHTHALMIC
BACITRACIN
! PADAGIS US 500 UNITS/GM A061212 001
BACITRACIN ZINC; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE
! PADAGIS US 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 A062166 002
UNITS/GM
BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE
AT AKORN 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 A065213 001 Jul 25, 2012
UNITS/GM
AT ! BAUSCH AND LOMB 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 A064068 001 Oct 30, 1995
UNITS/GM
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
LUMI-SPORYN
AT + CASPER PHARMA LLC EQ 400 UNITS/GM;EQ 3.5MG BASE/GM;EQ N050417 001
10,000 UNITS/GM
NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC
AT AKORN 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 A065088 001 Feb 06, 2004
UNITS/GM
AT ! BAUSCH AND LOMB 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 A064064 001 Oct 30, 1995
UNITS/GM
AT PADAGIS US 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 A060764 002
UNITS/GM
BACITRACIN ZINC; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
BACITRACIN ZINC AND POLYMYXIN B SULFATE
AT AKORN 500 UNITS/GM;10,000 UNITS/GM A064028 001 Jan 30, 1995
AT ! BAUSCH AND LOMB 500 UNITS/GM;10,000 UNITS/GM A064046 001 Jan 26, 1995
AT PADAGIS US 500 UNITS/GM;10,000 UNITS/GM A065022 001 Feb 27, 2002
BACLOFEN
GRANULES;ORAL
LYVISPAH
+ AMNEAL 5MG/PACKET N215422 001 Nov 22, 2021
+ 10MG/PACKET N215422 002 Nov 22, 2021
+! 20MG/PACKET N215422 003 Nov 22, 2021
INJECTABLE;INTRATHECAL
BACLOFEN
AP AMNEAL 0.05MG/ML A091193 001 May 03, 2016
AP 0.5MG/ML A091193 002 May 03, 2016
AP 2MG/ML A091193 003 May 03, 2016
AP MAIA PHARMS INC 0.05MG/ML A210777 001 Jan 15, 2021
AP 0.5MG/ML A210048 001 Sep 11, 2019
AP 1MG/ML A210315 001 Jul 30, 2019
AP 2MG/ML A210048 002 Sep 11, 2019
AP MYLAN LABS LTD 0.5MG/ML A209592 001 Mar 21, 2018
AP 1MG/ML A209594 001 Mar 06, 2018
AP 2MG/ML A209592 002 Mar 21, 2018
GABLOFEN
AP +! PIRAMAL CRITICAL 0.05MG/ML N022462 001 Nov 19, 2010
AP +! 0.5MG/ML N022462 002 Nov 19, 2010
AP +! 1MG/ML N022462 004 Jun 22, 2012
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-51(of 474)

BACLOFEN
INJECTABLE;INTRATHECAL
GABLOFEN
AP +! 2MG/ML N022462 003 Nov 19, 2010
LIORESAL
AP +! AMNEAL 0.05MG/ML N020075 003 Nov 07, 1996
AP +! 0.5MG/ML N020075 001 Jun 17, 1992
AP +! 2MG/ML N020075 002 Jun 17, 1992
SOLUTION;ORAL
OZOBAX
+! METACEL PHARMS LLC 5MG/5ML N208193 001 Sep 18, 2019
SUSPENSION;ORAL
FLEQSUVY
+! AZURITY 25MG/5ML N215602 001 Feb 04, 2022
TABLET;ORAL
BACLOFEN
AB AUROBINDO PHARMA 10MG A214099 001 Jul 13, 2021
LTD
AB 20MG A214099 002 Jul 13, 2021
AB BEXIMCO PHARMS USA 10MG A214114 001 Jul 16, 2021
AB 20MG A214114 002 Jul 16, 2021
AB EYWA PHARMA 5MG A211555 003 Nov 30, 2021
AB 10MG A211555 001 Feb 01, 2019
AB 20MG A211555 002 Feb 01, 2019
AB IMPAX 5MG A077971 003 Jul 07, 2021
AB 10MG A077971 001 Oct 26, 2007
AB 20MG A077971 002 Oct 26, 2007
AB INNOGENIX 5MG A212378 003 Apr 30, 2021
AB 10MG A212378 001 Oct 09, 2020
AB 20MG A212378 002 Oct 09, 2020
AB IVAX SUB TEVA 10MG A072234 001 Jul 21, 1988
PHARMS
AB ! 20MG A072235 001 Jul 21, 1988
AB KARTHA 5MG A214374 001 Mar 05, 2021
AB 10MG A214374 002 Mar 05, 2021
AB 20MG A214374 003 Mar 05, 2021
AB LANNETT CO INC 5MG A077241 003 Sep 22, 2021
AB 10MG A077241 002 Jul 06, 2007
AB 20MG A077241 001 Dec 20, 2005
AB MANKIND PHARMA 5MG A215885 001 Jan 25, 2022
AB 10MG A215885 002 Jan 25, 2022
AB 20MG A215885 003 Jan 25, 2022
AB NORTHSTAR HLTHCARE 10MG A078401 002 Sep 18, 2009
AB 20MG A078401 001 Sep 18, 2009
AB OXFORD PHARMS 10MG A077088 002 Oct 31, 2007
AB 20MG A077088 001 Oct 31, 2007
AB RUBICON 5MG A209102 001 Nov 28, 2017
AB 10MG A209102 002 Nov 28, 2017
AB 20MG A209102 003 Nov 28, 2017
AB UNICHEM 10MG A212067 001 Jul 09, 2020
AB 20MG A212067 002 Jul 09, 2020
AB UPSHER SMITH LABS 10MG A074584 001 Aug 19, 1996
AB 20MG A074584 002 Aug 19, 1996
AB VINTAGE PHARMS 10MG A077068 002 Aug 30, 2005
AB 20MG A077068 001 Aug 30, 2005
AB ZYDUS 5MG A211659 003 Apr 17, 2020
AB 10MG A211659 001 Nov 23, 2018
AB 20MG A211659 002 Nov 23, 2018
BALOXAVIR MARBOXIL
FOR SUSPENSION;ORAL
XOFLUZA
+! GENENTECH INC 2MG/ML N214410 001 Nov 23, 2020
TABLET;ORAL
XOFLUZA
+ GENENTECH INC 20MG N210854 001 Oct 24, 2018
+! 40MG N210854 002 Oct 24, 2018
+ 80MG N210854 003 Mar 18, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-52(of 474)

BALSALAZIDE DISODIUM
CAPSULE;ORAL
BALSALAZIDE DISODIUM
AB APOTEX INC 750MG A077883 001 Dec 28, 2007
AB HIKMA 750MG A077806 001 Dec 28, 2007
COLAZAL
AB +! VALEANT PHARMS INTL 750MG N020610 001 Jul 18, 2000
BARICITINIB
TABLET;ORAL
OLUMIANT
+ ELI LILLY AND CO 1MG N207924 002 Oct 08, 2019
+ 2MG N207924 001 May 31, 2018
+! 4MG N207924 003 May 10, 2022
BARIUM SULFATE
FOR SUSPENSION;ORAL
E-Z-HD
+! BRACCO 98% (334GM/BOT) N208036 001 Jan 11, 2016
E-Z-PAQUE
+! BRACCO 96% (169GM/BOT) N208036 002 Apr 07, 2017
VARIBAR THIN LIQUID
+! BRACCO 81% (120GM/BOT) N208036 004 Apr 30, 2019
PASTE;ORAL
VARIBAR PUDDING
BRACCO 40% N208844 001 Oct 14, 2016
SUSPENSION;ORAL
ENTERO VU 24%
+! BRACCO 24% (144GM/600ML) N208143 008 May 29, 2020
LIQUID E-Z-PAQUE
+! BRACCO 60% (213GM/BOT) N208143 003 Mar 01, 2017
READI-CAT 2
+! BRACCO 2% (9GM/BOT) N208143 001 Jan 15, 2016
READI-CAT 2 SMOOTHIE
+! BRACCO 2% (9GM/BOT) N208143 002 Jan 15, 2016
TAGITOL V
+! BRACCO 40% (8GM/BOT) N208143 005 Aug 04, 2017
VARIBAR HONEY
+! BRACCO 40% (100GM/250ML) N208143 007 Mar 26, 2018
VARIBAR NECTAR
+! BRACCO 40% (96GM/240ML) N208143 004 Jul 07, 2017
VARIBAR THIN HONEY
+! BRACCO 40% (100GM/250ML) N208143 006 Jan 23, 2018
BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED
TABLET;ORAL
DUAVEE
+! WYETH PHARMS EQ 20MG BASE;0.45MG N022247 001 Oct 03, 2013
BECLOMETHASONE DIPROPIONATE
AEROSOL, METERED;INHALATION
QVAR REDIHALER
+ NORTON WATERFORD 0.04MG/INH N207921 001 Aug 03, 2017
+ 0.08MG/INH N207921 002 Aug 03, 2017
AEROSOL, METERED;NASAL
QNASL
+ TEVA BRANDED PHARM 0.04MG/ACTUATION N202813 002 Dec 17, 2014
+! 0.08MG/ACTUATION N202813 001 Mar 23, 2012
BECLOMETHASONE DIPROPIONATE MONOHYDRATE
SPRAY, METERED;NASAL
BECONASE AQ
+! GLAXOSMITHKLINE EQ 0.042MG DIPROP/SPRAY N019389 001 Jul 27, 1987
BEDAQUILINE FUMARATE
TABLET;ORAL
SIRTURO
+ JANSSEN THERAP EQ 20MG BASE N204384 002 May 27, 2020
+! EQ 100MG BASE N204384 001 Dec 28, 2012
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-53(of 474)

BELINOSTAT
POWDER;INTRAVENOUS
BELEODAQ
+! ACROTECH BIOPHARMA 500MG/VIAL N206256 001 Jul 03, 2014
BELUMOSUDIL MESYLATE
TABLET;ORAL
REZUROCK
+! KADMON PHARMS LLC EQ 200MG BASE N214783 001 Jul 16, 2021
BELZUTIFAN
TABLET;ORAL
WELIREG
+! MERCK SHARP DOHME 40MG N215383 001 Aug 13, 2021
BEMPEDOIC ACID
TABLET;ORAL
NEXLETOL
+! ESPERION THERAPS 180MG N211616 001 Feb 21, 2020
INC
BEMPEDOIC ACID; EZETIMIBE
TABLET;ORAL
NEXLIZET
+! ESPERION THERAPS 180MG;10MG N211617 001 Feb 26, 2020
INC
BENAZEPRIL HYDROCHLORIDE
TABLET;ORAL
BENAZEPRIL HYDROCHLORIDE
AB AMNEAL PHARMS 5MG A076820 001 Feb 03, 2006
AB 10MG A076820 002 Feb 03, 2006
AB 20MG A076820 003 Feb 03, 2006
AB 40MG A076820 004 Feb 03, 2006
AB ANNORA PHARMA 5MG A077128 001 Mar 08, 2006
AB 10MG A077128 002 Mar 08, 2006
AB 20MG A077128 003 Mar 08, 2006
AB 40MG A077128 004 Mar 08, 2006
AB AUROBINDO PHARMA 10MG A078212 001 May 22, 2008
AB 20MG A078212 002 May 22, 2008
AB ! 40MG A078212 003 May 22, 2008
AB CADILA 5MG A078848 001 May 23, 2008
AB 10MG A078848 002 May 23, 2008
AB 20MG A078848 003 May 23, 2008
AB 40MG A078848 004 May 23, 2008
AB CHARTWELL RX 5MG A076402 001 Feb 11, 2004
AB 10MG A076402 002 Feb 11, 2004
AB 20MG A076402 003 Feb 11, 2004
AB 40MG A076402 004 Feb 11, 2004
AB HERITAGE PHARMA 5MG A076267 001 Feb 11, 2004
AB 10MG A076267 002 Feb 11, 2004
AB 20MG A076267 003 Feb 11, 2004
AB 40MG A076267 004 Feb 11, 2004
AB PRINSTON INC 5MG A076118 001 Feb 11, 2004
AB 10MG A076118 002 Feb 11, 2004
AB 20MG A076118 003 Feb 11, 2004
AB 40MG A076118 004 Feb 11, 2004
AB SUN PHARM INDS LTD 5MG A076344 001 Feb 11, 2004
AB 10MG A076344 002 Feb 11, 2004
AB 20MG A076344 003 Feb 11, 2004
AB 40MG A076344 004 Feb 11, 2004
AB TEVA 5MG A076211 001 Feb 11, 2004
AB 10MG A076211 002 Feb 11, 2004
AB 20MG A076211 003 Feb 11, 2004
AB 40MG A076211 004 Feb 11, 2004
LOTENSIN
AB + VALIDUS PHARMS 10MG N019851 002 Jun 25, 1991
AB + 20MG N019851 003 Jun 25, 1991
AB + 40MG N019851 004 Jun 25, 1991
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-54(of 474)

BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE


TABLET;ORAL
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
AB ANI PHARMS 5MG;6.25MG A076342 001 Feb 11, 2004
AB 10MG;12.5MG A076342 002 Feb 11, 2004
AB 20MG;12.5MG A076342 003 Feb 11, 2004
AB 20MG;25MG A076342 004 Feb 11, 2004
AB SANDOZ 5MG;6.25MG A076631 001 Feb 11, 2004
AB 10MG;12.5MG A076631 002 Feb 11, 2004
AB 20MG;12.5MG A076631 003 Feb 11, 2004
AB 20MG;25MG A076631 004 Feb 11, 2004
LOTENSIN HCT
AB + VALIDUS PHARMS 10MG;12.5MG N020033 002 May 19, 1992
AB + 20MG;12.5MG N020033 004 May 19, 1992
AB +! 20MG;25MG N020033 003 May 19, 1992
BENDAMUSTINE HYDROCHLORIDE
POWDER;IV (INFUSION)
BENDAMUSTINE HYDROCHLORIDE
AP ACCORD HLTHCARE 25MG/VIAL A205574 001 Dec 07, 2022
AP 100MG/VIAL A205574 002 Dec 07, 2022
AP DR REDDYS 25MG/VIAL A205376 001 Dec 07, 2022
AP 100MG/VIAL A205376 002 Dec 07, 2022
TREANDA
AP +! CEPHALON 25MG/VIAL N022249 002 May 01, 2009
AP +! 100MG/VIAL N022249 001 Mar 20, 2008
SOLUTION;INTRAVENOUS
BENDAMUSTINE HYDROCHLORIDE
+! APOTEX 100MG/4ML (25MG/ML) N215033 001 Dec 07, 2022
+! BAXTER HLTHCARE 100MG/4ML (25MG/ML) N216078 001 Dec 15, 2022
CORP
+! HOSPIRA 25MG/ML (25MG/ML) N211530 001 Dec 15, 2022
+! 100MG/4ML (25MG/ML) N211530 002 Dec 15, 2022
+! 200MG/8ML (25MG/ML) N211530 003 Dec 15, 2022
VIVIMUSTA
+! SLAYBACK PHARMA LLC 100MG/4ML (25MG/ML) N212209 001 Dec 07, 2022
SOLUTION;IV (INFUSION)
BELRAPZO
+! EAGLE PHARMS 100MG/4ML (25MG/ML) N205580 001 May 15, 2018
BENDEKA
+! EAGLE PHARMS 100MG/4ML (25MG/ML) N208194 001 Dec 07, 2015
BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM
SOLUTION/DROPS;OPHTHALMIC
ALTAFLUOR BENOX
+! ALTAIRE PHARMS INC 0.4%;0.25% N208582 001 Dec 14, 2017
FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE
+! BAUSCH LOMB IRELAND 0.4%;0.3% N211039 001 Mar 09, 2020
BENZNIDAZOLE
TABLET;ORAL
BENZNIDAZOLE
+ CHEMO RESEARCH SL 12.5MG N209570 001 Aug 29, 2017
+! 100MG N209570 002 Aug 29, 2017
BENZONATATE
CAPSULE;ORAL
BENZONATATE
AA ACELLA 100MG A091310 001 Jan 16, 2015
AA 200MG A091310 002 Jan 16, 2015
AA ALEMBIC LABS 100MG A040682 001 Jul 30, 2007
AA 200MG A040682 002 Jul 30, 2007
AA ASCENT PHARMS INC 100MG A211518 001 Feb 22, 2019
AA 150MG A211518 002 Feb 22, 2019
AA 200MG A211518 003 Feb 22, 2019
AA BIONPHARMA INC 100MG A081297 001 Jan 29, 1993
AA 200MG A081297 002 Oct 30, 2007
AA CHARTWELL RX 100MG A210562 001 Nov 09, 2018
AA 150MG A210562 002 Nov 09, 2018
AA 200MG A210562 003 Nov 09, 2018
AA CSPC-NBP PHARM 100MG A202765 002 Aug 25, 2017
AA 200MG A202765 001 Jul 31, 2015
AA PURACAP PHARM LLC 100MG A206948 001 Dec 19, 2018
AA 200MG A206948 002 Dec 19, 2018
AA STRIDES PHARMA 100MG A091133 001 Jul 30, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-55(of 474)

BENZONATATE
CAPSULE;ORAL
BENZONATATE
AA 200MG A091133 002 Jul 30, 2015
AA ! THEPHARMANETWORK 100MG A040627 001 Mar 30, 2007
LLC
AA ! 150MG A040627 003 Sep 24, 2014
AA ! 200MG A040627 002 Jul 25, 2007
AA ZYDUS PHARMS USA 100MG A040597 001 Jun 08, 2007
AA 200MG A040597 002 Jun 08, 2007
TESSALON
AA + PFIZER 100MG N011210 001
BENZOYL PEROXIDE
CREAM;TOPICAL
EPSOLAY
+! GALDERMA LABS LP 5% N214510 001 Apr 22, 2022
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
GEL;TOPICAL
ACANYA
AB +! BAUSCH 2.5%;EQ 1.2% BASE N050819 001 Oct 23, 2008
BENZACLIN
AB +! BAUSCH 5%;EQ 1% BASE N050756 001 Dec 21, 2000
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
AB ACTAVIS LABS UT INC 2.5%;EQ 1.2% BASE A205128 001 Jun 19, 2015
AB ENCUBE 5%;1.2% A212433 001 Apr 28, 2021
AB GLENMARK PHARMS 5%;EQ 1% BASE A209252 001 Mar 14, 2019
AB MYLAN PHARMS INC 5%;EQ 1% BASE A065443 001 Aug 11, 2009
AB PADAGIS ISRAEL 2.5%;EQ 1.2% BASE A205397 001 Sep 09, 2019
AB 5%;EQ 1% BASE A202440 001 Sep 21, 2015
AB ! 5%;1.2% A090979 001 Jun 26, 2012
AB TARO 2.5%;EQ 1.2% BASE A206575 001 Aug 19, 2019
AB 5%;EQ 1% BASE A208776 001 May 25, 2018
AB TARO PHARMS 5%;1.2% A206218 001 Dec 15, 2017
AB ZYDUS PHARMS 5%;1.2% A210794 001 Dec 28, 2018
DUAC
AB + STIEFEL 5%;1.2% N050741 001 Aug 26, 2002
ONEXTON
+! BAUSCH 3.75%;EQ 1.2% BASE N050819 002 Nov 24, 2014
BENZOYL PEROXIDE; ERYTHROMYCIN
GEL;TOPICAL
BENZAMYCIN
AB +! VALEANT INTL 5%;3% N050557 001 Oct 26, 1984
ERYTHROMYCIN AND BENZOYL PEROXIDE
AB LYNE 5%;3% A065385 001 Sep 18, 2015
BENZOYL PEROXIDE; TRETINOIN
CREAM;TOPICAL
TWYNEO
+! GALDERMA LABS LP 3%;0.1% N214902 001 Jul 26, 2021
BENZPHETAMINE HYDROCHLORIDE
TABLET;ORAL
BENZPHETAMINE HYDROCHLORIDE
AA CHARTWELL 50MG A090473 002 Sep 15, 2010
AA EPIC PHARMA LLC 50MG A090346 001 Dec 15, 2015
AA ! KVK TECH 50MG A090968 001 Jul 20, 2010
CHARTWELL 25MG A090473 001 Sep 15, 2010
BENZTROPINE MESYLATE
INJECTABLE;INJECTION
BENZTROPINE MESYLATE
AP FRESENIUS KABI USA 1MG/ML A090233 001 Jul 28, 2009
AP HIKMA 1MG/ML A209442 001 Oct 14, 2021
AP ! HIKMA FARMACEUTICA 1MG/ML A090287 001 Aug 31, 2009
AP NAVINTA LLC 1MG/ML A091525 001 Feb 05, 2013
TABLET;ORAL
BENZTROPINE MESYLATE
AA ! ASPEN GLOBAL INC 0.5MG A204713 001 Apr 14, 2015
AA ! 1MG A204713 002 Apr 14, 2015
AA ! 2MG A204713 003 Apr 14, 2015
AA CHARTWELL RX 1MG A081265 002 Jan 23, 1992
AA 2MG A081265 001 Jan 23, 1992
AA EPIC PHARMA LLC 0.5MG A072264 001 Feb 27, 1989
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-56(of 474)

BENZTROPINE MESYLATE
TABLET;ORAL
BENZTROPINE MESYLATE
AA 1MG A072265 001 Feb 27, 1989
AA 2MG A072266 001 Feb 27, 1989
AA INVAGEN PHARMS 0.5MG A090294 001 Mar 29, 2010
AA 1MG A090294 002 Mar 29, 2010
AA 2MG A090294 003 Mar 29, 2010
AA LEADING 0.5MG A090168 001 Nov 28, 2012
AA 1MG A090168 002 Nov 28, 2012
AA 2MG A090168 003 Nov 28, 2012
AA PLIVA 0.5MG A089058 001 Aug 10, 1988
AA 1MG A089059 001 Aug 10, 1988
AA 2MG A089060 001 Aug 10, 1988
AA VINTAGE 0.5MG A040715 001 Aug 27, 2007
AA 1MG A040715 002 Aug 27, 2007
AA 2MG A040715 003 Aug 27, 2007
BEPOTASTINE BESILATE
SOLUTION/DROPS;OPHTHALMIC
BEPOTASTINE BESILATE
AT APOTEX 1.5% A206066 001 Mar 05, 2019
AT MYLAN 1.5% A206220 001 Mar 18, 2019
BEPREVE
AT +! BAUSCH AND LOMB INC 1.5% N022288 001 Sep 08, 2009
BEROTRALSTAT HYDROCHLORIDE
CAPSULE;ORAL
ORLADEYO
+ BIOCRYST EQ 110MG BASE N214094 001 Dec 03, 2020
+! EQ 150MG BASE N214094 002 Dec 03, 2020
BESIFLOXACIN HYDROCHLORIDE
SUSPENSION/DROPS;OPHTHALMIC
BESIVANCE
+! BAUSCH AND LOMB EQ 0.6% BASE N022308 001 May 28, 2009
BETAINE
FOR SOLUTION;ORAL
BETAINE
AB ETON 1GM/SCOOPFUL A210508 001 Jan 28, 2022
AB NOVITIUM PHARMA 1GM/SCOOPFUL A214864 001 Nov 23, 2021
CYSTADANE
AB +! RECORDATI RARE 1GM/SCOOPFUL N020576 001 Oct 25, 1996
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
INJECTABLE;INJECTION
BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE
AB AM REGENT 3MG/ML;EQ 3MG BASE/ML A090747 001 Jul 31, 2009
CELESTONE SOLUSPAN
AB +! ORGANON 3MG/ML;EQ 3MG BASE/ML N014602 001
BETAMETHASONE DIPROPIONATE
CREAM;TOPICAL
BETAMETHASONE DIPROPIONATE
AB ACTAVIS MID EQ 0.05% BASE A070885 001 Feb 03, 1987
ATLANTIC
AB COSETTE EQ 0.05% BASE A210217 001 Oct 12, 2018
AB +! FOUGERA PHARMS EQ 0.05% BASE N019137 001 Jun 26, 1984
AB TARO EQ 0.05% BASE A073552 001 Apr 30, 1992
AB ZYDUS PHARMS EQ 0.05% BASE A208885 001 Jan 11, 2019
CREAM, AUGMENTED;TOPICAL
BETAMETHASONE DIPROPIONATE
AB FOUGERA PHARMS EQ 0.05% BASE A076215 001 Dec 09, 2003
AB ! GLENMARK GENERICS EQ 0.05% BASE A078930 001 Sep 23, 2008
AB PADAGIS ISRAEL EQ 0.05% BASE A076592 001 Dec 09, 2003
AB TARO EQ 0.05% BASE A076543 001 Dec 09, 2003
GEL, AUGMENTED;TOPICAL
BETAMETHASONE DIPROPIONATE
AB ! FOUGERA PHARMS EQ 0.05% BASE A075276 001 May 13, 2003
AB TARO EQ 0.05% BASE A076508 001 Dec 02, 2003
LOTION;TOPICAL
BETAMETHASONE DIPROPIONATE
AB COSETTE EQ 0.05% BASE A071467 001 Aug 10, 1987
AB ! FOUGERA PHARMS INC EQ 0.05% BASE A070275 001 Aug 12, 1985
AB PADAGIS US EQ 0.05% BASE A072538 001 Jan 31, 1990
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-57(of 474)

BETAMETHASONE DIPROPIONATE
LOTION, AUGMENTED;TOPICAL
BETAMETHASONE DIPROPIONATE
AB AKORN EQ 0.05% BASE A208849 001 Oct 11, 2019
AB FOUGERA PHARMS EQ 0.05% BASE A077111 001 May 21, 2007
AB PAI HOLDINGS PHARM EQ 0.05% BASE A206389 001 Feb 13, 2018
AB ! TARO EQ 0.05% BASE A077477 001 May 21, 2007
OINTMENT;TOPICAL
BETAMETHASONE DIPROPIONATE
AB ACTAVIS MID EQ 0.05% BASE A071012 001 Feb 03, 1987
ATLANTIC
AB CADILA EQ 0.05% BASE A214048 001 Jul 14, 2020
AB +! FOUGERA PHARMS INC EQ 0.05% BASE N019141 001 Sep 04, 1984
AB PADAGIS ISRAEL EQ 0.05% BASE A215847 001 Apr 12, 2022
AB TARO EQ 0.05% BASE A074271 001 Sep 15, 1994
AB TASMAN PHARMA EQ 0.05% BASE A215186 001 Feb 18, 2022
OINTMENT, AUGMENTED;TOPICAL
BETAMETHASONE DIPROPIONATE
AB ACTAVIS MID EQ 0.05% BASE A074304 001 Aug 31, 1995
ATLANTIC
AB FOUGERA PHARMS EQ 0.05% BASE A075373 001 Jun 22, 1999
AB LUPIN LTD EQ 0.05% BASE A209106 001 Dec 18, 2019
AB PAI HOLDINGS PHARM EQ 0.05% BASE A206118 001 Nov 09, 2017
AB TARO EQ 0.05% BASE A076753 001 Oct 12, 2004
DIPROLENE
AB +! ORGANON EQ 0.05% BASE N018741 001 Jul 27, 1983
SPRAY;TOPICAL
SERNIVO
+! PRIMUS PHARMS EQ 0.05% BASE/SPRAY N208079 001 Feb 05, 2016
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
AEROSOL, FOAM;TOPICAL
ENSTILAR
+! LEO PHARMA AS 0.064%;0.005% N207589 001 Oct 16, 2015
CREAM;TOPICAL
WYNZORA
+! MC2 0.064%;0.005% N213422 001 Jul 20, 2020
OINTMENT;TOPICAL
CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
AB PADAGIS ISRAEL 0.064%;0.005% A200174 001 Dec 12, 2014
AB TOLMAR 0.064%;0.005% A201615 001 Jan 14, 2013
TACLONEX
AB +! LEO PHARMA AS 0.064%;0.005% N021852 001 Jan 09, 2006
SUSPENSION;TOPICAL
CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
AB TARO PHARMS 0.064%;0.005% A213269 001 Sep 02, 2020
AB TOLMAR 0.064%;0.005% A210765 001 May 11, 2020
CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE
AB PADAGIS ISRAEL 0.064%;0.005% A212367 001 Sep 11, 2020
TACLONEX
AB +! LEO PHARMA AS 0.064%;0.005% N022185 001 May 09, 2008
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
CREAM;TOPICAL
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
AB ACTAVIS MID EQ 0.05% BASE;1% A076002 001 Aug 02, 2002
ATLANTIC
AB FOUGERA PHARMS EQ 0.05% BASE;1% A075502 001 Jun 05, 2001
AB GLENMARK PHARMS EQ 0.05% BASE;1% A202894 001 Oct 30, 2015
AB TARO EQ 0.05% BASE;1% A075673 001 May 29, 2001
LOTRISONE
AB +! ORGANON EQ 0.05% BASE;1% N018827 001 Jul 10, 1984
LOTION;TOPICAL
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
AB FOUGERA PHARMS EQ 0.05% BASE;1% A076516 001 Jun 16, 2005
AB ! TARO EQ 0.05% BASE;1% A076493 001 Jul 28, 2004
BETAMETHASONE VALERATE
AEROSOL, FOAM;TOPICAL
BETAMETHASONE VALERATE
AB PADAGIS ISRAEL 0.12% A078337 001 Nov 26, 2012
AB TARO 0.12% A208204 001 May 24, 2017
LUXIQ
AB +! MYLAN 0.12% N020934 001 Feb 28, 1999
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-58(of 474)

BETAMETHASONE VALERATE
CREAM;TOPICAL
BETA-VAL
AB COSETTE EQ 0.1% BASE N018642 001 Mar 24, 1983
BETAMETHASONE VALERATE
AB +! FOUGERA PHARMS INC EQ 0.1% BASE N018861 001 Aug 31, 1983
DERMABET
AB TARO EQ 0.1% BASE A072041 001 Jan 06, 1988
VALNAC
AB ACTAVIS MID EQ 0.1% BASE A070050 001 Oct 10, 1984
ATLANTIC
LOTION;TOPICAL
BETAMETHASONE VALERATE
AB ANIMA EQ 0.1% BASE A070052 001 Jul 31, 1985
AB +! FOUGERA PHARMS INC EQ 0.1% BASE N018866 001 Aug 31, 1983
OINTMENT;TOPICAL
BETA-VAL
AB COSETTE EQ 0.1% BASE A070069 001 Dec 19, 1985
BETAMETHASONE VALERATE
AB ACTAVIS MID EQ 0.1% BASE A070051 001 Oct 10, 1984
ATLANTIC
AB +! FOUGERA PHARMS INC EQ 0.1% BASE N018865 001 Aug 31, 1983
BETAXOLOL HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
BETAXOLOL HYDROCHLORIDE
AT ACELLA EQ 0.5% BASE A078694 001 Nov 16, 2009
AT AKORN EQ 0.5% BASE A075386 001 Jun 30, 2000
AT MEDIMETRIKS PHARMS EQ 0.5% BASE A075630 001 Apr 12, 2001
BETOPTIC
AT +! SANDOZ INC EQ 0.5% BASE N019270 001 Aug 30, 1985
SUSPENSION/DROPS;OPHTHALMIC
BETOPTIC S
+! NOVARTIS EQ 0.25% BASE N019845 001 Dec 29, 1989
TABLET;ORAL
BETAXOLOL HYDROCHLORIDE
AB EPIC PHARMA 10MG A075541 001 Oct 22, 1999
AB ! 20MG A075541 002 Oct 22, 1999
AB KVK TECH 10MG A078962 001 Jun 27, 2008
AB 20MG A078962 002 Jun 27, 2008
BETHANECHOL CHLORIDE
TABLET;ORAL
BETHANECHOL CHLORIDE
AA AIPING LIFE SCI 5MG A040728 002 Oct 26, 2007
AA 10MG A040728 003 Oct 26, 2007
AA 25MG A040728 004 Oct 26, 2007
AA 50MG A040728 001 Oct 26, 2007
AA ! AMNEAL PHARM 5MG A040855 001 Nov 21, 2007
AA ! 10MG A040855 002 Nov 21, 2007
AA ! 25MG A040855 003 Nov 21, 2007
AA ! 50MG A040855 004 Nov 21, 2007
AA UPSHER SMITH LABS 5MG A040633 001 Jun 01, 2005
AA 10MG A040634 001 Jun 01, 2005
AA 25MG A040635 001 Jun 01, 2005
AA 50MG A040636 001 Jun 01, 2005
DUVOID
AA CHARTWELL RX 10MG A086262 001
AA 25MG A086263 001
AA 50MG A085882 003
BEXAROTENE
CAPSULE;ORAL
BEXAROTENE
AB AMNEAL PHARMS NY 75MG A210105 001 Sep 04, 2018
AB ANI PHARMS 75MG A209861 001 May 08, 2018
AB BIONPHARMA INC 75MG A203174 001 Aug 12, 2014
AB HIKMA 75MG A203663 001 Jun 16, 2020
AB TEVA PHARMS USA 75MG A209931 001 Jan 14, 2021
AB UPSHER SMITH LABS 75MG A209886 001 Jul 25, 2018
TARGRETIN
AB +! VALEANT LUXEMBOURG 75MG N021055 001 Dec 29, 1999
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-59(of 474)

BEXAROTENE
GEL;TOPICAL
BEXAROTENE
AB AMNEAL 1% A215398 001 Apr 27, 2022
TARGRETIN
AB +! BAUSCH 1% N021056 001 Jun 28, 2000
BICALUTAMIDE
TABLET;ORAL
BICALUTAMIDE
AB ACCORD HLTHCARE 50MG A078917 001 Jul 06, 2009
AB APOTEX INC 50MG A200274 001 May 21, 2015
AB KENTON 50MG A091011 001 Jun 10, 2015
AB SANDOZ 50MG A078575 001 Jul 06, 2009
AB SUN PHARM 50MG A079110 001 Jul 06, 2009
AB WATSON LABS TEVA 50MG A078634 001 Aug 28, 2009
AB ZYDUS PHARMS USA 50MG A079089 001 Jul 06, 2009
INC
CASODEX
AB +! ANI PHARMS 50MG N020498 001 Oct 04, 1995
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
TABLET;ORAL
BIKTARVY
+ GILEAD SCIENCES INC EQ 30MG BASE;120MG;EQ 15MG BASE N210251 002 Oct 07, 2021
+! EQ 50MG BASE;200MG;EQ 25MG BASE N210251 001 Feb 07, 2018
BIMATOPROST
IMPLANT;OPHTHALMIC
DURYSTA
+! ALLERGAN INC 10MCG N211911 001 Mar 04, 2020
SOLUTION/DROPS;OPHTHALMIC
BIMATOPROST
AT ! ALEMBIC PHARMS 0.03% A210263 001 Apr 12, 2019
AT APOTEX INC 0.03% A090449 001 Jul 20, 2015
AT EUGIA PHARMA 0.03% A205537 001 Oct 06, 2022
AT GLAND PHARMA LTD 0.03% A210126 001 Mar 22, 2019
AT LUPIN LTD 0.03% A203991 001 Feb 20, 2015
AT MICRO LABS 0.03% A202505 001 Sep 08, 2020
AT SANDOZ INC 0.03% A202565 001 May 05, 2015
AT SOMERSET THERAPS 0.03% A207601 001 Jun 19, 2019
LLC
LUMIGAN
+! ALLERGAN 0.01% N022184 001 Aug 31, 2010
SOLUTION/DROPS;TOPICAL
BIMATOPROST
AT AKORN 0.03% A203051 001 Oct 09, 2018
AT ALEMBIC PHARMS 0.03% A210515 001 Jan 21, 2020
AT APOTEX INC 0.03% A201894 001 Dec 01, 2014
AT SANDOZ INC 0.03% A202719 001 Apr 19, 2016
LATISSE
AT +! ALLERGAN 0.03% N022369 001 Dec 24, 2008
BINIMETINIB
TABLET;ORAL
MEKTOVI
+! ARRAY BIOPHARMA INC 15MG N210498 001 Jun 27, 2018
BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
CAPSULE;ORAL
PYLERA
+! ALLERGAN 140MG;125MG;125MG N050786 001 Sep 28, 2006
BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
TABLET, CHEWABLE, TABLET, CAPSULE;ORAL
BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
! AILEX PHARMS LLC 262.4MG, N/A, N/A;N/A, 250MG, N/A;N/A, A202584 001 Nov 30, 2018
N/A, 500MG
BISOPROLOL FUMARATE
TABLET;ORAL
BISOPROLOL FUMARATE
AB ALEMBIC LABS 5MG A204891 001 Jan 11, 2017
AB 10MG A204891 002 Jan 11, 2017
AB AUROBINDO PHARMA 5MG A077910 001 Dec 27, 2006
AB 10MG A077910 002 Dec 27, 2006
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-60(of 474)

BISOPROLOL FUMARATE
TABLET;ORAL
BISOPROLOL FUMARATE
AB CADILA 5MG A215680 001 Jul 25, 2022
AB 10MG A215680 002 Jul 25, 2022
AB NOVITIUM PHARMA 5MG A215563 001 Oct 29, 2021
AB 10MG A215563 002 Oct 29, 2021
AB RUBICON 5MG A075643 001 Nov 16, 2000
AB 10MG A075643 002 Nov 16, 2000
AB UNICHEM 5MG A078635 001 Aug 18, 2009
AB ! 10MG A078635 002 Aug 18, 2009
AB UNITED RES LABS 5MG A075474 001 Oct 25, 2002
AB 10MG A075474 002 Oct 25, 2002
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
TABLET;ORAL
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
AB CADILA 2.5MG;6.25MG A215666 001 Nov 04, 2022
AB 5MG;6.25MG A215666 002 Nov 04, 2022
AB 10MG;6.25MG A215666 003 Nov 04, 2022
AB EDENBRIDGE PHARMS 2.5MG;6.25MG A212678 001 Jul 09, 2020
AB 5MG;6.25MG A212678 002 Jul 09, 2020
AB 10MG;6.25MG A212678 003 Jul 09, 2020
AB EPIC PHARMA 2.5MG;6.25MG A075579 001 Sep 25, 2000
AB 5MG;6.25MG A075579 002 Sep 25, 2000
AB 10MG;6.25MG A075579 003 Sep 25, 2000
AB GLENMARK PHARMS LTD 2.5MG;6.25MG A215995 001 Jan 26, 2022
AB 5MG;6.25MG A215995 002 Jan 26, 2022
AB 10MG;6.25MG A215995 003 Jan 26, 2022
AB MYLAN 2.5MG;6.25MG A075768 001 Sep 25, 2000
AB 5MG;6.25MG A075768 002 Sep 25, 2000
AB 10MG;6.25MG A075768 003 Sep 25, 2000
AB NOVITIUM PHARMA 2.5MG;6.25MG A215562 001 Nov 04, 2021
AB 5MG;6.25MG A215562 002 Nov 04, 2021
AB 10MG;6.25MG A215562 003 Nov 04, 2021
AB UNICHEM 2.5MG;6.25MG A079106 001 Jul 28, 2010
AB 5MG;6.25MG A079106 002 Jul 28, 2010
AB 10MG;6.25MG A079106 003 Jul 28, 2010
ZIAC
AB + TEVA BRANDED PHARM 2.5MG;6.25MG N020186 003 Mar 26, 1993
AB + 5MG;6.25MG N020186 001 Mar 26, 1993
AB +! 10MG;6.25MG N020186 002 Mar 26, 1993
BIVALIRUDIN
INJECTABLE;INTRAVENOUS
ANGIOMAX
AP +! SANDOZ INC 250MG/VIAL N020873 001 Dec 15, 2000
BIVALIRUDIN
AP ACCORD HLTHCARE 250MG/VIAL A206551 001 Nov 22, 2017
AP DR REDDYS 250MG/VIAL A201577 001 May 26, 2017
AP EUGIA PHARMA 250MG/VIAL A205962 001 Jul 27, 2018
AP FRESENIUS KABI USA 250MG/VIAL A090189 001 Oct 28, 2016
AP HAINAN POLY PHARM 250MG/VIAL A213078 001 May 28, 2021
AP HOSPIRA 250MG/VIAL A090811 001 Jul 14, 2015
AP 250MG/VIAL A090816 001 Jul 14, 2015
AP MEITHEAL 250MG/VIAL A091602 001 Jul 16, 2018
AP MYLAN INSTITUTIONAL 250MG/VIAL A202471 001 Jun 01, 2018
AP SHUANGCHENG 250MG/VIAL A210031 001 Oct 23, 2019
SOLUTION;INTRAVENOUS
ANGIOMAX RTU
+! MAIA PHARMS INC 250MG/50ML (5MG/ML) N211215 001 Jul 25, 2019
BLEOMYCIN SULFATE
INJECTABLE;INJECTION
BLEOMYCIN SULFATE
AP ! FRESENIUS KABI USA EQ 15 UNITS BASE/VIAL A065185 001 Jan 28, 2008
AP ! EQ 30 UNITS BASE/VIAL A065185 002 Jan 28, 2008
AP HIKMA EQ 15 UNITS BASE/VIAL A065042 002 Oct 17, 2001
AP EQ 30 UNITS BASE/VIAL A065042 001 Oct 17, 2001
AP HOSPIRA EQ 15 UNITS BASE/VIAL A065031 001 Mar 10, 2000
AP EQ 30 UNITS BASE/VIAL A065031 002 Mar 10, 2000
AP MEITHEAL EQ 15 UNITS BASE/VIAL A205030 001 Apr 20, 2018
AP EQ 30 UNITS BASE/VIAL A205030 002 Apr 20, 2018
AP TEVA PHARMS USA EQ 15 UNITS BASE/VIAL A065033 001 Jun 27, 2000
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-61(of 474)

BLEOMYCIN SULFATE
INJECTABLE;INJECTION
BLEOMYCIN SULFATE
AP EQ 30 UNITS BASE/VIAL A065033 002 Jun 27, 2000
BORTEZOMIB
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
BORTEZOMIB
AP ACCORD HLTHCARE 3.5MG/VIAL A204405 001 Jul 26, 2022
AP APOTEX 3.5MG/VIAL A205533 001 May 02, 2022
AP BAXTER HLTHCARE 3.5MG/VIAL A213823 001 May 02, 2022
CORP
AP DR REDDYS 3.5MG/VIAL A202963 001 Jul 26, 2022
AP EUGIA PHARMA 3.5MG/VIAL A212825 001 May 02, 2022
AP FRESENIUS KABI USA 3.5MG/VIAL A209659 001 May 02, 2022
AP HOSPIRA 3.5MG/VIAL A208460 001 Jul 26, 2022
AP JIANGSU HANSOH 3.5MG/VIAL A215011 001 Jul 26, 2022
PHARM
AP MEITHEAL 3.5MG/VIAL A212958 001 Jul 26, 2022
AP MSN 3.5MG/VIAL A209622 001 Jul 26, 2022
AP PHARMASCIENCE INC 3.5MG/VIAL A208392 001 May 02, 2022
AP QILU PHARM HAINAN 3.5MG/VIAL A210824 001 May 02, 2022
AP SANDOZ INC 3.5MG/VIAL A203654 001 Jul 26, 2022
AP WAVERLEY PHARMA INC 3.5MG/VIAL A211898 001 Oct 11, 2022
AP ZYDUS PHARMS 3.5MG/VIAL A210204 001 May 02, 2022
VELCADE
AP +! TAKEDA PHARMS USA 3.5MG/VIAL N021602 001 May 13, 2003
POWDER;INTRAVENOUS
BORTEZOMIB
DR REDDYS 3.5MG/VIAL N206927 001 Oct 04, 2019
FRESENIUS KABI USA 3.5MG/VIAL N205004 001 Nov 06, 2017
POWDER;INTRAVENOUS, SUBCUTANEOUS
BORTEZOMIB
+! HOSPIRA 1MG/VIAL N209191 001 May 02, 2022
+! 2.5MG/VIAL N209191 002 May 02, 2022
SOLUTION;INTRAVENOUS
BORTEZOMIB
+! ACCORD HLTHCARE 2.5MG/ML (2.5MG/ML) N215441 001 Jul 26, 2022
+! 3.5MG/1.4ML (2.5MG/ML) N215441 002 Jul 26, 2022
+! MAIA PHARMS INC 3.5MG/1.4ML (2.5MG/ML) N215331 002 Jul 27, 2022
BOSENTAN
TABLET;ORAL
BOSENTAN
AB HIKMA 62.5MG A208695 001 Apr 26, 2019
AB 125MG A208695 002 Apr 26, 2019
AB PAR PHARM INC 62.5MG A205699 001 Apr 26, 2019
AB 125MG A205699 002 Apr 26, 2019
AB SUN PHARM 62.5MG A209324 001 Apr 26, 2019
AB 125MG A209324 002 Apr 26, 2019
AB WATSON LABS INC 62.5MG A207110 001 Apr 26, 2019
AB 125MG A207110 002 Apr 26, 2019
AB ZYDUS PHARMS 62.5MG A207760 001 Apr 26, 2019
AB 125MG A207760 002 Apr 26, 2019
TRACLEER
AB + ACTELION 62.5MG N021290 001 Nov 20, 2001
AB +! 125MG N021290 002 Nov 20, 2001
TABLET, FOR SUSPENSION;ORAL
TRACLEER
+! ACTELION 32MG N209279 001 Sep 05, 2017
BOSUTINIB MONOHYDRATE
TABLET;ORAL
BOSULIF
+! PF PRISM CV EQ 100MG BASE N203341 001 Sep 04, 2012
+ EQ 400MG BASE N203341 003 Oct 27, 2017
+ EQ 500MG BASE N203341 002 Sep 04, 2012
BREMELANOTIDE ACETATE
SOLUTION;SUBCUTANEOUS
VYLEESI (AUTOINJECTOR)
+! PALATIN EQ 1.75MG BASE/0.3ML (EQ 1.75MG N210557 001 Jun 21, 2019
TECHNOLOGIES BASE/0.3 ML)
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-62(of 474)

BRETYLIUM TOSYLATE
INJECTABLE;INJECTION
BRETYLIUM TOSYLATE
! BRECKENRIDGE 50MG/ML A204386 001 Dec 21, 2018
BREXANOLONE
SOLUTION;INTRAVENOUS
ZULRESSO
+! SAGE THERAP 100MG/20ML (5MG/ML) N211371 001 Jun 17, 2019
BREXPIPRAZOLE
TABLET;ORAL
BREXPIPRAZOLE
AB TEVA PHARMS USA INC 0.25MG A213692 001 Aug 11, 2022
AB 0.5MG A213692 002 Aug 11, 2022
AB 1MG A213692 003 Aug 11, 2022
AB 2MG A213692 004 Aug 11, 2022
AB 3MG A213692 005 Aug 11, 2022
AB 4MG A213692 006 Aug 11, 2022
AB ZYDUS PHARMS 0.25MG A213660 001 Jan 10, 2023
AB 0.5MG A213660 002 Jan 10, 2023
AB 1MG A213660 003 Jan 10, 2023
AB 2MG A213660 004 Jan 10, 2023
AB 3MG A213660 005 Jan 10, 2023
AB 4MG A213660 006 Jan 10, 2023
REXULTI
AB + OTSUKA 0.25MG N205422 001 Jul 10, 2015
AB + 0.5MG N205422 002 Jul 10, 2015
AB + 1MG N205422 003 Jul 10, 2015
AB +! 2MG N205422 004 Jul 10, 2015
AB + 3MG N205422 005 Jul 10, 2015
AB + 4MG N205422 006 Jul 10, 2015
BRIGATINIB
TABLET;ORAL
ALUNBRIG
+ TAKEDA PHARMS USA 30MG N208772 001 Apr 28, 2017
+ 90MG N208772 002 Apr 28, 2017
+! 180MG N208772 003 Oct 02, 2017
BRILLIANT BLUE G
SOLUTION;OPHTHALMIC
TISSUEBLUE
+! DUTCH OPHTHALMIC 0.025% N209569 001 Dec 20, 2019
BRIMONIDINE TARTRATE
GEL;TOPICAL
BRIMONIDINE TARTRATE
AB PADAGIS ISRAEL EQ 0.33% BASE A209158 001 Sep 23, 2021
MIRVASO
AB +! GALDERMA LABS LP EQ 0.33% BASE N204708 001 Aug 23, 2013
SOLUTION/DROPS;OPHTHALMIC
ALPHAGAN P
AB +! ALLERGAN 0.1% N021770 001 Aug 19, 2005
BRIMONIDINE TARTRATE
AB APOTEX 0.1% A078480 001 Dec 21, 2022
ALPHAGAN P
AT +! ALLERGAN 0.15% N021262 001 Mar 16, 2001
BRIMONIDINE TARTRATE
AT AKORN 0.2% A076439 001 Mar 14, 2006
AT APOTEX 0.15% A078479 001 Jan 31, 2022
AT ! BAUSCH AND LOMB 0.2% A076260 001 May 28, 2003
AT INDOCO 0.2% A091691 001 Nov 18, 2014
AT SANDOZ INC 0.2% A076254 001 Sep 16, 2003
AT 0.2% A078075 001 Jan 30, 2008
AT SOMERSET THERAPS 0.2% A208992 001 Mar 11, 2019
LLC
QOLIANA
AT +! SANDOZ INC 0.15% N021764 001 May 22, 2006
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-63(of 474)

BRIMONIDINE TARTRATE; BRINZOLAMIDE


SUSPENSION/DROPS;OPHTHALMIC
SIMBRINZA
+! ALCON LABS INC 0.2%;1% N204251 001 Apr 19, 2013
BRIMONIDINE TARTRATE; TIMOLOL MALEATE
SOLUTION/DROPS;OPHTHALMIC
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
AB AKORN 0.2%;EQ 0.5% BASE A091086 001 Oct 31, 2022
AB APOTEX INC 0.2%;EQ 0.5% BASE A091442 001 Apr 20, 2022
AB SANDOZ INC 0.2%;EQ 0.5% BASE A091087 001 Apr 04, 2022
AB UPSHER SMITH LABS 0.2%;EQ 0.5% BASE A215598 001 Dec 12, 2022
AB WATSON LABS TEVA 0.2%;EQ 0.5% BASE A201949 001 Oct 04, 2022
COMBIGAN
AB +! ALLERGAN 0.2%;EQ 0.5% BASE N021398 001 Oct 30, 2007
BRINCIDOFOVIR
SUSPENSION;ORAL
TEMBEXA
+! EMERGENT BIODEFENSE 10MG/ML N214460 001 Jun 04, 2021
TABLET;ORAL
TEMBEXA
+! EMERGENT BIODEFENSE 100MG N214461 001 Jun 04, 2021
BRINZOLAMIDE
SUSPENSION/DROPS;OPHTHALMIC
AZOPT
AB +! NOVARTIS 1% N020816 001 Apr 01, 1998
BRINZOLAMIDE
AB BAUSCH AND LOMB 1% A204884 001 Aug 18, 2021
AB WATSON LABS INC 1% A209406 001 Nov 27, 2020
BRIVARACETAM
SOLUTION;INTRAVENOUS
BRIVIACT
+! UCB INC 50MG/5ML (10MG/ML) N205837 001 May 12, 2016
SOLUTION;ORAL
BRIVIACT
+! UCB INC 10MG/ML N205838 001 May 12, 2016
TABLET;ORAL
BRIVARACETAM
AB AUROBINDO PHARMA 50MG A214848 001 Jan 06, 2023
LTD
AB 100MG A214848 002 Jan 06, 2023
AB LUPIN LTD 10MG A214918 001 Dec 20, 2022
AB 25MG A214918 002 Dec 20, 2022
AB 50MG A214918 003 Dec 20, 2022
AB 75MG A214918 004 Dec 20, 2022
AB 100MG A214918 005 Dec 20, 2022
BRIVIACT
AB + UCB INC 10MG N205836 001 May 12, 2016
AB + 25MG N205836 002 May 12, 2016
AB + 50MG N205836 003 May 12, 2016
AB + 75MG N205836 004 May 12, 2016
AB +! 100MG N205836 005 May 12, 2016
BROMFENAC SODIUM
SOLUTION/DROPS;OPHTHALMIC
BROMFENAC SODIUM
AT2 ! AKORN EQ 0.09% ACID A203395 001 Jan 22, 2014
AT2 ALEMBIC PHARMS EQ 0.09% ACID A210560 001 Jun 21, 2019
AT2 EUGIA PHARMA EQ 0.09% ACID A204813 001 Mar 18, 2022
AT2 GLAND PHARMA LTD EQ 0.09% ACID A211029 001 Mar 17, 2020
BROMSITE
+! SUN PHARM EQ 0.075% ACID N206911 001 Apr 08, 2016
PROLENSA
+! BAUSCH AND LOMB EQ 0.07% ACID N203168 001 Apr 05, 2013
BROMOCRIPTINE MESYLATE
CAPSULE;ORAL
BROMOCRIPTINE MESYLATE
AB ! MYLAN EQ 5MG BASE A077226 001 Apr 04, 2005
AB ZYDUS PHARMS USA EQ 5MG BASE A078899 001 Jul 30, 2008
INC
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-64(of 474)

BROMOCRIPTINE MESYLATE
CAPSULE;ORAL
PARLODEL
AB + VALIDUS PHARMS EQ 5MG BASE N017962 002 Mar 01, 1982
TABLET;ORAL
BROMOCRIPTINE MESYLATE
AB ! PADAGIS US EQ 2.5MG BASE A077646 001 Oct 01, 2008
AB SANDOZ INC EQ 2.5MG BASE A074631 001 Jan 13, 1998
PARLODEL
AB + VALIDUS PHARMS EQ 2.5MG BASE N017962 001
CYCLOSET
+! VEROSCIENCE EQ 0.8MG BASE N020866 001 May 05, 2009
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
SYRUP;ORAL
BROMFED-DM
AA ! WOCKHARDT BIO AG 2MG/5ML;10MG/5ML;30MG/5ML A088811 001 Jun 07, 1985
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
AA ACELLA 2MG/5ML;10MG/5ML;30MG/5ML A203375 001 Sep 20, 2016
AA ALKEM LABS LTD 2MG/5ML;10MG/5ML;30MG/5ML A210647 001 Jul 14, 2020
AA BRECKENRIDGE 2MG/5ML;10MG/5ML;30MG/5ML A203997 001 Sep 30, 2020
AA CHARTWELL MOLECULAR 2MG/5ML;10MG/5ML;30MG/5ML A213125 001 Apr 17, 2020
AA EYWA 2MG/5ML;10MG/5ML;30MG/5ML A211170 001 Jun 16, 2020
AA MAYNE PHARMA INC 2MG/5ML;10MG/5ML;30MG/5ML A207676 001 Dec 04, 2018
AA PADAGIS US 2MG/5ML;10MG/5ML;30MG/5ML A205292 001 Jul 15, 2014
AA PHARM ASSOC 2MG/5ML;10MG/5ML;30MG/5ML A202940 001 Jul 21, 2014
AA TARO 2MG/5ML;10MG/5ML;30MG/5ML A205112 001 Feb 27, 2017
BUDESONIDE
AEROSOL, FOAM;RECTAL
UCERIS
+! SALIX 2MG/ACTUATION N205613 001 Oct 07, 2014
CAPSULE, DELAYED RELEASE;ORAL
BUDESONIDE
AB AMNEAL PHARMS 3MG A206200 001 Jul 31, 2017
AB AUROBINDO PHARMA 3MG A090410 001 May 16, 2011
USA
AB MAYNE PHARMA 3MG A206623 001 Apr 08, 2016
AB RISING 3MG A207367 001 Apr 07, 2017
AB ZYDUS PHARMS 3MG A206134 001 May 04, 2017
ENTOCORT EC
AB +! PADAGIS US 3MG N021324 001 Oct 02, 2001
ORTIKOS
+ SUN PHARM INDS INC 6MG N211929 001 Jun 13, 2019
+! 9MG N211929 002 Jun 13, 2019
TARPEYO
+! CALLIDITAS 4MG N215935 001 Dec 15, 2021
POWDER, METERED;INHALATION
PULMICORT FLEXHALER
+ ASTRAZENECA 0.08MG/INH N021949 001 Jul 12, 2006
+! 0.16MG/INH N021949 002 Jul 12, 2006
SUSPENSION;INHALATION
BUDESONIDE
AN CIPLA 0.25MG/2ML A205710 001 Nov 16, 2017
AN 0.5MG/2ML A205710 002 Nov 16, 2017
AN 1MG/2ML A205710 003 Nov 16, 2017
AN IMPAX LABS INC 0.25MG/2ML A078404 001 Jul 31, 2012
AN 0.5MG/2ML A078404 002 Jul 31, 2012
AN LUPIN 0.5MG/2ML A210897 001 Nov 09, 2018
AN NEPHRON 0.25MG/2ML A078202 001 Mar 30, 2009
AN 0.5MG/2ML A078202 002 Mar 30, 2009
AN SANDOZ INC 0.25MG/2ML A201966 003 Sep 27, 2013
AN 0.5MG/2ML A201966 002 Sep 27, 2013
AN 1MG/2ML A201966 001 Sep 27, 2013
AN SUN PHARM 0.25MG/2ML A211922 001 Apr 14, 2021
AN 0.5MG/2ML A211922 002 Apr 14, 2021
AN 1MG/2ML A211922 003 Apr 14, 2021
AN TEVA PHARMS 0.25MG/2ML A077519 001 Nov 18, 2008
AN 0.5MG/2ML A077519 002 Nov 18, 2008
AN TEVA PHARMS USA 1MG/2ML A204548 001 Mar 08, 2016
PULMICORT RESPULES
AN + ASTRAZENECA 0.25MG/2ML N020929 001 Aug 08, 2000
AN + 0.5MG/2ML N020929 002 Aug 08, 2000
AN +! 1MG/2ML N020929 003 Aug 08, 2000
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-65(of 474)

BUDESONIDE
TABLET, EXTENDED RELEASE;ORAL
BUDESONIDE
AB ACTAVIS LABS FL INC 9MG A205457 001 Jul 03, 2018
AB MYLAN 9MG A208851 001 Sep 17, 2020
UCERIS
AB +! SALIX 9MG N203634 001 Jan 14, 2013
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
AEROSOL, METERED;INHALATION
BREYNA
AB MYLAN 0.08MG/INH;0.0045MG/INH A211699 001 Mar 15, 2022
AB 0.16MG/INH;0.0045MG/INH A211699 002 Mar 15, 2022
SYMBICORT
AB +! ASTRAZENECA 0.08MG/INH;0.0045MG/INH N021929 001 Jul 21, 2006
AB +! 0.16MG/INH;0.0045MG/INH N021929 002 Jul 21, 2006
BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
AEROSOL, METERED;INHALATION
BREZTRI AEROSPHERE
+! ASTRAZENECA AB 0.16MG/INH;0.0048MG/INH;0.009MG/INH N212122 001 Jul 23, 2020
BUMETANIDE
INJECTABLE;INJECTION
BUMETANIDE
AP ATHENEX INC 0.25MG/ML A074441 001 Jan 27, 1995
AP GLAND PHARMA LTD 0.25MG/ML A216434 001 May 26, 2022
AP HOSPIRA 0.25MG/ML A074332 001 Oct 31, 1994
AP MSN 0.25MG/ML A215364 001 Aug 04, 2022
AP ! WEST-WARD PHARMS 0.25MG/ML A079196 001 Apr 30, 2008
INT
TABLET;ORAL
BUMETANIDE
AB AMNEAL PHARMS CO 0.5MG A209724 001 Oct 18, 2017
AB 1MG A209724 002 Oct 18, 2017
AB 2MG A209724 003 Oct 18, 2017
AB HERITAGE PHARMA 0.5MG A074225 001 Apr 24, 1995
AB 1MG A074225 002 Apr 24, 1995
AB 2MG A074225 003 Apr 24, 1995
AB SANDOZ 0.5MG A074700 001 Nov 21, 1996
AB 1MG A074700 002 Nov 21, 1996
AB ! 2MG A074700 003 Nov 21, 1996
AB UPSHER SMITH LABS 0.5MG A209916 001 Jan 23, 2018
AB 1MG A209916 002 Jan 23, 2018
AB 2MG A209916 003 Jan 23, 2018
AB ZYDUS PHARMS 0.5MG A202900 001 Apr 30, 2018
AB 1MG A202900 002 Apr 30, 2018
AB 2MG A202900 003 Apr 30, 2018
BUMEX
AB + VALIDUS PHARMS 0.5MG N018225 002 Feb 28, 1983
AB + 1MG N018225 001 Feb 28, 1983
AB + 2MG N018225 003 Jun 14, 1985
BUMETANIDE
BX RISING 0.5MG A212019 001 Dec 12, 2019
BX 1MG A212019 002 Dec 12, 2019
BX 2MG A212019 003 Dec 12, 2019
BUPIVACAINE
INJECTABLE, LIPOSOMAL;INJECTION
EXPAREL
+! PACIRA PHARMS INC 133MG/10ML (13.3MG/ML) N022496 001 Oct 28, 2011
+! 266MG/20ML (13.3MG/ML) N022496 002 Oct 28, 2011
SOLUTION, EXTENDED RELEASE;INFILTRATION
POSIMIR
+! INNOCOLL 660MG/5ML (132MG/ML) N204803 001 Feb 01, 2021
BUPIVACAINE HYDROCHLORIDE
IMPLANT;IMPLANTATION
XARACOLL
+! INNOCOLL PHARMS 100MG N209511 001 Aug 28, 2020
INJECTABLE;INJECTION
BUPIVACAINE HYDROCHLORIDE
AP EUGIA PHARMA 0.25% A207183 001 May 13, 2016
AP 0.5% A207183 002 May 13, 2016
AP HIKMA PHARMS 0.25% A205141 001 Feb 11, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-66(of 474)

BUPIVACAINE HYDROCHLORIDE
INJECTABLE;INJECTION
BUPIVACAINE HYDROCHLORIDE
AP 0.5% A205141 002 Feb 11, 2021
AP HOSPIRA 0.25% A070583 001 Feb 17, 1987
AP 0.25% A070590 001 Feb 17, 1987
AP 0.5% A070584 001 Feb 17, 1986
AP 0.5% A070597 001 Mar 03, 1987
AP 0.5% A070609 001 Mar 03, 1987
AP 0.75% A070585 001 Mar 03, 1987
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
AP EUGIA PHARMA 0.25% A203895 001 Nov 05, 2013
AP 0.5% A203895 002 Nov 05, 2013
AP 0.75% A203895 003 Nov 05, 2013
AP HIKMA PHARMS 0.25% A204842 001 Feb 11, 2021
AP 0.5% A204842 002 Feb 11, 2021
AP 0.75% A204842 003 Feb 11, 2021
MARCAINE HYDROCHLORIDE
AP +! HOSPIRA 0.25% N016964 001
AP +! 0.5% N016964 006
MARCAINE HYDROCHLORIDE PRESERVATIVE FREE
AP +! HOSPIRA 0.25% N016964 012
AP +! 0.5% N016964 005
AP +! 0.75% N016964 009
SENSORCAINE
AP FRESENIUS KABI USA 0.25% A070552 001 May 21, 1986
AP + 0.25% N018304 001
AP 0.5% A070553 001 May 21, 1986
AP + 0.5% N018304 002
AP 0.75% A070554 001 May 21, 1986
AP + 0.75% N018304 003
INJECTABLE;SPINAL
BUPIVACAINE HYDROCHLORIDE
AP B BRAUN MEDICAL INC 0.75% A209087 001 Apr 02, 2019
AP BAXTER HLTHCARE 0.75% A207266 001 Jul 25, 2016
CORP
AP HOSPIRA 0.75% A071810 001 Dec 11, 1987
AP HUONS 0.75% A212822 001 Dec 30, 2019
MARCAINE
AP +! HOSPIRA 0.75% N018692 001 May 04, 1984
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE
INJECTABLE;INJECTION
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
AP ! HOSPIRA 0.5%;0.005MG/ML A071168 001 Jun 16, 1988
AP 0.5%;0.005MG/ML A071170 001 Jun 16, 1988
! 0.25%;0.005MG/ML A071165 001 Jun 16, 1988
0.25%;0.005MG/ML A071167 001 Jun 16, 1988
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
INJECTABLE;INJECTION
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE
AP +! HOSPIRA 0.25%;0.0091MG/ML N016964 004
AP +! 0.5%;0.0091MG/ML N016964 008
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE
AP +! HOSPIRA 0.25%;0.0091MG/ML N016964 013
AP +! 0.5%;0.0091MG/ML N016964 007
AP +! 0.75%;0.0091MG/ML N016964 010
SENSORCAINE
AP FRESENIUS KABI USA 0.25%;0.0091MG/ML A070966 001 Oct 13, 1987
AP 0.25%;0.0091MG/ML A070967 001 Oct 13, 1987
AP 0.5%;0.0091MG/ML A070968 001 Oct 13, 1987
AP + 0.5%;0.0091MG/ML N018304 004 Sep 02, 1983
AP + 0.75%;0.0091MG/ML N018304 005 Sep 02, 1983
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
! SEPTODONT 0.5%;0.0091MG/ML A077250 001 Sep 27, 2006
BUPIVACAINE; MELOXICAM
SOLUTION, EXTENDED RELEASE;PERIARTICULAR
ZYNRELEF KIT
+! HERON THERAPS INC 200MG/7ML (29.25MG/ML);6MG/7ML N211988 002 May 12, 2021
(0.88MG/ML)
+! 400MG/14ML (29.25MG/ML);12MG/14ML N211988 004 May 12, 2021
(0.88MG/ML)
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-67(of 474)

BUPRENORPHINE
FILM, EXTENDED RELEASE;TRANSDERMAL
BUPRENORPHINE
AB ALVOGEN 5MCG/HR A207490 001 May 17, 2022
AB 10MCG/HR A207490 002 May 17, 2022
AB 15MCG/HR A207490 003 May 17, 2022
AB 20MCG/HR A207490 004 May 17, 2022
AB AMNEAL 5MCG/HR A211586 001 Apr 14, 2020
AB 7.5MCG/HR A211586 002 Apr 14, 2020
AB 10MCG/HR A211586 003 Apr 14, 2020
AB 15MCG/HR A211586 004 Apr 14, 2020
AB 20MCG/HR A211586 005 Apr 14, 2020
AB AVEVA 5MCG/HR A210272 001 Sep 23, 2021
AB 7.5MCG/HR A210272 002 Sep 23, 2021
AB 10MCG/HR A210272 003 Sep 23, 2021
AB 15MCG/HR A210272 004 Sep 23, 2021
AB 20MCG/HR A210272 005 Sep 23, 2021
AB WATSON LABS TEVA 5MCG/HR A204937 001 Nov 20, 2018
AB 7.5MCG/HR A204937 005 Jun 29, 2021
AB 10MCG/HR A204937 002 Nov 20, 2018
AB 15MCG/HR A204937 003 Nov 20, 2018
AB 20MCG/HR A204937 004 Nov 20, 2018
BUTRANS
AB + PURDUE PHARMA LP 5MCG/HR N021306 001 Jun 30, 2010
AB + 7.5MCG/HR N021306 005 Jun 30, 2014
AB + 10MCG/HR N021306 002 Jun 30, 2010
AB + 15MCG/HR N021306 004 Jul 25, 2013
AB +! 20MCG/HR N021306 003 Jun 30, 2010
SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS
SUBLOCADE
+ INDIVIOR INC 100MG/0.5ML (100MG/0.5ML) N209819 001 Nov 30, 2017
+! 300MG/1.5ML (200MG/ML) N209819 002 Nov 30, 2017
BUPRENORPHINE HYDROCHLORIDE
FILM;BUCCAL
BELBUCA
+ BDSI EQ 0.075MG BASE N207932 001 Oct 23, 2015
+ EQ 0.15MG BASE N207932 002 Oct 23, 2015
+ EQ 0.3MG BASE N207932 003 Oct 23, 2015
+ EQ 0.45MG BASE N207932 004 Oct 23, 2015
+ EQ 0.6MG BASE N207932 005 Oct 23, 2015
+ EQ 0.75MG BASE N207932 006 Oct 23, 2015
+! EQ 0.9MG BASE N207932 007 Oct 23, 2015
INJECTABLE;INJECTION
BUPRENEX
AP +! INDIVIOR INC EQ 0.3MG BASE/ML N018401 001
BUPRENORPHINE HYDROCHLORIDE
AP AM REGENT EQ 0.3MG BASE/ML A078331 001 Mar 27, 2007
AP HIKMA EQ 0.3MG BASE/ML A076931 001 Mar 02, 2005
AP HOSPIRA EQ 0.3MG BASE/ML A074137 001 Jun 03, 1996
AP PAR STERILE EQ 0.3MG BASE/ML A206586 001 Jul 28, 2015
PRODUCTS
TABLET;SUBLINGUAL
BUPRENORPHINE HYDROCHLORIDE
AB ACTAVIS ELIZABETH EQ 2MG BASE A090819 001 Feb 19, 2015
AB EQ 8MG BASE A090819 002 Feb 19, 2015
AB ETHYPHARM EQ 2MG BASE A090622 001 Sep 24, 2010
AB EQ 8MG BASE A090622 002 Sep 24, 2010
AB HIKMA EQ 2MG BASE A078633 001 Oct 08, 2009
AB ! EQ 8MG BASE A078633 002 Oct 08, 2009
AB RHODES PHARMS EQ 2MG BASE A207276 001 Mar 27, 2017
AB EQ 8MG BASE A207276 002 Mar 27, 2017
AB RUBICON EQ 2MG BASE A090279 001 Jun 10, 2015
AB EQ 8MG BASE A090279 002 Jun 10, 2015
AB SUN PHARM EQ 2MG BASE A201760 001 Jan 29, 2016
AB EQ 8MG BASE A201760 002 Jan 29, 2016
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
FILM;BUCCAL, SUBLINGUAL
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
AB ALVOGEN EQ 2MG BASE;EQ 0.5MG BASE A205954 001 Jan 24, 2019
AB EQ 4MG BASE;EQ 1MG BASE A205954 002 Jan 24, 2019
AB EQ 8MG BASE;EQ 2MG BASE A205954 003 Jan 24, 2019
AB EQ 12MG BASE;EQ 3MG BASE A205954 004 Jan 24, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-68(of 474)

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE


FILM;BUCCAL, SUBLINGUAL
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
AB AVEVA EQ 8MG BASE;EQ 2MG BASE A212756 001 Jun 02, 2022
AB EQ 12MG BASE;EQ 3MG BASE A212756 002 Jun 02, 2022
AB DR REDDYS LABS SA EQ 2MG BASE;EQ 0.5MG BASE A205299 001 Jun 14, 2018
AB EQ 4MG BASE;EQ 1MG BASE A205806 001 Jun 14, 2018
AB EQ 8MG BASE;EQ 2MG BASE A205299 002 Jun 14, 2018
AB EQ 12MG BASE;EQ 3MG BASE A205806 002 Jun 14, 2018
AB MYLAN TECHNOLOGIES EQ 2MG BASE;EQ 0.5MG BASE A211785 001 Apr 17, 2020
AB EQ 4MG BASE;EQ 1MG BASE A211785 002 Apr 17, 2020
AB EQ 8MG BASE;EQ 2MG BASE A207607 001 Jun 14, 2018
AB EQ 12MG BASE;EQ 3MG BASE A207607 002 Jun 14, 2018
SUBOXONE
AB + INDIVIOR INC EQ 2MG BASE;EQ 0.5MG BASE N022410 001 Aug 30, 2010
AB + EQ 4MG BASE;EQ 1MG BASE N022410 003 Aug 10, 2012
AB + EQ 8MG BASE;EQ 2MG BASE N022410 002 Aug 30, 2010
AB +! EQ 12MG BASE;EQ 3MG BASE N022410 004 Aug 10, 2012
TABLET;SUBLINGUAL
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
AB ACTAVIS ELIZABETH EQ 2MG BASE;EQ 0.5MG BASE A091422 001 Feb 22, 2013
AB EQ 8MG BASE;EQ 2MG BASE A091422 002 Feb 22, 2013
AB ALKEM LABS LTD EQ 2MG BASE;EQ 0.5MG BASE A214930 001 Jun 15, 2021
AB EQ 8MG BASE;EQ 2MG BASE A214930 002 Jun 15, 2021
AB AMNEAL PHARMS EQ 2MG BASE;EQ 0.5MG BASE A203136 001 Feb 22, 2013
AB EQ 8MG BASE;EQ 2MG BASE A203136 002 Feb 22, 2013
AB ETHYPHARM USA CORP EQ 2MG BASE;EQ 0.5MG BASE A204431 001 Oct 16, 2015
AB EQ 8MG BASE;EQ 2MG BASE A204431 002 Oct 16, 2015
AB HIKMA EQ 2MG BASE;EQ 0.5MG BASE A203326 001 Jun 27, 2014
AB ! EQ 8MG BASE;EQ 2MG BASE A203326 002 Jun 27, 2014
AB LANNETT CO INC EQ 2MG BASE;EQ 0.5MG BASE A205022 001 Sep 19, 2016
AB EQ 8MG BASE;EQ 2MG BASE A205022 002 Sep 19, 2016
AB RHODES PHARMS EQ 2MG BASE;EQ 0.5MG BASE A205601 001 Mar 30, 2020
AB EQ 8MG BASE;EQ 2MG BASE A205601 002 Mar 30, 2020
AB SPECGX LLC EQ 2MG BASE;EQ 0.5MG BASE A207000 001 Dec 13, 2017
AB EQ 8MG BASE;EQ 2MG BASE A207000 002 Dec 13, 2017
AB SUN PHARM EQ 2MG BASE;EQ 0.5MG BASE A201633 001 Aug 05, 2016
AB EQ 8MG BASE;EQ 2MG BASE A201633 002 Aug 05, 2016
AB WES PHARMA INC EQ 2MG BASE;EQ 0.5MG BASE A209069 001 Jul 17, 2020
AB EQ 8MG BASE;EQ 2MG BASE A209069 002 Jul 17, 2020
ZUBSOLV
+ OREXO US INC EQ 0.7MG BASE;EQ 0.18MG BASE N204242 006 Oct 04, 2016
+ EQ 1.4MG BASE;EQ 0.36MG BASE N204242 001 Jul 03, 2013
+ EQ 2.9MG BASE;EQ 0.71MG BASE N204242 005 Jun 04, 2015
+ EQ 5.7MG BASE;EQ 1.4MG BASE N204242 002 Jul 03, 2013
+ EQ 8.6MG BASE;EQ 2.1MG BASE N204242 003 Dec 11, 2014
+! EQ 11.4MG BASE;EQ 2.9MG BASE N204242 004 Dec 11, 2014
BUPROPION HYDROBROMIDE
TABLET, EXTENDED RELEASE;ORAL
APLENZIN
+ BAUSCH 174MG N022108 001 Apr 23, 2008
+ 348MG N022108 002 Apr 23, 2008
+! 522MG N022108 003 Apr 23, 2008
BUPROPION HYDROCHLORIDE
TABLET;ORAL
BUPROPION HYDROCHLORIDE
AB ALEMBIC PHARMS 75MG A203013 001 Jun 08, 2018
AB 100MG A203013 002 Jun 08, 2018
AB APNAR PHARMA LP 75MG A075584 001 Feb 07, 2000
AB 100MG A075584 002 Feb 07, 2000
AB APOTEX INC 75MG A076143 001 Jan 17, 2006
AB ! 100MG A076143 002 Jan 17, 2006
AB CADILA PHARMS LTD 75MG A208606 001 Jan 16, 2020
AB 100MG A208606 002 Jan 16, 2020
AB HERITAGE PHARMA 75MG A206975 001 Aug 19, 2016
AB 100MG A206975 002 Aug 19, 2016
AB INVAGEN PHARMS 75MG A207389 001 Sep 18, 2017
AB 100MG A207389 002 Sep 18, 2017
AB MICRO LABS 75MG A207403 001 Apr 17, 2020
AB 100MG A207403 002 Apr 17, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-69(of 474)

BUPROPION HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
BUPROPION HYDROCHLORIDE
AB1 ACTAVIS LABS FL INC 100MG A079095 001 Mar 24, 2009
AB1 150MG A079095 002 Mar 24, 2009
AB1 200MG A079095 003 Mar 24, 2009
AB1 ANCHEN PHARMS 100MG A091459 001 Jun 09, 2011
AB1 150MG A091459 002 Jun 09, 2011
AB1 200MG A091459 003 Jun 09, 2011
AB1 EPIC PHARMA 100MG A075932 001 Nov 25, 2003
AB1 150MG A075932 002 Mar 22, 2004
AB1 200MG A075932 003 Jun 22, 2005
AB1 IMPAX LABS 100MG A075913 001 Jan 28, 2004
AB1 150MG A075913 002 Mar 22, 2004
AB1 INVAGEN PHARMS 100MG A206674 001 Feb 09, 2016
AB1 150MG A206674 002 Feb 09, 2016
AB1 200MG A206674 003 Feb 09, 2016
AB1 PRINSTON INC 100MG A202304 001 May 26, 2015
AB1 150MG A202304 002 May 26, 2015
AB1 200MG A202304 003 May 26, 2015
AB1 SCIEGEN PHARMS INC 100MG A205794 001 Mar 01, 2016
AB1 150MG A205794 002 Mar 01, 2016
AB1 200MG A205794 003 Mar 01, 2016
AB1 SUN PHARM 100MG A078866 001 Apr 06, 2010
AB1 150MG A078866 002 Apr 06, 2010
AB1 200MG A078866 003 Apr 06, 2010
AB1 YICHANG HUMANWELL 100MG A211347 001 Oct 16, 2018
AB1 150MG A211347 002 Oct 16, 2018
AB1 200MG A211347 003 Oct 16, 2018
WELLBUTRIN SR
AB1 + GLAXOSMITHKLINE 100MG N020358 002 Oct 04, 1996
AB1 + 150MG N020358 003 Oct 04, 1996
AB1 +! 200MG N020358 004 Jun 14, 2002
BUPROPION HYDROCHLORIDE
AB2 ! ACTAVIS LABS FL INC 150MG A079094 001 Mar 24, 2009
AB2 ANCHEN PHARMS 150MG A091520 001 Jun 09, 2011
AB2 IMPAX LABS 150MG A075914 001 May 27, 2004
AB2 SANDOZ INC 150MG A077475 001 Mar 12, 2008
AB2 SCIEGEN PHARMS INC 150MG A206122 001 Aug 17, 2016
AB2 YICHANG HUMANWELL 150MG A216766 001 Jan 09, 2023
AB3 ACCORD HLTHCARE 150MG A210497 001 Oct 31, 2018
AB3 300MG A210497 002 Oct 31, 2018
AB3 ACTAVIS LABS FL INC 150MG A077715 001 Nov 26, 2008
AB3 ANBISON LAB 150MG A207224 001 Jun 30, 2017
AB3 300MG A207224 002 Jun 30, 2017
AB3 ANCHEN PHARMS 150MG A077284 001 Dec 14, 2006
AB3 300MG A077284 002 Dec 14, 2006
AB3 GRANULES 150MG A215568 001 Feb 02, 2022
AB3 300MG A215568 002 Feb 02, 2022
AB3 GRAVITI PHARMS 150MG A211020 001 Jan 28, 2019
AB3 300MG A211020 002 Jan 28, 2019
AB3 INVAGEN PHARMS 150MG A206556 001 Aug 26, 2016
AB3 300MG A206556 002 Aug 26, 2016
AB3 LUPIN LTD 150MG A090693 001 Apr 06, 2017
AB3 300MG A090693 002 Apr 06, 2017
AB3 SCIEGEN PHARMS INC 150MG A207479 001 Apr 12, 2017
AB3 300MG A207479 002 Apr 12, 2017
AB3 SINOTHERAPEUTICS 150MG A208652 001 Aug 21, 2017
INC
AB3 300MG A208652 002 Aug 21, 2017
AB3 SUN PHARM 150MG A200216 001 Nov 30, 2020
AB3 300MG A203650 001 Dec 31, 2020
AB3 TWI PHARMS 150MG A210081 001 Nov 03, 2017
AB3 300MG A210081 002 Nov 03, 2017
AB3 WATSON LABS INC 150MG A077285 001 Nov 26, 2008
AB3 300MG A077285 002 Aug 15, 2008
AB3 WOCKHARDT LTD 150MG A202189 001 Nov 21, 2012
AB3 300MG A202189 002 Jan 28, 2022
AB3 YICHANG HUMANWELL 150MG A210015 001 Jun 14, 2018
AB3 300MG A210015 002 Jun 14, 2018
AB3 ZHEJIANG JUTAI 150MG A211200 002 Apr 29, 2020
PHARM
AB3 300MG A211200 001 Sep 05, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-70(of 474)

BUPROPION HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
BUPROPION HYDROCHLORIDE
AB3 ZYDUS PHARMS 150MG A201567 002 Jul 23, 2018
AB3 300MG A201567 001 Jan 17, 2014
WELLBUTRIN XL
AB3 + BAUSCH 150MG N021515 001 Aug 28, 2003
AB3 +! 300MG N021515 002 Aug 28, 2003
FORFIVO XL
+! ALMATICA 450MG N022497 001 Nov 10, 2011
BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
TABLET, EXTENDED RELEASE;ORAL
AUVELITY
+! AXSOME 105MG;45MG N215430 001 Aug 18, 2022
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
CONTRAVE
+! NALPROPION 90MG;8MG N200063 001 Sep 10, 2014
BUSPIRONE HYDROCHLORIDE
TABLET;ORAL
BUSPIRONE HYDROCHLORIDE
AB ACCORD HLTHCARE 5MG A202557 001 Dec 30, 2014
AB 7.5MG A202557 002 Dec 30, 2014
AB 10MG A202557 003 Dec 30, 2014
AB ! 15MG A202557 004 Dec 30, 2014
AB 30MG A202557 005 Dec 30, 2014
AB AMNEAL PHARMS CO 5MG A208829 001 May 24, 2017
AB 7.5MG A208829 002 May 24, 2017
AB 10MG A208829 003 May 24, 2017
AB 15MG A208829 004 May 24, 2017
AB 30MG A208829 005 May 24, 2017
AB AUROBINDO PHARMA 5MG A078246 001 Feb 27, 2009
LTD
AB 7.5MG A078246 005 Feb 21, 2020
AB 10MG A078246 002 Feb 27, 2009
AB 15MG A078246 003 Feb 27, 2009
AB 30MG A078246 004 Feb 27, 2009
AB EPIC PHARMA LLC 5MG A208972 001 Apr 16, 2019
AB 7.5MG A208972 002 Apr 16, 2019
AB 10MG A208972 003 Apr 16, 2019
AB 15MG A208972 004 Apr 16, 2019
AB 30MG A208972 005 Apr 16, 2019
AB HERITAGE PHARMA 5MG A204582 001 Sep 18, 2015
AB 10MG A204582 002 Sep 18, 2015
AB 15MG A204582 003 Sep 18, 2015
AB 30MG A204582 004 Sep 18, 2015
AB IMPAX LABS INC 5MG A074253 001 Mar 28, 2001
AB 10MG A074253 002 Mar 28, 2001
AB 15MG A074253 003 Mar 13, 2002
AB INVENTIA HLTHCARE 5MG A209696 001 May 03, 2018
AB 7.5MG A209696 002 May 03, 2018
AB 10MG A209696 003 May 03, 2018
AB 15MG A209696 004 May 03, 2018
AB 30MG A209696 005 May 03, 2018
AB MYLAN 5MG A076008 003 Mar 01, 2002
AB 7.5MG A076008 002 Jul 08, 2013
AB 10MG A076008 004 Mar 01, 2002
AB 15MG A076008 005 Mar 28, 2001
AB 30MG A076008 001 Jun 28, 2001
AB OXFORD PHARMS 5MG A075388 001 May 09, 2002
AB 10MG A075388 002 May 09, 2002
AB 15MG A075388 003 May 09, 2002
AB 30MG A078302 001 Dec 17, 2007
AB RUBICON 5MG A075521 001 Apr 05, 2002
AB 7.5MG A075521 004 Mar 16, 2021
AB 10MG A075521 002 Apr 05, 2002
AB 15MG A075521 003 Apr 05, 2002
AB 30MG A075521 005 Mar 16, 2021
AB STRIDES PHARMA 5MG A202330 001 Aug 25, 2014
AB 7.5MG A202330 005 Feb 17, 2017
AB 10MG A202330 002 Aug 25, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-71(of 474)

BUSPIRONE HYDROCHLORIDE
TABLET;ORAL
BUSPIRONE HYDROCHLORIDE
AB 15MG A202330 003 Aug 25, 2014
AB 30MG A202330 004 Aug 25, 2014
AB TEVA 5MG A075022 001 Feb 28, 2002
AB 10MG A075022 002 Feb 28, 2002
AB 15MG A075022 003 Feb 28, 2002
AB 30MG A075022 004 Mar 25, 2004
AB UNICHEM 5MG A210907 001 Nov 14, 2019
AB 10MG A210907 002 Nov 14, 2019
AB 15MG A210907 003 Nov 14, 2019
AB 30MG A210907 004 Nov 14, 2019
AB YILING 5MG A202087 001 Dec 16, 2015
AB 10MG A202087 002 Dec 16, 2015
AB 15MG A202087 003 Dec 16, 2015
AB 30MG A202087 004 Dec 16, 2015
AB ZYDUS PHARMS 5MG A078888 001 Feb 07, 2014
AB 10MG A078888 002 Feb 07, 2014
AB 15MG A078888 003 Feb 07, 2014
AB 30MG A078888 004 Feb 07, 2014
BUSULFAN
INJECTABLE;INJECTION
BUSULFAN
AP ACCORD HLTHCARE INC 6MG/ML A210148 001 Feb 22, 2019
AP AM REGENT 6MG/ML A202259 001 Dec 22, 2015
AP AMNEAL 6MG/ML A209580 001 Dec 18, 2017
AP APOTEX 6MG/ML A210448 001 May 07, 2019
AP ARTHUR GRP 6MG/ML A205106 001 Sep 21, 2018
AP HOSPIRA 6MG/ML A205672 001 Jul 31, 2018
AP MEITHEAL 6MG/ML A212127 001 Oct 23, 2020
AP MYLAN INSTITUTIONAL 6MG/ML A208536 001 Nov 20, 2017
AP NEXUS PHARMS 6MG/ML A207794 001 Jan 14, 2019
AP PHARMASCIENCE INC 6MG/ML A207050 001 Mar 24, 2017
AP SHILPA 6MG/ML A210931 001 Apr 18, 2019
BUSULFEX
AP +! OTSUKA PHARM 6MG/ML N020954 001 Feb 04, 1999
TABLET;ORAL
MYLERAN
+! WOODWARD SPECL 2MG N009386 001
BUTENAFINE HYDROCHLORIDE
CREAM;TOPICAL
MENTAX
+! MYLAN 1% N020524 001 Oct 18, 1996
BUTOCONAZOLE NITRATE
CREAM;VAGINAL
GYNAZOLE-1
! PADAGIS ISRAEL 2% A200923 001 May 18, 2012
BUTORPHANOL TARTRATE
INJECTABLE;INJECTION
BUTORPHANOL TARTRATE
AP HIKMA 2MG/ML A075046 001 Aug 12, 1998
AP HIKMA FARMACEUTICA 1MG/ML A078400 001 May 01, 2009
AP 2MG/ML A078400 002 May 01, 2009
BUTORPHANOL TARTRATE PRESERVATIVE FREE
AP HIKMA 1MG/ML A075045 001 Aug 12, 1998
AP 2MG/ML A075045 002 Aug 12, 1998
AP ! HOSPIRA 1MG/ML A074626 001 Jan 23, 1997
AP ! 2MG/ML A074626 002 Jan 23, 1997
SPRAY, METERED;NASAL
BUTORPHANOL TARTRATE
AB APOTEX INC 1MG/SPRAY A075499 001 Dec 04, 2002
AB HIKMA 1MG/SPRAY A075824 001 Mar 12, 2002
AB ! RISING 1MG/SPRAY A075759 001 Aug 08, 2001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-72(of 474)

CABAZITAXEL
SOLUTION;INTRAVENOUS
CABAZITAXEL
AP ACCORD HLTHCARE 60MG/1.5ML (40MG/ML) A207693 001 Oct 26, 2022
JEVTANA KIT
AP +! SANOFI AVENTIS US 60MG/1.5ML (40MG/ML) N201023 001 Jun 17, 2010
CABERGOLINE
TABLET;ORAL
CABERGOLINE
AB ! INGENUS PHARMS LLC 0.5MG A204735 001 Aug 01, 2018
AB IVAX SUB TEVA 0.5MG A077750 001 Mar 07, 2007
PHARMS
AB STRIDES PHARMA 0.5MG A076310 001 Dec 29, 2005
CABOTEGRAVIR
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
APRETUDE
+! VIIV HLTHCARE 600MG/3ML (200MG/ML) N215499 001 Dec 20, 2021
CABOTEGRAVIR SODIUM
TABLET;ORAL
VOCABRIA
+! VIIV HLTHCARE EQ 30MG BASE N212887 001 Jan 21, 2021
CABOTEGRAVIR; RILPIVIRINE
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
CABENUVA KIT
+! VIIV HLTHCARE 400MG/2ML (200MG/ML);600MG/2ML N212888 001 Jan 21, 2021
(300MG/ML)
+! 600MG/3ML (200MG/ML);900MG/3ML N212888 002 Jan 21, 2021
(300MG/ML)
CABOZANTINIB S-MALATE
CAPSULE;ORAL
COMETRIQ
+! EXELIXIS EQ 20MG BASE N203756 001 Nov 29, 2012
+ EQ 80MG BASE N203756 002 Nov 29, 2012
TABLET;ORAL
CABOMETYX
+ EXELIXIS INC EQ 20MG BASE N208692 001 Apr 25, 2016
+ EQ 40MG BASE N208692 002 Apr 25, 2016
+! EQ 60MG BASE N208692 003 Apr 25, 2016
CAFFEINE CITRATE
SOLUTION;INTRAVENOUS
CAFCIT
AP +! HIKMA EQ 30MG BASE/3ML (EQ 10MG BASE/ML) N020793 001 Sep 21, 1999
CAFFEINE CITRATE
AP AM REGENT EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A077906 001 May 15, 2007
AP EUGIA PHARMA EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A205013 001 Sep 22, 2015
AP EXELA PHARMA EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A077233 001 Sep 21, 2006
SCIENCE
AP FRESENIUS KABI USA EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A077997 001 Jul 20, 2007
AP MICRO LABS EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A207400 001 Dec 14, 2017
AP SAGENT PHARMS EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A090827 001 Aug 29, 2012
SOLUTION;ORAL
CAFFEINE CITRATE
AA ! EXELA PHARMA EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A077304 001 Sep 21, 2006
AA FRESENIUS KABI USA EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A078002 001 Jan 31, 2008
AA MICRO LABS EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A213202 001 Dec 16, 2019
AA SAGENT PHARMS EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A091102 001 Aug 29, 2012
AA SUN PHARM EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A090357 001 Sep 30, 2009
CAFFEINE; ERGOTAMINE TARTRATE
SUPPOSITORY;RECTAL
MIGERGOT
+! COSETTE 100MG;2MG A086557 001 Oct 04, 1983
TABLET;ORAL
ERGOTAMINE TARTRATE AND CAFFEINE
! MIKART 100MG;1MG A040590 001 Sep 16, 2005
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-73(of 474)

CALCIFEDIOL
CAPSULE, EXTENDED RELEASE;ORAL
RAYALDEE
+! EIRGEN 0.03MG N208010 001 Jun 17, 2016
CALCIPOTRIENE
AEROSOL, FOAM;TOPICAL
SORILUX
+! MAYNE PHARMA 0.005% N022563 001 Oct 06, 2010
CREAM;TOPICAL
CALCIPOTRIENE
AB GLENMARK PHARMS 0.005% A205772 001 Jun 09, 2015
AB TOLMAR 0.005% A200935 001 May 30, 2012
DOVONEX
AB +! LEO PHARMA AS 0.005% N020554 001 Jul 22, 1996
OINTMENT;TOPICAL
CALCIPOTRIENE
AB ! GLENMARK PHARMS INC 0.005% A090633 001 Mar 24, 2010
DOVONEX
AB + LEO PHARMA AS 0.005% N020273 001 Dec 29, 1993
SOLUTION;TOPICAL
CALCIPOTRIENE
AT AKORN 0.005% A077579 001 Nov 19, 2009
AT COSETTE 0.005% A078468 001 Mar 24, 2011
AT FOUGERA PHARMS 0.005% A078305 001 May 06, 2008
AT NOVEL LABS INC 0.005% A207163 001 Dec 26, 2017
AT ! TOLMAR 0.005% A077029 001 Nov 20, 2009
CALCITONIN SALMON
INJECTABLE;INJECTION
CALCITONIN-SALMON
AP CUSTOPHARM INC 200 IU/ML A212416 001 May 14, 2021
AP PAR STERILE 200 IU/ML A209358 001 Nov 10, 2021
PRODUCTS
MIACALCIN
AP +! MYLAN IRELAND LTD 200 IU/ML N017808 002 Mar 29, 1991
SPRAY, METERED;NASAL
CALCITONIN-SALMON
! APOTEX INC 200 IU/SPRAY A076396 001 Nov 17, 2008
CALCITRIOL
CAPSULE;ORAL
CALCITRIOL
AB AMNEAL PHARMS 0.25MCG A203289 002 Jun 14, 2017
AB 0.5MCG A203289 001 Jun 14, 2017
AB BIONPHARMA INC 0.25MCG A091174 001 May 24, 2013
AB 0.5MCG A091174 002 May 24, 2013
AB HIKMA 0.25MCG A076917 001 Mar 27, 2006
AB STRIDES PHARMA 0.25MCG A091356 001 Dec 12, 2014
AB 0.5MCG A091356 002 Dec 12, 2014
AB SUN PHARM 0.25MCG A204556 001 Feb 21, 2019
AB 0.5MCG A204556 002 Feb 21, 2019
AB TEVA 0.25MCG A075765 001 Oct 12, 2001
AB 0.5MCG A075765 002 Oct 12, 2001
ROCALTROL
AB + VALIDUS PHARMS 0.25MCG N018044 001
AB +! 0.5MCG N018044 002
INJECTABLE;INJECTION
CALCITRIOL
AP ! AKORN 0.001MG/ML A078066 001 Jan 29, 2008
AP GLAND PHARMA LTD 0.001MG/ML A211030 001 Feb 03, 2020
OINTMENT;TOPICAL
VECTICAL
+! GALDERMA LABS LP 3MCG/GM N022087 001 Jan 23, 2009
SOLUTION;ORAL
CALCITRIOL
AA ELYSIUM 1MCG/ML A209798 001 Nov 21, 2018
AA HIKMA 1MCG/ML A076242 001 Jul 18, 2003
ROCALTROL
AA +! VALIDUS PHARMS 1MCG/ML N021068 001 Nov 20, 1998
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-74(of 474)

CALCIUM ACETATE
CAPSULE;ORAL
CALCIUM ACETATE
AB CHARTWELL RX 667MG A091312 001 Jun 01, 2012
AB HERITAGE PHARMS INC 667MG A202315 001 Jun 29, 2015
AB HIKMA 667MG A077728 001 Feb 26, 2008
AB INVAGEN PHARMS 667MG A203135 001 Feb 07, 2013
AB LUPIN LTD 667MG A202127 001 Jul 09, 2015
AB NOSTRUM LABS INC 667MG A203179 001 Oct 26, 2015
AB SUVEN PHARMS 667MG A211038 001 Feb 21, 2020
PHOSLO GELCAPS
AB +! FRESENIUS MEDCL 667MG N021160 003 Apr 02, 2001
SOLUTION;ORAL
PHOSLYRA
+! FRESENIUS MEDCL 667MG/5ML N022581 001 Apr 18, 2011
TABLET;ORAL
CALCIUM ACETATE
AB ! CHARTWELL MOLECULAR 667MG A202420 001 Feb 05, 2013
AB HERITAGE PHARMS INC 667MG A202885 001 Jan 22, 2015
AB PADAGIS US 667MG A091561 001 Apr 13, 2011
CALCIUM CHLORIDE
INJECTABLE;INJECTION
CALCIUM CHLORIDE 10%
AP AM REGENT 100MG/ML A209088 001 Jul 27, 2017
AP INTL MEDICATION SYS 100MG/ML A203477 001 May 09, 2018
AP MEDEFIL INC 100MG/ML A211553 001 May 01, 2019
CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER
AP +! HOSPIRA 100MG/ML N021117 001 Jan 28, 2000
CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM
BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE
SOLUTION;IRRIGATION
BSS PLUS
+! ALCON 0.154MG/ML;0.92MG/ML;0.184MG/ML;0.2MG/M N018469 001
L;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/M
L
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM
BICARBONATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER
+! BAXTER HLTHCARE N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.0 N021703 011 Oct 10, 2008
CORP 5GM/1000ML;0.314GM/1000ML;2.21GM/1000ML
;7.07GM/1000ML (5000ML)
PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML; N021703 006 Oct 25, 2006
CORP 3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;
6.46GM/1000ML (5000ML)
PRISMASOL BGK 2/0 IN PLASTIC CONTAINER
+! BAXTER HLTHCARE N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.0 N021703 002 Oct 25, 2006
CORP 3GM/1000ML;0.157GM/1000ML;3.09GM/1000ML
;6.46GM/1000ML (5000ML)
PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML; N021703 003 Oct 25, 2006
CORP 2.03GM/1000ML;0.157GM/1000ML;3.09GM/100
0ML;6.46GM/1000ML (5000ML)
PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER
+! BAXTER HLTHCARE N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.4 N021703 015 Oct 10, 2008
CORP 4GM/1000ML;0.314GM/1000ML;3.09GM/1000ML
;6.46GM/1000ML (5000ML)
PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML; N021703 004 Oct 25, 2006
CORP 3.05GM/1000ML;0.314GM/1000ML;3.09GM/100
0ML;6.46GM/1000ML (5000ML)
PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER
+! BAXTER HLTHCARE N/A/1000ML;N/A/1000ML;5.4GM/1000ML;2.44 N021703 014 Oct 10, 2008
CORP GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46
GM/1000ML (5000ML)
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
SOLUTION;INTRAPERITONEAL
DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
AT +! FRESENIUS MEDCL 25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;5 N018883 001 Nov 30, 1984
67MG/100ML;392MG/100ML
DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER
AT +! FRESENIUS MEDCL 25.7MG/100ML;1.5GM/100ML;5.08MG/100ML; N018883 004 Nov 30, 1984
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-75(of 474)

CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE


SOLUTION;INTRAPERITONEAL
DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER
538MG/100ML;448MG/100ML
DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER
AT +! FRESENIUS MEDCL 18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;5 N020171 001 Aug 19, 1992
38MG/100ML;448MG/100ML
DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
AT +! FRESENIUS MEDCL 25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;5 N018883 002 Nov 30, 1984
67MG/100ML;392MG/100ML
DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER
AT +! FRESENIUS MEDCL 25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;5 N018883 005 Nov 30, 1984
38MG/100ML;448MG/100ML
DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER
AT +! FRESENIUS MEDCL 18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;5 N020171 002 Aug 19, 1992
38MG/100ML;448MG/100ML
DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
AT +! FRESENIUS MEDCL 25.7MG/100ML;4.25GM/100ML;15.2MG/100ML; N018883 003 Nov 30, 1984
567MG/100ML;392MG/100ML
DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER
AT +! FRESENIUS MEDCL 25.7MG/100ML;4.25GM/100ML;5.08MG/100ML; N018883 006 Nov 30, 1984
538MG/100ML;448MG/100ML
DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER
AT +! FRESENIUS MEDCL 18.4MG/100ML;4.25GM/100ML;5.08MG/100ML; N020171 003 Aug 19, 1992
538MG/100ML;448MG/100ML
DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
AT + BAXTER HLTHCARE 18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;5 N020183 001 Dec 04, 1992
38MG/100ML;448MG/100ML
DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
AT + BAXTER HLTHCARE 18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;5 N020183 002 Dec 04, 1992
38MG/100ML;448MG/100ML
DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
AT + BAXTER HLTHCARE 18.3MG/100ML;4.25GM/100ML;5.08MG/100ML; N020183 004 Dec 04, 1992
538MG/100ML;448MG/100ML
DIANEAL LOW CALCIUM W/DEXTROSE 1.5% IN PLASTIC CONTAINER
AT + BAXTER HLTHCARE 18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;5 N017512 012 Jan 10, 1989
38MG/100ML;448MG/100ML
DIANEAL LOW CALCIUM W/DEXTROSE 2.5% IN PLASTIC CONTAINER
AT + BAXTER HLTHCARE 18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;5 N017512 013 Jul 11, 1990
38MG/100ML;448MG/100ML
DIANEAL LOW CALCIUM W/DEXTROSE 3.5% IN PLASTIC CONTAINER
AT + BAXTER HLTHCARE 18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;5 N017512 014 Jul 11, 1990
38MG/100ML;448MG/100ML
DIANEAL LOW CALCIUM W/DEXTROSE 4.25% IN PLASTIC CONTAINER
AT + BAXTER HLTHCARE 18.3MG/100ML;4.25GM/100ML;5.08MG/100ML; N017512 015 Jul 11, 1990
538MG/100ML;448MG/100ML
DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
AT + BAXTER HLTHCARE 25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;5 N017512 004
38MG/100ML;448MG/100ML
AT + 25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;5 N020163 001 Dec 04, 1992
38MG/100ML;448MG/100ML
DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
AT + BAXTER HLTHCARE 25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;5 N017512 005
38MG/100ML;448MG/100ML
AT + 25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;5 N020163 002 Dec 04, 1992
38MG/100ML;448MG/100ML
DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
AT + BAXTER HLTHCARE 25.7MG/100ML;4.25GM/100ML;5.08MG/100ML; N017512 006
538MG/100ML;448MG/100ML
AT + 25.7MG/100ML;4.25GM/100ML;5.08MG/100ML; N020163 003 Dec 04, 1992
538MG/100ML;448MG/100ML
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM
CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
INJECTABLE;INTRATHECAL
ELLIOTTS B SOLUTION
+! LUKARE MEDICAL LLC 0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9 N020577 001 Sep 27, 1996
MG/ML;7.3MG/ML;0.2MG/ML
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
INJECTABLE;INJECTION
DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
AP + ICU MEDICAL INC 20MG/100ML;5GM/100ML;30MG/100ML;600MG/1 N017608 001
00ML;310MG/100ML
DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER
AP B BRAUN 20MG/100ML;5GM/100ML;30MG/100ML;600MG/1 N019634 003 Feb 24, 1988
00ML;310MG/100ML
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-76(of 474)

CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE


INJECTABLE;INJECTION
LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 20MG/100ML;5GM/100ML;30MG/100ML;600MG/1 N016679 001
00ML;310MG/100ML
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 20MG/100ML;5GM/100ML;254MG/100ML;600MG/ N019367 006 Apr 05, 1985
100ML;310MG/100ML
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 20MG/100ML;5GM/100ML;179MG/100ML;600MG/ N019367 004 Apr 05, 1985
100ML;310MG/100ML
AP 20MG/100ML;5GM/100ML;328MG/100ML;600MG/ N019367 005 Apr 05, 1985
100ML;310MG/100ML
AP + ICU MEDICAL INC 20MG/100ML;5GM/100ML;179MG/100ML;600MG/ N019685 002 Oct 17, 1988
100ML;310MG/100ML
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 20MG/100ML;5GM/100ML;254MG/100ML;600MG/ N019367 007 Apr 05, 1985
100ML;310MG/100ML
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 20MG/100ML;5GM/100ML;328MG/100ML;600MG/ N019367 008 Apr 05, 1985
100ML;310MG/100ML
DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER
B BRAUN 10MG/100ML;2.5GM/100ML;15MG/100ML;300MG N019634 001 Feb 24, 1988
/100ML;160MG/100ML
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
BAXTER HLTHCARE 20MG/100ML;5GM/100ML;105MG/100ML;600MG/ N019367 002 Apr 05, 1985
100ML;310MG/100ML
20MG/100ML;5GM/100ML;179MG/100ML;600MG/ N019367 003 Apr 05, 1985
100ML;310MG/100ML
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
BAXTER HLTHCARE 20MG/100ML;5GM/100ML;105MG/100ML;600MG/ N019367 001 Apr 05, 1985
100ML;310MG/100ML
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
TPN ELECTROLYTES IN PLASTIC CONTAINER
+! HOSPIRA 16.5MG/ML;25.4MG/ML;74.6MG/ML;121MG/ML; N018895 001 Jul 20, 1984
16.1MG/ML
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM
CITRATE
SOLUTION;IRRIGATION
BALANCED SALT
AT B BRAUN 0.48MG/ML;0.3MG/ML;0.75MG/ML;3.9MG/ML;6 A091387 001 Feb 03, 2010
.4MG/ML;1.7MG/ML
BSS
AT +! ALCON 0.48MG/ML;0.3MG/ML;0.75MG/ML;3.9MG/ML;6 N020742 001 Dec 10, 1997
.4MG/ML;1.7MG/ML
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE;
SODIUM PHOSPHATE
INJECTABLE;INJECTION
PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER
+! BAXTER HLTHCARE N/A/1000ML;3.05GM/1000ML;0.314GM/1000ML N207026 002 Jan 13, 2015
CORP ;2.21GM/1000ML;6.95GM/1000ML;0.187GM/10
00ML (5000ML)
PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 3.68GM/1000ML;3.05GM/1000ML;0.314GM/100 N207026 001 Jan 13, 2015
CORP 0ML
;3.09GM/1000ML;6.34GM/1000ML;0.187GM/10
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
SOLUTION;PERFUSION, CARDIAC
CARDIOPLEGIC IN PLASTIC CONTAINER
AT BAXTER HLTHCARE 17.6MG/100ML;325.3MG/100ML;119.3MG/100M A075323 001 Apr 21, 2000
L;643MG/100ML
AT FRESENIUS KABI USA 17.6MG/100ML;325.3MG/100ML;119.3MG/100M A214623 001 Feb 18, 2022
L;643MG/100ML
PLEGISOL IN PLASTIC CONTAINER
AT +! HOSPIRA 17.6MG/100ML;325.3MG/100ML;119.3MG/100M N018608 001 Feb 26, 1982
L;643MG/100ML
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE;INJECTION
RINGER'S IN PLASTIC CONTAINER
AP B BRAUN 33MG/100ML;30MG/100ML;860MG/100ML N020002 001 Apr 17, 1992
AP BAXTER HLTHCARE 33MG/100ML;30MG/100ML;860MG/100ML N016693 001
AP ICU MEDICAL INC 33MG/100ML;30MG/100ML;860MG/100ML N018251 001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-77(of 474)

CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE


SOLUTION;IRRIGATION
RINGER'S IN PLASTIC CONTAINER
AT B BRAUN 33MG/100ML;30MG/100ML;860MG/100ML N018156 001
AT BAXTER HLTHCARE 33MG/100ML;30MG/100ML;860MG/100ML N018495 001 Feb 19, 1982
AT ICU MEDICAL INC 33MG/100ML;30MG/100ML;860MG/100ML N017635 001
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
INJECTABLE;INJECTION
LACTATED RINGER'S IN PLASTIC CONTAINER
AP B BRAUN 20MG/100ML;30MG/100ML;600MG/100ML;310MG N019632 001 Feb 29, 1988
/100ML
AP +! BAXTER HLTHCARE 20MG/100ML;30MG/100ML;600MG/100ML;310MG N016682 001
/100ML
AP FRESENIUS KABI USA 20MG/100ML;30MG/100ML;600MG/100ML;310MG A209338 001 Jan 28, 2019
/100ML
AP ICU MEDICAL INC 20MG/100ML;30MG/100ML;600MG/100ML;310MG N017641 001
/100ML
SOLUTION;IRRIGATION
LACTATED RINGER'S IN PLASTIC CONTAINER
AT +! B BRAUN 20MG/100ML;30MG/100ML;600MG/100ML;310MG N018681 001 Dec 27, 1982
/100ML
AT BAXTER HLTHCARE 20MG/100ML;30MG/100ML;600MG/100ML;310MG N018494 001 Feb 19, 1982
/100ML
AT +! 20MG/100ML;30MG/100ML;600MG/100ML;310MG N018921 001 Apr 03, 1984
/100ML
AT +! ICU MEDICAL INC 20MG/100ML;30MG/100ML;600MG/100ML;310MG N019416 001 Jan 17, 1986
/100ML
CALCIUM GLUCONATE
SOLUTION;INTRAVENOUS
CALCIUM GLUCONATE
AP +! FRESENIUS KABI USA 1GM/10ML (100MG/ML) N208418 001 Jun 15, 2017
AP NIVAGEN PHARMS INC 1GM/10ML (100MG/ML) A213071 001 Oct 14, 2022
+! FRESENIUS KABI USA 5GM/50ML (100MG/ML) N208418 002 Jun 15, 2017
+! 10GM/100ML (100MG/ML) N208418 003 Jun 15, 2017
CALCIUM GLUCONATE IN SODIUM CHLORIDE
+! FRESENIUS KABI USA 1GM/50ML (20MG/ML) N208418 004 Jun 17, 2021
+! 2GM/100ML (20MG/ML) N208418 005 Jun 17, 2021
+! HQ SPCLT PHARMA 1GM/50ML (20MG/ML) N210906 001 Oct 29, 2018
+! 1GM/100ML (10MG/ML) N210906 003 Jun 04, 2021
+! 2GM/100ML (20MG/ML) N210906 002 Oct 29, 2018
CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
SOLUTION;ORAL
XYWAV
+! JAZZ 0.234GM/ML;0.096GM/ML;0.13GM/ML;0.04GM/ N212690 001 Jul 21, 2020
ML
CANAGLIFLOZIN
TABLET;ORAL
INVOKANA
+ JANSSEN PHARMS 100MG N204042 001 Mar 29, 2013
+! 300MG N204042 002 Mar 29, 2013
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
TABLET;ORAL
INVOKAMET
+ JANSSEN PHARMS 50MG;500MG N204353 001 Aug 08, 2014
+ 50MG;1GM N204353 002 Aug 08, 2014
+ 150MG;500MG N204353 003 Aug 08, 2014
+! 150MG;1GM N204353 004 Aug 08, 2014
TABLET, EXTENDED RELEASE;ORAL
INVOKAMET XR
+ JANSSEN PHARMS 50MG;500MG N205879 001 Sep 20, 2016
+ 50MG;1GM N205879 002 Sep 20, 2016
+ 150MG;500MG N205879 003 Sep 20, 2016
+! 150MG;1GM N205879 004 Sep 20, 2016
CANDESARTAN CILEXETIL
TABLET;ORAL
ATACAND
AB + ANI PHARMS 4MG N020838 001 Jun 04, 1998
AB + 8MG N020838 002 Jun 04, 1998
AB + 16MG N020838 003 Jun 04, 1998
AB +! 32MG N020838 004 Jun 04, 1998
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-78(of 474)

CANDESARTAN CILEXETIL
TABLET;ORAL
CANDESARTAN CILEXETIL
AB ALEMBIC PHARMS 4MG A210302 001 Dec 04, 2018
AB 8MG A210302 002 Dec 04, 2018
AB 16MG A210302 003 Dec 04, 2018
AB 32MG A209119 001 Jun 20, 2017
AB MACLEODS PHARMS LTD 4MG A203813 001 Dec 05, 2016
AB 8MG A203813 002 Dec 05, 2016
AB 16MG A203813 003 Dec 05, 2016
AB 32MG A203813 004 Dec 05, 2016
AB MYLAN 4MG A078702 001 May 03, 2013
AB 8MG A078702 002 May 03, 2013
AB 16MG A078702 003 May 03, 2013
AB 32MG A078702 004 May 03, 2013
AB ZYDUS PHARMS 4MG A091390 001 Aug 23, 2017
AB 8MG A091390 002 Aug 23, 2017
AB 16MG A091390 003 Aug 23, 2017
AB 32MG A091390 004 Aug 23, 2017
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
TABLET;ORAL
ATACAND HCT
AB + ANI PHARMS 16MG;12.5MG N021093 001 Sep 05, 2000
AB + 32MG;12.5MG N021093 002 Sep 05, 2000
AB +! 32MG;25MG N021093 003 May 16, 2008
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
AB DR REDDYS LABS LTD 16MG;12.5MG A202965 001 Jun 03, 2013
AB 32MG;12.5MG A202965 002 Jun 03, 2013
AB 32MG;25MG A202965 003 Jun 03, 2013
AB MACLEODS PHARMS LTD 16MG;12.5MG A204100 001 Feb 27, 2015
AB 32MG;12.5MG A204100 002 Feb 27, 2015
AB 32MG;25MG A204100 003 Feb 27, 2015
AB MYLAN 16MG;12.5MG A090704 001 Dec 04, 2012
AB 32MG;12.5MG A090704 002 Dec 04, 2012
AB 32MG;25MG A090704 003 Dec 04, 2012
AB PRINSTON INC 16MG;12.5MG A207455 001 Apr 11, 2018
AB 32MG;12.5MG A207455 002 Apr 11, 2018
AB 32MG;25MG A207455 003 Apr 11, 2018
AB ZYDUS PHARMS 16MG;12.5MG A203466 001 Nov 27, 2017
AB 32MG;12.5MG A203466 002 Nov 27, 2017
AB 32MG;25MG A203466 003 Nov 27, 2017
CANGRELOR
POWDER;INTRAVENOUS
KENGREAL
+! CHIESI 50MG/VIAL N204958 001 Jun 22, 2015
CANNABIDIOL
SOLUTION;ORAL
EPIDIOLEX
+! GW RES LTD 100MG/ML N210365 001 Sep 28, 2018
CAPECITABINE
TABLET;ORAL
CAPECITABINE
AB ACCORD HLTHCARE 150MG A202593 001 Apr 23, 2015
AB 500MG A202593 002 Apr 23, 2015
AB ALKEM LABS LTD 150MG A207652 001 Nov 24, 2017
AB 500MG A207652 002 Nov 24, 2017
AB DR REDDYS 150MG A204345 001 Dec 04, 2020
AB 500MG A204345 002 Dec 04, 2020
AB EUGIA PHARMA 150MG A210604 001 Apr 17, 2018
AB 500MG A210604 002 Apr 17, 2018
AB HIKMA 150MG A200483 001 Jul 14, 2016
AB 500MG A200483 002 Jul 14, 2016
AB MSN 150MG A209365 001 Jul 02, 2018
AB 500MG A209365 002 Jul 02, 2018
AB RELIANCE LIFE 150MG A211724 001 Apr 27, 2020
AB 500MG A211724 002 Apr 27, 2020
AB RISING 150MG A090943 001 Aug 08, 2014
AB 500MG A090943 002 Aug 08, 2014
AB SHILPA 150MG A207456 001 Dec 12, 2016
AB 500MG A207456 002 Dec 12, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-79(of 474)

CAPECITABINE
TABLET;ORAL
CAPECITABINE
AB SUN PHARM 150MG A204668 001 Jun 21, 2019
AB 500MG A204668 002 Jun 21, 2019
AB TEVA PHARMS USA 150MG A091649 001 Sep 16, 2013
AB 500MG A091649 002 Sep 16, 2013
XELODA
AB + HOFFMANN LA ROCHE 150MG N020896 001 Apr 30, 1998
AB +! 500MG N020896 002 Apr 30, 1998
CAPMATINIB HYDROCHLORIDE
TABLET;ORAL
TABRECTA
+ NOVARTIS PHARM EQ 150MG BASE N213591 001 May 06, 2020
+! EQ 200MG BASE N213591 002 May 06, 2020
CAPSAICIN
PATCH;TOPICAL
QUTENZA
+! AVERITAS 8% N022395 001 Nov 16, 2009
CAPTOPRIL
TABLET;ORAL
CAPTOPRIL
AB AJANTA PHARMA LTD 12.5MG A212809 001 Dec 13, 2019
AB 25MG A212809 002 Dec 13, 2019
AB 50MG A212809 003 Dec 13, 2019
AB 100MG A212809 004 Dec 13, 2019
AB ANNORA PHARMA 12.5MG A074737 001 Oct 28, 1998
AB 25MG A074737 002 Oct 28, 1998
AB 50MG A074737 003 Oct 28, 1998
AB 100MG A074737 004 Oct 28, 1998
AB BOSCOGEN 12.5MG A074677 004 May 30, 1997
AB 25MG A074677 002 May 30, 1997
AB 50MG A074677 001 May 30, 1997
AB 100MG A074677 003 May 30, 1997
AB HIKMA INTL PHARMS 12.5MG A074505 001 Feb 13, 1996
AB 25MG A074505 002 Feb 13, 1996
AB 50MG A074505 003 Feb 13, 1996
AB ! 100MG A074505 004 Feb 13, 1996
AB PRINSTON INC 12.5MG A074477 001 Feb 13, 1996
AB 25MG A074477 002 Feb 13, 1996
AB 50MG A074477 003 Feb 13, 1996
AB 100MG A074477 004 Feb 13, 1996
AB WOCKHARDT 12.5MG A074532 001 Mar 28, 1997
AB 25MG A074532 002 Mar 28, 1997
AB 50MG A074532 003 Mar 28, 1997
AB 100MG A074532 004 Mar 28, 1997
CARBACHOL
SOLUTION;INTRAOCULAR
MIOSTAT
+! ALCON 0.01% N016968 001
CARBAMAZEPINE
CAPSULE, EXTENDED RELEASE;ORAL
CARBAMAZEPINE
AB APOTEX INC 100MG A078986 001 Nov 25, 2011
AB 200MG A078986 002 Nov 25, 2011
AB 300MG A078986 003 Nov 25, 2011
AB NOSTRUM LABS INC 100MG A076697 001 May 20, 2011
AB 200MG A076697 002 May 20, 2011
AB 300MG A076697 003 May 20, 2011
AB TARO 100MG A201106 001 Jun 21, 2013
AB 200MG A201106 002 Jun 21, 2013
AB 300MG A201106 003 Jun 21, 2013
AB TEVA PHARMS 100MG A078592 001 Sep 20, 2012
AB 200MG A078592 002 Sep 20, 2012
AB 300MG A078592 003 Sep 20, 2012
CARBATROL
AB + TAKEDA PHARMS USA 100MG N020712 003 Sep 30, 1997
AB + 200MG N020712 001 Sep 30, 1997
AB +! 300MG N020712 002 Sep 30, 1997
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-80(of 474)

CARBAMAZEPINE
CAPSULE, EXTENDED RELEASE;ORAL
EQUETRO
+ VALIDUS PHARMS 100MG N021710 001 Dec 10, 2004
+ 200MG N021710 002 Dec 10, 2004
+! 300MG N021710 003 Dec 10, 2004
SUSPENSION;ORAL
CARBAMAZEPINE
AB NOVITIUM PHARMA 100MG/5ML A214277 001 Oct 06, 2022
AB WOCKHARDT BIO AG 100MG/5ML A075714 001 Jun 05, 2002
TEGRETOL
AB +! NOVARTIS 100MG/5ML N018927 001 Dec 18, 1987
TERIL
AB TARO 100MG/5ML A076729 001 Sep 20, 2004
TABLET;ORAL
CARBAMAZEPINE
AB APOTEX INC 200MG A075948 001 Feb 27, 2002
AB TARO 200MG A074649 001 Oct 03, 1996
AB TORRENT PHARMS 100MG A077272 001 Dec 07, 2005
AB 200MG A077272 002 Dec 07, 2005
AB UMEDICA LABS PVT 100MG A207798 001 Apr 15, 2020
LTD
AB 200MG A207798 002 Apr 15, 2020
AB UNICHEM 200MG A213284 001 Aug 22, 2022
EPITOL
AB TEVA 200MG A070541 001 Sep 17, 1986
TEGRETOL
AB +! NOVARTIS 200MG N016608 001
CARBAMAZEPINE
TORRENT PHARMS 300MG A077272 003 Dec 07, 2005
400MG A077272 004 Dec 07, 2005
TABLET, CHEWABLE;ORAL
CARBAMAZEPINE
AB TARO PHARM INDS 100MG A075687 001 Oct 24, 2000
AB TORRENT PHARMS 100MG A075712 001 Jul 05, 2001
EPITOL
AB TEVA 100MG A073524 001 Jul 29, 1992
CARBAMAZEPINE
! TARO PHARM INDS 200MG A075687 002 Jul 29, 2002
TABLET, EXTENDED RELEASE;ORAL
CARBAMAZEPINE
AB ANBISON LAB 100MG A212948 001 Sep 30, 2021
AB 200MG A212948 002 Sep 30, 2021
AB 400MG A212948 003 Sep 30, 2021
AB CSPC OUYI 100MG A213311 001 Apr 13, 2021
AB 200MG A213311 002 Apr 13, 2021
AB 400MG A213311 003 Apr 13, 2021
AB TARO 100MG A078115 001 Mar 31, 2009
AB 200MG A078115 002 Mar 31, 2009
AB 400MG A078115 003 Mar 31, 2009
AB UMEDICA LABS PVT 100MG A216594 001 Aug 18, 2022
LTD
AB 200MG A216594 002 Aug 18, 2022
AB 400MG A216594 003 Aug 18, 2022
AB UNIQUE PHARM 100MG A211623 001 Apr 24, 2020
AB 200MG A211623 002 Apr 24, 2020
AB 400MG A211623 003 Apr 24, 2020
AB ZHEJIANG JIUZHOU 100MG A215591 001 Mar 31, 2022
AB 200MG A215591 002 Mar 31, 2022
AB 400MG A215591 003 Mar 31, 2022
AB ZYDUS PHARMS 100MG A205571 001 Feb 07, 2019
AB 200MG A205571 002 Feb 07, 2019
AB 400MG A205571 003 Feb 07, 2019
TEGRETOL-XR
AB + NOVARTIS 100MG N020234 001 Mar 25, 1996
AB + 200MG N020234 002 Mar 25, 1996
AB +! 400MG N020234 003 Mar 25, 1996
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-81(of 474)

CARBIDOPA
TABLET;ORAL
CARBIDOPA
AB ALVOGEN 25MG A204291 001 Jan 08, 2016
AB AUROBINDO PHARMA 25MG A211055 001 Oct 21, 2019
AB EDENBRIDGE PHARMS 25MG A205304 001 Feb 17, 2016
AB NOVEL LABS INC 25MG A204763 001 Oct 20, 2017
AB ZYDUS PHARMS 25MG A209910 001 May 07, 2018
LODOSYN
AB +! ATON 25MG N017830 001
CARBIDOPA; ENTACAPONE; LEVODOPA
TABLET;ORAL
CARBIDOPA, LEVODOPA AND ENTACAPONE
AB RISING 12.5MG;200MG;50MG A213212 001 Jan 25, 2022
AB 18.75MG;200MG;75MG A213212 002 Jan 25, 2022
AB 25MG;200MG;100MG A213212 003 Jan 25, 2022
AB 31.25MG;200MG;125MG A213212 004 Jan 25, 2022
AB 37.5MG;200MG;150MG A213212 005 Jan 25, 2022
AB 50MG;200MG;200MG A213212 006 Jan 25, 2022
AB SUN PHARM 25MG;200MG;100MG A079085 001 May 10, 2012
AB 37.5MG;200MG;150MG A079085 002 May 10, 2012
STALEVO 100
AB + ORION PHARMA 25MG;200MG;100MG N021485 002 Jun 11, 2003
STALEVO 125
AB + ORION PHARMA 31.25MG;200MG;125MG N021485 006 Aug 29, 2008
STALEVO 150
AB + ORION PHARMA 37.5MG;200MG;150MG N021485 003 Jun 11, 2003
STALEVO 200
AB +! ORION PHARMA 50MG;200MG;200MG N021485 004 Aug 02, 2007
STALEVO 50
AB +! ORION PHARMA 12.5MG;200MG;50MG N021485 001 Jun 11, 2003
STALEVO 75
AB + ORION PHARMA 18.75MG;200MG;75MG N021485 005 Aug 29, 2008
CARBIDOPA; LEVODOPA
CAPSULE, EXTENDED RELEASE;ORAL
RYTARY
+ IMPAX LABS INC 23.75MG;95MG N203312 001 Jan 07, 2015
+ 36.25MG;145MG N203312 002 Jan 07, 2015
+ 48.75MG;195MG N203312 003 Jan 07, 2015
+! 61.25MG;245MG N203312 004 Jan 07, 2015
SUSPENSION;ENTERAL
DUOPA
+! ABBVIE INC 4.63MG/ML;20MG/ML N203952 001 Jan 09, 2015
TABLET;ORAL
CARBIDOPA AND LEVODOPA
AB ACTAVIS ELIZABETH 10MG;100MG A074260 001 Sep 03, 1993
AB 25MG;100MG A074260 002 Sep 03, 1993
AB ! 25MG;250MG A074260 003 Sep 03, 1993
AB APOTEX INC 10MG;100MG A077120 001 Jun 02, 2008
AB 25MG;100MG A077120 002 Jun 02, 2008
AB 25MG;250MG A077120 003 Jun 02, 2008
AB AUROBINDO PHARMA 10MG;100MG A216537 001 Nov 28, 2022
LTD
AB 25MG;100MG A216537 002 Nov 28, 2022
AB 25MG;250MG A216537 003 Nov 28, 2022
AB MAYNE PHARMA 10MG;100MG A073618 001 Aug 28, 1992
AB 25MG;100MG A073589 001 Aug 28, 1992
AB 25MG;250MG A073607 001 Aug 28, 1992
AB MYLAN 10MG;100MG A090324 001 Sep 28, 2009
AB 25MG;100MG A090324 002 Sep 28, 2009
AB 25MG;250MG A090324 003 Sep 28, 2009
AB RUBICON 10MG;100MG A216505 001 Sep 21, 2022
AB 25MG;100MG A216505 002 Sep 21, 2022
AB 25MG;250MG A216505 003 Sep 21, 2022
AB SCIEGEN PHARMS INC 10MG;100MG A214092 001 May 07, 2021
AB 25MG;100MG A214092 002 May 07, 2021
AB 25MG;250MG A214092 003 May 07, 2021
AB SUN PHARM INDS 10MG;100MG A078536 001 Oct 28, 2008
AB 25MG;100MG A078536 002 Oct 28, 2008
AB 25MG;250MG A078536 003 Oct 28, 2008
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-82(of 474)

CARBIDOPA; LEVODOPA
TABLET;ORAL
SINEMET
AB + ORGANON 10MG;100MG N017555 001
AB + 25MG;100MG N017555 003
AB + 25MG;250MG N017555 002
DHIVY
+! AVION PHARMS 25MG;100MG N214869 001 Nov 12, 2021
TABLET, EXTENDED RELEASE;ORAL
CARBIDOPA AND LEVODOPA
AB ACCORD HLTHCARE 25MG;100MG A202323 001 Feb 08, 2013
AB 50MG;200MG A202323 002 Feb 08, 2013
AB ALEMBIC PHARMS 25MG;100MG A210341 001 Jun 05, 2019
AB 50MG;200MG A210341 002 Jun 05, 2019
AB APOTEX 25MG;100MG A076212 001 Jun 16, 2004
AB 50MG;200MG A076212 002 Jun 16, 2004
AB IMPAX LABS 25MG;100MG A076521 001 May 14, 2004
AB 50MG;200MG A076521 002 May 14, 2004
AB MYLAN 25MG;100MG A075091 002 Apr 21, 2000
AB 50MG;200MG A075091 001 Sep 30, 1999
AB SCIEGEN PHARMS INC 25MG;100MG A214091 001 Oct 05, 2021
AB 50MG;200MG A214091 002 Oct 05, 2021
AB SUN PHARM INDS 25MG;100MG A077828 001 Aug 23, 2007
AB ! 50MG;200MG A077828 002 Aug 23, 2007
TABLET, ORALLY DISINTEGRATING;ORAL
CARBIDOPA AND LEVODOPA
AB SUN PHARM 10MG;100MG A078690 001 Jul 31, 2009
AB 25MG;100MG A078690 002 Jul 31, 2009
! 25MG;250MG A078690 003 Jul 31, 2009
CARBINOXAMINE MALEATE
SOLUTION;ORAL
CARBINOXAMINE MALEATE
! MIKART 4MG/5ML A040458 001 Apr 25, 2003
SUSPENSION, EXTENDED RELEASE;ORAL
KARBINAL ER
+! AYTU 4MG/5ML N022556 001 Mar 28, 2013
TABLET;ORAL
CARBINOXAMINE MALEATE
AA INVAGEN PHARMS 4MG A090435 001 Apr 15, 2010
AA ! MIKART 4MG A040442 001 Mar 19, 2003
AA MISSION PHARMACAL 4MG A090756 001 May 27, 2011
CO
! MIKART 6MG A207484 001 May 31, 2016
CARBOPLATIN
INJECTABLE;INTRAVENOUS
CARBOPLATIN
AP ACCORD HLTHCARE 50MG/5ML (10MG/ML) A206775 001 Feb 09, 2017
AP 150MG/15ML (10MG/ML) A206775 002 Feb 09, 2017
AP 450MG/45ML (10MG/ML) A206775 003 Feb 09, 2017
AP 600MG/60ML (10MG/ML) A206775 004 Feb 09, 2017
AP AKORN 50MG/5ML (10MG/ML) A090475 001 Jul 29, 2009
AP 150MG/15ML (10MG/ML) A090475 002 Jul 29, 2009
AP 450MG/45ML (10MG/ML) A090475 003 Jul 29, 2009
AP 600MG/60ML (10MG/ML) A091268 002 Jul 28, 2010
AP EUGIA PHARMA 50MG/5ML (10MG/ML) A205487 001 Mar 28, 2016
AP 150MG/15ML (10MG/ML) A205487 002 Mar 28, 2016
AP 450MG/45ML (10MG/ML) A205487 003 Mar 28, 2016
AP 600MG/60ML (10MG/ML) A205487 004 Aug 03, 2020
AP FRESENIUS KABI USA 450MG/45ML (10MG/ML) A077247 003 Oct 21, 2004
AP 450MG/45ML (10MG/ML) A077266 003 Feb 15, 2006
AP 600MG/60ML (10MG/ML) A077266 004 Feb 15, 2006
AP GLAND PHARMA LTD 50MG/5ML (10MG/ML) A207324 001 Feb 15, 2017
AP 150MG/15ML (10MG/ML) A207324 002 Feb 15, 2017
AP 450MG/45ML (10MG/ML) A207324 003 Feb 15, 2017
AP 600MG/60ML (10MG/ML) A207324 004 Feb 15, 2017
AP HIKMA 50MG/5ML (10MG/ML) A077244 001 Oct 15, 2004
AP 150MG/15ML (10MG/ML) A077244 002 Oct 15, 2004
AP 450MG/45ML (10MG/ML) A077244 003 Oct 15, 2004
AP 600MG/60ML (10MG/ML) A077244 004 Jan 20, 2006
AP ! HOSPIRA 50MG/5ML (10MG/ML) A076517 001 Oct 14, 2004
AP ! 150MG/15ML (10MG/ML) A076517 002 Oct 14, 2004
AP ! 450MG/45ML (10MG/ML) A076517 003 Oct 14, 2004
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-83(of 474)

CARBOPLATIN
INJECTABLE;INTRAVENOUS
CARBOPLATIN
AP ! 600MG/60ML (10MG/ML) A077059 001 Nov 23, 2004
AP NOVAST LABS 50MG/5ML (10MG/ML) A208487 001 Apr 26, 2017
AP 150MG/15ML (10MG/ML) A208487 002 Apr 26, 2017
AP PHARMACHEMIE BV 50MG/5ML (10MG/ML) A077269 001 Oct 14, 2004
AP 150MG/15ML (10MG/ML) A077269 002 Oct 14, 2004
AP 450MG/45ML (10MG/ML) A077269 003 Oct 14, 2004
AP 600MG/60ML (10MG/ML) A077269 004 Dec 28, 2007
AP SANDOZ INC 50MG/5ML (10MG/ML) A078280 001 May 08, 2008
AP 150MG/15ML (10MG/ML) A078280 002 May 08, 2008
AP 450MG/45ML (10MG/ML) A078280 003 May 08, 2008
AP SUN PHARM 50MG/5ML (10MG/ML) A077926 001 Sep 19, 2008
AP 150MG/15ML (10MG/ML) A077926 002 Sep 19, 2008
AP 450MG/45ML (10MG/ML) A077926 003 Sep 19, 2008
AP TEYRO LABS 50MG/5ML (10MG/ML) A077861 001 Jan 18, 2007
AP 150MG/15ML (10MG/ML) A077861 002 Jan 18, 2007
AP 450MG/45ML (10MG/ML) A077861 003 Jan 18, 2007
AP 600MG/60ML (10MG/ML) A077861 004 Jan 18, 2007
! ACCORD HLTHCARE 1GM/100ML (10MG/ML) A206775 005 Apr 06, 2020
CARBOPROST TROMETHAMINE
INJECTABLE;INJECTION
CARBOPROST TROMETHAMINE
AP AMNEAL EQ 0.25MG BASE/ML A215337 001 Jan 27, 2022
AP DR REDDYS EQ 0.25MG BASE/ML A211941 001 Jul 02, 2019
AP LONG GROVE PHARMS EQ 0.25MG BASE/ML A214499 001 Aug 09, 2022
AP SUNNY EQ 0.25MG BASE/ML A213118 001 Mar 25, 2021
HEMABATE
AP +! PFIZER EQ 0.25MG BASE/ML N017989 001
CARFILZOMIB
POWDER;INTRAVENOUS
CARFILZOMIB
AP DR REDDYS 60MG/VIAL A209422 001 Sep 09, 2019
KYPROLIS
AP +! ONYX THERAP 60MG/VIAL N202714 001 Jul 20, 2012
+ 10MG/VIAL N202714 003 Jun 07, 2018
+ 30MG/VIAL N202714 002 Jun 03, 2016
CARGLUMIC ACID
TABLET, FOR SUSPENSION;ORAL
CARBAGLU
AB +! RECORDATI RARE 200MG N022562 001 Mar 18, 2010
CARGLUMIC ACID
AB NAVINTA LLC 200MG A213395 001 Jun 22, 2022
AB NOVITIUM PHARMA 200MG A213729 001 Oct 13, 2021
CARIPRAZINE HYDROCHLORIDE
CAPSULE;ORAL
VRAYLAR
+! ALLERGAN EQ 1.5MG BASE N204370 001 Sep 17, 2015
+ EQ 3MG BASE N204370 002 Sep 17, 2015
+ EQ 4.5MG BASE N204370 003 Sep 17, 2015
+ EQ 6MG BASE N204370 004 Sep 17, 2015
CARISOPRODOL
TABLET;ORAL
CARISOPRODOL
AA ACCELRX LABS 350MG A040576 001 Jun 07, 2005
AA AUROBINDO PHARMA 350MG A040792 001 Aug 06, 2009
AA CHARTWELL RX 350MG A040245 001 Sep 08, 1997
AA MLV 350MG A211789 001 Oct 20, 2021
AA NATCO 350MG A090988 001 Oct 28, 2014
AA NOSTRUM LABS INC 350MG A207237 002 Sep 21, 2020
AA NOVAST LABS 350MG A040823 001 Oct 22, 2008
AA ORIENT PHARMA CO 350MG A205085 001 Oct 28, 2014
LTD
AA OXFORD PHARMS 350MG A040188 001 Mar 07, 1997
AA SCIEGEN PHARMS INC 350MG A203374 001 Jan 27, 2014
AA WANBANG BIOPHARMS 350MG A081025 001 Apr 13, 1989
AA WATSON LABS 350MG A087499 001 Apr 20, 1982
AA WILSHIRE PHARMS INC 350MG A205126 002 Jul 08, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-84(of 474)

CARISOPRODOL
TABLET;ORAL
SOMA
AA + MYLAN SPECIALITY LP 350MG N011792 001
CARISOPRODOL
AB AUROBINDO PHARMA 250MG A040792 002 Nov 08, 2016
AB NOSTRUM LABS INC 250MG A207237 001 May 11, 2017
AB WILSHIRE PHARMS INC 250MG A205126 001 Jul 08, 2015
SOMA
AB +! MYLAN SPECIALITY LP 250MG N011792 004 Sep 13, 2007
CARMUSTINE
IMPLANT;INTRACRANIAL
GLIADEL
+! AZURITY 7.7MG N020637 001 Sep 23, 1996
INJECTABLE;INJECTION
BICNU
AP +! AVET LIFESCIENCES 100MG/VIAL N017422 001
CARMUSTINE
AP AMNEAL 100MG/VIAL A211229 001 Oct 16, 2018
AP DR REDDYS 100MG/VIAL A213207 001 Oct 22, 2020
AP HENGRUI PHARMA 100MG/VIAL A211202 001 Mar 12, 2021
AP INGENUS PHARMS LLC 100MG/VIAL A211011 001 Jun 21, 2022
AP MEITHEAL 100MG/VIAL A213460 001 Aug 02, 2021
AP NAVINTA LLC 100MG/VIAL A210179 001 Sep 11, 2018
AP STI PHARMA LLC 100MG/VIAL A209278 001 Apr 02, 2019
Carmustine
AP ACCORD HLTHCARE 100MG/VIAL A214117 001 Dec 27, 2022
POWDER;INTRAVENOUS
CARMUSTINE
+! ACCORD HLTHCARE 50MG/VIAL N215000 001 May 16, 2022
+! 300MG/VIAL N215000 002 May 16, 2022
CARTEOLOL HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
CARTEOLOL HYDROCHLORIDE
! SANDOZ INC 1% A075476 001 Jan 03, 2000
CARVEDILOL
TABLET;ORAL
CARVEDILOL
AB AUROBINDO PHARMA 3.125MG A078332 001 Sep 05, 2007
AB 6.25MG A078332 002 Sep 05, 2007
AB 12.5MG A078332 003 Sep 05, 2007
AB 25MG A078332 004 Sep 05, 2007
AB BEXIMCO USA 3.125MG A078384 001 Sep 05, 2007
AB 6.25MG A078384 002 Sep 05, 2007
AB 12.5MG A078384 003 Sep 05, 2007
AB 25MG A078384 004 Sep 05, 2007
AB CHARTWELL MOLECULAR 3.125MG A077474 001 Sep 05, 2007
AB 6.25MG A077474 002 Sep 05, 2007
AB 12.5MG A077474 003 Sep 05, 2007
AB 25MG A077474 004 Sep 05, 2007
AB DR REDDYS LABS LTD 3.125MG A076649 001 Sep 05, 2007
AB 6.25MG A076649 002 Sep 05, 2007
AB 12.5MG A076649 003 Sep 05, 2007
AB 25MG A076649 004 Sep 05, 2007
AB GLENMARK GENERICS 3.125MG A078251 001 Sep 05, 2007
AB 6.25MG A078251 002 Sep 05, 2007
AB 12.5MG A078251 003 Sep 05, 2007
AB 25MG A078251 004 Sep 05, 2007
AB LUPIN 3.125MG A078217 001 Sep 05, 2007
AB 6.25MG A078217 002 Sep 05, 2007
AB 12.5MG A078217 003 Sep 05, 2007
AB 25MG A078217 004 Sep 05, 2007
AB MYLAN 3.125MG A077316 001 Sep 05, 2007
AB 6.25MG A077316 002 Sep 05, 2007
AB 12.5MG A077316 003 Sep 05, 2007
AB 25MG A077316 004 Sep 05, 2007
AB RUBICON 3.125MG A078165 001 Sep 05, 2007
AB 6.25MG A078165 002 Sep 05, 2007
AB 12.5MG A078165 003 Sep 05, 2007
AB 25MG A078165 004 Sep 05, 2007
AB SANDOZ 3.125MG A078227 001 Sep 05, 2007
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-85(of 474)

CARVEDILOL
TABLET;ORAL
CARVEDILOL
AB 6.25MG A078227 002 Sep 05, 2007
AB 12.5MG A078227 003 Sep 05, 2007
AB 25MG A078227 004 Sep 05, 2007
AB SUN PHARM INDS LTD 3.125MG A076989 001 Sep 05, 2007
AB 6.25MG A076989 002 Sep 05, 2007
AB 12.5MG A076989 003 Sep 05, 2007
AB 25MG A076989 004 Sep 05, 2007
AB TARO 3.125MG A077780 001 Sep 05, 2007
AB 6.25MG A077780 002 Sep 05, 2007
AB 12.5MG A077780 003 Sep 05, 2007
AB 25MG A077780 004 Sep 05, 2007
AB TEVA 3.125MG A076373 001 Sep 05, 2007
AB 6.25MG A076373 002 Sep 05, 2007
AB 12.5MG A076373 003 Sep 05, 2007
AB 25MG A076373 004 Sep 05, 2007
AB ZYDUS PHARMS USA 3.125MG A077614 004 Sep 05, 2007
INC
AB 6.25MG A077614 001 Sep 05, 2007
AB 12.5MG A077614 002 Sep 05, 2007
AB 25MG A077614 003 Sep 05, 2007
COREG
AB + WOODWARD 3.125MG N020297 004 May 29, 1997
AB + 6.25MG N020297 003 Sep 14, 1995
AB +! 12.5MG N020297 002 Sep 14, 1995
AB + 25MG N020297 001 Sep 14, 1995
CARVEDILOL PHOSPHATE
CAPSULE, EXTENDED RELEASE;ORAL
CARVEDILOL PHOSPHATE
AB IMPAX LABS INC 10MG A204717 001 May 07, 2018
AB 20MG A204717 002 May 07, 2018
AB 40MG A204717 003 May 07, 2018
AB 80MG A204717 004 May 07, 2018
AB SUN PHARM 10MG A090132 001 Oct 25, 2017
INDUSTRIES
AB 20MG A090132 002 Oct 25, 2017
AB 40MG A090132 003 Oct 25, 2017
AB 80MG A090132 004 Oct 25, 2017
COREG CR
AB + WOODWARD 10MG N022012 001 Oct 20, 2006
AB + 20MG N022012 002 Oct 20, 2006
AB +! 40MG N022012 003 Oct 20, 2006
AB + 80MG N022012 004 Oct 20, 2006
CASIMERSEN
SOLUTION;INTRAVENOUS
AMONDYS 45
+! SAREPTA THERAPS INC 100MG/2ML (50MG/ML) N213026 001 Feb 25, 2021
CASPOFUNGIN ACETATE
POWDER;INTRAVENOUS
CANCIDAS
AP +! MERCK 50MG/VIAL N021227 001 Jan 26, 2001
AP +! 70MG/VIAL N021227 002 Jan 26, 2001
CASPOFUNGIN ACETATE
AP FRESENIUS KABI USA 50MG/VIAL N206110 001 Dec 30, 2016
AP 70MG/VIAL N206110 002 Dec 30, 2016
AP GLAND 50MG/VIAL A207092 001 Sep 29, 2017
AP 70MG/VIAL A207092 002 Sep 29, 2017
AP HENGRUI PHARMA 50MG/VIAL A200833 001 Jun 28, 2018
AP 70MG/VIAL A200833 002 Jun 28, 2018
AP UBI 50MG/VIAL A211263 001 Oct 01, 2021
AP 70MG/VIAL A211263 002 Oct 01, 2021
CEDAZURIDINE; DECITABINE
TABLET;ORAL
INQOVI
+! OTSUKA 100MG;35MG N212576 001 Jul 07, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-86(of 474)

CEFACLOR
CAPSULE;ORAL
CEFACLOR
AB HIKMA EQ 250MG BASE A065350 001 Apr 03, 2007
AB ! EQ 500MG BASE A065350 002 Apr 03, 2007
AB YUNG SHIN PHARM EQ 250MG BASE A065146 001 Jan 22, 2004
AB EQ 500MG BASE A065146 002 Jan 22, 2004
FOR SUSPENSION;ORAL
CEFACLOR
YUNG SHIN PHARM EQ 125MG BASE/5ML A065412 001 Feb 17, 2012
EQ 187MG BASE/5ML A065412 002 Feb 17, 2012
EQ 250MG BASE/5ML A065412 003 Feb 17, 2012
! EQ 375MG BASE/5ML A065412 004 Feb 17, 2012
TABLET, EXTENDED RELEASE;ORAL
CEFACLOR
TEVA EQ 375MG BASE A065058 001 Sep 04, 2002
! EQ 500MG BASE A065058 002 Sep 04, 2002
CEFADROXIL/CEFADROXIL HEMIHYDRATE
CAPSULE;ORAL
CEFADROXIL
AB AUROBINDO PHARMA EQ 500MG BASE A065352 001 Jan 25, 2007
AB HIKMA EQ 500MG BASE A065311 001 Feb 07, 2006
AB LUPIN EQ 500MG BASE A065392 001 May 29, 2007
AB ! TEVA PHARMS EQ 500MG BASE A065282 001 Jan 20, 2006
FOR SUSPENSION;ORAL
CEFADROXIL
AB AUROBINDO EQ 250MG BASE/5ML A065349 001 Apr 25, 2013
AB EQ 500MG BASE/5ML A065349 002 Apr 25, 2013
AB HIKMA PHARMS EQ 250MG BASE/5ML A091036 001 Nov 28, 2012
AB EQ 500MG BASE/5ML A091036 002 Nov 28, 2012
AB LUPIN EQ 250MG BASE/5ML A065396 001 Feb 21, 2008
AB ! EQ 500MG BASE/5ML A065396 002 Feb 21, 2008
TABLET;ORAL
CEFADROXIL
AB HIKMA EQ 1GM BASE A065260 001 Mar 30, 2006
AB ! TEVA PHARMS EQ 1GM BASE A062774 001 Apr 08, 1987
CEFAZOLIN SODIUM
INJECTABLE;INJECTION
CEFAZOLIN SODIUM
AP ACS DOBFAR EQ 500MG BASE/VIAL A065303 001 Oct 22, 2008
AP EQ 1GM BASE/VIAL A065303 002 Oct 22, 2008
AP EQ 10GM BASE/VIAL A065306 001 Oct 22, 2008
AP ! HIKMA FARMACEUTICA EQ 500MG BASE/VIAL A065047 001 Sep 18, 2001
AP ! EQ 1GM BASE/VIAL A065047 002 Sep 18, 2001
AP EQ 10GM BASE/VIAL A065143 001 Oct 18, 2004
AP QILU EQ 1GM BASE/VIAL A203661 001 Dec 28, 2015
AP ! EQ 10GM BASE/VIAL A209217 001 Oct 17, 2018
AP SANDOZ EQ 500MG BASE/VIAL A062831 001 Dec 09, 1988
AP EQ 1GM BASE/VIAL A062831 002 Dec 09, 1988
AP EQ 1GM BASE/VIAL A065345 001 May 09, 2007
AP EQ 10GM BASE/VIAL A062831 003 Sep 25, 1992
ANCEF IN PLASTIC CONTAINER
! BAXTER HLTHCARE EQ 20MG BASE/ML A063002 002 Mar 28, 1991
CEFAZOLIN AND DEXTROSE
+! B BRAUN EQ 1GM BASE/VIAL N050779 002 Jul 27, 2000
+ EQ 2GM BASE/VIAL N050779 003 Jan 13, 2012
CEFAZOLIN SODIUM
! ACS DOBFAR EQ 20GM BASE/VIAL A065306 002 Aug 18, 2014
QILU EQ 2GM BASE/VIAL A203661 002 Mar 11, 2022
! SAMSON MEDCL EQ 100GM BASE/VIAL A065141 001 Nov 29, 2006
! EQ 300GM BASE/VIAL A065141 002 Nov 29, 2006
POWDER;INTRAVENOUS
CEFAZOLIN SODIUM
+! HIKMA EQ 2GM BASE/VIAL N216109 001 Oct 07, 2022
+! EQ 3GM BASE/VIAL N216109 002 Oct 07, 2022
SOLUTION;INTRAVENOUS
CEFAZOLIN IN PLASTIC CONTAINER
+! BAXTER HLTHCARE EQ 1GM BASE/50ML (EQ 20MG BASE/ML) N207131 002 Feb 01, 2021
CORP
+! EQ 2GM BASE/100ML (EQ 20MG BASE/ML) N207131 001 Aug 07, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-87(of 474)

CEFDINIR
CAPSULE;ORAL
CEFDINIR
AB ALKEM LABS LTD 300MG A210220 001 Feb 19, 2021
AB AUROBINDO PHARMA 300MG A065434 001 Jan 07, 2008
AB LUPIN 300MG A065264 001 May 19, 2006
AB ORCHID HLTHCARE 300MG A065418 001 Jul 18, 2007
AB ! SANDOZ 300MG A065330 001 Apr 06, 2007
AB TEVA PHARMS 300MG A065368 001 May 09, 2007
FOR SUSPENSION;ORAL
CEFDINIR
AB ALKEM LABS LTD 125MG/5ML A210534 001 Feb 19, 2021
AB 250MG/5ML A210534 002 Feb 19, 2021
AB AUROBINDO PHARMA 125MG/5ML A065473 001 Dec 14, 2007
AB ! 250MG/5ML A065473 002 Dec 14, 2007
AB LUPIN 125MG/5ML A065259 001 May 31, 2006
AB 250MG/5ML A065259 002 May 07, 2007
AB ORCHID HLTHCARE 125MG/5ML A065429 001 Jul 18, 2007
AB 250MG/5ML A065429 002 Jul 18, 2007
AB SANDOZ 125MG/5ML A065337 001 Apr 06, 2007
AB 250MG/5ML A065337 002 Apr 06, 2007
AB TEVA PHARMS 125MG/5ML A065332 001 May 04, 2007
AB 250MG/5ML A065332 002 May 04, 2007
CEFEPIME HYDROCHLORIDE
INJECTABLE;INJECTION
CEFEPIME HYDROCHLORIDE
AP ACS DOBFAR EQ 1GM BASE/VIAL A065441 001 Mar 20, 2008
AP EQ 2GM BASE/VIAL A065441 002 Mar 20, 2008
AP ASTRAL EQ 1GM BASE/VIAL A212721 001 Jul 21, 2020
AP EQ 2GM BASE/VIAL A212721 002 Jul 21, 2020
AP QILU EQ 500MG BASE/VIAL A203704 001 Feb 01, 2016
AP EQ 1GM BASE/VIAL A203704 002 Feb 01, 2016
AP EQ 2GM BASE/VIAL A203704 003 Feb 01, 2016
AP SAGENT PHARMS INC EQ 1GM BASE/VIAL A091048 001 Jan 04, 2017
AP EQ 2GM BASE/VIAL A091048 002 Jan 04, 2017
MAXIPIME
AP +! HOSPIRA INC EQ 500MG BASE/VIAL N050679 001 Jan 18, 1996
AP +! EQ 1GM BASE/VIAL N050679 002 Jan 18, 1996
AP +! EQ 2GM BASE/VIAL N050679 003 Jan 18, 1996
CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER
B BRAUN EQ 1GM BASE/VIAL N050821 001 May 06, 2010
EQ 2GM BASE/VIAL N050821 002 May 06, 2010
CEFEPIME IN PLASTIC CONTAINER
+! BAXTER HLTHCARE EQ 1GM BASE/50ML (EQ 20MG BASE/ML) N050817 001 Aug 05, 2008
+! EQ 2GM BASE/100ML (EQ 20MG BASE/ML) N050817 002 Aug 05, 2008
POWDER;INTRAVENOUS
CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER
SAMSON MEDCL EQ 100GM BASE A209408 001 Aug 21, 2018
CEFIDEROCOL SULFATE TOSYLATE
POWDER;INTRAVENOUS
FETROJA
+! SHIONOGI INC EQ 1GM BASE/VIAL N209445 001 Nov 14, 2019
CEFIXIME
CAPSULE;ORAL
CEFIXIME
AB ALKEM LABS LTD 400MG A210574 001 Oct 09, 2018
SUPRAX
AB +! LUPIN LTD 400MG N203195 001 Jun 01, 2012
FOR SUSPENSION;ORAL
CEFIXIME
AB ALKEM LABS LTD 100MG/5ML A211775 001 Feb 19, 2021
AB 200MG/5ML A211775 002 Feb 19, 2021
AB AUROBINDO PHARMA 100MG/5ML A204835 001 Apr 14, 2015
LTD
AB 200MG/5ML A204835 002 Apr 14, 2015
AB BELCHER 100MG/5ML A206938 001 Feb 06, 2017
AB 200MG/5ML A206938 002 Feb 06, 2017
AB 500MG/5ML A206939 001 Feb 06, 2017
SUPRAX
AB +! LUPIN LTD 500MG/5ML N202091 001 Feb 20, 2013
AB ! LUPIN PHARMS 200MG/5ML A065355 001 Apr 10, 2007
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-88(of 474)

CEFIXIME
TABLET, CHEWABLE;ORAL
SUPRAX
LUPIN LTD 100MG A065380 001 Oct 25, 2010
150MG A065380 002 Oct 25, 2010
! 200MG A065380 003 Oct 25, 2010
CEFOTAXIME SODIUM
INJECTABLE;INJECTION
CEFOTAXIME
! HIKMA EQ 500MG BASE/VIAL A065072 001 Nov 20, 2002
! EQ 1GM BASE/VIAL A065072 002 Nov 20, 2002
! EQ 2GM BASE/VIAL A065072 003 Nov 20, 2002
! EQ 10GM BASE/VIAL A065071 001 Nov 20, 2002
CEFOTETAN DISODIUM
INJECTABLE;INJECTION
CEFOTAN
AP + PAI HOLDINGS PHARM EQ 1GM BASE/VIAL N050588 001 Dec 27, 1985
AP + EQ 2GM BASE/VIAL N050588 002 Dec 27, 1985
CEFOTETAN
AP ! FRESENIUS KABI USA EQ 1GM BASE/VIAL A065374 001 Aug 09, 2007
AP ! EQ 2GM BASE/VIAL A065374 002 Aug 09, 2007
CEFOXITIN SODIUM
INJECTABLE;INJECTION
CEFOXITIN
AP ! ACS DOBFAR EQ 1GM BASE/VIAL A065414 001 Jun 12, 2009
AP ! EQ 2GM BASE/VIAL A065414 002 Jun 12, 2009
AP ! EQ 10GM BASE/VIAL A065415 001 May 19, 2010
AP HIKMA EQ 1GM BASE/VIAL A065051 001 Sep 11, 2000
AP EQ 2GM BASE/VIAL A065051 002 Sep 11, 2000
AP EQ 10GM BASE/VIAL A065050 001 Sep 11, 2000
AP HIKMA FARMACEUTICA EQ 1GM BASE/VIAL A065238 001 Mar 12, 2010
AP EQ 2GM BASE/VIAL A065238 002 Mar 12, 2010
AP EQ 10GM BASE/VIAL A065239 001 Mar 02, 2010
CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER
AP +! B BRAUN EQ 1GM BASE/VIAL N065214 001 Mar 10, 2006
AP +! EQ 2GM BASE/VIAL N065214 002 Mar 10, 2006
POWDER;INTRAVENOUS
CEFOXITIN IN PLASTIC CONTAINER
SAMSON MEDCL EQ 100GM BASE A200938 001 Nov 16, 2015
CEFPODOXIME PROXETIL
FOR SUSPENSION;ORAL
CEFPODOXIME PROXETIL
AUROBINDO PHARMA EQ 50MG BASE/5ML A065409 001 Jun 08, 2007
LTD
! EQ 100MG BASE/5ML A065409 002 Jun 08, 2007
TABLET;ORAL
CEFPODOXIME PROXETIL
AB ALKEM LABS LTD EQ 100MG BASE A210568 001 May 18, 2022
AB EQ 200MG BASE A210568 002 May 18, 2022
AB AUROBINDO PHARMA EQ 100MG BASE A065370 001 Jun 11, 2007
AB EQ 200MG BASE A065370 002 Jun 11, 2007
AB ORCHID HLTHCARE EQ 100MG BASE A065388 001 Nov 14, 2007
AB EQ 200MG BASE A065388 002 Nov 14, 2007
AB SANDOZ EQ 100MG BASE A065462 001 May 28, 2008
AB ! EQ 200MG BASE A065462 002 May 28, 2008
CEFPROZIL
FOR SUSPENSION;ORAL
CEFPROZIL
AB APOTEX INC 125MG/5ML A065351 001 Feb 29, 2012
AB 250MG/5ML A065351 002 Feb 29, 2012
AB AUROBINDO PHARMA 125MG/5ML A065381 001 Jan 30, 2007
AB 250MG/5ML A065381 002 Jan 30, 2007
AB LUPIN 125MG/5ML A065261 001 Dec 19, 2005
AB ! 250MG/5ML A065261 002 Dec 19, 2005
TABLET;ORAL
CEFPROZIL
AB APOTEX INC 250MG A065327 001 Mar 26, 2008
AB 500MG A065327 002 Mar 26, 2008
AB AUROBINDO PHARMA 250MG A065340 001 May 24, 2007
AB 500MG A065340 002 May 24, 2007
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-89(of 474)

CEFPROZIL
TABLET;ORAL
CEFPROZIL
AB CHARTWELL RX 250MG A065235 001 Nov 14, 2005
AB 500MG A065235 002 Nov 14, 2005
AB LUPIN 250MG A065276 001 Dec 08, 2005
AB ! 500MG A065276 002 Dec 08, 2005
AB TEVA 250MG A065208 001 Dec 06, 2005
AB 500MG A065208 002 Dec 06, 2005
CEFTAROLINE FOSAMIL
POWDER;INTRAVENOUS
TEFLARO
+! ALLERGAN 400MG/VIAL N200327 001 Oct 29, 2010
+! 600MG/VIAL N200327 002 Oct 29, 2010
CEFTAZIDIME
INJECTABLE;INJECTION
CEFTAZIDIME
AP ACS DOBFAR 1GM/VIAL A062640 002 Nov 20, 1985
AP 2GM/VIAL A062640 003 Nov 20, 1985
AP 6GM/VIAL A062640 004 Feb 03, 1992
FORTAZ
AP +! PAI HOLDINGS PHARM 500MG/VIAL N050578 001 Jul 19, 1985
AP +! 1GM/VIAL N050578 002 Jul 19, 1985
AP +! 2GM/VIAL N050578 003 Jul 19, 1985
AP +! 6GM/VIAL N050578 004 Jul 19, 1985
TAZICEF
AP HOSPIRA 500MG/VIAL A062662 001 Mar 06, 1986
AP 1GM/VIAL A062662 002 Mar 06, 1986
AP 1GM/VIAL A064032 001 Oct 31, 1993
AP 2GM/VIAL A062662 003 Mar 06, 1986
AP 2GM/VIAL A064032 002 Oct 31, 1993
AP 6GM/VIAL A062662 004 Mar 06, 1986
CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
POWDER;INTRAVENOUS
ZERBAXA
+! CUBIST PHARMS LLC EQ 1GM BASE/VIAL;EQ 0.5GM BASE/VIAL N206829 001 Dec 19, 2014
CEFTRIAXONE SODIUM
INJECTABLE;INJECTION
CEFTRIAXONE
AP ACS DOBFAR EQ 500MG BASE/VIAL A065329 001 Jul 24, 2008
AP EQ 1GM BASE/VIAL A065329 002 Jul 24, 2008
AP EQ 2GM BASE/VIAL A065329 003 Jul 24, 2008
AP EQ 10GM BASE/VIAL A065328 001 Jul 24, 2008
AP QILU EQ 10GM BASE/VIAL A209218 001 Oct 17, 2018
AP ! SANDOZ EQ 10GM BASE/VIAL A065168 001 May 17, 2005
AP ! SANDOZ INC EQ 1GM BASE/VIAL A065204 001 May 03, 2005
AP ! EQ 2GM BASE/VIAL A065204 002 May 03, 2005
AP WOCKHARDT EQ 1GM BASE/VIAL A065180 001 May 12, 2006
CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER
AP +! B BRAUN EQ 1GM BASE/VIAL N050796 001 Apr 20, 2005
AP +! EQ 2GM BASE/VIAL N050796 002 Apr 20, 2005
CEFTRIAXONE SODIUM
AP ASTRAL EQ 10GM BASE/VIAL A091117 001 Jan 20, 2017
AP HIKMA EQ 10GM BASE/VIAL A090701 001 Oct 04, 2017
CEFTRIAXONE
SAMSON MEDCL EQ 100GM BASE/VIAL A090057 001 Apr 25, 2014
CEFTRIAXONE IN PLASTIC CONTAINER
! BAXTER HLTHCARE EQ 20MG BASE/ML A065224 001 Aug 23, 2005
! EQ 40MG BASE/ML A065224 002 Aug 23, 2005
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS
CEFTRIAXONE
AP AKORN EQ 250MG BASE/VIAL A065305 001 Jan 11, 2008
AP EQ 500MG BASE/VIAL A065305 002 Jan 11, 2008
AP EQ 1GM BASE/VIAL A065305 003 Jan 11, 2008
AP EQ 2GM BASE/VIAL A065305 004 Jan 11, 2008
AP ASTRAL EQ 250MG BASE/VIAL A091049 001 Jun 11, 2018
AP EQ 500MG BASE/VIAL A091049 002 Jun 11, 2018
AP EQ 1GM BASE/VIAL A091049 003 Jun 11, 2018
AP EQ 2GM BASE/VIAL A091049 004 Jun 11, 2018
AP HIKMA FARMACEUTICA EQ 250MG BASE/VIAL A065342 001 Jan 10, 2008
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-90(of 474)

CEFTRIAXONE SODIUM
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS
CEFTRIAXONE
AP EQ 500MG BASE/VIAL A065342 002 Jan 10, 2008
AP EQ 1GM BASE/VIAL A065342 003 Jan 10, 2008
AP EQ 2GM BASE/VIAL A065342 004 Jan 10, 2008
AP QILU EQ 250MG BASE/VIAL A203702 001 Jun 29, 2016
AP EQ 500MG BASE/VIAL A203702 002 Jun 29, 2016
AP EQ 1GM BASE/VIAL A203702 003 Jun 29, 2016
AP EQ 2GM BASE/VIAL A203702 004 Jun 29, 2016
AP ! SANDOZ EQ 250MG BASE/VIAL A065169 001 May 09, 2005
AP ! EQ 500MG BASE/VIAL A065169 002 May 09, 2005
AP ! EQ 1GM BASE/VIAL A065169 003 May 09, 2005
AP ! EQ 2GM BASE/VIAL A065169 004 May 09, 2005
AP WOCKHARDT EQ 250MG BASE/VIAL A065391 001 Apr 12, 2007
AP EQ 500MG BASE/VIAL A065391 002 Apr 12, 2007
AP EQ 2GM BASE/VIAL A065391 003 Apr 12, 2007
CEFUROXIME AXETIL
TABLET;ORAL
CEFUROXIME AXETIL
AB ALKEM LABS LTD EQ 250MG BASE A065496 001 Jun 07, 2010
AB EQ 500MG BASE A065496 002 Jun 07, 2010
AB APOTEX EQ 250MG BASE A065069 001 Oct 02, 2002
AB EQ 500MG BASE A065069 002 Oct 02, 2002
AB AUROBINDO PHARMA EQ 125MG BASE A065308 001 Mar 29, 2006
AB EQ 250MG BASE A065308 002 Mar 29, 2006
AB EQ 500MG BASE A065308 003 Mar 29, 2006
AB CHARTWELL RX EQ 125MG BASE A065166 001 Jul 29, 2005
AB EQ 250MG BASE A065166 002 Jul 29, 2005
AB EQ 500MG BASE A065166 003 Jul 29, 2005
AB LUPIN EQ 250MG BASE A065135 001 Jul 25, 2003
AB ! EQ 500MG BASE A065135 002 Jul 25, 2003
AB ORCHID HLTHCARE EQ 125MG BASE A065359 001 Feb 15, 2008
AB EQ 250MG BASE A065359 002 Feb 15, 2008
AB EQ 500MG BASE A065359 003 Feb 15, 2008
CEFUROXIME SODIUM
INJECTABLE;INJECTION
CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER
AP +! B BRAUN EQ 750MG BASE/VIAL N050780 001 Feb 21, 2001
AP +! EQ 1.5GM BASE/VIAL N050780 002 Feb 21, 2001
CEFUROXIME SODIUM
AP ACS DOBFAR SPA EQ 1.5GM BASE/VIAL A064125 002 May 30, 1997
AP EQ 7.5GM BASE/VIAL A064124 001 May 30, 1997
AP HIKMA FARMACEUTICA EQ 1.5GM BASE/VIAL A065048 002 Jan 09, 2004
AP EQ 7.5GM BASE/VIAL A065046 001 Jan 09, 2004
ZINACEF
AP +! PAI HOLDINGS PHARM EQ 1.5GM BASE/VIAL N050558 003 Oct 19, 1983
AP +! EQ 7.5GM BASE/VIAL N050558 004 Oct 23, 1986
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS
CEFUROXIME SODIUM
AB ACS DOBFAR SPA EQ 750MG BASE/VIAL A064125 001 May 30, 1997
AB HIKMA FARMACEUTICA EQ 750MG BASE/VIAL A065048 001 Jan 09, 2004
ZINACEF
AB +! PAI HOLDINGS PHARM EQ 750MG BASE/VIAL N050558 002 Oct 19, 1983
CELECOXIB
CAPSULE;ORAL
CELEBREX
AB + UPJOHN 50MG N020998 004 Dec 15, 2006
AB + 100MG N020998 001 Dec 31, 1998
AB + 200MG N020998 002 Dec 31, 1998
AB +! 400MG N020998 003 Aug 29, 2002
CELECOXIB
AB ALEMBIC PHARMS 50MG A204519 001 Aug 21, 2015
AB 100MG A204519 002 Aug 21, 2015
AB 200MG A204519 003 Aug 21, 2015
AB 400MG A204519 004 Aug 21, 2015
AB APOTEX INC 50MG A204197 001 Jun 02, 2015
AB 100MG A204197 002 Jun 02, 2015
AB 200MG A204197 003 Jun 02, 2015
AB AUROBINDO PHARMA 50MG A206827 001 Feb 01, 2016
AB 100MG A206827 002 Feb 01, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-91(of 474)

CELECOXIB
CAPSULE;ORAL
CELECOXIB
AB 200MG A206827 003 Feb 01, 2016
AB 400MG A206827 004 Feb 01, 2016
AB CADILA PHARMS LTD 50MG A208701 001 Nov 14, 2019
AB 100MG A208701 002 Nov 14, 2019
AB 200MG A208701 003 Nov 14, 2019
AB 400MG A208701 004 Nov 14, 2019
AB CIPLA 50MG A207446 001 Sep 23, 2015
AB 100MG A207446 002 Sep 23, 2015
AB 200MG A207446 003 Sep 23, 2015
AB 400MG A207446 004 Sep 23, 2015
AB CSPC OUYI 50MG A210071 001 Jan 23, 2018
AB 100MG A210071 002 Jan 23, 2018
AB 200MG A210071 003 Jan 23, 2018
AB LUPIN LTD 50MG A202240 001 Oct 29, 2014
AB 100MG A202240 002 Jun 09, 2015
AB 200MG A202240 003 Jun 09, 2015
AB 400MG A202240 004 Jun 09, 2015
AB MACLEODS PHARMS LTD 50MG A204590 001 Mar 16, 2016
AB 100MG A204590 002 Mar 16, 2016
AB 200MG A204590 003 Mar 16, 2016
AB 400MG A204590 004 Mar 16, 2016
AB MICRO LABS 50MG A204776 001 Apr 30, 2018
AB 100MG A204776 002 Apr 30, 2018
AB 200MG A204776 003 Apr 30, 2018
AB 400MG A204776 004 Apr 30, 2018
AB MYLAN 50MG A078857 001 May 30, 2014
AB 100MG A078857 002 Feb 11, 2015
AB 200MG A078857 003 Feb 11, 2015
AB 400MG A078857 004 Feb 11, 2015
AB NANJING 200MG A213598 001 May 13, 2020
AB QINGDAO BAHEAL 50MG A208856 001 Aug 07, 2019
PHARM
AB 100MG A208856 002 Aug 07, 2019
AB 200MG A208856 003 Aug 07, 2019
AB 400MG A208856 004 Aug 07, 2019
AB SCIEGEN PHARMS INC 50MG A205129 001 Dec 03, 2020
AB 100MG A205129 002 Dec 03, 2020
AB 200MG A205129 003 Dec 03, 2020
AB 400MG A205129 004 Dec 03, 2020
AB TEVA 50MG A076898 001 May 30, 2014
AB 100MG A076898 002 May 30, 2014
AB 200MG A076898 003 May 30, 2014
AB 400MG A076898 004 May 30, 2014
AB TIANJIN TIANYAO 50MG A207872 001 Feb 25, 2020
AB 100MG A207872 002 Feb 25, 2020
AB 200MG A207872 003 Feb 25, 2020
AB 400MG A207872 004 Feb 25, 2020
AB TORRENT 50MG A207677 001 Dec 23, 2015
AB 100MG A207677 002 Dec 23, 2015
AB 200MG A207677 003 Dec 23, 2015
AB 400MG A207677 004 Dec 23, 2015
AB UMEDICA LABS PVT 50MG A210628 001 Nov 27, 2019
LTD
AB 100MG A210628 002 Nov 27, 2019
AB 200MG A210628 003 Nov 27, 2019
AB 400MG A210628 004 Nov 27, 2019
AB WATSON LABS INC 50MG A200562 001 Feb 11, 2015
AB 100MG A200562 002 Feb 11, 2015
AB 200MG A200562 003 Feb 11, 2015
AB 400MG A200562 004 Feb 11, 2015
AB YILING 50MG A211412 001 Mar 06, 2020
AB 100MG A211412 002 Mar 06, 2020
AB 200MG A211412 003 Mar 06, 2020
AB 400MG A211412 004 Mar 06, 2020
BX AMNEAL PHARMS 50MG A208833 001 May 31, 2018
BX 100MG A208833 002 May 31, 2018
BX 200MG A208833 003 May 31, 2018
BX 400MG A208833 004 May 31, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-92(of 474)

CELECOXIB; TRAMADOL HYDROCHLORIDE


TABLET;ORAL
SEGLENTIS
+! KOWA PHARMS 56MG;44MG N213426 001 Oct 15, 2021
CENOBAMATE
TABLET;ORAL
XCOPRI
+! SK LIFE 12.5MG N212839 001 Mar 10, 2020
+ 25MG N212839 002 Mar 10, 2020
+ 50MG N212839 003 Mar 10, 2020
+ 100MG N212839 004 Mar 10, 2020
+ 150MG N212839 005 Mar 10, 2020
+ 200MG N212839 006 Mar 10, 2020
CEPHALEXIN
CAPSULE;ORAL
CEPHALEXIN
AB ALKEM LABS LTD EQ 250MG BASE A090836 001 Dec 20, 2010
AB EQ 500MG BASE A090836 002 Dec 20, 2010
AB AUROBINDO PHARMA EQ 250MG BASE A065253 001 Nov 16, 2005
AB EQ 500MG BASE A065253 002 Nov 16, 2005
AB BELCHER PHARMS EQ 250MG BASE A062713 001 Jul 15, 1988
AB EQ 500MG BASE A062713 002 Jul 15, 1988
AB CHARTWELL RX EQ 250MG BASE A065152 001 Feb 24, 2005
AB EQ 500MG BASE A065152 002 Feb 24, 2005
AB HIKMA EQ 250MG BASE A065215 001 Jan 24, 2006
AB EQ 500MG BASE A065215 002 Jan 24, 2006
AB LUPIN EQ 250MG BASE A065229 001 Nov 25, 2005
AB EQ 500MG BASE A065229 002 Nov 25, 2005
AB ORCHID HLTHCARE EQ 250MG BASE A065248 001 Jun 28, 2005
AB EQ 500MG BASE A065248 002 Jun 28, 2005
AB TEVA EQ 250MG BASE A062702 001 Feb 13, 1987
AB EQ 500MG BASE A062702 002 Feb 13, 1987
ALKEM LABS LTD EQ 333MG BASE A090836 003 Mar 29, 2013
! EQ 750MG BASE A090836 004 Mar 29, 2013
FOR SUSPENSION;ORAL
CEPHALEXIN
AB ALKEM LABS LTD EQ 125MG BASE/5ML A210221 001 Mar 26, 2019
AB EQ 250MG BASE/5ML A210221 002 Mar 26, 2019
AB LUPIN EQ 125MG BASE/5ML A065234 001 Aug 17, 2005
AB EQ 250MG BASE/5ML A065234 002 Aug 17, 2005
AB TEVA EQ 125MG BASE/5ML A062703 001 Feb 13, 1987
AB ! EQ 250MG BASE/5ML A062703 002 Feb 13, 1987
AB YUNG SHIN PHARM EQ 125MG BASE/5ML A065336 001 Jul 25, 2007
AB EQ 250MG BASE/5ML A065336 002 Jul 25, 2007
TABLET;ORAL
CEPHALEXIN
TEVA EQ 250MG BASE A063023 001 Jan 12, 1989
! EQ 500MG BASE A063024 001 Jan 12, 1989
CERITINIB
TABLET;ORAL
ZYKADIA
+! NOVARTIS 150MG N211225 001 Mar 18, 2019
CETIRIZINE HYDROCHLORIDE
SOLUTION;INTRAVENOUS
QUZYTTIR
+! JDP 10MG/ML (10MG/ML) N211415 001 Oct 04, 2019
SOLUTION/DROPS;OPHTHALMIC
ZERVIATE
+! EYEVANCE EQ 0.24% BASE N208694 001 May 30, 2017
SYRUP;ORAL
CETIRIZINE HYDROCHLORIDE
AA AMNEAL PHARMS 5MG/5ML A090766 001 Oct 07, 2009
AA BAJAJ 5MG/5ML A090191 001 Nov 12, 2009
AA BRECKENRIDGE 5MG/5ML A078488 001 Oct 06, 2008
AA CHARTWELL MOLECULAR 5MG/5ML A078876 001 May 11, 2012
AA ! PADAGIS US 5MG/5ML A078398 001 Jun 17, 2008
AA TARO 5MG/5ML A076601 001 Jun 20, 2008
AA TEVA PHARMS 5MG/5ML A077279 001 May 27, 2008
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-93(of 474)

CETRORELIX ACETATE
POWDER;SUBCUTANEOUS
CETRORELIX ACETATE
AP AKORN EQ 0.25MG BASE/VIAL A215737 001 Aug 12, 2022
CETROTIDE
AP +! EMD SERONO INC EQ 0.25MG BASE/VIAL N021197 001 Aug 11, 2000
CEVIMELINE HYDROCHLORIDE
CAPSULE;ORAL
CEVIMELINE HYDROCHLORIDE
AB HIKMA 30MG A091591 001 Jul 08, 2013
AB NOVEL LABS INC 30MG A204746 001 Dec 30, 2016
AB RISING 30MG A203775 001 Jun 04, 2014
EVOXAC
AB +! COSETTE 30MG N020989 002 Jan 11, 2000
CHENODIOL
TABLET;ORAL
CHENODIOL
! LGM PHARMA 250MG A091019 001 Oct 22, 2009
CHLORAMBUCIL
TABLET;ORAL
LEUKERAN
+! WOODWARD SPECL 2MG N010669 002
CHLORAMPHENICOL SODIUM SUCCINATE
INJECTABLE;INJECTION
CHLORAMPHENICOL SODIUM SUCCINATE
! FRESENIUS KABI USA EQ 1GM BASE/VIAL A062365 001 Aug 25, 1982
CHLORDIAZEPOXIDE HYDROCHLORIDE
CAPSULE;ORAL
CHLORDIAZEPOXIDE HYDROCHLORIDE
AB BARR 5MG A084768 001
AB 10MG A083116 001
AB ! 25MG A084769 001
AB CHARTWELL RX 5MG A084678 001
AB 10MG A084041 001
AB 25MG A084679 002
LIBRIUM
AB + BAUSCH 25MG A085475 001
AB + VALEANT PHARM INTL 5MG A085461 001
AB + 10MG A085472 001
CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
CAPSULE;ORAL
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
AB ALKEM LABS LTD 5MG;2.5MG A214065 001 Apr 26, 2021
AB AMNEAL 5MG;2.5MG A215555 001 Oct 25, 2021
AB CHARTWELL RX 5MG;2.5MG A213530 001 Oct 20, 2020
AB COREPHARMA 5MG;2.5MG A215453 001 Jul 29, 2022
AB DR REDDYS 5MG;2.5MG A214698 001 May 10, 2021
AB MICRO LABS 5MG;2.5MG A215835 001 Jul 19, 2022
AB MISEMER 5MG;2.5MG A210579 001 Jul 29, 2020
AB NUVO PHARMS INC 5MG;2.5MG A211421 001 Jul 07, 2020
LIBRAX
AB +! BAUSCH 5MG;2.5MG N012750 001
CHLORHEXIDINE GLUCONATE
SOLUTION;DENTAL
CHLORHEXIDINE GLUCONATE
AT BAJAJ 0.12% A075561 001 Nov 14, 2000
AT LYNE 0.12% A074291 001 Dec 28, 1995
AT PHARM ASSOC 0.12% A074522 001 Dec 15, 1995
AT WOCKHARDT BIO AG 0.12% A075006 001 Mar 03, 2004
AT XTTRIUM 0.12% A077789 001 Jun 18, 2009
PERIDEX
AT +! 3M 0.12% N019028 001 Aug 13, 1986
PERIOGARD
AT COLGATE-PALMOLIVE 0.12% A203212 001 Jan 28, 2016
CO
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-94(of 474)

CHLOROPROCAINE HYDROCHLORIDE
GEL;OPHTHALMIC
IHEEZO
+! HARROW EYE 3% N216227 001 Sep 27, 2022
INJECTABLE;INJECTION
CHLOROPROCAINE HYDROCHLORIDE
AP HIKMA 2% A040273 001 Sep 09, 1998
AP 3% A040273 002 Sep 09, 1998
NESACAINE
AP + FRESENIUS KABI USA 2% N009435 002
NESACAINE-MPF
AP +! FRESENIUS KABI USA 2% N009435 006 May 02, 1996
AP +! 3% N009435 007 May 02, 1996
NESACAINE
+! FRESENIUS KABI USA 1% N009435 001
SOLUTION;INTRATHECAL
CLOROTEKAL
+ B BRAUN MEDICAL INC 50MG/5ML (10MG/ML) N208791 001 Sep 26, 2017
CHLOROQUINE PHOSPHATE
TABLET;ORAL
CHLOROQUINE PHOSPHATE
AA IMPAX LABS 250MG A080880 001
AA 500MG A040516 001 Aug 29, 2003
AA IPCA LABS LTD 250MG A090610 001 Dec 03, 2009
AA 500MG A090249 001 Dec 03, 2009
AA ! NATCO PHARMA LTD 250MG A091621 001 Jan 21, 2011
AA ! 500MG A090612 001 Jan 21, 2011
AA SUVEN PHARMS 500MG A214756 001 Sep 03, 2021
CHLOROTHIAZIDE
SUSPENSION;ORAL
DIURIL
+! SALIX PHARMS 250MG/5ML N011870 001
CHLOROTHIAZIDE SODIUM
INJECTABLE;INJECTION
CHLOROTHIAZIDE SODIUM
AP AM REGENT EQ 500MG BASE/VIAL A202561 001 Apr 22, 2013
AP FRESENIUS KABI USA EQ 500MG BASE/VIAL A090896 001 Oct 16, 2009
AP RK PHARMA EQ 500MG BASE/VIAL A202493 001 Jun 18, 2014
AP SAGENT PHARMS INC EQ 500MG BASE/VIAL A202462 001 May 29, 2015
AP SUN PHARM EQ 500MG BASE/VIAL A091546 001 Jul 26, 2011
DIURIL
AP +! AKORN EQ 500MG BASE/VIAL N011145 005
CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE
TABLET, EXTENDED RELEASE;ORAL
TUXARIN ER
MAINPOINTE 8MG;54.3MG N206323 001 Jun 22, 2015
CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
SOLUTION;ORAL
HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
! PADAGIS US 4MG/5ML;5MG/5ML;60MG/5ML A204627 001 Apr 29, 2014
CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX
SUSPENSION, EXTENDED RELEASE;ORAL
HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX
! TRIS PHARMA INC EQ 8MG MALEATE/5ML;EQ 10MG A091632 001 Oct 01, 2010
BITARTRATE/5ML
CHLORPROMAZINE HYDROCHLORIDE
CONCENTRATE;ORAL
CHLORPROMAZINE HYDROCHLORIDE
! GENUS 30MG/ML A214542 001 Jun 02, 2021
! 100MG/ML A214542 002 Jun 02, 2021
INJECTABLE;INJECTION
CHLORPROMAZINE HYDROCHLORIDE
AP EUGIA PHARMA 25MG/ML A211816 001 Jul 07, 2020
AP +! WEST-WARD PHARMS 25MG/ML A083329 001
INT
TABLET;ORAL
CHLORPROMAZINE HYDROCHLORIDE
AB GLENMARK PHARMS LTD 10MG A212144 001 Mar 23, 2021
AB 25MG A212144 002 Mar 23, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-95(of 474)

CHLORPROMAZINE HYDROCHLORIDE
TABLET;ORAL
CHLORPROMAZINE HYDROCHLORIDE
AB 50MG A212144 003 Mar 23, 2021
AB 100MG A212144 004 Mar 23, 2021
AB 200MG A212144 005 Mar 23, 2021
AB LANNETT CO INC 10MG A212996 001 Jan 22, 2021
AB 25MG A212996 002 Jan 22, 2021
AB 50MG A212996 003 Jan 22, 2021
AB 100MG A212996 004 Jan 22, 2021
AB 200MG A212996 005 Jan 22, 2021
AB MSN 25MG A214827 001 Jan 27, 2022
AB 50MG A214827 002 Jan 27, 2022
AB 100MG A214827 003 Jan 27, 2022
AB 200MG A214827 004 Jan 27, 2022
AB SUN PHARM 10MG A214256 001 Oct 26, 2020
AB 25MG A214256 002 Oct 26, 2020
AB 50MG A214256 003 Oct 26, 2020
AB 100MG A214256 004 Oct 26, 2020
AB 200MG A214256 005 Oct 26, 2020
AB TEVA PHARMS 10MG A215659 001 Oct 25, 2021
AB 25MG A215659 002 Oct 25, 2021
AB 50MG A215659 003 Oct 25, 2021
AB 100MG A215659 004 Oct 25, 2021
AB 200MG A215659 005 Oct 25, 2021
AB + UPSHER SMITH LABS 10MG A083386 001
AB +! 25MG A084112 001
AB + 50MG A084113 001
AB +! 100MG A084114 001
AB + 200MG A084115 001
AB ZAMEER PHARMS 10MG A212630 001 Nov 29, 2021
AB 25MG A212630 002 Nov 29, 2021
AB 50MG A212630 003 Nov 29, 2021
AB 100MG A212630 004 Nov 29, 2021
AB 200MG A212630 005 Nov 29, 2021
AB ZYDUS 10MG A213368 001 Jan 17, 2020
AB 25MG A213368 002 Jan 17, 2020
AB 50MG A213368 003 Jan 17, 2020
AB 100MG A213368 004 Jan 17, 2020
AB 200MG A213368 005 Jan 17, 2020
BX AMNEAL PHARMS CO 10MG A209755 001 Sep 10, 2018
BX 25MG A209755 002 Sep 10, 2018
BX 50MG A209755 003 Sep 10, 2018
BX 100MG A209755 004 Sep 10, 2018
BX 200MG A209755 005 Sep 10, 2018
CHLORTHALIDONE
TABLET;ORAL
CHLORTHALIDONE
AB AJANTA PHARMA LTD 25MG A214129 001 Nov 27, 2020
AB 50MG A214129 002 Nov 27, 2020
AB ALEMBIC PHARMS 25MG A216262 001 Aug 26, 2022
AB 50MG A216262 002 Aug 26, 2022
AB ALKEM LABS LTD 25MG A213412 001 Feb 11, 2020
AB 50MG A213412 002 Feb 11, 2020
AB AMNEAL PHARMS CO 25MG A207204 001 Jul 01, 2019
AB 50MG A207204 002 Jul 01, 2019
AB APPCO 25MG A210742 001 Oct 12, 2018
AB 50MG A210742 002 Oct 12, 2018
AB CHARTWELL RX 25MG A211063 001 Feb 26, 2019
AB 50MG A211063 002 Feb 26, 2019
AB INVENTIA 25MG A211320 001 Feb 09, 2022
AB 50MG A211320 002 Feb 09, 2022
AB MANKIND PHARMA 25MG A215587 001 Aug 04, 2022
AB 50MG A215587 002 Aug 04, 2022
AB + MYLAN 25MG A086831 002
AB +! 50MG A086831 001
AB NOVAST LABS 25MG A206904 001 Mar 30, 2017
AB 50MG A206904 002 Mar 30, 2017
AB SUN PHARM 25MG A089286 002 Jul 21, 1986
INDUSTRIES
AB 50MG A089286 001 Jul 21, 1986
AB TAGI 25MG A212878 001 Feb 24, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-96(of 474)

CHLORTHALIDONE
TABLET;ORAL
CHLORTHALIDONE
AB 50MG A212875 001 Feb 24, 2022
AB UMEDICA LABS PVT 25MG A207222 001 May 24, 2018
LTD
AB 50MG A207222 002 May 24, 2018
AB UNICHEM 25MG A211627 001 Aug 06, 2019
AB 50MG A211627 002 Aug 06, 2019
AB ZYDUS PHARMS 25MG A207813 001 May 10, 2019
AB 50MG A207813 002 May 10, 2019
THALITONE
BX +! CASPER PHARMA LLC 25MG N019574 002 Feb 12, 1992
+ 15MG N019574 001 Dec 20, 1988
CHLORZOXAZONE
TABLET;ORAL
CHLORZOXAZONE
AA AUROBINDO PHARMA 500MG A089853 001 May 04, 1988
LTD
AA COREPHARMA 500MG A214941 002 Oct 20, 2022
AA MAYNE PHARMA 500MG A211849 002 Jul 21, 2020
AA ! MIKART 250MG A207483 001 Jun 24, 2016
AA NOVITIUM PHARMA 500MG A212254 001 Sep 12, 2019
AA SENORES PHARMS 250MG A215158 001 Jul 29, 2021
AA ! WATSON LABS 500MG A089859 001 May 04, 1988
AB COREPHARMA 375MG A214941 001 Oct 20, 2022
AB 750MG A214941 003 Oct 20, 2022
AB I3 PHARMS 375MG A212053 001 Sep 14, 2020
AB 750MG A212053 002 Sep 14, 2020
AB MAYNE PHARMA 375MG A211849 001 Jul 21, 2020
AB 750MG A211849 003 Jul 21, 2020
AB ! MIKART 375MG A040861 001 Jun 01, 2010
AB ! 750MG A040861 002 Jun 01, 2010
AB NOVITIUM PHARMA 375MG A212253 001 Nov 27, 2019
AB 750MG A212253 002 Nov 27, 2019
AB PAR PHARM INC 375MG A212743 002 Apr 29, 2021
AB 750MG A212743 001 Nov 02, 2020
AB RISING 375MG A213126 001 Apr 05, 2022
AB 500MG A213126 002 Apr 05, 2022
AB 750MG A213126 003 Apr 05, 2022
AB TEVA PHARMS USA INC 375MG A212898 001 Jun 17, 2020
AB 750MG A212898 002 Jun 17, 2020
CHOLESTYRAMINE
POWDER;ORAL
CHOLESTYRAMINE
AB AJANTA PHARMA LTD EQ 4GM RESIN/PACKET A211119 001 Apr 06, 2020
AB EQ 4GM RESIN/SCOOPFUL A211119 002 Apr 06, 2020
AB ALKEM LABS LTD EQ 4GM RESIN/PACKET A211856 001 Oct 19, 2021
AB EQ 4GM RESIN/SCOOPFUL A211856 002 Oct 19, 2021
AB ANI PHARMS EQ 4GM RESIN/PACKET A074554 001 Oct 02, 1996
AB EQ 4GM RESIN/SCOOPFUL A074554 002 Oct 02, 1996
AB ! EPIC PHARMA EQ 4GM RESIN/PACKET A074557 001 Aug 15, 1996
AB EQ 4GM RESIN/SCOOPFUL A074557 002 Aug 15, 1996
AB PAR PHARM EQ 4GM RESIN/PACKET A077204 001 Aug 26, 2005
AB EQ 4GM RESIN/SCOOPFUL A077204 002 Aug 26, 2005
AB TAGI EQ 4GM RESIN/PACKET A209597 001 Mar 09, 2021
AB EQ 4GM RESIN/SCOOPFUL A209597 002 Mar 09, 2021
AB ZYDUS PHARMS EQ 4GM RESIN/SCOOPFUL A202901 001 Jul 02, 2018
CHOLESTYRAMINE LIGHT
AB ALKEM LABS LTD EQ 4GM RESIN/PACKET A211799 001 Oct 19, 2021
AB EQ 4GM RESIN/SCOOPFUL A211799 002 Oct 19, 2021
AB ! EPIC PHARMA EQ 4GM RESIN/PACKET A074558 001 Aug 15, 1996
AB EQ 4GM RESIN/SCOOPFUL A074558 002 Aug 15, 1996
AB PAR PHARM EQ 4GM RESIN/PACKET A077203 001 Aug 26, 2005
AB EQ 4GM RESIN/SCOOPFUL A077203 002 Aug 26, 2005
AB TAGI EQ 4GM RESIN/PACKET A209599 001 Nov 12, 2020
AB EQ 4GM RESIN/SCOOPFUL A209599 002 Nov 12, 2020
AB ZYDUS PHARMS EQ 4GM RESIN/SCOOPFUL A202902 001 Apr 25, 2017
LOCHOLEST
AB CHARTWELL RX EQ 4GM RESIN/PACKET A074561 001 Aug 15, 1996
AB EQ 4GM RESIN/SCOOPFUL A074561 002 Aug 15, 1996
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-97(of 474)

CHOLESTYRAMINE
POWDER;ORAL
LOCHOLEST LIGHT
AB CHARTWELL RX EQ 4GM RESIN/PACKET A074562 001 Aug 15, 1996
AB EQ 4GM RESIN/SCOOPFUL A074562 002 Aug 15, 1996
PREVALITE
AB UPSHER SMITH LABS EQ 4GM RESIN/PACKET A073263 001 Feb 22, 1996
AB EQ 4GM RESIN/SCOOPFUL A073263 002 Oct 30, 1997
CHOLIC ACID
CAPSULE;ORAL
CHOLBAM
+ TRAVERE 50MG N205750 001 Mar 17, 2015
+! 250MG N205750 002 Mar 17, 2015
CHOLINE C-11
INJECTABLE;INTRAVENOUS
CHOLINE C-11
AP DECATUR 4-33.1mCi/ML A206319 001 Nov 13, 2015
AP +! MCPRF 4-33.1mCi/ML N203155 001 Sep 12, 2012
AP WA UNIV SCH MED 4-33.1mCi/ML A208413 001 Jan 10, 2017
CHOLINE FENOFIBRATE
CAPSULE, DELAYED RELEASE;ORAL
FENOFIBRIC ACID
AB ACTAVIS ELIZABETH EQ 45MG FENOFIBRIC ACID A200920 001 Oct 07, 2015
AB EQ 135MG FENOFIBRIC ACID A200920 002 Oct 07, 2015
AB ALEMBIC PHARMS EQ 45MG FENOFIBRIC ACID A208705 001 May 12, 2017
AB EQ 135MG FENOFIBRIC ACID A208705 002 May 12, 2017
AB ANCHEN PHARMS EQ 45MG FENOFIBRIC ACID A201573 002 Jul 18, 2013
AB EQ 135MG FENOFIBRIC ACID A201573 001 Jul 18, 2013
AB AUROBINDO PHARMA EQ 45MG FENOFIBRIC ACID A212598 001 Jul 25, 2019
LTD
AB EQ 135MG FENOFIBRIC ACID A212598 002 Jul 25, 2019
AB GRAVITI PHARMS EQ 45MG FENOFIBRIC ACID A211626 001 Jul 18, 2019
AB EQ 135MG FENOFIBRIC ACID A211626 002 Jul 18, 2019
AB IMPAX LABS INC EQ 45MG FENOFIBRIC ACID A200264 001 Sep 07, 2016
AB EQ 135MG FENOFIBRIC ACID A200264 002 Sep 07, 2016
AB LUPIN LTD EQ 45MG FENOFIBRIC ACID A200750 001 Dec 04, 2013
AB EQ 135MG FENOFIBRIC ACID A200750 002 Dec 04, 2013
AB MICRO LABS EQ 45MG FENOFIBRIC ACID A213450 001 Jun 16, 2020
AB EQ 135MG FENOFIBRIC ACID A213450 002 Jun 16, 2020
AB TWI PHARMS EQ 45MG FENOFIBRIC ACID A210469 001 Jul 05, 2019
AB EQ 135MG FENOFIBRIC ACID A210469 002 Jul 05, 2019
AB YICHANG HUMANWELL EQ 45MG FENOFIBRIC ACID A212562 001 Dec 23, 2020
AB EQ 135MG FENOFIBRIC ACID A212562 002 Dec 23, 2020
TRILIPIX
AB + ABBVIE EQ 45MG FENOFIBRIC ACID N022224 001 Dec 15, 2008
AB +! EQ 135MG FENOFIBRIC ACID N022224 002 Dec 15, 2008
CHROMIC CHLORIDE
INJECTABLE;INJECTION
CHROMIC CHLORIDE IN PLASTIC CONTAINER
+! HOSPIRA EQ 0.004MG CHROMIUM/ML N018961 001 Jun 26, 1986
CICLESONIDE
AEROSOL, METERED;INHALATION
ALVESCO
+! COVIS 0.08MG/INH N021658 002 Jan 10, 2008
+! 0.16MG/INH N021658 003 Jan 10, 2008
AEROSOL, METERED;NASAL
ZETONNA
+! COVIS 0.037MG/INH N202129 001 Jan 20, 2012
SPRAY, METERED;NASAL
OMNARIS
+! COVIS 0.05MG/SPRAY N022004 001 Oct 20, 2006
CICLOPIROX
CREAM;TOPICAL
CICLOPIROX
AB COSETTE 0.77% A078463 001 Dec 20, 2010
AB FOUGERA PHARMS 0.77% A076435 001 Dec 29, 2004
AB GLENMARK PHARMS 0.77% A090273 001 Nov 10, 2009
AB PADAGIS ISRAEL 0.77% A077364 001 Mar 03, 2006
AB TARO 0.77% A076790 001 Apr 12, 2005
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-98(of 474)

CICLOPIROX
CREAM;TOPICAL
LOPROX
AB +! MEDIMETRIKS PHARMS 0.77% N018748 001 Dec 30, 1982
GEL;TOPICAL
CICLOPIROX
AB FOUGERA PHARMS 0.77% A077896 001 Jun 10, 2008
AB ! GLENMARK GENERICS 0.77% A091595 001 Feb 29, 2012
AB PADAGIS US 0.77% A078266 001 Jan 07, 2009
SHAMPOO;TOPICAL
CICLOPIROX
AT ACTAVIS MID 1% A090490 001 Nov 24, 2009
ATLANTIC
AT FOUGERA PHARMS 1% A090146 001 May 25, 2010
AT PADAGIS US 1% A078594 001 Feb 16, 2010
AT PAI HOLDINGS PHARM 1% A209975 001 Apr 05, 2018
AT TARO 1% A090269 001 Feb 23, 2011
LOPROX
AT +! BAUSCH 1% N021159 001 Feb 28, 2003
SOLUTION;TOPICAL
CICLOPIROX
AT ACELLA 8% A078172 001 Sep 18, 2007
AT AKORN 8% A078270 001 Sep 18, 2007
AT CHARTWELL RX 8% A078046 001 Sep 18, 2007
AT COSETTE 8% A078233 001 Sep 18, 2007
AT PADAGIS US 8% A077623 001 Sep 18, 2007
AT RISING 8% A078124 001 Sep 18, 2007
AT TARO PHARM INDS 8% A078144 001 Sep 18, 2007
PENLAC
AT +! VALEANT BERMUDA 8% N021022 001 Dec 17, 1999
SUSPENSION;TOPICAL
CICLOPIROX
AB FOUGERA PHARMS 0.77% A076422 001 Aug 06, 2004
AB PADAGIS ISRAEL 0.77% A077676 001 Dec 15, 2006
AB TARO 0.77% A077092 001 Aug 10, 2005
LOPROX
AB +! MEDIMETRIKS PHARMS 0.77% N019824 001 Dec 30, 1988
CIDOFOVIR
INJECTABLE;INJECTION
CIDOFOVIR
AP EMCURE PHARMS LTD EQ 75MG BASE/ML A202501 001 Jul 26, 2012
AP ! MYLAN INSTITUTIONAL EQ 75MG BASE/ML A201276 001 Jun 27, 2012
CILASTATIN SODIUM; IMIPENEM
POWDER;INTRAVENOUS
IMIPENEM AND CILASTATIN
AP ACS DOBFAR EQ 500MG BASE/VIAL;500MG/VIAL A090577 002 Dec 21, 2011
AP HQ SPCLT PHARMA EQ 500MG BASE/VIAL;500MG/VIAL A207594 001 Dec 12, 2019
PRIMAXIN
AP +! MERCK EQ 500MG BASE/VIAL;500MG/VIAL N050587 002 Nov 26, 1985
IMIPENEM AND CILASTATIN
! ACS DOBFAR EQ 250MG BASE/VIAL;250MG/VIAL A090577 001 Dec 21, 2011
CILASTATIN SODIUM; IMIPENEM; RELEBACTAM
POWDER;INTRAVENOUS
RECARBRIO
+! MSD MERCK CO EQ 500MG N212819 001 Jul 16, 2019
BASE/VIAL;500MG/VIAL;250MG/VIAL
CILOSTAZOL
TABLET;ORAL
CILOSTAZOL
AB APOTEX INC 50MG A077030 001 Dec 10, 2004
AB 100MG A077030 002 Dec 10, 2004
AB CASI PHARMS INC 50MG A077310 001 Nov 08, 2005
AB 100MG A077021 001 Nov 23, 2004
AB CHARTWELL RX 50MG A077831 002 Sep 24, 2012
AB 100MG A077831 001 Sep 24, 2012
AB SLATE RUN PHARMA 50MG A077208 002 Mar 29, 2006
AB 100MG A077208 001 Mar 29, 2006
AB ! TEVA 50MG A077027 001 Nov 24, 2004
AB ! 100MG A077027 002 Nov 24, 2004
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-99(of 474)

CIMETIDINE
TABLET;ORAL
CIMETIDINE
AB MYLAN 200MG A074246 001 May 17, 1994
AB 300MG A074246 002 May 17, 1994
AB 400MG A074246 003 May 17, 1994
AB ! 800MG A074246 004 May 17, 1994
AB PLIVA 800MG A074566 001 Feb 27, 1997
AB TEVA 200MG A074151 001 May 17, 1994
AB 300MG A074151 002 May 17, 1994
AB 400MG A074151 003 May 17, 1994
AB 800MG A074463 001 May 17, 1994
CIMETIDINE HYDROCHLORIDE
SOLUTION;ORAL
CIMETIDINE HYDROCHLORIDE
AA ! AKORN EQ 300MG BASE/5ML A074664 001 Oct 28, 1997
AA PHARM ASSOC EQ 300MG BASE/5ML A074553 001 Jan 27, 1997
AA WOCKHARDT BIO AG EQ 300MG BASE/5ML A074757 001 Oct 17, 1997
CINACALCET HYDROCHLORIDE
TABLET;ORAL
CINACALCET HYDROCHLORIDE
AB ACCORD HLTHCARE EQ 30MG BASE A211892 001 May 15, 2020
AB EQ 60MG BASE A211892 002 May 15, 2020
AB EQ 90MG BASE A211892 003 May 15, 2020
AB ACME LABS EQ 30MG BASE A213325 001 May 18, 2020
AB EQ 60MG BASE A213325 002 May 18, 2020
AB EQ 90MG BASE A213325 003 May 18, 2020
AB ALKEM LABS LTD EQ 30MG BASE A210570 001 May 17, 2019
AB EQ 60MG BASE A210570 002 May 17, 2019
AB EQ 90MG BASE A210570 003 May 17, 2019
AB AUROBINDO PHARMA EQ 30MG BASE A206125 001 Mar 08, 2018
LTD
AB EQ 60MG BASE A206125 002 Mar 08, 2018
AB EQ 90MG BASE A206125 003 Mar 08, 2018
AB CIPLA EQ 30MG BASE A208915 001 Mar 08, 2018
AB EQ 60MG BASE A208915 002 Mar 08, 2018
AB EQ 90MG BASE A208915 003 Mar 08, 2018
AB DR REDDYS EQ 30MG BASE A208368 001 Sep 18, 2020
AB EQ 60MG BASE A208368 002 Sep 18, 2020
AB EQ 90MG BASE A208368 003 Sep 18, 2020
AB HETERO LABS LTD V EQ 30MG BASE A209403 001 Oct 07, 2020
AB EQ 60MG BASE A209403 002 Oct 07, 2020
AB EQ 90MG BASE A209403 003 Oct 07, 2020
AB PIRAMAL HLTHCARE UK EQ 30MG BASE A210207 001 Aug 01, 2018
AB EQ 60MG BASE A210207 002 Aug 01, 2018
AB EQ 90MG BASE A210207 003 Aug 01, 2018
AB STRIDES PHARMA EQ 30MG BASE A209226 001 Apr 30, 2018
AB EQ 60MG BASE A209226 002 Apr 30, 2018
AB EQ 90MG BASE A209226 003 Apr 30, 2018
AB SUN PHARM EQ 30MG BASE A207008 001 Oct 11, 2018
AB EQ 60MG BASE A207008 002 Oct 11, 2018
AB EQ 90MG BASE A207008 003 Oct 11, 2018
AB WATSON LABS TEVA EQ 30MG BASE A204377 001 Dec 27, 2018
AB EQ 60MG BASE A204377 002 Dec 27, 2018
AB EQ 90MG BASE A204377 003 Dec 27, 2018
SENSIPAR
AB + AMGEN EQ 30MG BASE N021688 001 Mar 08, 2004
AB + EQ 60MG BASE N021688 002 Mar 08, 2004
AB +! EQ 90MG BASE N021688 003 Mar 08, 2004
CIPROFLOXACIN
FOR SUSPENSION;ORAL
CIPRO
+ BAYER HLTHCARE 250MG/5ML N020780 001 Sep 26, 1997
+! 500MG/5ML N020780 002 Sep 26, 1997
INJECTABLE;INJECTION
CIPROFLOXACIN
AP ! BAXTER HLTHCARE 200MG/20ML (10MG/ML) A078062 001 Apr 29, 2008
CORP
AP ! 400MG/40ML (10MG/ML) A078062 002 Apr 29, 2008
AP HIKMA FARMACEUTICA 200MG/20ML (10MG/ML) A076717 001 Dec 22, 2009
AP 400MG/40ML (10MG/ML) A076717 002 Dec 22, 2009
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-100(of 474)

CIPROFLOXACIN
INJECTABLE;INJECTION
CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 200MG/100ML A078024 001 Mar 18, 2008
CORP
AP 400MG/200ML A078024 002 Mar 18, 2008
AP HIKMA FARMACEUTICA 400MG/200ML A078431 001 Nov 18, 2009
AP ! HOSPIRA 200MG/100ML A077753 001 Mar 18, 2008
AP ! 400MG/200ML A077753 002 Mar 18, 2008
AP INFORLIFE 200MG/100ML A078252 001 Mar 18, 2008
AP 400MG/200ML A078252 002 Mar 18, 2008
INJECTABLE, SUSPENSION;OTIC
OTIPRIO
+! ALK ABELLO 6% (60MG/ML) N207986 001 Dec 10, 2015
CIPROFLOXACIN HYDROCHLORIDE
OINTMENT;OPHTHALMIC
CILOXAN
+! NOVARTIS EQ 0.3% BASE N020369 001 Mar 30, 1998
SOLUTION/DROPS;OPHTHALMIC
CILOXAN
AT +! NOVARTIS EQ 0.3% BASE N019992 001 Dec 31, 1990
CIPROFLOXACIN HYDROCHLORIDE
AT AKORN EQ 0.3% BASE A076555 001 Dec 11, 2008
AT ALTAIRE PHARMS INC EQ 0.3% BASE A204613 001 May 03, 2018
AT FDC LTD EQ 0.3% BASE A077568 001 Jun 30, 2008
AT PAI HOLDINGS PHARM EQ 0.3% BASE A076754 001 Jun 09, 2004
AT RISING EQ 0.3% BASE A077689 001 Dec 13, 2006
AT WATSON LABS INC EQ 0.3% BASE A076673 001 Jan 21, 2005
SOLUTION/DROPS;OTIC
CETRAXAL
+! WRASER PHARMS EQ 0.2% BASE N021918 001 May 01, 2009
TABLET;ORAL
CIPRO
AB + BAYER HLTHCARE EQ 250MG BASE N019537 002 Oct 22, 1987
AB +! EQ 500MG BASE N019537 003 Oct 22, 1987
CIPROFLOXACIN HYDROCHLORIDE
AB AUROBINDO PHARMA EQ 250MG BASE A077859 001 Apr 26, 2007
AB EQ 500MG BASE A077859 002 Apr 26, 2007
AB EQ 750MG BASE A077859 003 Apr 26, 2007
AB CARLSBAD EQ 250MG BASE A076126 002 Jun 09, 2004
AB EQ 500MG BASE A076126 003 Jun 09, 2004
AB EQ 750MG BASE A076126 004 Jun 09, 2004
AB CHARTWELL EQ 250MG BASE A076896 001 Nov 04, 2004
AB EQ 500MG BASE A076896 002 Nov 04, 2004
AB EQ 750MG BASE A076896 003 Nov 04, 2004
AB DR REDDYS LABS LTD EQ 100MG BASE A075593 002 Jun 09, 2004
AB EQ 250MG BASE A075593 003 Jun 09, 2004
AB EQ 500MG BASE A075593 004 Jun 09, 2004
AB EQ 750MG BASE A075593 001 Jun 09, 2004
AB HIKMA EQ 250MG BASE A076558 002 Jun 09, 2004
AB EQ 500MG BASE A076558 003 Jun 09, 2004
AB EQ 750MG BASE A076558 004 Jun 09, 2004
AB IVAX SUB TEVA EQ 250MG BASE A076089 002 Jun 09, 2004
PHARMS
AB EQ 500MG BASE A076089 003 Jun 09, 2004
AB EQ 750MG BASE A076089 004 Jun 09, 2004
AB RISING EQ 500MG BASE A075817 003 Jun 09, 2004
AB TARO EQ 100MG BASE A076912 001 Feb 18, 2005
AB EQ 250MG BASE A076912 002 Oct 06, 2004
AB EQ 500MG BASE A076912 003 Oct 06, 2004
AB EQ 750MG BASE A076912 004 Oct 06, 2004
AB UNIQUE EQ 250MG BASE A076639 001 Sep 10, 2004
AB EQ 500MG BASE A076639 002 Sep 10, 2004
AB EQ 750MG BASE A076639 003 Sep 10, 2004
AB WATSON LABS EQ 100MG BASE A076794 001 Feb 10, 2005
AB EQ 250MG BASE A076794 002 Jun 09, 2004
AB EQ 500MG BASE A076794 003 Jun 09, 2004
AB EQ 750MG BASE A076794 004 Jun 09, 2004
AB YILING EQ 250MG BASE A208921 001 Jun 22, 2018
AB EQ 500MG BASE A208921 002 Jun 22, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-101(of 474)

CIPROFLOXACIN HYDROCHLORIDE; FLUOCINOLONE ACETONIDE


SOLUTION/DROPS;OTIC
OTOVEL
+! LABORATORIOS SALVAT EQ 0.3% BASE;0.025% N208251 001 Apr 29, 2016
CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE
SUSPENSION/DROPS;OTIC
CIPRO HC
+! NOVARTIS EQ 0.2% BASE;1% N020805 001 Feb 10, 1998
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
CIPROFLOXACIN EXTENDED RELEASE
AB ! ANCHEN PHARMS 425.2MG;EQ 574.9MG BASE A078166 001 Nov 27, 2007
AB DR REDDYS LABS LTD 425.2MG;EQ 574.9MG BASE A077701 001 Mar 26, 2007
! ANCHEN PHARMS 212.6MG;EQ 287.5MG BASE A078166 002 Nov 27, 2007
CIPROFLOXACIN; DEXAMETHASONE
SUSPENSION/DROPS;OTIC
CIPRODEX
AB +! NOVARTIS 0.3%;0.1% N021537 001 Jul 18, 2003
CIPROFLOXACIN AND DEXAMETHASONE
AB DR REDDYS 0.3%;0.1% A205548 001 Aug 10, 2020
AB SUN PHARM 0.3%;0.1% A210470 001 Aug 30, 2022
CISATRACURIUM BESYLATE
INJECTABLE;INJECTION
CISATRACURIUM BESYLATE
AP EUGIA PHARMA EQ 2MG BASE/ML A209144 001 May 08, 2020
AP FRESENIUS KABI USA EQ 2MG BASE/ML A203183 001 Feb 26, 2015
AP HENGRUI PHARMA EQ 2MG BASE/ML A209334 001 Aug 30, 2017
AP HIKMA EQ 10MG BASE/ML A203078 001 Jun 28, 2022
AP HOSPIRA EQ 2MG BASE/ML A203236 001 Mar 30, 2018
AP EQ 2MG BASE/ML A203238 001 Mar 30, 2018
AP EQ 10MG BASE/ML A203236 002 Mar 30, 2018
AP MEITHEAL EQ 2MG BASE/ML A211668 001 Apr 25, 2019
AP EQ 2MG BASE/ML A211669 001 Apr 25, 2019
AP EQ 10MG BASE/ML A211668 002 Apr 25, 2019
AP PIRAMAL CRITICAL EQ 2MG BASE/ML A215516 001 May 24, 2022
AP EQ 2MG BASE/ML A215517 001 Dec 14, 2022
AP EQ 10MG BASE/ML A215516 002 May 24, 2022
AP SAGENT PHARMS INC EQ 2MG BASE/ML A201836 001 Nov 06, 2020
AP EQ 2MG BASE/ML A201851 001 Nov 06, 2020
AP EQ 10MG BASE/ML A201836 002 Nov 06, 2020
AP SANDOZ INC EQ 2MG BASE/ML A200159 001 Feb 03, 2012
AP SOMERSET EQ 2MG BASE/ML A209132 001 Apr 24, 2019
AP ZYDUS PHARMS EQ 2MG BASE/ML A212171 001 Nov 04, 2019
AP EQ 10MG BASE/ML A212171 002 Nov 04, 2019
CISATRACURIUM BESYLATE PRESERVATIVE FREE
AP EUGIA PHARMA EQ 2MG BASE/ML A209665 001 Oct 27, 2020
AP FRESENIUS KABI USA EQ 2MG BASE/ML A203182 001 Feb 26, 2015
AP EQ 10MG BASE/ML A203182 002 Feb 26, 2015
AP HENGRUI PHARMA EQ 2MG BASE/ML A204960 001 Jan 27, 2017
AP EQ 10MG BASE/ML A204960 002 Sep 19, 2017
AP SANDOZ INC EQ 2MG BASE/ML A200154 001 Feb 03, 2012
AP EQ 10MG BASE/ML A200154 002 Feb 03, 2012
AP SOMERSET THERAPS EQ 2MG BASE/ML A206791 001 Feb 20, 2019
LLC
AP EQ 10MG BASE/ML A206791 002 Feb 20, 2019
NIMBEX
AP +! ABBVIE EQ 2MG BASE/ML N020551 001 Dec 15, 1995
NIMBEX PRESERVATIVE FREE
AP +! ABBVIE EQ 2MG BASE/ML N020551 003 Dec 15, 1995
AP +! EQ 10MG BASE/ML N020551 002 Dec 15, 1995
CISPLATIN
INJECTABLE;INJECTION
CISPLATIN
AP ACCORD HLTHCARE 1MG/ML A206774 001 Aug 18, 2015
AP ! FRESENIUS KABI USA 1MG/ML A074735 001 Jul 16, 1999
AP GLAND PHARMA LTD 1MG/ML A207323 001 Mar 17, 2017
AP HIKMA 1MG/ML A075036 001 Nov 07, 2000
AP + HQ SPCLT PHARMA 1MG/ML N018057 004 Nov 08, 1988
AP PHARMACHEMIE BV 1MG/ML A074656 001 May 16, 2000
+! HQ SPCLT PHARMA 50MG/VIAL N018057 002
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-102(of 474)

CITALOPRAM HYDROBROMIDE
CAPSULE;ORAL
CITALOPRAM HYDROBROMIDE
+! ALMATICA EQ 30MG BASE N215428 001 Jan 31, 2022
SOLUTION;ORAL
CITALOPRAM HYDROBROMIDE
AA AUROBINDO PHARMA EQ 10MG BASE/5ML A077812 001 Aug 28, 2006
AA CHARTWELL MOLECULAR EQ 10MG BASE/5ML A077629 001 Jun 14, 2006
AA HETERO LABS LTD III EQ 10MG BASE/5ML A201450 001 Dec 15, 2015
AA ! HIKMA EQ 10MG BASE/5ML A077043 001 Dec 13, 2004
TABLET;ORAL
CELEXA
AB + ALLERGAN EQ 10MG BASE N020822 001 Apr 27, 2000
AB + EQ 20MG BASE N020822 002 Jul 17, 1998
AB +! EQ 40MG BASE N020822 003 Jul 17, 1998
CITALOPRAM HYDROBROMIDE
AB AMNEAL PHARMS NY EQ 10MG BASE A077289 001 Nov 30, 2006
AB EQ 20MG BASE A077289 002 Nov 30, 2006
AB EQ 40MG BASE A077289 003 Nov 30, 2006
AB APOTEX INC EQ 10MG BASE A077046 001 Nov 24, 2004
AB AUROBINDO EQ 10MG BASE A077031 001 Oct 28, 2004
AB EQ 20MG BASE A077031 002 Oct 28, 2004
AB EQ 40MG BASE A077031 003 Oct 28, 2004
AB CHARTWELL MOLECULAR EQ 10MG BASE A077044 001 Nov 05, 2004
AB EQ 20MG BASE A077044 002 Nov 05, 2004
AB EQ 40MG BASE A077044 003 Nov 05, 2004
AB COSETTE EQ 10MG BASE A077048 001 Nov 16, 2004
AB EQ 20MG BASE A077048 002 Nov 16, 2004
AB EQ 40MG BASE A077048 003 Nov 16, 2004
AB DR REDDYS LABS LTD EQ 10MG BASE A077038 001 Oct 28, 2004
AB EQ 20MG BASE A077038 002 Oct 28, 2004
AB EQ 40MG BASE A077038 003 Oct 28, 2004
AB EPIC PHARMA EQ 10MG BASE A077045 003 Apr 29, 2005
AB EQ 20MG BASE A077045 002 Apr 29, 2005
AB EQ 40MG BASE A077045 001 Apr 29, 2005
AB GLENMARK GENERICS EQ 10MG BASE A077654 001 Feb 27, 2009
AB EQ 20MG BASE A077654 002 Feb 27, 2009
AB EQ 40MG BASE A077654 003 Feb 27, 2009
AB INVAGEN PHARMS EQ 10MG BASE A077534 001 Oct 03, 2006
AB EQ 20MG BASE A077534 002 Oct 03, 2006
AB EQ 40MG BASE A077534 003 Oct 03, 2006
AB MYLAN EQ 10MG BASE A077042 001 Nov 05, 2004
AB EQ 20MG BASE A077042 002 Nov 05, 2004
AB EQ 40MG BASE A077042 003 Nov 05, 2004
AB TORPHARM EQ 20MG BASE A077046 002 Nov 24, 2004
AB EQ 40MG BASE A077046 003 Nov 24, 2004
AB TORRENT PHARMS EQ 10MG BASE A078216 001 Mar 27, 2007
AB EQ 20MG BASE A078216 002 Mar 27, 2007
AB EQ 40MG BASE A078216 003 Mar 27, 2007
CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE
SOLUTION;IRRIGATION
RENACIDIN
+! UNITED GUARDIAN 6.602GM/100ML;198MG/100ML;3.177GM/100ML N019481 001 Oct 02, 1990
CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE
GEL;VAGINAL
PHEXXI
+! EVOFEM INC 1%;1.8%;0.4% N208352 001 May 22, 2020
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
FOR SOLUTION;ORAL
SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID
! HETERO LABS LTD V 12GM/PACKET;3.5GM/PACKET;10MG/PACKET A212789 001 Jul 18, 2022
SOLUTION;ORAL
CLENPIQ
+! FERRING PHARMS INC 12GM/BOT;3.5GM/BOT;10MG/BOT N209589 001 Nov 28, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-103(of 474)

CITRIC ACID; UREA C-13


FOR SOLUTION, TABLET, FOR SOLUTION;ORAL
IDKIT:HP
+! MERIDIAN BIOSCIENCE 4GM;75MG N021314 001 Dec 17, 2002
CLADRIBINE
INJECTABLE;INJECTION
CLADRIBINE
AP ! FRESENIUS KABI USA 1MG/ML A076571 001 Apr 22, 2004
AP HIKMA 1MG/ML A075405 001 Feb 28, 2000
AP HISUN PHARM 1MG/ML A210856 001 Nov 25, 2019
HANGZHOU
TABLET;ORAL
MAVENCLAD
+! EMD SERONO INC 10MG N022561 001 Mar 29, 2019
CLARITHROMYCIN
FOR SUSPENSION;ORAL
CLARITHROMYCIN
AB SANDOZ 125MG/5ML A065283 002 Sep 04, 2007
AB ! 250MG/5ML A065283 003 Sep 04, 2007
TABLET;ORAL
CLARITHROMYCIN
AB ALEMBIC PHARMS 250MG A210459 001 Jan 31, 2022
AB 500MG A210459 002 Jan 31, 2022
AB ! AUROBINDO 250MG A065489 001 Jul 25, 2012
AB ! 500MG A065489 002 Jul 25, 2012
AB CHARTWELL 250MG A065384 001 Aug 20, 2007
AB 500MG A065384 002 Aug 20, 2007
AB HEC PHARM 250MG A203584 001 Sep 28, 2015
AB 500MG A203584 002 Sep 28, 2015
AB SANDOZ 250MG A065144 001 Oct 18, 2005
AB 500MG A065136 001 Aug 25, 2005
AB STRIDES PHARMA 250MG A202710 001 Jun 10, 2013
AB 500MG A202710 002 Jun 10, 2013
AB TEVA 250MG A065155 001 May 31, 2005
AB 500MG A065155 002 May 31, 2005
TABLET, EXTENDED RELEASE;ORAL
CLARITHROMYCIN
AB ACTAVIS LABS FL INC 500MG A065145 001 Jun 24, 2004
AB ! MAYNE PHARMA 500MG A065154 001 May 18, 2005
AB SUNSHINE 500MG A208987 001 Jul 09, 2018
CLASCOTERONE
CREAM;TOPICAL
WINLEVI
+! SUN PHARM 1% N213433 001 Aug 26, 2020
CLEMASTINE FUMARATE
SYRUP;ORAL
CLEMASTINE FUMARATE
! GENUS EQ 0.5MG BASE/5ML A073399 001 Jun 30, 1994
TABLET;ORAL
CLEMASTINE FUMARATE
! TEVA 2.68MG A073283 001 Jan 31, 1992
CLEVIDIPINE
EMULSION;INTRAVENOUS
CLEVIPREX
+! CHIESI 25MG/50ML (0.5MG/ML) N022156 001 Aug 01, 2008
+! 50MG/100ML (0.5MG/ML) N022156 002 Aug 01, 2008
CLINDAMYCIN HYDROCHLORIDE
CAPSULE;ORAL
CLEOCIN HYDROCHLORIDE
AB + PFIZER EQ 75MG BASE N050162 001
AB + EQ 150MG BASE N050162 002
AB +! EQ 300MG BASE N050162 003 Apr 14, 1988
CLINDAMYCIN HYDROCHLORIDE
AB AUROBINDO PHARMA EQ 150MG BASE A065442 001 Aug 26, 2009
AB EQ 300MG BASE A065442 002 Aug 26, 2009
AB CHARTWELL MOLECULAR EQ 75MG BASE A065243 002 Aug 12, 2005
AB COSETTE EQ 150MG BASE A063029 001 Sep 20, 1989
AB EQ 300MG BASE A063029 002 Aug 05, 2005
AB EPIC PHARMA LLC EQ 150MG BASE A065194 001 Mar 22, 2004
AB EQ 300MG BASE A065194 002 Mar 22, 2004
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-104(of 474)

CLINDAMYCIN HYDROCHLORIDE
CAPSULE;ORAL
CLINDAMYCIN HYDROCHLORIDE
AB MICRO LABS EQ 75MG BASE A207402 001 Nov 05, 2018
AB EQ 150MG BASE A207402 002 Nov 05, 2018
AB EQ 300MG BASE A207402 003 Nov 05, 2018
AB SUN PHARM INDS LTD EQ 150MG BASE A065061 001 Feb 02, 2001
AB EQ 300MG BASE A065061 002 Feb 02, 2001
AB ZYDUS PHARMS USA EQ 75MG BASE A065217 001 Jan 31, 2005
AB EQ 150MG BASE A065217 002 Jan 31, 2005
AB EQ 300MG BASE A065217 003 Jan 31, 2005
CLINDAMYCIN PALMITATE HYDROCHLORIDE
FOR SOLUTION;ORAL
CLEOCIN
AA ! PFIZER EQ 75MG BASE/5ML A062644 001 Apr 07, 1986
CLINDAMYCIN PALMITATE HYDROCHLORIDE
AA ALEMBIC LABS EQ 75MG BASE/5ML A206958 001 May 05, 2017
AA AMNEAL PHARMS EQ 75MG BASE/5ML A203513 001 Mar 13, 2014
AA AUROBINDO PHARMA EQ 75MG BASE/5ML A202409 001 Apr 30, 2013
LTD
AA HERITAGE PHARMS INC EQ 75MG BASE/5ML A207047 001 May 11, 2018
AA LYNE EQ 75MG BASE/5ML A201821 001 Aug 28, 2012
AA PADAGIS US EQ 75MG BASE/5ML A090902 001 Jul 07, 2010
CLINDAMYCIN PHOSPHATE
AEROSOL, FOAM;TOPICAL
CLINDAMYCIN PHOSPHATE
AT GLENMARK PHARMS LTD 1% A210778 001 Sep 20, 2021
AT PADAGIS ISRAEL 1% A090785 001 Mar 31, 2010
AT TARO PHARM INDS LTD 1% A210004 001 Mar 11, 2020
EVOCLIN
AT +! MYLAN 1% N050801 001 Oct 22, 2004
CREAM;VAGINAL
CLEOCIN
AB +! PFIZER EQ 2% BASE N050680 002 Mar 02, 1998
CLINDAMYCIN PHOSPHATE
AB FOUGERA PHARMS EQ 2% BASE A065139 001 Dec 27, 2004
CLINDESSE
+! PADAGIS US EQ 2% BASE N050793 001 Nov 30, 2004
GEL;TOPICAL
CLEOCIN T
AB1 +! PFIZER EQ 1% BASE N050615 001 Jan 07, 1987
CLINDAMYCIN PHOSPHATE
AB1 AMNEAL EQ 1% BASE A215219 001 Nov 03, 2022
AB1 ENCUBE EQ 1% BASE A212438 001 Mar 11, 2021
AB1 FOUGERA PHARMS EQ 1% BASE A064160 001 Jan 28, 2000
AB1 GLENMARK PHARMS LTD EQ 1% BASE A214251 001 Feb 10, 2021
AB1 PADAGIS ISRAEL EQ 1% BASE A212104 001 Dec 31, 2020
AB1 SOLARIS PHARMA CORP EQ 1% BASE A211872 001 Jul 29, 2020
AB1 TARO PHARMS EQ 1% BASE A214052 001 Nov 10, 2020
CLINDAGEL
AB2 +! BAUSCH EQ 1% BASE N050782 001 Nov 27, 2000
CLINDAMYCIN PHOSPHATE
AB2 AMNEAL EQ 1% BASE A214668 001 Aug 05, 2022
AB2 SOLARIS PHARMA CORP EQ 1% BASE A212842 001 Aug 13, 2021
GEL;VAGINAL
XACIATO
+! DARE EQ 2% BASE N215650 001 Dec 07, 2021
INJECTABLE;INJECTION
CLEOCIN PHOSPHATE
AP PFIZER EQ 150MG BASE/ML A062803 001 Oct 16, 1987
AP +! EQ 150MG BASE/ML N050441 001
CLINDAMYCIN PHOSPHATE
AP ALMAJECT EQ 150MG BASE/ML A062800 001 Jul 24, 1987
AP EQ 150MG BASE/ML A062943 001 Sep 29, 1988
AP FRESENIUS KABI USA EQ 150MG BASE/ML A065346 001 Mar 29, 2007
AP EQ 150MG BASE/ML A065347 001 May 09, 2007
AP HIKMA EQ 150MG BASE/ML A062889 001 Apr 25, 1988
AP EQ 150MG BASE/ML A065206 001 Sep 24, 2004
AP SAGENT PHARMS INC EQ 150MG BASE/ML A090108 001 Sep 30, 2011
AP EQ 150MG BASE/ML A090109 001 Sep 30, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-105(of 474)

CLINDAMYCIN PHOSPHATE
INJECTABLE;INJECTION
CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER
AP AKORN EQ 6MG BASE/ML A203048 001 Apr 04, 2013
AP EQ 12MG BASE/ML A203048 002 Apr 04, 2013
AP EQ 18MG BASE/ML A203048 003 Apr 04, 2013
AP BAXTER HLTHCARE EQ 6MG BASE/ML A208084 001 Jun 28, 2017
CORP
AP EQ 12MG BASE/ML A208084 002 Jun 28, 2017
AP EQ 18MG BASE/ML A208084 003 Jun 28, 2017
AP ! SANDOZ INC EQ 6MG BASE/ML A201692 001 May 31, 2012
AP ! EQ 12MG BASE/ML A201692 002 May 31, 2012
AP ! EQ 18MG BASE/ML A201692 003 May 31, 2012
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
+! ABRAXIS PHARM EQ 900MG BASE/100ML N050635 001 Dec 22, 1989
LOTION;TOPICAL
CLEOCIN T
AB +! PFIZER EQ 1% BASE N050600 001 May 31, 1989
CLINDAMYCIN PHOSPHATE
AB ENCUBE EQ 1% BASE A215607 001 Jan 18, 2022
AB FOUGERA PHARMS EQ 1% BASE A065067 001 Jan 31, 2002
AB PADAGIS ISRAEL EQ 1% BASE A214604 001 Mar 08, 2021
AB TARO PHARMS EQ 1% BASE A214526 001 Jun 28, 2021
SOLUTION;INTRAVENOUS
CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE
+! BAXTER HLTHCARE EQ 300MG BASE/50ML (EQ 6MG BASE/ML) N208083 001 Apr 20, 2017
CORP
+! EQ 600MG BASE/50ML (EQ 12MG BASE/ML) N208083 002 Apr 20, 2017
+! EQ 900MG BASE/50ML (EQ 18MG BASE/ML) N208083 003 Apr 20, 2017
SOLUTION;TOPICAL
CLINDA-DERM
AT PADAGIS US EQ 1% BASE A063329 001 Sep 30, 1992
CLINDAMYCIN PHOSPHATE
AT CADILA EQ 1% BASE A208767 001 Jul 16, 2018
AT ENCUBE ETHICALS EQ 1% BASE A209914 001 Jan 28, 2019
AT FOUGERA PHARMS INC EQ 1% BASE A064159 001 Jun 05, 1997
AT GLASSHOUSE PHARMS EQ 1% BASE A209846 001 Feb 08, 2018
AT ! PADAGIS US EQ 1% BASE A064050 001 Nov 30, 1995
AT PAI HOLDINGS PHARM EQ 1% BASE A206945 001 Dec 30, 2016
AT TARO PHARM INDS EQ 1% BASE A065184 001 Mar 31, 2004
SUPPOSITORY;VAGINAL
CLEOCIN
+! PFIZER 100MG N050767 001 Aug 13, 1999
SWAB;TOPICAL
CLINDAMYCIN PHOSPHATE
AT AKORN EQ 1% BASE A065513 001 Jun 17, 2010
AT ! PADAGIS US EQ 1% BASE A065049 001 May 25, 2000
CLINDETS
AT PADAGIS US EQ 1% BASE A064136 001 Sep 30, 1996
CLINDAMYCIN PHOSPHATE; TRETINOIN
GEL;TOPICAL
CLINDAMYCIN PHOSPHATE AND TRETINOIN
AB1 ACTAVIS MID 1.2%;0.025% A202564 001 Jun 12, 2015
ATLANTIC
ZIANA
AB1 +! BAUSCH 1.2%;0.025% N050802 001 Nov 07, 2006
CLINDAMYCIN PHOSPHATE AND TRETINOIN
AB2 SOLARIS PHARMA CORP 1.2%;0.025% A212845 001 Feb 10, 2022
VELTIN
AB2 +! ALMIRALL 1.2%;0.025% N050803 001 Jul 16, 2010
CLOBAZAM
FILM;ORAL
SYMPAZAN
+ OTTER PHARMS 5MG N210833 001 Nov 01, 2018
+ 10MG N210833 002 Nov 01, 2018
+! 20MG N210833 003 Nov 01, 2018
SUSPENSION;ORAL
CLOBAZAM
AB ACCORD HLTHCARE 2.5MG/ML A216008 001 Sep 06, 2022
AB ALKEM LABS LTD 2.5MG/ML A213039 001 May 06, 2021
AB AMNEAL 2.5MG/ML A210039 001 Oct 22, 2018
AB AUROBINDO PHARMA 2.5MG/ML A214404 001 Mar 24, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-106(of 474)

CLOBAZAM
SUSPENSION;ORAL
CLOBAZAM
LTD
AB BIONPHARMA INC 2.5MG/ML A208819 001 Oct 22, 2018
AB CHARTWELL MOLECULAR 2.5MG/ML A213110 001 Apr 24, 2020
AB HETERO LABS LTD III 2.5MG/ML A209796 001 Feb 24, 2020
AB LUPIN LTD 2.5MG/ML A210546 001 Dec 28, 2018
AB MYLAN 2.5MG/ML A211259 001 Oct 22, 2018
AB TARO 2.5MG/ML A210978 001 Apr 15, 2019
AB UPSHER SMITH LABS 2.5MG/ML A210569 001 Oct 22, 2018
AB VISTAPHARM 2.5MG/ML A210746 001 Jul 10, 2019
ONFI
AB +! LUNDBECK PHARMS LLC 2.5MG/ML N203993 001 Dec 14, 2012
TABLET;ORAL
CLOBAZAM
AB ALKEM LABS LTD 10MG A212714 001 Sep 06, 2019
AB 20MG A212714 002 Sep 06, 2019
AB AMNEAL PHARMS CO 10MG A209718 001 Oct 22, 2018
AB 20MG A209718 002 Oct 22, 2018
AB BIONPHARMA INC 10MG A208825 001 Oct 22, 2018
AB 20MG A208825 002 Oct 22, 2018
AB BRECKENRIDGE 10MG A209308 001 Oct 22, 2018
AB 20MG A209308 002 Oct 22, 2018
AB HETERO LABS LTD III 10MG A209795 001 Oct 22, 2018
AB 20MG A209795 002 Oct 22, 2018
AB LUPIN LTD 10MG A210545 001 Dec 14, 2018
AB 20MG A210545 002 Dec 14, 2018
AB MICRO LABS 10MG A211711 001 Jan 30, 2019
AB 20MG A211711 002 Jan 30, 2019
AB MSN 10MG A213404 001 May 11, 2021
AB 20MG A213404 002 May 11, 2021
AB PIRAMAL HLTHCARE UK 10MG A209808 001 Oct 22, 2018
AB 20MG A209808 002 Oct 22, 2018
AB UPSHER SMITH LABS 10MG A209687 001 Oct 22, 2018
AB 20MG A209687 002 Oct 22, 2018
AB ZYDUS PHARMS 10MG A211449 001 Oct 22, 2018
AB 20MG A211449 002 Oct 22, 2018
ONFI
AB + LUNDBECK PHARMS LLC 10MG N202067 002 Oct 21, 2011
AB +! 20MG N202067 003 Oct 21, 2011
CLOBAZAM
ALKEM LABS LTD 5MG A212714 003 Dec 21, 2020
CLOBETASOL PROPIONATE
AEROSOL, FOAM;TOPICAL
CLOBETASOL PROPIONATE
AB1 ALEOR 0.05% A215838 001 Apr 21, 2022
DERMACEUTICALS
AB1 GLENMARK PHARMS LTD 0.05% A210809 001 Feb 15, 2019
AB1 PADAGIS ISRAEL 0.05% A077763 001 Mar 10, 2008
AB1 TARO 0.05% A208779 001 Oct 04, 2018
OLUX
AB1 +! MYLAN 0.05% N021142 001 May 26, 2000
CLOBETASOL PROPIONATE
AB2 GLENMARK PHARMS LTD 0.05% A211450 001 Sep 09, 2019
AB2 PADAGIS ISRAEL 0.05% A201402 001 Aug 14, 2012
OLUX E
AB2 +! MYLAN 0.05% N022013 001 Jan 12, 2007
CREAM;TOPICAL
CLOBETASOL PROPIONATE
AB1 ALEOR 0.05% A213291 001 Jan 27, 2020
DERMACEUTICALS
AB1 AMNEAL 0.05% A211256 001 Dec 26, 2018
AB1 AUROBINDO PHARMA 0.05% A075338 001 Feb 09, 2001
USA
AB1 COSETTE 0.05% A074139 001 Aug 03, 1994
AB1 ENCUBE 0.05% A212982 001 Aug 28, 2020
AB1 FOUGERA PHARMS INC 0.05% A074392 001 Sep 30, 1996
AB1 GLENMARK PHARMS 0.05% A209095 001 May 10, 2018
AB1 LUPIN LTD 0.05% A210208 001 Jan 30, 2018
AB1 PAI HOLDINGS PHARM 0.05% A209974 001 Apr 17, 2018
AB1 RISING 0.05% A211401 001 Jan 11, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-107(of 474)

CLOBETASOL PROPIONATE
CREAM;TOPICAL
CLOBETASOL PROPIONATE
AB1 TARO 0.05% A074249 001 Jul 08, 1996
AB1 TORRENT 0.05% A211836 001 Dec 30, 2019
AB1 XIROMED 0.05% A210034 001 Jun 15, 2018
AB1 ZYDUS PHARMS 0.05% A211074 001 Oct 15, 2018
CORMAX
AB1 ! AKORN 0.05% A074220 001 May 16, 1997
CLOBETASOL PROPIONATE (EMOLLIENT)
AB2 ANI PHARMS 0.05% A075733 001 Aug 22, 2001
AB2 ! FOUGERA PHARMS 0.05% A075430 001 May 26, 1999
AB2 PAI HOLDINGS PHARM 0.05% A209411 001 Aug 21, 2017
AB2 TARO 0.05% A075633 001 May 17, 2000
IMPOYZ
+! PRIMUS PHARMS 0.025% N209483 001 Nov 28, 2017
GEL;TOPICAL
CLOBETASOL PROPIONATE
AB ! FOUGERA PHARMS 0.05% A075368 001 Feb 15, 2000
AB PADAGIS US 0.05% A075027 001 Oct 31, 1997
AB PAI HOLDINGS PHARM 0.05% A208881 001 Mar 06, 2017
AB TARO 0.05% A075279 001 May 28, 1999
EMBELINE
AB AKORN 0.05% A076141 001 Apr 12, 2002
LOTION;TOPICAL
CLOBETASOL PROPIONATE
AB ACTAVIS MID 0.05% A078223 001 Dec 04, 2008
ATLANTIC
AB CADILA 0.05% A205249 001 Sep 24, 2019
AB LUPIN LTD 0.05% A209147 001 Sep 22, 2017
AB PAI HOLDINGS PHARM 0.05% A208667 001 Nov 29, 2016
AB TARO 0.05% A200302 001 Jul 02, 2012
CLOBEX
AB +! GALDERMA LABS LP 0.05% N021535 001 Jul 24, 2003
IMPEKLO
+! MYLAN 0.05% N213691 001 May 19, 2020
OINTMENT;TOPICAL
CLOBETASOL PROPIONATE
AB ALEOR 0.05% A211800 001 Mar 04, 2019
DERMACEUTICALS
AB AUROBINDO PHARMA 0.05% A075057 001 Aug 12, 1998
USA
AB COSETTE 0.05% A074089 001 Feb 16, 1994
AB ENCUBE 0.05% A211295 001 Nov 15, 2019
AB ! FOUGERA PHARMS 0.05% A074407 001 Feb 23, 1996
AB GLENMARK PHARMS 0.05% A208933 001 Mar 20, 2017
AB NOVEL LABS INC 0.05% A208841 001 May 04, 2018
AB PAI HOLDINGS PHARM 0.05% A208589 001 Jan 23, 2019
AB TARO 0.05% A074248 001 Jul 12, 1996
AB XIROMED 0.05% A209701 001 Apr 17, 2018
AB ZYDUS PHARMS 0.05% A210199 001 Oct 27, 2017
EMBELINE
AB AKORN 0.05% A074221 001 Mar 31, 1995
SHAMPOO;TOPICAL
CLOBETASOL PROPIONATE
AB ACTAVIS MID 0.05% A078854 001 Jun 07, 2011
ATLANTIC
AB AKORN 0.05% A209871 001 Oct 27, 2017
AB ALEOR 0.05% A213290 001 May 18, 2020
DERMACEUTICALS
AB AMNEAL 0.05% A214895 001 Jun 14, 2021
AB PADAGIS ISRAEL 0.05% A090974 001 Aug 09, 2012
AB TARO PHARMS 0.05% A214867 001 Mar 25, 2021
CLOBEX
AB +! GALDERMA LABS 0.05% N021644 001 Feb 05, 2004
SOLUTION;TOPICAL
CLOBETASOL PROPIONATE
AT ALEOR 0.05% A212881 001 Oct 21, 2019
DERMACEUTICALS
AT COSETTE 0.05% A074331 001 Dec 15, 1995
AT FOUGERA PHARMS 0.05% A075391 001 Feb 08, 1999
AT GLENMARK PHARMS LTD 0.05% A210190 001 Apr 18, 2018
AT MACLEODS PHARMS LTD 0.05% A209361 001 Oct 25, 2017
AT NOVEL LABS INC 0.05% A206075 001 Nov 23, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-108(of 474)

CLOBETASOL PROPIONATE
SOLUTION;TOPICAL
CLOBETASOL PROPIONATE
AT QUAGEN 0.05% A211240 001 Feb 17, 2022
AT SAPTALIS PHARMS 0.05% A211494 001 Oct 02, 2019
AT TARO 0.05% A075224 001 Nov 16, 1998
AT 0.05% A075363 001 Dec 29, 2000
EMBELINE
AT ! AKORN 0.05% A074222 001 Dec 06, 1995
SPRAY;TOPICAL
CLOBETASOL PROPIONATE
AT ALEOR 0.05% A211191 001 Oct 02, 2019
DERMACEUTICALS
AT GLENMARK PHARMS 0.05% A209004 001 Mar 26, 2018
AT LUPIN LTD 0.05% A208125 001 Mar 26, 2018
AT PADAGIS US 0.05% A090898 001 Jun 16, 2011
AT TARO 0.05% A208842 001 Mar 26, 2018
AT ZYDUS PHARMS 0.05% A206378 001 Feb 16, 2017
CLOBEX
AT +! GALDERMA LABS LP 0.05% N021835 001 Oct 27, 2005
CLOCORTOLONE PIVALATE
CREAM;TOPICAL
CLOCORTOLONE PIVALATE
AB TARO 0.1% A206370 001 Apr 21, 2020
CLODERM
AB +! EPI HLTH 0.1% N017765 001
CLOFARABINE
SOLUTION;INTRAVENOUS
CLOFARABINE
AP ABON PHARMS LLC 20MG/20ML (1MG/ML) A204029 001 May 09, 2017
AP ACCORD HLTHCARE 20MG/20ML (1MG/ML) A212034 001 Feb 22, 2019
AP AMNEAL 20MG/20ML (1MG/ML) A208857 001 Nov 06, 2017
AP DR REDDYS 20MG/20ML (1MG/ML) A205375 001 Nov 06, 2017
AP EUGIA PHARMA 20MG/20ML (1MG/ML) A212457 001 Oct 03, 2022
AP GLAND PHARMA LTD 20MG/20ML (1MG/ML) A207831 001 Oct 31, 2018
AP MEITHEAL 20MG/20ML (1MG/ML) A213461 001 Oct 23, 2020
AP MSN 20MG/20ML (1MG/ML) A209775 001 Dec 06, 2017
AP MYLAN LABS LTD 20MG/20ML (1MG/ML) A208860 001 Nov 06, 2017
CLOLAR
AP +! GENZYME 20MG/20ML (1MG/ML) N021673 001 Dec 28, 2004
CLOMIPHENE CITRATE
TABLET;ORAL
CLOMIPHENE CITRATE
! COSETTE 50MG A075528 001 Aug 30, 1999
CLOMIPRAMINE HYDROCHLORIDE
CAPSULE;ORAL
ANAFRANIL
AB +! SPECGX LLC 25MG N019906 001 Dec 29, 1989
AB + 50MG N019906 002 Dec 29, 1989
AB + 75MG N019906 003 Dec 29, 1989
CLOMIPRAMINE HYDROCHLORIDE
AB AJANTA PHARMA LTD 25MG A213897 001 Oct 02, 2020
AB 50MG A213897 002 Oct 02, 2020
AB 75MG A213897 003 Oct 02, 2020
AB ALEMBIC PHARMS 25MG A211822 001 Aug 04, 2021
AB 50MG A211822 002 Aug 04, 2021
AB 75MG A211822 003 Aug 04, 2021
AB AMNEAL PHARMS CO 25MG A208632 001 Oct 31, 2018
AB 50MG A208632 002 Oct 31, 2018
AB 75MG A208632 003 Oct 31, 2018
AB JUBILANT CADISTA 25MG A212218 001 Oct 21, 2019
AB 50MG A212218 002 Oct 21, 2019
AB 75MG A212218 003 Oct 21, 2019
AB LEADING 25MG A211364 001 Feb 07, 2020
AB 50MG A211364 002 Feb 07, 2020
AB 75MG A211364 003 Feb 07, 2020
AB LUPIN LTD 25MG A209294 001 Nov 21, 2018
AB 50MG A209294 002 Nov 21, 2018
AB 75MG A209294 003 Nov 21, 2018
AB MANKIND PHARMA 25MG A211767 001 Apr 08, 2019
AB 50MG A211767 002 Apr 08, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-109(of 474)

CLOMIPRAMINE HYDROCHLORIDE
CAPSULE;ORAL
CLOMIPRAMINE HYDROCHLORIDE
AB 75MG A211767 003 Apr 08, 2019
AB MICRO LABS 25MG A213219 001 Jun 22, 2020
AB 50MG A213219 002 Jun 22, 2020
AB 75MG A213219 003 Jun 22, 2020
AB MYLAN 25MG A074947 001 Apr 30, 1998
AB 50MG A074947 002 Apr 30, 1998
AB 75MG A074947 003 Apr 30, 1998
AB SANDOZ 25MG A074364 001 Mar 29, 1996
AB 25MG A074953 001 Jun 25, 1997
AB 50MG A074364 002 Mar 29, 1996
AB 50MG A074953 002 Jun 25, 1997
AB 75MG A074364 003 Mar 29, 1996
AB 75MG A074953 003 Jun 25, 1997
AB TARO 25MG A074694 001 Dec 31, 1996
AB 50MG A074694 002 Dec 31, 1996
AB 75MG A074694 003 Dec 31, 1996
AB TULEX PHARMS INC 25MG A210653 001 Apr 03, 2020
AB 50MG A210653 002 Apr 03, 2020
AB 75MG A210653 003 Apr 03, 2020
AB UNIQUE 25MG A212285 001 Aug 07, 2020
AB 50MG A212285 002 Aug 07, 2020
AB 75MG A212285 003 Aug 07, 2020
AB VGYAAN 25MG A213221 001 Jun 22, 2020
AB 50MG A213221 002 Jun 22, 2020
AB 75MG A213221 003 Jun 22, 2020
AB ZYDUS PHARMS 25MG A208961 001 Dec 27, 2017
AB 50MG A208961 002 Dec 27, 2017
AB 75MG A208961 003 Dec 27, 2017
CLONAZEPAM
TABLET;ORAL
CLONAZEPAM
AB ACCORD HLTHCARE 0.5MG A077147 001 May 02, 2005
AB 1MG A077147 002 May 02, 2005
AB 2MG A077147 003 May 02, 2005
AB ACTAVIS ELIZABETH 0.5MG A074869 001 Oct 31, 1996
AB 1MG A074869 002 Oct 31, 1996
AB 2MG A074869 003 Oct 31, 1996
AB PRINSTON INC 0.5MG A077856 001 Jun 28, 2006
AB 1MG A077856 002 Jun 28, 2006
AB 2MG A077856 003 Jun 28, 2006
AB RUBICON 0.5MG A075468 001 Oct 06, 2000
AB 1MG A075468 002 Oct 06, 2000
AB 2MG A075468 003 Oct 06, 2000
AB SANDOZ 0.5MG A074979 001 Aug 29, 1997
AB 1MG A074979 002 Aug 29, 1997
AB 2MG A074979 003 Aug 29, 1997
AB TEVA 0.5MG A074569 001 Sep 10, 1996
AB 1MG A074569 002 Sep 10, 1996
AB 2MG A074569 003 Sep 10, 1996
KLONOPIN
AB + CHEPLAPHARM 0.5MG N017533 001
AB +! 1MG N017533 002
AB + 2MG N017533 003
TABLET, ORALLY DISINTEGRATING;ORAL
CLONAZEPAM
AB ALEMBIC PHARMS 0.125MG A211033 001 Jun 28, 2019
AB 0.25MG A211033 002 Jun 28, 2019
AB 0.5MG A211033 003 Jun 28, 2019
AB 1MG A211033 004 Jun 28, 2019
AB 2MG A211033 005 Jun 28, 2019
AB BARR 0.125MG A077194 001 Aug 10, 2005
AB 0.25MG A077194 002 Aug 10, 2005
AB 0.5MG A077194 003 Aug 10, 2005
AB 1MG A077194 004 Aug 10, 2005
AB 2MG A077194 005 Aug 10, 2005
AB PAR PHARM 0.125MG A077171 001 Aug 03, 2005
AB 0.25MG A077171 002 Aug 03, 2005
AB 0.5MG A077171 003 Aug 03, 2005
AB ! 1MG A077171 004 Aug 03, 2005
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-110(of 474)

CLONAZEPAM
TABLET, ORALLY DISINTEGRATING;ORAL
CLONAZEPAM
AB 2MG A077171 005 Aug 03, 2005
AB SUN PHARM INDS INC 0.125MG A078654 001 Aug 27, 2014
AB 0.25MG A078654 002 Aug 27, 2014
AB 0.5MG A078654 003 Aug 27, 2014
AB 1MG A078654 004 Aug 27, 2014
AB 2MG A078654 005 Aug 27, 2014
CLONIDINE
SYSTEM;TRANSDERMAL
CATAPRES-TTS-1
AB + LAVIPHARM 0.1MG/24HR N018891 001 Oct 10, 1984
CATAPRES-TTS-2
AB + LAVIPHARM 0.2MG/24HR N018891 002 Oct 10, 1984
CATAPRES-TTS-3
AB +! LAVIPHARM 0.3MG/24HR N018891 003 Oct 10, 1984
CLONIDINE
AB ACTAVIS LABS UT INC 0.1MG/24HR A090873 001 May 06, 2014
AB 0.2MG/24HR A090873 002 May 06, 2014
AB 0.3MG/24HR A090873 003 May 06, 2014
AB AVEVA 0.1MG/24HR A076157 001 Aug 18, 2009
AB 0.2MG/24HR A076157 002 Aug 18, 2009
AB 0.3MG/24HR A076157 003 Aug 18, 2009
AB MAYNE PHARMA 0.1MG/24HR A079090 001 Aug 20, 2010
AB 0.2MG/24HR A079090 002 Aug 20, 2010
AB 0.3MG/24HR A079090 003 Aug 20, 2010
AB MYLAN TECHNOLOGIES 0.1MG/24HR A076166 001 Jul 16, 2010
AB 0.2MG/24HR A076166 002 Jul 16, 2010
AB 0.3MG/24HR A076166 003 Jul 16, 2010
TABLET, EXTENDED RELEASE;ORAL
NEXICLON XR
ATHENA EQ 0.17MG BASE N022500 001 Dec 03, 2009
CLONIDINE HYDROCHLORIDE
INJECTABLE;INJECTION
CLONIDINE HYDROCHLORIDE
AP FRESENIUS KABI USA 1MG/10ML (0.1MG/ML) A200673 001 Jul 08, 2011
AP 5MG/10ML (0.5MG/ML) A200673 002 Jul 08, 2011
AP HIKMA FARMACEUTICA 1MG/10ML (0.1MG/ML) A200300 001 Jan 26, 2011
AP ! 5MG/10ML (0.5MG/ML) A200300 002 Jan 26, 2011
AP XGEN PHARMS 1MG/10ML (0.1MG/ML) A203167 001 Oct 29, 2013
AP 5MG/10ML (0.5MG/ML) A203167 002 Oct 29, 2013
AP ZYDUS PHARMS 1MG/10ML (0.1MG/ML) A202601 001 Feb 20, 2014
AP 5MG/10ML (0.5MG/ML) A202601 002 Feb 20, 2014
DURACLON
AP + MYLAN INSTITUTIONAL 1MG/10ML (0.1MG/ML) N020615 001 Oct 02, 1996
TABLET;ORAL
CLONIDINE HYDROCHLORIDE
AB ACTAVIS ELIZABETH 0.1MG A070974 001 Dec 16, 1986
AB 0.2MG A070975 001 Dec 16, 1986
AB 0.3MG A070976 001 Dec 16, 1986
AB ALEMBIC PHARMS LTD 0.1MG A091368 001 Dec 06, 2011
AB 0.2MG A091368 002 Dec 06, 2011
AB 0.3MG A091368 003 Dec 06, 2011
AB AUROBINDO PHARMA 0.1MG A070886 002 Aug 31, 1988
LTD
AB 0.2MG A070886 001 Aug 31, 1988
AB 0.3MG A070886 003 Aug 31, 1988
AB CHARTWELL MOLECULES 0.1MG A071785 002 Apr 05, 1988
AB 0.2MG A071785 003 Apr 05, 1988
AB 0.3MG A071785 001 Apr 05, 1988
AB IMPAX LABS 0.1MG A078099 001 Aug 27, 2009
AB 0.2MG A078099 002 Aug 27, 2009
AB 0.3MG A078099 003 Aug 27, 2009
AB PRINSTON INC 0.1MG A077901 001 Mar 09, 2007
AB 0.2MG A077901 002 Mar 09, 2007
AB 0.3MG A077901 003 Mar 09, 2007
AB UNICHEM 0.1MG A078895 001 Aug 26, 2009
AB 0.2MG A078895 002 Aug 26, 2009
AB ! 0.3MG A078895 003 Aug 26, 2009
AB URL LABS 0.1MG A070923 003 Sep 04, 1987
AB 0.2MG A070923 002 Sep 04, 1987
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-111(of 474)

CLONIDINE HYDROCHLORIDE
TABLET;ORAL
CLONIDINE HYDROCHLORIDE
AB 0.3MG A070923 001 Sep 04, 1987
AB YUNG SHIN PHARM 0.1MG A202297 001 Jun 13, 2013
AB 0.2MG A202297 002 Jun 13, 2013
AB 0.3MG A202297 003 Jun 13, 2013
TABLET, EXTENDED RELEASE;ORAL
CLONIDINE HYDROCHLORIDE
AB1 ACTAVIS ELIZABETH 0.1MG A203320 001 May 15, 2015
AB1 AJANTA PHARMA LTD 0.1MG A209686 001 Nov 20, 2017
AB1 AMNEAL PHARMS NY 0.1MG A210052 001 Nov 20, 2017
AB1 ANCHEN PHARMS 0.1MG A202984 001 Sep 30, 2013
AB1 JUBILANT GENERICS 0.1MG A210338 001 Jan 29, 2018
AB1 LUPIN LTD 0.1MG A209285 001 Oct 23, 2017
AB1 NOVAST LABS 0.1MG A209675 001 Mar 05, 2019
AB1 XIAMEN LP PHARM CO 0.1MG A209757 001 Nov 20, 2017
KAPVAY
AB1 +! CONCORDIA PHARMS 0.1MG N022331 003 Sep 28, 2010
INC
CLONIDINE HYDROCHLORIDE
AB2 ACTAVIS ELIZABETH 0.1MG A202792 001 May 15, 2015
CLOPIDOGREL BISULFATE
TABLET;ORAL
CLOPIDOGREL BISULFATE
AB ACCORD HLTHCARE EQ 75MG BASE A202925 001 Mar 27, 2013
AB EQ 300MG BASE A202925 002 Mar 27, 2013
AB ACME LABS EQ 75MG BASE A078004 001 May 17, 2012
AB AMNEAL PHARMS EQ 75MG BASE A203751 001 Apr 11, 2014
AB APOTEX INC EQ 75MG BASE A076274 001 May 17, 2012
AB ! EQ 300MG BASE A076274 002 Mar 04, 2014
AB AUROBINDO PHARMA EQ 75MG BASE A090540 001 May 17, 2012
LTD
AB DR REDDYS EQ 75MG BASE A076273 001 Jan 14, 2008
AB DR REDDYS LABS LTD EQ 300MG BASE A091023 001 May 17, 2012
AB GRAVITI PHARMS EQ 75MG BASE A204359 001 Feb 02, 2017
AB MACLEODS PHARMS LTD EQ 75MG BASE A202928 001 Feb 10, 2014
AB POLYGEN PHARMS EQ 75MG BASE A213351 001 Jul 17, 2020
AB EQ 300MG BASE A213351 002 Jul 17, 2020
AB PRINSTON INC EQ 75MG BASE A206376 001 May 07, 2018
AB EQ 300MG BASE A206376 002 May 07, 2018
AB SCIEGEN PHARMS INC EQ 75MG BASE A204165 001 Sep 15, 2014
AB EQ 300MG BASE A204165 002 Sep 15, 2014
AB SUN PHARM EQ 75MG BASE A090494 001 May 17, 2012
AB TEVA EQ 75MG BASE A076999 001 May 17, 2012
AB TORRENT PHARMS LTD EQ 75MG BASE A090844 001 May 17, 2012
PLAVIX
AB + SANOFI AVENTIS US EQ 75MG BASE N020839 001 Nov 17, 1997
AB + EQ 300MG BASE N020839 002 Sep 20, 2007
CLORAZEPATE DIPOTASSIUM
TABLET;ORAL
CLORAZEPATE DIPOTASSIUM
AB AUROBINDO PHARMA 3.75MG A071858 002 Jul 17, 1987
AB 7.5MG A071858 003 Jul 17, 1987
AB ! 15MG A071858 001 Jul 17, 1987
AB COREPHARMA 3.75MG A215566 001 Jun 14, 2022
AB 7.5MG A215566 002 Jun 14, 2022
AB 15MG A215566 003 Jun 14, 2022
AB NOVITIUM PHARMA 3.75MG A213730 001 Jun 16, 2022
AB 7.5MG A213730 002 Jun 16, 2022
AB 15MG A213730 003 Dec 16, 2022
AB TARO 3.75MG A075731 003 Apr 27, 2000
AB 7.5MG A075731 002 Apr 27, 2000
AB 15MG A075731 001 Apr 27, 2000
TRANXENE
AB + KEY THERAP 7.5MG N017105 007
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-112(of 474)

CLOTRIMAZOLE
CREAM;TOPICAL
CLOTRIMAZOLE
AB FOUGERA PHARMS 1% A078338 001 Sep 02, 2008
AB GLENMARK PHARMS 1% A090219 001 Aug 03, 2010
AB ! TARO 1% A072640 001 Aug 31, 1993
SOLUTION;TOPICAL
CLOTRIMAZOLE
AT NOVITIUM PHARMA 1% A209815 001 Feb 14, 2019
AT ! TARO 1% A074580 001 Jul 29, 1996
AT TASMAN PHARMA 1% A212281 001 Jul 25, 2019
AT TEVA 1% A073306 001 Feb 28, 1995
TROCHE/LOZENGE;ORAL
CLOTRIMAZOLE
AB ! HIKMA 10MG A076387 001 Jul 29, 2004
AB PADAGIS US 10MG A076763 001 Oct 28, 2005
CLOZAPINE
SUSPENSION;ORAL
VERSACLOZ
+! TASMAN PHARMA 50MG/ML N203479 001 Feb 06, 2013
TABLET;ORAL
CLOZAPINE
AB ACCORD HLTHCARE 25MG A202873 001 Nov 25, 2015
AB 100MG A202873 002 Nov 25, 2015
AB AUROBINDO PHARMA 25MG A206433 001 Nov 29, 2016
AB 50MG A206433 002 Nov 29, 2016
AB 100MG A206433 003 Nov 29, 2016
AB 200MG A206433 004 Nov 29, 2016
AB IVAX SUB TEVA 25MG A074949 001 Nov 26, 1997
PHARMS
AB 50MG A074949 004 Apr 25, 2005
AB 50MG A076809 003 Dec 16, 2005
AB 100MG A074949 002 Nov 26, 1997
AB 100MG A076809 002 Dec 16, 2005
AB 200MG A076809 001 Dec 16, 2005
AB MAYNE PHARMA 25MG A203807 001 Sep 17, 2015
AB 50MG A203807 003 Aug 22, 2017
AB 100MG A203807 002 Sep 17, 2015
AB 200MG A203807 004 Aug 22, 2017
AB MYLAN 25MG A075417 001 May 27, 1999
AB 50MG A075417 004 Apr 15, 2010
AB 100MG A075417 002 May 27, 1999
AB 200MG A075417 005 Apr 15, 2010
AB SUN PHARM INDS INC 25MG A075713 001 Nov 15, 2002
AB 50MG A075713 003 Aug 19, 2005
AB 100MG A075713 002 Nov 15, 2002
AB 200MG A075713 004 Nov 07, 2017
CLOZARIL
AB + HERITAGE LIFE 25MG N019758 001 Sep 26, 1989
AB + 50MG N019758 003 May 20, 2019
AB +! 100MG N019758 002 Sep 26, 1989
AB + 200MG N019758 004 May 20, 2019
CLOZAPINE
IVAX SUB TEVA 12.5MG A074949 003 Jul 31, 2003
PHARMS
TABLET, ORALLY DISINTEGRATING;ORAL
CLOZAPINE
AB BARR LABS INC 25MG A090308 001 Nov 25, 2015
AB ! 100MG A090308 002 Nov 25, 2015
AB MYLAN 25MG A201824 002 Sep 15, 2015
AB 100MG A201824 003 Sep 15, 2015
BARR LABS INC 12.5MG A090308 003 Apr 09, 2018
TEVA PHARMS USA 150MG A203039 001 Nov 25, 2015
200MG A203039 002 Nov 25, 2015
COBICISTAT
TABLET;ORAL
TYBOST
+! GILEAD SCIENCES INC 150MG N203094 001 Sep 24, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-113(of 474)

COBICISTAT; DARUNAVIR
TABLET;ORAL
PREZCOBIX
+! JANSSEN PRODS 150MG;800MG N205395 001 Jan 29, 2015
COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
TABLET;ORAL
SYMTUZA
+! JANSSEN PRODS 150MG;800MG;200MG;EQ 10MG BASE N210455 001 Jul 17, 2018
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
TABLET;ORAL
GENVOYA
+! GILEAD SCIENCES INC 150MG;150MG;200MG;EQ 10MG BASE N207561 001 Nov 05, 2015
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
TABLET;ORAL
STRIBILD
+! GILEAD SCIENCES INC 150MG;150MG;200MG;300MG N203100 001 Aug 27, 2012
COBIMETINIB FUMARATE
TABLET;ORAL
COTELLIC
+! GENENTECH INC EQ 20MG BASE N206192 001 Nov 10, 2015
COCAINE HYDROCHLORIDE
SOLUTION;NASAL
GOPRELTO
+! GENUS LIFESCIENCES 4% N209963 001 Dec 14, 2017
NUMBRINO
+! CODY LABS INC 4% N209575 001 Jan 10, 2020
CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
SYRUP;ORAL
PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE
AA ! PHARM ASSOC 10MG/5ML;5MG/5ML;6.25MG/5ML A040660 001 Dec 07, 2006
PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE
AA AKORN 10MG/5ML;5MG/5ML;6.25MG/5ML A040674 001 Dec 23, 2014
PROMETHAZINE HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE
AA AMNEAL PHARMS 10MG/5ML;5MG/5ML;6.25MG/5ML A200963 001 Aug 26, 2015
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
SYRUP;ORAL
PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
AA +! ACTAVIS MID 10MG/5ML;6.25MG/5ML A088763 001 Oct 31, 1984
ATLANTIC
AA AKORN 10MG/5ML;6.25MG/5ML A040151 001 Aug 26, 1997
AA AMNEAL PHARMS 10MG/5ML;6.25MG/5ML A200894 001 Apr 24, 2013
AA NOSTRUM LABS INC 10MG/5ML;6.25MG/5ML A090180 001 Mar 17, 2010
AA QUAGEN 10MG/5ML;6.25MG/5ML A214238 001 Oct 08, 2020
AA TRIS PHARMA INC 10MG/5ML;6.25MG/5ML A200386 001 Jun 29, 2012
AA WOCKHARDT BIO AG 10MG/5ML;6.25MG/5ML A088875 001 Dec 17, 1984
PROMETHAZINE WITH CODEINE
AA PHARM ASSOC 10MG/5ML;6.25MG/5ML A040650 001 Jan 31, 2006
CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
SYRUP;ORAL
TRIACIN-C
! STI PHARMA LLC 10MG/5ML;30MG/5ML;1.25MG/5ML A088704 001 Mar 22, 1985
CODEINE SULFATE
TABLET;ORAL
CODEINE SULFATE
AB + HIKMA 15MG N022402 001 Jul 16, 2009
AB + 30MG N022402 002 Jul 16, 2009
AB +! 60MG N022402 003 Jul 16, 2009
AB LANNETT CO INC 15MG A203046 001 Jun 13, 2014
AB 30MG A203046 002 Jun 13, 2014
AB 60MG A203046 003 Jun 13, 2014
COLCHICINE
CAPSULE;ORAL
MITIGARE
+! HIKMA INTL PHARMS 0.6MG N204820 001 Sep 26, 2014
SOLUTION;ORAL
GLOPERBA
+! SCILEX PHARMS 0.6MG/5ML N210942 001 Jan 30, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-114(of 474)

COLCHICINE
TABLET;ORAL
COLCHICINE
AB ALKEM LABS LTD 0.6MG A211250 001 Feb 08, 2019
AB AMNEAL PHARMS 0.6MG A204711 001 Sep 28, 2016
AB AUROBINDO PHARMA 0.6MG A215444 001 Jan 06, 2022
LTD
AB DR REDDYS 0.6MG A209876 001 Sep 06, 2019
AB GRANULES 0.6MG A210425 001 Feb 05, 2020
AB HETERO LABS LTD V 0.6MG A208993 001 Aug 13, 2021
AB MYLAN 0.6MG A209470 001 Sep 16, 2019
AB PAR PHARM INC 0.6MG A203976 001 Aug 12, 2021
AB STRIDES PHARMA 0.6MG A209173 001 Mar 10, 2022
AB WATSON LABS INC 0.6MG A204461 001 Jul 31, 2019
AB ZYDUS PHARMS 0.6MG A211519 001 Feb 19, 2019
COLCRYS
AB +! TAKEDA PHARMS USA 0.6MG N022352 001 Jul 29, 2009
COLCHICINE
ZYDUS PHARMS 0.3MG A211519 002 Nov 14, 2019
COLCHICINE; PROBENECID
TABLET;ORAL
COL-PROBENECID
AB +! WATSON LABS 0.5MG;500MG A084279 001
PROBENECID AND COLCHICINE
AB NOVAST LABS 0.5MG;500MG A040618 001 May 13, 2008
COLESEVELAM HYDROCHLORIDE
FOR SUSPENSION;ORAL
COLESEVELAM HYDROCHLORIDE
AB ALKEM LABS LTD 3.75GM/PACKET A210316 001 May 06, 2019
AB GLENMARK PHARMS LTD 3.75GM/PACKET A202190 002 Jul 16, 2018
WELCHOL
AB +! COSETTE 3.75GM/PACKET N022362 002 Oct 02, 2009
COLESEVELAM HYDROCHLORIDE
GLENMARK PHARMS LTD 1.875GM/PACKET A202190 001 Jul 16, 2018
TABLET;ORAL
COLESEVELAM HYDROCHLORIDE
AB ALKEM LABS LTD 625MG A209038 001 Oct 05, 2018
AB BEIJING TIDE PHARM 625MG A206036 001 Oct 14, 2021
AB BIONPHARMA INC 625MG A208670 001 Sep 13, 2019
AB DR REDDYS 625MG A210889 001 Oct 05, 2018
AB GLENMARK PHARMS LTD 625MG A203480 001 May 18, 2018
AB IMPAX LABS INC 625MG A091600 001 May 16, 2018
AB INVENTIA 625MG A212050 001 Dec 04, 2020
AB SPH 625MG A213456 001 Jan 21, 2022
AB ZHEJIANG JINGXIN 625MG A209946 001 Jul 15, 2020
AB ZYDUS PHARMS 625MG A207765 001 Oct 07, 2019
WELCHOL
AB +! COSETTE 625MG N021176 001 May 26, 2000
COLESTIPOL HYDROCHLORIDE
GRANULE;ORAL
COLESTID
AB + PFIZER 5GM/SCOOPFUL N017563 003 Sep 22, 1995
AB +! 5GM/PACKET N017563 004 Sep 22, 1995
COLESTIPOL HYDROCHLORIDE
AB IMPAX LABS 5GM/SCOOPFUL A077277 001 May 02, 2006
AB 5GM/PACKET A077277 002 May 02, 2006
FLAVORED COLESTID
+ PFIZER 5GM/PACKET N017563 001
+ 5GM/SCOOPFUL N017563 002
TABLET;ORAL
COLESTID
AB + PFIZER 1GM N020222 001 Jul 19, 1994
COLESTIPOL HYDROCHLORIDE
AB ! IMPAX LABS 1GM A077510 001 Oct 24, 2006
AB ZYDUS PHARMS 1GM A215223 001 Mar 10, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-115(of 474)

COLISTIMETHATE SODIUM
INJECTABLE;INJECTION
COLISTIMETHATE SODIUM
AP EMCURE PHARMS LTD EQ 150MG BASE/VIAL A202359 001 Sep 28, 2012
AP FRESENIUS KABI USA EQ 150MG BASE/VIAL A065364 001 Apr 17, 2008
AP NEXUS PHARMS EQ 150MG BASE/VIAL A065177 001 Mar 19, 2004
AP SAGENT PHARMS INC EQ 150MG BASE/VIAL A201365 001 Feb 19, 2014
AP XELLIA PHARMS APS EQ 150MG BASE/VIAL A205356 001 May 29, 2015
AP XGEN PHARMS EQ 150MG BASE/VIAL A064216 001 Feb 26, 1999
COLY-MYCIN M
AP +! PAR STERILE EQ 150MG BASE/VIAL N050108 002
PRODUCTS
COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE
SUSPENSION/DROPS;OTIC
COLY-MYCIN S
+! ENDO PHARMS INC EQ 3MG BASE/ML;10MG/ML;EQ 3.3MG N050356 001
BASE/ML;0.5MG/ML
CONIVAPTAN HYDROCHLORIDE
INJECTABLE;INTRAVENOUS
VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER
+! CUMBERLAND PHARMS 20MG/100ML (0.2MG/ML) N021697 002 Oct 08, 2008
COPANLISIB DIHYDROCHLORIDE
POWDER;INTRAVENOUS
ALIQOPA
+! BAYER HEALTHCARE 60MG/VIAL N209936 001 Sep 14, 2017
COPPER
INTRAUTERINE DEVICE;INTRAUTERINE
PARAGARD T 380A
+! COOPERSURGICAL 309MG/COPPER N018680 001 Nov 15, 1984
COPPER CU-64 DOTATATE
SOLUTION;INTRAVENOUS
DETECTNET
+! RADIOMEDIX 4mL (1mCi/ML) N213227 001 Sep 03, 2020
CORTICOTROPIN
INJECTABLE;INJECTION
ACTHAR GEL
+! MALLINCKRODT ARD 80 UNITS/ML N008372 008
PURIFIED CORTROPHIN GEL
+! ANI PHARMS 80 UNITS/ML N008975 002
CORTISONE ACETATE
TABLET;ORAL
CORTISONE ACETATE
! HIKMA INTL PHARMS 25MG A080776 002
COSYNTROPIN
INJECTABLE;INJECTION
CORTROSYN
AP +! AMPHASTAR PHARMS 0.25MG/VIAL N016750 001
INC
COSYNTROPIN
AP MYLAN INSTITUTIONAL 0.25MG/VIAL A090574 001 Dec 17, 2009
AP SANDOZ 0.25MG/VIAL A202147 001 Jun 29, 2012
CRISABOROLE
OINTMENT;TOPICAL
EUCRISA
+! ANACOR PHARMS INC 2% N207695 001 Dec 14, 2016
CRIZOTINIB
CAPSULE;ORAL
XALKORI
+ PF PRISM CV 200MG N202570 001 Aug 26, 2011
+! 250MG N202570 002 Aug 26, 2011
CROFELEMER
TABLET, DELAYED RELEASE;ORAL
MYTESI
+! NAPO PHARMS INC 125MG N202292 001 Dec 31, 2012
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-116(of 474)

CROMOLYN SODIUM
CONCENTRATE;ORAL
CROMOLYN SODIUM
AA AILEX PHARMS LLC 100MG/5ML A209264 001 Oct 16, 2017
AA MICRO LABS LTD 100MG/5ML A202745 001 Apr 04, 2013
INDIA
AA RISING 100MG/5ML A202583 001 Oct 27, 2011
GASTROCROM
AA +! MYLAN SPECIALITY LP 100MG/5ML N020479 001 Feb 29, 1996
SOLUTION;INHALATION
CROMOLYN SODIUM
AN AILEX PHARMS LLC 10MG/ML A209453 001 Oct 16, 2017
AN FERA PHARMS LLC 10MG/ML A075437 001 Apr 21, 2000
AN MICRO LABS 10MG/ML A213658 001 Apr 29, 2022
AN ! TEVA PHARMS 10MG/ML A075271 001 Jan 18, 2000
AN WOCKHARDT BIO AG 10MG/ML A075346 001 Oct 25, 1999
SOLUTION/DROPS;OPHTHALMIC
CROMOLYN SODIUM
AT ! AKORN 4% A074706 001 Apr 29, 1998
AT SANDOZ INC 4% A075282 001 Jun 16, 1999
CROTAMITON
LOTION;TOPICAL
CROTAN
AT MARNEL PHARMS 10% A087204 001
EURAX
AT +! JOURNEY 10% N009112 003
CUPRIC CHLORIDE
INJECTABLE;INJECTION
CUPRIC CHLORIDE
AP EXELA PHARMA EQ 0.4MG COPPER/ML A212071 001 Oct 31, 2022
CUPRIC CHLORIDE IN PLASTIC CONTAINER
AP +! HOSPIRA EQ 0.4MG COPPER/ML N018960 001 Jun 26, 1986
CUPRIC SULFATE
INJECTABLE;INJECTION
CUPRIC SULFATE
! AM REGENT EQ 0.4MG COPPER/ML A216324 001 Dec 16, 2022
CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE
SOLUTION;INTRAVENOUS
MULTRYS
+! AM REGENT EQ 60MCG COPPER/ML;EQ 3MCG BASE/ML;EQ N209376 003 Jun 30, 2021
6MCG SELENIUM/ML;EQ 1000MCG BASE/ML
(1ML)
TRALEMENT
+! AM REGENT EQ 0.3MG COPPER/ML;EQ 55MCG BASE/ML;EQ N209376 001 Jul 02, 2020
60MCG SELENIUM/ML;EQ 3MG BASE/ML (1ML)
+! EQ 0.3MG COPPER/ML;EQ 55MCG BASE/ML;EQ N209376 002 Dec 02, 2020
60MCG SELENIUM/ML;EQ 3MG BASE/ML (5ML)
CYANOCOBALAMIN
INJECTABLE;INJECTION
CYANOCOBALAMIN
AP +! AM REGENT 1MG/ML A080737 001
AP EUGIA PHARMA 1MG/ML A213874 001 Dec 08, 2020
AP GLAND PHARMA LTD 1MG/ML A214390 001 Sep 24, 2020
AP MYLAN LABS LTD 1MG/ML A204829 001 Jun 05, 2017
AP SAGENT PHARMS INC 1MG/ML A215107 001 Nov 15, 2022
AP SANDOZ INC 1MG/ML A212915 001 Jan 04, 2021
AP SOLA PHARMS 1MG/ML A215417 001 Apr 15, 2022
AP SOMERSET THERAPS 1MG/ML A206503 001 Dec 11, 2015
LLC
AP 1MG/ML A209429 001 Dec 18, 2018
AP VITRUVIAS THERAP 1MG/ML A209255 001 Dec 18, 2018
AP WEST-WARD PHARMS 1MG/ML A080515 002
INT
AP ZYDUS PHARMS 1MG/ML A214655 001 Apr 15, 2022
DODEX
AP ACCORD HLTHCARE 1MG/ML A083022 001
VIBISONE
AP +! FRESENIUS KABI USA 1MG/ML A080557 003
SPRAY, METERED;NASAL
NASCOBAL
+! ENDO PHARMS INC 0.5MG/SPRAY N021642 001 Jan 31, 2005
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-117(of 474)

CYCLOBENZAPRINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
AMRIX
AB + TEVA PHARMS INTL 15MG N021777 001 Feb 01, 2007
AB +! 30MG N021777 002 Feb 01, 2007
CYCLOBENZAPRINE HYDROCHLORIDE
AB APOTEX 15MG A206703 001 Jul 24, 2018
AB 30MG A206703 002 Jul 24, 2018
AB TWI PHARMS INC 15MG A091281 001 Jan 31, 2013
AB 30MG A091281 002 Jan 31, 2013
TABLET;ORAL
CYCLOBENZAPRINE HYDROCHLORIDE
AB ACTAVIS LABS FL INC 5MG A071611 002 Feb 03, 2006
AB 7.5MG A071611 003 Feb 03, 2006
AB 10MG A071611 001 May 03, 1989
AB ALEMBIC LABS 5MG A078218 002 Jun 19, 2015
AB 7.5MG A078218 003 Nov 03, 2020
AB 10MG A078218 001 Apr 18, 2008
AB ANDA REPOSITORY 5MG A073541 002 Apr 06, 2006
AB 10MG A073541 001 May 23, 1995
AB AUROBINDO PHARMA 5MG A078643 001 Sep 26, 2008
AB 10MG A078643 002 Sep 26, 2008
AB INVAGEN PHARMS 5MG A090478 001 Jul 23, 2010
AB 10MG A090478 002 Jul 23, 2010
AB JUBILANT CADISTA 5MG A077563 001 Apr 19, 2006
AB 7.5MG A077563 003 Aug 25, 2017
AB 10MG A077563 002 Apr 19, 2006
AB KVK TECH 5MG A078048 001 Feb 28, 2011
AB 10MG A078048 002 Feb 28, 2011
AB OXFORD PHARMS 5MG A077209 002 Feb 03, 2006
AB 10MG A077209 001 Oct 04, 2005
AB PRINSTON INC 5MG A077797 001 Feb 28, 2007
AB 10MG A077797 002 Feb 28, 2007
AB RUBICON 5MG A208170 001 May 31, 2017
AB 7.5MG A208170 002 May 31, 2017
AB ! 10MG A208170 003 May 31, 2017
AB SUN PHARM INDS LTD 5MG A078722 001 May 12, 2008
AB 7.5MG A078722 002 May 12, 2008
AB 10MG A078722 003 May 12, 2008
AB UNICHEM 5MG A213324 001 Jul 06, 2020
AB 7.5MG A213324 002 Jul 06, 2020
AB 10MG A213324 003 Jul 05, 2020
CYCLOPENTOLATE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
AKPENTOLATE
AT AKORN 1% A040164 001 Jan 13, 1997
AT 2% A040165 001 Jan 13, 1997
CYCLOGYL
AT +! ALCON LABS INC 0.5% A084109 001
AT +! 1% A084110 001
AT +! 2% A084108 001
CYCLOPENTOLATE HYDROCHLORIDE
AT AKORN 0.5% A205937 001 Dec 09, 2015
PENTOLAIR
AT BAUSCH AND LOMB 1% A040075 001 Apr 29, 1994
CYCLOPENTOLATE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
CYCLOMYDRIL
! ALCON LABS INC 0.2%;1% A084300 001
CYCLOPHOSPHAMIDE
CAPSULE;ORAL
CYCLOPHOSPHAMIDE
AB ALEMBIC PHARMS 25MG A215892 001 Nov 10, 2022
AB 50MG A215892 002 Nov 10, 2022
AB ANIMA 25MG A209872 001 May 07, 2018
AB 50MG A209872 002 May 07, 2018
AB CIPLA 25MG A211608 001 Jan 18, 2019
AB 50MG A211608 002 Jan 18, 2019
AB + HIKMA 25MG N203856 001 Sep 16, 2013
AB +! 50MG N203856 002 Sep 16, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-118(of 474)

CYCLOPHOSPHAMIDE
INJECTABLE;INJECTION
CYCLOPHOSPHAMIDE
AP AMNEAL 500MG/VIAL A210046 001 May 25, 2018
AP 1GM/VIAL A210046 002 May 25, 2018
AP 2GM/VIAL A210046 003 May 25, 2018
AP ! BAXTER HLTHCARE 500MG/VIAL A040745 001 May 21, 2008
AP ! 1GM/VIAL A040745 002 May 21, 2008
AP ! 2GM/VIAL A040745 003 May 21, 2008
AP HENGRUI PHARMA 500MG/VIAL A204555 001 Oct 31, 2014
AP 1GM/VIAL A204555 002 Oct 31, 2014
AP 2GM/VIAL A204555 003 Oct 31, 2014
AP XELLIA PHARMS APS 500MG/VIAL A211757 001 Oct 18, 2022
AP 1GM/VIAL A211757 002 Oct 18, 2022
AP 2GM/VIAL A211757 003 Oct 18, 2022
SOLUTION;INTRAVENOUS
CYCLOPHOSPHAMIDE
+! EUGIA PHARMA 500MG/2.5ML (200MG/ML) N210735 001 Aug 25, 2021
SPECLTS
+! 1GM/5ML (200MG/ML) N210735 002 Aug 25, 2021
+! INGENUS PHARMS LLC 500MG/2.5ML (200MG/ML) N212501 001 Jul 30, 2020
+! 1GM/5ML (200MG/ML) N212501 002 Jul 30, 2020
+! 2GM/10ML (200MG/ML) N212501 003 Nov 19, 2021
TABLET;ORAL
CYTOXAN
+ BAXTER HLTHCARE 25MG N012141 002
+! 50MG N012141 001
CYCLOSERINE
CAPSULE;ORAL
SEROMYCIN
! CEROVENE INC 250MG A060593 001
CYCLOSPORINE
CAPSULE;ORAL
CYCLOSPORINE
AB1 APOTEX 25MG A210721 001 Jul 10, 2019
AB1 50MG A210721 002 Jul 10, 2019
AB1 100MG A210721 003 Jul 10, 2019
AB1 IVAX SUB TEVA 25MG A065110 003 Mar 29, 2005
PHARMS
AB1 50MG A065110 001 Mar 29, 2005
AB1 100MG A065110 002 Mar 29, 2005
AB1 MAYNE PHARMA 25MG A065044 002 Dec 20, 2000
AB1 100MG A065044 001 Dec 20, 2000
AB1 SANDOZ 25MG A065017 002 Jan 13, 2000
AB1 100MG A065017 001 Jan 13, 2000
AB1 STRIDES PHARMA 25MG A216046 001 Aug 02, 2022
AB1 50MG A216046 002 Aug 02, 2022
AB1 100MG A216046 003 Aug 02, 2022
GENGRAF
AB1 ABBVIE 25MG A065003 001 May 12, 2000
AB1 100MG A065003 003 May 12, 2000
NEORAL
AB1 + NOVARTIS 25MG N050715 001 Jul 14, 1995
AB1 +! 100MG N050715 002 Jul 14, 1995
CYCLOSPORINE
AB2 APOTEX 25MG A065040 001 May 09, 2002
AB2 100MG A065040 002 May 09, 2002
SANDIMMUNE
AB2 + NOVARTIS 25MG N050625 001 Mar 02, 1990
AB2 +! 100MG N050625 002 Mar 02, 1990
BX + 50MG N050625 003 Nov 23, 1992
EMULSION;OPHTHALMIC
CYCLOSPORINE
AB MYLAN 0.05% A205894 001 Feb 02, 2022
RESTASIS
AB +! ALLERGAN 0.05% N050790 001 Dec 23, 2002
RESTASIS MULTIDOSE
+! ALLERGAN 0.05% N050790 002 Oct 27, 2016
VERKAZIA
+! SANTEN 0.1% N214965 001 Jun 23, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-119(of 474)

CYCLOSPORINE
INJECTABLE;INJECTION
CYCLOSPORINE
AP HIKMA 50MG/ML A065004 001 Oct 29, 1999
AP PADAGIS US 50MG/ML A065151 001 Oct 07, 2003
SANDIMMUNE
AP +! NOVARTIS 50MG/ML N050573 001 Nov 14, 1983
SOLUTION;OPHTHALMIC
CEQUA
+! SUN PHARM 0.09% N210913 001 Aug 14, 2018
SOLUTION;ORAL
CYCLOSPORINE
AB1 ABBVIE 100MG/ML A065025 001 Mar 03, 2000
AB1 IVAX SUB TEVA 100MG/ML A065078 001 Mar 25, 2005
PHARMS
NEORAL
AB1 +! NOVARTIS 100MG/ML N050716 001 Jul 14, 1995
CYCLOSPORINE
AB2 WOCKHARDT BIO AG 100MG/ML A065133 001 Sep 17, 2004
SANDIMMUNE
AB2 +! NOVARTIS 100MG/ML N050574 001 Nov 14, 1983
CYPROHEPTADINE HYDROCHLORIDE
SYRUP;ORAL
CYPROHEPTADINE HYDROCHLORIDE
AA ANDA REPOSITORY 2MG/5ML A204823 001 Dec 27, 2016
AA CHARTWELL MOLECULAR 2MG/5ML A203191 001 Jul 13, 2017
AA ELYSIUM 2MG/5ML A209108 001 Oct 16, 2018
AA ! LYNE 2MG/5ML A040668 001 Jun 28, 2006
AA PHARM ASSOC 2MG/5ML A091295 001 Mar 28, 2013
AA QUAGEN 2MG/5ML A212423 001 May 22, 2019
TABLET;ORAL
CYPROHEPTADINE HYDROCHLORIDE
AA APPCO 4MG A206553 001 Nov 29, 2016
AA BEXIMCO PHARMS USA 4MG A206676 001 Apr 12, 2019
AA BOSCOGEN 4MG A040644 001 May 30, 2006
AA ELYSIUM 4MG A207555 001 Jan 31, 2017
AA +! HERITAGE PHARMA 4MG A087056 001
AA MOUNTAIN 4MG A040537 001 Sep 30, 2003
AA NOVAST LABS 4MG A205087 001 Sep 23, 2015
AA QUAGEN 4MG A212491 001 Feb 24, 2021
AA RISING 4MG A207783 001 Dec 29, 2016
AA STRIDES PHARMA 4MG A209172 001 Apr 11, 2018
AA ZYDUS PHARMS 4MG A208938 001 May 19, 2017
CYSTEAMINE BITARTRATE
CAPSULE;ORAL
CYSTAGON
+ MYLAN EQ 50MG BASE N020392 001 Aug 15, 1994
+! EQ 150MG BASE N020392 002 Aug 15, 1994
CAPSULE, DELAYED RELEASE;ORAL
PROCYSBI
+ HORIZON EQ 25MG BASE N203389 001 Apr 30, 2013
+! EQ 75MG BASE N203389 002 Apr 30, 2013
GRANULE, DELAYED RELEASE;ORAL
PROCYSBI
+ HORIZON EQ 75MG BASE/PACKET N213491 001 Feb 14, 2020
+! EQ 300MG BASE/PACKET N213491 002 Feb 14, 2020
CYSTEAMINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
CYSTADROPS
+! RECORDATI RARE EQ 0.37% BASE N211302 001 Aug 19, 2020
CYSTARAN
+! LEADIANT BIOSCI INC EQ 0.44% BASE N200740 001 Oct 02, 2012
CYSTEINE HYDROCHLORIDE
SOLUTION;INTRAVENOUS
ELCYS
+! EXELA PHARMA 500MG/10ML (50MG/ML) N210660 001 Apr 16, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-120(of 474)

CYTARABINE
INJECTABLE;INJECTION
CYTARABINE
AP ! FRESENIUS KABI USA 100MG/ML A076512 001 Jan 15, 2004
AP GLAND PHARMA LTD 100MG/VIAL A211937 001 Dec 23, 2019
AP 2GM/VIAL A211938 001 Dec 23, 2019
AP HIKMA 100MG/VIAL A071471 001 Aug 02, 1989
AP ! HOSPIRA 20MG/ML A071868 001 Jun 04, 1990
AP ! 20MG/ML A072168 001 Aug 31, 1990
AP ! 20MG/ML A072945 001 Feb 28, 1994
AP 100MG/ML A075383 001 Nov 22, 1999
AP MEITHEAL 20MG/ML A208485 001 Feb 28, 2022
AP 100MG/ML A205696 001 Jul 17, 2018
AP RISING 20MG/ML A200915 001 Dec 13, 2011
AP 100MG/ML A201784 001 Jan 30, 2012
AP ! WEST-WARD PHARMS 2GM/VIAL A074245 002 Aug 31, 1994
INT
! HIKMA 500MG/VIAL A071472 001 Aug 02, 1989
! WEST-WARD PHARMS 1GM/VIAL A074245 001 Aug 31, 1994
INT
CYTARABINE; DAUNORUBICIN
POWDER;INTRAVENOUS
VYXEOS
+! CELATOR PHARMS 100MG;44MG N209401 001 Aug 03, 2017
DABIGATRAN ETEXILATE MESYLATE
CAPSULE;ORAL
DABIGATRAN ETEXILATE MESYLATE
AB ALKEM LABS LTD EQ 75MG BASE A208040 001 Mar 11, 2020
AB EQ 150MG BASE A208040 002 Mar 11, 2020
AB HETERO LABS LTD III EQ 75MG BASE A207961 001 May 06, 2020
AB EQ 150MG BASE A207961 002 May 06, 2020
PRADAXA
AB + BOEHRINGER EQ 75MG BASE N022512 001 Oct 19, 2010
INGELHEIM
AB +! EQ 150MG BASE N022512 002 Oct 19, 2010
+ EQ 110MG BASE N022512 003 Nov 20, 2015
PELLETS;ORAL
PRADAXA
+ BOEHRINGER EQ 20MG BASE/PACKET N214358 001 Jun 21, 2021
INGELHEIM
+ EQ 30MG BASE/PACKET N214358 002 Jun 21, 2021
+ EQ 40MG BASE/PACKET N214358 003 Jun 21, 2021
+ EQ 50MG BASE/PACKET N214358 004 Jun 21, 2021
+ EQ 110MG BASE/PACKET N214358 005 Jun 21, 2021
+! EQ 150MG BASE/PACKET N214358 006 Jun 21, 2021
DABRAFENIB MESYLATE
CAPSULE;ORAL
TAFINLAR
+ NOVARTIS EQ 50MG BASE N202806 001 May 29, 2013
+! EQ 75MG BASE N202806 002 May 29, 2013
DACARBAZINE
INJECTABLE;INJECTION
DACARBAZINE
AP ! FRESENIUS KABI USA 200MG/VIAL A075371 002 Aug 27, 1999
AP HIKMA 200MG/VIAL A075812 001 Jun 15, 2001
AP 500MG/VIAL A075812 002 Oct 31, 2002
AP HOSPIRA 200MG/VIAL A075940 001 Oct 18, 2001
AP TEVA PHARMS USA 200MG/VIAL A075259 002 Aug 27, 1998
AP ! 500MG/VIAL A075259 001 Sep 22, 2000
! FRESENIUS KABI USA 100MG/VIAL A075371 001 Aug 27, 1999
DACOMITINIB
TABLET;ORAL
VIZIMPRO
+ PFIZER 15MG N211288 001 Sep 27, 2018
+ 30MG N211288 002 Sep 27, 2018
+! 45MG N211288 003 Sep 27, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-121(of 474)

DACTINOMYCIN
INJECTABLE;INJECTION
COSMEGEN
AP +! RECORDATI RARE 0.5MG/VIAL N050682 001
DACTINOMYCIN
AP EUGIA PHARMA 0.5MG/VIAL A203385 001 Nov 09, 2017
AP HISUN PHARM 0.5MG/VIAL A207232 001 Jul 16, 2019
HANGZHOU
AP MEITHEAL 0.5MG/VIAL A213463 001 Nov 13, 2020
AP XGEN PHARMS 0.5MG/VIAL A203999 001 May 20, 2019
DALBAVANCIN HYDROCHLORIDE
POWDER;INTRAVENOUS
DALVANCE
+! ALLERGAN EQ 500MG BASE/VIAL N021883 001 May 23, 2014
DALFAMPRIDINE
TABLET, EXTENDED RELEASE;ORAL
AMPYRA
AB +! ACORDA 10MG N022250 001 Jan 22, 2010
DALFAMPRIDINE
AB ACCORD HLTHCARE 10MG A206863 001 Jul 11, 2018
AB ACTAVIS LABS FL INC 10MG A206836 001 Jan 23, 2017
AB ALKEM LABS LTD 10MG A206765 001 Jul 30, 2018
AB AUROBINDO PHARMA 10MG A206811 001 Jan 23, 2017
AB MICRO LABS 10MG A210158 001 Mar 11, 2019
AB SUN PHARM 10MG A208292 001 May 21, 2019
DALFOPRISTIN; QUINUPRISTIN
INJECTABLE;INTRAVENOUS
SYNERCID
+! KING PHARMS 350MG/VIAL;150MG/VIAL N050748 001 Sep 21, 1999
DALTEPARIN SODIUM
INJECTABLE;SUBCUTANEOUS
FRAGMIN
+ PFIZER 2,500IU/0.2ML (12,500IU/ML) N020287 001 Dec 22, 1994
+ 5,000IU/0.2ML (25,000IU/ML) N020287 003 Mar 18, 1996
+ 7,500IU/0.3ML (25,000IU/ML) N020287 005 Apr 04, 2002
+ 10,000IU/ML (10,000IU/ML) N020287 004 Jan 30, 1998
+ 10,000IU/4ML (2,500IU/ML) N020287 012 Mar 15, 2022
+ 12,500IU/0.5ML (25,000IU/ML) N020287 009 May 01, 2007
+ 15,000IU/0.6ML (25,000IU/ML) N020287 010 May 01, 2007
+ 18,000IU/0.72ML (25,000IU/ML) N020287 011 May 01, 2007
+! 95,000IU/3.8ML (25,000IU/ML) N020287 006 Apr 04, 2002
DANAZOL
CAPSULE;ORAL
DANAZOL
AB BARR 50MG A074582 003 May 29, 1998
AB 100MG A074582 002 May 29, 1998
AB ! 200MG A074582 001 Aug 09, 1996
AB LANNETT CO INC 50MG A077246 002 Apr 19, 2007
AB 100MG A077246 003 Apr 19, 2007
AB 200MG A077246 001 Sep 28, 2005
DANTROLENE SODIUM
CAPSULE;ORAL
DANTRIUM
AB + PAR STERILE 25MG N017443 001
PRODUCTS
AB + 50MG N017443 003
AB +! 100MG N017443 002
DANTROLENE SODIUM
AB ELITE LABS INC 25MG A076686 001 Oct 24, 2005
AB 50MG A076686 002 Oct 24, 2005
AB 100MG A076686 003 Oct 24, 2005
AB IMPAX LABS 25MG A076856 001 Mar 01, 2005
AB 50MG A076856 002 Mar 01, 2005
AB 100MG A076856 003 Mar 01, 2005
FOR SUSPENSION;INTRAVENOUS
RYANODEX
+! EAGLE PHARMS 250MG/VIAL N205579 001 Jul 22, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-122(of 474)

DANTROLENE SODIUM
INJECTABLE;INJECTION
DANTRIUM
AP +! PAR STERILE 20MG/VIAL N018264 001
PRODUCTS
DANTROLENE SODIUM
AP HIKMA 20MG/VIAL A204762 001 Jun 19, 2017
REVONTO
AP USWM 20MG/VIAL A078378 001 Jul 24, 2007
DAPAGLIFLOZIN
TABLET;ORAL
FARXIGA
+ ASTRAZENECA AB 5MG N202293 001 Jan 08, 2014
+! 10MG N202293 002 Jan 08, 2014
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
XIGDUO XR
+ ASTRAZENECA AB 2.5MG;1GM N205649 005 Jul 28, 2017
+ 5MG;500MG N205649 001 Oct 29, 2014
+ 5MG;1GM N205649 002 Oct 29, 2014
+ 10MG;500MG N205649 003 Oct 29, 2014
+! 10MG;1GM N205649 004 Oct 29, 2014
DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE
TABLET;ORAL
QTERN
+ ASTRAZENECA AB 5MG;EQ 5MG BASE N209091 002 May 02, 2019
+! 10MG;EQ 5MG BASE N209091 001 Feb 27, 2017
DAPSONE
GEL;TOPICAL
ACZONE
AB +! ALLERGAN 5% N021794 001 Jul 07, 2005
AB +! ALMIRALL 7.5% N207154 001 Feb 24, 2016
DAPSONE
AB COSETTE 5% A210178 001 Mar 31, 2022
AB MYLAN 7.5% A213847 001 Feb 04, 2022
AB TARO 5% A209506 001 Oct 16, 2017
AB TARO PHARMS 7.5% A210191 001 Jun 26, 2019
AB TORRENT 7.5% A214722 001 Feb 10, 2022
TABLET;ORAL
DAPSONE
AB ACTAVIS LLC 25MG A204380 001 Mar 23, 2017
AB 100MG A204380 002 Mar 23, 2017
AB ALVOGEN 25MG A205429 001 Jan 07, 2016
AB 100MG A205429 002 Jan 07, 2016
AB + EVEREST LIFE SCI 25MG A086841 001
AB +! 100MG A086842 001
AB NOSTRUM LABS INC 25MG A203887 001 May 06, 2016
AB 100MG A203887 002 May 06, 2016
AB NOVITIUM PHARMA 25MG A206505 001 Dec 01, 2016
AB 100MG A206505 002 Dec 01, 2016
AB RISING 100MG A207165 001 May 08, 2019
DAPTOMYCIN
POWDER;INTRAVENOUS
CUBICIN
AP +! CUBIST PHARMS LLC 500MG/VIAL N021572 002 Sep 12, 2003
DAPTOMYCIN
AP ACCORD HLTHCARE 350MG/VIAL A212667 001 Jul 12, 2019
AP 500MG/VIAL A211961 001 Jun 24, 2019
AP ASPIRO 350MG/VIAL A216445 001 Dec 23, 2022
AP 500MG/VIAL A216413 001 Sep 23, 2022
AP BE PHARMS 350MG/VIAL A213425 001 Aug 20, 2020
AP 500MG/VIAL A212513 001 Jun 26, 2019
AP DR REDDYS 350MG/VIAL A211403 001 Aug 31, 2020
AP 500MG/VIAL A208375 001 May 01, 2019
AP EUGIA PHARMA 500MG/VIAL A213171 001 Sep 02, 2021
AP FRESENIUS KABI USA 500MG/VIAL A206077 001 Apr 11, 2018
AP HAINAN POLY PHARM 500MG/VIAL A215890 001 Aug 18, 2022
AP HANGZHOU ZHONGMEI 500MG/VIAL A215215 001 Nov 26, 2021
AP HENGRUI PHARMA 500MG/VIAL A212022 001 Aug 22, 2019
AP MEITHEAL 350MG/VIAL A213786 001 Jun 29, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-123(of 474)

DAPTOMYCIN
POWDER;INTRAVENOUS
DAPTOMYCIN
AP 500MG/VIAL A213623 001 Jun 29, 2021
AP MYLAN LABS LTD 500MG/VIAL A205037 001 Jun 05, 2018
AP QILU PHARM HAINAN 500MG/VIAL A215316 001 Aug 24, 2021
AP +! SAGENT PHARMS INC 350MG/VIAL N208385 001 Sep 12, 2017
AP 500MG/VIAL A207104 001 Nov 15, 2019
AP TEVA PHARMS USA 500MG/VIAL A091039 001 Mar 25, 2016
AP XELLIA PHARMS APS 500MG/VIAL A206005 001 Jun 15, 2016
+! HOSPIRA 350MG/VIAL N210282 001 Jun 21, 2021
+! 500MG/VIAL N210282 002 Jun 21, 2021
+! XELLIA PHARMS APS 350MG/VIAL N209949 001 Oct 20, 2017
DARIDOREXANT HYDROCHLORIDE
TABLET;ORAL
QUVIVIQ
+ IDORSIA EQ 25MG BASE N214985 001 Apr 07, 2022
+! EQ 50MG BASE N214985 002 Apr 07, 2022
DARIFENACIN HYDROBROMIDE
TABLET, EXTENDED RELEASE;ORAL
DARIFENACIN
AB MACLEODS PHARMS LTD EQ 7.5MG BASE A207302 001 Jul 28, 2017
AB ! EQ 15MG BASE A207302 002 Jul 28, 2017
DARIFENACIN HYDROBROMIDE
AB ALEMBIC PHARMS EQ 7.5MG BASE A207681 001 Dec 08, 2017
AB EQ 15MG BASE A207681 002 Dec 08, 2017
AB AUROBINDO PHARMA EQ 7.5MG BASE A206743 001 Sep 19, 2016
AB EQ 15MG BASE A206743 002 Sep 19, 2016
AB CIPLA EQ 7.5MG BASE A207664 001 Sep 01, 2016
AB EQ 15MG BASE A207664 002 Sep 01, 2016
AB POLYGEN PHARMS EQ 7.5MG BASE A211045 001 Jan 06, 2020
AB EQ 15MG BASE A211045 002 Jan 06, 2020
AB TORRENT EQ 7.5MG BASE A205209 001 Nov 17, 2016
AB EQ 15MG BASE A205209 002 Nov 17, 2016
DAROLUTAMIDE
TABLET;ORAL
NUBEQA
+! BAYER HEALTHCARE 300MG N212099 001 Jul 30, 2019
DARUNAVIR
SUSPENSION;ORAL
PREZISTA
+! JANSSEN PRODS 100MG/ML N202895 001 Dec 16, 2011
TABLET;ORAL
DARUNAVIR
AB LUPIN LTD 600MG A202073 001 Sep 29, 2022
AB 800MG A202073 002 Sep 29, 2022
AB TEVA PHARMS USA 600MG A202118 001 Nov 21, 2017
PREZISTA
AB + JANSSEN PRODS 600MG N021976 002 Feb 25, 2008
AB +! 800MG N021976 006 Nov 09, 2012
+ 75MG N021976 004 Dec 18, 2008
+ 150MG N021976 005 Dec 18, 2008
DASATINIB
TABLET;ORAL
SPRYCEL
+ BRISTOL MYERS 20MG N021986 001 Jun 28, 2006
SQUIBB
+ 50MG N021986 002 Jun 28, 2006
+ 70MG N021986 003 Jun 28, 2006
+ 80MG N021986 005 Oct 28, 2010
+! 100MG N021986 004 May 30, 2008
+ 140MG N021986 006 Oct 28, 2010
DASIGLUCAGON HYDROCHLORIDE
SOLUTION;SUBCUTANEOUS
ZEGALOGUE
+! ZEALAND PHARMA EQ 0.6MG BASE/0.6ML (EQ 0.6MG N214231 001 Mar 22, 2021
BASE/0.6ML)
ZEGALOGUE (AUTOINJECTOR)
+! ZEALAND PHARMA EQ 0.6MG BASE/0.6ML (EQ 0.6MG N214231 002 Mar 22, 2021
BASE/0.6ML)
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-124(of 474)

DAUNORUBICIN HYDROCHLORIDE
INJECTABLE;INJECTION
CERUBIDINE
AP ! HIKMA EQ 20MG BASE/VIAL A064103 001 Feb 03, 1995
DAUNORUBICIN HYDROCHLORIDE
AP FRESENIUS KABI USA EQ 20MG BASE/VIAL A065000 001 May 25, 1999
AP +! HIKMA EQ 5MG BASE/ML N050731 001 Jan 30, 1998
AP HISUN PHARM EQ 5MG BASE/ML A208759 001 Apr 12, 2019
HANGZHOU
AP TEVA PHARMS USA EQ 5MG BASE/ML A065035 001 Jan 24, 2000
FRESENIUS KABI USA EQ 5MG BASE/VIAL A065034 001 Nov 20, 2001
DECITABINE
INJECTABLE;INTRAVENOUS
DECITABINE
AP ! ACCORD HLTHCARE 50MG/VIAL A203475 001 Feb 27, 2017
AP CHEMI SPA 50MG/VIAL A206033 001 Sep 22, 2017
AP DR REDDYS 50MG/VIAL A203131 001 Jul 11, 2013
AP EUGIA PHARMA 50MG/VIAL A214569 001 Sep 20, 2021
AP GLAND 50MG/VIAL A205539 001 Nov 23, 2020
AP JIANGSU HANSOH 50MG/VIAL A213472 001 Apr 15, 2022
PHARM
AP LUPIN LTD 50MG/VIAL A210756 001 Nov 09, 2018
AP MEITHEAL 50MG/VIAL A212959 001 Jul 02, 2021
AP MSN 50MG/VIAL A212265 001 Aug 28, 2019
AP NIVAGEN PHARMS INC 50MG/VIAL A212117 001 Dec 07, 2020
AP NOVAST LABS 50MG/VIAL A210984 001 Sep 16, 2019
AP PHARMASCIENCE INC 50MG/VIAL A204607 001 May 31, 2017
AP QILU PHARM HAINAN 50MG/VIAL A212826 001 Apr 12, 2021
AP SAGENT PHARMS INC 50MG/VIAL A207100 001 Mar 16, 2018
AP SANDOZ INC 50MG/VIAL A202969 001 Aug 28, 2014
AP WOCKHARDT BIO AG 50MG/VIAL A209056 001 Apr 09, 2019
AP ZYDUS PHARMS 50MG/VIAL A214486 001 Nov 19, 2021
POWDER;INTRAVENOUS
DECITABINE
+! SUN PHARM 50MG/VIAL N205582 001 Jan 28, 2014
DEFERASIROX
GRANULE;ORAL
DEFERASIROX
AB ALKEM LABS LTD 90MG A213374 001 Jul 14, 2020
AB 180MG A213374 002 Jul 14, 2020
AB 360MG A213374 003 Jul 14, 2020
AB ANNORA PHARMA 180MG A216229 001 Sep 22, 2022
AB 360MG A216229 002 Sep 22, 2022
AB AUCTA 90MG A214559 001 Mar 09, 2021
AB 180MG A214559 002 Mar 09, 2021
AB 360MG A214559 003 Mar 09, 2021
AB CIPLA 90MG A215026 001 Feb 23, 2022
AB 180MG A215026 002 Feb 23, 2022
AB 360MG A215026 003 Feb 23, 2022
AB MSN 90MG A214650 003 Apr 20, 2022
AB 180MG A214650 001 Mar 17, 2021
AB 360MG A214650 002 Mar 17, 2021
AB TEVA PHARMS USA 90MG A214180 001 Nov 19, 2021
AB 180MG A214180 002 Nov 19, 2021
AB 360MG A214180 003 Nov 19, 2021
JADENU SPRINKLE
AB + NOVARTIS 90MG N207968 001 May 18, 2017
AB + 180MG N207968 002 May 18, 2017
AB +! 360MG N207968 003 May 18, 2017
TABLET;ORAL
DEFERASIROX
AB ACTAVIS ELIZABETH 90MG A208697 001 Dec 13, 2019
AB 180MG A208697 002 Dec 13, 2019
AB 360MG A208697 003 Dec 13, 2019
AB ALEMBIC PHARMS 90MG A211824 001 Nov 20, 2019
AB 180MG A211824 003 Jun 15, 2020
AB 360MG A211824 002 Nov 20, 2019
AB ALKEM LABS LTD 90MG A210555 001 Mar 30, 2020
AB 180MG A210555 003 Jul 02, 2020
AB 360MG A210555 002 Mar 30, 2020
AB ANNORA PHARMA 90MG A214341 001 May 14, 2021
AB 180MG A214341 002 May 14, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-125(of 474)

DEFERASIROX
TABLET;ORAL
DEFERASIROX
AB 360MG A214341 003 May 14, 2021
AB CELLTRION 90MG A212669 001 May 27, 2021
AB 180MG A212669 002 May 27, 2021
AB 360MG A212669 003 May 27, 2021
AB CIPLA 90MG A211852 001 Feb 11, 2020
AB 180MG A211852 003 Jun 15, 2020
AB 360MG A211852 002 Feb 11, 2020
AB MSN 90MG A210945 001 Nov 20, 2019
AB 180MG A210945 003 Jun 16, 2020
AB 360MG A210945 002 Nov 20, 2019
AB PIRAMAL HLTHCARE UK 90MG A212995 001 Dec 30, 2019
AB 180MG A212995 003 Jun 15, 2020
AB 360MG A212995 002 Dec 30, 2019
AB SUN PHARM 90MG A211641 001 Jan 02, 2020
AB 180MG A211641 003 Jun 15, 2020
AB 360MG A211641 002 Jan 02, 2020
AB ZYDUS PHARMS 90MG A211383 001 Nov 20, 2019
AB 180MG A211383 003 Jun 15, 2020
AB 360MG A211383 002 Nov 20, 2019
JADENU
AB + NOVARTIS PHARMS 90MG N206910 001 Mar 30, 2015
CORP
AB + 180MG N206910 002 Mar 30, 2015
AB +! 360MG N206910 003 Mar 30, 2015
TABLET, FOR SUSPENSION;ORAL
DEFERASIROX
AB ACTAVIS ELIZABETH 125MG A203560 001 Jan 26, 2016
AB 250MG A203560 002 Jan 26, 2016
AB 500MG A203560 003 Jan 26, 2016
AB ALEMBIC PHARMS 125MG A210060 001 Nov 20, 2019
AB 250MG A210060 002 Nov 20, 2019
AB 500MG A210060 003 Nov 20, 2019
AB ALKEM LABS LTD 125MG A210519 001 Nov 20, 2019
AB 250MG A210519 002 Nov 20, 2019
AB 500MG A210519 003 Nov 20, 2019
AB BIONPHARMA INC 125MG A210920 001 Nov 20, 2019
AB 250MG A210920 002 Nov 20, 2019
AB 500MG A210920 003 Nov 20, 2019
AB ICHNOS 125MG A209433 001 Jan 06, 2020
AB 250MG A209433 002 Jan 06, 2020
AB 500MG A209433 003 Jan 06, 2020
AB MSN 125MG A209878 001 Nov 20, 2019
AB 250MG A209878 002 Nov 20, 2019
AB 500MG A209878 003 Nov 20, 2019
AB SUN PHARM 125MG A209782 001 Nov 20, 2019
AB 250MG A209782 002 Nov 20, 2019
AB 500MG A209782 003 Nov 20, 2019
AB TEVA PHARMS USA 125MG A207124 001 Sep 23, 2022
AB 250MG A207124 002 Sep 23, 2022
AB 500MG A207124 003 Sep 23, 2022
EXJADE
AB + NOVARTIS 125MG N021882 001 Nov 02, 2005
AB + 250MG N021882 002 Nov 02, 2005
AB +! 500MG N021882 003 Nov 02, 2005
DEFERIPRONE
SOLUTION;ORAL
FERRIPROX
+! CHIESI 100MG/ML N208030 001 Sep 09, 2015
TABLET;ORAL
DEFERIPRONE
AB HIKMA 500MG A213239 001 Mar 29, 2021
AB 1GM A213239 002 Feb 08, 2022
AB TARO PHARM INDS LTD 500MG A208800 001 Feb 08, 2019
FERRIPROX
AB + CHIESI 500MG N021825 001 Oct 14, 2011
AB +! 1GM N021825 002 Jul 25, 2019
+! 1GM N212269 001 May 19, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-126(of 474)

DEFEROXAMINE MESYLATE
INJECTABLE;INJECTION
DEFEROXAMINE MESYLATE
AP FRESENIUS KABI USA 500MG/VIAL A078718 001 Sep 15, 2009
AP 2GM/VIAL A078718 002 Sep 15, 2009
AP GLAND PHARMA LTD 500MG/VIAL A207384 001 Sep 29, 2017
AP 2GM/VIAL A207384 002 Sep 29, 2017
AP HOSPIRA 500MG/VIAL A076019 001 Mar 17, 2004
AP ! 2GM/VIAL A076019 002 Mar 17, 2004
AP WEST-WARD PHARMS 500MG/VIAL A078086 001 May 30, 2007
INT
AP 2GM/VIAL A078086 002 May 30, 2007
DESFERAL
AP +! NOVARTIS 500MG/VIAL N016267 001
DEFIBROTIDE SODIUM
SOLUTION;INTRAVENOUS
DEFITELIO
+! JAZZ PHARMS INC 200MG/2.5ML (80MG/ML) N208114 001 Mar 30, 2016
DEFLAZACORT
SUSPENSION;ORAL
EMFLAZA
+! PTC THERAP 22.75MG/ML N208685 001 Feb 09, 2017
TABLET;ORAL
EMFLAZA
+ PTC THERAP 6MG N208684 001 Feb 09, 2017
+ 18MG N208684 002 Feb 09, 2017
+ 30MG N208684 003 Feb 09, 2017
+! 36MG N208684 004 Feb 09, 2017
DEGARELIX ACETATE
POWDER;SUBCUTANEOUS
FIRMAGON
+ FERRING EQ 80MG BASE/VIAL N022201 001 Dec 24, 2008
+! EQ 120MG BASE/VIAL N022201 002 Dec 24, 2008
DELAFLOXACIN MEGLUMINE
POWDER;INTRAVENOUS
BAXDELA
+! MELINTA EQ 300MG BASE/VIAL N208611 001 Jun 19, 2017
TABLET;ORAL
BAXDELA
+! MELINTA EQ 450MG BASE N208610 001 Jun 19, 2017
DEMECLOCYCLINE HYDROCHLORIDE
TABLET;ORAL
DEMECLOCYCLINE HYDROCHLORIDE
AB AKORN 150MG A065389 001 Dec 01, 2008
AB 300MG A065389 002 Dec 01, 2008
AB AMNEAL PHARM 150MG A065425 001 Feb 27, 2008
AB ! 300MG A065425 002 Feb 27, 2008
AB EPIC PHARMA LLC 150MG A065447 001 Aug 18, 2015
AB 300MG A065447 002 Aug 18, 2015
DEOXYCHOLIC ACID
SOLUTION;SUBCUTANEOUS
DEOXYCHOLIC ACID
AP SLAYBACK PHARMA LLC 20MG/2ML (10MG/ML) A212296 001 Apr 02, 2021
KYBELLA
AP +! KYTHERA BIOPHARMS 20MG/2ML (10MG/ML) N206333 001 Apr 29, 2015
DESFLURANE
LIQUID;INHALATION
DESFLURANE
AN SHANGHAI HENGRUI 100% A208234 001 Feb 26, 2018
SUPRANE
AN +! BAXTER HLTHCARE 100% N020118 001 Sep 18, 1992
DESIPRAMINE HYDROCHLORIDE
TABLET;ORAL
DESIPRAMINE HYDROCHLORIDE
AB ACTAVIS TOTOWA 10MG A074430 001 Feb 09, 1996
AB 25MG A071601 001 Jun 05, 1987
AB 50MG A071588 001 Jun 05, 1987
AB 75MG A071602 001 Oct 05, 1987
AB 100MG A071766 001 Oct 05, 1987
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-127(of 474)

DESIPRAMINE HYDROCHLORIDE
TABLET;ORAL
DESIPRAMINE HYDROCHLORIDE
AB 150MG A074430 002 Feb 09, 1996
AB ALEMBIC PHARMS 10MG A209785 001 Jul 07, 2021
AB 25MG A209785 002 Jul 07, 2021
AB 50MG A209785 003 Jul 07, 2021
AB 75MG A209785 004 Jul 07, 2021
AB 100MG A209785 005 Jul 07, 2021
AB 150MG A209785 006 Jul 07, 2021
AB AMNEAL PHARMS CO 10MG A208105 001 Mar 17, 2016
AB 25MG A208105 002 Mar 17, 2016
AB 50MG A208105 003 Mar 17, 2016
AB 75MG A208105 004 Mar 17, 2016
AB 100MG A208105 005 Mar 17, 2016
AB 150MG A208105 006 Mar 17, 2016
AB HERITAGE PHARMS 10MG A207433 001 May 05, 2016
AB 25MG A207433 002 May 05, 2016
AB 50MG A207433 003 May 05, 2016
AB 75MG A207433 004 May 05, 2016
AB 100MG A207433 005 May 05, 2016
AB 150MG A207433 006 May 05, 2016
AB NOVAST LABS 10MG A204963 001 Dec 26, 2017
AB 25MG A204963 002 Dec 26, 2017
AB 50MG A204963 003 Dec 26, 2017
AB 75MG A204963 004 Dec 26, 2017
AB 100MG A204963 005 Dec 26, 2017
AB 150MG A204963 006 Dec 26, 2017
AB SANDOZ 10MG A072099 001 May 24, 1988
AB 25MG A072100 001 May 24, 1988
AB 50MG A072101 001 May 24, 1988
AB 75MG A072102 001 Jun 20, 1988
AB 100MG A072103 001 Jun 20, 1988
AB 150MG A072104 001 Jun 20, 1988
NORPRAMIN
AB + VALIDUS PHARMS 10MG N014399 007 Feb 11, 1982
AB + 25MG N014399 001
AB + 50MG N014399 003
AB + 75MG N014399 004
AB +! 100MG N014399 005
AB + 150MG N014399 006
DESLORATADINE
TABLET;ORAL
CLARINEX
AB +! ORGANON 5MG N021165 001 Dec 21, 2001
DESLORATADINE
AB BELCHER PHARMS 5MG A078355 001 Apr 19, 2012
AB DR REDDYS LABS LTD 5MG A078365 001 Mar 08, 2011
AB LUPIN PHARMS 5MG A078352 001 Oct 25, 2010
AB ORBION PHARMS 5MG A078357 001 Feb 19, 2010
TABLET, ORALLY DISINTEGRATING;ORAL
DESLORATADINE
REDDYS 2.5MG A078367 001 Jul 12, 2010
! 5MG A078367 002 Jul 12, 2010
DESLORATADINE; PSEUDOEPHEDRINE SULFATE
TABLET, EXTENDED RELEASE;ORAL
CLARINEX-D 12 HOUR
+! ORGANON LLC 2.5MG;120MG N021313 001 Feb 01, 2006
DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR
! DR REDDYS LABS LTD 5MG;240MG A078366 001 Apr 26, 2011
DESMOPRESSIN ACETATE
INJECTABLE;INJECTION
DDAVP
AP +! FERRING PHARMS INC 0.004MG/ML N018938 001 Mar 30, 1984
DESMOPRESSIN ACETATE
AP AM REGENT 0.004MG/ML A091374 001 Feb 14, 2019
AP DR REDDYS 0.004MG/ML A215961 001 Aug 19, 2022
AP GLAND PHARMA LTD 0.004MG/ML A216922 001 Nov 16, 2022
AP SAGENT PHARMS INC 0.004MG/ML A204695 001 Aug 22, 2017
AP 0.004MG/ML A204751 001 Aug 22, 2017
AP SUN PHARM INDS LTD 0.004MG/ML A091280 001 Jan 25, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-128(of 474)

DESMOPRESSIN ACETATE
INJECTABLE;INJECTION
DESMOPRESSIN ACETATE
AP TEVA PHARMS USA 0.004MG/ML A074888 001 Oct 15, 1997
AP UBI 0.004MG/ML A210218 001 Feb 14, 2020
AP 0.004MG/ML A210223 001 Sep 17, 2020
SPRAY, METERED;NASAL
DESMOPRESSIN ACETATE
AB ! BAUSCH 0.01MG/SPRAY A074830 001 Jan 25, 1999
DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION)
AB APOTEX INC 0.01MG/SPRAY A076703 001 Jan 27, 2005
AB ! SUN PHARM 0.01MG/SPRAY A078271 001 Dec 23, 2013
AB ZYDUS PHARMS 0.01MG/SPRAY A091345 001 Oct 03, 2017
TABLET;ORAL
DDAVP
AB + FERRING PHARMS INC 0.1MG N019955 001 Sep 06, 1995
AB +! 0.2MG N019955 002 Sep 06, 1995
DESMOPRESSIN ACETATE
AB ABHAI LLC 0.1MG A210371 001 Jan 28, 2019
AB 0.2MG A210371 002 Jan 28, 2019
AB ACTAVIS LABS FL INC 0.1MG A076470 001 Jul 01, 2005
AB 0.2MG A076470 002 Jul 01, 2005
AB APOTEX INC 0.1MG A077414 001 Mar 07, 2006
AB 0.2MG A077414 002 Mar 07, 2006
AB GLENMARK PHARMS LTD 0.1MG A201831 001 May 28, 2015
AB 0.2MG A201831 002 May 28, 2015
AB HERITAGE PHARMA 0.1MG A207880 001 May 26, 2017
AB 0.2MG A207880 002 May 26, 2017
AB NOVAST LABS 0.1MG A208357 001 Jun 06, 2019
AB 0.2MG A208357 002 Jun 06, 2019
TABLET;SUBLINGUAL
NOCDURNA
+ FERRING PHARMS INC 0.0277MG N022517 001 Jun 21, 2018
+! 0.0553MG N022517 002 Jun 21, 2018
DESOGESTREL; ETHINYL ESTRADIOL
TABLET;ORAL-28
BEKYREE
AB LUPIN LTD 0.15MG,N/A;0.02MG,0.01MG A202226 001 Aug 12, 2015
CYCLESSA
AB +! ASPEN GLOBAL INC 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0. N021090 001 Dec 20, 2000
025MG
DESOGESTREL AND ETHINYL ESTRADIOL
AB ! DURAMED PHARMS BARR 0.15MG;0.03MG A075256 002 Aug 12, 1999
AB MYLAN LABS LTD 0.15MG,N/A;0.02MG,0.01MG A202296 001 Aug 30, 2013
AB NAARI PTE LTD 0.15MG,N/A;0.02MG,0.01MG A209170 001 Jun 05, 2017
AB NOVAST LABS 0.15MG;0.03MG A091234 001 Jul 12, 2013
AB WATSON LABS 0.15MG;0.03MG A076915 001 Jul 29, 2005
ENSKYCE
AB LUPIN LTD 0.15MG;0.03MG A201887 001 Mar 07, 2013
ISIBLOOM
AB XIROMED 0.15MG;0.03MG A202789 001 Aug 12, 2015
KALLIGA
AB AUROBINDO PHARMA 0.15MG;0.03MG A207081 001 May 17, 2017
KARIVA
AB ! BARR 0.15MG,N/A;0.02MG,0.01MG A075863 001 Apr 05, 2002
KIMIDESS
AB VINTAGE PHARMS 0.15MG,N/A;0.02MG,0.01MG A076681 001 Apr 30, 2015
PIMTREA
AB NOVAST LABS 0.15MG,N/A;0.02MG,0.01MG A091247 001 Aug 01, 2013
SIMLIYA
AB AUROBINDO PHARMA 0.15MG,N/A;0.02MG,0.01MG A206853 001 Mar 22, 2017
VELIVET
AB DURAMED PHARMS BARR 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0. A076455 001 Feb 24, 2004
025MG
VIORELE
AB GLENMARK GENERICS 0.15MG,N/A;0.02MG,0.01MG A091346 001 Apr 02, 2012
VOLNEA
AB XIROMED 0.15MG,N/A;0.02MG,0.01MG A202689 001 Sep 09, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-129(of 474)

DESONIDE
AEROSOL, FOAM;TOPICAL
VERDESO
+! ALMIRALL 0.05% N021978 001 Sep 19, 2006
CREAM;TOPICAL
DESONIDE
AB ALEOR 0.05% A214396 001 Dec 08, 2022
DERMACEUTICALS
AB CADILA 0.05% A210198 001 Nov 20, 2019
AB COSETTE 0.05% A074027 001 Sep 28, 1992
AB GLENMARK PHARMS 0.05% A209729 001 Jul 24, 2017
AB +! PADAGIS US 0.05% N017010 001
AB TARO 0.05% A073548 001 Jun 30, 1992
DESOWEN
AB GALDERMA LABS LP 0.05% N019048 001 Dec 14, 1984
GEL;TOPICAL
DESONIDE
! CINTEX SVCS 0.05% A202470 001 May 11, 2020
LOTION;TOPICAL
DESONIDE
AB ALEOR 0.05% A213632 001 Aug 24, 2020
DERMACEUTICALS
AB FOUGERA PHARMS 0.05% A075860 001 Mar 19, 2002
AB GLENMARK PHARMS 0.05% A209494 001 Sep 26, 2017
AB PAI HOLDINGS PHARM 0.05% A207855 001 Sep 28, 2017
AB TARO 0.05% A202161 001 Oct 31, 2014
DESOWEN
AB ! GALDERMA LABS LP 0.05% A072354 001 Jan 24, 1992
OINTMENT;TOPICAL
DESONIDE
AB AKORN 0.05% A208836 001 Mar 27, 2017
AB ALEOR 0.05% A212473 001 Oct 23, 2019
DERMACEUTICALS
AB ENCUBE ETHICALS 0.05% A210998 001 Jan 30, 2019
AB FOUGERA PHARMS 0.05% A075751 001 Mar 12, 2001
AB GLENMARK PHARMS LTD 0.05% A209996 001 Sep 15, 2017
AB +! PADAGIS US 0.05% N017426 001
AB PAI HOLDINGS PHARM 0.05% A212002 001 Mar 12, 2019
AB TARO 0.05% A074254 001 Aug 03, 1994
DESOWEN
AB GALDERMA LABS LP 0.05% A071425 001 Jun 15, 1988
DESOXIMETASONE
CREAM;TOPICAL
DESOXIMETASONE
AB ACTAVIS MID 0.25% A205082 001 Sep 04, 2015
ATLANTIC
AB CADILA 0.25% A205620 001 Sep 28, 2018
AB COSETTE 0.25% A209595 001 Mar 04, 2020
AB FOUGERA PHARMS 0.25% A078369 001 Jun 29, 2010
AB LUPIN 0.05% A208163 001 Jan 10, 2017
AB 0.25% A208164 001 Jan 09, 2017
AB PADAGIS ISRAEL 0.25% A076510 001 Jul 01, 2003
AB RISING 0.05% A210980 001 Dec 21, 2018
AB 0.25% A205594 001 Jul 02, 2018
TOPICORT
AB ! TARO PHARM INDS LTD 0.05% A073210 001 Nov 30, 1990
AB ! 0.25% A073193 001 Nov 30, 1990
GEL;TOPICAL
DESOXIMETASONE
AB AKORN 0.05% A090727 001 Mar 10, 2011
AB PADAGIS US 0.05% A077552 001 Jan 09, 2006
AB RISING 0.05% A204675 001 Aug 12, 2016
TOPICORT
AB ! TARO PHARM INDS LTD 0.05% A074904 001 Jul 14, 1998
OINTMENT;TOPICAL
DESOXIMETASONE
AB ACTAVIS MID 0.25% A204965 001 Nov 07, 2016
ATLANTIC
AB AKORN 0.25% A201005 001 Apr 24, 2014
AB CADILA 0.25% A205206 001 Sep 19, 2017
AB COSETTE 0.25% A206740 001 Dec 23, 2016
AB FOUGERA PHARMS 0.25% A078657 001 Sep 28, 2012
AB ! GLENMARK GENERICS 0.25% A202838 001 Sep 20, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-130(of 474)

DESOXIMETASONE
OINTMENT;TOPICAL
DESOXIMETASONE
AB LUPIN 0.05% A208044 001 Dec 12, 2016
AB 0.25% A208104 001 Dec 01, 2016
AB NOVEL LABS INC 0.25% A206792 001 May 10, 2016
AB PADAGIS ISRAEL 0.25% A077770 001 Apr 20, 2015
AB PAI HOLDINGS PHARM 0.25% A208101 001 Feb 25, 2016
AB RISING 0.25% A204272 001 Nov 30, 2016
AB THE J MOLNER 0.05% A209973 001 Oct 23, 2018
TOPICORT
AB +! TARO PHARM INDS LTD 0.05% N018594 001 Jan 17, 1985
SPRAY;TOPICAL
DESOXIMETASONE
AT LUPIN 0.25% A208124 001 Mar 16, 2018
AT PADAGIS ISRAEL 0.25% A206441 001 Jan 20, 2017
TOPICORT
AT +! TARO PHARMS 0.25% N204141 001 Apr 11, 2013
DESVENLAFAXINE
TABLET, EXTENDED RELEASE;ORAL
DESVENLAFAXINE
+ ALEMBIC PHARMS LTD 50MG N204150 001 Mar 04, 2013
+! 100MG N204150 002 Mar 04, 2013
DESVENLAFAXINE SUCCINATE
TABLET, EXTENDED RELEASE;ORAL
DESVENLAFAXINE SUCCINATE
AB ACTAVIS LABS FL EQ 25MG BASE A204065 001 Jul 29, 2016
AB EQ 50MG BASE A204065 002 Jul 29, 2016
AB EQ 100MG BASE A204065 003 Jul 29, 2016
AB ALEMBIC PHARMS EQ 25MG BASE A204003 003 Sep 14, 2018
AB EQ 50MG BASE A204003 001 Jun 29, 2015
AB EQ 100MG BASE A204003 002 Jun 29, 2015
AB HIKMA EQ 25MG BASE A204082 002 Aug 28, 2017
AB EQ 50MG BASE A204082 001 Feb 16, 2016
AB EQ 100MG BASE A204083 001 Feb 16, 2016
AB INTELLIPHARMACEUTIC EQ 50MG BASE A204805 001 May 07, 2019
S
AB EQ 100MG BASE A204805 002 May 07, 2019
AB LUPIN LTD EQ 25MG BASE A204172 003 Apr 13, 2022
AB EQ 50MG BASE A204172 001 Jun 29, 2015
AB EQ 100MG BASE A204172 002 Jun 29, 2015
AB RUBICON EQ 50MG BASE A204028 001 Jun 29, 2015
AB EQ 100MG BASE A204028 002 Jun 29, 2015
AB YICHANG HUMANWELL EQ 25MG BASE A210014 003 Oct 13, 2020
AB EQ 50MG BASE A210014 001 Oct 01, 2018
AB EQ 100MG BASE A210014 002 Oct 01, 2018
AB ZYDUS PHARMS EQ 25MG BASE A204020 003 Nov 30, 2022
AB EQ 50MG BASE A204020 001 Oct 11, 2017
AB EQ 100MG BASE A204020 002 Oct 11, 2017
PRISTIQ
AB + PF PRISM CV EQ 25MG BASE N021992 003 Aug 20, 2014
AB + EQ 50MG BASE N021992 001 Feb 29, 2008
AB +! EQ 100MG BASE N021992 002 Feb 29, 2008
DEUCRAVACITINIB
TABLET;ORAL
SOTYKTU
+! BRISTOL 6MG N214958 001 Sep 09, 2022
DEUTETRABENAZINE
TABLET;ORAL
AUSTEDO
+ TEVA BRANDED PHARM 6MG N208082 001 Apr 03, 2017
+ 9MG N208082 002 Apr 03, 2017
+! 12MG N208082 003 Apr 03, 2017
DEXAMETHASONE
CONCENTRATE;ORAL
DEXAMETHASONE INTENSOL
! HIKMA 1MG/ML A088252 001 Sep 01, 1983
ELIXIR;ORAL
DEXAMETHASONE
AA ! ANIMA 0.5MG/5ML A084754 001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-131(of 474)

DEXAMETHASONE
ELIXIR;ORAL
DEXAMETHASONE
AA CHARTWELL MOLECULAR 0.5MG/5ML A091188 001 May 11, 2011
AA LYNE 0.5MG/5ML A090891 001 Jul 12, 2011
IMPLANT;INTRAVITREAL
OZURDEX
+! ALLERGAN 0.7MG N022315 001 Jun 17, 2009
INSERT;OPHTHALMIC
DEXTENZA
+! OCULAR THERAPEUTIX 0.4MG N208742 001 Nov 30, 2018
SOLUTION;ORAL
DEXAMETHASONE
+! HIKMA 0.5MG/5ML A088248 001 Sep 01, 1983
SUSPENSION;INTRAOCULAR
DEXYCU KIT
+! EYEPOINT PHARMS 9% N208912 001 Feb 09, 2018
SUSPENSION/DROPS;OPHTHALMIC
MAXIDEX
+! NOVARTIS 0.1% N013422 001
TABLET;ORAL
DEXAMETHASONE
AB AMNEAL 2MG A216295 001 Sep 08, 2022
AB 4MG A215106 001 Oct 14, 2021
AB 6MG A215106 002 Oct 14, 2021
AB + HIKMA 1.5MG A084610 001
AB +! 2MG A087916 001 Aug 26, 1982
AB + 4MG A084612 001
AB +! 6MG A088316 001 Sep 15, 1983
AB LARKEN LABS INC 1.5MG A201270 001 Jul 17, 2017
AB NOVITIUM PHARMA 1.5MG A215604 001 Aug 08, 2022
AB 4MG A215604 002 Aug 08, 2022
AB 6MG A215604 003 Aug 08, 2022
AB PRASCO 4MG A080399 002 Apr 20, 2022
BP ALVOGEN 0.5MG A088481 002 Apr 28, 1983
BP 0.75MG A088481 003 Apr 28, 1983
BP 4MG A088481 004 Apr 28, 1983
BP 6MG A088481 001 Nov 28, 1983
BP + HIKMA 0.5MG A084611 001
BP + 0.75MG A084613 001
BP +! 1MG A088306 001 Sep 15, 1983
BP XSPIRE PHARMA 1.5MG A088237 001 Apr 28, 1983
HEMADY
+! DEXCEL 20MG N211379 001 Oct 03, 2019
DEXAMETHASONE SODIUM PHOSPHATE
INJECTABLE;INJECTION
DEXAMETHASONE SODIUM PHOSPHATE
AP AMNEAL EQ 4MG PHOSPHATE/ML A208689 001 Aug 22, 2018
AP EUGIA PHARMA EQ 4MG PHOSPHATE/ML A206781 001 Dec 01, 2015
AP EQ 10MG PHOSPHATE/ML A210966 001 Jun 05, 2020
AP EQ 10MG PHOSPHATE/ML A210967 001 Jun 07, 2019
AP +! FRESENIUS KABI USA EQ 4MG PHOSPHATE/ML A084916 001
AP EQ 4MG PHOSPHATE/ML A203129 001 Sep 30, 2015
AP ! EQ 10MG PHOSPHATE/ML A040572 001 Apr 22, 2005
AP EQ 10MG PHOSPHATE/ML A209192 001 Jul 06, 2018
AP GLAND PHARMA LTD EQ 4MG PHOSPHATE/ML A215654 001 Aug 04, 2021
AP MYLAN LABS LTD EQ 4MG PHOSPHATE/ML A040803 001 Aug 29, 2008
AP EQ 10MG PHOSPHATE/ML A040802 001 Aug 29, 2008
AP SOMERSET EQ 4MG PHOSPHATE/ML A207521 001 Jun 08, 2018
AP SOMERSET THERAPS EQ 10MG PHOSPHATE/ML A211036 001 May 10, 2019
LLC
AP WEST-WARD PHARMS EQ 4MG PHOSPHATE/ML A084282 001
INT
AP ! EQ 10MG PHOSPHATE/ML A087702 001 Sep 07, 1982
DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE
AP AMNEAL EQ 10MG PHOSPHATE/ML A208690 001 Aug 22, 2018
AP ! FRESENIUS KABI USA EQ 10MG PHOSPHATE/ML A040491 001 Apr 11, 2003
AP SOMERSET THERAPS EQ 10MG PHOSPHATE/ML A207442 001 Apr 19, 2018
LLC
SOLUTION/DROPS;OPHTHALMIC, OTIC
DEXAMETHASONE SODIUM PHOSPHATE
! BAUSCH AND LOMB EQ 0.1% PHOSPHATE A040069 001 Jul 26, 1996
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-132(of 474)

DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE


OINTMENT;OPHTHALMIC
MAXITROL
AT +! NOVARTIS 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM N050065 002
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
AT BAUSCH AND LOMB 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM A064063 001 Jul 25, 1994
AT PADAGIS US 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM A062938 001 Jul 31, 1989
SUSPENSION/DROPS;OPHTHALMIC
DEXASPORIN
AT BAUSCH AND LOMB 0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A064135 001 Sep 13, 1995
MAXITROL
AT +! IMPRIMIS PHARMS USA 0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML N050023 002
AT SANDOZ INC 0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A062341 001 May 22, 1984
DEXAMETHASONE; TOBRAMYCIN
OINTMENT;OPHTHALMIC
TOBRADEX
+! NOVARTIS 0.1%;0.3% N050616 001 Sep 28, 1988
SUSPENSION/DROPS;OPHTHALMIC
TOBRADEX
AB +! NOVARTIS 0.1%;0.3% N050592 001 Aug 18, 1988
TOBRAMYCIN AND DEXAMETHASONE
AB AMNEAL 0.1%;0.3% A212991 001 Jul 15, 2021
AB BAUSCH AND LOMB 0.1%;0.3% A064134 001 Oct 27, 1999
AB PADAGIS US 0.1%;0.3% A212715 001 Feb 11, 2022
TOBRADEX ST
+! EYEVANCE 0.05%;0.3% N050818 001 Feb 13, 2009
DEXCHLORPHENIRAMINE MALEATE
SYRUP;ORAL
DEXCHLORPHENIRAMINE MALEATE
AA +! PAI HOLDINGS PHARM 2MG/5ML A088251 001 Mar 23, 1984
POLMON
AA CAPELLON PHARMS LLC 2MG/5ML A202520 001 Jul 16, 2018
DEXLANSOPRAZOLE
CAPSULE, DELAYED RELEASE;ORAL
DEXILANT
AB + TAKEDA PHARMS USA 30MG N022287 001 Jan 30, 2009
AB +! 60MG N022287 002 Jan 30, 2009
DEXLANSOPRAZOLE
AB PAR PHARM INC 30MG A202294 002 Jun 16, 2022
AB 60MG A202294 001 Apr 19, 2017
AB TWI PHARMS 30MG A202666 001 Sep 16, 2022
AB 60MG A202666 002 Sep 16, 2022
DEXMEDETOMIDINE HYDROCHLORIDE
FILM;BUCCAL, SUBLINGUAL
IGALMI
+! BIOXCEL EQ 0.12MG BASE N215390 001 Apr 05, 2022
+! EQ 0.18MG BASE N215390 002 Apr 05, 2022
INJECTABLE;INJECTION
DEXMEDETOMIDINE HYDROCHLORIDE
AP ACCORD HLTHCARE EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) A204023 001 Feb 09, 2016
AP ACTAVIS INC EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) A204686 001 Oct 17, 2016
AP AKORN EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) A202585 001 Nov 24, 2014
AP AMNEAL PHARMS CO EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) A207551 001 May 20, 2020
AP EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) A207551 002 May 20, 2020
AP BAXTER HLTHCARE EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) A208532 001 Aug 21, 2018
CORP
AP EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) A208532 002 Aug 21, 2018
AP EUGIA PHARMA EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) A205867 001 Mar 17, 2016
AP EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) A210321 001 Dec 07, 2020
AP EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) A210321 002 Dec 07, 2020
AP FRESENIUS KABI USA EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML) A208129 001 Nov 29, 2018
AP EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) A201072 001 Sep 18, 2015
AP EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) A208129 002 Nov 29, 2018
AP EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) A208129 003 Nov 29, 2018
AP GLAND EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) A202126 001 Aug 20, 2015
AP GLAND PHARMA LTD EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) A209307 001 Jun 03, 2020
AP EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) A209307 002 Jun 03, 2020
AP HENGRUI PHARMA EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML) A209065 002 Jun 12, 2020
AP EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) A209065 001 Sep 19, 2017
AP EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) A209065 003 Jun 12, 2020
AP EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) A209065 004 Jun 12, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-133(of 474)

DEXMEDETOMIDINE HYDROCHLORIDE
INJECTABLE;INJECTION
DEXMEDETOMIDINE HYDROCHLORIDE
AP HIKMA EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) A205046 001 Apr 26, 2017
AP EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) A206407 001 Jan 30, 2020
AP EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) A206407 002 Jan 30, 2020
AP MEITHEAL EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) A204843 001 Jan 18, 2019
AP MYLAN INSTITUTIONAL EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) A202881 001 Aug 18, 2014
AP MYLAN LABS LTD EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) A212571 001 Aug 27, 2020
AP EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) A212571 002 Aug 27, 2020
AP PAR STERILE EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) A203972 001 Aug 18, 2014
PRODUCTS
AP EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) A208266 001 Sep 15, 2020
AP EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) A208266 002 Sep 15, 2020
AP SANDOZ INC EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) A091465 001 Jun 14, 2016
AP SLAYBACK PHARMA LLC EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) A212791 001 Dec 04, 2019
AP EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) A212791 002 Dec 04, 2019
AP TAGI EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML) A212857 001 Nov 23, 2020
AP EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) A212857 002 Nov 23, 2020
AP EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) A212857 003 Nov 23, 2020
AP TEVA PHARMS USA EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) A205272 001 Nov 28, 2017
AP ZYDUS PHARMS EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) A206798 001 Feb 27, 2018
PRECEDEX
AP +! HOSPIRA EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML) N021038 004 Nov 14, 2014
AP +! EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) N021038 001 Dec 17, 1999
AP +! EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) N021038 002 Mar 13, 2013
AP +! EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) N021038 003 Mar 13, 2013
+! EQ 1MG BASE/250ML (EQ 4MCG BASE/ML) N021038 005 Jan 31, 2020
SOLUTION;INTRAVENOUS
DEXMEDETOMIDINE HYDROCHLORIDE
+! HQ SPCLT PHARMA EQ 1MG BASE/10ML (EQ 100MCG BASE/ML) N206628 002 Oct 21, 2015
+ EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) N206628 003 Jun 22, 2018
+ EQ 400MCG BASE/4ML (EQ 100MCG BASE/ML) N206628 001 Oct 21, 2015
+ EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) N206628 004 Jun 22, 2018
DEXMETHYLPHENIDATE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
DEXMETHYLPHENIDATE HYDROCHLORIDE
AB ADARE PHARMS INC 5MG A210279 001 Oct 09, 2018
AB 10MG A210279 002 Oct 09, 2018
AB 15MG A210279 003 Oct 09, 2018
AB 20MG A210279 004 Oct 09, 2018
AB 25MG A210279 005 Oct 09, 2018
AB 30MG A210279 006 Oct 09, 2018
AB 35MG A210279 007 Oct 09, 2018
AB 40MG A210279 008 Oct 09, 2018
AB ASCENT PHARMS INC 5MG A215523 001 Dec 08, 2021
AB 10MG A215523 002 Dec 08, 2021
AB 15MG A215523 003 Dec 08, 2021
AB 20MG A215523 004 Dec 08, 2021
AB 25MG A215523 005 Dec 08, 2021
AB 30MG A215523 006 Dec 08, 2021
AB 35MG A215523 007 Dec 08, 2021
AB 40MG A215523 008 Dec 08, 2021
AB GRANULES 5MG A213813 001 Sep 09, 2020
AB 10MG A213813 002 Sep 09, 2020
AB 15MG A213813 003 Sep 09, 2020
AB 20MG A213813 004 Sep 09, 2020
AB 25MG A213813 005 Sep 09, 2020
AB 30MG A213813 006 Sep 09, 2020
AB 35MG A213813 007 Sep 09, 2020
AB 40MG A213813 008 Sep 09, 2020
AB IMPAX LABS INC 5MG A079108 001 Aug 05, 2015
AB 10MG A079108 002 Aug 05, 2015
AB 15MG A079108 003 May 19, 2014
AB 20MG A079108 004 Dec 21, 2015
AB 25MG A203614 001 Jul 05, 2017
AB 30MG A079108 005 Nov 21, 2013
AB 35MG A203614 002 Jul 05, 2017
AB INTELLIPHARMACEUTIC 5MG A078992 001 Nov 23, 2021
S
AB 10MG A078992 002 Nov 23, 2021
AB 15MG A078992 003 Nov 18, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-134(of 474)

DEXMETHYLPHENIDATE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
DEXMETHYLPHENIDATE HYDROCHLORIDE
AB 30MG A078992 004 Nov 18, 2013
AB 20MG A078992 005 Nov 23, 2021
AB 40MG A078992 006 Nov 23, 2021
AB PAR PHARM INC 5MG A202842 001 Nov 30, 2016
AB 10MG A202842 002 Nov 30, 2016
AB 15MG A202842 003 Nov 30, 2016
AB 20MG A202842 004 Nov 30, 2016
AB 25MG A202842 005 Nov 30, 2016
AB 30MG A202842 006 Nov 30, 2016
AB 35MG A202842 007 Nov 30, 2016
AB 40MG A202842 008 Nov 30, 2016
AB SUN PHARM INDS INC 5MG A206734 001 Nov 05, 2021
AB 10MG A206734 002 Nov 05, 2021
AB 15MG A206734 003 Nov 05, 2021
AB 20MG A206734 004 Nov 05, 2021
AB 25MG A206734 005 Nov 05, 2021
AB 30MG A206734 006 Nov 05, 2021
AB 35MG A206734 007 Nov 05, 2021
AB 40MG A206734 008 Nov 05, 2021
AB TEVA PHARMS USA 5MG A078908 001 Nov 19, 2013
AB 10MG A078908 002 Nov 19, 2013
AB 15MG A078908 004 May 19, 2014
AB 20MG A078908 003 Nov 19, 2013
AB 25MG A202731 001 Jul 05, 2017
AB 30MG A202731 003 May 19, 2014
AB 35MG A202731 004 Jul 05, 2017
AB 40MG A202731 002 Nov 19, 2013
FOCALIN XR
AB + NOVARTIS 5MG N021802 001 May 26, 2005
AB + 10MG N021802 002 May 26, 2005
AB + 15MG N021802 004 Aug 01, 2006
AB + 20MG N021802 003 May 26, 2005
AB + 25MG N021802 008 Apr 21, 2011
AB + 30MG N021802 005 Oct 23, 2009
AB + 35MG N021802 007 Apr 21, 2011
AB +! 40MG N021802 006 Aug 11, 2010
TABLET;ORAL
DEXMETHYLPHENIDATE HYDROCHLORIDE
AB ABHAI INC 2.5MG A206931 001 Dec 04, 2015
AB 5MG A206931 002 Dec 04, 2015
AB 10MG A206931 003 Dec 04, 2015
AB ALKEM LABS LTD 2.5MG A212631 001 Jul 19, 2019
AB 5MG A212631 002 Jul 19, 2019
AB 10MG A212631 003 Jul 19, 2019
AB CEDIPROF INC 5MG A209211 001 Sep 19, 2018
AB 10MG A209211 002 Sep 19, 2018
AB NOVEL LABS INC 2.5MG A204534 001 Dec 04, 2015
AB 5MG A204534 002 Dec 04, 2015
AB 10MG A204534 003 Dec 04, 2015
AB RHODES PHARMS 2.5MG A208756 001 Nov 20, 2017
AB 5MG A208756 002 Nov 20, 2017
AB 10MG A208756 003 Nov 20, 2017
AB SUN PHARM 2.5MG A201231 001 Sep 24, 2015
INDUSTRIES
AB 5MG A201231 002 Sep 24, 2015
AB 10MG A201231 003 Sep 24, 2015
AB TRIS PHARMA INC 2.5MG A207901 001 Aug 26, 2016
AB 5MG A207901 002 Aug 26, 2016
AB 10MG A207901 003 Aug 26, 2016
FOCALIN
AB + NOVARTIS 2.5MG N021278 001 Nov 13, 2001
AB + 5MG N021278 002 Nov 13, 2001
AB +! 10MG N021278 003 Nov 13, 2001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-135(of 474)

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE


CAPSULE;ORAL
AZSTARYS
+ COMMAVE THERAP EQ 5.2MG BASE;EQ 26.1MG BASE N212994 001 May 07, 2021
+ EQ 7.8MG BASE;EQ 39.2MG BASE N212994 002 May 07, 2021
+! EQ 10.4MG BASE;EQ 52.3MG BASE N212994 003 May 07, 2021
DEXRAZOXANE HYDROCHLORIDE
INJECTABLE;INJECTION
DEXRAZOXANE HYDROCHLORIDE
AP ! EUGIA PHARMA EQ 250MG BASE/VIAL A200752 001 Oct 19, 2011
AP ! EQ 500MG BASE/VIAL A200752 002 Oct 19, 2011
AP GLAND EQ 250MG BASE/VIAL A207321 002 Dec 16, 2019
AP EQ 500MG BASE/VIAL A207321 001 Nov 28, 2016
AP HIKMA EQ 250MG BASE/VIAL A076068 001 Sep 28, 2004
AP EQ 500MG BASE/VIAL A076068 002 Sep 28, 2004
DEXTROAMPHETAMINE
SYSTEM;TRANSDERMAL
XELSTRYM
+ NOVEN PHARMS INC 4.5MG/9HR N215401 001 Mar 22, 2022
+ 9MG/9HR N215401 002 Mar 22, 2022
+ 13.5MG/9HR N215401 003 Mar 22, 2022
+! 18MG/9HR N215401 004 Mar 22, 2022
DEXTROAMPHETAMINE SULFATE
CAPSULE, EXTENDED RELEASE;ORAL
DEXEDRINE
AB + IMPAX LABS INC 5MG N017078 001
AB + 10MG N017078 002
AB +! 15MG N017078 003
DEXTROAMPHETAMINE SULFATE
AB ACTAVIS ELIZABETH 5MG A203901 001 Nov 30, 2012
AB 10MG A203901 002 Nov 30, 2012
AB 15MG A203901 003 Nov 30, 2012
AB SPECGX LLC 5MG A076353 001 May 06, 2003
AB 10MG A076353 002 May 06, 2003
AB 15MG A076353 003 May 06, 2003
AB STRIDES PHARMA 5MG A205673 001 Oct 31, 2017
AB 10MG A205673 002 Oct 31, 2017
AB 15MG A205673 003 Oct 31, 2017
SOLUTION;ORAL
DEXTROAMPHETAMINE SULFATE
AA ! OUTLOOK PHARMS 5MG/5ML A040776 001 Jan 29, 2008
AA TRIS PHARMA INC 5MG/5ML A203644 001 May 29, 2013
TABLET;ORAL
DEXTROAMPHETAMINE SULFATE
AA ARBOR PHARMS LLC 5MG A090533 002 Oct 25, 2011
AA 10MG A090533 004 Oct 25, 2011
AA AUROLIFE PHARMA LLC 5MG A202893 001 Jul 31, 2013
AA 10MG A202893 002 Jul 31, 2013
AA AVANTHI INC 5MG A203548 001 Nov 23, 2015
AA 10MG A203548 002 Nov 23, 2015
AA BARR 5MG A040361 001 Jan 31, 2001
AA ! 10MG A040361 002 Jan 31, 2001
AA NOVEL LABS INC 5MG A204330 001 Mar 16, 2016
AA 10MG A204330 002 Mar 16, 2016
AA NUVO PHARM 5MG A210059 001 Oct 18, 2017
AA 10MG A210059 002 Oct 18, 2017
AA SPECGX LLC 5MG A040436 001 Jan 29, 2002
AA 10MG A040436 002 Jan 29, 2002
AA TRIS PHARMA INC 5MG A206095 001 Aug 18, 2022
AA 10MG A206095 002 Aug 18, 2022
ARBOR PHARMS LLC 2.5MG A090533 001 Oct 25, 2011
7.5MG A090533 003 Oct 25, 2011
15MG A090533 005 Oct 25, 2011
20MG A090533 006 Oct 25, 2011
30MG A090533 007 Oct 25, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-136(of 474)

DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE


SYRUP;ORAL
PROMETHAZINE DM
AA ! SLATE RUN PHARMA 15MG/5ML;6.25MG/5ML A040649 001 Feb 14, 2006
PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
AA AMNEAL PHARMS 15MG/5ML;6.25MG/5ML A090575 001 Feb 08, 2011
AA TRIS PHARMA INC 15MG/5ML;6.25MG/5ML A091687 001 Jun 28, 2012
PROMETHAZINE W/ DEXTROMETHORPHAN
AA WOCKHARDT BIO AG 15MG/5ML;6.25MG/5ML A088864 001 Jan 04, 1985
DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE
CAPSULE;ORAL
DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE
AB ACTAVIS ELIZABETH 20MG;10MG A202934 001 Oct 10, 2017
NUEDEXTA
AB +! AVANIR PHARMS 20MG;10MG N021879 001 Oct 29, 2010
DEXTROSE
INJECTABLE;INJECTION
DEXTROSE 10% IN PLASTIC CONTAINER
AP +! B BRAUN 10GM/100ML N019626 004 Feb 02, 1988
AP +! BAXTER HLTHCARE 10GM/100ML N016694 001
AP FRESENIUS KABI USA 10GM/100ML A209448 001 Jul 16, 2018
AP +! ICU MEDICAL INC 10GM/100ML N018080 001
DEXTROSE 5% IN PLASTIC CONTAINER
AP +! B BRAUN 50MG/ML N016730 002
AP +! 5GM/100ML N016730 001
AP +! 5GM/100ML N019626 002 Feb 02, 1988
AP +! BAXTER HLTHCARE 50MG/ML N016673 003 Oct 30, 1985
AP +! 50MG/ML N020179 002 Dec 07, 1992
AP +! 5GM/100ML N016673 001
AP +! 5GM/100ML N020179 001 Dec 07, 1992
AP FRESENIUS KABI USA 50MG/ML A207449 001 Oct 21, 2016
AP +! HOSPIRA 5GM/100ML N019466 001 Jul 15, 1985
AP +! 5GM/100ML N019479 001 Sep 17, 1985
AP +! ICU MEDICAL INC 50MG/ML N016367 002
DEXTROSE 50%
AP + HOSPIRA 500MG/ML N019445 001 Jun 03, 1986
AP INTL MEDICATION SYS 500MG/ML A203451 001 Mar 26, 2021
DEXTROSE 50% IN PLASTIC CONTAINER
AP +! BAXTER HLTHCARE 50GM/100ML N020047 001 Jul 02, 1991
AP +! ICU MEDICAL INC 50GM/100ML N018563 001 Mar 23, 1982
DEXTROSE 70% IN PLASTIC CONTAINER
AP +! B BRAUN 70GM/100ML N019626 005 Feb 18, 2015
AP +! BAXTER HLTHCARE 70GM/100ML N020047 003 Jul 02, 1991
AP +! ICU MEDICAL INC 70GM/100ML N018561 001 Mar 23, 1982
AP +! 70GM/100ML N019893 001 Dec 26, 1989
DEXTROSE 20% IN PLASTIC CONTAINER
+! ICU MEDICAL INC 20GM/100ML N018564 001 Mar 23, 1982
DEXTROSE 25%
+! HOSPIRA 250MG/ML N019445 002 Nov 23, 1998
DEXTROSE 30% IN PLASTIC CONTAINER
+! ICU MEDICAL INC 30GM/100ML N019345 001 Jan 26, 1985
DEXTROSE 40% IN PLASTIC CONTAINER
+! ICU MEDICAL INC 40GM/100ML N018562 001 Mar 23, 1982
DEXTROSE; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;21MG/100ML;128MG/100ML;234MG/ N017610 001
100ML
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE
INJECTABLE;INJECTION
ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;31MG/100ML;130MG/100ML;26MG/1 N019873 001 Jun 10, 1993
00ML;320MG/100ML
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE;
SODIUM LACTATE
INJECTABLE;INJECTION
DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER
BAXTER HLTHCARE 5GM/100ML;31MG/100ML;141MG/100ML;20MG/1 N017484 001
00ML;12MG/100ML;260MG/100ML
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-137(of 474)

DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM LACTATE;
SODIUM PHOSPHATE, MONOBASIC ANHYDROUS
INJECTABLE;INJECTION
IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;30MG/100ML;141MG/100ML;15MG/1 N019513 001 May 08, 1986
00ML;260MG/100ML;25MG/100ML
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM
GLUCONATE
INJECTABLE;INJECTION
NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;30MG/100ML;37MG/100ML;222MG/1 N017609 001
00ML;526MG/100ML;502MG/100ML
DEXTROSE; POTASSIUM CHLORIDE
INJECTABLE;INJECTION
DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075%
AP FRESENIUS KABI USA 5GM/100ML;75MG/100ML A212346 001 Sep 10, 2020
DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER
AP + BAXTER HLTHCARE 5GM/100ML;75MG/100ML N017634 004
DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15%
AP FRESENIUS KABI USA 5GM/100ML;150MG/100ML A212346 002 Sep 10, 2020
DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER
AP + BAXTER HLTHCARE 5GM/100ML;150MG/100ML N017634 001
DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
AP + BAXTER HLTHCARE 5GM/100ML;300MG/100ML N017634 002
POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;150MG/100ML N019699 004 Sep 29, 1989
POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;300MG/100ML N019699 006 Sep 29, 1989
DEXTROSE 5% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER
+ BAXTER HLTHCARE 5GM/100ML;224MG/100ML N017634 003
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;149MG/100ML N018371 001
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE;INJECTION
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ
AP BAXTER HLTHCARE 5GM/100ML;75MG/100ML;200MG/100ML N018037 006 Apr 13, 1982
AP 5GM/100ML;150MG/100ML;200MG/100ML N018037 007 Apr 13, 1982
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K)
AP BAXTER HLTHCARE 5GM/100ML;224MG/100ML;200MG/100ML N018037 004
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ
AP BAXTER HLTHCARE 5GM/100ML;150MG/100ML;200MG/100ML N018037 008 Apr 13, 1982
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K)
AP BAXTER HLTHCARE 5GM/100ML;300MG/100ML;200MG/100ML N018037 001
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ
AP BAXTER HLTHCARE 5GM/100ML;224MG/100ML;200MG/100ML N018037 005 Apr 13, 1982
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ
AP BAXTER HLTHCARE 5GM/100ML;300MG/100ML;200MG/100ML N018037 009 Apr 13, 1982
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ
AP BAXTER HLTHCARE 5GM/100ML;75MG/100ML;200MG/100ML N018037 002
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K)
AP BAXTER HLTHCARE 5GM/100ML;150MG/100ML;200MG/100ML N018037 003
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;75MG/100ML;330MG/100ML N018629 005 Mar 23, 1982
AP 5GM/100ML;150MG/100ML;330MG/100ML N018629 002 Mar 23, 1982
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;224MG/100ML;330MG/100ML N018629 003 Mar 23, 1982
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;150MG/100ML;330MG/100ML N018629 004 Mar 23, 1982
AP 5GM/100ML;300MG/100ML;330MG/100ML N018629 006 Mar 23, 1982
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;224MG/100ML;330MG/100ML N018629 007 Mar 23, 1982
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;300MG/100ML;330MG/100ML N018629 008 Mar 23, 1982
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;75MG/100ML;330MG/100ML N018629 001 Mar 23, 1982
DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;300MG/100ML;450MG/100ML N018008 010
POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;75MG/100ML;200MG/100ML N019630 008 Feb 17, 1988
POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;75MG/100ML;330MG/100ML N019630 014 Feb 17, 1988
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-138(of 474)

DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE


INJECTABLE;INJECTION
POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;75MG/100ML;450MG/100ML N019630 020 Feb 17, 1988
POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;75MG/100ML;900MG/100ML N019630 026 Feb 17, 1988
POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;150MG/100ML;200MG/100ML N019630 010 Feb 17, 1988
POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;150MG/100ML;330MG/100ML N019630 016 Feb 17, 1988
POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;150MG/100ML;450MG/100ML N019630 022 Feb 17, 1988
POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;150MG/100ML;900MG/100ML N019630 028 Feb 17, 1988
POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;300MG/100ML;200MG/100ML N019630 012 Feb 17, 1988
POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;300MG/100ML;330MG/100ML N019630 018 Feb 17, 1988
POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;300MG/100ML;450MG/100ML N019630 024 Feb 17, 1988
POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;300MG/100ML;900MG/100ML N019630 030 Feb 17, 1988
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45%
AP FRESENIUS KABI USA 5GM/100ML;149MG/100ML;450MG/100ML A213523 005 Oct 11, 2022
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;75MG/100ML;450MG/100ML N018008 005 Apr 28, 1982
AP 5GM/100ML;150MG/100ML;450MG/100ML N018008 006 Apr 28, 1982
AP +! ICU MEDICAL INC 5GM/100ML;74.5MG/100ML;450MG/100ML N018362 009 Jul 05, 1983
AP +! 5GM/100ML;149MG/100ML;450MG/100ML N018362 005 Mar 28, 1988
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;150MG/100ML;450MG/100ML N018008 007 Apr 28, 1982
AP +! ICU MEDICAL INC 5GM/100ML;149MG/100ML;450MG/100ML N018362 010 Jul 05, 1983
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;150MG/100ML;900MG/100ML N019308 005 Apr 05, 1985
AP +! ICU MEDICAL INC 5GM/100ML;149MG/100ML;900MG/100ML N019691 005 Mar 24, 1988
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;224MG/100ML;450MG/100ML N018008 008 Apr 28, 1982
AP +! ICU MEDICAL INC 5GM/100ML;224MG/100ML;450MG/100ML N018362 002
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;300MG/100ML;450MG/100ML N018008 009 Apr 28, 1982
AP +! ICU MEDICAL INC 5GM/100ML;298MG/100ML;450MG/100ML N018362 003
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;300MG/100ML;900MG/100ML N019308 007 Apr 05, 1985
AP +! ICU MEDICAL INC 5GM/100ML;298MG/100ML;900MG/100ML N019691 009 Mar 24, 1988
POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;37MG/100ML;200MG/100ML N019630 031 Feb 17, 1988
POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;37MG/100ML;450MG/100ML N019630 037 Feb 17, 1988
POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;37MG/100ML;900MG/100ML N019630 043 Feb 17, 1988
POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;37MG/100ML;110MG/100ML N019630 001 Feb 17, 1988
POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;37MG/100ML;200MG/100ML N019630 007 Feb 17, 1988
POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;37MG/100ML;330MG/100ML N019630 013 Feb 17, 1988
POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;37MG/100ML;450MG/100ML N019630 019 Feb 17, 1988
POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;37MG/100ML;900MG/100ML N019630 025 Feb 17, 1988
POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;75MG/100ML;200MG/100ML N019630 032 Feb 17, 1988
POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;75MG/100ML;450MG/100ML N019630 038 Feb 17, 1988
POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;75MG/100ML;900MG/100ML N019630 044 Feb 17, 1988
POTASSIUM CHLORIDE 0.075% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
B BRAUN 3.3GM/100ML;75MG/100ML;300MG/100ML N019630 049 May 07, 1992
POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;75MG/100ML;110MG/100ML N019630 002 Feb 17, 1988
POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;110MG/100ML;200MG/100ML N019630 033 Feb 17, 1988
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-139(of 474)

DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE


INJECTABLE;INJECTION
POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;110MG/100ML;450MG/100ML N019630 039 Feb 17, 1988
POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;110MG/100ML;900MG/100ML N019630 045 Feb 17, 1988
POTASSIUM CHLORIDE 0.11% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
B BRAUN 3.3GM/100ML;110MG/100ML;300MG/100ML N019630 050 May 07, 1992
POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;110MG/100ML;110MG/100ML N019630 003 Feb 17, 1988
POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;110MG/100ML;200MG/100ML N019630 009 Feb 17, 1988
POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;110MG/100ML;330MG/100ML N019630 015 Feb 17, 1988
POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;110MG/100ML;450MG/100ML N019630 021 Feb 17, 1988
POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;110MG/100ML;900MG/100ML N019630 027 Feb 17, 1988
POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;150MG/100ML;200MG/100ML N019630 034 Feb 17, 1988
POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;150MG/100ML;450MG/100ML N019630 040 Feb 17, 1988
POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;150MG/100ML;900MG/100ML N019630 046 Feb 17, 1988
POTASSIUM CHLORIDE 0.15% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
B BRAUN 3.3GM/100ML;150MG/100ML;300MG/100ML N019630 051 May 07, 1992
POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;150MG/100ML;110MG/100ML N019630 004 Feb 17, 1988
POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;220MG/100ML;200MG/100ML N019630 035 Feb 17, 1988
POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;220MG/100ML;450MG/100ML N019630 041 Feb 17, 1988
POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;220MG/100ML;900MG/100ML N019630 047 Feb 17, 1988
POTASSIUM CHLORIDE 0.22% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
B BRAUN 3.3GM/100ML;220MG/100ML;300MG/100ML N019630 052 May 07, 1992
POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;220MG/100ML;110MG/100ML N019630 005 Feb 17, 1988
POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;220MG/100ML;200MG/100ML N019630 011 Feb 17, 1988
POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;220MG/100ML;330MG/100ML N019630 017 Feb 17, 1988
POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;220MG/100ML;450MG/100ML N019630 023 Feb 17, 1988
POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;220MG/100ML;900MG/100ML N019630 029 Feb 17, 1988
POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;300MG/100ML;200MG/100ML N019630 036 Feb 17, 1988
POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;300MG/100ML;450MG/100ML N019630 042 Feb 17, 1988
POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;300MG/100ML;900MG/100ML N019630 048 Feb 17, 1988
POTASSIUM CHLORIDE 0.3% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
B BRAUN 3.3GM/100ML;300MG/100ML;300MG/100ML N019630 053 May 07, 1992
POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;300MG/100ML;110MG/100ML N019630 006 Feb 17, 1988
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
BAXTER HLTHCARE 5GM/100ML;75MG/100ML;900MG/100ML N019308 004 Apr 05, 1985
5GM/100ML;150MG/100ML;900MG/100ML N019308 002 Apr 05, 1985
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
+ ICU MEDICAL INC 5GM/100ML;149MG/100ML;225MG/100ML N018365 001
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
BAXTER HLTHCARE 5GM/100ML;300MG/100ML;900MG/100ML N019308 003 Apr 05, 1985
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
BAXTER HLTHCARE 5GM/100ML;224MG/100ML;900MG/100ML N019308 006 Apr 05, 1985
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
BAXTER HLTHCARE 5GM/100ML;150MG/100ML;450MG/100ML N018008 004
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
BAXTER HLTHCARE 5GM/100ML;150MG/100ML;900MG/100ML N019308 001 Apr 05, 1985
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-140(of 474)

DEXTROSE; SODIUM CHLORIDE


INJECTABLE;INJECTION
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
AP B BRAUN 2.5GM/100ML;450MG/100ML N019631 004 Feb 24, 1988
AP +! BAXTER HLTHCARE 2.5GM/100ML;450MG/100ML N016697 001
AP FRESENIUS KABI USA 2.5GM/100ML;450MG/100ML A211190 001 Dec 20, 2019
DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;200MG/100ML N019631 007 Feb 24, 1988
DEXTROSE 5% AND SODIUM CHLORIDE 0.225%
AP FRESENIUS KABI USA 5GM/100ML;225MG/100ML A211221 001 Sep 15, 2020
DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
AP +! ICU MEDICAL INC 5GM/100ML;225MG/100ML N017606 001
DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
AP FRESENIUS KABI USA 5GM/100ML;300MG/100ML A211194 001 Aug 26, 2020
AP +! ICU MEDICAL INC 5GM/100ML;300MG/100ML N017799 001
DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;330MG/100ML N019631 008 Feb 24, 1988
DEXTROSE 5% AND SODIUM CHLORIDE 0.45%
AP FRESENIUS KABI USA 5GM/100ML;450MG/100ML A211276 001 Sep 15, 2020
DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;450MG/100ML N019631 009 Feb 24, 1988
AP + ICU MEDICAL INC 5GM/100ML;450MG/100ML N017607 001
DEXTROSE 5% AND SODIUM CHLORIDE 0.9%
AP FRESENIUS KABI USA 5GM/100ML;900MG/100ML A211211 001 Sep 14, 2020
DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML;900MG/100ML N019631 010 Feb 24, 1988
AP +! ICU MEDICAL INC 5GM/100ML;900MG/100ML N017585 001
DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;200MG/100ML N016689 001
DEXTROSE 5% IN SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;330MG/100ML N016687 001
DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;450MG/100ML N016683 001
DEXTROSE 5% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML;900MG/100ML N016678 001
DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;110MG/100ML N019631 011 Feb 24, 1988
DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;200MG/100ML N019631 012 Feb 24, 1988
DEXTROSE 10% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;330MG/100ML N019631 013 Feb 24, 1988
DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;450MG/100ML N019631 014 Feb 24, 1988
DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;900MG/100ML N019631 015 Feb 24, 1988
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
B BRAUN 2.5GM/100ML;110MG/100ML N019631 001 Feb 24, 1988
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
B BRAUN 2.5GM/100ML;200MG/100ML N019631 002 Feb 24, 1988
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
B BRAUN 2.5GM/100ML;330MG/100ML N019631 003 Feb 24, 1988
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 2.5GM/100ML;900MG/100ML N019631 005 Feb 24, 1988
DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
B BRAUN 3.3GM/100ML;300MG/100ML N019631 016 Jan 19, 1990
DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;110MG/100ML N019631 006 Feb 24, 1988
DIATRIZOATE MEGLUMINE
SOLUTION;URETHRAL
CYSTOGRAFIN
+ BRACCO 30% N010040 018
CYSTOGRAFIN DILUTE
+ BRACCO 18% N010040 022 Nov 09, 1982
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
SOLUTION;ORAL, RECTAL
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM
AA GUARDIAN DRUG 66%;10% A214201 001 Jun 27, 2022
GASTROGRAFIN
AA +! BRACCO 66%;10% N011245 003
MD-GASTROVIEW
AA LIEBEL-FLARSHEIM 66%;10% A087388 001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-141(of 474)

DIAZEPAM
CONCENTRATE;ORAL
DIAZEPAM
AA CHARTWELL MOLECULAR 5MG/ML A204433 001 Apr 14, 2014
DIAZEPAM INTENSOL
AA ! HIKMA 5MG/ML A071415 001 Apr 03, 1987
GEL;RECTAL
DIASTAT
+! BAUSCH 2.5MG/0.5ML (5MG/ML) N020648 001 Jul 29, 1997
DIASTAT ACUDIAL
+! BAUSCH 10MG/2ML (5MG/ML) N020648 007 Sep 15, 2005
+! 20MG/4ML (5MG/ML) N020648 006 Sep 15, 2005
INJECTABLE;INJECTION
DIAZEPAM
AP ! BELOTECA INC 10MG/2ML (5MG/ML) A210363 001 Mar 18, 2019
AP 50MG/10ML (5MG/ML) A211998 001 Dec 26, 2019
AP FRESENIUS KABI USA 10MG/2ML (5MG/ML) A214745 001 Nov 10, 2022
AP HIKMA 10MG/2ML (5MG/ML) A070313 001 Dec 16, 1985
AP HOSPIRA 10MG/2ML (5MG/ML) A072079 001 Dec 20, 1988
AP ! 50MG/10ML (5MG/ML) A071583 001 Oct 13, 1987
SOLUTION;ORAL
DIAZEPAM
AA CHARTWELL MOLECULAR 5MG/5ML A206477 001 Jun 24, 2016
AA ! HIKMA 5MG/5ML A070928 001 Apr 03, 1987
SPRAY;NASAL
VALTOCO
+ NEURELIS INC 5MG/SPRAY N211635 001 Jan 10, 2020
+ 7.5MG/SPRAY N211635 002 Jan 10, 2020
+! 10MG/SPRAY N211635 003 Jan 10, 2020
TABLET;ORAL
DIAZEPAM
AB IVAX SUB TEVA 2MG A071307 001 Dec 10, 1986
PHARMS
AB 5MG A071321 001 Dec 10, 1986
AB 10MG A071322 001 Dec 10, 1986
AB MAYNE PHARMA 2MG A071134 001 Feb 03, 1987
AB 5MG A071135 001 Feb 03, 1987
AB 10MG A071136 001 Feb 03, 1987
AB MYLAN 2MG A070325 002 Sep 04, 1985
AB 5MG A070325 003 Sep 04, 1985
AB 10MG A070325 001 Sep 04, 1985
AB STRIDES PHARMA 2MG A077749 001 Mar 31, 2006
AB 5MG A077749 002 Mar 31, 2006
AB 10MG A077749 003 Mar 31, 2006
VALIUM
AB + WAYLIS THERAP 2MG N013263 002
AB + 5MG N013263 004
AB +! 10MG N013263 006
DIAZOXIDE
SUSPENSION;ORAL
DIAZOXIDE
AB E5 PHARMA INC 50MG/ML A211050 001 Dec 20, 2019
AB NOVITIUM PHARMA 50MG/ML A210799 001 Jul 08, 2020
PROGLYCEM
AB +! TEVA BRANDED PHARM 50MG/ML N017453 001
DICHLORPHENAMIDE
TABLET;ORAL
DICHLORPHENAMIDE
AB TORRENT 50MG A215924 001 Dec 29, 2022
KEVEYIS
AB +! XERIS 50MG N011366 002 Aug 07, 2015
DICLOFENAC EPOLAMINE
SYSTEM;TOPICAL
FLECTOR
+! INST BIOCHEM 1.3% N021234 001 Jan 31, 2007
LICART
+! IBSA INST BIO 1.3% N206976 001 Dec 19, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-142(of 474)

DICLOFENAC POTASSIUM
CAPSULE;ORAL
DICLOFENAC POTASSIUM
AB AUROBINDO PHARMA 25MG A213875 001 Oct 19, 2021
LTD
AB BIONPHARMA INC 25MG A204648 001 Feb 23, 2016
AB STRIDES PHARMA 25MG A210078 001 Dec 03, 2019
ZIPSOR
AB +! ASSERTIO 25MG N022202 001 Jun 16, 2009
FOR SOLUTION;ORAL
CAMBIA
AB +! ASSERTIO 50MG N022165 001 Jun 17, 2009
DICLOFENAC POTASSIUM
AB ALKEM LABS LTD 50MG A216635 001 Jul 20, 2022
AB ANNORA PHARMA 50MG A215375 001 Mar 04, 2022
AB PAR FORM 50MG A202964 001 May 02, 2016
TABLET;ORAL
CATAFLAM
AB AMICI 25MG A076561 002 Jul 21, 2021
AB 50MG A076561 001 Mar 18, 2004
DICLOFENAC POTASSIUM
AB NOVAST LABS 50MG A215585 001 Oct 08, 2021
AB ! RK PHARMA 50MG A075463 001 Jul 26, 1999
AB RUBICON 25MG A075229 002 Sep 16, 2021
AB 50MG A075229 001 Nov 20, 1998
AB TEVA 50MG A075219 001 Aug 06, 1998
AB UMEDICA LABS PVT 50MG A215750 001 May 11, 2022
LTD
DICLOFENAC SODIUM
GEL;TOPICAL
DICLOFENAC SODIUM
AB ACTAVIS MID 3% A206493 001 Dec 02, 2015
ATLANTIC
AB ALEOR 3% A212351 001 Jul 27, 2022
DERMACEUTICALS
AB GLENMARK PHARMS LTD 3% A208301 001 Sep 13, 2016
AB PADAGIS ISRAEL 3% A210893 001 Jul 27, 2018
AB ! TARO 3% A206298 001 Apr 28, 2016
AB TOLMAR 3% A200936 001 Oct 28, 2013
CIPLA 1% A209903 001 Aug 03, 2018
SOLUTION;TOPICAL
DICLOFENAC SODIUM
AB ALEOR 2% A212506 001 Nov 29, 2022
DERMACEUTICALS
AB AMNEAL 2% A208198 001 Aug 18, 2022
AB APOTEX 2% A207714 001 May 06, 2022
AB LUPIN PHARMS 2% A208021 001 Sep 20, 2022
AB TARO 2% A208098 001 Sep 29, 2022
PENNSAID
AB +! HORIZON 2% N204623 001 Jan 16, 2014
DICLOFENAC SODIUM
AT AKORN 1.5% A206655 001 Jan 28, 2021
AT AMNEAL PHARMS 1.5% A206116 001 Sep 02, 2016
AT CADILA 1.5% A206411 001 Apr 17, 2018
AT LUPIN LTD 1.5% A204132 001 Aug 20, 2015
AT NOVEL LABS INC 1.5% A205878 001 Dec 09, 2015
AT PAI HOLDINGS PHARM 1.5% A202769 001 Jul 08, 2015
AT ! TARO 1.5% A203818 001 Nov 26, 2014
AT WATSON LABS INC 1.5% A202852 001 Nov 24, 2014
SOLUTION/DROPS;OPHTHALMIC
DICLOFENAC SODIUM
AT ALTAIRE PHARMS INC 0.1% A203383 001 Nov 16, 2015
AT ! BAUSCH AND LOMB 0.1% A078792 001 Dec 28, 2007
AT RISING 0.1% A078553 001 Dec 28, 2007
AT SANDOZ INC 0.1% A078031 001 Feb 06, 2008
TABLET, DELAYED RELEASE;ORAL
DICLOFENAC SODIUM
AB ACTAVIS ELIZABETH 50MG A074514 001 Mar 26, 1996
AB 75MG A074514 002 Mar 26, 1996
AB CARLSBAD 25MG A075185 002 Nov 13, 1998
AB 50MG A075185 003 Nov 13, 1998
AB 75MG A075185 001 Nov 13, 1998
AB ! UNIQUE 25MG A090066 001 Dec 01, 2010
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-143(of 474)

DICLOFENAC SODIUM
TABLET, DELAYED RELEASE;ORAL
DICLOFENAC SODIUM
AB ! 50MG A090066 002 Dec 01, 2010
AB ! 75MG A077863 003 Jun 08, 2007
TABLET, EXTENDED RELEASE;ORAL
DICLOFENAC SODIUM
AB ! DEXCEL LTD 100MG A076201 001 Nov 06, 2002
AB RICONPHARMA LLC 100MG A216275 001 Sep 23, 2022
AB VPNA 100MG A075492 001 Feb 11, 2000
DICLOFENAC SODIUM; MISOPROSTOL
TABLET, DELAYED RELEASE;ORAL
ARTHROTEC
AB + PFIZER 50MG;0.2MG N020607 001 Dec 24, 1997
AB +! 75MG;0.2MG N020607 002 Dec 24, 1997
DICLOFENAC SODIUM AND MISOPROSTOL
AB ACTAVIS LABS FL INC 50MG;0.2MG A201089 001 Jul 09, 2012
AB 75MG;0.2MG A201089 002 Jul 09, 2012
AB AMNEAL PHARMS 50MG;0.2MG A203995 001 Nov 25, 2016
AB 75MG;0.2MG A203995 002 Nov 25, 2016
AB MICRO LABS 50MG;0.2MG A204355 001 Jul 15, 2021
AB 75MG;0.2MG A204355 002 Jul 15, 2021
AB SANDOZ 50MG;0.2MG A200158 001 May 09, 2013
AB 75MG;0.2MG A200158 002 May 09, 2013
AB YUNG SHIN PHARM 50MG;0.2MG A205143 001 Feb 19, 2020
AB 75MG;0.2MG A205143 002 Feb 19, 2020
DICLOXACILLIN SODIUM
CAPSULE;ORAL
DICLOXACILLIN SODIUM
AB AUROBINDO PHARMA EQ 250MG BASE A216845 001 Sep 23, 2022
AB EQ 500MG BASE A216845 002 Sep 23, 2022
AB TEVA EQ 250MG BASE A062286 001 Jun 03, 1982
AB ! EQ 500MG BASE A062286 002 Jun 03, 1982
DICYCLOMINE HYDROCHLORIDE
CAPSULE;ORAL
DICYCLOMINE HYDROCHLORIDE
AB AUROBINDO PHARMA 10MG A040319 001 Sep 07, 1999
USA
AB ! LANNETT 10MG A084285 001
AB TWI PHARMS 10MG A217054 001 Dec 27, 2022
AB WATSON LABS 10MG A085082 001 Jun 19, 1986
AB WEST WARD 10MG A040204 001 Feb 28, 1997
INJECTABLE;INJECTION
BENTYL
AP +! ALLERGAN 10MG/ML N008370 001 Oct 15, 1984
BENTYL PRESERVATIVE FREE
AP +! ALLERGAN 10MG/ML N008370 002 Oct 15, 1984
DICYCLOMINE HYDROCHLORIDE
AP AKORN 10MG/ML A207084 001 May 04, 2018
AP AM REGENT 10MG/ML A208353 001 Feb 17, 2017
AP FOSUN PHARMA 10MG/ML A210979 001 Jul 02, 2018
AP FRESENIUS KABI USA 10MG/ML A210257 001 Jan 25, 2019
AP NEXUS PHARMS 10MG/ML A206468 001 Feb 01, 2019
AP SLATE RUN PHARMA 10MG/ML A207076 001 Nov 02, 2018
DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE)
AP HIKMA 10MG/ML A040465 001 Jun 30, 2003
SYRUP;ORAL
DICYCLOMINE HYDROCHLORIDE
AA ! GENERICS 10MG/5ML A040169 001 Mar 24, 2005
AA HIKMA 10MG/5ML A212286 001 May 22, 2020
AA NOVITIUM PHARMA 10MG/5ML A214721 001 Apr 23, 2021
TABLET;ORAL
DICYCLOMINE HYDROCHLORIDE
AB COREPHARMA 20MG A216760 001 Nov 28, 2022
AB HIKMA PHARMS 20MG A040161 001 Oct 01, 1996
AB LANNETT 20MG A040230 001 Feb 26, 1999
AB RUBICON 20MG A216736 001 Dec 14, 2022
AB ! WATSON LABS 20MG A085223 001 Jul 30, 1986
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-144(of 474)

DIENOGEST; ESTRADIOL VALERATE


TABLET;ORAL
NATAZIA
+! BAYER HLTHCARE N/A,2MG,3MG,N/A,N/A;3MG,2MG,2MG,1MG,N/A N022252 001 May 06, 2010
DIETHYLPROPION HYDROCHLORIDE
TABLET;ORAL
DIETHYLPROPION HYDROCHLORIDE
AA AVANTHI INC 25MG A201212 001 Dec 22, 2010
AA ! LANNETT CO INC 25MG A200177 001 Jul 18, 2011
TABLET, EXTENDED RELEASE;ORAL
DIETHYLPROPION HYDROCHLORIDE
AB ! LANNETT CO INC 75MG A091680 001 Oct 24, 2011
DIFELIKEFALIN ACETATE
SOLUTION;INTRAVENOUS
KORSUVA
+! CARA THERAP EQ 0.065MG BASE/1.3ML (EQ 0.05MG N214916 001 Aug 23, 2021
BASE/ML)
DIFLORASONE DIACETATE
CREAM;TOPICAL
DIFLORASONE DIACETATE
BX ! ANI PHARMS 0.05% A076263 001 Dec 20, 2002
BX ! TARO 0.05% A075508 001 Apr 24, 2000
OINTMENT;TOPICAL
DIFLORASONE DIACETATE
AB FOUGERA PHARMS 0.05% A075374 001 Apr 27, 1999
AB RISING 0.05% A207440 001 Feb 27, 2017
AB ! TARO 0.05% A075331 001 May 14, 1999
AB THE J MOLNER 0.05% A210753 001 Jun 12, 2018
DIFLUNISAL
TABLET;ORAL
DIFLUNISAL
AB HERITAGE PHARMA 500MG A202845 001 Mar 08, 2012
AB ! TEVA 500MG A073673 001 Jul 31, 1992
AB ZYDUS PHARMS 500MG A203547 001 Jun 16, 2017
DIFLUPREDNATE
EMULSION;OPHTHALMIC
DIFLUPREDNATE
AB AMNEAL 0.05% A211526 001 Nov 17, 2021
AB CIPLA 0.05% A211776 001 Aug 09, 2021
AB DR REDDYS 0.05% A214894 001 Nov 16, 2022
DUREZOL
AB +! NOVARTIS 0.05% N022212 001 Jun 23, 2008
DIGOXIN
ELIXIR;ORAL
DIGOXIN
AA AMICI 0.05MG/ML A215209 001 Mar 11, 2022
AA +! HIKMA 0.05MG/ML N021648 001 Aug 26, 2004
AA NOVITIUM PHARMA 0.05MG/ML A213000 001 Oct 04, 2019
INJECTABLE;INJECTION
DIGOXIN
AP SANDOZ INC 0.25MG/ML A040481 001 Aug 21, 2003
AP WEST-WARD PHARMS 0.25MG/ML A083391 001
INT
LANOXIN
AP +! COVIS 0.25MG/ML N009330 002
LANOXIN PEDIATRIC
+! COVIS 0.1MG/ML N009330 004
TABLET;ORAL
DIGOXIN
AB AUROBINDO PHARMA 0.0625MG A214982 001 Feb 08, 2022
LTD
AB 0.125MG A214982 002 Feb 08, 2022
AB 0.25MG A214982 003 Feb 08, 2022
AB HIKMA INTL PHARMS 0.125MG A077002 002 Oct 30, 2007
AB 0.25MG A077002 001 Oct 30, 2007
AB IMPAX LABS 0.125MG A078556 001 Jul 20, 2009
AB 0.25MG A078556 002 Jul 20, 2009
AB NOVITIUM PHARMA 0.0625MG A215307 003 Aug 25, 2022
AB 0.125MG A215307 001 Nov 22, 2021
AB 0.25MG A215307 002 Nov 22, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-145(of 474)

DIGOXIN
TABLET;ORAL
DIGOXIN
AB RISING 0.125MG A040282 001 Dec 23, 1999
AB 0.25MG A040282 002 Dec 23, 1999
AB STEVENS J 0.125MG A076268 001 Jul 26, 2002
AB 0.25MG A076268 002 Jul 26, 2002
AB SUN PHARM INDS INC 0.125MG A076363 001 Jan 31, 2003
AB 0.25MG A076363 002 Jan 31, 2003
LANOXIN
AB + CONCORDIA 0.0625MG N020405 001 Sep 30, 1997
AB + 0.125MG N020405 002 Sep 30, 1997
AB +! 0.25MG N020405 004 Sep 30, 1997
DIHYDROERGOTAMINE MESYLATE
INJECTABLE;INJECTION
DIHYDROERGOTAMINE MESYLATE
AP HIKMA 1MG/ML A040453 001 Jun 09, 2003
AP ! HIKMA PHARMS 1MG/ML A206621 001 Sep 15, 2017
AP PADAGIS US 1MG/ML A040475 001 Apr 28, 2003
AP PROVEPHARM SAS 1MG/ML A212046 001 Jan 07, 2020
AP SAGENT PHARMS INC 1MG/ML A207264 001 Jul 11, 2018
SPRAY, METERED;NASAL
DIHYDROERGOTAMINE MESYLATE
AB CIPLA 0.5MG/SPRAY A212907 001 May 20, 2020
AB HIKMA 0.5MG/SPRAY A211393 001 Feb 28, 2020
MIGRANAL
AB +! BAUSCH 0.5MG/SPRAY N020148 001 Dec 08, 1997
TRUDHESA
+! IMPEL PHARMS 0.725MG/SPRAY N213436 001 Sep 02, 2021
DILTIAZEM HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
DILTIAZEM HYDROCHLORIDE
AB1 GLENMARK PHARMS LTD 60MG A212317 001 Mar 22, 2021
AB1 90MG A212317 002 Mar 22, 2021
AB1 120MG A212317 003 Mar 22, 2021
AB1 MAYNE PHARMA INTL 60MG A215775 001 May 05, 2022
AB1 90MG A215775 002 May 05, 2022
AB1 120MG A215775 003 May 05, 2022
AB1 MYLAN 60MG A074910 001 May 02, 1997
AB1 90MG A074910 002 May 02, 1997
AB1 ! 120MG A074910 003 May 02, 1997
AB2 ACCORD HLTHCARE 120MG A206997 001 Apr 28, 2020
AB2 180MG A206997 002 Apr 28, 2020
AB2 240MG A206997 003 Apr 28, 2020
AB2 AMTA 120MG A216304 001 Aug 08, 2022
AB2 180MG A216304 002 Aug 08, 2022
AB2 240MG A216304 003 Aug 08, 2022
AB2 APOTEX 120MG A074943 003 Dec 19, 2000
AB2 180MG A074943 002 Dec 19, 2000
AB2 ! 240MG A074943 001 Aug 06, 1998
CARDIZEM CD
AB3 + BAUSCH 120MG N020062 001 Aug 10, 1992
AB3 + 180MG N020062 002 Dec 27, 1991
AB3 + 240MG N020062 003 Dec 27, 1991
AB3 + 300MG N020062 004 Dec 27, 1991
AB3 +! 360MG N020062 005 Aug 24, 1999
CARTIA XT
AB3 ACTAVIS LABS FL INC 120MG A074752 002 Jul 09, 1998
AB3 180MG A074752 001 Jul 09, 1998
AB3 240MG A074752 003 Jul 09, 1998
AB3 300MG A074752 004 Jul 09, 1998
DILTIAZEM HYDROCHLORIDE
AB3 ACTAVIS ELIZABETH 360MG A202463 001 Dec 07, 2012
AB3 NOVAST LABS 120MG A208783 001 Jun 14, 2019
AB3 180MG A208783 002 Jun 14, 2019
AB3 240MG A208783 003 Jun 14, 2019
AB3 300MG A208783 004 Jun 14, 2019
AB3 360MG A208783 005 Jun 14, 2019
AB3 PAR PHARM 120MG A074984 001 Dec 20, 1999
AB3 180MG A074984 002 Dec 20, 1999
AB3 240MG A074984 003 Dec 20, 1999
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-146(of 474)

DILTIAZEM HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
DILTIAZEM HYDROCHLORIDE
AB3 300MG A074984 004 Dec 20, 1999
AB3 SUN PHARM 120MG A203023 001 Jun 08, 2017
AB3 180MG A203023 002 Jun 08, 2017
AB3 240MG A203023 003 Jun 08, 2017
AB3 300MG A203023 004 Jun 08, 2017
AB3 360MG A090492 005 Oct 28, 2011
AB3 360MG A203023 005 Jun 08, 2017
AB3 TWI PHARMS 120MG A205231 001 Aug 30, 2018
AB3 180MG A205231 002 Aug 30, 2018
AB3 240MG A205231 003 Aug 30, 2018
AB3 300MG A205231 004 Aug 30, 2018
AB3 360MG A205231 005 Aug 30, 2018
AB3 VALEANT PHARMS 120MG A075116 001 Dec 23, 1999
NORTH
AB3 180MG A075116 002 Dec 23, 1999
AB3 240MG A075116 003 Dec 23, 1999
AB3 300MG A075116 004 Dec 23, 1999
AB3 ZYDUS PHARMS 120MG A206534 001 Aug 08, 2017
AB3 180MG A206534 002 Aug 08, 2017
AB3 240MG A206534 003 Aug 08, 2017
AB3 300MG A206534 004 Aug 08, 2017
AB3 360MG A206534 005 Aug 08, 2017
AB4 SANDOZ 120MG A091022 001 Sep 28, 2012
AB4 180MG A091022 002 Sep 28, 2012
AB4 240MG A091022 003 Sep 28, 2012
AB4 300MG A091022 004 Sep 28, 2012
AB4 360MG A091022 005 Sep 28, 2012
AB4 420MG A091022 006 Sep 28, 2012
AB4 SUN PHARM 120MG A090421 001 Nov 15, 2010
AB4 180MG A090421 002 Nov 15, 2010
AB4 240MG A090421 003 Nov 15, 2010
AB4 300MG A090421 004 Nov 15, 2010
AB4 360MG A090421 005 Nov 15, 2010
AB4 ZYDUS PHARMS 120MG A206641 001 Aug 11, 2017
AB4 180MG A206641 002 Aug 11, 2017
AB4 240MG A206641 003 Aug 11, 2017
AB4 300MG A206641 004 Aug 11, 2017
AB4 360MG A206641 005 Aug 11, 2017
AB4 420MG A206641 006 Aug 11, 2017
TAZTIA XT
AB4 ACTAVIS LABS FL INC 120MG A075401 001 Apr 10, 2003
AB4 180MG A075401 002 Apr 10, 2003
AB4 240MG A075401 003 Apr 10, 2003
AB4 300MG A075401 004 Apr 10, 2003
AB4 360MG A075401 005 Apr 10, 2003
TIAZAC
AB4 + BAUSCH 120MG N020401 001 Sep 11, 1995
AB4 + 180MG N020401 002 Sep 11, 1995
AB4 + 240MG N020401 003 Sep 11, 1995
AB4 + 300MG N020401 004 Sep 11, 1995
AB4 + 360MG N020401 005 Sep 11, 1995
AB4 +! 420MG N020401 006 Oct 16, 1998
INJECTABLE;INJECTION
DILTIAZEM HYDROCHLORIDE
AP AKORN 5MG/ML A075086 001 Apr 09, 1998
AP ! ATHENEX INC 5MG/ML A074617 001 Feb 28, 1996
AP HIKMA FARMACEUTICA 5MG/ML A202651 001 Aug 09, 2012
AP HOSPIRA 5MG/ML A074941 001 Apr 15, 1998
AP WEST-WARD PHARMS 5MG/ML A078538 001 Dec 17, 2008
INT
! HOSPIRA 100MG/VIAL A075853 001 Dec 17, 2002
TABLET;ORAL
CARDIZEM
AB + BAUSCH 30MG N018602 001 Nov 05, 1982
AB + 60MG N018602 002 Nov 05, 1982
AB + 90MG N018602 003 Dec 08, 1986
AB +! 120MG N018602 004 Dec 08, 1986
DILTIAZEM HYDROCHLORIDE
AB EDENBRIDGE PHARMS 30MG A211596 001 Nov 18, 2019
AB 60MG A211596 002 Nov 18, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-147(of 474)

DILTIAZEM HYDROCHLORIDE
TABLET;ORAL
DILTIAZEM HYDROCHLORIDE
AB 90MG A211596 003 Nov 18, 2019
AB 120MG A211596 004 Nov 18, 2019
AB SCIEGEN PHARMS INC 30MG A216521 001 Sep 23, 2022
AB 60MG A216521 002 Sep 23, 2022
AB 90MG A216521 003 Sep 23, 2022
AB 120MG A216521 004 Sep 23, 2022
AB TEVA 30MG A074185 001 May 31, 1995
AB 60MG A074185 002 May 31, 1995
AB 90MG A074185 003 May 31, 1995
AB 120MG A074185 004 May 31, 1995
TABLET, EXTENDED RELEASE;ORAL
CARDIZEM LA
AB + BAUSCH 120MG N021392 001 Feb 06, 2003
AB + 180MG N021392 002 Feb 06, 2003
AB + 240MG N021392 003 Feb 06, 2003
AB + 300MG N021392 004 Feb 06, 2003
AB + 360MG N021392 005 Feb 06, 2003
AB +! 420MG N021392 006 Feb 06, 2003
DILTIAZEM HYDROCHLORIDE
AB ACTAVIS LABS FL INC 120MG A077686 006 Mar 15, 2010
AB 180MG A077686 005 Mar 15, 2010
AB 240MG A077686 004 Mar 15, 2010
AB 300MG A077686 003 Mar 15, 2010
AB 360MG A077686 002 Mar 15, 2010
AB 420MG A077686 001 Mar 15, 2010
DIMENHYDRINATE
INJECTABLE;INJECTION
DIMENHYDRINATE
! FRESENIUS KABI USA 50MG/ML A040519 001 Jun 23, 2004
DIMERCAPROL
INJECTABLE;INJECTION
BAL
+! AKORN 10% N005939 001
DIMETHYL FUMARATE
CAPSULE, DELAYED RELEASE;ORAL
DIMETHYL FUMARATE
AB ACCORD HLTHCARE 120MG A210499 001 Sep 24, 2020
AB 240MG A210499 002 Sep 24, 2020
AB ALKEM LABS LTD 120MG A210440 001 Sep 24, 2020
AB 240MG A210440 002 Sep 24, 2020
AB AMNEAL 120MG A210402 001 Sep 24, 2020
AB 240MG A210402 002 Sep 24, 2020
AB AUROBINDO PHARMA 120MG A210385 001 Dec 22, 2022
AB 240MG A210385 002 Dec 22, 2022
AB CIPLA 120MG A210305 001 Sep 24, 2020
AB 240MG A210305 002 Sep 24, 2020
AB GLENMARK PHARMS LTD 120MG A210309 001 Oct 06, 2020
AB 240MG A210309 002 Oct 06, 2020
AB HETERO LABS LTD III 120MG A210500 001 Sep 24, 2020
AB 240MG A210500 002 Sep 24, 2020
AB LUPIN 120MG A210226 001 Oct 05, 2020
AB 240MG A210226 002 Oct 05, 2020
AB MSN 120MG A210460 001 Sep 24, 2020
AB 240MG A210460 002 Sep 24, 2020
AB MYLAN 120MG A210531 001 Aug 17, 2020
AB 240MG A210531 002 Aug 17, 2020
AB PRINSTON INC 120MG A210414 001 Oct 18, 2022
AB 240MG A210414 002 Oct 18, 2022
AB TWI PHARMS 120MG A210382 001 Oct 14, 2020
AB 240MG A210382 002 Oct 14, 2020
TECFIDERA
AB + BIOGEN INC 120MG N204063 001 Mar 27, 2013
AB +! 240MG N204063 002 Mar 27, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-148(of 474)

DIMETHYL SULFOXIDE
SOLUTION;INTRAVESICAL
RIMSO-50
+! MYLAN INSTITUTIONAL 50% N017788 001
DINOPROSTONE
GEL;ENDOCERVICAL
PREPIDIL
+! PFIZER 0.5MG/3GM N019617 001 Dec 09, 1992
INSERT, EXTENDED RELEASE;VAGINAL
CERVIDIL
+! FERRING PHARMS INC 10MG N020411 001 Mar 30, 1995
DIPHENHYDRAMINE HYDROCHLORIDE
ELIXIR;ORAL
DIPHENHYDRAMINE HYDROCHLORIDE
! PHARM ASSOC 12.5MG/5ML A087513 001 Feb 10, 1982
INJECTABLE;INJECTION
DIPHENHYDRAMINE HYDROCHLORIDE
AP APP PHARMS 50MG/ML A040466 001 May 28, 2002
AP MICRO LABS 50MG/ML A205723 001 Aug 22, 2018
AP MYLAN INSTITUTIONAL 50MG/ML A040498 001 Jul 12, 2005
AP +! WEST-WARD PHARMS 50MG/ML A080817 002
INT
DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE
AP FRESENIUS KABI USA 50MG/ML A091526 001 Mar 26, 2013
DIPYRIDAMOLE
INJECTABLE;INJECTION
DIPYRIDAMOLE
AP ! CHARTWELL 5MG/ML A074939 001 Apr 13, 1998
INJECTABLE
AP FRESENIUS KABI USA 5MG/ML A074956 001 Sep 30, 1998
AP HIKMA 5MG/ML A074521 001 Oct 18, 1996
TABLET;ORAL
DIPYRIDAMOLE
AB ANI PHARMS 25MG A086944 002 Apr 16, 1991
AB 50MG A086944 001 Feb 25, 1992
AB 75MG A086944 003 Feb 25, 1992
AB BARR 25MG A087184 001 Oct 03, 1990
AB 50MG A087716 001 Oct 03, 1990
AB 75MG A087717 001 Oct 03, 1990
AB IMPAX LABS 25MG A040782 001 Jul 18, 2007
AB 50MG A040782 002 Jul 18, 2007
AB 75MG A040782 003 Jul 18, 2007
AB MURTY PHARMS 25MG A040733 001 Feb 13, 2007
AB 50MG A040733 002 Feb 13, 2007
AB 75MG A040733 003 Feb 13, 2007
AB OXFORD PHARMS 25MG A040542 001 Apr 21, 2006
AB 50MG A040542 002 Apr 21, 2006
AB 75MG A040542 003 Apr 21, 2006
AB ZYDUS PHARMS USA 25MG A040874 001 Jan 28, 2008
INC
AB 50MG A040874 002 Jan 28, 2008
AB 75MG A040874 003 Jan 28, 2008
PERSANTINE
AB + BOEHRINGER 25MG N012836 003 Dec 22, 1986
INGELHEIM
AB + 50MG N012836 004 Feb 06, 1987
AB +! 75MG N012836 005 Feb 06, 1987
DIROXIMEL FUMARATE
CAPSULE, DELAYED RELEASE;ORAL
VUMERITY
+! BIOGEN INC 231MG N211855 001 Oct 29, 2019
DISOPYRAMIDE PHOSPHATE
CAPSULE;ORAL
DISOPYRAMIDE PHOSPHATE
AB MAYNE PHARMA EQ 100MG BASE A070173 001 May 31, 1985
AB EQ 150MG BASE A070173 002 May 31, 1985
AB TEVA EQ 100MG BASE A070101 001 Feb 22, 1985
AB EQ 150MG BASE A070102 001 Feb 22, 1985
NORPACE
AB + PFIZER EQ 100MG BASE N017447 001
AB +! EQ 150MG BASE N017447 002
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-149(of 474)

DISOPYRAMIDE PHOSPHATE
CAPSULE, EXTENDED RELEASE;ORAL
NORPACE CR
+ PFIZER EQ 100MG BASE N018655 001 Jul 20, 1982
+! EQ 150MG BASE N018655 002 Jul 20, 1982
DISULFIRAM
TABLET;ORAL
DISULFIRAM
AB ALVOGEN 250MG A091681 001 Aug 08, 2013
AB CHARTWELL MOLECULES 250MG A091563 001 Dec 31, 2012
AB 500MG A091563 002 Dec 31, 2012
AB HIKMA 250MG A202652 001 Feb 05, 2014
AB ! 500MG A202652 002 Feb 05, 2014
AB SIGMAPHARM LABS LLC 250MG A091619 001 Mar 28, 2011
AB 500MG A091619 002 Mar 28, 2011
DIVALPROEX SODIUM
CAPSULE, DELAYED REL PELLETS;ORAL
DEPAKOTE
AB +! ABBVIE EQ 125MG VALPROIC ACID N019680 001 Sep 12, 1989
DIVALPROEX SODIUM
AB AJANTA PHARMA LTD EQ 125MG VALPROIC ACID A213181 001 Mar 02, 2020
AB DR REDDYS LABS LTD EQ 125MG VALPROIC ACID A078979 001 Jan 23, 2009
AB ZYDUS PHARMS USA EQ 125MG VALPROIC ACID A078919 001 Jan 27, 2009
INC
TABLET, DELAYED RELEASE;ORAL
DEPAKOTE
AB + ABBVIE EQ 125MG VALPROIC ACID N018723 003 Oct 26, 1984
AB + EQ 250MG VALPROIC ACID N018723 001 Mar 10, 1983
AB +! EQ 500MG VALPROIC ACID N018723 002 Mar 10, 1983
DIVALPROEX SODIUM
AB ACTAVIS LABS FL INC EQ 500MG VALPROIC ACID A079080 001 Feb 25, 2011
AB APOTEX EQ 125MG VALPROIC ACID A077615 003 Jul 29, 2008
AB EQ 250MG VALPROIC ACID A077615 002 Jul 29, 2008
AB EQ 500MG VALPROIC ACID A077615 001 Jul 29, 2008
AB AUROBINDO PHARMA EQ 125MG VALPROIC ACID A090554 001 Apr 21, 2011
LTD
AB EQ 250MG VALPROIC ACID A090554 002 Apr 21, 2011
AB EQ 500MG VALPROIC ACID A090554 003 Apr 21, 2011
AB CELLTRION EQ 125MG VALPROIC ACID A077296 001 Jul 31, 2008
AB EQ 250MG VALPROIC ACID A077296 002 Jul 31, 2008
AB EQ 500MG VALPROIC ACID A077296 003 Jul 31, 2008
AB DR REDDYS LABS LTD EQ 125MG VALPROIC ACID A078755 001 Jul 29, 2008
AB EQ 250MG VALPROIC ACID A078755 002 Jul 29, 2008
AB EQ 500MG VALPROIC ACID A078755 003 Jul 29, 2008
AB INVATECH EQ 125MG VALPROIC ACID A078290 003 Jul 29, 2008
AB EQ 250MG VALPROIC ACID A078290 002 Jul 29, 2008
AB EQ 500MG VALPROIC ACID A078290 001 Jul 29, 2008
AB LUPIN EQ 125MG VALPROIC ACID A078790 001 Jul 29, 2008
AB EQ 250MG VALPROIC ACID A078790 002 Jul 29, 2008
AB EQ 500MG VALPROIC ACID A078790 003 Jul 29, 2008
AB ORBION PHARMS EQ 125MG VALPROIC ACID A078853 001 Nov 25, 2008
AB EQ 250MG VALPROIC ACID A078853 002 Nov 25, 2008
AB EQ 500MG VALPROIC ACID A078853 003 Nov 25, 2008
AB PRINSTON INC EQ 125MG VALPROIC ACID A090210 001 Nov 30, 2009
AB EQ 250MG VALPROIC ACID A090210 002 Nov 30, 2009
AB EQ 500MG VALPROIC ACID A090210 003 Nov 30, 2009
AB SUN PHARM INDS EQ 125MG VALPROIC ACID A078597 001 Jul 29, 2008
AB EQ 250MG VALPROIC ACID A078597 002 Jul 29, 2008
AB EQ 500MG VALPROIC ACID A078597 003 Jul 29, 2008
AB UNICHEM LABS LTD EQ 125MG VALPROIC ACID A079163 001 Apr 05, 2011
AB EQ 250MG VALPROIC ACID A079163 002 Apr 05, 2011
AB EQ 500MG VALPROIC ACID A079163 003 Apr 05, 2011
AB UPSHER SMITH LABS EQ 125MG VALPROIC ACID A078182 001 Jul 29, 2008
AB EQ 250MG VALPROIC ACID A078182 002 Jul 29, 2008
AB EQ 500MG VALPROIC ACID A078182 003 Jul 29, 2008
AB ZYDUS PHARMS USA EQ 125MG VALPROIC ACID A077100 001 Mar 05, 2009
INC
AB EQ 250MG VALPROIC ACID A077100 002 Mar 05, 2009
AB EQ 500MG VALPROIC ACID A077100 003 Mar 05, 2009
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-150(of 474)

DIVALPROEX SODIUM
TABLET, EXTENDED RELEASE;ORAL
DEPAKOTE ER
AB + ABBVIE EQ 250MG VALPROIC ACID N021168 002 May 31, 2002
AB +! EQ 500MG VALPROIC ACID N021168 001 Aug 04, 2000
DIVALPROEX SODIUM
AB AMNEAL PHARMS EQ 250MG VALPROIC ACID A203730 001 May 29, 2015
AB EQ 500MG VALPROIC ACID A203730 002 May 29, 2015
AB AUROBINDO PHARMA EQ 250MG VALPROIC ACID A202419 001 Jun 02, 2014
LTD
AB EQ 500MG VALPROIC ACID A202419 002 Jun 02, 2014
AB DR REDDYS LABS LTD EQ 250MG VALPROIC ACID A090161 001 Mar 15, 2012
AB LUPIN LTD EQ 250MG VALPROIC ACID A209286 001 Oct 18, 2019
AB EQ 500MG VALPROIC ACID A209286 002 Oct 18, 2019
AB MYLAN EQ 250MG VALPROIC ACID A077567 001 Jan 29, 2009
AB EQ 500MG VALPROIC ACID A077567 002 Jan 29, 2009
AB REDDYS EQ 500MG VALPROIC ACID A090070 001 Mar 12, 2012
AB UNICHEM EQ 250MG VALPROIC ACID A214643 001 Feb 25, 2022
AB EQ 500MG VALPROIC ACID A214643 002 Feb 25, 2022
AB WOCKHARDT EQ 250MG VALPROIC ACID A078705 002 Feb 10, 2009
AB EQ 500MG VALPROIC ACID A078705 001 Aug 04, 2009
AB ZYDUS PHARMS USA EQ 250MG VALPROIC ACID A078239 001 Feb 27, 2009
INC
AB EQ 500MG VALPROIC ACID A078239 002 Aug 04, 2009
DOBUTAMINE HYDROCHLORIDE
INJECTABLE;INJECTION
DOBUTAMINE HYDROCHLORIDE
AP HAINAN POLY EQ 12.5MG BASE/ML A216131 001 Dec 21, 2022
AP HIKMA EQ 12.5MG BASE/ML A074277 001 Oct 31, 1994
AP ! HOSPIRA EQ 12.5MG BASE/ML A074086 001 Nov 29, 1993
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
AP +! BAXTER HLTHCARE EQ 50MG BASE/100ML N020255 001 Oct 19, 1993
AP +! EQ 100MG BASE/100ML N020255 003 Oct 19, 1993
AP +! EQ 200MG BASE/100ML N020255 004 Oct 19, 1993
AP +! EQ 400MG BASE/100ML N020255 005 Oct 19, 1993
AP +! HOSPIRA EQ 50MG BASE/100ML N020201 003 Oct 19, 1993
AP +! EQ 100MG BASE/100ML N020201 002 Oct 19, 1993
AP +! EQ 200MG BASE/100ML N020201 001 Oct 19, 1993
AP +! EQ 400MG BASE/100ML N020201 006 Jul 07, 1994
DOCETAXEL
INJECTABLE;INJECTION
DOCETAXEL
AP + ACCORD HLTHCARE 20MG/ML (20MG/ML) N201195 003 Apr 20, 2012
AP + 80MG/4ML (20MG/ML) N201195 004 Apr 20, 2012
AP +! 160MG/8ML (20MG/ML) N201195 005 Apr 20, 2012
AP ACTAVIS LLC 20MG/ML (20MG/ML) N203551 001 Apr 12, 2013
AP 80MG/4ML (20MG/ML) N203551 002 Apr 12, 2013
AP 160MG/8ML (20MG/ML) N203551 004 Sep 21, 2015
AP AMNEAL 20MG/ML (20MG/ML) A209640 001 Jan 19, 2018
AP 80MG/4ML (20MG/ML) A209640 002 Jan 19, 2018
AP 160MG/8ML (20MG/ML) A209640 003 Jan 19, 2018
AP DR REDDYS 20MG/ML (20MG/ML) A204193 001 Nov 05, 2014
AP 80MG/4ML (20MG/ML) A204193 002 Nov 05, 2014
AP EUGIA PHARMA 20MG/2ML (10MG/ML) A214575 001 Jun 25, 2021
AP 80MG/8ML (10MG/ML) A214575 002 Jun 25, 2021
AP 160MG/16ML (10MG/ML) A214575 003 Jun 25, 2021
AP GLAND PHARMA LTD 20MG/2ML (10MG/ML) A213510 001 Jul 01, 2021
AP 80MG/8ML (10MG/ML) A213510 002 Jul 01, 2021
AP 160MG/16ML (10MG/ML) A213510 003 Jul 01, 2021
AP HENGRUI PHARMA 20MG/ML (20MG/ML) A207252 001 Aug 09, 2017
AP 80MG/4ML (20MG/ML) A207252 002 Aug 09, 2017
AP 160MG/8ML (20MG/ML) A207252 003 Aug 09, 2017
AP HIKMA 20MG/ML (20MG/ML) A204490 001 Jan 14, 2021
AP 80MG/4ML (20MG/ML) A204490 002 Jan 14, 2021
AP +! HOSPIRA INC 20MG/2ML (10MG/ML) N022234 001 Mar 08, 2011
AP +! 80MG/8ML (10MG/ML) N022234 002 Mar 08, 2011
AP +! 160MG/16ML (10MG/ML) N022234 003 Mar 08, 2011
AP INGENUS PHARMS LLC 80MG/8ML (10MG/ML) A207563 002 Aug 31, 2017
AP 160MG/16ML (10MG/ML) A207563 003 Aug 31, 2017
AP MEITHEAL 20MG/2ML (10MG/ML) A209634 001 Aug 24, 2018
AP 80MG/8ML (10MG/ML) A209634 002 Aug 24, 2018
AP 160MG/16ML (10MG/ML) A209634 003 Aug 24, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-151(of 474)

DOCETAXEL
INJECTABLE;INJECTION
DOCETAXEL
AP MYLAN LABS LTD 20MG/2ML (10MG/ML) A210072 001 Jul 02, 2018
AP 80MG/8ML (10MG/ML) A210848 001 Jul 06, 2018
AP 160MG/8ML (20MG/ML) A208137 001 Apr 01, 2019
AP 160MG/16ML (10MG/ML) A208859 001 Apr 30, 2018
AP SANDOZ 20MG/2ML (10MG/ML) N201525 001 Jun 29, 2011
AP 80MG/8ML (10MG/ML) N201525 002 Jun 29, 2011
AP 160MG/16ML (10MG/ML) N201525 003 Jun 29, 2011
AP SHILPA 20MG/ML (20MG/ML) A210327 001 May 16, 2019
AP +! 20MG/ML (20MG/ML) N205934 001 Dec 22, 2015
AP 80MG/4ML (20MG/ML) A210327 002 May 16, 2019
AP +! 80MG/4ML (20MG/ML) N205934 002 Dec 22, 2015
AP 160MG/8ML (20MG/ML) A210327 003 May 16, 2019
AP +! 160MG/8ML (20MG/ML) N205934 003 Dec 22, 2015
AP SUN PHARM 20MG/ML (20MG/ML) N022534 003 Jan 08, 2019
AP 80MG/4ML (20MG/ML) N022534 004 Jan 08, 2019
AP 160MG/8ML (20MG/ML) N022534 005 Jan 08, 2019
TAXOTERE
AP +! SANOFI AVENTIS US 20MG/ML (20MG/ML) N020449 003 Aug 03, 2010
AP +! 80MG/4ML (20MG/ML) N020449 004 Aug 02, 2010
AP +! 160MG/8ML (20MG/ML) N020449 005 Apr 13, 2012
DOCETAXEL
ACTAVIS LLC 140MG/7ML (20MG/ML) N203551 003 Apr 12, 2013
+ HOSPIRA INC 20MG/ML (20MG/ML) N022234 004 Jun 23, 2016
+ 80MG/4ML (20MG/ML) N022234 005 Jun 23, 2016
+ 160MG/8ML (20MG/ML) N022234 007 Jan 24, 2017
SOLUTION;INTRAVENOUS
DOCETAXEL
+! MERIDIAN LABS 20MG/2ML (10MG/ML) N215813 001 Nov 22, 2022
+! 80MG/8ML (10MG/ML) N215813 002 Nov 22, 2022
+! 160MG/16ML (10MG/ML) N215813 003 Nov 22, 2022
DOFETILIDE
CAPSULE;ORAL
DOFETILDE
AB AUROBINDO PHARMA 0.125MG A210740 001 Jan 22, 2019
LTD
AB 0.25MG A210740 002 Jan 22, 2019
AB 0.5MG A210740 003 Jan 22, 2019
DOFETILIDE
AB ACCORD HLTHCARE 0.125MG A213338 001 Jun 19, 2020
AB 0.25MG A213338 002 Jun 19, 2020
AB 0.5MG A213338 003 Jun 19, 2020
AB BIONPHARMA INC 0.125MG A208625 001 Apr 10, 2018
AB 0.25MG A208625 002 Apr 10, 2018
AB 0.5MG A208625 003 Apr 10, 2018
AB GRANULES 0.125MG A212750 001 Oct 14, 2021
AB 0.25MG A212750 002 Oct 14, 2021
AB 0.5MG A212750 003 Oct 14, 2021
AB MAYNE PHARMA INC 0.125MG A207058 001 Jun 06, 2016
AB 0.25MG A207058 002 Jun 06, 2016
AB 0.5MG A207058 003 Jun 06, 2016
AB MSN 0.125MG A213220 001 Jan 29, 2020
AB 0.25MG A213220 002 Jan 29, 2020
AB 0.5MG A213220 003 Jan 29, 2020
AB SIGMAPHARM LABS LLC 0.125MG A207746 001 Mar 26, 2018
AB 0.25MG A207746 002 Mar 26, 2018
AB 0.5MG A207746 003 Mar 26, 2018
AB STRIDES PHARMA 0.125MG A208519 001 Oct 09, 2018
AB 0.25MG A208519 002 Oct 09, 2018
AB 0.5MG A208519 003 Oct 09, 2018
AB SUN PHARM 0.125MG A210466 001 Oct 09, 2018
AB 0.25MG A210466 002 Oct 09, 2018
AB 0.5MG A210466 003 Oct 09, 2018
TIKOSYN
AB + PFIZER 0.125MG N020931 001 Oct 01, 1999
AB + 0.25MG N020931 002 Oct 01, 1999
AB +! 0.5MG N020931 003 Oct 01, 1999
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-152(of 474)

DOLASETRON MESYLATE
TABLET;ORAL
ANZEMET
+! VALIDUS PHARMS 50MG N020623 001 Sep 11, 1997
DOLUTEGRAVIR SODIUM
TABLET;ORAL
TIVICAY
+ VIIV HLTHCARE EQ 10MG BASE N204790 002 Jun 09, 2016
+ EQ 25MG BASE N204790 003 Jun 09, 2016
+! EQ 50MG BASE N204790 001 Aug 12, 2013
TABLET, FOR SUSPENSION;ORAL
TIVICAY PD
+! VIIV HLTHCARE EQ 5MG BASE N213983 001 Jun 12, 2020
DOLUTEGRAVIR SODIUM; LAMIVUDINE
TABLET;ORAL
DOVATO
+! VIIV HLTHCARE EQ 50MG BASE;300MG N211994 001 Apr 08, 2019
DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE
TABLET;ORAL
JULUCA
+! VIIV HLTHCARE EQ 50MG BASE;EQ 25MG BASE N210192 001 Nov 21, 2017
DONEPEZIL HYDROCHLORIDE
SYSTEM;TRANSDERMAL
ADLARITY
+ CORIUM 5MG/DAY N212304 001 Mar 11, 2022
+! 10MG/DAY N212304 002 Mar 11, 2022
TABLET;ORAL
ARICEPT
AB + EISAI INC 5MG N020690 002 Nov 25, 1996
AB +! 10MG N020690 001 Nov 25, 1996
AB +! 23MG N022568 001 Jul 23, 2010
DONEPEZIL HYDROCHLORIDE
AB ACI 5MG A078662 001 May 31, 2011
AB 10MG A078662 002 May 31, 2011
AB ALEMBIC PHARMS LTD 5MG A201724 001 Feb 25, 2013
AB 10MG A201724 002 Feb 25, 2013
AB AUROBINDO 5MG A090056 001 May 31, 2011
AB 10MG A090056 002 May 31, 2011
AB CADILA 5MG A090100 001 Oct 24, 2012
AB 10MG A090100 002 Oct 24, 2012
AB CADILA PHARMS LTD 5MG A204609 001 Sep 19, 2017
AB 10MG A204609 002 Sep 19, 2017
AB CHARTWELL RX 5MG A090425 001 May 31, 2011
AB 10MG A090425 002 May 31, 2011
AB CIPLA LTD 5MG A077518 001 May 31, 2011
AB 10MG A077518 002 May 31, 2011
AB DEXCEL 23MG A203713 001 Feb 19, 2016
AB DR REDDYS 23MG A202723 001 Jul 24, 2013
AB DR REDDYS LABS LTD 5MG A201001 001 May 31, 2011
AB 10MG A201001 002 May 31, 2011
AB HETERO LABS LTD V 5MG A203034 001 Jan 30, 2015
AB 10MG A203034 002 Jan 30, 2015
AB INDICUS PHARMA 5MG A201634 001 Jun 13, 2012
AB 10MG A201634 002 Jun 13, 2012
AB JUBILANT GENERICS 5MG A090768 001 May 31, 2011
AB 10MG A090768 002 May 31, 2011
AB LUPIN LTD 23MG A202782 001 Oct 30, 2015
AB MACLEODS PHARMS LTD 5MG A201146 001 Aug 17, 2012
AB 10MG A201146 002 Aug 17, 2012
AB 23MG A202631 001 Jan 22, 2014
AB PRINSTON INC 5MG A200292 001 May 31, 2011
AB 10MG A200292 002 May 31, 2011
AB RISING 5MG A202114 001 Jul 05, 2013
AB 10MG A202114 002 Jul 05, 2013
AB SCIEGEN PHARMS INC 5MG A203907 001 Oct 29, 2014
AB 10MG A203907 002 Oct 29, 2014
AB STRIDES PHARMA 5MG A090551 001 May 31, 2011
AB 10MG A090551 002 May 31, 2011
AB SUN PHARM INDS 5MG A090493 001 May 31, 2011
AB 10MG A090493 002 May 31, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-153(of 474)

DONEPEZIL HYDROCHLORIDE
TABLET;ORAL
DONEPEZIL HYDROCHLORIDE
AB TORRENT PHARMS 5MG A090686 001 May 31, 2011
AB 10MG A090686 002 May 31, 2011
AB TWI PHARMS 23MG A203104 001 Oct 29, 2014
AB ZYDUS PHARMS 23MG A203162 001 Aug 31, 2017
TABLET, ORALLY DISINTEGRATING;ORAL
DONEPEZIL HYDROCHLORIDE
AB HISUN PHARM 5MG A205269 001 Jul 27, 2018
HANGZHOU
AB 10MG A205269 002 Jul 27, 2018
AB MACLEODS PHARMS LTD 5MG A201787 001 Dec 14, 2012
AB 10MG A201787 002 Dec 14, 2012
AB SANDOZ 5MG A091198 001 May 10, 2011
AB ! 10MG A091198 002 May 10, 2011
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
NAMZARIC
+ ALLERGAN 10MG;7MG N206439 003 Jul 18, 2016
+ 10MG;14MG N206439 001 Dec 23, 2014
+ 10MG;21MG N206439 004 Jul 18, 2016
+! 10MG;28MG N206439 002 Dec 23, 2014
DOPAMINE HYDROCHLORIDE
INJECTABLE;INJECTION
DOPAMINE HYDROCHLORIDE
AP HIKMA INTL PHARMS 40MG/ML A207707 001 Apr 11, 2018
AP 80MG/ML A207707 002 Apr 11, 2018
AP +! HOSPIRA 40MG/ML N018132 001
AP +! 80MG/100ML N018132 002 Feb 04, 1982
AP +! 80MG/ML N018132 004 Jul 09, 1982
AP +! 160MG/100ML N018132 003 Feb 04, 1982
DOPAMINE HYDROCHLORIDE AND DEXTROSE 5%
AP +! B BRAUN 80MG/100ML N019099 002 Oct 15, 1986
AP +! 320MG/100ML N019099 004 Oct 15, 1986
DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER
AP +! B BRAUN 160MG/100ML N019099 003 Oct 15, 1986
DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
AP +! BAXTER HLTHCARE 80MG/100ML N019615 001 Mar 27, 1987
AP +! 160MG/100ML N019615 002 Mar 27, 1987
AP +! 320MG/100ML N019615 003 Mar 27, 1987
AP +! HOSPIRA 80MG/100ML N018826 001 Sep 30, 1983
AP +! 160MG/100ML N018826 002 Sep 30, 1983
AP +! 320MG/100ML N018826 003 Sep 30, 1983
DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER
+! B BRAUN 40MG/100ML N019099 001 Oct 15, 1986
DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 640MG/100ML N019615 004 Mar 27, 1987
DORAVIRINE
TABLET;ORAL
PIFELTRO
+! MSD MERCK CO 100MG N210806 001 Aug 30, 2018
DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
TABLET;ORAL
DELSTRIGO
+! MSD MERCK CO 100MG;300MG;300MG N210807 001 Aug 30, 2018
DORZOLAMIDE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
DORZOLAMIDE HYDROCHLORIDE
AT AKORN EQ 2% BASE A077846 001 Oct 28, 2008
AT ALEMBIC PHARMS EQ 2% BASE A212639 001 Aug 09, 2019
AT BAUSCH AND LOMB EQ 2% BASE A090143 001 Jun 25, 2009
AT FDC LTD EQ 2% BASE A205294 001 Jan 24, 2019
AT GLAND PHARMA LTD EQ 2% BASE A215660 001 Jan 27, 2022
AT INDOCO EQ 2% BASE A202053 001 Sep 11, 2014
AT ! MICRO LABS EQ 2% BASE A204778 001 Nov 08, 2019
AT SANDOZ INC EQ 2% BASE A078748 001 Nov 06, 2008
AT EQ 2% BASE A078981 001 Apr 13, 2009
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-154(of 474)

DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE


SOLUTION/DROPS;OPHTHALMIC
COSOPT
AT +! THEA PHARMA EQ 2% BASE;EQ 0.5% BASE N020869 001 Apr 07, 1998
COSOPT PF
AT +! THEA PHARMA EQ 2% BASE;EQ 0.5% BASE N202667 001 Feb 01, 2012
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
AT AKORN EQ 2% BASE;EQ 0.5% BASE A077847 001 Oct 28, 2008
AT EQ 2% BASE;EQ 0.5% BASE A203058 001 Sep 22, 2014
AT ALEMBIC PHARMS EQ 2% BASE;EQ 0.5% BASE A213099 001 May 04, 2021
AT BAUSCH AND LOMB EQ 2% BASE;EQ 0.5% BASE A090037 001 Jul 14, 2009
AT EUGIA PHARMA EQ 2% BASE;EQ 0.5% BASE A207629 001 May 14, 2021
AT EQ 2% BASE;EQ 0.5% BASE A207630 001 Jul 24, 2018
AT FDC LTD EQ 2% BASE;EQ 0.5% BASE A205295 001 Jun 13, 2019
AT GLAND PHARMA LTD EQ 2% BASE;EQ 0.5% BASE A215520 001 Sep 19, 2022
AT INDOCO EQ 2% BASE;EQ 0.5% BASE A202054 001 Sep 03, 2014
AT MICRO LABS EQ 2% BASE;EQ 0.5% BASE A204777 001 May 28, 2020
AT EQ 2% BASE;EQ 0.5% BASE A215936 001 Jan 25, 2022
AT SANDOZ EQ 2% BASE;EQ 0.5% BASE A078749 001 Nov 06, 2008
AT SANDOZ INC EQ 2% BASE;EQ 0.5% BASE A090604 001 Nov 18, 2009
AT SOMERSET EQ 2% BASE;EQ 0.5% BASE A207523 001 Jun 25, 2019
AT TEVA PHARMS EQ 2% BASE;EQ 0.5% BASE A078704 001 Sep 28, 2009
DOXAPRAM HYDROCHLORIDE
INJECTABLE;INJECTION
DOPRAM
AP +! HIKMA 20MG/ML N014879 001
DOXAPRAM HYDROCHLORIDE
AP CHARTWELL 20MG/ML A076266 001 Jan 10, 2003
INJECTABLE
DOXAZOSIN MESYLATE
TABLET;ORAL
CARDURA
AB +! VIATRIS EQ 1MG BASE N019668 001 Nov 02, 1990
AB + EQ 2MG BASE N019668 002 Nov 02, 1990
AB + EQ 4MG BASE N019668 003 Nov 02, 1990
AB + EQ 8MG BASE N019668 004 Nov 02, 1990
DOXAZOSIN MESYLATE
AB ACCORD HLTHCARE EQ 1MG BASE A202824 001 Jun 11, 2014
AB EQ 2MG BASE A202824 002 Jun 11, 2014
AB EQ 4MG BASE A202824 003 Jun 11, 2014
AB EQ 8MG BASE A202824 004 Jun 11, 2014
AB APOTEX EQ 1MG BASE A075580 001 Oct 18, 2000
AB EQ 2MG BASE A075580 002 Oct 18, 2000
AB EQ 4MG BASE A075580 003 Oct 18, 2000
AB EQ 8MG BASE A075580 004 Oct 18, 2000
AB PHARMGEN EQ 1MG BASE A212727 001 Mar 15, 2022
AB EQ 2MG BASE A212727 002 Mar 15, 2022
AB EQ 4MG BASE A212727 003 Mar 15, 2022
AB EQ 8MG BASE A212727 004 Mar 15, 2022
AB PLIVA EQ 1MG BASE A075750 001 Jun 08, 2001
AB EQ 2MG BASE A075750 002 Jun 08, 2001
AB EQ 4MG BASE A075750 003 Jun 08, 2001
AB EQ 8MG BASE A075750 004 Jun 08, 2001
AB TEVA EQ 1MG BASE A075536 001 Oct 18, 2000
AB EQ 2MG BASE A075536 002 Oct 18, 2000
AB EQ 4MG BASE A075536 003 Oct 18, 2000
AB EQ 8MG BASE A075536 004 Oct 18, 2000
AB UPSHER SMITH LABS EQ 1MG BASE A209013 001 Apr 17, 2018
AB EQ 2MG BASE A209013 002 Apr 17, 2018
AB EQ 4MG BASE A209013 003 Apr 17, 2018
AB EQ 8MG BASE A209013 004 Apr 17, 2018
AB ZYDUS PHARMS EQ 1MG BASE A208719 001 Jul 07, 2017
AB EQ 2MG BASE A208719 002 Jul 07, 2017
AB EQ 4MG BASE A208719 003 Jul 07, 2017
AB EQ 8MG BASE A208719 004 Jul 07, 2017
BX HERITAGE PHARMA EQ 1MG BASE A205210 001 Feb 13, 2018
BX EQ 2MG BASE A205210 002 Feb 13, 2018
BX EQ 4MG BASE A205210 003 Feb 13, 2018
BX EQ 8MG BASE A205210 004 Feb 13, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-155(of 474)

DOXAZOSIN MESYLATE
TABLET, EXTENDED RELEASE;ORAL
CARDURA XL
+ VIATRIS EQ 4MG BASE N021269 001 Feb 22, 2005
+! EQ 8MG BASE N021269 002 Feb 22, 2005
DOXEPIN HYDROCHLORIDE
CAPSULE;ORAL
DOXEPIN HYDROCHLORIDE
AB AJANTA PHARMA LTD EQ 10MG BASE A212624 001 Sep 13, 2019
AB EQ 25MG BASE A212624 002 Sep 13, 2019
AB EQ 50MG BASE A212624 003 Sep 13, 2019
AB EQ 75MG BASE A212624 004 Sep 13, 2019
AB EQ 100MG BASE A212624 005 Sep 13, 2019
AB ALEMBIC PHARMS EQ 10MG BASE A215076 001 Apr 21, 2021
AB EQ 25MG BASE A215076 002 Apr 21, 2021
AB EQ 50MG BASE A215076 003 Apr 21, 2021
AB EQ 75MG BASE A215076 004 Apr 21, 2021
AB EQ 100MG BASE A215076 005 Apr 21, 2021
AB AMNEAL PHARMS CO EQ 10MG BASE A207482 001 Jun 28, 2017
AB EQ 25MG BASE A207482 002 Jun 28, 2017
AB EQ 50MG BASE A207482 003 Jun 28, 2017
AB EQ 75MG BASE A207482 004 Jun 28, 2017
AB EQ 100MG BASE A207482 005 Jun 28, 2017
AB APPCO EQ 10MG BASE A214908 001 Apr 01, 2021
AB EQ 25MG BASE A214908 002 Apr 01, 2021
AB EQ 50MG BASE A214908 003 Apr 01, 2021
AB EQ 75MG BASE A214908 004 Apr 01, 2021
AB EQ 100MG BASE A214908 005 Apr 01, 2021
AB AUROBINDO PHARMA EQ 10MG BASE A211603 001 Mar 27, 2019
LTD
AB EQ 25MG BASE A211603 002 Mar 27, 2019
AB EQ 50MG BASE A211603 003 Mar 27, 2019
AB EQ 75MG BASE A211603 004 Mar 27, 2019
AB EQ 100MG BASE A211603 005 Mar 27, 2019
AB CHARTWELL RX EQ 10MG BASE A210268 001 Sep 04, 2020
AB EQ 25MG BASE A210268 002 Sep 04, 2020
AB EQ 50MG BASE A210268 003 Sep 04, 2020
AB EQ 75MG BASE A210268 004 Sep 04, 2020
AB EQ 100MG BASE A210268 005 Sep 04, 2020
AB CONTRACT PHARMACAL EQ 10MG BASE A213474 001 Jul 28, 2020
AB EQ 25MG BASE A213474 002 Jul 28, 2020
AB EQ 50MG BASE A213474 003 Jul 28, 2020
AB EQ 75MG BASE A213474 004 Jul 28, 2020
AB EQ 100MG BASE A213474 005 Jul 28, 2020
AB EDENBRIDGE PHARMS EQ 150MG BASE A213796 001 Apr 19, 2022
AB EPIC PHARMA LLC EQ 10MG BASE A210675 001 Oct 16, 2020
AB EQ 25MG BASE A210675 002 Oct 16, 2020
AB EQ 50MG BASE A210675 004 Mar 03, 2022
AB EQ 75MG BASE A210675 005 Mar 03, 2022
AB EQ 100MG BASE A210675 003 Oct 16, 2020
AB JUBILANT CADISTA EQ 10MG BASE A215483 001 Mar 14, 2022
AB EQ 25MG BASE A215483 002 Mar 14, 2022
AB EQ 50MG BASE A215483 003 Mar 14, 2022
AB EQ 75MG BASE A215483 004 Mar 14, 2022
AB EQ 100MG BASE A215483 005 Mar 14, 2022
AB LEADING EQ 10MG BASE A211619 001 Mar 09, 2021
AB EQ 25MG BASE A211619 002 Mar 09, 2021
AB EQ 50MG BASE A211619 003 Mar 09, 2021
AB EQ 75MG BASE A211619 004 Mar 09, 2021
AB EQ 100MG BASE A211619 005 Mar 09, 2021
AB EQ 150MG BASE A211618 001 Mar 01, 2021
AB MANKIND PHARMA EQ 10MG BASE A215710 001 Feb 09, 2022
AB EQ 25MG BASE A215710 002 Feb 09, 2022
AB EQ 50MG BASE A215710 003 Feb 09, 2022
AB EQ 75MG BASE A215710 004 Feb 09, 2022
AB EQ 100MG BASE A215710 005 Feb 09, 2022
AB MSN EQ 10MG BASE A215113 001 Jun 24, 2022
AB EQ 25MG BASE A215113 002 Jun 24, 2022
AB EQ 50MG BASE A215113 003 Jun 24, 2022
AB EQ 75MG BASE A215113 004 Jun 24, 2022
AB EQ 100MG BASE A215113 005 Jun 24, 2022
AB MYLAN PHARMS INC EQ 10MG BASE A070791 002 May 13, 1986
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-156(of 474)

DOXEPIN HYDROCHLORIDE
CAPSULE;ORAL
DOXEPIN HYDROCHLORIDE
AB ! EQ 25MG BASE A070791 003 May 13, 1986
AB EQ 50MG BASE A070791 001 May 13, 1986
AB EQ 75MG BASE A070791 004 May 13, 1986
AB ! EQ 100MG BASE A070791 005 May 13, 1986
AB ! PAR PHARM EQ 150MG BASE A071422 006 Nov 09, 1987
AB TARO PHARM INDS LTD EQ 10MG BASE A213063 001 Jul 01, 2020
AB EQ 25MG BASE A213063 002 Jul 01, 2020
AB EQ 50MG BASE A213063 003 Jul 01, 2020
AB EQ 75MG BASE A213063 004 Jul 01, 2020
AB EQ 100MG BASE A213063 005 Jul 01, 2020
CONCENTRATE;ORAL
DOXEPIN HYDROCHLORIDE
AA ! LANNETT CO INC EQ 10MG BASE/ML A074721 001 Dec 29, 1998
AA XTTRIUM LABS INC EQ 10MG BASE/ML A071918 001 Jul 20, 1988
CREAM;TOPICAL
ZONALON
+! MYLAN 5% N020126 001 Apr 01, 1994
TABLET;ORAL
DOXEPIN HYDROCHLORIDE
AB ACTAVIS ELIZABETH EQ 3MG BASE A201951 001 Jul 26, 2013
AB EQ 6MG BASE A201951 002 Jul 26, 2013
AB RK PHARMA EQ 3MG BASE A202337 001 Jan 20, 2016
AB EQ 6MG BASE A202337 002 Jan 20, 2016
AB STRIDES PHARMA EQ 3MG BASE A202510 001 Jul 24, 2020
AB EQ 6MG BASE A202510 002 Jul 24, 2020
SILENOR
AB + CURRAX EQ 3MG BASE N022036 001 Mar 17, 2010
AB +! EQ 6MG BASE N022036 002 Mar 17, 2010
DOXERCALCIFEROL
CAPSULE;ORAL
DOXERCALCIFEROL
AB AVET 0.5MCG A205360 001 Sep 15, 2020
AB 1MCG A205360 002 Sep 15, 2020
AB 2.5MCG A205360 003 Sep 15, 2020
AB RISING 0.5MCG A201518 001 Sep 09, 2016
AB 1MCG A201518 002 Sep 09, 2016
AB 2.5MCG A201518 003 Sep 09, 2016
HECTOROL
AB + SANOFI 0.5MCG N020862 002 Apr 23, 2004
AB + 1MCG N020862 003 Jul 13, 2009
AB +! 2.5MCG N020862 001 Jun 09, 1999
INJECTABLE;INJECTION
DOXERCALCIFEROL
AP AMNEAL 2MCG/ML (2MCG/ML) A208974 001 May 24, 2017
AP 4MCG/2ML (2MCG/ML) A208974 002 May 24, 2017
AP EUGIA PHARMA 2MCG/ML (2MCG/ML) A213717 001 Jan 24, 2022
AP 4MCG/2ML (2MCG/ML) A213717 002 Jan 24, 2022
AP GLAND PHARMA LTD 4MCG/2ML (2MCG/ML) A210452 001 Sep 26, 2019
AP HIKMA 4MCG/2ML (2MCG/ML) A091101 001 Aug 30, 2013
AP + HOSPIRA 4MCG/2ML (2MCG/ML) N208614 001 Jul 24, 2018
AP LUPIN LTD 4MCG/2ML (2MCG/ML) A210801 001 Nov 01, 2018
AP MEITHEAL 4MCG/2ML (2MCG/ML) A211670 001 Feb 07, 2020
AP SANDOZ INC 4MCG/2ML (2MCG/ML) A091333 001 May 05, 2014
AP 4MCG/2ML (2MCG/ML) A200926 001 Feb 04, 2014
HECTOROL
AP + SANOFI 2MCG/ML (2MCG/ML) N021027 002 Apr 06, 2000
AP +! 4MCG/2ML (2MCG/ML) N021027 001 Apr 06, 2000
DOXORUBICIN HYDROCHLORIDE
INJECTABLE;INJECTION
DOXORUBICIN HYDROCHLORIDE
AP ACTAVIS INC 2MG/ML A203622 001 Jun 27, 2014
AP 200MG/100ML A203622 002 Jun 27, 2014
AP AMNEAL 20MG/VIAL A208888 001 Feb 17, 2017
AP 50MG/VIAL A208888 002 Feb 17, 2017
AP FRESENIUS KABI USA 2MG/ML A063277 001 Oct 26, 1995
AP GLAND PHARMA LTD 2MG/ML A209825 001 Aug 11, 2017
AP HIKMA 2MG/ML A062975 001 Mar 17, 1989
AP ! 10MG/VIAL A062921 001 Mar 17, 1989
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-157(of 474)

DOXORUBICIN HYDROCHLORIDE
INJECTABLE;INJECTION
DOXORUBICIN HYDROCHLORIDE
AP ! 20MG/VIAL A062921 002 Mar 17, 1989
AP ! 50MG/VIAL A062921 003 Mar 17, 1989
AP 200MG/100ML A064097 001 Sep 13, 1994
AP MYLAN LABS LTD 50MG/VIAL A200170 002 Oct 28, 2011
AP +! PFIZER 2MG/ML N050629 001 Dec 23, 1987
AP +! 200MG/100ML N050629 002 May 03, 1988
AP PHARMACHEMIE BV 2MG/ML A063336 001 Feb 28, 1995
AP 10MG/VIAL A063097 001 May 21, 1990
AP 20MG/VIAL A063097 002 May 21, 1990
AP 50MG/VIAL A063097 003 May 21, 1990
AP 200MG/100ML A063336 004 Feb 28, 1995
AP SAGENT PHARMS 2MG/ML A091495 001 Mar 18, 2013
AP SUN PHARM INDS 2MG/ML A091418 001 Feb 15, 2012
+ PFIZER 150MG/75ML N050629 003 Mar 28, 2011
INJECTABLE, LIPOSOMAL;INJECTION
DOXIL (LIPOSOMAL)
AB + BAXTER HLTHCARE 20MG/10ML (2MG/ML) N050718 001 Nov 17, 1995
CORP
AB + 50MG/25ML (2MG/ML) N050718 002 Jun 13, 2000
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
AB AYANA PHARMA LTD 20MG/10ML (2MG/ML) A207228 001 Oct 12, 2021
AB 50MG/25ML (2MG/ML) A207228 002 Oct 12, 2021
AB CELERITY PHARMS 20MG/10ML (2MG/ML) A212219 001 Oct 19, 2022
AB 50MG/25ML (2MG/ML) A212219 002 Oct 19, 2022
AB DR REDDYS 20MG/10ML (2MG/ML) A208657 001 May 15, 2017
AB 50MG/25ML (2MG/ML) A208657 002 May 15, 2017
AB ! SUN PHARM 20MG/10ML (2MG/ML) A203263 001 Feb 04, 2013
AB ! 50MG/25ML (2MG/ML) A203263 002 Feb 04, 2013
AB ZYDUS 20MG/10ML (2MG/ML) A212299 001 Sep 10, 2020
AB 50MG/25ML (2MG/ML) A212299 002 Sep 10, 2020
DOXYCYCLINE
CAPSULE;ORAL
DOXYCYCLINE
AB ALEMBIC PHARMS EQ 75MG BASE A209165 001 Jul 28, 2017
AB EQ 100MG BASE A209165 002 Jul 28, 2017
AB COSETTE EQ 50MG BASE A204446 001 May 28, 2015
AB EQ 75MG BASE A204446 002 May 28, 2015
AB EQ 100MG BASE A204446 003 May 28, 2015
AB LUPIN LTD EQ 50MG BASE A204234 001 Mar 05, 2014
AB EQ 75MG BASE A204234 002 Mar 05, 2014
AB EQ 100MG BASE A204234 003 Mar 05, 2014
AB MAYNE PHARMA INC EQ 50MG BASE A209396 001 Sep 29, 2017
AB EQ 75MG BASE A209396 002 Sep 29, 2017
AB EQ 100MG BASE A209396 003 Sep 29, 2017
AB STRIDES PHARMA EQ 50MG BASE A065055 001 Dec 01, 2000
AB EQ 100MG BASE A065055 002 Dec 01, 2000
AB ! EQ 150MG BASE A065055 003 Jul 15, 2005
AB SUN PHARM INDS LTD EQ 50MG BASE A065053 001 Nov 22, 2000
AB EQ 75MG BASE A065053 003 Sep 10, 2003
AB ! EQ 100MG BASE A065053 002 Nov 22, 2000
AB ZYDUS PHARMS EQ 50MG BASE A205115 001 Feb 18, 2016
AB EQ 75MG BASE A205115 002 Feb 18, 2016
AB EQ 100MG BASE A205115 003 Feb 18, 2016
MONODOX
AB + CHARTWELL RX EQ 50MG BASE N050641 002 Feb 10, 1992
AB + EQ 75MG BASE N050641 003 Oct 18, 2006
AB + EQ 100MG BASE N050641 001 Dec 29, 1989
AB + EQ 150MG BASE N050641 004 Feb 17, 2022
ORACEA
+! GALDERMA LABS LP 40MG N050805 001 May 26, 2006
FOR SUSPENSION;ORAL
DOXYCYCLINE
AB CHARTWELL EQ 25MG BASE/5ML A065454 001 Jul 16, 2008
AB LUPIN LTD EQ 25MG BASE/5ML A201678 001 Mar 18, 2013
VIBRAMYCIN
AB +! PFIZER EQ 25MG BASE/5ML N050006 001
TABLET;ORAL
DOXYCYCLINE
AB HERITAGE PHARMS EQ 50MG BASE A091605 001 Dec 20, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-158(of 474)

DOXYCYCLINE
TABLET;ORAL
DOXYCYCLINE
AB EQ 75MG BASE A091605 002 Dec 20, 2011
AB EQ 100MG BASE A091605 003 Dec 20, 2011
AB ! EQ 150MG BASE A091605 004 Dec 20, 2011
AB LANNETT CO INC EQ 50MG BASE A065285 001 Dec 08, 2005
AB EQ 75MG BASE A065285 003 Jul 30, 2008
AB EQ 100MG BASE A065285 002 Dec 08, 2005
AB EQ 150MG BASE A065285 004 Jul 30, 2008
AB STRIDES PHARMA EQ 50MG BASE A065070 001 Dec 15, 2000
AB EQ 75MG BASE A065070 003 Dec 30, 2002
AB EQ 100MG BASE A065070 002 Dec 15, 2000
AB EQ 150MG BASE A065070 004 Jul 14, 2005
AB SUN PHARM INDS LTD EQ 50MG BASE A065356 001 May 31, 2006
AB EQ 75MG BASE A065356 002 May 31, 2006
AB EQ 100MG BASE A065356 003 May 31, 2006
AB EQ 150MG BASE A065356 004 Jul 29, 2010
AB ZYDUS PHARMS EQ 50MG BASE A209582 001 Sep 28, 2017
AB EQ 75MG BASE A209582 002 Sep 28, 2017
AB EQ 100MG BASE A209582 003 Sep 28, 2017
AB EQ 150MG BASE A209582 004 Sep 28, 2017
DOXYCYCLINE CALCIUM
SUSPENSION;ORAL
VIBRAMYCIN
+! PFIZER EQ 50MG BASE/5ML N050480 001
DOXYCYCLINE HYCLATE
CAPSULE;ORAL
DOXYCYCLINE HYCLATE
AB ACTAVIS LABS FL INC EQ 50MG BASE A062031 002 Oct 13, 1982
AB EQ 100MG BASE A062031 001
AB ALEMBIC PHARMS EQ 50MG BASE A210527 001 Jun 13, 2018
AB EQ 100MG BASE A210527 002 Jun 13, 2018
AB AMNEAL PHARMS EQ 100MG BASE A207289 001 Jun 27, 2016
AB CADILA EQ 50MG BASE A207774 001 May 31, 2018
AB EQ 100MG BASE A207774 002 May 31, 2018
AB CHANGZHOU PHARM EQ 100MG BASE A209402 001 Oct 07, 2019
AB CHARTWELL EQ 50MG BASE A062500 001 Sep 11, 1984
AB EQ 100MG BASE A062500 002 Sep 11, 1984
AB HIKMA INTL PHARMS EQ 50MG BASE A062396 002 Nov 07, 1984
AB EQ 100MG BASE A062396 001 May 07, 1984
AB SUN PHARM EQ 50MG BASE A062676 002 Jul 10, 1986
INDUSTRIES
AB EQ 100MG BASE A062676 001 Jul 10, 1986
VIBRAMYCIN
AB +! PFIZER EQ 100MG BASE N050007 002
INJECTABLE;INJECTION
DOXY 100
AP ! FRESENIUS KABI USA EQ 100MG BASE/VIAL A062475 001 Dec 09, 1983
DOXY 200
AP ! FRESENIUS KABI USA EQ 200MG BASE/VIAL A062475 002 Dec 09, 1983
DOXYCYCLINE
AP ! HIKMA EQ 100MG BASE/VIAL A062569 001 Mar 09, 1988
AP MYLAN LABS LTD EQ 100MG BASE/VIAL A091406 001 Aug 21, 2012
AP ZYDUS PHARMS EQ 100MG BASE/VIAL A207757 001 Sep 28, 2017
AP EQ 200MG BASE/VIAL A207757 002 Sep 28, 2017
DOXYCYCLINE HYCLATE
AP PAR STERILE EQ 100MG BASE/VIAL A216690 001 Dec 07, 2022
PRODUCTS
AP WEST-WARD PHARMS EQ 100MG BASE/VIAL A062992 001 Feb 16, 1989
INT
AP EQ 200MG BASE/VIAL A062992 002 Feb 16, 1989
TABLET;ORAL
ACTICLATE
AB + ALMIRALL EQ 75MG BASE N205931 001 Jul 25, 2014
AB +! EQ 150MG BASE N205931 002 Jul 25, 2014
DOXYCYCLINE HYCLATE
AB ACELLA EQ 100MG BASE A210664 001 Mar 16, 2020
AB ACTAVIS LABS FL INC EQ 100MG BASE A062421 001 Feb 02, 1983
AB AJANTA PHARMA LTD EQ 75MG BASE A211584 001 Jun 01, 2020
AB EQ 150MG BASE A211584 002 Jun 01, 2020
AB ALEMBIC PHARMS EQ 20MG BASE A210537 001 Mar 03, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-159(of 474)

DOXYCYCLINE HYCLATE
TABLET;ORAL
DOXYCYCLINE HYCLATE
AB EQ 50MG BASE A210536 002 Sep 14, 2021
AB EQ 75MG BASE A211744 001 Jun 30, 2020
AB EQ 150MG BASE A211744 002 Jun 30, 2020
AB APOTEX EQ 75MG BASE A209243 001 Apr 15, 2019
AB EQ 150MG BASE A209243 002 Apr 15, 2019
AB CADILA EQ 100MG BASE A207773 001 Oct 30, 2017
AB CARIBE HOLDINGS EQ 50MG BASE A062269 003 Oct 05, 1983
AB ! EQ 100MG BASE A062269 002 Nov 08, 1982
AB CHANGZHOU PHARM EQ 100MG BASE A211343 001 Oct 09, 2019
AB CHARTWELL EQ 50MG BASE A062505 002 Jul 27, 2021
AB EQ 100MG BASE A062505 001 Sep 11, 1984
AB ! CHARTWELL MOLECULAR EQ 20MG BASE A065277 001 Nov 10, 2005
AB EPIC PHARMA LLC EQ 20MG BASE A065182 001 May 13, 2005
AB EQ 75MG BASE A214207 001 Dec 16, 2020
AB EQ 150MG BASE A214207 002 Dec 16, 2020
AB HIKMA INTL PHARMS EQ 100MG BASE A065095 001 Jul 02, 2003
AB LARKEN LABS EQ 20MG BASE A065287 001 Feb 28, 2006
AB LUPIN LTD EQ 75MG BASE A208818 001 Sep 27, 2017
AB EQ 150MG BASE A208818 002 Sep 27, 2017
AB MAYNE PHARMA INC EQ 75MG BASE A208765 001 Jun 14, 2017
AB EQ 150MG BASE A208765 002 Jun 14, 2017
AB NOVEL LABS INC EQ 100MG BASE A207558 001 Sep 06, 2017
AB SUN PHARM EQ 20MG BASE A065134 001 May 13, 2005
INDUSTRIES
AB EQ 100MG BASE A062677 001 Jul 10, 1986
TABLET, DELAYED RELEASE;ORAL
DORYX
AB + MAYNE PHARMA EQ 50MG BASE N050795 006 Dec 19, 2014
AB + EQ 75MG BASE N050795 001 May 06, 2005
AB + EQ 100MG BASE N050795 002 May 06, 2005
AB + EQ 150MG BASE N050795 003 Jun 20, 2008
AB +! EQ 200MG BASE N050795 005 Apr 11, 2013
DOXYCYCLINE HYCLATE
AB ACTAVIS ELIZABETH EQ 50MG BASE A090134 003 May 22, 2018
AB EQ 75MG BASE A090134 001 Dec 14, 2011
AB EQ 100MG BASE A090134 002 Dec 14, 2011
AB EQ 200MG BASE A090134 004 May 22, 2018
AB ALEMBIC PHARMS EQ 75MG BASE A213075 001 Jan 03, 2022
AB EQ 100MG BASE A213075 002 Jan 03, 2022
AB EQ 150MG BASE A213075 003 Jan 03, 2022
AB EQ 200MG BASE A213075 004 Jan 03, 2022
AB HERITAGE PHARMS EQ 75MG BASE A200856 001 Apr 30, 2013
AB EQ 100MG BASE A200856 002 Apr 30, 2013
AB EQ 150MG BASE A200856 003 Apr 30, 2013
AB EQ 200MG BASE A200856 004 Nov 13, 2018
AB PRINSTON INC EQ 50MG BASE A207494 003 Feb 19, 2019
AB EQ 150MG BASE A207494 001 Nov 15, 2016
AB EQ 200MG BASE A207494 002 Nov 15, 2016
DORYX
+ MAYNE PHARMA EQ 80MG BASE N050795 004 Apr 11, 2013
DORYX MPC
+ MAYNE PHARMA EQ 60MG BASE N050795 007 May 20, 2016
+! EQ 120MG BASE N050795 008 May 20, 2016
DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
TABLET, DELAYED RELEASE;ORAL
DICLEGIS
AB +! DUCHESNAY 10MG;10MG N021876 001 Apr 08, 2013
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
AB ACTAVIS LABS FL INC 10MG;10MG A205811 001 Aug 19, 2016
AB MYLAN PHARMS INC 10MG;10MG A207825 001 Jul 06, 2020
AB PAR PHARM INC 10MG;10MG A208518 001 Dec 06, 2017
TABLET, EXTENDED RELEASE;ORAL
BONJESTA
+! DUCHESNAY 20MG;20MG N209661 001 Nov 07, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-160(of 474)

DRONABINOL
CAPSULE;ORAL
DRONABINOL
AB AKORN 2.5MG A079217 001 Jun 20, 2014
AB 5MG A079217 002 Jun 20, 2014
AB 10MG A079217 003 Jun 20, 2014
AB ASCENT PHARMS INC 2.5MG A207421 001 Feb 07, 2020
AB 5MG A207421 002 Feb 07, 2020
AB 10MG A207421 003 Feb 07, 2020
AB SVC PHARMA 2.5MG A078292 001 Jun 27, 2008
AB 5MG A078292 002 Jun 27, 2008
AB 10MG A078292 003 Jun 27, 2008
MARINOL
AB + ALKEM LABS LTD 2.5MG N018651 001 May 31, 1985
AB +! 5MG N018651 002 May 31, 1985
AB + 10MG N018651 003 May 31, 1985
SOLUTION;ORAL
SYNDROS
+! BENUVIA OPERATIONS 5MG/ML N205525 001 Mar 23, 2017
DRONEDARONE HYDROCHLORIDE
TABLET;ORAL
MULTAQ
+! SANOFI AVENTIS US EQ 400MG BASE N022425 001 Jul 01, 2009
DROPERIDOL
INJECTABLE;INJECTION
DROPERIDOL
AP AM REGENT 2.5MG/ML A072123 001 Oct 24, 1988
AP EUROHLTH INTL SARL 2.5MG/ML A208197 001 Dec 14, 2017
AP HOSPIRA 2.5MG/ML A071981 001 Feb 29, 1988
INAPSINE
AP +! AKORN 2.5MG/ML N016796 001
DROSPIRENONE
TABLET;ORAL
SLYND
+! EXELTIS USA INC 4MG N211367 001 May 23, 2019
TABLET, CHEWABLE;ORAL
DROSPIRENONE
+! EXELTIS USA INC 3.5MG N216285 001 Jun 29, 2022
DROSPIRENONE; ESTETROL
TABLET;ORAL
NEXTSTELLIS
+! MAYNE PHARMA 3MG;14.2MG N214154 001 Apr 15, 2021
DROSPIRENONE; ESTRADIOL
TABLET;ORAL
ANGELIQ
+ BAYER HLTHCARE 0.25MG;0.5MG N021355 001 Feb 29, 2012
+! 0.5MG;1MG N021355 002 Sep 28, 2005
DROSPIRENONE; ETHINYL ESTRADIOL
TABLET;ORAL
DROSPIRENONE AND ETHINYL ESTRADIOL
AB BARR 3MG;0.02MG A078515 001 Mar 30, 2009
AB GLENMARK PHARMS LTD 3MG;0.02MG A204296 001 Aug 17, 2015
AB HETERO LABS 3MG;0.02MG A211944 001 Mar 22, 2019
AB HLTHCARE 3MG;0.02MG A203291 001 Jul 18, 2017
AB MYLAN LABS LTD 3MG;0.02MG A202594 001 Oct 22, 2015
AB WATSON LABS 3MG;0.02MG A078833 001 Nov 28, 2011
LO-ZUMANDIMINE
AB AUROBINDO PHARMA 3MG;0.02MG A209632 001 Feb 27, 2018
LTD
LORYNA
AB XIROMED 3MG;0.02MG A079221 001 Mar 28, 2011
MELAMISA
AB NOVAST LABS 3MG;0.02MG A202016 001 Jan 26, 2016
NIKKI
AB LUPIN LTD 3MG;0.02MG A201661 001 May 27, 2014
YAZ
AB +! BAYER HLTHCARE 3MG;0.02MG N021676 001 Mar 16, 2006
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-161(of 474)

DROSPIRENONE; ETHINYL ESTRADIOL


TABLET;ORAL-28
DROSPIRENONE AND ETHINYL ESTRADIOL
AB BARR 3MG;0.03MG A077527 001 May 09, 2008
AB GLENMARK PHARMS LTD 3MG;0.03MG A204848 001 Mar 25, 2016
AB HETERO LABS 3MG;0.03MG A213034 001 Jan 24, 2020
AB LUPIN LTD 3MG;0.03MG A201663 001 Dec 18, 2012
AB MAYNE PHARMA 3MG;0.03MG A090081 001 Sep 07, 2010
AB MYLAN LABS LTD 3MG;0.03MG A202131 001 May 04, 2015
AB NAARI PTE LTD 3MG;0.03MG A207245 001 Nov 22, 2016
SYEDA
AB XIROMED 3MG;0.03MG A090114 001 Mar 28, 2011
YAELA
AB NOVAST LABS 3MG;0.03MG A202015 001 Nov 19, 2014
YASMIN
AB +! BAYER HLTHCARE 3MG;0.03MG N021098 001 May 11, 2001
ZUMANDIMINE
AB AUROBINDO PHARMA 3MG;0.03MG A209407 001 Mar 26, 2018
LTD
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
TABLET;ORAL
BEYAZ
AB +! BAYER HLTHCARE 3MG,N/A;0.02MG,N/A;0.451MG,0.451MG N022532 001 Sep 24, 2010
DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM
AB LUPIN LTD 3MG,N/A;0.02MG,N/A;0.451MG,0.451MG A205947 001 Jun 13, 2018
AB WATSON LABS INC 3MG,N/A;0.02MG,N/A;0.451MG,0.451MG A203593 001 Oct 11, 2016
AB 3MG,N/A;0.03MG,N/A;0.451MG,0.451MG A203594 001 Oct 11, 2016
SAFYRAL
AB +! BAYER HLTHCARE 3MG,N/A;0.03MG,N/A;0.451MG,0.451MG N022574 001 Dec 16, 2010
TYDEMY
AB LUPIN LTD 3MG,N/A;0.03MG,N/A;0.451MG,0.451MG A205948 001 Dec 12, 2017
DROXIDOPA
CAPSULE;ORAL
DROXIDOPA
AB AJANTA PHARMA LTD 100MG A214391 001 Feb 18, 2021
AB 200MG A214391 002 Feb 18, 2021
AB 300MG A214391 003 Feb 18, 2021
AB ALKEM LABS LTD 100MG A213911 001 Feb 18, 2021
AB 200MG A213911 002 Feb 18, 2021
AB 300MG A213911 003 Feb 18, 2021
AB ANNORA 100MG A211726 002 Aug 09, 2021
AB 200MG A211726 003 Aug 09, 2021
AB 300MG A211726 001 Feb 18, 2021
AB AUROBINDO PHARMA 100MG A214387 001 Feb 18, 2021
LTD
AB 200MG A214387 002 Feb 18, 2021
AB 300MG A214387 003 Feb 18, 2021
AB BIONPHARMA INC 100MG A213033 001 Apr 28, 2021
AB 200MG A213033 002 Apr 28, 2021
AB 300MG A213033 003 Apr 28, 2021
AB HIKMA 100MG A212835 001 Feb 18, 2021
AB 200MG A212835 002 Feb 18, 2021
AB 300MG A212835 003 Feb 18, 2021
AB LUPIN PHARMS 100MG A211652 001 Feb 18, 2021
AB 200MG A211652 002 Feb 18, 2021
AB 300MG A211652 003 Feb 18, 2021
AB MSN PHARMS INC 100MG A211741 001 Feb 18, 2021
AB 200MG A211741 002 Feb 18, 2021
AB 300MG A211741 003 Feb 18, 2021
AB SCIEGEN PHARMS INC 100MG A214017 001 Feb 18, 2021
AB 200MG A214017 002 Feb 18, 2021
AB 300MG A214017 003 Feb 18, 2021
AB SLATE RUN PHARMA 100MG A215265 001 Nov 01, 2021
AB 200MG A215265 002 Nov 01, 2021
AB 300MG A215265 003 Nov 01, 2021
AB SUN PHARM 100MG A214384 001 Feb 18, 2021
AB 200MG A214384 002 Feb 18, 2021
AB 300MG A214384 003 Feb 18, 2021
AB TRIS PHARMA INC 100MG A214543 001 May 05, 2021
AB 200MG A214543 002 May 05, 2021
AB 300MG A214543 003 May 05, 2021
AB UPSHER SMITH LABS 100MG A213661 001 Feb 18, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-162(of 474)

DROXIDOPA
CAPSULE;ORAL
DROXIDOPA
AB 200MG A213661 002 Feb 18, 2021
AB 300MG A213661 003 Feb 18, 2021
AB ZYDUS PHARMS 100MG A211818 001 Feb 18, 2021
AB 200MG A211818 002 Feb 18, 2021
AB 300MG A211818 003 Feb 18, 2021
NORTHERA
AB + LUNDBECK NA LTD 100MG N203202 001 Feb 18, 2014
AB + 200MG N203202 002 Feb 18, 2014
AB +! 300MG N203202 003 Feb 18, 2014
DULOXETINE HYDROCHLORIDE
CAPSULE, DELAYED REL PELLETS;ORAL
CYMBALTA
AB + LILLY EQ 20MG BASE N021427 001 Aug 03, 2004
AB + EQ 30MG BASE N021427 002 Aug 03, 2004
AB +! EQ 60MG BASE N021427 004 Aug 03, 2004
DULOXETINE HYDROCHLORIDE
AB ACTAVIS ELIZABETH EQ 20MG BASE A090776 001 Dec 17, 2013
AB EQ 30MG BASE A090776 002 Dec 17, 2013
AB EQ 60MG BASE A090776 003 Dec 17, 2013
AB AJANTA PHARMA LTD EQ 20MG BASE A208706 001 Jan 06, 2017
AB EQ 30MG BASE A208706 002 Jan 06, 2017
AB EQ 40MG BASE A208706 004 Mar 11, 2019
AB EQ 60MG BASE A208706 003 Jan 06, 2017
AB ALEMBIC PHARMS EQ 20MG BASE A202949 001 Jun 09, 2014
AB EQ 30MG BASE A202949 002 Jun 09, 2014
AB EQ 60MG BASE A202949 003 Jun 09, 2014
AB ALKEM LABS LTD EQ 20MG BASE A203197 001 Aug 26, 2015
AB EQ 30MG BASE A203197 002 Aug 26, 2015
AB EQ 60MG BASE A203197 003 Aug 26, 2015
AB ANCHEN PHARMS EQ 20MG BASE A090780 001 Oct 28, 2015
AB EQ 30MG BASE A090780 002 Oct 28, 2015
AB EQ 60MG BASE A090780 003 Oct 28, 2015
AB APOTEX EQ 20MG BASE A202045 001 Jun 11, 2014
AB EQ 30MG BASE A202045 002 Jun 11, 2014
AB EQ 60MG BASE A202045 003 Jun 11, 2014
AB AUROBINDO PHARMA EQ 20MG BASE A090778 001 Dec 11, 2013
LTD
AB EQ 30MG BASE A090778 002 Dec 11, 2013
AB EQ 60MG BASE A090778 003 Dec 11, 2013
AB BRECKENRIDGE EQ 20MG BASE A203088 001 Jun 11, 2014
AB EQ 30MG BASE A203088 002 Jun 11, 2014
AB EQ 40MG BASE A203088 004 May 18, 2018
AB EQ 60MG BASE A203088 003 Jun 11, 2014
AB CSPC OUYI EQ 20MG BASE A211310 001 Oct 16, 2018
AB EQ 30MG BASE A211310 002 Oct 16, 2018
AB EQ 60MG BASE A211310 003 Oct 16, 2018
AB HETERO LABS LTD III EQ 20MG BASE A204343 001 Aug 03, 2016
AB EQ 30MG BASE A204343 002 Aug 03, 2016
AB EQ 60MG BASE A204343 003 Aug 03, 2016
AB INVENTIA EQ 20MG BASE A202336 001 Oct 28, 2015
AB EQ 30MG BASE A202336 002 Oct 28, 2015
AB EQ 60MG BASE A202336 003 Oct 28, 2015
AB LUPIN LTD EQ 20MG BASE A090694 001 Dec 11, 2013
AB EQ 30MG BASE A090694 002 Dec 11, 2013
AB EQ 40MG BASE A090694 003 Dec 11, 2013
AB EQ 60MG BASE A090694 004 Dec 11, 2013
AB MACLEODS PHARMS LTD EQ 20MG BASE A204815 001 Mar 23, 2017
AB EQ 30MG BASE A204815 002 Mar 23, 2017
AB EQ 60MG BASE A204815 003 Mar 23, 2017
AB MARKSANS PHARMA EQ 20MG BASE A090723 001 Dec 11, 2013
AB EQ 30MG BASE A090723 002 Dec 11, 2013
AB EQ 60MG BASE A090723 003 Dec 11, 2013
AB PRINSTON INC EQ 20MG BASE A206653 001 May 18, 2017
AB EQ 30MG BASE A206653 002 May 18, 2017
AB EQ 60MG BASE A206653 003 May 18, 2017
AB QINGDAO BAHEAL EQ 20MG BASE A210599 001 Apr 17, 2019
PHARM
AB EQ 30MG BASE A210599 002 Apr 17, 2019
AB EQ 60MG BASE A210599 003 Apr 17, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-163(of 474)

DULOXETINE HYDROCHLORIDE
CAPSULE, DELAYED REL PELLETS;ORAL
DULOXETINE HYDROCHLORIDE
AB SUN PHARM EQ 20MG BASE A090745 001 Dec 11, 2013
AB EQ 30MG BASE A090745 002 Dec 11, 2013
AB EQ 60MG BASE A090745 003 Dec 11, 2013
AB SUNSHINE EQ 20MG BASE A212328 001 Feb 11, 2021
AB EQ 30MG BASE A212328 002 Feb 11, 2021
AB EQ 60MG BASE A212328 003 Feb 11, 2021
AB TORRENT EQ 20MG BASE A090774 001 Dec 11, 2013
AB EQ 30MG BASE A090774 002 Dec 11, 2013
AB EQ 60MG BASE A090774 003 Dec 11, 2013
AB ZYDUS HLTHCARE EQ 20MG BASE A090739 001 Jan 08, 2014
AB EQ 30MG BASE A090739 002 Jan 08, 2014
AB EQ 60MG BASE A090739 003 Jan 08, 2014
AB ZYDUS PHARMS EQ 20MG BASE A090728 001 Jan 08, 2014
AB EQ 30MG BASE A090728 002 Jan 08, 2014
AB EQ 60MG BASE A090728 003 Jan 08, 2014
DRIZALMA SPRINKLE
+ SUN PHARM EQ 30MG BASE N212516 002 Jul 19, 2019
+ EQ 40MG BASE N212516 003 Jul 19, 2019
+! EQ 60MG BASE N212516 004 Jul 19, 2019
DUTASTERIDE
CAPSULE;ORAL
AVODART
AB +! WOODWARD 0.5MG N021319 001 Nov 20, 2001
DUTASTERIDE
AB ACELLA 0.5MG A206373 001 Mar 17, 2016
AB AMNEAL PHARMS 0.5MG A203118 001 Nov 20, 2015
AB ASCENT PHARMS INC 0.5MG A206574 001 Oct 21, 2016
AB AUROBINDO PHARMA 0.5MG A202660 001 Nov 20, 2015
LTD
AB BARR 0.5MG A090095 001 Dec 21, 2010
AB BIONPHARMA INC 0.5MG A200899 001 Nov 20, 2015
AB CADILA 0.5MG A204373 001 Oct 04, 2017
AB HUMANWELL PURACAP 0.5MG A209909 001 Nov 21, 2017
AB MARKSANS PHARMA 0.5MG A204376 001 Apr 07, 2017
AB STRIDES PHARMA 0.5MG A204262 001 Nov 20, 2015
AB VINTAGE 0.5MG A202421 001 Nov 20, 2015
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
CAPSULE;ORAL
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
AB ANCHEN PHARMS 0.5MG;0.4MG A202509 001 Feb 26, 2014
AB ZYDUS PHARMS 0.5MG;0.4MG A207769 001 May 24, 2018
JALYN
AB +! WOODWARD 0.5MG;0.4MG N022460 001 Jun 14, 2010
DUVELISIB
CAPSULE;ORAL
COPIKTRA
+ SECURA 15MG N211155 001 Sep 24, 2018
+ 25MG N211155 002 Sep 24, 2018
DYCLONINE HYDROCHLORIDE
SOLUTION;TOPICAL
DYCLOPRO
! NOVOCOL INC 0.5% A200480 001 Nov 20, 2018
! 1% A200480 002 Nov 20, 2018
ECHOTHIOPHATE IODIDE
FOR SOLUTION;OPHTHALMIC
PHOSPHOLINE IODIDE
+! FERA PHARMS LLC 0.125% N011963 001
ECONAZOLE NITRATE
AEROSOL, FOAM;TOPICAL
ECOZA
+! RESILIA PHARMS 1% N205175 001 Oct 24, 2013
CREAM;TOPICAL
ECONAZOLE NITRATE
AB ! PADAGIS ISRAEL 1% A076479 001 Jun 23, 2004
AB PAI HOLDINGS PHARM 1% A076574 001 Dec 17, 2004
AB TARO 1% A076005 001 Nov 26, 2002
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-164(of 474)

EDARAVONE
SOLUTION;INTRAVENOUS
RADICAVA
+! MITSUBISHI TANABE 30MG/100ML (0.3MG/ML) N209176 001 May 05, 2017
+! 60MG/100ML (0.6MG/ML) N209176 002 Nov 15, 2018
SUSPENSION;ORAL
RADICAVA ORS
+! MITSUBISHI TANABE 105MG/5ML N215446 001 May 12, 2022
EDETATE CALCIUM DISODIUM
INJECTABLE;INJECTION
CALCIUM DISODIUM VERSENATE
+! BAUSCH 200MG/ML N008922 001
EDOXABAN TOSYLATE
TABLET;ORAL
SAVAYSA
+ DAIICHI SANKYO INC EQ 15MG BASE N206316 001 Jan 08, 2015
+ EQ 30MG BASE N206316 002 Jan 08, 2015
+! EQ 60MG BASE N206316 003 Jan 08, 2015
EFAVIRENZ
CAPSULE;ORAL
EFAVIRENZ
AB AUROBINDO PHARMA 50MG A078064 001 Dec 15, 2017
AB 200MG A078064 003 Dec 15, 2017
SUSTIVA
AB + BRISTOL MYERS 50MG N020972 001 Sep 17, 1998
SQUIBB
AB +! 200MG N020972 003 Sep 17, 1998
EFAVIRENZ
AUROBINDO PHARMA 100MG A078064 002 Dec 15, 2017
TABLET;ORAL
EFAVIRENZ
AB AUROBINDO PHARMA 600MG A077673 001 Sep 21, 2018
LTD
AB CIPLA 600MG A204766 001 Jun 15, 2018
AB ! HETERO LABS LTD III 600MG A078886 001 Apr 27, 2018
AB STRIDES PHARMA 600MG A204869 001 Mar 12, 2018
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
TABLET;ORAL
ATRIPLA
AB +! GILEAD SCIENCES 600MG;200MG;300MG N021937 001 Jul 12, 2006
EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE
AB AUROBINDO PHARMA 600MG;200MG;300MG A203041 001 Sep 04, 2018
AB CIPLA 600MG;200MG;300MG A206894 001 Jun 03, 2019
AB HETERO LABS LTD V 600MG;200MG;300MG A203053 001 Jan 24, 2022
AB LAURUS 600MG;200MG;300MG A213541 001 Dec 22, 2021
AB MACLEODS PHARMS LTD 600MG;200MG;300MG A204287 001 Sep 13, 2021
AB TEVA PHARMS USA 600MG;200MG;300MG A091215 001 Nov 09, 2018
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
TABLET;ORAL
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
AB LAURUS 400MG;300MG;300MG A213038 001 May 14, 2020
AB 600MG;300MG;300MG A212786 001 May 14, 2020
SYMFI
AB +! MYLAN LABS LTD 600MG;300MG;300MG N022142 001 Mar 22, 2018
SYMFI LO
AB +! MYLAN 400MG;300MG;300MG N208255 001 Feb 05, 2018
EFINACONAZOLE
SOLUTION;TOPICAL
EFINACONAZOLE
AB NIVAGEN PHARMS INC 10% A211969 001 Jun 21, 2021
AB TEVA PHARMS USA 10% A211827 001 Dec 16, 2020
JUBLIA
AB +! BAUSCH 10% N203567 001 Jun 06, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-165(of 474)

ELAGOLIX SODIUM
TABLET;ORAL
ORILISSA
+ ABBVIE INC EQ 150MG BASE N210450 001 Jul 23, 2018
+! EQ 200MG BASE N210450 002 Jul 23, 2018
ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM
CAPSULE;ORAL
ORIAHNN (COPACKAGED)
+! ABBVIE INC EQ 300MG BASE,1MG,0.5MG; EQ 300MG BASE N213388 001 May 29, 2020
ELBASVIR; GRAZOPREVIR
TABLET;ORAL
ZEPATIER
+! MSD SUB MERCK 50MG;100MG N208261 001 Jan 28, 2016
ELETRIPTAN HYDROBROMIDE
TABLET;ORAL
ELETRIPTAN HYDROBROMIDE
AB AJANTA PHARMA LTD EQ 20MG BASE A205186 001 Aug 29, 2017
AB EQ 40MG BASE A205186 002 Aug 29, 2017
AB AUROBINDO PHARMA EQ 20MG BASE A210708 001 Jan 15, 2019
AB EQ 40MG BASE A210708 002 Jan 15, 2019
AB BEXIMCO PHARMS USA EQ 20MG BASE A215467 001 Jul 13, 2022
AB EQ 40MG BASE A215467 002 Jul 13, 2022
AB MYLAN EQ 20MG BASE A205152 001 Aug 11, 2017
AB EQ 40MG BASE A205152 002 Aug 11, 2017
AB TEVA PHARMS USA EQ 20MG BASE A202040 001 Jun 27, 2017
AB EQ 40MG BASE A202040 002 Jun 27, 2017
AB ZYDUS PHARMS EQ 20MG BASE A206409 001 Jun 16, 2017
AB EQ 40MG BASE A206409 002 Jun 16, 2017
RELPAX
AB + UPJOHN EQ 20MG BASE N021016 001 Dec 26, 2002
AB +! EQ 40MG BASE N021016 002 Dec 26, 2002
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
TABLET;ORAL
TRIKAFTA (COPACKAGED)
+ VERTEX PHARMS INC 50MG,37.5MG,25MG; 75MG N212273 002 Jun 08, 2021
+! 100MG,75MG,50MG; 150MG N212273 001 Oct 21, 2019
ELIGLUSTAT TARTRATE
CAPSULE;ORAL
CERDELGA
AB +! GENZYME CORP EQ 84MG BASE N205494 001 Aug 19, 2014
ELIGLUSTAT TARTRATE
AB AIZANT EQ 84MG BASE A212463 001 Sep 08, 2021
ELTROMBOPAG OLAMINE
FOR SUSPENSION;ORAL
PROMACTA KIT
+ NOVARTIS EQ 12.5MG ACID/PACKET N207027 002 Sep 27, 2018
+! EQ 25MG ACID/PACKET N207027 001 Aug 24, 2015
TABLET;ORAL
PROMACTA
+ NOVARTIS EQ 12.5MG ACID N022291 004 Oct 20, 2011
+ EQ 25MG ACID N022291 001 Nov 20, 2008
+ EQ 50MG ACID N022291 002 Nov 20, 2008
+! EQ 75MG ACID N022291 003 Sep 08, 2009
ELUXADOLINE
TABLET;ORAL
VIBERZI
+ ALLERGAN HOLDINGS 75MG N206940 001 May 27, 2015
+! 100MG N206940 002 May 27, 2015
EMPAGLIFLOZIN
TABLET;ORAL
EMPAGLIFLOZIN
AB ZYDUS PHARMS 10MG A212138 001 Aug 03, 2022
AB 25MG A212138 002 Aug 03, 2022
JARDIANCE
AB + BOEHRINGER 10MG N204629 001 Aug 01, 2014
INGELHEIM
AB +! 25MG N204629 002 Aug 01, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-166(of 474)

EMPAGLIFLOZIN; LINAGLIPTIN
TABLET;ORAL
GLYXAMBI
+ BOEHRINGER 10MG;5MG N206073 001 Jan 30, 2015
INGELHEIM
+! 25MG;5MG N206073 002 Jan 30, 2015
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
TRIJARDY XR
+ BOEHRINGER 5MG;2.5MG;1GM N212614 001 Jan 27, 2020
INGELHEIM
+ 10MG;5MG;1GM N212614 002 Jan 27, 2020
+ 12.5MG;2.5MG;1GM N212614 003 Jan 27, 2020
+! 25MG;5MG;1GM N212614 004 Jan 27, 2020
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
TABLET;ORAL
SYNJARDY
+ BOEHRINGER 5MG;500MG N206111 001 Aug 26, 2015
INGELHEIM
+ 5MG;1GM N206111 002 Aug 26, 2015
+ 12.5MG;500MG N206111 003 Aug 26, 2015
+! 12.5MG;1GM N206111 004 Aug 26, 2015
TABLET, EXTENDED RELEASE;ORAL
SYNJARDY XR
+ BOEHRINGER 5MG;1GM N208658 001 Dec 09, 2016
INGELHEIM
+ 10MG;1GM N208658 002 Dec 09, 2016
+ 12.5MG;1GM N208658 003 Dec 09, 2016
+! 25MG;1GM N208658 004 Dec 09, 2016
EMTRICITABINE
CAPSULE;ORAL
EMTRICITABINE
AB CIPLA 200MG A091168 001 Jul 02, 2018
EMTRIVA
AB +! GILEAD 200MG N021500 001 Jul 02, 2003
SOLUTION;ORAL
EMTRIVA
+! GILEAD 10MG/ML N021896 001 Sep 28, 2005
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
TABLET;ORAL
ODEFSEY
+! GILEAD SCIENCES INC 200MG;EQ 25MG BASE;EQ 25MG BASE N208351 001 Mar 01, 2016
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
TABLET;ORAL
COMPLERA
+! GILEAD SCIENCES INC 200MG;EQ 25MG BASE;300MG N202123 001 Aug 10, 2011
EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
TABLET;ORAL
DESCOVY
+ GILEAD SCIENCES INC 120MG;EQ 15MG BASE N208215 002 Jan 07, 2022
+! 200MG;EQ 25MG BASE N208215 001 Apr 04, 2016
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
TABLET;ORAL
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
AB HETERO LABS LTD III 200MG;300MG A201806 001 Oct 07, 2021
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
AB AMNEAL PHARMS CO 100MG;150MG A209721 001 Aug 22, 2018
AB 133MG;200MG A209721 002 Aug 22, 2018
AB 167MG;250MG A209721 003 Aug 22, 2018
AB 200MG;300MG A209721 004 Aug 22, 2018
AB APOTEX 200MG;300MG A208740 001 Jun 16, 2021
AB AUROBINDO PHARMA 200MG;300MG A090513 001 Jan 26, 2018
AB CIPLA 200MG;300MG A090958 001 Apr 02, 2021
AB LAURUS 200MG;300MG A212114 001 Jul 26, 2019
AB LUPIN LTD 200MG;300MG A204131 001 Jun 04, 2021
AB MACLEODS PHARMS LTD 200MG;300MG A203442 001 May 15, 2020
AB MYLAN 200MG;300MG A206436 001 Apr 09, 2018
AB STRIDES PHARMA 200MG;300MG A091055 001 Jan 13, 2021
AB TEVA PHARMS USA 200MG;300MG A090894 001 Jun 08, 2017
AB ZYDUS PHARMS 100MG;150MG A212689 002 Jul 01, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-167(of 474)

EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE


TABLET;ORAL
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
AB 133MG;200MG A212689 003 Jul 01, 2021
AB 167MG;250MG A212689 004 Jul 01, 2021
AB 200MG;300MG A212689 001 Feb 28, 2020
TRUVADA
AB + GILEAD 100MG;150MG N021752 002 Mar 10, 2016
AB + 133MG;200MG N021752 003 Mar 10, 2016
AB + 167MG;250MG N021752 004 Mar 10, 2016
AB +! 200MG;300MG N021752 001 Aug 02, 2004
ENALAPRIL MALEATE
SOLUTION;ORAL
ENALAPRIL MALEATE
AB ALKEM LABS LTD 1MG/ML A213714 001 Mar 30, 2022
AB ANNORA PHARMA 1MG/ML A214467 001 Feb 24, 2022
AB BIONPHARMA INC 1MG/ML A212408 001 Aug 10, 2021
EPANED
AB +! AZURITY 1MG/ML N208686 001 Sep 20, 2016
TABLET;ORAL
ENALAPRIL MALEATE
AB HERITAGE PHARMA 2.5MG A075479 001 Aug 22, 2000
AB 5MG A075479 002 Aug 22, 2000
AB 10MG A075479 003 Aug 22, 2000
AB 20MG A075479 004 Aug 22, 2000
AB PRINSTON INC 2.5MG A213273 001 Jul 07, 2022
AB 5MG A213273 002 Jul 07, 2022
AB 10MG A213273 003 Jul 07, 2022
AB 20MG A213273 004 Jul 07, 2022
AB SANDOZ INC 2.5MG A075496 001 Aug 22, 2000
AB 5MG A075496 002 Aug 22, 2000
AB 10MG A075459 001 Aug 22, 2000
AB 20MG A075459 002 Aug 22, 2000
AB TARO 2.5MG A075657 001 Jan 23, 2001
AB 5MG A075657 002 Jan 23, 2001
AB 10MG A075657 003 Jan 23, 2001
AB 20MG A075657 004 Jan 23, 2001
AB WOCKHARDT LTD 2.5MG A075483 001 Aug 22, 2000
AB 5MG A075483 002 Aug 22, 2000
AB 10MG A075483 003 Aug 22, 2000
AB 20MG A075483 004 Aug 22, 2000
VASOTEC
AB + BAUSCH 2.5MG N018998 005 Jul 26, 1988
AB + 5MG N018998 001 Dec 24, 1985
AB + 10MG N018998 002 Dec 24, 1985
AB +! 20MG N018998 003 Dec 24, 1985
ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE
TABLET;ORAL
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE
AB COSETTE 5MG;12.5MG A075727 001 Sep 18, 2001
AB 10MG;25MG A075727 002 Sep 18, 2001
AB DR REDDYS LABS LTD 5MG;12.5MG A075909 001 Oct 15, 2001
AB 10MG;25MG A075909 002 Oct 15, 2001
AB TARO PHARM INDS 5MG;12.5MG A075788 001 Sep 18, 2001
AB 10MG;25MG A075788 002 Sep 18, 2001
VASERETIC
AB + BAUSCH 5MG;12.5MG N019221 003 Jul 12, 1995
AB +! 10MG;25MG N019221 001 Oct 31, 1986
ENALAPRILAT
INJECTABLE;INJECTION
ENALAPRILAT
AP CHARTWELL 1.25MG/ML A075634 001 Aug 22, 2000
INJECTABLE
AP ! HIKMA FARMACEUTICA 1.25MG/ML A078687 001 Dec 23, 2008
AP HOSPIRA 1.25MG/ML A075458 001 Aug 22, 2000
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-168(of 474)

ENASIDENIB MESYLATE
TABLET;ORAL
IDHIFA
+ BRISTOL MYERS EQ 50MG BASE N209606 001 Aug 01, 2017
SQUIBB
+! EQ 100MG BASE N209606 002 Aug 01, 2017
ENCORAFENIB
CAPSULE;ORAL
BRAFTOVI
+! ARRAY BIOPHARMA INC 75MG N210496 002 Jun 27, 2018
ENFUVIRTIDE
INJECTABLE;SUBCUTANEOUS
FUZEON
+! ROCHE 90MG/VIAL N021481 001 Mar 13, 2003
ENOXAPARIN SODIUM
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
ENOXAPARIN SODIUM
AB AMPHASTAR PHARMS 300MG/3ML (100MG/ML) A208600 001 Mar 14, 2019
INC
AB NANJING KING-FRIEND 300MG/3ML (100MG/ML) A214856 001 Jun 14, 2022
AB SANDOZ INC 300MG/3ML (100MG/ML) A078660 001 Nov 28, 2011
LOVENOX
AB + SANOFI AVENTIS US 300MG/3ML (100MG/ML) N020164 009 Jan 23, 2003
INJECTABLE;SUBCUTANEOUS
ENOXAPARIN SODIUM (PRESERVATIVE FREE)
AP AMPHASTAR PHARM 30MG/0.3ML (100MG/ML) A076684 001 Sep 19, 2011
AP 40MG/0.4ML (100MG/ML) A076684 002 Sep 19, 2011
AP 60MG/0.6ML (100MG/ML) A076684 003 Sep 19, 2011
AP 80MG/0.8ML (100MG/ML) A076684 004 Sep 19, 2011
AP 100MG/ML (100MG/ML) A076684 005 Sep 19, 2011
AP 120MG/0.8ML (150MG/ML) A076684 006 Sep 19, 2011
AP 150MG/ML (150MG/ML) A076684 007 Sep 19, 2011
AP APOTEX INC 30MG/0.3ML (100MG/ML) A078990 001 Sep 28, 2018
AP 40MG/0.4ML (100MG/ML) A078990 002 Sep 28, 2018
AP 60MG/0.6ML (100MG/ML) A078990 003 Sep 28, 2018
AP 80MG/0.8ML (100MG/ML) A078990 004 Sep 28, 2018
AP 100MG/ML (100MG/ML) A078990 005 Sep 28, 2018
AP 120MG/0.8ML (150MG/ML) A078990 006 Sep 28, 2018
AP 150MG/ML (150MG/ML) A078990 007 Sep 28, 2018
AP NANJING KING-FRIEND 30MG/0.3ML (100MG/ML) A206834 001 Nov 29, 2019
AP 40MG/0.4ML (100MG/ML) A206834 002 Nov 29, 2019
AP 60MG/0.6ML (100MG/ML) A206834 003 Nov 29, 2019
AP 80MG/0.8ML (100MG/ML) A206834 004 Nov 29, 2019
AP 100MG/ML (100MG/ML) A206834 005 Nov 29, 2019
AP 120MG/0.8ML (150MG/ML) A206834 006 Nov 29, 2019
AP 150MG/ML (150MG/ML) A206834 007 Nov 29, 2019
AP SANDOZ 30MG/0.3ML (100MG/ML) A077857 002 Jul 23, 2010
AP 40MG/0.4ML (100MG/ML) A077857 003 Jul 23, 2010
AP 60MG/0.6ML (100MG/ML) A077857 004 Jul 23, 2010
AP 80MG/0.8ML (100MG/ML) A077857 005 Jul 23, 2010
AP 100MG/ML (100MG/ML) A077857 001 Jul 23, 2010
AP 120MG/0.8ML (150MG/ML) A077857 006 Jul 23, 2010
AP 150MG/ML (150MG/ML) A077857 007 Jul 23, 2010
AP ZYDUS PHARMS 30MG/0.3ML (100MG/ML) A076726 001 Jun 23, 2014
AP 40MG/0.4ML (100MG/ML) A076726 002 Jun 23, 2014
AP 60MG/0.6ML (100MG/ML) A076726 003 Jun 23, 2014
AP 80MG/0.8ML (100MG/ML) A076726 004 Jun 23, 2014
AP 100MG/ML (100MG/ML) A076726 005 Jun 23, 2014
AP 120MG/0.8ML (150MG/ML) A076726 006 Jun 23, 2014
AP 150MG/ML (150MG/ML) A076726 007 Jun 23, 2014
LOVENOX (PRESERVATIVE FREE)
AP + SANOFI AVENTIS US 30MG/0.3ML (100MG/ML) N020164 001 Mar 29, 1993
AP + 40MG/0.4ML (100MG/ML) N020164 002 Jan 30, 1998
AP + 60MG/0.6ML (100MG/ML) N020164 003 Mar 27, 1998
AP + 80MG/0.8ML (100MG/ML) N020164 004 Mar 27, 1998
AP +! 100MG/ML (100MG/ML) N020164 005 Mar 27, 1998
AP + 120MG/0.8ML (150MG/ML) N020164 007 Jun 02, 2000
AP + 150MG/ML (150MG/ML) N020164 008 Jun 02, 2000
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-169(of 474)

ENTACAPONE
TABLET;ORAL
COMTAN
AB +! ORION PHARMA 200MG N020796 001 Oct 19, 1999
ENTACAPONE
AB AJANTA PHARMA LTD 200MG A205792 001 Aug 31, 2017
AB ALEMBIC PHARMS 200MG A212601 001 Jan 04, 2022
AB AUROBINDO PHARMA 200MG A203437 001 Jun 19, 2015
LTD
AB MACLEODS PHARMS LTD 200MG A207210 001 Jun 05, 2017
AB SUN PHARM 200MG A090690 001 Jul 16, 2012
AB SUNSHINE 200MG A206669 001 Oct 03, 2018
AB WOCKHARDT BIO AG 200MG A078941 001 Aug 16, 2012
ENTECAVIR
SOLUTION;ORAL
BARACLUDE
+! BRISTOL MYERS 0.05MG/ML N021798 001 Mar 29, 2005
SQUIBB
TABLET;ORAL
BARACLUDE
AB + BRISTOL MYERS 0.5MG N021797 001 Mar 29, 2005
SQUIBB
AB +! 1MG N021797 002 Mar 29, 2005
ENTECAVIR
AB AMNEAL PHARMS 0.5MG A206652 001 Nov 12, 2015
AB 1MG A206652 002 Nov 12, 2015
AB AUROBINDO PHARMA 0.5MG A206217 001 Aug 26, 2015
AB 1MG A206217 002 Aug 26, 2015
AB BRECKENRIDGE 0.5MG A208721 001 Mar 15, 2018
AB 1MG A208721 002 Mar 15, 2018
AB BRIGHTGENE 0.5MG A212126 001 Sep 25, 2019
AB 1MG A212126 002 Sep 25, 2019
AB CASI PHARMS INC 0.5MG A206672 001 May 11, 2017
AB 1MG A206672 002 May 11, 2017
AB CIPLA 0.5MG A206872 001 Dec 06, 2016
AB 1MG A206872 002 Dec 06, 2016
AB HETERO LABS LTD V 0.5MG A205740 001 Aug 21, 2015
AB 1MG A205740 002 Aug 21, 2015
AB PHARMADAX INC 0.5MG A212106 001 Aug 10, 2020
AB 1MG A212106 002 Aug 10, 2020
AB PRINSTON INC 0.5MG A208782 001 Oct 10, 2017
AB 1MG A208782 002 Oct 10, 2017
AB ZYDUS PHARMS 0.5MG A206745 001 Jun 23, 2017
AB 1MG A206745 002 Jun 23, 2017
ENTRECTINIB
CAPSULE;ORAL
ROZLYTREK
+ GENENTECH INC 100MG N212725 001 Aug 15, 2019
+! 200MG N212725 002 Aug 15, 2019
ENZALUTAMIDE
CAPSULE;ORAL
XTANDI
+! ASTELLAS 40MG N203415 001 Aug 31, 2012
TABLET;ORAL
XTANDI
+ ASTELLAS 40MG N213674 001 Aug 04, 2020
+! 80MG N213674 002 Aug 04, 2020
EPHEDRINE HYDROCHLORIDE
SOLUTION;INTRAVENOUS
REZIPRES
+! DR REDDYS LABS SA 23.5MG/5ML (4.7MG/ML) N213536 001 Jun 14, 2021
EPHEDRINE SULFATE
SOLUTION;INTRAVENOUS
AKOVAZ
AP +! EXELA PHARMA 50MG/ML (50MG/ML) N208289 001 Apr 29, 2016
CORPHEDRA
AP PAR STERILE 50MG/ML (50MG/ML) N208943 001 Jan 27, 2017
PRODUCTS
EPHEDRINE SULFATE
AP AKORN 50MG/ML (50MG/ML) N208609 001 Mar 01, 2017
AP AMNEAL 50MG/ML (50MG/ML) A212932 001 Oct 23, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-170(of 474)

EPHEDRINE SULFATE
SOLUTION;INTRAVENOUS
EPHEDRINE SULFATE
AP DR REDDYS 50MG/ML (50MG/ML) A212649 001 Oct 03, 2020
AP EUGIA PHARMA 50MG/ML (50MG/ML) A214579 001 Jun 14, 2021
AP FRESENIUS KABI USA 50MG/ML (50MG/ML) A209646 001 Aug 04, 2020
AP GLAND PHARMA LTD 50MG/ML (50MG/ML) A216146 001 Feb 25, 2022
AP HIKMA 50MG/ML (50MG/ML) A214334 001 Dec 15, 2020
AP MANKIND PHARMA 50MG/ML (50MG/ML) A216129 001 Apr 14, 2022
AP SANDOZ INC 50MG/ML (50MG/ML) A209784 001 Aug 23, 2017
AP XIROMED 50MG/ML (50MG/ML) A215825 001 Apr 21, 2022
AKOVAZ
+! EXELA PHARMA 25MG/5ML (5MG/ML) N208289 002 Aug 02, 2021
EMERPHED
+! NEXUS PHARMS 50MG/10ML (5MG/ML) N213407 001 Apr 17, 2020
EPHEDRINE SULFATE
+! ENDO VENTURES 25MG/5ML (5MG/ML) N213994 002 Apr 22, 2022
+! 50MG/10ML (5MG/ML) N213994 001 Oct 16, 2020
EPINASTINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
EPINASTINE HYDROCHLORIDE
AT APOTEX 0.05% A090919 001 Oct 31, 2011
AT BRECKENRIDGE 0.05% A090870 001 Mar 14, 2011
AT ! SOMERSET THERAPS 0.05% A090951 001 Oct 31, 2011
LLC
EPINEPHRINE
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
EPINEPHRINE (AUTOINJECTOR)
AB TEVA PHARMS USA 0.15MG/DELIVERY A090589 002 Aug 16, 2018
AB 0.3MG/DELIVERY A090589 001 Aug 16, 2018
EPIPEN
AB +! MYLAN SPECIALITY LP 0.3MG/DELIVERY N019430 001 Dec 22, 1987
EPIPEN JR.
AB +! MYLAN SPECIALITY LP 0.15MG/DELIVERY N019430 002 Dec 22, 1987
ADRENACLICK
BX +! IMPAX EQ 0.15MG/DELIVERY N020800 003 Nov 25, 2009
BX +! EQ 0.3MG/DELIVERY N020800 004 Nov 25, 2009
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
ADRENALIN
AP +! PAR STERILE EQ 1MG BASE/ML (EQ 1MG BASE/ML) N204200 001 Dec 07, 2012
PRODUCTS
AP +! EQ 30MG BASE/30ML (EQ 1MG BASE/ML) N204640 001 Dec 18, 2013
EPINEPHRINE
AP AM REGENT EQ 1MG BASE/ML (EQ 1MG BASE/ML) A207568 001 Jul 06, 2018
AP INTL MEDICATION SYS EQ 30MG BASE/30ML (EQ 1MG BASE/ML) A211880 001 Apr 24, 2020
+! BPI LABS 10MG/10ML (1MG/ML) N205029 002 Feb 04, 2022
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS
AUVI-Q
BX +! KALEO INC EQ 0.15MG/DELIVERY N201739 002 Aug 10, 2012
BX + EQ 0.3MG/DELIVERY N201739 001 Aug 10, 2012
+ EQ 0.1MG/DELIVERY N201739 003 Nov 17, 2017
SYMJEPI
+! ADAMIS PHARMS CORP 0.15MG/0.3ML (0.15MG/0.3ML) N207534 002 Sep 27, 2018
+! 0.3MG/0.3ML (0.3MG/0.3ML) N207534 001 Jun 15, 2017
SOLUTION;INTRAVENOUS
EPINEPHRINE
+! HOSPIRA 1MG/10ML (0.1MG/ML) N209359 001 Nov 05, 2019
+! INTL MEDICATION SYS 1MG/10ML (0.1MG/ML) N211363 001 Aug 15, 2022
SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS
EPINEPHRINE
+! BPI LABS 1MG/ML (1MG/ML) N205029 001 Jul 29, 2014
EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
LIGNOSPAN FORTE
+! DEPROCO EQ 0.02MG BASE/ML;2% A088389 001 Jan 22, 1985
LIGNOSPAN STANDARD
+! DEPROCO EQ 0.01MG BASE/ML;2% A088390 001 Jan 22, 1985
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-171(of 474)

EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE


INJECTABLE;INJECTION
CITANEST FORTE DENTAL
AP +! DENTSPLY PHARM 0.005MG/ML;4% N021383 001
PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE
AP SEPTODONT INC 0.005MG/ML;4% A078959 001 Aug 30, 2011
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
AP B BRAUN MEDICAL INC 0.005MG/ML;1.5% A208475 001 Sep 08, 2021
AP HOSPIRA 0.005MG/ML;0.5% A089635 001 Jun 21, 1988
AP 0.005MG/ML;1.5% A088571 001 Sep 13, 1985
AP 0.005MG/ML;1.5% A089645 001 Jun 21, 1988
AP 0.005MG/ML;2% A089651 001 Jun 21, 1988
AP 0.01MG/ML;1% A089644 001 Jun 21, 1988
AP ! 0.01MG/ML;2% A089646 001 Jun 21, 1988
XYLOCAINE W/ EPINEPHRINE
AP +! FRESENIUS KABI USA 0.005MG/ML;0.5% N006488 012
AP +! 0.005MG/ML;1.5% N006488 017
AP +! 0.005MG/ML;2% N006488 019 Nov 13, 1986
AP +! 0.01MG/ML;1% N006488 004
AP +! 0.02MG/ML;2% N006488 005
+! 0.005MG/ML;1% N006488 018 Nov 13, 1986
EPIRUBICIN HYDROCHLORIDE
INJECTABLE;INJECTION
ELLENCE
AP +! PFIZER INC 200MG/100ML (2MG/ML) N050778 001 Sep 15, 1999
AP + 50MG/25ML (2MG/ML) N050778 002 Sep 15, 1999
EPIRUBICIN HYDROCHLORIDE
AP AKORN 50MG/25ML (2MG/ML) A090163 001 Jun 24, 2009
AP CIPLA LTD 50MG/25ML (2MG/ML) A065361 001 Oct 22, 2007
AP 200MG/100ML (2MG/ML) A065361 002 Oct 22, 2007
AP HIKMA 50MG/25ML (2MG/ML) A065289 001 Jun 27, 2007
AP 200MG/100ML (2MG/ML) A065289 002 Jun 27, 2007
AP HISUN PHARM 50MG/25ML (2MG/ML) A090075 001 Mar 25, 2010
HANGZHOU
AP 200MG/100ML (2MG/ML) A090075 002 Mar 25, 2010
AP IMPAX LABS INC 50MG/25ML (2MG/ML) A065331 001 Aug 09, 2007
AP 200MG/100ML (2MG/ML) A065331 002 Aug 09, 2007
EPLERENONE
TABLET;ORAL
EPLERENONE
AB ACCORD HLTHCARE 25MG A206922 001 Jul 13, 2017
AB 50MG A206922 002 Jul 13, 2017
AB BRECKENRIDGE 25MG A208283 001 Sep 14, 2018
AB 50MG A208283 002 Sep 14, 2018
AB CHARTWELL RX 25MG A078482 001 Jul 30, 2008
AB 50MG A078482 002 Jul 30, 2008
AB KARTHA 25MG A214663 001 Mar 23, 2022
AB 50MG A214663 002 Mar 23, 2022
AB PIRAMAL HLTHCARE UK 25MG A212765 001 Aug 10, 2020
AB 50MG A212765 002 Aug 10, 2020
AB PRASCO 25MG A203896 001 Feb 02, 2017
AB 50MG A203896 002 Feb 02, 2017
AB SANDOZ 25MG A078510 001 Aug 01, 2008
AB 50MG A078510 002 Aug 01, 2008
AB WESTMINSTER PHARMS 25MG A207842 001 Oct 25, 2021
AB 50MG A207842 002 Oct 25, 2021
INSPRA
AB + UPJOHN 25MG N021437 001 Sep 27, 2002
AB +! 50MG N021437 002 Sep 27, 2002
EPOPROSTENOL SODIUM
INJECTABLE;INJECTION
EPOPROSTENOL SODIUM
AP1 TEVA PHARMS USA EQ 0.5MG BASE/VIAL A078396 001 Apr 23, 2008
AP1 EQ 1.5MG BASE/VIAL A078396 002 Apr 23, 2008
FLOLAN
AP1 +! GLAXOSMITHKLINE LLC EQ 0.5MG BASE/VIAL N020444 001 Sep 20, 1995
AP1 +! EQ 1.5MG BASE/VIAL N020444 002 Sep 20, 1995
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-172(of 474)

EPOPROSTENOL SODIUM
INJECTABLE;INJECTION
EPOPROSTENOL SODIUM
AP2 SUN PHARM EQ 0.5MG BASE/VIAL A210473 001 Jan 15, 2021
AP2 EQ 1.5MG BASE/VIAL A210473 002 Jan 15, 2021
VELETRI
AP2 +! ACTELION EQ 0.5MG BASE/VIAL N022260 002 Jun 28, 2012
AP2 +! EQ 1.5MG BASE/VIAL N022260 001 Jun 27, 2008
EPTIFIBATIDE
INJECTABLE;INJECTION
EPTIFIBATIDE
AP ACCORD HLTHCARE 2MG/ML A205557 001 Nov 06, 2017
AP 75MG/100ML A205557 002 Nov 06, 2017
AP BAXTER HLTHCARE 75MG/100ML A208554 002 Nov 23, 2018
CORP
AP EUGIA PHARMA 2MG/ML A206127 001 Dec 08, 2015
AP 75MG/100ML A206127 002 Dec 08, 2015
AP HAINAN POLY PHARM 2MG/ML A209864 001 Jan 25, 2019
AP 75MG/100ML A209864 002 Jan 25, 2019
AP ! MYLAN LABS LTD 2MG/ML A203258 001 Jul 20, 2018
AP ! 75MG/100ML A203258 002 Jul 20, 2018
AP SAGENT PHARMS INC 2MG/ML A204693 001 Mar 07, 2018
AP 75MG/100ML A204693 002 Mar 07, 2018
AP SHUANGCHENG 2MG/ML A213081 001 Sep 07, 2021
AP 75MG/100ML A213081 002 Apr 20, 2022
AP TEVA PHARMS USA 2MG/ML A090854 001 Jun 12, 2015
ERAVACYCLINE DIHYDROCHLORIDE
POWDER;INTRAVENOUS
XERAVA
+! TETRAPHASE PHARMS EQ 50MG BASE/VIAL N211109 001 Aug 27, 2018
+! EQ 100MG BASE/VIAL N211109 002 Jun 03, 2020
ERDAFITINIB
TABLET;ORAL
BALVERSA
+ JANSSEN BIOTECH 3MG N212018 001 Apr 12, 2019
+ 4MG N212018 002 Apr 12, 2019
+! 5MG N212018 003 Apr 12, 2019
ERGOCALCIFEROL
CAPSULE;ORAL
DRISDOL
AA +! VALIDUS PHARMS 50,000 IU N003444 001
ERGOCALCIFEROL
AA ALEMBIC LABS 50,000 IU A040833 001 May 20, 2009
AA PURACAP PHARM LLC 50,000 IU A204276 001 Dec 07, 2018
AA STRIDES PHARMA 50,000 IU A090455 001 Aug 03, 2010
AA SUN PHARM INDS INC 50,000 IU A040865 001 Dec 29, 2009
VITAMIN D
AA BIONPHARMA INC 50,000 IU A080704 001
ERGOLOID MESYLATES
TABLET;ORAL
ERGOLOID MESYLATES
! SUN PHARM 1MG A081113 001 Oct 31, 1991
INDUSTRIES
ERGOTAMINE TARTRATE
TABLET;SUBLINGUAL
ERGOMAR
! TERSERA 2MG A087693 001 Feb 24, 1983
ERIBULIN MESYLATE
SOLUTION;INTRAVENOUS
HALAVEN
+! EISAI INC 1MG/2ML (0.5MG/ML) N201532 001 Nov 15, 2010
ERLOTINIB HYDROCHLORIDE
TABLET;ORAL
ERLOTINIB HYDROCHLORIDE
AB ALEMBIC PHARMS EQ 25MG BASE A214719 001 Jul 08, 2021
AB EQ 100MG BASE A214719 002 Jul 08, 2021
AB EQ 150MG BASE A214719 003 Jul 08, 2021
AB APOTEX EQ 25MG BASE A208396 001 Nov 05, 2019
AB EQ 100MG BASE A208396 002 Nov 05, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-173(of 474)

ERLOTINIB HYDROCHLORIDE
TABLET;ORAL
ERLOTINIB HYDROCHLORIDE
AB EQ 150MG BASE A208396 003 Nov 05, 2019
AB MSN EQ 25MG BASE A214366 001 May 10, 2021
AB EQ 100MG BASE A214366 002 May 10, 2021
AB EQ 150MG BASE A214366 003 May 10, 2021
AB NATCO PHARMA LTD EQ 25MG BASE A208488 001 Nov 05, 2019
AB EQ 100MG BASE A208488 002 Nov 05, 2019
AB EQ 150MG BASE A208488 003 Nov 05, 2019
AB RISING EQ 25MG BASE A091002 001 Jun 11, 2014
AB EQ 100MG BASE A091002 002 Jun 11, 2014
AB EQ 150MG BASE A091002 003 Jun 11, 2014
AB SHILPA EQ 25MG BASE A211960 001 Nov 05, 2019
AB EQ 100MG BASE A211960 002 Nov 05, 2019
AB EQ 150MG BASE A211960 003 Nov 05, 2019
AB SUN PHARM EQ 25MG BASE A210300 001 Nov 05, 2019
AB EQ 100MG BASE A210300 002 Nov 05, 2019
AB EQ 150MG BASE A210300 003 Nov 05, 2019
AB TEVA PHARMS USA INC EQ 25MG BASE A091059 001 Nov 09, 2020
AB EQ 100MG BASE A091059 002 Aug 28, 2015
AB EQ 150MG BASE A091059 003 Aug 28, 2015
AB ZYDUS PHARMS EQ 25MG BASE A213065 001 Apr 16, 2020
AB EQ 100MG BASE A213065 002 Apr 16, 2020
AB EQ 150MG BASE A213065 003 Apr 16, 2020
TARCEVA
AB + OSI PHARMS EQ 25MG BASE N021743 001 Nov 18, 2004
AB + EQ 100MG BASE N021743 002 Nov 18, 2004
AB +! EQ 150MG BASE N021743 003 Nov 18, 2004
ERTAPENEM SODIUM
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS
ERTAPENEM SODIUM
AP ACS DOBFAR SPA EQ 1GM BASE/VIAL A208790 001 Apr 16, 2018
AP EUGIA PHARMA EQ 1GM BASE/VIAL A209133 001 Jun 25, 2018
AP GLAND PHARMA LTD EQ 1GM BASE/VIAL A212040 001 Mar 26, 2021
AP SAVIOR LIFETEC CORP EQ 1GM BASE/VIAL A207647 001 Mar 19, 2019
INVANZ
AP +! MSD SUB MERCK EQ 1GM BASE/VIAL N021337 001 Nov 21, 2001
ERTUGLIFLOZIN
TABLET;ORAL
STEGLATRO
+ MSD SUB MERCK 5MG N209803 001 Dec 19, 2017
+! 15MG N209803 002 Dec 19, 2017
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
TABLET;ORAL
SEGLUROMET
+ MSD SUB MERCK 2.5MG;500MG N209806 001 Dec 19, 2017
+ 2.5MG;1GM N209806 002 Dec 19, 2017
+ 7.5MG;500MG N209806 003 Dec 19, 2017
+! 7.5MG;1GM N209806 004 Dec 19, 2017
ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE
TABLET;ORAL
STEGLUJAN
+ MSD SUB MERCK 5MG;EQ 100MG BASE N209805 001 Dec 19, 2017
+! 15MG;EQ 100MG BASE N209805 002 Dec 19, 2017
ERYTHROMYCIN
CAPSULE, DELAYED REL PELLETS;ORAL
ERYC
AB +! MAYNE PHARMA 250MG N050536 001
ERYTHROMYCIN
AB ARBOR PHARMS LLC 250MG A062746 001 Dec 22, 1986
GEL;TOPICAL
ERYGEL
AT +! MYLAN 2% N050617 001 Oct 21, 1987
ERYTHROMYCIN
AT FOUGERA PHARMS 2% A064184 001 Sep 30, 1997
AT PADAGIS US 2% A063211 001 Jan 29, 1993
AT PAI HOLDINGS PHARM 2% A208154 001 Jul 19, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-174(of 474)

ERYTHROMYCIN
OINTMENT;OPHTHALMIC
ERYTHROMYCIN
AT AKORN 0.5% A064030 001 Jul 18, 1996
AT BAUSCH AND LOMB 0.5% A064067 001 Jul 29, 1994
AT ! PADAGIS US 0.5% A062447 001 Sep 26, 1983
SOLUTION;TOPICAL
ERYTHRA-DERM
AT MICRO LABS 2% A062687 001 Feb 05, 1988
ERYTHROMYCIN
AT ! PADAGIS US 2% A063038 001 Jan 11, 1991
AT PAI HOLDINGS PHARM 2% A208100 001 Nov 20, 2017
AT XTTRIUM LABS INC 2% A062825 001 Oct 23, 1987
SWAB;TOPICAL
ERYTHROMYCIN
AT AKORN 2% A090215 001 May 12, 2010
AT ! PADAGIS US 2% A064126 001 Jul 03, 1996
TABLET;ORAL
ERYTHROMYCIN
AB ALKEM LABS LTD 250MG A216066 001 Jul 13, 2022
AB 500MG A216066 002 Jul 13, 2022
AB AMNEAL PHARMS CO 250MG A209720 001 Mar 09, 2018
AB 500MG A209720 002 Mar 09, 2018
AB ARBOR PHARMS LLC 250MG A061621 001
AB ! 500MG A061621 002
AB CADILA PHARMS LTD 250MG A213628 001 Jun 28, 2021
AB 500MG A213628 002 Jun 28, 2021
AB TEVA PHARMS USA INC 250MG A214549 001 Feb 11, 2021
AB 500MG A214549 002 Feb 11, 2021
AB TORRENT 250MG A212015 001 Jul 06, 2020
AB 500MG A212015 002 Jul 06, 2020
TABLET, DELAYED RELEASE;ORAL
ERY-TAB
AB ARBOR PHARMS LLC 250MG A062298 001
AB 333MG A062298 003 Mar 29, 1982
AB ! 500MG A062298 002
ERYTHROMYCIN
AB AMNEAL PHARMS CO 250MG A210954 001 Jul 02, 2019
AB 333MG A210954 002 Jul 02, 2019
AB 500MG A210954 003 Jul 02, 2019
AB TORRENT 250MG A211975 001 Jul 26, 2021
AB 500MG A211975 002 Jul 26, 2021
ERYTHROMYCIN ETHYLSUCCINATE
GRANULE;ORAL
E.E.S.
AB + AZURITY EQ 200MG BASE/5ML N050207 001
ERYPED
AB + AZURITY EQ 200MG BASE/5ML N050207 003 Mar 30, 1987
AB +! EQ 400MG BASE/5ML N050207 002
ERYTHROMYCIN ETHYLSUCCINATE
AB AMNEAL PHARMS EQ 200MG BASE/5ML A211204 001 Nov 01, 2019
AB EQ 400MG BASE/5ML A211204 002 Nov 01, 2019
AB ANI PHARMS EQ 200MG BASE/5ML A062055 001
AB EQ 200MG BASE/5ML A062055 003 Nov 02, 2018
AB EQ 400MG BASE/5ML A062055 002 Nov 02, 2018
AB CADILA PHARMS LTD EQ 200MG BASE/5ML A216212 001 Nov 21, 2022
AB EQ 400MG BASE/5ML A216212 002 Nov 21, 2022
TABLET;ORAL
E.E.S. 400
BX ! ARBOR PHARMS LLC EQ 400MG BASE A061905 002 Aug 12, 1982
ERYTHROMYCIN ETHYLSUCCINATE
BX ! ARBOR PHARMS LLC EQ 400MG BASE A061904 001
ERYTHROMYCIN LACTOBIONATE
INJECTABLE;INJECTION
ERYTHROCIN
AP HOSPIRA EQ 500MG BASE/VIAL A062638 001 Oct 31, 1986
AP +! EQ 500MG BASE/VIAL N050609 001 Sep 24, 1986
ERYTHROMYCIN LACTOBIONATE
AP EXELA PHARMA EQ 500MG BASE/VIAL A211086 001 Sep 17, 2020
AP NEXUS PHARMS EQ 500MG BASE/VIAL A215290 001 Feb 14, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-175(of 474)

ERYTHROMYCIN STEARATE
TABLET;ORAL
ERYTHROCIN STEARATE
! ARBOR PHARMS LLC EQ 250MG BASE A060359 001
ESCITALOPRAM OXALATE
SOLUTION;ORAL
ESCITALOPRAM OXALATE
AA AMNEAL PHARMS EQ 5MG BASE/5ML A202227 001 Mar 14, 2012
AA AUROBINDO PHARMA EQ 5MG BASE/5ML A079062 001 Apr 02, 2012
LTD
AA ! HETERO LABS LTD III EQ 5MG BASE/5ML A202221 001 Jun 12, 2012
AA LANNETT CO INC EQ 5MG BASE/5ML A090477 001 Jun 12, 2013
AA MACLEODS PHARMS LTD EQ 5MG BASE/5ML A202754 001 Mar 31, 2016
AA TARO EQ 5MG BASE/5ML A079121 001 May 03, 2012
TABLET;ORAL
ESCITALOPRAM OXALATE
AB ACCORD HLTHCARE EQ 5MG BASE A202389 001 Sep 11, 2012
AB EQ 10MG BASE A202389 002 Sep 11, 2012
AB EQ 20MG BASE A202389 003 Sep 11, 2012
AB AMNEAL PHARMS EQ 5MG BASE A205619 001 May 17, 2017
AB EQ 10MG BASE A205619 002 May 17, 2017
AB EQ 20MG BASE A205619 003 May 17, 2017
AB AUROBINDO PHARMA EQ 5MG BASE A090432 001 Sep 11, 2012
LTD
AB EQ 10MG BASE A090432 002 Sep 11, 2012
AB EQ 20MG BASE A090432 003 Sep 11, 2012
AB CADILA EQ 5MG BASE A077734 001 Sep 11, 2012
AB EQ 10MG BASE A077734 002 Sep 11, 2012
AB EQ 20MG BASE A077734 003 Sep 11, 2012
AB GRAVITI PHARMS EQ 5MG BASE A078777 001 Sep 11, 2012
AB EQ 10MG BASE A078777 002 Sep 11, 2012
AB EQ 20MG BASE A078777 003 Sep 11, 2012
AB INVAGEN PHARMS EQ 5MG BASE A078604 001 Sep 11, 2012
AB EQ 10MG BASE A078604 002 Sep 11, 2012
AB EQ 20MG BASE A078604 003 Sep 11, 2012
AB JUBILANT GENERICS EQ 5MG BASE A202280 001 Sep 12, 2012
AB EQ 10MG BASE A202280 002 Sep 12, 2012
AB EQ 20MG BASE A202280 003 Sep 12, 2012
AB LUPIN LTD EQ 5MG BASE A078169 001 Sep 11, 2012
AB EQ 10MG BASE A078169 002 Sep 11, 2012
AB EQ 20MG BASE A078169 003 Sep 11, 2012
AB PHARM ASSOC EQ 5MG BASE A077512 001 Sep 12, 2012
AB EQ 10MG BASE A077512 002 Sep 12, 2012
AB EQ 20MG BASE A077512 003 Sep 12, 2012
AB PRINSTON INC EQ 5MG BASE A078032 001 Aug 28, 2015
AB EQ 10MG BASE A078032 002 Aug 28, 2015
AB EQ 20MG BASE A078032 003 Aug 28, 2015
AB TORRENT PHARMS LTD EQ 5MG BASE A090939 001 Sep 11, 2012
AB EQ 10MG BASE A090939 002 Sep 11, 2012
AB EQ 20MG BASE A090939 003 Sep 11, 2012
LEXAPRO
AB + ALLERGAN EQ 5MG BASE N021323 001 Aug 14, 2002
AB + EQ 10MG BASE N021323 002 Aug 14, 2002
AB +! EQ 20MG BASE N021323 003 Aug 14, 2002
ESKETAMINE HYDROCHLORIDE
SPRAY;NASAL
SPRAVATO
+! JANSSEN PHARMS EQ 28MG BASE N211243 001 Mar 05, 2019
ESLICARBAZEPINE ACETATE
TABLET;ORAL
APTIOM
AB + SUNOVION PHARMS INC 200MG N022416 001 Nov 08, 2013
AB + 400MG N022416 002 Nov 08, 2013
AB + 600MG N022416 003 Nov 08, 2013
AB +! 800MG N022416 004 Nov 08, 2013
ESLICARBAZEPINE ACETATE
AB DR REDDYS 200MG A211238 001 Jun 29, 2021
AB 400MG A211238 002 Jun 29, 2021
AB 600MG A211238 003 Jun 29, 2021
AB 800MG A211238 004 Jun 29, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-176(of 474)

ESMOLOL HYDROCHLORIDE
INJECTABLE;INJECTION
BREVIBLOC
AP +! BAXTER HLTHCARE 10MG/ML N019386 006 Feb 25, 2003
ESMOLOL HYDROCHLORIDE
AP AMNEAL 10MG/ML A216603 001 Dec 13, 2022
AP 20MG/ML A216603 002 Dec 13, 2022
AP EUGIA PHARMA 10MG/ML A205520 001 Jul 23, 2015
AP 10MG/ML A216244 001 Mar 21, 2022
AP 20MG/ML A216244 002 Mar 21, 2022
AP FRESENIUS KABI USA 10MG/ML A076573 001 May 02, 2005
AP GLAND PHARMA LTD 10MG/ML A208538 001 Aug 14, 2019
AP HIKMA 10MG/ML A076323 001 Aug 10, 2004
AP HQ SPCLT PHARMA 10MG/ML A214172 001 Dec 02, 2022
AP 20MG/ML A214172 002 Dec 02, 2022
AP MYLAN INSTITUTIONAL 10MG/ML A076474 001 May 02, 2005
AP MYLAN LABS LTD 10MG/ML A206608 001 Jun 08, 2018
AP 20MG/ML A206608 002 Jun 08, 2018
AP SAGENT PHARMS INC 10MG/ML A207107 001 Jun 08, 2018
AP 20MG/ML A207107 002 Jun 08, 2018
BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 2GM/100ML N019386 005 Jan 27, 2003
BREVIBLOC IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 1GM/100ML N019386 004 Feb 16, 2001
SOLUTION;INTRAVENOUS
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
+! HQ SPCLT PHARMA 2GM/100ML (20MG/ML) N205703 002 Apr 07, 2016
ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER
+! HQ SPCLT PHARMA 2.5GM/250ML (10MG/ML) N205703 001 Apr 07, 2016
ESOMEPRAZOLE MAGNESIUM
CAPSULE, DELAYED REL PELLETS;ORAL
ESOMEPRAZOLE MAGNESIUM
AB ALKEM LABS LTD EQ 20MG BASE A208333 001 Oct 20, 2017
AB EQ 40MG BASE A208333 002 Oct 20, 2017
AB AUROBINDO PHARMA EQ 20MG BASE A205606 001 Apr 21, 2016
LTD
AB EQ 40MG BASE A205606 002 Apr 21, 2016
AB CISEN EQ 20MG BASE A213158 001 Sep 22, 2020
AB EQ 40MG BASE A213158 002 Sep 22, 2020
AB CSPC OUYI EQ 20MG BASE A212949 001 Oct 02, 2020
AB EQ 40MG BASE A212949 002 Oct 02, 2020
AB DR REDDYS EQ 20MG BASE A078279 001 Sep 25, 2015
AB EQ 40MG BASE A078279 002 Sep 25, 2015
AB ETHYPHARM EQ 20MG BASE A090841 001 Mar 31, 2021
AB EQ 40MG BASE A090841 002 Mar 31, 2021
AB GLENMARK PHARMS EQ 20MG BASE A209495 001 May 10, 2019
AB EQ 40MG BASE A209495 002 May 10, 2019
AB GRAVITI PHARMS EQ 20MG BASE A213486 001 Mar 19, 2021
AB EQ 40MG BASE A213486 002 Mar 19, 2021
AB HETERO LABS LTD III EQ 20MG BASE A202784 001 Sep 21, 2015
AB EQ 20MG BASE A211977 001 Jun 02, 2020
AB EQ 40MG BASE A202784 002 Sep 21, 2015
AB EQ 40MG BASE A211977 002 Jun 02, 2020
AB INDCHEMIE HEALTH EQ 20MG BASE A210559 001 Feb 26, 2021
AB EQ 40MG BASE A210559 002 Feb 26, 2021
AB IVAX SUB TEVA EQ 20MG BASE A078003 001 Jan 26, 2015
PHARMS
AB EQ 40MG BASE A078003 002 Jan 26, 2015
AB LANNETT CO INC EQ 20MG BASE A205563 001 Sep 01, 2017
AB EQ 40MG BASE A205563 002 Sep 01, 2017
AB MYLAN EQ 20MG BASE A078936 001 Aug 02, 2015
AB EQ 40MG BASE A078936 002 Aug 03, 2015
AB SUN PHARM EQ 20MG BASE A209735 001 Apr 30, 2018
AB EQ 40MG BASE A209735 002 Apr 30, 2018
AB TORRENT EQ 20MG BASE A203636 001 Oct 19, 2015
AB EQ 40MG BASE A203636 002 Oct 19, 2015
AB ZYDUS PHARMS EQ 20MG BASE A206296 001 May 22, 2019
AB EQ 40MG BASE A206296 002 May 22, 2019
NEXIUM
AB + ASTRAZENECA EQ 20MG BASE N021153 001 Feb 20, 2001
AB +! EQ 40MG BASE N021153 002 Feb 20, 2001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-177(of 474)

ESOMEPRAZOLE MAGNESIUM
FOR SUSPENSION, DELAYED RELEASE;ORAL
ESOMEPRAZOLE MAGNESIUM
AB CIPLA EQ 10MG BASE/PACKET A211752 001 Mar 23, 2020
AB EQ 20MG BASE/PACKET A211751 001 Mar 23, 2020
AB EQ 40MG BASE/PACKET A211751 002 Mar 23, 2020
NEXIUM
AB + ASTRAZENECA EQ 10MG BASE/PACKET N022101 001 Feb 27, 2008
AB + EQ 20MG BASE/PACKET N021957 001 Oct 20, 2006
AB +! EQ 40MG BASE/PACKET N021957 002 Oct 20, 2006
+ EQ 2.5MG BASE/PACKET N021957 003 Dec 15, 2011
+ EQ 5MG BASE/PACKET N021957 004 Dec 15, 2011
ESOMEPRAZOLE MAGNESIUM; NAPROXEN
TABLET, DELAYED RELEASE;ORAL
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
AB ACTAVIS LABS FL INC EQ 20MG BASE;375MG A204470 001 Aug 24, 2022
AB EQ 20MG BASE;500MG A204470 002 Aug 24, 2022
AB AJANTA PHARMA LTD EQ 20MG BASE;375MG A213699 001 Oct 06, 2022
AB EQ 20MG BASE;500MG A213699 002 Oct 06, 2022
AB DR REDDYS EQ 20MG BASE;375MG A204206 001 Feb 18, 2020
AB EQ 20MG BASE;500MG A204206 002 Feb 18, 2020
AB MYLAN EQ 20MG BASE;375MG A204920 001 Jul 20, 2021
AB EQ 20MG BASE;500MG A204920 002 Jul 20, 2021
VIMOVO
AB + HORIZON EQ 20MG BASE;375MG N022511 002 Apr 30, 2010
AB +! EQ 20MG BASE;500MG N022511 001 Apr 30, 2010
ESOMEPRAZOLE SODIUM
INJECTABLE;INTRAVENOUS
ESOMEPRAZOLE SODIUM
AP ACCORD HLTHCARE EQ 40MG BASE/VIAL A205379 001 Sep 25, 2015
AP DEVA HOLDING AS EQ 40MG BASE/VIAL A207181 001 Mar 06, 2017
AP ! EUGIA PHARMA EQ 40MG BASE/VIAL A204657 002 Aug 10, 2016
AP GLAND PHARMA LTD EQ 20MG BASE/VIAL A203349 001 Apr 01, 2020
AP EQ 40MG BASE/VIAL A203349 002 Apr 01, 2020
AP HAINAN POLY EQ 40MG BASE/VIAL A215732 001 Feb 10, 2022
AP SUN PHARM EQ 40MG BASE/VIAL A200882 002 Mar 18, 2013
NEXIUM IV
AP +! ASTRAZENECA EQ 40MG BASE/VIAL N021689 002 Mar 31, 2005
ESTAZOLAM
TABLET;ORAL
ESTAZOLAM
AB MAYNE PHARMA 1MG A074921 001 Jul 10, 1997
AB ! 2MG A074921 002 Jul 10, 1997
AB NOVITIUM PHARMA 1MG A074826 001 Jul 03, 1997
AB 2MG A074826 002 Jul 03, 1997
AB WATSON LABS 1MG A074818 001 Aug 19, 1997
AB 2MG A074818 002 Aug 19, 1997
ESTRADIOL
CREAM;VAGINAL
ESTRACE
AB +! ALLERGAN 0.01% A086069 001 Jan 31, 1984
ESTRADIOL
AB ALVOGEN 0.01% A209767 001 Mar 05, 2018
AB MYLAN 0.01% A208788 001 Dec 29, 2017
AB PADAGIS ISRAEL 0.01% A210194 001 Jan 22, 2018
AB PRASCO LABS LLC 0.01% A212313 001 Jul 15, 2021
AB TEVA PHARMS USA 0.01% A210488 001 Mar 30, 2018
FILM, EXTENDED RELEASE;TRANSDERMAL
CLIMARA
AB + BAYER HLTHCARE 0.06MG/24HR N020375 006 May 27, 2003
ESTRADIOL
AB MYLAN TECHNOLOGIES 0.06MG/24HR A075182 005 Jul 20, 2006
CLIMARA
AB2 + BAYER HLTHCARE 0.025MG/24HR N020375 004 Mar 05, 1999
AB2 + 0.0375MG/24HR N020375 005 May 27, 2003
AB2 + 0.05MG/24HR N020375 001 Dec 22, 1994
AB2 + 0.075MG/24HR N020375 003 Mar 23, 1998
AB2 +! 0.1MG/24HR N020375 002 Dec 22, 1994
ESTRADIOL
AB2 MYLAN TECHNOLOGIES 0.025MG/24HR A075182 003 Jan 26, 2005
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-178(of 474)

ESTRADIOL
FILM, EXTENDED RELEASE;TRANSDERMAL
ESTRADIOL
AB2 0.0375MG/24HR A075182 004 Jul 20, 2006
AB2 0.05MG/24HR A075182 006 Feb 24, 2000
AB2 0.075MG/24HR A075182 002 Jan 26, 2005
AB2 0.1MG/24HR A075182 001 Feb 24, 2000
AB3 AMNEAL 0.025MG/24HR A211396 001 Sep 28, 2020
AB3 0.0375MG/24HR A211396 002 Sep 28, 2020
AB3 0.05MG/24HR A211396 003 Sep 28, 2020
AB3 0.075MG/24HR A211396 004 Sep 28, 2020
AB3 0.1MG/24HR A211396 005 Sep 28, 2020
AB3 MYLAN TECHNOLOGIES 0.025MG/24HR A206685 001 Aug 15, 2018
AB3 0.0375MG/24HR A206685 002 Aug 15, 2018
AB3 0.05MG/24HR A206685 003 Aug 15, 2018
AB3 0.075MG/24HR A206685 004 Aug 15, 2018
AB3 0.1MG/24HR A206685 005 Aug 15, 2018
MINIVELLE
AB3 + NOVEN 0.025MG/24HR N203752 005 Sep 23, 2014
AB3 + 0.0375MG/24HR N203752 001 Oct 29, 2012
AB3 + 0.05MG/24HR N203752 003 Oct 29, 2012
AB3 + 0.075MG/24HR N203752 002 Oct 29, 2012
AB3 +! 0.1MG/24HR N203752 004 Oct 29, 2012
GEL;TRANSDERMAL
DIVIGEL
AB +! VERTICAL PHARMS LLC 0.1% N022038 001 Jun 04, 2007
ESTRADIOL
AB CHEMO RESEARCH SL 0.1% A211783 001 Aug 10, 2022
GEL, METERED;TRANSDERMAL
ELESTRIN
+! MYLAN SPECIALITY LP 0.06% (0.87GM/ACTIVATION) N021813 001 Dec 15, 2006
ESTROGEL
+! ASCEND THERAPS US 0.06% (1.25GM/ACTIVATION) N021166 002 Feb 09, 2004
INSERT;VAGINAL
IMVEXXY
+ THERAPEUTICSMD INC 0.004MG N208564 001 May 29, 2018
+! 0.01MG N208564 002 May 29, 2018
INSERT, EXTENDED RELEASE;VAGINAL
ESTRING
+! PFIZER 0.0075MG/24HR N020472 001 Apr 26, 1996
SPRAY;TRANSDERMAL
EVAMIST
+! PADAGIS US 1.53MG/SPRAY N022014 001 Jul 27, 2007
SYSTEM;TRANSDERMAL
ESTRADIOL
AB1 AMNEAL 0.025MG/24HR A211293 001 Feb 04, 2019
AB1 0.0375MG/24HR A211293 002 Feb 04, 2019
AB1 0.05MG/24HR A211293 003 Feb 04, 2019
AB1 0.075MG/24HR A211293 004 Feb 04, 2019
AB1 0.1MG/24HR A211293 005 Feb 04, 2019
AB1 MYLAN TECHNOLOGIES 0.025MG/24HR A201675 001 Dec 19, 2014
AB1 0.0375MG/24HR A201675 002 Dec 19, 2014
AB1 0.05MG/24HR A201675 003 Dec 19, 2014
AB1 0.075MG/24HR A201675 004 Dec 19, 2014
AB1 0.1MG/24HR A201675 005 Dec 19, 2014
AB1 ZYDUS NOVELTECH INC 0.025MG/24HR A206241 001 Dec 01, 2022
AB1 0.0375MG/24HR A206241 002 Dec 01, 2022
AB1 0.05MG/24HR A206241 003 Dec 01, 2022
AB1 0.075MG/24HR A206241 004 Dec 01, 2022
AB1 0.1MG/24HR A206241 005 Dec 01, 2022
VIVELLE-DOT
AB1 + NOVARTIS 0.025MG/24HR N020538 009 May 03, 2002
AB1 + 0.0375MG/24HR N020538 005 Jan 08, 1999
AB1 + 0.05MG/24HR N020538 006 Jan 08, 1999
AB1 + 0.075MG/24HR N020538 007 Jan 08, 1999
AB1 +! 0.1MG/24HR N020538 008 Jan 08, 1999
MENOSTAR
+! BAYER HLTHCARE 0.014MG/24HR N021674 001 Jun 08, 2004
TABLET;ORAL
ESTRADIOL
AB BARR LABS INC 0.5MG A040197 001 Oct 22, 1997
AB 1MG A040197 002 Oct 22, 1997
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-179(of 474)

ESTRADIOL
TABLET;ORAL
ESTRADIOL
AB ! 2MG A040197 003 Oct 22, 1997
AB EPIC PHARMA 0.5MG A040275 001 Dec 29, 1998
AB 1MG A040275 002 Dec 29, 1998
AB 2MG A040275 003 Dec 29, 1998
TABLET;VAGINAL
ESTRADIOL
AB AMNEAL PHARMS 10MCG A205256 001 May 29, 2015
AB GLENMARK PHARMS LTD 10MCG A210264 001 Sep 14, 2018
AB TEVA PHARMS USA 10MCG A206388 001 Jul 21, 2017
VAGIFEM
AB +! NOVO NORDISK INC 10MCG N020908 002 Nov 25, 2009
ESTRADIOL ACETATE
INSERT, EXTENDED RELEASE;VAGINAL
FEMRING
+ MILLICENT EQ 0.05MG BASE/24HR N021367 001 Mar 20, 2003
+! EQ 0.1MG BASE/24HR N021367 002 Mar 20, 2003
ESTRADIOL CYPIONATE
INJECTABLE;INJECTION
DEPO-ESTRADIOL
! PFIZER 5MG/ML A085470 003
ESTRADIOL VALERATE
INJECTABLE;INJECTION
DELESTROGEN
AO +! PAR STERILE 10MG/ML N009402 002
PRODUCTS
AO +! 20MG/ML N009402 004
AO +! 40MG/ML N009402 003
ESTRADIOL VALERATE
AO AM REGENT 20MG/ML A090920 001 Jan 19, 2010
AO 40MG/ML A090920 002 Jan 19, 2010
AO HIKMA 10MG/ML A203723 001 Apr 21, 2020
AO 20MG/ML A203723 002 Apr 21, 2020
AO 40MG/ML A203723 003 Apr 21, 2020
ESTRADIOL; LEVONORGESTREL
FILM, EXTENDED RELEASE;TRANSDERMAL
CLIMARA PRO
+! BAYER HLTHCARE 0.045MG/24HR;0.015MG/24HR N021258 001 Nov 21, 2003
ESTRADIOL; NORETHINDRONE ACETATE
FILM, EXTENDED RELEASE;TRANSDERMAL
COMBIPATCH
+ NOVEN PHARMS INC 0.05MG/24HR;0.14MG/24HR N020870 001 Aug 07, 1998
+! 0.05MG/24HR;0.25MG/24HR N020870 002 Aug 07, 1998
TABLET;ORAL
ACTIVELLA
AB +! AMNEAL 1MG;0.5MG N020907 001 Nov 18, 1998
ESTRADIOL AND NORETHINDRONE ACETATE
AB BARR 1MG;0.5MG A079193 001 May 11, 2010
AB BRECKENRIDGE PHARM 0.5MG;0.1MG A078324 002 Jun 09, 2011
AB 1MG;0.5MG A078324 001 Apr 17, 2008
AB MYLAN LABS LTD 0.5MG;0.1MG A207261 001 Feb 10, 2017
AB 1MG;0.5MG A207261 002 Feb 10, 2017
AB NOVAST LABS 0.5MG;0.1MG A210612 001 Apr 03, 2019
AB 1MG;0.5MG A210612 002 Apr 03, 2019
AMABELZ
BX LUPIN LTD 0.5MG;0.1MG A203339 001 Jun 20, 2016
BX 1MG;0.5MG A203339 002 Jun 20, 2016
ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX
TABLET;ORAL
MYFEMBREE
+! MYOVANT SCIENCES 1MG;0.5MG;40MG N214846 001 May 26, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-180(of 474)

ESTRADIOL; NORGESTIMATE
TABLET;ORAL
ESTRADIOL AND NORGESTIMATE
! BARR 1MG,1MG;N/A,0.09MG A076812 001 Apr 29, 2005
ESTRADIOL; PROGESTERONE
CAPSULE;ORAL
BIJUVA
+! MAYNE PHARMA 1MG;100MG N210132 001 Oct 28, 2018
ESTRAMUSTINE PHOSPHATE SODIUM
CAPSULE;ORAL
EMCYT
+! PHARMACIA AND EQ 140MG PHOSPHATE N018045 001
UPJOHN
ESTROGENS, CONJUGATED
CREAM;TOPICAL, VAGINAL
PREMARIN
+! WYETH PHARMS 0.625MG/GM N020216 001
INJECTABLE;INJECTION
PREMARIN
+! WYETH PHARMS 25MG/VIAL N010402 001
TABLET;ORAL
PREMARIN
+ WYETH PHARMS 0.3MG N004782 003
+ 0.45MG N004782 006 Jul 16, 2003
+! 0.625MG N004782 004
+! 0.9MG N004782 005 Jan 26, 1984
+! 1.25MG N004782 001
ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE
TABLET;ORAL-28
PREMPHASE 14/14
+! WYETH PHARMS 0.625MG,0.625MG;N/A,5MG N020527 002 Nov 17, 1995
PREMPRO
+! WYETH PHARMS 0.3MG;1.5MG N020527 005 Jun 04, 2003
+! 0.45MG;1.5MG N020527 004 Mar 12, 2003
+! 0.625MG;2.5MG N020527 001 Nov 17, 1995
+! 0.625MG;5MG N020527 003 Jan 09, 1998
ESTROGENS, ESTERIFIED
TABLET;ORAL
MENEST
MONARCH PHARMS 0.3MG A084951 001
0.625MG A084948 001
1.25MG A084950 001
! 2.5MG A084949 001
ESTROPIPATE
TABLET;ORAL
OGEN 5
+ PFIZER 6MG A083220 004
ESZOPICLONE
TABLET;ORAL
ESZOPICLONE
AB AUROBINDO PHARMA 1MG A208451 001 Sep 15, 2016
AB 2MG A208451 002 Sep 15, 2016
AB 3MG A208451 003 Sep 15, 2016
AB DR REDDYS 1MG A091024 001 Apr 15, 2014
AB 2MG A091024 002 Apr 15, 2014
AB 3MG A091024 003 Apr 15, 2014
AB GLENMARK GENERICS 1MG A091166 001 Apr 15, 2014
AB 2MG A091166 002 Apr 15, 2014
AB 3MG A091166 003 Apr 15, 2014
AB LUPIN LTD 1MG A091124 001 Sep 13, 2011
AB 2MG A091124 002 Sep 13, 2011
AB 3MG A091124 003 Sep 13, 2011
AB MACLEODS PHARMS LTD 1MG A202929 001 Jan 30, 2015
AB 2MG A202929 002 Jan 30, 2015
AB 3MG A202929 003 Jan 30, 2015
AB MYLAN PHARMS INC 1MG A091151 001 Mar 26, 2013
AB 2MG A091151 002 Mar 26, 2013
AB 3MG A091151 003 Mar 26, 2013
AB ORBION PHARMS 1MG A091113 001 Jun 10, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-181(of 474)

ESZOPICLONE
TABLET;ORAL
ESZOPICLONE
AB 2MG A091113 002 Jun 10, 2014
AB 3MG A091113 003 Jun 10, 2014
AB SUN PHARM 1MG A091103 001 Apr 03, 2013
AB 2MG A091103 002 Apr 03, 2013
AB 3MG A091103 003 Apr 03, 2013
AB TEVA 1MG A091169 001 May 23, 2011
AB 2MG A091169 002 May 23, 2011
AB 3MG A091169 003 May 23, 2011
LUNESTA
AB + WOODWARD 1MG N021476 001 Dec 15, 2004
AB + 2MG N021476 002 Dec 15, 2004
AB +! 3MG N021476 003 Dec 15, 2004
ETELCALCETIDE
SOLUTION;INTRAVENOUS
PARSABIV
+! KAI PHARMS INC 2.5MG/0.5ML (2.5MG/0.5ML) N208325 001 Feb 07, 2017
+! 5MG/ML (5MG/ML) N208325 002 Feb 07, 2017
+! 10MG/2ML (5MG/ML) N208325 003 Feb 07, 2017
ETEPLIRSEN
SOLUTION;INTRAVENOUS
EXONDYS 51
+! SAREPTA THERAPS INC 100MG/2ML (50MG/ML) N206488 001 Sep 19, 2016
+! 500MG/10ML (50MG/ML) N206488 002 Sep 19, 2016
ETHACRYNATE SODIUM
INJECTABLE;INJECTION
EDECRIN
AP +! BAUSCH EQ 50MG BASE/VIAL N016093 001
ETHACRYNATE SODIUM
AP MYLAN INSTITUTIONAL EQ 50MG BASE/VIAL A204634 001 Aug 23, 2016
AP PAR STERILE EQ 50MG BASE/VIAL A205473 001 Jul 29, 2015
PRODUCTS
AP VPI PHARMS INC EQ 50MG BASE/VIAL A208663 001 Jun 09, 2020
AP ZYDUS PHARMS EQ 50MG BASE/VIAL A207758 001 Nov 17, 2017
ETHACRYNIC ACID
TABLET;ORAL
EDECRIN
AB +! BAUSCH 25MG N016092 001
ETHACRYNIC ACID
AB AGNITIO 25MG A211809 001 Jul 12, 2019
AB AMNEAL PHARMS CO 25MG A208805 001 May 08, 2018
AB EDENBRIDGE PHARMS 25MG A205609 001 Jun 30, 2016
AB HIKMA 25MG A207262 001 Feb 23, 2017
AB LUPIN LTD 25MG A211719 001 Sep 06, 2019
AB PAR PHARM INC 25MG A208501 001 Jul 21, 2017
AB SCIEGEN PHARMS INC 25MG A211232 001 Aug 27, 2019
AB STRIDES PHARMA 25MG A213240 001 Oct 19, 2020
AB UPSHER SMITH LABS 25MG A212417 001 Feb 19, 2020
ETHAMBUTOL HYDROCHLORIDE
TABLET;ORAL
ETHAMBUTOL HYDROCHLORIDE
AB AKORN 100MG A075095 001 Nov 30, 1999
AB 400MG A075095 002 Nov 30, 1999
AB LUPIN 100MG A078939 001 Jun 17, 2009
AB 400MG A078939 002 Jun 17, 2009
MYAMBUTOL
AB + STI PHARMA LLC 100MG N016320 001
AB +! 400MG N016320 003
ETHANOLAMINE OLEATE
INJECTABLE;INJECTION
ETHAMOLIN
+! QOL MEDCL 50MG/ML N019357 001 Dec 22, 1988
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-182(of 474)

ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE


TABLET;ORAL-28
ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL
AB MYLAN LABS LTD 0.035MG;1MG A204703 001 Jul 28, 2016
AB 0.05MG;1MG A204704 001 Feb 09, 2016
KELNOR
AB BARR 0.035MG;1MG A076785 001 May 23, 2005
LO-MALMOREDE
AB NOVAST LABS 0.035MG;1MG A209548 001 Feb 11, 2019
MALMOREDE
AB NOVAST LABS 0.05MG;1MG A209547 001 Jul 25, 2018
ZOVIA 1/50E-28
AB ! WATSON LABS 0.05MG;1MG A072723 001 Dec 30, 1991
ETHINYL ESTRADIOL; ETONOGESTREL
RING;VAGINAL
ELURYNG
AB AMNEAL 0.015MG/24HR;0.12MG/24HR A210830 001 Dec 11, 2019
ETHINYL ESTRADIOL; ETONOGESTREL
AB TEVA PHARMS USA INC 0.015MG/24HR;0.12MG/24HR A204305 001 Jan 13, 2021
HALOETTE
AB MAYNE PHARMA 0.015MG/24HR;0.12MG/24HR A211328 001 Aug 05, 2022
NUVARING
AB +! ORGANON USA ORGANON 0.015MG/24HR;0.12MG/24HR N021187 001 Oct 03, 2001
ETHINYL ESTRADIOL; LEVONORGESTREL
SYSTEM;TRANSDERMAL
TWIRLA
+! AGILE 0.03MG/24HR;0.12MG/24HR N204017 001 Feb 14, 2020
TABLET;ORAL
ASHLYNA
AB GLENMARK GENERICS 0.03MG,0.01MG;0.15MG,N/A A203163 001 Feb 23, 2015
DAYSEE
AB LUPIN LTD 0.03MG,0.01MG;0.15MG,N/A A091467 001 Apr 10, 2013
DOLISHALE
AB NOVAST LABS 0.02MG;0.09MG A091692 001 Oct 22, 2020
ICLEVIA
AB AUROBINDO PHARMA 0.03MG;0.15MG A206850 001 Jun 29, 2018
LTD
INTROVALE
AB XIROMED 0.03MG;0.15MG A079064 001 Sep 27, 2010
JAIMIESS
AB XIROMED 0.03MG,0.01MG;0.15MG,N/A A203770 001 Dec 27, 2017
LEVONORGESTREL AND ETHINYL ESTRADIOL
AB AMNEAL PHARMS 0.03MG;0.15MG A203871 001 Nov 13, 2015
AB 0.03MG,0.01MG;0.15MG,N/A A203872 001 Dec 22, 2015
AB GLENMARK GENERICS 0.02MG;0.09MG A202791 001 Apr 09, 2015
AB GLENMARK PHARMS LTD 0.03MG;0.15MG A203164 001 Jun 12, 2015
AB LUPIN LTD 0.03MG;0.15MG A091440 001 Oct 23, 2012
AB MYLAN LABS LTD 0.03MG;0.15MG A200490 001 Apr 21, 2015
AB ! WATSON LABS 0.02MG;0.09MG A079218 001 Jun 06, 2011
LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL
AB LUPIN LTD 0.02MG,0.1MG;0.01MG,N/A A091674 001 Oct 26, 2011
AB MAYNE PHARMA 0.03MG,0.01MG;0.15MG,N/A A078834 001 May 31, 2011
AB MYLAN LABS LTD 0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.1 A206053 001 Oct 02, 2017
5MG;0.01MG,N/A
AB 0.02MG,0.1MG;0.01MG,N/A A200493 001 Jun 17, 2015
AB 0.03MG,0.01MG;0.15MG,N/A A200492 001 May 27, 2015
AB XIROMED 0.02MG,0.1MG;0.01MG,N/A A205131 001 Dec 14, 2017
LO SIMPESSE
AB AUROBINDO PHARMA 0.02MG,0.1MG;0.01MG,N/A A206852 001 Apr 28, 2017
LOSEASONIQUE
AB TEVA BRANDED PHARM 0.02MG,0.1MG;0.01MG,N/A N022262 001 Oct 24, 2008
QUARTETTE
AB +! TEVA BRANDED PHARM 0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.1 N204061 001 Mar 28, 2013
5MG;0.01MG,N/A
QUASENSE
AB WATSON LABS 0.03MG;0.15MG A077101 001 Sep 06, 2006
SEASONALE
AB +! TEVA BRANDED PHARM 0.03MG;0.15MG N021544 001 Sep 05, 2003
SEASONIQUE
AB +! TEVA BRANDED PHARM 0.03MG,0.01MG;0.15MG,N/A N021840 001 May 25, 2006
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-183(of 474)

ETHINYL ESTRADIOL; LEVONORGESTREL


TABLET;ORAL
SETLAKIN
AB NOVAST LABS 0.03MG;0.15MG A090716 001 Sep 15, 2014
SIMPESSE
AB AUROBINDO PHARMA 0.03MG,0.01MG;0.15MG,N/A A206851 001 Apr 07, 2017
BALCOLTRA
+! AVION PHARMS 0.02MG;0.1MG N208612 001 Jan 09, 2018
TYBLUME
+! EXELTIS USA INC 0.02MG;0.1MG N209405 001 Mar 30, 2020
TABLET;ORAL-28
ALTAVERA
AB XIROMED 0.03MG;0.15MG A079102 001 Aug 03, 2010
AYUNA
AB AUROBINDO PHARMA 0.03MG;0.15MG A206866 001 Sep 23, 2016
ENPRESSE-28
AB DURAMED PHARMS BARR 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 A075809 002 Jul 16, 2001
25MG
KURVELO
AB LUPIN LTD 0.03MG;0.15MG A091408 001 Oct 17, 2012
LEVONEST
AB NOVAST LABS LTD 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 A090719 001 Dec 29, 2010
25MG
LEVONORGESTREL AND ETHINYL ESTRADIOL
AB AMNEAL PHARMS 0.03MG;0.15MG A201095 001 Dec 08, 2014
AB MYLAN LABS LTD 0.03MG;0.15MG A091663 001 Dec 21, 2012
AB NAARI PTE LTD 0.03MG;0.15MG A207033 001 Oct 09, 2020
LEVORA 0.15/30-28
AB ! MAYNE PHARMA 0.03MG;0.15MG A073594 001 Dec 13, 1993
MARLISSA
AB GLENMARK GENERICS 0.03MG;0.15MG A091452 001 Feb 29, 2012
MYZILRA
AB VINTAGE PHARMS LLC 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 A077502 001 Nov 23, 2011
25MG
PORTIA-28
AB BARR 0.03MG;0.15MG A075866 002 May 23, 2002
TRIVORA-28
AB ! MAYNE PHARMA 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 A074538 002 Dec 18, 1997
25MG
AFIRMELLE
AB1 AUROBINDO PHARMA 0.02MG;0.1MG A206886 001 Nov 14, 2016
AVIANE-28
AB1 DURAMED PHARMS BARR 0.02MG;0.1MG A075796 001 Apr 30, 2001
FALMINA
AB1 NOVAST LABS LTD 0.02MG;0.1MG A090721 001 Mar 28, 2012
LEVONORGESTREL AND ETHINYL ESTRADIOL
AB1 AMNEAL PHARMS 0.02MG;0.1MG A201108 001 Feb 05, 2014
AB1 LUPIN LTD 0.02MG;0.1MG A091425 001 Jan 18, 2013
AB1 ! MAYNE PHARMA 0.02MG;0.1MG A076625 001 Nov 18, 2004
AB1 MYLAN LABS LTD 0.02MG;0.1MG A200245 001 Oct 09, 2013
AB1 NAARI PTE LTD 0.02MG;0.1MG A207065 001 Aug 17, 2020
VIENVA
AB1 XIROMED 0.02MG;0.1MG A201088 001 May 21, 2015
LESSINA-28
AB2 BARR 0.02MG;0.1MG A075803 002 Mar 20, 2002
LEVONORGESTREL AND ETHINYL ESTRADIOL
AB2 ! MAYNE PHARMA 0.02MG;0.1MG A077681 001 May 31, 2006
BX LUPIN LTD 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 A200248 001 Nov 19, 2015
25MG
ETHINYL ESTRADIOL; NORELGESTROMIN
FILM, EXTENDED RELEASE;TRANSDERMAL
ETHINYL ESTRADIOL AND NORELGESTROMIN
AB AMNEAL 0.035MG/24HR;0.15MG/24HR A213950 001 Feb 25, 2021
ONSURA
AB TEVA PHARMS USA 0.035MG/24HR;0.15MG/24HR A213977 001 Aug 25, 2021
XULANE
AB ! MYLAN TECHNOLOGIES 0.035MG/24HR;0.15MG/24HR A200910 001 Apr 16, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-184(of 474)

ETHINYL ESTRADIOL; NORETHINDRONE


TABLET;ORAL
NEXESTA FE
AB AUROBINDO PHARMA 0.035MG;0.4MG A207535 001 Feb 02, 2017
NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
AB AMNEAL PHARMS 0.035MG;0.4MG A078892 001 Sep 26, 2011
AB BARR 0.035MG;0.4MG A078965 001 Aug 05, 2010
AB LUPIN LTD 0.035MG;0.4MG A091332 001 Mar 23, 2016
AB ! MYLAN LABS LTD 0.035MG;0.4MG A202086 001 Apr 01, 2015
AB NAARI PTE LTD 0.035MG;0.4MG A207066 001 Mar 29, 2017
TABLET;ORAL-21
NORTREL 1/35-21
AB BARR 0.035MG;1MG A072693 001 Feb 28, 1992
NORTREL 7/7/7
BARR 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M A075478 001 Aug 30, 2002
G
TABLET;ORAL-28
ALYACEN 1/35
AB GLENMARK GENERICS 0.035MG;1MG A091634 001 Jan 19, 2012
ALYACEN 7/7/7
AB GLENMARK GENERICS 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M A091636 001 Jan 19, 2012
G
ARANELLE
AB BARR 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG A076783 001 Sep 29, 2004
BALZIVA-28
AB ! BARR 0.035MG;0.4MG A076238 001 Apr 22, 2004
BRIELLYN
AB GLENMARK GENERICS 0.035MG;0.4MG A090538 001 Mar 22, 2011
CYONANZ
AB AUROBINDO PHARMA 0.035MG;0.5MG A207055 001 Oct 21, 2016
DASETTA 1/35
AB NOVAST LABS LTD 0.035MG;1MG A090948 001 Dec 22, 2011
DASETTA 7/7/7
AB ! NOVAST LABS LTD 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M A090946 001 Dec 22, 2011
G
GILDAGIA
AB VINTAGE PHARMS 0.035MG;0.4MG A078376 001 Nov 06, 2012
NORETHINDRONE AND ETHINYL ESTRADIOL
AB NAARI PTE LTD 0.035MG;1MG A206864 001 Apr 28, 2017
AB WATSON LABS 0.035MG;0.4MG A078323 001 Feb 04, 2010
AB WATSON LABS TEVA 0.035MG;1MG A070687 001 Jan 29, 1987
NORTREL 0.5/35-28
AB BARR 0.035MG;0.5MG A072695 001 Feb 28, 1992
NORTREL 1/35-28
AB ! BARR 0.035MG;1MG A072696 001 Feb 28, 1992
NORTREL 7/7/7
AB BARR 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M A075478 002 Aug 30, 2002
G
NYLIA 1/35
AB AUROBINDO PHARMA 0.035MG;1MG A207056 001 Oct 21, 2016
NYLIA 7/7/7
AB AUROBINDO PHARMA 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M A207054 001 Oct 21, 2016
G
PHILITH
AB NOVAST LABS LTD 0.035MG;0.4MG A090947 001 Dec 22, 2011
RHUZDAH
AB AUROBINDO PHARMA 0.035MG;0.4MG A207585 001 Oct 11, 2022
TRI-NORINYL 28-DAY
AB +! MAYNE PHARMA 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG N018977 002 Apr 13, 1984
VYFEMLA
AB LUPIN LTD 0.035MG;0.4MG A201886 001 Sep 26, 2013
WERA
AB ! NOVAST LABS LTD 0.035MG;0.5MG A091204 001 Mar 27, 2012
PIRMELLA 1/35
BX LUPIN LTD 0.035MG;1MG A201512 001 Apr 24, 2013
PIRMELLA 7/7/7
BX LUPIN LTD 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M A201510 001 Apr 24, 2013
G
NORETHINDRONE AND ETHINYL ESTRADIOL (10/11)
WATSON LABS TEVA 0.035MG,0.035MG;0.5MG,1MG A071044 001 Apr 01, 1988
TABLET, CHEWABLE;ORAL
KAITLIB FE
AB LUPIN LTD 0.025MG;0.8MG A203448 001 Dec 17, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-185(of 474)

ETHINYL ESTRADIOL; NORETHINDRONE


TABLET, CHEWABLE;ORAL
NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
AB +! APIL 0.025MG;0.8MG N022573 001 Dec 22, 2010
AB MYLAN LABS LTD 0.025MG;0.8MG A203371 001 Apr 23, 2014
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
CAPSULE;ORAL
GEMMILY
AB XIROMED 0.02MG;1MG A213317 001 Nov 09, 2020
MERZEE
AB SLAYBACK PHARMA LLC 0.02MG;1MG A212706 001 Dec 18, 2020
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
AB AMNEAL PHARMS 0.02MG;1MG A214292 001 Jul 20, 2021
AB GLENMARK PHARMS LTD 0.02MG;1MG A213418 001 Jul 27, 2022
TAYTULLA
AB +! APIL 0.02MG;1MG N204426 001 Apr 19, 2013
TABLET;ORAL
AUROVELA 24 FE
AB AUROBINDO PHARMA 0.02MG;1MG A207504 001 Jun 15, 2017
BLISOVI 24 FE
AB LUPIN LTD 0.02MG;1MG A091398 001 Oct 28, 2015
FINZALA
AB TEVA PHARMS USA INC 0.02MG;1MG A210087 001 Apr 07, 2020
FYAVOLV
AB LUPIN LTD 0.005MG;1MG A204213 002 Dec 10, 2015
AB 0.0025MG;0.5MG A204213 001 Dec 10, 2015
GILDESS 24 FE
AB VINTAGE PHARMS 0.02MG;1MG A090293 001 Dec 01, 2014
LARIN 24 FE
AB NOVAST LABS 0.02MG;1MG A202994 001 Feb 18, 2015
LERIBANE
AB NOVAST LABS 0.0025MG;0.5MG A203435 002 Jun 03, 2016
AB 0.005MG;1MG A203435 001 Jun 03, 2016
MIBELAS 24 FE
AB LUPIN 0.02MG;1MG A206287 001 May 24, 2016
MINASTRIN 24 FE
AB +! APIL 0.02MG;1MG N203667 001 May 08, 2013
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
AB ! BARR LABS INC 0.005MG;1MG A076221 001 Nov 06, 2009
AB GLENMARK GENERICS 0.0025MG;0.5MG A203038 001 Apr 02, 2015
AB 0.005MG;1MG A203038 002 Apr 02, 2015
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
AB BARR LABS INC 0.02MG;1MG A090938 001 Dec 01, 2014
AB ! GLENMARK PHARMS LTD 0.02MG;1MG A204847 001 Nov 17, 2017
AB 0.02MG;1MG A210369 001 Dec 26, 2017
AB XIROMED 0.02MG;1MG A209609 001 Jul 16, 2018
LO LOESTRIN FE
+! APIL 0.01MG,0.01MG;1MG,N/A N022501 001 Oct 21, 2010
TABLET;ORAL-21
AUROVELA 1.5/30
AB AUROBINDO PHARMA 0.03MG;1.5MG A207581 001 Jun 26, 2017
AUROVELA 1/20
AB AUROBINDO PHARMA 0.02MG;1MG A207506 001 Jun 16, 2017
HAILEY 1.5/30
AB GLENMARK PHARMS 0.03MG;1.5MG A209297 001 Jun 05, 2018
JUNEL 1.5/30
AB BARR 0.03MG;1.5MG A076381 001 May 30, 2003
JUNEL 1/20
AB BARR 0.02MG;1MG A076380 001 May 30, 2003
LARIN 1.5/30
AB NOVAST LABS 0.03MG;1.5MG A202996 001 Mar 20, 2014
LARIN 1/20
AB NOVAST LABS 0.02MG;1MG A202995 001 Dec 04, 2013
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
AB GLENMARK PHARMS LTD 0.02MG;1MG A206969 001 Jan 20, 2016
AB MYLAN LABS LTD 0.02MG;1MG A202771 001 Nov 06, 2013
AB 0.03MG;1.5MG A202770 001 Feb 19, 2015
TRI-LEGEST 21
BARR 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG A076405 001 Oct 26, 2007
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-186(of 474)

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE


TABLET;ORAL-28
AUROVELA FE 1.5/30
AB AUROBINDO PHARMA 0.03MG;1.5MG A207580 001 Jun 15, 2017
AUROVELA FE 1/20
AB AUROBINDO PHARMA 0.02MG;1MG A207505 001 Jun 16, 2017
BLISOVI FE 1/20
AB LUPIN LTD 0.02MG;1MG A201584 001 Nov 18, 2015
CHABELINA FE
AB ! NOVAST LABS 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG A202962 001 Apr 15, 2020
HAILEY FE 1.5/30
AB GLENMARK PHARMS 0.03MG;1.5MG A209031 001 Jun 05, 2018
HAILEY FE 1/20
AB GLENMARK PHARMS LTD 0.02MG;1MG A206597 001 Nov 21, 2017
JUNEL FE 1.5/30
AB ! BARR 0.03MG;1.5MG A076064 001 Sep 18, 2003
JUNEL FE 1/20
AB BARR 0.02MG;1MG A076081 001 Sep 18, 2003
LARIN FE 1.5/30
AB NOVAST LABS 0.03MG;1.5MG A091453 001 Aug 23, 2013
LARIN FE 1/20
AB NOVAST LABS 0.02MG;1MG A091454 001 Aug 26, 2013
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
AB MYLAN 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG A205069 001 Jun 22, 2018
AB MYLAN LABS LTD 0.02MG;1MG A202772 001 Nov 14, 2013
AB 0.03MG;1.5MG A202741 001 Feb 20, 2015
TRI-LEGEST FE
AB BARR 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG A076105 001 Oct 26, 2007
BLISOVI FE 1.5/30
BX LUPIN LTD 0.03MG;1.5MG A201585 001 Nov 18, 2015
ETHINYL ESTRADIOL; NORGESTIMATE
TABLET;ORAL-28
ESTARYLLA
AB XIROMED 0.035MG;0.25MG A090794 001 Jan 30, 2013
MILI
AB AUROBINDO PHARMA 0.035MG;0.25MG A205449 001 Jul 07, 2016
LTD
MONO-LINYAH
AB NOVAST LABS LTD 0.035MG;0.25MG A090523 001 May 23, 2012
NORGESTIMATE AND ETHINYL ESTRADIOL
AB AMNEAL PHARMS 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, A203870 001 Nov 12, 2015
0.25MG
AB 0.035MG;0.25MG A203865 001 Oct 27, 2015
AB 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG, A203873 001 May 12, 2016
0.25MG
AB ! GLENMARK GENERICS 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, A200494 001 Jun 17, 2011
0.25MG
AB 0.035MG;0.25MG A200538 001 Apr 05, 2012
AB ! GLENMARK PHARMS 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG, A204057 001 Feb 23, 2016
0.25MG
AB LUPIN LTD 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, A205588 001 Apr 26, 2016
0.25MG
AB 0.035MG;0.25MG A205630 001 Oct 27, 2016
AB LUPIN PHARMS 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG, A200541 001 Jun 25, 2012
0.25MG
AB NAARI PTE LTD 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, A200383 001 Apr 07, 2015
0.25MG
AB 0.035MG;0.25MG A200384 001 Apr 07, 2015
PREVIFEM
AB VINTAGE PHARMS LLC 0.035MG;0.25MG A076334 001 Jan 09, 2004
SPRINTEC
AB ! BARR 0.035MG;0.25MG A075804 001 Sep 25, 2002
TRI LO SPRINTEC
AB BARR LABS INC 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG, A076784 001 Jun 29, 2009
0.25MG
TRI-ESTARYLLA
AB XIROMED 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, A090793 001 Jan 30, 2013
0.25MG
TRI-LINYAH
AB NOVAST LABS LTD 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, A090524 001 May 30, 2012
0.25MG
TRI-LO-ESTARYLLA
AB XIROMED 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG, A091232 001 Jun 29, 2015
0.25MG
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-187(of 474)

ETHINYL ESTRADIOL; NORGESTIMATE


TABLET;ORAL-28
TRI-LO-LINYAH
AB NOVAST LABS 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG, A090541 001 Sep 02, 2022
0.25MG
TRI-LO-MILI
AB AUROBINDO PHARMA 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG, A205762 001 Nov 04, 2016
0.25MG
TRI-MILI
AB AUROBINDO PHARMA 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, A205441 001 Jul 06, 2016
LTD 0.25MG
TRI-SPRINTEC
AB BARR 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, A075808 001 Dec 29, 2003
0.25MG
ETHINYL ESTRADIOL; NORGESTREL
TABLET;ORAL-21
CRYSELLE
AB DURAMED PHARMS BARR 0.03MG;0.3MG A075840 001 Nov 30, 2001
TABLET;ORAL-28
CRYSELLE
AB ! DURAMED PHARMS BARR 0.03MG;0.3MG A075840 002 Nov 30, 2001
ELINEST
AB NOVAST LABS LTD 0.03MG;0.3MG A091105 001 Mar 28, 2012
LOW-OGESTREL-28
AB MAYNE PHARMA 0.03MG;0.3MG A075288 002 Jul 28, 1999
ETHINYL ESTRADIOL; SEGESTERONE ACETATE
RING;VAGINAL
ANNOVERA
+! THERAPEUTICSMD INC 0.013MG/24HR;0.15MG/24HR N209627 001 Aug 10, 2018
ETHIODIZED OIL
OIL;INTRALYMPHATIC, INTRAUTERINE
LIPIODOL
+! GUERBET EQ 4.8GM IODINE/10ML (EQ 480MG N009190 001
IODINE/ML)
ETHIONAMIDE
TABLET;ORAL
TRECATOR
+! WYETH PHARMS 250MG N013026 002
ETHOSUXIMIDE
CAPSULE;ORAL
ETHOSUXIMIDE
AB AKORN 250MG A040686 001 May 28, 2008
AB BIONPHARMA INC 250MG A040430 001 Oct 28, 2002
AB HERITAGE PHARMS INC 250MG A200892 001 Sep 25, 2012
AB PURACAP PHARM LLC 250MG A210654 001 Mar 16, 2020
AB STRIDES PHARMA 250MG A211928 001 Feb 19, 2019
ZARONTIN
AB +! PARKE DAVIS 250MG N012380 001
SYRUP;ORAL
ETHOSUXIMIDE
AA MIKART 250MG/5ML A040506 001 Dec 22, 2003
AA PHARM ASSOC 250MG/5ML A040253 001 Nov 22, 2000
ZARONTIN
AA +! PARKE-DAVIS 250MG/5ML A080258 001
ETODOLAC
CAPSULE;ORAL
ETODOLAC
AB ANI PHARMS 200MG A075126 001 Sep 16, 1999
AB 300MG A075126 002 Sep 16, 1999
AB APOTEX 200MG A075419 001 Jul 28, 2000
AB 300MG A075419 002 Jul 28, 2000
AB TARO 200MG A075078 001 Apr 30, 1998
AB ! 300MG A075078 002 Apr 30, 1998
TABLET;ORAL
ETODOLAC
AB AMNEAL PHARMS CO 400MG A208834 001 Jun 07, 2018
AB 500MG A208834 002 Jun 07, 2018
AB APOTEX INC 400MG A076004 001 Dec 03, 2002
AB 500MG A076004 002 Dec 03, 2002
AB BAYSHORE PHARMS LLC 400MG A210704 001 Dec 16, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-188(of 474)

ETODOLAC
TABLET;ORAL
ETODOLAC
AB 500MG A210704 002 Dec 16, 2020
AB EDENBRIDGE PHARMS 400MG A209888 001 Nov 30, 2018
AB 500MG A209888 002 Nov 30, 2018
AB SANDOZ 400MG A074903 001 Apr 11, 1997
AB 500MG A074903 002 Apr 19, 1999
AB TARO PHARM INDS 400MG A075074 001 Mar 11, 1998
AB ! 500MG A075074 002 Apr 25, 2000
TABLET, EXTENDED RELEASE;ORAL
ETODOLAC
AB BAYSHORE PHARMS LLC 400MG A212263 001 Nov 24, 2020
AB 500MG A212263 002 Nov 24, 2020
AB 600MG A212263 003 Nov 24, 2020
AB TARO 400MG A076174 001 Mar 13, 2003
AB 500MG A076174 002 Mar 13, 2003
AB 600MG A076174 003 Mar 13, 2003
AB TEVA 400MG A075665 003 Feb 05, 2001
AB 500MG A075665 002 Jul 31, 2000
AB ! 600MG A075665 001 Jul 31, 2000
AB ZYDUS PHARMS 400MG A091134 001 Jan 23, 2014
AB 500MG A091134 002 Jan 23, 2014
AB 600MG A091134 003 Jan 23, 2014
ETOMIDATE
INJECTABLE;INJECTION
AMIDATE
AP +! HOSPIRA 2MG/ML N018227 001 Sep 07, 1982
ETOMIDATE
AP CAPLIN 2MG/ML A215028 001 Dec 18, 2020
AP EMCURE PHARMS LTD 2MG/ML A204618 001 Aug 13, 2014
AP EUGIA PHARMA 2MG/ML A206126 001 Feb 24, 2017
AP GLAND PHARMA LTD 2MG/ML A209058 001 Apr 18, 2017
AP HIKMA 2MG/ML A074593 001 Nov 04, 1996
AP 2MG/ML A202354 001 Feb 25, 2016
AP MYLAN LABS LTD 2MG/ML A201044 001 Feb 07, 2017
AP ZYDUS PHARMS 2MG/ML A202360 001 Jul 18, 2014
ETONOGESTREL
IMPLANT;IMPLANTATION
NEXPLANON
+! ORGANON 68MG/IMPLANT N021529 002 May 31, 2011
ETOPOSIDE
CAPSULE;ORAL
ETOPOSIDE
! MYLAN 50MG A075635 001 Sep 19, 2001
INJECTABLE;INJECTION
ETOPOSIDE
AP ACCORD HLTHCARE 20MG/ML A074513 001 Mar 14, 1996
AP ! FRESENIUS KABI USA 20MG/ML A074983 001 Sep 30, 1998
AP HIKMA 20MG/ML A074290 001 Jul 17, 1995
AP TEVA PHARMS USA 20MG/ML A074529 001 Jul 24, 1996
ETOPOSIDE PHOSPHATE
INJECTABLE;INJECTION
ETOPOPHOS PRESERVATIVE FREE
+! CHEPLAPHARM EQ 100MG BASE/VIAL N020457 001 May 17, 1996
ETRAVIRINE
TABLET;ORAL
ETRAVIRINE
AB AMNEAL 100MG A214196 002 Jun 14, 2021
AB 200MG A214196 003 Jun 14, 2021
AB CARNEGIE 100MG A215402 001 Apr 13, 2022
AB 200MG A215402 002 Apr 13, 2022
INTELENCE
AB + JANSSEN R AND D 100MG N022187 001 Jan 18, 2008
AB +! 200MG N022187 002 Dec 22, 2010
+ 25MG N022187 003 Mar 26, 2012
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-189(of 474)

EVEROLIMUS
TABLET;ORAL
AFINITOR
AB + NOVARTIS 2.5MG N022334 003 Jul 09, 2010
AB +! 5MG N022334 001 Mar 30, 2009
AB + 7.5MG N022334 004 Mar 30, 2012
AB + 10MG N022334 002 Mar 30, 2009
EVEROLIMUS
AB ALKEM LABS LTD 0.25MG A214138 001 Nov 26, 2021
AB 0.5MG A214138 002 Nov 26, 2021
AB 0.75MG A214138 003 Nov 26, 2021
AB 1MG A214138 004 Nov 26, 2021
AB BIOCON PHARMA 2.5MG A214182 001 Feb 11, 2021
AB 5MG A214182 002 Feb 11, 2021
AB 7.5MG A214182 003 Feb 11, 2021
AB 10MG A214182 004 Feb 11, 2021
AB BRECKENRIDGE 0.25MG A205432 001 May 20, 2021
AB 0.5MG A205432 002 May 20, 2021
AB 0.75MG A205432 003 May 20, 2021
AB 2.5MG A205426 001 Mar 05, 2021
AB 5MG A205426 002 Mar 05, 2021
AB 7.5MG A205426 003 Mar 05, 2021
AB 10MG A205426 004 Mar 05, 2021
AB HIKMA 0.25MG A206133 001 Apr 12, 2018
AB 0.5MG A206133 002 Apr 12, 2018
AB 0.75MG A206133 003 Apr 12, 2018
AB 1MG A206133 004 Nov 18, 2021
AB 2.5MG A207486 001 Jun 08, 2020
AB 5MG A207486 002 Jun 08, 2020
AB 7.5MG A207486 003 Jun 08, 2020
AB 10MG A207486 004 Nov 23, 2021
AB MYLAN 2.5MG A212936 001 Jun 08, 2020
AB 5MG A212936 002 Jun 08, 2020
AB 7.5MG A212936 003 Jun 08, 2020
AB 10MG A212936 004 Jun 08, 2020
AB PAR PHARM 0.25MG A205775 001 Oct 18, 2021
AB 0.5MG A205775 002 Oct 18, 2021
AB 0.75MG A205775 003 Oct 18, 2021
AB 1MG A205775 004 Oct 18, 2021
AB 2.5MG A207934 001 Dec 09, 2019
AB 5MG A207934 002 Dec 09, 2019
AB 7.5MG A207934 003 Dec 09, 2019
AB 10MG A207934 004 Dec 09, 2020
AB TEVA PHARMS USA 2.5MG A210050 001 Dec 09, 2019
AB 5MG A210050 002 Dec 09, 2019
AB 7.5MG A210050 003 Dec 09, 2019
ZORTRESS
AB + NOVARTIS 0.25MG N021560 001 Apr 20, 2010
AB + 0.5MG N021560 002 Apr 20, 2010
AB + 0.75MG N021560 003 Apr 20, 2010
AB +! 1MG N021560 004 Aug 10, 2018
TABLET, FOR SUSPENSION;ORAL
AFINITOR DISPERZ
AB + NOVARTIS PHARM 2MG N203985 001 Aug 29, 2012
AB + 3MG N203985 002 Aug 29, 2012
AB +! 5MG N203985 003 Aug 29, 2012
EVEROLIMUS
AB MYLAN 2MG A210130 001 Apr 19, 2019
AB 3MG A210130 002 Apr 19, 2019
AB 5MG A210130 003 Apr 19, 2019
EXEMESTANE
TABLET;ORAL
AROMASIN
AB +! PFIZER 25MG N020753 001 Oct 21, 1999
EXEMESTANE
AB ALVOGEN 25MG A200898 001 Jul 28, 2014
AB BRECKENRIDGE 25MG A211031 001 Feb 21, 2019
AB CIPLA 25MG A210323 001 Apr 27, 2018
AB EUGIA PHARMA 25MG A216454 001 May 20, 2022
AB HIKMA 25MG A077431 001 Apr 01, 2011
AB QILU 25MG A213547 001 Apr 13, 2020
AB RISING 25MG A203315 001 Mar 10, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-190(of 474)

EXEMESTANE
TABLET;ORAL
EXEMESTANE
AB UPSHER SMITH LABS 25MG A209208 001 Jul 26, 2017
AB ZYDUS PHARMS 25MG A202602 001 Oct 03, 2018
EXENATIDE SYNTHETIC
INJECTABLE;SUBCUTANEOUS
BYETTA
+! ASTRAZENECA AB 300MCG/1.2ML (250MCG/ML) N021773 001 Apr 28, 2005
+! 600MCG/2.4ML (250MCG/ML) N021773 002 Apr 28, 2005
SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS
BYDUREON BCISE
+! ASTRAZENECA AB 2MG/0.85ML (2MG/0.85ML) N209210 001 Oct 20, 2017
EZETIMIBE
TABLET;ORAL
EZETIMIBE
AB ACCORD HLTHCARE 10MG A211550 001 Oct 26, 2018
AB ALKEM LABS LTD 10MG A209234 001 Dec 21, 2017
AB AMNEAL PHARMS CO 10MG A208803 001 Jun 12, 2017
AB AUROBINDO PHARMA 10MG A209838 001 Aug 25, 2017
AB GLENMARK PHARMS LTD 10MG A078560 001 Jun 26, 2015
AB HETERO LABS LTD III 10MG A210859 001 Jul 26, 2022
AB OHM LABS INC 10MG A207311 001 Jun 12, 2017
AB ORIENT PHARMA 10MG A215693 001 Sep 13, 2022
AB SANDOZ INC 10MG A203931 001 Jun 12, 2017
AB SCIEGEN PHARMS INC 10MG A210673 001 Oct 23, 2020
AB WATSON LABS INC 10MG A200831 001 Jun 12, 2017
AB ZYDUS PHARMS 10MG A204331 001 Jun 12, 2017
ZETIA
AB +! ORGANON 10MG N021445 001 Oct 25, 2002
EZETIMIBE; SIMVASTATIN
TABLET;ORAL
EZETIMIBE AND SIMVASTATIN
AB ALKEM LABS LTD 10MG;10MG A209222 001 Dec 22, 2017
AB 10MG;20MG A209222 002 Dec 22, 2017
AB 10MG;40MG A209222 003 Dec 22, 2017
AB 10MG;80MG A209222 004 Dec 22, 2017
AB AMNEAL PHARMS CO 10MG;10MG A208831 001 Nov 21, 2017
AB 10MG;20MG A208831 002 Nov 21, 2017
AB 10MG;40MG A208831 003 Nov 21, 2017
AB 10MG;80MG A208831 004 Nov 21, 2017
AB DR REDDYS LABS SA 10MG;10MG A200909 001 Apr 26, 2017
AB 10MG;20MG A200909 002 Apr 26, 2017
AB 10MG;40MG A200909 003 Apr 26, 2017
AB 10MG;80MG A200909 004 Apr 26, 2017
AB GLENMARK PHARMS LTD 10MG;10MG A208699 001 Jun 27, 2019
AB 10MG;20MG A208699 002 Jun 27, 2019
AB 10MG;40MG A208699 003 Jun 27, 2019
AB 10MG;80MG A208699 004 Jun 27, 2019
AB WATSON LABS INC 10MG;10MG A202968 001 Apr 26, 2017
AB 10MG;20MG A202968 002 Apr 26, 2017
AB 10MG;40MG A202968 003 Apr 26, 2017
AB 10MG;80MG A202968 004 Apr 26, 2017
VYTORIN
AB + ORGANON 10MG;10MG N021687 001 Jul 23, 2004
AB + 10MG;20MG N021687 002 Jul 23, 2004
AB + 10MG;40MG N021687 003 Jul 23, 2004
AB +! 10MG;80MG N021687 004 Jul 23, 2004
FAMCICLOVIR
TABLET;ORAL
FAMCICLOVIR
AB APOTEX 125MG A091480 001 Jul 22, 2011
AB 250MG A091480 002 Jul 22, 2011
AB 500MG A091480 003 Jul 22, 2011
AB AUROBINDO PHARMA 125MG A091114 001 Mar 21, 2011
LTD
AB 250MG A091114 002 Mar 21, 2011
AB 500MG A091114 003 Mar 21, 2011
AB HETERO LABS LTD V 125MG A202438 001 Sep 10, 2014
AB 250MG A202438 002 Sep 10, 2014
AB 500MG A202438 003 Sep 10, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-191(of 474)

FAMCICLOVIR
TABLET;ORAL
FAMCICLOVIR
AB MACLEODS PHARMS LTD 125MG A201022 001 Jan 12, 2012
AB 250MG A201022 002 Jan 12, 2012
AB 500MG A201022 003 Jan 12, 2012
AB TEVA PHARMS 125MG A077487 001 Aug 24, 2007
AB 250MG A077487 002 Aug 24, 2007
AB ! 500MG A077487 003 Aug 24, 2007
FAMOTIDINE
FOR SUSPENSION;ORAL
FAMOTIDINE
AB AKORN 40MG/5ML A201995 001 May 30, 2014
AB AMNEALS PHARMS 40MG/5ML A216427 001 Aug 04, 2022
AB ! LUPIN LTD 40MG/5ML A090440 001 Jun 29, 2010
AB NAVINTA LLC 40MG/5ML A091020 001 May 27, 2010
AB NOVEL LABS INC 40MG/5ML A201695 001 Dec 17, 2012
AB NOVITIUM PHARMA 40MG/5ML A215043 001 Apr 20, 2021
INJECTABLE;INJECTION
FAMOTIDINE
AP ATHENEX INC 10MG/ML A075651 001 Apr 16, 2001
AP 10MG/ML A075684 001 Apr 16, 2001
AP FRESENIUS KABI USA 10MG/ML A075709 001 Apr 16, 2001
AP ! HIKMA 10MG/ML A075488 001 Apr 16, 2001
AP MYLAN LABS LTD 10MG/ML A078641 001 Jun 25, 2008
AP ZYDUS PHARMS 10MG/ML A215828 001 Nov 22, 2022
FAMOTIDINE PRESERVATIVE FREE
AP ATHENEX INC 10MG/ML A075622 001 Apr 16, 2001
AP 10MG/ML A075825 001 Apr 17, 2001
AP FRESENIUS KABI USA 10MG/ML A075813 001 Apr 16, 2001
AP ! HIKMA 10MG/ML A075486 001 Apr 16, 2001
AP MYLAN LABS LTD 10MG/ML A078642 001 Jun 25, 2008
FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER
! BAXTER HLTHCARE 0.4MG/ML A075591 001 May 10, 2001
TABLET;ORAL
FAMOTIDINE
AB ALEMBIC PHARMS LTD 20MG A078916 001 May 22, 2009
AB 40MG A078916 002 May 22, 2009
AB ALKEM LABS LTD 20MG A215630 001 Jan 07, 2022
AB 40MG A215630 002 Jan 07, 2022
AB ANNORA PHARMA 20MG A215767 001 Nov 04, 2021
AB 40MG A215767 002 Nov 04, 2021
AB APOTEX 20MG A075611 001 Jul 23, 2001
AB 40MG A075611 002 Jul 23, 2001
AB ASCENT PHARMS INC 20MG A215689 001 Oct 15, 2021
AB 40MG A215689 002 Oct 15, 2021
AB AUROBINDO PHARMA 20MG A206530 001 Dec 22, 2015
LTD
AB ! 40MG A206530 002 Dec 22, 2015
AB CARLSBAD 20MG A075805 001 Apr 16, 2001
AB 40MG A075805 002 Apr 16, 2001
AB CELLTRION 20MG A075786 001 Apr 16, 2001
AB 40MG A075786 002 Apr 16, 2001
AB DR REDDYS LABS LTD 20MG A075718 001 Apr 16, 2001
AB 40MG A075718 002 Apr 16, 2001
AB IVAX SUB TEVA 20MG A075511 001 Apr 16, 2001
PHARMS
AB 40MG A075511 002 Apr 16, 2001
AB ZYDUS PHARMS 20MG A216441 001 Jun 03, 2022
AB 40MG A216441 002 Jun 03, 2022
FAMOTIDINE; IBUPROFEN
TABLET;ORAL
DUEXIS
AB +! HORIZON 26.6MG;800MG N022519 001 Apr 23, 2011
IBUPROFEN AND FAMOTIDINE
AB ALKEM LABS LTD 26.6MG;800MG A211890 001 Aug 03, 2021
AB TEVA PHARMS USA 26.6MG;800MG A211278 001 Oct 29, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-192(of 474)

FEBUXOSTAT
TABLET;ORAL
FEBUXOSTAT
AB ALEMBIC PHARMS 40MG A205421 001 Jul 01, 2019
AB 80MG A205421 002 Jul 01, 2019
AB ALKEM LABS LTD 40MG A212924 001 Dec 07, 2021
AB 80MG A212924 002 Dec 07, 2021
AB DR REDDYS 40MG A205374 001 Oct 22, 2020
AB 80MG A205374 002 Oct 22, 2020
AB HIKMA 40MG A205414 001 Oct 15, 2019
AB 80MG A205414 002 Oct 15, 2019
AB INDOCO 40MG A210292 001 Dec 30, 2019
AB 80MG A210292 002 Dec 30, 2019
AB MSN 40MG A210461 001 Dec 30, 2019
AB 80MG A210461 002 Dec 30, 2019
AB MYLAN 40MG A205385 001 Jul 01, 2019
AB 80MG A205385 002 Jul 01, 2019
AB PRINSTON INC 40MG A206266 001 Mar 28, 2022
AB 80MG A206266 002 Mar 28, 2022
AB SUN PHARM 40MG A205467 001 Jul 01, 2019
AB 80MG A205467 002 Jul 01, 2019
AB SUNSHINE 40MG A213069 001 Jun 02, 2020
AB 80MG A213069 002 Jun 02, 2020
AB ZYDUS PHARMS 40MG A205443 001 Jan 09, 2023
AB 80MG A205443 002 Jan 09, 2023
ULORIC
AB + TAKEDA PHARMS USA 40MG N021856 001 Feb 13, 2009
AB +! 80MG N021856 002 Feb 13, 2009
FEDRATINIB HYDROCHLORIDE
CAPSULE;ORAL
INREBIC
+! IMPACT EQ 100MG BASE N212327 001 Aug 16, 2019
FELBAMATE
SUSPENSION;ORAL
FELBAMATE
AB AMNEAL PHARMS 600MG/5ML A202385 001 Dec 16, 2011
AB NOVITIUM PHARMA 600MG/5ML A211333 001 May 31, 2019
AB TARO 600MG/5ML A206314 001 Jun 16, 2017
FELBATOL
AB +! MYLAN SPECIALITY LP 600MG/5ML N020189 003 Jul 29, 1993
TABLET;ORAL
FELBAMATE
AB ALVOGEN 400MG A204595 001 Jan 11, 2016
AB 600MG A204595 002 Jan 11, 2016
AB AMNEAL PHARMS 400MG A201680 001 Sep 13, 2011
AB 600MG A201680 002 Sep 13, 2011
AB ANI PHARMS 400MG A202284 001 Nov 04, 2015
AB 600MG A202284 002 Nov 04, 2015
AB CADILA 400MG A208970 001 May 30, 2017
AB 600MG A208970 002 May 30, 2017
AB TARO 400MG A207093 001 Apr 20, 2017
AB 600MG A207093 002 Apr 20, 2017
FELBATOL
AB + MYLAN SPECIALITY LP 400MG N020189 001 Jul 29, 1993
AB +! 600MG N020189 002 Jul 29, 1993
FELODIPINE
TABLET, EXTENDED RELEASE;ORAL
FELODIPINE
AB AUROBINDO PHARMA 2.5MG A203417 001 Jan 17, 2013
LTD
AB 5MG A203417 002 Jan 17, 2013
AB 10MG A203417 003 Jan 17, 2013
AB GLENMARK GENERICS 2.5MG A090365 001 Dec 17, 2010
AB 5MG A090365 002 Dec 17, 2010
AB 10MG A090365 003 Dec 17, 2010
AB HERITAGE PHARMS 2.5MG A201964 001 Nov 08, 2013
AB 5MG A201964 002 Nov 08, 2013
AB 10MG A201964 003 Nov 08, 2013
AB ORBION PHARMS 2.5MG A203032 001 May 21, 2015
AB 5MG A203032 002 May 21, 2015
AB 10MG A203032 003 May 21, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-193(of 474)

FELODIPINE
TABLET, EXTENDED RELEASE;ORAL
FELODIPINE
AB SUN PHARM INDS LTD 2.5MG A091200 001 Dec 13, 2013
AB 5MG A091200 002 Dec 13, 2013
AB 10MG A091200 003 Dec 13, 2013
AB SUN PHARM 2.5MG A075896 001 Nov 02, 2004
INDUSTRIES
AB 5MG A075896 002 Nov 02, 2004
AB 10MG A075896 003 Nov 02, 2004
AB TORRENT PHARMS LTD 2.5MG A202170 001 Nov 28, 2011
AB 5MG A202170 002 Nov 28, 2011
AB ! 10MG A202170 003 Nov 28, 2011
AB VINTAGE PHARMS LLC 2.5MG A200815 001 Oct 28, 2011
AB 5MG A200815 002 Oct 28, 2011
AB 10MG A200815 003 Oct 28, 2011
AB YILING 2.5MG A210847 001 Oct 26, 2018
AB 5MG A210847 002 Oct 26, 2018
AB 10MG A210847 003 Oct 26, 2018
AB YUNG SHIN PHARM 2.5MG A204800 001 Apr 29, 2019
AB 5MG A204800 002 Apr 29, 2019
AB 10MG A204800 003 Apr 29, 2019
FENFLURAMINE HYDROCHLORIDE
SOLUTION;ORAL
FINTEPLA
+! ZOGENIX INC EQ 2.2MG BASE/ML N212102 001 Jun 25, 2020
FENOFIBRATE
CAPSULE;ORAL
ANTARA (MICRONIZED)
AB + LUPIN 43MG N021695 001 Nov 30, 2004
AB +! 130MG N021695 003 Nov 30, 2004
FENOFIBRATE
AB SUN PHARM INDS LTD 43MG A201748 001 Oct 31, 2014
AB 130MG A201748 002 Oct 31, 2014
FENOFIBRATE (MICRONIZED)
AB AJANTA PHARMA LTD 67MG A210705 001 Sep 10, 2018
AB 134MG A210705 002 Sep 10, 2018
AB ! 200MG A210705 003 Sep 10, 2018
AB ALEMBIC PHARMS 67MG A213842 001 Oct 19, 2020
AB 134MG A213842 002 Oct 19, 2020
AB 200MG A213842 003 Oct 19, 2020
AB ANI PHARMS 67MG A209504 001 Apr 30, 2018
AB 134MG A209504 002 Apr 30, 2018
AB 200MG A209504 003 Apr 30, 2018
AB APOTEX 43MG A202252 001 Jul 26, 2013
AB 130MG A202252 002 Jul 26, 2013
AB AUROBINDO PHARMA 67MG A212232 001 Sep 20, 2021
LTD
AB 134MG A212232 002 Sep 20, 2021
AB 200MG A212232 003 Sep 20, 2021
AB DR REDDYS LABS SA 43MG A090859 001 Mar 01, 2012
AB 130MG A090859 002 Mar 01, 2012
AB GLENMARK PHARMS LTD 67MG A205566 001 Apr 07, 2017
AB 134MG A205566 002 Apr 07, 2017
AB 200MG A205566 003 Apr 07, 2017
AB INVAGEN PHARMS 67MG A207378 001 Mar 28, 2017
AB 134MG A207378 002 Mar 28, 2017
AB 200MG A207378 003 Mar 28, 2017
AB REYOUNG 67MG A207805 001 Nov 16, 2017
AB 134MG A207805 002 Nov 16, 2017
AB 200MG A207805 003 Nov 16, 2017
AB RHODES PHARMS 67MG A075753 001 Sep 03, 2002
AB 134MG A075753 002 Apr 09, 2002
AB 200MG A075753 003 Apr 09, 2002
AB TORRENT 67MG A210782 001 Jun 26, 2018
AB 134MG A210782 002 Jun 26, 2018
AB 200MG A210782 003 Jun 26, 2018
ANTARA (MICRONIZED)
+! LUPIN 90MG N021695 005 Oct 18, 2013
LIPOFEN
+ CIPHER PHARMS INC 50MG N021612 001 Jan 11, 2006
+! 150MG N021612 003 Jan 11, 2006
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-194(of 474)

FENOFIBRATE
TABLET;ORAL
FENOFIBRATE
AB AJANTA PHARMA LTD 54MG A210138 001 Jul 23, 2018
AB 160MG A210138 002 Jul 23, 2018
AB ALEMBIC LABS 54MG A209660 001 Feb 11, 2019
AB 160MG A209660 002 Feb 11, 2019
AB ALEMBIC PHARMS 48MG A210476 001 Aug 09, 2019
AB 145MG A210476 002 Aug 09, 2019
AB AMNEAL 48MG A209951 001 Feb 09, 2018
AB 54MG A209950 001 Mar 19, 2018
AB 145MG A209951 002 Feb 09, 2018
AB 160MG A209950 002 Mar 19, 2018
AB AUROBINDO PHARMA 48MG A205118 001 May 05, 2016
AB 54MG A216798 001 Sep 27, 2022
AB 145MG A205118 002 May 05, 2016
AB 160MG A216798 002 Sep 27, 2022
AB AUSTARPHARMA 48MG A208476 001 Feb 10, 2021
AB 54MG A207803 001 Dec 19, 2017
AB 145MG A208476 002 Feb 10, 2021
AB 160MG A207803 002 Dec 19, 2017
AB CIPLA 48MG A208709 001 Dec 15, 2016
AB 145MG A208709 002 Dec 15, 2016
AB DR REDDYS 54MG A210670 001 Sep 06, 2019
AB 160MG A210670 002 Sep 06, 2019
AB GRAVITI PHARMS 48MG A211122 001 Mar 18, 2020
AB 54MG A210606 001 Aug 17, 2018
AB 145MG A211122 002 Mar 18, 2020
AB 160MG A210606 002 Aug 17, 2018
AB HETERO LABS LTD III 48MG A204598 001 Jul 12, 2016
AB 145MG A204598 002 Jul 12, 2016
AB IMPAX LABS 54MG A076509 001 Mar 26, 2008
AB ! 160MG A076509 002 Mar 26, 2008
AB LUPIN LTD 48MG A090856 001 Dec 23, 2011
AB 54MG A204019 001 Aug 17, 2015
AB 145MG A090856 002 Dec 23, 2011
AB 160MG A204019 002 Aug 17, 2015
AB MANKIND PHARMA 54MG A213864 001 Jun 12, 2020
AB 160MG A213864 002 Jun 12, 2020
AB MYLAN 54MG A076520 001 Oct 25, 2007
AB 160MG A076520 003 Oct 25, 2007
AB MYLAN PHARMS INC 40MG A204475 001 Jun 23, 2016
AB 48MG A202856 001 Dec 07, 2012
AB 120MG A204475 002 Jun 23, 2016
AB 145MG A202856 002 Dec 07, 2012
AB PRINSTON INC 48MG A211080 001 Aug 28, 2018
AB 145MG A211080 002 Aug 28, 2018
AB RHODES PHARMS 54MG A076433 001 May 13, 2005
AB 160MG A076433 002 May 13, 2005
AB SUN PHARM 48MG A200884 001 Sep 07, 2017
AB 145MG A200884 002 Sep 07, 2017
AB SUN PHARM INDS LTD 54MG A076635 001 Oct 31, 2005
AB 160MG A076635 003 Oct 31, 2005
AB VALEANT PHARMS 48MG A090715 001 Apr 05, 2012
NORTH
AB 145MG A090715 002 Apr 05, 2012
FENOGLIDE
AB + SALIX 40MG N022118 001 Aug 10, 2007
AB +! 120MG N022118 002 Aug 10, 2007
TRICOR
AB + ABBVIE 48MG N021656 001 Nov 05, 2004
AB +! 145MG N021656 002 Nov 05, 2004
TRIGLIDE
BX + SKYEPHARMA AG 160MG N021350 002 May 07, 2005
FENOFIBRATE
SUN PHARM INDS LTD 107MG A076635 002 Oct 31, 2005
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-195(of 474)

FENOLDOPAM MESYLATE
INJECTABLE;INJECTION
CORLOPAM
AP +! HOSPIRA EQ 10MG BASE/ML N019922 001 Sep 23, 1997
FENOLDOPAM MESYLATE
AP HIKMA EQ 10MG BASE/ML A076582 001 Oct 12, 2004
AP SANDOZ INC EQ 10MG BASE/ML A077155 001 Feb 15, 2005
FENOPROFEN CALCIUM
CAPSULE;ORAL
FENOPROFEN CALCIUM
AB RISING EQ 400MG BASE A214475 001 Jul 18, 2022
NALFON
AB +! XSPIRE PHARMA EQ 400MG BASE N017604 004 Jul 21, 2009
+ EQ 200MG BASE N017604 003
TABLET;ORAL
FENOPROFEN CALCIUM
! XSPIRE PHARMA EQ 600MG BASE A072267 001 Aug 17, 1988
FENTANYL
FILM, EXTENDED RELEASE;TRANSDERMAL
FENTANYL-100
AB KINDEVA 100MCG/HR A202097 005 Nov 04, 2016
AB MYLAN TECHNOLOGIES 100MCG/HR A076258 004 Jan 28, 2005
AB SPECGX LLC 100MCG/HR A077154 004 Feb 09, 2011
FENTANYL-12
AB KINDEVA 12.5MCG/HR A202097 001 Nov 04, 2016
AB MYLAN TECHNOLOGIES 12.5MCG/HR A076258 005 Jan 23, 2007
AB SPECGX LLC 12.5MCG/HR A077154 005 Jun 11, 2015
FENTANYL-25
AB KINDEVA 25MCG/HR A202097 002 Nov 04, 2016
AB MYLAN TECHNOLOGIES 25MCG/HR A076258 001 Jan 28, 2005
AB ! SPECGX LLC 25MCG/HR A077154 001 Feb 09, 2011
FENTANYL-37
AB MYLAN TECHNOLOGIES 37.5MCG/HR A076258 006 Dec 29, 2014
AB SPECGX LLC 37.5MCG/HR A077154 006 Jan 14, 2020
FENTANYL-50
AB KINDEVA 50MCG/HR A202097 003 Nov 04, 2016
AB MYLAN TECHNOLOGIES 50MCG/HR A076258 002 Jan 28, 2005
AB SPECGX LLC 50MCG/HR A077154 002 Feb 09, 2011
FENTANYL-62
AB MYLAN TECHNOLOGIES 62.5MCG/HR A076258 007 Dec 29, 2014
AB SPECGX LLC 62.5MCG/HR A077154 007 Jan 14, 2020
FENTANYL-75
AB KINDEVA 75MCG/HR A202097 004 Nov 04, 2016
AB MYLAN TECHNOLOGIES 75MCG/HR A076258 003 Jan 28, 2005
AB SPECGX LLC 75MCG/HR A077154 003 Feb 09, 2011
FENTANYL-87
MYLAN TECHNOLOGIES 87.5MCG/HR A076258 008 Dec 29, 2014
FENTANYL CITRATE
INJECTABLE;INJECTION
FENTANYL CITRATE
AP FRESENIUS KABI USA EQ 0.05MG BASE/ML A212086 001 Sep 01, 2020
AP HOSPIRA EQ 0.05MG BASE/ML N019115 001 Jan 12, 1985
FENTANYL CITRATE PRESERVATIVE FREE
AP FRESENIUS KABI USA EQ 0.05MG BASE/ML A210762 001 May 03, 2019
AP +! HIKMA EQ 0.05MG BASE/ML N019101 001 Jul 11, 1984
AP HOSPIRA EQ 0.05MG BASE/ML A072786 001 Sep 24, 1991
SUBLIMAZE PRESERVATIVE FREE
AP +! AKORN EQ 0.05MG BASE/ML N016619 001
TABLET;BUCCAL, SUBLINGUAL
FENTORA
+ CEPHALON EQ 0.1MG BASE N021947 001 Sep 25, 2006
+ EQ 0.2MG BASE N021947 002 Sep 25, 2006
+! EQ 0.4MG BASE N021947 003 Sep 25, 2006
+ EQ 0.6MG BASE N021947 004 Sep 25, 2006
+ EQ 0.8MG BASE N021947 005 Sep 25, 2006
TROCHE/LOZENGE;TRANSMUCOSAL
ACTIQ
AB + CEPHALON EQ 0.2MG BASE N020747 001 Nov 04, 1998
AB +! EQ 0.4MG BASE N020747 002 Nov 04, 1998
AB + EQ 0.6MG BASE N020747 003 Nov 04, 1998
AB + EQ 0.8MG BASE N020747 004 Nov 04, 1998
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-196(of 474)

FENTANYL CITRATE
TROCHE/LOZENGE;TRANSMUCOSAL
ACTIQ
AB + EQ 1.2MG BASE N020747 005 Nov 04, 1998
AB + EQ 1.6MG BASE N020747 006 Nov 04, 1998
FENTANYL CITRATE
AB SPECGX LLC EQ 0.2MG BASE A078907 001 Oct 30, 2009
AB EQ 0.4MG BASE A078907 002 Oct 30, 2009
AB EQ 0.6MG BASE A078907 003 Oct 30, 2009
AB EQ 0.8MG BASE A078907 004 Oct 30, 2009
AB EQ 1.2MG BASE A078907 005 Oct 30, 2009
AB EQ 1.6MG BASE A078907 006 Oct 30, 2009
FERRIC CARBOXYMALTOSE
SOLUTION;INTRAVENOUS
INJECTAFER
+! AM REGENT 750MG IRON/15ML (50MG IRON/ML) N203565 001 Jul 25, 2013
+! 100MG IRON/2ML (50MG IRON/ML) N203565 004 Feb 04, 2022
+! 500MG IRON/10ML (50MG IRON/ML) N203565 002 Oct 08, 2020
+! 1GM IRON/20ML (50MG IRON/ML) N203565 003 Apr 28, 2021
FERRIC CITRATE
TABLET;ORAL
AURYXIA
+! KERYX BIOPHARMS EQ 210MG IRON N205874 001 Sep 05, 2014
FERRIC DERISOMALTOSE
SOLUTION;INTRAVENOUS
MONOFERRIC
+! PHARMACOSMOS AS 1GM/10ML (100MG/ML) N208171 003 Jan 16, 2020
FERRIC HEXACYANOFERRATE(II)
CAPSULE;ORAL
RADIOGARDASE (PRUSSIAN BLUE)
+! HEYL CHEMISCH 500MG N021626 001 Oct 02, 2003
FERRIC MALTOL
CAPSULE;ORAL
ACCRUFER
+! SHIELD TX 30MG IRON N212320 001 Jul 25, 2019
FERRIC OXYHYDROXIDE
INJECTABLE;INJECTION
FERRLECIT
AB +! SANOFI AVENTIS US EQ 62.5MG IRON/5ML (EQ 12.5MG IRON/ML) N020955 001 Feb 18, 1999
SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE
AB WEST-WARD PHARMS EQ 62.5MG IRON/5ML (EQ 12.5MG IRON/ML) A078215 001 Mar 31, 2011
INT
INFED
BP +! ALLERGAN EQ 100MG IRON/2ML (EQ 50MG IRON/ML) N017441 001
INJECTABLE;INTRAVENOUS
VENOFER
+ AM REGENT EQ 50MG IRON/2.5ML (EQ 20MG IRON/ML) N021135 002 Mar 20, 2005
+! EQ 100MG IRON/5ML (EQ 20MG IRON/ML) N021135 001 Nov 06, 2000
+ EQ 200MG IRON/10ML (EQ 20MG IRON/ML) N021135 004 Feb 09, 2007
TABLET, CHEWABLE;ORAL
VELPHORO
+! VIFOR FRESENIUS EQ 500MG IRON N205109 001 Nov 27, 2013
FERUMOXYTOL
SOLUTION;INTRAVENOUS
FERAHEME
AB +! COVIS EQ 510MG IRON/17ML (EQ 30MG IRON/ML) N022180 001 Jun 30, 2009
FERUMOXYTOL
AB SANDOZ INC EQ 510MG IRON/17ML (EQ 30MG IRON/ML) A206604 001 Jan 15, 2021
FESOTERODINE FUMARATE
TABLET, EXTENDED RELEASE;ORAL
FESOTERODINE FUMARATE
AB ACCORD HLTHCARE 4MG A205012 001 Jan 04, 2023
AB 8MG A205012 002 Jan 04, 2023
AB ACTAVIS LABS FL INC 4MG A204868 001 Jan 04, 2023
AB 8MG A204868 002 Jan 04, 2023
AB ALEMBIC PHARMS 4MG A204973 001 Jan 04, 2023
AB 8MG A204973 002 Jan 04, 2023
AB ALKEM LABS LTD 4MG A204827 001 Dec 10, 2015
AB 8MG A204827 002 Dec 10, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-197(of 474)

FESOTERODINE FUMARATE
TABLET, EXTENDED RELEASE;ORAL
FESOTERODINE FUMARATE
AB AMNEAL PHARMS NY 4MG A205002 001 Jan 04, 2023
AB 8MG A205002 002 Jan 04, 2023
AB ANI PHARMS 4MG A204504 001 Jan 04, 2023
AB 8MG A204504 002 Jan 04, 2023
AB AUROBINDO PHARMA 4MG A205007 001 Feb 17, 2017
AB 8MG A205007 002 Feb 17, 2017
AB DR REDDYS 4MG A204975 001 Aug 13, 2019
AB 8MG A204975 002 Aug 13, 2019
AB LUPIN LTD 4MG A204983 001 Jan 05, 2023
AB 8MG A204983 002 Jan 05, 2023
AB ZYDUS PHARMS 4MG A204946 001 Oct 03, 2017
AB 8MG A204946 002 Oct 03, 2017
TOVIAZ
AB + PFIZER 4MG N022030 001 Oct 31, 2008
AB +! 8MG N022030 002 Oct 31, 2008
FEXINIDAZOLE
TABLET;ORAL
FEXINIDAZOLE
+! SANOFI 600MG N214429 001 Jul 16, 2021
FEXOFENADINE HYDROCHLORIDE
TABLET;ORAL
FEXOFENADINE HYDROCHLORIDE
AB DR REDDYS LABS LTD 30MG A076502 001 Apr 11, 2006
AB 60MG A076502 002 Apr 11, 2006
AB 180MG A076502 003 Apr 11, 2006
AB RISING 60MG A077081 003 Apr 11, 2008
AB 180MG A077081 001 Apr 16, 2007
AB TEVA 30MG A076447 001 Sep 01, 2005
AB 60MG A076447 002 Sep 01, 2005
AB 180MG A076447 003 Sep 01, 2005
FIDAXOMICIN
FOR SUSPENSION;ORAL
DIFICID
+! CUBIST PHARMS LLC 40MG/ML N213138 001 Jan 24, 2020
TABLET;ORAL
DIFICID
+! CUBIST PHARMS LLC 200MG N201699 001 May 27, 2011
FINASTERIDE
TABLET;ORAL
FINASTERIDE
AB ACCORD HLTHCARE 1MG A091643 001 Nov 05, 2013
AB 5MG A090121 001 Feb 23, 2010
AB ALKEM LABS LTD 1MG A207750 001 Jan 06, 2017
AB 5MG A204304 001 Jan 05, 2017
AB AUROBINDO PHARMA 5MG A078341 001 Oct 30, 2007
AB AUROBINDO PHARMA 1MG A203687 001 Nov 05, 2013
LTD
AB CIPLA 1MG A077335 001 Nov 20, 2014
AB DR REDDYS LABS INC 1MG A076436 001 Jul 28, 2006
AB DR REDDYS LABS LTD 5MG A076437 001 Feb 28, 2007
AB HETERO LABS LTD III 1MG A090060 001 Jul 01, 2013
AB 5MG A090061 001 Jun 07, 2010
AB SUN PHARM 1MG A090508 001 Jul 01, 2013
AB 5MG A090507 001 Aug 16, 2011
AB TEVA 5MG A076511 001 Dec 15, 2006
AB ZYDUS PHARMS USA 5MG A078900 001 Dec 28, 2009
INC
PROPECIA
AB +! ORGANON 1MG N020788 001 Dec 19, 1997
PROSCAR
AB +! ORGANON 5MG N020180 001 Jun 19, 1992
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-198(of 474)

FINASTERIDE; TADALAFIL
CAPSULE;ORAL
ENTADFI
+! VERU 5MG;5MG N215423 001 Dec 09, 2021
FINERENONE
TABLET;ORAL
KERENDIA
+ BAYER HLTHCARE 10MG N215341 001 Jul 09, 2021
+! 20MG N215341 002 Jul 09, 2021
FINGOLIMOD HYDROCHLORIDE
CAPSULE;ORAL
FINGOLIMOD HYDROCHLORIDE
AB ACCORD HLTHCARE EQ 0.5MG BASE A207991 001 Oct 28, 2020
AB ALKEM LABS LTD EQ 0.5MG BASE A208004 001 Dec 30, 2020
AB APOTEX EQ 0.5MG BASE A207993 001 Dec 18, 2020
AB DR REDDYS EQ 0.5MG BASE A208000 001 Mar 05, 2021
AB GLENMARK PHARMS LTD EQ 0.5MG BASE A207985 001 Jun 18, 2020
AB HEC PHARM CO LTD EQ 0.5MG BASE A207939 001 Nov 10, 2021
AB HETERO LABS LTD V EQ 0.5MG BASE A207933 001 May 18, 2020
AB MYLAN EQ 0.5MG BASE A208005 001 Jan 19, 2021
AB PRINSTON INC EQ 0.5MG BASE A208003 001 Sep 07, 2022
AB SUN PHARM EQ 0.5MG BASE A208014 001 Dec 04, 2019
AB ZYDUS PHARMS EQ 0.5MG BASE A207994 001 Oct 14, 2020
GILENYA
AB +! NOVARTIS EQ 0.5MG BASE N022527 001 Sep 21, 2010
+ EQ 0.25MG BASE N022527 002 May 11, 2018
FINGOLIMOD LAURYL SULFATE
TABLET, ORALLY DISINTEGRATING;ORAL
TASCENSO ODT
+ HANDA EQ 0.25MG BASE N214962 001 Dec 23, 2021
+! EQ 0.5MG BASE N214962 002 Dec 09, 2022
FISH OIL TRIGLYCERIDES
EMULSION;INTRAVENOUS
OMEGAVEN
+! FRESENIUS KABI USA 5GM/50ML (0.1GM/ML) N210589 001 Jul 27, 2018
+! 10GM/100ML (0.1GM/ML) N210589 002 Jul 27, 2018
FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL
EMULSION;INTRAVENOUS
SMOFLIPID 20%
+! FRESENIUS KABI USA 3GM/100ML;6GM/100ML;5GM/100ML;6GM/100ML N207648 001 Jul 13, 2016
(100ML)
+! 3GM/100ML;6GM/100ML;5GM/100ML;6GM/100ML N207648 002 Jul 13, 2016
(250ML)
+! 3GM/100ML;6GM/100ML;5GM/100ML;6GM/100ML N207648 003 Jul 13, 2016
(500ML)
+! 3GM/100ML;6GM/100ML;5GM/100ML;6GM/100ML N207648 004 Aug 10, 2018
(1000ML)
FLAVOXATE HYDROCHLORIDE
TABLET;ORAL
FLAVOXATE HYDROCHLORIDE
AB EPIC PHARMA 100MG A076835 001 Nov 30, 2005
AB ! PADAGIS US 100MG A076831 001 Dec 16, 2004
FLECAINIDE ACETATE
TABLET;ORAL
FLECAINIDE ACETATE
AB AMNEAL PHARM 50MG A075442 001 Jul 31, 2001
AB 100MG A075442 002 Jul 31, 2001
AB 150MG A075442 003 Jul 31, 2001
AB ANI PHARMS 50MG A075882 001 Oct 28, 2002
AB 100MG A075882 002 Oct 28, 2002
AB 150MG A075882 003 Oct 28, 2002
AB AUROBINDO PHARMA 50MG A202821 001 Nov 03, 2017
LTD
AB 100MG A202821 002 Nov 03, 2017
AB 150MG A202821 003 Nov 03, 2017
AB BEXIMCO PHARMS USA 50MG A210683 001 Sep 16, 2020
AB 100MG A210683 002 Sep 16, 2020
AB 150MG A210683 003 Sep 16, 2020
AB HIKMA 50MG A076278 001 Jan 14, 2003
AB 100MG A076278 002 Jan 14, 2003
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-199(of 474)

FLECAINIDE ACETATE
TABLET;ORAL
FLECAINIDE ACETATE
AB ! 150MG A076278 003 Jan 14, 2003
AB SUN PHARM INDS LTD 50MG A076421 001 Mar 28, 2003
AB 100MG A076421 002 Mar 28, 2003
AB 150MG A076421 003 Mar 28, 2003
AB YICHANG HUMANWELL 50MG A215599 001 Sep 08, 2022
AB 100MG A215599 002 Sep 08, 2022
AB 150MG A215599 003 Sep 08, 2022
FLIBANSERIN
TABLET;ORAL
ADDYI
+! SPROUT PHARMS 100MG N022526 001 Aug 18, 2015
FLORBETABEN F-18
SOLUTION;INTRAVENOUS
NEURACEQ
+! LIFE MOLECULAR 1.4-135mCi/ML N204677 001 Mar 19, 2014
FLORBETAPIR F-18
SOLUTION;INTRAVENOUS
AMYVID
+! AVID RADIOPHARMS 10-30ML (13.5-51mCi/ML) N202008 002 Apr 06, 2012
INC
+! 10-50ML (13.5-51mCi/ML) N202008 003 Apr 06, 2012
FLORTAUCIPIR F-18
SOLUTION;INTRAVENOUS
TAUVID
+! AVID RADIOPHARMS 30ML (8.1-51mCi/ML) N212123 001 May 28, 2020
INC
+! 50ML (8.1-51mCi/ML) N212123 002 May 28, 2020
+! 50ML (8.1-100mCi/ML) N212123 003 Jul 01, 2022
+! 100ML (8.1-100mCi/ML) N212123 004 Jul 01, 2022
FLOXURIDINE
INJECTABLE;INJECTION
FLOXURIDINE
AP FRESENIUS KABI USA 500MG/VIAL A075837 001 Feb 22, 2001
AP ! HIKMA 500MG/VIAL A075387 001 Apr 16, 2000
FLUCICLOVINE F-18
SOLUTION;INTRAVENOUS
AXUMIN
+! BLUE EARTH 9-221mCi/ML N208054 001 May 27, 2016
FLUCONAZOLE
FOR SUSPENSION;ORAL
DIFLUCAN
AB + PFIZER 50MG/5ML N020090 001 Dec 23, 1993
AB +! 200MG/5ML N020090 002 Dec 23, 1993
FLUCONAZOLE
AB AUROBINDO PHARMA 50MG/5ML A079150 001 Sep 18, 2009
AB 200MG/5ML A079150 002 Sep 18, 2009
INJECTABLE;INJECTION
FLUCONAZOLE IN SODIUM CHLORIDE 0.9%
AP BAXTER HLTHCARE 200MG/100ML (2MG/ML) A077947 001 May 26, 2010
CORP
AP 400MG/200ML (2MG/ML) A077947 002 May 26, 2010
AP FRESENIUS KABI USA 200MG/100ML (2MG/ML) A076145 001 Jul 29, 2004
AP 400MG/200ML (2MG/ML) A076145 002 Jul 29, 2004
AP HIKMA 200MG/100ML (2MG/ML) A076087 001 Jul 29, 2004
AP 400MG/200ML (2MG/ML) A076087 003 Jul 29, 2004
AP HIKMA FARMACEUTICA 200MG/100ML (2MG/ML) A076736 001 Aug 23, 2005
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 200MG/100ML (2MG/ML) A076766 001 Jul 29, 2004
AP 400MG/200ML (2MG/ML) A076766 002 Jul 29, 2004
AP HIKMA FARMACEUTICA 200MG/100ML (2MG/ML) A078698 001 Jan 30, 2012
AP 400MG/200ML (2MG/ML) A078698 002 Jan 30, 2012
AP HOSPIRA 200MG/100ML (2MG/ML) A076303 001 Jul 29, 2004
AP 400MG/200ML (2MG/ML) A076303 002 Jul 29, 2004
AP ! INFORLIFE 200MG/100ML (2MG/ML) A079104 001 Jul 30, 2009
AP ! 400MG/200ML (2MG/ML) A079104 002 Jul 30, 2009
AP WEST-WARD PHARMS 200MG/100ML (2MG/ML) A078107 001 Jul 30, 2008
INT
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-200(of 474)

FLUCONAZOLE
INJECTABLE;INJECTION
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP 400MG/200ML (2MG/ML) A078107 002 Jul 30, 2008
AP WOODWARD 200MG/100ML (2MG/ML) A077909 001 May 26, 2010
AP 400MG/200ML (2MG/ML) A077909 002 May 26, 2010
FLUCONAZOLE IN SODIUM CHLORIDE 0.9%
HIKMA 100MG/50ML (2MG/ML) A076087 002 Sep 26, 2008
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
WOODWARD 100MG/50ML (2MG/ML) A077909 003 Apr 20, 2015
TABLET;ORAL
DIFLUCAN
AB + PFIZER 50MG N019949 001 Jan 29, 1990
AB + 100MG N019949 002 Jan 29, 1990
AB + 150MG N019949 004 Jun 30, 1994
AB +! 200MG N019949 003 Jan 29, 1990
FLUCONAZOLE
AB ANI PHARMS 50MG A078423 001 Mar 07, 2011
AB 100MG A078423 002 Mar 07, 2011
AB 150MG A078423 003 Mar 07, 2011
AB 200MG A078423 004 Mar 07, 2011
AB AUROBINDO PHARMA 50MG A077731 001 Oct 07, 2008
AB 100MG A077731 002 Oct 07, 2008
AB 150MG A077731 003 Oct 07, 2008
AB 200MG A077731 004 Oct 07, 2008
AB CHARTWELL 50MG A076665 001 Jul 29, 2004
AB 100MG A076665 002 Jul 29, 2004
AB 150MG A076665 003 Jul 29, 2004
AB 200MG A076665 004 Jul 29, 2004
AB DR REDDYS LABS INC 50MG A076658 001 Jul 29, 2004
AB 100MG A076658 002 Jul 29, 2004
AB 150MG A076658 003 Jul 29, 2004
AB 200MG A076658 004 Jul 29, 2004
AB GLENMARK GENERICS 50MG A077253 001 Jan 25, 2006
AB 100MG A077253 002 Jan 25, 2006
AB 150MG A077253 003 Jan 25, 2006
AB 200MG A077253 004 Jan 25, 2006
AB TARO 50MG A076507 001 Jul 29, 2004
AB 100MG A076507 002 Jul 29, 2004
AB 150MG A076507 003 Jul 29, 2004
AB 200MG A076507 004 Jul 29, 2004
AB THINQ PHARM-CRO PVT 50MG A076957 001 Sep 28, 2005
AB 100MG A076957 002 Sep 28, 2005
AB 150MG A076957 004 Feb 27, 2017
AB 200MG A076957 003 Sep 28, 2005
AB ZYDUS PHARMS 50MG A208963 001 Feb 16, 2017
AB 100MG A208963 002 Feb 16, 2017
AB 150MG A208963 003 Feb 16, 2017
AB 200MG A208963 004 Feb 16, 2017
FLUCYTOSINE
CAPSULE;ORAL
ANCOBON
AB + BAUSCH 250MG N017001 001
AB +! 500MG N017001 002
FLUCYTOSINE
AB AUROBINDO PHARMA 250MG A213665 001 May 01, 2020
LTD
AB 500MG A213665 002 May 01, 2020
AB HIKMA 250MG A206550 001 Oct 17, 2017
AB 500MG A206550 002 Oct 17, 2017
AB NOVEL LABS INC 250MG A204652 001 Jul 07, 2017
AB 500MG A204652 002 Jul 07, 2017
AB SIGMAPHARM LABS LLC 250MG A201566 001 Jun 28, 2011
AB 500MG A201566 002 Jun 28, 2011
AB STRIDES PHARMA 250MG A212632 001 Apr 17, 2020
AB 500MG A212632 002 Apr 17, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-201(of 474)

FLUDARABINE PHOSPHATE
INJECTABLE;INJECTION
FLUDARABINE PHOSPHATE
AP ACTAVIS LLC 50MG/2ML (25MG/ML) A203738 001 Feb 28, 2017
AP ! ACTAVIS TOTOWA 50MG/VIAL A078610 001 Feb 11, 2009
AP AREVA PHARMS 50MG/2ML (25MG/ML) A090724 001 Sep 27, 2010
AP ! FRESENIUS KABI USA 50MG/2ML (25MG/ML) A078393 001 Oct 15, 2007
AP 50MG/VIAL A078544 001 Oct 15, 2007
AP HIKMA 50MG/VIAL A076349 001 Aug 28, 2003
AP SAGENT PHARMS INC 50MG/2ML (25MG/ML) A076661 001 Apr 28, 2004
AP +! SANDOZ 50MG/2ML (25MG/ML) N022137 001 Sep 21, 2007
FLUDEOXYGLUCOSE F-18
INJECTABLE;INTRAVENOUS
FLUDEOXYGLUCOSE F18
AP 3D IMAGING DRUG 20-300mCi/ML A203778 001 Oct 30, 2015
AP BIOMEDCL RES FDN 20-300mCi/ML A203710 001 May 01, 2015
AP 20-300mCi/ML A203837 001 May 01, 2015
AP BRIGHAM WOMENS 20-300mCi/ML A203816 001 Oct 30, 2014
AP CARDINAL HEALTH 414 20-300mCi/ML A203603 001 Nov 13, 2015
AP 20-500mCi/ML A203603 002 Sep 27, 2018
AP CHILDRENS HOSP MI 20-300mCi/ML A204385 001 Oct 29, 2014
AP DECATUR 20-300mCi/ML A204463 001 Oct 21, 2014
AP ESSENTIAL ISOTOPES 20-300mCi/ML A203946 001 Feb 05, 2014
AP +! FEINSTEIN 20-400mCi/ML N021870 002 Nov 21, 2008
AP ISOLOGIC INNOVATIVE 20-300mCi/ML A204525 001 Oct 29, 2014
AP JUBILANT DRAXIMAGE 20-300mCi/ML A203920 001 Jun 23, 2015
AP KETTERING MEDCTR 4-40mCi/ML A204759 001 Oct 27, 2015
AP KREITCHMAN PET CTR 10-100mCi/ML A203942 001 Apr 11, 2016
AP MA GENERAL HOSP 20-300mCi/ML A204333 001 Sep 25, 2014
AP MCPRF 20-240mCi/ML A203612 001 Aug 05, 2013
AP MEM SLOAN-KETTERING 20-300mCi/ML A208679 001 Dec 08, 2016
AP METHODIST HOSP RES 20-300mCi/ML A203904 001 Apr 23, 2015
AP MIPS CRF 20-300mCi/ML A204472 001 Sep 11, 2015
AP NCM USA BRONX LLC 20-300mCi/ML A204512 001 Jan 07, 2015
AP ! PETNET 20-200mCi/ML A079086 001 Feb 25, 2011
AP PHARMALOGIC HLDGS 20-200mCi/ML A203664 001 Feb 04, 2014
AP PRECISION NUCLEAR 20-500mCi/ML A204546 001 Apr 07, 2015
AP ! QUEEN HAMAMATSU PET 10-100mCi/ML A203771 001 Aug 31, 2015
AP SHERTECH LABS LLC 20-300mCi/ML A204264 001 Dec 18, 2014
AP SOFIE 20-300mCi/ML A203591 001 Aug 31, 2015
AP ! 20-500mCi/ML A203665 001 Feb 14, 2013
AP TRUSTEES UNIV PA 20-200mCi/ML A203801 001 Oct 29, 2014
AP ! UCLA BIOMEDICAL 4-40mCi/ML A203811 001 Jun 27, 2013
AP UCSF RODIOPHARM 20-300mCi/ML A203902 001 May 09, 2014
AP UIHC PET IMAGING 20-300mCi/ML A203990 001 Aug 06, 2014
AP UNIV MICHIGAN 20-300mCi/ML A204531 001 Jul 17, 2015
AP UNIV SOUTHERN CA 20-300mCi/ML A209341 001 Dec 16, 2020
AP UNIV TX MD ANDERSON 20-300mCi/ML A203246 002 Jan 13, 2014
AP UNIV UTAH CYCLOTRON 20-300mCi/ML A204498 001 Jun 23, 2015
AP WISCONSIN 20-500mCi/ML A203709 001 Oct 23, 2013
AP WUSM CYCLOTRON 20-300mCi/ML A203935 001 Feb 05, 2014
NORTHLAND 4-500mCi/ML A203994 001 Feb 04, 2015
NUKEMED 4-500mCi/ML A203911 001 Apr 22, 2015
UNIV TX MD ANDERSON 20-150mCi/ML A203246 001 Jan 13, 2014
FLUDROCORTISONE ACETATE
TABLET;ORAL
FLUDROCORTISONE ACETATE
AB BARR 0.1MG A040425 001 Jan 21, 2003
AB HIKMA 0.1MG A216013 001 Oct 27, 2022
AB ! IMPAX LABS 0.1MG A040431 001 Mar 18, 2002
AB NOVITIUM PHARMA 0.1MG A215279 001 May 31, 2022
FLUMAZENIL
INJECTABLE;INJECTION
FLUMAZENIL
AP BAXTER HLTHCARE 0.5MG/5ML (0.1MG/ML) A076755 002 Oct 12, 2004
CORP
AP 1MG/10ML (0.1MG/ML) A076755 001 Oct 12, 2004
AP FRESENIUS KABI USA 0.5MG/5ML (0.1MG/ML) A076955 002 Oct 12, 2004
AP 1MG/10ML (0.1MG/ML) A076955 001 Oct 12, 2004
AP HIKMA 0.5MG/5ML (0.1MG/ML) A076256 002 Oct 12, 2004
AP 0.5MG/5ML (0.1MG/ML) A076787 002 Oct 12, 2004
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-202(of 474)

FLUMAZENIL
INJECTABLE;INJECTION
FLUMAZENIL
AP 1MG/10ML (0.1MG/ML) A076256 001 Oct 12, 2004
AP 1MG/10ML (0.1MG/ML) A076787 001 Oct 12, 2004
AP HIKMA FARMACEUTICA 0.5MG/5ML (0.1MG/ML) A078527 001 Mar 23, 2009
AP ! 1MG/10ML (0.1MG/ML) A078527 002 Mar 23, 2009
AP RISING 0.5MG/5ML (0.1MG/ML) A078595 001 May 13, 2008
AP SAGENT PHARMS 0.5MG/5ML (0.1MG/ML) A090584 001 Aug 28, 2012
AP 1MG/10ML (0.1MG/ML) A090584 002 Aug 28, 2012
AP SANDOZ INC 0.5MG/5ML (0.1MG/ML) A077071 001 May 03, 2005
AP 1MG/10ML (0.1MG/ML) A077071 002 May 03, 2005
FLUNISOLIDE
SPRAY, METERED;NASAL
FLUNISOLIDE
AB ! BAUSCH 0.025MG/SPRAY A074805 001 Feb 20, 2002
AB RICONPHARMA LLC 0.025MG/SPRAY A207802 001 Jun 16, 2022
AB RISING 0.025MG/SPRAY A077704 001 Aug 03, 2006
FLUOCINOLONE ACETONIDE
CREAM;TOPICAL
FLUOCINOLONE ACETONIDE
AT COSETTE 0.01% A089526 001 Jul 26, 1988
AT 0.025% A210747 001 Nov 05, 2018
AT FOUGERA PHARMS INC 0.01% A088170 001 Dec 16, 1982
AT 0.025% A088169 001 Dec 16, 1982
AT TARO 0.025% A087104 001 Apr 27, 1982
SYNALAR
AT +! MEDIMETRIKS PHARMS 0.01% N012787 004
AT +! 0.025% N012787 002
AT +! 0.025% N012787 005
IMPLANT;INTRAVITREAL
ILUVIEN
+! ALIMERA SCIENCES 0.19MG N201923 001 Sep 26, 2014
INC
RETISERT
+! BAUSCH AND LOMB 0.59MG N021737 001 Apr 08, 2005
YUTIQ
+! EYEPOINT PHARMS 0.18MG N210331 001 Oct 12, 2018
OIL;TOPICAL
DERMA-SMOOTHE/FS
AT +! HILL DERMAC 0.01% N019452 001 Feb 03, 1988
AT +! 0.01% N019452 002 Nov 09, 2005
FLUCINOLONE ACETONIDE
AT GLENMARK PHARMS LTD 0.01% A210556 001 Oct 25, 2018
FLUOCINOLONE ACETONIDE
AT LYNE 0.01% A090982 001 Apr 25, 2016
AT 0.01% A203377 001 Apr 25, 2016
AT PADAGIS ISRAEL 0.01% A202847 001 Aug 09, 2013
AT 0.01% A202848 001 Aug 09, 2013
AT QUAGEN 0.01% A212760 001 Apr 02, 2021
AT 0.01% A212761 001 Apr 02, 2021
AT TARO 0.01% A202368 001 May 19, 2016
AT 0.01% A209336 001 May 19, 2016
FLUOCINONIDE ACETONIDE
AT GLENMARK PHARMS LTD 0.01% A210539 001 Oct 26, 2018
OIL/DROPS;OTIC
DERMOTIC
AT +! HILL DERMAC 0.01% N019452 003 Nov 09, 2005
FLAC
AT ANDA REPOSITORY 0.01% A210736 001 Apr 11, 2018
FLUOCINOLONE ACETONIDE
AT LYNE 0.01% A203378 001 Apr 25, 2016
AT PADAGIS ISRAEL 0.01% A202849 001 Jul 17, 2017
AT QUAGEN 0.01% A212762 001 Apr 02, 2021
AT TASMAN PHARMA 0.01% A213264 001 Feb 05, 2021
FLUOCINONIDE ACETONIDE
AT GLENMARK PHARMS LTD 0.01% A211815 001 Dec 14, 2018
OINTMENT;TOPICAL
FLUOCINOLONE ACETONIDE
AT COSETTE 0.025% A089524 001 Jul 26, 1988
AT FOUGERA PHARMS INC 0.025% A088168 001 Dec 16, 1982
AT TARO 0.025% A040041 001 Sep 15, 1994
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-203(of 474)

FLUOCINOLONE ACETONIDE
OINTMENT;TOPICAL
SYNALAR
AT +! MEDIMETRIKS PHARMS 0.025% N013960 001
SHAMPOO;TOPICAL
CAPEX
+! GALDERMA LABS LP 0.01% N020001 001 Aug 27, 1990
SOLUTION;TOPICAL
FLUOCINOLONE ACETONIDE
AT ENCUBE ETHICALS 0.01% A209913 001 Feb 13, 2019
AT FOUGERA PHARMS INC 0.01% A088167 001 Dec 16, 1982
AT GLASSHOUSE PHARMS 0.01% A209596 001 Dec 26, 2017
AT LUPIN 0.01% A206422 001 Sep 02, 2015
AT TARO 0.01% A089124 001 Sep 11, 1985
SYNALAR
AT +! MEDIMETRIKS PHARMS 0.01% N015296 001
FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN
CREAM;TOPICAL
TRI-LUMA
+! GALDERMA LABS LP 0.01%;4%;0.05% N021112 001 Jan 18, 2002
FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE
CREAM;TOPICAL
NEO-SYNALAR
! MEDIMETRIKS PHARMS 0.025%;EQ 3.5MG BASE/GM A060700 001
FLUOCINONIDE
CREAM;TOPICAL
FLUOCINONIDE
AB AMNEAL 0.1% A211111 001 Jun 04, 2018
AB CADILA 0.1% A208989 001 Feb 10, 2020
AB FOUGERA PHARMS INC 0.1% A200735 001 Jul 14, 2014
AB GLENMARK GENERICS 0.1% A091282 001 Jul 14, 2014
AB PADAGIS ISRAEL 0.1% A090256 001 Jan 14, 2014
AB PAI HOLDINGS PHARM 0.1% A211758 001 Apr 03, 2019
AB TARO 0.1% A200734 001 Jul 14, 2014
VANOS
AB +! BAUSCH 0.1% N021758 001 Feb 11, 2005
FLUOCINONIDE
AB1 AMNEAL 0.05% A210554 001 Aug 21, 2018
AB1 COSETTE 0.05% A073085 001 Feb 14, 1992
AB1 FOUGERA PHARMS INC 0.05% A073030 001 Oct 17, 1994
AB1 TARO 0.05% A071500 001 Jun 10, 1987
AB1 +! 0.05% N019117 001 Jun 26, 1984
AB1 TEVA 0.05% A072488 001 Feb 06, 1989
FLUOCINONIDE EMULSIFIED BASE
AB2 COSETTE 0.05% A074204 001 Jun 13, 1995
AB2 FOUGERA PHARMS 0.05% A076586 001 Jun 23, 2004
AB2 ! TARO PHARM INDS LTD 0.05% A072494 001 Jan 19, 1989
AB2 TEVA 0.05% A072490 001 Feb 07, 1989
GEL;TOPICAL
FLUOCINONIDE
AB + ALVOGEN 0.05% N017373 001
AB COSETTE 0.05% A072537 001 Feb 07, 1989
AB FOUGERA PHARMS INC 0.05% A072933 001 Dec 30, 1994
AB PAI HOLDINGS PHARM 0.05% A209030 001 Jun 19, 2018
AB ! TARO 0.05% A074935 001 Jul 29, 1997
OINTMENT;TOPICAL
FLUOCINONIDE
AB FOUGERA PHARMS 0.05% A074905 001 Aug 26, 1997
AB NOVEL LABS INC 0.05% A207538 001 Jul 31, 2017
AB PAI HOLDINGS PHARM 0.05% A207680 001 Sep 28, 2018
AB ! TARO 0.05% A075008 001 Jun 30, 1999
AB TEVA 0.05% A073481 001 Dec 27, 1991
AB XIROMED 0.05% A212976 001 Nov 26, 2019
LIDEX
AB + ALVOGEN 0.05% N016909 002
SOLUTION;TOPICAL
FLUOCINONIDE
AT COSETTE 0.05% A071535 001 Dec 02, 1988
AT ENCUBE ETHICALS 0.05% A209699 001 Nov 29, 2018
AT FOUGERA PHARMS INC 0.05% A072934 001 Feb 27, 1995
AT GLASSHOUSE PHARMS 0.05% A209118 001 Apr 23, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-204(of 474)

FLUOCINONIDE
SOLUTION;TOPICAL
FLUOCINONIDE
AT MACLEODS PHARMS LTD 0.05% A209283 001 Apr 23, 2018
AT NOVEL LABS INC 0.05% A206003 001 Jul 21, 2017
AT PAI HOLDINGS PHARM 0.05% A207554 001 Mar 18, 2019
AT ! TARO 0.05% A074799 001 Dec 31, 1996
AT ZYDUS PHARMS 0.05% A208948 001 Jul 17, 2018
LIDEX
AT + ALVOGEN 0.05% N018849 001 Apr 06, 1984
FLUORESCEIN SODIUM
INJECTABLE;INTRAVENOUS
AK-FLUOR 10%
AP + AKORN EQ 500MG BASE/5ML (EQ 100MG BASE/ML) N022186 001 Aug 08, 2008
FLUORESCITE
AP +! ALCON LABS INC EQ 500MG BASE/5ML (EQ 100MG BASE/ML) N021980 001 Mar 28, 2006
AK-FLUOR 25%
+! AKORN EQ 500MG BASE/2ML (EQ 250MG BASE/ML) N022186 002 Aug 08, 2008
FLUORODOPA F-18
SOLUTION;INTRAVENOUS
FLUORODOPA F18
+! FEINSTEIN 0.42-8.33mCi/ML N200655 001 Oct 10, 2019
FLUOROESTRADIOL F-18
SOLUTION;INTRAVENOUS
CERIANNA
+! ZIONEXA 50ML (4-100mCi/ML) N212155 001 May 20, 2020
FLUOROMETHOLONE
SUSPENSION/DROPS;OPHTHALMIC
FML
+! ALLERGAN 0.1% N016851 002 Jul 28, 1982
FML FORTE
+! ALLERGAN 0.25% N019216 001 Apr 23, 1986
FLUOROMETHOLONE ACETATE
SUSPENSION/DROPS;OPHTHALMIC
FLAREX
+! EYEVANCE 0.1% N019079 001 Feb 11, 1986
FLUOROURACIL
CREAM;TOPICAL
EFUDEX
AB +! BAUSCH 5% N016831 003
FLUOROURACIL
AB ACCORD HLTHCARE 5% A214845 001 Oct 07, 2021
AB MAYNE PHARMA 5% A077524 001 Apr 11, 2008
AB TARO 5% A090368 001 Mar 05, 2010
CARAC
+! VALEANT PHARMS 0.5% N020985 001 Oct 27, 2000
NORTH
TOLAK
+! HILL DERMACEUTICALS 4% N022259 001 Sep 18, 2015
INJECTABLE;INJECTION
FLUOROURACIL
AP ! ACCORD HLTHCARE 500MG/10ML (50MG/ML) A040743 002 Apr 26, 2007
AP ! 1GM/20ML (50MG/ML) A040743 001 Apr 26, 2007
AP ! 2.5GM/50ML (50MG/ML) A040798 002 Apr 26, 2007
AP ! 5GM/100ML (50MG/ML) A040798 001 Apr 26, 2007
AP FRESENIUS KABI USA 500MG/10ML (50MG/ML) A040279 002 Sep 30, 1998
AP 1GM/20ML (50MG/ML) A040279 001 Sep 30, 1998
AP 2.5GM/50ML (50MG/ML) A040278 001 Sep 30, 1998
AP 5GM/100ML (50MG/ML) A040278 002 Sep 30, 1998
AP GLAND PHARMA LTD 500MG/10ML (50MG/ML) A210123 001 Oct 27, 2017
AP 1GM/20ML (50MG/ML) A210123 002 Oct 27, 2017
AP 2.5GM/50ML (50MG/ML) A210124 001 Dec 26, 2017
AP 5GM/100ML (50MG/ML) A210124 002 Dec 26, 2017
AP SAGENT PHARMS INC 500MG/10ML (50MG/ML) A203608 001 May 11, 2017
AP 1GM/20ML (50MG/ML) A203608 002 May 11, 2017
AP 2.5GM/50ML (50MG/ML) A203609 001 Feb 17, 2016
AP 5GM/100ML (50MG/ML) A203609 002 Feb 17, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-205(of 474)

FLUOROURACIL
SOLUTION;TOPICAL
EFUDEX
AT +! BAUSCH 2% N016831 001
FLUOROURACIL
AT TARO 2% A076526 001 Nov 05, 2003
! 5% A076526 002 Nov 05, 2003
FLUOXETINE HYDROCHLORIDE
CAPSULE;ORAL
FLUOXETINE HYDROCHLORIDE
AB ALEMBIC PHARMS LTD EQ 40MG BASE A090223 003 Mar 19, 2009
AB APNAR PHARMA LP EQ 40MG BASE A075049 003 Jan 29, 2002
AB AUROBINDO PHARMA EQ 40MG BASE A078619 003 Jan 31, 2008
AB CADILA PHARMS LTD EQ 40MG BASE A206993 003 May 23, 2019
AB HERITAGE PHARMS EQ 40MG BASE A201336 003 Oct 01, 2012
AB IVAX SUB TEVA EQ 40MG BASE A075245 003 Sep 28, 2004
PHARMS
AB MARKSANS PHARMA EQ 40MG BASE A075465 003 Aug 02, 2001
AB MICRO LABS EQ 40MG BASE A216232 003 Mar 29, 2022
AB SCIEGEN PHARMS INC EQ 40MG BASE A204597 003 Mar 16, 2015
AB SUN PHARM INDS LTD EQ 40MG BASE A076990 001 Dec 13, 2004
AB TEVA EQ 40MG BASE A075452 003 Jan 29, 2002
PROZAC
AB +! ELI LILLY AND CO EQ 40MG BASE N018936 003 Jun 15, 1999
FLUOXETINE HYDROCHLORIDE
AB1 ALEMBIC PHARMS LTD EQ 10MG BASE A090223 001 Mar 19, 2009
AB1 EQ 20MG BASE A090223 002 Mar 19, 2009
AB1 APNAR PHARMA LP EQ 10MG BASE A075049 001 Aug 02, 2001
AB1 EQ 20MG BASE A075049 002 Jan 29, 2002
AB1 AUROBINDO PHARMA EQ 10MG BASE A078619 001 Jan 31, 2008
AB1 EQ 20MG BASE A078619 002 Jan 31, 2008
AB1 CADILA PHARMS LTD EQ 10MG BASE A206993 001 May 23, 2019
AB1 EQ 20MG BASE A206993 002 May 23, 2019
AB1 HERITAGE PHARMS EQ 10MG BASE A201336 001 Oct 01, 2012
AB1 EQ 20MG BASE A201336 002 Oct 01, 2012
AB1 IVAX SUB TEVA EQ 10MG BASE A075245 002 Jan 31, 2002
PHARMS
AB1 EQ 20MG BASE A075245 001 Jan 31, 2002
AB1 LANDELA PHARM EQ 10MG BASE A075464 001 Jan 30, 2002
AB1 EQ 20MG BASE A075464 002 Jan 30, 2002
AB1 MARKSANS PHARMA EQ 10MG BASE A075465 001 Jan 29, 2002
AB1 EQ 20MG BASE A075465 002 Jan 29, 2002
AB1 MICRO LABS EQ 10MG BASE A216232 001 Mar 29, 2022
AB1 EQ 20MG BASE A216232 002 Mar 29, 2022
AB1 SCIEGEN PHARMS INC EQ 10MG BASE A204597 001 Mar 16, 2015
AB1 EQ 20MG BASE A204597 002 Mar 16, 2015
AB1 TEVA EQ 10MG BASE A075452 001 Jan 29, 2002
AB1 EQ 20MG BASE A075452 002 Jan 29, 2002
AB1 TEVA PHARMS USA EQ 10MG BASE A076001 001 Jan 29, 2002
AB1 EQ 20MG BASE A076001 002 Jan 29, 2002
PROZAC
AB1 + ELI LILLY AND CO EQ 10MG BASE N018936 006 Dec 23, 1992
AB1 + EQ 20MG BASE N018936 001 Dec 29, 1987
CAPSULE, DELAYED REL PELLETS;ORAL
FLUOXETINE HYDROCHLORIDE
! DR REDDYS LABS LTD EQ 90MG BASE A078572 001 Mar 22, 2010
SOLUTION;ORAL
FLUOXETINE HYDROCHLORIDE
AA APTAPHARMA INC EQ 20MG BASE/5ML A216953 001 Nov 15, 2022
AA AUROBINDO PHARMA EQ 20MG BASE/5ML A079209 001 Mar 20, 2009
AA LANNETT CO INC EQ 20MG BASE/5ML A077849 001 Feb 09, 2007
AA NOVITIUM PHARMA EQ 20MG BASE/5ML A216448 001 Nov 09, 2022
AA ! PHARM ASSOC EQ 20MG BASE/5ML A076015 001 Jan 30, 2002
AA TEVA EQ 20MG BASE/5ML A075506 001 Aug 02, 2001
AA WOCKHARDT BIO AG EQ 20MG BASE/5ML A075514 001 Aug 29, 2002
TABLET;ORAL
FLUOXETINE HYDROCHLORIDE
AB ALEMBIC PHARMS EQ 10MG BASE A208698 001 Apr 05, 2017
AB EQ 20MG BASE A208698 002 Apr 05, 2017
AB +! ALMATICA EQ 60MG BASE N202133 001 Oct 06, 2011
AB AUROBINDO PHARMA EQ 10MG BASE A213286 001 Apr 08, 2020
LTD
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-206(of 474)

FLUOXETINE HYDROCHLORIDE
TABLET;ORAL
FLUOXETINE HYDROCHLORIDE
AB EQ 20MG BASE A213286 002 Apr 08, 2020
AB EQ 60MG BASE A213265 001 Jun 10, 2020
AB DR REDDYS EQ 10MG BASE A076006 001 Jan 30, 2002
AB ! EQ 20MG BASE A076006 002 Apr 23, 2018
AB EQ 60MG BASE A211721 001 Jan 25, 2019
AB INVENTIA HLTHCARE EQ 60MG BASE A209695 001 Nov 20, 2017
AB LUPIN LTD EQ 10MG BASE A211653 001 Apr 15, 2019
AB EQ 20MG BASE A211653 002 Apr 15, 2019
AB EQ 60MG BASE A211632 001 Feb 08, 2019
AB PAR FORM EQ 10MG BASE A203836 001 Aug 19, 2016
AB EQ 20MG BASE A203836 002 Aug 19, 2016
AB PAR PHARM INC EQ 60MG BASE A209419 001 Nov 16, 2017
AB PIRAMAL HLTHCARE UK EQ 10MG BASE A211444 001 Sep 13, 2022
AB EQ 20MG BASE A211444 002 Sep 13, 2022
AB SCIEGEN PHARMS INC EQ 10MG BASE A210935 001 Mar 20, 2019
AB EQ 20MG BASE A210935 002 Mar 20, 2019
AB EQ 60MG BASE A211282 001 Jan 10, 2019
AB TARO EQ 60MG BASE A211477 001 Nov 21, 2018
AB TEVA EQ 10MG BASE A075872 001 Jan 29, 2002
AB EQ 20MG BASE A075872 002 Jan 04, 2019
AB TEVA PHARMS USA EQ 60MG BASE A211051 001 Dec 03, 2018
AB UPSHER SMITH LABS EQ 10MG BASE A211696 001 Jan 30, 2019
AB EQ 20MG BASE A211696 002 Jan 30, 2019
TORRENT EQ 10MG BASE A206937 001 Oct 21, 2016
! EQ 20MG BASE A206937 002 Oct 21, 2016
FLUOXETINE HYDROCHLORIDE; OLANZAPINE
CAPSULE;ORAL
OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
AB EPIC PHARMA EQ 25MG BASE;EQ 3MG BASE A078901 005 Nov 16, 2012
AB EQ 25MG BASE;EQ 6MG BASE A078901 001 Nov 16, 2012
AB EQ 25MG BASE;EQ 12MG BASE A078901 003 Nov 16, 2012
AB EQ 50MG BASE;EQ 6MG BASE A078901 002 Nov 16, 2012
AB EQ 50MG BASE;EQ 12MG BASE A078901 004 Nov 16, 2012
AB PAR PHARM EQ 25MG BASE;EQ 3MG BASE A077742 001 Nov 02, 2012
AB EQ 25MG BASE;EQ 6MG BASE A077742 002 Nov 02, 2012
AB EQ 25MG BASE;EQ 12MG BASE A077742 003 Nov 02, 2012
AB EQ 50MG BASE;EQ 6MG BASE A077742 004 Nov 02, 2012
AB EQ 50MG BASE;EQ 12MG BASE A077742 005 Nov 02, 2012
AB TEVA PHARMS EQ 25MG BASE;EQ 3MG BASE A202074 001 Mar 25, 2013
AB EQ 25MG BASE;EQ 6MG BASE A077528 001 Jun 19, 2012
AB EQ 25MG BASE;EQ 12MG BASE A077528 002 Jun 19, 2012
AB EQ 50MG BASE;EQ 6MG BASE A077528 003 Jun 19, 2012
AB EQ 50MG BASE;EQ 12MG BASE A077528 004 Jun 19, 2012
SYMBYAX
AB + LILLY EQ 25MG BASE;EQ 3MG BASE N021520 001 Apr 09, 2007
AB + EQ 25MG BASE;EQ 6MG BASE N021520 002 Dec 24, 2003
AB + EQ 25MG BASE;EQ 12MG BASE N021520 004 Dec 24, 2003
AB +! EQ 50MG BASE;EQ 6MG BASE N021520 003 Dec 24, 2003
AB + EQ 50MG BASE;EQ 12MG BASE N021520 005 Dec 24, 2003
FLUPHENAZINE DECANOATE
INJECTABLE;INJECTION
FLUPHENAZINE DECANOATE
AO EUGIA PHARMA 25MG/ML A207739 001 Oct 17, 2017
AO ! FRESENIUS KABI USA 25MG/ML A071413 001 Jul 14, 1987
AO HIKMA 25MG/ML A074531 001 Aug 30, 1996
AO MYLAN LABS LTD 25MG/ML A075918 001 Aug 17, 2001
AO PAR STERILE 25MG/ML A203732 001 Jul 03, 2014
PRODUCTS
FLUPHENAZINE HYDROCHLORIDE
CONCENTRATE;ORAL
FLUPHENAZINE HYDROCHLORIDE
! PHARM ASSOC 5MG/ML A074725 001 Sep 16, 1996
ELIXIR;ORAL
FLUPHENAZINE HYDROCHLORIDE
! PHARM ASSOC 2.5MG/5ML A040146 001 Aug 21, 1996
INJECTABLE;INJECTION
FLUPHENAZINE HYDROCHLORIDE
! FRESENIUS KABI USA 2.5MG/ML A089556 001 Apr 16, 1987
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-207(of 474)

FLUPHENAZINE HYDROCHLORIDE
TABLET;ORAL
FLUPHENAZINE HYDROCHLORIDE
AB AJANTA PHARMA LTD 1MG A217410 001 Jan 05, 2023
AB 2.5MG A217410 002 Jan 05, 2023
AB 5MG A217410 003 Jan 05, 2023
AB 10MG A217410 004 Jan 05, 2023
AB AMNEAL 1MG A213647 001 Jul 09, 2020
AB 2.5MG A213647 002 Jul 09, 2020
AB 5MG A213647 003 Jul 09, 2020
AB 10MG A213647 004 Jul 09, 2020
AB APOTEX 1MG A216649 001 Jul 15, 2022
AB 2.5MG A216649 002 Jul 15, 2022
AB 5MG A216649 003 Jul 15, 2022
AB 10MG A216649 004 Jul 15, 2022
AB CEROVENE INC 1MG A214534 001 Jan 07, 2021
AB 2.5MG A214534 002 Jan 07, 2021
AB 5MG A214534 003 Jan 07, 2021
AB 10MG A214534 004 Jan 07, 2021
AB LANNETT CO INC 1MG A089743 002 Aug 25, 1988
AB 2.5MG A089743 003 Aug 25, 1988
AB ! 5MG A089743 004 Aug 25, 1988
AB 10MG A089743 001 Aug 25, 1988
AB NOVITIUM PHARMA 1MG A214674 001 Mar 01, 2021
AB 2.5MG A214674 002 Mar 01, 2021
AB 5MG A214674 003 Mar 01, 2021
AB 10MG A214674 004 Mar 01, 2021
AB PRASCO 1MG A089804 002 Aug 12, 1988
AB 2.5MG A089804 003 Aug 12, 1988
AB 5MG A089804 004 Aug 12, 1988
AB 10MG A089804 001 Aug 12, 1988
AB SANDOZ INC 1MG A216891 001 Nov 15, 2022
AB 2.5MG A216891 002 Nov 15, 2022
AB 5MG A216891 003 Nov 15, 2022
AB 10MG A216891 004 Nov 15, 2022
AB TARO PHARM INDS LTD 1MG A215674 001 Apr 14, 2022
AB 2.5MG A215674 002 Apr 14, 2022
AB 5MG A215674 003 Apr 14, 2022
AB 10MG A215674 004 Apr 14, 2022
AB TWI PHARMS 1MG A215848 004 Dec 14, 2022
AB 2.5MG A215848 001 Apr 01, 2022
AB 5MG A215848 002 Apr 01, 2022
AB 10MG A215848 003 Apr 01, 2022
AB UPSHER SMITH LABS 1MG A213784 001 Oct 24, 2022
AB 2.5MG A213784 002 Oct 24, 2022
AB 5MG A213784 003 Oct 24, 2022
AB 10MG A213784 004 Oct 24, 2022
AB ZAMEER PHARMS 1MG A215141 001 Oct 20, 2021
AB 2.5MG A215141 002 Oct 20, 2021
AB 5MG A215141 003 Oct 20, 2021
AB 10MG A215141 004 Oct 20, 2021
AB ZYDUS 1MG A214552 001 May 27, 2021
AB 2.5MG A214552 002 May 27, 2021
AB 5MG A214552 003 May 27, 2021
AB 10MG A214552 004 May 27, 2021
FLURANDRENOLIDE
LOTION;TOPICAL
CORDRAN
AT +! ALMIRALL 0.05% N013790 001
FLURANDRENOLIDE
AT PADAGIS ISRAEL 0.05% A207133 001 Aug 30, 2016
OINTMENT;TOPICAL
CORDRAN
AT +! ALMIRALL 0.05% N012806 001
FLURANDRENOLIDE
AT TELIGENT 0.05% A207851 001 Dec 30, 2016
TAPE;TOPICAL
CORDRAN
+! ALMIRALL 0.004MG/SQ CM N016455 001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-208(of 474)

FLURAZEPAM HYDROCHLORIDE
CAPSULE;ORAL
FLURAZEPAM HYDROCHLORIDE
RISING 15MG A070345 002 Nov 27, 1985
! 30MG A070345 001 Nov 27, 1985
FLURBIPROFEN
TABLET;ORAL
FLURBIPROFEN
! TEVA 100MG A074431 001 May 31, 1995
FLURBIPROFEN SODIUM
SOLUTION/DROPS;OPHTHALMIC
FLURBIPROFEN SODIUM
! BAUSCH AND LOMB 0.03% A074447 001 Jan 04, 1995
FLUTAMIDE
CAPSULE;ORAL
FLUTAMIDE
! WAYLIS THERAP 125MG A075298 001 Sep 18, 2001
FLUTEMETAMOL F-18
INJECTABLE;INTRAVENOUS
VIZAMYL
+! GE HEALTHCARE 121.5mCi/30ML (4.05mCi/ML) N203137 002 Oct 25, 2013
FLUTICASONE FUROATE
POWDER;INHALATION
ARNUITY ELLIPTA
+! GLAXOSMITHKLINE 0.05MG/INH N205625 003 May 17, 2018
+! 0.1MG/INH N205625 001 Aug 20, 2014
+! 0.2MG/INH N205625 002 Aug 20, 2014
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
POWDER;INHALATION
TRELEGY ELLIPTA
+! GLAXOSMITHKLINE 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ N209482 001 Sep 18, 2017
0.025MG BASE/INH
+! 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ N209482 002 Sep 09, 2020
0.025MG BASE/INH
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
POWDER;INHALATION
BREO ELLIPTA
+! GLAXO GRP LTD 0.1MG/INH;EQ 0.025MG BASE/INH N204275 001 May 10, 2013
+! 0.2MG/INH;EQ 0.025MG BASE/INH N204275 002 Apr 30, 2015
FLUTICASONE PROPIONATE
AEROSOL, METERED;INHALATION
FLOVENT HFA
+! GLAXO GRP LTD 0.044MG/INH N021433 003 May 14, 2004
+! 0.11MG/INH N021433 002 May 14, 2004
+! 0.22MG/INH N021433 001 May 14, 2004
CREAM;TOPICAL
FLUTICASONE PROPIONATE
AB COSETTE 0.05% A077055 001 Jun 30, 2006
AB FOUGERA PHARMS 0.05% A076451 001 May 14, 2004
AB ! PADAGIS ISRAEL 0.05% A076793 001 May 14, 2004
LOTION;TOPICAL
FLUTICASONE PROPIONATE
AB ! GLENMARK GENERICS 0.05% A090759 001 May 02, 2011
AB PADAGIS ISRAEL 0.05% A091553 001 Jul 30, 2013
OINTMENT;TOPICAL
FLUTICASONE PROPIONATE
AB COSETTE 0.005% A077168 001 Mar 03, 2006
AB ! PADAGIS ISRAEL 0.005% A076668 001 May 14, 2004
POWDER;INHALATION
ARMONAIR DIGIHALER
+ TEVA PHARM 0.055MG/INH N208798 004 Feb 20, 2020
+ 0.113MG/INH N208798 005 Feb 20, 2020
+! 0.232MG/INH N208798 006 Feb 20, 2020
FLOVENT DISKUS 100
+! GLAXO GRP LTD 0.1MG/INH N020833 002 Sep 29, 2000
FLOVENT DISKUS 250
+! GLAXO GRP LTD 0.25MG/INH N020833 003 Sep 29, 2000
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-209(of 474)

FLUTICASONE PROPIONATE
POWDER;INHALATION
FLOVENT DISKUS 50
+! GLAXO GRP LTD 0.05MG/INH N020833 001 Sep 29, 2000
SPRAY, METERED;NASAL
FLUTICASONE PROPIONATE
AB AKORN 0.05MG/SPRAY A077570 001 Jan 16, 2008
AB APOTEX INC 0.05MG/SPRAY A077538 001 Sep 12, 2007
AB ! HIKMA 0.05MG/SPRAY A076504 001 Feb 22, 2006
AB WOCKHARDT BIO AG 0.05MG/SPRAY A078492 001 Jan 09, 2012
XHANCE
+! OPTINOSE US INC 0.093MG N209022 001 Sep 18, 2017
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
AEROSOL, METERED;INHALATION
ADVAIR HFA
+! GLAXO GRP LTD 0.045MG/INH;EQ 0.021MG BASE/INH N021254 001 Jun 08, 2006
+! 0.115MG/INH;EQ 0.021MG BASE/INH N021254 002 Jun 08, 2006
+! 0.23MG/INH;EQ 0.021MG BASE/INH N021254 003 Jun 08, 2006
POWDER;INHALATION
ADVAIR DISKUS 100/50
AB +! GLAXO GRP LTD 0.1MG/INH;EQ 0.05MG BASE/INH N021077 001 Aug 24, 2000
ADVAIR DISKUS 250/50
AB +! GLAXO GRP LTD 0.25MG/INH;EQ 0.05MG BASE/INH N021077 002 Aug 24, 2000
ADVAIR DISKUS 500/50
AB +! GLAXO GRP LTD 0.5MG/INH;EQ 0.05MG BASE/INH N021077 003 Aug 24, 2000
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE
AB HIKMA 0.1MG/INH;EQ 0.05MG BASE/INH A203433 001 Dec 17, 2020
AB 0.25MG/INH;EQ 0.05MG BASE/INH A203433 002 Dec 17, 2020
AB TEVA PHARMS USA 0.1MG/INH;EQ 0.05MG BASE/INH A213948 001 Dec 13, 2021
AB 0.25MG/INH;EQ 0.05MG BASE/INH A213948 002 Dec 13, 2021
AB 0.5MG/INH;EQ 0.05MG BASE/INH A213948 003 Dec 13, 2021
WIXELA INHUB
AB MYLAN 0.1MG/INH;EQ 0.05MG BASE/INH A208891 001 Jan 30, 2019
AB 0.25MG/INH;EQ 0.05MG BASE/INH A208891 002 Jan 30, 2019
AB 0.5MG/INH;EQ 0.05MG BASE/INH A208891 003 Jan 30, 2019
AIRDUO DIGIHALER
+ TEVA PHARM 0.055MG/INH;EQ 0.014MG BASE/INH N208799 004 Jul 12, 2019
+ 0.113MG/INH;EQ 0.014MG BASE/INH N208799 005 Jul 12, 2019
+ 0.232MG/INH;EQ 0.014MG BASE/INH N208799 006 Jul 12, 2019
AIRDUO RESPICLICK
+ TEVA PHARM 0.055MG/INH;EQ 0.014MG BASE/INH N208799 001 Jan 27, 2017
+ 0.113MG/INH;EQ 0.014MG BASE/INH N208799 002 Jan 27, 2017
+! 0.232MG/INH;EQ 0.014MG BASE/INH N208799 003 Jan 27, 2017
FLUVASTATIN SODIUM
CAPSULE;ORAL
FLUVASTATIN SODIUM
AB MYLAN PHARMS INC EQ 20MG BASE A090595 001 Apr 11, 2012
AB ! EQ 40MG BASE A090595 002 Apr 11, 2012
AB TEVA PHARMS EQ 20MG BASE A078407 001 Jun 12, 2012
AB EQ 40MG BASE A078407 002 Jun 12, 2012
TABLET, EXTENDED RELEASE;ORAL
FLUVASTATIN SODIUM
AB BEIJING EQ 80MG BASE A209397 001 Apr 26, 2021
AB TEVA PHARMS USA EQ 80MG BASE A079011 001 Jan 27, 2016
LESCOL XL
AB +! NOVARTIS EQ 80MG BASE N021192 001 Oct 06, 2000
FLUVOXAMINE MALEATE
CAPSULE, EXTENDED RELEASE;ORAL
FLUVOXAMINE MALEATE
AB ACTAVIS ELIZABETH 100MG A091482 001 Apr 23, 2013
AB ! 150MG A091482 002 Nov 18, 2013
AB ANCHEN PHARMS 100MG A091476 001 Mar 13, 2013
AB 150MG A091476 002 Mar 13, 2013
AB BIONPHARMA INC 100MG A212182 002 Sep 16, 2020
AB 150MG A212182 001 May 11, 2020
TABLET;ORAL
FLUVOXAMINE MALEATE
AB APOTEX 25MG A075902 001 May 07, 2001
AB 50MG A075902 002 May 07, 2001
AB 100MG A075902 003 May 07, 2001
AB UPSHER SMITH LABS 25MG A075888 001 Nov 29, 2000
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-210(of 474)

FLUVOXAMINE MALEATE
TABLET;ORAL
FLUVOXAMINE MALEATE
AB 50MG A075888 002 Nov 29, 2000
AB ! 100MG A075888 003 Nov 29, 2000
LUVOX
AB ANI PHARMS 25MG N021519 001 Dec 20, 2007
AB 50MG N021519 002 Dec 20, 2007
AB 100MG N021519 003 Dec 20, 2007
FOLIC ACID
INJECTABLE;INJECTION
FOLIC ACID
AP ! FRESENIUS KABI USA 5MG/ML A089202 001 Feb 18, 1986
AP XGEN PHARMS 5MG/ML A202522 001 Nov 06, 2019
TABLET;ORAL
FOLIC ACID
AA ! AMNEAL PHARM 1MG A040625 001 Jul 21, 2005
AA ATHEM 1MG A211064 001 Mar 08, 2019
AA CADILA PHARMS LTD 1MG A202437 001 Jan 27, 2014
AA CHARTWELL MOLECULAR 1MG A090035 001 Jun 09, 2009
AA LEADING 1MG A040796 001 Jan 12, 2009
AA NUVO PHARMS INC 1MG A204418 001 Jul 28, 2015
AA QINGDAO BAHEAL 1MG A091145 001 Jul 12, 2013
PHARM
AA +! WATSON LABS 1MG A080680 001
FOMEPIZOLE
INJECTABLE;INJECTION
FOMEPIZOLE
AP AM REGENT 1.5GM/1.5ML (1GM/ML) A078368 001 Dec 14, 2007
AP ! MYLAN INSTITUTIONAL 1.5GM/1.5ML (1GM/ML) A078639 001 Mar 03, 2008
AP NAVINTA LLC 1.5GM/1.5ML (1GM/ML) A078537 001 Mar 06, 2008
FONDAPARINUX SODIUM
INJECTABLE;SUBCUTANEOUS
ARIXTRA
AP +! MYLAN IRELAND LTD 2.5MG/0.5ML N021345 001 Dec 07, 2001
AP +! 5MG/0.4ML N021345 002 May 28, 2004
AP +! 7.5MG/0.6ML N021345 003 May 28, 2004
AP +! 10MG/0.8ML N021345 004 May 28, 2004
FONDAPARINUX SODIUM
AP DR REDDYS LABS LTD 2.5MG/0.5ML A091316 001 Jul 11, 2011
AP 5MG/0.4ML A091316 002 Jul 11, 2011
AP 7.5MG/0.6ML A091316 003 Jul 11, 2011
AP 10MG/0.8ML A091316 004 Jul 11, 2011
AP EUGIA PHARMA 2.5MG/0.5ML A206918 001 Dec 26, 2017
AP 5MG/0.4ML A206918 002 Dec 26, 2017
AP 7.5MG/0.6ML A206918 003 Dec 26, 2017
AP 10MG/0.8ML A206918 004 Dec 26, 2017
AP HENGRUI PHARMA 2.5MG/0.5ML A206812 001 May 15, 2018
AP 5MG/0.4ML A206812 002 May 15, 2018
AP 7.5MG/0.6ML A206812 003 May 15, 2018
AP 10MG/0.8ML A206812 004 May 15, 2018
AP SCINOPHARM TAIWAN 2.5MG/0.5ML A208615 001 Nov 14, 2018
AP 5MG/0.4ML A208615 002 Nov 14, 2018
AP 7.5MG/0.6ML A208615 003 Nov 14, 2018
AP 10MG/0.8ML A208615 004 Nov 14, 2018
FORMOTEROL FUMARATE
SOLUTION;INHALATION
FORMOTEROL FUMARATE
AN ALEMBIC PHARMS 0.02MG/2ML A215078 001 Nov 22, 2021
AN AUCTA 0.02MG/2ML A216486 001 Nov 25, 2022
AN LUPIN 0.02MG/2ML A215053 001 Aug 22, 2022
AN SLAYBACK PHARMA LLC 0.02MG/2ML A215621 001 Dec 13, 2022
AN TEVA PHARMS USA INC 0.02MG/2ML A091141 001 Jun 22, 2021
PERFOROMIST
AN +! MYLAN SPECLT 0.02MG/2ML N022007 001 May 11, 2007
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-211(of 474)

FORMOTEROL FUMARATE; GLYCOPYRROLATE


AEROSOL, METERED;INHALATION
BEVESPI AEROSPHERE
+! ASTRAZENECA 0.0048MG/INH;0.0090MG/INH N208294 001 Apr 25, 2016
FORMOTEROL FUMARATE; MOMETASONE FUROATE
AEROSOL, METERED;INHALATION
DULERA
+ ORGANON LLC 0.005MG/INH;0.05MG/INH N022518 003 Aug 12, 2019
+! 0.005MG/INH;0.1MG/INH N022518 001 Jun 22, 2010
+! 0.005MG/INH;0.2MG/INH N022518 002 Jun 22, 2010
FOSAMPRENAVIR CALCIUM
SUSPENSION;ORAL
LEXIVA
+! VIIV HLTHCARE EQ 50MG BASE/ML N022116 001 Jun 14, 2007
TABLET;ORAL
FOSAMPRENAVIR CALCIUM
AB MYLAN EQ 700MG BASE A204060 001 Apr 15, 2016
AB SUN PHARM EQ 700MG BASE A204024 001 Nov 20, 2019
LEXIVA
AB +! VIIV HLTHCARE EQ 700MG BASE N021548 001 Oct 20, 2003
FOSAPREPITANT DIMEGLUMINE
POWDER;INTRAVENOUS
EMEND
AP +! MERCK AND CO INC EQ 150MG BASE/VIAL N022023 002 Nov 12, 2010
FOSAPREPITANT DIMEGLUMINE
AP ACCORD HLTHCARE EQ 150MG BASE/VIAL A204025 001 Aug 26, 2020
AP ASPIRO EQ 150MG BASE/VIAL A214616 001 Jul 29, 2021
AP BAXTER HLTHCARE EQ 150MG BASE/VIAL A211860 001 Sep 05, 2019
CORP
AP BE PHARMS EQ 150MG BASE/VIAL A212309 001 Sep 05, 2019
AP CHIA TAI TIANQING EQ 150MG BASE/VIAL A212143 001 Mar 03, 2021
AP DR REDDYS EQ 150MG BASE/VIAL A211160 001 Dec 09, 2020
AP EUGIA PHARMA EQ 150MG BASE/VIAL A210625 001 Jan 12, 2021
AP FRESENIUS KABI USA EQ 150MG BASE/VIAL A206197 001 Jun 09, 2016
AP LUPIN LTD EQ 150MG BASE/VIAL A210689 001 Sep 05, 2019
AP MSN EQ 150MG BASE/VIAL A209965 001 Sep 05, 2019
AP MYLAN LABS LTD EQ 150MG BASE/VIAL A204015 002 Sep 05, 2019
AP NAVINTA LLC EQ 150MG BASE/VIAL A212957 002 Aug 20, 2020
AP QILU PHARM HAINAN EQ 150MG BASE/VIAL A213106 001 Sep 08, 2020
TEVA PHARMS USA EQ 150MG BASE/VIAL N210064 001 Sep 05, 2019
FOSCARNET SODIUM
INJECTABLE;INJECTION
FOSCARNET SODIUM
AP FRESENIUS KABI USA 2.4GM/100ML A212483 001 Jan 29, 2021
AP GLAND PHARMA LTD 2.4GM/100ML A213001 001 Apr 21, 2021
FOSCAVIR
AP +! CLINIGEN HLTHCARE 2.4GM/100ML N020068 001 Sep 27, 1991
FOSDENOPTERIN HYDROBROMIDE
POWDER;INTRAVENOUS
NULIBRY
+! SENTYNL THERAPS INC EQ 9.5MG BASE/VIAL N214018 001 Feb 26, 2021
FOSFOMYCIN TROMETHAMINE
FOR SOLUTION;ORAL
FOSFOMYCIN TROMETHAMINE
AA ALKEM LABS LTD EQ 3GM BASE/PACKET A214554 001 Oct 21, 2021
AA CIPLA EQ 3GM BASE/PACKET A211881 001 Jan 26, 2022
AA XIROMED EQ 3GM BASE/PACKET A212548 001 Oct 06, 2020
MONUROL
AA +! ZAMBON SPA EQ 3GM BASE/PACKET N050717 001 Dec 19, 1996
FOSINOPRIL SODIUM
TABLET;ORAL
FOSINOPRIL SODIUM
AB APOTEX INC 10MG A076906 001 May 17, 2005
AB 20MG A076906 002 May 17, 2005
AB 40MG A076906 003 May 17, 2005
AB AUROBINDO PHARMA 10MG A091163 001 Mar 30, 2011
LTD
AB 20MG A091163 002 Mar 30, 2011
AB 40MG A091163 003 Mar 30, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-212(of 474)

FOSINOPRIL SODIUM
TABLET;ORAL
FOSINOPRIL SODIUM
AB CHARTWELL RX 10MG A076483 001 Apr 23, 2004
AB 20MG A076483 002 Apr 23, 2004
AB 40MG A076483 003 Apr 23, 2004
AB INVAGEN PHARMS 10MG A077222 001 Apr 20, 2005
AB 20MG A077222 002 Apr 20, 2005
AB 40MG A077222 003 Apr 20, 2005
AB PRINSTON INC 10MG A205670 001 Aug 29, 2016
AB 20MG A205670 002 Aug 29, 2016
AB 40MG A205670 003 Aug 29, 2016
AB TEVA 10MG A076139 001 Nov 25, 2003
AB 20MG A076139 002 Nov 25, 2003
AB ! 40MG A076139 003 Nov 25, 2003
FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE
TABLET;ORAL
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
AB AUROBINDO PHARMA 10MG;12.5MG A079245 001 Jul 09, 2009
AB ! 20MG;12.5MG A079245 002 Jul 09, 2009
AB INVAGEN PHARMS 10MG;12.5MG A090228 001 Jul 09, 2009
AB 20MG;12.5MG A090228 002 Jul 09, 2009
AB SANDOZ 10MG;12.5MG A076961 001 Sep 28, 2005
AB 20MG;12.5MG A076961 002 Sep 28, 2005
FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE
POWDER;INTRAVENOUS
AKYNZEO
+! HELSINN HLTHCARE EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL N210493 001 Apr 19, 2018
SOLUTION;INTRAVENOUS
AKYNZEO
+! HELSINN HLTHCARE EQ 235MG BASE/20ML (EQ 11.75MG N210493 002 May 27, 2020
BASE/ML);EQ 0.25MG BASE/20ML (EQ
0.0125MG BASE/ML)
FOSPHENYTOIN SODIUM
INJECTABLE;INJECTION
CEREBYX
AP +! PARKE DAVIS EQ 50MG PHENYTOIN NA/ML N020450 001 Aug 05, 1996
FOSPHENYTOIN SODIUM
AP FRESENIUS KABI USA EQ 50MG PHENYTOIN NA/ML A078052 001 Aug 06, 2007
AP HIKMA EQ 50MG PHENYTOIN NA/ML A077481 001 Aug 06, 2007
AP EQ 50MG PHENYTOIN NA/ML A077989 001 Aug 06, 2007
AP HIKMA FARMACEUTICA EQ 50MG PHENYTOIN NA/ML A078765 001 Dec 02, 2009
AP MYLAN LABS LTD EQ 50MG PHENYTOIN NA/ML A078736 001 Jun 08, 2010
AP SUN PHARM EQ 50MG PHENYTOIN NA/ML A078417 001 Mar 18, 2008
AP WOCKHARDT EQ 50MG PHENYTOIN NA/ML A078137 001 Aug 06, 2007
FOSTAMATINIB DISODIUM
TABLET;ORAL
TAVALISSE
+ RIGEL PHARMS INC EQ 100MG BASE N209299 001 Apr 17, 2018
+! EQ 150MG BASE N209299 002 Apr 17, 2018
FOSTEMSAVIR TROMETHAMINE
TABLET, EXTENDED RELEASE;ORAL
RUKOBIA
+! VIIV HLTHCARE EQ 600MG BASE N212950 001 Jul 02, 2020
FROVATRIPTAN SUCCINATE
TABLET;ORAL
FROVA
AB +! ENDO PHARMS EQ 2.5MG BASE N021006 001 Nov 08, 2001
FROVATRIPTAN SUCCINATE
AB AMNEAL PHARMS CO EQ 2.5MG BASE A211292 001 Nov 06, 2018
AB GLENMARK PHARMS LTD EQ 2.5MG BASE A204730 001 Mar 11, 2016
AB MYLAN EQ 2.5MG BASE A202931 001 Aug 28, 2014
AB RENATA EQ 2.5MG BASE A213891 001 Apr 06, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-213(of 474)

FULVESTRANT
SOLUTION;INTRAMUSCULAR
FASLODEX
AO +! ASTRAZENECA 250MG/5ML (50MG/ML) N021344 001 Apr 25, 2002
FULVESTRANT
AO ACCORD HLTHCARE 250MG/5ML (50MG/ML) A211689 001 Nov 17, 2020
AO ALEMBIC PHARMS 250MG/5ML (50MG/ML) A215077 001 Dec 22, 2022
AO AMNEAL 250MG/5ML (50MG/ML) A210044 001 Mar 04, 2019
AO CHIA TAI TIANQING 250MG/5ML (50MG/ML) A211422 001 Feb 07, 2020
AO DR REDDYS 250MG/5ML (50MG/ML) A209246 001 Aug 07, 2020
AO EUGIA PHARMA 250MG/5ML (50MG/ML) A208811 001 Jul 23, 2019
AO GLENMARK PHARMS INC 250MG/5ML (50MG/ML) A207754 001 Aug 22, 2019
AO HBT LABS INC 250MG/5ML (50MG/ML) A209714 001 Nov 21, 2019
AO JIANGSU HANSOH 250MG/5ML (50MG/ML) A214682 001 Feb 10, 2022
PHARM
AO SAGENT PHARMS INC 250MG/5ML (50MG/ML) A205871 001 Aug 22, 2019
AO SANDOZ INC 250MG/5ML (50MG/ML) A205935 001 May 14, 2019
AO XIROMED 250MG/5ML (50MG/ML) A213553 001 Aug 13, 2021
AO ZYDUS PHARMS 250MG/5ML (50MG/ML) A215234 001 Jul 29, 2021
FRESENIUS KABI USA 250MG/5ML (50MG/ML) N210326 001 May 20, 2019
TEVA PHARMS USA INC 250MG/5ML (50MG/ML) N210063 001 Aug 19, 2019
FUROSEMIDE
INJECTABLE;INJECTION
FUROSEMIDE
AP ACCORD HLTHCARE 10MG/ML A070017 001 Dec 15, 1986
AP AREVA PHARMS 10MG/ML A208435 001 Dec 18, 2020
AP ATHENEX INC 10MG/ML A214766 001 Jan 27, 2021
AP ! BAXTER HLTHCARE 10MG/ML A202747 001 Jan 27, 2014
CORP
AP EMCURE PHARMS LTD 10MG/ML A203428 001 Aug 26, 2014
AP EUGIA PHARMA 10MG/ML A212174 001 May 03, 2019
AP FRESENIUS KABI USA 10MG/ML N018902 001 May 22, 1984
AP GLAND PHARMA LTD 10MG/ML A213902 001 Jul 01, 2020
AP HOSPIRA 10MG/ML A075241 001 May 28, 1999
AP 10MG/ML N018667 001 May 28, 1982
AP MANKIND PHARMA 10MG/ML A216860 001 Dec 16, 2022
AP MEITHEAL 10MG/ML A212803 001 Jan 27, 2022
AP WOCKHARDT 10MG/ML A077941 001 Mar 22, 2007
SOLUTION;ORAL
FUROSEMIDE
! HIKMA 10MG/ML A070434 001 Apr 22, 1987
40MG/5ML A070433 001 Apr 22, 1987
SOLUTION;SUBCUTANEOUS
FUROSCIX
+! SCPHARMACEUTICALS 80MG/10ML (8MG/ML) N209988 001 Oct 07, 2022
TABLET;ORAL
FUROSEMIDE
AB EPIC PHARMA LLC 20MG N018569 002
AB 40MG N018569 001
AB 80MG N018569 005 Aug 14, 1984
AB GRAVITI PHARMS 20MG A216629 001 Oct 17, 2022
AB 40MG A216629 002 Oct 17, 2022
AB 80MG A216629 003 Oct 17, 2022
AB HIKMA 20MG N018823 001 Nov 10, 1983
AB 40MG N018823 002 Nov 10, 1983
AB 80MG A070086 001 Jan 24, 1986
AB IPCA LABS LTD 20MG A078010 001 Sep 18, 2006
AB 40MG A078010 002 Sep 18, 2006
AB 80MG A078010 003 Sep 18, 2006
AB LEADING 20MG A077293 001 Nov 09, 2005
AB 40MG A077293 002 Nov 09, 2005
AB 80MG A077293 003 Nov 09, 2005
AB MYLAN 20MG N018487 001
AB 40MG N018487 002
AB 80MG A070082 001 Oct 29, 1986
AB PRINSTON INC 20MG A076796 001 Mar 26, 2004
AB 40MG A076796 002 Mar 26, 2004
AB 80MG A076796 003 Mar 26, 2004
LASIX
AB + VALIDUS PHARMS 20MG N016273 002
AB + 40MG N016273 001
AB +! 80MG N016273 003
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-214(of 474)

FUTIBATINIB
TABLET;ORAL
LYTGOBI
+! TAIHO ONCOLOGY 4MG N214801 001 Sep 30, 2022
GABAPENTIN
CAPSULE;ORAL
GABAPENTIN
AB ACI 100MG A206943 001 May 14, 2018
AB 300MG A206943 002 May 14, 2018
AB 400MG A206943 003 May 14, 2018
AB ACTAVIS ELIZABETH 100MG A075350 001 Sep 12, 2003
AB 300MG A075350 002 Sep 12, 2003
AB 400MG A075350 003 Sep 12, 2003
AB ALKEM 100MG A090858 001 Dec 17, 2010
AB 300MG A090858 002 Dec 17, 2010
AB 400MG A090858 003 Dec 17, 2010
AB AMNEAL PHARMS NY 100MG A078428 001 Jul 25, 2007
AB 300MG A078428 002 Jul 25, 2007
AB 400MG A078428 003 Jul 25, 2007
AB ASCENT PHARMS INC 100MG A214956 001 May 10, 2021
AB 300MG A214956 002 May 10, 2021
AB 400MG A214956 003 May 10, 2021
AB AUROBINDO PHARMA 100MG A078787 001 Jan 31, 2008
AB 300MG A078787 002 Jan 31, 2008
AB 400MG A078787 003 Jan 31, 2008
AB CSPC OUYI 100MG A075477 001 Mar 23, 2005
AB 300MG A075477 002 Mar 23, 2005
AB 400MG A075477 003 Mar 23, 2005
AB GRANULES 100MG A075360 001 Apr 06, 2005
AB 300MG A075360 002 Apr 06, 2005
AB 400MG A075360 003 Apr 06, 2005
AB GRAVITI PHARMS 100MG A207099 001 Mar 24, 2017
AB 300MG A207099 002 Mar 24, 2017
AB 400MG A207099 003 Mar 24, 2017
AB INVAGEN PHARMS 100MG A090705 001 Dec 30, 2009
AB 300MG A090705 002 Dec 30, 2009
AB 400MG A090705 003 Dec 30, 2009
AB MARKSANS PHARMA 100MG A090007 001 Jul 21, 2011
AB 300MG A090007 002 Jul 21, 2011
AB 400MG A090007 003 Jul 21, 2011
AB SCIEGEN PHARMS INC 100MG A204989 001 Feb 18, 2016
AB 300MG A204989 002 Feb 18, 2016
AB 400MG A204989 003 Feb 18, 2016
AB STRIDES PHARMA 100MG A211314 001 Oct 16, 2018
AB 300MG A211314 002 Oct 16, 2018
AB 400MG A211314 003 Oct 16, 2018
AB SUN PHARM INDS LTD 100MG A077242 001 Aug 24, 2006
AB 300MG A077242 002 Aug 24, 2006
AB 400MG A077242 003 Aug 24, 2006
AB TARO 100MG A077261 001 Aug 02, 2013
AB 300MG A077261 002 Aug 02, 2013
AB 400MG A077261 003 Aug 02, 2013
AB ZHEJIANG YONGTAI 100MG A213603 001 Aug 17, 2020
AB 300MG A213603 002 Aug 17, 2020
AB 400MG A213603 003 Aug 17, 2020
NEURONTIN
AB + VIATRIS 100MG N020235 001 Dec 30, 1993
AB + 300MG N020235 002 Dec 30, 1993
AB +! 400MG N020235 003 Dec 30, 1993
SOLUTION;ORAL
GABAPENTIN
AA ACELLA PHARMS LLC 250MG/5ML A076403 001 May 01, 2012
AA AKORN 250MG/5ML A078974 001 Feb 18, 2011
AA AMNEAL PHARMS 250MG/5ML A202024 001 Mar 23, 2012
AA BELCHER 250MG/5ML A091286 001 Mar 14, 2016
AA TARO 250MG/5ML A076672 001 Jul 03, 2013
NEURONTIN
AA +! VIATRIS 250MG/5ML N021129 001 Mar 02, 2000
TABLET;ORAL
GABAPENTIN
AB ACI 600MG A203244 002 Jul 12, 2013
AB 800MG A203244 001 Jul 12, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-215(of 474)

GABAPENTIN
TABLET;ORAL
GABAPENTIN
AB ACTAVIS ELIZABETH 600MG A075694 001 Oct 21, 2004
AB 800MG A075694 002 Oct 21, 2004
AB ALKEM LABS LTD 600MG A206402 001 Dec 23, 2015
AB 800MG A206402 002 Dec 23, 2015
AB APOTEX INC 100MG A077894 001 Oct 10, 2006
AB 300MG A077894 002 Oct 10, 2006
AB 400MG A077894 003 Oct 10, 2006
AB ASCENT PHARMS INC 600MG A214957 001 Oct 01, 2021
AB 800MG A214957 002 Oct 01, 2021
AB AUROBINDO PHARMA 600MG A200651 001 Oct 06, 2011
LTD
AB 800MG A200651 002 Oct 06, 2011
AB CSPC OUYI 600MG A207057 001 Oct 26, 2017
AB 800MG A207057 002 Oct 26, 2017
AB GLENMARK PHARMS LTD 600MG A077662 001 Aug 18, 2006
AB 800MG A077662 002 Aug 18, 2006
AB INVAGEN PHARMS 600MG A202764 001 Oct 16, 2012
AB 800MG A202764 002 Oct 16, 2012
AB IVAX SUB TEVA 100MG A076017 001 Apr 28, 2004
PHARMS
AB 300MG A076017 002 Apr 28, 2004
AB 400MG A076017 003 Apr 28, 2004
AB RUBICON 600MG A077661 004 Sep 13, 2006
AB 800MG A077661 005 Sep 13, 2006
AB SCIEGEN PHARMS INC 600MG A205101 001 Feb 04, 2016
AB 800MG A205101 002 Feb 04, 2016
AB SUN PHARM INDS LTD 600MG A077525 001 Aug 24, 2006
AB 800MG A077525 002 Aug 24, 2006
AB ZYDUS PHARMS USA 600MG A078926 001 Feb 11, 2011
INC
AB 800MG A078926 002 Feb 11, 2011
NEURONTIN
AB + VIATRIS 600MG N020882 001 Oct 09, 1998
AB +! 800MG N020882 002 Oct 09, 1998
GRALISE
BX +! ALMATICA 300MG N022544 001 Jan 28, 2011
BX +! 600MG N022544 002 Jan 28, 2011
GABAPENTIN ENACARBIL
TABLET, EXTENDED RELEASE;ORAL
HORIZANT
+ AZURITY 300MG N022399 002 Dec 13, 2011
+! 600MG N022399 001 Apr 06, 2011
GADOBENATE DIMEGLUMINE
INJECTABLE;INTRAVENOUS
MULTIHANCE
+! BRACCO 2.645GM/5ML (529MG/ML) N021357 001 Nov 23, 2004
+! 5.29GM/10ML (529MG/ML) N021357 002 Nov 23, 2004
+! 7.935GM/15ML (529MG/ML) N021357 003 Nov 23, 2004
+! 10.58GM/20ML (529MG/ML) N021357 004 Nov 23, 2004
MULTIHANCE MULTIPACK
+! BRACCO 26.45GM/50ML (529MG/ML) N021358 001 Nov 23, 2004
+! 52.9GM/100ML (529MG/ML) N021358 002 Nov 23, 2004
GADOBUTROL
SOLUTION;INTRAVENOUS
GADAVIST
AP +! BAYER HLTHCARE 1.20944GM/2ML (604.72MG/ML) N201277 006 Dec 18, 2013
AP +! 4.5354GM/7.5ML (604.72MG/ML) N201277 001 Mar 14, 2011
AP +! 6.0472GM/10ML (604.72MG/ML) N201277 002 Mar 14, 2011
AP +! 9.0708GM/15ML (604.72MG/ML) N201277 003 Mar 14, 2011
GADOBUTROL
AP HENGRUI PHARMA 1.20944GM/2ML (604.72MG/ML) A215061 001 Nov 17, 2022
AP 4.5354GM/7.5ML (604.72MG/ML) A215061 002 Nov 17, 2022
AP 6.0472GM/10ML (604.72MG/ML) A215061 003 Nov 17, 2022
AP 9.0708GM/15ML (604.72MG/ML) A215061 004 Nov 17, 2022
GADAVIST
+! BAYER HLTHCARE 18.1416GM/30ML (604.72MG/ML) N201277 004 Mar 14, 2011
+! 39.3068GM/65ML (604.72MG/ML) N201277 005 Mar 14, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-216(of 474)

GADODIAMIDE
INJECTABLE;INJECTION
OMNISCAN
+! GE HEALTHCARE 287MG/ML N020123 001 Jan 08, 1993
+! 28.7GM/100ML (287MG/ML) N022066 002 Sep 05, 2007
GADOPICLENOL
SOLUTION;INTRAVENOUS
ELUCIREM
+! GUERBET 1.4553GM/3ML (485.1MG/ML) N216986 001 Sep 21, 2022
+! 3.63825GM/7.5ML (485.1MG/ML) N216986 002 Sep 21, 2022
+! 4.851GM/10ML (485.1MG/ML) N216986 003 Sep 21, 2022
+! 7.2765GM/15ML (485.1MG/ML) N216986 004 Sep 21, 2022
+! 14.553GM/30ML (485.1MG/ML) N216986 005 Sep 21, 2022
+! 24.255GM/50ML (485.1MG/ML) N216986 006 Sep 21, 2022
+! 48.51GM/100ML (485.1MG/ML) N216986 007 Sep 21, 2022
GADOTERATE MEGLUMINE
SOLUTION;INTRAVENOUS
CLARISCAN
AP GE HEALTHCARE 7.538GM/20ML (376.9MG/ML) A210016 003 Nov 01, 2019
AP 1.8845GM/5ML (376.9MG/ML) A210016 005 Nov 24, 2020
AP 3.769GM/10ML (376.9MG/ML) A210016 001 Nov 01, 2019
AP 5.6535GM/15ML (376.9MG/ML) A210016 002 Nov 01, 2019
AP 37.69GM/100ML (376.9MG/ML) A210016 004 Aug 04, 2020
DOTAREM
AP +! GUERBET 37.69GM/100ML (376.9MG/ML) N204781 001 Mar 20, 2013
AP +! 1.8845GM/5ML (376.9MG/ML) N204781 005 Mar 31, 2017
AP +! 3.769GM/10ML (376.9MG/ML) N204781 002 Mar 20, 2013
AP +! 5.6535GM/15ML (376.9MG/ML) N204781 003 Mar 20, 2013
AP +! 7.538GM/20ML (376.9MG/ML) N204781 004 Mar 20, 2013
GADOTERATE MEGLUMINE
AP HENGRUI PHARMA 1.8845GM/5ML (376.9MG/ML) A215304 001 Apr 11, 2022
AP 3.769GM/10ML (376.9MG/ML) A215304 002 Apr 11, 2022
AP 5.6535GM/15ML (376.9MG/ML) A215304 003 Apr 11, 2022
AP 7.538GM/20ML (376.9MG/ML) A215304 004 Apr 11, 2022
AP 37.69GM/100ML (376.9MG/ML) A215982 001 Apr 15, 2022
GADOTERIDOL
INJECTABLE;INJECTION
PROHANCE
+! BRACCO 279.3MG/ML N020131 001 Nov 16, 1992
PROHANCE MULTIPACK
+! BRACCO 279.3MG/ML N021489 001 Oct 09, 2003
GADOXETATE DISODIUM
SOLUTION;INTRAVENOUS
EOVIST
+! BAYER HLTHCARE 1.8143GM/10ML (181.43MG/ML) N022090 001 Jul 03, 2008
+ 2.72145GM/15ML (181.43MG/ML) N022090 002 Feb 04, 2013
GALANTAMINE HYDROBROMIDE
CAPSULE, EXTENDED RELEASE;ORAL
GALANTAMINE HYDROBROMIDE
AB AUROBINDO PHARMA EQ 8MG BASE A204895 001 Aug 05, 2016
AB EQ 16MG BASE A204895 002 Aug 05, 2016
AB EQ 24MG BASE A204895 003 Aug 05, 2016
AB BARR EQ 8MG BASE A078189 001 Sep 15, 2008
AB EQ 16MG BASE A078189 002 Sep 15, 2008
AB EQ 24MG BASE A078189 003 Sep 15, 2008
AB SUN PHARM EQ 8MG BASE A090178 001 Feb 02, 2011
AB EQ 16MG BASE A090178 002 Feb 02, 2011
AB EQ 24MG BASE A090178 003 Feb 02, 2011
AB WATSON LABS EQ 8MG BASE A079028 001 Dec 15, 2008
AB EQ 16MG BASE A079028 002 Dec 15, 2008
AB EQ 24MG BASE A079028 003 Dec 15, 2008
RAZADYNE ER
AB +! JANSSEN PHARMS EQ 8MG BASE N021615 001 Apr 01, 2005
AB + EQ 16MG BASE N021615 002 Apr 01, 2005
AB + EQ 24MG BASE N021615 003 Apr 01, 2005
SOLUTION;ORAL
GALANTAMINE HYDROBROMIDE
! HIKMA 4MG/ML A078185 001 Jan 30, 2009
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-217(of 474)

GALANTAMINE HYDROBROMIDE
TABLET;ORAL
GALANTAMINE HYDROBROMIDE
AB AUROBINDO PHARMA EQ 4MG BASE A090957 001 Mar 29, 2011
LTD
AB EQ 8MG BASE A090957 002 Mar 29, 2011
AB EQ 12MG BASE A090957 003 Mar 29, 2011
AB BARR EQ 4MG BASE A077605 001 Aug 28, 2008
AB EQ 8MG BASE A077605 002 Aug 28, 2008
AB EQ 12MG BASE A077605 003 Aug 28, 2008
AB DR REDDYS LABS LTD EQ 4MG BASE A077593 001 Sep 11, 2008
AB EQ 8MG BASE A077593 002 Sep 11, 2008
AB EQ 12MG BASE A077593 003 Sep 11, 2008
AB SANDOZ EQ 4MG BASE A077589 001 Jun 22, 2009
AB EQ 8MG BASE A077589 002 Jun 22, 2009
AB EQ 12MG BASE A077589 003 Jun 22, 2009
AB ! YABAO PHARM EQ 4MG BASE A077604 001 Feb 06, 2009
AB EQ 8MG BASE A077604 002 Feb 06, 2009
AB EQ 12MG BASE A077604 003 Feb 06, 2009
AB ZYDUS PHARMS USA EQ 4MG BASE A078898 001 Feb 17, 2011
INC
AB EQ 8MG BASE A078898 002 Feb 17, 2011
AB EQ 12MG BASE A078898 003 Feb 17, 2011
GALLIUM CITRATE GA-67
INJECTABLE;INJECTION
GALLIUM CITRATE GA 67
BS CURIUM 2mCi/ML N018058 001
BS LANTHEUS MEDCL 2mCi/ML N017478 001
GALLIUM DOTATATE GA-68
POWDER;INTRAVENOUS
NETSPOT
+! AAA USA INC 2.1-5.5mCi/ML N208547 001 Jun 01, 2016
GALLIUM GA-68 DOTATOC
SOLUTION;INTRAVENOUS
GALLIUM GA 68 DOTATOC
+! UIHC PET IMAGING 0.5-4mCi/ML N210828 001 Aug 21, 2019
GALLIUM GA-68 GOZETOTIDE
POWDER;INTRAVENOUS
ILLUCCIX
+! TELIX N/A N214032 001 Dec 17, 2021
LOCAMETZ
+! AAA USA NOVARTIS N/A N215841 001 Mar 23, 2022
SOLUTION;INTRAVENOUS
GALLIUM GA 68 GOZETOTIDE
+! UNIV CA LOS ANGELES 0.5-5mCi/mL N212642 001 Dec 01, 2020
+! UNIV OF CA SAN FRAN 0.5-5mCi/mL N212643 001 Dec 01, 2020
GANAXOLONE
SUSPENSION;ORAL
ZTALMY
+! MARINUS 50MG/ML N215904 001 Jun 01, 2022
GANCICLOVIR
GEL;OPHTHALMIC
ZIRGAN
+! BAUSCH AND LOMB 0.15% N022211 001 Sep 15, 2009
SOLUTION;INTRAVENOUS
GANZYK-RTU
+! EXELA PHARMA 500MG/250ML (2MG/ML) N209347 001 Feb 17, 2017
GANCICLOVIR SODIUM
INJECTABLE;INJECTION
GANCICLOVIR SODIUM
AP FRESENIUS KABI USA EQ 500MG BASE/VIAL A090658 001 Jun 21, 2010
AP HAINAN POLY PHARM EQ 500MG BASE/VIAL A204204 001 Nov 08, 2018
AP HIKMA EQ 500MG BASE/VIAL A076222 001 Jul 16, 2003
AP PAR STERILE EQ 500MG BASE/VIAL A204950 001 Dec 06, 2016
PRODUCTS
AP ! PHARMASCIENCE INC EQ 500MG BASE/VIAL A207645 001 Dec 08, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-218(of 474)

GANIRELIX ACETATE
INJECTABLE;INJECTION
FYREMADEL
AP SUN PHARM 250MCG/0.5ML A204246 001 Nov 30, 2018
GANIRELIX ACETATE
AP AMPHASTAR PHARMS 250MCG/0.5ML A212613 001 Apr 07, 2022
INC
AP MEITHEAL 250MCG/0.5ML A214996 001 Jun 06, 2022
AP +! ORGANON USA INC 250MCG/0.5ML N021057 001 Jul 29, 1999
GATIFLOXACIN
SOLUTION/DROPS;OPHTHALMIC
GATIFLOXACIN
AT AKORN 0.5% A203189 001 Sep 03, 2014
AT LUPIN LTD 0.5% A202653 001 Aug 28, 2013
AT SANDOZ INC 0.5% A204227 001 Jul 11, 2016
ZYMAXID
AT +! ALLERGAN 0.5% N022548 001 May 18, 2010
ZYMAR
+! ALLERGAN 0.3% N021493 001 Mar 28, 2003
GEFITINIB
TABLET;ORAL
GEFITINIB
AB APOTEX 250MG A209532 001 Sep 23, 2022
IRESSA
AB +! ASTRAZENECA 250MG N206995 001 Jul 13, 2015
GEMCITABINE HYDROCHLORIDE
INJECTABLE;INJECTION
GEMCITABINE HYDROCHLORIDE
AP ACCORD HLTHCARE EQ 200MG BASE/VIAL A091594 001 Jul 25, 2011
AP EQ 1GM BASE/VIAL A091594 002 Jul 25, 2011
AP EQ 2GM BASE/VIAL A091594 003 Jul 25, 2011
AP DR REDDYS LABS LTD EQ 200MG BASE/VIAL A091365 001 Jul 25, 2011
AP EQ 1GM BASE/VIAL A091365 002 Jul 25, 2011
AP EQ 2GM BASE/VIAL A202997 001 May 07, 2013
AP FRESENIUS KABI USA EQ 200MG BASE/VIAL A090799 001 Jul 25, 2011
AP EQ 1GM BASE/VIAL A090799 002 Jul 25, 2011
AP EQ 2GM BASE/VIAL A090242 003 May 16, 2011
AP EQ 2GM BASE/VIAL A090799 003 May 16, 2011
AP GLAND PHARMA LTD EQ 200MG BASE/VIAL A204520 001 Jan 05, 2016
AP EQ 1GM BASE/VIAL A204520 002 Jan 05, 2016
AP HIKMA INTL PHARMS EQ 200MG BASE/VIAL A206617 001 Jun 25, 2021
AP EQ 1GM BASE/VIAL A206617 002 Jun 25, 2021
AP HOSPIRA EQ 200MG BASE/VIAL A078339 001 Jul 25, 2011
AP EQ 1GM BASE/VIAL A078339 002 Jul 25, 2011
AP +! HOSPIRA INC 200MG/5.26ML (38MG/ML) N200795 001 Aug 04, 2011
AP +! 1GM/26.3ML (38MG/ML) N200795 002 Aug 04, 2011
AP ! EQ 2GM BASE/VIAL A079183 001 Nov 15, 2010
AP +! 2GM/52.6ML (38MG/ML) N200795 003 Aug 04, 2011
AP ! JIANGSU HANSOH EQ 200MG BASE/VIAL A202485 001 May 07, 2013
PHARM
AP ! EQ 1GM BASE/VIAL A202485 002 May 07, 2013
AP MEITHEAL 200MG/5.26ML (38MG/ML) A212129 001 Dec 11, 2020
AP 1GM/26.3ML (38MG/ML) A212129 002 Dec 11, 2020
AP 2GM/52.6ML (38MG/ML) A212129 003 Dec 11, 2020
AP MYLAN LABS LTD 200MG/5.26ML (38MG/ML) A205242 001 Dec 06, 2017
AP 1GM/26.3ML (38MG/ML) A205242 002 Dec 06, 2017
AP 2GM/52.6ML (38MG/ML) A205242 003 Dec 06, 2017
AP SAGENT PHARMS INC 200MG/5.26ML (38MG/ML) A209077 001 Jul 20, 2018
AP 1GM/26.3ML (38MG/ML) A209077 002 Jul 20, 2018
AP 2GM/52.6ML (38MG/ML) A209077 003 Jul 20, 2018
AP SHILPA EQ 200MG BASE/VIAL A207575 001 Feb 22, 2019
AP 200MG/5.26ML (38MG/ML) A210991 001 Oct 04, 2019
AP EQ 1GM BASE/VIAL A207575 002 Feb 22, 2019
AP 1GM/26.3ML (38MG/ML) A210991 002 Oct 04, 2019
AP 2GM/52.6ML (38MG/ML) A210991 003 Oct 04, 2019
AP SUN PHARM EQ 200MG BASE/VIAL A078433 001 Jul 25, 2011
AP EQ 1GM BASE/VIAL A078433 002 Jul 25, 2011
AP TEYRO LABS EQ 200MG BASE/VIAL A078759 001 Jul 25, 2011
AP EQ 1GM BASE/VIAL A078759 002 Jul 25, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-219(of 474)

GEMCITABINE HYDROCHLORIDE
SOLUTION;INTRAVENOUS
GEMCITABINE HYDROCHLORIDE
+! ACCORD HLTHCARE 1GM/10ML (100MG/ML) N209604 002 Aug 03, 2017
+! 1.5GM/15ML (100MG/ML) N209604 003 Aug 03, 2017
+! 2GM/20ML (100MG/ML) N209604 004 Aug 03, 2017
+! 200MG/2ML (100MG/ML) N209604 001 Aug 03, 2017
INFUGEM
+! SUN PHARM EQ 1200MG BASE/120ML (EQ 10MG BASE/ML) N208313 001 Jul 16, 2018
+! EQ 1300MG BASE/130ML (EQ 10MG BASE/ML) N208313 002 Jul 16, 2018
+! EQ 1400MG BASE/140ML (EQ 10MG BASE/ML) N208313 003 Jul 16, 2018
+! EQ 1500MG BASE/150ML (EQ 10MG BASE/ML) N208313 004 Jul 16, 2018
+! EQ 1600MG BASE/160ML (EQ 10MG BASE/ML) N208313 005 Jul 16, 2018
+! EQ 1700MG BASE/170ML (EQ 10MG BASE/ML) N208313 006 Jul 16, 2018
+! EQ 1800MG BASE/180ML (EQ 10MG BASE/ML) N208313 007 Jul 16, 2018
+! EQ 1900MG BASE/190ML (EQ 10MG BASE/ML) N208313 008 Jul 16, 2018
+! EQ 2000MG BASE/200ML (EQ 10MG BASE/ML) N208313 009 Jul 16, 2018
+! EQ 2200MG BASE/220ML (EQ 10MG BASE/ML) N208313 010 Jul 16, 2018
GEMFIBROZIL
TABLET;ORAL
GEMFIBROZIL
AB APOTEX 600MG A075034 001 Jul 20, 1998
AB ASCENT PHARMS INC 600MG A214603 001 Jan 13, 2021
AB AUROBINDO PHARMA 600MG A202726 001 Sep 16, 2015
LTD
AB CADILA PHARMS LTD 600MG A203266 001 Jun 17, 2016
AB CARIBE HOLDINGS 600MG A078012 001 Mar 26, 2007
AB CHARTWELL MOLECULES 600MG A074270 001 Sep 27, 1993
AB IMPAX PHARMS 600MG A078207 001 Jun 01, 2007
AB INVAGEN PHARMS 600MG A077836 001 Jul 27, 2006
AB NORTHSTAR HLTHCARE 600MG A079072 001 Sep 13, 2010
LOPID
AB +! PFIZER PHARMS 600MG N018422 003 Nov 20, 1986
GENTAMICIN SULFATE
CREAM;TOPICAL
GENTAMICIN SULFATE
AT COSETTE EQ 0.1% BASE A064056 001 Apr 29, 1994
AT ! PADAGIS US EQ 0.1% BASE A062307 001
INJECTABLE;INJECTION
GENTAMICIN SULFATE
AP ! FRESENIUS KABI USA EQ 10MG BASE/ML A062366 002 Feb 06, 1986
AP ! EQ 40MG BASE/ML A062366 001 Aug 04, 1983
AP HOSPIRA EQ 10MG BASE/ML A062420 001 Aug 15, 1983
AP EQ 40MG BASE/ML A062420 002 Aug 15, 1983
GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE EQ 1.2MG BASE/ML A062373 007 Sep 07, 1982
AP EQ 1.6MG BASE/ML A062373 008 Sep 07, 1982
AP EQ 80MG BASE/100ML A062373 002 Sep 07, 1982
AP EQ 100MG BASE/100ML A062373 005 Sep 07, 1982
AP HOSPIRA EQ 1.2MG BASE/ML A062414 001 Aug 15, 1983
AP EQ 1.6MG BASE/ML A062414 003 Aug 15, 1983
AP EQ 80MG BASE/100ML A062414 008 Aug 15, 1983
AP EQ 100MG BASE/100ML A062414 010 Aug 15, 1983
! BAXTER HLTHCARE EQ 2MG BASE/ML A062373 009 Sep 07, 1982
! EQ 120MG BASE/100ML A062373 006 Sep 07, 1982
OINTMENT;OPHTHALMIC
GENTAMICIN SULFATE
AT ! AKORN EQ 0.3% BASE A064093 001 Aug 31, 1995
AT FERA PHARMS LLC EQ 0.3% BASE A065024 001 Jul 30, 2004
OINTMENT;TOPICAL
GENTAMICIN SULFATE
AT COSETTE EQ 0.1% BASE A064054 001 Apr 29, 1994
AT FOUGERA PHARMS INC EQ 0.1% BASE A062533 001 Oct 05, 1984
AT ! PADAGIS US EQ 0.1% BASE A062351 001 Feb 18, 1982
AT PAI HOLDINGS PHARM EQ 0.1% BASE A209233 001 Dec 31, 2018
AT TARO EQ 0.1% BASE A062477 001 Dec 23, 1983
SOLUTION/DROPS;OPHTHALMIC
GENOPTIC
AT ! ALLERGAN EQ 0.3% BASE A062452 001 Oct 10, 1984
GENTAK
AT AKORN EQ 0.3% BASE A064163 001 Oct 12, 2001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-220(of 474)

GENTAMICIN SULFATE
SOLUTION/DROPS;OPHTHALMIC
GENTAMICIN SULFATE
AT BAUSCH AND LOMB EQ 0.3% BASE A064048 001 May 11, 1994
AT PADAGIS US EQ 0.3% BASE A065121 001 Jan 30, 2004
AT SANDOZ INC EQ 0.3% BASE A062196 001
GENTAMICIN SULFATE; PREDNISOLONE ACETATE
OINTMENT;OPHTHALMIC
PRED-G
+! ALLERGAN EQ 0.3% BASE;0.6% N050612 001 Dec 01, 1989
GILTERITINIB FUMARATE
TABLET;ORAL
XOSPATA
+! ASTELLAS EQ 40MG BASE N211349 001 Nov 28, 2018
GIVOSIRAN SODIUM
SOLUTION;SUBCUTANEOUS
GIVLAARI
+! ALNYLAM PHARMS INC EQ 189MG BASE/ML (EQ 189MG BASE/ML) N212194 001 Nov 20, 2019
GLASDEGIB MALEATE
TABLET;ORAL
DAURISMO
+ PFIZER EQ 25MG BASE N210656 001 Nov 21, 2018
+! EQ 100MG BASE N210656 002 Nov 21, 2018
GLATIRAMER ACETATE
INJECTABLE;SUBCUTANEOUS
COPAXONE
AP +! TEVA PHARMS USA 20MG/ML N020622 002 Feb 12, 2002
AP +! 40MG/ML N020622 003 Jan 28, 2014
GLATIRAMER ACETATE
AP MYLAN 20MG/ML A091646 001 Oct 03, 2017
AP 40MG/ML A206936 001 Oct 03, 2017
GLATOPA
AP SANDOZ INC 20MG/ML A090218 001 Apr 16, 2015
AP 40MG/ML A206921 001 Feb 12, 2018
GLECAPREVIR; PIBRENTASVIR
PELLETS;ORAL
MAVYRET
+! ABBVIE INC 50MG;20MG/PACKET N215110 001 Jun 10, 2021
TABLET;ORAL
MAVYRET
+! ABBVIE INC 100MG;40MG N209394 001 Aug 03, 2017
GLIMEPIRIDE
TABLET;ORAL
AMARYL
AB +! SANOFI AVENTIS US 1MG N020496 001 Nov 30, 1995
AB + 2MG N020496 002 Nov 30, 1995
AB + 4MG N020496 003 Nov 30, 1995
GLIMEPIRIDE
AB ACCORD HLTHCARE 1MG A078181 001 Aug 23, 2007
AB 2MG A078181 002 Aug 23, 2007
AB 4MG A078181 003 Aug 23, 2007
AB AUROBINDO PHARMA 1MG A202759 001 Jun 29, 2012
LTD
AB 2MG A202759 002 Jun 29, 2012
AB 4MG A202759 003 Jun 29, 2012
AB CARLSBAD 1MG A077911 001 Sep 22, 2009
AB 2MG A077911 002 Sep 22, 2009
AB 4MG A077911 003 Sep 22, 2009
AB CHARTWELL MOLECULAR 1MG A077295 001 Oct 06, 2005
AB 2MG A077295 002 Oct 06, 2005
AB 4MG A077295 003 Oct 06, 2005
AB DR REDDYS LABS LTD 1MG A077091 001 Oct 06, 2005
AB 2MG A077091 002 Oct 06, 2005
AB 4MG A077091 003 Oct 06, 2005
AB INDOCO REMEDIES 1MG A202112 001 Apr 17, 2013
AB 2MG A202112 002 Apr 17, 2013
AB 4MG A202112 003 Apr 17, 2013
AB MICRO LABS 1MG A091220 001 Jun 29, 2012
AB 2MG A091220 002 Jun 29, 2012
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-221(of 474)

GLIMEPIRIDE
TABLET;ORAL
GLIMEPIRIDE
AB 4MG A091220 004 Jun 29, 2012
AB 8MG A091220 006 Jun 29, 2012
AB PRINSTON INC 1MG A077370 001 Dec 23, 2005
AB 2MG A077370 002 Dec 23, 2005
AB 4MG A077370 003 Dec 23, 2005
AB 8MG A077370 004 Dec 23, 2005
MICRO LABS 3MG A091220 003 Jun 29, 2012
6MG A091220 005 Jun 29, 2012
GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE
TABLET;ORAL
DUETACT
AB +! TAKEDA PHARMS USA 2MG;30MG N021925 001 Jul 28, 2006
AB + 4MG;30MG N021925 002 Jul 28, 2006
PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
AB SANDOZ 2MG;30MG A201049 001 Jan 04, 2013
AB 4MG;30MG A201049 002 Jan 04, 2013
GLIPIZIDE
TABLET;ORAL
GLIPIZIDE
AB ACCORD HLTHCARE 5MG A074550 001 Sep 11, 1997
AB 10MG A074550 002 Sep 11, 1997
AB ANI PHARMS 5MG A074497 001 Aug 31, 1995
AB 10MG A074497 002 Aug 31, 1995
AB APOTEX 5MG A075795 001 Jun 13, 2001
AB ! 10MG A075795 002 Jun 13, 2001
AB AUROBINDO PHARMA 5MG A074226 001 May 10, 1994
USA
AB 10MG A074226 002 May 10, 1994
AB SANDOZ 5MG A074305 001 Apr 07, 1995
AB 10MG A074305 002 Apr 07, 1995
AB SUN PHARM INDS INC 5MG A077820 001 Jul 11, 2006
AB 10MG A077820 002 Jul 11, 2006
AB WATSON LABS TEVA 5MG A074223 001 Feb 27, 1995
AB 10MG A074223 002 Feb 27, 1995
TABLET, EXTENDED RELEASE;ORAL
GLIPIZIDE
AB AUROBINDO PHARMA 2.5MG A206928 001 May 12, 2017
AB 5MG A206928 002 May 12, 2017
AB 10MG A206928 003 May 12, 2017
AB UNIQUE 2.5MG A204720 001 Dec 29, 2016
AB 5MG A204720 002 Dec 29, 2016
AB 10MG A204720 003 Dec 29, 2016
AB WATSON LABS 2.5MG A076467 003 Mar 27, 2006
AB 5MG A076467 001 Sep 08, 2003
AB 10MG A076467 002 Nov 07, 2003
AB ZYDUS PHARMS 2.5MG A203499 001 Jul 16, 2018
AB 5MG A203499 002 Jul 16, 2018
AB 10MG A203499 003 Jul 16, 2018
GLUCOTROL XL
AB + PFIZER 2.5MG N020329 003 Aug 10, 1999
AB + 5MG N020329 001 Apr 26, 1994
AB +! 10MG N020329 002 Apr 26, 1994
GLIPIZIDE; METFORMIN HYDROCHLORIDE
TABLET;ORAL
GLIPIZIDE AND METFORMIN HYDROCHLORIDE
AB EPIC PHARMA LLC 2.5MG;250MG A077507 001 Oct 27, 2005
AB 2.5MG;500MG A077507 002 Oct 27, 2005
AB 5MG;500MG A077507 003 Oct 27, 2005
AB HERITAGE PHARMS 2.5MG;250MG A078728 001 Jun 23, 2010
AB 2.5MG;500MG A078728 002 Jun 23, 2010
AB 5MG;500MG A078728 003 Jun 23, 2010
AB TEVA PHARMS 2.5MG;250MG A077270 001 Oct 28, 2005
AB 2.5MG;500MG A077270 002 Oct 28, 2005
AB ! 5MG;500MG A077270 003 Oct 28, 2005
AB ZYDUS PHARMS USA 2.5MG;250MG A078905 001 Jan 31, 2011
INC
AB 2.5MG;500MG A078905 002 Jan 31, 2011
AB 5MG;500MG A078905 003 Jan 31, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-222(of 474)

GLUCAGON
INJECTABLE;INJECTION
GLUCAGON
AP AMPHASTAR PHARMS 1MG/VIAL A208086 001 Dec 28, 2020
INC
AP +! LILLY 1MG/VIAL N020928 001 Sep 11, 1998
POWDER;NASAL
BAQSIMI
+! ELI LILLY AND CO 3MG N210134 001 Jul 24, 2019
SOLUTION;SUBCUTANEOUS
GVOKE HYPOPEN
+! XERIS 0.5MG/0.1ML (0.5MG/0.1ML) N212097 003 Sep 10, 2019
+! 1MG/0.2ML (1MG/0.2ML) N212097 004 Sep 10, 2019
GVOKE PFS
+! XERIS 0.5MG/0.1ML (0.5MG/0.1ML) N212097 001 Sep 10, 2019
+! 1MG/0.2ML (1MG/0.2ML) N212097 002 Sep 10, 2019
GLUCAGON HYDROCHLORIDE
INJECTABLE;INJECTION
GLUCAGEN
+! NOVO NORDISK EQ 1MG BASE/VIAL N020918 001 Jun 22, 1998
POWDER;INTRAMUSCULAR, INTRAVENOUS
GLUCAGON
+! FRESENIUS KABI USA EQ 1MG BASE/VIAL N201849 001 May 08, 2015
GLYBURIDE
TABLET;ORAL
GLYBURIDE (MICRONIZED)
AB HIKMA 1.5MG A075890 001 Jul 31, 2003
AB 3MG A075890 002 Jul 31, 2003
AB 6MG A075890 003 Jul 31, 2003
AB TEVA 1.5MG A074686 001 Apr 20, 1999
AB 3MG A074686 002 Apr 20, 1999
AB 6MG A074686 004 Apr 20, 1999
GLYNASE
AB + PFIZER 1.5MG N020051 001 Mar 04, 1992
AB + 3MG N020051 002 Mar 04, 1992
AB +! 6MG N020051 004 Sep 24, 1993
GLYBURIDE
AB1 CADILA PHARMS LTD 1.25MG A203379 001 Jan 04, 2019
AB1 2.5MG A203379 002 Jan 04, 2019
AB1 5MG A203379 003 Jan 04, 2019
AB1 EPIC PHARMA LLC 1.25MG A076257 001 Jun 27, 2002
AB1 2.5MG A076257 002 Jun 27, 2002
AB1 5MG A076257 003 Jun 27, 2002
AB1 HERITAGE PHARMS 1.25MG A090937 001 Feb 28, 2011
AB1 2.5MG A090937 002 Feb 28, 2011
AB1 5MG A090937 003 Feb 28, 2011
AB1 ORIENT PHARMA CO 1.25MG A206483 001 Feb 22, 2019
LTD
AB1 2.5MG A206483 002 Feb 22, 2019
AB1 5MG A206483 003 Feb 22, 2019
AB1 TEVA 1.25MG A074388 001 Aug 29, 1995
AB1 2.5MG A074388 002 Aug 29, 1995
AB1 ! 5MG A074388 003 Aug 29, 1995
AB1 ZYDUS PHARMS 1.25mg A206749 001 May 10, 2016
AB1 2.5mg A206749 002 May 10, 2016
AB1 5MG A206749 003 May 10, 2016
DIABETA
AB2 + SANOFI AVENTIS US 1.25MG N017532 001 May 01, 1984
AB2 + 2.5MG N017532 002 May 01, 1984
AB2 +! 5MG N017532 003 May 01, 1984
GLYBURIDE
AB2 IMPAX LABS INC 1.25MG A206079 001 Sep 30, 2015
AB2 2.5MG A206079 002 Sep 30, 2015
AB2 5MG A206079 003 Sep 30, 2015
GLYBURIDE (MICRONIZED)
TEVA 4.5MG A074686 003 Apr 20, 1999
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-223(of 474)

GLYBURIDE; METFORMIN HYDROCHLORIDE


TABLET;ORAL
GLYBURIDE AND METFORMIN HYDROCHLORIDE
AB ACTAVIS ELIZABETH 1.25MG;250MG A076716 001 Jun 28, 2005
AB 2.5MG;500MG A076716 002 Jun 28, 2005
AB 5MG;500MG A076716 003 Jun 28, 2005
AB AUROBINDO PHARMA 1.25MG;250MG A077870 001 Nov 14, 2007
AB ! 2.5MG;500MG A077870 002 Nov 14, 2007
AB 5MG;500MG A077870 003 Nov 14, 2007
AB IMPAX LABS INC 1.25MG;250MG A076345 001 Feb 18, 2004
AB 2.5MG;500MG A076345 002 Feb 18, 2004
AB 5MG;500MG A076345 003 Feb 18, 2004
AB ZYDUS PHARMS 1.25MG;250MG A206748 001 Feb 29, 2016
AB 2.5MG;500MG A206748 002 Feb 29, 2016
AB 5MG;500MG A206748 003 Feb 29, 2016
GLYCEROL PHENYLBUTYRATE
LIQUID;ORAL
RAVICTI
+! HORIZON THERAP 1.1GM/ML N203284 001 Feb 01, 2013
GLYCINE
SOLUTION;IRRIGATION
AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER
AT +! BAXTER HLTHCARE 1.5GM/100ML N017865 001
GLYCINE 1.5% IN PLASTIC CONTAINER
AT B BRAUN 1.5GM/100ML N016784 001
AT ICU MEDICAL INC 1.5GM/100ML N018315 001
GLYCOPYRROLATE
INJECTABLE;INJECTION
GLYCOPYRROLATE
AP ACCORD HLTHCARE 0.2MG/ML A213238 001 Jul 08, 2020
AP ALEMBIC PHARMS 0.2MG/ML A214635 001 Oct 26, 2022
AP AM REGENT 0.2MG/ML A089335 001 Jul 23, 1986
AP AMNEAL 0.2MG/ML A208973 001 Jun 15, 2017
AP 0.2MG/ML A215333 001 Oct 21, 2022
AP APOTEX 0.2MG/ML A210246 001 Oct 29, 2019
AP ASPEN 0.2MG/ML A212871 001 Nov 29, 2022
AP ATHENEX INC 0.2MG/ML A210083 001 Feb 21, 2020
AP CAPLIN 0.2MG/ML A211705 001 Mar 20, 2019
AP FRESENIUS KABI USA 0.2MG/ML A209024 001 Oct 31, 2018
AP 0.2MG/ML A209328 001 Oct 27, 2017
AP GLAND PHARMA LTD 0.2MG/ML A212612 001 Sep 30, 2019
AP ! HIKMA FARMACEUTICA 0.2MG/ML A090963 001 Sep 21, 2011
AP MEITHEAL 0.2MG/ML A212802 001 Jul 06, 2021
AP NIVAGEN PHARMS INC 0.2MG/ML A212591 001 Oct 13, 2021
AP PIRAMAL CRITICAL 0.2MG/ML A210842 001 Oct 25, 2018
AP PRINSTON INC 0.2MG/ML A210927 001 Oct 31, 2018
AP SANDOZ INC 0.2MG/ML A211334 001 May 14, 2019
AP SOMERSET THERAPS 0.2MG/ML A207639 001 Jun 23, 2017
LLC
AP XIROMED 0.2MG/ML A212227 001 Mar 04, 2021
SOLUTION;INHALATION
LONHALA MAGNAIR KIT
+! SUNOVION RESP 25MCG/ML N208437 001 Dec 05, 2017
SOLUTION;INTRAMUSCULAR, INTRAVENOUS
GLYCOPYRROLATE
+! FRESENIUS KABI USA 0.6MG/3ML (0.2MG/ML) N214919 001 Apr 21, 2022
GLYRX-PF
+! EXELA PHARMA 0.2MG/ML (0.2MG/ML) N210997 001 Jul 11, 2018
+! 0.4MG/2ML (0.2MG/ML) N210997 002 Jul 11, 2018
+! 0.6MG/3ML (0.2MG/ML) N210997 004 Dec 14, 2020
+! 1MG/5ML (0.2MG/ML) N210997 003 Apr 09, 2020
SOLUTION;ORAL
CUVPOSA
AA +! MERZ PHARMS 1MG/5ML N022571 001 Jul 28, 2010
GLYCOPYRROLATE
AA ANNORA PHARMA 1MG/5ML A213698 001 Jul 05, 2022
AA PAR PHARM INC 1MG/5ML A204438 001 Aug 09, 2021
AA SUVEN PHARMS 1MG/5ML A212467 001 Jul 05, 2022
TABLET;ORAL
GLYCOPYRROLATE
AA ALEMBIC LABS 1MG A203657 001 Nov 30, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-224(of 474)

GLYCOPYRROLATE
TABLET;ORAL
GLYCOPYRROLATE
AA 2MG A203657 002 Nov 30, 2018
AA AUROLIFE PHARMA LLC 1MG A202675 001 Apr 15, 2013
AA 2MG A202675 002 Oct 30, 2018
AA DR REDDYS LABS LTD 1MG A040847 001 Mar 21, 2008
AA 2MG A040847 002 Mar 21, 2008
AA HERITAGE PHARMS INC 1MG A207201 001 Jan 03, 2017
AA 2MG A207201 002 Jan 03, 2017
AA KENTON 1MG A091182 001 Feb 03, 2014
AA 2MG A091182 002 Feb 03, 2014
AA LEADING 1MG A090195 001 Sep 21, 2012
AA 2MG A090195 002 Sep 21, 2012
AA NATCO 1MG A091413 001 Jun 20, 2016
AA 2MG A091413 002 Jun 20, 2016
AA OXFORD PHARMS 1MG A090020 001 Oct 19, 2011
AA 2MG A090020 002 Oct 19, 2011
AA ! PAR PHARM 1MG A040653 001 Aug 31, 2006
AA ! 2MG A040653 002 Aug 31, 2006
AA RISING 1MG A040821 001 Dec 29, 2008
AA 2MG A040821 002 Dec 29, 2008
AA SUN PHARM INDS LTD 1MG A040844 001 Aug 18, 2009
AA 2MG A040844 002 Aug 18, 2009
ROBINUL
AA + CASPER PHARMA LLC 1MG N012827 001
ROBINUL FORTE
AA + CASPER PHARMA LLC 2MG N012827 002
GLYCOPYRROLATE
LGM PHARMA 1.5MG A091522 001 Mar 12, 2012
TABLET, ORALLY DISINTEGRATING;ORAL
DARTISLA ODT
+! EDENBRIDGE PHARMS 1.7MG N215019 001 Dec 16, 2021
GLYCOPYRRONIUM TOSYLATE
CLOTH;TOPICAL
QBREXZA
+! JOURNEY EQ 2.4% BASE N210361 001 Jun 28, 2018
GOLODIRSEN
SOLUTION;INTRAVENOUS
VYONDYS 53
+! SAREPTA THERAPS INC 100MG/2ML (50MG/ML) N211970 001 Dec 12, 2019
GOSERELIN ACETATE
IMPLANT;IMPLANTATION
ZOLADEX
+! TERSERA EQ 3.6MG BASE N019726 001 Dec 29, 1989
+! EQ 10.8MG BASE N020578 001 Jan 11, 1996
GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
SOLUTION/DROPS;OPHTHALMIC
NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN
AT AMRING PHARMS 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 A065187 001 Oct 28, 2005
UNITS/ML
AT ! BAUSCH AND LOMB 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 A064047 001 Jan 31, 1996
UNITS/ML
NEOSPORIN
AT ! MONARCH PHARMS 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 A060582 001
UNITS/ML
GRANISETRON
FILM, EXTENDED RELEASE;TRANSDERMAL
SANCUSO
+! KYOWA KIRIN 3.1MG/24HR N022198 001 Sep 12, 2008
INJECTION, EXTENDED RELEASE;SUBCUTANEOUS
SUSTOL
+! HERON THERAPS INC 10MG/0.4ML (10MG/0.4ML) N022445 001 Aug 09, 2016
GRANISETRON HYDROCHLORIDE
INJECTABLE;INJECTION
GRANISETRON HYDROCHLORIDE
AP AKORN EQ 1MG BASE/ML (EQ 1MG BASE/ML) A079078 001 Sep 14, 2009
AP EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A079078 002 Sep 14, 2009
AP AMNEAL EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) A078262 001 Dec 31, 2007
AP EQ 1MG BASE/ML (EQ 1MG BASE/ML) A078258 001 Jun 30, 2008
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-225(of 474)

GRANISETRON HYDROCHLORIDE
INJECTABLE;INJECTION
GRANISETRON HYDROCHLORIDE
AP EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A078258 002 Jun 30, 2008
AP BIONPHARMA INC EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) A078863 001 Jun 30, 2008
AP EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A078880 001 Jun 30, 2008
AP ! DR REDDYS EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) A078392 001 Dec 31, 2007
AP ! EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A077297 001 Jun 30, 2008
AP FRESENIUS KABI USA EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) A078522 001 Dec 31, 2007
AP EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A078090 001 Jun 30, 2008
AP HIKMA EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) A077913 001 Jun 26, 2008
AP EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A077186 001 Jun 30, 2008
AP EQ 1MG BASE/ML (EQ 1MG BASE/ML) A077187 001 Jun 30, 2008
AP EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A077177 001 Dec 31, 2007
AP HIKMA FARMACEUTICA EQ 1MG BASE/ML (EQ 1MG BASE/ML) A078629 001 Dec 23, 2009
AP EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A078629 002 Dec 23, 2009
AP MYLAN ASI EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) A091136 001 Apr 09, 2010
AP EQ 1MG BASE/ML (EQ 1MG BASE/ML) A091136 002 Apr 09, 2010
AP EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A091137 002 Apr 09, 2010
AP SANDOZ INC EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) A078534 001 Apr 30, 2009
AP EQ 1MG BASE/ML (EQ 1MG BASE/ML) A078531 001 Apr 30, 2009
AP EQ 1MG BASE/ML (EQ 1MG BASE/ML) A078835 001 Jun 30, 2008
AP EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A078531 002 Apr 30, 2009
AP EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A078835 002 Jun 30, 2008
GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE
AP BIONPHARMA INC EQ 1MG BASE/ML (EQ 1MG BASE/ML) A078863 002 Jun 30, 2008
AP ! FRESENIUS KABI USA EQ 1MG BASE/ML (EQ 1MG BASE/ML) A078096 001 Jun 30, 2008
TABLET;ORAL
GRANISETRON HYDROCHLORIDE
AB APOTEX INC EQ 1MG BASE A078843 001 Feb 27, 2008
AB CHARTWELL MOLECULAR EQ 1MG BASE A078037 001 Feb 27, 2008
AB DR REDDYS LABS LTD EQ 1MG BASE A078846 001 Feb 27, 2009
AB ! HIKMA EQ 1MG BASE A077842 001 Dec 31, 2007
AB NATCO PHARMA EQ 1MG BASE A078969 001 Jun 22, 2009
AB ORBION PHARMS EQ 1MG BASE A078678 001 Feb 13, 2008
AB TARO EQ 1MG BASE A090817 001 May 28, 2010
GRISEOFULVIN, MICROCRYSTALLINE
TABLET;ORAL
FULVICIN-U/F
CHARTWELL RX 250MG A060569 002
500MG A060569 001
GRISEOFULVIN, MICROSIZE
SUSPENSION;ORAL
GRISEOFULVIN
AB ! ACTAVIS MID 125MG/5ML A065394 001 Jul 06, 2007
ATLANTIC
AB CHARTWELL RX 125MG/5ML A065200 001 Mar 02, 2005
AB CIPLA 125MG/5ML A065354 001 Sep 10, 2007
AB COSETTE 125MG/5ML A065438 001 Oct 08, 2010
TABLET;ORAL
GRISEOFULVIN
AB ! SANDOZ INC 500MG A091592 002 Aug 07, 2013
AB SIGMAPHARM LABS LLC 500MG A202482 001 Oct 22, 2012
SANDOZ INC 250MG A091592 001 Aug 07, 2013
GRISEOFULVIN, ULTRAMICROCRYSTALLINE
TABLET;ORAL
FULVICIN P/G
CHARTWELL RX 125MG A061996 001
250MG A061996 002
FULVICIN P/G 165
CHARTWELL RX 165MG A061996 003 Apr 06, 1982
FULVICIN P/G 330
CHARTWELL RX 330MG A061996 004 Apr 06, 1982
GRISEOFULVIN, ULTRAMICROSIZE
TABLET;ORAL
GRIS-PEG
AB + BAUSCH 125MG N050475 001
AB + 250MG N050475 002
GRISEOFULVIN, ULTRAMICROSIZE
AB MOUNTAIN 125MG A204371 001 Jan 09, 2014
AB ! 250MG A204371 002 Jan 09, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-226(of 474)

GRISEOFULVIN, ULTRAMICROSIZE
TABLET;ORAL
GRISEOFULVIN, ULTRAMICROSIZE
AB SANDOZ INC 125MG A202805 001 Dec 26, 2018
AB 250MG A202805 002 Dec 26, 2018
GRISEOFULVIN,ULTRAMICROSIZE
AB SIGMAPHARM LABS LLC 125MG A202545 001 Oct 22, 2012
AB 250MG A202545 002 Oct 22, 2012
GUANFACINE HYDROCHLORIDE
TABLET;ORAL
GUANFACINE HYDROCHLORIDE
AB AMNEAL PHARM EQ 1MG BASE A075109 001 Nov 25, 1998
AB ! EQ 2MG BASE A075109 002 Nov 25, 1998
AB EPIC PHARMA LLC EQ 1MG BASE A074673 001 Feb 28, 1997
AB EQ 2MG BASE A074673 002 Feb 28, 1997
AB TWI PHARMS EQ 1MG BASE A216399 001 Jun 08, 2022
AB EQ 2MG BASE A216399 002 Jun 08, 2022
AB UNICHEM EQ 1MG BASE A214689 001 Mar 03, 2021
AB EQ 2MG BASE A214689 002 Mar 03, 2021
AB WATSON LABS EQ 1MG BASE A074145 001 Oct 17, 1995
AB EQ 2MG BASE A074145 002 Oct 17, 1995
TABLET, EXTENDED RELEASE;ORAL
GUANFACINE HYDROCHLORIDE
AB ACTAVIS ELIZABETH EQ 1MG BASE A200881 001 Oct 05, 2012
AB EQ 2MG BASE A200881 002 Oct 05, 2012
AB EQ 3MG BASE A200881 003 Oct 05, 2012
AB EQ 4MG BASE A200881 004 Oct 05, 2012
AB APOTEX EQ 1MG BASE A205430 001 Jul 25, 2018
AB EQ 2MG BASE A205430 002 Jul 25, 2018
AB EQ 3MG BASE A205430 003 Jul 25, 2018
AB EQ 4MG BASE A205430 004 Jul 25, 2018
AB SANDOZ INC EQ 1MG BASE A202568 001 Jun 03, 2015
AB EQ 2MG BASE A202568 002 Jun 03, 2015
AB EQ 3MG BASE A202568 003 Jun 03, 2015
AB EQ 4MG BASE A202568 004 Jun 03, 2015
AB SUN PHARM EQ 1MG BASE A205689 001 Nov 16, 2017
AB EQ 2MG BASE A205689 002 Nov 16, 2017
AB EQ 3MG BASE A205689 003 Nov 16, 2017
AB EQ 4MG BASE A205689 004 Nov 16, 2017
AB TEVA PHARMS USA EQ 1MG BASE A201382 001 Jun 02, 2015
AB EQ 2MG BASE A201382 002 Jun 02, 2015
AB EQ 3MG BASE A201382 003 Jun 02, 2015
AB EQ 4MG BASE A201382 004 Jun 02, 2015
AB TWI PHARMS EQ 1MG BASE A201408 001 Jun 02, 2015
AB EQ 2MG BASE A201408 002 Jun 02, 2015
AB EQ 3MG BASE A201408 003 Jun 02, 2015
AB EQ 4MG BASE A201408 004 Jun 02, 2015
AB YICHANG HUMANWELL EQ 1MG BASE A213428 001 Nov 25, 2020
AB EQ 2MG BASE A213428 002 Nov 25, 2020
AB EQ 3MG BASE A213428 003 Nov 25, 2020
AB EQ 4MG BASE A213428 004 Nov 25, 2020
INTUNIV
AB + TAKEDA PHARMS USA EQ 1MG BASE N022037 001 Sep 02, 2009
AB + EQ 2MG BASE N022037 002 Sep 02, 2009
AB + EQ 3MG BASE N022037 003 Sep 02, 2009
AB +! EQ 4MG BASE N022037 004 Sep 02, 2009
HALCINONIDE
CREAM;TOPICAL
HALCINONIDE
AB GLASSHOUSE PHARMS 0.1% A214723 001 Sep 08, 2021
AB MYLAN 0.1% A211027 001 Aug 12, 2019
HALOG
AB +! SUN PHARM INDS INC 0.1% N017556 001
OINTMENT;TOPICAL
HALOG
+! SUN PHARM INDS INC 0.1% N017824 001
SOLUTION;TOPICAL
HALOG
+! SUN PHARM INDS INC 0.1% N017823 001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-227(of 474)

HALOBETASOL PROPIONATE
AEROSOL, FOAM;TOPICAL
LEXETTE
+! MAYNE PHARMA 0.05% N210566 001 May 24, 2018
CREAM;TOPICAL
HALOBETASOL PROPIONATE
AB ! COSETTE 0.05% A078162 001 Apr 24, 2007
AB FOUGERA PHARMS 0.05% A077001 001 Dec 16, 2004
AB PADAGIS ISRAEL 0.05% A077123 001 Dec 16, 2004
AB TARO 0.05% A077227 001 Aug 04, 2005
LOTION;TOPICAL
BRYHALI
+! BAUSCH 0.01% N209355 001 Nov 06, 2018
ULTRAVATE
+! SUN PHARM 0.05% N208183 001 Nov 06, 2015
INDUSTRIES
OINTMENT;TOPICAL
HALOBETASOL PROPIONATE
AB COSETTE 0.05% A077109 001 Jun 14, 2005
AB ! PADAGIS ISRAEL 0.05% A076872 001 Dec 16, 2004
AB PAI HOLDINGS PHARM 0.05% A209978 001 Mar 20, 2018
AB QUAGEN 0.05% A213560 001 Oct 06, 2020
AB TARO 0.05% A076994 001 Dec 16, 2004
HALOBETASOL PROPIONATE; TAZAROTENE
LOTION;TOPICAL
DUOBRII
+! BAUSCH 0.01%;0.045% N209354 001 Apr 25, 2019
HALOPERIDOL
TABLET;ORAL
HALOPERIDOL
AB ACTAVIS GROUP 0.5MG A200854 001 Jul 01, 2022
AB 1MG A200854 002 Jul 01, 2022
AB 2MG A200854 003 Jul 01, 2022
AB 5MG A200854 004 Jul 01, 2022
AB 10MG A200854 005 Jul 01, 2022
AB 20MG A200854 006 Jul 01, 2022
AB CYCLE 2MG A071130 001 Feb 17, 1987
AB 5MG A071131 001 Feb 17, 1987
AB 10MG A071132 001 May 12, 1987
AB INNOGENIX 0.5MG A071173 002 Jan 02, 1987
AB 1MG A071173 003 Jan 02, 1987
AB 2MG A071173 004 Jan 02, 1987
AB 5MG A071173 005 Jan 07, 1988
AB 10MG A071173 001 Jan 07, 1988
AB 20MG A071173 006 Jan 07, 1988
AB MSN 0.5MG A216004 001 Nov 18, 2022
AB 1MG A216004 002 Nov 18, 2022
AB 2MG A216004 003 Nov 18, 2022
AB 5MG A216004 004 Nov 18, 2022
AB 10MG A216004 005 Nov 18, 2022
AB 20MG A216004 006 Nov 18, 2022
AB MYLAN 0.5MG A070278 006 Jun 10, 1986
AB 1MG A070278 004 Jun 10, 1986
AB ! 2MG A070278 001 Jun 10, 1986
AB 5MG A070278 005 Jun 10, 1986
AB 10MG A070278 002 Jul 16, 2009
AB 20MG A070278 003 Jul 16, 2009
AB SANDOZ 0.5MG A071209 002 Nov 17, 1986
AB 1MG A071209 003 Nov 17, 1986
AB 5MG A071209 001 Nov 17, 1986
AB 10MG A071210 001 Mar 11, 1988
AB 20MG A071211 001 Mar 11, 1988
AB UPSHER SMITH LABS 0.5MG A211061 001 Jan 08, 2020
AB 1MG A211061 002 Jan 08, 2020
AB 2MG A211061 003 Jan 08, 2020
AB 5MG A211061 004 Jan 08, 2020
AB 10MG A211061 005 Jan 08, 2020
AB 20MG A211061 006 Jan 08, 2020
AB ZYDUS PHARMS USA 5MG A077580 003 Nov 29, 2007
AB 10MG A077580 004 Nov 29, 2007
AB 20MG A077580 005 Nov 29, 2007
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-228(of 474)

HALOPERIDOL DECANOATE
INJECTABLE;INJECTION
HALDOL
AO +! JANSSEN PHARMS EQ 50MG BASE/ML N018701 001 Jan 14, 1986
AO +! EQ 100MG BASE/ML N018701 002 Jan 31, 1997
HALOPERIDOL DECANOATE
AO FRESENIUS KABI USA EQ 50MG BASE/ML A074893 001 Dec 19, 1997
AO EQ 100MG BASE/ML A074893 002 Dec 19, 1997
AO GLAND PHARMA LTD EQ 50MG BASE/ML A205241 001 May 12, 2017
AO EQ 100MG BASE/ML A205241 002 May 12, 2017
AO HIKMA EQ 50MG BASE/ML A074811 001 Jan 30, 1998
AO EQ 100MG BASE/ML A075305 001 Sep 28, 1998
AO MEITHEAL EQ 50MG BASE/ML A214507 001 Jul 26, 2021
AO EQ 100MG BASE/ML A214507 002 Jul 26, 2021
AO MYLAN LABS LTD EQ 50MG BASE/ML A075440 001 Feb 28, 2000
AO EQ 100MG BASE/ML A075440 002 Feb 28, 2000
AO SOMERSET THERAPS EQ 50MG BASE/ML A209101 001 Jul 03, 2018
LLC
AO EQ 100MG BASE/ML A209101 002 Jul 03, 2018
AO TEVA PHARMS USA EQ 50MG BASE/ML A075393 001 May 11, 1999
AO EQ 100MG BASE/ML A075393 002 May 11, 1999
AO ZYDUS PHARMS EQ 50MG BASE/ML A211180 001 Oct 22, 2019
AO EQ 100MG BASE/ML A211180 002 Oct 22, 2019
HALOPERIDOL LACTATE
CONCENTRATE;ORAL
HALOPERIDOL
AA LANNETT CO INC EQ 2MG BASE/ML A073364 001 Sep 28, 1993
AA ! PHARM ASSOC EQ 2MG BASE/ML A073037 001 Feb 26, 1993
INJECTABLE;INJECTION
HALOPERIDOL
AP FRESENIUS KABI USA EQ 5MG BASE/ML A075689 001 Mar 09, 2001
AP EQ 5MG BASE/ML A210356 001 Jul 01, 2019
AP GLAND PHARMA LTD EQ 5MG BASE/ML A076774 001 Aug 25, 2004
AP HIKMA EQ 5MG BASE/ML A075858 001 Jun 18, 2001
AP ! MYLAN LABS LTD EQ 5MG BASE/ML A078347 001 Sep 14, 2009
AP SAGENT PHARMS EQ 5MG BASE/ML A091637 001 Sep 02, 2011
AP EQ 5MG BASE/ML A200742 001 Sep 02, 2011
HEPARIN SODIUM
INJECTABLE;INJECTION
HEPARIN SODIUM
AP BE PHARMS 1,000 UNITS/ML A214804 001 Dec 29, 2020
AP 10,000 UNITS/ML A214839 001 Dec 29, 2020
AP +! FRESENIUS KABI USA 1,000 UNITS/ML N017029 001
AP 5,000 UNITS/ML A206552 001 Jun 10, 2016
AP +! 5,000 UNITS/ML N017651 006
AP +! 10,000 UNITS/ML N017029 003
AP +! 20,000 UNITS/ML N017029 004
AP GLAND 1,000 UNITS/ML A205323 002 Nov 18, 2019
AP 5,000 UNITS/ML A205323 001 Feb 06, 2017
AP +! HIKMA 1,000 UNITS/ML N017037 001
AP +! 5,000 UNITS/ML N017037 002
AP +! 10,000 UNITS/ML N017037 003
AP HOSPIRA INC 1,000 UNITS/ML A090571 001 Aug 31, 2009
AP 5,000 UNITS/ML A090571 002 Aug 31, 2009
AP 10,000 UNITS/ML A090571 003 Aug 31, 2009
AP MYLAN LABS LTD 1,000 UNITS/ML A203851 001 Nov 30, 2017
AP 5,000 UNITS/ML A203851 002 Nov 30, 2017
AP 10,000 UNITS/ML A203851 003 Nov 30, 2017
AP 20,000 UNITS/ML A203852 001 Nov 30, 2017
AP NANJING KING-FRIEND 1,000 UNITS/ML A211005 001 Dec 14, 2018
AP 1,000 UNITS/ML A211007 001 May 28, 2019
AP 5,000 UNITS/ML A211007 002 May 28, 2019
AP 10,000 UNITS/ML A211007 003 May 28, 2019
AP 20,000 UNITS/ML A211004 001 Feb 24, 2020
AP SAGENT PHARMS 1,000 UNITS/ML A090808 001 Jun 30, 2010
AP 5,000 UNITS/ML A090808 002 Jun 30, 2010
AP 10,000 UNITS/ML A090808 003 Jun 30, 2010
AP 20,000 UNITS/ML A090809 001 Jun 30, 2010
AP SANDOZ 1,000 UNITS/ML A091682 001 Jun 08, 2011
AP 5,000 UNITS/ML A091682 002 Jun 08, 2011
AP 10,000 UNITS/ML A201002 001 Jun 08, 2011
AP SHENZHEN TECHDOW 1,000 UNITS/ML A202957 001 Jun 12, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-229(of 474)

HEPARIN SODIUM
INJECTABLE;INJECTION
HEPARIN SODIUM
AP 5,000 UNITS/ML A202733 001 Jun 12, 2014
AP 5,000 UNITS/ML A202957 002 Jun 12, 2014
AP 10,000 UNITS/ML A203198 001 Jun 12, 2014
AP 20,000 UNITS/ML A203198 002 Jun 12, 2014
HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 200 UNITS/100ML N018609 001 Apr 28, 1982
HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP +! B BRAUN 200 UNITS/100ML N019953 001 Jul 20, 1992
AP FRESENIUS KABI USA 200 UNITS/100ML A212441 001 Jul 24, 2020
AP +! HOSPIRA 200 UNITS/100ML N018916 010 Jun 23, 1989
HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
AP HOSPIRA 10,000 UNITS/100ML N019339 003 Mar 27, 1985
HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 200 UNITS/100ML N018609 002 Apr 28, 1982
HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP FRESENIUS KABI USA 200 UNITS/100ML A212441 002 Jul 24, 2020
AP +! HOSPIRA 200 UNITS/100ML N018916 011 Jun 23, 1989
HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
AP +! B BRAUN 5,000 UNITS/100ML N019952 004 Jul 20, 1992
AP +! 10,000 UNITS/100ML N019952 005 Jul 20, 1992
AP HOSPIRA 5,000 UNITS/100ML N019339 004 Mar 27, 1985
AP 10,000 UNITS/100ML N019339 002 Mar 27, 1985
HEPARIN SODIUM IN PLASTIC CONTAINER
AP +! FRESENIUS KABI USA 1,000 UNITS/ML N017029 013 Dec 05, 1985
AP +! 5,000 UNITS/ML N017029 014 Dec 05, 1985
AP +! 10,000 UNITS/ML N017029 015 Dec 05, 1985
AP +! 20,000 UNITS/ML N017029 016 Dec 05, 1985
HEPARIN SODIUM PRESERVATIVE FREE
AP +! FRESENIUS KABI USA 1,000 UNITS/ML N017029 010 Apr 28, 1986
AP +! 10,000 UNITS/ML N017029 019 Nov 22, 2010
AP HOSPIRA 10,000 UNITS/ML A089522 001 May 04, 1987
AP SAGENT PHARMS 1,000 UNITS/ML A090810 001 Jun 30, 2010
AP SHENZHEN TECHDOW 1,000 UNITS/ML A202732 001 Jun 12, 2014
HEPARIN SODIUM
B BRAUN MEDICAL INC 5,000 UNITS/0.5ML A208827 001 Nov 19, 2018
+! FRESENIUS KABI USA 10,000 UNITS/ML N017029 020 Mar 31, 2011
! HOSPIRA 5,000 UNITS/ML A088100 001 Apr 28, 1983
+! PFIZER 1,000 UNITS/ML N201370 001 Jul 21, 2011
+! 5,000 UNITS/ML N201370 002 Jul 21, 2011
HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
HOSPIRA 5,000 UNITS/100ML N019339 001 Mar 27, 1985
HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
HOSPIRA 5,000 UNITS/100ML N018916 006 Jan 31, 1984
HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
BAXTER HLTHCARE 2,000 UNITS/1000ML N018609 004 Apr 23, 2020
HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
+! B BRAUN 4,000 UNITS/100ML N019952 001 Jul 20, 1992
HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
HOSPIRA 5,000 UNITS/100ML N018916 007 Jan 31, 1984
10,000 UNITS/100ML N018916 008 Jan 31, 1984
HEPARIN SODIUM PRESERVATIVE FREE
+! PFIZER 1,000 UNITS/ML N201370 004 Jul 21, 2011
HEXACHLOROPHENE
SPONGE;TOPICAL
PRE-OP
AT +! DAVIS AND GECK 480MG N017433 001
PRE-OP II
AT + DAVIS AND GECK 480MG N017433 002
HEXAMINOLEVULINATE HYDROCHLORIDE
FOR SOLUTION;INTRAVESICAL
CYSVIEW KIT
+! PHOTOCURE ASA 100MG/VIAL N022555 001 May 28, 2010
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-230(of 474)

HISTRELIN ACETATE
IMPLANT;SUBCUTANEOUS
SUPPRELIN LA
+! ENDO PHARM 50MG N022058 001 May 03, 2007
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
SYRUP;ORAL
HYCODAN
AA + GENUS 1.5MG/5ML;5MG/5ML N005213 002 Jul 26, 1988
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
AA ABHAI LLC 1.5MG/5ML;5MG/5ML A207487 001 Feb 21, 2017
AA ACTAVIS MID 1.5MG/5ML;5MG/5ML A088017 001 Jul 05, 1983
ATLANTIC
AA ! AKORN 1.5MG/5ML;5MG/5ML A040613 001 Feb 08, 2008
AA NOVEL LABS INC 1.5MG/5ML;5MG/5ML A203535 001 Feb 13, 2017
AA PADAGIS US 1.5MG/5ML;5MG/5ML A205731 001 Feb 15, 2017
AA WOCKHARDT BIO AG 1.5MG/5ML;5MG/5ML A088008 001 Mar 03, 1983
TABLET;ORAL
HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
AA ! AVANTHI INC 1.5MG;5MG A207176 001 Aug 07, 2017
HYCODAN
AA + GENUS 1.5MG;5MG N005213 001 Jul 26, 1988
HYDRALAZINE HYDROCHLORIDE
INJECTABLE;INJECTION
HYDRALAZINE HYDROCHLORIDE
AP ! AKORN 20MG/ML A040730 001 Apr 21, 2009
AP AM REGENT 20MG/ML A040136 001 Jun 30, 1997
AP BEOWULF ASSET 20MG/ML A203110 001 Jun 29, 2015
AP FRESENIUS KABI USA 20MG/ML A040388 001 Mar 13, 2001
AP HIKMA 20MG/ML A213667 001 Dec 18, 2020
AP MYLAN INSTITUTIONAL 20MG/ML A204680 001 Apr 28, 2016
AP NAVINTA LLC 20MG/ML A202938 001 Mar 28, 2013
TABLET;ORAL
HYDRALAZINE HYDROCHLORIDE
AA ALKEM LABS LTD 10MG A200737 001 Dec 07, 2012
AA 25MG A200737 002 Dec 07, 2012
AA 50MG A200737 003 Dec 07, 2012
AA 100MG A200737 004 Dec 07, 2012
AA CADILA PHARMS LTD 25MG A203845 001 Sep 18, 2014
AA 50MG A203845 002 Sep 18, 2014
AA 100MG A203845 003 Sep 18, 2014
AA GLENMARK PHARMS LTD 10MG A090527 001 May 27, 2009
AA 25MG A090527 002 May 27, 2009
AA 50MG A090527 003 May 27, 2009
AA 100MG A090527 004 May 27, 2009
AA HERITAGE PHARMS 10MG A086242 001 Feb 04, 2010
AA 25MG A086242 003
AA 50MG A086242 002
AA 100MG A086242 004 Feb 04, 2010
AA HETERO LABS LTD III 10MG A040901 001 Sep 12, 2008
AA 25MG A040901 002 Sep 12, 2008
AA 50MG A040901 003 Sep 12, 2008
AA 100MG A040901 004 Sep 12, 2008
AA INVAGEN PHARMS 10MG A090255 001 Dec 15, 2008
AA 25MG A090255 002 Dec 15, 2008
AA 50MG A090255 003 Dec 15, 2008
AA 100MG A090255 004 Dec 15, 2008
AA ! PLIVA 10MG A089097 001 Dec 18, 1985
AA +! 25MG A088467 001 May 01, 1984
AA +! 50MG A088468 001 May 01, 1984
AA ! 100MG A089098 001 Dec 18, 1985
AA SCIEGEN PHARMS INC 10MG A205236 001 May 26, 2017
AA 25MG A205236 002 May 26, 2017
AA 50MG A205236 003 May 26, 2017
AA 100MG A205236 004 May 26, 2017
AA STRIDES PHARMA 10MG A087836 001 Oct 05, 1982
AA 25MG A086961 002
AA 25MG A200770 001 May 03, 2013
AA 50MG A086962 001
AA 50MG A200770 002 May 03, 2013
AA 100MG A088391 001 Sep 27, 1983
AA 100MG A200770 003 May 03, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-231(of 474)

HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE


CAPSULE;ORAL
HYDRA-ZIDE
STRIDES PHARMA 25MG;25MG A088957 001 Oct 21, 1985
! 50MG;50MG A088946 001 Oct 21, 1985
HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE
TABLET;ORAL
BIDIL
AB +! AZURITY 37.5MG;20MG N020727 001 Jun 23, 2005
ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE
AB RICONPHARMA LLC 37.5MG;20MG A215586 001 Apr 06, 2022
HYDROCHLOROTHIAZIDE
CAPSULE;ORAL
HYDROCHLOROTHIAZIDE
AB AUROBINDO PHARMA 12.5MG A078164 001 Sep 18, 2007
AB IPCA LABS LTD 12.5MG A079237 001 Apr 02, 2009
AB JUBILANT CADISTA 12.5MG A078391 001 Feb 11, 2008
AB PRINSTON INC 12.5MG A075907 001 Sep 17, 2002
AB SCIEGEN PHARMS INC 12.5MG A203561 001 Jan 14, 2019
AB SUN PHARM INDS INC 12.5MG A090651 001 Apr 07, 2014
AB UNICHEM 12.5MG A090510 001 Jan 19, 2010
MICROZIDE
AB +! TEVA BRANDED PHARM 12.5MG N020504 001 Dec 27, 1996
TABLET;ORAL
HYDROCHLOROTHIAZIDE
AB ! ACCORD HLTHCARE 12.5MG A202556 001 Sep 24, 2012
AB 25MG A202556 002 Sep 24, 2012
AB 50MG A202556 003 Sep 24, 2012
AB ACTAVIS ELIZABETH 12.5MG A040707 001 Feb 27, 2007
AB AUROBINDO PHARMA 25MG A040780 001 Jul 20, 2007
AB 50MG A040780 002 Jul 20, 2007
AB HERITAGE PHARMS 25MG A085182 002
AB 50MG A085182 001
AB IPCA LABS LTD 12.5MG A040807 001 Jul 20, 2007
AB 25MG A040807 002 Jul 20, 2007
AB 50MG A040807 003 Jul 20, 2007
AB + IVAX SUB TEVA 25MG A083177 001
PHARMS
AB +! 50MG A083177 002
AB LEADING 12.5MG A040702 003 May 10, 2017
AB 25MG A040702 001 Mar 16, 2007
AB 50MG A040702 002 Mar 16, 2007
AB OXFORD PHARMS 25MG A087059 001
AB 50MG A087068 001
AB PRINSTON INC 25MG A040412 001 Mar 29, 2002
AB 50MG A040412 002 Mar 29, 2002
AB SCIEGEN PHARMS INC 25MG A203018 001 Jul 23, 2014
AB 50MG A203018 002 Jul 23, 2014
AB UNICHEM 25MG A040907 001 Aug 15, 2008
AB 50MG A040907 002 Aug 15, 2008
HYDROCHLOROTHIAZIDE; IRBESARTAN
TABLET;ORAL
AVALIDE
AB +! SANOFI AVENTIS US 12.5MG;150MG N020758 002 Sep 30, 1997
AB +! 12.5MG;300MG N020758 003 Aug 31, 1998
IRBESARTAN AND HYDROCHLOROTHIAZIDE
AB ALEMBIC PHARMS 12.5MG;150MG A091370 001 Oct 15, 2012
AB 12.5MG;300MG A091370 002 Oct 15, 2012
AB 25MG;300MG A091370 003 Oct 12, 2016
AB AUROBINDO PHARMA 12.5MG;150MG A203630 001 Feb 22, 2013
LTD
AB 12.5MG;300MG A203630 002 Feb 22, 2013
AB 25MG;300MG A203630 003 Mar 31, 2016
AB DR REDDYS LABS LTD 12.5MG;150MG A203500 001 Sep 27, 2012
AB 12.5MG;300MG A203500 002 Sep 27, 2012
AB HIKMA 12.5MG;150MG A090351 001 Oct 15, 2012
AB 12.5MG;300MG A090351 002 Oct 15, 2012
AB 25MG;300MG A090351 003 Jun 08, 2017
AB HISUN PHARM 12.5MG;150MG A207896 001 Oct 14, 2016
HANGZHOU
AB 12.5MG;300MG A207896 002 Oct 14, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-232(of 474)

HYDROCHLOROTHIAZIDE; IRBESARTAN
TABLET;ORAL
IRBESARTAN AND HYDROCHLOROTHIAZIDE
AB LUPIN LTD 12.5MG;150MG A201524 001 Feb 27, 2013
AB 12.5MG;300MG A201524 002 Feb 27, 2013
AB MACLEODS PHARMS LTD 12.5MG;150MG A202414 001 Sep 27, 2012
AB 12.5MG;300MG A202414 002 Sep 27, 2012
AB PRINSTON INC 12.5MG;150MG A203072 001 May 09, 2014
AB 12.5MG;300MG A203072 002 May 09, 2014
AB SANDOZ 12.5MG;150MG A077446 001 Sep 27, 2012
AB 12.5MG;300MG A077446 002 Sep 27, 2012
AB TEVA 12.5MG;150MG A077369 001 Mar 30, 2012
AB 12.5MG;300MG A077369 002 Mar 30, 2012
HYDROCHLOROTHIAZIDE; LISINOPRIL
TABLET;ORAL
LISINOPRIL AND HYDROCHLOROTHIAZIDE
AB AUROBINDO 12.5MG;10MG A077606 001 Mar 14, 2006
AB 12.5MG;20MG A077606 002 Mar 14, 2006
AB 25MG;20MG A077606 003 Mar 14, 2006
AB INVAGEN PHARMS 12.5MG;10MG A204058 001 May 23, 2017
AB 12.5MG;20MG A204058 002 May 23, 2017
AB 25MG;20MG A204058 003 May 23, 2017
AB LUPIN 12.5MG;10MG A077912 001 Sep 27, 2006
AB 12.5MG;20MG A077912 002 Sep 27, 2006
AB 25MG;20MG A077912 003 Sep 27, 2006
AB PRINSTON INC 12.5MG;10MG A076230 001 Jul 01, 2002
AB 12.5MG;20MG A076230 002 Jul 01, 2002
AB 25MG;20MG A076230 003 Jul 01, 2002
AB SANDOZ 12.5MG;10MG A076262 001 Jul 01, 2002
AB 12.5MG;20MG A076262 002 Jul 01, 2002
AB 25MG;20MG A076262 003 Jul 01, 2002
AB SUN PHARM INDS LTD 12.5MG;10MG A076007 001 Jul 01, 2002
AB 12.5MG;20MG A076007 002 Jul 01, 2002
AB 25MG;20MG A076007 003 Jul 01, 2002
AB WATSON LABS 12.5MG;10MG A076194 003 Jul 01, 2002
AB 12.5MG;20MG A076194 001 Jul 01, 2002
AB 25MG;20MG A076194 002 Jul 01, 2002
ZESTORETIC
AB + ALMATICA 12.5MG;10MG N019888 003 Nov 18, 1993
AB +! 12.5MG;20MG N019888 001 Sep 20, 1990
AB +! 25MG;20MG N019888 002 Jul 20, 1989
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
TABLET;ORAL
HYZAAR
AB + ORGANON 12.5MG;50MG N020387 001 Apr 28, 1995
AB + 12.5MG;100MG N020387 003 Oct 20, 2005
AB + 25MG;100MG N020387 002 Nov 10, 1998
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
AB ALEMBIC PHARMS LTD 12.5MG;50MG A091617 001 Feb 17, 2012
AB 12.5MG;100MG A091617 002 Feb 17, 2012
AB 25MG;100MG A091617 003 Feb 17, 2012
AB AUROBINDO PHARMA 12.5MG;50MG A091629 001 Oct 06, 2010
AB 12.5MG;100MG A091629 002 Oct 06, 2010
AB ! 25MG;100MG A091629 003 Jan 06, 2010
AB IPCA LABS LTD 12.5MG;50MG A201682 001 Mar 01, 2013
AB 12.5MG;100MG A201682 002 Mar 01, 2013
AB 25MG;100MG A201682 003 Mar 01, 2013
AB JUBILANT CADISTA 12.5MG;50MG A201845 001 Sep 18, 2012
AB 12.5MG;100MG A201845 002 Sep 18, 2012
AB 25MG;100MG A201845 003 Sep 18, 2012
AB LUPIN LTD 12.5MG;50MG A078245 001 Oct 06, 2010
AB 12.5MG;100MG A078245 002 May 21, 2010
AB 25MG;100MG A078245 003 Oct 06, 2010
AB MACLEODS PHARMS LTD 12.5MG;50MG A202289 001 Aug 09, 2012
AB 12.5MG;100MG A202289 002 Aug 09, 2012
AB 25MG;100MG A202289 003 Aug 09, 2012
AB PRINSTON INC 12.5MG;50MG A204901 001 Nov 06, 2017
AB 12.5MG;100MG A204901 002 Nov 06, 2017
AB 25MG;100MG A204901 003 Nov 06, 2017
AB SANDOZ 12.5MG;50MG A077948 001 Oct 06, 2010
AB 12.5MG;100MG A077948 003 Aug 19, 2010
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-233(of 474)

HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM


TABLET;ORAL
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
AB 25MG;100MG A077948 002 Oct 06, 2010
AB TEVA PHARMS 12.5MG;50MG A077157 001 Apr 06, 2010
AB 12.5MG;100MG A077157 002 Apr 06, 2010
AB 25MG;100MG A077157 003 Apr 06, 2010
AB UNICHEM 12.5MG;50MG A204832 001 Jul 21, 2017
AB 12.5MG;100MG A204832 002 Jul 21, 2017
AB 25MG;100MG A204832 003 Jul 21, 2017
AB ZYDUS PHARMS USA 12.5MG;50MG A078385 001 Oct 06, 2010
INC
AB 25MG;100MG A078385 002 Oct 06, 2010
HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE
TABLET;ORAL
LOPRESSOR HCT
AB + VALIDUS PHARMS 25MG;50MG N018303 001 Dec 31, 1984
METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
AB ALEMBIC PHARMS 25MG;50MG A202870 001 Nov 06, 2013
AB ! 25MG;100MG A202870 002 Nov 06, 2013
AB 50MG;100MG A202870 003 Nov 06, 2013
AB MYLAN 25MG;50MG A076792 001 Aug 20, 2004
AB 25MG;100MG A076792 002 Aug 20, 2004
AB 50MG;100MG A076792 003 Aug 20, 2004
AB SUN PHARM INDS 25MG;50MG A090654 001 Jan 19, 2012
AB 25MG;100MG A090654 002 Jan 19, 2012
AB 50MG;100MG A090654 003 Jan 19, 2012
HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
TABLET;ORAL
MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
AB GLENMARK PHARMS 12.5MG;7.5MG A090718 001 Mar 17, 2010
AB 12.5MG;15MG A090718 002 Mar 17, 2010
AB 25MG;15MG A090718 003 Mar 17, 2010
AB TEVA 12.5MG;7.5MG A076980 001 Mar 07, 2007
AB 12.5MG;15MG A076980 003 Mar 07, 2007
AB ! 25MG;15MG A076980 002 Mar 07, 2007
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
TABLET;ORAL
BENICAR HCT
AB + COSETTE 12.5MG;20MG N021532 002 Jun 05, 2003
AB + 12.5MG;40MG N021532 003 Jun 05, 2003
AB +! 25MG;40MG N021532 005 Jun 05, 2003
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
AB ACCORD HLTHCARE 12.5MG;20MG A209281 001 Feb 07, 2019
AB 12.5MG;40MG A209281 002 Feb 07, 2019
AB 25MG;40MG A209281 003 Feb 07, 2019
AB ALEMBIC PHARMS 12.5MG;20MG A204233 001 Apr 24, 2017
AB 12.5MG;40MG A204233 002 Apr 24, 2017
AB 25MG;40MG A204233 003 Apr 24, 2017
AB AUROBINDO PHARMA 12.5MG;20MG A205391 001 Apr 24, 2017
AB 12.5MG;40MG A205391 002 Apr 24, 2017
AB 25MG;40MG A205391 003 Apr 24, 2017
AB PRINSTON INC 12.5MG;20MG A207804 001 Apr 24, 2017
AB 12.5MG;40MG A207804 002 Apr 24, 2017
AB 25MG;40MG A207804 003 Apr 24, 2017
AB TEVA PHARMS USA 12.5MG;40MG A200532 002 Apr 24, 2017
AB TORRENT 12.5MG;20MG A206515 001 May 03, 2017
AB 12.5MG;40MG A206515 002 May 03, 2017
AB 25MG;40MG A206515 003 May 03, 2017
AB UMEDICA LABS PVT 12.5MG;20MG A208847 001 Sep 17, 2019
LTD
AB 12.5MG;40MG A208847 003 Sep 17, 2019
AB 25MG;40MG A208847 002 Sep 17, 2019
HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
TABLET;ORAL
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
AB APOTEX CORP 12.5MG;EQ 10MG BASE A091524 001 Mar 12, 2013
AB 12.5MG;EQ 20MG BASE A091524 002 Mar 12, 2013
AB 25MG;EQ 20MG BASE A091524 003 Mar 12, 2013
AB AUROBINDO PHARMA 12.5MG;EQ 10MG BASE A078450 001 Aug 24, 2007
AB 12.5MG;EQ 20MG BASE A078450 002 Aug 24, 2007
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-234(of 474)

HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE


TABLET;ORAL
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
AB ! 25MG;EQ 20MG BASE A078450 003 Aug 24, 2007
AB INVAGEN PHARMS 12.5MG;EQ 10MG BASE A201356 001 Apr 20, 2011
AB 12.5MG;EQ 20MG BASE A201356 002 Apr 20, 2011
AB 25MG;EQ 20MG BASE A201356 003 Apr 20, 2011
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
TABLET;ORAL
ALDACTAZIDE
AB + PFIZER 25MG;25MG N012616 004 Dec 30, 1982
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
AB MYLAN 25MG;25MG A086513 001
AB SUN PHARM 25MG;25MG A089534 001 Jul 02, 1987
INDUSTRIES
ALDACTAZIDE
+! PFIZER 50MG;50MG N012616 005 Dec 30, 1982
HYDROCHLOROTHIAZIDE; TELMISARTAN
TABLET;ORAL
MICARDIS HCT
AB + BOEHRINGER 12.5MG;40MG N021162 001 Nov 17, 2000
INGELHEIM
AB + 12.5MG;80MG N021162 002 Nov 17, 2000
AB +! 25MG;80MG N021162 003 Apr 19, 2004
TELMISARTAN AND HYDROCHLOROTHIAZIDE
AB ALEMBIC PHARMS 12.5MG;40MG A203010 001 Feb 25, 2014
AB 12.5MG;80MG A203010 002 Feb 25, 2014
AB 25MG;80MG A203010 003 Feb 25, 2014
AB AUROBINDO PHARMA 12.5MG;40MG A208727 001 Dec 15, 2016
AB 12.5MG;80MG A208727 002 Dec 15, 2016
AB 25MG;80MG A208727 003 Dec 15, 2016
AB GLENMARK PHARMS LTD 12.5MG;40MG A202544 001 Mar 04, 2019
AB 12.5MG;80MG A202544 002 Mar 04, 2019
AB 25MG;80MG A202544 003 Mar 04, 2019
AB LUPIN LTD 12.5MG;40MG A091351 001 Aug 07, 2014
AB 12.5MG;80MG A091351 002 Aug 07, 2014
AB 25MG;80MG A091351 003 Aug 07, 2014
AB PRINSTON INC 12.5MG;40MG A209028 001 Nov 06, 2017
AB 12.5MG;80MG A209028 002 Nov 06, 2017
AB 25MG;80MG A209028 003 Nov 06, 2017
AB ZYDUS PHARMS 12.5MG;40MG A204221 001 Aug 15, 2017
AB 12.5MG;80MG A204221 002 Aug 15, 2017
AB 25MG;80MG A204221 003 Aug 15, 2017
HYDROCHLOROTHIAZIDE; TRIAMTERENE
CAPSULE;ORAL
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
AB CADILA 25MG;37.5MG A208358 001 Feb 11, 2019
AB LANNETT CO INC 25MG;37.5MG A201407 001 Dec 09, 2011
AB ! SANDOZ 25MG;37.5MG A074821 001 Jun 05, 1997
TABLET;ORAL
MAXZIDE
AB +! AUROBINDO PHARMA 50MG;75MG N019129 001 Oct 22, 1984
USA
MAXZIDE-25
AB + AUROBINDO PHARMA 25MG;37.5MG N019129 003 May 13, 1988
USA
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
AB APOTEX INC 25MG;37.5MG A071251 002 May 05, 1998
AB 50MG;75MG A071251 001 Apr 17, 1988
AB RUBICON 25MG;37.5MG A216211 001 Feb 23, 2022
AB 50MG;75MG A216211 002 Feb 23, 2022
AB SANDOZ 25MG;37.5MG A073281 001 Apr 30, 1992
AB 50MG;75MG A072011 001 Jun 17, 1988
AB WATSON LABS 25MG;37.5MG A073449 001 Sep 23, 1993
AB 50MG;75MG A071851 001 Nov 30, 1988
AB ZYDUS PHARMS 25MG;37.5MG A208360 001 Jun 29, 2018
AB 50MG;75MG A208360 002 Jun 29, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-235(of 474)

HYDROCHLOROTHIAZIDE; VALSARTAN
TABLET;ORAL
DIOVAN HCT
AB + NOVARTIS 12.5MG;80MG N020818 001 Mar 06, 1998
AB + 12.5MG;160MG N020818 002 Mar 06, 1998
AB + 12.5MG;320MG N020818 004 Apr 28, 2006
AB + 25MG;160MG N020818 003 Jan 17, 2002
AB +! 25MG;320MG N020818 005 Apr 28, 2006
VALSARTAN AND HYDROCHLOROTHIAZIDE
AB ALEMBIC PHARMS 12.5MG;80MG A201662 001 Mar 21, 2013
AB 12.5MG;160MG A201662 002 Mar 21, 2013
AB 12.5MG;320MG A201662 003 Mar 21, 2013
AB 25MG;160MG A201662 004 Mar 21, 2013
AB 25MG;320MG A201662 005 Mar 21, 2013
AB AUROBINDO PHARMA 12.5MG;80MG A202519 001 Mar 21, 2013
LTD
AB 12.5MG;160MG A202519 002 Mar 21, 2013
AB 12.5MG;320MG A202519 003 Mar 21, 2013
AB 25MG;160MG A202519 004 Mar 21, 2013
AB 25MG;320MG A202519 005 Mar 21, 2013
AB LUPIN LTD 12.5MG;80MG A078946 003 Mar 21, 2013
AB 12.5MG;160MG A078946 004 Mar 21, 2013
AB 12.5MG;320MG A078946 001 Mar 21, 2013
AB 25MG;160MG A078946 005 Mar 21, 2013
AB 25MG;320MG A078946 002 Mar 21, 2013
AB MACLEODS PHARMS LTD 12.5MG;80MG A203145 001 Apr 19, 2013
AB 12.5MG;160MG A203145 002 Apr 19, 2013
AB 12.5MG;320MG A203145 003 Apr 19, 2013
AB 25MG;160MG A203145 004 Apr 19, 2013
AB 25MG;320MG A203145 005 Apr 19, 2013
AB MYLAN PHARMS INC 12.5MG;80MG A078020 001 Sep 21, 2012
AB 12.5MG;160MG A078020 002 Sep 21, 2012
AB 12.5MG;320MG A078020 004 Sep 21, 2012
AB 25MG;160MG A078020 003 Sep 21, 2012
AB 25MG;320MG A078020 005 Sep 21, 2012
AB PRINSTON INC 12.5MG;80MG A206083 001 Feb 08, 2016
AB 12.5MG;160MG A206083 002 Feb 08, 2016
AB 12.5MG;320MG A206083 003 Feb 08, 2016
AB 25MG;160MG A206083 004 Feb 08, 2016
AB 25MG;320MG A206083 005 Feb 08, 2016
HYDROCODONE BITARTRATE
CAPSULE, EXTENDED RELEASE;ORAL
HYDROCODONE BITARTRATE
! ALVOGEN 10MG A206986 001 Jan 21, 2020
15MG A206986 002 Jan 21, 2020
20MG A206986 003 Jan 21, 2020
30MG A206986 004 Jan 21, 2020
40MG A206986 005 Jan 21, 2020
50MG A206986 006 Jan 21, 2020
TABLET, EXTENDED RELEASE;ORAL
HYDROCODONE BITARTRATE
AB ALVOGEN 20MG A208269 001 Mar 01, 2021
AB 30MG A208269 002 Mar 01, 2021
AB 40MG A208269 003 Mar 01, 2021
AB 60MG A208269 004 Mar 01, 2021
AB 80MG A208269 005 Mar 01, 2021
AB 100MG A208269 006 Mar 01, 2021
AB 120MG A208269 007 Mar 01, 2021
HYSINGLA ER
AB +! PURDUE PHARMA LP 20MG N206627 001 Nov 20, 2014
AB + 30MG N206627 002 Nov 20, 2014
AB + 40MG N206627 003 Nov 20, 2014
AB + 60MG N206627 004 Nov 20, 2014
AB + 80MG N206627 005 Nov 20, 2014
AB + 100MG N206627 006 Nov 20, 2014
AB + 120MG N206627 007 Nov 20, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-236(of 474)

HYDROCODONE BITARTRATE; IBUPROFEN


TABLET;ORAL
HYDROCODONE
AB NOSTRUM LABS INC 5MG;200MG A077723 003 Nov 06, 2006
HYDROCODONE BITARTRATE AND IBUPROFEN
AB ACTAVIS LABS FL INC 7.5MG;200MG A076604 001 Dec 31, 2003
AB AMNEAL PHARMS NY 5MG;200MG A076642 002 Mar 18, 2004
AB ! 7.5MG;200MG A076642 001 Oct 12, 2004
AB AUROLIFE PHARMA LLC 7.5MG;200MG A204575 001 Jun 02, 2016
AB NOSTRUM LABS INC 7.5MG;200MG A077723 001 Nov 06, 2006
10MG;200MG A077723 002 Nov 06, 2006
HYDROCORTISONE
CREAM;TOPICAL
ALA-CORT
AT CROWN LABS 2.5% A080706 007 Jan 05, 2016
AT 1% A080706 006
ANUSOL HC
AT SALIX PHARMS 2.5% A088250 001 Jun 06, 1984
HYDROCORTISONE
AT ACTAVIS MID 1% A087795 001 May 03, 1983
ATLANTIC
AT 2.5% A089682 001 Mar 10, 1988
AT +! FOUGERA PHARMS INC 1% A080693 003
AT ! 2.5% A089414 001 Dec 16, 1986
AT PADAGIS US 2.5% A085025 001
AT RISING 2.5% A040879 001 Aug 20, 2010
AT TARO PHARM INDS LTD 2.5% A088799 001 Nov 09, 1984
ENEMA;RECTAL
COLOCORT
AB CHARTWELL 100MG/60ML A075172 001 Dec 03, 1999
CORTENEMA
AB +! ANI PHARMS 100MG/60ML N016199 001
GRANULE;ORAL
ALKINDI SPRINKLE
+ ETON 0.5MG N213876 001 Sep 29, 2020
+ 1MG N213876 002 Sep 29, 2020
+ 2MG N213876 003 Sep 29, 2020
+! 5MG N213876 004 Sep 29, 2020
LOTION;TOPICAL
HYDROCORTISONE
AT TARO 2.5% A040247 001 Jul 23, 1999
STIE-CORT
AT ! PADAGIS US 2.5% A089074 001 Nov 26, 1985
ALA-SCALP
DERM RX 2% A083231 001
OINTMENT;TOPICAL
HYDROCORTISONE
AT +! FOUGERA PHARMS 1% A080692 001
AT ! FOUGERA PHARMS INC 2.5% A081203 001 May 28, 1993
AT PADAGIS US 2.5% A085027 001
AT TARO 1% A086257 001
HYDROCORTISONE IN ABSORBASE
AT CMP PHARMA INC 1% A088138 001 Sep 06, 1985
SOLUTION;TOPICAL
TEXACORT
! MISSION PHARMA 2.5% A081271 001 Apr 17, 1992
TABLET;ORAL
CORTEF
AB + PHARMACIA AND 5MG N008697 003
UPJOHN
AB + 10MG N008697 001
AB +! 20MG N008697 002
HYDROCORTISONE
AB IMPAX LABS INC 5MG A040646 001 Mar 30, 2007
AB 10MG A040646 002 Mar 30, 2007
AB 20MG A040646 003 Mar 30, 2007
AB STRIDES PHARMA 5MG A207029 001 Apr 27, 2017
AB 10MG A207029 002 Apr 27, 2017
AB 20MG A207029 003 Apr 27, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-237(of 474)

HYDROCORTISONE ACETATE
AEROSOL, METERED;RECTAL
CORTIFOAM
+! MYLAN SPECIALITY LP 10% N017351 001 Feb 10, 1982
CREAM;TOPICAL
MICORT-HC
SEBELA IRELAND LTD 2.5% A040396 001 Feb 27, 2001
HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE
AEROSOL, METERED;TOPICAL
EPIFOAM
BX MYLAN SPECIALITY LP 1%;1% A086457 001
PROCTOFOAM HC
BX +! MYLAN SPECIALITY LP 1%;1% A086195 001
CREAM;TOPICAL
PRAMOSONE
SEBELA IRELAND LTD 0.5%;1% A083778 001
1%;1% A085368 001
LOTION;TOPICAL
PRAMOSONE
SEBELA IRELAND LTD 1%;1% A085980 001
2.5%;1% A085979 001
HYDROCORTISONE BUTYRATE
CREAM;TOPICAL
HYDROCORTISONE BUTYRATE
AB1 TARO PHARM INDS 0.1% A076654 001 Aug 03, 2005
LOCOID
AB1 +! BAUSCH 0.1% N018514 001 Mar 31, 1982
HYDROCORTISONE BUTYRATE
AB2 ACTAVIS MID 0.1% A205134 001 Dec 08, 2017
ATLANTIC
AB2 GLENMARK GENERICS 0.1% A202145 001 Sep 27, 2013
LOCOID LIPOCREAM
AB2 +! PRECISION DERMAT 0.1% N020769 001 Sep 08, 1997
LOTION;TOPICAL
HYDROCORTISONE BUTYRATE
AB LUPIN LTD 0.1% A210209 001 Aug 17, 2018
AB THE J MOLNER 0.1% A209556 001 Nov 21, 2017
LOCOID
AB +! BAUSCH 0.1% N022076 001 May 18, 2007
OINTMENT;TOPICAL
HYDROCORTISONE BUTYRATE
AB TARO 0.1% A076842 001 Dec 27, 2004
LOCOID
AB +! PRECISION DERMAT 0.1% N018652 001 Oct 29, 1982
SOLUTION;TOPICAL
HYDROCORTISONE BUTYRATE
AT TARO PHARM INDS 0.1% A076364 001 Jan 14, 2004
LOCOID
AT +! BAUSCH 0.1% N019116 001 Feb 25, 1987
HYDROCORTISONE PROBUTATE
CREAM;TOPICAL
PANDEL
+! ANI PHARMS 0.1% N020453 001 Feb 28, 1997
HYDROCORTISONE SODIUM SUCCINATE
INJECTABLE;INJECTION
SOLU-CORTEF
+! PHARMACIA AND EQ 100MG BASE/VIAL N009866 001
UPJOHN
+! EQ 250MG BASE/VIAL N009866 002
+! EQ 500MG BASE/VIAL N009866 003
+! EQ 1GM BASE/VIAL N009866 004
HYDROCORTISONE VALERATE
CREAM;TOPICAL
HYDROCORTISONE VALERATE
AB COSETTE 0.2% A213724 001 Feb 11, 2021
AB ENCUBE ETHICALS 0.2% A211047 001 Nov 04, 2021
AB GLENMARK PHARMS LTD 0.2% A211129 001 Oct 12, 2018
AB LUPIN LTD 0.2% A210307 001 Aug 15, 2019
AB PADAGIS ISRAEL 0.2% A075666 001 May 24, 2000
AB ! TARO 0.2% A075042 001 Aug 25, 1998
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-238(of 474)

HYDROCORTISONE VALERATE
OINTMENT;TOPICAL
HYDROCORTISONE VALERATE
AB COSETTE 0.2% A211764 001 Mar 04, 2020
AB GLENMARK PHARMS LTD 0.2% A211750 001 Dec 14, 2018
AB ! TARO 0.2% A075043 001 Aug 25, 1998
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
SOLUTION/DROPS;OTIC
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
AT ! BAUSCH AND LOMB 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A064053 001 Dec 29, 1995
AT SANDOZ INC 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A062423 001 Aug 25, 1983
SUSPENSION/DROPS;OPHTHALMIC
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
! SANDOZ INC 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A062874 001 May 11, 1988
SUSPENSION/DROPS;OTIC
CASPORYN HC
AT +! CASPER PHARMA LLC 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML N060613 001
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
AT AMRING PHARMS 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A065219 001 May 01, 2006
AT SANDOZ INC 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A062488 001 Nov 06, 1985
OTICAIR
AT BAUSCH AND LOMB 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A064065 001 Aug 28, 1996
HYDROMORPHONE HYDROCHLORIDE
INJECTABLE;INJECTION
DILAUDID
AP +! FRESENIUS KABI USA 1MG/ML N019034 003 Apr 30, 2009
AP +! 2MG/ML N019034 004 Apr 30, 2009
HYDROMORPHONE HYDROCHLORIDE
AP AKORN 10MG/ML A078228 001 Apr 14, 2010
AP 10MG/ML A078261 001 Apr 14, 2010
AP EUROHLTH INTL SARL 2MG/ML A202159 001 Apr 27, 2018
AP HOSPIRA INC 1MG/ML N200403 001 Dec 01, 2011
AP 2MG/ML N200403 002 Dec 01, 2011
AP 4MG/ML N200403 003 Dec 01, 2011
AP 10MG/ML A078591 001 Jun 17, 2008
DILAUDID
+! FRESENIUS KABI USA 0.2MG/ML N019034 006 Jan 16, 2020
HYDROMORPHONE HYDROCHLORIDE
HOSPIRA INC 0.5MG/0.5ML N200403 004 Jun 13, 2022
SOLUTION;ORAL
DILAUDID
AA +! RHODES PHARMS 5MG/5ML N019891 001 Dec 07, 1992
HYDROMORPHONE HYDROCHLORIDE
AA ASCENT PHARMS INC 5MG/5ML A210176 001 Oct 27, 2017
AA HIKMA 5MG/5ML A074653 001 Jul 29, 1998
TABLET;ORAL
DILAUDID
AB + RHODES PHARMS 2MG N019892 003 Nov 09, 2007
AB + 4MG N019892 002 Nov 09, 2007
AB +! 8MG N019892 001 Dec 07, 1992
HYDROMORPHONE HYDROCHLORIDE
AB ASCENT PHARMS INC 2MG A210506 001 Jan 17, 2018
AB 4MG A210506 002 Jan 17, 2018
AB 8MG A210506 003 Jan 17, 2018
AB AUROLIFE PHARMA LLC 2MG A205814 001 May 13, 2016
AB 4MG A205814 002 May 13, 2016
AB 8MG A205814 003 May 13, 2016
AB SPECGX LLC 2MG A076855 002 Sep 19, 2007
AB 4MG A076855 003 Sep 19, 2007
AB 8MG A076855 001 Dec 23, 2004
TABLET, EXTENDED RELEASE;ORAL
HYDROMORPHONE HYDROCHLORIDE
AB ASCENT PHARMS INC 8MG A212133 001 Sep 23, 2020
AB 12MG A212133 002 Sep 23, 2020
AB 16MG A212133 003 Sep 23, 2020
AB 32MG A212133 004 Sep 23, 2020
AB OSMOTICA PHARM US 8MG A205629 001 Jul 07, 2016
AB 12MG A205629 002 Jul 07, 2016
AB 16MG A205629 003 Jul 07, 2016
AB ! 32MG A205629 004 Jul 07, 2016
AB PADAGIS US 8MG A204278 001 Apr 06, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-239(of 474)

HYDROMORPHONE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
HYDROMORPHONE HYDROCHLORIDE
AB 12MG A204278 002 Apr 06, 2015
AB 16MG A204278 003 Apr 06, 2015
AB 32MG A204278 004 Sep 20, 2017
HYDROXOCOBALAMIN
INJECTABLE;INJECTION
CYANOKIT
+! BTG INTL 5GM/VIAL (5GM/KIT) N022041 001 Apr 08, 2011
HYDROXOCOBALAMIN
! ACTAVIS LLC 1MG/ML A085998 001
HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE
SOLUTION/DROPS;OPHTHALMIC
PAREMYD
+! AKORN 1%;0.25% N019261 001 Jan 30, 1992
HYDROXYCHLOROQUINE SULFATE
TABLET;ORAL
HYDROXYCHLOROQUINE SULFATE
AB ACCORD HLTHCARE 100MG A213342 002 Aug 18, 2021
AB 200MG A213342 001 Apr 07, 2020
AB 300MG A213342 003 Aug 18, 2021
AB ! 400MG A213342 004 Aug 18, 2021
AB ALKALOIDA ZRT 200MG A201691 001 May 08, 2018
AB AMNEAL PHARMS CO 200MG A210577 001 May 15, 2018
AB APPCO 100MG A210441 002 Sep 19, 2022
AB 200MG A210441 001 May 01, 2018
AB 300MG A210441 003 Sep 19, 2022
AB 400MG A210441 004 Sep 19, 2022
AB AUROBINDO PHARMA 200MG A040274 001 May 29, 1998
USA
AB IPCA LABS LTD 200MG A040766 001 Jun 14, 2007
AB LAURUS 200MG A210959 001 Jan 15, 2019
AB LUPIN LTD 200MG A210543 001 Jul 06, 2018
AB RISE PHARMA 200MG A212902 001 May 14, 2020
AB SANDOZ 200MG A040104 001 Nov 30, 1995
AB TEVA PHARMS 200MG A040081 001 Sep 30, 1994
AB ZYDUS PHARMS USA 200MG A040657 001 Sep 21, 2007
INC
PLAQUENIL
AB +! CONCORDIA 200MG N009768 001
HYDROXYCHLOROQUINE SULFATE
+ NOVITIUM PHARMA 200MG N214581 001 Jan 14, 2022
+! 300MG N214581 002 Jan 14, 2022
HYDROXYPROGESTERONE CAPROATE
SOLUTION;INTRAMUSCULAR
HYDROXYPROGESTERONE CAPROATE
AP AM REGENT 250MG/ML (250MG/ML) A210723 001 Jun 21, 2018
AP ASPEN 250MG/ML (250MG/ML) A211777 001 Aug 08, 2019
AP EUGIA PHARMA 250MG/ML (250MG/ML) A211071 001 Apr 16, 2019
AP SLAYBACK PHARMA LLC 250MG/ML (250MG/ML) A210877 001 Mar 22, 2019
MAKENA PRESERVATIVE FREE
AP +! COVIS 250MG/ML (250MG/ML) N021945 002 Feb 19, 2016
HYDROXYPROGESTERONE CAPROATE
AP1 EUGIA PHARMA 1250MG/5ML (250MG/ML) A211070 001 Apr 16, 2019
AP1 SLAYBACK PHARMA LLC 1250MG/5ML (250MG/ML) A210618 001 Dec 28, 2018
AP1 SUN PHARM 1250MG/5ML (250MG/ML) A208381 001 Apr 09, 2019
MAKENA
AP1 +! COVIS 1250MG/5ML (250MG/ML) N021945 001 Feb 03, 2011
HYDROXYPROGESTERONE CAPROATE
! ASPEN GLOBAL INC 1250MG/5ML (250MG/ML) A200271 001 Aug 24, 2015
SOLUTION;SUBCUTANEOUS
MAKENA (AUTOINJECTOR)
+! COVIS 275MG/1.1ML (250MG/ML) N021945 004 Feb 14, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-240(of 474)

HYDROXYPROPYL CELLULOSE
INSERT;OPHTHALMIC
LACRISERT
+! VALEANT PHARMS INTL 5MG N018771 001
HYDROXYUREA
CAPSULE;ORAL
HYDREA
AB +! CHEPLAPHARM 500MG N016295 001
HYDROXYUREA
AB BARR 500MG A075143 001 Oct 16, 1998
AB LEADING 500MG A213438 001 Apr 08, 2020
AB PAR PHARM 500MG A075340 001 Feb 24, 1999
DROXIA
+ CHEPLAPHARM 200MG N016295 002 Feb 25, 1998
+ 300MG N016295 003 Feb 25, 1998
+ 400MG N016295 004 Feb 25, 1998
TABLET;ORAL
SIKLOS
+ ADDMEDICA SAS 100MG N208843 001 Dec 21, 2017
+! 1GM N208843 002 Dec 21, 2017
HYDROXYZINE HYDROCHLORIDE
INJECTABLE;INJECTION
HYDROXYZINE HYDROCHLORIDE
! AM REGENT 25MG/ML A087408 001
! 50MG/ML A087408 002
SYRUP;ORAL
HYDROXYZINE HYDROCHLORIDE
AA LANNETT CO INC 10MG/5ML A201674 001 Aug 21, 2013
AA +! WOCKHARDT BIO AG 10MG/5ML A087294 001 Apr 12, 1982
TABLET;ORAL
HYDROXYZINE HYDROCHLORIDE
AB AIPING LIFE SCI 10MG A040804 001 Jun 30, 2008
AB 25MG A040804 002 Jun 30, 2008
AB 50MG A040804 003 Jun 30, 2008
AB AMNEAL PHARM 10MG A040808 001 Sep 24, 2008
AB 25MG A040808 002 Sep 24, 2008
AB 50MG A040808 003 Sep 24, 2008
AB AUROBINDO PHARMA 10MG A087871 002 Dec 20, 1982
LTD
AB 25MG A087871 003 Dec 20, 1982
AB 50MG A087871 001 Dec 20, 1982
AB EPIC PHARMA LLC 10MG A040604 002 Dec 28, 2004
AB 25MG A040604 003 Dec 28, 2004
AB 50MG A040604 001 Dec 28, 2004
AB HERITAGE PHARMA 10MG A204279 001 Aug 20, 2014
AB 25MG A204279 002 Aug 20, 2014
AB 50MG A204279 003 Aug 20, 2014
AB HETERO LABS LTD III 10MG A040805 001 May 29, 2008
AB 25MG A040805 002 May 29, 2008
AB 50MG A040805 003 May 29, 2008
AB INVAGEN PHARMS 10MG A040812 001 Mar 12, 2008
AB 25MG A040812 002 Mar 12, 2008
AB 50MG A040812 003 Mar 12, 2008
AB KVK TECH 10MG A040786 001 Mar 20, 2007
AB 25MG A040786 002 Mar 20, 2007
AB 50MG A040786 003 Mar 20, 2007
AB NORTHSTAR HLTHCARE 10MG A040840 002 Mar 31, 2008
AB 25MG A040840 003 Mar 31, 2008
AB 50MG A040840 001 Mar 31, 2008
AB NUVO PHARMS INC 10MG A207121 002 Mar 29, 2017
AB 25MG A207121 001 Mar 29, 2017
AB 50MG A207121 003 Mar 29, 2017
AB +! PLIVA 10MG A088617 001 Jan 10, 1986
AB +! 25MG A088618 001 Jan 10, 1986
AB +! 50MG A088619 001 Jan 10, 1986
AB PRINSTON INC 10MG A040580 003 May 27, 2005
AB 25MG A040580 002 May 27, 2005
AB 50MG A040580 001 May 27, 2005
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-241(of 474)

HYDROXYZINE PAMOATE
CAPSULE;ORAL
HYDROXYZINE PAMOATE
AB BARR EQ 25MG HYDROCHLORIDE A088496 001 Jun 15, 1984
AB EQ 50MG HYDROCHLORIDE A088487 001 Jun 15, 1984
AB IMPAX LABS INC EQ 25MG HYDROCHLORIDE A040156 001 Jul 15, 1996
AB EQ 50MG HYDROCHLORIDE A040156 002 Jul 15, 1996
AB SANDOZ EQ 25MG HYDROCHLORIDE A087479 001
AB ! EQ 50MG HYDROCHLORIDE A086183 001
VISTARIL
AB + PFIZER EQ 25MG HYDROCHLORIDE N011459 002
AB + EQ 50MG HYDROCHLORIDE N011459 004
HYDROXYZINE PAMOATE
BX HERITAGE PHARMA EQ 25MG HYDROCHLORIDE A201507 001 Jun 03, 2013
BX EQ 50MG HYDROCHLORIDE A201507 002 Jun 03, 2013
BARR EQ 100MG HYDROCHLORIDE A088488 001 Jun 15, 1984
IBANDRONATE SODIUM
INJECTABLE;INTRAVENOUS
IBANDRONATE SODIUM
AP ACCORD HLTHCARE EQ 3MG BASE/3ML A206058 001 Feb 05, 2016
AP ! APOTEX EQ 3MG BASE/3ML A204222 001 Oct 16, 2015
AP EUGIA PHARMA EQ 3MG BASE/3ML A205332 001 Aug 19, 2015
AP MYLAN LABS LTD EQ 3MG BASE/3ML A202671 001 Sep 02, 2014
AP SAGENT PHARMS INC EQ 3MG BASE/3ML A202235 001 Sep 02, 2014
AP SUN PHARM EQ 3MG BASE/3ML A090853 001 Feb 14, 2014
TABLET;ORAL
IBANDRONATE SODIUM
AB APOTEX INC EQ 150MG BASE A078948 001 Mar 19, 2012
AB AUROBINDO PHARMA EQ 150MG BASE A204502 001 Mar 11, 2016
AB ! DR REDDYS LABS LTD EQ 150MG BASE A078997 001 Apr 30, 2012
AB MACLEODS PHARMS LTD EQ 150MG BASE A206887 001 Oct 31, 2017
AB ORBION PHARMS EQ 150MG BASE A078998 001 Mar 19, 2012
AB WATSON LABS TEVA EQ 150MG BASE A079003 001 Mar 20, 2012
IBREXAFUNGERP CITRATE
TABLET;ORAL
BREXAFEMME
+! SCYNEXIS EQ 150MG BASE N214900 001 Jun 01, 2021
IBRUTINIB
CAPSULE;ORAL
IMBRUVICA
+ PHARMACYCLICS INC 70MG N205552 002 Dec 20, 2017
+! 140MG N205552 001 Nov 13, 2013
SUSPENSION;ORAL
IMBRUVICA
+! PHARMACYCLICS INC 70MG/ML N217003 001 Aug 24, 2022
TABLET;ORAL
IMBRUVICA
+ PHARMACYCLICS INC 140MG N210563 001 Feb 16, 2018
+ 280MG N210563 002 Feb 16, 2018
+ 420MG N210563 003 Feb 16, 2018
+! 560MG N210563 004 Feb 16, 2018
IBUPROFEN
SOLUTION;INTRAVENOUS
CALDOLOR
+! CUMBERLAND PHARMS 800MG/8ML (100MG/ML) N022348 002 Jun 11, 2009
+! 800MG/200ML (4MG/ML) N022348 003 Jan 25, 2019
SUSPENSION;ORAL
IBUPROFEN
AB ! ACTAVIS MID 100MG/5ML A074978 001 Mar 25, 1998
ATLANTIC
AB AUROBINDO PHARMA 100MG/5ML A209178 001 Feb 16, 2018
LTD
AB PADAGIS US 100MG/5ML A076925 001 Sep 23, 2004
AB TARO 100MG/5ML A209204 001 Jun 23, 2017
TABLET;ORAL
IBUPROFEN
AB ALKEM LABS LTD 400MG A214699 001 Sep 13, 2021
AB 600MG A214699 002 Sep 13, 2021
AB 800MG A214699 003 Sep 13, 2021
AB AMNEAL PHARMS NY 400MG A071334 001 Nov 25, 1986
AB 400MG A078558 001 Jun 18, 2007
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-242(of 474)

IBUPROFEN
TABLET;ORAL
IBUPROFEN
AB 600MG A071335 001 Nov 25, 1986
AB 600MG A078558 002 Jun 18, 2007
AB 800MG A071935 001 Oct 13, 1987
AB 800MG A078558 003 Jun 18, 2007
AB AUROBINDO PHARMA 400MG A213794 001 May 08, 2020
LTD
AB 600MG A213794 002 May 08, 2020
AB 800MG A213794 003 May 08, 2020
AB CONTRACT PHARMACAL 400MG A071268 002 Oct 15, 1986
AB 600MG A071268 001 Oct 15, 1986
AB 800MG A071268 003 Jul 01, 1988
AB DR REDDYS LA 400MG A075682 001 Nov 14, 2001
AB 600MG A075682 002 Nov 14, 2001
AB ! 800MG A075682 003 Nov 14, 2001
AB DR REDDYS LABS INC 400MG A076112 001 Oct 31, 2001
AB 600MG A076112 002 Oct 31, 2001
AB 800MG A076112 003 Oct 31, 2001
AB GRANULES 400MG A091625 001 Sep 15, 2015
AB 600MG A091625 002 Sep 15, 2015
AB 800MG A091625 003 Sep 15, 2015
AB MARKSANS PHARMA 400MG A090796 001 Dec 21, 2010
AB 600MG A090796 002 Dec 21, 2010
AB 800MG A090796 003 Dec 21, 2010
AB SHANDONG XINHUA 400MG A202413 001 Nov 23, 2016
AB 600MG A202413 002 Nov 23, 2016
AB 800MG A202413 003 Nov 23, 2016
AB STRIDES PHARMA 400MG A078329 001 Feb 05, 2009
AB 600MG A078329 002 Feb 05, 2009
AB 800MG A078329 003 Feb 05, 2009
AB YICHANG HUMANWELL 400MG A215318 001 Mar 30, 2022
AB 600MG A215318 002 Mar 30, 2022
AB 800MG A215318 003 Mar 30, 2022
IBUPROFEN LYSINE
INJECTABLE;INTRAVENOUS
IBUPROFEN LYSINE
AP XGEN PHARMS EQ 20MG BASE/2ML (EQ 10MG BASE/ML) A202402 001 Mar 30, 2016
NEOPROFEN
AP +! RECORDATI RARE EQ 20MG BASE/2ML (EQ 10MG BASE/ML) N021903 001 Apr 13, 2006
IBUTILIDE FUMARATE
INJECTABLE;INJECTION
CORVERT
AP +! PFIZER 0.1MG/ML N020491 001 Dec 28, 1995
IBUTILIDE FUMARATE
AP MYLAN INSTITUTIONAL 0.1MG/ML A090643 001 Jan 11, 2010
ICATIBANT ACETATE
INJECTABLE;SUBCUTANEOUS
FIRAZYR
AP +! TAKEDA PHARMS USA EQ 30MG BASE/3ML (EQ 10MG BASE/ML) N022150 001 Aug 25, 2011
ICATIBANT ACETATE
AP CIPLA EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A212446 001 Jul 13, 2020
AP FRESENIUS KABI USA EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A208317 001 Jun 18, 2020
AP JIANGSU HANSOH EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A211021 001 Mar 09, 2020
PHARM
AP NANG KUANG PHARM CO EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A212081 001 Dec 16, 2020
AP SLAYBACK PHARMA LLC EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A211501 001 Sep 01, 2020
AP TEVA PHARMS USA EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A210118 001 Jul 15, 2019
ICODEXTRIN
SOLUTION;INTRAPERITONEAL
EXTRANEAL
+! BAXTER HLTHCARE 7.5GM/100ML N021321 001 Dec 20, 2002
ICOSAPENT ETHYL
CAPSULE;ORAL
ICOSAPENT ETHYL
AB APOTEX 1GM A209437 001 Jun 30, 2021
AB DR REDDYS 1GM A209499 001 Aug 07, 2020
AB HIKMA 1GM A209457 001 May 21, 2020
AB TEVA PHARMS USA 500MG A209525 001 Sep 11, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-243(of 474)

ICOSAPENT ETHYL
CAPSULE;ORAL
ICOSAPENT ETHYL
AB 1GM A209525 002 Sep 11, 2020
VASCEPA
AB + AMARIN PHARMS 500MG N202057 002 Feb 16, 2017
AB +! 1GM N202057 001 Jul 26, 2012
IDARUBICIN HYDROCHLORIDE
INJECTABLE;INJECTION
IDAMYCIN PFS
AP +! PFIZER 1MG/ML N050734 001 Feb 17, 1997
IDARUBICIN HYDROCHLORIDE
AP HIKMA 1MG/ML A065275 001 Dec 14, 2006
AP 1MG/ML A065288 001 May 15, 2007
IDARUBICIN HYDROCHLORIDE PFS
AP TEVA PHARMS USA 1MG/ML A065036 001 May 01, 2002
IDELALISIB
TABLET;ORAL
ZYDELIG
+ GILEAD SCIENCES INC 100MG N205858 001 Jul 23, 2014
+! 150MG N205858 002 Jul 23, 2014
IFOSFAMIDE
INJECTABLE;INJECTION
IFEX
AP + BAXTER HLTHCARE 1GM/VIAL N019763 001 Dec 30, 1988
AP + 3GM/VIAL N019763 002 Dec 30, 1988
IFOSFAMIDE
AP ! FRESENIUS KABI USA 1GM/VIAL A076078 001 May 28, 2002
AP ! 3GM/VIAL A076078 002 May 28, 2002
AP HIKMA 1GM/20ML (50MG/ML) A076619 001 Jun 29, 2011
AP 3GM/60ML (50MG/ML) A076619 002 Jun 29, 2011
AP ! TEVA PHARMS USA 1GM/20ML (50MG/ML) A076657 001 Apr 04, 2007
AP ! 3GM/60ML (50MG/ML) A076657 002 Apr 04, 2007
ILOPERIDONE
TABLET;ORAL
FANAPT
+! VANDA PHARMS INC 1MG N022192 001 May 06, 2009
+ 2MG N022192 002 May 06, 2009
+ 4MG N022192 003 May 06, 2009
+ 6MG N022192 004 May 06, 2009
+ 8MG N022192 005 May 06, 2009
+ 10MG N022192 006 May 06, 2009
+ 12MG N022192 007 May 06, 2009
ILOPROST
SOLUTION;INHALATION
VENTAVIS
+! ACTELION 10MCG/ML (10MCG/ML) N021779 002 Dec 08, 2005
+! 20MCG/ML (20MCG/ML) N021779 003 Aug 07, 2009
IMATINIB MESYLATE
TABLET;ORAL
GLEEVEC
AB + NOVARTIS EQ 100MG BASE N021588 001 Apr 18, 2003
AB +! EQ 400MG BASE N021588 002 Apr 18, 2003
IMATINIB MESYLATE
AB APOTEX EQ 100MG BASE A079179 001 Aug 05, 2016
AB EQ 400MG BASE A079179 002 Aug 05, 2016
AB BRECKENRIDGE EQ 100MG BASE A205990 001 Feb 08, 2019
AB EQ 400MG BASE A205990 002 Feb 08, 2019
AB DR REDDYS EQ 100MG BASE A206547 001 Aug 13, 2018
AB EQ 400MG BASE A206547 002 Aug 13, 2018
AB EUGIA PHARMA EQ 100MG BASE A212773 001 Jul 23, 2020
AB EQ 400MG BASE A212773 002 Jul 23, 2020
AB HIKMA EQ 100MG BASE A207586 001 Jul 13, 2018
AB EQ 400MG BASE A207586 002 Jul 13, 2018
AB MYLAN EQ 100MG BASE A204644 001 Jun 21, 2017
AB EQ 400MG BASE A204644 002 Jun 21, 2017
AB NATCO PHARMA LTD EQ 100MG BASE A207818 001 Mar 01, 2019
AB EQ 400MG BASE A207818 002 Mar 01, 2019
AB QILU PHARM HAINAN EQ 100MG BASE A212135 001 Jun 21, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-244(of 474)

IMATINIB MESYLATE
TABLET;ORAL
IMATINIB MESYLATE
AB EQ 400MG BASE A212135 002 Jun 21, 2022
AB SHILPA EQ 100MG BASE A208302 001 Jan 17, 2019
AB EQ 400MG BASE A208302 002 Jan 17, 2019
AB SUN PHARM EQ 100MG BASE A078340 001 Dec 03, 2015
AB EQ 400MG BASE A078340 002 Dec 03, 2015
AB TEVA PHARMS USA EQ 100MG BASE A204285 001 Aug 04, 2016
AB EQ 400MG BASE A204285 002 Aug 04, 2016
AB WOCKHARDT BIO AG EQ 100MG BASE A208429 001 Jan 17, 2019
AB EQ 400MG BASE A208429 002 Jan 17, 2019
AB ZYDUS PHARMS EQ 100MG BASE A210658 001 Apr 08, 2020
AB EQ 400MG BASE A210658 002 Apr 08, 2020
IMIPRAMINE HYDROCHLORIDE
TABLET;ORAL
IMIPRAMINE HYDROCHLORIDE
AB LEADING 10MG A040903 001 Oct 24, 2012
AB 25MG A040903 002 Oct 24, 2012
AB 50MG A040903 003 Oct 24, 2012
AB OXFORD PHARMS 10MG A040751 003 Feb 28, 2008
AB 25MG A040751 002 Feb 28, 2008
AB 50MG A040751 001 Feb 28, 2008
AB SANDOZ 10MG A084936 002
AB 25MG A083745 001
AB 50MG A084937 001
AB + SPECGX LLC 10MG A087846 002 May 22, 1984
AB + 25MG A087846 003 May 22, 1984
AB STRIDES PHARMA 10MG A088292 001 Oct 21, 1983
AB 25MG A088262 001 Oct 21, 1983
AB 50MG A088276 001 Oct 21, 1983
AB SUN PHARM 10MG A081048 001 Jun 05, 1990
INDUSTRIES
AB 25MG A081049 001 Jun 05, 1990
AB 50MG A081050 001 Jun 05, 1990
TOFRANIL
AB +! SPECGX LLC 50MG A087846 001 May 22, 1984
IMIPRAMINE PAMOATE
CAPSULE;ORAL
IMIPRAMINE PAMOATE
AB ! HIKMA EQ 75MG HYDROCHLORIDE A091099 001 Apr 16, 2010
AB EQ 100MG HYDROCHLORIDE A091099 002 Apr 16, 2010
AB EQ 125MG HYDROCHLORIDE A091099 003 Apr 16, 2010
AB EQ 150MG HYDROCHLORIDE A091099 004 Apr 16, 2010
AB LUPIN LTD EQ 75MG HYDROCHLORIDE A090444 001 Apr 16, 2010
AB EQ 100MG HYDROCHLORIDE A090444 002 Apr 16, 2010
AB EQ 125MG HYDROCHLORIDE A090444 003 Apr 16, 2010
AB EQ 150MG HYDROCHLORIDE A090444 004 Apr 16, 2010
IMIQUIMOD
CREAM;TOPICAL
ALDARA
AB +! BAUSCH 5% N020723 001 Feb 27, 1997
IMIQUIMOD
AB APOTEX INC 5% A091308 001 Apr 06, 2012
AB FOUGERA PHARMS 5% A078548 001 Feb 25, 2010
AB GLENMARK GENERICS 5% A201994 001 Mar 06, 2012
AB PADAGIS ISRAEL 5% A078837 001 Sep 07, 2010
AB TARO 3.75% A205971 001 Jan 26, 2021
AB 5% A200173 001 Apr 15, 2011
ZYCLARA
AB +! BAUSCH 3.75% N022483 001 Mar 25, 2010
+! 2.5% N022483 002 Jul 15, 2011
INAMRINONE LACTATE
INJECTABLE;INJECTION
AMRINONE LACTATE
! HIKMA EQ 5MG BASE/ML A075513 001 May 09, 2000
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-245(of 474)

INCLISIRAN SODIUM
SOLUTION;SUBCUTANEOUS
LEQVIO
+! NOVARTIS EQ 284MG BASE/1.5ML (EQ 189MG BASE/ML) N214012 001 Dec 22, 2021
INDAPAMIDE
TABLET;ORAL
INDAPAMIDE
AB ACTAVIS ELIZABETH 1.25MG A074722 001 Jun 17, 1996
AB 2.5MG A074722 002 Jun 17, 1996
AB ANI PHARMS 1.25MG A074299 002 Apr 29, 1996
AB ! 2.5MG A074299 001 Jul 27, 1995
INDIGOTINDISULFONATE SODIUM
SOLUTION;INTRAVENOUS
BLUDIGO
+! PROVEPHARM SAS 40MG/5ML (8MG/ML) N216264 001 Jul 08, 2022
INDIUM IN-111 CHLORIDE
INJECTABLE;INJECTION
INDIUM IN 111 CHLORIDE
+! CURIUM 5mCi/0.5ML N019841 001 Sep 27, 1994
INDIUM IN-111 OXYQUINOLINE
INJECTABLE;INJECTION
INDIUM IN 111 OXYQUINOLINE
AP BWXT ITG 1mCi/ML A202586 001 Jul 25, 2018
AP +! GE HEALTHCARE 1mCi/ML N019044 001 Dec 24, 1985
INDIUM IN-111 PENTETATE DISODIUM
INJECTABLE;INTRATHECAL
MPI INDIUM DTPA IN 111
+! GE HEALTHCARE 1mCi/ML N017707 001 Feb 18, 1982
INDIUM IN-111 PENTETREOTIDE KIT
INJECTABLE;INJECTION
OCTREOSCAN
+! CURIUM 3mCi/ML N020314 001 Jun 02, 1994
INDOCYANINE GREEN
INJECTABLE;INJECTION
IC-GREEN
AP +! AKORN 25MG/VIAL N011525 001
INDOCYANINE GREEN
AP RENEW PHARMS 25MG/VIAL A040811 001 Nov 21, 2007
POWDER;INTRAVENOUS, INTERSTITIAL
SPY AGENT GREEN KIT
+! NOVADAQ TECH 25MG/VIAL N211580 001 Nov 21, 2018
INDOMETHACIN
CAPSULE;ORAL
INDOMETHACIN
AB CADILA 25MG A090403 001 Nov 15, 2010
AB 50MG A090403 002 Nov 15, 2010
AB CHARTWELL MOLECULES 50MG A070651 001 Mar 05, 1986
AB GLENMARK GENERICS 25MG A091276 001 Dec 22, 2010
AB ! 50MG A091276 002 Dec 22, 2010
AB HETERO LABS LTD III 25MG A091240 001 Apr 12, 2011
AB 50MG A091240 002 Apr 12, 2011
AB SANDOZ 25MG A070673 001 Apr 29, 1987
AB 50MG A070674 001 Apr 29, 1987
CAPSULE, EXTENDED RELEASE;ORAL
INDOMETHACIN
AB AMNEAL PHARMS 75MG A091549 001 Dec 01, 2010
AB AVANTHI INC 75MG A079175 001 Mar 06, 2009
AB CHARTWELL RX 75MG A200529 001 Nov 30, 2010
AB GLENMARK PHARMS LTD 75MG A203501 001 Jun 22, 2017
AB HETERO LABS LTD III 75MG A201807 001 Sep 28, 2012
AB NOVAST LABS 75MG A204853 001 May 08, 2017
AB ! SANDOZ 75MG A074464 001 May 28, 1998
AB ZYDUS PHARMS 75MG A202711 001 Sep 25, 2017
INJECTABLE;INJECTION
INDOMETHACIN
+! FRESENIUS KABI USA EQ 1MG BASE/VIAL N022536 001 Mar 17, 2010
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-246(of 474)

INDOMETHACIN
SUPPOSITORY;RECTAL
INDOMETHACIN
! COSETTE 50MG A073314 001 Aug 31, 1992
SUSPENSION;ORAL
INDOCIN
+! EGALET 25MG/5ML N018332 001 Oct 10, 1985
INDOMETHACIN SODIUM
INJECTABLE;INJECTION
INDOMETHACIN SODIUM
AP HOSPIRA EQ 1MG BASE/VIAL A204118 001 Apr 19, 2016
AP ! NAVINTA LLC EQ 1MG BASE/VIAL A206561 001 Jul 19, 2017
AP WEST-WARD PHARMS EQ 1MG BASE/VIAL A078713 001 Jul 16, 2008
INT
INFIGRATINIB PHOSPHATE
CAPSULE;ORAL
TRUSELTIQ
+ HELSINN HLTHCARE 25MG N214622 001 May 28, 2021
+! 100MG N214622 002 May 28, 2021
INOTERSEN SODIUM
SOLUTION;SUBCUTANEOUS
TEGSEDI
+! AKCEA THERAPS EQ 284MG BASE/1.5ML (EQ 189.3MG N211172 001 Oct 05, 2018
BASE/ML)
IOBENGUANE I-131
SOLUTION;INTRAVENOUS
AZEDRA
+! PROGENICS PHARMS 15mCi/ML N209607 001 Jul 30, 2018
INC
IOBENGUANE SULFATE I-123
SOLUTION;INTRAVENOUS
ADREVIEW
+! GE HEALTHCARE 10mCi/5ML (2mCi/ML) N022290 001 Sep 19, 2008
IODIXANOL
INJECTABLE;INJECTION
IODIXANOL
AP HENGRUI PHARMA 55% A214271 001 May 19, 2022
AP 65.2% A214271 002 May 19, 2022
VISIPAQUE 270
AP +! GE HEALTHCARE 55% N020351 001 Mar 22, 1996
VISIPAQUE 320
AP +! GE HEALTHCARE 65.2% N020351 002 Mar 22, 1996
65.2% N020808 002 Aug 29, 1997
IOFLUPANE I-123
SOLUTION;INTRAVENOUS
DATSCAN
AP +! GE HLTHCARE INC 5mCi/2.5ML (2mCi/ML) N022454 001 Jan 14, 2011
IOFLUPANE I-123
AP CURIUM 5mCi/2.5ML (2mCi/ML) A213792 001 Mar 30, 2022
IOHEXOL
INJECTABLE;INJECTION
OMNIPAQUE 140
+! GE HEALTHCARE 30.2% N018956 005 Nov 30, 1988
SOLUTION;INJECTION, ORAL
OMNIPAQUE 350
+! GE HEALTHCARE 75.5% N018956 004 Dec 26, 1985
75.5% N020608 003 Oct 24, 1995
SOLUTION;INJECTION, ORAL, RECTAL
OMNIPAQUE 180
+! GE HEALTHCARE 38.8% N018956 001 Dec 26, 1985
OMNIPAQUE 240
+! GE HEALTHCARE 51.8% N018956 002 Dec 26, 1985
OMNIPAQUE 300
+! GE HEALTHCARE 64.7% N018956 003 Dec 26, 1985
64.7% N020608 002 Oct 24, 1995
SOLUTION;ORAL
OMNIPAQUE 12
+! GE HEALTHCARE 2.6% N018956 009 Apr 17, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-247(of 474)

IOHEXOL
SOLUTION;ORAL
OMNIPAQUE 9
+! GE HEALTHCARE 1.9% N018956 008 Apr 17, 2018
IOPAMIDOL
INJECTABLE;INJECTION
ISOVUE-200
+! BRACCO 41% N018735 006 Jul 07, 1987
ISOVUE-250
+! BRACCO 51% N018735 007 Jul 06, 1992
+! 51% N020327 002 Oct 12, 1994
ISOVUE-300
+! BRACCO 61% N018735 002 Dec 31, 1985
+! 61% N020327 003 Oct 12, 1994
ISOVUE-370
+! BRACCO 76% N018735 003 Dec 31, 1985
+! 76% N020327 004 Oct 12, 1994
ISOVUE-M 200
+! BRACCO 41% N018735 001 Dec 31, 1985
ISOVUE-M 300
+! BRACCO 61% N018735 004 Dec 31, 1985
IOPROMIDE
INJECTABLE;INJECTION
ULTRAVIST (PHARMACY BULK)
+! BAYER HLTHCARE 62.3% N021425 001 Sep 20, 2002
+! 76.9% N021425 002 Sep 20, 2002
ULTRAVIST 300
+! BAYER HLTHCARE 62.3% N020220 002 May 10, 1995
ULTRAVIST 370
+! BAYER HLTHCARE 76.9% N020220 001 May 10, 1995
IOTHALAMATE MEGLUMINE
INJECTABLE;INJECTION
CONRAY
+! LIEBEL-FLARSHEIM 60% N013295 001
SOLUTION;INTRAVESICAL
CYSTO-CONRAY II
LIEBEL-FLARSHEIM 17.2% N017057 002
IOTHALAMATE SODIUM I-125
INJECTABLE;INJECTION
GLOFIL-125
ISOTEX 250-300uCi/ML N017279 001
IOVERSOL
INJECTABLE;INJECTION
OPTIRAY 300
+! LIEBEL-FLARSHEIM 64% N019710 004 Jan 22, 1992
+! 64% N020923 004 May 13, 1999
OPTIRAY 320
+! LIEBEL-FLARSHEIM 68% N019710 001 Dec 30, 1988
+! 68% N020923 002 May 29, 1998
OPTIRAY 350
+! LIEBEL-FLARSHEIM 74% N019710 005 Jan 22, 1992
+! 74% N020923 003 May 28, 1998
IPRATROPIUM BROMIDE
AEROSOL, METERED;INHALATION
ATROVENT HFA
+! BOEHRINGER 0.021MG/INH N021527 001 Nov 27, 2004
INGELHEIM
SOLUTION;INHALATION
IPRATROPIUM BROMIDE
AN LUOXIN AUROVITAS 0.02% A206543 001 Oct 27, 2016
AN NEPHRON 0.02% A075562 001 Sep 27, 2001
AN ! RITEDOSE CORP 0.02% A075693 001 Jan 26, 2001
AN SUN PHARM 0.02% A207903 001 Jan 03, 2017
SPRAY, METERED;NASAL
IPRATROPIUM BROMIDE
AB AMNEAL 0.021MG/SPRAY A215104 001 Aug 16, 2022
AB 0.042MG/SPRAY A215105 001 Aug 16, 2022
AB APOTEX INC 0.021MG/SPRAY A076156 001 Apr 18, 2003
AB 0.042MG/SPRAY A076155 001 Apr 18, 2003
AB BAUSCH 0.021MG/SPRAY A076025 001 Mar 31, 2003
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-248(of 474)

IPRATROPIUM BROMIDE
SPRAY, METERED;NASAL
IPRATROPIUM BROMIDE
AB 0.042MG/SPRAY A076103 001 Mar 31, 2003
AB ! HIKMA 0.021MG/SPRAY A076664 001 Nov 05, 2003
AB ! 0.042MG/SPRAY A076598 001 Nov 05, 2003
IRBESARTAN
TABLET;ORAL
AVAPRO
AB + SANOFI AVENTIS US 75MG N020757 001 Sep 30, 1997
AB + 150MG N020757 002 Sep 30, 1997
AB +! 300MG N020757 003 Sep 30, 1997
IRBESARTAN
AB ALEMBIC PHARMS LTD 75MG A091236 001 Oct 15, 2012
AB 150MG A091236 002 Oct 15, 2012
AB 300MG A091236 003 Oct 15, 2012
AB AMNEAL PHARMS 75MG A204740 001 Apr 17, 2018
AB 150MG A204740 002 Apr 17, 2018
AB 300MG A204740 003 Apr 17, 2018
AB AUROBINDO PHARMA 75MG A203081 001 Sep 27, 2012
LTD
AB 150MG A203081 002 Sep 27, 2012
AB 300MG A203081 003 Sep 27, 2012
AB CHARTWELL MOLECULAR 75MG A077205 001 Nov 14, 2012
AB 150MG A077205 002 Nov 14, 2012
AB 300MG A077205 003 Nov 14, 2012
AB HETERO LABS LTD V 75MG A202910 001 Sep 27, 2012
AB 150MG A202910 002 Sep 27, 2012
AB 300MG A202910 003 Sep 27, 2012
AB HISUN PHARM 75MG A206194 001 Jun 14, 2016
HANGZHOU
AB 150MG A206194 002 Jun 14, 2016
AB 300MG A206194 003 Jun 14, 2016
AB JUBILANT GENERICS 75MG A203534 001 Feb 23, 2015
AB 150MG A203534 002 Feb 23, 2015
AB 300MG A203534 003 Feb 23, 2015
AB LUPIN LTD 75MG A201531 001 Oct 15, 2012
AB 150MG A201531 002 Oct 15, 2012
AB 300MG A201531 003 Oct 15, 2012
AB MACLEODS PHARMS LTD 75MG A202254 001 Oct 03, 2012
AB 150MG A202254 002 Oct 03, 2012
AB 300MG A202254 003 Oct 03, 2012
AB PRINSTON INC 75MG A203071 001 Sep 27, 2012
AB 150MG A203071 002 Sep 27, 2012
AB 300MG A203071 003 Sep 27, 2012
AB SANDOZ 75MG A077466 001 Sep 27, 2012
AB 150MG A077466 002 Sep 27, 2012
AB 300MG A077466 003 Sep 27, 2012
AB SCIEGEN PHARMS INC 75MG A204774 001 Dec 07, 2015
AB 150MG A204774 002 Dec 07, 2015
AB 300MG A204774 003 Dec 07, 2015
AB TEVA PHARMS 75MG A077159 001 Mar 30, 2012
AB 150MG A077159 002 Mar 30, 2012
AB 300MG A077159 003 Mar 30, 2012
AB ZYDUS PHARMS USA 75MG A079213 001 Sep 27, 2012
INC
AB 150MG A079213 002 Sep 27, 2012
AB 300MG A079213 003 Sep 27, 2012
IRINOTECAN HYDROCHLORIDE
INJECTABLE;INJECTION
CAMPTOSAR
AP +! PFIZER INC 40MG/2ML (20MG/ML) N020571 001 Jun 14, 1996
AP +! 100MG/5ML (20MG/ML) N020571 002 Jun 14, 1996
AP +! 300MG/15ML (20MG/ML) N020571 003 Aug 05, 2010
IRINOTECAN HYDROCHLORIDE
AP ACCORD HLTHCARE 40MG/2ML (20MG/ML) A079068 001 Nov 21, 2008
AP 100MG/5ML (20MG/ML) A079068 002 Nov 21, 2008
AP ACTAVIS TOTOWA 40MG/2ML (20MG/ML) A078589 001 Feb 27, 2008
AP 100MG/5ML (20MG/ML) A078589 002 Feb 27, 2008
AP 500MG/25ML (20MG/ML) A078589 003 Nov 18, 2015
AP AKORN 40MG/2ML (20MG/ML) A090726 001 Sep 16, 2009
AP 100MG/5ML (20MG/ML) A090726 002 Sep 16, 2009
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-249(of 474)

IRINOTECAN HYDROCHLORIDE
INJECTABLE;INJECTION
IRINOTECAN HYDROCHLORIDE
AP EUGIA PHARMA 40MG/2ML (20MG/ML) A213278 001 Nov 02, 2020
AP 100MG/5ML (20MG/ML) A213278 002 Nov 02, 2020
AP 300MG/15ML (20MG/ML) A213278 003 Nov 02, 2020
AP 500MG/25ML (20MG/ML) A213278 004 Apr 11, 2022
AP FRESENIUS KABI USA 40MG/2ML (20MG/ML) A077776 001 Feb 27, 2008
AP 100MG/5ML (20MG/ML) A077776 002 Feb 27, 2008
AP GLAND PHARMA LTD 40MG/2ML (20MG/ML) A212993 001 Nov 18, 2019
AP 100MG/5ML (20MG/ML) A212993 002 Nov 18, 2019
AP HENGRUI PHARMA 40MG/2ML (20MG/ML) A090675 002 Dec 16, 2011
AP 100MG/5ML (20MG/ML) A090675 001 Dec 16, 2011
AP HIKMA FARMACEUTICA 40MG/2ML (20MG/ML) A091032 001 Dec 20, 2010
AP 100MG/5ML (20MG/ML) A091032 002 Dec 20, 2010
AP HISUN PHARM 40MG/2ML (20MG/ML) A090016 001 Jan 28, 2009
HANGZHOU
AP 100MG/5ML (20MG/ML) A090016 002 Jan 28, 2009
AP HOSPIRA 40MG/2ML (20MG/ML) A077915 001 Feb 27, 2008
AP 100MG/5ML (20MG/ML) A077915 002 Feb 27, 2008
AP ! 500MG/25ML (20MG/ML) A078796 001 Feb 27, 2008
AP INTAS PHARMS USA 40MG/2ML (20MG/ML) A203054 001 Aug 31, 2017
AP 100MG/5ML (20MG/ML) A203054 002 Aug 31, 2017
AP NOVAST LABS 40MG/2ML (20MG/ML) A206935 001 May 26, 2017
AP 100MG/5ML (20MG/ML) A206935 002 May 26, 2017
AP QILU PHARM HAINAN 40MG/2ML (20MG/ML) A203380 001 May 03, 2016
AP 100MG/5ML (20MG/ML) A203380 002 May 03, 2016
AP 300MG/15ML (20MG/ML) A203380 003 May 03, 2016
AP SHILPA 40MG/2ML (20MG/ML) A208718 001 Dec 28, 2018
AP 100MG/5ML (20MG/ML) A208718 002 Dec 28, 2018
AP 300MG/15ML (20MG/ML) A208718 003 Aug 16, 2019
AP TEVA PHARMS USA 500MG/25ML (20MG/ML) A090101 001 Nov 26, 2008
AP WEST-WARD PHARMS 40MG/2ML (20MG/ML) A078753 001 Dec 24, 2008
INT
AP 100MG/5ML (20MG/ML) A078753 002 Dec 24, 2008
AP ZENNOVA 40MG/2ML (20MG/ML) A090393 002 May 13, 2011
AP 100MG/5ML (20MG/ML) A090393 003 May 13, 2011
INJECTABLE, LIPOSOMAL;INTRAVENOUS
ONIVYDE
+! IPSEN INC EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML) N207793 001 Oct 22, 2015
ISAVUCONAZONIUM SULFATE
CAPSULE;ORAL
CRESEMBA
+ ASTELLAS 74.5MG N207500 002 Nov 22, 2022
+! 186MG N207500 001 Mar 06, 2015
POWDER;INTRAVENOUS
CRESEMBA
+! ASTELLAS 372MG N207501 001 Mar 06, 2015
ISOCARBOXAZID
TABLET;ORAL
MARPLAN
+! VALIDUS PHARMS INC 10MG N011961 001
ISOFLURANE
LIQUID;INHALATION
FORANE
AN +! BAXTER HLTHCARE 99.9% N017624 001
ISOFLURANE
AN HALOCARBON PRODS 99.9% A075225 001 Oct 20, 1999
AN PIRAMAL CRITICAL 99.9% A074416 001 Sep 30, 1994
AN PIRAMAL PHARMA 99.9% A074502 001 Jun 27, 1995
ISONIAZID
INJECTABLE;INJECTION
ISONIAZID
! SANDOZ INC 100MG/ML A040648 001 Jul 05, 2005
SYRUP;ORAL
ISONIAZID
+! CMP PHARMA INC 50MG/5ML A088235 001 Nov 10, 1983
TABLET;ORAL
ISONIAZID
AA ! BARR 100MG A080936 001
AA ! 300MG A080937 002
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-250(of 474)

ISONIAZID
TABLET;ORAL
ISONIAZID
AA MIKART 100MG A040090 001 Jun 26, 1997
AA 300MG A040090 002 Jun 26, 1997
AA THEPHARMANETWORK 100MG A202610 001 Oct 29, 2014
LLC
AA 300MG A202610 002 Oct 29, 2014
ISOPROTERENOL HYDROCHLORIDE
INJECTABLE;INJECTION
ISOPROTERENOL HYDROCHLORIDE
AP AM REGENT 0.2MG/ML A214775 001 Oct 19, 2022
AP AMNEAL 0.2MG/ML A210576 001 Oct 17, 2018
AP AMPHASTAR PHARMS 0.2MG/ML A210106 001 Jun 18, 2018
INC
AP AMRING PHARMS 0.2MG/ML A211237 001 May 19, 2021
AP AVET LIFESCIENCES 0.2MG/ML A212189 001 Nov 19, 2021
AP CIPLA 0.2MG/ML A210322 001 Jun 12, 2018
AP EUGIA PHARMA 0.2MG/ML A211864 001 Feb 09, 2021
AP MICRO LABS 0.2MG/ML A210845 001 Feb 16, 2021
AP MYLAN LABS LTD 0.2MG/ML A212573 001 Sep 06, 2022
AP NEXUS PHARMS 0.2MG/ML A206961 001 Aug 02, 2017
AP STI PHARMA LLC 0.2MG/ML A215542 001 Sep 20, 2022
ISUPREL
AP +! BAUSCH 0.2MG/ML N010515 001
ISOSORBIDE DINITRATE
TABLET;ORAL
ISORDIL
AB + BAUSCH 5MG N012093 007 Jul 29, 1988
AB +! 40MG N012093 001 Jul 29, 1988
ISOSORBIDE DINITRATE
AB HIKMA INTL PHARMS 5MG A086067 001 Oct 29, 1987
AB 10MG A086066 001 Oct 29, 1987
AB 20MG A088088 001 Nov 02, 1987
AB PAR PHARM 5MG A086923 001 Mar 12, 1987
AB 10MG A086925 001 Mar 12, 1987
AB 20MG A087537 001 Oct 02, 1987
AB ! 30MG A087946 001 Jan 12, 1988
AB PAR PHARM INC 40MG A211290 001 Nov 23, 2021
AB RUBICON 5MG A215723 001 Jul 08, 2022
AB 10MG A215723 002 Jul 08, 2022
AB 20MG A215723 003 Jul 08, 2022
AB 30MG A215723 004 Jul 08, 2022
AB 40MG A215723 005 Jul 08, 2022
AB SANDOZ 5MG A086221 001 Jan 07, 1988
AB 10MG A086223 001 Jan 07, 1988
AB 20MG A089367 001 Apr 07, 1988
AB ZYDUS 5MG A213057 001 Nov 20, 2019
AB 10MG A213057 002 Nov 20, 2019
AB 20MG A213057 003 Nov 20, 2019
AB 30MG A213057 004 Nov 20, 2019
AB 40MG A213057 005 Nov 20, 2019
TABLET, EXTENDED RELEASE;ORAL
ISOSORBIDE DINITRATE
! SUN PHARM INDS INC 40MG A040009 001 Dec 30, 1998
ISOSORBIDE MONONITRATE
TABLET;ORAL
ISOSORBIDE MONONITRATE
AB ACTAVIS ELIZABETH 10MG A075037 002 Oct 30, 1998
AB 20MG A075037 001 Oct 30, 1998
MONOKET
AB + ECI PHARMS LLC 10MG N020215 002 Jun 30, 1993
AB +! 20MG N020215 001 Jun 30, 1993
TABLET, EXTENDED RELEASE;ORAL
ISOSORBIDE MONONITRATE
AB AUROBINDO PHARMA 30MG A216557 001 Nov 07, 2022
AB 60MG A216557 002 Nov 07, 2022
AB 120MG A216557 003 Nov 07, 2022
AB CHARTWELL MOLECULAR 30MG A075155 002 Jan 13, 2000
AB 60MG A075155 001 Oct 30, 1998
AB ! 120MG A075155 003 Aug 04, 2000
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-251(of 474)

ISOSORBIDE MONONITRATE
TABLET, EXTENDED RELEASE;ORAL
ISOSORBIDE MONONITRATE
AB DEXCEL LTD 30MG A075522 002 Sep 20, 2016
AB 60MG A075522 001 Apr 17, 2000
AB 120MG A210822 001 Aug 29, 2018
AB RICONPHARMA LLC 30MG A210918 001 Nov 05, 2018
AB 60MG A210918 002 Nov 05, 2018
AB 120MG A210918 003 Nov 05, 2018
AB SHANDONG 120MG A214115 001 Apr 29, 2022
AB TORRENT PHARMS 30MG A200270 001 Jun 03, 2011
AB 60MG A200495 001 Jun 03, 2011
AB 120MG A200495 002 Jun 03, 2011
AB ZYDUS HLTHCARE 30MG A075395 001 Mar 16, 2000
AB 60MG A075395 002 Mar 16, 2000
AB 120MG A075395 003 Mar 16, 2000
ISOSULFAN BLUE
INJECTABLE;INJECTION
ISOSULFAN BLUE
AP MEITHEAL 1% A213130 001 Nov 03, 2021
AP MSN 1% A216090 001 Sep 16, 2022
AP ! MYLAN INSTITUTIONAL 1% A090874 001 Jul 20, 2010
ISOTRETINOIN
CAPSULE;ORAL
AMNESTEEM
AB1 MYLAN PHARMS INC 10MG A075945 001 Nov 08, 2002
AB1 20MG A075945 002 Nov 08, 2002
AB1 40MG A075945 003 Nov 08, 2002
CLARAVIS
AB1 TEVA PHARMS USA 10MG A076356 001 Apr 11, 2003
AB1 20MG A076135 002 Apr 11, 2003
AB1 30MG A076135 003 May 11, 2006
AB1 ! 40MG A076135 001 Apr 11, 2003
ISOTRETINOIN
AB1 AMNEAL PHARMS NY 10MG A207792 001 Sep 29, 2017
AB1 20MG A207792 002 Sep 29, 2017
AB1 30MG A207792 003 Sep 29, 2017
AB1 40MG A207792 004 Sep 29, 2017
MYORISAN
AB1 DOUGLAS PHARMS 10MG A076485 001 Jan 19, 2012
AB1 20MG A076485 002 Jan 19, 2012
AB1 30MG A076485 004 Aug 25, 2015
AB1 40MG A076485 003 Jan 19, 2012
ZENATANE
AB1 DR REDDYS LABS LTD 10MG A202099 001 Mar 25, 2013
AB1 20MG A202099 002 Mar 25, 2013
AB1 30MG A202099 004 Feb 23, 2015
AB1 40MG A202099 003 Mar 25, 2013
ABSORICA
AB2 + SUN PHARM INDS INC 10MG N021951 001 May 25, 2012
AB2 + 20MG N021951 002 May 25, 2012
AB2 + 25MG N021951 005 Aug 15, 2014
AB2 + 30MG N021951 003 May 25, 2012
AB2 + 35MG N021951 006 Aug 15, 2014
AB2 +! 40MG N021951 004 May 25, 2012
ISOTRETINOIN
AB2 ACTAVIS LABS FL 10MG A205063 001 Mar 31, 2021
AB2 20MG A205063 002 Mar 31, 2021
AB2 25MG A205063 003 Mar 31, 2021
AB2 30MG A205063 004 Mar 31, 2021
AB2 35MG A205063 005 Mar 31, 2021
AB2 40MG A205063 006 Mar 31, 2021
AB2 UPSHER SMITH LABS 10MG A212333 001 Sep 21, 2021
AB2 20MG A212333 002 Sep 21, 2021
AB2 30MG A212333 003 Sep 21, 2021
AB2 40MG A213571 001 Apr 12, 2021
ABSORICA LD
+ SUN PHARM 8MG N211913 001 Nov 05, 2019
+ 16MG N211913 002 Nov 05, 2019
+ 24MG N211913 004 Nov 05, 2019
+! 32MG N211913 006 Nov 05, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-252(of 474)

ISRADIPINE
CAPSULE;ORAL
ISRADIPINE
AB ELITE LABS INC 2.5MG A077169 001 Apr 24, 2006
AB 5MG A077169 002 Apr 24, 2006
AB WATSON LABS TEVA 2.5MG A077317 001 Jan 05, 2006
AB ! 5MG A077317 002 Jan 05, 2006
ISTRADEFYLLINE
TABLET;ORAL
NOURIANZ
+ KYOWA KIRIN 20MG N022075 001 Aug 27, 2019
+! 40MG N022075 002 Aug 27, 2019
ITRACONAZOLE
CAPSULE;ORAL
ITRACONAZOLE
AB ACCORD HLTHCARE 100MG A205991 001 May 26, 2016
AB ALEMBIC PHARMS 100MG A206741 001 Dec 13, 2016
AB ALKEM LABS LTD 100MG A208591 001 Jun 12, 2017
AB AMNEAL PHARMS 100MG A205080 001 Sep 26, 2016
AB PAR PHARM INC 100MG A205724 001 Dec 13, 2016
AB SANDOZ 100MG A076104 001 May 28, 2004
AB TORRENT 100MG A209460 001 Aug 24, 2018
AB ZYDUS PHARMS 100MG A204672 001 Sep 19, 2017
SPORANOX
AB +! JANSSEN PHARMS 100MG N020083 001 Sep 11, 1992
TOLSURA
+! MAYNE PHARMA 65MG N208901 001 Dec 11, 2018
SOLUTION;ORAL
ITRACONAZOLE
AA AMNEAL PHARMS 10MG/ML A205573 001 Oct 30, 2015
AA ANNORA PHARMA 10MG/ML A212239 001 Sep 01, 2020
SPORANOX
AA +! JANSSEN PHARMS 10MG/ML N020657 001 Feb 21, 1997
IVABRADINE
SOLUTION;ORAL
CORLANOR
+! AMGEN INC 5MG/5ML (1MG/ML) N209964 001 Apr 22, 2019
IVABRADINE HYDROCHLORIDE
TABLET;ORAL
CORLANOR
AB + AMGEN INC EQ 5MG BASE N206143 001 Apr 15, 2015
AB +! EQ 7.5MG BASE N206143 002 Apr 15, 2015
IVABRADINE HYDROCHLORIDE
AB ANNORA PHARMA EQ 5MG BASE A213366 001 Oct 05, 2022
AB EQ 7.5MG BASE A213366 002 Oct 05, 2022
IVACAFTOR
GRANULE;ORAL
KALYDECO
+ VERTEX PHARMS INC 25MG/PACKET N207925 003 Apr 29, 2019
+ 50MG/PACKET N207925 001 Mar 17, 2015
+! 75MG/PACKET N207925 002 Mar 17, 2015
TABLET;ORAL
KALYDECO
+! VERTEX PHARMS 150MG N203188 001 Jan 31, 2012
IVACAFTOR; IVACAFTOR, TEZACAFTOR
TABLET;ORAL
SYMDEKO (COPACKAGED)
+ VERTEX PHARMS INC 75MG;75MG, 50MG N210491 002 Jun 21, 2019
+! 150MG;150MG, 100MG N210491 001 Feb 12, 2018
IVACAFTOR; LUMACAFTOR
GRANULE;ORAL
ORKAMBI
+ VERTEX PHARMS INC 94MG/PACKET;75MG/PACKET N211358 003 Sep 02, 2022
+ 125MG/PACKET;100MG/PACKET N211358 001 Aug 07, 2018
+! 188MG/PACKET;150MG/PACKET N211358 002 Aug 07, 2018
TABLET;ORAL
ORKAMBI
+ VERTEX PHARMS INC 125MG;100MG N206038 002 Sep 28, 2016
+! 125MG;200MG N206038 001 Jul 02, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-253(of 474)

IVERMECTIN
CREAM;TOPICAL
IVERMECTIN
AB TEVA PHARMS USA 1% A210019 001 Sep 13, 2019
AB ZYDUS 1% A215210 001 Aug 02, 2022
SOOLANTRA
AB +! GALDERMA LABS LP 1% N206255 001 Dec 19, 2014
TABLET;ORAL
IVERMECTIN
AB EDENBRIDGE PHARMS 3MG A204154 001 Oct 24, 2014
STROMECTOL
AB +! MERCK SHARP DOHME 3MG N050742 002 Oct 08, 1998
IVOSIDENIB
TABLET;ORAL
TIBSOVO
+! SERVIER 250MG N211192 001 Jul 20, 2018
IXABEPILONE
INJECTABLE;INTRAVENOUS
IXEMPRA KIT
+! R-PHARM US LLC 15MG/VIAL N022065 001 Oct 16, 2007
+! 45MG/VIAL N022065 002 Oct 16, 2007
IXAZOMIB CITRATE
CAPSULE;ORAL
NINLARO
+ TAKEDA PHARMS USA EQ 2.3MG BASE N208462 001 Nov 20, 2015
+ EQ 3MG BASE N208462 002 Nov 20, 2015
+! EQ 4MG BASE N208462 003 Nov 20, 2015
KETAMINE HYDROCHLORIDE
INJECTABLE;INJECTION
KETALAR
AP +! PAR STERILE EQ 10MG BASE/ML N016812 001
PRODUCTS
AP +! EQ 50MG BASE/ML N016812 002
AP +! EQ 100MG BASE/ML N016812 003
KETAMINE HYDROCHLORIDE
AP EUGIA PHARMA EQ 10MG BASE/ML A076092 001 Sep 30, 2008
AP EQ 50MG BASE/ML A076092 002 Dec 28, 2001
AP EQ 100MG BASE/ML A076092 003 Oct 25, 2002
AP HIKMA EQ 50MG BASE/ML A074524 001 Mar 22, 1996
AP EQ 100MG BASE/ML A074524 002 Mar 22, 1996
AP HOSPIRA EQ 50MG BASE/ML A074549 001 Jun 27, 1996
AP EQ 100MG BASE/ML A074549 002 Jun 27, 1996
KETOCONAZOLE
AEROSOL, FOAM;TOPICAL
EXTINA
AB +! MYLAN 2% N021738 001 Jun 12, 2007
KETOCONAZOLE
AB PADAGIS ISRAEL 2% A091550 001 Aug 25, 2011
AB XIROMED 2% A213601 001 May 21, 2021
CREAM;TOPICAL
KETOCONAZOLE
AB ENCUBE 2% A212443 001 May 20, 2021
AB FOUGERA PHARMS 2% A076294 001 Apr 28, 2004
AB TASMAN PHARMA 2% A215185 001 Nov 17, 2021
AB ! TEVA 2% A075581 001 Apr 25, 2000
KETOZOLE
AB TARO 2% A075638 001 Dec 18, 2002
SHAMPOO;TOPICAL
KETOCONAZOLE
AB ! PADAGIS ISRAEL 2% A076419 001 Jan 07, 2004
AB TOLMAR 2% A076942 001 Apr 11, 2005
TABLET;ORAL
KETOCONAZOLE
AB SENORES PHARMS 200MG A075912 001 Jan 10, 2002
AB STRIDES PHARMA 200MG A210457 001 Jun 18, 2018
AB ! TARO 200MG A075319 001 Jun 15, 1999
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-254(of 474)

KETOPROFEN
CAPSULE;ORAL
KETOPROFEN
AB MISEMER 50MG A074014 002 Jan 29, 1993
AB TEVA 50MG A073516 001 Dec 22, 1992
MISEMER 25MG A074014 001 Jan 29, 1993
! 75MG A074014 003 Jan 29, 1993
CAPSULE, EXTENDED RELEASE;ORAL
KETOPROFEN
! MYLAN 200MG A075679 001 Feb 20, 2002
KETOROLAC TROMETHAMINE
INJECTABLE;INJECTION
KETOROLAC TROMETHAMINE
AP ALEMBIC PHARMS 15MG/ML A214456 001 Nov 02, 2022
AP 30MG/ML A214456 002 Nov 02, 2022
AP BAXTER HLTHCARE 15MG/ML A209900 002 Jul 25, 2018
CORP
AP 30MG/ML A209900 001 Sep 15, 2017
AP FRESENIUS KABI USA 15MG/ML A075784 001 Jan 11, 2002
AP 15MG/ML A203242 001 Oct 07, 2015
AP 30MG/ML A075784 002 Jan 11, 2002
AP 30MG/ML A203242 002 Oct 07, 2015
AP GLAND 15MG/ML A204216 001 Nov 01, 2016
AP 30MG/ML A204216 002 Nov 01, 2016
AP HIKMA 15MG/ML A075772 001 Jul 21, 2004
AP 30MG/ML A075772 002 Jul 21, 2004
AP ! HOSPIRA 15MG/ML A074802 001 Jun 05, 1997
AP ! 30MG/ML A074802 002 Jun 05, 1997
AP 30MG/ML A074993 002 Jan 27, 1999
AP NEPHRON 30MG/ML A211445 001 Aug 20, 2020
AP SAGENT PHARMS INC 15MG/ML A091065 001 Nov 27, 2013
AP 30MG/ML A091065 002 Nov 27, 2013
AP SANDOZ INC 30MG/ML A076271 002 Oct 06, 2004
AP SUN PHARM 15MG/ML A078737 001 Oct 06, 2008
AP 30MG/ML A078737 002 Oct 06, 2008
AP WOCKHARDT 15MG/ML A077942 001 Mar 27, 2007
AP 30MG/ML A077942 002 Mar 27, 2007
SOLUTION/DROPS;OPHTHALMIC
ACULAR
AT +! ALLERGAN 0.5% N019700 001 Nov 09, 1992
ACULAR LS
AT +! ALLERGAN 0.4% N021528 001 May 30, 2003
KETOROLAC TROMETHAMINE
AT AKORN 0.5% A078434 001 Nov 05, 2009
AT APOTEX INC 0.4% A077308 001 Nov 05, 2009
AT 0.5% A076109 001 Nov 05, 2009
AT MICRO LABS LTD 0.5% A203410 001 Apr 05, 2019
INDIA
AT SANDOZ INC 0.5% A076583 001 Nov 05, 2009
AT SUN PHARM 0.5% A090017 001 Nov 05, 2009
ACUVAIL
+! ALLERGAN 0.45% N022427 001 Jul 22, 2009
SPRAY, METERED;NASAL
SPRIX
+! ZYLA 15.75MG/SPRAY N022382 001 May 14, 2010
TABLET;ORAL
KETOROLAC TROMETHAMINE
AB ATNAHS PHARMA US 10MG A216407 001 Oct 21, 2022
AB CYCLE 10MG A210616 001 Aug 16, 2018
AB HETERO LABS LTD III 10MG A216651 001 Aug 25, 2022
AB MYLAN 10MG A074761 001 May 16, 1997
AB SENORES PHARMS 10MG A215788 001 Mar 23, 2022
AB ! TEVA 10MG A074754 001 May 16, 1997
AB ZYDUS 10MG A217038 001 Oct 21, 2022
KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE
SOLUTION;IRRIGATION
KETOROLAC TROMETHAMINE AND PHENYLEPHRINE HYDROCHLORIDE
AT LUPIN LTD EQ 0.3% BASE;EQ 1% BASE A210183 001 Jul 01, 2019
OMIDRIA
AT +! RAYNER SURGICAL EQ 0.3% BASE;EQ 1% BASE N205388 001 May 30, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-255(of 474)

KETOTIFEN FUMARATE
DRUG-ELUTING CONTACT LENS;OPHTHALMIC
ACUVUE THERAVISION WITH KETOTIFEN
+! JOHNSON JOHNSON EQ 19MCG BASE N022388 001 Feb 25, 2022
VISN
L-GLUTAMINE
FOR SOLUTION;ORAL
ENDARI
+ EMMAUS MEDCL 5GM/PACKET N208587 001 Jul 07, 2017
LABETALOL HYDROCHLORIDE
INJECTABLE;INJECTION
LABETALOL HYDROCHLORIDE
AP AKORN 5MG/ML A075431 001 Nov 29, 1999
AP BAXTER HLTHCARE 5MG/ML A076051 001 Jul 05, 2002
CORP
AP CAPLIN 5MG/ML A214533 001 Sep 07, 2021
AP GLAND PHARMA LTD 5MG/ML A090699 001 Apr 03, 2012
AP HIKMA 5MG/ML A075303 001 May 28, 1999
AP ! HOSPIRA 5MG/ML A075239 001 Nov 29, 1999
AP ! 5MG/ML A075240 001 Nov 29, 1999
SOLUTION;INTRAVENOUS
LABETALOL HYDROCHLORIDE
+! HIKMA 10MG/2ML (5MG/ML) N213330 005 Mar 18, 2022
LABETALOL HYDROCHLORIDE IN DEXTROSE
+! HIKMA 200MG/200ML (1MG/ML) N213330 001 Nov 09, 2020
LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE
+! HIKMA 100MG/100ML (1MG/ML) N213330 002 Nov 09, 2020
+! 200MG/200ML (1MG/ML) N213330 003 Nov 09, 2020
+! 300MG/300ML (1MG/ML) N213330 004 Nov 09, 2020
TABLET;ORAL
LABETALOL HYDROCHLORIDE
AB APPCO 100MG A209603 001 Jun 20, 2018
AB 200MG A209603 002 Jun 20, 2018
AB 300MG A209603 003 Jun 20, 2018
AB CADILA PHARMS LTD 100MG A211325 001 May 13, 2019
AB 200MG A211325 002 May 13, 2019
AB 300MG A211325 003 May 13, 2019
AB EPIC PHARMA LLC 100MG A212990 001 Sep 30, 2020
AB 200MG A212990 002 Sep 30, 2020
AB 300MG A212990 003 Sep 30, 2020
AB EYWA 100MG A207863 001 Feb 04, 2019
AB 200MG A207863 002 Feb 04, 2019
AB 300MG A207863 003 Feb 04, 2019
AB HERITAGE PHARMA 100MG A074787 001 Aug 03, 1998
AB 200MG A074787 002 Aug 03, 1998
AB 300MG A074787 003 Aug 03, 1998
AB INNOGENIX 100MG A075215 001 Jul 29, 1999
AB 200MG A075215 002 Jul 29, 1999
AB 300MG A075215 003 Jul 29, 1999
AB PAR FORM 100MG A200908 001 Jul 10, 2012
AB ! 200MG A200908 002 Jul 10, 2012
AB 300MG A200908 003 Jul 10, 2012
AB RUBICON 100MG A211953 001 Aug 18, 2021
AB 200MG A211953 002 Aug 18, 2021
AB 300MG A211953 003 Aug 18, 2021
AB SANDOZ 100MG A075113 001 Aug 04, 1998
AB ! 200MG A075113 002 Aug 04, 1998
AB 300MG A075113 003 Aug 04, 1998
AB WATSON LABS 100MG A075133 001 Aug 03, 1998
AB 200MG A075133 002 Aug 03, 1998
AB 300MG A075133 003 Aug 03, 1998
AB ZYDUS PHARMS 100MG A207743 001 Sep 19, 2017
AB 200MG A207743 002 Sep 19, 2017
AB 300MG A207743 003 Sep 19, 2017
TRANDATE
AB + ALVOGEN 200MG N018716 002 Aug 01, 1984
AB + 300MG N018716 003 Aug 01, 1984
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-256(of 474)

LACOSAMIDE
SOLUTION;INTRAVENOUS
LACOSAMIDE
AP ASPIRO 200MG/20ML (10MG/ML) A216335 001 Sep 14, 2022
AP FRESENIUS KABI USA 200MG/20ML (10MG/ML) A214677 001 May 03, 2022
AP GLAND PHARMA LTD 200MG/20ML (10MG/ML) A215628 001 Sep 19, 2022
AP INDOCO 200MG/20ML (10MG/ML) A214301 001 Apr 07, 2022
AP ZYDUS PHARMS 200MG/20ML (10MG/ML) A209465 001 Jun 29, 2022
VIMPAT
AP +! UCB INC 200MG/20ML (10MG/ML) N022254 001 Oct 28, 2008
SOLUTION;ORAL
LACOSAMIDE
AA ALKEM LABS LTD 10MG/ML A214672 001 May 19, 2022
AA APOTEX 10MG/ML A206355 001 Sep 26, 2022
AA HETERO LABS LTD III 10MG/ML A209301 001 May 31, 2022
AA NOVITIUM PHARMA 10MG/ML A216151 001 Aug 26, 2022
VIMPAT
AA +! UCB INC 10MG/ML N022255 001 Apr 20, 2010
TABLET;ORAL
LACOSAMIDE
AB ACCORD HLTHCARE 50MG A205011 001 Jul 12, 2022
AB 100MG A205011 002 Jul 12, 2022
AB 150MG A205011 003 Jul 12, 2022
AB 200MG A205011 004 Jul 12, 2022
AB ACTAVIS LABS FL INC 50MG A204855 001 Jan 05, 2023
AB 100MG A204855 002 Jan 05, 2023
AB 150MG A204855 003 Jan 05, 2023
AB 200MG A204855 004 Jan 05, 2023
AB ALEMBIC PHARMS 50MG A204974 001 Mar 17, 2022
AB 100MG A204974 002 Mar 17, 2022
AB 150MG A204974 003 Mar 17, 2022
AB 200MG A204974 004 Mar 17, 2022
AB ALKEM LABS LTD 50MG A214695 001 Mar 31, 2022
AB 100MG A214695 002 Mar 31, 2022
AB 150MG A214695 003 Mar 31, 2022
AB 200MG A214695 004 Mar 31, 2022
AB AMNEAL PHARMS 50MG A204857 001 Mar 17, 2022
AB 100MG A204857 002 Mar 17, 2022
AB 150MG A204857 003 Mar 17, 2022
AB 200MG A204857 004 Mar 17, 2022
AB APOTEX 50MG A214567 001 Sep 23, 2022
AB 100MG A214567 002 Sep 23, 2022
AB 150MG A214567 003 Sep 23, 2022
AB 200MG A214567 004 Sep 23, 2022
AB AUROBINDO PHARMA 50MG A204994 001 Jan 05, 2023
LTD
AB 100MG A204994 002 Jan 05, 2023
AB 150MG A204994 003 Jan 05, 2023
AB 200MG A204994 004 Jan 05, 2023
AB GLENMARK PHARMS LTD 50MG A205006 001 Mar 17, 2022
AB 100MG A205006 002 Mar 17, 2022
AB 150MG A205006 003 Mar 17, 2022
AB 200MG A205006 004 Mar 17, 2022
AB HETERO LABS LTD V 50MG A204787 001 Mar 17, 2022
AB 100MG A204787 002 Mar 17, 2022
AB 150MG A204787 003 Mar 17, 2022
AB 200MG A204787 004 Mar 17, 2022
AB INDOCO 50MG A208308 001 Mar 17, 2022
AB 100MG A208308 002 Mar 17, 2022
AB 150MG A208308 003 Mar 17, 2022
AB 200MG A208308 004 Mar 17, 2022
AB MSN LABS PVT LTD 50MG A204921 001 Mar 17, 2022
AB 100MG A204921 002 Mar 17, 2022
AB 150MG A204921 003 Mar 17, 2022
AB 200MG A204921 004 Mar 17, 2022
AB SCIEGEN PHARMS INC 50MG A205237 001 Mar 17, 2022
AB 100MG A205237 002 Mar 17, 2022
AB 150MG A205237 003 Mar 17, 2022
AB 200MG A205237 004 Mar 17, 2022
AB SUN PHARM 50MG A205031 001 Mar 17, 2022
AB 100MG A205031 002 Mar 17, 2022
AB 150MG A205031 003 Mar 17, 2022
AB 200MG A205031 004 Mar 17, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-257(of 474)

LACOSAMIDE
TABLET;ORAL
VIMPAT
AB + UCB INC 50MG N022253 001 Oct 28, 2008
AB + 100MG N022253 002 Oct 28, 2008
AB + 150MG N022253 003 Oct 28, 2008
AB +! 200MG N022253 004 Oct 28, 2008
LACTULOSE
FOR SOLUTION;ORAL
LACTULOSE
! CUMBERLAND PHARMS 10GM/PACKET A074712 001 Dec 10, 1997
! 20GM/PACKET A074712 002 Dec 10, 1997
SOLUTION;ORAL
LACTULOSE
AA ! AKORN 10GM/15ML A074076 001 Jul 03, 1995
AA CHARTWELL RX 10GM/15ML A209517 001 Nov 23, 2018
AA FRESENIUS KABI 10GM/15ML A090503 001 Jan 25, 2012
AA LANNETT CO INC 10GM/15ML A075993 001 Jul 26, 2001
AA PHARM ASSOC 10GM/15ML A074623 001 Jul 30, 1996
AA VISTAPHARM 10GM/15ML A074138 001 Sep 30, 1992
AA WOCKHARDT BIO AG 10GM/15ML A074602 001 Nov 14, 1996
SOLUTION;ORAL, RECTAL
GENERLAC
AA WOCKHARDT BIO AG 10GM/15ML A074603 001 Oct 31, 1996
LACTULOSE
AA AKORN 10GM/15ML A074077 001 Jul 03, 1995
AA ! FRESENIUS KABI 10GM/15ML A090502 001 Jan 25, 2012
LAMIVUDINE
SOLUTION;ORAL
EPIVIR
AA +! VIIV HLTHCARE 10MG/ML N020596 001 Nov 17, 1995
LAMIVUDINE
AA AUROBINDO PHARMA 10MG/ML A077695 001 Nov 21, 2016
AA LANNETT CO INC 10MG/ML A203564 001 Oct 31, 2014
EPIVIR-HBV
+! GLAXOSMITHKLINE 5MG/ML N021004 001 Dec 08, 1998
TABLET;ORAL
EPIVIR
AB + VIIV HLTHCARE 150MG N020564 001 Nov 17, 1995
AB +! 300MG N020564 003 Jun 24, 2002
EPIVIR-HBV
AB +! GLAXOSMITHKLINE 100MG N021003 001 Dec 08, 1998
LAMIVUDINE
AB ANNORA 100MG A211306 001 Mar 21, 2019
AB APOTEX 100MG A202941 001 Jan 02, 2014
AB 150MG A091606 001 Dec 02, 2011
AB 300MG A091606 002 Dec 02, 2011
AB AUROBINDO PHARMA 150MG A077464 001 Nov 21, 2016
AB 300MG A077464 002 Nov 21, 2016
AB BRECKENRIDGE 150MG A203586 001 Nov 21, 2016
AB CIPLA 150MG A077221 001 Mar 03, 2017
AB 300MG A077221 002 Mar 03, 2017
AB HETERO LABS LTD V 100MG A203260 001 Jan 02, 2014
AB 150MG A203277 001 Jan 06, 2014
AB 300MG A203277 002 Jan 06, 2014
AB LUPIN LTD 150MG A205217 001 Dec 18, 2014
AB 300MG A205217 002 Dec 18, 2014
AB MACLEODS PHARMS LTD 150MG A090198 001 May 01, 2019
AB 300MG A090198 002 May 01, 2019
AB MYLAN LABS LTD 150MG A078545 001 Mar 05, 2019
AB 300MG A078545 002 Mar 05, 2019
AB STRIDES PHARMA 150MG A090457 001 Apr 19, 2018
AB 300MG A090457 002 Apr 19, 2018
AB UPSHER SMITH LABS 150MG A206974 001 Nov 21, 2016
AB 300MG A206974 002 Nov 21, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-258(of 474)

LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE


TABLET;ORAL
CIMDUO
+! MYLAN LABS LTD 300MG;300MG N022141 001 Feb 28, 2018
LAMIVUDINE; ZIDOVUDINE
TABLET;ORAL
COMBIVIR
AB +! VIIV HLTHCARE 150MG;300MG N020857 001 Sep 26, 1997
LAMIVUDINE AND ZIDOVUDINE
AB ANDA REPOSITORY 150MG;300MG A206375 001 Apr 10, 2018
AB AUROBINDO PHARMA 150MG;300MG A077558 001 May 05, 2017
AB AUROBINDO PHARMA 150MG;300MG A202418 001 May 15, 2012
LTD
AB CIPLA 150MG;300MG A077411 001 Sep 07, 2018
AB HETERO LABS LTD III 150MG;300MG A079124 001 Sep 17, 2015
AB HETERO LABS LTD V 150MG;300MG A203259 001 Feb 03, 2014
AB LUPIN LTD 150MG;300MG A090246 001 May 15, 2012
AB MACLEODS PHARMS LTD 150MG;300MG A090679 001 Aug 29, 2018
AB STRIDES PHARMA 150MG;300MG A079128 001 May 13, 2015
LAMOTRIGINE
TABLET;ORAL
LAMICTAL
AB +! GLAXOSMITHKLINE LLC 25MG N020241 005 Dec 27, 1994
AB + 100MG N020241 001 Dec 27, 1994
AB + 150MG N020241 002 Dec 27, 1994
AB + 200MG N020241 003 Dec 27, 1994
LAMOTRIGINE
AB ALEMBIC PHARMS LTD 25MG A090607 001 Jan 13, 2011
AB 100MG A090607 002 Jan 13, 2011
AB 150MG A090607 003 Jan 13, 2011
AB 200MG A090607 004 Jan 13, 2011
AB ALKEM LABS LTD 25MG A200694 001 Jun 14, 2013
AB 100MG A200694 002 Jun 14, 2013
AB 150MG A200694 003 Jun 14, 2013
AB 200MG A200694 004 Jun 14, 2013
AB AUROBINDO PHARMA 25MG A078956 001 Jan 27, 2009
AB 100MG A078956 002 Jan 27, 2009
AB 150MG A078956 003 Jan 27, 2009
AB 200MG A078956 004 Jan 27, 2009
AB DR REDDYS LABS LTD 25MG A076708 001 Jan 27, 2009
AB 100MG A076708 002 Jan 27, 2009
AB 150MG A076708 003 Jan 27, 2009
AB 200MG A076708 004 Jan 27, 2009
AB GLENMARK GENERICS 25MG A090169 001 May 12, 2012
AB 100MG A090169 002 May 12, 2012
AB 150MG A090169 003 May 12, 2012
AB 200MG A090169 004 May 12, 2012
AB JUBILANT CADISTA 25MG A079132 001 Jan 27, 2009
AB 100MG A079132 002 Jan 27, 2009
AB 150MG A079132 003 Jan 27, 2009
AB 200MG A079132 004 Jan 27, 2009
AB LUPIN LTD 25MG A078691 001 Jun 01, 2010
AB 100MG A078691 002 Jun 01, 2010
AB 150MG A078691 003 Jun 01, 2010
AB 200MG A078691 004 Jun 01, 2010
AB RUBICON 25MG A078625 001 Jan 27, 2009
AB 100MG A078625 002 Jan 27, 2009
AB 150MG A078625 003 Jan 27, 2009
AB 200MG A078625 004 Jan 27, 2009
AB TARO PHARM INDS 25MG A078525 001 Jan 27, 2009
AB 100MG A078525 002 Jan 27, 2009
AB 150MG A078525 003 Jan 27, 2009
AB 200MG A078525 004 Jan 27, 2009
AB TORRENT PHARMS 25MG A078947 001 Jan 27, 2009
AB 100MG A078947 002 Jan 27, 2009
AB 150MG A078947 003 Jan 27, 2009
AB 200MG A078947 004 Jan 27, 2009
AB UNICHEM LABS LTD 25MG A090170 001 Oct 06, 2011
AB 100MG A090170 002 Oct 06, 2011
AB 150MG A090170 003 Oct 06, 2011
AB 200MG A090170 004 Oct 06, 2011
AB ZYDUS PHARMS USA 25MG A077633 001 Jan 27, 2009
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-259(of 474)

LAMOTRIGINE
TABLET;ORAL
LAMOTRIGINE
AB 100MG A077633 003 Jan 27, 2009
AB 150MG A077633 004 Jan 27, 2009
AB 200MG A077633 005 Jan 27, 2009
50MG A077633 002 Jan 27, 2009
250MG A077633 006 Jan 27, 2009
TABLET, EXTENDED RELEASE;ORAL
LAMICTAL XR
AB + GLAXOSMITHKLINE LLC 25MG N022115 001 May 29, 2009
AB +! 50MG N022115 002 May 29, 2009
AB + 100MG N022115 003 May 29, 2009
AB +! 200MG N022115 004 May 29, 2009
AB + 250MG N022115 006 Jun 21, 2011
AB + 300MG N022115 005 Apr 14, 2010
LAMOTRIGINE
AB ACTAVIS ELIZABETH 100MG A200672 003 Oct 17, 2013
AB 200MG A200672 004 Oct 17, 2013
AB 25MG A200672 001 Oct 17, 2013
AB 50MG A200672 002 Oct 17, 2013
AB 250MG A200672 006 Nov 13, 2013
AB 300MG A200672 005 Oct 17, 2013
AB AMNEAL PHARMS 25MG A207497 001 Nov 30, 2018
AB 50MG A207497 002 Nov 30, 2018
AB 100MG A207497 003 Nov 30, 2018
AB 200MG A207497 004 Nov 30, 2018
AB 250MG A207497 005 Nov 30, 2018
AB 300MG A207497 006 Nov 30, 2018
AB ANCHEN PHARMS 25MG A201374 001 Dec 26, 2012
AB 50MG A201374 002 Dec 26, 2012
AB 100MG A201374 003 Dec 26, 2012
AB 200MG A201374 004 Dec 26, 2012
AB 250MG A201374 005 Dec 26, 2012
AB 300MG A201374 006 Dec 26, 2012
AB DR REDDYS LABS LTD 25MG A202383 001 Jun 19, 2013
AB 50MG A202383 002 Jun 19, 2013
AB 100MG A202383 003 Jun 19, 2013
AB 200MG A202383 004 Jun 19, 2013
AB 250MG A202383 006 Sep 06, 2018
AB 300MG A202383 005 Jun 19, 2013
AB PAR PHARM 25MG A201791 001 Jan 18, 2013
AB 50MG A201791 002 Jan 18, 2013
AB 100MG A201791 003 Jan 18, 2013
AB 200MG A201791 004 Jan 18, 2013
AB 250MG A201791 005 Jan 18, 2013
AB 300MG A201791 006 Jan 18, 2013
AB RUBICON 100MG A202887 003 Jun 17, 2013
AB 200MG A202887 004 Jun 17, 2013
AB TORRENT 25MG A203370 001 Dec 23, 2013
AB 50MG A203370 002 Dec 23, 2013
AB 100MG A203370 003 Dec 23, 2013
AB WOCKHARDT BIO AG 25MG A202498 001 Jan 04, 2013
AB 50MG A202498 002 Jan 04, 2013
AB 100MG A202498 003 Jan 04, 2013
AB 200MG A202498 004 Jan 04, 2013
AB 300MG A202498 005 Jan 04, 2013
AB YILING 25MG A213949 001 Dec 08, 2021
AB 50MG A213949 002 Dec 08, 2021
AB 100MG A213949 003 Dec 08, 2021
AB 200MG A213949 004 Dec 08, 2021
AB 250MG A213949 005 Dec 08, 2021
AB 300MG A213949 006 Dec 08, 2021
AB ZYDUS PHARMS 25MG A207763 001 Apr 01, 2020
AB 50MG A207763 002 Apr 01, 2020
AB 100MG A207763 003 Apr 01, 2020
AB 200MG A207763 004 Apr 01, 2020
AB 250MG A207763 005 Apr 01, 2020
AB 300MG A207763 006 Apr 01, 2020
TABLET, FOR SUSPENSION;ORAL
LAMICTAL CD
AB + GLAXOSMITHKLINE LLC 2MG N020764 004 Sep 08, 2000
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-260(of 474)

LAMOTRIGINE
TABLET, FOR SUSPENSION;ORAL
LAMICTAL CD
AB + 5MG N020764 001 Aug 24, 1998
AB +! 25MG N020764 002 Aug 24, 1998
LAMOTRIGINE
AB ALEMBIC PHARMS 5MG A201168 001 Jun 12, 2014
AB 25MG A201168 002 Jun 12, 2014
AB AUROBINDO PHARMA 5MG A090401 002 Nov 04, 2009
AB 25MG A090401 003 Nov 04, 2009
AB DR REDDYS LABS LTD 5MG A076701 001 Jan 22, 2009
AB 25MG A076701 002 Jan 22, 2009
AB GLENMARK PHARMS LTD 5MG A079099 001 Feb 19, 2009
AB 25MG A079099 002 Feb 19, 2009
AB TARO 5MG A079204 001 Feb 04, 2009
AB 25MG A079204 002 Feb 04, 2009
AB WATSON LABS 2MG A076928 001 Jan 22, 2009
AB 5MG A076928 002 Jan 22, 2009
AB 25MG A076928 003 Jan 22, 2009
AB ZYDUS PHARMS USA 5MG A078009 002 Jan 22, 2009
INC
AB 25MG A078009 003 Jan 22, 2009
TABLET, ORALLY DISINTEGRATING;ORAL
LAMICTAL ODT
AB + GLAXOSMITHKLINE LLC 25MG N022251 001 May 08, 2009
AB +! 50MG N022251 002 May 08, 2009
AB + 100MG N022251 003 May 08, 2009
AB + 200MG N022251 004 May 08, 2009
LAMOTRIGINE
AB AJANTA PHARMA LTD 25MG A213271 001 Jan 19, 2021
AB 50MG A213271 002 Jan 19, 2021
AB 100MG A213271 003 Jan 19, 2021
AB 200MG A213271 004 Jan 19, 2021
AB AMRING PHARMS 25MG A214124 001 Feb 03, 2022
AB 50MG A214124 002 Feb 03, 2022
AB 100MG A214124 003 Feb 03, 2022
AB 200MG A214124 004 Feb 03, 2022
AB PAR PHARM 25MG A204158 001 Oct 27, 2015
AB 50MG A204158 002 Oct 27, 2015
AB 100MG A204158 003 Oct 27, 2015
AB 200MG A204158 004 Oct 27, 2015
AB SCIEGEN PHARMS INC 25MG A206382 001 Jun 17, 2016
AB 50MG A206382 002 Jun 17, 2016
AB 100MG A206382 003 Jun 17, 2016
AB 200MG A206382 004 Jun 17, 2016
LANREOTIDE ACETATE
SOLUTION;SUBCUTANEOUS
LANREOTIDE ACETATE
+! INVAGEN PHARMS EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML) N215395 001 Dec 17, 2021
+! EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML) N215395 002 Dec 17, 2021
+! EQ 120MG BASE/0.5ML (EQ 120MG N215395 003 Dec 17, 2021
BASE/0.5ML)
SOMATULINE DEPOT
+! IPSEN PHARMA EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML) N022074 001 Aug 30, 2007
+! EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML) N022074 002 Aug 30, 2007
+! EQ 120MG BASE/0.5ML (EQ 120MG N022074 003 Aug 30, 2007
BASE/0.5ML)
LANSOPRAZOLE
CAPSULE, DELAYED REL PELLETS;ORAL
LANSOPRAZOLE
AB ALKEM LABS LTD 15MG A207394 001 Jan 18, 2019
AB 30MG A207394 002 Jan 18, 2019
AB CHARTWELL MOLECULAR 15MG A207156 001 Sep 28, 2017
AB 30MG A207156 002 Sep 28, 2017
AB DR REDDYS LABS LTD 15MG A091269 001 Oct 15, 2010
AB 30MG A091269 002 Oct 15, 2010
AB HETERO LABS LTD III 15MG A203083 001 May 18, 2020
AB 30MG A203083 002 May 18, 2020
AB INVENTIA 15MG A205868 001 Aug 30, 2017
AB 30MG A205868 002 Aug 30, 2017
AB MYLAN PHARMS INC 15MG A090763 001 Nov 10, 2009
AB 30MG A090763 002 Nov 10, 2009
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-261(of 474)

LANSOPRAZOLE
CAPSULE, DELAYED REL PELLETS;ORAL
LANSOPRAZOLE
AB NATCO PHARMA LTD 15MG A201921 001 Dec 18, 2012
AB 30MG A201921 002 Dec 18, 2012
AB SANDOZ 15MG A090331 001 Apr 23, 2010
AB 30MG A090331 002 Apr 23, 2010
AB SUN PHARM 15MG A202637 001 Sep 13, 2013
AB 30MG A091509 001 Sep 13, 2013
AB TEVA PHARMS 15MG A077255 001 Nov 10, 2009
AB 30MG A077255 002 Nov 10, 2009
AB WOCKHARDT 15MG A202176 001 Sep 14, 2012
AB 30MG A202176 002 Sep 14, 2012
AB XIROMED 15MG A203203 001 Jul 25, 2016
AB 30MG A203203 002 Jul 25, 2016
AB ZYDUS HLTHCARE 15MG A202366 001 Aug 19, 2013
AB 30MG A202366 002 Aug 19, 2013
PREVACID
AB +! TAKEDA PHARMS USA 30MG N020406 002 May 10, 1995
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
LANSOPRAZOLE
AB DR REDDYS 15MG A210465 001 Feb 01, 2021
AB 30MG A210465 002 Feb 01, 2021
AB MYLAN 15MG A202396 001 Nov 28, 2018
AB 30MG A202396 002 Nov 28, 2018
AB TEVA PHARMS USA 15MG A208784 001 Sep 21, 2017
AB 30MG A208784 002 Sep 21, 2017
AB ZYDUS PHARMS 15MG A200816 001 Nov 27, 2018
AB 30MG A200816 002 Nov 27, 2018
PREVACID
AB + TAKEDA PHARMS USA 15MG N021428 001 Aug 30, 2002
AB +! 30MG N021428 002 Aug 30, 2002
LANTHANUM CARBONATE
POWDER;ORAL
FOSRENOL
+ TAKEDA PHARMS USA EQ 750MG BASE N204734 001 Sep 24, 2014
+! EQ 1GM BASE N204734 002 Sep 24, 2014
TABLET, CHEWABLE;ORAL
FOSRENOL
AB + TAKEDA PHARMS USA EQ 500MG BASE N021468 002 Oct 26, 2004
AB + EQ 750MG BASE N021468 003 Nov 23, 2005
AB +! EQ 1GM BASE N021468 004 Nov 23, 2005
LANTHANUM CARBONATE
AB BARR EQ 500MG BASE A090977 001 Jan 27, 2022
AB EQ 750MG BASE A090977 002 Jan 27, 2022
AB EQ 1GM BASE A090977 003 Jan 27, 2022
AB INVAGEN PHARMS EQ 500MG BASE A206868 001 Jan 24, 2022
AB EQ 750MG BASE A206868 002 Jan 24, 2022
AB EQ 1GM BASE A206868 003 Jan 24, 2022
AB NATCO PHARMA LTD EQ 500MG BASE A090978 001 Aug 11, 2017
AB EQ 750MG BASE A090978 002 Aug 11, 2017
AB EQ 1GM BASE A090978 003 Aug 11, 2017
LAPATINIB DITOSYLATE
TABLET;ORAL
LAPATINIB DITOSYLATE
AB NATCO PHARMA LTD EQ 250MG BASE A203007 001 Sep 29, 2020
TYKERB
AB +! NOVARTIS EQ 250MG BASE N022059 001 Mar 13, 2007
LAROTRECTINIB SULFATE
CAPSULE;ORAL
VITRAKVI
+ BAYER HLTHCARE EQ 25MG BASE N210861 001 Nov 26, 2018
+! EQ 100MG BASE N210861 002 Nov 26, 2018
SOLUTION;ORAL
VITRAKVI
+! BAYER HEALTHCARE EQ 20MG BASE/ML N211710 001 Nov 26, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-262(of 474)

LASMIDITAN SUCCINATE
TABLET;ORAL
REYVOW
+ ELI LILLY AND CO EQ 50MG BASE N211280 001 Jan 31, 2020
+! EQ 100MG BASE N211280 002 Jan 31, 2020
LATANOPROST
EMULSION;OPHTHALMIC
XELPROS
+! SUN PHARM 0.005% N206185 001 Sep 12, 2018
SOLUTION/DROPS;OPHTHALMIC
LATANOPROST
AT AKORN 0.005% A090887 001 Jul 19, 2011
AT AMRING PHARMS 0.005% A200925 001 Mar 22, 2011
AT BAUSCH AND LOMB 0.005% A201006 001 Mar 22, 2011
AT DR REDDYS LABS LTD 0.005% A202077 001 Feb 11, 2013
AT FDC LTD 0.005% A202442 001 Apr 22, 2016
AT SANDOZ INC 0.005% A091449 001 Mar 22, 2011
AT SOMERSET 0.005% A201786 001 Mar 22, 2011
XALATAN
AT +! UPJOHN 0.005% N020597 001 Jun 05, 1996
IYUZEH
+! THEA PHARMA 0.005% N216472 001 Dec 13, 2022
LATANOPROST; NETARSUDIL DIMESYLATE
SOLUTION/DROPS;OPHTHALMIC
ROCKLATAN
+! AERIE PHARMS INC 0.005%;EQ 0.02% BASE N208259 001 Mar 12, 2019
LATANOPROSTENE BUNOD
SOLUTION/DROPS;OPHTHALMIC
VYZULTA
+! BAUSCH AND LOMB 0.024% N207795 001 Nov 02, 2017
LEDIPASVIR; SOFOSBUVIR
PELLETS;ORAL
HARVONI
+ GILEAD SCIENCES INC 33.75MG;150MG/PACKET N212477 001 Aug 28, 2019
+! 45MG;200MG/PACKET N212477 002 Aug 28, 2019
TABLET;ORAL
HARVONI
+ GILEAD SCIENCES INC 45MG;200MG N205834 002 Aug 28, 2019
+! 90MG;400MG N205834 001 Oct 10, 2014
LEFAMULIN ACETATE
SOLUTION;INTRAVENOUS
XENLETA
+! NABRIVA EQ 150MG BASE/15ML (EQ 10MG BASE/ML) N211673 001 Aug 19, 2019
TABLET;ORAL
XENLETA
+! NABRIVA EQ 600MG BASE N211672 001 Aug 19, 2019
LEFLUNOMIDE
TABLET;ORAL
ARAVA
AB + SANOFI AVENTIS US 10MG N020905 001 Sep 10, 1998
AB +! 20MG N020905 002 Sep 10, 1998
LEFLUNOMIDE
AB ABHAI LLC 10MG A212453 001 Jun 03, 2019
AB 20MG A212453 002 Jun 03, 2019
AB AET PHARMA 10MG A213497 001 May 10, 2021
AB 20MG A213497 002 May 10, 2021
AB ALEMBIC PHARMS LTD 10MG A091369 001 Nov 21, 2011
AB 20MG A091369 002 Nov 21, 2011
AB APOTEX INC 10MG A077090 001 Sep 13, 2005
AB 20MG A077090 002 Sep 13, 2005
AB AUROBINDO PHARMA 10MG A213652 001 Mar 29, 2021
AB 20MG A213652 002 Mar 29, 2021
AB HERITAGE PHARMS 10MG A077086 001 Sep 13, 2005
AB 20MG A077086 002 Sep 13, 2005
AB LUPIN LTD 10MG A211863 001 Feb 04, 2020
AB 20MG A211863 002 Feb 04, 2020
AB WANBANG BIOPHARMS 10MG A077087 001 Sep 13, 2005
AB 20MG A077087 002 Sep 13, 2005
AB ZYDUS 10MG A212308 001 Apr 24, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-263(of 474)

LEFLUNOMIDE
TABLET;ORAL
LEFLUNOMIDE
AB 20MG A212308 002 Apr 24, 2019
ARAVA
+! SANOFI AVENTIS US 100MG N020905 003 Sep 10, 1998
LEMBOREXANT
TABLET;ORAL
DAYVIGO
+ EISAI INC 5MG N212028 001 Apr 07, 2020
+! 10MG N212028 002 Apr 07, 2020
LENACAPAVIR SODIUM
SOLUTION;SUBCUTANEOUS
SUNLENCA
+! GILEAD SCIENCES INC EQ 463.5MG BASE/1.5ML (EQ 309MG N215973 001 Dec 22, 2022
BASE/ML)
TABLET;ORAL
SUNLENCA
+! GILEAD SCIENCES INC EQ 300MG BASE N215974 001 Dec 22, 2022
LENALIDOMIDE
CAPSULE;ORAL
LENALIDOMIDE
AB APOTEX 5MG A211022 001 Aug 30, 2022
AB 10MG A211022 002 Aug 30, 2022
AB 15MG A211022 003 Aug 30, 2022
AB 25MG A211022 004 Aug 30, 2022
AB ARROW INTL 5MG A201452 001 May 21, 2021
AB 10MG A201452 002 May 21, 2021
AB 15MG A201452 003 May 21, 2021
AB 25MG A201452 004 May 21, 2021
AB CIPLA 5MG A210435 001 Sep 06, 2022
AB 10MG A210435 002 Sep 06, 2022
AB 15MG A210435 003 Sep 06, 2022
AB 25MG A210435 004 Sep 06, 2022
AB DR REDDYS 2.5MG A209348 001 Oct 14, 2021
AB 5MG A209348 003 Aug 30, 2022
AB 10MG A209348 004 Aug 30, 2022
AB 15MG A209348 005 Aug 30, 2022
AB 20MG A209348 002 Oct 14, 2021
AB 25MG A209348 006 Aug 30, 2022
AB LOTUS PHARM CO LTD 5MG A210480 001 Aug 31, 2022
AB 10MG A210480 002 Aug 31, 2022
AB 15MG A210480 003 Aug 31, 2022
AB 25MG A210480 004 Aug 31, 2022
AB MYLAN 5MG A213912 001 Aug 30, 2022
AB 10MG A213912 002 Aug 30, 2022
AB 15MG A213912 003 Aug 30, 2022
AB 25MG A213912 004 Aug 30, 2022
AB ZYDUS PHARMS 5MG A210154 001 Sep 12, 2022
AB 10MG A210154 002 Sep 12, 2022
AB 15MG A210154 003 Sep 12, 2022
AB 25MG A210154 004 Sep 12, 2022
REVLIMID
AB + CELGENE 2.5MG N021880 005 Dec 21, 2011
AB + 5MG N021880 001 Dec 27, 2005
AB + 10MG N021880 002 Dec 27, 2005
AB + 15MG N021880 003 Jun 29, 2006
AB + 20MG N021880 006 Jun 05, 2013
AB +! 25MG N021880 004 Jun 29, 2006
LENVATINIB MESYLATE
CAPSULE;ORAL
LENVIMA
+ EISAI INC EQ 4MG BASE N206947 001 Feb 13, 2015
+! EQ 10MG BASE N206947 002 Feb 13, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-264(of 474)

LETERMOVIR
SOLUTION;INTRAVENOUS
PREVYMIS
+! MERCK SHARP DOHME 240MG/12ML (20MG/ML) N209940 001 Nov 08, 2017
+! 480MG/24ML (20MG/ML) N209940 002 Nov 08, 2017
TABLET;ORAL
PREVYMIS
+ MERCK SHARP DOHME 240MG N209939 001 Nov 08, 2017
+! 480MG N209939 002 Nov 08, 2017
LETROZOLE
TABLET;ORAL
FEMARA
AB +! NOVARTIS PHARMS 2.5MG N020726 001 Jul 25, 1997
LETROZOLE
AB ACCORD HLTHCARE 2.5MG A090934 001 Jun 03, 2011
AB BEIJING YILING 2.5MG A205869 001 Nov 14, 2018
AB DR REDDYS LABS LTD 2.5MG A091191 001 Jun 03, 2011
AB EUGIA PHARMA 2.5MG A211717 001 Jan 11, 2019
AB NATCO PHARMA LTD 2.5MG A200161 001 Jun 03, 2011
AB TEVA PHARMS 2.5MG A090289 001 Jun 03, 2011
LETROZOLE; RIBOCICLIB SUCCINATE
TABLET;ORAL
KISQALI FEMARA CO-PACK (COPACKAGED)
+! NOVARTIS 2.5MG;EQ 200MG BASE N209935 001 May 04, 2017
LEUCOVORIN CALCIUM
INJECTABLE;INJECTION
LEUCOVORIN CALCIUM
AP FRESENIUS KABI USA EQ 10MG BASE/ML A207226 001 Jul 27, 2018
AP ! HIKMA EQ 50MG BASE/VIAL A089384 001 Sep 14, 1987
AP ! EQ 100MG BASE/VIAL A089717 001 Mar 28, 1988
AP TEVA PHARMS USA EQ 100MG BASE/VIAL A081277 001 Sep 28, 1993
AP EQ 350MG BASE/VIAL A040174 001 Jun 12, 1997
LEUCOVORIN CALCIUM PRESERVATIVE FREE
AP FRESENIUS KABI USA EQ 200MG BASE/VIAL A040258 001 Feb 26, 1999
AP ! EQ 500MG BASE/VIAL A040286 001 Feb 26, 1999
AP ! HIKMA EQ 10MG BASE/ML A040347 001 Apr 25, 2000
AP ! EQ 200MG BASE/VIAL A040056 001 May 23, 1995
AP ! EQ 350MG BASE/VIAL A040335 001 Apr 20, 2000
AP MYLAN LABS LTD EQ 100MG BASE/VIAL A203800 001 May 19, 2017
AP EQ 200MG BASE/VIAL A203800 002 May 19, 2017
AP EQ 350MG BASE/VIAL A203800 003 May 19, 2017
AP SAGENT PHARMS EQ 50MG BASE/VIAL A200753 001 Sep 06, 2012
AP EQ 100MG BASE/VIAL A200753 002 Sep 06, 2012
AP EQ 200MG BASE/VIAL A200753 003 Sep 06, 2012
AP EQ 350MG BASE/VIAL A200855 001 Sep 06, 2012
AP SAGENT PHARMS INC EQ 500MG BASE/VIAL A209110 001 Oct 26, 2017
LEUCOVORIN CALCIUM
FRESENIUS KABI USA EQ 10MG BASE/ML A207241 001 Mar 14, 2018
TABLET;ORAL
LEUCOVORIN CALCIUM
AB BARR EQ 5MG BASE A071198 001 Sep 24, 1987
AB EQ 25MG BASE A071199 001 Sep 24, 1987
AB EPIC PHARMA LLC EQ 5MG BASE A074544 001 Aug 28, 1997
AB EQ 10MG BASE A074544 003 May 19, 2021
AB EQ 15MG BASE A074544 004 May 19, 2021
AB EQ 25MG BASE A074544 002 Aug 28, 1997
AB HIKMA EQ 5MG BASE A072733 001 Feb 22, 1993
AB EQ 10MG BASE A072734 001 Feb 22, 1993
AB EQ 15MG BASE A072735 001 Feb 22, 1993
AB ! EQ 25MG BASE A072736 001 Feb 22, 1993
AB LEADING EQ 5MG BASE A213929 001 Oct 22, 2020
AB EQ 10MG BASE A213929 002 Oct 22, 2020
AB EQ 15MG BASE A213929 003 Oct 22, 2020
AB EQ 25MG BASE A213929 004 Oct 22, 2020
AB NOVAST LABS EQ 5MG BASE A211132 001 Jul 30, 2020
AB EQ 10MG BASE A211132 002 Jul 30, 2020
AB EQ 15MG BASE A211132 003 Jul 30, 2020
AB EQ 25MG BASE A211132 004 Jul 30, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-265(of 474)

LEUPROLIDE ACETATE
FOR SUSPENSION;INTRAMUSCULAR
LUTRATE DEPOT KIT
+! INVAGEN PHARMS 22.5MG/VIAL N205054 001 Aug 28, 2018
INJECTABLE;INJECTION
LEUPROLIDE ACETATE
AP AMNEAL 1MG/0.2ML A215336 001 Oct 28, 2022
AP EUGIA PHARMA 1MG/0.2ML A212963 001 Jun 06, 2022
AP ! SANDOZ 1MG/0.2ML A074728 001 Aug 04, 1998
AP SUN PHARM 1MG/0.2ML A078885 001 Mar 09, 2009
AP TEVA PHARMS USA 1MG/0.2ML A075471 001 Oct 25, 2000
AP VGYAAN 1MG/0.2ML A213829 001 Aug 13, 2021
LUPRON DEPOT
+! ABBVIE ENDOCRINE 3.75MG N020011 002 Oct 26, 1995
INC
+! 7.5MG/VIAL N019732 001 Jan 26, 1989
+! 11.25MG/VIAL N020708 001 Mar 07, 1997
+ 22.5MG/VIAL N020517 001 Dec 22, 1995
+! 30MG/VIAL N020517 002 May 30, 1997
+! 45MG/VIAL N020517 003 Jun 17, 2011
POWDER;INTRAMUSCULAR
LUPRON DEPOT-PED KIT
+! ABBVIE ENDOCRINE 7.5MG N020263 002 Apr 16, 1993
INC
+! 11.25MG N020263 005 Jan 21, 1994
+! 11.25MG N020263 007 Aug 15, 2011
+! 15MG N020263 006 Jan 21, 1994
+! 30MG N020263 008 Aug 15, 2011
POWDER;SUBCUTANEOUS
ELIGARD KIT
+! TOLMAR THERAP 7.5MG N021343 001 Jan 23, 2002
+! 22.5MG N021379 001 Jul 24, 2002
+! 30MG N021488 001 Feb 13, 2003
+! 45MG N021731 001 Dec 14, 2004
FENSOLVI KIT
+! TOLMAR 45MG N213150 001 May 01, 2020
LEUPROLIDE MESYLATE
EMULSION;SUBCUTANEOUS
CAMCEVI KIT
+! ACCORD EQ 42MG BASE N211488 001 May 25, 2021
LEVALBUTEROL HYDROCHLORIDE
SOLUTION;INHALATION
LEVALBUTEROL HYDROCHLORIDE
AN CIPLA EQ 0.021% BASE A078171 002 Dec 13, 2013
AN EQ 0.042% BASE A078171 003 Dec 13, 2013
AN EQ 0.0103% BASE A078171 001 Dec 13, 2013
AN IMPAX LABS INC EQ 0.0103% BASE A077756 003 Apr 09, 2008
AN EQ 0.021% BASE A077756 001 Apr 09, 2008
AN EQ 0.042% BASE A077756 002 Apr 09, 2008
AN LUOXIN AUROVITAS EQ 0.25% BASE A207628 001 Jan 31, 2017
AN EQ 0.0103% BASE A207625 001 Dec 30, 2016
AN EQ 0.021% BASE A207625 002 Dec 30, 2016
AN EQ 0.042% BASE A207625 003 Dec 30, 2016
AN MYLAN SPECIALITY LP EQ 0.25% BASE A078309 001 Mar 20, 2009
AN RITEDOSE CORP EQ 0.0103% BASE A203653 001 Mar 22, 2016
AN EQ 0.021% BASE A203653 002 Mar 22, 2016
AN EQ 0.042% BASE A203653 003 Mar 22, 2016
AN SUN PHARM EQ 0.0103% BASE A207820 001 Nov 05, 2018
AN EQ 0.021% BASE A207820 002 Nov 05, 2018
AN EQ 0.042% BASE A207820 003 Nov 05, 2018
AN TEVA PARENTERAL EQ 0.25% BASE A200875 001 Sep 11, 2014
AN TEVA PHARMS USA EQ 0.0103% BASE A090297 001 Apr 26, 2013
AN EQ 0.021% BASE A090297 002 Apr 26, 2013
AN EQ 0.042% BASE A090297 003 Apr 26, 2013
XOPENEX
AN +! AKORN EQ 0.0103% BASE N020837 003 Jan 30, 2002
AN +! EQ 0.021% BASE N020837 001 Mar 25, 1999
AN +! EQ 0.042% BASE N020837 002 Mar 25, 1999
AN +! EQ 0.25% BASE N020837 004 Jul 18, 2003
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-266(of 474)

LEVALBUTEROL TARTRATE
AEROSOL, METERED;INHALATION
XOPENEX HFA
+! LUPIN EQ 0.045MG BASE/INH N021730 001 Mar 11, 2005
LEVAMLODIPINE MALEATE
TABLET;ORAL
CONJUPRI
+ CSPC OUYI EQ 2.5MG BASE N212895 002 Dec 19, 2019
+! EQ 5MG BASE N212895 003 Dec 19, 2019
LEVETIRACETAM
INJECTABLE;INTRAVENOUS
KEPPRA
AP +! UCB INC 500MG/5ML (100MG/ML) N021872 001 Jul 31, 2006
LEVETIRACETAM
AP BEOWULF ASSET 500MG/5ML (100MG/ML) A091485 001 Aug 05, 2011
AP EUGIA PHARMA 500MG/5ML (100MG/ML) A204312 001 Feb 01, 2016
AP FRESENIUS KABI USA 500MG/5ML (100MG/ML) A090876 001 Aug 13, 2015
AP HAINAN POLY PHARM 500MG/5ML (100MG/ML) A209781 001 Mar 20, 2018
AP HIKMA FARMACEUTICA 500MG/5ML (100MG/ML) A090981 001 Oct 13, 2011
AP HOSPIRA INC 500MG/5ML (100MG/ML) A202869 001 Apr 06, 2012
AP MICRO LABS 500MG/5ML (100MG/ML) A211954 001 Aug 09, 2019
AP MSN 500MG/5ML (100MG/ML) A215980 001 Nov 15, 2022
AP MYLAN LABS LTD 500MG/5ML (100MG/ML) A203308 001 Sep 16, 2016
AP PRINSTON INC 500MG/5ML (100MG/ML) A209474 001 Mar 28, 2022
AP SAGENT PHARMS 500MG/5ML (100MG/ML) A091627 001 Jun 26, 2013
AP SUN PHARM INDS LTD 500MG/5ML (100MG/ML) A090754 001 Jun 16, 2010
LEVETIRACETAM IN SODIUM CHLORIDE
AP EUGIA PHARMA 500MG/100ML (5MG/ML) A207160 001 Jan 04, 2017
AP 1GM/100ML (10MG/ML) A207160 002 Jan 04, 2017
AP 1.5GM/100ML (15MG/ML) A207160 003 Jan 04, 2017
AP GLAND PHARMA LTD 500MG/100ML (5MG/ML) A206880 001 Oct 25, 2017
AP 1GM/100ML (10MG/ML) A206880 002 Oct 25, 2017
AP 1.5GM/100ML (15MG/ML) A206880 003 Oct 25, 2017
AP +! HQ SPECIALITY 500MG/100ML (5MG/ML) N202543 001 Nov 09, 2011
PHARMA
AP +! 1GM/100ML (10MG/ML) N202543 002 Nov 09, 2011
AP +! 1.5GM/100ML (15MG/ML) N202543 003 Nov 09, 2011
AP NEXUS PHARMS 500MG/100ML (5MG/ML) A213532 001 Jul 06, 2020
AP 1GM/100ML (10MG/ML) A213532 002 Jul 06, 2020
AP 1.5GM/100ML (15MG/ML) A213532 003 Jul 06, 2020
+! HQ SPECIALITY 250MG/50ML (5MG/ML) N202543 004 Dec 14, 2020
PHARMA
SOLUTION;ORAL
KEPPRA
AA +! UCB INC 100MG/ML N021505 001 Jul 15, 2003
LEVETIRACETAM
AA ACI 100MG/ML A078582 001 Jan 15, 2009
AA ACTAVIS MID 100MG/ML A078976 001 Jan 15, 2009
ATLANTIC
AA AIPING PHARM INC 100MG/ML A090079 001 Apr 11, 2012
AA AKORN 100MG/ML A090601 001 Feb 28, 2012
AA ALEMBIC LABS 100MG/ML A203067 001 May 09, 2013
AA AMNEAL PHARMS 100MG/ML A090992 001 Oct 27, 2009
AA AUROBINDO PHARMA 100MG/ML A079063 001 Jan 15, 2009
AA BELCHER 100MG/ML A090461 001 Sep 30, 2010
AA BRECKENRIDGE 100MG/ML A079120 001 Jan 16, 2009
AA CHARTWELL MOLECULAR 100MG/ML A090263 001 Apr 03, 2009
AA HETERO LABS LTD III 100MG/ML A203052 001 Feb 28, 2013
AA LUPIN LTD 100MG/ML A090893 001 Oct 17, 2011
AA MSN 100MG/ML A214757 001 Jul 15, 2022
AA PHARM ASSOC 100MG/ML A201157 001 Jun 04, 2015
AA TARO 100MG/ML A078774 001 Feb 10, 2009
TABLET;ORAL
KEPPRA
AB + UCB INC 250MG N021035 001 Nov 30, 1999
AB + 500MG N021035 002 Nov 30, 1999
AB + 750MG N021035 003 Nov 30, 1999
AB +! 1GM N021035 004 Jan 06, 2006
LEVETIRACETAM
AB ACCORD HLTHCARE 250MG A090843 001 Feb 14, 2011
AB 500MG A090843 002 Feb 14, 2011
AB 750MG A090843 003 Feb 14, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-267(of 474)

LEVETIRACETAM
TABLET;ORAL
LEVETIRACETAM
AB 1GM A090843 004 Feb 14, 2011
AB ACI 250MG A078042 001 Jan 15, 2009
AB 500MG A078042 002 Jan 15, 2009
AB 750MG A078042 003 Jan 15, 2009
AB 1GM A078042 004 Jan 15, 2009
AB ALKEM LABS LTD 250MG A216375 001 May 27, 2022
AB 500MG A216375 002 May 27, 2022
AB 750MG A216375 003 May 27, 2022
AB 1GM A216375 004 May 27, 2022
AB AUROBINDO PHARMA 250MG A078993 001 Jan 15, 2009
AB 500MG A078993 002 Jan 15, 2009
AB 750MG A078993 003 Jan 15, 2009
AB 1GM A078993 004 Jan 15, 2009
AB CHARTWELL RX 250MG A201293 001 Jun 14, 2011
AB 500MG A201293 002 Jun 14, 2011
AB 750MG A201293 003 Jun 14, 2011
AB 1GM A201293 004 Jun 14, 2011
AB DR REDDYS LABS LTD 250MG A076920 001 Jan 15, 2009
AB 500MG A076920 002 Jan 15, 2009
AB 750MG A076920 003 Jan 15, 2009
AB 1GM A078904 001 Jan 15, 2009
AB HETERO LABS LTD III 250MG A090515 001 Oct 08, 2010
AB 500MG A090515 002 Oct 08, 2010
AB 750MG A090515 003 Oct 08, 2010
AB 1GM A090515 004 Oct 08, 2010
AB INVAGEN PHARMS 250MG A078234 001 Jan 15, 2009
AB 500MG A078234 002 Jan 15, 2009
AB 750MG A078234 003 Jan 15, 2009
AB LUPIN 250MG A078154 001 Jan 15, 2009
AB 500MG A078154 002 Jan 15, 2009
AB 750MG A078154 003 Jan 15, 2009
AB 1GM A090025 001 Jan 15, 2009
AB MSN 250MG A214815 001 Oct 07, 2022
AB 500MG A214815 002 Oct 07, 2022
AB 750MG A214815 003 Oct 07, 2022
AB 1GM A214815 004 Oct 07, 2022
AB MYLAN 250MG A076919 001 Nov 04, 2008
AB 500MG A076919 002 Nov 04, 2008
AB 750MG A076919 003 Nov 04, 2008
AB 1GM A090261 001 Dec 08, 2009
AB ORBION PHARMS 250MG A078526 001 Jan 15, 2009
AB 500MG A078526 002 Jan 15, 2009
AB 750MG A078526 003 Jan 15, 2009
AB 1GM A090484 001 Aug 05, 2010
AB OXFORD PHARMS 250MG A077319 001 Mar 20, 2009
AB 500MG A077319 002 Mar 20, 2009
AB 750MG A077319 003 Mar 20, 2009
AB PRINSTON INC 250MG A078106 001 Feb 10, 2009
AB 500MG A078106 002 Feb 10, 2009
AB 750MG A078106 003 Feb 10, 2009
AB 1GM A078106 004 Feb 10, 2009
AB SCIEGEN PHARMS INC 250MG A215069 003 May 27, 2022
AB 500MG A215069 004 May 27, 2022
AB 750MG A215069 001 Jun 11, 2021
AB 1GM A215069 002 Jun 11, 2021
AB STALLION LABS 250MG A079042 001 Jan 15, 2009
AB 500MG A079042 002 Jan 15, 2009
AB 750MG A079042 003 Jan 15, 2009
AB 1GM A079042 004 Jan 15, 2009
AB TARO 250MG A078960 004 Feb 01, 2010
AB 500MG A078960 003 Feb 01, 2010
AB 750MG A078960 002 Feb 01, 2010
AB 1GM A078960 001 Feb 01, 2010
AB TORRENT PHARMS 250MG A078858 001 Jan 15, 2009
AB 500MG A078858 002 Jan 15, 2009
AB 750MG A078858 003 Jan 15, 2009
AB 1GM A078858 004 Jan 15, 2009
AB VIWIT PHARM 250MG A078869 001 Mar 13, 2009
AB 500MG A078869 002 Mar 13, 2009
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-268(of 474)

LEVETIRACETAM
TABLET;ORAL
LEVETIRACETAM
AB 750MG A078869 003 Mar 13, 2009
AB 1GM A078869 004 Mar 13, 2009
AB VKT PHARMA 250MG A090767 001 Jul 28, 2010
AB 500MG A090767 002 Jul 28, 2010
AB 750MG A090767 003 Jul 28, 2010
AB 1GM A090767 004 Jul 28, 2010
AB ZHEJIANG JINGXIN 250MG A091491 001 Dec 14, 2010
AB 500MG A091491 002 Dec 14, 2010
AB 750MG A091491 003 Dec 14, 2010
AB 1GM A091491 004 Dec 14, 2010
AB ZYDUS PHARMS USA 250MG A078918 001 Apr 29, 2009
INC
AB 1GM A078918 002 Apr 29, 2009
TABLET, EXTENDED RELEASE;ORAL
KEPPRA XR
AB + UCB INC 500MG N022285 001 Sep 12, 2008
AB +! 750MG N022285 002 Feb 12, 2009
LEVETIRACETAM
AB ACTAVIS LABS FL INC 500MG A091093 001 Sep 12, 2011
AB 750MG A091093 002 Sep 12, 2011
AB AIPING PHARM INC 500MG A204754 001 Aug 26, 2016
AB 750MG A204754 002 Aug 26, 2016
AB ANCHEN PHARMS 500MG A091360 001 Oct 04, 2011
AB 750MG A091360 002 Oct 04, 2011
AB ANDA REPOSITORY 500MG A204511 001 Feb 23, 2016
AB 750MG A204511 002 Feb 23, 2016
AB APOTEX INC 500MG A091261 001 Sep 12, 2011
AB 750MG A091261 002 Sep 12, 2011
AB HISUN PHARM 500MG A207175 001 Sep 28, 2017
HANGZHOU
AB 750MG A207175 002 Sep 28, 2017
AB LUPIN LTD 500MG A091399 001 Sep 12, 2011
AB 750MG A091399 002 Sep 12, 2011
AB OVERSEAS 750MG A212688 001 Jun 11, 2020
AB PHARMADAX INC 500MG A201464 001 May 25, 2012
AB 750MG A201464 002 May 25, 2012
AB PRINSTON INC 500MG A202533 001 Jul 20, 2012
AB 500MG A203468 001 May 21, 2015
AB 750MG A202533 002 Jul 20, 2012
AB 750MG A203468 002 May 21, 2015
AB SCIEGEN PHARMS INC 500MG A205130 001 Nov 27, 2020
AB 750MG A205130 002 Nov 27, 2020
AB SUN PHARM 500MG A203059 001 Sep 09, 2013
AB 750MG A203059 002 Sep 09, 2013
ELEPSIA XR
+ TRIPOINT 1GM N204417 001 Dec 20, 2018
+! 1.5GM N204417 002 Dec 20, 2018
LEVETIRACETAM
APOTEX 1GM A202958 001 Feb 25, 2015
TABLET, FOR SUSPENSION;ORAL
SPRITAM
+ APRECIA PHARMS 250MG N207958 001 Jul 31, 2015
+ 500MG N207958 002 Jul 31, 2015
+ 750MG N207958 003 Jul 31, 2015
+! 1GM N207958 004 Jul 31, 2015
LEVOBUNOLOL HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
BETAGAN
AT +! ALLERGAN 0.5% N019219 002 Dec 19, 1985
LEVOBUNOLOL HYDROCHLORIDE
AT BAUSCH AND LOMB 0.5% A074326 001 Mar 04, 1994
LEVOCARNITINE
INJECTABLE;INJECTION
CARNITOR
AP +! LEADIANT BIOSCI INC 200MG/ML N020182 001 Dec 16, 1992
LEVOCARNITINE
AP AM REGENT 200MG/ML A075861 001 Jun 22, 2001
AP HIKMA 200MG/ML A075567 001 Mar 29, 2001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-269(of 474)

LEVOCARNITINE
SOLUTION;ORAL
CARNITOR
AA +! LEADIANT BIOSCI INC 1GM/10ML N019257 001 Apr 10, 1986
CARNITOR SF
AA + LEADIANT BIOSCI INC 1GM/10ML N019257 002 Mar 28, 2007
LEVOCARNITINE
AA AKORN 1GM/10ML A077399 001 Oct 25, 2007
AA LYNE 1GM/10ML A076851 001 Aug 10, 2004
AA NOVITIUM PHARMA 1GM/10ML A211676 001 Aug 14, 2019
AA SAPTALIS PHARMS 1GM/10ML A212533 001 Nov 10, 2021
LEVOCARNITINE SF
AA NOVITIUM PHARMA 1GM/10ML A211676 002 Aug 14, 2019
TABLET;ORAL
CARNITOR
AB +! LEADIANT BIOSCI INC 330MG N018948 001 Dec 27, 1985
LEVOCARNITINE
AB NOVITIUM PHARMA 330MG A216384 001 Dec 09, 2022
AB RISING 330MG A076858 001 Sep 20, 2004
LEVOCETIRIZINE DIHYDROCHLORIDE
SOLUTION;ORAL
LEVOCETIRIZINE DIHYDROCHLORIDE
AA CHARTWELL MOLECULAR 2.5MG/5ML A204599 001 May 15, 2017
AA ! PADAGIS US 2.5MG/5ML A091263 001 Nov 07, 2011
AA TARO PHARM INDS LTD 2.5MG/5ML A202673 001 Jul 26, 2013
LEVOCETIRIZINE HYDROCHLORIDE
AA HETERO LABS LTD III 2.5MG/5ML A210914 001 Apr 01, 2019
TABLET;ORAL
LEVOCETIRIZINE DIHYDROCHLORIDE
AB DR REDDYS LABS LTD 5MG A090392 001 Feb 24, 2011
AB ! GLENMARK GENERICS 5MG A090385 001 Feb 24, 2011
AB HETERO LABS LTD III 5MG A091264 001 Jun 29, 2012
AB MACLEODS PHARMS LTD 5MG A205564 001 Jan 11, 2016
AB MICRO LABS LTD 5MG A202046 001 Sep 17, 2013
INDIA
AB SCIEGEN PHARMS INC 5MG A203646 001 Sep 09, 2014
AB SUN PHARM 5MG A090362 001 Jan 31, 2013
AB SYNTHON PHARMS 5MG A090229 001 Nov 26, 2010
AB TEVA PHARMS 5MG A090199 001 Aug 22, 2011
LEVODOPA
POWDER;INHALATION
INBRIJA
+! ACORDA 42MG N209184 001 Dec 21, 2018
LEVOFLOXACIN
INJECTABLE;INJECTION
LEVOFLOXACIN
AP ! AKORN EQ 500MG/20ML (EQ 25MG/ML) A091644 001 Jun 20, 2011
AP ! EQ 750MG/30ML (EQ 25MG/ML) A091644 002 Jun 20, 2011
AP BAXTER HLTHCARE EQ 500MG/20ML (EQ 25MG/ML) A091436 001 Jun 05, 2013
CORP
AP GLAND PHARMA LTD EQ 500MG/20ML (EQ 25MG/ML) A205540 001 Apr 22, 2020
AP EQ 750MG/30ML (EQ 25MG/ML) A205540 002 Apr 22, 2020
LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
AP BAXTER HLTHCARE EQ 250MG/50ML (EQ 5MG/ML) A091397 001 Aug 08, 2013
CORP
AP EQ 500MG/100ML (EQ 5MG/ML) A091397 002 Aug 08, 2013
AP EQ 750MG/150ML (EQ 5MG/ML) A091397 003 Aug 08, 2013
AP FRESENIUS KABI USA EQ 250MG/50ML (EQ 5MG/ML) A200674 001 Jun 19, 2013
AP EQ 500MG/100ML (EQ 5MG/ML) A200674 002 Jun 19, 2013
AP EQ 750MG/150ML (EQ 5MG/ML) A200674 003 Jun 19, 2013
AP GLAND PHARMA LTD EQ 250MG/50ML (EQ 5MG/ML) A206908 001 Dec 30, 2020
AP EQ 500MG/100ML (EQ 5MG/ML) A206908 002 Dec 30, 2020
AP EQ 750MG/150ML (EQ 5MG/ML) A206908 003 Dec 30, 2020
AP HIKMA FARMACEUTICA EQ 250MG/50ML (EQ 5MG/ML) A091375 001 Sep 16, 2011
AP EQ 500MG/100ML (EQ 5MG/ML) A091375 002 Sep 16, 2011
AP EQ 750MG/150ML (EQ 5MG/ML) A091375 003 Sep 16, 2011
AP HOSPIRA EQ 250MG/50ML (EQ 5MG/ML) A078579 001 Sep 03, 2015
AP EQ 500MG/100ML (EQ 5MG/ML) A078579 002 Sep 03, 2015
AP EQ 750MG/150ML (EQ 5MG/ML) A078579 003 Sep 03, 2015
AP ! INFORLIFE EQ 250MG/50ML (EQ 5MG/ML) A090343 001 Jul 07, 2011
AP ! EQ 500MG/100ML (EQ 5MG/ML) A090343 002 Jul 07, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-270(of 474)

LEVOFLOXACIN
INJECTABLE;INJECTION
LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
AP ! EQ 750MG/150ML (EQ 5MG/ML) A090343 003 Jul 07, 2011
SOLUTION;ORAL
LEVOFLOXACIN
AA ! AKORN 250MG/10ML A091678 001 Jun 20, 2011
AA LANNETT CO INC 250MG/10ML A205222 001 May 25, 2018
SOLUTION/DROPS;OPHTHALMIC
LEVOFLOXACIN
AT AKORN 0.5% A090268 001 Dec 20, 2010
AT ! RISING 0.5% A077700 001 Dec 20, 2010
MICRO LABS LTD 1.5% A205600 001 Feb 27, 2019
INDIA
TABLET;ORAL
LEVOFLOXACIN
AB APOTEX INC 250MG A090787 001 Sep 29, 2011
AB 500MG A090787 002 Sep 29, 2011
AB 750MG A090787 003 Sep 29, 2011
AB AUROBINDO PHARMA 250MG A201043 001 Jun 20, 2011
LTD
AB 500MG A201043 002 Jun 20, 2011
AB ! 750MG A201043 003 Jun 20, 2011
AB CADILA 250MG A077652 001 Sep 07, 2012
AB 500MG A077652 002 Sep 07, 2012
AB 750MG A077652 003 Sep 07, 2012
AB CELLTRION 250MG A090367 001 Jun 20, 2011
AB 500MG A090367 002 Jun 20, 2011
AB 750MG A090367 003 Jun 20, 2011
AB CHARTWELL MOLECULAR 250MG A076890 001 Mar 30, 2012
AB 500MG A076890 002 Mar 30, 2012
AB 750MG A076890 003 Mar 30, 2012
AB DR REDDYS LABS INC 250MG A076710 001 Jun 20, 2011
AB 500MG A076710 002 Jun 20, 2011
AB 750MG A076710 003 Jun 20, 2011
AB GLENMARK GENERICS 250MG A200250 001 Jun 20, 2011
AB 500MG A200250 002 Jun 20, 2011
AB 750MG A200250 003 Jun 20, 2011
AB HEC PHARM 250MG A204968 001 Feb 05, 2019
AB 500MG A204968 002 Feb 05, 2019
AB 750MG A204968 003 Feb 05, 2019
AB HETERO LABS LTD V 250MG A202801 001 Jan 08, 2015
AB 500MG A202801 002 Jan 08, 2015
AB 750MG A202801 003 Jan 08, 2015
AB LUPIN 250MG A078424 001 Jun 20, 2011
AB 500MG A078424 002 Jun 20, 2011
AB 750MG A078424 003 Jun 20, 2011
AB MACLEODS PHARMS LTD 250MG A200839 001 Mar 22, 2012
AB 500MG A200839 002 Mar 22, 2012
AB 750MG A200839 003 Mar 22, 2012
AB ORBION PHARMS 250MG A202200 001 Jan 30, 2012
AB 500MG A202200 002 Jan 30, 2012
AB 750MG A202200 003 Jan 30, 2012
AB SANDOZ 250MG A077438 001 Jun 20, 2011
AB 500MG A077438 002 Jun 20, 2011
AB 750MG A077438 003 Jun 20, 2011
AB TEVA 250MG A076361 001 Jun 20, 2011
AB 500MG A076361 002 Jun 20, 2011
AB 750MG A076361 003 Jun 20, 2011
LEVOKETOCONAZOLE
TABLET;ORAL
RECORLEV
+! STRONGBRIDGE 150MG N214133 001 Dec 30, 2021
LEVOLEUCOVORIN
POWDER;INTRAVENOUS
KHAPZORY
+! ACROTECH BIOPHARMA 175MG/VIAL N211226 001 Oct 19, 2018
+! 300MG/VIAL N211226 002 Oct 19, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-271(of 474)

LEVOLEUCOVORIN CALCIUM
POWDER;INTRAVENOUS
FUSILEV
AP +! ACROTECH BIOPHARMA EQ 50MG BASE/VIAL N020140 001 Mar 07, 2008
LEVOLEUCOVORIN CALCIUM
AP MEITHEAL EQ 50MG BASE/VIAL A211003 001 Aug 22, 2019
SOLUTION;INTRAVENOUS
LEVOLEUCOVORIN CALCIUM
AP AMNEAL EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) A207548 001 Sep 08, 2017
AP GLAND PHARMA LTD EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) A210892 001 Sep 14, 2018
AP ! MEITHEAL EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) A211002 001 Aug 16, 2019
AP SANDOZ INC EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) A203563 001 Mar 09, 2015
! GLAND PHARMA LTD EQ 250MG BASE/25ML (EQ 10MG BASE/ML) A210892 002 Sep 14, 2018
LEVOMILNACIPRAN HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
FETZIMA
AB + ALLERGAN EQ 20MG BASE N204168 001 Jul 25, 2013
AB + EQ 40MG BASE N204168 002 Jul 25, 2013
AB + EQ 80MG BASE N204168 003 Jul 25, 2013
AB +! EQ 120MG BASE N204168 004 Jul 25, 2013
LEVOMILNACIPRAN HYDROCHLORIDE
AB AUROBINDO PHARMA EQ 20MG BASE A210826 001 Jan 06, 2023
LTD
AB EQ 40MG BASE A210826 002 Jan 06, 2023
AB EQ 80MG BASE A210826 003 Jan 06, 2023
AB EQ 120MG BASE A210826 004 Jan 06, 2023
LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
INJECTABLE;INJECTION
SCANDONEST L
! DEPROCO 0.05MG/ML;2% A088388 001 Oct 10, 1984
LEVONORGESTREL
INTRAUTERINE DEVICE;INTRAUTERINE
KYLEENA
+! BAYER HLTHCARE 19.5MG N208224 001 Sep 16, 2016
LILETTA
+! MEDICINES360 52MG N206229 001 Feb 26, 2015
MIRENA
+! BAYER HLTHCARE 52MG N021225 001 Dec 06, 2000
SKYLA
+! BAYER HLTHCARE 13.5MG N203159 001 Jan 09, 2013
LEVORPHANOL TARTRATE
TABLET;ORAL
LEVORPHANOL TARTRATE
AB NOVITIUM PHARMA 2MG A213479 001 Jul 01, 2020
AB SPECGX LLC 2MG A212024 001 Dec 13, 2019
AB SUN PHARM INDS INC 2MG A213906 001 Jun 17, 2021
AB VIRTUS PHARMS 2MG A211484 001 Dec 13, 2018
NOVITIUM PHARMA 1MG A213479 003 Jul 20, 2021
! 3MG A213479 002 Jan 12, 2021
LEVOTHYROXINE SODIUM
CAPSULE;ORAL
LEVOTHYROXINE SODIUM
AB TEVA PHARMS USA INC 0.2MG A211369 004 Nov 09, 2022
TIROSINT
AB +! INSTITUT 0.2MG N021924 012 Apr 25, 2017
BIOCHIMIQUE
+ 0.013MG N021924 013 Aug 01, 2007
+ 0.025MG N021924 002 Oct 13, 2006
+ 0.0375MG N021924 014 Jun 22, 2022
+ 0.044MG N021924 015 Jun 22, 2022
+ 0.05MG N021924 003 Oct 13, 2006
+ 0.0625MG N021924 016 Jun 22, 2022
+ 0.075MG N021924 004 Oct 13, 2006
+ 0.088MG N021924 010 Oct 02, 2009
+ 0.1MG N021924 005 Oct 13, 2006
+ 0.112MG N021924 008 Oct 02, 2009
+ 0.125MG N021924 006 Oct 13, 2006
+ 0.137MG N021924 009 Oct 02, 2009
+ 0.15MG N021924 007 Oct 13, 2006
+ 0.175MG N021924 011 Apr 25, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-272(of 474)

LEVOTHYROXINE SODIUM
POWDER;INTRAVENOUS
LEVOTHYROXINE SODIUM
AP +! FRESENIUS KABI USA 100MCG/VIAL N202231 001 Jun 24, 2011
AP +! 200MCG/VIAL N202231 002 Jun 24, 2011
AP +! 500MCG/VIAL N202231 003 Jun 24, 2011
AP MAIA PHARMS INC 100MCG/VIAL A208749 001 Dec 21, 2018
AP 200MCG/VIAL A208749 002 Dec 21, 2018
AP 500MCG/VIAL A208749 003 Dec 21, 2018
AP PIRAMAL CRITICAL 100MCG/VIAL A206163 001 Jun 29, 2016
AP 500MCG/VIAL A206163 002 Jun 29, 2016
SOLUTION;INTRAVENOUS
LEVOTHYROXINE SODIUM
+! FRESENIUS KABI USA 100MCG/5ML (20MCG/ML) N210632 001 Apr 11, 2019
+! 200MCG/5ML (40MCG/ML) N210632 002 Apr 11, 2019
+! 500MCG/5ML (100MCG/ML) N210632 003 Apr 11, 2019
+! HIKMA 100MCG/ML N214253 001 May 17, 2021
SOLUTION;ORAL
ERMEZA
+! MYLAN 150MCG/5ML N215809 001 Apr 29, 2022
THYQUIDITY
+! AZURITY 100MCG/5ML N214047 001 Nov 30, 2020
TIROSINT-SOL
+ INSTITUT 13MCG/ML N206977 001 Dec 15, 2016
BIOCHIMIQUE
+ 25MCG/ML N206977 002 Dec 15, 2016
+ 37.5MCG/ML N206977 013 Jan 13, 2021
+ 44MCG/ML N206977 014 Jan 13, 2021
+ 50MCG/ML N206977 003 Dec 15, 2016
+ 62.5MCG/ML N206977 015 Jan 13, 2021
+ 75MCG/ML N206977 004 Dec 15, 2016
+ 88MCG/ML N206977 005 Dec 15, 2016
+ 100MCG/ML N206977 006 Dec 15, 2016
+ 112MCG/ML N206977 007 Dec 15, 2016
+ 125MCG/ML N206977 008 Dec 15, 2016
+ 137MCG/ML N206977 009 Dec 15, 2016
+ 150MCG/ML N206977 010 Dec 15, 2016
+ 175MCG/ML N206977 011 Dec 15, 2016
+! 200MCG/ML N206977 012 Dec 15, 2016
LEVOTHYROXINE SODIUM **
**See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL
LEVOTHYROXINE SODIUM
--> MACLEODS PHARMS LTD --> AB1,AB2 0.025MG A211417 001 Dec 21, 2022
--> --> AB1,AB2 0.05MG A211417 002 Dec 21, 2022
--> --> AB1,AB2 0.075MG A211417 003 Dec 21, 2022
--> --> AB1,AB2 0.088MG A211417 004 Dec 21, 2022
--> --> AB1,AB2 0.1MG A211417 005 Dec 21, 2022
--> --> AB1,AB2 0.112MG A211417 006 Dec 21, 2022
--> --> AB1,AB2 0.125MG A211417 007 Dec 21, 2022
--> --> AB1,AB2 0.137MG A211417 008 Dec 21, 2022
--> --> AB1,AB2 0.15MG A211417 009 Dec 21, 2022
--> --> AB1,AB2 0.175MG A211417 010 Dec 21, 2022
--> --> AB1,AB2 0.2MG A211417 011 Dec 21, 2022
--> --> AB1,AB2 0.3MG A211417 012 Dec 21, 2022
SYNTHROID
--> + ABBVIE --> AB1,AB2 0.025MG N021402 001 Jul 24, 2002
--> + --> AB1,AB2 0.05MG N021402 002 Jul 24, 2002
--> + --> AB1,AB2 0.075MG N021402 003 Jul 24, 2002
--> + --> AB1,AB2 0.088MG N021402 004 Jul 24, 2002
--> + --> AB1,AB2 0.1MG N021402 005 Jul 24, 2002
--> + --> AB1,AB2 0.112MG N021402 006 Jul 24, 2002
--> + --> AB1,AB2 0.125MG N021402 007 Jul 24, 2002
--> + --> AB1,AB2 0.137MG N021402 008 Jul 24, 2002
--> + --> AB1,AB2 0.15MG N021402 009 Jul 24, 2002
--> + --> AB1,AB2 0.175MG N021402 010 Jul 24, 2002
--> + --> AB1,AB2 0.2MG N021402 012 Jul 24, 2002
--> +! --> AB1,AB2 0.3MG N021402 011 Jul 24, 2002
LEVO-T
--> CEDIPROF INC --> AB1,AB2,AB3 0.025MG N021342 001 Mar 01, 2002

--> --> AB1,AB2, 0.05MG N021342 002 Mar 01, 2002


43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-273(of 474)

LEVOTHYROXINE SODIUM **
**See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL
LEVO-T
AB3 0.05MG
--> --> AB1,AB2,AB3 0.075MG N021342 003 Mar 01, 2002

--> --> AB1,AB2,AB3 0.088MG N021342 004 Mar 01, 2002

--> --> AB1,AB2,AB3 0.1MG N021342 005 Mar 01, 2002

--> --> AB1,AB2,AB3 0.112MG N021342 006 Mar 01, 2002

--> --> AB1,AB2,AB3 0.125MG N021342 007 Mar 01, 2002

--> --> AB1,AB2,AB3 0.137MG N021342 012 Dec 08, 2003

--> --> AB1,AB2,AB3 0.15MG N021342 008 Mar 01, 2002

--> --> AB1,AB2,AB3 0.175MG N021342 009 Mar 01, 2002

--> --> AB1,AB2,AB3 0.2MG N021342 010 Mar 01, 2002

--> --> AB1,AB2,AB3 0.3MG N021342 011 Mar 01, 2002

LEVOTHYROXINE SODIUM
--> LUPIN --> AB1,AB2,AB3 0.025MG A209713 001 Jan 18, 2019

--> --> AB1,AB2,AB3 0.05MG A209713 002 Jan 18, 2019

--> --> AB1,AB2,AB3 0.075MG A209713 003 Jan 18, 2019

--> --> AB1,AB2,AB3 0.088MG A209713 004 Jan 18, 2019

--> --> AB1,AB2,AB3 0.1MG A209713 005 Jan 18, 2019

--> --> AB1,AB2,AB3 0.112MG A209713 006 Jan 18, 2019

--> --> AB1,AB2,AB3 0.125MG A209713 007 Jan 18, 2019

--> --> AB1,AB2,AB3 0.137MG A209713 008 Jan 18, 2019

--> --> AB1,AB2,AB3 0.15MG A209713 009 Jan 18, 2019

--> --> AB1,AB2,AB3 0.175MG A209713 010 Jan 18, 2019

--> --> AB1,AB2,AB3 0.2MG A209713 011 Jan 18, 2019

--> --> AB1,AB2,AB3 0.3MG A209713 012 Jan 18, 2019

UNITHROID
--> + STEVENS J --> AB1,AB2,AB3 0.025MG N021210 001 Aug 21, 2000

--> + --> AB1,AB2,AB3 0.05MG N021210 002 Aug 21, 2000

--> + --> AB1,AB2,AB3 0.075MG N021210 003 Aug 21, 2000

--> + --> AB1,AB2,AB3 0.088MG N021210 004 Aug 21, 2000

--> + --> AB1,AB2,AB3 0.1MG N021210 005 Aug 21, 2000

--> + --> AB1,AB2,AB3 0.112MG N021210 006 Aug 21, 2000

--> + --> AB1,AB2,AB3 0.125MG N021210 007 Aug 21, 2000

--> + --> AB1,AB2,AB3 0.137MG N021210 012 Feb 08, 2008

--> + --> AB1,AB2,AB3 0.15MG N021210 008 Aug 21, 2000

--> + --> AB1,AB2,AB3 0.175MG N021210 009 Aug 21, 2000

--> + --> AB1,AB2,AB3 0.2MG N021210 010 Aug 21, 2000

--> +! --> AB1,AB2,AB3 0.3MG N021210 011 Aug 21, 2000

LEVOLET
--> GENUS LIFESCIENCES --> 0.025MG N021137 001 Jun 06, 2003
AB1,AB2,AB3,AB4
--> --> AB1,AB2, 0.05MG N021137 002 Jun 06, 2003
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-274(of 474)

LEVOTHYROXINE SODIUM **
**See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL
LEVOLET
AB3,AB4 0.05MG
--> --> 0.075MG N021137 003 Jun 06, 2003
AB1,AB2,AB3,AB4
--> --> 0.088MG N021137 004 Jun 06, 2003
AB1,AB2,AB3,AB4
--> --> 0.1MG N021137 005 Jun 06, 2003
AB1,AB2,AB3,AB4
--> --> 0.112MG N021137 006 Jun 06, 2003
AB1,AB2,AB3,AB4
--> --> 0.125MG N021137 007 Jun 06, 2003
AB1,AB2,AB3,AB4
--> --> 0.137MG N021137 008 Jun 06, 2003
AB1,AB2,AB3,AB4
--> --> 0.15MG N021137 009 Jun 06, 2003
AB1,AB2,AB3,AB4
--> --> 0.175MG N021137 010 Jun 06, 2003
AB1,AB2,AB3,AB4
--> --> 0.2MG N021137 011 Jun 06, 2003
AB1,AB2,AB3,AB4
--> --> 0.3MG N021137 012 Jun 06, 2003
AB1,AB2,AB3,AB4
LEVOTHYROXINE SODIUM
--> ACCORD HLTHCARE --> 0.025MG A212399 001 Oct 19, 2020
AB1,AB2,AB3,AB4
--> --> 0.05MG A212399 002 Oct 19, 2020
AB1,AB2,AB3,AB4
--> --> 0.075MG A212399 003 Oct 19, 2020
AB1,AB2,AB3,AB4
--> --> 0.088MG A212399 004 Oct 19, 2020
AB1,AB2,AB3,AB4
--> --> 0.1MG A212399 005 Oct 19, 2020
AB1,AB2,AB3,AB4
--> --> 0.112MG A212399 006 Oct 19, 2020
AB1,AB2,AB3,AB4
--> --> 0.125MG A212399 007 Oct 19, 2020
AB1,AB2,AB3,AB4
--> --> 0.137MG A212399 008 Oct 19, 2020
AB1,AB2,AB3,AB4
--> --> 0.15MG A212399 009 Oct 19, 2020
AB1,AB2,AB3,AB4
--> --> 0.175MG A212399 010 Oct 19, 2020
AB1,AB2,AB3,AB4
--> --> 0.2MG A212399 011 Oct 19, 2020
AB1,AB2,AB3,AB4
--> --> 0.3MG A212399 012 Oct 19, 2020
AB1,AB2,AB3,AB4
--> MYLAN --> 0.025MG A076187 001 Jun 05, 2002
AB1,AB2,AB3,AB4
--> --> 0.05MG A076187 002 Jun 05, 2002
AB1,AB2,AB3,AB4
--> --> 0.075MG A076187 003 Jun 05, 2002
AB1,AB2,AB3,AB4
--> --> 0.088MG A076187 004 Jun 05, 2002
AB1,AB2,AB3,AB4
--> --> 0.1MG A076187 005 Jun 05, 2002
AB1,AB2,AB3,AB4
--> --> 0.112MG A076187 006 Jun 05, 2002
AB1,AB2,AB3,AB4
--> --> 0.125MG A076187 007 Jun 05, 2002
AB1,AB2,AB3,AB4
--> --> 0.137MG A076187 012 Dec 13, 2006
AB1,AB2,AB3,AB4
--> --> 0.15MG A076187 008 Jun 05, 2002
AB1,AB2,AB3,AB4
--> --> 0.175MG A076187 009 Jun 05, 2002
AB1,AB2,AB3,AB4
--> --> 0.2MG A076187 010 Jun 05, 2002
AB1,AB2,AB3,AB4
--> ! --> 0.3MG A076187 011 Jun 05, 2002
AB1,AB2,AB3,AB4
THYRO-TABS
--> + ALVOGEN --> 0.025MG N021116 001 Oct 24, 2002
AB1,AB2,AB3,AB4
--> + --> 0.05MG N021116 002 Oct 24, 2002
AB1,AB2,AB3,AB4
--> + --> AB1,AB2, 0.075MG N021116 003 Oct 24, 2002
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-275(of 474)

LEVOTHYROXINE SODIUM **
**See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL
THYRO-TABS
AB3,AB4 0.075MG
--> + --> 0.088MG N021116 010 Oct 24, 2002
AB1,AB2,AB3,AB4
--> + --> 0.1MG N021116 004 Oct 24, 2002
AB1,AB2,AB3,AB4
--> + --> 0.112MG N021116 011 Oct 24, 2002
AB1,AB2,AB3,AB4
--> + --> 0.125MG N021116 005 Oct 24, 2002
AB1,AB2,AB3,AB4
--> + --> 0.137MG N021116 012 Dec 07, 2004
AB1,AB2,AB3,AB4
--> + --> 0.15MG N021116 006 Oct 24, 2002
AB1,AB2,AB3,AB4
--> + --> 0.175MG N021116 007 Oct 24, 2002
AB1,AB2,AB3,AB4
--> + --> 0.2MG N021116 008 Oct 24, 2002
AB1,AB2,AB3,AB4
--> + --> 0.3MG N021116 009 Oct 24, 2002
AB1,AB2,AB3,AB4
LEVOXYL
--> + KING PHARMS --> AB1,AB3 0.025MG N021301 001 May 25, 2001
--> + --> AB1,AB3 0.05MG N021301 002 May 25, 2001
--> + --> AB1,AB3 0.075MG N021301 003 May 25, 2001
--> + --> AB1,AB3 0.088MG N021301 004 May 25, 2001
--> + --> AB1,AB3 0.1MG N021301 005 May 25, 2001
--> + --> AB1,AB3 0.112MG N021301 006 May 25, 2001
--> + --> AB1,AB3 0.125MG N021301 007 May 25, 2001
--> + --> AB1,AB3 0.137MG N021301 008 May 25, 2001
--> + --> AB1,AB3 0.15MG N021301 009 May 25, 2001
--> + --> AB1,AB3 0.175MG N021301 010 May 25, 2001
--> +! --> AB1,AB3 0.2MG N021301 011 May 25, 2001
EUTHYROX
AB2 PROVELL 0.025MG N021292 001 May 31, 2002
AB2 0.05MG N021292 002 May 31, 2002
AB2 0.075MG N021292 003 May 31, 2002
AB2 0.088MG N021292 004 May 31, 2002
AB2 0.1MG N021292 005 May 31, 2002
AB2 0.112MG N021292 006 May 31, 2002
AB2 0.125MG N021292 007 May 31, 2002
AB2 0.137MG N021292 008 May 31, 2002
AB2 0.15MG N021292 009 May 31, 2002
AB2 0.175MG N021292 010 May 31, 2002
AB2 0.2MG N021292 011 May 31, 2002
LEVOTHYROXINE SODIUM
AB2 WATSON LABS TEVA 0.025MG A207588 001 May 10, 2022
AB2 0.05MG A207588 002 May 10, 2022
AB2 0.075MG A207588 003 May 10, 2022
AB2 0.088MG A207588 004 May 10, 2022
AB2 0.1MG A207588 005 May 10, 2022
AB2 0.112MG A207588 006 May 10, 2022
AB2 0.125MG A207588 007 May 10, 2022
AB2 0.137MG A207588 008 May 10, 2022
AB2 0.15MG A207588 009 May 10, 2022
AB2 0.175MG A207588 010 May 10, 2022
AB2 0.2MG A207588 011 May 10, 2022
AB2 0.3MG A207588 012 May 10, 2022
LIDOCAINE
OINTMENT;TOPICAL
LIDOCAINE
AT ALEOR 5% A211469 001 Nov 23, 2018
DERMACEUTICALS
AT ALKEM LABS LTD 5% A207810 001 Mar 10, 2017
AT AMNEAL PHARMS 5% A206297 001 Aug 07, 2015
AT COSETTE 5% A211019 001 Dec 12, 2018
AT DR REDDYS 5% A208660 001 Jan 05, 2021
AT +! FOUGERA PHARMS INC 5% A080198 001
AT GLENMARK PHARMS LTD 5% A206498 001 Sep 09, 2016
AT MACLEODS PHARMS LTD 5% A211697 001 Mar 16, 2020
AT PAI HOLDINGS PHARM 5% A205318 001 Feb 01, 2016
AT QUAGEN 5% A212695 001 Apr 20, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-276(of 474)

LIDOCAINE
OINTMENT;TOPICAL
LIDOCAINE
AT SEPTODONT INC 5% A040911 001 May 23, 2011
AT STRIDES PHARMA 5% A210958 001 Dec 11, 2018
AT TARO 5% A086724 001
AT VITRUVIAS THERAP 5% A208822 001 Sep 25, 2017
PATCH;TOPICAL
LIDOCAINE
AB ACTAVIS LABS UT INC 5% A200675 001 Aug 23, 2012
AB AMNEAL 5% A206463 001 Aug 24, 2020
AB MYLAN TECHNOLOGIES 5% A202346 001 Aug 07, 2015
AB NAL PHARM 5% A205882 001 Apr 29, 2021
AB RHODES PHARMS 5% A209190 001 Apr 30, 2020
LIDODERM
AB +! TEIKOKU PHARMA USA 5% N020612 001 Mar 19, 1999
ZTLIDO
+! SCILEX PHARMS 1.8% N207962 001 Feb 28, 2018
LIDOCAINE HYDROCHLORIDE
GEL;OPHTHALMIC
AKTEN
+! THEA PHARMA 3.5% N022221 001 Oct 07, 2008
INJECTABLE;INJECTION
LIDOCAINE HYDROCHLORIDE
AP AFAXYS 1% A215132 001 Jun 09, 2022
AP ASPIRO 1% A214336 001 Nov 08, 2021
AP 1% A214339 001 Nov 08, 2021
AP 2% A214339 002 Nov 08, 2021
AP B BRAUN MEDICAL INC 1% A208474 001 Aug 03, 2018
AP EUGIA PHARMA 1% A207182 001 Oct 30, 2017
AP 2% A207182 002 Oct 30, 2017
AP FRESENIUS KABI USA 1% A080404 002
AP 2% A080404 003
AP HOSPIRA 0.5% A088328 001 May 17, 1984
AP ! 1% A083158 001
AP 1% A088329 001 May 17, 1984
AP 2% A040078 001 Jun 23, 1995
AP ! 2% A083158 002
AP 2% A088294 001 May 17, 1984
AP HUONS 1% A212821 001 May 07, 2020
AP INTL MEDICATION 1% A083173 001
AP 2% A083173 002
AP SINTETICA US 1% A214267 001 Sep 19, 2022
AP 2% A214267 002 Sep 19, 2022
AP 4% A214269 001 May 05, 2022
AP SPECTRA MDCL 1% A208017 001 Apr 18, 2018
DEVICES
AP WEST-WARD PHARMS 1% A080407 001
INT
AP 2% A080407 002
LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
AP B BRAUN 200MG/100ML N019830 002 Apr 08, 1992
AP BAXTER HLTHCARE 200MG/100ML N018461 002
LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
AP B BRAUN 400MG/100ML N019830 003 Apr 08, 1992
AP BAXTER HLTHCARE 400MG/100ML N018461 003
LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER
AP B BRAUN 800MG/100ML N019830 004 Apr 08, 1992
AP BAXTER HLTHCARE 800MG/100ML N018461 004 Feb 22, 1982
LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER
AP FRESENIUS KABI USA 1% A088586 001 Jul 24, 1985
AP HOSPIRA 0.5% A088325 001 Jul 31, 1984
AP 1% A088299 001 Jul 31, 1984
AP 2% A088327 001 Jul 31, 1984
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
AP EUGIA PHARMA 1% A203040 001 Mar 14, 2013
AP 1% A203082 001 Mar 14, 2013
AP 2% A203040 002 Mar 14, 2013
AP 2% A203082 002 Mar 14, 2013
AP FRESENIUS KABI USA 2% N017584 001
AP 4% N017584 002
AP HOSPIRA 1% A080408 001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-277(of 474)

LIDOCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
AP 1.5% A080408 002
AP ! 4% A088295 001 May 17, 1984
AP WEST-WARD PHARMS 1% A084625 001
INT
AP 2% A084625 002
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER
AP HOSPIRA 1% A040302 001 Sep 28, 1998
AP 2% A040302 002 Sep 28, 1998
XYLOCAINE
AP +! FRESENIUS KABI USA 0.5% N006488 008
AP +! 1% N006488 007
AP +! 1.5% N006488 010
AP +! 2% N006488 002
INJECTABLE;SPINAL
LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%
+! HOSPIRA 5% A083914 001
JELLY;TOPICAL
GLYDO
AT SAGENT PHARMS INC 2% A201094 001 Apr 28, 2014
LIDOCAINE HYDROCHLORIDE
AT ! AKORN 2% A040433 001 Feb 12, 2003
AT INTL MEDICATION 2% A086283 001
SOLUTION;ORAL
LIDOCAINE HYDROCHLORIDE
AT ! AKORN 2% A040014 001 Jul 10, 1995
AT WOCKHARDT BIO AG 2% A087872 001 Nov 18, 1982
LIDOCAINE HYDROCHLORIDE VISCOUS
AT LANNETT CO INC 2% A040708 001 Feb 27, 2007
LIDOCAINE VISCOUS
AT HIKMA 2% A088802 001 Apr 26, 1985
SOLUTION;TOPICAL
LARYNG-O-JET KIT
AT INTL MEDICATION 4% A086364 001
LIDOCAINE HYDROCHLORIDE
AT ! HIKMA 4% A088803 001 Apr 03, 1985
AT LANNETT CO INC 4% A040710 001 Feb 27, 2007
AT NOVITIUM PHARMA 4% A216250 001 Mar 23, 2022
AT PAI HOLDINGS PHARM 4% A204494 001 Mar 12, 2014
AT WOCKHARDT BIO AG 4% A087881 001 Nov 18, 1982
SYSTEM;INTRADERMAL
ZINGO
POWDER PHARMS 0.5MG N022114 001 Aug 16, 2007
LIDOCAINE; PRILOCAINE
CREAM;TOPICAL
LIDOCAINE AND PRILOCAINE
AB ! AKORN 2.5%;2.5% A076290 001 Sep 25, 2003
AB ALEOR 2.5%;2.5% A213923 001 Apr 08, 2022
DERMACEUTICALS
AB ENCUBE 2.5%;2.5% A076320 001 Aug 27, 2003
AB FOUGERA PHARMS 2.5%;2.5% A076453 001 Aug 18, 2003
AB PADAGIS US 2.5%;2.5% A212482 001 Jul 27, 2021
AB PAI HOLDINGS PHARM 2.5%;2.5% A205887 001 Jun 29, 2018
GEL;PERIODONTAL
ORAQIX
+! DENTSPLY PHARM 2.5%;2.5% N021451 001 Dec 19, 2003
LIDOCAINE; TETRACAINE
CREAM;TOPICAL
PLIAGLIS
+! TARO PHARMS 7%;7% N021717 001 Jun 29, 2006
LIFITEGRAST
SOLUTION/DROPS;OPHTHALMIC
XIIDRA
+! NOVARTIS 5% N208073 001 Jul 11, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-278(of 474)

LINACLOTIDE
CAPSULE;ORAL
LINZESS
+! ALLERGAN 72MCG N202811 003 Jan 25, 2017
+! 145MCG N202811 001 Aug 30, 2012
+ 290MCG N202811 002 Aug 30, 2012
LINAGLIPTIN
TABLET;ORAL
LINAGLIPTIN
AB SUNSHINE 5MG A208335 001 Aug 31, 2021
TRADJENTA
AB +! BOEHRINGER 5MG N201280 001 May 02, 2011
INGELHEIM
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
TABLET;ORAL
JENTADUETO
AB + BOEHRINGER 2.5MG;500MG N201281 001 Jan 30, 2012
INGELHEIM
AB + 2.5MG;850MG N201281 002 Jan 30, 2012
AB +! 2.5MG;1GM N201281 003 Jan 30, 2012
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
AB SUNSHINE 2.5MG;500MG A208336 001 Aug 30, 2021
AB 2.5MG;850MG A208336 002 Aug 30, 2021
AB 2.5MG;1GM A208336 003 Aug 30, 2021
TABLET, EXTENDED RELEASE;ORAL
JENTADUETO XR
+ BOEHRINGER 2.5MG;1GM N208026 001 May 27, 2016
INGELHEIM
+! 5MG;1GM N208026 002 May 27, 2016
LINCOMYCIN HYDROCHLORIDE
INJECTABLE;INJECTION
LINCOCIN
AP +! PFIZER EQ 300MG BASE/ML N050317 001
LINCOMYCIN HYDROCHLORIDE
AP GLAND PHARMA LTD EQ 300MG BASE/ML A215657 001 Sep 26, 2022
AP HAINAN POLY EQ 300MG BASE/ML A216662 001 Dec 21, 2022
AP MICRO LABS EQ 300MG BASE/ML A215082 001 Nov 08, 2021
AP XGEN PHARMS EQ 300MG BASE/ML A201746 001 Jun 04, 2015
LINEZOLID
FOR SUSPENSION;ORAL
LINEZOLID
AB HETERO LABS 100MG/5ML A211813 001 Oct 31, 2022
AB HIKMA 100MG/5ML A200068 001 Jun 03, 2015
ZYVOX
AB +! PFIZER 100MG/5ML N021132 001 Apr 18, 2000
SOLUTION;INTRAVENOUS
LINEZOLID
AP EUGIA PHARMA 600MG/300ML (2MG/ML) A206917 001 Aug 04, 2016
AP FRESENIUS KABI USA 600MG/300ML (2MG/ML) A204764 001 Mar 15, 2016
AP HIKMA 600MG/300ML (2MG/ML) A206454 001 Aug 22, 2022
AP HQ SPCLT PHARMA 200MG/100ML (2MG/ML) A207001 001 Jul 07, 2017
AP 600MG/300ML (2MG/ML) A207001 002 Jul 07, 2017
AP MYLAN LABS LTD 200MG/100ML (2MG/ML) A205154 001 Dec 06, 2017
AP 600MG/300ML (2MG/ML) A205154 002 Dec 06, 2017
AP NANG KUANG PHARM CO 200MG/100ML (2MG/ML) A207354 001 Dec 20, 2016
AP 600MG/300ML (2MG/ML) A207354 002 Dec 20, 2016
AP SAGENT PHARMS INC 200MG/100ML (2MG/ML) A204696 001 Mar 02, 2017
AP 600MG/300ML (2MG/ML) A204696 002 Mar 02, 2017
AP SANDOZ INC 200MG/100ML (2MG/ML) A200904 001 Jul 16, 2015
AP 600MG/300ML (2MG/ML) A200904 002 Jul 16, 2015
ZYVOX
AP + PFIZER 200MG/100ML (2MG/ML) N021131 001 Apr 18, 2000
AP +! 600MG/300ML (2MG/ML) N021131 003 Apr 18, 2000
LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
+! HOSPIRA 600MG/300ML (2MG/ML) N206473 001 Jun 18, 2015
TABLET;ORAL
LINEZOLID
AB ALEMBIC PHARMS 600MG A205233 001 Dec 21, 2015
AB ALKEM LABS LTD 600MG A205517 001 Dec 21, 2015
AB CELLTRION 600MG A210702 001 Apr 25, 2019
AB GLENMARK PHARMS 600MG A078987 001 Dec 21, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-279(of 474)

LINEZOLID
TABLET;ORAL
LINEZOLID
AB HETERO LABS LTD V 600MG A204239 001 Dec 21, 2015
AB NOVEL LABS INC 600MG A207526 001 Aug 22, 2016
AB ZYDUS PHARMS 600MG A206097 001 Feb 22, 2017
ZYVOX
AB +! PFIZER 600MG N021130 002 Apr 18, 2000
LIOTHYRONINE SODIUM
INJECTABLE;INJECTION
LIOTHYRONINE SODIUM
AP XGEN PHARMS EQ 0.01MG BASE/ML A076923 001 Aug 17, 2005
TRIOSTAT
AP +! PAR STERILE EQ 0.01MG BASE/ML N020105 001 Dec 31, 1991
PRODUCTS
TABLET;ORAL
CYTOMEL
AB + KING PHARMS EQ 0.005MG BASE N010379 001
AB + EQ 0.025MG BASE N010379 002
AB + EQ 0.05MG BASE N010379 003
LIOTHYRONINE SODIUM
AB MAYNE PHARMA INC EQ 0.005MG BASE A090097 001 Mar 20, 2009
AB EQ 0.025MG BASE A090097 002 Mar 20, 2009
AB EQ 0.05MG BASE A090097 003 Mar 20, 2009
AB SIGMAPHARM LABS LLC EQ 0.005MG BASE A200295 001 Nov 29, 2012
AB EQ 0.025MG BASE A200295 002 Nov 29, 2012
AB ! EQ 0.05MG BASE A200295 003 Nov 29, 2012
AB SUN PHARM EQ 0.005MG BASE A091382 001 Apr 20, 2016
AB EQ 0.025MG BASE A091382 002 Apr 20, 2016
AB EQ 0.05MG BASE A091382 003 Apr 20, 2016
AB TEVA PHARMS USA EQ 0.005MG BASE A211510 001 Oct 26, 2018
AB EQ 0.025MG BASE A211510 002 Oct 26, 2018
AB EQ 0.05MG BASE A211510 003 Oct 26, 2018
AB ZYDUS EQ 0.005MG BASE A214803 001 Jan 22, 2021
AB EQ 0.025MG BASE A214803 002 Jan 22, 2021
AB EQ 0.05MG BASE A214803 003 Jan 22, 2021
LIRAGLUTIDE RECOMBINANT
SOLUTION;SUBCUTANEOUS
SAXENDA
+! NOVO 18MG/3ML (6MG/ML) N206321 001 Dec 23, 2014
VICTOZA
+! NOVO NORDISK INC 18MG/3ML (6MG/ML) N022341 001 Jan 25, 2010
LISDEXAMFETAMINE DIMESYLATE
CAPSULE;ORAL
VYVANSE
+ TAKEDA PHARMS USA 10MG N021977 007 Oct 30, 2014
+ 20MG N021977 004 Dec 10, 2007
+ 30MG N021977 001 Feb 23, 2007
+ 40MG N021977 005 Dec 10, 2007
+ 50MG N021977 002 Feb 23, 2007
+ 60MG N021977 006 Dec 10, 2007
+! 70MG N021977 003 Feb 23, 2007
TABLET, CHEWABLE;ORAL
VYVANSE
+ TAKEDA PHARMS USA 10MG N208510 001 Jan 28, 2017
+ 20MG N208510 002 Jan 28, 2017
+ 30MG N208510 003 Jan 28, 2017
+ 40MG N208510 004 Jan 28, 2017
+ 50MG N208510 005 Jan 28, 2017
+! 60MG N208510 006 Jan 28, 2017
LISINOPRIL
SOLUTION;ORAL
QBRELIS
+! AZURITY 1MG/ML N208401 001 Jul 29, 2016
TABLET;ORAL
LISINOPRIL
AB ACCORD HLTHCARE 2.5MG A202554 001 Jul 30, 2013
AB 5MG A202554 002 Jul 30, 2013
AB 10MG A202554 003 Jul 30, 2013
AB 20MG A202554 004 Jul 30, 2013
AB 30MG A202554 005 Jul 30, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-280(of 474)

LISINOPRIL
TABLET;ORAL
LISINOPRIL
AB 40MG A202554 006 Jul 30, 2013
AB ASCENT PHARMS INC 2.5MG A075903 001 Jul 01, 2002
AB 5MG A075903 002 Jul 01, 2002
AB 10MG A075903 003 Jul 01, 2002
AB 20MG A075903 004 Jul 01, 2002
AB 30MG A075903 005 Jul 01, 2002
AB 40MG A075903 006 Jul 01, 2002
AB AUROBINDO 2.5MG A077622 001 Feb 22, 2006
AB 5MG A077622 002 Feb 22, 2006
AB 10MG A077622 003 Feb 22, 2006
AB 20MG A077622 004 Feb 22, 2006
AB 30MG A077622 005 Feb 22, 2006
AB 40MG A077622 006 Feb 22, 2006
AB CHARTWELL RX 2.5MG A075994 001 Jul 01, 2002
AB 5MG A075994 002 Jul 01, 2002
AB 10MG A075994 003 Jul 01, 2002
AB 20MG A075994 004 Jul 01, 2002
AB 30MG A075994 005 Jul 01, 2002
AB 40MG A075994 006 Jul 01, 2002
AB COREPHARMA 2.5MG A076102 001 Sep 30, 2002
AB 5MG A076102 002 Sep 30, 2002
AB 10MG A076102 003 Sep 30, 2002
AB 20MG A076102 004 Sep 30, 2002
AB 30MG A076102 005 Sep 30, 2002
AB 40MG A076102 006 Sep 30, 2002
AB INVAGEN PHARMS 2.5MG A203508 001 Oct 29, 2013
AB 5MG A203508 002 Oct 29, 2013
AB 10MG A203508 003 Oct 29, 2013
AB 20MG A203508 004 Oct 29, 2013
AB 30MG A203508 005 Oct 29, 2013
AB 40MG A203508 006 Oct 29, 2013
AB LUPIN 2.5MG A077321 001 Sep 09, 2005
AB 5MG A077321 002 Sep 09, 2005
AB 10MG A077321 003 Sep 09, 2005
AB 20MG A077321 004 Sep 09, 2005
AB 30MG A077321 005 Sep 09, 2005
AB 40MG A077321 006 Sep 09, 2005
AB PRINSTON INC 2.5MG A075743 001 Jul 01, 2002
AB 2.5MG A076164 004 Jul 01, 2002
AB 5MG A075743 002 Jul 01, 2002
AB 5MG A076164 005 Jul 01, 2002
AB 10MG A075743 003 Jul 01, 2002
AB 10MG A076164 006 Jul 01, 2002
AB 20MG A075743 004 Jul 01, 2002
AB 20MG A076164 001 Jul 01, 2002
AB 30MG A075743 005 Jul 01, 2002
AB 30MG A076164 002 Jul 01, 2002
AB 40MG A075743 006 Jul 01, 2002
AB 40MG A076164 003 Jul 01, 2002
AB SUN PHARM INDS LTD 2.5MG A075944 001 Jul 01, 2002
AB 5MG A075944 002 Jul 01, 2002
AB 10MG A075944 003 Jul 01, 2002
AB 20MG A075944 004 Jul 01, 2002
AB 30MG A075944 006 Feb 11, 2003
AB 40MG A075944 005 Jul 01, 2002
AB WATSON LABS 2.5MG A076059 001 Jul 01, 2002
AB 5MG A076059 002 Jul 01, 2002
AB 10MG A076059 003 Jul 01, 2002
AB 20MG A076059 004 Jul 01, 2002
AB 30MG A076059 005 Jul 01, 2002
AB 40MG A076059 006 Jul 01, 2002
AB WOCKHARDT BIO AG 2.5MG A078402 001 Apr 19, 2007
AB 5MG A078402 002 Apr 19, 2007
AB 10MG A078402 003 Apr 19, 2007
AB 20MG A078402 004 Apr 19, 2007
AB 30MG A078402 005 Apr 19, 2007
AB 40MG A078402 006 Apr 19, 2007
AB YILING 2.5MG A212041 001 Sep 15, 2020
AB 5MG A212041 002 Sep 15, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-281(of 474)

LISINOPRIL
TABLET;ORAL
LISINOPRIL
AB 10MG A212041 003 Sep 15, 2020
AB 20MG A208920 001 Mar 04, 2021
AB 30MG A208920 002 Mar 04, 2021
AB 40MG A208920 003 Mar 04, 2021
ZESTRIL
AB + ALMATICA 2.5MG N019777 005 Apr 29, 1993
AB + 5MG N019777 001 May 19, 1988
AB + 10MG N019777 002 May 19, 1988
AB + 20MG N019777 003 May 19, 1988
AB + 30MG N019777 006 Jan 20, 1999
AB +! 40MG N019777 004 May 19, 1988
LITHIUM CARBONATE
CAPSULE;ORAL
LITHIUM CARBONATE
AB ALEMBIC LTD 150MG A079159 001 Jan 12, 2009
AB 300MG A079159 002 Jan 12, 2009
AB 600MG A079159 003 Jan 12, 2009
AB GLENMARK GENERICS 150MG A079139 001 Feb 03, 2009
AB 300MG A079139 002 Feb 03, 2009
AB 600MG A079139 003 Feb 03, 2009
AB HETERO LABS LTD III 150MG A090702 001 Sep 25, 2009
AB 300MG A090702 002 Sep 25, 2009
AB 600MG A090702 003 Sep 25, 2009
AB + HIKMA 150MG N017812 002 Jan 28, 1987
AB + 300MG N017812 001
AB +! 600MG N017812 003 Jan 28, 1987
TABLET;ORAL
LITHIUM CARBONATE
AB +! HIKMA 300MG N018558 001 Jan 29, 1982
AB SUN PHARM INDS INC 300MG A091027 001 Jun 24, 2010
TABLET, EXTENDED RELEASE;ORAL
LITHIUM CARBONATE
AB GLENMARK GENERICS 450MG A091616 001 Feb 14, 2011
AB GLENMARK PHARMS INC 300MG A091544 001 Dec 27, 2010
AB HERITAGE PHARMA 300MG A205532 001 Sep 29, 2016
AB HIKMA 300MG A076832 001 Oct 28, 2004
AB ! 450MG A076691 001 Jan 05, 2004
AB MYLAN PHARMS INC 300MG A202288 001 Jun 29, 2012
AB 450MG A202219 001 Aug 08, 2012
AB UNIQUE 300MG A204779 001 Jul 27, 2015
AB 450MG A205663 001 Jun 05, 2017
LITHOBID
AB +! ANI PHARMS 300MG N018027 001
LITHIUM CITRATE
SYRUP;ORAL
LITHIUM CITRATE
! PAI HOLDINGS PHARM EQ 300MG CARBONATE/5ML A070755 001 May 21, 1986
LODOXAMIDE TROMETHAMINE
SOLUTION/DROPS;OPHTHALMIC
ALOMIDE
+! NOVARTIS EQ 0.1% BASE N020191 001 Sep 23, 1993
LOFEXIDINE HYDROCHLORIDE
TABLET;ORAL
LUCEMYRA
+! USWM EQ 0.18MG BASE N209229 001 May 16, 2018
LOMITAPIDE MESYLATE
CAPSULE;ORAL
JUXTAPID
+ AMRYT EQ 5MG BASE N203858 001 Dec 21, 2012
+ EQ 10MG BASE N203858 002 Dec 21, 2012
+ EQ 20MG BASE N203858 003 Dec 21, 2012
+ EQ 30MG BASE N203858 004 Apr 23, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-282(of 474)

LOMUSTINE
CAPSULE;ORAL
GLEOSTINE
+ CORDEN PHARMA 10MG N017588 001
+ 40MG N017588 002
+! 100MG N017588 003
LONAFARNIB
CAPSULE;ORAL
ZOKINVY
+ EIGER BIOPHARMS 50MG N213969 001 Nov 20, 2020
+! 75MG N213969 002 Nov 20, 2020
LOPERAMIDE HYDROCHLORIDE
CAPSULE;ORAL
LOPERAMIDE HYDROCHLORIDE
AB BIONPHARMA INC 2MG A215579 001 Oct 22, 2021
AB EDENBRIDGE PHARMS 2MG A215001 001 Oct 06, 2021
AB ! MYLAN 2MG A072741 001 Sep 18, 1991
AB TEVA 2MG A073192 001 Apr 30, 1992
LOPINAVIR; RITONAVIR
SOLUTION;ORAL
KALETRA
AA +! ABBVIE 80MG/ML;20MG/ML N021251 001 Sep 15, 2000
LOPINAVIR AND RITONAVIR
AA LANNETT CO INC 80MG/ML;20MG/ML A207407 001 Dec 27, 2016
TABLET;ORAL
KALETRA
AB + ABBVIE 100MG;25MG N021906 002 Nov 09, 2007
AB +! 200MG;50MG N021906 001 Oct 28, 2005
LOPINAVIR AND RITONAVIR
AB HETERO LABS LTD III 100MG;25MG A091677 001 Jun 04, 2021
AB 200MG;50MG A091677 002 Jun 04, 2021
AB LAURUS 100MG;25MG A213857 001 Mar 21, 2022
AB 200MG;50MG A213857 002 Mar 21, 2022
LORAZEPAM
CAPSULE, EXTENDED RELEASE;ORAL
LOREEV XR
+ ALMATICA 1MG N214826 001 Aug 27, 2021
+ 1.5MG N214826 004 Feb 16, 2022
+ 2MG N214826 002 Aug 27, 2021
+! 3MG N214826 003 Aug 27, 2021
CONCENTRATE;ORAL
LORAZEPAM
AA AKORN 2MG/ML A200169 001 Jan 30, 2012
AA AMNEAL PHARMS 2MG/ML A091383 001 Dec 23, 2009
AA LUPIN LTD 2MG/ML A091407 001 Feb 19, 2013
AA PHARM ASSOC 2MG/ML A090260 001 Jun 15, 2010
LORAZEPAM INTENSOL
AA ! HIKMA 2MG/ML A072755 001 Jun 28, 1991
INJECTABLE;INJECTION
ATIVAN
AP +! HIKMA 2MG/ML N018140 001
AP +! 4MG/ML N018140 002
LORAZEPAM
AP AKORN 2MG/ML A075025 001 Jul 23, 1998
AP HOSPIRA 2MG/ML A074243 001 Apr 12, 1994
AP 2MG/ML A074282 001 May 27, 1994
AP 4MG/ML A074243 002 Apr 12, 1994
AP 4MG/ML A074282 002 May 27, 1994
AP INTL MEDICATION SYS 2MG/ML A076150 001 Nov 15, 2004
TABLET;ORAL
ATIVAN
AB + BAUSCH 0.5MG N017794 001
AB + 1MG N017794 002
AB +! 2MG N017794 003
LORAZEPAM
AB AMNEAL PHARMS 0.5MG A078826 001 Jun 23, 2010
AB 1MG A078826 002 Jun 23, 2010
AB 2MG A078826 003 Jun 23, 2010
AB AUROLIFE PHARMA LLC 0.5MG A203572 001 Dec 22, 2017
AB 1MG A203572 002 Dec 22, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-283(of 474)

LORAZEPAM
TABLET;ORAL
LORAZEPAM
AB 2MG A203572 003 Dec 22, 2017
AB LEADING 0.5MG A078203 001 Jul 30, 2007
AB 1MG A078203 002 Jul 30, 2007
AB 2MG A078203 003 Jul 30, 2007
AB OXFORD PHARMS 0.5MG A077754 001 May 10, 2006
AB 1MG A077754 002 May 10, 2006
AB 2MG A077754 003 May 10, 2006
AB SANDOZ 0.5MG A071141 002 Apr 21, 1987
AB 1MG A071141 003 Apr 21, 1987
AB 2MG A071141 001 Apr 21, 1987
AB WATSON LABS 0.5MG A072926 001 Oct 31, 1991
AB 1MG A072927 001 Oct 31, 1991
AB 2MG A072928 001 Oct 31, 1991
LORLATINIB
TABLET;ORAL
LORBRENA
+ PFIZER 25MG N210868 001 Nov 02, 2018
+! 100MG N210868 002 Nov 02, 2018
LOSARTAN POTASSIUM
TABLET;ORAL
COZAAR
AB + ORGANON 25MG N020386 001 Apr 14, 1995
AB + 50MG N020386 002 Apr 14, 1995
AB +! 100MG N020386 003 Oct 13, 1998
LOSARTAN POTASSIUM
AB ALEMBIC PHARMS LTD 25MG A090428 001 Oct 06, 2010
AB 50MG A090428 002 Oct 06, 2010
AB 100MG A090428 003 Oct 06, 2010
AB AUROBINDO PHARMA 25MG A090083 001 Oct 06, 2010
AB 50MG A090083 002 Oct 06, 2010
AB 100MG A090083 003 Oct 06, 2010
AB HETERO LABS LTD V 25MG A203835 001 Aug 12, 2015
AB 50MG A203835 002 Aug 12, 2015
AB 100MG A203835 003 Aug 12, 2015
AB IPCA LABS LTD 25MG A200290 001 Aug 30, 2013
AB 50MG A200290 002 Aug 30, 2013
AB 100MG A200290 003 Aug 30, 2013
AB JUBILANT CADISTA 25MG A201170 001 Sep 18, 2012
AB 50MG A201170 002 Sep 18, 2012
AB 100MG A201170 003 Sep 18, 2012
AB LUPIN LTD 25MG A078232 001 Oct 06, 2010
AB 50MG A078232 002 Oct 06, 2010
AB 100MG A078232 003 Oct 06, 2010
AB MACLEODS PHARMS LTD 25MG A202230 001 May 30, 2012
AB 50MG A202230 002 May 30, 2012
AB 100MG A202230 003 May 30, 2012
AB MICRO LABS 25MG A091541 001 Sep 24, 2012
AB 50MG A091541 002 Sep 24, 2012
AB 100MG A091541 003 Sep 24, 2012
AB PRINSTON INC 25MG A091497 001 Jun 06, 2011
AB 50MG A091497 002 Jun 06, 2011
AB 100MG A091497 003 Jun 06, 2011
AB SANDOZ 25MG A077424 001 Oct 06, 2010
AB 50MG A077424 002 Oct 06, 2010
AB 100MG A077424 003 Oct 06, 2010
AB STRIDES PHARMA 25MG A090382 001 Oct 06, 2010
AB 50MG A090382 002 Oct 06, 2010
AB 100MG A090382 003 Oct 06, 2010
AB UNICHEM 25MG A203030 001 Oct 14, 2015
AB 50MG A203030 002 Oct 14, 2015
AB 100MG A203030 003 Oct 14, 2015
AB WATSON LABS 25MG A091129 001 Oct 06, 2010
AB 50MG A091129 002 Oct 06, 2010
AB 100MG A091129 003 Oct 06, 2010
AB ZYDUS PHARMS USA 25MG A078243 001 Oct 06, 2010
INC
AB 50MG A078243 002 Oct 06, 2010
AB 100MG A078243 003 Oct 06, 2010
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-284(of 474)

LOTEPREDNOL ETABONATE
GEL;OPHTHALMIC
LOTEMAX
AB +! BAUSCH AND LOMB INC 0.5% N202872 001 Sep 28, 2012
LOTEPREDNOL ETABONATE
AB AKORN 0.5% A212080 001 Feb 10, 2021
LOTEMAX SM
+! BAUSCH AND LOMB INC 0.38% N208219 001 Feb 22, 2019
OINTMENT;OPHTHALMIC
LOTEMAX
+! BAUSCH AND LOMB 0.5% N200738 001 Apr 15, 2011
SUSPENSION/DROPS;OPHTHALMIC
LOTEMAX
AB +! BAUSCH AND LOMB 0.5% N020583 001 Mar 09, 1998
LOTEPREDNOL ETABONATE
AB AKORN 0.5% A207609 001 Apr 17, 2019
AB SUN PHARM 0.5% A212450 001 Feb 26, 2021
ALREX
+! BAUSCH AND LOMB 0.2% N020803 001 Mar 09, 1998
EYSUVIS
+! ALCON LABS INC 0.25% N210933 001 Oct 26, 2020
INVELTYS
+! ALCON LABS INC 1% N210565 001 Aug 22, 2018
LOTEPREDNOL ETABONATE; TOBRAMYCIN
SUSPENSION/DROPS;OPHTHALMIC
ZYLET
+! BAUSCH AND LOMB 0.5%;0.3% N050804 001 Dec 14, 2004
LOVASTATIN
TABLET;ORAL
LOVASTATIN
AB ACTAVIS ELIZABETH 10MG A075828 001 Dec 17, 2001
AB 20MG A075828 002 Dec 17, 2001
AB 40MG A075828 003 Dec 17, 2001
AB CARLSBAD 10MG A075991 001 Jun 05, 2002
AB 20MG A075991 002 Jun 05, 2002
AB ! 40MG A075991 003 Jun 05, 2002
AB CHARTWELL RX 10MG A075300 001 Dec 17, 2001
AB 20MG A075300 002 Dec 17, 2001
AB 40MG A075300 003 Dec 17, 2001
AB COREPHARMA 10MG A077748 001 Feb 28, 2007
AB 20MG A077748 002 Feb 28, 2007
AB 40MG A077748 003 Feb 28, 2007
AB EPIC PHARMA 10MG A075636 001 Dec 17, 2001
AB 20MG A075636 002 Dec 17, 2001
AB 40MG A075636 003 Dec 17, 2001
AB LUPIN 10MG A078296 001 Mar 14, 2008
AB 20MG A078296 002 Nov 01, 2007
AB 40MG A078296 003 Nov 01, 2007
AB TEVA 10MG A075551 003 Dec 17, 2001
AB 20MG A075551 002 Dec 17, 2001
AB 40MG A075551 001 Dec 17, 2001
TABLET, EXTENDED RELEASE;ORAL
ALTOPREV
+ COVIS 20MG N021316 002 Jun 26, 2002
+ 40MG N021316 003 Jun 26, 2002
+! 60MG N021316 004 Jun 26, 2002
LOXAPINE
POWDER;INHALATION
ADASUVE
+! ALEXZA PHARMS 10MG N022549 001 Dec 21, 2012
LOXAPINE SUCCINATE
CAPSULE;ORAL
LOXAPINE SUCCINATE
AB ELITE LABS INC EQ 5MG BASE A076868 001 Aug 04, 2005
AB EQ 10MG BASE A076868 002 Aug 04, 2005
AB EQ 25MG BASE A076868 003 Aug 04, 2005
AB EQ 50MG BASE A076868 004 Aug 04, 2005
AB LANNETT CO INC EQ 5MG BASE A090695 001 Sep 26, 2011
AB EQ 10MG BASE A090695 002 Sep 26, 2011
AB EQ 25MG BASE A090695 003 Sep 26, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-285(of 474)

LOXAPINE SUCCINATE
CAPSULE;ORAL
LOXAPINE SUCCINATE
AB EQ 50MG BASE A090695 004 Sep 26, 2011
AB WATSON LABS EQ 5MG BASE A072204 001 Jun 15, 1988
AB EQ 10MG BASE A072205 001 Jun 15, 1988
AB ! EQ 25MG BASE A072206 001 Jun 15, 1988
AB EQ 50MG BASE A072062 001 Jun 15, 1988
LUBIPROSTONE
CAPSULE;ORAL
AMITIZA
AB + SUCAMPO PHARMA LLC 8MCG N021908 002 Apr 29, 2008
AB +! 24MCG N021908 001 Jan 31, 2006
LUBIPROSTONE
AB DR REDDYS 8MCG A206994 001 Feb 08, 2022
AB 24MCG A206994 002 Feb 08, 2022
AB TEVA PHARMS USA INC 8MCG A209920 001 Jan 18, 2022
AB 24MCG A209920 002 Jan 18, 2022
LULICONAZOLE
CREAM;TOPICAL
LUZU
+! BAUSCH 1% N204153 001 Nov 14, 2013
LUMASIRAN SODIUM
SOLUTION;SUBCUTANEOUS
OXLUMO
+! ALNYLAM PHARMS INC EQ 94.5MG/0.5ML BASE (EQ 94.5MG/0.5ML N214103 001 Nov 23, 2020
BASE)
LUMATEPERONE TOSYLATE
CAPSULE;ORAL
CAPLYTA
+ INTRA-CELLULAR EQ 10.5MG BASE N209500 002 Apr 22, 2022
+ EQ 21MG BASE N209500 003 Apr 22, 2022
+! EQ 42MG BASE N209500 001 Dec 20, 2019
LURASIDONE HYDROCHLORIDE
TABLET;ORAL
LATUDA
AB + SUNOVION PHARMS INC 20MG N200603 003 Dec 07, 2011
AB +! 40MG N200603 001 Oct 28, 2010
AB + 60MG N200603 005 Jul 12, 2013
AB + 80MG N200603 002 Oct 28, 2010
AB + 120MG N200603 004 Apr 26, 2012
LURASIDONE HYDROCHLORIDE
AB ACCORD HLTHCARE 20MG A208049 001 Jan 03, 2019
AB 40MG A208049 002 Jan 03, 2019
AB 60MG A208049 003 Jan 03, 2019
AB 80MG A208049 004 Jan 03, 2019
AB 120MG A208049 005 Jan 03, 2019
AB ALEMBIC PHARMS 20MG A213248 001 May 13, 2021
AB 40MG A213248 002 May 13, 2021
AB 60MG A213248 003 May 13, 2021
AB 80MG A213248 004 May 13, 2021
AB 120MG A213248 005 May 13, 2021
AB ALKEM LABS LTD 20MG A212244 001 Dec 13, 2022
AB 40MG A212244 002 Dec 13, 2022
AB 60MG A212244 003 Dec 13, 2022
AB 80MG A212244 004 Dec 13, 2022
AB 120MG A212244 005 Dec 13, 2022
AB DR REDDYS 20MG A208047 001 Aug 24, 2021
AB 40MG A208047 002 Aug 24, 2021
AB 60MG A208047 003 Aug 24, 2021
AB 80MG A208047 004 Aug 24, 2021
AB INVAGEN PHARMS 20MG A208028 001 Jan 03, 2019
AB 40MG A208028 002 Jan 03, 2019
AB 60MG A208028 003 Jan 03, 2019
AB 80MG A208028 004 Jan 03, 2019
AB 120MG A208028 005 Jan 03, 2019
AB MSN 20MG A208037 001 Sep 09, 2022
AB 40MG A208037 002 Sep 09, 2022
AB 60MG A208037 003 Sep 09, 2022
AB 80MG A208037 004 Sep 09, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-286(of 474)

LURASIDONE HYDROCHLORIDE
TABLET;ORAL
LURASIDONE HYDROCHLORIDE
AB 120MG A208037 005 Sep 09, 2022
AB SUN PHARM 20MG A208066 001 Jan 04, 2019
AB 40MG A208066 002 Jan 04, 2019
AB 60MG A208066 003 Jan 04, 2019
AB 80MG A208066 004 Jan 04, 2019
AB 120MG A208066 005 Jan 04, 2019
AB ZYDUS PHARMS 20MG A208052 001 Mar 19, 2019
AB 40MG A208052 002 Mar 19, 2019
AB 60MG A208052 003 Mar 19, 2019
AB 80MG A208052 004 Mar 19, 2019
AB 120MG A208052 005 Mar 19, 2019
LURBINECTEDIN
POWDER;INTRAVENOUS
ZEPZELCA
+! JAZZ 4MG/VIAL N213702 001 Jun 15, 2020
LUSUTROMBOPAG
TABLET;ORAL
MULPLETA
+! SHIONOGI INC 3MG N210923 001 Jul 31, 2018
LUTETIUM LU 177 DOTATATE
SOLUTION;INTRAVENOUS
LUTATHERA
+! AAA USA INC 10mCi/ML N208700 001 Jan 26, 2018
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
SOLUTION;INTRAVENOUS
PLUVICTO
+! AAA USA NOVARTIS 27mCi/ML N215833 001 Mar 23, 2022
MACIMORELIN ACETATE
FOR SOLUTION;ORAL
MACRILEN
+! NOVO EQ 60MG BASE/POUCH N205598 001 Dec 20, 2017
MACITENTAN
TABLET;ORAL
OPSUMIT
+! ACTELION 10MG N204410 001 Oct 18, 2013
MAFENIDE ACETATE
CREAM;TOPICAL
SULFAMYLON
+! RISING EQ 85MG BASE/GM N016763 001
FOR SOLUTION;TOPICAL
MAFENIDE ACETATE
! NOVAST LABS 5% A206716 001 Jul 31, 2017
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM
CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
INJECTABLE;INJECTION
ISOLYTE S PH 7.4 IN PLASTIC CONTAINER
+! B BRAUN 30MG/100ML;37MG/100ML;0.82MG/100ML;370M N019696 001 Sep 29, 1989
G/100ML;530MG/100ML;500MG/100ML;12MG/10
0ML
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
INJECTABLE;INJECTION
ISOLYTE S IN PLASTIC CONTAINER
B BRAUN 30MG/100ML;37MG/100ML;370MG/100ML;530MG N019711 001 Sep 29, 1989
/100ML;500MG/100ML
NORMOSOL-R IN PLASTIC CONTAINER
ICU MEDICAL INC 30MG/100ML;37MG/100ML;222MG/100ML;526MG N017586 001
/100ML;502MG/100ML
PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 30MG/100ML;37MG/100ML;368MG/100ML;526MG N017378 001
/100ML;502MG/100ML
PLASMA-LYTE A IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 30MG/100ML;37MG/100ML;368MG/100ML;526MG N017378 002 Nov 22, 1982
/100ML;502MG/100ML
SOLUTION;IRRIGATION
PHYSIOLYTE IN PLASTIC CONTAINER
B BRAUN 30MG/100ML;37MG/100ML;370MG/100ML; N019024 001 Jun 08, 1984
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-287(of 474)

MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
SOLUTION;IRRIGATION
PHYSIOLYTE IN PLASTIC CONTAINER
530MG/100ML;500MG/100ML
PHYSIOSOL IN PLASTIC CONTAINER
ICU MEDICAL INC 30MG/100ML;37MG/100ML;222MG/100ML;526MG N017637 002 Jul 08, 1982
/100ML;502MG/100ML
MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
SOLUTION;INJECTION
NORMOCARB HF 25
+! DIALYSIS SUPS 0.21GM/100ML;2.8GM/100ML;9.07GM/100ML N021910 001 Jul 26, 2006
NORMOCARB HF 35
+! DIALYSIS SUPS 0.21GM/100ML;3.97GM/100ML;8.3GM/100ML N021910 002 Jul 26, 2006
MAGNESIUM SULFATE
INJECTABLE;INJECTION
MAGNESIUM SULFATE
AP B BRAUN MEDICAL INC 2GM/50ML (40MG/ML) A207967 001 Apr 26, 2021
AP 4GM/100ML (40MG/ML) A207967 002 Apr 26, 2021
AP 4GM/50ML (80MG/ML) A207967 003 Apr 26, 2021
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
AP B BRAUN MEDICAL INC 1GM/100ML A207966 001 Oct 27, 2020
AP BAXTER HLTHCARE 1GM/100ML A211965 001 Aug 11, 2020
CORP
AP FRESENIUS KABI USA 1GM/100ML A206486 001 Mar 07, 2016
AP +! HOSPIRA 1GM/100ML N020488 001 Jul 11, 1995
AP HQ SPCLT PHARMA 1GM/100ML A207349 001 Mar 02, 2016
AP MYLAN LABS LTD 1GM/100ML A209932 001 Sep 10, 2018
MAGNESIUM SULFATE IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 2GM/50ML (40MG/ML) A211966 001 Jun 01, 2020
CORP
AP 4GM/50ML (80MG/ML) A211966 002 Jun 01, 2020
AP 4GM/100ML (40MG/ML) A211966 003 Jun 01, 2020
AP FRESENIUS KABI USA 4GM/100ML (40MG/ML) A206485 001 Mar 15, 2016
AP 4GM/50ML (80MG/ML) A206485 002 Mar 15, 2016
AP 2GM/50ML (40MG/ML) A206485 003 Mar 15, 2016
AP 20GM/500ML (40MG/ML) A206485 004 Mar 15, 2016
AP 40GM/1000ML (40MG/ML) A206485 005 Mar 15, 2016
AP GLAND PHARMA LTD 2GM/50ML (40MG/ML) A213917 001 Jul 10, 2020
AP 4GM/100ML (40MG/ML) A213917 002 Jul 10, 2020
AP + HOSPIRA 2GM/50ML (40MG/ML) N020309 003 Jan 26, 2007
AP +! 4GM/100ML (40MG/ML) N020309 001 Jun 24, 1994
AP +! 4GM/50ML (80MG/ML) N020309 002 Jun 24, 1994
AP + 20GM/500ML (40MG/ML) N020309 004 Jan 18, 1995
AP + 40GM/1000ML (40MG/ML) N020309 005 Jan 18, 1995
AP HQ SPCLT PHARMA 2GM/50ML (40MG/ML) A207350 001 Dec 06, 2017
AP 4GM/100ML (40MG/ML) A207350 002 Dec 06, 2017
AP 4GM/50ML (80MG/ML) A207350 003 Dec 06, 2017
AP 20GM/500ML (40MG/ML) A207350 004 Dec 06, 2017
AP 40GM/1000ML (40MG/ML) A207350 005 Dec 06, 2017
AP MILLA PHARMS 2GM/50ML (40MG/ML) A209642 001 Nov 08, 2021
AP 4GM/100ML (40MG/ML) A209642 002 Nov 08, 2021
AP 4GM/50ML (80MG/ML) A209642 003 Nov 08, 2021
AP MYLAN LABS LTD 2GM/50ML (40MG/ML) A209911 001 Sep 14, 2018
AP 4GM/100ML (40MG/ML) A209911 002 Sep 14, 2018
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
+! HOSPIRA 2GM/100ML N020488 002 Jul 11, 1995
SOLUTION;INTRAMUSCULAR, INTRAVENOUS
MAGNESIUM SULFATE
AP EXELA PHARMA 5GM/10ML (500MG/ML) A206039 001 Dec 18, 2014
AP +! FRESENIUS KABI USA 5GM/10ML (500MG/ML) N019316 001 Sep 08, 1986
AP +! 10GM/20ML (500MG/ML) N019316 003 Jan 29, 2016
AP ! HOSPIRA 5GM/10ML (500MG/ML) A075151 001 Apr 25, 2000
AP 10GM/20ML (500MG/ML) A202411 001 May 14, 2015
+! FRESENIUS KABI USA 1GM/2ML (500MG/ML) N019316 002 Sep 08, 1986
+! 25GM/50ML (500MG/ML) N019316 004 Jan 29, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-288(of 474)

MAGNESIUM SULFATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM
PHOSPHATE
SOLUTION;IRRIGATION
TIS-U-SOL
AT BAXTER HLTHCARE 20MG/100ML;40MG/100ML;6.25MG/100ML;800M N018508 001 Feb 19, 1982
G/100ML;8.75MG/100ML
TIS-U-SOL IN PLASTIC CONTAINER
AT BAXTER HLTHCARE 20MG/100ML;40MG/100ML;6.25MG/100ML;800M N018336 001
G/100ML;8.75MG/100ML
MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE
TABLET;ORAL
SUTAB
+! BRAINTREE LABS 0.225GM;0.188GM;1.479GM N213135 001 Nov 10, 2020
MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE
SOLUTION;ORAL
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
AA NOVEL LABS INC 1.6GM/BOT;3.13GM/BOT;17.5GM/BOT A202511 001 Feb 23, 2017
SUPREP BOWEL PREP KIT
AA +! BRAINTREE LABS 1.6GM/BOT;3.13GM/BOT;17.5GM/BOT N022372 001 Aug 05, 2010
MALATHION
LOTION;TOPICAL
MALATHION
! SUVEN PHARMS 0.5% A091559 001 May 23, 2012
MANGANESE CHLORIDE
INJECTABLE;INJECTION
MANGANESE CHLORIDE IN PLASTIC CONTAINER
+! HOSPIRA EQ 0.1MG MANGANESE/ML N018962 001 Jun 26, 1986
MANNITOL
INJECTABLE;INJECTION
MANNITOL 10% IN PLASTIC CONTAINER
AP B BRAUN 10GM/100ML N020006 002 Jul 26, 1993
MANNITOL 15% IN PLASTIC CONTAINER
AP B BRAUN 15GM/100ML N020006 003 Jul 26, 1993
MANNITOL 20% IN PLASTIC CONTAINER
AP B BRAUN 20GM/100ML N020006 004 Jul 26, 1993
AP ICU MEDICAL INC 20GM/100ML N019603 004 Jan 08, 1990
MANNITOL 25%
AP FRESENIUS KABI USA 12.5GM/50ML A080677 001
AP HOSPIRA 12.5GM/50ML N016269 006 Aug 25, 1994
MANNITOL 5% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML N020006 001 Jul 26, 1993
OSMITROL 10% IN WATER
AP BAXTER HLTHCARE 10GM/100ML N013684 002
OSMITROL 10% IN WATER IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 10GM/100ML N013684 006
OSMITROL 15% IN WATER
AP BAXTER HLTHCARE 15GM/100ML N013684 004
OSMITROL 15% IN WATER IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 15GM/100ML N013684 008
OSMITROL 20% IN WATER
AP BAXTER HLTHCARE 20GM/100ML N013684 003
OSMITROL 20% IN WATER IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 20GM/100ML N013684 007
OSMITROL 5% IN WATER
AP BAXTER HLTHCARE 5GM/100ML N013684 001
OSMITROL 5% IN WATER IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 5GM/100ML N013684 005
POWDER;INHALATION
ARIDOL KIT
+! PHARMAXIS LTD N/A,5MG,10MG,20MG,40MG N022368 001 Oct 05, 2010
BRONCHITOL
+! CHIESI 40MG N202049 001 Oct 30, 2020
MANNITOL; SORBITOL
SOLUTION;IRRIGATION
SORBITOL-MANNITOL IN PLASTIC CONTAINER
+! ICU MEDICAL INC 540MG/100ML;2.7GM/100ML N018316 001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-289(of 474)

MARALIXIBAT CHLORIDE
SOLUTION;ORAL
LIVMARLI
+! MIRUM EQ 9.5MG BASE/ML N214662 001 Sep 29, 2021
MARAVIROC
SOLUTION;ORAL
SELZENTRY
+! VIIV HLTHCARE 20MG/ML N208984 001 Nov 04, 2016
TABLET;ORAL
MARAVIROC
AB HETERO LABS LTD III 150MG A203347 001 Feb 07, 2022
AB 300MG A203347 002 Feb 07, 2022
SELZENTRY
AB + VIIV HLTHCARE 150MG N022128 001 Aug 06, 2007
AB +! 300MG N022128 002 Aug 06, 2007
+ 25MG N022128 003 Nov 04, 2016
+ 75MG N022128 004 Nov 04, 2016
MARIBAVIR
TABLET;ORAL
LIVTENCITY
+! TAKEDA PHARMS USA 200MG N215596 001 Nov 23, 2021
MAVACAMTEN
CAPSULE;ORAL
CAMZYOS
+ BRISTOL 2.5MG N214998 001 Apr 28, 2022
+ 5MG N214998 002 Apr 28, 2022
+ 10MG N214998 003 Apr 28, 2022
+! 15MG N214998 004 Apr 28, 2022
MEBENDAZOLE
TABLET, CHEWABLE;ORAL
EMVERM
! IMPAX LABS INC 100MG A073580 001 Jan 04, 1995
MECAMYLAMINE HYDROCHLORIDE
TABLET;ORAL
MECAMYLAMINE HYDROCHLORIDE
! LGM PHARMA 2.5MG A204054 001 Mar 19, 2013
MECHLORETHAMINE HYDROCHLORIDE
GEL;TOPICAL
VALCHLOR
+! HELSINN EQ 0.016% BASE N202317 001 Aug 23, 2013
MECLIZINE HYDROCHLORIDE
TABLET;ORAL
ANTIVERT
AA + CASPER PHARMA LLC 12.5MG N010721 006
AA + 25MG N010721 004
AA + 50MG N010721 001 Jan 20, 1982
MECLIZINE HYDROCHLORIDE
AA ! AMNEAL PHARMS 12.5MG A201451 001 Feb 23, 2011
AA ! 25MG A201451 002 Feb 23, 2011
AA ANI PHARMS 12.5MG A084657 002
AA 25MG A084657 001
AA APNAR PHARMA LP 12.5MG A087128 002
AA 25MG A087128 001
AA EPIC PHARMA LLC 12.5MG A200294 001 Apr 13, 2012
AA 25MG A200294 002 Apr 13, 2012
AA INDICUS PHARMA 12.5MG A205136 001 Feb 22, 2019
AA 25MG A205136 002 Feb 22, 2019
AA 50MG A205136 003 Feb 22, 2019
AA INVAGEN PHARMS 12.5MG A200432 001 Feb 17, 2022
AA 25MG A200432 002 Feb 17, 2022
AA 50MG A200432 003 Feb 17, 2022
AA INVATECH 25MG A084092 003 May 22, 1989
AA JUBILANT CADISTA 12.5MG A040659 001 Jun 04, 2010
AA 25MG A040659 002 Jun 04, 2010
AA LUPIN LTD 12.5MG A203003 001 Aug 11, 2022
AA 25MG A203003 002 Aug 11, 2022
AA 50MG A203003 003 Aug 11, 2022
AA SANDOZ 12.5MG A084843 002 May 22, 1989
AA ZYDUS 12.5MG A213957 001 Jun 23, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-290(of 474)

MECLIZINE HYDROCHLORIDE
TABLET;ORAL
MECLIZINE HYDROCHLORIDE
AA 25MG A213957 002 Jun 23, 2020
TABLET, CHEWABLE;ORAL
ANTIVERT
AA + CASPER PHARMA LLC 25MG N010721 005
MECLIZINE HYDROCHLORIDE
AA INVAGEN PHARMS 25MG A200791 001 Feb 17, 2022
MECLOFENAMATE SODIUM
CAPSULE;ORAL
MECLOFENAMATE SODIUM
MYLAN EQ 50MG BASE A071081 002 Sep 03, 1986
! EQ 100MG BASE A071081 001 Sep 03, 1986
MEDROXYPROGESTERONE ACETATE
INJECTABLE;INJECTION
DEPO-PROVERA
AB +! PFIZER 150MG/ML N020246 001 Oct 29, 1992
MEDROXYPROGESTERONE ACETATE
AB AMPHASTAR PHARMS 150MG/ML A077235 001 Nov 28, 2017
INC
AB 150MG/ML A077334 001 Nov 28, 2017
AB EUGIA PHARMA 150MG/ML A212824 001 Aug 22, 2022
AB 150MG/ML A212844 001 Aug 31, 2022
AB HIKMA 150MG/ML A214309 001 Jan 05, 2023
AB MYLAN LABS LTD 150MG/ML A210227 001 Oct 12, 2018
AB TEVA PHARMS USA 150MG/ML A076553 001 Jul 28, 2004
INJECTABLE;SUBCUTANEOUS
DEPO-SUBQ PROVERA 104
+! PFIZER 104MG/0.65ML N021583 001 Dec 17, 2004
TABLET;ORAL
MEDROXYPROGESTERONE ACETATE
AB BARR 2.5MG A040159 001 Aug 09, 1996
AB 5MG A040159 002 Aug 09, 1996
AB 10MG A040159 003 Aug 09, 1996
PROVERA
AB + PFIZER 2.5MG N011839 001
AB + 5MG N011839 003
AB +! 10MG N011839 004
MEFENAMIC ACID
CAPSULE;ORAL
MEFENAMIC ACID
AB BELCHER 250MG A091608 001 Jun 02, 2014
AB LUPIN LTD 250MG A091322 001 Jul 22, 2011
AB MICRO LABS 250MG A090562 001 Nov 19, 2010
PONSTEL
AB +! AVION PHARMS 250MG N015034 003
MEFLOQUINE HYDROCHLORIDE
TABLET;ORAL
MEFLOQUINE HYDROCHLORIDE
AB ! BARR 250MG A076392 001 Dec 29, 2003
AB HIKMA 250MG A076523 001 Oct 01, 2004
MEGESTROL ACETATE
SUSPENSION;ORAL
MEGACE ES
AB +! ENDO PHARMS INC 125MG/ML N021778 001 Jul 05, 2005
MEGESTROL ACETATE
AB AKORN 40MG/ML A203960 001 Jun 09, 2017
AB BRECKENRIDGE 125MG/ML A204688 001 Dec 01, 2017
AB ! STRIDES PHARMA 40MG/ML A075671 001 Jul 25, 2001
AB TWI PHARMS 125MG/ML A203139 001 Aug 27, 2014
AB WOCKHARDT BIO AG 40MG/ML A076721 001 Nov 01, 2004
TABLET;ORAL
MEGESTROL ACETATE
AB BARR 20MG A074621 002 Aug 16, 1996
AB 40MG A074621 001 Nov 30, 1995
AB STRIDES PHARMA 20MG A072422 001 Aug 08, 1988
AB ! 40MG A072423 001 Aug 08, 1988
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-291(of 474)

MELOXICAM
CAPSULE;ORAL
MELOXICAM
AB LUPIN LTD 5MG A209487 001 Jun 01, 2020
AB ! 10MG A209487 002 Jun 01, 2020
AB NOVITIUM PHARMA 5MG A211398 001 Mar 09, 2021
AB 10MG A211398 002 Mar 09, 2021
SUSPENSION;ORAL
MELOXICAM
+! AVONDALE PHARMS 7.5MG/5ML N021530 001 Jun 01, 2004
TABLET;ORAL
MELOXICAM
AB APOTEX INC 7.5MG A077882 001 Jul 20, 2006
AB 15MG A077882 002 Jul 20, 2006
AB AUROBINDO PHARMA 7.5MG A078008 001 Oct 02, 2006
AB 15MG A078008 002 Oct 02, 2006
AB CIPLA 7.5MG A077929 001 Jul 19, 2006
AB 15MG A077929 002 Jul 19, 2006
AB DR REDDYS LABS INC 7.5MG A077931 001 Jul 25, 2006
AB 15MG A077931 002 Jul 25, 2006
AB GLENMARK GENERICS 7.5MG A077932 001 Jul 19, 2006
AB 15MG A077932 002 Jul 19, 2006
AB LUPIN PHARMS 7.5MG A077944 001 Jul 19, 2006
AB 15MG A077944 002 Jul 19, 2006
AB PURACAP PHARM 7.5MG A077938 001 Jul 19, 2006
AB 15MG A077938 002 Jul 19, 2006
AB STRIDES PHARMA 7.5MG A077928 001 May 13, 2009
AB 15MG A077928 002 May 13, 2009
AB TARO 7.5MG A078102 001 Nov 07, 2006
AB 15MG A078102 002 Nov 07, 2006
AB UNICHEM 7.5MG A077927 001 Dec 20, 2006
AB 15MG A077927 002 Dec 20, 2006
AB YUNG SHIN PHARM 7.5MG A077918 001 Dec 07, 2006
AB 15MG A077918 002 Dec 07, 2006
AB ZYDUS PHARMS USA 7.5MG A077921 001 Jul 19, 2006
AB 15MG A077921 002 Jul 19, 2006
MOBIC
AB + BOEHRINGER 7.5MG N020938 001 Apr 13, 2000
INGELHEIM
AB +! 15MG N020938 002 Aug 23, 2000
MELPHALAN
TABLET;ORAL
MELPHALAN
! ALVOGEN 2MG A207809 001 Mar 22, 2017
MELPHALAN HYDROCHLORIDE
INJECTABLE;INJECTION
MELPHALAN HYDROCHLORIDE
AP ACTAVIS LLC EQ 50MG BASE/VIAL A206018 001 Dec 19, 2016
AP ALMAJECT EQ 50MG BASE/VIAL A204817 001 May 17, 2019
AP ARTHUR GRP EQ 50MG BASE/VIAL A211463 001 Sep 13, 2019
AP BPI LABS EQ 50MG BASE/VIAL A209197 001 May 08, 2020
AP DR REDDYS EQ 50MG BASE/VIAL A203655 001 Dec 08, 2017
AP FRESENIUS KABI USA EQ 50MG BASE/VIAL A203393 001 Dec 22, 2017
AP GLAND PHARMA LTD EQ 50MG BASE/VIAL A209826 001 May 28, 2019
AP HIKMA EQ 50MG BASE/VIAL A090303 001 Oct 28, 2010
AP INGENUS PHARMS LLC EQ 50MG BASE/VIAL A210947 001 Feb 18, 2020
AP MEITHEAL EQ 50MG BASE/VIAL A212960 001 May 28, 2021
AP ! MYLAN INSTITUTIONAL EQ 50MG BASE/VIAL A090270 001 Jun 09, 2009
AP SAGENT PHARMS INC EQ 50MG BASE/VIAL A201379 001 Feb 28, 2017
POWDER;INTRAVENOUS
EVOMELA
+! ACROTECH BIOPHARMA EQ 50MG BASE/VIAL N207155 001 Mar 10, 2016
MEMANTINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
MEMANTINE HYDROCHLORIDE
AB AMNEAL PHARMS 7MG A205825 001 Oct 12, 2016
AB 14MG A205825 002 Oct 12, 2016
AB 21MG A205825 003 Oct 12, 2016
AB 28MG A205825 004 Oct 12, 2016
AB ANI PHARMS 28MG A205365 004 Feb 28, 2020
AB APOTEX 7MG A206135 001 Nov 22, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-292(of 474)

MEMANTINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
MEMANTINE HYDROCHLORIDE
AB 14MG A206135 002 Nov 22, 2016
AB 21MG A206135 003 Nov 22, 2016
AB 28MG A206135 004 Nov 22, 2016
AB AUROBINDO PHARMA 7MG A214651 001 Aug 09, 2021
LTD
AB 14MG A214651 002 Aug 09, 2021
AB 21MG A214651 003 Aug 09, 2021
AB 28MG A214651 004 Aug 09, 2021
AB LUPIN LTD 7MG A206028 001 Sep 28, 2016
AB 14MG A206028 002 Sep 28, 2016
AB 21MG A206028 003 Sep 28, 2016
AB 28MG A206028 004 Sep 28, 2016
AB XIAMEN LP PHARM CO 7MG A213985 001 Oct 11, 2022
AB 14MG A213985 002 Oct 11, 2022
AB 28MG A213985 003 Oct 11, 2022
AB YICHANG HUMANWELL 7MG A211100 001 Apr 02, 2021
AB 14MG A211100 002 Apr 02, 2021
AB 21MG A211100 003 Apr 02, 2021
AB 28MG A211100 004 Apr 02, 2021
AB ZYDUS PHARMS 7MG A203293 001 Aug 03, 2017
AB 14MG A203293 002 Aug 03, 2017
AB 21MG A203293 003 Aug 03, 2017
AB 28MG A203293 004 Aug 03, 2017
NAMENDA XR
AB + ALLERGAN 7MG N022525 001 Jun 21, 2010
AB + 14MG N022525 002 Jun 21, 2010
AB + 21MG N022525 003 Jun 21, 2010
AB +! 28MG N022525 004 Jun 21, 2010
SOLUTION;ORAL
MEMANTINE HYDROCHLORIDE
AA APOTEX 2MG/ML A209955 001 Feb 09, 2018
AA ! CHARTWELL MOLECULAR 2MG/ML A204033 001 Oct 13, 2015
AA MACLEODS PHARMS LTD 2MG/ML A202790 001 Oct 13, 2015
AA SETON PHARMS 2MG/ML A210319 001 Aug 31, 2020
TABLET;ORAL
MEMANTINE HYDROCHLORIDE
AB AJANTA PHARMA LTD 5MG A206528 001 Nov 30, 2015
AB 10MG A206528 002 Nov 30, 2015
AB ALEMBIC PHARMS 5MG A200891 001 Oct 13, 2015
AB 10MG A200891 002 Oct 13, 2015
AB AMNEAL PHARMS 5MG A090041 001 Apr 10, 2015
AB 10MG A090041 002 Apr 10, 2015
AB AUROBINDO PHARMA 5MG A203175 001 Oct 13, 2015
LTD
AB 10MG A203175 002 Oct 13, 2015
AB CADILA 5MG A090961 001 Jul 10, 2017
AB 10MG A090961 002 Jul 10, 2017
AB CELLTRION 5MG A090073 001 Sep 04, 2015
AB 10MG A090073 002 Sep 04, 2015
AB DR REDDYS LABS LTD 5MG A090048 001 Apr 14, 2010
AB 10MG A090048 002 Apr 14, 2010
AB HETERO LABS LTD V 5MG A204389 001 Sep 26, 2022
AB 10MG A204389 002 Sep 26, 2022
AB HIKMA 5MG A208173 001 Feb 28, 2020
AB 10MG A208173 002 Feb 28, 2020
AB LUPIN LTD 5MG A090051 001 Apr 10, 2015
AB 10MG A090051 002 Apr 10, 2015
AB MACLEODS PHARMS LTD 5MG A202840 001 Oct 13, 2015
AB 10MG A202840 002 Oct 13, 2015
AB POLYGEN PHARMS 5MG A210587 001 Dec 11, 2020
AB 10MG A210587 002 Dec 11, 2020
AB PURACAP PHARM LLC 5MG A206855 001 Nov 17, 2015
AB 10MG A206855 002 Nov 17, 2015
AB RENATA 5MG A209527 001 May 07, 2018
AB 10MG A209527 002 May 07, 2018
AB STRIDES PHARMA 5MG A202350 001 May 23, 2017
AB 10MG A202350 002 May 23, 2017
AB SUN PHARM 5MG A090058 001 May 05, 2010
AB 10MG A090058 002 May 05, 2010
AB UNICHEM 5MG A200022 001 Oct 13, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-293(of 474)

MEMANTINE HYDROCHLORIDE
TABLET;ORAL
MEMANTINE HYDROCHLORIDE
AB 10MG A200022 002 Oct 13, 2015
AB UPSHER SMITH LABS 5MG A090043 001 Jul 31, 2015
AB 10MG A090043 002 Jul 31, 2015
NAMENDA
AB + ALLERGAN 5MG N021487 001 Oct 16, 2003
AB +! 10MG N021487 002 Oct 16, 2003
MEPERIDINE HYDROCHLORIDE
INJECTABLE;INJECTION
DEMEROL
AP +! HOSPIRA 25MG/ML N021171 001
AP +! 50MG/ML N021171 002
AP +! 75MG/ML N021171 003
AP +! 100MG/ML N021171 004
MEPERIDINE HYDROCHLORIDE
AP WEST-WARD PHARMS 25MG/ML A080445 001
INT
AP 25MG/ML A080455 007
AP 50MG/ML A080445 002
AP 50MG/ML A080455 008
AP 75MG/ML A080445 003
AP 75MG/ML A080455 009
AP 100MG/ML A080445 004
AP 100MG/ML A080455 010
MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE
! WEST-WARD PHARMS 10MG/ML A081002 001 Jul 30, 1993
INT
SYRUP;ORAL
MEPERIDINE HYDROCHLORIDE
! HIKMA 50MG/5ML A088744 001 Jan 30, 1985
TABLET;ORAL
MEPERIDINE HYDROCHLORIDE
EPIC PHARMA 50MG A040331 001 May 28, 1999
100MG A040331 002 May 28, 1999
MEPIVACAINE HYDROCHLORIDE
INJECTABLE;INJECTION
CARBOCAINE
AP +! HOSPIRA 1% N012250 001
AP +! 1.5% N012250 005
AP +! 2% N012250 002
POLOCAINE
AP FRESENIUS KABI USA 1% A089407 001 Dec 01, 1986
AP 2% A089410 001 Dec 01, 1986
POLOCAINE-MPF
AP FRESENIUS KABI USA 1% A089406 001 Dec 01, 1986
AP 1.5% A089408 001 Dec 01, 1986
AP 2% A089409 001 Dec 01, 1986
SCANDONEST PLAIN
AP ! DEPROCO 3% A088387 001 Oct 10, 1984
MEPROBAMATE
TABLET;ORAL
MEPROBAMATE
AA ! ALEMBIC PHARMS LTD 200MG A090122 001 Feb 18, 2009
AA ! 400MG A090122 002 Feb 18, 2009
AA INVAGEN PHARMS 200MG A040797 001 Feb 27, 2008
AA 400MG A040797 002 Feb 27, 2008
MERCAPTOPURINE
SUSPENSION;ORAL
PURIXAN
+! NOVA LABS LTD 20MG/ML N205919 001 Apr 28, 2014
TABLET;ORAL
MERCAPTOPURINE
AB DR REDDYS LABS SA 50MG A040461 001 Feb 11, 2004
AB ! HIKMA 50MG A040528 001 Feb 13, 2004
AB MYLAN 50MG A040594 001 Jul 01, 2005
PURINETHOL
AB + STASON PHARMS 50MG N009053 002
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-294(of 474)

MEROPENEM
INJECTABLE;INJECTION
MEROPENEM
AP ACS DOBFAR 500MG/VIAL A091404 001 Oct 26, 2011
AP 1GM/VIAL A091404 002 Oct 26, 2011
AP ACS DOBFAR SPA 500MG/VIAL A204139 001 Jun 09, 2016
AP 1GM/VIAL A204139 002 Jun 09, 2016
AP AMNEAL PHARMS 500MG/VIAL A205883 001 Apr 12, 2016
AP 1GM/VIAL A205883 002 Apr 12, 2016
AP BROOKS STERISCIENCE 500MG/VIAL A216154 001 Aug 18, 2022
AP 1GM/VIAL A216154 002 Aug 18, 2022
AP DAEWOONG PHARM CO 500MG/VIAL A204854 001 Dec 18, 2015
AP 1GM/VIAL A204854 002 Dec 18, 2015
AP EUGIA PHARMA 500MG/VIAL A205835 001 Mar 27, 2017
AP 1GM/VIAL A205835 002 Mar 27, 2017
AP GLAND 500MG/VIAL A206141 001 Jun 08, 2016
AP 1GM/VIAL A206141 002 Jun 08, 2016
AP HQ SPCLT PHARMA 500MG/VIAL A210773 001 Aug 16, 2019
AP 1GM/VIAL A210773 002 Aug 16, 2019
AP SAVIOR LIFETEC CORP 500MG/VIAL A206086 001 Apr 19, 2016
AP 1GM/VIAL A206086 002 Apr 19, 2016
MERREM
AP +! PFIZER 500MG/VIAL N050706 003 Jun 21, 1996
AP +! 1GM/VIAL N050706 001 Jun 21, 1996
POWDER;INTRAVENOUS
MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
B BRAUN MEDICAL INC 500MG/VIAL N202106 001 Apr 30, 2015
1GM/VIAL N202106 002 Apr 30, 2015
MEROPENEM; VABORBACTAM
POWDER;INTRAVENOUS
VABOMERE
+! REMPEX 1GM/VIAL;1GM/VIAL N209776 001 Aug 29, 2017
MESALAMINE
CAPSULE, DELAYED RELEASE;ORAL
DELZICOL
AB +! APIL 400MG N204412 001 Feb 01, 2013
MESALAMINE
AB TEVA PHARMS USA 400MG A207873 001 May 09, 2019
CAPSULE, EXTENDED RELEASE;ORAL
APRISO
AB +! VALEANT PHARMS INTL 375MG N022301 001 Oct 31, 2008
MESALAMINE
AB ALEMBIC PHARMS 375MG A216967 001 Oct 28, 2022
AB ALKEM LABS LTD 375MG A214242 001 Jul 15, 2021
AB MYLAN 375MG A207271 001 Nov 20, 2019
AB SUN PHARM 500MG A214585 001 May 11, 2022
AB ZYDUS PHARMS 375MG A208954 001 Aug 12, 2021
PENTASA
AB +! TAKEDA PHARMS USA 500MG N020049 002 Jul 08, 2004
+ 250MG N020049 001 May 10, 1993
ENEMA;RECTAL
MESALAMINE
AB PADAGIS ISRAEL 4GM/60ML A076751 001 Sep 17, 2004
ROWASA
AB +! MYLAN SPECIALITY LP 4GM/60ML N019618 001 Dec 24, 1987
SFROWASA
AB + MYLAN SPECIALITY LP 4GM/60ML N019618 002 Jun 20, 2008
SUPPOSITORY;RECTAL
CANASA
AB +! ALLERGAN 1GM N021252 002 Nov 05, 2004
MESALAMINE
AB ACTAVIS MID 1GM A205654 001 Aug 14, 2020
ATLANTIC
AB AMRING PHARMS 1GM A208362 001 Jun 21, 2019
AB ANNORA PHARMA 1GM A213377 001 Mar 19, 2020
AB MYLAN 1GM A204354 001 Nov 24, 2015
AB PHARM SOURCING 1GM A207448 001 Apr 19, 2019
AB SANDOZ INC 1GM A202065 001 Jun 12, 2019
AB ZYDUS PHARMS 1GM A208953 001 Feb 12, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-295(of 474)

MESALAMINE
TABLET, DELAYED RELEASE;ORAL
LIALDA
AB +! TAKEDA PHARMS USA 1.2GM N022000 001 Jan 16, 2007
MESALAMINE
AB ACTAVIS LABS FL 1.2GM A203817 001 Mar 23, 2018
AB SUN PHARM 1.2GM A211858 001 Jan 25, 2019
AB ZYDUS PHARMS 1.2GM A091640 001 Jun 05, 2017
! 800MG A203286 001 Jul 21, 2017
MESNA
INJECTABLE;INTRAVENOUS
MESNA
AP FRESENIUS KABI USA 100MG/ML A075811 001 Apr 26, 2001
AP GLAND 100MG/ML A206992 001 Dec 18, 2017
AP HIKMA 100MG/ML A075739 001 Jan 09, 2004
AP SAGENT PHARMS INC 100MG/ML A090913 001 Apr 13, 2010
MESNEX
AP +! BAXTER HLTHCARE 100MG/ML N019884 001 Dec 30, 1988
TABLET;ORAL
MESNEX
+! BAXTER HLTHCARE 400MG N020855 001 Mar 21, 2002
METAPROTERENOL SULFATE
SYRUP;ORAL
METAPROTERENOL SULFATE
! ANDA REPOSITORY 10MG/5ML A073632 001 Jul 22, 1992
METARAMINOL BITARTRATE
INJECTABLE;INJECTION
METARAMINOL BITARTRATE
SLAYBACK PHARMA LLC EQ 10MG BASE/ML A211304 001 Aug 24, 2021
METAXALONE
TABLET;ORAL
METAXALONE
AB ACTAVIS LABS FL INC 800MG A203695 001 Jun 15, 2017
AB AMNEAL PHARMS 800MG A203399 001 Jun 21, 2013
AB LANNETT CO INC 800MG A204770 001 Nov 22, 2016
AB MOUNTAIN 400MG A040486 001 Feb 27, 2015
AB SANDOZ 800MG A040445 001 Mar 31, 2010
AB SCIEGEN PHARMS INC 400MG A207466 002 Mar 13, 2020
AB 800MG A207466 001 Aug 31, 2017
SKELAXIN
AB +! KING PHARMS 800MG N013217 003 Aug 30, 2002
METAXALONE
BX APPCO 800MG A208774 001 Sep 24, 2018
METFORMIN HYDROCHLORIDE
SOLUTION;ORAL
METFORMIN HYDROCHLORIDE
AB ! SAPTALIS PHARMS 500MG/5ML A211309 001 Mar 03, 2020
AB VISTAPHARM 500MG/5ML A212677 001 Aug 19, 2022
TABLET;ORAL
METFORMIN HYDROCHLORIDE
AB ALKEM 500MG A091184 001 Nov 01, 2010
AB 850MG A091184 002 Nov 01, 2010
AB 1GM A091184 003 Nov 01, 2010
AB AMNEAL PHARMS NY 500MG A077880 001 Jun 05, 2006
AB 850MG A077880 002 Jun 05, 2006
AB 1GM A077880 003 Jun 05, 2006
AB APOTEX 500MG A075984 001 Apr 23, 2002
AB 500MG A090666 001 Dec 07, 2011
AB 850MG A075984 002 Apr 23, 2002
AB 850MG A090666 002 Dec 07, 2011
AB 1GM A075984 003 Apr 23, 2002
AB 1GM A090666 003 Dec 07, 2011
AB ATLAS PHARMS LLC 500MG A076033 001 Jan 24, 2002
AB 850MG A076033 002 Jan 24, 2002
AB 1GM A076033 003 Jan 24, 2002
AB AUROBINDO 500MG A077095 001 Jan 14, 2005
AB 850MG A077095 002 Jan 14, 2005
AB 1GM A077095 003 Jan 14, 2005
AB CHARTWELL 500MG A075972 001 Jan 24, 2002
AB 850MG A075972 002 Jan 24, 2002
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-296(of 474)

METFORMIN HYDROCHLORIDE
TABLET;ORAL
METFORMIN HYDROCHLORIDE
AB 1GM A075972 003 Jan 24, 2002
AB CSPC OUYI 500MG A205096 001 Jul 11, 2016
AB 850MG A205096 002 Jul 11, 2016
AB 1GM A205096 003 Jul 11, 2016
AB DR REDDYS LABS INC 500MG A077787 001 Aug 23, 2006
AB 850MG A077787 002 Aug 23, 2006
AB 1GM A077787 003 Aug 23, 2006
AB EPIC PHARMA 500MG A075965 001 Jan 25, 2002
AB 850MG A075965 002 Jan 25, 2002
AB 1GM A075965 003 Jan 25, 2002
AB GLENMARK GENERICS 500MG A078170 001 May 23, 2008
AB 850MG A078170 002 May 23, 2008
AB 1GM A078170 003 May 23, 2008
AB GRANULES INDIA 500MG A090564 001 Apr 22, 2010
AB 850MG A090564 002 Apr 22, 2010
AB ! 1GM A090564 003 Apr 22, 2010
AB HARMAN FINOCHEM 500MG A213320 001 Dec 03, 2021
AB 850MG A213320 002 Dec 03, 2021
AB 1GM A213320 003 Dec 03, 2021
AB LAURUS 500MG A209882 001 Aug 27, 2018
AB 850MG A209882 002 Aug 27, 2018
AB 1GM A209882 003 Aug 27, 2018
AB MARKSANS PHARMA 500MG A090888 001 Mar 12, 2012
AB 850MG A090888 002 Mar 12, 2012
AB 1GM A090888 003 Mar 12, 2012
AB MYLAN 500MG A075973 001 Jan 25, 2002
AB 850MG A075973 002 Jan 25, 2002
AB 1GM A075973 003 Jan 25, 2002
AB SCIEGEN PHARMS INC 500MG A203769 001 Sep 11, 2013
AB 850MG A203769 002 Sep 11, 2013
AB 1GM A203769 003 Sep 11, 2013
AB SUN PHARM INDS INC 500MG A075967 001 Jan 29, 2002
AB 850MG A075967 002 Jan 29, 2002
AB 1GM A075967 003 Jan 29, 2002
AB ZYDUS HLTHCARE 500MG A203686 001 Aug 28, 2014
AB 850MG A203686 002 Aug 28, 2014
AB 1GM A203686 003 Aug 28, 2014
AB ZYDUS PHARMS USA 500MG A077064 001 Apr 18, 2005
AB 850MG A077064 002 Apr 18, 2005
AB 1GM A077064 003 Apr 18, 2005
CHARTWELL 625MG A075972 005 Jan 24, 2002
750MG A075972 004 Jan 24, 2002
TABLET, EXTENDED RELEASE;ORAL
METFORMIN HYDROCHLORIDE
AB ACTAVIS LABS FL INC 750MG A076869 001 Apr 12, 2005
AB ! ALKEM LABS LTD 750MG A206145 002 Oct 22, 2018
AB AMNEAL PHARMS NY 750MG A078596 002 Jan 03, 2008
AB AUROBINDO PHARMA 750MG A079118 002 Jul 20, 2012
LTD
AB BEXIMCO PHARMS USA 750MG A207427 002 Dec 13, 2016
AB CADILA 750MG A077078 001 Apr 21, 2005
AB CSPC OUYI 750MG A078321 002 Apr 17, 2008
AB GRANULES 750MG A209313 002 Mar 16, 2018
AB INTELLIPHARMACEUTIC 750MG A202306 002 Feb 23, 2017
S
AB MACLEODS PHARMS LTD 750MG A206955 002 Dec 07, 2016
AB MARKSANS PHARMA 750MG A090295 002 Apr 29, 2016
AB NOSTRUM PHARMS LLC 750MG A076756 002 Dec 12, 2011
AB PRINSTON INC 750MG A208880 002 Sep 10, 2018
AB SUN PHARM INDS (IN) 750MG A077336 002 Feb 09, 2006
AB TEVA 750MG A076864 001 Apr 12, 2005
AB UNICHEM 750MG A213359 002 Aug 11, 2021
AB YICHANG HUMANWELL 750MG A211052 002 Sep 24, 2018
AB1 ALIGNSCIENCE PHARMA 500MG A209303 001 Mar 19, 2018
AB1 ALKEM LABS LTD 500MG A206145 001 Oct 22, 2018
AB1 AMNEAL PHARMS NY 500MG A078596 001 Jan 03, 2008
AB1 AUROBINDO PHARMA 500MG A079118 001 Jul 20, 2012
LTD
AB1 BEXIMCO PHARMS USA 500MG A207427 001 Dec 13, 2016
AB1 CADILA 500MG A077060 001 Apr 20, 2005
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-297(of 474)

METFORMIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
METFORMIN HYDROCHLORIDE
AB1 CSPC OUYI 500MG A078321 001 Apr 17, 2008
AB1 GRANULES 500MG A209313 001 Mar 16, 2018
AB1 INTELLIPHARMACEUTIC 500MG A202306 001 Feb 23, 2017
S
AB1 INVENTIA 500MG A201991 001 Jan 18, 2012
AB1 MACLEODS PHARMS LTD 500MG A206955 001 Dec 07, 2016
AB1 MARKSANS PHARMA 500MG A090295 001 Apr 29, 2016
AB1 NOSTRUM PHARMS LLC 500MG A076756 001 Jul 26, 2006
AB1 PRINSTON INC 500MG A208880 001 Sep 10, 2018
AB1 SANDOZ 500MG A076873 001 Dec 14, 2004
AB1 SUN PHARM INDS (IN) 500MG A077336 001 Feb 09, 2006
AB1 TEVA 500MG A076269 001 Jun 18, 2004
AB1 UNICHEM 500MG A213359 001 Aug 11, 2021
AB1 YICHANG HUMANWELL 500MG A211052 001 Sep 24, 2018
FORTAMET
AB2 + ANDRX LABS LLC 1GM N021574 002 Apr 27, 2004
METFORMIN HYDROCHLORIDE
AB2 AJANTA PHARMA LTD 500MG A213651 001 Apr 09, 2020
AB2 1GM A213651 002 Apr 09, 2020
AB2 LUPIN LTD 500MG A090692 001 Jun 29, 2011
AB2 ! 1GM A090692 002 Jun 29, 2011
AB2 MYLAN PHARMS INC 500MG A200690 001 Aug 01, 2012
AB2 1GM A200690 002 Aug 01, 2012
AB2 NOSTRUM LABS INC 500MG A203832 001 Dec 26, 2017
AB2 1GM A203832 002 Dec 26, 2017
AB2 NOVAST LABS 500MG A209674 001 Nov 02, 2018
AB2 1GM A209674 002 Nov 02, 2018
AB2 QINGDAO BAHEAL 500MG A209993 001 Dec 27, 2018
PHARM
AB2 1GM A209993 002 Dec 27, 2018
AB2 SCIEGEN PHARMS INC 500MG A214629 001 Feb 22, 2022
AB2 1GM A214629 002 Feb 22, 2022
AB2 TWI PHARMS 500MG A213247 001 Sep 29, 2021
AB2 1GM A213247 002 Sep 29, 2021
GLUMETZA
AB3 + SANTARUS INC 500MG N021748 001 Jun 03, 2005
AB3 +! 1GM N021748 002 Jun 03, 2005
METFORMIN HYDROCHLORIDE
AB3 ACTAVIS LABS FL INC 500MG A203755 001 Aug 01, 2016
AB3 1GM A203755 002 Aug 01, 2016
AB3 AJANTA PHARMA LTD 500MG A213962 001 Mar 09, 2021
AB3 1GM A213962 002 Mar 09, 2021
AB3 APOTEX 500MG A213356 001 Dec 13, 2021
AB3 1GM A213356 002 Dec 13, 2021
AB3 GLENMARK PHARMS LTD 500MG A212969 001 Nov 25, 2019
AB3 1GM A212969 002 Nov 25, 2019
AB3 GRANULES 500MG A213344 001 Jan 12, 2021
AB3 1GM A213344 002 Jan 12, 2021
AB3 LUPIN LTD 500MG A091664 001 Jul 19, 2013
AB3 1GM A091664 002 Jul 19, 2013
AB3 MICRO LABS 500MG A212448 001 Jan 10, 2023
AB3 1GM A212448 002 Jan 10, 2023
AB3 PRINSTON INC 500MG A212681 001 Jun 09, 2022
AB3 1GM A212681 002 Jun 09, 2022
AB3 SCIEGEN PHARMS INC 500MG A213334 001 Apr 16, 2021
AB3 1GM A213334 002 Apr 16, 2021
AB3 SUN PHARM 500MG A202917 001 Aug 01, 2016
AB3 1GM A202917 002 Aug 01, 2016
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
TABLET;ORAL
ACTOPLUS MET
AB +! TAKEDA PHARMS USA 850MG;EQ 15MG BASE N021842 002 Aug 29, 2005
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
AB AUROBINDO PHARMA 500MG;EQ 15MG BASE A200823 001 Feb 13, 2013
LTD
AB 850MG;EQ 15MG BASE A200823 002 Feb 13, 2013
AB MACLEODS PHARMS LTD 500MG;EQ 15MG BASE A204802 001 Nov 05, 2015
AB 850MG;EQ 15MG BASE A204802 002 Nov 05, 2015
AB TEVA PHARMS USA 500MG;EQ 15MG BASE A091155 001 Mar 10, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-298(of 474)

METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE


TABLET;ORAL
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
AB 850MG;EQ 15MG BASE A091155 002 Mar 10, 2014
METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
KOMBIGLYZE XR
+ ASTRAZENECA AB 500MG;EQ 5MG BASE N200678 001 Nov 05, 2010
+ 1GM;EQ 2.5MG BASE N200678 003 Nov 05, 2010
+! 1GM;EQ 5MG BASE N200678 002 Nov 05, 2010
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
TABLET;ORAL
JANUMET
+ MERCK SHARP DOHME 500MG;EQ 50MG BASE N022044 001 Mar 30, 2007
+! 1GM;EQ 50MG BASE N022044 002 Mar 30, 2007
TABLET, EXTENDED RELEASE;ORAL
JANUMET XR
+ MERCK SHARP DOHME 500MG;EQ 50MG BASE N202270 001 Feb 02, 2012
+ 1GM;EQ 50MG BASE N202270 002 Feb 02, 2012
+! 1GM;EQ 100MG BASE N202270 003 Feb 02, 2012
METHACHOLINE CHLORIDE
FOR SOLUTION;INHALATION
PROVOCHOLINE
+! METHAPHARM 100MG/VIAL N019193 001 Oct 31, 1986
METHADONE HYDROCHLORIDE
CONCENTRATE;ORAL
METHADONE HYDROCHLORIDE
AA HIKMA 10MG/ML A040180 001 Apr 30, 1998
AA LANNETT CO INC 10MG/ML A212093 001 Nov 02, 2020
AA SPECGX LLC 10MG/ML A207368 001 Aug 22, 2019
AA VISTAPHARM 10MG/ML A040088 001 Nov 30, 1994
METHADONE HYDROCHLORIDE INTENSOL
AA HIKMA 10MG/ML A089897 001 Sep 06, 1988
METHADOSE
AA +! SPECGX LLC 10MG/ML N017116 002
INJECTABLE;INJECTION
METHADONE HYDROCHLORIDE
AP AKORN 10MG/ML A208306 001 Oct 27, 2017
AP +! MYLAN INSTITUTIONAL 10MG/ML N021624 001
SOLUTION;ORAL
METHADONE HYDROCHLORIDE
AA +! HIKMA 5MG/5ML A087393 001
AA +! 10MG/5ML A087997 001 Aug 30, 1982
AA SPECGX LLC 5MG/5ML A207537 001 Oct 02, 2019
AA 10MG/5ML A207537 002 Oct 01, 2019
AA VISTAPHARM 5MG/5ML A090707 001 Jun 30, 2010
AA 10MG/5ML A090707 002 Jun 30, 2010
TABLET;ORAL
METHADONE HYDROCHLORIDE
AA ASCENT PHARMS INC 5MG A211228 001 Jan 03, 2019
AA 10MG A211228 002 Jan 03, 2019
AA AUROLIFE PHARMA LLC 5MG A203502 001 Aug 31, 2015
AA 10MG A203502 002 Aug 31, 2015
AA EPIC PHARMA LLC 5MG A090065 001 Aug 18, 2015
AA 10MG A090065 002 Aug 18, 2015
AA ROXANE 5MG A088108 001 Mar 08, 1983
AA 10MG A088109 001 Mar 08, 1983
AA ! SPECGX LLC 5MG A040517 001 Apr 27, 2004
AA ! 10MG A040517 002 Apr 27, 2004
AA SUN PHARM 5MG A208305 001 Mar 30, 2018
INDUSTRIES
AA 10MG A208305 002 Mar 30, 2018
AA THEPHARMANETWORK 5MG A090635 002 Sep 22, 2020
LLC
AA 10MG A090635 001 Nov 25, 2009
AA VISTAPHARM 10MG A040241 002 May 29, 1998
AA 10MG A204166 001 Mar 16, 2020
TABLET, FOR SUSPENSION;ORAL
METHADONE HYDROCHLORIDE
AA +! HIKMA 40MG N017058 001
AA SPECGX LLC 40MG A077142 001 Jul 12, 2005
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-299(of 474)

METHADONE HYDROCHLORIDE
TABLET, FOR SUSPENSION;ORAL
METHADONE HYDROCHLORIDE
AA VISTAPHARM 40MG A075082 001 Mar 25, 1998
METHADOSE
AA SPECGX LLC 40MG A074184 001 Apr 29, 1993
METHAMPHETAMINE HYDROCHLORIDE
TABLET;ORAL
DESOXYN
AA +! KEY THERAP 5MG N005378 002
METHAMPHETAMINE HYDROCHLORIDE
AA HIKMA 5MG A203846 001 Nov 17, 2015
AA MAYNE PHARMA INC 5MG A091189 001 Apr 21, 2010
METHAZOLAMIDE
TABLET;ORAL
METHAZOLAMIDE
AB ANI PHARMS 25MG A040001 001 Jun 30, 1993
AB 50MG A040001 002 Jun 30, 1993
AB BAUSCH AND LOMB INC 25MG A207438 001 Oct 05, 2018
AB 50MG A207438 002 Oct 05, 2018
AB MIKART 25MG A040062 001 Jan 27, 1994
AB ! 50MG A040062 002 Jan 27, 1994
AB SANDOZ 25MG A040036 001 Jun 30, 1993
AB 50MG A040036 002 Jun 30, 1993
AB TAGI 25MG A215615 001 Oct 18, 2022
AB 50MG A215615 002 Oct 18, 2022
METHENAMINE HIPPURATE
TABLET;ORAL
HIPREX
AB + VALIDUS PHARMS 1GM N017681 001
METHENAMINE HIPPURATE
AB ! AUROBINDO PHARMA 1GM A205661 001 Jul 05, 2016
LTD
AB MICRO LABS 1GM A212172 001 Aug 01, 2019
AB NOVAST LABS 1GM A210068 001 Nov 27, 2020
UREX
AB ALVOGEN 1GM N016151 001
METHIMAZOLE
TABLET;ORAL
METHIMAZOLE
AB AIPING LIFE SCI 5MG A040547 001 Feb 18, 2005
AB 10MG A040547 002 Feb 18, 2005
AB CHARTWELL RX 5MG A040411 001 Mar 27, 2001
AB 10MG A040411 002 Mar 27, 2001
AB HERITAGE PHARMA 5MG A040734 001 Dec 14, 2007
AB 10MG A040734 002 Dec 14, 2007
AB MYLAN 5MG A040350 001 Mar 29, 2000
AB ! 10MG A040350 002 Mar 29, 2000
AB RISING 5MG A202068 001 Mar 07, 2012
AB 10MG A202068 002 Mar 07, 2012
METHOCARBAMOL
SOLUTION;IM-IV
METHOCARBAMOL
AP AM REGENT 1GM/10ML (100MG/ML) A207496 001 Jun 22, 2017
AP BAXTER HLTHCARE 1GM/10ML (100MG/ML) A215065 001 Jul 14, 2022
CORP
AP EUGIA PHARMA 1GM/10ML (100MG/ML) A206128 001 May 27, 2016
AP FRESENIUS KABI USA 1GM/10ML (100MG/ML) A209331 001 Apr 17, 2018
AP GLAND PHARMA LTD 1GM/10ML (100MG/ML) A211504 001 Oct 26, 2018
AP HAINAN POLY 1GM/10ML (100MG/ML) A208116 001 Jan 19, 2017
AP MONTEREY PHARMS LLC 1GM/10ML (100MG/ML) A205354 001 Oct 27, 2016
AP NAVINTA LLC 1GM/10ML (100MG/ML) A206071 001 Nov 24, 2017
AP SAGENT PHARMS INC 1GM/10ML (100MG/ML) A205404 001 Jul 18, 2017
AP SOMERSET THERAPS 1GM/10ML (100MG/ML) A207522 001 Jul 31, 2017
LLC
ROBAXIN
AP +! HIKMA 1GM/10ML (100MG/ML) N011790 001
TABLET;ORAL
METHOCARBAMOL
AA ACME LABS 500MG A203550 001 Feb 08, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-300(of 474)

METHOCARBAMOL
TABLET;ORAL
METHOCARBAMOL
AA 750MG A203550 002 Feb 08, 2017
AA AUSTARPHARMA LLC 500MG A200958 001 Oct 21, 2011
AA 750MG A200958 002 Oct 21, 2011
AA BEXIMCO PHARMS USA 500MG A208507 001 Jul 21, 2017
AA 750MG A208507 002 Jul 21, 2017
AA ! GRANULES 500MG A209312 001 May 07, 2018
AA ! 750MG A209312 002 May 07, 2018
AA HETERO LABS LTD III 500MG A090200 001 Nov 06, 2009
AA 750MG A090200 002 Nov 06, 2009
AA MLV 500MG A212623 001 Apr 30, 2021
AA 750MG A212623 002 Apr 30, 2021
AA OXFORD PHARMS 500MG A040489 001 Jan 29, 2003
AA 750MG A040489 002 Jan 29, 2003
AA PRINSTON INC 500MG A086988 002
AA 750MG A086988 001
! AUSTARPHARMA LLC 1GM A200958 003 Dec 06, 2021
METHOHEXITAL SODIUM
INJECTABLE;INJECTION
BREVITAL SODIUM
+! PAR STERILE 500MG/VIAL N011559 001
PRODUCTS
METHOTREXATE
SOLUTION;ORAL
JYLAMVO
+! THERAKIND 2MG/ML N212479 001 Nov 29, 2022
SOLUTION;SUBCUTANEOUS
OTREXUP
+! OTTER PHARMS 10MG/0.4ML (10MG/0.4ML) N204824 001 Oct 11, 2013
+! 12.5MG/0.4ML (12.5MG/0.4ML) N204824 006 Mar 24, 2016
+! 15MG/0.4ML (15MG/0.4ML) N204824 002 Oct 11, 2013
+! 17.5MG/0.4ML (17.5MG/0.4ML) N204824 007 Mar 24, 2016
+! 20MG/0.4ML (20MG/0.4ML) N204824 003 Oct 11, 2013
+! 22.5MG/0.4ML (22.5MG/0.4ML) N204824 008 Mar 24, 2016
+! 25MG/0.4ML (25MG/0.4ML) N204824 004 Oct 11, 2013
RASUVO
+! MEDEXUS 7.5MG/0.15ML (7.5MG/0.15ML) N205776 001 Jul 10, 2014
+! 10MG/0.20ML (10MG/0.20ML) N205776 002 Jul 10, 2014
+! 12.5MG/0.25ML (12.5MG/0.25ML) N205776 003 Jul 10, 2014
+! 15MG/0.30ML (15MG/0.30ML) N205776 004 Jul 10, 2014
+! 17.5MG/0.35ML (17.5MG/0.35ML) N205776 005 Jul 10, 2014
+! 20MG/0.4ML (20MG/0.4ML) N205776 006 Jul 10, 2014
+! 22.5MG/0.45ML (22.5MG/0.45ML) N205776 007 Jul 10, 2014
+! 25MG/0.5ML (25MG/0.5ML) N205776 008 Jul 10, 2014
+! 30MG/0.6ML (30MG/0.6ML) N205776 010 Jul 10, 2014
REDITREX
+! NORDIC GRP 15MG/0.6ML (15MG/0.6ML) N210737 004 Nov 27, 2019
+! 20MG/0.8ML (20MG/0.8ML) N210737 006 Nov 27, 2019
+! 25MG/1ML (25MG/1ML) N210737 008 Nov 27, 2019
METHOTREXATE SODIUM
INJECTABLE;INJECTION
METHOTREXATE PRESERVATIVE FREE
AP FRESENIUS KABI USA EQ 1GM BASE/VIAL A040266 001 Feb 26, 1999
METHOTREXATE SODIUM
AP ! FRESENIUS KABI USA EQ 50MG BASE/2ML (EQ 25MG BASE/ML) A040263 001 Feb 26, 1999
AP ! HIKMA EQ 100MG BASE/4ML (EQ 25MG BASE/ML) A089341 001 Sep 16, 1986
AP +! HOSPIRA EQ 50MG BASE/2ML (EQ 25MG BASE/ML) N011719 010 Dec 15, 2004
METHOTREXATE SODIUM PRESERVATIVE FREE
AP ! ACCORD HLTHCARE EQ 50MG BASE/2ML (EQ 25MG BASE/ML) A040767 001 Apr 30, 2007
AP ! EQ 250MG BASE/10ML (EQ 25MG BASE/ML) A040768 001 Apr 30, 2007
AP ! EQ 1GM BASE/40ML (EQ 25MG BASE/ML) A040716 001 Apr 30, 2007
AP ! HIKMA EQ 50MG BASE/2ML (EQ 25MG BASE/ML) A089340 001 Sep 16, 1986
AP EQ 250MG BASE/10ML (EQ 25MG BASE/ML) A089343 001 Sep 16, 1986
AP +! HOSPIRA EQ 1GM BASE/40ML (EQ 25MG BASE/ML) N011719 012 Apr 13, 2005
AP PHARMACHEMIE BV EQ 50MG BASE/2ML (EQ 25MG BASE/ML) A040843 002 Jan 11, 2010
AP EQ 250MG BASE/10ML (EQ 25MG BASE/ML) A040843 004 Jan 11, 2010
AP EQ 1GM BASE/40ML (EQ 25MG BASE/ML) A040843 001 Jan 11, 2010
AP SAGENT PHARMS INC EQ 50MG BASE/2ML (EQ 25MG BASE/ML) A203407 001 Aug 09, 2018
AP EQ 250MG BASE/10ML (EQ 25MG BASE/ML) A203407 002 Aug 09, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-301(of 474)

METHOTREXATE SODIUM
INJECTABLE;INJECTION
METHOTREXATE SODIUM PRESERVATIVE FREE
AP EQ 1GM BASE/40ML (EQ 25MG BASE/ML) A203407 003 Aug 09, 2018
AP SANDOZ INC EQ 50MG BASE/2ML (EQ 25MG BASE/ML) A090039 001 Mar 31, 2009
AP EQ 250MG BASE/10ML (EQ 25MG BASE/ML) A090039 002 Mar 31, 2009
AP EQ 1GM BASE/40ML (EQ 25MG BASE/ML) A090029 001 Mar 31, 2009
METHOTREXATE SODIUM
! HIKMA EQ 200MG BASE/8ML (EQ 25MG BASE/ML) A089342 001 Sep 16, 1986
METHOTREXATE SODIUM PRESERVATIVE FREE
! HIKMA EQ 1GM BASE/VIAL A040632 001 Aug 12, 2005
PHARMACHEMIE BV EQ 100MG BASE/4ML (EQ 25MG BASE/ML) A040843 003 Feb 27, 2012
SOLUTION;ORAL
XATMEP
+! AZURITY EQ 2.5MG BASE/ML N208400 001 Apr 25, 2017
TABLET;ORAL
METHOTREXATE SODIUM
AB ACCORD HLTHCARE EQ 2.5MG BASE A213343 001 Jan 24, 2020
AB AMNEAL PHARMS EQ 2.5MG BASE A210040 001 Dec 22, 2017
AB BARR EQ 2.5MG BASE A081099 001 Oct 15, 1990
AB EUGIA PHARMA EQ 2.5MG BASE A210454 001 Jan 30, 2020
AB ! HIKMA EQ 2.5MG BASE A040054 001 Aug 01, 1994
AB LOTUS PHARM CO LTD EQ 2.5MG BASE A209787 001 Apr 23, 2021
AB MYLAN EQ 2.5MG BASE A081235 001 May 15, 1992
AB SUN PHARM EQ 2.5MG BASE A201749 001 May 21, 2015
AB ZYDUS PHARMS EQ 2.5MG BASE A207812 001 Jan 13, 2017
TREXALL
BARR EQ 5MG BASE A040385 001 Mar 21, 2001
EQ 7.5MG BASE A040385 002 Mar 21, 2001
EQ 10MG BASE A040385 003 Mar 21, 2001
! EQ 15MG BASE A040385 004 Mar 21, 2001
METHOXSALEN
CAPSULE;ORAL
METHOXSALEN
AB STRIDES PHARMA 10MG A202687 001 Jun 05, 2014
OXSORALEN-ULTRA
AB +! BAUSCH 10MG N019600 001 Oct 30, 1986
INJECTABLE;INJECTION
UVADEX
+! MALLINCKRODT HOSP 0.02MG/ML N020969 001 Feb 25, 1999
METHSCOPOLAMINE BROMIDE
TABLET;ORAL
METHSCOPOLAMINE BROMIDE
AA BAYSHORE PHARMS LLC 2.5MG A200602 001 Sep 24, 2012
AA ! 5MG A200602 002 Sep 24, 2012
AA BRECKENRIDGE PHARM 2.5MG A040642 001 Dec 06, 2011
AA 5MG A040642 002 Dec 06, 2011
METHSUXIMIDE
CAPSULE;ORAL
CELONTIN
+! PARKE DAVIS 300MG N010596 008
METHYLENE BLUE
SOLUTION;INTRAVENOUS
PROVAYBLUE
+! PROVEPHARM SAS 10MG/2ML (5MG/ML) N204630 002 Jul 18, 2019
+! 50MG/10ML (5MG/ML) N204630 001 Apr 08, 2016
METHYLERGONOVINE MALEATE
INJECTABLE;INJECTION
METHERGINE
AP +! EDISON THERAPS LLC 0.2MG/ML N006035 004
METHYLERGONOVINE MALEATE
AP AM REGENT 0.2MG/ML A090193 001 Nov 24, 2008
AP BRECKENRIDGE 0.2MG/ML A040889 001 Sep 13, 2010
TABLET;ORAL
METHYLERGONOVINE MALEATE
AB AMNEAL PHARMS 0.2MG A211483 001 Sep 10, 2018
AB GRANULES 0.2MG A210424 001 May 15, 2018
AB ! NOVEL LABS INC 0.2MG A091577 001 May 02, 2011
AB RISING 0.2MG A211919 001 Jan 15, 2021
AB TEVA PHARMS USA 0.2MG A211455 001 Mar 20, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-302(of 474)

METHYLERGONOVINE MALEATE
TABLET;ORAL
METHYLERGONOVINE MALEATE
AB TULEX PHARMS INC 0.2MG A212233 001 May 01, 2020
METHYLNALTREXONE BROMIDE
SOLUTION;SUBCUTANEOUS
RELISTOR
+! SALIX PHARMS 8MG/0.4ML (8MG/0.4ML) N021964 002 Sep 27, 2010
+! 12MG/0.6ML (12MG/0.6ML) N021964 001 Apr 24, 2008
+! 12MG/0.6ML (12MG/0.6ML) N021964 003 Sep 27, 2010
TABLET;ORAL
RELISTOR
+! SALIX 150MG N208271 001 Jul 19, 2016
METHYLPHENIDATE
FILM, EXTENDED RELEASE;TRANSDERMAL
DAYTRANA
AB + NOVEN PHARMS INC 10MG/9HR (1.1MG/HR) N021514 001 Apr 06, 2006
AB + 15MG/9HR (1.6MG/HR) N021514 002 Apr 06, 2006
AB + 20MG/9HR (2.2MG/HR) N021514 003 Apr 06, 2006
AB +! 30MG/9HR (3.3MG/HR) N021514 004 Apr 06, 2006
METHYLPHENIDATE
AB MYLAN TECH VIATRIS 10MG/9HR (1.1MG/HR) A206497 001 Mar 14, 2022
AB 15MG/9HR (1.6MG/HR) A206497 002 Mar 14, 2022
AB 20MG/9HR (2.2MG/HR) A206497 003 Mar 14, 2022
AB 30MG/9HR (3.3MG/HR) A206497 004 Mar 14, 2022
TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
COTEMPLA XR-ODT
+ NEOS THERAPS INC 8.6MG N205489 001 Jun 19, 2017
+ 17.3MG N205489 002 Jun 19, 2017
+! 25.9MG N205489 003 Jun 19, 2017
METHYLPHENIDATE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
METHYLPHENIDATE HYDROCHLORIDE
AB1 GRANULES 10MG A211796 001 May 23, 2019
AB1 20MG A211796 002 May 23, 2019
AB1 30MG A211796 003 May 23, 2019
AB1 40MG A211796 004 May 23, 2019
AB1 60MG A211796 005 May 23, 2019
AB1 MAYNE PHARMA 10MG A200886 001 Feb 26, 2018
AB1 20MG A078458 001 Dec 01, 2011
AB1 30MG A078458 002 Dec 01, 2011
AB1 40MG A078458 003 Dec 01, 2011
AB1 ! 60MG A078458 004 Jun 23, 2016
RITALIN LA
AB1 + NOVARTIS 10MG N021284 004 Apr 10, 2004
AB1 + 20MG N021284 001 Jun 05, 2002
AB1 + 30MG N021284 002 Jun 05, 2002
AB1 + 40MG N021284 003 Jun 05, 2002
METADATE CD
AB2 + AYTU BIOPHARMA 10MG N021259 003 May 27, 2003
AB2 + 20MG N021259 001 Apr 03, 2001
AB2 + 30MG N021259 002 Jun 19, 2003
AB2 + 40MG N021259 004 Feb 19, 2006
AB2 + 50MG N021259 005 Feb 19, 2006
AB2 +! 60MG N021259 006 Feb 19, 2006
METHYLPHENIDATE HYDROCHLORIDE
AB2 IMPAX LABS INC 10MG A205105 001 Jul 28, 2016
AB2 20MG A205105 002 Jul 28, 2016
AB2 30MG A205105 003 Jul 28, 2016
AB2 40MG A205105 004 Jul 28, 2016
AB2 50MG A205105 005 Jul 28, 2016
AB2 60MG A205105 006 Jul 28, 2016
AB2 SPECGX LLC 10MG A203583 001 Sep 29, 2015
AB2 20MG A203583 002 Sep 29, 2015
AB2 30MG A203583 003 Sep 29, 2015
AB2 40MG A203583 004 Sep 29, 2015
AB2 50MG A203583 005 Sep 29, 2015
AB2 60MG A203583 006 Sep 29, 2015
AB2 TEVA PHARMS 10MG A077707 001 Jul 19, 2012
AB2 20MG A077707 002 Jul 19, 2012
AB2 30MG A077707 003 Jul 19, 2012
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-303(of 474)

METHYLPHENIDATE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
METHYLPHENIDATE HYDROCHLORIDE
AB2 40MG A078873 001 Jul 19, 2012
AB2 50MG A078873 002 Jul 19, 2012
AB2 60MG A078873 003 Jul 19, 2012
APTENSIO XR
AB3 + RHODES PHARMS 10MG N205831 001 Apr 17, 2015
AB3 + 15MG N205831 002 Apr 17, 2015
AB3 + 20MG N205831 003 Apr 17, 2015
AB3 + 30MG N205831 004 Apr 17, 2015
AB3 + 40MG N205831 005 Apr 17, 2015
AB3 + 50MG N205831 006 Apr 17, 2015
AB3 +! 60MG N205831 007 Apr 17, 2015
METHYLPHENIDATE HYDROCHLORIDE
AB3 ACTAVIS ELIZABETH 10MG A208861 001 Dec 13, 2018
AB3 15MG A208861 002 Dec 13, 2018
AB3 20MG A208861 003 Dec 13, 2018
AB3 30MG A208861 004 Dec 13, 2018
AB3 40MG A208861 005 Dec 13, 2018
AB3 50MG A208861 006 Dec 13, 2018
AB3 60MG A208861 007 Dec 13, 2018
JORNAY PM
+ IRONSHORE PHARMS 20MG N209311 001 Aug 08, 2018
+ 40MG N209311 002 Aug 08, 2018
+ 60MG N209311 003 Aug 08, 2018
+ 80MG N209311 004 Aug 08, 2018
+! 100MG N209311 005 Aug 08, 2018
FOR SUSPENSION, EXTENDED RELEASE;ORAL
METHYLPHENIDATE HYDROCHLORIDE
AB ACTAVIS LABS FL INC 5MG/ML A206049 001 May 17, 2018
QUILLIVANT XR
AB +! NEXTWAVE 5MG/ML N202100 001 Sep 27, 2012
SOLUTION;ORAL
METHYLIN
AA +! SPECGX LLC 5MG/5ML N021419 001 Dec 19, 2002
AA +! 10MG/5ML N021419 002 Dec 19, 2002
METHYLPHENIDATE HYDROCHLORIDE
AA ABHAI LLC 5MG/5ML A207485 001 Nov 18, 2016
AA 10MG/5ML A207485 002 Nov 18, 2016
AA ALKEM LABS LTD 5MG/5ML A211647 001 Mar 30, 2020
AA 10MG/5ML A211647 002 Mar 30, 2020
AA ANDA REPOSITORY 5MG/5ML A210764 001 Apr 10, 2020
AA 10MG/5ML A210764 002 Apr 10, 2020
AA ASCENT PHARMS INC 5MG/5ML A207417 001 Jan 29, 2021
AA 10MG/5ML A207417 002 Jan 29, 2021
AA BRECKENRIDGE 5MG/5ML A201466 001 Nov 12, 2013
AA 10MG/5ML A201466 002 Nov 12, 2013
AA EYWA 5MG/5ML A210139 001 Oct 03, 2018
AA 10MG/5ML A210139 002 Oct 03, 2018
AA NOVEL LABS INC 5MG/5ML A204602 001 Aug 14, 2015
AA 10MG/5ML A204602 002 Aug 14, 2015
AA QUAGEN 5MG/5ML A213567 001 Jun 04, 2020
AA 10MG/5ML A213567 002 Jun 04, 2020
AA TRIS PHARMA INC 5MG/5ML A091601 001 Jul 23, 2010
AA 10MG/5ML A091601 002 Jul 23, 2010
TABLET;ORAL
METHYLPHENIDATE HYDROCHLORIDE
AB ABHAI INC 5MG A206932 001 May 11, 2017
AB 10MG A206932 002 May 11, 2017
AB 20MG A206932 003 May 11, 2017
AB ACCORD HLTHCARE 5MG A213936 001 Oct 28, 2020
AB 10MG A213936 002 Oct 28, 2020
AB 20MG A213936 003 Oct 28, 2020
AB ALKEM LABS LTD 5MG A211779 001 Oct 04, 2019
AB 10MG A211779 002 Oct 04, 2019
AB 20MG A211779 003 Oct 04, 2019
AB ASCENT PHARMS INC 5MG A207416 001 Sep 22, 2015
AB 10MG A207416 002 Sep 22, 2015
AB 20MG A207416 003 Sep 22, 2015
AB BIONPHARMA INC 5MG A209753 001 Mar 02, 2018
AB 10MG A209753 002 Mar 02, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-304(of 474)

METHYLPHENIDATE HYDROCHLORIDE
TABLET;ORAL
METHYLPHENIDATE HYDROCHLORIDE
AB 20MG A209753 003 Mar 02, 2018
AB MOUNTAIN 5MG A091159 001 Mar 12, 2014
AB 10MG A091159 002 Mar 12, 2014
AB 20MG A091159 003 Mar 12, 2014
AB NOVEL LABS INC 5MG A207884 001 Nov 13, 2015
AB 10MG A207884 002 Nov 13, 2015
AB 20MG A207884 003 Nov 13, 2015
AB OXFORD PHARMS 5MG A202892 001 Sep 23, 2014
AB 10MG A202892 002 Sep 23, 2014
AB 20MG A202892 003 Sep 23, 2014
AB PRINSTON INC 5MG A212697 001 Jul 23, 2020
AB 10MG A212697 002 Jul 23, 2020
AB 20MG A212697 003 Jul 23, 2020
AB SPECGX LLC 5MG A040300 001 Nov 27, 1998
AB 10MG A040300 002 Nov 27, 1998
AB 20MG A040300 003 Nov 27, 1998
AB SUN PHARM INDS INC 5MG A090710 001 Mar 15, 2012
AB 10MG A090710 002 Mar 15, 2012
AB 20MG A090710 003 Mar 15, 2012
RITALIN
AB + NOVARTIS 5MG N010187 003
AB + 10MG N010187 006
AB +! 20MG N010187 010
TABLET, CHEWABLE;ORAL
METHYLPHENIDATE HYDROCHLORIDE
AB ASCENT PHARMS INC 2.5MG A210354 001 Dec 29, 2017
AB 5MG A210354 002 Dec 29, 2017
AB ! 10MG A210354 003 Dec 29, 2017
AB RISING 2.5MG A205756 001 Nov 07, 2016
AB 5MG A205756 002 Nov 07, 2016
AB 10MG A205756 003 Nov 07, 2016
TABLET, EXTENDED RELEASE;ORAL
CONCERTA
AB + JANSSEN PHARMS 18MG N021121 001 Aug 01, 2000
AB + 27MG N021121 004 Apr 01, 2002
AB + 36MG N021121 002 Aug 01, 2000
AB +! 54MG N021121 003 Dec 08, 2000
METHYLIN ER
AB SPECGX LLC 10MG A075629 001 May 09, 2000
AB 20MG A075629 002 May 09, 2000
METHYLPHENIDATE HYDROCHLORIDE
AB ABHAI LLC 10MG A207488 001 Jun 09, 2015
AB ! 20MG A207488 002 Jun 09, 2015
AB ACTAVIS LABS FL 18MG A076772 001 Mar 22, 2018
AB 27MG A076772 002 Mar 22, 2018
AB 36MG A076772 003 Mar 22, 2018
AB 54MG A076655 001 Mar 21, 2018
AB 72MG A076655 002 Feb 28, 2022
AB ALKEM LABS LTD 20MG A212288 001 Oct 06, 2020
AB ANDOR PHARMS 18MG A211918 001 Apr 24, 2019
AB 27MG A211918 002 Apr 24, 2019
AB 36MG A211918 003 Apr 24, 2019
AB 54MG A211918 004 Apr 24, 2019
AB ASCENT PHARMS INC 18MG A211009 001 Sep 03, 2019
AB 27MG A211009 002 Sep 03, 2019
AB 36MG A211009 003 Sep 03, 2019
AB 54MG A211009 004 Sep 03, 2019
AB AUROLIFE PHARMA LLC 18MG A206726 001 Oct 21, 2016
AB 27MG A206726 002 Oct 21, 2016
AB 36MG A206726 003 Oct 21, 2016
AB 54MG A206726 004 Oct 21, 2016
AB DR REDDYS 18MG A213473 001 Jul 29, 2020
AB 27MG A213473 002 Jul 29, 2020
AB 36MG A213473 003 Jul 29, 2020
AB 54MG A213473 004 Jul 29, 2020
AB GRANULES 10MG A210992 001 Nov 21, 2018
AB 20MG A210992 002 Nov 21, 2018
AB OSMOTICA 18MG A205327 001 Jul 28, 2017
AB 27MG A205327 002 Jul 28, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-305(of 474)

METHYLPHENIDATE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
METHYLPHENIDATE HYDROCHLORIDE
AB 36MG A205327 003 Jul 28, 2017
AB 54MG A205327 004 Jul 28, 2017
AB ! 72MG A205327 005 Jul 28, 2017
AB SUN PHARM INDS INC 18MG A205135 001 Aug 19, 2020
AB 27MG A205135 002 Aug 19, 2020
AB 36MG A205135 003 Aug 19, 2020
AB 54MG A205135 004 Aug 19, 2020
BX AMNEAL PHARMS 18MG A207515 001 Feb 01, 2018
BX 27MG A207515 002 Feb 01, 2018
BX 36MG A207515 003 Feb 01, 2018
BX 54MG A207515 004 Feb 01, 2018
BX LANNETT CO INC 18MG A091695 001 Jul 09, 2013
BX 27MG A091695 002 Jul 09, 2013
BX 36MG A091695 003 Sep 23, 2013
BX 54MG A091695 004 Sep 23, 2013
BX SPECGX LLC 27MG A202608 001 Dec 28, 2012
BX 36MG A202608 002 Dec 28, 2012
BX 54MG A202608 003 Dec 28, 2012
RELEXXII
+ OSMOTICA PHARM US 18MG N216117 001 Jun 23, 2022
+ 27MG N216117 002 Jun 23, 2022
+ 36MG N216117 003 Jun 23, 2022
+ 45MG N216117 004 Jun 23, 2022
+ 54MG N216117 005 Jun 23, 2022
+ 63MG N216117 006 Jun 23, 2022
+! 72MG N216117 007 Jun 23, 2022
TABLET, EXTENDED RELEASE, CHEWABLE;ORAL
QUILLICHEW ER
+ NEXTWAVE PHARMS 20MG N207960 001 Dec 04, 2015
+ 30MG N207960 002 Dec 04, 2015
+! 40MG N207960 003 Dec 04, 2015
METHYLPREDNISOLONE
TABLET;ORAL
MEDROL
AB + PFIZER 2MG N011153 002
AB + 4MG N011153 001
AB + 8MG N011153 004
AB + 16MG N011153 003
AB +! 32MG N011153 006
METHYLPREDNISOLONE
AB JUBILANT CADISTA 4MG A040189 001 Oct 31, 1997
AB 8MG A040189 002 Oct 31, 1997
AB 16MG A040189 003 Jul 20, 2007
AB 32MG A040189 004 Jul 20, 2007
AB PRAXGEN 4MG A212262 001 Jun 27, 2019
AB SANDOZ 4MG A040194 001 Oct 31, 1997
AB TIANJIN TIANYAO 4MG A204072 001 May 14, 2018
AB VINTAGE PHARMS 4MG A040183 001 Dec 22, 1998
AB WATSON LABS 4MG A040232 001 Oct 16, 1997
AB ZYDUS PHARMS 4MG A206751 001 Apr 23, 2018
AB 8MG A206751 002 Apr 23, 2018
AB 16MG A206751 003 Apr 23, 2018
AB 32MG A206751 004 Apr 23, 2018
METHYLPREDNISOLONE ACETATE
INJECTABLE;INJECTION
DEPO-MEDROL
AB + PFIZER 40MG/ML N011757 001
AB + 80MG/ML N011757 004
METHYLPREDNISOLONE ACETATE
AB ! AMNEAL 40MG/ML A210043 001 May 20, 2019
AB ! 80MG/ML A210043 002 May 20, 2019
AB PAR STERILE 80MG/ML A214297 002 Jan 21, 2022
PRODUCTS
AB ! SAGENT PHARMS INC 40MG/ML A201835 002 Jun 27, 2018
AB ! 80MG/ML A201835 003 Jun 27, 2018
AB SANDOZ INC 40MG/ML A040719 001 Jan 29, 2009
AB 40MG/ML A040794 001 Mar 05, 2009
AB 80MG/ML A040719 002 Jan 29, 2009
AB 80MG/ML A040794 002 Mar 05, 2009
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-306(of 474)

METHYLPREDNISOLONE ACETATE
INJECTABLE;INJECTION
METHYLPREDNISOLONE ACETATE
AB SLAYBACK PHARMA LLC 80MG/ML A214870 001 Jan 03, 2023
AB TEVA PHARMS USA 40MG/ML A040557 001 Feb 23, 2005
AB 40MG/ML A040620 001 Oct 27, 2006
AB 80MG/ML A040557 002 Feb 23, 2005
AB 80MG/ML A040620 002 Oct 27, 2006
DEPO-MEDROL
+! PFIZER 20MG/ML N011757 002
METHYLPREDNISOLONE SODIUM SUCCINATE
INJECTABLE;INJECTION
METHYLPREDNISOLONE SODIUM SUCCINATE
AP AMNEAL EQ 40MG BASE/VIAL A207549 001 Nov 09, 2016
AP EQ 125MG BASE/VIAL A207549 002 Nov 09, 2016
AP FRESENIUS KABI USA EQ 40MG BASE/VIAL A040583 001 Jul 30, 2004
AP EQ 125MG BASE/VIAL A040583 002 Jul 30, 2004
AP EQ 1GM BASE/VIAL A040612 001 Aug 12, 2004
AP HIKMA EQ 40MG BASE/VIAL A203125 001 Sep 26, 2022
AP EQ 125MG BASE/VIAL A203125 002 Sep 26, 2022
AP EQ 500MG BASE/VIAL A202691 001 Feb 16, 2016
AP EQ 1GM BASE/VIAL A202691 002 Feb 16, 2016
AP SAGENT PHARMS INC EQ 40MG BASE/VIAL A040888 001 Jul 18, 2011
AP EQ 125MG BASE/VIAL A040888 002 Jul 18, 2011
AP EQ 500MG BASE/VIAL A040888 003 Jul 18, 2011
AP EQ 1GM BASE/VIAL A040888 004 Jul 18, 2011
AP EQ 2GM BASE/VIAL A040888 005 Jul 18, 2011
AP TIANJIN KINGYORK EQ 40MG BASE/VIAL A212396 001 Apr 20, 2021
AP EQ 125MG BASE/VIAL A212396 002 Apr 20, 2021
AP EQ 500MG BASE/VIAL A212396 003 Apr 20, 2021
AP EQ 1GM BASE/VIAL A212396 004 Apr 20, 2021
AP EQ 2GM BASE/VIAL A212396 005 Apr 20, 2021
SOLU-MEDROL
AP +! PHARMACIA AND EQ 40MG BASE/VIAL N011856 003
UPJOHN
AP +! EQ 125MG BASE/VIAL N011856 004
AP +! EQ 500MG BASE/VIAL N011856 005
AP +! EQ 1GM BASE/VIAL N011856 006
AP +! EQ 2GM BASE/VIAL N011856 007 Feb 27, 1985
METHYLTESTOSTERONE
CAPSULE;ORAL
METHYLTESTOSTERONE
AB ! IMPAX LABS INC 10MG A204851 001 Sep 21, 2015
AB NOVITIUM PHARMA 10MG A215270 001 Feb 18, 2022
TABLET;ORAL
ANDROID 25
BP VALEANT PHARM INTL 25MG A087147 001
METHYLTESTOSTERONE
BP IMPAX LABS 10MG A080767 002
METOCLOPRAMIDE HYDROCHLORIDE
INJECTABLE;INJECTION
METOCLOPRAMIDE
AP EMCURE PHARMS LTD EQ 5MG BASE/ML A204756 001 Dec 20, 2013
METOCLOPRAMIDE HYDROCHLORIDE
AP FRESENIUS KABI USA EQ 5MG BASE/ML A091392 001 Apr 19, 2013
AP ! HOSPIRA EQ 5MG BASE/ML A073118 001 Jan 17, 1991
AP TEVA PHARMS USA EQ 5MG BASE/ML A073135 001 Nov 27, 1991
SOLUTION;ORAL
METOCLOPRAMIDE HYDROCHLORIDE
AA ANI PHARMS EQ 5MG BASE/5ML A071402 001 Jun 25, 1993
AA PHARM ASSOC EQ 5MG BASE/5ML A072744 001 May 28, 1991
AA VISTAPHARM EQ 5MG BASE/5ML A075051 001 Jan 26, 2001
AA ! WOCKHARDT BIO AG EQ 5MG BASE/5ML A074703 001 Oct 31, 1997
SPRAY, METERED;NASAL
GIMOTI
+! EVOKE PHARMA INC EQ 15MG BASE/SPRAY N209388 001 Jun 19, 2020
TABLET;ORAL
METOCLOPRAMIDE HYDROCHLORIDE
AB IMPAX LABS INC EQ 5MG BASE A071250 002 Dec 28, 1995
AB EQ 10MG BASE A071250 001 Feb 03, 1988
AB IPCA LABS LTD EQ 5MG BASE A078807 001 Jun 12, 2008
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-307(of 474)

METOCLOPRAMIDE HYDROCHLORIDE
TABLET;ORAL
METOCLOPRAMIDE HYDROCHLORIDE
AB EQ 10MG BASE A078807 002 Jun 12, 2008
AB STRIDES PHARMA EQ 5MG BASE A077878 001 Aug 28, 2006
AB EQ 10MG BASE A070581 001 Oct 17, 1985
AB EQ 10MG BASE A077878 002 Aug 28, 2006
AB TEVA EQ 5MG BASE A072801 001 Jun 15, 1993
AB EQ 10MG BASE A070184 001 Jul 29, 1985
REGLAN
AB + ANI PHARMS EQ 5MG BASE N017854 002 May 05, 1987
AB +! EQ 10MG BASE N017854 001
TABLET, ORALLY DISINTEGRATING;ORAL
METOCLOPRAMIDE HYDROCHLORIDE
NOVEL LABS INC EQ 5MG BASE A202191 001 Aug 15, 2014
! EQ 10MG BASE A202191 002 Aug 15, 2014
METOLAZONE
TABLET;ORAL
METOLAZONE
AB AACE PHARMS 2.5MG A216216 001 Oct 25, 2022
AB 5MG A216216 002 Oct 25, 2022
AB 10MG A216216 003 Oct 25, 2022
AB ALEMBIC PHARMS 2.5MG A213251 001 Dec 02, 2020
AB 5MG A213251 002 Dec 02, 2020
AB 10MG A213251 003 Dec 02, 2020
AB BAYSHORE PHARMS LLC 2.5MG A214799 001 Mar 30, 2021
AB 5MG A214799 002 Mar 30, 2021
AB 10MG A214799 003 Mar 30, 2021
AB INNOGENIX 2.5MG A213827 001 Mar 30, 2021
AB 5MG A213827 002 Mar 30, 2021
AB 10MG A213827 003 Mar 30, 2021
AB MYLAN 2.5MG A076698 001 Dec 23, 2003
AB 5MG A076698 002 Oct 19, 2004
AB 10MG A076698 003 Oct 19, 2004
AB RENATA 2.5MG A215616 001 Oct 24, 2022
AB 5MG A215616 002 Oct 24, 2022
AB 10MG A215616 003 Oct 24, 2022
AB RUBICON 2.5MG A215184 001 Aug 20, 2021
AB 5MG A215184 002 Aug 20, 2021
AB 10MG A215184 003 Aug 20, 2021
AB SANDOZ 2.5MG A076732 001 Dec 19, 2003
AB ! 5MG A076466 001 Dec 19, 2003
AB ! 10MG A076466 002 Dec 19, 2003
METOPROLOL SUCCINATE
CAPSULE, EXTENDED RELEASE;ORAL
KAPSPARGO SPRINKLE
+ SPIL EQ 25MG TARTRATE N210428 001 Jan 26, 2018
+ EQ 50MG TARTRATE N210428 002 Jan 26, 2018
+ EQ 100MG TARTRATE N210428 003 Jan 26, 2018
+! EQ 200MG TARTRATE N210428 004 Jan 26, 2018
TABLET, EXTENDED RELEASE;ORAL
METOPROLOL SUCCINATE
AB ACCORD HLTHCARE EQ 25MG TARTRATE A215637 001 Oct 18, 2022
AB EQ 50MG TARTRATE A215637 002 Oct 18, 2022
AB EQ 100MG TARTRATE A215637 003 Oct 18, 2022
AB EQ 200MG TARTRATE A215637 004 Oct 18, 2022
AB ACTAVIS ELIZABETH EQ 25MG TARTRATE A204161 001 Nov 25, 2016
AB EQ 50MG TARTRATE A204161 002 Nov 25, 2016
AB EQ 100MG TARTRATE A204161 003 Nov 25, 2016
AB EQ 200MG TARTRATE A204161 004 Nov 25, 2016
AB ACTAVIS LABS FL INC EQ 50MG TARTRATE A076862 001 Aug 03, 2009
AB ALKEM LABS LTD EQ 25MG TARTRATE A211143 001 Nov 25, 2020
AB EQ 50MG TARTRATE A211143 002 Nov 25, 2020
AB EQ 100MG TARTRATE A211143 003 Nov 25, 2020
AB EQ 200MG TARTRATE A211143 004 Nov 25, 2020
AB CIPLA EQ 50MG TARTRATE A207465 001 Oct 26, 2018
AB EQ 100MG TARTRATE A207465 002 Oct 26, 2018
AB EQ 200MG TARTRATE A207465 003 Oct 26, 2018
AB DR REDDYS LABS LTD EQ 25MG TARTRATE A090617 001 Aug 01, 2012
AB EQ 50MG TARTRATE A090617 002 Aug 01, 2012
AB HETERO LABS LTD III EQ 25MG TARTRATE A205541 001 Nov 06, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-308(of 474)

METOPROLOL SUCCINATE
TABLET, EXTENDED RELEASE;ORAL
METOPROLOL SUCCINATE
AB EQ 50MG TARTRATE A205541 002 Nov 06, 2020
AB EQ 100MG TARTRATE A205541 003 Nov 06, 2020
AB EQ 200MG TARTRATE A205541 004 Nov 06, 2020
AB MYLAN PHARMS INC EQ 25MG TARTRATE A202033 001 Dec 15, 2011
AB EQ 50MG TARTRATE A202033 002 Dec 15, 2011
AB EQ 100MG TARTRATE A202033 003 Dec 15, 2011
AB EQ 200MG TARTRATE A202033 004 Dec 15, 2011
AB NOVAST LABS EQ 25MG TARTRATE A204106 001 Feb 06, 2018
AB EQ 50MG TARTRATE A204106 002 Feb 06, 2018
AB EQ 100MG TARTRATE A204106 003 Feb 06, 2018
AB EQ 200MG TARTRATE A204106 004 Feb 06, 2018
AB PHARMADAX INC EQ 25MG TARTRATE A203028 001 Mar 31, 2020
AB EQ 50MG TARTRATE A203028 002 Mar 31, 2020
AB EQ 100MG TARTRATE A203699 001 Mar 30, 2020
AB EQ 200MG TARTRATE A203699 002 Mar 30, 2020
AB REDDYS EQ 100MG TARTRATE A078889 001 Aug 15, 2012
AB EQ 200MG TARTRATE A078889 002 Aug 15, 2012
AB SUNSHINE EQ 50MG TARTRATE A214004 001 Sep 26, 2022
AB EQ 100MG TARTRATE A214004 002 Sep 26, 2022
AB EQ 200MG TARTRATE A214004 003 Sep 26, 2022
AB VISUM PHARM EQ 25MG TARTRATE A207206 001 Dec 19, 2018
AB EQ 50MG TARTRATE A207206 002 Dec 19, 2018
AB EQ 100MG TARTRATE A207206 003 Dec 19, 2018
AB EQ 200MG TARTRATE A207206 004 Dec 19, 2018
AB WOCKHARDT EQ 25MG TARTRATE A090615 001 Jul 22, 2010
AB EQ 50MG TARTRATE A090615 002 Jul 22, 2010
AB EQ 100MG TARTRATE A090615 003 Jul 22, 2010
AB EQ 200MG TARTRATE A090615 004 Jul 22, 2010
AB YICHANG HUMANWELL EQ 25MG TARTRATE A213854 004 Aug 01, 2022
AB EQ 50MG TARTRATE A213854 003 Nov 08, 2021
AB EQ 100MG TARTRATE A213854 001 Feb 12, 2021
AB EQ 200MG TARTRATE A213854 002 Feb 12, 2021
AB ZYDUS PHARMS EQ 25MG TARTRATE A203894 001 Mar 23, 2018
AB EQ 50MG TARTRATE A203894 002 Mar 23, 2018
AB EQ 100MG TARTRATE A203894 003 Mar 23, 2018
AB EQ 200MG TARTRATE A203894 004 Mar 23, 2018
TOPROL-XL
AB + TOPROL EQ 25MG TARTRATE N019962 004 Feb 05, 2001
AB +! EQ 50MG TARTRATE N019962 001 Jan 10, 1992
AB + EQ 100MG TARTRATE N019962 002 Jan 10, 1992
AB +! EQ 200MG TARTRATE N019962 003 Jan 10, 1992
METOPROLOL TARTRATE
INJECTABLE;INJECTION
METOPROLOL TARTRATE
AP BAXTER HLTHCARE 1MG/ML A078950 001 Apr 29, 2013
CORP
AP FRESENIUS KABI USA 1MG/ML A091045 001 Oct 25, 2010
AP GLAND PHARMA LTD 1MG/ML A204205 001 Aug 27, 2014
AP HIKMA 1MG/ML A076495 001 Jul 07, 2003
AP HIKMA FARMACEUTICA 1MG/ML A077761 001 May 30, 2007
AP HOSPIRA 1MG/ML A074133 001 Dec 21, 1993
AP 1MG/ML A075160 001 Jul 06, 1998
AP ! 1MG/ML A078085 001 Apr 29, 2008
AP SANDOZ INC 1MG/ML A077360 001 Oct 02, 2007
TABLET;ORAL
LOPRESSOR
AB + VALIDUS PHARMS 50MG N017963 001
AB + 100MG N017963 002
METOPROLOL TARTRATE
AB ALEMBIC PHARMS LTD 25MG A202871 001 May 28, 2013
AB 50MG A202871 002 May 28, 2013
AB 100MG A202871 003 May 28, 2013
AB AUROBINDO PHARMA 25MG A077739 001 Sep 11, 2007
AB 50MG A077739 002 Sep 11, 2007
AB 100MG A077739 003 Sep 11, 2007
AB IPCA LABS LTD 25MG A078459 001 Jun 17, 2008
AB 50MG A078459 002 Jun 17, 2008
AB 100MG A078459 003 Jun 17, 2008
AB MYLAN 25MG A076704 001 Jan 16, 2004
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-309(of 474)

METOPROLOL TARTRATE
TABLET;ORAL
METOPROLOL TARTRATE
AB 37.5MG A076704 004 Mar 18, 2015
AB 50MG A076704 002 Jan 16, 2004
AB 75MG A076704 005 Mar 18, 2015
AB ! 100MG A076704 003 Jan 16, 2004
AB RUBICON 25MG A200981 001 Oct 28, 2014
AB 37.5MG A200981 004 Aug 21, 2019
AB 50MG A200981 002 Oct 28, 2014
AB 75MG A200981 005 Aug 21, 2019
AB 100MG A200981 003 Oct 28, 2014
AB SUN PHARM INDS INC 25MG A076670 001 Jan 15, 2004
AB 50MG A074644 001 Dec 10, 1996
AB 100MG A074644 002 Dec 10, 1996
AB YOUNGTECH PHARMS 25MG A208955 001 Feb 05, 2020
INC
AB 50MG A208955 002 Feb 05, 2020
AB 100MG A208955 003 Feb 05, 2020
METRONIDAZOLE
CAPSULE;ORAL
FLAGYL
AB +! PFIZER 375MG N020334 001 May 03, 1995
METRONIDAZOLE
AB ALEMBIC PHARMS 375MG A079065 001 Jun 23, 2009
AB STRIDES PHARMA 375MG A076522 001 Jan 29, 2004
CREAM;TOPICAL
METROCREAM
AB +! GALDERMA LABS LP 0.75% N020531 001 Sep 20, 1995
METRONIDAZOLE
AB COSETTE 0.75% A077549 001 Dec 19, 2007
AB FOUGERA PHARMS 0.75% A076408 001 May 28, 2004
NORITATE
+! BAUSCH 1% N020743 001 Sep 26, 1997
GEL;TOPICAL
METROGEL
AB +! GALDERMA LABS LP 0.75% N019737 001 Nov 22, 1988
AB +! 1% N021789 001 Jun 30, 2005
METRONIDAZOLE
AB ALEOR 1% A212646 001 Sep 03, 2021
DERMACEUTICALS
AB COSETTE 0.75% A078178 001 Jan 19, 2011
AB ENCUBE 0.75% A077547 001 Jul 13, 2006
AB FOUGERA PHARMS 0.75% A077018 001 Jun 06, 2006
AB TARO 0.75% A077819 001 Jul 18, 2006
AB 1% A204651 001 Mar 14, 2017
AB TOLMAR 1% A090903 001 Jul 22, 2011
GEL;VAGINAL
METROGEL-VAGINAL
AB +! BAUSCH 0.75% N020208 001 Aug 17, 1992
METRONIDAZOLE
AB GLENMARK PHARMS LTD 0.75% A215794 001 Jan 27, 2022
AB PADAGIS ISRAEL 0.75% A211786 001 Jul 02, 2019
AB SOLARIS PHARMA CORP 0.75% A213648 001 Oct 14, 2021
VANDAZOLE
BX ! TEVA PHARMS 0.75% N021806 001 May 20, 2005
NUVESSA
+! CHEMO RESEARCH SL 1.3% N205223 001 Mar 24, 2014
INJECTABLE;INJECTION
FLAGYL I.V. RTU IN PLASTIC CONTAINER
AP +! BAXTER HLTHCARE 500MG/100ML N018657 001
METRO I.V. IN PLASTIC CONTAINER
AP +! B BRAUN 500MG/100ML N018900 001 Sep 29, 1983
METRONIDAZOLE IN PLASTIC CONTAINER
AP BAXTER HLTHCARE 500MG/100ML A078084 001 Mar 31, 2008
CORP
AP GLAND PHARMA LTD 500MG/100ML A212435 001 Aug 03, 2020
AP +! HOSPIRA 500MG/100ML N018890 002 Nov 18, 1983
AP INFORLIFE 500MG/100ML A206191 001 Feb 25, 2019
LOTION;TOPICAL
METROLOTION
AB +! GALDERMA LABS LP 0.75% N020901 001 Nov 24, 1998
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-310(of 474)

METRONIDAZOLE
LOTION;TOPICAL
METRONIDAZOLE
AB FOUGERA PHARMS 0.75% A077197 001 May 24, 2006
TABLET;ORAL
FLAGYL
AB + PFIZER 250MG N012623 001
AB +! 500MG N012623 003
METRONIDAZOLE
AB ALEMBIC LABS 250MG A208681 001 Jun 20, 2017
AB 500MG A208681 002 Jun 20, 2017
AB ALEMBIC PHARMS LTD 250MG A079067 001 Mar 13, 2009
AB 500MG A079067 002 Mar 13, 2009
AB AMICI 250MG A070772 001 Jul 16, 1986
AB 500MG A070772 002 Jul 16, 1986
AB AUROBINDO PHARMA 250MG A203974 001 May 29, 2015
LTD
AB 500MG A203974 002 May 29, 2015
AB CADILA 250MG A206560 001 Nov 16, 2016
AB 500MG A206560 002 Nov 16, 2016
AB CADILA PHARMS LTD 250MG A209794 001 Dec 12, 2017
AB 500MG A209794 002 Dec 12, 2017
AB FLAMINGO PHARMS 250MG A207309 001 May 16, 2016
AB 500MG A207309 002 May 16, 2016
AB HERITAGE PHARMS INC 250MG A205245 001 Sep 23, 2015
AB 500MG A205245 002 Sep 23, 2015
AB LUPIN LTD 250MG A209096 001 Sep 12, 2017
AB 500MG A209096 002 Sep 12, 2017
AB PLIVA 500MG A070033 001 Dec 06, 1984
AB STRIDES PHARMA 250MG A070040 001 Jan 29, 1985
AB 250MG A208162 001 May 25, 2016
AB 500MG A070039 001 Jan 29, 1985
AB 500MG A208162 002 May 25, 2016
AB TEVA PHARMS USA 250MG A070027 001 Nov 06, 1984
AB UNICHEM 250MG A203458 001 Jan 22, 2014
AB 500MG A203458 002 Jan 22, 2014
AB WATSON LABS 250MG A070035 001 Dec 20, 1984
AB WATSON LABS INC 500MG A070044 001 Feb 08, 1985
METYRAPONE
CAPSULE;ORAL
METOPIRONE
+! HRA PHARMA 250MG N012911 002 Aug 09, 1996
METYROSINE
CAPSULE;ORAL
DEMSER
AB +! BAUSCH 250MG N017871 001
METYROSINE
AB AMNEAL 250MG A213734 001 Jul 24, 2020
MEXILETINE HYDROCHLORIDE
CAPSULE;ORAL
MEXILETINE HYDROCHLORIDE
AB ANI PHARMS 150MG A074450 001 May 16, 1996
AB 200MG A074450 002 May 16, 1996
AB 250MG A074450 003 May 16, 1996
AB ANNORA PHARMA 150MG A216463 001 Nov 09, 2022
AB 200MG A216463 002 Nov 09, 2022
AB 250MG A216463 003 Nov 09, 2022
AB AUCTA 150MG A215315 001 Aug 26, 2022
AB 200MG A215315 002 Aug 26, 2022
AB 250MG A215315 003 Aug 26, 2022
AB CROSSMEDIKA SA 150MG A213500 001 Jul 22, 2020
AB 200MG A213500 002 Jul 22, 2020
AB 250MG A213500 003 Jul 22, 2020
AB NOVAST LABS 150MG A214352 001 Jan 25, 2021
AB 200MG A214352 002 Jan 25, 2021
AB 250MG A214352 003 Jan 25, 2021
AB SENORES PHARMS 150MG A214089 001 Oct 01, 2021
AB 200MG A214089 002 Oct 01, 2021
AB 250MG A214089 003 Oct 01, 2021
AB TEVA 150MG A074377 001 May 16, 1995
AB 200MG A074377 002 May 16, 1995
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-311(of 474)

MEXILETINE HYDROCHLORIDE
CAPSULE;ORAL
MEXILETINE HYDROCHLORIDE
AB ! 250MG A074377 003 May 16, 1995
MICAFUNGIN SODIUM
INJECTABLE;INTRAVENOUS
MICAFUNGIN SODIUM
AP APOTEX EQ 50MG BASE/VIAL A208366 001 Nov 05, 2020
AP EQ 100MG BASE/VIAL A208366 002 Nov 05, 2020
AP FRESENIUS KABI USA EQ 50MG BASE/VIAL A207344 001 May 17, 2019
AP EQ 100MG BASE/VIAL A207344 002 May 17, 2019
AP HIKMA EQ 50MG BASE/VIAL A213261 001 Jul 09, 2021
AP EQ 100MG BASE/VIAL A213261 002 Jul 09, 2021
AP JIANGSU HANSOH EQ 50MG BASE/VIAL A213363 001 Jul 09, 2021
PHARM
AP EQ 100MG BASE/VIAL A213363 002 Jul 09, 2021
AP MEITHEAL EQ 50MG BASE/VIAL A215381 001 Sep 28, 2022
AP EQ 100MG BASE/VIAL A215381 002 Sep 28, 2022
AP XELLIA PHARMS APS EQ 50MG BASE/VIAL A211713 001 Jun 02, 2021
AP EQ 100MG BASE/VIAL A211713 002 Jun 02, 2021
AP ZYDUS PHARMS EQ 50MG BASE/VIAL A215241 001 Oct 24, 2022
AP EQ 100MG BASE/VIAL A215241 002 Oct 24, 2022
MYCAMINE
AP +! ASTELLAS EQ 50MG BASE/VIAL N021506 002 Mar 16, 2005
AP +! EQ 100MG BASE/VIAL N021506 003 Jun 27, 2006
POWDER;INTRAVENOUS
MICAFUNGIN
+! PAR STERILE EQ 50MG BASE/VIAL N212156 001 Jun 16, 2021
PRODUCTS
+! EQ 100MG BASE/VIAL N212156 002 Jun 16, 2021
MICONAZOLE
TABLET;BUCCAL
ORAVIG
+! GALT PHARMS 50MG N022404 001 Apr 16, 2010
MICONAZOLE NITRATE
SUPPOSITORY;VAGINAL
MICONAZOLE NITRATE
AB ACTAVIS PHARMA 200MG A073508 001 Nov 19, 1993
MONISTAT 3
AB +! MEDTECH PRODUCTS 200MG N018888 001 Aug 15, 1984
MICONAZOLE NITRATE; WHITE PETROLATUM; ZINC OXIDE
OINTMENT;TOPICAL
VUSION
+! MYLAN 0.25%;81.35%;15% N021026 001 Feb 16, 2006
MIDAZOLAM
SOLUTION;INTRAVENOUS
MIDAZOLAM IN 0.8% SODIUM CHLORIDE
+! EXELA PHARMA 50MG/50ML (1MG/ML) N215868 001 Jul 20, 2022
+! 100MG/100ML (1MG/ML) N215868 002 Jul 20, 2022
MIDAZOLAM IN 0.9% SODIUM CHLORIDE
+! INFORLIFE 50MG/50ML (1MG/ML) N211844 001 Mar 22, 2021
+! 100MG/100ML (1MG/ML) N211844 002 Mar 22, 2021
SPRAY;NASAL
NAYZILAM
+! UCB INC 5MG/SPRAY N211321 001 May 17, 2019
MIDAZOLAM HYDROCHLORIDE
INJECTABLE;INJECTION
MIDAZOLAM HYDROCHLORIDE
AP AKORN EQ 1MG BASE/ML A075494 001 Jun 30, 2000
AP EQ 5MG BASE/ML A075494 002 Jun 30, 2000
AP FRESENIUS KABI USA EQ 1MG BASE/ML A075154 002 Jun 20, 2000
AP EQ 5MG BASE/ML A075154 001 Jun 20, 2000
AP GLAND PHARMA LTD EQ 1MG BASE/ML A090696 001 Feb 29, 2012
AP EQ 5MG BASE/ML A090850 001 Jan 25, 2012
AP HIKMA EQ 1MG BASE/ML A075243 001 Jun 20, 2000
AP EQ 1MG BASE/ML A075247 002 Jun 23, 2000
AP EQ 1MG BASE/ML A075324 001 Jun 20, 2000
AP EQ 1MG BASE/ML A075421 002 Jun 20, 2000
AP EQ 1MG BASE/ML A212847 001 Dec 11, 2020
AP EQ 5MG BASE/ML A075243 002 Jun 20, 2000
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-312(of 474)

MIDAZOLAM HYDROCHLORIDE
INJECTABLE;INJECTION
MIDAZOLAM HYDROCHLORIDE
AP EQ 5MG BASE/ML A075247 001 Jun 23, 2000
AP EQ 5MG BASE/ML A075324 002 Jun 20, 2000
AP EQ 5MG BASE/ML A075421 001 Jun 20, 2000
AP EQ 5MG BASE/ML A212847 002 Dec 11, 2020
AP ! HOSPIRA EQ 1MG BASE/ML A075293 001 Jun 20, 2000
AP ! EQ 5MG BASE/ML A075293 002 Jun 20, 2000
MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE
AP FRESENIUS KABI USA EQ 1MG BASE/ML A203460 001 Aug 22, 2014
AP EQ 5MG BASE/ML A203460 002 Aug 22, 2014
AP ! HOSPIRA EQ 1MG BASE/ML A075857 001 Jul 22, 2002
AP ! EQ 5MG BASE/ML A075857 002 Jul 22, 2002
MIDAZOLAM HYDROCHLORIDE
FRESENIUS KABI USA EQ 5MG BASE/ML A208878 001 Mar 28, 2017
SOLUTION;INTRAMUSCULAR
SEIZALAM
+! MMT EQ 50MG BASE/10ML (EQ 5MG BASE/ML) N209566 001 Sep 14, 2018
SYRUP;ORAL
MIDAZOLAM HYDROCHLORIDE
AA ! HIKMA EQ 2MG BASE/ML A075873 001 Apr 30, 2002
AA PADAGIS US EQ 2MG BASE/ML A076379 001 May 02, 2005
MIDODRINE HYDROCHLORIDE
TABLET;ORAL
MIDODRINE HYDROCHLORIDE
AB ALEMBIC PHARMS 2.5MG A214734 001 Jan 21, 2021
AB 5MG A214734 002 Jan 21, 2021
AB 10MG A214734 003 Jan 21, 2021
AB APOTEX 2.5MG A077746 001 Sep 12, 2006
AB 5MG A077746 002 Sep 12, 2006
AB 10MG A077746 003 Sep 12, 2006
AB AUROBINDO PHARMA 2.5MG A212774 001 Aug 10, 2020
LTD
AB 5MG A212774 002 Aug 10, 2020
AB 10MG A212774 003 Aug 10, 2020
AB IMPAX PHARMS 2.5MG A076449 001 May 27, 2004
AB 5MG A076449 002 May 27, 2004
AB 10MG A076449 003 Dec 16, 2005
AB MYLAN PHARMS INC 2.5MG A076577 001 Sep 10, 2003
AB 5MG A076577 002 Sep 10, 2003
AB 10MG A076577 003 Sep 10, 2003
AB PAR PHARM INC 2.5MG A207169 001 Oct 29, 2018
AB 5MG A207169 002 Oct 29, 2018
AB 10MG A207169 003 Oct 29, 2018
AB RUBICON 2.5MG A212543 001 Aug 19, 2019
AB 5MG A212543 002 Aug 19, 2019
AB 10MG A212543 003 Aug 19, 2019
AB UNIQUE 2.5MG A207613 001 Nov 02, 2018
AB 5MG A207613 002 Nov 02, 2018
AB 10MG A207613 003 Nov 02, 2018
AB XIROMED 2.5MG A207849 001 Oct 01, 2020
AB 5MG A207849 002 Oct 01, 2020
AB 10MG A207849 003 Oct 01, 2020
AB ZYDUS 2.5MG A213055 001 Sep 01, 2020
AB 5MG A213055 002 Sep 01, 2020
AB 10MG A213055 003 Sep 01, 2020
ORVATEN
AB UPSHER SMITH LABS 2.5MG A076725 001 Nov 03, 2004
AB ! 5MG A076725 002 Nov 03, 2004
AB 10MG A076725 003 Nov 03, 2004
MIDOSTAURIN
CAPSULE;ORAL
RYDAPT
+! NOVARTIS 25MG N207997 001 Apr 28, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-313(of 474)

MIFEPRISTONE
TABLET;ORAL
KORLYM
AB +! CORCEPT THERAP 300MG N202107 001 Feb 17, 2012
MIFEPREX
AB +! DANCO LABS LLC 200MG N020687 001 Sep 28, 2000
MIFEPRISTONE
AB GENBIOPRO 200MG A091178 001 Apr 11, 2019
AB TEVA PHARMS USA INC 300MG A211436 001 Aug 03, 2020
MIGALASTAT HYDROCHLORIDE
CAPSULE;ORAL
GALAFOLD
+! AMICUS THERAP US EQ 123MG BASE N208623 001 Aug 10, 2018
MIGLITOL
TABLET;ORAL
GLYSET
AB +! PFIZER 25MG N020682 001 Dec 18, 1996
AB + 50MG N020682 002 Dec 18, 1996
AB + 100MG N020682 003 Dec 18, 1996
MIGLITOL
AB WESTMINSTER PHARMS 25MG A203965 001 Feb 24, 2015
AB 50MG A203965 002 Feb 24, 2015
AB 100MG A203965 003 Feb 24, 2015
MIGLUSTAT
CAPSULE;ORAL
MIGLUSTAT
AB ANI PHARMS 100MG A208342 001 Apr 17, 2018
AB BRECKENRIDGE 100MG A209325 001 Feb 03, 2022
AB EDENBRIDGE PHARMS 100MG A209821 001 Aug 06, 2020
ZAVESCA
AB +! ACTELION 100MG N021348 001 Jul 31, 2003
MILNACIPRAN HYDROCHLORIDE
TABLET;ORAL
SAVELLA
+ ALLERGAN 12.5MG N022256 001 Jan 14, 2009
+ 25MG N022256 002 Jan 14, 2009
+! 50MG N022256 003 Jan 14, 2009
+ 100MG N022256 004 Jan 14, 2009
MILRINONE LACTATE
INJECTABLE;INJECTION
MILRINONE LACTATE
AP CAPLIN EQ 1MG BASE/ML A214380 001 Apr 16, 2021
AP FRESENIUS KABI USA EQ 1MG BASE/ML A075936 001 May 28, 2002
AP HIKMA EQ 1MG BASE/ML A075530 001 May 28, 2002
AP EQ 1MG BASE/ML A075660 001 May 28, 2002
AP ! HIKMA FARMACEUTICA EQ 1MG BASE/ML A077966 001 Dec 03, 2010
AP HOSPIRA EQ 1MG BASE/ML A203280 001 Sep 03, 2014
AP MEITHEAL EQ 1MG BASE/ML A211671 001 Mar 24, 2020
MILRINONE LACTATE IN DEXTROSE 5%
AP EUGIA PHARMA EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) A209666 001 Sep 03, 2020
AP EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) A209666 002 Sep 03, 2020
AP WOODWARD EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) A077151 002 Jul 20, 2005
MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
AP ! BAXTER HLTHCARE EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) A075834 001 May 28, 2002
AP ! EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) A075834 002 May 28, 2002
AP GLAND PHARMA LTD EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) A213585 001 Jul 16, 2020
AP EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) A213585 002 Jul 16, 2020
AP HOSPIRA EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) A075885 001 May 28, 2002
AP EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) A075885 002 May 28, 2002
AP WEST-WARD PHARMS EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) A078113 001 May 21, 2008
INT
AP EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) A078113 002 May 21, 2008
MILRINONE LACTATE IN PLASTIC CONTAINER
AP HIKMA FARMACEUTICA EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) A090038 001 Jan 21, 2010
AP EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) A090038 002 Jan 21, 2010
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-314(of 474)

MILTEFOSINE
CAPSULE;ORAL
IMPAVIDO
+! KNIGHT THERAPS 50MG N204684 001 Mar 19, 2014
MINOCYCLINE HYDROCHLORIDE
AEROSOL, FOAM;TOPICAL
AMZEEQ
+! JOURNEY EQ 4% BASE N212379 001 Oct 18, 2019
ZILXI
+! JOURNEY EQ 1.5% BASE N213690 001 May 28, 2020
CAPSULE;ORAL
DYNACIN
AB ALVOGEN EQ 50MG BASE A063067 003 Aug 14, 1990
AB EQ 75MG BASE A063067 002 Sep 15, 1999
AB EQ 100MG BASE A063067 001 Jul 31, 1990
MINOCIN
AB + BAUSCH EQ 50MG BASE N050649 001 May 31, 1990
AB + EQ 100MG BASE N050649 002 May 31, 1990
MINOCYCLINE HYDROCHLORIDE
AB AUROBINDO PHARMA EQ 50MG BASE A065470 001 Mar 11, 2008
AB EQ 75MG BASE A065470 002 Mar 11, 2008
AB EQ 100MG BASE A065470 003 Mar 11, 2008
AB IMPAX LABS EQ 50MG BASE A065005 001 Mar 23, 1999
AB EQ 75MG BASE A065005 003 Apr 18, 2001
AB EQ 100MG BASE A065005 002 Mar 23, 1999
AB SUN PHARM INDS INC EQ 50MG BASE A090867 001 May 13, 2013
AB EQ 75MG BASE A090867 002 May 13, 2013
AB EQ 100MG BASE A090867 003 May 13, 2013
AB TORRENT EQ 50MG BASE A065062 001 Nov 30, 2000
AB EQ 75MG BASE A065062 002 Nov 30, 2000
AB EQ 100MG BASE A065062 003 Nov 30, 2000
AB WATSON LABS EQ 75MG BASE A063065 002 Jun 10, 1999
AB EQ 100MG BASE A063065 001 Dec 30, 1991
AB WATSON LABS TEVA EQ 50MG BASE A063181 001 Dec 30, 1991
AB ZYDUS EQ 50MG BASE A063011 001 Mar 02, 1992
AB EQ 75MG BASE A063009 002 Aug 12, 2003
AB ! EQ 100MG BASE A063009 001 Mar 02, 1992
CAPSULE, EXTENDED RELEASE;ORAL
XIMINO
JOURNEY EQ 45MG BASE N201922 001 Jul 11, 2012
EQ 90MG BASE N201922 003 Jul 11, 2012
EQ 135MG BASE N201922 005 Jul 11, 2012
INJECTABLE;INJECTION
MINOCIN
AP +! REMPEX EQ 100MG BASE/VIAL N050444 001
MINOCYCLINE HYDROCHLORIDE
AP NEXUS PHARMS EQ 100MG BASE/VIAL A214934 001 Jul 22, 2022
POWDER, EXTENDED RELEASE;DENTAL
ARESTIN
+! ORAPHARMA EQ 1MG BASE N050781 001 Feb 16, 2001
TABLET;ORAL
MINOCYCLINE HYDROCHLORIDE
AB AUROBINDO PHARMA EQ 50MG BASE A213662 001 May 01, 2020
LTD
AB EQ 75MG BASE A213662 002 May 01, 2020
AB EQ 100MG BASE A213662 003 May 01, 2020
AB BEXIMCO PHARMS USA EQ 50MG BASE A215466 001 May 27, 2022
AB EQ 75MG BASE A215466 002 May 27, 2022
AB EQ 100MG BASE A215466 003 May 27, 2022
AB DR REDDYS LABS LTD EQ 50MG BASE A065436 001 Dec 26, 2007
AB EQ 75MG BASE A065436 002 Dec 26, 2007
AB EQ 100MG BASE A065436 003 Dec 26, 2007
AB STRIDES PHARMA EQ 50MG BASE A065131 001 Apr 16, 2003
AB EQ 75MG BASE A065131 002 Apr 16, 2003
AB ! EQ 100MG BASE A065131 003 Apr 16, 2003
AB SUN PHARM EQ 50MG BASE A090217 001 Jan 29, 2016
INDUSTRIES
AB EQ 75MG BASE A090217 002 Jan 29, 2016
AB EQ 100MG BASE A090217 003 Jan 29, 2016
AB TORRENT EQ 50MG BASE A065156 001 Jan 06, 2004
AB EQ 75MG BASE A065156 002 Jan 06, 2004
AB EQ 100MG BASE A065156 003 Jan 06, 2004
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-315(of 474)

MINOCYCLINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
MINOCYCLINE HYDROCHLORIDE
AB ALKEM LABS LTD EQ 45MG BASE A204453 001 Sep 28, 2016
AB EQ 55MG BASE A204453 008 Dec 19, 2019
AB EQ 65MG BASE A204453 006 Mar 16, 2018
AB EQ 80MG BASE A204453 002 Sep 28, 2016
AB EQ 90MG BASE A204453 003 Sep 28, 2016
AB EQ 105MG BASE A204453 004 Sep 28, 2016
AB EQ 115MG BASE A204453 007 Mar 16, 2018
AB EQ 135MG BASE A204453 005 Sep 28, 2016
AB AUROBINDO PHARMA EQ 45MG BASE A202261 001 Nov 19, 2012
LTD
AB EQ 55MG BASE A202261 008 Aug 21, 2019
AB EQ 65MG BASE A202261 002 Sep 28, 2018
AB EQ 80MG BASE A202261 006 Jun 13, 2016
AB EQ 90MG BASE A202261 003 Nov 19, 2012
AB EQ 105MG BASE A202261 007 Jun 13, 2016
AB EQ 115MG BASE A202261 004 Sep 28, 2018
AB EQ 135MG BASE A202261 005 Nov 19, 2012
AB LUPIN LTD EQ 45MG BASE A091424 001 Nov 30, 2011
AB EQ 55MG BASE A091424 002 Nov 30, 2011
AB EQ 90MG BASE A091424 003 Nov 30, 2011
AB EQ 135MG BASE A091424 004 Nov 30, 2011
AB SANDOZ EQ 45MG BASE A090422 001 Aug 13, 2009
AB EQ 90MG BASE A090422 002 Aug 13, 2009
AB ! EQ 135MG BASE A090422 003 Aug 13, 2009
AB SIDMAK LABS INDIA EQ 45MG BASE A204394 001 Dec 30, 2015
AB EQ 55MG BASE A204394 002 Oct 07, 2022
AB EQ 65MG BASE A204394 003 Oct 07, 2022
AB EQ 80MG BASE A204394 004 Dec 30, 2015
AB EQ 105MG BASE A204394 005 Dec 30, 2015
AB EQ 115MG BASE A204394 006 Oct 07, 2022
AB EQ 135MG BASE A204394 007 Dec 30, 2015
AB SUN PHARM INDS LTD EQ 45MG BASE A091118 001 Sep 25, 2014
AB EQ 65MG BASE A091118 003 Dec 03, 2019
AB EQ 80MG BASE A091118 004 Sep 25, 2014
AB EQ 90MG BASE A091118 005 Sep 25, 2014
AB EQ 105MG BASE A091118 006 Sep 25, 2014
AB EQ 115MG BASE A091118 007 Dec 03, 2019
AB EQ 135MG BASE A091118 008 Sep 25, 2014
AB ZYDUS PHARMS EQ 45MG BASE A203553 001 Nov 16, 2017
AB EQ 80MG BASE A203553 004 Nov 16, 2017
AB EQ 90MG BASE A203553 005 Nov 16, 2017
AB EQ 105MG BASE A203553 006 Nov 16, 2017
AB EQ 135MG BASE A203553 008 Nov 16, 2017
SOLODYN
AB + BAUSCH EQ 55MG BASE N050808 008 Aug 27, 2010
AB + EQ 65MG BASE N050808 004 Jul 23, 2009
AB + EQ 80MG BASE N050808 007 Aug 27, 2010
AB + EQ 105MG BASE N050808 006 Aug 27, 2010
AB +! EQ 115MG BASE N050808 005 Jul 23, 2009
MINOLIRA
EPI HLTH EQ 105MG BASE N209269 001 May 08, 2017
! EQ 135MG BASE N209269 002 May 08, 2017
MINOXIDIL
TABLET;ORAL
MINOXIDIL
AB PAR PHARM 2.5MG A071826 001 Nov 14, 1988
AB 10MG A071839 001 Nov 14, 1988
AB SUN PHARM 2.5MG A072709 002 Dec 14, 1995
INDUSTRIES
AB 10MG A072709 001 Dec 14, 1995
AB WATSON LABS 2.5MG A071344 001 Mar 03, 1987
AB ! 10MG A071345 001 Mar 03, 1987
MIRABEGRON
FOR SUSPENSION, EXTENDED RELEASE;ORAL
MYRBETRIQ GRANULES
+! APGDI 8MG/ML N213801 001 Mar 25, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-316(of 474)

MIRABEGRON
TABLET, EXTENDED RELEASE;ORAL
MIRABEGRON
AB LUPIN LTD 25MG A209485 001 Sep 28, 2022
AB 50MG A209485 002 Sep 28, 2022
AB ZYDUS PHARMS 25MG A209488 001 Sep 29, 2022
AB 50MG A209488 002 Sep 29, 2022
MYRBETRIQ
AB +! APGDI 25MG N202611 001 Jun 28, 2012
AB +! 50MG N202611 002 Jun 28, 2012
MIRTAZAPINE
TABLET;ORAL
MIRTAZAPINE
AB APOTEX INC 15MG A077666 001 Aug 22, 2007
AB 30MG A077666 002 Aug 22, 2007
AB 45MG A077666 003 Aug 22, 2007
AB AUROBINDO 7.5MG A076921 001 Oct 22, 2004
AB 15MG A076921 002 Oct 22, 2004
AB 30MG A076921 003 Oct 22, 2004
AB 45MG A076921 004 Oct 22, 2004
AB MYLAN 15MG A076122 001 Jun 19, 2003
AB 30MG A076122 002 Jun 19, 2003
AB 45MG A076122 003 Jun 19, 2003
AB SUN PHARM INDS INC 7.5MG A076541 004 Apr 22, 2004
AB 15MG A076541 001 Apr 22, 2004
AB 30MG A076541 002 Apr 22, 2004
AB 45MG A076541 003 Apr 22, 2004
AB TEVA 15MG A076119 001 Jan 24, 2003
AB 30MG A076119 002 Jan 24, 2003
AB 45MG A076119 003 Jun 19, 2003
AB UPSHER SMITH LABS 15MG A076219 001 Jun 19, 2003
AB 30MG A076219 002 Jun 19, 2003
AB 45MG A076219 003 Jun 19, 2003
REMERON
AB +! ORGANON USA INC 15MG N020415 001 Jun 14, 1996
AB + 30MG N020415 002 Jun 14, 1996
TABLET, ORALLY DISINTEGRATING;ORAL
MIRTAZAPINE
AB AUROBINDO PHARMA 15MG A077376 002 Dec 08, 2005
AB 30MG A077376 003 Dec 08, 2005
AB 45MG A077376 004 Feb 28, 2006
AB SQUARE PHARMS 15MG A205798 001 Jun 01, 2017
AB 30MG A205798 002 Jun 01, 2017
AB 45MG A205798 003 Jun 01, 2017
REMERON SOLTAB
AB +! ORGANON USA INC 15MG N021208 001 Jan 12, 2001
AB + 30MG N021208 002 Jan 12, 2001
AB + 45MG N021208 003 Jan 12, 2001
MISOPROSTOL
TABLET;ORAL
CYTOTEC
AB + PFIZER 0.1MG N019268 003 Sep 21, 1990
AB +! 0.2MG N019268 001 Dec 27, 1988
MISOPROSTOL
AB ANI PHARMS 0.1MG A076095 001 Jul 10, 2002
AB 0.2MG A076095 002 Jul 10, 2002
AB MICRO LABS 0.1MG A216872 001 Oct 17, 2022
AB 0.2MG A216872 002 Oct 17, 2022
BX NOVEL LABS INC 0.1MG A091667 001 Jul 25, 2012
BX 0.2MG A091667 002 Jul 25, 2012
MITAPIVAT SULFATE
TABLET;ORAL
PYRUKYND
+ AGIOS PHARMS INC EQ 5MG BASE N216196 001 Feb 17, 2022
+ EQ 20MG BASE N216196 002 Feb 17, 2022
+! EQ 50MG BASE N216196 003 Feb 17, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-317(of 474)

MITOMYCIN
FOR SOLUTION;TOPICAL
MITOSOL
+! MOBIUS THERAP 0.2MG/VIAL N022572 001 Feb 07, 2012
INJECTABLE;INJECTION
MITOMYCIN
AP ! ACCORD HLTHCARE 5MG/VIAL A064144 001 Apr 30, 1998
AP ! 20MG/VIAL A064144 002 Apr 30, 1998
AP ! 40MG/VIAL A064144 003 Aug 11, 2009
AP GLAND PHARMA LTD 5MG/VIAL A215687 001 Oct 20, 2021
AP 20MG/VIAL A215687 002 Oct 20, 2021
AP 40MG/VIAL A216648 001 Nov 22, 2022
AP HIKMA 5MG/VIAL A064180 001 Dec 23, 1999
AP 20MG/VIAL A064117 002 Apr 19, 1995
AP 20MG/VIAL A064180 002 Dec 23, 1999
AP 40MG/VIAL A064117 003 Jun 02, 1999
AP MEITHEAL 5MG/VIAL A214505 001 Sep 08, 2022
AP 20MG/VIAL A214505 002 Sep 08, 2022
AP 40MG/VIAL A214504 001 Sep 06, 2022
AP RK PHARMA 5MG/VIAL A202670 001 Oct 13, 2017
AP 20MG/VIAL A202670 002 Oct 13, 2017
AP 40MG/VIAL A203386 001 Oct 13, 2017
POWDER;PYELOCALYCEAL
JELMYTO
+! UROGEN PHARMA 40MG/VIAL N211728 001 Apr 15, 2020
MITOTANE
TABLET;ORAL
LYSODREN
+! HRA PHARMA 500MG N016885 001
MITOXANTRONE HYDROCHLORIDE
INJECTABLE;INJECTION
MITOXANTRONE HYDROCHLORIDE
AP FRESENIUS KABI USA EQ 20MG BASE/10ML (EQ 2MG BASE/ML) A077496 001 Apr 11, 2006
AP EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) A077496 002 Apr 11, 2006
AP EQ 30MG BASE/15ML (EQ 2MG BASE/ML) A077496 003 Apr 11, 2006
AP HIKMA EQ 20MG BASE/10ML (EQ 2MG BASE/ML) A076611 001 Apr 11, 2006
AP EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) A076611 002 Apr 11, 2006
AP EQ 30MG BASE/15ML (EQ 2MG BASE/ML) A076611 003 Apr 11, 2006
AP ! HOSPIRA EQ 20MG BASE/10ML (EQ 2MG BASE/ML) A076871 001 Apr 11, 2006
AP ! EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) A076871 002 Apr 11, 2006
AP ! EQ 30MG BASE/15ML (EQ 2MG BASE/ML) A076871 003 Apr 11, 2006
AP TEVA PHARMS USA EQ 20MG BASE/10ML (EQ 2MG BASE/ML) A077356 001 Apr 11, 2006
AP EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) A077356 002 Apr 11, 2006
AP EQ 30MG BASE/15ML (EQ 2MG BASE/ML) A077356 003 Apr 11, 2006
MIVACURIUM CHLORIDE
SOLUTION;INTRAVENOUS
MIVACURIUM CHLORIDE
WOODWARD EQ 10MG BASE/5ML (EQ 2MG BASE/ML) A209708 001 Oct 12, 2021
EQ 20MG BASE/10ML (EQ 2MG BASE/ML) A209708 002 Oct 12, 2021
MOBOCERTINIB SUCCINATE
CAPSULE;ORAL
EXKIVITY
+! TAKEDA PHARMS USA EQ 40MG BASE N215310 001 Sep 15, 2021
MODAFINIL
TABLET;ORAL
MODAFINIL
AB ALEMBIC PHARMS 100MG A202700 001 Oct 18, 2012
AB 200MG A202700 002 Oct 18, 2012
AB APOTEX INC 100MG A077667 001 Feb 03, 2014
AB 200MG A077667 002 Feb 03, 2014
AB APPCO 100MG A207196 001 Aug 16, 2017
AB 200MG A207196 002 Aug 16, 2017
AB AUROBINDO PHARMA 100MG A202566 001 Sep 27, 2012
LTD
AB 200MG A202566 002 Sep 27, 2012
AB CADILA 100MG A209966 001 Sep 14, 2017
AB 200MG A209966 002 Sep 14, 2017
AB ORBION PHARMS 100MG A078963 001 Sep 26, 2012
AB 200MG A078963 002 Sep 26, 2012
AB WATSON LABS INC 100MG A076715 001 Nov 01, 2012
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-318(of 474)

MODAFINIL
TABLET;ORAL
MODAFINIL
AB 200MG A076715 002 Nov 01, 2012
PROVIGIL
AB + CEPHALON 100MG N020717 001 Dec 24, 1998
AB +! 200MG N020717 002 Dec 24, 1998
MOEXIPRIL HYDROCHLORIDE
TABLET;ORAL
MOEXIPRIL HYDROCHLORIDE
AB APOTEX INC 7.5MG A078454 001 Jun 02, 2008
AB 15MG A078454 002 Jun 02, 2008
AB CHARTWELL RX 7.5MG A077536 001 Nov 30, 2006
AB 15MG A077536 002 Nov 30, 2006
AB GLENMARK GENERICS 7.5MG A090416 001 Mar 30, 2010
AB 15MG A090416 002 Mar 30, 2010
AB TEVA 7.5MG A076204 001 May 08, 2003
AB ! 15MG A076204 002 May 08, 2003
MOLINDONE HYDROCHLORIDE
TABLET;ORAL
MOLINDONE HYDROCHLORIDE
EPIC PHARMA LLC 5MG A090453 001 Mar 20, 2015
10MG A090453 002 Mar 20, 2015
! 25MG A090453 003 Mar 20, 2015
MOMETASONE FUROATE
AEROSOL, METERED;INHALATION
ASMANEX HFA
+ ORGANON LLC 0.05MG/INH N205641 003 Aug 12, 2019
+ 0.10MG/INH N205641 001 Apr 25, 2014
+! 0.20MG/INH N205641 002 Apr 25, 2014
CREAM;TOPICAL
MOMETASONE FUROATE
AB COSETTE 0.1% A077447 001 May 22, 2006
AB ! GLENMARK GENERICS 0.1% A078541 001 May 28, 2008
AB TARO 0.1% A076679 001 Dec 21, 2004
IMPLANT;IMPLANTATION
SINUVA
+ INTERSECT ENT INC 1.35MG N209310 001 Dec 08, 2017
LOTION;TOPICAL
ELOCON
AB +! ORGANON 0.1% N019796 001 Mar 30, 1989
MOMETASONE FUROATE
AB COSETTE 0.1% A077678 001 Nov 21, 2007
AB FOUGERA PHARMS 0.1% A075919 001 Nov 29, 2007
AB GLENMARK GENERICS 0.1% A090506 001 Aug 09, 2010
AB PADAGIS ISRAEL 0.1% A077180 001 Apr 06, 2005
AB TARO 0.1% A076788 001 Mar 15, 2006
OINTMENT;TOPICAL
MOMETASONE FUROATE
AB COSETTE 0.1% A077401 001 Jun 20, 2006
AB FOUGERA PHARMS 0.1% A077061 001 Mar 28, 2005
AB ! GLENMARK GENERICS 0.1% A078571 001 May 28, 2008
AB PADAGIS US 0.1% A076067 001 Mar 18, 2002
POWDER;INHALATION
ASMANEX TWISTHALER
+ ORGANON LLC 0.11MG/INH N021067 002 Feb 01, 2008
+! 0.22MG/INH N021067 001 Mar 30, 2005
SPRAY, METERED;NASAL
MOMETASONE FUROATE
AB AMNEAL PHARMS 0.05MG/SPRAY A207989 001 Apr 03, 2017
AB ! APOTEX INC 0.05MG/SPRAY A091161 001 Mar 22, 2016
MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
SPRAY, METERED;NASAL
RYALTRIS
+! GLENMARK SPECIALTY 0.025MG/SPRAY;0.665MG/SPRAY N211746 001 Jan 13, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-319(of 474)

MONOMETHYL FUMARATE
CAPSULE, DELAYED RELEASE;ORAL
BAFIERTAM
+! BANNER LIFE 95MG N210296 001 Apr 28, 2020
SCIENCES
MONTELUKAST SODIUM
GRANULE;ORAL
MONTELUKAST SODIUM
AB AJANTA PHARMA LTD EQ 4MG BASE/PACKET A203438 001 Jul 31, 2015
AB AUROBINDO PHARMA EQ 4MG BASE/PACKET A213471 001 Feb 18, 2020
LTD
AB DR REDDYS LABS LTD EQ 4MG BASE/PACKET A202906 001 Sep 17, 2012
AB TEVA PHARMS EQ 4MG BASE/PACKET A090955 001 Aug 03, 2012
AB TORRENT EQ 4MG BASE/PACKET A210431 001 Jul 31, 2018
SINGULAIR
AB +! ORGANON EQ 4MG BASE/PACKET N021409 001 Jul 26, 2002
TABLET;ORAL
MONTELUKAST SODIUM
AB ACCORD HLTHCARE EQ 10MG BASE A202717 001 Sep 21, 2012
AB AMNEAL PHARMS EQ 10MG BASE A204604 001 Sep 04, 2015
AB ANBISON LAB EQ 10MG BASE A205683 001 Jan 12, 2016
AB AUROBINDO PHARMA EQ 10MG BASE A202468 001 Aug 03, 2012
LTD
AB CHARTWELL MOLECULAR EQ 10MG BASE A201522 001 Aug 03, 2012
AB CIPLA EQ 10MG BASE A207463 001 Oct 28, 2016
AB DR REDDYS LABS LTD EQ 10MG BASE A201582 001 Aug 06, 2012
AB GLENMARK GENERICS EQ 10MG BASE A090926 001 Aug 03, 2012
AB GRAVITI PHARMS EQ 10MG BASE A209012 001 Apr 24, 2017
AB HETERO LABS LTD V EQ 10MG BASE A202843 001 Sep 10, 2014
AB MACLEODS PHARMS LTD EQ 10MG BASE A203366 001 Sep 11, 2014
AB SANDOZ INC EQ 10MG BASE A200889 001 Aug 03, 2012
AB TEVA PHARMS EQ 10MG BASE A078605 001 Aug 03, 2012
AB TORRENT PHARMS LTD EQ 10MG BASE A201515 001 Aug 03, 2012
AB UNICHEM EQ 10MG BASE A204290 001 Oct 08, 2015
AB UNIMARK REMEDIES EQ 10MG BASE A202859 001 Oct 30, 2014
LTD
SINGULAIR
AB +! ORGANON EQ 10MG BASE N020829 002 Feb 20, 1998
TABLET, CHEWABLE;ORAL
MONTELUKAST SODIUM
AB AMNEAL PHARMS EQ 4MG BASE A205107 001 Sep 04, 2020
AB EQ 5MG BASE A205107 002 Sep 04, 2020
AB ANBISON LAB EQ 4MG BASE A205695 001 Nov 05, 2015
AB EQ 5MG BASE A205695 002 Nov 05, 2015
AB AUROBINDO PHARMA EQ 4MG BASE A202096 001 Aug 03, 2012
LTD
AB EQ 5MG BASE A202096 002 Aug 03, 2012
AB CIPLA EQ 4MG BASE A207464 001 Dec 06, 2018
AB EQ 5MG BASE A207464 002 Dec 06, 2018
AB DR REDDYS LABS LTD EQ 4MG BASE A201581 001 Aug 06, 2012
AB EQ 5MG BASE A201581 002 Aug 06, 2012
AB GRAVITI PHARMS EQ 4MG BASE A209011 001 Apr 18, 2017
AB EQ 5MG BASE A209011 002 Apr 18, 2017
AB HETERO LABS LTD V EQ 4MG BASE A204093 001 May 22, 2015
AB EQ 5MG BASE A204093 002 May 22, 2015
AB LANNETT CO INC EQ 4MG BASE A200405 001 Aug 03, 2012
AB EQ 5MG BASE A200405 002 Aug 03, 2012
AB MACLEODS PHARMS LTD EQ 4MG BASE A203582 001 Mar 12, 2015
AB EQ 5MG BASE A203582 002 Mar 12, 2015
AB SANDOZ INC EQ 4MG BASE A091414 001 Aug 03, 2012
AB EQ 5MG BASE A091414 002 Aug 03, 2012
AB TEVA PHARMS EQ 4MG BASE A078723 001 Aug 03, 2012
AB EQ 5MG BASE A078723 002 Aug 03, 2012
AB TORRENT PHARMS LTD EQ 4MG BASE A090984 001 Aug 03, 2012
AB EQ 5MG BASE A090984 002 Aug 03, 2012
AB UNICHEM EQ 4MG BASE A208621 001 Jul 02, 2018
AB EQ 5MG BASE A208621 002 Jul 02, 2018
AB UNIMARK REMEDIES EQ 4MG BASE A203037 001 Oct 30, 2014
LTD
AB EQ 5MG BASE A203037 002 Oct 30, 2014
SINGULAIR
AB + ORGANON EQ 4MG BASE N020830 002 Mar 03, 2000
AB +! EQ 5MG BASE N020830 001 Feb 20, 1998
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-320(of 474)

MORPHINE SULFATE
CAPSULE, EXTENDED RELEASE;ORAL
MORPHINE SULFATE
ACTAVIS ELIZABETH 30MG A079040 001 Jan 16, 2013
45MG A079040 002 Jan 16, 2013
60MG A079040 003 Jan 16, 2013
75MG A079040 004 Jan 16, 2013
90MG A079040 005 Jan 16, 2013
! 120MG A079040 006 Jan 16, 2013
! UPSHER SMITH LABS 10MG A202104 001 Jun 03, 2013
20MG A202104 002 Jun 03, 2013
30MG A202104 003 Jun 03, 2013
50MG A202104 004 Jun 03, 2013
60MG A202104 005 Jun 03, 2013
80MG A202104 006 Jun 03, 2013
! 100MG A202104 007 Jun 03, 2013
INJECTABLE;INJECTION
DURAMORPH PF
AP +! HIKMA 0.5MG/ML N018565 001 Sep 18, 1984
AP +! 1MG/ML N018565 002 Sep 18, 1984
INFUMORPH
AP +! HIKMA 10MG/ML N018565 003 Jul 19, 1991
AP +! 25MG/ML N018565 004 Jul 19, 1991
MITIGO
AP PIRAMAL CRITICAL 10MG/ML A204393 001 Jul 16, 2018
AP 25MG/ML A204393 002 Jul 16, 2018
MORPHINE SULFATE
AP ! HIKMA 4MG/ML A205758 001 May 21, 2015
AP ! 8MG/ML A205758 002 May 21, 2015
AP 10MG/ML A205758 003 May 21, 2015
AP HOSPIRA 0.5MG/ML A071849 001 May 11, 1988
AP 0.5MG/ML A073509 001 Sep 30, 1992
AP 1MG/ML A073510 001 Sep 30, 1992
AP + HOSPIRA INC 4MG/ML N202515 002 Nov 14, 2011
AP + 8MG/ML N202515 003 Nov 14, 2011
AP + 10MG/ML N202515 004 Nov 14, 2011
+! 2MG/ML N202515 001 Nov 14, 2011
+! 50MG/ML N202515 006 Apr 29, 2021
INTL MEDICATION SYS 1MG/ML A202861 001 Apr 29, 2021
SOLUTION;INTRAMUSCULAR, INTRAVENOUS
MORPHINE SULFATE
+! FRESENIUS KABI USA 2MG/ML (2MG/ML) N204223 001 Oct 30, 2013
+! 4MG/ML (4MG/ML) N204223 002 Oct 30, 2013
+! 5MG/ML (5MG/ML) N204223 003 Oct 30, 2013
+! 8MG/ML (8MG/ML) N204223 004 Oct 30, 2013
+! 10MG/ML (10MG/ML) N204223 005 Oct 30, 2013
SOLUTION;ORAL
MORPHINE SULFATE
AA AKORN 100MG/5ML A208809 001 Jul 06, 2017
AA + HIKMA 10MG/5ML N022195 001 Mar 17, 2008
AA + 20MG/5ML N022195 002 Mar 17, 2008
AA +! 100MG/5ML N022195 003 Jan 25, 2010
AA PADAGIS US 100MG/5ML A201574 001 Aug 06, 2012
AA PHARM ASSOC 100MG/5ML A206573 001 Nov 14, 2016
AA RHODES PHARMS 10MG/5ML A206308 001 Jun 22, 2017
AA 20MG/5ML A206420 001 Jul 12, 2016
AA 100MG/5ML A206308 002 Jun 22, 2017
AA SPECGX LLC 100MG/5ML A202348 001 Jul 15, 2011
AA TRIS PHARMA INC 10MG/5ML A203518 001 May 12, 2015
AA 100MG/5ML A203518 002 May 12, 2015
TABLET;ORAL
MORPHINE SULFATE
AB ALKEM LABS LTD 15MG A212451 001 Dec 03, 2020
AB 30MG A212451 002 Dec 03, 2020
AB + HIKMA 15MG N022207 001 Mar 17, 2008
AB +! 30MG N022207 002 Mar 17, 2008
AB MAYNE PHARMA INC 15MG A207270 001 Jan 12, 2022
AB 30MG A207270 002 Jan 12, 2022
AB UPSHER SMITH LABS 15MG A210610 001 Jul 22, 2019
AB 30MG A210610 002 Jul 22, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-321(of 474)

MORPHINE SULFATE
TABLET, EXTENDED RELEASE;ORAL
MORPHINE SULFATE
AB ACTAVIS ELIZABETH 15MG A203849 001 Apr 06, 2015
AB 30MG A203849 002 Apr 06, 2015
AB 60MG A203849 003 Apr 06, 2015
AB 100MG A203849 004 Apr 06, 2015
AB 200MG A203849 005 Apr 06, 2015
AB DAVA PHARMS INC 15MG A075407 001 Jan 28, 2000
AB MAYNE PHARMA INC 15MG A205386 001 Oct 28, 2016
AB 30MG A205386 002 Oct 28, 2016
AB 60MG A205386 003 Oct 28, 2016
AB 100MG A205386 004 Oct 28, 2016
AB NOVEL LABS INC 15MG A203602 001 Dec 16, 2015
AB 30MG A203602 002 Dec 16, 2015
AB 60MG A203602 003 Dec 16, 2015
AB 100MG A203602 004 Dec 16, 2015
AB 200MG A203602 005 Dec 16, 2015
AB RHODES PHARMS 15MG A074862 001 Jul 07, 1998
AB 30MG A074862 002 Jul 07, 1998
AB 60MG A074862 003 Jul 07, 1998
AB 100MG A074769 001 Jul 02, 1998
AB 200MG A074769 002 Jul 02, 1998
AB SPECGX LLC 15MG A076412 001 Jul 31, 2003
AB 30MG A076412 002 Jul 31, 2003
AB 60MG A076412 003 Jul 31, 2003
AB 100MG A076438 001 Jul 03, 2003
AB 200MG A076438 002 Jul 03, 2003
AB STRIDES PHARMA 15MG A075295 001 Oct 28, 1998
AB 30MG A075295 002 Oct 28, 1998
AB 60MG A075295 003 Oct 28, 1998
AB 100MG A075295 004 Sep 15, 2000
AB 200MG A075295 005 Sep 15, 2000
AB SUN PHARM INDS LTD 15MG A078761 001 May 11, 2012
AB 30MG A078761 002 May 11, 2012
AB 60MG A078761 003 May 11, 2012
AB 100MG A078761 004 May 11, 2012
AB 200MG A078761 005 May 11, 2012
MS CONTIN
AB + PURDUE PHARMA LP 15MG N019516 003 Sep 12, 1989
AB + 30MG N019516 001 May 29, 1987
AB + 60MG N019516 002 Apr 08, 1988
AB +! 100MG N019516 004 Jan 16, 1990
AB + 200MG N019516 005 Nov 08, 1993
MOXIDECTIN
TABLET;ORAL
MOXIDECTIN
+! MDGH 2MG N210867 001 Jun 13, 2018
MOXIFLOXACIN HYDROCHLORIDE
SOLUTION;INTRAVENOUS
MOXIFLOXACIN HYDROCHLORIDE
+! FRESENIUS KABI USA EQ 400MG BASE/250ML (EQ 1.6MG BASE/ML) N205572 001 Apr 03, 2015
MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER
! MYLAN LABS LTD 400MG/250ML (1.6MG/ML) A205833 001 May 05, 2017
SOLUTION/DROPS;OPHTHALMIC
MOXIFLOXACIN HYDROCHLORIDE
AT1 AKORN EQ 0.5% BASE A202916 001 Nov 09, 2017
AT1 ALEMBIC PHARMS EQ 0.5% BASE A209469 001 Feb 13, 2019
AT1 APOTEX EQ 0.5% BASE A090080 001 Jun 30, 2017
AT1 EUGIA PHARMA EQ 0.5% BASE A206242 001 Oct 04, 2017
AT1 GLAND PHARMA LTD EQ 0.5% BASE A208778 001 Mar 30, 2020
AT1 INDOCO EQ 0.5% BASE A202525 001 Mar 06, 2015
AT1 LUPIN LTD EQ 0.5% BASE A202867 001 Sep 04, 2014
AT1 MYLAN EQ 0.5% BASE A206447 001 Mar 30, 2020
AT1 UPSHER SMITH LABS EQ 0.5% BASE A212616 001 Feb 10, 2021
VIGAMOX
AT1 +! NOVARTIS EQ 0.5% BASE N021598 001 Apr 15, 2003
MOXEZA
AT2 +! IMPRIMIS PHARMS USA EQ 0.5% BASE N022428 001 Nov 19, 2010
MOXIFLOXACIN HYDROCHLORIDE
AT2 LUPIN LTD EQ 0.5% BASE A204079 001 May 28, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-322(of 474)

MOXIFLOXACIN HYDROCHLORIDE
TABLET;ORAL
MOXIFLOXACIN HYDROCHLORIDE
AB AUROBINDO PHARMA EQ 400MG BASE A202632 001 Mar 04, 2014
LTD
AB CROSSMEDIKA SA EQ 400MG BASE A205348 001 Jan 14, 2016
AB ! DR REDDYS EQ 400MG BASE A076938 001 Mar 04, 2014
AB MSN EQ 400MG BASE A208682 001 Sep 22, 2017
AB NOVEL LABS INC EQ 400MG BASE A207285 001 Feb 13, 2017
AB TEVA PHARMS USA EQ 400MG BASE A077437 001 Feb 18, 2014
AB TORRENT EQ 400MG BASE A200160 001 Apr 03, 2014
MUPIROCIN
OINTMENT;TOPICAL
MUPIROCIN
AB FOUGERA PHARMS 2% A065192 001 Nov 30, 2005
AB GLENMARK PHARMS 2% A090480 001 Jun 08, 2011
AB ! PADAGIS ISRAEL 2% A065123 001 Nov 07, 2003
AB TARO 2% A065170 001 Sep 23, 2005
AB TEVA 2% A065085 001 Nov 07, 2003
CENTANY
BX PADAGIS US 2% N050788 001 Dec 04, 2002
MUPIROCIN CALCIUM
CREAM;TOPICAL
MUPIROCIN
AB ALEOR EQ 2% BASE A213053 001 Nov 16, 2021
DERMACEUTICALS
AB AMNEAL EQ 2% BASE A214811 001 Nov 15, 2022
AB ENCUBE EQ 2% BASE A213076 001 Aug 31, 2021
AB ! GLENMARK PHARMS INC EQ 2% BASE A201587 001 Jan 24, 2013
AB PADAGIS ISRAEL EQ 2% BASE A212465 001 Aug 03, 2022
AB TARO EQ 2% BASE A207116 001 Apr 27, 2020
MYCOPHENOLATE MOFETIL
CAPSULE;ORAL
CELLCEPT
AB +! ROCHE PALO 250MG N050722 001 May 03, 1995
MYCOPHENOLATE MOFETIL
AB ACCORD HLTHCARE 250MG A090253 001 May 04, 2009
AB ALKEM LABS LTD 250MG A200197 001 Jun 13, 2013
AB CONCORD BIOTECH LTD 250MG A210181 001 Jan 08, 2019
AB HIKMA 250MG A065410 001 Jul 29, 2008
AB MYLAN 250MG A065520 001 May 04, 2009
AB SANDOZ 250MG A065379 001 Oct 15, 2008
AB STRIDES PHARMA 250MG A090055 001 Jun 10, 2010
AB TEVA PHARMS 250MG A065491 001 May 06, 2009
AB ZHEJIANG HISUN 250MG A204077 001 Nov 13, 2017
PHARM
FOR SUSPENSION;ORAL
CELLCEPT
AB +! ROCHE PALO 200MG/ML N050759 001 Oct 01, 1998
MYCOPHENOLATE MOFETIL
AB ALKEM LABS LTD 200MG/ML A203005 001 Nov 14, 2014
AB AMNEAL 200MG/ML A214871 001 Nov 02, 2021
AB LANNETT CO INC 200MG/ML A214525 001 Jul 29, 2021
AB TEVA PHARMS USA 200MG/ML A211272 001 Jan 25, 2022
AB VISTAPHARM 200MG/ML A210370 001 Feb 12, 2019
TABLET;ORAL
CELLCEPT
AB +! ROCHE PALO 500MG N050723 001 Jun 19, 1997
MYCOPHENOLATE MOFETIL
AB ACCORD HLTHCARE 500MG A065416 001 May 04, 2009
AB ALKEM LABS LTD 500MG A091249 001 Nov 04, 2011
AB AMNEAL 500MG A090606 001 Jul 16, 2010
AB CONCORD BIOTECH LTD 500MG A212087 001 Jul 31, 2020
AB HIKMA 500MG A065413 001 Jul 29, 2008
AB MYLAN 500MG A065521 001 May 04, 2009
AB SANDOZ 500MG A065451 001 Oct 15, 2008
AB STRIDES PHARMA 500MG A090456 001 Jun 10, 2010
AB ZHEJIANG HISUN 500MG A204076 001 Nov 16, 2017
PHARM
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-323(of 474)

MYCOPHENOLATE MOFETIL HYDROCHLORIDE


INJECTABLE;INJECTION
CELLCEPT
AP +! ROCHE PALO 500MG/VIAL N050758 001 Aug 12, 1998
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
AP AKORN 500MG/VIAL A204043 001 Feb 28, 2017
AP MEITHEAL 500MG/VIAL A212130 001 Jan 15, 2021
AP MYLAN LABS LTD 500MG/VIAL A203859 001 Mar 31, 2017
AP PAR STERILE 500MG/VIAL A203575 001 Oct 28, 2016
PRODUCTS
AP STERISCIENCE 500MG/VIAL A216390 001 Dec 23, 2022
AP ZYDUS PHARMS 500MG/VIAL A204473 001 Aug 31, 2017
MYCOPHENOLIC SODIUM
TABLET, DELAYED RELEASE;ORAL
MYCOPHENOLIC SODIUM
AB ACCORD HLTHCARE EQ 180MG BASE A202555 001 Aug 23, 2017
AB EQ 360MG BASE A202555 002 Aug 23, 2017
AB ALKEM LABS LTD EQ 180MG BASE A208315 001 Sep 23, 2021
AB EQ 360MG BASE A208315 002 Sep 23, 2021
AB AMTA EQ 180MG BASE A214376 001 Feb 10, 2021
AB EQ 360MG BASE A214376 002 Feb 10, 2021
AB APOTEX INC EQ 180MG BASE A091558 001 Aug 21, 2012
AB EQ 360MG BASE A091558 002 Aug 19, 2014
AB BIOCON PHARMA EQ 180MG BASE A214630 001 Nov 29, 2021
AB EQ 360MG BASE A214630 002 Nov 29, 2021
AB CONCORD BIOTECH LTD EQ 180MG BASE A211173 001 Dec 13, 2019
AB EQ 360MG BASE A211173 002 Dec 13, 2019
AB RK PHARMA EQ 180MG BASE A091248 002 Jan 08, 2014
AB EQ 360MG BASE A091248 001 Jan 08, 2014
AB TWI PHARMS EQ 180MG BASE A214289 001 Nov 03, 2021
AB EQ 360MG BASE A214289 002 Nov 03, 2021
MYFORTIC
AB + NOVARTIS EQ 180MG BASE N050791 001 Feb 27, 2004
AB +! EQ 360MG BASE N050791 002 Feb 27, 2004
NABILONE
CAPSULE;ORAL
CESAMET
+! BAUSCH 1MG N018677 001 Dec 26, 1985
NABUMETONE
TABLET;ORAL
NABUMETONE
AB ANNORA PHARMA 500MG A090445 001 Jan 12, 2011
AB 750MG A090445 002 Jan 12, 2011
AB CHARTWELL MOLECULES 500MG A076009 001 Jan 24, 2003
AB 750MG A076009 002 Jan 24, 2003
AB CHARTWELL RX 500MG A075280 001 Feb 25, 2002
AB 750MG A075280 002 Feb 25, 2002
AB INVAGEN PHARMS 500MG A078671 001 Mar 07, 2008
AB ! 750MG A078671 002 Mar 07, 2008
AB LGM PHARMA 500MG A203166 001 Aug 30, 2019
AB 750MG A203166 002 Aug 30, 2019
AB SCIEGEN PHARMS INC 500MG A078420 001 Sep 24, 2008
AB 750MG A078420 002 Sep 24, 2008
AB WATSON LABS 500MG A091083 001 Jun 13, 2011
AB 750MG A091083 002 Jun 13, 2011
LGM PHARMA 1GM A203166 003 Aug 30, 2019
NADOLOL
TABLET;ORAL
CORGARD
AB + USWM 20MG N018063 005 Oct 28, 1986
AB + 40MG N018063 001
AB +! 80MG N018063 002
NADOLOL
AB AMNEAL PHARMS CO 20MG A208832 001 Jun 02, 2017
AB 40MG A208832 002 Jun 02, 2017
AB 80MG A208832 003 Jun 02, 2017
AB AUROBINDO PHARMA 20MG A201893 003 Jun 07, 2022
AB 40MG A201893 001 Sep 16, 2015
AB 80MG A201893 002 Sep 16, 2015
AB BEXIMCO PHARMS USA 20MG A210955 001 Jul 23, 2018
AB 40MG A210955 002 Jul 23, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-324(of 474)

NADOLOL
TABLET;ORAL
NADOLOL
AB 80MG A210955 003 Jul 23, 2018
AB CHARTWELL RX 20MG A209309 001 Oct 05, 2017
AB 40MG A209309 002 Oct 05, 2017
AB 80MG A209309 003 Oct 05, 2017
AB HERITAGE PHARMA 20MG A074229 001 Aug 30, 1996
AB 40MG A074229 002 Aug 30, 1996
AB 80MG A074255 001 Jan 24, 1996
AB INVAGEN PHARMS 20MG A203455 001 Dec 18, 2015
AB 40MG A203455 002 Dec 18, 2015
AB 80MG A203455 003 Dec 18, 2015
AB RISING 20MG A074172 001 Oct 31, 1993
AB 40MG A074172 002 Oct 31, 1993
AB 80MG A074172 003 Oct 31, 1993
AB SANDOZ 20MG A074501 001 Nov 09, 1995
AB 40MG A074501 002 Nov 09, 1995
AB 80MG A074501 003 Nov 09, 1995
AB VGYAAN 20MG A212856 001 Sep 13, 2019
AB 40MG A212856 002 Sep 13, 2019
AB 80MG A212856 003 Sep 13, 2019
AB ZYDUS PHARMS 20MG A207761 001 Jul 28, 2017
AB 40MG A207761 002 Jul 28, 2017
AB 80MG A207761 003 Jul 28, 2017
NAFARELIN ACETATE
SPRAY, METERED;NASAL
SYNAREL
+! PFIZER EQ 0.2MG BASE/SPRAY N019886 001 Feb 13, 1990
NAFCILLIN SODIUM
INJECTABLE;INJECTION
NAFCILLIN SODIUM
AP ANTIBIOTICE EQ 1GM BASE/VIAL A090560 001 Oct 03, 2011
AP EQ 2GM BASE/VIAL A090560 002 Oct 03, 2011
AP EUGIA PHARMA EQ 1GM BASE/VIAL A091613 001 Dec 26, 2012
SPECLTS
AP EQ 2GM BASE/VIAL A091613 002 Dec 26, 2012
AP EQ 10GM BASE/VIAL A091614 001 Dec 26, 2012
AP FRESENIUS EQ 10GM BASE/VIAL A206761 001 Jun 02, 2020
AP ISTITUTO BIO ITA EQ 1GM BASE/VIAL A090002 001 Jun 30, 2011
SPA
AP EQ 2GM BASE/VIAL A090002 002 Jun 30, 2011
AP EQ 10GM BASE/VIAL A090005 001 Apr 20, 2011
AP SAGENT PHARMS EQ 1GM BASE/VIAL A090582 001 Aug 24, 2012
AP EQ 2GM BASE/VIAL A090582 002 Aug 24, 2012
AP EQ 10GM BASE/VIAL A090580 001 Aug 24, 2012
AP ! SANDOZ EQ 1GM BASE/VIAL A062527 002 Aug 02, 1984
AP ! EQ 1GM BASE/VIAL A062732 001 Dec 23, 1986
AP ! EQ 2GM BASE/VIAL A062527 003 Aug 02, 1984
AP ! EQ 2GM BASE/VIAL A062732 002 Dec 23, 1986
AP ! EQ 10GM BASE/VIAL A062527 004 Aug 02, 1984
NALLPEN IN PLASTIC CONTAINER
+! BAXTER HLTHCARE EQ 20MG BASE/ML N050655 001 Oct 31, 1989
+! EQ 2GM BASE/100ML N050655 002 Oct 31, 1989
NAFTIFINE HYDROCHLORIDE
CREAM;TOPICAL
NAFTIFINE HYDROCHLORIDE
AB TARO PHARMS 2% A206901 001 Jan 06, 2016
AB TOLMAR 2% A206960 001 Apr 10, 2017
AB XIROMED 2% A210038 001 Sep 22, 2020
NAFTIN
AB +! SEBELA IRELAND LTD 2% N019599 002 Jan 13, 2012
NAFTIFINE HYDROCHLORIDE
! TARO PHARMS 1% A205975 001 Sep 08, 2016
GEL;TOPICAL
NAFTIFINE HYDROCHLORIDE
AB TOLMAR 1% A206165 001 Mar 20, 2019
NAFTIN
AB +! SEBELA IRELAND LTD 1% N019356 001 Jun 18, 1990
AB +! 2% N204286 001 Jun 27, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-325(of 474)

NALBUPHINE HYDROCHLORIDE
INJECTABLE;INJECTION
NALBUPHINE HYDROCHLORIDE
AP ! HOSPIRA 10MG/ML A070914 001 Feb 03, 1989
AP ! 10MG/ML A070915 001 Feb 03, 1989
AP ! 20MG/ML A070916 001 Feb 03, 1989
AP ! 20MG/ML A070918 001 Feb 03, 1989
NALDEMEDINE TOSYLATE
TABLET;ORAL
SYMPROIC
+! BDSI EQ 0.2MG BASE N208854 001 Mar 23, 2017
NALMEFENE HYDROCHLORIDE
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
NALMEFENE HYDROCHLORIDE
! PURDUE PHARMA LP EQ 2MG BASE/2ML (EQ 1MG BASE/ML) A212955 001 Feb 08, 2022
NALOXEGOL OXALATE
TABLET;ORAL
MOVANTIK
+ REDHILL EQ 12.5MG BASE N204760 001 Sep 16, 2014
+! EQ 25MG BASE N204760 002 Sep 16, 2014
NALOXONE HYDROCHLORIDE
INJECTABLE;INJECTION
NALOXONE
AP HIKMA 0.4MG/ML A070299 001 Sep 24, 1986
NALOXONE HYDROCHLORIDE
AP ACCORD HLTHCARE 0.4MG/ML A216624 001 Oct 26, 2022
AP 1MG/ML A216624 002 Oct 26, 2022
AP AKORN 0.4MG/ML A208871 001 Feb 28, 2017
AP 0.4MG/ML A208872 001 Mar 14, 2017
AP BAXTER HLTHCARE 0.4MG/ML A214785 001 Jan 29, 2021
CORP
AP 0.4MG/ML A214792 001 Nov 07, 2022
AP DR REDDYS 1MG/ML A213209 001 Mar 16, 2020
AP EUGIA PHARMA 0.4MG/ML A212455 001 Oct 15, 2019
AP 1MG/ML A213279 001 Jan 14, 2021
AP 0.4MG/ML A212456 001 Nov 04, 2019
AP HIKMA 1MG/ML A212300 001 Jun 10, 2022
AP ! HOSPIRA 0.4MG/ML A070172 001 Sep 24, 1986
AP ! 0.4MG/ML A070256 001 Jan 07, 1987
AP ! 0.4MG/ML A070257 001 Jan 07, 1987
AP ! INTL MEDICATION 1MG/ML A072076 001 Mar 24, 1988
AP MYLAN INSTITUTIONAL 0.4MG/ML A204997 001 Mar 06, 2014
AP 0.4MG/ML A205014 001 Jun 29, 2016
AP MYLAN LABS LTD 1MG/ML A213843 001 Jun 09, 2022
AP PAR STERILE 1MG/ML A215964 001 Jul 29, 2022
PRODUCTS
AP SOMERSET THERAPS 0.4MG/ML A207633 001 Aug 08, 2017
LLC
AP 0.4MG/ML A207634 001 Jul 26, 2017
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS
ZIMHI
+! ADAMIS PHARMS CORP 5MG/0.5ML (5MG/0.5ML) N212854 001 Oct 15, 2021
SPRAY;NASAL
KLOXXADO
+! HIKMA 8MG/SPRAY N212045 001 Apr 29, 2021
SPRAY, METERED;NASAL
NALOXONE HYDROCHLORIDE
AB PADAGIS ISRAEL 4MG/SPRAY A211951 001 Jun 21, 2022
AB TEVA PHARMS USA 4MG/SPRAY A209522 001 Apr 19, 2019
NARCAN
AB +! EMERGENT 4MG/SPRAY N208411 001 Nov 18, 2015
NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE
TABLET;ORAL
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE
AB LUPIN EQ 0.5MG BASE;EQ 50MG BASE A075735 001 Jul 11, 2001
AB SUN PHARM INDS LTD EQ 0.5MG BASE;EQ 50MG BASE A075523 001 Mar 17, 2000
AB ! WATSON LABS EQ 0.5MG BASE;EQ 50MG BASE A074736 001 Jan 21, 1997
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-326(of 474)

NALTREXONE
FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
VIVITROL
+! ALKERMES 380MG/VIAL N021897 001 Apr 13, 2006
NALTREXONE HYDROCHLORIDE
TABLET;ORAL
NALTREXONE HYDROCHLORIDE
AB ACCORD HLTHCARE 50MG A091205 001 Aug 17, 2011
AB BARR 50MG A074918 001 May 08, 1998
AB CHARTWELL 50MG A207905 001 Jul 21, 2017
AB ELITE LABS 50MG A075274 001 May 26, 1999
AB ! SPECGX LLC 50MG A076264 002 Mar 22, 2002
AB SUN PHARM 50MG A090356 001 Feb 24, 2012
SPECGX LLC 25MG A076264 001 Mar 22, 2002
100MG A076264 003 Mar 22, 2002
NAPROXEN
SUSPENSION;ORAL
NAPROSYN
AB + ATNAHS PHARMA US 25MG/ML N018965 001 Mar 23, 1987
NAPROXEN
AB AMNEAL 25MG/ML A212705 001 Jul 31, 2020
AB HETERO LABS LTD III 25MG/ML A215776 001 Jun 07, 2022
AB ! HIKMA 25MG/ML A074190 001 Mar 30, 1994
AB NOVITIUM PHARMA 25MG/ML A211910 001 Mar 10, 2021
TABLET;ORAL
NAPROSYN
AB +! ATNAHS PHARMA US 500MG N017581 004 Apr 15, 1982
NAPROXEN
AB AMNEAL PHARMS NY 250MG A075927 001 Dec 18, 2001
AB 375MG A075927 002 Dec 18, 2001
AB 500MG A075927 003 Dec 18, 2001
AB AUROBINDO PHARMA 250MG A200429 001 Nov 08, 2011
AB 375MG A200429 002 Nov 08, 2011
AB 500MG A200429 003 Nov 08, 2011
AB GLENMARK GENERICS 250MG A078250 001 Mar 28, 2007
AB 375MG A078250 002 Mar 28, 2007
AB 500MG A078250 003 Mar 28, 2007
AB GRANULES 250MG A074140 001 Dec 21, 1993
AB 375MG A074140 002 Dec 21, 1993
AB 500MG A074140 003 Dec 21, 1993
AB INVAGEN PHARMS 250MG A091305 001 Aug 24, 2011
AB 375MG A091305 002 Aug 24, 2011
AB 500MG A091305 003 Aug 24, 2011
AB MARKSANS PHARMA 250MG A091416 001 Feb 14, 2011
AB 375MG A091416 002 Feb 14, 2011
AB 500MG A091416 003 Feb 14, 2011
AB SCIEGEN PHARMS INC 250MG A212517 001 Feb 21, 2020
AB 375MG A212517 002 Feb 21, 2020
AB 500MG A212517 003 Feb 21, 2020
AB TEVA 250MG A074201 001 Dec 21, 1993
AB 375MG A074201 002 Dec 21, 1993
AB 500MG A074201 003 Dec 21, 1993
AB ZYDUS PHARMS USA 250MG A078620 001 Jun 07, 2007
AB 375MG A078620 002 Jun 07, 2007
AB 500MG A078620 003 Jun 07, 2007
TABLET, DELAYED RELEASE;ORAL
EC-NAPROSYN
AB +! ATNAHS PHARMA US 375MG N020067 002 Oct 14, 1994
AB +! 500MG N020067 003 Oct 14, 1994
NAPROXEN
AB NUVO PHARMS INC 375MG A091432 001 Sep 19, 2011
AB 500MG A091432 002 Sep 19, 2011
AB TEVA 375MG A075227 001 Jun 30, 1998
AB 500MG A075227 002 Jun 30, 1998
NAPROXEN SODIUM
TABLET;ORAL
ANAPROX DS
AB +! ATNAHS PHARMA US EQ 500MG BASE N018164 003 Sep 30, 1987
NAPROXEN SODIUM
AB AMNEAL PHARMS NY EQ 250MG BASE A078432 001 Apr 25, 2007
AB EQ 500MG BASE A078432 002 Apr 25, 2007
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-327(of 474)

NAPROXEN SODIUM
TABLET;ORAL
NAPROXEN SODIUM
AB AUROBINDO PHARMA EQ 250MG BASE A200629 001 Oct 31, 2011
LTD
AB EQ 500MG BASE A200629 002 Oct 31, 2011
AB DR REDDYS LABS LTD EQ 250MG BASE A078486 001 Jul 26, 2007
AB EQ 500MG BASE A078486 002 Jul 26, 2007
AB GLENMARK PHARMS LTD EQ 250MG BASE A078314 001 Apr 27, 2007
AB EQ 500MG BASE A078314 002 Apr 27, 2007
AB SCIEGEN PHARMS INC EQ 250MG BASE A212199 001 Oct 30, 2019
AB EQ 500MG BASE A212199 002 Oct 30, 2019
TABLET, EXTENDED RELEASE;ORAL
NAPRELAN
AB + ALMATICA EQ 375MG BASE N020353 001 Jan 05, 1996
AB + EQ 500MG BASE N020353 002 Jan 05, 1996
AB +! EQ 750MG BASE N020353 003 Jan 05, 1996
NAPROXEN SODIUM
AB ACTAVIS LABS FL INC EQ 375MG BASE A075416 002 Apr 23, 2003
AB EQ 500MG BASE A075416 001 Aug 27, 2002
AB EQ 750MG BASE A075416 003 Aug 11, 2016
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
TABLET;ORAL
SUMATRIPTAN AND NAPROXEN SODIUM
AB AUROBINDO PHARMA 500MG;EQ 85MG BASE A207457 001 Feb 15, 2018
LTD
AB RISING 500MG;EQ 85MG BASE A090872 001 Sep 04, 2018
AB SUN PHARM 500MG;EQ 85MG BASE A202803 001 Jul 20, 2018
TREXIMET
AB +! CURRAX 500MG;EQ 85MG BASE N021926 001 Apr 15, 2008
NARATRIPTAN HYDROCHLORIDE
TABLET;ORAL
AMERGE
AB + GLAXOSMITHKLINE LLC EQ 1MG BASE N020763 002 Feb 10, 1998
AB +! EQ 2.5MG BASE N020763 001 Feb 10, 1998
NARATRIPTAN
AB HERITAGE PHARMS EQ 1MG BASE A200502 001 Feb 28, 2011
AB EQ 2.5MG BASE A200502 002 Feb 28, 2011
AB HIKMA EQ 1MG BASE A090381 001 Jul 07, 2010
AB EQ 2.5MG BASE A090381 002 Jul 07, 2010
AB ORBION PHARMS EQ 1MG BASE A091441 001 Apr 30, 2012
AB EQ 2.5MG BASE A091441 002 Apr 30, 2012
AB PADAGIS US EQ 1MG BASE A091326 001 Jul 08, 2010
AB EQ 2.5MG BASE A091326 002 Jul 08, 2010
AB SUN PHARM INDS LTD EQ 2.5MG BASE A091552 001 Feb 14, 2011
NATAMYCIN
SUSPENSION;OPHTHALMIC
NATACYN
+! EYEVANCE 5% N050514 001
NATEGLINIDE
TABLET;ORAL
NATEGLINIDE
AB CADILA PHARMS LTD 60MG A206432 001 Apr 19, 2019
AB 120MG A206432 002 Apr 19, 2019
AB DR REDDYS LABS LTD 60MG A077461 001 Sep 09, 2009
AB 120MG A077461 002 Sep 09, 2009
AB RISING 60MG A205544 001 Jun 18, 2018
AB 120MG A205544 002 Jun 18, 2018
AB STRIDES PHARMA 60MG A077463 001 Sep 09, 2009
AB 120MG A077463 002 Sep 09, 2009
AB WATSON LABS 60MG A077462 001 Mar 30, 2011
AB 120MG A077462 002 Mar 30, 2011
AB ZYDUS PHARMS 60MG A205248 001 Jul 06, 2016
AB ! 120MG A205248 002 Jul 06, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-328(of 474)

NEBIVOLOL HYDROCHLORIDE
TABLET;ORAL
BYSTOLIC
AB + ALLERGAN EQ 2.5MG BASE N021742 002 Dec 17, 2007
AB + EQ 5MG BASE N021742 003 Dec 17, 2007
AB + EQ 10MG BASE N021742 004 Dec 17, 2007
AB +! EQ 20MG BASE N021742 005 Oct 08, 2008
NEBIVOLOL HYDROCHLORIDE
AB ANI PHARMS EQ 2.5MG BASE A203659 001 Apr 16, 2015
AB EQ 5MG BASE A203659 002 Apr 16, 2015
AB EQ 10MG BASE A203659 003 Apr 16, 2015
AB EQ 20MG BASE A203659 004 Apr 16, 2015
AB AUROBINDO PHARMA EQ 2.5MG BASE A211053 001 Dec 17, 2021
LTD
AB EQ 5MG BASE A211053 002 Dec 17, 2021
AB EQ 10MG BASE A211053 003 Dec 17, 2021
AB EQ 20MG BASE A211053 004 Dec 17, 2021
AB CADILA PHARMS LTD EQ 2.5MG BASE A208717 001 Dec 17, 2021
AB EQ 5MG BASE A208717 002 Dec 17, 2021
AB EQ 10MG BASE A208717 003 Dec 17, 2021
AB EQ 20MG BASE A208717 004 Dec 17, 2021
AB HETERO LABS LTD III EQ 2.5MG BASE A203825 001 Nov 03, 2020
AB EQ 5MG BASE A203825 002 Nov 03, 2020
AB EQ 10MG BASE A203825 003 Nov 03, 2020
AB EQ 20MG BASE A203825 004 Nov 03, 2020
AB INDCHEMIE HEALTH EQ 2.5MG BASE A203828 001 Jul 29, 2015
AB EQ 5MG BASE A203828 002 Jul 29, 2015
AB EQ 10MG BASE A203828 003 Jul 29, 2015
AB EQ 20MG BASE A203828 004 Jul 29, 2015
AB MANKIND PHARMA EQ 2.5MG BASE A216172 001 Nov 14, 2022
AB EQ 5MG BASE A216172 002 Nov 14, 2022
AB EQ 10MG BASE A216172 003 Nov 14, 2022
AB EQ 20MG BASE A216172 004 Nov 14, 2022
AB PRINSTON INC EQ 2.5MG BASE A212682 001 Apr 07, 2022
AB EQ 5MG BASE A212682 002 Apr 07, 2022
AB EQ 10MG BASE A212682 003 Apr 07, 2022
AB EQ 20MG BASE A212682 004 Apr 07, 2022
AB REYOUNG EQ 2.5MG BASE A212917 001 Dec 17, 2021
AB EQ 5MG BASE A212917 002 Dec 17, 2021
AB EQ 10MG BASE A212917 003 Dec 17, 2021
AB EQ 20MG BASE A212917 004 Dec 17, 2021
AB TORRENT EQ 2.5MG BASE A203966 001 Mar 02, 2018
AB EQ 5MG BASE A203966 002 Mar 02, 2018
AB EQ 10MG BASE A203966 003 Mar 02, 2018
AB EQ 20MG BASE A203966 004 Mar 02, 2018
NEBIVOLOL HYDROCHLORIDE; VALSARTAN
TABLET;ORAL
VYDUO
PRINSTON INC EQ 5MG BASE;80MG A210596 001 Sep 19, 2022
NEFAZODONE HYDROCHLORIDE
TABLET;ORAL
NEFAZODONE HYDROCHLORIDE
TEVA 50MG A076037 001 Sep 16, 2003
100MG A076037 002 Sep 16, 2003
150MG A076037 003 Sep 16, 2003
200MG A076037 004 Sep 16, 2003
! 250MG A076037 005 Sep 16, 2003
NELARABINE
INJECTABLE;INTRAVENOUS
ARRANON
AP +! NOVARTIS 250MG/50ML (5MG/ML) N021877 001 Oct 28, 2005
NELARABINE
AP DR REDDYS 250MG/50ML (5MG/ML) A216934 001 Dec 23, 2022
AP KINDOS 250MG/50ML (5MG/ML) A216038 001 Jan 10, 2023
AP ZYDUS PHARMS 250MG/50ML (5MG/ML) A215037 001 Nov 17, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-329(of 474)

NELFINAVIR MESYLATE
TABLET;ORAL
VIRACEPT
+! AGOURON PHARMS EQ 250MG BASE N020779 001 Mar 14, 1997
+! EQ 625MG BASE N021503 001 Apr 30, 2003
NEOMYCIN SULFATE
TABLET;ORAL
NEOMYCIN SULFATE
AA ! TEVA 500MG A060304 001
AA XGEN PHARMS 500MG A065220 001 Jul 28, 2006
NEOMYCIN SULFATE; POLYMYXIN B SULFATE
SOLUTION;IRRIGATION
NEOMYCIN AND POLYMYXIN B SULFATE
AT WATSON LABS EQ 40MG BASE/ML;200,000 UNITS/ML A062664 001 Apr 08, 1986
AT XGEN PHARMS EQ 40MG BASE/ML;200,000 UNITS/ML A065106 001 Jan 31, 2006
AT EQ 40MG BASE/ML;200,000 UNITS/ML A065108 001 Jan 31, 2006
NEOSPORIN G.U. IRRIGANT
AT ! MONARCH PHARMS EQ 40MG BASE/ML;200,000 UNITS/ML A060707 001
NEOSTIGMINE METHYLSULFATE
SOLUTION;INTRAVENOUS
BLOXIVERZ
AP +! EXELA PHARMA 5MG/10ML (0.5MG/ML) N204078 001 May 31, 2013
AP +! 10MG/10ML (1MG/ML) N204078 002 May 31, 2013
NEOSTIGMINE METHYLSULFATE
AP AMNEAL 5MG/10ML (0.5MG/ML) A210051 001 Jun 15, 2018
AP 10MG/10ML (1MG/ML) A210051 002 Jun 15, 2018
AP AMPHASTAR PHARMS 5MG/10ML (0.5MG/ML) A209933 001 Sep 25, 2017
INC
AP 10MG/10ML (1MG/ML) A209933 002 Sep 25, 2017
AP AMRING PHARMS 5MG/10ML (0.5MG/ML) A210989 001 Aug 22, 2018
AP 10MG/10ML (1MG/ML) A210989 002 Aug 22, 2018
AP BE PHARMS 5MG/10ML (0.5MG/ML) A212512 001 May 13, 2019
AP 10MG/10ML (1MG/ML) A212512 002 May 13, 2019
AP CAPLIN 5MG/10ML (0.5MG/ML) A213074 001 Apr 20, 2021
AP 10MG/10ML (1MG/ML) A213074 002 Apr 20, 2021
AP DR REDDYS 3MG/3ML (1MG/ML) A216291 001 Jul 06, 2022
AP 5MG/10ML (0.5MG/ML) A209135 001 Jul 10, 2018
AP 10MG/10ML (1MG/ML) A209135 002 Jul 10, 2018
AP EUROHLTH INTL SARL 5MG/10ML (0.5MG/ML) A207042 001 Dec 28, 2015
AP 10MG/10ML (1MG/ML) A207042 002 Dec 28, 2015
AP +! FRESENIUS KABI USA 3MG/3ML (1MG/ML) N203629 003 Sep 18, 2018
AP GLAND PHARMA LTD 5MG/10ML (0.5MG/ML) A212968 001 Oct 16, 2019
AP 10MG/10ML (1MG/ML) A212968 002 Oct 16, 2019
AP HIKMA 3MG/3ML (1MG/ML) A216206 001 Jul 13, 2022
AP INDOCO 5MG/10ML (0.5MG/ML) A210652 001 Oct 01, 2021
AP 10MG/10ML (1MG/ML) A210652 002 Oct 01, 2021
AP MEITHEAL 5MG/10ML (0.5MG/ML) A212804 001 Apr 05, 2021
AP 10MG/10ML (1MG/ML) A212804 002 Apr 05, 2021
AP NIVAGEN PHARMS INC 5MG/10ML (0.5MG/ML) A212627 001 Nov 03, 2022
AP 10MG/10ML (1MG/ML) A212627 002 Nov 03, 2022
AP PAR STERILE 5MG/10ML (0.5MG/ML) A208405 001 Apr 26, 2017
PRODUCTS
AP 10MG/10ML (1MG/ML) A208405 002 Apr 26, 2017
NEOSTIGMINE METHYSULFATE
AP AVET LIFESCIENCES 5MG/10ML (0.5MG/ML) A208230 001 Nov 25, 2022
AP 10MG/10ML (1MG/ML) A208230 002 Nov 25, 2022
NEOSTIGMINE METHYLSULFATE
+! FRESENIUS KABI USA 5MG/10ML (0.5MG/ML) N203629 001 Jan 08, 2015
+! 10MG/10ML (1MG/ML) N203629 002 Jan 08, 2015
NEPAFENAC
SUSPENSION/DROPS;OPHTHALMIC
ILEVRO
+! NOVARTIS 0.3% N203491 001 Oct 16, 2012
NEVANAC
+! NOVARTIS 0.1% N021862 001 Aug 19, 2005
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-330(of 474)

NERATINIB MALEATE
TABLET;ORAL
NERLYNX
+! PUMA BIOTECH EQ 40MG BASE N208051 001 Jul 17, 2017
NETARSUDIL MESYLATE
SOLUTION/DROPS;OPHTHALMIC
RHOPRESSA
+! AERIE PHARMS INC EQ 0.02% BASE N208254 001 Dec 18, 2017
NETUPITANT; PALONOSETRON HYDROCHLORIDE
CAPSULE;ORAL
AKYNZEO
+! HELSINN HLTHCARE 300MG;EQ 0.5MG BASE N205718 001 Oct 10, 2014
NEVIRAPINE
SUSPENSION;ORAL
NEVIRAPINE
AA AUROBINDO 50MG/5ML A077702 001 May 22, 2012
AA CIPLA 50MG/5ML A207684 001 Aug 03, 2017
VIRAMUNE
AA +! BOEHRINGER 50MG/5ML N020933 001 Sep 11, 1998
INGELHEIM
TABLET;ORAL
NEVIRAPINE
AB AUROBINDO 200MG A077521 001 May 22, 2012
AB CIPLA 200MG A077956 001 May 22, 2012
AB HETERO LABS LTD III 200MG A078584 001 May 22, 2012
AB ! MACLEODS PHARMS LTD 200MG A090688 001 Jan 14, 2019
AB MICRO LABS LTD 200MG A203080 001 May 22, 2012
AB MYLAN PHARMS INC 200MG A202523 001 May 22, 2012
AB STRIDES PHARMA 200MG A078195 001 May 22, 2012
TABLET, EXTENDED RELEASE;ORAL
NEVIRAPINE
AB AUROBINDO PHARMA 100MG A208616 001 Nov 23, 2016
AB 400MG A207698 001 Feb 28, 2017
AB MACLEODS PHARMS LTD 400MG A206879 001 Oct 06, 2017
AB MYLAN 400MG A205651 001 Oct 27, 2014
AB SANDOZ INC 400MG A203411 001 Apr 03, 2014
VIRAMUNE XR
AB + BOEHRINGER 100MG N201152 002 Nov 08, 2012
INGELHEIM
AB +! 400MG N201152 001 Mar 25, 2011
NIACIN
TABLET;ORAL
NIACOR
! AVONDALE PHARMS 500MG A040378 001 May 03, 2000
TABLET, EXTENDED RELEASE;ORAL
NIACIN
AB AMNEAL PHARMS 500MG A203578 001 Jul 24, 2015
AB 750MG A204178 001 Dec 11, 2015
AB 1GM A203578 002 Jul 24, 2015
AB AUROBINDO PHARMA 500MG A209236 001 Feb 01, 2018
LTD
AB 750MG A209236 002 Feb 01, 2018
AB 1GM A209236 003 Feb 01, 2018
AB BARR 500MG A076378 001 Apr 26, 2005
AB 750MG A076378 002 Apr 26, 2005
AB 1GM A076250 001 Apr 14, 2005
AB LANNETT CO INC 500MG A203899 001 Jun 16, 2017
AB 1GM A203899 002 Jun 16, 2017
AB LUPIN LTD 500MG A090860 001 Mar 20, 2014
AB 750MG A090892 001 Mar 20, 2014
AB 1GM A090446 001 Mar 20, 2014
AB MACLEODS PHARMS LTD 500MG A204934 001 Mar 03, 2022
AB 1GM A204934 002 Mar 03, 2022
AB SUN PHARM 500MG A200484 001 Apr 23, 2014
AB ! 750MG A201273 001 Apr 23, 2014
AB ! 1GM A200484 002 Apr 23, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-331(of 474)

NICARDIPINE HYDROCHLORIDE
CAPSULE;ORAL
NICARDIPINE HYDROCHLORIDE
AB ANI PHARMS 20MG A074670 001 Oct 28, 1996
AB 30MG A074670 002 Oct 28, 1996
AB EPIC PHARMA 20MG A074928 001 Mar 19, 1998
AB ! 30MG A074928 002 Mar 19, 1998
AB GLENMARK PHARMS LTD 20MG A216357 001 Dec 16, 2022
AB 30MG A216357 002 Dec 16, 2022
INJECTABLE;INJECTION
NICARDIPINE HYDROCHLORIDE
AP ! AM REGENT 25MG/10ML (2.5MG/ML) A090534 001 Nov 17, 2009
AP EUGIA PHARMA 25MG/10ML (2.5MG/ML) A211121 001 Apr 08, 2021
AP SUN PHARM 25MG/10ML (2.5MG/ML) N078405 001 Nov 17, 2009
+! HIKMA INTL PHARMS 25MG/10ML (2.5MG/ML) N022276 001 Jul 24, 2008
INJECTABLE;INTRAVENOUS
CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
+! CHIESI 40MG/200ML (0.2MG/ML) N019734 004 Nov 07, 2008
CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER
+! CHIESI 20MG/200ML (0.1MG/ML) N019734 003 Jul 31, 2008
CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER
+! CHIESI 20MG/200ML (0.1MG/ML) N019734 002 Jul 31, 2008
NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
+! HIKMA INTL PHARMS 20MG/200ML (0.1MG/ML) N022276 002 Apr 07, 2016
+! 40MG/200ML (0.2MG/ML) N022276 003 Apr 07, 2016
NICOTINE
INHALANT;ORAL
NICOTROL
+! PFIZER 4MG/CARTRIDGE N020714 001 May 02, 1997
SPRAY, METERED;NASAL
NICOTROL
+! PFIZER INC 0.5MG/SPRAY N020385 001 Mar 22, 1996
NIFEDIPINE
CAPSULE;ORAL
NIFEDIPINE
AB ACELLA 10MG A072781 001 Jul 30, 1993
AB ACTAVIS ELIZABETH 10MG A072579 001 Jan 08, 1991
AB 20MG A072556 001 Sep 20, 1990
AB HERITAGE PHARMA 10MG A202644 001 Apr 25, 2013
AB 20MG A202644 002 Apr 25, 2013
AB LEADING 10MG A073250 001 Oct 08, 1991
AB 20MG A074045 001 Apr 30, 1992
PROCARDIA
AB +! PFIZER 10MG N018482 001
TABLET, EXTENDED RELEASE;ORAL
NIFEDIPINE
AB1 AUROBINDO PHARMA 30MG A213361 001 Jul 19, 2021
AB1 60MG A213361 002 Jul 19, 2021
AB1 90MG A213361 003 Jul 19, 2021
AB1 NOVAST LABS 30MG A202987 001 Aug 25, 2016
AB1 ! 60MG A202987 002 Aug 25, 2016
AB1 ! 90MG A202987 003 Aug 25, 2016
AB1 VALEANT PHARMS 30MG A075269 001 Dec 04, 2000
NORTH
AB1 60MG A075269 002 Dec 04, 2000
AB1 90MG A076070 001 Aug 16, 2002
AB1 ZYDUS PHARMS 30MG A210184 001 Jun 29, 2018
AB1 60MG A210184 002 Jun 29, 2018
AB1 90MG A210184 003 Jun 29, 2018
AB2 ALEMBIC PHARMS 30MG A216896 001 Nov 18, 2022
AB2 60MG A216896 002 Nov 18, 2022
AB2 90MG A216896 003 Nov 18, 2022
AB2 ALKEM LABS LTD 30MG A216067 001 Mar 29, 2022
AB2 60MG A216067 002 Mar 29, 2022
AB2 90MG A216067 003 Mar 29, 2022
AB2 ELITE PHARM 90MG A212016 001 Nov 18, 2020
SOLUTION
AB2 NOVAST LABS 30MG A210614 001 Mar 12, 2019
AB2 60MG A210614 002 Mar 12, 2019
AB2 90MG A210614 003 Mar 12, 2019
AB2 OSMOTICA PHARM US 30MG A077127 001 Nov 21, 2005
AB2 60MG A077127 002 Nov 21, 2005
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-332(of 474)

NIFEDIPINE
TABLET, EXTENDED RELEASE;ORAL
NIFEDIPINE
AB2 90MG A077127 003 Oct 03, 2007
AB2 PHARMADAX INC 30MG A216019 001 Nov 18, 2022
AB2 60MG A216019 002 Nov 18, 2022
AB2 SPIL 30MG A210838 001 Apr 16, 2019
AB2 60MG A210838 002 Apr 16, 2019
AB2 90MG A210838 003 Apr 16, 2019
AB2 TWI PHARMS 30MG A203126 001 Apr 03, 2014
AB2 60MG A203126 002 Apr 03, 2014
AB2 90MG A203126 003 Apr 03, 2014
AB2 VALEANT PHARMS 30MG A075289 002 Feb 06, 2001
NORTH
AB2 60MG A075289 001 Sep 27, 2000
AB2 ZYDUS PHARMS 30MG A210012 001 Dec 19, 2017
AB2 60MG A210012 002 Dec 19, 2017
AB2 90MG A210012 003 Dec 19, 2017
PROCARDIA XL
AB2 + PFIZER 30MG N019684 001 Sep 06, 1989
AB2 + 60MG N019684 002 Sep 06, 1989
AB2 +! 90MG N019684 003 Sep 06, 1989
NIFURTIMOX
TABLET;ORAL
LAMPIT
+ BAYER HEALTHCARE 30MG N213464 001 Aug 06, 2020
+! 120MG N213464 002 Aug 06, 2020
NILOTINIB HYDROCHLORIDE
CAPSULE;ORAL
TASIGNA
+ NOVARTIS EQ 50MG BASE N022068 003 Mar 22, 2018
+ EQ 150MG BASE N022068 002 Jun 17, 2010
+! EQ 200MG BASE N022068 001 Oct 29, 2007
NILUTAMIDE
TABLET;ORAL
NILANDRON
AB +! CONCORDIA 150MG N020169 002 Apr 30, 1999
NILUTAMIDE
AB ANI PHARMS 150MG A207631 001 Jul 15, 2016
NIMODIPINE
CAPSULE;ORAL
NIMODIPINE
AB ! BIONPHARMA INC 30MG A076740 001 Jan 17, 2008
AB HERITAGE PHARMS 30MG A077811 001 May 02, 2007
AB THEPHARMANETWORK 30MG A090103 001 Apr 07, 2014
LLC
SOLUTION;ORAL
NYMALIZE
+! AZURITY 6MG/ML N203340 002 Apr 08, 2020
NINTEDANIB ESYLATE
CAPSULE;ORAL
OFEV
+ BOEHRINGER EQ 100MG BASE N205832 001 Oct 15, 2014
INGELHEIM
+! EQ 150MG BASE N205832 002 Oct 15, 2014
NIRAPARIB TOSYLATE
CAPSULE;ORAL
ZEJULA
+! GLAXOSMITHKLINE EQ 100MG BASE N208447 001 Mar 27, 2017
NISOLDIPINE
TABLET, EXTENDED RELEASE;ORAL
NISOLDIPINE
AB MYLAN 8.5MG A091001 001 Jan 26, 2011
AB 17MG A091001 002 Jan 26, 2011
AB 34MG A091001 004 Jan 26, 2011
SULAR
AB +! COVIS 8.5MG N020356 008 Jan 02, 2008
AB +! 17MG N020356 007 Jan 02, 2008
AB +! 34MG N020356 005 Jan 02, 2008
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-333(of 474)

NISOLDIPINE
TABLET, EXTENDED RELEASE;ORAL
NISOLDIPINE
! MYLAN 20MG A079051 001 Jul 25, 2008
25.5MG A091001 003 Jan 26, 2011
30MG A079051 002 Jul 25, 2008
! 40MG A079051 003 Jul 25, 2008
NITAZOXANIDE
FOR SUSPENSION;ORAL
ALINIA
+! ROMARK 100MG/5ML N021498 001 Nov 22, 2002
TABLET;ORAL
ALINIA
AB +! ROMARK 500MG N021497 001 Jul 21, 2004
NITAZOXANIDE
AB RISING 500MG A213820 001 Nov 27, 2020
NITISINONE
CAPSULE;ORAL
NITISINONE
AB MEDUNIK 2MG A212390 001 May 26, 2022
AB 5MG A212390 002 May 26, 2022
AB 10MG A212390 003 May 26, 2022
AB NOVITIUM PHARMA 2MG A211041 001 Aug 26, 2019
AB 5MG A211041 002 Aug 26, 2019
AB 10MG A211041 003 Aug 26, 2019
AB TORRENT 2MG A215908 001 Jan 09, 2023
AB 5MG A215908 002 Jan 09, 2023
AB 10MG A215908 003 Jan 09, 2023
AB 20MG A215908 004 Jan 09, 2023
ORFADIN
AB + SWEDISH ORPHAN 2MG N021232 001 Jan 18, 2002
AB + 5MG N021232 002 Jan 18, 2002
AB + 10MG N021232 003 Jan 18, 2002
AB +! 20MG N021232 004 Jun 13, 2016
SUSPENSION;ORAL
ORFADIN
+! SWEDISH ORPHAN 4MG/ML N206356 001 Apr 22, 2016
TABLET;ORAL
NITYR
+ CYCLE 2MG N209449 001 Jul 26, 2017
+ 5MG N209449 002 Jul 26, 2017
+! 10MG N209449 003 Jul 26, 2017
NITRIC OXIDE
GAS;INHALATION
INOMAX
AA +! MALLINCKRODT HOSP 800PPM N020845 003 Dec 23, 1999
NOXIVENT
AA LINDE GAS EQUIP 800PPM A207141 002 Oct 02, 2018
GENOSYL
+! VERO BIOTECH 800PPM N202860 001 Dec 20, 2019
NOXIVENT
LINDE GAS EQUIP 100PPM A207141 001 Oct 02, 2018
NITROFURANTOIN
SUSPENSION;ORAL
FURADANTIN
AB +! CASPER PHARMA LLC 25MG/5ML N009175 001
NITROFURANTOIN
AB ACTAVIS MID 25MG/5ML A205180 001 May 03, 2016
ATLANTIC
AB NOSTRUM LABS INC 25MG/5ML A201355 001 Aug 14, 2013
AB NOVEL LABS INC 25MG/5ML A201693 001 Sep 08, 2014
NITROFURANTOIN, MACROCRYSTALLINE
CAPSULE;ORAL
MACRODANTIN
AB + ALMATICA 25MG N016620 003
AB + 50MG N016620 001
AB +! 100MG N016620 002
NITROFURANTOIN
AB ACTAVIS LABS FL INC 25MG A091095 001 Jun 18, 2015
AB 50MG A091095 002 Jun 18, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-334(of 474)

NITROFURANTOIN, MACROCRYSTALLINE
CAPSULE;ORAL
NITROFURANTOIN
AB 100MG A091095 003 Jun 18, 2015
AB ALEMBIC PHARMS 25MG A211935 001 Jun 25, 2021
AB 50MG A211935 002 Jun 25, 2021
AB 100MG A211935 003 Jun 25, 2021
AB IMPAX LABS INC 50MG A073671 001 Jan 28, 1993
AB 100MG A073652 001 Jan 28, 1993
AB NOVEL LABS INC 50MG A203233 001 Jul 09, 2018
AB 100MG A203233 002 Jul 09, 2018
AB SUN PHARM 25MG A201722 001 Feb 16, 2016
INDUSTRIES
AB 50MG A201722 002 Feb 16, 2016
AB 100MG A201722 003 Feb 16, 2016
AB ZYDUS PHARMS 50MG A205005 001 Dec 12, 2017
AB 100MG A205005 002 Dec 12, 2017
NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE
CAPSULE;ORAL
MACROBID
AB +! ALMATICA 75MG;25MG N020064 001 Dec 24, 1991
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
AB ALVOGEN 75MG;25MG A215002 001 Jul 20, 2022
AB AMNEAL PHARMS 75MG;25MG A207372 001 May 15, 2017
AB INVENTIA 75MG;25MG A211013 001 Feb 18, 2022
AB SANDOZ 75MG;25MG A077066 001 Apr 05, 2005
AB SUNNY 75MG;25MG A208516 001 May 24, 2018
AB WATSON LABS INC 75MG;25MG A202250 001 Jul 08, 2015
NITROGLYCERIN
AEROSOL, METERED;SUBLINGUAL
NITROMIST
+! EVUS 0.4MG/SPRAY N021780 001 Nov 02, 2006
FILM, EXTENDED RELEASE;TRANSDERMAL
NITROGLYCERIN
AB2 ! MYLAN TECHNOLOGIES 0.1MG/HR A074559 004 Feb 06, 1998
AB2 ! 0.2MG/HR A074559 003 Aug 30, 1996
AB2 ! 0.4MG/HR A074559 002 Aug 30, 1996
AB2 ! 0.6MG/HR A074559 001 Aug 30, 1996
AB2 ZYDUS PHARMS 0.1MG/HR A089885 002 Oct 30, 2017
AB2 0.2MG/HR A089884 001 Oct 30, 1998
AB2 0.4MG/HR A089885 001 Oct 30, 1998
AB2 0.6MG/HR A089886 001 Oct 30, 1998
NITRO-DUR
+! USPHARMA 0.1MG/HR N020145 001 Apr 04, 1995
+! 0.2MG/HR N020145 002 Apr 04, 1995
+! 0.3MG/HR N020145 003 Apr 04, 1995
+! 0.4MG/HR N020145 004 Apr 04, 1995
+! 0.6MG/HR N020145 005 Apr 04, 1995
+! 0.8MG/HR N020145 006 Apr 04, 1995
INJECTABLE;INJECTION
NITROGLYCERIN IN DEXTROSE 5%
AP +! BAXTER HLTHCARE 10MG/100ML N019970 001 Dec 29, 1989
AP +! 20MG/100ML N019970 002 Dec 29, 1989
AP +! 40MG/100ML N019970 003 Dec 29, 1989
NITROGLYCERIN
! AM REGENT 5MG/ML A072034 001 May 24, 1988
OINTMENT;INTRA-ANAL
RECTIV
+! ALLERGAN 0.4% N021359 001 Jun 21, 2011
OINTMENT;TRANSDERMAL
NITROGLYCERIN
! FOUGERA PHARMS INC 2% A087355 001 Jul 08, 1988
SPRAY, METERED;SUBLINGUAL
NITROGLYCERIN
AB PADAGIS ISRAEL 0.4MG/SPRAY A091496 001 Sep 20, 2013
NITROLINGUAL PUMPSPRAY
AB +! POHL BOSKAMP 0.4MG/SPRAY N018705 002 Jan 10, 1997
TABLET;SUBLINGUAL
NITROGLYCERIN
AB DR REDDYS 0.3MG A208191 001 Aug 26, 2016
AB 0.4MG A208191 002 Aug 26, 2016
AB 0.6MG A208191 003 Aug 26, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-335(of 474)

NITROGLYCERIN
TABLET;SUBLINGUAL
NITROGLYCERIN
AB GLENMARK PHARMS SA 0.3MG A206391 001 Sep 19, 2017
AB 0.4MG A206391 002 Sep 19, 2017
AB 0.6MG A206391 003 Sep 19, 2017
AB NATCO 0.3MG A211604 001 Apr 30, 2019
AB 0.4MG A211604 002 Apr 30, 2019
AB 0.6MG A211604 003 Apr 30, 2019
AB RUBICON 0.3MG A209779 001 May 03, 2021
AB 0.4MG A209779 002 May 03, 2021
AB 0.6MG A209779 003 May 03, 2021
NITROSTAT
AB + VIATRIS 0.3MG N021134 001 May 01, 2000
AB + 0.4MG N021134 002 May 01, 2000
AB +! 0.6MG N021134 003 May 01, 2000
NIZATIDINE
CAPSULE;ORAL
NIZATIDINE
AB DR REDDYS LABS LTD 150MG A077314 001 Sep 15, 2005
AB 300MG A077314 002 Sep 15, 2005
AB EPIC PHARMA 150MG A076178 001 Jul 05, 2002
AB 300MG A076178 002 Jul 05, 2002
AB GLENMARK GENERICS 150MG A090618 001 Jul 15, 2011
AB 300MG A090618 002 Jul 15, 2011
AB WATSON LABS 150MG A075616 001 Jul 09, 2002
AB ! 300MG A075616 002 Jul 09, 2002
NOREPINEPHRINE BITARTRATE
INJECTABLE;INJECTION
LEVOPHED
AP +! HOSPIRA EQ 1MG BASE/ML N007513 001
NOREPINEPHRINE BITARTRATE
AP AMNEAL EQ 1MG BASE/ML A210839 001 Dec 17, 2018
AP BAXTER HLTHCARE EQ 1MG BASE/ML A040859 001 Mar 27, 2012
CORP
AP BRECKENRIDGE EQ 1MG BASE/ML A214455 001 Jan 22, 2021
AP FRESENIUS KABI USA EQ 1MG BASE/ML A211382 001 Nov 03, 2020
AP GLAND PHARMA LTD EQ 1MG BASE/ML A214323 001 May 06, 2021
AP HIKMA EQ 1MG BASE/ML A040462 001 Oct 31, 2003
AP EQ 1MG BASE/ML A203662 001 Nov 07, 2018
AP MYLAN LABS LTD EQ 1MG BASE/ML A211242 001 Oct 04, 2018
AP SANDOZ INC EQ 1MG BASE/ML A211359 001 Oct 18, 2018
AP SUN PHARM EQ 1MG BASE/ML A211980 001 Jan 29, 2021
AP TEVA PHARMS USA EQ 1MG BASE/ML A040455 001 Mar 03, 2003
SOLUTION;INTRAVENOUS
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
+! INFORLIFE EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) N215700 001 Sep 15, 2022
+! EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) N215700 002 Sep 15, 2022
+! EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) N215700 003 Sep 15, 2022
+! NEVAKAR INJECTABLES EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML) N214628 001 Oct 06, 2022
+! EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) N214628 002 Oct 06, 2022
+! EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) N214628 003 Oct 06, 2022
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE
+! BAXTER HLTHCARE EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) N214313 001 Jan 15, 2021
CORP
+! EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) N214313 002 Jan 15, 2021
NORETHINDRONE
TABLET;ORAL-28
CAMILA
AB1 MAYNE PHARMA 0.35MG A076177 001 Oct 21, 2002
HEATHER
AB1 GLENMARK GENERICS 0.35MG A090454 001 Apr 23, 2010
INCASSIA
AB1 AUROBINDO PHARMA 0.35MG A207304 001 Sep 23, 2016
NOR-QD
AB1 +! TEVA BRANDED PHARM 0.35MG N017060 001
NORETHINDRONE
AB1 LUPIN LTD 0.35MG A091325 001 Sep 19, 2011
AB1 MYLAN LABS LTD 0.35MG A201483 001 Jun 24, 2013
AB1 NAARI PTE LTD 0.35MG A206807 001 Dec 13, 2016
AB1 NOVAST LABS 0.35MG A202014 001 Sep 13, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-336(of 474)

NORETHINDRONE
TABLET;ORAL-28
EMZAHH
AB2 AUROBINDO PHARMA 0.35MG A216796 001 Jan 06, 2023
ERRIN
AB2 MAYNE PHARMA 0.35MG A076225 001 Oct 21, 2002
JENCYCLA
AB2 LUPIN LTD 0.35MG A091323 001 Mar 28, 2013
NORETHINDRONE
AB2 GLENMARK GENERICS 0.35MG A091209 001 Jul 22, 2010
AB2 ! MYLAN LABS LTD 0.35MG A200980 001 Jun 12, 2013
AB2 NOVAST LABS 0.35MG A200961 001 Sep 13, 2013
NORETHINDRONE ACETATE
TABLET;ORAL
NORETHINDRONE ACETATE
AB AMNEAL PHARMS 5MG A200275 001 Jul 30, 2012
AB ! BARR 5MG A075951 001 May 25, 2001
AB GLENMARK GENERICS 5MG A091090 001 Jul 21, 2010
AB MYLAN LABS LTD 5MG A205278 001 Nov 10, 2016
AB NOVAST LABS 5MG A206490 001 Nov 05, 2018
NORTRIPTYLINE HYDROCHLORIDE
CAPSULE;ORAL
NORTRIPTYLINE HYDROCHLORIDE
AB MAYNE PHARMA EQ 10MG BASE A073556 002 Mar 30, 1992
AB EQ 25MG BASE A073556 003 Mar 30, 1992
AB EQ 50MG BASE A073556 004 Mar 30, 1992
AB EQ 75MG BASE A073556 001 Mar 30, 1992
AB TARO EQ 10MG BASE A075520 004 May 08, 2000
AB EQ 25MG BASE A075520 003 May 08, 2000
AB EQ 50MG BASE A075520 001 May 08, 2000
AB EQ 75MG BASE A075520 002 May 08, 2000
AB TEVA EQ 10MG BASE A074132 001 Mar 27, 1995
AB EQ 25MG BASE A074132 002 Mar 27, 1995
AB EQ 50MG BASE A074132 003 Mar 27, 1995
AB EQ 75MG BASE A074132 004 Mar 27, 1995
PAMELOR
AB + SPECGX LLC EQ 10MG BASE N018013 001
AB + EQ 25MG BASE N018013 002
AB + EQ 50MG BASE N018013 004
AB +! EQ 75MG BASE N018013 003
SOLUTION;ORAL
NORTRIPTYLINE HYDROCHLORIDE
! PHARM ASSOC EQ 10MG BASE/5ML A075606 001 Aug 23, 2000
NUSINERSEN SODIUM
SOLUTION;INTRATHECAL
SPINRAZA
+! BIOGEN IDEC EQ 12MG BASE/5ML (EQ 2.4MG BASE/ML) N209531 001 Dec 23, 2016
NYSTATIN
CREAM;TOPICAL
NYSTATIN
AT ACTAVIS MID 100,000 UNITS/GM A062949 001 Jun 13, 1988
ATLANTIC
AT COSETTE 100,000 UNITS/GM A061966 001
AT CROWN LABS INC 100,000 UNITS/GM A207733 001 Sep 26, 2017
AT FOUGERA PHARMS 100,000 UNITS/GM A062129 001
AT MACLEODS PHARMS LTD 100,000 UNITS/GM A213566 001 Aug 10, 2021
AT PADAGIS US 100,000 UNITS/GM A062225 001
AT ! TARO 100,000 UNITS/GM A064022 001 Jan 29, 1993
AT TORRENT 100,000 UNITS/GM A212557 001 Jul 24, 2019
OINTMENT;TOPICAL
NYSTATIN
AT ACTAVIS MID 100,000 UNITS/GM A062840 001 Nov 13, 1987
ATLANTIC
AT CADILA 100,000 UNITS/GM A207767 001 May 25, 2018
AT COSETTE 100,000 UNITS/GM A209114 001 Oct 06, 2017
AT ! FOUGERA PHARMS 100,000 UNITS/GM A062124 002 Sep 23, 1982
AT LYNE 100,000 UNITS/GM A209082 001 May 21, 2018
AT MACLEODS PHARMS LTD 100,000 UNITS/GM A213826 001 Jan 14, 2021
AT PADAGIS US 100,000 UNITS/GM A062472 001 Feb 13, 1984
AT TORRENT 100,000 UNITS/GM A211838 001 Jan 28, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-337(of 474)

NYSTATIN
POWDER;TOPICAL
NYSTATIN
AT EPIC PHARMA LLC 100,000 UNITS/GM A210532 001 Apr 30, 2018
AT LUPIN 100,000 UNITS/GM A065138 001 Jul 23, 2004
AT LYNE 100,000 UNITS/GM A208838 001 May 30, 2017
AT ! MAYNE PHARMA INC 100,000 UNITS/GM A065203 001 Jul 15, 2004
AT UPSHER SMITH LABS 100,000 UNITS/GM A065183 001 May 03, 2005
AT XGEN PHARMS 100,000 UNITS/GM A065175 001 Dec 17, 2004
AT ZYDUS PHARMS 100,000 UNITS/GM A208581 001 Jun 08, 2017
NYSTOP
AT PADAGIS US 100,000 UNITS/GM A064118 001 Aug 16, 1996
SUSPENSION;ORAL
NYSTATIN
AA DASTECH GENERICS 100,000 UNITS/ML A062832 001 Dec 27, 1991
AA FOUGERA PHARMS INC 100,000 UNITS/ML A062517 001 Jun 07, 1984
AA GENUS 100,000 UNITS/ML A065148 001 Jun 28, 2005
AA LEADING 100,000 UNITS/ML A214346 001 Mar 10, 2022
AA PHARM ASSOC 100,000 UNITS/ML A203621 001 Jan 07, 2016
AA TARO 100,000 UNITS/ML A062876 001 Feb 29, 1988
AA VISTAPHARM 100,000 UNITS/ML A064142 001 Jun 25, 1998
AA 100,000 UNITS/ML A064142 002 Mar 07, 2011
AA ! WOCKHARDT BIO AG 100,000 UNITS/ML A062512 001 Oct 29, 1984
TABLET;ORAL
NYSTATIN
AA HERITAGE PHARMS 500,000 UNITS A062474 001 Dec 22, 1983
AA SUN PHARM 500,000 UNITS A062838 001 Dec 22, 1988
INDUSTRIES
AA ! TEVA 500,000 UNITS A062506 001 Jan 16, 1984
NYSTATIN; TRIAMCINOLONE ACETONIDE
CREAM;TOPICAL
MYKACET
AT COSETTE 100,000 UNITS/GM;0.1% A062367 001 May 28, 1985
NYSTATIN AND TRIAMCINOLONE ACETONIDE
AT ALEOR 100,000 UNITS/GM;0.1% A214090 001 Mar 31, 2021
DERMACEUTICALS
AT AMNEAL 100,000 UNITS/GM;0.1% A209990 001 Feb 15, 2018
AT CROWN LABS INC 100,000 UNITS/GM;0.1% A207730 001 Dec 26, 2017
AT DR REDDYS 100,000 UNITS/GM;0.1% A208326 001 Oct 26, 2016
AT FOUGERA PHARMS INC 100,000 UNITS/GM;0.1% A062599 001 Oct 08, 1985
AT GLENMARK PHARMS LTD 100,000 UNITS/GM;0.1% A208136 001 Oct 24, 2016
AT LUPIN LTD 100,000 UNITS/GM;0.1% A208205 001 May 31, 2018
AT MACLEODS PHARMS LTD 100,000 UNITS/GM;0.1% A214181 001 Jul 13, 2022
AT PADAGIS ISRAEL 100,000 UNITS/GM;0.1% A208479 001 Aug 14, 2017
AT ! TARO 100,000 UNITS/GM;0.1% A062364 001 Dec 22, 1987
AT TORRENT 100,000 UNITS/GM;0.1% A213142 001 Jul 14, 2020
OINTMENT;TOPICAL
MYKACET
AT COSETTE 100,000 UNITS/GM;0.1% A062733 001 Mar 06, 1987
NYSTATIN AND TRIAMCINOLONE ACETONIDE
AT AKORN 100,000 UNITS/GM;0.1% A207217 001 Aug 04, 2017
AT ALEOR 100,000 UNITS/GM;0.1% A214186 001 Mar 04, 2022
DERMACEUTICALS
AT CADILA 100,000 UNITS/GM;0.1% A207764 001 Nov 08, 2018
AT DR REDDYS 100,000 UNITS/GM;0.1% A207741 001 Jan 31, 2017
AT FOUGERA PHARMS INC 100,000 UNITS/GM;0.1% A062602 001 Oct 09, 1985
AT GLENMARK PHARMS LTD 100,000 UNITS/GM;0.1% A208300 001 Jun 23, 2016
AT MACLEODS PHARMS LTD 100,000 UNITS/GM;0.1% A214751 001 Aug 17, 2021
AT PADAGIS ISRAEL 100,000 UNITS/GM;0.1% A207380 001 Dec 20, 2016
AT PAI HOLDINGS PHARM 100,000 UNITS/GM;0.1% A208287 001 Dec 30, 2016
AT RISING 100,000 UNITS/GM;0.1% A206785 001 Dec 29, 2016
AT STRIDES PHARMA 100,000 UNITS/GM;0.1% A210077 001 Jan 29, 2018
AT ! TARO 100,000 UNITS/GM;0.1% A063305 001 Mar 29, 1993
OBETICHOLIC ACID
TABLET;ORAL
OCALIVA
+ INTERCEPT PHARMS 5MG N207999 001 May 27, 2016
INC
+! 10MG N207999 002 May 27, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-338(of 474)

OCTREOTIDE ACETATE
CAPSULE, DELAYED RELEASE;ORAL
MYCAPSSA
+! AMRYT EQ 20MG BASE N208232 001 Jun 26, 2020
INJECTABLE;INJECTION
OCTREOTIDE ACETATE
AP FRESENIUS KABI USA EQ 0.2MG BASE/ML A077450 001 Feb 10, 2006
AP EQ 1MG BASE/ML A077450 002 Feb 10, 2006
AP HERITAGE PHARMS EQ 0.05MG BASE/ML A204669 001 Dec 27, 2018
AP EQ 0.1MG BASE/ML A204669 002 Dec 27, 2018
AP EQ 0.2MG BASE/ML A203765 001 Sep 07, 2018
AP EQ 0.5MG BASE/ML A204669 003 Dec 27, 2018
AP EQ 1MG BASE/ML A203765 002 Sep 07, 2018
AP SAGENT PHARMS INC EQ 0.2MG BASE/ML A091041 001 Nov 12, 2013
AP EQ 1MG BASE/ML A091041 002 Nov 12, 2013
AP TEVA PHARMS USA EQ 0.05MG BASE/ML A075957 001 Oct 03, 2005
AP EQ 0.1MG BASE/ML A075957 002 Oct 03, 2005
AP EQ 0.2MG BASE/ML A075959 001 Nov 21, 2005
AP EQ 0.5MG BASE/ML A075957 003 Oct 03, 2005
AP EQ 1MG BASE/ML A075959 002 Nov 21, 2005
AP ! WEST-WARD PHARMS EQ 0.2MG BASE/ML A076330 001 Apr 08, 2005
INT
AP ! EQ 1MG BASE/ML A076330 002 Apr 08, 2005
OCTREOTIDE ACETATE (PRESERVATIVE FREE)
AP FRESENIUS KABI USA EQ 0.05MG BASE/ML A077457 001 Feb 10, 2006
AP EQ 0.1MG BASE/ML A077457 002 Feb 10, 2006
AP EQ 0.5MG BASE/ML A077457 003 Feb 10, 2006
AP MYLAN INSTITUTIONAL EQ 0.05MG BASE/ML A079198 001 Feb 10, 2011
AP EQ 0.1MG BASE/ML A079198 002 Feb 10, 2011
AP EQ 0.5MG BASE/ML A079198 003 Feb 10, 2011
AP SAGENT PHARMS INC EQ 0.05MG BASE/ML A090834 001 Nov 12, 2013
AP EQ 0.1MG BASE/ML A090834 002 Nov 12, 2013
AP EQ 0.5MG BASE/ML A090834 003 Nov 12, 2013
AP ! WEST-WARD PHARMS EQ 0.05MG BASE/ML A076313 001 Mar 28, 2005
INT
AP ! EQ 0.1MG BASE/ML A076313 003 Mar 28, 2005
AP ! EQ 0.5MG BASE/ML A076313 002 Mar 28, 2005
SANDOSTATIN
AP +! NOVARTIS EQ 0.05MG BASE/ML N019667 001 Oct 21, 1988
AP +! EQ 0.1MG BASE/ML N019667 002 Oct 21, 1988
AP +! EQ 0.5MG BASE/ML N019667 003 Oct 21, 1988
SANDOSTATIN LAR
+ NOVARTIS EQ 10MG BASE/VIAL N021008 001 Nov 25, 1998
+ EQ 20MG BASE/VIAL N021008 002 Nov 25, 1998
+! EQ 30MG BASE/VIAL N021008 003 Nov 25, 1998
ODEVIXIBAT
CAPSULE;ORAL
BYLVAY
+ ALBIREO 0.4MG N215498 002 Jul 20, 2021
+! 1.2MG N215498 004 Jul 20, 2021
CAPSULE, PELLETS;ORAL
BYLVAY
+ ALBIREO 0.2MG N215498 001 Jul 20, 2021
+! 0.6MG N215498 003 Jul 20, 2021
OFLOXACIN
SOLUTION/DROPS;OPHTHALMIC
OCUFLOX
AT +! ALLERGAN 0.3% N019921 001 Jul 30, 1993
OFLOXACIN
AT AKORN 0.3% A076407 001 Apr 15, 2008
AT ALTAIRE PHARMS INC 0.3% A202692 001 Apr 29, 2013
AT APOTEX INC 0.3% A076513 001 May 14, 2004
AT BAUSCH AND LOMB 0.3% A076622 001 May 14, 2004
AT FDC LTD 0.3% A078559 001 Feb 25, 2009
AT MANKIND PHARMA 0.3% A215886 001 Nov 23, 2022
SOLUTION/DROPS;OTIC
OFLOXACIN
AT AKORN 0.3% A076616 001 Mar 17, 2008
AT AMNEAL 0.3% A211525 001 Aug 30, 2019
AT APOTEX INC 0.3% A076527 001 Sep 28, 2007
AT ! BAUSCH AND LOMB 0.3% A076128 001 Mar 17, 2008
AT MANKIND PHARMA 0.3% A216130 001 Jul 14, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-339(of 474)

OFLOXACIN
TABLET;ORAL
OFLOXACIN
AB CADILA PHARMS LTD 200MG A091656 001 Sep 18, 2014
AB 300MG A091656 002 Sep 18, 2014
AB 400MG A091656 003 Sep 18, 2014
AB DR REDDYS LABS LTD 200MG A077098 001 Feb 10, 2006
AB 300MG A077098 002 Feb 10, 2006
AB 400MG A077098 003 Feb 10, 2006
AB LARKEN LABS 400MG A076093 003 Sep 02, 2003
AB TEVA 200MG A076182 001 Sep 02, 2003
AB 300MG A076182 002 Sep 02, 2003
AB ! 400MG A076182 003 Sep 02, 2003
OLANZAPINE
INJECTABLE;INTRAMUSCULAR
OLANZAPINE
AP AM REGENT 10MG/VIAL A201741 001 Mar 20, 2012
AP EUGIA PHARMA 10MG/VIAL A210968 001 Oct 22, 2020
AP SANDOZ INC 10MG/VIAL A201588 001 Oct 24, 2011
ZYPREXA
AP +! LILLY 10MG/VIAL N021253 001 Mar 29, 2004
TABLET;ORAL
OLANZAPINE
AB ALKEM LABS LTD 2.5MG A202295 001 Oct 20, 2015
AB 5MG A202295 002 Oct 20, 2015
AB 7.5MG A202295 003 Oct 20, 2015
AB 10MG A202295 004 Oct 20, 2015
AB 15MG A202295 005 Oct 20, 2015
AB 20MG A202295 006 Oct 20, 2015
AB APOTEX INC 2.5MG A090798 001 Apr 23, 2012
AB 5MG A090798 002 Apr 23, 2012
AB 7.5MG A090798 003 Apr 23, 2012
AB 10MG A090798 004 Apr 23, 2012
AB 15MG A090798 005 Apr 23, 2012
AB 20MG A090798 006 Apr 23, 2012
AB AUROBINDO PHARMA 2.5MG A202050 001 Apr 23, 2012
LTD
AB 5MG A202050 002 Apr 23, 2012
AB 7.5MG A202050 003 Apr 23, 2012
AB 10MG A202050 004 Apr 23, 2012
AB 15MG A202050 005 Apr 23, 2012
AB 20MG A202050 006 Apr 23, 2012
AB CHARTWELL MOLECULAR 2.5MG A203333 001 Mar 15, 2016
AB 5MG A203333 002 Mar 15, 2016
AB 7.5MG A203333 003 Mar 15, 2016
AB 10MG A203333 004 Mar 15, 2016
AB 15MG A203333 005 Mar 15, 2016
AB 20MG A203333 006 Mar 15, 2016
AB DR REDDYS LABS LTD 2.5MG A076255 001 Apr 23, 2012
AB 5MG A076255 002 Apr 23, 2012
AB 7.5MG A076255 003 Apr 23, 2012
AB 10MG A076255 004 Apr 23, 2012
AB 15MG A076133 001 Apr 23, 2012
AB 20MG A076133 002 Oct 24, 2011
AB INDOCO 2.5MG A206155 001 Jul 31, 2020
AB 5MG A206155 002 Jul 31, 2020
AB 7.5MG A206155 003 Jul 31, 2020
AB 10MG A206155 004 Jul 31, 2020
AB 15MG A206155 005 Jul 31, 2020
AB 20MG A206155 006 Jul 31, 2020
AB MACLEODS PHARMS LTD 2.5MG A202862 001 Aug 15, 2014
AB 5MG A202862 002 Aug 15, 2014
AB 7.5MG A202862 003 Aug 15, 2014
AB 10MG A202862 004 Aug 15, 2014
AB 15MG A202862 005 Aug 15, 2014
AB 20MG A202862 006 Aug 15, 2014
AB ORBION PHARMS 2.5MG A202287 001 Apr 23, 2012
AB 5MG A202287 002 Apr 23, 2012
AB 7.5MG A202287 003 Apr 23, 2012
AB 10MG A202287 004 Apr 23, 2012
AB 15MG A202287 005 Apr 23, 2012
AB 20MG A202287 006 Apr 23, 2012
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-340(of 474)

OLANZAPINE
TABLET;ORAL
OLANZAPINE
AB QILU 2.5MG A204319 001 Jan 27, 2016
AB 5MG A204319 002 Jan 27, 2016
AB 7.5MG A204319 003 Jan 27, 2016
AB 10MG A204319 004 Jan 27, 2016
AB 15MG A204319 005 Jan 27, 2016
AB 20MG A204319 006 Jan 27, 2016
AB SUN PHARM INDS 2.5MG A091038 001 Apr 23, 2012
AB 5MG A091038 002 Apr 23, 2012
AB 7.5MG A091038 003 Apr 23, 2012
AB 10MG A091038 004 Apr 23, 2012
AB 15MG A091038 005 Apr 23, 2012
AB 20MG A091038 006 Apr 23, 2012
AB ZYDUS PHARMS 2.5MG A090459 001 Jul 16, 2018
AB 5MG A090459 002 Jul 16, 2018
AB 7.5MG A090459 003 Jul 16, 2018
AB 10MG A090459 004 Jul 16, 2018
AB 15MG A090459 005 Jul 16, 2018
AB 20MG A090459 006 Jul 16, 2018
ZYPREXA
AB + LILLY 2.5MG N020592 001 Sep 30, 1996
AB +! 5MG N020592 002 Sep 30, 1996
AB + 7.5MG N020592 003 Sep 30, 1996
AB + 10MG N020592 004 Sep 30, 1996
AB + 15MG N020592 005 Sep 09, 1997
AB + 20MG N020592 006 Sep 09, 1997
TABLET, ORALLY DISINTEGRATING;ORAL
OLANZAPINE
AB APOTEX INC 5MG A091265 001 Oct 24, 2011
AB 10MG A091265 002 Oct 24, 2011
AB 15MG A091265 003 Oct 24, 2011
AB 20MG A091265 004 Oct 24, 2011
AB AUROBINDO PHARMA 5MG A203708 001 May 15, 2014
LTD
AB 10MG A203708 002 May 15, 2014
AB 15MG A203708 003 May 15, 2014
AB 20MG A203708 004 May 15, 2014
AB BARR LABS INC 5MG A077243 001 Jan 30, 2012
AB 10MG A077243 002 Jan 30, 2012
AB 15MG A077243 003 Jan 30, 2012
AB 20MG A077243 004 Jan 30, 2012
AB CHARTWELL MOLECULAR 5MG A203456 001 Mar 16, 2016
AB 10MG A203456 002 Mar 16, 2016
AB 15MG A203456 003 Mar 16, 2016
AB 20MG A203456 004 Mar 16, 2016
AB DR REDDYS LABS LTD 5MG A076534 001 Oct 24, 2011
AB 10MG A076534 002 Oct 24, 2011
AB 15MG A076534 003 Oct 24, 2011
AB 20MG A076534 004 Oct 24, 2011
AB HEC PHARM 5MG A208146 001 Jul 02, 2018
AB 10MG A208146 002 Jul 02, 2018
AB 15MG A208146 003 Jul 02, 2018
AB 20MG A208146 004 Jul 02, 2018
AB JUBILANT GENERICS 5MG A200221 001 Sep 12, 2012
AB 10MG A200221 002 Sep 12, 2012
AB 15MG A200221 003 Sep 12, 2012
AB 20MG A200221 004 Sep 12, 2012
AB MACLEODS PHARMS LTD 5MG A203044 001 Feb 20, 2015
AB 10MG A203044 002 Feb 20, 2015
AB 15MG A203044 003 Feb 20, 2015
AB 20MG A203044 004 Feb 20, 2015
AB MYLAN 5MG A202285 001 May 12, 2014
AB 10MG A202285 002 May 12, 2014
AB 15MG A202285 003 May 12, 2014
AB 20MG A202285 004 May 12, 2014
AB ORBION PHARMS 5MG A202937 001 Mar 02, 2015
AB 10MG A202937 002 Mar 02, 2015
AB 15MG A202937 003 Mar 02, 2015
AB 20MG A202937 004 Mar 02, 2015
AB STRIDES PHARMA 5MG A078109 001 Oct 24, 2011
AB 10MG A078109 002 Oct 24, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-341(of 474)

OLANZAPINE
TABLET, ORALLY DISINTEGRATING;ORAL
OLANZAPINE
AB 15MG A078109 003 Oct 24, 2011
AB 20MG A078109 004 Oct 24, 2011
AB SUN PHARM INDS 5MG A090881 001 Feb 28, 2012
AB 10MG A090881 002 Feb 28, 2012
AB 15MG A090881 003 Feb 28, 2012
AB 20MG A090881 004 Feb 28, 2012
AB TORRENT 5MG A091415 001 Oct 25, 2011
AB 10MG A091415 002 Oct 25, 2011
AB 15MG A091415 003 Oct 25, 2011
AB 20MG A091415 004 Oct 25, 2011
ZYPREXA ZYDIS
AB +! LILLY 5MG N021086 001 Apr 06, 2000
AB + 10MG N021086 002 Apr 06, 2000
AB + 15MG N021086 003 Apr 06, 2000
AB + 20MG N021086 004 Apr 06, 2000
OLANZAPINE PAMOATE
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
ZYPREXA RELPREVV
+ ELI LILLY CO EQ 210MG BASE/VIAL N022173 001 Dec 11, 2009
+ EQ 300MG BASE/VIAL N022173 002 Dec 11, 2009
+! EQ 405MG BASE/VIAL N022173 003 Dec 11, 2009
OLANZAPINE; SAMIDORPHAN L-MALATE
TABLET;ORAL
LYBALVI
+! ALKERMES INC 5MG;EQ 10MG BASE N213378 001 May 28, 2021
+ 10MG;EQ 10MG BASE N213378 002 May 28, 2021
+ 15MG;EQ 10MG BASE N213378 003 May 28, 2021
+ 20MG;EQ 10MG BASE N213378 004 May 28, 2021
OLAPARIB
TABLET;ORAL
LYNPARZA
+ ASTRAZENECA 100MG N208558 001 Aug 17, 2017
+! 150MG N208558 002 Aug 17, 2017
OLICERIDINE
SOLUTION;INTRAVENOUS
OLINVYK
+! TREVENA 1MG/ML (1MG/ML) N210730 001 Oct 30, 2020
+! 2MG/2ML (1MG/ML) N210730 002 Oct 30, 2020
+! 30MG/30ML (1MG/ML) N210730 003 Oct 30, 2020
OLIVE OIL; SOYBEAN OIL
EMULSION;INTRAVENOUS
CLINOLIPID 20%
+! BAXTER HLTHCARE 16%(160GM/1000ML);4% (40GM/1000ML) N204508 001 Oct 03, 2013
CORP
OLMESARTAN MEDOXOMIL
TABLET;ORAL
BENICAR
AB + COSETTE 5MG N021286 001 Apr 25, 2002
AB + 20MG N021286 003 Apr 25, 2002
AB +! 40MG N021286 004 Apr 25, 2002
OLMESARTAN MEDOXOMIL
AB ACCORD HLTHCARE 5MG A207662 001 Apr 24, 2017
AB 20MG A207662 002 Apr 24, 2017
AB 40MG A207662 003 Apr 24, 2017
AB ALEMBIC PHARMS 5MG A203012 001 Apr 24, 2017
AB 20MG A203012 002 Apr 24, 2017
AB 40MG A203012 003 Apr 24, 2017
AB ALKEM LABS LTD 5MG A206763 001 Apr 24, 2017
AB 20MG A206763 002 Apr 24, 2017
AB 40MG A206763 003 Apr 24, 2017
AB AUROBINDO PHARMA 5MG A204798 001 Apr 24, 2017
AB 20MG A204798 002 Apr 24, 2017
AB 40MG A204798 003 Apr 24, 2017
AB GLENMARK PHARMS LTD 5MG A203281 001 May 25, 2017
AB 20MG A203281 002 May 25, 2017
AB 40MG A203281 003 May 25, 2017
AB MACLEODS PHARMS LTD 5MG A204814 001 Apr 24, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-342(of 474)

OLMESARTAN MEDOXOMIL
TABLET;ORAL
OLMESARTAN MEDOXOMIL
AB 20MG A204814 002 Apr 24, 2017
AB 40MG A204814 003 Apr 24, 2017
AB MICRO LABS 5MG A206372 001 Sep 17, 2019
AB 20MG A206372 002 Sep 17, 2019
AB 40MG A206372 003 Sep 17, 2019
AB PRINSTON INC 5MG A206720 001 Dec 02, 2022
AB 20MG A206720 002 Dec 02, 2022
AB 40MG A206720 003 Dec 02, 2022
AB QILU 5MG A210552 001 Jan 10, 2019
AB 20MG A210552 002 Jan 10, 2019
AB 40MG A210552 003 Jan 10, 2019
AB SCIEGEN PHARMS INC 5MG A208130 001 Jun 29, 2018
AB 20MG A208130 002 Jun 29, 2018
AB 40MG A208130 003 Jun 29, 2018
AB SUNSHINE 5MG A211049 001 Feb 22, 2019
AB 20MG A211049 002 Feb 22, 2019
AB 40MG A211049 003 Feb 22, 2019
AB TORRENT 5MG A202375 001 Apr 24, 2017
AB 20MG A202375 002 Apr 24, 2017
AB 40MG A202375 003 Apr 24, 2017
AB UMEDICA LABS PVT 5MG A207135 001 Jul 18, 2019
LTD
AB 20MG A207135 002 Jul 18, 2019
AB 40MG A207135 003 Jul 18, 2019
AB ZYDUS PHARMS 5MG A205192 001 Apr 24, 2017
AB 20MG A205192 002 Apr 24, 2017
AB 40MG A205192 003 Apr 24, 2017
OLODATEROL HYDROCHLORIDE
SPRAY, METERED;INHALATION
STRIVERDI RESPIMAT
+! BOEHRINGER EQ 0.0025MG BASE/INH N203108 001 Jul 31, 2014
INGELHEIM
OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE
SPRAY, METERED;INHALATION
STIOLTO RESPIMAT
+! BOEHRINGER EQ 0.0025MG BASE/INH;EQ 0.0025MG N206756 001 May 21, 2015
INGELHEIM BASE/INH
OLOPATADINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
OLOPATADINE HYDROCHLORIDE
SOMERSET THERAPS EQ 0.1% BASE A206306 001 Dec 07, 2015
LLC
SPRAY, METERED;NASAL
OLOPATADINE HYDROCHLORIDE
AB AKORN 0.665MG/SPRAY A213757 001 Aug 19, 2020
AB AMNEAL 0.665MG/SPRAY A210901 001 Jan 28, 2020
AB APOTEX INC 0.665MG/SPRAY A091572 001 Oct 08, 2014
AB PADAGIS ISRAEL 0.665MG/SPRAY A202853 001 Jan 31, 2017
PATANASE
AB +! NOVARTIS 0.665MG/SPRAY N021861 001 Apr 15, 2008
OLSALAZINE SODIUM
CAPSULE;ORAL
DIPENTUM
+! MYLAN SPCLT VIATRIS 250MG N019715 001 Jul 31, 1990
OLUTASIDENIB
CAPSULE;ORAL
REZLIDHIA
+! RIGEL PHARMS INC 150MG N215814 001 Dec 01, 2022
OMACETAXINE MEPESUCCINATE
POWDER;SUBCUTANEOUS
SYNRIBO
+! TEVA PHARMS INTL 3.5MG/VIAL N203585 001 Oct 26, 2012
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-343(of 474)

OMADACYCLINE TOSYLATE
POWDER;INTRAVENOUS
NUZYRA
+! PARATEK PHARMS INC EQ 100MG BASE/VIAL N209817 001 Oct 02, 2018
TABLET;ORAL
NUZYRA
+! PARATEK PHARMS INC EQ 150MG BASE N209816 001 Oct 02, 2018
OMEGA-3-ACID ETHYL ESTERS
CAPSULE;ORAL
LOVAZA
AB +! WOODWARD 1GM CONTAINS AT LEAST 900MG OF THE N021654 001 Nov 10, 2004
ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
OMEGA-3-ACID ETHYL ESTERS
AB AMNEAL PHARMS 1GM CONTAINS AT LEAST 900MG OF THE A204940 001 Nov 27, 2015
ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
AB APOTEX 1GM CONTAINS AT LEAST 900MG OF THE A090973 001 Sep 30, 2014
ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
AB ASCENT PHARMS INC 1GM CONTAINS AT LEAST 900MG OF THE A207420 001 Feb 25, 2019
ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
AB BIONPHARMA INC 1GM CONTAINS AT LEAST 900MG OF THE A206455 001 Aug 07, 2019
ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
AB CSPC-NBP PHARM 1GM CONTAINS AT LEAST 900MG OF THE A211979 001 May 12, 2020
ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
AB GLW 1GM CONTAINS AT LEAST 900MG OF THE A091028 001 Apr 07, 2014
ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
AB 1GM CONTAINS AT LEAST 900MG OF THE A212504 001 Aug 19, 2020
ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
AB MANKIND PHARMA 1GM CONTAINS AT LEAST 900MG OF THE A215458 001 Nov 15, 2021
ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
AB PURACAP PHARM LLC 1GM CONTAINS AT LEAST 900MG OF THE A210093 001 Jun 15, 2020
ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
AB SOFGEN PHARMS 1GM CONTAINS AT LEAST 900MG OF THE A211355 001 Jul 10, 2019
ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
AB STRIDES PHARMA 1GM CONTAINS AT LEAST 900MG OF THE A203893 001 Sep 19, 2017
ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
AB SUN PHARM 1GM CONTAINS AT LEAST 900MG OF THE A210834 001 Jan 09, 2020
ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
OMEPRAZOLE
CAPSULE, DELAYED REL PELLETS;ORAL
OMEPRAZOLE
AB ACTAVIS LABS FL INC 10MG A075347 001 May 30, 2008
AB 20MG A075347 002 May 30, 2008
AB 40MG A075347 003 May 30, 2008
AB APOTEX 10MG A076048 001 Oct 22, 2007
AB 20MG A076048 002 Oct 22, 2007
AB 40MG A076048 003 Jan 21, 2009
AB AUROBINDO PHARMA 10MG A203270 001 Aug 19, 2015
AB 20MG A203270 002 Aug 19, 2015
AB 40MG A203270 003 Aug 19, 2015
AB BRECKENRIDGE 10MG A203481 001 Jul 03, 2017
AB 20MG A203481 002 Jul 03, 2017
AB 40MG A203481 003 Jul 03, 2017
AB DR REDDYS LABS LTD 10MG A075576 003 Oct 22, 2007
AB 10MG A078490 002 Mar 16, 2009
AB 20MG A075576 002 Oct 22, 2007
AB 20MG A078490 003 Mar 16, 2009
AB 40MG A075576 001 Jan 21, 2009
AB 40MG A078490 001 Apr 17, 2009
AB GLENMARK GENERICS 10MG A091672 001 Oct 31, 2014
AB 20MG A091672 002 Oct 31, 2014
AB 40MG A091672 003 Oct 31, 2014
AB HETERO LABS LTD III 10MG A204012 001 Sep 26, 2019
AB 20MG A204012 002 Sep 26, 2019
AB IMPAX LABS 10MG A075785 001 Oct 22, 2007
AB 20MG A075785 002 Oct 22, 2007
AB 40MG A075785 003 Jan 21, 2009
AB LANNETT CO INC 10MG A075410 001 Nov 01, 2002
AB 20MG A075410 002 Nov 01, 2002
AB 40MG A075410 003 Jan 23, 2009
AB SANDOZ 10MG A075757 001 Jan 28, 2003
AB ! 20MG A075757 002 Jan 28, 2003
AB ! 40MG A076515 001 Jan 21, 2009
AB TEVA PHARMS USA 20MG A204661 001 Jun 13, 2017
AB XIROMED 10MG A212977 001 Dec 10, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-344(of 474)

OMEPRAZOLE
CAPSULE, DELAYED REL PELLETS;ORAL
OMEPRAZOLE
AB 20MG A212977 002 Dec 10, 2020
AB ZYDUS PHARMS USA 10MG A091352 001 Nov 19, 2012
INC
AB 20MG A091352 002 Nov 19, 2012
AB 40MG A091352 003 Nov 19, 2012
OMEPRAZOLE MAGNESIUM
FOR SUSPENSION, DELAYED RELEASE;ORAL
PRILOSEC
+ COVIS EQ 2.5MG BASE/PACKET N022056 001 Mar 20, 2008
+! EQ 10MG BASE/PACKET N022056 002 Mar 20, 2008
OMEPRAZOLE; SODIUM BICARBONATE
CAPSULE;ORAL
OMEPRAZOLE AND SODIUM BICARBONATE
AB AJANTA PHARMA LTD 20MG;1.1GM A204228 001 Jul 15, 2016
AB 40MG;1.1GM A204228 002 Jul 15, 2016
AB AUROLIFE PHARMA LLC 20MG;1.1GM A204922 001 Aug 19, 2016
AB 40MG;1.1GM A204922 002 Aug 19, 2016
AB DR REDDYS 20MG;1.1GM A204068 001 Jul 15, 2016
AB 40MG;1.1GM A204068 002 Jul 15, 2016
AB GUARDIAN DRUG 20MG;1.1GM A212587 001 Apr 30, 2020
AB 40MG;1.1GM A212587 002 Apr 30, 2020
AB SCIEGEN PHARMS INC 20MG;1.1GM A207476 001 Dec 06, 2016
AB 40MG;1.1GM A207476 002 Dec 06, 2016
AB ZYDUS PHARMS 20MG;1.1GM A203290 001 May 25, 2018
AB 40MG;1.1GM A203290 002 May 25, 2018
ZEGERID
AB + SALIX 20MG;1.1GM N021849 001 Feb 27, 2006
AB +! 40MG;1.1GM N021849 002 Feb 27, 2006
FOR SUSPENSION;ORAL
OMEPRAZOLE AND SODIUM BICARBONATE
AB AJANTA PHARMA LTD 20MG/PACKET;1.68GM/PACKET A205545 001 Jul 27, 2016
AB 40MG/PACKET;1.68GM/PACKET A205545 002 Jul 27, 2016
AB STRIDES PHARMA 20MG/PACKET;1.68GM/PACKET A079182 001 Apr 19, 2013
AB 40MG/PACKET;1.68GM/PACKET A079182 002 Apr 19, 2013
ZEGERID
AB + SALIX 20MG/PACKET;1.68GM/PACKET N021636 001 Jun 15, 2004
AB +! 40MG/PACKET;1.68GM/PACKET N021636 002 Dec 21, 2004
KONVOMEP
+! AZURITY 2MG/ML;84MG/ML N213593 001 Aug 30, 2022
OMIDENEPAG ISOPROPYL
SOLUTION;OPHTHALMIC
OMLONTI
+! SANTEN 0.002% N215092 001 Sep 22, 2022
ONDANSETRON
TABLET, ORALLY DISINTEGRATING;ORAL
ONDANSETRON
AB AUROBINDO PHARMA 4MG A090469 001 Apr 12, 2010
AB ! 8MG A090469 002 Apr 12, 2010
AB CHARTWELL MOLECULES 4MG A077406 003 Dec 26, 2006
AB 8MG A077406 004 Dec 26, 2006
AB GLENMARK GENERICS 4MG A078152 001 Jun 27, 2007
AB 8MG A078152 002 Jun 27, 2007
AB MYLAN 4MG A078139 001 Jun 25, 2007
AB 8MG A078139 002 Jun 25, 2007
AB SANDOZ 4MG A078050 001 Aug 13, 2007
AB 8MG A078050 002 Aug 13, 2007
AB SUN PHARM INDS 4MG A077557 001 Aug 02, 2007
AB 8MG A077557 002 Aug 02, 2007
AB SUN PHARM INDS LTD 4MG A078602 001 Feb 24, 2011
AB 8MG A078602 002 Feb 24, 2011
CHARTWELL MOLECULES 16MG A077406 001 Dec 26, 2006
24MG A077406 002 Dec 26, 2006
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-345(of 474)

ONDANSETRON HYDROCHLORIDE
INJECTABLE;INJECTION
ONDANSETRON HYDROCHLORIDE
AP ACCORD HLTHCARE EQ 2MG BASE/ML A206846 001 Jul 13, 2015
AP FRESENIUS KABI USA EQ 2MG BASE/ML A076974 001 Dec 26, 2006
AP GLAND PHARMA LTD EQ 2MG BASE/ML A079224 001 Sep 25, 2009
AP ! EQ 2MG BASE/ML A090648 001 Jun 15, 2012
AP HIKMA EQ 2MG BASE/ML A076967 001 Dec 26, 2006
AP EQ 2MG BASE/ML A077365 001 Dec 26, 2006
AP HIKMA FARMACEUTICA EQ 2MG BASE/ML A076781 001 Dec 26, 2006
AP HOSPIRA EQ 2MG BASE/ML A077473 001 Dec 26, 2006
AP ! QILU PHARM HAINAN EQ 2MG BASE/ML A203711 001 Sep 08, 2014
AP SANDOZ INC EQ 2MG BASE/ML A077430 001 Jun 27, 2007
AP WOCKHARDT EQ 2MG BASE/ML A077577 001 Dec 26, 2006
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
AP ACCORD HLTHCARE EQ 2MG BASE/ML A206845 001 Mar 10, 2016
AP ! BAXTER HLTHCARE EQ 2MG BASE/ML A078287 001 Feb 22, 2013
CORP
AP FRESENIUS KABI USA EQ 2MG BASE/ML A076972 001 Dec 26, 2006
AP EQ 2MG BASE/ML A202253 001 Jul 19, 2013
AP HIKMA EQ 2MG BASE/ML A077011 001 Dec 26, 2006
AP EQ 2MG BASE/ML A077541 001 Dec 26, 2006
AP HOSPIRA EQ 2MG BASE/ML A077548 001 Dec 26, 2006
AP SANDOZ INC EQ 2MG BASE/ML A077551 001 Jun 27, 2007
AP WOCKHARDT EQ 2MG BASE/ML A077716 001 Dec 26, 2006
SOLUTION;ORAL
ONDANSETRON HYDROCHLORIDE
AA AMNEAL PHARMS EQ 4MG BASE/5ML A091483 001 Jan 31, 2011
AA AUROBINDO PHARMA EQ 4MG BASE/5ML A078776 001 Nov 28, 2007
AA ! HIKMA EQ 4MG BASE/5ML A076960 001 Dec 26, 2006
AA LANNETT CO INC EQ 4MG BASE/5ML A091342 001 Jan 27, 2011
AA PHARM ASSOC EQ 4MG BASE/5ML A078127 001 Jun 25, 2007
AA TARO EQ 4MG BASE/5ML A077009 001 Nov 30, 2007
TABLET;ORAL
ONDANSETRON HYDROCHLORIDE
AB APOTEX EQ 4MG BASE A077306 001 Jun 25, 2007
AB EQ 8MG BASE A077306 002 Jun 25, 2007
AB AUROBINDO PHARMA EQ 4MG BASE A078539 001 Jul 31, 2007
AB EQ 8MG BASE A078539 002 Jul 31, 2007
AB CASI PHARMS INC EQ 4MG BASE A077517 001 Jun 25, 2007
AB EQ 8MG BASE A077517 002 Jun 25, 2007
AB CHARTWELL MOLECULES EQ 4MG BASE A077303 001 Jun 25, 2007
AB EQ 8MG BASE A077303 002 Jun 25, 2007
AB ! EQ 24MG BASE A077303 004 Jun 25, 2007
AB DR REDDYS LABS LTD EQ 4MG BASE A076183 003 Dec 26, 2006
AB EQ 8MG BASE A076183 002 Dec 26, 2006
AB GLENMARK GENERICS EQ 4MG BASE A077535 001 Jun 25, 2007
AB EQ 8MG BASE A077535 002 Jun 25, 2007
AB IPCA LABS LTD EQ 4MG BASE A203761 001 Jan 23, 2014
AB EQ 8MG BASE A203761 002 Jan 23, 2014
AB NATCO PHARMA LTD EQ 4MG BASE A077851 001 Jun 25, 2007
AB EQ 8MG BASE A077851 002 Jun 25, 2007
AB SUN PHARM INDS (IN) EQ 4MG BASE A077050 001 Jun 25, 2007
AB EQ 8MG BASE A077050 002 Jun 25, 2007
OPICAPONE
CAPSULE;ORAL
ONGENTYS
+ NEUROCRINE 25MG N212489 001 Apr 24, 2020
+! 50MG N212489 002 Apr 24, 2020
ORITAVANCIN DIPHOSPHATE
POWDER;INTRAVENOUS
KIMYRSA
+! MELINTA THERAP EQ 1.2GM BASE/VIAL N214155 001 Mar 12, 2021
ORBACTIV
+! MELINTA THERAP EQ 400MG BASE/VIAL N206334 001 Aug 06, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-346(of 474)

ORLISTAT
CAPSULE;ORAL
XENICAL
+! CHEPLAPHARM 120MG N020766 001 Apr 23, 1999
ORPHENADRINE CITRATE
INJECTABLE;INJECTION
ORPHENADRINE CITRATE
AP ! AKORN 30MG/ML A040484 001 May 24, 2006
AP HIKMA 30MG/ML A040463 001 Mar 04, 2003
AP SAGENT PHARMS 30MG/ML A090585 001 Aug 30, 2011
AP WATSON LABS 30MG/ML A084779 001 Mar 15, 1982
TABLET, EXTENDED RELEASE;ORAL
ORPHENADRINE CITRATE
AB ANDA REPOSITORY 100MG A040249 001 Jan 29, 1999
AB BAYSHORE PHARMS LLC 100MG A091158 001 Jul 27, 2012
AB LUPIN 100MG A040284 001 Jun 19, 1998
AB ! SANDOZ 100MG A040327 001 Feb 15, 2000
OSELTAMIVIR PHOSPHATE
CAPSULE;ORAL
OSELTAMIVIR PHOSPHATE
AB ACCORD HLTHCARE EQ 30MG BASE A214726 001 Jul 25, 2022
AB EQ 45MG BASE A214726 002 Jul 25, 2022
AB EQ 75MG BASE A214726 003 Jul 25, 2022
AB ALEMBIC PHARMS EQ 30MG BASE A211823 001 Jun 24, 2019
AB EQ 45MG BASE A211823 002 Jun 24, 2019
AB EQ 75MG BASE A211823 003 Jun 24, 2019
AB AMNEAL PHARMS EQ 30MG BASE A209093 001 May 17, 2017
AB EQ 45MG BASE A209093 002 May 17, 2017
AB EQ 75MG BASE A209093 003 May 17, 2017
AB EPIC PHARMA LLC EQ 30MG BASE A215208 001 Oct 01, 2021
AB EQ 45MG BASE A215208 002 Oct 01, 2021
AB EQ 75MG BASE A215208 003 Oct 01, 2021
AB HETERO LABS LTD III EQ 30MG BASE A209438 001 Feb 23, 2018
AB EQ 45MG BASE A209438 002 Feb 23, 2018
AB EQ 75MG BASE A209438 003 Feb 23, 2018
AB LUPIN EQ 30MG BASE A208348 001 Jan 09, 2018
AB EQ 45MG BASE A208348 002 Jan 09, 2018
AB EQ 75MG BASE A208348 003 Jan 09, 2018
AB MACLEODS PHARMS LTD EQ 30MG BASE A207211 001 Sep 14, 2017
AB EQ 45MG BASE A207211 002 Sep 14, 2017
AB EQ 75MG BASE A207211 003 Sep 14, 2017
AB MSN EQ 30MG BASE A212544 001 May 20, 2020
AB EQ 45MG BASE A212544 002 May 20, 2020
AB EQ 75MG BASE A212544 003 May 20, 2020
AB NATCO EQ 30MG BASE A202595 001 Aug 03, 2016
AB EQ 45MG BASE A202595 002 Aug 03, 2016
AB EQ 75MG BASE A202595 003 Aug 03, 2016
AB STRIDES PHARMA EQ 30MG BASE A209421 001 Jun 08, 2018
AB EQ 45MG BASE A209421 002 Jun 08, 2018
AB EQ 75MG BASE A209421 003 Jun 08, 2018
AB ZYDUS PHARMS EQ 30MG BASE A208578 001 Feb 24, 2017
AB EQ 45MG BASE A208578 002 Feb 24, 2017
AB EQ 75MG BASE A208578 003 Feb 24, 2017
TAMIFLU
AB + ROCHE EQ 30MG BASE N021087 003 Jul 02, 2007
AB + EQ 45MG BASE N021087 002 Jul 02, 2007
AB +! EQ 75MG BASE N021087 001 Oct 27, 1999
FOR SUSPENSION;ORAL
OSELTAMIVIR PHOSPHATE
AB AJANTA PHARMA LTD EQ 6MG BASE/ML A212784 001 May 27, 2020
AB ALVOGEN EQ 6MG BASE/ML A208823 001 Oct 31, 2017
AB AMNEAL PHARMS NY EQ 6MG BASE/ML A210186 001 Feb 27, 2018
AB APTAPHARMA INC EQ 6MG BASE/ML A212858 001 Aug 30, 2021
AB HETERO LABS LTD V EQ 6MG BASE/ML A209590 001 Mar 28, 2022
AB LUPIN EQ 6MG BASE/ML A208347 001 Feb 20, 2018
AB MSN EQ 6MG BASE/ML A215313 001 May 02, 2022
AB STRIDES PHARMA EQ 6MG BASE/ML A211894 001 Jan 13, 2022
AB SUNSHINE EQ 6MG BASE/ML A213594 001 Jan 05, 2022
AB TEVA PHARMS USA EQ 6MG BASE/ML A211125 001 Feb 27, 2019
AB ZYDUS PHARMS EQ 6MG BASE/ML A209113 001 Sep 14, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-347(of 474)

OSELTAMIVIR PHOSPHATE
FOR SUSPENSION;ORAL
TAMIFLU
AB +! ROCHE EQ 6MG BASE/ML N021246 002 Mar 21, 2011
OSILODROSTAT PHOSPHATE
TABLET;ORAL
ISTURISA
+ RECORDATI RARE EQ 1MG BASE N212801 001 Mar 06, 2020
+ EQ 5MG BASE N212801 002 Mar 06, 2020
+! EQ 10MG BASE N212801 003 Mar 06, 2020
OSIMERTINIB MESYLATE
TABLET;ORAL
TAGRISSO
+ ASTRAZENECA EQ 40MG BASE N208065 001 Nov 13, 2015
+! EQ 80MG BASE N208065 002 Nov 13, 2015
OSPEMIFENE
TABLET;ORAL
OSPHENA
+! DUCHESNAY 60MG N203505 001 Feb 26, 2013
OTESECONAZOLE
CAPSULE;ORAL
VIVJOA
+! MYCOVIA PHARMS 150MG N215888 001 Apr 26, 2022
OXACILLIN SODIUM
INJECTABLE;INJECTION
OXACILLIN SODIUM
AP EUGIA PHARMA EQ 1GM BASE/VIAL A201539 001 Jan 18, 2013
SPECLTS
AP EQ 2GM BASE/VIAL A201539 002 Jan 18, 2013
AP EQ 10GM BASE/VIAL A201538 001 Jan 18, 2013
AP FRESENIUS KABI USA EQ 1GM BASE/VIAL A206198 001 Jul 20, 2020
AP EQ 2GM BASE/VIAL A206198 002 Jul 20, 2020
AP EQ 10GM BASE/VIAL A206199 001 Jul 27, 2020
AP PIRAMAL CRITICAL EQ 10GM BASE/VIAL A206760 001 Oct 26, 2017
AP ! SAGENT PHARMS EQ 1GM BASE/VIAL A091246 001 Mar 30, 2012
AP ! EQ 2GM BASE/VIAL A091246 002 Mar 30, 2012
AP ! EQ 10GM BASE/VIAL A091245 001 Mar 30, 2012
AP STERISCIENCE EQ 2GM BASE/VIAL A091486 002 Aug 25, 2014
AP WOCKHARDT BIO AG EQ 1GM BASE/VIAL A207147 001 Jul 31, 2017
AP EQ 2GM BASE/VIAL A207147 002 Jul 31, 2017
AP EQ 10GM BASE/VIAL A207148 001 Nov 24, 2017
BACTOCILL IN PLASTIC CONTAINER
+! BAXTER HLTHCARE EQ 20MG BASE/ML N050640 001 Oct 26, 1989
+! EQ 40MG BASE/ML N050640 002 Oct 26, 1989
OXALIPLATIN
INJECTABLE;INTRAVENOUS
ELOXATIN
AP +! SANOFI AVENTIS US 50MG/10ML (5MG/ML) N021759 001 Jan 31, 2005
AP +! 100MG/20ML (5MG/ML) N021759 002 Jan 31, 2005
OXALIPLATIN
AP ACCORD HLTHCARE 50MG/10ML (5MG/ML) A207474 001 Mar 21, 2017
AP 100MG/20ML (5MG/ML) A207474 002 Mar 21, 2017
AP ACTAVIS LLC 50MG/10ML (5MG/ML) A204880 001 Mar 05, 2018
AP 100MG/20ML (5MG/ML) A204880 002 Mar 05, 2018
AP ! ACTAVIS TOTOWA 50MG/VIAL A078803 001 Aug 08, 2012
AP ! 100MG/VIAL A078803 002 Aug 08, 2012
AP EUGIA PHARMA 50MG/10ML (5MG/ML) A205529 001 Sep 06, 2017
AP 100MG/20ML (5MG/ML) A205529 002 Sep 06, 2017
AP FRESENIUS KABI USA 50MG/10ML (5MG/ML) A078811 001 Jun 10, 2010
AP 100MG/20ML (5MG/ML) A078811 002 Jun 10, 2010
AP 50MG/VIAL A078819 001 Jun 02, 2010
AP 50MG/10ML (5MG/ML) A090030 001 Jan 31, 2017
AP 100MG/VIAL A078819 002 Jun 02, 2010
AP 100MG/20ML (5MG/ML) A090030 002 Jan 31, 2017
AP GLAND 50MG/10ML (5MG/ML) A207325 001 Feb 10, 2017
AP 100MG/20ML (5MG/ML) A207325 002 Feb 10, 2017
AP GLAND PHARMA LTD 50MG/VIAL A207385 001 May 23, 2017
AP 100MG/VIAL A207385 002 May 23, 2017
AP HENGRUI PHARMA 50MG/10ML (5MG/ML) A203869 001 Jun 18, 2014
AP 100MG/20ML (5MG/ML) A203869 002 Jun 18, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-348(of 474)

OXALIPLATIN
INJECTABLE;INTRAVENOUS
OXALIPLATIN
AP HOSPIRA WORLDWIDE 50MG/10ML (5MG/ML) A078813 001 Aug 07, 2009
AP 100MG/20ML (5MG/ML) A078813 002 Aug 07, 2009
AP MYLAN LABS LTD 50MG/10ML (5MG/ML) A091358 001 Aug 07, 2012
AP 100MG/20ML (5MG/ML) A091358 002 Aug 07, 2012
AP NOVAST LABS 50MG/10ML (5MG/ML) A207562 001 Oct 16, 2018
AP 100MG/20ML (5MG/ML) A207562 002 Oct 16, 2018
AP QILU PHARM HAINAN 50MG/10ML (5MG/ML) A204368 001 Jun 07, 2016
AP 50MG/VIAL A204616 001 May 11, 2016
AP 100MG/20ML (5MG/ML) A204368 002 Jun 07, 2016
AP 100MG/VIAL A204616 002 May 11, 2016
AP SANDOZ 50MG/10ML (5MG/ML) A078817 001 Jan 24, 2011
AP 100MG/20ML (5MG/ML) A078817 002 Jan 24, 2011
AP +! TEVA PHARMS 50MG/10ML (5MG/ML) N022160 001 Aug 07, 2009
AP +! 100MG/20ML (5MG/ML) N022160 002 Aug 07, 2009
! QILU PHARM HAINAN 200MG/40ML (5MG/ML) A204368 003 Jun 07, 2016
OXANDROLONE
TABLET;ORAL
OXANDROLONE
AB PAR PHARM 2.5MG A077827 001 Jun 22, 2007
AB ! 10MG A077827 002 Jun 22, 2007
AB UPSHER SMITH LABS 2.5MG A076761 001 Dec 01, 2006
AB 10MG A078033 001 Mar 22, 2007
OXAPROZIN
TABLET;ORAL
DAYPRO
AB +! PFIZER 600MG N018841 004 Oct 29, 1992
OXAPROZIN
AB AMNEAL PHARMS CO 600MG A208633 001 May 04, 2017
AB CHARTWELL 600MG A075987 001 Sep 02, 2004
AB DR REDDYS LABS LTD 600MG A075855 001 Jan 31, 2001
AB SANDOZ 600MG A075845 001 Jan 31, 2001
AB TEVA 600MG A075849 001 Jul 03, 2002
OXAZEPAM
CAPSULE;ORAL
OXAZEPAM
AB ACTAVIS ELIZABETH 10MG A072253 002 Apr 14, 1988
AB 15MG A072253 003 Apr 14, 1988
AB ! 30MG A072253 001 Apr 14, 1988
AB EPIC PHARMA 10MG A071813 001 Apr 19, 1988
AB 15MG A071756 001 Apr 19, 1988
AB 30MG A071814 001 Apr 19, 1988
AB UNITED RES LABS 10MG A071026 002 Aug 10, 1987
AB 15MG A071026 003 Aug 10, 1987
AB 30MG A071026 001 Aug 10, 1987
OXCARBAZEPINE
SUSPENSION;ORAL
OXCARBAZEPINE
AB AKORN 300MG/5ML A211420 001 Jul 09, 2021
AB AMNEAL PHARMS 300MG/5ML A202961 001 Sep 17, 2012
AB AUCTA 300MG/5ML A215332 001 Nov 30, 2022
AB BIONPHARMA INC 300MG/5ML A209652 001 Nov 04, 2022
AB GLASSHOUSE PHARMS 300MG/5ML A212428 001 Jun 21, 2021
AB HIKMA 300MG/5ML A201193 001 Oct 03, 2012
AB RUBICON 300MG/5ML A215726 001 Aug 30, 2022
AB SUN PHARM INDS LTD 300MG/5ML A078734 001 Jun 26, 2009
TRILEPTAL
AB +! NOVARTIS 300MG/5ML N021285 001 May 25, 2001
TABLET;ORAL
OXCARBAZEPINE
AB ANNORA PHARMA 150MG A215939 001 Jan 11, 2022
AB 300MG A215939 002 Jan 11, 2022
AB 600MG A215939 003 Jan 11, 2022
AB BRECKENRIDGE PHARM 150MG A078069 001 Jan 11, 2008
AB 300MG A078069 002 Jan 11, 2008
AB 600MG A078069 003 Jan 11, 2008
AB GLENMARK PHARMS LTD 150MG A077802 001 Oct 09, 2007
AB 300MG A077802 002 Oct 09, 2007
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-349(of 474)

OXCARBAZEPINE
TABLET;ORAL
OXCARBAZEPINE
AB 600MG A077802 003 Oct 09, 2007
AB RUBICON 150MG A077747 001 Apr 09, 2008
AB 300MG A077747 002 Apr 09, 2008
AB 600MG A077747 003 Apr 09, 2008
AB SUN PHARM INDS 150MG A077794 001 Oct 09, 2007
AB 300MG A077794 002 Oct 09, 2007
AB 600MG A077794 003 Oct 09, 2007
AB TARO 150MG A077801 001 Nov 15, 2007
AB 300MG A077801 002 Nov 15, 2007
AB 600MG A077801 003 Nov 15, 2007
TRILEPTAL
AB + NOVARTIS 150MG N021014 001 Jan 14, 2000
AB + 300MG N021014 002 Jan 14, 2000
AB +! 600MG N021014 003 Jan 14, 2000
TABLET, EXTENDED RELEASE;ORAL
OXTELLAR XR
+ SUPERNUS PHARMS 150MG N202810 001 Oct 19, 2012
+ 300MG N202810 002 Oct 19, 2012
+! 600MG N202810 003 Oct 19, 2012
OXICONAZOLE NITRATE
CREAM;TOPICAL
OXICONAZOLE NITRATE
AB TARO PHARMS EQ 1% BASE A205076 001 Mar 07, 2016
OXISTAT
AB +! FOUGERA PHARMS EQ 1% BASE N019828 001 Dec 30, 1988
LOTION;TOPICAL
OXISTAT
+! ANI PHARMS EQ 1% BASE N020209 001 Sep 30, 1992
OXYBUTYNIN
FILM, EXTENDED RELEASE;TRANSDERMAL
OXYTROL
+! ALLERGAN 3.9MG/24HR N021351 002 Feb 26, 2003
OXYBUTYNIN CHLORIDE
GEL;TRANSDERMAL
GELNIQUE
+! ALLERGAN 10% (100MG/PACKET) N022204 001 Jan 27, 2009
SYRUP;ORAL
OXYBUTYNIN CHLORIDE
AA ! LANNETT CO INC 5MG/5ML A074520 001 Mar 29, 1996
AA PHARM ASSOC 5MG/5ML A075137 001 Dec 18, 1998
TABLET;ORAL
OXYBUTYNIN CHLORIDE
AB ABHAI LLC 5MG A209335 001 Dec 22, 2017
AB APPCO 5MG A209025 001 Dec 21, 2017
AB BEXIMCO PHARMS USA 5MG A213550 001 Jul 14, 2022
AB LEADING 5MG A212798 001 Apr 06, 2020
AB NOVAST LABS 5MG A210611 001 Oct 30, 2019
AB NOVITIUM PHARMA 5MG A209823 001 Oct 23, 2017
AB ! STRIDES PHARMA 5MG A075079 001 Oct 31, 1997
AB 5MG A208165 001 Dec 17, 2020
AB TEVA PHARMS USA 5MG A071655 001 Nov 14, 1988
AB TULEX PHARMS INC 5MG A210125 001 Sep 06, 2018
AB UPSHER SMITH LABS 5MG A074625 001 Jul 31, 1996
BX EMCURE PHARMS LTD 5MG A211682 001 May 10, 2019
BX EYWA 5MG A211062 001 Feb 06, 2019
TABLET, EXTENDED RELEASE;ORAL
DITROPAN XL
AB + JANSSEN PHARMS 5MG N020897 001 Dec 16, 1998
AB + 10MG N020897 002 Dec 16, 1998
OXYBUTYNIN CHLORIDE
AB ACCORD HLTHCARE 5MG A207138 001 Feb 29, 2016
AB 10MG A207138 002 Feb 29, 2016
AB ! 15MG A207138 003 Feb 29, 2016
AB AJANTA PHARMA LTD 5MG A211655 001 Feb 28, 2019
AB 10MG A211655 002 Feb 28, 2019
AB 15MG A211655 003 Feb 28, 2019
AB AMNEAL PHARMS 5MG A204010 001 Nov 23, 2015
AB 10MG A204010 002 Nov 23, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-350(of 474)

OXYBUTYNIN CHLORIDE
TABLET, EXTENDED RELEASE;ORAL
OXYBUTYNIN CHLORIDE
AB 15MG A204010 003 Nov 23, 2015
AB BIONPHARMA INC 5MG A210717 001 Dec 17, 2019
AB 10MG A210717 002 Dec 17, 2019
AB 15MG A210717 003 Dec 17, 2019
AB OSMOTICA PHARM US 5MG A078503 001 Feb 04, 2009
AB 10MG A078503 002 Feb 04, 2009
AB 15MG A078503 003 Feb 04, 2009
AB RUBICON 5MG A214415 001 Oct 27, 2020
AB 10MG A214415 002 Oct 27, 2020
AB 15MG A214415 003 Oct 27, 2020
AB UNIQUE 5MG A206121 001 May 27, 2016
AB 10MG A206121 002 May 27, 2016
AB 15MG A206121 003 May 27, 2016
AB ZYDUS PHARMS 5MG A202332 001 Jun 26, 2017
AB 10MG A202332 002 Jun 26, 2017
AB 15MG A202332 003 Jun 26, 2017
OXYCODONE
CAPSULE, EXTENDED RELEASE;ORAL
XTAMPZA ER
+ COLLEGIUM PHARM INC 9MG N208090 001 Apr 26, 2016
+ 13.5MG N208090 002 Apr 26, 2016
+ 18MG N208090 003 Apr 26, 2016
+ 27MG N208090 004 Apr 26, 2016
+! 36MG N208090 005 Apr 26, 2016
OXYCODONE HYDROCHLORIDE
CAPSULE;ORAL
OXYCODONE HYDROCHLORIDE
AB ANI PHARMS 5MG A205177 001 Mar 31, 2016
AB AVANTHI INC 5MG A202773 001 Aug 17, 2015
AB +! GENUS LIFESCIENCES 5MG N200534 001 Oct 20, 2010
AB MAYNE PHARMA INC 5MG A203107 001 Jul 26, 2012
AB NOVEL LABS INC 5MG A204752 001 Aug 24, 2015
SOLUTION;ORAL
OXYCODONE HYDROCHLORIDE
AA ABHAI LLC 5MG/5ML A208593 001 Jul 21, 2017
AA 100MG/5ML A208593 002 Jul 21, 2017
AA AKORN 5MG/5ML A208817 001 Aug 10, 2017
AA 100MG/5ML A208795 001 Aug 07, 2017
AA ALKEM LABS LTD 5MG/5ML A211748 001 Feb 07, 2019
AA 100MG/5ML A211749 001 Feb 04, 2019
AA ANI PHARMS 5MG/5ML A204979 001 Jun 01, 2015
AA ASCENT PHARMS INC 5MG/5ML A209021 001 Nov 09, 2017
AA 100MG/5ML A209021 002 Nov 09, 2017
AA EYWA 5MG/5ML A207511 001 Nov 23, 2016
AA 100MG/5ML A209897 001 Sep 06, 2017
AA + GENUS LIFESCIENCES 5MG/5ML N200535 002 Aug 22, 2013
AA +! 100MG/5ML N200535 001 Oct 20, 2010
AA HIKMA 5MG/5ML A204037 001 Jul 15, 2013
AA MAYNE PHARMA INC 100MG/5ML A204092 001 Jun 05, 2014
AA PHARM ASSOC 5MG/5ML A206914 001 Feb 01, 2019
AA 100MG/5ML A206822 001 Aug 15, 2017
AA QUAGEN 5MG/5ML A213761 001 Jun 02, 2021
AA 100MG/5ML A213761 002 Jun 02, 2021
AA SPECGX LLC 5MG/5ML A210758 001 Apr 30, 2018
AA 100MG/5ML A210758 002 Apr 30, 2018
AA +! VISTAPHARM 5MG/5ML N201194 001 Jan 12, 2012
AA 100MG/5ML A202537 001 Jul 30, 2012
TABLET;ORAL
OXYCODONE HYDROCHLORIDE
AB ALVOGEN 5MG A202116 001 Dec 30, 2011
AB 15MG A202116 002 Dec 30, 2011
AB 30MG A202116 003 Dec 30, 2011
AB AMNEAL PHARMS 5MG A203638 001 Jun 03, 2014
AB 10MG A203638 002 Jun 03, 2014
AB 15MG A203638 003 Jun 03, 2014
AB 20MG A203638 004 Jun 03, 2014
AB 30MG A203638 005 Jun 03, 2014
AB ASCENT PHARMS INC 15MG A207418 001 Aug 07, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-351(of 474)

OXYCODONE HYDROCHLORIDE
TABLET;ORAL
OXYCODONE HYDROCHLORIDE
AB 30MG A207418 002 Aug 07, 2017
AB AUROLIFE PHARMA LLC 5MG A202160 001 Nov 19, 2012
AB 15MG A202160 002 Nov 19, 2012
AB 30MG A202160 003 Nov 19, 2012
AB AVANTHI INC 5MG A091393 001 Aug 31, 2009
AB ! 10MG A091393 002 Aug 31, 2009
AB 15MG A091393 003 Aug 31, 2009
AB 20MG A091393 004 Aug 31, 2009
AB 30MG A091393 005 Aug 31, 2009
AB EPIC PHARMA LLC 5MG A090895 001 Aug 24, 2009
AB 5MG A202662 001 Sep 22, 2015
AB 10MG A202662 002 Sep 22, 2015
AB 15MG A090895 002 Aug 24, 2009
AB 15MG A202662 003 Sep 22, 2015
AB 20MG A202662 005 Apr 27, 2017
AB 30MG A090895 003 Aug 24, 2009
AB 30MG A202662 004 Sep 22, 2015
AB NOVEL LABS INC 5MG A204021 001 Jun 12, 2017
AB 10MG A204021 002 Jun 12, 2017
AB 15MG A204021 003 Jun 12, 2017
AB 20MG A204021 004 Jun 12, 2017
AB 30MG A204021 005 Jun 12, 2017
AB NUVO PHARM 5MG A207119 001 Apr 12, 2016
AB 10MG A207119 002 Apr 12, 2016
AB 15MG A207119 003 Apr 12, 2016
AB 20MG A207119 004 Apr 12, 2016
AB 30MG A207119 005 Apr 12, 2016
AB RHODES PHARMS 5MG A091490 001 Mar 09, 2011
AB 10MG A091490 002 Mar 09, 2011
AB 15MG A091490 003 Mar 09, 2011
AB 20MG A091490 004 Mar 09, 2011
AB 30MG A091490 005 Mar 09, 2011
AB SPECGX LLC 5MG A076758 003 Mar 19, 2007
AB 10MG A076758 004 Oct 12, 2021
AB 15MG A076758 001 Jun 30, 2004
AB 20MG A076758 005 Oct 12, 2021
AB 30MG A076758 002 Jun 30, 2004
AB SUN PHARM INDS INC 5MG A090659 001 Apr 10, 2009
AB 10MG A090659 005 Nov 06, 2012
AB 15MG A090659 002 Apr 10, 2009
AB 20MG A090659 004 Nov 06, 2012
AB 30MG A090659 003 Apr 10, 2009
ROXICODONE
AB + SPECGX LLC 5MG N021011 003 May 15, 2009
AB +! 15MG N021011 001 Aug 31, 2000
AB + 30MG N021011 002 Aug 31, 2000
OXAYDO
+ ZYLA 5MG N202080 001 Jun 17, 2011
+ 7.5MG N202080 002 Jun 17, 2011
ROXYBOND
PROTEGA PHARMS 5MG N209777 001 Apr 20, 2017
15MG N209777 002 Apr 20, 2017
30MG N209777 003 Apr 20, 2017
TABLET, EXTENDED RELEASE;ORAL
OXYCONTIN
+ PURDUE PHARMA LP 10MG N022272 001 Apr 05, 2010
+ 15MG N022272 002 Apr 05, 2010
+ 20MG N022272 003 Apr 05, 2010
+ 30MG N022272 004 Apr 05, 2010
+! 40MG N022272 005 Apr 05, 2010
+ 60MG N022272 006 Apr 05, 2010
+ 80MG N022272 007 Apr 05, 2010
OXYMETAZOLINE HYDROCHLORIDE
CREAM;TOPICAL
RHOFADE
+! EPI HLTH 1% N208552 001 Jan 18, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-352(of 474)

OXYMETAZOLINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
UPNEEQ
+! RVL PHARMS 0.1% N212520 001 Jul 08, 2020
OXYMETAZOLINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE
SPRAY, METERED;NASAL
KOVANAZE
+! ST RENATUS 0.1MG/SPRAY;6MG/SPRAY N208032 001 Jun 29, 2016
OXYMORPHONE HYDROCHLORIDE
TABLET;ORAL
OXYMORPHONE HYDROCHLORIDE
AB ASCENT PHARMS INC 5MG A210175 001 Feb 02, 2018
AB 10MG A210175 002 Feb 02, 2018
AB AUROLIFE PHARMA LLC 5MG A204459 001 Apr 26, 2016
AB 10MG A204459 002 Apr 26, 2016
AB AVANTHI INC 5MG A203601 001 Jan 30, 2013
AB ! 10MG A203601 002 Jan 30, 2013
AB EPIC PHARMA LLC 5MG A201187 001 Dec 15, 2014
AB 10MG A201187 002 Dec 15, 2014
AB HIKMA 5MG A090964 001 Sep 27, 2010
AB 10MG A090964 002 Sep 27, 2010
AB SPECGX LLC 5MG A202321 001 Apr 25, 2013
AB 10MG A202321 002 Apr 25, 2013
AB TEVA 5MG A091443 002 Feb 15, 2011
AB 10MG A091443 001 Feb 15, 2011
TABLET, EXTENDED RELEASE;ORAL
OXYMORPHONE HYDROCHLORIDE
IMPAX LABS 5MG A079087 001 Jun 14, 2010
7.5MG A079087 002 Dec 21, 2010
10MG A079087 003 Jun 14, 2010
15MG A079087 004 Dec 21, 2010
20MG A079087 005 Jun 14, 2010
30MG A079087 006 Jul 22, 2010
! 40MG A079087 007 Jun 14, 2010
OXYTOCIN
INJECTABLE;INJECTION
OXYTOCIN
AP +! FRESENIUS KABI USA 10USP UNITS/ML (10USP UNITS/ML) N018248 001
AP +! 100USP UNITS/10ML (10USP UNITS/ML) N018248 002
AP +! HIKMA 10USP UNITS/ML (10USP UNITS/ML) N018243 001
AP +! 100USP UNITS/10ML (10USP UNITS/ML) N018243 002 Jan 10, 2007
AP HIKMA FARMACEUTICA 10USP UNITS/ML (10USP UNITS/ML) A200219 001 Feb 13, 2013
AP SAGENT PHARMS INC 10USP UNITS/ML (10USP UNITS/ML) A091676 001 Jul 13, 2018
AP 100USP UNITS/10ML (10USP UNITS/ML) A091676 002 Jul 13, 2018
PITOCIN
AP +! PAR STERILE 10USP UNITS/ML (10USP UNITS/ML) N018261 001
PRODUCTS
AP + 100USP UNITS/10ML (10USP UNITS/ML) N018261 002 Jul 27, 2007
OXYTOCIN
+! FRESENIUS KABI USA 300USP UNITS/30ML (10USP UNITS/ML) N018248 003 Jul 27, 2007
PITOCIN
+ PAR STERILE 500USP UNITS/50ML (10USP UNITS/ML) N018261 003 Sep 05, 2012
PRODUCTS
OZANIMOD HYDROCHLORIDE
CAPSULE;ORAL
ZEPOSIA
+ CELGENE INTL EQ 0.23MG BASE N209899 001 Mar 25, 2020
+ EQ 0.46MG BASE N209899 002 Mar 25, 2020
+! EQ 0.92MG BASE N209899 003 Mar 25, 2020
OZENOXACIN
CREAM;TOPICAL
XEPI
+! FERRER 1% N208945 001 Dec 11, 2017
INTERNACIONAL
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-353(of 474)

PACLITAXEL
INJECTABLE;INJECTION
PACLITAXEL
AP ACCORD HLTHCARE 6MG/ML A205720 001 Aug 17, 2018
AP ACTAVIS TOTOWA 6MG/ML A090130 001 Dec 09, 2009
AP ALEMBIC PHARMS 6MG/ML A216874 001 Oct 20, 2022
AP FRESENIUS KABI USA 6MG/ML A077574 001 Nov 27, 2006
AP GLAND PHARMA LTD 6MG/ML A207326 001 Aug 23, 2016
AP HIKMA 6MG/ML A075190 001 Jan 28, 2002
AP ! HOSPIRA 6MG/ML A076131 001 May 08, 2002
AP MSN 6MG/ML A213434 001 Aug 24, 2020
AP TEVA PHARMS 6MG/ML A075184 001 Jan 25, 2002
POWDER;INTRAVENOUS
ABRAXANE
+! BRISTOL-MYERS 100MG/VIAL N021660 001 Jan 07, 2005
PACLITAXEL
+! HBT LABS INC 100MG/VIAL N211875 001 Jul 27, 2022
PACRITINIB CITRATE
CAPSULE;ORAL
VONJO
+! CTI BIOPHARMA CORP EQ 100MG BASE N208712 001 Feb 28, 2022
PAFOLACIANINE SODIUM
SOLUTION;INTRAVENOUS
CYTALUX
+! ON TARGET LABS EQ 3.2MG BASE/1.6ML (EQ 2MG BASE/ML) N214907 001 Nov 29, 2021
PALBOCICLIB
CAPSULE;ORAL
IBRANCE
+ PFIZER 75MG N207103 001 Feb 03, 2015
+ 100MG N207103 002 Feb 03, 2015
+! 125MG N207103 003 Feb 03, 2015
TABLET;ORAL
IBRANCE
+ PFIZER 75MG N212436 001 Nov 01, 2019
+ 100MG N212436 002 Nov 01, 2019
+! 125MG N212436 003 Nov 01, 2019
PALIPERIDONE
TABLET, EXTENDED RELEASE;ORAL
INVEGA
AB + JANSSEN PHARMS 1.5MG N021999 006 Aug 26, 2008
AB + 3MG N021999 001 Dec 19, 2006
AB +! 6MG N021999 002 Dec 19, 2006
AB + 9MG N021999 003 Dec 19, 2006
PALIPERIDONE
AB ACTAVIS LABS FL INC 1.5MG A202645 001 Aug 03, 2015
AB 3MG A202645 002 Aug 03, 2015
AB 6MG A202645 003 Aug 03, 2015
AB 9MG A202645 004 Aug 03, 2015
AB AMNEAL PHARMS 1.5MG A204707 001 Sep 23, 2019
AB 3MG A204707 002 Sep 23, 2019
AB 6MG A204707 003 Sep 23, 2019
AB 9MG A204707 004 Sep 23, 2019
AB CSPC OUYI 1.5MG A212807 001 Oct 29, 2020
AB 3MG A212807 002 Oct 29, 2020
AB 6MG A212807 003 Oct 29, 2020
AB 9MG A212807 004 Oct 29, 2020
AB INVENTIA 1.5MG A204452 001 Jun 12, 2019
AB 3MG A204452 002 Jun 12, 2019
AB 6MG A204452 003 Jun 12, 2019
AB 9MG A204452 004 Jun 12, 2019
AB LUPIN LTD 1.5MG A208643 001 Jun 29, 2022
AB 3MG A208643 002 Jun 29, 2022
AB 6MG A208643 003 Jun 29, 2022
AB 9MG A208643 004 Jun 29, 2022
AB RK PHARMA 1.5MG A203802 001 Sep 24, 2015
AB 3MG A203802 002 Sep 24, 2015
AB 6MG A203802 003 Sep 24, 2015
AB 9MG A203802 004 Sep 24, 2015
AB SUN PHARM 1.5mg A205618 001 Apr 06, 2018
AB 3MG A205618 002 Apr 06, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-354(of 474)

PALIPERIDONE
TABLET, EXTENDED RELEASE;ORAL
PALIPERIDONE
AB 6MG A205618 003 Apr 06, 2018
AB 9MG A205618 004 Apr 06, 2018
PALIPERIDONE PALMITATE
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
INVEGA HAFYERA
+ JANSSEN PHARMS 1.092GM/3.5ML (312MG/ML) N207946 005 Aug 30, 2021
+ 1.560GM/5ML (312MG/ML) N207946 006 Aug 30, 2021
INVEGA SUSTENNA
+ JANSSEN PHARMS 39MG/0.25ML (39MG/0.25ML) N022264 001 Jul 31, 2009
+ 78MG/0.5ML (78MG/0.5ML) N022264 002 Jul 31, 2009
+ 117MG/0.75ML (117MG/0.75ML) N022264 003 Jul 31, 2009
+! 156MG/ML (156MG/ML) N022264 004 Jul 31, 2009
+ 234MG/1.5ML (156MG/ML) N022264 005 Jul 31, 2009
INVEGA TRINZA
+ JANSSEN PHARMS 273MG/0.875ML (273MG/0.875ML) N207946 001 May 18, 2015
+ 410MG/1.315ML (311.79MG/ML) N207946 002 May 18, 2015
+ 546MG/1.75ML (312MG/ML) N207946 003 May 18, 2015
+! 819MG/2.625ML (312MG/ML) N207946 004 May 18, 2015
PALONOSETRON HYDROCHLORIDE
INJECTABLE;INTRAVENOUS
PALONOSETRON HYDROCHLORIDE
AP BAXTER HLTHCARE EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A206916 001 Nov 12, 2021
CORP
AP CIPLA EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A206396 001 Sep 19, 2018
AP ! DR REDDYS EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A201533 002 Apr 21, 2016
AP EMCURE PHARMS LTD EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A202951 002 Jun 29, 2021
AP EUGIA PHARMA EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A204702 001 Nov 06, 2018
AP FRESENIUS KABI USA EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A206801 001 Sep 19, 2018
AP EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A206802 001 Sep 19, 2018
AP HOSPIRA EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A207005 001 Sep 19, 2018
AP INGENUS PHARMS LLC EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A208789 001 May 22, 2020
AP MYLAN INSTITUTIONAL EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A206416 001 Sep 19, 2018
AP QILU PHARM HAINAN EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A205648 001 Sep 19, 2018
AP SAGENT PHARMS INC EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A204289 001 Sep 19, 2018
AP EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A205870 001 Sep 19, 2018
AP SANDOZ INC EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A202521 001 Oct 13, 2015
AP TEVA PHARMS USA EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A090713 001 Mar 23, 2018
AP VIRTUS PHARM EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A209287 001 Sep 19, 2018
! EMCURE PHARMS LTD EQ 0.075MG BASE/1.5ML (EQ 0.05MG A202951 001 Jun 29, 2021
BASE/ML)
SOLUTION;INTRAVENOUS
PALONOSETRON HYDROCHLORIDE
HIKMA EQ 0.25MG BASE/2ML (EQ 0.125MG BASE/ML) N207963 001 Aug 22, 2016
PAMIDRONATE DISODIUM
INJECTABLE;INJECTION
PAMIDRONATE DISODIUM
AP AREVA PHARMS 30MG/VIAL A077433 001 Nov 26, 2008
AP 90MG/VIAL A077433 003 Nov 26, 2008
AP DR REDDYS 30MG/10ML (3MG/ML) A078156 001 Aug 19, 2008
AP 60MG/10ML (6MG/ML) A078156 002 Aug 19, 2008
AP 90MG/10ML (9MG/ML) A078156 003 Aug 19, 2008
AP HIKMA 30MG/VIAL A075290 001 Apr 30, 2001
AP +! 30MG/10ML (3MG/ML) N021113 001 Mar 04, 2002
AP 90MG/VIAL A075290 003 Apr 30, 2001
AP +! 90MG/10ML (9MG/ML) N021113 002 Mar 04, 2002
AP ! HOSPIRA 30MG/10ML (3MG/ML) A075841 001 Jun 27, 2002
AP ! 60MG/10ML (6MG/ML) A075841 002 Jun 27, 2002
AP ! 90MG/10ML (9MG/ML) A075841 003 Jun 27, 2002
AP MYLAN LABS LTD 30MG/10ML (3MG/ML) A078520 001 Oct 31, 2008
AP 90MG/10ML (9MG/ML) A078520 002 Oct 31, 2008
AP SAGENT PHARMS INC 30MG/10ML (3MG/ML) A078373 001 Dec 23, 2008
AP 90MG/10ML (9MG/ML) A078373 002 Dec 23, 2008
AREVA PHARMS 60MG/VIAL A077433 002 Nov 26, 2008
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-355(of 474)

PANCURONIUM BROMIDE
INJECTABLE;INJECTION
PANCURONIUM BROMIDE
AP ! DR REDDYS 1MG/ML A072759 001 Jul 31, 1990
AP HOSPIRA 1MG/ML A072320 001 Jan 19, 1989
! DR REDDYS 2MG/ML A072760 001 Jul 31, 1990
PANTOPRAZOLE SODIUM
FOR SUSPENSION, DELAYED RELEASE;ORAL
PANTOPRAZOLE SODIUM
AB SUN PHARM EQ 40MG BASE A213725 001 Jun 30, 2020
PROTONIX
AB +! WYETH PHARMS EQ 40MG BASE N022020 001 Nov 14, 2007
INJECTABLE;INTRAVENOUS
PANTOPRAZOLE SODIUM
AP ACIC PHARMS EQ 40MG BASE/VIAL A209524 001 Aug 30, 2021
AP AKORN EQ 40MG BASE/VIAL A079197 001 Nov 08, 2012
AP ASPIRO EQ 40MG BASE/VIAL A213778 001 May 18, 2022
AP BE PHARMS EQ 40MG BASE/VIAL A216171 001 May 18, 2022
AP EUGIA PHARMA EQ 40MG BASE/VIAL A205675 001 Mar 30, 2016
AP GLAND PHARMA LTD EQ 40MG BASE/VIAL A204400 001 May 18, 2022
AP MEITHEAL EQ 40MG BASE/VIAL A215860 001 Aug 29, 2022
AP SANDOZ INC EQ 40MG BASE/VIAL A090296 001 Jul 14, 2015
AP SUN PHARM EQ 40MG BASE/VIAL A077674 001 Aug 19, 2019
PROTONIX IV
AP +! WYETH PHARMS EQ 40MG BASE/VIAL N020988 001 Mar 22, 2001
POWDER;INTRAVENOUS
PANTOPRAZOLE SODIUM
+! HIKMA EQ 40MG BASE/VIAL N209463 001 Jun 30, 2017
TABLET, DELAYED RELEASE;ORAL
PANTOPRAZOLE SODIUM
AB ACTAVIS TOTOWA EQ 20MG BASE A090797 001 Feb 07, 2011
AB EQ 40MG BASE A090797 002 Feb 07, 2011
AB AMNEAL PHARMS EQ 20MG BASE A205119 001 Jan 26, 2016
AB EQ 40MG BASE A205119 002 Jan 26, 2016
AB AUROBINDO PHARMA EQ 20MG BASE A202038 001 Sep 28, 2012
LTD
AB EQ 40MG BASE A202038 002 Sep 28, 2012
AB DR REDDYS LABS LTD EQ 20MG BASE A077619 001 Jan 19, 2011
AB EQ 40MG BASE A077619 002 Jan 19, 2011
AB HETERO LABS LTD V EQ 20MG BASE A202882 001 Sep 10, 2014
AB EQ 40MG BASE A202882 002 Sep 10, 2014
AB INGENUS PHARMS LLC EQ 40MG BASE A211368 001 Mar 01, 2019
AB LANNETT CO INC EQ 20MG BASE A078281 001 Jan 20, 2011
AB EQ 40MG BASE A078281 002 Jan 20, 2011
AB MANKIND PHARMA EQ 40MG BASE A215880 001 Jul 26, 2022
AB MYLAN PHARMS INC EQ 20MG BASE A090970 001 Jan 19, 2011
AB EQ 40MG BASE A090970 002 Jan 19, 2011
AB ORBION PHARMS EQ 20MG BASE A202052 001 Dec 02, 2014
AB EQ 40MG BASE A202052 002 Dec 02, 2014
AB RUBICON EQ 20MG BASE A090807 001 May 02, 2012
AB EQ 40MG BASE A090807 002 May 02, 2012
AB TORRENT PHARMS EQ 20MG BASE A090074 001 Jan 19, 2011
AB EQ 40MG BASE A090074 002 Jan 19, 2011
AB WOCKHARDT BIO AG EQ 20MG BASE A091231 001 Jan 19, 2011
AB EQ 40MG BASE A091231 002 Jan 19, 2011
PROTONIX
AB + WYETH PHARMS EQ 20MG BASE N020987 002 Jun 12, 2001
AB +! EQ 40MG BASE N020987 001 Feb 02, 2000
PARICALCITOL
CAPSULE;ORAL
PARICALCITOL
AB AMNEAL PHARMS 1MCG A204327 001 Jan 13, 2016
AB 2MCG A204327 002 Jan 13, 2016
AB 4MCG A204327 003 Jan 13, 2016
AB AUROBINDO PHARMA 1MCG A207672 001 Jan 14, 2016
LTD
AB 2MCG A207672 002 Jan 14, 2016
AB 4MCG A207672 003 Jan 14, 2016
AB BIONPHARMA INC 1MCG A202539 001 Mar 27, 2014
AB 2MCG A202539 002 Mar 27, 2014
AB 4MCG A202539 003 Mar 27, 2014
AB DR REDDYS 1MCG A091412 001 Jun 24, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-356(of 474)

PARICALCITOL
CAPSULE;ORAL
PARICALCITOL
AB 2MCG A091412 002 Jun 24, 2014
AB 4MCG A091412 003 Jun 24, 2014
AB MARKSANS PHARMA 1MCG A204948 001 Oct 07, 2016
AB 2MCG A204948 002 Oct 07, 2016
AB 4MCG A204948 003 Oct 07, 2016
AB RISING 1MCG A202124 001 Jun 24, 2014
AB 2MCG A202124 002 Jun 24, 2014
AB 4MCG A202124 003 Jun 24, 2014
AB TEVA PHARMS USA 1MCG A090829 001 Sep 27, 2013
AB 2MCG A090829 002 Sep 27, 2013
AB ! 4MCG A090829 003 Sep 27, 2013
ZEMPLAR
AB + ABBVIE 1MCG N021606 001 May 26, 2005
AB + 2MCG N021606 002 May 26, 2005
SOLUTION;INTRAVENOUS
PARICALCITOL
AP ACCORD HLTHCARE 0.002MG/ML (0.002MG/ML) N207174 001 Feb 04, 2016
AP 0.005MG/ML (0.005MG/ML) N207174 002 Feb 04, 2016
AP 0.01MG/2ML (0.005MG/ML) N207174 003 Feb 04, 2016
AP AMNEAL PHARMS CO 0.002MG/ML (0.002MG/ML) A206699 001 Mar 09, 2017
AP 0.005MG/ML (0.005MG/ML) A206699 002 Mar 09, 2017
AP 0.01MG/2ML (0.005MG/ML) A206699 003 Mar 09, 2017
AP DR REDDYS 0.002MG/ML (0.002MG/ML) A204910 001 Aug 17, 2016
AP 0.005MG/ML (0.005MG/ML) A204910 002 Aug 17, 2016
AP 0.01MG/2ML (0.005MG/ML) A204910 003 Aug 17, 2016
AP EUGIA PHARMA 0.002MG/ML (0.002MG/ML) A205982 001 Oct 09, 2018
AP 0.005MG/ML (0.005MG/ML) A205982 002 Oct 09, 2018
AP 0.01MG/2ML (0.005MG/ML) A205982 003 Oct 09, 2018
AP HIKMA PHARMS 0.002MG/ML (0.002MG/ML) N205917 001 Nov 18, 2014
AP 0.005MG/ML (0.005MG/ML) N205917 002 Nov 18, 2014
AP 0.01MG/2ML (0.005MG/ML) N205917 003 Nov 18, 2014
AP HOSPIRA 0.002MG/ML (0.002MG/ML) N201657 001 Oct 21, 2014
AP 0.005MG/ML (0.005MG/ML) N201657 002 Oct 21, 2014
AP 0.01MG/2ML (0.005MG/ML) N201657 003 Oct 21, 2014
AP RISING 0.005MG/ML (0.005MG/ML) A203897 002 Nov 02, 2017
AP 0.01MG/2ML (0.005MG/ML) A203897 003 Nov 02, 2017
AP SANDOZ INC 0.002MG/ML (0.002MG/ML) A091108 001 Jul 27, 2011
AP 0.005MG/ML (0.005MG/ML) A091108 002 Jul 27, 2011
AP 0.01MG/2ML (0.005MG/ML) A091108 003 Jul 27, 2011
ZEMPLAR
AP +! ABBVIE 0.002MG/ML (0.002MG/ML) N020819 002 Feb 01, 2000
AP +! 0.005MG/ML (0.005MG/ML) N020819 001 Apr 17, 1998
AP +! 0.01MG/2ML (0.005MG/ML) N020819 003 Feb 01, 2000
PAROMOMYCIN SULFATE
CAPSULE;ORAL
PAROMOMYCIN SULFATE
AA HERITAGE PHARMS EQ 250MG BASE A065173 001 Dec 14, 2007
AA ! SUN PHARM INDS INC EQ 250MG BASE A064171 001 Jun 30, 1997
PAROXETINE HYDROCHLORIDE
SUSPENSION;ORAL
PAROXETINE HYDROCHLORIDE
AB NOVITIUM PHARMA EQ 10MG BASE/5ML A215003 001 Sep 03, 2021
PAXIL
AB +! APOTEX EQ 10MG BASE/5ML N020710 001 Jun 25, 1997
TABLET;ORAL
PAROXETINE
AB PRINSTON INC EQ 10MG BASE A203854 001 Oct 31, 2014
AB EQ 20MG BASE A203854 002 Oct 31, 2014
AB EQ 30MG BASE A203854 003 Oct 31, 2014
AB EQ 40MG BASE A203854 004 Oct 31, 2014
PAROXETINE HYDROCHLORIDE
AB APOTEX EQ 10MG BASE A075356 001 Jul 30, 2003
AB EQ 20MG BASE A075356 002 Jul 30, 2003
AB EQ 30MG BASE A075356 003 Jul 30, 2003
AB EQ 40MG BASE A075356 004 Jul 30, 2003
AB AUROBINDO PHARMA EQ 10MG BASE A078406 001 Jul 25, 2007
AB EQ 20MG BASE A078406 002 Jul 25, 2007
AB EQ 30MG BASE A078406 003 Jul 25, 2007
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-357(of 474)

PAROXETINE HYDROCHLORIDE
TABLET;ORAL
PAROXETINE HYDROCHLORIDE
AB EQ 40MG BASE A078406 004 Jul 25, 2007
AB CHARTWELL RX EQ 10MG BASE A076618 001 Aug 15, 2005
AB EQ 20MG BASE A076618 002 Aug 15, 2005
AB EQ 30MG BASE A076618 003 Aug 15, 2005
AB EQ 40MG BASE A076618 004 Aug 15, 2005
AB MYLAN EQ 10MG BASE A078902 001 Mar 13, 2008
AB EQ 20MG BASE A078902 002 Mar 13, 2008
AB EQ 30MG BASE A078902 003 Mar 13, 2008
AB EQ 40MG BASE A078902 004 Mar 13, 2008
AB OXFORD PHARMS EQ 10MG BASE A076968 001 Jun 21, 2010
AB EQ 20MG BASE A076968 002 Jun 21, 2010
AB EQ 30MG BASE A076968 003 Jun 21, 2010
AB EQ 40MG BASE A076968 004 Jun 21, 2010
AB YILING EQ 10MG BASE A211248 001 Nov 02, 2021
AB EQ 20MG BASE A211248 002 Nov 02, 2021
AB EQ 30MG BASE A211248 003 Nov 02, 2021
AB EQ 40MG BASE A211248 004 Nov 02, 2021
AB ZYDUS PHARMS USA EQ 10MG BASE A077584 001 Mar 07, 2007
AB EQ 20MG BASE A077584 002 Mar 07, 2007
AB EQ 30MG BASE A077584 003 Mar 07, 2007
AB EQ 40MG BASE A077584 004 Mar 07, 2007
PAXIL
AB + APOTEX EQ 10MG BASE N020031 001 Dec 29, 1992
AB + EQ 20MG BASE N020031 002 Dec 29, 1992
AB + EQ 30MG BASE N020031 003 Dec 29, 1992
AB +! EQ 40MG BASE N020031 005 Dec 29, 1992
TABLET, EXTENDED RELEASE;ORAL
PAROXETINE HYDROCHLORIDE
AB AUROBINDO PHARMA EQ 12.5MG BASE A077873 001 Jun 29, 2007
USA
AB EQ 25MG BASE A077873 002 Jun 29, 2007
AB EQ 37.5MG BASE A091427 001 Apr 14, 2011
AB CADILA PHARMS LTD EQ 12.5MG BASE A212645 001 Aug 27, 2021
AB EQ 25MG BASE A212645 002 Aug 27, 2021
AB EQ 37.5MG BASE A212645 003 Aug 27, 2021
AB CSPC OUYI EQ 12.5MG BASE A213485 001 Feb 16, 2021
AB EQ 25MG BASE A213485 002 Feb 16, 2021
AB EQ 37.5MG BASE A213485 003 Feb 16, 2021
AB LANNETT CO INC EQ 12.5MG BASE A204744 001 Jun 10, 2016
AB EQ 25MG BASE A204744 002 Jun 10, 2016
AB EQ 37.5MG BASE A204744 003 Jun 10, 2016
AB LUPIN LTD EQ 12.5MG BASE A204134 001 Jan 20, 2017
AB EQ 25MG BASE A204134 002 Jan 20, 2017
AB EQ 37.5MG BASE A204134 003 Jan 20, 2017
AB SCIECURE PHARMA INC EQ 12.5MG BASE A209293 001 Jun 12, 2018
AB EQ 25MG BASE A209293 002 Jun 12, 2018
AB EQ 37.5MG BASE A209293 003 Jun 12, 2018
PAXIL CR
AB + APOTEX EQ 12.5MG BASE N020936 001 Feb 16, 1999
AB + EQ 25MG BASE N020936 002 Feb 16, 1999
AB +! EQ 37.5MG BASE N020936 003 Dec 06, 2000
PAROXETINE MESYLATE
CAPSULE;ORAL
BRISDELLE
AB +! SEBELA IRELAND LTD EQ 7.5MG BASE N204516 001 Jun 28, 2013
PAROXETINE MESYLATE
AB ACTAVIS LABS FL INC EQ 7.5MG BASE A207139 001 Jun 20, 2017
AB PRINSTON INC EQ 7.5MG BASE A207188 001 Aug 18, 2017
TABLET;ORAL
PEXEVA
+ SEBELA IRELAND LTD EQ 10MG BASE N021299 001 Jul 03, 2003
+ EQ 20MG BASE N021299 002 Jul 03, 2003
+ EQ 30MG BASE N021299 003 Jul 03, 2003
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-358(of 474)

PASIREOTIDE DIASPARTATE
SOLUTION;SUBCUTANEOUS
SIGNIFOR
+ RECORDATI RARE EQ 0.3MG BASE/ML (EQ 0.3MG BASE/ML) N200677 001 Dec 14, 2012
+ EQ 0.6MG BASE/ML (EQ 0.6MG BASE/ML) N200677 002 Dec 14, 2012
+! EQ 0.9MG BASE/ML (EQ 0.9MG BASE/ML) N200677 003 Dec 14, 2012
PASIREOTIDE PAMOATE
FOR SUSPENSION;INTRAMUSCULAR
SIGNIFOR LAR KIT
+ RECORDATI RARE EQ 10MG BASE/VIAL N203255 004 Jun 29, 2018
+ EQ 20MG BASE/VIAL N203255 001 Dec 15, 2014
+ EQ 30MG BASE/VIAL N203255 005 Jun 29, 2018
+ EQ 40MG BASE/VIAL N203255 002 Dec 15, 2014
+! EQ 60MG BASE/VIAL N203255 003 Dec 15, 2014
PATIROMER SORBITEX CALCIUM
POWDER;ORAL
VELTASSA
+ VIFOR PHARMA EQ 8.4GM BASE/PACKET N205739 001 Oct 21, 2015
+ EQ 16.8GM BASE/PACKET N205739 002 Oct 21, 2015
+! EQ 25.2GM BASE/PACKET N205739 003 Oct 21, 2015
PATISIRAN SODIUM
SOLUTION;INTRAVENOUS
ONPATTRO
+! ALNYLAM PHARMS INC EQ 10MG BASE/5ML (EQ 2MG BASE/ML) N210922 001 Aug 10, 2018
PAZOPANIB HYDROCHLORIDE
TABLET;ORAL
VOTRIENT
+! NOVARTIS EQ 200MG BASE N022465 001 Oct 19, 2009
PEGCETACOPLAN
SOLUTION;SUBCUTANEOUS
EMPAVELI
+! APELLIS PHARMS 1080MG/20ML (54MG/ML) N215014 001 May 14, 2021
PEMETREXED
SOLUTION;INTRAVENOUS
PEMETREXED
+! ACTAVIS LLC 100MG/4ML (25MG/ML) N208419 001 Aug 21, 2020
+! 500MG/20ML (25MG/ML) N208419 002 Aug 21, 2020
+! 1GM/40ML (25MG/ML) N208419 003 Aug 21, 2020
PEMFEXY
+! EAGLE PHARMS 500MG/20ML (25MG/ML) N209472 001 Feb 08, 2020
PEMETREXED DISODIUM
POWDER;INTRAVENOUS
ALIMTA
AP +! LILLY EQ 100MG BASE/VIAL N021462 002 Sep 07, 2007
AP +! EQ 500MG BASE/VIAL N021462 001 Feb 04, 2004
PEMETREXED DISODIUM
AP ACCORD HLTHCARE EQ 100MG BASE/VIAL A203485 001 May 25, 2022
AP EQ 500MG BASE/VIAL A203485 002 May 25, 2022
AP EQ 1GM BASE/VIAL A203485 003 May 25, 2022
AP AMNEAL EQ 500MG BASE/VIAL A210047 001 Aug 04, 2022
AP APOTEX EQ 100MG BASE/VIAL A203774 001 May 25, 2022
AP EQ 500MG BASE/VIAL A203774 002 May 25, 2022
AP EQ 750MG BASE/VIAL A209851 001 May 25, 2022
AP EQ 1GM BASE/VIAL A209085 001 May 25, 2022
AP BAXTER HLTHCARE EQ 100MG BASE/VIAL A214436 001 Aug 18, 2022
CORP
AP EQ 500MG BASE/VIAL A214436 002 Aug 18, 2022
AP DR REDDYS EQ 100MG BASE/VIAL A202596 001 May 25, 2022
AP EQ 500MG BASE/VIAL A202596 002 May 25, 2022
AP EQ 1GM BASE/VIAL A202596 003 May 25, 2022
AP EUGIA PHARMA EQ 100MG BASE/VIAL A214632 001 May 25, 2022
AP EQ 500MG BASE/VIAL A214632 002 May 25, 2022
AP EQ 1GM BASE/VIAL A214632 003 May 25, 2022
AP FRESENIUS KABI USA EQ 100MG BASE/VIAL A090384 001 May 25, 2022
AP EQ 500MG BASE/VIAL A090384 002 May 25, 2022
AP ! EQ 750MG BASE/VIAL A090384 003 May 25, 2022
AP ! EQ 1GM BASE/VIAL A090384 004 May 25, 2022
AP HONG KONG EQ 100MG BASE/VIAL A215479 001 Dec 13, 2022
AP EQ 500MG BASE/VIAL A215479 002 Dec 13, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-359(of 474)

PEMETREXED DISODIUM
POWDER;INTRAVENOUS
PEMETREXED DISODIUM
AP EQ 750MG BASE/VIAL A215479 003 Dec 13, 2022
AP EQ 1GM BASE/VIAL A215479 004 Dec 13, 2022
AP JIANGSU HANSOH EQ 100MG BASE/VIAL A208696 001 May 25, 2022
PHARM
AP EQ 500MG BASE/VIAL A208696 002 May 25, 2022
AP NANG KUANG PHARM CO EQ 100MG BASE/VIAL A207352 001 May 25, 2022
AP EQ 500MG BASE/VIAL A207352 002 May 25, 2022
AP QILU PHARM HAINAN EQ 100MG BASE/VIAL A204890 001 May 25, 2022
AP EQ 500MG BASE/VIAL A204890 002 May 25, 2022
AP WAVERLEY PHARMA INC EQ 100MG BASE/VIAL A211899 001 May 25, 2022
AP EQ 500MG BASE/VIAL A211899 002 May 25, 2022
AP ZYDUS PHARMS EQ 100MG BASE/VIAL A214073 001 May 25, 2022
AP EQ 500MG BASE/VIAL A214073 002 May 25, 2022
AP EQ 1GM BASE/VIAL A214073 003 May 25, 2022
SOLUTION;INTRAVENOUS
PEMETREXED DISODIUM
+! ACCORD HLTHCARE EQ 100MG BASE/4ML (EQ 25MG BASE/ML) N214408 001 Jul 19, 2022
+! EQ 500MG BASE/20ML (EQ 25MG BASE/ML) N214408 002 Jul 19, 2022
+! EQ 850MG BASE/34ML (EQ 25MG BASE/ML) N214408 003 Jul 19, 2022
+! EQ 1GM BASE/40ML (EQ 25MG BASE/ML) N214408 004 Jul 19, 2022
+! HOSPIRA EQ 100MG BASE/4ML (EQ 25MG BASE/ML) N214218 001 Jun 22, 2022
+! EQ 500MG BASE/20ML (EQ 25MG BASE/ML) N214218 002 Jun 22, 2022
+! EQ 1GM BASE/40ML (EQ 25MG BASE/ML) N214218 003 Jun 22, 2022
+! SANDOZ INC EQ 100MG BASE/4ML (EQ 25MG BASE/MG) N214657 001 May 26, 2022
+! EQ 500MG BASE/20ML (EQ 25MG BASE/ML) N214657 002 May 26, 2022
+! EQ 1GM BASE/40ML (EQ 25MG BASE/ML) N214657 003 May 26, 2022
PEMETREXED DITROMETHAMINE
POWDER;INTRAVENOUS
PEMETREXED DITROMETHAMINE
+! HOSPIRA EQ 100MG BASE/VIAL N208746 001 Jun 10, 2022
+! EQ 500MG BASE/VIAL N208746 002 Jun 10, 2022
PEMIGATINIB
TABLET;ORAL
PEMAZYRE
+ INCYTE CORP 4.5MG N213736 001 Apr 17, 2020
+ 9MG N213736 002 Apr 17, 2020
+! 13.5MG N213736 003 Apr 17, 2020
PENCICLOVIR
CREAM;TOPICAL
DENAVIR
AB +! MYLAN 1% N020629 001 Sep 24, 1996
PENCICLOVIR
AB TEVA PHARMS USA 1% A212710 001 Nov 09, 2022
PENICILLAMINE
CAPSULE;ORAL
CUPRIMINE
AB +! VALEANT PHARMS INTL 250MG N019853 001
PENICILLAMINE
AB ANI PHARMS 250MG A209921 001 May 07, 2019
AB APOTEX 250MG A213310 001 Apr 28, 2020
AB BRECKENRIDGE 250MG A215409 001 Aug 23, 2021
AB DR REDDYS 250MG A211867 001 Aug 04, 2020
AB GRANULES 250MG A211735 001 Dec 02, 2020
AB INVAGEN PHARMS 250MG A213293 001 Aug 19, 2021
AB NAVINTA LLC 250MG A214363 001 Oct 08, 2021
AB PAR PHARM INC 250MG A211231 001 Dec 23, 2019
AB WATSON LABS INC 250MG A210976 001 Jun 24, 2019
TABLET;ORAL
DEPEN
AB +! MYLAN SPECIALITY LP 250MG N019854 001
PENICILLAMINE
AB LUPIN LTD 250MG A212933 001 Nov 30, 2020
AB PAR PHARM INC 250MG A211196 001 Dec 23, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-360(of 474)

PENICILLIN G BENZATHINE
INJECTABLE;INJECTION
BICILLIN L-A
BC +! KING PHARMS LLC 600,000 UNITS/ML N050141 001
PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE
INJECTABLE;INJECTION
BICILLIN C-R
+! KING PHARMS LLC 300,000 UNITS/ML;300,000 UNITS/ML N050138 001
BICILLIN C-R 900/300
+! KING PHARMS LLC 900,000 UNITS/2ML;300,000 UNITS/2ML N050138 003
PENICILLIN G POTASSIUM
INJECTABLE;INJECTION
PENICILLIN G POTASSIUM
AP ACS DOBFAR SPA 20,000,000 UNITS/VIAL A205043 002 Oct 26, 2018
AP 5,000,000 UNITS/VIAL A205043 001 Oct 26, 2018
AP HQ SPECLT PHARMA 5,000,000 UNITS/VIAL A065149 002 Jul 23, 2009
AP 20,000,000 UNITS/VIAL A065149 003 Jul 23, 2009
AP ISTITUTO BIO ITA 5,000,000 UNITS/VIAL A065448 001 Aug 18, 2009
SPA
AP 20,000,000 UNITS/VIAL A065448 002 Aug 18, 2009
AP SANDOZ 5,000,000 UNITS/VIAL A065079 002 Aug 30, 2002
AP 20,000,000 UNITS/VIAL A065079 003 Aug 30, 2002
PFIZERPEN
AP ! PFIZER 5,000,000 UNITS/VIAL A060657 002
AP ! 20,000,000 UNITS/VIAL A060657 003
PENICILLIN G POTASSIUM
HQ SPECLT PHARMA 1,000,000 UNITS/VIAL A065149 001 Jul 23, 2009
PENICILLIN G POTASSIUM IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 20,000 UNITS/ML N050638 001 Jun 25, 1990
+! 40,000 UNITS/ML N050638 002 Jun 25, 1990
+! 60,000 UNITS/ML N050638 003 Jun 25, 1990
PENICILLIN G PROCAINE
INJECTABLE;INJECTION
PENICILLIN G PROCAINE
! KING PHARMS LLC 300,000 UNITS/ML A060101 002
! 600,000 UNITS/ML A060101 001
PENICILLIN G SODIUM
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS
PENICILLIN G SODIUM
! SANDOZ 5,000,000 UNITS/VIAL A065068 001 Feb 26, 2001
PENICILLIN V POTASSIUM
FOR SOLUTION;ORAL
PENICILLIN-VK
TEVA EQ 125MG BASE/5ML A060456 001
! EQ 250MG BASE/5ML A060456 002
TABLET;ORAL
PENICILLIN V POTASSIUM
AB AUROBINDO PHARMA EQ 250MG BASE A065435 001 Apr 29, 2008
AB EQ 500MG BASE A065435 002 Apr 29, 2008
AB HIKMA PHARMS EQ 250MG BASE A090549 001 Oct 11, 2013
AB EQ 500MG BASE A090549 002 Oct 11, 2013
AB SANDOZ EQ 250MG BASE A064071 001 Nov 30, 1995
AB ! EQ 500MG BASE A064071 002 Nov 30, 1995
AB STRIDES PHARMA EQ 250MG BASE A062936 001 Nov 25, 1988
AB EQ 500MG BASE A062935 001 Nov 23, 1988
PENICILLIN-VK
AB TEVA EQ 250MG BASE A060711 002
AB EQ 500MG BASE A060711 003
PENTAMIDINE ISETHIONATE
FOR SOLUTION;INHALATION
NEBUPENT
AN +! FRESENIUS KABI USA 300MG/VIAL N019887 001 Jun 15, 1989
PENTAMIDINE ISETHIONATE
AN SETON PHARMS 300MG/VIAL A206667 001 Apr 24, 2019
INJECTABLE;INJECTION
PENTAM
AP +! FRESENIUS KABI USA 300MG/VIAL N019264 001 Oct 16, 1984
PENTAMIDINE ISETHIONATE
AP EMCURE PHARMS LTD 300MG/VIAL A213806 001 Jan 07, 2021
AP SETON PHARMS 300MG/VIAL A206666 001 Sep 28, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-361(of 474)

PENTAMIDINE ISETHIONATE
INJECTABLE;INJECTION
PENTAMIDINE ISETHIONATE
AP XGEN PHARMS 300MG/VIAL A206982 001 Mar 17, 2022
PENTOBARBITAL SODIUM
INJECTABLE;INJECTION
NEMBUTAL SODIUM
AP +! AKORN 50MG/ML A083246 001
PENTOBARBITAL SODIUM
AP ATHENEX 50MG/ML A206677 001 Nov 27, 2017
AP HIKMA 50MG/ML A203619 001 Nov 13, 2017
AP SAGENT PHARMS INC 50MG/ML A206404 001 May 23, 2016
PENTOSAN POLYSULFATE SODIUM
CAPSULE;ORAL
ELMIRON
+! JANSSEN PHARMS 100MG N020193 001 Sep 26, 1996
PENTOSTATIN
INJECTABLE;INJECTION
NIPENT
AP +! HOSPIRA INC 10MG/VIAL N020122 001 Oct 11, 1991
PENTOSTATIN
AP WEST-WARD PHARMS 10MG/VIAL A077841 001 Aug 07, 2007
INT
PENTOXIFYLLINE
TABLET, EXTENDED RELEASE;ORAL
PENTOXIFYLLINE
AB ! APOTEX 400MG A075191 001 Jun 09, 1999
AB VALEANT PHARMS 400MG A075028 001 Jul 20, 1998
PERAMIVIR
SOLUTION;INTRAVENOUS
RAPIVAB
+! BIOCRYST 200MG/20ML (10MG/ML) N206426 001 Dec 19, 2014
PERAMPANEL
SUSPENSION;ORAL
FYCOMPA
+! EISAI INC 0.5MG/ML N208277 001 Apr 29, 2016
TABLET;ORAL
FYCOMPA
+ EISAI INC 2MG N202834 001 Oct 22, 2012
+ 4MG N202834 002 Oct 22, 2012
+ 6MG N202834 003 Oct 22, 2012
+ 8MG N202834 004 Oct 22, 2012
+ 10MG N202834 005 Oct 22, 2012
+! 12MG N202834 006 Oct 22, 2012
PERFLUTREN
INJECTABLE;INTRAVENOUS
DEFINITY
+! LANTHEUS MEDCL 6.52MG/ML N021064 001 Jul 31, 2001
DEFINITY RT
+! LANTHEUS MEDCL 6.52MG/ML N021064 002 Nov 17, 2020
PERINDOPRIL ERBUMINE
TABLET;ORAL
PERINDOPRIL ERBUMINE
AUROBINDO PHARMA 2MG A079070 001 Nov 10, 2009
4MG A079070 002 Nov 10, 2009
! 8MG A079070 003 Nov 10, 2009
PERMETHRIN
CREAM;TOPICAL
PERMETHRIN
AB ACTAVIS LABS 5% A074806 001 Jan 23, 1998
AB ENCUBE ETHICALS 5% A211303 001 Apr 03, 2019
AB ! PADAGIS ISRAEL 5% A076369 001 Apr 21, 2003
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-362(of 474)

PERPHENAZINE
TABLET;ORAL
PERPHENAZINE
AB APPCO 2MG A210163 001 May 18, 2022
AB 4MG A210163 002 May 18, 2022
AB 8MG A210163 003 May 18, 2022
AB 16MG A210163 004 May 18, 2022
AB RISING 2MG A205056 001 Mar 01, 2019
AB 4MG A205056 002 Mar 01, 2019
AB 8MG A205056 003 Mar 01, 2019
AB 16MG A205056 004 Mar 01, 2019
AB SANDOZ 2MG A089685 002 Dec 08, 1988
AB 4MG A089685 003 Dec 08, 1988
AB 8MG A089685 001 Dec 08, 1988
AB ! 16MG A089685 004 Dec 08, 1988
AB VINTAGE PHARMS 2MG A040226 001 Dec 31, 1998
AB 4MG A040226 002 Dec 31, 1998
AB 8MG A040226 003 Dec 31, 1998
AB 16MG A040226 004 Dec 31, 1998
AB WATSON LABS INC 2MG A207582 001 Oct 17, 2016
AB 4MG A207582 002 Oct 17, 2016
AB 8MG A207582 003 Oct 17, 2016
AB 16MG A207582 004 Oct 17, 2016
AB WILSHIRE PHARMS INC 2MG A205973 001 Dec 17, 2015
AB 4MG A205973 002 Dec 17, 2015
AB 8MG A205973 003 Dec 17, 2015
AB 16MG A205973 004 Dec 17, 2015
AB ZYDUS PHARMS 2MG A205232 001 Apr 06, 2020
AB 4MG A205232 002 Apr 06, 2020
AB 8MG A205232 003 Apr 06, 2020
AB 16MG A205232 004 Apr 06, 2020
PEXIDARTINIB HYDROCHLORIDE
CAPSULE;ORAL
TURALIO
+ DAIICHI SANKYO INC EQ 125MG BASE N211810 002 Oct 14, 2022
+! EQ 200MG BASE N211810 001 Aug 02, 2019
PHENDIMETRAZINE TARTRATE
CAPSULE, EXTENDED RELEASE;ORAL
PHENDIMETRAZINE TARTRATE
+! VIRTUS PHARMS 105MG N018074 001
TABLET;ORAL
BONTRIL PDM
AA +! VALEANT 35MG A085272 001
PHENDIMETRAZINE TARTRATE
AA CHARTWELL 35MG A089452 001 Oct 30, 1991
AA ELITE LABS INC 35MG A040762 001 Jan 28, 2008
AA KVK TECH 35MG A091042 001 Aug 31, 2010
AA VIRTUS PHARMS 35MG A085588 001
PHENELZINE SULFATE
TABLET;ORAL
NARDIL
AB +! PARKE DAVIS EQ 15MG BASE N011909 002
PHENELZINE SULFATE
AB NOVEL LABS INC EQ 15MG BASE A200181 001 Dec 08, 2010
PHENOBARBITAL SODIUM
POWDER;INTRAVENOUS
SEZABY
+! SUN PHARM INDS INC 100MG/VIAL N215910 001 Nov 17, 2022
PHENOXYBENZAMINE HYDROCHLORIDE
CAPSULE;ORAL
DIBENZYLINE
AB + CONCORDIA 10MG N008708 001
PHENOXYBENZAMINE HYDROCHLORIDE
AB AMNEAL 10MG A212568 001 Oct 27, 2020
AB HIKMA 10MG A201050 001 Jul 16, 2012
AB NOVITIUM PHARMA 10MG A215042 001 Jul 19, 2022
AB ! PAR PHARM INC 10MG A204522 001 Jan 24, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-363(of 474)

PHENTERMINE HYDROCHLORIDE
CAPSULE;ORAL
ADIPEX-P
AA +! TEVA 37.5MG A088023 001 Aug 02, 1983
PHENTERMINE HYDROCHLORIDE
AA AUROLIFE PHARMA LLC 15MG A204318 001 Nov 09, 2016
AA 30MG A204318 002 Nov 09, 2016
AA ELITE LABS 15MG A202248 001 Sep 28, 2012
AA 30MG A202248 002 Sep 28, 2012
AA ELITE LABS INC 37.5MG A040228 001 Jun 19, 1997
AA INVAGEN PHARMS 15MG A202858 001 Feb 14, 2014
AA 30MG A202858 002 Feb 14, 2014
AA 30MG A204414 001 May 05, 2014
AA 37.5MG A202846 001 Feb 05, 2014
AA KVK TECH 15MG A040886 002 Mar 31, 2008
AA 30MG A040875 001 Mar 21, 2008
AA 30MG A040886 001 Mar 31, 2008
AA 37.5MG A040887 001 Apr 24, 2008
AA LANNETT 15MG A087022 002 Jan 20, 2012
AA 30MG A087022 001 Feb 03, 1983
AA NUVO PHARM 15MG A205019 001 Dec 05, 2014
AA 30MG A205019 002 Dec 05, 2014
AA 37.5MG A205017 001 Sep 25, 2014
AA +! SANDOZ 15MG A087190 002
AA +! 30MG A086945 001 Jul 20, 1983
AA +! 30MG A087190 001
AA SUN PHARM 30MG A040525 001 Oct 23, 2003
INDUSTRIES
TABLET;ORAL
ADIPEX-P
AA +! TEVA 37.5MG A085128 001
LOMAIRA
AA ! AVANTHI INC 8MG A203495 001 Sep 12, 2016
PHENTERMINE HYDROCHLORIDE
AA AUROLIFE PHARMA LLC 37.5MG A203068 001 Aug 06, 2014
AA ELITE LABS 37.5MG A200272 001 Jan 31, 2011
AA ELITE LABS INC 37.5MG A040190 001 May 30, 1997
AA INVAGEN PHARMS 37.5MG A202942 001 Feb 05, 2014
AA KVK TECH 37.5MG A040876 001 Mar 31, 2008
AA KVK TECH INC 8MG A203436 001 Mar 17, 2017
AA MERRO PHARM USA 37.5MG A206342 001 Nov 18, 2016
AA NUVO PHARM 37.5MG A205008 001 Sep 25, 2014
AA PRINSTON INC 37.5MG A040377 001 Jan 04, 2002
AA SUN PHARM 37.5MG A040526 001 Oct 23, 2003
INDUSTRIES
TABLET, ORALLY DISINTEGRATING;ORAL
PHENTERMINE HYDROCHLORIDE
ZYDUS PHARMS 15MG A204663 001 Jun 28, 2017
30MG A204663 002 Jun 28, 2017
37.5MG A204663 003 Jun 28, 2017
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
CAPSULE, EXTENDED RELEASE;ORAL
QSYMIA
+ VIVUS EQ 3.75MG BASE;23MG N022580 001 Jul 17, 2012
+ EQ 7.5MG BASE;46MG N022580 002 Jul 17, 2012
+ EQ 11.25MG BASE;69MG N022580 003 Jul 17, 2012
+! EQ 15MG BASE;92MG N022580 004 Jul 17, 2012
PHENTOLAMINE MESYLATE
INJECTABLE;INJECTION
PHENTOLAMINE MESYLATE
AP ! HIKMA 5MG/VIAL A040235 001 Mar 11, 1998
AP PRECISION DOSE INC 5MG/VIAL A207686 001 Jul 14, 2017
ORAVERSE
+! SEPTODONT HOLDING 0.4MG/1.7ML N022159 001 May 09, 2008
PHENYLEPHRINE HYDROCHLORIDE
SOLUTION;INTRAVENOUS
PHENYLEPHRINE HYDROCHLORIDE
AP1 ACCORD HLTHCARE 10MG/ML (10MG/ML) A213237 001 Jul 01, 2020
AP1 50MG/5ML (10MG/ML) A213237 002 Jul 01, 2020
AP1 100MG/10ML (10MG/ML) A213237 003 Jul 01, 2020
AP1 AMNEAL 10MG/ML (10MG/ML) A211079 001 Jul 05, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-364(of 474)

PHENYLEPHRINE HYDROCHLORIDE
SOLUTION;INTRAVENOUS
PHENYLEPHRINE HYDROCHLORIDE
AP1 50MG/5ML (10MG/ML) A211078 001 Jul 19, 2018
AP1 100MG/10ML (10MG/ML) A211078 002 Jul 19, 2018
AP1 CAPLIN 10MG/ML (10MG/ML) A213318 001 Jun 11, 2020
AP1 50MG/5ML (10MG/ML) A213318 002 Jun 11, 2020
AP1 100MG/10ML (10MG/ML) A213318 003 Jun 11, 2020
AP1 EUGIA PHARMA 50MG/5ML (10MG/ML) A210697 001 Nov 13, 2020
AP1 100MG/10ML (10MG/ML) A210697 002 Nov 13, 2020
AP1 FRESENIUS KABI USA 50MG/5ML (10MG/ML) A210666 001 Jan 30, 2019
AP1 100MG/10ML (10MG/ML) A210666 002 Jan 30, 2019
AP1 GLAND PHARMA LTD 10MG/ML (10MG/ML) A211920 003 Apr 08, 2021
AP1 50MG/5ML (10MG/ML) A211920 001 Jun 05, 2020
AP1 100MG/10ML (10MG/ML) A211920 002 Jun 05, 2020
AP1 MANKIND PHARMA 10MG/ML (10MG/ML) A217069 001 Aug 30, 2022
AP1 50MG/5ML (10MG/ML) A217069 002 Aug 30, 2022
AP1 100MG/10ML (10MG/ML) A217069 003 Aug 30, 2022
AP1 MEITHEAL 50MG/5ML (10MG/ML) A210333 001 Apr 27, 2018
AP1 100MG/10ML (10MG/ML) A210333 002 Apr 27, 2018
AP1 PAR STERILE 50MG/5ML (10MG/ML) A210025 002 Dec 21, 2018
PRODUCTS
AP1 100MG/10ML (10MG/ML) A210025 003 Dec 21, 2018
AP1 PROVEPHARM SAS 10MG/ML (10MG/ML) A211081 001 Jul 17, 2020
AP1 50MG/5ML (10MG/ML) A211081 002 Jul 17, 2020
AP1 100MG/10ML (10MG/ML) A211081 003 Jul 17, 2020
AP1 SAGENT PHARMS INC 10MG/ML (10MG/ML) A209967 001 Jan 16, 2020
AP1 50MG/5ML (10MG/ML) A209967 002 Jan 16, 2020
AP1 100MG/10ML (10MG/ML) A209967 003 Jan 16, 2020
AP1 SANDOZ INC 10MG/ML (10MG/ML) A208905 001 Jan 31, 2019
AP1 50MG/5ML (10MG/ML) A208905 002 Jan 31, 2019
AP1 100MG/10ML (10MG/ML) A208905 003 Jan 31, 2019
VAZCULEP
AP1 +! EXELA PHARMA 10MG/ML (10MG/ML) N204300 001 Jun 27, 2014
AP1 +! 50MG/5ML (10MG/ML) N204300 002 Jun 27, 2014
AP1 +! 100MG/10ML (10MG/ML) N204300 003 Jun 27, 2014
PHENYLEPHRINE HYDROCHLORIDE
AP2 EUGIA PHARMA 10MG/ML (10MG/ML) A210696 001 Jan 07, 2021
AP2 FRESENIUS KABI USA 10MG/ML (10MG/ML) A210665 001 Jan 29, 2019
AP2 +! HIKMA 10MG/ML (10MG/ML) N203826 001 Dec 20, 2012
AP2 +! 50MG/5ML (10MG/ML) N203826 002 Jun 19, 2019
AP2 +! 100MG/10ML (10MG/ML) N203826 003 Jun 19, 2019
AP2 MEITHEAL 10MG/ML (10MG/ML) A210334 001 Apr 27, 2018
BIORPHEN
+! DR REDDYS LABS SA 0.5MG/5ML (0.1MG/ML) N212909 001 Oct 21, 2019
SOLUTION/DROPS;OPHTHALMIC
PHENYLEPHRINE HYDROCHLORIDE
AT +! AKORN 2.5% N207926 001 Jan 15, 2015
AT +! 10% N207926 002 Jan 15, 2015
AT MANKIND PHARMA 2.5% A216859 001 Sep 29, 2022
AT 10% A216496 001 Jan 11, 2023
AT +! PARAGON BIOTECK 2.5% N203510 001 Mar 21, 2013
AT +! 10% N203510 002 Mar 21, 2013
PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
SYRUP;ORAL
PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE
AA AKORN 5MG/5ML;6.25MG/5ML A040675 001 Dec 23, 2014
AA ! PHARM ASSOC 5MG/5ML;6.25MG/5ML A040654 001 Dec 07, 2006
PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE
AA AMNEAL PHARMS 5MG/5ML;6.25MG/5ML A040902 001 Aug 25, 2009
PHENYTOIN
SUSPENSION;ORAL
DILANTIN-125
AB +! VIATRIS 125MG/5ML N008762 001
PHENYTOIN
AB PAI HOLDINGS PHARM 125MG/5ML A040420 001 Apr 19, 2002
AB TARO 125MG/5ML A040521 001 Mar 08, 2004
AB VISTAPHARM 125MG/5ML A040342 001 Jan 31, 2001
AB 125MG/5ML A040342 002 Aug 18, 2005
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-365(of 474)

PHENYTOIN
TABLET, CHEWABLE;ORAL
DILANTIN
AB +! PHARMACIA 50MG A084427 001
PHENYTOIN
AB EPIC PHARMA LLC 50MG A040884 001 Nov 28, 2014
AB RISING 50MG A200691 001 Dec 26, 2012
AB TARO 50MG A200565 001 Apr 17, 2014
PHENYTOIN SODIUM
CAPSULE;ORAL
DILANTIN
AB +! VIATRIS 100MG EXTENDED A084349 002
EXTENDED PHENYTOIN SODIUM
AB AMNEAL PHARMS NY 100MG EXTENDED A040765 001 Nov 12, 2008
AB MYLAN 100MG EXTENDED A040298 001 Dec 28, 1998
AB SUN PHARM INDS 200MG EXTENDED A040731 001 Jun 30, 2008
AB 300MG EXTENDED A040731 002 Jun 30, 2008
AB TARO 100MG EXTENDED A040684 001 Sep 05, 2006
AB UNICHEM 100MG EXTENDED A213834 001 Oct 13, 2022
PHENYTEK
AB MYLAN 200MG EXTENDED A040298 002 Dec 06, 2001
AB ! 300MG EXTENDED A040298 003 Dec 06, 2001
PHENYTOIN SODIUM
AB AUROBINDO PHARMA 100MG EXTENDED A204309 001 Jun 10, 2015
DILANTIN
+! VIATRIS 30MG EXTENDED A084349 001
INJECTABLE;INJECTION
PHENYTOIN SODIUM
AP ACELLA 50MG/ML A040573 001 Sep 13, 2006
AP +! WEST-WARD PHARMS 50MG/ML A084307 001
INT
PHYTONADIONE
INJECTABLE;INJECTION
PHYTONADIONE
AB1 DR REDDYS 10MG/ML A207719 001 May 22, 2019
VITAMIN K1
AB1 +! HOSPIRA 10MG/ML A087955 001 Jul 25, 1983
PHYTONADIONE
BP +! INTL MEDICATION 1MG/0.5ML A083722 001
VITAMIN K1
BP +! HOSPIRA 1MG/0.5ML A087954 001 Jul 25, 1983
PHYTONADIONE
! CIPLA 1MG/0.5ML A214596 001 Apr 22, 2022
! 10MG/ML A214596 002 Apr 22, 2022
TABLET;ORAL
MEPHYTON
AB +! BAUSCH 5MG N010104 003
PHYTONADIONE
AB AMNEAL PHARMS CO 5MG A209373 001 May 11, 2018
AB ZYDUS 5MG A210189 001 Feb 20, 2019
PIFLUFOLASTAT F-18
SOLUTION;INTRAVENOUS
PYLARIFY
+! PROGENICS PHARMS 50ML (1-80mCi/ML) N214793 001 May 26, 2021
INC
PILOCARPINE HYDROCHLORIDE
SOLUTION;OPHTHALMIC
ISOPTO CARPINE
AT +! NOVARTIS 1% N200890 001 Jun 22, 2010
AT +! 2% N200890 002 Jun 22, 2010
AT +! 4% N200890 003 Jun 22, 2010
PILOCARPINE HYDROCHLORIDE
AT AKORN 1% A204398 001 Sep 27, 2017
AT 2% A204398 002 Sep 27, 2017
AT 4% A204398 003 Sep 27, 2017
AT AMNEAL 1% A214193 001 Sep 21, 2020
AT 2% A214193 002 Sep 21, 2020
AT 4% A214193 003 Sep 21, 2020
AT SOMERSET THERAPS 1% A210384 001 Nov 25, 2019
LLC
AT 2% A210384 002 Nov 25, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-366(of 474)

PILOCARPINE HYDROCHLORIDE
SOLUTION;OPHTHALMIC
PILOCARPINE HYDROCHLORIDE
AT 4% A210384 003 Nov 25, 2019
VUITY
+! ABBVIE INC 1.25% N214028 001 Oct 28, 2021
TABLET;ORAL
PILOCARPINE HYDROCHLORIDE
AB AMICI 5MG A076963 001 Dec 22, 2004
AB 7.5MG A076963 002 Feb 27, 2007
AB AUROBINDO PHARMA 5MG A212377 001 Aug 13, 2019
LTD
AB 7.5MG A212377 002 Aug 13, 2019
AB IMPAX LABS 5MG A077248 001 Mar 31, 2006
AB 7.5MG A077248 002 Mar 31, 2006
AB LANNETT CO INC 5MG A077220 001 Oct 14, 2005
AB 7.5MG A077220 002 May 06, 2009
AB PADAGIS US 5MG A076746 001 Nov 16, 2004
SALAGEN
AB + CONCORDIA 5MG N020237 001 Mar 22, 1994
AB +! 7.5MG N020237 002 Apr 18, 2003
PIMAVANSERIN TARTRATE
CAPSULE;ORAL
NUPLAZID
+! ACADIA PHARMS INC EQ 34MG BASE N210793 001 Jun 28, 2018
TABLET;ORAL
NUPLAZID
+! ACADIA PHARMS INC EQ 10MG BASE N207318 002 Jun 28, 2018
PIMECROLIMUS
CREAM;TOPICAL
ELIDEL
AB +! BAUSCH 1% N021302 001 Dec 13, 2001
PIMECROLIMUS
AB ACTAVIS LABS UT INC 1% A209345 001 Dec 27, 2018
AB GLENMARK PHARMS LTD 1% A211769 001 Aug 29, 2019
PIMOZIDE
TABLET;ORAL
PIMOZIDE
PAR PHARM 1MG A204521 001 Sep 28, 2015
! 2MG A204521 002 Sep 28, 2015
PINDOLOL
TABLET;ORAL
PINDOLOL
AB ANI PHARMS 5MG A073609 002 Mar 29, 1993
AB 10MG A073609 001 Mar 29, 1993
AB AUROBINDO PHARMA 5MG A074019 001 Sep 03, 1992
USA
AB ! 10MG A074019 002 Sep 03, 1992
AB BAYSHORE PHARMS LLC 5MG A211712 001 Aug 01, 2019
AB 10MG A211712 002 Aug 01, 2019
AB NOSTRUM LABS INC 5MG A205415 001 Jan 13, 2016
AB 10MG A205415 002 Jan 13, 2016
AB SUN PHARM 5MG A074063 001 Jan 27, 1994
INDUSTRIES
AB 10MG A074063 002 Jan 27, 1994
PIOGLITAZONE HYDROCHLORIDE
TABLET;ORAL
ACTOS
AB + TAKEDA PHARMS USA EQ 15MG BASE N021073 001 Jul 15, 1999
AB + EQ 30MG BASE N021073 002 Jul 15, 1999
AB +! EQ 45MG BASE N021073 003 Jul 15, 1999
PIOGLITAZONE HYDROCHLORIDE
AB ACCORD HLTHCARE EQ 15MG BASE A200044 001 Feb 13, 2013
AB EQ 30MG BASE A200044 002 Feb 13, 2013
AB EQ 45MG BASE A200044 003 Feb 13, 2013
AB ANNORA PHARMA EQ 15MG BASE A204133 001 Apr 07, 2014
AB EQ 30MG BASE A204133 002 Apr 07, 2014
AB EQ 45MG BASE A204133 003 Apr 07, 2014
AB AUROBINDO PHARMA EQ 15MG BASE A200268 001 Feb 13, 2013
LTD
AB EQ 30MG BASE A200268 002 Feb 13, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-367(of 474)

PIOGLITAZONE HYDROCHLORIDE
TABLET;ORAL
PIOGLITAZONE HYDROCHLORIDE
AB EQ 45MG BASE A200268 003 Feb 13, 2013
AB CELLTRION EQ 15MG BASE A076798 001 Oct 26, 2012
AB EQ 30MG BASE A076798 002 Oct 26, 2012
AB EQ 45MG BASE A076798 003 Oct 26, 2012
AB MACLEODS PHARMS LTD EQ 15MG BASE A202467 001 Feb 06, 2013
AB EQ 30MG BASE A202467 002 Feb 06, 2013
AB EQ 45MG BASE A202467 003 Feb 06, 2013
AB PRINSTON INC EQ 15MG BASE A207806 001 Apr 17, 2018
AB EQ 30MG BASE A207806 002 Apr 17, 2018
AB EQ 45MG BASE A207806 003 Apr 17, 2018
AB PURACAP PHARM LLC EQ 15MG BASE A206738 001 Oct 06, 2017
AB EQ 30MG BASE A206738 002 Oct 06, 2017
AB EQ 45MG BASE A206738 003 Oct 06, 2017
AB SANDOZ EQ 15MG BASE A078670 001 Feb 13, 2013
AB EQ 30MG BASE A078670 002 Feb 13, 2013
AB EQ 45MG BASE A078670 003 Feb 13, 2013
AB SHUANGCHENG EQ 15MG BASE A210165 001 Jan 22, 2021
AB EQ 30MG BASE A210165 002 Jan 22, 2021
AB EQ 45MG BASE A210165 003 Jan 22, 2021
AB TEVA PHARMS USA EQ 15MG BASE A077210 001 Jan 10, 2014
AB EQ 30MG BASE A077210 002 Jan 10, 2014
AB EQ 45MG BASE A077210 003 Jan 10, 2014
AB ZYDUS PHARMS USA EQ 15MG BASE A202456 001 Feb 13, 2013
INC
AB EQ 30MG BASE A202456 002 Feb 13, 2013
AB EQ 45MG BASE A202456 003 Feb 13, 2013
PIPERACILLIN SODIUM
INJECTABLE;INJECTION
PIPERACILLIN
! ISTITUTO BIO ITA EQ 2GM BASE/VIAL A065114 001 Nov 14, 2003
SPA
! EQ 3GM BASE/VIAL A065114 002 Nov 14, 2003
! EQ 4GM BASE/VIAL A065114 003 Nov 14, 2003
! EQ 40GM BASE/VIAL A065157 001 Jul 12, 2004
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
INJECTABLE;INJECTION
PIPERACILLIN AND TAZOBACTAM
AP ASTRAL EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL A212287 001 Jul 29, 2019
AP EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL A212287 002 Jul 29, 2019
AP EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL A212287 003 Jul 29, 2019
AP EUGIA PHARMA EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL A065498 001 May 23, 2011
SPECLTS
AP EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL A065498 002 May 23, 2011
AP EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL A065498 003 May 23, 2011
AP FRESENIUS KABI EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL A203719 001 May 18, 2018
AP EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL A203719 002 May 18, 2018
AP EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL A203719 003 May 18, 2018
AP EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL A203720 001 May 11, 2018
AP FRESENIUS KABI USA EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL A206204 001 May 11, 2018
AP ISTITUTO BIO ITA EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL A065523 001 May 31, 2011
SPA
AP EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL A065523 002 May 31, 2011
AP EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL A065523 003 May 31, 2011
AP EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL A090498 001 May 31, 2011
AP PROVEPHARM SAS EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL A207847 001 Jan 13, 2017
AP EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL A207847 002 Jan 13, 2017
AP EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL A207848 002 Jan 13, 2017
AP EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL A207847 003 Jan 13, 2017
AP EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL A207848 001 May 11, 2018
AP QILU EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL A204959 001 Aug 10, 2018
AP EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL A204959 002 Aug 10, 2018
AP EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL A204959 003 Aug 10, 2018
AP SAGENT PHARMS INC EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL A208674 001 Feb 16, 2021
AP EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL A208674 002 Feb 16, 2021
AP EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL A208674 003 Feb 16, 2021
AP EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL A208675 001 Feb 16, 2021
AP SANDOZ EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL A065362 001 Oct 21, 2010
AP EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL A065363 001 Oct 21, 2010
AP EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL A065362 002 Oct 21, 2010
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-368(of 474)

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM


INJECTABLE;INJECTION
PIPERACILLIN AND TAZOBACTAM
AP EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL A065363 002 Oct 21, 2010
AP EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL A065362 003 Oct 21, 2010
AP EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL A065363 003 Oct 21, 2010
AP SANDOZ INC EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL A203557 001 Oct 29, 2014
AP EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL A203557 002 Jul 08, 2021
AP STERISCIENCE EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL A065458 001 Aug 15, 2014
AP EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL A065458 002 Aug 15, 2014
AP EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL A065458 003 Aug 15, 2014
AP ! WOCKHARDT BIO AG EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL A206996 001 Mar 22, 2017
AP ! EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL A206996 002 Mar 22, 2017
AP ! EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL A206996 003 Mar 22, 2017
AP ! EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL A207146 001 Mar 17, 2017
ZOSYN IN PLASTIC CONTAINER
+! WYETH PHARMS EQ 40MG BASE/ML;EQ 5MG BASE/ML N050750 001 Feb 24, 1998
+! EQ 60MG BASE/ML;EQ 7.5MG BASE/ML N050750 002 Feb 24, 1998
+! EQ 4GM BASE/100ML;EQ 500MG BASE/100ML N050750 003 Feb 24, 1998
PIRFENIDONE
CAPSULE;ORAL
ESBRIET
AB +! GENENTECH INC 267MG N022535 001 Oct 15, 2014
PIRFENIDONE
AB ACCORD HLTHCARE 267MG A212731 001 Jan 20, 2022
AB AMNEAL 267MG A212569 001 Jan 03, 2022
AB LAURUS 267MG A212724 001 Jul 19, 2022
AB SANDOZ INC 267MG A212600 001 Jun 13, 2022
AB SCIEGEN PHARMS INC 267MG A212077 001 Aug 01, 2022
TABLET;ORAL
ESBRIET
AB + GENENTECH INC 267MG N208780 001 Jan 11, 2017
AB +! 801MG N208780 003 Jan 11, 2017
PIRFENIDONE
AB ACCORD HLTHCARE 267MG A212730 001 Jan 25, 2022
AB 801MG A212730 002 Jan 25, 2022
AB AIZANT 267MG A212747 001 Jul 21, 2022
AB 534MG A212747 002 Jul 21, 2022
AB 801MG A212747 003 Jul 21, 2022
AB ALEMBIC PHARMS 267MG A212708 001 May 20, 2022
AB 801MG A212708 002 May 20, 2022
AB AMNEAL 267MG A212570 001 Mar 25, 2022
AB 801MG A212570 002 Mar 25, 2022
AB HETERO LABS LTD V 267MG A212674 001 Sep 21, 2022
AB 801MG A212674 002 Sep 21, 2022
AB LAURUS 267MG A212722 001 Jul 19, 2022
AB 534MG A212722 002 Jul 19, 2022
AB 801MG A212722 003 Jul 19, 2022
AB MICRO LABS 267MG A212680 001 May 18, 2022
AB 801MG A212680 002 May 18, 2022
AB MSN 267MG A212772 001 May 24, 2022
AB 801MG A212772 002 May 24, 2022
AB SANDOZ INC 267MG A212560 001 Apr 28, 2022
AB 801MG A212560 002 Apr 28, 2022
AB SCIEGEN PHARMS INC 267MG A212078 001 Aug 01, 2022
AB 801MG A212078 002 Aug 01, 2022
AB TEVA PHARMS USA 267MG A212759 001 Jan 25, 2022
AB 801MG A212759 002 Jan 25, 2022
PIROXICAM
CAPSULE;ORAL
FELDENE
AB + PFIZER 10MG N018147 002 Apr 06, 1982
AB +! 20MG N018147 003 Apr 06, 1982
PIROXICAM
AB CADILA 10MG A205585 001 Jul 17, 2018
AB 20MG A205585 002 Jul 17, 2018
AB FLAMINGO PHARMS 10MG A207938 001 Sep 09, 2016
AB 20MG A207938 002 Sep 09, 2016
AB HIKMA 10MG A209256 001 Aug 11, 2017
AB 20MG A209256 002 Aug 11, 2017
AB MICRO LABS 10MG A206152 001 Dec 29, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-369(of 474)

PIROXICAM
CAPSULE;ORAL
PIROXICAM
AB 20MG A206152 002 Dec 29, 2017
AB NOSTRUM LABS INC 10MG A074118 002 Jun 15, 1993
AB 20MG A074118 001 Jun 15, 1993
AB STRIDES PHARMA 10MG A206136 001 Jun 20, 2017
AB 10MG A210347 001 Jan 26, 2018
AB 20MG A206136 002 Jun 20, 2017
AB 20MG A210347 002 Jan 26, 2018
AB TEVA 10MG A074131 001 Dec 11, 1992
AB 20MG A074131 002 Dec 11, 1992
BX UNICHEM 10MG A208340 001 Apr 13, 2017
BX 20MG A208340 002 Apr 13, 2017
PITAVASTATIN CALCIUM
TABLET;ORAL
LIVALO
AB + KOWA CO EQ 1MG BASE N022363 001 Aug 03, 2009
AB + EQ 2MG BASE N022363 002 Aug 03, 2009
AB +! EQ 4MG BASE N022363 003 Aug 03, 2009
PITAVASTATIN CALCIUM
AB AUROBINDO PHARMA EQ 1MG BASE A206015 001 Dec 20, 2016
AB EQ 2MG BASE A206015 002 Dec 20, 2016
AB EQ 4MG BASE A206015 003 Dec 20, 2016
AB ORIENT PHARMA CO EQ 1MG BASE A205932 001 Feb 03, 2017
LTD
AB EQ 2MG BASE A205932 002 Feb 03, 2017
AB EQ 4MG BASE A205932 003 Feb 03, 2017
AB SAWAI USA EQ 1MG BASE A205955 001 Feb 03, 2017
AB EQ 2MG BASE A205955 002 Feb 03, 2017
AB EQ 4MG BASE A205955 003 Feb 03, 2017
PITAVASTATIN MAGNESIUM
TABLET;ORAL
ZYPITAMAG
+ MEDICURE EQ 2MG BASE N208379 002 Jul 14, 2017
+! EQ 4MG BASE N208379 003 Jul 14, 2017
PITOLISANT HYDROCHLORIDE
TABLET;ORAL
WAKIX
+ HARMONY EQ 4.45MG BASE N211150 001 Aug 14, 2019
+! EQ 17.8MG BASE N211150 002 Aug 14, 2019
PLAZOMICIN SULFATE
SOLUTION;INTRAVENOUS
ZEMDRI
+! CIPLA USA EQ 500MG BASE/10ML (EQ 50MG BASE/ML) N210303 001 Jun 25, 2018
PLECANATIDE
TABLET;ORAL
TRULANCE
+! SALIX 3MG N208745 001 Jan 19, 2017
PLERIXAFOR
SOLUTION;SUBCUTANEOUS
MOZOBIL
+! GENZYME 24MG/1.2ML (20MG/ML) N022311 001 Dec 15, 2008
PODOFILOX
GEL;TOPICAL
CONDYLOX
+! ALLERGAN 0.5% N020529 001 Mar 13, 1997
SOLUTION;TOPICAL
CONDYLOX
AT +! TEVA BRANDED PHARM 0.5% N019795 001 Dec 13, 1990
PODOFILOX
AT PADAGIS US 0.5% A075600 001 Jan 29, 2002
POLIDOCANOL
SOLUTION;INTRAVENOUS
ASCLERA
+ CHEMISCH FBRK 10MG/2ML (5MG/ML) N021201 001 Mar 30, 2010
KRSSLR
+! 20MG/2ML (10MG/ML) N021201 002 Mar 30, 2010
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-370(of 474)

POLIDOCANOL
SOLUTION;INTRAVENOUS
VARITHENA
+! PROVENSIS 180MG/18ML (10MG/ML) N205098 001 Nov 25, 2013
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
FOR SOLUTION;ORAL
NULYTELY
AA +! BRAINTREE 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/ N019797 001 Apr 22, 1991
BOT
NULYTELY-FLAVORED
AA +! BRAINTREE 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/ N019797 002 Nov 18, 1994
BOT
PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE
AA STRIDES PHARMA 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/ A204559 001 Apr 13, 2015
BOT
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE
ANHYDROUS
FOR SOLUTION;ORAL
COLYTE WITH FLAVOR PACKS
AA MYLAN SPECIALITY LP 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ N018983 012 Oct 08, 1998
BOT;22.72GM/BOT
GOLYTELY
AA +! BRAINTREE 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ N019011 001 Jul 13, 1984
BOT;22.74GM/BOT
PEG 3350 AND ELECTROLYTES
AA NOVEL LABS INC 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ A090231 001 Jun 01, 2009
BOT;22.74GM/BOT
AA 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ A090186 001 Jun 01, 2009
BOT;22.72GM/BOT
POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES
AA STRIDES PHARMA 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ A204558 001 Dec 21, 2018
BOT;22.74GM/BOT
POLYMYXIN B SULFATE
INJECTABLE;INJECTION
POLYMYXIN B SULFATE
AP EUGIA PHARMA EQ 500,000 UNITS BASE/VIAL A206589 001 Apr 04, 2016
AP FRESENIUS KABI USA EQ 500,000 UNITS BASE/VIAL A065372 001 Jan 10, 2008
AP GLAND EQ 500,000 UNITS BASE/VIAL A207322 001 Apr 14, 2016
AP ! XELLIA PHARMS APS EQ 500,000 UNITS BASE/VIAL A202766 001 Jan 15, 2014
AP XGEN PHARMS EQ 500,000 UNITS BASE/VIAL A063000 001 Sep 30, 1994
POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
SOLUTION/DROPS;OPHTHALMIC
POLYTRIM
AT +! ALLERGAN 10,000 UNITS/ML;EQ 1MG BASE/ML N050567 001 Oct 20, 1988
TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE
AT AKORN 10,000 UNITS/ML;EQ 1MG BASE/ML A065006 001 Dec 17, 1998
AT BAUSCH AND LOMB 10,000 UNITS/ML;EQ 1MG BASE/ML A064120 001 Feb 14, 1997
AT SANDOZ INC 10,000 UNITS/ML;EQ 1MG BASE/ML A064211 001 Apr 13, 1998
POMALIDOMIDE
CAPSULE;ORAL
POMALYST
+ CELGENE 1MG N204026 001 Feb 08, 2013
+ 2MG N204026 002 Feb 08, 2013
+ 3MG N204026 003 Feb 08, 2013
+! 4MG N204026 004 Feb 08, 2013
PONATINIB HYDROCHLORIDE
TABLET;ORAL
ICLUSIG
+ TAKEDA PHARMS USA EQ 10MG BASE N203469 004 Dec 18, 2020
+ EQ 15MG BASE N203469 001 Dec 14, 2012
+ EQ 30MG BASE N203469 003 Apr 23, 2015
+! EQ 45MG BASE N203469 002 Dec 14, 2012
PONESIMOD
TABLET;ORAL
PONVORY
+! JANSSEN PHARMS 2MG N213498 001 Mar 18, 2021
+ 3MG N213498 002 Mar 18, 2021
+ 4MG N213498 003 Mar 18, 2021
+ 5MG N213498 004 Mar 18, 2021
+ 6MG N213498 005 Mar 18, 2021
+ 7MG N213498 006 Mar 18, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-371(of 474)

PONESIMOD
TABLET;ORAL
PONVORY
+ 8MG N213498 007 Mar 18, 2021
+ 9MG N213498 008 Mar 18, 2021
+ 10MG N213498 009 Mar 18, 2021
+ 20MG N213498 010 Mar 18, 2021
PORFIMER SODIUM
INJECTABLE;INJECTION
PHOTOFRIN
PINNACLE BIOLGS 75MG/VIAL N020451 001 Dec 27, 1995
POSACONAZOLE
FOR SUSPENSION, DELAYED RELEASE;ORAL
NOXAFIL POWDERMIX KIT
+! MSD MERCK CO 300MG N214770 001 May 31, 2021
SOLUTION;INTRAVENOUS
NOXAFIL
AP +! MERCK SHARP DOHME 300MG/16.7ML (18MG/ML) N205596 001 Mar 13, 2014
POSACONAZOLE
AP PAR STERILE 300MG/16.7ML (18MG/ML) A208768 001 May 25, 2022
PRODUCTS
SUSPENSION;ORAL
NOXAFIL
AB +! SCHERING 40MG/ML N022003 001 Sep 15, 2006
POSACONAZOLE
AB HIKMA 40MG/ML A208773 001 May 15, 2020
TABLET, DELAYED RELEASE;ORAL
NOXAFIL
AB +! MERCK SHARP DOHME 100MG N205053 001 Nov 25, 2013
POSACONAZOLE
AB ACTAVIS LABS FL INC 100MG A207355 001 Nov 30, 2022
AB AET PHARMA 100MG A213454 001 Feb 01, 2021
AB AMNEAL 100MG A216626 001 Dec 22, 2022
AB BIOCON PHARMA 100MG A214476 001 Feb 04, 2022
AB DR REDDYS 100MG A212500 001 Apr 07, 2022
AB HETERO LABS LTD III 100MG A214321 001 Dec 08, 2022
AB SINOTHERAPEUTICS 100MG A212411 001 Aug 21, 2019
INC
AB SPECGX LLC 100MG A212226 001 May 10, 2022
POTASSIUM ACETATE
INJECTABLE;INJECTION
POTASSIUM ACETATE
AP EXELA PHARMA 2MEQ/ML A206203 001 Dec 29, 2015
AP +! HOSPIRA 2MEQ/ML N018896 001 Jul 20, 1984
POTASSIUM CHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
KLOR-CON
AB UPSHER SMITH LABS 8MEQ A203106 001 Jul 10, 2015
AB 10MEQ A203106 002 Jul 10, 2015
POTASSIUM CHLORIDE
AB ACTAVIS LABS FL INC 8MEQ A077419 001 Jun 02, 2008
AB ! 10MEQ A077419 002 Jun 02, 2008
AB ADARE PHARMS INC 8MEQ A208864 001 Mar 17, 2017
AB 10MEQ A208864 002 Mar 17, 2017
AB AMNEAL PHARMS 10MEQ A202128 001 Feb 22, 2013
AB ANCHEN PHARMS 8MEQ A202886 001 Dec 26, 2013
AB 10MEQ A202886 002 Dec 26, 2013
AB GLENMARK PHARMS LTD 10MEQ A202868 001 Jan 19, 2016
AB GRANULES 8MEQ A214686 001 Feb 16, 2021
AB 10MEQ A214686 002 Feb 16, 2021
AB LUPIN LTD 8MEQ A203002 001 Dec 18, 2015
AB 10MEQ A203002 002 Dec 18, 2015
AB NOVEL LABS INC 8MEQ A204828 001 Aug 16, 2016
AB 10MEQ A204828 002 Aug 16, 2016
AB PADAGIS US 8MEQ A200185 001 May 18, 2011
AB 10MEQ A200185 002 May 18, 2011
AB PRINSTON INC 8MEQ A209026 001 Jun 11, 2019
AB 10MEQ A209026 002 Jun 11, 2019
AB STRIDES PHARMA 8MEQ A205549 001 Dec 08, 2015
AB 10MEQ A205549 002 Dec 08, 2015
AB ZYDUS PHARMS 8MEQ A208445 001 Mar 11, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-372(of 474)

POTASSIUM CHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
POTASSIUM CHLORIDE
AB 10MEQ A208445 002 Mar 11, 2019
FOR SOLUTION;ORAL
KLOR-CON
AA UPSHER SMITH LABS 20MEQ A209662 001 Oct 23, 2017
POTASSIUM CHLORIDE
AA AMNEAL 20MEQ A210902 001 May 23, 2019
AA BELCHER 20MEQ A212183 001 May 06, 2019
AA EPIC PHARMA LLC 20MEQ A210200 001 Nov 23, 2018
AA NOVEL LABS INC 20MEQ A210241 001 Nov 21, 2018
AA +! PHARMA RES SOFTWARE 20MEQ N208019 001 Aug 19, 2015
AA RUBICON 20MEQ A214108 001 Mar 24, 2022
AA STRIDES PHARMA 20MEQ A211667 001 Mar 11, 2021
INJECTABLE;INJECTION
POTASSIUM CHLORIDE
AP B BRAUN 2MEQ/ML A085870 001
AP +! HOSPIRA 2MEQ/ML A080205 001
POTASSIUM CHLORIDE 10MEQ
AP FRESENIUS KABI USA 14.9MG/ML A211087 001 Sep 09, 2020
AP 746MG/100ML A211087 002 Sep 09, 2020
AP NEXUS PHARMS 14.9MG/ML A214727 001 Mar 18, 2021
AP 745MG/100ML A214727 002 Mar 18, 2021
POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER
AP +! BAXTER HLTHCARE 14.9MG/ML N019904 001 Dec 26, 1989
AP +! 746MG/100ML N019904 005 Dec 17, 1990
AP +! ICU MEDICAL INC 14.9MG/ML N020161 005 Nov 30, 1992
AP +! 745MG/100ML N020161 001 Nov 30, 1992
POTASSIUM CHLORIDE 20MEQ
AP FRESENIUS KABI USA 29.8MG/ML A211087 003 Sep 09, 2020
AP 1.49GM/100ML A211087 005 May 07, 2021
AP NEXUS PHARMS 29.8MG/ML A214727 003 Mar 18, 2021
AP 1.49GM/100ML A214727 004 Mar 18, 2021
POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER
AP +! BAXTER HLTHCARE 29.8MG/ML N019904 002 Dec 26, 1989
AP +! 1.49GM/100ML N019904 006 Dec 17, 1990
AP +! ICU MEDICAL INC 29.8MG/ML N020161 006 Aug 11, 1998
AP +! 1.49GM/100ML N020161 002 Nov 30, 1992
POTASSIUM CHLORIDE 40MEQ
AP FRESENIUS KABI USA 2.98GM/100ML A211087 004 Sep 09, 2020
AP NEXUS PHARMS 2.98GM/100ML A214727 005 Mar 18, 2021
POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER
AP +! BAXTER HLTHCARE 2.98GM/100ML N019904 004 Dec 26, 1989
AP +! ICU MEDICAL INC 2.98GM/100ML N020161 004 Aug 11, 1998
POTASSIUM CHLORIDE IN PLASTIC CONTAINER
AP FRESENIUS KABI USA 2MEQ/ML A088901 001 Jan 25, 1985
AP 2MEQ/ML A088908 001 Jan 25, 1985
POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER
+! BAXTER HLTHCARE 2.24GM/100ML N019904 003 Dec 26, 1989
SOLUTION;ORAL
POTASSIUM CHLORIDE
AA AMNEAL 20MEQ/15ML A210041 001 Jul 19, 2018
AA 40MEQ/15ML A210041 002 Jul 19, 2018
AA APOTEX 20MEQ/15ML A211067 001 Aug 08, 2018
AA 40MEQ/15ML A211067 002 Aug 08, 2018
AA + GENUS LIFESCIENCES 20MEQ/15ML N206814 001 Dec 22, 2014
AA +! 40MEQ/15ML N206814 002 Dec 22, 2014
AA GRANULES 20MEQ/15ML A213392 001 Jan 29, 2021
AA 40MEQ/15ML A213392 002 Jan 29, 2021
AA GUARDIAN DRUG 20MEQ/15ML A214892 001 Dec 30, 2022
AA 40MEQ/15ML A214892 002 Dec 30, 2022
AA NOVEL LABS INC 20MEQ/15ML A209786 001 Aug 29, 2018
AA 40MEQ/15ML A209786 002 Aug 29, 2018
AA PHARM ASSOC 20MEQ/15ML A210766 001 Mar 29, 2019
AA 40MEQ/15ML A210766 002 Mar 29, 2019
AA RUBICON 20MEQ/15ML A214656 001 Jan 13, 2022
AA 40MEQ/15ML A214656 002 Jan 13, 2022
AA SAPTALIS PHARMS 20MEQ/15ML A211648 001 May 21, 2021
AA 40MEQ/15ML A211648 002 May 21, 2021
AA STRIDES PHARMA 40MEQ/15ML A211665 001 Nov 17, 2022
AA WES PHARMA INC 20MEQ/15ML A213062 001 Jun 06, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-373(of 474)

POTASSIUM CHLORIDE
SOLUTION;ORAL
POTASSIUM CHLORIDE
AA 40MEQ/15ML A213062 002 Jun 06, 2022
TABLET, EXTENDED RELEASE;ORAL
KLOR-CON M10
AB1 UPSHER SMITH LABS 10MEQ A074726 002 Aug 09, 2000
KLOR-CON M15
AB1 UPSHER SMITH LABS 15MEQ A074726 003 Jun 06, 2003
KLOR-CON M20
AB1 ! UPSHER SMITH LABS 20MEQ A074726 001 Nov 20, 1998
POTASSIUM CHLORIDE
AB1 ACTAVIS LABS FL INC 10MEQ A075604 001 Apr 10, 2002
AB1 20MEQ A075604 002 Apr 10, 2002
AB1 ADARE PHARMS INC 10MEQ A076368 002 Jun 05, 2019
AB1 20MEQ A076368 001 Aug 18, 2004
AB1 AMNEAL 10MEQ A212861 001 May 08, 2020
AB1 20MEQ A212861 003 May 08, 2020
AB1 ASCENT PHARMS INC 10MEQ A214422 001 Dec 29, 2020
AB1 15MEQ A214422 002 Dec 29, 2020
AB1 20MEQ A214422 003 Dec 29, 2020
AB1 GLENMARK PHARMS LTD 10MEQ A203562 001 Jul 26, 2016
AB1 20MEQ A203562 002 Jul 26, 2016
AB1 GRANULES 10MEQ A214452 001 Oct 21, 2020
AB1 20MEQ A214452 002 Oct 21, 2020
AB1 GUANGZHOU NOVAKEN 10MEQ A214395 001 Jan 28, 2021
AB1 20MEQ A214395 002 Jan 28, 2021
AB1 NOVEL LABS INC 10MEQ A206347 001 Jan 21, 2016
AB1 20MEQ A206347 002 Jan 21, 2016
AB1 PRINSTON INC 10MEQ A209922 001 Apr 30, 2019
AB1 15MEQ A209922 002 Apr 30, 2019
AB1 20MEQ A209922 003 Apr 30, 2019
AB1 ZYDUS PHARMS 10MEQ A210395 001 Sep 17, 2020
AB1 20MEQ A210395 002 Sep 17, 2020
KLOR-CON
AB2 + UPSHER SMITH LABS 8MEQ N019123 001 Apr 17, 1986
AB2 +! 10MEQ N019123 002 Apr 17, 1986
POTASSIUM CHLORIDE
AB2 AUROBINDO PHARMA 8MEQ A210921 001 Dec 19, 2018
AB2 10MEQ A210921 002 Dec 19, 2018
AB2 GRANULES 8MEQ A211797 001 Mar 04, 2020
AB2 10MEQ A211797 002 Mar 04, 2020
AB2 MYLAN 8MEQ A204662 001 Aug 21, 2014
AB2 10MEQ A204662 002 Aug 21, 2014
AB2 NOVEL LABS INC 8MEQ A206759 001 Aug 09, 2016
AB2 10MEQ A206759 002 Aug 09, 2016
AB2 PADAGIS US 8MEQ A205993 001 Nov 05, 2015
AB2 10MEQ A205993 002 Nov 05, 2015
AB2 STRIDES PHARMA 8MEQ A210733 001 Aug 31, 2018
AB2 10MEQ A210733 002 Aug 31, 2018
AB2 YICHANG HUMANWELL 8MEQ A209314 001 Jun 22, 2018
AB2 10MEQ A209314 002 Jun 22, 2018
K-TAB
AB3 + ABBVIE 10MEQ N018279 001
AB3 +! 20MEQ N018279 003 Nov 25, 2013
POTASSIUM CHLORIDE
AB3 RUBICON 10MEQ A215725 001 Jul 25, 2022
AB3 20MEQ A215725 002 Jul 25, 2022
AB3 VITRUVIAS THERAP 10MEQ A209688 001 Jan 12, 2018
AB3 20MEQ A209688 002 Jan 12, 2018
AB3 YICHANG HUMANWELL 10MEQ A212561 001 Sep 30, 2019
AB3 20MEQ A212561 002 Sep 30, 2019
POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE;INJECTION
POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
AP ICU MEDICAL INC 149MG/100ML;450MG/100ML A078446 001 Sep 10, 2008
POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45%
AP +! BAXTER HLTHCARE 150MG/100ML;450MG/100ML N017648 005 Nov 26, 2002
AP FRESENIUS KABI USA 150MG/100ML;450MG/100ML A212347 001 Sep 17, 2020
POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9%
AP +! BAXTER HLTHCARE 150MG/100ML;900MG/100ML N017648 001
AP FRESENIUS KABI USA 150MG/100ML;900MG/100ML A212347 003 Jun 02, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-374(of 474)

POTASSIUM CHLORIDE; SODIUM CHLORIDE


INJECTABLE;INJECTION
POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP B BRAUN 150MG/100ML;900MG/100ML N019708 004 Sep 29, 1989
POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9%
AP +! BAXTER HLTHCARE 300MG/100ML;900MG/100ML N017648 002
AP FRESENIUS KABI USA 300MG/100ML;900MG/100ML A212347 002 Sep 17, 2020
POTASSIUM CHLORIDE 20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP ICU MEDICAL INC 149MG/100ML;900MG/100ML N019686 001 Oct 17, 1988
POTASSIUM CHLORIDE 40MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP ICU MEDICAL INC 298MG/100ML;900MG/100ML N019686 002 Oct 17, 1988
POTASSIUM CITRATE
TABLET, EXTENDED RELEASE;ORAL
POTASSIUM CITRATE
AB ANI PHARMS 10MEQ A212779 001 Jan 14, 2020
AB 15MEQ A212779 002 Jan 14, 2020
AB ASCENT PHARMS INC 5MEQ A214420 001 Feb 05, 2021
AB 10MEQ A214420 002 Feb 05, 2021
AB 15MEQ A214420 003 Feb 05, 2021
AB BIONPHARMA INC 10MEQ A212799 001 Jun 29, 2020
AB 15MEQ A212799 002 Jun 29, 2020
AB EYWA 5MEQ A214426 001 Feb 19, 2021
AB 10MEQ A214426 002 Feb 19, 2021
AB 15MEQ A214426 003 Feb 19, 2021
AB RISING 5MEQ A077440 001 Jun 09, 2006
AB 10MEQ A077440 002 Jun 09, 2006
AB STRIDES PHARMA 5MEQ A206813 001 Sep 11, 2017
AB 10MEQ A206813 002 Sep 11, 2017
AB 15MEQ A206813 003 Sep 11, 2017
AB TEVA PHARMS USA INC 5MEQ A209758 001 Mar 05, 2018
AB 10MEQ A209758 002 Mar 05, 2018
AB 15MEQ A209758 003 Mar 05, 2018
AB ZYDUS PHARMS 5MEQ A203546 001 Aug 06, 2014
AB 10MEQ A203546 002 Aug 06, 2014
AB 15MEQ A203546 003 Aug 06, 2014
UROCIT-K
AB + MISSION PHARMA 5MEQ N019071 001 Aug 30, 1985
AB + 10MEQ N019071 002 Aug 31, 1992
AB +! 15MEQ N019071 003 Dec 30, 2009
POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC
SOLUTION;INTRAVENOUS
POTASSIUM PHOSPHATES
+! CMP DEV LLC 4.5GM/15ML (300MG/ML);2.65GM/15ML N212121 001 Sep 19, 2019
(175MG/ML)
+! FRESENIUS KABI USA 1.18GM/5ML (236MG/ML);1.12GM/5ML N212832 001 Nov 26, 2019
(224MG/ML)
+! 3.54GM/15ML (236MG/ML);3.36GM/15ML N212832 002 Nov 26, 2019
(224MG/ML)
+! 11.8GM/50ML (236MG/ML);11.2GM/50ML N212832 003 Nov 26, 2019
(224MG/ML)
POVIDONE-IODINE
SOLUTION/DROPS;OPHTHALMIC
BETADINE
+! ALCON PHARMS LTD 5% N018634 001 Dec 17, 1986
PRALATREXATE
SOLUTION;INTRAVENOUS
FOLOTYN
+ ACROTECH BIOPHARMA 20MG/ML (20MG/ML) N022468 001 Sep 24, 2009
+! 40MG/2ML (20MG/ML) N022468 002 Sep 24, 2009
PRALIDOXIME CHLORIDE
INJECTABLE;INJECTION
PROTOPAM CHLORIDE
+! BAXTER HLTHCARE 1GM/VIAL N014134 001
CORP
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-375(of 474)

PRALSETINIB
CAPSULE;ORAL
GAVRETO
+! GENENTECH INC 100MG N213721 001 Sep 04, 2020
PRAMIPEXOLE DIHYDROCHLORIDE
TABLET;ORAL
PRAMIPEXOLE DIHYDROCHLORIDE
AB AUROBINDO PHARMA 0.125MG A202633 001 Oct 26, 2012
LTD
AB 0.25MG A202633 002 Oct 26, 2012
AB 0.5MG A202633 003 Oct 26, 2012
AB 0.75MG A202633 004 Oct 26, 2012
AB 1MG A202633 005 Oct 26, 2012
AB 1.5MG A202633 006 Oct 26, 2012
AB GLENMARK GENERICS 0.125MG A090781 001 Oct 08, 2010
AB ! 0.25MG A090781 002 Oct 08, 2010
AB 0.5MG A090781 003 Oct 08, 2010
AB 0.75MG A090781 006 Sep 11, 2015
AB 1MG A090781 004 Oct 08, 2010
AB 1.5MG A090781 005 Oct 08, 2010
AB RISING 0.25MG A211088 001 Oct 03, 2018
AB 0.5MG A211088 002 Oct 03, 2018
AB 0.75MG A211088 003 Oct 03, 2018
AB 1MG A211088 004 Oct 03, 2018
AB 1.5MG A211088 005 Oct 03, 2018
AB SCIEGEN PHARMS INC 0.125MG A203855 001 Oct 28, 2014
AB 0.25MG A203855 002 Oct 28, 2014
AB 0.5MG A203855 003 Oct 28, 2014
AB 0.75MG A203855 004 Oct 28, 2014
AB 1MG A203855 005 Oct 28, 2014
AB 1.5MG A203855 006 Oct 28, 2014
AB STRIDES PHARMA 0.125MG A202702 001 Jun 03, 2014
AB 0.25MG A202702 002 Jun 03, 2014
AB 0.5MG A202702 003 Jun 03, 2014
AB 0.75MG A202702 004 Jun 03, 2014
AB 1MG A202702 005 Jun 03, 2014
AB 1.5MG A202702 006 Jun 03, 2014
AB TORRENT PHARMS 0.125MG A090865 001 Oct 08, 2010
AB 0.25MG A090865 002 Oct 08, 2010
AB 0.5MG A090865 003 Oct 08, 2010
AB 0.75MG A090865 004 Oct 08, 2010
AB 1MG A090865 005 Oct 08, 2010
AB 1.5MG A090865 006 Oct 08, 2010
AB ZENNOVA 0.125MG A090151 001 Apr 30, 2012
AB 0.25MG A090151 002 Apr 30, 2012
AB 0.5MG A090151 003 Apr 30, 2012
AB 0.75MG A090151 006 Apr 30, 2012
AB 1MG A090151 004 Apr 30, 2012
AB 1.5MG A090151 005 Apr 30, 2012
AB ZYDUS PHARMS USA 0.125MG A078920 001 Jul 06, 2010
INC
AB 0.25MG A078920 002 Jul 06, 2010
AB 0.5MG A078920 003 Jul 06, 2010
AB 0.75MG A078920 006 Nov 23, 2022
AB 1MG A078920 004 Jul 06, 2010
AB 1.5MG A078920 005 Jul 06, 2010
TABLET, EXTENDED RELEASE;ORAL
MIRAPEX ER
AB +! BOEHRINGER 0.375MG N022421 001 Feb 19, 2010
INGELHEIM
AB + 0.75MG N022421 002 Feb 19, 2010
AB + 1.5MG N022421 003 Feb 19, 2010
AB + 2.25MG N022421 006 Jun 17, 2011
AB + 3MG N022421 004 Feb 19, 2010
AB + 3.75MG N022421 007 Jun 17, 2011
AB + 4.5MG N022421 005 Feb 19, 2010
PRAMIPEXOLE DIHYDROCHLORIDE
AB ACTAVIS ELIZABETH 0.375MG A201963 001 Apr 21, 2016
AB 0.75MG A201963 002 Apr 21, 2016
AB 1.5MG A201963 003 Apr 21, 2016
AB 2.25MG A203615 001 Oct 14, 2016
AB 3MG A201963 004 Apr 21, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-376(of 474)

PRAMIPEXOLE DIHYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
PRAMIPEXOLE DIHYDROCHLORIDE
AB 3.75MG A203615 002 Jan 03, 2017
AB 4.5MG A201963 005 Apr 21, 2016
AB ALEMBIC PHARMS 0.375MG A204518 001 Jan 02, 2019
AB 0.75MG A204518 002 Jan 02, 2019
AB 1.5MG A204518 003 Jan 02, 2019
AB 2.25MG A204518 004 Jan 02, 2019
AB 3MG A204518 005 Jan 02, 2019
AB 3.75MG A204518 006 Jan 02, 2019
AB 4.5MG A204518 007 Jan 02, 2019
AB DR REDDYS 0.375MG A203354 001 Aug 07, 2015
AB 0.75MG A203354 002 Aug 07, 2015
AB 1.5MG A203354 003 Aug 07, 2015
AB 3MG A203354 004 Aug 07, 2015
AB 4.5MG A203354 005 Aug 07, 2015
AB MACLEODS PHARMS LTD 0.375MG A206156 001 Jun 24, 2016
AB 0.75MG A206156 002 Jun 24, 2016
AB 1.5MG A206156 003 Jun 24, 2016
AB 2.25MG A206156 004 Jun 24, 2016
AB 3MG A206156 005 Jun 24, 2016
AB 3.75MG A206156 007 Jan 23, 2017
AB 4.5MG A206156 006 Jun 24, 2016
AB NOVAST LABS 0.375MG A213444 001 Feb 03, 2022
AB 0.75MG A213444 002 Feb 03, 2022
AB 1.5MG A213444 003 Feb 03, 2022
AB 2.25MG A213444 004 Feb 03, 2022
AB 3MG A213444 005 Feb 03, 2022
AB 3.75MG A213444 006 Feb 03, 2022
AB 4.5MG A213444 007 Feb 03, 2022
AB SANDOZ INC 0.375MG A202353 001 Dec 04, 2014
AB 0.75MG A202353 002 Dec 04, 2014
AB 1.5MG A202353 003 Dec 04, 2014
AB 3MG A202353 004 Dec 04, 2014
AB 4.5MG A202353 005 Dec 04, 2014
AB XIAMEN LP PHARM CO 0.375MG A212797 001 Jun 11, 2021
AB 0.75MG A212797 002 Jun 11, 2021
AB ZYDUS PHARMS 0.375MG A202891 001 Dec 12, 2017
AB 0.75MG A202891 002 Dec 12, 2017
AB 1.5MG A202891 003 Dec 12, 2017
AB 2.25MG A202891 004 Dec 12, 2017
AB 3MG A202891 005 Dec 12, 2017
AB 3.75MG A202891 006 Dec 12, 2017
AB 4.5MG A202891 007 Dec 12, 2017
PRAMLINTIDE ACETATE
INJECTABLE;SUBCUTANEOUS
SYMLIN
+ ASTRAZENECA AB EQ 1.5MG BASE/1.5ML (EQ 1MG BASE/ML) N021332 002 Sep 25, 2007
+! EQ 2.7MG BASE/2.7ML (EQ 1MG BASE/ML) N021332 003 Sep 25, 2007
PRASTERONE
INSERT;VAGINAL
INTRAROSA
+! MILLICENT 6.5MG N208470 001 Nov 16, 2016
PRASUGREL
TABLET;ORAL
PRASUGREL HYDROCHLORIDE
AB LUPIN LTD EQ 5MG BASE A205930 001 Jan 09, 2023
AB EQ 10MG BASE A205930 002 Jan 09, 2023
PRASUGREL HYDROCHLORIDE
TABLET;ORAL
EFFIENT
AB + COSETTE EQ 5MG BASE N022307 001 Jul 10, 2009
AB +! EQ 10MG BASE N022307 002 Jul 10, 2009
PRASUGREL
AB ACCORD HLTHCARE EQ 5MG BASE A205987 001 Feb 02, 2018
AB EQ 10MG BASE A205987 002 Feb 02, 2018
AB AUROBINDO PHARMA EQ 5MG BASE A205888 001 Oct 16, 2017
AB EQ 10MG BASE A205888 002 Oct 16, 2017
AB HEC PHARM EQ 5MG BASE A206021 001 Jan 16, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-377(of 474)

PRASUGREL HYDROCHLORIDE
TABLET;ORAL
PRASUGREL
AB EQ 10MG BASE A206021 002 Jan 16, 2019
AB MYLAN EQ 5MG BASE A205927 001 Jul 12, 2017
AB EQ 10MG BASE A205927 002 Jul 12, 2017
AB PANACEA EQ 5MG BASE A205897 001 Oct 16, 2017
AB EQ 10MG BASE A205897 002 Oct 16, 2017
BX AMNEAL PHARMS EQ 5MG BASE A205913 001 Jun 19, 2018
BX EQ 10MG BASE A205913 002 Jun 19, 2018
PRAVASTATIN SODIUM
TABLET;ORAL
PRAVASTATIN SODIUM
AB ACCORD HLTHCARE 10MG A207068 001 Nov 17, 2016
AB 20MG A207068 002 Nov 17, 2016
AB 40MG A207068 003 Nov 17, 2016
AB 80MG A207068 004 Nov 17, 2016
AB APNAR PHARMA LP 10MG A077491 002 Oct 23, 2006
AB 20MG A077491 003 Oct 23, 2006
AB 40MG A077491 004 Oct 23, 2006
AB 80MG A077491 001 Feb 11, 2008
AB APOTEX 10MG A076341 001 Oct 23, 2006
AB 20MG A076341 002 Oct 23, 2006
AB 40MG A076341 003 Oct 23, 2006
AB 80MG A076341 004 Dec 28, 2007
AB AUROBINDO PHARMA 10MG A203367 001 Feb 02, 2017
AB 20MG A203367 002 Feb 02, 2017
AB 40MG A203367 003 Feb 02, 2017
AB 80MG A203367 004 Feb 02, 2017
AB BIOCON PHARMA 10MG A209869 001 Apr 13, 2018
AB 20MG A209869 002 Apr 13, 2018
AB 40MG A209869 003 Apr 13, 2018
AB 80MG A209869 004 Apr 13, 2018
AB CIPLA 10MG A077904 001 Oct 23, 2006
AB 20MG A077904 002 Oct 23, 2006
AB 40MG A077904 003 Oct 23, 2006
AB 80MG A077904 004 Mar 22, 2016
AB DR REDDYS LABS INC 10MG A076714 001 Oct 23, 2006
AB 20MG A076714 002 Oct 23, 2006
AB 40MG A076714 003 Oct 23, 2006
AB 80MG A076714 004 Dec 28, 2007
AB GLENMARK GENERICS 10MG A077987 001 May 11, 2007
AB 20MG A077987 002 May 11, 2007
AB 40MG A077987 003 May 11, 2007
AB 80MG A077987 004 Dec 28, 2007
AB LUPIN PHARMS 10MG A077917 001 Jan 08, 2008
AB 20MG A077917 002 Jan 08, 2008
AB 40MG A077917 003 Jan 08, 2008
AB 80MG A077917 004 Jan 08, 2008
AB TEVA 10MG A076056 001 Apr 24, 2006
AB 20MG A076056 002 Apr 24, 2006
AB 40MG A076056 003 Apr 24, 2006
AB ! TEVA PHARMS 80MG A077793 001 Jan 15, 2008
AB WATSON LABS 10MG A076939 004 Oct 23, 2006
AB 20MG A076939 003 Oct 23, 2006
AB 40MG A076939 002 Oct 23, 2006
AB 80MG A076939 001 Dec 28, 2007
AB ZYDUS PHARMS USA 20MG A077751 002 Apr 30, 2008
AB 40MG A077751 003 Apr 30, 2008
AB 80MG A077751 004 Apr 30, 2008
PRAZIQUANTEL
TABLET;ORAL
BILTRICIDE
AB +! BAYER HLTHCARE 600MG N018714 001 Dec 29, 1982
PRAZIQUANTEL
AB PAR PHARM INC 600MG A208820 001 Nov 27, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-378(of 474)

PRAZOSIN HYDROCHLORIDE
CAPSULE;ORAL
MINIPRESS
AB + PFIZER EQ 1MG BASE N017442 002
AB +! EQ 2MG BASE N017442 003
AB + EQ 5MG BASE N017442 001
PRAZOSIN HYDROCHLORIDE
AB APPCO EQ 1MG BASE A213406 001 Oct 21, 2022
AB EQ 2MG BASE A213406 002 Oct 21, 2022
AB EQ 5MG BASE A213406 003 Oct 21, 2022
AB GRANULES EQ 1MG BASE A214608 001 Dec 23, 2021
AB EQ 2MG BASE A214608 002 Dec 23, 2021
AB EQ 5MG BASE A214608 003 Dec 23, 2021
AB MANKIND PHARMA EQ 1MG BASE A215697 001 Dec 30, 2022
AB EQ 2MG BASE A215697 002 Dec 30, 2022
AB EQ 5MG BASE A215697 003 Dec 30, 2022
AB MYLAN EQ 1MG BASE A072575 003 May 16, 1989
AB EQ 2MG BASE A072575 002 May 16, 1989
AB EQ 5MG BASE A072575 001 May 16, 1989
AB NOVITIUM PHARMA EQ 1MG BASE A210971 001 Oct 03, 2018
AB EQ 2MG BASE A210971 002 Oct 03, 2018
AB EQ 5MG BASE A210971 003 Oct 03, 2018
AB TEVA PHARMS EQ 1MG BASE A071745 002 Sep 12, 1988
AB EQ 2MG BASE A071745 003 Sep 12, 1988
AB EQ 5MG BASE A071745 001 Sep 12, 1988
PREDNICARBATE
OINTMENT;TOPICAL
PREDNICARBATE
! FOUGERA PHARMS 0.1% A077236 001 Mar 09, 2007
PREDNISOLONE
SYRUP;ORAL
PREDNISOLONE
AA ! AKORN 15MG/5ML A040401 001 Feb 27, 2003
AA CHARTWELL RX 15MG/5ML A040323 001 May 13, 1999
AA LANNETT CO INC 15MG/5ML A040775 001 Sep 21, 2007
AA PHARM ASSOC 15MG/5ML A040399 001 Mar 05, 2003
AA WOCKHARDT BIO AG 15MG/5ML A040313 001 Sep 10, 2003
PRELONE
AA TEVA 15MG/5ML A089081 001 Feb 04, 1986
TABLET;ORAL
PREDNISOLONE
+! WATSON LABS 5MG A080354 001
PREDNISOLONE ACETATE
SUSPENSION/DROPS;OPHTHALMIC
OMNIPRED
AB +! NOVARTIS 1% N017469 001
PRED FORTE
AB +! ALLERGAN 1% N017011 001
PRED MILD
+! ALLERGAN 0.12% N017100 001
PREDNISOLONE SODIUM PHOSPHATE
SOLUTION;ORAL
PEDIAPRED
AA +! SETON PHARM EQ 5MG BASE/5ML N019157 001 May 28, 1986
PREDNISOLONE SODIUM PHOSPHATE
AA AKORN EQ 5MG BASE/5ML A075183 001 Mar 26, 2003
AA AMNEAL EQ 15MG BASE/5ML A216715 001 Oct 25, 2022
AA CHARTWELL RX EQ 5MG BASE/5ML A075988 001 May 25, 2004
AA EDENBRIDGE PHARMS EQ 10MG BASE/5ML A203559 001 Dec 20, 2016
AA EQ 20MG BASE/5ML A203559 002 Dec 20, 2016
AA ! PHARM ASSOC EQ 10MG BASE/5ML A078465 001 Mar 07, 2008
AA EQ 15MG BASE/5ML A076913 001 Apr 25, 2005
AA ! EQ 20MG BASE/5ML A078988 001 Jun 09, 2008
AA WOCKHARDT BIO AG EQ 5MG BASE/5ML A075099 001 Jun 28, 2002
AA ! EQ 15MG BASE/5ML A076895 001 Oct 04, 2004
! MISSION PHARMA EQ 25MG BASE/5ML A091396 001 Sep 13, 2010
PHARM ASSOC EQ 30MG BASE/5ML A204962 001 Mar 11, 2020
SOLUTION/DROPS;OPHTHALMIC
PREDNISOLONE SODIUM PHOSPHATE
! BAUSCH AND LOMB EQ 0.9% PHOSPHATE A040070 001 Jul 29, 1994
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-379(of 474)

PREDNISOLONE SODIUM PHOSPHATE


TABLET, ORALLY DISINTEGRATING;ORAL
ORAPRED ODT
+ CONCORDIA PHARMS EQ 10MG BASE N021959 001 Jun 01, 2006
INC
+ EQ 15MG BASE N021959 002 Jun 01, 2006
+! EQ 30MG BASE N021959 003 Jun 01, 2006
PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM
SOLUTION/DROPS;OPHTHALMIC
SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE
! BAUSCH AND LOMB EQ 0.23% PHOSPHATE;10% A074449 001 Dec 29, 1995
PREDNISONE
SOLUTION;ORAL
PREDNISONE
+! HIKMA 5MG/5ML A088703 001 Nov 08, 1984
PREDNISONE INTENSOL
! HIKMA 5MG/ML A088810 001 Feb 20, 1985
TABLET;ORAL
PREDNISONE
AB AMNEAL 1MG A213385 001 Jun 16, 2020
AB 5MG A213385 002 Jun 16, 2020
AB 10MG A213386 001 Jun 24, 2020
AB 20MG A213386 002 Jun 24, 2020
AB AUROBINDO PHARMA 1MG A215671 001 Nov 16, 2021
LTD
AB 2.5MG A215672 001 Mar 28, 2022
AB 5MG A215672 002 Mar 28, 2022
AB 10MG A215672 003 Mar 28, 2022
AB 20MG A215672 004 Mar 28, 2022
AB 50MG A215672 005 Mar 28, 2022
AB GENEYORK PHARMS 1MG A211496 001 Dec 28, 2018
AB 2.5MG A211495 001 Dec 07, 2018
AB 5MG A211495 002 Dec 07, 2018
AB 10MG A210525 001 Dec 04, 2018
AB 20MG A210525 002 Dec 04, 2018
AB 50MG A210525 003 Dec 04, 2018
AB +! HIKMA 1MG A087800 001 Apr 22, 1982
AB ! 2.5MG A087801 001 Apr 22, 1982
AB ! 5MG A080352 001
AB +! 10MG A084122 001
AB +! 20MG A087342 001
AB ! 50MG A084283 001
AB JUBILANT CADISTA 1MG A040611 001 Jun 06, 2005
AB 5MG A040362 002 Aug 29, 2001
AB 10MG A040362 001 Aug 29, 2001
AB 20MG A040362 003 Jun 29, 2005
AB MYLAN 5MG A080292 001
AB 10MG A088832 001 Dec 04, 1985
AB 20MG A083677 001
AB NOVITIUM PHARMA 1MG A215246 001 Jul 06, 2021
AB 2.5MG A211575 001 Nov 15, 2019
AB 5MG A211575 002 Nov 15, 2019
AB 10MG A211575 003 Nov 15, 2019
AB 20MG A211575 004 Nov 15, 2019
AB 50MG A211575 005 Nov 15, 2019
AB STRIDES PHARMA 1MG A210785 001 Sep 02, 2020
AB 2.5MG A209727 001 Nov 20, 2020
AB 5MG A209727 002 Nov 20, 2020
AB 10MG A208412 001 Feb 11, 2021
AB 20MG A208412 002 Feb 11, 2021
AB 50MG A208412 003 Jan 11, 2022
AB SUN PHARM 5MG A089247 002 Dec 04, 1985
INDUSTRIES
AB 10MG A089247 003 Dec 04, 1985
AB 20MG A089247 001 Dec 04, 1985
AB VINTAGE PHARMS 1MG A040584 001 Dec 21, 2004
AB 2.5MG A040581 001 Dec 21, 2004
AB 5MG A040256 001 Jul 12, 2002
AB 10MG A040256 002 Jul 12, 2002
AB 20MG A040392 001 Feb 12, 2003
AB WATSON LABS 5MG A080356 001
AB 10MG A085162 001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-380(of 474)

PREDNISONE
TABLET;ORAL
PREDNISONE
AB 20MG A085161 001
TABLET, DELAYED RELEASE;ORAL
PREDNISONE
AB ACTAVIS LABS FL INC 1MG A204867 001 Apr 25, 2017
AB 2MG A204867 002 Apr 25, 2017
AB 5MG A204867 003 Apr 25, 2017
RAYOS
AB + HORIZON 1MG N202020 001 Jul 26, 2012
AB + 2MG N202020 002 Jul 26, 2012
AB +! 5MG N202020 003 Jul 26, 2012
PREGABALIN
CAPSULE;ORAL
LYRICA
AB + UPJOHN 25MG N021446 001 Dec 30, 2004
AB + 50MG N021446 002 Dec 30, 2004
AB + 75MG N021446 003 Dec 30, 2004
AB + 100MG N021446 004 Dec 30, 2004
AB + 150MG N021446 005 Dec 30, 2004
AB + 200MG N021446 006 Dec 30, 2004
AB + 225MG N021446 007 Dec 30, 2004
AB +! 300MG N021446 008 Dec 30, 2004
PREGABALIN
AB ACTAVIS ELIZABETH 25MG A091025 001 Jul 09, 2020
AB 50MG A091025 002 Jul 09, 2020
AB 75MG A091025 003 Jul 09, 2020
AB 100MG A091025 004 Jul 09, 2020
AB 150MG A091025 005 Jul 09, 2020
AB 200MG A091025 006 Jul 09, 2020
AB 225MG A091025 007 Jul 09, 2020
AB 300MG A091025 008 Jul 09, 2020
AB ALEMBIC PHARMS 25MG A203459 001 Jul 19, 2019
AB 50MG A203459 002 Jul 19, 2019
AB 75MG A203459 003 Jul 19, 2019
AB 100MG A203459 004 Jul 19, 2019
AB 150MG A203459 005 Jul 19, 2019
AB 200MG A203459 006 Jul 19, 2019
AB 225MG A203459 007 Jul 19, 2019
AB 300MG A203459 008 Jul 19, 2019
AB ALKEM LABS LTD 25MG A207799 007 Sep 30, 2019
AB 50MG A207799 008 Sep 30, 2019
AB 75MG A207799 001 Jul 19, 2019
AB 100MG A207799 002 Jul 19, 2019
AB 150MG A207799 003 Jul 19, 2019
AB 200MG A207799 004 Jul 19, 2019
AB 225MG A207799 005 Jul 19, 2019
AB 300MG A207799 006 Jul 19, 2019
AB AMNEAL PHARMS CO 25MG A209743 001 Jul 19, 2019
AB 50MG A209743 002 Jul 19, 2019
AB 75MG A209743 003 Jul 19, 2019
AB 100MG A209743 004 Jul 19, 2019
AB 150MG A209743 005 Jul 19, 2019
AB 200MG A209743 006 Jul 19, 2019
AB 225MG A209743 007 Jul 19, 2019
AB 300MG A209743 008 Jul 19, 2019
AB APOTEX 25MG A211685 001 Jul 07, 2021
AB 50MG A211685 002 Jul 07, 2021
AB 75MG A211685 003 Jul 07, 2021
AB 100MG A211685 004 Jul 07, 2021
AB 150MG A211685 005 Jul 07, 2021
AB 200MG A211685 006 Jul 07, 2021
AB 225MG A211685 007 Jul 07, 2021
AB 300MG A211685 008 Jul 07, 2021
AB CELLTRION 50MG A212865 001 Mar 20, 2020
AB 75MG A212865 002 Mar 20, 2020
AB 100MG A212865 003 Mar 20, 2020
AB 150MG A212865 004 Mar 20, 2020
AB CHANGZHOU PHARM 50MG A214322 001 Jul 15, 2021
AB 75MG A214322 002 Jul 15, 2021
AB 100MG A214322 003 Jul 15, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-381(of 474)

PREGABALIN
CAPSULE;ORAL
PREGABALIN
AB 150MG A214322 004 Jul 15, 2021
AB 200MG A214322 005 Jul 15, 2021
AB 225MG A214322 006 Jul 15, 2021
AB 300MG A214322 007 Jul 15, 2021
AB CIPLA 25MG A212280 001 Jan 10, 2020
AB 50MG A212280 002 Jan 10, 2020
AB 75MG A212280 003 Jan 10, 2020
AB 100MG A212280 004 Jan 10, 2020
AB 150MG A212280 005 Jan 10, 2020
AB 200MG A212280 006 Jan 10, 2020
AB 225MG A212280 007 Jan 10, 2020
AB 300MG A212280 008 Jan 10, 2020
AB DR REDDYS 25MG A209664 001 Jul 19, 2019
AB 50MG A209664 002 Jul 19, 2019
AB 75MG A209664 003 Jul 19, 2019
AB 100MG A209664 004 Jul 19, 2019
AB 150MG A209664 005 Jul 19, 2019
AB 200MG A209664 006 Jul 19, 2019
AB 225MG A209664 007 Jul 19, 2019
AB 300MG A209664 008 Jul 19, 2019
AB ESKAYEF 25MG A212988 001 Mar 08, 2022
AB 50MG A212988 002 Mar 08, 2022
AB 75MG A212988 003 Mar 08, 2022
AB 100MG A212988 004 Mar 08, 2022
AB 150MG A212988 005 Mar 08, 2022
AB 200MG A212988 006 Mar 08, 2022
AB 225MG A212988 007 Mar 08, 2022
AB 300MG A212988 008 Mar 08, 2022
AB HETERO LABS LTD III 25MG A206912 001 Oct 08, 2019
AB 50MG A206912 002 Oct 08, 2019
AB 75MG A206912 003 Oct 08, 2019
AB 100MG A206912 004 Oct 08, 2019
AB 150MG A206912 005 Oct 08, 2019
AB 200MG A206912 006 Oct 08, 2019
AB 225MG A206912 007 Oct 08, 2019
AB 300MG A206912 008 Oct 08, 2019
AB HIKAL 25MG A213423 001 Mar 23, 2020
AB 50MG A213423 002 Mar 23, 2020
AB 75MG A213423 003 Mar 23, 2020
AB 100MG A213423 004 Mar 23, 2020
AB 150MG A213423 005 Mar 23, 2020
AB 200MG A213423 006 Mar 23, 2020
AB 225MG A213423 007 Mar 23, 2020
AB 300MG A213423 008 Mar 23, 2020
AB INVAGEN PHARMS 25MG A211384 001 Jul 19, 2019
AB 50MG A211384 002 Jul 19, 2019
AB 75MG A211384 003 Jul 19, 2019
AB 100MG A211384 004 Jul 19, 2019
AB 150MG A211384 005 Jul 19, 2019
AB 200MG A211384 006 Jul 19, 2019
AB 225MG A211384 007 Jul 19, 2019
AB 300MG A211384 008 Jul 19, 2019
AB MARKSANS PHARMA 25MG A216197 001 Jul 18, 2022
AB 50MG A216197 002 Jul 18, 2022
AB 75MG A216197 003 Jul 18, 2022
AB 100MG A216197 004 Jul 18, 2022
AB 150MG A216197 005 Jul 18, 2022
AB 200MG A216197 006 Jul 18, 2022
AB 225MG A216197 007 Jul 18, 2022
AB 300MG A216197 008 Jul 18, 2022
AB MSN 25MG A209357 001 Jul 19, 2019
AB 50MG A209357 002 Jul 19, 2019
AB 75MG A209357 003 Jul 19, 2019
AB 100MG A209357 004 Jul 19, 2019
AB 150MG A209357 005 Jul 19, 2019
AB 200MG A209357 006 Jul 19, 2019
AB 225MG A209357 007 Jul 19, 2019
AB 300MG A209357 008 Jul 19, 2019
AB PRINSTON INC 25MG A207883 001 Sep 01, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-382(of 474)

PREGABALIN
CAPSULE;ORAL
PREGABALIN
AB 50MG A207883 002 Sep 01, 2022
AB 75MG A207883 003 Sep 01, 2022
AB 100MG A207883 004 Sep 01, 2022
AB 150MG A207883 005 Sep 01, 2022
AB 200MG A207883 006 Sep 01, 2022
AB 225MG A207883 007 Sep 01, 2022
AB 300MG A207883 008 Sep 01, 2022
AB RENATA 50MG A210585 001 Dec 26, 2019
AB 75MG A210585 002 Dec 26, 2019
AB 100MG A210585 003 Dec 26, 2019
AB 150MG A210585 004 Dec 26, 2019
AB 200MG A210585 005 Dec 26, 2019
AB 300MG A210585 006 Dec 26, 2019
AB RISING 25MG A210432 001 Jul 19, 2019
AB 50MG A210432 002 Jul 19, 2019
AB 75MG A210432 003 Jul 19, 2019
AB 100MG A210432 004 Jul 19, 2019
AB 150MG A210432 005 Jul 19, 2019
AB 200MG A210432 006 Jul 19, 2019
AB 225MG A210432 007 Jul 19, 2019
AB 300MG A210432 008 Jul 19, 2019
AB SCIEGEN PHARMS INC 25MG A208677 001 Jul 19, 2019
AB 50MG A208677 002 Jul 19, 2019
AB 75MG A208677 003 Jul 19, 2019
AB 100MG A208677 004 Jul 19, 2019
AB 150MG A208677 005 Jul 19, 2019
AB 200MG A208677 006 Jul 19, 2019
AB 225MG A208677 007 Jul 19, 2019
AB 300MG A208677 008 Jul 19, 2019
AB SHUANGCHENG 75MG A210891 001 Sep 30, 2019
AB 300MG A210891 002 Sep 30, 2019
AB SUN PHARM 25MG A091157 001 Nov 29, 2019
AB 50MG A091157 002 Nov 29, 2019
AB 75MG A091157 003 Nov 29, 2019
AB 100MG A091157 004 Nov 29, 2019
AB 150MG A091157 005 Nov 29, 2019
AB 200MG A091157 006 Nov 29, 2019
AB 225MG A091157 007 Nov 29, 2019
AB 300MG A091157 008 Nov 29, 2019
AB TEVA PHARMS 25MG A091219 001 Jul 19, 2019
AB 50MG A091219 002 Jul 19, 2019
AB 75MG A091224 001 Jul 19, 2019
AB 100MG A091224 002 Jul 19, 2019
AB 150MG A091224 003 Jul 19, 2019
AB 200MG A091224 004 Jul 19, 2019
AB 225MG A091224 005 Jul 19, 2019
AB 300MG A091224 006 Jul 19, 2019
AB ZYDUS PHARMS 25MG A206752 001 Dec 09, 2022
AB 50MG A206752 002 Dec 09, 2022
AB 75MG A206752 003 Dec 09, 2022
AB 100MG A206752 004 Dec 09, 2022
AB 150MG A206752 005 Dec 09, 2022
AB 200MG A206752 006 Dec 09, 2022
AB 225MG A206752 007 Dec 09, 2022
AB 300MG A206752 008 Dec 09, 2022
SOLUTION;ORAL
LYRICA
AA +! UPJOHN 20MG/ML N022488 001 Jan 04, 2010
PREGABALIN
AA ALKEM LABS LTD 20MG/ML A207623 001 Jul 19, 2019
AA INVATECH 20MG/ML A212604 001 Feb 18, 2022
TABLET, EXTENDED RELEASE;ORAL
LYRICA CR
AB + UPJOHN 82.5MG N209501 001 Oct 11, 2017
AB + 165MG N209501 002 Oct 11, 2017
AB +! 330MG N209501 003 Oct 11, 2017
PREGABALIN
AB ALVOGEN 82.5MG A211593 001 Apr 13, 2021
AB 165MG A211593 002 Apr 13, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-383(of 474)

PREGABALIN
TABLET, EXTENDED RELEASE;ORAL
PREGABALIN
AB 330MG A211593 003 Apr 13, 2021
AB APOTEX 165MG A213313 001 Apr 13, 2021
AB 330MG A213313 002 Apr 13, 2021
AB MSN 82.5MG A213226 001 Apr 13, 2021
AB 165MG A213226 002 Apr 13, 2021
AB 330MG A213226 003 Apr 13, 2021
AB RUBICON 82.5MG A215249 001 Mar 22, 2022
AB 165MG A215249 002 Mar 22, 2022
AB 330MG A215249 003 Mar 22, 2022
AB SCIEGEN PHARMS INC 82.5MG A215675 001 Sep 14, 2022
AB 165MG A215675 002 Sep 14, 2022
AB 330MG A215675 003 Sep 14, 2022
AB SUN PHARM 82.5MG A211889 001 Apr 13, 2021
AB 165MG A211889 002 Apr 13, 2021
AB 330MG A211889 003 Apr 13, 2021
AB ZYDUS PHARMS 82.5MG A215577 001 Aug 26, 2022
AB 165MG A215577 002 Aug 26, 2022
AB 330MG A215577 003 Aug 26, 2022
PRETOMANID
TABLET;ORAL
PRETOMANID
+! MYLAN IRELAND LTD 200MG N212862 001 Aug 14, 2019
PRILOCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
PRILOCAINE HYDROCHLORIDE
! SEPTODONT INC 4% A079235 001 Sep 29, 2010
PRIMAQUINE PHOSPHATE
TABLET;ORAL
PRIMAQUINE
AB +! SANOFI AVENTIS US EQ 15MG BASE N008316 001
PRIMAQUINE PHOSPHATE
AB BAYSHORE PHARMS LLC EQ 15MG BASE A204476 001 Feb 25, 2014
AB NOVAST LABS EQ 15MG BASE A206043 001 Jun 23, 2016
PRIMIDONE
TABLET;ORAL
MYSOLINE
AB +! VALEANT 50MG N009170 003
AB + 250MG N009170 002
PRIMIDONE
AB AMNEAL PHARM 50MG A040866 001 Apr 23, 2008
AB 250MG A040866 002 Apr 23, 2008
AB ANDA REPOSITORY 50MG A040626 001 Sep 29, 2005
AB 250MG A040626 002 Sep 29, 2005
AB LANNETT 50MG A084903 002 May 24, 2001
AB 250MG A084903 001
AB OXFORD PHARMS 50MG A040586 001 Feb 24, 2005
AB 250MG A040586 002 Feb 24, 2005
AB RUBICON 50MG A214896 001 Jun 28, 2022
AB 125MG A214896 003 Dec 28, 2022
AB 250MG A214896 002 Jun 28, 2022
AB WATSON LABS 250MG A083551 001
PROBENECID
TABLET;ORAL
PROBALAN
AB LANNETT 500MG A080966 001
PROBENECID
AB ! WATSON LABS TEVA 500MG A084442 004 Mar 29, 1983
PROCAINAMIDE HYDROCHLORIDE
INJECTABLE;INJECTION
PROCAINAMIDE HYDROCHLORIDE
AP ! HOSPIRA 100MG/ML A089069 001 Feb 12, 1986
AP INTL MEDICATION 100MG/ML A088636 001 Jul 31, 1984
AP NEXUS PHARMS 100MG/ML A206332 001 Oct 13, 2017
AP 500MG/ML A206332 002 Oct 13, 2017
! HOSPIRA 500MG/ML A089070 001 Feb 12, 1986
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-384(of 474)

PROCARBAZINE HYDROCHLORIDE
CAPSULE;ORAL
MATULANE
+! LEADIANT BIOSCI INC EQ 50MG BASE N016785 001
PROCHLORPERAZINE
SUPPOSITORY;RECTAL
COMPRO
AB PADAGIS US 25MG A040246 001 Jun 28, 2000
PROCHLORPERAZINE
AB ! COSETTE 25MG A040058 001 Nov 24, 1993
PROCHLORPERAZINE EDISYLATE
INJECTABLE;INJECTION
PROCHLORPERAZINE EDISYLATE
AP AMNEAL EQ 5MG BASE/ML A214192 001 Nov 28, 2022
AP ATHENEX INC EQ 5MG BASE/ML A040540 001 May 28, 2004
AP CAPLIN EQ 5MG BASE/ML A214379 001 Apr 22, 2021
AP ! EMCURE PHARMS LTD EQ 5MG BASE/ML A204147 001 Oct 15, 2013
AP EUGIA PHARMA EQ 5MG BASE/ML A213873 001 Jul 14, 2022
AP GLAND PHARMA LTD EQ 5MG BASE/ML A214107 001 Sep 22, 2021
AP HIKMA EQ 5MG BASE/ML A089903 001 Aug 29, 1989
AP EQ 5MG BASE/ML A213630 001 Nov 22, 2022
AP MYLAN LABS LTD EQ 5MG BASE/ML A210710 001 Oct 25, 2018
AP NEXUS PHARMS EQ 5MG BASE/ML A204860 001 Feb 15, 2019
AP VIWIT PHARM EQ 5MG BASE/ML A213626 001 Sep 28, 2021
PROCHLORPERAZINE MALEATE
TABLET;ORAL
PROCHLORPERAZINE MALEATE
AB NOVITIUM PHARMA EQ 5MG BASE A216202 001 Jun 13, 2022
AB EQ 10MG BASE A216202 002 Jun 13, 2022
AB ZYDUS EQ 5MG BASE A216495 001 Aug 08, 2022
AB EQ 10MG BASE A216495 002 Aug 08, 2022
PROCOMP
AB JUBILANT CADISTA EQ 5MG BASE A040268 001 Feb 27, 1998
AB ! EQ 10MG BASE A040268 002 Feb 27, 1998
PROGESTERONE
CAPSULE;ORAL
PROGESTERONE
AB AMNEAL PHARMS NY 100MG A207724 001 Sep 07, 2017
AB 200MG A207724 002 Sep 07, 2017
AB BIONPHARMA INC 100MG A200900 001 Aug 16, 2013
AB 200MG A200900 002 Aug 16, 2013
AB DR REDDYS 100MG A208801 001 Feb 28, 2017
AB 200MG A208801 002 Feb 28, 2017
AB EUGIA PHARMA 100MG A211285 001 Oct 26, 2018
AB 200MG A211285 002 Oct 26, 2018
AB XIROMED 100MG A205229 001 Oct 20, 2017
AB 200MG A205229 002 Oct 20, 2017
PROMETRIUM
AB + VIRTUS PHARMS 100MG N019781 001 May 14, 1998
AB +! 200MG N019781 002 Oct 15, 1999
PROGESTERONE
BX SOFGEN PHARMS 100MG A200456 001 Sep 28, 2012
BX 200MG A200456 002 Sep 28, 2012
GEL;VAGINAL
CRINONE
+! ALLERGAN 4% N020701 001 Jul 31, 1997
+! 8% N020701 002 Jul 31, 1997
INJECTABLE;INJECTION
PROGESTERONE
AO ! EUGIA PHARMA 50MG/ML A210965 001 Dec 06, 2018
AO FRESENIUS KABI USA 50MG/ML A075906 001 Apr 25, 2001
AO HIKMA FARMACEUTICA 50MG/ML A091033 001 Oct 28, 2010
AO XIROMED 50MG/ML A215634 001 Jan 05, 2022
INSERT;VAGINAL
ENDOMETRIN
+! FERRING 100MG N022057 001 Jun 21, 2007
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-385(of 474)

PROMETHAZINE HYDROCHLORIDE
INJECTABLE;INJECTION
PROMETHAZINE HYDROCHLORIDE
AP +! WEST-WARD PHARMS 25MG/ML A083312 001
INT
AP +! 50MG/ML A083312 002
AP XGEN PHARMS 25MG/ML A040737 001 Apr 24, 2008
AP 50MG/ML A040737 002 Apr 24, 2008
SUPPOSITORY;RECTAL
PROMETHAZINE HYDROCHLORIDE
AB ANNORA PHARMA 12.5MG A216446 001 Nov 02, 2022
AB 25MG A216446 002 Nov 02, 2022
AB COSETTE 12.5MG A040428 002 Mar 31, 2003
AB ! 25MG A040428 001 Feb 05, 2002
AB PADAGIS ISRAEL 12.5MG A040500 001 Jun 30, 2003
AB 25MG A040500 002 Jun 30, 2003
AB TARO 12.5MG A040603 001 Oct 26, 2006
AB 25MG A040603 002 Oct 26, 2006
PROMETHEGAN
! COSETTE 50MG A087165 001 Aug 14, 1987
SYRUP;ORAL
PROMETHAZINE HYDROCHLORIDE
AA AKORN 6.25MG/5ML A040026 001 Sep 25, 1998
AA AMNEAL PHARMS 6.25MG/5ML A040882 001 Dec 30, 2009
AA NOSTRUM LABS INC 6.25MG/5ML A040891 001 Mar 13, 2009
AA PHARM ASSOC 6.25MG/5ML A040643 001 Apr 26, 2006
AA QUAGEN 6.25MG/5ML A213890 001 Jul 12, 2021
AA TARO 6.25MG/5ML A040718 001 Apr 04, 2007
AA TRIS PHARMA INC 6.25MG/5ML A091675 001 Jun 28, 2012
PROMETHAZINE PLAIN
AA +! WOCKHARDT BIO AG 6.25MG/5ML A087953 001 Nov 15, 1982
TABLET;ORAL
PROMETHAZINE HYDROCHLORIDE
AB AMNEAL PHARMS NY 12.5MG A091179 001 Dec 13, 2010
AB 25MG A091179 002 Dec 13, 2010
AB 50MG A091179 003 Dec 13, 2010
AB KVK TECH 12.5MG A040712 002 May 04, 2007
AB 25MG A040712 001 Jul 31, 2006
AB 50MG A040712 003 Jul 31, 2006
AB PRINSTON INC 12.5MG A040622 001 Jul 18, 2006
AB 25MG A040622 002 Jul 18, 2006
AB 50MG A040622 003 Jul 18, 2006
AB QUAGEN 12.5MG A040673 001 Mar 05, 2008
AB 25MG A040673 002 Mar 05, 2008
AB 50MG A040673 003 Mar 05, 2008
AB + SANDOZ 25MG A084176 003
AB +! 50MG A084176 001
AB STRIDES PHARMA 12.5MG A209177 001 Jun 30, 2017
AB 25MG A209177 002 Jun 30, 2017
AB 50MG A209177 003 Jun 30, 2017
AB SUN PHARM INDS INC 12.5MG A040863 001 Dec 30, 2008
AB 25MG A040863 002 Dec 30, 2008
AB 50MG A040863 003 Dec 30, 2008
AB WATSON LABS 25MG A083426 001
AB 50MG A083711 001
AB ZYDUS PHARMS USA 12.5MG A040596 001 Nov 18, 2005
AB 25MG A040596 002 Nov 18, 2005
AB 50MG A040596 003 Nov 18, 2005
PROPAFENONE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
PROPAFENONE HYDROCHLORIDE
AB GLENMARK PHARMS LTD 225MG A205268 001 Sep 08, 2017
AB 325MG A205268 002 Sep 08, 2017
AB 425MG A205268 003 Sep 08, 2017
AB RISING 225MG A205956 001 Jul 02, 2018
AB 325MG A205956 002 Jul 02, 2018
AB 425MG A205956 003 Jul 02, 2018
AB STRIDES PHARMA 225MG A078540 001 Oct 18, 2010
AB 325MG A078540 002 Oct 18, 2010
AB 425MG A078540 003 Oct 18, 2010
AB TWI PHARMS 225MG A212928 001 Jun 18, 2020
AB 325MG A212928 002 Jun 18, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-386(of 474)

PROPAFENONE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
PROPAFENONE HYDROCHLORIDE
AB 425MG A212928 003 Jun 18, 2020
AB UPSHER SMITH LABS 225MG A212744 001 Jun 25, 2020
AB 325MG A212744 002 Jun 25, 2020
AB 425MG A212744 003 Jun 25, 2020
AB WATSON LABS INC 225MG A202688 001 Aug 24, 2015
AB 325MG A202688 002 Aug 24, 2015
AB 425MG A202688 003 Aug 24, 2015
AB ZYDUS 225MG A214184 001 Apr 21, 2021
AB 325MG A214184 002 Apr 21, 2021
AB 425MG A214184 003 Apr 21, 2021
RYTHMOL SR
AB + GLAXOSMITHKLINE LLC 225MG N021416 001 Sep 04, 2003
AB + 325MG N021416 002 Sep 04, 2003
AB +! 425MG N021416 003 Sep 04, 2003
PROPAFENONE HYDROCHLORIDE
BX SINOTHERAPEUTICS 225MG A210339 001 Jan 04, 2019
INC
BX 325MG A210339 002 Jan 04, 2019
BX 425MG A210339 003 Jan 04, 2019
TABLET;ORAL
PROPAFENONE HYDROCHLORIDE
AB ANI PHARMS 150MG A076550 001 Apr 23, 2004
AB 225MG A076550 002 Apr 23, 2004
AB 300MG A076550 003 Apr 23, 2004
AB AUROBINDO PHARMA 150MG A202445 001 May 11, 2016
AB 225MG A202445 002 May 11, 2016
AB 300MG A202445 003 May 11, 2016
AB STRIDES PHARMA 150MG A075938 001 Oct 17, 2002
AB 225MG A075938 002 Oct 17, 2002
AB ! 300MG A075938 003 Oct 17, 2002
AB SUN PHARM 150MG A075998 001 Nov 29, 2001
INDUSTRIES
AB 225MG A075998 002 Nov 29, 2001
AB 300MG A075998 003 Nov 29, 2001
AB WATSON LABS 150MG A075203 001 Oct 24, 2000
AB 225MG A075203 002 Oct 24, 2000
PROPARACAINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
ALCAINE
AT ALCON LABS INC 0.5% A080027 001
PROPARACAINE HYDROCHLORIDE
AT ! AKORN 0.5% A040277 001 Mar 16, 2000
AT BAUSCH AND LOMB 0.5% A040074 001 Sep 29, 1995
PROPOFOL
INJECTABLE;INJECTION
DIPRIVAN
AB +! FRESENIUS KABI USA 10MG/ML N019627 002 Jun 11, 1996
PROPOFOL
AB DR REDDYS 10MG/ML A205067 001 Nov 15, 2018
AB EMCURE PHARMS LTD 10MG/ML A206408 001 Oct 12, 2021
AB HIKMA 10MG/ML A074848 001 Apr 19, 2005
AB HOSPIRA 10MG/ML A077908 001 Mar 17, 2006
AB INNOPHARMA 10MG/ML A205576 001 Sep 16, 2020
AB SAGENT PHARMS INC 10MG/ML A075102 001 Jan 04, 1999
AB WATSON LABS INC 10MG/ML A205307 001 Dec 22, 2015
PROPRANOLOL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
INDERAL LA
AB + ANI PHARMS 60MG N018553 004 Mar 18, 1987
AB + 80MG N018553 002 Apr 19, 1983
AB + 120MG N018553 003 Apr 19, 1983
AB +! 160MG N018553 001 Apr 19, 1983
PROPRANOLOL HYDROCHLORIDE
AB ACTAVIS ELIZABETH 60MG A078494 001 Aug 10, 2007
AB 80MG A078494 002 Aug 10, 2007
AB 120MG A078494 003 Aug 10, 2007
AB 160MG A078494 004 Aug 10, 2007
AB ADARE PHARMS INC 60MG A078703 001 Jul 15, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-387(of 474)

PROPRANOLOL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
PROPRANOLOL HYDROCHLORIDE
AB 80MG A078703 002 Jul 15, 2011
AB 120MG A078703 003 Jul 15, 2011
AB 160MG A078703 004 Jul 15, 2011
AB AMTA 60MG A212026 001 Jan 06, 2020
AB 80MG A212026 002 Jan 06, 2020
AB 120MG A212026 003 Jan 06, 2020
AB 160MG A212026 004 Jan 06, 2020
AB NORTEC DEV ASSOC 60MG A078065 001 Jan 26, 2007
AB 80MG A078065 002 Jan 26, 2007
AB 120MG A078065 003 Jan 26, 2007
AB 160MG A078065 004 Jan 26, 2007
AB ZYDUS PHARMS USA 60MG A090321 001 Mar 25, 2011
INC
AB 80MG A090321 002 Mar 25, 2011
AB 120MG A090321 003 Mar 25, 2011
AB 160MG A090321 004 Mar 25, 2011
INNOPRAN XL
BX + ANI PHARMS 80MG N021438 001 Mar 12, 2003
BX +! 120MG N021438 002 Mar 12, 2003
INJECTABLE;INJECTION
PROPRANOLOL HYDROCHLORIDE
AP FRESENIUS KABI USA 1MG/ML A075826 001 Aug 31, 2001
AP ! HIKMA FARMACEUTICA 1MG/ML A077760 001 Jan 31, 2008
SOLUTION;ORAL
HEMANGEOL
+! PIERRE FABRE DERMA 4.28MG/ML N205410 001 Mar 14, 2014
PROPRANOLOL HYDROCHLORIDE
! HIKMA 20MG/5ML A070979 001 May 15, 1987
! 40MG/5ML A070690 001 May 15, 1987
TABLET;ORAL
PROPRANOLOL HYDROCHLORIDE
AB IMPAX LABS INC 10MG A071972 001 Apr 06, 1988
AB 20MG A071972 002 Apr 06, 1988
AB 40MG A071972 003 Apr 06, 1988
AB 60MG A071976 002 May 13, 1986
AB 80MG A071976 001 Apr 06, 1988
AB INNOGENIX 10MG A070322 002 Oct 22, 1985
AB 20MG A070322 003 Oct 22, 1985
AB 40MG A070322 004 Oct 22, 1985
AB 60MG A070322 005 Sep 24, 1986
AB 80MG A070322 001 Aug 04, 1986
AB IPCA LABS LTD 10MG A078955 001 Jun 02, 2008
AB 20MG A078955 002 Jun 02, 2008
AB 40MG A078955 003 Jun 02, 2008
AB 60MG A078955 004 Jun 02, 2008
AB 80MG A078955 005 Jun 02, 2008
AB MYLAN 10MG A070213 002 Nov 19, 1985
AB 20MG A070213 003 Nov 19, 1985
AB 40MG A070213 001 Nov 19, 1985
AB 60MG A070213 005 Apr 08, 2011
AB 80MG A070213 004 Nov 19, 1985
AB NORTHSTAR HLTHCARE 10MG A078213 001 Jan 10, 2008
AB 20MG A078213 002 Jan 10, 2008
AB 40MG A078213 003 Jan 10, 2008
AB 60MG A078213 004 Jan 10, 2008
AB 80MG A078213 005 Jan 10, 2008
AB VINTAGE PHARMS 10MG A070221 002 Aug 01, 1986
AB 20MG A070221 003 Aug 01, 1986
AB 40MG A070221 004 Aug 01, 1986
AB 60MG A070221 005 Sep 24, 1986
AB 80MG A070221 001 Apr 14, 1986
AB WATSON LABS 10MG A070175 001 May 13, 1986
AB 20MG A070176 001 May 13, 1986
AB 40MG A070177 001 May 13, 1986
AB ! 80MG A070178 001 May 13, 1986
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-388(of 474)

PROPYLTHIOURACIL
TABLET;ORAL
PROPYLTHIOURACIL
BD ACTAVIS ELIZABETH 50MG A080172 001
BD +! DAVA PHARMS INC 50MG N006188 001
BD QUAGEN 50MG A080154 001
PROTAMINE SULFATE
INJECTABLE;INJECTION
PROTAMINE SULFATE
! FRESENIUS KABI USA 10MG/ML A089454 001 Apr 07, 1987
PROTRIPTYLINE HYDROCHLORIDE
TABLET;ORAL
PROTRIPTYLINE HYDROCHLORIDE
AB EPIC PHARMA LLC 5MG A202220 001 Nov 19, 2012
AB 10MG A202220 002 Nov 19, 2012
AB HIKMA 5MG A078913 001 Sep 16, 2008
AB ! 10MG A078913 002 Sep 16, 2008
AB SIGMAPHARM LABS LLC 5MG A090462 001 May 03, 2010
AB 10MG A090462 002 May 03, 2010
PRUCALOPRIDE SUCCINATE
TABLET;ORAL
MOTEGRITY
+ TAKEDA PHARMS USA EQ 1MG BASE N210166 001 Dec 14, 2018
+! EQ 2MG BASE N210166 002 Dec 14, 2018
PYRAZINAMIDE
TABLET;ORAL
PYRAZINAMIDE
AB ! AKORN 500MG A081319 001 Jun 30, 1992
AB MACLEODS PHARMS LTD 500MG A212541 001 Jul 27, 2020
AB + NOVITIUM PHARMA 500MG A080157 001
PYRIDOSTIGMINE BROMIDE
INJECTABLE;INJECTION
MESTINON
AP +! BAUSCH 5MG/ML N009830 001
REGONOL
AP SANDOZ INC 5MG/ML N017398 001
SYRUP;ORAL
MESTINON
AA +! BAUSCH 60MG/5ML N015193 001
PYRIDOSTIGMINE BROMIDE
AA AMNEAL 60MG/5ML A212702 001 Jan 10, 2020
AA ELYSIUM 60MG/5ML A208797 001 Jan 09, 2020
AA MILLA PHARMS 60MG/5ML A212405 001 Apr 19, 2022
AA NOVITIUM PHARMA 60MG/5ML A211694 001 Mar 08, 2019
TABLET;ORAL
MESTINON
AB +! BAUSCH 60MG N009829 002
PYRIDOSTIGMINE BROMIDE
AB EYWA 30MG A211181 002 May 14, 2019
AB 60MG A211181 001 Jul 20, 2018
AB IMPAX LABS 30MG A040502 002 Jun 28, 2022
AB 60MG A040502 001 Apr 24, 2003
AB ZYDUS PHARMS 60MG A205650 001 Jun 22, 2015
TABLET, EXTENDED RELEASE;ORAL
MESTINON
AB +! BAUSCH 180MG N011665 001
PYRIDOSTIGMINE BROMIDE
AB ALVOGEN 180MG A204737 001 Jun 26, 2015
AB IMPAX LABS INC 180MG A203184 001 Sep 15, 2015
AB RISING 180MG A205464 001 Aug 15, 2017
PYRIDOXINE HYDROCHLORIDE
INJECTABLE;INJECTION
PYRIDOXINE HYDROCHLORIDE
+! FRESENIUS KABI USA 100MG/ML A080618 001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-389(of 474)

PYRIMETHAMINE
TABLET;ORAL
DARAPRIM
AB +! VYERA PHARMS LLC 25MG N008578 001
PYRIMETHAMINE
AB ALVOGEN 25MG A211271 001 Jul 27, 2021
AB AUROBINDO PHARMA 25MG A216983 001 Oct 25, 2022
LTD
AB CEROVENE INC 25MG A207127 001 Feb 28, 2020
AB TEVA PHARMS 25MG A215506 001 Aug 13, 2021
QUAZEPAM
TABLET;ORAL
DORAL
+! GALT PHARMS 15MG N018708 001 Dec 27, 1985
QUETIAPINE FUMARATE
TABLET;ORAL
QUETIAPINE FUMARATE
AB ACCORD HLTHCARE EQ 25MG BASE A202152 001 Mar 27, 2012
AB EQ 50MG BASE A202152 002 Mar 27, 2012
AB EQ 100MG BASE A202152 003 Mar 27, 2012
AB EQ 200MG BASE A202152 004 Mar 27, 2012
AB EQ 300MG BASE A202152 005 Mar 27, 2012
AB EQ 400MG BASE A202152 006 Mar 27, 2012
AB ALKEM LABS LTD EQ 25MG BASE A201504 001 Feb 12, 2013
AB EQ 50MG BASE A201504 002 Feb 12, 2013
AB EQ 100MG BASE A201504 003 Feb 12, 2013
AB EQ 150MG BASE A201504 004 Feb 12, 2013
AB EQ 200MG BASE A201504 005 Feb 12, 2013
AB EQ 300MG BASE A201504 006 Feb 12, 2013
AB EQ 400MG BASE A201504 007 Feb 12, 2013
AB AUROBINDO PHARMA EQ 25MG BASE A091388 001 Mar 27, 2012
LTD
AB EQ 50MG BASE A091388 002 Mar 27, 2012
AB EQ 100MG BASE A091388 003 Mar 27, 2012
AB EQ 150MG BASE A091388 004 Mar 27, 2012
AB EQ 200MG BASE A091388 005 Mar 27, 2012
AB EQ 300MG BASE A091388 006 Mar 27, 2012
AB EQ 400MG BASE A091388 007 Mar 27, 2012
AB DR REDDYS LABS LTD EQ 25MG BASE A077380 001 Mar 27, 2012
AB EQ 50MG BASE A077380 002 Mar 27, 2012
AB EQ 100MG BASE A077380 003 Mar 27, 2012
AB EQ 150MG BASE A077380 004 Mar 27, 2012
AB EQ 200MG BASE A077380 005 Mar 27, 2012
AB EQ 300MG BASE A077380 006 Mar 27, 2012
AB EQ 400MG BASE A077380 007 Mar 27, 2012
AB HETERO LABS LTD V EQ 25MG BASE A204316 001 Jun 16, 2022
AB EQ 50MG BASE A204316 002 Jun 16, 2022
AB EQ 100MG BASE A204316 003 Jun 16, 2022
AB EQ 200MG BASE A204316 004 Jun 16, 2022
AB EQ 300MG BASE A204316 005 Jun 16, 2022
AB EQ 400MG BASE A204316 006 Jun 16, 2022
AB HIKMA EQ 25MG BASE A090120 001 Mar 27, 2012
AB EQ 50MG BASE A090749 001 Mar 27, 2012
AB EQ 100MG BASE A090749 002 Mar 27, 2012
AB EQ 200MG BASE A090749 003 Mar 27, 2012
AB EQ 300MG BASE A090749 004 Mar 27, 2012
AB EQ 400MG BASE A090749 005 Mar 27, 2012
AB LUPIN LTD EQ 25MG BASE A201109 001 Mar 27, 2012
AB EQ 50MG BASE A201109 002 Mar 27, 2012
AB EQ 100MG BASE A201109 003 Mar 27, 2012
AB EQ 200MG BASE A201109 004 Mar 27, 2012
AB EQ 300MG BASE A201109 005 Mar 27, 2012
AB EQ 400MG BASE A201109 006 Mar 27, 2012
AB MACLEODS PHARMS LTD EQ 25MG BASE A203359 001 May 17, 2016
AB EQ 50MG BASE A203359 002 May 17, 2016
AB EQ 100MG BASE A203359 003 May 17, 2016
AB EQ 200MG BASE A203359 004 May 17, 2016
AB EQ 300MG BASE A203359 005 May 17, 2016
AB EQ 400MG BASE A203359 006 May 17, 2016
AB PRINSTON INC EQ 25MG BASE A206954 001 Aug 24, 2022
AB EQ 50MG BASE A206954 002 Aug 24, 2022
AB EQ 100MG BASE A206954 003 Aug 24, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-390(of 474)

QUETIAPINE FUMARATE
TABLET;ORAL
QUETIAPINE FUMARATE
AB EQ 200MG BASE A206954 004 Aug 24, 2022
AB EQ 300MG BASE A206954 005 Aug 24, 2022
AB EQ 400MG BASE A206954 006 Aug 24, 2022
AB SANDOZ EQ 25MG BASE A078679 001 Dec 14, 2012
AB EQ 50MG BASE A078679 002 Dec 14, 2012
AB EQ 100MG BASE A078679 003 Dec 14, 2012
AB EQ 150MG BASE A078679 004 Dec 14, 2012
AB EQ 200MG BASE A078679 005 Dec 14, 2012
AB EQ 300MG BASE A078679 006 Dec 14, 2012
AB EQ 400MG BASE A078679 007 Dec 14, 2012
AB SUN PHARM EQ 25MG BASE A201190 001 Mar 27, 2012
AB EQ 50MG BASE A201190 002 Mar 27, 2012
AB EQ 100MG BASE A201190 003 Mar 27, 2012
AB EQ 200MG BASE A201190 004 Mar 27, 2012
AB EQ 300MG BASE A201190 005 Mar 27, 2012
AB EQ 400MG BASE A201190 006 Mar 27, 2012
AB TEVA PHARMS EQ 25MG BASE A077745 001 Mar 27, 2012
AB EQ 50MG BASE A077745 002 Mar 27, 2012
AB EQ 100MG BASE A077745 003 Mar 27, 2012
AB EQ 150MG BASE A077745 004 Mar 27, 2012
AB EQ 200MG BASE A077745 005 Mar 27, 2012
AB EQ 300MG BASE A077745 006 Mar 27, 2012
AB EQ 400MG BASE A077745 007 Mar 27, 2012
AB UNICHEM EQ 25MG BASE A202674 001 Mar 08, 2016
AB EQ 50MG BASE A202674 002 Mar 08, 2016
AB EQ 100MG BASE A202674 003 Mar 08, 2016
AB EQ 200MG BASE A202674 004 Mar 08, 2016
AB EQ 300MG BASE A202674 005 Mar 08, 2016
AB EQ 400MG BASE A202674 006 Mar 08, 2016
AB ZENNOVA EQ 25MG BASE A090960 001 Mar 27, 2012
AB EQ 50MG BASE A090960 002 Mar 27, 2012
AB EQ 100MG BASE A090960 003 Mar 27, 2012
AB EQ 200MG BASE A090960 004 Mar 27, 2012
AB EQ 300MG BASE A090960 005 Mar 27, 2012
AB EQ 400MG BASE A090960 006 Mar 27, 2012
SEROQUEL
AB +! ASTRAZENECA EQ 25MG BASE N020639 001 Sep 26, 1997
AB + EQ 50MG BASE N020639 007 Oct 04, 2005
AB + EQ 100MG BASE N020639 002 Sep 26, 1997
AB + EQ 200MG BASE N020639 003 Sep 26, 1997
AB +! EQ 300MG BASE N020639 005 Jul 26, 2000
AB + EQ 400MG BASE N020639 006 Oct 04, 2005
TABLET, EXTENDED RELEASE;ORAL
QUETIAPINE FUMARATE
AB ACCORD HLTHCARE EQ 50MG BASE A206252 001 Nov 29, 2017
AB EQ 150MG BASE A090681 001 May 09, 2017
AB EQ 200MG BASE A090681 002 May 09, 2017
AB EQ 300MG BASE A090681 003 May 09, 2017
AB EQ 400MG BASE A090681 004 Nov 01, 2016
AB ALIGNSCIENCE PHARMA EQ 150MG BASE A209497 001 Sep 28, 2018
AB EQ 200MG BASE A209497 002 Sep 28, 2018
AB AUROBINDO PHARMA EQ 50MG BASE A207655 001 Nov 29, 2017
AB EQ 150MG BASE A207655 002 Nov 29, 2017
AB EQ 200MG BASE A207655 003 Nov 29, 2017
AB EQ 300MG BASE A207655 004 Nov 29, 2017
AB EQ 400MG BASE A207655 005 Nov 29, 2017
AB INTELLIPHARMACEUTIC EQ 50MG BASE A202939 001 May 09, 2017
S
AB EQ 150MG BASE A202939 002 May 09, 2017
AB EQ 200MG BASE A202939 003 May 09, 2017
AB EQ 300MG BASE A202939 004 May 09, 2017
AB EQ 400MG BASE A202939 005 May 09, 2017
AB LUPIN LTD EQ 50MG BASE A204203 001 May 17, 2017
AB EQ 150MG BASE A204203 002 May 17, 2017
AB EQ 200MG BASE A204203 003 May 17, 2017
AB EQ 300MG BASE A204203 004 May 17, 2017
AB EQ 400MG BASE A204203 005 May 17, 2017
AB MACLEODS PHARMS LTD EQ 150MG BASE A204253 001 Nov 29, 2017
AB EQ 200MG BASE A204253 002 Nov 29, 2017
AB EQ 300MG BASE A204253 003 Nov 29, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-391(of 474)

QUETIAPINE FUMARATE
TABLET, EXTENDED RELEASE;ORAL
QUETIAPINE FUMARATE
AB EQ 400MG BASE A204253 004 Nov 29, 2017
AB NOVAST LABS EQ 50MG BASE A208947 001 Nov 29, 2017
AB EQ 150MG BASE A208947 002 Nov 29, 2017
AB EQ 200MG BASE A208947 003 Nov 29, 2017
AB EQ 300MG BASE A208947 004 Nov 29, 2017
AB EQ 400MG BASE A208947 005 Nov 29, 2017
AB PAR PHARM EQ 50MG BASE A090482 001 May 09, 2017
AB EQ 150MG BASE A090482 002 May 09, 2017
AB EQ 200MG BASE A090482 003 May 09, 2017
AB EQ 300MG BASE A090482 004 May 09, 2017
AB EQ 400MG BASE A090482 005 May 09, 2017
AB PHARMADAX INC EQ 50MG BASE A206260 001 May 09, 2017
AB EQ 150MG BASE A206260 002 May 09, 2017
AB EQ 200MG BASE A206260 003 May 09, 2017
AB EQ 300MG BASE A206260 004 May 09, 2017
AB EQ 400MG BASE A206260 005 May 09, 2017
AB PRINSTON INC EQ 50MG BASE A208781 001 Apr 26, 2022
AB EQ 150MG BASE A208781 002 Apr 26, 2022
AB EQ 200MG BASE A208781 003 Apr 26, 2022
AB EQ 300MG BASE A208781 004 Apr 26, 2022
AB SCIEGEN PHARMS INC EQ 50MG BASE A209635 005 Nov 16, 2018
AB EQ 150MG BASE A209635 001 Nov 29, 2017
AB EQ 200MG BASE A209635 002 Nov 29, 2017
AB EQ 300MG BASE A209635 003 Nov 29, 2017
AB EQ 400MG BASE A209635 004 Nov 29, 2017
AB UNICHEM EQ 50MG BASE A215478 001 Aug 15, 2022
AB EQ 150MG BASE A215478 002 Aug 15, 2022
AB EQ 200MG BASE A215478 003 Aug 15, 2022
AB EQ 300MG BASE A215478 004 Aug 15, 2022
AB EQ 400MG BASE A215478 005 Aug 15, 2022
SEROQUEL XR
AB + ASTRAZENECA EQ 50MG BASE N022047 001 May 17, 2007
AB + EQ 150MG BASE N022047 005 Aug 11, 2008
AB +! EQ 200MG BASE N022047 002 May 17, 2007
AB + EQ 300MG BASE N022047 003 May 17, 2007
AB + EQ 400MG BASE N022047 004 May 17, 2007
QUINAPRIL HYDROCHLORIDE
TABLET;ORAL
QUINAPRIL HYDROCHLORIDE
AB AUROBINDO PHARMA EQ 5MG BASE A202725 001 Apr 29, 2013
LTD
AB EQ 10MG BASE A202725 002 Apr 29, 2013
AB EQ 20MG BASE A202725 003 Apr 29, 2013
AB EQ 40MG BASE A202725 004 Apr 29, 2013
AB INVAGEN PHARMS EQ 5MG BASE A078457 001 Aug 24, 2007
AB EQ 10MG BASE A078457 002 Aug 24, 2007
AB EQ 20MG BASE A078457 003 Aug 24, 2007
AB EQ 40MG BASE A078457 004 Aug 24, 2007
AB LUPIN EQ 5MG BASE A077690 001 Jun 20, 2006
AB EQ 10MG BASE A077690 002 Jun 20, 2006
AB EQ 20MG BASE A077690 003 Jun 20, 2006
AB ! EQ 40MG BASE A077690 004 Jun 20, 2006
AB PRINSTON INC EQ 5MG BASE A205823 001 Sep 15, 2016
AB EQ 10MG BASE A205823 002 Sep 15, 2016
AB EQ 20MG BASE A205823 003 Sep 15, 2016
AB EQ 40MG BASE A205823 004 Sep 15, 2016
QUINIDINE GLUCONATE
TABLET, EXTENDED RELEASE;ORAL
QUINIDINE GLUCONATE
AB EYWA 324MG A212589 001 Sep 17, 2021
AB ! SUN PHARM 324MG A089338 001 Feb 11, 1987
INDUSTRIES
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-392(of 474)

QUINIDINE SULFATE
TABLET;ORAL
QUINIDINE SULFATE
! EPIC PHARMA 200MG A088072 002
! 300MG A088072 001 Sep 26, 1983
QUININE SULFATE
CAPSULE;ORAL
QUALAQUIN
AB +! SUN PHARM 324MG N021799 001 Aug 12, 2005
INDUSTRIES
QUININE SULFATE
AB AMNEAL PHARMS 324MG A203729 001 Jul 15, 2015
AB LUPIN LTD 324MG A203112 001 Apr 24, 2015
AB NOVAST LABS 324MG A204372 001 Jul 22, 2015
AB TEVA PHARMS 324MG A091661 001 Sep 28, 2012
RABEPRAZOLE SODIUM
TABLET, DELAYED RELEASE;ORAL
ACIPHEX
AB +! WOODWARD 20MG N020973 002 Aug 19, 1999
RABEPRAZOLE SODIUM
AB ALKEM LABS LTD 20MG A208644 001 Apr 24, 2018
AB AMNEAL PHARMS 20MG A204179 001 Jul 31, 2015
AB AUROBINDO PHARMA 20MG A205761 001 Feb 17, 2017
AB DR REDDYS 20MG A076824 001 Nov 08, 2013
AB LANNETT CO INC 20MG A090678 001 Nov 08, 2013
AB LUPIN LTD 20MG A078964 001 Nov 08, 2013
AB RUBICON 20MG A204237 001 Nov 18, 2015
AB TORRENT 20MG A202376 001 Nov 08, 2013
RADIUM RA-223 DICHLORIDE
SOLUTION;INTRAVENOUS
XOFIGO
+! BAYER HLTHCARE 162mCi/6ML (27mCi/ML) N203971 001 May 15, 2013
RALOXIFENE HYDROCHLORIDE
TABLET;ORAL
EVISTA
AB +! LILLY 60MG N020815 001 Dec 09, 1997
RALOXIFENE HYDROCHLORIDE
AB AMNEAL PHARMS 60MG A208206 001 Apr 08, 2016
AB AUROBINDO PHARMA 60MG A204310 001 Aug 28, 2015
AB CADILA PHARMS LTD 60MG A211324 001 Aug 18, 2020
AB GLENMARK PHARMS LTD 60MG A204491 001 Mar 22, 2016
AB INVAGEN PHARMS 60MG A090842 001 Sep 24, 2014
AB SCIEGEN PHARMS INC 60MG A206384 001 Oct 12, 2016
AB TEVA PHARMS USA 60MG A078193 001 Mar 04, 2014
AB WATSON LABS INC 60MG A200825 001 Jan 21, 2015
RALTEGRAVIR POTASSIUM
POWDER;ORAL
ISENTRESS
+! MSD SUB MERCK EQ 100MG BASE/PACKET N205786 001 Dec 20, 2013
TABLET;ORAL
ISENTRESS
+! MSD SUB MERCK EQ 400MG BASE N022145 001 Oct 12, 2007
ISENTRESS HD
+! MSD SUB MERCK EQ 600MG BASE N022145 002 May 26, 2017
TABLET, CHEWABLE;ORAL
ISENTRESS
+ MSD SUB MERCK EQ 25MG BASE N203045 001 Dec 21, 2011
+! EQ 100MG BASE N203045 002 Dec 21, 2011
RAMELTEON
TABLET;ORAL
RAMELTEON
AB ACTAVIS LABS FL INC 8MG A091610 001 Aug 19, 2015
AB DR REDDYS LABS SA 8MG A091693 001 Jul 26, 2013
AB ENALTEC 8MG A215435 001 Aug 24, 2022
AB GRANULES 8MG A213186 001 Aug 21, 2020
AB I3 PHARMS 8MG A212650 001 Apr 10, 2020
AB UPSHER SMITH LABS 8MG A213815 001 Oct 26, 2020
AB XIROMED 8MG A216209 001 Nov 25, 2022
AB ZYDUS PHARMS 8MG A211567 001 Jul 22, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-393(of 474)

RAMELTEON
TABLET;ORAL
ROZEREM
AB +! TAKEDA PHARMS USA 8MG N021782 001 Jul 22, 2005
RAMIPRIL
CAPSULE;ORAL
ALTACE
AB + KING PHARMS LLC 1.25MG N019901 001 Jan 28, 1991
AB + 2.5MG N019901 002 Jan 28, 1991
AB + 5MG N019901 003 Jan 28, 1991
AB +! 10MG N019901 004 Jan 28, 1991
RAMIPRIL
AB ACCORD HLTHCARE 1.25MG A202392 001 Apr 15, 2014
AB 2.5MG A202392 002 Apr 15, 2014
AB 5MG A202392 003 Apr 15, 2014
AB 10MG A202392 004 Apr 15, 2014
AB APOTEX 1.25MG A079116 001 Jun 20, 2008
AB 2.5MG A079116 002 Jun 20, 2008
AB 5MG A079116 003 Jun 20, 2008
AB 10MG A079116 004 Jun 20, 2008
AB AUROBINDO PHARMA 1.25MG A091604 001 Jun 08, 2011
LTD
AB 2.5MG A091604 002 Jun 08, 2011
AB 5MG A091604 003 Jun 08, 2011
AB 10MG A091604 004 Jun 08, 2011
AB CHARTWELL MOLECULAR 1.25MG A078745 001 Jun 18, 2008
AB 2.5MG A078745 002 Jun 18, 2008
AB 5MG A078745 003 Jun 18, 2008
AB 10MG A078745 004 Jun 18, 2008
AB DR REDDYS LABS LTD 1.25MG A078191 001 Jun 18, 2008
AB 2.5MG A078191 002 Jun 18, 2008
AB 5MG A078191 003 Jun 18, 2008
AB 10MG A078191 004 Jun 18, 2008
AB HIKMA 1.25MG A077900 001 Jun 18, 2008
AB 2.5MG A077900 002 Jun 18, 2008
AB 5MG A077900 003 Jun 18, 2008
AB 10MG A077900 004 Jun 18, 2008
AB LUPIN 1.25MG A077626 001 Jun 09, 2008
AB 2.5MG A077626 002 Jun 09, 2008
AB 5MG A077626 003 Jun 09, 2008
AB 10MG A077626 004 Jun 09, 2008
AB WATSON LABS 1.25MG A076549 001 Oct 24, 2005
AB 2.5MG A076549 002 Oct 24, 2005
AB 10MG A076549 004 Oct 24, 2005
AB ZYDUS PHARMS USA 1.25MG A078832 001 Sep 02, 2008
AB 2.5MG A078832 002 Sep 02, 2008
AB 5MG A078832 003 Sep 02, 2008
AB 10MG A078832 004 Sep 02, 2008
RANITIDINE HYDROCHLORIDE
CAPSULE;ORAL
RANITIDINE HYDROCHLORIDE
AB DR REDDYS LABS LTD EQ 150MG BASE A075742 001 Nov 29, 2000
AB EQ 300MG BASE A075742 002 Nov 29, 2000
AB SANDOZ EQ 150MG BASE A074655 001 Oct 22, 1997
AB ! EQ 300MG BASE A074655 002 Oct 22, 1997
INJECTABLE;INJECTION
RANITIDINE HYDROCHLORIDE
AP HIKMA EQ 25MG BASE/ML A074777 001 Mar 02, 2005
AP EQ 25MG BASE/ML A077458 001 Feb 16, 2006
AP ZYDUS PHARMS USA EQ 25MG BASE/ML A091534 001 Feb 22, 2013
INC
ZANTAC
AP +! PAI HOLDINGS PHARM EQ 25MG BASE/ML N019090 001 Oct 19, 1984
SYRUP;ORAL
RANITIDINE HYDROCHLORIDE
AA LANNETT CO INC EQ 15MG BASE/ML A091288 001 Dec 09, 2010
AA ! PHARM ASSOC EQ 15MG BASE/ML A077405 001 Sep 21, 2007
TABLET;ORAL
RANITIDINE HYDROCHLORIDE
AB APOTEX EQ 150MG BASE A074680 001 Sep 12, 1997
AB EQ 300MG BASE A074680 002 Sep 12, 1997
AB DR REDDYS LABS INC EQ 150MG BASE A076705 001 Jul 27, 2005
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-394(of 474)

RANITIDINE HYDROCHLORIDE
TABLET;ORAL
RANITIDINE HYDROCHLORIDE
AB EQ 300MG BASE A076705 002 Jul 27, 2005
AB GLENMARK PHARMS INC EQ 150MG BASE A078542 001 Nov 19, 2008
AB EQ 300MG BASE A078542 002 Nov 19, 2008
AB PAR PHARM EQ 150MG BASE A075180 001 Jan 28, 1999
AB EQ 300MG BASE A075180 002 Jan 28, 1999
AB SANDOZ EQ 150MG BASE A074467 001 Aug 29, 1997
AB EQ 300MG BASE A074467 002 Aug 29, 1997
AB VKT PHARMA EQ 150MG BASE A211289 001 Jan 31, 2019
AB EQ 300MG BASE A211289 002 Jan 31, 2019
RANOLAZINE
GRANULES, EXTENDED RELEASE;ORAL
ASPRUZYO SPRINKLE
+ SPIL 500MG N216018 001 Feb 28, 2022
+! 1GM N216018 002 Feb 28, 2022
TABLET, EXTENDED RELEASE;ORAL
RANEXA
AB + GILEAD 500MG N021526 002 Jan 27, 2006
AB +! 1GM N021526 001 Feb 12, 2007
RANOLAZINE
AB ACTAVIS ELIZABETH 500MG A208862 001 May 28, 2019
AB 1GM A208862 002 May 28, 2019
AB AJANTA PHARMA LTD 500MG A210054 001 May 28, 2019
AB 1GM A210054 002 May 28, 2019
AB ALKEM LABS LTD 500MG A209953 001 Nov 30, 2020
AB 1GM A209953 002 Nov 30, 2020
AB AUROBINDO PHARMA 500MG A209081 001 Dec 23, 2022
AB 1GM A209081 002 Dec 23, 2022
AB CADILA 500MG A210188 001 Aug 19, 2019
AB 1GM A210188 002 Aug 19, 2019
AB GLENMARK PHARMS LTD 500MG A211082 001 Jul 05, 2019
AB 1GM A211082 002 Jul 05, 2019
AB GRAVITI PHARMS 500MG A212889 001 Jan 28, 2021
AB 1GM A212889 002 Jan 28, 2021
AB HETERO LABS LTD III 500MG A212788 001 May 05, 2022
AB 1GM A212788 002 May 05, 2022
AB I3 PHARMS 500MG A213517 001 Apr 27, 2022
AB 1GM A213517 002 Apr 27, 2022
AB LUPIN LTD 500MG A201046 001 Jul 29, 2013
AB 1GM A201046 002 Jul 29, 2013
AB MANKIND PHARMA 500MG A212284 001 Feb 12, 2020
AB 1GM A212284 002 Feb 12, 2020
AB MICRO LABS 500MG A211745 001 Feb 27, 2020
AB 1GM A211745 002 Feb 27, 2020
AB PRAXGEN 500MG A212781 001 Mar 23, 2020
AB 1GM A212781 002 Mar 23, 2020
AB SCIEGEN PHARMS INC 500MG A211829 001 Jun 04, 2019
AB 1GM A211829 002 Jun 04, 2019
AB SUN PHARM 500MG A211707 001 May 28, 2019
AB 1GM A211707 002 May 28, 2019
AB SUNSHINE 500MG A211865 001 Mar 23, 2020
AB 1GM A211865 002 Mar 23, 2020
AB VKT PHARMA 500MG A214035 001 Jan 19, 2022
AB 1GM A214035 002 Jan 19, 2022
RASAGILINE MESYLATE
TABLET;ORAL
AZILECT
AB + TEVA EQ 0.5MG BASE N021641 001 May 16, 2006
AB +! EQ 1MG BASE N021641 002 May 16, 2006
RASAGILINE MESYLATE
AB ALKEM LABS LTD EQ 0.5MG BASE A201889 001 Oct 30, 2017
AB EQ 1MG BASE A201889 002 Oct 30, 2017
AB AUROBINDO PHARMA EQ 0.5MG BASE A201971 001 May 15, 2017
USA
AB EQ 1MG BASE A201971 002 May 15, 2017
AB CHARTWELL RX EQ 0.5MG BASE A201892 001 Jul 27, 2018
AB EQ 1MG BASE A201892 002 Jul 27, 2018
AB INDOCO EQ 0.5MG BASE A206153 001 Oct 04, 2019
AB EQ 1MG BASE A206153 002 Oct 04, 2019
AB MICRO LABS EQ 0.5MG BASE A207004 001 Mar 29, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-395(of 474)

RASAGILINE MESYLATE
TABLET;ORAL
RASAGILINE MESYLATE
AB EQ 1MG BASE A207004 002 Mar 29, 2019
AB ORBION PHARMS EQ 0.5MG BASE A201970 001 Mar 15, 2016
AB EQ 1MG BASE A201970 002 Mar 15, 2016
REGADENOSON
SOLUTION;INTRAVENOUS
LEXISCAN
AP +! ASTELLAS 0.4MG/5ML (0.08MG/ML) N022161 001 Apr 10, 2008
REGADENOSON
AP ACCORD HLTHCARE 0.4MG/5ML (0.08MG/ML) A213236 001 Apr 11, 2022
AP APOTEX 0.4MG/5ML (0.08MG/ML) A207604 001 Apr 11, 2022
AP DR REDDYS 0.4MG/5ML (0.08MG/ML) A213210 001 Apr 11, 2022
AP EUGIA PHARMA 0.4MG/5ML (0.08MG/ML) A216437 001 Oct 26, 2022
AP GLAND PHARMA LTD 0.4MG/5ML (0.08MG/ML) A207320 001 Jul 12, 2022
AP HOSPIRA 0.4MG/5ML (0.08MG/ML) A214349 001 Aug 31, 2022
AP MEITHEAL 0.4MG/5ML (0.08MG/ML) A212806 001 Apr 11, 2022
REGORAFENIB
TABLET;ORAL
STIVARGA
+! BAYER HLTHCARE 40MG N203085 001 Sep 27, 2012
RELUGOLIX
TABLET;ORAL
ORGOVYX
+! MYOVANT SCIENCES 120MG N214621 001 Dec 18, 2020
REMDESIVIR
POWDER;INTRAVENOUS
VEKLURY
+! GILEAD SCIENCES INC 100MG/VIAL N214787 001 Oct 22, 2020
SOLUTION;INTRAVENOUS
VEKLURY
+! GILEAD SCIENCES INC 100MG/20ML (5MG/ML) N214787 002 Oct 22, 2020
REMIFENTANIL HYDROCHLORIDE
INJECTABLE;INJECTION
REMIFENTANIL HYDROCHLORIDE
AP FRESENIUS KABI USA EQ 1MG BASE/VIAL A206223 001 Jan 16, 2018
AP EQ 2MG BASE/VIAL A206223 002 Jan 16, 2018
AP EQ 5MG BASE/VIAL A206223 003 Jan 16, 2018
AP HIKMA EQ 1MG BASE/VIAL A210594 001 Oct 13, 2020
AP EQ 2MG BASE/VIAL A210594 002 Oct 13, 2020
AP EQ 5MG BASE/VIAL A210594 003 Oct 13, 2020
ULTIVA
AP + MYLAN INSTITUTIONAL EQ 1MG BASE/VIAL N020630 001 Jul 12, 1996
AP + EQ 2MG BASE/VIAL N020630 002 Jul 12, 1996
AP +! EQ 5MG BASE/VIAL N020630 003 Jul 12, 1996
REMIMAZOLAM BESYLATE
POWDER;INTRAVENOUS
BYFAVO
+! ACACIA EQ 20MG BASE/VIAL N212295 001 Oct 06, 2020
REPAGLINIDE
TABLET;ORAL
REPAGLINIDE
AB AUROBINDO PHARMA 0.5MG A203820 001 Jan 22, 2014
LTD
AB 1MG A203820 002 Jan 22, 2014
AB ! 2MG A203820 003 Jan 22, 2014
AB CHARTWELL RX 0.5MG A078555 001 Nov 22, 2013
AB 1MG A078555 002 Jan 22, 2014
AB 2MG A078555 003 Jan 22, 2014
AB PADAGIS US 0.5MG A201189 001 Jul 17, 2013
AB 1MG A201189 002 Jan 22, 2014
AB 2MG A201189 003 Jan 22, 2014
AB SUN PHARM INDS INC 1MG A077571 002 Jul 11, 2013
AB 2MG A077571 003 Jul 11, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-396(of 474)

RETAPAMULIN
OINTMENT;TOPICAL
ALTABAX
+! ALMIRALL 1% N022055 001 Apr 12, 2007
REVEFENACIN
SOLUTION;INHALATION
YUPELRI
+! MYLAN IRELAND LTD 175MCG/3ML N210598 001 Nov 09, 2018
RIBAVIRIN
CAPSULE;ORAL
RIBAVIRIN
AB ! AUROBINDO PHARMA 200MG A079117 001 Sep 17, 2009
AB ZYDUS PHARMS USA 200MG A077224 001 Oct 28, 2005
FOR SOLUTION;INHALATION
RIBAVIRIN
AN NAVINTA LLC 6GM/VIAL A207366 001 Oct 06, 2016
VIRAZOLE
AN +! BAUSCH 6GM/VIAL N018859 001 Dec 31, 1985
TABLET;ORAL
RIBAVIRIN
AB AUROBINDO PHARMA 200MG A079111 001 Sep 17, 2009
AB SANDOZ 200MG A077743 001 Oct 03, 2006
AB ZYDUS PHARMS USA 200MG A077094 001 Dec 05, 2005
RIBOCICLIB SUCCINATE
TABLET;ORAL
KISQALI
+! NOVARTIS EQ 200MG BASE N209092 001 Mar 13, 2017
RIBOFLAVIN 5'-PHOSPHATE SODIUM
SOLUTION/DROPS;OPHTHALMIC
PHOTREXA
+! GLAUKOS 0.146% N203324 001 Apr 15, 2016
PHOTREXA VISCOUS IN DEXTRAN 20%
+! GLAUKOS 0.146% N203324 002 Apr 15, 2016
RIFABUTIN
CAPSULE;ORAL
MYCOBUTIN
AB +! PFIZER 150MG N050689 001 Dec 23, 1992
RIFABUTIN
AB LUPIN LTD 150MG A090033 001 Feb 24, 2014
AB NOVITIUM PHARMA 150MG A215041 001 Dec 17, 2021
RIFAMPIN
CAPSULE;ORAL
RIFAMPIN
AB AKORN 150MG A065028 001 Mar 14, 2001
AB 300MG A065028 002 Mar 14, 2001
AB CHARTWELL MOLECULAR 150MG A065390 001 Mar 28, 2008
AB 300MG A065390 002 Mar 28, 2008
AB EPIC PHARMA 150MG A064150 002 Jan 02, 1998
AB 300MG A064150 001 May 28, 1997
AB LUPIN PHARMS 150MG A090034 001 Aug 21, 2013
AB ! 300MG A090034 002 Aug 21, 2013
RIMACTANE
AB OXFORD PHARMS 300MG N050429 001
INJECTABLE;INJECTION
RIFADIN
AP +! SANOFI AVENTIS US 600MG/VIAL N050627 001 May 25, 1989
RIFAMPIN
AP AKORN 600MG/VIAL A065502 001 Sep 21, 2010
AP FRESENIUS KABI USA 600MG/VIAL A091181 001 Aug 21, 2014
AP HIKMA 600MG/VIAL A064217 001 Oct 29, 1999
AP HIKMA PHARMS 600MG/VIAL A205039 001 Mar 03, 2016
AP MYLAN LABS LTD 600MG/VIAL A065421 001 May 22, 2008
RIFAMYCIN SODIUM
TABLET, DELAYED RELEASE;ORAL
AEMCOLO
+! REDHILL EQ 194MG BASE N210910 001 Nov 16, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-397(of 474)

RIFAPENTINE
TABLET;ORAL
PRIFTIN
+! SANOFI AVENTIS US 150MG N021024 001 Jun 22, 1998
RIFAXIMIN
TABLET;ORAL
XIFAXAN
+! SALIX PHARMS 200MG N021361 001 May 25, 2004
+! 550MG N021361 002 Mar 24, 2010
RILPIVIRINE HYDROCHLORIDE
TABLET;ORAL
EDURANT
+! JANSSEN PRODS EQ 25MG BASE N202022 001 May 20, 2011
RILUZOLE
FILM;ORAL
EXSERVAN
+! AQUESTIVE 50MG N212640 001 Nov 22, 2019
SUSPENSION;ORAL
TIGLUTIK KIT
+! ITALFARMACO SA 50MG/10ML N209080 001 Sep 05, 2018
TABLET;ORAL
RILUTEK
AB +! COVIS 50MG N020599 001 Dec 12, 1995
RILUZOLE
AB ALKEM LABS LTD 50MG A204048 001 Mar 30, 2016
AB GLENMARK PHARMS LTD 50MG A091394 001 Jun 18, 2013
AB IMPAX LABS 50MG A076173 001 Jan 29, 2003
AB KENTON 50MG A206045 001 Dec 09, 2019
AB MYLAN PHARMS INC 50MG A203042 001 Jul 01, 2013
AB SUN PHARM INDS LTD 50MG A091417 001 Jun 18, 2013
RIMANTADINE HYDROCHLORIDE
TABLET;ORAL
FLUMADINE
AB +! SUN PHARM INDS INC 100MG N019649 001 Sep 17, 1993
RIMANTADINE HYDROCHLORIDE
AB IMPAX LABS 100MG A076132 001 Aug 30, 2002
RIMEGEPANT SULFATE
TABLET, ORALLY DISINTEGRATING;ORAL
NURTEC ODT
+! BIOHAVEN IRELAND EQ 75MG BASE N212728 001 Feb 27, 2020
RIOCIGUAT
TABLET;ORAL
ADEMPAS
AB + BAYER HLTHCARE 0.5MG N204819 001 Oct 08, 2013
AB + 1MG N204819 002 Oct 08, 2013
AB + 1.5MG N204819 003 Oct 08, 2013
AB + 2MG N204819 004 Oct 08, 2013
AB +! 2.5MG N204819 005 Oct 08, 2013
RIOCIGUAT
AB MSN 0.5MG A211135 001 Sep 01, 2022
AB 1MG A211135 002 Sep 01, 2022
AB 1.5MG A211135 003 Sep 01, 2022
AB 2MG A211135 004 Sep 01, 2022
AB 2.5MG A211135 005 Sep 01, 2022
RIPRETINIB
TABLET;ORAL
QINLOCK
+! DECIPHERA PHARMS 50MG N213973 001 May 15, 2020
RISDIPLAM
FOR SOLUTION;ORAL
EVRYSDI
+! GENENTECH INC 0.75MG/ML N213535 001 Aug 07, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-398(of 474)

RISEDRONATE SODIUM
TABLET;ORAL
ACTONEL
AB +! APIL 35MG N020835 003 May 25, 2002
AB +! 150MG N020835 005 Apr 22, 2008
RISEDRONATE SODIUM
AB APOTEX INC 35MG A090877 001 Nov 30, 2015
AB 75MG A090877 002 Jun 10, 2014
AB 150MG A090877 003 Jun 10, 2014
AB AUROBINDO PHARMA 150MG A206768 001 Oct 21, 2016
AB AUROBINDO PHARMA 5MG A200296 001 Nov 30, 2015
LTD
AB 30MG A200296 002 Nov 30, 2015
AB 35MG A200296 003 Nov 30, 2015
AB MACLEODS PHARMS LTD 5MG A203533 001 Dec 09, 2015
AB 30MG A203533 002 Dec 09, 2015
AB 35MG A203533 003 Nov 29, 2016
AB ORBION PHARMS 30MG A205280 001 May 13, 2019
AB 35MG A205280 002 May 13, 2019
AB SUN PHARM 5MG A090886 001 Nov 30, 2015
AB 30MG A090886 002 Nov 30, 2015
AB 35MG A090886 003 Nov 30, 2015
AB 75MG A090886 004 Jun 10, 2014
AB 150MG A090886 005 Jun 10, 2014
AB TEVA PHARMS USA 5MG A077132 001 Oct 05, 2007
AB 30MG A077132 002 Oct 05, 2007
AB 35MG A077132 003 Oct 05, 2007
AB 150MG A079215 001 Jun 13, 2014
TABLET, DELAYED RELEASE;ORAL
ATELVIA
AB +! APIL 35MG N022560 001 Oct 08, 2010
RISEDRONATE SODIUM
AB SUN PHARM 35MG A203925 001 Jul 09, 2019
AB TEVA PHARMS USA 35MG A203217 001 May 18, 2015
RISPERIDONE
FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS
PERSERIS KIT
+ INDIVIOR INC 90MG N210655 001 Jul 27, 2018
+! 120MG N210655 002 Jul 27, 2018
INJECTABLE;INTRAMUSCULAR
RISPERDAL CONSTA
+ JANSSEN PHARMS 12.5MG/VIAL N021346 004 Apr 12, 2007
+! 25MG/VIAL N021346 001 Oct 29, 2003
+ 37.5MG/VIAL N021346 002 Oct 29, 2003
+ 50MG/VIAL N021346 003 Oct 29, 2003
SOLUTION;ORAL
RISPERDAL
AA +! JANSSEN PHARMS 1MG/ML N020588 001 Jun 10, 1996
RISPERIDONE
AA AMNEAL PHARMS 1MG/ML A091384 001 May 25, 2011
AA AUROBINDO PHARMA 1MG/ML A078452 001 Sep 04, 2009
LTD
AA CHARTWELL MOLECULAR 1MG/ML A202386 001 Jan 12, 2015
AA HIKMA 1MG/ML A076904 001 Jul 29, 2009
AA LANNETT CO INC 1MG/ML A079158 001 Dec 03, 2010
AA PHARM ASSOC 1MG/ML A077719 001 Jul 29, 2009
AA TARO 1MG/ML A090347 001 Feb 07, 2011
AA TRIS PHARMA INC 1MG/ML A079059 001 Dec 12, 2012
TABLET;ORAL
RISPERDAL
AB + JANSSEN PHARMS 0.25MG N020272 008 May 10, 1999
AB + 0.5MG N020272 007 Jan 27, 1999
AB +! 1MG N020272 001 Dec 29, 1993
AB + 2MG N020272 002 Dec 29, 1993
AB + 3MG N020272 003 Dec 29, 1993
AB + 4MG N020272 004 Dec 29, 1993
RISPERIDONE
AB AJANTA PHARMA LTD 0.25MG A201003 001 Aug 24, 2011
AB 0.5MG A201003 002 Aug 24, 2011
AB 1MG A201003 003 Aug 24, 2011
AB 2MG A201003 004 Aug 24, 2011
AB 3MG A201003 005 Aug 24, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-399(of 474)

RISPERIDONE
TABLET;ORAL
RISPERIDONE
AB 4MG A201003 006 Aug 24, 2011
AB AMNEAL 0.25MG A078071 001 Jun 17, 2009
AB 0.5MG A078071 002 Jun 17, 2009
AB 1MG A078071 003 Jun 17, 2009
AB 2MG A078071 004 Jun 17, 2009
AB 3MG A078071 005 Jun 17, 2009
AB 4MG A078071 006 Jun 17, 2009
AB APOTEX INC 0.25MG A077953 001 Sep 15, 2008
AB 0.5MG A077953 002 Sep 15, 2008
AB 1MG A077953 003 Sep 15, 2008
AB 2MG A077953 004 Sep 15, 2008
AB 3MG A077953 005 Sep 15, 2008
AB 4MG A077953 006 Sep 15, 2008
AB CELLTRION 0.25MG A078871 001 Oct 09, 2008
AB 0.5MG A078871 002 Oct 09, 2008
AB 1MG A078871 003 Oct 09, 2008
AB 2MG A078871 004 Oct 09, 2008
AB 3MG A078871 005 Oct 09, 2008
AB 4MG A078871 006 Oct 09, 2008
AB CHARTWELL MOLECULAR 0.25MG A077543 001 May 18, 2011
AB 0.5MG A077543 002 May 18, 2011
AB 1MG A077543 003 May 18, 2011
AB 2MG A077543 004 May 18, 2011
AB 3MG A077543 005 May 18, 2011
AB 4MG A077543 006 May 18, 2011
AB DR REDDYS LABS LTD 0.25MG A076879 001 Oct 24, 2008
AB 0.5MG A076879 002 Oct 24, 2008
AB 1MG A076879 003 Oct 24, 2008
AB 2MG A076879 004 Oct 24, 2008
AB 3MG A076879 005 Oct 24, 2008
AB 4MG A076879 006 Oct 24, 2008
AB PRINSTON INC 0.25MG A077493 001 Nov 29, 2011
AB 0.5MG A077493 002 Nov 29, 2011
AB 1MG A077493 003 Nov 29, 2011
AB 2MG A077493 004 Nov 29, 2011
AB 3MG A077493 005 Nov 29, 2011
AB 4MG A077493 006 Nov 29, 2011
AB RENATA 0.25MG A078707 001 Dec 29, 2008
AB 0.5MG A078707 002 Dec 29, 2008
AB 1MG A078707 003 Dec 29, 2008
AB 2MG A078707 004 Dec 29, 2008
AB 3MG A078707 005 Dec 29, 2008
AB 4MG A078707 006 Dec 29, 2008
AB RISING 0.25MG A078269 001 Oct 08, 2008
AB 0.5MG A078269 002 Oct 08, 2008
AB 1MG A078269 003 Oct 08, 2008
AB 2MG A078269 004 Oct 08, 2008
AB 3MG A078269 005 Oct 08, 2008
AB 4MG A078269 006 Oct 08, 2008
AB SANDOZ 0.25MG A078528 001 Oct 16, 2009
AB 0.5MG A078528 002 Oct 16, 2009
AB 1MG A078528 003 Oct 16, 2009
AB 2MG A078528 004 Oct 16, 2009
AB 3MG A078528 005 Oct 16, 2009
AB 4MG A078528 006 Oct 16, 2009
AB TORRENT PHARMS 0.25MG A079088 001 Oct 30, 2008
AB 0.5MG A079088 002 Oct 30, 2008
AB 1MG A079088 003 Oct 30, 2008
AB 2MG A079088 004 Oct 30, 2008
AB 3MG A079088 005 Oct 30, 2008
AB 4MG A079088 006 Oct 30, 2008
AB ZYDUS PHARMS USA 0.25MG A078040 001 Oct 16, 2008
INC
AB 0.5MG A078040 002 Oct 16, 2008
AB 1MG A078040 003 Oct 16, 2008
AB 2MG A078040 004 Oct 16, 2008
AB 3MG A078040 005 Oct 16, 2008
AB 4MG A078040 006 Oct 16, 2008
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-400(of 474)

RISPERIDONE
TABLET, ORALLY DISINTEGRATING;ORAL
RISPERIDONE
AB DR REDDYS LABS LTD 0.5MG A077328 001 Feb 24, 2009
AB 1MG A077328 002 Oct 05, 2009
AB 2MG A077328 003 Feb 24, 2009
AB 3MG A077328 004 Nov 30, 2009
AB 4MG A077328 005 Nov 30, 2009
AB JUBILANT GENERICS 0.5MG A090839 001 Nov 04, 2011
AB ! 1MG A090839 002 Nov 04, 2011
AB 2MG A090839 003 Nov 04, 2011
AB 3MG A090839 004 Nov 04, 2011
AB 4MG A090839 005 Nov 04, 2011
AB PAR PHARM 0.5MG A077494 002 Apr 30, 2009
AB 1MG A077494 003 Oct 26, 2009
AB 2MG A077494 004 Apr 30, 2009
AB 3MG A077494 005 Apr 30, 2009
AB 4MG A077494 006 Apr 30, 2009
AB SANDOZ 0.5MG A078116 001 Dec 22, 2009
AB 1MG A078116 002 Dec 22, 2009
AB 2MG A078116 003 Dec 22, 2009
AB 3MG A078116 004 Dec 22, 2009
AB 4MG A078116 005 Dec 22, 2009
AB SUN PHARM INDS LTD 0.5MG A077542 001 Aug 06, 2010
AB 0.5MG A078464 001 Apr 08, 2013
AB 1MG A077542 002 Aug 06, 2010
AB 1MG A078464 002 Apr 08, 2013
AB 2MG A077542 003 Aug 06, 2010
AB 2MG A078464 003 Apr 08, 2013
AB 3MG A078464 004 Apr 08, 2013
AB 3MG A078474 001 Aug 06, 2010
AB 4MG A078464 005 Apr 08, 2013
AB 4MG A078474 002 Aug 06, 2010
AB ZYDUS PHARMS USA 0.5MG A078516 001 May 01, 2009
AB 2MG A078516 003 May 01, 2009
PAR PHARM 0.25MG A077494 001 Apr 30, 2009
RITONAVIR
POWDER;ORAL
NORVIR
+! ABBVIE INC 100MG/PACKET N209512 001 Jun 07, 2017
SOLUTION;ORAL
NORVIR
+! ABBVIE 80MG/ML N020659 001 Mar 01, 1996
TABLET;ORAL
NORVIR
AB +! ABBVIE 100MG N022417 001 Feb 10, 2010
RITONAVIR
AB AMNEAL 100MG A208890 001 Sep 17, 2018
AB AUROBINDO PHARMA 100MG A206614 001 Sep 17, 2018
LTD
AB CIPLA 100MG A202573 001 Jan 15, 2015
AB 100MG A203759 001 May 10, 2022
AB HETERO LABS LTD III 100MG A204587 001 Sep 17, 2018
RIVAROXABAN
FOR SUSPENSION;ORAL
XARELTO
+! JANSSEN PHARMS 1MG/ML N215859 001 Dec 20, 2021
TABLET;ORAL
XARELTO
+ JANSSEN PHARMS 2.5MG N022406 004 Oct 11, 2018
+ 10MG N022406 001 Jul 01, 2011
+ 15MG N022406 002 Nov 04, 2011
+! 20MG N022406 003 Nov 04, 2011
RIVASTIGMINE
FILM, EXTENDED RELEASE;TRANSDERMAL
EXELON
AB + NOVARTIS 4.6MG/24HR N022083 001 Jul 06, 2007
AB +! 9.5MG/24HR N022083 002 Jul 06, 2007
AB + 13.3MG/24HR N022083 005 Aug 31, 2012
RIVASTIGMINE
AB ALVOGEN 4.6MG/24HR A204403 001 Sep 03, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-401(of 474)

RIVASTIGMINE
FILM, EXTENDED RELEASE;TRANSDERMAL
RIVASTIGMINE
AB 9.5MG/24HR A204403 002 Sep 03, 2015
AB 13.3MG/24HR A204403 003 Aug 31, 2015
AB AMNEAL PHARMS 4.6MG/24HR A207308 001 Jan 08, 2019
AB 9.5MG/24HR A207308 002 Jan 08, 2019
AB 13.3MG/24HR A207308 003 Jan 08, 2019
AB BRECKENRIDGE 4.6MG/24HR A209063 001 Nov 26, 2019
AB 9.5MG/24HR A209063 002 Nov 26, 2019
AB 13.3MG/24HR A209063 003 Nov 26, 2019
AB MYLAN TECHNOLOGIES 4.6MG/24HR A205622 001 Jun 20, 2018
AB 9.5MG/24HR A205622 002 Jun 20, 2018
AB 13.3MG/24HR A205622 003 Jun 20, 2018
AB ZYDUS PHARMS 4.6MG/24HR A206318 001 Mar 04, 2019
AB 9.5MG/24HR A206318 002 Mar 04, 2019
AB 13.3MG/24HR A206318 003 Mar 04, 2019
RIVASTIGMINE TARTRATE
CAPSULE;ORAL
RIVASTIGMINE TARTRATE
AB ALEMBIC PHARMS LTD EQ 1.5MG BASE A091689 001 Jun 12, 2012
AB EQ 3MG BASE A091689 002 Jun 12, 2012
AB EQ 4.5MG BASE A091689 003 Jun 12, 2012
AB EQ 6MG BASE A091689 004 Jun 12, 2012
AB AUROBINDO PHARMA EQ 1.5MG BASE A204572 001 Mar 25, 2016
AB EQ 3MG BASE A204572 002 Mar 25, 2016
AB EQ 4.5MG BASE A204572 003 Mar 25, 2016
AB EQ 6MG BASE A204572 004 Mar 25, 2016
AB CADILA PHARMS LTD EQ 1.5MG BASE A203844 001 Feb 13, 2017
AB EQ 3MG BASE A203844 002 Feb 13, 2017
AB EQ 4.5MG BASE A203844 003 Feb 13, 2017
AB EQ 6MG BASE A203844 004 Feb 13, 2017
AB CHARTWELL RX EQ 1.5MG BASE A207797 001 Sep 28, 2017
AB EQ 3MG BASE A207797 002 Sep 28, 2017
AB EQ 4.5MG BASE A207797 003 Sep 28, 2017
AB EQ 6MG BASE A207797 004 Sep 28, 2017
AB ! DR REDDYS LABS INC EQ 1.5MG BASE A077130 001 Oct 31, 2007
AB EQ 3MG BASE A077130 002 Oct 31, 2007
AB EQ 4.5MG BASE A077130 003 Oct 31, 2007
AB ! EQ 6MG BASE A077130 004 Oct 31, 2007
AB MACLEODS PHARMS LTD EQ 1.5MG BASE A203148 001 Aug 22, 2014
AB EQ 3MG BASE A203148 002 Aug 22, 2014
AB EQ 4.5MG BASE A203148 003 Aug 22, 2014
AB EQ 6MG BASE A203148 004 Aug 22, 2014
AB ORBION PHARMS EQ 1.5MG BASE A090879 001 Jun 10, 2015
AB EQ 3MG BASE A090879 002 Jun 10, 2015
AB EQ 4.5MG BASE A090879 003 Jun 10, 2015
AB EQ 6MG BASE A090879 004 Jun 10, 2015
AB SUN PHARM EQ 1.5MG BASE A077131 001 Oct 22, 2007
AB EQ 3MG BASE A077131 002 Oct 22, 2007
AB EQ 4.5MG BASE A077131 003 Oct 22, 2007
AB EQ 6MG BASE A077131 004 Oct 22, 2007
AB WATSON LABS EQ 1.5MG BASE A077129 001 Jan 08, 2008
AB EQ 3MG BASE A077129 002 Jan 08, 2008
AB EQ 4.5MG BASE A077129 003 Jan 08, 2008
AB EQ 6MG BASE A077129 004 Jan 08, 2008
RIZATRIPTAN BENZOATE
TABLET;ORAL
MAXALT
AB +! ORGANON LLC EQ 10MG BASE N020864 002 Jun 29, 1998
RIZATRIPTAN BENZOATE
AB ALKEM LABS LTD EQ 5MG BASE A203269 001 Feb 18, 2016
AB EQ 10MG BASE A203269 002 Feb 18, 2016
AB AUROBINDO PHARMA EQ 5MG BASE A202490 001 Dec 31, 2012
LTD
AB EQ 10MG BASE A202490 002 Dec 31, 2012
AB CELLTRION EQ 5MG BASE A077526 001 Mar 26, 2013
AB EQ 10MG BASE A077526 002 Mar 26, 2013
AB GLENMARK GENERICS EQ 5MG BASE A201967 001 Dec 31, 2012
AB EQ 10MG BASE A201967 002 Dec 31, 2012
AB INVAGEN PHARMS EQ 5MG BASE A204339 001 Jul 01, 2013
AB EQ 10MG BASE A204339 002 Jul 01, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-402(of 474)

RIZATRIPTAN BENZOATE
TABLET;ORAL
RIZATRIPTAN BENZOATE
AB MACLEODS PHARMS LTD EQ 5MG BASE A203147 001 Feb 11, 2014
AB EQ 10MG BASE A203147 002 Feb 11, 2014
AB MYLAN PHARMS INC EQ 5MG BASE A201993 001 Dec 31, 2012
AB EQ 10MG BASE A201993 002 Dec 31, 2012
AB NATCO PHARMA LTD EQ 5MG BASE A200482 001 Dec 31, 2012
AB EQ 10MG BASE A200482 002 Dec 31, 2012
AB PHARMGEN EQ 5MG BASE A202047 001 Dec 31, 2012
AB EQ 10MG BASE A202047 002 Dec 31, 2012
AB TEVA PHARMS EQ 5MG BASE A077263 001 Dec 31, 2012
AB EQ 10MG BASE A077263 002 Dec 31, 2012
TABLET, ORALLY DISINTEGRATING;ORAL
MAXALT-MLT
AB +! ORGANON EQ 10MG BASE N020865 002 Jun 29, 1998
RIZATRIPTAN BENZOATE
AB AUROBINDO PHARMA EQ 5MG BASE A203062 001 Jul 01, 2013
LTD
AB EQ 10MG BASE A203062 002 Jul 01, 2013
AB GLENMARK PHARMS LTD EQ 5MG BASE A201914 001 Jul 01, 2013
AB EQ 10MG BASE A201914 002 Jul 01, 2013
AB MACLEODS PHARMS LTD EQ 5MG BASE A203146 001 Sep 19, 2014
AB EQ 10MG BASE A203146 002 Sep 19, 2014
AB NATCO PHARMA LTD EQ 5MG BASE A203478 001 Jul 01, 2013
AB EQ 10MG BASE A203478 002 Jul 01, 2013
AB PANACEA EQ 5MG BASE A204722 001 Jan 11, 2017
AB EQ 10MG BASE A204722 002 Jan 11, 2017
AB UNICHEM EQ 5MG BASE A207835 001 Mar 07, 2017
AB EQ 10MG BASE A207835 002 Mar 07, 2017
ROCURONIUM BROMIDE
INJECTABLE;INJECTION
ROCURONIUM BROMIDE
AP EUGIA PHARMA 50MG/5ML (10MG/ML) A206206 001 Apr 12, 2017
AP 100MG/10ML (10MG/ML) A206206 002 Apr 12, 2017
AP FRESENIUS KABI USA 50MG/5ML (10MG/ML) A078651 001 Dec 29, 2008
AP 100MG/10ML (10MG/ML) A078651 002 Dec 29, 2008
AP GLAND PHARMA LTD 50MG/5ML (10MG/ML) A205656 001 Apr 04, 2018
AP 100MG/10ML (10MG/ML) A205656 002 Apr 04, 2018
AP HOSPIRA 50MG/5ML (10MG/ML) A078519 001 Nov 26, 2008
AP 100MG/10ML (10MG/ML) A078519 002 Nov 26, 2008
AP MYLAN INSTITUTIONAL 50MG/5ML (10MG/ML) A079199 001 Nov 26, 2008
AP 100MG/10ML (10MG/ML) A079199 002 Nov 26, 2008
AP PIRAMAL CRITICAL 50MG/5ML (10MG/ML) A210437 001 Aug 13, 2019
AP 100MG/10ML (10MG/ML) A210437 002 Aug 13, 2019
AP PRINSTON INC 50MG/5ML (10MG/ML) A212668 001 May 26, 2022
AP 100MG/10ML (10MG/ML) A212668 002 May 26, 2022
AP SAGENT PHARMS INC 50MG/5ML (10MG/ML) A091458 001 Jul 28, 2010
AP 100MG/10ML (10MG/ML) A091458 002 Jul 28, 2010
AP ! SANDOZ INC 50MG/5ML (10MG/ML) A079195 001 Dec 05, 2008
AP ! 100MG/10ML (10MG/ML) A079195 002 Dec 05, 2008
AP TAMARANG 50MG/5ML (10MG/ML) A091115 001 Aug 27, 2012
AP 100MG/10ML (10MG/ML) A091115 002 Aug 27, 2012
AP WEST WARD PHARM 50MG/5ML (10MG/ML) A204679 001 Feb 28, 2017
CORP
AP 100MG/10ML (10MG/ML) A204679 002 Feb 28, 2017
ROFLUMILAST
CREAM;TOPICAL
ZORYVE
+! ARCUTIS 0.3% N215985 001 Jul 29, 2022
TABLET;ORAL
DALIRESP
AB + ASTRAZENECA 250MCG N022522 002 Jan 23, 2018
AB +! 500MCG N022522 001 Feb 28, 2011
ROFLUMILAST
AB HETERO LABS LTD III 500MCG A208213 001 Nov 23, 2018
AB MICRO LABS 500MCG A208180 001 Mar 22, 2019
AB MSN 250MCG A208256 001 Sep 07, 2022
AB 500MCG A208256 002 Sep 07, 2022
AB MYLAN 500MCG A208257 001 Jul 13, 2018
AB PRINSTON INC 500MCG A208299 001 May 10, 2022
AB STRIDES PHARMA 500MCG A208247 001 Mar 30, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-403(of 474)

ROFLUMILAST
TABLET;ORAL
ROFLUMILAST
AB TORRENT 500MCG A208272 001 Aug 06, 2018
AB ZYDUS PHARMS 500MCG A208303 001 Feb 10, 2022
ROLAPITANT HYDROCHLORIDE
TABLET;ORAL
VARUBI
+! TERSERA EQ 90MG BASE N206500 001 Sep 01, 2015
ROMIDEPSIN
POWDER;INTRAVENOUS
ISTODAX
AP +! CELGENE 10MG/VIAL N022393 001 Nov 05, 2009
ROMIDEPSIN
AP FRESENIUS KABI USA 10MG/VIAL A206254 001 Oct 12, 2021
ROPINIROLE HYDROCHLORIDE
TABLET;ORAL
ROPINIROLE HYDROCHLORIDE
AB ACCORD HLTHCARE EQ 0.25MG BASE A204022 001 Feb 28, 2017
AB EQ 0.5MG BASE A204022 002 Feb 28, 2017
AB EQ 1MG BASE A204022 003 Feb 28, 2017
AB EQ 2MG BASE A204022 004 Feb 28, 2017
AB EQ 3MG BASE A204022 005 Feb 28, 2017
AB EQ 4MG BASE A204022 006 Feb 28, 2017
AB EQ 5MG BASE A204022 007 Feb 28, 2017
AB ALEMBIC LTD EQ 0.25MG BASE A090429 001 Mar 24, 2010
AB EQ 0.5MG BASE A090429 002 Mar 24, 2010
AB EQ 1MG BASE A090429 003 Mar 24, 2010
AB EQ 2MG BASE A090429 004 Mar 24, 2010
AB EQ 3MG BASE A090429 005 Mar 24, 2010
AB EQ 4MG BASE A090429 006 Mar 24, 2010
AB EQ 5MG BASE A090429 007 Mar 24, 2010
AB CADILA EQ 0.25MG BASE A090411 001 Jun 01, 2009
AB EQ 0.5MG BASE A090411 002 Jun 01, 2009
AB EQ 1MG BASE A090411 003 Jun 01, 2009
AB EQ 2MG BASE A090411 004 Jun 01, 2009
AB EQ 3MG BASE A090411 005 Jun 01, 2009
AB EQ 4MG BASE A090411 006 Jun 01, 2009
AB EQ 5MG BASE A090411 007 Jun 01, 2009
AB CELLTRION EQ 0.25MG BASE A079050 001 May 29, 2008
AB EQ 0.5MG BASE A079050 002 May 29, 2008
AB EQ 1MG BASE A079050 003 May 29, 2008
AB EQ 2MG BASE A079050 004 May 29, 2008
AB EQ 3MG BASE A079050 005 May 29, 2008
AB EQ 4MG BASE A079050 006 May 29, 2008
AB EQ 5MG BASE A079050 007 May 29, 2008
AB GLENMARK GENERICS EQ 0.25MG BASE A090135 001 Feb 25, 2010
AB EQ 0.5MG BASE A090135 002 Feb 25, 2010
AB EQ 1MG BASE A090135 003 Feb 25, 2010
AB EQ 2MG BASE A090135 004 Feb 25, 2010
AB EQ 3MG BASE A090135 005 Feb 25, 2010
AB EQ 4MG BASE A090135 006 Feb 25, 2010
AB EQ 5MG BASE A090135 007 Feb 25, 2010
AB MLV EQ 0.25MG BASE A079165 001 Feb 07, 2012
AB EQ 0.5MG BASE A079165 002 Feb 07, 2012
AB EQ 1MG BASE A079165 003 Feb 07, 2012
AB EQ 2MG BASE A079165 004 Feb 07, 2012
AB EQ 3MG BASE A079165 005 Feb 07, 2012
AB EQ 4MG BASE A079165 006 Feb 07, 2012
AB EQ 5MG BASE A079165 007 Feb 07, 2012
AB MYLAN EQ 0.25MG BASE A078881 001 May 05, 2008
AB EQ 0.5MG BASE A078881 002 May 05, 2008
AB EQ 1MG BASE A078881 003 May 05, 2008
AB EQ 2MG BASE A078881 004 May 05, 2008
AB EQ 3MG BASE A078881 005 May 05, 2008
AB EQ 4MG BASE A078881 006 May 05, 2008
AB EQ 5MG BASE A078881 007 May 19, 2008
AB ORBION PHARMS EQ 0.25MG BASE A079229 001 Nov 28, 2012
AB EQ 0.5MG BASE A079229 002 Nov 28, 2012
AB EQ 1MG BASE A079229 003 Nov 28, 2012
AB EQ 2MG BASE A079229 004 Nov 28, 2012
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-404(of 474)

ROPINIROLE HYDROCHLORIDE
TABLET;ORAL
ROPINIROLE HYDROCHLORIDE
AB EQ 3MG BASE A079229 005 Nov 28, 2012
AB EQ 4MG BASE A079229 006 Nov 28, 2012
AB EQ 5MG BASE A079229 007 Nov 28, 2012
AB ! PRINSTON INC EQ 0.25MG BASE A078110 001 May 05, 2008
AB EQ 0.5MG BASE A078110 002 May 05, 2008
AB EQ 1MG BASE A078110 003 May 05, 2008
AB EQ 2MG BASE A078110 004 May 05, 2008
AB EQ 3MG BASE A078110 005 May 05, 2008
AB EQ 4MG BASE A078110 006 May 05, 2008
AB EQ 5MG BASE A078110 007 Jul 11, 2008
TABLET, EXTENDED RELEASE;ORAL
ROPINIROLE HYDROCHLORIDE
AB ACTAVIS ELIZABETH EQ 2MG BASE A090869 001 May 17, 2012
AB EQ 4MG BASE A090869 002 May 17, 2012
AB EQ 6MG BASE A090869 003 May 17, 2012
AB EQ 8MG BASE A090869 004 May 17, 2012
AB EQ 12MG BASE A090869 005 May 17, 2012
AB ALEMBIC PHARMS EQ 2MG BASE A202786 001 Apr 22, 2013
AB EQ 4MG BASE A202786 002 Apr 22, 2013
AB EQ 6MG BASE A202786 003 Apr 22, 2013
AB EQ 8MG BASE A202786 004 Apr 22, 2013
AB EQ 12MG BASE A202786 005 Apr 22, 2013
AB CELLTRION EQ 2MG BASE A091395 001 Aug 27, 2012
AB EQ 4MG BASE A091395 002 Aug 27, 2012
AB EQ 6MG BASE A091395 003 Aug 27, 2012
AB EQ 8MG BASE A091395 004 Aug 27, 2012
AB EQ 12MG BASE A091395 005 Aug 27, 2012
AB ! DR REDDYS LABS LTD EQ 2MG BASE A201576 001 Jun 06, 2012
AB EQ 4MG BASE A201576 002 Jun 06, 2012
AB EQ 6MG BASE A201576 003 Jun 06, 2012
AB EQ 8MG BASE A201576 004 Jun 06, 2012
AB EQ 12MG BASE A201576 005 Jun 06, 2012
AB PRINSTON INC EQ 2MG BASE A204413 001 May 11, 2022
AB EQ 4MG BASE A204413 002 May 11, 2022
AB EQ 6MG BASE A204413 003 May 11, 2022
AB EQ 8MG BASE A204413 004 May 11, 2022
AB EQ 12MG BASE A204413 005 May 11, 2022
AB SANDOZ INC EQ 2MG BASE A201047 001 Jun 06, 2012
AB EQ 4MG BASE A201047 003 Jun 06, 2012
AB EQ 6MG BASE A201047 004 Jun 06, 2012
AB EQ 8MG BASE A201047 005 Jun 06, 2012
AB EQ 12MG BASE A201047 006 Jun 06, 2012
ROPIVACAINE HYDROCHLORIDE
SOLUTION;INJECTION
NAROPIN
AP + FRESENIUS KABI USA 20MG/10ML (2MG/ML) N020533 001 May 01, 1998
AP + 40MG/20ML (2MG/ML) N020533 002 Sep 24, 1996
AP + 100MG/20ML (5MG/ML) N020533 003 May 01, 1998
AP + 100MG/10ML (10MG/ML) N020533 005 Sep 24, 1996
AP + 150MG/20ML (7.5MG/ML) N020533 004 Sep 24, 1996
AP + 150MG/30ML (5MG/ML) N020533 008 Sep 24, 1996
AP + 200MG/100ML (2MG/ML) N020533 006 Sep 24, 1996
AP +! 200MG/20ML (10MG/ML) N020533 011 Sep 24, 1996
AP + 400MG/200ML (2MG/ML) N020533 007 Sep 24, 1996
AP + 500MG/100ML (5MG/ML) N020533 009 Jan 04, 2011
AP + 1GM/200ML (5MG/ML) N020533 010 Jan 04, 2011
ROPIVACAINE HYDROCHLORIDE
AP AKORN 200MG/100ML (2MG/ML) A204636 001 Mar 16, 2018
AP 400MG/200ML (2MG/ML) A204636 002 Mar 16, 2018
AP 150MG/30ML (5MG/ML) A203955 001 Apr 11, 2016
AP CAPLIN 40MG/20ML (2MG/ML) A212808 001 Apr 09, 2020
AP 100MG/20ML (5MG/ML) A212808 002 Apr 09, 2020
AP 150MG/30ML (5MG/ML) A212808 003 Apr 09, 2020
AP 200MG/20ML (10MG/ML) A212808 004 Apr 09, 2020
AP EUGIA PHARMA 40MG/20ML (2MG/ML) A205612 001 Jul 13, 2016
AP 100MG/20ML (5MG/ML) A205612 003 Jul 13, 2016
AP 100MG/10ML (10MG/ML) A205612 006 Jul 13, 2016
AP 150MG/30ML (5MG/ML) A205612 004 Jul 13, 2016
AP 150MG/20ML (7.5MG/ML) A205612 005 Jul 13, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-405(of 474)

ROPIVACAINE HYDROCHLORIDE
SOLUTION;INJECTION
ROPIVACAINE HYDROCHLORIDE
AP 200MG/100ML (2MG/ML) A205612 002 Jul 13, 2016
AP 200MG/20ML (10MG/ML) A205612 007 Jul 13, 2016
AP GLAND PHARMA LTD 200MG/100ML (2MG/ML) A210102 001 Aug 18, 2022
AP 400MG/200ML (2MG/ML) A210102 002 Aug 18, 2022
AP HIKMA 40MG/20ML (2MG/ML) A214074 001 Jul 20, 2020
AP 150MG/30ML (5MG/ML) A214074 002 Jul 20, 2020
AP 150MG/20ML (7.5MG/ML) A214074 003 Jul 20, 2020
AP 200MG/20ML (10MG/ML) A214074 004 Jul 20, 2020
AP HOSPIRA 20MG/10ML (2MG/ML) A090194 001 Sep 23, 2014
AP 40MG/20ML (2MG/ML) A090194 005 Sep 23, 2014
AP 100MG/10ML (10MG/ML) A090194 004 Sep 23, 2014
AP 150MG/30ML (5MG/ML) A090194 002 Sep 23, 2014
AP 150MG/20ML (7.5MG/ML) A090194 003 Sep 23, 2014
AP 200MG/20ML (10MG/ML) A090194 006 Sep 23, 2014
AP INFORLIFE 200MG/100ML (2MG/ML) A206166 001 Jun 11, 2018
AP 400MG/200ML (2MG/ML) A206166 002 Jun 11, 2018
AP 500MG/100ML (5MG/ML) A206166 003 Jun 11, 2018
AP 1GM/200ML (5MG/ML) A206166 004 Jun 11, 2018
AP NAVINTA LLC 150MG/30ML (5MG/ML) A078601 002 Jul 17, 2014
AP 200MG/20ML (10MG/ML) A078601 003 Jul 17, 2014
AP SOMERSET THERAPS 20MG/10ML (2MG/ML) A207636 001 Jun 15, 2018
LLC
AP 40MG/20ML (2MG/ML) A207636 002 Jun 15, 2018
AP 100MG/20ML (5MG/ML) A207636 003 Jun 15, 2018
AP 100MG/10ML (10MG/ML) A207636 006 Jun 15, 2018
AP 150MG/30ML (5MG/ML) A207636 004 Jun 15, 2018
AP 150MG/20ML (7.5MG/ML) A207636 005 Jun 15, 2018
AP 200MG/20ML (10MG/ML) A207636 007 Jun 15, 2018
ROSIGLITAZONE MALEATE
TABLET;ORAL
AVANDIA
+ WOODWARD EQ 2MG BASE N021071 002 May 25, 1999
+ EQ 4MG BASE N021071 003 May 25, 1999
ROSUVASTATIN CALCIUM
CAPSULE;ORAL
EZALLOR SPRINKLE
+ SUN PHARM EQ 5MG BASE N208647 001 Dec 18, 2018
+ EQ 10MG BASE N208647 002 Dec 18, 2018
+ EQ 20MG BASE N208647 003 Dec 18, 2018
+! EQ 40MG BASE N208647 004 Dec 18, 2018
TABLET;ORAL
CRESTOR
AB + IPR EQ 5MG BASE N021366 002 Aug 12, 2003
AB + EQ 10MG BASE N021366 003 Aug 12, 2003
AB + EQ 20MG BASE N021366 004 Aug 12, 2003
AB +! EQ 40MG BASE N021366 005 Aug 12, 2003
ROSUVASTATIN CALCIUM
AB ACCORD HLTHCARE EQ 5MG BASE A206434 001 Oct 31, 2016
AB EQ 10MG BASE A206434 002 Oct 31, 2016
AB EQ 20MG BASE A206434 003 Oct 31, 2016
AB EQ 40MG BASE A206434 004 Oct 31, 2016
AB ALKEM LABS LTD EQ 5MG BASE A206465 001 Mar 21, 2017
AB EQ 10MG BASE A206465 002 Mar 21, 2017
AB EQ 20MG BASE A206465 003 Mar 21, 2017
AB EQ 40MG BASE A206465 004 Mar 21, 2017
AB AUROBINDO PHARMA EQ 5MG BASE A079170 001 Jul 19, 2016
LTD
AB EQ 10MG BASE A079170 002 Jul 19, 2016
AB EQ 20MG BASE A079170 003 Jul 19, 2016
AB EQ 40MG BASE A079170 004 Jul 19, 2016
AB BIOCON PHARMA EQ 5MG BASE A207752 001 Oct 31, 2016
AB EQ 10MG BASE A207752 002 Oct 31, 2016
AB EQ 20MG BASE A207752 003 Oct 31, 2016
AB EQ 40MG BASE A207752 004 Oct 31, 2016
AB CADILA PHARMS LTD EQ 5MG BASE A207453 001 Nov 23, 2016
AB EQ 10MG BASE A207453 002 Nov 23, 2016
AB EQ 20MG BASE A207453 003 Nov 23, 2016
AB EQ 40MG BASE A207453 004 Nov 23, 2016
AB CHANGZHOU PHARM EQ 5MG BASE A207408 001 Oct 31, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-406(of 474)

ROSUVASTATIN CALCIUM
TABLET;ORAL
ROSUVASTATIN CALCIUM
AB EQ 10MG BASE A207408 002 Oct 31, 2016
AB EQ 20MG BASE A207408 003 Oct 31, 2016
AB EQ 40MG BASE A207408 004 Oct 31, 2016
AB CHARTWELL RX EQ 5MG BASE A079168 001 Jul 19, 2016
AB EQ 10MG BASE A079168 002 Jul 19, 2016
AB EQ 20MG BASE A079168 003 Jul 19, 2016
AB EQ 40MG BASE A079168 004 Jul 19, 2016
AB GLENMARK PHARMS EQ 5MG BASE A079172 001 Jul 19, 2016
AB EQ 10MG BASE A079172 002 Jul 19, 2016
AB EQ 20MG BASE A079172 003 Jul 19, 2016
AB EQ 40MG BASE A079172 004 Jul 19, 2016
AB HETERO LABS LTD V EQ 5MG BASE A207616 001 Oct 31, 2016
AB EQ 10MG BASE A207616 002 Oct 31, 2016
AB EQ 20MG BASE A207616 003 Oct 31, 2016
AB EQ 40MG BASE A207616 004 Oct 31, 2016
AB LUPIN EQ 5MG BASE A205587 001 Jul 31, 2017
AB EQ 10MG BASE A205587 002 Jul 31, 2017
AB EQ 20MG BASE A205587 003 Jul 31, 2017
AB EQ 40MG BASE A205587 004 Jul 31, 2017
AB MSN EQ 5MG BASE A208898 001 Nov 22, 2017
AB EQ 10MG BASE A208898 002 Nov 22, 2017
AB EQ 20MG BASE A208898 003 Nov 22, 2017
AB EQ 40MG BASE A208898 004 Nov 22, 2017
AB RENATA EQ 5MG BASE A207062 001 Oct 31, 2016
AB EQ 10MG BASE A207062 002 Oct 31, 2016
AB EQ 20MG BASE A207062 003 Oct 31, 2016
AB EQ 40MG BASE A207062 004 Oct 31, 2016
AB SANDOZ INC EQ 5MG BASE A079171 001 Jul 19, 2016
AB EQ 10MG BASE A079171 002 Jul 19, 2016
AB EQ 20MG BASE A079171 003 Jul 19, 2016
AB EQ 40MG BASE A079171 004 Jul 19, 2016
AB SCIEGEN PHARMS INC EQ 5MG BASE A206381 001 Apr 24, 2019
AB EQ 10MG BASE A206381 002 Apr 24, 2019
AB EQ 20MG BASE A206381 003 Apr 24, 2019
AB EQ 40MG BASE A206381 004 Apr 24, 2019
AB SHANDONG EQ 5MG BASE A207375 001 May 07, 2019
AB EQ 10MG BASE A207375 002 May 07, 2019
AB EQ 20MG BASE A207375 003 May 07, 2019
AB EQ 40MG BASE A207375 004 May 07, 2019
AB SUN PHARM EQ 5MG BASE A079169 001 Jul 19, 2016
AB EQ 10MG BASE A079169 002 Jul 19, 2016
AB EQ 20MG BASE A079169 003 Jul 19, 2016
AB EQ 40MG BASE A079169 004 Jul 19, 2016
AB TORRENT EQ 5MG BASE A201619 001 Oct 31, 2016
AB EQ 10MG BASE A201619 002 Oct 31, 2016
AB EQ 20MG BASE A201619 003 Oct 31, 2016
AB EQ 40MG BASE A201619 004 Oct 31, 2016
AB WATSON LABS INC EQ 5MG BASE A079167 001 Apr 29, 2016
AB EQ 10MG BASE A079167 002 Apr 29, 2016
AB EQ 20MG BASE A079167 003 Apr 29, 2016
AB EQ 40MG BASE A079167 004 Apr 29, 2016
AB ZHEJIANG YONGTAI EQ 5MG BASE A212059 001 Nov 04, 2019
AB EQ 10MG BASE A212059 002 Nov 04, 2019
AB EQ 20MG BASE A212059 003 Nov 04, 2019
AB EQ 40MG BASE A212059 004 Nov 04, 2019
ROTIGOTINE
FILM, EXTENDED RELEASE;TRANSDERMAL
NEUPRO
+ UCB INC 1MG/24HR N021829 004 Apr 02, 2012
+! 2MG/24HR N021829 001 May 09, 2007
+ 3MG/24HR N021829 005 Apr 02, 2012
+ 4MG/24HR N021829 002 May 09, 2007
+ 6MG/24HR N021829 003 May 09, 2007
+ 8MG/24HR N021829 006 Apr 02, 2012
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-407(of 474)

RUBIDIUM CHLORIDE RB-82


INJECTABLE;INJECTION
CARDIOGEN-82
BRACCO N/A N019414 001 Dec 29, 1989
SOLUTION;INTRAVENOUS
RUBY-FILL
JUBILANT N/A N202153 001 Sep 30, 2016
RUCAPARIB CAMSYLATE
TABLET;ORAL
RUBRACA
+ CLOVIS ONCOLOGY INC EQ 200MG BASE N209115 001 Dec 19, 2016
+ EQ 250MG BASE N209115 003 May 01, 2017
+! EQ 300MG BASE N209115 002 Dec 19, 2016
RUFINAMIDE
SUSPENSION;ORAL
BANZEL
AB +! EISAI INC 40MG/ML N201367 001 Mar 03, 2011
RUFINAMIDE
AB ALKEM LABS LTD 40MG/ML A213410 001 Feb 23, 2021
AB AUROBINDO PHARMA 40MG/ML A216549 001 Oct 26, 2022
AB BIONPHARMA INC 40MG/ML A211388 001 Apr 23, 2019
AB GLASSHOUSE PHARMS 40MG/ML A214009 001 Nov 07, 2022
AB HIKMA 40MG/ML A207363 001 Apr 23, 2019
AB LUPIN LTD 40MG/ML A213457 001 Dec 18, 2020
TABLET;ORAL
BANZEL
AB + EISAI INC 200MG N021911 002 Nov 14, 2008
AB +! 400MG N021911 003 Nov 14, 2008
RUFINAMIDE
AB GLENMARK PHARMS LTD 200MG A205075 001 May 16, 2016
AB 400MG A205075 002 May 16, 2016
AB HETERO LABS LTD III 200MG A204993 001 May 11, 2021
AB 400MG A204993 002 May 11, 2021
AB HIKMA 200MG A204988 001 May 16, 2016
AB 400MG A204988 002 May 16, 2016
AB LUPIN LTD 200MG A204964 002 Aug 17, 2022
AB 400MG A204964 003 Aug 17, 2022
AB MYLAN 200MG A205095 001 May 16, 2016
AB 400MG A205095 002 May 16, 2016
LUPIN LTD 100MG A204964 001 Aug 17, 2022
RUXOLITINIB PHOSPHATE
CREAM;TOPICAL
OPZELURA
+! INCYTE CORP EQ 1.5% BASE N215309 001 Sep 21, 2021
TABLET;ORAL
JAKAFI
+ INCYTE CORP EQ 5MG BASE N202192 001 Nov 16, 2011
+ EQ 10MG BASE N202192 002 Nov 16, 2011
+ EQ 15MG BASE N202192 003 Nov 16, 2011
+ EQ 20MG BASE N202192 004 Nov 16, 2011
+! EQ 25MG BASE N202192 005 Nov 16, 2011
SACUBITRIL; VALSARTAN
TABLET;ORAL
ENTRESTO
+ NOVARTIS PHARMS 24MG;26MG N207620 001 Jul 07, 2015
CORP
+ 49MG;51MG N207620 002 Jul 07, 2015
+! 97MG;103MG N207620 003 Jul 07, 2015
SAFINAMIDE MESYLATE
TABLET;ORAL
XADAGO
+ MDD US EQ 50MG BASE N207145 001 Mar 21, 2017
+! EQ 100MG BASE N207145 002 Mar 21, 2017
SALMETEROL XINAFOATE
POWDER;INHALATION
SEREVENT
+! GLAXOSMITHKLINE EQ 0.05MG BASE/INH N020692 001 Sep 19, 1997
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-408(of 474)

SAPROPTERIN DIHYDROCHLORIDE
POWDER;ORAL
KUVAN
AB +! BIOMARIN PHARM 100MG/PACKET N205065 001 Dec 19, 2013
AB + 500MG/PACKET N205065 002 Oct 27, 2015
SAPROPTERIN DIHYDROCHLORIDE
AB ANNORA PHARMA 100MG/PACKET A215420 001 Aug 18, 2022
AB 500MG/PACKET A215420 002 Aug 18, 2022
AB DR REDDYS 100MG/PACKET A209452 001 Mar 30, 2021
AB 500MG/PACKET A215798 001 May 13, 2022
AB PAR PHARM INC 100MG/PACKET A207207 001 Aug 20, 2019
AB 500MG/PACKET A210027 001 Aug 20, 2019
TABLET;ORAL
KUVAN
AB +! BIOMARIN PHARM 100MG N022181 001 Dec 13, 2007
SAPROPTERIN DIHYDROCHLORIDE
AB ANNORA PHARMA 100MG A215534 001 Aug 23, 2022
AB DR REDDYS 100MG A207685 001 Jun 15, 2021
AB PAR PHARM INC 100MG A207200 001 May 10, 2019
SARECYCLINE HYDROCHLORIDE
TABLET;ORAL
SEYSARA
+ ALMIRALL EQ 60MG BASE N209521 001 Oct 01, 2018
+ EQ 100MG BASE N209521 002 Oct 01, 2018
+! EQ 150MG BASE N209521 003 Oct 01, 2018
SAXAGLIPTIN HYDROCHLORIDE
TABLET;ORAL
ONGLYZA
+ ASTRAZENECA AB EQ 2.5MG BASE N022350 001 Jul 31, 2009
+! EQ 5MG BASE N022350 002 Jul 31, 2009
SCOPOLAMINE
SYSTEM;TRANSDERMAL
SCOPOLAMINE
AB ACTAVIS LABS UT INC 1MG/72HR A208769 001 Jan 10, 2022
AB MYLAN TECHNOLOGIES 1MG/72HR A203753 001 Jun 19, 2019
AB PADAGIS US 1MG/72HR A078830 001 Jan 30, 2015
AB RICONPHARMA LLC 1MG/72HR A212342 001 Nov 24, 2020
TRANSDERM SCOP
AB +! BAXTER HLTHCARE 1MG/72HR N017874 001
CORP
SECNIDAZOLE
GRANULE;ORAL
SOLOSEC
+! LUPIN 2GM/PACKET N209363 001 Sep 15, 2017
SECRETIN SYNTHETIC HUMAN
FOR SOLUTION;INTRAVENOUS
CHIRHOSTIM
+! CHIRHOCLIN 16MCG/VIAL N021256 001 Apr 09, 2004
+ 40MCG/VIAL N021256 002 Jun 21, 2007
SELEGILINE
FILM, EXTENDED RELEASE;TRANSDERMAL
EMSAM
+! SOMERSET 6MG/24HR N021336 001 Feb 27, 2006
+ 9MG/24HR N021336 002 Feb 27, 2006
+ 12MG/24HR N021336 003 Feb 27, 2006
SELEGILINE HYDROCHLORIDE
CAPSULE;ORAL
SELEGILINE HYDROCHLORIDE
AB ! APOTEX 5MG A075321 001 Dec 04, 1998
AB NOVITIUM PHARMA 5MG A075352 001 Nov 30, 1998
AB RISING 5MG A206803 001 Apr 02, 2019
TABLET;ORAL
SELEGILINE HYDROCHLORIDE
AB ! APOTEX INC 5MG A074871 001 Jun 06, 1997
AB I3 PHARMS 5MG A074672 001 Apr 01, 1997
TABLET, ORALLY DISINTEGRATING;ORAL
ZELAPAR
+! BAUSCH 1.25MG N021479 001 Jun 14, 2006
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-409(of 474)

SELENIOUS ACID
SOLUTION;INTRAVENOUS
SELENIOUS ACID
+! AM REGENT EQ 12MCG SELENIUM/2ML (EQ 6MCG N209379 003 Aug 30, 2021
SELENIUM/ML)
+! EQ 60MCG SELENIUM/ML (EQ 60MCG N209379 002 Jan 25, 2021
SELENIUM/ML)
+! EQ 600MCG SELENIUM/10ML (EQ 60MCG N209379 001 Apr 30, 2019
SELENIUM/ML)
SELENIUM SULFIDE
LOTION/SHAMPOO;TOPICAL
SELENIUM SULFIDE
! PADAGIS US 2.5% A089996 001 Jan 10, 1991
SELEXIPAG
POWDER;INTRAVENOUS
UPTRAVI
+! ACTELION 1.8MG/VIAL N214275 001 Jul 29, 2021
TABLET;ORAL
SELEXIPAG
AB ZYDUS 0.2MG A214302 001 Dec 21, 2022
AB 0.4MG A214302 002 Dec 21, 2022
AB 0.6MG A214302 003 Dec 21, 2022
AB 0.8MG A214302 004 Dec 21, 2022
AB 1MG A214302 005 Dec 21, 2022
AB 1.2MG A214302 006 Dec 21, 2022
AB 1.4MG A214302 007 Dec 21, 2022
AB 1.6MG A214302 008 Dec 21, 2022
UPTRAVI
AB + ACTELION 0.2MG N207947 001 Dec 21, 2015
AB +! 0.4MG N207947 002 Dec 21, 2015
AB + 0.6MG N207947 003 Dec 21, 2015
AB + 0.8MG N207947 004 Dec 21, 2015
AB + 1MG N207947 005 Dec 21, 2015
AB + 1.2MG N207947 006 Dec 21, 2015
AB + 1.4MG N207947 007 Dec 21, 2015
AB + 1.6MG N207947 008 Dec 21, 2015
SELINEXOR
TABLET;ORAL
XPOVIO
+ KARYOPHARM THERAPS 20MG N212306 001 Jul 03, 2019
+ 40MG N212306 002 Apr 15, 2021
+ 50MG N212306 003 Apr 15, 2021
+! 60MG N212306 004 Apr 15, 2021
SELPERCATINIB
CAPSULE;ORAL
RETEVMO
+ LOXO ONCOL ELI 40MG N213246 001 May 08, 2020
LILLY
+! 80MG N213246 002 May 08, 2020
SELUMETINIB SULFATE
CAPSULE;ORAL
KOSELUGO
+ ASTRAZENECA EQ 10MG BASE N213756 001 Apr 10, 2020
+! EQ 25MG BASE N213756 002 Apr 10, 2020
SEMAGLUTIDE
SOLUTION;SUBCUTANEOUS
OZEMPIC
+! NOVO 2MG/1.5ML (1.34MG/ML) N209637 001 Dec 05, 2017
+! 2MG/3ML (0.68MG/ML) N209637 004 Oct 06, 2022
+! 4MG/3ML (1.34MG/ML) N209637 002 Apr 09, 2019
+! 8MG/3ML (2.68MG/ML) N209637 003 Mar 28, 2022
WEGOVY
+! NOVO 0.25MG/0.5ML (0.25MG/0.5ML) N215256 001 Jun 04, 2021
+! 0.5MG/0.5ML (0.5MG/0.5ML) N215256 002 Jun 04, 2021
+! 1MG/0.5ML (1MG/0.5ML) N215256 003 Jun 04, 2021
+! 1.7MG/0.75ML (1.7MG/0.75ML) N215256 004 Jun 04, 2021
+! 2.4MG/0.75ML (2.4MG/0.75ML) N215256 005 Jun 04, 2021
TABLET;ORAL
RYBELSUS
+ NOVO 3MG N213051 001 Sep 20, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-410(of 474)

SEMAGLUTIDE
TABLET;ORAL
RYBELSUS
+ 7MG N213051 002 Sep 20, 2019
+! 14MG N213051 003 Sep 20, 2019
SERTACONAZOLE NITRATE
CREAM;TOPICAL
ERTACZO
+! BAUSCH 2% N021385 001 Dec 10, 2003
SERTRALINE HYDROCHLORIDE
CAPSULE;ORAL
SERTRALINE HYDROCHLORIDE
+ ALMATICA EQ 150MG BASE N215133 001 Oct 04, 2021
+! EQ 200MG BASE N215133 002 Oct 04, 2021
CONCENTRATE;ORAL
SERTRALINE HYDROCHLORIDE
AA ACI EQ 20MG BASE/ML A076934 001 Jun 30, 2006
AA AUROBINDO PHARMA EQ 20MG BASE/ML A078861 001 Oct 31, 2008
ZOLOFT
AA +! VIATRIS EQ 20MG BASE/ML N020990 001 Dec 07, 1999
TABLET;ORAL
SERTRALINE HYDROCHLORIDE
AB ACCORD HLTHCARE EQ 25MG BASE A202825 001 Nov 07, 2014
AB EQ 50MG BASE A202825 002 Nov 07, 2014
AB EQ 100MG BASE A202825 003 Nov 07, 2014
AB ACI EQ 25MG BASE A076881 001 Feb 06, 2007
AB EQ 50MG BASE A076881 002 Feb 06, 2007
AB EQ 100MG BASE A076881 003 Feb 06, 2007
AB ASCENT PHARMS INC EQ 25MG BASE A214790 001 May 03, 2021
AB EQ 50MG BASE A214790 002 May 03, 2021
AB EQ 100MG BASE A214790 003 May 03, 2021
AB AUROBINDO PHARMA EQ 25MG BASE A077206 001 Feb 06, 2007
AB EQ 50MG BASE A077206 002 Feb 06, 2007
AB EQ 100MG BASE A077206 003 Feb 06, 2007
AB GRANULES EQ 25MG BASE A078403 001 Jan 08, 2008
AB EQ 50MG BASE A078403 002 Jan 08, 2008
AB EQ 100MG BASE A078403 003 Jan 08, 2008
AB INVAGEN PHARMS EQ 25MG BASE A077397 001 Feb 06, 2007
AB EQ 50MG BASE A077397 002 Feb 06, 2007
AB EQ 100MG BASE A077397 003 Feb 06, 2007
AB LUPIN EQ 25MG BASE A077670 001 Feb 06, 2007
AB EQ 50MG BASE A077670 002 Feb 06, 2007
AB EQ 100MG BASE A077670 003 Feb 06, 2007
AB OXFORD PHARMS EQ 25MG BASE A078175 001 Jul 21, 2010
AB EQ 50MG BASE A078175 002 Jul 21, 2010
AB EQ 100MG BASE A078175 003 Jul 21, 2010
AB REYOUNG EQ 25MG BASE A078677 001 Mar 04, 2009
AB EQ 50MG BASE A078677 002 Mar 04, 2009
AB EQ 100MG BASE A078677 003 Mar 04, 2009
AB SCIEGEN PHARMS INC EQ 25MG BASE A076442 001 Apr 30, 2007
AB EQ 50MG BASE A076442 002 Apr 30, 2007
AB EQ 100MG BASE A076442 003 Apr 30, 2007
AB VIWIT PHARM EQ 25MG BASE A076882 001 Feb 06, 2007
AB EQ 50MG BASE A076882 002 Feb 06, 2007
AB EQ 100MG BASE A076882 003 Feb 06, 2007
ZOLOFT
AB + VIATRIS EQ 25MG BASE N019839 005 Mar 06, 1996
AB + EQ 50MG BASE N019839 001 Dec 30, 1991
AB +! EQ 100MG BASE N019839 002 Dec 30, 1991
SETMELANOTIDE ACETATE
SOLUTION;SUBCUTANEOUS
IMCIVREE
+! RHYTHM EQ 10MG/ML BASE (EQ 10MG/ML BASE) N213793 001 Nov 25, 2020
SEVELAMER CARBONATE
FOR SUSPENSION;ORAL
RENVELA
AB + GENZYME 800MG/PACKET N022318 001 Aug 12, 2009
AB +! 2.4GM/PACKET N022318 002 Feb 18, 2009
SEVELAMER CARBONATE
AB AUROBINDO PHARMA 800MG/PACKET A207624 001 Jun 13, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-411(of 474)

SEVELAMER CARBONATE
FOR SUSPENSION;ORAL
SEVELAMER CARBONATE
AB 2.4GM/PACKET A207624 002 Jun 13, 2017
AB BIONPHARMA INC 800MG/PACKET A209374 001 May 17, 2021
AB DR REDDYS 800MG/PACKET A210464 001 Oct 25, 2018
AB 2.4GM/PACKET A210464 002 Oct 25, 2018
AB IMPAX 800MG/PACKET A211316 001 Nov 20, 2020
AB 2.4GM/PACKET A211316 002 Nov 20, 2020
TABLET;ORAL
RENVELA
AB +! SANOFI 800MG N022127 001 Oct 19, 2007
SEVELAMER CARBONATE
AB AMNEAL PHARMS CO 800MG A207288 001 Nov 28, 2017
AB ANXIN 800MG A212970 001 Apr 09, 2020
AB ARTHUR GRP 800MG A200959 001 Mar 20, 2018
AB AUROBINDO PHARMA 800MG A207179 001 Jul 17, 2017
AB DR REDDYS 800MG A206094 001 Sep 29, 2017
AB INVAGEN PHARMS 800MG A203860 001 Oct 26, 2017
AB MICRO LABS 800MG A215537 001 Feb 07, 2022
AB RISING 800MG A204451 001 Nov 29, 2018
AB ZYDUS PHARMS 800MG A207759 001 Aug 11, 2020
SEVELAMER HYDROCHLORIDE
TABLET;ORAL
RENAGEL
AB + GENZYME 400MG N021179 001 Jul 12, 2000
AB +! 800MG N021179 002 Jul 12, 2000
SEVELAMER HYDROCHLORIDE
AB GLENMARK PHARMS LTD 400MG A204724 001 Feb 08, 2019
AB 800MG A204724 002 Feb 08, 2019
AB LUPIN LTD 400MG A213145 001 Jun 16, 2021
AB 800MG A213145 002 Jun 16, 2021
SEVOFLURANE
LIQUID;INHALATION
SEVOFLURANE
AN BAXTER HLTHCARE 100% A075895 001 Jul 02, 2002
AN HALOCARBON PRODS 100% A078650 001 Nov 19, 2007
AN SHANGHAI HENGRUI 100% A203793 001 Nov 03, 2015
SOJOURN
AN PIRAMAL CRITICAL 100% A077867 001 May 02, 2007
ULTANE
AN +! ABBVIE 100% N020478 001 Jun 07, 1995
SILDENAFIL CITRATE
FOR SUSPENSION;ORAL
REVATIO
AB +! VIATRIS EQ 10MG BASE/ML N203109 001 Aug 30, 2012
SILDENAFIL CITRATE
AB AJANTA PHARMA LTD EQ 10MG BASE/ML A212883 001 Nov 27, 2019
AB ALKEM LABS LTD EQ 10MG BASE/ML A212440 001 Nov 27, 2019
AB AMNEAL PHARMS EQ 10MG BASE/ML A211092 001 Nov 27, 2019
AB APPCO EQ 10MG BASE/ML A213814 001 Apr 29, 2021
AB APTAPHARMA INC EQ 10MG BASE/ML A213041 001 Aug 06, 2020
AB AUROBINDO PHARMA EQ 10MG BASE/ML A214773 001 Dec 23, 2022
LTD
AB HETERO LABS LTD V EQ 10MG BASE/ML A213014 001 May 11, 2021
AB LUPIN LTD EQ 10MG BASE/ML A211638 001 Mar 23, 2022
AB MSN EQ 10MG BASE/ML A214641 001 Feb 08, 2022
AB NOVITIUM PHARMA EQ 10MG BASE/ML A212260 001 May 31, 2019
AB TARO PHARM INDS LTD EQ 10MG BASE/ML A215522 001 Nov 16, 2021
AB TEVA PHARMS USA EQ 10MG BASE/ML A211534 001 May 29, 2020
AB ZYDUS EQ 10MG BASE/ML A215708 001 Sep 29, 2022
SOLUTION;INTRAVENOUS
REVATIO
AP +! VIATRIS EQ 10MG BASE/12.5ML (EQ 0.8MG BASE/ML) N022473 001 Nov 18, 2009
SILDENAFIL CITRATE
AP EUGIA PHARMA EQ 10MG BASE/12.5ML (EQ 0.8MG BASE/ML) A203988 001 Apr 01, 2015
TABLET;ORAL
REVATIO
AB +! VIATRIS EQ 20MG BASE N021845 001 Jun 03, 2005
SILDENAFIL CITRATE
AB AJANTA PHARMA LTD EQ 20MG BASE A210394 001 May 04, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-412(of 474)

SILDENAFIL CITRATE
TABLET;ORAL
SILDENAFIL CITRATE
AB EQ 25MG BASE A206401 001 Oct 12, 2018
AB EQ 50MG BASE A206401 002 Oct 12, 2018
AB EQ 100MG BASE A206401 003 Oct 12, 2018
AB AMNEAL PHARMS EQ 20MG BASE A202025 001 Feb 28, 2013
AB AMNEAL PHARMS NY EQ 25MG BASE A202023 001 Jun 27, 2018
AB EQ 50MG BASE A202023 002 Jun 27, 2018
AB EQ 100MG BASE A202023 003 Jun 27, 2018
AB APPCO EQ 25MG BASE A207178 001 Mar 02, 2020
AB EQ 50MG BASE A207178 002 Mar 02, 2020
AB EQ 100MG BASE A207178 003 Mar 02, 2020
AB AUROBINDO PHARMA EQ 20MG BASE A203963 001 Nov 18, 2015
LTD
AB EQ 25MG BASE A203962 001 Jun 11, 2018
AB EQ 50MG BASE A203962 002 Jun 11, 2018
AB EQ 100MG BASE A203962 003 Jun 11, 2018
AB CHARTWELL RX EQ 20MG BASE A202598 001 Nov 06, 2012
AB HETERO LABS LTD V EQ 20MG BASE A203623 001 Nov 26, 2014
AB EQ 25MG BASE A202659 001 Jun 11, 2018
AB EQ 50MG BASE A202659 002 Jun 11, 2018
AB EQ 100MG BASE A202659 003 Jun 11, 2018
AB LUPIN LTD EQ 25MG BASE A212051 001 Mar 22, 2019
AB EQ 50MG BASE A212051 002 Mar 22, 2019
AB EQ 100MG BASE A212051 003 Mar 22, 2019
AB MACLEODS PHARMS LTD EQ 20MG BASE A203814 001 Dec 17, 2013
AB MYLAN EQ 25MG BASE A201171 001 Mar 25, 2019
AB EQ 50MG BASE A201171 002 Mar 25, 2019
AB EQ 100MG BASE A201171 003 Mar 25, 2019
AB MYLAN PHARMS INC EQ 20MG BASE A201150 001 Nov 09, 2012
AB REYOUNG EQ 25MG BASE A208494 001 Jun 12, 2020
AB EQ 50MG BASE A208494 002 Jun 12, 2020
AB EQ 100MG BASE A208494 003 Jun 12, 2020
AB RUBICON EQ 20MG BASE A204883 001 Jun 20, 2016
AB EQ 25MG BASE A204882 001 Jun 11, 2018
AB EQ 50MG BASE A204882 002 Jun 11, 2018
AB EQ 100MG BASE A204882 003 Jun 11, 2018
AB SUNSHINE EQ 25MG BASE A213032 001 Jun 11, 2020
AB EQ 50MG BASE A213032 002 Jun 11, 2020
AB EQ 100MG BASE A213032 003 Jun 11, 2020
AB TEVA EQ 25MG BASE A077342 001 Mar 09, 2016
AB EQ 50MG BASE A077342 002 Mar 09, 2016
AB EQ 100MG BASE A077342 003 Mar 09, 2016
AB TEVA PHARMS EQ 20MG BASE A078380 001 Jan 07, 2013
AB TORRENT EQ 25MG BASE A091448 001 Jun 11, 2018
AB EQ 50MG BASE A091448 002 Jun 11, 2018
AB EQ 100MG BASE A091448 003 Jun 11, 2018
AB TORRENT PHARMS LTD EQ 20MG BASE A091479 001 Nov 06, 2012
AB UMEDICA LABS PVT EQ 25MG BASE A209302 003 Jun 15, 2021
LTD
AB EQ 50MG BASE A209302 001 Aug 25, 2020
AB EQ 100MG BASE A209302 002 Aug 25, 2020
AB WATSON LABS INC EQ 20MG BASE A202503 001 Nov 06, 2012
VIAGRA
AB + VIATRIS EQ 25MG BASE N020895 001 Mar 27, 1998
AB + EQ 50MG BASE N020895 002 Mar 27, 1998
AB +! EQ 100MG BASE N020895 003 Mar 27, 1998
SILODOSIN
CAPSULE;ORAL
RAPAFLO
AB +! ALLERGAN 4MG N022206 001 Oct 08, 2008
AB + 8MG N022206 002 Oct 08, 2008
SILODOSIN
AB AJANTA PHARMA LTD 4MG A211060 001 Dec 03, 2018
AB 8MG A211060 002 Dec 03, 2018
AB AMNEAL PHARMS CO 4MG A209745 001 Dec 03, 2018
AB 8MG A209745 002 Dec 03, 2018
AB AUROBINDO PHARMA 4MG A210626 001 Dec 10, 2018
LTD
AB 8MG A210626 002 Dec 10, 2018
AB HETERO LABS LTD V 4MG A204793 001 Feb 14, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-413(of 474)

SILODOSIN
CAPSULE;ORAL
SILODOSIN
AB 8MG A204793 002 Feb 14, 2020
AB LUPIN LTD 4MG A206541 001 Dec 03, 2018
AB 8MG A206541 002 Dec 03, 2018
AB MACLEODS PHARMS LTD 4MG A211166 001 Dec 03, 2018
AB 8MG A211166 002 Dec 03, 2018
AB MSN 4MG A210687 001 Dec 03, 2018
AB 8MG A210687 002 Dec 03, 2018
AB PRINSTON INC 4MG A209029 001 Jan 04, 2022
AB 8MG A209029 002 Jan 04, 2022
AB SANDOZ INC 4MG A204726 001 Mar 31, 2017
AB 8MG A204726 002 Mar 31, 2017
AB ZYDUS PHARMS 4MG A204816 001 Dec 08, 2022
AB 8MG A204816 002 Dec 08, 2022
SILVER SULFADIAZINE
CREAM;TOPICAL
SILVADENE
AB +! KING PHARMS LLC 1% N017381 001
SSD
AB DR REDDYS LA 1% N018578 001 Feb 25, 1982
THERMAZENE
AB THEPHARMANETWORK 1% N018810 001 Dec 23, 1985
LLC
SIMVASTATIN
SUSPENSION;ORAL
FLOLIPID
+ TCG FLUENT PHARMA 20MG/5ML N206679 001 Apr 21, 2016
+! 40MG/5ML N206679 002 Apr 21, 2016
TABLET;ORAL
SIMVASTATIN
AB ACCORD HLTHCARE 5MG A078155 005 Apr 05, 2013
AB 10MG A078155 002 Feb 26, 2008
AB 20MG A078155 003 Feb 26, 2008
AB 40MG A078155 004 Feb 26, 2008
AB 80MG A078155 001 Feb 26, 2008
AB AUROBINDO PHARMA 5MG A077691 001 Dec 20, 2006
AB 10MG A077691 002 Dec 20, 2006
AB 20MG A077691 003 Dec 20, 2006
AB 40MG A077691 004 Dec 20, 2006
AB 80MG A077691 005 Dec 20, 2006
AB BIOCON PHARMA 5MG A078034 001 Dec 20, 2006
AB 10MG A078034 002 Dec 20, 2006
AB 20MG A078034 003 Dec 20, 2006
AB 40MG A078034 004 Dec 20, 2006
AB 80MG A078034 005 Dec 20, 2006
AB DR REDDYS LABS INC 5MG A077752 005 Jan 23, 2008
AB 10MG A077752 001 Dec 20, 2006
AB 20MG A077752 002 Dec 20, 2006
AB 40MG A077752 003 Dec 20, 2006
AB 80MG A077752 004 Dec 20, 2006
AB HETERO LABS LTD III 5MG A200895 001 Nov 25, 2014
AB 10MG A200895 002 Nov 25, 2014
AB 20MG A200895 003 Nov 25, 2014
AB 40MG A200895 004 Nov 25, 2014
AB 80MG A200895 005 Nov 25, 2014
AB HISUN PHARM 10MG A206557 001 Nov 13, 2017
HANGZHOU
AB 20MG A206557 002 Nov 13, 2017
AB 40MG A206557 003 Nov 13, 2017
AB 80MG A206557 004 Nov 13, 2017
AB LUPIN 5MG A078103 005 Apr 14, 2009
AB 10MG A078103 001 May 11, 2007
AB 20MG A078103 002 May 11, 2007
AB 40MG A078103 003 May 11, 2007
AB ! 80MG A078103 004 May 11, 2007
AB MICRO LABS 5MG A090383 001 Sep 16, 2011
AB 10MG A090383 002 Sep 16, 2011
AB 20MG A090383 003 Sep 16, 2011
AB 40MG A090383 004 Sep 16, 2011
AB 80MG A090383 005 Sep 16, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-414(of 474)

SIMVASTATIN
TABLET;ORAL
SIMVASTATIN
AB OXFORD PHARMS 5MG A078735 001 Aug 30, 2010
AB 10MG A078735 002 Aug 30, 2010
AB 20MG A078735 003 Aug 30, 2010
AB 40MG A078735 004 Aug 30, 2010
AB 80MG A078735 005 Aug 30, 2010
AB WATSON LABS TEVA 5MG A076685 001 Dec 20, 2006
AB 10MG A076685 002 Dec 20, 2006
AB 20MG A076685 003 Dec 20, 2006
AB 40MG A076685 004 Dec 20, 2006
AB 80MG A076685 005 Dec 20, 2006
AB ZYDUS PHARMS USA 5MG A077837 001 Dec 20, 2006
AB 10MG A077837 002 Dec 20, 2006
AB 20MG A077837 003 Dec 20, 2006
AB 40MG A077837 004 Dec 20, 2006
AB 80MG A077837 005 Dec 20, 2006
ZOCOR
AB + ORGANON 5MG N019766 001 Dec 23, 1991
AB + 10MG N019766 002 Dec 23, 1991
AB + 20MG N019766 003 Dec 23, 1991
AB + 40MG N019766 004 Dec 23, 1991
SINCALIDE
INJECTABLE;INJECTION
KINEVAC
+! BRACCO 0.005MG/VIAL N017697 001
POWDER;INTRAVENOUS
SINCALIDE
+! MAIA PHARMS INC 0.005MG/VIAL N210850 001 Nov 22, 2022
SINECATECHINS
OINTMENT;TOPICAL
VEREGEN
+! ANI PHARMS 15% N021902 001 Oct 31, 2006
SIPONIMOD FUMARIC ACID
TABLET;ORAL
MAYZENT
+ NOVARTIS EQ 0.25MG BASE N209884 001 Mar 26, 2019
+ EQ 1MG BASE N209884 003 Aug 24, 2021
+! EQ 2MG BASE N209884 002 Mar 26, 2019
SIROLIMUS
GEL;TOPICAL
HYFTOR
+! NOBELPHARMA 0.2% N213478 001 Mar 22, 2022
POWDER;INTRAVENOUS
FYARRO
+! AADI 100MG/VIAL N213312 001 Nov 22, 2021
SOLUTION;ORAL
RAPAMUNE
AA +! PF PRISM CV 1MG/ML N021083 001 Sep 15, 1999
SIROLIMUS
AA AMNEAL 1MG/ML A211212 001 Oct 18, 2019
AA APOTEX 1MG/ML A211406 001 Oct 22, 2019
AA NOVITIUM PHARMA 1MG/ML A211040 001 Jan 28, 2019
TABLET;ORAL
RAPAMUNE
AB + PF PRISM CV 0.5MG N021110 004 Jan 25, 2010
AB + 1MG N021110 001 Aug 25, 2000
AB +! 2MG N021110 002 Aug 22, 2002
SIROLIMUS
AB ALKEM LABS LTD 0.5MG A214753 001 Mar 12, 2021
AB 1MG A214753 002 Mar 12, 2021
AB 2MG A214753 003 Mar 12, 2021
AB DR REDDYS 1MG A201578 001 Oct 27, 2014
AB 2MG A201578 002 Oct 27, 2014
AB GLENMARK PHARMS LTD 0.5MG A208691 001 Oct 16, 2020
AB 1MG A208691 002 Oct 16, 2020
AB 2MG A208691 003 Oct 16, 2020
AB ZYDUS PHARMS 0.5MG A201676 003 Jan 08, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-415(of 474)

SITAGLIPTIN PHOSPHATE
TABLET;ORAL
JANUVIA
+ MERCK SHARP DOHME EQ 25MG BASE N021995 001 Oct 16, 2006
+ EQ 50MG BASE N021995 002 Oct 16, 2006
+! EQ 100MG BASE N021995 003 Oct 16, 2006
SODIUM ACETATE
INJECTABLE;INJECTION
SODIUM ACETATE
AP +! HOSPIRA 2MEQ/ML N018893 001 May 04, 1983
AP MILLA PHARMS 2MEQ/ML A214805 001 May 04, 2021
FRESENIUS KABI USA 4MEQ/ML A206687 001 Oct 30, 2017
SODIUM BENZOATE; SODIUM PHENYLACETATE
SOLUTION;INTRAVENOUS
AMMONUL
AP +! BAUSCH 10%;10% (5GM/50ML;5GM/50ML) N020645 001 Feb 17, 2005
SODIUM PHENYLACETATE AND SODIUM BENZOATE
AP AILEX PHARMS LLC 10%;10% (5GM/50ML;5GM/50ML) A207096 001 Feb 24, 2016
AP MAIA PHARMS INC 10%;10% (5GM/50ML;5GM/50ML) A208521 001 May 08, 2017
AP NAVINTA LLC 10%;10% (5GM/50ML;5GM/50ML) A205880 001 Aug 04, 2016
+! MAIA PHARMS INC 10%;10% (2GM/20ML;2GM/20ML) N215025 001 Jun 10, 2021
SODIUM BICARBONATE
INJECTABLE;INJECTION
SODIUM BICARBONATE
AP ! EXELA PHARMA 0.5MEQ/ML A211091 001 Jun 20, 2019
AP ! 0.9MEQ/ML A211091 002 Jun 20, 2019
AP ! 1MEQ/ML A211091 003 Jun 20, 2019
AP HOSPIRA 0.5MEQ/ML A202679 001 Mar 07, 2017
AP ! 0.5MEQ/ML A202981 001 Mar 04, 2016
AP 0.9MEQ/ML A202494 001 Mar 06, 2017
AP 1MEQ/ML A202432 001 Sep 26, 2017
AP 1MEQ/ML A202494 002 Mar 06, 2017
AP INTL MEDICATION SYS 1MEQ/ML A203449 001 Sep 19, 2017
HOSPIRA 1MEQ/ML A202495 001 Mar 06, 2017
SODIUM CHLORIDE
INJECTABLE;INJECTION
BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP FRESENIUS KABI USA 9MG/ML A088911 001 Feb 07, 1985
AP +! HOSPIRA 9MG/ML N018800 001 Oct 29, 1982
SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
AP + B BRAUN 450MG/100ML N019635 001 Mar 09, 1988
AP +! BAXTER HLTHCARE 450MG/100ML N018016 001
AP FRESENIUS KABI USA 450MG/100ML A208122 001 Jul 23, 2018
AP HOSPIRA 450MG/100ML N019759 001 Jun 08, 1988
AP +! ICU MEDICAL INC 450MG/100ML N018090 001
SODIUM CHLORIDE 0.9%
AP HIKMA 9MG/ML A201850 001 Jan 20, 2012
AP SPECTRA MDCL 9MG/ML A206171 001 Jul 21, 2017
DEVICES
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP +! B BRAUN 900MG/100ML N017464 001
AP +! 900MG/100ML N019635 002 Mar 09, 1988
AP +! BAXTER HLTHCARE 9MG/ML N016677 004 Oct 30, 1985
AP + 9MG/ML N020178 002 Dec 07, 1992
AP +! 900MG/100ML N016677 001
AP +! 900MG/100ML N020178 001 Dec 07, 1992
AP ! FRESENIUS KABI USA 9MG/ML A088912 001 Jan 10, 1985
AP 900MG/100ML A207310 001 Sep 19, 2017
AP FRESENIUS MEDCL 900MG/100ML A078177 001 Apr 12, 2007
AP HAEMONETICS 900MG/100ML A076316 001 Oct 27, 2004
AP +! HOSPIRA 9MG/ML N018803 001 Oct 29, 1982
AP + 9MG/ML N019465 002 Jul 15, 1985
AP +! 900MG/100ML N019465 001 Jul 15, 1985
AP +! 900MG/100ML N019480 001 Sep 17, 1985
AP +! ICU MEDICAL INC 900MG/100ML N016366 001
AP LABORATORIOS 900MG/100ML A207956 001 May 25, 2017
GRIFOLS
AP NEPHRON 9MG/ML A211968 001 Apr 23, 2020
AP ! TARO 9MG/ML A077407 001 Aug 11, 2006
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-416(of 474)

SODIUM CHLORIDE
INJECTABLE;INJECTION
SODIUM CHLORIDE 3% IN PLASTIC CONTAINER
AP B BRAUN 3GM/100ML N019635 003 Mar 09, 1988
AP +! BAXTER HLTHCARE 3GM/100ML N019022 001 Nov 01, 1983
AP FRESENIUS KABI USA 3GM/100ML A209476 001 Mar 13, 2019
SODIUM CHLORIDE 5% IN PLASTIC CONTAINER
AP B BRAUN 5GM/100ML N019635 004 Mar 09, 1988
AP + BAXTER HLTHCARE 5GM/100ML N019022 002 Nov 01, 1983
SODIUM CHLORIDE 0.9%
+ B BRAUN 9MG/10ML N019635 005 Aug 08, 2016
HIKMA 9MG/ML A201833 001 Sep 24, 2013
+! MEDEFIL INC 90MG/10ML (9MG/ML) N202832 006 Jan 06, 2012
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
+ LIEBEL-FLARSHEIM 1012.5MG/125ML (9MG/ML) N021569 002 Jul 27, 2006
SODIUM CHLORIDE 23.4%
FRESENIUS KABI USA 234MG/ML A212248 001 Apr 28, 2021
SOLUTION;INTRAVENOUS
SODIUM CHLORIDE 14.6%
AP FRESENIUS KABI USA 100MEQ/40ML (2.5MEQ/ML) A212070 002 Apr 28, 2021
AP +! HOSPIRA 100MEQ/40ML (2.5MEQ/ML) N018897 002 Jul 20, 1984
SODIUM CHLORIDE 23.4%
AP FRESENIUS KABI USA 400MEQ/100ML (4MEQ/ML) A212070 003 Feb 14, 2022
AP +! HOSPIRA 400MEQ/100ML (4MEQ/ML) N018897 003 Jun 18, 2020
SODIUM CHLORIDE 14.6%
FRESENIUS KABI USA 50MEQ/20ML (2.5MEQ/ML) A212070 001 Apr 28, 2021
SOLUTION;IRRIGATION
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AT +! B BRAUN 900MG/100ML N016733 001
AT BAXTER HLTHCARE 900MG/100ML N017427 001
AT 900MG/100ML N017867 001
AT + ICU MEDICAL INC 900MG/100ML N017514 001
AT 900MG/100ML N018314 001
SOLUTION FOR SLUSH;IRRIGATION
SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER
+! BAXTER HLTHCARE 900MG/100ML N019319 002 May 17, 1985
SODIUM FLUORIDE F-18
INJECTABLE;INTRAVENOUS
SODIUM FLUORIDE F-18
AP 3D IMAGING DRUG 10-200mCi/ML A203777 001 Oct 19, 2015
AP BAMF 10-200mCi/ML A216126 001 Dec 06, 2022
AP BIOMEDCL RES FDN 10-200mCi/ML A204351 001 Jan 09, 2015
AP CARDINAL HEALTH 414 10-200mCi/ML A203780 001 Jul 30, 2015
AP ESSENTIAL ISOTOPES 10-200mCi/ML A204541 001 Oct 29, 2014
AP HOT SHOTS NM LLC 10-200mCi/ML A204530 001 Jul 29, 2015
AP JUBILANT DRAXIMAGE 10-200mCi/ML A203968 001 Oct 23, 2015
AP KREITCHMAN PET CTR 10-200mCi/ML A203936 001 May 19, 2016
AP MIDWEST MEDCL 10-200mCi/ML A204440 001 Nov 17, 2015
AP MIPS CRF 10-200mCi/ML A204517 001 Jul 21, 2015
AP NCM USA BRONX LLC 10-200mCi/ML A204513 001 Nov 28, 2014
AP NUKEMED 10-200mCi/ML A203912 001 Apr 22, 2015
AP PETNET 10-200mCi/ML A203890 001 Sep 28, 2015
AP PRECISION NUCLEAR 10-200mCi/ML A204542 001 Feb 27, 2015
AP SHERTECH LABS LLC 10-200mCi/ML A204315 001 Sep 22, 2014
AP SOFIE 10-200mCi/ML A203592 001 Aug 18, 2015
AP ! 10-200mCi/ML A203544 001 Dec 26, 2012
AP UNIV UTAH CYCLOTRON 10-200mCi/ML A204497 001 Apr 20, 2015
! MCPRF 10-91.5mCi/ML A203605 001 Jun 28, 2013
THE FEINSTEIN INST 20-600mCi/ML A204328 001 Nov 19, 2014
SODIUM IODIDE I-123
CAPSULE;ORAL
SODIUM IODIDE I 123
AA +! CARDINAL HEALTH 418 100uCi N018671 001 May 27, 1982
AA +! 200uCi N018671 002 May 27, 1982
AA CURIUM 100uCi A071909 001 Feb 28, 1989
AA 200uCi A071910 001 Feb 28, 1989
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-417(of 474)

SODIUM IODIDE I-131


CAPSULE;ORAL
SODIUM IODIDE I 131
+ JUBILANT 0.009-0.1mCi N021305 006 May 19, 2005
SOLUTION;ORAL
HICON
AA +! JUBILANT 250-1000mCi N021305 007 Dec 05, 2011
SODIUM IODIDE I 131
AA INTL ISOTOPES 250-1000mCi A209166 001 Feb 05, 2020
SODIUM NITRITE
SOLUTION;INTRAVENOUS
SODIUM NITRITE
+! HOPE PHARMS 300MG/10ML (30MG/ML) N203922 001 Feb 14, 2012
SODIUM NITRITE; SODIUM THIOSULFATE
SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS
NITHIODOTE
+! HOPE PHARMS 300MG/10ML(30MG/ML),N/A;N/A,12.5GM/50ML N201444 001 Jan 14, 2011
(250MG/ML)
SODIUM NITROPRUSSIDE
INJECTABLE;INJECTION
SODIUM NITROPRUSSIDE
AP AMNEAL 25MG/ML A209493 001 Nov 07, 2017
AP BE PHARMS 25MG/ML A214971 001 Jul 12, 2021
AP CAPLIN 25MG/ML A211016 001 Nov 29, 2019
AP DR REDDYS 25MG/ML A210114 001 Apr 10, 2019
AP HAINAN POLY PHARM 25MG/ML A214199 001 Aug 25, 2020
AP MEDICURE 25MG/ML A209584 001 Aug 10, 2018
AP ! MICRO LABS 25MG/ML A209352 001 Dec 08, 2017
AP MYLAN LABS LTD 25MG/ML A210763 001 Apr 17, 2018
AP NEXUS PHARMS 25MG/ML A207499 001 May 25, 2017
AP SAGENT PHARMS INC 25MG/ML A207426 001 Dec 08, 2016
AP SOMERSET THERAPS 25MG/ML A210882 001 Aug 17, 2018
LLC
AP XIROMED 25MG/ML A211277 001 Oct 29, 2020
SOLUTION;INTRAVENOUS
NIPRIDE RTU IN SODIUM CHLORIDE 0.9%
AP +! EXELA PHARMA 20MG/100ML (0.2MG/ML) N209387 003 Jul 13, 2018
AP +! 50MG/100ML (0.5MG/ML) N209387 001 Mar 08, 2017
SODIUM NITROPRUSSIDE
AP HAINAN POLY 20MG/100ML (0.2MG/ML) A215846 002 Aug 26, 2022
AP 50MG/100ML (0.5MG/ML) A215846 003 Aug 26, 2022
10MG/50ML (0.2MG/ML) A215846 001 Aug 26, 2022
SODIUM OXYBATE
SOLUTION;ORAL
XYREM
+! JAZZ PHARMS 0.5GM/ML N021196 001 Jul 17, 2002
SODIUM PHENYLBUTYRATE
FOR SUSPENSION;ORAL
OLPRUVA
+ ACER 2GM/PACKET N214860 001 Dec 22, 2022
+ 3GM/PACKET N214860 002 Dec 22, 2022
+ 4GM/PACKET N214860 003 Dec 22, 2022
+ 5GM/PACKET N214860 004 Dec 22, 2022
+ 6GM/PACKET N214860 005 Dec 22, 2022
+! 6.67GM/PACKET N214860 006 Dec 22, 2022
PELLETS;ORAL
PHEBURANE
+! MEDUNIK 84GM/BOT N216513 001 Jun 17, 2022
POWDER;ORAL
BUPHENYL
AB +! HORIZON THERAP 3GM/TEASPOONFUL N020573 001 Apr 30, 1996
SODIUM PHENYLBUTYRATE
AB PAR PHARM 3GM/TEASPOONFUL A203918 001 Jun 15, 2016
AB SIGMAPHARM LABS LLC 3GM/TEASPOONFUL A202819 001 Mar 22, 2013
TABLET;ORAL
BUPHENYL
AB +! HORIZON THERAP 500MG N020572 001 May 13, 1996
SODIUM PHENYLBUTYRATE
AB GLENMARK PHARMS LTD 500MG A216462 001 Nov 01, 2022
AB PAR PHARM 500MG A204395 001 Apr 15, 2016
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-418(of 474)

SODIUM PHENYLBUTYRATE; TAURURSODIOL


FOR SUSPENSION;ORAL
RELYVRIO
+! AMYLYX 3GM/PACKET; 1GM/PACKET N216660 001 Sep 29, 2022
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
TABLET;ORAL
MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE
AB NOVEL LABS INC 0.398GM;1.102GM A079247 001 Dec 30, 2011
OSMOPREP
AB +! SALIX PHARMS 0.398GM;1.102GM N021892 001 Mar 16, 2006
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
INJECTABLE;INJECTION
SODIUM PHOSPHATES
AP FRESENIUS KABI USA 142MG/ML;276MG/ML A209997 001 Mar 30, 2022
SODIUM PHOSPHATES IN PLASTIC CONTAINER
AP +! HOSPIRA 142MG/ML;276MG/ML N018892 001 May 10, 1983
SODIUM POLYSTYRENE SULFONATE
POWDER;ORAL, RECTAL
KALEXATE
AA ! KVK TECH 454GM/BOT A040905 001 Mar 30, 2009
KIONEX
AA ANI PHARMS 454GM/BOT A040029 001 Feb 06, 1998
SODIUM POLYSTYRENE SULFONATE
AA AIPING LIFE SCI 453.6GM/BOT A090313 001 Dec 21, 2011
AA BELCHER 454GM/BOT A205727 001 Feb 23, 2016
AA CHARTWELL RX 454GM/BOT A206815 001 Feb 18, 2016
AA CMP PHARMA INC 454GM/BOT A089910 001 Jan 19, 1989
AA EPIC PHARMA LLC 453.6GM/BOT A202333 001 Mar 19, 2014
AA NUVO PHARMS INC 454GM/BOT A204071 001 Nov 28, 2014
KALEXATE
KVK TECH 15GM/BOT A040905 002 Apr 03, 2015
SODIUM POLYSTYRENE SULFONATE
NUVO PHARMS INC 15GM/BOT A204071 002 Nov 28, 2014
SUSPENSION;ORAL, RECTAL
KIONEX
AA ANI PHARMS 15GM/60ML A040028 001 Sep 17, 2007
SPS
AA +! CMP PHARMA INC 15GM/60ML A087859 001 Dec 08, 1982
SODIUM TETRADECYL SULFATE
INJECTABLE;INJECTION
SODIUM TETRADECYL SULFATE
AP HIKMA 60MG/2ML (30MG/ML) A209937 001 Dec 09, 2019
SOTRADECOL
AP ! MYLAN INSTITUTIONAL 60MG/2ML (30MG/ML) A040541 002 Nov 12, 2004
! 20MG/2ML (10MG/ML) A040541 001 Nov 12, 2004
SODIUM THIOSULFATE
SOLUTION;INTRAVENOUS
PEDMARK
+! FENNEC PHARMS INC 12.5GM/100ML (125MG/ML) N212937 001 Sep 20, 2022
SODIUM THIOSULFATE
+! HOPE PHARMS 12.5GM/50ML (250MG/ML) N203923 001 Feb 14, 2012
SODIUM ZIRCONIUM CYCLOSILICATE
FOR SUSPENSION;ORAL
LOKELMA
+ ASTRAZENECA 5GM/PACKET N207078 001 May 18, 2018
+! 10GM/PACKET N207078 002 May 18, 2018
SOFOSBUVIR
PELLETS;ORAL
SOVALDI
+ GILEAD SCIENCES INC 150MG/PACKET N212480 001 Aug 28, 2019
+! 200MG/PACKET N212480 002 Aug 28, 2019
TABLET;ORAL
SOVALDI
+ GILEAD SCIENCES INC 200MG N204671 002 Aug 28, 2019
+! 400MG N204671 001 Dec 06, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-419(of 474)

SOFOSBUVIR; VELPATASVIR
PELLETS;ORAL
EPCLUSA
+ GILEAD SCIENCES INC 150MG;37.5MG/PACKET N214187 001 Jun 10, 2021
+! 200MG;50MG/PACKET N214187 002 Jun 10, 2021
TABLET;ORAL
EPCLUSA
+ GILEAD SCIENCES INC 200MG;50MG N208341 002 Mar 19, 2020
+! 400MG;100MG N208341 001 Jun 28, 2016
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
TABLET;ORAL
VOSEVI
+! GILEAD SCIENCES INC 400MG;100MG;100MG N209195 001 Jul 18, 2017
SOLIFENACIN SUCCINATE
SUSPENSION;ORAL
VESICARE LS
+! ASTELLAS 1MG/ML N209529 001 May 26, 2020
TABLET;ORAL
SOLIFENACIN SUCCINATE
AB ALEMBIC PHARMS 5MG A205575 001 May 20, 2019
AB 10MG A205575 002 May 20, 2019
AB ALKEM LABS LTD 5MG A210224 001 May 20, 2019
AB 10MG A210224 002 May 20, 2019
AB ANNORA PHARMA 5MG A215761 001 Jun 15, 2022
AB 10MG A215761 002 Jun 15, 2022
AB AUROBINDO PHARMA 5MG A206817 001 Dec 27, 2022
AB 10MG A206817 002 Dec 27, 2022
AB AUSTARPHARMA 5MG A210281 001 May 20, 2019
AB 10MG A210281 002 May 20, 2019
AB CELLTRION 5MG A210582 001 May 20, 2019
AB 10MG A210582 002 May 20, 2019
AB CIPLA 5MG A209839 001 May 20, 2019
AB 10MG A209839 002 May 20, 2019
AB GLENMARK PHARMS INC 5MG A209239 001 May 20, 2019
AB 10MG A209239 002 May 20, 2019
AB GRAVITI PHARMS 5MG A211423 001 Dec 11, 2019
AB 10MG A211423 002 Dec 11, 2019
AB MSN 5MG A210688 001 May 20, 2019
AB 10MG A210688 002 May 20, 2019
AB QILU 5MG A209333 001 May 20, 2019
AB 10MG A209333 002 May 20, 2019
AB SCIEGEN PHARMS INC 5MG A211657 001 May 20, 2019
AB 10MG A211657 002 May 20, 2019
AB STRIDES PHARMA 5MG A212214 001 Sep 26, 2019
AB 10MG A212214 002 Sep 26, 2019
AB TEVA PHARMS USA 5MG A091464 001 Apr 02, 2014
AB 10MG A091464 002 Apr 02, 2014
AB UNICHEM 5MG A211701 001 Aug 27, 2019
AB 10MG A211701 002 Aug 27, 2019
AB WATSON LABS INC 5MG A202551 001 May 20, 2019
AB 10MG A202551 002 May 20, 2019
VESICARE
AB + ASTELLAS 5MG N021518 001 Nov 19, 2004
AB +! 10MG N021518 002 Nov 19, 2004
SOLRIAMFETOL HYDROCHLORIDE
TABLET;ORAL
SUNOSI
+ AXSOME MALTA EQ 75MG BASE N211230 001 Jun 17, 2019
+! EQ 150MG BASE N211230 002 Jun 17, 2019
SONIDEGIB PHOSPHATE
CAPSULE;ORAL
ODOMZO
+! SUN PHARM EQ 200MG BASE N205266 001 Jul 24, 2015
SORAFENIB TOSYLATE
TABLET;ORAL
NEXAVAR
AB +! BAYER HLTHCARE EQ 200MG BASE N021923 001 Dec 20, 2005
SORAFENIB TOSYLATE
AB DR REDDYS EQ 200MG BASE A216073 001 Jun 07, 2022
AB MYLAN EQ 200MG BASE A207012 001 Sep 10, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-420(of 474)

SORAFENIB TOSYLATE
TABLET;ORAL
SORAFENIB TOSYLATE
AB TEVA PHARMS USA INC EQ 200MG BASE A209567 001 Nov 12, 2020
AB YABAO PHARM EQ 200MG BASE A209050 001 Nov 09, 2022
SORBITOL
SOLUTION;IRRIGATION
SORBITOL 3% IN PLASTIC CONTAINER
BAXTER HLTHCARE 3GM/100ML N017863 001
SORBITOL 3.3% IN PLASTIC CONTAINER
B BRAUN 3.3GM/100ML N016741 001
SOTALOL HYDROCHLORIDE
SOLUTION;INTRAVENOUS
SOTALOL HYDROCHLORIDE
+! ALTATHERA PHARMS 150MG/10ML (15MG/ML) N022306 001 Jul 02, 2009
LLC
SOLUTION;ORAL
SOTYLIZE
+! AZURITY 5MG/ML (5MG/ML) N205108 001 Oct 22, 2014
TABLET;ORAL
BETAPACE
AB + LEGACY PHARMA 80MG N019865 001 Oct 30, 1992
AB + 120MG N019865 005 Apr 20, 1994
AB +! 160MG N019865 002 Oct 30, 1992
AB + 240MG N019865 003 Oct 30, 1992
BETAPACE AF
AB + LEGACY PHARMA 80MG N021151 001 Feb 22, 2000
AB + 120MG N021151 002 Feb 22, 2000
AB +! 160MG N021151 003 Feb 22, 2000
SORINE
AB UPSHER SMITH LABS 80MG A075500 001 Apr 27, 2001
AB 120MG A075500 004 Apr 27, 2001
AB 160MG A075500 002 Apr 27, 2001
AB 240MG A075500 003 Apr 27, 2001
SOTALOL HYDROCHLORIDE
AB APOTEX 80MG A076140 001 Sep 26, 2002
AB 80MG A076214 001 Aug 27, 2003
AB 120MG A076140 002 Sep 26, 2002
AB 120MG A076214 002 Aug 27, 2003
AB 160MG A076140 003 Sep 26, 2002
AB 160MG A076214 003 Aug 27, 2003
AB 240MG A076140 004 Sep 26, 2002
AB BEXIMCO PHARMS USA 80MG A207428 001 Oct 21, 2016
AB 80MG A207429 001 Nov 02, 2018
AB 120MG A207428 002 Oct 21, 2016
AB 120MG A207429 002 Nov 02, 2018
AB 160MG A207428 003 Oct 21, 2016
AB 160MG A207429 003 Nov 02, 2018
AB EPIC PHARMA INC 80MG A077070 001 Nov 04, 2005
AB 120MG A077070 002 Nov 04, 2005
AB 160MG A077070 003 Nov 04, 2005
AB OXFORD PHARMS 80MG A075563 001 Nov 07, 2003
AB 120MG A075563 002 Nov 07, 2003
AB 160MG A075563 003 Nov 07, 2003
AB 240MG A075563 004 Nov 07, 2003
AB TEVA 80MG A075429 001 May 01, 2000
AB 120MG A075429 002 May 01, 2000
AB 160MG A075429 003 May 01, 2000
AB 240MG A075429 004 May 01, 2000
SOTORASIB
TABLET;ORAL
LUMAKRAS
+! AMGEN INC 120MG N214665 001 May 28, 2021
SOYBEAN OIL
INJECTABLE;INJECTION
INTRALIPID 10%
AP +! FRESENIUS 10% N017643 001
INTRALIPID 20%
AP +! FRESENIUS 20% N018449 001
AP +! 20% N020248 001 Aug 07, 1996
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-421(of 474)

SOYBEAN OIL
INJECTABLE;INJECTION
NUTRILIPID 10%
AP +! B BRAUN 10% N019531 001 May 28, 1993
NUTRILIPID 20%
AP +! B BRAUN 20% N019531 002 May 28, 1993
INTRALIPID 30%
+! FRESENIUS 30% N019942 001 Dec 30, 1993
SPINOSAD
SUSPENSION;TOPICAL
NATROBA
+! PARAPRO LLC 0.9% N022408 001 Jan 18, 2011
SPIRONOLACTONE
SUSPENSION;ORAL
CAROSPIR
+! CMP DEV LLC 25MG/5ML N209478 001 Aug 04, 2017
TABLET;ORAL
ALDACTONE
AB + PFIZER 25MG N012151 009 Dec 30, 1983
AB + 50MG N012151 008 Dec 30, 1982
AB +! 100MG N012151 010 Dec 30, 1983
SPIRONOLACTONE
AB ACCORD HLTHCARE 25MG A203512 001 Sep 19, 2016
AB 50MG A203512 002 Sep 19, 2016
AB 100MG A203512 003 Sep 19, 2016
AB AMNEAL PHARMS 25MG A091426 001 Jul 02, 2010
AB 50MG A091426 002 Jul 02, 2010
AB 100MG A091426 003 Jul 02, 2010
AB AUROBINDO PHARMA 25MG A202187 001 Mar 06, 2014
AB 50MG A202187 002 Mar 06, 2014
AB 100MG A202187 003 Mar 06, 2014
AB JUBILANT GENERICS 25MG A203253 001 Apr 23, 2014
AB 50MG A203253 002 Apr 23, 2014
AB 100MG A203253 003 Apr 23, 2014
AB MYLAN 25MG A040424 001 Aug 20, 2001
AB 50MG A040424 002 Aug 20, 2001
AB 100MG A040424 003 Aug 20, 2001
AB OXFORD PHARMS 25MG A040750 001 Aug 29, 2006
AB 50MG A040750 002 Aug 29, 2006
AB 100MG A040750 003 Aug 29, 2006
AB SUN PHARM 25MG A089424 001 Jul 23, 1986
INDUSTRIES
AB 50MG A089424 002 Aug 11, 1999
AB 100MG A089424 003 Aug 11, 1999
AB ZYDUS PHARMS 25MG A205936 001 Jul 18, 2018
AB 50MG A205936 002 Jul 18, 2018
AB 100MG A205936 003 Jul 18, 2018
STERILE WATER FOR INJECTION
LIQUID;N/A
BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER
AP +! HOSPIRA 100% N018802 001 Oct 27, 1982
STERILE WATER FOR INJECTION
AP FRESENIUS KABI USA 100% A209689 001 Nov 24, 2017
AP HIKMA 100% (10ML) A206369 001 Sep 02, 2015
AP +! HOSPIRA 100% (10ML) N018801 002 Oct 27, 1982
AP ! MEDEFIL INC 100% (5ML) A211188 004 Dec 02, 2019
AP 100% (10ML) A211188 005 Dec 02, 2019
AP NEPHRON 100% (5ML) A211222 001 Feb 10, 2021
STERILE WATER FOR INJECTION IN PLASTIC CONTAINER
AP +! B BRAUN 100% N019633 001 Feb 29, 1988
AP +! BAXTER HLTHCARE 100% N018632 001 Jun 30, 1982
AP +! 100% N018632 002 Apr 19, 1988
AP FRESENIUS KABI USA 100% A088400 001 Jan 16, 1984
AP +! ICU MEDICAL INC 100% N018233 001
AP +! 100% N019869 001 Dec 26, 1989
AP TARO 100% A077393 001 Aug 11, 2006
STERILE WATER FOR INJECTION
+! HOSPIRA 100% (20ML) N018801 003 Oct 27, 1982
+! 100% (50ML) N018801 004 Oct 27, 1982
+! 100% (100ML) N018801 005 Oct 27, 1982
MEDEFIL INC 100% (1ML) A211188 001 Dec 02, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-422(of 474)

STERILE WATER FOR INJECTION


LIQUID;N/A
STERILE WATER FOR INJECTION
! 100% (2.5ML) A211188 002 Dec 02, 2019
! 100% (3ML) A211188 003 Dec 02, 2019
STERILE WATER FOR IRRIGATION
LIQUID;IRRIGATION
STERILE WATER
AT + BAXTER HLTHCARE 100% N017428 001
STERILE WATER IN PLASTIC CONTAINER
AT + B BRAUN 100% N016734 001
AT BAXTER HLTHCARE 100% N017866 001
AT ICU MEDICAL INC 100% N017513 001
AT 100% N018313 001
STIRIPENTOL
CAPSULE;ORAL
DIACOMIT
+ BIOCODEX SA 250MG N206709 001 Aug 20, 2018
+! 500MG N206709 002 Aug 20, 2018
FOR SUSPENSION;ORAL
DIACOMIT
+ BIOCODEX SA 250MG/PACKET N207223 001 Aug 20, 2018
+! 500MG/PACKET N207223 002 Aug 20, 2018
STREPTOMYCIN SULFATE
INJECTABLE;INJECTION
STREPTOMYCIN SULFATE
! XGEN PHARMS EQ 1GM BASE/VIAL A064210 001 Jun 30, 1998
STREPTOZOCIN
INJECTABLE;INJECTION
ZANOSAR
+! TEVA PHARMS USA 1GM/VIAL N050577 001 May 07, 1982
STRONTIUM CHLORIDE SR-89
INJECTABLE;INJECTION
METASTRON
AP +! Q BIOMED 1mCi/ML N020134 001 Jun 18, 1993
STRONTIUM CHLORIDE SR-89
AP Q BIOMED 1mCi/ML A075941 001 Jan 06, 2003
SUCCIMER
CAPSULE;ORAL
CHEMET
+! RECORDATI RARE 100MG N019998 002 Jan 30, 1991
SUCCINYLCHOLINE CHLORIDE
INJECTABLE;INJECTION
ANECTINE
AP +! SANDOZ INC 20MG/ML N008453 002
QUELICIN
AP +! HOSPIRA 20MG/ML N008845 006
SUCCINYLCHOLINE CHLORIDE
AP ACCORD HLTHCARE 20MG/ML A213705 001 May 20, 2020
AP AMNEAL 20MG/ML A211432 001 Nov 16, 2018
AP AMRING PHARMS 20MG/ML A210231 001 Jun 04, 2018
AP ASPIRO 20MG/ML A213810 001 May 04, 2020
AP BRECKENRIDGE 20MG/ML A212638 001 Oct 09, 2019
AP DEVA HOLDING AS 20MG/ML A214491 001 Dec 21, 2020
AP DR REDDYS 20MG/ML A210698 001 Aug 02, 2019
AP FRESENIUS KABI USA 20MG/ML A211346 001 Nov 20, 2020
AP GLAND PHARMA LTD 20MG/ML A214246 001 Jun 16, 2020
AP HIKMA 20MG/ML A213229 001 Jun 12, 2020
AP INDOCO 20MG/ML A214308 001 May 22, 2020
AP MEITHEAL 20MG/ML A214514 001 Oct 19, 2021
AP MICRO LABS 20MG/ML A214879 001 Nov 24, 2020
AP NEXUS PHARMS 20MG/ML A213552 001 Oct 27, 2020
AP NIVAGEN PHARMS INC 20MG/ML A211625 001 May 19, 2020
AP SAGENT PHARMS INC 20MG/ML A215022 001 Mar 29, 2021
AP SOMERSET THERAPS 20MG/ML A211589 001 Jan 15, 2020
LLC
AP ! ZYDUS PHARMS 20MG/ML A209467 001 May 04, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-423(of 474)

SUCCINYLCHOLINE CHLORIDE
SOLUTION;INTRAMUSCULAR, INTRAVENOUS
SUCCINYLCHOLINE CHLORIDE
+! HIKMA 100MG/5ML (20MG/ML) N215143 001 Aug 20, 2021
SUCRALFATE
SUSPENSION;ORAL
CARAFATE
AB +! ALLERGAN 1GM/10ML N019183 001 Dec 16, 1993
SUCRALFATE
AB AMNEAL 1GM/10ML A209356 001 Dec 02, 2019
AB MYLAN 1GM/10ML A212913 001 Sep 12, 2022
AB VISTAPHARM 1GM/10ML A211884 001 Mar 15, 2022
TABLET;ORAL
CARAFATE
AB +! ALLERGAN 1GM N018333 001
SUCRALFATE
AB AMNEAL PHARMS 1GM A215576 001 Apr 15, 2022
AB NOSTRUM LABS INC 1GM A074415 001 Jun 08, 1998
AB TEVA 1GM A070848 001 Mar 29, 1996
SUFENTANIL CITRATE
INJECTABLE;INJECTION
SUFENTA PRESERVATIVE FREE
AP +! AKORN EQ 0.05MG BASE/ML N019050 001 May 04, 1984
SUFENTANIL CITRATE
AP HIKMA EQ 0.05MG BASE/ML A074413 001 Dec 15, 1995
AP HOSPIRA EQ 0.05MG BASE/ML A074534 001 Dec 11, 1996
TABLET;SUBLINGUAL
DSUVIA
+! ACELRX PHARMS EQ 0.03MG BASE N209128 001 Nov 02, 2018
SUGAMMADEX SODIUM
SOLUTION;INTRAVENOUS
BRIDION
+ ORGANON SUB MERCK EQ 200MG BASE/2ML (EQ 100MG BASE/ML) N022225 002 Dec 15, 2015
+! EQ 500MG BASE/5ML (EQ 100MG BASE/ML) N022225 001 Dec 15, 2015
SULCONAZOLE NITRATE
CREAM;TOPICAL
EXELDERM
+! JOURNEY 1% N018737 001 Feb 28, 1989
SOLUTION;TOPICAL
EXELDERM
+! JOURNEY 1% N018738 001 Aug 30, 1985
SULFACETAMIDE SODIUM
LOTION;TOPICAL
KLARON
AB +! BAUSCH 10% N019931 001 Dec 23, 1996
SULFACETAMIDE SODIUM
AB FOUGERA PHARMS 10% A077015 001 Nov 17, 2006
AB PADAGIS US 10% A078649 001 Mar 23, 2009
AB TARO 10% A078668 001 May 20, 2009
OINTMENT;OPHTHALMIC
SULFACETAMIDE SODIUM
! PADAGIS US 10% A080029 001
SOLUTION/DROPS;OPHTHALMIC
BLEPH-10
AT +! ALLERGAN 10% A080028 001
SULFACETAMIDE SODIUM
AT AKORN 10% A040215 001 May 25, 1999
AT BAUSCH AND LOMB 10% A040066 001 Dec 28, 1994
AT SANDOZ INC 10% A089560 001 Oct 18, 1988
SULFADIAZINE
TABLET;ORAL
SULFADIAZINE
! EPIC PHARMA 500MG A040091 001 Jul 29, 1994
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-424(of 474)

SULFAMETHOXAZOLE; TRIMETHOPRIM
INJECTABLE;INJECTION
SULFAMETHOXAZOLE AND TRIMETHOPRIM
AP ! MYLAN LABS LTD 80MG/ML;16MG/ML A206607 001 Aug 30, 2017
AP SOMERSET 80MG/ML;16MG/ML A212231 001 Jun 26, 2019
AP TEVA PHARMS USA 80MG/ML;16MG/ML A073303 001 Oct 31, 1991
SUSPENSION;ORAL
SULFAMETHOXAZOLE AND TRIMETHOPRIM
AB ! AKORN 200MG/5ML;40MG/5ML A074650 001 Dec 29, 1997
AB AUROBINDO PHARMA 200MG/5ML;40MG/5ML A091348 001 Jun 08, 2010
AB LANNETT CO INC 200MG/5ML;40MG/5ML A077785 001 Jan 24, 2007
AB NOVITIUM PHARMA 200MG/5ML;40MG/5ML A214330 001 Feb 08, 2022
AB PRASCO 200MG/5ML;40MG/5ML A077612 001 Nov 13, 2006
SULFATRIM PEDIATRIC
AB PHARM ASSOC 200MG/5ML;40MG/5ML N018615 001 Jan 07, 1983
TABLET;ORAL
BACTRIM
AB + SUN PHARM 400MG;80MG N017377 001
INDUSTRIES
BACTRIM DS
AB +! SUN PHARM 800MG;160MG N017377 002
INDUSTRIES
SEPTRA
AB MONARCH PHARMS 400MG;80MG N017376 001
SEPTRA DS
AB MONARCH PHARMS 800MG;160MG N017376 002
SULFAMETHOXAZOLE AND TRIMETHOPRIM
AB AMNEAL PHARMS NY 400MG;80MG A076899 001 Jan 27, 2005
AB 800MG;160MG A076899 002 Jan 27, 2005
AB AUROBINDO PHARMA 400MG;80MG A090624 001 Feb 16, 2010
AB 800MG;160MG A090624 002 Feb 16, 2010
AB CHARTWELL MOLECULES 400MG;80MG A078060 002 Jan 25, 2007
AB 800MG;160MG A078060 001 Jan 25, 2007
AB GLENMARK GENERICS 400MG;80MG A090828 002 Dec 22, 2010
AB 800MG;160MG A090828 001 Dec 22, 2010
AB SUN PHARM 400MG;80MG A071017 002 Aug 25, 1986
INDUSTRIES
AB 800MG;160MG A071017 001 Aug 25, 1986
AB VISTA PHARMS 400MG;80MG A076817 001 Oct 07, 2005
AB 800MG;160MG A076817 002 Oct 07, 2005
SULFASALAZINE
TABLET;ORAL
AZULFIDINE
AB +! PFIZER 500MG N007073 001
SULFASALAZINE
AB CHARTWELL 500MG A080197 001
AB NUVO PHARMS INC 500MG A040349 001 Jan 11, 2002
AB WATSON LABS 500MG A085828 001
TABLET, DELAYED RELEASE;ORAL
AZULFIDINE EN-TABS
AB +! PFIZER 500MG N007073 002 Apr 06, 1983
SULFASALAZINE
AB NUVO PHARMS INC 500MG A075339 001 Jan 11, 2002
SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES
FOR SUSPENSION;INTRAVENOUS
LUMASON
+! BRACCO 60.7MG/25MG N203684 001 Oct 15, 2014
SULINDAC
TABLET;ORAL
SULINDAC
AB EPIC PHARMA 150MG A072710 001 Mar 25, 1991
AB 200MG A072711 001 Mar 25, 1991
AB SUN PHARM 150MG A072050 001 Apr 17, 1991
INDUSTRIES
AB 200MG A072051 001 Apr 17, 1991
AB WATSON LABS 150MG A071891 001 Apr 03, 1990
AB ! 200MG A071795 001 Apr 03, 1990
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-425(of 474)

SUMATRIPTAN
SPRAY;NASAL
IMITREX
AB +! GLAXOSMITHKLINE 5MG/SPRAY N020626 001 Aug 26, 1997
AB +! 20MG/SPRAY N020626 003 Aug 26, 1997
SUMATRIPTAN
AB CIPLA 20MG/SPRAY A214209 001 Feb 22, 2021
AB FLORIDA 20MG/SPRAY A208967 001 Feb 17, 2021
AB LANNETT CO INC 5MG/SPRAY A204841 001 Feb 19, 2016
AB 20MG/SPRAY A204841 002 Feb 19, 2016
AB PADAGIS ISRAEL 5MG/SPRAY A213465 002 Sep 21, 2020
AB 20MG/SPRAY A213465 001 Sep 21, 2020
TOSYMRA
+! UPSHER SMITH LABS 10MG/SPRAY N210884 001 Jan 25, 2019
SUMATRIPTAN SUCCINATE
INJECTABLE;SUBCUTANEOUS
IMITREX STATDOSE
AB +! GLAXOSMITHKLINE EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) N020080 002 Feb 01, 2006
AB +! EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) N020080 003 Dec 23, 1996
SUMATRIPTAN SUCCINATE
AB ANTARES PHARMA INC EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) A078319 001 Dec 10, 2015
AB EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A078319 002 Dec 10, 2015
AB DR REDDYS EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A090495 001 Jan 29, 2014
AB SUN PHARM EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A090358 001 Jun 21, 2011
IMITREX
AP +! GLAXOSMITHKLINE EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) N020080 001 Dec 28, 1992
SUMATRIPTAN SUCCINATE
AP CAPLIN EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A213998 001 Jul 13, 2021
AP EUGIA PHARMA EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A202758 001 Apr 23, 2013
AP FRESENIUS KABI USA EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A079242 001 Mar 02, 2009
AP HIKMA EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A200183 001 Sep 16, 2013
AP PAR PHARM EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A077332 001 Oct 09, 2009
AP WEST-WARD PHARMS EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A079123 001 Feb 06, 2009
INT
AP WOCKHARDT EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A078593 001 Feb 06, 2009
POWDER;NASAL
ONZETRA XSAIL
+! CURRAX EQ 11MG BASE N206099 001 Jan 27, 2016
SOLUTION;SUBCUTANEOUS
ZEMBRACE SYMTOUCH
+ UPSHER SMITH LABS EQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML) N208223 001 Jan 28, 2016
TABLET;ORAL
IMITREX
AB + GLAXOSMITHKLINE EQ 25MG BASE N020132 002 Jun 01, 1995
AB + EQ 50MG BASE N020132 003 Jun 01, 1995
AB +! EQ 100MG BASE N020132 001 Jun 01, 1995
SUMATRIPTAN SUCCINATE
AB AUROBINDO PHARMA EQ 25MG BASE A078327 001 Aug 10, 2009
AB EQ 50MG BASE A078327 002 Aug 10, 2009
AB EQ 100MG BASE A078327 003 Aug 10, 2009
AB COREPHARMA EQ 25MG BASE A200263 001 Jun 19, 2012
AB EQ 50MG BASE A200263 002 Jun 19, 2012
AB EQ 100MG BASE A200263 003 Jun 19, 2012
AB DR REDDYS LABS INC EQ 25MG BASE A076847 001 Aug 10, 2009
AB EQ 50MG BASE A076847 002 Aug 10, 2009
AB EQ 100MG BASE A076847 003 Aug 10, 2009
AB MYLAN EQ 25MG BASE A077744 001 Aug 10, 2009
AB EQ 50MG BASE A077744 002 Aug 10, 2009
AB EQ 100MG BASE A077744 003 Aug 10, 2009
AB ORBION PHARMS EQ 25MG BASE A078284 001 Aug 10, 2009
AB EQ 50MG BASE A078284 002 Aug 10, 2009
AB EQ 100MG BASE A078284 003 Aug 10, 2009
AB SUN PHARM INDS EQ 25MG BASE A078295 001 Aug 10, 2009
AB EQ 50MG BASE A078295 002 Aug 10, 2009
AB EQ 100MG BASE A078295 003 Aug 10, 2009
AB SUN PHARM INDS LTD EQ 25MG BASE A076554 001 Aug 10, 2009
AB EQ 50MG BASE A076554 002 Aug 10, 2009
AB EQ 100MG BASE A076572 001 Feb 09, 2009
AB WATSON LABS EQ 25MG BASE A076933 001 Aug 10, 2009
AB EQ 50MG BASE A076933 002 Aug 10, 2009
AB EQ 100MG BASE A076933 003 Aug 10, 2009
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-426(of 474)

SUNITINIB MALATE
CAPSULE;ORAL
SUNITINIB MALATE
AB DR REDDYS EQ 12.5MG BASE A215843 001 Apr 11, 2022
AB EQ 25MG BASE A215843 002 Apr 11, 2022
AB EQ 37.5MG BASE A215843 003 Apr 11, 2022
AB EQ 50MG BASE A215843 004 Apr 11, 2022
AB MYLAN EQ 12.5MG BASE A201275 001 Dec 06, 2021
AB EQ 25MG BASE A201275 002 Dec 06, 2021
AB EQ 37.5MG BASE A201275 003 Dec 06, 2021
AB EQ 50MG BASE A201275 004 Dec 06, 2021
AB SUN PHARM EQ 12.5MG BASE A213914 001 Aug 16, 2021
AB EQ 25MG BASE A213914 002 Aug 16, 2021
AB EQ 37.5MG BASE A213914 003 Aug 16, 2021
AB EQ 50MG BASE A213914 004 Aug 16, 2021
AB TEVA PHARMS USA EQ 12.5MG BASE A213803 001 Nov 30, 2021
AB EQ 25MG BASE A213803 002 Nov 30, 2021
AB EQ 37.5MG BASE A213803 003 Nov 30, 2021
AB EQ 50MG BASE A213803 004 Nov 30, 2021
SUTENT
AB + CPPI CV EQ 12.5MG BASE N021938 001 Jan 26, 2006
AB + EQ 25MG BASE N021938 002 Jan 26, 2006
AB + EQ 37.5MG BASE N021938 004 Mar 31, 2009
AB +! EQ 50MG BASE N021938 003 Jan 26, 2006
SUVOREXANT
TABLET;ORAL
BELSOMRA
+ MERCK SHARP DOHME 5MG N204569 001 Aug 13, 2014
+ 10MG N204569 002 Aug 13, 2014
+ 15MG N204569 003 Aug 13, 2014
+! 20MG N204569 004 Aug 13, 2014
TACROLIMUS
CAPSULE;ORAL
PROGRAF
AB + ASTELLAS EQ 0.5MG BASE N050708 003 Aug 24, 1998
AB + EQ 1MG BASE N050708 001 Apr 08, 1994
AB +! EQ 5MG BASE N050708 002 Apr 08, 1994
TACROLIMUS
AB ACCORD HLTHCARE EQ 0.5MG BASE A091195 001 Aug 31, 2011
AB EQ 1MG BASE A091195 002 Aug 31, 2011
AB EQ 5MG BASE A091195 003 Aug 31, 2011
AB ALKEM LABS LTD EQ 0.5MG BASE A203740 001 Nov 12, 2020
AB EQ 1MG BASE A203740 002 Nov 12, 2020
AB EQ 5MG BASE A203740 003 Nov 12, 2020
AB BELCHER EQ 0.5MG BASE A206651 001 Nov 30, 2017
AB EQ 1MG BASE A206651 002 Nov 30, 2017
AB EQ 5MG BASE A206651 003 Nov 30, 2017
AB BIOCON PHARMA EQ 0.5MG BASE A212297 001 Nov 10, 2020
AB EQ 1MG BASE A212297 002 Nov 10, 2020
AB EQ 5MG BASE A212297 003 Nov 10, 2020
AB CONCORD BIOTECH LTD EQ 1MG BASE A213112 002 Nov 10, 2020
AB EQ 5MG BASE A213112 003 Nov 10, 2020
AB DR REDDYS LABS LTD EQ 0.5MG BASE A090509 001 May 12, 2010
AB EQ 1MG BASE A090509 002 May 12, 2010
AB EQ 5MG BASE A090509 003 May 12, 2010
AB GLENMARK PHARMS LTD EQ 0.5MG BASE A206662 001 Nov 10, 2020
AB EQ 1MG BASE A206662 002 Nov 10, 2020
AB EQ 5MG BASE A206662 003 Nov 10, 2020
AB MYLAN EQ 0.5MG BASE A090596 001 Sep 17, 2010
AB EQ 1MG BASE A090596 002 Sep 17, 2010
AB EQ 5MG BASE A090596 003 Sep 17, 2010
AB PANACEA EQ 0.5MG BASE A090802 001 Sep 28, 2012
AB EQ 1MG BASE A090802 002 Sep 28, 2012
AB EQ 5MG BASE A090802 003 Sep 28, 2012
AB SANDOZ EQ 0.5MG BASE A065461 001 Aug 10, 2009
AB EQ 1MG BASE A065461 002 Aug 10, 2009
AB EQ 5MG BASE A065461 003 Aug 10, 2009
AB STRIDES PHARMA EQ 0.5MG BASE A090687 001 Jul 22, 2014
AB EQ 1MG BASE A090687 002 Jul 22, 2014
AB EQ 5MG BASE A090687 003 Jul 22, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-427(of 474)

TACROLIMUS
CAPSULE, EXTENDED RELEASE;ORAL
ASTAGRAF XL
+ ASTELLAS EQ 0.5MG BASE N204096 001 Jul 19, 2013
+ EQ 1MG BASE N204096 002 Jul 19, 2013
+! EQ 5MG BASE N204096 003 Jul 19, 2013
FOR SUSPENSION;ORAL
PROGRAF
+ ASTELLAS EQ 0.2MG BASE/PACKET N210115 001 May 24, 2018
+! EQ 1MG BASE/PACKET N210115 002 May 24, 2018
INJECTABLE;INJECTION
PROGRAF
+! ASTELLAS EQ 5MG BASE/ML N050709 001 Apr 08, 1994
OINTMENT;TOPICAL
PROTOPIC
AB +! LEO PHARMA AS 0.03% N050777 001 Dec 08, 2000
AB +! 0.1% N050777 002 Dec 08, 2000
TACROLIMUS
AB ACCORD HLTHCARE 0.03% A211688 001 Jan 31, 2019
AB 0.1% A211688 002 Jan 31, 2019
AB FOUGERA PHARMS INC 0.03% A200744 001 Sep 09, 2014
AB 0.1% A200744 002 Sep 09, 2014
AB GLENMARK PHARMS LTD 0.1% A210393 001 Apr 16, 2018
TABLET, EXTENDED RELEASE;ORAL
ENVARSUS XR
+ VELOXIS PHARMS INC EQ 0.75MG BASE N206406 001 Jul 10, 2015
+ EQ 1MG BASE N206406 002 Jul 10, 2015
+! EQ 4MG BASE N206406 003 Jul 10, 2015
TADALAFIL
SUSPENSION;ORAL
TADLIQ
+! CMP DEV LLC 20MG/5ML N214522 001 Jun 17, 2022
TABLET;ORAL
CIALIS
AB1 + LILLY 2.5MG N021368 004 Jan 07, 2008
AB1 + 5MG N021368 001 Nov 21, 2003
AB1 + 10MG N021368 002 Nov 21, 2003
AB1 +! 20MG N021368 003 Nov 21, 2003
TADALAFIL
AB1 ACCORD HLTHCARE 2.5MG A209167 001 Mar 26, 2019
AB1 5MG A209167 002 Mar 26, 2019
AB1 10MG A209167 003 Oct 23, 2019
AB1 20MG A209167 004 Mar 26, 2019
AB1 AJANTA PHARMA LTD 2.5MG A209654 001 Mar 26, 2019
AB1 5MG A209654 002 Mar 26, 2019
AB1 10MG A209654 003 Mar 26, 2019
AB1 20MG A209654 004 Mar 26, 2019
AB1 ALEMBIC PHARMS 2.5MG A204809 001 Mar 26, 2019
AB1 5MG A204809 002 Mar 26, 2019
AB1 10MG A204809 003 Mar 26, 2019
AB1 20MG A204809 004 Mar 26, 2019
AB1 AMNEAL PHARMS CO 2.5MG A209744 001 Mar 26, 2019
AB1 5MG A209744 002 Mar 26, 2019
AB1 10MG A209744 003 Mar 26, 2019
AB1 20MG A209744 004 Mar 26, 2019
AB1 AUROBINDO PHARMA 2.5MG A206285 001 Mar 26, 2019
LTD
AB1 5MG A206285 002 Mar 26, 2019
AB1 10MG A206285 003 Mar 26, 2019
AB1 20MG A206285 004 Mar 26, 2019
AB1 AUSTARPHARMA 2.5MG A208824 001 Oct 27, 2020
AB1 5MG A208824 002 Oct 27, 2020
AB1 10MG A208824 003 Oct 27, 2020
AB1 20MG A208824 004 Oct 27, 2020
AB1 CIPLA 2.5MG A209539 001 Mar 26, 2019
AB1 5MG A209539 002 Mar 26, 2019
AB1 10MG A209539 003 Mar 26, 2019
AB1 20MG A209539 004 Mar 26, 2019
AB1 DR REDDYS 2.5MG A210069 001 Mar 26, 2019
AB1 5MG A210069 002 Mar 26, 2019
AB1 10MG A210069 003 Mar 26, 2019
AB1 20MG A210069 004 Mar 26, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-428(of 474)

TADALAFIL
TABLET;ORAL
TADALAFIL
AB1 HETERO LABS LTD III 2.5MG A209908 001 Mar 26, 2019
AB1 5MG A209908 002 Mar 26, 2019
AB1 10MG A209908 003 Mar 26, 2019
AB1 20MG A209908 004 Mar 26, 2019
AB1 LUPIN LTD 2.5MG A210567 001 Mar 26, 2019
AB1 5MG A210567 002 Mar 26, 2019
AB1 10MG A210567 003 Mar 26, 2019
AB1 20MG A210567 004 Mar 26, 2019
AB1 MACLEODS PHARMS LTD 2.5MG A207244 001 Oct 07, 2019
AB1 5MG A207244 002 Oct 07, 2019
AB1 10MG A207244 003 Oct 07, 2019
AB1 20MG A207244 004 Oct 07, 2019
AB1 PRINSTON INC 2.5MG A210609 001 Aug 11, 2022
AB1 5MG A210609 002 Aug 11, 2022
AB1 10MG A210609 003 Aug 11, 2022
AB1 20MG A210609 004 Aug 11, 2022
AB1 QILU PHARM HAINAN 2.5MG A210420 001 Mar 26, 2019
AB1 5MG A210420 002 Mar 26, 2019
AB1 10MG A210420 003 Mar 26, 2019
AB1 20MG A210420 004 Mar 26, 2019
AB1 SUN PHARM 2.5MG A208934 001 Mar 26, 2019
AB1 5MG A208934 002 Mar 26, 2019
AB1 10MG A208934 003 Mar 26, 2019
AB1 20MG A208934 004 Mar 26, 2019
AB1 SUNSHINE 2.5MG A211335 001 Mar 26, 2019
AB1 5MG A211335 002 Mar 26, 2019
AB1 10MG A211335 003 Mar 26, 2019
AB1 20MG A211335 004 Mar 26, 2019
AB1 TEVA PHARMS USA 2.5MG A090141 001 May 22, 2018
AB1 5MG A090141 002 May 22, 2018
AB1 10MG A090141 003 May 22, 2018
AB1 20MG A090141 004 May 22, 2018
AB1 TORRENT 2.5MG A211839 001 Mar 26, 2019
AB1 5MG A211839 002 Mar 26, 2019
AB1 10MG A211839 003 Mar 26, 2019
AB1 20MG A211839 004 Mar 26, 2019
AB1 UMEDICA LABS PVT 2.5MG A211298 001 Oct 23, 2020
LTD
AB1 5MG A211298 002 Oct 23, 2020
AB1 10MG A211298 003 Oct 23, 2020
AB1 20MG A211298 004 Oct 23, 2020
AB1 VKT PHARMA 2.5MG A215556 001 Nov 04, 2021
AB1 5MG A215556 002 Nov 04, 2021
AB1 10MG A215556 003 Nov 04, 2021
AB1 20MG A215556 004 Nov 04, 2021
AB1 ZYDUS PHARMS 2.5MG A206693 001 Mar 26, 2019
AB1 5MG A206693 002 Mar 26, 2019
AB1 10MG A206693 003 Mar 26, 2019
AB1 20MG A206693 004 Mar 26, 2019
ADCIRCA
AB2 +! ELI LILLY CO 20MG N022332 001 May 22, 2009
ALYQ
AB2 TEVA PHARMS INC 20MG A216932 001 Oct 12, 2022
AB2 TEVA PHARMS USA 20MG A209942 001 Feb 05, 2019
TADALAFIL
AB2 AJANTA PHARMA LTD 20MG A210392 001 Feb 05, 2019
AB2 AUROBINDO PHARMA 20MG A206286 001 Feb 05, 2019
LTD
AB2 CIPLA 20MG A210255 001 Feb 05, 2019
AB2 DR REDDYS 20MG A210145 001 Feb 05, 2019
AB2 HETERO LABS LTD III 20MG A209907 001 Feb 05, 2019
AB2 LUPIN LTD 20MG A210572 001 Feb 05, 2019
AB2 MACLEODS PHARMS LTD 20MG A207290 001 Oct 16, 2019
AB2 PRINSTON INC 20MG A210608 001 Aug 11, 2022
AB2 SUNSHINE 20MG A213496 001 Nov 23, 2020
AB2 TORRENT 20MG A212062 001 Mar 26, 2019
BX UNICHEM 2.5MG A209250 001 Mar 26, 2019
BX 5MG A209250 002 Mar 26, 2019
BX 10MG A209250 003 Mar 26, 2019
BX 20MG A209250 004 Mar 26, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-429(of 474)

TAFAMIDIS
CAPSULE;ORAL
VYNDAMAX
+! FOLDRX PHARMS 61MG N212161 001 May 03, 2019
TAFAMIDIS MEGLUMINE
CAPSULE;ORAL
VYNDAQEL
+! FOLDRX PHARMS 20MG N211996 001 May 03, 2019
TAFENOQUINE SUCCINATE
TABLET;ORAL
ARAKODA
+! 60 DEGREES PHARMS EQ 100MG BASE N210607 001 Aug 08, 2018
KRINTAFEL
+! GLAXOSMITHKLINE EQ 150MG BASE N210795 001 Jul 20, 2018
TAFLUPROST
SOLUTION/DROPS;OPHTHALMIC
TAFLUPROST
AT MICRO LABS 0.0015% A209051 001 Aug 19, 2019
AT SANDOZ INC 0.0015% A209040 001 Jan 28, 2022
ZIOPTAN
AT +! THEA PHARMA 0.0015% N202514 001 Feb 10, 2012
TALAZOPARIB TOSYLATE
CAPSULE;ORAL
TALZENNA
+ PFIZER EQ 0.25MG BASE N211651 001 Oct 16, 2018
+ EQ 0.5MG BASE N211651 003 Sep 20, 2021
+ EQ 0.75MG BASE N211651 004 Sep 20, 2021
+! EQ 1MG BASE N211651 002 Oct 16, 2018
TALC
AEROSOL;INTRAPLEURAL
SCLEROSOL
+! SCIARRA LABS 4GM/SPRAY N020587 001 Dec 24, 1997
POWDER;INTRAPLEURAL
STERITALC
+ NOVATECH SA 2GM/VIAL N205555 001 May 01, 2017
+ 3GM/VIAL N205555 002 May 01, 2017
+! 4GM/VIAL N205555 003 May 01, 2017
TALC
+! SCIARRA LABS 5GM/BOT N021388 001 Dec 15, 2003
TAMOXIFEN CITRATE
SOLUTION;ORAL
SOLTAMOX
+! MAYNE PHARMA INC EQ 20MG BASE/10ML N021807 001 Oct 29, 2005
TABLET;ORAL
TAMOXIFEN CITRATE
AB ACTAVIS LABS FL INC EQ 10MG BASE A070929 001 Feb 20, 2003
AB EQ 20MG BASE A070929 002 Feb 20, 2003
AB APOTEX EQ 10MG BASE A090878 001 Sep 23, 2011
AB EQ 20MG BASE A090878 002 Sep 23, 2011
AB EUGIA PHARMA EQ 10MG BASE A213358 001 Aug 14, 2020
AB EQ 20MG BASE A213358 002 Aug 14, 2020
AB MAYNE PHARMA EQ 10MG BASE A075797 001 Feb 20, 2003
AB ! EQ 20MG BASE A075797 002 Feb 20, 2003
AB MYLAN EQ 10MG BASE A074732 002 Feb 20, 2003
AB EQ 20MG BASE A074732 001 Feb 20, 2003
AB ZYDUS PHARMS EQ 10MG BASE A206694 001 Oct 27, 2017
AB EQ 20MG BASE A206694 002 Oct 27, 2017
TAMSULOSIN HYDROCHLORIDE
CAPSULE;ORAL
FLOMAX
AB +! SANOFI 0.4MG N020579 001 Apr 15, 1997
TAMSULOSIN HYDROCHLORIDE
AB ALKEM LABS LTD 0.4MG A207405 001 Aug 11, 2017
AB ANBISON LAB 0.4MG A211885 001 Oct 17, 2019
AB AUROBINDO PHARMA 0.4MG A202433 001 Apr 30, 2013
LTD
AB IMPAX LABS 0.4MG A090377 001 Mar 02, 2010
AB MACLEODS PHARMS LTD 0.4MG A204645 001 Jan 20, 2017
AB SANDOZ 0.4MG A078015 001 Apr 27, 2010
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-430(of 474)

TAMSULOSIN HYDROCHLORIDE
CAPSULE;ORAL
TAMSULOSIN HYDROCHLORIDE
AB SUN PHARM INDS LTD 0.4MG A090931 001 Jul 15, 2010
AB SYNTHON PHARMS 0.4MG A078801 001 Apr 27, 2010
AB TEVA PHARMS 0.4MG A077630 001 Apr 27, 2010
AB WOCKHARDT 0.4MG A078938 001 Apr 27, 2010
AB ZYDUS PHARMS USA 0.4MG A078225 001 Apr 27, 2010
INC
TAPENTADOL HYDROCHLORIDE
TABLET;ORAL
NUCYNTA
+ COLLEGIUM PHARM INC EQ 50MG BASE N022304 001 Nov 20, 2008
+ EQ 75MG BASE N022304 002 Nov 20, 2008
+! EQ 100MG BASE N022304 003 Nov 20, 2008
TABLET, EXTENDED RELEASE;ORAL
NUCYNTA ER
+ COLLEGIUM PHARM INC EQ 50MG BASE N200533 001 Aug 25, 2011
+ EQ 100MG BASE N200533 002 Aug 25, 2011
+ EQ 150MG BASE N200533 003 Aug 25, 2011
+ EQ 200MG BASE N200533 004 Aug 25, 2011
+! EQ 250MG BASE N200533 005 Aug 25, 2011
TAPINAROF
CREAM;TOPICAL
VTAMA
+! DERMAVANT SCI 1% N215272 001 May 23, 2022
TASIMELTEON
CAPSULE;ORAL
HETLIOZ
AB +! VANDA PHARMS INC 20MG N205677 001 Jan 31, 2014
TASIMELTEON
AB APOTEX CORP 20MG A211607 001 Dec 20, 2022
AB TEVA PHARMS USA INC 20MG A211601 001 Dec 12, 2022
SUSPENSION;ORAL
HETLIOZ LQ
+! VANDA PHARMS INC 4MG/ML N214517 001 Dec 01, 2020
TAVABOROLE
SOLUTION;TOPICAL
KERYDIN
AB +! ANACOR PHARMS INC 5% N204427 001 Jul 07, 2014
TAVABOROLE
AB ALEOR 5% A212188 001 Oct 21, 2020
DERMACEUTICALS
AB AMNEAL 5% A212256 001 Nov 25, 2020
AB CHARTWELL RX 5% A211963 001 Feb 03, 2021
AB CIPLA 5% A212224 001 Feb 09, 2021
AB ENCUBE 5% A211297 001 Oct 13, 2020
AB LUPIN LTD 5% A212168 001 Feb 08, 2021
AB PADAGIS US 5% A211848 001 Oct 13, 2020
AB TARO PHARMS 5% A212215 001 May 07, 2021
TAZAROTENE
AEROSOL, FOAM;TOPICAL
FABIOR
+! MAYNE PHARMA 0.1% N202428 001 May 11, 2012
CREAM;TOPICAL
AVAGE
AB +! ALLERGAN 0.1% N021184 003 Sep 30, 2002
TAZAROTENE
AB COSETTE 0.1% A208662 001 Dec 22, 2017
AB TARO PHARMS 0.1% A208258 001 Apr 03, 2017
TAZORAC
AB +! ALLERGAN 0.1% N021184 002 Sep 29, 2000
+! 0.05% N021184 001 Sep 29, 2000
GEL;TOPICAL
TAZAROTENE
AB COSETTE 0.05% A215433 001 Sep 13, 2022
AB 0.1% A214136 001 Sep 13, 2022
TAZORAC
AB +! ALLERGAN 0.05% N020600 001 Jun 13, 1997
AB +! 0.1% N020600 002 Jun 13, 1997
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-431(of 474)

TAZAROTENE
LOTION;TOPICAL
ARAZLO
+! BAUSCH 0.045% N211882 001 Dec 18, 2019
TAZEMETOSTAT HYDROBROMIDE
TABLET;ORAL
TAZVERIK
+! EPIZYME INC EQ 200MG BASE N211723 001 Jan 23, 2020
TECHNETIUM TC-99M BICISATE KIT
INJECTABLE;INJECTION
NEUROLITE
+! LANTHEUS MEDCL N/A N020256 001 Nov 23, 1994
TECHNETIUM TC-99M EXAMETAZIME KIT
INJECTABLE;INJECTION
CERETEC
+! GE HEALTHCARE N/A N019829 001 Dec 30, 1988
POWDER;INTRAVENOUS
DRAX EXAMETAZIME
JUBILANT N/A N208870 001 Aug 17, 2017
TECHNETIUM TC-99M MEBROFENIN KIT
INJECTABLE;INJECTION
CHOLETEC
AP +! BRACCO N/A N018963 001 Jan 21, 1987
TECHNETIUM TC-99M MEBROFENIN
AP SUN PHARM INDS INC N/A A078242 001 Jan 29, 2008
TECHNETIUM TC-99M MEDRONATE
INJECTABLE;INJECTION
DRAXIMAGE MDP-25
+! JUBILANT N/A N018035 002 Feb 27, 2004
TECHNETIUM TC-99M MEDRONATE KIT
INJECTABLE;INJECTION
CIS-MDP
AP SUN PHARM INDS INC N/A N018124 001
TECHNETIUM TC-99M MEDRONATE KIT
AP CARDINAL HEALTH 414 N/A N018107 001
TECHNETIUM TC-99M MERTIATIDE KIT
INJECTABLE;INJECTION
TECHNESCAN MAG3
AP +! CURIUM N/A N019882 001 Jun 15, 1990
TECHNETIUM TC99M MERTIATIDE KIT
AP MEDI-RADIOPHARMA N/A A206489 001 Feb 06, 2020
AP SUN PHARM INDS INC N/A A208994 001 Jul 12, 2019
TECHNETIUM TC-99M OXIDRONATE KIT
INJECTABLE;INJECTION
TECHNESCAN
+! CURIUM N/A N018321 001
TECHNETIUM TC-99M PENTETATE KIT
INJECTABLE;INJECTION
DRAXIMAGE DTPA
+! JUBILANT N/A N018511 001 Dec 29, 1989
TECHNETIUM TC-99M PYROPHOSPHATE KIT
INJECTABLE;INJECTION
CIS-PYRO
AP SUN PHARM INDS INC N/A N019039 001 Jun 30, 1987
TECHNESCAN PYP KIT
AP CURIUM N/A N017538 001
TECHNETIUM TC-99M RED BLOOD CELL KIT
INJECTABLE;INJECTION
ULTRATAG
+! CURIUM N/A N019981 001 Jun 10, 1991
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-432(of 474)

TECHNETIUM TC-99M SESTAMIBI KIT


INJECTABLE;INJECTION
CARDIOLITE
AP +! LANTHEUS MEDCL N/A N019785 001 Dec 21, 1990
TECHNETIUM TC 99M SESTAMIBI
AP CARDINAL HEALTH 414 N/A A078809 001 Apr 28, 2009
AP CURIUM N/A A078098 001 Sep 22, 2008
AP JUBILANT DRAXIMAGE N/A A078806 001 Apr 29, 2009
AP SUN PHARM INDS INC 10-30mCi A079157 001 Jul 10, 2009
TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR
SOLUTION;INTRAVENOUS
TECHNELITE
+! LANTHEUS MEDCL 1-20 CI/GENERATOR N017771 002 Feb 12, 2014
ULTRA-TECHNEKOW FM
+! CURIUM 1-19 CI/GENERATOR N017243 003 Feb 18, 2014
SOLUTION;INTRAVENOUS, INTRAVESICULAR, OPHTHALMIC
RADIOGENIX SYSTEM
+ NORTHSTAR MEDICAL 30-1153mCi/GENERATOR N202158 001 Feb 08, 2018
TECHNETIUM TC-99M SUCCIMER
POWDER;INTRAVENOUS
NEPHROSCAN
+! THERAGNOSTICS N/A N214993 001 Feb 18, 2022
TECHNETIUM TC-99M SULFUR COLLOID KIT
SOLUTION;INJECTION, ORAL
AN-SULFUR COLLOID
+! SUN PHARM INDS INC N/A N017858 001
TECHNETIUM TC-99M TETROFOSMIN KIT
INJECTABLE;INJECTION
MYOVIEW
+! GE HEALTHCARE N/A N020372 001 Feb 09, 1996
MYOVIEW 30ML
+! GE HEALTHCARE N/A N020372 002 Jul 07, 2005
TECHNETIUM TC-99M TILMANOCEPT
INJECTABLE;INJECTION
LYMPHOSEEK KIT
+! CARDINAL HEALTH 414 N/A N202207 001 Mar 13, 2013
TECOVIRIMAT
CAPSULE;ORAL
TPOXX
+! SIGA TECHNOLOGIES 200MG N208627 001 Jul 13, 2018
SOLUTION;INTRAVENOUS
TPOXX
+! SIGA TECHNOLOGIES 200MG/20ML (10MG/ML) N214518 001 May 18, 2022
TEDIZOLID PHOSPHATE
POWDER;INTRAVENOUS
SIVEXTRO
+! CUBIST PHARMS LLC 200MG/VIAL N205436 001 Jun 20, 2014
TABLET;ORAL
SIVEXTRO
+! CUBIST PHARMS LLC 200MG N205435 001 Jun 20, 2014
TEDUGLUTIDE RECOMBINANT
POWDER;SUBCUTANEOUS
GATTEX KIT
+! TAKEDA PHARMS USA 5MG/VIAL N203441 001 Dec 21, 2012
TELAVANCIN HYDROCHLORIDE
POWDER;INTRAVENOUS
VIBATIV
+! CUMBERLAND PHARMS EQ 750MG BASE/VIAL N022110 002 Sep 11, 2009
TELMISARTAN
TABLET;ORAL
MICARDIS
AB + BOEHRINGER 20MG N020850 003 Apr 04, 2000
INGELHEIM
AB + 40MG N020850 001 Nov 10, 1998
AB +! 80MG N020850 002 Nov 10, 1998
TELMISARTAN
AB ALEMBIC PHARMS 20MG A202130 001 Jul 07, 2014
AB 40MG A202130 002 Jul 07, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-433(of 474)

TELMISARTAN
TABLET;ORAL
TELMISARTAN
AB 80MG A202130 003 Jul 07, 2014
AB AMNEAL PHARMS 20MG A204415 001 Sep 08, 2015
AB 40MG A204415 002 Sep 08, 2015
AB 80MG A204415 003 Sep 08, 2015
AB AUROBINDO PHARMA 20MG A206511 001 Sep 03, 2015
AB 40MG A206511 002 Sep 03, 2015
AB 80MG A206511 003 Sep 03, 2015
AB CADILA PHARMS LTD 20MG A208605 001 Jul 25, 2017
AB 40MG A208605 002 Jul 25, 2017
AB 80MG A208605 003 Jul 25, 2017
AB CELLTRION 20MG A078710 001 Jan 08, 2014
AB 40MG A078710 002 Jan 08, 2014
AB 80MG A078710 003 Jan 08, 2014
AB GLENMARK PHARMS LTD 20MG A090032 001 Jul 07, 2014
AB 40MG A090032 002 Jul 07, 2014
AB 80MG A090032 003 Jul 07, 2014
AB HETERO LABS LTD V 20MG A205901 001 Apr 22, 2016
AB 40MG A205901 002 Apr 22, 2016
AB 80MG A205901 003 Apr 22, 2016
AB INVENTIA 20MG A205150 001 Oct 30, 2015
AB 40MG A205150 002 Oct 30, 2015
AB 80MG A205150 003 Oct 30, 2015
AB MICRO LABS 20MG A207016 001 Oct 03, 2017
AB 40MG A207016 002 Oct 03, 2017
AB 80MG A207016 003 Oct 03, 2017
AB MYLAN 20MG A202397 001 Jul 07, 2014
AB 40MG A202397 002 Jul 07, 2014
AB 80MG A202397 003 Jul 07, 2014
AB PRINSTON INC 20MG A207882 001 May 03, 2017
AB 40MG A207882 002 May 03, 2017
AB 80MG A207882 003 May 03, 2017
AB SANDOZ INC 20MG A203867 001 Nov 03, 2014
AB 40MG A203867 002 Nov 03, 2014
AB 80MG A203867 003 Nov 03, 2014
AB ZYDUS PHARMS 20MG A203325 001 Aug 26, 2014
AB 40MG A203325 002 Aug 26, 2014
AB 80MG A203325 003 Aug 26, 2014
TELOTRISTAT ETIPRATE
TABLET;ORAL
XERMELO
+! TERSERA EQ 250MG BASE N208794 001 Feb 28, 2017
TEMAZEPAM
CAPSULE;ORAL
RESTORIL
AB + SPECGX LLC 7.5MG N018163 003 Oct 25, 1991
AB + 15MG N018163 001
AB + 22.5MG N018163 004 Nov 02, 2004
AB +! 30MG N018163 002
TEMAZEPAM
AB ACTAVIS ELIZABETH 15MG A071620 002 Aug 07, 1987
AB 30MG A071620 001 Aug 07, 1987
AB ALEMBIC PHARMS 7.5MG A211542 001 Nov 23, 2018
AB 15MG A211542 002 Nov 23, 2018
AB 22.5MG A211542 003 Nov 23, 2018
AB 30MG A211542 004 Nov 23, 2018
AB AMNEAL PHARMS 7.5MG A203482 001 May 23, 2016
AB 15MG A203482 002 May 23, 2016
AB 22.5MG A203482 003 May 23, 2016
AB 30MG A203482 004 May 23, 2016
AB NOVEL LABS INC 7.5MG A071457 002 Jun 22, 2012
AB 15MG A071456 001 Apr 21, 1987
AB 22.5MG A071457 003 Jun 22, 2012
AB 30MG A071457 001 Apr 21, 1987
AB PRINSTON INC 7.5MG A201781 001 Jun 04, 2015
AB 15MG A201781 002 Jun 04, 2015
AB 22.5MG A201781 003 Jun 04, 2015
AB 30MG A201781 004 Jun 04, 2015
AB SANDOZ 15MG A071427 001 Jan 12, 1988
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-434(of 474)

TEMAZEPAM
CAPSULE;ORAL
TEMAZEPAM
AB 30MG A071428 001 Jan 12, 1988
AB SUN PHARM 7.5MG A078581 001 Sep 08, 2009
INDUSTRIES
AB 22.5MG A071175 002 Sep 14, 2009
TEMOZOLOMIDE
CAPSULE;ORAL
TEMOZOLOMIDE
AB ACCORD HLTHCARE 5MG A201528 001 Feb 27, 2017
AB 20MG A201528 002 Feb 27, 2017
AB 100MG A201528 003 Feb 27, 2017
AB 140MG A201528 004 Feb 27, 2017
AB 180MG A201528 005 Feb 27, 2017
AB ! 250MG A201528 006 Feb 27, 2017
AB AMNEAL PHARMS 5MG A203691 001 May 08, 2015
AB 20MG A203691 002 May 08, 2015
AB 100MG A203691 003 May 08, 2015
AB 140MG A203691 004 May 08, 2015
AB 180MG A203691 005 May 08, 2015
AB 250MG A203691 006 May 08, 2015
AB CHARTWELL 5MG A206413 001 Apr 12, 2016
AB 20MG A206413 002 Apr 12, 2016
AB 100MG A206413 003 Apr 12, 2016
AB 140MG A206413 004 Apr 12, 2016
AB 180MG A206413 005 Apr 12, 2016
AB 250MG A206413 006 Apr 12, 2016
AB CHEMI SPA 5MG A204639 001 Nov 23, 2016
AB 20MG A204639 002 Nov 23, 2016
AB 100MG A204639 003 Nov 23, 2016
AB 140MG A204639 004 Nov 23, 2016
AB 180MG A204639 005 Nov 23, 2016
AB 250MG A204639 006 Nov 23, 2016
AB DEVA HOLDING AS 5MG A207658 001 Apr 26, 2017
AB 20MG A207658 002 Apr 26, 2017
AB 100MG A207658 003 Apr 26, 2017
AB 140MG A207658 004 Apr 26, 2017
AB 180MG A207658 005 Apr 26, 2017
AB 250MG A207658 006 Apr 26, 2017
AB HERITAGE 5MG A078879 001 Mar 01, 2010
AB 20MG A078879 002 Mar 01, 2010
AB 100MG A078879 003 Mar 01, 2010
AB 140MG A078879 005 Mar 01, 2010
AB 180MG A078879 006 Mar 01, 2010
AB 250MG A078879 004 Mar 01, 2010
AB NIVAGEN PHARMS INC 5MG A213328 001 Nov 23, 2021
AB 20MG A213328 002 Nov 23, 2021
AB 100MG A213328 003 Nov 23, 2021
AB 140MG A213328 004 Nov 23, 2021
AB 180MG A213328 005 Nov 23, 2021
AB 250MG A213328 006 Nov 23, 2021
AB RISING 5MG A206309 001 Apr 27, 2016
AB 20MG A206309 002 Apr 27, 2016
AB 100MG A206309 003 Apr 27, 2016
AB 140MG A206309 004 Apr 27, 2016
AB 180MG A206309 005 Apr 27, 2016
AB 250MG A206309 006 Apr 27, 2016
AB SUN PHARM 5MG A201742 001 Feb 12, 2014
AB 20MG A201742 002 Feb 12, 2014
AB 100MG A201742 003 Feb 12, 2014
AB 140MG A201742 004 Feb 12, 2014
AB 180MG A201742 005 Feb 12, 2014
AB 250MG A201742 006 Feb 12, 2014
AB ZYDUS PHARMS 5MG A206750 001 Jul 31, 2017
AB 20MG A206750 002 Jul 31, 2017
AB 100MG A206750 003 Jul 31, 2017
AB 140MG A206750 004 Jul 31, 2017
AB 180MG A206750 005 Jul 31, 2017
AB 250MG A206750 006 Jul 31, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-435(of 474)

TEMOZOLOMIDE
POWDER;INTRAVENOUS
TEMODAR
+! MERCK SHARP DOHME 100MG/VIAL N022277 001 Feb 27, 2009
TEMSIROLIMUS
SOLUTION;INTRAVENOUS
TEMSIROLIMUS
AP ACCORD HLTHCARE 25MG/ML (25MG/ML) A203153 001 Jul 30, 2018
AP GLAND PHARMA LTD 25MG/ML (25MG/ML) A207383 001 Aug 16, 2019
TORISEL
AP +! PF PRISM CV 25MG/ML (25MG/ML) N022088 001 May 30, 2007
TENAPANOR HYDROCHLORIDE
TABLET;ORAL
IBSRELA
+! ARDELYX INC EQ 50MG BASE N211801 001 Sep 12, 2019
TENOFOVIR ALAFENAMIDE FUMARATE
TABLET;ORAL
VEMLIDY
+! GILEAD SCIENCES INC EQ 25MG BASE N208464 001 Nov 10, 2016
TENOFOVIR DISOPROXIL FUMARATE
POWDER;ORAL
VIREAD
+! GILEAD SCIENCES INC 40MG/SCOOPFUL N022577 001 Jan 18, 2012
TABLET;ORAL
TENOFOVIR DISOPROXIL FUMARATE
AB AUROBINDO PHARMA 150MG A090647 001 Jan 26, 2018
AB 200MG A090647 002 Jan 26, 2018
AB 250MG A090647 003 Jan 26, 2018
AB 300MG A090647 004 Jan 26, 2018
AB CASI PHARMS INC 300MG A209550 001 Feb 26, 2018
AB CHARTWELL 300MG A206481 001 Jul 26, 2018
AB CIPLA 300MG A078800 001 Jan 26, 2018
AB HETERO LABS LTD III 300MG A090636 001 Jan 26, 2018
AB MACLEODS PHARMS LTD 300MG A203232 001 Jan 26, 2018
AB QILU 200MG A209498 001 Mar 02, 2018
AB 250MG A209498 002 Mar 02, 2018
AB 300MG A209498 003 Mar 02, 2018
AB STRIDES PHARMA 300MG A090742 001 Jan 26, 2018
AB TEVA PHARMS USA 150MG A091612 002 Jan 26, 2018
AB 200MG A091612 003 Jan 26, 2018
AB 250MG A091612 004 Jan 26, 2018
AB 300MG A091612 001 Mar 18, 2015
VIREAD
AB + GILEAD SCIENCES INC 150MG N021356 002 Jan 18, 2012
AB + 200MG N021356 003 Jan 18, 2012
AB + 250MG N021356 004 Jan 18, 2012
AB +! 300MG N021356 001 Oct 26, 2001
TEPOTINIB HYDROCHLORIDE
TABLET;ORAL
TEPMETKO
+! EMD SERONO INC EQ 225MG BASE N214096 001 Feb 03, 2021
TERAZOSIN HYDROCHLORIDE
CAPSULE;ORAL
TERAZOSIN HYDROCHLORIDE
AB APNAR PHARMA LP EQ 1MG BASE A074823 001 Mar 30, 1998
AB EQ 2MG BASE A074823 002 Mar 30, 1998
AB EQ 5MG BASE A074823 003 Mar 30, 1998
AB EQ 10MG BASE A074823 004 Mar 30, 1998
AB HERITAGE PHARMA EQ 1MG BASE A075614 002 Jan 30, 2001
AVET
AB EQ 2MG BASE A075614 001 Jan 30, 2001
AB EQ 5MG BASE A075614 003 Jan 30, 2001
AB EQ 10MG BASE A075614 004 Jan 30, 2001
AB ! JUBILANT CADISTA EQ 1MG BASE A075317 001 Dec 20, 2004
AB EQ 2MG BASE A075317 002 Dec 20, 2004
AB EQ 5MG BASE A075317 003 Dec 20, 2004
AB EQ 10MG BASE A075317 004 Dec 20, 2004
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-436(of 474)

TERBINAFINE HYDROCHLORIDE
TABLET;ORAL
TERBINAFINE HYDROCHLORIDE
AB ! AUROBINDO PHARMA EQ 250MG BASE A078297 001 Jul 02, 2007
AB BRECKENRIDGE PHARM EQ 250MG BASE A077714 001 Jun 04, 2010
AB CHARTWELL EQ 250MG BASE A078199 001 Jul 02, 2007
AB CIPLA EQ 250MG BASE A077137 001 Jul 02, 2007
AB DR REDDYS LABS INC EQ 250MG BASE A076390 001 Jul 02, 2007
AB EMED MEDCL EQ 250MG BASE A077919 001 Jul 02, 2007
AB GLENMARK GENERICS EQ 250MG BASE A078157 001 Jul 02, 2007
AB INVAGEN PHARMS EQ 250MG BASE A077533 001 Jul 02, 2007
AB ORBION PHARMS EQ 250MG BASE A078163 001 Jul 02, 2007
TERBUTALINE SULFATE
INJECTABLE;INJECTION
TERBUTALINE SULFATE
AP ! CHARTWELL 1MG/ML A076770 001 Apr 23, 2004
INJECTABLE
AP FRESENIUS KABI USA 1MG/ML A076887 001 May 26, 2004
AP HIKMA FARMACEUTICA 1MG/ML A078630 001 May 20, 2009
AP UNITED BIOMEDCL 1MG/ML A200122 001 Nov 08, 2013
TABLET;ORAL
BRETHINE
AB + ANI PHARMS 2.5MG N017849 001
AB + 5MG N017849 002
TERBUTALINE SULFATE
AB IMPAX LABS 2.5MG A075877 001 Jun 26, 2001
AB 5MG A075877 002 Jun 26, 2001
AB LANNETT CO INC 2.5MG A077152 001 Mar 25, 2005
AB ! 5MG A077152 002 Mar 25, 2005
AB TWI PHARMS 2.5MG A211832 001 Jun 19, 2020
AB 5MG A211832 002 Jun 19, 2020
TERCONAZOLE
CREAM;VAGINAL
TERCONAZOLE
AB FOUGERA PHARMS 0.4% A076712 001 Feb 18, 2005
AB ! TARO 0.4% A076043 001 Jan 19, 2005
BX +! FOUGERA PHARMS INC 0.8% N021735 001 Oct 01, 2004
BX ! TARO 0.8% A075953 001 Apr 06, 2004
SUPPOSITORY;VAGINAL
TERCONAZOLE
AB ! PADAGIS ISRAEL 80MG A077149 001 Mar 17, 2006
AB TARO 80MG A077553 001 Mar 09, 2007
TERIFLUNOMIDE
TABLET;ORAL
AUBAGIO
AB + SANOFI AVENTIS US 7MG N202992 001 Sep 12, 2012
AB +! 14MG N202992 002 Sep 12, 2012
TERIFLUNOMIDE
AB ACCORD HLTHCARE 7MG A209690 001 Jan 07, 2019
AB 14MG A209690 002 Jan 07, 2019
AB ALEMBIC PHARMS 7MG A209572 001 Apr 19, 2019
AB 14MG A209572 002 Apr 19, 2019
AB GLENMARK PHARMS 7MG A209663 001 Nov 15, 2018
AB 14MG A209663 002 Nov 15, 2018
AB SANDOZ INC 7MG A209710 001 Jan 03, 2019
AB 14MG A209710 002 Jan 03, 2019
TERIPARATIDE
SOLUTION;SUBCUTANEOUS
BONSITY
ALVOGEN 0.62MG/2.48ML (0.25MG/ML) N211939 001 Oct 04, 2019
FORTEO
+! LILLY 0.6MG/2.4ML (0.25MG/ML) N021318 002 Jun 25, 2008
TERLIPRESSIN ACETATE
POWDER;INTRAVENOUS
TERLIVAZ
+! MALLINCKRODT EQ 0.85MG BASE/VIAL N022231 001 Sep 14, 2022
IRELAND
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-437(of 474)

TESTOSTERONE
FILM, EXTENDED RELEASE;TRANSDERMAL
ANDRODERM
+! ALLERGAN 2MG/24HR N020489 003 Oct 20, 2011
+! 4MG/24HR N020489 004 Oct 20, 2011
GEL;TRANSDERMAL
TESTOSTERONE
AB1 ACTAVIS LABS UT INC 25MG/2.5GM PACKET A076737 001 Jan 27, 2006
AB1 ! 50MG/5GM PACKET A076737 002 Jan 27, 2006
AB1 ENCUBE 50MG/5GM PACKET A212984 001 Nov 09, 2021
AB1 STRIDES PHARMA 25MG/2.5GM PACKET A076744 001 May 23, 2007
AB1 50MG/5GM PACKET A076744 002 May 23, 2007
TESTIM
AB2 +! AUXILIUM PHARMS LLC 50MG/5GM PACKET N021454 001 Oct 31, 2002
TESTOSTERONE
AB2 ACTAVIS LABS UT INC 1.62% (20.25MG/1.25GM PACKET) A204570 002 Jul 17, 2020
AB2 1.62% (40.5MG/2.5GM PACKET) A204570 003 Jul 17, 2020
AB2 50MG/5GM PACKET A091073 001 Sep 18, 2017
AB2 PADAGIS ISRAEL 1.62% (20.25MG/1.25GM PACKET) A205781 001 Jul 12, 2017
AB2 ! 1.62% (40.5MG/2.5GM PACKET) A205781 002 Jul 12, 2017
VOGELXO
AB2 UPSHER SMITH LABS 50MG/5GM PACKET N204399 002 Jun 04, 2014
GEL, METERED;NASAL
NATESTO
ACERUS 5.5MG/0.122GM ACTUATION N205488 001 May 28, 2014
GEL, METERED;TRANSDERMAL
ANDROGEL
AB +! ABBVIE 1.62% (20.25MG/1.25GM ACTUATION) N022309 001 Apr 29, 2011
FORTESTA
AB +! ENDO PHARMS 10MG/0.5GM ACTUATION N021463 001 Dec 29, 2010
TESTOSTERONE
AB ACTAVIS LABS UT INC 1.62% (20.25MG/1.25GM ACTUATION) A204570 001 Apr 10, 2019
AB 10MG/0.5GM ACTUATION A204571 001 Aug 05, 2015
AB AMNEAL 1.62% (20.25MG/1.25GM ACTUATION) A207373 001 Apr 10, 2019
AB DR REDDYS 1.62% (20.25MG/1.25GM ACTUATION) A208620 001 Apr 10, 2019
AB LUPIN 1.62% (20.25MG/1.25GM ACTUATION) A208560 001 Apr 10, 2019
AB PADAGIS ISRAEL 1.62% (20.25MG/1.25GM ACTUATION) A204268 001 Aug 04, 2015
AB TWI PHARMS 1.62% (20.25MG/1.25GM ACTUATION) A209390 001 Sep 23, 2019
AB XIROMED 1.62% (20.25MG/1.25GM ACTUATION) A210835 001 Apr 16, 2020
BX ! ACTAVIS LABS UT INC 12.5MG/1.25GM ACTUATION A076737 003 Mar 09, 2015
VOGELXO
BX UPSHER SMITH LABS 12.5MG/1.25GM ACTUATION N204399 003 Jun 04, 2014
PELLET;IMPLANTATION
TESTOPEL
! AUXILIUM PHARMS INC 75MG A080911 001
SOLUTION, METERED;TRANSDERMAL
TESTOSTERONE
AT ACTAVIS LABS UT INC 30MG/1.5ML ACTUATION A205328 001 Aug 07, 2017
AT CIPLA 30MG/1.5ML ACTUATION A209533 001 Jan 29, 2018
AT DASH PHARMS 30MG/1.5ML ACTUATION A212301 001 Jan 11, 2021
AT LUPIN LTD 30MG/1.5ML ACTUATION A208061 001 Oct 23, 2017
AT ! PADAGIS ISRAEL 30MG/1.5ML ACTUATION A204255 001 Feb 28, 2017
AT TWI PHARMS 30MG/1.5ML ACTUATION A209836 001 Sep 03, 2021
TESTOSTERONE CYPIONATE
INJECTABLE;INJECTION
DEPO-TESTOSTERONE
AO +! PFIZER 100MG/ML A085635 002
AO +! 200MG/ML A085635 003
TESTOSTERONE CYPIONATE
AO AM REGENT 200MG/ML A207742 001 Jun 16, 2017
AO CIPLA 100MG/ML A210362 001 Jun 19, 2018
AO 200MG/ML A210362 002 Jun 19, 2018
AO HIKMA 100MG/ML A090387 001 Jul 15, 2010
AO 200MG/ML A090387 002 Jul 15, 2010
AO HIKMA FARMACEUTICA 200MG/ML A091244 001 May 01, 2012
AO PADAGIS US 200MG/ML A040530 001 Jan 31, 2005
AO SANDOZ INC 100MG/ML A040615 001 Aug 10, 2006
AO 200MG/ML A040615 002 Aug 10, 2006
AO SUN PHARM INDS LTD 100MG/ML A201720 001 Jun 03, 2013
AO 200MG/ML A201720 002 Jun 03, 2013
AO WATSON PHARMS INC 200MG/ML A086030 001
AO WILSHIRE PHARMS INC 200MG/ML A206368 001 Apr 24, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-438(of 474)

TESTOSTERONE ENANTHATE
INJECTABLE;INJECTION
TESTOSTERONE ENANTHATE
AO HIKMA FARMACEUTICA 200MG/ML A091120 001 Sep 18, 2012
AO NEXUS PHARMS 200MG/ML A040575 001 Jun 14, 2006
AO ! WATSON PHARMS INC 200MG/ML A085598 001
SOLUTION;SUBCUTANEOUS
XYOSTED (AUTOINJECTOR)
+! ANTARES PHARMA INC 50MG/0.5ML (50MG/0.5ML) N209863 001 Sep 28, 2018
+! 75MG/0.5ML (75MG/0.5ML) N209863 002 Sep 28, 2018
+! 100MG/0.5ML (100MG/0.5ML) N209863 003 Sep 28, 2018
TESTOSTERONE UNDECANOATE
CAPSULE;ORAL
JATENZO
+ TOLMAR 158MG N206089 001 Mar 27, 2019
+ 198MG N206089 002 Mar 27, 2019
+! 237MG N206089 003 Mar 27, 2019
KYZATREX
+ MARIUS PHARMS LLC 100MG N213953 001 Jul 27, 2022
+ 150MG N213953 002 Jul 27, 2022
+! 200MG N213953 003 Jul 27, 2022
TLANDO
+! ANTARES PHARMA INC 112.5MG N208088 001 Mar 28, 2022
INJECTABLE;INTRAMUSCULAR
AVEED
+! ENDO PHARMS INC 750MG/3ML (250MG/ML) N022219 001 Mar 05, 2014
TETRABENAZINE
TABLET;ORAL
TETRABENAZINE
AB ACTAVIS LABS FL INC 25MG A206686 001 Jul 07, 2017
AB APOTEX 12.5MG A206093 001 Mar 17, 2020
AB 25MG A206093 002 Mar 17, 2020
AB BIONPHARMA INC 12.5MG A208826 001 Dec 18, 2017
AB 25MG A208826 002 Dec 18, 2017
AB DR REDDYS 12.5MG A209284 001 Jan 08, 2018
AB 25MG A209284 002 Jan 08, 2018
AB HETERO LABS LTD V 12.5MG A204574 001 Feb 03, 2016
AB 25MG A204574 002 Feb 03, 2016
AB LUPIN LTD 12.5MG A210544 001 Apr 20, 2018
AB 25MG A210544 002 Apr 20, 2018
AB MYLAN 12.5MG A207682 001 Jan 31, 2017
AB 25MG A207682 002 Jan 31, 2017
AB PIRAMAL HLTHCARE UK 12.5MG A213316 001 Jan 22, 2020
AB 25MG A213316 002 Jan 22, 2020
AB SUN PHARM 12.5MG A206129 001 Aug 17, 2015
AB 25MG A206129 002 Aug 17, 2015
XENAZINE
AB + BAUSCH 12.5MG N021894 001 Aug 15, 2008
AB +! 25MG N021894 002 Aug 15, 2008
TETRACAINE HYDROCHLORIDE
SOLUTION;OPHTHALMIC
TETRACAINE HYDROCHLORIDE
+! ALCON LABS 0.5% N208135 001 Feb 29, 2016
+! BAUSCH LOMB IRELAND 0.5% N210821 001 Mar 12, 2019
TETRACYCLINE HYDROCHLORIDE
CAPSULE;ORAL
ACHROMYCIN V
AB + AVET 250MG N050278 003
AB +! 500MG N050278 001
TETRACYCLINE HYDROCHLORIDE
AB AMNEAL PHARMS NY 250MG A210674 001 Sep 18, 2018
AB 500MG A210674 002 Sep 18, 2018
AB BRECKENRIDGE 250MG A210662 001 Nov 07, 2018
AB 500MG A210662 002 Nov 07, 2018
AB CHARTWELL TETRA 250MG A062752 001 Aug 12, 1988
AB 500MG A062752 002 Aug 12, 1988
AB STRIDES PHARMA 250MG A212635 001 Mar 03, 2020
AB 500MG A212635 002 Mar 03, 2020
AB WATSON LABS 250MG A061837 001
AB 500MG A061837 002
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-439(of 474)

TETRAHYDROZOLINE HYDROCHLORIDE
SOLUTION;NASAL
TYZINE
! FOUGERA PHARMS 0.05% A086576 002
0.1% A086576 001
SPRAY;NASAL
TYZINE
! FOUGERA PHARMS 0.1% A086576 003
THALIDOMIDE
CAPSULE;ORAL
THALOMID
+ CELGENE 50MG N020785 001 Jul 16, 1998
+ 100MG N020785 002 Jan 17, 2003
+ 150MG N020785 004 Jan 10, 2007
+! 200MG N020785 003 Jan 17, 2003
THALLOUS CHLORIDE TL-201
INJECTABLE;INJECTION
THALLOUS CHLORIDE TL 201
AP +! CURIUM 1mCi/ML N018150 001
AP +! LANTHEUS MEDCL 1mCi/ML N017806 001
THEOPHYLLINE
CAPSULE, EXTENDED RELEASE;ORAL
THEO-24
ACTIENT PHARMS 100MG A087942 001 Aug 22, 1983
! AUXILIUM PHARMS INC 400MG A081034 001 Feb 28, 1992
+ AUXILIUM PHARMS LLC 200MG A087943 001 Aug 22, 1983
300MG A087944 001 Aug 22, 1983
INJECTABLE;INJECTION
THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER
+! B BRAUN 40MG/100ML N019826 001 Aug 14, 1992
THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER
+! B BRAUN 80MG/100ML N019826 002 Aug 14, 1992
THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER
+! B BRAUN 160MG/100ML N019826 003 Aug 14, 1992
THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER
+! B BRAUN 320MG/100ML N019826 006 Aug 14, 1992
SOLUTION;ORAL
THEOPHYLLINE
AA ! CHARTWELL MOLECULAR 80MG/15ML A091156 001 Apr 13, 2011
AA TRIS PHARMA INC 80MG/15ML A091586 001 Jun 15, 2012
SOLUTION, ELIXIR;ORAL
ELIXOPHYLLIN
AA +! NOSTRUM LABS INC 80MG/15ML A085186 001
THEOPHYLLINE
AA PHARM ASSOC 80MG/15ML A206344 001 Dec 16, 2016
TABLET, EXTENDED RELEASE;ORAL
THEOPHYLLINE
AB ALEMBIC PHARMS 300MG A090430 001 Oct 27, 2010
AB ! 450MG A090430 002 Oct 27, 2010
AB GLENMARK GENERICS 400MG A090355 001 Jul 13, 2010
AB 600MG A090355 002 Jul 13, 2010
AB GLENMARK PHARMS LTD 300MG A212184 001 Jun 03, 2021
AB 450MG A212184 002 Jun 03, 2021
AB HERITAGE PHARMA 300MG A089763 001 Apr 30, 1990
AVET
AB 450MG A081236 001 Nov 09, 1992
AB NOSTRUM LABS INC 400MG A040560 003 Apr 21, 2006
AB ! 600MG A040560 002 Apr 21, 2006
AB + RHODES PHARMS 400MG A040086 002 Sep 01, 1982
AB 600MG A040086 001 Apr 15, 1996
AB TEVA PHARMS INC 300MG A216961 001 Oct 12, 2022
AB 450MG A216961 002 Oct 12, 2022
THIAMINE HYDROCHLORIDE
INJECTABLE;INJECTION
THIAMINE HYDROCHLORIDE
AP EUGIA PHARMA 100MG/ML A208703 001 Apr 20, 2022
AP +! FRESENIUS KABI USA 100MG/ML A080556 001
AP MYLAN INSTITUTIONAL 100MG/ML A091623 001 Jun 25, 2012
AP SAGENT PHARMS INC 100MG/ML A206106 001 Dec 01, 2017
AP WEST-WARD PHARMS 100MG/ML A080575 001
INT
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-440(of 474)

THIOGUANINE
TABLET;ORAL
THIOGUANINE
+! WOODWARD SPECL 40MG N012429 001
THIORIDAZINE HYDROCHLORIDE
TABLET;ORAL
THIORIDAZINE HYDROCHLORIDE
MYLAN 10MG A088004 002 Mar 15, 1983
25MG A088004 003 Mar 15, 1983
50MG A088004 004 Mar 15, 1983
! 100MG A088004 001 Nov 18, 1983
THIOTEPA
INJECTABLE;INJECTION
THIOTEPA
AP BELOTECA INC 15MG/VIAL A211831 001 Dec 08, 2021
AP DR REDDYS 15MG/VIAL A210337 001 May 04, 2018
AP HENGRUI PHARMA 15MG/VIAL A209150 001 May 04, 2018
AP STI PHARMA LLC 15MG/VIAL A208242 001 Jan 10, 2020
AP ! WEST-WARD PHARMS 15MG/VIAL A075547 001 Apr 02, 2001
INT
POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
TEPADINA
AP +! ADIENNE SA 15MG/VIAL N208264 001 Jan 26, 2017
AP +! 100MG/VIAL N208264 002 Jan 26, 2017
THIOTEPA
AP GLAND PHARMA LTD 15MG/VIAL A214222 001 Mar 08, 2021
AP 100MG/VIAL A214222 002 Jan 03, 2022
AP MSN 15MG/VIAL A213049 001 Mar 04, 2020
AP 100MG/VIAL A213049 002 Mar 04, 2020
THIOTHIXENE
CAPSULE;ORAL
THIOTHIXENE
AB AMNEAL 1MG A215456 001 Feb 28, 2022
AB 2MG A215456 002 Feb 28, 2022
AB 5MG A215456 003 Feb 28, 2022
AB 10MG A215456 004 Feb 28, 2022
AB MYLAN 1MG A071093 002 Jun 23, 1987
AB 2MG A071093 003 Jun 23, 1987
AB 5MG A071093 004 Jun 23, 1987
AB 10MG A071093 001 Jun 23, 1987
AB NOVITIUM PHARMA 1MG A211642 001 Apr 05, 2019
AB 2MG A211642 002 Apr 05, 2019
AB ! 5MG A211642 003 Apr 05, 2019
AB 10MG A211642 004 Apr 05, 2019
TIAGABINE HYDROCHLORIDE
TABLET;ORAL
GABITRIL
AB + CEPHALON 2MG N020646 005 Apr 16, 1999
AB +! 4MG N020646 001 Sep 30, 1997
AB + 12MG N020646 002 Sep 30, 1997
AB + 16MG N020646 003 Sep 30, 1997
TIAGABINE HYDROCHLORIDE
AB MSN 2MG A214816 001 Nov 16, 2021
AB 4MG A214816 002 Nov 16, 2021
AB 12MG A214816 003 Nov 16, 2021
AB 16MG A214816 004 Nov 16, 2021
AB SUN PHARM INDS 2MG A077555 001 Nov 04, 2011
AB 4MG A077555 002 Nov 04, 2011
TICAGRELOR
TABLET;ORAL
BRILINTA
AB +! ASTRAZENECA 90MG N022433 001 Jul 20, 2011
TICAGRELOR
AB HISUN PHARM 90MG A208575 001 Jan 23, 2019
HANGZHOU
BRILINTA
+ ASTRAZENECA 60MG N022433 002 Sep 03, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-441(of 474)

TICLOPIDINE HYDROCHLORIDE
TABLET;ORAL
TICLOPIDINE HYDROCHLORIDE
AB APOTEX 250MG A075089 001 Jul 01, 1999
AB ! TEVA 250MG A075149 001 Aug 20, 1999
TIGECYCLINE
POWDER;INTRAVENOUS
TIGECYCLINE
AP AMNEAL 50MG/VIAL N211158 001 Aug 02, 2018
AP APOTEX 50MG/VIAL A204439 001 Dec 21, 2018
AP EUGIA PHARMA 50MG/VIAL A206335 001 Jun 11, 2019
AP +! FRESENIUS KABI USA 50MG/VIAL N205645 001 Dec 01, 2016
AP MEITHEAL 50MG/VIAL A214020 001 May 13, 2021
AP SANDOZ INC 50MG/VIAL A091620 001 May 27, 2015
TYGACIL
AP +! PF PRISM CV 50MG/VIAL N021821 001 Jun 15, 2005
TIGECYCLINE
ACCORD HLTHCARE INC 50MG/VIAL N208744 001 Jan 18, 2018
TIMOLOL
SOLUTION/DROPS;OPHTHALMIC
BETIMOL
AT +! THEA PHARMA EQ 0.25% BASE N020439 001 Mar 31, 1995
AT +! EQ 0.5% BASE N020439 002 Mar 31, 1995
TIMOLOL
AT AKORN EQ 0.25% BASE A205309 001 Sep 30, 2016
AT EQ 0.5% BASE A205309 002 Sep 30, 2016
TIMOLOL MALEATE
SOLUTION, GEL FORMING/DROPS;OPHTHALMIC
TIMOLOL MALEATE
AB ! ALEMBIC PHARMS EQ 0.25% BASE A212942 001 Oct 22, 2020
AB ! EQ 0.5% BASE A212942 002 Oct 22, 2020
AB DR REDDYS EQ 0.25% BASE A215733 001 Sep 22, 2022
AB EQ 0.5% BASE A215733 002 Sep 22, 2022
AB GLAND PHARMA LTD EQ 0.25% BASE A214645 001 Jun 24, 2022
AB +! SANDOZ INC EQ 0.25% BASE N020963 001 Oct 21, 1998
AB +! EQ 0.5% BASE N020963 002 Oct 21, 1998
TIMOPTIC-XE
AB + BAUSCH AND LOMB INC EQ 0.25% BASE N020330 001 Nov 04, 1993
AB + EQ 0.5% BASE N020330 002 Nov 04, 1993
SOLUTION/DROPS;OPHTHALMIC
TIMOLOL MALEATE
AT1 AKORN EQ 0.5% BASE A074466 001 Mar 25, 1997
AT1 BAUSCH AND LOMB EQ 0.25% BASE A074778 001 Mar 25, 1997
AT1 EQ 0.5% BASE A074776 001 Mar 25, 1997
AT1 FDC LTD EQ 0.25% BASE A077259 001 Apr 30, 2008
AT1 EQ 0.5% BASE A077259 002 Apr 30, 2008
AT1 MANKIND PHARMA EQ 0.25% BASE A078771 001 Sep 28, 2009
AT1 EQ 0.5% BASE A078771 002 Sep 28, 2009
AT1 PACIFIC PHARMA EQ 0.25% BASE A074746 001 Mar 25, 1997
AT1 EQ 0.5% BASE A074747 001 Mar 25, 1997
AT1 ! SANDOZ INC EQ 0.25% BASE A074261 001 Apr 28, 1995
AT1 ! EQ 0.5% BASE A074262 001 Apr 28, 1995
TIMOPTIC
AT1 + BAUSCH AND LOMB INC EQ 0.25% BASE N018086 001
AT1 + EQ 0.5% BASE N018086 002
ISTALOL
AT2 +! BAUSCH AND LOMB EQ 0.5% BASE N021516 001 Jun 04, 2004
TIMOLOL MALEATE
AT2 APOTEX EQ 0.5% BASE A204936 001 Apr 17, 2015
AT3 AKORN EQ 0.5% BASE A212291 001 Sep 11, 2020
AT3 AMRING PHARMS EQ 0.25% BASE A212592 001 Dec 13, 2021
AT3 EQ 0.5% BASE A212592 002 Dec 13, 2021
AT3 INGENUS PHARMS LLC EQ 0.25% BASE A216533 001 Sep 13, 2022
AT3 EQ 0.5% BASE A216533 002 Sep 13, 2022
AT3 MICRO LABS EQ 0.5% BASE A216596 001 Sep 07, 2022
TIMOPTIC IN OCUDOSE
AT3 +! BAUSCH AND LOMB INC EQ 0.25% BASE N019463 001 Nov 05, 1986
AT3 +! EQ 0.5% BASE N019463 002 Nov 05, 1986
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-442(of 474)

TIMOLOL MALEATE
TABLET;ORAL
TIMOLOL MALEATE
AB ELYSIUM 5MG A207556 001 May 02, 2019
AB 10MG A207556 002 May 02, 2019
AB 20MG A207556 003 May 02, 2019
AB MYLAN 5MG A072668 002 Jun 08, 1990
AB 10MG A072668 003 Jun 08, 1990
AB ! 20MG A072668 001 Jun 08, 1990
TINIDAZOLE
TABLET;ORAL
TINDAMAX
AB + MISSION PHARMA 250MG N021618 001 May 17, 2004
AB +! 500MG N021618 002 May 17, 2004
TINIDAZOLE
AB EDENBRIDGE PHARMS 250MG A203808 001 Aug 04, 2015
AB 500MG A203808 002 Aug 04, 2015
AB NOVEL LABS INC 250MG A202044 001 Apr 30, 2012
AB 500MG A202044 002 Apr 30, 2012
AB UNIQUE 250MG A202489 001 Oct 09, 2013
AB 500MG A202489 002 Oct 09, 2013
TIOPRONIN
TABLET;ORAL
THIOLA
AB +! MISSION PHARMA 100MG N019569 001 Aug 11, 1988
TIOPRONIN
AB PAR PHARM INC 100MG A216198 001 Jun 02, 2022
AB TEVA PHARMS USA INC 100MG A214326 001 Apr 26, 2021
TABLET, DELAYED RELEASE;ORAL
THIOLA EC
+ MISSION PHARMACAL 100MG N211843 001 Jun 28, 2019
CO
+! 300MG N211843 002 Jun 28, 2019
TIOTROPIUM BROMIDE
POWDER;INHALATION
SPIRIVA
+! BOEHRINGER EQ 0.018MG BASE/INH N021395 001 Jan 30, 2004
INGELHEIM
SPRAY, METERED;INHALATION
SPIRIVA RESPIMAT
+! BOEHRINGER EQ 0.00125MG BASE/INH N021936 002 Sep 15, 2015
INGELHEIM
+! EQ 0.0025MG BASE/INH N021936 001 Sep 24, 2014
TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE
TABLET;ORAL
LONSURF
+ TAIHO ONCOLOGY EQ 6.14MG BASE;15MG N207981 001 Sep 22, 2015
+! EQ 8.19MG BASE;20MG N207981 002 Sep 22, 2015
TIPRANAVIR
CAPSULE;ORAL
APTIVUS
+! BOEHRINGER 250MG N021814 001 Jun 22, 2005
INGELHEIM
TIRBANIBULIN
OINTMENT;TOPICAL
KLISYRI
+! ALMIRALL 1% N213189 001 Dec 14, 2020
TIROFIBAN HYDROCHLORIDE
SOLUTION;INJECTION
AGGRASTAT
+! MEDICURE EQ 3.75MG BASE/15ML (EQ 0.25MG BASE/ML) N020912 002 Aug 31, 2016
SOLUTION;INTRAVENOUS
AGGRASTAT
AP +! MEDICURE EQ 12.5MG BASE/250ML (EQ 0.05MG N020913 003 Apr 20, 2000
BASE/ML)
TIROFIBAN HYDROCHLORIDE
AP GLAND PHARMA LTD EQ 12.5MG BASE/250ML (EQ 0.05MG A206888 001 Apr 08, 2021
BASE/ML)
AGGRASTAT
+ MEDICURE EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML) N020913 002 May 17, 2002
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-443(of 474)

TIRZEPATIDE
SOLUTION;SUBCUTANEOUS
MOUNJARO
+! ELI LILLY AND CO 2.5MG/0.5ML (2.5MG/0.5ML) N215866 001 May 13, 2022
+! 5MG/0.5ML (5MG/0.5ML) N215866 002 May 13, 2022
+! 7.5MG/0.5ML (7.5MG/0.5ML) N215866 003 May 13, 2022
+! 10MG/0.5ML (10MG/0.5ML) N215866 004 May 13, 2022
+! 12.5MG/0.5ML (12.5MG/0.5ML) N215866 005 May 13, 2022
+! 15MG/0.5ML (15MG/0.5ML) N215866 006 May 13, 2022
TIVOZANIB HYDROCHLORIDE
CAPSULE;ORAL
FOTIVDA
+ AVEO PHARMS EQ 0.89MG BASE N212904 001 Mar 10, 2021
+! EQ 1.34MG BASE N212904 002 Mar 10, 2021
TIZANIDINE HYDROCHLORIDE
CAPSULE;ORAL
TIZANIDINE HYDROCHLORIDE
AB ALEMBIC PHARMS EQ 2MG BASE A213223 001 Jan 13, 2020
AB EQ 4MG BASE A213223 002 Jan 13, 2020
AB EQ 6MG BASE A213223 003 Jan 13, 2020
AB ALKEM LABS LTD EQ 2MG BASE A212196 001 Mar 27, 2019
AB EQ 4MG BASE A212196 002 Mar 27, 2019
AB EQ 6MG BASE A212196 003 Mar 27, 2019
AB APOTEX INC EQ 2MG BASE A078868 001 Feb 03, 2012
AB EQ 4MG BASE A078868 002 Feb 03, 2012
AB EQ 6MG BASE A078868 003 Feb 03, 2012
AB AUROBINDO PHARMA EQ 2MG BASE A213544 001 Mar 24, 2020
LTD
AB EQ 4MG BASE A213544 002 Mar 24, 2020
AB EQ 6MG BASE A213544 003 Mar 24, 2020
AB CADILA PHARMS LTD EQ 2MG BASE A210021 001 Mar 26, 2019
AB EQ 4MG BASE A210021 002 Mar 26, 2019
AB EQ 6MG BASE A210021 003 Mar 26, 2019
AB JUBILANT GENERICS EQ 2MG BASE A209605 001 Aug 04, 2017
AB EQ 4MG BASE A209605 002 Aug 04, 2017
AB EQ 6MG BASE A209605 003 Aug 04, 2017
AB NOVAST LABS EQ 2MG BASE A210267 001 Mar 12, 2019
AB EQ 4MG BASE A210267 002 Mar 12, 2019
AB EQ 6MG BASE A210267 003 Mar 12, 2019
AB RUBICON EQ 2MG BASE A213798 001 May 27, 2020
AB EQ 4MG BASE A213798 002 May 27, 2020
AB EQ 6MG BASE A213798 003 May 27, 2020
AB ZYDUS PHARMS EQ 2MG BASE A208622 001 Mar 03, 2017
AB EQ 4MG BASE A208622 002 Mar 03, 2017
AB EQ 6MG BASE A208622 003 Mar 03, 2017
ZANAFLEX
AB + LEGACY PHARMA EQ 2MG BASE N021447 001 Aug 29, 2002
AB + EQ 4MG BASE N021447 002 Aug 29, 2002
AB +! EQ 6MG BASE N021447 003 Aug 29, 2002
TABLET;ORAL
TIZANIDINE HYDROCHLORIDE
AB ALKEM LABS LTD EQ 2MG BASE A211798 001 Jan 25, 2019
AB EQ 4MG BASE A211798 002 Jan 25, 2019
AB APOTEX EQ 2MG BASE A076533 001 Jan 16, 2004
AB EQ 4MG BASE A076533 002 Jan 16, 2004
AB CADILA EQ 2MG BASE A208187 001 Mar 09, 2018
AB EQ 4MG BASE A208187 002 Mar 09, 2018
AB CASI PHARMS INC EQ 2MG BASE A076280 001 Nov 26, 2002
AB EQ 4MG BASE A076280 002 Jun 27, 2002
AB DR REDDYS LABS INC EQ 2MG BASE A076286 001 Jul 03, 2002
AB EQ 4MG BASE A076286 002 Jul 03, 2002
AB EPIC PHARMA LLC EQ 2MG BASE A076347 001 Oct 11, 2002
AB EQ 4MG BASE A076347 002 Oct 11, 2002
AB OXFORD PHARMS EQ 2MG BASE A076281 001 Oct 20, 2003
AB EQ 4MG BASE A076281 002 Oct 20, 2003
AB SUN PHARM INDS INC EQ 2MG BASE A076416 001 Sep 29, 2003
AB EQ 4MG BASE A076416 002 Sep 29, 2003
AB UNICHEM LABS LTD EQ 2MG BASE A091283 001 Nov 28, 2012
AB EQ 4MG BASE A091283 002 Nov 28, 2012
ZANAFLEX
AB +! LEGACY PHARMA EQ 4MG BASE N020397 001 Nov 27, 1996
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-444(of 474)

TOBRAMYCIN
OINTMENT;OPHTHALMIC
TOBREX
+! NOVARTIS 0.3% N050555 001
POWDER;INHALATION
TOBI PODHALER
+! MYLAN SPECIALITY LP 28MG N201688 001 Mar 22, 2013
SOLUTION;INHALATION
BETHKIS
AN +! CHIESI 300MG/4ML N201820 001 Oct 12, 2012
KITABIS PAK
AN PULMOFLOW INC 300MG/5ML N205433 001 Dec 02, 2014
TOBI
AN +! MYLAN SPECIALITY LP 300MG/5ML N050753 001 Dec 22, 1997
TOBRAMYCIN
AN AKORN 300MG/5ML A201422 001 May 28, 2014
AN ALKEM LABS LTD 300MG/5ML A212848 001 Apr 01, 2021
AN AMNEAL PHARMS 300MG/5ML A205501 001 Jul 13, 2015
AN DR REDDYS LABS SA 300MG/5ML A207080 001 Jul 09, 2018
AN LUPIN 300MG/5ML A208964 001 Mar 22, 2017
AN MANKIND PHARMA 300MG/4ML A216725 001 Sep 22, 2022
AN SUN PHARM 300MG/5ML A207136 001 Dec 26, 2019
AN TEVA PHARMS USA 300MG/5ML A091589 001 Oct 10, 2013
AN 300MG/4ML A210915 001 Jun 26, 2019
SOLUTION/DROPS;OPHTHALMIC
AKTOB
AT AKORN 0.3% A064096 001 Jan 31, 1996
TOBRAMYCIN
AT ALEMBIC PHARMS 0.3% A211847 001 Apr 19, 2019
AT BAUSCH AND LOMB 0.3% A064052 001 Nov 29, 1993
AT FERA PHARMS 0.3% A065026 001 Sep 11, 2001
AT GLAND PHARMA LTD 0.3% A212628 001 Mar 09, 2021
AT SOMERSET THERAPS 0.3% A207444 001 Jun 28, 2017
LLC
TOBREX
AT +! NOVARTIS 0.3% N050541 001
AT SANDOZ INC 0.3% A062535 001 Dec 13, 1984
TOBRAMYCIN SULFATE
INJECTABLE;INJECTION
TOBRAMYCIN SULFATE
AP BAXTER HLTHCARE EQ 40MG BASE/ML A206965 001 Jul 01, 2016
CORP
AP FRESENIUS KABI USA EQ 10MG BASE/ML A065122 001 Nov 29, 2002
AP ! EQ 40MG BASE/ML A065122 002 Nov 29, 2002
AP EQ 1.2GM BASE/VIAL N050789 001 Jul 13, 2004
AP GLAND PHARMA LTD EQ 10MG BASE/ML A209621 001 Feb 11, 2021
AP EQ 40MG BASE/ML A209621 002 Feb 11, 2021
AP EQ 1.2GM BASE/VIAL A211189 001 May 18, 2021
AP HIKMA EQ 40MG BASE/ML A063117 001 Apr 26, 1991
AP ! HOSPIRA EQ 10MG BASE/ML A063112 001 Apr 30, 1991
AP EQ 40MG BASE/ML A063111 001 Apr 30, 1991
AP MYLAN LABS LTD EQ 40MG BASE/ML A065407 001 Mar 11, 2008
AP XELLIA PHARMS APS EQ 1.2GM BASE/VIAL A205685 001 Sep 16, 2014
AP ! XGEN PHARMS EQ 1.2GM BASE/VIAL A065013 001 Aug 17, 2001
TOBRAMYCIN SULFATE (PHARMACY BULK)
AP ! FRESENIUS KABI USA EQ 40MG BASE/ML A065120 001 Nov 29, 2002
AP GLAND PHARMA LTD EQ 40MG BASE/ML A209346 001 Feb 09, 2021
TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
! HOSPIRA EQ 1.2MG BASE/ML A063081 003 Jul 31, 1990
! EQ 1.6MG BASE/ML A063081 006 Jun 02, 1993
! EQ 80MG BASE/100ML A063081 001 Jul 31, 1990
TOFACITINIB CITRATE
SOLUTION;ORAL
XELJANZ
+! PFIZER EQ 1MG/ML BASE N213082 001 Sep 25, 2020
TABLET;ORAL
XELJANZ
+ PF PRISM CV EQ 5MG BASE N203214 001 Nov 06, 2012
+! EQ 10MG BASE N203214 002 May 30, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-445(of 474)

TOFACITINIB CITRATE
TABLET, EXTENDED RELEASE;ORAL
XELJANZ XR
+ PFIZER EQ 11MG BASE N208246 001 Feb 23, 2016
+! EQ 22MG BASE N208246 002 Dec 12, 2019
TOLCAPONE
TABLET;ORAL
TASMAR
AB +! BAUSCH 100MG N020697 001 Jan 29, 1998
TOLCAPONE
AB NOVAST LABS 100MG A208937 001 Aug 07, 2018
AB PAR PHARM INC 100MG A204584 001 Mar 26, 2015
TOLTERODINE TARTRATE
CAPSULE, EXTENDED RELEASE;ORAL
DETROL LA
AB + UPJOHN 2MG N021228 001 Dec 22, 2000
AB +! 4MG N021228 002 Dec 22, 2000
TOLTERODINE TARTRATE
AB AJANTA PHARMA LTD 2MG A213397 001 May 19, 2020
AB 4MG A213397 002 May 19, 2020
AB AMTA 2MG A213858 001 Feb 02, 2021
AB 4MG A213858 002 Feb 02, 2021
AB HETERO LABS LTD III 2MG A206419 001 Dec 12, 2017
AB 4MG A206419 002 Dec 12, 2017
AB INVENTIA HLTHCARE 2MG A204562 001 Aug 19, 2019
AB 4MG A204562 002 Aug 19, 2019
AB TEVA PHARMS USA 2MG A079141 001 Nov 22, 2016
AB 4MG A079141 002 Nov 22, 2016
AB TORRENT 2MG A203016 001 Aug 11, 2015
AB 4MG A203016 002 Aug 11, 2015
TABLET;ORAL
DETROL
AB + UPJOHN 1MG N020771 001 Mar 25, 1998
AB +! 2MG N020771 002 Mar 25, 1998
TOLTERODINE TARTRATE
AB ATHEM 1MG A210775 001 Dec 30, 2019
AB 2MG A210775 002 Dec 30, 2019
AB HETERO LABS LTD V 1MG A204397 001 Aug 02, 2021
AB 2MG A204397 002 Aug 02, 2021
AB IVAX SUB TEVA 1MG A077006 001 Feb 23, 2015
PHARMS
AB 2MG A077006 002 Feb 23, 2015
AB MACLEODS PHARMS LTD 1MG A203409 001 Aug 31, 2015
AB 2MG A203409 002 Aug 31, 2015
AB UNICHEM 1MG A205399 001 Aug 05, 2020
AB 2MG A205399 002 Aug 05, 2020
AB UNIQUE 1MG A204721 001 Jan 24, 2020
AB 2MG A204721 002 Jan 24, 2020
TOLVAPTAN
TABLET;ORAL
SAMSCA
AB + OTSUKA 15MG N022275 001 May 19, 2009
AB +! 30MG N022275 002 May 19, 2009
TOLVAPTAN
AB ALKEM LABS LTD 15MG A211891 003 Sep 06, 2022
AB 30MG A211891 001 May 19, 2020
AB APOTEX 15MG A207605 002 Sep 06, 2022
AB 30MG A207605 001 May 19, 2020
AB HETERO LABS LTD V 15MG A205646 002 Sep 06, 2022
AB 30MG A205646 001 Jul 16, 2021
AB PAR PHARM INC 15MG A206119 001 Feb 15, 2022
AB 30MG A206119 002 Feb 15, 2022
JYNARQUE
+ OTSUKA 15MG N204441 001 Apr 23, 2018
+ 30MG N204441 002 Apr 23, 2018
+! 45MG N204441 003 Apr 23, 2018
+ 60MG N204441 004 Apr 23, 2018
+ 90MG N204441 005 Apr 23, 2018
TOLVAPTAN
ALKEM LABS LTD 60MG A211891 002 May 19, 2020
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-446(of 474)

TOPIRAMATE
CAPSULE;ORAL
TOPAMAX
AB + JANSSEN PHARMS 15MG N020844 001 Oct 26, 1998
AB +! 25MG N020844 002 Oct 26, 1998
TOPIRAMATE
AB TEVA 15MG A076575 001 Apr 17, 2009
AB 25MG A076575 002 Apr 17, 2009
AB WATSON LABS 15MG A077868 001 Apr 15, 2009
AB 25MG A077868 002 Apr 15, 2009
AB ZYDUS PHARMS USA 15MG A078877 001 Oct 14, 2009
INC
AB 25MG A078877 002 Oct 14, 2009
CAPSULE, EXTENDED RELEASE;ORAL
TOPIRAMATE
AB1 ZYDUS PHARMS 25MG A207382 001 Nov 24, 2017
AB1 50MG A207382 002 Nov 24, 2017
AB1 100MG A207382 003 Nov 24, 2017
TROKENDI XR
AB1 + SUPERNUS PHARMS 25MG N201635 001 Aug 16, 2013
AB1 + 50MG N201635 002 Aug 16, 2013
AB1 + 100MG N201635 003 Aug 16, 2013
QUDEXY XR
AB2 + UPSHER SMITH LABS 25MG N205122 001 Mar 11, 2014
AB2 + 50MG N205122 002 Mar 11, 2014
AB2 + 100MG N205122 003 Mar 11, 2014
AB2 + 150MG N205122 004 Mar 11, 2014
AB2 +! 200MG N205122 005 Mar 11, 2014
TOPIRAMATE
AB2 GLENMARK PHARMS LTD 25MG A210278 001 Feb 01, 2021
AB2 50MG A210278 002 Feb 01, 2021
AB2 100MG A210278 003 Feb 01, 2021
AB2 150MG A210278 004 Feb 01, 2021
AB2 200MG A210278 005 Feb 01, 2021
AB2 ZYDUS PHARMS 25MG A208949 001 Nov 29, 2022
AB2 50MG A208949 002 Nov 29, 2022
AB2 100MG A208949 003 Nov 29, 2022
AB2 150MG A208949 004 Nov 29, 2022
AB2 200MG A208949 005 Nov 29, 2022
TROKENDI XR
BC +! SUPERNUS PHARMS 200MG N201635 004 Aug 16, 2013
SOLUTION;ORAL
EPRONTIA
+! AZURITY 25MG/ML N214679 001 Nov 05, 2021
TABLET;ORAL
TOPAMAX
AB + JANSSEN PHARMS 25MG N020505 004 Dec 24, 1996
AB + 50MG N020505 005 Dec 24, 1996
AB +! 100MG N020505 001 Dec 24, 1996
AB + 200MG N020505 002 Dec 24, 1996
TOPIRAMATE
AB ACCORD HLTHCARE 25MG A076311 001 Mar 27, 2009
AB 50MG A076311 002 Mar 27, 2009
AB 100MG A076311 003 Mar 27, 2009
AB 200MG A076311 004 Mar 27, 2009
AB ASCENT PHARMS INC 25MG A215414 001 Aug 26, 2021
AB 50MG A215414 002 Aug 26, 2021
AB 100MG A215414 003 Aug 26, 2021
AB 200MG A215414 004 Aug 26, 2021
AB AUROBINDO PHARMA 25MG A078462 001 Mar 27, 2009
AB 50MG A078462 002 Mar 27, 2009
AB 100MG A078462 003 Mar 27, 2009
AB 200MG A078462 004 Mar 27, 2009
AB CIPLA LTD 25MG A076343 001 Mar 27, 2009
AB 50MG A076343 002 Mar 27, 2009
AB 100MG A076343 003 Mar 27, 2009
AB 200MG A076343 004 Mar 27, 2009
AB GLENMARK GENERICS 25MG A077627 001 Mar 27, 2009
AB 50MG A077627 002 Mar 27, 2009
AB 100MG A077627 003 Mar 27, 2009
AB 200MG A077627 004 Mar 27, 2009
AB INVAGEN PHARMS 25MG A079162 001 Mar 27, 2009
AB 50MG A079162 002 Mar 27, 2009
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-447(of 474)

TOPIRAMATE
TABLET;ORAL
TOPIRAMATE
AB 100MG A079162 003 Mar 27, 2009
AB 200MG A079162 004 Mar 27, 2009
AB SUN PHARM 25MG A090278 001 Mar 27, 2009
AB 50MG A090278 002 Mar 27, 2009
AB 100MG A090278 003 Mar 27, 2009
AB 200MG A090278 004 Mar 27, 2009
AB SUN PHARM INDS LTD 25MG A076327 001 Mar 27, 2009
AB 100MG A076327 002 Mar 27, 2009
AB 200MG A076327 003 Mar 27, 2009
AB TEVA 25MG A076317 001 Mar 27, 2009
AB 50MG A076317 002 Mar 27, 2009
AB 100MG A076317 003 Mar 27, 2009
AB 200MG A076317 004 Mar 27, 2009
AB UNICHEM LABS LTD 25MG A090162 001 Mar 27, 2009
AB 50MG A090162 002 Mar 27, 2009
AB 100MG A090162 003 Mar 27, 2009
AB 200MG A090162 004 Feb 19, 2013
AB VIWIT PHARM 25MG A077733 001 Mar 27, 2009
AB 50MG A077733 002 Mar 27, 2009
AB 100MG A077733 003 Mar 27, 2009
AB 200MG A077733 004 Mar 27, 2009
AB ZYDUS PHARMS USA 25MG A078235 001 Mar 27, 2009
INC
AB 50MG A078235 002 Mar 27, 2009
AB 100MG A078235 003 Mar 27, 2009
AB 200MG A078235 004 Mar 27, 2009
TOPOTECAN HYDROCHLORIDE
CAPSULE;ORAL
HYCAMTIN
+ NOVARTIS EQ 0.25MG BASE N020981 001 Oct 11, 2007
+! EQ 1MG BASE N020981 002 Oct 11, 2007
INJECTABLE;INJECTION
HYCAMTIN
AP +! NOVARTIS EQ 4MG BASE/VIAL N020671 001 May 28, 1996
TOPOTECAN HYDROCHLORIDE
AP ACCORD HLTHCARE EQ 4MG BASE/VIAL A202351 001 Jun 26, 2013
AP ACTAVIS TOTOWA EQ 4MG BASE/VIAL A090620 001 Dec 02, 2010
AP DR REDDYS LABS LTD EQ 4MG BASE/VIAL A201191 001 Mar 09, 2011
AP FRESENIUS KABI USA EQ 4MG BASE/VIAL A091089 001 Nov 29, 2010
AP NOVAST LABS EQ 4MG BASE/VIAL A206962 001 Nov 30, 2016
AP SAGENT PHARMS EQ 4MG BASE/VIAL A091284 001 Jan 26, 2011
AP TEYRO LABS EQ 4MG BASE/VIAL A091199 001 Dec 01, 2010
SOLUTION;INTRAVENOUS
TOPOTECAN HYDROCHLORIDE
AP ACCORD HLTHCARE EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A204406 002 Jul 06, 2017
AP +! HOSPIRA INC EQ 4MG BASE/4ML (EQ 1MG BASE/ML) N200582 001 Feb 02, 2011
AP TEVA PHARMS USA EQ 4MG BASE/4ML (EQ 1MG BASE/ML) N022453 001 Dec 20, 2012
ACCORD HLTHCARE EQ 1MG BASE/ML (EQ 1MG BASE/ML) A204406 001 Jul 06, 2017
TOREMIFENE CITRATE
TABLET;ORAL
FARESTON
AB +! KYOWA KIRIN EQ 60MG BASE N020497 001 May 29, 1997
TOREMIFENE CITRATE
AB MSN EQ 60MG BASE A212818 001 Aug 18, 2020
AB RISING EQ 60MG BASE A208813 001 Dec 04, 2018
TORSEMIDE
TABLET;ORAL
TORSEMIDE
AB AUROBINDO PHARMA 5MG A078249 001 Oct 17, 2007
AB 10MG A078249 002 Oct 17, 2007
AB 20MG A078249 003 Oct 17, 2007
AB 100MG A078249 004 Oct 17, 2007
AB COREPHARMA 5MG A076894 001 May 31, 2005
AB 10MG A076894 002 May 31, 2005
AB 20MG A076894 003 May 31, 2005
AB 100MG A076894 004 May 31, 2005
AB HETERO LABS LTD III 5MG A079234 001 Jan 27, 2009
AB 10MG A079234 002 Jan 27, 2009
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-448(of 474)

TORSEMIDE
TABLET;ORAL
TORSEMIDE
AB 20MG A079234 003 Jan 27, 2009
AB 100MG A079234 004 Jan 27, 2009
AB HIKMA 5MG A076943 001 Mar 01, 2005
AB 10MG A076943 002 Mar 01, 2005
AB 20MG A076943 003 Mar 01, 2005
AB PLIVA PHARM IND 5MG A076346 001 May 30, 2003
AB 10MG A076346 002 May 30, 2003
AB ! 20MG A076346 003 May 30, 2003
AB 100MG A076346 004 Oct 19, 2004
AB STRIDES PHARMA 5MG A076226 001 May 27, 2003
AB 5MG A090613 001 Mar 22, 2011
AB 10MG A076226 002 May 27, 2003
AB 10MG A090613 002 Mar 22, 2011
AB 20MG A076226 003 May 27, 2003
AB 20MG A090613 003 Mar 22, 2011
AB 100MG A076226 004 May 27, 2003
AB 100MG A090613 004 Mar 22, 2011
AB TEVA 5MG A076110 001 May 14, 2002
AB 10MG A076110 002 May 14, 2002
AB 20MG A076110 003 May 14, 2002
AB 100MG A076110 004 May 14, 2002
SOAANZ
+! SARFE PHARMS 20MG N213218 001 Jun 14, 2021
+ 40MG N213218 003 Nov 17, 2021
+ 60MG N213218 002 Jun 14, 2021
TRABECTEDIN
POWDER;INTRAVENOUS
YONDELIS
+! JANSSEN PRODS 1MG/VIAL N207953 001 Oct 23, 2015
TRAMADOL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
CONZIP
+! CIPHER PHARMS INC 100MG N022370 001 May 07, 2010
+ 200MG N022370 002 May 07, 2010
+ 300MG N022370 003 May 07, 2010
SOLUTION;ORAL
QDOLO
+! ATHENA 5MG/ML N214044 001 Sep 01, 2020
TABLET;ORAL
TRAMADOL HYDROCHLORIDE
AB ACI 50MG A202075 001 Nov 28, 2011
AB AMNEAL PHARMS 50MG A076003 001 Jun 20, 2002
AB APOTEX 50MG A075981 001 Jul 10, 2002
AB AUROBINDO PHARMA 50MG A203494 001 Mar 31, 2014
LTD
AB CSPC OUYI PHARM CO 50MG A091498 001 Mar 29, 2013
AB IPCA LABS LTD 50MG A201973 001 Nov 16, 2012
AB MERRO PHARM USA 50MG A206706 001 Jul 02, 2019
AB PLIVA 50MG A075982 001 Jul 01, 2002
AB RUBICON 50MG A208708 001 Jun 28, 2019
AB ! SUN PHARM INDS INC 50MG A075964 001 Jun 19, 2002
AB TEVA 50MG A075977 001 Jun 19, 2002
AB UNICHEM 50MG A211825 001 Aug 09, 2019
AB ZYDUS PHARMS USA 50MG A090404 001 Jan 31, 2011
INC
RUBICON 100MG A208708 002 Jun 28, 2019
TABLET, EXTENDED RELEASE;ORAL
TRAMADOL HYDROCHLORIDE
AB1 ! LUPIN LTD 100MG A200503 001 Aug 29, 2011
AB1 200MG A200503 002 Aug 29, 2011
AB1 300MG A200503 003 Aug 29, 2011
AB1 SUN PHARM 100MG A201384 001 Dec 07, 2011
AB1 200MG A201384 002 Dec 07, 2011
AB1 300MG A201384 003 Dec 07, 2011
AB2 ACTAVIS ELIZABETH 100MG A091609 001 Jun 27, 2012
AB2 200MG A091609 002 Jun 27, 2012
AB2 300MG A091609 003 Jun 27, 2012
AB2 ! SUN PHARM 100MG A091607 001 Dec 30, 2011
AB2 200MG A091607 002 Dec 30, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-449(of 474)

TRAMADOL HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
TRAMADOL HYDROCHLORIDE
AB2 300MG A091607 003 Dec 30, 2011
TRAMETINIB DIMETHYL SULFOXIDE
TABLET;ORAL
MEKINIST
+ NOVARTIS EQ 0.5MG N204114 001 May 29, 2013
+! EQ 2MG N204114 003 May 29, 2013
TRANDOLAPRIL
TABLET;ORAL
TRANDOLAPRIL
AB AUROBINDO PHARMA 1MG A078438 001 Jun 12, 2007
AB 2MG A078438 002 Jun 12, 2007
AB 4MG A078438 003 Jun 12, 2007
AB EPIC PHARMA 1MG A078508 003 Jun 18, 2008
AB 2MG A078508 001 Jun 18, 2008
AB 4MG A078508 002 Jun 18, 2008
AB LUPIN 1MG A077522 001 Jun 12, 2007
AB 2MG A077522 002 Jun 12, 2007
AB ! 4MG A077522 003 Jun 12, 2007
AB TEVA PHARMS 1MG A077489 001 Dec 12, 2006
AB 2MG A077489 002 Dec 12, 2006
AB 4MG A077489 003 Dec 12, 2006
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE
GLENMARK GENERICS 1MG;240MG A079135 004 Aug 30, 2010
2MG;180MG A079135 001 May 26, 2010
2MG;240MG A079135 002 May 26, 2010
! 4MG;240MG A079135 003 May 05, 2010
TRANEXAMIC ACID
INJECTABLE;INJECTION
CYKLOKAPRON
AP +! PFIZER 100MG/ML N019281 001 Dec 30, 1986
TRANEXAMIC ACID
AP ACIC PHARMS 100MG/ML A202436 001 Feb 11, 2014
AP AKORN 100MG/ML A202373 001 Nov 17, 2011
AP AM REGENT 100MG/ML A201885 001 Aug 10, 2011
AP AMNEAL PHARMS CO 100MG/ML A208840 001 Feb 28, 2017
AP APOTEX 100MG/ML A209860 001 Jan 14, 2020
AP CAPLIN 100MG/ML A212360 001 Jul 17, 2019
AP EMCURE PHARMS LTD 100MG/ML A203521 001 Aug 12, 2014
AP EUGIA PHARMA 100MG/ML A205035 001 Jan 14, 2016
AP FRESENIUS KABI USA 100MG/ML A091596 001 Mar 02, 2012
AP GLAND 100MG/ML A207239 001 Feb 13, 2017
AP MICRO LABS 100MG/ML A206713 001 Jun 27, 2017
AP MYLAN INSTITUTIONAL 100MG/ML A091657 001 Nov 03, 2011
AP PROVEPHARM SAS 100MG/ML A212676 001 Jul 17, 2019
AP XGEN PHARMS 100MG/ML A201580 001 Jun 14, 2013
SOLUTION;INTRAVENOUS
TRANEXAMIC ACID
+! EXELA PHARMA 1GM/100ML (10MG/ML) N212020 001 Apr 15, 2019
TABLET;ORAL
LYSTEDA
AB +! AMRING PHARMS 650MG N022430 001 Nov 13, 2009
TRANEXAMIC ACID
AB ACTAVIS LABS FL INC 650MG A202093 001 Dec 27, 2012
AB ANI PHARMS 650MG A203256 001 Jul 25, 2016
TRANYLCYPROMINE SULFATE
TABLET;ORAL
PARNATE
AB +! CONCORDIA EQ 10MG BASE N012342 003 Aug 16, 1985
TRANYLCYPROMINE SULFATE
AB CROSSMEDIKA SA EQ 10MG BASE A213503 001 Jun 27, 2022
AB NOVITIUM PHARMA EQ 10MG BASE A206856 001 Apr 17, 2018
AB STRIDES PHARMA EQ 10MG BASE A040640 001 Jun 29, 2006
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-450(of 474)

TRAVOPROST
SOLUTION/DROPS;OPHTHALMIC
TRAVATAN Z
AT +! NOVARTIS 0.004% N021994 001 Sep 21, 2006
TRAVOPROST
AT APOTEX 0.004% A203431 001 Jul 10, 2015
AT MICRO LABS 0.004% A203767 001 Mar 19, 2021
AT MYLAN 0.004% A205050 001 Jul 07, 2017
AT1 ALEMBIC PHARMS 0.004% A210458 001 Dec 20, 2019
AT1 ! STRIDES PHARMA 0.004% A091340 001 Mar 01, 2013
TRAZODONE HYDROCHLORIDE
TABLET;ORAL
TRAZODONE HYDROCHLORIDE
AB ACCORD HLTHCARE 50MG A206923 001 Sep 08, 2017
AB 100MG A206923 002 Sep 08, 2017
AB 150MG A206923 003 Sep 08, 2017
AB 300MG A206923 004 Sep 08, 2017
AB APOTEX 50MG A071258 001 Mar 25, 1987
AB ! APOTEX INC 100MG A071196 001 Mar 25, 1987
AB 150MG A071196 002 Apr 26, 1999
AB 300MG A071196 003 Apr 26, 1999
AB AUROLIFE PHARMA LLC 50MG A204852 001 Feb 05, 2020
AB 100MG A204852 002 Feb 05, 2020
AB 150MG A204852 003 Feb 05, 2020
AB 300MG A204852 004 Feb 05, 2020
AB OXFORD PHARMS 50MG A072192 001 Feb 02, 1989
AB 100MG A072193 001 Feb 02, 1989
AB PLIVA 150MG A071525 001 Mar 09, 1988
AB SUN PHARM 50MG A073137 002 Mar 24, 1993
INDUSTRIES
AB 100MG A073137 001 Mar 24, 1993
AB 150MG A073137 003 Dec 22, 1995
AB TEVA PHARMS USA 50MG A071523 001 Dec 11, 1987
AB 100MG A071524 001 Dec 11, 1987
AB TORRENT 50MG A202180 001 Nov 27, 2013
AB 100MG A202180 002 Nov 27, 2013
AB 150MG A202180 003 Nov 27, 2013
AB 300MG A202180 004 Nov 27, 2013
AB ZYDUS PHARMS 50MG A205253 001 Oct 10, 2017
AB 100MG A205253 002 Oct 10, 2017
AB 150MG A205253 003 Oct 10, 2017
AB 300MG A205253 004 Oct 10, 2017
TREPROSTINIL
INJECTABLE;IV (INFUSION), SUBCUTANEOUS
REMODULIN
AP +! UNITED THERAP 1MG/ML N021272 001 May 21, 2002
AP +! 2.5MG/ML N021272 002 May 21, 2002
AP +! 5MG/ML N021272 003 May 21, 2002
AP +! 10MG/ML N021272 004 May 21, 2002
TREPROSTINIL
AP ALEMBIC GLOBAL 1MG/ML A211574 001 Feb 11, 2021
AP 2.5MG/ML A211574 002 Feb 11, 2021
AP 5MG/ML A211574 003 Feb 11, 2021
AP 10MG/ML A211574 004 Feb 11, 2021
AP PAR STERILE 1MG/ML A209382 001 Sep 24, 2019
PRODUCTS
AP 2.5MG/ML A209382 002 Sep 24, 2019
AP 5MG/ML A209382 003 Sep 24, 2019
AP 10MG/ML A209382 004 Sep 24, 2019
AP SANDOZ INC 1MG/ML A203649 001 Nov 30, 2017
AP 2.5MG/ML A203649 002 Nov 30, 2017
AP 5MG/ML A203649 003 Nov 30, 2017
AP 10MG/ML A203649 004 Nov 30, 2017
AP TEVA PHARMS USA 1MG/ML A206648 001 Sep 26, 2019
AP 2.5MG/ML A206648 002 Sep 26, 2019
AP 5MG/ML A206648 003 Sep 26, 2019
AP 10MG/ML A206648 004 Sep 26, 2019
REMODULIN
+! UNITED THERAP 20MG/ML N021272 005 Jul 30, 2021
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-451(of 474)

TREPROSTINIL
POWDER;INHALATION
TYVASO DPI
+ UNITED THERAP 0.016MG/INH N214324 001 May 23, 2022
+ 0.032MG/INH N214324 002 May 23, 2022
+ 0.048MG/INH N214324 003 May 23, 2022
+! 0.064MG/INH N214324 004 May 23, 2022
SOLUTION;INHALATION
TYVASO
+! UNITED THERAP 0.6MG/ML N022387 001 Jul 30, 2009
TREPROSTINIL DIOLAMINE
TABLET, EXTENDED RELEASE;ORAL
ORENITRAM
+ UNITED THERAP EQ 0.125MG BASE N203496 001 Dec 20, 2013
+ EQ 0.25MG BASE N203496 002 Dec 20, 2013
+! EQ 1MG BASE N203496 003 Dec 20, 2013
+ EQ 2.5MG BASE N203496 004 Dec 20, 2013
+ EQ 5MG BASE N203496 005 Oct 07, 2016
TRETINOIN
CAPSULE;ORAL
TRETINOIN
AB ANCHEN PHARMS 10MG A201687 001 Oct 24, 2012
AB ! BARR LABS INC 10MG A077684 001 Jun 22, 2007
AB GLENMARK PHARMS LTD 10MG A208279 001 Dec 23, 2016
CREAM;TOPICAL
AVITA
AB MYLAN PHARMS INC 0.025% N020404 003 Jan 14, 1997
RETIN-A
AB +! VALEANT BERMUDA 0.025% N019049 001 Sep 16, 1988
AB +! VALEANT PHARMS 0.1% N017340 001
NORTH
TRETINOIN
AB PADAGIS US 0.025% A075264 001 Dec 24, 1998
AB 0.1% A075213 001 Dec 24, 1998
AB TARO PHARMS 0.025% A215713 001 Jan 05, 2023
AB 0.1% A211645 001 Jan 22, 2019
RETIN-A
AB1 +! VALEANT BERMUDA 0.05% N017522 001
TRETINOIN
AB1 PADAGIS US 0.05% A075265 001 Dec 24, 1998
AB1 TARO PHARMS 0.05% A211644 001 Jan 25, 2019
RENOVA
+! VALEANT PHARMS 0.02% N021108 001 Aug 31, 2000
NORTH
GEL;TOPICAL
ATRALIN
AB +! DOW PHARM 0.05% N022070 001 Jul 26, 2007
RETIN-A
AB +! VALEANT INTL 0.01% N017955 001
AB +! 0.025% N017579 002
TRETINOIN
AB MYLAN 0.05% A207955 001 Aug 13, 2015
AB PADAGIS US 0.01% A075589 001 Jun 11, 2002
AB 0.025% A075529 001 Feb 22, 2000
AVITA
BT MYLAN 0.025% N020400 001 Jan 29, 1998
RETIN-A MICRO
+! VALEANT INTL 0.04% N020475 002 May 10, 2002
+! 0.1% N020475 001 Feb 07, 1997
RETIN-A-MICRO
+! VALEANT INTL 0.06% N020475 004 Oct 23, 2017
+! 0.08% N020475 003 Jan 28, 2014
LOTION;TOPICAL
ALTRENO
+! DOW PHARM 0.05% N209353 001 Aug 23, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-452(of 474)

TRIAMCINOLONE ACETONIDE
CREAM;TOPICAL
TRIAMCINOLONE ACETONIDE
AT ALKEM LABS LTD 0.025% A207651 001 Dec 26, 2017
AT 0.1% A207651 002 Dec 26, 2017
AT 0.5% A207651 003 Dec 26, 2017
AT COSETTE 0.025% A089797 001 May 31, 1991
AT 0.1% A089798 001 May 31, 1991
AT ENCUBE 0.1% A208848 001 Sep 18, 2017
AT +! FOUGERA PHARMS 0.025% A085692 001
AT +! 0.1% A085692 003
AT +! 0.5% A085692 002
AT GLENMARK PHARMS LTD 0.1% A207117 001 Aug 05, 2016
AT LUPIN 0.025% A208763 001 Feb 01, 2017
AT 0.1% A208763 002 Feb 01, 2017
AT 0.5% A208763 003 Feb 01, 2017
AT MACLEODS PHARMS LTD 0.025% A209535 001 May 18, 2018
AT 0.1% A209535 002 May 18, 2018
AT 0.5% A209535 003 May 18, 2018
AT MICRO LABS 0.025% A040671 001 Jun 09, 2006
AT 0.1% A040671 002 Jun 09, 2006
AT PADAGIS US 0.025% A086413 002
AT 0.1% A086413 003
AT 0.5% A086413 001
AT STRIDES PHARMA 0.025% A210346 001 Feb 11, 2019
AT 0.1% A210346 002 Feb 11, 2019
AT 0.5% A210346 003 Feb 11, 2019
AT TARO PHARM INDS LTD 0.1% A040039 001 Nov 26, 1997
TRIDERM
AT CROWN LABS 0.025% A088042 002 Mar 25, 2015
AT 0.1% A088042 001 Mar 19, 1984
AT 0.5% A088042 003 Mar 25, 2015
FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR
ZILRETTA
+! PACIRA PHARMS INC 32MG/VIAL N208845 001 Oct 06, 2017
INJECTABLE;INJECTION
KENALOG-40
AB +! APOTHECON 40MG/ML N014901 001
TRIAMCINOLONE ACETONIDE
AB AMNEAL 40MG/ML A207550 001 Dec 11, 2017
AB EUGIA PHARMA 40MG/ML A212400 001 Jul 05, 2022
AB LONG GROVE PHARMS 40MG/ML A213543 001 Jan 19, 2022
AB MYLAN LABS LTD 40MG/ML A212567 001 Nov 02, 2022
AB TEVA PHARMS USA 40MG/ML A209852 001 Oct 05, 2018
KENALOG-10
+ APOTHECON 10MG/ML N012041 001
KENALOG-80
+! APOTHECON 80MG/ML N014901 002 Apr 12, 2019
INJECTABLE;INTRAVITREAL
TRIESENCE
+! NOVARTIS 40MG/ML (40MG/ML) N022048 001 Nov 29, 2007
LOTION;TOPICAL
TRIAMCINOLONE ACETONIDE
AT AKORN 0.025% A202374 001 May 08, 2013
AT 0.1% A202374 002 May 08, 2013
AT COSETTE 0.1% A089129 001 Aug 14, 1986
AT FOUGERA PHARMS 0.025% A040467 001 Apr 21, 2003
AT 0.1% A040467 002 Apr 21, 2003
AT MICRO LABS 0.1% A040672 002 Dec 13, 2006
AT PAI HOLDINGS PHARM 0.025% A204608 001 Jul 07, 2016
AT 0.1% A204606 001 Jul 07, 2016
AT QUAGEN 0.025% A213559 001 Jul 01, 2020
AT 0.1% A213559 002 Jul 01, 2020
AT ! WOCKHARDT BIO AG 0.025% A088450 001 Apr 01, 1985
AT ! 0.1% A088451 001 Apr 03, 1985
OINTMENT;TOPICAL
TRIAMCINOLONE ACETONIDE
AT CINTEX SVCS 0.05% A213619 001 Nov 10, 2020
AT COSETTE 0.025% A089795 001 Dec 23, 1988
AT 0.1% A089796 001 Dec 23, 1988
AT 0.5% A208925 001 Oct 06, 2017
AT ENCUBE 0.05% A212384 001 Nov 29, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-453(of 474)

TRIAMCINOLONE ACETONIDE
OINTMENT;TOPICAL
TRIAMCINOLONE ACETONIDE
AT 0.1% A205373 001 May 13, 2016
AT FOUGERA PHARMS 0.025% A085691 001
AT 0.1% A085691 003
AT 0.5% A085691 002
AT GLENMARK PHARMS 0.1% A208320 001 Aug 22, 2017
AT GLENMARK PHARMS LTD 0.5% A206379 001 Jul 22, 2016
AT MACLEODS PHARMS LTD 0.025% A209828 001 Nov 23, 2018
AT 0.1% A209828 002 Nov 23, 2018
AT 0.5% A209828 003 Nov 23, 2018
AT NOVEL LABS INC 0.1% A207365 001 Oct 12, 2018
AT PADAGIS ISRAEL 0.05% A212460 001 Feb 05, 2021
AT +! PADAGIS US 0.025% A087385 002
AT +! 0.1% A087385 003
AT +! 0.5% A087385 001
AT PAI HOLDINGS PHARM 0.5% A208590 001 Mar 03, 2017
AT STRIDES PHARMA 0.05% A212356 001 Jun 01, 2020
AT TARO PHARM INDS LTD 0.1% A040037 001 Sep 30, 1994
TRIANEX
AT ! CMP PHARMA INC 0.05% A089595 001 Mar 23, 1995
PASTE;DENTAL
TRIAMCINOLONE ACETONIDE
AT AKORN 0.1% A206312 001 Aug 11, 2016
AT COSETTE 0.1% A205592 001 Jan 12, 2017
AT LYNE 0.1% A040771 001 Jul 01, 2010
AT QUAGEN 0.1% A214582 001 Dec 09, 2022
AT ! TARO 0.1% A070730 001 Oct 01, 1986
SPRAY;TOPICAL
KENALOG
AT +! SUN PHARM INDS INC 0.147MG/GM N012104 001
TRIAMCINOLONE ACETONIDE
AT AKORN 0.147MG/GM A207094 001 Dec 07, 2016
AT PADAGIS ISRAEL 0.147MG/GM A205782 001 Apr 13, 2015
AT RISING 0.147MG/GM A206786 001 Sep 08, 2017
SUSPENSION;INJECTION
XIPERE
+! BAUSCH AND LOMB INC 40MG/ML N211950 001 Oct 22, 2021
TRIAMTERENE
CAPSULE;ORAL
DYRENIUM
AB + CONCORDIA 50MG N013174 001
AB +! 100MG N013174 002
TRIAMTERENE
AB AGNITIO 50MG A211581 001 Aug 19, 2019
AB 100MG A211581 002 Aug 19, 2019
AB EYWA 50MG A214768 001 Jul 06, 2022
AB 100MG A214768 002 Jul 06, 2022
TRIAZOLAM
TABLET;ORAL
HALCION
AB + PFIZER 0.125MG N017892 003 Apr 26, 1985
AB +! 0.25MG N017892 001 Nov 15, 1982
TRIAZOLAM
AB HIKMA 0.125MG A074224 001 Jun 01, 1994
AB 0.25MG A074224 002 Jun 01, 1994
AB NOVAST LABS 0.125MG A214219 001 Oct 20, 2020
AB 0.25MG A214219 002 Oct 20, 2020
AB SANDOZ INC 0.125MG A216890 001 Nov 08, 2022
AB 0.25MG A216890 002 Nov 08, 2022
AB ZYDUS PHARMS 0.125MG A213003 001 Dec 28, 2022
AB 0.25MG A213003 002 Dec 28, 2022
TRICLABENDAZOLE
TABLET;ORAL
EGATEN
+! NOVARTIS 250MG N208711 001 Feb 13, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-454(of 474)

TRIENTINE HYDROCHLORIDE
CAPSULE;ORAL
SYPRINE
AB +! BAUSCH 250MG N019194 001 Nov 08, 1985
TRIENTINE HYDROCHLORIDE
AB DR REDDYS 250MG A211076 001 Jul 03, 2019
AB ECI PHARMS LLC 250MG A209945 001 Aug 13, 2021
AB HETERO LABS LTD III 250MG A216356 001 Jun 23, 2022
AB NAVINTA LLC 250MG A211251 001 Jan 16, 2019
AB PAR PHARM INC 250MG A210096 001 Sep 25, 2019
AB RISING 250MG A212238 001 Feb 20, 2020
AB WATSON LABS TEVA 250MG A207567 001 Feb 07, 2018
AB ZYDUS PHARMS 250MG A211554 001 Apr 26, 2019
BX MSN 250MG A211134 001 May 22, 2019
TRIENTINE TETRAHYDROCHLORIDE
TABLET;ORAL
CUVRIOR
+! ORPHALAN 300MG N215760 001 Apr 28, 2022
TRIFAROTENE
CREAM;TOPICAL
AKLIEF
+! GALDERMA LABS LP 0.005% N211527 001 Oct 04, 2019
TRIFLUOPERAZINE HYDROCHLORIDE
TABLET;ORAL
TRIFLUOPERAZINE HYDROCHLORIDE
AB MYLAN EQ 1MG BASE A040209 001 Jul 07, 1997
AB EQ 2MG BASE A040209 002 Jul 07, 1997
AB EQ 5MG BASE A040209 003 Jul 07, 1997
AB ! EQ 10MG BASE A040209 004 Jul 07, 1997
AB SANDOZ EQ 1MG BASE A085785 001
AB EQ 2MG BASE A085786 001
AB EQ 5MG BASE A085789 001
AB EQ 10MG BASE A085788 001
TRIFLURIDINE
SOLUTION/DROPS;OPHTHALMIC
TRIFLURIDINE
AT SANDOZ INC 1% A074311 001 Oct 06, 1995
VIROPTIC
AT +! MONARCH PHARMS 1% N018299 001
TRIHEPTANOIN
LIQUID;ORAL
DOJOLVI
+! ULTRAGENYX PHARM 100% w/w N213687 001 Jun 30, 2020
INC
TRIHEXYPHENIDYL HYDROCHLORIDE
ELIXIR;ORAL
TRIHEXYPHENIDYL HYDROCHLORIDE
AA MIKART 2MG/5ML A040251 001 Sep 27, 1999
AA ! PHARM ASSOC 2MG/5ML A040177 001 Apr 17, 1997
TABLET;ORAL
TRIHEXYPHENIDYL HYDROCHLORIDE
AA NATCO PHARMA LTD 2MG A091630 001 Nov 17, 2010
AA 5MG A091630 002 Nov 17, 2010
AA NOVITIUM PHARMA 2MG A040254 001 Dec 24, 1998
AA 5MG A040254 002 Dec 24, 1998
AA ! WATSON LABS 2MG A084363 001
AA ! 5MG A084364 001
TRILACICLIB DIHYDROCHLORIDE
POWDER;INTRAVENOUS
COSELA
+! G1 THERAP EQ 300MG BASE/VIAL N214200 001 Feb 12, 2021
TRIMETHOBENZAMIDE HYDROCHLORIDE
CAPSULE;ORAL
TRIMETHOBENZAMIDE HYDROCHLORIDE
AB LUPIN 300MG A076546 001 Aug 20, 2003
AB ! SUN PHARM 300MG A076570 001 Aug 28, 2003
INDUSTRIES
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-455(of 474)

TRIMETHOBENZAMIDE HYDROCHLORIDE
INJECTABLE;INJECTION
TIGAN
+! PAR STERILE 100MG/ML N017530 001
PRODUCTS
TRIMETHOPRIM
TABLET;ORAL
TRIMETHOPRIM
AB +! MAYNE PHARMA 100MG N018679 001 Jul 30, 1982
AB NOVEL LABS INC 100MG A091437 001 Jun 15, 2011
AB NOVITIUM PHARMA 100MG A216393 001 Oct 28, 2022
AB WATSON LABS 100MG A070049 001 Jun 06, 1985
TRIMIPRAMINE MALEATE
CAPSULE;ORAL
TRIMIPRAMINE MALEATE
AB CROSSMEDIKA SA EQ 25MG BASE A208127 001 Apr 15, 2016
AB ! EQ 50MG BASE A208127 002 Apr 15, 2016
AB EQ 100MG BASE A208127 003 Apr 15, 2016
AB ELITE LABS INC EQ 25MG BASE A077361 001 Aug 02, 2006
AB EQ 50MG BASE A077361 002 Aug 02, 2006
AB EQ 100MG BASE A077361 003 Aug 02, 2006
TRIPTORELIN PAMOATE
FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
TRIPTODUR KIT
+! AZURITY EQ 22.5MG BASE/VIAL N208956 001 Jun 29, 2017
INJECTABLE;INTRAMUSCULAR
TRELSTAR
+! VERITY EQ 3.75MG BASE/VIAL N020715 001 Jun 15, 2000
+! EQ 11.25MG BASE/VIAL N021288 001 Jun 29, 2001
+! EQ 22.5MG BASE/VIAL N022437 001 Mar 10, 2010
TROMETHAMINE
SOLUTION;INJECTION
THAM
+! HOSPIRA 18GM/500ML (3.6GM/100ML) N013025 002
TROPICAMIDE
SOLUTION/DROPS;OPHTHALMIC
MYDRIACYL
AT +! ALCON LABS INC 1% A084306 001
AT +! SANDOZ INC 0.5% A084305 001
TROPICACYL
AT AKORN 0.5% A040314 001 Sep 29, 2000
AT 1% A040315 001 Sep 29, 2000
TROPICAMIDE
AT BAUSCH AND LOMB 0.5% A040067 001 Jul 27, 1994
AT 1% A040064 001 Jul 27, 1994
AT SOMERSET THERAPS 1% A207524 001 Dec 12, 2019
LLC
TROSPIUM CHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
TROSPIUM CHLORIDE
AB ! ACTAVIS LABS FL INC 60MG A091289 001 Oct 12, 2012
AB AMTA 60MG A214760 001 Apr 30, 2021
AB GRANULES 60MG A213185 001 Apr 23, 2020
AB PADAGIS US 60MG A201291 001 May 24, 2013
TABLET;ORAL
TROSPIUM CHLORIDE
AB APOTEX 20MG A091513 001 Dec 06, 2011
AB ! GLENMARK GENERICS 20MG A091575 001 Aug 13, 2010
AB HERITAGE PHARMS INC 20MG A204945 001 Aug 30, 2016
AB INVAGEN PHARMS 20MG A091688 001 Aug 23, 2016
AB PADAGIS US 20MG A091573 001 Nov 17, 2010
AB ZAMEER PHARMS 20MG A215781 001 Feb 16, 2022
TRYPAN BLUE
SOLUTION;OPHTHALMIC
VISIONBLUE
+! DORC 0.06% N021670 001 Dec 16, 2004
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-456(of 474)

TUCATINIB
TABLET;ORAL
TUKYSA
+ SEAGEN 50MG N213411 001 Apr 17, 2020
+! 150MG N213411 002 Apr 17, 2020
UBROGEPANT
TABLET;ORAL
UBRELVY
+ ALLERGAN 50MG N211765 001 Dec 23, 2019
+! 100MG N211765 002 Dec 23, 2019
ULIPRISTAL ACETATE
TABLET;ORAL
ELLA
AB +! LAB HRA PHARMA 30MG N022474 001 Aug 13, 2010
LOGILIA
AB TEVA PHARMS USA 30MG A207952 001 Feb 13, 2017
UMECLIDINIUM BROMIDE
POWDER;INHALATION
INCRUSE ELLIPTA
+! GLAXO GRP ENGLAND EQ 62.5MCG BASE/INH N205382 001 Apr 30, 2014
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
POWDER;INHALATION
ANORO ELLIPTA
+! GLAXOSMITHKLINE EQ 0.0625MG BASE/INH;EQ 0.025MG N203975 001 Dec 18, 2013
BASE/INH
UPADACITINIB
TABLET, EXTENDED RELEASE;ORAL
RINVOQ
+ ABBVIE INC 15MG N211675 001 Aug 16, 2019
+ 30MG N211675 002 Jan 14, 2022
+! 45MG N211675 003 Mar 16, 2022
UREA, C-14
CAPSULE;ORAL
PYTEST
+! AVENT 1uCi N020617 001 May 09, 1997
PYTEST KIT
+! AVENT 1uCi N020617 002 May 09, 1997
URIDINE TRIACETATE
GRANULE;ORAL
VISTOGARD
+! WELLSTAT THERAP 10GM/PACKET N208159 001 Dec 11, 2015
XURIDEN
+! WELLSTAT THERAP 2GM/PACKET N208169 001 Sep 04, 2015
URSODIOL
CAPSULE;ORAL
ACTIGALL
AB +! TEVA BRANDED PHARM 300MG N019594 002 Dec 31, 1987
URSODIOL
AB ABHAI LLC 300MG A210707 001 May 17, 2018
AB AMNEAL PHARMS CO 300MG A211301 001 Oct 16, 2018
AB AUROBINDO PHARMA 300MG A214849 001 Nov 28, 2022
LTD
AB CHARTWELL RX 300MG A213555 001 Aug 17, 2020
AB EPIC PHARMA 300MG A075517 001 Mar 14, 2000
AB EYWA PHARMA 300MG A212452 001 Oct 30, 2019
AB LANNETT CO INC 300MG A079082 001 Dec 15, 2008
AB MYLAN 300MG A090530 001 Feb 17, 2010
AB RISING 300MG A213200 001 Feb 12, 2020
AB STRIDES PHARMA 300MG A210344 001 Jan 22, 2021
AB TEVA PHARMS 300MG A075592 001 May 25, 2000
AB ZYDUS 300MG A214295 001 Oct 16, 2020
LGM PHARMA 200MG A205789 001 May 08, 2020
! 400MG A205789 002 May 08, 2020
TABLET;ORAL
URSO 250
AB + ALLERGAN 250MG N020675 001 Dec 10, 1997
URSO FORTE
AB +! ALLERGAN 500MG N020675 002 Jul 21, 2004
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-457(of 474)

URSODIOL
TABLET;ORAL
URSODIOL
AB GLENMARK GENERICS 250MG A090801 001 Jul 12, 2011
AB 500MG A090801 002 Jul 12, 2011
AB PAR PHARM 250MG A202540 001 Feb 14, 2013
AB 500MG A202540 002 Feb 14, 2013
AB STRIDES PHARMA 250MG A213504 001 Aug 20, 2020
AB 500MG A213504 002 Aug 20, 2020
AB ZYDUS 250MG A211145 001 Oct 30, 2018
AB 500MG A211145 002 Oct 30, 2018
VALACYCLOVIR HYDROCHLORIDE
TABLET;ORAL
VALACYCLOVIR HYDROCHLORIDE
AB APOTEX EQ 500MG BASE A090500 001 Apr 04, 2014
AB EQ 1GM BASE A090500 002 Apr 04, 2014
AB AUROBINDO PHARMA EQ 500MG BASE A090682 001 May 24, 2010
AB EQ 1GM BASE A090682 002 May 24, 2010
AB CADILA EQ 500MG BASE A079137 001 Dec 29, 2017
AB EQ 1GM BASE A079137 002 Dec 29, 2017
AB CIPLA EQ 500MG BASE A077135 001 May 24, 2010
AB EQ 1GM BASE A077135 002 May 24, 2010
AB HETERO LABS LTD V EQ 500MG BASE A203047 001 Apr 08, 2015
AB EQ 1GM BASE A203047 002 Apr 08, 2015
AB JUBILANT GENERICS EQ 500MG BASE A201506 001 Apr 03, 2012
AB EQ 1GM BASE A201506 002 Apr 03, 2012
AB MYLAN PHARMS INC EQ 500MG BASE A078518 001 May 24, 2010
AB EQ 1GM BASE A078518 002 May 24, 2010
AB SANDOZ EQ 500MG BASE A077478 001 May 24, 2010
AB EQ 1GM BASE A077478 002 May 24, 2010
AB SUN PHARM INDS LTD EQ 500MG BASE A076588 001 Jan 31, 2007
AB EQ 1GM BASE A076588 002 Jan 31, 2007
AB TIME-CAP LABS INC EQ 500MG BASE A079012 001 May 24, 2010
AB EQ 1GM BASE A079012 002 May 24, 2010
AB WOCKHARDT BIO AG EQ 1GM BASE A090216 002 May 24, 2010
AB EQ 500MG BASE A090216 001 May 24, 2010
AB YILING EQ 500MG BASE A209553 001 Mar 18, 2020
AB EQ 1GM BASE A209553 002 Mar 18, 2020
VALTREX
AB + GLAXOSMITHKLINE EQ 500MG BASE N020487 001 Jun 23, 1995
AB +! EQ 1GM BASE N020487 002 Jun 23, 1995
VALBENAZINE TOSYLATE
CAPSULE;ORAL
INGREZZA
+ NEUROCRINE EQ 40MG BASE N209241 001 Apr 11, 2017
+ EQ 60MG BASE N209241 003 Apr 23, 2021
+! EQ 80MG BASE N209241 002 Oct 04, 2017
VALGANCICLOVIR HYDROCHLORIDE
FOR SOLUTION;ORAL
VALCYTE
AB +! HOFFMANN LA ROCHE 50MG/ML N022257 001 Aug 28, 2009
VALGANCICLOVIR HYDROCHLORIDE
AB ACTAVIS LABS FL INC 50MG/ML A205220 001 Jul 18, 2016
AB AJANTA PHARMA LTD 50MG/ML A212890 001 Jan 13, 2020
AB AUROBINDO PHARMA 50MG/ML A215124 001 Nov 17, 2022
AB GRANULES 50MG/ML A213306 001 Jan 31, 2020
AB HETERO LABS LTD V 50MG/ML A211475 001 Oct 04, 2022
AB MSN 50MG/ML A210169 001 Feb 17, 2022
TABLET;ORAL
VALCYTE
AB +! HOFFMANN LA ROCHE EQ 450MG BASE N021304 001 Mar 29, 2001
VALGANCICLOVIR HYDROCHLORIDE
AB AJANTA PHARMA LTD EQ 450MG BASE A212234 001 Dec 26, 2019
AB AUROBINDO PHARMA EQ 450MG BASE A204750 001 Mar 31, 2016
LTD
AB CIPLA EQ 450MG BASE A209672 001 Nov 09, 2018
AB DR REDDYS EQ 450MG BASE A203511 001 Nov 04, 2014
AB EQ 450MG BASE A206876 001 Dec 12, 2017
AB HETERO LABS LTD V EQ 450MG BASE A205166 001 Mar 18, 2016
AB STRIDES PHARMA EQ 450MG BASE A200790 001 Nov 04, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-458(of 474)

VALPROATE SODIUM
INJECTABLE;INJECTION
VALPROATE SODIUM
AP ATHENEX INC EQ 100MG BASE/ML A076295 001 Nov 14, 2002
AP FRESENIUS KABI USA EQ 100MG BASE/ML A076539 001 Jun 26, 2003
AP ! HIKMA FARMACEUTICA EQ 100MG BASE/ML A078523 001 Feb 17, 2010
VALPROIC ACID
CAPSULE;ORAL
VALPROIC ACID
AB ! BIONPHARMA INC 250MG A073484 001 Jun 29, 1993
AB CATALENT 250MG A073229 001 Oct 29, 1991
AB SUN PHARM INDS LTD 250MG A091037 001 Feb 22, 2013
BX EYWA 250MG A207611 001 Aug 05, 2019
SYRUP;ORAL
VALPROIC ACID
AA CHARTWELL RX 250MG/5ML A075782 001 Dec 22, 2000
AA ECI PHARMS LLC 250MG/5ML A090517 001 May 28, 2010
AA HIGH TECH PHARMA 250MG/5ML A074060 001 Jan 13, 1995
AA ! PHARM ASSOC 250MG/5ML A075379 001 Dec 15, 2000
VALRUBICIN
SOLUTION;INTRAVESICAL
VALRUBICIN
AO HIKMA 40MG/ML A206430 001 Apr 19, 2019
VALSTAR PRESERVATIVE FREE
AO +! ENDO PHARM 40MG/ML N020892 001 Sep 25, 1998
VALSARTAN
SOLUTION;ORAL
VALSARTAN
NOVITIUM PHARMA 20MG/5ML A214102 001 Nov 02, 2021
TABLET;ORAL
DIOVAN
AB + NOVARTIS 40MG N021283 004 Aug 14, 2002
AB + 80MG N021283 001 Jul 18, 2001
AB + 160MG N021283 002 Jul 18, 2001
AB +! 320MG N021283 003 Jul 18, 2001
VALSARTAN
AB ALEMBIC PHARMS 40MG A091367 001 Jan 05, 2015
AB 80MG A091367 002 Jan 05, 2015
AB 160MG A091367 003 Jan 05, 2015
AB 320MG A091367 004 Jan 05, 2015
AB ALKEM LABS LTD 40MG A205536 001 Mar 12, 2019
AB 80MG A205536 002 Mar 12, 2019
AB 160MG A205536 003 Mar 12, 2019
AB 320MG A205536 004 Mar 12, 2019
AB AMNEAL PHARMS 40MG A204011 001 Jan 11, 2016
AB 80MG A204011 002 Jan 11, 2016
AB 160MG A204011 003 Jan 11, 2016
AB 320MG A204011 004 Jan 11, 2016
AB AUROBINDO PHARMA 40MG A202223 001 Jan 05, 2015
LTD
AB 80MG A202223 002 Jan 05, 2015
AB 160MG A202223 003 Jan 05, 2015
AB 320MG A202223 004 Jan 05, 2015
AB DR REDDYS 40MG A201618 001 Oct 05, 2021
AB 80MG A201618 002 Oct 05, 2021
AB 160MG A201618 003 Oct 05, 2021
AB 320MG A201618 004 Oct 05, 2021
AB HETERO LABS LTD V 40MG A203311 001 Jan 05, 2015
AB 80MG A203311 002 Jan 05, 2015
AB 160MG A203311 003 Jan 05, 2015
AB 320MG A203311 004 Jan 05, 2015
AB IVAX PHARMS 40MG A077530 001 Jan 04, 2016
AB 80MG A077530 002 Jan 04, 2016
AB 160MG A077530 003 Jan 04, 2016
AB 320MG A077530 004 Jan 04, 2016
AB JUBILANT GENERICS 40MG A203536 001 Jan 05, 2015
AB 80MG A203536 002 Jan 05, 2015
AB 160MG A203536 003 Jan 05, 2015
AB 320MG A203536 004 Jan 05, 2015
AB LUPIN LTD 40MG A201677 001 Jan 05, 2015
AB 80MG A201677 002 Jan 05, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-459(of 474)

VALSARTAN
TABLET;ORAL
VALSARTAN
AB 160MG A201677 003 Jan 05, 2015
AB 320MG A201677 004 Jan 05, 2015
AB MACLEODS PHARMS LTD 40MG A202696 001 Sep 16, 2016
AB 80MG A202696 002 Sep 16, 2016
AB 160MG A202696 003 Sep 16, 2016
AB 320MG A202696 004 Sep 16, 2016
AB MYLAN 40MG A090866 001 Jan 05, 2015
AB 80MG A090866 002 Jan 05, 2015
AB 160MG A090866 003 Jan 05, 2015
AB 320MG A090866 004 Jan 05, 2015
AB OHM LABS INC 40MG A077492 001 Jun 26, 2014
AB 80MG A077492 002 Jun 26, 2014
AB 160MG A077492 003 Jun 26, 2014
AB 320MG A077492 004 Jun 26, 2014
AB PRINSTON INC 40MG A204821 001 Jun 09, 2015
AB 80MG A204821 002 Jun 09, 2015
AB 160MG A204821 003 Jun 09, 2015
AB 320MG A204821 004 Jun 09, 2015
AB SCIEGEN PHARMS INC 40MG A204038 001 Oct 27, 2021
AB 80MG A204038 002 Oct 27, 2021
AB 160MG A204038 003 Oct 27, 2021
AB 320MG A204038 004 Oct 27, 2021
AB SQUARE PHARMS 40MG A205347 001 Apr 09, 2018
AB 80MG A205347 002 Apr 09, 2018
AB 160MG A205347 003 Apr 09, 2018
AB 320MG A205347 004 Apr 09, 2018
VANCOMYCIN
SOLUTION;INTRAVENOUS, ORAL
VANCOMYCIN
+! XELLIA PHARMS APS 5GM/100ML (50MG/ML) N213895 001 Aug 26, 2021
VANCOMYCIN HYDROCHLORIDE
CAPSULE;ORAL
VANCOCIN HYDROCHLORIDE
AB + ANI PHARMS EQ 125MG BASE N050606 001 Apr 15, 1986
AB +! EQ 250MG BASE N050606 002 Apr 15, 1986
VANCOMYCIN HYDROCHLORIDE
AB AKORN EQ 125MG BASE A065478 001 Apr 09, 2012
AB EQ 250MG BASE A065478 002 Apr 09, 2012
AB LUPIN LTD EQ 125MG BASE A090439 001 Jan 28, 2015
AB EQ 250MG BASE A090439 002 Jan 28, 2015
AB ORIENT PHARMA CO EQ 125MG BASE A210729 001 Apr 29, 2019
LTD
AB EQ 250MG BASE A210729 002 Apr 29, 2019
AB STRIDES PHARMA EQ 125MG BASE A065490 001 Apr 09, 2012
AB EQ 250MG BASE A065490 002 Apr 09, 2012
AB WATSON LABS EQ 125MG BASE A065510 001 Apr 09, 2012
AB EQ 250MG BASE A065510 002 Apr 09, 2012
FOR SOLUTION;ORAL
FIRVANQ KIT
AB +! AZURITY EQ 25MG BASE/ML N208910 001 Jan 26, 2018
AB +! EQ 50MG BASE/ML N208910 002 Jan 26, 2018
VANCOMYCIN HYDROCHLORIDE
AB ALKEM LABS LTD EQ 25MG BASE/ML A214913 001 Nov 14, 2022
AB EQ 50MG BASE/ML A214913 002 Nov 14, 2022
VANCOCIN HYDROCHLORIDE
! ANI PHARMS EQ 250MG BASE/5ML A061667 002 Jul 13, 1983
INJECTABLE;INJECTION
VANCOMYCIN HYDROCHLORIDE
AP ASPIRO EQ 500MG BASE/VIAL A216591 001 Jul 06, 2022
AP EQ 1GM BASE/VIAL A216591 002 Jul 06, 2022
AP EUGIA PHARMA EQ 500MG BASE/VIAL A205780 001 Mar 31, 2016
AP EQ 1GM BASE/VIAL A205780 002 Mar 31, 2016
AP EQ 5GM BASE/VIAL A205779 001 Mar 29, 2016
AP EQ 10GM BASE/VIAL A205779 002 Mar 29, 2016
AP ! FRESENIUS KABI USA EQ 500MG BASE/VIAL A062663 001 Mar 17, 1987
AP EQ 750MG BASE/VIAL A062663 005 Aug 17, 2016
AP ! EQ 1GM BASE/VIAL A062663 002 Jul 31, 1987
AP ! EQ 5GM BASE/VIAL A062663 003 Jun 03, 1988
AP ! EQ 10GM BASE/VIAL A062663 004 Nov 28, 1997
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-460(of 474)

VANCOMYCIN HYDROCHLORIDE
INJECTABLE;INJECTION
VANCOMYCIN HYDROCHLORIDE
AP GLAND PHARMA LTD EQ 500MG BASE/VIAL A205694 001 Jan 21, 2016
AP EQ 1GM BASE/VIAL A205694 002 Jan 21, 2016
AP HAINAN POLY EQ 5GM BASE/VIAL A215821 001 Nov 18, 2021
AP EQ 10GM BASE/VIAL A215821 002 Nov 18, 2021
AP HAINAN POLY PHARM EQ 500MG BASE/VIAL A212332 001 Jun 12, 2019
AP EQ 1GM BASE/VIAL A212332 002 Jun 12, 2019
AP HIKMA EQ 5GM BASE/VIAL A204360 001 Oct 15, 2018
AP EQ 10GM BASE/VIAL A204360 002 Oct 15, 2018
AP HIKMA PHARMS EQ 750MG BASE/VIAL A206616 001 Oct 03, 2018
AP ! HOSPIRA EQ 500MG BASE/VIAL A062911 001 Aug 04, 1988
AP ! EQ 500MG BASE/VIAL A062931 001 Oct 29, 1992
AP EQ 750MG BASE/VIAL A062912 002 Jan 07, 2009
AP EQ 750MG BASE/VIAL A062933 002 May 27, 2009
AP ! EQ 1GM BASE/VIAL A062912 001 Aug 04, 1988
AP ! EQ 1GM BASE/VIAL A062933 001 Oct 29, 1992
AP ! EQ 5GM BASE/VIAL A063076 001 Dec 21, 1990
AP EQ 10GM BASE/VIAL A063076 002 Sep 14, 2020
AP HOSPIRA INC EQ 10GM BASE/VIAL A065455 001 Apr 29, 2009
AP MEITHEAL EQ 500MG BASE/VIAL A215197 001 Jul 28, 2022
AP EQ 750MG BASE/VIAL A215195 001 Sep 15, 2022
AP EQ 1GM BASE/VIAL A215197 002 Jul 28, 2022
AP EQ 5GM BASE/VIAL A215196 001 Jul 27, 2022
AP EQ 10GM BASE/VIAL A215196 002 Jul 27, 2022
AP MYLAN LABS LTD EQ 500MG BASE/VIAL A065397 001 Dec 30, 2008
AP EQ 1GM BASE/VIAL A065397 002 Dec 30, 2008
AP EQ 5GM BASE/VIAL A065432 001 Dec 30, 2008
AP ! EQ 10GM BASE/VIAL A091554 001 Sep 19, 2011
AP PHARM ASSOC EQ 500MG BASE/VIAL A065401 001 Jun 30, 2008
AP EQ 1GM BASE/VIAL A065401 002 Jun 30, 2008
AP SAGENT PHARMS EQ 5GM BASE/VIAL A200837 001 Aug 10, 2012
AP EQ 10GM BASE/VIAL A200837 002 Sep 02, 2014
AP SANDOZ INC EQ 5GM BASE/VIAL A201048 001 Aug 10, 2012
AP EQ 10GM BASE/VIAL A201048 002 Aug 10, 2012
AP XELLIA PHARMS APS EQ 5GM BASE/VIAL A204125 001 Dec 28, 2015
AP EQ 10GM BASE/VIAL A204125 002 Dec 28, 2015
AP EQ 500MG BASE/VIAL A204107 001 Dec 28, 2015
AP EQ 1GM BASE/VIAL A204107 002 Dec 28, 2015
VANCOCIN HYDROCHLORIDE IN PLASTIC CONTAINER
+! BAXTER HLTHCARE EQ 500MG BASE/100ML N050671 001 Apr 29, 1993
+! EQ 750MG BASE/150ML N050671 002 Dec 20, 2010
+! EQ 1GM BASE/200ML N050671 003 Mar 01, 1999
VANCOMYCIN HYDROCHLORIDE
! HOSPIRA EQ 1.5GM BASE/VIAL A062912 003 Jul 10, 2020
POWDER;INTRAVENOUS
VANCOMYCIN HYDROCHLORIDE
+! MYLAN LABS LTD EQ 750MG BASE/VIAL N209481 002 Jul 10, 2018
+! EQ 1.25GM BASE/VIAL N209481 003 Jul 10, 2018
+! EQ 1.5GM BASE/VIAL N209481 004 Jul 10, 2018
VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER
SAMSON MEDCL EQ 100GM BASE A091532 001 Jan 06, 2016
SOLUTION;INTRAVENOUS
VANCOMYCIN HYDROCHLORIDE
+! XELLIA PHARMS APS EQ 500MG BASE/100ML (EQ 5MG BASE/ML) N211962 001 Feb 15, 2019
+! EQ 750MG BASE/150ML (EQ 5MG BASE/ML) N211962 005 May 13, 2020
+! EQ 1GM BASE/200ML (EQ 5MG BASE/ML) N211962 002 Feb 15, 2019
+! EQ 1.25GM BASE/250ML (EQ 5MG BASE/ML) N211962 006 May 13, 2020
+! EQ 1.5GM BASE/300ML (EQ 5MG BASE/ML) N211962 003 Feb 15, 2019
+! EQ 1.75GM BASE/350ML (EQ 5MG BASE/ML) N211962 007 May 13, 2020
+! EQ 2GM BASE/400ML (EQ 5MG BASE/ML) N211962 004 Feb 15, 2019
VANDETANIB
TABLET;ORAL
CAPRELSA
+ GENZYME CORP 100MG N022405 001 Apr 06, 2011
+! 300MG N022405 002 Apr 06, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-461(of 474)

VARDENAFIL HYDROCHLORIDE
TABLET;ORAL
VARDENAFIL HYDROCHLORIDE
AB ALEMBIC PHARMS EQ 2.5MG BASE A214031 001 Aug 04, 2020
AB EQ 5MG BASE A214031 002 Aug 04, 2020
AB EQ 10MG BASE A214031 003 Aug 04, 2020
AB EQ 20MG BASE A214031 004 Aug 04, 2020
AB CROSSMEDIKA SA EQ 2.5MG BASE A209057 001 Oct 31, 2018
AB EQ 5MG BASE A209057 002 Oct 31, 2018
AB EQ 10MG BASE A209057 003 Oct 31, 2018
AB EQ 20MG BASE A209057 004 Oct 31, 2018
AB MACLEODS PHARMS LTD EQ 2.5MG BASE A204632 001 Oct 22, 2019
AB EQ 5MG BASE A204632 002 Oct 22, 2019
AB EQ 10MG BASE A204632 003 Oct 22, 2019
AB EQ 20MG BASE A204632 004 Oct 22, 2019
AB TEVA PHARMS EQ 2.5MG BASE A091347 001 May 03, 2012
AB EQ 5MG BASE A091347 002 May 03, 2012
AB EQ 10MG BASE A091347 003 May 03, 2012
AB EQ 20MG BASE A091347 004 May 03, 2012
AB ZYDUS PHARMS EQ 2.5MG BASE A208960 001 Oct 31, 2018
AB EQ 5MG BASE A208960 002 Oct 31, 2018
AB EQ 10MG BASE A208960 003 Oct 31, 2018
AB ! EQ 20MG BASE A208960 004 Oct 31, 2018
TABLET, ORALLY DISINTEGRATING;ORAL
VARDENAFIL HYDROCHLORIDE
AB ! ALEMBIC PHARMS 10MG A208324 001 Nov 16, 2018
AB MACLEODS PHARMS LTD 10MG A205988 001 Mar 10, 2020
VARENICLINE TARTRATE
SPRAY;NASAL
TYRVAYA
+! OYSTER POINT PHARMA EQ 0.03MG BASE/SPRAY N213978 001 Oct 15, 2021
TABLET;ORAL
VARENICLINE TARTRATE
PAR PHARM INC EQ 0.5MG BASE A201785 001 Aug 11, 2021
! EQ 1MG BASE A201785 002 Aug 11, 2021
VASOPRESSIN
SOLUTION;INTRAVENOUS
VASOPRESSIN
AP AMNEAL 20UNITS/ML (20UNITS/ML) A212944 001 Aug 05, 2022
AP AMPHASTAR PHARMS 20UNITS/ML (20UNITS/ML) A211857 001 Jul 18, 2022
INC
AP EAGLE PHARMS 20UNITS/ML (20UNITS/ML) A211538 001 Dec 15, 2021
AP EUGIA PHARMA 20UNITS/ML (20UNITS/ML) A214314 001 Aug 15, 2022
VASOSTRICT
AP +! PAR STERILE 20UNITS/ML (20UNITS/ML) N204485 001 Apr 17, 2014
PRODUCTS
VASOPRESSIN
+! AM REGENT 20UNITS/ML (20UNITS/ML) N212593 001 Aug 03, 2020
VASOSTRICT
+! PAR STERILE 20UNITS/100ML (0.2UNITS/ML) N204485 005 Apr 21, 2021
PRODUCTS
+! 40UNITS/100ML (0.4UNITS/ML) N204485 003 Apr 15, 2020
+! 60UNITS/100ML (0.6UNITS/ML) N204485 004 Apr 15, 2020
+! 200UNITS/10ML (20UNITS/ML) N204485 002 Dec 17, 2016
VECURONIUM BROMIDE
INJECTABLE;INJECTION
VECURONIUM BROMIDE
AP EUGIA PHARMA 10MG/VIAL A206670 001 Dec 20, 2018
AP 20MG/VIAL A206670 002 Dec 20, 2018
AP GLAND 10MG/VIAL A205390 001 May 26, 2016
AP 20MG/VIAL A205390 002 May 26, 2016
AP HIKMA 10MG/VIAL A075549 001 Jun 13, 2000
AP 10MG/VIAL A203725 001 Jul 30, 2019
AP 20MG/VIAL A075549 002 Jun 13, 2000
AP 20MG/VIAL A203725 002 Jul 30, 2019
AP HOSPIRA 10MG/VIAL A075164 001 Oct 21, 1999
AP 20MG/VIAL A075164 002 Oct 21, 1999
AP MYLAN LABS LTD 10MG/VIAL A090243 001 May 11, 2010
AP 20MG/VIAL A090243 002 May 11, 2010
AP SAGENT PHARMS INC 10MG/VIAL A078274 001 Dec 29, 2008
AP 20MG/VIAL A078274 002 Dec 29, 2008
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-462(of 474)

VECURONIUM BROMIDE
INJECTABLE;INJECTION
VECURONIUM BROMIDE
AP ! SUN PHARM 10MG/VIAL A079001 001 Jun 17, 2009
AP ! 20MG/VIAL A079001 002 Jun 17, 2009
AP TEVA PHARMS USA 10MG/VIAL A074688 001 Aug 25, 1999
AP 20MG/VIAL A074688 002 Aug 25, 1999
VEMURAFENIB
TABLET;ORAL
ZELBORAF
+! HOFFMANN LA ROCHE 240MG N202429 001 Aug 17, 2011
VENETOCLAX
TABLET;ORAL
VENCLEXTA
+ ABBVIE INC 10MG N208573 001 Apr 11, 2016
+ 50MG N208573 002 Apr 11, 2016
+! 100MG N208573 003 Apr 11, 2016
VENLAFAXINE BESYLATE
TABLET, EXTENDED RELEASE;ORAL
VENLAFAXINE BESYLATE
+! ALMATICA EQ 112.5MG BASE N215429 001 Jun 29, 2022
VENLAFAXINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
EFFEXOR XR
AB + UPJOHN EQ 37.5MG BASE N020699 001 Oct 20, 1997
AB + EQ 75MG BASE N020699 002 Oct 20, 1997
AB +! EQ 150MG BASE N020699 004 Oct 20, 1997
VENLAFAXINE HYDROCHLORIDE
AB ANNORA PHARMA EQ 37.5MG BASE A212277 001 Jul 08, 2019
AB EQ 75MG BASE A212277 002 Jul 08, 2019
AB EQ 150MG BASE A212277 003 Jul 08, 2019
AB AUROBINDO PHARMA EQ 37.5MG BASE A200834 001 Apr 14, 2011
LTD
AB EQ 75MG BASE A200834 002 Apr 14, 2011
AB EQ 150MG BASE A200834 003 Apr 14, 2011
AB DR REDDYS LABS LTD EQ 37.5MG BASE A078421 001 May 06, 2011
AB EQ 75MG BASE A078421 002 May 06, 2011
AB EQ 150MG BASE A078421 003 May 06, 2011
AB INTELLIPHARMACEUTIC EQ 37.5MG BASE A201272 001 Nov 23, 2018
S
AB EQ 75MG BASE A201272 002 Nov 23, 2018
AB EQ 150MG BASE A201272 003 Nov 23, 2018
AB INVENTIA HLTHCARE EQ 37.5MG BASE A203332 001 Mar 12, 2020
AB EQ 75MG BASE A203332 002 Mar 12, 2020
AB EQ 150MG BASE A203332 003 Mar 12, 2020
AB MACLEODS PHARMS LTD EQ 37.5MG BASE A204889 001 Oct 05, 2017
AB EQ 75MG BASE A204889 002 Oct 05, 2017
AB EQ 150MG BASE A204889 003 Oct 05, 2017
AB ORBION PHARMS EQ 37.5MG BASE A091123 001 Jul 11, 2011
AB EQ 75MG BASE A091123 002 Jul 11, 2011
AB EQ 150MG BASE A091123 003 Jul 11, 2011
AB TEVA EQ 37.5MG BASE A076565 001 Jun 28, 2010
AB EQ 75MG BASE A076565 002 Jun 28, 2010
AB EQ 150MG BASE A076565 003 Jun 28, 2010
AB TORRENT EQ 37.5MG BASE A090899 001 Jun 01, 2011
AB EQ 75MG BASE A090899 002 Jun 01, 2011
AB EQ 150MG BASE A090899 003 Jun 01, 2011
AB VALEANT PHARMS EQ 37.5MG BASE A090071 001 Apr 15, 2011
NORTH
AB EQ 75MG BASE A090071 002 Apr 15, 2011
AB EQ 150MG BASE A090071 003 Apr 15, 2011
AB WOCKHARDT BIO AG EQ 37.5MG BASE A078865 001 Apr 14, 2011
AB EQ 75MG BASE A078865 002 Apr 14, 2011
AB EQ 150MG BASE A078865 003 Apr 14, 2011
AB YICHANG HUMANWELL EQ 37.5MG BASE A214654 001 Aug 06, 2021
AB EQ 75MG BASE A214654 002 Aug 06, 2021
AB EQ 150MG BASE A214654 003 Aug 06, 2021
AB ZYDUS PHARMS USA EQ 37.5MG BASE A090174 001 Apr 14, 2011
INC
AB EQ 75MG BASE A090174 002 Apr 14, 2011
AB EQ 150MG BASE A090174 003 Apr 14, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-463(of 474)

VENLAFAXINE HYDROCHLORIDE
TABLET;ORAL
VENLAFAXINE HYDROCHLORIDE
AB ALEMBIC PHARMS LTD EQ 25MG BASE A078932 001 Dec 14, 2010
AB EQ 37.5MG BASE A078932 002 Dec 14, 2010
AB EQ 50MG BASE A078932 003 Dec 14, 2010
AB EQ 75MG BASE A078932 004 Dec 14, 2010
AB EQ 100MG BASE A078932 005 Dec 14, 2010
AB AMNEAL PHARMS EQ 25MG BASE A079098 001 May 11, 2010
AB EQ 37.5MG BASE A079098 002 May 11, 2010
AB EQ 50MG BASE A079098 003 May 11, 2010
AB EQ 75MG BASE A079098 004 May 11, 2010
AB EQ 100MG BASE A079098 005 May 11, 2010
AB AUROBINDO PHARMA EQ 25MG BASE A090555 001 Apr 07, 2010
AB EQ 37.5MG BASE A090555 002 Apr 07, 2010
AB EQ 50MG BASE A090555 003 Apr 07, 2010
AB EQ 75MG BASE A090555 004 Apr 07, 2010
AB EQ 100MG BASE A090555 005 Apr 07, 2010
AB CADILA PHARMS LTD EQ 25MG BASE A206250 001 Nov 21, 2018
AB EQ 37.5MG BASE A206250 002 Nov 21, 2018
AB EQ 50MG BASE A206250 003 Nov 21, 2018
AB EQ 75MG BASE A206250 004 Nov 21, 2018
AB EQ 100MG BASE A206250 005 Nov 21, 2018
AB DR REDDYS LABS LTD EQ 25MG BASE A078301 001 Jun 13, 2008
AB EQ 37.5MG BASE A078301 002 Jun 13, 2008
AB EQ 50MG BASE A078301 003 Jun 13, 2008
AB EQ 75MG BASE A078301 004 Jun 13, 2008
AB EQ 100MG BASE A078301 005 Jun 13, 2008
AB HERITAGE PHARMS EQ 25MG BASE A078554 001 Jan 09, 2009
AB EQ 37.5MG BASE A078554 002 Jan 09, 2009
AB EQ 50MG BASE A078554 003 Jan 09, 2009
AB EQ 75MG BASE A078554 004 Jan 09, 2009
AB EQ 100MG BASE A078554 005 Jan 09, 2009
AB SUN PHARM INDS INC EQ 25MG BASE A078627 001 Jun 13, 2008
AB EQ 37.5MG BASE A078627 002 Jun 13, 2008
AB EQ 50MG BASE A078627 003 Jun 13, 2008
AB EQ 75MG BASE A078627 004 Jun 13, 2008
AB EQ 100MG BASE A078627 005 Jun 13, 2008
AB TEVA EQ 25MG BASE A076690 001 Aug 03, 2006
AB EQ 37.5MG BASE A076690 002 Aug 03, 2006
AB ! EQ 50MG BASE A076690 003 Aug 03, 2006
AB EQ 75MG BASE A076690 004 Aug 03, 2006
AB EQ 100MG BASE A076690 005 Aug 03, 2006
AB YAOPHARMA CO LTD EQ 25MG BASE A202036 001 May 28, 2015
AB EQ 37.5MG BASE A202036 002 May 28, 2015
AB EQ 50MG BASE A202036 003 May 28, 2015
AB EQ 75MG BASE A202036 004 May 28, 2015
AB EQ 100MG BASE A202036 005 May 28, 2015
AB ZYDUS PHARMS USA EQ 25MG BASE A077653 001 Jun 13, 2008
AB EQ 37.5MG BASE A077653 002 Jun 13, 2008
AB EQ 50MG BASE A077653 003 Jun 13, 2008
AB EQ 75MG BASE A077653 004 Jun 13, 2008
AB EQ 100MG BASE A077653 005 Jun 13, 2008
TABLET, EXTENDED RELEASE;ORAL
VENLAFAXINE HYDROCHLORIDE
AB ALKEM LABS LTD EQ 37.5MG BASE A214127 001 Jun 10, 2021
AB EQ 75MG BASE A214127 002 Jun 10, 2021
AB EQ 150MG BASE A214127 003 Jun 10, 2021
AB EQ 225MG BASE A214127 004 Jun 10, 2021
AB APPCO EQ 150MG BASE A214609 001 Jun 30, 2021
AB EQ 225MG BASE A214609 002 Jun 30, 2021
AB ASCENT PHARMS INC EQ 37.5MG BASE A214419 001 Oct 21, 2020
AB EQ 75MG BASE A214419 002 Oct 21, 2020
AB EQ 150MG BASE A214419 003 Oct 21, 2020
AB EQ 225MG BASE A214419 004 Oct 21, 2020
AB CADILA PHARMS LTD EQ 75MG BASE A211323 001 Aug 29, 2019
AB EQ 150MG BASE A211323 002 Aug 29, 2019
AB EQ 225MG BASE A211323 003 Aug 29, 2019
AB DEXCEL EQ 75MG BASE A213927 001 Jan 21, 2021
AB EQ 150MG BASE A209193 001 Oct 31, 2019
AB EQ 225MG BASE A209193 002 Oct 31, 2019
AB NOSTRUM LABS INC EQ 150MG BASE A205468 002 Mar 24, 2017
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-464(of 474)

VENLAFAXINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
VENLAFAXINE HYDROCHLORIDE
AB EQ 225MG BASE A205468 003 Mar 24, 2017
AB + OSMOTICA PHARM EQ 37.5MG BASE N022104 001 May 20, 2008
AB + EQ 75MG BASE N022104 002 May 20, 2008
AB +! EQ 150MG BASE N022104 003 May 20, 2008
AB + EQ 225MG BASE N022104 004 May 20, 2008
AB SUN PHARM EQ 37.5MG BASE A091272 001 Aug 18, 2010
AB EQ 75MG BASE A091272 002 Aug 18, 2010
AB EQ 150MG BASE A091272 003 Aug 18, 2010
AB EQ 225MG BASE A091272 004 Jan 08, 2019
AB UNIQUE EQ 37.5MG BASE A216044 001 Nov 28, 2022
AB EQ 75MG BASE A216044 002 Nov 28, 2022
AB EQ 150MG BASE A216044 003 Nov 28, 2022
AB EQ 225MG BASE A216044 004 Nov 28, 2022
AB ZYDUS PHARMS EQ 37.5MG BASE A215622 001 Aug 30, 2022
AB EQ 75MG BASE A215622 002 Aug 30, 2022
AB EQ 150MG BASE A215622 003 Aug 30, 2022
AB EQ 225MG BASE A215622 004 Aug 30, 2022
VERAPAMIL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
VERAPAMIL HYDROCHLORIDE
AB MYLAN 120MG A075138 001 Apr 20, 1999
AB 180MG A075138 002 Apr 20, 1999
AB 240MG A075138 003 Apr 20, 1999
VERELAN
AB + SOCIETAL CDMO 120MG N019614 001 May 29, 1990
AB + 180MG N019614 003 Jan 09, 1992
AB + 240MG N019614 002 May 29, 1990
+! 360MG N019614 004 May 10, 1996
VERELAN PM
+ SOCIETAL CDMO 100MG N020943 001 Nov 25, 1998
+ 200MG N020943 002 Nov 25, 1998
+! 300MG N020943 003 Nov 25, 1998
INJECTABLE;INJECTION
VERAPAMIL HYDROCHLORIDE
AP ACIC PHARMS 2.5MG/ML A215829 001 Mar 17, 2022
AP ! EUGIA PHARMA 2.5MG/ML A212965 001 Jul 06, 2020
AP GLAND PHARMA LTD 2.5MG/ML A214361 001 Oct 15, 2020
AP MANKIND PHARMA 2.5MG/ML A214653 001 Jun 15, 2022
AP ZYDUS PHARMS 2.5MG/ML A214215 001 Oct 15, 2020
SOLUTION;INTRAVENOUS
VERAPAMIL HYDROCHLORIDE
AP AMNEAL 5MG/2ML (2.5MG/ML) A210994 001 Jul 13, 2018
AP 10MG/4ML (2.5MG/ML) A210994 002 Jul 13, 2018
AP AREVA PHARMS 5MG/2ML (2.5MG/ML) A213352 002 Sep 16, 2020
AP 10MG/4ML (2.5MG/ML) A213352 001 Mar 17, 2020
AP CAPLIN 5MG/2ML (2.5MG/ML) A213232 001 Mar 25, 2020
AP 10MG/4ML (2.5MG/ML) A213232 002 Mar 25, 2020
AP EXELA PHARMA 5MG/2ML (2.5MG/ML) N018925 001 Mar 30, 1984
AP ! HOSPIRA 5MG/2ML (2.5MG/ML) A070738 001 May 06, 1987
AP ! 5MG/2ML (2.5MG/ML) A075136 001 Oct 20, 1998
AP ! 5MG/2ML (2.5MG/ML) A070737 001 May 06, 1987
AP ! 10MG/4ML (2.5MG/ML) A070737 002 May 06, 1987
AP MICRO LABS 5MG/2ML (2.5MG/ML) A211370 001 Dec 28, 2018
AP 10MG/4ML (2.5MG/ML) A211370 002 Dec 28, 2018
AP SOMERSET 5MG/2ML (2.5MG/ML) A211035 001 Jun 18, 2018
AP 10MG/4ML (2.5MG/ML) A211035 002 Jun 18, 2018
AP SOMERSET THERAPS 5MG/2ML (2.5MG/ML) A211015 001 Jun 18, 2018
LLC
AP 10MG/4ML (2.5MG/ML) A211015 002 Jun 18, 2018
TABLET;ORAL
VERAPAMIL HYDROCHLORIDE
AB HERITAGE PHARMS 40MG A071881 002 Oct 14, 2015
AB 80MG A071881 003 Apr 05, 1988
AB ! 120MG A071881 001 Apr 05, 1988
AB WATSON LABS 40MG A072924 001 Jun 29, 1993
AB 80MG A070995 001 Oct 01, 1986
AB 120MG A070994 001 Oct 01, 1986
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-465(of 474)

VERAPAMIL HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
CALAN SR
AB +! PFIZER 120MG N019152 003 Mar 06, 1991
AB +! 240MG N019152 001 Dec 16, 1986
VERAPAMIL HYDROCHLORIDE
AB CADILA PHARMS LTD 180MG A206173 001 May 05, 2017
AB 240MG A206173 002 May 05, 2017
AB GLENMARK GENERICS 120MG A090700 001 Aug 03, 2011
AB ! 180MG A090700 002 Aug 03, 2011
AB 240MG A078906 001 Sep 17, 2009
AB IVAX SUB TEVA 120MG A073568 002 Oct 10, 1997
PHARMS
AB 180MG A074330 001 Jan 31, 1994
AB 240MG A073568 001 Jul 31, 1992
AB STRIDES PHARMA 120MG A075072 001 May 25, 1999
AB 240MG A075072 003 May 25, 1999
AB SUN PHARM INDS INC 120MG A090529 001 Dec 30, 2011
AB 180MG A090529 002 Dec 30, 2011
AB 240MG A090529 003 Dec 30, 2011
VERICIGUAT
TABLET;ORAL
VERQUVO
+ MERCK SHARP DOHME 2.5MG N214377 001 Jan 19, 2021
+ 5MG N214377 002 Jan 19, 2021
+! 10MG N214377 003 Jan 19, 2021
VERTEPORFIN
INJECTABLE;INJECTION
VISUDYNE
+! VALEANT LUXEMBOURG 15MG/VIAL N021119 001 Apr 12, 2000
VIBEGRON
TABLET;ORAL
GEMTESA
+! UROVANT 75MG N213006 001 Dec 23, 2020
VIGABATRIN
FOR SOLUTION;ORAL
SABRIL
AA +! LUNDBECK PHARMS LLC 500MG/PACKET N022006 001 Aug 21, 2009
VIGABATRIN
AA ACCORD HLTHCARE 500MG/PACKET A214425 001 Nov 13, 2020
AA ALKEM LABS LTD 500MG/PACKET A213375 001 Dec 02, 2020
AA AMNEAL PHARMS 500MG/PACKET A210155 001 Mar 13, 2018
AA ANNORA PHARMA 500MG/PACKET A213519 001 Jan 26, 2021
AA AUROBINDO PHARMA 500MG/PACKET A213899 001 Sep 29, 2021
LTD
AA DEXCEL 500MG/PACKET A214992 001 May 13, 2021
AA DR REDDYS 500MG/PACKET A211481 001 Nov 20, 2018
AA INVAGEN PHARMS 500MG/PACKET A211592 001 Dec 03, 2019
AA MSN 500MG/PACKET A215363 001 Sep 07, 2022
AA PAR PHARM INC 500MG/PACKET A208218 001 Apr 27, 2017
AA PROPEL PHARMA 500MG/PACKET A213390 001 Jul 29, 2021
AA PYROS PHARMS 500MG/PACKET A214961 001 Jun 24, 2022
AA TEVA PHARMS USA 500MG/PACKET A209824 001 Apr 23, 2018
VIGADRONE
AA AUCTA 500MG/PACKET A210196 001 Jun 21, 2018
TABLET;ORAL
SABRIL
AB +! LUNDBECK PHARMS LLC 500MG N020427 001 Aug 21, 2009
VIGABATRIN
AB AMNEAL PHARMS 500MG A210042 001 Jun 22, 2022
AB AUROBINDO PHARMA 500MG A215601 001 May 10, 2022
LTD
AB DEXCEL 500MG A215109 001 Sep 23, 2021
AB DR REDDYS 500MG A211539 001 Jan 29, 2021
AB HIKMA 500MG A213104 001 Aug 29, 2022
AB TEVA PHARMS USA 500MG A209822 001 Jan 14, 2019
AB ZYDUS 500MG A215707 001 Jan 19, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-466(of 474)

VILAZODONE HYDROCHLORIDE
TABLET;ORAL
VIIBRYD
AB +! ALLERGAN 10MG N022567 001 Jan 21, 2011
AB + 20MG N022567 002 Jan 21, 2011
AB + 40MG N022567 003 Jan 21, 2011
VILAZODONE HYDROCHLORIDE
AB ACCORD HLTHCARE 10MG A208209 001 Apr 27, 2021
AB 20MG A208209 002 Apr 27, 2021
AB 40MG A208209 003 Apr 27, 2021
AB ALEMBIC PHARMS 10MG A208202 001 Jan 10, 2020
AB 20MG A208202 002 Jan 10, 2020
AB 40MG A208202 003 Jan 10, 2020
AB INVAGEN PHARMS 10MG A208200 001 Apr 07, 2021
AB 20MG A208200 003 Dec 06, 2022
AB 40MG A208200 002 Apr 07, 2021
AB TEVA PHARMS USA 10MG A208212 001 Sep 30, 2019
AB 20MG A208212 002 Sep 30, 2019
AB 40MG A208212 003 Sep 30, 2019
VILOXAZINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
QELBREE
+ SUPERNUS PHARMS EQ 100MG BASE N211964 001 Apr 02, 2021
+ EQ 150MG BASE N211964 002 Apr 02, 2021
+! EQ 200MG BASE N211964 003 Apr 02, 2021
VILTOLARSEN
SOLUTION;INTRAVENOUS
VILTEPSO
+! NIPPON SHINYAKU 250MG/5ML (50MG/ML) N212154 001 Aug 12, 2020
VINBLASTINE SULFATE
INJECTABLE;INJECTION
VINBLASTINE SULFATE
! FRESENIUS KABI USA 1MG/ML A089515 001 Apr 29, 1987
! HIKMA 10MG/VIAL A089395 001 Apr 09, 1987
VINCRISTINE SULFATE
INJECTABLE;INJECTION
VINCRISTINE SULFATE PFS
AP ! HOSPIRA 1MG/ML A071484 001 Apr 19, 1988
AP TEVA PHARMS USA 1MG/ML A075493 001 Sep 01, 1999
VINORELBINE TARTRATE
INJECTABLE;INJECTION
VINORELBINE TARTRATE
AP ACTAVIS TOTOWA EQ 10MG BASE/ML A078011 001 Jul 22, 2009
AP DR REDDYS EQ 10MG BASE/ML A202017 001 Sep 12, 2013
AP HIKMA EQ 10MG BASE/ML A075992 001 Jun 10, 2003
AP EQ 10MG BASE/ML A076461 001 Dec 11, 2003
AP ! JIANGSU HANSOH EQ 10MG BASE/ML A091106 001 Sep 26, 2012
PHARM
VISMODEGIB
CAPSULE;ORAL
ERIVEDGE
+! GENENTECH 150MG N203388 001 Jan 30, 2012
VITAMIN A PALMITATE
INJECTABLE;INJECTION
AQUASOL A
+! CASPER PHARMA LLC EQ 50,000 UNITS BASE/ML N006823 001
VOCLOSPORIN
CAPSULE;ORAL
LUPKYNIS
+! AURINIA 7.9MG N213716 001 Jan 22, 2021
VORAPAXAR SULFATE
TABLET;ORAL
ZONTIVITY
+! XSPIRE PHARMA EQ 2.08MG BASE N204886 001 May 08, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-467(of 474)

VORICONAZOLE
FOR SUSPENSION;ORAL
VFEND
AB +! PF PRISM CV 200MG/5ML N021630 001 Dec 19, 2003
VORICONAZOLE
AB AMNEAL PHARMS 200MG/5ML A205034 001 Apr 13, 2016
AB NOVEL LABS INC 200MG/5ML A206799 001 May 31, 2016
INJECTABLE;INTRAVENOUS
VFEND
AP +! PF PRISM CV 200MG/VIAL N021267 001 May 24, 2002
VORICONAZOLE
AP ALMAJECT 200MG/VIAL A206398 001 Mar 23, 2016
AP GLAND PHARMA LTD 200MG/VIAL A211099 001 Mar 31, 2020
AP HAINAN POLY PHARM 200MG/VIAL A211661 001 Nov 30, 2018
AP MEITHEAL 200MG/VIAL A214516 001 May 09, 2022
AP SANDOZ INC 200MG/VIAL A090862 001 May 30, 2012
AP ZYDUS PHARMS 200MG/VIAL A208983 001 Jul 16, 2018
POWDER;INTRAVENOUS
VORICONAZOLE
AP XELLIA PHARMS APS 200MG/VIAL N208562 001 Mar 09, 2017
TABLET;ORAL
VFEND
AB + PF PRISM CV 50MG N021266 001 May 24, 2002
AB +! 200MG N021266 002 May 24, 2002
VORICONAZOLE
AB AJANTA PHARMA LTD 50MG A206181 001 May 24, 2016
AB 200MG A206181 002 May 24, 2016
AB AKORN 50MG A207049 001 Sep 07, 2016
AB 200MG A207049 002 Sep 07, 2016
AB AUROBINDO PHARMA 50MG A206837 001 Jan 22, 2016
LTD
AB 200MG A206837 002 Jan 22, 2016
AB CADILA 50MG A206747 001 May 24, 2016
AB 200MG A206747 002 May 24, 2016
AB GLENMARK PHARMS LTD 50MG A203503 001 Sep 02, 2015
AB 200MG A203503 002 Sep 02, 2015
AB MYLAN PHARMS INC 50MG A090547 001 Apr 22, 2010
AB 200MG A090547 002 Apr 22, 2010
AB NOVEL LABS INC 50MG A207371 001 May 24, 2016
AB 200MG A207371 002 May 24, 2016
AB PRINSTON INC 50MG A206654 001 Aug 08, 2016
AB 200MG A206654 002 Aug 08, 2016
AB RISING 50MG A206762 001 May 24, 2016
AB 200MG A206762 002 May 24, 2016
AB SANDOZ INC 50MG A200265 001 Dec 12, 2011
AB 200MG A200265 002 Dec 12, 2011
VORINOSTAT
CAPSULE;ORAL
ZOLINZA
+! MSD SUB MERCK 100MG N021991 001 Oct 06, 2006
VORTIOXETINE HYDROBROMIDE
TABLET;ORAL
TRINTELLIX
+ TAKEDA PHARMS USA EQ 5MG BASE N204447 001 Sep 30, 2013
+ EQ 10MG BASE N204447 002 Sep 30, 2013
+! EQ 20MG BASE N204447 004 Sep 30, 2013
VOSORITIDE
POWDER;SUBCUTANEOUS
VOXZOGO
+! BIOMARIN PHARM 0.4MG/VIAL N214938 001 Nov 19, 2021
+! 0.56MG/VIAL N214938 002 Nov 19, 2021
+! 1.2MG/VIAL N214938 003 Nov 19, 2021
VOXELOTOR
TABLET;ORAL
OXBRYTA
+ GLOBAL BLOOD 300MG N213137 002 Oct 14, 2022
THERAPS
+! 500MG N213137 001 Nov 25, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-468(of 474)

VOXELOTOR
TABLET, FOR SUSPENSION;ORAL
OXBRYTA
+! GLOBAL BLOOD 300MG N216157 001 Dec 17, 2021
THERAPS
VUTRISIRAN
SOLUTION;SUBCUTANEOUS
AMVUTTRA
+! ALNYLAM PHARMS INC 25MG/0.5ML (25MG/0.5ML) N215515 001 Jun 13, 2022
WARFARIN SODIUM
TABLET;ORAL
JANTOVEN
AB UPSHER SMITH LABS 1MG A040416 001 Oct 02, 2003
AB 2MG A040416 002 Oct 02, 2003
AB 2.5MG A040416 003 Oct 02, 2003
AB 3MG A040416 004 Oct 02, 2003
AB 4MG A040416 005 Oct 02, 2003
AB 5MG A040416 006 Oct 02, 2003
AB 6MG A040416 007 Oct 02, 2003
AB 7.5MG A040416 008 Oct 02, 2003
AB 10MG A040416 009 Oct 02, 2003
WARFARIN SODIUM
AB AMNEAL PHARMS 1MG A202202 001 Mar 04, 2013
AB 2MG A202202 002 Mar 04, 2013
AB 2.5MG A202202 003 Mar 04, 2013
AB 3MG A202202 004 Mar 04, 2013
AB 4MG A202202 005 Mar 04, 2013
AB 5MG A202202 006 Mar 04, 2013
AB 6MG A202202 007 Mar 04, 2013
AB 7.5MG A202202 008 Mar 04, 2013
AB 10MG A202202 009 Mar 04, 2013
AB BARR 1MG A040145 001 Mar 26, 1997
AB 2MG A040145 002 Mar 26, 1997
AB 2.5MG A040145 003 Mar 26, 1997
AB 3MG A040145 008 Nov 05, 1998
AB 4MG A040145 004 Mar 26, 1997
AB 5MG A040145 005 Mar 26, 1997
AB 6MG A040145 009 Nov 05, 1998
AB 7.5MG A040145 006 Mar 26, 1997
AB 10MG A040145 007 Mar 26, 1997
AB INVAGEN PHARMS 1MG A090935 001 May 25, 2011
AB 2MG A090935 002 May 25, 2011
AB 2.5MG A090935 003 May 25, 2011
AB 3MG A090935 004 May 25, 2011
AB 4MG A090935 005 May 25, 2011
AB 5MG A090935 006 May 25, 2011
AB 6MG A090935 007 May 25, 2011
AB 7.5MG A090935 008 May 25, 2011
AB 10MG A090935 009 May 25, 2011
AB IPCA LABS LTD 1MG A200104 001 Jun 27, 2013
AB 2MG A200104 002 Jun 27, 2013
AB 2.5MG A200104 003 Jun 27, 2013
AB 3MG A200104 004 Jun 27, 2013
AB 4MG A200104 005 Jun 27, 2013
AB 5MG A200104 006 Jun 27, 2013
AB 6MG A200104 007 Jun 27, 2013
AB 7.5MG A200104 008 Jun 27, 2013
AB 10MG A200104 009 Jun 27, 2013
AB PLIVA 1MG A040616 009 Jul 05, 2006
AB 2MG A040616 001 Jul 05, 2006
AB 2.5MG A040616 002 Jul 05, 2006
AB 3MG A040616 003 Jul 05, 2006
AB 4MG A040616 004 Jul 05, 2006
AB 5MG A040616 005 Jul 05, 2006
AB 6MG A040616 006 Jul 05, 2006
AB 7.5MG A040616 007 Jul 05, 2006
AB ! 10MG A040616 008 Jul 05, 2006
AB TARO 1MG A040301 002 Jul 15, 1999
AB 2MG A040301 003 Jul 15, 1999
AB 2.5MG A040301 004 Jul 15, 1999
AB 3MG A040301 005 Jul 15, 1999
AB 4MG A040301 006 Jul 15, 1999
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-469(of 474)

WARFARIN SODIUM
TABLET;ORAL
WARFARIN SODIUM
AB 5MG A040301 007 Jul 15, 1999
AB 6MG A040301 008 Jul 15, 1999
AB 7.5MG A040301 009 Jul 15, 1999
AB 10MG A040301 001 Jul 15, 1999
AB ZYDUS PHARMS USA 1MG A040663 001 May 30, 2006
AB 2MG A040663 002 May 30, 2006
AB 2.5MG A040663 003 May 30, 2006
AB 3MG A040663 004 May 30, 2006
AB 4MG A040663 005 May 30, 2006
AB 5MG A040663 006 May 30, 2006
AB 6MG A040663 007 May 30, 2006
AB 7.5MG A040663 008 May 30, 2006
AB 10MG A040663 009 May 30, 2006
XENON XE-133
GAS;INHALATION
XENON XE 133
CURIUM 10mCi/VIAL N018327 001 Mar 09, 1982
20mCi/VIAL N018327 002 Mar 09, 1982
LANTHEUS MEDCL 10mCi/VIAL N017284 001
20mCi/VIAL N017284 002
ZAFIRLUKAST
TABLET;ORAL
ACCOLATE
AB + STRIDES PHARMA 10MG N020547 003 Sep 17, 1999
AB +! 20MG N020547 001 Sep 26, 1996
ZAFIRLUKAST
AB ANNORA PHARMA 10MG A212475 001 Sep 10, 2020
AB 20MG A212475 002 Sep 10, 2020
AB DR REDDYS LABS LTD 10MG A090372 001 Nov 18, 2010
AB 20MG A090372 002 Nov 18, 2010
AB RISING PHARMS 10MG A204928 001 Aug 25, 2022
AB 20MG A204928 002 Aug 25, 2022
ZALEPLON
CAPSULE;ORAL
SONATA
AB + PFIZER 5MG N020859 001 Aug 13, 1999
AB +! 10MG N020859 002 Aug 13, 1999
ZALEPLON
AB AUROBINDO PHARMA 5MG A078829 001 Jun 06, 2008
AB 10MG A078829 002 Jun 06, 2008
AB CHARTWELL MOLECULAR 5MG A077505 001 Jun 20, 2008
AB 10MG A077505 002 Jun 20, 2008
AB HIKMA 5MG A077237 001 Jun 06, 2008
AB 10MG A077237 002 Jun 06, 2008
AB ORBION PHARMS 5MG A090374 001 Sep 17, 2009
AB 10MG A090374 002 Sep 17, 2009
AB UNICHEM 5MG A078989 001 Jun 06, 2008
AB 10MG A078989 002 Jun 06, 2008
ZANAMIVIR
POWDER;INHALATION
RELENZA
+! GLAXOSMITHKLINE 5MG N021036 001 Jul 26, 1999
ZANUBRUTINIB
CAPSULE;ORAL
BRUKINSA
+! BEIGENE 80MG N213217 001 Nov 14, 2019
ZICONOTIDE ACETATE
INJECTABLE;INTRATHECAL
PRIALT
+! TERSERA 100MCG/1ML (100MCG/ML) N021060 002 Dec 28, 2004
+! 500MCG/20ML (25MCG/ML) N021060 001 Dec 28, 2004
+! 500MCG/5ML (100MCG/ML) N021060 004 Dec 28, 2004
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-470(of 474)

ZIDOVUDINE
CAPSULE;ORAL
RETROVIR
AB +! VIIV HLTHCARE 100MG N019655 001 Mar 19, 1987
ZIDOVUDINE
AB AUROBINDO PHARMA 100MG A078128 001 Mar 27, 2006
LTD
AB CIPLA LTD 100MG A078349 001 May 23, 2007
INJECTABLE;INJECTION
RETROVIR
+! VIIV HLTHCARE 10MG/ML N019951 001 Feb 02, 1990
SOLUTION;ORAL
RETROVIR
AA +! VIIV HLTHCARE 50MG/5ML N019910 001 Sep 28, 1989
ZIDOVUDINE
AA AUROBINDO 50MG/5ML A077268 001 Sep 19, 2005
AA CIPLA LTD 50MG/5ML A077981 001 Jun 26, 2008
TABLET;ORAL
ZIDOVUDINE
AB AUROBINDO 300MG A077267 001 Sep 19, 2005
AB CIPLA 300MG A090561 001 Oct 27, 2010
AB ! HETERO LABS LTD III 300MG A090092 001 Apr 25, 2008
AB MYLAN PHARMS INC 300MG A078922 001 Feb 14, 2008
ZILEUTON
TABLET;ORAL
ZYFLO
+! CHIESI 600MG N020471 003 Dec 09, 1996
TABLET, EXTENDED RELEASE;ORAL
ZILEUTON
AB ANNORA PHARMA 600MG A215742 001 Oct 11, 2022
AB DASH PHARMS 600MG A211390 001 Oct 23, 2020
AB RISING 600MG A204929 001 Mar 17, 2017
AB STRIDES PHARMA 600MG A212670 001 Dec 16, 2019
ZYFLO CR
AB +! CHIESI 600MG N022052 001 May 30, 2007
ZILEUTON
BX LUPIN LTD 600MG A211972 001 Nov 05, 2019
ZINC ACETATE
CAPSULE;ORAL
GALZIN
+ TEVA EQ 25MG ZINC N020458 001 Jan 28, 1997
+! EQ 50MG ZINC N020458 002 Jan 28, 1997
ZINC CHLORIDE
INJECTABLE;INJECTION
ZINC CHLORIDE
AP EXELA PHARMA EQ 1MG ZINC/ML A212007 001 May 21, 2021
ZINC CHLORIDE IN PLASTIC CONTAINER
AP +! HOSPIRA EQ 1MG ZINC/ML N018959 001 Jun 26, 1986
ZINC SULFATE
SOLUTION;INTRAVENOUS
ZINC SULFATE
AP +! AM REGENT EQ 10MG BASE/10ML (EQ 1MG BASE/ML) N209377 003 Apr 15, 2020
AP +! EQ 25MG BASE/5ML (EQ 5MG BASE/ML) N209377 002 Jul 18, 2019
AP +! EQ 30MG BASE/10ML (EQ 3MG BASE/ML) N209377 001 Jul 18, 2019
AP GLAND PHARMA LTD EQ 25MG BASE/5ML (EQ 5MG BASE/ML) A216249 001 May 03, 2022
AP EQ 30MG BASE/10ML (EQ 3MG BASE/ML) A216249 002 May 03, 2022
ZINC SULFATE MONOHYDRATE
SOLUTION;INTRAVENOUS
ZINC SULFATE
AP FRESENIUS KABI USA EQ 10MG BASE/10ML (EQ 1MG BASE/ML) A216145 001 Dec 27, 2022
AP EQ 25MG BASE/5ML (EQ 5MG BASE/ML) A216145 002 Dec 27, 2022
AP EQ 30MG BASE/10ML (EQ 3MG BASE/ML) A216145 003 Dec 27, 2022
ZIPRASIDONE HYDROCHLORIDE
CAPSULE;ORAL
GEODON
AB +! VIATRIS EQ 20MG BASE N020825 001 Feb 05, 2001
AB + EQ 40MG BASE N020825 002 Feb 05, 2001
AB + EQ 60MG BASE N020825 003 Feb 05, 2001
AB + EQ 80MG BASE N020825 004 Feb 05, 2001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-471(of 474)

ZIPRASIDONE HYDROCHLORIDE
CAPSULE;ORAL
ZIPRASIDONE HYDROCHLORIDE
AB APOTEX EQ 20MG BASE A077561 001 Mar 02, 2012
AB EQ 40MG BASE A077561 002 Mar 02, 2012
AB EQ 60MG BASE A077561 003 Mar 02, 2012
AB EQ 80MG BASE A077561 004 Mar 02, 2012
AB AUROBINDO PHARMA EQ 20MG BASE A204117 001 Dec 27, 2016
AB EQ 40MG BASE A204117 002 Dec 27, 2016
AB EQ 60MG BASE A204117 003 Dec 27, 2016
AB EQ 80MG BASE A204117 004 Dec 27, 2016
AB CADILA EQ 20MG BASE A208988 001 Aug 22, 2017
AB EQ 40MG BASE A208988 002 Aug 22, 2017
AB EQ 60MG BASE A208988 003 Aug 22, 2017
AB EQ 80MG BASE A208988 004 Aug 22, 2017
AB CHARTWELL RX EQ 20MG BASE A090348 001 Sep 05, 2012
AB EQ 40MG BASE A090348 002 Sep 05, 2012
AB EQ 60MG BASE A090348 003 Sep 05, 2012
AB EQ 80MG BASE A090348 004 Sep 05, 2012
AB DR REDDYS LABS INC EQ 20MG BASE A077565 001 Mar 02, 2012
AB EQ 40MG BASE A077565 002 Mar 02, 2012
AB EQ 60MG BASE A077565 003 Mar 02, 2012
AB EQ 80MG BASE A077565 004 Mar 02, 2012
AB LUPIN PHARMS EQ 20MG BASE A077560 001 Mar 02, 2012
AB EQ 40MG BASE A077560 002 Mar 02, 2012
AB EQ 60MG BASE A077560 003 Mar 02, 2012
AB EQ 80MG BASE A077560 004 Mar 02, 2012
AB MACLEODS PHARMS LTD EQ 20MG BASE A204375 001 Feb 17, 2017
AB EQ 40MG BASE A204375 002 Feb 17, 2017
AB EQ 60MG BASE A204375 003 Feb 17, 2017
AB EQ 80MG BASE A204375 004 Feb 17, 2017
AB SANDOZ INC EQ 20MG BASE A077562 001 Jun 01, 2012
AB EQ 40MG BASE A077562 002 Jun 01, 2012
AB EQ 60MG BASE A077562 003 Jun 01, 2012
AB EQ 80MG BASE A077562 004 Jun 01, 2012
ZIPRASIDONE MESYLATE
POWDER;INTRAMUSCULAR
GEODON
AP +! VIATRIS EQ 20MG BASE/VIAL N020919 001 Jun 21, 2002
ZIPRASIDONE MESYLATE
AP GLAND PHARMA LTD EQ 20MG BASE/VIAL A211908 001 Dec 26, 2019
AP MSN EQ 20MG BASE/VIAL A216091 001 Sep 15, 2022
ZOLEDRONIC ACID
INJECTABLE;INTRAVENOUS
RECLAST
AP +! NOVARTIS EQ 5MG BASE/100ML N021817 001 Apr 16, 2007
ZOLEDRONIC
AP GLAND PHARMA LTD EQ 4MG BASE/100ML A205749 001 Jun 29, 2018
ZOLEDRONIC ACID
AP ACCORD HLTHCARE EQ 4MG BASE/5ML A205279 001 Nov 28, 2016
AP AKORN EQ 4MG BASE/5ML A202548 001 May 22, 2014
AP EQ 5MG BASE/100ML A200918 001 Aug 21, 2014
AP AMNEAL EQ 4MG BASE/100ML A210174 001 Oct 27, 2017
AP APOTEX EQ 5MG BASE/100ML A204367 001 Dec 24, 2015
AP BPI LABS EQ 4MG BASE/5ML A207341 001 Dec 29, 2017
AP BRECKENRIDGE EQ 4MG BASE/5ML A091170 001 Mar 04, 2013
AP EQ 4MG BASE/5ML A202571 001 May 07, 2013
AP EQ 5MG BASE/100ML A202163 001 Aug 05, 2013
AP DR REDDYS LABS LTD EQ 4MG BASE/5ML A091186 001 Mar 04, 2013
AP EQ 5MG BASE/100ML A091363 001 Mar 29, 2013
AP FRESENIUS KABI USA EQ 4MG BASE/5ML A091516 001 Apr 23, 2015
AP GLAND EQ 5MG BASE/100ML A204217 001 Aug 18, 2016
AP GLAND PHARMA LTD EQ 4MG BASE/5ML A202930 001 Aug 05, 2013
AP EQ 5MG BASE/100ML A209578 001 Aug 08, 2019
AP HIKMA FARMACEUTICA EQ 4MG BASE/5ML A202182 001 Jun 03, 2013
AP HOSPIRA EQ 4MG BASE/5ML A090621 001 Mar 19, 2015
AP HOSPIRA INC EQ 5MG BASE/100ML A202837 001 Apr 05, 2013
AP INFORLIFE EQ 4MG BASE/100ML N203231 001 Aug 02, 2013
AP EQ 5MG BASE/100ML A202828 001 Sep 23, 2013
AP INGENUS PHARMS LLC EQ 4MG BASE/5ML A208968 001 Feb 19, 2020
AP MYLAN LABS LTD EQ 4MG BASE/5ML A202650 001 Mar 04, 2013
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-472(of 474)

ZOLEDRONIC ACID
INJECTABLE;INTRAVENOUS
ZOLEDRONIC ACID
AP EQ 5MG BASE/100ML A203841 001 Feb 14, 2017
AP EQ 5MG BASE/100ML A205254 001 Oct 27, 2017
AP SAGENT PHARMS INC EQ 4MG BASE/5ML A091493 001 Nov 24, 2014
AP USV EQ 4MG BASE/5ML A202923 001 Sep 04, 2014
ZOMETA
AP +! NOVARTIS EQ 4MG BASE/5ML N021223 002 Mar 07, 2003
AP +! EQ 4MG BASE/100ML N021223 003 Jun 17, 2011
SOLUTION;INTRAVENOUS
ZOLEDRONIC ACID
HOSPIRA EQ 4MG BASE/100ML (EQ 0.04MG BASE/ML) N204016 001 Dec 28, 2015
ZOLMITRIPTAN
SPRAY;NASAL
ZOLMITRIPTAN
AB PADAGIS ISRAEL 2.5MG/SPRAY A212469 001 Sep 30, 2021
AB 5MG/SPRAY A212469 002 Sep 30, 2021
ZOMIG
AB + ASTRAZENECA 2.5MG/SPRAY N021450 003 Sep 16, 2013
AB +! 5MG/SPRAY N021450 004 Sep 30, 2003
TABLET;ORAL
ZOLMITRIPTAN
AB AJANTA PHARMA LTD 2.5MG A204041 001 May 20, 2016
AB 5MG A204041 002 May 20, 2016
AB ALEMBIC PHARMS 2.5MG A204232 001 Sep 30, 2015
AB 5MG A204232 002 Sep 30, 2015
AB APPCO 2.5MG A206973 001 Jun 30, 2017
AB 5MG A206973 002 Jun 30, 2017
AB AUROBINDO PHARMA 2.5MG A207021 001 May 11, 2016
AB 5MG A207021 002 May 11, 2016
AB GLENMARK GENERICS 2.5MG A201779 001 May 14, 2013
AB 5MG A201779 002 May 14, 2013
AB INVAGEN PHARMS 2.5MG A204284 001 Apr 09, 2014
AB 5MG A204284 002 Apr 09, 2014
AB JUBILANT GENERICS 2.5MG A202279 001 Nov 20, 2014
AB 5MG A202279 002 Nov 20, 2014
AB ORBION PHARMS 2.5MG A203726 001 Oct 21, 2019
AB 5MG A203726 002 Oct 21, 2019
AB PLD ACQUISITIONS 2.5MG A207867 001 Feb 27, 2017
LLC
AB 5MG A207867 002 Feb 27, 2017
AB ZYDUS PHARMS 2.5MG A203019 001 Jul 11, 2018
AB 5MG A203019 002 Jul 11, 2018
ZOMIG
AB + IPR 2.5MG N020768 001 Nov 25, 1997
AB +! 5MG N020768 002 Nov 25, 1997
TABLET, ORALLY DISINTEGRATING;ORAL
ZOLMITRIPTAN
AB ALEMBIC PHARMS 2.5MG A205074 001 Dec 01, 2016
AB 5MG A205074 002 Dec 01, 2016
AB GLENMARK GENERICS 2.5MG A202560 001 May 14, 2013
AB 5MG A202560 002 May 14, 2013
AB JUBILANT GENERICS 2.5MG A202956 001 Sep 17, 2015
AB 5MG A202956 002 Sep 17, 2015
AB ZYDUS PHARMS USA 2.5MG A202890 001 May 15, 2013
INC
AB 5MG A202890 002 May 15, 2013
ZOMIG-ZMT
AB + ASTRAZENECA 2.5MG N021231 001 Feb 13, 2001
AB +! 5MG N021231 002 Sep 17, 2001
ZOLPIDEM TARTRATE
TABLET;ORAL
AMBIEN
AB + SANOFI AVENTIS US 5MG N019908 001 Dec 16, 1992
AB +! 10MG N019908 002 Dec 16, 1992
ZOLPIDEM TARTRATE
AB ACME LABS 5MG A077214 001 Apr 23, 2007
AB 10MG A077214 002 Apr 23, 2007
AB APOTEX INC 5MG A077884 001 Apr 23, 2007
AB 10MG A077884 002 Apr 23, 2007
AB AUROBINDO PHARMA 5MG A078413 001 May 04, 2007
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-473(of 474)

ZOLPIDEM TARTRATE
TABLET;ORAL
ZOLPIDEM TARTRATE
AB 10MG A078413 002 May 04, 2007
AB CHARTWELL MOLECULAR 5MG A077388 001 Jul 30, 2012
AB 10MG A077388 002 Jul 30, 2012
AB INVAGEN PHARMS 5MG A078184 001 Sep 07, 2007
AB 10MG A078184 002 Sep 07, 2007
AB SANDOZ INC 5MG A077322 001 Apr 23, 2007
AB 10MG A077322 002 Apr 23, 2007
AB TEVA 5MG A076410 001 Apr 23, 2007
AB 10MG A076410 002 Apr 23, 2007
AB TORRENT PHARMS 5MG A077903 001 Aug 17, 2007
AB 10MG A077903 002 Aug 17, 2007
TABLET;SUBLINGUAL
EDLUAR
AB + MYLAN SPECIALITY LP 5MG N021997 001 Mar 13, 2009
AB +! 10MG N021997 002 Mar 13, 2009
ZOLPIDEM TARTRATE
AB DR REDDYS 1.75MG A204503 001 Nov 18, 2016
AB 3.5MG A204503 002 Nov 18, 2016
AB NOVEL LABS INC 1.75MG A204299 001 Jun 03, 2015
AB ! 3.5MG A204299 002 Jun 03, 2015
AB PAR FORM 5MG A201509 001 Aug 01, 2016
AB 10MG A201509 002 Aug 01, 2016
AB PAR PHARM INC 1.75MG A204229 001 Sep 11, 2017
AB 3.5MG A204229 002 Sep 11, 2017
TABLET, EXTENDED RELEASE;ORAL
AMBIEN CR
AB + SANOFI AVENTIS US 6.25MG N021774 002 Sep 02, 2005
AB +! 12.5MG N021774 001 Sep 02, 2005
ZOLPIDEM TARTRATE
AB ACTAVIS LABS FL INC 6.25MG A090153 001 Mar 25, 2013
AB 12.5MG A090153 002 Mar 25, 2013
AB ANCHEN PHARMS 6.25MG A078148 002 Apr 14, 2011
AB 12.5MG A078148 001 Dec 03, 2010
AB APOTEX INC 6.25MG A200266 001 Sep 10, 2013
AB 12.5MG A200266 002 Sep 10, 2013
AB BRECKENRIDGE 6.25MG A213592 001 Jun 04, 2020
AB 12.5MG A213592 002 Jun 04, 2020
AB LUPIN LTD 6.25MG A078970 001 Sep 11, 2013
AB 12.5MG A078970 002 Sep 11, 2013
AB SANDOZ 6.25MG A090107 001 Jul 01, 2011
AB 12.5MG A090107 002 Jul 01, 2011
AB SUN PHARM 6.25MG A204170 001 Jan 24, 2017
AB 12.5MG A204170 002 Jan 24, 2017
ZONISAMIDE
CAPSULE;ORAL
ZONEGRAN
AB + CONCORDIA 25MG N020789 003 Aug 22, 2003
AB +! 100MG N020789 001 Mar 27, 2000
ZONISAMIDE
AB APOTEX INC 25MG A077642 001 Dec 22, 2005
AB 50MG A077642 002 Dec 22, 2005
AB 100MG A077642 003 Dec 22, 2005
AB AUROBINDO PHARMA 25MG A077645 002 Sep 29, 2006
LTD
AB 50MG A077645 003 Sep 29, 2006
AB 100MG A077645 001 Dec 22, 2005
AB BIONPHARMA INC 25MG A077813 001 Aug 16, 2006
AB 50MG A077813 002 Aug 16, 2006
AB 100MG A077813 003 Aug 16, 2006
AB CADILA 25MG A077625 001 Oct 16, 2006
AB 50MG A077625 002 Oct 16, 2006
AB 100MG A077625 003 Oct 16, 2006
AB GLENMARK GENERICS 25MG A077651 001 Jan 30, 2006
AB 50MG A077651 002 Jan 30, 2006
AB 100MG A077651 003 Jan 30, 2006
AB GRANULES 25MG A077636 003 Jul 27, 2006
AB 50MG A077636 002 Jul 27, 2006
AB 100MG A077636 001 Dec 22, 2005
AB INVAGEN PHARMS 25MG A077869 001 May 31, 2006
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
PRESCRIPTION DRUG PRODUCT LIST 3-474(of 474)

ZONISAMIDE
CAPSULE;ORAL
ZONISAMIDE
AB 50MG A077869 002 May 31, 2006
AB 100MG A077869 003 May 31, 2006
AB SUN PHARM INDS (IN) 25MG A077634 001 Mar 17, 2006
AB 50MG A077634 002 Mar 17, 2006
AB 100MG A077634 003 Mar 17, 2006
AB UNICHEM 25MG A214492 001 Jan 26, 2021
AB 50MG A214492 002 Jan 26, 2021
AB 100MG A214492 003 Jan 26, 2021
SUSPENSION;ORAL
ZONISADE
+! AZURITY 100MG/5ML N214273 001 Jul 15, 2022
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-1(of 20)

ACETAMINOPHEN
SUPPOSITORY;RECTAL
ACEPHEN
COSETTE 120MG N018060 001
325MG A072344 001 Mar 27, 1992
650MG A072237 001 Mar 27, 1992
ACETAMINOPHEN
PERRIGO NEW YORK 120MG A070607 001 Apr 06, 1987
650MG A070608 001 Dec 01, 1986
+ TARO PHARM INDS LTD 120MG N018337 003 Sep 12, 1983
+ 325MG N018337 002
+! 650MG N018337 001
INFANTS' FEVERALL
+ TARO PHARM INDS LTD 80MG N018337 004 Aug 26, 1992
TABLET, EXTENDED RELEASE;ORAL
ACETAMINOPHEN
AUROBINDO PHARMA 650MG A207229 001 Nov 09, 2016
GRANULES 650MG A211544 001 Apr 16, 2019
HERITAGE PHARMA 650MG A207035 001 May 31, 2018
MARKSANS PHARMA 650MG A215486 001 Aug 25, 2021
OHM LABS 650MG A076200 001 Mar 19, 2002
PERRIGO 650MG A075077 001 Feb 25, 2000
SUN PHARM INDS LTD 650MG A078569 001 Dec 14, 2011
TYLENOL
+! J AND J CONSUMER 650MG N019872 001 Jun 08, 1994
INC
+! 650MG N019872 002 Jan 11, 2001
ACETAMINOPHEN; ASPIRIN; CAFFEINE
TABLET;ORAL
ACETAMINOPHEN, ASPIRIN AND CAFFEINE
AUROBINDO PHARMA 250MG;250MG;65MG A211695 001 Feb 02, 2022
LTD
GRANULES 250MG;250MG;65MG A214039 001 Feb 23, 2021
PERRIGO 250MG;250MG;65MG A075794 001 Nov 26, 2001
EXCEDRIN (MIGRAINE)
+! GLAXOSMITHKLINE 250MG;250MG;65MG N020802 001 Jan 14, 1998
CONS
ACETAMINOPHEN; IBUPROFEN
TABLET;ORAL
ADVIL DUAL ACTION WITH ACETAMINOPHEN
+! GLAXOSMITHKLINE 250MG;125MG N211733 001 Feb 28, 2020
ADAPALENE
GEL;TOPICAL
ADAPALENE
GLENMARK GENERICS 0.1% A091314 001 Jul 01, 2010
P AND L 0.1% A090962 001 Jun 02, 2010
TARO PHARMS 0.1% A215940 001 Jan 14, 2022
DIFFERIN
+! GALDERMA LABS LP 0.1% N020380 002 Jul 08, 2016
ALCAFTADINE
SOLUTION/DROPS;OPHTHALMIC
LASTACAFT
+! ALLERGAN 0.25% N022134 001 Jul 28, 2010
ALCOHOL; CHLORHEXIDINE GLUCONATE
SOLUTION;TOPICAL
AVAGARD
+! 3M 61%;1% N021074 001 Jun 07, 2001
ASPIRIN
CAPSULE;ORAL
VAZALORE
+ PLX PHARMA 81MG N203697 002 Feb 26, 2021
+! 325MG N203697 001 Jan 14, 2013
AVOBENZONE; ECAMSULE; OCTOCRYLENE
CREAM;TOPICAL
ANTHELIOS SX
+! LOREAL USA 2%;2%;10% N021502 001 Jul 21, 2006
CAPITAL SOLEIL 15
+! LOREAL USA 2%;3%;10% N021501 001 Oct 02, 2006
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-2(of 20)

AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE


CREAM;TOPICAL
ANTHELIOS 20
+! LOREAL USA 2%;2%;10%;2% N021471 001 Oct 05, 2006
ANTHELIOS 40
+! LOREAL USA 2%;3%;10%;5% N022009 001 Mar 31, 2008
+! 2%;3%;10%;5% N022009 002 Oct 29, 2009
AZELASTINE HYDROCHLORIDE
SPRAY, METERED;NASAL
ASTEPRO ALLERGY
+! BAYER HLTHCARE 0.2055MG/SPRAY N213872 001 Jun 17, 2021
CHILDREN'S ASTEPRO ALLERGY
+! BAYER HLTHCARE 0.2055MG/SPRAY N213872 002 Jun 17, 2021
BENTOQUATAM
LOTION;TOPICAL
IVY BLOCK
+! STAND HOMEOPATH 5% N020532 001 Aug 26, 1996
BRIMONIDINE TARTRATE
SOLUTION/DROPS;OPHTHALMIC
LUMIFY
+! BAUSCH AND LOMB INC 0.025% N208144 001 Dec 22, 2017
BUDESONIDE
SPRAY, METERED;NASAL
BUDESONIDE
APOTEX INC 0.032MG/SPRAY A078949 002 Nov 20, 2015
RHINOCORT ALLERGY
+! J AND J CONSUMER 0.032MG/SPRAY N020746 003 Mar 23, 2015
INC
BUTENAFINE HYDROCHLORIDE
CREAM;TOPICAL
BUTENAFINE HYDROCHLORIDE
TARO PHARMS 1% A205181 001 Nov 16, 2017
LOTRIMIN ULTRA
+! BAYER HEALTHCARE 1% N021307 001 Dec 07, 2001
LLC
CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE
TABLET, CHEWABLE;ORAL
FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE
PERRIGO R AND D 800MG;10MG;165MG A077355 001 Feb 06, 2008
800MG;10MG;165MG A204782 001 Aug 29, 2016
PEPCID COMPLETE
+! J AND J CONSUMER 800MG;10MG;165MG N020958 001 Oct 16, 2000
INC
CETIRIZINE HYDROCHLORIDE
CAPSULE;ORAL
CETIRIZINE HYDROCHLORIDE ALLERGY
APOTEX 10MG A207235 001 Aug 12, 2016
AUROBINDO PHARMA 10MG A209107 001 Jul 20, 2018
LTD
+ BIONPHARMA INC 5MG N022429 001 Jul 23, 2009
+! 10MG N022429 004 Jul 23, 2009
CATALENT 10MG A213105 001 Sep 21, 2020
STRIDES PHARMA 10MG A205291 001 Jul 21, 2017
CETIRIZINE HYDROCHLORIDE HIVES RELIEF
AUROBINDO PHARMA 10MG A209107 002 Jul 20, 2018
LTD
+ BIONPHARMA INC 5MG N022429 003 Jul 23, 2009
+! 10MG N022429 002 Jul 23, 2009
SYRUP;ORAL
CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
AMNEAL PHARMS 5MG/5ML A090765 002 Oct 07, 2009
AUROBINDO PHARMA 5MG/5ML A090750 002 Feb 02, 2010
BAJAJ 5MG/5ML A091327 001 Oct 17, 2011
CHARTWELL MOLECULAR 5MG/5ML A091130 001 Apr 22, 2011
HETERO LABS LTD III 5MG/5ML A210622 001 Mar 13, 2019
PERRIGO R AND D 5MG/5ML A204226 001 Sep 09, 2013
5MG/5ML A090254 002 Apr 09, 2008
QUAGEN 5MG/5ML A212266 001 May 16, 2019
TARO 5MG/5ML A090182 002 Apr 22, 2008
5MG/5ML A201546 001 May 20, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-3(of 20)

CETIRIZINE HYDROCHLORIDE
SYRUP;ORAL
CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
AMNEAL PHARMS 5MG/5ML A090765 001 Oct 07, 2009
AUROBINDO PHARMA 5MG/5ML A090750 001 Feb 02, 2010
BAJAJ 5MG/5ML A091327 002 Oct 17, 2011
CHARTWELL MOLECULAR 5MG/5ML A091130 002 Apr 22, 2011
PERRIGO R AND D 5MG/5ML A090254 001 Apr 09, 2008
TARO 5MG/5ML A090182 001 Apr 22, 2008
5MG/5ML A201546 002 May 20, 2011
CHILDREN'S ZYRTEC ALLERGY
+! J AND J CONSUMER 5MG/5ML N022155 002 Nov 16, 2007
INC
CHILDREN'S ZYRTEC HIVES RELIEF
+! J AND J CONSUMER 5MG/5ML N022155 001 Nov 16, 2007
INC
TABLET;ORAL
CETIRIZINE HYDROCHLORIDE ALLERGY
AMNEAL PHARMS NY 5MG A078780 001 Jan 21, 2010
10MG A078780 004 Jan 21, 2010
APOTEX INC 5MG A078317 001 Dec 27, 2007
10MG A078317 002 Dec 27, 2007
AUROBINDO PHARMA 5MG A090760 001 Aug 05, 2015
LTD
10MG A090760 003 Aug 05, 2015
CONTRACT PHARMACAL 5MG A076047 001 Dec 27, 2007
10MG A076047 002 Dec 27, 2007
DR REDDYS LABS LTD 5MG A078343 004 Jan 15, 2008
10MG A078343 003 Jan 15, 2008
GLENMARK PHARMS INC 5MG A078427 003 Dec 28, 2007
10MG A078427 004 Dec 28, 2007
GRANULES 10MG A209274 001 Dec 22, 2017
IPCA LABS LTD 5MG A202277 002 Mar 11, 2014
10MG A202277 004 Mar 11, 2014
MARKSANS PHARMA 5MG A078933 001 Jun 15, 2010
10MG A078933 002 Jun 15, 2010
MYLAN 5MG A076677 001 Dec 27, 2007
10MG A076677 002 Dec 27, 2007
ORBION PHARMS 5MG A078862 001 Feb 19, 2009
10MG A078862 002 Feb 19, 2009
PERRIGO R AND D 5MG A078336 001 Dec 27, 2007
10MG A078336 002 Dec 27, 2007
PLD ACQUISITIONS 5MG A077946 001 Dec 27, 2007
10MG A077946 002 Dec 27, 2007
SUN PHARM INDS LTD 5MG A077498 001 Dec 27, 2007
10MG A077498 002 Dec 27, 2007
TARO 5MG A078072 001 Jul 22, 2009
5MG A078072 003 Jul 22, 2009
UNIQUE 5MG A077829 001 Aug 26, 2009
10MG A077829 004 Aug 26, 2009
CETIRIZINE HYDROCHLORIDE HIVES
DR REDDYS LABS LTD 5MG A078343 001 Jan 15, 2008
10MG A078343 002 Jan 15, 2008
IPCA LABS LTD 5MG A202277 001 Mar 11, 2014
10MG A202277 003 Mar 11, 2014
MARKSANS PHARMA 5MG A078933 003 Jun 15, 2010
10MG A078933 004 Jun 15, 2010
MYLAN 5MG A076677 004 Dec 27, 2007
10MG A076677 003 Dec 27, 2007
ORBION PHARMS 5MG A078862 003 Feb 19, 2009
10MG A078862 004 Feb 19, 2009
PERRIGO R AND D 5MG A078336 003 Dec 27, 2007
10MG A078336 004 Dec 27, 2007
SUN PHARM INDS LTD 5MG A077498 003 Dec 27, 2007
10MG A077498 004 Dec 27, 2007
UNIQUE 5MG A077829 003 Aug 26, 2009
! 10MG A077829 002 Aug 26, 2009
CETIRIZINE HYDROCHLORIDE HIVES RELIEF
AMNEAL PHARMS NY 5MG A078780 003 Jan 21, 2010
10MG A078780 002 Jan 21, 2010
AUROBINDO PHARMA 5MG A090760 002 Aug 05, 2015
LTD
10MG A090760 004 Aug 05, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-4(of 20)

CETIRIZINE HYDROCHLORIDE
TABLET;ORAL
CETIRIZINE HYDROCHLORIDE HIVES RELIEF
TARO 10MG A078072 002 Jul 22, 2009
10MG A078072 004 Jul 22, 2009
ZYRTEC ALLERGY
+! J AND J CONSUMER 10MG N019835 004 Nov 16, 2007
INC
TABLET, CHEWABLE;ORAL
CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
JUBILANT GENERICS 5MG A091116 001 Feb 19, 2015
10MG A091116 002 Feb 19, 2015
NOVEL LABS INC 5MG A206793 001 Mar 08, 2016
10MG A206793 002 Mar 08, 2016
SANDOZ 5MG A078692 001 Feb 14, 2008
! 10MG A078692 002 Feb 14, 2008
SUN PHARM 5MG A090142 001 Aug 30, 2011
10MG A090142 002 Aug 30, 2011
CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
JUBILANT GENERICS 5MG A091116 003 Feb 19, 2015
10MG A091116 004 Feb 19, 2015
SUN PHARM 5MG A090142 003 Aug 30, 2011
10MG A090142 004 Aug 30, 2011
CHILDREN'S ZYRTEC ALLERGY
+ J AND J CONSUMER 2.5MG N021621 007 Nov 30, 2020
INC
+ 10MG N021621 004 Nov 16, 2007
TABLET, ORALLY DISINTEGRATING;ORAL
CETIRIZINE HYDROCHLORIDE
AUROBINDO PHARMA 10MG A213557 001 Sep 11, 2020
LTD
CETIRIZINE HYDROCHLORIDE ALLERGY
PERRIGO R AND D 10MG A205490 001 Sep 02, 2015
ZYRTEC ALLERGY
+! J AND J CONSUMER 10MG N022578 001 Sep 03, 2010
INC
CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
IVAX SUB TEVA 5MG;120MG A077170 001 Feb 25, 2008
PHARMS
PERRIGO R AND D 5MG;120MG A210719 001 Nov 16, 2018
PLD ACQUISITIONS 5MG;120MG A077991 001 Mar 05, 2008
SUN PHARM INDS LTD 5MG;120MG A090922 001 Sep 28, 2012
ZYRTEC-D 12 HOUR
+! J AND J CONSUMER 5MG;120MG N021150 002 Nov 09, 2007
INC
CHLORHEXIDINE GLUCONATE
AEROSOL, METERED;TOPICAL
EXIDINE
+! XTTRIUM 4% N019127 001 Dec 24, 1984
CLOTH;TOPICAL
CHLORHEXIDINE GLUCONATE
+! SAGE PRODS 2% N021669 001 Apr 25, 2005
READYPREP CHG
MEDLINE INDUSTRIES 2% N207964 001 Nov 20, 2018
SOLUTION;TOPICAL
CHG SCRUB
ECOLAB 4% N019258 002 Jul 22, 1986
CHLORHEXIDINE GLUCONATE
BAJAJ 0.75% N020111 001 Sep 11, 1997
CIDA-STAT
ECOLAB 2% N019258 001 Jul 22, 1986
EXIDINE
+! XTTRIUM 2% N019422 001 Dec 17, 1985
4% N019125 001 Dec 24, 1984
HIBICLENS
+! MOLNLYCKE HLTH 4% N017768 001
HIBISTAT
+! MOLNLYCKE HLTH 0.5% N018300 001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-5(of 20)

CHLORHEXIDINE GLUCONATE
SPONGE;TOPICAL
BIOSCRUB
GRIFFEN 4% N019822 001 Mar 31, 1989
CHLORHEXIDINE GLUCONATE
! BECTON DICKINSON 4% A072525 001 Oct 24, 1989
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL
SOLUTION;TOPICAL
SOLUPREP
+! 3M HEALTH CARE 2%;70% N208288 001 Aug 08, 2018
SPONGE;TOPICAL
CHLORAPREP ONE-STEP
+! BECTON DICKINSON CO 2%;70% (3ML) N020832 001 Jul 14, 2000
+! 2%;70% (10.5ML) N020832 004 Aug 20, 2003
+! 2%;70% (26ML) N020832 006 Nov 21, 2006
+! 2%;70% (1ML) N020832 008 Oct 23, 2008
CHLORAPREP ONE-STEP FREPP
+! BECTON DICKINSON CO 2%;70% (1.5ML) N020832 003 Apr 26, 2002
CHLORAPREP WITH TINT
+! BECTON DICKINSON CO 2%;70% (26ML) N020832 002 May 03, 2005
+! 2%;70% (10.5ML) N020832 005 Apr 03, 2006
+! 2%;70% (3ML) N020832 007 Oct 10, 2006
SWAB;TOPICAL
CHLORAPREP ONE-STEP SEPP
+! BECTON DICKINSON CO 2%;70% (0.67ML) N021555 001 Oct 07, 2002
CHLORAPREP SINGLE SWABSTICK
+! BECTON DICKINSON CO 2%;70% (1.75ML) N021555 002 May 10, 2005
CHLORAPREP TRIPLE SWABSTICK
+! BECTON DICKINSON CO 2%;70% (5.25ML) N021555 003 Jun 10, 2009
PREVANTICS MAXI SWABSTICK
+! PROF DSPLS 3.15%;70% (5.1ML) N021524 003 Jun 03, 2005
PREVANTICS SWAB
+! PROF DSPLS 3.15%;70% (1ML) N021524 001 Jun 03, 2005
PREVANTICS SWABSTICK
+! PROF DSPLS 3.15%;70% (1.6ML) N021524 002 Jun 03, 2005
CHLORPHENIRAMINE MALEATE
TABLET, EXTENDED RELEASE;ORAL
CHLORPHENIRAMINE MALEATE
! AVANTHI INC 12MG A040829 001 May 13, 2009
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE
TABLET;ORAL
ADVIL ALLERGY AND CONGESTION RELIEF
+! GLAXOSMITHKLINE 4MG;200MG;10MG N022113 001 Dec 21, 2011
ADVIL MULTI-SYMPTOM COLD & FLU
+! GLAXOSMITHKLINE 4MG;200MG;10MG N022113 002 Apr 28, 2017
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
SUSPENSION;ORAL
CHILDREN'S ADVIL ALLERGY SINUS
+! GLAXOSMITHKLINE 1MG/5ML;100MG/5ML;15MG/5ML N021587 001 Feb 24, 2004
TABLET;ORAL
ADVIL ALLERGY SINUS
+! GLAXOSMITHKLINE 2MG;200MG;30MG N021441 001 Dec 19, 2002
CIMETIDINE
TABLET;ORAL
CIMETIDINE
APOTEX 100MG A074948 001 Jun 19, 1998
200MG A074948 002 Jul 26, 2002
IVAX SUB TEVA 200MG A075345 001 Jun 16, 1999
PHARMS
L PERRIGO CO 200MG A075285 001 Oct 29, 1998
TAGAMET HB
+! MEDTECH PRODUCTS 200MG N020238 002 Aug 21, 1996
CLOTRIMAZOLE
CREAM;VAGINAL
CLOTRIMAZOLE
! P AND L 1% A074165 001 Jul 16, 1993
TARO 1% A072641 001 Dec 04, 1995
TRIVAGIZOLE 3
TARO 2% N021143 001 Apr 12, 2000
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-6(of 20)

CROMOLYN SODIUM
SPRAY, METERED;NASAL
CROMOLYN SODIUM
! BAUSCH AND LOMB 5.2MG/SPRAY A075702 001 Jul 03, 2001
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
TABLET, EXTENDED RELEASE;ORAL
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
ACTAVIS LABS FL 30MG;600MG A091070 001 Aug 31, 2015
60MG;1.2GM A091070 002 Aug 31, 2015
AMNEAL PHARMS 30MG;600MG A209692 001 Nov 01, 2018
60MG;1.2GM A209692 002 Nov 01, 2018
AUROBINDO PHARMA 30MG;600MG A206941 001 Mar 17, 2017
60MG;1.2GM A206941 002 Mar 17, 2017
PERRIGO R AND D 30MG;600MG A207602 002 Mar 05, 2018
60MG;1.2GM A207602 001 Mar 05, 2018
SUN PHARM 30MG;600MG A214781 001 Jul 01, 2021
60MG;1.2GM A214781 002 Jul 01, 2021
MUCINEX DM
+ RB HLTH 30MG;600MG N021620 002 Apr 29, 2004
+! 60MG;1.2GM N021620 001 Apr 29, 2004
DEXTROMETHORPHAN POLISTIREX
SUSPENSION, EXTENDED RELEASE;ORAL
DELSYM
+! RB HLTH EQ 30MG HYDROBROMIDE/5ML N018658 001 Oct 08, 1982
DEXTROMETHORPHAN POLISTIREX
AMNEAL EQ 30MG HYDROBROMIDE/5ML A203133 001 Jul 28, 2017
TRIS PHARMA INC EQ 30MG HYDROBROMIDE/5ML A091135 001 May 25, 2012
DICLOFENAC SODIUM
GEL;TOPICAL
DICLOFENAC SODIUM
AKORN 1% A209484 001 Nov 21, 2018
AMNEAL PHARMS 1% A208077 001 Mar 18, 2016
AUROLIFE PHARMA LLC 1% A204306 001 May 06, 2019
ENCUBE 1% A210986 001 Jan 27, 2020
PERRIGO PHARMA INTL 1% A211253 001 May 16, 2019
VOLTAREN ARTHRITIS PAIN
+! GLAXOSMITHKLINE 1% N022122 001 Oct 17, 2007
CONS
DIPHENHYDRAMINE CITRATE; IBUPROFEN
TABLET;ORAL
ADVIL PM
+! GLAXOSMITHKLINE 38MG;200MG N021394 001 Dec 21, 2005
IBUPROFEN AND DIPHENHYDRAMINE CITRATE
AUROBINDO PHARMA 38MG;200MG A216204 001 May 31, 2022
DR REDDYS LABS LTD 38MG;200MG A090619 001 Jul 08, 2009
PERRIGO R AND D 38MG;200MG A079113 001 Dec 22, 2008
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
CAPSULE;ORAL
ADVIL PM
+! GLAXOSMITHKLINE 25MG;EQ 200MG FREE ACID AND POTASSIUM N021393 001 Dec 21, 2005
SALT
IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE
AUROBINDO PHARMA 25MG;EQ 200MG FREE ACID AND POTASSIUM A210676 001 Feb 14, 2019
LTD SALT
BIONPHARMA INC 25MG;EQ 200MG FREE ACID AND POTASSIUM A090397 001 Nov 22, 2010
SALT
STRIDES PHARMA 25MG;EQ 200MG FREE ACID AND POTASSIUM A200888 001 Mar 05, 2012
SALT
DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
TABLET;ORAL
ALEVE PM
+! BAYER HLTHCARE 25MG;220MG N205352 001 Jan 17, 2014
NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
AMNEAL PHARMS CO 25MG;220MG A209726 001 Oct 23, 2018
APOTEX 25MG;220MG A211830 001 Aug 22, 2019
GRANULES 25MG;220MG A213663 001 Sep 24, 2020
PERRIGO R AND D 25MG;220MG A208499 001 May 10, 2019
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-7(of 20)

DOCOSANOL
CREAM;TOPICAL
ABREVA
+! GLAXOSMITHKLINE 10% N020941 001 Jul 25, 2000
DOCOSANOL
ALEOR 10% A215839 001 May 03, 2022
DERMACEUTICALS
ENCUBE 10% A212385 001 Oct 07, 2022
P AND L 10% A208754 001 Nov 19, 2018
DOXYLAMINE SUCCINATE
TABLET;ORAL
DOXYLAMINE SUCCINATE
LNK 25MG A040564 001 Aug 27, 2004
PERRIGO 25MG A040167 001 Sep 18, 1996
UNISOM
+! CHATTEM 25MG N018066 001
EPINEPHRINE
AEROSOL, METERED;INHALATION
PRIMATENE MIST
+! ARMSTRONG PHARMS 0.125MG/INH N205920 001 Nov 07, 2018
ESOMEPRAZOLE MAGNESIUM
CAPSULE, DELAYED RELEASE;ORAL
ESOMEPRAZOLE MAGNESIUM
AMNEAL PHARMS NY EQ 20MG BASE A209716 001 Jun 05, 2019
AUROBINDO PHARMA EQ 20MG BASE A209339 001 Oct 16, 2017
DR REDDYS EQ 20MG BASE A207673 001 May 15, 2018
GRAVITI PHARMS EQ 20MG BASE A216349 001 Jun 24, 2022
HETERO LABS LTD III EQ 20MG BASE A208939 001 May 28, 2020
EQ 20MG BASE A212507 001 Jun 02, 2020
PERRIGO R AND D EQ 20MG BASE A207193 001 Aug 18, 2017
SUN PHARM EQ 20MG BASE A212866 001 May 04, 2020
NEXIUM 24HR
+! ASTRAZENECA LP EQ 20MG BASE N204655 001 Mar 28, 2014
TABLET, DELAYED RELEASE;ORAL
ESOMEPRAZOLE MAGNESIUM
DR REDDYS EQ 20MG BASE A211571 001 May 14, 2020
MYLAN EQ 20MG BASE A212088 001 Jun 25, 2020
NEXIUM 24HR
+! ASTRAZENECA LP EQ 20MG BASE N207920 001 Nov 23, 2015
FAMOTIDINE
TABLET;ORAL
FAMOTIDINE
ANNORA PHARMA 10MG A215766 001 Nov 08, 2021
20MG A215766 002 Nov 08, 2021
ASCENT PHARMS INC 10MG A216030 001 Nov 03, 2021
20MG A216030 002 Nov 03, 2021
AUROBINDO PHARMA 10MG A206531 001 Apr 26, 2016
20MG A206531 002 Apr 26, 2016
DR REDDYS LABS LTD 10MG A077367 002 Aug 17, 2001
20MG A077367 001 Sep 25, 2006
GLENMARK PHARMS INC 10MG A077146 001 Mar 07, 2005
20MG A090837 001 Aug 04, 2010
P AND L 10MG A075512 001 Jul 26, 2001
PERRIGO 10MG A075400 001 Mar 18, 2005
PERRIGO R AND D 20MG A077351 001 Sep 25, 2006
SUN PHARM INDS LTD 10MG A090283 001 Nov 17, 2009
20MG A090283 002 Nov 17, 2009
VKT PHARMA 10MG A215822 001 Jan 28, 2022
20MG A215822 002 Jan 28, 2022
PEPCID AC
+ J AND J CONSUMER 10MG N020325 001 Apr 28, 1995
INC
10MG N020902 001 Aug 05, 1999
+! 20MG N020325 002 Sep 23, 2003
TABLET, CHEWABLE;ORAL
PEPCID AC
+! J AND J CONSUMER 20MG N020801 002 Dec 17, 2007
INC
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-8(of 20)

FEXOFENADINE HYDROCHLORIDE
SUSPENSION;ORAL
CHILDREN'S ALLEGRA ALLERGY
+! CHATTEM SANOFI 30MG/5ML N201373 001 Jan 24, 2011
CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY
P AND L 30MG/5ML A203330 001 Nov 18, 2014
TARO 30MG/5ML A208123 001 Nov 09, 2017
CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES
! P AND L 30MG/5ML A203330 002 Nov 18, 2014
TARO 30MG/5ML A208123 002 Nov 09, 2017
TABLET;ORAL
ALLEGRA ALLERGY
+ CHATTEM SANOFI 60MG N020872 007 Jan 24, 2011
+! 180MG N020872 010 Jan 24, 2011
ALLEGRA HIVES
+! CHATTEM SANOFI 180MG N020872 009 Jan 24, 2011
CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY
AUROLIFE PHARMA LLC 30MG A202039 001 Nov 19, 2014
DR REDDYS LABS LTD 30MG A076502 004 Apr 12, 2011
HETERO LABS LTD V 30MG A204097 001 Aug 19, 2016
TEVA 30MG A076447 004 Apr 13, 2011
WOCKHARDT 30MG A079112 002 Feb 08, 2012
CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES
DR REDDYS LABS LTD 30MG A076502 005 Apr 12, 2011
TEVA 30MG A076447 005 Apr 13, 2011
WOCKHARDT 30MG A079112 001 Feb 08, 2012
FEXOFENADINE HYDROCHLORIDE
L PERRIGO CO 60MG A212971 001 Feb 24, 2020
180MG A212971 002 Feb 24, 2020
FEXOFENADINE HYDROCHLORIDE ALLERGY
AUROLIFE PHARMA LLC 60MG A202039 002 Nov 19, 2014
180MG A202039 003 Nov 19, 2014
DR REDDYS LABS LTD 60MG A076502 006 Apr 12, 2011
180MG A076502 008 Apr 12, 2011
GRANULES 60MG A211075 001 Oct 18, 2019
180MG A211075 002 Oct 18, 2019
HETERO LABS LTD V 60MG A204097 002 Aug 19, 2016
180MG A204097 003 Aug 19, 2016
RISING 60MG A077081 006 Jul 21, 2011
180MG A077081 008 Jul 21, 2011
SCIEGEN PHARMS INC 60MG A204507 002 Sep 16, 2015
180MG A204507 003 Sep 16, 2015
SUN PHARM INDS 180MG A091567 006 Feb 06, 2012
TEVA 60MG A076447 006 Apr 13, 2011
180MG A076447 008 Apr 13, 2011
UNIQUE 180MG A210137 001 Aug 13, 2018
WOCKHARDT 60MG A079112 004 Feb 08, 2012
180MG A079112 006 Feb 08, 2012
FEXOFENADINE HYDROCHLORIDE HIVES
DR REDDYS LABS LTD 60MG A076502 007 Apr 12, 2011
180MG A076502 009 Apr 12, 2011
RISING 60MG A077081 007 Jul 21, 2011
180MG A077081 009 Jul 21, 2011
SCIEGEN PHARMS INC 60MG A204507 004 Sep 16, 2015
180MG A204507 005 Sep 16, 2015
SUN PHARM INDS 180MG A091567 005 Feb 06, 2012
TEVA 60MG A076447 007 Apr 13, 2011
WOCKHARDT 60MG A079112 003 Feb 08, 2012
180MG A079112 005 Feb 08, 2012
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION
+! CHATTEM SANOFI 60MG;120MG N020786 002 Jan 24, 2011
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION
+! CHATTEM SANOFI 180MG;240MG N021704 002 Jan 24, 2011
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
AUROBINDO PHARMA 60MG;120MG A209116 001 Oct 30, 2017
DR REDDYS 60MG;120MG A076667 001 Nov 18, 2014
60MG;120MG A215434 001 May 31, 2022
DR REDDYS LABS LTD 180MG;240MG A079043 002 Jun 22, 2011
SUN PHARM 60MG;120MG A090818 001 Jan 29, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-9(of 20)

FLUTICASONE FUROATE
SPRAY, METERED;NASAL
FLONASE SENSIMIST ALLERGY RELIEF
+! GLAXOSMITHKLINE 0.0275MG/SPRAY N022051 002 Aug 02, 2016
CONS
FLUTICASONE PROPIONATE
SPRAY, METERED;NASAL
FLONASE ALLERGY RELIEF
+ GLAXOSMITHKLINE 0.05MG/SPRAY N205434 001 Jul 23, 2014
CONS
FLUTICASONE PROPIONATE
AKORN 0.05MG/SPRAY A208024 001 Apr 17, 2019
APOTEX 0.05MG/SPRAY A208150 001 Feb 29, 2016
! HIKMA 0.05MG/SPRAY A207957 001 May 26, 2016
GUAIFENESIN
TABLET, EXTENDED RELEASE;ORAL
GUAIFENESIN
ACTAVIS LABS FL 1.2GM A091009 002 Sep 03, 2015
AMNEAL PHARMS 600MG A207342 001 Jul 11, 2018
1.2GM A207342 002 Jul 11, 2018
AUROBINDO PHARMA 600MG A210453 001 Oct 21, 2019
1.2GM A210453 002 Oct 21, 2019
DR REDDYS 600MG A215932 001 Mar 15, 2022
1.2GM A215932 002 Mar 15, 2022
GRANULES 600MG A213420 001 May 08, 2020
1.2GM A213420 002 May 08, 2020
GUARDIAN DRUG 600MG A209215 001 Sep 06, 2017
1.2GM A209215 002 Sep 06, 2017
OHM LABS INC 600MG A209254 001 Jul 16, 2018
1.2GM A209254 002 Jul 16, 2018
PERRIGO R AND D 600MG A078912 001 Nov 23, 2011
1.2GM A078912 002 Nov 05, 2020
MUCINEX
+ RB HLTH 600MG N021282 001 Jul 12, 2002
+! 1.2GM N021282 002 Dec 18, 2002
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE
ACTAVIS LABS FL 600MG;60MG A091071 001 May 27, 2015
1.2GM;120MG A091071 002 May 27, 2015
AUROBINDO PHARMA 600MG;60MG A213203 001 Mar 25, 2020
LTD
1.2GM;120MG A213203 002 Mar 25, 2020
DR REDDYS 600MG;60MG A208369 001 Dec 29, 2017
1.2GM;120MG A208369 002 Dec 29, 2017
GRANULES 600MG;60MG A216082 001 Aug 22, 2022
1.2GM;120MG A216082 002 Aug 22, 2022
L PERRIGO CO 600MG;60MG A214407 001 Feb 01, 2022
1.2GM;120MG A214407 002 Feb 01, 2022
SUN PHARM INDS INC 600MG;60MG A212542 001 Apr 28, 2020
1.2GM;120MG A212542 002 Apr 28, 2020
MUCINEX D
+ RB HLTH 600MG;60MG N021585 001 Jun 22, 2004
+! 1.2GM;120MG N021585 002 Jun 22, 2004
IBUPROFEN
CAPSULE;ORAL
ADVIL LIQUI-GELS
+! GLAXOSMITHKLINE EQ 200MG FREE ACID AND POTASSIUM SALT N020402 001 Apr 20, 1995
ADVIL MIGRAINE LIQUI-GELS
+! GLAXOSMITHKLINE EQ 200MG FREE ACID AND POTASSIUM SALT N020402 002 Mar 16, 2000
IBUPROFEN
AMNEAL PHARMS EQ 200MG FREE ACID AND POTASSIUM SALT A202300 001 Dec 23, 2011
ASCENT PHARMS INC EQ 200MG FREE ACID AND POTASSIUM SALT A206999 001 Dec 21, 2017
AUROBINDO PHARMA EQ 200MG FREE ACID AND POTASSIUM SALT A207753 001 Jun 29, 2018
LTD
BIONPHARMA INC EQ 200MG FREE ACID AND POTASSIUM SALT A078682 001 Mar 24, 2009
HUMANWELL PURACAP EQ 200MG FREE ACID AND POTASSIUM SALT A206568 001 Jun 21, 2016
MARKSANS PHARMA EQ 200MG FREE ACID AND POTASSIUM SALT A079205 001 Jun 26, 2009
P AND L DEV LLC EQ 200MG FREE ACID AND POTASSIUM SALT A077338 001 Jul 10, 2009
SOFGEN PHARMS EQ 200MG FREE ACID AND POTASSIUM SALT A203599 001 Sep 07, 2016
STRIDES PHARMA EQ 200MG FREE ACID AND POTASSIUM SALT A204469 001 Mar 28, 2018
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-10(of 20)

IBUPROFEN
CAPSULE;ORAL
MIDOL LIQUID GELS
+! BIONPHARMA INC 200MG N021472 001 Oct 18, 2002
SUSPENSION;ORAL
CHILDREN'S ADVIL
GLAXOSMITHKLINE 100MG/5ML N020589 001 Jun 27, 1996
CHILDREN'S ADVIL-FLAVORED
GLAXOSMITHKLINE 100MG/5ML N020589 002 Nov 07, 1997
CHILDREN'S IBUPROFEN
PERRIGO 100MG/5ML A074937 001 Dec 22, 1998
CHILDREN'S MOTRIN
+! J AND J CONSUMER 100MG/5ML N020516 001 Jun 16, 1995
INC
IBUPROFEN
APTAPHARMA INC 100MG/5ML A210602 001 Nov 23, 2018
ARISE 100MG/5ML A200457 001 Aug 18, 2011
AUROBINDO PHARMA 100MG/5ML A209179 001 Apr 17, 2018
LTD
GUARDIAN DRUG 100MG/5ML A210149 001 Aug 17, 2018
P AND L 100MG/5ML A074916 001 Apr 30, 1999
TARO 100MG/5ML A209207 001 Jun 27, 2017
SUSPENSION/DROPS;ORAL
CHILDREN'S MOTRIN
+! J AND J CONSUMER 40MG/ML N020603 001 Jun 10, 1996
INC
IBUPROFEN
GUARDIAN DRUG 40MG/ML A210755 001 Sep 26, 2018
L PERRIGO CO 40MG/ML A075217 001 Dec 16, 1998
TRIS PHARMA INC 40MG/ML A079058 001 Aug 31, 2009
INFANT'S ADVIL
+! GLAXOSMITHKLINE 50MG/1.25ML N020812 002 Jan 12, 2000
TABLET;ORAL
ADVIL
+! GLAXOSMITHKLINE 200MG N018989 001 May 18, 1984
IBUPROFEN
AMNEAL PHARMS 200MG A079233 001 Mar 18, 2014
AMNEAL PHARMS NY 200MG A071333 001 Feb 17, 1987
200MG A072199 001 May 23, 1988
AUROBINDO PHARMA 200MG A208865 001 Nov 08, 2017
AVEMA PHARMA 200MG A076460 001 Nov 26, 2003
CONTRACT PHARMACAL 200MG A072299 001 Jul 01, 1988
DR REDDYS LA 200MG A075661 001 Dec 12, 2001
DR REDDYS LABS INC 200MG A076117 001 Nov 20, 2001
GRANULES 200MG A202312 001 Oct 07, 2016
GRANULES INDIA 200MG A079174 001 Dec 10, 2010
LNK 200MG A075010 001 Mar 01, 1999
200MG A075139 001 Mar 01, 1999
MARKSANS PHARMA 200MG A091237 001 Feb 08, 2011
200MG A091239 001 Feb 01, 2011
MCNEIL 200MG A073019 001 Mar 30, 1994
OHM 200MG A071163 001 Jul 15, 1986
PERRIGO 200MG A072096 001 Dec 08, 1987
! PERRIGO R AND D 200MG A077349 001 Jun 21, 2005
SHANDONG XINHUA 200MG A207095 001 May 05, 2017
200MG A207095 002 Aug 21, 2018
STRIDES PHARMA 200MG A070481 001 Sep 24, 1986
200MG A079129 001 Mar 28, 2011
200MG A091355 001 Apr 04, 2011
200MG A206989 001 Jun 29, 2018
200MG A207052 001 May 30, 2017
VINTAGE PHARMS 200MG A071229 001 Apr 01, 1987
JUNIOR STRENGTH ADVIL
GLAXOSMITHKLINE 100MG N020267 002 Dec 13, 1996
JUNIOR STRENGTH MOTRIN
J AND J CONSUMER 100MG N020602 001 Jun 10, 1996
INC
MOTRIN IB
+ J AND J CONSUMER 200MG N019012 003 Dec 17, 1990
INC
TABLET, CHEWABLE;ORAL
CHILDREN'S ADVIL
GLAXOSMITHKLINE 50MG N020944 001 Dec 18, 1998
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-11(of 20)

IBUPROFEN
TABLET, CHEWABLE;ORAL
IBUPROFEN
! PERRIGO 100MG A076359 002 Jan 16, 2004
JUNIOR STRENGTH ADVIL
GLAXOSMITHKLINE 100MG N020944 002 Dec 18, 1998
IBUPROFEN SODIUM
TABLET;ORAL
ADVIL
+! GLAXOSMITHKLINE EQ 200MG BASE N201803 001 Jun 12, 2012
IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE
TABLET;ORAL
ADVIL CONGESTION RELIEF
+! GLAXOSMITHKLINE 200MG;10MG N022565 001 May 27, 2010
IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
PERRIGO R AND D 200MG;10MG A203200 001 Jul 03, 2014
IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
CAPSULE;ORAL
ADVIL COLD AND SINUS
+! GLAXOSMITHKLINE EQ 200MG FREE ACID AND POTASSIUM N021374 001 May 30, 2002
SALT;30MG
IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE
AUROBINDO PHARMA EQ 200MG FREE ACID AND POTASSIUM A209235 001 Dec 01, 2017
SALT;30MG
SUSPENSION;ORAL
CHILDREN'S ADVIL COLD
GLAXOSMITHKLINE 100MG/5ML;15MG/5ML N021373 001 Apr 18, 2002
CHILDREN'S MOTRIN COLD
+! J AND J CONSUMER 100MG/5ML;15MG/5ML N021128 001 Aug 01, 2000
INC
TABLET;ORAL
ADVIL COLD AND SINUS
+! GLAXOSMITHKLINE 200MG;30MG N019771 001 Sep 19, 1989
IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE
DR REDDYS LABS LTD 200MG;30MG A077628 001 Aug 14, 2006
IBUPROHM COLD AND SINUS
OHM LABS 200MG;30MG A074567 001 Apr 17, 2001
SINE-AID IB
J AND J CONSUMER 200MG;30MG N019899 001 Dec 31, 1992
INC
IODINE POVACRYLEX; ISOPROPYL ALCOHOL
SPONGE;TOPICAL
DURAPREP
+! 3M EQ 0.7% IODINE;74% (6ML) N021586 001 Sep 29, 2006
+! EQ 0.7% IODINE;74% (26ML) N021586 002 Sep 29, 2006
ISOPROPYL ALCOHOL
SOLUTION;TOPICAL
ZURAGARD
+! ZUREX PHARMA 70% N210872 001 Apr 26, 2019
IVERMECTIN
LOTION;TOPICAL
IVERMECTIN
TARO 0.5% A210720 001 May 06, 2020
SKLICE
+! ARBOR PHARMS LLC 0.5% N202736 001 Feb 07, 2012
KETOCONAZOLE
SHAMPOO;TOPICAL
NIZORAL ANTI-DANDRUFF
+! KRAMER 1% N020310 001 Oct 10, 1997
KETOTIFEN FUMARATE
SOLUTION/DROPS;OPHTHALMIC
ALAWAY
+! BAUSCH AND LOMB EQ 0.025% BASE N021996 001 Dec 01, 2006
BAUSCH AND LOMB INC EQ 0.025% BASE A208158 001 Sep 24, 2020
CHILDREN'S ALAWAY
+ BAUSCH AND LOMB EQ 0.025% BASE N021996 002 Feb 11, 2015
KETOTIFEN FUMARATE
AKORN EQ 0.025% BASE A077958 001 Jul 26, 2007
APOTEX INC EQ 0.025% BASE A077354 001 May 09, 2006
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-12(of 20)

KETOTIFEN FUMARATE
SOLUTION/DROPS;OPHTHALMIC
KETOTIFEN FUMARATE
BAYSHORE PHARMS LLC EQ 0.025% BASE A204059 001 Jun 01, 2020
ZADITOR
! ALCON PHARMS LTD EQ 0.025% BASE A077200 001 Sep 02, 2008
LANSOPRAZOLE
CAPSULE, DELAYED REL PELLETS;ORAL
LANSOPRAZOLE
DR REDDYS LABS LTD 15MG A202194 001 May 18, 2012
GLENMARK PHARMS INC 15MG A202727 001 May 18, 2012
MYLAN 15MG A203187 001 Jun 01, 2016
NATCO 15MG A203306 001 Jan 13, 2016
PERRIGO R AND D 15MG A202319 001 May 18, 2012
PREVACID 24 HR
+! PERRIGO PHARMA INTL 15MG N022327 001 May 18, 2009
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
LANSOPRAZOLE
DEXCEL 15MG N208025 001 Jun 07, 2016
LEVOCETIRIZINE DIHYDROCHLORIDE
SOLUTION;ORAL
XYZAL ALLERGY 24HR
+! CHATTEM SANOFI 2.5MG/5ML N209090 001 Jan 31, 2017
TABLET;ORAL
LEVOCETIRIZINE DIHYDROCHLORIDE
APOTEX 5MG A211443 001 Apr 21, 2021
DR REDDYS 5MG A210375 001 Jan 19, 2018
HETERO LABS LTD III 5MG A213513 001 Apr 29, 2020
MICRO LABS 5MG A211551 001 Nov 20, 2018
PERRIGO R AND D 5MG A211983 001 Mar 28, 2019
XYZAL ALLERGY 24HR
+! CHATTEM SANOFI 5MG N209089 001 Jan 31, 2017
LEVONORGESTREL
TABLET;ORAL
ATHENTIA NEXT
AUROBINDO PHARMA 1.5MG A206867 001 Dec 08, 2015
FALLBACK SOLO
LUPIN LTD 1.5MG A201446 001 Jun 19, 2014
HER STYLE
NOVAST LABS 1.5MG A207976 001 Mar 11, 2016
LEVONORGESTREL
GLENMARK PHARMS LTD 1.5MG A207044 001 Mar 25, 2016
LABORATOIRE HRA 1.5MG A204044 001 Jul 03, 2018
MYLAN LABS LTD 1.5MG A202739 001 Oct 31, 2014
NAARI PTE LTD 1.5MG A202380 001 May 29, 2015
NOVEL LABS INC 1.5MG A202508 001 Feb 22, 2013
PERRIGO R AND D 1.5MG A202334 001 Aug 20, 2014
XIROMED 1.5MG A205329 001 Sep 18, 2018
OPCICON ONE-STEP
SUN PHARM 1.5MG A202635 001 Sep 11, 2014
PLAN B ONE-STEP
+! FDN CONSUMER 1.5MG N021998 001 Jul 10, 2009
LOPERAMIDE HYDROCHLORIDE
CAPSULE;ORAL
LOPERAMIDE HYDROCHLORIDE
+ BIONPHARMA INC 1MG N021855 001 Aug 04, 2005
+! 2MG N021855 002 Aug 04, 2005
STRIDES PHARMA 2MG A213070 001 Aug 11, 2021
SOLUTION;ORAL
IMODIUM A-D
+! J AND J CONSUMER 1MG/5ML N019487 001 Mar 01, 1988
INC
LOPERAMIDE HYDROCHLORIDE
WOCKHARDT BIO AG 1MG/5ML A074730 001 Aug 28, 1997
SUSPENSION;ORAL
IMODIUM A-D
+! J AND J CONSUMER 1MG/7.5ML N019487 002 Jul 08, 2004
INC
LOPERAMIDE HYDROCHLORIDE
PERRIGO R AND D 1MG/7.5ML A091292 001 May 20, 2011
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-13(of 20)

LOPERAMIDE HYDROCHLORIDE
TABLET;ORAL
IMODIUM A-D
+! J AND J CONSUMER 2MG N019860 001 Nov 22, 1989
INC
LOPERAMIDE HYDROCHLORIDE
AUROBINDO PHARMA 2MG A206548 001 Dec 15, 2015
L PERRIGO CO 2MG A075232 001 Jan 06, 2000
LNK 2MG A076497 001 Jun 10, 2003
OHM LABS 2MG A074091 001 Dec 10, 1992
LOPERAMIDE HYDROCHLORIDE; SIMETHICONE
TABLET;ORAL
IMODIUM MULTI-SYMPTOM RELIEF
+! J AND J CONSUMER 2MG;125MG N021140 001 Nov 30, 2000
INC
LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE
AUROBINDO PHARMA 2MG;125MG A211059 001 Dec 14, 2020
LTD
BIONPHARMA INC 2MG;125MG A213484 001 Sep 10, 2021
GRANULES 2MG;125MG A215981 001 Aug 29, 2022
GUARDIAN DRUG 2MG;125MG A214541 001 May 27, 2021
HETERO LABS LTD V 2MG;125MG A211438 001 Jun 17, 2021
PERRIGO R AND D 2MG;125MG A209837 001 Sep 05, 2018
SUN PHARM INDS LTD 2MG;125MG A077500 001 Sep 06, 2006
LORATADINE
CAPSULE;ORAL
CLARITIN
+! BAYER HEALTHCARE 10MG N021952 001 Jun 16, 2008
LLC
LORATADINE
BIONPHARMA INC 10MG A202538 001 Dec 21, 2018
MARKSANS PHARMA 10MG A206214 001 Sep 23, 2016
SUSPENSION;ORAL
LORATADINE
+! TARO 1MG/ML N021734 001 Oct 04, 2005
SYRUP;ORAL
CLARITIN
+! BAYER HEALTHCARE 1MG/ML N020641 002 Nov 27, 2002
LLC
LORATADINE
AUROBINDO PHARMA 1MG/ML A208931 001 Jun 29, 2018
LTD
HETERO LABS LTD III 1MG/ML A210409 001 May 07, 2021
LANNETT CO INC 1MG/ML A077421 001 Jun 29, 2006
PERRIGO 1MG/ML A075728 001 Aug 20, 2004
TARO 1MG/ML A076805 001 Aug 20, 2004
1MG/ML A201865 001 Jul 31, 2015
WOCKHARDT BIO AG 1MG/ML A075815 001 Aug 20, 2004
TABLET;ORAL
CLARITIN
+! BAYER HEALTHCARE 10MG N019658 002 Nov 27, 2002
LLC
CLARITIN HIVES RELIEF
+! BAYER HEALTHCARE 10MG N019658 003 Nov 19, 2003
LLC
LORATADINE
APOTEX INC 10MG A076471 001 Feb 14, 2006
APPCO 10MG A207569 001 Mar 12, 2019
AUROBINDO PHARMA 10MG A208314 001 Apr 16, 2018
LTD
GRANULES 10MG A210722 001 Dec 23, 2019
MYLAN 10MG A076154 001 Aug 20, 2003
PERRIGO 10MG A076301 001 Jun 25, 2004
PLD ACQUISITIONS 10MG A075209 001 Jan 21, 2003
LLC
SUN PHARM INDS LTD 10MG A076134 001 Aug 18, 2003
UNIQUE PHARM 10MG A214684 001 Jan 07, 2021
TABLET, CHEWABLE;ORAL
CHILDREN'S CLARITIN
+ BAYER HEALTHCARE 5MG N021891 001 Aug 23, 2006
LLC
CLARITIN
+! BAYER HEALTHCARE 10MG N021891 002 Nov 21, 2018
LLC
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-14(of 20)

LORATADINE
TABLET, CHEWABLE;ORAL
LORATADINE
PERRIGO PHARMA INTL 5MG A210033 001 Jun 12, 2019
SUN PHARM 5MG A210088 001 Apr 16, 2018
TABLET, ORALLY DISINTEGRATING;ORAL
ALAVERT
FDN CONSUMER 10MG N021375 001 Dec 19, 2002
CLARITIN HIVES RELIEF REDITAB
+! BAYER HEALTHCARE 10MG N020704 003 Nov 19, 2003
LLC
CLARITIN REDITABS
+! BAYER HEALTHCARE 5MG N021993 001 Dec 12, 2006
LLC
+! 10MG N020704 002 Nov 27, 2002
LORATADINE
AUROBINDO PHARMA 10MG A208477 001 Apr 11, 2018
LTD
PERRIGO PHARMA INTL 10MG A076011 001 Sep 29, 2003
RUBICON 10MG A214280 001 Sep 10, 2020
TENSHI 5MG A212795 001 Sep 18, 2020
10MG A213294 001 Oct 30, 2020
LORATADINE REDIDOSE
SUN PHARM INDS LTD 10MG A077153 001 Apr 11, 2007
LORATADINE; PSEUDOEPHEDRINE SULFATE
TABLET, EXTENDED RELEASE;ORAL
CLARITIN-D
+! BAYER HEALTHCARE 5MG;120MG N019670 002 Nov 27, 2002
LLC
CLARITIN-D 24 HOUR
+! BAYER HEALTHCARE 10MG;240MG N020470 002 Nov 27, 2002
LLC
LORATADINE AND PSEUDOEPHEDRINE SULFATE
P AND L 10MG;240MG A075706 001 Feb 21, 2003
PERRIGO PHARMA INTL 5MG;120MG A076050 001 Jan 30, 2003
10MG;240MG A075989 001 Mar 04, 2004
SUN PHARM INDS LTD 10MG;240MG A076557 001 Sep 22, 2004
MENTHOL; METHYL SALICYLATE
PATCH;TOPICAL
SALONPAS
+! HISAMITSU PHARM CO 3%;10% N022029 001 Feb 20, 2008
+ 3%;10% N022029 002 Nov 05, 2012
MICONAZOLE NITRATE
CREAM;TOPICAL, VAGINAL
MICONAZOLE 3 COMBINATION PACK
PERRIGO 2%,4% A076357 001 Mar 30, 2004
MONISTAT 3 COMBINATION PACK
+ MEDTECH PRODUCTS 2%,4% N021261 003 Jun 17, 2003
MONISTAT 3 COMBINATION PACK (PREFILLED)
+! MEDTECH PRODUCTS 2%,4% N021261 001 Feb 02, 2001
CREAM;VAGINAL
MICONAZOLE 3
TARO 4% A076773 001 Mar 02, 2005
MICONAZOLE 7
P AND L 2% A074164 001 Mar 29, 1996
MICONAZOLE NITRATE
COSETTE 2% A074366 001 Feb 22, 1996
PERRIGO 2% A074760 001 May 15, 1997
PERRIGO R AND D 4% A091366 001 Jan 15, 2010
TARO PHARMS 2% A074444 001 Jan 13, 1997
MONISTAT 3
+! MEDTECH PRODUCTS 4% N020827 001 Mar 30, 1998
MONISTAT 7
+! MEDTECH PRODUCTS 2% N017450 002 Feb 15, 1991
CREAM, INSERT;TOPICAL, VAGINAL
MICONAZOLE NITRATE
PERRIGO R AND D 2%,1.2GM A079114 001 Jun 02, 2010
MONISTAT 1 COMBINATION PACK
+! MEDTECH PRODUCTS 2%,1.2GM N021308 001 Jun 29, 2001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-15(of 20)

MICONAZOLE NITRATE
CREAM, SUPPOSITORY;TOPICAL, VAGINAL
M-ZOLE 3 COMBINATION PACK
P AND L 2%,200MG A074926 001 Apr 16, 1999
MICONAZOLE NITRATE COMBINATION PACK
L PERRIGO CO 2%,200MG A075329 001 Apr 20, 1999
MONISTAT 3 COMBINATION PACK
+! MEDTECH PRODUCTS 2%,200MG N020670 002 Apr 16, 1996
MONISTAT 7 COMBINATION PACK
+! MEDTECH PRODUCTS 2%,100MG N020288 002 Apr 26, 1993
SUPPOSITORY;VAGINAL
MICONAZOLE NITRATE
COSETTE 100MG A074414 001 Apr 30, 1997
P AND L 100MG A073507 001 Nov 19, 1993
MONISTAT 7
+! MEDTECH PRODUCTS 100MG N018520 002 Feb 15, 1991
MINOXIDIL
AEROSOL, FOAM;TOPICAL
MEN'S ROGAINE
+! JOHNSON AND JOHNSON 5% N021812 001 Jan 20, 2006
MINOXIDIL
PERRIGO PHARMA INTL 5% A091344 001 Apr 28, 2011
MINOXIDIL (FOR MEN)
P AND L 5% A208092 001 Feb 17, 2017
TARO 5% A209074 001 Dec 31, 2018
MINOXIDIL (FOR WOMEN)
P AND L 5% A208092 002 Jul 27, 2017
TARO 5% A209074 002 Apr 22, 2019
WOMEN'S ROGAINE
+! JOHNSON AND JOHNSON 5% N021812 002 Feb 28, 2014
SOLUTION;TOPICAL
MINOXIDIL (FOR MEN)
L PERRIGO CO 2% A075357 001 Jul 30, 1999
P AND L 2% A074588 001 Apr 05, 1996
WOCKHARDT BIO AG 2% A074767 001 Feb 28, 1997
MINOXIDIL (FOR WOMEN)
L PERRIGO CO 2% A075357 002 Jul 30, 1999
MINOXIDIL EXTRA STRENGTH (FOR MEN)
P AND L 5% A075518 001 Nov 17, 2000
PERRIGO 5% A075598 001 Jun 13, 2001
WOCKHARDT BIO AG 5% A075438 001 Feb 27, 2003
ROGAINE (FOR MEN)
+! JOHNSON AND JOHNSON 2% N019501 002 Feb 09, 1996
ROGAINE (FOR WOMEN)
+! JOHNSON AND JOHNSON 2% N019501 003 Feb 09, 1996
ROGAINE EXTRA STRENGTH (FOR MEN)
+! JOHNSON AND JOHNSON 5% N020834 001 Nov 14, 1997
THEROXIDIL
PURE SOURCE 2% A078176 001 Nov 09, 2007
5% A076239 001 Aug 24, 2004
MOMETASONE FUROATE
SPRAY, METERED;NASAL
NASONEX 24HR ALLERGY
+! PERRIGO PHARMA INTL 0.05MG/SPRAY N215712 001 Mar 17, 2022
NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE
SOLUTION/DROPS;OPHTHALMIC
NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
AKORN 0.025%;0.3% A202795 001 Jan 24, 2013
ALTAIRE PHARMS INC 0.02675%;0.315% A078208 001 Sep 27, 2010
NAPHCON-A
+! ALCON 0.025%;0.3% N020226 001 Jun 08, 1994
OPCON-A
+! BAUSCH AND LOMB 0.02675%;0.315% N020065 001 Jun 08, 1994
VISINE
+! JOHNSON AND JOHNSON 0.025%;0.3% N020485 001 Jan 31, 1996
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-16(of 20)

NAPROXEN SODIUM
CAPSULE;ORAL
NAPROXEN SODIUM
+! BIONPHARMA INC EQ 200MG BASE N021920 001 Feb 17, 2006
CATALENT EQ 200MG BASE A202807 001 Jan 04, 2019
PATHEON SOFTGELS EQ 200MG BASE A214463 001 Jan 10, 2023
PURACAP PHARM LLC EQ 200MG BASE A208363 001 Mar 15, 2018
STRIDES PHARMA EQ 200MG BASE A215472 001 Aug 17, 2022
TABLET;ORAL
ALEVE
+! BAYER 220MG N020204 002 Jan 11, 1994
NAPROXEN SODIUM
AMNEAL PHARMS NY 220MG A079096 001 Dec 16, 2008
AUROBINDO PHARMA 220MG A205497 001 Mar 18, 2016
LTD
CONTRACT PHARMACAL 220MG A074635 001 Jan 13, 1997
DR REDDYS LABS INC 220MG A075168 001 Jul 28, 1998
GRANULES INDIA 220MG A091353 001 Sep 20, 2011
HETERO LABS LTD V 220MG A211065 001 Oct 28, 2022
LNK INTL INC 220MG A204872 001 Jan 23, 2017
MARKSANS PHARMA 220MG A090545 001 Mar 16, 2011
NOVELGENIX THERAPS 220MG A207612 001 Nov 16, 2018
PERRIGO 220MG A074661 001 Jan 13, 1997
SUN PHARM INDS LTD 220MG A091183 001 May 20, 2011
YICHANG HUMANWELL 220MG A212033 001 Aug 30, 2019
NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE
DR REDDYS LABS INC 220MG;120MG A077381 001 Sep 27, 2006
! PERRIGO 220MG;120MG A076518 001 Mar 17, 2004
NICOTINE
FILM, EXTENDED RELEASE;TRANSDERMAL
HABITROL
+ DR REDDYS LABS SA 7MG/24HR N020076 004 Nov 12, 1999
+ 14MG/24HR N020076 005 Nov 12, 1999
+! 21MG/24HR N020076 006 Nov 12, 1999
NICODERM CQ
+ CHATTEM SANOFI 7MG/24HR N020165 006 Aug 02, 1996
+ 14MG/24HR N020165 005 Aug 02, 1996
+! 21MG/24HR N020165 004 Aug 02, 1996
NICOTINE
AVEVA 7MG/24HR A074612 002 Jul 28, 2003
14MG/24HR A074612 003 Oct 20, 1997
21MG/24HR A074612 001 Oct 20, 1997
NICOTINE POLACRILEX
GUM, CHEWING;BUCCAL
NICORETTE
+ GLAXOSMITHKLINE EQ 2MG BASE N018612 002 Feb 09, 1996
+ EQ 2MG BASE N018612 004 Sep 25, 2000
+! EQ 4MG BASE N020066 002 Feb 09, 1996
+ EQ 4MG BASE N020066 004 Sep 25, 2000
NICORETTE (MINT)
+ GLAXOSMITHKLINE EQ 2MG BASE N018612 003 Dec 23, 1998
+ EQ 4MG BASE N020066 003 Dec 23, 1998
NICOTINE POLACRILEX
FERTIN PHARMA EQ 4MG BASE A214354 001 Dec 21, 2022
L PERRIGO CO EQ 2MG BASE A076775 001 Sep 16, 2004
EQ 2MG BASE A076777 001 Sep 16, 2004
EQ 4MG BASE A076779 001 Sep 16, 2004
EQ 4MG BASE A076789 001 Sep 16, 2004
P AND L EQ 2MG BASE A074507 001 Mar 15, 1999
EQ 2MG BASE A076569 001 Jul 29, 2004
EQ 2MG BASE A078699 001 Dec 29, 2008
EQ 2MG BASE A079044 001 Jul 08, 2009
EQ 2MG BASE A079216 001 Jul 08, 2009
EQ 2MG BASE A204794 001 May 10, 2016
EQ 4MG BASE A074707 001 Mar 19, 1999
EQ 4MG BASE A076568 002 Jul 29, 2004
EQ 4MG BASE A078697 001 Dec 29, 2008
EQ 4MG BASE A079038 001 Jul 08, 2009
EQ 4MG BASE A079219 001 Jul 08, 2009
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-17(of 20)

NICOTINE POLACRILEX
GUM, CHEWING;BUCCAL
NICOTINE POLACRILEX
EQ 4MG BASE A204833 001 Feb 26, 2016
PERRIGO R AND D EQ 2MG BASE A078325 001 Oct 30, 2006
EQ 2MG BASE A078547 001 May 24, 2007
EQ 2MG BASE A091349 001 Jul 20, 2011
EQ 2MG BASE A206394 001 Dec 15, 2016
EQ 4MG BASE A078326 001 Oct 30, 2006
EQ 4MG BASE A078546 001 May 24, 2007
EQ 4MG BASE A091354 001 Jul 20, 2011
EQ 4MG BASE A206393 001 Dec 15, 2016
TROCHE/LOZENGE;ORAL
NICORETTE
+ GLAXOSMITHKLINE EQ 2MG BASE N022360 001 May 18, 2009
+! EQ 4MG BASE N022360 002 May 18, 2009
+ GLAXOSMITHKLINE EQ 2MG BASE N021330 001 Oct 31, 2002
CONS
+! EQ 4MG BASE N021330 002 Oct 31, 2002
NICOTINE POLACRILEX
AUROBINDO PHARMA EQ 2MG BASE A213266 001 Aug 03, 2021
EQ 4MG BASE A213266 002 Aug 03, 2021
AUROBINDO PHARMA EQ 2MG BASE A215357 001 May 13, 2022
LTD
EQ 4MG BASE A215357 002 May 13, 2022
DR REDDYS LABS SA EQ 2MG BASE A212796 001 Jan 08, 2020
EQ 2MG BASE A212983 001 Feb 21, 2020
EQ 2MG BASE A213233 001 Aug 04, 2020
EQ 4MG BASE A212796 002 Jan 08, 2020
EQ 4MG BASE A212983 002 Feb 21, 2020
EQ 4MG BASE A213233 002 Aug 04, 2020
P AND L EQ 2MG BASE A208875 001 Oct 31, 2019
EQ 2MG BASE A209206 001 Jun 26, 2018
EQ 2MG BASE A209519 001 Jul 02, 2018
EQ 2MG BASE A209520 001 Oct 31, 2019
EQ 2MG BASE A210711 001 Oct 31, 2019
EQ 2MG BASE A210712 001 Sep 06, 2019
EQ 2MG BASE A212056 001 Jul 26, 2019
EQ 2MG BASE A212057 001 May 14, 2020
EQ 4MG BASE A208875 002 Oct 31, 2019
EQ 4MG BASE A209206 002 Jun 26, 2018
EQ 4MG BASE A209519 002 Jul 02, 2018
EQ 4MG BASE A209520 002 Oct 31, 2019
EQ 4MG BASE A210711 002 Oct 31, 2019
EQ 4MG BASE A210712 002 Sep 06, 2019
EQ 4MG BASE A212056 002 Jul 26, 2019
EQ 4MG BASE A212057 002 May 14, 2020
PERRIGO R AND D EQ 2MG BASE A077007 001 Jan 31, 2006
EQ 2MG BASE A090711 001 Jul 10, 2009
EQ 2MG BASE A090821 001 Jul 10, 2009
EQ 2MG BASE A203690 001 Oct 09, 2012
EQ 4MG BASE A077007 002 Jan 31, 2006
EQ 4MG BASE A090711 002 Jul 10, 2009
EQ 4MG BASE A090821 002 Jul 10, 2009
EQ 4MG BASE A203690 002 Oct 09, 2012
PLD ACQUISITIONS EQ 2MG BASE A207868 001 Feb 07, 2019
EQ 4MG BASE A207868 002 Feb 07, 2019
NIZATIDINE
TABLET;ORAL
AXID AR
+! GLAXOSMITHKLINE 75MG N020555 001 May 09, 1996
OLOPATADINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
OLOPATADINE HYDROCHLORIDE
AKORN EQ 0.1% BASE A204532 001 Jan 10, 2017
EQ 0.2% BASE A204723 001 Dec 05, 2017
ALEMBIC PHARMS EQ 0.1% BASE A209919 001 Dec 07, 2018
EQ 0.2% BASE A209420 001 Apr 29, 2019
APOTEX EQ 0.1% BASE A078350 001 Dec 07, 2015
APOTEX INC EQ 0.2% BASE A090918 001 Dec 05, 2017
BARR LABS INC EQ 0.2% BASE A090848 001 Jul 13, 2015
EUGIA PHARMA EQ 0.1% BASE A204812 001 Dec 18, 2015
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-18(of 20)

OLOPATADINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
OLOPATADINE HYDROCHLORIDE
EQ 0.2% BASE A209995 001 Apr 04, 2019
GLAND PHARMA LTD EQ 0.1% BASE A209619 001 Aug 02, 2019
EQ 0.2% BASE A209752 001 May 20, 2020
USV EQ 0.1% BASE A203152 001 Dec 07, 2015
PATADAY ONCE DAILY RELIEF
+! ALCON LABS INC EQ 0.2% BASE N021545 001 Dec 22, 2004
+! EQ 0.7% BASE N206276 001 Jan 30, 2015
PATADAY TWICE DAILY RELIEF
+! ALCON LABS INC EQ 0.1% BASE N020688 001 Dec 18, 1996
OMEPRAZOLE
TABLET, DELAYED RELEASE;ORAL
OMEPRAZOLE
APOTEX 20MG A210070 001 Feb 11, 2019
+! DEXCEL PHARMA 20MG N022032 001 Dec 04, 2007
DR REDDYS 20MG A207740 001 Nov 05, 2018
SUN PHARM 20MG A207891 001 Oct 12, 2018
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
OMEPRAZOLE
+! DEXCEL 20MG N209400 001 Jul 05, 2017
OMEPRAZOLE MAGNESIUM
CAPSULE, DELAYED RELEASE;ORAL
OMEPRAZOLE MAGNESIUM
! DR REDDYS LABS LTD EQ 20MG BASE A078878 001 Jun 05, 2009
L PERRIGO CO EQ 20MG BASE A216096 001 May 24, 2022
SPIL EQ 20MG BASE A210593 001 Jul 20, 2018
TABLET, DELAYED RELEASE;ORAL
OMEPRAZOLE MAGNESIUM
AUROBINDO PHARMA EQ 20MG BASE A206877 001 Jun 06, 2018
HETERO LABS LTD III EQ 20MG BASE A211732 001 Mar 25, 2020
P AND L EQ 20MG BASE A206582 001 Jun 01, 2020
PRILOSEC OTC
+! ASTRAZENECA EQ 20MG BASE N021229 001 Jun 20, 2003
OMEPRAZOLE; SODIUM BICARBONATE
CAPSULE;ORAL
OMEPRAZOLE AND SODIUM BICARBONATE
AUROLIFE PHARMA LLC 20MG;1.1GM A204923 001 Nov 07, 2016
PERRIGO R AND D 20MG;1.1GM A201361 001 Jul 15, 2016
ZYDUS PHARMS 20MG;1.1GM A203345 001 Mar 16, 2018
ZEGERID OTC
+! RILEY CONSUMER 20MG;1.1GM N022281 001 Dec 01, 2009
FOR SUSPENSION;ORAL
ZEGERID OTC
+! RILEY CONSUMER 20MG/PACKET;1.68GM/PACKET N022283 001 Jun 17, 2013
ORLISTAT
CAPSULE;ORAL
ALLI
+! GLAXOSMITHKLINE 60MG N021887 001 Feb 07, 2007
CONS
OXYBUTYNIN
FILM, EXTENDED RELEASE;TRANSDERMAL
OXYTROL FOR WOMEN
+! ALLERGAN 3.9MG/24HR N202211 001 Jan 25, 2013
OXYMETAZOLINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
VISINE L.R.
+! JOHNSON AND JOHNSON 0.025% N019407 001 Mar 31, 1989
PERMETHRIN
LOTION;TOPICAL
NIX
+! MEDTECH PRODUCTS 1% N019918 001 May 02, 1990
PERMETHRIN
ACTAVIS MID 1% A075014 001 Mar 28, 2000
ATLANTIC
PERRIGO NEW YORK 1% A076090 001 Dec 20, 2001
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-19(of 20)

POLYETHYLENE GLYCOL 3350


FOR SOLUTION;ORAL
MIRALAX
+! BAYER HEALTHCARE 17GM/SCOOPFUL N022015 001 Oct 06, 2006
LLC
POLYETHYLENE GLYCOL 3350
ANI PHARMS 17GM/SCOOPFUL A202850 001 Dec 15, 2015
ANNORA PHARMA 17GM/SCOOPFUL A214990 001 Apr 14, 2021
AUROBINDO PHARMA 17GM/SCOOPFUL A209017 001 Apr 09, 2018
LTD
LGM PHARMA 17GM/SCOOPFUL A090812 001 Oct 07, 2009
MYLAN 17GM/PACKET A078915 001 Oct 06, 2009
17GM/SCOOPFUL A078915 002 Oct 06, 2009
NOVEL LABS INC 17GM/SCOOPFUL A091077 001 Oct 06, 2009
NOVELGENIX THERAPS 17GM/SCOOPFUL A202071 001 Dec 28, 2012
NUVO PHARMS INC 17GM/SCOOPFUL A206105 001 Oct 28, 2016
PERRIGO R AND D 17GM/PACKET A090685 001 Oct 06, 2009
17GM/SCOOPFUL A090685 002 Oct 06, 2009
STRIDES PHARMA 17GM/SCOOPFUL A079214 001 Jan 31, 2013
17GM/SCOOPFUL A203928 001 Aug 24, 2016
17GM/PACKET A203928 002 Aug 24, 2016
POTASSIUM IODIDE
SOLUTION;ORAL
POTASSIUM IODIDE
! MISSION PHARMACAL 65MG/ML A206211 001 Mar 24, 2016
CO
TABLET;ORAL
IOSAT
+ ANBEX 65MG N018664 002 May 12, 2011
+! 130MG N018664 001 Oct 14, 1982
THYROSAFE
! BTG INTL 65MG A076350 001 Sep 10, 2002
POVIDONE-IODINE
SOLUTION;TOPICAL
POVIDONE IODINE
+! ALLEGIANCE HLTHCARE 1% N019522 001 Mar 31, 1989
SPONGE;TOPICAL
E-Z SCRUB 201
+! BECTON DICKINSON 20% N019240 001 Nov 29, 1985
E-Z SCRUB 241
+! BECTON DICKINSON 10% N019476 001 Jan 07, 1987
PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
PSEUDOEPHEDRINE HYDROCHLORIDE
AUROBINDO PHARMA 120MG A209008 001 Jun 09, 2017
! L PERRIGO CO 120MG A075153 001 Feb 26, 1999
SUN PHARM INDS LTD 120MG A077442 001 Sep 28, 2005
SUDAFED 24 HOUR
+! J AND J CONSUMER 240MG N020021 002 Dec 15, 1992
INC
PURIFIED WATER
SOLUTION;OPHTHALMIC
PUR-WASH
+! NIAGARA PHARMS 98.3% N022305 001 Sep 01, 2011
RANITIDINE HYDROCHLORIDE
TABLET;ORAL
RANITIDINE HYDROCHLORIDE
DR REDDYS LABS LTD EQ 75MG BASE A075294 001 Mar 28, 2000
EQ 150MG BASE A078192 001 Aug 31, 2007
THINQ PHARM-CRO PVT EQ 75MG BASE A210250 001 Aug 30, 2019
EQ 150MG BASE A210228 001 Aug 30, 2019
TERBINAFINE
GEL;TOPICAL
LAMISIL AT
+! GLAXOSMITHKLINE 1% N021958 001 Jul 24, 2006
CONS
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
OTC DRUG PRODUCT LIST 4-20(of 20)

TERBINAFINE HYDROCHLORIDE
CREAM;TOPICAL
LAMISIL
+! GLAXOSMITHKLINE 1% N020980 001 Mar 09, 1999
TERBINAFINE HYDROCHLORIDE
TARO 1% A077511 001 Jul 02, 2007
SOLUTION;TOPICAL
LAMISIL AT
+! GLAXOSMITHKLINE 1% N021124 001 Mar 17, 2000
CONS
SPRAY;TOPICAL
LAMISIL AT
+! GLAXOSMITHKLINE 1% N021124 002 Mar 17, 2000
CONS
TIOCONAZOLE
OINTMENT;VAGINAL
TIOCONAZOLE
PERRIGO 6.5% A075915 001 Nov 21, 2001
VAGISTAT-1
+! COMBE 6.5% N020676 001 Feb 11, 1997
TRIAMCINOLONE ACETONIDE
SPRAY, METERED;NASAL
NASACORT ALLERGY 24 HOUR
+! CHATTEM SANOFI 0.055MG/SPRAY N020468 002 Oct 11, 2013
TRIAMCINOLONE ACETONIDE
PERRIGO PHARMA INTL 0.055MG/SPRAY A078104 002 Nov 14, 2014
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST 5 - 1 of 4

DRUG PRODUCTS WITH APPROVAL UNDER SECTION 505 OF THE ACT


ADMINISTERED BY THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH LIST

0.9% SODIUM CHLORIDE INJECTION USP SOLUTION


INJECTABLE; INJECTION
NONE
FRESENIUS KABI AG N125695 Sep 05, 2019

ANTICOAGULANT 4% SODIUM CITRATE SOLUTION USP


INJECTABLE; INJECTION
NONE
N760305 Jun 30, 1978
HAEMONETICS
MANUFACTURING INC

NONE
CSL PLASMA INC A125750 Apr 25, 2022

ANTICOAGULANT CITRATE DEXTROSE SOLUTION (ACD)


INJECTABLE; INJECTION
NONE
CITRA LABS LLC N020037 Aug 26, 2003
ACD-A SOLUTION
TERUMO BCT INC A010228 Feb 25, 2002
ADSOL WITH ACD-A
FENWAL INC N000922 Aug 29, 2002
ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A
HAEMONETICS CORP A980728 Feb 06, 2002
AS3 SOLUTION/ACD-A
TERUMO BCT INC N001214 May 29, 2002
ANTICOAGULANT CITRATE DEXTROSE SOLUTION A
TERUMO BCT INC
A110057 May 11, 2012

ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP


INJECTABLE; INJECTION
NONE
FENWAL INC N160918 Mar 17, 1978

ANTICOAGULANT CITRATE PHOSPHATE 2X DEXTROSE SOLUTION (CP2D)


INJECTABLE; INJECTION
CITRATE PHOSPHATE DOUBLE DEXTROSE/ADDITIVE SOLUTION 3
HAEMONETICS CORP N000127 Jan 18, 2002

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE SOLUTION


INJECTABLE; INJECTION
NONE
TERUMO MEDICAL CORP N820528 Nov 03, 1982

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE SOLUTION (CPDA)


INJECTABLE; INJECTION
CPDA-1 BLOOD-PACK UNIT (PL 146 PLASTIC) 250, 450, 500 ML BLOOD PACK UNITS
FENWAL INC N770420 May 12, 1978

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE SOLUTION USP


INJECTABLE; INJECTION
BLOOD PACK UNIT CPDA-1 IN PLASTIC CONTAINER
FENWAL INC N940404 Jul 28, 1994
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST 5 - 2 of 4

DRUG PRODUCTS WITH APPROVAL UNDER SECTION 505 OF THE ACT


ADMINISTERED BY THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH LIST

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE-1 SOLUTION


INJECTABLE; INJECTION
NONE
HAEMONETICS
MANUFACTURING INC N800077 Nov 06, 1980

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION


INJECTABLE; INJECTION
ADSOL IN PLASTIC CONTAINER
FENWAL INC N900223 Dec 27, 1991

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION (CPD)


INJECTABLE; INJECTION
CPD ANTICOAGULANT IN PL 2209 PLASTIC CONTAINER
FENWAL INC N900224 Dec 27, 1991
MACOPRODUCTIONS SAS CPD/AS-1: MACOPHARMA LEUCOFLEX MTL1 LEUKOREDUCTION SYSTEM FOR BLOOD
COMPONENTS KNOWN AS MTL1-WB
MACOPHARMA N040083 Nov 21, 2005
NONE
TERUMO BCT INC A070025 Jan 06, 2009

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION USP


INJECTABLE; INJECTION
NONE
FENWAL INC N170401 Dec 06, 1977
N811012 Jun 28, 1983

PALL CORP N800222 Aug 23, 1982

TERUMO MEDICAL CORP N781211 Jun 10, 1981

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION USP WITH: AS-1:


DEXTROSE USP; SODIUM CHLORIDE USP; MANNITOL USP; ADENINE
INJECTABLE; INJECTION
ADSOL RED BLOOD CELL PRESERVATIVE SOLUTION
FENWAL INC N811104 May 16, 1983

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION USP WITH: AS-5:


DEXTROSE USP; SODIUM CHLORIDE USP; MANNITOL USP; ADENINE
INJECTABLE; INJECTION
OPTISOL RED BLOOD CELL PRESERVATIVE SOLUTION
TERUMO MEDICAL CORP N880217 Oct 07, 1988

ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE SOLUTION WITH:


AS-3: CITRIC ACID USP; MONOBASIC SODIUM PHOSPHATE USP; SODIUM CHLORIDE USP; ADENINE;
DEXTROSE USP; SODIUM CITRATE USP
INJECTABLE; INJECTION
AS-3 NUTRICEL ADDITIVE SYSTEM
HAEMONETICS 0.042GM/100ML;0.276GM/100ML; N820915 Oct 19, 1984
MANUFACTURING INC 0.410GM/100ML;0.30GM/100ML;
1.10GM/100ML;0.588GM/100ML
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST 5 - 3 of 4

DRUG PRODUCTS WITH APPROVAL UNDER SECTION 505 OF THE ACT


ADMINISTERED BY THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH LIST

ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE SOLUTION WITH:


AS-2: CITRIC ACID USP; DIBASIC SODIUM PHOSPHATE USP; SODIUM CHLORIDE USP; ADENINE;
DEXTROSE USP; SODIUM CITRATE USP
INJECTABLE; INJECTION
AS-2 NUTRICEL ADDITIVE SYSTEM
MEDSEP CORP 0.042GM/100ML;0.285GM/100ML; N820915 Sep 22, 1983
0.718GM/100ML;0.017GM/100ML;
0.396GM/100ML;0.588GM/100ML

ANTICOAGULANT SODIUM CITRATE 4% SOLUTION


INJECTABLE; INJECTION
NONE
HAEMONETICS CORPORATION N980123 Mar 03, 2000

LABORATORIES
GRIFOIS, S.A. A125697 Oct 25, 2019

TERUMO BCT A125608 Jun 26, 2018

ANTICOAGULANT SODIUM CITRATE SOLUTION


INJECTABLE; INJECTION
TRICITRASOL
CITRA LABS, LLC N010409 Jul 10, 2003

ANTICOAGULANT SODIUM CITRATE SOLUTION USP


INJECTABLE; INJECTION
NONE
FENWAL INC N770923 Jan 20, 1978
TERUMO MEDICAL CORP N781214 Feb 08, 1980

CORD BLOOD STERILE COLLECTION BAG, ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION
(CPD)
STERILE CORD BLOOD COLLECTION UNIT
NONE
MACOPHARMA N125552 Dec 21, 2016

DEXTRAN 1 IN SODIUM CHLORIDE 0.6%


INJECTABLE; INJECTION
PROMIT
MEDA AB N830715 Oct 30, 1984

DEXTRAN 40, 10% IN DEXTROSE 5%


INJECTABLE; INJECTION
LMD IN GLASS BOTTLE
HOSPIRA INC 10GM/100ML;5GM/100ML A720563 Oct 30, 1992

DEXTRAN 40, 10% IN SODIUM CHLORIDE 0.9%


INJECTABLE; INJECTION
LMD IN PLASTIC CONTAINER
HOSPIRA INC 10GM/100ML;0.9GM/100ML A720562 Oct 30, 1992

HETASTARCH 6% IN LACTATED ELECTROLYTE INJECTION


INJECTABLE; INJECTION
HEXTEND
BIOTIME INC 6GM/100ML N200952 Mar 31, 1999
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST 5 - 4 of 4

DRUG PRODUCTS WITH APPROVAL UNDER SECTION 505 OF THE ACT


ADMINISTERED BY THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH LIST

HETASTARCH 6% IN SODIUM CHLORIDE 0.9%


INJECTABLE; INJECTION
6% HETASTARCH IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
HOSPIRA INC 6GM/100ML;0.9GM/100ML A740193 Jan 30, 1995
HESPAN IN PLASTIC CONTAINER
B BRAUN MEDICAL INC 6GM/100ML;0.9GM/100ML N890105 Apr 04, 1991
NONE
TEVA PHARMACEUTICALS 6GM/100ML;0.9GM/100ML A740592 Nov 12, 1998
USA INC

ISOPLATE SOLUTION IN THE 500 ML EXCEL CONTAINER


STORAGE/PROCESSING SOLUTION ONLY; SHOULD NEVER BE
INFUSED DIRECTLY TO THE PATIENT.
ISOPLATE SOLUTION
TERUMO BCT N90067 Mar 05, 2013

LEUKOCYTE REDUCTION FILTRATION SYSTEM FOR WHOLE BLOOD WITH CPD ANTICOAGULANT AND
SOLX ADDITIVE
INJECTABLE; INJECTION
LEUKOSEP HWB-600-XL
HEMERUS MEDICAL, LLC N110059 Apr 25, 2013

RED BLOOD CELL PROCESSING SOLUTION


STORAGE/PROCESSING SOLUTION ONLY; SHOULD NEVER BE
INFUSED DIRECTLY TO THE PATIENT.
REJUVESOL
CITRA LABS LLC N950522 Feb 26, 1997

SODIUM CHLORIDE; SODIUM ACETATE; SODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE,


DIABASIC ANHYDROUS; SODIUM PHOSPHATE MONOBASIC, MONOHYDRATE
STORAGE/PROCESSING SOLUTION ONLY; SHOULD NEVER BE
INFUSED DIRECTLY TO THE PATIENT.
INTERSOL SOLUTION
FRESENIUS KABI USA, LLC 2.26GM/500ML;2.21GM/500ML;1.59GM/ N080041 Dec 09, 2009
500ML;1.53GM/500ML;0.465GM/500ML
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-1(of 478)
** See List Footnote
ABACAVIR SULFATE
TABLET;ORAL
ABACAVIR SULFATE
APOTEX INC EQ 300MG BASE A201570 001 Dec 17, 2012
ABACAVIR SULFATE; LAMIVUDINE
TABLET;ORAL
ABACAVIR SULFATE AND LAMIVUDINE
AUROBINDO PHARMA EQ 600MG BASE;300MG A206151 001 Mar 28, 2017
TEVA PHARMS USA EQ 600MG BASE;300MG A079246 001 Sep 29, 2016
ZYDUS PHARMS EQ 600MG BASE;300MG A208990 001 Nov 15, 2018
ABAMETAPIR
LOTION;TOPICAL
XEGLYZE
+ HATCHTECH 0.74% N206966 001 Jul 24, 2020
ABARELIX
INJECTABLE;INTRAMUSCULAR
PLENAXIS
SPECIALITY EUROPEAN 100MG/VIAL N021320 001 Nov 25, 2003
ABIRATERONE ACETATE
TABLET;ORAL
ABIRATERONE ACETATE
TEVA PHARMS USA 125MG A212206 001 Jun 24, 2022
ACAMPROSATE CALCIUM
TABLET, DELAYED RELEASE;ORAL
ACAMPROSATE CALCIUM
BARR LABS DIV TEVA 333MG A200143 001 Nov 18, 2013
CAMPRAL
+ FOREST LABS 333MG ** N021431 001 Jul 29, 2004
ACARBOSE
TABLET;ORAL
ACARBOSE
HANGZHOU ZHONGMEI 25MG A213821 001 Aug 18, 2020
50MG A213821 002 Aug 18, 2020
100MG A213821 003 Aug 18, 2020
MYLAN 25MG A091053 001 Jan 06, 2011
50MG A091053 002 Jan 06, 2011
100MG A091053 003 Jan 06, 2011
PRECOSE
+ BAYER HLTHCARE 25MG ** N020482 004 May 29, 1997
+ 50MG ** N020482 001 Sep 06, 1995
+ 100MG ** N020482 002 Sep 06, 1995
ACEBUTOLOL HYDROCHLORIDE
CAPSULE;ORAL
ACEBUTOLOL HYDROCHLORIDE
MYLAN EQ 200MG BASE A074288 001 Apr 24, 1995
EQ 400MG BASE A074288 002 Apr 24, 1995
SECTRAL
+ PROMIUS PHARMA EQ 200MG BASE ** N018917 001 Dec 28, 1984
+ EQ 400MG BASE ** N018917 003 Dec 28, 1984
ACETAMINOPHEN
INJECTABLE;INJECTION
INJECTAPAP
ORTHO MCNEIL PHARM 100MG/ML N017785 001 Mar 07, 1986
POWDER;INTRAVENOUS
ACETAMINOPHEN
+ RISING 1GM/VIAL N206610 001 Jan 15, 2021
SOLUTION;INTRAVENOUS
OFIRMEV
+ MALLINCKRODT HOSP 1GM/100ML (10MG/ML) N022450 001 Nov 02, 2010
SUPPOSITORY;RECTAL
ACEPHEN
COSETTE 120MG A072218 001 Mar 27, 1992
325MG N018060 003 Dec 18, 1986
650MG N018060 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-2(of 478)
** See List Footnote
ACETAMINOPHEN
SUPPOSITORY;RECTAL
ACETAMINOPHEN
ABLE 120MG A073106 001 Feb 27, 1995
325MG A073107 001 Feb 27, 1995
650MG A073108 001 Feb 27, 1995
ACINO PRODS 120MG A071010 001 May 12, 1987
650MG A071011 001 May 12, 1987
NEOPAP
POLYMEDICA 120MG N016401 001
TYLENOL
J AND J CONSUMER INC 120MG N017756 002
650MG N017756 001
TABLET, EXTENDED RELEASE;ORAL
ACETAMINOPHEN
SUN PHARM INDS LTD 650MG A090205 001 Nov 18, 2009
ACETAMINOPHEN; ASPIRIN; CODEINE PHOSPHATE
CAPSULE;ORAL
ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE
MIKART 150MG;180MG;15MG A081095 001 Oct 26, 1990
150MG;180MG;30MG A081096 001 Oct 26, 1990
150MG;180MG;60MG A081097 001 Oct 26, 1990
CODEINE, ASPIRIN, APAP FORMULA NO. 2
+ SCHERER LABS 150MG;180MG;15MG A085640 001
CODEINE, ASPIRIN, APAP FORMULA NO. 3
+ SCHERER LABS 150MG;180MG;30MG A085639 001
CODEINE, ASPIRIN, APAP FORMULA NO. 4
SCHERER LABS 150MG;180MG;60MG A085638 001
ACETAMINOPHEN; BUTALBITAL
CAPSULE;ORAL
BANCAP
FOREST PHARMS 325MG;50MG A088889 001 Jan 16, 1986
BUCET
MALLINCKRODT 650MG;50MG A088991 001 Jun 28, 1985
PHRENILIN FORTE
VALEANT 650MG;50MG A088831 001 Jun 19, 1985
TENCON
MALLINCKRODT 650MG;50MG A089405 001 May 15, 1990
TRIAPRIN
DUNHALL 325MG;50MG A089268 001 Jul 02, 1987
TABLET;ORAL
BUTALBITAL AND ACETAMINOPHEN
ALVOGEN 325MG;50MG A205120 001 Oct 30, 2015
HALSEY 325MG;50MG A089568 001 Oct 05, 1988
+ WATSON LABS 325MG;50MG A087550 001 Oct 19, 1984
BUTAPAP
MIKART 650MG;50MG A089988 001 Oct 26, 1992
PHRENILIN
+ VALEANT 325MG;50MG ** A087811 001 Jun 19, 1985
SEDAPAP
MAYRAND 650MG;50MG A088944 001 Oct 17, 1985
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
CAPSULE;ORAL
ANOQUAN
SHIRE 325MG;50MG;40MG A087628 001 Oct 01, 1986
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
+ GILBERT LABS 325MG;50MG;40MG ** A088825 001 Dec 05, 1984
GRAHAM DM 325MG;50MG;40MG A088743 001 Jul 18, 1985
325MG;50MG;40MG A088765 001 Mar 27, 1985
325MG;50MG;40MG A089067 001 Apr 19, 1985
HIKMA 300MG;50MG;40MG A215135 001 Mar 25, 2022
325MG;50MG;40MG A215135 002 Mar 25, 2022
500MG;50MG;40MG A040261 001 Oct 28, 1998
MALLINCKRODT 325MG;50MG;40MG A088758 001 Mar 27, 1985
ESGIC-PLUS
MIKART 500MG;50MG;40MG A040085 001 Mar 28, 1996

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-3(of 478)
** See List Footnote
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
CAPSULE;ORAL
FEMCET
MALLINCKRODT 325MG;50MG;40MG A089102 001 Jun 19, 1985
MEDIGESIC PLUS
US CHEM 325MG;50MG;40MG A089115 001 Jan 14, 1986
TRIAD
MALLINCKRODT 325MG;50MG;40MG A089023 001 Jun 19, 1985
TABLET;ORAL
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
ABLE 325MG;50MG;40MG A040390 001 Jul 23, 2001
500MG;50MG;40MG A040394 001 Jul 23, 2001
ALVOGEN 325MG;50MG;40MG A204984 001 Jan 10, 2017
GILBERT LABS 325MG;50MG;40MG A087629 001 Nov 13, 1984
HIKMA 500MG;50MG;40MG A040336 001 Aug 18, 1999
HIKMA PHARMS 325MG;50MG;40MG A089718 001 Jun 12, 1995
MIKART 750MG;50MG;40MG A040496 001 Dec 23, 2003
MIRROR PHARMS LLC 500MG;50MG;40MG A040883 001 Dec 23, 2008
NESHER PHARMS 325MG;50MG;40MG A211543 001 Jul 17, 2020
SPECGX LLC 325MG;50MG;40MG A087804 001 Jan 24, 1985
SUN PHARM INDUSTRIES 325MG;50MG;40MG A040601 001 Jul 29, 2005
VINTAGE PHARMS 500MG;50MG;40MG A040513 001 Aug 25, 2003
WATSON LABS 325MG;50MG;40MG A089536 001 Feb 16, 1988
500MG;50MG;40MG A040267 001 Jul 30, 1998
ESGIC
FOREST PHARMS 325MG;50MG;40MG A089660 001 Dec 23, 1988
ESGIC-PLUS
MIKART 500MG;50MG;40MG A089451 001 May 23, 1988
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
CAPSULE;ORAL
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
ABLE 325MG;50MG;40MG;30MG A076528 001 Aug 21, 2003
HIKMA INTL PHARMS 325MG;50MG;40MG;30MG A075618 001 Mar 23, 2001
PHRENILIN WITH CAFFEINE AND CODEINE
VALEANT 325MG;50MG;40MG;30MG A074911 001 Aug 22, 2001
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
CAPSULE;ORAL
ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE
MIKART 356.4MG;30MG;16MG A040109 001 Aug 26, 1997
WRASER PHARMS LLC 356.4MG;30MG;16MG A040688 001 Apr 03, 2007
DHC PLUS
PHARM RES ASSOC 356.4MG;30MG;16MG A088584 001 Mar 04, 1986
SYNALGOS-DC-A
LEITNER PHARMS 356.4MG;30MG;16MG A089166 001 May 14, 1986
TABLET;ORAL
ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE
BOCA PHARMA LLC 712.8MG;60MG;32MG A040701 001 Apr 03, 2007
MIKART 712.8MG;60MG;32MG A040316 001 Apr 28, 1999
WEST-WARD PHARM CORP 712.8MG;60MG;32MG A040637 001 Sep 22, 2006
ACETAMINOPHEN; CLEMASTINE FUMARATE; PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET;ORAL
TAVIST ALLERGY/SINUS/HEADACHE
NOVARTIS 500MG;EQ 0.25MG BASE;30MG N021082 001 Mar 01, 2001
ACETAMINOPHEN; CODEINE PHOSPHATE
CAPSULE;ORAL
ACETAMINOPHEN AND CODEINE PHOSPHATE
TEVA 300MG;15MG A088537 001 Jun 04, 1984
300MG;30MG A088324 001 Dec 29, 1983
300MG;60MG A088599 001 Jun 01, 1984
PHENAPHEN W/ CODEINE NO. 2
ROBINS AH 325MG;15MG A084444 001
PHENAPHEN W/ CODEINE NO. 3
+ ROBINS AH 325MG;30MG A084445 001
PHENAPHEN W/ CODEINE NO. 4
+ ROBINS AH 325MG;60MG A084446 001
PROVAL #3
SOLVAY 325MG;30MG A085685 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-4(of 478)
** See List Footnote
ACETAMINOPHEN; CODEINE PHOSPHATE
CAPSULE;ORAL
TYLENOL W/ CODEINE NO. 3
ORTHO MCNEIL PHARM 300MG;30MG A087422 001
TYLENOL W/ CODEINE NO. 4
ORTHO MCNEIL PHARM 300MG;60MG A087421 001
SOLUTION;ORAL
ACETAMINOPHEN AND CODEINE PHOSPHATE
ACI 120MG/5ML;12MG/5ML A086366 001
+ ACTAVIS MID ATLANTIC 120MG/5ML;12MG/5ML A085861 001
CHARTWELL MOLECULAR 120MG/5ML;12MG/5ML A091238 001 Nov 10, 2011
DAVA PHARMS INC 120MG/5ML;12MG/5ML A040098 001 Sep 20, 1996
WOCKHARDT BIO AG 120MG/5ML;12MG/5ML A087006 001
TYLENOL W/ CODEINE
+ ORTHO MCNEIL PHARM 120MG/5ML;12MG/5ML A085057 001
SUSPENSION;ORAL
CAPITAL AND CODEINE
ACTAVIS MID ATLANTIC 120MG/5ML;12MG/5ML A085883 001
VALEANT PHARMS LLC 120MG/5ML;12MG/5ML A086024 001
TABLET;ORAL
ACETAMINOPHEN AND CODEINE PHOSPHATE
ABLE 300MG;30MG A040452 001 Aug 01, 2002
300MG;60MG A040459 001 Aug 01, 2002
AM THERAP 300MG;15MG A089478 001 Mar 03, 1987
300MG;15MG A089481 001 Mar 03, 1987
300MG;30MG A089479 001 Mar 03, 1987
300MG;30MG A089482 001 Mar 03, 1987
300MG;60MG A089480 001 Mar 03, 1987
300MG;60MG A089483 001 Mar 03, 1987
CHARTWELL 300MG;15MG A089997 001 Dec 28, 1994
300MG;30MG A089998 001 Dec 28, 1994
300MG;60MG A089999 001 Dec 28, 1994
DURAMED PHARMS BARR 300MG;15MG A040223 001 Nov 18, 1997
300MG;15MG A088353 001 Feb 06, 1984
300MG;30MG A040223 002 Nov 18, 1997
300MG;30MG A088354 001 Feb 06, 1984
300MG;60MG A040223 003 Nov 18, 1997
300MG;60MG A088355 001 Feb 06, 1984
EVERYLIFE 325MG;30MG A085217 001
FOSUN PHARMA 300MG;30MG A081250 001 Jul 16, 1992
300MG;60MG A081249 001 Jul 16, 1992
HALSEY 300MG;15MG A083871 001
300MG;30MG A083872 001
300MG;60MG A086549 001
KV PHARM 300MG;30MG A085288 001
300MG;60MG A085365 001
325MG;15MG A085364 001
325MG;45MG ** A085363 001
LEDERLE 300MG;30MG A087141 001
MIKART 300MG;30MG A089238 001 Feb 25, 1986
300MG;60MG A089244 001 Feb 25, 1986
650MG;30MG A089231 001 Mar 03, 1986
650MG;60MG A089363 001 Sep 09, 1991
MUTUAL PHARM 300MG;15MG A085795 001
300MG;30MG A085794 001
300MG;60MG A087653 001 Apr 13, 1982
PURACAP PHARM 300MG;30MG A087762 001 Dec 10, 1982
+ PUREPAC PHARM 300MG;30MG A086681 001
300MG;30MG A089080 001 Jul 17, 1986
300MG;60MG A086683 001
RHODES PHARMS 300MG;15MG A089673 002 Feb 10, 1988
300MG;30MG A089673 003 Feb 10, 1988
300MG;60MG A089673 001 Feb 10, 1988
ROXANE 300MG;15MG A084659 001
300MG;30MG A084656 001
300MG;60MG A084667 001
500MG;15MG A089511 001 Apr 25, 1989
500MG;30MG A089512 001 Apr 25, 1989
500MG;60MG A089513 001 Apr 25, 1989

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-5(of 478)
** See List Footnote
ACETAMINOPHEN; CODEINE PHOSPHATE
TABLET;ORAL
ACETAMINOPHEN AND CODEINE PHOSPHATE
+ SANDOZ 300MG;15MG A087433 001
300MG;30MG A085291 002
+ 300MG;30MG A085917 001
300MG;60MG A085964 001
300MG;60MG A087423 001
STRIDES PHARMA 300MG;15MG A089990 001 Sep 30, 1988
300MG;30MG A089805 001 Sep 30, 1988
300MG;60MG A089828 001 Sep 30, 1988
SUPERPHARM 300MG;15MG A089183 001 Oct 18, 1985
300MG;30MG A089184 001 Oct 18, 1985
300MG;30MG A089253 001 May 19, 1986
300MG;60MG A089185 001 Oct 18, 1985
300MG;60MG A089254 001 May 19, 1986
USL PHARMA 300MG;30MG A087919 001 Jun 22, 1982
300MG;60MG A087920 001 Jun 22, 1982
VALEANT PHARM INTL 300MG;30MG A085896 001
VITARINE 300MG;30MG A085676 001
WARNER CHILCOTT 300MG;15MG A085992 001
300MG;30MG A085218 002
300MG;60MG A087306 001
WATSON LABS 300MG;15MG A087277 001 May 26, 1982
300MG;30MG A087276 001 May 26, 1982
300MG;60MG A087275 001 May 26, 1982
WATSON LABS FLORIDA 300MG;15MG A040443 001 Jan 22, 2003
300MG;30MG A040443 002 Jan 22, 2003
300MG;60MG A040443 003 Jan 22, 2003
WHITEWORTH TOWN PLSN 300MG;30MG A084360 001
300MG;60MG A085607 001
CAPITAL AND CODEINE
CARNRICK 325MG;30MG A083643 001
CODRIX
WATSON LABS FLORIDA 500MG;15MG A040447 001 Feb 26, 2003
500MG;30MG A040441 001 Mar 27, 2003
500MG;60MG A040488 001 Mar 28, 2003
EMPRACET W/ CODEINE PHOSPHATE #3
GLAXOSMITHKLINE 300MG;30MG A083951 001
EMPRACET W/ CODEINE PHOSPHATE #4
GLAXOSMITHKLINE 300MG;60MG A083951 002
PAPA-DEINE #3
VANGARD 300MG;30MG A088037 001 Mar 20, 1984
PAPA-DEINE #4
VANGARD 300MG;60MG A088715 001 Mar 20, 1984
PHENAPHEN-650 W/ CODEINE
ROBINS AH 650MG;30MG A085856 001
TYLENOL W/ CODEINE
ORTHO MCNEIL PHARM 325MG;7.5MG ** A085056 001
325MG;15MG ** A085056 002
325MG;30MG ** A085056 003
325MG;60MG ** A085056 004
TYLENOL W/ CODEINE NO. 1
JANSSEN PHARMS 300MG;7.5MG A085055 001
TYLENOL W/ CODEINE NO. 2
+ JANSSEN PHARMS 300MG;15MG A085055 002
TYLENOL W/ CODEINE NO. 3
+ JANSSEN PHARMS 300MG;30MG A085055 003
TYLENOL W/ CODEINE NO. 4
+ JANSSEN PHARMS 300MG;60MG A085055 004
ACETAMINOPHEN; DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
TABLET, EXTENDED RELEASE;ORAL
DRIXORAL PLUS
SCHERING PLOUGH 500MG;3MG;60MG N019453 001 May 22, 1987

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-6(of 478)
** See List Footnote
ACETAMINOPHEN; HYDROCODONE BITARTRATE
CAPSULE;ORAL
ACETAMINOPHEN AND HYDROCODONE BITARTRATE
CENT PHARMS 500MG;5MG A088898 001 Mar 27, 1985
ALLAY
IVAX PHARMS 500MG;5MG A089907 001 Jan 13, 1989
BANCAP HC
FOREST PHARMS 500MG;5MG A087961 001 Mar 17, 1983
CO-GESIC
CENT PHARMS 500MG;5MG A089360 001 Mar 02, 1988
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MALLINCKRODT 500MG;5MG A088956 001 Jul 19, 1985
500MG;5MG A089006 001 Aug 09, 1985
MIKART 500MG;5MG A081067 001 Nov 30, 1989
500MG;5MG A081068 001 Nov 30, 1989
500MG;5MG A081069 001 Nov 30, 1989
500MG;5MG A081070 001 Nov 30, 1989
500MG;5MG A089008 001 Feb 21, 1986
LORCET-HD
MALLINCKRODT 500MG;5MG A087336 001 Jul 08, 1982
SOLUTION;ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MALLINCKRODT 500MG/15ML;7.5MG/15ML A040418 001 Jun 27, 2001
MALLINCKRODT INC 500MG/15ML;10MG/15ML A040508 001 Aug 29, 2003
MIKART 500MG/15ML;5MG/15ML A081226 001 Oct 27, 1992
500MG/15ML;5MG/15ML A089557 001 Apr 29, 1992
500MG/15ML;7.5MG/15ML A081051 001 Aug 28, 1992
NESHER PHARMS 500MG/15ML;7.5MG/15ML A040366 001 Jan 23, 2002
PHARM ASSOC 500MG/15ML;7.5MG/15ML A040182 001 Mar 13, 1998
TRIS PHARMA INC 300MG/15ML;10MG/15ML A201295 002 Dec 30, 2021
325MG/15ML;7.5MG/15ML A201295 001 Dec 30, 2021
VINTAGE PHARMS 500MG/15ML;7.5MG/15ML A040520 001 Oct 30, 2003
ZYFREL
CYPRESS PHARM INC 325MG/15ML;7.5MG/15ML A090468 001 Apr 14, 2016
TABLET;ORAL
ANEXSIA
MALLINCKRODT 500MG;5MG A089160 001 Apr 23, 1987
750MG;10MG A040468 001 Oct 31, 2002
ANEXSIA 7.5/650
MALLINCKRODT 650MG;7.5MG A089725 001 Sep 30, 1987
CO-GESIC
UCB INC 500MG;5MG A087757 001 May 03, 1982
DURADYNE DHC
FOREST PHARMS 500MG;5MG A087809 001 Mar 17, 1983
HY-PHEN
ASCHER 500MG;5MG A087677 001 May 03, 1982
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
ABLE 325MG;5MG A040478 001 Nov 08, 2002
325MG;7.5MG A040464 001 Oct 23, 2002
325MG;10MG A040464 002 Oct 23, 2002
500MG;5MG A040477 001 Nov 06, 2002
500MG;7.5MG A040490 001 May 21, 2003
500MG;10MG A040473 001 Nov 06, 2002
650MG;7.5MG A040474 001 Jan 02, 2003
650MG;10MG A040476 001 Oct 23, 2002
750MG;7.5MG A040469 001 Oct 25, 2002
ACTAVIS LABS FL INC 300MG;5MG A206470 001 Jun 02, 2016
300MG;7.5MG A206470 002 Jun 02, 2016
300MG;10MG A206470 003 Jun 02, 2016
ALVOGEN 300MG;5MG A208540 001 Nov 08, 2018
300MG;7.5MG A208540 002 Nov 08, 2018
300MG;10MG A208540 003 Nov 08, 2018
325MG;2.5MG A209958 001 Oct 24, 2018
325MG;5MG A209958 002 Oct 24, 2018
325MG;7.5MG A209958 003 Oct 24, 2018
325MG;10MG A209958 004 Oct 24, 2018
AMNEAL PHARMS NY 500MG;5MG A040729 001 Aug 25, 2006
500MG;7.5MG A040748 001 Aug 25, 2006
500MG;10MG A040813 001 Feb 23, 2007

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-7(of 478)
** See List Footnote
ACETAMINOPHEN; HYDROCODONE BITARTRATE
TABLET;ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
650MG;7.5MG A040754 001 Aug 25, 2006
650MG;10MG A040757 001 Aug 25, 2006
750MG;7.5MG A040769 001 Aug 28, 2006
APIL 500MG;10MG A040148 002 Feb 14, 1997
BARR 500MG;2.5MG A040307 001 Jul 26, 2000
500MG;5MG A040308 001 Jul 26, 2000
500MG;5MG A088577 001 Dec 21, 1984
500MG;7.5MG A040307 002 Jul 26, 2000
500MG;10MG A040309 001 Jul 26, 2000
650MG;7.5MG A040307 003 Jul 26, 2000
650MG;10MG A040307 004 Jul 26, 2000
750MG;7.5MG A040308 002 Jul 26, 2000
CARACO 500MG;5MG A090265 001 Dec 23, 2008
500MG;7.5MG A090265 002 Dec 23, 2008
500MG;10MG A090265 003 Dec 23, 2008
650MG;7.5MG A090380 001 Dec 23, 2008
650MG;10MG A090380 002 Dec 23, 2008
660MG;10MG A090380 003 Dec 23, 2008
750MG;7.5MG A090380 004 Dec 23, 2008
CEROVENE INC 325MG;5MG A211690 001 Feb 07, 2020
325MG;7.5MG A211690 002 Feb 07, 2020
325MG;10MG A211690 003 Feb 07, 2020
CHARTWELL 325MG;7.5MG A040248 001 Apr 28, 2000
325MG;10MG A040248 002 Apr 28, 2000
GRANULES 325MG;5MG A211729 001 Jan 03, 2020
325MG;7.5MG A211729 002 Jan 03, 2020
325MG;10MG A211729 003 Jan 03, 2020
HALSEY 500MG;5MG A089554 001 Jun 12, 1987
IVAX PHARMS 500MG;5MG A089696 001 Apr 21, 1988
LANNETT CO INC 300MG;5MG A207171 001 Jun 20, 2017
300MG;7.5MG A207171 002 Jun 20, 2017
300MG;10MG A207171 003 Jun 20, 2017
325MG;5MG A207172 001 Jun 22, 2017
325MG;7.5MG A207172 002 Jun 22, 2017
325MG;10MG A207172 003 Jun 22, 2017
MALLINCKRODT 500MG;5MG A040084 002 Jun 01, 1995
500MG;7.5MG A040201 001 Feb 27, 1998
500MG;10MG A040201 002 Feb 27, 1998
650MG;10MG A040084 004 Oct 16, 1996
660MG;10MG A040084 003 Jul 29, 1996
750MG;7.5MG A040084 001 Jun 01, 1995
MIKART 325MG;2.5MG A040846 001 Jun 09, 2010
500MG;2.5MG A089698 001 Aug 25, 1989
500MG;5MG A089271 001 Jul 16, 1986
500MG;5MG A089697 001 Jan 28, 1992
500MG;7.5MG A089699 001 Aug 25, 1989
650MG;5MG A040849 001 Jun 09, 2010
650MG;7.5MG A089689 001 Jun 29, 1988
650MG;10MG A081223 001 May 29, 1992
MUTUAL PHARM 500MG;5MG A040236 001 Sep 25, 1997
650MG;7.5MG A040240 002 Nov 26, 1997
650MG;10MG A040240 001 Nov 26, 1997
750MG;7.5MG A040236 002 Sep 25, 1997
NOSTRUM LABS INC 325MG;2.5MG A209924 001 Nov 16, 2018
325MG;5MG A209924 002 Nov 16, 2018
325MG;7.5MG A209924 003 Nov 16, 2018
325MG;10MG A209924 004 Nov 16, 2018
RANBAXY 500MG;5MG A040825 001 Aug 16, 2007
500MG;10MG A040824 001 Aug 16, 2007
RANBAXY LABS LTD 750MG;7.5MG A040822 001 Aug 16, 2007
SANDOZ 500MG;5MG A040149 001 Jan 27, 1997
750MG;7.5MG A040149 002 Jan 27, 1997
STRIDES PHARMA 300MG;5MG A205001 001 Jul 05, 2016
300MG;7.5MG A205001 002 Jul 05, 2016
300MG;10MG A205001 003 Jul 05, 2016
SUN PHARM INDS LTD 325MG;10MG A040826 001 Aug 16, 2007

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-8(of 478)
** See List Footnote
ACETAMINOPHEN; HYDROCODONE BITARTRATE
TABLET;ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
UCB INC 500MG;10MG A040210 001 Aug 13, 1997
650MG;7.5MG A040134 001 Nov 21, 1996
UPSHER SMITH LABS 325MG;5MG A206484 001 Mar 24, 2017
325MG;7.5MG A206484 002 Mar 24, 2017
325MG;10MG A206484 003 Mar 24, 2017
USL PHARMA 500MG;5MG A089290 001 May 29, 1987
500MG;5MG A089291 001 May 29, 1987
VINTAGE PHARMS 300MG;5MG A090415 001 Jan 24, 2011
300MG;7.5MG A090415 002 Jan 24, 2011
300MG;10MG A090415 003 Jan 24, 2011
500MG;2.5MG A040144 002 Apr 25, 1997
500MG;5MG A089831 001 Sep 07, 1988
500MG;5MG A089971 001 Dec 02, 1988
500MG;7.5MG A040144 001 Feb 22, 1996
500MG;10MG A040356 001 May 31, 2000
650MG;7.5MG A040155 001 Apr 14, 1997
650MG;10MG A040143 001 Feb 22, 1996
660MG;10MG A040358 001 May 31, 2000
750MG;7.5MG A040157 001 Apr 12, 1996
VINTAGE PHARMS LLC 500MG;5MG A040281 001 Sep 30, 1998
500MG;7.5MG A040280 001 Sep 30, 1998
650MG;7.5MG A040280 002 Sep 30, 1998
650MG;10MG A040280 003 Sep 30, 1998
750MG;7.5MG A040281 002 Sep 30, 1998
WATSON LABS 500MG;2.5MG A040123 003 Mar 04, 1996
500MG;2.5MG A081079 001 Aug 30, 1991
500MG;5MG A040122 001 Mar 04, 1996
500MG;5MG A089883 001 Dec 01, 1988
500MG;7.5MG A040123 004 Mar 04, 1996
500MG;7.5MG A081080 001 Aug 30, 1991
650MG;7.5MG A040094 001 Sep 29, 1995
650MG;7.5MG A040123 001 Mar 04, 1996
650MG;10MG A040094 002 Sep 29, 1995
650MG;10MG A040123 002 Mar 04, 1996
660MG;10MG A040094 003 Aug 08, 2000
750MG;7.5MG A040122 002 Mar 04, 1996
750MG;7.5MG A081083 001 Aug 30, 1991
750MG;10MG A040094 004 Mar 22, 1999
WATSON LABS FLORIDA 500MG;5MG A040493 001 May 28, 2003
660MG;10MG A040495 001 May 28, 2003
750MG;7.5MG A040494 001 May 28, 2003
LORTAB
UCB INC 500MG;5MG A087722 001 Jul 09, 1982
500MG;10MG A040100 001 Jan 26, 1996
NORCET
ABANA 500MG;5MG A088871 001 May 15, 1986
NORCO
APIL 325MG;2.5MG A040148 004 Jul 07, 2014
325MG;5MG A040099 001 Jun 25, 1997
325MG;5MG A040148 005 Jul 07, 2014
325MG;7.5MG A040148 003 Sep 12, 2000
325MG;10MG A040148 001 Feb 14, 1997
TYCOLET
ORTHO MCNEIL PHARM 500MG;5MG A089385 001 Aug 27, 1986
VICODIN
ABBOTT 500MG;5MG A085667 001
ABBVIE 500MG;5MG A088058 001 Jan 07, 1983
VICODIN ES
ABBVIE 750MG;7.5MG A089736 001 Dec 09, 1988
VICODIN HP
ABBVIE 660MG;10MG A040117 001 Sep 23, 1996
ZYDONE
VINTAGE PHARMS LLC 400MG;5MG A040288 001 Nov 27, 1998
400MG;7.5MG A040288 002 Nov 27, 1998
400MG;10MG A040288 003 Nov 27, 1998

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-9(of 478)
** See List Footnote
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
CAPSULE;ORAL
OXYCODONE AND ACETAMINOPHEN
ACTAVIS ELIZABETH 500MG;5MG A040199 001 Dec 30, 1998
BARR 500MG;5MG A040304 001 Oct 02, 2000
DURAMED PHARMS BARR 500MG;5MG A040289 001 Mar 16, 1999
HALSEY 500MG;5MG A089994 001 May 04, 1989
MALLINCKRODT 500MG;5MG A040257 001 Aug 04, 1998
MUTUAL PHARM 500MG;5MG A040219 001 Jan 22, 1998
VINTAGE PHARMS 500MG;5MG A040106 001 Jul 30, 1996
VINTAGE PHARMS LLC 500MG;5MG A040303 001 Dec 30, 1999
WATSON LABS 500MG;5MG A040234 001 Oct 30, 1997
ROXILOX
ROXANE 500MG;5MG A040061 001 Jul 03, 1995
TYLOX
JANSSEN PHARMS 500MG;5MG A088790 001 Dec 12, 1984
TYLOX-325
ORTHO MCNEIL PHARM 325MG;5MG A088246 001 Nov 08, 1984
SOLUTION;ORAL
OXYCODONE AND ACETAMINOPHEN
SPECGX LLC 325MG/5ML;5MG/5ML A040680 001 Sep 29, 2006
OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN
VINTAGE PHARMS 325MG/5ML;5MG/5ML A203573 001 Dec 18, 2014
ROXICET
HIKMA 325MG/5ML;5MG/5ML A089351 001 Dec 03, 1986
TABLET;ORAL
OXYCODONE 2.5/APAP 500
BRISTOL MYERS SQUIBB 500MG;2.5MG A085910 001
OXYCODONE 5/APAP 500
BRISTOL MYERS SQUIBB 500MG;5MG A085911 001
OXYCODONE AND ACETAMINOPHEN
ACTAVIS ELIZABETH 325MG;5MG A040203 001 Mar 15, 1999
325MG;7.5MG A040800 001 Apr 03, 2012
325MG;10MG A040800 002 Apr 03, 2012
AMNEAL PHARMS NY 500MG;7.5MG A040789 001 Nov 27, 2007
650MG;10MG A040789 002 Nov 27, 2007
BARR 325MG;5MG A087406 001
CEROVENE INC 325MG;5MG A207574 001 Dec 13, 2016
DURAMED PHARMS BARR 325MG;5MG A040272 001 Jun 30, 1998
GRANULES 325MG;2.5MG A211708 001 Oct 31, 2019
325MG;5MG A211708 002 Oct 31, 2019
325MG;7.5MG A211708 003 Oct 31, 2019
325MG;10MG A211708 004 Oct 31, 2019
LANNETT CO INC 325MG;5MG A207333 001 Sep 25, 2017
325MG;10MG A207333 002 Sep 25, 2017
MALLINCKRODT 500MG;7.5MG A040550 001 Jun 30, 2004
650MG;10MG A040550 002 Jun 30, 2004
MAYNE PHARMA INC 500MG;7.5MG A090177 005 Oct 20, 2008
650MG;10MG A090177 006 Oct 20, 2008
MIKART 400MG;2.5MG A040679 001 May 16, 2006
400MG;5MG A040687 001 Apr 27, 2006
400MG;7.5MG A040698 001 Apr 27, 2006
400MG;10MG A040692 001 Apr 27, 2006
500MG;10MG A040676 001 Apr 19, 2006
NESHER PHARMS 325MG;2.5MG A210079 001 Dec 28, 2017
325MG;5MG A210079 002 Dec 28, 2017
325MG;7.5MG A210079 003 Dec 28, 2017
325MG;10MG A210079 004 Dec 28, 2017
NOSTRUM LABS INC 325MG;5MG A209385 001 Jul 02, 2018
325MG;7.5MG A209385 002 Jul 02, 2018
325MG;10MG A209385 003 Jul 02, 2018
VINTAGE PHARMS 325MG;2.5MG A090733 001 Jul 11, 2013
325MG;5MG A040105 001 Jul 30, 1996
325MG;7.5MG A090734 001 Jul 11, 2013
325MG;10MG A090734 002 Jul 11, 2013
WATSON LABS 325MG;5MG A040171 001 Oct 30, 1997
325MG;7.5MG A040535 001 Sep 05, 2003
325MG;10MG A040535 002 Sep 05, 2003
500MG;7.5MG A040371 001 Dec 29, 2000

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-10(of 478)
** See List Footnote
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
TABLET;ORAL
OXYCODONE AND ACETAMINOPHEN
650MG;10MG A040371 002 Dec 29, 2000
PERCOCET
+ VINTAGE PHARMS LLC 325MG;5MG A085106 002
500MG;7.5MG A040341 001 Jul 26, 1999
650MG;10MG A040341 002 Jul 26, 1999
ROXICET
+ HIKMA 325MG;5MG A087003 001
ROXICET 5/500
ROXANE 500MG;5MG A089775 001 Jan 12, 1989
TABLET, EXTENDED RELEASE;ORAL
XARTEMIS XR
+ MALLINCKRODT INC 325MG;7.5MG N204031 001 Mar 11, 2014
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE
CAPSULE;ORAL
TYLOX
ORTHO MCNEIL PHARM 500MG;4.5MG;0.38MG A085375 001
ACETAMINOPHEN; PENTAZOCINE HYDROCHLORIDE
TABLET;ORAL
ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE
GAVIS PHARMS 650MG;EQ 25MG BASE A076202 001 Aug 02, 2002
WATSON LABS 650MG;EQ 25MG BASE A074699 001 Mar 24, 2000
TALACEN
SANOFI AVENTIS US 650MG;EQ 25MG BASE N018458 001 Sep 23, 1982
ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE
TABLET;ORAL
DARVOCET
AAIPHARMA LLC 325MG;32.5MG N016844 001
DOLENE AP-65
LEDERLE 650MG;65MG A085100 001
PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN
MYLAN 325MG;32MG A083689 001
650MG;65MG A083978 001
SANDOZ 650MG;65MG A089959 001 Jul 18, 1989
VINTAGE PHARMS 650MG;65MG A040507 001 Jul 30, 2003
WATSON LABS 650MG;65MG A040139 001 Dec 16, 1996
WYGESIC
CARACO 650MG;65MG A084999 001
ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE
TABLET;ORAL
DARVOCET A500
XANODYNE PHARM 500MG;100MG A076429 001 Sep 10, 2003
DARVOCET-N 100
XANODYNE PHARM 650MG;100MG N017122 002
DARVOCET-N 50
XANODYNE PHARM 325MG;50MG N017122 001
PROPACET 100
TEVA 650MG;100MG A070107 001 Jun 12, 1985
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
ABLE 650MG;100MG A075838 001 Jul 11, 2001
ACTAVIS ELIZABETH 650MG;100MG A070910 001 Jan 02, 1987
CORNERSTONE 325MG;100MG A076743 001 May 07, 2004
500MG;100MG A076750 001 Jun 28, 2004
HALSEY 325MG;50MG A072105 001 May 13, 1988
650MG;100MG A072106 001 May 13, 1988
IVAX SUB TEVA PHARMS 650MG;100MG A070146 001 Aug 02, 1985
MALLINCKRODT 650MG;100MG A075738 001 Feb 02, 2001
MIRROR PHARMS 650MG;100MG A077821 001 Feb 11, 2008
MUTUAL PHARM 325MG;50MG A070115 001 Jun 12, 1985
650MG;100MG A070116 001 Jun 12, 1985
650MG;100MG A070615 001 Mar 21, 1986
650MG;100MG A070771 001 Mar 21, 1986
650MG;100MG A070775 001 Mar 21, 1986
MYLAN 650MG;100MG A072195 001 Feb 16, 1988
MYLAN PHARMS INC 650MG;100MG A070145 001 Jun 12, 1985

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-11(of 478)
** See List Footnote
ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE
TABLET;ORAL
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
SANDOZ 650MG;100MG A070443 001 Jan 23, 1986
SUPERPHARM 650MG;100MG A071319 001 Jan 06, 1987
TEVA 650MG;100MG A070732 001 Jan 03, 1986
650MG;100MG A074119 001 Dec 19, 1994
VINTAGE PHARMS 325MG;50MG A074843 002 Feb 15, 2001
650MG;100MG A074843 001 Feb 12, 1997
WATSON LABS 325MG;50MG A070398 001 Dec 18, 1986
650MG;100MG A070399 001 Dec 18, 1986
WATSON LABS FLORIDA 500MG;100MG A077196 001 Jun 28, 2005
650MG;100MG A076609 001 Nov 16, 2004
WOCKHARDT LTD 325MG;50MG A077677 001 Mar 16, 2007
650MG;100MG A077677 002 Mar 16, 2007
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
TABLET;ORAL
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN
GRAVITI PHARMS 325MG;37.5MG A076914 001 Jul 26, 2006
MACLEODS PHARMS LTD 325MG;37.5MG A206885 001 May 02, 2017
NOSTRUM LABS INC 325MG;37.5MG A078778 001 Apr 07, 2014
STRIDES PHARMA 325MG;37.5MG A076475 001 Apr 21, 2005
ACETAZOLAMIDE
CAPSULE, EXTENDED RELEASE;ORAL
ACETAZOLAMIDE
INDICUS PHARMA 500MG A090779 001 Jul 14, 2011
RISING 500MG A203917 001 Jun 18, 2019
DIAMOX
+ TEVA BRANDED PHARM 500MG ** N012945 001
TABLET;ORAL
ACETAZOLAMIDE
ALRA 250MG A083320 001
ASCOT 250MG A087686 001 Oct 20, 1982
HERITAGE PHARMA 250MG A088882 001 Oct 22, 1985
SUN PHARM INDUSTRIES 125MG A089753 002 Jun 22, 1988
250MG A089753 001 Jun 22, 1988
VANGARD 250MG A087654 001 Feb 05, 1982
WATSON LABS 250MG A084498 002
DIAMOX
+ TEVA BRANDED PHARM 125MG ** N008943 001
+ 250MG ** N008943 002
ACETAZOLAMIDE SODIUM
INJECTABLE;INJECTION
ACETAZOLAMIDE SODIUM
HOSPIRA EQ 500MG BASE/VIAL A040108 001 Oct 30, 1995
PAR STERILE PRODUCTS EQ 500MG BASE/VIAL A205358 001 Jun 20, 2017
DIAMOX
+ TEVA WOMENS EQ 500MG BASE/VIAL ** N009388 001
ACETIC ACID, GLACIAL
SOLUTION/DROPS;OTIC
ACETASOL
ACTAVIS MID ATLANTIC 2% A087146 001
ACETIC ACID
KV PHARM 2% A085493 001
WOCKHARDT BIO AG 2% A040166 001 Jul 26, 1996
ORLEX
WARNER CHILCOTT 2% A086845 001
ACETIC ACID, GLACIAL; ALUMINUM ACETATE
SOLUTION/DROPS;OTIC
ACETIC ACID 2% IN AQUEOUS ALUMINUM ACETATE
BAUSCH AND LOMB 2%;0.79% A040063 001 Feb 25, 1994
BOROFAIR
PHARMAFAIR 2%;0.79% A088606 001 Aug 21, 1985
DOMEBORO
+ BAYER PHARMS 2%;0.79% A084476 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-12(of 478)
** See List Footnote
ACETIC ACID, GLACIAL; DESONIDE
SOLUTION/DROPS;OTIC
TRIDESILON
BAYER PHARMS 2%;0.05% N017914 001
ACETIC ACID, GLACIAL; HYDROCORTISONE
SOLUTION/DROPS;OTIC
ACETASOL HC
ACTAVIS MID ATLANTIC 2%;1% A087143 001 Jan 13, 1982
ACETIC ACID W/ HYDROCORTISONE
KV PHARM 2%;1% A085492 001
HYDROCORTISONE AND ACETIC ACID
BAUSCH AND LOMB 2%;1% A040097 001 Oct 31, 1994
WOCKHARDT 2%;1% A040168 001 Aug 30, 1996
ORLEX HC
WARNER CHILCOTT 2%;1% A086844 001
ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE
SUSPENSION/DROPS;OTIC
NEO-CORT-DOME
BAYER PHARMS 2%;1%;EQ 0.35% BASE N050238 001
ACETOHEXAMIDE
TABLET;ORAL
ACETOHEXAMIDE
ANI PHARMS 250MG A070870 002 Feb 09, 1987
500MG A070870 001 Feb 09, 1987
USL PHARMA 250MG A070753 001 Nov 03, 1986
500MG A070754 001 Nov 03, 1986
WATSON LABS TEVA 250MG A071893 001 Nov 25, 1987
500MG A071894 001 Nov 25, 1987
DYMELOR
LILLY 250MG N013378 002
500MG N013378 001
ACETOPHENAZINE MALEATE
TABLET;ORAL
TINDAL
SCHERING 20MG N012254 002
ACETRIZOATE SODIUM
SOLUTION;INTRAUTERINE
SALPIX
ORTHO MCNEIL PHARM 53% N009008 001
ACETYLCHOLINE CHLORIDE
FOR SOLUTION;OPHTHALMIC
MIOCHOL
+ NOVARTIS 20MG/VIAL ** N016211 001
ACETYLCYSTEINE
INJECTABLE;INTRAVENOUS
ACETYLCYSTEINE
EXELA PHARMA 6GM/30ML (200MG/ML) A204797 001 Apr 15, 2021
RISING 6GM/30ML (200MG/ML) A203624 001 Jun 19, 2015
SOLUTION;INHALATION, ORAL
ACETYLCYSTEINE
HOSPIRA 10% A071364 001 May 01, 1989
20% A071365 001 May 01, 1989
ROXANE 10% A072323 001 Apr 30, 1992
10% A072621 001 Sep 30, 1992
20% A072324 001 Apr 30, 1992
20% A072622 001 Sep 30, 1992
MUCOMYST
+ APOTHECON 10% ** N013601 002
+ 20% ** N013601 001
MUCOSIL-10
DEY 10% A070575 001 Oct 14, 1986
MUCOSIL-20
DEY 20% A070576 001 Oct 14, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-13(of 478)
** See List Footnote
ACETYLCYSTEINE
TABLET, EFFERVESCENT;ORAL
CETYLEV
+ ARBOR PHARMS LLC 500MG N207916 001 Jan 29, 2016
+ 2.5GM N207916 002 Jan 29, 2016
ACETYLCYSTEINE; ISOPROTERENOL HYDROCHLORIDE
SOLUTION;INHALATION
MUCOMYST W/ ISOPROTERENOL
MEAD JOHNSON 10%;0.05% N017366 001
ACETYLDIGITOXIN
TABLET;ORAL
ACYLANID
NOVARTIS 0.1MG N009436 001
ACITRETIN
CAPSULE;ORAL
ACITRETIN
MYLAN 17.5MG A203707 001 Sep 10, 2015
22.5MG A203707 002 Sep 10, 2015
SORIATANE
+ STIEFEL LABS INC 10MG N019821 001 Oct 28, 1996
+ 17.5MG N019821 003 Aug 06, 2009
+ 22.5MG N019821 004 Aug 06, 2009
+ 25MG N019821 002 Oct 28, 1996
ACRISORCIN
CREAM;TOPICAL
AKRINOL
SCHERING 2MG/GM N012470 001
ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE
CAPSULE;ORAL
SEMPREX-D
+ AUXILIUM PHARMS LLC 8MG;60MG N019806 001 Mar 25, 1994
ACYCLOVIR
CAPSULE;ORAL
ACYCLOVIR
ACTAVIS ELIZABETH 200MG A074906 001 Aug 26, 1997
CHARTWELL MOLECULES 200MG A074872 001 Apr 22, 1997
IVAX SUB TEVA PHARMS 200MG A074674 001 Apr 22, 1997
LEK PHARM 200MG A074750 001 Apr 22, 1997
MYLAN 200MG A074727 001 Apr 22, 1997
200MG A074977 001 Apr 13, 1998
RANBAXY 200MG A074975 001 Sep 30, 1998
ROXANE 200MG A074570 002 Apr 22, 1997
STRIDES PHARMA 200MG A074833 001 Apr 22, 1997
TEVA 200MG A074828 001 Apr 22, 1997
TEVA PHARMS 200MG A074914 001 Nov 26, 1997
WATSON LABS 200MG A075101 001 Apr 15, 1998
ZOVIRAX
+ MYLAN 200MG ** N018828 001 Jan 25, 1985
OINTMENT;OPHTHALMIC
AVACLYR
+ FERA PHARMS LLC 3% ** N202408 001 Mar 29, 2019
OINTMENT;TOPICAL
ACYCLOVIR
ANDA REPOSITORY 5% A206437 001 Jul 31, 2017
PADAGIS ISRAEL 5% A205659 001 Feb 20, 2019
PRINSTON INC 5% A212202 001 Nov 15, 2021
SUSPENSION;ORAL
ACYCLOVIR
AUROBINDO PHARMA 200MG/5ML A216331 001 Mar 31, 2022
TABLET;ORAL
ACYCLOVIR
ACTAVIS ELIZABETH 400MG A074870 001 Jun 05, 1997
800MG A074870 002 Jun 05, 1997
CHARTWELL MOLECULES 400MG A074834 001 Apr 24, 1997
800MG A074834 002 Apr 24, 1997
IVAX SUB TEVA PHARMS 400MG A074836 001 Apr 22, 1997

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-14(of 478)
** See List Footnote
ACYCLOVIR
TABLET;ORAL
ACYCLOVIR
800MG A074836 002 Apr 22, 1997
LEK PHARM 400MG A074658 001 Apr 22, 1997
800MG A074658 002 Apr 22, 1997
MYLAN 400MG A074976 001 Apr 13, 1998
400MG A075211 001 Sep 28, 1998
800MG A074976 002 Apr 13, 1998
800MG A075211 002 Sep 28, 1998
SUN PHARM INDS LTD 400MG A074980 001 Sep 30, 1998
800MG A074980 002 Sep 30, 1998
TEVA 200MG ** A074556 001 Apr 22, 1997
TEVA PHARMS 400MG A075021 001 Mar 18, 1998
800MG A075021 002 Mar 18, 1998
ZOVIRAX
+ MYLAN 400MG ** N020089 001 Apr 30, 1991
+ 800MG ** N020089 002 Apr 30, 1991
ACYCLOVIR SODIUM
INJECTABLE;INJECTION
ACYCLOVIR
ABBVIE EQ 50MG BASE/ML A075114 001 Jul 26, 1999
ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE
EUROHLTH INTL SARL EQ 500MG BASE/VIAL A074885 001 Dec 19, 1997
EQ 1GM BASE/VIAL A074885 002 Dec 19, 1997
ACYCLOVIR SODIUM
APOTHECON EQ 500MG BASE/VIAL A074897 001 Feb 27, 1998
EQ 1GM BASE/VIAL A074897 002 Feb 27, 1998
CHARTWELL INJECTABLE EQ 500MG BASE/VIAL A074596 002 Apr 22, 1997
EQ 1GM BASE/VIAL A074596 001 Apr 22, 1997
DR REDDYS EQ 50MG BASE/ML A207919 001 Jun 17, 2020
EUROHLTH INTL SARL EQ 500MG BASE/VIAL A074913 001 Oct 15, 1997
EQ 1GM BASE/VIAL A074913 002 Oct 15, 1997
FRESENIUS KABI USA EQ 500MG BASE/VIAL A075015 001 Apr 30, 1998
HIKMA EQ 500MG BASE/VIAL A205771 001 Feb 29, 2016
EQ 1GM BASE/VIAL A205771 002 Feb 29, 2016
HOSPIRA EQ 25MG BASE/ML A074720 001 Apr 22, 1997
EQ 50MG BASE/ML A075065 001 Feb 25, 1999
EQ 500MG BASE/VIAL A074663 001 Apr 22, 1997
EQ 500MG BASE/VIAL A074758 001 Apr 22, 1997
EQ 1GM BASE/VIAL A074663 002 Apr 22, 1997
EQ 1GM BASE/VIAL A074758 002 Apr 22, 1997
MYLAN LABS LTD EQ 500MG BASE/VIAL A203927 001 Mar 29, 2017
EQ 1GM BASE/VIAL A203927 002 Mar 29, 2017
TEVA PARENTERAL EQ 50MG BASE/ML A075627 001 Mar 28, 2001
EQ 500MG BASE/VIAL A074969 001 Aug 26, 1997
EQ 1GM BASE/VIAL A074969 002 Aug 26, 1997
ZYDUS PHARMS EQ 500MG BASE/VIAL A206606 001 Jun 13, 2017
EQ 1GM BASE/VIAL A206606 002 Jun 13, 2017
ZOVIRAX
+ GLAXOSMITHKLINE EQ 1GM BASE/VIAL ** N018603 002 Jun 29, 1989
+ EQ 250MG BASE/VIAL ** N018603 003 Aug 30, 1983
+ EQ 500MG BASE/VIAL ** N018603 001 Oct 22, 1982
ADAPALENE
GEL;TOPICAL
ADAPALENE
ENCUBE ETHICALS 0.3% A200298 001 Jun 14, 2012
SOLUTION;TOPICAL
DIFFERIN
+ GALDERMA LABS LP 0.1% ** N020338 001 May 31, 1996
ADAPALENE; BENZOYL PEROXIDE
GEL;TOPICAL
ADAPALENE AND BENZOYL PEROXIDE
ACTAVIS MID ATLANTIC 0.1%;2.5% A203790 001 Sep 30, 2015
ENCUBE 0.1%;2.5% A206164 001 May 23, 2018

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-15(of 478)
** See List Footnote
ADENOSINE
INJECTABLE;INJECTION
ADENOCARD
+ ASTELLAS 3MG/ML ** N019937 002 Oct 30, 1989
ADENOSINE
AM REGENT 3MG/ML A090010 001 Apr 28, 2009
HIKMA 3MG/ML A076501 001 Jun 16, 2004
MYLAN LABS LTD 3MG/ML A078640 001 Mar 21, 2014
TEVA PHARMS USA 3MG/ML A076564 001 Jun 16, 2004
3MG/ML A078676 001 Jul 31, 2008
WOCKHARDT 3MG/ML A090220 001 Jul 20, 2009
SOLUTION;INTRAVENOUS
ADENOSCAN
+ ASTELLAS 60MG/20ML (3MG/ML) ** N020059 001 May 18, 1995
+ 90MG/30ML (3MG/ML) ** N020059 002 May 18, 1995
ALATROFLOXACIN MESYLATE
INJECTABLE;INJECTION
TROVAN PRESERVATIVE FREE
PFIZER EQ 200MG BASE/VIAL N020760 001 Dec 18, 1997
EQ 300MG BASE/VIAL N020760 002 Dec 18, 1997
ALBENDAZOLE
TABLET;ORAL
ALBENDAZOLE
LUPIN LTD 200MG A211636 001 Jun 10, 2020
ALBENZA
+ IMPAX LABS INC 200MG N020666 001 Jun 11, 1996
ALBUTEROL
AEROSOL, METERED;INHALATION
ALBUTEROL
ARMSTRONG PHARMS 0.09MG/INH A072273 001 Aug 14, 1996
GENPHARM 0.09MG/INH A073045 001 Aug 19, 1997
IVAX SUB TEVA PHARMS 0.09MG/INH A073272 001 Dec 28, 1995
PLIVA 0.09MG/INH A074072 001 Aug 01, 1996
PROVENTIL
SCHERING 0.09MG/INH N017559 001
VENTOLIN
GLAXOSMITHKLINE 0.09MG/INH N018473 001
ALBUTEROL SULFATE
AEROSOL, METERED;INHALATION
ALBUTEROL SULFATE
PADAGIS US EQ 0.09MG BASE/INH A203760 001 Feb 24, 2020
CAPSULE;INHALATION
VENTOLIN ROTACAPS
GLAXOSMITHKLINE EQ 0.2MG BASE N019489 001 May 04, 1988
SOLUTION;INHALATION
ACCUNEB
+ MYLAN SPECIALITY LP EQ 0.042% BASE N020949 001 Apr 30, 2001
ALBUTEROL SULFATE
ACTAVIS MID ATLANTIC EQ 0.083% BASE A073533 001 Sep 26, 1995
AKORN EQ 0.083% BASE A075063 001 Feb 09, 1999
APOTEX INC EQ 0.021% BASE A078623 001 Apr 05, 2010
EQ 0.042% BASE A078623 002 Apr 05, 2010
EQ 0.083% BASE A075717 001 Feb 02, 2007
EQ 0.5% BASE A076391 001 Apr 01, 2003
BAUSCH EQ 0.083% BASE A075358 001 Mar 29, 2000
EQ 0.5% BASE A075050 001 Jun 18, 1998
COPLEY PHARM EQ 0.083% BASE A073495 001 May 28, 1993
EQ 0.5% BASE A073307 001 Nov 27, 1991
LANDELA PHARM EQ 0.083% BASE A077569 001 Apr 04, 2006
LUOXIN AUROVITAS EQ 0.021% BASE A211888 001 Apr 20, 2020
EQ 0.042% BASE A211888 002 Apr 20, 2020
MYLAN SPECLT EQ 0.083% BASE ** A072652 001 Feb 21, 1992
ROXANE EQ 0.083% BASE A075129 001 Feb 13, 2001
TEVA PHARMS EQ 0.083% BASE A075343 001 Nov 09, 1999
WATSON LABS INC EQ 0.083% BASE A076370 001 Nov 24, 2003
WOCKHARDT EU OPERATN EQ 0.083% BASE A075394 001 Nov 22, 1999

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-16(of 478)
** See List Footnote
ALBUTEROL SULFATE
SOLUTION;INHALATION
PROVENTIL
+ SCHERING EQ 0.083% BASE ** N019243 002 Jan 14, 1987
+ EQ 0.5% BASE ** N019243 001 Jan 14, 1987
VENTOLIN
+ GLAXOSMITHKLINE EQ 0.083% BASE ** N019773 001 Apr 23, 1992
EQ 0.5% BASE ** N019269 002 Jan 16, 1987
SYRUP;ORAL
ALBUTEROL SULFATE
ACTAVIS MID ATLANTIC EQ 2MG BASE/5ML A075262 001 Mar 30, 1999
MOVA EQ 2MG BASE/5ML A074302 001 Sep 30, 1994
WATSON LABS EQ 2MG BASE/5ML A073165 001 Apr 29, 1993
PROVENTIL
+ SCHERING EQ 2MG BASE/5ML ** N018062 001 Jan 19, 1983
VENTOLIN
GLAXOSMITHKLINE EQ 2MG BASE/5ML ** N019621 001 Jun 10, 1987
TABLET;ORAL
ALBUTEROL SULFATE
AM THERAP EQ 2MG BASE A072449 001 Dec 05, 1989
EQ 4MG BASE A072450 001 Dec 05, 1989
AUROBINDO PHARMA LTD EQ 2MG BASE A213657 001 May 14, 2020
EQ 4MG BASE A213657 002 May 14, 2020
CHARTWELL RX EQ 2MG BASE A072151 001 Dec 05, 1989
EQ 4MG BASE A072151 002 Dec 05, 1989
COPLEY PHARM EQ 2MG BASE A072966 001 Nov 22, 1991
EQ 4MG BASE A072967 001 Nov 22, 1991
EYWA EQ 2MG BASE A213524 001 Oct 08, 2020
EQ 4MG BASE A213524 002 Oct 08, 2020
PLIVA EQ 2MG BASE A072316 001 Dec 05, 1989
EQ 4MG BASE A072317 001 Dec 05, 1989
STRIDES PHARMA EQ 2MG BASE A072860 002 Dec 20, 1989
EQ 4MG BASE A072860 001 Dec 20, 1989
TEVA EQ 2MG BASE A072619 001 Dec 05, 1989
EQ 2MG BASE A072779 001 Jun 25, 1993
EQ 2MG BASE A072938 001 Mar 30, 1990
EQ 4MG BASE A072620 001 Dec 05, 1989
EQ 4MG BASE A072780 001 Jun 25, 1993
EQ 4MG BASE A072939 001 Mar 30, 1990
UCB INC EQ 2MG BASE A073120 001 Sep 29, 1992
EQ 4MG BASE A073121 001 Sep 29, 1992
WARNER CHILCOTT EQ 2MG BASE A072817 001 Jan 09, 1990
EQ 4MG BASE A072818 001 Jan 09, 1990
WATSON LABS EQ 2MG BASE A072629 001 Jan 31, 1991
EQ 2MG BASE A072764 001 Aug 28, 1991
EQ 4MG BASE A072630 001 Jan 31, 1991
EQ 4MG BASE A072765 001 Aug 28, 1991
PROVENTIL
+ SCHERING EQ 2MG BASE ** N017853 001 May 07, 1982
+ EQ 4MG BASE ** N017853 002 May 07, 1982
VENTOLIN
GLAXOSMITHKLINE EQ 2MG BASE N019112 001 Jul 10, 1986
EQ 4MG BASE N019112 002 Jul 10, 1986
TABLET, EXTENDED RELEASE;ORAL
ALBUTEROL SULFATE
RISING EQ 4MG BASE A078092 002 Jan 29, 2007
EQ 8MG BASE A078092 001 Jan 29, 2007
PROVENTIL
SCHERING EQ 4MG BASE N019383 001 Jul 13, 1987
VOLMAX
+ MURO EQ 4MG BASE N019604 002 Dec 23, 1992
+ EQ 8MG BASE N019604 001 Dec 23, 1992
VOSPIRE ER
STRIDES PHARMA EQ 4MG BASE A076130 002 Sep 26, 2002
EQ 8MG BASE A076130 003 Sep 26, 2002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-17(of 478)
** See List Footnote
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE
AEROSOL, METERED;INHALATION
COMBIVENT
BOEHRINGER INGELHEIM EQ 0.09MG BASE/INH;0.018MG/INH N020291 001 Oct 24, 1996
SOLUTION;INHALATION
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
APOTEX INC EQ 0.083% BASE;0.017% A077117 001 Dec 31, 2007
FOSUN PHARMA EQ 0.083% BASE;0.017% A076867 001 Dec 21, 2006
LUOXIN AUROVITAS EQ 0.083% BASE;0.017% A206532 001 Jul 08, 2020
TEVA PHARMS EQ 0.083% BASE;0.017% A076724 001 Dec 31, 2007
WATSON LABS TEVA EQ 0.083% BASE;0.017% A077063 001 Dec 31, 2007
DUONEB
+ MYLAN SPECIALITY LP EQ 0.083% BASE;0.017% ** N020950 001 Mar 21, 2001
ALCLOMETASONE DIPROPIONATE
CREAM;TOPICAL
ACLOVATE
+ FOUGERA PHARMS 0.05% ** N018707 001 Dec 14, 1982
OINTMENT;TOPICAL
ACLOVATE
+ FOUGERA PHARMS 0.05% ** N018702 001 Dec 14, 1982
ALENDRONATE SODIUM
SOLUTION;ORAL
FOSAMAX
+ MERCK EQ 70MG BASE/75ML ** N021575 001 Sep 17, 2003
TABLET;ORAL
ALENDRONATE SODIUM
CHARTWELL RX EQ 5MG BASE A075871 001 Apr 22, 2009
EQ 10MG BASE A075871 002 Apr 22, 2009
EQ 35MG BASE A075871 004 Apr 22, 2009
EQ 40MG BASE A075871 003 Apr 22, 2009
EQ 70MG BASE A075871 005 Apr 22, 2009
IMPAX LABS INC EQ 5MG BASE A075710 001 Feb 06, 2008
EQ 10MG BASE A075710 002 Feb 06, 2008
EQ 35MG BASE A075710 003 Feb 06, 2008
EQ 40MG BASE A075710 004 Feb 06, 2008
EQ 70MG BASE A075710 005 Feb 06, 2008
JUBILANT CADISTA EQ 5MG BASE A090557 001 Feb 18, 2010
EQ 10MG BASE A090557 002 Feb 18, 2010
EQ 35MG BASE A090557 003 Feb 18, 2010
EQ 70MG BASE A090557 004 Feb 18, 2010
MYLAN EQ 35MG BASE A078638 001 Aug 04, 2008
EQ 70MG BASE A078638 002 Aug 04, 2008
PICKET PHARMS EQ 5MG BASE A079049 003 Aug 04, 2008
EQ 10MG BASE A079049 004 Aug 04, 2008
EQ 35MG BASE A079049 001 Aug 04, 2008
EQ 70MG BASE A079049 002 Aug 04, 2008
RISING EQ 5MG BASE A076584 001 Aug 04, 2008
EQ 10MG BASE A076584 002 Aug 04, 2008
EQ 35MG BASE A076584 003 Aug 04, 2008
EQ 70MG BASE A076584 004 Aug 04, 2008
TEVA PHARMS EQ 35MG BASE A076184 002 Aug 04, 2008
EQ 70MG BASE A076184 001 Feb 06, 2008
FOSAMAX
+ ORGANON EQ 5MG BASE ** N020560 003 Apr 25, 1997
+ EQ 10MG BASE ** N020560 001 Sep 29, 1995
+ EQ 35MG BASE ** N020560 004 Oct 20, 2000
+ EQ 40MG BASE ** N020560 002 Sep 29, 1995
ALFUZOSIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
ALFUZOSIN HYDROCHLORIDE
HERITAGE PHARMA 10MG A079056 001 Jul 18, 2011
MYLAN 10MG A079014 001 Jul 18, 2011
TORRENT PHARMS 10MG A079054 001 Jul 18, 2011
WOCKHARDT 10MG A090221 001 Aug 10, 2012

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-18(of 478)
** See List Footnote
ALISKIREN HEMIFUMARATE
CAPSULE, PELLET;ORAL
TEKTURNA
+ NODEN PHARMA EQ 37.5MG BASE N210709 001 Nov 14, 2017
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE
TABLET;ORAL
TEKAMLO
NOVARTIS EQ 150MG BASE;EQ 5MG BASE N022545 001 Aug 26, 2010
EQ 150MG BASE;EQ 10MG BASE N022545 002 Aug 26, 2010
EQ 300MG BASE;EQ 5MG BASE N022545 003 Aug 26, 2010
EQ 300MG BASE;EQ 10MG BASE N022545 004 Aug 26, 2010
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE
TABLET;ORAL
AMTURNIDE
NOVARTIS EQ 150MG BASE;EQ 5MG BASE;12.5MG N200045 001 Dec 21, 2010
EQ 300MG BASE;EQ 5MG BASE;12.5MG N200045 002 Dec 21, 2010
EQ 300MG BASE;EQ 5MG BASE;25MG N200045 003 Dec 21, 2010
EQ 300MG BASE;EQ 10MG BASE;12.5MG N200045 004 Dec 21, 2010
EQ 300MG BASE;EQ 10MG BASE;25MG N200045 005 Dec 21, 2010
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
TABLET;ORAL
TEKTURNA HCT
+ NODEN PHARMA EQ 150MG BASE;12.5MG N022107 001 Jan 18, 2008
+ EQ 150MG BASE;25MG N022107 002 Jan 18, 2008
+ EQ 300MG BASE;12.5MG N022107 003 Jan 18, 2008
+ EQ 300MG BASE;25MG N022107 004 Jan 18, 2008
ALISKIREN HEMIFUMARATE; VALSARTAN
TABLET;ORAL
VALTURNA
NOVARTIS EQ 150MG BASE;160MG N022217 001 Sep 16, 2009
EQ 300MG BASE;320MG N022217 002 Sep 16, 2009
ALKAVERVIR
TABLET;ORAL
VERILOID
3M 2MG N007336 002
3MG N007336 003
ALLOPURINOL
TABLET;ORAL
ALLOPURINOL
FOSUN PHARMA 100MG A070268 001 Dec 31, 1985
MUTUAL PHARM 100MG A070466 001 Dec 24, 1985
300MG A070467 001 Dec 24, 1985
PURACAP PHARM 100MG A070150 001 Dec 10, 1985
300MG A070147 001 Dec 10, 1985
PUREPAC PHARM 100MG A070579 001 Apr 14, 1986
300MG A070580 001 Apr 14, 1986
SANDOZ 300MG A070269 001 Dec 31, 1985
SUN PHARM INDS INC 100MG A078390 001 Aug 30, 2007
300MG A078390 002 Aug 30, 2007
SUPERPHARM 100MG A070950 001 Nov 30, 1988
300MG A070951 001 Nov 30, 1988
WATSON LABS 100MG N018241 001 Nov 16, 1984
100MG N018785 001 Sep 28, 1984
300MG N018241 002 Nov 16, 1984
300MG N018785 002 Sep 28, 1984
LOPURIN
ABBOTT 100MG N018297 001
300MG N018297 002
ALLOPURINOL; LESINURAD
TABLET;ORAL
DUZALLO
+ IRONWOOD PHARMS INC 200MG;200MG N209203 001 Aug 18, 2017
+ 300MG;200MG N209203 002 Aug 18, 2017

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-19(of 478)
** See List Footnote
ALMOTRIPTAN MALATE
TABLET;ORAL
AXERT
+ JANSSEN PHARMS EQ 6.25MG BASE ** N021001 001 May 07, 2001
+ EQ 12.5MG BASE ** N021001 002 May 07, 2001
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
TABLET;ORAL
OSENI
+ TAKEDA PHARMS USA EQ 12.5MG BASE;EQ 15MG BASE N022426 004 Jan 25, 2013
+ EQ 12.5MG BASE;EQ 45MG BASE N022426 006 Jan 25, 2013
ALOSETRON HYDROCHLORIDE
TABLET;ORAL
ALOSETRON HYDROCHLORIDE
EYWA PHARMA EQ 0.5MG BASE A211621 001 Sep 16, 2019
EQ 1MG BASE A211621 002 Sep 16, 2019
PAR PHARM INC EQ 0.5MG BASE A206113 001 Feb 23, 2018
EQ 1MG BASE A206113 002 Feb 23, 2018
ALPRAZOLAM
SOLUTION;ORAL
ALPRAZOLAM
ROXANE 0.5MG/5ML A074314 001 Oct 31, 1993
TABLET;ORAL
ALPRAZOLAM
ANI PHARMS 0.25MG A074085 001 Feb 16, 1994
0.5MG A074085 002 Feb 16, 1994
1MG A074085 003 Feb 16, 1994
2MG A074085 004 Feb 26, 1996
IVAX SUB TEVA PHARMS 0.25MG A074294 001 Jul 29, 1994
0.5MG A074294 002 Jul 29, 1994
1MG A074294 003 Jul 29, 1994
2MG A074294 004 Jul 29, 1994
MYLAN 0.25MG A074215 001 Jan 27, 1994
0.5MG A074215 002 Jan 27, 1994
1MG A074215 003 Jan 27, 1994
2MG A074215 004 Jan 27, 1994
MYLAN PHARMS INC 0.25MG A074046 001 Oct 19, 1993
0.5MG A074046 002 Oct 19, 1993
1MG A074046 003 Oct 19, 1993
2MG A074046 004 May 07, 1997
OXFORD PHARMS 0.25MG A078491 001 Sep 25, 2008
0.5MG A078491 002 Sep 25, 2008
1MG A078491 003 Sep 25, 2008
2MG A078491 004 Dec 12, 2008
ROXANE 0.25MG A074199 001 Oct 19, 1993
0.5MG A074199 002 Oct 19, 1993
1MG A074199 003 Oct 19, 1993
WATSON LABS 0.25MG A074456 001 Aug 31, 1995
0.25MG A074479 001 Jan 21, 1997
0.5MG A074456 002 Aug 31, 1995
0.5MG A074479 002 Jan 21, 1997
1MG A074456 003 Aug 31, 1995
1MG A074479 003 Jan 21, 1997
TABLET, EXTENDED RELEASE;ORAL
ALPRAZOLAM
ACTAVIS LABS FL INC 0.5MG A077198 001 May 13, 2010
1MG A077198 002 May 13, 2010
2MG A077198 003 May 13, 2010
3MG A077198 004 May 13, 2010
ANI PHARMS 0.5MG A077725 001 Jul 31, 2006
0.5MG A077979 001 Feb 28, 2007
1MG A077725 002 Jul 31, 2006
1MG A077979 002 Feb 28, 2007
2MG A077725 004 Jul 31, 2006
2MG A077979 003 Feb 28, 2007
3MG A077725 003 Jul 31, 2006
3MG A077979 004 Feb 28, 2007
HERITAGE PHARMS INC 0.5MG A078489 001 Oct 17, 2008
1MG A078489 002 Oct 17, 2008

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-20(of 478)
** See List Footnote
ALPRAZOLAM
TABLET, EXTENDED RELEASE;ORAL
ALPRAZOLAM
2MG A078489 003 Oct 17, 2008
3MG A078489 004 Oct 17, 2008
IMPAX LABS 0.5MG A077968 004 May 24, 2007
1MG A077968 003 May 24, 2007
2MG A077968 002 May 24, 2007
3MG A077968 001 May 24, 2007
IMPAX LABS INC 0.5MG A077996 001 Jan 31, 2007
1MG A077996 002 Jan 31, 2007
2MG A077996 003 Jan 31, 2007
3MG A077996 004 Jan 31, 2007
MYLAN 0.5MG A077391 002 Jan 26, 2006
1MG A077391 003 Jan 26, 2006
2MG A077391 004 Jan 26, 2006
3MG A077391 001 Jan 26, 2006
SANDOZ INC 0.5MG A077777 001 Jun 30, 2006
1MG A077777 002 Jun 30, 2006
2MG A077777 003 Jun 30, 2006
3MG A077777 004 Jun 30, 2006
VINTAGE PHARMS 0.5MG A078442 001 Oct 15, 2007
1MG A078442 002 Oct 15, 2007
2MG A078442 003 Oct 15, 2007
3MG A078442 004 Oct 15, 2007
TABLET, ORALLY DISINTEGRATING;ORAL
NIRAVAM
+ UCB INC 0.25MG ** N021726 001 Jan 19, 2005
+ 0.5MG ** N021726 002 Jan 19, 2005
+ 1MG ** N021726 003 Jan 19, 2005
+ 2MG ** N021726 004 Jan 19, 2005
ALPROSTADIL
INJECTABLE;INJECTION
CAVERJECT
+ PFIZER 0.005MG/VIAL N020379 003 Jun 27, 1996
0.005MG/ML N020755 001 Oct 31, 1997
0.01MG/ML N020755 002 Oct 01, 1997
0.02MG/ML N020755 003 Oct 01, 1997
EDEX
AUXILIUM PHARMS LLC 0.005MG/VIAL N020649 001 Jun 12, 1997
SUPPOSITORY;URETHRAL
MUSE
+ MYLAN SPECIALITY LP 0.125MG N020700 001 Nov 19, 1996
ALSEROXYLON
TABLET;ORAL
RAUTENSIN
NOVARTIS 2MG N009215 001
RAUWILOID
3M 2MG N008867 001
ALTRETAMINE
CAPSULE;ORAL
HEXALEN
+ EISAI INC 50MG N019926 001 Dec 26, 1990
ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE
TABLET, CHEWABLE;ORAL
ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE
PENNEX 80MG;20MG A089449 001 Nov 27, 1987
FOAMCOAT
GUARDIAN DRUG 80MG;20MG A071793 001 Sep 04, 1987
FOAMICON
NOVARTIS 80MG;20MG A072687 001 Jun 28, 1989
GAVISCON
+ CHATTEM SANOFI 80MG;20MG N018685 001 Dec 09, 1983
+ 160MG;40MG N018685 002 Dec 09, 1983

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-21(of 478)
** See List Footnote
AMANTADINE HYDROCHLORIDE
CAPSULE;ORAL
AMANTADINE HYDROCHLORIDE
ACTAVIS ELIZABETH 100MG A077659 001 Feb 23, 2006
CHARTWELL MOLECULAR 100MG A209221 001 Jun 15, 2017
INVAGEN PHARMS 100MG A207570 001 Sep 30, 2016
WATSON LABS 100MG A071382 001 Jan 21, 1987
WATSON LABS INC 100MG A208107 001 Dec 06, 2016
SYMADINE
SOLVAY 100MG A071000 001 Sep 04, 1986
SYMMETREL
+ ENDO PHARMS 100MG ** N016020 001
SYRUP;ORAL
AMANTADINE HYDROCHLORIDE
ANDA REPOSITORY 50MG/5ML A076352 001 Sep 10, 2004
G AND W LABS INC 50MG/5ML A072655 001 Oct 30, 1990
TEVA PHARMS 50MG/5ML A073115 001 Aug 23, 1991
VINTAGE 50MG/5ML A077992 001 Dec 12, 2006
XTTRIUM LABS INC 50MG/5ML A075060 001 Dec 24, 1998
SYMMETREL
+ ENDO PHARMS 50MG/5ML ** N016023 002
TABLET;ORAL
AMANTADINE HYDROCHLORIDE
EDENBRIDGE PHARMS 100MG A212407 001 May 27, 2022
INVAGEN PHARMS 100MG A207571 001 Jan 31, 2017
JUBILANT GENERICS 100MG A210403 001 Feb 07, 2018
SYMMETREL
+ ENDO PHARMS 100MG ** N018101 001
TABLET, EXTENDED RELEASE;ORAL
OSMOLEX ER
+ ADAMAS OPERATIONS EQ 161MG BASE N209410 004 Apr 22, 2020
+ EQ 258MG BASE N209410 003 Feb 16, 2018
AMBENONIUM CHLORIDE
TABLET;ORAL
MYTELASE
SANOFI AVENTIS US 10MG N010155 002
AMCINONIDE
CREAM;TOPICAL
CYCLOCORT
+ ASTELLAS 0.025% ** N018116 001
+ 0.1% ** N018116 002
LOTION;TOPICAL
CYCLOCORT
+ ASTELLAS 0.1% N019729 001 Jun 13, 1988
OINTMENT;TOPICAL
CYCLOCORT
+ ASTELLAS 0.1% ** N018498 001
AMDINOCILLIN
INJECTABLE;INJECTION
COACTIN
ROCHE 250MG/VIAL N050565 001 Dec 21, 1984
500MG/VIAL N050565 002 Dec 21, 1984
1GM/VIAL N050565 003 Dec 21, 1984
AMIFOSTINE
INJECTABLE;INJECTION
AMIFOSTINE
EUGIA PHARMA SPECLTS 500MG/VIAL A204363 001 Jul 17, 2017
ETHYOL
CLINIGEN 375MG/VIAL N020221 002 Sep 10, 1999
AMIKACIN SULFATE
INJECTABLE;INJECTION
AMIKACIN SULFATE
ABBOTT EQ 250MG BASE/ML A063265 001 Nov 30, 1994
EQ 250MG BASE/ML A063266 001 Oct 31, 1994
HIKMA EQ 50MG BASE/ML A063274 001 May 18, 1992
EQ 250MG BASE/ML A063275 001 May 18, 1992
HOSPIRA EQ 50MG BASE/ML A063263 001 Nov 30, 1994

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-22(of 478)
** See List Footnote
AMIKACIN SULFATE
INJECTABLE;INJECTION
AMIKACIN SULFATE
EQ 50MG BASE/ML A063350 001 Jul 30, 1993
EQ 62.5MG BASE/ML A063283 001 Oct 31, 1994
EQ 250MG BASE/ML A063264 001 Nov 30, 1994
EQ 250MG BASE/ML A063350 002 Jul 30, 1993
EQ 250MG BASE/ML A064098 001 Jun 26, 1995
EQ 250MG BASE/ML A064099 001 Jun 20, 1995
IGI LABS INC EQ 50MG BASE/ML A063167 001 Dec 14, 1995
EQ 250MG BASE/ML A063169 001 Dec 14, 1995
TEVA PHARMS USA EQ 50MG BASE/ML A064045 001 Sep 28, 1993
AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
HOSPIRA EQ 500MG BASE/100ML A064146 001 Apr 02, 1997
AMIKIN
APOTHECON EQ 50MG BASE/ML A062311 001
EQ 50MG BASE/ML A062562 001 Sep 20, 1984
+ EQ 50MG BASE/ML ** N050495 001
EQ 250MG BASE/ML A062311 002
EQ 250MG BASE/ML A062562 002 Sep 20, 1984
+ EQ 250MG BASE/ML ** N050495 002
AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
APOTHECON EQ 5MG BASE/ML N050618 002 Nov 30, 1987
EQ 10MG BASE/ML N050618 001 Nov 30, 1987
AMILORIDE HYDROCHLORIDE
TABLET;ORAL
AMILORIDE HYDROCHLORIDE
CHARTWELL RX 5MG A204180 001 Aug 07, 2015
AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
TABLET;ORAL
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
CHARTWELL RX EQ 5MG ANHYDROUS;50MG A073357 001 Nov 27, 1991
TEVA EQ 5MG ANHYDROUS;50MG A070795 001 Apr 17, 1988
WATSON LABS EQ 5MG ANHYDROUS;50MG A073334 001 Jul 19, 1991
HYDRO-RIDE
PAR PHARM EQ 5MG ANHYDROUS;50MG A070347 001 Dec 25, 1990
MODURETIC 5-50
+ MERCK EQ 5MG ANHYDROUS;50MG ** N018201 001
AMINO ACIDS
INJECTABLE;INJECTION
AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE
HOSPIRA 5.2% (5.2GM/100ML) N018901 001 Apr 06, 1984
AMINOSYN 10%
ICU MEDICAL INC 10% (10GM/100ML) N017673 003
AMINOSYN 10% (PH6)
ICU MEDICAL INC 10% (10GM/100ML) N017673 008 Nov 18, 1985
AMINOSYN 3.5%
ICU MEDICAL INC 3.5% (3.5GM/100ML) N017789 004
AMINOSYN 3.5% IN PLASTIC CONTAINER
ABBOTT 3.5% (3.5GM/100ML) N018804 001 May 15, 1984
3.5% (3.5GM/100ML) N018875 001 Aug 08, 1984
AMINOSYN 5%
ICU MEDICAL INC 5% (5GM/100ML) N017673 001
AMINOSYN 7%
ICU MEDICAL INC 7% (7GM/100ML) N017673 002
AMINOSYN 7% (PH6)
ICU MEDICAL INC 7% (7GM/100ML) N017673 006 Nov 18, 1985
AMINOSYN 8.5%
ICU MEDICAL INC 8.5% (8.5GM/100ML) N017673 004
AMINOSYN 8.5% (PH6)
ICU MEDICAL INC 8.5% (8.5GM/100ML) N017673 007 Nov 18, 1985
AMINOSYN II 10%
ICU MEDICAL INC 10% (10GM/100ML) N019438 005 Apr 03, 1986
AMINOSYN II 3.5%
ICU MEDICAL INC 3.5% (3.5GM/100ML) N019438 001 Apr 03, 1986
AMINOSYN II 3.5% IN PLASTIC CONTAINER
ABBOTT 3.5% (3.5GM/100ML) N019491 001 Oct 10, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-23(of 478)
** See List Footnote
AMINO ACIDS
INJECTABLE;INJECTION
AMINOSYN II 5%
ICU MEDICAL INC 5% (5GM/100ML) N019438 002 Apr 03, 1986
AMINOSYN II 7%
ICU MEDICAL INC 7% (7GM/100ML) N019438 003 Apr 03, 1986
AMINOSYN II 8.5%
ICU MEDICAL INC 8.5% (8.5GM/100ML) N019438 004 Apr 03, 1986
AMINOSYN-HBC 7%
ICU MEDICAL INC 7% (7GM/100ML) N019374 001 Jul 12, 1985
AMINOSYN-HBC 7% IN PLASTIC CONTAINER
ABBOTT 7% (7GM/100ML) N019400 001 Jul 23, 1986
AMINOSYN-HF 8%
ICU MEDICAL INC 8% (8GM/100ML) A020345 001 Apr 04, 1996
AMINOSYN-RF 5.2%
ICU MEDICAL INC 5.2% (5.2GM/100ML) N018429 001
BRANCHAMIN 4%
BAXTER HLTHCARE 4% (4GM/100ML) N018678 001 Sep 28, 1984
BRANCHAMIN 4% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4% (4GM/100ML) N018684 001 Sep 28, 1984
FREAMINE 8.5%
B BRAUN 8.5% (8.5GM/100ML) N016822 001
FREAMINE II 8.5%
B BRAUN 8.5% (8.5GM/100ML) N016822 002
HEPATASOL 8%
BAXTER HLTHCARE 8% (8GM/100ML) A020360 001 Apr 04, 1996
NEOPHAM 6.4%
HOSPIRA 6.4% (6.4GM/100ML) N018792 001 Jan 17, 1984
NEPHRAMINE 5.4%
B BRAUN 5.4% (5.4GM/100ML) N017766 001
NOVAMINE 11.4%
HOSPIRA INC 11.4% (11.4GM/100ML) N017957 003 Aug 09, 1982
NOVAMINE 15%
HOSPIRA INC 15% (75GM/500ML) N017957 004 Nov 28, 1986
NOVAMINE 15% SULFITE FREE IN PLASTIC CONTAINER
BAXTER HLTHCARE 15% (15GM/100ML) ** N020107 001 Feb 05, 1993
NOVAMINE 8.5%
HOSPIRA INC 8.5% (8.5GM/100ML) N017957 002 Aug 09, 1982
RENAMIN W/O ELECTROLYTES
BAXTER HLTHCARE 6.5% (6.5GM/100ML) N017493 007 Oct 15, 1982
TRAVASOL 10% W/O ELECTROLYTES
BAXTER HLTHCARE 10% (10GM/100ML) N017493 006
TRAVASOL 5.5% W/O ELECTROLYTES
BAXTER HLTHCARE 5.5% (5.5GM/100ML) N017493 004
TRAVASOL 8.5% W/O ELECTROLYTES
BAXTER HLTHCARE 8.5% (8.5GM/100ML) N017493 005
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM
PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE;INJECTION
AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
ABBOTT 3.5%;36.8MG/100ML;25GM/100ML;51MG/100ML N019714 001 Sep 12, 1988
;22.4MG/100ML;261MG/100ML;205MG/100ML

HOSPIRA INC 3.5%;36.8MG/100ML;25GM/100ML;51MG/100ML N019683 001 Nov 07, 1988


;22.4MG/100ML;261MG/100ML;205MG/100ML

AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER


ABBOTT 4.25%;36.8MG/100ML;20GM/100ML;51MG/100M N019714 002 Sep 12, 1988
L;22.4MG/100ML;261MG/100ML;205MG/100ML

HOSPIRA INC 4.25%;36.8MG/100ML;20GM/100ML;51MG/100M N019683 002 Nov 07, 1988


L;22.4MG/100ML;261MG/100ML;205MG/100ML

AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER


ABBOTT 4.25%;36.8MG/100ML;25GM/100ML;51MG/100M N019714 004 Sep 12, 1988
L;22.4MG/100ML;261MG/100ML;205MG/100ML

HOSPIRA INC 4.25%;36.8MG/100ML;25GM/100ML;51MG/100M N019683 003 Nov 07, 1988


L;22.4MG/100ML;261MG/100ML;205MG/100ML

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-24(of 478)
** See List Footnote
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM
PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE;INJECTION
AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
ABBOTT 5%;36.8MG/100ML;25GM/100ML;51MG/100ML;2 N019714 003 Sep 12, 1988
2.4MG/100ML;261MG/100ML;205MG/100ML
HOSPIRA INC 5%;36.8MG/100ML;25GM/100ML;51MG/100ML;2 N019683 004 Nov 07, 1988
2.4MG/100ML;261MG/100ML;205MG/100ML
AMINO ACIDS; DEXTROSE
INJECTABLE;INJECTION
AMINOSYN 3.5% W/ DEXTROSE 25% IN PLASTIC CONTAINER
ABBOTT 3.5%;25GM/100ML N019118 001 Oct 11, 1984
AMINOSYN 3.5% W/ DEXTROSE 5% IN PLASTIC CONTAINER
ABBOTT 3.5%;5GM/100ML N019120 001 Oct 11, 1984
AMINOSYN 4.25% W/ DEXTROSE 25% IN PLASTIC CONTAINER
ABBOTT 4.25%;25GM/100ML N019119 001 Oct 11, 1984
AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER
ABBOTT 3.5%;25GM/100ML N019505 002 Nov 07, 1986
3.5%;25GM/100ML N019713 006 Sep 09, 1988
HOSPIRA 3.5%;25GM/100ML N019681 001 Nov 01, 1988
AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER
ABBOTT 3.5%;5GM/100ML N019506 001 Nov 07, 1986
3.5%;5GM/100ML N019713 002 Sep 09, 1988
HOSPIRA 3.5%;5GM/100ML N019681 002 Nov 01, 1988
AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
ABBOTT 4.25%;10GM/100ML N019713 001 Sep 09, 1988
HOSPIRA 4.25%;10GM/100ML N019681 004 Nov 01, 1988
AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER
ABBOTT 4.25%;20GM/100ML N019713 004 Sep 09, 1988
HOSPIRA 4.25%;20GM/100ML N019681 005 Nov 01, 1988
AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER
ABBOTT 4.25%;25GM/100ML N019504 002 Nov 07, 1986
4.25%;25GM/100ML N019713 005 Sep 09, 1988
HOSPIRA 4.25%;25GM/100ML N019681 003 Nov 01, 1988
AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER
ABBOTT 5%;25GM/100ML N019565 001 Dec 17, 1986
5%;25GM/100ML N019713 003 Sep 09, 1988
HOSPIRA 5%;25GM/100ML N019681 006 Nov 01, 1988
TRAVASOL 2.75% IN DEXTROSE 10% IN PLASTIC CONTAINER
BAXTER HLTHCARE 2.75%;10GM/100ML N019520 002 Sep 23, 1988
TRAVASOL 2.75% IN DEXTROSE 15% IN PLASTIC CONTAINER
BAXTER HLTHCARE 2.75%;15GM/100ML N019520 003 Sep 23, 1988
TRAVASOL 2.75% IN DEXTROSE 20% IN PLASTIC CONTAINER
BAXTER HLTHCARE 2.75%;20GM/100ML N019520 004 Sep 23, 1988
TRAVASOL 2.75% IN DEXTROSE 25% IN PLASTIC CONTAINER
BAXTER HLTHCARE 2.75%;25GM/100ML N019520 005 Sep 23, 1988
TRAVASOL 2.75% IN DEXTROSE 5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 2.75%;5GM/100ML N019520 001 Sep 23, 1988
TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4.25%;10GM/100ML N019520 007 Sep 23, 1988
TRAVASOL 4.25% IN DEXTROSE 15% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4.25%;15GM/100ML N019520 008 Sep 23, 1988
TRAVASOL 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4.25%;20GM/100ML N019520 009 Sep 23, 1988
TRAVASOL 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4.25%;25GM/100ML N019520 010 Sep 23, 1988
TRAVASOL 4.25% IN DEXTROSE 5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4.25%;5GM/100ML N019520 006 Sep 23, 1988
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; POTASSIUM CHLORIDE; POTASSIUM
PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE;INJECTION
AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER
ABBOTT 4.25%;10GM/100ML;51MG/100ML;176.5MG/100 N019712 002 Sep 08, 1988
ML;22.4MG/100ML;104.5MG/100ML;205MG/100
ML
HOSPIRA INC 4.25%;10GM/100ML;51MG/100ML;176.5MG/100 N019682 003 Nov 01, 1988
ML;22.4MG/100ML;104.5MG/100ML;205MG/100
ML

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-25(of 478)
** See List Footnote
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC;
SODIUM CHLORIDE
INJECTABLE;INJECTION
AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER
ABBOTT 3.5%;25GM/100ML;51MG/100ML;22.4MG/100ML N019564 002 Dec 16, 1986
;261MG/100ML;205MG/100ML
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER
ABBOTT 4.25%;25GM/100ML;51MG/100ML;22.4MG/100M N019564 004 Dec 16, 1986
L;261MG/100ML;205MG/100ML
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE,
DIBASIC, HEPTAHYDRATE
INJECTABLE;INJECTION
AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER
ABBOTT 3.5%;5GM/100ML;30MG/100ML;97MG/100ML;12 N019564 001 Dec 16, 1986
0MG/100ML;49.3MG/100ML
3.5%;5GM/100ML;30MG/100ML;97MG/100ML;12 N019712 001 Sep 08, 1988
0MG/100ML;49.3MG/100ML
HOSPIRA INC 3.5%;5GM/100ML;30MG/100ML;97MG/100ML;12 N019682 001 Nov 01, 1988
0MG/100ML;49.3MG/100ML
AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER
ABBOTT 4.25%;10GM/100ML;30MG/100ML;97MG/100ML; N019564 003 Dec 16, 1986
120MG/100ML;49.3MG/100ML
HOSPIRA INC 4.25%;5GM/100ML;30MG/100ML;97MG/100ML;1 N019682 002 Nov 01, 1988
20MG/100ML;49.3MG/100ML
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM
CHLORIDE
INJECTABLE;INJECTION
TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER
BAXTER HLTHCARE 2.75%;10GM/100ML;51MG/100ML;261MG/100ML N020147 002 Oct 23, 1995
;216MG/100ML;112MG/100ML
TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER
BAXTER HLTHCARE 2.75%;15GM/100ML;51MG/100ML;261MG/100ML N020147 003 Oct 23, 1995
;216MG/100ML;112MG/100ML
TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER
BAXTER HLTHCARE 2.75%;20GM/100ML;51MG/100ML;261MG/100ML N020147 004 Oct 23, 1995
;216MG/100ML;112MG/100ML
TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER
BAXTER HLTHCARE 2.75%;25GM/100ML;51MG/100ML;261MG/100ML N020147 005 Oct 23, 1995
;216MG/100ML;112MG/100ML
TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 2.75%;5GM/100ML;51MG/100ML;261MG/100ML; N020147 001 Oct 23, 1995
216MG/100ML;112MG/100ML
TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4.25%;10GM/100ML;51MG/100ML;261MG/100ML N020147 007 Oct 23, 1995
;297MG/100ML;77MG/100ML
TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4.25%;15GM/100ML;51MG/100ML;261MG/100ML N020147 008 Oct 23, 1995
;297MG/100ML;77MG/100ML
TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4.25%;20GM/100ML;51MG/100ML;261MG/100ML N020147 009 Oct 23, 1995
;297MG/100ML;77MG/100ML
TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4.25%;25GM/100ML;51MG/100ML;261MG/100ML N020147 010 Oct 23, 1995
;297MG/100ML;77MG/100ML
TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4.25%;5GM/100ML;51MG/100ML;261MG/100ML; N020147 006 Oct 23, 1995
297MG/100ML;77MG/100ML
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
AMINOSYN 3.5% M
ICU MEDICAL INC 3.5%;21MG/100ML;40MG/100ML;128MG/100ML; N017789 003
234MG/100ML
AMINOSYN 3.5% M IN PLASTIC CONTAINER
ABBOTT 3.5%;21MG/100ML;40MG/100ML;128MG/100ML; N018804 002 May 15, 1984
234MG/100ML
3.5%;21MG/100ML;40MG/100ML;128MG/100ML; N018875 002 Aug 08, 1984
234MG/100ML

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-26(of 478)
** See List Footnote
AMINO ACIDS; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
AMINOSYN 3.5% M
ICU MEDICAL INC 3.5%;21MG/100ML;128MG/100ML;234MG/100ML N017789 005
AMINO ACIDS; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC,
HEPTAHYDRATE
INJECTABLE;INJECTION
AMINOSYN II 3.5% M IN PLASTIC CONTAINER
ABBOTT 3.5%;32MG/100ML;128MG/100ML;222MG/100ML N019493 001 Oct 16, 1986
;49MG/100ML
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE
INJECTABLE;INJECTION
VEINAMINE 8%
HOSPIRA INC 8%;61MG/100ML;211MG/100ML;56MG/100ML;38 N017957 001
8MG/100ML
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE;INJECTION
AMINOSYN II 10% W/ ELECTROLYTES
ICU MEDICAL INC 10%;102MG/100ML;45MG/100ML;522MG/100ML; N019437 004 Apr 03, 1986
410MG/100ML
AMINOSYN II 7% W/ ELECTROLYTES
ICU MEDICAL INC 7%;102MG/100ML;45MG/100ML;522MG/100ML;4 N019437 006 Apr 03, 1986
10MG/100ML
AMINOSYN II 8.5% W/ ELECTROLYTES
ICU MEDICAL INC 8.5%;102MG/100ML;45MG/100ML;522MG/100ML N019437 005 Apr 03, 1986
;410MG/100ML
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC
INJECTABLE;INJECTION
AMINOSYN 8.5% W/ELECTROLYTES
ICU MEDICAL INC 8.5%;102MG/100ML;487MG/100ML;28MG/100ML N017673 009 Oct 25, 2002
;425MG/100ML
AMINOSYN II 8.5% W/ELECTROLYTES
ICU MEDICAL INC 8.5%;102MG/100ML;492MG/100ML;60MG/100ML N019437 008 Oct 25, 2002
;425MG/100ML
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC,
HEPTAHYDRATE
INJECTABLE;INJECTION
AMINOSYN II 3.5% M
ICU MEDICAL INC 3.5%;30MG/100ML;97MG/100ML;120MG/100ML; N019437 007 Apr 03, 1986
49MG/100ML
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER
BAXTER HLTHCARE 3.5%;51MG/100ML;131MG/100ML;218MG/100ML N020177 001 Oct 23, 1995
;35MG/100ML
TRAVASOL 3.5% W/ ELECTROLYTES
BAXTER HLTHCARE 3.5%;51MG/100ML;131MG/100ML;218MG/100ML N017493 003
;35MG/100ML
TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER
BAXTER HLTHCARE 5.5%;102MG/100ML;522MG/100ML;431MG/100M N020173 001 Oct 27, 1995
L;224MG/100ML
TRAVASOL 5.5% W/ ELECTROLYTES
BAXTER HLTHCARE 5.5%;102MG/100ML;522MG/100ML;431MG/100M N017493 001
L;224MG/100ML
TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER
BAXTER HLTHCARE 8.5%;102MG/100ML;522MG/100ML;594MG/100M N020173 002 Oct 27, 1995
L;154MG/100ML
TRAVASOL 8.5% W/ ELECTROLYTES
BAXTER HLTHCARE 8.5%;102MG/100ML;522MG/100ML;594MG/100M N017493 002
L;154MG/100ML
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE;INJECTION
AMINOSYN 7% W/ ELECTROLYTES
ICU MEDICAL INC 7%;102MG/100ML;522MG/100ML;410MG/100ML N017789 002
AMINOSYN 8.5% W/ ELECTROLYTES
ICU MEDICAL INC 8.5%;102MG/100ML;522MG/100ML;410MG/100M N017673 005
L

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-27(of 478)
** See List Footnote
AMINOCAPROIC ACID
INJECTABLE;INJECTION
AMICAR
+ AKORN 250MG/ML ** N015229 002
AMINOCAPROIC ACID
ABRAXIS PHARM 250MG/ML A070522 001 Jun 17, 1986
BAXTER HLTHCARE 250MG/ML N018590 001 Oct 29, 1982
HOSPIRA 250MG/ML A070888 001 Jun 16, 1988
SOLUTION;ORAL
AMINOCAPROIC ACID
AKORN 0.25GM/ML A074759 001 Sep 02, 1998
TABLET;ORAL
AMINOCAPROIC
AKORN 500MG A075602 001 May 24, 2001
AMINOCAPROIC ACID
EDENBRIDGE PHARMS 500MG A212110 001 Jun 14, 2021
AMINOGLUTETHIMIDE
TABLET;ORAL
CYTADREN
NOVARTIS 250MG N018202 001
AMINOHIPPURATE SODIUM
INJECTABLE;INJECTION
AMINOHIPPURATE SODIUM
MERCK 20% N005619 001
AMINOPHYLLINE
ENEMA;RECTAL
SOMOPHYLLIN
FISONS 300MG/5ML N018232 001 Apr 02, 1982
INJECTABLE;INJECTION
AMINOPHYLLIN
+ GD SEARLE LLC 25MG/ML A087243 001 May 24, 1982
+ 25MG/ML A087621 001 May 24, 1982
AMINOPHYLLINE
ABRAXIS PHARM 25MG/ML A084568 001
25MG/ML A087200 001
25MG/ML A087250 001 Jan 06, 1982
25MG/ML A087886 001 Aug 30, 1983
25MG/ML A088407 001 Jan 25, 1984
AM REGENT 25MG/ML A087600 001
ELKINS SINN 25MG/ML A087239 001
HOSPIRA 25MG/ML A087601 001 Jul 23, 1982
INTL MEDICATION 25MG/ML A087209 001 Feb 01, 1982
25MG/ML A087867 001 Nov 10, 1983
25MG/ML A087868 001 Nov 10, 1983
KING PHARMS 25MG/ML A086606 001
LUITPOLD 25MG/ML A087240 001
LYPHOMED 25MG/ML A087431 001
PHARMA SERVE NY 25MG/ML A087387 001 Jun 03, 1983
25MG/ML A087392 001 Dec 15, 1983
SMITH AND NEPHEW 25MG/ML A088429 001 May 30, 1985
25MG/ML A088749 001 May 30, 1985
TEVA PARENTERAL 25MG/ML A081142 001 Sep 25, 1991
AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%
HOSPIRA 100MG/100ML A088147 002 May 03, 1983
200MG/100ML A088147 003 May 03, 1983
AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
HOSPIRA 100MG/100ML N018924 001 Dec 12, 1984
200MG/100ML N018924 002 Dec 12, 1984
400MG/100ML N018924 003 Dec 12, 1984
500MG/100ML N018924 004 Dec 12, 1984
SOLUTION;ORAL
AMINOPHYLLINE
MORTON GROVE 105MG/5ML A088156 001 Dec 05, 1983
ROXANE 105MG/5ML A088126 001 Aug 19, 1983
AMINOPHYLLINE DYE FREE
ACTAVIS MID ATLANTIC 105MG/5ML A087727 001 Apr 16, 1982

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-28(of 478)
** See List Footnote
AMINOPHYLLINE
SOLUTION;ORAL
SOMOPHYLLIN
FISONS 105MG/5ML A086466 001
SOMOPHYLLIN-DF
FISONS 105MG/5ML A087045 001
SUPPOSITORY;RECTAL
TRUPHYLLINE
COSETTE 250MG A085498 001 Mar 23, 1983
500MG A085498 002 Jan 03, 1983
TABLET;ORAL
AMINOPHYLLIN
GD SEARLE LLC 100MG N002386 002
200MG N002386 003
AMINOPHYLLINE
ANI PHARMS 100MG A085261 004
200MG A085261 002
ASCOT 100MG A087522 001 Feb 12, 1982
200MG A087523 001 Feb 12, 1982
BARR 100MG A088297 001 Aug 19, 1983
200MG A088298 001 Aug 19, 1983
DURAMED PHARMS BARR 100MG A088182 001 Mar 31, 1983
200MG A088183 001 Mar 31, 1983
HALSEY 100MG A084674 001
HIKMA INTL PHARMS 100MG A084540 001
200MG A085003 001
IMPAX LABS 100MG A084574 001
200MG A084576 001
KV PHARM 100MG A085284 001
200MG A085289 001
LANNETT 100MG A084588 001
200MG A084588 002
PAL PAK 100MG A084533 001
PANRAY 100MG A084552 001
200MG A084552 002
PUREPAC PHARM 100MG A084699 001
200MG A085333 001
ROXANE 100MG A087500 001 Feb 09, 1982
200MG A087501 001 Feb 09, 1982
VALEANT PHARM INTL 200MG A084563 001
VANGARD 100MG A088314 001 Oct 03, 1983
200MG A088319 001 Oct 03, 1983
VINTAGE PHARMS 100MG A085409 001
200MG A085410 001
WATSON LABS 100MG A085567 001
200MG A085564 001
TABLET, DELAYED RELEASE;ORAL
AMINOPHYLLINE
IMPAX LABS 100MG A084577 001
200MG A084575 001
TABLICAPS 100MG A084632 002
VALE 100MG A084531 001
200MG A084530 001
TABLET, EXTENDED RELEASE;ORAL
PHYLLOCONTIN
PHARM RES ASSOC 225MG A086760 001
AMINOSALICYLATE SODIUM
POWDER;ORAL
P.A.S. SODIUM
CENTURY PHARMS 4GM/PACKET A080947 001
SODIUM AMINOSALICYLATE
HEXCEL 100% A080097 001
TABLET;ORAL
PARASAL SODIUM
PANRAY 500MG N006811 006
1GM N006811 011
SODIUM P.A.S.
LANNETT 500MG A080138 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-29(of 478)
** See List Footnote
AMINOSALICYLATE SODIUM
TABLET;ORAL
TEEBACIN
CONSOLIDATED MIDLAND 500MG N007320 002
AMINOSALICYLATE SODIUM; AMINOSALICYLIC ACID
TABLET;ORAL
NEOPASALATE
MEDPOINTE PHARM HLC 846MG;112MG A080059 002
AMINOSALICYLIC ACID
TABLET;ORAL
PARASAL
PANRAY 500MG N006811 001
1GM N006811 002
AMINOSALICYLIC ACID RESIN COMPLEX
POWDER;ORAL
REZIPAS
BRISTOL MYERS SQUIBB EQ 500MG BASE/GM N009052 001
AMIODARONE HYDROCHLORIDE
INJECTABLE;INJECTION
AMIODARONE HYDROCHLORIDE
AKORN 50MG/ML A076232 001 Jul 05, 2006
BEDFORD 50MG/ML A076018 001 Oct 15, 2002
BEDFORD LABS 50MG/ML A076299 001 Oct 24, 2002
BEN VENUE 50MG/ML A076088 001 Oct 15, 2002
DR REDDYS 50MG/ML A076163 001 Sep 05, 2003
EUGIA PHARMA 50MG/ML A204550 001 Oct 25, 2017
HOSPIRA 50MG/ML A075955 001 Oct 18, 2002
50MG/ML A076108 001 Oct 15, 2002
50MG/ML A203885 001 Nov 25, 2013
INTL MEDICATION SYS 50MG/ML N021594 001 Feb 04, 2004
PAR STERILE PRODUCTS 50MG/ML A076394 001 Apr 25, 2003
CORDARONE
+ WYETH PHARMS INC 50MG/ML ** N020377 001 Aug 03, 1995
NEXTERONE
+ BAXTER HLTHCARE 50MG/ML ** N022325 001 Dec 24, 2008
TABLET;ORAL
AMIODARONE HYDROCHLORIDE
MYLAN 200MG A075188 001 Feb 24, 1999
TEVA 200MG A074895 001 Apr 16, 1999
UPSHER SMITH LABS 200MG A075315 001 Dec 23, 1998
400MG A075315 002 Jun 30, 2000
CORDARONE
+ WYETH PHARMS 200MG ** N018972 001 Dec 24, 1985
AMITRIPTYLINE HYDROCHLORIDE
CONCENTRATE;ORAL
ENDEP
+ ROCHE 40MG/ML ** A085749 001
INJECTABLE;INJECTION
AMITRIPTYLINE HYDROCHLORIDE
WATSON LABS 10MG/ML A085594 001
ELAVIL
ASTRAZENECA 10MG/ML N012704 001
TABLET;ORAL
AMITID
BRISTOL MYERS SQUIBB 10MG A086454 001
25MG A086454 002
50MG A086454 003
75MG A086454 004
100MG A086454 005
AMITRIL
WARNER CHILCOTT 10MG A083939 001
25MG A083937 001
50MG A083938 002
75MG A084957 001
100MG A085093 001
150MG A086295 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-30(of 478)
** See List Footnote
AMITRIPTYLINE HYDROCHLORIDE
TABLET;ORAL
AMITRIPTYLINE HYDROCHLORIDE
AIPING PHARM INC 10MG A212654 002 Sep 29, 2021
25MG A212654 001 Apr 07, 2020
50MG A212654 003 Sep 29, 2021
75MG A212654 004 Sep 29, 2021
100MG A212654 005 Sep 29, 2021
150MG A212654 006 Sep 29, 2021
AM THERAP 25MG A088672 001 Nov 20, 1984
50MG A088673 001 Nov 20, 1984
75MG A088674 001 Nov 20, 1984
100MG A088675 001 Nov 20, 1984
ANI PHARMS 10MG A085031 002
25MG A085031 001
50MG A085031 003
75MG A085031 004
AUROBINDO PHARMA USA 10MG A086009 002
25MG A086009 003
50MG A086009 001
75MG A086009 004
100MG A086009 005
150MG A086009 006
COPLEY PHARM 10MG A088421 001 Apr 30, 1984
25MG A088422 001 Apr 30, 1984
50MG A088423 001 Apr 30, 1984
75MG A088424 001 Apr 30, 1984
100MG A088425 001 Apr 30, 1984
150MG A088426 001 Apr 30, 1984
HALSEY 10MG A085923 001
25MG A085922 001
50MG A085925 001
50MG A087557 001 Mar 05, 1982
75MG A085926 001 May 20, 1983
100MG A085927 001 May 20, 1983
LEDERLE 10MG A086744 001
10MG A087366 001 Jan 04, 1982
25MG A086746 001
25MG A087367 001 May 03, 1982
50MG A086743 001
50MG A087181 001 Jan 04, 1982
75MG A086745 001
75MG A087369 001 Jan 04, 1982
100MG A086747 001
100MG A087368 001 May 03, 1982
150MG A087370 001 Jan 04, 1982
MUTUAL PHARM 10MG A085744 001
25MG A085627 001
50MG A085745 001
75MG A085743 001
100MG A085742 002 May 11, 1982
150MG A089423 001 Feb 17, 1987
PAR PHARM 10MG A088697 001 Sep 25, 1984
25MG A088698 001 Sep 25, 1984
50MG A088699 001 Sep 25, 1984
75MG A088700 001 Sep 25, 1984
100MG A088701 001 Sep 25, 1984
150MG A088702 001 Sep 25, 1984
PLIVA 10MG A088883 001 Sep 26, 1984
25MG A088884 001 Sep 26, 1984
50MG A088885 001 Sep 26, 1984
75MG A088886 001 Sep 26, 1984
100MG A088887 001 Sep 26, 1984
150MG A088888 001 Sep 26, 1984
PUREPAC PHARM 10MG A088075 001 Sep 16, 1983
10MG A088084 001 Jul 18, 1983
25MG A088076 001 May 20, 1983
25MG A088085 001 Jul 18, 1983
50MG A088077 001 Sep 16, 1983

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-31(of 478)
** See List Footnote
AMITRIPTYLINE HYDROCHLORIDE
TABLET;ORAL
AMITRIPTYLINE HYDROCHLORIDE
50MG A088105 001 Jul 18, 1983
75MG A088078 001 Sep 16, 1983
75MG A088106 001 Jul 18, 1983
100MG A088079 001 Sep 16, 1983
100MG A088107 001 Jul 18, 1983
ROXANE 10MG A086002 001
10MG A086144 001
25MG A085944 001
25MG A086145 001
50MG A085945 001
50MG A086143 001
75MG A086004 001
75MG A086147 001
100MG A086003 001
100MG A086146 001
150MG A086090 001
150MG A086148 001
SUN PHARM INDS INC 10MG A040816 002 Jun 27, 2008
25MG A040816 001 Jun 27, 2008
50MG A040816 003 Jun 27, 2008
75MG A040816 004 Jun 27, 2008
100MG A040816 005 Jun 27, 2008
150MG A040816 006 Jun 27, 2008
SUPERPHARM 10MG A088853 001 Nov 13, 1984
25MG A088854 001 Nov 13, 1984
50MG A088855 001 Nov 13, 1984
75MG A088856 001 Nov 13, 1984
100MG A088857 001 Nov 13, 1984
TEVA 10MG A086610 001
25MG A086859 001
50MG A086857 001
75MG A086860 001
100MG A085836 001
100MG A086854 001
150MG A086853 001
UCB INC 10MG A085864 001
25MG A085935 001
50MG A085936 001
75MG A086337 001
100MG A086336 001
150MG A086335 001
USL PHARMA 25MG A087775 001 Feb 10, 1982
VANGARD 10MG A087632 001 Feb 01, 1982
50MG A087616 001 Feb 08, 1982
75MG A087617 001 Feb 05, 1982
100MG A087639 001 Feb 08, 1982
VINTAGE PHARMS 10MG A040218 001 Sep 11, 1997
25MG A040218 002 Sep 11, 1997
50MG A040218 003 Sep 11, 1997
75MG A040218 004 Sep 11, 1997
100MG A040218 005 Sep 11, 1997
150MG A040218 006 Sep 11, 1997
WATSON LABS 10MG A085816 001
10MG A088620 001 Mar 02, 1984
25MG A085817 001
25MG A088621 001 Mar 02, 1984
50MG A085815 001
50MG A088622 001 Mar 02, 1984
75MG A085819 001
75MG A088633 001 Mar 02, 1984
100MG A085820 001
100MG A088634 001 Mar 02, 1984
150MG A085821 001
150MG A088635 001 Mar 02, 1984
WEST WARD 10MG A087647 001 Mar 05, 1982
25MG A087278 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-32(of 478)
** See List Footnote
AMITRIPTYLINE HYDROCHLORIDE
TABLET;ORAL
ELAVIL
+ ASTRAZENECA 10MG ** N012703 001
+ 25MG ** N012703 003
+ 50MG ** N012703 004
+ 75MG ** N012703 005
+ 100MG ** N012703 006
+ 150MG ** N012703 007
ENDEP
ROCHE 10MG A083639 001
25MG A083639 002
50MG A083639 003
75MG A083639 004
100MG A083639 005
150MG A085303 001
AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE
TABLET;ORAL
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE
HERITAGE PHARMA EQ 12.5MG BASE;5MG A072052 001 Dec 16, 1988
EQ 25MG BASE;10MG A072053 001 Dec 16, 1988
STRIDES PHARMA EQ 12.5MG BASE;5MG A072277 001 May 09, 1988
EQ 25MG BASE;10MG A072278 001 May 09, 1988
UNITED RES LABS EQ 12.5MG BASE;5MG A070765 001 Dec 10, 1986
EQ 25MG BASE;10MG A070766 001 Dec 10, 1986
USL PHARMA EQ 12.5MG BASE;5MG A070477 001 Jan 12, 1988
EQ 25MG BASE;10MG A070478 001 Jan 12, 1988
LIMBITROL
+ HERITAGE PHARMS INC EQ 12.5MG BASE;5MG ** N016949 001
LIMBITROL DS
+ HERITAGE PHARMS INC EQ 25MG BASE;10MG ** N016949 002
AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE
TABLET;ORAL
ETRAFON 2-10
SCHERING 10MG;2MG ** N014713 007
ETRAFON 2-25
SCHERING 25MG;2MG ** N014713 004
ETRAFON-A
SCHERING 10MG;4MG ** N014713 002
ETRAFON-FORTE
SCHERING 25MG;4MG ** N014713 006
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
FOSUN PHARMA 10MG;2MG A071062 001 Nov 27, 1987
10MG;4MG A071862 001 Dec 21, 1987
25MG;2MG A071063 001 Nov 27, 1987
25MG;4MG A071064 001 Nov 27, 1987
50MG;4MG A071863 001 Dec 21, 1987
HERITAGE PHARMA 10MG;2MG A073007 001 Oct 17, 1991
10MG;4MG A073009 001 Oct 17, 1991
25MG;2MG A073008 001 Oct 17, 1991
25MG;4MG A073010 001 Oct 17, 1991
IVAX SUB TEVA PHARMS 10MG;2MG A070935 001 Sep 11, 1986
10MG;4MG A070937 001 Sep 11, 1986
25MG;2MG A070936 001 Sep 11, 1986
25MG;4MG A070938 001 Sep 11, 1986
50MG;4MG A070939 001 Sep 12, 1986
PAR PHARM 10MG;2MG A070565 001 Sep 11, 1986
10MG;4MG A070620 001 Sep 11, 1986
25MG;2MG A070621 001 Sep 11, 1986
25MG;4MG A070595 001 Sep 11, 1986
50MG;4MG A070574 001 Sep 11, 1986
SUN PHARM INDUSTRIES 10MG;2MG A071077 001 Nov 12, 1986
10MG;4MG A071078 001 Nov 12, 1986
25MG;2MG A070297 001 Nov 12, 1986
25MG;4MG A071079 001 Nov 12, 1986
WATSON LABS 10MG;2MG A070373 001 Aug 25, 1986
10MG;2MG A072539 001 Feb 15, 1989
10MG;4MG A070375 001 Aug 25, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-33(of 478)
** See List Footnote
AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE
TABLET;ORAL
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
10MG;4MG A072540 001 Feb 15, 1989
25MG;2MG A070374 001 Aug 25, 1986
25MG;2MG A072541 001 Feb 15, 1989
25MG;4MG A070376 001 Aug 25, 1986
25MG;4MG A072134 001 Feb 15, 1989
50MG;4MG A070377 001 Nov 04, 1986
50MG;4MG A071558 001 Mar 02, 1987
50MG;4MG A072135 001 Feb 15, 1989
TRIAVIL 2-10
NEW RIVER 10MG;2MG ** N014715 004
TRIAVIL 2-25
NEW RIVER 25MG;2MG ** N014715 002
TRIAVIL 4-10
NEW RIVER 10MG;4MG ** N014715 003
TRIAVIL 4-25
NEW RIVER 25MG;4MG ** N014715 005
TRIAVIL 4-50
NEW RIVER 50MG;4MG ** N014715 006
AMLEXANOX
PASTE;DENTAL
APHTHASOL
ULURU 5% N020511 001 Dec 17, 1996
PATCH;TOPICAL
AMLEXANOX
ULURU 2MG N021727 001 Sep 29, 2004
AMLODIPINE BESYLATE
TABLET;ORAL
AMLODIPINE BESYLATE
AMNEAL PHARMS NY EQ 2.5MG BASE A078477 001 Jan 16, 2008
EQ 5MG BASE A078477 002 Jan 16, 2008
EQ 10MG BASE A078477 003 Jan 16, 2008
CHARTWELL RX EQ 2.5MG BASE A076859 001 Sep 10, 2007
EQ 5MG BASE A076859 002 Sep 10, 2007
EQ 10MG BASE A076859 003 Sep 10, 2007
GEDEON RICHTER USA EQ 2.5MG BASE A077333 001 Jul 17, 2007
EQ 5MG BASE A077333 002 Jul 17, 2007
EQ 10MG BASE A077333 003 Jul 17, 2007
GENPHARM EQ 2.5MG BASE A077362 001 Jul 09, 2007
EQ 5MG BASE A077362 002 Jul 09, 2007
EQ 10MG BASE A077362 003 Jul 09, 2007
HIKMA EQ 2.5MG BASE A077262 001 Jul 09, 2007
EQ 5MG BASE A077262 002 Jul 09, 2007
EQ 10MG BASE A077262 003 Jul 09, 2007
HIKMA PHARMS EQ 2.5MG BASE A077771 001 Apr 12, 2011
EQ 5MG BASE A077771 002 Apr 12, 2011
EQ 10MG BASE A077771 003 Apr 12, 2011
MACLEODS PHARMS LTD EQ 5MG BASE A201380 001 Apr 13, 2012
EQ 10MG BASE A201380 002 Apr 13, 2012
MYLAN EQ 2.5MG BASE A076418 001 Oct 03, 2005
EQ 2.5MG BASE A078224 001 Feb 27, 2008
EQ 5MG BASE A076418 002 Oct 03, 2005
EQ 5MG BASE A078224 002 Feb 27, 2008
EQ 10MG BASE A076418 003 Oct 03, 2005
EQ 10MG BASE A078224 003 Feb 27, 2008
PURACAP PHARM EQ 2.5MG BASE A078131 001 Sep 04, 2007
EQ 5MG BASE A078131 002 Sep 04, 2007
EQ 10MG BASE A078131 003 Sep 04, 2007
SOVEREIGN PHARMS EQ 2.5MG BASE A204900 001 Jul 23, 2015
EQ 5MG BASE A204900 002 Jul 23, 2015
EQ 10MG BASE A204900 003 Jul 23, 2015
SUN PHARM INDS INC EQ 2.5MG BASE A078231 001 Nov 30, 2007
EQ 5MG BASE A078231 002 Nov 30, 2007
EQ 10MG BASE A078231 003 Nov 30, 2007
SUN PHARM INDUSTRIES EQ 2.5MG BASE A078081 001 Jan 31, 2008
EQ 5MG BASE A078081 002 Jan 31, 2008

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-34(of 478)
** See List Footnote
AMLODIPINE BESYLATE
TABLET;ORAL
AMLODIPINE BESYLATE
EQ 10MG BASE A078081 003 Jan 31, 2008
SUNSHINE EQ 2.5MG BASE A206524 001 May 04, 2018
EQ 5MG BASE A206524 002 May 04, 2018
EQ 10MG BASE A206524 003 May 04, 2018
SYNTHON PHARMS EQ 2.5MG BASE A077080 001 Jun 27, 2007
EQ 5MG BASE A077080 002 Jun 27, 2007
EQ 10MG BASE A077080 003 Jun 27, 2007
TORRENT PHARMS EQ 2.5MG BASE A078573 001 Sep 22, 2008
EQ 5MG BASE A078573 002 Sep 22, 2008
EQ 10MG BASE A078573 003 Sep 22, 2008
UPSHER SMITH LABS EQ 2.5MG BASE A077759 001 Jul 09, 2007
EQ 5MG BASE A077759 002 Jul 09, 2007
EQ 10MG BASE A077759 003 Jul 09, 2007
WATSON LABS EQ 2.5MG BASE A077671 001 Jul 19, 2007
EQ 5MG BASE A077671 002 Jul 19, 2007
EQ 10MG BASE A077671 003 Jul 19, 2007
WOCKHARDT EQ 2.5MG BASE A078500 001 Sep 06, 2007
EQ 5MG BASE A078500 002 Sep 06, 2007
EQ 10MG BASE A078500 003 Sep 06, 2007
TABLET, ORALLY DISINTEGRATING;ORAL
AMLODIPINE BESYLATE
+ SYNTHON PHARMS EQ 2.5MG BASE N022026 001 Sep 27, 2007
+ EQ 5MG BASE N022026 002 Sep 27, 2007
+ EQ 10MG BASE N022026 003 Sep 27, 2007
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM
TABLET;ORAL
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
MYLAN EQ 2.5MG BASE;EQ 10MG BASE A200465 001 Nov 29, 2013
EQ 2.5MG BASE;EQ 20MG BASE A200465 002 Nov 29, 2013
EQ 2.5MG BASE;EQ 40MG BASE A200465 003 Nov 29, 2013
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
CAPSULE;ORAL
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
CIPLA EQ 2.5MG BASE;10MG A077215 001 Dec 07, 2018
EQ 5MG BASE;10MG A077215 002 Dec 07, 2018
EQ 5MG BASE;20MG A077215 003 Dec 07, 2018
EQ 10MG BASE;20MG A077215 004 Dec 07, 2018
MYLAN EQ 2.5MG BASE;10MG A077375 001 May 21, 2010
EQ 5MG BASE;10MG A077375 002 May 21, 2010
EQ 5MG BASE;20MG A077375 003 May 21, 2010
EQ 5MG BASE;40MG A079047 001 Jul 05, 2011
EQ 10MG BASE;20MG A077375 004 May 21, 2010
EQ 10MG BASE;40MG A079047 002 Jul 05, 2011
STRIDES PHARMA EQ 2.5MG BASE;10MG A078381 001 Jul 29, 2010
EQ 5MG BASE;10MG A078381 002 Jul 29, 2010
EQ 5MG BASE;20MG A078381 003 Jul 29, 2010
EQ 5MG BASE;40MG A078381 005 Jul 29, 2010
EQ 10MG BASE;20MG A078381 004 Jul 29, 2010
EQ 10MG BASE;40MG A078381 006 Jul 29, 2010
TEVA PHARMS EQ 2.5MG BASE;10MG A077179 001 May 18, 2007
EQ 5MG BASE;10MG A077179 002 May 18, 2007
EQ 5MG BASE;20MG A077179 003 May 18, 2007
EQ 5MG BASE;40MG A077179 005 Jul 05, 2011
EQ 10MG BASE;20MG A077179 004 May 18, 2007
EQ 10MG BASE;40MG A077179 006 Jul 05, 2011
AMLODIPINE BESYLATE; CELECOXIB
TABLET;ORAL
CONSENSI
+ PURPLE BIOTECH EQ 2.5MG BASE;200MG N210045 001 May 31, 2018
+ EQ 5MG BASE;200MG N210045 002 May 31, 2018
+ EQ 10MG BASE;200MG N210045 003 May 31, 2018

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-35(of 478)
** See List Footnote
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN
TABLET;ORAL
AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE
TEVA PHARMS EQ 5MG BASE;12.5MG;160MG A200435 001 Sep 25, 2012
EQ 5MG BASE;25MG;160MG A200435 002 Sep 25, 2012
EQ 10MG BASE;12.5MG;160MG A200435 005 Sep 25, 2012
EQ 10MG BASE;25MG;160MG A200435 003 Sep 25, 2012
EQ 10MG BASE;25MG;320MG A200435 004 Sep 25, 2012
TORRENT EQ 5MG BASE;12.5MG;160MG A201593 001 Jun 03, 2015
EQ 5MG BASE;25MG;160MG A201593 002 Jun 03, 2015
EQ 10MG BASE;12.5MG;160MG A201593 003 Jun 03, 2015
EQ 10MG BASE;25MG;160MG A201593 004 Jun 03, 2015
EQ 10MG BASE;25MG;320MG A201593 005 Jun 03, 2015
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
TABLET;ORAL
AMLODIPINE AND OLMESARTAN MEDOXOMIL
ACCORD HLTHCARE INC EQ 5MG BASE;20MG A209600 001 Aug 30, 2018
EQ 5MG BASE;40MG A209600 003 Aug 30, 2018
EQ 10MG BASE;20MG A209600 002 Aug 30, 2018
EQ 10MG BASE;40MG A209600 004 Aug 30, 2018
JUBILANT GENERICS EQ 5MG BASE;20MG A207450 001 May 15, 2017
EQ 5MG BASE;40MG A207450 002 May 15, 2017
EQ 10MG BASE;20MG A207450 003 May 15, 2017
EQ 10MG BASE;40MG A207450 004 May 15, 2017
SCIEGEN PHARMS INC EQ 5MG BASE;20MG A209010 001 Dec 03, 2018
EQ 5MG BASE;40MG A209010 002 Dec 03, 2018
EQ 10MG BASE;20MG A209010 003 Dec 03, 2018
EQ 10MG BASE;40MG A209010 004 Dec 03, 2018
TEVA PHARMS USA EQ 5MG BASE;20MG A091154 001 Oct 26, 2016
EQ 5MG BASE;40MG A091154 002 Oct 26, 2016
EQ 10MG BASE;20MG A091154 003 Oct 26, 2016
EQ 10MG BASE;40MG A091154 004 Oct 26, 2016
TORRENT EQ 5MG BASE;20MG A202933 001 Nov 25, 2016
EQ 5MG BASE;40MG A202933 002 Nov 25, 2016
EQ 10MG BASE;20MG A202933 003 Nov 25, 2016
EQ 10MG BASE;40MG A202933 004 Nov 25, 2016
AMLODIPINE BESYLATE; TELMISARTAN
TABLET;ORAL
TELMISARTAN AND AMLODIPINE
ALEMBIC PHARMS EQ 5MG BASE;40MG A205234 001 Nov 17, 2016
EQ 5MG BASE;80MG A205234 003 Nov 17, 2016
EQ 10MG BASE;40MG A205234 002 Nov 17, 2016
EQ 10MG BASE;80MG A205234 004 Nov 17, 2016
TORRENT EQ 5MG BASE;40MG A202517 001 Jan 08, 2014
EQ 5MG BASE;80MG A202517 003 Jan 08, 2014
EQ 10MG BASE;40MG A202517 002 Jan 08, 2014
EQ 10MG BASE;80MG A202517 004 Jan 08, 2014
TWYNSTA
+ BOEHRINGER INGELHEIM EQ 5MG BASE;40MG N022401 001 Oct 16, 2009
+ EQ 5MG BASE;80MG N022401 003 Oct 16, 2009
+ EQ 10MG BASE;40MG N022401 002 Oct 16, 2009
+ EQ 10MG BASE;80MG N022401 004 Oct 16, 2009
AMLODIPINE BESYLATE; VALSARTAN
TABLET;ORAL
AMLODIPINE BESYLATE AND VALSARTAN
TEVA PHARMS USA EQ 5MG BASE;160MG A091235 001 Mar 30, 2015
EQ 5MG BASE;320MG A091235 003 Mar 30, 2015
EQ 10MG BASE;160MG A091235 002 Mar 30, 2015
EQ 10MG BASE;320MG A091235 004 Mar 30, 2015
TORRENT EQ 5MG BASE;160MG A202377 001 Mar 30, 2015
EQ 5MG BASE;320MG A202377 002 Mar 30, 2015
EQ 10MG BASE;160MG A202377 003 Mar 30, 2015
EQ 10MG BASE;320MG A202377 004 Mar 30, 2015

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-36(of 478)
** See List Footnote
AMLODIPINE MALEATE
TABLET;ORAL
AMVAZ
DR REDDYS LABS INC 2.5MG N021435 001 Oct 31, 2003
5MG N021435 002 Oct 31, 2003
10MG N021435 003 Oct 31, 2003
AMMONIA N-13
INJECTABLE;INTRAVENOUS
AMMONIA N 13
CENTRAL RADIOPHARM 3.75-260mCi/ML A204539 001 Jun 23, 2015
UNIV TX MD ANDERSON 30mCi-300mCi/8ML (3.75-37.5mCi/ML) A203933 001 Jun 27, 2014
AMMONIUM CHLORIDE
INJECTABLE;INJECTION
AMMONIUM CHLORIDE
ABBOTT 5MEQ/ML A083130 001
GD SEARLE LLC 3MEQ/ML A086205 001
AMMONIUM CHLORIDE 0.9% IN NORMAL SALINE
MCGAW 900MG/100ML N006580 001
AMMONIUM CHLORIDE 2.14%
B BRAUN 40MEQ/100ML A085734 001
AMMONIUM LACTATE
CREAM;TOPICAL
AMMONIUM LACTATE
WATSON LABS INC EQ 12% BASE A076829 001 Feb 07, 2006
LAC-HYDRIN
+ SUN PHARM INDS INC EQ 12% BASE ** N020508 001 Aug 29, 1996
LOTION;TOPICAL
AMMONIUM LACTATE
WATSON LABS INC EQ 12% BASE A075575 001 Jun 11, 2002
LAC-HYDRIN
+ SUN PHARM INDS INC EQ 12% BASE ** N019155 001 Apr 24, 1985
AMODIAQUINE HYDROCHLORIDE
TABLET;ORAL
CAMOQUIN HYDROCHLORIDE
PARKE DAVIS EQ 200MG BASE N006441 001
AMOXAPINE
TABLET;ORAL
AMOXAPINE
CHARTWELL RX 25MG A072943 001 Jun 28, 1991
50MG A072944 001 Jun 28, 1991
100MG A072878 001 Jun 28, 1991
150MG A072879 001 Jun 28, 1991
WATSON PHARMS TEVA 25MG A072418 001 Aug 01, 1989
50MG A072419 001 Aug 01, 1989
100MG A072420 001 May 11, 1989
150MG A072421 001 May 11, 1989
ASENDIN
LEDERLE 25MG N018021 001
50MG N018021 002
100MG N018021 003
150MG N018021 004
AMOXICILLIN
CAPSULE;ORAL
AMOXICILLIN
LABS ATRAL 250MG A062528 001 Aug 07, 1985
500MG A062528 002 Aug 07, 1985
MYLAN 250MG A062067 001
500MG A062067 002
STRIDES PHARMA 250MG A062884 001 Feb 25, 1988
500MG A062881 001 Feb 25, 1988
SUN PHARM INDS LTD 250MG A065016 001 Apr 08, 1999
500MG A065016 002 Apr 08, 1999
TEVA 250MG A062853 001 Dec 22, 1987
250MG A063030 001 Feb 28, 1989
500MG A062854 001 Dec 22, 1987
500MG A063031 001 Feb 28, 1989

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-37(of 478)
** See List Footnote
AMOXICILLIN
CAPSULE;ORAL
AMOXIL
+ GLAXOSMITHKLINE 250MG ** N050459 001
+ 500MG ** N050459 002
TRIMOX
APOTHECON 250MG A061885 001
250MG A062098 001
250MG A062152 001
250MG A063099 001 Mar 20, 1992
500MG A061885 002
500MG A062098 002
500MG A062152 002
500MG A063099 002 Mar 20, 1992
UTIMOX
PARKE DAVIS 250MG A062107 001
500MG A062107 002
WYMOX
WYETH AYERST 250MG A062120 001
500MG A062120 002
FOR SUSPENSION;ORAL
AMOXICILLIN
BELCHER PHARMS 125MG/5ML A062059 001
250MG/5ML A062059 002
MYLAN 125MG/5ML A062090 001
250MG/5ML A062090 002
SUN PHARM INDS LTD 200MG/5ML A065113 001 Nov 29, 2002
400MG/5ML A065113 002 Nov 29, 2002
TEVA 125MG/5ML A061931 001
125MG/5ML A062946 001 Nov 01, 1988
250MG/5ML A063001 001 Jan 06, 1989
AMOXIL
+ GLAXOSMITHKLINE 50MG/ML ** N050460 005
+ 125MG/5ML ** N050460 001
+ 250MG/5ML ** N050460 002
+ US ANTIBIOTICS 200MG/5ML ** N050760 001 Apr 15, 1999
+ 400MG/5ML ** N050760 002 Apr 15, 1999
LAROTID
+ GLAXOSMITHKLINE 50MG/ML ** N050460 006
POLYMOX
APOTHECON 125MG/5ML A061851 001
125MG/5ML A062323 001
250MG/5ML A061851 002
250MG/5ML A062323 002
TRIMOX
APOTHECON 50MG/ML A061886 001
125MG/5ML A061886 002
125MG/5ML A062099 001
125MG/5ML A062154 001
125MG/5ML A062885 001 Mar 08, 1988
250MG/5ML A061886 003
250MG/5ML A062099 002
250MG/5ML A062154 002
250MG/5ML A062885 002 Mar 08, 1988
UTIMOX
PARKE DAVIS 125MG/5ML A062127 001
250MG/5ML A062127 002
WYMOX
WYETH AYERST 125MG/5ML A062131 001
250MG/5ML A062131 002
TABLET;ORAL
AMOXICILLIN
STRIDES PHARMA 875MG A065344 001 Jan 15, 2009
SUN PHARM INDS LTD 500MG A065059 001 Nov 24, 2000
875MG A065059 002 Nov 24, 2000
AMOXIL
+ US ANTIBIOTICS 500MG ** N050754 002 Jul 10, 1998
+ 875MG ** N050754 001 Jul 10, 1998

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-38(of 478)
** See List Footnote
AMOXICILLIN
TABLET, CHEWABLE;ORAL
AMOXICILLIN
APOTHECON 125MG A064131 001 May 06, 1996
250MG A064131 002 May 06, 1996
HIKMA 125MG A205274 001 Jun 25, 2020
250MG A205274 002 Jun 25, 2020
STRIDES PHARMA 125MG A064139 001 Jan 29, 1996
250MG A064139 002 Jan 29, 1996
SUN PHARM INDS LTD 125MG A065021 001 Dec 23, 1999
200MG A065060 001 Nov 29, 2000
250MG A065021 002 Dec 23, 1999
400MG A065060 002 Nov 29, 2000
TEVA 125MG A064031 001 Dec 19, 1996
250MG A064031 002 Dec 19, 1996
AMOXIL
+ US ANTIBIOTICS 125MG ** N050542 002
200MG N050761 001 Apr 15, 1999
+ 250MG ** N050542 001
400MG N050761 002 Apr 15, 1999
TABLET, EXTENDED RELEASE;ORAL
MOXATAG
+ PRAGMA 775MG N050813 001 Jan 23, 2008
TABLET, FOR SUSPENSION;ORAL
AMOXICILLIN
AUROBINDO PHARMA LTD 200MG A065324 001 Jan 17, 2007
400MG A065324 002 Jan 17, 2007
DISPERMOX
RANBAXY LABS LTD 200MG A065080 002 Aug 11, 2003
400MG A065080 001 Aug 11, 2003
600MG A065159 001 Dec 04, 2003
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE
CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED)
ANI PHARMS 500MG;500MG;30MG A200218 001 Aug 30, 2013
PREVPAC (COPACKAGED)
+ TAKEDA PHARMS USA 500MG;500MG;30MG ** N050757 001 Dec 02, 1997
AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE
CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL
OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN
+ CUMBERLAND PHARMS 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20M N050824 001 Feb 08, 2011
G
AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE
CAPSULE, TABLET, TABLET;ORAL
VOQUEZNA TRIPLE PAK
+ PHATHOM 500MG;500MG;EQ 20MG BASE N215152 001 May 03, 2022
AMOXICILLIN; CLAVULANATE POTASSIUM
FOR SUSPENSION;ORAL
AMOXICILLIN AND CLAVULANATE POTASSIUM
SUN PHARM INDS LTD 200MG/5ML;EQ 28.5MG BASE/5ML A065132 001 Mar 19, 2003
400MG/5ML;EQ 57MG BASE/5ML A065132 002 Mar 19, 2003
600MG/5ML;EQ 42.9MG BASE/5ML A065207 002 Jan 30, 2007
AUGMENTIN '200'
+ US ANTIBIOTICS 200MG/5ML;EQ 28.5MG BASE/5ML N050725 001 May 31, 1996
AUGMENTIN '400'
+ US ANTIBIOTICS 400MG/5ML;EQ 57MG BASE/5ML N050725 002 May 31, 1996
TABLET;ORAL
AMOXICILLIN AND CLAVULANATE POTASSIUM
APOTEX INC 250MG;EQ 125MG BASE A065333 001 Feb 24, 2009
500MG;EQ 125MG BASE A065333 002 Feb 24, 2009
875MG;EQ 125MG BASE A065317 003 Oct 20, 2008
SUN PHARM INDS LTD 500MG;EQ 125MG BASE A065109 001 Nov 04, 2002
875MG;EQ 125MG BASE A065102 001 Sep 17, 2002
AUGMENTIN '250'
+ US ANTIBIOTICS 250MG;EQ 125MG BASE ** N050564 001 Aug 06, 1984
AUGMENTIN '500'
+ US ANTIBIOTICS 500MG;EQ 125MG BASE ** N050564 002 Aug 06, 1984

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-39(of 478)
** See List Footnote
AMOXICILLIN; CLAVULANATE POTASSIUM
TABLET, CHEWABLE;ORAL
AMOXICILLIN AND CLAVULANATE POTASSIUM
SANDOZ 200MG;EQ 28.5MG BASE A065065 001 Apr 18, 2002
400MG;EQ 57MG BASE A065065 002 Apr 18, 2002
SUN PHARM INDS LTD 200MG;EQ 28.5MG BASE A065161 001 Dec 03, 2003
400MG;EQ 57MG BASE A065161 002 Dec 03, 2003
AUGMENTIN '125'
+ US ANTIBIOTICS 125MG;EQ 31.25MG BASE ** N050597 001 Jul 22, 1985
AUGMENTIN '200'
+ US ANTIBIOTICS 200MG;EQ 28.5MG BASE N050726 001 May 31, 1996
AUGMENTIN '250'
+ US ANTIBIOTICS 250MG;EQ 62.5MG BASE ** N050597 002 Jul 22, 1985
AUGMENTIN '400'
+ US ANTIBIOTICS 400MG;EQ 57MG BASE N050726 002 May 31, 1996
TABLET, EXTENDED RELEASE;ORAL
AUGMENTIN XR
+ US ANTIBIOTICS 1GM;EQ 62.5MG BASE N050785 001 Sep 25, 2002
AMOXICILLIN; VONOPRAZAN FUMARATE
CAPSULE, TABLET;ORAL
VOQUEZNA DUAL PAK
+ PHATHOM 500MG;EQ 20MG BASE N215153 001 May 03, 2022
AMPHETAMINE
SUSPENSION, EXTENDED RELEASE;ORAL
ADZENYS ER
+ NEOS THERAPS INC EQ 1.25MG BASE/ML N204325 001 Sep 15, 2017
AMPHETAMINE ADIPATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE ADIPATE; DEXTROAMPHETAMINE SULFATE
CAPSULE;ORAL
DELCOBESE
TEVA 1.25MG;1.25MG;1.25MG;1.25MG ** A083564 001
2.5MG;2.5MG;2.5MG;2.5MG ** A083564 002
3.75MG;3.75MG;3.75MG;3.75MG ** A083564 003
5MG;5MG;5MG;5MG ** A083564 004
TABLET;ORAL
DELCOBESE
TEVA 1.25MG;1.25MG;1.25MG;1.25MG A083563 004
2.5MG;2.5MG;2.5MG;2.5MG A083563 003
3.75MG;3.75MG;3.75MG;3.75MG A083563 002
5MG;5MG;5MG;5MG A083563 001
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE
SULFATE
CAPSULE, EXTENDED RELEASE;ORAL
DETROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
LANNETT CO INC 1.25MG;1.25MG;1.25MG;1.25MG A214403 001 Nov 26, 2021
2.5MG;2.5MG;2.5MG;2.5MG A214403 002 Nov 26, 2021
3.75MG;3.75MG;3.75MG;3.75MG A214403 003 Nov 26, 2021
5MG;5MG;5MG;5MG A214403 004 Nov 26, 2021
6.25MG;6.25MG;6.25MG;6.25MG A214403 005 Nov 26, 2021
7.5MG;7.5MG;7.5MG;7.5MG A214403 006 Nov 26, 2021
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
ANI PHARMS 2.5MG;2.5MG;2.5MG;2.5MG A205401 002 Jan 22, 2019
AUROLIFE PHARMA LLC 1.25MG;1.25MG;1.25MG;1.25MG A211876 001 Jun 24, 2020
2.5MG;2.5MG;2.5MG;2.5MG A211876 002 Jun 24, 2020
3.75MG;3.75MG;3.75MG;3.75MG A211876 003 Jun 24, 2020
5MG;5MG;5MG;5MG A211876 004 Jun 24, 2020
6.25MG;6.25MG;6.25MG;6.25MG A211876 005 Jun 24, 2020
7.5MG;7.5MG;7.5MG;7.5MG A211876 006 Jun 24, 2020
NESHER PHARMS 1.25MG;1.25MG;1.25MG;1.25MG A210080 001 Jul 17, 2019
2.5MG;2.5MG;2.5MG;2.5MG A210080 002 Jul 17, 2019
3.75MG;3.75MG;3.75MG;3.75MG A210080 003 Jul 17, 2019
5MG;5MG;5MG;5MG A210080 004 Jul 17, 2019
6.25MG;6.25MG;6.25MG;6.25MG A210080 005 Jul 17, 2019
7.5MG;7.5MG;7.5MG;7.5MG A210080 006 Jul 17, 2019
PAR PHARM INC 1.25MG;1.25MG;1.25MG;1.25MG A206159 001 May 31, 2019
2.5MG;2.5MG;2.5MG;2.5MG A206159 002 May 31, 2019
3.75MG;3.75MG;3.75MG;3.75MG A206159 003 May 31, 2019
5MG;5MG;5MG;5MG A206159 004 May 31, 2019

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-40(of 478)
** See List Footnote
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE
SULFATE
CAPSULE, EXTENDED RELEASE;ORAL
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
6.25MG;6.25MG;6.25MG;6.25MG A206159 005 May 31, 2019
7.5MG;7.5MG;7.5MG;7.5MG A206159 006 May 31, 2019
TEVA 1.25MG;1.25MG;1.25MG;1.25MG A077488 001 Apr 29, 2013
2.5MG;2.5MG;2.5MG;2.5MG A077488 002 Apr 29, 2013
3.75MG;3.75MG;3.75MG;3.75MG A077488 003 Apr 29, 2013
5MG;5MG;5MG;5MG A077488 004 Apr 29, 2013
6.25MG;6.25MG;6.25MG;6.25MG A077488 005 Apr 29, 2013
7.5MG;7.5MG;7.5MG;7.5MG A077488 006 Apr 29, 2013
TEVA PHARMS USA 3.125MG;3.125MG;3.125MG;3.125MG A210876 001 Jan 31, 2022
6.25MG;6.25MG;6.25MG;6.25MG A210876 002 Jan 31, 2022
9.375MG;9.375MG;9.375MG;9.375MG A210876 003 Jan 31, 2022
12.5MG;12.5MG;12.5MG;12.5MG A210876 004 Jan 31, 2022
DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE
BARR LABS INC 1.25MG;1.25MG;1.25MG;1.25MG A076536 001 Feb 12, 2013
2.5MG;2.5MG;2.5MG;2.5MG A076536 002 Feb 12, 2013
3.75MG;3.75MG;3.75MG;3.75MG A076536 003 Feb 12, 2013
5MG;5MG;5MG;5MG A076536 004 Feb 12, 2013
6.25MG;6.25MG;6.25MG;6.25MG A076536 005 Feb 12, 2013
7.5MG;7.5MG;7.5MG;7.5MG A076536 006 Feb 12, 2013
TABLET;ORAL
ADDERALL 10
+ TEVA WOMENS 2.5MG;2.5MG;2.5MG;2.5MG ** N011522 007 Feb 13, 1996
ADDERALL 12.5
+ TEVA WOMENS 3.125MG;3.125MG;3.125MG;3.125MG ** N011522 012 Aug 31, 2000
ADDERALL 15
+ TEVA WOMENS 3.75MG;3.75MG;3.75MG;3.75MG ** N011522 013 Aug 31, 2000
ADDERALL 20
+ TEVA WOMENS 5MG;5MG;5MG;5MG ** N011522 008 Feb 13, 1996
ADDERALL 30
+ TEVA WOMENS 7.5MG;7.5MG;7.5MG;7.5MG ** N011522 010 May 12, 1997
ADDERALL 5
+ TEVA WOMENS 1.25MG;1.25MG;1.25MG;1.25MG ** N011522 009 May 12, 1997
ADDERALL 7.5
+ TEVA WOMENS 1.875MG;1.875MG;1.875MG;1.875MG ** N011522 011 Aug 31, 2000
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
ACCORD HLTHCARE 1.25MG;1.25MG;1.25MG;1.25MG A214347 001 Nov 22, 2021
1.875MG;1.875MG;1.875MG;1.875MG A214347 002 Nov 22, 2021
2.5MG;2.5MG;2.5MG;2.5MG A214347 003 Nov 22, 2021
3.125MG;3.125MG;3.125MG;3.125MG A214347 004 Nov 22, 2021
3.75MG;3.75MG;3.75MG;3.75MG A214347 005 Nov 22, 2021
5MG;5MG;5MG;5MG A214347 006 Nov 22, 2021
7.5MG;7.5MG;7.5MG;7.5MG A214347 007 Nov 22, 2021
ACTAVIS ELIZABETH 1.25MG;1.25MG;1.25MG;1.25MG A040456 001 May 06, 2003
2.5MG;2.5MG;2.5MG;2.5MG A040456 002 May 06, 2003
5MG;5MG;5MG;5MG A040456 003 May 06, 2003
7.5MG;7.5MG;7.5MG;7.5MG A040456 004 May 06, 2003
CEDIPROF INC 1.25MG;1.25MG;1.25MG;1.25MG A210754 001 Jul 05, 2022
2.5MG;2.5MG;2.5MG;2.5MG A210754 002 Jul 05, 2022
3.75MG;3.75MG;3.75MG;3.75MG A210754 003 Jul 05, 2022
5MG;5MG;5MG;5MG A210754 004 Jul 05, 2022
7.5MG;7.5MG;7.5MG;7.5MG A210754 005 Jul 05, 2022
LANNETT CO INC 1.25MG;1.25MG;1.25MG;1.25MG A215565 001 Jul 08, 2022
1.875MG;1.875MG;1.875MG;1.875MG A215565 002 Jul 08, 2022
2.5MG;2.5MG;2.5MG;2.5MG A215565 003 Jul 08, 2022
3.125MG;3.125MG;3.125MG;3.125MG A215565 004 Jul 08, 2022
3.75MG;3.75MG;3.75MG;3.75MG A215565 005 Jul 08, 2022
5MG;5MG;5MG;5MG A215565 006 Jul 08, 2022
7.5MG;7.5MG;7.5MG;7.5MG A215565 007 Jul 08, 2022
MYLAN 1.25MG;1.25MG;1.25MG;1.25MG A206721 001 Nov 10, 2015
1.875MG;1.875MG;1.875MG;1.875MG A206721 002 Nov 10, 2015
2.5MG;2.5MG;2.5MG;2.5MG A206721 003 Nov 10, 2015
3.125MG;3.125MG;3.125MG;3.125MG A206721 004 Nov 10, 2015
3.75MG;3.75MG;3.75MG;3.75MG A206721 005 Nov 10, 2015
5MG;5MG;5MG;5MG A206721 006 Nov 10, 2015
7.5MG;7.5MG;7.5MG;7.5MG A206721 007 Nov 10, 2015

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-41(of 478)
** See List Footnote
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE
SULFATE
TABLET;ORAL
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
TEVA PHARMS 1.25MG;1.25MG;1.25MG;1.25MG A040472 001 Sep 30, 2003
2.5MG;2.5MG;2.5MG;2.5MG A040472 002 Sep 30, 2003
5MG;5MG;5MG;5MG A040472 003 Sep 30, 2003
7.5MG;7.5MG;7.5MG;7.5MG A040472 004 Sep 30, 2003
AMPHETAMINE RESIN COMPLEX; DEXTROAMPHETAMINE RESIN COMPLEX
CAPSULE, EXTENDED RELEASE;ORAL
BIPHETAMINE 12.5
UCB INC EQ 6.25MG BASE;EQ 6.25MG BASE N010093 007
BIPHETAMINE 20
UCB INC EQ 10MG BASE;EQ 10MG BASE N010093 003
BIPHETAMINE 7.5
UCB INC EQ 3.75MG BASE;EQ 3.75MG BASE N010093 009
AMPHETAMINE SULFATE
TABLET;ORAL
AMPHETAMINE SULFATE
GLENMARK PHARMS LTD 5MG A212186 001 Jan 27, 2021
10MG A212186 002 Jan 27, 2021
+ LANNETT 5MG A083901 001 Aug 31, 1984
+ 10MG A083901 002 Aug 31, 1984
MAYNE PHARMA 5MG A213898 001 Jul 14, 2020
10MG A213898 002 Jul 14, 2020
NOVAST LABS 5MG A213763 001 Aug 24, 2020
10MG A213763 002 Aug 24, 2020
TABLET, ORALLY DISINTEGRATING;ORAL
EVEKEO ODT
+ AZURITY 2.5MG N209905 005 Apr 16, 2021
AMPHOTERICIN B
CREAM;TOPICAL
FUNGIZONE
APOTHECON 3% N050314 001
INJECTABLE;INJECTION
AMPHOTERICIN B
ABBOTT 50MG/VIAL A064141 001 Dec 23, 1996
ABRAXIS PHARM 50MG/VIAL A062728 001 Apr 13, 1987
TEVA PARENTERAL 50MG/VIAL A064062 001 Mar 31, 1995
FUNGIZONE
APOTHECON 50MG/VIAL A060517 001
INJECTABLE, LIPID COMPLEX;INJECTION
AMPHOTEC
ALKOPHARMA USA 50MG/VIAL N050729 001 Nov 22, 1996
100MG/VIAL N050729 002 Nov 22, 1996
LOTION;TOPICAL
FUNGIZONE
APOTHECON 3% A060570 001
OINTMENT;TOPICAL
FUNGIZONE
APOTHECON 3% N050313 001
SUSPENSION;ORAL
FUNGIZONE
BRISTOL MYERS SQUIBB 100MG/ML N050341 003
AMPICILLIN SODIUM
INJECTABLE;INJECTION
AMPICILLIN SODIUM
ACS DOBFAR SPA EQ 500MG BASE/VIAL A090884 001 Apr 03, 2013
EQ 1GM BASE/VIAL A090884 002 Apr 03, 2013
EQ 2GM BASE/VIAL A090884 003 Apr 03, 2013
APOTHECON EQ 125MG BASE/VIAL A062860 001 Feb 05, 1988
EQ 250MG BASE/VIAL A062860 002 Feb 05, 1988
EQ 500MG BASE/VIAL A062860 003 Feb 05, 1988
EQ 1GM BASE/VIAL A062860 004 Feb 05, 1988
EQ 2GM BASE/VIAL A062860 005 Feb 05, 1988
CONSOLIDATED PHARM EQ 125MG BASE/VIAL A061936 005
EQ 250MG BASE/VIAL A061936 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-42(of 478)
** See List Footnote
AMPICILLIN SODIUM
INJECTABLE;INJECTION
AMPICILLIN SODIUM
EQ 500MG BASE/VIAL A061936 002
EQ 1GM BASE/VIAL A061936 003
EQ 2GM BASE/VIAL A061936 004
EUGIA PHARMA SPECLTS EQ 125MG BASE/VIAL A065499 001 Aug 17, 2010
HIKMA EQ 125MG BASE/VIAL A062692 001 Jun 24, 1986
EQ 250MG BASE/VIAL A062692 002 Jun 24, 1986
EQ 500MG BASE/VIAL A062692 003 Jun 24, 1986
EQ 1GM BASE/VIAL A062692 004 Jun 24, 1986
EQ 2GM BASE/VIAL A062692 005 Jun 24, 1986
EQ 10GM BASE/VIAL A062692 006 Jun 24, 1986
HOSPIRA EQ 250MG BASE/VIAL A202864 001 Sep 04, 2015
EQ 500MG BASE/VIAL A202864 002 Sep 04, 2015
EQ 1GM BASE/VIAL A202864 003 Sep 04, 2015
EQ 2GM BASE/VIAL A202864 004 Sep 04, 2015
EQ 10GM BASE/VIAL A202865 001 Sep 04, 2015
HQ SPECLT PHARMA EQ 125MG BASE/VIAL A062772 005 Apr 15, 1993
EQ 500MG BASE/VIAL A062772 008 Apr 15, 1993
EQ 1GM BASE/VIAL A062772 002 Apr 15, 1993
EQ 2GM BASE/VIAL A062772 004 Apr 15, 1993
INTL MEDICATION EQ 1GM BASE/VIAL A062634 002 Jan 09, 1987
EQ 2GM BASE/VIAL A062634 003 Jan 09, 1987
ISTITUTO BIO ITA SPA EQ 125MG BASE/VIAL A062797 001 Jul 12, 1993
LILLY EQ 500MG BASE/VIAL A062565 001 Apr 04, 1985
EQ 1GM BASE/VIAL A062565 002 Apr 04, 1985
EQ 2GM BASE/VIAL A062565 003 Jun 24, 1986
MYLAN LABS LTD EQ 250MG BASE/VIAL A201025 001 Apr 09, 2014
EQ 500MG BASE/VIAL A201025 002 Apr 09, 2014
WATSON LABS INC EQ 125MG BASE/VIAL A062816 001 Oct 24, 1988
EQ 250MG BASE/VIAL A062816 002 Oct 24, 1988
EQ 500MG BASE/VIAL A062816 003 Oct 24, 1988
EQ 1GM BASE/VIAL A062816 004 Oct 24, 1988
EQ 2GM BASE/VIAL A062816 005 Oct 24, 1988
EQ 10GM BASE/VIAL A062994 001 Sep 15, 1988
OMNIPEN-N
WYETH AYERST EQ 125MG BASE/VIAL A060626 001
EQ 125MG BASE/VIAL A062718 001 Dec 16, 1986
EQ 250MG BASE/VIAL A060626 002
EQ 250MG BASE/VIAL A062718 002 Dec 16, 1986
EQ 500MG BASE/VIAL A060626 003
EQ 500MG BASE/VIAL A062718 003 Dec 16, 1986
EQ 1GM BASE/VIAL A060626 004
EQ 1GM BASE/VIAL A062718 004 Dec 16, 1986
EQ 2GM BASE/VIAL A060626 005
EQ 2GM BASE/VIAL A062718 005 Dec 16, 1986
PENBRITIN-S
+ WYETH AYERST EQ 125MG BASE/VIAL ** N050072 001
+ EQ 250MG BASE/VIAL ** N050072 002
+ EQ 500MG BASE/VIAL ** N050072 003
+ EQ 1GM BASE/VIAL ** N050072 004
+ EQ 2GM BASE/VIAL ** N050072 005
+ EQ 4GM BASE/VIAL ** N050072 006
POLYCILLIN-N
BRISTOL EQ 125MG BASE/VIAL ** N050309 001
EQ 250MG BASE/VIAL ** N050309 002
EQ 500MG BASE/VIAL ** N050309 003
EQ 1GM BASE/VIAL ** N050309 004
EQ 2GM BASE/VIAL ** N050309 005
TOTACILLIN-N
GLAXOSMITHKLINE EQ 125MG BASE/VIAL A060677 001
EQ 250MG BASE/VIAL A060677 002
EQ 500MG BASE/VIAL A060677 003
EQ 1GM BASE/VIAL A060677 004
EQ 1GM BASE/VIAL A062727 001 Dec 19, 1986
EQ 2GM BASE/VIAL A060677 005
EQ 2GM BASE/VIAL A062727 002 Dec 19, 1986
EQ 10GM BASE/VIAL A060677 006

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-43(of 478)
** See List Footnote
AMPICILLIN SODIUM; SULBACTAM SODIUM
INJECTABLE;INJECTION
AMPICILLIN AND SULBACTAM
EUGIA PHARMA SPECLTS EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL A090340 001 Sep 20, 2010
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL A090340 002 Sep 20, 2010
HOSPIRA INC EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL A090375 001 Dec 21, 2011
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL A090653 001 Dec 21, 2011
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL A090375 002 Dec 21, 2011
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL A090653 002 Dec 21, 2011
EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL A090646 001 Dec 21, 2011
PHARM ASSOC EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL A065316 001 Jun 29, 2007
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL A065316 002 Jun 29, 2007
UNASYN
PFIZER EQ 500MG BASE/VIAL;EQ 250MG BASE/VIAL N050608 003 Dec 31, 1986
AMPICILLIN/AMPICILLIN TRIHYDRATE
CAPSULE;ORAL
AMCILL
PARKE DAVIS EQ 250MG BASE A062041 001
EQ 500MG BASE A062041 002
AMPICILLIN TRIHYDRATE
BELCHER PHARMS EQ 250MG BASE A061602 001
EQ 500MG BASE A061602 002
HERITAGE PHARMA EQ 250MG BASE A061502 001
EQ 500MG BASE A061502 002
IVAX SUB TEVA PHARMS EQ 250MG BASE A060765 001
EQ 500MG BASE A060765 002
LEDERLE EQ 250MG BASE A062208 001
EQ 500MG BASE A062208 002
MYLAN EQ 250MG BASE A061755 001
EQ 500MG BASE A061755 002
PUREPAC PHARM EQ 250MG BASE A061853 001
EQ 500MG BASE A061853 002
SANDOZ EQ 250MG BASE A064082 001 Aug 29, 1995
STRIDES PHARMA EQ 250MG BASE A062883 001 Feb 25, 1988
EQ 500MG BASE A062882 001 Feb 25, 1988
VITARINE EQ 250MG BASE A061387 001
EQ 500MG BASE A061387 003
OMNIPEN (AMPICILLIN)
WYETH AYERST 250MG A060624 001
500MG A060624 002
PENBRITIN
WYETH AYERST EQ 250MG BASE A060908 001
EQ 500MG BASE A060908 002
PFIZERPEN-A
PFIZER EQ 250MG BASE A062050 001
EQ 500MG BASE A062050 002
POLYCILLIN
BRISTOL EQ 250MG BASE N050310 001
EQ 500MG BASE N050310 002
PRINCIPEN
APOTHECON EQ 250MG BASE A062888 001 Mar 04, 1988
EQ 500MG BASE A062888 002 Mar 04, 1988
BRISTOL MYERS SQUIBB EQ 250MG BASE A061392 001
EQ 500MG BASE A061392 002
PRINCIPEN '250'
APOTHECON EQ 250MG BASE A062157 002
EQ 250MG BASE N050056 001
PRINCIPEN '500'
APOTHECON EQ 500MG BASE A062157 001
EQ 500MG BASE N050056 002
TOTACILLIN
GLAXOSMITHKLINE EQ 250MG BASE A060060 001
EQ 250MG BASE A062212 001
EQ 500MG BASE A060060 002
EQ 500MG BASE A062212 002
FOR SUSPENSION;ORAL
AMCILL
PARKE DAVIS EQ 125MG BASE/5ML A062030 001
EQ 250MG BASE/5ML A062030 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-44(of 478)
** See List Footnote
AMPICILLIN/AMPICILLIN TRIHYDRATE
FOR SUSPENSION;ORAL
AMPICILLIN TRIHYDRATE
BELCHER PHARMS EQ 125MG BASE/5ML A061601 001
EQ 250MG BASE/5ML A061601 002
DAVA PHARMS INC EQ 125MG BASE/5ML A062982 001 Feb 10, 1989
EQ 250MG BASE/5ML A062982 002 Feb 10, 1989
MYLAN EQ 125MG BASE/5ML A061829 002
EQ 250MG BASE/5ML A061829 001
PUREPAC PHARM EQ 125MG BASE/5ML A061980 001
EQ 250MG BASE/5ML A061980 002
TEVA EQ 125MG BASE/5ML A061370 001
EQ 250MG BASE/5ML A061370 002
OMNIPEN (AMPICILLIN)
WYETH AYERST 100MG/ML A060625 001
125MG/5ML A060625 002
250MG/5ML A060625 003
500MG/5ML A060625 004
PENBRITIN
WYETH AYERST EQ 100MG BASE/ML N050019 001
EQ 125MG BASE/5ML N050019 002
EQ 250MG BASE/5ML N050019 003
PFIZERPEN-A
PFIZER EQ 125MG BASE/5ML A062049 001
EQ 250MG BASE/5ML A062049 002
POLYCILLIN
APOTHECON EQ 125MG BASE/5ML A062297 001
EQ 250MG BASE/5ML A062297 002
BRISTOL EQ 100MG BASE/ML N050308 004
EQ 125MG BASE/5ML N050308 001
EQ 250MG BASE/5ML N050308 002
EQ 500MG BASE/5ML N050308 003
PRINCIPEN
APOTHECON EQ 100MG BASE/ML A061394 001
EQ 125MG BASE/5ML A061394 002
EQ 250MG BASE/5ML A061394 003
PRINCIPEN '125'
APOTHECON EQ 125MG BASE/5ML A060127 002
EQ 125MG BASE/5ML A062151 001
PRINCIPEN '250'
APOTHECON EQ 250MG BASE/5ML A060127 001
EQ 250MG BASE/5ML A062151 002
TOTACILLIN
GLAXOSMITHKLINE EQ 125MG BASE/5ML A060666 001
EQ 125MG BASE/5ML A062223 001
EQ 250MG BASE/5ML A060666 002
EQ 250MG BASE/5ML A062223 002
TABLET, CHEWABLE;ORAL
POLYCILLIN
BRISTOL EQ 125MG BASE N050093 001
AMPICILLIN/AMPICILLIN TRIHYDRATE; PROBENECID
CAPSULE;ORAL
PRINCIPEN W/ PROBENECID
APOTHECON EQ 389MG BASE;111MG A062150 001
EQ 389MG BASE;111MG N050488 001
FOR SUSPENSION;ORAL
POLYCILLIN-PRB
APOTHECON EQ 3.5GM BASE/BOT;1GM/BOT A061898 001
BRISTOL EQ 3.5GM BASE/BOT;1GM/BOT N050457 001
PROBAMPACIN
COSETTE EQ 3.5GM BASE/BOT;1GM/BOT A061741 001
AMPRENAVIR
CAPSULE;ORAL
AGENERASE
GLAXOSMITHKLINE 50MG N021007 001 Apr 15, 1999
150MG N021007 002 Apr 15, 1999

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-45(of 478)
** See List Footnote
AMPRENAVIR
SOLUTION;ORAL
AGENERASE
+ GLAXOSMITHKLINE 15MG/ML ** N021039 001 Apr 15, 1999
ANAGRELIDE HYDROCHLORIDE
CAPSULE;ORAL
AGRYLIN
+ TAKEDA PHARMS USA EQ 1MG BASE ** N020333 002 Mar 14, 1997
ANAGRELIDE HYDROCHLORIDE
BARR EQ 0.5MG BASE A076530 001 Apr 18, 2005
EQ 1MG BASE A076530 002 Apr 18, 2005
CHARTWELL RX EQ 0.5MG BASE A076683 001 Apr 18, 2005
EQ 1MG BASE A076683 002 Apr 18, 2005
MYLAN EQ 0.5MG BASE A076811 001 Apr 18, 2005
EQ 1MG BASE A076811 002 Apr 18, 2005
RISING EQ 0.5MG BASE A077613 001 Jun 27, 2006
EQ 1MG BASE A077613 002 Jun 27, 2006
ROXANE EQ 0.5MG BASE A076489 001 Apr 18, 2005
EQ 1MG BASE A076489 002 Apr 18, 2005
WATSON LABS EQ 0.5MG BASE A076417 001 Apr 18, 2005
EQ 1MG BASE A076417 002 Apr 18, 2005
ANASTROZOLE
TABLET;ORAL
ANASTROZOLE
APOTEX INC 1MG A200654 001 May 11, 2012
CHARTWELL MOLECULAR 1MG A091331 001 Jan 05, 2011
FRESENIUS KABI USA 1MG A090088 001 Jun 28, 2010
HIKMA 1MG A078485 001 Jun 28, 2010
IMPAX LABS INC 1MG A091242 001 May 31, 2012
MYLAN 1MG A091051 001 Jun 28, 2010
PICKET PHARMS 1MG A090732 001 Jun 28, 2010
SANDOZ 1MG A079007 001 Jun 28, 2010
SUN PHARM INDS LTD 1MG A091177 001 Jul 15, 2011
SYNTHON PHARMS 1MG A078322 001 Jun 28, 2010
WATSON LABS TEVA 1MG A078984 001 Jun 28, 2010
ANGIOTENSIN II ACETATE
SOLUTION;INTRAVENOUS
GIAPREZA
+ LA JOLLA PHARMA EQ 5MG BASE/2ML (EQ 2.5MG BASE/ML) N209360 002 Dec 21, 2017
ANILERIDINE HYDROCHLORIDE
TABLET;ORAL
LERITINE
MERCK EQ 25MG BASE N010585 002
ANILERIDINE PHOSPHATE
INJECTABLE;INJECTION
LERITINE
MERCK 25MG/ML N010520 003
ANISINDIONE
TABLET;ORAL
MIRADON
SCHERING 50MG N010909 003
ANISOTROPINE METHYLBROMIDE
TABLET;ORAL
ANISOTROPINE METHYLBROMIDE
WATSON LABS 50MG A086046 001
VALPIN 50
ENDO PHARMS 50MG N013428 001
ANTAZOLINE PHOSPHATE; NAPHAZOLINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
VASOCON-A
NOVARTIS 0.5%;0.05% N018746 002 Jul 11, 1994

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-46(of 478)
** See List Footnote
APIXABAN
TABLET;ORAL
APIXABAN
BIONPHARMA INC 2.5MG A210152 001 Apr 08, 2020
5MG A210152 002 Apr 08, 2020
BRECKENRIDGE 2.5MG A209845 001 Jul 26, 2021
5MG A209845 002 Jul 26, 2021
MICRO LABS 2.5MG A210013 001 Dec 23, 2019
5MG A210013 002 Dec 23, 2019
MYLAN 2.5MG A210128 001 Dec 23, 2019
5MG A210128 002 Dec 23, 2019
APOMORPHINE HYDROCHLORIDE
INJECTABLE;SUBCUTANEOUS
APOKYN
MDD US 20MG/2ML (10MG/ML) N021264 001 Apr 20, 2004
APREMILAST
TABLET;ORAL
APREMILAST
AMNEAL 10MG A211782 001 Jun 30, 2021
20MG A211782 002 Jun 30, 2021
30MG A211782 003 Jun 30, 2021
UNICHEM 10MG A211819 001 Feb 17, 2021
20MG A211819 002 Feb 17, 2021
30MG A211819 003 Feb 17, 2021
APREPITANT
CAPSULE;ORAL
EMEND
+ MERCK 40MG ** N021549 003 Jun 30, 2006
ARBUTAMINE HYDROCHLORIDE
INJECTABLE;INJECTION
GENESA
GENSIA AUTOMEDICS 0.05MG/ML N020420 001 Sep 12, 1997
ARDEPARIN SODIUM
INJECTABLE;INJECTION
NORMIFLO
+ PHARMACIA AND UPJOHN 5,000 UNITS/0.5ML ** N020227 002 May 23, 1997
+ 10,000 UNITS/0.5ML ** N020227 001 May 23, 1997
ARFORMOTEROL TARTRATE
SOLUTION;INHALATION
ARFORMOTEROL TARTRATE
GLENMARK PHARMS LTD EQ 0.015MG BASE/2ML A213132 001 Jun 22, 2021
RITEDOSE CORP EQ 0.015MG BASE/2ML A214736 001 Mar 02, 2022
ARGATROBAN
INJECTABLE;INTRAVENOUS
ARGATROBAN IN 0.9% SODIUM CHLORIDE
TEVA PHARMS USA 250MG/250ML (1MG/ML) N206769 001 Dec 15, 2014
ARGATROBAN IN SODIUM CHLORIDE
+ CIPLA 50MG/50ML (1MG/ML) N022434 001 Jun 29, 2011
SOLUTION;INTRAVENOUS
ARGATROBAN IN DEXTROSE
SANDOZ 125MG/125ML (1MG/ML) N201743 001 May 09, 2011
ARIPIPRAZOLE
INJECTABLE;INTRAMUSCULAR
ABILIFY
OTSUKA 9.75MG/1.3ML (7.5MG/ML) N021866 001 Sep 20, 2006
SOLUTION;ORAL
ABILIFY
+ OTSUKA 1MG/ML ** N021713 001 Dec 10, 2004
TABLET;ORAL
ARIPIPRAZOLE
MYLAN 2MG A206240 001 Sep 19, 2018
5MG A206240 002 Sep 19, 2018
10MG A206240 003 Sep 19, 2018
15MG A206240 004 Sep 19, 2018
20MG A206240 005 Sep 19, 2018

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-47(of 478)
** See List Footnote
ARIPIPRAZOLE
TABLET;ORAL
ARIPIPRAZOLE
30MG A206240 006 Sep 19, 2018
TEVA PHARMS USA 2MG A078607 001 Apr 28, 2015
5MG A078607 002 Apr 28, 2015
10MG A078608 001 Apr 28, 2015
15MG A078708 001 Apr 28, 2015
20MG A078708 002 Apr 28, 2015
30MG A078708 003 Apr 28, 2015
ZYDUS PHARMS 2MG A090472 001 Jan 07, 2019
5MG A090472 002 Jan 07, 2019
10MG A090472 003 Jan 07, 2019
15MG A090472 004 Jan 07, 2019
20MG A090472 005 Jan 07, 2019
30MG A090472 006 Jan 07, 2019
TABLET, ORALLY DISINTEGRATING;ORAL
ABILIFY
+ OTSUKA 10MG ** N021729 002 Jun 07, 2006
+ 15MG ** N021729 003 Jun 07, 2006
+ 20MG ** N021729 004 Jun 07, 2006
+ 30MG ** N021729 005 Jun 07, 2006
ARMODAFINIL
TABLET;ORAL
ARMODAFINIL
APOTEX INC 50MG A201514 001 Mar 25, 2019
150MG A201514 002 Mar 25, 2019
250MG A201514 003 Mar 25, 2019
WATSON LABS INC 100MG A200156 002 Aug 29, 2012
200MG A200156 004 Aug 29, 2012
NUVIGIL
+ CEPHALON 100MG ** N021875 002 Mar 26, 2009
ARSENIC TRIOXIDE
INJECTABLE;INJECTION
ARSENIC TRIOXIDE
INGENUS PHARMS LLC 2MG/ML A209315 002 Jan 14, 2021
TRISENOX
+ CEPHALON 1MG/ML ** N021248 001 Sep 25, 2000
ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
INJECTABLE;INJECTION
ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE
HOSPIRA 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG A079138 001 Jun 18, 2010
BASE/ML)
ULTACAN
HANSAMED INC 4%;EQ 0.0085MG BASE/1.7ML (4%; EQ A201751 001 Jul 11, 2017
0.005MG BASE/ML)
ULTACAN FORTE
HANSAMED INC 4%;EQ 0.017MG BASE/1.7ML (4%; EQ 0.01MG A201750 001 Jul 11, 2017
BASE/ML)
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE;
PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE;
VITAMIN A; VITAMIN E
FOR SOLUTION;INTRAVENOUS
M.V.I. PEDIATRIC
+ HOSPIRA 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/ N018920 001 Sep 21, 2000
VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;
0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG
BASE/VIAL;0.7MG/VIAL;7MG/VIAL

ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE;


PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A
PALMITATE; VITAMIN E
INJECTABLE;INJECTION
BEROCCA PN
ROCHE 50MG/ML;0.03MG/ML;0.0025MG/ML;7.5MG/ML; N006071 003 Oct 10, 1985
100
IU/ML;0.2MG/ML;20MG/ML;2MG/ML;1.8MG/ML;

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-48(of 478)
** See List Footnote
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE;
PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A;
VITAMIN E
INJECTABLE;INJECTION
M.V.C. 9+3
ABRAXIS PHARM 10MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;2 N018440 002 Aug 08, 1985
0
IU/ML;0.04MG/ML;4MG/ML;0.4MG/ML;0.36MG/
M.V.I.-12 ADULT
HOSPIRA 10MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;2 N008809 004 Aug 08, 1985
0
IU/ML;0.04MG/ML;4MG/ML;0.4MG/ML;0.36MG/
+ 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML; N008809 006 Sep 09, 2004
0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0
.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML
MVC PLUS
WATSON LABS 10MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;2 N018439 002 Aug 08, 1985
0
IU/ML;0.04MG/ML;4MG/ML;0.4MG/ML;0.36MG/
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE;
PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A;
VITAMIN E; VITAMIN K
INJECTABLE;INTRAVENOUS
M.V.I. ADULT
+ HOSPIRA 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15M N021625 001 Jan 30, 2004
G/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIA
L;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL
;10MG/VIAL;0.15MG/VIAL
M.V.I. ADULT (PHARMACY BULK PACKAGE)
+ HOSPIRA 200MG/5ML;0.06MG/5ML;0.005MG/5ML;15MG/5 N021643 001 Feb 18, 2004
ML;0.005MG/5ML;0.6MG/5ML;40MG/5ML;6MG/5
ML;3.6MG/5ML;6MG/5ML;1MG/5ML;10MG/5ML;0
.15MG/5ML
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE;
PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
INJECTABLE;INJECTION
M.V.I.-12 ADULT
HOSPIRA 20MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;2 N008809 005 Apr 22, 2004
0
IU/ML;0.6MG/ML;4MG/ML;0.4MG/ML;0.36MG/M
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE;
PYRIDOXINE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE; VITAMIN A; VITAMIN E
INJECTABLE;INJECTION
M.V.I.-12 LYOPHILIZED
TELIGENT 100MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15M N018933 002 Aug 08, 1985
G/VIAL;5MCG/VIAL;0.4MG/VIAL;40MG/VIAL;4
MG/VIAL;3.6MG/VIAL;3MG/VIAL;1MG/VIAL;10
MG/VIAL
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PANTOTHENIC ACID;
PHYTONADIONE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; VITAMIN A PALMITATE; VITAMIN E
INJECTABLE;INJECTION
VITAPED
HOSPIRA N/A,80MG/VIAL;N/A,0.02MG/VIAL;N/A,0.001 N020176 001 Dec 29, 1993
MG/VIAL;400
IU/10ML,N/A;N/A,0.14MG/VIAL;N/A,17MG/VI
AL;N/A,5MG/VIAL;0.2MG/10ML,N/A;N/A,1MG/
VIAL;N/A,1.4MG/VIAL;N/A,1.2MG/VIAL;EQ
2,300 UNITS BASE/10ML,N/A;7 IU/10ML,N/A
ASPIRIN
TABLET;ORAL
BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN
BAYER 500MG N021317 001 Oct 18, 2001
TABLET, EXTENDED RELEASE;ORAL
8-HOUR BAYER
BAYER 650MG N016030 001
MEASURIN
BAYER 650MG N016030 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-49(of 478)
** See List Footnote
ASPIRIN; BUTALBITAL
TABLET;ORAL
AXOTAL
SAVAGE LABS 650MG;50MG A088305 001 Oct 13, 1983
ASPIRIN; BUTALBITAL; CAFFEINE
CAPSULE;ORAL
BUTALBITAL, ASPIRIN AND CAFFEINE
LGM PHARMA 500MG;50MG;40MG A205230 001 Oct 18, 2021
WATSON LABS 325MG;50MG;40MG A086231 002 Feb 12, 1985
FIORINAL
+ ALLERGAN 325MG;50MG;40MG N017534 005 Apr 16, 1986
TABLET;ORAL
BUTALBITAL, ASPIRIN AND CAFFEINE
ACTAVIS ELIZABETH 325MG;50MG;40MG A086710 002 Aug 23, 1983
FOSUN PHARMA 325MG;50MG;40MG A086398 002 Apr 06, 1984
HALSEY 325MG;50MG;40MG A089448 001 Dec 01, 1986
+ HIKMA INTL PHARMS 325MG;50MG;40MG A086162 002 Feb 16, 1984
IVAX PHARMS 325MG;50MG;40MG A085441 002 Oct 31, 1984
PURACAP PHARM 325MG;50MG;40MG A087048 002 Dec 09, 1983
QUANTUM PHARMICS 325MG;50MG;40MG A088972 001 Jun 18, 1985
WATSON LABS 325MG;50MG;40MG A086237 002 Mar 23, 1984
FIORINAL
+ ALLERGAN 325MG;50MG;40MG ** N017534 003 Apr 16, 1986
LANORINAL
LANNETT 325MG;50MG;40MG A086986 002 Oct 18, 1985
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
CAPSULE;ORAL
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
MAYNE PHARMA INC 325MG;50MG;40MG;30MG A203335 001 Oct 30, 2015
STRIDES PHARMA 325MG;50MG;40MG;30MG A075351 001 Mar 05, 1999
WATSON LABS 325MG;50MG;40MG;30MG A074359 001 Aug 31, 1995
FIORINAL W/CODEINE
+ ALLERGAN 325MG;50MG;40MG;30MG N019429 003 Oct 26, 1990
ASPIRIN; CAFFEINE; DIHYDROCODEINE BITARTRATE
CAPSULE;ORAL
SYNALGOS-DC
+ SUN PHARM INDUSTRIES 356.4MG;30MG;16MG N011483 004 Sep 06, 1983
ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
TABLET;ORAL
INVAGESIC
SANDOZ 385MG;30MG;25MG A074817 001 Nov 27, 1996
INVAGESIC FORTE
SANDOZ 770MG;60MG;50MG A074817 002 Nov 27, 1996
NORGESIC
+ BAUSCH 385MG;30MG;25MG ** N013416 003 Oct 27, 1982
NORGESIC FORTE
+ BAUSCH 770MG;60MG;50MG ** N013416 004 Oct 27, 1982
ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE
SANDOZ 385MG;30MG;25MG A074654 001 Dec 31, 1996
770MG;60MG;50MG A074654 002 Dec 31, 1996
STEVENS J 385MG;30MG;25MG A074988 001 Apr 30, 1999
770MG;60MG;50MG A074988 002 Apr 30, 1999
ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE
CAPSULE;ORAL
COMPOUND 65
ALRA 389MG;32.4MG;65MG A084553 002 Aug 17, 1983
DARVON COMPOUND
XANODYNE PHARM 389MG;32.4MG;32MG N010996 006 Mar 08, 1983
DARVON COMPOUND-65
XANODYNE PHARM 389MG;32.4MG;65MG N010996 007 Mar 08, 1983
PROPOXYPHENE COMPOUND 65
IVAX SUB TEVA PHARMS 389MG;32.4MG;65MG A083077 002 Dec 07, 1984
+ SANDOZ 389MG;32.4MG;65MG A080044 002 Sep 16, 1983
TEVA 389MG;32.4MG;65MG A089025 001 Mar 29, 1985
PROPOXYPHENE COMPOUND-65
SANDOZ 389MG;32.4MG;65MG A083101 002 Jun 24, 1985

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-50(of 478)
** See List Footnote
ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE
CAPSULE;ORAL
PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE
WATSON LABS 389MG;32.4MG;65MG A085732 002 Sep 03, 1984
ASPIRIN; CARISOPRODOL
TABLET;ORAL
CARISOPRODOL AND ASPIRIN
HERITAGE PHARMS 325MG;200MG A089594 001 Mar 31, 1989
NOVAST LABS 325MG;200MG A040832 001 Jan 07, 2010
OXFORD PHARMS 325MG;200MG A040252 001 Dec 10, 1997
SANDOZ 325MG;200MG A040116 001 Apr 25, 1996
CARISOPRODOL COMPOUND
WATSON LABS 325MG;200MG A088809 001 Oct 03, 1985
SOMA COMPOUND
MEDA PHARMS 325MG;200MG ** N012365 005 Jul 11, 1983
ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE
TABLET;ORAL
CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE
INGENUS PHARMS NJ 325MG;200MG;16MG A040860 001 Jan 07, 2010
OXFORD PHARMS 325MG;200MG;16MG A040283 001 Dec 29, 1998
SANDOZ 325MG;200MG;16MG A040118 001 Apr 16, 1996
SOMA COMPOUND W/ CODEINE
MEDA PHARMS 325MG;200MG;16MG ** N012366 002 Jul 11, 1983
ASPIRIN; DIPYRIDAMOLE
CAPSULE, EXTENDED RELEASE;ORAL
AGGRENOX
+ BOEHRINGER INGELHEIM 25MG;200MG N020884 001 Nov 22, 1999
ASPIRIN AND DIPYRIDAMOLE
ANI PHARMS 25MG;200MG A206964 001 Jan 18, 2017
CHARTWELL MOLECULAR 25MG;200MG A204552 001 Mar 20, 2019
SUN PHARM 25MG;200MG A208572 001 Aug 21, 2018
ASPIRIN; HYDROCODONE BITARTRATE
TABLET;ORAL
AZDONE
SCHWARZ PHARMA 500MG;5MG ** A089420 001 Jan 25, 1988
VICOPRIN
ABBOTT 500MG;5MG A086333 001 Sep 14, 1983
ASPIRIN; MEPROBAMATE
TABLET;ORAL
EQUAGESIC
SUN PHARM INDUSTRIES 325MG;200MG N011702 003 Dec 29, 1983
MEPRO-ASPIRIN
SANDOZ 325MG;200MG A089127 001 Mar 02, 1987
MEPROBAMATE AND ASPIRIN
PAR PHARM 325MG;200MG A089126 001 Aug 19, 1986
MICRAININ
MEDPOINTE PHARM HLC 325MG;200MG A084978 001
Q-GESIC
QUANTUM PHARMICS 325MG;200MG A088740 001 Jun 01, 1984
ASPIRIN; METHOCARBAMOL
TABLET;ORAL
METHOCARBAMOL AND ASPIRIN
IVAX SUB TEVA PHARMS 325MG;400MG A087211 001 Dec 22, 1982
MCNEIL 325MG;400MG A089193 001 Feb 12, 1986
PAR PHARM 325MG;400MG A089657 001 Nov 04, 1988
STEVENS J 325MG;400MG A081145 001 Jan 31, 1995
ROBAXISAL
ROBINS AH 325MG;400MG N012281 001
ASPIRIN; OMEPRAZOLE
TABLET, DELAYED RELEASE;ORAL
YOSPRALA
+ GENUS LIFESCIENCES 81MG;40MG N205103 001 Sep 14, 2016
+ 325MG;40MG N205103 002 Sep 14, 2016

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-51(of 478)
** See List Footnote
ASPIRIN; OXYCODONE HYDROCHLORIDE
TABLET;ORAL
OXYCODONE AND ASPIRIN
ACTAVIS LABS FL INC 325MG;4.8355MG A090084 001 Mar 22, 2011
MAYNE PHARMA INC 325MG;4.8355MG A091670 001 Mar 16, 2011
ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE
TABLET;ORAL
CODOXY
HALSEY 325MG;4.5MG;0.38MG A087464 001 Jul 01, 1982
OXYCODONE AND ASPIRIN
ANI PHARMS 325MG;4.5MG;0.38MG A040255 001 Feb 27, 1998
SUN PHARM INDUSTRIES 325MG;4.5MG;0.38MG A040260 001 Jul 17, 1998
325MG;4.5MG;0.38MG A087794 001 May 26, 1982
OXYCODONE AND ASPIRIN (HALF-STRENGTH)
ROXANE 325MG;2.25MG;0.19MG A087742 001 Jun 04, 1982
PERCODAN
ENDO PHARMS 325MG;4.5MG;0.38MG ** N007337 006
PERCODAN-DEMI
ENDO PHARMS 325MG;2.25MG;0.19MG ** N007337 005
ROXIPRIN
ROXANE 325MG;4.5MG;0.38MG A087743 001 Jun 04, 1982
ASPIRIN; PENTAZOCINE HYDROCHLORIDE
TABLET;ORAL
TALWIN COMPOUND
+ SANOFI AVENTIS US 325MG;EQ 12.5MG BASE ** N016891 001
ASPIRIN; PRAVASTATIN SODIUM
TABLET;ORAL
PRAVIGARD PAC (COPACKAGED)
BRISTOL MYERS SQUIBB 81MG;20MG N021387 001 Jun 24, 2003
81MG;40MG N021387 002 Jun 24, 2003
81MG;80MG N021387 003 Jun 24, 2003
325MG;20MG N021387 004 Jun 24, 2003
325MG;40MG N021387 005 Jun 24, 2003
325MG;80MG N021387 006 Jun 24, 2003
ASPIRIN; PROPOXYPHENE HYDROCHLORIDE
CAPSULE;ORAL
DARVON W/ ASA
XANODYNE PHARM 325MG;65MG N010996 005
ASPIRIN; PROPOXYPHENE NAPSYLATE
CAPSULE;ORAL
DARVON-N W/ ASA
AAIPHARMA LLC 325MG;100MG N016829 001
TABLET;ORAL
DARVON-N W/ ASA
AAIPHARMA LLC 325MG;100MG N016863 001
ATAZANAVIR SULFATE
CAPSULE;ORAL
ATAZANAVIR SULFATE
AMNEAL EQ 100MG BASE A209717 001 Jun 01, 2020
MYLAN EQ 150MG BASE A208177 001 Sep 24, 2018
EQ 200MG BASE A208177 002 Sep 24, 2018
EQ 300MG BASE A208177 003 Sep 24, 2018
ZYDUS PHARMS EQ 150MG BASE A210575 001 Jun 04, 2020
EQ 200MG BASE A210575 002 Jun 04, 2020
EQ 300MG BASE A210575 003 Jun 04, 2020
REYATAZ
+ BRISTOL MYERS SQUIBB EQ 100MG BASE ** N021567 001 Jun 20, 2003
+ EQ 150MG BASE N021567 002 Jun 20, 2003
ATENOLOL
INJECTABLE;INJECTION
TENORMIN
+ ASTRAZENECA 0.5MG/ML ** N019058 001 Sep 13, 1989
TABLET;ORAL
ATENOLOL
ABLE 25MG A076907 001 Jul 30, 2004
50MG A076907 002 Jul 30, 2004

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-52(of 478)
** See List Footnote
ATENOLOL
TABLET;ORAL
ATENOLOL
100MG A076907 003 Jul 30, 2004
APOTHECON 50MG A073317 001 Mar 20, 1992
100MG A073318 001 Mar 20, 1992
CHARTWELL RX 25MG A074265 001 Feb 28, 1994
50MG A074265 002 Feb 28, 1994
100MG A074265 003 Feb 28, 1994
MYLAN 25MG A074126 003 Aug 26, 1998
50MG A074126 001 Mar 23, 1994
100MG A074126 002 Mar 23, 1994
NORTHSTAR HLTHCARE 25MG A078254 001 Sep 25, 2009
50MG A078254 002 Sep 25, 2009
100MG A078254 003 Sep 25, 2009
NOSTRUM LABS 50MG A074127 001 Feb 21, 1995
100MG A074127 002 Feb 21, 1995
PLIVA 25MG A074101 001 Jul 17, 1997
50MG A074101 002 Jul 17, 1997
100MG A074101 003 Jul 17, 1997
SCS 50MG A073676 001 Oct 30, 1992
100MG A073676 002 Oct 30, 1992
STRIDES PHARMA 25MG A074099 001 Apr 28, 1992
50MG A073542 001 Dec 19, 1991
100MG A073543 001 Dec 19, 1991
SUN PHARM INDS INC 25MG A078210 001 Jul 10, 2007
50MG A078210 002 Jul 10, 2007
100MG A078210 003 Jul 10, 2007
SUN PHARM INDUSTRIES 25MG A074499 001 Jul 30, 1997
50MG A073475 001 Mar 30, 1993
100MG A073476 001 Mar 30, 1993
TEVA 50MG A073315 001 May 28, 1993
100MG A073316 001 May 28, 1993
TEVA PHARMS 50MG A074120 001 Feb 24, 1995
100MG A074120 002 Feb 24, 1995
WATSON LABS 50MG A073352 001 Dec 27, 1991
WATSON LABS TEVA 100MG A073353 001 Dec 27, 1991
ATENOLOL; CHLORTHALIDONE
TABLET;ORAL
ATENOLOL AND CHLORTHALIDONE
MYLAN 50MG;25MG A074203 001 Oct 31, 1993
100MG;25MG A074203 002 Oct 31, 1993
NOSTRUM LABS 50MG;25MG A074404 001 May 14, 1998
100MG;25MG A074404 002 May 14, 1998
PLIVA 50MG;25MG A074107 001 Sep 24, 1997
100MG;25MG A074107 002 Sep 24, 1997
SUN PHARM INDUSTRIES 50MG;25MG A073582 002 Apr 29, 1993
100MG;25MG A073582 001 Apr 29, 1993
ATOMOXETINE HYDROCHLORIDE
CAPSULE;ORAL
ATOMOXETINE HYDROCHLORIDE
STRIDES PHARMA 10MG A079021 001 Feb 18, 2021
18MG A079021 002 Feb 18, 2021
25MG A079021 003 Feb 18, 2021
40MG A079021 004 Feb 18, 2021
60MG A079021 005 Feb 18, 2021
80MG A079021 006 Feb 18, 2021
100MG A079021 007 Feb 18, 2021
STRATTERA
LILLY 5MG N021411 001 Nov 26, 2002
ATORVASTATIN CALCIUM
TABLET;ORAL
ATORVASTATIN CALCIUM
PERRIGO R AND D EQ 10MG BASE A208478 001 Jun 23, 2020
EQ 20MG BASE A208478 002 Jun 23, 2020
TEVA PHARMS EQ 10MG BASE A078773 001 May 29, 2012
EQ 20MG BASE A078773 002 May 29, 2012
EQ 40MG BASE A078773 003 May 29, 2012

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-53(of 478)
** See List Footnote
ATORVASTATIN CALCIUM
TABLET;ORAL
ATORVASTATIN CALCIUM
EQ 80MG BASE A078773 004 May 29, 2012
ATORVASTATIN CALCIUM; EZETIMIBE
TABLET;ORAL
LIPTRUZET
+ ORGANON EQ 10MG BASE;10MG ** N200153 001 May 03, 2013
+ EQ 20MG BASE;10MG ** N200153 002 May 03, 2013
+ EQ 40MG BASE;10MG ** N200153 003 May 03, 2013
+ EQ 80MG BASE;10MG ** N200153 004 May 03, 2013
ATOVAQUONE
TABLET;ORAL
MEPRON
+ GLAXOSMITHKLINE LLC 250MG ** N020259 001 Nov 25, 1992
ATRACURIUM BESYLATE
INJECTABLE;INJECTION
ATRACURIUM BESYLATE
BAXTER HLTHCARE 10MG/ML A074824 001 Sep 30, 1997
BAXTER HLTHCARE CORP 10MG/ML A074753 001 Jan 23, 1997
HOSPIRA 10MG/ML A074632 001 Dec 23, 1996
10MG/ML A074740 001 Mar 28, 1997
MYLAN LABS LTD 10MG/ML A206096 001 Jun 22, 2017
TEVA PARENTERAL 10MG/ML A074784 001 Jun 11, 1997
WATSON PHARMS TEVA 10MG/ML A074945 001 Jul 28, 1998
ATRACURIUM BESYLATE PRESERVATIVE FREE
BAXTER HLTHCARE 10MG/ML A074825 001 Sep 30, 1997
BAXTER HLTHCARE CORP 10MG/ML A074768 001 Jan 23, 1997
HOSPIRA 10MG/ML A074633 001 Dec 23, 1996
10MG/ML A074639 001 Mar 25, 1997
10MG/ML A074741 001 Mar 28, 1997
MYLAN LABS LTD 10MG/ML A206001 001 Apr 07, 2017
WATSON LABS INC 10MG/ML A074944 001 Jul 28, 1998
TRACRIUM
+ HOSPIRA 10MG/ML ** N018831 002 Jun 20, 1985
TRACRIUM PRESERVATIVE FREE
+ HOSPIRA 10MG/ML ** N018831 001 Nov 23, 1983
ATROPINE
SOLUTION;INTRAMUSCULAR
ATROPINE
ABBVIE EQ 2MG SULFATE/0.7ML A071295 001 Jan 30, 1987
ATROPINE (AUTOINJECTOR)
RAFA LABS LTD EQ 2MG SULFATE/0.7ML (EQ 2MG N212319 001 Jul 09, 2018
SULFATE/0.7ML)
ATROPINE SULFATE
AEROSOL, METERED;INHALATION
ATROPINE SULFATE
US ARMY EQ 0.36MG BASE/INH N020056 001 Sep 19, 1990
ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE
TABLET;ORAL
MOTOFEN HALF-STRENGTH
SEBELA IRELAND LTD 0.025MG;0.5MG N017744 001
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE
CAPSULE;ORAL
DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE
SCHERER RP 0.025MG;2.5MG A086440 001
SOLUTION;ORAL
COLONAID
MEDPOINTE PHARM HLC 0.025MG/5ML;2.5MG/5ML A085735 001
LOMANATE
ALPHARMA US PHARMS 0.025MG/5ML;2.5MG/5ML A085746 001
LOMOTIL
GD SEARLE LLC 0.025MG/5ML;2.5MG/5ML N012699 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-54(of 478)
** See List Footnote
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE
TABLET;ORAL
COLONAID
MEDPOINTE PHARM HLC 0.025MG;2.5MG A085737 001
DI-ATRO
MD PHARM 0.025MG;2.5MG A085266 001
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
ABLE 0.025MG;2.5MG A040395 001 Nov 27, 2000
ASCOT 0.025MG;2.5MG A087934 001 Jul 19, 1983
FOSUN PHARMA 0.025MG;2.5MG A086173 001
HEATHER 0.025MG;2.5MG A086798 001
HIKMA 0.025MG;2.5MG A087765 001 Mar 15, 1982
INWOOD LABS 0.025MG;2.5MG A085509 001
KV PHARM 0.025MG;2.5MG A085659 001
LEDERLE 0.025MG;2.5MG A086950 001
MAYNE PHARMA INC 0.025MG;2.5MG A210789 001 Jun 03, 2020
PARKE DAVIS 0.025MG;2.5MG A087131 001
PVT FORM 0.025MG;2.5MG A085766 001
R AND S PHARMA 0.025MG;2.5MG A085035 001
ROXANE 0.025MG;2.5MG A086057 001
STRIDES PHARMA 0.025MG;2.5MG A040357 001 May 02, 2000
SUN PHARM INDUSTRIES 0.025MG;2.5MG A085506 001
USL PHARMA 0.025MG;2.5MG A087842 001 Mar 29, 1982
VALEANT PHARM INTL 0.025MG;2.5MG A087195 001 Feb 16, 1982
WATSON LABS 0.025MG;2.5MG A085876 001
LO-TROL
VANGARD 0.025MG;2.5MG A088009 001 Mar 25, 1983
LOGEN
SUPERPHARM 0.025MG;2.5MG A088962 001 May 10, 1985
LONOX
FOSUN PHARMA 0.025MG;2.5MG A085311 002
LOW-QUEL
HALSEY 0.025MG;2.5MG A085211 001
ATROPINE SULFATE; EDROPHONIUM CHLORIDE
INJECTABLE;INJECTION
ENLON-PLUS
+ MYLAN 0.14MG/ML;10MG/ML N019678 001 Nov 06, 1991
MYLAN INSTITUTIONAL 0.14MG/ML;10MG/ML N019677 001 Nov 06, 1991
ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE
INJECTABLE;INJECTION
ATROPINE AND DEMEROL
ABBVIE 0.4MG/ML;50MG/ML A087853 001 Nov 26, 1982
0.4MG/ML;75MG/ML A087847 001 Nov 26, 1982
0.4MG/ML;100MG/ML A087848 001 Nov 26, 1982
MEPERIDINE AND ATROPINE SULFATE
WYETH AYERST 0.4MG/ML;50MG/ML A085121 001
0.4MG/ML;75MG/ML A085121 002
0.4MG/ML;100MG/ML A085121 003
ATROPINE; PRALIDOXIME CHLORIDE
INJECTABLE;INTRAMUSCULAR
ATNAA
US ARMY 2.1MG/0.7ML;600MG/2ML N021175 001 Jan 17, 2002
AVOBENZONE; OCTINOXATE; OXYBENZONE
LOTION;TOPICAL
SHADE UVAGUARD
+ BAYER HEALTHCARE LLC 3%;7.5%;3% N020045 001 Dec 07, 1992
AZACITIDINE
POWDER;INTRAVENOUS, SUBCUTANEOUS
AZACITIDINE
LUPIN LTD 100MG/VIAL A210748 001 Feb 27, 2019
MYLAN INSTITUTIONAL 100MG/VIAL A204949 001 Apr 28, 2016

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-55(of 478)
** See List Footnote
AZATADINE MALEATE
TABLET;ORAL
OPTIMINE
SCHERING 1MG N017601 001
AZATADINE MALEATE; PSEUDOEPHEDRINE SULFATE
TABLET, EXTENDED RELEASE;ORAL
TRINALIN
SCHERING 1MG;120MG N018506 001 Mar 23, 1982
AZATHIOPRINE
TABLET;ORAL
IMURAN
+ SEBELA IRELAND LTD 25MG ** N016324 002
AZATHIOPRINE SODIUM
INJECTABLE;INJECTION
IMURAN
+ CASPER PHARMA LLC EQ 100MG BASE/VIAL ** N017391 001
AZELAIC ACID
AEROSOL, FOAM;TOPICAL
AZELAIC ACID
TEVA PHARMS USA 15% A210928 001 Oct 07, 2020
AZELASTINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
AZELASTINE HYDROCHLORIDE
AKORN 0.05% A203660 001 Nov 08, 2016
OPTIVAR
+ MYLAN SPECIALITY LP 0.05% ** N021127 001 May 22, 2000
SPRAY, METERED;NASAL
ASTELIN
+ MYLAN SPCLT VIATRIS 0.137MG/SPRAY N020114 001 Nov 01, 1996
ASTEPRO
+ MYLAN SPECIALITY LP 0.137MG/SPRAY N022203 001 Oct 15, 2008
0.2055MG/SPRAY N022203 002 Aug 31, 2009
AZELASTINE HYDROCHLORIDE
AKORN 0.2055MG/SPRAY A210032 001 Aug 23, 2019
AMNEAL 0.2055MG/SPRAY A208199 001 Dec 15, 2017
APOTEX INC 0.2055MG/SPRAY A201846 001 Aug 31, 2012
AUROBINDO PHARMA LTD 0.2055MG/SPRAY A212775 001 Nov 12, 2020
HIKMA 0.2055MG/SPRAY A207243 001 Sep 22, 2017
AZILSARTAN KAMEDOXOMIL
TABLET;ORAL
AZILSARTAN MEDOXOMIL
LUPIN LTD EQ 40MG MEDOXOMIL A214489 001 Jul 20, 2022
EQ 80MG MEDOXOMIL A214489 002 Jul 20, 2022
AZITHROMYCIN
CAPSULE;ORAL
ZITHROMAX
+ PFIZER EQ 250MG BASE ** N050670 001 Nov 01, 1991
FOR SUSPENSION;ORAL
AZITHROMYCIN
CHARTWELL RX EQ 100MG BASE/5ML A065488 001 May 15, 2015
EQ 200MG BASE/5ML A065488 002 May 15, 2015
SANDOZ EQ 100MG BASE/5ML A065297 001 Sep 18, 2006
EQ 200MG BASE/5ML A065297 002 Sep 18, 2006
TARO EQ 200MG BASE/5ML A211521 001 Dec 11, 2019
TEVA PHARMS EQ 100MG BASE/5ML A065419 001 Jun 24, 2008
EQ 200MG BASE/5ML A065419 002 Jun 24, 2008
FOR SUSPENSION, EXTENDED RELEASE;ORAL
ZMAX
+ PF PRISM CV EQ 2GM BASE/BOT N050797 001 Jun 10, 2005
INJECTABLE;INJECTION
AZITHROMYCIN
HIKMA EQ 500MG BASE/VIAL A065265 001 Jan 18, 2007
MYLAN ASI EQ 500MG BASE/VIAL A065506 001 Mar 24, 2009
RISING EQ 500MG BASE/VIAL A204732 001 Jan 26, 2017
TEVA PARENTERAL EQ 500MG BASE/VIAL N050809 001 Dec 19, 2006
EQ 2.5GM BASE/VIAL N050809 002 Dec 19, 2006

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-56(of 478)
** See List Footnote
AZITHROMYCIN
TABLET;ORAL
AZITHROMYCIN
APOTEX CORP EQ 250MG BASE A065507 001 Jul 13, 2011
EQ 500MG BASE A065509 001 Jul 13, 2011
EQ 600MG BASE A065508 001 Jul 13, 2011
MYLAN EQ 250MG BASE A065365 001 May 30, 2007
EQ 500MG BASE A065366 001 May 30, 2007
EQ 600MG BASE A065360 001 Jan 08, 2007
TEVA EQ 250MG BASE A065153 001 Nov 14, 2005
EQ 600MG BASE A065150 001 Nov 14, 2005
YUNG SHIN PHARM EQ 500MG BASE A211318 001 Mar 17, 2021
ZITHROMAX
+ PFIZER EQ 600MG BASE ** N050730 001 Jun 12, 1996
AZITHROMYCIN DIHYDRATE; TROVAFLOXACIN MESYLATE
FOR SUSPENSION, TABLET;ORAL
TROVAN/ZITHROMAX COMPLIANCE PAK
PFIZER EQ 1GM BASE,N/A;N/A,EQ 100MG BASE N050762 001 Dec 18, 1998
AZLOCILLIN SODIUM
INJECTABLE;INJECTION
AZLIN
BAYER PHARMS EQ 2GM BASE/VIAL A062388 001 Sep 08, 1982
EQ 2GM BASE/VIAL A062417 001 Oct 12, 1982
EQ 2GM BASE/VIAL N050562 001 Sep 03, 1982
EQ 3GM BASE/VIAL A062388 002 Sep 08, 1982
EQ 3GM BASE/VIAL A062417 002 Oct 12, 1982
EQ 3GM BASE/VIAL N050562 002 Sep 03, 1982
EQ 4GM BASE/VIAL A062388 003 Sep 08, 1982
EQ 4GM BASE/VIAL A062417 003 Oct 12, 1982
EQ 4GM BASE/VIAL N050562 003 Sep 03, 1982
AZTREONAM
INJECTABLE;INJECTION
AZACTAM
BRISTOL MYERS SQUIBB 500MG/VIAL N050580 001 Dec 31, 1986
AZACTAM IN PLASTIC CONTAINER
BRISTOL MYERS SQUIBB 10MG/ML N050632 003 May 24, 1989
+ 20MG/ML N050632 002 May 24, 1989
+ 40MG/ML N050632 001 May 24, 1989
AZTREONAM
HIKMA 1GM/VIAL A065286 001 Mar 23, 2011
2GM/VIAL A065286 002 Mar 23, 2011
BACAMPICILLIN HYDROCHLORIDE
FOR SUSPENSION;ORAL
SPECTROBID
PFIZER 125MG/5ML N050556 001 Mar 23, 1982
TABLET;ORAL
SPECTROBID
PFIZER 400MG N050520 001
800MG N050520 002 Sep 12, 1983
BACITRACIN
OINTMENT;OPHTHALMIC
BACIGUENT
PHARMACIA AND UPJOHN 500 UNITS/GM A060734 001
BACITRACIN
LILLY 500 UNITS/GM A060687 001
PHARMADERM 500 UNITS/GM A062158 001
PHARMAFAIR 500 UNITS/GM A062453 001 Mar 28, 1984
OINTMENT;TOPICAL
BACITRACIN
COMBE 500 UNITS/GM A062799 001 May 14, 1987
NASKA 500 UNITS/GM A062857 001 Nov 13, 1987
POWDER;FOR RX COMPOUNDING
BACI-RX
X GEN PHARMS 5,000,000 UNITS/BOT A061580 001
BACITRACIN
APOTHEKERNES 5,000,000 UNITS/BOT A061699 001
PADDOCK LLC 5,000,000 UNITS/BOT A062456 001 Jul 27, 1983

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-57(of 478)
** See List Footnote
BACITRACIN ZINC
POWDER;FOR RX COMPOUNDING
ZIBA-RX
X GEN PHARMS 500,000 UNITS/BOT A061737 001
BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
CORTISPORIN
+ CASPER PHARMA LLC 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 N050416 002
UNITS/GM **
ZINC BACITRACIN,NEOMYCIN SULFATE,POLYMYXIN B SULFATE & HYDROCORTISONE
PHARMAFAIR 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 A062389 001 Jul 02, 1982
UNITS/GM
OINTMENT;TOPICAL
CORTISPORIN
+ MONARCH PHARMS 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 N050168 002 May 04, 1984
UNITS/GM
NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE
PHARMAFAIR 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 A062381 001 Sep 06, 1985
UNITS/GM
BACITRACIN ZINC; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT;TOPICAL
LANABIOTIC
COMBE 400 UNITS/GM;40MG/GM;EQ 5MG A062499 001 Jun 03, 1985
BASE/GM;5,000 UNITS/GM
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE
PHARMAFAIR 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 A062386 001 Sep 09, 1982
UNITS/GM
BACITRACIN-NEOMYCIN-POLYMYXIN
PHARMADERM 400 UNITS/GM;EQ 3.5MG BASE/GM;5,000 A062167 001
UNITS/GM
NEO-POLYCIN
DOW PHARM 500 UNITS/GM;EQ 3.5MG BASE/GM;10,000 A060647 001
UNITS/GM
OINTMENT;TOPICAL
BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE
NASKA 400 UNITS/GM;EQ 3.5MG BASE/GM;5,000 A062833 001 Nov 09, 1987
UNITS/GM
BACITRACIN ZINC; POLYMYXIN B SULFATE
AEROSOL;TOPICAL
POLYSPORIN
GLAXOSMITHKLINE 10,000 UNITS/GM;2,000,000 UNITS/GM N050167 002 Mar 01, 1985
OINTMENT;OPHTHALMIC
OCUMYCIN
PHARMAFAIR 500 UNITS/GM;10,000 UNITS/GM A062430 001 Apr 08, 1983
POLYSPORIN
MONARCH PHARMS 500 UNITS/GM;10,000 UNITS/GM ** A061229 001
OINTMENT;TOPICAL
BACITRACIN ZINC-POLYMYXIN B SULFATE
NASKA 500 UNITS/GM;10,000 UNITS/GM A062849 001 Nov 13, 1987
BACITRACIN; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE
ALTANA 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 A060731 002
UNITS/GM
BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
MYCITRACIN
PHARMACIA AND UPJOHN 500 UNITS/GM;EQ 3.5MG BASE/GM;10,000 A061048 001
UNITS/GM
BACITRACIN; POLYMYXIN B SULFATE
DISC;TOPICAL
LANABIOTIC
COMBE 500 UNITS/GM;5,000 UNITS/GM N050598 001 Sep 22, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-58(of 478)
** See List Footnote
BACLOFEN
TABLET;ORAL
BACLOFEN
APPCO 10MG A090334 001 Feb 18, 2010
20MG A090334 002 Feb 18, 2010
MYLAN 10MG A077181 001 Jul 29, 2005
20MG A077121 002 Jul 29, 2005
SUN PHARM INDS INC 10MG A077862 001 Aug 14, 2006
20MG A077862 002 Aug 14, 2006
TEVA 10MG A073043 001 Feb 27, 1992
20MG A073044 001 Feb 27, 1992
USL PHARMA 10MG A071260 001 May 06, 1988
20MG A071261 001 May 06, 1988
WATSON LABS 10MG A072824 001 Sep 18, 1991
10MG A073092 001 Jan 28, 1994
10MG A074698 001 Aug 20, 1996
20MG A072825 001 Sep 18, 1991
20MG A073093 001 Jan 28, 1994
20MG A074698 002 Aug 20, 1996
LIORESAL
+ NOVARTIS 10MG ** N017851 001
+ 20MG ** N017851 003 Jan 20, 1982
TABLET, ORALLY DISINTEGRATING;ORAL
KEMSTRO
+ UCB INC 10MG N021589 001 Oct 30, 2003
+ 20MG N021589 002 Oct 30, 2003
BALSALAZIDE DISODIUM
CAPSULE;ORAL
BALSALAZIDE DISODIUM
MYLAN 750MG A077807 001 Dec 28, 2007
TABLET;ORAL
BALSALAZIDE DISODIUM
STRIDES PHARMA 1.1GM A206336 001 Sep 08, 2015
GIAZO
+ VALEANT PHARMS INTL 1.1GM ** N022205 001 Feb 03, 2012
BARIUM SULFATE
FOR SUSPENSION;ORAL
E-Z-CAT DRY
+ BRACCO 40% (9GM/POUCH) N208036 003 Jan 03, 2017
BECLOMETHASONE DIPROPIONATE
AEROSOL, METERED;INHALATION
BECLOVENT
GLAXOSMITHKLINE 0.042MG/INH N018153 001
QVAR 40
+ TEVA BRANDED PHARM 0.04MG/INH ** N020911 002 Sep 15, 2000
QVAR 80
+ TEVA BRANDED PHARM 0.08MG/INH ** N020911 001 Sep 15, 2000
VANCERIL
SCHERING 0.042MG/INH N017573 001
VANCERIL DOUBLE STRENGTH
SCHERING 0.084MG/INH N020486 001 Dec 24, 1996
AEROSOL, METERED;NASAL
BECONASE
GLAXOSMITHKLINE 0.042MG/INH N018584 001
VANCENASE
SCHERING 0.042MG/INH N018521 001
BECLOMETHASONE DIPROPIONATE MONOHYDRATE
SPRAY, METERED;NASAL
VANCENASE AQ
SCHERING EQ 0.042MG DIPROP/SPRAY N019589 001 Dec 23, 1987
EQ 0.084MG DIPROP/SPRAY N020469 001 Jun 26, 1996

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-59(of 478)
** See List Footnote
BENAZEPRIL HYDROCHLORIDE
TABLET;ORAL
BENAZEPRIL HYDROCHLORIDE
ANI PHARMS 5MG A076333 001 Feb 11, 2004
10MG A076333 002 Feb 11, 2004
20MG A076333 003 Feb 11, 2004
40MG A076333 004 Feb 11, 2004
GENPHARM 5MG A076476 001 Feb 11, 2004
10MG A076476 002 Feb 11, 2004
20MG A076476 003 Feb 11, 2004
40MG A076476 004 Feb 11, 2004
RISING 5MG A076430 001 Feb 11, 2004
10MG A076430 002 Feb 11, 2004
20MG A076430 003 Feb 11, 2004
40MG A076430 004 Feb 11, 2004
LOTENSIN
+ VALIDUS PHARMS 5MG N019851 001 Jun 25, 1991
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
TABLET;ORAL
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
ANI PHARMS 5MG;6.25MG A076348 001 Feb 11, 2004
10MG;12.5MG A076348 002 Feb 11, 2004
20MG;12.5MG A076348 003 Feb 11, 2004
20MG;25MG A076348 004 Feb 11, 2004
APOTEX 5MG;6.25MG A078794 001 Aug 21, 2014
10MG;12.5MG A078794 002 Aug 21, 2014
20MG;12.5MG A078794 003 Aug 21, 2014
20MG;25MG A078794 004 Aug 21, 2014
AUROBINDO PHARMA USA 5MG;6.25MG A076688 001 Feb 11, 2004
10MG;12.5MG A076688 002 Feb 11, 2004
20MG;12.5MG A076688 003 Feb 11, 2004
20MG;25MG A076688 004 Feb 11, 2004
MYLAN PHARMS INC 5MG;6.25MG A076612 001 Feb 11, 2004
10MG;12.5MG A076612 002 Feb 11, 2004
20MG;12.5MG A076612 003 Feb 11, 2004
20MG;25MG A076612 004 Feb 11, 2004
SUN PHARM INDS LTD 5MG;6.25MG A077483 001 Sep 08, 2005
10MG;12.5MG A077483 002 Sep 08, 2005
20MG;12.5MG A077483 003 Sep 08, 2005
20MG;25MG A077483 004 Sep 08, 2005
LOTENSIN HCT
+ VALIDUS PHARMS 5MG;6.25MG ** N020033 001 May 19, 1992
BENDAMUSTINE HYDROCHLORIDE
SOLUTION;IV (INFUSION)
TREANDA
+ CEPHALON 45MG/0.5ML (90MG/ML) N022249 003 Sep 13, 2013
+ 180MG/2ML (90MG/ML) N022249 004 Sep 13, 2013
BENDROFLUMETHIAZIDE
TABLET;ORAL
NATURETIN-10
APOTHECON 10MG N012164 003
NATURETIN-2.5
APOTHECON 2.5MG N012164 001
NATURETIN-5
APOTHECON 5MG N012164 002
BENDROFLUMETHIAZIDE; NADOLOL
TABLET;ORAL
CORZIDE
+ KING PHARMS LLC 5MG;40MG N018647 001 May 25, 1983
+ 5MG;80MG N018647 002 May 25, 1983
NADOLOL AND BENDROFLUMETHIAZIDE
IMPAX LABS 5MG;40MG A077833 001 Mar 30, 2007
5MG;80MG A077833 002 Mar 30, 2007
MYLAN 5MG;40MG A078688 001 Feb 15, 2008
5MG;80MG A078688 002 Feb 15, 2008

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-60(of 478)
** See List Footnote
BENOXINATE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
BENOXINATE HYDROCHLORIDE
SOLA BARNES HIND 0.4% A084149 001
BENTIROMIDE
SOLUTION;ORAL
CHYMEX
SAVAGE LABS 500MG/7.5ML N018366 001 Dec 29, 1983
BENZONATATE
CAPSULE;ORAL
BENZONATATE
MIKART 100MG A040851 001 Nov 09, 2009
150MG A040851 002 Nov 09, 2009
200MG A040851 003 Nov 09, 2009
NESHER PHARMS 100MG A040795 001 Oct 31, 2007
200MG A040795 002 Oct 31, 2007
SUN PHARM INDS INC 100MG A040587 001 Mar 19, 2008
200MG A040587 002 Mar 19, 2008
TESSALON
+ PFIZER 200MG ** N011210 003 Jun 25, 1999
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
GEL;TOPICAL
BENZACLIN
BAUSCH 5%;EQ 1% BASE N050756 002 Apr 20, 2007
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
ENCUBE 2.5%;EQ 1.2% BASE A207194 001 Aug 19, 2019
5%;EQ 1% BASE A204087 001 Jun 27, 2017
TARO 3.75%;EQ 1.2% BASE A208683 001 Jun 05, 2018
TOLMAR 5%;1.2% A203688 001 Aug 25, 2016
BENZOYL PEROXIDE; ERYTHROMYCIN
GEL;TOPICAL
AKTIPAK
+ BIOFRONTERA 5%;3% N050769 001 Nov 27, 2000
ERYTHROMYCIN AND BENZOYL PEROXIDE
ENCUBE 5%;3% A065112 001 Mar 29, 2004
BENZPHETAMINE HYDROCHLORIDE
TABLET;ORAL
BENZPHETAMINE HYDROCHLORIDE
EMCURE PHARMS LTD 50MG A202061 001 Jan 27, 2012
EPIC PHARMA LLC 50MG A040714 001 Oct 29, 2007
IMPAX LABS 50MG A040845 001 Nov 18, 2008
SCINOPHARM TAIWAN 50MG A040578 001 Apr 17, 2006
SPECGX LLC 50MG A040773 001 Apr 25, 2007
TEDOR PHARM 25MG A040747 002 Nov 20, 2015
50MG A040747 001 Mar 30, 2007
DIDREX
+ PFIZER 25MG ** N012427 003
+ 50MG ** N012427 002
BENZQUINAMIDE HYDROCHLORIDE
INJECTABLE;INJECTION
EMETE-CON
PFIZER EQ 50MG BASE/VIAL N016820 001
SUPPOSITORY;RECTAL
EMETE-CON
ROERIG EQ 100MG BASE N016818 006
BENZTHIAZIDE
TABLET;ORAL
AQUATAG
SOLVAY 25MG N016001 001
50MG N016001 002
BENZTHIAZIDE
PVT FORM 50MG A083206 001
EXNA
AH ROBINS INC 50MG N012489 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-61(of 478)
** See List Footnote
BENZTHIAZIDE
TABLET;ORAL
FOVANE
PFIZER 50MG N012128 002
URESE
PFIZER 25MG N012128 003
BENZTROPINE MESYLATE
INJECTABLE;INJECTION
BENZTROPINE MESYLATE
LUITPOLD 1MG/ML A091152 001 Mar 29, 2010
COGENTIN
+ AKORN 1MG/ML N012015 001
TABLET;ORAL
BENZTROPINE MESYLATE
AIPING PHARM INC 0.5MG A040103 001 Dec 12, 1996
1MG A040103 002 Dec 12, 1996
2MG A040103 003 Dec 12, 1996
LANNETT CO INC 0.5MG ** A088877 001 Apr 11, 1985
1MG ** A088894 001 Apr 11, 1985
2MG ** A088895 001 Apr 11, 1985
OXFORD PHARMS 0.5MG A040706 002 Feb 14, 2008
1MG A040706 003 Feb 14, 2008
2MG A040706 001 Feb 14, 2008
QUANTUM PHARMICS 0.5MG A088514 001 Jan 31, 1984
1MG A088510 001 Jan 31, 1984
2MG A088511 001 Jan 31, 1984
USL PHARMA 0.5MG A089211 001 Jun 14, 1988
1MG A089212 001 Jun 14, 1988
2MG A089213 001 Jun 14, 1988
COGENTIN
+ MERCK 0.5MG ** N009193 004
+ 1MG ** N009193 003
+ 2MG ** N009193 002
BENZYL ALCOHOL
LOTION;TOPICAL
ULESFIA
+ SHIONOGI INC 5% ** N022129 001 Apr 09, 2009
BENZYL BENZOATE
EMULSION;TOPICAL
BENZYL BENZOATE
LANNETT 50% A084535 001
BEPRIDIL HYDROCHLORIDE
TABLET;ORAL
BEPADIN
MEDPOINTE PHARM HLC 200MG N019001 001 Dec 28, 1990
300MG N019001 002 Dec 28, 1990
400MG N019001 003 Dec 28, 1990
VASCOR
JOHNSON AND JOHNSON 200MG N019002 001 Dec 28, 1990
300MG N019002 002 Dec 28, 1990
400MG N019002 003 Dec 28, 1990
BETA CAROTENE
CAPSULE;ORAL
SOLATENE
ROCHE 30MG N017589 001
BETAMETHASONE
CREAM;TOPICAL
CELESTONE
SCHERING 0.2% N014762 001
SYRUP;ORAL
CELESTONE
MERCK SHARP DOHME 0.6MG/5ML N014215 002
TABLET;ORAL
CELESTONE
SCHERING 0.6MG N012657 003

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-62(of 478)
** See List Footnote
BETAMETHASONE BENZOATE
CREAM;TOPICAL
UTICORT
PARKE DAVIS 0.025% N016998 002
GEL;TOPICAL
UTICORT
PARKE DAVIS 0.025% N017244 001
LOTION;TOPICAL
UTICORT
PARKE DAVIS 0.025% N017528 001
OINTMENT;TOPICAL
UTICORT
PARKE DAVIS 0.025% N018089 001
BETAMETHASONE DIPROPIONATE
CREAM;TOPICAL
ALPHATREX
SAVAGE LABS EQ 0.05% BASE N019138 001 Jun 26, 1984
BETAMETHASONE DIPROPIONATE
PERRIGO NEW YORK EQ 0.05% BASE A072536 001 Jan 31, 1990
EQ 0.05% BASE A074579 001 Nov 26, 1997
PHARMADERM EQ 0.05% BASE N019136 001 Jun 26, 1984
TARO EQ 0.05% BASE A071143 001 Jun 17, 1987
TEVA EQ 0.05% BASE A071476 001 Aug 10, 1987
DIPROSONE
SCHERING EQ 0.05% BASE N017536 001
CREAM, AUGMENTED;TOPICAL
BETAMETHASONE DIPROPIONATE
ANDA REPOSITORY EQ 0.05% BASE A076603 001 Jan 23, 2004
DIPROLENE
SCHERING EQ 0.05% BASE N019408 001 Jan 31, 1986
DIPROLENE AF
+ ORGANON EQ 0.05% BASE ** N019555 001 Apr 27, 1987
DISC;TOPICAL
DIPROSONE
SCHERING EQ 0.1% BASE N017829 001
GEL, AUGMENTED;TOPICAL
DIPROLENE
SCHERING EQ 0.05% BASE N019408 002 Nov 22, 1991
LOTION;TOPICAL
ALPHATREX
SAVAGE LABS EQ 0.05% BASE A070273 001 Aug 12, 1985
BETAMETHASONE DIPROPIONATE
ACTAVIS MID ATLANTIC EQ 0.05% BASE A070281 001 Jul 31, 1985
AKORN EQ 0.05% BASE A209896 001 Feb 06, 2018
ALPHARMA US PHARMS EQ 0.05% BASE A071085 001 Feb 03, 1987
COSETTE EQ 0.05% BASE A071882 001 Jun 06, 1988
PHARMGEN EQ 0.05% BASE A070274 001 Aug 12, 1985
TARO EQ 0.05% BASE A072276 001 Aug 24, 1988
EQ 0.05% BASE A074272 001 Sep 30, 1994
DIPROSONE
+ SCHERING EQ 0.05% BASE ** N017781 001
LOTION, AUGMENTED;TOPICAL
DIPROLENE
+ ORGANON EQ 0.05% BASE ** N019716 001 Aug 01, 1988
OINTMENT;TOPICAL
ALPHATREX
SAVAGE LABS EQ 0.05% BASE N019143 001 Sep 04, 1984
BETAMETHASONE DIPROPIONATE
PERRIGO NEW YORK EQ 0.05% BASE A072526 001 Jan 31, 1990
PHARMADERM EQ 0.05% BASE N019140 001 Sep 04, 1984
TEVA EQ 0.05% BASE A071477 001 Aug 10, 1987
DIPROSONE
SCHERING EQ 0.05% BASE N017691 001
SPRAY;TOPICAL
BETAMETHASONE DIPROPIONATE
TARO PHARMS EQ 0.05% BASE/SPRAY A211722 001 Jun 17, 2020

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-63(of 478)
** See List Footnote
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
LOTION;TOPICAL
LOTRISONE
+ MERCK SHARP DOHME EQ 0.05% BASE;1% ** N020010 001 Dec 08, 2000
BETAMETHASONE SODIUM PHOSPHATE
INJECTABLE;INJECTION
BETAMETHASONE SODIUM PHOSPHATE
WATSON LABS EQ 3MG BASE/ML A085738 001
CELESTONE
+ SCHERING EQ 3MG BASE/ML ** N017561 001
BETAMETHASONE VALERATE
AEROSOL, FOAM;TOPICAL
BETAMETHASONE VALERATE
NOVAST LABS 0.12% A207144 001 May 24, 2017
CREAM;TOPICAL
BETADERM
ROACO EQ 0.1% BASE N018839 001 Jun 30, 1983
BETAMETHASONE VALERATE
PERRIGO NEW YORK EQ 0.1% BASE A070053 001 Jun 10, 1986
PHARMADERM EQ 0.1% BASE N018860 002 Aug 31, 1983
PHARMAFAIR EQ 0.1% BASE A070485 001 May 29, 1987
TARO EQ 0.1% BASE A070062 001 May 14, 1985
BETATREX
SAVAGE LABS EQ 0.1% BASE N018862 001 Aug 31, 1983
VALISONE
SCHERING EQ 0.01% BASE N016322 002
EQ 0.1% BASE N016322 001
LOTION;TOPICAL
BETA-VAL
COSETTE EQ 0.1% BASE A070072 001 Jun 27, 1985
BETAMETHASONE VALERATE
PHARMADERM EQ 0.1% BASE N018870 001 Aug 31, 1983
PHARMAFAIR EQ 0.1% BASE A070484 001 May 29, 1987
TEVA PHARMS EQ 0.1% BASE A071883 001 Apr 22, 1988
BETATREX
SAVAGE LABS EQ 0.1% BASE N018867 001 Aug 31, 1983
VALISONE
SCHERING EQ 0.1% BASE N016932 001
OINTMENT;TOPICAL
BETAMETHASONE VALERATE
PERRIGO NEW YORK EQ 0.1% BASE A071478 001 Dec 23, 1987
PHARMADERM EQ 0.1% BASE N018864 001 Aug 31, 1983
PHARMAFAIR EQ 0.1% BASE A070486 001 May 29, 1987
BETATREX
SAVAGE LABS EQ 0.1% BASE N018863 001 Aug 31, 1983
VALISONE
SCHERING EQ 0.1% BASE N016740 001
BETAXOLOL HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
BETAXOLOL HYDROCHLORIDE
APOTEX INC EQ 0.5% BASE A075446 001 Sep 28, 2000
TABLET;ORAL
KERLONE
SANOFI AVENTIS US 10MG ** N019507 001 Oct 27, 1989
20MG ** N019507 002 Oct 27, 1989
BETAXOLOL HYDROCHLORIDE; CHLORTHALIDONE
TABLET;ORAL
KERLEDEX
SANOFI AVENTIS US 5MG;12.5MG N019807 001 Oct 30, 1992
10MG;12.5MG N019807 002 Oct 30, 1992
BETAXOLOL HYDROCHLORIDE; PILOCARPINE HYDROCHLORIDE
SUSPENSION/DROPS;OPHTHALMIC
BETOPTIC PILO
ALCON EQ 0.25% BASE;1.75% N020619 001 Apr 17, 1997

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-64(of 478)
** See List Footnote
BETAZOLE HYDROCHLORIDE
INJECTABLE;INJECTION
HISTALOG
LILLY 50MG/ML N009344 001
BETHANECHOL CHLORIDE
INJECTABLE;INJECTION
URECHOLINE
+ ODYSSEY PHARMS 5MG/ML ** N006536 001
TABLET;ORAL
BETHANECHOL CHLORIDE
ABLE 5MG A040492 001 Jul 27, 2004
10MG A040483 001 Jul 27, 2004
25MG A040485 001 Jul 27, 2004
50MG A040509 001 Jul 27, 2004
ACTAVIS ELIZABETH 5MG A040552 001 Oct 28, 2004
10MG A040553 001 Oct 28, 2004
25MG A040554 001 Oct 28, 2004
50MG A040551 001 Oct 28, 2004
ASCOT 10MG A088288 001 Jun 08, 1983
25MG A088289 001 Jun 08, 1983
HERITAGE PHARMA 5MG A091256 001 May 04, 2010
10MG A091256 002 May 04, 2010
25MG A091256 003 May 04, 2010
50MG A091256 004 May 04, 2010
IMPAX LABS 5MG A040721 001 Nov 01, 2006
10MG A040721 002 Nov 01, 2006
25MG A040721 003 Nov 01, 2006
50MG A040721 004 Nov 01, 2006
IVAX SUB TEVA PHARMS 25MG A084689 001
LANNETT 5MG A084702 001
10MG A084712 001
25MG A084074 001
LANNETT CO INC 5MG A040677 002 Mar 27, 2008
10MG A040677 003 Mar 27, 2008
25MG A040677 004 Mar 27, 2008
50MG A040677 001 Mar 27, 2008
SANDOZ 5MG A084353 001
10MG A084378 001
10MG A084379 001
25MG A084383 001
25MG A084384 001
SUN PHARM INDS INC 5MG A040897 001 Apr 22, 2009
10MG A040897 002 Apr 22, 2009
25MG A040897 003 Apr 22, 2009
50MG A040897 004 Apr 22, 2009
WATSON LABS 5MG A084402 001
5MG A085230 002
5MG A085841 001
10MG A084408 001
10MG A085228 001
10MG A085842 001
25MG A084441 001
25MG A085229 001
25MG A085839 001
50MG A087397 001
50MG A087444 001
WOCKHARDT 5MG A040532 001 Sep 29, 2003
10MG A040533 001 Sep 29, 2003
25MG A040534 001 Sep 29, 2003
50MG A040518 001 Sep 29, 2003
MYOTONACHOL
GLENWOOD 5MG A084188 001
10MG A084188 003
25MG A084188 004
URECHOLINE
ODYSSEY PHARMS 5MG A089095 001 Dec 19, 1985
+ 5MG ** N006536 003
+ 10MG A088440 001 May 29, 1984
+ 10MG ** N006536 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-65(of 478)
** See List Footnote
BETHANECHOL CHLORIDE
TABLET;ORAL
URECHOLINE
+ 25MG A088441 001 May 29, 1984
+ 25MG ** N006536 004
50MG A089096 001 Dec 19, 1985
+ 50MG ** N006536 005
BETHANIDINE SULFATE
TABLET;ORAL
TENATHAN
ROBINS AH 10MG N017675 001
25MG N017675 002
BETRIXABAN
CAPSULE;ORAL
BEVYXXA
+ PORTOLA PHARMS INC 40MG N208383 001 Jun 23, 2017
+ 80MG N208383 002 Jun 23, 2017
BICALUTAMIDE
TABLET;ORAL
BICALUTAMIDE
FRESENIUS KABI USA 50MG A079045 001 May 13, 2010
KUDCO IRELAND 50MG A077995 001 Jul 06, 2009
MYLAN 50MG A079185 001 Jul 06, 2009
ROXANE 50MG A078285 001 Mar 24, 2011
SYNTHON PHARMS 50MG A077973 001 Jul 06, 2009
TEVA 50MG A076932 001 Jul 06, 2009
BIMATOPROST
SOLUTION/DROPS;OPHTHALMIC
BIMATOPROST
AKORN 0.03% A203299 001 Nov 08, 2018
LUMIGAN
+ ALLERGAN 0.03% ** N021275 001 Mar 16, 2001
BIPERIDEN HYDROCHLORIDE
TABLET;ORAL
AKINETON
ABBVIE 2MG N012003 001
BIPERIDEN LACTATE
INJECTABLE;INJECTION
AKINETON
ABBVIE 5MG/ML N012418 002
BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL
HALFLYTELY
+ BRAINTREE 5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM N021551 003 Jul 16, 2010
;N/A,5.6GM **
PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL
NOVEL LABS INC 5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM A202217 001 Aug 20, 2014
;N/A,5.6GM
BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
TABLET, CHEWABLE, TABLET, CAPSULE;ORAL
HELIDAC
+ CASPER PHARMA LLC 262.4MG,N/A,N/A;N/A,250MG,N/A;N/A,N/A,5 N050719 001 Aug 15, 1996
00MG **
BISOPROLOL FUMARATE
TABLET;ORAL
BISOPROLOL FUMARATE
MYLAN 5MG A075831 001 Dec 14, 2005
10MG A075831 002 Dec 14, 2005
TEVA PHARMS 5MG A075644 001 Jun 26, 2001
10MG A075644 002 Jun 26, 2001
ZEBETA
+ TEVA WOMENS 5MG ** N019982 002 Jul 31, 1992
+ 10MG ** N019982 001 Jul 31, 1992

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-66(of 478)
** See List Footnote
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
TABLET;ORAL
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
ACTAVIS ELIZABETH 2.5MG;6.25MG A075672 001 Sep 25, 2000
5MG;6.25MG A075672 002 Sep 25, 2000
10MG;6.25MG A075672 003 Sep 25, 2000
APOTHECON 2.5MG;6.25MG A075642 002 Dec 27, 2000
5MG;6.25MG A075642 001 Dec 27, 2000
10MG;6.25MG A075642 003 Dec 27, 2000
CHARTWELL RX 2.5MG;6.25MG A075527 001 Sep 25, 2000
5MG;6.25MG A075527 003 Sep 25, 2000
10MG;6.25MG A075527 002 Sep 25, 2000
IVAX SUB TEVA PHARMS 2.5MG;6.25MG A075632 001 Sep 27, 2000
5MG;6.25MG A075632 002 Sep 27, 2000
10MG;6.25MG A075632 003 Sep 27, 2000
TEVA 2.5MG;6.25MG A075686 001 Jan 19, 2001
5MG;6.25MG A075686 002 Jan 19, 2001
10MG;6.25MG A075686 003 Jan 19, 2001
WATSON LABS TEVA 2.5MG;6.25MG A075469 001 Sep 25, 2000
5MG;6.25MG A075469 002 Sep 25, 2000
10MG;6.25MG A075469 003 Sep 25, 2000
BITOLTEROL MESYLATE
AEROSOL, METERED;INHALATION
TORNALATE
SANOFI AVENTIS US 0.37MG/INH N018770 001 Dec 28, 1984
SOLUTION;INHALATION
TORNALATE
SANOFI AVENTIS US 0.2% N019548 001 Feb 19, 1992
BIVALIRUDIN
INJECTABLE;INTRAVENOUS
BIVALIRUDIN
APOTEX 250MG/VIAL A204876 001 Jul 06, 2017
SOLUTION;INTRAVENOUS
BIVALIRUDIN IN 0.9% SODIUM CHLORIDE
+ BAXTER HLTHCARE CORP 250MG/50ML (5MG/ML) N208374 001 Dec 21, 2017
+ 500MG/100ML (5MG/ML) N208374 002 Dec 21, 2017
BLEOMYCIN SULFATE
INJECTABLE;INJECTION
BLENOXANE
+ BRISTOL MYERS SQUIBB EQ 15 UNITS BASE/VIAL ** N050443 001
+ EQ 30 UNITS BASE/VIAL ** N050443 002 Sep 07, 1995
BLEOMYCIN SULFATE
CIPLA EQ 15 UNITS BASE/VIAL A209439 001 Mar 11, 2019
PHARMACHEMIE BV EQ 15 UNITS BASE/VIAL A065201 001 Dec 13, 2007
TEVA PARENTERAL EQ 15 UNITS BASE/VIAL A064084 001 Jun 01, 1996
EQ 30 UNITS BASE/VIAL A064084 002 Jun 01, 1996
BOCEPREVIR
CAPSULE;ORAL
VICTRELIS
MERCK SHARP DOHME 200MG N202258 001 May 13, 2011
BORTEZOMIB
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
BORTEZOMIB
MYLAN LABS LTD 3.5MG/VIAL A205160 001 Oct 31, 2022
TEVA PHARMS USA 3.5MG/VIAL A205857 001 May 02, 2022
SOLUTION;INTRAVENOUS
BORTEZOMIB
+ MAIA PHARMS INC 3.5MG/3.5ML (1MG/ML) N215331 001 Jul 27, 2022
BOSENTAN
TABLET;ORAL
BOSENTAN
ALEMBIC PHARMS 62.5MG A211461 001 Jan 23, 2020
125MG A211461 002 Jan 23, 2020
ALVOGEN PINE BROOK 62.5MG A206002 001 Apr 26, 2019
125MG A206002 002 Apr 26, 2019
AMNEAL PHARMS CO 62.5MG A209742 001 Apr 26, 2019

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-67(of 478)
** See List Footnote
BOSENTAN
TABLET;ORAL
BOSENTAN
125MG A209742 002 Apr 26, 2019
CHARTWELL MOLECULAR 62.5MG A210342 001 Jan 03, 2020
125MG A210342 002 Jan 03, 2020
MYLAN 62.5MG A205173 001 Jan 15, 2020
125MG A205173 002 Jan 15, 2020
NATCO PHARMA LTD 62.5MG A206987 001 Apr 26, 2019
125MG A206987 002 Apr 26, 2019
BRETYLIUM TOSYLATE
INJECTABLE;INJECTION
BRETYLIUM TOSYLATE
ABRAXIS PHARM 50MG/ML A070134 001 Apr 29, 1986
100MG/ML A071298 001 Feb 13, 1987
ASTRAZENECA 50MG/ML A071151 001 Aug 10, 1987
50MG/ML A071152 001 Aug 10, 1987
50MG/ML A071153 001 Aug 10, 1987
HIKMA 50MG/ML A070545 001 May 14, 1986
50MG/ML A070546 001 May 14, 1986
+ HOSPIRA 50MG/ML ** N019030 001 Apr 29, 1986
50MG/ML N019033 001 Apr 29, 1986
INTL MEDICATION 50MG/ML A070119 001 Apr 29, 1986
LUITPOLD 50MG/ML A070891 001 Jul 26, 1988
BRETYLIUM TOSYLATE IN DEXTROSE 5%
ABBOTT 200MG/100ML N019005 002 Apr 29, 1986
400MG/100ML N019005 003 Apr 29, 1986
800MG/100ML N019005 001 Apr 29, 1986
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 100MG/100ML N019121 001 Apr 29, 1986
200MG/100ML N019121 002 Apr 29, 1986
400MG/100ML N019121 003 Apr 29, 1986
BAXTER HLTHCARE 200MG/100ML N019837 002 Apr 12, 1989
400MG/100ML N019837 001 Apr 12, 1989
HOSPIRA INC 200MG/100ML N019008 002 Apr 29, 1986
400MG/100ML N019008 003 Apr 29, 1986
800MG/100ML N019008 001 Apr 29, 1986
BRETYLOL
HOSPIRA 50MG/ML N017954 001
BREXPIPRAZOLE
TABLET;ORAL
BREXPIPRAZOLE
SANDOZ INC 0.25MG A213570 001 Sep 26, 2022
0.5MG A213570 002 Sep 26, 2022
1MG A213570 003 Sep 26, 2022
2MG A213570 004 Sep 26, 2022
3MG A213570 005 Sep 26, 2022
4MG A213570 006 Sep 26, 2022
BRIMONIDINE TARTRATE
SOLUTION/DROPS;OPHTHALMIC
ALPHAGAN
+ ALLERGAN 0.2% ** N020613 001 Sep 06, 1996
0.5% N020490 001 Mar 13, 1997
BRIMONIDINE TARTRATE
TEVA PARENTERAL 0.2% A076372 001 Sep 10, 2004
BRIVARACETAM
TABLET;ORAL
BRIVARACETAM
SUNSHINE 10MG A214748 001 Jun 09, 2022
25MG A214748 002 Jun 09, 2022
50MG A214748 003 Jun 09, 2022
75MG A214748 004 Jun 09, 2022
100MG A214748 005 Jun 09, 2022
ZYDUS PHARMS 10MG A214501 001 Oct 03, 2022
25MG A214501 002 Oct 03, 2022
50MG A214501 003 Oct 03, 2022
75MG A214501 004 Oct 03, 2022

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-68(of 478)
** See List Footnote
BRIVARACETAM
TABLET;ORAL
BRIVARACETAM
100MG A214501 005 Oct 03, 2022
BROMFENAC SODIUM
SOLUTION/DROPS;OPHTHALMIC
BROMDAY
+ BAUSCH AND LOMB INC EQ 0.09% ACID ** N021664 002 Oct 16, 2010
BROMFENAC SODIUM
AMRING PHARMS EQ 0.09% ACID A202030 001 Jan 09, 2013
APOTEX EQ 0.09% ACID A202435 001 Jun 19, 2014
EQ 0.09% ACID A202620 001 Jun 23, 2014
CHARTWELL RX EQ 0.09% ACID A201941 001 Feb 10, 2015
COASTAL PHARMS EQ 0.09% ACID A201211 001 May 11, 2011
RISING EQ 0.09% ACID A203368 001 Jun 03, 2019
XIBROM
+ BAUSCH AND LOMB INC EQ 0.09% ACID ** N021664 001 Mar 24, 2005
BROMOCRIPTINE MESYLATE
CAPSULE;ORAL
BROMOCRIPTINE MESYLATE
LEK PHARM EQ 5MG BASE A075100 001 Dec 10, 1998
TABLET;ORAL
BROMOCRIPTINE MESYLATE
MYLAN EQ 2.5MG BASE A076962 001 Sep 24, 2004
BROMODIPHENHYDRAMINE HYDROCHLORIDE
CAPSULE;ORAL
AMBODRYL
PARKE DAVIS 25MG N007984 001
BROMODIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE
SYRUP;ORAL
AMBENYL
FOREST LABS 12.5MG/5ML;10MG/5ML N009319 006 Jan 10, 1984
BROMANYL
ALPHARMA US PHARMS 12.5MG/5ML;10MG/5ML A088343 001 Aug 15, 1984
BROMODIPHENHYDRAMINE HYDROCHLORIDE AND CODEINE PHOSPHATE
WOCKHARDT 12.5MG/5ML;10MG/5ML A088626 001 Oct 12, 1984
BROMPHENIRAMINE MALEATE
ELIXIR;ORAL
BROMPHENIRAMINE MALEATE
ALPHARMA US PHARMS 2MG/5ML A086936 001
KV PHARM 2MG/5ML A085466 001
PHARM ASSOC 2MG/5ML A087517 001
USL PHARMA 2MG/5ML A087964 001 Jan 25, 1983
INJECTABLE;INJECTION
BROMPHENIRAMINE MALEATE
WATSON LABS 10MG/ML A083821 001
100MG/ML A083820 001
DIMETANE-TEN
WYETH AYERST 10MG/ML N011418 002
TABLET;ORAL
BROMPHENIRAMINE MALEATE
BARR 4MG A084468 001
IVAX SUB TEVA PHARMS 4MG A084351 001
NEWTRON PHARMS 4MG A086987 001
NEXGEN PHARMA INC 4MG A086187 001
PAR PHARM 4MG A087009 001
PIONEER PHARMS 4MG A088604 001 Jul 13, 1984
UPSHER SMITH LABS 4MG A083215 001
VITARINE 4MG A085850 001
WATSON LABS 4MG A083123 001
4MG A085769 001
DIMETANE
WYETH CONS 4MG N010799 003
TABLET, EXTENDED RELEASE;ORAL
DIMETANE
WYETH CONS 8MG N010799 010 Jun 10, 1983
12MG N010799 011 Jun 10, 1983

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-69(of 478)
** See List Footnote
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
SYRUP;ORAL
BROMANATE DM
ALPHARMA US PHARMS 2MG/5ML;10MG/5ML;30MG/5ML A088722 001 Mar 07, 1985
BROMFED-DM
WOCKHARDT 2MG/5ML;10MG/5ML;30MG/5ML A089681 001 Dec 22, 1988
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
RHODES PHARMS 2MG/5ML;10MG/5ML;30MG/5ML A202955 001 Nov 05, 2020
DIMETANE-DX
+ ROBINS AH 2MG/5ML;10MG/5ML;30MG/5ML ** N019279 001 Aug 24, 1984
BROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE
ALZA 16MG;240MG N019672 001 Mar 29, 1996
BUCLIZINE HYDROCHLORIDE
TABLET;ORAL
BUCLADIN-S
STUART PHARMS 50MG N010911 006
BUDESONIDE
AEROSOL, METERED;NASAL
RHINOCORT
ASTRAZENECA 0.032MG/INH N020233 001 Feb 14, 1994
CAPSULE, DELAYED RELEASE;ORAL
BUDESONIDE
BARR LABS DIV TEVA 3MG A090379 001 Apr 02, 2014
NATCO 3MG A206724 001 Nov 23, 2016
SCIECURE PHARMA INC 3MG A209041 001 Sep 28, 2017
POWDER, METERED;INHALATION
PULMICORT
ASTRAZENECA 0.16MG/INH N020441 002 Jun 24, 1997
0.32MG/INH N020441 003 Jun 24, 1997
BUMETANIDE
INJECTABLE;INJECTION
BUMETANIDE
HOSPIRA 0.25MG/ML A074160 001 Oct 30, 1997
TEVA PARENTERAL 0.25MG/ML A074613 001 Nov 18, 1997
BUMEX
+ VALIDUS PHARMS 0.25MG/ML ** N018226 001 Feb 28, 1983
BUPIVACAINE HYDROCHLORIDE
INJECTABLE;INJECTION
BUPIVACAINE HYDROCHLORIDE
CIVICA 0.5% A211096 001 Feb 19, 2019
HOSPIRA 0.25% A070586 001 Mar 03, 1987
0.25% N018053 002
0.5% N018053 001
0.75% A070587 001 Mar 03, 1987
0.75% N018053 003
STERISCIENCE 0.25% A091503 001 Oct 18, 2011
0.5% A091503 002 Oct 18, 2011
BUPIVACAINE HYDROCHLORIDE KIT
HOSPIRA 0.075% N019978 001 Sep 03, 1992
0.114% N019978 002 Sep 03, 1992
0.23% N019978 003 Sep 03, 1992
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
INTL MEDICATED 0.25% A076012 001 Jan 09, 2002
0.5% A076012 002 Jan 09, 2002
0.75% A076012 003 Jan 09, 2002
STERISCIENCE 0.25% A091487 002 Oct 18, 2011
0.5% A091487 001 Oct 18, 2011
0.75% A091487 003 Oct 18, 2011
INJECTABLE;SPINAL
SENSORCAINE
FRESENIUS KABI USA 0.75% A071202 001 Apr 15, 1987

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-70(of 478)
** See List Footnote
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE
INJECTABLE;INJECTION
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
HOSPIRA 0.25%;0.005MG/ML A071166 001 Jun 16, 1988
0.5%;0.005MG/ML A071169 001 Jun 16, 1988
0.75%;0.005MG/ML A071171 001 Jun 16, 1988
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
INJECTABLE;INJECTION
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
+ HOSPIRA 0.5%;0.0091MG/ML N022046 001 Jul 13, 1983
BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
DUOCAINE
AMPHASTAR PHARMS INC EQ 0.375% (37.5MG/10ML);EQ 1% N021496 001 May 23, 2003
(100MG/10ML)
BUPIVACAINE; MELOXICAM
SOLUTION, EXTENDED RELEASE;PERIARTICULAR
ZYNRELEF KIT
+ HERON THERAPS INC 60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML N211988 001 May 12, 2021
(0.88MG/ML)
+ 300MG/10.5ML (29.25MG/ML);9MG/10.5ML N211988 003 May 12, 2021
(0.88MG/ML)
BUPRENORPHINE
FILM, EXTENDED RELEASE;TRANSDERMAL
BUPRENORPHINE
MYLAN TECH VIATRIS 5MCG/HR A210162 001 May 03, 2021
7.5MCG/HR A210162 002 May 03, 2021
10MCG/HR A210162 003 May 03, 2021
15MCG/HR A210162 004 May 03, 2021
20MCG/HR A210162 005 May 03, 2021
BUPRENORPHINE HYDROCHLORIDE
FILM;BUCCAL
BUPRENORPHINE HYDROCHLORIDE
ALVOGEN EQ 0.075MG BASE A211594 001 Aug 03, 2021
EQ 0.15MG BASE A211594 002 Aug 03, 2021
EQ 0.3MG BASE A211594 003 Aug 03, 2021
EQ 0.45MG BASE A211594 004 Aug 03, 2021
EQ 0.6MG BASE A211594 005 Aug 03, 2021
EQ 0.75MG BASE A211594 006 Aug 03, 2021
EQ 0.9MG BASE A211594 007 Aug 03, 2021
IMPLANT;IMPLANTATION
PROBUPHINE
+ TITAN PHARMS EQ 80MG BASE/IMPLANT N204442 001 May 26, 2016
TABLET;SUBLINGUAL
BUPRENORPHINE HYDROCHLORIDE
BARR EQ 2MG BASE A090360 001 May 07, 2010
EQ 8MG BASE A090360 002 May 07, 2010
MYLAN EQ 2MG BASE A201066 001 Mar 06, 2015
EQ 8MG BASE A201066 002 Mar 06, 2015
SUBUTEX
+ INDIVIOR INC EQ 2MG BASE ** N020732 002 Oct 08, 2002
+ EQ 8MG BASE ** N020732 003 Oct 08, 2002
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
FILM;BUCCAL
BUNAVAIL
+ BDSI EQ 2.1MG BASE;EQ 0.3MG BASE N205637 001 Jun 06, 2014
+ EQ 4.2MG BASE;EQ 0.7MG BASE N205637 002 Jun 06, 2014
+ EQ 6.3MG BASE;EQ 1MG BASE N205637 003 Jun 06, 2014
FILM;SUBLINGUAL
CASSIPA
+ TEVA PHARMS USA EQ 16MG BASE;EQ 4MG BASE N208042 001 Sep 07, 2018
TABLET;SUBLINGUAL
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
MAYNE PHARMA INC EQ 2MG BASE;EQ 0.5MG BASE A206953 001 Jul 17, 2020
EQ 8MG BASE;EQ 2MG BASE A206953 002 Jul 17, 2020
TEVA PHARMS USA EQ 2MG BASE;EQ 0.5MG BASE A091149 001 Sep 08, 2014
EQ 8MG BASE;EQ 2MG BASE A091149 002 Sep 08, 2014

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-71(of 478)
** See List Footnote
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
TABLET;SUBLINGUAL
SUBOXONE
+ INDIVIOR INC EQ 2MG BASE;EQ 0.5MG BASE ** N020733 001 Oct 08, 2002
+ EQ 8MG BASE;EQ 2MG BASE ** N020733 002 Oct 08, 2002
BUPROPION HYDROCHLORIDE
TABLET;ORAL
BUPROPION HYDROCHLORIDE
AUROBINDO PHARMA USA 75MG A075491 001 Apr 17, 2000
100MG A075491 002 Apr 17, 2000
HERITAGE PHARMA 75MG A075310 001 Nov 29, 1999
100MG A075310 002 Nov 29, 1999
INVATECH 75MG A075613 002 Oct 10, 2000
100MG A075613 001 Oct 10, 2000
WELLBUTRIN
+ GLAXOSMITHKLINE 50MG ** N018644 001 Dec 30, 1985
+ 75MG ** N018644 002 Dec 30, 1985
+ 100MG ** N018644 003 Dec 30, 1985
TABLET, EXTENDED RELEASE;ORAL
BUPROPION HYDROCHLORIDE
ACTAVIS LABS FL INC 300MG A077715 002 Jun 13, 2007
AUROBINDO PHARMA USA 100MG A090325 001 Apr 08, 2010
150MG A090325 002 Apr 08, 2010
150MG A090942 001 Jul 14, 2010
200MG A090325 003 Apr 08, 2010
300MG A090942 002 Jul 14, 2010
IMPAX LABS 150MG A077415 001 Nov 26, 2008
200MG A076711 001 Dec 03, 2004
300MG A077415 002 Dec 15, 2006
JUBILANT GENERICS 100MG A202774 001 Oct 11, 2013
150MG A202774 002 Oct 11, 2013
150MG A202775 001 Oct 11, 2013
150MG A207459 001 Jun 30, 2017
200MG A202774 003 Oct 11, 2013
300MG A207459 002 Jun 30, 2017
MYLAN 150MG A090941 001 May 03, 2010
SANDOZ 100MG A076845 001 Jul 14, 2005
150MG A076834 001 Jul 14, 2005
150MG A076845 002 Jul 14, 2005
SUN PHARM 150MG A200695 001 Dec 18, 2014
TORRENT 100MG A203969 001 Oct 31, 2014
150MG A203969 002 Oct 31, 2014
200MG A203969 003 Oct 31, 2014
WATSON LABS INC 100MG A077455 001 Jul 19, 2010
150MG A077455 002 Mar 12, 2008
200MG A077455 003 Jul 19, 2010
WOCKHARDT LTD 100MG A201331 001 Aug 30, 2012
150MG A201331 002 Aug 30, 2012
200MG A201331 003 Aug 30, 2012
WELLBUTRIN SR
GLAXOSMITHKLINE 50MG N020358 001 Oct 04, 1996
ZYBAN
GLAXOSMITHKLINE 100MG N020711 002 May 14, 1997
+ 150MG ** N020711 003 May 14, 1997
BUSPIRONE HYDROCHLORIDE
CAPSULE;ORAL
BUSPAR
+ BRISTOL MYERS SQUIBB 5MG N021190 001 Dec 20, 2000
+ 7.5MG N021190 002 Dec 20, 2000
+ 10MG N021190 003 Dec 20, 2000
+ 15MG N021190 004 Dec 20, 2000
TABLET;ORAL
BUSPAR
+ BRISTOL MYERS SQUIBB 5MG ** N018731 001 Sep 29, 1986
+ 10MG ** N018731 002 Sep 29, 1986
+ 15MG ** N018731 003 Apr 22, 1996
+ 30MG ** N018731 004 Apr 22, 1996

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-72(of 478)
** See List Footnote
BUSPIRONE HYDROCHLORIDE
TABLET;ORAL
BUSPIRONE HYDROCHLORIDE
EGIS 5MG A075119 001 Mar 14, 2002
10MG A075119 002 Mar 14, 2002
15MG A075119 003 Jan 23, 2003
FOSUN PHARMA 5MG A075413 001 Mar 19, 2002
10MG A075413 002 Mar 19, 2002
15MG A075413 003 Mar 19, 2002
IVAX SUB TEVA PHARMS 5MG ** A075385 001 Mar 01, 2002
10MG ** A075385 002 Mar 01, 2002
15MG ** A075385 003 Mar 01, 2002
MYLAN 5MG A075467 001 Feb 28, 2002
7.5MG A075467 002 Mar 28, 2001
10MG A075467 003 Feb 28, 2002
15MG A075467 004 Feb 28, 2002
NESHER PHARMS 5MG A075572 001 Feb 27, 2002
10MG A075572 002 Feb 27, 2002
15MG A075572 003 Feb 27, 2002
BUSULFAN
INJECTABLE;INJECTION
BUSULFAN
ACTAVIS LLC 6MG/ML A205139 001 Dec 08, 2017
MYLAN LABS LTD 6MG/ML A205184 001 Jul 13, 2018
BUTABARBITAL SODIUM
CAPSULE;ORAL
BUTICAPS
MEDPOINTE PHARM HLC 15MG A085381 001
30MG A085381 002
50MG A085381 003
100MG A085381 004
ELIXIR;ORAL
BUTABARB
ALPHARMA US PHARMS 30MG/5ML A085873 001
BUTABARBITAL SODIUM
WOCKHARDT 30MG/5ML A085383 001
BUTALAN
LANNETT 33.3MG/5ML A085880 001
BUTISOL SODIUM
MEDA PHARMS 30MG/5ML A085380 001
SARISOL
HALSEY 30MG/5ML A084723 001
TABLET;ORAL
BUTABARBITAL
BUNDY 30MG A085550 001
BUTABARBITAL SODIUM
SANDOZ 15MG A084292 003 Feb 09, 1982
+ 15MG A085938 001
30MG A084272 002
30MG A085934 001
SOLVAY 16.2MG A083606 001
32.4MG A083898 001
48.6MG A083897 001
97.2MG A083896 001
TEVA 15MG A088632 001 May 18, 1985
30MG A088631 001 May 01, 1985
WATSON LABS 15MG A085764 001
30MG A085772 001
WHITEWORTH TOWN PLSN 15MG A083325 002
30MG A083337 001
BUTISOL SODIUM
MYLAN SPECIALITY LP 15MG ** N000793 002
+ 30MG N000793 004
50MG ** N000793 003
100MG ** N000793 005
SARISOL NO. 1
HALSEY 15MG A084719 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-73(of 478)
** See List Footnote
BUTABARBITAL SODIUM
TABLET;ORAL
SARISOL NO. 2
HALSEY 30MG A084719 002
SODIUM BUTABARBITAL
HIKMA 15MG A085418 001
30MG A085432 001
IVAX SUB TEVA PHARMS 15MG A083484 001
30MG A084040 001
LANNETT 15MG A085849 001
30MG A085866 001
100MG A085881 001
MARSHALL PHARMA 16.2MG A083524 001
32.4MG A083858 001
BUTENAFINE HYDROCHLORIDE
CREAM;TOPICAL
MENTAX-TC
MYLAN 1% N021408 001 Oct 17, 2002
BUTOCONAZOLE NITRATE
CREAM;VAGINAL
BUTOCONAZOLE NITRATE
PADAGIS US 2% N019881 001 Feb 07, 1997
FEMSTAT
ROCHE PALO 2% N019215 001 Nov 25, 1985
FEMSTAT 3
+ BAYER 2% N020421 001 Dec 21, 1995
SUPPOSITORY;VAGINAL
FEMSTAT
ROCHE PALO 100MG N019359 001 Nov 25, 1985
BUTORPHANOL TARTRATE
INJECTABLE;INJECTION
BUTORPHANOL TARTRATE
BAXTER HLTHCARE CORP 2MG/ML A075697 001 Oct 23, 2001
HIKMA FARMACEUTICA 2MG/ML A078247 001 Apr 29, 2009
HOSPIRA 1MG/ML A075342 001 Nov 04, 1999
1MG/ML A075559 001 Mar 20, 2000
2MG/ML A075342 002 Nov 04, 1999
2MG/ML A075559 002 Mar 20, 2000
BUTORPHANOL TARTRATE PRESERVATIVE FREE
BAXTER HLTHCARE CORP 1MG/ML A075695 001 Oct 23, 2001
2MG/ML A075695 002 Oct 23, 2001
HOSPIRA 1MG/ML A074620 001 Jan 22, 1997
1MG/ML A075170 001 Sep 28, 1998
2MG/ML A074620 002 Jan 22, 1997
2MG/ML A075170 002 Sep 28, 1998
STADOL
+ APOTHECON 2MG/ML ** N017857 004
STADOL PRESERVATIVE FREE
+ APOTHECON 1MG/ML ** N017857 001
+ 2MG/ML ** N017857 002
SPRAY, METERED;NASAL
STADOL
BRISTOL MYERS SQUIBB 1MG/SPRAY ** N019890 001 Dec 12, 1991
CABAZITAXEL
SOLUTION;INTRAVENOUS
CABAZITAXEL
+ ACCORD HLTHCARE 60MG/3ML (20MG/ML) N207949 001 Dec 29, 2021
BRECKENRIDGE 60MG/1.5ML (40MG/ML) A207619 001 Jun 23, 2022
CABERGOLINE
TABLET;ORAL
CABERGOLINE
ACTAVIS LABS FL INC 0.5MG A078035 001 Apr 21, 2008
APOTEX CORP 0.5MG A201503 001 Mar 08, 2013
IMPAX LABS INC 0.5MG A077843 001 Jul 03, 2007
MYLAN 0.5MG A202947 001 Dec 02, 2013

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-74(of 478)
** See List Footnote
CABERGOLINE
TABLET;ORAL
DOSTINEX
+ PFIZER 0.5MG ** N020664 001 Dec 23, 1996
CAFFEINE CITRATE
SOLUTION;INTRAVENOUS
CAFFEINE CITRATE
SUN PHARM EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A090077 001 Sep 30, 2009
SOLUTION;ORAL
CAFCIT
+ HIKMA EQ 30MG BASE/3ML (EQ 10MG BASE/ML) N020793 002 Apr 12, 2000
CAFFEINE CITRATE
AM REGENT EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A090064 001 Nov 20, 2009
CAFFEINE; ERGOTAMINE TARTRATE
SUPPOSITORY;RECTAL
CAFERGOT
+ NOVARTIS 100MG;2MG ** N009000 002
TABLET;ORAL
CAFERGOT
NOVARTIS 100MG;1MG N006620 001
+ SANDOZ 100MG;1MG A084294 001
ERGOTAMINE TARTRATE AND CAFFEINE
HIKMA INTL PHARMS 100MG;1MG A040510 001 Sep 17, 2004
WIGRAINE
ORGANON USA INC 100MG;1MG A086562 001
CALCIFEDIOL
CAPSULE;ORAL
CALDEROL
ORGANON USA INC 0.02MG N018312 001
0.05MG N018312 002
CALCIPOTRIENE
SOLUTION;TOPICAL
DOVONEX
+ LEO PHARM 0.005% ** N020611 001 Mar 03, 1997
CALCITONIN HUMAN
INJECTABLE;INJECTION
CIBACALCIN
NOVARTIS 0.5MG/VIAL N018470 001 Oct 31, 1986
CALCITONIN SALMON
INJECTABLE;INJECTION
CALCIMAR
+ SANOFI AVENTIS US 200 IU/ML ** N017769 001
400 IU/VIAL N017497 001
CALCITONIN-SALMON
IGI LABS INC 200 IU/ML A073690 001 Apr 14, 1995
MIACALCIN
+ MYLAN IRELAND LTD 100 IU/ML N017808 001 Jul 03, 1986
SPRAY, METERED;NASAL
CALCITONIN-SALMON
PAR PHARM 200 IU/SPRAY A076979 001 Jun 08, 2009
MIACALCIN
+ MYLAN IRELAND LTD 200 IU/SPRAY ** N020313 002 Aug 17, 1995
CALCITONIN SALMON RECOMBINANT
SPRAY, METERED;NASAL
FORTICAL
UPSHER SMITH LABS 200 IU/SPRAY ** N021406 001 Aug 12, 2005
CALCITRIOL
INJECTABLE;INJECTION
CALCIJEX
+ ABBVIE 0.001MG/ML ** N018874 001 Sep 25, 1986
+ 0.002MG/ML ** N018874 002 Sep 25, 1986
CALCITRIOL
AKORN 0.002MG/ML A078066 002 Jan 29, 2008
AM REGENT 0.001MG/ML A075746 001 Sep 26, 2003
0.002MG/ML A075746 002 Sep 26, 2003

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-75(of 478)
** See List Footnote
CALCITRIOL
INJECTABLE;INJECTION
CALCITRIOL
FRESENIUS KABI USA 0.001MG/ML A075836 001 Dec 31, 2002
0.002MG/ML A075836 002 Dec 31, 2002
FRESENIUS MEDCL 0.001MG/ML A075766 001 Feb 20, 2003
0.002MG/ML A075766 002 Feb 20, 2003
HOSPIRA 0.001MG/ML A075816 001 Jan 16, 2004
0.002MG/ML A075816 002 Jan 16, 2004
ROCKWELL MEDCL 0.001MG/ML A076206 001 Sep 17, 2003
SAGENT PHARMS 0.001MG/ML A077102 001 Feb 08, 2006
TEVA PARENTERAL 0.001MG/ML A075823 001 Mar 31, 2003
0.002MG/ML A075823 002 Mar 31, 2003
CALCIUM ACETATE
CAPSULE;ORAL
CALCIUM ACETATE
AMNEAL PHARMS 667MG A201658 001 Oct 06, 2014
LOTUS PHARM CO LTD 667MG A203298 001 Jul 26, 2016
PHOSLO
FRESENIUS MEDCL 333.5MG N021160 001 Apr 02, 2001
667MG N021160 002 Apr 02, 2001
TABLET;ORAL
CALCIUM ACETATE
HIKMA 667MG A077693 001 Jan 30, 2008
ELIPHOS
CYPRESS PHARM 667MG A078502 001 Nov 25, 2008
PHOSLO
+ FRESENIUS MEDCL 667MG ** N019976 001 Dec 10, 1990
CALCIUM CARBONATE; RISEDRONATE SODIUM
TABLET;ORAL
ACTONEL WITH CALCIUM (COPACKAGED)
+ WARNER CHILCOTT EQ 500MG BASE;35MG ** N021823 001 Aug 12, 2005
CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM
BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE
SOLUTION;IRRIGATION
METHOTREXATE SODIUM
AKORN 0.154MG/ML;0.92MG/ML;0.184MG/ML;0.2MG/M N020079 001 Feb 26, 1999
L;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/M
L
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM
BICARBONATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER
+ BAXTER HLTHCARE CORP N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.0 N021703 010 Oct 10, 2008
5GM/1000ML;0.157GM/1000ML;2.21GM/1000ML
;7.07GM/1000ML (5000ML)
PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER
BAXTER HLTHCARE CORP 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML; N021703 012 Oct 10, 2008
3.05GM/1000ML;0.157GM/1000ML;2.21GM/100
0ML;7.07GM/1000ML (5000ML)
PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER
+ BAXTER HLTHCARE CORP 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML; N021703 013 Oct 10, 2008
3.05GM/1000ML;0.314GM/1000ML;2.21GM/100
0ML;7.07GM/1000ML (5000ML)
PRISMASOL BGK 4/0 IN PLASTIC CONTAINER
BAXTER HLTHCARE CORP N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.0 N021703 005 Oct 25, 2006
5GM/1000ML;0.314GM/1000ML;3.09GM/1000ML
;6.46GM/1000ML (5000ML)
PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER
BAXTER HLTHCARE CORP 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML; N021703 008 Oct 25, 2006
2.03GM/1000ML;0.314GM/1000ML;3.09GM/100
0ML;6.46GM/1000ML (5000ML)
PRISMASOL BK 0/0 IN PLASTIC CONTAINER
BAXTER HLTHCARE CORP N/A/1000ML;N/A/1000ML;5.4GM/1000ML;3.05 N021703 007 Oct 25, 2006
GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46
GM/1000ML (5000ML)
PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER
+ BAXTER HLTHCARE CORP 5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2 N021703 001 Oct 25, 2006
.03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6
.46GM/1000ML (5000ML)

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-76(of 478)
** See List Footnote
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM
BICARBONATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER
BAXTER HLTHCARE CORP 3.68GM/1000ML;N/A/1000ML;5.4GM/1000ML;3 N021703 009 Oct 25, 2006
.05GM/1000ML;0.314GM/1000ML;3.09GM/1000
ML;6.46GM/1000ML (5000ML)
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; OXIGLUTATIONE; POTASSIUM CHLORIDE; SODIUM
BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE
SOLUTION;IRRIGATION
NAVSTEL
ALCON PHARMS LTD 0.154MG/ML;0.92MG/ML;0.2MG/ML;0.184MG/M N022193 001 Jul 24, 2008
L;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/M
L
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM
CHLORIDE
INJECTABLE;INJECTION
ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 37MG/100ML;5GM/100ML;31MG/100ML;120MG/1 N019864 001 Jun 10, 1993
00ML;330MG/100ML;88MG/100ML
ISOLYTE R W/ DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 37MG/100ML;5GM/100ML;31MG/100ML;120MG/1 N018271 001
00ML;330MG/100ML;88MG/100ML
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM
CHLORIDE; SODIUM CITRATE
INJECTABLE;INJECTION
ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 35MG/100ML;5GM/100ML;30MG/100ML;74MG/10 N019867 001 Dec 20, 1993
0ML;640MG/100ML;500MG/100ML;74MG/100ML

ISOLYTE E W/ DEXTROSE 5% IN PLASTIC CONTAINER


B BRAUN 35MG/100ML;5GM/100ML;30MG/100ML;74MG/10 N018269 002 Jan 17, 1983
0ML;640MG/100ML;500MG/100ML;74MG/100ML

CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM
CHLORIDE; SODIUM LACTATE
INJECTABLE;INJECTION
PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER
+ BAXTER HLTHCARE 37MG/100ML;5GM/100ML;30MG/100ML;119MG/1 N017390 001
00ML;161MG/100ML;94MG/100ML;138MG/100ML
**
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
SOLUTION;INTRAPERITONEAL
DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER
B BRAUN 510MG/100ML;30GM/100ML;200MG/100ML;9.2G N018807 001 Aug 26, 1983
M/100ML;9.6GM/100ML
510MG/100ML;30GM/100ML;200MG/100ML;9.4G N018807 003 Aug 26, 1983
M/100ML;11GM/100ML
DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER
B BRAUN 510MG/100ML;50GM/100ML;200MG/100ML;9.2G N018807 002 Aug 26, 1983
M/100ML;9.6GM/100ML
510MG/100ML;50GM/100ML;200MG/100ML;9.4G N018807 004 Aug 26, 1983
M/100ML;11GM/100ML
DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER
B BRAUN 29MG/100ML;2.5GM/100ML;15MG/100ML;610MG N018460 006 Jan 29, 1986
/100ML;560MG/100ML
DIALYTE W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
B BRAUN 29MG/100ML;1.5GM/100ML;15MG/100ML;610MG N018460 001
/100ML;560MG/100ML
DIALYTE W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
B BRAUN 29MG/100ML;4.25GM/100ML;15MG/100ML;610M N018460 003
G/100ML;560MG/100ML
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
SOLUTION;INTRAPERITONEAL
DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
FRESENIUS MEDCL 25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;5 N018379 002
67MG/100ML;392MG/100ML
DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
FRESENIUS MEDCL 25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;5 N018379 003
67MG/100ML;392MG/100ML

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-77(of 478)
** See List Footnote
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
SOLUTION;INTRAPERITONEAL
DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
FRESENIUS MEDCL 25.7MG/100ML;3.5GM/100ML;15.2MG/100ML;5 N018379 007 Jun 24, 1988
67MG/100ML;392MG/100ML
DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
FRESENIUS MEDCL 25.7MG/100ML;4.25GM/100ML;15.2MG/100ML; N018379 001
567MG/100ML;392MG/100ML
DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
FRESENIUS MEDCL 25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;5 N018379 004 Jul 07, 1982
38MG/100ML;448MG/100ML
DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
FRESENIUS MEDCL 25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;5 N018379 005 Jul 07, 1982
38MG/100ML;448MG/100ML
DELFLEX-LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
FRESENIUS MEDCL 25.7MG/100ML;3.5GM/100ML;5.08MG/100ML;5 N018379 008 Jun 24, 1988
38MG/100ML;448MG/100ML
DELFLEX-LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
FRESENIUS MEDCL 25.7MG/100ML;4.25GM/100ML;5.08MG/100ML; N018379 006 Jul 07, 1982
538MG/100ML;448MG/100ML
DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER
B BRAUN 26MG/100ML;1.5GM/100ML;5MG/100ML;530MG/ N018460 007 Jan 29, 1986
100ML;450MG/100ML
26MG/100ML;1.5GM/100ML;15MG/100ML;560MG N018460 002
/100ML;390MG/100ML
DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER
B BRAUN 26MG/100ML;2.5GM/100ML;5MG/100ML;530MG/ N018460 005 Nov 02, 1983
100ML;450MG/100ML
26MG/100ML;5GM/100ML;5MG/100ML;530MG/10 N018460 008 Jan 29, 1986
0ML;450MG/100ML
DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER
B BRAUN 26MG/100ML;4.25GM/100ML;5MG/100ML;530MG N018460 009 Jan 29, 1986
/100ML;450MG/100ML
26MG/100ML;4.25GM/100ML;15MG/100ML;560M N018460 004
G/100ML;390MG/100ML
DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;5 N017512 001
67MG/100ML;392MG/100ML
DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;5 N017512 003
67MG/100ML;392MG/100ML
DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
BAXTER HLTHCARE 25.7MG/100ML;4.25GM/100ML;15.2MG/100ML; N017512 002
567MG/100ML;392MG/100ML
DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
+ BAXTER HLTHCARE 18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;5 N020183 003 Dec 04, 1992
38MG/100ML;448MG/100ML
DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;5 N017512 007 Jul 09, 1984
67MG/100ML;392MG/100ML
DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;5 N017512 008 Jul 09, 1984
67MG/100ML;392MG/100ML
DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 25.7MG/100ML;3.5GM/100ML;15.2MG/100ML;5 N017512 010 Nov 18, 1985
67MG/100ML;392MG/100ML
DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
BAXTER HLTHCARE 25.7MG/100ML;4.25GM/100ML;15.2MG/100ML; N017512 009 Jul 09, 1984
567MG/100ML;392MG/100ML
DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
+ BAXTER HLTHCARE 25.7MG/100ML;3.5GM/100ML;5.08MG/100ML;5 N017512 011 Nov 18, 1985
38MG/100ML;448MG/100ML
INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
FRESENIUS 18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;5 A020374 001 Jun 13, 1994
38MG/100ML;448MG/100ML
INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
FRESENIUS 18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;5 A020374 002 Jun 13, 1994
38MG/100ML;448MG/100ML
INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
FRESENIUS 18.4MG/100ML;3.5GM/100ML;5.08MG/100ML;5 A020374 003 Jun 13, 1994
38MG/100ML;448MG/100ML
INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
FRESENIUS 18.4MG/100ML;4.25GM/100ML;5.08MG/100ML; A020374 004 Jun 13, 1994
538MG/100ML;448MG/100ML

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-78(of 478)
** See List Footnote
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER
B BRAUN 20MG/100ML;5GM/100ML;30MG/100ML;380MG/1 N018258 001
00ML;600MG/100ML
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE;INJECTION
DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER
HOSPIRA 33MG/100ML;5GM/100ML;30MG/100ML;860MG/1 N018254 001
00ML
DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER
B BRAUN 33MG/100ML;5GM/100ML;30MG/100ML;860MG/1 N018256 001
00ML
33MG/100ML;5GM/100ML;30MG/100ML;860MG/1 N020000 001 Apr 17, 1992
00ML
BAXTER HLTHCARE 33MG/100ML;5GM/100ML;30MG/100ML;860MG/1 N016695 001
00ML
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
INJECTABLE;INJECTION
DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER
B BRAUN 4MG/100ML;4GM/100ML;6MG/100ML;120MG/100 N019634 002 Feb 24, 1988
ML;62MG/100ML
DEXTROSE 5% AND LACTATED RINGER'S
FRESENIUS KABI USA 20MG/100ML;5GM/100ML;30MG/100ML;600MG/1 A210332 001 Mar 28, 2022
00ML;310MG/100ML
DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER
B BRAUN 20MG/100ML;5GM/100ML;30MG/100ML;600MG/1 N017510 001
00ML;310MG/100ML
MILES 20MG/100ML;5GM/100ML;30MG/100ML;600MG/1 N018499 001
00ML;310MG/100ML
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
+ ICU MEDICAL INC 20MG/100ML;5GM/100ML;104MG/100ML;600MG/ N019685 005 Oct 17, 1988
100ML;310MG/100ML
+ 20MG/100ML;5GM/100ML;179MG/100ML;600MG/ N019685 006 Oct 17, 1988
100ML;310MG/100ML
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
+ ICU MEDICAL INC 20MG/100ML;5GM/100ML;254MG/100ML;600MG/ N019685 007 Oct 17, 1988
100ML;310MG/100ML
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
FRESENIUS KABI USA 20MG/100ML;5GM/100ML;179MG/100ML;600MG/ A211428 001 Nov 09, 2021
100ML;310MG/100ML
+ ICU MEDICAL INC 20MG/100ML;5GM/100ML;328MG/100ML;600MG/ N019685 008 Oct 17, 1988
100ML;310MG/100ML
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
+ ICU MEDICAL INC 20MG/100ML;5GM/100ML;254MG/100ML;600MG/ N019685 003 Oct 17, 1988
100ML;310MG/100ML
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
+ ICU MEDICAL INC 20MG/100ML;5GM/100ML;328MG/100ML;600MG/ N019685 004 Oct 17, 1988
100ML;310MG/100ML
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
+ ICU MEDICAL INC 20MG/100ML;5GM/100ML;104MG/100ML;600MG/ N019685 001 Oct 17, 1988
100ML;310MG/100ML
CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE
SOLUTION;INTRAPERITONEAL
INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
FRESENIUS MEDCL 25.7MG/100ML;1.5GM/100ML;538MG/100ML;44 N019395 001 Mar 26, 1986
8MG/100ML
INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
FRESENIUS MEDCL 25.7MG/100ML;2.5GM/100ML;538MG/100ML;44 N019395 002 Mar 26, 1986
8MG/100ML
INPERSOL-ZM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
FRESENIUS MEDCL 25.7MG/100ML;4.25GM/100ML;538MG/100ML;4 N019395 003 Mar 26, 1986
48MG/100ML
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
TPN ELECTROLYTES IN PLASTIC CONTAINER
ABBOTT 16.5MG/ML;25.4MG/ML;74.6MG/ML;121MG/ML; N019399 001 Jun 16, 1986
16.1MG/ML

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-79(of 478)
** See List Footnote
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM
CITRATE
INJECTABLE;INJECTION
ISOLYTE E IN PLASTIC CONTAINER
B BRAUN 35MG/100ML;30MG/100ML;74MG/100ML;640MG/ N018899 001 Oct 31, 1983
100ML;500MG/100ML;74MG/100ML
35MG/100ML;30MG/100ML;74MG/100ML;640MG/ N019718 001 Sep 29, 1989
100ML;500MG/100ML;74MG/100ML
SOLUTION;IRRIGATION
BALANCED SALT
AKORN 0.48MG/ML;0.3MG/ML;0.75MG/ML;3.9MG/ML;6 A075503 001 Sep 27, 2006
.4MG/ML;1.7MG/ML
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM
LACTATE
INJECTABLE;INJECTION
PLASMA-LYTE R IN PLASTIC CONTAINER
BAXTER HLTHCARE 36.8MG/100ML;30.5MG/100ML;74.6MG/100ML; N017438 001
640MG/100ML;496MG/100ML;89.6MG/100ML
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
ACETATED RINGER'S IN PLASTIC CONTAINER
B BRAUN 20MG/100ML;30MG/100ML;380MG/100ML;600MG N018725 001 Nov 29, 1982
/100ML
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE;INJECTION
RINGER'S IN PLASTIC CONTAINER
B BRAUN 33MG/100ML;30MG/100ML;860MG/100ML N018721 001 Nov 09, 1982
SOLUTION;IRRIGATION
RINGER'S IN PLASTIC CONTAINER
ABBOTT 33MG/100ML;30MG/100ML;860MG/100ML N018462 001
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
INJECTABLE;INJECTION
LACTATED RINGER'S IN PLASTIC CONTAINER
ABBOTT 20MG/100ML;30MG/100ML;600MG/100ML;310MG N019485 001 Oct 24, 1985
/100ML
B BRAUN 20MG/100ML;30MG/100ML;600MG/100ML;310MG N018023 001
/100ML
MILES 20MG/100ML;30MG/100ML;600MG/100ML;310MG N018417 001
/100ML
SOLUTION;IRRIGATION
LACTATED RINGER'S IN PLASTIC CONTAINER
BAXTER HLTHCARE 20MG/100ML;30MG/100ML;600MG/100ML;310MG N019933 001 Aug 29, 1989
/100ML
CALCIUM GLUCEPTATE
INJECTABLE;INJECTION
CALCIUM GLUCEPTATE
+ ABBOTT EQ 90MG CALCIUM/5ML A080001 001
EQ 90MG CALCIUM/5ML A083159 001
ABRAXIS PHARM EQ 90MG CALCIUM/5ML A089373 001 Apr 30, 1987
LILLY EQ 90MG CALCIUM/5ML N006470 001
CALCIUM METRIZOATE; MEGLUMINE METRIZOATE; METRIZOATE MAGNESIUM; METRIZOATE SODIUM
INJECTABLE;INJECTION
ISOPAQUE 440
GE HEALTHCARE 0.78MG/ML;75.9MG/ML;0.15MG/ML;16.6MG/ML N016847 001
CALCIUM; MEGLUMINE; METRIZOIC ACID
INJECTABLE;INJECTION
ISOPAQUE 280
GE HEALTHCARE 0.35MG/ML;140.1MG/ML;461.8MG/ML N017506 001
CANDESARTAN CILEXETIL
TABLET;ORAL
CANDESARTAN CILEXETIL
APOTEX INC 4MG A202079 001 Jan 10, 2014
8MG A202079 002 Jan 10, 2014
16MG A202079 003 Jan 10, 2014
32MG A202079 004 Jan 10, 2014

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-80(of 478)
** See List Footnote
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
TABLET;ORAL
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
APOTEX INC 16MG;12.5MG A202884 001 Dec 04, 2012
32MG;12.5MG A202884 002 Dec 04, 2012
32MG;25MG A202884 003 Jun 03, 2013
CANDICIDIN
OINTMENT;VAGINAL
VANOBID
SANOFI AVENTIS US 0.6MG/GM A061596 001
TABLET;VAGINAL
VANOBID
SANOFI AVENTIS US 3MG A061613 001
CAPECITABINE
TABLET;ORAL
CAPECITABINE
AMNEAL PHARMS 150MG A204741 001 Feb 28, 2017
500MG A204741 002 Feb 28, 2017
CAPREOMYCIN SULFATE
INJECTABLE;INJECTION
CAPASTAT SULFATE
+ AKORN EQ 1GM BASE/VIAL N050095 001
CAPREOMYCIN SULFATE
HISUN PHARM HANGZHOU EQ 1GM BASE/VIAL A204796 001 Oct 18, 2018
MYLAN LABS LTD EQ 1GM BASE/VIAL A202634 001 Nov 27, 2017
CAPTOPRIL
TABLET;ORAL
CAPOTEN
+ STRIDES PHARMA 12.5MG ** N018343 005 Jan 17, 1985
+ 25MG ** N018343 002
+ 37.5MG ** N018343 006 Sep 17, 1986
+ 50MG ** N018343 001
+ 75MG ** N018343 007 Jun 13, 1995
+ 100MG ** N018343 003
+ 150MG ** N018343 004 Jun 13, 1995
CAPTOPRIL
APOTHECON 12.5MG A074472 001 Mar 31, 1995
25MG A074472 002 Mar 31, 1995
50MG A074472 003 Mar 31, 1995
100MG A074472 004 Mar 31, 1995
CHARTWELL RX 12.5MG A074363 001 Nov 09, 1995
12.5MG A074519 001 Feb 13, 1996
25MG A074363 002 Nov 09, 1995
25MG A074519 002 Feb 13, 1996
50MG A074363 003 Nov 09, 1995
50MG A074519 003 Feb 13, 1996
100MG A074363 004 Nov 09, 1995
100MG A074519 004 Feb 13, 1996
COSETTE 12.5MG A074433 001 Feb 13, 1996
12.5MG A074462 001 Feb 13, 1996
12.5MG A074483 001 Feb 13, 1996
25MG A074433 002 Feb 13, 1996
25MG A074462 002 Feb 13, 1996
25MG A074483 002 Feb 13, 1996
50MG A074433 003 Feb 13, 1996
50MG A074462 003 Feb 13, 1996
50MG A074483 003 Feb 13, 1996
100MG A074433 004 Feb 13, 1996
100MG A074462 004 Feb 13, 1996
100MG A074483 004 Feb 13, 1996
DAVA PHARMS INC 12.5MG A074423 001 Feb 13, 1996
25MG A074423 002 Feb 13, 1996
50MG A074423 003 Feb 13, 1996
100MG A074423 004 Feb 13, 1996
EGIS PHARMS 12.5MG A074748 004 May 29, 1997
25MG A074748 002 May 29, 1997
50MG A074748 001 May 29, 1997

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-81(of 478)
** See List Footnote
CAPTOPRIL
TABLET;ORAL
CAPTOPRIL
100MG A074748 003 May 29, 1997
G AND W LABS INC 12.5MG A074590 004 Aug 30, 1996
25MG A074590 002 Aug 30, 1996
50MG A074590 001 Aug 30, 1996
100MG A074590 003 Aug 30, 1996
MYLAN 12.5MG A074434 001 Feb 13, 1996
25MG A074434 002 Feb 13, 1996
50MG A074434 003 Feb 13, 1996
100MG A074434 004 Feb 13, 1996
OXFORD PHARMS 12.5MG A074418 001 Feb 13, 1996
25MG A074418 002 Feb 13, 1996
50MG A074418 003 Feb 13, 1996
100MG A074418 004 Feb 13, 1996
PUREPAC PHARM 12.5MG A074640 001 Mar 31, 1997
25MG A074640 002 Mar 31, 1997
50MG A074640 003 Mar 31, 1997
100MG A074640 004 Mar 31, 1997
SANDOZ 12.5MG A074481 001 Feb 13, 1996
25MG A074481 002 Feb 13, 1996
50MG A074481 003 Feb 13, 1996
100MG A074481 004 Feb 13, 1996
SETON PHARMS 12.5MG A212223 001 Oct 30, 2019
25MG A212223 002 Oct 30, 2019
50MG A212223 003 Oct 30, 2019
100MG A212223 004 Oct 30, 2019
STRIDES PHARMA 12.5MG A074493 001 Feb 13, 1996
25MG A074493 002 Feb 13, 1996
50MG A074493 003 Feb 13, 1996
100MG A074493 004 Feb 13, 1996
TEVA 12.5MG A074322 001 Feb 13, 1996
25MG A074322 002 Feb 13, 1996
50MG A074322 003 Feb 13, 1996
100MG A074322 004 Feb 13, 1996
WATSON LABS 12.5MG A074386 001 May 23, 1996
12.5MG A074451 001 Feb 13, 1996
12.5MG A074576 001 Apr 23, 1996
25MG A074386 002 May 23, 1996
25MG A074451 002 Feb 13, 1996
25MG A074576 002 Apr 23, 1996
50MG A074386 003 May 23, 1996
50MG A074451 003 Feb 13, 1996
50MG A074576 003 Apr 23, 1996
100MG A074386 004 May 23, 1996
100MG A074451 004 Feb 13, 1996
100MG A074576 004 Apr 23, 1996
CAPTOPRIL; HYDROCHLOROTHIAZIDE
TABLET;ORAL
CAPOZIDE 25/15
+ APOTHECON 25MG;15MG ** N018709 001 Oct 12, 1984
CAPOZIDE 25/25
+ APOTHECON 25MG;25MG ** N018709 002 Oct 12, 1984
CAPOZIDE 50/15
+ APOTHECON 50MG;15MG ** N018709 004 Oct 12, 1984
CAPOZIDE 50/25
+ APOTHECON 50MG;25MG ** N018709 003 Oct 12, 1984
CAPTOPRIL AND HYDROCHLOROTHIAZIDE
COSETTE 25MG;15MG A074827 001 Dec 29, 1997
25MG;25MG A074827 002 Dec 29, 1997
50MG;15MG A074827 004 Dec 29, 1997
50MG;25MG A074827 003 Dec 29, 1997
IVAX SUB TEVA PHARMS 25MG;15MG A075055 001 Jun 18, 1998
25MG;25MG A075055 002 Jun 18, 1998
50MG;15MG A075055 004 Jun 18, 1998
50MG;25MG A075055 003 Jun 18, 1998
RISING 25MG;15MG A074896 001 Dec 29, 1997
25MG;25MG A074896 002 Dec 29, 1997

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-82(of 478)
** See List Footnote
CAPTOPRIL; HYDROCHLOROTHIAZIDE
TABLET;ORAL
CAPTOPRIL AND HYDROCHLOROTHIAZIDE
50MG;15MG A074896 004 Dec 29, 1997
50MG;25MG A074896 003 Dec 29, 1997
STRIDES PHARMA 25MG;15MG A074788 001 Dec 29, 1997
25MG;25MG A074788 002 Dec 29, 1997
50MG;15MG A074788 004 Dec 29, 1997
50MG;25MG A074788 003 Dec 29, 1997
WATSON LABS 50MG;25MG A074832 001 Dec 29, 1997
CARBACHOL
SOLUTION;INTRAOCULAR
CARBACHOL
PHARMAFAIR 0.01% A070292 001 May 21, 1986
CARBASTAT
NOVARTIS 0.01% A073677 001 Apr 28, 1995
CARBAMAZEPINE
SOLUTION;INTRAVENOUS
CARNEXIV
+ LUNDBECK PHARMS LLC 200MG/20ML (10MG/ML) N206030 001 Oct 07, 2016
SUSPENSION;ORAL
CARBAMAZEPINE
TARO 100MG/5ML A075875 001 Dec 21, 2000
TABLET;ORAL
CARBAMAZEPINE
ACTAVIS ELIZABETH 200MG A071696 001 Nov 09, 1987
INWOOD LABS 200MG A070231 001 Aug 14, 1986
PLIVA 200MG A071479 001 Jul 24, 1987
USL PHARMA 200MG A070300 001 May 15, 1986
VGYAAN 200MG A214328 001 Aug 16, 2021
WARNER CHILCOTT 200MG A070429 001 Jan 02, 1987
TERIL
TARO 200MG A076525 001 Sep 26, 2003
TABLET, CHEWABLE;ORAL
CARBAMAZEPINE
JUBILANT CADISTA 100MG A071940 001 Feb 01, 1988
TEGRETOL
+ NOVARTIS 100MG ** N018281 001
TABLET, EXTENDED RELEASE;ORAL
CARBAMAZEPINE
RICONPHARMA LLC 100MG A216404 001 Dec 02, 2022
200MG A216404 002 Dec 02, 2022
400MG A216404 003 Dec 02, 2022
CARBENICILLIN DISODIUM
INJECTABLE;INJECTION
GEOPEN
ROERIG EQ 1GM BASE/VIAL N050306 001
EQ 2GM BASE/VIAL N050306 004
EQ 5GM BASE/VIAL N050306 002
EQ 10GM BASE/VIAL N050306 006
EQ 30GM BASE/VIAL N050306 007
PYOPEN
GLAXOSMITHKLINE EQ 1GM BASE/VIAL N050298 001
EQ 2GM BASE/VIAL N050298 002
EQ 5GM BASE/VIAL N050298 003
EQ 10GM BASE/VIAL N050298 006
EQ 20GM BASE/VIAL N050298 007
CARBENICILLIN INDANYL SODIUM
TABLET;ORAL
GEOCILLIN
PFIZER EQ 382MG BASE N050435 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-83(of 478)
** See List Footnote
CARBIDOPA
TABLET;ORAL
CARBIDOPA
ANI PHARMS 25MG A203261 001 Mar 10, 2014
CARBIDOPA; ENTACAPONE; LEVODOPA
TABLET;ORAL
CARBIDOPA, LEVODOPA AND ENTACAPONE
MYLAN 12.5MG;200MG;50MG A203424 001 Aug 13, 2020
18.75MG;200MG;75MG A203424 002 Aug 13, 2020
25MG;200MG;100MG A203424 003 Aug 13, 2020
31.25MG;200MG;125MG A203424 004 Aug 13, 2020
37.5MG;200MG;150MG A203424 005 Aug 13, 2020
50MG;200MG;200MG A203424 006 Aug 13, 2020
WOCKHARDT LTD 12.5MG;200MG;50MG A090786 001 Nov 20, 2012
18.75MG;200MG;75MG A090833 001 Nov 20, 2012
25MG;200MG;100MG A090833 002 Nov 20, 2012
31.25MG;200MG;125MG A090833 003 Nov 20, 2012
37.5MG;200MG;150MG A090833 004 Nov 20, 2012
50MG;200MG;200MG A090833 005 Nov 20, 2012
CARBIDOPA; LEVODOPA
TABLET;ORAL
CARBIDOPA AND LEVODOPA
ANI PHARMS 10MG;100MG A073587 002 Jun 29, 1995
25MG;100MG A073587 001 Jun 29, 1995
25MG;250MG A073587 003 Jun 29, 1995
SCS 10MG;100MG A074080 001 Mar 25, 1994
25MG;100MG A074080 002 Mar 25, 1994
25MG;250MG A074080 003 Mar 25, 1994
WATSON LABS 10MG;100MG A073381 001 Sep 28, 1993
25MG;100MG A073382 001 Sep 28, 1993
25MG;250MG A073383 001 Sep 28, 1993
TABLET, EXTENDED RELEASE;ORAL
CARBIDOPA AND LEVODOPA
KV PHARM 50MG;200MG A076663 001 Jun 24, 2004
SINEMET CR
+ ORGANON LLC 25MG;100MG ** N019856 002 Dec 24, 1992
+ 50MG;200MG ** N019856 001 May 30, 1991
TABLET, FOR SUSPENSION;ORAL
CARBILEV
RANBAXY 10MG;100MG A076643 001 Jun 10, 2005
25MG;100MG A076643 002 Jun 10, 2005
25MG;250MG A076643 003 Jun 10, 2005
TABLET, ORALLY DISINTEGRATING;ORAL
CARBIDOPA AND LEVODOPA
IMPAX LABS 10MG;100MG A090631 001 Jun 08, 2010
25MG;100MG A090631 002 Jun 08, 2010
25MG;250MG A090631 003 Jun 08, 2010
RISING 10MG;100MG A078893 001 Sep 18, 2008
25MG;100MG A078893 002 Sep 18, 2008
25MG;250MG A078893 003 Sep 18, 2008
PARCOPA
UCB INC 10MG;100MG ** A076699 001 Aug 27, 2004
25MG;100MG ** A076699 002 Aug 27, 2004
25MG;250MG ** A076699 003 Aug 27, 2004
CARBINOXAMINE MALEATE
ELIXIR;ORAL
CLISTIN
+ MCNEIL 4MG/5ML ** N008955 001
SOLUTION;ORAL
CARBINOXAMINE MALEATE
CYPRESS PHARM 4MG/5ML A090418 001 May 04, 2010
VINTAGE PHARMS 4MG/5ML A040814 001 Feb 26, 2008
TABLET;ORAL
CARBINOXAMINE MALEATE
CYPRESS PHARM 4MG A090417 001 Aug 23, 2010
STRIDES PHARMA 4MG A040639 002 May 30, 2008

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-84(of 478)
** See List Footnote
CARBINOXAMINE MALEATE
TABLET;ORAL
CLISTIN
+ ORTHO MCNEIL PHARM 4MG ** N008915 001
CARBOPLATIN
INJECTABLE;INJECTION
CARBOPLATIN
CIPLA LTD 50MG/VIAL A077383 001 Jan 27, 2006
150MG/VIAL A077383 002 Jan 27, 2006
450MG/VIAL A077383 003 Jan 27, 2006
FRESENIUS KABI USA 50MG/VIAL A076235 001 Oct 14, 2004
150MG/VIAL A076235 002 Oct 14, 2004
450MG/VIAL A076235 003 Oct 14, 2004
HIKMA 50MG/VIAL A076099 001 Oct 14, 2004
150MG/VIAL A076099 002 Oct 14, 2004
450MG/VIAL A076099 003 Oct 14, 2004
HOSPIRA 50MG/VIAL A076473 001 Oct 27, 2004
150MG/VIAL A076473 002 Oct 27, 2004
450MG/VIAL A076473 003 Oct 27, 2004
MYLAN LABS LTD 50MG/VIAL A091510 001 May 29, 2012
150MG/VIAL A091510 002 May 29, 2012
450MG/VIAL A091510 003 May 29, 2012
PLIVA 50MG/VIAL A076602 001 Nov 16, 2004
150MG/VIAL A076602 002 Nov 16, 2004
450MG/VIAL A076602 003 Nov 16, 2004
SANDOZ 50MG/VIAL A076959 001 Mar 18, 2005
150MG/VIAL A076959 002 Mar 18, 2005
450MG/VIAL A076959 003 Mar 18, 2005
WATSON LABS TEVA 50MG/VIAL A076162 001 Oct 14, 2004
150MG/VIAL A076162 002 Oct 14, 2004
450MG/VIAL A076162 003 Oct 14, 2004
PARAPLATIN
+ CORDEN PHARMA 50MG/VIAL ** N019880 001 Mar 03, 1989
+ 150MG/VIAL ** N019880 002 Mar 03, 1989
+ 450MG/VIAL ** N019880 003 Mar 03, 1989
INJECTABLE;INTRAVENOUS
CARBOPLATIN
ACTAVIS TOTOWA 50MG/5ML (10MG/ML) A078732 001 Feb 06, 2012
150MG/15ML (10MG/ML) A078732 002 Feb 06, 2012
450MG/45ML (10MG/ML) A078732 003 Feb 06, 2012
600MG/60ML (10MG/ML) A078732 004 Feb 06, 2012
FRESENIUS KABI USA 50MG/5ML (10MG/ML) A077432 001 Sep 29, 2006
150MG/15ML (10MG/ML) A077432 002 Sep 29, 2006
450MG/45ML (10MG/ML) A077432 003 Sep 29, 2006
50MG/5ML (10MG/ML) A077247 001 Oct 21, 2004
50MG/5ML (10MG/ML) A077266 001 Feb 15, 2006
150MG/15ML (10MG/ML) A077247 002 Oct 21, 2004
150MG/15ML (10MG/ML) A077266 002 Feb 15, 2006
MEITHEAL 50MG/5ML (10MG/ML) A077096 001 Jun 14, 2005
150MG/15ML (10MG/ML) A077096 002 Jun 14, 2005
450MG/45ML (10MG/ML) A077096 003 Jun 14, 2005
600MG/60ML (10MG/ML) A077096 004 Jun 03, 2013
MYLAN INSTITUTIONAL 50MG/5ML (10MG/ML) A077998 001 Apr 24, 2007
150MG/15ML (10MG/ML) A077998 002 Apr 24, 2007
450MG/45ML (10MG/ML) A077998 003 Apr 24, 2007
MYLAN LABS LTD 50MG/5ML (10MG/ML) A091063 001 Nov 09, 2011
150MG/15ML (10MG/ML) A091063 002 Nov 09, 2011
450MG/45ML (10MG/ML) A091063 003 Nov 09, 2011
600MG/60ML (10MG/ML) A091063 004 Nov 09, 2011
1GM/100ML (10MG/ML) A091478 001 Nov 23, 2011
NOVAST LABS 450MG/45ML (10MG/ML) A208487 003 Apr 26, 2017
600MG/60ML (10MG/ML) A208487 004 Apr 26, 2017
PHARMACHEMIE BV 50MG/5ML (10MG/ML) A077679 001 Feb 25, 2009
150MG/15ML (10MG/ML) A077679 002 Feb 25, 2009
450MG/45ML (10MG/ML) A077679 003 Feb 25, 2009
PLIVA LACHEMA 50MG/5ML (10MG/ML) A078631 001 Dec 02, 2008
150MG/15ML (10MG/ML) A078631 002 Dec 02, 2008
450MG/45ML (10MG/ML) A078631 003 Dec 02, 2008
600MG/60ML (10MG/ML) A078631 004 Dec 02, 2008

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-85(of 478)
** See List Footnote
CARBOPLATIN
INJECTABLE;INTRAVENOUS
CARBOPLATIN
TEVA PARENTERAL 50MG/5ML (10MG/ML) A077389 001 Mar 30, 2007
150MG/15ML (10MG/ML) A077389 002 Mar 30, 2007
450MG/45ML (10MG/ML) A077389 003 Mar 30, 2007
TEVA PHARMS USA 50MG/5ML (10MG/ML) A077139 001 Sep 21, 2005
150MG/15ML (10MG/ML) A077139 002 Sep 21, 2005
450MG/45ML (10MG/ML) A077139 003 Sep 21, 2005
600MG/60ML (10MG/ML) A077139 004 Sep 21, 2005
PARAPLATIN
+ CORDENPHARMA 50MG/5ML (10MG/ML) ** N020452 001 Jul 14, 2003
+ 150MG/15ML (10MG/ML) ** N020452 002 Jul 14, 2003
+ 450MG/45ML (10MG/ML) ** N020452 003 Jul 14, 2003
+ 600MG/60ML (10MG/ML) ** N020452 004 Jan 15, 2004
CARFILZOMIB
POWDER;INTRAVENOUS
CARFILZOMIB
APOTEX 30MG/VIAL A211185 001 Mar 20, 2020
60MG/VIAL A209425 001 Mar 16, 2020
BRECKENRIDGE 10MG/VIAL A209330 001 Jun 11, 2021
60MG/VIAL A209330 002 Jun 11, 2021
CARIPRAZINE HYDROCHLORIDE
CAPSULE;ORAL
CARIPRAZINE HYDROCHLORIDE
SUN PHARM EQ 1.5MG BASE A213932 001 Sep 30, 2022
EQ 3MG BASE A213932 002 Sep 30, 2022
EQ 4.5MG BASE A213932 003 Sep 30, 2022
EQ 6MG BASE A213932 004 Sep 30, 2022
ZYDUS PHARMS EQ 1.5MG BASE A213984 001 Sep 09, 2022
EQ 3MG BASE A213984 002 Sep 09, 2022
EQ 4.5MG BASE A213984 003 Sep 09, 2022
EQ 6MG BASE A213984 004 Sep 09, 2022
CARISOPRODOL
CAPSULE;ORAL
SOMA
+ MYLAN SPECIALITY LP 250MG N011792 003
TABLET;ORAL
CARISOPRODOL
ABLE 350MG A040421 001 Jun 21, 2001
EPIC PHARMA LLC 350MG A040397 001 Sep 21, 2000
HIKMA INTL PHARMS 350MG A040124 001 Jan 24, 1996
PIONEER PHARMS 350MG A089390 001 Oct 13, 1988
SANDOZ 350MG A089566 001 Aug 30, 1988
STRIDES PHARMA 250MG A205513 001 Nov 12, 2015
350MG A205513 002 Nov 12, 2015
SUN PHARM INDS LTD 350MG A040755 001 Feb 27, 2007
SUN PHARM INDUSTRIES 350MG A089346 001 Oct 17, 1991
WATSON LABS 350MG A040152 001 Dec 03, 1996
350MG A085433 001
WATSON LABS TEVA 350MG A086179 001
RELA
SCHERING 350MG N012155 001
CARPHENAZINE MALEATE
CONCENTRATE;ORAL
PROKETAZINE
WYETH AYERST 50MG/ML N014173 001
TABLET;ORAL
PROKETAZINE
WYETH AYERST 12.5MG N012768 001
25MG N012768 002
50MG N012768 004

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-86(of 478)
** See List Footnote
CARPROFEN
TABLET;ORAL
RIMADYL
ROCHE 100MG N018550 002 Dec 31, 1987
150MG N018550 003 Dec 31, 1987
CARTEOLOL HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
CARTEOLOL HYDROCHLORIDE
APOTEX INC 1% A076097 001 Feb 06, 2002
BAUSCH AND LOMB 1% A075546 001 Jan 20, 2000
OCUPRESS
+ NOVARTIS 1% ** N019972 001 May 23, 1990
TABLET;ORAL
CARTROL
ABBVIE 2.5MG N019204 001 Dec 28, 1988
5MG N019204 002 Dec 28, 1988
10MG N019204 003 Dec 28, 1988
CARVEDILOL
TABLET;ORAL
CARVEDILOL
ACI 3.125MG A078786 001 Dec 22, 2009
6.25MG A078786 002 Dec 22, 2009
12.5MG A078786 003 Dec 22, 2009
25MG A078786 004 Dec 22, 2009
HIKMA 3.125MG A077887 001 Sep 07, 2007
6.25MG A077887 002 Sep 07, 2007
12.5MG A077887 003 Sep 07, 2007
25MG A077887 004 Sep 07, 2007
PLIVA HRVATSKA DOO 3.125MG A078240 001 Oct 30, 2007
6.25MG A078240 002 Oct 30, 2007
12.5MG A078240 003 Oct 30, 2007
25MG A078240 004 Oct 30, 2007
SUN PHARM INDS INC 3.125MG A077346 004 Sep 05, 2007
6.25MG A077346 001 Sep 05, 2007
12.5MG A077346 002 Sep 05, 2007
25MG A077346 003 Sep 05, 2007
CASPOFUNGIN ACETATE
POWDER;INTRAVENOUS
CASPOFUNGIN ACETATE
CIPLA 50MG/VIAL A209489 001 Jul 12, 2018
70MG/VIAL A209489 002 Jul 12, 2018
MYLAN LABS LTD 50MG/VIAL A207650 001 Sep 29, 2017
70MG/VIAL A207650 002 Sep 29, 2017
XELLIA PHARMS APS 50MG/VIAL A205923 001 Jul 02, 2018
70MG/VIAL A205923 002 Jul 02, 2018
CEFACLOR
CAPSULE;ORAL
CECLOR
+ LILLY EQ 250MG BASE ** N050521 001
+ EQ 500MG BASE ** N050521 002
CEFACLOR
CEPH INTL EQ 250MG BASE A062205 001
EQ 500MG BASE A062205 002
DAVA PHARMS INC EQ 250MG BASE A064107 001 Apr 27, 1995
EQ 500MG BASE A064107 002 Apr 27, 1995
HERITAGE PHARMA EQ 250MG BASE A064148 001 May 23, 1996
EQ 500MG BASE A064148 002 May 23, 1996
IVAX SUB TEVA PHARMS EQ 250MG BASE A064061 001 Apr 27, 1995
EQ 500MG BASE A064061 002 Apr 27, 1995
RANBAXY EQ 250MG BASE A064156 001 Aug 28, 1997
EQ 500MG BASE A064156 002 Aug 28, 1997
TEVA EQ 250MG BASE A064081 001 Sep 16, 1996
EQ 250MG BASE A064145 001 Jun 24, 1996
EQ 500MG BASE A064081 002 Sep 16, 1996
EQ 500MG BASE A064145 002 Jun 24, 1996

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-87(of 478)
** See List Footnote
CEFACLOR
FOR SUSPENSION;ORAL
CECLOR
+ LILLY EQ 125MG BASE/5ML ** N050522 001
+ EQ 250MG BASE/5ML ** N050522 002
CEFACLOR
DAVA PHARMS INC EQ 125MG BASE/5ML A064114 001 Apr 28, 1995
EQ 187MG BASE/5ML A064115 001 Apr 28, 1995
EQ 250MG BASE/5ML A064116 001 Apr 28, 1995
EQ 375MG BASE/5ML A064110 001 Apr 28, 1995
FACTA FARMA EQ 125MG BASE/5ML A062206 001
EQ 187MG BASE/5ML A062206 003 Apr 20, 1988
EQ 250MG BASE/5ML A062206 002
EQ 375MG BASE/5ML A062206 004 Apr 20, 1988
IVAX SUB TEVA PHARMS EQ 125MG BASE/5ML A064087 001 Apr 28, 1995
EQ 187MG BASE/5ML A064086 001 Apr 28, 1995
EQ 250MG BASE/5ML A064085 001 Apr 28, 1995
EQ 375MG BASE/5ML A064070 001 Apr 28, 1995
RANBAXY EQ 125MG BASE/5ML A064166 001 Oct 02, 1997
EQ 187MG BASE/5ML A064165 001 Oct 02, 1997
EQ 250MG BASE/5ML A064164 001 Oct 02, 1997
EQ 375MG BASE/5ML A064155 001 Oct 02, 1997
WATSON LABS INC EQ 125MG BASE/5ML A064204 001 Feb 18, 1998
EQ 187MG BASE/5ML A064205 001 Feb 18, 1998
EQ 250MG BASE/5ML A064206 001 Feb 18, 1998
EQ 375MG BASE/5ML A064207 001 Feb 18, 1998
TABLET, CHEWABLE;ORAL
RANICLOR
RANBAXY LABS LTD EQ 125MG BASE A065092 001 Dec 22, 2003
EQ 187MG BASE A065092 002 Dec 22, 2003
EQ 250MG BASE A065092 003 Dec 22, 2003
EQ 375MG BASE A065092 004 Dec 22, 2003
TABLET, EXTENDED RELEASE;ORAL
CECLOR CD
LILLY EQ 375MG BASE ** N050673 001 Jun 28, 1996
EQ 500MG BASE ** N050673 002 Jun 28, 1996
CEFACLOR
WORLD GEN EQ 500MG BASE A065057 001 Jan 05, 2001
CEFADROXIL/CEFADROXIL HEMIHYDRATE
CAPSULE;ORAL
CEFADROXIL
CHARTWELL RX EQ 500MG BASE A065309 001 Sep 18, 2006
CSPC OUYI EQ 500MG BASE A205072 001 Jul 28, 2017
IVAX SUB TEVA PHARMS EQ 500MG BASE A062766 001 Mar 03, 1987
PUREPAC PHARM EQ 500MG BASE A063017 001 Jan 05, 1989
RANBAXY LABS LTD EQ 500MG BASE A065015 001 Jun 22, 1999
SANDOZ EQ 500MG BASE A062291 001
TEVA EQ 500MG BASE A062695 001 Feb 10, 1989
DURICEF
WARNER CHILCOTT EQ 250MG BASE N050512 002
+ EQ 500MG BASE ** N050512 001
ULTRACEF
BRISTOL EQ 500MG BASE A062378 001 Mar 16, 1982
FOR SUSPENSION;ORAL
CEFADROXIL
ANI PHARMS EQ 125MG BASE/5ML A062698 001 Mar 01, 1989
EQ 250MG BASE/5ML A062698 002 Mar 01, 1989
EQ 250MG BASE/5ML A065278 001 Jan 20, 2006
EQ 500MG BASE/5ML A062698 003 Mar 01, 1989
EQ 500MG BASE/5ML A065278 002 Jan 20, 2006
APOTHECON EQ 125MG BASE/5ML A062334 001
EQ 250MG BASE/5ML A062334 002
EQ 500MG BASE/5ML A062334 003
CHARTWELL RX EQ 250MG BASE/5ML A065307 002 Oct 16, 2006
EQ 500MG BASE/5ML A065307 003 Oct 16, 2006
SUN PHARM INDS LTD EQ 125MG BASE/5ML A065115 001 Mar 26, 2003
EQ 250MG BASE/5ML A065115 002 Mar 26, 2003
EQ 500MG BASE/5ML A065115 003 Mar 26, 2003

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-88(of 478)
** See List Footnote
CEFADROXIL/CEFADROXIL HEMIHYDRATE
FOR SUSPENSION;ORAL
DURICEF
+ WARNER CHILCOTT EQ 125MG BASE/5ML ** N050527 002
+ EQ 250MG BASE/5ML ** N050527 003
+ EQ 500MG BASE/5ML ** N050527 001
ULTRACEF
BRISTOL EQ 125MG BASE/5ML A062376 001 Mar 16, 1982
EQ 250MG BASE/5ML A062376 002 Mar 16, 1982
EQ 500MG BASE/5ML A062376 003 Mar 16, 1982
TABLET;ORAL
CEFADROXIL
CHARTWELL RX EQ 1GM BASE A065301 001 Sep 18, 2006
RANBAXY EQ 1GM BASE A065018 001 Apr 23, 1999
DURICEF
+ WARNER CHILCOTT EQ 1GM BASE ** N050528 001
ULTRACEF
APOTHECON EQ 1GM BASE A062390 001 Jun 10, 1982
BRISTOL EQ 1GM BASE A062408 001 Aug 31, 1982
CEFAMANDOLE NAFATE
INJECTABLE;INJECTION
MANDOL
LILLY EQ 500MG BASE/VIAL N050504 001
EQ 1GM BASE/VIAL A062560 001 Sep 10, 1985
EQ 1GM BASE/VIAL N050504 002
EQ 2GM BASE/VIAL A062560 002 Sep 10, 1985
EQ 2GM BASE/VIAL N050504 003
EQ 10GM BASE/VIAL N050504 004
CEFAZOLIN SODIUM
INJECTABLE;INJECTION
ANCEF
+ GLAXOSMITHKLINE EQ 250MG BASE/VIAL ** N050461 001
+ EQ 500MG BASE/VIAL N050461 002
+ EQ 1GM BASE/VIAL ** N050461 003
+ EQ 5GM BASE/VIAL ** N050461 004
+ EQ 10GM BASE/VIAL ** N050461 005
ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER
+ BAXTER HLTHCARE EQ 10MG BASE/ML N050566 003 Jun 08, 1983
+ EQ 20MG BASE/ML N050566 004 Jun 08, 1983
ANCEF IN PLASTIC CONTAINER
BAXTER HLTHCARE EQ 10MG BASE/ML A063002 001 Mar 28, 1991
ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
+ BAXTER HLTHCARE EQ 10MG BASE/ML N050566 001 Jun 08, 1983
+ EQ 20MG BASE/ML N050566 002 Jun 08, 1983
CEFAZOLIN AND DEXTROSE
B BRAUN EQ 500MG BASE/VIAL N050779 001 Jul 27, 2000
CEFAZOLIN SODIUM
ABRAXIS PHARM EQ 500MG BASE/VIAL A062688 002 Nov 17, 1986
EQ 1GM BASE/VIAL A062688 003 Nov 17, 1986
EQ 10GM BASE/VIAL A062688 004 Nov 17, 1986
EQ 20GM BASE/VIAL A062688 005 Aug 03, 1987
AUROBINDO PHARMA EQ 500MG BASE/VIAL A065395 001 Aug 08, 2008
EQ 1GM BASE/VIAL A065395 002 Aug 08, 2008
BEDFORD EQ 250MG BASE/VIAL A062894 001 Jul 21, 1988
EQ 500MG BASE/VIAL A062894 002 Jul 21, 1988
EQ 1GM BASE/VIAL A062894 003 Jul 21, 1988
EQ 5GM BASE/VIAL A062894 004 Jul 21, 1988
EQ 10GM BASE/VIAL A062894 005 Jul 21, 1988
CEPHAZONE PHARMA EQ 500MG BASE/VIAL A065280 001 Mar 18, 2009
EQ 1GM BASE/VIAL A065280 002 Mar 18, 2009
EQ 10GM BASE/VIAL A065295 001 Mar 18, 2009
EQ 20GM BASE/VIAL A065296 001 Mar 18, 2009
DR REDDYS EQ 250MG BASE/VIAL A062988 001 Dec 29, 1989
EQ 500MG BASE/VIAL A062988 002 Dec 29, 1989
EQ 1GM BASE/VIAL A062988 003 Dec 29, 1989
EQ 5GM BASE/VIAL A062989 001 Dec 29, 1989
EQ 10GM BASE/VIAL A062989 002 Dec 29, 1989
EQ 20GM BASE/VIAL A062989 003 Dec 29, 1989

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-89(of 478)
** See List Footnote
CEFAZOLIN SODIUM
INJECTABLE;INJECTION
CEFAZOLIN SODIUM
FACTA FARMA EQ 500MG BASE/VIAL A063214 001 Dec 27, 1991
EQ 1GM BASE/VIAL A063207 001 Dec 27, 1991
EQ 10GM BASE/VIAL A063209 001 Dec 27, 1991
EQ 20GM BASE/VIAL A063209 002 Apr 30, 1999
FRESENIUS KABI USA EQ 500MG BASE/VIAL ** A064169 001 Aug 14, 1998
EQ 1GM BASE/VIAL ** A064169 002 Aug 14, 1998
EQ 10GM BASE/VIAL A064170 001 Mar 18, 1998
EQ 20GM BASE/VIAL A064170 002 Mar 18, 1998
GLAXOSMITHKLINE EQ 1GM BASE/VIAL A064033 001 Oct 31, 1993
HIKMA EQ 250MG BASE/VIAL A062807 001 Jan 12, 1988
EQ 500MG BASE/VIAL A062807 002 Jan 12, 1988
EQ 1GM BASE/VIAL A062807 003 Jan 12, 1988
EQ 5GM BASE/VIAL A062807 004 Jan 12, 1988
EQ 10GM BASE/VIAL A062807 005 Jan 12, 1988
EQ 20GM BASE/VIAL A062807 006 Jan 12, 1988
HOSPIRA EQ 1GM BASE/VIAL A201654 001 Feb 03, 2016
HOSPIRA INC EQ 500MG BASE/VIAL A065226 001 Apr 21, 2005
EQ 1GM BASE/VIAL A065226 002 Apr 21, 2005
EQ 1GM BASE/VIAL A065244 001 Aug 12, 2005
EQ 10GM BASE/VIAL A065247 001 Aug 12, 2005
STERI PHARMA EQ 500MG BASE/VIAL A063216 001 Dec 27, 1991
EQ 1GM BASE/VIAL A063208 001 Dec 27, 1991
TEVA PHARMS EQ 250MG BASE/VIAL A063016 001 Mar 14, 1989
EQ 500MG BASE/VIAL A063016 002 Mar 14, 1989
EQ 1GM BASE/VIAL A063016 003 Mar 14, 1989
EQ 5GM BASE/VIAL A063018 001 Mar 05, 1990
EQ 10GM BASE/VIAL A063018 002 Mar 05, 1990
KEFZOL
ACS DOBFAR EQ 250MG BASE/VIAL A061773 001
EQ 500MG BASE/VIAL A061773 002
EQ 1GM BASE/VIAL A061773 003
EQ 10GM BASE/VIAL A061773 004
EQ 20GM BASE/VIAL A061773 005 Sep 08, 1987
LILLY EQ 500MG BASE/VIAL A062557 001 Sep 10, 1985
EQ 1GM BASE/VIAL A062557 002 Sep 10, 1985
CEFDINIR
CAPSULE;ORAL
OMNICEF
+ ABBVIE 300MG ** N050739 001 Dec 04, 1997
FOR SUSPENSION;ORAL
OMNICEF
+ ABBVIE 125MG/5ML ** N050749 001 Dec 04, 1997
+ 250MG/5ML ** N050749 002 Jul 29, 2004
CEFDITOREN PIVOXIL
TABLET;ORAL
SPECTRACEF
VANSEN PHARMA 200MG N021222 001 Aug 29, 2001
400MG N021222 002 Jul 21, 2008
CEFEPIME HYDROCHLORIDE
INJECTABLE;INJECTION
CEFEPIME HYDROCHLORIDE
FOSUN PHARMA EQ 500MG BASE/VIAL A090291 001 Dec 21, 2010
EQ 1GM BASE/VIAL A090291 002 Dec 21, 2010
EQ 2GM BASE/VIAL A090291 003 Dec 21, 2010
HOSPIRA INC EQ 500MG BASE/VIAL A065369 001 Jun 18, 2007
EQ 1GM BASE/VIAL A065369 002 Jun 18, 2007
EQ 1GM BASE/VIAL A202268 001 Jul 30, 2012
EQ 2GM BASE/VIAL A065369 003 Jun 18, 2007
EQ 2GM BASE/VIAL A202268 002 Jul 30, 2012

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-90(of 478)
** See List Footnote
CEFIXIME
FOR SUSPENSION;ORAL
CEFIXIME
SANDOZ INC 100MG/5ML A206144 001 Nov 17, 2017
200MG/5ML A206144 002 Nov 17, 2017
SUPRAX
+ LEDERLE 100MG/5ML ** N050622 001 Apr 28, 1989
LUPIN PHARMS 100MG/5ML A065129 001 Feb 23, 2004
TABLET;ORAL
SUPRAX
+ LEDERLE 200MG ** N050621 001 Apr 28, 1989
+ 400MG ** N050621 002 Apr 28, 1989
LUPIN PHARMS 400MG A065130 001 Feb 12, 2004
CEFMENOXIME HYDROCHLORIDE
INJECTABLE;INJECTION
CEFMAX
TAP PHARM EQ 500MG BASE/VIAL N050571 001 Dec 30, 1987
EQ 1GM BASE/VIAL N050571 002 Dec 30, 1987
EQ 2GM BASE/VIAL N050571 003 Dec 30, 1987
CEFMETAZOLE SODIUM
INJECTABLE;INJECTION
ZEFAZONE
+ PHARMACIA AND UPJOHN EQ 1GM BASE/VIAL ** N050637 001 Dec 11, 1989
+ EQ 2GM BASE/VIAL ** N050637 002 Dec 11, 1989
ZEFAZONE IN PLASTIC CONTAINER
+ PHARMACIA AND UPJOHN EQ 20MG BASE/ML ** N050683 001 Dec 29, 1992
+ EQ 40MG BASE/ML ** N050683 002 Dec 29, 1992
CEFONICID SODIUM
INJECTABLE;INJECTION
MONOCID
GLAXOSMITHKLINE EQ 500MG BASE/VIAL N050579 001 May 23, 1984
EQ 1GM BASE/VIAL A063295 001 Jul 26, 1993
EQ 1GM BASE/VIAL N050579 002 May 23, 1984
EQ 2GM BASE/VIAL N050579 003 May 23, 1984
EQ 10GM BASE/VIAL N050579 004 May 23, 1984
CEFOPERAZONE SODIUM
INJECTABLE;INJECTION
CEFOBID
PFIZER EQ 1GM BASE/VIAL A063333 001 Mar 31, 1995
EQ 1GM BASE/VIAL N050551 001 Nov 18, 1982
EQ 2GM BASE/VIAL A063333 002 Mar 31, 1995
EQ 2GM BASE/VIAL N050551 002 Nov 18, 1982
EQ 10GM BASE/VIAL N050551 003 Mar 05, 1990
CEFOBID IN PLASTIC CONTAINER
PFIZER EQ 20MG BASE/ML N050613 002 Jul 31, 1987
EQ 40MG BASE/ML N050613 001 Jul 23, 1986
CEFORANIDE
INJECTABLE;INJECTION
PRECEF
APOTHECON 500MG/VIAL A062579 001 Nov 26, 1984
1GM/VIAL A062579 002 Nov 26, 1984
2GM/VIAL A062579 003 Nov 26, 1984
10GM/VIAL A062579 004 Nov 26, 1984
20GM/VIAL A062579 005 Nov 26, 1984
BRISTOL 500MG/VIAL N050554 001 May 24, 1984
1GM/VIAL N050554 002 May 24, 1984
2GM/VIAL N050554 003 May 24, 1984
10GM/VIAL N050554 004 May 24, 1984
20GM/VIAL N050554 005 May 24, 1984
CEFOTAXIME SODIUM
INJECTABLE;INJECTION
CEFOTAXIME
FRESENIUS KABI USA EQ 500MG BASE/VIAL A064200 001 Mar 24, 2000
EQ 1GM BASE/VIAL A064200 002 Mar 24, 2000
EQ 2GM BASE/VIAL A064200 003 Mar 24, 2000
EQ 10GM BASE/VIAL A064201 001 Mar 24, 2000

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-91(of 478)
** See List Footnote
CEFOTAXIME SODIUM
INJECTABLE;INJECTION
CEFOTAXIME
EQ 20GM BASE/VIAL A064201 002 Mar 24, 2000
WOCKHARDT EQ 1GM BASE/VIAL A065197 001 Aug 29, 2006
CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER
B BRAUN EQ 2GM BASE N050792 001 Jul 29, 2004
CEFOTAXIME AND DEXTROSE 3.9% IN PLASTIC CONTAINER
B BRAUN EQ 1GM BASE N050792 002 Jul 29, 2004
CEFOTAXIME SODIUM
AUROBINDO PHARMA EQ 500MG BASE/VIAL A065517 001 Nov 06, 2009
EQ 1GM BASE/VIAL A065517 002 Nov 06, 2009
EQ 2GM BASE/VIAL A065517 003 Nov 06, 2009
AUROBINDO PHARMA LTD EQ 10GM BASE/VIAL A065516 001 Nov 06, 2009
CEPHAZONE PHARMA EQ 10GM BASE/VIAL A065348 001 Jan 25, 2010
HOSPIRA EQ 1GM BASE/VIAL A203132 001 Feb 19, 2016
EQ 2GM BASE/VIAL A203132 002 Feb 19, 2016
HOSPIRA INC EQ 500MG BASE/VIAL A065290 001 Aug 11, 2006
EQ 1GM BASE/VIAL A065290 002 Aug 11, 2006
EQ 1GM BASE/VIAL A065293 001 Aug 10, 2006
EQ 2GM BASE/VIAL A065290 003 Aug 11, 2006
EQ 2GM BASE/VIAL A065293 002 Aug 10, 2006
EQ 10GM BASE/VIAL A065292 001 Aug 10, 2006
LUPIN EQ 500MG BASE/VIAL A065124 001 Sep 24, 2003
EQ 1GM BASE/VIAL A065124 002 Sep 24, 2003
EQ 2GM BASE/VIAL A065124 003 Sep 24, 2003
WOCKHARDT EQ 500MG BASE/VIAL A065197 002 Jun 20, 2008
EQ 2GM BASE/VIAL A065197 003 Jun 20, 2008
CLAFORAN
SANOFI AVENTIS US EQ 1GM BASE/VIAL A062659 001 Jan 13, 1987
EQ 2GM BASE/VIAL A062659 002 Jan 13, 1987
+ VALIDUS PHARMS EQ 500MG BASE/VIAL ** N050547 001
+ EQ 1GM BASE/VIAL ** N050547 002
+ EQ 2GM BASE/VIAL ** N050547 003
+ EQ 10GM BASE/VIAL ** N050547 004 Dec 29, 1983
CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
VALIDUS PHARMS EQ 20MG BASE/ML N050596 002 May 20, 1985
EQ 40MG BASE/ML N050596 004 May 20, 1985
CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
VALIDUS PHARMS EQ 20MG BASE/ML N050596 001 May 20, 1985
EQ 40MG BASE/ML N050596 003 May 20, 1985
CEFOTETAN DISODIUM
INJECTABLE;INJECTION
CEFOTAN
PAI HOLDINGS PHARM EQ 10GM BASE/VIAL N050588 003 Apr 25, 1988
TELIGENT EQ 1GM BASE/VIAL A063293 001 Apr 29, 1993
EQ 2GM BASE/VIAL A063293 002 Apr 29, 1993
CEFOTAN IN PLASTIC CONTAINER
PAI HOLDINGS PHARM EQ 20MG BASE/ML N050694 002 Jul 30, 1993
EQ 40MG BASE/ML N050694 001 Jul 30, 1993
CEFOTETAN
FRESENIUS KABI USA EQ 10GM BASE/VIAL A065375 001 Aug 09, 2007
HIKMA EQ 1GM BASE/VIAL A091031 001 Oct 26, 2011
EQ 2GM BASE/VIAL A091031 002 Oct 26, 2011
WEST-WARD PHARM CORP EQ 10GM BASE/VIAL A091030 001 Oct 26, 2011
CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER
+ B BRAUN EQ 1GM BASE/VIAL N065430 001 Aug 09, 2007
+ EQ 2GM BASE/VIAL N065430 002 Aug 09, 2007
CEFOTIAM HYDROCHLORIDE
INJECTABLE;INJECTION
CERADON
TAKEDA EQ 1GM BASE/VIAL N050601 001 Dec 30, 1988

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-92(of 478)
** See List Footnote
CEFOXITIN SODIUM
INJECTABLE;INJECTION
CEFOXITIN
ACS DOBFAR SPA EQ 1GM BASE/VIAL A065467 001 Aug 31, 2011
EQ 2GM BASE/VIAL A065467 002 Aug 31, 2011
EQ 10GM BASE/VIAL A065464 001 Aug 31, 2011
FRESENIUS KABI USA EQ 1GM BASE/VIAL ** A065012 001 Jul 03, 2000
EQ 2GM BASE/VIAL ** A065012 002 Jul 03, 2000
EQ 10GM BASE/VIAL A065011 001 Jul 03, 2000
HOSPIRA INC EQ 1GM BASE/VIAL A065313 001 Jan 23, 2006
EQ 2GM BASE/VIAL A065313 002 Jan 23, 2006
EQ 10GM BASE/VIAL A065312 001 Feb 13, 2006
MEFOXIN
MYLAN INSTITUTIONAL EQ 1GM BASE/VIAL A062757 001 Jan 08, 1987
+ EQ 1GM BASE/VIAL ** N050517 001
EQ 2GM BASE/VIAL A062757 002 Jan 08, 1987
+ EQ 2GM BASE/VIAL ** N050517 002
+ EQ 10GM BASE/VIAL ** N050517 003
MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
+ MERCK EQ 20MG BASE/ML ** N050581 003 Sep 20, 1984
+ EQ 40MG BASE/ML ** N050581 004 Sep 20, 1984
MEFOXIN IN PLASTIC CONTAINER
MYLAN INSTITUTIONAL EQ 20MG BASE/ML A063182 001 Jan 25, 1993
EQ 40MG BASE/ML A063182 002 Jan 25, 1993
MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
+ MERCK EQ 20MG BASE/ML ** N050581 002 Sep 20, 1984
+ EQ 40MG BASE/ML ** N050581 001 Sep 20, 1984
CEFPIRAMIDE SODIUM
INJECTABLE;INJECTION
CEFPIRAMIDE SODIUM
WYETH AYERST EQ 1GM BASE/VIAL N050633 002 Jan 31, 1989
EQ 2GM BASE/VIAL N050633 003 Jan 31, 1989
EQ 10GM BASE/VIAL N050633 005 Jan 31, 1989
CEFPODOXIME PROXETIL
FOR SUSPENSION;ORAL
BANAN
SANKYO EQ 50MG BASE/5ML N050688 002 Aug 07, 1992
EQ 100MG BASE/5ML N050688 001 Aug 07, 1992
CEFPODOXIME PROXETIL
SANDOZ EQ 50MG BASE/5ML A090031 001 Jan 14, 2009
EQ 100MG BASE/5ML A090031 002 Jan 14, 2009
SUN PHARM INDS LTD EQ 50MG BASE/5ML A065082 001 May 31, 2002
EQ 100MG BASE/5ML A065082 002 May 31, 2002
VANTIN
+ PHARMACIA AND UPJOHN EQ 50MG BASE/5ML ** N050675 001 Aug 07, 1992
+ EQ 100MG BASE/5ML ** N050675 002 Aug 07, 1992
TABLET;ORAL
BANAN
SANKYO EQ 100MG BASE N050687 001 Aug 07, 1992
EQ 200MG BASE N050687 002 Aug 07, 1992
CEFPODOXIME PROXETIL
SUN PHARM INDS LTD EQ 100MG BASE A065083 001 Aug 20, 2003
EQ 200MG BASE A065083 002 Aug 20, 2003
VANTIN
+ PHARMACIA AND UPJOHN EQ 100MG BASE ** N050674 001 Aug 07, 1992
+ EQ 200MG BASE ** N050674 002 Aug 07, 1992
CEFPROZIL
FOR SUSPENSION;ORAL
CEFPROZIL
CHARTWELL RX 125MG/5ML A065236 001 Dec 08, 2005
250MG/5ML A065236 002 Dec 08, 2005
ORCHID HLTHCARE 125MG/5ML A065284 002 Dec 30, 2005
250MG/5ML A065284 001 Dec 30, 2005
RANBAXY LABS LTD 125MG/5ML A065202 001 Jun 30, 2006
250MG/5ML A065202 002 Jun 30, 2006
SANDOZ 125MG/5ML A065257 001 Dec 08, 2005
250MG/5ML A065257 002 Dec 08, 2005

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-93(of 478)
** See List Footnote
CEFPROZIL
FOR SUSPENSION;ORAL
CEFZIL
+ CORDEN PHARMA 125MG/5ML ** N050665 001 Dec 23, 1991
+ 250MG/5ML ** N050665 002 Dec 23, 1991
TABLET;ORAL
CEFPROZIL
ORCHID HLTHCARE 250MG A065267 001 Dec 19, 2005
500MG A065267 002 Dec 19, 2005
RANBAXY LABS LTD 250MG A065198 001 Dec 13, 2006
500MG A065198 002 Dec 13, 2006
WOCKHARDT 250MG A065428 001 Jun 14, 2007
500MG A065428 002 Jun 14, 2007
CEFZIL
+ CORDEN PHARMA 250MG ** N050664 001 Dec 23, 1991
+ 500MG ** N050664 002 Dec 23, 1991
CEFTAROLINE FOSAMIL
POWDER;INTRAVENOUS
CEFTAROLINE FOSAMIL
APOTEX 400MG/VIAL A208075 001 Sep 21, 2021
600MG/VIAL A208075 002 Sep 21, 2021
CEFTAZIDIME
INJECTABLE;INJECTION
CEFTAZIDIME
ACS DOBFAR 500MG/VIAL A062640 001 Nov 20, 1985
AUROBINDO PHARMA LTD 500MG/VIAL A065481 001 May 28, 2010
1GM/VIAL A065481 002 May 28, 2010
2GM/VIAL A065481 003 May 28, 2010
6GM/VIAL A065482 001 May 28, 2010
WOCKHARDT 1GM/VIAL A065196 001 Oct 15, 2008
CEFTAZIDIME IN DEXTROSE CONTAINER
+ B BRAUN EQ 1GM BASE N050823 001 Jun 13, 2011
+ EQ 2GM BASE N050823 002 Jun 13, 2011
CEPTAZ
GLAXOSMITHKLINE 500MG/VIAL N050646 001 Sep 27, 1990
1GM/VIAL N050646 002 Sep 27, 1990
2GM/VIAL N050646 003 Sep 27, 1990
10GM/VIAL N050646 004 Sep 27, 1990
PENTACEF
GLAXOSMITHKLINE 1GM/VIAL A063322 001 Nov 07, 1995
1GM/VIAL A064006 001 Mar 31, 1992
2GM/VIAL A063322 002 Nov 07, 1995
2GM/VIAL A064006 002 Mar 31, 1992
6GM/VIAL A064008 001 Mar 31, 1992
10GM/VIAL A064008 002 Mar 31, 1992
TAZIDIME
LILLY 1GM/VIAL A062655 001 Nov 20, 1985
2GM/VIAL A062655 002 Nov 20, 1985
TAZIDIME IN PLASTIC CONTAINER
LILLY 1GM/VIAL A062739 001 Jul 10, 1986
2GM/VIAL A062739 002 Jul 10, 1986
CEFTAZIDIME SODIUM
INJECTABLE;INJECTION
CEFTAZIDIME SODIUM IN PLASTIC CONTAINER
BAXTER HLTHCARE EQ 10MG BASE/ML A063221 001 Apr 29, 1993
EQ 20MG BASE/ML A063221 002 Apr 29, 1993
EQ 40MG BASE/ML A063221 003 Apr 29, 1993
FORTAZ IN PLASTIC CONTAINER
PAI HOLDINGS PHARM EQ 10MG BASE/ML N050634 001 Apr 28, 1989
+ EQ 20MG BASE/ML N050634 002 Apr 28, 1989
+ EQ 40MG BASE/ML N050634 003 Apr 28, 1989

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-94(of 478)
** See List Footnote
CEFTIBUTEN DIHYDRATE
CAPSULE;ORAL
CEDAX
SI PHARMS EQ 400MG BASE N050685 002 Dec 20, 1995
FOR SUSPENSION;ORAL
CEDAX
+ SI PHARMS EQ 90MG BASE/5ML ** N050686 001 Dec 20, 1995
+ EQ 180MG BASE/5ML ** N050686 002 Dec 20, 1995
CEFTIZOXIME SODIUM
INJECTABLE;INJECTION
CEFIZOX
ASTELLAS EQ 500MG BASE/VIAL N050560 001 Sep 15, 1983
EQ 1GM BASE/VIAL A063294 002 Mar 31, 1994
EQ 1GM BASE/VIAL N050560 002 Sep 15, 1983
EQ 2GM BASE/VIAL A063294 003 Mar 31, 1994
EQ 2GM BASE/VIAL N050560 003 Sep 15, 1983
EQ 10GM BASE/VIAL N050560 005 Mar 19, 1993
CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER
ASTELLAS EQ 20MG BASE/ML N050589 001 Oct 03, 1984
EQ 40MG BASE/ML N050589 002 Oct 03, 1984
CEFIZOX IN PLASTIC CONTAINER
ASTELLAS EQ 20MG BASE/ML N050589 003 Apr 13, 1995
EQ 40MG BASE/ML N050589 004 Apr 13, 1995
CEFTRIAXONE SODIUM
INJECTABLE;INJECTION
CEFTRIAXONE
AGILA SPECLTS EQ 10GM BASE/VIAL A091068 001 Jan 07, 2013
AUROBINDO PHARMA LTD EQ 10GM BASE/VIAL A065504 001 Jul 31, 2008
BEDFORD EQ 10GM BASE/VIAL A065475 001 Aug 18, 2008
FACTA FARMA EQ 10GM BASE/VIAL A065269 001 Feb 28, 2007
FRESENIUS KABI USA EQ 10GM BASE/VIAL A065252 001 Feb 15, 2006
HOSPIRA INC EQ 1GM BASE/VIAL A065231 001 Aug 02, 2005
EQ 1GM BASE/VIAL A202563 001 Aug 20, 2012
EQ 2GM BASE/VIAL A065231 002 Aug 02, 2005
EQ 2GM BASE/VIAL A202563 002 Aug 20, 2012
EQ 10GM BASE/VIAL A065232 001 Aug 02, 2005
LUPIN EQ 10GM BASE/VIAL A065263 001 Sep 12, 2006
TEVA EQ 10GM BASE/VIAL A065274 001 May 01, 2006
ROCEPHIN
HOFFMANN LA ROCHE EQ 250MG BASE/VIAL A063239 001 Aug 13, 1993
EQ 500MG BASE/VIAL A062654 001 Apr 30, 1987
EQ 500MG BASE/VIAL A063239 002 Aug 13, 1993
EQ 1GM BASE/VIAL A062654 002 Apr 30, 1987
EQ 1GM BASE/VIAL A063239 003 Aug 13, 1993
EQ 2GM BASE/VIAL A062654 003 Apr 30, 1987
+ EQ 10GM BASE/VIAL ** N050585 005 Dec 21, 1984
ROCHE EQ 250MG BASE/VIAL A062510 001 Mar 12, 1985
EQ 500MG BASE/VIAL A062510 002 Mar 12, 1985
EQ 1GM BASE/VIAL A062510 003 Mar 12, 1985
ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER
+ HOFFMANN LA ROCHE EQ 10MG BASE/ML ** N050624 001 Feb 11, 1987
+ EQ 20MG BASE/ML ** N050624 002 Feb 11, 1987
+ EQ 40MG BASE/ML ** N050624 003 Feb 11, 1987
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS
CEFTRIAXONE
AUROBINDO PHARMA LTD EQ 250MG BASE/VIAL A065505 001 Jul 31, 2008
EQ 500MG BASE/VIAL A065505 002 Jul 31, 2008
EQ 1GM BASE/VIAL A065505 003 Jul 31, 2008
EQ 2GM BASE/VIAL A065505 004 Jul 31, 2008
BEDFORD EQ 250MG BASE/VIAL A065465 001 Aug 18, 2008
EQ 500MG BASE/VIAL A065465 002 Aug 18, 2008
EQ 1GM BASE/VIAL A065465 003 Aug 18, 2008
EQ 2GM BASE/VIAL A065465 004 Aug 18, 2008
CEPHAZONE PHARMA EQ 250MG BASE/VIAL A065294 001 Mar 26, 2007
EQ 500MG BASE/VIAL A065294 002 Mar 26, 2007
EQ 1GM BASE/VIAL A065294 003 Mar 26, 2007
EQ 2GM BASE/VIAL A065294 004 Mar 26, 2007
FACTA FARMA EQ 1GM BASE/VIAL A065268 001 Feb 28, 2007

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-95(of 478)
** See List Footnote
CEFTRIAXONE SODIUM
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS
CEFTRIAXONE
EQ 2GM BASE/VIAL A065268 002 Feb 28, 2007
FRESENIUS KABI USA EQ 250MG BASE/VIAL A065245 001 Feb 15, 2006
EQ 500MG BASE/VIAL A065245 002 Feb 15, 2006
EQ 1GM BASE/VIAL A065245 003 Feb 15, 2006
EQ 2GM BASE/VIAL A065245 004 Feb 15, 2006
HOSPIRA INC EQ 250MG BASE/VIAL A065230 001 Aug 02, 2005
EQ 500MG BASE/VIAL A065230 002 Aug 02, 2005
EQ 1GM BASE/VIAL A065230 003 Aug 02, 2005
EQ 2GM BASE/VIAL A065230 004 Aug 02, 2005
LUPIN EQ 250MG BASE/VIAL A065125 001 Sep 30, 2003
EQ 500MG BASE/VIAL A065125 002 Sep 30, 2003
EQ 1GM BASE/VIAL A065125 003 Sep 30, 2003
EQ 2GM BASE/VIAL A065125 004 Sep 30, 2003
TEVA EQ 1GM BASE/VIAL A065262 001 Jun 29, 2006
EQ 2GM BASE/VIAL A065262 002 Jun 29, 2006
TEVA PHARMS USA EQ 250MG BASE/VIAL A065227 001 Mar 15, 2007
EQ 500MG BASE/VIAL A065227 002 Mar 15, 2007
EQ 1GM BASE/VIAL A065227 003 Mar 15, 2007
EQ 2GM BASE/VIAL A065227 004 Mar 15, 2007
ROCEPHIN
+ HOFFMANN LA ROCHE EQ 250MG BASE/VIAL ** N050585 001 Dec 21, 1984
+ EQ 500MG BASE/VIAL ** N050585 002 Dec 21, 1984
+ EQ 1GM BASE/VIAL ** N050585 003 Dec 21, 1984
+ EQ 2GM BASE/VIAL ** N050585 004 Dec 21, 1984
CEFTRIAXONE SODIUM; LIDOCAINE
INJECTABLE;INJECTION
ROCEPHIN KIT
HOFFMANN LA ROCHE EQ 500MG BASE/VIAL,N/A;N/A,1% N050585 007 May 08, 1996
EQ 1GM BASE/VIAL,N/A;N/A,1% N050585 006 May 08, 1996
CEFUROXIME AXETIL
FOR SUSPENSION;ORAL
CEFTIN
+ GLAXOSMITHKLINE EQ 125MG BASE/5ML N050672 001 Jun 30, 1994
+ EQ 250MG BASE/5ML N050672 002 Apr 29, 1997
CEFUROXIME AXETIL
SUN PHARM INDS LTD EQ 125MG BASE/5ML A065323 001 Feb 05, 2008
EQ 250MG BASE/5ML A065323 002 Feb 05, 2008
TABLET;ORAL
CEFTIN
+ GLAXOSMITHKLINE EQ 125MG BASE ** N050605 001 Dec 28, 1987
+ EQ 250MG BASE ** N050605 002 Dec 28, 1987
+ EQ 500MG BASE ** N050605 003 Dec 28, 1987
CEFUROXIME AXETIL
ANI PHARMS EQ 250MG BASE A065190 001 Oct 18, 2004
EQ 500MG BASE A065190 002 Oct 18, 2004
FOSUN PHARMA EQ 250MG BASE A065126 001 Oct 28, 2003
EQ 500MG BASE A065126 002 Oct 28, 2003
RANBAXY LABS LTD EQ 125MG BASE A065043 003 Feb 15, 2002
EQ 250MG BASE A065043 002 Feb 15, 2002
EQ 500MG BASE A065043 001 Feb 15, 2002
SUN PHARM INDS LTD EQ 125MG BASE A065118 001 Apr 25, 2003
EQ 250MG BASE A065118 002 Apr 25, 2003
EQ 500MG BASE A065118 003 Apr 25, 2003
CEFUROXIME SODIUM
INJECTABLE;INJECTION
CEFUROXIME SODIUM
FRESENIUS KABI USA EQ 1.5GM BASE/VIAL A065001 002 May 30, 2001
EQ 7.5GM BASE/VIAL A065002 001 Sep 28, 1998
HOSPIRA INC EQ 1.5GM BASE/VIAL A065483 002 Oct 15, 2008
EQ 1.5GM BASE/VIAL A065503 001 Oct 15, 2008
EQ 7.5GM BASE/VIAL A065484 001 Oct 15, 2008
TEVA PHARMS EQ 7.5GM BASE/VIAL A064191 001 Apr 16, 1998
WATSON LABS INC EQ 1.5GM BASE/VIAL A064035 002 Feb 26, 1993
EQ 7.5GM BASE/VIAL A064036 001 Feb 26, 1993

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-96(of 478)
** See List Footnote
CEFUROXIME SODIUM
INJECTABLE;INJECTION
CEFUROXIME SODIUM IN PLASTIC CONTAINER
SAMSON MEDCL EQ 75GM BASE/VIAL A065251 001 Dec 30, 2009
EQ 225GM BASE/VIAL A065251 002 Dec 30, 2009
KEFUROX
ACS DOBFAR EQ 1.5GM BASE/VIAL A062591 002 Jan 10, 1986
EQ 7.5GM BASE/VIAL A062591 003 Dec 17, 1987
LILLY EQ 1.5GM BASE/VIAL A062592 002 Jan 10, 1986
KEFUROX IN PLASTIC CONTAINER
LILLY EQ 1.5GM BASE/VIAL A062590 002 Jan 10, 1986
ZINACEF IN PLASTIC CONTAINER
PAI HOLDINGS PHARM EQ 15MG BASE/ML N050643 001 Apr 28, 1989
+ EQ 30MG BASE/ML N050643 002 Apr 28, 1989
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS
CEFUROXIME SODIUM
FRESENIUS KABI USA EQ 750MG BASE/VIAL A065001 001 May 30, 2001
HOSPIRA INC EQ 750MG BASE/VIAL A065483 001 Oct 15, 2008
TEVA PHARMS EQ 750MG BASE/VIAL A064192 002 Apr 16, 1998
EQ 1.5GM BASE/VIAL A064192 001 Apr 16, 1998
WATSON LABS INC EQ 750MG BASE/VIAL A064035 001 Feb 26, 1993
KEFUROX
ACS DOBFAR EQ 750MG BASE/VIAL A062591 001 Jan 10, 1986
INJECTABLE;INTRAVENOUS
KEFUROX
LILLY EQ 750MG BASE/VIAL A062592 001 Jan 10, 1986
KEFUROX IN PLASTIC CONTAINER
LILLY EQ 750MG BASE/VIAL A062590 001 Jan 10, 1986
CELECOXIB
CAPSULE;ORAL
CELECOXIB
ACIC PHARMS 200MG A212925 001 Dec 09, 2020
400MG A212925 002 Dec 09, 2020
JUBILANT GENERICS 50MG A207061 001 Apr 04, 2017
100MG A207061 002 Apr 04, 2017
200MG A207061 003 Apr 04, 2017
400MG A207061 004 Apr 04, 2017
UNICHEM 50MG A213301 001 Jan 12, 2021
100MG A213301 002 Jan 12, 2021
200MG A213301 003 Jan 12, 2021
400MG A213301 004 Jan 12, 2021
SOLUTION;ORAL
ELYXYB
+ BDSI 25MG/ML N212157 001 May 05, 2020
CELLULOSE SODIUM PHOSPHATE
POWDER;ORAL
CALCIBIND
MISSION PHARMA 2.5GM/PACKET N018757 002 Dec 28, 1982
300GM/BOT N018757 003 Oct 16, 1984
CEPHALEXIN
CAPSULE;ORAL
CEPHALEXIN
APOTHECON EQ 250MG BASE A062973 001 Nov 08, 1988
EQ 250MG BASE A063063 001 Sep 29, 1989
EQ 250MG BASE A063186 001 Dec 30, 1994
EQ 500MG BASE A062974 001 Nov 23, 1988
EQ 500MG BASE A063063 002 Sep 29, 1989
EQ 500MG BASE A063186 002 Dec 30, 1994
BARR EQ 250MG BASE A062773 001 Jun 26, 1987
EQ 500MG BASE A062775 001 Apr 22, 1987
FACTA FARMA EQ 250MG BASE A062118 001
EQ 500MG BASE A062118 002
IVAX SUB TEVA PHARMS EQ 250MG BASE A061969 001
EQ 500MG BASE A061969 002
PUREPAC PHARM EQ 250MG BASE A062809 001 Apr 22, 1987
EQ 500MG BASE A062809 002 Apr 22, 1987
STEVENS J EQ 250MG BASE A062870 001 Mar 17, 1988
EQ 500MG BASE A062869 001 Mar 17, 1988

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-97(of 478)
** See List Footnote
CEPHALEXIN
CAPSULE;ORAL
CEPHALEXIN
SUN PHARM INDS (IN) EQ 250MG BASE A062791 001 Jun 11, 1987
EQ 500MG BASE A062791 002 Jun 11, 1987
SUN PHARM INDS LTD EQ 250MG BASE A065007 001 Sep 16, 1999
EQ 500MG BASE A065007 002 Sep 16, 1999
TEVA EQ 250MG BASE A062760 001 Apr 24, 1987
EQ 250MG BASE A062821 001 Feb 05, 1988
EQ 500MG BASE A062761 001 Apr 24, 1987
EQ 500MG BASE A062823 001 Feb 05, 1988
YOSHITOMI EQ 250MG BASE A062872 001 Jun 20, 1988
EQ 500MG BASE A062871 001 Jul 05, 1988
KEFLEX
+ PRAGMA EQ 250MG BASE ** N050405 002
+ EQ 333MG BASE ** N050405 004 May 12, 2006
+ EQ 500MG BASE ** N050405 003
+ EQ 750MG BASE ** N050405 005 May 12, 2006
FOR SUSPENSION;ORAL
CEPHALEXIN
APOTHECON EQ 125MG BASE/5ML A062986 001 Apr 18, 1991
EQ 250MG BASE/5ML A062987 001 Jul 25, 1989
BARR EQ 125MG BASE/5ML A062778 001 Aug 06, 1987
EQ 250MG BASE/5ML A062777 001 Aug 06, 1987
CHARTWELL RX EQ 125MG BASE/5ML A065326 001 Jul 10, 2006
EQ 250MG BASE/5ML A065326 002 Jul 10, 2006
FACTA FARMA EQ 100MG BASE/ML ** A062117 001
EQ 125MG BASE/5ML ** A062117 002
EQ 250MG BASE/5ML ** A062117 003
HIKMA PHARMS EQ 125MG BASE/5ML A065444 001 Aug 28, 2009
EQ 250MG BASE/5ML A065444 002 Aug 28, 2009
SUN PHARM INDS LTD EQ 125MG BASE/5ML A065081 001 Jul 27, 2001
EQ 250MG BASE/5ML A065081 002 Jul 27, 2001
TEVA EQ 125MG BASE/5ML A062767 001 Jun 16, 1987
EQ 125MG BASE/5ML A062873 001 May 23, 1988
EQ 250MG BASE/5ML A062768 001 Jun 16, 1987
EQ 250MG BASE/5ML A062867 001 Apr 15, 1988
VITARINE EQ 125MG BASE/5ML A062779 001 Dec 22, 1987
EQ 250MG BASE/5ML A062781 001 Dec 22, 1987
KEFLEX
+ PRAGMA EQ 100MG BASE/ML ** N050406 003
+ EQ 125MG BASE/5ML ** N050406 001
+ EQ 250MG BASE/5ML ** N050406 002
TABLET;ORAL
CEPHALEXIN
BARR EQ 250MG BASE A062826 001 Aug 17, 1987
EQ 500MG BASE A062827 001 Aug 17, 1987
VITARINE EQ 250MG BASE A062863 001 Aug 11, 1988
EQ 500MG BASE A062863 002 Aug 11, 1988
EQ 1GM BASE A062863 003 Aug 11, 1988
KEFLET
LILLY EQ 250MG BASE A062745 001 Dec 01, 1986
EQ 250MG BASE N050440 003 Feb 26, 1987
EQ 500MG BASE A062745 002 Dec 01, 1986
EQ 500MG BASE N050440 001
EQ 1GM BASE N050440 002
TABLET, FOR SUSPENSION;ORAL
PANIXINE DISPERDOSE
RANBAXY LABS LTD EQ 125MG BASE A065100 002 Sep 11, 2003
EQ 250MG BASE A065100 001 Sep 11, 2003
CEPHALEXIN HYDROCHLORIDE
TABLET;ORAL
KEFTAB
LILLY EQ 250MG BASE N050614 001 Oct 29, 1987
EQ 333MG BASE N050614 003 May 16, 1988
EQ 500MG BASE N050614 002 Oct 29, 1987

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-98(of 478)
** See List Footnote
CEPHALOGLYCIN
CAPSULE;ORAL
KAFOCIN
LILLY 250MG N050219 001
CEPHALOTHIN SODIUM
INJECTABLE;INJECTION
CEPHALOTHIN
INTL MEDICATION EQ 500MG BASE/VIAL A062426 001 May 03, 1985
EQ 1GM BASE/VIAL A062426 002 May 03, 1985
EQ 2GM BASE/VIAL A062426 003 May 03, 1985
EQ 4GM BASE/VIAL A062426 004 May 03, 1985
CEPHALOTHIN SODIUM
ABBOTT EQ 1GM BASE/VIAL A062547 001 Sep 11, 1985
EQ 1GM BASE/VIAL A062548 001 Sep 11, 1985
EQ 2GM BASE/VIAL A062547 002 Sep 11, 1985
EQ 2GM BASE/VIAL A062548 002 Sep 11, 1985
ABRAXIS PHARM EQ 1GM BASE/VIAL A062666 002 Jun 10, 1987
EQ 2GM BASE/VIAL A062666 001 Jun 10, 1987
BRISTOL EQ 1GM BASE/VIAL A062464 001 May 07, 1984
EQ 2GM BASE/VIAL A062464 002 May 07, 1984
EQ 4GM BASE/VIAL A062464 003 May 07, 1984
CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER
BAXTER HLTHCARE EQ 20MG BASE/ML A062422 003 Jan 31, 1984
EQ 20MG BASE/ML A062422 005 Jul 16, 1991
EQ 20MG BASE/ML A062730 001 Mar 05, 1987
EQ 40MG BASE/ML A062422 004 Jan 31, 1984
EQ 40MG BASE/ML A062422 006 Jul 16, 1991
EQ 40MG BASE/ML A062730 002 Mar 05, 1987
CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER
BAXTER HLTHCARE EQ 20MG BASE/ML A062422 001 Jan 31, 1984
EQ 40MG BASE/ML A062422 002 Jan 31, 1984
KEFLIN
LILLY EQ 1GM BASE/VIAL N050482 001
EQ 2GM BASE/VIAL N050482 002
EQ 4GM BASE/VIAL N050482 003
EQ 20GM BASE/VIAL N050482 007
KEFLIN IN PLASTIC CONTAINER
LILLY EQ 1GM BASE/VIAL A062549 001 Sep 10, 1985
EQ 2GM BASE/VIAL A062549 002 Sep 10, 1985
SEFFIN
GLAXOSMITHKLINE EQ 1GM BASE/VIAL A062435 001 Nov 15, 1983
EQ 2GM BASE/VIAL A062435 002 Nov 15, 1983
EQ 10GM BASE/VIAL A062435 003 Nov 15, 1983
CEPHAPIRIN SODIUM
INJECTABLE;INJECTION
CEFADYL
APOTHECON EQ 500MG BASE/VIAL A062961 001 Sep 20, 1988
EQ 500MG BASE/VIAL N050446 005
EQ 1GM BASE/VIAL A061769 001
EQ 1GM BASE/VIAL A062724 001 Dec 23, 1986
EQ 1GM BASE/VIAL A062961 002 Sep 20, 1988
EQ 1GM BASE/VIAL N050446 001
EQ 2GM BASE/VIAL A061769 002
EQ 2GM BASE/VIAL A062724 002 Dec 23, 1986
EQ 2GM BASE/VIAL A062961 003 Sep 20, 1988
EQ 2GM BASE/VIAL N050446 002
EQ 4GM BASE/VIAL A061769 003
EQ 4GM BASE/VIAL A062961 004 Sep 20, 1988
EQ 4GM BASE/VIAL N050446 003
EQ 20GM BASE/VIAL N050446 004
CEPHAPIRIN SODIUM
ABRAXIS PHARM EQ 500MG BASE/VIAL A062723 001 Nov 17, 1986
EQ 1GM BASE/VIAL A062723 002 Nov 17, 1986
EQ 2GM BASE/VIAL A062723 003 Nov 17, 1986
EQ 4GM BASE/VIAL A062723 004 Nov 17, 1986
EQ 20GM BASE/VIAL A062723 005 Nov 17, 1986
HIKMA EQ 500MG BASE/VIAL A062720 001 Jul 02, 1987
EQ 1GM BASE/VIAL A062720 002 Jul 02, 1987

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-99(of 478)
** See List Footnote
CEPHAPIRIN SODIUM
INJECTABLE;INJECTION
CEPHAPIRIN SODIUM
EQ 2GM BASE/VIAL A062720 003 Jul 02, 1987
EQ 20GM BASE/VIAL A062720 004 Jul 02, 1987
CEPHRADINE
CAPSULE;ORAL
ANSPOR
GLAXOSMITHKLINE 250MG A061859 001
500MG A061859 002
CEPHRADINE
BARR 250MG A062850 001 Apr 22, 1988
500MG A062851 001 Apr 22, 1988
IVAX SUB TEVA PHARMS 250MG A062762 001 Mar 06, 1987
500MG A062762 002 Mar 06, 1987
TEVA 250MG A062683 001 Jan 09, 1987
500MG A062683 002 Jan 09, 1987
VITARINE 250MG A062813 001 Feb 25, 1988
500MG A062813 002 Feb 25, 1988
VELOSEF
APOTHECON 250MG A061764 001
500MG A061764 002
VELOSEF '250'
ERSANA 250MG N050548 001
VELOSEF '500'
ERSANA 500MG N050548 002
FOR SUSPENSION;ORAL
ANSPOR
GLAXOSMITHKLINE 125MG/5ML A061866 001
250MG/5ML A061866 002
CEPHRADINE
BARR 125MG/5ML A062858 001 May 19, 1988
250MG/5ML A062859 001 May 19, 1988
TEVA 125MG/5ML A062693 001 Jan 09, 1987
250MG/5ML A062693 002 Jan 09, 1987
VELOSEF '125'
APOTHECON 125MG/5ML A061763 001
VELOSEF '250'
APOTHECON 250MG/5ML A061763 002
INJECTABLE;INJECTION
VELOSEF
APOTHECON 250MG/VIAL A061976 001
500MG/VIAL A061976 002
1GM/VIAL A061976 004
2GM/VIAL A061976 003
4GM/VIAL A061976 005
TABLET;ORAL
VELOSEF
BRISTOL MYERS SQUIBB 1GM N050530 001
CERITINIB
CAPSULE;ORAL
ZYKADIA
+ NOVARTIS 150MG N205755 001 Apr 29, 2014
CERIVASTATIN SODIUM
TABLET;ORAL
BAYCOL
BAYER PHARMS 0.05MG N020740 001 Jun 26, 1997
0.1MG N020740 002 Jun 26, 1997
0.2MG N020740 003 Jun 26, 1997
0.3MG N020740 004 Jun 26, 1997
0.4MG N020740 005 May 24, 1999
0.8MG N020740 006 Jul 24, 2000

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-100(of 478)
** See List Footnote
CERULETIDE DIETHYLAMINE
INJECTABLE;INJECTION
TYMTRAN
PHARMACIA AND UPJOHN 0.02MG/ML N018296 001
CETIRIZINE HYDROCHLORIDE
SYRUP;ORAL
CETIRIZINE HYDROCHLORIDE
ACTAVIS MID ATLANTIC 5MG/5ML A078617 001 Feb 02, 2010
AUROBINDO PHARMA LTD 5MG/5ML A090751 001 Dec 16, 2009
LANNETT CO INC 5MG/5ML A078496 001 Sep 25, 2009
PHARM ASSOC 5MG/5ML A078412 001 Jun 18, 2008
RANBAXY LABS LTD 5MG/5ML A077472 001 Jun 18, 2008
TORRENT 5MG/5ML A078870 001 Apr 27, 2009
WOCKHARDT 5MG/5ML A078757 001 Aug 28, 2009
CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
CHARTWELL RX 5MG/5ML A090378 002 May 09, 2008
CYPRESS PHARM 5MG/5ML A090300 001 Oct 10, 2008
PHARM ASSOC 5MG/5ML A090188 002 Apr 22, 2008
RANBAXY LABS LTD 5MG/5ML A090183 002 Apr 24, 2008
TORRENT 5MG/5ML A090474 002 Mar 30, 2009
TRIS PHARMA INC 5MG/5ML A090572 001 Nov 16, 2012
CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
CHARTWELL RX 5MG/5ML A090378 001 May 09, 2008
CYPRESS PHARM 5MG/5ML A090300 002 Oct 10, 2008
PHARM ASSOC 5MG/5ML A090188 001 Apr 22, 2008
RANBAXY LABS LTD 5MG/5ML A090183 001 Apr 24, 2008
TORRENT 5MG/5ML A090474 001 Mar 30, 2009
TRIS PHARMA INC 5MG/5ML A090572 002 Nov 16, 2012
ZYRTEC
J AND J CONSUMER INC 5MG/5ML ** N020346 001 Sep 27, 1996
TABLET;ORAL
CETIRIZINE HYDROCHLORIDE ALLERGY
CIPLA LTD 5MG A077318 001 Jul 25, 2013
10MG A077318 002 Jul 25, 2013
HERITAGE PHARMA 5MG A078615 003 Dec 28, 2007
10MG A078615 004 Dec 28, 2007
SUN PHARM INDS INC 5MG A077499 001 Dec 27, 2007
10MG A077499 002 Dec 27, 2007
TORRENT PHARMS LLC 5MG A079191 001 Apr 15, 2010
10MG A079191 004 Apr 15, 2010
UNICHEM 5MG A078680 003 Jun 26, 2009
10MG A078680 004 Jun 26, 2009
CETIRIZINE HYDROCHLORIDE HIVES
SUN PHARM INDS INC 5MG A077499 003 Dec 27, 2007
10MG A077499 004 Dec 27, 2007
UNICHEM 5MG A078680 001 Jun 26, 2009
10MG A078680 002 Jun 26, 2009
CETIRIZINE HYDROCHLORIDE HIVES RELIEF
TORRENT PHARMS LLC 5MG A079191 003 Apr 15, 2010
10MG A079191 002 Apr 15, 2010
ZYRTEC ALLERGY
+ J AND J CONSUMER INC 5MG N019835 003 Nov 16, 2007
ZYRTEC HIVES RELIEF
+ J AND J CONSUMER INC 5MG N019835 005 Nov 16, 2007
+ 10MG N019835 006 Nov 16, 2007
TABLET, CHEWABLE;ORAL
CETIRIZINE HYDROCHLORIDE ALLERGY
SUN PHARM INDS INC 5MG A077631 004 Jan 11, 2008
10MG A077631 003 Jan 11, 2008
CETIRIZINE HYDROCHLORIDE HIVES RELIEF
SUN PHARM INDS INC 5MG A077631 001 Jan 11, 2008
10MG A077631 002 Jan 11, 2008
CHILDREN'S ZYRTEC ALLERGY
+ J AND J CONSUMER INC 5MG ** N021621 003 Nov 16, 2007
CHILDREN'S ZYRTEC HIVES RELIEF
+ J AND J CONSUMER INC 5MG ** N021621 005 Nov 16, 2007
+ 10MG ** N021621 006 Nov 16, 2007

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-101(of 478)
** See List Footnote
CETRORELIX ACETATE
POWDER;SUBCUTANEOUS
CETROTIDE
+ EMD SERONO INC EQ 3MG BASE/VIAL N021197 002 Aug 11, 2000
CETYL ALCOHOL; COLFOSCERIL PALMITATE; TYLOXAPOL
FOR SUSPENSION;INTRATRACHEAL
EXOSURF NEONATAL
GLAXOSMITHKLINE 12MG/VIAL;108MG/VIAL;8MG/VIAL N020044 001 Aug 02, 1990
CEVIMELINE HYDROCHLORIDE
CAPSULE;ORAL
CEVIMELINE HYDROCHLORIDE
APOTEX INC 30MG A091260 001 Aug 25, 2011
CHENODIOL
TABLET;ORAL
CHENIX
+ LEADIANT BIOSCI INC 250MG ** N018513 002 Jul 28, 1983
CHLOPHEDIANOL HYDROCHLORIDE
SYRUP;ORAL
ULO
3M 25MG/5ML N012126 001
CHLORAMPHENICOL
CREAM;TOPICAL
CHLOROMYCETIN
PARKE DAVIS 1% N050183 001
FOR SOLUTION;OPHTHALMIC
CHLOROMYCETIN
PARKEDALE 25MG/VIAL N050143 001
INJECTABLE;INJECTION
CHLOROMYCETIN
PARKE DAVIS 250MG/ML N050153 001
OINTMENT;OPHTHALMIC
CHLORAMPHENICOL
ALTANA 1% A060133 001
CHLOROFAIR
PHARMAFAIR 1% A062439 001 Apr 21, 1983
CHLOROMYCETIN
PARKEDALE 1% N050156 001
CHLOROPTIC S.O.P.
ALLERGAN 1% A061187 001
ECONOCHLOR
ALCON 1% A061648 001
SOLUTION/DROPS;OPHTHALMIC
CHLORAMPHENICOL
AKORN 0.5% A062042 001
ALCON 0.5% A062628 001 Sep 25, 1985
CHLOROFAIR
PHARMAFAIR 0.5% A062437 001 Apr 14, 1983
CHLOROPTIC
ALLERGAN 0.5% N050091 001
ECONOCHLOR
ALCON 0.5% A061645 001
OPHTHOCHLOR
PARKEDALE 0.5% A061220 001
OPTOMYCIN
OPTOPICS 0.5% A062171 001 Mar 31, 1982
SOLUTION/DROPS;OTIC
CHLOROMYCETIN
PARKEDALE 0.5% N050205 001
CHLORAMPHENICOL SODIUM SUCCINATE
INJECTABLE;INJECTION
CHLORAMPHENICOL
ELKINS SINN EQ 1GM BASE/VIAL A062406 001 Nov 09, 1982
CHLORAMPHENICOL SODIUM SUCCINATE
GRUPPO LEPETIT EQ 1GM BASE/VIAL A062278 001
CHLOROMYCETIN
+ PARKEDALE EQ 1GM BASE/VIAL N050155 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-102(of 478)
** See List Footnote
CHLORAMPHENICOL SODIUM SUCCINATE
INJECTABLE;INJECTION
MYCHEL-S
ANGUS EQ 1GM BASE/VIAL A060132 001
CHLORAMPHENICOL; HYDROCORTISONE ACETATE
FOR SUSPENSION;OPHTHALMIC
CHLOROMYCETIN HYDROCORTISONE
PARKEDALE 12.5MG/VIAL;25MG/VIAL N050202 001
CHLORAMPHENICOL; HYDROCORTISONE ACETATE; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
OPHTHOCORT
PARKEDALE 10MG/GM;5MG/GM;10,000 UNITS/GM N050201 002
CHLORAMPHENICOL; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
CHLOROMYXIN
PARKE DAVIS 1%;10,000 UNITS/GM N050203 002
CHLORAMPHENICOL; PREDNISOLONE
OINTMENT;OPHTHALMIC
CHLOROPTIC-P S.O.P.
ALLERGAN 1%;0.5% A061188 001
CHLORDIAZEPOXIDE
CAPSULE, EXTENDED RELEASE;ORAL
LIBRELEASE
VALEANT PHARM INTL 30MG N017813 001 Sep 12, 1983
TABLET;ORAL
LIBRITABS
VALEANT PHARM INTL 5MG A085482 001
10MG A085481 001
25MG A085488 001
CHLORDIAZEPOXIDE HYDROCHLORIDE
CAPSULE;ORAL
A-POXIDE
ABBOTT 5MG A085447 001
5MG A085517 001
10MG A085447 002
10MG A085518 001
25MG A085447 003
25MG A085513 001
CHLORDIAZACHEL
RACHELLE 5MG A085086 001
10MG A084639 001
25MG A085087 001
CHLORDIAZEPOXIDE HYDROCHLORIDE
ASCOT 5MG A087525 001 Jan 07, 1982
10MG A087524 001 Jan 07, 1982
25MG A087512 001 Jan 07, 1982
FERRANTE 5MG A085118 001
10MG A085119 001
25MG A085120 001
HALSEY 5MG A085340 001
10MG A085339 001
25MG A084685 001
IMPAX LABS 5MG A086213 001
10MG A085113 001
25MG A086212 001
IVAX SUB TEVA PHARMS 5MG A083741 001
10MG A083742 001
25MG A083570 001
LEDERLE 5MG A086892 001
5MG A087234 001
10MG A086876 001
10MG A087037 001
25MG A086893 001
25MG A087231 001
MAST MM 10MG A086217 001
MYLAN 5MG A084886 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-103(of 478)
** See List Footnote
CHLORDIAZEPOXIDE HYDROCHLORIDE
CAPSULE;ORAL
CHLORDIAZEPOXIDE HYDROCHLORIDE
10MG A084601 001
25MG A084887 001
PARKE DAVIS 5MG A085163 001
10MG A084598 001
25MG A085164 001
PIONEER PHARMS 10MG A089533 001 Jul 15, 1988
25MG A089558 001 Jul 15, 1988
PUREPAC PHARM 5MG A085155 001
10MG A084939 002
25MG A085144 001
ROXANE 5MG A084706 001
10MG A084700 001
25MG A084705 001
SUPERPHARM 5MG A088987 001 Apr 25, 1985
10MG A088986 001 Apr 25, 1985
25MG A088988 001 Apr 25, 1985
TEVA 5MG A088705 001 Jan 18, 1985
10MG A088706 001 Jan 18, 1985
25MG A086494 001
25MG A088707 001 Jan 18, 1985
UPSHER SMITH LABS 5MG A084919 001
+ 10MG A084920 001
25MG A084823 001
USL PHARMA 5MG A084644 001
10MG A084623 001
25MG A084645 001
VANGARD 5MG A088129 001 Mar 28, 1983
10MG A088010 001 Mar 28, 1983
25MG A088130 001 Mar 28, 1983
WATSON LABS 5MG A086383 001
10MG A086294 001
25MG A086382 001
WEST WARD 5MG A085014 001
10MG A085000 001
25MG A085294 001
LIBRIUM
+ VALEANT PHARM INTL 5MG ** N012249 002
+ 10MG ** N012249 001
+ 25MG ** N012249 003
LYGEN
ALRA 5MG A085107 001
10MG A085009 001
25MG A085108 001
INJECTABLE;INJECTION
LIBRIUM
BAUSCH 100MG/AMP N012301 001
CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
CAPSULE;ORAL
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
TEVA PHARMS USA 5MG;2.5MG A211476 001 Nov 02, 2021
CHLORDIAZEPOXIDE; ESTROGENS, ESTERIFIED
TABLET;ORAL
MENRIUM 10-4
ROCHE 10MG;0.4MG N014740 006
MENRIUM 5-2
ROCHE 5MG;0.2MG N014740 002
MENRIUM 5-4
ROCHE 5MG;0.4MG N014740 004
CHLORHEXIDINE GLUCONATE
SOLUTION;DENTAL
CHLORHEXIDINE GLUCONATE
AKORN 0.12% A074356 001 May 07, 1996
PAROEX
SUNSTAR AMERICAS 0.12% A076434 001 Nov 29, 2005

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-104(of 478)
** See List Footnote
CHLORHEXIDINE GLUCONATE
SOLUTION;DENTAL
PERIOGARD
COLGATE PALMOLIVE CO 0.12% A073695 001 Jan 14, 1994
SOLUTION;TOPICAL
BRIAN CARE
SOAPCO 4% A071419 001 Dec 17, 1987
EXIDINE
XTTRIUM 2.5% N019421 001 Dec 17, 1985
MICRODERM
J AND J 4% A072255 001 Apr 15, 1991
PREVACARE R
J AND J 0.5% A072292 001 Jan 28, 1992
STERI-STAT
MATRIX MEDCL 4% A070104 001 Jul 24, 1986
SPONGE;TOPICAL
CHLORHEXIDINE GLUCONATE
KENDALL IL 4% N019490 001 Mar 27, 1987
E-Z SCRUB
BECTON DICKINSON 4% A073416 001 Mar 14, 2000
HIBICLENS
+ MOLNLYCKE HLTH 4% ** N018423 001
MICRODERM
J AND J 4% A072295 001 Feb 28, 1991
PHARMASEAL SCRUB CARE
CAREFUSION 2200 4% N019793 001 Dec 02, 1988
TABLET;DENTAL
PERIOCHIP
+ DEXCEL PHARMA 2.5MG N020774 001 May 15, 1998
CHLORMERODRIN HG-197
INJECTABLE;INJECTION
CHLORMERODRIN HG 197
BRACCO 0.6-1.4mCi/ML N017269 001
CHLORMEZANONE
TABLET;ORAL
TRANCOPAL
SANOFI AVENTIS US 100MG N011467 003
200MG N011467 005
CHLOROPROCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
CHLOROPROCAINE HYDROCHLORIDE
HOSPIRA 2% A087447 001 Apr 16, 1982
3% A087446 001 Apr 16, 1982
NESACAINE-MPF
FRESENIUS KABI USA 2% N009435 003
3% N009435 004
CHLOROQUINE HYDROCHLORIDE
INJECTABLE;INJECTION
ARALEN HYDROCHLORIDE
SANOFI AVENTIS US EQ 40MG BASE/ML N006002 002
CHLOROQUINE PHOSPHATE
TABLET;ORAL
ARALEN
+ SANOFI AVENTIS US 500MG ** N006002 001
CHLOROQUINE PHOSPHATE
HIKMA PHARMS 250MG ** A083082 001
500MG ** A083082 002 Sep 17, 1999
MD PHARM 250MG A087228 001
PUREPAC PHARM 250MG A080886 001
TEVA 250MG A087504 001 Jan 13, 1982
WATSON LABS 250MG A087979 001 Dec 21, 1982
500MG A088030 001 Dec 21, 1982

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-105(of 478)
** See List Footnote
CHLOROQUINE PHOSPHATE; PRIMAQUINE PHOSPHATE
TABLET;ORAL
ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATE
SANOFI AVENTIS US EQ 300MG BASE;EQ 45MG BASE N014860 002
CHLOROTHIAZIDE
TABLET;ORAL
CHLOROTHIAZIDE
ABC HOLDING 250MG A085569 001
HIKMA INTL PHARMS 250MG A086028 001 Jul 14, 1982
500MG A087736 001 Jul 14, 1982
LEDERLE 250MG A086940 001
500MG A086938 001
MYLAN 250MG A084217 002
500MG A084217 001
SANDOZ 250MG A085485 001
WATSON LABS 250MG A085165 001
250MG A085173 001
250MG A086795 001 Aug 15, 1983
500MG A084026 001 Sep 01, 1982
500MG A086796 001 Aug 15, 1983
DIURIL
+ AKORN 250MG ** N011145 004
+ 500MG ** N011145 002
CHLOROTHIAZIDE; METHYLDOPA
TABLET;ORAL
ALDOCLOR-150
MERCK 150MG;250MG N016016 001
ALDOCLOR-250
MERCK 250MG;250MG N016016 002
METHYLDOPA AND CHLOROTHIAZIDE
PAR PHARM 150MG;250MG A070783 001 Nov 06, 1987
250MG;250MG A070654 001 Nov 06, 1987
CHLOROTHIAZIDE; RESERPINE
TABLET;ORAL
CHLOROTHIAZIDE AND RESERPINE
HIKMA 250MG;0.125MG A088557 001 Dec 22, 1983
500MG;0.125MG A088365 001 Dec 22, 1983
CHLOROTHIAZIDE W/ RESERPINE
WATSON LABS 250MG;0.125MG A084853 001
500MG;0.125MG A088151 001 Jun 09, 1983
CHLOROTHIAZIDE-RESERPINE
MYLAN 250MG;0.125MG A087744 001 May 06, 1982
500MG;0.125MG A087745 001 May 06, 1982
DIUPRES-250
MERCK 250MG;0.125MG N011635 003 Aug 26, 1987
DIUPRES-500
MERCK 500MG;0.125MG N011635 006 Aug 26, 1987
CHLOROTRIANISENE
CAPSULE;ORAL
CHLOROTRIANISENE
BANNER PHARMACAPS 12MG A084652 001
TACE
SANOFI AVENTIS US 12MG N008102 004
25MG N011444 001
72MG N016235 001
CHLOROXINE
SHAMPOO;TOPICAL
CAPITROL
WESTWOOD SQUIBB 2% N017594 001
CHLORPHENESIN CARBAMATE
TABLET;ORAL
MAOLATE
PAMLAB LLC 400MG N014217 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-106(of 478)
** See List Footnote
CHLORPHENIRAMINE MALEATE
CAPSULE, EXTENDED RELEASE;ORAL
CHLORPHENIRAMINE MALEATE
AUROLIFE PHARMA LLC 12MG A070797 001 Aug 12, 1988
TELDRIN
GLAXOSMITHKLINE 8MG N017369 001
12MG N017369 002
INJECTABLE;INJECTION
CHLOR-TRIMETON
SCHERING PLOUGH 10MG/ML N008826 001
100MG/ML N008794 001
CHLORPHENIRAMINE MALEATE
BEL MAR 10MG/ML A080821 001
ELKINS SINN 10MG/ML A080797 001
WATSON LABS 10MG/ML A083593 001
10MG/ML A086096 001
100MG/ML A086095 001
PYRIDAMAL 100
BEL MAR 100MG/ML A083733 001
SYRUP;ORAL
CHLOR-TRIMETON
SCHERING 2MG/5ML N006921 006
CHLORPHENIRAMINE MALEATE
PHARM ASSOC 2MG/5ML A087520 001 Feb 10, 1982
TABLET;ORAL
ANTAGONATE
BAYER PHARMS 4MG A083381 001
CHLOR-TRIMETON
SCHERING 4MG N006921 002
CHLORPHENIRAMINE MALEATE
ANABOLIC 4MG A083078 001
AUROLIFE PHARMA LLC 4MG A080961 001
BELL PHARMA 4MG A083062 001
ELKINS SINN 4MG A080938 001
IMPAX LABS 4MG A080809 001
IVAX SUB TEVA PHARMS 4MG A080779 001
KV PHARM 4MG A087164 001
LEDERLE 4MG A086941 001
NEWTRON PHARMS 4MG A086519 001
PANRAY 4MG A083243 001
PHARMAVITE 4MG A085104 001
PHARMERAL 4MG A083753 001
PIONEER PHARMS 4MG A088556 001 Jul 13, 1984
PUREPAC PHARM 4MG A086306 001
PVT FORM 4MG A080786 001
ROXANE 4MG A080626 001
SUN PHARM INDUSTRIES 4MG A080700 001
VITARINE 4MG A085837 001
WATSON LABS 4MG A080696 001
4MG A080791 001
4MG A085139 001
WEST WARD 4MG A083787 001
KLOROMIN
HALSEY 4MG A083629 001
PHENETRON
LANNETT 4MG A080846 001
TABLET, EXTENDED RELEASE;ORAL
CHLOR-TRIMETON
+ BAYER HEALTHCARE LLC 8MG ** N007638 001
+ 12MG ** N007638 002
EFIDAC 24 CHLORPHENIRAMINE MALEATE
ALZA 16MG N019746 002 Nov 18, 1994
CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE
SOLUTION;ORAL
HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE
ACELLA 4MG/5ML;5MG/5ML A206891 001 Jun 09, 2017
TRIS PHARMA INC 4MG/5ML;5MG/5ML A206438 001 Jan 27, 2015

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-107(of 478)
** See List Footnote
CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE
SOLUTION;ORAL
VITUZ
+ PERSION 4MG/5ML;5MG/5ML N204307 001 Feb 20, 2013
CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
SOLUTION;ORAL
HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
MAYNE PHARMA INC 4MG/5ML;5MG/5ML;60MG/5ML A205657 001 Aug 03, 2015
TORRENT 4MG/5ML;5MG/5ML;60MG/5ML A206660 001 May 15, 2017
TRIS PHARMA INC 4MG/5ML;5MG/5ML;60MG/5ML A203838 001 Nov 26, 2014
ZUTRIPRO
+ PERSION 4MG/5ML;5MG/5ML;60MG/5ML ** N022439 001 Jun 08, 2011
CHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
COLD CAPSULE IV
GRAHAM DM 12MG;75MG N018793 001 Apr 25, 1985
COLD CAPSULE V
GRAHAM DM 8MG;75MG N018794 001 Apr 23, 1985
TABLET, EXTENDED RELEASE;ORAL
TRIAMINIC-12
NOVARTIS 12MG;75MG N018115 001
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
CODIMAL-L.A. 12
SCHWARZ PHARMA 12MG;120MG N018935 001 Apr 15, 1985
ISOCLOR
FISONS 8MG;120MG N018747 001 Mar 06, 1986
PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE
CENT PHARMS 8MG;120MG N019428 001 Aug 02, 1988
GRAHAM DM 8MG;120MG N018844 001 Mar 20, 1985
12MG;120MG N018843 001 Mar 18, 1985
KV PHARM 12MG;120MG A071455 001 Mar 01, 1989
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
TABLET, EXTENDED RELEASE;ORAL
CHLOR-TRIMETON
+ BAYER HEALTHCARE LLC 8MG;120MG N018397 001
CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
SUSPENSION, EXTENDED RELEASE;ORAL
CODEPREX
LANNETT CO INC EQ 4MG MALEATE/5ML;EQ 20MG BASE/5ML N021369 001 Jun 21, 2004
PENNTUSS
FISONS EQ 4MG MALEATE/5ML;EQ 10MG BASE/5ML N018928 001 Aug 14, 1985
TUZISTRA XR
+ TRIS PHARMA INC EQ 2.8MG BASE/5ML;EQ 14.7MG BASE/5ML N207768 001 Apr 30, 2015
CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX
CAPSULE, EXTENDED RELEASE;ORAL
TUSSICAPS
ECR PHARMA EQ 4MG MALEATE;EQ 5MG BITARTRATE A077273 002 Sep 24, 2007
EQ 8MG MALEATE;EQ 10MG BITARTRATE A077273 001 Sep 24, 2007
SUSPENSION, EXTENDED RELEASE;ORAL
HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX
NEOS THERAPS INC EQ 8MG MALEATE/5ML;EQ 10MG A091671 001 Jun 29, 2012
BITARTRATE/5ML
TUSSIONEX PENNKINETIC
+ UCB INC EQ 8MG MALEATE/5ML;EQ 10MG N019111 001 Dec 31, 1987
BITARTRATE/5ML **
CHLORPHENTERMINE HYDROCHLORIDE
TABLET;ORAL
PRE-SATE
PARKE DAVIS EQ 65MG BASE N014696 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-108(of 478)
** See List Footnote
CHLORPROMAZINE
SUPPOSITORY;RECTAL
THORAZINE
+ GLAXOSMITHKLINE 25MG ** N009149 024
+ 100MG ** N009149 033
CHLORPROMAZINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
THORAZINE
GLAXOSMITHKLINE 30MG N011120 016
75MG N011120 017
150MG N011120 018
200MG N011120 019
300MG N011120 020
CONCENTRATE;ORAL
CHLORPROMAZINE HYDROCHLORIDE
ACTAVIS MID ATLANTIC 100MG/ML A086863 001
PHARM ASSOC 30MG/ML A040231 001 Dec 30, 1999
100MG/ML A040224 001 Jan 26, 1999
WOCKHARDT 30MG/ML A087032 001 Jul 08, 1982
100MG/ML A087053 001
CHLORPROMAZINE HYDROCHLORIDE INTENSOL
HIKMA 30MG/ML A088157 001 Apr 27, 1983
100MG/ML A088158 001 Apr 27, 1983
SONAZINE
FOSUN PHARMA 30MG/ML A080983 004
100MG/ML A080983 005
THORAZINE
+ GLAXOSMITHKLINE 30MG/ML ** N009149 032
+ 100MG/ML ** N009149 043
INJECTABLE;INJECTION
CHLORPROMAZINE HYDROCHLORIDE
ABRAXIS PHARM 25MG/ML A084911 001
DR REDDYS 25MG/ML A080365 001
MARSAM PHARMS LLC 25MG/ML A089563 001 Apr 15, 1988
WATSON LABS 25MG/ML A085591 001
WYETH AYERST 25MG/ML A080370 001
THORAZINE
+ GLAXOSMITHKLINE 25MG/ML ** N009149 011
SYRUP;ORAL
CHLORPROMAZINE HYDROCHLORIDE
ALPHARMA US PHARMS 10MG/5ML A086712 001
SONAZINE
FOSUN PHARMA 10MG/5ML A083040 001
THORAZINE
+ GLAXOSMITHKLINE 10MG/5ML ** N009149 022
TABLET;ORAL
CHLORPROMAZINE HYDROCHLORIDE
ABBOTT 10MG A084414 001
25MG A084415 001
50MG A084411 001
100MG A084412 001
200MG A084413 001
APPCO 10MG A213590 001 Aug 31, 2020
25MG A213590 002 Aug 31, 2020
50MG A213590 003 Aug 31, 2020
100MG A213590 004 Aug 31, 2020
200MG A213590 005 Aug 31, 2020
CYCLE 10MG A085331 001
25MG A085331 002
50MG A085331 003
100MG A085331 004
200MG A085331 005
IVAX SUB TEVA PHARMS 10MG A083549 001
25MG A083549 002
50MG A083549 003
100MG A083574 001
200MG A083575 001
KV PHARM 10MG A085750 002 Jan 04, 1982
25MG A085751 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-109(of 478)
** See List Footnote
CHLORPROMAZINE HYDROCHLORIDE
TABLET;ORAL
CHLORPROMAZINE HYDROCHLORIDE
50MG A085484 001
100MG A085752 001
200MG A085748 002 Jan 04, 1982
LEDERLE 10MG A084803 001
25MG A084801 001
50MG A084800 001
100MG A084789 001
200MG A084802 001
PUREPAC PHARM 10MG A080403 004
25MG A080403 001
50MG A080403 002
100MG A080403 003
200MG A080403 005
PVT FORM 25MG A080340 001
50MG A080340 002
200MG A080340 003
SANDOZ 10MG ** A080439 001
25MG ** A080439 002
50MG ** A080439 003
100MG ** A080439 004
200MG ** A080439 005
VANGARD 10MG A088038 001 Aug 16, 1982
25MG A087645 001
50MG A087646 001
WATSON LABS 10MG A085959 001
25MG A085956 001
50MG A085960 001
100MG A085957 001
200MG A085958 001
WEST WARD 10MG A087783 001 Sep 16, 1982
25MG A087865 001 Sep 16, 1982
50MG A087878 001 Sep 15, 1982
100MG A087884 001 Sep 15, 1982
200MG A087880 001 Sep 16, 1982
PROMAPAR
PARKE DAVIS 10MG A086886 001
25MG A084423 001
50MG A086887 001
100MG A086888 001
200MG A086885 001
THORAZINE
GLAXOSMITHKLINE 10MG ** N009149 002
25MG ** N009149 007
50MG ** N009149 013
100MG ** N009149 018
200MG ** N009149 020
CHLORPROPAMIDE
TABLET;ORAL
CHLORPROPAMIDE
ANI PHARMS 100MG A088768 001 Oct 11, 1984
100MG A088812 001 Oct 19, 1984
100MG A088840 001 Oct 25, 1984
100MG A088918 001 Oct 16, 1984
100MG A088921 001 Apr 12, 1985
100MG A089446 001 Nov 17, 1986
250MG A087353 001
250MG A088813 001 Oct 19, 1984
250MG A088826 001 Sep 26, 1984
250MG A088919 001 Oct 16, 1984
250MG A088922 001 Apr 12, 1985
250MG A089447 001 Nov 17, 1986
DAVA PHARMS INC 100MG A089561 001 Sep 04, 1987
250MG A089562 001 Sep 04, 1987
HALSEY 100MG A089321 001 Jan 16, 1986
250MG A088662 001 Jan 09, 1986
MYLAN 100MG A088549 002 Jun 01, 1984

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-110(of 478)
** See List Footnote
CHLORPROPAMIDE
TABLET;ORAL
CHLORPROPAMIDE
250MG A088549 001 Jun 01, 1984
PAR PHARM 100MG A088175 001 Feb 27, 1984
250MG A088176 001 Feb 27, 1984
RISING 100MG A088725 001 Aug 31, 1984
250MG A088726 001 Aug 31, 1984
SANDOZ 250MG A084669 001
SUPERPHARM 100MG A088694 001 Sep 17, 1984
250MG A088695 001 Sep 17, 1984
USL PHARMA 100MG A088708 001 Aug 30, 1984
250MG A088709 001 Aug 30, 1984
WATSON LABS 100MG A086865 001 Sep 24, 1984
100MG A088608 001 Apr 12, 1984
250MG A086866 001
250MG A088568 001 Apr 12, 1984
WATSON LABS TEVA 100MG A088852 001 Sep 26, 1984
DIABINESE
+ PFIZER 100MG N011641 003
+ 250MG N011641 006
GLUCAMIDE
ANI PHARMS 250MG A088641 001 Oct 11, 1984
CHLORPROTHIXENE
CONCENTRATE;ORAL
TARACTAN
ROCHE 100MG/5ML N016149 002
INJECTABLE;INJECTION
TARACTAN
ROCHE 12.5MG/ML N012487 001
TABLET;ORAL
TARACTAN
ROCHE 10MG N012486 005
25MG N012486 004
50MG N012486 003
100MG N012486 001
CHLORTETRACYCLINE HYDROCHLORIDE
OINTMENT;OPHTHALMIC
AUREOMYCIN
LEDERLE 1% N050404 001
CHLORTHALIDONE
TABLET;ORAL
CHLORTHALIDONE
ABBOTT 25MG A087364 001
50MG A087384 001
ANI PHARMS 25MG A087296 001
25MG A087706 001
25MG A088164 001 Jan 09, 1984
50MG A087689 001
ASCOT 25MG A087698 001 Oct 20, 1982
50MG A087699 001 Oct 20, 1982
BARR LABS INC 25MG A088902 001 Sep 19, 1985
50MG A088903 001 Sep 19, 1985
COSETTE 50MG A088651 001 May 30, 1985
DAVA PHARMS INC 25MG A087451 001
50MG A087450 001
IVAX PHARMS 25MG A087555 001
50MG A087176 001
50MG A087947 001 Feb 27, 1984
KV PHARM 25MG A087311 001
50MG A087312 001
MUTUAL PHARM 25MG A087292 001
25MG A089738 001 Sep 19, 1988
50MG A087293 001
50MG A089739 001 Sep 19, 1988
PIONEER PHARMS 50MG A089591 001 Jul 21, 1988
PUREPAC PHARM 25MG A088139 001 Jul 16, 1986
50MG A088140 001 Aug 11, 1983

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-111(of 478)
** See List Footnote
CHLORTHALIDONE
TABLET;ORAL
CHLORTHALIDONE
SANDOZ 25MG A087380 001
50MG A087118 001
50MG A087381 001
SUNNY 25MG A209068 001 Jan 25, 2022
50MG A209068 002 Jan 25, 2022
SUPERPHARM 25MG A087473 001 Feb 09, 1983
50MG A087247 001 Feb 09, 1983
USL PHARMA 25MG A089051 001 Jun 01, 1987
50MG A089052 001 Jun 01, 1987
VANGARD 25MG A088012 001 Jul 14, 1982
50MG A088073 001 Mar 25, 1983
WARNER CHILCOTT 25MG A087515 001 Jan 24, 1983
50MG A087516 001 Feb 09, 1983
WATSON LABS 25MG A087050 001
25MG A087100 001
50MG A087029 001
50MG A087082 001
50MG A087521 001
HYGROTON
+ SANOFI AVENTIS US 25MG ** N012283 004
+ 50MG ** N012283 003
THALITONE
MONARCH PHARMS 25MG A088051 001 Nov 12, 1982
CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE
TABLET;ORAL
CLONIDINE HYDROCHLORIDE AND CHLORTHALIDONE
PAR PHARM 15MG;0.1MG A071179 001 Dec 16, 1987
15MG;0.2MG A071178 001 Dec 16, 1987
15MG;0.3MG A071142 001 Dec 16, 1987
CLORPRES
MYLAN 15MG;0.1MG A071325 003 Feb 09, 1987
15MG;0.2MG A071325 002 Feb 09, 1987
15MG;0.3MG A071325 001 Feb 09, 1987
COMBIPRES
+ BOEHRINGER INGELHEIM 15MG;0.1MG ** N017503 001
+ 15MG;0.2MG ** N017503 002
+ 15MG;0.3MG ** N017503 003 Apr 10, 1984
CHLORTHALIDONE; METOPROLOL TARTRATE
CAPSULE;ORAL
LOPRESSIDONE
NOVARTIS 25MG;100MG N019451 001 Dec 31, 1987
25MG;200MG N019451 002 Dec 31, 1987
CHLORTHALIDONE; RESERPINE
TABLET;ORAL
DEMI-REGROTON
SANOFI AVENTIS US 25MG;0.125MG N015103 002
REGROTON
SANOFI AVENTIS US 50MG;0.25MG N015103 001
CHLORZOXAZONE
TABLET;ORAL
CHLORZOXAZONE
ACTAVIS ELIZABETH 250MG A088928 001 May 08, 1987
500MG A040113 001 Sep 29, 1995
BARR 500MG A089895 001 May 04, 1988
GLENMARK PHARMS LTD 375MG A212185 001 May 26, 2020
750MG A212185 002 May 26, 2020
OHM LABS 250MG A081298 001 Dec 29, 1993
500MG A081299 001 Dec 29, 1993
PIONEER PHARMS 250MG A089592 001 Jan 06, 1989
500MG A089948 001 Jan 06, 1989
RISING 250MG A089852 001 May 04, 1988
STRIDES PHARMA 250MG A087981 001 Sep 20, 1983
SUN PHARM INDUSTRIES 500MG A089970 001 Sep 27, 1990
WATSON LABS 250MG A086901 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-112(of 478)
** See List Footnote
CHLORZOXAZONE
TABLET;ORAL
CHLORZOXAZONE
250MG A086948 001 Aug 09, 1982
500MG A040137 001 Aug 09, 1996
500MG A081019 001 Jul 29, 1991
500MG A081040 001 Aug 22, 1989
PARAFLEX
+ ORTHO MCNEIL PHARM 250MG ** N011300 003
PARAFON FORTE DSC
+ JANSSEN R AND D 500MG ** N011529 002 Jun 15, 1987
STRIFON FORTE DSC
FERNDALE LABS 500MG A081008 001 Dec 23, 1988
CHOLESTYRAMINE
BAR, CHEWABLE;ORAL
CHOLYBAR
PARKE DAVIS EQ 4GM RESIN/BAR A071621 001 May 26, 1988
EQ 4GM RESIN/BAR A071739 001 May 26, 1988
POWDER;ORAL
CHOLESTYRAMINE
IVAX SUB TEVA PHARMS EQ 4GM RESIN/PACKET A074771 001 Jul 09, 1997
EQ 4GM RESIN/SCOOPFUL A074771 002 Jul 09, 1997
TEVA EQ 4GM RESIN/PACKET A074347 001 May 28, 1998
EQ 4GM RESIN/SCOOPFUL A074347 002 May 28, 1998
UPSHER SMITH LABS EQ 4GM RESIN/PACKET A214877 001 Jan 21, 2022
EQ 4GM RESIN/SCOOPFUL A214877 002 Jan 21, 2022
CHOLESTYRAMINE LIGHT
TEVA EQ 4GM RESIN/PACKET A074348 001 May 28, 1998
EQ 4GM RESIN/SCOOPFUL A074348 002 May 28, 1998
TEVA PHARMS EQ 4GM RESIN/PACKET A074555 001 Sep 30, 1998
EQ 4GM RESIN/SCOOPFUL A074555 002 Sep 30, 1998
QUESTRAN
+ BRISTOL MYERS EQ 4GM RESIN/PACKET ** N016640 001
+ EQ 4GM RESIN/SCOOPFUL ** N016640 003
QUESTRAN LIGHT
+ BRISTOL MYERS EQ 4GM RESIN/PACKET ** N019669 001 Dec 05, 1988
+ EQ 4GM RESIN/SCOOPFUL ** N019669 003 Dec 05, 1988
TABLET;ORAL
QUESTRAN
APOTHECON EQ 800MG RESIN A073403 002 Dec 27, 1999
EQ 1GM RESIN A073403 001 Apr 28, 1994
CHOLINE C-11
INJECTABLE;INTRAVENOUS
CHOLINE C-11
UCSF RODIOPHARM 4-33.1mCi/ML A208444 001 Nov 20, 2017
UNIV TX MD ANDERSON 4-100mCi/ML A205690 001 Oct 29, 2015
CHOLINE FENOFIBRATE
CAPSULE, DELAYED RELEASE;ORAL
FENOFIBRIC ACID
MYLAN PHARMS INC EQ 45MG FENOFIBRIC ACID A200913 001 Mar 25, 2013
EQ 135MG FENOFIBRIC ACID A200913 002 Mar 25, 2013
CHROMIC CHLORIDE
INJECTABLE;INJECTION
CHROMIC CHLORIDE
ABRAXIS PHARM EQ 0.004MG CHROMIUM/ML N019271 001 May 05, 1987
CHROMIC PHOSPHATE P-32
INJECTABLE;INJECTION
PHOSPHOCOL P32
CURIUM 5mCi/ML N017084 001
CICLOPIROX
GEL;TOPICAL
CICLOPIROX
+ ALVOGEN 0.77% N020519 001 Jul 21, 1997
SOLUTION;TOPICAL
CICLOPIROX
AKORN 8% A078975 001 Feb 17, 2010

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-113(of 478)
** See List Footnote
CICLOPIROX
SOLUTION;TOPICAL
CICLOPIROX
ENCUBE 8% A077687 001 Sep 18, 2007
MYLAN PHARMS INC 8% A078567 001 Sep 18, 2007
TEVA PHARMS 8% A078079 001 Sep 18, 2007
CIDOFOVIR
INJECTABLE;INJECTION
VISTIDE
+ GILEAD SCIENCES INC EQ 75MG BASE/ML ** N020638 001 Jun 26, 1996
CILASTATIN SODIUM; IMIPENEM
INJECTABLE;INJECTION
PRIMAXIN
MERCK EQ 250MG BASE/VIAL;250MG/VIAL A062756 001 Jan 08, 1987
EQ 500MG BASE/VIAL;500MG/VIAL A062756 002 Jan 08, 1987
POWDER;INTRAMUSCULAR
PRIMAXIN
MERCK EQ 500MG BASE/VIAL;500MG/VIAL N050630 001 Dec 14, 1990
EQ 750MG BASE/VIAL;750MG/VIAL N050630 002 Dec 14, 1990
POWDER;INTRAVENOUS
IMIPENEM AND CILASTATIN
HOSPIRA INC EQ 250MG BASE/VIAL;250MG/VIAL A090825 001 Nov 16, 2011
EQ 500MG BASE/VIAL;500MG/VIAL A090825 002 Nov 16, 2011
EQ 500MG BASE/VIAL;500MG/VIAL A091007 001 Nov 16, 2011
PRIMAXIN
+ MERCK EQ 250MG BASE/VIAL;250MG/VIAL ** N050587 001 Nov 26, 1985
CILOSTAZOL
TABLET;ORAL
CILOSTAZOL
ACTAVIS ELIZABETH 100MG A077028 002 Nov 26, 2004
EPIC PHARMA LLC 50MG A077022 002 Mar 11, 2005
100MG A077022 001 Nov 23, 2004
HIKMA 50MG A077024 001 May 17, 2005
100MG A077024 002 May 17, 2005
IVAX SUB TEVA PHARMS 100MG A077020 002 Mar 01, 2005
MYLAN 50MG A077323 002 Apr 20, 2006
100MG A077323 001 Apr 20, 2006
MYLAN PHARMS INC 50MG A077019 001 Nov 23, 2004
100MG A077019 002 Nov 23, 2004
NOSTRUM LABS INC 50MG A077708 001 Sep 28, 2009
100MG A077708 002 Sep 28, 2009
PLIVA HRVATSKA DOO 50MG A077898 001 Oct 29, 2007
100MG A077898 002 Oct 29, 2007
PLETAL
+ OTSUKA 50MG ** N020863 001 Jan 15, 1999
+ 100MG ** N020863 002 Jan 15, 1999
CIMETIDINE
SUSPENSION;ORAL
TAGAMET HB 200
GLAXOSMITHKLINE 200MG/20ML N020951 001 Jul 09, 1999
TABLET;ORAL
CIMETIDINE
CHARTWELL MOLECULES 200MG A074329 002 May 17, 1994
300MG A074329 003 May 17, 1994
400MG A074329 004 May 17, 1994
800MG A074329 001 May 17, 1994
CHARTWELL RX 200MG A074100 001 Jan 31, 1995
300MG A074100 002 Jan 31, 1995
400MG A074100 003 Jan 31, 1995
800MG A074100 004 Jan 31, 1995
CONTRACT PHARMACAL 200MG A074961 001 Jun 19, 1998
200MG A074963 001 Jun 19, 1998
CYCLE 300MG A074361 001 Dec 23, 1994
400MG A074361 002 Dec 23, 1994
800MG A074371 001 Dec 23, 1994
HIKMA 200MG A074890 001 Dec 18, 1998
300MG A074890 002 Dec 18, 1998

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-114(of 478)
** See List Footnote
CIMETIDINE
TABLET;ORAL
CIMETIDINE
400MG A074890 003 Dec 18, 1998
800MG A074890 004 Dec 18, 1998
IVAX SUB TEVA PHARMS 200MG A074401 001 May 30, 1995
200MG A074424 001 Jul 28, 1995
300MG A074401 002 May 30, 1995
300MG A074424 002 Jul 28, 1995
400MG A074401 003 May 30, 1995
400MG A074424 003 Jul 28, 1995
800MG A074402 001 May 30, 1995
800MG A074424 004 Jul 28, 1995
NOVITIUM PHARMA 300MG A074340 001 Jun 23, 1995
400MG A074340 002 Jun 23, 1995
800MG A074339 001 Jun 23, 1995
PERRIGO 100MG A074972 001 Jun 19, 1998
PLIVA 200MG A074568 001 Feb 27, 1997
300MG A074568 002 Feb 27, 1997
400MG A074568 003 Feb 27, 1997
SANDOZ INC 100MG A075122 001 Jun 19, 1998
200MG A074250 001 Jun 29, 1995
200MG A075122 002 Jun 19, 1998
300MG A074250 002 Jun 29, 1995
400MG A074250 003 Jun 29, 1995
800MG A074250 004 Jun 29, 1995
TEVA 200MG A074365 001 Feb 28, 1995
300MG A074365 002 Feb 28, 1995
400MG A074365 003 Feb 28, 1995
800MG A074365 004 Feb 28, 1995
UPSHER SMITH LABS 200MG A074506 001 Jan 24, 1996
300MG A074506 002 Jan 24, 1996
400MG A074506 003 Jan 24, 1996
800MG A074506 004 Jan 24, 1996
WATSON LABS INC 200MG A074349 001 Aug 30, 1996
300MG A074349 002 Aug 30, 1996
400MG A074349 003 Aug 30, 1996
800MG A074316 001 Feb 28, 1996
WATSON LABS TEVA 200MG A075425 001 Jul 29, 1999
TAGAMET
+ GLAXOSMITHKLINE 200MG ** N017920 002
+ 300MG ** N017920 003
+ 400MG ** N017920 004 Dec 14, 1983
+ 800MG ** N017920 005 Apr 30, 1986
TAGAMET HB
+ MEDTECH PRODUCTS 100MG ** N020238 001 Jun 19, 1995
CIMETIDINE HYDROCHLORIDE
INJECTABLE;INJECTION
CIMETIDINE HYDROCHLORIDE
DAVA PHARMS INC EQ 300MG BASE/2ML A074428 001 Apr 25, 1996
HOSPIRA EQ 300MG BASE/2ML A074296 001 Mar 28, 1997
EQ 300MG BASE/2ML A074344 001 Jan 31, 1995
EQ 300MG BASE/2ML A074345 001 Jan 31, 1995
EQ 300MG BASE/2ML A074412 001 Mar 28, 1997
EQ 300MG BASE/2ML A074422 001 Jan 31, 1995
LUITPOLD EQ 300MG BASE/2ML A074353 001 Dec 20, 1994
TEVA PARENTERAL EQ 300MG BASE/2ML A074252 001 Nov 26, 1997
VINTAGE PHARMS LLC EQ 300MG BASE/2ML A074005 001 Aug 31, 1994
CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
HOSPIRA EQ 6MG BASE/ML A074269 001 Dec 27, 1994
EQ 90MG BASE/100ML A074468 005 Dec 29, 1994
EQ 120MG BASE/100ML A074468 006 Dec 29, 1994
EQ 180MG BASE/100ML A074468 003 Dec 29, 1994
EQ 240MG BASE/100ML A074468 004 Dec 29, 1994
EQ 360MG BASE/100ML A074468 001 Dec 29, 1994
EQ 480MG BASE/100ML A074468 002 Dec 29, 1994
TAGAMET
GLAXOSMITHKLINE EQ 300MG BASE/2ML ** N017939 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-115(of 478)
** See List Footnote
CIMETIDINE HYDROCHLORIDE
INJECTABLE;INJECTION
TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
+ GLAXOSMITHKLINE EQ 6MG BASE/ML ** N019434 001 Oct 31, 1985
SOLUTION;ORAL
CIMETIDINE HYDROCHLORIDE
ANI PHARMS EQ 300MG BASE/5ML A074610 001 Sep 26, 1996
EQ 300MG BASE/5ML A074859 001 Jul 09, 1998
EQ 300MG BASE/5ML A075110 001 Jun 18, 1998
CHARTWELL MOLECULAR EQ 300MG BASE/5ML A074251 001 Dec 22, 1994
CYCLE EQ 300MG BASE/5ML A074541 001 Aug 05, 1997
G AND W LABS INC EQ 300MG BASE/5ML A074176 001 Jun 01, 1994
PHARM ASSOC EQ 300MG BASE/5ML A075560 001 Mar 15, 2000
TAGAMET
GLAXOSMITHKLINE EQ 300MG BASE/5ML ** N017924 001
CINACALCET HYDROCHLORIDE
TABLET;ORAL
CINACALCET HYDROCHLORIDE
AMNEAL PHARMS 30MG A204364 001 Dec 02, 2021
60MG A204364 002 Dec 02, 2021
90MG A204364 003 Dec 02, 2021
LUPIN LTD EQ 30MG BASE A210548 001 Jun 28, 2019
EQ 60MG BASE A210548 002 Jun 28, 2019
EQ 90MG BASE A210548 003 Jun 28, 2019
MYLAN EQ 30MG BASE A203422 001 Oct 16, 2018
EQ 60MG BASE A203422 002 Oct 16, 2018
EQ 90MG BASE A203422 003 Oct 16, 2018
CINOXACIN
CAPSULE;ORAL
CINOBAC
LILLY 250MG N018067 001
500MG N018067 002
CINOXACIN
TEVA 250MG A073005 001 Feb 28, 1992
500MG A073006 001 Feb 28, 1992
CIPROFLOXACIN
FOR SUSPENSION;ORAL
CIPROFLOXACIN
CHARTWELL 250MG/5ML A200563 001 Mar 05, 2014
500MG/5ML A200563 002 Mar 05, 2014
INJECTABLE;INJECTION
CIPRO
+ BAYER HLTHCARE 400MG/40ML (10MG/ML) ** N019847 001 Dec 26, 1990
+ 200MG/20ML (10MG/ML) ** N019847 002 Dec 26, 1990
1200MG/120ML (10MG/ML) ** N019847 003 Dec 26, 1990
CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER
+ BAYER HLTHCARE 200MG/100ML ** N019857 001 Dec 26, 1990
+ 400MG/200ML ** N019857 002 Dec 26, 1990
CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
BAYER PHARMS 200MG/100ML N019858 001 Dec 26, 1990
CIPROFLOXACIN
BEDFORD LABS 200MG/20ML (10MG/ML) A076992 001 Aug 28, 2006
400MG/40ML (10MG/ML) A076992 002 Aug 28, 2006
1200MG/120ML (10MG/ML) A076993 001 Aug 28, 2006
DR REDDYS 200MG/20ML (10MG/ML) A077782 001 Aug 28, 2006
400MG/40ML (10MG/ML) A077782 002 Aug 28, 2006
FRESENIUS KABI USA 200MG/20ML (10MG/ML) A076484 001 Aug 28, 2006
400MG/40ML (10MG/ML) A076484 002 Aug 28, 2006
HOSPIRA 200MG/20ML (10MG/ML) A077245 001 Aug 28, 2006
400MG/40ML (10MG/ML) A077245 002 Aug 28, 2006
CIPROFLOXACIN IN DEXTROSE 5%
HIKMA FARMACEUTICA 200MG/100ML A076757 001 Apr 21, 2008
CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 200MG/100ML A077888 001 Mar 18, 2008
400MG/200ML A077888 002 Mar 18, 2008
BEDFORD 200MG/100ML A078114 001 Mar 18, 2008
400MG/200ML A078114 002 Mar 18, 2008
TEVA PHARMS 200MG/100ML A077138 001 Mar 18, 2008

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-116(of 478)
** See List Footnote
CIPROFLOXACIN
INJECTABLE;INJECTION
CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
400MG/200ML A077138 002 Mar 18, 2008
CIPROFLOXACIN HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
CIPROFLOXACIN HYDROCHLORIDE
AMRING PHARMS EQ 0.3% BASE A078598 001 Jan 16, 2008
RUBICON EQ 0.3% BASE A075928 001 Jun 09, 2004
TABLET;ORAL
CIPRO
+ BAYER HLTHCARE EQ 100MG BASE ** N019537 001 Apr 08, 1996
+ EQ 750MG BASE ** N019537 004 Oct 22, 1987
CIPROFLOXACIN HYDROCHLORIDE
AIPING PHARM INC EQ 250MG BASE A076593 002 Jun 09, 2004
EQ 500MG BASE A076593 003 Jun 09, 2004
EQ 750MG BASE A076593 004 Jun 09, 2004
AMNEAL EQ 100MG BASE A075939 001 Mar 03, 2005
EQ 250MG BASE A075939 002 Jun 09, 2004
EQ 500MG BASE A075939 003 Jun 09, 2004
EQ 750MG BASE A075939 004 Jun 09, 2004
BARR EQ 250MG BASE A074124 001 Jun 09, 2004
EQ 500MG BASE A074124 002 Jun 09, 2004
EQ 750MG BASE A074124 003 Jun 09, 2004
MYLAN EQ 250MG BASE A075685 002 Jun 09, 2004
EQ 500MG BASE A075685 003 Jun 09, 2004
EQ 750MG BASE A075685 001 Jun 09, 2004
NOSTRUM LABS EQ 250MG BASE A076138 001 Jun 09, 2004
EQ 500MG BASE A076138 002 Jun 09, 2004
EQ 750MG BASE A076138 003 Jun 09, 2004
PLIVA EQ 100MG BASE A076426 001 Jun 15, 2005
EQ 250MG BASE A076426 002 Jun 15, 2005
EQ 500MG BASE A076426 003 Jun 15, 2005
EQ 750MG BASE A076426 004 Jun 15, 2005
RISING EQ 100MG BASE A075817 001 Jun 25, 2007
EQ 250MG BASE A075817 002 Jun 09, 2004
EQ 750MG BASE A075817 004 Jun 09, 2004
SUN PHARM INDS LTD EQ 250MG BASE A075747 001 Jun 09, 2004
EQ 500MG BASE A075747 002 Jun 09, 2004
EQ 750MG BASE A075747 003 Jun 09, 2004
TEVA EQ 250MG BASE A076136 001 Jun 09, 2004
EQ 500MG BASE A076136 002 Jun 09, 2004
EQ 750MG BASE A076136 003 Jun 09, 2004
TABLET, EXTENDED RELEASE;ORAL
PROQUIN XR
DEPOMED INC EQ 500MG BASE N021744 001 May 19, 2005
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
CIPRO XR
BAYER HLTHCARE 212.6MG;EQ 287.5MG BASE ** N021473 001 Dec 13, 2002
425.2MG;EQ 574.9MG BASE ** N021473 002 Aug 28, 2003
CIPROFLOXACIN EXTENDED RELEASE
ANI PHARMS 212.6MG;EQ 287.5MG BASE A077809 002 Nov 30, 2010
425.2MG;EQ 574.9MG BASE A077809 001 Nov 30, 2010
DR REDDYS LABS LTD 212.6MG;EQ 287.5MG BASE A077701 002 Oct 31, 2007
FOSUN PHARMA 212.6MG;EQ 287.5MG BASE A078712 001 Dec 11, 2007
MYLAN PHARMS INC 212.6MG;EQ 287.5MG BASE A078183 001 Mar 22, 2007
425.2MG;EQ 574.9MG BASE A078183 002 Mar 22, 2007
CISAPRIDE MONOHYDRATE
SUSPENSION;ORAL
PROPULSID
JANSSEN PHARMS EQ 1MG BASE/ML N020398 001 Sep 15, 1995
TABLET;ORAL
PROPULSID
JANSSEN PHARMS EQ 10MG BASE N020210 001 Jul 29, 1993
EQ 20MG BASE N020210 002 Dec 23, 1993

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-117(of 478)
** See List Footnote
CISAPRIDE MONOHYDRATE
TABLET, ORALLY DISINTEGRATING;ORAL
PROPULSID QUICKSOLV
JANSSEN PHARMA EQ 20MG BASE N020767 001 Nov 07, 1997
CISATRACURIUM BESYLATE
INJECTABLE;INJECTION
CISATRACURIUM BESYLATE
ACCORD HLTHCARE EQ 2MG BASE/ML A205873 001 Jun 16, 2017
PIRAMAL HLTHCARE UK EQ 2MG BASE/ML A212190 001 May 04, 2020
EQ 2MG BASE/ML A212432 001 Mar 11, 2022
EQ 10MG BASE/ML A212432 002 Mar 11, 2022
ZYDUS PHARMS EQ 2MG BASE/ML A213527 001 Aug 31, 2020
CISATRACURIUM BESYLATE PRESERVATIVE FREE
ACCORD HLTHCARE EQ 2MG BASE/ML A205872 001 Jun 16, 2017
EQ 10MG BASE/ML A205872 002 Jun 16, 2017
CISPLATIN
INJECTABLE;INJECTION
CISPLATIN
BEDFORD 10MG/VIAL A074713 001 Nov 14, 2000
50MG/VIAL A074713 002 Nov 14, 2000
MYLAN LABS LTD 1MG/ML A091062 001 Apr 18, 2012
TEVA PHARMS USA 1MG/ML A074814 001 May 16, 2000
PLATINOL
+ HQ SPCLT PHARMA 10MG/VIAL N018057 001
PLATINOL-AQ
+ HQ SPCLT PHARMA 0.5MG/ML N018057 003 Jul 18, 1984
CITALOPRAM HYDROBROMIDE
CAPSULE;ORAL
CITALOPRAM HYDROBROMIDE
MYLAN PHARMS INC EQ 10MG BASE A077668 001 Feb 28, 2007
EQ 20MG BASE A077668 002 Feb 28, 2007
EQ 40MG BASE A077668 003 Feb 28, 2007
SOLUTION;ORAL
CELEXA
+ FOREST LABS EQ 10MG BASE/5ML ** N021046 001 Dec 22, 1999
CITALOPRAM HYDROBROMIDE
PHARM ASSOC EQ 10MG BASE/5ML A077601 001 Nov 15, 2005
TABLET;ORAL
CELEXA
ALLERGAN EQ 60MG BASE N020822 004 Jul 17, 1998
CITALOPRAM HYDROBROMIDE
EPIC PHARMA LLC EQ 10MG BASE A077036 001 Oct 28, 2004
EQ 20MG BASE A077036 002 Oct 28, 2004
EQ 40MG BASE A077036 003 Oct 28, 2004
FOSUN PHARMA EQ 10MG BASE A077035 001 Oct 28, 2004
EQ 10MG BASE A077040 001 Aug 17, 2005
EQ 20MG BASE A077035 002 Oct 28, 2004
EQ 20MG BASE A077040 002 Aug 17, 2005
EQ 40MG BASE A077035 003 Oct 28, 2004
EQ 40MG BASE A077040 003 Aug 17, 2005
HERITAGE PHARMA EQ 10MG BASE A077033 001 Oct 28, 2004
EQ 10MG BASE A077034 001 Jun 30, 2005
EQ 10MG BASE A077213 001 Mar 31, 2006
EQ 10MG BASE A077232 001 Oct 31, 2005
EQ 20MG BASE A077033 002 Oct 28, 2004
EQ 20MG BASE A077034 002 Jun 30, 2005
EQ 20MG BASE A077213 002 Mar 31, 2006
EQ 20MG BASE A077232 002 Oct 31, 2005
EQ 40MG BASE A077033 003 Oct 28, 2004
EQ 40MG BASE A077034 003 Jun 30, 2005
EQ 40MG BASE A077213 003 Mar 31, 2006
EQ 40MG BASE A077232 003 Oct 31, 2005
JUBILANT GENERICS EQ 10MG BASE A205407 001 Dec 23, 2015
EQ 20MG BASE A205407 002 Dec 23, 2015
EQ 40MG BASE A205407 003 Dec 23, 2015
MYLAN EQ 10MG BASE A077039 001 Feb 03, 2005
EQ 20MG BASE A077039 002 Feb 03, 2005
EQ 40MG BASE A077039 003 Feb 03, 2005

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-118(of 478)
** See List Footnote
CITALOPRAM HYDROBROMIDE
TABLET;ORAL
CITALOPRAM HYDROBROMIDE
MYLAN PHARMS INC EQ 10MG BASE A077037 001 Nov 05, 2004
EQ 20MG BASE A077037 002 Nov 05, 2004
EQ 40MG BASE A077037 003 Nov 05, 2004
NATCO PHARMA LTD EQ 20MG BASE A077141 002 Apr 10, 2008
EQ 40MG BASE A077141 001 Apr 10, 2008
ROXANE EQ 10MG BASE A077041 001 Nov 23, 2004
EQ 20MG BASE A077041 002 Nov 23, 2004
EQ 40MG BASE A077041 003 Nov 23, 2004
SUN PHARM INDS INC EQ 10MG BASE A077032 001 Nov 12, 2004
EQ 20MG BASE A077032 002 Nov 12, 2004
EQ 40MG BASE A077032 003 Nov 12, 2004
SUN PHARM INDUSTRIES EQ 10MG BASE A077052 001 Jul 03, 2006
EQ 20MG BASE A077052 002 Jul 03, 2006
EQ 40MG BASE A077052 003 Jul 03, 2006
TARO EQ 10MG BASE A077278 001 Mar 22, 2006
EQ 20MG BASE A077278 002 Mar 22, 2006
EQ 40MG BASE A077278 003 Mar 22, 2006
TABLET, ORALLY DISINTEGRATING;ORAL
CITALOPRAM HYDROBROMIDE
+ BIOVAIL LABS INTL EQ 10MG BASE N021763 001 Dec 20, 2005
+ EQ 20MG BASE N021763 002 Dec 20, 2005
+ EQ 40MG BASE N021763 003 Dec 20, 2005
CITRIC ACID; MAGNESIUM OXIDE; SODIUM CARBONATE
SOLUTION;IRRIGATION
IRRIGATING SOLUTION G IN PLASTIC CONTAINER
BAXTER HLTHCARE 3.24GM/100ML;380MG/100ML;430MG/100ML N018519 001 Jun 22, 1982
UROLOGIC G IN PLASTIC CONTAINER
HOSPIRA 3.24GM/100ML;380MG/100ML;430MG/100ML N018904 001 May 27, 1983
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
FOR SOLUTION;ORAL
PREPOPIK
+ FERRING PHARMS INC 12GM/PACKET;3.5GM/PACKET;10MG/PACKET ** N202535 001 Jul 16, 2012
CLADRIBINE
INJECTABLE;INJECTION
CLADRIBINE
MYLAN LABS LTD 1MG/ML A200510 001 Oct 06, 2011
LEUSTATIN
+ JANSSEN PHARMS 1MG/ML ** N020229 001 Feb 26, 1993
CLARITHROMYCIN
FOR SUSPENSION;ORAL
BIAXIN
+ ABBVIE 125MG/5ML N050698 001 Dec 23, 1993
187MG/5ML N050698 003 Sep 30, 1998
+ 250MG/5ML N050698 002 Dec 23, 1993
CLARITHROMYCIN
SUN PHARM INDS LTD 125MG/5ML A065382 001 Aug 30, 2007
250MG/5ML A065382 002 Aug 30, 2007
TABLET;ORAL
BIAXIN
+ ABBVIE 250MG ** N050662 001 Oct 31, 1991
+ 500MG ** N050662 002 Oct 31, 1991
CLARITHROMYCIN
AJANTA PHARMA LTD 250MG A206714 001 Apr 25, 2019
500MG A206714 002 Apr 25, 2019
HIKMA 250MG A065178 002 May 25, 2004
500MG A065178 001 May 25, 2004
IVAX SUB TEVA PHARMS 250MG A065137 001 May 31, 2005
500MG A065137 002 May 31, 2005
MYLAN 250MG A065195 001 Mar 11, 2005
500MG A065195 002 Mar 11, 2005
SUN PHARM INDS LTD 250MG A065174 001 Sep 24, 2004
500MG A065174 002 Sep 24, 2004
WOCKHARDT 250MG A065266 001 May 31, 2006
500MG A065266 002 May 31, 2006

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-119(of 478)
** See List Footnote
CLARITHROMYCIN
TABLET, EXTENDED RELEASE;ORAL
BIAXIN XL
+ ABBVIE 500MG ** N050775 001 Mar 03, 2000
CLARITHROMYCIN
ANI PHARMS 500MG A065250 001 Aug 25, 2005
LUPIN LTD 500MG A202532 001 Sep 15, 2015
NOSTRUM LABS INC 500MG A203243 001 Feb 29, 2016
RANBAXY 1GM A065210 001 Jan 26, 2005
CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM
INJECTABLE;INJECTION
TIMENTIN
GLAXOSMITHKLINE EQ 100MG BASE/VIAL;EQ 3GM BASE/VIAL A062691 001 Dec 19, 1986
EQ 100MG BASE/VIAL;EQ 3GM BASE/VIAL N050590 001 Apr 01, 1985
EQ 200MG BASE/VIAL;EQ 3GM BASE/VIAL N050590 002 Apr 01, 1985
EQ 1GM BASE/VIAL;EQ 30GM BASE/VIAL N050590 003 Aug 18, 1987
TIMENTIN IN PLASTIC CONTAINER
GLAXOSMITHKLINE EQ 100MG BASE/100ML;EQ 3GM BASE/100ML N050658 001 Dec 15, 1989
CLEMASTINE FUMARATE
SYRUP;ORAL
CLEMASTINE FUMARATE
ACTAVIS MID ATLANTIC EQ 0.5MG BASE/5ML A074075 001 Oct 31, 1993
APOTEX INC EQ 0.5MG BASE/5ML A075703 001 Nov 27, 2000
CHARTWELL MOLECULAR EQ 0.5MG BASE/5ML A074884 001 Dec 17, 1997
TEVA PHARMS EQ 0.5MG BASE/5ML A073095 001 Apr 21, 1992
WOCKHARDT BIO AG EQ 0.5MG BASE/5ML A074863 001 Mar 13, 1998
TAVIST
+ NOVARTIS EQ 0.5MG BASE/5ML ** N018675 001 Jun 28, 1985
TABLET;ORAL
CLEMASTINE FUMARATE
ANI PHARMS 1.34MG A073282 001 Jan 31, 1992
1.34MG A073282 002 Dec 03, 1992
L PERRIGO CO 1.34MG A074512 001 Nov 22, 1995
PLD ACQUISITIONS LLC 1.34MG A073458 001 Oct 31, 1993
SANDOZ 2.68MG A073459 001 Oct 31, 1993
TAVIST
+ NOVARTIS 2.68MG N017661 001
TAVIST-1
+ GLAXOSMITHKLINE CONS 1.34MG ** N020925 001 Aug 21, 1992
NOVARTIS 1.34MG N017661 002
1.34MG N017661 003 Aug 21, 1992
CLEVIDIPINE
EMULSION;INTRAVENOUS
CLEVIPREX
+ CHIESI 125MG/250ML (0.5MG/ML) N022156 003 Nov 08, 2013
CLIDINIUM BROMIDE
CAPSULE;ORAL
QUARZAN
ROCHE 2.5MG N010355 001
5MG N010355 002
CLINDAMYCIN HYDROCHLORIDE
CAPSULE;ORAL
CLEOCIN
PHARMACIA AND UPJOHN EQ 75MG BASE A061809 001
EQ 150MG BASE A061809 002
CLINDAMYCIN HYDROCHLORIDE
CHARTWELL MOLECULAR EQ 150MG BASE A065243 003 Aug 12, 2005
EQ 300MG BASE A065243 001 Aug 12, 2005
MYLAN PHARMS INC EQ 75MG BASE A091225 001 May 31, 2011
EQ 150MG BASE A091225 002 May 31, 2011
EQ 300MG BASE A091225 003 May 31, 2011
TEVA EQ 75MG BASE A063027 001 Sep 20, 1989
WATSON LABS EQ 75MG BASE A063082 001 Jul 31, 1991
EQ 150MG BASE A063083 001 Jul 31, 1991
EQ 300MG BASE A063083 002 Mar 18, 2003

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-120(of 478)
** See List Footnote
CLINDAMYCIN PALMITATE HYDROCHLORIDE
FOR SOLUTION;ORAL
CLEOCIN
PHARMACIA AND UPJOHN EQ 75MG BASE/5ML ** A061827 001
CLINDAMYCIN PALMITATE HYDROCHLORIDE
MYLAN EQ 75MG BASE/5ML A203063 001 May 25, 2016
CLINDAMYCIN PHOSPHATE
CREAM;VAGINAL
CLEOCIN
PFIZER EQ 2% BASE N050680 001 Aug 11, 1992
INJECTABLE;INJECTION
CLEOCIN PHOSPHATE
PHARMACIA AND UPJOHN EQ 150MG BASE/ML A061839 001
CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
+ PFIZER EQ 6MG BASE/ML ** N050639 001 Aug 30, 1989
+ EQ 12MG BASE/ML ** N050639 002 Aug 30, 1989
+ EQ 18MG BASE/ML ** N050639 003 Apr 10, 1991
CLINDAMYCIN PHOSPHATE
ABRAXIS PHARM EQ 150MG BASE/ML A062747 001 Jun 03, 1988
ALMAJECT EQ 150MG BASE/ML A062801 001 Jul 24, 1987
BEDFORD EQ 150MG BASE/ML A063163 001 Jun 30, 1994
BRISTOL MYERS SQUIBB EQ 150MG BASE/ML A062908 001 Feb 01, 1989
HIKMA EQ 150MG BASE/ML A062806 001 Oct 15, 1987
EQ 150MG BASE/ML A062953 001 Apr 21, 1988
EQ 150MG BASE/ML A063068 001 Aug 28, 1989
IGI LABS INC EQ 150MG BASE/ML A062928 001 Feb 13, 1989
LOCH EQ 150MG BASE/ML A062905 001 May 09, 1988
MARSAM PHARMS LLC EQ 150MG BASE/ML A062913 001 Oct 20, 1988
RISING EQ 150MG BASE/ML A204748 001 Oct 10, 2017
EQ 150MG BASE/ML A204749 001 Oct 10, 2017
SOLOPAK EQ 150MG BASE/ML A062819 001 Mar 15, 1988
EQ 150MG BASE/ML A062852 001 Mar 17, 1988
TEVA PARENTERAL EQ 150MG BASE/ML A063041 001 Dec 29, 1989
EQ 150MG BASE/ML A063282 001 May 29, 1992
WATSON LABS EQ 150MG BASE/ML A062900 001 Jun 08, 1988
EQ 150MG BASE/ML A063079 001 Mar 05, 1990
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
ABRAXIS PHARM EQ 12MG BASE/ML N050636 001 Dec 22, 1989
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
ABBOTT LABS EQ 6MG BASE/ML A065027 001 Jun 29, 2001
EQ 12MG BASE/ML A065027 002 Jun 29, 2001
EQ 18MG BASE/ML A065027 003 Jun 29, 2001
BAXTER HLTHCARE EQ 6MG BASE/ML N050648 001 Dec 29, 1989
EQ 12MG BASE/ML N050648 002 Dec 29, 1989
EQ 900MG BASE/100ML N050648 003 Dec 29, 1989
SOLUTION;TOPICAL
CLEOCIN T
+ PFIZER EQ 1% BASE N050537 001
PHARMACIA AND UPJOHN EQ 1% BASE A062363 001 Feb 08, 1982
CLINDAMYCIN PHOSPHATE
BOCA PHARMA LLC EQ 1% BASE A062944 001 Jan 11, 1989
FOUGERA PHARMS EQ 1% BASE A065254 001 Feb 14, 2006
G AND W LABS INC EQ 1% BASE A062811 001 Sep 01, 1988
NOVAST LABS EQ 1% BASE A064108 001 Sep 27, 1996
VINTAGE PHARMS EQ 1% BASE A062930 001 Jun 28, 1989
EQ 1% BASE A203343 001 May 29, 2015
WOCKHARDT BIO AG EQ 1% BASE A063304 001 Jul 15, 1997
SWAB;TOPICAL
CLEOCIN
+ PFIZER EQ 1% BASE N050537 002 Feb 22, 1994
CLIOQUINOL; NYSTATIN
OINTMENT;TOPICAL
NYSTAFORM
BAYER PHARMS 10MG/GM;100,000 UNITS/GM N050235 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-121(of 478)
** See List Footnote
CLOBAZAM
SUSPENSION;ORAL
CLOBAZAM
HIKMA 2.5MG/ML A209715 001 Oct 22, 2018
TEVA PHARMS USA 2.5MG/ML A211032 001 Jan 31, 2020
TABLET;ORAL
CLOBAZAM
ACCORD HLTHCARE 10MG A212398 001 May 23, 2019
20MG A212398 002 May 23, 2019
APOTEX 10MG A209853 001 Jun 09, 2020
20MG A209853 002 Jun 09, 2020
BRECKENRIDGE 5MG A209308 003 Oct 19, 2021
CELLTRION 10MG A211959 001 Dec 09, 2020
20MG A211959 002 Dec 09, 2020
CHARTWELL MOLECULAR 10MG A212092 001 Oct 30, 2019
20MG A212092 002 Oct 30, 2019
HIKMA 10MG A208785 001 Oct 22, 2018
20MG A208785 002 Oct 22, 2018
TARO 10MG A209440 001 Oct 22, 2018
20MG A209440 002 Oct 22, 2018
ONFI
+ LUNDBECK PHARMS LLC 5MG ** N202067 001 Oct 21, 2011
CLOBETASOL PROPIONATE
AEROSOL, FOAM;TOPICAL
CLOBETASOL PROPIONATE
INGENUS PHARMS LLC 0.05% A206805 001 Jul 31, 2017
CREAM;TOPICAL
CLOBETASOL PROPIONATE
GLASSHOUSE PHARMS 0.05% A211207 001 Mar 26, 2021
TEVA PHARMS USA 0.05% A074087 001 Feb 16, 1994
EMBELINE E
AKORN 0.05% A075325 001 Dec 24, 1998
TEMOVATE
+ FOUGERA PHARMS 0.05% ** N019322 001 Dec 27, 1985
TEMOVATE E
+ FOUGERA PHARMS 0.05% ** N020340 001 Jun 17, 1994
GEL;TOPICAL
TEMOVATE
+ FOUGERA PHARMS 0.05% ** N020337 001 Apr 29, 1994
LOTION;TOPICAL
CLOBETASOL PROPIONATE
AKORN 0.05% A211348 001 Oct 26, 2018
OINTMENT;TOPICAL
CLOBETASOL PROPIONATE
ACTAVIS MID ATLANTIC 0.05% A074128 001 Aug 03, 1994
AMNEAL 0.05% A210551 001 Aug 21, 2018
TORRENT 0.05% A212926 001 Oct 25, 2019
TEMOVATE
+ FOUGERA PHARMS 0.05% ** N019323 001 Dec 27, 1985
SOLUTION;TOPICAL
CLOBETASOL PROPIONATE
ENCUBE 0.05% A076977 001 Aug 05, 2005
PRINSTON INC 0.05% A213139 001 Feb 08, 2021
WOCKHARDT BIO AG 0.05% A075205 001 Nov 13, 1998
TEMOVATE
+ FOUGERA PHARMS 0.05% ** N019966 001 Feb 22, 1990
SPRAY;TOPICAL
CLOBETASOL PROPIONATE
AKORN 0.05% A207218 001 Apr 28, 2017
APOTEX 0.05% A210446 001 Apr 17, 2018
CLOFARABINE
SOLUTION;INTRAVENOUS
CLOFARABINE
HOSPIRA 20MG/20ML (1MG/ML) A210283 001 Dec 27, 2018
NOVAST LABS 20MG/20ML (1MG/ML) A210270 001 Sep 14, 2018

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-122(of 478)
** See List Footnote
CLOFAZIMINE
CAPSULE;ORAL
LAMPRENE
+ NOVARTIS 50MG N019500 002 Dec 15, 1986
100MG N019500 001 Dec 15, 1986
CLOFIBRATE
CAPSULE;ORAL
ATROMID-S
WYETH AYERST 500MG N016099 002
CLOFIBRATE
BANNER PHARMACAPS 500MG A073396 001 Mar 20, 1992
SANDOZ 500MG A072191 001 May 02, 1988
TEVA 500MG A072600 001 Jul 25, 1991
USL PHARMA 500MG A070531 001 Jun 16, 1986
WATSON LABS 500MG A071603 001 Sep 18, 1987
CLOMIPHENE CITRATE
TABLET;ORAL
CLOMID
+ SANOFI AVENTIS US 50MG ** N016131 002
MILOPHENE
GRANATA BIO 50MG A072196 001 Dec 20, 1988
SEROPHENE
EMD SERONO 50MG N018361 001 Mar 22, 1982
CLOMIPRAMINE HYDROCHLORIDE
CAPSULE;ORAL
CLOMIPRAMINE HYDROCHLORIDE
TEVA 25MG A074849 001 Apr 04, 1997
25MG A074958 001 Aug 26, 1997
50MG A074849 002 Apr 04, 1997
50MG A074958 002 Aug 26, 1997
75MG A074849 003 Apr 04, 1997
75MG A074958 003 Aug 26, 1997
WATSON LABS 25MG A074600 001 Nov 27, 1996
25MG A074751 001 Sep 30, 1998
50MG A074600 002 Nov 27, 1996
50MG A074751 002 Sep 30, 1998
75MG A074600 003 Nov 27, 1996
75MG A074751 003 Sep 30, 1998
CLONAZEPAM
TABLET;ORAL
CLONAZEPAM
AUROBINDO PHARMA USA 0.5MG A075150 001 Oct 05, 1998
1MG A075150 002 Oct 05, 1998
2MG A075150 003 Oct 05, 1998
MYLAN PHARMS INC 0.5MG A074940 001 Oct 30, 1997
1MG A074940 002 Oct 30, 1997
2MG A074940 003 Oct 30, 1997
SANDOZ 0.5MG A074925 001 Sep 30, 1997
1MG A074925 002 Sep 30, 1997
2MG A074925 003 Sep 30, 1997
SUN PHARM INDS INC 0.5MG A075423 001 Apr 27, 2001
1MG A075423 002 Apr 27, 2001
2MG A075423 003 Apr 27, 2001
TEVA 0.5MG A074920 001 Aug 04, 1998
1MG A074920 002 Aug 04, 1998
2MG A074920 003 Aug 04, 1998
WATSON LABS 0.5MG A074964 001 Dec 30, 1997
1MG A074964 002 Dec 30, 1997
2MG A074964 003 Dec 30, 1997
KLONOPIN
CHEPLAPHARM 0.125MG N017533 005 Apr 09, 1997
0.25MG N017533 006 Apr 09, 1997
TABLET, ORALLY DISINTEGRATING;ORAL
KLONOPIN RAPIDLY DISINTEGRATING
+ ROCHE 0.125MG ** N020813 001 Dec 23, 1997
+ 0.25MG ** N020813 002 Dec 23, 1997
+ 0.5MG ** N020813 003 Dec 23, 1997

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-123(of 478)
** See List Footnote
CLONAZEPAM
TABLET, ORALLY DISINTEGRATING;ORAL
KLONOPIN RAPIDLY DISINTEGRATING
+ 1MG ** N020813 004 Dec 23, 1997
+ 2MG ** N020813 005 Dec 23, 1997
CLONIDINE
SUSPENSION, EXTENDED RELEASE;ORAL
CLONIDINE
TRIS PHARMA INC EQ 0.09MG BASE/ML N022499 001 Dec 03, 2009
TABLET, EXTENDED RELEASE;ORAL
NEXICLON XR
ATHENA EQ 0.26MG BASE N022500 002 Dec 03, 2009
CLONIDINE HYDROCHLORIDE
INJECTABLE;INJECTION
CLONIDINE HYDROCHLORIDE
AM REGENT 1MG/10ML (0.1MG/ML) A091104 001 Oct 08, 2009
5MG/10ML (0.5MG/ML) A091104 002 Oct 08, 2009
DURACLON
+ MYLAN INSTITUTIONAL 5MG/10ML (0.5MG/ML) ** N020615 002 Apr 27, 1999
TABLET;ORAL
CATAPRES
+ BOEHRINGER INGELHEIM 0.1MG N017407 001
+ 0.2MG N017407 002
+ 0.3MG N017407 003
CLONIDINE HYDROCHLORIDE
AM THERAP 0.1MG A070881 001 Jul 08, 1986
0.2MG A070882 001 Jul 08, 1986
0.3MG A070883 001 Jul 08, 1986
DURAMED PHARMS BARR 0.1MG A071103 001 Aug 14, 1986
0.2MG A071102 001 Aug 14, 1986
0.3MG A071101 001 Aug 14, 1986
INTERPHARM 0.1MG A071252 001 Oct 01, 1986
0.2MG A071253 001 Oct 01, 1986
0.3MG A071254 001 Oct 01, 1986
PAR PHARM 0.1MG A070461 001 Jul 08, 1986
0.2MG A070460 001 Jul 08, 1986
0.3MG A070459 001 Jul 08, 1986
RISING 0.1MG A070317 002 Jul 09, 1987
0.2MG A070317 003 Jun 09, 1987
0.3MG A070317 001 Jun 09, 1987
SUN PHARM INDS INC 0.1MG A090329 001 Jul 03, 2014
0.2MG A090329 002 Jul 03, 2014
0.3MG A090329 003 Jul 03, 2014
TEVA 0.1MG A070747 001 Jul 08, 1986
0.2MG A070702 001 Jul 08, 1986
0.3MG A070659 001 Jul 08, 1986
WARNER CHILCOTT 0.1MG A072138 001 Jun 13, 1988
0.2MG A072139 001 Jun 13, 1988
0.3MG A072140 001 Jun 13, 1988
WATSON LABS 0.1MG A070395 001 Mar 23, 1987
0.1MG A070965 001 Jul 08, 1986
0.2MG A070396 001 Mar 23, 1987
0.2MG A070964 001 Jul 08, 1986
0.3MG A070397 001 Mar 23, 1987
0.3MG A070963 001 Jul 08, 1986
TABLET, EXTENDED RELEASE;ORAL
CLONIDINE HYDROCHLORIDE
ACTAVIS ELIZABETH 0.2MG A202792 002 May 15, 2015
0.2MG A203320 002 May 15, 2015
ANCHEN PHARMS 0.1MG A202983 001 Apr 02, 2014
0.2MG A202983 002 Apr 02, 2014
0.2MG A202984 002 Sep 30, 2013
MAYNE PHARMA INC 0.1MG A210680 001 Apr 30, 2018
UPSHER SMITH LABS 0.1MG A211433 001 Oct 12, 2018
JENLOGA
+ CONCORDIA PHARMS INC 0.1MG ** N022331 001 Sep 30, 2009
+ 0.2MG ** N022331 002 May 25, 2010

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-124(of 478)
** See List Footnote
CLONIDINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
KAPVAY
+ CONCORDIA PHARMS INC 0.2MG ** N022331 004 Sep 28, 2010
CLOPIDOGREL BISULFATE
TABLET;ORAL
CLOPIDOGREL BISULFATE
ACTAVIS TOTOWA EQ 75MG BASE A090307 001 May 28, 2013
ANI PHARMS EQ 300MG BASE A090625 001 May 17, 2012
EQ 300MG BASE A091216 001 May 17, 2012
CADILA EQ 75MG BASE A201686 001 Oct 10, 2012
CELLTRION EQ 75MG BASE A202266 001 Aug 14, 2012
EQ 300MG BASE A202266 002 Nov 20, 2012
RISING EQ 75MG BASE A077665 001 May 17, 2012
EQ 300MG BASE A077665 002 May 17, 2012
SUN PHARM INDUSTRIES EQ 75MG BASE A078133 001 Jun 10, 2013
CLORAZEPATE DIPOTASSIUM
CAPSULE;ORAL
CLORAZEPATE DIPOTASSIUM
ABLE 3.75MG A071777 001 Jul 14, 1987
7.5MG A071778 001 Jul 14, 1987
15MG A071779 001 Jul 14, 1987
AM THERAP 3.75MG A071429 001 Jun 23, 1987
7.5MG A071430 001 Jun 23, 1987
15MG A071431 001 Jun 23, 1987
DAVA PHARMS INC 3.75MG A071742 001 Dec 14, 1987
7.5MG A071743 001 Dec 14, 1987
15MG A071744 001 Dec 14, 1987
GD SEARLE LLC 3.75MG A071727 001 Dec 18, 1987
7.5MG A071728 001 Dec 18, 1987
15MG A071729 001 Dec 18, 1987
MYLAN 3.75MG A071509 001 Oct 19, 1987
7.5MG A071510 001 Oct 19, 1987
15MG A071511 001 Oct 19, 1987
PUREPAC PHARM 3.75MG A071924 001 Apr 25, 1988
7.5MG A071925 001 Apr 25, 1988
15MG A071926 001 Apr 25, 1988
QUANTUM PHARMICS 3.75MG A071549 001 Sep 12, 1988
7.5MG A071550 001 Sep 12, 1988
15MG A071522 001 Sep 12, 1988
RISING 3.75MG A072112 002 Aug 26, 1988
7.5MG A072112 003 Aug 26, 1988
15MG A072112 001 Aug 26, 1988
USL PHARMA 3.75MG A071242 001 Jun 23, 1987
7.5MG A071243 001 Jun 23, 1987
15MG A071244 001 Jun 23, 1987
WARNER CHILCOTT 3.75MG A071774 001 Mar 01, 1988
7.5MG A071775 001 Mar 01, 1988
15MG A071776 001 Mar 01, 1988
WATSON LABS 3.75MG A071878 001 Mar 15, 1988
7.5MG A071879 001 Mar 15, 1988
15MG A071860 001 Mar 15, 1988
TRANXENE
+ KEY THERAP 3.75MG ** N017105 001
+ 7.5MG ** N017105 002
+ 15MG ** N017105 003
TABLET;ORAL
CLORAZEPATE DIPOTASSIUM
ABLE 3.75MG A071780 001 Jun 26, 1987
7.5MG A071781 001 Jun 26, 1987
15MG A071782 001 Jun 26, 1987
AM THERAP 3.75MG A071747 001 Jun 23, 1987
7.5MG A071748 001 Jun 23, 1987
15MG A071749 001 Jun 23, 1987
AUROLIFE PHARMA LLC 3.75MG A072514 002 May 11, 1990
7.5MG A072514 003 May 11, 1990
15MG A072514 001 May 11, 1990
LEDERLE 3.75MG A072013 001 Dec 15, 1987

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-125(of 478)
** See List Footnote
CLORAZEPATE DIPOTASSIUM
TABLET;ORAL
CLORAZEPATE DIPOTASSIUM
7.5MG A072014 001 Dec 15, 1987
15MG A072015 001 Dec 15, 1987
PUREPAC PHARM 3.75MG A072330 001 Aug 08, 1988
7.5MG A072331 001 Aug 08, 1988
15MG A072332 001 Aug 08, 1988
QUANTUM PHARMICS 3.75MG A071730 001 Oct 26, 1987
7.5MG A071731 001 Oct 26, 1987
15MG A071702 001 Oct 26, 1987
SUN PHARM INDS LTD 3.75MG A076911 001 Sep 29, 2004
7.5MG A076911 002 Sep 29, 2004
15MG A076911 003 Sep 29, 2004
WARNER CHILCOTT 3.75MG A071828 001 Mar 03, 1988
7.5MG A071829 001 Mar 03, 1988
15MG A071830 001 Mar 03, 1988
WATSON LABS 3.75MG A071852 001 Feb 09, 1988
7.5MG A071853 001 Feb 09, 1988
15MG A071854 001 Feb 09, 1988
GEN-XENE
ALRA 3.75MG A071787 001 Apr 26, 1988
7.5MG A071788 001 Apr 26, 1988
15MG A071789 001 Apr 26, 1988
TRANXENE
+ KEY THERAP 3.75MG ** N017105 006
+ 15MG ** N017105 008
TRANXENE SD
+ KEY THERAP 11.25MG ** N017105 005
+ 22.5MG ** N017105 004
CLOTRIMAZOLE
CREAM;TOPICAL
LOTRIMIN
SCHERING PLOUGH 1% ** N017619 001
MYCELEX
BAYER HEALTHCARE LLC 1% N018183 001
CREAM;VAGINAL
GYNE-LOTRIMIN
+ BAYER HEALTHCARE LLC 1% ** N018052 002 Nov 30, 1990
GYNE-LOTRIMIN 3
+ BAYER HEALTHCARE LLC 2% N020574 001 Nov 24, 1998
MYCELEX-7
BAYER HEALTHCARE LLC 1% N018230 002 Dec 26, 1991
CREAM, TABLET;TOPICAL, VAGINAL
GYNE-LOTRIMIN 3 COMBINATION PACK
+ BAYER HEALTHCARE LLC 1%,200MG N020526 002 Jul 29, 1996
GYNE-LOTRIMIN COMBINATION PACK
+ BAYER HEALTHCARE LLC 1%,100MG N020289 002 Apr 26, 1993
MYCELEX-7 COMBINATION PACK
BAYER HEALTHCARE LLC 1%,100MG N020389 002 Jun 23, 1994
LOTION;TOPICAL
LOTRIMIN
SCHERING 1% N018813 001 Feb 17, 1984
SOLUTION;TOPICAL
LOTRIMIN
+ SCHERING PLOUGH 1% ** N017613 001
MYCELEX
+ BAYER HLTHCARE 1% ** N018181 001
TABLET;VAGINAL
GYNE-LOTRIMIN
+ BAYER HEALTHCARE LLC 100MG N017717 002 Nov 30, 1990
GYNE-LOTRIMIN 3
+ BAYER HEALTHCARE LLC 200MG N020525 001 Jul 29, 1996
GYNIX
TEVA PHARMS 100MG A073249 001 Feb 13, 1998
MYCELEX-7
BAYER HEALTHCARE LLC 100MG N018182 002 Dec 26, 1991

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-126(of 478)
** See List Footnote
CLOTRIMAZOLE
TABLET;VAGINAL
MYCELEX-G
BAYER PHARMS 500MG N019069 001 Apr 19, 1985
TROCHE/LOZENGE;ORAL
MYCELEX
+ BAYER HLTHCARE 10MG ** N018713 001 Jun 17, 1983
CLOXACILLIN SODIUM
CAPSULE;ORAL
CLOXACILLIN SODIUM
APOTHECON EQ 250MG BASE A061452 001
EQ 500MG BASE A061452 002
TEVA EQ 250MG BASE A062240 001
EQ 500MG BASE A062240 002
CLOXAPEN
GLAXOSMITHKLINE EQ 250MG BASE A061806 001
EQ 250MG BASE A062233 001
EQ 500MG BASE A061806 002
EQ 500MG BASE A062233 002
FOR SOLUTION;ORAL
CLOXACILLIN SODIUM
TEVA EQ 125MG BASE/5ML A062268 001
EQ 125MG BASE/5ML A062978 001 Apr 06, 1989
TEGOPEN
APOTHECON EQ 125MG BASE/5ML A061453 001
EQ 125MG BASE/5ML N050192 001
CLOZAPINE
TABLET;ORAL
CLOZAPINE
MYLAN 12.5MG A075417 003 Apr 15, 2010
PAR PHARM 25MG A075162 001 Apr 26, 2005
100MG A075162 002 Apr 26, 2005
SANDOZ 25MG A074546 001 Aug 30, 1996
100MG A074546 002 Aug 30, 1996
ZYDUS PHARMS 25MG A209480 001 Dec 06, 2017
50MG A209480 002 Dec 06, 2017
100MG A209480 003 Dec 06, 2017
200MG A209480 004 Dec 06, 2017
TABLET, ORALLY DISINTEGRATING;ORAL
FAZACLO ODT
+ JAZZ 12.5MG ** N021590 004 May 30, 2007
+ 25MG ** N021590 001 Feb 10, 2004
50MG ** N021590 003 Jun 03, 2005
+ 100MG ** N021590 002 Feb 10, 2004
+ 150MG ** N021590 005 Jul 09, 2010
+ 200MG ** N021590 006 Jul 09, 2010
CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
SYRUP;ORAL
PHENERGAN VC W/ CODEINE
+ ANI PHARMS 10MG/5ML;5MG/5ML;6.25MG/5ML ** N008306 005 Apr 02, 1984
PHERAZINE VC W/ CODEINE
HALSEY 10MG/5ML;5MG/5ML;6.25MG/5ML A088870 001 Mar 02, 1987
PROMETH VC W/ CODEINE
NOSTRUM LABS INC 10MG/5ML;5MG/5ML;6.25MG/5ML A088764 001 Oct 31, 1984
PROMETHAZINE VC W/ CODEINE
CENCI 10MG/5ML;5MG/5ML;6.25MG/5ML A088816 001 Nov 22, 1985
WOCKHARDT 10MG/5ML;5MG/5ML;6.25MG/5ML A088896 001 Jan 04, 1985
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
SYRUP;ORAL
PHENERGAN W/ CODEINE
+ ANI PHARMS 10MG/5ML;6.25MG/5ML ** N008306 004 Apr 02, 1984
PHERAZINE W/ CODEINE
HALSEY 10MG/5ML;6.25MG/5ML A088739 001 Dec 23, 1988
PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
PHARM ASSOC 10MG/5ML;6.25MG/5ML A089647 001 Dec 22, 1988
PROMETHAZINE W/ CODEINE
CENCI 10MG/5ML;6.25MG/5ML A088814 001 Nov 22, 1985

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-127(of 478)
** See List Footnote
CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
SYRUP;ORAL
ACTIFED W/ CODEINE
GLAXOSMITHKLINE 10MG/5ML;30MG/5ML;1.25MG/5ML N012575 003 Apr 04, 1984
TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W/ CODEINE
CENCI 10MG/5ML;30MG/5ML;1.25MG/5ML A089018 001 Jul 23, 1986
TRIPROLIDINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE AND CODEINE PHOSPHATE
WOCKHARDT 10MG/5ML;30MG/5ML;1.25MG/5ML A088833 001 Nov 16, 1984
CODEINE SULFATE
SOLUTION;ORAL
CODEINE SULFATE
HIKMA 30MG/5ML N202245 001 Jun 30, 2011
COLCHICINE
CAPSULE;ORAL
COLCHICINE
PAR PHARM INC 0.6MG A208678 001 Nov 29, 2018
COLCHICINE; PROBENECID
TABLET;ORAL
COLBENEMID
+ MERCK 0.5MG;500MG ** N012383 001
PROBEN-C
WATSON LABS 0.5MG;500MG A085552 001
PROBENECID AND COLCHICINE
ANI PHARMS 0.5MG;500MG A083734 001
BEECHAM 0.5MG;500MG A084321 001
IMPAX LABS 0.5MG;500MG A083720 002
SANDOZ 0.5MG;500MG A086130 001
PROBENECID W/ COLCHICINE
LEDERLE 0.5MG;500MG A086954 001
WATSON LABS 0.5MG;500MG A083221 001
COLESEVELAM HYDROCHLORIDE
BAR, CHEWABLE;ORAL
WELCHOL
+ COSETTE 3.75GM N210895 001 Apr 03, 2019
CAPSULE;ORAL
WELCHOL
COSETTE 375MG N021141 001 May 26, 2000
FOR SUSPENSION;ORAL
COLESEVELAM HYDROCHLORIDE
WATSON LABS INC 1.875GM/PACKET A202178 001 Sep 01, 2020
3.75GM/PACKET A202178 002 Sep 01, 2020
WELCHOL
+ COSETTE 1.875GM/PACKET ** N022362 001 Oct 02, 2009
TABLET;ORAL
COLESEVELAM HYDROCHLORIDE
INVAGEN PHARMS 625MG A212602 001 Apr 20, 2020
LUPIN LTD 625MG A201354 001 Dec 17, 2020
WATSON LABS INC 625MG A200830 001 Sep 02, 2020
COLISTIN SULFATE
SUSPENSION;ORAL
COLY-MYCIN S
PARKE DAVIS EQ 25MG BASE/5ML N050355 001
CONIVAPTAN HYDROCHLORIDE
INJECTABLE;INTRAVENOUS
VAPRISOL
CUMBERLAND PHARMS 20MG/4ML (5MG/ML) N021697 001 Dec 29, 2005
COPPER
INTRAUTERINE DEVICE;INTRAUTERINE
CU-7
GD SEARLE LLC 89MG N017408 001
TATUM-T
GD SEARLE LLC 120MG N018205 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-128(of 478)
** See List Footnote
CORTICOTROPIN
INJECTABLE;INJECTION
ACTH
PARKEDALE 25 UNITS/VIAL N008317 002
40 UNITS/VIAL N008317 004
ACTHAR
SANOFI AVENTIS US 25 UNITS/VIAL N007504 002
40 UNITS/VIAL N007504 003
ACTHAR GEL
MALLINCKRODT ARD 40 UNITS/ML N008372 006
CORTICOTROPIN
ORGANICS LAGRANGE 40 UNITS/ML N010831 001
80 UNITS/ML N010831 002
WATSON LABS 40 UNITS/VIAL A088772 001 Nov 21, 1984
PURIFIED CORTROPHIN GEL
ANI PHARMS 40 UNITS/ML N008975 001
CORTICOTROPIN-ZINC HYDROXIDE
INJECTABLE;INJECTION
CORTROPHIN-ZINC
ANI PHARMS 40 UNITS/ML N009854 001
CORTISONE ACETATE
INJECTABLE;INJECTION
CORTISONE ACETATE
PHARMACIA AND UPJOHN 25MG/ML N008126 002
WATSON LABS 25MG/ML A083147 003
25MG/ML A085677 001
50MG/ML A083147 004
50MG/ML A085677 002
CORTONE
MERCK 25MG/ML N007110 002
50MG/ML N007110 003
TABLET;ORAL
CORTISONE ACETATE
BARR 25MG A083471 001
CHARTWELL MOLECULAR 25MG A080694 001
ELKINS SINN 25MG A080836 001
EVERYLIFE 25MG A084246 001
HEATHER 25MG A085736 001
IMPAX LABS 25MG N009458 001
INWOOD LABS 25MG A080731 001
IVAX SUB TEVA PHARMS 25MG A080630 001
25MG A083536 001
PANRAY 5MG N008284 002
25MG N008284 001
PHARMACIA AND UPJOHN 5MG N008126 003
10MG N008126 004
25MG N008126 001
PUREPAC PHARM 25MG A080493 001
VITARINE 25MG A080333 001
WATSON LABS 25MG A085884 001
WHITEWORTH TOWN PLSN 25MG A080341 001
CORTONE
+ MERCK 25MG ** N007750 003
COSYNTROPIN
SOLUTION;INTRAVENOUS
COSYNTROPIN
SANDOZ INC 0.25MG/ML (0.25MG/ML) N022028 001 Feb 21, 2008
CROMOLYN SODIUM
AEROSOL, METERED;INHALATION
INTAL
KING PHARMS LLC 0.8MG/INH N018887 001 Dec 05, 1985
CAPSULE;INHALATION
INTAL
+ SANOFI AVENTIS US 20MG ** N016990 001
CAPSULE;ORAL
GASTROCROM
UCB INC 100MG N019188 001 Dec 22, 1989

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-129(of 478)
** See List Footnote
CROMOLYN SODIUM
CONCENTRATE;ORAL
CROMOLYN SODIUM
GENERA PHARMS 100MG/5ML A090954 001 Dec 18, 2009
SOLUTION;INHALATION
CROMOLYN SODIUM
ACTAVIS MID ATLANTIC 10MG/ML A075067 001 Jul 19, 1999
BAUSCH 10MG/ML A075585 001 Dec 21, 2000
HIKMA 10MG/ML A075333 001 Apr 30, 2002
MYLAN SPECIALITY LP 10MG/ML A074209 001 Apr 26, 1994
ROXANE 10MG/ML A075175 001 Sep 30, 1999
WATSON LABS 10MG/ML A076469 001 Jun 17, 2005
INTAL
+ KING PHARMS LLC 10MG/ML ** N018596 001 May 28, 1982
SOLUTION/DROPS;OPHTHALMIC
CROLOM
BAUSCH AND LOMB 4% A074443 001 Jan 30, 1995
CROMOLYN SODIUM
APOTEX INC 4% A075615 001 Jan 26, 2001
CROMOPTIC
KING PHARMS 4% A075088 001 Apr 27, 1999
OPTICROM
+ ALLERGAN 4% ** N018155 001 Oct 03, 1984
SPRAY, METERED;NASAL
CROMOLYN SODIUM
ACTAVIS MID ATLANTIC 5.2MG/SPRAY A074800 001 Jul 26, 2001
HH AND P 5.2MG/SPRAY A077976 001 Sep 07, 2007
PERRIGO 5.2MG/SPRAY A075427 001 Dec 12, 2001
NASALCROM
+ BLACKSMITH BRANDS 5.2MG/SPRAY ** N020463 001 Jan 03, 1997
CROTAMITON
CREAM;TOPICAL
EURAX
+ JOURNEY 10% N006927 001
CRYPTENAMINE ACETATES
INJECTABLE;INJECTION
UNITENSEN
MEDPOINTE PHARM HLC 260CSR UNIT/ML N008814 001
CRYPTENAMINE TANNATES
TABLET;ORAL
UNITENSEN
MEDPOINTE PHARM HLC 260CSR UNIT N009217 001
CUPRIC SULFATE
INJECTABLE;INJECTION
CUPRIC SULFATE
+ ABRAXIS PHARM EQ 0.4MG COPPER/ML ** N019350 001 May 05, 1987
CYANOCOBALAMIN
GEL, METERED;NASAL
NASCOBAL
PAR PHARM 0.5MG/INH N019722 001 Nov 05, 1996
INJECTABLE;INJECTION
BERUBIGEN
PHARMACIA AND UPJOHN 1MG/ML N006798 001
BETALIN 12
LILLY 0.1MG/ML A080855 001
1MG/ML A080855 002
COBAVITE
WATSON LABS 0.1MG/ML A083013 001
1MG/ML A083064 001
CYANOCOBALAMIN
ABRAXIS PHARM 0.03MG/ML A080510 003
0.1MG/ML A080510 001
1MG/ML A080510 002
AKORN 1MG/ML A087969 001 Nov 10, 1983
DELL LABS 0.03MG/ML A080689 001
0.1MG/ML A080689 002
1MG/ML A080689 003

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-130(of 478)
** See List Footnote
CYANOCOBALAMIN
INJECTABLE;INJECTION
CYANOCOBALAMIN
DR REDDYS 0.1MG/ML A080573 002
1MG/ML A080573 001
FRESENIUS KABI USA 0.1MG/ML A080557 002
LUITPOLD 0.03MG/ML A080668 001
LYPHOMED 1MG/ML A083075 001
MYLAN INSTITUTIONAL 1MG/ML A040451 001 Sep 23, 2003
SANOFI AVENTIS US 1MG/ML A080564 001
SOLOPAK 1MG/ML A087551 001 Feb 29, 1984
WARNER CHILCOTT 1MG/ML N007085 002
WATSON LABS 0.1MG/ML A083120 001
1MG/ML A083120 002
WYETH AYERST 0.1MG/ML A080554 001
1MG/ML A080554 002
XIROMED 1MG/ML A215046 001 Aug 20, 2021
REDISOL
MERCK 1MG/ML N006668 010
RUBIVITE
BEL MAR 0.03MG/ML N010791 004
0.05MG/ML N010791 001
0.1MG/ML N010791 002
0.12MG/ML N010791 005
1MG/ML N010791 003
RUBRAMIN PC
BRISTOL MYERS SQUIBB 0.1MG/ML N006799 002
+ 1MG/ML ** N006799 004
+ 1MG/ML ** N006799 010 Apr 28, 1988
RUVITE
SAVAGE LABS 1MG/ML A080570 002
VI-TWEL
BAYER HLTHCARE 1MG/ML N007012 002
SPRAY, METERED;NASAL
CALOMIST
PAR PHARM 25MCG/SPRAY N022102 001 Jul 27, 2007
CYANOCOBALAMIN
PADAGIS ISRAEL 0.5MG/SPRAY A212458 001 Sep 09, 2020
TABLET;ORAL
CYANOCOBALAMIN
WEST WARD 1MG A084264 001
CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; CYANOCOBALAMIN CO-58
N/A;N/A
DICOPAC KIT
GE HEALTHCARE N/A;N/A;N/A N017406 001
CYANOCOBALAMIN; TANNIC ACID; ZINC ACETATE
INJECTABLE;INJECTION
DEPINAR
ARMOUR PHARM 0.5MG/ML;2.3MG/ML;1MG/ML N011208 001
CYCLACILLIN
FOR SUSPENSION;ORAL
CYCLAPEN-W
WYETH AYERST 125MG/5ML N050508 001
250MG/5ML N050508 002
500MG/5ML N050508 003
TABLET;ORAL
CYCLACILLIN
TEVA 250MG A062895 001 Aug 04, 1988
500MG A062895 002 Aug 04, 1988
CYCLAPEN-W
WYETH AYERST 250MG N050509 001
500MG N050509 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-131(of 478)
** See List Footnote
CYCLIZINE LACTATE
INJECTABLE;INJECTION
MAREZINE
GLAXOSMITHKLINE 50MG/ML N009495 001
CYCLOBENZAPRINE HYDROCHLORIDE
TABLET;ORAL
CYCLOBENZAPRINE HYDROCHLORIDE
CHARTWELL RX 5MG A072854 002 Feb 03, 2006
10MG A072854 001 Nov 19, 1991
PLIVA 10MG A074421 001 Sep 29, 1995
RISING 5MG A073144 002 Feb 03, 2006
7.5MG A073144 003 Mar 25, 2013
10MG A073144 001 May 30, 1991
SANDOZ 10MG A073683 001 Feb 26, 1993
WATSON LABS 10MG A073143 001 Nov 27, 1991
10MG A074436 001 Nov 30, 1994
FLEXERIL
+ JANSSEN RES AND DEV 5MG ** N017821 001
+ 10MG ** N017821 002
CYCLOPENTOLATE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
AK-PENTOLATE
AKORN 1% A085555 001
CYCLOPENTOLATE HYDROCHLORIDE
ALCON PHARMS LTD 1% A089162 001 Jan 24, 1991
SOLA BARNES HIND 1% A084150 001
1% A084863 001
PENTOLAIR
PHARMAFAIR 0.5% A088643 001 Feb 09, 1987
1% A088150 001 Feb 25, 1983
CYCLOPHOSPHAMIDE
CAPSULE;ORAL
CYCLOPHOSPHAMIDE
ANI PHARMS 25MG A207014 001 Mar 19, 2018
50MG A207014 002 Mar 19, 2018
INJECTABLE;INJECTION
CYCLOPHOSPHAMIDE
BAXTER HLTHCARE 100MG/VIAL A088371 001 Jul 03, 1986
200MG/VIAL A088372 001 Jul 03, 1986
500MG/VIAL A088373 001 Jul 03, 1986
1GM/VIAL A088374 001 Sep 24, 1986
CYTOXAN
+ BAXTER HLTHCARE 100MG/VIAL ** N012142 001
+ 200MG/VIAL ** N012142 002
CYTOXAN (LYOPHILIZED)
+ BAXTER HLTHCARE 500MG/VIAL N012142 003
+ 500MG/VIAL ** N012142 008 Jan 04, 1984
+ 1GM/VIAL N012142 004 Aug 30, 1982
+ 1GM/VIAL ** N012142 010 Sep 24, 1985
+ 2GM/VIAL N012142 005 Aug 30, 1982
+ 2GM/VIAL ** N012142 009 Dec 10, 1985
LYOPHILIZED CYTOXAN
+ BAXTER HLTHCARE 100MG/VIAL ** N012142 006 Dec 05, 1985
+ 200MG/VIAL ** N012142 007 Dec 10, 1985
NEOSAR
BEDFORD 100MG/VIAL A087442 001 Feb 16, 1982
200MG/VIAL A087442 002 Feb 16, 1982
500MG/VIAL A087442 003 Feb 16, 1982
1GM/VIAL A087442 004 Jul 08, 1983
2GM/VIAL A087442 005 Mar 30, 1989
TEVA PARENTERAL 100MG/VIAL A040015 001 Apr 29, 1993
200MG/VIAL A040015 002 Apr 29, 1993
500MG/VIAL A040015 003 Apr 29, 1993
1GM/VIAL A040015 004 Apr 29, 1993
2GM/VIAL A040015 005 Apr 29, 1993

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-132(of 478)
** See List Footnote
CYCLOPHOSPHAMIDE
TABLET;ORAL
CYCLOPHOSPHAMIDE
ROXANE 25MG A040032 001 Aug 17, 1999
50MG A040032 002 Aug 17, 1999
CYCLOSPORINE
CAPSULE;ORAL
GENGRAF
ABBVIE 50MG A065003 002 May 12, 2000
NEORAL
+ NOVARTIS 50MG ** N050715 003 Jul 14, 1995
SOLUTION;ORAL
CYCLOSPORINE
MAYNE PHARMA 100MG/ML A065054 001 Dec 18, 2001
PHARM ASSOC 100MG/ML A065167 001 Jan 05, 2005
CYCLOTHIAZIDE
TABLET;ORAL
ANHYDRON
LILLY 2MG N013157 002
FLUIDIL
PHARMACIA AND UPJOHN 2MG N018173 001
CYCRIMINE HYDROCHLORIDE
TABLET;ORAL
PAGITANE
LILLY 1.25MG N008951 001
2.5MG N008951 002
CYPROHEPTADINE HYDROCHLORIDE
SYRUP;ORAL
CYPROHEPTADINE HYDROCHLORIDE
+ ACTAVIS MID ATLANTIC 2MG/5ML ** A086833 001
HALSEY 2MG/5ML A089199 001 Jul 03, 1986
MORTON GROVE 2MG/5ML A087001 001 Nov 04, 1982
NASKA 2MG/5ML A089021 001 Dec 21, 1987
TRIS PHARMA INC 2MG/5ML A205431 001 Dec 21, 2021
PERIACTIN
+ MERCK 2MG/5ML ** N013220 002
TABLET;ORAL
CYPROHEPTADINE HYDROCHLORIDE
AM THERAP 4MG A088798 001 Feb 15, 1985
ASCOT 4MG A087685 001 Oct 25, 1982
CHARTWELL RX 4MG A088212 001 May 26, 1983
DURAMED PHARMS BARR 4MG A088232 001 Oct 25, 1983
FOSUN PHARMA 4MG A086808 001
HALSEY 4MG A089057 001 Jul 03, 1986
KV PHARM 4MG A086737 001
MD PHARM 4MG A087566 001 Nov 10, 1982
MYLAN 4MG A086678 001
PIONEER PHARMS 4MG A087839 001 Feb 08, 1984
PLIVA 4MG A088205 001 Jul 26, 1983
STRIDES PHARMA 4MG A087129 001
SUPERPHARM 4MG A087405 001
VITARINE 4MG A087284 001
WATSON LABS 4MG A085245 001
4MG A086165 001
4MG A086580 001
PERIACTIN
+ MERCK 4MG ** N012649 001
CYSTEINE HYDROCHLORIDE
INJECTABLE;INJECTION
CYSTEINE HYDROCHLORIDE
+ HOSPIRA 7.25% ** N019523 001 Oct 22, 1986
SOLUTION;INTRAVENOUS
CYSTEINE HYDROCHLORIDE
DR REDDYS LABS SA 500MG/10ML (50MG/ML) A214082 001 Apr 08, 2022
NOURESS
+ BAXTER HLTHCARE CORP 500MG/10ML (50MG/ML) N212535 001 Dec 13, 2019

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-133(of 478)
** See List Footnote
CYTARABINE
INJECTABLE;INJECTION
CYTARABINE
MEITHEAL 20MG/ML A206189 001 Jun 26, 2020
20MG/ML A206190 001 Nov 09, 2017
MYLAN LABS LTD 20MG/ML A200916 001 Dec 13, 2011
RISING 20MG/ML A200914 001 Dec 13, 2011
+ TEVA PARENTERAL 100MG/VIAL ** N016793 001
+ 500MG/VIAL ** N016793 002
+ 1GM/VIAL ** N016793 003 Dec 21, 1987
+ 2GM/VIAL ** N016793 004 Dec 21, 1987
CYTOSAR-U
TEVA PHARMS USA 100MG/VIAL A075206 001 Dec 30, 1998
500MG/VIAL A075206 002 Dec 30, 1998
1GM/VIAL A075206 004 Dec 30, 1998
2GM/VIAL A075206 003 Dec 30, 1998
INJECTABLE, LIPOSOMAL;INJECTION
DEPOCYT
+ PACIRA PHARMS INC 10MG/ML N021041 001 Apr 01, 1999
DACARBAZINE
INJECTABLE;INJECTION
DACARBAZINE
ABRAXIS PHARM 100MG/VIAL A070962 001 Aug 28, 1986
200MG/VIAL A070990 001 Aug 28, 1986
DTIC-DOME
+ BAYER HLTHCARE 100MG/VIAL ** N017575 001
+ 200MG/VIAL ** N017575 002
DACLATASVIR DIHYDROCHLORIDE
TABLET;ORAL
DAKLINZA
+ BRISTOL-MYERS SQUIBB EQ 30MG BASE N206843 001 Jul 24, 2015
+ EQ 60MG BASE N206843 002 Jul 24, 2015
+ EQ 90MG BASE N206843 003 Apr 13, 2016
DACTINOMYCIN
INJECTABLE;INJECTION
DACTINOMYCIN
AM REGENT 0.5MG/VIAL A202562 001 Aug 23, 2013
HIKMA 0.5MG/VIAL A090304 001 Mar 16, 2010
DALFAMPRIDINE
TABLET, EXTENDED RELEASE;ORAL
DALFAMPRIDINE
HIKMA 10MG A206646 001 Oct 24, 2018
RISING 10MG A206858 001 Jul 06, 2020
DALFOPRISTIN; QUINUPRISTIN
INJECTABLE;INTRAVENOUS
SYNERCID
KING PHARMS 420MG/VIAL;180MG/VIAL N050748 002 Aug 24, 2000
DALTEPARIN SODIUM
INJECTABLE;INJECTION
FRAGMIN
PFIZER 7,500 IU/0.75ML N020287 008 Apr 04, 2002
INJECTABLE;SUBCUTANEOUS
FRAGMIN
PFIZER 10,000IU/0.4ML (25,000IU/ML) N020287 002 May 01, 2007
95,000IU/9.5ML (10,000IU/ML) N020287 007 Apr 04, 2002
DANAPAROID SODIUM
INJECTABLE;INJECTION
ORGARAN
ASPEN GLOBAL INC 750 UNITS/0.6ML N020430 001 Dec 24, 1996

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-134(of 478)
** See List Footnote
DANAZOL
CAPSULE;ORAL
DANAZOL
AM THERAP 200MG A071569 001 Dec 30, 1987
DANOCRINE
SANOFI AVENTIS US 50MG ** N017557 003
100MG ** N017557 004
200MG ** N017557 002
DANTROLENE SODIUM
INJECTABLE;INJECTION
DANTROLENE SODIUM
EUGIA PHARMA SPECLTS 20MG/VIAL A205239 001 Feb 18, 2016
DAPAGLIFLOZIN
TABLET;ORAL
DAPAGLIFLOZIN
ZYDUS PHARMS 5MG A211582 001 Feb 22, 2022
10MG A211582 002 Feb 22, 2022
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
QTERNMET XR
+ ASTRAZENECA AB 2.5MG;1GM;EQ 2.5MG BASE N210874 001 May 02, 2019
+ 5MG;1GM;EQ 2.5MG BASE N210874 002 May 02, 2019
+ 5MG;1GM;EQ 5MG BASE N210874 003 May 02, 2019
+ 10MG;1GM;EQ 5MG BASE N210874 004 May 02, 2019
DAPIPRAZOLE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
DAPIPRAZOLE HYDROCHLORIDE
+ FERA PHARMS 0.5% ** N019849 001 Dec 31, 1990
WOODWARD 0.5% A204902 001 May 30, 2019
DAPSONE
TABLET;ORAL
DAPSONE
ANDA REPOSITORY 25MG A204074 001 May 10, 2016
100MG A204074 002 May 10, 2016
TARO 25MG A209430 001 Mar 01, 2019
100MG A209430 002 Mar 01, 2019
DAPTOMYCIN
POWDER;INTRAVENOUS
CUBICIN
CUBIST PHARMS LLC 250MG/VIAL N021572 001 Sep 12, 2003
CUBICIN RF
+ CUBIST PHARMS LLC 500MG/VIAL N021572 003 Jul 06, 2016
DAPTOMYCIN
HISUN PHARM HANGZHOU 500MG/VIAL A212250 001 Apr 21, 2021
HOSPIRA 500MG/VIAL A202857 001 Sep 12, 2014
DAPZURA RT
+ BAXTER HLTHCARE CORP 500MG/VIAL N213645 001 Jan 25, 2022
DARIFENACIN HYDROBROMIDE
TABLET, EXTENDED RELEASE;ORAL
DARIFENACIN HYDROBROMIDE
ANCHEN PHARMS EQ 7.5MG BASE A091190 001 Mar 13, 2015
EQ 15MG BASE A091190 002 Mar 13, 2015
JUBILANT GENERICS EQ 7.5MG BASE A205550 001 Oct 12, 2016
EQ 15MG BASE A205550 002 Oct 12, 2016
XIROMED EQ 7.5MG BASE A209571 002 Oct 22, 2019
EQ 15MG BASE A209571 001 Oct 22, 2019
ENABLEX
+ APIL EQ 7.5MG BASE N021513 001 Dec 22, 2004
+ EQ 15MG BASE N021513 002 Dec 22, 2004

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-135(of 478)
** See List Footnote
DARUNAVIR
TABLET;ORAL
PREZISTA
+ JANSSEN PRODS 300MG ** N021976 001 Jun 23, 2006
+ 400MG ** N021976 003 Oct 21, 2008
DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
TABLET;ORAL
VIEKIRA PAK (COPACKAGED)
+ ABBVIE INC EQ 250MG BASE;12.5MG, 75MG, 50MG N206619 001 Dec 19, 2014
DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR
TABLET, EXTENDED RELEASE;ORAL
VIEKIRA XR
+ ABBVIE INC EQ 200MG BASE;8.33MG;50MG;33.33MG ** N208624 001 Jul 22, 2016
DASATINIB
TABLET;ORAL
DASATINIB
APOTEX 80MG A203180 001 Nov 23, 2021
140MG A203180 002 Nov 23, 2021
APOTEX INC 20MG A202103 001 Jun 10, 2016
50MG A202103 002 Jun 10, 2016
70MG A202103 003 Jun 10, 2016
100MG A202103 004 Jun 10, 2016
DAUNORUBICIN CITRATE
INJECTABLE, LIPOSOMAL;INJECTION
DAUNOXOME
GALEN (UK) EQ 2MG BASE/ML N050704 002 Apr 08, 1996
DAUNORUBICIN HYDROCHLORIDE
INJECTABLE;INJECTION
CERUBIDINE
SANOFI AVENTIS US EQ 20MG BASE/VIAL A061876 001
WYETH AYERST EQ 20MG BASE/VIAL ** N050484 001
DAUNORUBICIN HYDROCHLORIDE
HISUN PHARM HANGZHOU EQ 20MG BASE/VIAL A206195 001 Apr 25, 2019
TEVA PARENTERAL EQ 20MG BASE/VIAL A064212 001 Jun 23, 1998
EQ 50MG BASE/VIAL A064212 002 May 03, 1999
DECAMETHONIUM BROMIDE
INJECTABLE;INJECTION
SYNCURINE
GLAXOSMITHKLINE 1MG/ML N006931 002
DECITABINE
INJECTABLE;INTRAVENOUS
DACOGEN
+ OTSUKA 50MG/VIAL N021790 001 May 02, 2006
DECITABINE
CIPLA 50MG/VIAL A208601 001 Nov 16, 2017
DEFERASIROX
GRANULE;ORAL
DEFERASIROX
AMNEAL 90MG A214194 003 Aug 02, 2021
180MG A214194 001 Feb 09, 2021
360MG A214194 002 Feb 09, 2021
TABLET;ORAL
DEFERASIROX
AMNEAL 90MG A210727 001 Dec 27, 2019
180MG A210727 003 Jun 15, 2020
360MG A210727 002 Dec 27, 2019
TEVA PHARMS USA 90MG A209223 001 Nov 25, 2019
180MG A209223 003 Apr 24, 2020
360MG A209223 002 Nov 25, 2019
TABLET, FOR SUSPENSION;ORAL
DEFERASIROX
ZYDUS PHARMS 125MG A208882 001 May 05, 2020
250MG A208882 002 May 05, 2020
500MG A208882 003 May 05, 2020

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-136(of 478)
** See List Footnote
DEFERIPRONE
SOLUTION;ORAL
FERRIPROX
+ CHIESI 80MG/ML N208030 002 Apr 20, 2018
DEFEROXAMINE MESYLATE
INJECTABLE;INJECTION
DEFEROXAMINE MESYLATE
DR REDDYS 500MG/VIAL A076806 001 Mar 31, 2006
2GM/VIAL A076806 002 Mar 31, 2006
DESFERAL
+ NOVARTIS 2GM/VIAL N016267 002 May 25, 2000
DELAVIRDINE MESYLATE
TABLET;ORAL
RESCRIPTOR
+ VIIV HLTHCARE 100MG N020705 001 Apr 04, 1997
+ 200MG N020705 002 Jul 14, 1999
DEMECARIUM BROMIDE
SOLUTION/DROPS;OPHTHALMIC
HUMORSOL
MERCK 0.125% N011860 002
0.25% N011860 001
DEMECLOCYCLINE HYDROCHLORIDE
CAPSULE;ORAL
DECLOMYCIN
LEDERLE 150MG N050262 001
SYRUP;ORAL
DECLOMYCIN
LEDERLE 75MG/5ML N050257 001
TABLET;ORAL
DECLOMYCIN
COREPHARMA 75MG ** N050261 001
150MG ** N050261 002
300MG ** N050261 003
DEMECLOCYCLINE HYDROCHLORIDE
BARR 150MG A065171 001 Dec 13, 2004
300MG A065171 002 Dec 13, 2004
IMPAX LABS 150MG A065094 001 Mar 22, 2004
300MG A065094 002 Mar 22, 2004
DESERPIDINE
TABLET;ORAL
HARMONYL
ABBVIE 0.1MG N010796 001
0.25MG N010796 002
DESERPIDINE; HYDROCHLOROTHIAZIDE
TABLET;ORAL
ORETICYL 25
ABBVIE 0.125MG;25MG N012148 001
ORETICYL 50
ABBVIE 0.125MG;50MG N012148 003
ORETICYL FORTE
ABBVIE 0.25MG;25MG N012148 002
DESERPIDINE; METHYCLOTHIAZIDE
TABLET;ORAL
ENDURONYL
ABBOTT 0.25MG;5MG N012775 001
ENDURONYL FORTE
ABBOTT 0.5MG;5MG N012775 002
METHYCLOTHIAZIDE AND DESERPIDINE
WATSON LABS 0.25MG;5MG A088486 001 Aug 10, 1984
0.5MG;5MG A088452 001 Aug 10, 1984

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-137(of 478)
** See List Footnote
DESIPRAMINE HYDROCHLORIDE
CAPSULE;ORAL
PERTOFRANE
SANOFI AVENTIS US 25MG N013621 001
50MG N013621 002
TABLET;ORAL
DESIPRAMINE HYDROCHLORIDE
ANI PHARMS 10MG A205153 001 Oct 28, 2016
25MG A071803 002 Dec 08, 1987
25MG A205153 002 Oct 28, 2016
50MG A071803 003 Dec 08, 1987
50MG A205153 003 Oct 28, 2016
75MG A071803 004 Dec 08, 1987
75MG A205153 004 Oct 28, 2016
100MG A071803 001 May 29, 1997
100MG A205153 005 Oct 28, 2016
150MG A071803 005 May 29, 1997
150MG A205153 006 Oct 28, 2016
USL PHARMA 25MG A071864 001 Sep 09, 1987
50MG A071865 001 Sep 09, 1987
75MG A071866 001 Sep 09, 1987
100MG A071867 001 Sep 09, 1987
DESLANOSIDE
INJECTABLE;INJECTION
CEDILANID-D
NOVARTIS 0.2MG/ML N009282 002
DESLORATADINE
SOLUTION;ORAL
CLARINEX
+ MERCK SHARP DOHME 0.5MG/ML ** N021300 001 Sep 01, 2004
DESLORATADINE
TARO 0.5MG/ML A202936 001 May 26, 2016
TARO PHARM INDS LTD 0.5MG/ML A202592 001 Jun 30, 2015
TABLET;ORAL
DESLORATADINE
MYLAN PHARMS INC 5MG A078351 001 Feb 10, 2012
PERRIGO 5MG A078361 001 Dec 22, 2011
SANDOZ 5MG A078364 001 Dec 03, 2010
SUN PHARM INDS 5MG A078359 001 Nov 16, 2010
TABLET, ORALLY DISINTEGRATING;ORAL
CLARINEX
+ ORGANON 2.5MG ** N021312 002 Jul 14, 2005
+ 5MG ** N021312 001 Jun 26, 2002
DESLORATADINE; PSEUDOEPHEDRINE SULFATE
TABLET, EXTENDED RELEASE;ORAL
CLARINEX D 24 HOUR
+ ORGANON 5MG;240MG ** N021605 001 Mar 03, 2005
DESMOPRESSIN ACETATE
INJECTABLE;INJECTION
DDAVP
FERRING PHARMS INC 0.015MG/ML N018938 002 Apr 25, 1995
DESMOPRESSIN ACETATE
BEDFORD 0.004MG/ML A074575 001 Feb 18, 2000
HOSPIRA 0.004MG/ML A075220 001 Aug 28, 2000
DESMOPRESSIN ACETATE PRESERVATIVE FREE
BEDFORD 0.004MG/ML A074574 001 Feb 18, 2000
SOLUTION;NASAL
CONCENTRAID
FERRING 0.01% N019776 001 Dec 26, 1990
DDAVP
+ FERRING PHARMS INC 0.01% N017922 001
DESMOPRESSIN ACETATE
SUN PHARM INDS 0.01% A077212 001 Apr 12, 2012
SPRAY, METERED;NASAL
DDAVP
+ FERRING PHARMS INC 0.01MG/SPRAY ** N017922 002 Feb 06, 1989

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-138(of 478)
** See List Footnote
DESMOPRESSIN ACETATE
SPRAY, METERED;NASAL
DDAVP (NEEDS NO REFRIGERATION)
+ FERRING PHARMS INC 0.01MG/SPRAY N017922 003 Aug 07, 1996
MINIRIN
+ FERRING 0.01MG/SPRAY N021333 001 Sep 16, 2002
NOCTIVA
+ ACERUS PHARMS 0.00083MG/SPRAY N201656 001 Mar 03, 2017
+ 0.00166MG/SPRAY N201656 002 Mar 03, 2017
STIMATE
FERRING PHARMS INC 0.15MG/SPRAY N020355 001 Mar 07, 1994
STIMATE (NEEDS NO REFRIGERATION)
+ FERRING PHARMS INC 0.15MG/SPRAY N020355 002 Oct 24, 2007
TABLET;ORAL
DESMOPRESSIN ACETATE
FERRING 0.1MG N021795 001 May 08, 2008
0.2MG N021795 002 May 08, 2008
IMPAX LABS INC 0.1MG A077122 001 Jan 25, 2006
0.2MG A077122 002 Jan 25, 2006
MYLAN 0.1MG A200653 001 Jun 27, 2014
0.2MG A200653 002 Jun 27, 2014
DESOGESTREL; ETHINYL ESTRADIOL
TABLET;ORAL-21
DESOGEN
ORGANON USA INC 0.15MG;0.03MG N020071 001 Dec 10, 1992
DESOGESTREL AND ETHINYL ESTRADIOL
DURAMED PHARMS BARR 0.15MG;0.03MG A075256 001 Aug 12, 1999
ORTHO-CEPT
+ JANSSEN PHARMS 0.15MG;0.03MG ** N020301 001 Dec 14, 1992
TABLET;ORAL-28
DESOGEN
ORGANON USA INC 0.15MG;0.03MG N020071 002 Dec 10, 1992
DESOGESTREL AND ETHINYL ESTRADIOL
MAYNE PHARMA 0.15MG,N/A;0.02MG,0.01MG A076916 001 Dec 29, 2008
0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0. A077182 001 Jan 24, 2006
025MG
MYLAN LABS LTD 0.15MG;0.03MG A202085 001 May 20, 2015
NAARI PTE LTD 0.15MG;0.03MG A207067 001 Sep 13, 2018
EMOQUETTE
VINTAGE PHARMS LLC 0.15MG;0.03MG A076675 001 Feb 25, 2011
MIRCETTE
+ TEVA BRANDED PHARM 0.15MG,N/A;0.02MG,0.01MG ** N020713 001 Apr 22, 1998
ORTHO-CEPT
+ JANSSEN PHARMS 0.15MG;0.03MG ** N020301 002 Dec 14, 1992
DESONIDE
GEL;TOPICAL
DESONATE
+ LEO PHARMA AS 0.05% ** N021844 001 Oct 20, 2006
DESOXIMETASONE
CREAM;TOPICAL
DESOXIMETASONE
AKORN 0.05% A203787 001 Jan 06, 2017
0.25% A203234 001 Jun 12, 2015
TOPICORT
+ TARO PHARM INDS LTD 0.25% ** N017856 001
TOPICORT LP
+ TARO PHARM INDS LTD 0.05% ** N018309 001
GEL;TOPICAL
TOPICORT
+ TARO PHARM INDS LTD 0.05% ** N018586 001 Mar 29, 1982
OINTMENT;TOPICAL
DESOXIMETASONE
ALTANA 0.25% A073440 001 Apr 01, 1998
TOPICORT
TARO PHARM INDS LTD 0.25% A074286 001 Jun 07, 1996
+ 0.25% ** N018763 001 Sep 30, 1983

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-139(of 478)
** See List Footnote
DESOXYCORTICOSTERONE ACETATE
INJECTABLE;INJECTION
DOCA
ORGANON USA INC 5MG/ML N001104 001
PELLET;IMPLANTATION
PERCORTEN
NOVARTIS 125MG N005151 001
DESOXYCORTICOSTERONE PIVALATE
INJECTABLE;INJECTION
PERCORTEN
NOVARTIS 25MG/ML N008822 001
DESVENLAFAXINE
TABLET, EXTENDED RELEASE;ORAL
KHEDEZLA
OSMOTICA PHARM CORP 50MG N204683 001 Jul 10, 2013
100MG N204683 002 Jul 10, 2013
DESVENLAFAXINE FUMARATE
TABLET, EXTENDED RELEASE;ORAL
DESVENLAFAXINE
+ SUN PHARM EQ 50MG BASE N205583 001 Jan 28, 2014
+ EQ 100MG BASE N205583 002 Jan 28, 2014
TEVA PHARMS USA EQ 50MG BASE N205208 001 Oct 11, 2013
EQ 100MG BASE N205208 002 Oct 11, 2013
DESVENLAFAXINE SUCCINATE
TABLET, EXTENDED RELEASE;ORAL
DESVENLAFAXINE SUCCINATE
MYLAN EQ 50MG BASE A204095 001 Jun 29, 2015
EQ 100MG BASE A204095 002 Jun 29, 2015
DEXAMETHASONE
AEROSOL;TOPICAL
AEROSEB-DEX
ALLERGAN HERBERT 0.01% ** A083296 002
DECASPRAY
+ MERCK 0.04% ** N012731 002
ELIXIR;ORAL
DECADRON
MERCK 0.5MG/5ML N012376 002
DEXAMETHASONE
ALPHARMA US PHARMS 0.5MG/5ML A088997 001 Oct 10, 1986
+ WOCKHARDT BIO AG 0.5MG/5ML A088254 001 Jul 27, 1983
HEXADROL
ASPEN GLOBAL INC 0.5MG/5ML N012674 001
GEL;TOPICAL
DECADERM
MERCK 0.1% N013538 001
SUSPENSION/DROPS;OPHTHALMIC
DEXAMETHASONE
WATSON LABS 0.1% A089170 001 May 09, 1989
TABLET;ORAL
DECADRON
+ MERCK 0.25MG ** N011664 004
+ 0.5MG ** N011664 001
+ 0.75MG ** N011664 002
+ 1.5MG ** N011664 003
+ 4MG ** N011664 005
+ 6MG ** N011664 006 Jul 30, 1982
DEXAMETHASONE
BAUSCH 1.5MG A040700 001 Aug 15, 2008
HERITAGE PHARMA 1.5MG A085456 001
IMPAX LABS 0.75MG A085376 001
PHOENIX LABS NY 0.75MG A083806 001
PRASCO 0.75MG A080399 001
PVT FORM 0.75MG A083420 001
ROXANE 0.25MG A084614 001
STRIDES PHARMA 0.25MG A088149 001 Apr 28, 1983
SUN PHARM INDUSTRIES 0.25MG A084013 001
0.25MG A084764 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-140(of 478)
** See List Footnote
DEXAMETHASONE
TABLET;ORAL
DEXAMETHASONE
0.5MG A084084 001
0.5MG A084766 001
0.75MG A084081 001
0.75MG A084765 001
1.5MG A084086 001
1.5MG A084763 001
UPSHER SMITH 0.75MG A087534 001
1.5MG A087533 001
WATSON LABS 0.25MG A085455 001
0.5MG A085458 001
0.75MG A080968 001
0.75MG A084457 001
0.75MG A085818 001
1.5MG A085840 001
WHITEWORTH TOWN PLSN 0.75MG A084327 001
DEXONE 0.5
SOLVAY 0.5MG A084991 001
DEXONE 0.75
SOLVAY 0.75MG A084993 001
DEXONE 1.5
SOLVAY 1.5MG A084990 001
DEXONE 4
SOLVAY 4MG A084992 001
HEXADROL
ASPEN GLOBAL INC 0.5MG N012675 004
0.75MG N012675 007
1.5MG N012675 009
4MG N012675 010
DEXAMETHASONE ACETATE
INJECTABLE;INJECTION
DECADRON-LA
+ MERCK EQ 8MG BASE/ML ** N016675 001
DEXAMETHASONE ACETATE
WATSON LABS EQ 8MG BASE/ML A084315 001
WATSON LABS TEVA EQ 16MG BASE/ML A087711 001 May 24, 1982
DEXAMETHASONE SODIUM PHOSPHATE
AEROSOL;NASAL
DEXACORT
UCB INC EQ 0.1MG PHOSPHATE/INH N014242 001
AEROSOL, METERED;INHALATION
DEXACORT
UCB INC EQ 0.1MG PHOSPHATE/INH N013413 001
CREAM;TOPICAL
DECADRON
MERCK EQ 0.1% PHOSPHATE N011983 002
INJECTABLE;INJECTION
DECADRON
+ MERCK EQ 4MG PHOSPHATE/ML ** N012071 002
+ EQ 24MG PHOSPHATE/ML ** N012071 004
DEXACEN-4
CENT PHARMS EQ 4MG PHOSPHATE/ML A084342 001
DEXAMETHASONE
ABRAXIS PHARM EQ 4MG PHOSPHATE/ML A088448 001 Jan 25, 1984
FRESENIUS KABI USA EQ 10MG PHOSPHATE/ML A088469 001 Jan 25, 1984
DEXAMETHASONE SODIUM PHOSPHATE
AKORN EQ 4MG PHOSPHATE/ML A084493 001
BEL MAR EQ 4MG PHOSPHATE/ML A084752 001
DELL LABS EQ 4MG PHOSPHATE/ML A083161 001
DR REDDYS EQ 4MG PHOSPHATE/ML A089169 001 Apr 09, 1986
INTL MEDICATION EQ 20MG PHOSPHATE/ML A088522 001 Feb 17, 1984
+ LUITPOLD EQ 4MG PHOSPHATE/ML A087440 001 Jul 21, 1982
LYPHOMED EQ 4MG PHOSPHATE/ML A087065 001
TEVA PARENTERAL EQ 4MG PHOSPHATE/ML A081125 001 Aug 31, 1990
EQ 10MG PHOSPHATE/ML A081126 001 Aug 31, 1990
WATSON LABS EQ 4MG PHOSPHATE/ML A083702 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-141(of 478)
** See List Footnote
DEXAMETHASONE SODIUM PHOSPHATE
INJECTABLE;INJECTION
DEXAMETHASONE SODIUM PHOSPHATE
EQ 4MG PHOSPHATE/ML A084355 001
EQ 10MG PHOSPHATE/ML A087668 001 Jul 01, 1982
EQ 24MG PHOSPHATE/ML A085606 001
WYETH AYERST EQ 4MG PHOSPHATE/ML A085641 001
HEXADROL
+ ASPEN GLOBAL INC EQ 4MG PHOSPHATE/ML ** N014694 002
+ EQ 10MG PHOSPHATE/ML ** N014694 003
EQ 20MG PHOSPHATE/ML N014694 004
OINTMENT;OPHTHALMIC
DECADRON
MERCK EQ 0.05% PHOSPHATE N011977 001
DEXAIR
PHARMAFAIR EQ 0.05% PHOSPHATE A088071 001 Dec 28, 1982
MAXIDEX
ALCON EQ 0.05% PHOSPHATE A083342 001
SOLUTION/DROPS;OPHTHALMIC
DEXAIR
PHARMAFAIR EQ 0.1% PHOSPHATE A088433 001 Dec 15, 1983
DEXAMETHASONE SODIUM PHOSPHATE
SOLA BARNES HIND EQ 0.1% PHOSPHATE A084170 001
EQ 0.1% PHOSPHATE A084173 001
SOLUTION/DROPS;OPHTHALMIC, OTIC
DECADRON
+ MERCK EQ 0.1% PHOSPHATE N011984 001
DEXAMETHASONE SODIUM PHOSPHATE
SANDOZ INC EQ 0.1% PHOSPHATE A088771 001 Jan 16, 1985
SOLUTION/DROPS;OTIC
DEXAMETHASONE SODIUM PHOSPHATE
AKORN EQ 0.1% PHOSPHATE A084855 001
DEXAMETHASONE SODIUM PHOSPHATE; LIDOCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
DECADRON W/ XYLOCAINE
MERCK EQ 4MG PHOSPHATE/ML;10MG/ML N013334 002
DEXAMETHASONE SODIUM PHOSPHATE; NEOMYCIN SULFATE
OINTMENT;OPHTHALMIC
NEODECADRON
MERCK EQ 0.05% PHOSPHATE;EQ 3.5MG BASE/GM N050324 001
SOLUTION/DROPS;OPHTHALMIC
NEODECADRON
MERCK EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML N050322 001
NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE
BAUSCH AND LOMB EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML A064055 001 Oct 30, 1995
NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE
ALCON PHARMS LTD EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML A062714 001 Jul 21, 1986
PHARMAFAIR EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML A062539 001 Jan 10, 1985
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
DEXACIDIN
NOVARTIS 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM A062566 001 Feb 22, 1985
DEXASPORIN
PHARMAFAIR 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM A062411 001 May 16, 1983
SUSPENSION/DROPS;OPHTHALMIC
DEXACIDIN
NOVARTIS 0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A062544 001 Oct 29, 1984
DEXASPORIN
PHARMAFAIR 0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A062428 001 May 18, 1983
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
ALCON PHARMS LTD 0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A062721 001 Nov 17, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-142(of 478)
** See List Footnote
DEXBROMPHENIRAMINE MALEATE
SYRUP;ORAL
DISOMER
SCHERING 2MG/5ML N011814 002
TABLET;ORAL
DISOMER
SCHERING 2MG N011814 001
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
TABLET;ORAL
DISOPHROL
SCHERING 2MG;60MG N012394 002
TABLET, EXTENDED RELEASE;ORAL
BROMPHERIL
COPLEY PHARM 6MG;120MG A089116 001 Jan 22, 1987
DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE
AVANTHI INC 6MG;120MG A078648 001 Feb 27, 2013
DISOBROM
SANDOZ 6MG;120MG A070770 001 Sep 30, 1991
DISOPHROL
SCHERING PLOUGH 6MG;120MG N013483 004 Sep 13, 1982
DRIXORAL
+ SCHERING PLOUGH 6MG;120MG ** N013483 003 Sep 13, 1982
RESPORAL
PIONEER PHARMS 6MG;120MG A089139 001 Jun 16, 1988
DEXCHLORPHENIRAMINE MALEATE
SYRUP;ORAL
POLARAMINE
SCHERING 2MG/5ML A086837 001 Jul 19, 1982
TABLET;ORAL
DEXCHLORPHENIRAMINE MALEATE
ANI PHARMS 2MG A088682 001 Jan 17, 1986
POLARAMINE
+ SCHERING 2MG A086835 001
DEXLANSOPRAZOLE
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
DEXILANT SOLUTAB
+ TAKEDA PHARMS USA 30MG N208056 001 Jan 26, 2016
DEXMEDETOMIDINE HYDROCHLORIDE
INJECTABLE;INJECTION
DEXMEDETOMIDINE HYDROCHLORIDE
AM REGENT EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) A203773 001 May 12, 2017
PIRAMAL CRITICAL EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) A214794 001 Sep 03, 2021
SLAYBACK PHARMA LLC EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML) A212791 003 May 08, 2020
DEXMETHYLPHENIDATE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
DEXMETHYLPHENIDATE HYDROCHLORIDE
AUROLIFE PHARMA LLC 5MG A204266 001 Aug 25, 2015
10MG A204266 002 Aug 25, 2015
15MG A204266 003 Aug 25, 2015
20MG A204266 004 Dec 21, 2015
25MG A204266 005 May 04, 2021
30MG A202580 001 Aug 28, 2013
35MG A204266 006 May 04, 2021
40MG A204266 007 Aug 25, 2015
TABLET;ORAL
DEXMETHYLPHENIDATE HYDROCHLORIDE
BIONPHARMA INC 5MG A209754 001 Mar 24, 2020
10MG A209754 002 Mar 24, 2020
LANNETT CO INC 2.5MG A209468 001 Sep 25, 2017
5MG A209468 002 Sep 25, 2017
10MG A209468 003 Sep 25, 2017
TEVA PHARMS 2.5MG A077107 003 Jan 29, 2007
5MG A077107 001 Jan 29, 2007
10MG A077107 002 Jan 29, 2007

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-143(of 478)
** See List Footnote
DEXRAZOXANE HYDROCHLORIDE
INJECTABLE;INJECTION
TOTECT
+ CLINIGEN EQ 500MG BASE/VIAL ** N022025 001 Sep 06, 2007
ZINECARD
+ PFIZER EQ 250MG BASE/VIAL N020212 001 May 26, 1995
+ EQ 500MG BASE/VIAL N020212 002 May 26, 1995
DEXTROAMPHETAMINE SULFATE
CAPSULE;ORAL
DEXAMPEX
TEVA 15MG A085355 001
CAPSULE, EXTENDED RELEASE;ORAL
DEXTROAMPHETAMINE SULFATE
ABLE 5MG A076814 001 Aug 25, 2004
10MG A076814 002 Aug 25, 2004
15MG A076814 003 Aug 25, 2004
MAYNE PHARMA 5MG A076137 001 Jan 18, 2002
10MG A076137 002 Jan 18, 2002
15MG A076137 003 Jan 18, 2002
MYLAN 5MG A206735 001 Jan 27, 2016
10MG A206735 002 Jan 27, 2016
15MG A206735 003 Jan 27, 2016
NESHER PHARMS 5MG A209111 001 Jun 27, 2017
10MG A209111 002 Jun 27, 2017
15MG A209111 003 Jun 27, 2017
STRIDES PHARMA 5MG A205077 001 Jun 21, 2019
10MG A205077 002 Jun 21, 2019
15MG A205077 003 Jun 21, 2019
ELIXIR;ORAL
DEXEDRINE
GLAXOSMITHKLINE 5MG/5ML ** A083902 001
TABLET;ORAL
DEXAMPEX
TEVA 5MG A083735 001
10MG A083735 002
DEXEDRINE
+ GLAXOSMITHKLINE 5MG ** A084935 001
DEXTROAMPHETAMINE SULFATE
ANI PHARMS 5MG A085370 001
EPIC PHARMA LLC 5MG A090652 001 Mar 07, 2014
10MG A090652 002 Mar 07, 2014
HALSEY 10MG A083930 001
LANNETT 5MG A083903 001
10MG A083903 003
15MG A085652 001
MAST MM 5MG A086521 001
NESHER PHARMS 5MG A040365 001 Oct 31, 2002
5MG A206588 001 Mar 28, 2016
10MG A040367 001 Oct 31, 2002
10MG A206588 002 Mar 28, 2016
PUREPAC PHARM 5MG A084125 001
SANDOZ 10MG A085371 001
STRIDES PHARMA 5MG A040299 001 May 13, 1999
VITARINE 5MG A084986 001
10MG A085892 001
WINDER LABS LLC 2.5MG A212160 001 Jun 07, 2021
5MG A212160 002 Jun 07, 2021
7.5MG A212160 003 Jun 07, 2021
10MG A212160 004 Jun 07, 2021
15MG A212160 005 Jun 07, 2021
20MG A212160 006 Jun 07, 2021
30MG A212160 007 Jun 07, 2021
DEXTROSTAT
+ SHIRE 5MG ** A084051 001
+ 10MG ** A084051 002
FERNDEX
FERNDALE LABS 5MG A084001 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-144(of 478)
** See List Footnote
DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE
SYRUP;ORAL
PHERAZINE DM
HALSEY 15MG/5ML;6.25MG/5ML A088913 001 Mar 02, 1987
PROMETH W/ DEXTROMETHORPHAN
G AND W LABS INC 15MG/5ML;6.25MG/5ML ** A088762 001 Oct 31, 1984
PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
AKORN 15MG/5ML;6.25MG/5ML A040027 001 Jul 31, 1996
+ ANI PHARMS 15MG/5ML;6.25MG/5ML ** N011265 002 Apr 02, 1984
DEXTROSE
INJECTABLE;INJECTION
DEXTROSE 10% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML N018046 001
MILES 10GM/100ML N018504 001
DEXTROSE 2.5% IN PLASTIC CONTAINER
B BRAUN 2.5GM/100ML N018358 001
2.5GM/100ML N019626 001 Feb 02, 1988
DEXTROSE 20% IN PLASTIC CONTAINER
+ BAXTER HLTHCARE 20GM/100ML ** N017521 004
DEXTROSE 30% IN PLASTIC CONTAINER
+ BAXTER HLTHCARE 30GM/100ML ** N017521 003
DEXTROSE 38.5% IN PLASTIC CONTAINER
ABBOTT 38.5GM/100ML N018923 001 Sep 19, 1984
DEXTROSE 40% IN PLASTIC CONTAINER
+ BAXTER HLTHCARE 40GM/100ML ** N017521 002
DEXTROSE 5% IN PLASTIC CONTAINER
DHL 5GM/100ML N019971 001 Sep 28, 1995
+ ICU MEDICAL INC 50MG/ML N019222 001 Jul 13, 1984
DEXTROSE 50% IN PLASTIC CONTAINER
+ BAXTER HLTHCARE 50GM/100ML ** N017521 001
ICU MEDICAL INC 50GM/100ML N019894 001 Dec 26, 1989
DEXTROSE 60%
B BRAUN 60GM/100ML N017995 002 Sep 22, 1982
DEXTROSE 60% IN PLASTIC CONTAINER
B BRAUN 60GM/100ML N017995 001
+ BAXTER HLTHCARE 60GM/100ML ** N017521 005 Mar 26, 1982
60GM/100ML N020047 002 Jul 02, 1991
HOSPIRA 60GM/100ML N019346 001 Jan 25, 1985
DEXTROSE 7.7% IN PLASTIC CONTAINER
B BRAUN 7.7GM/100ML N019626 003 Feb 02, 1988
DEXTROSE 70% IN PLASTIC CONTAINER
+ BAXTER HLTHCARE 70GM/100ML ** N017521 006 Mar 26, 1982
DEXTROSE; MAGNESIUM ACETATE TETRAHYDRATE; POTASSIUM ACETATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 5GM/100ML;32MG/100ML;128MG/100ML;234MG/ N017385 001
100ML
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE
INJECTABLE;INJECTION
ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;31MG/100ML;130MG/100ML;26MG/1 N019025 001 Dec 27, 1984
00ML;320MG/100ML
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE;
SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS
INJECTABLE;INJECTION
IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER
HOSPIRA 5GM/100ML;53MG/100ML;100MG/100ML;100MG/ N019515 001 May 08, 1986
100ML;180MG/100ML;280MG/100ML;16MG/100M
L
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;30MG/100ML;97MG/100ML;220MG/1 N019844 001 Jun 10, 1993
00ML;140MG/100ML
ISOLYTE H W/ DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;30MG/100ML;97MG/100ML;220MG/1 N018273 001
00ML;140MG/100ML

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-145(of 478)
** See List Footnote
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM
GLUCONATE
INJECTABLE;INJECTION
ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;30MG/100ML;37MG/100ML;370MG/1 N019843 001 Aug 09, 1993
00ML;530MG/100ML;500MG/100ML
ISOLYTE S W/ DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;30MG/100ML;37MG/100ML;370MG/1 N018274 001
00ML;530MG/100ML;500MG/100ML
PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER
+ BAXTER HLTHCARE 5GM/100ML;30MG/100ML;37MG/100ML;368MG/1 N017451 001
00ML;526MG/100ML;502MG/100ML
DEXTROSE; POTASSIUM CHLORIDE
INJECTABLE;INJECTION
POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;37MG/100ML N019699 001 Sep 29, 1989
POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;75MG/100ML N018744 001 Nov 09, 1982
5GM/100ML;75MG/100ML N019699 002 Sep 29, 1989
POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;110MG/100ML N019699 003 Sep 29, 1989
POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;150MG/100ML N018744 002 Nov 09, 1982
POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;220MG/100ML N018744 003 Nov 09, 1982
5GM/100ML;220MG/100ML N019699 005 Sep 29, 1989
POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;300MG/100ML N018744 004 Nov 09, 1982
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;224MG/100ML N018371 003
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;298MG/100ML N018371 002
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM LACTATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC
ANHYDROUS
INJECTABLE;INJECTION
IONOSOL T AND DEXTROSE 5% IN PLASTIC CONTAINER
HOSPIRA 5GM/100ML;111MG/100ML;256MG/100ML;146MG N019514 001 May 08, 1986
/100ML;207MG/100ML
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;150MG/100ML;130MG/100ML;280MG N019870 001 Jun 10, 1993
/100ML;91MG/100ML
ISOLYTE M W/ DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;150MG/100ML;130MG/100ML;280MG N018270 001
/100ML;91MG/100ML
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE
INJECTABLE;INJECTION
DEXTROSE 5% AND ELECTROLYTE NO. 75 IN PLASTIC CONTAINER
BAXTER HLTHCARE 5GM/100ML;205MG/100ML;100MG/100ML;120MG N018840 001 Jun 29, 1983
/100ML;220MG/100ML
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE;INJECTION
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.075%
B BRAUN 5GM/100ML;75MG/100ML;200MG/100ML N018268 009
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;150MG/100ML;200MG/100ML N018268 004
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;220MG/100ML;200MG/100ML N018268 005
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;300MG/100ML;200MG/100ML N018268 006
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;75MG/100ML;330MG/100ML N018268 011 Jan 18, 1986
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;150MG/100ML;330MG/100ML N018268 012 Jan 18, 1986
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;220MG/100ML;330MG/100ML N018268 013 Jan 18, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-146(of 478)
** See List Footnote
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE;INJECTION
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.30% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;300MG/100ML;330MG/100ML N018268 014 Jan 18, 1986
DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.075%
B BRAUN 5GM/100ML;75MG/100ML;450MG/100ML N018268 010
DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;150MG/100ML;450MG/100ML N018268 001
DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;220MG/100ML;450MG/100ML N018268 002
DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;300MG/100ML;450MG/100ML N018268 003
DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER
BAXTER HLTHCARE 5GM/100ML;224MG/100ML;450MG/100ML N018008 003
DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER
BAXTER HLTHCARE 5GM/100ML;300MG/100ML;450MG/100ML N018008 001
DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER
BAXTER HLTHCARE 5GM/100ML;75MG/100ML;450MG/100ML N018008 002
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
FRESENIUS KABI USA 5GM/100ML;149MG/100ML;225MG/100ML A212348 001 Jul 30, 2021
+ ICU MEDICAL INC 5GM/100ML;74.5MG/100ML;225MG/100ML ** N018365 002 Jul 05, 1983
+ 5GM/100ML;149MG/100ML;225MG/100ML ** N018365 006 Mar 28, 1988
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;74.5MG/100ML;300MG/100ML N018876 001 Jan 17, 1986
5GM/100ML;149MG/100ML;300MG/100ML N018876 006 Mar 28, 1988
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45%
FRESENIUS KABI USA 5GM/100ML;74.5MG/100ML;450MG/100ML A213523 001 Mar 09, 2021
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
+ ICU MEDICAL INC 5GM/100ML;74.5MG/100ML;900MG/100ML N019691 002 Mar 24, 1988
+ 5GM/100ML;149MG/100ML;900MG/100ML N019691 004 Mar 24, 1988
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;224MG/100ML;225MG/100ML ** N018365 008 Mar 28, 1988
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;224MG/100ML;300MG/100ML N018876 007 Mar 28, 1988
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
+ ICU MEDICAL INC 5GM/100ML;224MG/100ML;450MG/100ML N018362 006 Mar 28, 1988
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
+ ICU MEDICAL INC 5GM/100ML;224MG/100ML;900MG/100ML N019691 006 Mar 24, 1988
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
FRESENIUS KABI USA 5GM/100ML;149MG/100ML;225MG/100ML A212348 002 Jul 30, 2021
+ ICU MEDICAL INC 5GM/100ML;298MG/100ML;225MG/100ML ** N018365 009 Mar 28, 1988
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;298MG/100ML;300MG/100ML N018876 008 Mar 28, 1988
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45%
FRESENIUS KABI USA 5GM/100ML;149MG/100ML;450MG/100ML A213523 002 Mar 09, 2021
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
+ ICU MEDICAL INC 5GM/100ML;298MG/100ML;450MG/100ML N018362 007 Mar 28, 1988
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9%
FRESENIUS KABI USA 5GM/100ML;149MG/100ML;900MG/100ML A213445 001 Mar 09, 2021
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
+ ICU MEDICAL INC 5GM/100ML;298MG/100ML;900MG/100ML N019691 008 Mar 24, 1988
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;149MG/100ML;300MG/100ML N018876 002 Jan 17, 1986
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;224MG/100ML;225MG/100ML ** N018365 003 Jul 05, 1983
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;224MG/100ML;300MG/100ML N018876 003 Jan 17, 1986
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45%
FRESENIUS KABI USA 5GM/100ML;224MG/100ML;450MG/100ML A213523 003 Mar 09, 2021
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
+ ICU MEDICAL INC 5GM/100ML;224MG/100ML;900MG/100ML N019691 007 Mar 24, 1988
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;298MG/100ML;225MG/100ML ** N018365 004 Jul 05, 1983
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;298MG/100ML;300MG/100ML N018876 004 Mar 28, 1988
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45%
FRESENIUS KABI USA 5GM/100ML;298MG/100ML;450MG/100ML A213523 004 Mar 09, 2021
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9%
FRESENIUS KABI USA 5GM/100ML;298MG/100ML;900MG/100ML A213445 002 Mar 09, 2021

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-147(of 478)
** See List Footnote
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE;INJECTION
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;74.5MG/100ML;225MG/100ML ** N018365 005 Mar 28, 1988
5GM/100ML;149MG/100ML;225MG/100ML ** N018365 007 Mar 28, 1988
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML;74.5MG/100ML;300MG/100ML N018876 005 Mar 28, 1988
5GM/100ML;149MG/100ML;300MG/100ML N018876 009 Mar 28, 1988
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
+ ICU MEDICAL INC 5GM/100ML;74.5MG/100ML;450MG/100ML N018362 008 Mar 28, 1988
+ 5GM/100ML;149MG/100ML;450MG/100ML N018362 004 Mar 28, 1988
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
+ ICU MEDICAL INC 5GM/100ML;74.5MG/100ML;900MG/100ML N019691 001 Mar 24, 1988
+ 5GM/100ML;149MG/100ML;900MG/100ML N019691 003 Mar 24, 1988
DEXTROSE; SODIUM CHLORIDE
INJECTABLE;INJECTION
DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;200MG/100ML N018386 001
DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;450MG/100ML N018229 001
DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 10GM/100ML;900MG/100ML N018047 001
BAXTER HLTHCARE 10GM/100ML;900MG/100ML N016696 001
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN 2.5GM/100ML;450MG/100ML N018030 001
HOSPIRA 2.5GM/100ML;450MG/100ML N018096 001
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 2.5GM/100ML;900MG/100ML N018376 001
DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
ABBOTT 3.3GM/100ML;300MG/100ML N018055 001
DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;110MG/100ML N018030 005
DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;200MG/100ML N018030 004
MILES 5GM/100ML;200MG/100ML N018399 001
DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
ABBOTT 5GM/100ML;225MG/100ML N019482 001 Oct 04, 1985
DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
ABBOTT 5GM/100ML;300MG/100ML N019486 001 Oct 04, 1985
MILES 5GM/100ML;300MG/100ML N018501 001
DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
B BRAUN 5GM/100ML;330MG/100ML N018030 003
DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
ABBOTT 5GM/100ML;450MG/100ML N019484 001 Oct 04, 1985
B BRAUN 5GM/100ML;450MG/100ML N018030 002
MILES 5GM/100ML;450MG/100ML N018400 001
DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
ABBOTT 5GM/100ML;900MG/100ML N019483 001 Oct 04, 1985
B BRAUN 5GM/100ML;900MG/100ML N018026 001
MILES 5GM/100ML;900MG/100ML N018500 001
DEXTROTHYROXINE SODIUM
TABLET;ORAL
CHOLOXIN
ABBVIE 1MG N012302 005
2MG N012302 002
4MG N012302 004
6MG N012302 006
DEZOCINE
INJECTABLE;INJECTION
DALGAN
ASTRAZENECA 5MG/ML N019082 001 Dec 29, 1989
10MG/ML N019082 002 Dec 29, 1989
15MG/ML N019082 003 Dec 29, 1989

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-148(of 478)
** See List Footnote
DIATRIZOATE MEGLUMINE
INJECTABLE;INJECTION
ANGIOVIST 282
BAYER HLTHCARE 60% A087726 001 Sep 23, 1982
CARDIOGRAFIN
BRACCO 85% N011620 002
DIATRIZOATE MEGLUMINE
BRACCO 76% N010040 017
HYPAQUE
GE HEALTHCARE 30% N016403 002
60% N016403 001
RENO-60
BRACCO 60% N010040 016
RENO-DIP
BRACCO 30% N010040 012
UROVIST MEGLUMINE DIU/CT
BAYER HLTHCARE 30% A087739 001 Sep 23, 1982
SOLUTION;URETERAL
RENO-30
BRACCO 30% N010040 021
UROVIST CYSTO
BAYER HLTHCARE 30% A087729 001 Sep 23, 1982
UROVIST CYSTO PEDIATRIC
BAYER HLTHCARE 30% A087731 001 Sep 23, 1982
SOLUTION;URETHRAL
HYPAQUE-CYSTO
GE HEALTHCARE 30% N016403 003
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
INJECTABLE;INJECTION
ANGIOVIST 292
BAYER HLTHCARE 52%;8% A087724 001 Sep 23, 1982
ANGIOVIST 370
BAYER HLTHCARE 66%;10% A087723 001 Sep 23, 1982
DIATRIZOATE-60
INTL MEDICATION 52%;8% A088166 001 Jun 17, 1983
HYPAQUE-76
GE HEALTHCARE 66%;10% A086505 001
HYPAQUE-M,75%
GE HEALTHCARE 50%;25% N010220 003
HYPAQUE-M,90%
GE HEALTHCARE 60%;30% N010220 002
MD-60
MALLINCKRODT 52%;8% A087074 001
MD-76
MALLINCKRODT 66%;10% A087073 001
MD-76R
+ LIEBEL-FLARSHEIM 66%;10% N019292 001 Sep 29, 1989
RENOCAL-76
BRACCO 66%;10% A089347 001 Jun 01, 1988
RENOGRAFIN-60
BRACCO 52%;8% N010040 006
RENOGRAFIN-76
+ BRACCO 66%;10% N010040 001
RENOVIST
BRACCO 34.3%;35% N010040 020
RENOVIST II
BRACCO 28.5%;29.1% N010040 019
SOLUTION;ORAL, RECTAL
GASTROVIST
BAYER HLTHCARE 66%;10% A087728 001 Sep 23, 1982
DIATRIZOATE MEGLUMINE; IODIPAMIDE MEGLUMINE
SOLUTION;INTRAUTERINE
SINOGRAFIN
+ BRACCO 52.7%;26.8% N011324 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-149(of 478)
** See List Footnote
DIATRIZOATE SODIUM
FOR SOLUTION;ORAL, RECTAL
HYPAQUE
GE HEALTHCARE 100% N011386 001
INJECTABLE;INJECTION
HYPAQUE
GE HEALTHCARE 25% N009561 003
50% N009561 001
MD-50
MALLINCKRODT 50% A087075 001
UROVIST SODIUM 300
BAYER HLTHCARE 50% A087725 001 Sep 23, 1982
SOLUTION;ORAL, RECTAL
HYPAQUE
GE HEALTHCARE 40% N011386 003
SOLUTION;URETERAL
HYPAQUE SODIUM 20%
GE HEALTHCARE 20% N009561 002
DIAZEPAM
CAPSULE, EXTENDED RELEASE;ORAL
VALRELEASE
ROCHE 15MG N018179 001
GEL;RECTAL
DIASTAT
+ BAUSCH 5MG/ML (5MG/ML) ** N020648 002 Jul 29, 1997
+ 10MG/2ML (5MG/ML) ** N020648 003 Jul 29, 1997
+ 15MG/3ML (5MG/ML) ** N020648 004 Jul 29, 1997
+ 20MG/4ML (5MG/ML) ** N020648 005 Jul 29, 1997
INJECTABLE;INJECTION
DIAZEPAM
ABRAXIS PHARM 5MG/ML A070662 001 Jun 25, 1986
HIKMA 5MG/ML A070311 001 Dec 16, 1985
5MG/ML A070312 001 Dec 16, 1985
5MG/ML A071308 001 Jul 17, 1987
5MG/ML A071309 001 Jul 17, 1987
5MG/ML A071310 001 Jul 17, 1987
HOSPIRA 5MG/ML A071584 001 Oct 13, 1987
MARSAM PHARMS LLC 5MG/ML A072371 001 Jan 29, 1993
PARENTA PHARMS 5MG/ML A076815 001 Apr 15, 2004
US ARMY 5MG/ML ** N020124 001 Dec 05, 1990
WARNER CHILCOTT 5MG/ML A071613 001 Oct 22, 1987
5MG/ML A071614 001 Oct 22, 1987
WATSON LABS 5MG/ML A070296 001 Feb 12, 1986
5MG/ML A070911 001 Aug 28, 1986
5MG/ML A070912 001 Aug 28, 1986
5MG/ML A070930 001 Dec 01, 1986
WATSON LABS INC 5MG/ML A072370 001 Jan 29, 1993
5MG/ML A072397 001 Jan 29, 1993
DIZAC
PHARMACIA AND UPJOHN 5MG/ML ** N019287 001 Jun 18, 1993
VALIUM
+ ROCHE 5MG/ML ** N016087 001
TABLET;ORAL
DIAZEPAM
ACTAVIS ELIZABETH 2MG A070781 001 Mar 19, 1986
5MG A070706 001 Mar 19, 1986
10MG A070707 001 Mar 19, 1986
BARR 2MG A070152 001 Nov 01, 1985
10MG A070154 001 Nov 01, 1985
DAVA PHARMS INC 2MG A070228 002 Sep 26, 1985
5MG A070228 003 Sep 26, 1985
10MG A070228 001 Sep 26, 1985
DURAMED PHARMS BARR 2MG A070894 001 Aug 27, 1986
5MG A070895 001 Aug 27, 1986
10MG A070896 001 Aug 27, 1986
FERNDALE LABS 2MG A070903 001 Apr 01, 1987
5MG A070904 001 Apr 01, 1987
10MG A070905 001 Apr 01, 1987
HALSEY 2MG A070987 001 Aug 15, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-150(of 478)
** See List Footnote
DIAZEPAM
TABLET;ORAL
DIAZEPAM
5MG A070996 001 Aug 15, 1986
10MG A070956 001 Aug 15, 1986
IVAX SUB TEVA PHARMS 2MG A070360 001 Sep 04, 1985
5MG A070361 001 Sep 04, 1985
10MG A070362 001 Sep 04, 1985
MARTEC USA LLC 10MG A072402 001 Apr 25, 1989
NUVO PHARM 10MG A070464 001 Feb 25, 1986
PIONEER PHARMS 2MG A070787 001 Aug 02, 1988
5MG A070788 001 Aug 02, 1988
10MG A070776 001 Aug 02, 1988
ROXANE 2MG A070356 001 Jun 17, 1986
5MG A070357 001 Jun 17, 1986
10MG A070358 001 Jun 17, 1986
TEVA PHARMS 5MG A070153 001 Nov 01, 1985
UPSHER SMITH LABS 2MG A070302 001 Dec 20, 1985
5MG A070303 001 Dec 20, 1985
10MG A070304 001 Dec 20, 1985
VIRTUS PHARMS 2MG A070462 001 Feb 25, 1986
5MG A070463 001 Feb 25, 1986
WARNER CHILCOTT 2MG A070209 001 Sep 04, 1985
5MG A070210 001 Sep 04, 1985
10MG A070222 001 Sep 04, 1985
WATSON LABS 2MG A070456 001 Nov 01, 1985
5MG A070457 001 Nov 01, 1985
10MG A070458 001 Nov 01, 1985
Q-PAM
QUANTUM PHARMICS 2MG A070423 001 Dec 12, 1985
2MG A072431 001 Apr 29, 1988
5MG A070424 001 Dec 12, 1985
5MG A072432 001 Apr 29, 1988
10MG A070425 001 Dec 12, 1985
10MG A072433 001 Apr 29, 1988
DIAZOXIDE
CAPSULE;ORAL
PROGLYCEM
TEVA BRANDED PHARM 50MG N017425 001
100MG N017425 002
INJECTABLE;INJECTION
DIAZOXIDE
ABRAXIS PHARM 15MG/ML A071519 001 Aug 26, 1987
HYPERSTAT
SCHERING 15MG/ML N016996 001
DIBUCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
HEAVY SOLUTION NUPERCAINE
NOVARTIS 2.5MG/ML N006203 001
DICHLORPHENAMIDE
TABLET;ORAL
DARANIDE
+ XERIS 50MG ** N011366 001
DICLOFENAC
CAPSULE;ORAL
ZORVOLEX
+ ZYLA 18MG ** N204592 001 Oct 18, 2013
+ 35MG N204592 002 Oct 18, 2013
DICLOFENAC POTASSIUM
TABLET;ORAL
CATAFLAM
+ NOVARTIS 25MG ** N020142 001 Nov 24, 1993
+ 50MG ** N020142 002 Nov 24, 1993
DICLOFENAC POTASSIUM
SANDOZ 50MG A075582 001 Feb 23, 2001
SUN PHARM INDUSTRIES 50MG A075470 001 Feb 21, 2002
WATSON LABS TEVA 50MG A075152 001 Nov 27, 1998

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-151(of 478)
** See List Footnote
DICLOFENAC SODIUM
GEL;TOPICAL
SOLARAZE
+ FOUGERA PHARMS 3% ** N021005 001 Oct 16, 2000
SOLUTION;INTRAVENOUS
DICLOFENAC SODIUM
RISING 37.5MG/ML (37.5MG/ML) A208786 001 Jun 18, 2019
DYLOJECT
+ JAVELIN PHARMS INC 37.5MG/ML (37.5MG/ML) ** N022396 001 Dec 23, 2014
SOLUTION;TOPICAL
DICLOFENAC SODIUM
APOTEX INC 1.5% A202027 001 May 27, 2014
RISING 1.5% A206715 001 Aug 07, 2017
TWI PHARMS 1.5% A202393 001 Nov 24, 2014
PENNSAID
+ NUVO PHARMS INC 1.5% ** N020947 001 Nov 04, 2009
SOLUTION/DROPS;OPHTHALMIC
DICLOFENAC SODIUM
AKORN 0.1% A077845 001 Apr 17, 2008
FALCON PHARMS 0.1% N020809 001 May 04, 1998
RUBICON 0.1% A077600 001 Nov 13, 2008
VOLTAREN
+ NOVARTIS 0.1% N020037 001 Mar 28, 1991
TABLET, DELAYED RELEASE;ORAL
DICLOFENAC SODIUM
AUROBINDO PHARMA USA 50MG A075281 002 Feb 12, 2002
75MG A075281 003 Feb 12, 2002
CHARTWELL RX 25MG A074376 001 Sep 28, 1995
50MG A074376 002 Sep 28, 1995
75MG A074394 001 Nov 30, 1995
MICRO LABS 50MG A074986 001 Feb 26, 1999
75MG A074986 002 Feb 26, 1999
PLIVA 50MG A074432 002 Jul 29, 1999
75MG A074432 003 Jul 29, 1999
ROXANE 25MG A074391 001 Jun 29, 1995
50MG A074391 002 Jun 29, 1995
75MG A074391 003 Jun 29, 1995
TEVA 50MG A074723 001 Mar 30, 1999
75MG A074390 001 Aug 15, 1996
TEVA PHARMS 25MG A074459 001 Jun 25, 1997
50MG A074459 002 Jun 25, 1997
75MG A074459 003 Jun 25, 1997
VOLTAREN
+ NOVARTIS 25MG ** N019201 001 Jul 28, 1988
+ 50MG ** N019201 002 Jul 28, 1988
+ 75MG ** N019201 003 Jul 28, 1988
TABLET, EXTENDED RELEASE;ORAL
DICLOFENAC SODIUM
ACTAVIS ELIZABETH 100MG A075910 001 Jan 07, 2002
MYLAN 100MG A076152 001 Dec 13, 2001
VOLTAREN-XR
+ NOVARTIS 100MG ** N020254 001 Mar 08, 1996
DICLOFENAC SODIUM; MISOPROSTOL
TABLET, DELAYED RELEASE;ORAL
DICLOFENAC SODIUM AND MISOPROSTOL
EXELA HOLDINGS 50MG;0.2MG A200540 001 Mar 14, 2014
75MG;0.2MG A200540 002 Mar 14, 2014
DICLOXACILLIN SODIUM
CAPSULE;ORAL
DICLOXACILLIN SODIUM
SANDOZ EQ 125MG BASE A061454 002
EQ 250MG BASE A061454 001
EQ 500MG BASE A061454 003
DYCILL
GLAXOSMITHKLINE EQ 250MG BASE A060254 002
EQ 250MG BASE A062238 001
EQ 500MG BASE A060254 003
EQ 500MG BASE A062238 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-152(of 478)
** See List Footnote
DICLOXACILLIN SODIUM
CAPSULE;ORAL
PATHOCIL
+ WYETH AYERST EQ 250MG BASE ** N050011 002
+ EQ 500MG BASE ** N050011 003 Mar 28, 1983
FOR SUSPENSION;ORAL
DICLOXACILLIN SODIUM
APOTHECON EQ 62.5MG BASE/5ML A061455 001
DYNAPEN
APOTHECON EQ 62.5MG BASE/5ML N050337 002
PATHOCIL
WYETH AYERST EQ 62.5MG BASE/5ML N050092 001
DICUMAROL
CAPSULE;ORAL
DICUMAROL
LILLY 25MG N005509 003
50MG N005509 001
TABLET;ORAL
DICUMAROL
ABBVIE 25MG N005545 003
50MG N005545 004
100MG N005545 005
DICYCLOMINE HYDROCHLORIDE
CAPSULE;ORAL
BENTYL
+ ALLERGAN 10MG ** N007409 003 Oct 15, 1984
DICYCLOMINE HYDROCHLORIDE
PIONEER PHARMS 10MG A089361 001 Jan 10, 1989
SUN PHARM INDUSTRIES 10MG A084505 001 Oct 21, 1986
WATSON LABS 10MG A083179 001 Feb 12, 1986
INJECTABLE;INJECTION
DICYCLOMINE HYDROCHLORIDE
ATHENEX INC 10MG/ML A212058 001 Apr 26, 2019
DR REDDYS 10MG/ML A080614 001 Feb 11, 1986
HIKMA 10MG/ML A210788 001 Feb 11, 2019
SYRUP;ORAL
BENTYL
+ APTALIS PHARMA US 10MG/5ML ** N007961 002 Oct 15, 1984
DICYCLOMINE HYDROCHLORIDE
ALPHARMA US PHARMS 10MG/5ML A084479 001
TABLET;ORAL
BENTYL
+ ALLERGAN 20MG ** N007409 001 Oct 15, 1984
DICYCLOMINE HYDROCHLORIDE
AUROBINDO PHARMA USA 20MG A040317 001 Sep 07, 1999
PIONEER PHARMS 20MG A088585 001 Aug 20, 1986
SUN PHARM INDUSTRIES 20MG A084600 001 Jul 29, 1985
WATSON LABS 20MG A084361 001 Feb 06, 1986
DIDANOSINE
CAPSULE, DELAYED REL PELLETS;ORAL
DIDANOSINE
AUROBINDO PHARMA 125MG A090094 001 Sep 24, 2008
200MG A090094 002 Sep 24, 2008
250MG A090094 003 Sep 24, 2008
400MG A090094 004 Sep 24, 2008
BARR 200MG A077167 001 Dec 03, 2004
250MG A077167 002 Dec 03, 2004
400MG A077167 003 Dec 03, 2004
MYLAN PHARMS INC 125MG A090788 001 Apr 08, 2010
200MG A090788 002 Apr 08, 2010
250MG A090788 003 Apr 08, 2010
400MG A090788 004 Apr 08, 2010
VIDEX EC
+ BRISTOL MYERS SQUIBB 125MG ** N021183 001 Oct 31, 2000
+ 200MG ** N021183 002 Oct 31, 2000
+ 250MG ** N021183 003 Oct 31, 2000
+ 400MG ** N021183 004 Oct 31, 2000

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-153(of 478)
** See List Footnote
DIDANOSINE
FOR SOLUTION;ORAL
DIDANOSINE
AUROBINDO PHARMA 10MG/ML A078112 001 Mar 08, 2007
VIDEX
+ BRISTOL 10MG/ML N020156 001 Oct 09, 1991
BRISTOL MYERS SQUIBB 100MG/PACKET N020155 003 Oct 09, 1991
167MG/PACKET N020155 004 Oct 09, 1991
250MG/PACKET N020155 005 Oct 09, 1991
375MG/PACKET N020155 006 Oct 09, 1991
TABLET, CHEWABLE;ORAL
VIDEX
+ BRISTOL MYERS SQUIBB 25MG ** N020154 002 Oct 09, 1991
+ 50MG ** N020154 003 Oct 09, 1991
+ 100MG ** N020154 004 Oct 09, 1991
+ 150MG ** N020154 005 Oct 09, 1991
+ 200MG ** N020154 006 Oct 28, 1999
TABLET, FOR SUSPENSION;ORAL
DIDANOSINE
AUROBINDO 100MG A077275 001 Aug 14, 2012
150MG A077275 002 Aug 14, 2012
200MG A077275 003 Aug 14, 2012
DIENESTROL
CREAM;VAGINAL
DIENESTROL
ORTHO MCNEIL PHARM 0.01% N006110 005
DV
SANOFI AVENTIS US 0.01% A083518 001
ESTRAGUARD
SOLVAY 0.01% A084436 001
SUPPOSITORY;VAGINAL
DV
SANOFI AVENTIS US 0.7MG A083517 001
DIETHYLCARBAMAZINE CITRATE
TABLET;ORAL
HETRAZAN
LEDERLE 50MG N006459 001
DIETHYLPROPION HYDROCHLORIDE
TABLET;ORAL
DIETHYLPROPION HYDROCHLORIDE
CHARTWELL RX 25MG A088267 001 Aug 25, 1983
25MG A088268 001 Aug 25, 1983
EPIC PHARMA LLC 25MG A040828 001 Nov 05, 2008
SANDOZ 25MG A085916 001
TEVA 25MG A088642 001 Sep 20, 1984
UCB INC 25MG A085544 001
WATSON LABS 25MG A085741 001
TENUATE
+ NOSTRUM LABS INC 25MG N011722 002
SANOFI AVENTIS US 25MG N017668 001
TEPANIL
3M 25MG N011673 001
TABLET, EXTENDED RELEASE;ORAL
TENUATE
SANOFI AVENTIS US 75MG N017669 001
TENUATE DOSPAN
+ NOSTRUM LABS INC 75MG N012546 001
TEPANIL TEN-TAB
3M 75MG N017956 001
DIETHYLSTILBESTROL
INJECTABLE;INJECTION
STILBESTROL
BRISTOL MYERS SQUIBB 0.2MG/ML N004056 003
0.5MG/ML N004056 004
1MG/ML N004056 005
5MG/ML N004056 006

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-154(of 478)
** See List Footnote
DIETHYLSTILBESTROL
SUPPOSITORY;VAGINAL
DIETHYLSTILBESTROL
LILLY 0.1MG N004040 001
0.5MG N004040 002
STILBESTROL
BRISTOL MYERS SQUIBB 0.1MG N004056 001
0.5MG N004056 002
TABLET;ORAL
DIETHYLSTILBESTROL
LILLY 0.1MG N004041 002
0.5MG N004041 003
1MG N004041 004
5MG N004041 005
STILBESTROL
TABLICAPS 0.5MG A083004 001
1MG A083002 001
5MG A083006 001
STILBETIN
BRISTOL MYERS SQUIBB 0.1MG N004056 007
0.25MG N004056 017
0.5MG N004056 008
1MG N004056 009
5MG N004056 010
TABLET, DELAYED RELEASE;ORAL
DIETHYLSTILBESTROL
LILLY 0.1MG N004039 002
0.25MG N004039 005
0.5MG N004039 003
1MG N004039 004
5MG N004039 006
STILBESTROL
TABLICAPS 0.5MG A083003 001
1MG A083005 001
5MG A083007 001
STILBETIN
BRISTOL MYERS SQUIBB 0.1MG N004056 011
0.5MG N004056 012
1MG N004056 013
5MG N004056 014
DIETHYLSTILBESTROL DIPHOSPHATE
INJECTABLE;INJECTION
STILPHOSTROL
BAYER PHARMS 250MG/5ML N010010 001
TABLET;ORAL
STILPHOSTROL
BAYER PHARMS 50MG N010010 002
DIFLORASONE DIACETATE
CREAM;TOPICAL
DIFLORASONE DIACETATE
FOUGERA PHARMS 0.05% A075187 001 Mar 30, 1998
FLORONE
PFIZER 0.05% ** N017741 001
FLORONE E
PFIZER 0.05% N019259 001 Aug 28, 1985
PSORCON
+ TARO PHARMS NORTH 0.05% ** N020205 001 Nov 20, 1992
OINTMENT;TOPICAL
DIFLORASONE DIACETATE
AKORN 0.05% A206572 001 Jul 24, 2015
PSORCON
+ PFIZER 0.05% N019260 001 Aug 28, 1985
PSORCON E
PFIZER 0.05% N017994 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-155(of 478)
** See List Footnote
DIFLUNISAL
TABLET;ORAL
DIFLUNISAL
ANI PHARMS 500MG A074604 001 Jun 10, 1996
DASTECH INTL 250MG A073562 001 Nov 27, 1992
500MG A073563 001 Nov 27, 1992
PUREPAC PHARM 250MG A074285 001 May 07, 1996
500MG A074285 002 May 07, 1996
TEVA 250MG A073679 001 Jul 31, 1992
WATSON LABS 250MG A074400 001 Jul 17, 1997
500MG A074400 002 Jul 17, 1997
DOLOBID
+ MERCK 250MG ** N018445 001 Apr 19, 1982
+ 500MG ** N018445 002 Apr 19, 1982
DIGITOXIN
INJECTABLE;INJECTION
CRYSTODIGIN
LILLY 0.2MG/ML A084100 005
DIGOXIN
CAPSULE;ORAL
LANOXICAPS
GLAXOSMITHKLINE LLC 0.05MG N018118 002 Jul 26, 1982
0.1MG N018118 003 Jul 26, 1982
0.15MG N018118 004 Sep 24, 1984
0.2MG N018118 001 Jul 26, 1982
INJECTABLE;INJECTION
DIGOXIN
ABRAXIS PHARM 0.25MG/ML A083217 001
HOSPIRA 0.25MG/ML A040093 001 May 16, 1996
0.25MG/ML A040206 001 Aug 28, 1998
WYETH AYERST 0.25MG/ML A084386 001
DIGOXIN PEDIATRIC
HOSPIRA 0.1MG/ML A040092 001 Apr 25, 1996
TABLET;ORAL
LANOXIN
+ CONCORDIA 0.1875MG N020405 003 Sep 30, 1997
0.375MG N020405 005 Sep 30, 1997
0.5MG N020405 006 Sep 30, 1997
DIHYDROERGOTAMINE MESYLATE
INJECTABLE;INJECTION
D.H.E. 45
+ BAUSCH 1MG/ML N005929 001
SPRAY, METERED;NASAL
DIHYDROERGOTAMINE MESYLATE
AMNEAL 0.5MG/SPRAY A214105 001 Jan 04, 2022
DIHYDROERGOTAMINE MESYLATE; HEPARIN SODIUM; LIDOCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
EMBOLEX
NOVARTIS 0.5MG/0.5ML;2,500 N018885 001 Nov 30, 1984
UNITS/0.5ML;5.33MG/0.5ML
0.5MG/0.7ML;5,000 N018885 002 Nov 30, 1984
UNITS/0.7ML;7.46MG/0.7ML
DILTIAZEM HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
CARDIZEM SR
+ BIOVAIL 60MG ** N019471 001 Jan 23, 1989
+ 90MG ** N019471 002 Jan 23, 1989
+ 120MG ** N019471 003 Jan 23, 1989
+ 180MG ** N019471 004 Jan 23, 1989
DILACOR XR
+ ALLERGAN 120MG ** N020092 001 May 29, 1992
+ 180MG ** N020092 002 May 29, 1992
+ 240MG ** N020092 003 May 29, 1992
DILT-CD
APOTEX 120MG A076151 001 May 20, 2004
180MG A076151 002 May 20, 2004
240MG A076151 003 May 20, 2004

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-156(of 478)
** See List Footnote
DILTIAZEM HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
DILT-CD
300MG A076151 004 May 20, 2004
DILTIAZEM HYDROCHLORIDE
ACTAVIS LABS FL INC 120MG A074852 001 Oct 10, 1997
180MG A074852 002 Oct 10, 1997
240MG A074852 003 Oct 10, 1997
BIOVAIL 60MG A074845 001 Sep 15, 1999
90MG A074845 002 Sep 15, 1999
120MG A074845 003 Sep 15, 1999
120MG N020939 001 Jan 28, 2000
180MG N020939 002 Jan 28, 2000
240MG N020939 003 Jan 28, 2000
300MG N020939 004 Jan 28, 2000
360MG N020939 005 Sep 14, 2001
420MG N020939 006 Sep 14, 2001
MYLAN 120MG A075124 002 Mar 18, 1998
180MG A075124 003 Mar 18, 1998
240MG A075124 001 Mar 18, 1998
NESHER PHARMS 120MG A076563 002 Sep 12, 2006
180MG A076563 003 Sep 12, 2006
240MG A076563 004 Sep 12, 2006
300MG A076563 005 Sep 12, 2006
360MG A076563 006 Sep 12, 2006
420MG A076563 001 Sep 12, 2006
PAR PHARM 360MG A209766 001 May 30, 2018
SUN PHARM 120MG A090492 001 Oct 28, 2011
180MG A090492 002 Oct 28, 2011
240MG A090492 003 Oct 28, 2011
300MG A090492 004 Oct 28, 2011
TEVA 60MG A074079 001 Nov 30, 1993
90MG A074079 002 Nov 30, 1993
120MG A074079 003 Nov 30, 1993
DILTZAC
APOTEX 120MG A076395 001 Feb 01, 2006
180MG A076395 002 Feb 01, 2006
240MG A076395 003 Feb 01, 2006
300MG A076395 004 Feb 01, 2006
360MG A076395 005 Feb 01, 2006
INJECTABLE;INJECTION
CARDIZEM
BIOVAIL 100MG/VIAL ** N020792 001 Sep 05, 1997
+ BIOVAIL LABS INTL 5MG/ML ** N020027 001 Oct 24, 1991
+ 25MG/VIAL ** N020027 003 Aug 18, 1995
DILTIAZEM HYDROCHLORIDE
DR REDDYS 5MG/ML A074894 001 Aug 26, 1997
HOSPIRA 5MG/ML A075004 001 Feb 16, 2000
5MG/ML A075106 001 Apr 29, 1999
INTL MEDICATION 5MG/ML A075749 001 Nov 21, 2001
MYLAN LABS LTD 5MG/ML A075375 001 Sep 30, 1999
SOLUTION;INTRAVENOUS
DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5%
+ EXELA PHARMA 125MG/125ML (1MG/ML) N215252 001 Oct 28, 2021
+ 250MG/250ML (1MG/ML) N215252 002 Oct 28, 2021
TABLET;ORAL
DILTIAZEM HYDROCHLORIDE
APOTHECON 30MG A074051 001 Mar 31, 1993
60MG A074051 002 Mar 31, 1993
90MG A074051 003 Mar 31, 1993
120MG A074051 004 Mar 31, 1993
CHARTWELL MOLECULES 30MG A074093 001 Nov 05, 1992
60MG A074093 002 Nov 05, 1992
90MG A074093 003 Nov 05, 1992
120MG A074093 004 Nov 05, 1992
IVAX SUB TEVA PHARMS 30MG A074168 001 Mar 03, 1995
60MG A074168 002 Mar 03, 1995
90MG A074168 003 Mar 03, 1995
120MG A074168 004 Mar 03, 1995

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-157(of 478)
** See List Footnote
DILTIAZEM HYDROCHLORIDE
TABLET;ORAL
DILTIAZEM HYDROCHLORIDE
RISING 30MG A072838 004 Nov 05, 1992
60MG A072838 003 Nov 05, 1992
90MG A072838 002 Nov 05, 1992
120MG A072838 001 Nov 05, 1992
TEVA 30MG A074084 001 Feb 25, 1994
60MG A074084 002 Feb 25, 1994
TEVA PHARMS 30MG A074067 001 Nov 05, 1992
60MG A074067 002 Nov 05, 1992
90MG A074067 003 Nov 05, 1992
120MG A074067 004 Nov 05, 1992
DILTIAZEM MALATE
TABLET, EXTENDED RELEASE;ORAL
TIAMATE
MERCK EQ 120MG HYDROCHLORIDE N020506 001 Oct 04, 1996
EQ 180MG HYDROCHLORIDE N020506 002 Oct 04, 1996
EQ 240MG HYDROCHLORIDE N020506 003 Oct 04, 1996
DILTIAZEM MALATE; ENALAPRIL MALEATE
TABLET, EXTENDED RELEASE;ORAL
TECZEM
BIOVAIL EQ 180MG HYDROCHLORIDE;5MG N020507 001 Oct 04, 1996
DIMENHYDRINATE
INJECTABLE;INJECTION
DIMENHYDRINATE
BAXTER HLTHCARE 50MG/ML A084767 001
WATSON LABS 50MG/ML A083531 001
+ WATSON LABS TEVA 50MG/ML A080615 001
WYETH AYERST 50MG/ML A084316 001
LIQUID;ORAL
DIMENHYDRINATE
ALRA 12.5MG/4ML A080715 001
TABLET;ORAL
DIMENHYDRINATE
HEATHER 50MG A080841 001
NEXGEN PHARMA INC 50MG A085985 001
+ WATSON LABS 50MG A085166 001
DIMETHYL FUMARATE
CAPSULE, DELAYED RELEASE;ORAL
DIMETHYL FUMARATE
SAWAI USA 120MG A210285 001 Dec 21, 2021
240MG A210285 002 Dec 21, 2021
SOLA PHARMS 120MG A210436 001 Mar 26, 2021
240MG A210436 002 Mar 26, 2021
ZYDUS PHARMS 120MG A210538 001 Sep 24, 2020
240MG A210538 002 Sep 24, 2020
DIMETHYL SULFOXIDE
SOLUTION;INTRAVESICAL
DIMETHYL SULFOXIDE
MYLAN INSTITUTIONAL 50% A076185 001 Nov 29, 2002
DIMYRISTOYL LECITHIN; PERFLEXANE
INJECTABLE;INTRAVENOUS
IMAGENT
VESSELON SPV LLC 0.92MG/VIAL;0.092MG/VIAL N021191 001 May 31, 2002
DINOPROST TROMETHAMINE
INJECTABLE;INJECTION
PROSTIN F2 ALPHA
PHARMACIA AND UPJOHN EQ 5MG BASE/ML N017434 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-158(of 478)
** See List Footnote
DINOPROSTONE
SUPPOSITORY;VAGINAL
PROSTIN E2
+ PFIZER 20MG N017810 001
DIPHEMANIL METHYLSULFATE
TABLET;ORAL
PRANTAL
SCHERING 100MG N008114 004
DIPHENHYDRAMINE HYDROCHLORIDE
CAPSULE;ORAL
BENADRYL
MCNEIL CONS 25MG N005845 007
50MG N005845 001
DIPHENHYDRAMINE HYDROCHLORIDE
ALRA 25MG A080519 004
50MG A080519 003
ANABOLIC 50MG A083275 001
ELKINS SINN 25MG A085701 001
50MG A085701 002
FOSUN PHARMA 25MG A080832 001
25MG A080845 002
50MG A080832 002
50MG A080845 001
HALSEY 50MG A087914 001 Jun 04, 1984
HEATHER 25MG A084524 001
50MG A083953 001
HERITAGE PHARMA 50MG A080727 001
50MG A080738 001
HIKMA INTL PHARMS 50MG A083567 001
IMPAX LABS 25MG A080807 001
50MG A080807 002
IVAX SUB TEVA PHARMS 25MG A080762 001
50MG A080762 002
LANNETT 25MG A080868 001
50MG A080868 002
LEDERLE 25MG A086874 001
50MG A086875 001
LNK 25MG A087977 001 Jan 27, 1983
50MG A087978 001 Jan 27, 1983
MK LABS 25MG A083087 001
50MG A083087 002
MUTUAL PHARM 25MG A084506 001
NEWTRON PHARMS 25MG A086543 001
50MG A086544 001
NEXGEN PHARMA INC 25MG A083634 001
PERRIGO 25MG A083061 001
50MG A083061 002
PIONEER PHARMS 25MG A089101 001 Dec 20, 1985
50MG A088880 001 Dec 20, 1985
PUREPAC PHARM 25MG A085156 001
50MG A085150 001
PVT FORM 25MG A083027 001
50MG A083027 002
ROXANE 50MG A080635 001
SUN PHARM INDUSTRIES 25MG A089488 001 Jan 02, 1987
50MG A089489 001 Jan 02, 1987
SUPERPHARM 25MG A089040 001 May 15, 1985
50MG A089041 001 May 15, 1985
TEVA 25MG A085874 001
50MG A085874 002
VALEANT PHARM INTL 25MG A080596 001
50MG A080592 001
VANGARD 25MG A088034 001 Oct 27, 1982
50MG A087630 001
WATSON LABS 25MG A080728 001
25MG A083797 001
25MG A085138 001
50MG A083797 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-159(of 478)
** See List Footnote
DIPHENHYDRAMINE HYDROCHLORIDE
CAPSULE;ORAL
DIPHENHYDRAMINE HYDROCHLORIDE
50MG A085083 001
WHITEWORTH TOWN PLSN 25MG A083441 001
50MG A080800 001
ELIXIR;ORAL
BELIX
HALSEY 12.5MG/5ML A086586 001 Oct 03, 1983
BENADRYL
MCNEIL CONS 12.5MG/5ML N005845 004
DIBENIL
CENCI 12.5MG/5ML A088304 001 Dec 16, 1983
DIPHEN
USL PHARMA 12.5MG/5ML A084640 001
DIPHENHYDRAMINE HYDROCHLORIDE
BUNDY 12.5MG/5ML A083674 001
CENCI 12.5MG/5ML A087941 001 Dec 17, 1982
KV PHARM 12.5MG/5ML A085621 001
LANNETT 12.5MG/5ML A080939 002
LEDERLE 12.5MG/5ML A086937 001
MK LABS 12.5MG/5ML A083088 002
NASKA 12.5MG/5ML A088680 001 May 31, 1985
PERRIGO 12.5MG/5ML A083063 001
PUREPAC PHARM 12.5MG/5ML A083237 001 Jan 25, 1982
PVT FORM 12.5MG/5ML A085287 001
ROXANE 12.5MG/5ML A080643 001
HYDRAMINE
ALPHARMA US PHARMS 12.5MG/5ML A080763 002
INJECTABLE;INJECTION
BENADRYL
MCNEIL CONS 10MG/ML N006146 001
+ 50MG/ML ** N006146 002
BENADRYL PRESERVATIVE FREE
+ MCNEIL CONS 50MG/ML ** N009486 001
DIPHENHYDRAMINE HYDROCHLORIDE
BEL MAR 10MG/ML A080822 001
DR REDDYS 10MG/ML A080873 001
50MG/ML A080873 002
EUROHLTH INTL SARL 50MG/ML A083183 001
HOSPIRA 50MG/ML A040140 001 Nov 20, 1998
LYPHOMED 10MG/ML A087066 001
WATSON LABS 10MG/ML A083533 001
WYETH AYERST 50MG/ML A080577 001
DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE
ABRAXIS PHARM 50MG/ML A080586 002
DR REDDYS 50MG/ML A080873 003
INTL MEDICATION 50MG/ML A084094 001
SYRUP;ORAL
ANTITUSSIVE
PERRIGO 12.5MG/5ML A071292 001 Apr 10, 1987
BELDIN
HALSEY 12.5MG/5ML A089179 001 Jun 05, 1986
BENYLIN
PARKE DAVIS 12.5MG/5ML N006514 004
DIPHEN
MORTON GROVE 12.5MG/5ML A070118 001 Oct 01, 1985
DIPHENHYDRAMINE HYDROCHLORIDE
AKORN 12.5MG/5ML A072416 001 Sep 28, 1990
ALPHARMA US PHARMS 12.5MG/5ML A070497 001 Apr 25, 1989
CUMBERLAND SWAN 12.5MG/5ML A073611 001 Aug 20, 1992
HYDRAMINE
ALPHARMA US PHARMS 12.5MG/5ML A070205 001 Jan 28, 1986
SILPHEN
LANNETT CO INC 12.5MG/5ML A072646 001 Feb 27, 1992
VICKS FORMULA 44
WARNER CHILCOTT 12.5MG/5ML A070524 001 Jan 14, 1987

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-160(of 478)
** See List Footnote
DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
TABLET;ORAL
NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
P AND L 25MG;220MG A207597 001 Jan 25, 2019
DIPHENHYDRAMINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
SOLUTION;ORAL
BENYLIN
PARKE DAVIS 12.5MG/5ML;30MG/5ML N019014 001 Jun 11, 1985
DIPHENIDOL HYDROCHLORIDE
TABLET;ORAL
VONTROL
GLAXOSMITHKLINE EQ 25MG BASE N016033 001
DIPHENYLPYRALINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
HISPRIL
GLAXOSMITHKLINE 5MG N011945 001
DIPIVEFRIN HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
AKPRO
AKORN 0.1% A074382 001 Sep 29, 1995
DIPIVEFRIN HYDROCHLORIDE
BAUSCH AND LOMB 0.1% A074188 001 May 19, 1995
FALCON PHARMS 0.1% A073636 001 Jun 30, 1994
PROPINE
ALLERGAN 0.1% N018239 001
DIPYRIDAMOLE
INJECTABLE;INJECTION
DIPYRIDAMOLE
DR REDDYS 5MG/ML A074952 001 Nov 26, 1997
EUGIA PHARMA SPECLTS 5MG/ML A075769 001 Nov 27, 2002
HOSPIRA 5MG/ML A074601 001 Dec 19, 1997
IV PERSANTINE
+ BOEHRINGER INGELHEIM 5MG/ML ** N019817 001 Dec 13, 1990
TABLET;ORAL
DIPYRIDAMOLE
ANDA REPOSITORY 25MG A040898 001 Apr 23, 2008
50MG A040898 002 Apr 23, 2008
75MG A040898 003 Apr 23, 2008
GLENMARK GENERICS 25MG A088999 001 Feb 05, 1991
50MG A089000 001 Feb 05, 1991
75MG A089001 001 Feb 05, 1991
PUREPAC PHARM 25MG A089425 001 Jul 12, 1990
50MG A089426 001 Jul 12, 1990
75MG A089427 001 Jul 12, 1990
WATSON LABS 50MG A087160 001 Jun 07, 1996
DIRITHROMYCIN
TABLET, DELAYED RELEASE;ORAL
DYNABAC
LILLY RES LABS 250MG N050678 001 Jun 19, 1995
DISOPYRAMIDE PHOSPHATE
CAPSULE;ORAL
DISOPYRAMIDE PHOSPHATE
INTERPHARM EQ 100MG BASE A071190 001 Jan 15, 1987
EQ 150MG BASE A071191 001 Jan 15, 1987
IVAX SUB TEVA PHARMS EQ 100MG BASE A070186 001 Nov 18, 1985
EQ 150MG BASE A070187 001 Nov 18, 1985
MYLAN EQ 100MG BASE A070138 001 Jun 14, 1985
EQ 150MG BASE A070139 001 Jun 14, 1985
RISING EQ 100MG BASE A070470 001 Dec 10, 1985
EQ 150MG BASE A070471 001 Dec 10, 1985
SUN PHARM INDUSTRIES EQ 100MG BASE A070351 001 Dec 17, 1985
EQ 150MG BASE A070352 001 Dec 17, 1985
SUPERPHARM EQ 100MG BASE A070940 001 Feb 09, 1987
EQ 150MG BASE A070941 001 Feb 09, 1987
WATSON LABS EQ 100MG BASE A070240 001 Feb 02, 1986
EQ 150MG BASE A070241 001 Feb 02, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-161(of 478)
** See List Footnote
DISOPYRAMIDE PHOSPHATE
CAPSULE, EXTENDED RELEASE;ORAL
DISOPYRAMIDE PHOSPHATE
NESHER PHARMS EQ 150MG BASE A071200 001 Dec 15, 1987
DISULFIRAM
TABLET;ORAL
ANTABUSE
+ ODYSSEY PHARMS 250MG A088482 001 Dec 08, 1983
+ 500MG A088483 001 Dec 08, 1983
+ TEVA WOMENS 250MG ** N007883 003
+ 500MG ** N007883 002
DISULFIRAM
MYLAN 250MG A203916 001 Mar 04, 2015
500MG A203916 002 Mar 04, 2015
STRIDES PHARMA 250MG A088792 001 Aug 14, 1984
500MG A088793 001 Aug 14, 1984
WATSON LABS 250MG A086889 001
250MG A087973 001 Aug 05, 1983
500MG A087974 001 Aug 05, 1983
WATSON LABS TEVA 500MG A086890 001
DIVALPROEX SODIUM
CAPSULE, DELAYED REL PELLETS;ORAL
DIVALPROEX SODIUM
RISING EQ 125MG VALPROIC ACID A090407 001 Mar 28, 2011
TEVA PHARMS USA EQ 125MG VALPROIC ACID A211505 001 Nov 17, 2020
TABLET, DELAYED RELEASE;ORAL
DEPAKOTE CP
ABBOTT EQ 250MG BASE N019794 001 Jul 11, 1990
EQ 500MG BASE N019794 002 Jul 11, 1990
DIVALPROEX SODIUM
ANCHEN PHARMS EQ 500MG VALPROIC ACID A078411 001 Nov 03, 2008
MYLAN EQ 125MG VALPROIC ACID A077254 001 Jul 29, 2008
EQ 125MG VALPROIC ACID A090062 001 Mar 17, 2009
EQ 250MG VALPROIC ACID A077254 002 Jul 29, 2008
EQ 250MG VALPROIC ACID A090062 002 Mar 17, 2009
EQ 500MG VALPROIC ACID A077254 003 Jul 29, 2008
EQ 500MG VALPROIC ACID A090062 003 Mar 17, 2009
TEVA EQ 125MG VALPROIC ACID A076941 001 Jul 29, 2008
EQ 250MG VALPROIC ACID A076941 002 Jul 29, 2008
EQ 500MG VALPROIC ACID A076941 003 Jul 29, 2008
TABLET, EXTENDED RELEASE;ORAL
DIVALPROEX SODIUM
AMTA EQ 250MG VALPROIC ACID A214462 001 Mar 15, 2021
EQ 500MG VALPROIC ACID A214462 002 Mar 15, 2021
ANCHEN PHARMS EQ 250MG VALPROIC ACID A078445 001 Feb 26, 2009
EQ 500MG VALPROIC ACID A078445 002 Aug 04, 2009
COSETTE EQ 500MG VALPROIC ACID A078700 001 Aug 03, 2009
IMPAX LABS EQ 250MG VALPROIC ACID A078791 001 May 06, 2009
EQ 500MG VALPROIC ACID A078791 002 Aug 04, 2009
DOBUTAMINE HYDROCHLORIDE
INJECTABLE;INJECTION
DOBUTAMINE HYDROCHLORIDE
BAXTER HLTHCARE EQ 12.5MG BASE/ML A074381 001 Sep 26, 1996
DR REDDYS EQ 12.5MG BASE/ML A074995 001 Mar 31, 1998
HOSPIRA EQ 12.5MG BASE/ML A074292 001 Feb 16, 1995
EQ 1.25GM BASE/100ML A074634 001 Sep 27, 1996
LUITPOLD EQ 12.5MG BASE/ML A074545 001 Jun 25, 1998
TELIGENT EQ 12.5MG BASE/ML A074098 001 Feb 21, 1995
TEVA PARENTERAL EQ 12.5MG BASE/ML A074206 001 Oct 19, 1993
WATSON LABS EQ 12.5MG BASE/ML A074114 001 Nov 30, 1993
WATSON LABS INC EQ 12.5MG BASE/ML A074279 001 Feb 18, 1998
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
HOSPIRA EQ 50MG BASE/100ML N020269 001 Oct 19, 1993
EQ 100MG BASE/100ML N020269 002 Oct 19, 1993
EQ 200MG BASE/100ML N020269 003 Oct 19, 1993
DOBUTREX
+ LILLY EQ 12.5MG BASE/ML ** N017820 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-162(of 478)
** See List Footnote
DOCETAXEL
INJECTABLE;INJECTION
DOCEFREZ
+ SUN PHARM 20MG/VIAL N022534 001 May 03, 2011
+ 80MG/VIAL N022534 002 May 03, 2011
DOCETAXEL
+ ACCORD HLTHCARE 20MG/0.5ML (40MG/ML) N201195 001 Jun 08, 2011
+ 80MG/2ML (40MG/ML) N201195 002 Jun 08, 2011
APOTEX INC 20MG/0.5ML (40MG/ML) N022312 001 Jan 11, 2012
80MG/2ML (40MG/ML) N022312 002 Jan 11, 2012
DFB ONCOLOGY LTD 20MG/ML (20MG/ML) A206177 001 Jan 20, 2017
80MG/4ML (20MG/ML) A206177 002 Jan 20, 2017
200MG/10ML (20MG/ML) A206177 003 Jan 20, 2017
HENGRUI PHARMA 40MG/ML A203170 001 Feb 15, 2017
+ HOSPIRA INC 120MG/6ML (20MG/ML) N022234 006 Jun 23, 2016
INGENUS PHARMS LLC 20MG/2ML (10MG/ML) A207563 001 Aug 31, 2017
PFIZER LABS 20MG/2ML (10MG/ML) N202356 001 Mar 13, 2014
80MG/8ML (10MG/ML) N202356 002 Mar 13, 2014
130MG/13ML (10MG/ML) N202356 003 Mar 13, 2014
200MG/20ML (10MG/ML) N202356 004 Mar 13, 2014
TEVA PHARMS USA 20MG/ML (20MG/ML) A203877 001 Sep 16, 2015
80MG/4ML (20MG/ML) A203877 002 Sep 16, 2015
TAXOTERE
+ SANOFI AVENTIS US 40MG/ML ** N020449 001 May 14, 1996
DOFETILIDE
CAPSULE;ORAL
DOFETILIDE
NOVAST LABS 0.125MG A212410 001 Dec 27, 2019
0.25MG A212410 002 Dec 27, 2019
0.5MG A212410 003 Dec 27, 2019
PRINSTON INC 0.125MG A211223 001 Dec 17, 2019
0.25MG A211223 002 Dec 17, 2019
0.5MG A211223 003 Dec 17, 2019
TEVA PHARMS USA 0.125MG A210018 001 Apr 15, 2022
0.25MG A210018 002 Apr 15, 2022
0.5MG A210018 003 Apr 15, 2022
VGYAAN 0.125MG A215323 001 Apr 14, 2022
0.25MG A215323 002 Apr 14, 2022
0.5MG A215323 003 Apr 14, 2022
DOLASETRON MESYLATE
INJECTABLE;INJECTION
ANZEMET
+ VALIDUS PHARMS 12.5MG/0.625ML (20MG/ML) N020624 002 Sep 11, 1997
+ 100MG/5ML (20MG/ML) N020624 001 Sep 11, 1997
500MG/25ML (20MG/ML) N020624 003 Dec 11, 2001
TABLET;ORAL
ANZEMET
+ VALIDUS PHARMS 100MG N020623 002 Sep 11, 1997
DONEPEZIL HYDROCHLORIDE
SOLUTION;ORAL
ARICEPT
EISAI INC 5MG/5ML N021719 001 Oct 18, 2004
TABLET;ORAL
DONEPEZIL HYDROCHLORIDE
ACCORD HLTHCARE 5MG A201335 001 Aug 29, 2011
10MG A201335 002 Aug 29, 2011
ACTAVIS ELIZABETH 23MG A202415 001 Dec 17, 2015
APOTEX 5MG A078841 001 Jun 02, 2011
10MG A078841 002 Jun 02, 2011
HERITAGE PHARMA 5MG A077344 001 May 31, 2011
10MG A077344 002 May 31, 2011
HIKMA PHARMS 5MG A090247 001 May 31, 2011
10MG A090247 002 May 31, 2011
HISUN PHARM HANGZHOU 23MG A202410 001 Mar 24, 2017
INDICUS PHARMA 23MG A203419 001 Apr 12, 2016
MYLAN PHARMS INC 5MG A090521 001 May 31, 2011
10MG A090521 002 May 31, 2011
OSMOTICA PHARM US 23MG A203114 001 Jan 26, 2016

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-163(of 478)
** See List Footnote
DONEPEZIL HYDROCHLORIDE
TABLET;ORAL
DONEPEZIL HYDROCHLORIDE
PAR PHARM 23MG A202542 001 Jul 24, 2013
RISING 23MG A202656 001 Oct 22, 2015
SANDOZ 5MG A090290 001 May 31, 2011
10MG A090290 002 May 31, 2011
SUN PHARM 23MG A204293 001 Jun 05, 2015
SUN PHARM INDS LTD 5MG A076786 001 Nov 26, 2010
10MG A076786 002 Nov 26, 2010
UNICHEM 5MG A203656 001 Jun 23, 2016
10MG A203656 002 Jun 23, 2016
WOCKHARDT 5MG A091267 001 May 31, 2011
10MG A091267 002 May 31, 2011
TABLET, ORALLY DISINTEGRATING;ORAL
ARICEPT ODT
+ EISAI INC 5MG N021720 001 Oct 18, 2004
+ 10MG N021720 002 Oct 18, 2004
DONEPEZIL HYDROCHLORIDE
HERITAGE PHARMA 5MG A078388 002 Nov 26, 2010
10MG A078388 001 Nov 26, 2010
SUN PHARM INDUSTRIES 5MG A077975 002 Dec 11, 2009
10MG A077975 001 Dec 11, 2009
UNICHEM 5MG A204831 001 Nov 10, 2016
10MG A204831 002 Nov 10, 2016
ZYDUS PHARMS USA INC 5MG A090175 001 May 10, 2011
10MG A090175 002 May 10, 2011
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE
AMNEAL PHARMS 10MG;14MG A208328 001 Jan 27, 2017
10MG;28MG A208328 002 Jan 27, 2017
DOPAMINE HYDROCHLORIDE
INJECTABLE;INJECTION
DOPAMINE HYDROCHLORIDE
ABBOTT 40MG/ML A070656 001 Jan 24, 1989
80MG/ML A070657 001 Jan 24, 1989
ABRAXIS PHARM 40MG/ML A070012 001 Jun 12, 1985
40MG/ML A070058 001 Mar 20, 1985
80MG/ML A070013 001 Jun 12, 1985
80MG/ML A070059 001 Mar 20, 1985
160MG/ML A070364 001 Dec 04, 1985
AM REGENT 40MG/ML A070799 001 Feb 11, 1987
80MG/ML A070820 001 Feb 11, 1987
160MG/ML A070826 001 Feb 11, 1987
BAXTER HLTHCARE 40MG/ML N018398 001
80MG/ML N018398 002 Mar 22, 1982
HOSPIRA 40MG/ML A074403 001 May 23, 1996
IGI LABS INC 40MG/ML A070087 001 Oct 23, 1985
80MG/ML A070089 001 Oct 23, 1985
80MG/ML A070090 001 Oct 23, 1985
80MG/ML A070091 001 Oct 23, 1985
160MG/ML A070092 001 Oct 23, 1985
160MG/ML A070093 001 Oct 23, 1985
160MG/ML A070094 001 Oct 23, 1985
INTL MEDICATION 40MG/ML N018014 001
LYPHOMED 40MG/ML N018549 001 Mar 11, 1983
SMITH AND NEPHEW 40MG/ML A070011 001 Aug 29, 1985
40MG/ML A070046 001 Aug 29, 1985
80MG/ML A070047 001 Aug 29, 1985
TELIGENT 40MG/ML N018656 001 Jun 28, 1983
TEVA PARENTERAL 40MG/ML A072999 001 Oct 23, 1991
80MG/ML A073000 001 Oct 23, 1991
WARNER CHILCOTT 40MG/ML A070558 001 Sep 20, 1985
40MG/ML N018138 001
80MG/ML A070559 001 Sep 20, 1985
DOPAMINE HYDROCHLORIDE IN DEXTROSE 5%
HOSPIRA 1.6MG/ML N020542 001 Aug 30, 1995

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-164(of 478)
** See List Footnote
DOPAMINE HYDROCHLORIDE
INJECTABLE;INJECTION
INTROPIN
HOSPIRA 40MG/ML N017395 001
80MG/ML N017395 002
160MG/ML N017395 003
DORIPENEM
INJECTABLE;INTRAVENOUS
DORIBAX
+ SHIONOGI INC 250MG/VIAL ** N022106 002 Oct 05, 2010
+ 500MG/VIAL ** N022106 001 Oct 12, 2007
DORZOLAMIDE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
DORZOLAMIDE HYDROCHLORIDE
AM REGENT EQ 2% BASE A079186 001 Nov 18, 2009
RUBICON EQ 2% BASE A078395 001 Oct 28, 2008
TEVA PHARMS EQ 2% BASE A078756 001 Dec 04, 2008
ZAMBON SPA EQ 2% BASE A091034 001 Dec 04, 2013
TRUSOPT
+ MSD SUB MERCK EQ 2% BASE N020408 001 Dec 09, 1994
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE
SOLUTION/DROPS;OPHTHALMIC
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
CHARTWELL MOLECULAR EQ 2% BASE;EQ 0.5% BASE A201998 001 Dec 17, 2014
RUBICON EQ 2% BASE;EQ 0.5% BASE A078201 001 Oct 28, 2008
ZAMBON SPA EQ 2% BASE;EQ 0.5% BASE A091180 001 Dec 04, 2013
DOXACURIUM CHLORIDE
INJECTABLE;INJECTION
NUROMAX
ABBVIE EQ 1MG BASE/ML N019946 001 Mar 07, 1991
DOXAPRAM HYDROCHLORIDE
INJECTABLE;INJECTION
DOXAPRAM HYDROCHLORIDE
WATSON LABS 20MG/ML A073529 001 Jan 30, 1992
DOXAZOSIN MESYLATE
TABLET;ORAL
DOXAZOSIN MESYLATE
ACTAVIS ELIZABETH EQ 1MG BASE A075574 001 Oct 18, 2000
EQ 2MG BASE A075574 002 Oct 18, 2000
EQ 4MG BASE A075574 003 Oct 18, 2000
EQ 8MG BASE A075574 004 Oct 18, 2000
ANI PHARMS EQ 1MG BASE A075432 001 Oct 18, 2000
EQ 2MG BASE A075432 002 Oct 18, 2000
EQ 4MG BASE A075432 003 Oct 18, 2000
EQ 8MG BASE A075432 004 Oct 18, 2000
AUROBINDO PHARMA USA EQ 1MG BASE A075509 001 Oct 19, 2000
EQ 2MG BASE A075509 002 Oct 19, 2000
EQ 4MG BASE A075509 003 Oct 19, 2000
EQ 8MG BASE A075509 004 Oct 19, 2000
CHARTWELL RX EQ 1MG BASE A075646 001 Oct 18, 2000
EQ 2MG BASE A075646 002 Oct 18, 2000
EQ 4MG BASE A075646 003 Oct 18, 2000
EQ 8MG BASE A075646 004 Oct 18, 2000
GENPHARM EQ 1MG BASE A075466 001 Oct 18, 2000
EQ 2MG BASE A075466 002 Oct 18, 2000
EQ 4MG BASE A075466 003 Oct 18, 2000
EQ 8MG BASE A075466 004 Oct 18, 2000
IVAX SUB TEVA PHARMS EQ 1MG BASE A075453 001 Oct 18, 2000
EQ 2MG BASE A075453 002 Oct 18, 2000
EQ 4MG BASE A075453 003 Oct 18, 2000
EQ 8MG BASE A075453 004 Oct 18, 2000
NESHER PHARMS EQ 1MG BASE A075609 001 Oct 18, 2000
EQ 2MG BASE A075609 002 Oct 18, 2000
EQ 4MG BASE A075609 003 Oct 18, 2000
EQ 8MG BASE A075609 004 Oct 18, 2000
STRIDES PHARMA EQ 1MG BASE A076161 001 Jun 10, 2004

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-165(of 478)
** See List Footnote
DOXAZOSIN MESYLATE
TABLET;ORAL
DOXAZOSIN MESYLATE
EQ 2MG BASE A076161 002 Jun 10, 2004
EQ 4MG BASE A076161 003 Jun 10, 2004
EQ 8MG BASE A076161 004 Jun 10, 2004
TEVA EQ 1MG BASE A075353 001 Jan 12, 2001
EQ 2MG BASE A075353 002 Jan 12, 2001
EQ 4MG BASE A075353 003 Jan 12, 2001
EQ 8MG BASE A075353 004 Jan 12, 2001
WATSON LABS INC EQ 1MG BASE A075426 001 Oct 18, 2000
EQ 2MG BASE A075426 002 Oct 18, 2000
EQ 4MG BASE A075426 003 Oct 18, 2000
EQ 8MG BASE A075426 004 Oct 18, 2000
DOXEPIN HYDROCHLORIDE
CAPSULE;ORAL
DOXEPIN HYDROCHLORIDE
DAVA PHARMS INC EQ 10MG BASE A071685 001 Jan 05, 1988
EQ 25MG BASE A071686 001 Jan 05, 1988
EQ 50MG BASE A071673 001 Jan 05, 1988
EQ 75MG BASE A071674 001 Jan 05, 1988
EQ 100MG BASE A071675 001 Jan 05, 1988
EQ 150MG BASE A071676 001 Jan 05, 1988
LANNETT CO INC EQ 10MG BASE A212997 001 Jul 24, 2020
EQ 25MG BASE A212997 002 Jul 24, 2020
EQ 50MG BASE A212997 003 Jul 24, 2020
EQ 75MG BASE A212997 004 Jul 24, 2020
EQ 100MG BASE A212997 005 Jul 24, 2020
NEW RIVER EQ 10MG BASE N016987 001
EQ 25MG BASE N016987 002
EQ 50MG BASE N016987 003
EQ 75MG BASE N016987 006
EQ 100MG BASE N016987 004
EQ 150MG BASE N016987 007 Apr 13, 1987
PAR PHARM EQ 10MG BASE A071422 002 Nov 09, 1987
EQ 25MG BASE A071422 003 Nov 09, 1987
EQ 50MG BASE A071422 004 Nov 09, 1987
EQ 75MG BASE A071422 005 Nov 09, 1987
EQ 100MG BASE A071422 001 Nov 09, 1987
PUREPAC PHARM EQ 10MG BASE A073054 001 Dec 28, 1990
EQ 25MG BASE A072109 001 Dec 28, 1990
EQ 50MG BASE A073055 001 Dec 28, 1990
EQ 75MG BASE A072386 001 Sep 08, 1988
EQ 100MG BASE A072110 001 Sep 08, 1988
EQ 150MG BASE A072387 001 Sep 08, 1988
QUANTUM PHARMICS EQ 10MG BASE A070972 001 Sep 29, 1987
EQ 25MG BASE A070973 001 Sep 29, 1987
EQ 50MG BASE A070931 001 Sep 29, 1987
EQ 75MG BASE A070932 001 Sep 29, 1987
EQ 100MG BASE A072375 001 Mar 15, 1989
EQ 150MG BASE A072376 001 Mar 15, 1989
SANDOZ EQ 10MG BASE A071487 001 Mar 02, 1987
EQ 25MG BASE A070827 001 May 15, 1986
EQ 50MG BASE A070828 001 May 15, 1986
EQ 75MG BASE A070825 001 May 15, 1986
EQ 100MG BASE A071562 001 Mar 02, 1987
SUN PHARM INDUSTRIES EQ 25MG BASE A071502 001 Feb 18, 1988
EQ 50MG BASE A071653 001 Feb 18, 1988
EQ 75MG BASE A071654 001 Feb 18, 1988
EQ 100MG BASE A071521 001 Feb 18, 1988
WATSON LABS EQ 10MG BASE A070952 001 Mar 04, 1987
EQ 10MG BASE A071485 001 Apr 30, 1987
EQ 10MG BASE A072985 001 Mar 29, 1991
EQ 25MG BASE A070953 001 May 15, 1986
EQ 25MG BASE A071486 001 Apr 30, 1987
EQ 25MG BASE A072986 001 Mar 29, 1991
EQ 50MG BASE A070954 001 May 15, 1986
EQ 50MG BASE A071238 001 Apr 30, 1987
EQ 75MG BASE A071326 001 Apr 30, 1987

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-166(of 478)
** See List Footnote
DOXEPIN HYDROCHLORIDE
CAPSULE;ORAL
DOXEPIN HYDROCHLORIDE
EQ 75MG BASE A071763 001 Feb 09, 1988
EQ 100MG BASE A070955 001 May 15, 1986
EQ 100MG BASE A071239 001 Apr 30, 1987
EQ 150MG BASE A071764 001 Feb 09, 1988
WATSON LABS TEVA EQ 50MG BASE A072987 001 Mar 29, 1991
SINEQUAN
+ PFIZER EQ 10MG BASE ** N016798 003
+ EQ 25MG BASE ** N016798 001
+ EQ 50MG BASE ** N016798 002
+ EQ 75MG BASE ** N016798 006
+ EQ 100MG BASE ** N016798 005
+ EQ 150MG BASE ** N016798 007
CONCENTRATE;ORAL
DOXEPIN HYDROCHLORIDE
PHARM ASSOC EQ 10MG BASE/ML A075924 001 Jan 15, 2004
TEVA PHARMS EQ 10MG BASE/ML A071609 001 Nov 09, 1987
SINEQUAN
+ PFIZER EQ 10MG BASE/ML ** N017516 001
DOXERCALCIFEROL
CAPSULE;ORAL
DOXERCALCIFEROL
HIKMA 0.5MCG A091433 001 Sep 23, 2011
1MCG A091433 002 Jan 14, 2014
2.5MCG A091433 003 Jan 14, 2014
INJECTABLE;INJECTION
DOXERCALCIFEROL
AKORN 2MCG/ML (2MCG/ML) A203929 002 Mar 28, 2016
4MCG/2ML (2MCG/ML) A203929 001 May 07, 2015
AMNEAL 4MCG/2ML (2MCG/ML) A208975 001 May 24, 2017
+ HOSPIRA 10MCG/5ML (2MCG/ML) N208614 002 Jul 24, 2018
SUN PHARM 2MCG/ML (2MCG/ML) A203875 001 Nov 14, 2019
4MCG/2ML (2MCG/ML) A203875 002 Nov 14, 2019
DOXORUBICIN HYDROCHLORIDE
INJECTABLE;INJECTION
ADRIAMYCIN PFS
PFIZER 2MG/ML A063165 001 Jan 30, 1991
200MG/100ML A063165 002 Jan 30, 1991
DOXORUBICIN HYDROCHLORIDE
ALMAJECT 2MG/ML A065515 001 Nov 08, 2012
HISUN PHARM HANGZHOU 20MG/VIAL A206062 001 May 13, 2019
HLTHCARE 2MG/ML A200146 001 Jul 18, 2012
MYLAN LABS LTD 2MG/ML A200901 001 Feb 14, 2012
10MG/VIAL A200170 001 Oct 28, 2011
PFIZER 10MG/VIAL N050467 001
20MG/VIAL N050467 003 May 20, 1985
50MG/VIAL N050467 002
150MG/VIAL N050467 004 Jul 22, 1987
TEVA PHARMS USA 2MG/ML A064140 001 Jul 28, 1995
200MG/100ML A064140 002 Jul 28, 1995
RUBEX
BRISTOL MYERS SQUIBB 10MG/VIAL A062926 001 Apr 13, 1989
50MG/VIAL A062926 002 Apr 13, 1989
100MG/VIAL A062926 003 Apr 13, 1989
DOXYCYCLINE
CAPSULE;ORAL
DOXYCYCLINE
IMPAX LABS INC EQ 150MG BASE A200065 001 Feb 17, 2011
RISING EQ 50MG BASE A208942 001 Jan 21, 2021
EQ 75MG BASE A208942 002 Jan 21, 2021
EQ 100MG BASE A208942 003 Jan 21, 2021
SANDOZ INC EQ 50MG BASE A065032 001 Jun 30, 2000
EQ 100MG BASE A065032 002 Jun 30, 2000
STRIDES PHARMA EQ 75MG BASE A065055 004 Apr 18, 2005
EQ 150MG BASE A202778 001 Jun 08, 2012
WATSON LABS EQ 50MG BASE A065041 001 Apr 28, 2000

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-167(of 478)
** See List Footnote
DOXYCYCLINE
CAPSULE;ORAL
DOXYCYCLINE
EQ 100MG BASE A065041 002 Apr 28, 2000
FOR SUSPENSION;ORAL
DOXYCHEL
RACHELLE EQ 25MG BASE/5ML A061720 001
TABLET;ORAL
DOXYCYCLINE
APPCO EQ 50MG BASE A065377 001 Nov 07, 2006
EQ 75MG BASE A065377 002 Nov 07, 2006
EQ 100MG BASE A065377 003 Nov 07, 2006
EQ 150MG BASE A065427 001 Jun 07, 2007
SANDOZ INC EQ 50MG BASE A065353 001 Nov 27, 2006
EQ 75MG BASE A065353 002 Nov 27, 2006
EQ 100MG BASE A065353 003 Nov 27, 2006
SUN PHARM INDUSTRIES EQ 50MG BASE A065471 001 Apr 17, 2009
EQ 75MG BASE A065471 002 Apr 17, 2009
EQ 100MG BASE A065471 003 Apr 17, 2009
DOXYCYCLINE HYCLATE
CAPSULE;ORAL
ACTICLATE CAP
+ ALMIRALL EQ 75MG BASE N208253 001 Apr 26, 2016
DOXY-LEMMON
TEVA EQ 50MG BASE A062497 001 Aug 23, 1984
EQ 100MG BASE A062497 002 Jun 15, 1984
DOXYCYCLINE HYCLATE
AJANTA PHARMA LTD EQ 50MG BASE A211012 001 Sep 24, 2018
EQ 100MG BASE A211012 002 Sep 24, 2018
HALSEY EQ 50MG BASE A062119 002 May 24, 1985
EQ 100MG BASE A062119 001 May 24, 1985
HEATHER EQ 50MG BASE A062463 001 Dec 07, 1983
EQ 100MG BASE A062463 002 Dec 07, 1983
HIKMA INTL PHARMS EQ 20MG BASE A065103 001 May 13, 2005
INTERPHARM EQ 50MG BASE A062763 001 Sep 02, 1988
EQ 100MG BASE A062763 002 Sep 02, 1988
MUTUAL PHARM EQ 50MG BASE A062418 001 Jan 28, 1983
EQ 100MG BASE A062418 002 Jan 28, 1983
NESHER PHARMS EQ 50MG BASE A208263 001 Nov 22, 2021
EQ 100MG BASE A208263 002 Nov 22, 2021
NOSTRUM LABS INC EQ 50MG BASE A209393 001 Dec 10, 2020
EQ 100MG BASE A209393 002 Dec 10, 2020
PAR PHARM EQ 50MG BASE A062434 001 Oct 19, 1984
EQ 100MG BASE A062442 001 Dec 22, 1983
PVT FORM EQ 50MG BASE A062631 001 Jul 24, 1986
EQ 100MG BASE A062631 002 Jul 24, 1986
RANBAXY EQ 50MG BASE A062479 001 Dec 23, 1983
EQ 100MG BASE A062479 002 Dec 23, 1983
STRIDES PHARMA EQ 50MG BASE A062337 001 Mar 29, 1982
EQ 100MG BASE A062337 002 Mar 29, 1982
SUPERPHARM EQ 50MG BASE A062469 001 Oct 31, 1984
EQ 100MG BASE A062469 002 Oct 31, 1984
WARNER CHILCOTT EQ 50MG BASE A062594 001 Dec 05, 1985
EQ 100MG BASE A062594 002 Dec 05, 1985
WATSON LABS EQ 50MG BASE A061717 001
EQ 50MG BASE A062142 001
EQ 100MG BASE A061717 002
EQ 100MG BASE A062142 002
ZHEJIANG YONGTAI EQ 50MG BASE A212610 001 Mar 31, 2020
EQ 100MG BASE A212610 002 Mar 31, 2020
PERIOSTAT
+ COLLAGENEX EQ 20MG BASE ** N050744 001 Sep 30, 1998
VIBRAMYCIN
+ PFIZER EQ 50MG BASE ** N050007 001
CAPSULE, COATED PELLETS;ORAL
DOXYCYCLINE HYCLATE
PLIVA EQ 100MG BASE A063187 001 Jun 30, 1992

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-168(of 478)
** See List Footnote
DOXYCYCLINE HYCLATE
CAPSULE, DELAYED RELEASE;ORAL
DORYX
+ MAYNE PHARMA EQ 75MG BASE N050582 002 Aug 13, 2001
+ EQ 100MG BASE N050582 001 Jul 22, 1985
WARNER CHILCOTT EQ 100MG BASE A062653 001 Oct 30, 1985
DOXYCYCLINE HYCLATE
BAUSCH EQ 75MG BASE A065281 001 Dec 21, 2005
EQ 100MG BASE A065281 002 Dec 21, 2005
INJECTABLE;INJECTION
DOXYCHEL HYCLATE
RACHELLE EQ 100MG BASE/VIAL A061953 001
DOXYCYCLINE
HIKMA EQ 100MG BASE/VIAL A062450 001 Oct 27, 1983
EQ 200MG BASE/VIAL A062450 002 Oct 27, 1983
EQ 200MG BASE/VIAL A062569 002 Mar 09, 1988
VIBRAMYCIN
+ PFIZER EQ 100MG BASE/VIAL ** N050442 002
+ EQ 200MG BASE/VIAL ** N050442 001
SYSTEM, EXTENDED RELEASE;PERIODONTAL
ATRIDOX
+ DEN-MAT 50MG N050751 001 Sep 03, 1998
TABLET;ORAL
DOXY-LEMMON
TEVA EQ 100MG BASE A062581 001 Mar 15, 1985
DOXYCYCLINE HYCLATE
ALEMBIC PHARMS EQ 100MG BASE A210536 001 May 14, 2020
AMICI EQ 100MG BASE A213475 001 Mar 10, 2021
AMNEAL EQ 100MG BASE A216599 001 Oct 24, 2022
AMNEAL PHARMS CO EQ 75MG BASE A209372 001 Oct 06, 2017
EQ 150MG BASE A209372 002 Oct 06, 2017
EMCURE PHARMS LTD EQ 100MG BASE A209969 001 Nov 09, 2018
HEATHER EQ 100MG BASE A062462 001 May 11, 1983
HERITAGE PHARMA EQ 20MG BASE A065163 001 May 13, 2005
INTERPHARM EQ 100MG BASE A062764 001 Sep 02, 1988
MUTUAL PHARM EQ 100MG BASE A062391 001 Sep 30, 1982
MYLAN EQ 100MG BASE A062432 001 Feb 15, 1983
PRAXGEN EQ 100MG BASE A212487 001 Mar 30, 2022
RISING EQ 75MG BASE A209987 001 Oct 05, 2020
EQ 150MG BASE A209987 002 Oct 05, 2020
STRIDES PHARMA EQ 100MG BASE A062538 001 Apr 07, 1986
SUPERPHARM EQ 100MG BASE A062494 001 Feb 20, 1985
WARNER CHILCOTT EQ 100MG BASE A062593 001 Aug 28, 1985
WATSON LABS EQ 50MG BASE A062392 001 Mar 31, 1983
EQ 100MG BASE A062392 002 Mar 31, 1983
LYMEPAK
+ CHARTWELL PHARMA EQ 100MG BASE N209844 001 Jun 15, 2018
PERIOSTAT
+ GALDERMA LABS LP EQ 20MG BASE ** N050783 001 Feb 02, 2001
VIBRA-TABS
+ PFIZER EQ 100MG BASE ** N050533 001
TABLET, DELAYED RELEASE;ORAL
DOXYCYCLINE HYCLATE
IMPAX LABS INC EQ 75MG BASE A090505 001 Dec 28, 2010
EQ 100MG BASE A090505 002 Dec 28, 2010
MYLAN PHARMS INC EQ 150MG BASE A091052 001 Feb 08, 2012
RISING EQ 50MG BASE A090431 003 May 23, 2016
EQ 75MG BASE A090431 001 Dec 28, 2010
EQ 80MG BASE A090431 004 Apr 29, 2016
EQ 100MG BASE A090431 002 Dec 28, 2010
EQ 200MG BASE A090431 005 May 19, 2016
ZYDUS PHARMS EQ 75MG BASE A206772 001 Dec 21, 2018
EQ 100MG BASE A206772 002 Dec 21, 2018
EQ 150MG BASE A206772 003 Dec 21, 2018

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-169(of 478)
** See List Footnote
DOXYLAMINE SUCCINATE
CAPSULE;ORAL
UNISOM
PFIZER 25MG N019440 001 Feb 05, 1986
TABLET;ORAL
DECAPRYN
SANOFI AVENTIS US 12.5MG N006412 015
25MG N006412 014
DOXY-SLEEP-AID
PAR PHARM 25MG A070156 001 Jul 02, 1987
DOXYLAMINE SUCCINATE
COPLEY PHARM 25MG A088900 002 Feb 12, 1988
QUANTUM PHARMICS 25MG A088603 001 Aug 07, 1984
DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
BENDECTIN
SANOFI AVENTIS US 10MG;10MG ** N010598 002
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
ACTAVIS LABS FL INC 20MG;20MG A212472 001 Mar 01, 2022
DROMOSTANOLONE PROPIONATE
INJECTABLE;INJECTION
DROLBAN
LILLY 50MG/ML N012936 001
DRONABINOL
CAPSULE;ORAL
DRONABINOL
INSYS THERAP 2.5MG A078501 001 Aug 19, 2011
5MG A078501 002 Aug 19, 2011
10MG A078501 003 Aug 19, 2011
LANNETT CO INC 2.5MG A201463 001 May 18, 2018
5MG A201463 002 May 18, 2018
10MG A201463 003 May 18, 2018
DROPERIDOL
INJECTABLE;INJECTION
DROPERIDOL
ABRAXIS PHARM 2.5MG/ML A070992 001 Nov 17, 1986
2.5MG/ML A070993 001 Nov 17, 1986
ASTRAZENECA 2.5MG/ML A072018 001 Oct 20, 1988
HOSPIRA 2.5MG/ML A071645 001 Apr 07, 1988
2.5MG/ML A072272 001 Aug 31, 1995
IGI LABS INC 2.5MG/ML A072019 001 Oct 19, 1988
2.5MG/ML A072020 001 Oct 19, 1988
2.5MG/ML A072021 001 Oct 19, 1988
LUITPOLD 2.5MG/ML A072335 001 Oct 24, 1988
SMITH AND NEPHEW 2.5MG/ML A071750 001 Sep 06, 1988
SOLOPAK 2.5MG/ML A071754 001 Sep 06, 1988
2.5MG/ML A071755 001 Sep 06, 1988
WATSON LABS 2.5MG/ML A073520 001 Nov 27, 1991
2.5MG/ML A073521 001 Nov 27, 1991
2.5MG/ML A073523 001 Nov 27, 1991
DROPERIDOL; FENTANYL CITRATE
INJECTABLE;INJECTION
FENTANYL CITRATE AND DROPERIDOL
ASTRAZENECA 2.5MG/ML;EQ 0.05MG BASE/ML A072026 001 Apr 13, 1989
2.5MG/ML;EQ 0.05MG BASE/ML A072027 001 Apr 13, 1989
2.5MG/ML;EQ 0.05MG BASE/ML A072028 001 Apr 13, 1989
HOSPIRA 2.5MG/ML;EQ 0.05MG BASE/ML A071982 001 May 04, 1988
INNOVAR
AKORN 2.5MG/ML;EQ 0.05MG BASE/ML N016049 001
DROSPIRENONE; ETHINYL ESTRADIOL
TABLET;ORAL
DROSPIRENONE AND ETHINYL ESTRADIOL
JUBILANT CADISTA 3MG;0.02MG A209423 001 Dec 22, 2017
KYRA
SUN PHARM 3MG;0.02MG A202318 001 Jul 23, 2019

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-170(of 478)
** See List Footnote
DROSPIRENONE; ETHINYL ESTRADIOL
TABLET;ORAL-28
DROSPIRENONE AND ETHINYL ESTRADIOL
APOTEX 3MG;0.03MG A205876 001 Sep 21, 2016
JUBILANT CADISTA 3MG;0.03MG A210017 001 Sep 10, 2018
KEMEYA
SUN PHARM 3MG;0.03MG A202138 001 Mar 13, 2019
DROXIDOPA
CAPSULE;ORAL
DROXIDOPA
CELLTRION 100MG A214217 001 May 05, 2022
200MG A214217 002 May 05, 2022
300MG A214217 003 May 05, 2022
TEVA PHARMS USA INC 100MG A213162 001 Feb 18, 2021
200MG A213162 002 Feb 18, 2021
300MG A213162 003 Feb 18, 2021
DULOXETINE HYDROCHLORIDE
CAPSULE, DELAYED REL PELLETS;ORAL
DRIZALMA SPRINKLE
+ SUN PHARM EQ 20MG BASE N212516 001 Jul 19, 2019
DULOXETINE HYDROCHLORIDE
TEVA PHARMS USA EQ 20MG BASE A090783 001 Dec 11, 2013
EQ 30MG BASE A090783 002 Dec 11, 2013
EQ 60MG BASE A090783 003 Dec 11, 2013
YAOPHARMA CO LTD EQ 20MG BASE A207219 001 Aug 16, 2019
EQ 30MG BASE A207219 002 Aug 16, 2019
EQ 60MG BASE A207219 003 Aug 16, 2019
DUTASTERIDE
CAPSULE;ORAL
DUTASTERIDE
ACTAVIS LABS FL INC 0.5MG A202808 001 Nov 20, 2015
APOTEX INC 0.5MG A204292 001 Nov 24, 2015
HERITAGE PHARMS INC 0.5MG A207935 001 Oct 13, 2017
HIKMA 0.5MG A202204 001 Nov 23, 2015
MYLAN 0.5MG A203241 001 Jun 14, 2016
NOSTRUM LABS INC 0.5MG A204705 001 Nov 20, 2015
RISING 0.5MG A202530 001 Nov 20, 2015
STRIDES PHARMA 0.5MG A208227 001 Jun 22, 2018
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
CAPSULE;ORAL
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
ACTAVIS LABS FL INC 0.5MG;0.4MG A202975 001 Nov 20, 2015
DYCLONINE HYDROCHLORIDE
SOLUTION;TOPICAL
DYCLONE
+ ASTRAZENECA 0.5% ** N009925 002
+ 1% ** N009925 001
DYDROGESTERONE
TABLET;ORAL
GYNOREST
+ SOLVAY 5MG ** N017388 001
+ 10MG ** N017388 002
DYPHYLLINE
ELIXIR;ORAL
NEOTHYLLINE
TEVA 160MG/15ML N007794 003
INJECTABLE;INJECTION
NEOTHYLLINE
TEVA 250MG/ML N009088 001
TABLET;ORAL
DILOR
SAVAGE LABS 200MG A084514 001
DILOR-400
SAVAGE LABS 400MG A084751 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-171(of 478)
** See List Footnote
DYPHYLLINE
TABLET;ORAL
LUFYLLIN
MYLAN SPECIALITY LP 200MG A084566 001
400MG A084566 002
NEOTHYLLINE
TEVA 200MG N007794 001
400MG N007794 002
ECHOTHIOPHATE IODIDE
FOR SOLUTION;OPHTHALMIC
PHOSPHOLINE IODIDE
FERA PHARMS LLC 0.03% N011963 002
0.06% N011963 004
0.25% N011963 003
ECONAZOLE NITRATE
CREAM;TOPICAL
ECONAZOLE NITRATE
CHARTWELL RX 1% A076075 001 Nov 26, 2002
MYLAN 1% A210364 001 Apr 18, 2018
SPECTAZOLE
+ ALVOGEN 1% N018751 001 Dec 23, 1982
EDETATE CALCIUM DISODIUM
TABLET;ORAL
CALCIUM DISODIUM VERSENATE
BAUSCH 500MG N008922 002
EDROPHONIUM CHLORIDE
INJECTABLE;INJECTION
EDROPHONIUM CHLORIDE
HOSPIRA 10MG/ML A040131 001 Feb 24, 1998
WATSON LABS 10MG/ML A040044 001 Mar 20, 1996
EDROPHONIUM CHLORIDE PRESERVATIVE FREE
WATSON LABS 10MG/ML A040043 001 Mar 20, 1996
ENLON
MYLAN INSTITUTIONAL 10MG/ML A088873 001 Aug 06, 1985
REVERSOL
ORGANON USA INC 10MG/ML A089624 001 May 13, 1988
TENSILON
+ PAI HOLDINGS PHARM 10MG/ML ** N007959 001
TENSILON PRESERVATIVE FREE
+ PAI HOLDINGS PHARM 10MG/ML ** N007959 002
EFAVIRENZ
CAPSULE;ORAL
SUSTIVA
+ BRISTOL MYERS SQUIBB 100MG ** N020972 002 Sep 17, 1998
TABLET;ORAL
EFAVIRENZ
AUROBINDO PHARMA 600MG A205322 001 Aug 30, 2018
MYLAN 600MG A091471 001 Feb 17, 2016
STRIDES PHARMA 600MG A078509 001 Jun 16, 2021
SUSTIVA
+ BRISTOL MYERS SQUIBB 300MG ** N021360 001 Feb 01, 2002
+ 600MG N021360 002 Feb 01, 2002
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
TABLET;ORAL
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
+ AUROBINDO PHARMA LTD 600MG;300MG;300MG N022343 001 Aug 15, 2018
MACLEODS PHARMS LTD 400MG;300MG;300MG N210649 001 Mar 15, 2019
EFINACONAZOLE
SOLUTION;TOPICAL
EFINACONAZOLE
AUROBINDO PHARMA LTD 10% A212066 001 Mar 29, 2021
LUPIN LTD 10% A212169 001 Mar 02, 2022
PADAGIS US 10% A211851 001 Dec 16, 2020
ZYDUS 10% A212178 001 Jul 15, 2022

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-172(of 478)
** See List Footnote
EFLORNITHINE HYDROCHLORIDE
CREAM;TOPICAL
VANIQA
+ SKINMEDICA 13.9% N021145 001 Jul 27, 2000
INJECTABLE;INJECTION
ORNIDYL
SANOFI AVENTIS US 200MG/ML N019879 002 Nov 28, 1990
ELETRIPTAN HYDROBROMIDE
TABLET;ORAL
ELETRIPTAN HYDROBROMIDE
AMNEAL PHARMS CO EQ 20MG BASE A206787 001 May 25, 2018
EQ 40MG BASE A206787 002 May 25, 2018
YUNG SHIN PHARM EQ 20MG BASE A209680 001 Jul 13, 2020
EQ 40MG BASE A209680 002 Jul 13, 2020
ELIGLUSTAT TARTRATE
CAPSULE;ORAL
ELIGLUSTAT TARTRATE
DR REDDYS EQ 84MG BASE A212449 001 Aug 17, 2022
TEVA PHARMS USA INC EQ 84MG BASE A212474 001 Dec 27, 2021
ELTROMBOPAG OLAMINE
TABLET;ORAL
PROMACTA
+ NOVARTIS EQ 100MG ACID ** N022291 005 Nov 16, 2012
ELVITEGRAVIR
TABLET;ORAL
VITEKTA
+ GILEAD SCIENCES INC 85MG N203093 001 Sep 24, 2014
+ 150MG N203093 002 Sep 24, 2014
EMEDASTINE DIFUMARATE
SOLUTION/DROPS;OPHTHALMIC
EMADINE
+ NOVARTIS 0.05% N020706 001 Dec 29, 1997
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
TABLET;ORAL
EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
ZYDUS PHARMS 5MG;500MG A212198 001 Jul 07, 2022
5MG;1GM A212198 002 Jul 07, 2022
12.5MG;500MG A212198 003 Jul 07, 2022
12.5MG;1GM A212198 004 Jul 07, 2022
ENALAPRIL MALEATE
FOR SOLUTION;ORAL
EPANED KIT
+ SILVERGATE PHARMS 1MG/ML ** N204308 001 Aug 13, 2013
SOLUTION;ORAL
ENALAPRIL MALEATE
AMNEAL 1MG/ML A212894 001 Jun 29, 2022
TABLET;ORAL
ENALAPRIL MALEATE
AIPING PHARM INC 2.5MG A075178 002 Mar 23, 2001
5MG A075178 001 Mar 23, 2001
10MG A075178 003 Mar 23, 2001
20MG A075178 004 Mar 23, 2001
APOTHECON 2.5MG A075583 001 Aug 22, 2000
5MG A075583 002 Aug 22, 2000
10MG A075583 003 Aug 22, 2000
20MG A075583 004 Aug 22, 2000
AUROBINDO PHARMA USA 2.5MG A075480 001 Aug 22, 2000
5MG A075480 002 Aug 22, 2000
10MG A075480 003 Aug 22, 2000
20MG A075480 004 Aug 22, 2000
BEXIMCO PHARMS USA 2.5MG A075621 001 Aug 22, 2000
5MG A075621 002 Aug 22, 2000
10MG A075621 003 Aug 22, 2000
20MG A075621 004 Aug 22, 2000
IVAX SUB TEVA PHARMS 2.5MG A075482 001 Aug 22, 2000
5MG A075482 002 Aug 22, 2000

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-173(of 478)
** See List Footnote
ENALAPRIL MALEATE
TABLET;ORAL
ENALAPRIL MALEATE
10MG A075482 003 Aug 22, 2000
20MG A075482 004 Aug 22, 2000
KRKA DD NOVO MESTO 2.5MG A075370 001 Aug 22, 2000
5MG A075370 002 Aug 22, 2000
10MG A075369 001 Aug 22, 2000
20MG A075369 002 Aug 22, 2000
MYLAN 2.5MG A075472 001 Aug 22, 2000
5MG A075472 002 Aug 22, 2000
10MG A075472 003 Aug 22, 2000
20MG A075472 004 Aug 22, 2000
SANDOZ 2.5MG A075048 001 Aug 22, 2000
5MG A075048 002 Aug 22, 2000
10MG A075048 003 Aug 22, 2000
20MG A075048 004 Aug 22, 2000
SUN PHARM INDS LTD 2.5MG A075556 001 Aug 22, 2000
5MG A075556 002 Aug 22, 2000
10MG A075556 003 Aug 22, 2000
20MG A075556 004 Aug 22, 2000
WATSON LABS 2.5MG A075501 001 Aug 22, 2000
5MG A075501 002 Aug 22, 2000
10MG A075501 003 Aug 22, 2000
20MG A075501 004 Aug 22, 2000
ENALAPRIL MALEATE; FELODIPINE
TABLET, EXTENDED RELEASE;ORAL
LEXXEL
ASTRAZENECA 5MG;2.5MG N020668 002 Oct 28, 1998
5MG;5MG N020668 001 Dec 27, 1996
ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE
TABLET;ORAL
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE
CHARTWELL RX 5MG;12.5MG A076116 001 Sep 19, 2001
10MG;25MG A076116 002 Sep 19, 2001
IVAX SUB TEVA PHARMS 5MG;12.5MG A075736 001 Mar 25, 2003
10MG;25MG A075736 002 Mar 25, 2003
NOSTRUM LABS INC 5MG;12.5MG A076486 001 Oct 27, 2004
10MG;25MG A076486 002 Oct 27, 2004
RISING 5MG;12.5MG A075624 001 Sep 18, 2001
10MG;25MG A075624 002 Sep 18, 2001
ENALAPRILAT
INJECTABLE;INJECTION
ENALAPRILAT
DR REDDYS 1.25MG/ML A075578 001 Aug 22, 2000
HOSPIRA 1.25MG/ML A075456 001 Aug 22, 2000
1.25MG/ML A075571 001 Aug 22, 2000
VASOTEC
+ BIOVAIL LABS INTL 1.25MG/ML ** N019309 001 Feb 09, 1988
ENCORAFENIB
CAPSULE;ORAL
BRAFTOVI
+ ARRAY BIOPHARMA INC 50MG N210496 001 Jun 27, 2018
ENFLURANE
LIQUID;INHALATION
ENFLURANE
ABBOTT 99.9% A070803 001 Sep 08, 1987
PIRAMAL CRITICAL 99.9% A074396 001 Jul 29, 1994
ETHRANE
BAXTER HLTHCARE 99.9% N017087 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-174(of 478)
** See List Footnote
ENOXACIN
TABLET;ORAL
PENETREX
SANOFI AVENTIS US 200MG N019616 004 Dec 31, 1991
400MG N019616 005 Dec 31, 1991
ENOXAPARIN SODIUM
INJECTABLE;SUBCUTANEOUS
LOVENOX (PRESERVATIVE FREE)
+ SANOFI AVENTIS US 90MG/0.6ML (150MG/ML) ** N020164 006 Jun 02, 2000
ENTACAPONE
TABLET;ORAL
ENTACAPONE
MYLAN PHARMS INC 200MG A202394 001 May 13, 2013
ENTECAVIR
TABLET;ORAL
ENTECAVIR
ACCORD HLTHCARE 0.5MG A205824 001 Aug 25, 2017
1MG A205824 002 Aug 25, 2017
RISING 0.5MG A206226 001 Mar 26, 2019
1MG A206226 002 Mar 26, 2019
STRIDES PHARMA 0.5MG A206294 001 Nov 23, 2016
1MG A206294 002 Nov 23, 2016
SUNSHINE 0.5MG A211978 001 May 20, 2020
1MG A211978 002 May 20, 2020
TEVA PHARMS USA 0.5MG A202122 001 Aug 26, 2014
1MG A202122 002 Aug 26, 2014
YAOPHARMA CO LTD 0.5MG A212201 001 Nov 04, 2019
1MG A212201 002 Nov 04, 2019
YUNG SHIN PHARM 0.5MG A208195 001 Nov 10, 2021
1MG A208195 002 Nov 10, 2021
ENZALUTAMIDE
CAPSULE;ORAL
ENZALUTAMIDE
ACTAVIS LABS FL INC 40MG A209614 001 May 14, 2021
APOTEX 40MG A209645 001 Apr 22, 2022
EPHEDRINE HYDROCHLORIDE
SOLUTION;INTRAVENOUS
REZIPRES
+ DR REDDYS LABS SA 47MG/ML (47MG/ML) N213536 002 Jun 14, 2021
+ 47MG/5ML (9.4MG/ML) N213536 003 Jun 14, 2021
EPINASTINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
ELESTAT
+ ALLERGAN 0.05% N021565 001 Oct 16, 2003
EPINASTINE HYDROCHLORIDE
AKORN 0.05% A204055 001 May 05, 2017
CHARTWELL RX 0.05% A203384 001 Dec 07, 2016
SUN PHARM INDS 0.05% A091626 001 Oct 31, 2011
EPINEPHRINE
AEROSOL, METERED;INHALATION
BRONKAID MIST
STERLING 0.25MG/INH N016803 001
EPINEPHRINE
ARMSTRONG PHARMS 0.2MG/INH A087907 001 May 23, 1984
PRIMATENE MIST
WYETH CONS 0.2MG/INH N016126 001
INJECTABLE;INJECTION
SUS-PHRINE SULFITE FREE
FOREST LABS 1.5MG/AMP N007942 003 Feb 05, 1999
5MG/ML N007942 001
INJECTABLE;INTRAMUSCULAR
EPI E Z PEN JR
MYLAN SPECIALITY LP 0.15MG/DELIVERY N019430 004 Aug 03, 1995
EPIPEN E Z PEN
MYLAN SPECIALITY LP 0.3MG/DELIVERY N019430 003 Aug 03, 1995

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-175(of 478)
** See List Footnote
EPINEPHRINE
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
TWINJECT 0.15
IMPAX EQ 0.15MG/DELIVERY N020800 002 May 28, 2004
TWINJECT 0.3
IMPAX EQ 0.3MG/DELIVERY N020800 001 May 30, 2003
EPINEPHRINE BITARTRATE
AEROSOL, METERED;INHALATION
BRONITIN MIST
WYETH CONS 0.3MG/INH N016126 002
MEDIHALER-EPI
3M 0.3MG/INH N010374 003
EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
DURANEST
+ ASTRAZENECA 0.005MG/ML;1% ** N017751 006
+ 0.005MG/ML;1.5% ** N017751 007
+ DENTSPLY PHARM 0.005MG/ML;1.5% ** N021384 001
EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
CITANEST FORTE
ASTRAZENECA 0.005MG/ML;4% N014763 008
EPINEPHRINE; ETIDOCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
DURANEST
+ ASTRAZENECA 0.005MG/ML;0.5% ** N017751 004
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE
CARLISLE 0.01MG/ML;2% A084720 001
0.02MG/ML;2% A084732 001
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
BELMORA LLC 0.01MG/ML;2% A080504 004 Oct 19, 1983
0.02MG/ML;2% A080504 005 Oct 19, 1983
EASTMAN KODAK 0.01MG/ML;2% A040057 002 Feb 26, 1993
0.02MG/ML;2% A040057 001 Feb 26, 1993
HOSPIRA 0.005MG/ML;1% A089649 001 Jun 21, 1988
0.005MG/ML;1.5% A089650 001 Jun 21, 1988
0.01MG/ML;2% A078772 001 May 12, 2008
0.02MG/ML;2% A078772 002 May 12, 2008
WEST-WARD PHARMS INT 0.01MG/ML;1% A080406 001
0.01MG/ML;2% A080406 002
LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE
ABBOTT 0.01MG/ML;1% A083154 001
BEL MAR 0.01MG/ML;1% A080820 001
0.01MG/ML;2% A080757 001
DELL LABS 0.01MG/ML;1% A083389 001
0.01MG/ML;2% A083390 001
INTL MEDICATION 0.01MG/ML;1% A086402 001
WATSON LABS 0.01MG/ML;1% A080377 003
0.01MG/ML;1% A085463 001
0.01MG/ML;2% A080377 004
LIDOCATON
PHARMATON 0.01MG/ML;2% A084729 001 Aug 17, 1983
0.02MG/ML;2% A084728 001 Aug 17, 1983
OCTOCAINE
SEPTODONT 0.01MG/ML;2% A084048 001
0.02MG/ML;2% A084048 002
XYLOCAINE DENTAL WITH EPINEPHRINE
DENTSPLY PHARM 0.01MG/ML;2% ** N021381 001
0.02MG/ML;2% ** N021381 002
XYLOCAINE W/ EPINEPHRINE
ASTRAZENECA 0.005MG/ML;1% N010418 006
0.005MG/ML;1.5% N010418 010
0.005MG/ML;2% N010418 008
FRESENIUS KABI USA 0.01MG/ML;2% N006488 003

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-176(of 478)
** See List Footnote
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
PATCH;IONTOPHORESIS, TOPICAL
LIDOSITE TOPICAL SYSTEM KIT
VYTERIS 1.05MG/PATCH;100MG/PATCH N021504 001 May 06, 2004
SOLUTION;IONTOPHORESIS
IONTOCAINE
IOMED 0.01MG/ML;2% N020530 001 Dec 21, 1995
SOLUTION;IONTOPHORESIS, TOPICAL
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
EMPI 0.01MG/ML;2% N021486 001 Oct 26, 2004
EPINEPHRINE; PROCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
PROCAINE HYDROCHLORIDE W/ EPINEPHRINE
BEL MAR 0.02MG/ML;1% A080758 001
0.02MG/ML;2% A080759 001
EPIRUBICIN HYDROCHLORIDE
INJECTABLE;INJECTION
EPIRUBICIN HYDROCHLORIDE
ACTAVIS TOTOWA 10MG/5ML (2MG/ML) A065445 001 Sep 18, 2008
50MG/25ML (2MG/ML) A065445 002 Sep 18, 2008
200MG/100ML (2MG/ML) A065445 003 Sep 18, 2008
EBEWE PHARMA 50MG/25ML (2MG/ML) A065339 001 Dec 22, 2009
200MG/100ML (2MG/ML) A065339 002 Dec 22, 2009
FRESENIUS KABI USA 10MG/5ML (2MG/ML) A065408 001 Oct 15, 2007
50MG/25ML (2MG/ML) A065408 002 Oct 15, 2007
150MG/75ML (2MG/ML) A065408 003 Oct 15, 2007
200MG/100ML (2MG/ML) A065408 004 Oct 15, 2007
200MG/100ML (2MG/ML) A065411 001 Aug 20, 2007
50MG/25ML (2MG/ML) A065411 002 Aug 20, 2007
HOSPIRA 10MG/5ML (2MG/ML) A065343 001 Apr 19, 2007
50MG/25ML (2MG/ML) A065343 002 Apr 19, 2007
150MG/75ML (2MG/ML) A065343 003 Apr 19, 2007
200MG/100ML (2MG/ML) A065343 004 Apr 19, 2007
MYLAN INSTITUTIONAL 50MG/25ML (2MG/ML) A065371 001 Nov 28, 2007
200MG/100ML (2MG/ML) A065371 002 Nov 28, 2007
MYLAN LABS LTD 50MG/25ML (2MG/ML) A091599 001 Mar 12, 2012
200MG/100ML (2MG/ML) A091599 002 Mar 12, 2012
ZENNOVA 50MG/25ML (2MG/ML) A090266 001 Apr 15, 2011
200MG/100ML (2MG/ML) A090266 002 Apr 15, 2011
POWDER;INTRAVENOUS
EPIRUBICIN HYDROCHLORIDE
HOSPIRA 50MG/VIAL N050807 001 Sep 15, 2006
200MG/VIAL N050807 002 Sep 15, 2006
EPLERENONE
TABLET;ORAL
INSPRA
UPJOHN 100MG N021437 003 Sep 27, 2002
EPROSARTAN MESYLATE
TABLET;ORAL
EPROSARTAN MESYLATE
MYLAN PHARMS INC EQ 400MG BASE A202012 001 Nov 16, 2011
EQ 600MG BASE A202012 002 Nov 16, 2011
TEVETEN
ABBVIE EQ 300MG BASE ** N020738 004 Dec 22, 1997
+ EQ 400MG BASE ** N020738 005 Dec 22, 1997
+ EQ 600MG BASE ** N020738 006 May 27, 1999
EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE
TABLET;ORAL
TEVETEN HCT
ABBVIE 600MG;12.5MG N021268 001 Nov 01, 2001
600MG;25MG N021268 002 Nov 01, 2001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-177(of 478)
** See List Footnote
EPTIFIBATIDE
INJECTABLE;INJECTION
EPTIFIBATIDE
AKORN 2MG/ML A204589 001 Apr 18, 2017
75MG/100ML A204589 002 Apr 18, 2017
AMNEAL PHARMS 2MG/ML A205581 001 Dec 08, 2016
75MG/100ML A205581 002 Dec 08, 2016
BAXTER HLTHCARE CORP 2MG/ML A208554 001 Nov 23, 2018
HYBIO 2MG/ML A207864 001 Mar 20, 2020
75MG/100ML A207864 002 Mar 20, 2020
TEVA PHARMS USA 75MG/100ML A091555 001 Jun 05, 2015
USV 2MG/ML A204361 001 Mar 14, 2019
2MG/ML A204362 001 Mar 11, 2019
75MG/100ML A204361 002 Mar 14, 2019
INTEGRILIN
+ MSD SUB MERCK 2MG/ML ** N020718 001 May 18, 1998
+ 75MG/100ML ** N020718 002 May 18, 1998
ERGOCALCIFEROL
CAPSULE;ORAL
DELTALIN
LILLY 50,000 IU A080884 001
ERGOCALCIFEROL
SIGMAPHARM LABS LLC 50,000 IU A091004 001 Jul 14, 2010
VITAMIN D
CHARTWELL MOLECULAR 50,000 IU A080825 001
CHASE CHEM 50,000 IU A080747 001
EVERYLIFE 50,000 IU A080956 001
IMPAX LABS 50,000 IU A080951 001
VITARINE 50,000 IU A084053 001
WEST WARD 50,000 IU A083102 001
ERGOLOID MESYLATES
CAPSULE;ORAL
HYDERGINE LC
NOVARTIS 1MG N018706 001 Jan 18, 1983
SOLUTION;ORAL
HYDERGINE
NOVARTIS 1MG/ML N018418 001
TABLET;ORAL
ERGOLOID MESYLATES
MUTUAL PHARM 1MG A088891 001 Nov 01, 1985
WATSON LABS 1MG A086433 001 May 27, 1982
1MG A087244 001 Aug 16, 1982
GERIMAL
WATSON LABS 1MG A088207 001 Mar 22, 1984
HYDERGINE
NOVARTIS 0.5MG ** N017993 003
+ 1MG ** N017993 001
TABLET;SUBLINGUAL
ALKERGOT
SANDOZ 0.5MG A085153 001
1MG A087417 001
CIRCANOL
3M 0.5MG A084868 001
1MG A085809 001
DEAPRIL-ST
BRISTOL MYERS SQUIBB 1MG A085020 002
ERGOLOID MESYLATES
KV PHARM 0.5MG A085899 001
0.5MG A086265 001
1MG A085900 001
1MG A086264 001
LEDERLE 0.5MG A086984 001
1MG A086985 001
SUN PHARM INDUSTRIES 0.5MG A087407 001
1MG A087552 001
SUPERPHARM 0.5MG A089233 001 Sep 23, 1986
1MG A089234 001 Sep 23, 1986
VANGARD 0.5MG A088013 001 Sep 20, 1982

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-178(of 478)
** See List Footnote
ERGOLOID MESYLATES
TABLET;SUBLINGUAL
ERGOLOID MESYLATES
1MG A088014 001 Sep 20, 1982
WATSON LABS 0.5MG A084930 001
0.5MG A087233 001
1MG A085177 001
1MG A087183 001
GERIMAL
WATSON LABS 0.5MG A086189 001
1MG A086188 001
HYDERGINE
NOVARTIS 0.5MG N009087 002
1MG N009087 001
HYDROGENATED ERGOT ALKALOIDS
IVAX PHARMS 0.5MG A087186 001
1MG A087185 001
ERGOTAMINE TARTRATE
AEROSOL, METERED;INHALATION
MEDIHALER ERGOTAMINE
3M 0.36MG/INH N012102 001
TABLET;SUBLINGUAL
ERGOSTAT
WATSON LABS INC 2MG A088337 001 Jun 08, 1984
WIGRETTES
ORGANON USA INC 2MG A086750 001 Jul 29, 1982
ERLOTINIB HYDROCHLORIDE
TABLET;ORAL
ERLOTINIB HYDROCHLORIDE
ACCORD HLTHCARE EQ 25MG BASE A211083 001 Jul 02, 2020
EQ 100MG BASE A211083 002 Jul 02, 2020
EQ 150MG BASE A211083 003 Jul 02, 2020
EUGIA PHARMA EQ 25MG BASE A216342 001 Jun 22, 2022
EQ 100MG BASE A216342 002 Jun 22, 2022
EQ 150MG BASE A216342 003 Jun 22, 2022
ERYTHROMYCIN
CAPSULE, DELAYED REL PELLETS;ORAL
ERYC
PARKE DAVIS 250MG A062546 001 Jul 25, 1985
250MG A062618 001 Sep 25, 1985
WARNER CHILCOTT LLC 250MG A062338 001
ERYC 125
PARKE DAVIS 125MG A062648 001 Oct 24, 1985
ERYC SPRINKLES
HOSPIRA 125MG N050593 001 Jul 22, 1985
ERYTHROMYCIN
BARR 250MG A063098 001 May 04, 1989
GEL;TOPICAL
E-GLADES
MYLAN 2% A065009 001 Mar 18, 2002
EMGEL
ALTANA 2% A063107 001 Aug 23, 1991
LOTION;TOPICAL
E-SOLVE 2
SYOSSET 2% A062467 001 Jul 03, 1985
OINTMENT;OPHTHALMIC
ERYTHROMYCIN
PHARMADERM 5MG/GM A062446 001 Sep 26, 1983
PHARMAFAIR 5MG/GM A062481 001 Apr 05, 1984
ILOTYCIN
DISTA 0.5% ** N050368 001
OINTMENT;TOPICAL
AKNE-MYCIN
+ BAUSCH 2% N050584 001 Jan 10, 1985
POWDER;FOR RX COMPOUNDING
ERYTHROMYCIN
PADDOCK LLC 100% N050610 001 Nov 07, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-179(of 478)
** See List Footnote
ERYTHROMYCIN
SOLUTION;TOPICAL
A/T/S
TARO 2% A062405 001 Nov 18, 1982
C-SOLVE-2
FOUGERA PHARMS 2% A062468 001 Jul 03, 1985
ERYDERM
ARBOR PHARMS INC 2% A062290 001
ERYMAX
MERZ PHARMS 2% A062508 002 Jul 11, 1985
ERYTHRO-STATIN
AKORN 2% A064101 001 Oct 22, 1996
ERYTHROMYCIN
ALPHARMA US PHARMS 1.5% A062328 001 Apr 19, 1982
2% A062326 001 Apr 19, 1982
2% A062327 001 Apr 19, 1982
2% A062342 001 Feb 25, 1982
2% A062957 001 Jul 21, 1988
BAUSCH 2% A064039 001 Jan 27, 1994
FOUGERA PHARMS 2% A064187 001 Sep 30, 1997
LILLY 2% N050532 001
PHARMAFAIR 1.5% A062485 001 Jul 11, 1984
2% A062616 001 Jul 25, 1985
RENAISSANCE PHARMA 2% A064127 001 Feb 14, 1997
SANSAC
DOW PHARM 2% A062522 001 Jan 24, 1985
STATICIN
+ WESTWOOD SQUIBB 1.5% ** N050526 001
T-STAT
WESTWOOD SQUIBB 2% ** A062436 001 Mar 09, 1983
SWAB;TOPICAL
C-SOLVE-2
IVAX SUB TEVA PHARMS 2% A062751 001 Jul 30, 1993
ERYCETTE
+ JOHNSON AND JOHNSON 2% ** N050594 001 Feb 15, 1985
ERYTHROMYCIN
FOUGERA PHARMS 2% A065320 001 Jul 25, 2006
MYLAN 2% A064128 001 Jul 03, 1996
T-STAT
WESTWOOD SQUIBB 2% A062748 001 Jul 23, 1987
TABLET, COATED PARTICLES;ORAL
PCE
+ AZURITY 333MG N050611 001 Sep 09, 1986
+ 500MG N050611 002 Aug 22, 1990
TABLET, DELAYED RELEASE;ORAL
E-BASE
BARR 333MG A063028 001 May 15, 1990
333MG A063086 001 May 15, 1990
500MG A062999 001 Nov 25, 1988
E-MYCIN
ARBOR PHARMS INC 250MG A060272 001
333MG A060272 002
ILOTYCIN
DISTA 250MG A061910 001
R-P MYCIN
SOLVAY 250MG A061659 001
ROBIMYCIN
ROBINS AH 250MG A061633 001
ERYTHROMYCIN ESTOLATE
CAPSULE;ORAL
ERYTHROMYCIN ESTOLATE
BARR EQ 125MG BASE A062162 001
EQ 250MG BASE A062162 002
IVAX SUB TEVA PHARMS EQ 250MG BASE A062237 001
WATSON LABS EQ 250MG BASE A062087 001
ILOSONE
LILLY EQ 125MG BASE A061897 001
EQ 250MG BASE A061897 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-180(of 478)
** See List Footnote
ERYTHROMYCIN ESTOLATE
FOR SUSPENSION;ORAL
ILOSONE
DISTA EQ 125MG BASE/5ML A061893 001
SUSPENSION;ORAL
ERYTHROMYCIN ESTOLATE
ALPHARMA US PHARMS EQ 125MG BASE/5ML A062353 001 Nov 18, 1982
EQ 250MG BASE/5ML A062409 001 Dec 16, 1982
COSETTE EQ 125MG BASE/5ML A062169 001 Oct 17, 1990
EQ 250MG BASE/5ML A062169 002 Oct 17, 1990
LIFE LABS EQ 250MG BASE/5ML A062362 001 Dec 17, 1982
ILOSONE
LILLY EQ 125MG BASE/5ML A061894 001
EQ 125MG BASE/5ML N050010 001
EQ 250MG BASE/5ML A061894 002
EQ 250MG BASE/5ML N050010 002
SUSPENSION/DROPS;ORAL
ILOSONE
LILLY EQ 100MG BASE/ML A061894 003
TABLET;ORAL
ILOSONE
LILLY EQ 500MG BASE A061896 001
TABLET, CHEWABLE;ORAL
ILOSONE
DISTA EQ 125MG BASE A061895 001
EQ 250MG BASE A061895 002
ERYTHROMYCIN ESTOLATE; SULFISOXAZOLE ACETYL
SUSPENSION;ORAL
ILOSONE SULFA
LILLY EQ 125MG BASE/5ML;EQ 600MG BASE/5ML N050599 001 Sep 29, 1989
ERYTHROMYCIN ETHYLSUCCINATE
GRANULE;ORAL
ERYTHROMYCIN ETHYLSUCCINATE
PAR PHARM INC EQ 200MG BASE/5ML A211991 001 Oct 23, 2019
EQ 400MG BASE/5ML A211991 002 Oct 23, 2019
PEDIAMYCIN
ROSS LABS EQ 200MG BASE/5ML A062305 001
SUSPENSION;ORAL
E-MYCIN E
PHARMACIA AND UPJOHN EQ 200MG BASE/5ML A062198 001
EQ 400MG BASE/5ML A062198 002
E.E.S. 200
ARBOR PHARMS LLC EQ 200MG BASE/5ML ** A061639 001
E.E.S. 400
ARBOR PHARMS LLC EQ 400MG BASE/5ML ** A061639 002
ERYTHROMYCIN ETHYLSUCCINATE
ALPHARMA US PHARMS EQ 200MG BASE/5ML A062200 001
EQ 400MG BASE/5ML A062200 002
DISTA EQ 200MG BASE/5ML A062177 001
EQ 400MG BASE/5ML A062177 002
NASKA EQ 400MG BASE/5ML A062674 001 Mar 10, 1987
PARKE DAVIS EQ 200MG BASE/5ML A062231 001
EQ 400MG BASE/5ML A062231 002
PHARMAFAIR EQ 200MG BASE/5ML A062559 001 Mar 15, 1985
EQ 400MG BASE/5ML A062558 001 Mar 15, 1985
PEDIAMYCIN
ARBOR PHARMS LLC EQ 200MG BASE/5ML A062304 001
PEDIAMYCIN 400
ARBOR PHARMS LLC EQ 400MG BASE/5ML A062304 002
WYAMYCIN E
WYETH AYERST EQ 200MG BASE/5ML A062123 002
EQ 400MG BASE/5ML A062123 001
SUSPENSION/DROPS;ORAL
PEDIAMYCIN
ROSS LABS EQ 100MG BASE/2.5ML A062305 002
TABLET;ORAL
E.E.S. 400
ARBOR PHARMS LLC EQ 400MG BASE A061905 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-181(of 478)
** See List Footnote
ERYTHROMYCIN ETHYLSUCCINATE
TABLET;ORAL
ERYTHROMYCIN ETHYLSUCCINATE
BARR EQ 400MG BASE A062256 001
MYLAN EQ 400MG BASE A062847 001 Sep 14, 1988
TABLET, CHEWABLE;ORAL
E.E.S.
AZURITY EQ 200MG BASE N050297 002
ERYPED
AZURITY EQ 200MG BASE N050297 003 Jul 05, 1988
PEDIAMYCIN
ROSS LABS EQ 200MG BASE A062306 001
ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL
GRANULE;ORAL
ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
BARR EQ 200MG BASE/5ML;EQ 600MG BASE/5ML A062759 001 May 20, 1988
ERYZOLE
ALRA EQ 200MG BASE/5ML;EQ 600MG BASE/5ML A062758 001 Jun 15, 1988
PEDIAZOLE
ROSS LABS EQ 200MG BASE/5ML;EQ 600MG BASE/5ML ** N050529 001
ERYTHROMYCIN GLUCEPTATE
INJECTABLE;INJECTION
ILOTYCIN GLUCEPTATE
DISTA EQ 250MG BASE/VIAL N050370 001
EQ 500MG BASE/VIAL N050370 002
EQ 1GM BASE/VIAL N050370 003
ERYTHROMYCIN LACTOBIONATE
INJECTABLE;INJECTION
ERYTHROCIN
ABBOTT EQ 500MG BASE/VIAL A062586 001 Jan 04, 1988
EQ 1GM BASE/VIAL A062586 002 Jan 04, 1988
HOSPIRA EQ 500MG BASE/VIAL N050182 002
EQ 1GM BASE/VIAL A062638 002 Oct 31, 1986
EQ 1GM BASE/VIAL N050182 003
+ EQ 1GM BASE/VIAL N050609 002 Sep 24, 1986
ERYTHROMYCIN
ELKINS SINN EQ 500MG BASE/VIAL A062563 001 Mar 28, 1985
EQ 1GM BASE/VIAL A062563 002 Mar 28, 1985
ERYTHROMYCIN LACTOBIONATE
ABRAXIS PHARM EQ 500MG BASE/VIAL A062604 001 Nov 24, 1986
EQ 1GM BASE/VIAL A062604 002 Nov 24, 1986
BAXTER HLTHCARE EQ 500MG BASE/VIAL A062993 001 May 09, 1989
EQ 1GM BASE/VIAL A062993 002 May 09, 1989
TEVA PARENTERAL EQ 500MG BASE/VIAL A063253 001 Jul 30, 1993
EQ 1GM BASE/VIAL A063253 002 Jul 30, 1993
ERYTHROMYCIN STEARATE
TABLET;ORAL
BRISTAMYCIN
BRISTOL EQ 250MG BASE A061304 001
EQ 250MG BASE A061887 001
ERYPAR
PARKE DAVIS EQ 250MG BASE A062032 001
EQ 500MG BASE A062032 002
WARNER CHILCOTT EQ 250MG BASE A062322 001
ERYTHROCIN STEARATE
ARBOR PHARMS LLC EQ 125MG BASE A060359 002
EQ 500MG BASE A060359 003
ERYTHROMYCIN STEARATE
ANI PHARMS EQ 250MG BASE A061461 001
EQ 250MG BASE A061591 001
EQ 500MG BASE A061461 002
EQ 500MG BASE A063179 001 May 15, 1990
LEDERLE EQ 250MG BASE A062089 001
EQ 500MG BASE A062089 002
MYLAN EQ 250MG BASE A061505 001
EQ 500MG BASE A061505 002
PUREPAC PHARM EQ 250MG BASE A061743 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-182(of 478)
** See List Footnote
ERYTHROMYCIN STEARATE
TABLET;ORAL
ERYTHROMYCIN STEARATE
WATSON LABS EQ 250MG BASE A062121 002
EQ 500MG BASE A062121 001
ETHRIL 250
BRISTOL MYERS SQUIBB EQ 250MG BASE A061605 001
ETHRIL 500
BRISTOL MYERS SQUIBB EQ 500MG BASE A061605 002
PFIZER-E
PFIZER EQ 250MG BASE A061791 001
EQ 500MG BASE A061791 002
WYAMYCIN S
WYETH AYERST EQ 250MG BASE A061675 001
EQ 500MG BASE A061675 002
ESCITALOPRAM OXALATE
CAPSULE;ORAL
ESCITALOPRAM OXALATE
MYLAN PHARMS INC EQ 5MG BASE A077660 001 Jul 31, 2007
EQ 10MG BASE A077660 002 Jul 31, 2007
EQ 20MG BASE A077660 003 Jul 31, 2007
SOLUTION;ORAL
ESCITALOPRAM OXALATE
ANTRIM PHARMS LLC EQ 5MG BASE/5ML A203967 001 May 26, 2015
LEXAPRO
+ ALLERGAN EQ 5MG BASE/5ML ** N021365 001 Nov 27, 2002
TABLET;ORAL
ESCITALOPRAM OXALATE
HIKMA PHARMS EQ 5MG BASE A078766 001 Sep 11, 2012
EQ 10MG BASE A078766 002 Sep 11, 2012
EQ 20MG BASE A078766 003 Sep 11, 2012
MACLEODS PHARMS LTD EQ 5MG BASE A202210 001 Sep 11, 2012
EQ 10MG BASE A202210 002 Sep 11, 2012
EQ 20MG BASE A202210 003 Sep 11, 2012
MYLAN EQ 5MG BASE A077550 001 May 14, 2015
EQ 10MG BASE A077550 002 May 14, 2015
EQ 20MG BASE A077550 003 May 14, 2015
TEVA PHARMS USA EQ 5MG BASE A076765 001 Mar 14, 2012
EQ 10MG BASE A076765 002 Mar 14, 2012
EQ 20MG BASE A076765 003 Mar 14, 2012
ESMOLOL HYDROCHLORIDE
INJECTABLE;INJECTION
BREVIBLOC
BAXTER HLTHCARE 10MG/ML N019386 003 Aug 15, 1988
20MG/ML N019386 007 May 28, 2003
ESMOLOL HYDROCHLORIDE
AM REGENT 10MG/ML A201126 001 Feb 20, 2015
ESOMEPRAZOLE MAGNESIUM
CAPSULE, DELAYED REL PELLETS;ORAL
ESOMEPRAZOLE MAGNESIUM
AMNEAL PHARMS NY EQ 20MG BASE A209647 001 Apr 10, 2019
EQ 40MG BASE A209647 002 Apr 10, 2019
GUANGZHOU NOVAKEN EQ 20MG BASE A213859 001 Nov 18, 2020
EQ 40MG BASE A213859 002 Nov 18, 2020
HEC PHARM EQ 20MG BASE A207265 002 May 18, 2018
EQ 40MG BASE A207265 001 May 18, 2018
CAPSULE, DELAYED RELEASE;ORAL
ESOMEPRAZOLE MAGNESIUM
MYLAN EQ 20MG BASE A212376 001 Oct 16, 2019
TABLET, DELAYED RELEASE;ORAL
ESOMEPRAZOLE MAGNESIUM
P AND L EQ 20MG BASE A209202 001 Mar 05, 2019
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
ESOMEPRAZOLE MAGNESIUM
+ DEXCEL EQ 20MG BASE N214278 001 Oct 20, 2020

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-183(of 478)
** See List Footnote
ESOMEPRAZOLE SODIUM
INJECTABLE;INTRAVENOUS
ESOMEPRAZOLE SODIUM
EUGIA PHARMA EQ 20MG BASE/VIAL A204657 001 Aug 10, 2016
MYLAN EQ 20MG BASE/VIAL A202686 001 May 17, 2017
EQ 40MG BASE/VIAL A202686 002 May 17, 2017
SUN PHARM EQ 20MG BASE/VIAL A200882 001 Mar 18, 2013
NEXIUM IV
+ ASTRAZENECA EQ 20MG BASE/VIAL ** N021689 001 Mar 31, 2005
ESOMEPRAZOLE STRONTIUM
CAPSULE, DELAYED RELEASE;ORAL
ESOMEPRAZOLE STRONTIUM
+ BELCHER 24.65MG N202342 001 Aug 06, 2013
+ 49.3MG N202342 002 Aug 06, 2013
ESTAZOLAM
TABLET;ORAL
PROSOM
+ ABBOTT 1MG ** N019080 001 Dec 26, 1990
+ 2MG ** N019080 002 Dec 26, 1990
ESTRADIOL
FILM, EXTENDED RELEASE;TRANSDERMAL
ALORA
ALLERGAN 0.025MG/24HR N020655 004 Apr 05, 2002
0.05MG/24HR N020655 001 Dec 20, 1996
0.075MG/24HR N020655 002 Dec 20, 1996
0.1MG/24HR N020655 003 Dec 20, 1996
FEMPATCH
PARKE DAVIS 0.025MG/24HR N020417 001 Dec 03, 1996
GEL;TOPICAL
ESTROGEL
ASCEND THERAPS US 0.06% N021166 001 Feb 09, 2004
SYSTEM;TRANSDERMAL
ESCLIM
WOMEN FIRST HLTHCARE 0.025MG/24HR N020847 001 Aug 04, 1998
0.0375MG/24HR N020847 002 Aug 04, 1998
0.05MG/24HR N020847 003 Aug 04, 1998
0.075MG/24HR N020847 004 Aug 04, 1998
0.1MG/24HR N020847 005 Aug 04, 1998
ESTRADERM
+ NOVARTIS 0.05MG/24HR N019081 002 Sep 10, 1986
+ 0.1MG/24HR N019081 003 Sep 10, 1986
ESTRADIOL
ORTHO MCNEIL PHARM 0.05MG/24HR N021048 001 Sep 20, 1999
0.075MG/24HR N021048 002 Sep 20, 1999
0.1MG/24HR N021048 003 Sep 20, 1999
VIVELLE
NOVARTIS 0.025MG/24HR N020323 005 Aug 16, 2000
0.0375MG/24HR N020323 001 Oct 28, 1994
0.05MG/24HR N020323 002 Oct 28, 1994
0.075MG/24HR N020323 003 Oct 28, 1994
0.1MG/24HR N020323 004 Oct 28, 1994
TABLET;ORAL
ESTRACE
BRISTOL MYERS SQUIBB 0.5MG A081295 001 Jun 30, 1993
+ 1MG A084499 001
+ 2MG A084500 001
ESTRADIOL
LANNETT CO INC 0.5MG A040138 001 Jan 30, 1998
1MG A040138 002 Jan 30, 1998
2MG A040138 003 Jan 30, 1998
MAYNE PHARMA 0.5MG A040114 003 Mar 14, 1996
1MG A040114 001 Mar 14, 1996
2MG A040114 002 Mar 14, 1996
MYLAN 0.5MG A040326 001 Apr 21, 1999
1MG A040326 002 Apr 21, 1999
2MG A040326 003 Apr 21, 1999
USL PHARMA 0.5MG A040297 001 Apr 17, 2002
1MG A040297 002 Apr 17, 2002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-184(of 478)
** See List Footnote
ESTRADIOL
TABLET;ORAL
ESTRADIOL
2MG A040297 003 Apr 17, 2002
GYNODIOL
DURAMED PHARMS BARR 0.5MG A040212 001 Dec 29, 1997
1MG A040212 002 Dec 29, 1997
1.5MG A040212 003 Dec 29, 1997
2MG A040212 004 Dec 29, 1997
INNOFEM
NOVO NORDISK INC 0.5MG A040312 001 Nov 19, 1999
1MG A040312 002 Nov 19, 1999
2MG A040312 003 Nov 19, 1999
TABLET;VAGINAL
VAGIFEM
+ NOVO NORDISK INC 25MCG ** N020908 001 Mar 26, 1999
ESTRADIOL ACETATE
TABLET;ORAL
FEMTRACE
+ APIL 0.45MG N021633 001 Aug 20, 2004
+ 0.9MG N021633 002 Aug 20, 2004
+ 1.8MG N021633 003 Aug 20, 2004
ESTRADIOL CYPIONATE
INJECTABLE;INJECTION
DEPO-ESTRADIOL
PFIZER 1MG/ML A085470 001
3MG/ML A085470 002
ESTRADIOL CYPIONATE
DR REDDYS 5MG/ML A085620 001
ESTRADIOL CYPIONATE; MEDROXYPROGESTERONE ACETATE
INJECTABLE;INTRAMUSCULAR
LUNELLE
PHARMACIA AND UPJOHN 5MG/0.5ML;25MG/0.5ML N020874 001 Oct 05, 2000
ESTRADIOL CYPIONATE; TESTOSTERONE CYPIONATE
INJECTABLE;INJECTION
DEPO-TESTADIOL
PHARMACIA AND UPJOHN 2MG/ML;50MG/ML N017968 001
TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE
WATSON LABS 2MG/ML;50MG/ML A085603 001 Mar 13, 1986
ESTRADIOL HEMIHYDRATE
EMULSION;TOPICAL
ESTRASORB
+ EXELTIS USA INC 0.25% N021371 001 Oct 09, 2003
ESTRADIOL VALERATE
INJECTABLE;INJECTION
ESTRADIOL VALERATE
DR REDDYS 20MG/ML A083547 001
40MG/ML A083714 001
FOSUN PHARMA 10MG/ML A040628 001 Oct 04, 2007
20MG/ML A040628 002 Oct 04, 2007
40MG/ML A040628 003 Oct 04, 2007
WATSON LABS 10MG/ML A083546 001
ESTRADIOL VALERATE; TESTOSTERONE ENANTHATE
INJECTABLE;INJECTION
DITATE-DS
SAVAGE LABS 8MG/ML;180MG/ML A086423 001
TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE
WATSON LABS 4MG/ML;90MG/ML A085865 001
8MG/ML;180MG/ML A085860 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-185(of 478)
** See List Footnote
ESTRADIOL; NORETHINDRONE ACETATE
TABLET;ORAL
ACTIVELLA
+ AMNEAL 0.5MG;0.1MG N020907 002 Dec 28, 2006
ESTRADIOL AND NORETHINDRONE ACETATE
NAARI PTE LTD 1MG;0.5MG A210233 001 Feb 28, 2018
TEVA PHARMS USA 0.5MG;0.1MG A200747 001 Mar 08, 2012
ESTRADIOL; NORGESTIMATE
TABLET;ORAL
PREFEST
+ TEVA WOMENS 1MG,1MG;N/A,0.09MG ** N021040 001 Oct 22, 1999
ESTRADIOL; PROGESTERONE
CAPSULE;ORAL
BIJUVA
+ MAYNE PHARMA 0.5MG;100MG N210132 002 Dec 28, 2021
ESTRADIOL AND PROGESTERONE
AMNEAL PHARMS 1MG;100MG A214293 001 May 16, 2022
ESTROGENS, CONJUGATED
TABLET;ORAL
PREMARIN
WYETH PHARMS 2.5MG N004782 002
ESTROGENS, CONJUGATED SYNTHETIC A
CREAM;VAGINAL
SYNTHETIC CONJUGATED ESTROGENS A
TEVA WOMENS 0.625MG/GM N021788 001 Nov 28, 2008
TABLET;ORAL
CENESTIN
+ ASPEN 0.3MG ** N020992 001 Jun 21, 2002
+ 0.45MG ** N020992 005 Feb 05, 2004
+ 0.625MG ** N020992 002 Mar 24, 1999
+ 0.9MG ** N020992 003 Mar 24, 1999
+ 1.25MG ** N020992 004 Mar 13, 2000
ESTROGENS, CONJUGATED SYNTHETIC B
TABLET;ORAL
ENJUVIA
ASPEN 0.3MG N021443 001 Dec 20, 2004
0.45MG N021443 002 Dec 20, 2004
0.625MG ** N021443 003 May 10, 2004
0.9MG N021443 005 Apr 27, 2007
1.25MG ** N021443 004 May 10, 2004
ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE
TABLET;ORAL-28
PREMPHASE (PREMARIN;CYCRIN 14/14)
WYETH PHARMS INC 0.625MG,0.625MG;N/A,5MG N020303 002 Dec 30, 1994
PREMPRO (PREMARIN;CYCRIN)
WYETH PHARMS INC 0.625MG,0.625MG;2.5MG,2.5MG N020303 001 Dec 30, 1994
ESTROGENS, CONJUGATED; MEPROBAMATE
TABLET;ORAL
MILPREM-200
MEDPOINTE PHARM HLC 0.45MG;200MG N011045 002
MILPREM-400
MEDPOINTE PHARM HLC 0.45MG;400MG N011045 001
PMB 200
WYETH AYERST 0.45MG;200MG N010971 005
PMB 400
WYETH AYERST 0.45MG;400MG N010971 003
ESTROGENS, ESTERIFIED
TABLET;ORAL
AMNESTROGEN
BRISTOL MYERS SQUIBB 0.3MG A083266 001
0.625MG A083266 002
1.25MG A083266 003
2.5MG A083266 004
ESTERIFIED ESTROGENS
PVT FORM 0.625MG A083414 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-186(of 478)
** See List Footnote
ESTROGENS, ESTERIFIED
TABLET;ORAL
ESTERIFIED ESTROGENS
1.25MG A083765 001
2.5MG A085907 001
SANDOZ 1.25MG A085302 001
ESTRATAB
SOLVAY 0.3MG A086715 001
0.625MG A083209 001
1.25MG A083856 001
2.5MG A083857 001
EVEX
ROCHE PALO 0.625MG A084215 001
1.25MG A083376 002
FEMOGEN
PVT FORM 0.625MG A085076 001
1.25MG A085008 001
2.5MG A085007 001
ESTRONE
INJECTABLE;INJECTION
ESTROGENIC SUBSTANCE
WYETH AYERST 2MG/ML A083488 001
ESTRONE
DR REDDYS 5MG/ML A085239 001
WATSON LABS 2MG/ML A083397 001
NATURAL ESTROGENIC SUBSTANCE-ESTRONE
WATSON LABS 2MG/ML A085237 001 Nov 23, 1982
THEELIN
PARKEDALE 1MG/ML N003977 001
2MG/ML N003977 002
5MG/ML N003977 003
ESTROPIPATE
CREAM;VAGINAL
OGEN
PHARMACIA AND UPJOHN 1.5MG/GM A084710 001
TABLET;ORAL
ESTROPIPATE
BARR 0.75MG A040135 001 Nov 27, 1996
1.5MG A040135 002 Nov 27, 1996
3MG A040135 003 Nov 27, 1996
DURAMED PHARMS BARR 0.75MG A040296 001 Nov 01, 1999
1.5MG A040296 002 Nov 01, 1999
3MG A040296 003 Nov 01, 1999
MYLAN 0.75MG A040359 001 Aug 26, 1999
1.5MG A040359 002 Aug 26, 1999
3MG A040359 003 Aug 26, 1999
WATSON LABS 0.75MG A081213 001 Sep 23, 1993
1.5MG A081214 001 Sep 23, 1993
6MG A081216 001 Sep 23, 1993
WATSON LABS TEVA 3MG A081215 001 Sep 23, 1993
OGEN .625
+ PFIZER 0.75MG A083220 001
OGEN 1.25
+ PFIZER 1.5MG A083220 002
OGEN 2.5
+ PFIZER 3MG A083220 003
ORTHO-EST
SUN PHARM INDS INC 0.75MG A089567 001 Feb 27, 1991
1.5MG A089582 001 Jul 17, 1991
ESZOPICLONE
TABLET;ORAL
ESZOPICLONE
CHARTWELL RX 1MG A091165 001 Jul 14, 2011
2MG A091165 002 Jul 14, 2011
3MG A091165 003 Jul 14, 2011
HIKMA 1MG A091153 001 Apr 15, 2014
2MG A091153 002 Apr 15, 2014
3MG A091153 003 Apr 15, 2014

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-187(of 478)
** See List Footnote
ESZOPICLONE
TABLET;ORAL
ESZOPICLONE
NOSTRUM LABS INC 1MG A203087 001 May 08, 2019
2MG A203087 002 May 08, 2019
3MG A203087 003 May 08, 2019
ETHACRYNIC ACID
TABLET;ORAL
EDECRIN
BAUSCH 50MG N016092 002
ETHACRYNIC ACID
ALVOGEN 25MG A205709 001 Jul 24, 2018
ETHAMBUTOL HYDROCHLORIDE
TABLET;ORAL
ETHAMBUTOL HYDROCHLORIDE
BARR 400MG A076057 001 Nov 26, 2001
MYAMBUTOL
STI PHARMA LLC 200MG N016320 002
500MG N016320 004
ETHCHLORVYNOL
CAPSULE;ORAL
ETHCHLORVYNOL
BANNER PHARMACAPS 100MG A084463 001
200MG A084463 002
500MG A084463 003
750MG A084463 004
PLACIDYL
ABBVIE 100MG N010021 004
200MG N010021 007
500MG N010021 002
750MG N010021 010
ETHINAMATE
CAPSULE;ORAL
VALMID
DISTA 500MG N009750 001
ETHINYL ESTRADIOL
TABLET;ORAL
ESTINYL
SCHERING 0.02MG N005292 001
0.05MG N005292 002
0.5MG N005292 003
FEMINONE
PHARMACIA AND UPJOHN 0.05MG N016649 001
LYNORAL
ORGANON USA INC 0.01MG N005490 003
0.05MG N005490 002
ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE
TABLET;ORAL-21
DEMULEN 1/35-21
GD SEARLE LLC 0.035MG;1MG ** N018168 001
DEMULEN 1/50-21
GD SEARLE LLC 0.05MG;1MG N016927 001
ZOVIA 1/35E-21
WATSON PHARMS TEVA 0.035MG;1MG A072720 001 Dec 30, 1991
ZOVIA 1/50E-21
WATSON LABS 0.05MG;1MG A072722 001 Dec 30, 1991
TABLET;ORAL-28
DEMULEN 1/35-28
GD SEARLE LLC 0.035MG;1MG ** N018160 001
DEMULEN 1/50-28
GD SEARLE LLC 0.05MG;1MG ** N016936 001
ZOVIA 1/35E-28
MAYNE PHARMA 0.035MG;1MG A072721 001 Dec 30, 1991

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-188(of 478)
** See List Footnote
ETHINYL ESTRADIOL; ETONOGESTREL
RING;VAGINAL
VERARING
DR REDDYS LABS SA 0.015MG/24HR;0.12MG/24HR A207577 001 Dec 09, 2021
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
TABLET;ORAL-28
NORQUEST FE
PFIZER 0.035MG;75MG;1MG N018926 001 Jul 18, 1986
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE ACETATE
TABLET;ORAL-28
NORLESTRIN FE 1/50
PARKE DAVIS 0.05MG;75MG;1MG N016766 001
NORLESTRIN FE 2.5/50
PARKE DAVIS 0.05MG;75MG;2.5MG N016854 001
ETHINYL ESTRADIOL; LEVONORGESTREL
TABLET;ORAL
FAYOSIM
LUPIN LTD 0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.1 A205943 001 Mar 29, 2016
5MG;0.01MG,N/A
LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL
MAYNE PHARMA 0.02MG,0.1MG;0.01MG,N/A A200407 001 Oct 25, 2011
LYBREL
+ WYETH PHARMS INC 0.02MG;0.09MG ** N021864 001 May 22, 2007
PREVEN EMERGENCY CONTRACEPTIVE KIT
TEVA BRANDED PHARM 0.05MG;0.25MG N020946 001 Sep 01, 1998
SYLEVIA
SUN PHARM 0.03MG;0.15MG A202988 001 Feb 06, 2019
TABLET;ORAL-21
ALESSE
+ CADENCE HEALTH 0.02MG;0.1MG ** N020683 001 Mar 27, 1997
AVIANE-21
DURAMED PHARMS BARR 0.02MG;0.1MG A075796 002 Apr 30, 2001
ENPRESSE-21
DURAMED PHARMS BARR 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 A075809 001 Jul 16, 2001
25MG
LESSINA-21
BARR 0.02MG;0.1MG A075803 001 Mar 20, 2002
LEVLITE
+ BAYER HLTHCARE 0.02MG;0.1MG ** N020860 001 Jul 13, 1998
LEVONORGESTREL AND ETHINYL ESTRADIOL
BARR 0.02MG;0.1MG A075862 001 Apr 29, 2003
LEVORA 0.15/30-21
WATSON LABS 0.03MG;0.15MG A073592 001 Dec 13, 1993
NORDETTE-21
TEVA BRANDED PHARM 0.03MG;0.15MG N018668 001 May 10, 1982
PORTIA-21
BARR 0.03MG;0.15MG A075866 001 May 23, 2002
TRIPHASIL-21
+ WYETH PHARMS 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 N019192 001 Nov 01, 1984
25MG **
TRIVORA-21
MAYNE PHARMA 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 A074538 001 Dec 18, 1997
25MG
TABLET;ORAL-28
ALESSE
+ CADENCE HEALTH 0.02MG;0.1MG ** N020683 002 Mar 27, 1997
CERINTA
SUN PHARM 0.02MG;0.1MG A202817 001 Jan 07, 2019
ELIFEMME
XIROMED 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 A202507 001 Dec 04, 2015
25MG
LEVLITE
+ BAYER HLTHCARE 0.02MG;0.1MG ** N020860 002 Jul 13, 1998
LEVONORGESTREL AND ETHINYL ESTRADIOL
BARR 0.02MG;0.1MG A075862 002 Apr 29, 2003
MYLAN LABS LTD 0.02MG;0.1MG A202247 001 Dec 08, 2014
0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 A202970 001 Mar 23, 2018
25MG

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-189(of 478)
** See List Footnote
ETHINYL ESTRADIOL; LEVONORGESTREL
TABLET;ORAL-28
NORDETTE-28
+ TEVA BRANDED PHARM 0.03MG;0.15MG ** N018782 001 Jul 21, 1982
ORSYTHIA
VINTAGE PHARMS LLC 0.02MG;0.1MG A077099 001 May 11, 2011
TRIPHASIL-28
+ WYETH PHARMS INC 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 N019190 001 Nov 01, 1984
25MG **
ETHINYL ESTRADIOL; NORELGESTROMIN
FILM, EXTENDED RELEASE;TRANSDERMAL
ORTHO EVRA
+ JANSSEN PHARMS 0.035MG/24HR;0.15MG/24HR ** N021180 001 Nov 20, 2001
ETHINYL ESTRADIOL; NORETHINDRONE
TABLET;ORAL
FEMCON FE
+ APIL 0.035MG;0.4MG ** N021490 001 Nov 14, 2003
TABLET;ORAL-21
BALZIVA-21
BARR 0.035MG;0.4MG A076198 001 Apr 22, 2004
BREVICON 21-DAY
ALLERGAN 0.035MG;0.5MG N017566 001
GENCEPT 10/11-21
BARR 0.035MG,0.035MG;0.5MG,1MG A072694 001 Feb 28, 1992
MODICON 21
ORTHO MCNEIL PHARM 0.035MG;0.5MG ** N017488 001
N.E.E. 1/35 21
LPI 0.035MG;1MG A071541 001 Dec 14, 1987
NORCEPT-E 1/35 21
ORTHO MCNEIL PHARM 0.035MG;1MG A071545 001 Feb 09, 1989
NORETHIN 1/35E-21
WATSON PHARMS TEVA 0.035MG;1MG A071480 001 Apr 12, 1988
NORETHINDRONE AND ETHINYL ESTRADIOL
WATSON LABS 0.035MG;0.4MG A078379 001 Feb 23, 2010
0.035MG;0.5MG A070684 001 Jan 29, 1987
WATSON PHARMS TEVA 0.035MG;1MG A070685 001 Jan 29, 1987
NORETHINDRONE AND ETHINYL ESTRADIOL (10/11)
WATSON LABS 0.035MG,0.035MG;0.5MG,1MG A071043 001 Apr 01, 1988
NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)
WATSON LABS TEVA 0.035MG,0.035MG;0.5MG,1MG A071041 001 Sep 24, 1991
NORINYL 1+35 21-DAY
ALLERGAN 0.035MG;1MG N017565 001
NORTREL 0.5/35-21
BARR 0.035MG;0.5MG A072692 001 Feb 28, 1992
ORTHO-NOVUM 1/35-21
ORTHO MCNEIL PHARM 0.035MG;1MG ** N017489 002
ORTHO-NOVUM 10/11-21
+ ORTHO MCNEIL JANSSEN 0.035MG,0.035MG;0.5MG,1MG ** N018354 001 Jan 11, 1982
ORTHO-NOVUM 7/14-21
ORTHO MCNEIL PHARM 0.035MG,0.035MG;0.5MG,1MG ** N019004 001 Apr 04, 1984
ORTHO-NOVUM 7/7/7-21
JANSSEN PHARMS 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M N018985 001 Apr 04, 1984
G
OVCON-35
+ WARNER CHILCOTT 0.035MG;0.4MG ** N018127 001
OVCON-50
WARNER CHILCOTT 0.05MG;1MG N018128 001
TRI-NORINYL 21-DAY
MAYNE PHARMA 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG N018977 001 Apr 13, 1984
TABLET;ORAL-28
BREVICON 28-DAY
ALLERGAN 0.035MG;0.5MG N017743 001
CYCLAFEM 0.5/35
VINTAGE PHARMS 0.035MG;0.5MG A203413 001 Dec 16, 2015
CYCLAFEM 1/35
VINTAGE PHARMS LLC 0.035MG;1MG A076337 001 Nov 12, 2010
CYCLAFEM 7/7/7
VINTAGE PHARMS LLC 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M A076338 001 Nov 16, 2010
G

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-190(of 478)
** See List Footnote
ETHINYL ESTRADIOL; NORETHINDRONE
TABLET;ORAL-28
GENCEPT 10/11-28
BARR 0.035MG,0.035MG;0.5MG,1MG A072697 001 Feb 28, 1992
MODICON 28
+ JANSSEN PHARMS 0.035MG;0.5MG N017735 001
N.E.E. 1/35 28
LPI 0.035MG;1MG A071542 001 Dec 14, 1987
NORCEPT-E 1/35 28
ORTHO MCNEIL PHARM 0.035MG;1MG A071546 001 Feb 09, 1989
NORETHIN 1/35E-28
WATSON LABS 0.035MG;1MG A071481 001 Apr 12, 1988
NORETHINDRONE AND ETHINYL ESTRADIOL
MAYNE PHARMA 0.035MG;0.5MG A070686 001 Jan 29, 1987
MYLAN LABS LTD 0.035MG;0.4MG A200897 001 May 11, 2015
0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M A200486 001 Dec 28, 2015
G
0.035MG;0.5MG A200488 001 Oct 21, 2015
0.035MG;1MG A200489 001 Oct 21, 2015
0.05MG;1MG A203006 001 Aug 05, 2013
WATSON LABS 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M A076393 001 Feb 04, 2010
G
NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)
WATSON LABS 0.035MG,0.035MG;0.5MG,1MG A071042 001 Sep 24, 1991
NORINYL 1+35 28-DAY
ALLERGAN 0.035MG;1MG N017565 002
ORTHO-NOVUM 1/35-28
+ JANSSEN PHARMS 0.035MG;1MG ** N017919 002
ORTHO-NOVUM 10/11-28
+ ORTHO MCNEIL JANSSEN 0.035MG,0.035MG;0.5MG,1MG N018354 002 Jan 11, 1982
ORTHO-NOVUM 7/14-28
ORTHO MCNEIL PHARM 0.035MG,0.035MG;0.5MG,1MG ** N019004 002 Apr 04, 1984
ORTHO-NOVUM 7/7/7-28
+ JANSSEN PHARMS 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M N018985 002 Apr 04, 1984
G **
OVCON-35
+ WARNER CHILCOTT LLC 0.035MG;0.4MG ** N017716 001
OVCON-50
WARNER CHILCOTT LLC 0.05MG;1MG ** N017576 001
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
CAPSULE;ORAL
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
MAYNE PHARMA 0.02MG;1MG A213901 001 Apr 28, 2022
TABLET;ORAL
FEMHRT
+ APIL 0.0025MG;0.5MG N021065 001 Jan 14, 2005
+ 0.005MG;1MG ** N021065 002 Oct 15, 1999
LOESTRIN 24 FE
+ TEVA BRANDED PHARM 0.02MG;1MG ** N021871 001 Feb 17, 2006
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
MYLAN LABS LTD 0.0025MG;0.5MG A207260 001 Feb 02, 2017
0.005MG;1MG A207259 001 Dec 27, 2016
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
MYLAN LABS LTD 0.01MG,0.01MG;1MG,N/A A205049 001 May 31, 2016
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
AMNEAL PHARMS 0.02MG;1MG A078267 001 Sep 01, 2009
0.02MG;1MG A207514 001 Sep 11, 2017
APOTEX 0.02MG;1MG A208639 001 Mar 21, 2018
MYLAN LABS LTD 0.02MG;1MG A202742 001 Oct 30, 2014
0.02MG;1MG A206120 001 Sep 12, 2017
TABLET;ORAL-21
ESTROSTEP 21
+ APIL 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG ** N020130 001 Oct 09, 1996
GILDESS 1.5/30
VINTAGE PHARMS LLC 0.03MG;1.5MG A077075 002 Jul 24, 2012
GILDESS 1/20
VINTAGE PHARMS LLC 0.02MG;1MG A077077 002 Jul 24, 2012
LOESTRIN 21 1.5/30
+ TEVA BRANDED PHARM 0.03MG;1.5MG N017875 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-191(of 478)
** See List Footnote
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
TABLET;ORAL-21
LOESTRIN 21 1/20
+ TEVA BRANDED PHARM 0.02MG;1MG N017876 001
LOESTRIN FE 1.5/30
+ TEVA BRANDED PHARM 0.03MG;1.5MG N017355 001
MICROGESTIN 1.5/30
MAYNE PHARMA 0.03MG;1.5MG A075548 002 Jul 30, 2003
MICROGESTIN 1/20
MAYNE PHARMA 0.02MG;1MG A075647 002 Jul 30, 2003
NORLESTRIN 21 1/50
PARKE DAVIS 0.05MG;1MG N016749 001
NORLESTRIN 21 2.5/50
PARKE DAVIS 0.05MG;2.5MG N016852 001
TABLET;ORAL-28
ESTROSTEP FE
+ APIL 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG N020130 002 Oct 09, 1996
GILDESS FE 1.5/30
VINTAGE PHARMS LLC 0.03MG;1.5MG A077075 001 Apr 28, 2005
GILDESS FE 1/20
VINTAGE PHARMS LLC 0.02MG;1MG A077077 001 May 20, 2005
LOESTRIN FE 1/20
+ TEVA BRANDED PHARM 0.02MG;1MG N017354 001
MICROGESTIN FE 1.5/30
MAYNE PHARMA 0.03MG;1.5MG A075548 001 Feb 05, 2001
MICROGESTIN FE 1/20
MAYNE PHARMA 0.02MG;1MG A075647 001 Feb 05, 2001
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
MAYNE PHARMA 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG A076629 001 Mar 18, 2010
NORLESTRIN 28 1/50
PARKE DAVIS 0.05MG;1MG N016723 001
TABLET, CHEWABLE, TABLET;ORAL
LO MINASTRIN FE
+ APIL 0.01MG,0.01MG,N/A;1MG,N/A,N/A N204654 001 Jul 24, 2013
ETHINYL ESTRADIOL; NORGESTIMATE
TABLET;ORAL-21
ORTHO CYCLEN-21
JANSSEN PHARMS 0.035MG;0.25MG ** N019653 001 Dec 29, 1989
ORTHO TRI-CYCLEN
JANSSEN PHARMS 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, N019697 002 Jul 03, 1992
0.25MG **
TABLET;ORAL-28
NORGESTIMATE AND ETHINYL ESTRADIOL
MYLAN 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, A201897 001 Jan 27, 2016
0.25MG
0.035MG;0.25MG A201896 001 Jan 27, 2016
MYLAN LABS LTD 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG, A202132 001 Sep 09, 2015
0.25MG
WATSON LABS 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG, A090479 001 Mar 09, 2011
0.25MG
0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, A076626 001 Aug 17, 2006
0.25MG
0.035MG;0.25MG A076627 001 Aug 17, 2006
ORTHO CYCLEN-28
+ JANSSEN PHARMS 0.035MG;0.25MG ** N019653 002 Dec 29, 1989
ORTHO TRI-CYCLEN
+ JANSSEN PHARMS 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, N019697 001 Jul 03, 1992
0.25MG **
ORTHO TRI-CYCLEN LO
+ JANSSEN PHARMS 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG, N021241 001 Aug 22, 2002
0.25MG **
TRI-PREVIFEM
VINTAGE PHARMS LLC 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG, A076335 001 Mar 26, 2004
0.25MG

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-192(of 478)
** See List Footnote
ETHINYL ESTRADIOL; NORGESTREL
TABLET;ORAL-21
LO/OVRAL
+ CADENCE HEALTH 0.03MG;0.3MG N017612 001
LOW-OGESTREL-21
MAYNE PHARMA 0.03MG;0.3MG A075288 001 Jul 28, 1999
OGESTREL 0.5/50-21
WATSON LABS 0.05MG;0.5MG A075406 001 Dec 15, 1999
OVRAL
WYETH PHARMS 0.05MG;0.5MG N016672 001
TABLET;ORAL-28
LO/OVRAL-28
+ WYETH PHARMS 0.03MG;0.3MG ** N017802 001
NORGESTREL AND ETHINYL ESTRADIOL
MYLAN LABS LTD 0.03MG;0.3MG A201828 001 Jun 21, 2016
0.05MG;0.5MG A202875 001 May 08, 2017
OGESTREL 0.5/50-28
WATSON LABS 0.05MG;0.5MG A075406 002 Dec 15, 1999
OVRAL-28
WYETH PHARMS 0.05MG;0.5MG N016806 001
ETHOPROPAZINE HYDROCHLORIDE
TABLET;ORAL
PARSIDOL
PARKE DAVIS 10MG N009078 003
50MG N009078 006
100MG N009078 008
ETHOSUXIMIDE
SYRUP;ORAL
ETHOSUXIMIDE
TEVA PHARMS 250MG/5ML A081306 001 Jul 30, 1993
ETHOTOIN
TABLET;ORAL
PEGANONE
+ RECORDATI RARE 250MG N010841 001
500MG N010841 003
ETHOXZOLAMIDE
TABLET;ORAL
CARDRASE
PHARMACIA AND UPJOHN 62.5MG N011047 002
125MG N011047 001
ETHAMIDE
ALLERGAN 125MG N016144 001
ETHYLESTRENOL
ELIXIR;ORAL
MAXIBOLIN
ORGANON USA INC 2MG/5ML N014006 002
TABLET;ORAL
MAXIBOLIN
ORGANON USA INC 2MG N014005 002
ETHYNODIOL DIACETATE; MESTRANOL
TABLET;ORAL-20
OVULEN
GD SEARLE LLC 1MG;0.1MG N016029 002
TABLET;ORAL-21
OVULEN-21
GD SEARLE LLC 1MG;0.1MG N016029 003
TABLET;ORAL-28
OVULEN-28
GD SEARLE LLC 1MG;0.1MG N016705 001
ETIDOCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
DURANEST
+ ASTRAZENECA 0.5% ** N017751 003
+ 1% ** N017751 005

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-193(of 478)
** See List Footnote
ETIDRONATE DISODIUM
INJECTABLE;INJECTION
DIDRONEL
MGI PHARMA INC 50MG/ML N019545 001 Apr 20, 1987
TABLET;ORAL
DIDRONEL
+ APIL 200MG ** N017831 001
+ 400MG ** N017831 002
ETIDRONATE DISODIUM
MYLAN 200MG A075800 001 Jan 24, 2003
400MG A075800 002 Jan 24, 2003
ETODOLAC
CAPSULE;ORAL
ETODOLAC
ANI PHARMS 200MG A074840 001 Aug 29, 1997
200MG A074844 001 Dec 23, 1997
200MG A074899 001 Jul 08, 1997
300MG A074840 002 Aug 29, 1997
300MG A074844 002 Dec 23, 1997
300MG A074899 002 Jul 08, 1997
BIOPHARM 300MG A074929 001 Jan 30, 1998
CHARTWELL MOLECULES 200MG A074842 001 Jul 17, 1997
300MG A074842 002 Jul 17, 1997
MYLAN 200MG A074932 001 May 16, 1997
200MG A075071 001 Sep 30, 1998
300MG A074932 002 May 16, 1997
300MG A075071 002 Sep 30, 1998
SANDOZ 200MG A074942 001 Sep 30, 1997
300MG A074942 002 Sep 30, 1997
LODINE
+ WYETH PHARMS INC 200MG ** N018922 002 Jan 31, 1991
+ 300MG N018922 003 Jan 31, 1991
TABLET;ORAL
ETODOLAC
BIOPHARM 400MG A074927 001 Oct 30, 1997
CHARTWELL MOLECULES 400MG A074841 001 Jun 27, 1997
IVAX SUB TEVA PHARMS 400MG A074883 001 Feb 28, 1997
500MG A074883 002 Nov 20, 1998
MYLAN 400MG A075012 001 Sep 30, 1998
400MG A075104 001 Feb 06, 1998
500MG A075012 002 Sep 30, 1998
500MG A075104 002 Nov 20, 1998
OXFORD PHARMS 400MG A074819 001 Feb 28, 1997
500MG A074819 002 Apr 28, 1998
PHARMGEN 400MG A074839 001 Jul 11, 1997
400MG A074846 001 Feb 28, 1997
RANBAXY LABS LTD 400MG A075226 001 Nov 24, 1998
500MG A075226 002 Nov 24, 1998
TEVA 400MG A074847 001 Apr 23, 1999
400MG A075009 001 Nov 26, 1997
500MG A074847 002 Apr 23, 1999
500MG A075009 002 Dec 28, 1999
WATSON LABS 400MG A074892 001 Apr 16, 1997
400MG A075069 001 Apr 16, 1998
500MG A074892 002 Oct 29, 1998
LODINE
+ WYETH PHARMS INC 400MG ** N018922 004 Jul 29, 1993
+ 500MG ** N018922 005 Jun 28, 1996
TABLET, EXTENDED RELEASE;ORAL
ETODOLAC
ACTAVIS ELIZABETH 400MG A075696 001 Jul 31, 2000
ANI PHARMS 400MG A075943 001 Jul 26, 2002
500MG A075943 002 Jul 26, 2002
600MG A075943 003 Jul 26, 2002
WATSON LABS FLORIDA 400MG A075829 001 Nov 30, 2001
500MG A075829 002 Nov 30, 2001
LODINE XL
WYETH PHARMS INC 400MG ** N020584 001 Oct 25, 1996
500MG ** N020584 003 Jan 20, 1998

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-194(of 478)
** See List Footnote
ETODOLAC
TABLET, EXTENDED RELEASE;ORAL
LODINE XL
+ 600MG ** N020584 002 Oct 25, 1996
ETOMIDATE
INJECTABLE;INJECTION
ETOMIDATE
LUITPOLD 2MG/ML A078867 001 Dec 22, 2009
PAR STERILE PRODUCTS 2MG/ML A091297 001 Jun 20, 2012
RISING 2MG/ML A078289 001 Jan 02, 2009
ETONOGESTREL
IMPLANT;IMPLANTATION
IMPLANON
ORGANON 68MG/IMPLANT N021529 001 Jul 17, 2006
ETOPOSIDE
CAPSULE;ORAL
VEPESID
+ STRIDES PHARMA 50MG N019557 001 Dec 30, 1986
+ 100MG N019557 002 Dec 30, 1986
INJECTABLE;INJECTION
ETOPOSIDE
HOSPIRA 20MG/ML A074320 001 Aug 30, 1995
20MG/ML A074351 001 Aug 30, 1995
MYLAN LABS LTD 20MG/ML A203507 001 Nov 20, 2017
20MG/ML A204927 001 Oct 31, 2017
PHARMACHEMIE BV 20MG/ML A074227 001 Feb 22, 1996
PIERRE FABRE 20MG/ML A074813 001 Jul 09, 1997
TEVA PARENTERAL 20MG/ML A074510 001 Jun 29, 1995
TEVA PHARMS USA 20MG/ML A074284 001 Feb 10, 1994
WATSON LABS 20MG/ML A074228 001 Oct 15, 1996
WATSON LABS INC 20MG/ML A074968 001 Jan 09, 1998
TOPOSAR
TEVA PARENTERAL 20MG/ML A074166 001 Feb 27, 1995
VEPESID
+ CORDEN PHARMA 20MG/ML ** N018768 001 Nov 10, 1983
ETOPOSIDE PHOSPHATE
INJECTABLE;INJECTION
ETOPOPHOS PRESERVATIVE FREE
BRISTOL MYERS SQUIBB EQ 500MG BASE/VIAL N020906 001 Feb 27, 1998
EQ 1GM BASE/VIAL N020906 002 Feb 27, 1998
ETRAVIRINE
TABLET;ORAL
ETRAVIRINE
AMNEAL 25MG A214196 001 Jun 14, 2021
ETRETINATE
CAPSULE;ORAL
TEGISON
ROCHE 10MG N019369 001 Sep 30, 1986
25MG N019369 002 Sep 30, 1986
EVANS BLUE
INJECTABLE;INJECTION
EVANS BLUE
PARKE DAVIS 0.5% ** N008041 001
EVEROLIMUS
TABLET;ORAL
EVEROLIMUS
TEVA PHARMS USA 10MG A210050 004 Dec 09, 2019
EXEMESTANE
TABLET;ORAL
EXEMESTANE
AMNEAL PHARMS 25MG A206421 001 Dec 28, 2018
MAYNE PHARMA INC 25MG A208764 001 Aug 08, 2019

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-195(of 478)
** See List Footnote
EXENATIDE SYNTHETIC
FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS
BYDUREON
+ ASTRAZENECA AB 2MG/VIAL N022200 001 Jan 27, 2012
BYDUREON PEN
+ ASTRAZENECA AB 2MG N022200 002 Feb 28, 2014
EZETIMIBE
TABLET;ORAL
EZETIMIBE
APOTEX 10MG A208332 001 Jun 12, 2017
RISING 10MG A201790 001 Apr 26, 2019
TEVA PHARMS USA 10MG A078724 001 Jun 12, 2017
EZETIMIBE; ROSUVASTATIN CALCIUM
TABLET;ORAL
ROSZET
+ ALTHERA PHARMS 10MG;EQ 5MG BASE N213072 001 Mar 23, 2021
+ 10MG;EQ 10MG BASE N213072 002 Mar 23, 2021
+ 10MG;EQ 20MG BASE N213072 003 Mar 23, 2021
+ 10MG;EQ 40MG BASE N213072 004 Mar 23, 2021
EZETIMIBE; SIMVASTATIN
TABLET;ORAL
EZETIMIBE AND SIMVASTATIN
ANI PHARMS 10MG;10MG A201890 001 Apr 26, 2017
10MG;20MG A201890 002 Apr 26, 2017
10MG;40MG A201890 003 Apr 26, 2017
10MG;80MG A201890 004 Apr 26, 2017
AUROBINDO PHARMA USA 10MG;10MG A200082 001 Dec 17, 2020
10MG;20MG A200082 002 Dec 17, 2020
10MG;40MG A200082 003 Dec 17, 2020
10MG;80MG A200082 004 Dec 17, 2020
EZOGABINE
TABLET;ORAL
POTIGA
+ GLAXOSMITHKLINE 50MG N022345 001 Jun 10, 2011
+ 200MG N022345 002 Jun 10, 2011
+ 300MG N022345 003 Jun 10, 2011
+ 400MG N022345 004 Jun 10, 2011
FAMCICLOVIR
TABLET;ORAL
FAMCICLOVIR
CIPLA 125MG A078278 001 Mar 21, 2011
250MG A078278 002 Mar 21, 2011
500MG A078278 003 Mar 21, 2011
HIKMA 125MG A090128 001 Mar 21, 2011
250MG A090128 002 Mar 21, 2011
500MG A090128 003 Mar 21, 2011
MYLAN 125MG A201333 001 Mar 24, 2011
250MG A201333 002 Mar 24, 2011
500MG A201333 003 Mar 24, 2011
FAMVIR
+ NOVARTIS 125MG ** N020363 003 Dec 11, 1995
+ 250MG ** N020363 001 Apr 26, 1996
+ 500MG ** N020363 002 Jun 29, 1994
FAMOTIDINE
FOR SUSPENSION;ORAL
PEPCID
+ SALIX PHARMS 40MG/5ML ** N019527 001 Feb 02, 1987
INJECTABLE;INJECTION
FAMOTIDINE
APOTEX INC 10MG/ML A075942 001 Aug 02, 2002
APOTHECON 10MG/ML A075707 001 Apr 16, 2001
HIKMA 10MG/ML A075799 001 Apr 30, 2002
HOSPIRA 10MG/ML A075705 001 Apr 16, 2001
10MG/ML A075870 001 Nov 23, 2001
10MG/ML A075905 001 Nov 23, 2001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-196(of 478)
** See List Footnote
FAMOTIDINE
INJECTABLE;INJECTION
FAMOTIDINE PRESERVATIVE FREE
AKORN 10MG/ML A076324 001 Nov 27, 2002
APOTHECON 10MG/ML A075708 001 Apr 16, 2001
HIKMA 10MG/ML A075789 001 Apr 30, 2002
HOSPIRA 10MG/ML A075669 001 Apr 16, 2001
FAMOTIDINE PRESERVATIVE FREE (PHARMACY BULK)
AKORN 10MG/ML A076322 001 Nov 27, 2002
FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER
ABBVIE 0.4MG/ML A075729 001 Dec 17, 2001
PEPCID
+ MERCK 10MG/ML ** N019510 001 Nov 04, 1986
PEPCID PRESERVATIVE FREE
+ MERCK 10MG/ML ** N019510 004 Nov 04, 1986
PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER
+ MERCK SHARP DOHME 0.4MG/ML ** N020249 001 Feb 18, 1994
TABLET;ORAL
FAMOTIDINE
ACTAVIS ELIZABETH 20MG A075650 001 Sep 14, 2001
40MG A075650 002 Sep 14, 2001
APOTEX 10MG A075610 001 Mar 12, 2002
MANKIND PHARMA 20MG A075302 001 Apr 16, 2001
40MG A075302 002 Apr 16, 2001
MYLAN 10MG A075674 001 Dec 21, 2001
MYLAN PHARMS INC 20MG A075457 001 Apr 18, 2001
40MG A075457 002 Apr 18, 2001
PERRIGO R AND D 20MG A077352 002 Jul 27, 2005
40MG A077352 001 Jul 27, 2005
RISING 20MG A075704 001 Apr 16, 2001
40MG A075704 002 Apr 16, 2001
SANDOZ 10MG A076101 001 Oct 21, 2002
20MG A075607 001 May 10, 2001
20MG A075793 001 Apr 16, 2001
40MG A075607 002 May 10, 2001
40MG A075793 002 Apr 16, 2001
SUN PHARM INDUSTRIES 20MG A075639 002 Dec 12, 2001
40MG A075639 001 Dec 12, 2001
TEVA 10MG A075312 001 May 31, 2001
20MG A075311 001 Apr 16, 2001
40MG A075311 002 Apr 16, 2001
WATSON LABS 10MG A075404 001 Nov 28, 2001
20MG A075062 002 Apr 16, 2001
40MG A075062 001 Apr 16, 2001
PEPCID
+ BAUSCH 20MG ** N019462 001 Oct 15, 1986
+ 40MG ** N019462 002 Oct 15, 1986
TABLET, CHEWABLE;ORAL
FAMOTIDINE
PERRIGO 10MG A075715 001 Aug 22, 2003
PEPCID AC
+ J AND J CONSUMER INC 10MG ** N020801 001 Sep 24, 1998
TABLET, ORALLY DISINTEGRATING;ORAL
FLUXID
UCB INC 20MG N021712 001 Sep 24, 2004
40MG N021712 002 Sep 24, 2004
PEPCID RPD
MERCK 20MG N020752 001 May 28, 1998
40MG N020752 002 May 28, 1998
FELODIPINE
TABLET, EXTENDED RELEASE;ORAL
FELODIPINE
JUBILANT GENERICS 2.5MG A203983 001 Aug 19, 2016
5MG A203983 002 Aug 19, 2016
10MG A203983 003 Aug 19, 2016
MYLAN 2.5MG A078855 001 Apr 17, 2008
5MG A078855 002 Apr 17, 2008
10MG A078855 003 Apr 17, 2008
WOCKHARDT 2.5MG A091484 001 Aug 15, 2012

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-197(of 478)
** See List Footnote
FELODIPINE
TABLET, EXTENDED RELEASE;ORAL
FELODIPINE
5MG A091484 002 Aug 15, 2012
10MG A091484 003 Aug 15, 2012
PLENDIL
+ ASTRAZENECA 2.5MG ** N019834 004 Sep 22, 1994
+ 5MG ** N019834 001 Jul 25, 1991
+ 10MG ** N019834 002 Jul 25, 1991
FENOFIBRATE
CAPSULE;ORAL
ANTARA (MICRONIZED)
+ LUPIN 30MG N021695 004 Oct 18, 2013
87MG N021695 002 Nov 30, 2004
FENOFIBRATE (MICRONIZED)
IMPAX LABS 67MG A075868 001 Oct 27, 2003
134MG A075868 002 Oct 27, 2003
200MG A075868 003 Oct 27, 2003
MYLAN PHARMS INC 43MG A202579 001 Jan 10, 2013
130MG A202579 002 Jan 10, 2013
NOVAST LABS 67MG A207564 001 Apr 19, 2019
134MG A207564 002 Apr 19, 2019
200MG A207564 003 Apr 19, 2019
RISING 67MG A202676 001 Oct 23, 2012
134MG A202676 002 Oct 23, 2012
200MG A202676 003 Oct 23, 2012
LIPIDIL
ABBVIE 100MG N019304 001 Dec 31, 1993
LIPOFEN
CIPHER PHARMS INC 100MG N021612 002 Jan 11, 2006
TRICOR (MICRONIZED)
+ ABBVIE 67MG ** N019304 002 Feb 09, 1998
+ 134MG ** N019304 003 Jun 30, 1999
+ 200MG ** N019304 004 Jun 30, 1999
TABLET;ORAL
FENOFIBRATE
ALEMBIC PHARMS 54MG A213252 001 Jan 17, 2020
160MG A213252 002 Jan 17, 2020
MYLAN 107MG A076520 002 Dec 29, 2005
TRICOR
+ ABBVIE INC 54MG ** N021203 001 Sep 04, 2001
+ 160MG ** N021203 003 Sep 04, 2001
TRIGLIDE
SKYEPHARMA AG 50MG N021350 001 May 07, 2005
FENOFIBRIC ACID
TABLET;ORAL
FIBRICOR
+ ATHENA 35MG N022418 001 Aug 14, 2009
+ 105MG N022418 002 Aug 14, 2009
FENOLDOPAM MESYLATE
INJECTABLE;INJECTION
FENOLDOPAM MESYLATE
LUITPOLD EQ 10MG BASE/ML A076656 001 Dec 01, 2003
TEVA PARENTERAL EQ 10MG BASE/ML A077826 001 Mar 07, 2007
FENOPROFEN CALCIUM
CAPSULE;ORAL
FENOPROFEN CALCIUM
AM THERAP EQ 200MG BASE A072307 001 Aug 22, 1988
EQ 300MG BASE A072308 001 Aug 22, 1988
HALSEY EQ 200MG BASE A072355 001 Aug 17, 1988
EQ 300MG BASE A072356 001 Aug 17, 1988
PAR PHARM EQ 200MG BASE A072437 001 Aug 22, 1988
EQ 300MG BASE A072438 001 Aug 22, 1988
QUANTUM PHARMICS EQ 200MG BASE A072214 001 Aug 17, 1988
EQ 300MG BASE A071738 001 Aug 17, 1988
RISING EQ 200MG BASE A072394 001 Oct 17, 1988
EQ 300MG BASE A072395 001 Oct 17, 1988

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-198(of 478)
** See List Footnote
FENOPROFEN CALCIUM
CAPSULE;ORAL
FENOPROFEN CALCIUM
WARNER CHILCOTT EQ 200MG BASE A072946 001 Apr 30, 1991
EQ 300MG BASE A072472 001 Apr 30, 1991
WATSON LABS EQ 200MG BASE A072294 001 Aug 17, 1988
EQ 200MG BASE A072981 001 Aug 19, 1991
EQ 300MG BASE A072293 001 Aug 17, 1988
EQ 300MG BASE A072982 001 Aug 19, 1991
NALFON
XSPIRE PHARMA EQ 300MG BASE N017604 002
TABLET;ORAL
FENOPROFEN CALCIUM
AM THERAP EQ 600MG BASE A072309 001 Aug 17, 1988
ANI PHARMS EQ 600MG BASE A072274 001 May 02, 1988
DAVA PHARMS INC EQ 600MG BASE A072326 001 Aug 17, 1988
HALSEY EQ 600MG BASE A072357 001 Aug 17, 1988
IVAX SUB TEVA PHARMS EQ 600MG BASE A072557 001 Aug 29, 1988
QUANTUM PHARMICS EQ 600MG BASE A072194 001 Aug 17, 1988
RISING EQ 600MG BASE A072396 001 Oct 17, 1988
STRIDES PHARMA EQ 600MG BASE A072429 001 Aug 17, 1988
SUN PHARM INDUSTRIES EQ 600MG BASE A072902 001 Dec 21, 1990
USL PHARMA EQ 600MG BASE A072362 001 Aug 17, 1988
WATSON LABS EQ 600MG BASE A072165 001 Aug 17, 1988
EQ 600MG BASE A072602 001 Oct 11, 1988
WATSON LABS TEVA EQ 600MG BASE A072407 001 Aug 17, 1988
NALFON
DISTA EQ 600MG BASE N017710 001
FENTANYL
FILM, EXTENDED RELEASE;TRANSDERMAL
DURAGESIC-100
+ JANSSEN PHARMS 100MCG/HR N019813 001 Aug 07, 1990
DURAGESIC-12
+ JANSSEN PHARMS 12.5MCG/HR N019813 005 Feb 04, 2005
DURAGESIC-25
+ JANSSEN PHARMS 25MCG/HR N019813 004 Aug 07, 1990
DURAGESIC-37
+ JANSSEN PHARMS 37.5MCG/HR N019813 006 Jan 24, 2018
DURAGESIC-50
+ JANSSEN PHARMS 50MCG/HR N019813 003 Aug 07, 1990
DURAGESIC-75
+ JANSSEN PHARMS 75MCG/HR N019813 002 Aug 07, 1990
FENTANYL-100
ACTAVIS LABS UT INC 100MCG/HR A076709 004 Aug 20, 2007
AVEVA 100MCG/HR A077449 004 Oct 20, 2008
LAVIPHARM LABS 100MCG/HR A077051 004 Aug 04, 2006
MAYNE PHARMA 100MCG/HR A077062 004 Aug 20, 2007
NOVEN 100MCG/HR A077775 004 Oct 16, 2009
FENTANYL-12
AVEVA 12.5MCG/HR A077449 005 Sep 11, 2015
FENTANYL-25
ACTAVIS LABS UT INC 25MCG/HR A076709 001 Aug 20, 2007
AVEVA 25MCG/HR A077449 001 Oct 20, 2008
LAVIPHARM LABS 25MCG/HR A077051 001 Aug 04, 2006
MAYNE PHARMA 25MCG/HR A077062 001 Aug 20, 2007
NOVEN 25MCG/HR A077775 001 Oct 16, 2009
FENTANYL-37
AVEVA 37.5MCG/HR A077449 006 Dec 06, 2017
FENTANYL-50
ACTAVIS LABS UT INC 50MCG/HR A076709 002 Aug 20, 2007
AVEVA 50MCG/HR A077449 002 Oct 20, 2008
LAVIPHARM LABS 50MCG/HR A077051 002 Aug 04, 2006
MAYNE PHARMA 50MCG/HR A077062 002 Aug 20, 2007
NOVEN 50MCG/HR A077775 002 Oct 16, 2009
FENTANYL-62
AVEVA 62.5MCG/HR A077449 007 Dec 06, 2017
FENTANYL-75
ACTAVIS LABS UT INC 75MCG/HR A076709 003 Aug 20, 2007
AVEVA 75MCG/HR A077449 003 Oct 20, 2008

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-199(of 478)
** See List Footnote
FENTANYL
FILM, EXTENDED RELEASE;TRANSDERMAL
FENTANYL-75
LAVIPHARM LABS 75MCG/HR A077051 003 Aug 04, 2006
MAYNE PHARMA 75MCG/HR A077062 003 Aug 20, 2007
NOVEN 75MCG/HR A077775 003 Oct 16, 2009
FENTANYL-87
AVEVA 87.5MCG/HR A077449 008 Dec 06, 2017
SPRAY;SUBLINGUAL
SUBSYS
+ BTCP PHARMA 0.1MG N202788 001 Jan 04, 2012
+ 0.2MG N202788 002 Jan 04, 2012
+ 0.4MG N202788 003 Jan 04, 2012
+ 0.6MG N202788 004 Jan 04, 2012
+ 0.8MG N202788 005 Jan 04, 2012
+ 1.2MG N202788 006 Aug 30, 2012
+ 1.6MG N202788 007 Aug 30, 2012
FENTANYL CITRATE
FILM;BUCCAL
ONSOLIS
ADALVO EQ 0.2MG BASE N022266 001 Jul 16, 2009
EQ 0.4MG BASE N022266 002 Jul 16, 2009
EQ 0.6MG BASE N022266 003 Jul 16, 2009
EQ 0.8MG BASE N022266 004 Jul 16, 2009
EQ 1.2MG BASE N022266 005 Jul 16, 2009
INJECTABLE;INJECTION
FENTANYL CITRATE
ABBOTT EQ 0.05MG BASE/ML A070636 001 Apr 30, 1990
EQ 0.05MG BASE/ML A070637 001 Apr 30, 1990
WATSON LABS EQ 0.05MG BASE/ML A073488 001 Jun 30, 1992
FENTANYL CITRATE PRESERVATIVE FREE
DR REDDYS EQ 0.05MG BASE/ML A074917 001 Feb 03, 1998
SPRAY, METERED;NASAL
LAZANDA
+ BTCP PHARMA EQ 0.1MG BASE N022569 001 Jun 30, 2011
+ EQ 0.3MG BASE N022569 003 Dec 21, 2015
+ EQ 0.4MG BASE N022569 002 Jun 30, 2011
TABLET;BUCCAL, SUBLINGUAL
FENTANYL CITRATE
MAYNE PHARMA EQ 0.1MG BASE A206329 001 Aug 22, 2022
EQ 0.2MG BASE A206329 002 Aug 22, 2022
EQ 0.3MG BASE A206329 003 Aug 22, 2022
EQ 0.4MG BASE A206329 004 Aug 22, 2022
EQ 0.6MG BASE A206329 005 Aug 22, 2022
EQ 0.8MG BASE A206329 006 Aug 22, 2022
WATSON LABS EQ 0.1MG BASE A079075 001 Jan 07, 2011
EQ 0.2MG BASE A079075 002 Jan 07, 2011
EQ 0.4MG BASE A079075 003 Jan 07, 2011
EQ 0.6MG BASE A079075 004 Jan 07, 2011
EQ 0.8MG BASE A079075 005 Jan 07, 2011
FENTORA
+ CEPHALON EQ 0.3MG BASE ** N021947 006 Mar 02, 2007
TABLET;SUBLINGUAL
ABSTRAL
+ SENTYNL THERAPS INC EQ 0.1MG BASE ** N022510 001 Jan 07, 2011
+ EQ 0.2MG BASE ** N022510 002 Jan 07, 2011
+ EQ 0.3MG BASE ** N022510 003 Jan 07, 2011
+ EQ 0.4MG BASE ** N022510 004 Jan 07, 2011
+ EQ 0.6MG BASE ** N022510 005 Jan 07, 2011
+ EQ 0.8MG BASE ** N022510 006 Jan 07, 2011
FENTANYL CITRATE
ACTAVIS LABS FL INC EQ 0.1MG BASE A207338 001 Nov 17, 2017
EQ 0.2MG BASE A207338 002 Nov 17, 2017
EQ 0.3MG BASE A207338 003 Nov 17, 2017
EQ 0.4MG BASE A207338 004 Nov 17, 2017
EQ 0.6MG BASE A207338 005 Nov 17, 2017
EQ 0.8MG BASE A207338 006 Nov 17, 2017

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-200(of 478)
** See List Footnote
FENTANYL CITRATE
TROCHE/LOZENGE;ORAL
FENTANYL
CEPHALON EQ 0.1MG BASE N020195 007 Oct 30, 1995
EQ 0.2MG BASE N020195 001 Oct 04, 1993
EQ 0.3MG BASE N020195 002 Oct 04, 1993
EQ 0.4MG BASE N020195 003 Oct 04, 1993
TROCHE/LOZENGE;TRANSMUCOSAL
FENTANYL CITRATE
PAR PHARM EQ 0.2MG BASE A077312 001 Oct 30, 2009
EQ 0.4MG BASE A077312 002 Oct 30, 2009
EQ 0.6MG BASE A077312 003 Oct 30, 2009
EQ 0.8MG BASE A077312 004 Oct 30, 2009
EQ 1.2MG BASE A077312 005 Oct 30, 2009
EQ 1.6MG BASE A077312 006 Oct 30, 2009
FENTANYL HYDROCHLORIDE
SYSTEM;IONTOPHORESIS, TRANSDERMAL
IONSYS
+ THE MEDICINES CO EQ 40MCG BASE/ACTIVATION N021338 001 May 22, 2006
FERRIC AMMONIUM CITRATE
FOR SOLUTION;ORAL
FERRISELTZ
OTSUKA 600MG/PACKET N020292 001 Oct 14, 1997
FERRIC DERISOMALTOSE
SOLUTION;INTRAVENOUS
MONOFERRIC
+ PHARMACOSMOS AS 100MG/ML (100MG/ML) N208171 001 Jan 16, 2020
+ 500MG/5ML (100MG/ML) N208171 002 Jan 16, 2020
FERRIC OXYHYDROXIDE
INJECTABLE;INJECTION
DEXFERRUM
AM REGENT EQ 50MG IRON/ML N040024 001 Feb 23, 1996
IRON DEXTRAN
SANOFI AVENTIS US EQ 50MG IRON/ML N010787 002
PROFERDEX
NEW RIVER EQ 50MG IRON/ML N017807 001
INJECTABLE;INTRAVENOUS
VENOFER
AM REGENT EQ 65MG IRON/3.25ML (EQ 20MG IRON/ML) N021135 005 Mar 29, 2013
EQ 75MG IRON/3.75ML (EQ 20MG IRON/ML) N021135 003 Mar 29, 2005
FERRIC PYROPHOSPHATE CITRATE
FOR SOLUTION;INTRAVENOUS
TRIFERIC
+ ROCKWELL MEDICAL INC 272MG IRON/PACKET N208551 001 Apr 25, 2016
SOLUTION;INTRAVENOUS
TRIFERIC
+ ROCKWELL MEDICAL INC 27.2MG IRON/5ML (5.44MG IRON/ML) N206317 001 Jan 23, 2015
+ 272MG IRON/50ML (5.44MG IRON/ML) N206317 002 Sep 04, 2015
TRIFERIC AVNU
+ ROCKWELL MEDICAL INC 6.75MG IRON/4.5ML (1.5MG IRON/ML) N212860 001 Mar 27, 2020
FERROUS CITRATE, FE-59
INJECTABLE;INJECTION
FERROUS CITRATE FE 59
MALLINCKRODT 25uCi/ML N016729 001
FERROUS SULFATE; FOLIC ACID
CAPSULE;ORAL
FOLVRON
LEDERLE 182MG;0.33MG N006012 003
FERUMOXIDES
INJECTABLE;INJECTION
FERIDEX I.V.
AMAG PHARMS INC EQ 11.2MG IRON/ML N020416 001 Aug 30, 1996

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-201(of 478)
** See List Footnote
FERUMOXSIL
SUSPENSION;ORAL
GASTROMARK
AMAG PHARMS INC EQ 0.175MG IRON/ML N020410 001 Dec 06, 1996
FEXOFENADINE HYDROCHLORIDE
CAPSULE;ORAL
ALLEGRA
CHATTEM SANOFI 60MG ** N020625 001 Jul 25, 1996
FEXOFENADINE HYDROCHLORIDE
BARR 60MG A076169 001 Jul 13, 2005
SUSPENSION;ORAL
ALLEGRA
+ CHATTEM SANOFI 30MG/5ML N021963 001 Oct 16, 2006
CHILDREN'S ALLEGRA HIVES
+ CHATTEM SANOFI 30MG/5ML ** N201373 002 Jan 24, 2011
FEXOFENADINE HYDROCHLORIDE
P AND L 30MG/5ML A201311 001 Jul 25, 2012
TABLET;ORAL
ALLEGRA HIVES
+ CHATTEM SANOFI 60MG N020872 008 Jan 24, 2011
CHILDREN'S ALLEGRA ALLERGY
+ CHATTEM SANOFI 30MG ** N020872 005 Jan 24, 2011
CHILDREN'S ALLEGRA HIVES
+ CHATTEM SANOFI 30MG N020872 006 Jan 24, 2011
CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY
RISING 30MG A077081 004 Jul 21, 2011
SUN PHARM INDS 30MG A091567 002 Feb 06, 2012
CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES
RISING 30MG A077081 005 Jul 21, 2011
SUN PHARM INDS 30MG A091567 001 Feb 06, 2012
FEXOFENADINE HYDROCHLORIDE
BARR 30MG A076191 001 Aug 31, 2005
60MG A076191 002 Aug 31, 2005
180MG A076191 003 Aug 31, 2005
RISING 30MG A077081 002 Apr 11, 2008
FEXOFENADINE HYDROCHLORIDE ALLERGY
SUN PHARM INDS 60MG A091567 004 Feb 06, 2012
FEXOFENADINE HYDROCHLORIDE HIVES
SUN PHARM INDS 60MG A091567 003 Feb 06, 2012
TABLET, ORALLY DISINTEGRATING;ORAL
CHILDREN'S ALLEGRA ALLERGY
+ CHATTEM SANOFI 30MG N021909 002 Jan 24, 2011
CHILDREN'S ALLEGRA HIVES
+ CHATTEM SANOFI 30MG ** N021909 003 Jan 24, 2011
CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY
DR REDDYS LABS LTD 30MG A202978 001 Jan 18, 2013
CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES
DR REDDYS LABS LTD 30MG A202978 002 Jan 18, 2013
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
BARR 60MG;120MG A076236 001 Apr 14, 2005
IMPAX PHARMS 60MG;120MG A076298 001 Nov 12, 2010
FINAFLOXACIN
SUSPENSION/DROPS;OTIC
XTORO
+ MERLION PHARMS GMBH 0.3% N206307 001 Dec 17, 2014
FINASTERIDE
TABLET;ORAL
FINASTERIDE
ACTAVIS TOTOWA 1MG A078371 001 Nov 05, 2013
ACTAVIS TOTOWA TEVA 5MG A077914 001 Mar 28, 2007
GEDEON RICHTER USA 5MG A077251 001 Dec 22, 2006
IVAX SUB TEVA PHARMS 5MG A076340 001 Jun 19, 2006
MYLAN 1MG A078161 001 Nov 05, 2013
5MG A077578 001 Dec 18, 2006
TEVA 1MG A076905 001 Nov 05, 2013

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-202(of 478)
** See List Footnote
FINGOLIMOD HYDROCHLORIDE
CAPSULE;ORAL
FINGOLIMOD HYDROCHLORIDE
BIOCON LTD EQ 0.5MG BASE A207979 001 Dec 04, 2019
STRIDES PHARMA EQ 0.5MG BASE A207971 001 Jun 29, 2020
TEVA PHARMS USA EQ 0.25MG BASE A212152 001 Nov 12, 2021
EQ 0.5MG BASE A208008 001 Jul 02, 2020
FLAVOXATE HYDROCHLORIDE
TABLET;ORAL
FLAVOXATE HYDROCHLORIDE
IMPAX PHARMS 100MG A076234 001 Aug 28, 2003
URISPAS
ORTHO MCNEIL JANSSEN 100MG N016769 001
FLECAINIDE ACETATE
TABLET;ORAL
FLECAINIDE ACETATE
ANI PHARMS 50MG A076030 001 Oct 28, 2002
100MG A076030 002 Oct 28, 2002
150MG A076030 003 Oct 28, 2002
CHARTWELL 50MG A079164 001 Jul 09, 2009
100MG A079164 002 Jul 09, 2009
150MG A079164 003 Jul 09, 2009
TAMBOCOR
+ ALVOGEN 50MG ** N018830 004 Aug 23, 1988
+ 100MG ** N018830 001 Oct 31, 1985
+ 150MG ** N018830 003 Jun 03, 1988
200MG N018830 002 Oct 31, 1985
FLORBETAPIR F-18
SOLUTION;INTRAVENOUS
AMYVID
AVID RADIOPHARMS INC 10ML (13.5-51mCi/ML) N202008 001 Apr 06, 2012
FLOXURIDINE
INJECTABLE;INJECTION
FLOXURIDINE
AM REGENT 500MG/VIAL A203008 001 Nov 22, 2017
FUDR
+ HOSPIRA 500MG/VIAL ** N016929 001
FLUCONAZOLE
FOR SUSPENSION;ORAL
FLUCONAZOLE
HIKMA 50MG/5ML A076246 001 Jul 29, 2004
200MG/5ML A076246 002 Jul 29, 2004
IVAX SUB TEVA PHARMS 50MG/5ML A077523 001 Sep 12, 2007
200MG/5ML A077523 002 Sep 12, 2007
SUN PHARM INDS LTD 50MG/5ML A076332 001 Jul 29, 2004
200MG/5ML A076332 002 Jul 29, 2004
TARO PHARM INDS 50MG/5ML A076918 001 Dec 18, 2006
200MG/5ML A076918 002 Dec 18, 2006
INJECTABLE;INJECTION
DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER
+ PFIZER 200MG/100ML (2MG/ML) N019950 003 Sep 29, 1992
+ 400MG/200ML (2MG/ML) N019950 005 Jul 08, 1994
DIFLUCAN IN SODIUM CHLORIDE 0.9%
+ PFIZER 200MG/100ML (2MG/ML) N019950 001 Jan 29, 1990
+ 400MG/200ML (2MG/ML) N019950 006 Jan 29, 1990
DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
+ PFIZER 200MG/100ML (2MG/ML) N019950 002 Jan 29, 1990
+ 400MG/200ML (2MG/ML) N019950 004 Jan 29, 1990
FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER
HIKMA FARMACEUTICA 200MG/100ML (2MG/ML) A078764 001 Jan 30, 2012
400MG/200ML (2MG/ML) A078764 002 Jan 30, 2012
HOSPIRA 200MG/100ML (2MG/ML) A076304 001 Jul 29, 2004
400MG/200ML (2MG/ML) A076304 002 Jul 29, 2004
MYLAN LABS LTD 200MG/100ML (2MG/ML) A076888 001 Mar 25, 2005
400MG/200ML (2MG/ML) A076888 002 Mar 25, 2005
WOODWARD 200MG/100ML (2MG/ML) A077988 001 May 26, 2010
400MG/200ML (2MG/ML) A077988 002 May 26, 2010

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-203(of 478)
** See List Footnote
FLUCONAZOLE
INJECTABLE;INJECTION
FLUCONAZOLE IN SODIUM CHLORIDE 0.9%
DR REDDYS 200MG/100ML (2MG/ML) A076653 001 Jul 29, 2004
400MG/200ML (2MG/ML) A076653 002 Jul 29, 2004
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
DR REDDYS 200MG/100ML (2MG/ML) A076837 001 Jan 13, 2005
400MG/200ML (2MG/ML) A076837 002 Jan 13, 2005
HOSPIRA 200MG/100ML (2MG/ML) A076617 001 Jul 29, 2004
400MG/200ML (2MG/ML) A076617 002 Jul 29, 2004
MYLAN LABS LTD 200MG/100ML (2MG/ML) A076889 001 Mar 25, 2005
400MG/200ML (2MG/ML) A076889 002 Mar 25, 2005
TABLET;ORAL
FLUCONAZOLE
ANI PHARMS 50MG A076086 001 Jul 29, 2004
100MG A076086 002 Jul 29, 2004
150MG A076086 003 Jul 29, 2004
200MG A076086 004 Jul 29, 2004
GEDEON RICHTER USA 50MG A076432 001 Jul 29, 2004
100MG A076432 002 Jul 29, 2004
150MG A076432 003 Jul 29, 2004
200MG A076432 004 Jul 29, 2004
IVAX SUB TEVA PHARMS 50MG A076077 001 Jul 29, 2004
100MG A076077 002 Jul 29, 2004
150MG A076077 003 Jul 29, 2004
200MG A076077 004 Jul 29, 2004
MYLAN 50MG A076351 001 Jul 29, 2004
100MG A076351 002 Jul 29, 2004
150MG A076351 003 Jul 29, 2004
200MG A076351 004 Jul 29, 2004
MYLAN PHARMS INC 50MG A076042 001 Jul 29, 2004
100MG A076042 002 Jul 29, 2004
150MG A076042 003 Jul 29, 2004
200MG A076042 004 Jul 29, 2004
PLIVA 50MG A076424 001 Jul 29, 2004
100MG A076424 002 Jul 29, 2004
150MG A076424 003 Jul 29, 2004
200MG A076424 004 Jul 29, 2004
RANBAXY LABS LTD 50MG A076386 001 Jul 29, 2004
100MG A076386 002 Jul 29, 2004
150MG A076386 003 Jul 29, 2004
200MG A076386 004 Jul 29, 2004
ROXANE 50MG A076213 001 Jul 29, 2004
100MG A076213 002 Jul 29, 2004
150MG A076213 003 Jul 29, 2004
200MG A076213 004 Jul 29, 2004
TEVA 50MG A074681 001 Jul 29, 2004
100MG A074681 002 Jul 29, 2004
150MG A074681 003 Jul 29, 2004
200MG A074681 004 Jul 29, 2004
FLUCYTOSINE
CAPSULE;ORAL
FLUCYTOSINE
STRIDES PHARMA 250MG A207536 001 Jun 18, 2018
500MG A207536 002 Jun 18, 2018
FLUDARABINE PHOSPHATE
INJECTABLE;INJECTION
FLUDARA
+ GENZYME CORP 50MG/VIAL ** N020038 001 Apr 18, 1991
FLUDARABINE PHOSPHATE
HOSPIRA 50MG/VIAL A077790 001 Apr 06, 2007
MYLAN LABS LTD 50MG/2ML (25MG/ML) A200647 001 Dec 21, 2011
50MG/VIAL A200648 001 Oct 16, 2012
TABLET;ORAL
OFORTA
SANOFI AVENTIS US 10MG N022273 001 Dec 18, 2008

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-204(of 478)
** See List Footnote
FLUDEOXYGLUCOSE F-18
INJECTABLE;INJECTION
FLUDEOXYGLUCOSE F18
+ DOWNSTATE CLINCL 4-40mCi/ML ** N020306 001 Aug 19, 1994
+ 4-90mCi/ML ** N020306 002 Sep 25, 2001
INJECTABLE;INTRAVENOUS
FLUDEOXYGLUCOSE F18
+ FEINSTEIN 20-200mCi/ML ** N021870 001 Aug 19, 2005
HOT SHOTS NM LLC 4-500mCi/ML A203937 001 Oct 30, 2014
MIDWEST MEDCL 20-200mCi/ML A203736 001 Nov 19, 2015
UNIV TX SW MEDCTR 20-200mCi/ML A210265 001 Feb 06, 2020
WEILL MEDCL COLL 10-100mCi/ML ** N021768 001 Aug 05, 2004
FLUDROCORTISONE ACETATE
TABLET;ORAL
FLORINEF
+ CASPER PHARMA LLC 0.1MG ** N010060 001
FLUDROCORTISONE ACETATE
HIKMA PHARMS 0.1MG A091302 001 Jul 22, 2011
FLUMAZENIL
INJECTABLE;INJECTION
FLUMAZENIL
DR REDDYS 0.5MG/5ML (0.1MG/ML) A076589 002 Oct 12, 2004
1MG/10ML (0.1MG/ML) A076589 001 Oct 12, 2004
RISING 1MG/10ML (0.1MG/ML) A078595 002 May 13, 2008
ROMAZICON
+ HOFFMANN LA ROCHE 1MG/10ML (0.1MG/ML) ** N020073 001 Dec 20, 1991
+ 0.5MG/5ML (0.1MG/ML) ** N020073 002 Dec 20, 1991
FLUMETHASONE PIVALATE
CREAM;TOPICAL
LOCORTEN
NOVARTIS 0.03% N016379 001
FLUNISOLIDE
AEROSOL, METERED;INHALATION
AEROBID
ROCHE PALO 0.25MG/INH N018340 001 Aug 17, 1984
AEROSPAN HFA
+ MYLAN SPECIALITY LP 0.078MG/INH N021247 001 Jan 27, 2006
SPRAY, METERED;NASAL
FLUNISOLIDE
APOTEX 0.029MG/SPRAY A077436 001 Aug 09, 2007
NASALIDE
+ IVAX RES 0.025MG/SPRAY ** N018148 001
NASAREL
TEVA BRANDED PHARM 0.029MG/SPRAY N020409 001 Mar 08, 1995
FLUOCINOLONE ACETONIDE
CREAM;TOPICAL
FLUOCET
ALPHARMA US PHARMS 0.025% A088360 001 Jan 16, 1984
FLUOCINOLONE ACETONIDE
ALLIED 0.01% A088047 001 Dec 16, 1982
ALPHARMA US PHARMS 0.01% A088361 001 Jan 16, 1984
COSETTE 0.025% A089525 001 Jul 26, 1988
MLV 0.025% A088045 001 Dec 16, 1982
PERRIGO NEW YORK 0.01% A086810 001 Mar 04, 1982
0.025% A086811 001 Mar 04, 1982
PHARMAFAIR 0.01% A088499 001 Aug 02, 1984
0.025% A088506 001 Aug 02, 1984
TARO 0.01% A040035 001 Oct 31, 1994
0.01% A087102 001 Apr 27, 1982
0.025% A040042 001 Oct 31, 1994
USL PHARMA 0.01% A088757 001 Feb 11, 1985
0.025% A088756 001 Mar 28, 1985
FLUONID
ALLERGAN HERBERT 0.025% A087156 002 Sep 06, 1984
FLUOTREX
SAVAGE LABS 0.01% A088174 001 May 06, 1983
0.025% A088173 001 Mar 09, 1983

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-205(of 478)
** See List Footnote
FLUOCINOLONE ACETONIDE
CREAM;TOPICAL
SYNALAR-HP
MEDIMETRIKS PHARMS 0.2% N016161 002
GEL;TOPICAL
FLUONID
ALLERGAN HERBERT 0.025% A087300 001 May 27, 1982
OIL;TOPICAL
FLUOCINOLONE ACETONIDE
AKORN 0.01% A091514 001 Jun 25, 2015
AMNEAL 0.01% A201759 001 Oct 17, 2011
0.01% A201764 001 Oct 17, 2011
OIL/DROPS;OTIC
FLUOCINOLONE ACETONIDE
AKORN 0.01% A202705 001 Sep 09, 2016
AMNEAL 0.01% A091306 001 Oct 17, 2011
OINTMENT;TOPICAL
FLUOCINOLONE ACETONIDE
PHARMADERM 0.025% A088046 001 Dec 16, 1982
PHARMAFAIR 0.025% A088507 001 Feb 27, 1984
USL PHARMA 0.025% A088742 001 Feb 08, 1985
FLUONID
ALLERGAN HERBERT 0.025% A087157 001 Sep 06, 1984
FLUOTREX
SAVAGE LABS 0.025% A088172 001 Mar 09, 1983
SOLUTION;TOPICAL
FLUOCINOLONE ACETONIDE
ACTAVIS LABS UT INC 0.01% A208386 001 Oct 21, 2016
ALLIED 0.01% A088048 001 Dec 16, 1982
ALPHARMA US PHARMS 0.01% A087159 001 Jun 16, 1982
BAUSCH AND LOMB 0.01% A040059 001 Dec 20, 1993
COSETTE 0.01% A207441 001 Sep 28, 2016
PAI HOLDINGS PHARM 0.01% A088312 001 Jan 27, 1984
PHARMAFAIR 0.01% A088449 001 Feb 08, 1984
FLUONID
ALLERGAN HERBERT 0.01% A087158 001 Mar 17, 1983
FLUOTREX
SAVAGE LABS 0.01% A088171 001 Mar 09, 1983
FLUOCINONIDE
CREAM;TOPICAL
FLUOCINONIDE
ENCUBE 0.05% A211410 001 Oct 16, 2018
PERRIGO NEW YORK 0.05% A071790 001 Jul 13, 1988
LIDEX
+ ALVOGEN 0.05% N016908 002
LIDEX-E
+ ALVOGEN 0.05% ** N016908 003
SOLUTION;TOPICAL
FLUOCINONIDE
TARO 0.05% A072857 001 Aug 02, 1989
TEVA 0.05% A072511 001 Feb 07, 1989
TEVA PHARMS 0.05% A072522 001 Sep 28, 1990
FLUORESCEIN SODIUM
INJECTABLE;INJECTION
FUNDUSCEIN-25
+ NOVARTIS 25% ** N017869 001
FLUOROMETHOLONE
CREAM;TOPICAL
OXYLONE
PHARMACIA AND UPJOHN 0.025% N011748 001
OINTMENT;OPHTHALMIC
FML
+ ALLERGAN 0.1% N017760 001 Sep 04, 1985
SUSPENSION/DROPS;OPHTHALMIC
FLUOR-OP
NOVARTIS 0.1% A070185 001 Feb 27, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-206(of 478)
** See List Footnote
FLUOROMETHOLONE ACETATE; TOBRAMYCIN
SUSPENSION/DROPS;OPHTHALMIC
TOBRASONE
EYEVANCE 0.1%;0.3% N050628 001 Jul 21, 1989
FLUOROMETHOLONE; SULFACETAMIDE SODIUM
SUSPENSION/DROPS;OPHTHALMIC
FML-S
ALLERGAN 0.1%;10% N019525 001 Sep 29, 1989
FLUOROURACIL
CREAM;TOPICAL
FLUOROPLEX
+ CHARTWELL RX 1% N016988 001
FLUOROURACIL
MYLAN 0.5% A203122 001 Apr 20, 2015
INJECTABLE;INJECTION
ADRUCIL
PHARMACIA AND UPJOHN 50MG/ML A081222 001 Jun 28, 1991
+ 50MG/ML ** N017959 001
TEVA PARENTERAL 50MG/ML A040023 001 Oct 18, 1991
50MG/ML A081225 001 Aug 28, 1991
FLUOROURACIL
ABIC 50MG/ML A088929 001 Mar 04, 1986
ABRAXIS PHARM 50MG/ML A089152 001 Mar 21, 1986
50MG/ML A089428 001 Jan 12, 1987
50MG/ML A089519 001 Mar 12, 1987
BEDFORD 50MG/ML A089508 001 Jan 26, 1988
EBEWE PHARMA 500MG/10ML (50MG/ML) A040772 001 Aug 11, 2008
EUGIA PHARMA SPECLTS 500MG/10ML (50MG/ML) A202668 001 Jul 17, 2012
1GM/20ML (50MG/ML) A202668 002 Jul 17, 2012
2.5GM/50ML (50MG/ML) A202669 001 Jul 17, 2012
5GM/100ML (50MG/ML) A202669 002 Jul 17, 2012
FRESENIUS KABI USA 50MG/ML A040291 001 Mar 24, 1999
50MG/ML A040379 001 Nov 15, 2000
MARCHAR 50MG/ML A087791 001 Jan 18, 1983
NOVAST LABS 500MG/10ML (50MG/ML) A209219 001 Dec 12, 2019
1GM/20ML (50MG/ML) A209219 002 Dec 12, 2019
2.5GM/50ML (50MG/ML) A209271 002 Dec 11, 2019
5GM/100ML (50MG/ML) A209271 001 Dec 11, 2019
SANDOZ 2.5GM/50ML (50MG/ML) A091299 001 May 02, 2011
5GM/100ML (50MG/ML) A091299 002 May 02, 2011
SMITH AND NEPHEW 50MG/ML A088766 001 Dec 28, 1984
50MG/ML A088767 001 Dec 28, 1984
50MG/ML A089434 001 Mar 26, 1987
+ SPECTRUM PHARMS 2.5GM/50ML (50MG/ML) ** N012209 002 Jul 29, 2016
50MG/ML A087792 001 Oct 13, 1982
+ 500MG/10ML (50MG/ML) ** N012209 001
TEVA PHARMS USA 500MG/10ML (50MG/ML) A040333 001 Jan 27, 2000
2.5GM/50ML (50MG/ML) A040334 001 Feb 25, 2000
5GM/100ML (50MG/ML) A040334 002 Feb 25, 2000
SOLUTION;TOPICAL
EFUDEX
+ BAUSCH 5% ** N016831 002
FLUOROPLEX
ELORAC 1% N016765 001
FLUOXETINE HYDROCHLORIDE
CAPSULE;ORAL
FLUOXETINE
SUN PHARM INDUSTRIES EQ 10MG BASE A075787 001 Jan 29, 2002
EQ 20MG BASE A075787 002 Jan 29, 2002
WATSON LABS EQ 10MG BASE A075662 001 Jan 29, 2002
EQ 20MG BASE A075662 002 Jan 29, 2002
FLUOXETINE HYDROCHLORIDE
ACCORD HLTHCARE EQ 10MG BASE A202729 001 Aug 27, 2020
EQ 20MG BASE A202729 002 Aug 27, 2020
EQ 40MG BASE A202729 003 Aug 27, 2020
ANI PHARMS EQ 10MG BASE A076287 001 May 20, 2008
EQ 20MG BASE A076287 002 May 20, 2008
BARR EQ 10MG BASE A074803 002 Jan 30, 2002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-207(of 478)
** See List Footnote
FLUOXETINE HYDROCHLORIDE
CAPSULE;ORAL
FLUOXETINE HYDROCHLORIDE
EQ 20MG BASE A074803 001 Aug 02, 2001
EQ 40MG BASE A076251 001 May 18, 2005
BEXIMCO PHARMS USA EQ 10MG BASE A075807 001 Jan 29, 2002
EQ 20MG BASE A075807 002 Jan 29, 2002
CARLSBAD EQ 10MG BASE A076022 001 Jan 30, 2002
EQ 20MG BASE A076022 002 Jan 30, 2002
CR DOUBLE CRANE EQ 10MG BASE A076165 001 Feb 01, 2002
EQ 20MG BASE A076165 002 Feb 01, 2002
GRANULES EQ 10MG BASE A078143 001 Jan 16, 2008
EQ 20MG BASE A078143 002 Jan 16, 2008
EQ 40MG BASE A078143 003 Jan 16, 2008
MYLAN EQ 10MG BASE A075207 001 Jan 30, 2002
EQ 10MG BASE A078045 001 Nov 17, 2008
EQ 20MG BASE A075207 002 Jan 30, 2002
EQ 20MG BASE A078045 002 Nov 17, 2008
EQ 40MG BASE A075207 003 May 25, 2007
MYLAN PHARMS INC EQ 10MG BASE A075577 001 Jan 29, 2002
EQ 20MG BASE A075577 002 Jan 29, 2002
SANDOZ EQ 10MG BASE A077469 001 Nov 17, 2008
EQ 20MG BASE A077469 002 Nov 17, 2008
SPECGX LLC EQ 10MG BASE A075658 001 Jan 29, 2002
EQ 20MG BASE A075658 002 Jan 29, 2002
STRIDES PHARMA EQ 10MG BASE A076922 001 Dec 16, 2004
EQ 20MG BASE A076922 002 Dec 16, 2004
EQ 40MG BASE A076922 003 Dec 16, 2004
PROZAC
ELI LILLY AND CO EQ 60MG BASE N018936 004 Jun 15, 1999
SARAFEM
+ ELI LILLY AND CO EQ 10MG BASE ** N018936 007 Jul 06, 2000
+ EQ 20MG BASE ** N018936 008 Jul 06, 2000
CAPSULE, DELAYED REL PELLETS;ORAL
FLUOXETINE HYDROCHLORIDE
BARR EQ 90MG BASE A076237 001 Mar 24, 2010
PROZAC WEEKLY
+ LILLY EQ 90MG BASE ** N021235 001 Feb 26, 2001
SOLUTION;ORAL
FLUOXETINE HYDROCHLORIDE
ACTAVIS MID ATLANTIC EQ 20MG BASE/5ML A075690 001 Jan 31, 2002
AKORN EQ 20MG BASE/5ML A075525 001 Jun 27, 2002
LANNETT CO INC EQ 20MG BASE/5ML A076458 001 May 14, 2004
NOSTRUM LABS INC EQ 20MG BASE/5ML A075292 001 Feb 07, 2002
SPECGX LLC EQ 20MG BASE/5ML A075920 001 Jan 29, 2002
PROZAC
+ LILLY EQ 20MG BASE/5ML ** N020101 001 Apr 24, 1991
TABLET;ORAL
FLUOXETINE HYDROCHLORIDE
BARR EQ 10MG BASE A075810 001 Feb 01, 2002
FOSUN PHARMA EQ 10MG BASE A076024 001 Jan 29, 2002
G AND W LABS INC EQ 60MG BASE A212191 001 Jul 05, 2019
IVAX SUB TEVA PHARMS EQ 10MG BASE A075865 001 Feb 28, 2002
EQ 40MG BASE A075865 003 Aug 30, 2004
RISING EQ 10MG BASE A075755 001 Aug 02, 2001
EQ 20MG BASE A075755 002 Aug 02, 2001
PROZAC
+ LILLY EQ 10MG BASE ** N020974 001 Mar 09, 1999
+ EQ 20MG BASE ** N020974 002 Mar 09, 1999
SARAFEM
+ APIL EQ 10MG BASE ** N021860 001 May 19, 2006
+ EQ 15MG BASE ** N021860 002 May 19, 2006
+ EQ 20MG BASE ** N021860 003 May 19, 2006
SELFEMRA
TEVA PHARMS USA EQ 10MG BASE A200151 001 Feb 03, 2014
EQ 15MG BASE A200151 002 Feb 03, 2014
EQ 20MG BASE A200151 003 Feb 03, 2014

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-208(of 478)
** See List Footnote
FLUOXYMESTERONE
TABLET;ORAL
ANDROID-F
VALEANT PHARM INTL 10MG A087196 001
FLUOXYMESTERONE
UPSHER SMITH LABS 10MG A088342 001 Oct 21, 1983
VALEANT PHARM INTL 10MG A088221 001 May 05, 1983
WATSON LABS 2MG A088260 001 Dec 06, 1983
5MG A088265 001 Dec 06, 1983
10MG A088309 001 Dec 06, 1983
HALOTESTIN
PHARMACIA AND UPJOHN 2MG N010611 002
5MG N010611 006
10MG N010611 010
ORA-TESTRYL
BRISTOL MYERS SQUIBB 2MG N011359 001
5MG N011359 002
FLUPHENAZINE DECANOATE
INJECTABLE;INJECTION
FLUPHENAZINE DECANOATE
HOSPIRA 25MG/ML A074966 001 Apr 16, 1998
TEVA PARENTERAL 25MG/ML A074795 001 Sep 10, 1996
PROLIXIN DECANOATE
+ BRISTOL MYERS SQUIBB 25MG/ML ** N016727 001
FLUPHENAZINE ENANTHATE
INJECTABLE;INJECTION
PROLIXIN ENANTHATE
APOTHECON 25MG/ML ** N016110 001
FLUPHENAZINE HYDROCHLORIDE
CONCENTRATE;ORAL
FLUPHENAZINE HYDROCHLORIDE
ANI PHARMS 5MG/ML A073058 001 Aug 30, 1991
PERMITIL
SCHERING 5MG/ML ** N016008 001
PROLIXIN
APOTHECON 5MG/ML A070533 001 Nov 07, 1985
ELIXIR;ORAL
FLUPHENAZINE HYDROCHLORIDE
ANI PHARMS 2.5MG/5ML A081310 001 Apr 29, 1993
PROLIXIN
+ APOTHECON 2.5MG/5ML ** N012145 003
INJECTABLE;INJECTION
PROLIXIN
APOTHECON 2.5MG/ML ** N011751 005
TABLET;ORAL
FLUPHENAZINE HYDROCHLORIDE
SANDOZ 1MG A089586 002 Oct 16, 1987
2.5MG A089586 003 Oct 16, 1987
5MG A089586 004 Oct 16, 1987
10MG A089586 001 Oct 16, 1987
WATSON LABS 1MG A088555 001 Dec 18, 1987
2.5MG A088544 001 Dec 18, 1987
5MG A088527 001 Dec 18, 1987
10MG A088550 001 Dec 18, 1987
PERMITIL
SCHERING 0.25MG N012034 001
2.5MG N012034 004
5MG N012034 005
10MG N012034 006
PROLIXIN
+ APOTHECON 1MG ** N011751 004
+ 2.5MG ** N011751 001
+ 5MG ** N011751 003
+ 10MG ** N011751 002
TABLET, EXTENDED RELEASE;ORAL
PERMITIL
SCHERING 1MG N012419 004

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-209(of 478)
** See List Footnote
FLUPREDNISOLONE
TABLET;ORAL
ALPHADROL
PHARMACIA AND UPJOHN 1.5MG N012259 002
FLURANDRENOLIDE
CREAM;TOPICAL
CORDRAN SP
+ ALMIRALL 0.025% ** N012806 003
+ 0.05% N012806 002
FLURANDRENOLIDE
CINTEX SVCS 0.05% A205342 001 Apr 13, 2016
LOTION;TOPICAL
FLURANDRENOLIDE
ALPHARMA US PHARMS 0.05% A087203 001 Apr 29, 1982
CINTEX SVCS 0.05% A205343 001 Dec 22, 2016
OINTMENT;TOPICAL
CORDRAN
+ ALMIRALL 0.025% ** N012806 004
FLURANDRENOLIDE; NEOMYCIN SULFATE
CREAM;TOPICAL
CORDRAN N
LILLY 0.05%;EQ 3.5MG BASE/GM N050346 001
OINTMENT;TOPICAL
CORDRAN N
LILLY 0.05%;EQ 3.5MG BASE/GM N050345 001
FLURAZEPAM HYDROCHLORIDE
CAPSULE;ORAL
DALMANE
VALEANT PHARM INTL 15MG ** N016721 001
+ 30MG ** N016721 002
FLURAZEPAM HYDROCHLORIDE
HALSEY 15MG A071808 001 Jan 07, 1988
30MG A071809 001 Jan 07, 1988
HERITAGE PHARMA 15MG A071205 001 Nov 25, 1986
15MG A072368 001 Mar 30, 1989
30MG A071068 001 Nov 25, 1986
30MG A072369 001 Mar 30, 1989
HIKMA 30MG A071108 001 Dec 08, 1986
HIKMA INTL PHARMS 15MG A071107 001 Dec 08, 1986
PUREPAC PHARM 15MG A071927 001 Sep 09, 1987
30MG A071551 001 Sep 09, 1987
RISING 15MG A071717 002 Jul 31, 1991
30MG A071717 001 Jul 31, 1991
STRIDES PHARMA 15MG A070444 001 Mar 20, 1986
30MG A070445 001 Mar 20, 1986
SUN PHARM INDUSTRIES 15MG A070454 001 Aug 04, 1986
30MG A070455 001 Aug 04, 1986
SUPERPHARM 15MG A071659 001 Aug 04, 1988
30MG A071660 001 Aug 04, 1988
USL PHARMA 15MG A070562 001 Jul 09, 1987
30MG A070563 001 Jul 09, 1987
WARNER CHILCOTT 15MG A071767 001 Dec 04, 1987
30MG A071768 001 Dec 04, 1987
FLURBIPROFEN
TABLET;ORAL
ANSAID
PHARMACIA AND UPJOHN 50MG N018766 002 Oct 31, 1988
100MG N018766 003 Oct 31, 1988
FLURBIPROFEN
IVAX SUB TEVA PHARMS 50MG A074411 001 May 31, 1995
100MG A074411 002 May 31, 1995
MYLAN 50MG A074358 001 Jun 20, 1994
100MG A074358 002 Jun 20, 1994
PLIVA 50MG A074647 001 Apr 01, 1997
100MG A074647 002 Apr 01, 1997
RISING 50MG A074448 001 Jul 28, 1995
100MG A074448 002 Jul 28, 1995

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-210(of 478)
** See List Footnote
FLURBIPROFEN
TABLET;ORAL
FLURBIPROFEN
SUN PHARM INDS INC 50MG A075058 001 Apr 27, 2001
100MG A075058 002 Apr 27, 2001
TEVA 50MG A074405 002 May 24, 1995
100MG A074405 001 May 24, 1995
THERAGEN 100MG A074560 002 May 16, 1997
FLURBIPROFEN SODIUM
SOLUTION/DROPS;OPHTHALMIC
OCUFEN
+ ALLERGAN 0.03% ** N019404 001 Dec 31, 1986
FLUTAMIDE
CAPSULE;ORAL
EULEXIN
+ SCHERING 125MG ** N018554 001 Jan 27, 1989
FLUTAMIDE
ACTAVIS LABS FL INC 125MG A075820 001 Sep 18, 2001
CHARTWELL RX 125MG A075818 001 Sep 18, 2001
CIPLA 125MG A075780 001 Sep 19, 2001
MYLAN 125MG A076224 001 May 09, 2003
FLUTEMETAMOL F-18
INJECTABLE;INTRAVENOUS
VIZAMYL
+ GE HEALTHCARE 40.5mCi/10ML (4.05mCi/ML) N203137 001 Oct 25, 2013
FLUTICASONE PROPIONATE
AEROSOL, METERED;INHALATION
FLOVENT
GLAXOSMITHKLINE 0.044MG/INH N020548 001 Mar 27, 1996
0.11MG/INH N020548 002 Mar 27, 1996
0.22MG/INH N020548 003 Mar 27, 1996
CREAM;TOPICAL
CUTIVATE
+ FOUGERA PHARMS 0.05% ** N019958 001 Dec 18, 1990
FLUTICASONE PROPIONATE
ENCUBE 0.05% A076633 001 May 14, 2004
NESHER PHARMS 0.05% A076865 001 Sep 10, 2004
LOTION;TOPICAL
CUTIVATE
+ FOUGERA PHARMS 0.05% N021152 001 Mar 31, 2005
OINTMENT;TOPICAL
CUTIVATE
+ FOUGERA PHARMS 0.005% ** N019957 001 Dec 14, 1990
FLUTICASONE PROPIONATE
FOUGERA PHARMS 0.005% A076300 001 May 14, 2004
TARO PHARM INDS 0.005% A077145 001 Jun 14, 2005
POWDER;INHALATION
ARMONAIR DIGIHALER
+ TEVA PHARM 0.03MG/INH N208798 008 Apr 08, 2022
ARMONAIR RESPICLICK
+ TEVA PHARM 0.03MG/INH N208798 007 Jul 09, 2021
+ 0.055MG/INH N208798 001 Jan 27, 2017
+ 0.113MG/INH N208798 002 Jan 27, 2017
+ 0.232MG/INH N208798 003 Jan 27, 2017
FLOVENT
GLAXOSMITHKLINE 0.044MG/INH N020549 001 Nov 07, 1997
0.088MG/INH N020549 002 Nov 07, 1997
0.22MG/INH N020549 003 Nov 07, 1997
SPRAY, METERED;NASAL
FLONASE
+ GLAXOSMITHKLINE 0.05MG/SPRAY ** N020121 001 Oct 19, 1994

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-211(of 478)
** See List Footnote
FLUVASTATIN SODIUM
CAPSULE;ORAL
LESCOL
+ NOVARTIS EQ 20MG BASE ** N020261 001 Dec 31, 1993
+ EQ 40MG BASE ** N020261 002 Dec 31, 1993
TABLET, EXTENDED RELEASE;ORAL
FLUVASTATIN SODIUM
MYLAN EQ 80MG BASE A202458 001 Sep 11, 2015
FLUVOXAMINE MALEATE
CAPSULE, EXTENDED RELEASE;ORAL
FLUVOXAMINE MALEATE
TORRENT 100MG A203240 001 Oct 31, 2014
150MG A203240 002 Oct 31, 2014
LUVOX CR
+ JAZZ PHARMS 100MG ** N022033 001 Feb 28, 2008
+ 150MG ** N022033 002 Feb 28, 2008
TABLET;ORAL
FLUVOXAMINE MALEATE
ACTAVIS ELIZABETH 25MG A075901 001 Dec 28, 2000
50MG A075901 002 Dec 28, 2000
100MG A075901 003 Dec 28, 2000
ANI PHARMS 25MG A075897 001 Jan 25, 2001
25MG A075898 001 Mar 12, 2001
50MG A075897 002 Jan 25, 2001
50MG A075898 002 Mar 12, 2001
100MG A075897 003 Jan 25, 2001
100MG A075898 003 Mar 12, 2001
CHARTWELL RX 25MG A075900 001 Feb 23, 2006
50MG A075900 002 Feb 23, 2006
100MG A075900 003 Feb 23, 2006
HERITAGE PHARMA 25MG A075894 001 Apr 18, 2001
50MG A075894 002 Apr 18, 2001
100MG A075894 003 Apr 18, 2001
MYLAN 25MG A075889 001 Nov 29, 2000
50MG A075889 002 Nov 29, 2000
50MG A075950 001 Oct 15, 2001
100MG A075889 003 Nov 29, 2000
100MG A075950 002 Oct 15, 2001
SUN PHARM INDUSTRIES 25MG A076125 001 Apr 29, 2002
50MG A076125 002 Apr 29, 2002
100MG A076125 003 Apr 29, 2002
SYNTHON PHARMS 25MG A075899 001 Jan 17, 2001
50MG A075899 002 Jan 17, 2001
100MG A075899 003 Jan 17, 2001
TEVA 25MG A075893 001 Sep 10, 2002
50MG A075893 002 Sep 10, 2002
100MG A075893 003 Sep 10, 2002
UPSHER SMITH LABS 25MG A075887 001 Jan 05, 2001
50MG A075887 002 Jan 05, 2001
100MG A075887 003 Jan 05, 2001
LUVOX
+ SOLVAY 25MG ** N020243 001 Dec 05, 1994
+ 50MG ** N020243 002 Dec 05, 1994
+ 100MG ** N020243 003 Dec 05, 1994
+ 150MG ** N020243 004 Dec 05, 1994
FOLIC ACID
INJECTABLE;INJECTION
FOLIC ACID
BEN VENUE 5MG/ML A081066 001 Dec 29, 1993
FOLVITE
+ WYETH PHARMS INC 5MG/ML ** N005897 008
TABLET;ORAL
FOLIC ACID
BARR 1MG A089177 001 Jan 08, 1986
CONTRACT PHARMACAL 1MG A085061 001
EVERYLIFE 1MG A080755 001
HALSEY 1MG A083598 001
HIKMA PHARMS 1MG A080600 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-212(of 478)
** See List Footnote
FOLIC ACID
TABLET;ORAL
FOLIC ACID
IMPAX LABS 1MG A080686 001
IVAX SUB TEVA PHARMS 1MG A083000 001
JUBILANT CADISTA 1MG A040514 001 Jun 14, 2005
LANNETT 1MG A080816 001
LILLY 1MG ** N006135 003
MK LABS 1MG A083526 001
NEXGEN PHARMA INC 1MG A084915 001
PHARMERAL 1MG A084158 001
PIONEER PHARMS 1MG A088949 001 Sep 13, 1985
PUREPAC PHARM 1MG A080784 001
SANDOZ 1MG A084472 001
SUN PHARM INDUSTRIES 1MG A040582 001 Jul 18, 2005
TABLICAPS 1MG A083133 002
UDL 1MG A088199 001 Mar 29, 1983
USL PHARMA 1MG A087828 001 May 13, 1982
VALEANT PHARM INTL 1MG A080903 001
VANGARD 1MG A088730 001 Mar 23, 1984
VINTAGE 1MG A040756 001 Jun 04, 2010
VINTAGE PHARMS 1MG A086296 001
WATSON LABS 1MG A083141 001
1MG A085141 002
WHITEWORTH TOWN PLSN 1MG A080691 002
FOLICET
MISSION PHARMA 1MG A087438 001
FOLVITE
WYETH PHARMS INC 1MG ** N005897 004
FOMEPIZOLE
INJECTABLE;INJECTION
ANTIZOL
+ PAR PHARM INC 1.5GM/1.5ML (1GM/ML) ** N020696 001 Dec 04, 1997
FOMEPIZOLE
MYLAN INSTITUTIONAL 1.5GM/1.5ML (1GM/ML) A079033 001 Apr 07, 2009
FOMIVIRSEN SODIUM
INJECTABLE;INJECTION
VITRAVENE PRESERVATIVE FREE
NOVARTIS 6.6MG/ML N020961 001 Aug 26, 1998
FORMOTEROL FUMARATE
POWDER;INHALATION
FORADIL
+ NOVARTIS 0.012MG/INH N020831 001 Feb 16, 2001
FORADIL CERTIHALER
NOVARTIS 0.0085MG/INH N021592 001 Dec 15, 2006
FOSAPREPITANT DIMEGLUMINE
POWDER;INTRAVENOUS
EMEND
+ MERCK AND CO INC EQ 115MG BASE/VIAL ** N022023 001 Jan 25, 2008
FOSAPREPITANT DIMEGLUMINE
APOTEX EQ 150MG BASE/VIAL A205020 001 Sep 05, 2019
ARTHUR GRP EQ 150MG BASE/VIAL A211624 001 Sep 05, 2019
EQ 150MG BASE/VIAL A213199 001 Oct 04, 2021
MYLAN LABS LTD EQ 115MG BASE/VIAL A204015 001 Sep 05, 2019
SANDOZ INC EQ 150MG BASE/VIAL A203939 001 Dec 08, 2020
FOSCARNET SODIUM
INJECTABLE;INJECTION
FOSCARNET SODIUM
HOSPIRA 2.4GM/100ML A077174 001 May 31, 2005
FOSINOPRIL SODIUM
TABLET;ORAL
FOSINOPRIL SODIUM
ACTAVIS LABS FL INC 10MG A076620 001 Oct 15, 2004
20MG A076620 002 Oct 15, 2004
40MG A076620 003 Oct 15, 2004
RANBAXY LABS LTD 10MG A076580 001 Apr 23, 2004

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-213(of 478)
** See List Footnote
FOSINOPRIL SODIUM
TABLET;ORAL
FOSINOPRIL SODIUM
20MG A076580 002 Apr 23, 2004
40MG A076580 003 Apr 23, 2004
UPSHER SMITH LABS 10MG A076188 001 Oct 08, 2004
20MG A076188 002 Oct 08, 2004
40MG A076188 003 Oct 08, 2004
WATSON LABS 10MG A076987 001 Dec 23, 2004
10MG A077531 001 Aug 31, 2006
20MG A076987 002 Dec 23, 2004
20MG A077531 002 Aug 31, 2006
40MG A076987 003 Dec 23, 2004
40MG A077531 003 Aug 31, 2006
MONOPRIL
+ BRISTOL MYERS SQUIBB 10MG ** N019915 002 May 16, 1991
+ 20MG ** N019915 003 May 16, 1991
+ 40MG ** N019915 004 Mar 28, 1995
FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE
TABLET;ORAL
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
ANI PHARMS 10MG;12.5MG A076608 001 Dec 03, 2004
10MG;12.5MG A077144 001 Aug 16, 2005
20MG;12.5MG A076608 002 Dec 03, 2004
20MG;12.5MG A077144 002 Aug 16, 2005
EMCURE PHARMS LTD 10MG;12.5MG A079025 001 Sep 17, 2010
20MG;12.5MG A079025 002 Sep 17, 2010
MYLAN 10MG;12.5MG A077705 001 Aug 14, 2006
20MG;12.5MG A077705 002 Aug 14, 2006
SUN PHARM INDS LTD 10MG;12.5MG A076739 001 Dec 17, 2004
20MG;12.5MG A076739 002 Dec 17, 2004
TEVA 10MG;12.5MG A076945 001 Jul 05, 2006
20MG;12.5MG A076945 002 Jul 05, 2006
MONOPRIL-HCT
+ BRISTOL MYERS SQUIBB 10MG;12.5MG ** N020286 002 Nov 30, 1994
+ 20MG;12.5MG ** N020286 001 Nov 30, 1994
FOSPHENYTOIN SODIUM
INJECTABLE;INJECTION
FOSPHENYTOIN SODIUM
AM REGENT EQ 50MG PHENYTOIN NA/ML A078277 001 Aug 06, 2007
EQ 50MG PHENYTOIN NA/ML A090099 001 May 13, 2010
AMNEAL EQ 50MG PHENYTOIN NA/ML A078476 001 Mar 18, 2008
APOTEX INC EQ 50MG PHENYTOIN NA/ML A078126 001 Aug 06, 2007
DR REDDYS EQ 50MG PHENYTOIN NA/ML A076886 001 Aug 06, 2007
HOSPIRA EQ 50MG PHENYTOIN NA/ML A078158 001 Aug 06, 2007
SOLUTION;INTRAVENOUS
SESQUIENT
+ LUPIN EQ 100MG PHENYTOIN NA/2ML (EQ 50MG N210864 001 Nov 05, 2020
PHENYTOIN NA/ML)
+ EQ 500MG PHENYTOIN NA/10ML (EQ 50MG N210864 002 Nov 05, 2020
PHENYTOIN NA/ML)
FOSPROPOFOL DISODIUM
SOLUTION;INTRAVENOUS
LUSEDRA
EISAI INC 1050MG/30ML (35MG/ML) N022244 001 Dec 12, 2008
FULVESTRANT
SOLUTION;INTRAMUSCULAR
FASLODEX
+ ASTRAZENECA 125MG/2.5ML (50MG/ML) N021344 002 Apr 25, 2002
FULVESTRANT
APOTEX 250MG/5ML (50MG/ML) A211730 001 Jun 11, 2021

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-214(of 478)
** See List Footnote
FURAZOLIDONE
SUSPENSION;ORAL
FUROXONE
SHIRE 50MG/15ML N011323 002
TABLET;ORAL
FUROXONE
SHIRE 100MG N011270 002
FUROSEMIDE
INJECTABLE;INJECTION
FUROSEMIDE
ABRAXIS PHARM 10MG/ML N018507 001 Jul 30, 1982
10MG/ML N019036 001 Aug 13, 1984
+ AM REGENT 10MG/ML ** N018579 001 Nov 30, 1983
AMNEAL PHARMS CO 10MG/ML A207552 001 Jul 20, 2016
ASTRAZENECA 10MG/ML A070014 001 Sep 09, 1985
HIKMA 10MG/ML A071439 001 Sep 14, 1990
10MG/ML N018267 001
HOSPIRA 10MG/ML A070578 001 Jul 08, 1987
10MG/ML A072080 001 Aug 13, 1991
10MG/ML A074337 001 Oct 31, 1994
IGI LABS INC 10MG/ML A070095 001 Sep 09, 1985
10MG/ML A070096 001 Sep 09, 1985
INTL MEDICATION 10MG/ML N018025 001
MARSAM PHARMS LLC 10MG/ML A074017 001 Jun 30, 1994
SMITH AND NEPHEW 10MG/ML A070023 001 Feb 05, 1986
10MG/ML A070078 001 Feb 05, 1986
WARNER CHILCOTT 10MG/ML N018420 001 Feb 26, 1982
WATSON LABS 10MG/ML A070019 001 Sep 22, 1986
10MG/ML A070604 001 Jan 02, 1987
WYETH AYERST 10MG/ML N018670 001 Jul 20, 1982
LASIX
+ SANOFI AVENTIS US 10MG/ML ** N016363 001
SOLUTION;ORAL
FUROSEMIDE
WOCKHARDT BIO AG 10MG/ML A070655 001 Oct 02, 1987
LASIX
SANOFI AVENTIS US 10MG/ML N017688 001
TABLET;ORAL
FUROSEMIDE
ANI PHARMS 20MG A071379 001 Jan 02, 1987
40MG A070413 001 Feb 26, 1986
80MG A071594 001 Feb 09, 1988
AVET 20MG N018413 001 Nov 30, 1983
40MG N018413 002 Nov 30, 1983
EPIC PHARMA LLC 40MG N018750 002 Jul 30, 1984
INTL MEDICATION 20MG N018753 001 Feb 28, 1984
40MG N018753 002 Feb 28, 1984
KALAPHARM 20MG N018868 001 Jun 28, 1983
40MG N018868 002 Jun 28, 1983
STRIDES PHARMA 20MG N018415 001 Jul 27, 1982
40MG N018415 002 Jul 27, 1982
80MG N018415 003 Nov 26, 1984
SUN PHARM INDS INC 20MG A091258 001 Apr 01, 2014
40MG A091258 002 Apr 01, 2014
40MG N018790 001 Nov 29, 1983
80MG A091258 003 Apr 01, 2014
SUN PHARM INDUSTRIES 20MG A070043 001 Sep 26, 1985
80MG A070100 001 Jan 26, 1988
SUPERPHARM 20MG N018370 002 Jun 26, 1984
40MG N018370 001 Feb 10, 1983
WARNER CHILCOTT 20MG N018419 001 Jan 31, 1983
40MG N018419 002 Jan 31, 1983
80MG N018419 003 Nov 13, 1984
WATSON LABS 20MG A070412 001 Feb 26, 1986
20MG N018369 001 May 14, 1982
40MG A070450 001 Nov 22, 1985
40MG N018369 002 May 14, 1982
WATSON LABS TEVA 20MG A070449 001 Nov 22, 1985
80MG A070528 001 Jan 07, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-215(of 478)
** See List Footnote
GABAPENTIN
CAPSULE;ORAL
GABAPENTIN
CHARTWELL RX 100MG A091008 001 Oct 26, 2017
300MG A091008 002 Oct 26, 2017
400MG A091008 003 Oct 26, 2017
HIKMA 100MG A078150 001 Sep 25, 2007
300MG A078150 002 Sep 25, 2007
400MG A078150 003 Sep 25, 2007
MYLAN 100MG A090158 001 Feb 14, 2011
300MG A090158 002 Feb 14, 2011
400MG A090158 003 Feb 14, 2011
SANDOZ 100MG A075428 001 Jan 24, 2006
100MG A075539 001 Apr 06, 2005
300MG A075428 002 Jan 24, 2006
300MG A075539 002 Apr 06, 2005
400MG A075428 003 Jan 24, 2006
400MG A075539 003 Apr 06, 2005
SUN PHARM INDS LTD 100MG A076606 001 Oct 07, 2005
300MG A076606 002 Oct 07, 2005
400MG A076606 003 Oct 07, 2005
SUN PHARM INDUSTRIES 100MG A076537 001 Jun 30, 2005
300MG A076537 002 Jun 30, 2005
400MG A076537 003 Jun 30, 2005
TEVA PHARMS 100MG A075435 001 Oct 08, 2004
300MG A075435 002 Oct 08, 2004
400MG A075435 003 Oct 08, 2004
WATSON LABS 100MG A075485 003 May 11, 2007
300MG A075485 002 May 11, 2007
400MG A075485 001 May 11, 2007
SOLUTION;ORAL
GABAPENTIN
PAI HOLDINGS PHARM 250MG/5ML A211330 001 Dec 03, 2019
TABLET;ORAL
GABAPENTIN
HIKMA PHARMS 600MG A078782 001 Jul 21, 2011
800MG A078782 002 Jul 21, 2011
INVATECH 600MG A076877 001 Jul 06, 2006
800MG A076877 002 Jul 06, 2006
IVAX SUB TEVA PHARMS 600MG A076017 004 Apr 29, 2005
800MG A076017 005 Apr 29, 2005
LUPIN LTD 600MG A209306 001 Aug 24, 2018
800MG A209306 002 Aug 24, 2018
MYLAN PHARMS INC 600MG A090335 001 Jun 01, 2010
800MG A090335 002 Jun 01, 2010
RANBAXY 600MG A076605 001 Sep 14, 2005
800MG A076605 002 Sep 14, 2005
SANDOZ 600MG A076120 001 Jan 27, 2006
800MG A076120 002 Jan 27, 2006
TEVA 600MG A075827 001 Dec 15, 2004
800MG A075827 002 Dec 15, 2004
TEVA PHARMS USA 600MG A205807 001 Mar 10, 2017
800MG A205807 002 Mar 10, 2017
GADODIAMIDE
INJECTABLE;INJECTION
OMNISCAN
GE HEALTHCARE 14.35GM/50ML (287MG/ML) N022066 001 Sep 05, 2007
GADOFOSVESET TRISODIUM
SOLUTION;INTRAVENOUS
ABLAVAR
LANTHEUS MEDCL 2440MG/10ML (244MG/ML) N021711 001 Dec 22, 2008
3660MG/15ML (244MG/ML) N021711 002 Dec 22, 2008

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-216(of 478)
** See List Footnote
GADOPENTETATE DIMEGLUMINE
INJECTABLE;INJECTION
MAGNEVIST
+ BAYER HLTHCARE 469.01MG/ML N019596 001 Jun 02, 1988
+ 469.01MG/ML N021037 001 Mar 10, 2000
GADOVERSETAMIDE
INJECTABLE;INJECTION
OPTIMARK
+ LIEBEL-FLARSHEIM 1654.5MG/5ML (330.9MG/ML) N020937 001 Dec 08, 1999
+ 3309MG/10ML (330.9MG/ML) N020937 002 Dec 08, 1999
+ 4963.5MG/15ML (330.9MG/ML) N020937 003 Dec 08, 1999
+ 6618MG/20ML (330.9MG/ML) N020937 004 Dec 08, 1999
+ 16.545GM/50ML (330.9MG/ML) N020975 001 Dec 08, 1999
OPTIMARK IN PLASTIC CONTAINER
+ LIEBEL-FLARSHEIM 3309MG/10ML (330.9MG/ML) N020976 002 Dec 08, 1999
+ 4963.5MG/15ML (330.9MG/ML) N020976 003 Dec 08, 1999
+ 6618MG/20ML (330.9MG/ML) N020976 004 Dec 08, 1999
+ 9927MG/30ML (330.9MG/ML) N020976 001 Dec 08, 1999
GALANTAMINE HYDROBROMIDE
CAPSULE, EXTENDED RELEASE;ORAL
GALANTAMINE HYDROBROMIDE
IMPAX LABS EQ 8MG BASE A078484 001 May 27, 2009
EQ 16MG BASE A078484 002 May 27, 2009
EQ 24MG BASE A078484 003 May 27, 2009
MYLAN EQ 8MG BASE A090900 001 Jan 24, 2011
EQ 16MG BASE A090900 002 Jan 24, 2011
EQ 24MG BASE A090900 003 Jan 24, 2011
SOLUTION;ORAL
RAZADYNE
JANSSEN PHARMS 4MG/ML ** N021224 001 Jun 22, 2001
TABLET;ORAL
GALANTAMINE HYDROBROMIDE
APOTEX INC EQ 4MG BASE A077781 001 Sep 27, 2011
EQ 8MG BASE A077781 002 Sep 27, 2011
EQ 12MG BASE A077781 003 Sep 27, 2011
HERITAGE PHARMA EQ 4MG BASE A077585 001 Sep 15, 2009
EQ 4MG BASE A077587 001 Jul 09, 2009
EQ 8MG BASE A077585 002 Sep 15, 2009
EQ 8MG BASE A077587 002 Jul 09, 2009
EQ 12MG BASE A077585 003 Sep 15, 2009
EQ 12MG BASE A077587 003 Jul 09, 2009
HIKMA EQ 4MG BASE A077608 001 Feb 11, 2009
EQ 8MG BASE A077608 002 Feb 11, 2009
EQ 12MG BASE A077608 003 Feb 11, 2009
MYLAN EQ 4MG BASE A077590 001 May 29, 2009
EQ 4MG BASE A077603 001 Aug 28, 2008
EQ 8MG BASE A077590 002 May 29, 2009
EQ 8MG BASE A077603 002 Aug 28, 2008
EQ 12MG BASE A077590 003 May 29, 2009
EQ 12MG BASE A077603 003 Aug 28, 2008
RAZADYNE
+ JANSSEN PHARMS EQ 4MG BASE N021169 001 Feb 28, 2001
+ EQ 8MG BASE N021169 002 Feb 28, 2001
+ EQ 12MG BASE N021169 003 Feb 28, 2001
GALLAMINE TRIETHIODIDE
INJECTABLE;INJECTION
FLAXEDIL
DAVIS AND GECK 20MG/ML N007842 001
100MG/ML N007842 002
GALLIUM CITRATE GA-67
INJECTABLE;INJECTION
GALLIUM CITRATE GA 67
GE HEALTHCARE 1mCi/ML N017700 001
NEOSCAN
GE HEALTHCARE 2mCi/ML N017655 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-217(of 478)
** See List Footnote
GALLIUM NITRATE
INJECTABLE;INJECTION
GANITE
CHAPTER 7 TRUSTEE 25MG/ML ** N019961 002 Jan 17, 1991
GANCICLOVIR
CAPSULE;ORAL
CYTOVENE
+ ROCHE PALO 250MG ** N020460 001 Dec 22, 1994
+ 500MG ** N020460 002 Dec 12, 1997
GANCICLOVIR
RANBAXY LABS LTD 250MG A076457 001 Jun 27, 2003
500MG A076457 002 Jun 27, 2003
IMPLANT;IMPLANTATION
VITRASERT
BAUSCH AND LOMB 4.5MG N020569 001 Mar 04, 1996
GANCICLOVIR SODIUM
INJECTABLE;INJECTION
CYTOVENE
+ CHEPLAPHARM EQ 500MG BASE/VIAL ** N019661 001 Jun 23, 1989
GANCICLOVIR SODIUM
AM REGENT EQ 500MG BASE/VIAL A202624 001 Sep 18, 2013
CUSTOPHARM INC EQ 500MG BASE/VIAL A212001 001 Jun 20, 2019
STERISCIENCE EQ 500MG BASE/VIAL A204560 001 Nov 17, 2017
GATIFLOXACIN
SOLUTION/DROPS;OPHTHALMIC
GATIFLOXACIN
APOTEX INC 0.3% A079084 001 Aug 19, 2011
RISING 0.5% A206446 001 Jun 08, 2018
TORRENT 0.5% A213542 001 Nov 03, 2021
GEFITINIB
TABLET;ORAL
IRESSA
ASTRAZENECA 250MG N021399 001 May 05, 2003
GEMCITABINE HYDROCHLORIDE
INJECTABLE;INJECTION
GEMCITABINE HYDROCHLORIDE
ACTAVIS INC 200MG/5.26ML (38MG/ML) A204549 001 Apr 11, 2016
1GM/26.3ML (38MG/ML) A204549 002 Apr 11, 2016
2GM/52.6ML (38MG/ML) A204549 003 Apr 11, 2016
ACTAVIS TOTOWA EQ 200MG BASE/VIAL A079160 001 Jul 25, 2011
EQ 1GM BASE/VIAL A079160 002 Jul 25, 2011
EQ 2GM BASE/VIAL A079160 003 Jul 28, 2016
AM REGENT EQ 200MG BASE/VIAL A202031 001 May 07, 2013
EQ 1GM BASE/VIAL A202031 002 May 07, 2013
APOTEX 200MG/5.26ML (38MG/ML) A206776 001 May 23, 2017
1GM/26.3ML (38MG/ML) A206776 002 May 23, 2017
2GM/52.6ML (38MG/ML) A206776 003 May 23, 2017
EMCURE PHARMS LTD EQ 200MG BASE/VIAL A202063 001 Sep 11, 2012
EQ 1GM BASE/VIAL A202063 002 Sep 11, 2012
HAMELN RDS GMBH EQ 200MG BASE/VIAL A090663 001 Sep 10, 2012
EQ 1GM BASE/VIAL A090663 002 Sep 10, 2012
MYLAN LABS LTD EQ 200MG BASE/VIAL A200145 001 Jul 25, 2011
EQ 1GM BASE/VIAL A200145 002 Jul 25, 2011
EQ 2GM BASE/VIAL A200145 003 Jul 25, 2011
NOVAST LABS 200MG/5.26ML (38MG/ML) A210383 001 Feb 14, 2019
1GM/26.3ML (38MG/ML) A210383 002 Feb 14, 2019
2GM/52.6ML (38MG/ML) A210383 003 Feb 14, 2019
SAGENT PHARMS EQ 200MG BASE/VIAL A091597 001 May 07, 2013
EQ 1GM BASE/VIAL A091597 002 May 07, 2013
TEVA PHARMS EQ 200MG BASE/VIAL A077983 002 Jan 25, 2011
EQ 1GM BASE/VIAL A077983 001 Jan 25, 2011
GEMZAR
+ LILLY EQ 200MG BASE/VIAL ** N020509 001 May 15, 1996
+ EQ 1GM BASE/VIAL ** N020509 002 May 15, 1996

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-218(of 478)
** See List Footnote
GEMFIBROZIL
CAPSULE;ORAL
GEMFIBROZIL
MYLAN 300MG A073466 001 Jan 25, 1993
PUREPAC PHARM 300MG A072929 001 Jan 29, 1993
LOPID
PFIZER PHARMS 200MG N018422 001
300MG N018422 002
TABLET;ORAL
GEMFIBROZIL
CADILA 600MG A204189 001 Aug 28, 2018
CHARTWELL RX 600MG A074615 001 Sep 29, 1995
HIKMA PHARMS 600MG A078599 001 Aug 16, 2010
MYLAN 600MG A074452 001 Feb 16, 1995
PUREPAC PHARM 600MG A074360 001 Aug 31, 1994
SUN PHARM INDS INC 600MG A079239 001 Dec 29, 2008
TEVA 600MG A074256 001 Oct 31, 1993
WATSON LABS 600MG A074156 001 Oct 24, 1994
600MG A074442 001 Apr 28, 1995
GEMIFLOXACIN MESYLATE
TABLET;ORAL
FACTIVE
+ LG CHEM LTD EQ 320MG BASE N021158 001 Apr 04, 2003
GEMIFLOXACIN MESYLATE
ORBION PHARMS EQ 320MG BASE A090466 001 Jun 15, 2015
GENTAMICIN SULFATE
CREAM;TOPICAL
GARAMYCIN
SCHERING EQ 0.1% BASE ** A060462 001
GENTAFAIR
PHARMAFAIR EQ 0.1% BASE A062458 001 Sep 01, 1983
GENTAMICIN SULFATE
ALPHARMA US PHARMS EQ 0.1% BASE A062471 001 Sep 27, 1983
FOUGERA PHARMS INC EQ 0.1% BASE A062531 001 Jul 05, 1984
PHARMADERM EQ 1MG BASE/GM A062530 001 Jul 05, 1984
TARO EQ 0.1% BASE A062427 001 May 26, 1983
INJECTABLE;INJECTION
APOGEN
KING PHARMS EQ 10MG BASE/ML A062289 001
EQ 40MG BASE/ML A062289 002
BRISTAGEN
BRISTOL EQ 40MG BASE/ML A062288 001
GARAMYCIN
SCHERING EQ 1MG BASE/ML ** A061716 002
EQ 10MG BASE/ML ** A061739 001
EQ 40MG BASE/ML ** A061716 001
GENTAFAIR
PHARMAFAIR EQ 40MG BASE/ML A062493 001 Aug 28, 1985
GENTAMICIN
INTL MEDICATION EQ 1MG BASE/ML A062325 003 Jun 23, 1982
EQ 40MG BASE/ML A062325 001
EQ 100MG BASE/100ML A062325 004 Jun 23, 1982
GENTAMICIN SULFATE
ABBOTT EQ 1.2MG BASE/ML A062413 001 Aug 11, 1983
EQ 1.4MG BASE/ML A062413 002 Aug 11, 1983
EQ 1.6MG BASE/ML A062413 003 Aug 11, 1983
EQ 1.8MG BASE/ML A062413 004 Aug 11, 1983
EQ 2MG BASE/ML A062413 005 Aug 11, 1983
EQ 60MG BASE/100ML A062413 006 Aug 11, 1983
EQ 70MG BASE/100ML A062413 007 Aug 11, 1983
EQ 80MG BASE/100ML A062413 008 Aug 11, 1983
EQ 90MG BASE/100ML A062413 009 Aug 11, 1983
EQ 100MG BASE/100ML A062413 010 Aug 11, 1983
FRESENIUS KABI USA EQ 10MG BASE/ML A062356 001 Mar 04, 1982
EQ 40MG BASE/ML A062356 002 Mar 04, 1982
HIKMA EQ 10MG BASE/ML A062251 002
EQ 40MG BASE/ML A062251 001
HOSPIRA EQ 10MG BASE/ML A062612 004 Feb 20, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-219(of 478)
** See List Footnote
GENTAMICIN SULFATE
INJECTABLE;INJECTION
GENTAMICIN SULFATE
KALAPHARM EQ 40MG BASE/ML A062354 001 Apr 05, 1982
PHARM SPEC EQ 40MG BASE/ML A062340 001 Mar 28, 1983
SOLOPAK EQ 10MG BASE/ML A062507 001 Jun 06, 1985
EQ 40MG BASE/ML A062507 002 Jun 06, 1985
TEVA PARENTERAL EQ 10MG BASE/ML A063149 001 Nov 21, 1991
EQ 40MG BASE/ML A063106 002 Nov 21, 1991
WATSON LABS EQ 10MG BASE/ML A062318 002
EQ 40MG BASE/ML A062318 001
WYETH AYERST EQ 10MG BASE/ML A062264 001
EQ 40MG BASE/ML A062264 002
GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN EQ 0.8MG BASE/ML A062814 001 Aug 28, 1987
EQ 1.2MG BASE/ML A062814 002 Aug 28, 1987
EQ 1.4MG BASE/ML A062814 003 Aug 28, 1987
EQ 1.6MG BASE/ML A062814 004 Aug 28, 1987
EQ 1.8MG BASE/ML A062814 005 Aug 28, 1987
EQ 2MG BASE/ML A062814 006 Aug 28, 1987
EQ 2.4MG BASE/ML A062814 007 Aug 28, 1987
EQ 40MG BASE/100ML A062814 008 Aug 28, 1987
EQ 60MG BASE/100ML A062814 009 Aug 28, 1987
EQ 70MG BASE/100ML A062814 010 Aug 28, 1987
EQ 80MG BASE/100ML A062814 011 Aug 28, 1987
EQ 90MG BASE/100ML A062814 012 Aug 28, 1987
EQ 100MG BASE/100ML A062814 013 Aug 28, 1987
EQ 120MG BASE/100ML A062814 014 Aug 28, 1987
BAXTER HLTHCARE EQ 0.8MG BASE/ML A062373 001 Sep 07, 1982
EQ 2.4MG BASE/ML A062373 010 Sep 07, 1982
EQ 40MG BASE/100ML A062373 003 Sep 07, 1982
EQ 60MG BASE/100ML A062373 004 Sep 07, 1982
HOSPIRA EQ 1.2MG BASE/ML A062588 001 Jan 06, 1986
EQ 1.4MG BASE/ML A062414 002 Aug 15, 1983
EQ 1.4MG BASE/ML A062588 002 Jan 06, 1986
EQ 1.6MG BASE/ML A062588 003 Jan 06, 1986
EQ 1.8MG BASE/ML A062414 004 Aug 15, 1983
EQ 1.8MG BASE/ML A062588 004 Jan 06, 1986
EQ 2MG BASE/ML A062414 005 Aug 15, 1983
EQ 2MG BASE/ML A062588 005 Jan 06, 1986
EQ 60MG BASE/100ML A062414 006 Aug 15, 1983
EQ 60MG BASE/100ML A062588 006 Jan 06, 1986
EQ 70MG BASE/100ML A062414 007 Aug 15, 1983
EQ 70MG BASE/100ML A062588 007 Jan 06, 1986
EQ 80MG BASE/100ML A062588 008 Jan 06, 1986
EQ 90MG BASE/100ML A062414 009 Aug 15, 1983
EQ 90MG BASE/100ML A062588 009 Jan 06, 1986
EQ 100MG BASE/100ML A062588 010 Jan 06, 1986
U-GENCIN
PHARMACIA AND UPJOHN EQ 10MG BASE/ML A062248 001
EQ 40MG BASE/ML A062248 002
INJECTABLE;INTRATHECAL
GARAMYCIN
+ SCHERING EQ 2MG BASE/ML ** N050505 001
OINTMENT;OPHTHALMIC
GARAMYCIN
SCHERING EQ 0.3% BASE N050425 001
GENTACIDIN
NOVARTIS EQ 0.3% BASE A062501 001 Jul 26, 1984
GENTAFAIR
PHARMAFAIR EQ 3MG BASE/GM A062443 001 May 26, 1983
OINTMENT;TOPICAL
GARAMYCIN
SCHERING EQ 0.1% BASE ** A060463 001
GENTAFAIR
PHARMAFAIR EQ 0.1% BASE A062444 001 May 26, 1983
GENTAMICIN SULFATE
ALPHARMA US PHARMS EQ 0.1% BASE A062496 001 Mar 14, 1984
PHARMADERM EQ 0.1% BASE A062534 001 Oct 10, 1984

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-220(of 478)
** See List Footnote
GENTAMICIN SULFATE
SOLUTION/DROPS;OPHTHALMIC
GARAMYCIN
+ SCHERING EQ 0.3% BASE ** N050039 002
GENTACIDIN
NOVARTIS EQ 0.3% BASE A062480 001 Mar 30, 1984
GENTAFAIR
PHARMAFAIR EQ 0.3% BASE A062440 001 May 03, 1983
GENTAMICIN SULFATE
AKORN EQ 0.3% BASE A062635 001 Jan 08, 1987
ALCON PHARMS LTD EQ 0.3% BASE A062523 001 Nov 25, 1985
PACO EQ 3MG BASE/ML A062932 001 Nov 07, 1988
GENTAMICIN SULFATE; PREDNISOLONE ACETATE
SUSPENSION/DROPS;OPHTHALMIC
PRED-G
+ ALLERGAN EQ 0.3% BASE;1% N050586 001 Jun 10, 1988
GENTIAN VIOLET
SUPPOSITORY;VAGINAL
GVS
SAVAGE LABS 0.4% A083513 001
TAMPON;VAGINAL
GENAPAX
KEY PHARMS 5MG A085017 001
GLATIRAMER ACETATE
FOR SOLUTION;SUBCUTANEOUS
COPAXONE
TEVA PHARMS USA 20MG/VIAL N020622 001 Dec 20, 1996
GLIMEPIRIDE
TABLET;ORAL
GLIMEPIRIDE
ACTAVIS LABS FL INC 1MG A076995 001 Apr 27, 2010
2MG A076995 002 Apr 27, 2010
4MG A076995 003 Apr 27, 2010
EPIC PHARMA LLC 1MG A077274 001 Oct 06, 2005
2MG A077274 002 Oct 06, 2005
4MG A077274 003 Oct 06, 2005
HIKMA PHARMS 1MG A078952 001 Aug 01, 2013
2MG A078952 002 Aug 01, 2013
4MG A078952 003 Aug 01, 2013
MYLAN 1MG A077486 001 Feb 10, 2006
1MG A077624 001 Nov 28, 2005
2MG A077486 002 Feb 10, 2006
2MG A077624 002 Nov 28, 2005
4MG A077486 003 Feb 10, 2006
4MG A077624 003 Nov 28, 2005
RANBAXY 3MG A077366 001 Oct 06, 2005
6MG A077366 002 Oct 06, 2005
RANBAXY LABS LTD 1MG A076875 001 Oct 06, 2005
2MG A076875 002 Oct 06, 2005
4MG A076875 003 Oct 06, 2005
8MG A076875 004 Oct 06, 2005
TEVA 1MG A076802 001 Oct 06, 2005
2MG A076802 002 Oct 06, 2005
4MG A076802 003 Oct 06, 2005
WATSON LABS 1MG A077280 001 Feb 03, 2006
2MG A077280 002 Feb 03, 2006
4MG A077280 003 Feb 03, 2006
GLIMEPIRIDE; ROSIGLITAZONE MALEATE
TABLET;ORAL
AVANDARYL
+ SB PHARMCO 1MG;4MG ** N021700 001 Nov 23, 2005
+ 2MG;4MG ** N021700 002 Nov 23, 2005
+ 2MG;8MG ** N021700 004 Mar 30, 2007
+ 4MG;4MG ** N021700 003 Nov 23, 2005
+ 4MG;8MG ** N021700 005 Mar 30, 2007

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-221(of 478)
** See List Footnote
GLIMEPIRIDE; ROSIGLITAZONE MALEATE
TABLET;ORAL
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
TEVA PHARMS USA 1MG;4MG A078709 001 Apr 01, 2016
2MG;4MG A078709 002 Apr 01, 2016
2MG;8MG A078709 004 Apr 01, 2016
4MG;4MG A078709 003 Apr 01, 2016
4MG;8MG A078709 005 Apr 01, 2016
GLIPIZIDE
TABLET;ORAL
GLIPIZIDE
ANI PHARMS 5MG A074387 001 Mar 04, 1996
10MG A074387 002 Mar 04, 1996
BARR LABS INC 5MG A074619 001 Apr 04, 1997
10MG A074619 002 Apr 04, 1997
CHARTWELL RX 5MG A074542 001 Jun 20, 1995
10MG A074542 002 Jun 20, 1995
MYLAN 5MG A074438 001 Jun 20, 1995
10MG A074438 002 Jun 20, 1995
OXFORD PHARMS 5MG A074378 001 Nov 28, 1994
10MG A074378 002 Nov 28, 1994
WATSON LABS 5MG A074370 001 Nov 22, 1994
10MG A074370 002 Nov 22, 1994
GLUCOTROL
+ PFIZER 2.5MG ** N017783 003 May 11, 1993
+ 5MG N017783 001 May 08, 1984
+ 10MG N017783 002 May 08, 1984
TABLET, EXTENDED RELEASE;ORAL
GLIPIZIDE
MYLAN 2.5MG A202298 001 May 19, 2015
5MG A202298 002 May 19, 2015
10MG A202298 003 May 19, 2015
PAR PHARM 5MG A076159 002 Sep 20, 2013
10MG A076159 001 Sep 20, 2013
GLIPIZIDE; METFORMIN HYDROCHLORIDE
TABLET;ORAL
GLIPIZIDE AND METFORMIN HYDROCHLORIDE
MYLAN 2.5MG;250MG A078083 001 Apr 12, 2007
2.5MG;500MG A078083 002 Apr 12, 2007
5MG;500MG A078083 003 Apr 12, 2007
SUN PHARM INDS INC 2.5MG;250MG A077620 001 Jan 11, 2008
2.5MG;500MG A077620 002 Jan 11, 2008
5MG;500MG A077620 003 Jan 11, 2008
METAGLIP
+ BRISTOL MYERS SQUIBB 2.5MG;250MG ** N021460 001 Oct 21, 2002
+ 2.5MG;500MG ** N021460 002 Oct 21, 2002
+ 5MG;500MG ** N021460 003 Oct 21, 2002
GLUCAGON HYDROCHLORIDE
INJECTABLE;INJECTION
GLUCAGON
+ LILLY EQ 1MG BASE/VIAL ** N012122 001
+ EQ 10MG BASE/VIAL ** N012122 002
GLUTETHIMIDE
CAPSULE;ORAL
DORIDEN
SANOFI AVENTIS US 500MG N009519 008
TABLET;ORAL
DORIDEN
SANOFI AVENTIS US 250MG N009519 002
500MG N009519 005
GLUTETHIMIDE
HALSEY 250MG A089458 001 Oct 10, 1986
500MG A089459 001 Oct 10, 1986
LANNETT 250MG A083475 001
500MG A085571 001
UCB INC 500MG A085171 001
UPSHER SMITH LABS 500MG A083234 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-222(of 478)
** See List Footnote
GLUTETHIMIDE
TABLET;ORAL
GLUTETHIMIDE
VITARINE 500MG A087297 001
WATSON LABS 500MG A084362 001
500MG A085763 001
GLYBURIDE
TABLET;ORAL
GLYBURIDE
ACTAVIS ELIZABETH 1.5MG A075947 001 Nov 14, 2002
3MG A075947 002 Nov 14, 2002
6MG A075947 003 Nov 14, 2002
AUROBINDO PHARMA 1.25MG A077537 001 Oct 18, 2007
2.5MG A077537 002 Oct 18, 2007
5MG A077537 003 Oct 18, 2007
CHARTWELL RX 1.25MG A203581 001 Apr 14, 2016
2.5MG A203581 002 Apr 14, 2016
5MG A203581 003 Apr 14, 2016
GLYBURIDE (MICRONIZED)
CHARTWELL RX 1.5MG A075174 001 Jun 22, 1998
3MG A075174 002 Jun 22, 1998
MYLAN 1.5MG A074792 001 Jun 26, 1998
3MG A074792 002 Jun 26, 1998
6MG A074792 003 Aug 17, 1999
SANOFI AVENTIS US 1.5MG N020055 001 Apr 17, 1992
3MG N020055 002 Apr 17, 1992
6MG N020055 003 Mar 08, 2000
STRIDES PHARMA 1.5MG A074591 001 Dec 22, 1997
3MG A074591 002 Dec 22, 1997
4.5MG A074591 003 Dec 22, 1997
6MG A074591 004 Dec 22, 1997
GLYNASE
+ PFIZER 4.5MG ** N020051 003 Sep 24, 1993
MICRONASE
+ PFIZER 1.25MG ** N017498 001 May 01, 1984
2.5MG N017498 002 May 01, 1984
+ 5MG ** N017498 003 May 01, 1984
GLYBURIDE; METFORMIN HYDROCHLORIDE
TABLET;ORAL
GLUCOVANCE
+ BRISTOL MYERS SQUIBB 1.25MG;250MG ** N021178 001 Jul 31, 2000
+ 2.5MG;500MG ** N021178 002 Jul 31, 2000
+ 5MG;500MG ** N021178 003 Jul 31, 2000
GLYBURIDE AND METFORMIN HYDROCHLORIDE
HERITAGE PHARMS 1.25MG;250MG A079009 001 Jun 03, 2009
2.5MG;500MG A079009 002 Jun 03, 2009
5MG;500MG A079009 003 Jun 03, 2009
IMPAX LABS INC 1.25MG;250MG A076731 001 Nov 19, 2004
2.5MG;500MG A076731 002 Nov 19, 2004
5MG;500MG A076731 003 Nov 19, 2004
TEVA 1.25MG;250MG A076821 001 Jan 27, 2005
2.5MG;500MG A076821 002 Jan 27, 2005
5MG;500MG A076821 003 Jan 27, 2005
GLYCEROL PHENYLBUTYRATE
LIQUID;ORAL
GLYCEROL PHENYLBUTYRATE
PAR PHARM INC 1.1GM/ML A205742 001 Dec 02, 2021
GLYCINE
SOLUTION;IRRIGATION
GLYCINE 1.5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 1.5GM/100ML N018522 001 Feb 19, 1982
HOSPIRA 1.5GM/100ML N017633 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-223(of 478)
** See List Footnote
GLYCOPYRROLATE
INJECTABLE;INJECTION
GLYCOPYRROLATE
ABRAXIS PHARM 0.2MG/ML A088475 001 Jun 12, 1984
EUGIA PHARMA 0.2MG/ML A210244 001 Nov 28, 2018
HOSPIRA 0.2MG/ML A089393 001 Jun 15, 1988
TEVA PARENTERAL 0.2MG/ML A081169 001 Sep 10, 1991
WATSON LABS 0.2MG/ML A086947 001 Jun 24, 1983
ZYDUS PHARMS 0.2MG/ML A214213 001 Nov 09, 2021
ROBINUL
+ HIKMA 0.2MG/ML ** N017558 001
ROBINS AH 0.2MG/ML N014764 001
POWDER;INHALATION
SEEBRI
+ NOVARTIS 15.6MCG/INH N207923 001 Oct 29, 2015
TABLET;ORAL
GLYCOPYRROLATE
CHARTWELL RX 1MG A040568 001 Dec 22, 2004
2MG A040568 002 Dec 22, 2004
HIKMA INTL PHARMS 1MG A040836 001 Mar 05, 2009
2MG A040836 002 Mar 05, 2009
WATSON LABS 1MG A085562 001
1MG A086902 001
2MG A085563 001
2MG A086178 001
2MG A086900 001
GLYCOPYRROLATE; INDACATEROL MALEATE
POWDER;INHALATION
UTIBRON
+ NOVARTIS 15.6MCG/INH;27.5MCG/INH N207930 001 Oct 29, 2015
GONADORELIN ACETATE
INJECTABLE;INJECTION
LUTREPULSE KIT
FERRING 0.8MG/VIAL N019687 001 Oct 10, 1989
3.2MG/VIAL N019687 002 Oct 10, 1989
GONADORELIN HYDROCHLORIDE
INJECTABLE;INJECTION
FACTREL
HIKMA EQ 0.1MG BASE/VIAL N018123 001 Sep 30, 1982
EQ 0.2MG BASE/VIAL N018123 002 Sep 30, 1982
EQ 0.5MG BASE/VIAL N018123 003 Sep 30, 1982
GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
SOLUTION/DROPS;OPHTHALMIC
NEO-POLYCIN
DOW PHARM 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 A060427 001
UNITS/ML
NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN
IPHARM 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 A062818 001 Oct 11, 1988
UNITS/ML
WATSON LABS 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 A062788 001 Jun 11, 1987
UNITS/ML
NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN
PHARMAFAIR 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 A062383 001 Aug 31, 1982
UNITS/ML
GRANISETRON HYDROCHLORIDE
INJECTABLE;INJECTION
GRANISETRON HYDROCHLORIDE
AKORN EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) A079119 001 Sep 10, 2009
AM REGENT EQ 1MG BASE/ML (EQ 1MG BASE/ML) A091274 001 Sep 22, 2010
BAXTER HLTHCARE CORP EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) A078197 001 Dec 31, 2007
EQ 1MG BASE/ML (EQ 1MG BASE/ML) A078198 001 Jun 30, 2008
EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A078198 002 Jun 30, 2008
EUGIA PHARMA EQ 1MG BASE/ML (EQ 1MG BASE/ML) A204238 001 Jul 06, 2016
EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A204238 002 Jul 06, 2016
MYLAN LABS LTD EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) A203454 001 Apr 04, 2017
EQ 1MG BASE/ML (EQ 1MG BASE/ML) A203454 002 Apr 04, 2017
EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A203453 001 Jan 31, 2017

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-224(of 478)
** See List Footnote
GRANISETRON HYDROCHLORIDE
INJECTABLE;INJECTION
GRANISETRON HYDROCHLORIDE
SANDOZ INC EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) A078808 001 Apr 29, 2008
TEVA PHARMS USA EQ 1MG BASE/ML (EQ 1MG BASE/ML) A077963 001 Jan 03, 2008
WOCKHARDT USA EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) A078566 001 Feb 29, 2008
EQ 1MG BASE/ML (EQ 1MG BASE/ML) A078564 001 Jun 30, 2008
EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A078565 001 Jun 30, 2008
YUNG SHIN PHARM EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) A202647 001 Mar 06, 2020
EQ 1MG BASE/ML (EQ 1MG BASE/ML) A202648 001 Jun 29, 2020
EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A202648 002 Jun 29, 2020
GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE
DR REDDYS EQ 1MG BASE/ML (EQ 1MG BASE/ML) A077165 001 Dec 31, 2007
KYTRIL
+ ROCHE EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) ** N020239 003 Sep 17, 2004
+ EQ 1MG BASE/ML (EQ 1MG BASE/ML) ** N020239 004 Mar 11, 1994
+ EQ 3MG BASE/ML ** N020239 001 Dec 29, 1993
+ EQ 4MG BASE/4ML (EQ 1MG BASE/ML) ** N020239 002 Mar 11, 1994
SOLUTION;ORAL
GRANISOL
INTRA SANA LABS EQ 2MG BASE/10ML A078334 001 Feb 28, 2008
KYTRIL
+ ROCHE EQ 2MG BASE/10ML ** N021238 001 Jun 27, 2001
TABLET;ORAL
GRANISETRON HYDROCHLORIDE
BARR EQ 1MG BASE A078221 001 Dec 31, 2007
EPIC PHARMA LLC EQ 1MG BASE A078260 001 Dec 31, 2007
MYLAN EQ 1MG BASE A078725 001 Jan 30, 2008
TEVA PHARMS EQ 1MG BASE A078080 001 Dec 31, 2007
KYTRIL
+ ROCHE EQ 1MG BASE ** N020305 001 Mar 16, 1995
+ EQ 2MG BASE ** N020305 002 Jun 15, 1998
GREPAFLOXACIN HYDROCHLORIDE
TABLET;ORAL
RAXAR
OTSUKA EQ 200MG BASE N020695 001 Nov 06, 1997
EQ 400MG BASE N020695 002 May 14, 1998
EQ 600MG BASE N020695 003 May 14, 1998
GRISEOFULVIN, MICROCRYSTALLINE
CAPSULE;ORAL
GRISACTIN
WYETH AYERST 125MG N050051 002
250MG N050051 001
SUSPENSION;ORAL
GRIFULVIN V
+ JOHNSON AND JOHNSON 125MG/5ML ** N050448 001
TABLET;ORAL
GRIFULVIN V
J AND J 125MG A060618 001
250MG A060618 002
500MG A060618 003
VALEANT LUXEMBOURG 125MG A062279 001
250MG ** A062279 002
GRISACTIN
WYETH AYERST 500MG A060212 001
GRISEOFULVIN, MICROSIZE
SUSPENSION;ORAL
GRIFULVIN V
VALEANT LUXEMBOURG 125MG/5ML ** A062483 001 Jan 26, 1984
TABLET;ORAL
GRIFULVIN V
VALEANT LUXEMBOURG 500MG A062279 003

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-225(of 478)
** See List Footnote
GRISEOFULVIN, ULTRAMICROCRYSTALLINE
TABLET;ORAL
GRISACTIN ULTRA
WYETH AYERST 125MG A062178 001
165MG A062438 001 Nov 17, 1983
250MG A062178 002
330MG A062438 002 Nov 17, 1983
ULTRAGRIS-165
PLIVA 165MG A062645 001 Jun 30, 1992
ULTRAGRIS-330
PLIVA 330MG A062646 001 Jun 30, 1992
GUAIFENESIN; HYDROCODONE BITARTRATE
SOLUTION;ORAL
FLOWTUSS
CHARTWELL RX 200MG/5ML;2.5MG/5ML N022424 001 May 14, 2015
OBREDON
+ SOVEREIGN PHARMS 200MG/5ML;2.5MG/5ML N205474 001 Nov 14, 2014
TABLET;ORAL
XTRELUS
+ ECI PHARMS LLC 400MG;5MG N208085 001 Apr 25, 2018
GUAIFENESIN; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
SOLUTION;ORAL
HYCOFENIX
+ CHARTWELL RX 200MG/5ML;2.5MG/5ML;30MG/5ML N022279 001 May 14, 2015
GUANABENZ ACETATE
TABLET;ORAL
GUANABENZ ACETATE
ANI PHARMS EQ 4MG BASE A074149 001 Apr 07, 1995
EQ 4MG BASE A074267 001 Jun 01, 1994
EQ 8MG BASE A074149 002 Apr 07, 1995
EQ 8MG BASE A074267 002 Jun 01, 1994
CHARTWELL RX EQ 4MG BASE A074517 001 Sep 30, 1998
EQ 8MG BASE A074517 002 Sep 30, 1998
WATSON LABS EQ 4MG BASE A074025 001 Feb 28, 1994
EQ 8MG BASE A074025 002 Feb 28, 1994
WYTENSIN
WYETH AYERST EQ 4MG BASE N018587 001 Sep 07, 1982
EQ 8MG BASE N018587 002 Sep 07, 1982
EQ 16MG BASE N018587 003 Sep 07, 1982
GUANADREL SULFATE
TABLET;ORAL
HYLOREL
PHARMACIA AND UPJOHN 10MG N018104 001 Dec 29, 1982
25MG N018104 002 Dec 29, 1982
GUANETHIDINE MONOSULFATE
TABLET;ORAL
GUANETHIDINE MONOSULFATE
WATSON LABS EQ 10MG SULFATE A086113 001 Mar 26, 1985
EQ 25MG SULFATE A086114 001 Mar 26, 1985
ISMELIN
NOVARTIS EQ 10MG SULFATE N012329 001
EQ 25MG SULFATE N012329 002
GUANETHIDINE MONOSULFATE; HYDROCHLOROTHIAZIDE
TABLET;ORAL
ESIMIL
NOVARTIS 10MG;25MG N013553 001
GUANFACINE HYDROCHLORIDE
TABLET;ORAL
GUANFACINE HYDROCHLORIDE
AUROBINDO PHARMA USA EQ 1MG BASE A074796 001 Jan 27, 1997
EQ 2MG BASE A074796 002 Jan 27, 1997
WATSON LABS EQ 1MG BASE A074762 001 Jun 25, 1997
EQ 2MG BASE A074762 002 Jun 25, 1997
TENEX
+ PROMIUS PHARMA EQ 1MG BASE ** N019032 001 Oct 27, 1986
+ EQ 2MG BASE ** N019032 002 Nov 07, 1988

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-226(of 478)
** See List Footnote
GUANFACINE HYDROCHLORIDE
TABLET;ORAL
TENEX
EQ 3MG BASE ** N019032 003 Nov 07, 1988
TABLET, EXTENDED RELEASE;ORAL
GUANFACINE HYDROCHLORIDE
IMPAX LABS INC EQ 1MG BASE A202238 001 Oct 20, 2015
EQ 2MG BASE A202238 002 Oct 20, 2015
EQ 3MG BASE A202238 003 Oct 20, 2015
EQ 4MG BASE A202238 004 Oct 20, 2015
MYLAN EQ 1MG BASE A202578 001 Jun 02, 2015
EQ 2MG BASE A202578 002 Jun 02, 2015
EQ 3MG BASE A202578 003 Jun 02, 2015
EQ 4MG BASE A202578 004 Jun 02, 2015
GUANIDINE HYDROCHLORIDE
TABLET;ORAL
GUANIDINE HYDROCHLORIDE
MERCK SHARP DOHME 125MG N001546 001
HALAZEPAM
TABLET;ORAL
PAXIPAM
SCHERING 20MG N017736 003
40MG N017736 004
HALCINONIDE
CREAM;TOPICAL
HALOG
WESTWOOD SQUIBB 0.025% N017818 001
HALOG-E
SUN PHARM INDS INC 0.1% N018234 001
OINTMENT;TOPICAL
HALOG
BRISTOL MYERS SQUIBB 0.025% N018125 001
HALOBETASOL PROPIONATE
CREAM;TOPICAL
ULTRAVATE
+ SUN PHARM INDS INC 0.05% ** N019967 001 Dec 27, 1990
LOTION;TOPICAL
HALOBETASOL PROPIONATE
PADAGIS ISRAEL 0.05% A211464 001 Jun 03, 2020
OINTMENT;TOPICAL
HALOBETASOL PROPIONATE
COSETTE 0.05% A077721 001 Sep 07, 2006
FOUGERA PHARMS 0.05% A076903 001 Dec 16, 2004
ULTRAVATE
+ SUN PHARM INDS INC 0.05% ** N019968 001 Dec 17, 1990
HALOFANTRINE HYDROCHLORIDE
TABLET;ORAL
HALFAN
GLAXOSMITHKLINE 250MG N020250 001 Jul 24, 1992
HALOPERIDOL
TABLET;ORAL
HALDOL
+ ORTHO MCNEIL 0.5MG ** N015921 001
+ 1MG ** N015921 002
+ 2MG ** N015921 003
+ 5MG ** N015921 004
+ 10MG ** N015921 005
+ 20MG ** N015921 006 Feb 02, 1982
HALDOL SOLUTAB
ORTHO MCNEIL PHARM 1MG N017079 001
HALOPERIDOL
CYCLE 0.5MG A071128 001 Feb 17, 1987
1MG A071129 001 Feb 17, 1987
20MG A071133 001 May 12, 1987
DURAMED PHARMS BARR 0.5MG A071216 001 Dec 04, 1986
1MG A071217 001 Dec 04, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-227(of 478)
** See List Footnote
HALOPERIDOL
TABLET;ORAL
HALOPERIDOL
2MG A071218 001 Dec 04, 1986
5MG A071219 001 Dec 04, 1986
10MG A071220 001 Jul 07, 1987
20MG A071221 001 Jul 07, 1987
LEDERLE 0.5MG A072727 001 Sep 19, 1989
1MG A072728 001 Sep 19, 1989
2MG A072729 001 Sep 19, 1989
5MG A072730 001 Sep 19, 1989
10MG A072731 001 Sep 19, 1989
20MG A072732 001 Sep 19, 1989
PAR PHARM 20MG A071328 001 Jul 20, 1987
PUREPAC PHARM 0.5MG A071071 001 Nov 03, 1986
1MG A071072 001 Nov 03, 1986
2MG A071073 001 Nov 03, 1986
5MG A071074 001 Nov 03, 1986
10MG A071075 001 Aug 04, 1987
20MG A071076 001 Aug 04, 1987
QUANTUM PHARMICS 0.5MG A071255 001 Feb 17, 1987
1MG A071269 001 Feb 17, 1987
2MG A071256 001 Feb 17, 1987
5MG A071257 001 Feb 17, 1987
ROYCE LABS 0.5MG A071722 001 Dec 24, 1987
1MG A071723 001 Dec 24, 1987
2MG A071724 001 Dec 24, 1987
5MG A071725 001 Dec 24, 1987
10MG A072121 001 Dec 24, 1987
20MG A072122 001 Dec 24, 1987
SANDOZ 2MG A071209 004 Nov 17, 1986
SCS 0.5MG A070720 001 Jun 10, 1986
1MG A070721 001 Jun 10, 1986
2MG A070722 001 Jun 10, 1986
5MG A070723 001 Jun 10, 1986
10MG A070724 001 Jun 10, 1986
20MG A070725 001 Sep 24, 1986
STRIDES PHARMA 0.5MG A071235 002 Nov 03, 1986
1MG A071235 003 Nov 03, 1986
2MG A071235 001 Nov 03, 1986
5MG A071235 004 Nov 03, 1986
10MG A071235 005 Jul 20, 1987
WATSON LABS 0.5MG A070981 001 Mar 06, 1987
0.5MG A071571 001 Jun 03, 1988
1MG A070982 001 Mar 06, 1987
1MG A071572 001 Jun 03, 1988
2MG A070983 001 Mar 06, 1987
2MG A071573 001 Jun 03, 1988
5MG A070984 001 Mar 06, 1987
5MG A071374 001 Jun 03, 1988
10MG A071375 001 Jun 03, 1988
10MG A072113 001 Aug 27, 1991
20MG A071376 001 Jun 03, 1988
20MG A072353 001 Aug 27, 1991
HALOPERIDOL DECANOATE
INJECTABLE;INJECTION
HALOPERIDOL DECANOATE
HOSPIRA EQ 50MG BASE/ML A075176 001 Feb 09, 2000
EQ 100MG BASE/ML A075176 002 Feb 09, 2000
SANDOZ INC EQ 50MG BASE/ML A076463 001 Jun 24, 2005
EQ 100MG BASE/ML A076463 002 Jun 24, 2005
HALOPERIDOL LACTATE
CONCENTRATE;ORAL
HALDOL
+ ORTHO MCNEIL EQ 2MG BASE/ML ** N015922 001
HALOPERIDOL
ALPHARMA EQ 2MG BASE/ML A070318 001 Apr 11, 1986
MORTON GROVE EQ 2MG BASE/ML A070710 001 Mar 07, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-228(of 478)
** See List Footnote
HALOPERIDOL LACTATE
CONCENTRATE;ORAL
HALOPERIDOL
SCS EQ 2MG BASE/ML A070726 001 Jun 10, 1986
TEVA EQ 2MG BASE/ML A071015 001 Aug 25, 1987
TEVA PHARMS EQ 2MG BASE/ML A071617 001 Dec 01, 1988
HALOPERIDOL INTENSOL
HIKMA EQ 2MG BASE/ML A072045 001 Apr 12, 1988
INJECTABLE;INJECTION
HALDOL
+ JANSSEN PHARMS EQ 5MG BASE/ML ** N015923 001
HALOPERIDOL
ABRAXIS PHARM EQ 5MG BASE/ML A071187 001 Jan 20, 1987
AKORN EQ 5MG BASE/ML A204849 001 Sep 06, 2017
BAXTER HLTHCARE CORP EQ 5MG BASE/ML A076791 001 Aug 25, 2004
EQ 5MG BASE/ML A076828 001 Aug 25, 2004
FOSUN PHARMA EQ 5MG BASE/ML A076464 001 Sep 29, 2004
MARSAM PHARMS LLC EQ 5MG BASE/ML A072516 001 Feb 25, 1993
EQ 5MG BASE/ML A072517 001 Feb 25, 1993
SMITH AND NEPHEW EQ 5MG BASE/ML A070802 001 Dec 14, 1987
SOLOPAK EQ 5MG BASE/ML A070800 001 Dec 14, 1987
EQ 5MG BASE/ML A070801 001 Dec 14, 1987
EQ 5MG BASE/ML A070864 001 Dec 14, 1987
TEVA PHARMS USA EQ 5MG BASE/ML A076035 001 Aug 29, 2001
WATSON LABS EQ 5MG BASE/ML A070713 001 May 17, 1988
EQ 5MG BASE/ML A070714 001 May 17, 1988
EQ 5MG BASE/ML A070744 001 May 17, 1988
SOLUTION;ORAL
HALOPERIDOL LACTATE
ACTAVIS MID ATLANTIC EQ 1MG BASE/ML A074536 001 Nov 02, 1995
HALOPROGIN
CREAM;TOPICAL
HALOTEX
WESTWOOD SQUIBB 1% N016942 001
SOLUTION;TOPICAL
HALOTEX
WESTWOOD SQUIBB 1% N016943 001
HALOTHANE
LIQUID;INHALATION
FLUOTHANE
WYETH AYERST 99.99% N011338 001
HALOTHANE
BH 99.99% A084977 001
HALOCARBON 99.99% A080810 001
HOSPIRA 99.99% A083254 001
HEPARIN CALCIUM
INJECTABLE;INJECTION
CALCIPARINE
SANOFI AVENTIS US 25,000 UNITS/ML N018237 001
HEPARIN SODIUM
INJECTABLE;INJECTION
HEPARIN LOCK FLUSH
HOSPIRA 100 UNITS/ML N005264 010
INTL MEDICATION 10 UNITS/ML A086357 001
500 UNITS/ML A086357 002
LUITPOLD 10 UNITS/ML A089063 001 Oct 09, 1985
100 UNITS/ML A089064 001 Oct 09, 1985
PARKE DAVIS 10 UNITS/ML N017346 006
SMITH AND NEPHEW 10 UNITS/ML A087904 001 Apr 20, 1983
10 UNITS/ML A087958 001 Apr 20, 1983
10 UNITS/ML A088458 001 Jul 26, 1984
10 UNITS/ML A088580 001 Oct 25, 1984
100 UNITS/ML A087906 001 Apr 20, 1983
100 UNITS/ML A087959 001 Apr 20, 1983
100 UNITS/ML A088460 001 Jul 26, 1984
100 UNITS/ML A088581 001 Oct 25, 1984
SOLOPAK 10 UNITS/ML A087903 001 Apr 20, 1983

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-229(of 478)
** See List Footnote
HEPARIN SODIUM
INJECTABLE;INJECTION
HEPARIN LOCK FLUSH
10 UNITS/ML A088457 001 Oct 25, 1984
100 UNITS/ML A087905 001 Apr 20, 1983
100 UNITS/ML A088459 001 Jul 26, 1984
HEPARIN SODIUM
ABRAXIS PHARM 1,000 UNITS/ML N017033 001
1,000 UNITS/ML N017979 001
5,000 UNITS/ML N017979 003
10,000 UNITS/ML N017979 002
AKORN 1,000 UNITS/ML N017486 001
5,000 UNITS/ML N017486 002
10,000 UNITS/ML N017486 003
20,000 UNITS/ML N017486 004
40,000 UNITS/ML N017486 005
CASI PHARMS INC 5,000 UNITS/ML A091659 001 Jun 08, 2011
CHAMBERLIN PARENTERL 1,000 UNITS/ML N017130 001
5,000 UNITS/ML N017130 002
10,000 UNITS/ML N017130 003
20,000 UNITS/ML N017130 004
DELL LABS 1,000 UNITS/ML N017540 001
5,000 UNITS/ML N017540 002
10,000 UNITS/ML N017540 003
20,000 UNITS/ML N017540 004
40,000 UNITS/ML N017540 005
DR REDDYS 1,000 UNITS/ML A040007 001 Jun 07, 1996
1,000 UNITS/ML N017064 002
2,500 UNITS/ML N017064 015
3,000 UNITS/ML N017064 016
4,000 UNITS/ML N017064 017
5,000 UNITS/ML N017064 003
6,000 UNITS/ML N017064 018
7,500 UNITS/ML N017064 019
10,000 UNITS/ML N017064 004
20,000 UNITS/ML N017064 005
40,000 UNITS/ML N017064 006
FRESENIUS KABI USA 1,000 UNITS/ML N017651 005
5,000 UNITS/ML N017029 002
10,000 UNITS/ML N017651 003
20,000 UNITS/ML N017651 008
+ HIKMA 1,000 UNITS/ML ** N017007 001
+ 2,500 UNITS/ML ** N017007 007
+ 5,000 UNITS/ML ** N017007 002
+ 5,000 UNITS/0.5ML ** N017007 010
5,000 UNITS/0.5ML N017037 013 Apr 07, 1986
+ 7,500 UNITS/ML ** N017007 003
+ 10,000 UNITS/ML ** N017007 004
+ 15,000 UNITS/ML ** N017007 005
+ 20,000 UNITS/ML ** N017007 006
HOSPIRA 2,500 UNITS/ML A088099 001 Apr 28, 1983
10,000 UNITS/ML A040095 001 Jul 26, 1996
LILLY 1,000 UNITS/ML N005521 001
10,000 UNITS/ML N005521 002
20,000 UNITS/ML N005521 004
LUITPOLD 1,000 UNITS/ML A087452 001 Oct 31, 1983
NANJING KING-FRIEND 5,000 UNITS/ML A212061 001 Jul 15, 2020
ORGANON USA INC 1,000 UNITS/ML N000552 008
5,000 UNITS/ML N000552 009
10,000 UNITS/ML N000552 010
PARKE DAVIS 1,000 UNITS/ML N017346 001
5,000 UNITS/ML N017346 002
7,500 UNITS/ML N017346 003
10,000 UNITS/ML N017346 004
20,000 UNITS/ML N017346 005
+ PFIZER 10,000 UNITS/ML N201370 003 Jul 21, 2011
PHARM SPEC 1,000 UNITS/ML N017780 001
5,000 UNITS/ML N017780 002
10,000 UNITS/ML N017780 003

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-230(of 478)
** See List Footnote
HEPARIN SODIUM
INJECTABLE;INJECTION
HEPARIN SODIUM
20,000 UNITS/ML N017780 004
40,000 UNITS/ML N017780 005
PHARMACIA AND UPJOHN 1,000 UNITS/ML N004570 001
5,000 UNITS/ML N004570 002
10,000 UNITS/ML N004570 003
SMITH AND NEPHEW 1,000 UNITS/ML A088239 001 Jul 26, 1984
SOLOPAK 1,000 UNITS/ML A087043 001
5,000 UNITS/ML A087077 001
5,000 UNITS/0.5ML A087395 001
10,000 UNITS/ML A087107 001
10,000 UNITS/0.5ML A087363 001
WATSON LABS INC 1,000 UNITS/ML A040008 001 Oct 10, 1995
HEPARIN SODIUM 1,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
MCGAW 200 UNITS/100ML N019130 001 Dec 31, 1984
HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 200 UNITS/100ML N019042 001 Mar 29, 1985
HEPARIN SODIUM 10,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 2,000 UNITS/100ML N018814 002 Jul 09, 1985
HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5%
HOSPIRA 10,000 UNITS/100ML N018911 006 Jan 30, 1985
HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45%
HOSPIRA 10,000 UNITS/100ML N018911 001 Jan 30, 1985
10,000 UNITS/100ML N018916 005 Jan 31, 1984
HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%
HOSPIRA 10,000 UNITS/100ML N018911 003 Jan 30, 1985
10,000 UNITS/100ML N018916 002 Jan 31, 1984
HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5%
HOSPIRA 5,000 UNITS/100ML N018911 007 Jan 30, 1985
HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN 5,000 UNITS/100ML N019802 001 Jul 20, 1992
HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.9%
HOSPIRA 5,000 UNITS/100ML N018911 005 Jan 30, 1985
5,000 UNITS/100ML N018916 003 Jan 31, 1984
HEPARIN SODIUM 2,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
MCGAW 200 UNITS/100ML N019130 003 Dec 31, 1984
HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 200 UNITS/100ML N019042 002 Mar 29, 1985
HEPARIN SODIUM 20,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4,000 UNITS/100ML N018814 001 Oct 31, 1983
HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
HOSPIRA 4,000 UNITS/100ML N019805 001 Jan 25, 1989
HEPARIN SODIUM 25,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 5,000 UNITS/100ML N018814 003 Jul 09, 1985
10,000 UNITS/100ML N018814 004 Jul 02, 1987
HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5%
HOSPIRA 5,000 UNITS/100ML N018911 009 Jan 30, 1985
10,000 UNITS/100ML N018911 008 Jan 30, 1985
HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 5,000 UNITS/100ML N019134 001 Mar 29, 1985
HOSPIRA 5,000 UNITS/100ML N019805 002 Jan 25, 1989
HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN 5,000 UNITS/100ML N019802 005 Jul 20, 1992
10,000 UNITS/100ML N019802 002 Jul 20, 1992
HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9%
HOSPIRA 5,000 UNITS/100ML N018911 004 Jan 30, 1985
HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 5,000 UNITS/100ML N019135 001 Mar 29, 1985
5,000 UNITS/100ML N019802 003 Jul 20, 1992
HOSPIRA 5,000 UNITS/100ML N018916 009 Jan 31, 1984
HEPARIN SODIUM 5,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
BAXTER HLTHCARE 500 UNITS/100ML N018609 003 Apr 28, 1982
HEPARIN SODIUM 5,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
MCGAW 1,000 UNITS/100ML N019130 002 Dec 31, 1984
HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45%
HOSPIRA 100 UNITS/ML N018911 002 Jan 30, 1985
100 UNITS/ML N018916 004 Jan 31, 1984

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-231(of 478)
** See List Footnote
HEPARIN SODIUM
INJECTABLE;INJECTION
HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9%
HOSPIRA 1,000 UNITS/100ML N018916 001 Jan 31, 1984
HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 1,000 UNITS/100ML N019042 004 Mar 29, 1985
HEPARIN SODIUM PRESERVATIVE FREE
DR REDDYS 1,000 UNITS/ML A089464 001 Jun 03, 1986
HOSPIRA 2,000 UNITS/ML N005264 013 Apr 07, 1986
2,500 UNITS/ML N005264 014 Apr 07, 1986
NANJING KING-FRIEND 10,000 UNITS/ML A212060 001 Apr 02, 2020
PHARMA SERVE NY 1,000 UNITS/ML A086129 001
LIPO-HEPIN
3M 1,000 UNITS/0.5ML N017027 001
1,000 UNITS/ML N017027 006
5,000 UNITS/0.5ML N017027 002
5,000 UNITS/ML N017027 008
7,500 UNITS/0.5ML N017027 010
10,000 UNITS/0.5ML N017027 003
10,000 UNITS/ML N017027 009
15,000 UNITS/0.5ML N017027 011
20,000 UNITS/0.5ML N017027 004
20,000 UNITS/ML N017027 007
40,000 UNITS/ML N017027 005
LIQUAEMIN LOCK FLUSH
ORGANON USA INC 100 UNITS/ML N000552 007
LIQUAEMIN SODIUM
ORGANON USA INC 1,000 UNITS/ML N000552 004
5,000 UNITS/ML N000552 003
10,000 UNITS/ML N000552 005
20,000 UNITS/ML N000552 001
40,000 UNITS/ML N000552 002
LIQUAEMIN SODIUM PRESERVATIVE FREE
ORGANON USA INC 1,000 UNITS/ML N000552 011 Apr 11, 1986
5,000 UNITS/ML N000552 012 Apr 11, 1986
10,000 UNITS/ML N000552 013 Apr 11, 1986
PANHEPRIN
HOSPIRA 1,000 UNITS/ML N005264 004
5,000 UNITS/ML N005264 006
10,000 UNITS/ML N005264 007
20,000 UNITS/ML N005264 008
40,000 UNITS/ML N005264 009
SODIUM HEPARIN
ABRAXIS PHARM 5,000 UNITS/ML N017033 002
10,000 UNITS/ML N017033 003
20,000 UNITS/ML N017033 004
BAXTER HLTHCARE 1,000 UNITS/ML N017036 001 Mar 04, 1988
HETACILLIN
FOR SUSPENSION;ORAL
VERSAPEN
BRISTOL EQ 112.5MG AMPICIL/ML A061398 001
EQ 112.5MG AMPICIL/5ML N050060 001
EQ 112.5MG AMPICIL/ML N050060 003
EQ 225MG AMPICIL/5ML A061398 002
HETACILLIN POTASSIUM
CAPSULE;ORAL
VERSAPEN-K
BRISTOL EQ 225MG AMPICIL A061396 001
EQ 450MG AMPICIL A061396 002
HEXACHLOROPHENE
AEROSOL;TOPICAL
SEPTISOL
VESTAL LABS 0.23% N017424 001
TURGEX
XTTRIUM 3% N018375 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-232(of 478)
** See List Footnote
HEXACHLOROPHENE
EMULSION;TOPICAL
HEXA-GERM
HUNTINGTON LABS 3% N017411 001
PHISOHEX
SANOFI AVENTIS US 3% N006882 001
3% N008402 001
SOY-DOME
BAYER PHARMS 3% N017405 001
TURGEX
XTTRIUM 3% N019055 001 Nov 30, 1984
SOAP;TOPICAL
GAMOPHEN
ARBROOK 2% N006270 003
SOLUTION;TOPICAL
DIAL
DIAL 0.25% N017421 002
GERMA-MEDICA
HUNTINGTON LABS 1% N017412 001
GERMA-MEDICA "MG"
HUNTINGTON LABS 0.25% N017412 002
SEPTI-SOFT
CALGON 0.25% N017460 001
SEPTISOL
VESTAL LABS 0.25% N017423 001
SPONGE;TOPICAL
E-Z SCRUB
BECTON DICKINSON 450MG N017452 001
HEXASCRUB
PROF DSPLS 3% N018363 001
PHISO-SCRUB
SANOFI AVENTIS US 3% N017446 001
SCRUBTEAM SURGICAL SPONGEBRUSH
3M 330MG N017413 001
HEXAFLUORENIUM BROMIDE
INJECTABLE;INJECTION
MYLAXEN
MEDPOINTE PHARM HLC 20MG/ML N009789 003
HEXOCYCLIUM METHYLSULFATE
TABLET;ORAL
TRAL
ABBVIE 25MG N010599 001
HEXYLCAINE HYDROCHLORIDE
SOLUTION;TOPICAL
CYCLAINE
MERCK 5% N008472 001
HISTAMINE PHOSPHATE
INJECTABLE;INJECTION
HISTAMINE PHOSPHATE
LILLY EQ 0.1MG BASE/ML N000734 003
EQ 0.2MG BASE/ML N000734 002
EQ 1MG BASE/ML N000734 001
HISTRELIN ACETATE
IMPLANT;SUBCUTANEOUS
VANTAS
+ ENDO PHARM 50MG N021732 001 Oct 12, 2004
INJECTABLE;INJECTION
SUPPRELIN
SHIRE EQ 0.2MG BASE/ML N019836 001 Dec 24, 1991
EQ 0.5MG BASE/ML N019836 002 Dec 24, 1991
EQ 1MG BASE/ML N019836 003 Dec 24, 1991

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-233(of 478)
** See List Footnote
HOMATROPINE METHYLBROMIDE
TABLET;ORAL
HOMAPIN-10
MISSION PHARMA 10MG A086308 001
HOMAPIN-5
MISSION PHARMA 5MG A086309 001
TABLET, CHEWABLE;ORAL
EQUIPIN
MISSION PHARMA 3MG A086310 001
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
SYRUP;ORAL
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
IVAX SUB TEVA PHARMS 1.5MG/5ML;5MG/5ML A040285 001 Jul 19, 1999
NOSTRUM LABS INC 1.5MG/5ML;5MG/5ML A210663 001 Jun 11, 2019
TORRENT 1.5MG/5ML;5MG/5ML A204765 001 Mar 06, 2017
HYDROPANE
HALSEY 1.5MG/5ML;5MG/5ML A088066 001 Jun 28, 1985
TABLET;ORAL
HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
ACTAVIS ELIZABETH 1.5MG;5MG A040295 001 Dec 01, 2000
NOVEL LABS INC 1.5MG;5MG A091528 001 Apr 20, 2011
TUSSIGON
KING PHARMS 1.5MG;5MG A088508 001 Jul 30, 1985
HYDRALAZINE HYDROCHLORIDE
INJECTABLE;INJECTION
APRESOLINE
+ NOVARTIS 20MG/ML ** N008303 003
HYDRALAZINE HYDROCHLORIDE
ABRAXIS PHARM 20MG/ML A089532 001 Aug 11, 1987
SMITH AND NEPHEW 20MG/ML A088518 001 Apr 20, 1984
SOLOPAK 20MG/ML A088517 001 Aug 22, 1985
TEVA PARENTERAL 20MG/ML A040373 001 Feb 23, 2000
TABLET;ORAL
APRESOLINE
+ NOVARTIS 10MG ** N008303 004
+ 25MG ** N008303 001
+ 50MG ** N008303 002
+ 100MG ** N008303 005
DRALZINE
TEVA 25MG A084301 001
HYDRALAZINE HYDROCHLORIDE
ACTAVIS ELIZABETH 25MG A088560 001 Oct 04, 1984
50MG A088649 001 Oct 18, 1984
ACTAVIS GRP PTC 10MG A091679 001 Mar 04, 2013
25MG A091679 002 Mar 04, 2013
50MG A091679 003 Mar 04, 2013
100MG A091679 004 Mar 04, 2013
ANDA REPOSITORY 10MG A089359 001 Jul 25, 1986
25MG A089258 001 May 05, 1986
50MG A089259 001 May 05, 1986
100MG A088729 001 Apr 11, 1985
ASCOT 25MG A088310 001 Dec 19, 1984
50MG A088311 001 Dec 19, 1984
CHARTWELL RX 10MG A088846 001 Feb 26, 1985
25MG A088847 001 Feb 26, 1985
50MG A088848 001 Feb 26, 1985
100MG A088849 001 Feb 26, 1985
HALSEY 10MG A089218 001 Jan 22, 1986
25MG A089130 001 Jan 15, 1986
50MG A089222 001 Jan 22, 1986
100MG A089178 001 Jan 15, 1986
HERITAGE PHARMS INC 10MG A040858 001 Feb 26, 2010
25MG A040858 002 Feb 26, 2010
50MG A040858 003 Feb 26, 2010
100MG A040858 004 Feb 26, 2010
IMPAX LABS 25MG A084922 001
50MG A084923 001
IVAX SUB TEVA PHARMS 10MG A084443 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-234(of 478)
** See List Footnote
HYDRALAZINE HYDROCHLORIDE
TABLET;ORAL
HYDRALAZINE HYDROCHLORIDE
25MG A084437 001
50MG A084469 002
100MG A084581 001
MUTUAL PHARM 10MG A088728 001 Apr 11, 1985
25MG A084106 002
50MG A084107 002
MYLAN 10MG A090413 001 Dec 08, 2010
25MG A090413 002 Dec 08, 2010
50MG A090413 003 Dec 08, 2010
100MG A090413 004 Dec 08, 2010
PUREPAC PHARM 25MG A088177 001 Jul 29, 1983
50MG A088178 001 Aug 15, 1983
QUANTUM PHARMICS 10MG A088671 001 May 01, 1984
25MG A088657 001 Jun 15, 1984
50MG A088652 001 May 08, 1984
100MG A088686 001 May 01, 1984
STRIDES PHARMA 10MG A200770 004 Jun 25, 2019
SUPERPHARM 10MG A088787 001 Aug 28, 1984
25MG A088788 001 Aug 28, 1984
50MG A088789 001 Aug 28, 1984
UPSHER SMITH LABS 10MG A083241 001
10MG A209251 001 Jul 09, 2018
25MG A083560 001
25MG A209251 002 Jul 09, 2018
50MG A083561 001
50MG A085088 001
50MG A209251 003 Jul 09, 2018
100MG A209251 004 Jul 09, 2018
USL PHARMA 25MG A087780 001 Mar 29, 1982
50MG A087751 001 Mar 29, 1982
VANGARD 25MG A087712 001
50MG A087908 001 May 07, 1982
VITARINE 25MG A086088 001
WATSON LABS 25MG A084504 001
25MG A085532 002 May 24, 1982
50MG A084503 001
50MG A085533 002 May 25, 1982
WEST WARD 25MG A088240 001 May 27, 1983
50MG A088241 001 May 27, 1983
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
CAPSULE;ORAL
APRESAZIDE
+ NOVARTIS 25MG;25MG A084735 001
+ 50MG;50MG A084810 001
100MG;50MG A084811 001
HYDRA-ZIDE
STRIDES PHARMA 100MG;50MG A088961 001 Oct 21, 1985
HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
SOLVAY 25MG;25MG A087608 001 Feb 08, 1982
50MG;50MG A087213 001 Feb 08, 1982
100MG;50MG A087609 001 Feb 08, 1982
SUPERPHARM 25MG;25MG A089200 001 Feb 09, 1987
50MG;50MG A089201 001 Feb 09, 1987
WATSON LABS 25MG;25MG A085457 001 Mar 04, 1982
50MG;50MG A085446 001 Mar 04, 1982
100MG;50MG A085440 001 Mar 04, 1982
HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50
IVAX PHARMS 100MG;50MG A088358 001 Apr 10, 1984
HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25
IVAX PHARMS 25MG;25MG A088356 001 Apr 10, 1984
HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/50
IVAX PHARMS 50MG;50MG A088357 001 Apr 10, 1984
TABLET;ORAL
APRESOLINE-ESIDRIX
NOVARTIS 25MG;15MG N012026 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-235(of 478)
** See List Footnote
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
TABLET;ORAL
HYDRALAZINE AND HYDROCHLOROTHIAZIDE
WATSON LABS 25MG;15MG A085827 001
HYDROCHLOROTHIAZIDE W/ HYDRALAZINE
WATSON LABS 25MG;15MG A085373 001
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE
TABLET;ORAL
CAM-AP-ES
CHARTWELL RX 25MG;15MG;0.1MG A084897 001
HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE AND RESERPINE
IVAX SUB TEVA PHARMS 25MG;15MG;0.1MG A084291 001
HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINE
MYLAN 25MG;15MG;0.1MG A087085 001
HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE
WATSON LABS 25MG;15MG;0.1MG A085771 001
HYDRAP-ES
SANDOZ 25MG;15MG;0.1MG A084876 001
HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE
WATSON LABS 25MG;15MG;0.1MG A083770 001
HYDROSERPINE PLUS (R-H-H)
IVAX SUB TEVA PHARMS 25MG;15MG;0.1MG A083877 001
RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
SOLVAY 25MG;15MG;0.1MG A088376 001 Oct 28, 1983
SUN PHARM INDUSTRIES 25MG;15MG;0.1MG A088570 001 Apr 10, 1984
WATSON LABS 25MG;15MG;0.1MG A085549 001
25MG;15MG;0.1MG A087556 001
RESERPINE, HYDROCHLOROTHIAZIDE, AND HYDRALAZINE HYDROCHLORIDE
LEDERLE 25MG;15MG;0.1MG A087709 001 May 13, 1982
SER-A-GEN
SOLVAY 25MG;15MG;0.1MG A087210 001
SER-AP-ES
NOVARTIS 25MG;15MG;0.1MG N012193 005
UNIPRES
SOLVAY 25MG;15MG;0.1MG A085893 001
25MG;15MG;0.1MG A086298 001
HYDRALAZINE HYDROCHLORIDE; RESERPINE
TABLET;ORAL
DRALSERP
SANDOZ 25MG;0.1MG A084617 001
SERPASIL-APRESOLINE
NOVARTIS 25MG;0.1MG N009296 004
50MG;0.2MG N009296 002
HYDROCHLOROTHIAZIDE
CAPSULE;ORAL
HYDROCHLOROTHIAZIDE
ALEMBIC PHARMS LTD 12.5MG A200645 001 Nov 30, 2010
APOTEX 12.5MG A078389 001 May 16, 2008
CHARTWELL MOLECULAR 12.5MG A091662 001 Jan 27, 2012
HIKMA INTL PHARMS 12.5MG A077885 001 Nov 26, 2007
IVAX SUB TEVA PHARMS 12.5MG A077005 001 Jul 13, 2005
MYLAN 12.5MG A075640 001 Jan 28, 2000
SOLUTION;ORAL
HYDROCHLOROTHIAZIDE
MORTON GROVE 50MG/5ML A089661 001 Jun 20, 1988
+ ROXANE 50MG/5ML A088587 001 Jul 02, 1984
HYDROCHLOROTHIAZIDE INTENSOL
ROXANE 100MG/ML A088588 001 Jul 02, 1984
TABLET;ORAL
ESIDRIX
NOVARTIS 25MG N011793 005
50MG N011793 008
100MG N011793 009
HYDRO-D
HALSEY 25MG A086504 001
50MG A083891 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-236(of 478)
** See List Footnote
HYDROCHLOROTHIAZIDE
TABLET;ORAL
HYDROCHLOROTHIAZIDE
ABC HOLDING 50MG A085672 001
ACTAVIS ELIZABETH 25MG A085054 002
50MG A085208 001
ALRA 25MG A086369 001
50MG A083554 001
APOTEX 25MG A040774 001 Oct 03, 2007
50MG A040774 002 Oct 03, 2007
ASCOT 25MG A087539 001 Feb 03, 1982
50MG A087540 001 Feb 03, 1982
AUROLIFE PHARMA LLC 25MG A083899 001
50MG A085219 001
BARR 50MG A084771 001
CHARTWELL RX 25MG A085683 001
25MG A087565 001 Mar 09, 1982
50MG A083965 001
50MG A084912 001
DAVA PHARMS INC 100MG A087060 001
ELKINS SINN 50MG A085152 002
HEATHER 50MG A084135 001
HIKMA INTL PHARMS 25MG A084878 002 Jul 12, 2006
50MG A084878 001
IMPAX LABS 25MG A084029 001
50MG A083607 002
100MG A085098 001
INWOOD LABS 25MG A084776 001
25MG A085067 001
50MG A084776 002
IVAX SUB TEVA PHARMS 50MG A084658 001
+ 100MG A085022 001
JUBILANT CADISTA 25MG A040809 001 Sep 04, 2007
50MG A040809 002 Sep 04, 2007
LANNETT CO INC 25MG A084325 001
50MG A084324 001
MAST MM 25MG A086192 001
50MG A086192 002
MYLAN 25MG A084880 001
50MG A085112 001
MYLAN PHARMS INC 12.5MG A040770 001 Jan 23, 2007
25MG A040735 002 Jan 23, 2007
50MG A040735 003 Jan 23, 2007
PVT FORM 50MG A086597 001
ROXANE 25MG A085004 001
50MG A084536 002
50MG A085005 001
SOLVAY 25MG A085323 001
SUN PHARM INDS INC 12.5MG A040857 001 May 30, 2008
25MG A040810 001 Mar 27, 2007
50MG A040810 002 Mar 27, 2007
SUN PHARM INDUSTRIES 25MG A083972 001
50MG A083972 002
100MG A083972 003
SUPERPHARM 25MG A088827 001 Dec 28, 1984
50MG A088828 001 Dec 28, 1984
100MG A088829 001 Dec 28, 1984
TEVA 25MG A088924 001 Feb 07, 1985
50MG A088923 001 Feb 07, 1985
USL PHARMA 25MG A087827 001 Apr 19, 1982
50MG A087752 001 Apr 19, 1982
VANGARD 25MG A087638 001
50MG A087610 001
WARNER CHILCOTT 25MG A087586 001 May 03, 1982
50MG A087587 001 May 03, 1982
WATSON LABS 25MG A081189 001 Jan 24, 1992
25MG A083458 001
25MG A085232 002
50MG A083456 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-237(of 478)
** See List Footnote
HYDROCHLOROTHIAZIDE
TABLET;ORAL
HYDROCHLOROTHIAZIDE
50MG A085233 001
50MG A086087 001
50MG A086594 001
100MG A081190 001 Jan 24, 1992
100MG A085099 001
100MG A087002 001
WATSON LABS TEVA 50MG A083232 001
WEST WARD 25MG A084899 001
WHITEWORTH TOWN PLSN 25MG A083809 002
50MG A083809 001
100MG A085347 001
HYDRODIURIL
+ MERCK 25MG ** N011835 003
+ 50MG ** N011835 006
+ 100MG ** N011835 007
ORETIC
ABBVIE 25MG N011971 001
50MG N011971 002
ZIDE
SOLVAY 50MG A083925 001
HYDROCHLOROTHIAZIDE; IRBESARTAN
TABLET;ORAL
AVALIDE
+ SANOFI AVENTIS US 12.5MG;75MG ** N020758 001 Sep 30, 1997
+ 25MG;300MG ** N020758 004 Mar 15, 2005
IRBESARTAN AND HYDROCHLOROTHIAZIDE
APOTEX INC 12.5MG;150MG A201505 001 Oct 15, 2012
12.5MG;300MG A201505 002 Oct 15, 2012
ATLAS PHARMS LLC 12.5MG;150MG A203036 001 Jan 15, 2016
12.5MG;300MG A203036 002 Jan 15, 2016
25MG;300MG A203036 003 Jan 15, 2016
MYLAN PHARMS INC 12.5MG;150MG A077969 001 Sep 27, 2012
12.5MG;300MG A077969 002 Sep 27, 2012
25MG;300MG A077969 003 Jul 20, 2016
TEVA 25MG;300MG A077369 003 Mar 30, 2012
UNICHEM 12.5MG;150MG A207018 001 Sep 19, 2017
12.5MG;300MG A207018 002 Sep 19, 2017
WATSON LABS INC 12.5MG;150MG A091539 001 Oct 22, 2012
12.5MG;300MG A091539 002 Oct 22, 2012
HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE
TABLET;ORAL
NORMOZIDE
SCHERING 25MG;100MG N019046 001 Apr 06, 1987
25MG;200MG N019046 002 Apr 06, 1987
25MG;300MG N019046 003 Apr 06, 1987
25MG;400MG N019046 004 Apr 06, 1987
TRANDATE HCT
GLAXOSMITHKLINE 25MG;100MG N019174 001 Apr 10, 1987
25MG;200MG N019174 002 Apr 10, 1987
25MG;300MG N019174 003 Apr 10, 1987
25MG;400MG N019174 004 Apr 10, 1987
HYDROCHLOROTHIAZIDE; LISINOPRIL
TABLET;ORAL
LISINOPRIL AND HYDROCHLOROTHIAZIDE
COREPHARMA 12.5MG;10MG A076674 001 Oct 05, 2004
12.5MG;20MG A076674 002 Oct 05, 2004
25MG;20MG A076674 003 Oct 05, 2004
EPIC PHARMA 12.5MG;10MG A075926 001 Jul 01, 2002
12.5MG;20MG A075926 002 Jul 01, 2002
25MG;20MG A075926 003 Jul 01, 2002
HERITAGE PHARMA 12.5MG;10MG A075776 001 Jul 01, 2002
12.5MG;20MG A075776 002 Jul 01, 2002
25MG;20MG A075776 003 Jul 01, 2002
HIKMA INTL PHARMS 12.5MG;10MG A076265 001 Jul 08, 2002
12.5MG;20MG A076265 002 Jul 08, 2002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-238(of 478)
** See List Footnote
HYDROCHLOROTHIAZIDE; LISINOPRIL
TABLET;ORAL
LISINOPRIL AND HYDROCHLOROTHIAZIDE
25MG;20MG A076265 003 Jul 08, 2002
MYLAN 12.5MG;10MG A076113 001 Jul 01, 2002
12.5MG;20MG A076113 002 Jul 01, 2002
25MG;20MG A076113 003 Jul 01, 2002
TEVA 12.5MG;10MG A075869 001 Jul 01, 2002
12.5MG;20MG A075869 002 Jul 01, 2002
25MG;20MG A075869 003 Jul 01, 2002
PRINZIDE
+ MERCK 12.5MG;10MG ** N019778 003 Nov 18, 1993
+ 12.5MG;20MG ** N019778 001 Feb 16, 1989
+ 25MG;20MG ** N019778 002 Feb 16, 1989
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
TABLET;ORAL
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
APOTEX 12.5MG;50MG A090150 001 Oct 06, 2010
12.5MG;100MG A090150 002 Aug 11, 2010
25MG;100MG A090150 003 Oct 06, 2010
HIKMA 12.5MG;50MG A077732 002 Oct 06, 2010
12.5MG;100MG A077732 001 Apr 06, 2010
25MG;100MG A077732 003 Oct 06, 2010
MYLAN 12.5MG;50MG A091652 001 Oct 06, 2010
12.5MG;100MG A091652 002 Apr 06, 2010
25MG;100MG A091652 003 Oct 06, 2010
TORRENT PHARMS 12.5MG;50MG A090528 001 Oct 06, 2010
12.5MG;100MG A090528 003 Apr 06, 2010
25MG;100MG A090528 002 Oct 06, 2010
WATSON LABS 12.5MG;50MG A200180 001 Jan 12, 2011
12.5MG;100MG A200180 002 Jan 12, 2011
25MG;100MG A200180 003 Jan 12, 2011
HYDROCHLOROTHIAZIDE; METHYLDOPA
TABLET;ORAL
ALDORIL 15
MERCK 15MG;250MG N013402 001
ALDORIL 25
MERCK 25MG;250MG N013402 002
ALDORIL D30
MERCK 30MG;500MG N013402 003
ALDORIL D50
MERCK 50MG;500MG N013402 004
METHYLDOPA AND HYDROCHLOROTHIAZIDE
CHARTWELL RX 15MG;250MG A070182 001 Jan 15, 1986
25MG;250MG A070183 001 Jan 15, 1986
30MG;500MG A070543 001 Jan 15, 1986
50MG;500MG A070544 001 Jan 15, 1986
DAVA PHARMS INC 15MG;250MG A072507 001 Jun 02, 1989
25MG;250MG A072508 001 Jun 02, 1989
30MG;500MG A072509 001 Jun 02, 1989
50MG;500MG A072510 001 Jun 02, 1989
IVAX SUB TEVA PHARMS 15MG;250MG A071458 001 Mar 08, 1988
25MG;250MG A071459 001 Mar 08, 1988
30MG;500MG A071460 001 Mar 08, 1988
50MG;500MG A071461 001 Mar 08, 1988
PARKE DAVIS 15MG;250MG A071897 001 Nov 23, 1987
25MG;250MG A071898 001 Nov 23, 1987
30MG;500MG A071899 001 Nov 23, 1987
50MG;500MG A071900 001 Nov 23, 1987
PUREPAC PHARM 15MG;250MG A070853 001 Oct 08, 1986
25MG;250MG A070688 001 Apr 24, 1986
30MG;500MG A070854 001 Oct 08, 1986
50MG;500MG A070689 001 Apr 24, 1986
RISING 15MG;250MG A070265 002 Jan 23, 1986
25MG;250MG A070265 001 Jan 23, 1986
SANDOZ 15MG;250MG A070829 001 Mar 09, 1987
25MG;250MG A070830 001 Mar 09, 1987
STRIDES PHARMA 15MG;250MG A070616 001 Feb 02, 1987

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-239(of 478)
** See List Footnote
HYDROCHLOROTHIAZIDE; METHYLDOPA
TABLET;ORAL
METHYLDOPA AND HYDROCHLOROTHIAZIDE
25MG;250MG A070612 001 Feb 02, 1987
30MG;500MG A070613 001 Feb 02, 1987
50MG;500MG A070614 001 Feb 02, 1987
TEVA 15MG;250MG A071819 001 Apr 08, 1988
25MG;250MG A071820 001 Apr 08, 1988
30MG;500MG A071821 001 Apr 08, 1988
50MG;500MG A071822 001 Apr 08, 1988
WATSON LABS 15MG;250MG A070365 001 Mar 19, 1986
15MG;250MG A070958 001 Feb 06, 1989
15MG;250MG A071920 001 Aug 29, 1988
25MG;250MG A070366 001 Apr 16, 1986
25MG;250MG A070959 001 Jan 19, 1989
25MG;250MG A071921 001 Aug 29, 1988
30MG;500MG A070367 001 Mar 19, 1986
30MG;500MG A071069 001 Jan 19, 1989
30MG;500MG A071922 001 Aug 29, 1988
50MG;500MG A070368 001 Apr 16, 1986
50MG;500MG A070960 001 Feb 06, 1989
50MG;500MG A071923 001 Aug 29, 1988
HYDROCHLOROTHIAZIDE; METOPROLOL SUCCINATE
TABLET, EXTENDED RELEASE;ORAL
DUTOPROL
+ CONCORDIA 12.5MG;EQ 25MG TARTRATE ** N021956 001 Aug 28, 2006
+ 12.5MG;EQ 50MG TARTRATE ** N021956 002 Aug 28, 2006
+ 12.5MG;EQ 100MG TARTRATE ** N021956 003 Aug 28, 2006
HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE
TABLET;ORAL
LOPRESSOR HCT
+ VALIDUS PHARMS 25MG;100MG ** N018303 002 Dec 31, 1984
+ 50MG;100MG ** N018303 003 Dec 31, 1984
HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
TABLET;ORAL
MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
CHARTWELL RX 12.5MG;7.5MG A090096 001 Sep 25, 2008
12.5MG;15MG A090096 002 Sep 25, 2008
25MG;15MG A090096 003 Sep 25, 2008
HERITAGE PHARMS 12.5MG;7.5MG A202150 001 Mar 07, 2014
12.5MG;15MG A202150 002 Mar 07, 2014
25MG;15MG A202150 003 Mar 07, 2014
UNIRETIC
UCB INC 12.5MG;7.5MG ** N020729 001 Jun 27, 1997
12.5MG;15MG ** N020729 003 Feb 14, 2002
25MG;15MG ** N020729 002 Jun 27, 1997
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
TABLET;ORAL
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
MYLAN 12.5MG;20MG A078827 001 Oct 26, 2016
12.5MG;40MG A078827 002 Oct 26, 2016
25MG;40MG A078827 003 Oct 26, 2016
TEVA PHARMS USA 12.5MG;20MG A200532 001 Apr 24, 2017
25MG;40MG A200532 003 Apr 24, 2017
HYDROCHLOROTHIAZIDE; PINDOLOL
TABLET;ORAL
VISKAZIDE
NOVARTIS 25MG;5MG N018872 001 Jul 22, 1987
25MG;10MG N018872 002 Jul 22, 1987
HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
INDERIDE LA 120/50
WYETH AYERST 50MG;120MG N019059 002 Jul 03, 1985
INDERIDE LA 160/50
WYETH AYERST 50MG;160MG N019059 003 Jul 03, 1985

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-240(of 478)
** See List Footnote
HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
INDERIDE LA 80/50
WYETH AYERST 50MG;80MG N019059 001 Jul 03, 1985
TABLET;ORAL
INDERIDE-40/25
+ WYETH PHARMS INC 25MG;40MG ** N018031 001
INDERIDE-80/25
+ WYETH PHARMS INC 25MG;80MG ** N018031 002
PROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDE
DURAMED PHARMS BARR 25MG;40MG A071126 001 Mar 02, 1987
25MG;80MG A071127 001 Mar 02, 1987
PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
ACTAVIS ELIZABETH 25MG;40MG A070851 001 May 15, 1986
25MG;80MG A070852 001 May 15, 1986
ANI PHARMS 25MG;40MG A070705 002 Oct 01, 1986
25MG;40MG A072043 002 Mar 14, 1988
25MG;80MG A070705 001 Oct 01, 1986
25MG;80MG A072043 001 Mar 14, 1988
CHARTWELL RX 25MG;40MG A071060 001 Aug 26, 1987
25MG;80MG A071061 001 Aug 26, 1987
IVAX SUB TEVA PHARMS 25MG;40MG A071552 001 Dec 01, 1988
25MG;80MG A071553 001 Dec 01, 1988
RISING 25MG;40MG A070947 002 Mar 04, 1987
25MG;80MG A070947 001 Apr 01, 1987
WARNER CHILCOTT 25MG;40MG A071771 001 Jan 26, 1988
25MG;80MG A071772 001 Jan 26, 1988
WATSON LABS 25MG;40MG A070301 001 Apr 18, 1986
25MG;40MG A071498 001 Dec 18, 1991
25MG;80MG A070305 001 Apr 18, 1986
25MG;80MG A071501 001 Dec 18, 1991
HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
TABLET;ORAL
ACCURETIC
+ PFIZER PHARMS 12.5MG;EQ 10MG BASE N020125 001 Dec 28, 1999
+ 12.5MG;EQ 20MG BASE N020125 002 Dec 28, 1999
+ 25MG;EQ 20MG BASE N020125 003 Dec 28, 1999
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
LUPIN 12.5MG;EQ 10MG BASE A076374 001 Mar 31, 2004
12.5MG;EQ 20MG BASE A076374 002 Mar 31, 2004
25MG;EQ 20MG BASE A076374 003 Mar 31, 2004
MYLAN 12.5MG;EQ 10MG BASE A077093 001 Mar 28, 2005
12.5MG;EQ 20MG BASE A077093 002 Mar 28, 2005
25MG;EQ 20MG BASE A077093 003 Mar 28, 2005
SUN PHARM INDS LTD 12.5MG;EQ 10MG BASE A078211 001 Mar 04, 2009
12.5MG;EQ 20MG BASE A078211 002 Mar 04, 2009
25MG;EQ 20MG BASE A078211 003 Mar 04, 2009
HYDROCHLOROTHIAZIDE; RESERPINE
TABLET;ORAL
H.R.-50
WHITEWORTH TOWN PLSN 50MG;0.125MG A085338 001
HYDRO-RESERP
ABC HOLDING 50MG;0.125MG A084714 002 Jun 29, 1982
HYDRO-SERP "25"
SANDOZ 25MG;0.125MG A084827 001
HYDRO-SERP "50"
SANDOZ 50MG;0.125MG A085213 001
HYDROCHLOROTHIAZIDE W/ RESERPINE
IVAX SUB TEVA PHARMS 25MG;0.1MG A083572 001
25MG;0.125MG A083571 001
50MG;0.1MG A083568 001
50MG;0.125MG A083573 001
PHARMERAL 25MG;0.125MG A085421 001
50MG;0.125MG A085420 001
ROXANE 50MG;0.125MG A084603 001
WATSON LABS 25MG;0.125MG A084466 001
25MG;0.125MG A085317 001
25MG;0.125MG A086330 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-241(of 478)
** See List Footnote
HYDROCHLOROTHIAZIDE; RESERPINE
TABLET;ORAL
HYDROCHLOROTHIAZIDE W/ RESERPINE
50MG;0.125MG A083666 001
50MG;0.125MG A084467 001
50MG;0.125MG A086331 001
HYDROPRES 25
MERCK 25MG;0.125MG N011958 002
HYDROPRES 50
MERCK 50MG;0.125MG N011958 003
RESERPINE AND HYDROCHLOROTHIAZIDE
BARR 25MG;0.125MG A084580 001
50MG;0.125MG A084579 001
SANDOZ 50MG;0.125MG A088200 001 Jan 31, 1984
RESERPINE AND HYDROCHLOROTHIAZIDE-50
WEST WARD 50MG;0.125MG A088189 001 May 10, 1984
SERPASIL-ESIDRIX #1
NOVARTIS 25MG;0.1MG N011878 003
SERPASIL-ESIDRIX #2
NOVARTIS 50MG;0.1MG N011878 005
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
TABLET;ORAL
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
ASCOT 25MG;25MG A088025 001 Nov 23, 1984
CHARTWELL RX 25MG;25MG A086881 001
MUTUAL PHARM 25MG;25MG A087267 001
PUREPAC PHARM 25MG;25MG A087999 001 Nov 06, 1985
SUPERPHARM 25MG;25MG A089137 001 Aug 26, 1985
WATSON LABS 25MG;25MG A087398 001
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
IVAX PHARMS 25MG;25MG A087004 002 May 24, 1982
LEDERLE 25MG;25MG A087511 001
PARKE DAVIS 25MG;25MG A087948 001 Feb 22, 1983
PUREPAC PHARM 25MG;25MG A088054 001 Aug 18, 1983
UPSHER SMITH 25MG;25MG A087553 001
USL PHARMA 25MG;25MG A087651 001
VANGARD 25MG;25MG A087655 001
WATSON LABS 25MG;25MG A085974 001
25MG;25MG A086026 001
HYDROCHLOROTHIAZIDE; TELMISARTAN
TABLET;ORAL
TELMISARTAN AND HYDROCHLOROTHIAZIDE
MACLEODS PHARMS LTD 12.5MG;40MG A204169 001 Nov 02, 2015
12.5MG;80MG A204169 002 Nov 02, 2015
25MG;80MG A204169 003 Nov 02, 2015
MYLAN 12.5MG;40MG A091648 001 Feb 25, 2014
12.5MG;80MG A091648 002 Feb 25, 2014
25MG;80MG A091648 003 Feb 25, 2014
TORRENT 12.5MG;40MG A201192 001 Feb 25, 2014
12.5MG;80MG A201192 002 Feb 25, 2014
25MG;80MG A201192 003 Feb 25, 2014
HYDROCHLOROTHIAZIDE; TIMOLOL MALEATE
TABLET;ORAL
TIMOLIDE 10-25
MERCK 25MG;10MG N018061 001
HYDROCHLOROTHIAZIDE; TRIAMTERENE
CAPSULE;ORAL
DYAZIDE
+ GLAXOSMITHKLINE LLC 25MG;37.5MG ** N016042 003 Mar 03, 1994
25MG;50MG ** N016042 002
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
ANI PHARMS 25MG;37.5MG A074970 001 Jan 06, 1998
25MG;50MG A074259 001 Mar 30, 1995
CHARTWELL RX 25MG;50MG A073191 001 Jul 31, 1991
DURAMED PHARMS BARR 25MG;37.5MG A075052 001 Jun 18, 1999
MYLAN 25MG;37.5MG A074701 001 Jun 07, 1996
NOVARTIS 25MG;37.5MG A074857 001 Sep 09, 1997

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-242(of 478)
** See List Footnote
HYDROCHLOROTHIAZIDE; TRIAMTERENE
CAPSULE;ORAL
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
VITARINE 25MG;50MG A071737 001 Feb 12, 1988
TABLET;ORAL
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
AM THERAP 50MG;75MG A072022 001 Apr 17, 1988
ANI PHARMS 50MG;75MG A073467 001 Jan 31, 1996
PLIVA 25MG;37.5MG A074026 001 Apr 26, 1996
QUANTUM PHARMICS 50MG;75MG A071980 001 Apr 17, 1988
WATSON LABS 50MG;75MG A071969 001 Apr 17, 1988
HYDROCHLOROTHIAZIDE; VALSARTAN
TABLET;ORAL
VALSARTAN AND HYDROCHLOROTHIAZIDE
APOTEX INC 12.5MG;80MG A203026 001 Mar 21, 2013
12.5MG;160MG A203026 002 Mar 21, 2013
12.5MG;320MG A203026 003 Mar 21, 2013
25MG;160MG A203026 004 Mar 21, 2013
25MG;320MG A203026 005 Mar 21, 2013
CADILA 12.5MG;80MG A203000 001 Mar 15, 2019
12.5MG;160MG A203000 002 Mar 15, 2019
12.5MG;320MG A203000 003 Mar 15, 2019
25MG;160MG A203000 004 Mar 15, 2019
25MG;320MG A203000 005 Mar 15, 2019
WATSON LABS TEVA 12.5MG;80MG A091519 001 Mar 21, 2013
12.5MG;160MG A091519 002 Mar 21, 2013
12.5MG;320MG A091519 003 Mar 21, 2013
25MG;160MG A091519 004 Mar 21, 2013
25MG;320MG A091519 005 Mar 21, 2013
HYDROCODONE BITARTRATE
CAPSULE, EXTENDED RELEASE;ORAL
ZOHYDRO ER
+ RECRO GAINESVILLE 10MG N202880 001 Oct 25, 2013
+ 15MG N202880 002 Oct 25, 2013
+ 20MG N202880 003 Oct 25, 2013
+ 30MG N202880 004 Oct 25, 2013
+ 40MG N202880 005 Oct 25, 2013
+ 50MG N202880 006 Oct 25, 2013
TABLET, EXTENDED RELEASE;ORAL
VANTRELA ER
+ TEVA BRANDED PHARM 15MG N207975 001 Jan 17, 2017
+ 30MG N207975 002 Jan 17, 2017
+ 45MG N207975 003 Jan 17, 2017
+ 60MG N207975 004 Jan 17, 2017
+ 90MG N207975 005 Jan 17, 2017
HYDROCODONE BITARTRATE; IBUPROFEN
TABLET;ORAL
HYDROCODONE BITARTRATE AND IBUPROFEN
ANI PHARMS 5MG;200MG A077454 001 Jun 23, 2010
SUN PHARM INDS INC 2.5MG;200MG A091633 001 May 28, 2013
5MG;200MG A091633 002 May 28, 2013
7.5MG;200MG A091633 003 May 28, 2013
10MG;200MG A091633 004 May 28, 2013
TEVA 7.5MG;200MG A076023 001 Apr 11, 2003
REPREXAIN
AMNEAL PHARMS NY 2.5MG;200MG A076642 003 Oct 19, 2007
10MG;200MG A076642 004 Oct 19, 2007
VICOPROFEN
+ ABBVIE 7.5MG;200MG ** N020716 001 Sep 23, 1997
HYDROCODONE BITARTRATE; PHENYLPROPANOLAMINE HYDROCHLORIDE
SYRUP;ORAL
CODAMINE
ALPHARMA US PHARMS 5MG/5ML;25MG/5ML A075103 001 Sep 29, 2000

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-243(of 478)
** See List Footnote
HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
SOLUTION;ORAL
HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
MAYNE PHARMA INC 5MG/5ML;60MG/5ML A205658 001 Nov 17, 2015
PADAGIS US 5MG/5ML;60MG/5ML A204658 001 Apr 29, 2014
TORRENT 5MG/5ML;60MG/5ML A206661 001 Jan 23, 2019
TRIS PHARMA INC 5MG/5ML;60MG/5ML A203839 001 Oct 28, 2014
REZIRA
+ PERSION 5MG/5ML;60MG/5ML ** N022442 001 Jun 08, 2011
HYDROCORTAMATE HYDROCHLORIDE
OINTMENT;TOPICAL
MAGNACORT
PFIZER 0.5% N010554 001
HYDROCORTISONE
AEROSOL;TOPICAL
AEROSEB-HC
ALLERGAN HERBERT 0.5% A085805 001
CREAM;TOPICAL
CORT-DOME
BAYER PHARMS 0.5% N009585 003
1% N009585 001
DERMACORT
MONARCH PHARMS 1% A083011 002
ELDECORT
VALEANT PHARM INTL 1% A080459 001
2.5% A084055 001
FLEXICORT
WESTWOOD SQUIBB 0.5% A087136 003 Apr 08, 1982
1% A087136 002 Apr 08, 1982
2.5% A087136 001 Apr 08, 1982
H-CORT
PHARM ASSOC 0.5% A086823 001
HC #1
BAYER PHARMS 0.5% A080438 001
HC #4
BAYER PHARMS 1% A080438 002
HC (HYDROCORTISONE)
C AND M PHARMA 0.5% A080482 003
1% A080482 004
HI-COR
C AND M PHARMA 2.5% A080483 001
HYDROCORTISONE
ALPHARMA US PHARMS 2.5% A089754 001 Feb 01, 1989
ALTANA 0.5% A080848 002
1% A080848 003
AMBIX 1% A086080 001
2.5% A086271 001
CHARTWELL MOLECULAR 2.5% A040503 001 Mar 12, 2004
ENCUBE 2.5% A203810 001 Jul 23, 2018
EVERYLIFE 0.5% A080452 001
1% A080452 002
G AND W LABS 1% A084059 001
INGRAM PHARM 0.5% A080456 002
1% A080456 003
IVAX PHARMS 1% A085733 001
NASKA 1% A089706 001 Mar 10, 1988
PERRIGO NEW YORK 0.5% A084970 002
1% A085026 001
PHARMADERM 1% A088845 001 Feb 27, 1986
2.5% A089413 001 Dec 16, 1986
PHARMAFAIR 1% A087838 001 Jul 28, 1982
STIEFEL 1% A086170 001
SYOSSET 0.5% A085527 001
TARO 0.5% A086154 001
TARO PHARM INDS LTD 1% A086155 001
TEVA 0.5% A080400 002
1% A080400 003
1% A085191 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-244(of 478)
** See List Footnote
HYDROCORTISONE
CREAM;TOPICAL
HYDROCORTISONE
2.5% A080400 004
TOPIDERM 1% A089273 001 Feb 17, 1989
USL PHARMA 1% A088027 001 Sep 27, 1983
2.5% A088029 001 Sep 27, 1983
WHITEWORTH TOWN PLSN 1% A080496 002
HYTONE
+ VALEANT INTL 1% ** A080472 003
+ 2.5% ** A080472 004
NOGENIC HC
IVAX PHARMS 1% A087427 001 Apr 04, 1988
NUTRACORT
BAUSCH 0.5% A080442 002
1% A080442 003
PENECORT
ALLERGAN HERBERT 1% A088216 001 Jun 06, 1984
PROCTOCORT
MONARCH PHARMS 1% A083011 001
SYNACORT
BAUSCH 0.5% A087459 001
+ 1% A087458 001
+ 2.5% A087457 001
ENEMA;RECTAL
HYDROCORTISONE
TEVA PHARMS 100MG/60ML A074171 001 May 27, 1994
GEL;TOPICAL
NUTRACORT
HEALTHPOINT 1% A084698 001
PENECORT
ALLERGAN HERBERT 1% A088215 001 Jun 06, 1984
INJECTABLE;INJECTION
CORTEF
PHARMACIA AND UPJOHN 50MG/ML N009864 001
LOTION;TOPICAL
ACTICORT
BAKER NORTON 1% A086535 001
ALA-CORT
CROWN LABS 1% A083201 001
BALNEOL-HC
SOLVAY 1% A088041 001 Dec 03, 1982
BETA-HC
BETA DERMAC 1% A089495 001 Jan 25, 1988
CETACORT
BAUSCH 0.5% A080426 002
1% A080426 001
CORT-DOME
BAYER PHARMS 0.5% N009895 003
1% N009895 001
DERMACORT
SOLVAY 0.5% A084573 002
1% A086462 001
EPICORT
BLULINE 0.5% A083219 002
GLYCORT
HERAN 1% A087489 001 Oct 03, 1983
H-CORT
PHARM ASSOC 0.5% A086824 001
HYDROCORTISONE
ALPHARMA US PHARMS 0.5% A087317 001 Jun 07, 1982
1% A087315 001 Jun 07, 1982
CHARTWELL MOLECULAR 2.5% A040417 001 Jul 30, 2003
FOUGERA PHARMS 2.5% A040351 001 Jul 25, 2000
MERICON 0.5% A085282 001
1% A085282 002 Feb 26, 1987
NASKA 1% A089705 001 Apr 25, 1988
PAI HOLDINGS PHARM 2.5% A203804 001 Jul 27, 2018
PERRIGO NEW YORK 0.5% A085662 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-245(of 478)
** See List Footnote
HYDROCORTISONE
LOTION;TOPICAL
HYDROCORTISONE
1% A085663 001
TARO 1% A089024 001 Feb 12, 1986
HYTONE
+ VALEANT INTL 1% ** A080473 003
+ 2.5% ** A080473 004 Nov 30, 1982
NUTRACORT
DOW PHARM 0.5% A080443 002
1% A080443 003
2.5% A087644 001 Aug 24, 1982
STIE-CORT
PADAGIS US 1% A089066 001 Nov 25, 1985
OINTMENT;TOPICAL
CORTRIL
PFIZER GLOBAL 1% N009176 001
2.5% N009176 002
HC (HYDROCORTISONE)
C AND M PHARMA 0.5% A080481 001
1% A080481 002
HYDROCORTISONE
ACTAVIS MID ATLANTIC 1% A087796 001 Oct 13, 1982
ALTANA 0.5% A080489 002
1% A080489 003
AMBIX 1% A086079 001
2.5% A086272 001
NASKA 1% A089704 001 Mar 10, 1988
PERRIGO NEW YORK 0.5% A084969 003
1% A085028 001
PHARMADERM 1% A088842 001 Feb 09, 1987
TARO 0.5% A086256 001
2.5% A040310 001 Dec 29, 2000
USL PHARMA 1% A088061 001 Sep 27, 1983
2.5% A088039 001 Sep 27, 1983
HYTONE
+ DERMIK LABS 1% ** A080474 003
+ 2.5% ** A080474 004
PENECORT
ALLERGAN HERBERT 2.5% A088217 001 Jun 06, 1984
POWDER;FOR RX COMPOUNDING
H-CORT
TORCH 100% A087834 001 Mar 29, 1982
HYDRO-RX
X GEN PHARMS 100% A085982 001
HYDROCORTISONE
PADDOCK LLC 100% A088082 001 Apr 08, 1983
SOLUTION;TOPICAL
PENECORT
+ ALLERGAN HERBERT 1% A088214 001 Jun 06, 1984
TEXACORT
MISSION PHARMA 1% A080425 001
TABLET;ORAL
CORTRIL
PFIZER 10MG N009127 005
20MG N009127 003
HYDROCORTISONE
BARR 20MG A083999 001
CHARTWELL MOLECULAR 20MG A085070 001
ELKINS SINN 20MG A080624 001
FERRANTE 10MG A080568 001
20MG A080568 002
HIKMA INTL PHARMS 5MG A083365 002 Feb 23, 2015
10MG A083365 003 Feb 23, 2015
20MG A083365 001
IMPAX LABS 20MG A080781 001
INWOOD LABS 20MG A080732 001
NEXGEN PHARMA INC 20MG A083140 001
PANRAY 10MG N009659 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-246(of 478)
** See List Footnote
HYDROCORTISONE
TABLET;ORAL
HYDROCORTISONE
20MG N009659 002
PARKE DAVIS 20MG A084243 001
PUREPAC PHARM 10MG A084247 003 Aug 31, 1982
20MG A080395 001
20MG A084247 002
ROXANE 10MG A088539 001 Mar 21, 1984
SANDOZ 20MG A080642 002
STRIDES PHARMA 5MG A040761 001 Jul 16, 2007
10MG A040761 002 Jul 16, 2007
20MG A040761 003 Jul 16, 2007
WATSON LABS 20MG A080355 001
WHITEWORTH TOWN PLSN 10MG A080344 001
20MG A080344 002
HYDROCORTONE
MERCK 10MG N008506 007
20MG N008506 011
TABLET;VAGINAL
CORTRIL
PFIPHARMECS 10MG N009796 001
HYDROCORTISONE ACETATE
CREAM;TOPICAL
CARMOL HC
+ FOUGERA PHARMS 1% A080505 001
HEMSOL-HC
ABLE 1% A081274 001 Jun 19, 1992
HYDROCORTISONE ACETATE
CENCI 1% A080419 001 Jan 25, 1982
IMPERIUM 2.5% A040259 001 Jul 29, 1999
PARKE DAVIS 1% A089914 001 Jan 03, 1989
PUREPAC PHARM 0.5% A086050 001
+ 1% A086052 001
MICORT-HC
SEBELA IRELAND LTD 2% A040398 001 Mar 29, 2002
U-CORT
TARO 1% A089472 001 Jun 13, 1988
INJECTABLE;INJECTION
CORTEF ACETATE
PHARMACIA AND UPJOHN 50MG/ML N009378 002
CORTRIL
PFIZER 25MG/ML N009164 001
HYDROCORTISONE ACETATE
AKORN 25MG/ML N009637 001
50MG/ML N009637 002
BEL MAR 25MG/ML A083739 001
50MG/ML A083739 002
WATSON LABS 25MG/ML A083128 001
25MG/ML A083759 001
50MG/ML A083759 002
50MG/ML A085214 001
HYDROCORTONE
MERCK 25MG/ML N008228 001
50MG/ML N008228 004
LOTION;TOPICAL
DRICORT
INGRAM PHARM 0.5% A086207 001
OINTMENT;OPHTHALMIC
HYDROCORTISONE ACETATE
FERA PHARMS 0.5% A080828 001
OINTMENT;OPHTHALMIC, OTIC
HYDROCORTONE
MERCK 1.5% N009018 003
OINTMENT;TOPICAL
CORTEF ACETATE
PHARMACIA AND UPJOHN 1% N008917 002
+ 2.5% ** N008917 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-247(of 478)
** See List Footnote
HYDROCORTISONE ACETATE
PASTE;TOPICAL
ORABASE HCA
COLGATE 0.5% A083205 001
POWDER;FOR RX COMPOUNDING
HYDROCORTISONE ACETATE
X GEN PHARMS 100% A085981 001
HYDROCORTISONE ACETATE; NEOMYCIN SULFATE
CREAM;TOPICAL
NEO-CORTEF
PHARMACIA AND UPJOHN 1%;EQ 3.5MG BASE/GM A061049 001
2.5%;EQ 3.5MG BASE/GM A061049 002
OINTMENT;OPHTHALMIC
NEO-CORTEF
PHARMACIA AND UPJOHN 0.5%;EQ 3.5MG BASE/GM A060610 001
1.5%;EQ 3.5MG BASE/GM A060610 002
OINTMENT;TOPICAL
NEO-CORTEF
PHARMACIA AND UPJOHN 0.5%;EQ 3.5MG BASE/GM A060751 001
1%;EQ 3.5MG BASE/GM A060751 002
2.5%;EQ 3.5MG BASE/GM A060751 003
SUSPENSION/DROPS;OPHTHALMIC
COR-OTICIN
AKORN 1.5%;EQ 3.5MG BASE/ML A060188 001
NEO-CORTEF
PHARMACIA AND UPJOHN 0.5%;EQ 3.5MG BASE/ML A060612 002
1.5%;EQ 3.5MG BASE/ML A060612 001
HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
CREAM;TOPICAL
CORTISPORIN
+ MONARCH PHARMS 0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM N050218 001 Aug 09, 1985
HYDROCORTISONE ACETATE; OXYTETRACYCLINE HYDROCHLORIDE
SUSPENSION;OPHTHALMIC
TERRA-CORTRIL
PFIZER 1.5%;EQ 5MG BASE/ML A061016 001
HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE
AEROSOL, METERED;TOPICAL
HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROCHLORIDE 1%
GENUS 1%;1% A089440 001 May 17, 1988
LOTION;TOPICAL
PRAMOSONE
FERNDALE LABS 0.5%;1% A083213 002
HYDROCORTISONE BUTYRATE
CREAM;TOPICAL
LOCOID
YAMANOUCHI 0.1% N018795 001 Jan 07, 1983
OINTMENT;TOPICAL
LOCOID
YAMANOUCHI 0.1% N019106 001 Jul 03, 1984
SOLUTION;TOPICAL
LOCOID
YAMANOUCHI 0.1% N019819 001 Sep 15, 1988
HYDROCORTISONE CYPIONATE
SUSPENSION;ORAL
CORTEF
PHARMACIA AND UPJOHN EQ 10MG BASE/5ML N009900 001
HYDROCORTISONE SODIUM PHOSPHATE
INJECTABLE;INJECTION
HYDROCORTONE
+ MERCK EQ 50MG BASE/ML N012052 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-248(of 478)
** See List Footnote
HYDROCORTISONE SODIUM SUCCINATE
INJECTABLE;INJECTION
A-HYDROCORT
ABBOTT EQ 100MG BASE/VIAL A085928 001
EQ 100MG BASE/VIAL A089577 001 Apr 11, 1989
EQ 250MG BASE/VIAL A089578 001 Apr 11, 1989
EQ 500MG BASE/VIAL A089579 001 Apr 11, 1989
EQ 1GM BASE/VIAL A089580 001 Apr 11, 1989
HOSPIRA EQ 100MG BASE/VIAL A040666 001 Apr 06, 2006
EQ 100MG BASE/VIAL A085929 001
EQ 250MG BASE/VIAL A085930 001
EQ 500MG BASE/VIAL A085931 001
EQ 1GM BASE/VIAL A085932 001
HYDROCORTISONE SODIUM SUCCINATE
ABRAXIS PHARM EQ 100MG BASE/VIAL A088667 001 Jun 08, 1984
EQ 100MG BASE/VIAL A088712 001 Jun 08, 1984
EQ 250MG BASE/VIAL A088668 001 Jun 08, 1984
EQ 500MG BASE/VIAL A088669 001 Jun 08, 1984
EQ 1GM BASE/VIAL A088670 001 Jun 08, 1984
BAXTER HLTHCARE EQ 100MG BASE/VIAL A086619 001
EQ 250MG BASE/VIAL A087567 001
EQ 500MG BASE/VIAL A087568 001
EQ 1GM BASE/VIAL A087569 001
INTL MEDICATION EQ 100MG BASE/VIAL A087532 001 Mar 19, 1982
WATSON LABS EQ 100MG BASE/VIAL A084737 002
EQ 100MG BASE/VIAL A084738 001
EQ 250MG BASE/VIAL A084737 001
EQ 500MG BASE/VIAL A084747 001
EQ 1GM BASE/VIAL A084748 001
HYDROCORTISONE VALERATE
CREAM;TOPICAL
HYDROCORTISONE VALERATE
COSETTE 0.2% A074489 001 Aug 12, 1998
WESTCORT
+ SUN PHARM INDS INC 0.2% ** N017950 001
OINTMENT;TOPICAL
HYDROCORTISONE VALERATE
FOUGERA PHARMS 0.2% A075085 001 Jul 31, 2001
WESTCORT
+ SUN PHARM INDS INC 0.2% ** N018726 001 Aug 08, 1983
HYDROCORTISONE; NEOMYCIN SULFATE
CREAM;TOPICAL
NEO-CORT-DOME
BAYER PHARMS 0.5%;EQ 3.5MG BASE/GM N050237 006 Jun 05, 1984
1%;EQ 3.5MG BASE/GM N050237 005 Jun 05, 1984
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
SOLUTION/DROPS;OTIC
CORTISPORIN
+ MONARCH PHARMS 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML ** N050479 001
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
AMRING PHARMS 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A065216 001 Oct 31, 2005
NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE
PHARMAFAIR 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A062394 001 Sep 29, 1982
OTOCORT
WATSON LABS 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A060730 002
SUSPENSION/DROPS;OPHTHALMIC
CORTISPORIN
MONARCH PHARMS 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML N050169 001
NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE
PHARMAFAIR 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A062623 001 Sep 24, 1985
SUSPENSION/DROPS;OTIC
NEOMYCIN SULFATE, POLYMYXIN B SULFATE & HYDROCORTISONE
PHARMAFAIR 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A062617 001 Sep 18, 1985
OTICAIR
PHARMAFAIR 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A062399 001 Nov 18, 1982
OTOBIONE
SCHERING 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A061816 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-249(of 478)
** See List Footnote
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
SUSPENSION/DROPS;OTIC
OTOCORT
ACTAVIS LABS FL INC 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A062521 001 Jul 11, 1985
PEDIOTIC
MONARCH PHARMS 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML A062822 001 Sep 29, 1987
HYDROCORTISONE; POLYMYXIN B SULFATE
SOLUTION/DROPS;OTIC
OTOBIOTIC
SCHERING 5MG/ML;EQ 10,000 UNITS BASE/ML A062302 001
PYOCIDIN
FOREST LABS 5MG/ML;EQ 10,000 UNITS BASE/ML A061606 001
HYDROCORTISONE; TETRACYCLINE HYDROCHLORIDE
OINTMENT;OPHTHALMIC
ACHROMYCIN
LEDERLE 1.5%;1% N050272 001
HYDROCORTISONE; UREA
CREAM;TOPICAL
ALPHADERM
BIOGLAN 1%;10% A086008 001
CALMURID HC
PHARMACIA AND UPJOHN 1%;10% A083947 001
HYDROFLUMETHIAZIDE
TABLET;ORAL
DIUCARDIN
WYETH AYERST 50MG A083383 001
HYDROFLUMETHIAZIDE
PAR PHARM 50MG A088850 001 May 31, 1985
WATSON LABS 50MG A088031 001 Apr 06, 1983
50MG A088528 001 Aug 15, 1984
SALURON
+ SHIRE LLC 50MG N011949 001
HYDROFLUMETHIAZIDE; RESERPINE
TABLET;ORAL
HYDROFLUMETHIAZIDE AND RESERPINE
USL PHARMA 50MG;0.125MG A088195 001 Oct 26, 1983
WATSON LABS 25MG;0.125MG A088127 001 Mar 22, 1983
50MG;0.125MG A088110 001 Mar 22, 1983
RESERPINE AND HYDROFLUMETHIAZIDE
IVAX PHARMS 50MG;0.125MG A088932 001 Jan 11, 1985
PAR PHARM 50MG;0.125MG A088907 001 Sep 20, 1985
SALUTENSIN
SHIRE 50MG;0.125MG N012359 003
SALUTENSIN-DEMI
SHIRE 25MG;0.125MG N012359 004
HYDROGEN PEROXIDE
SOLUTION;TOPICAL
ESKATA
+ ACLARIS 40% N209305 001 Dec 14, 2017
HYDROMORPHONE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
PALLADONE
PURDUE PHARMA LP 12MG N021044 001 Sep 24, 2004
16MG N021044 002 Sep 24, 2004
24MG N021044 003 Sep 24, 2004
32MG N021044 004 Sep 24, 2004
INJECTABLE;INJECTION
DILAUDID
+ FRESENIUS KABI USA 4MG/ML N019034 005 Apr 30, 2009
DILAUDID-HP
+ FRESENIUS KABI USA 10MG/ML N019034 001 Jan 11, 1984
250MG/VIAL N019034 002 Aug 04, 1994
HYDROMORPHONE HYDROCHLORIDE
BARR 10MG/ML A076444 001 Apr 25, 2003
HOSPIRA 10MG/ML A074598 001 Jun 19, 1997
WATSON LABS 10MG/ML A074317 001 Aug 23, 1995

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-250(of 478)
** See List Footnote
HYDROMORPHONE HYDROCHLORIDE
SOLUTION;ORAL
HYDROMORPHONE HYDROCHLORIDE
ANDA REPOSITORY 5MG/5ML A207108 001 Apr 22, 2020
TABLET;ORAL
HYDROMORPHONE HYDROCHLORIDE
ANDA REPOSITORY 2MG A077471 002 Dec 09, 2009
4MG A077471 003 Dec 09, 2009
8MG A077471 001 Dec 09, 2009
HIKMA 4MG A074597 003 May 29, 2009
8MG A074597 001 Jul 29, 1998
NESHER PHARMS 2MG A077311 001 Nov 09, 2005
4MG A077311 002 Nov 09, 2005
8MG A077311 003 Nov 09, 2005
NOSTRUM LABS INC 8MG A076723 001 Oct 18, 2005
TABLET, EXTENDED RELEASE;ORAL
EXALGO
+ SPECGX LLC 8MG ** N021217 001 Mar 01, 2010
+ 12MG ** N021217 002 Mar 01, 2010
+ 16MG ** N021217 003 Mar 01, 2010
+ 32MG ** N021217 004 Aug 24, 2012
HYDROMORPHONE HYDROCHLORIDE
ACTAVIS LABS FL INC 8MG A202144 001 May 12, 2014
12MG A202144 002 May 12, 2014
16MG A202144 003 May 12, 2014
32MG A202144 004 Jun 30, 2016
HYDROXOCOBALAMIN
INJECTABLE;INJECTION
ALPHAREDISOL
MERCK 1MG/ML A080778 001
CYANOKIT
BTG INTL 2.5GM/VIAL (5GM/KIT) N022041 002 Dec 15, 2006
HYDROXOCOBALAMIN
ABRAXIS PHARM 1MG/ML A084921 001
WATSON LABS 1MG/ML A085528 001
HYDROXOMIN
BEL MAR 1MG/ML A084629 001
HYDROXYAMPHETAMINE HYDROBROMIDE
SOLUTION/DROPS;OPHTHALMIC
PAREDRINE
PHARMICS 1% N000004 004
HYDROXYCHLOROQUINE SULFATE
TABLET;ORAL
HYDROXYCHLOROQUINE SULFATE
HIKMA PHARMS 200MG A040760 001 Aug 15, 2007
INVATECH 200MG A040150 001 Jan 27, 1996
WATSON LABS 200MG A040133 001 Nov 30, 1995
HYDROXYPROGESTERONE CAPROATE
INJECTABLE;INJECTION
HYDROXYPROGESTERONE CAPROATE
AKORN 125MG/ML N018004 001
ALLERGAN 125MG/ML N017439 001
250MG/ML N017439 002
SOLUTION;INTRAMUSCULAR
DELALUTIN
+ BRISTOL MYERS SQUIBB 125MG/ML (125MG/ML) ** N010347 004
+ 125MG/ML (125MG/ML) ** N016911 001
+ 250MG/ML (250MG/ML) ** N010347 002
+ 250MG/ML (250MG/ML) ** N016911 002
HYDROXYPROGESTERONE CAPROATE
AM REGENT 1250MG/5ML (250MG/ML) A210724 001 Aug 09, 2019
EUGIA PHARMA 1250MG/5ML (250MG/ML) A211142 001 May 09, 2019

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-251(of 478)
** See List Footnote
HYDROXYSTILBAMIDINE ISETHIONATE
INJECTABLE;INJECTION
HYDROXYSTILBAMIDINE ISETHIONATE
SANOFI AVENTIS US 225MG/AMP N009166 001
HYDROXYUREA
CAPSULE;ORAL
HYDROXYUREA
BARR 250MG A075143 002 Sep 21, 2000
BARR LABS INC 250MG A075020 002 Jun 26, 2000
500MG A075020 001 Jul 30, 1998
ROXANE 500MG A074476 001 Aug 18, 1995
TABLET;ORAL
HYDROXYUREA
BARR 1GM A075734 001 Aug 29, 2000
HYDROXYZINE HYDROCHLORIDE
INJECTABLE;INJECTION
HYDROXYZINE
BAXTER HLTHCARE 50MG/ML A085551 002
HYDROXYZINE HYDROCHLORIDE
ALTANA 25MG/ML A087273 001 Apr 20, 1982
50MG/ML A087273 002 Apr 20, 1982
BAXTER HLTHCARE 25MG/ML A085551 001
DR REDDYS 50MG/ML A085779 001
FRESENIUS KABI USA 25MG/ML A087329 001
25MG/ML A088184 001 Mar 31, 1983
50MG/ML A087329 002
50MG/ML A088185 001 Mar 31, 1983
HOSPIRA 25MG/ML A087416 001
50MG/ML A086821 001
50MG/ML A087546 001
PHARMAFAIR 25MG/ML A088862 001 Feb 14, 1986
25MG/ML A089106 001 Feb 14, 1986
50MG/ML A088881 001 Feb 14, 1986
50MG/ML A089107 001 Feb 14, 1986
SMITH AND NEPHEW 25MG/ML A087592 001
SOLOPAK 25MG/ML A086822 001
25MG/ML A087591 001
50MG/ML A087310 001
50MG/ML A087593 001
50MG/ML A087595 001
50MG/ML A087596 001
WATSON LABS 25MG/ML A085778 001
25MG/ML A087274 001
50MG/ML A087274 002
WYETH AYERST 25MG/ML A086258 001
50MG/ML A086258 002
ORGATRAX
ORGANON USA INC 25MG/ML A087014 001
50MG/ML A087014 002
VISTARIL
+ PFIZER 25MG/ML ** N011111 001
+ 50MG/ML ** N011111 002
SYRUP;ORAL
ATARAX
ROERIG 10MG/5ML ** N010485 001
HYDROXYZINE HYDROCHLORIDE
AKORN 10MG/5ML A040010 001 Oct 28, 1994
ALPHARMA US PHARMS 10MG/5ML A088785 001 Feb 03, 1988
ANIMA 10MG/5ML A086880 001
KV PHARM 10MG/5ML A087730 001 Jul 01, 1982
PAI HOLDINGS PHARM 10MG/5ML A040391 001 Apr 10, 2002
TORRENT 10MG/5ML A210634 001 Feb 26, 2019
TABLET;ORAL
ATARAX
+ PFIZER 10MG ** N010392 001
+ 25MG ** N010392 004
+ 50MG ** N010392 006
+ 100MG ** N010392 005

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-252(of 478)
** See List Footnote
HYDROXYZINE HYDROCHLORIDE
TABLET;ORAL
HYDROXYZINE HYDROCHLORIDE
ABLE 10MG A040559 001 Jul 22, 2004
25MG A040562 001 Jul 22, 2004
50MG A040563 001 Jul 22, 2004
ACTAVIS ELIZABETH 10MG A089071 001 Jul 22, 1986
25MG A089072 001 Jul 22, 1986
50MG A089073 001 Jul 22, 1986
HALSEY 10MG A089366 001 May 02, 1988
25MG A089117 001 May 02, 1988
50MG A089396 001 May 02, 1988
IVAX PHARMS 10MG A087216 001
25MG A087410 001
50MG A087411 001
KV PHARM 10MG A087819 001 Jun 23, 1982
25MG A087820 001 Jun 23, 1982
50MG A087821 001 Jun 23, 1982
100MG A087822 001 Jun 23, 1982
MUTUAL PHARM 10MG A088409 001 Nov 15, 1983
25MG A087857 001 Apr 18, 1983
50MG A087860 001 Apr 18, 1983
PLIVA 100MG A081054 001 Sep 25, 1995
PUREPAC PHARM 10MG A088120 001 Sep 25, 1984
25MG A088121 001 Sep 25, 1984
50MG A088122 001 Sep 25, 1984
QUANTUM PHARMICS 10MG A088540 001 Oct 22, 1985
25MG A088551 001 Oct 22, 1985
50MG A088529 001 Oct 22, 1985
RISING 10MG A091176 001 Jun 07, 2010
25MG A091176 002 Jun 07, 2010
50MG A091176 003 Jun 07, 2010
SANDOZ 10MG A087246 002
25MG A085247 001
50MG A087245 001
STRIDES PHARMA 10MG A087602 001 Jan 22, 1982
25MG A087603 001 Jan 22, 1982
50MG A087604 001 Jan 22, 1982
SUN PHARM INDS INC 10MG A040899 001 Jun 10, 2008
25MG A040899 002 Jun 10, 2008
50MG A040899 003 Jun 10, 2008
SUN PHARM INDUSTRIES 10MG A089381 001 May 19, 1986
25MG A089382 001 May 19, 1986
50MG A089383 001 May 19, 1986
100MG A087862 001 Apr 18, 1983
SUPERPHARM 10MG A088794 001 Dec 05, 1984
25MG A088795 001 Dec 05, 1984
50MG A088796 001 Dec 05, 1984
USL PHARMA 10MG A089121 001 Mar 20, 1986
25MG A089122 001 Mar 20, 1986
50MG A089123 001 Mar 20, 1986
WATSON LABS 10MG A081149 001 Mar 18, 1994
10MG A086827 001
10MG A088348 001 Sep 15, 1983
25MG A081150 001 Mar 18, 1994
25MG A086829 001
25MG A088349 001 Sep 15, 1983
50MG A081151 001 Mar 18, 1994
50MG A086836 001
50MG A088350 001 Sep 15, 1983
HYDROXYZINE PAMOATE
CAPSULE;ORAL
HY-PAM "25"
TEVA EQ 25MG HYDROCHLORIDE A088713 001 Mar 04, 1985
HYDROXYZINE PAMOATE
BEXIMCO PHARMS USA EQ 25MG HYDROCHLORIDE A081127 001 Jun 28, 1991
DURAMED PHARMS BARR EQ 25MG HYDROCHLORIDE A088593 001 Feb 29, 1984
EQ 50MG HYDROCHLORIDE A088594 001 Feb 29, 1984
EQ 100MG HYDROCHLORIDE A088595 001 Feb 29, 1984

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-253(of 478)
** See List Footnote
HYDROXYZINE PAMOATE
CAPSULE;ORAL
HYDROXYZINE PAMOATE
IVAX SUB TEVA PHARMS EQ 25MG HYDROCHLORIDE A087761 001 Mar 05, 1982
EQ 50MG HYDROCHLORIDE A087760 001 Mar 05, 1982
PAR PHARM EQ 25MG HYDROCHLORIDE A087656 001 Jun 11, 1982
EQ 25MG HYDROCHLORIDE A089145 001 Mar 17, 1986
EQ 50MG HYDROCHLORIDE A087657 001 Jun 11, 1982
EQ 50MG HYDROCHLORIDE A089146 001 Mar 17, 1986
EQ 100MG HYDROCHLORIDE A087658 001 Jun 11, 1982
SANDOZ EQ 50MG HYDROCHLORIDE A081128 001 Jun 28, 1991
EQ 100MG HYDROCHLORIDE A081129 001 Jun 28, 1991
SUPERPHARM EQ 25MG HYDROCHLORIDE A089031 001 Jan 02, 1987
EQ 50MG HYDROCHLORIDE A089032 001 Jan 02, 1987
EQ 100MG HYDROCHLORIDE A089033 001 Jan 02, 1987
VANGARD EQ 25MG HYDROCHLORIDE A088392 001 Sep 19, 1983
EQ 50MG HYDROCHLORIDE A088393 001 Sep 19, 1983
WATSON LABS EQ 25MG HYDROCHLORIDE A081165 001 Jul 31, 1991
EQ 25MG HYDROCHLORIDE A086698 001
EQ 25MG HYDROCHLORIDE A086840 001 Jul 01, 1982
EQ 50MG HYDROCHLORIDE A086695 001
EQ 50MG HYDROCHLORIDE A086705 001 Jul 01, 1982
EQ 50MG HYDROCHLORIDE A087767 001 Aug 16, 1982
EQ 100MG HYDROCHLORIDE A086697 001
EQ 100MG HYDROCHLORIDE A086728 001 Oct 05, 1982
EQ 100MG HYDROCHLORIDE A087790 001 Aug 16, 1982
VISTARIL
PFIZER EQ 100MG HYDROCHLORIDE ** N011459 006
SUSPENSION;ORAL
VISTARIL
PFIZER EQ 25MG HYDROCHLORIDE/5ML N011795 001
IBANDRONATE SODIUM
INJECTABLE;INTRAVENOUS
BONIVA
+ ROCHE EQ 3MG BASE/3ML ** N021858 001 Jan 06, 2006
IBANDRONATE SODIUM
EMCURE PHARMS LTD EQ 3MG BASE/3ML A203987 001 Sep 02, 2014
NANG KUANG PHARM CO EQ 3MG BASE/3ML A204329 001 Jun 16, 2021
TABLET;ORAL
BONIVA
+ HOFFMANN LA ROCHE EQ 2.5MG BASE ** N021455 001 May 16, 2003
+ EQ 150MG BASE ** N021455 002 Mar 24, 2005
IBANDRONATE SODIUM
MYLAN PHARMS INC EQ 150MG BASE A078995 001 Mar 19, 2012
SUN PHARM INDUSTRIES EQ 150MG BASE A078996 001 Aug 15, 2012
IBRUTINIB
CAPSULE;ORAL
IBRUTINIB
ZYDUS 70MG A211344 001 Mar 31, 2021
140MG A211344 002 Mar 31, 2021
IBUPROFEN
CAPSULE;ORAL
IBUPROFEN
CONTRACT PHARMACAL 200MG A074782 001 Jul 06, 1998
MIDOL
BAYER 200MG ** A070626 001 Sep 02, 1987
200MG ** A071002 001 Sep 02, 1987
SOLUTION;INTRAVENOUS
CALDOLOR
CUMBERLAND PHARMS 400MG/4ML (100MG/ML) N022348 001 Jun 11, 2009
SUSPENSION;ORAL
CHILDREN'S ADVIL
GLAXOSMITHKLINE 100MG/5ML N019833 002 Sep 19, 1989
CHILDREN'S ELIXSURE
MOBERG PHARMA NORTH 100MG/5ML N021604 001 Jan 07, 2004
IBU
ABBOTT 100MG/5ML N019784 001 Dec 18, 1989

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-254(of 478)
** See List Footnote
IBUPROFEN
SUSPENSION;ORAL
IBUPROFEN
AKORN 100MG/5ML A205647 001 Nov 03, 2016
STRIDES PHARMA 100MG/5ML A211666 001 Feb 22, 2021
100MG/5ML A215311 001 May 27, 2022
MOTRIN
+ MCNEIL CONSUMER 100MG/5ML ** N019842 001 Sep 19, 1989
SUSPENSION/DROPS;ORAL
IBUPROFEN
STRIDES PHARMA 50MG/1.25ML A214071 001 Jun 09, 2022
MOTRIN
MCNEIL 40MG/ML N020476 001 May 25, 1995
PEDIATRIC ADVIL
+ GLAXOSMITHKLINE 100MG/2.5ML N020812 001 Jan 30, 1998
TABLET;ORAL
ACHES-N-PAIN
LEDERLE 200MG A071065 001 May 28, 1987
CAP-PROFEN
PERRIGO 200MG A072097 001 Dec 08, 1987
IBU
BASF 400MG A070083 001 Feb 22, 1985
400MG N018197 001
600MG A070088 001 Feb 08, 1985
600MG A070099 001 Mar 29, 1985
800MG A070745 001 Jul 23, 1986
IBU-TAB
ALRA 400MG A071058 001 Aug 11, 1988
600MG A071059 001 Aug 11, 1988
800MG A071965 001 Aug 11, 1988
IBU-TAB 200
ALRA 200MG A071057 001 Aug 11, 1988
IBUPRIN
PLIVA 200MG A071773 001 Jul 16, 1987
IBUPROFEN
ABBOTT 600MG A070556 001 Jun 14, 1985
800MG A071264 001 Jul 25, 1986
ANI PHARMS 200MG A071144 001 Jan 20, 1987
200MG A072901 001 Dec 19, 1991
200MG A072903 001 Dec 19, 1991
CONTRACT PHARMACAL 200MG A071265 001 Oct 15, 1986
200MG A071265 002 Sep 10, 1987
200MG A071735 001 Sep 10, 1987
200MG A073691 001 Feb 25, 1994
200MG A074931 001 Jul 20, 1998
HALSEY 200MG A071027 001 Sep 29, 1987
300MG A071028 001 Mar 23, 1987
400MG A071029 001 Mar 23, 1987
600MG A071030 001 Mar 23, 1987
800MG A072137 001 Feb 05, 1988
IVAX SUB TEVA PHARMS 200MG A071154 001 Oct 27, 1987
200MG A072040 001 Apr 29, 1988
400MG A071145 001 Sep 23, 1986
600MG A071146 001 Sep 23, 1986
800MG A071769 001 May 08, 1987
J AND J CONSUMER INC 400MG A070081 001 Jun 16, 1986
L PERRIGO CO 400MG A077114 001 Jul 18, 2005
600MG A077114 002 Jul 18, 2005
800MG A077114 003 Jul 18, 2005
LEDERLE 400MG A070629 001 Sep 19, 1986
600MG A070630 001 Sep 19, 1986
LEINER 300MG A071266 001 Oct 15, 1986
LNK 100MG A076741 001 Jun 17, 2004
MCNEIL 600MG A070476 001 Jun 16, 1986
MERRO PHARM 200MG A070985 001 Oct 02, 1987
MYLAN 200MG A071870 001 May 05, 1988
400MG A070045 001 Sep 24, 1985
600MG A070057 001 Sep 24, 1985
800MG A071999 001 Dec 03, 1987

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-255(of 478)
** See List Footnote
IBUPROFEN
TABLET;ORAL
IBUPROFEN
NORTHSTAR HLTHCARE 400MG A078132 001 Sep 10, 2007
600MG A078132 002 Sep 10, 2007
800MG A078132 003 Sep 10, 2007
OHM LABS 400MG A070818 001 Dec 26, 1985
P AND L DEV LLC 200MG A070733 001 Sep 19, 1986
PAR PHARM 300MG A070328 001 Aug 06, 1985
PERRIGO 200MG A072098 001 Dec 08, 1987
200MG A075995 001 Mar 14, 2002
PLIVA 400MG A071666 001 Jun 18, 1987
600MG A071667 001 Jun 18, 1987
800MG A071668 001 Jun 18, 1987
PUREPAC PHARM 200MG A071122 001 Oct 03, 1986
200MG A071664 001 Feb 03, 1987
300MG A071123 001 Sep 19, 1986
400MG A071124 001 Sep 19, 1986
600MG A071125 001 Sep 19, 1986
800MG A071964 001 Feb 01, 1988
RISING 300MG A070736 002 Jun 12, 1986
400MG A070736 003 Jun 12, 1986
600MG A070736 001 Jun 12, 1986
800MG A071938 001 Jan 14, 1988
SANDOZ 200MG A071807 001 Feb 25, 1988
200MG A074525 001 Dec 15, 1995
200MG A074533 001 Dec 15, 1995
400MG A072064 001 Jan 14, 1988
600MG A072065 001 Jan 14, 1988
800MG A072169 001 Dec 11, 1987
STRIDES PHARMA 200MG A071575 001 May 08, 1987
400MG A070329 001 Aug 06, 1985
600MG A070330 001 Aug 06, 1985
800MG A070986 001 Jul 25, 1986
SUN PHARM INDUSTRIES 200MG A070493 001 Dec 24, 1985
200MG A070908 001 Sep 26, 1986
200MG A071462 001 Oct 02, 1986
400MG A070079 001 Jul 24, 1985
600MG A070080 001 Jul 24, 1985
800MG A071448 001 Feb 18, 1987
SUNSHINE 400MG A204062 001 Sep 10, 2018
600MG A204062 002 Sep 10, 2018
800MG A204062 003 Sep 10, 2018
SUPERPHARM 600MG A070709 001 Apr 25, 1986
TEVA 200MG A073141 001 May 29, 1992
400MG A073343 001 Jun 30, 1992
600MG A073344 001 Jun 30, 1992
800MG A073345 001 Jun 30, 1992
ULTRATAB LABS INC 200MG A209076 001 Jan 06, 2020
VINTAGE PHARMS 200MG A071639 001 Feb 02, 1988
200MG A072249 001 Jan 10, 1989
300MG A071230 001 Oct 22, 1986
400MG A071231 001 Oct 22, 1986
400MG A071644 001 Feb 01, 1988
600MG A071232 001 Oct 22, 1986
800MG A072004 001 Nov 18, 1987
WATSON LABS 200MG A070435 001 Mar 05, 1986
200MG A071765 001 Sep 04, 1987
200MG A071905 001 Mar 08, 1988
300MG A071338 001 Dec 01, 1986
400MG A070038 001 Sep 06, 1985
400MG A070436 001 Aug 21, 1985
600MG A070041 001 Sep 06, 1985
600MG A070437 001 Aug 21, 1985
800MG A071547 001 Jul 02, 1987
800MG A071911 001 Oct 13, 1987
YICHANG HUMANWELL 200MG A214003 001 Oct 19, 2020
IBUPROHM
OHM LABS 200MG A071214 001 Dec 01, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-256(of 478)
** See List Footnote
IBUPROFEN
TABLET;ORAL
IBUPROHM
400MG A070469 001 Aug 29, 1985
JUNIOR STRENGTH IBUPROFEN
L PERRIGO CO 100MG A075367 001 Apr 22, 1999
MEDIPREN
MCNEIL 200MG A070475 001 Feb 06, 1986
200MG A071215 001 Jun 26, 1986
MIDOL
BAYER 200MG A070591 001 Sep 02, 1987
200MG A071001 001 Sep 02, 1987
MOTRIN
+ MCNEIL CONSUMER 300MG ** N017463 003
+ 400MG ** N017463 002
+ 600MG ** N017463 004
+ 800MG ** N017463 005 May 22, 1985
MCNEIL PED 100MG N020418 001 Nov 16, 1994
MOTRIN MIGRAINE PAIN
J AND J CONSUMER INC 200MG N019012 004 Feb 25, 2000
NUPRIN
BRISTOL MYERS 200MG A072035 001 Feb 16, 1988
200MG A072036 001 Feb 16, 1988
J AND J CONSUMER INC 200MG N019012 001 May 18, 1984
200MG N019012 002 Jul 29, 1987
RUFEN
BASF 600MG N018197 002 Mar 05, 1984
TAB-PROFEN
PERRIGO 200MG A072095 001 Dec 08, 1987
TABLET, CHEWABLE;ORAL
CHILDREN'S MOTRIN
+ J AND J CONSUMER INC 50MG N020601 001 Nov 15, 1996
IBUPROFEN
PERRIGO 50MG A076359 001 Jan 16, 2004
JUNIOR STRENGTH MOTRIN
+ J AND J CONSUMER INC 100MG N020601 003 Nov 15, 1996
MOTRIN
MCNEIL PED 50MG N020135 001 Nov 16, 1994
100MG N020135 002 Nov 16, 1994
IBUPROFEN SODIUM
TABLET;ORAL
IBUPROFEN SODIUM
PERRIGO R AND D EQ 200MG BASE A206581 001 Aug 03, 2015
IBUPROFEN; OXYCODONE HYDROCHLORIDE
TABLET;ORAL
COMBUNOX
+ FOREST LABS 400MG;5MG ** N021378 001 Nov 26, 2004
OXYCODONE HYDROCHLORIDE AND IBUPROFEN
ACTAVIS ELIZABETH 400MG;5MG A078769 001 Jan 04, 2008
BARR LABS INC 400MG;5MG A078316 001 Nov 29, 2007
WATSON LABS 400MG;5MG A078394 001 Nov 26, 2007
IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
SUSPENSION;ORAL
IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE
PERRIGO 100MG/5ML;15MG/5ML A076478 001 Nov 05, 2003
TABLET;ORAL
IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE
CONTRACT PHARMACAL 200MG;30MG A075588 001 Apr 08, 2002
IBUTILIDE FUMARATE
INJECTABLE;INJECTION
IBUTILIDE FUMARATE
LUITPOLD 0.1MG/ML A090240 001 Jan 11, 2010
MYLAN INSTITUTIONAL 0.1MG/ML A090924 001 Jan 11, 2010

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-257(of 478)
** See List Footnote
ICATIBANT ACETATE
INJECTABLE;SUBCUTANEOUS
ICATIBANT ACETATE
DR REDDYS EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A213054 001 Oct 05, 2020
GLENMARK PHARMS LTD EQ 30MG BASE/3ML (EQ 10MG BASE/ML) A213222 001 May 21, 2021
IDARUBICIN HYDROCHLORIDE
INJECTABLE;INJECTION
IDAMYCIN
PFIZER 5MG/VIAL N050661 002 Sep 27, 1990
10MG/VIAL N050661 001 Sep 27, 1990
20MG/VIAL N050661 003 Apr 25, 1995
IDARUBICIN HYDROCHLORIDE
FRESENIUS KABI USA 1MG/ML A065440 001 Aug 04, 2009
MYLAN LABS LTD 1MG/ML A200144 001 Oct 11, 2012
SANDOZ 1MG/ML A091293 001 Mar 29, 2011
TEVA PARENTERAL 5MG/VIAL A065037 003 May 01, 2002
10MG/VIAL A065037 002 May 01, 2002
20MG/VIAL A065037 001 May 01, 2002
IDOXURIDINE
OINTMENT;OPHTHALMIC
STOXIL
GLAXOSMITHKLINE 0.5% N015868 001
SOLUTION/DROPS;OPHTHALMIC
DENDRID
+ ALCON 0.1% N014169 001
HERPLEX
ALLERGAN 0.1% N013935 002
STOXIL
GLAXOSMITHKLINE 0.1% N013934 001
IFOSFAMIDE
INJECTABLE;INJECTION
IFOSFAMIDE
FRESENIUS KABI USA 1GM/20ML (50MG/ML) A090181 001 Sep 22, 2009
3GM/60ML (50MG/ML) A090181 002 Sep 22, 2009
MYLAN LABS LTD 1GM/20ML (50MG/ML) A201689 001 Nov 26, 2012
3GM/60ML (50MG/ML) A201689 002 Nov 26, 2012
IFOSFAMIDE; MESNA
INJECTABLE;INJECTION
IFEX/MESNEX KIT
BAXTER HLTHCARE 1GM/VIAL;100MG/ML N019763 003 Oct 10, 1992
3GM/VIAL;100MG/ML N019763 004 Oct 10, 1992
INJECTABLE;INTRAVENOUS
IFOSFAMIDE/MESNA KIT
TEVA PHARMS USA 1GM/20ML;1GM/10ML (50MG/ML;100MG/ML) A075874 001 Feb 26, 2002
3GM/60ML;1GM/10ML (50MG/ML;100MG/ML) A075874 002 Feb 26, 2002
ILOPERIDONE
TABLET;ORAL
ILOPERIDONE
INVENTIA 1MG A207231 001 Nov 28, 2016
2MG A207231 002 Nov 28, 2016
4MG A207231 003 Nov 28, 2016
6MG A207231 004 Nov 28, 2016
8MG A207231 005 Nov 28, 2016
10MG A207231 006 Nov 28, 2016
12MG A207231 007 Nov 28, 2016
LUPIN LTD 1MG A206890 001 May 05, 2022
2MG A206890 002 May 05, 2022
4MG A206890 003 May 05, 2022
6MG A206890 004 May 05, 2022
8MG A206890 005 May 05, 2022
10MG A206890 006 May 05, 2022
12MG A206890 007 May 05, 2022
TARO PHARM INDS LTD 1MG A207098 001 Jul 22, 2019
2MG A207098 002 Jul 22, 2019
4MG A207098 003 Jul 22, 2019
6MG A207098 004 Jul 22, 2019
8MG A207098 005 Jul 22, 2019

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-258(of 478)
** See List Footnote
ILOPERIDONE
TABLET;ORAL
ILOPERIDONE
10MG A207098 006 Jul 22, 2019
12MG A207098 007 Jul 22, 2019
ILOPROST
SOLUTION;INHALATION
VENTAVIS
ACTELION 20MCG/2ML (10MCG/ML) N021779 001 Dec 29, 2004
IMATINIB MESYLATE
CAPSULE;ORAL
GLEEVEC
+ NOVARTIS EQ 50MG BASE ** N021335 001 May 10, 2001
+ EQ 100MG BASE ** N021335 002 May 10, 2001
TABLET;ORAL
IMATINIB MESYLATE
AMNEAL PHARMS EQ 100MG BASE A207495 001 Feb 08, 2019
EQ 400MG BASE A207495 002 Feb 08, 2019
IMIPRAMINE HYDROCHLORIDE
CONCENTRATE;ORAL
IMIPRAMINE HYDROCHLORIDE
NOVARTIS 25MG/ML A086765 001
INJECTABLE;INJECTION
TOFRANIL
NOVARTIS 12.5MG/ML N011838 002
TABLET;ORAL
IMIPRAMINE HYDROCHLORIDE
CHARTWELL 10MG A090441 002 Mar 11, 2010
25MG A090441 003 Mar 11, 2010
50MG A090441 001 Mar 11, 2010
LEDERLE 10MG A086269 001
25MG A086267 001
50MG A086268 001
PAR PHARM 10MG A089422 001 Jul 14, 1987
25MG A089497 001 Jul 14, 1987
ROXANE 10MG A083799 001
25MG A083799 002
50MG A083799 003
SANDOZ 10MG A085200 001
25MG A084869 002
50MG A085133 001
TEVA 10MG A083729 001
25MG A083729 004
50MG A083729 003
USL PHARMA 25MG A087776 001 Feb 10, 1982
VANGARD 10MG A088036 001 Nov 03, 1982
25MG A087619 001 Feb 09, 1982
50MG A087631 001 Jan 04, 1982
WATSON LABS 10MG A085220 001
10MG A085875 001
25MG A084252 002
25MG A085878 001
50MG A085221 001
50MG A085877 001
WEST WARD 25MG A088222 001 May 26, 1983
50MG A088223 001 May 26, 1983
JANIMINE
ABBOTT 10MG N017895 001
25MG N017895 002
50MG N017895 003
PRAMINE
ALRA 10MG A083827 001
25MG A083827 002
50MG A083827 003
PRESAMINE
SANOFI AVENTIS US 10MG N011836 006
25MG N011836 003
50MG N011836 007

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-259(of 478)
** See List Footnote
IMIPRAMINE PAMOATE
CAPSULE;ORAL
IMIPRAMINE PAMOATE
RISING EQ 75MG HYDROCHLORIDE A202338 001 Jun 28, 2013
EQ 100MG HYDROCHLORIDE A202338 002 Jun 28, 2013
EQ 125MG HYDROCHLORIDE A202338 003 Jun 28, 2013
EQ 150MG HYDROCHLORIDE A202338 004 Jun 28, 2013
TOFRANIL-PM
+ SPECGX LLC EQ 75MG HYDROCHLORIDE ** N017090 001
+ EQ 100MG HYDROCHLORIDE ** N017090 004
+ EQ 125MG HYDROCHLORIDE ** N017090 003
+ EQ 150MG HYDROCHLORIDE ** N017090 002
IMIQUIMOD
CREAM;TOPICAL
IMIQUIMOD
COSETTE 5% A200481 001 Apr 18, 2011
ENCUBE 5% A091044 001 Feb 28, 2011
STRIDES PHARMA 5% A202002 001 Jun 24, 2014
INAMRINONE LACTATE
INJECTABLE;INJECTION
AMRINONE LACTATE
BAXTER HLTHCARE CORP EQ 5MG BASE/ML A075542 001 May 10, 2000
HOSPIRA EQ 5MG BASE/ML A074616 001 Aug 03, 1998
INOCOR
SANOFI AVENTIS US EQ 5MG BASE/ML N018700 001 Jul 31, 1984
INDACATEROL MALEATE
POWDER;INHALATION
ARCAPTA NEOHALER
+ NOVARTIS EQ 75MCG BASE N022383 001 Jul 01, 2011
INDAPAMIDE
TABLET;ORAL
INDAPAMIDE
ANI PHARMS 1.25MG A074498 002 Feb 12, 1998
1.25MG A075201 001 Dec 04, 1998
2.5MG A074498 001 Oct 31, 1996
2.5MG A075201 002 Dec 04, 1998
CHARTWELL RX 1.25MG A074594 001 May 23, 1996
2.5MG A074594 002 May 23, 1996
MYLAN PHARMS INC 1.25MG A075105 001 Jul 23, 1998
2.5MG A075105 002 Jul 23, 1998
RISING 1.25MG A074461 002 Mar 26, 1997
2.5MG A074461 001 Mar 27, 1996
TEVA 1.25MG A074665 001 Apr 04, 1997
2.5MG A074665 002 Apr 04, 1997
WATSON LABS 1.25MG A074585 001 Sep 26, 1996
2.5MG A074585 002 Sep 26, 1996
LOZOL
+ SANOFI AVENTIS US 1.25MG ** N018538 002 Apr 29, 1993
+ 2.5MG ** N018538 001 Jul 06, 1983
INDECAINIDE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
DECABID
LILLY EQ 50MG BASE N019693 001 Dec 29, 1989
EQ 75MG BASE N019693 002 Dec 29, 1989
EQ 100MG BASE N019693 003 Dec 29, 1989
INDINAVIR SULFATE
CAPSULE;ORAL
CRIXIVAN
MERCK SHARP DOHME EQ 100MG BASE N020685 006 Apr 19, 2000
+ EQ 200MG BASE N020685 003 Mar 13, 1996
EQ 333MG BASE N020685 005 Dec 17, 1998
+ EQ 400MG BASE N020685 001 Mar 13, 1996

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-260(of 478)
** See List Footnote
INDIUM IN-111 CHLORIDE
INJECTABLE;INJECTION
INDICLOR
+ GE HEALTHCARE 2mCi/0.2ML N019862 001 Dec 29, 1992
INDOCYANINE GREEN
INJECTABLE;INJECTION
IC-GREEN
AKORN 10MG/VIAL ** N011525 003
40MG/VIAL ** N011525 004
50MG/VIAL ** N011525 002
INDOMETHACIN
CAPSULE;ORAL
INDO-LEMMON
TEVA 25MG A070266 001 Nov 07, 1985
50MG A070267 001 Nov 07, 1985
INDOCIN
+ EGALET 25MG ** N016059 001
+ 50MG ** N016059 002
INDOMETHACIN
ABLE 25MG A076666 001 Dec 17, 2003
50MG A076666 002 Dec 17, 2003
ANI PHARMS 25MG A071148 001 Mar 18, 1987
50MG A071149 001 Mar 18, 1987
CHARTWELL MOLECULES 25MG N018829 002 Aug 06, 1984
50MG N018829 001 Aug 06, 1984
CYCLE 25MG A070353 001 Jun 18, 1985
50MG A070354 001 Jun 18, 1985
DURAMED PHARMS BARR 25MG A070326 001 Oct 18, 1985
50MG A070327 001 Oct 18, 1985
HALSEY 25MG A070782 001 Jun 03, 1987
50MG A070635 001 Jun 03, 1987
HERITAGE PHARMA 25MG A070719 001 Feb 12, 1986
50MG A070756 001 Feb 12, 1986
HERITAGE PHARMS 25MG N018851 001 May 18, 1984
50MG N018851 002 May 18, 1984
IVAX SUB TEVA PHARMS 25MG N018730 001 May 04, 1984
50MG N018730 002 May 04, 1984
JUBILANT GENERICS 25MG A205215 001 Aug 25, 2017
50MG A205215 002 Aug 25, 2017
MUTUAL PHARM 25MG A070067 001 Oct 03, 1986
50MG A070068 001 Oct 03, 1986
PARKE DAVIS 25MG N018806 001 Nov 23, 1984
50MG N018806 002 Nov 23, 1984
PIONEER PHARMS 25MG A070813 001 Aug 11, 1986
50MG A070592 001 Aug 11, 1986
RISING 25MG N018858 001 Apr 20, 1984
50MG A070624 001 Sep 04, 1985
50MG N018858 002 Apr 20, 1984
SUN PHARM INDS INC 25MG A091401 001 Mar 28, 2013
50MG A091401 002 Mar 28, 2013
SUN PHARM INDUSTRIES 25MG A070900 002 Feb 09, 1987
50MG A070900 001 Feb 09, 1987
SUPERPHARM 25MG A070487 001 Oct 10, 1986
50MG A070488 001 Oct 10, 1986
TEVA 25MG A071342 001 Apr 18, 1988
50MG A071343 001 Apr 18, 1988
WATSON LABS 25MG A070529 001 Oct 18, 1985
25MG A070784 001 Aug 20, 1986
25MG A072996 001 Jul 31, 1991
25MG N018690 001 Jul 31, 1984
50MG A070530 001 Oct 18, 1985
50MG A070785 001 Aug 20, 1986
50MG A071635 001 May 18, 1987
50MG A072997 001 Jul 31, 1991
50MG N018690 002 Jul 31, 1984
TIVORBEX
+ GENUS 20MG N204768 001 Feb 24, 2014
+ 40MG N204768 002 Feb 24, 2014

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-261(of 478)
** See List Footnote
INDOMETHACIN
CAPSULE, EXTENDED RELEASE;ORAL
INDOCIN SR
+ EGALET 75MG ** N018185 001 Feb 23, 1982
INDOMETHACIN
ABLE 75MG A076114 001 Feb 06, 2002
AUROBINDO PHARMA 75MG A204243 001 Dec 27, 2016
INWOOD LABS 75MG A072410 001 Mar 15, 1989
JUBILANT GENERICS 75MG A202706 001 Oct 05, 2015
RISING 75MG A202139 001 Mar 20, 2014
WATSON LABS INC 75MG A202572 001 Dec 09, 2013
SUPPOSITORY;RECTAL
INDOCIN
+ EGALET 50MG ** N017814 001 Aug 13, 1984
SUSPENSION;ORAL
INDOMETHACIN
HIKMA 25MG/5ML A071412 001 Mar 18, 1987
INDOMETHACIN SODIUM
INJECTABLE;INJECTION
INDOCIN
+ RECORDATI RARE EQ 1MG BASE/VIAL ** N018878 001 Jan 30, 1985
INGENOL MEBUTATE
GEL;TOPICAL
INGENOL MEBUTATE
PADAGIS ISRAEL 0.015% A209018 001 Jan 07, 2019
0.05% A209019 001 Jan 09, 2019
PICATO
+ LEO LABS 0.015% N202833 001 Jan 23, 2012
+ 0.05% N202833 002 Jan 23, 2012
INULIN
INJECTABLE;INJECTION
INULIN AND SODIUM CHLORIDE
ISO TEX 100MG/ML N002282 001
INVERT SUGAR
INJECTABLE;INJECTION
TRAVERT 10% IN PLASTIC CONTAINER
BAXTER HLTHCARE 10GM/100ML N016717 001
IOBENGUANE SULFATE I-131
INJECTABLE;INJECTION
IOBENGUANE SULFATE I 131
PHARMALUCENCE 2.3mCi/ML N020084 001 Mar 25, 1994
IOCETAMIC ACID
TABLET;ORAL
CHOLEBRINE
MALLINCKRODT 750MG N017129 001
IODAMIDE MEGLUMINE
INJECTABLE;INJECTION
RENOVUE-65
BRACCO 65% N017902 001
RENOVUE-DIP
BRACCO 24% N017903 001
IODIPAMIDE MEGLUMINE
INJECTABLE;INJECTION
CHOLOGRAFIN MEGLUMINE
BRACCO 10.3% N009321 007
+ 52% N009321 003
IODIPAMIDE SODIUM
INJECTABLE;INJECTION
CHOLOGRAFIN SODIUM
BRACCO 20% N009321 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-262(of 478)
** See List Footnote
IODIXANOL
INJECTABLE;INJECTION
VISIPAQUE 270
GE HEALTHCARE 55% N020808 001 Aug 29, 1997
IODOHIPPURATE SODIUM I-123
INJECTABLE;INJECTION
NEPHROFLOW
GE HEALTHCARE 1mCi/ML N018289 001 Dec 28, 1984
IODOHIPPURATE SODIUM I-131
INJECTABLE;INJECTION
HIPPURAN I 131
MALLINCKRODT 0.25mCi/ML N016666 001
HIPPUTOPE
BRACCO 1-2mCi/VIAL N015419 002
IODOHIPPURATE SODIUM I 131
PHARMALUCENCE 0.2mCi/ML N017313 001
IODOXAMATE MEGLUMINE
INJECTABLE;INJECTION
CHOLOVUE
BRACCO 9.9% N018077 001
40.3% N018076 001
IOFETAMINE HYDROCHLORIDE I-123
INJECTABLE;INJECTION
SPECTAMINE
IMP 1mCi/ML N019432 001 Dec 24, 1987
IOHEXOL
FOR SOLUTION;ORAL
ORALTAG
INTERPHARMA PRAHA AS 9.7GM/BOT N205383 001 Mar 26, 2015
INJECTABLE;INJECTION
OMNIPAQUE 210
GE HEALTHCARE 45.3% N018956 006 Jun 30, 1989
SOLUTION;INJECTION, ORAL, RECTAL
OMNIPAQUE 240
GE HEALTHCARE 51.8% N020608 001 Oct 24, 1995
SOLUTION;URETHRAL
OMNIPAQUE 70
GE HEALTHCARE 15.1% N018956 007 Jun 01, 1994
IOPAMIDOL
INJECTABLE;INJECTION
IOPAMIDOL
BAXTER HLTHCARE 41% A074629 001 Nov 06, 1996
51% A074629 004 Mar 31, 1998
61% A074629 002 Nov 06, 1996
76% A074629 003 Nov 06, 1996
HOSPIRA 61% A074734 001 Dec 10, 1996
76% A074734 002 Dec 10, 1996
IOPAMIDOL-200
COOK IMAGING 41% A074881 001 Jul 28, 2000
HOSPIRA 41% A074898 001 Dec 30, 1997
IOPAMIDOL-200 IN PLASTIC CONTAINER
HOSPIRA 41% A074636 001 Dec 30, 1997
IOPAMIDOL-250
COOK IMAGING 51% A074881 002 Jul 28, 2000
FRESENIUS KABI USA 51% A074679 001 Apr 02, 1997
HOSPIRA 51% A074898 002 Dec 30, 1997
51% A075005 001 Feb 24, 1998
IOPAMIDOL-250 IN PLASTIC CONTAINER
HOSPIRA 51% A074636 002 Dec 30, 1997
IOPAMIDOL-300
ABBVIE 61% A074638 001 Apr 30, 1997
COOK IMAGING 61% A074881 003 Jul 28, 2000
FRESENIUS KABI USA 61% A074679 002 Apr 02, 1997
HOSPIRA 61% A074898 003 Dec 30, 1997
61% A075005 002 Feb 24, 1998

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-263(of 478)
** See List Footnote
IOPAMIDOL
INJECTABLE;INJECTION
IOPAMIDOL-300 IN PLASTIC CONTAINER
HOSPIRA 61% A074636 003 Dec 30, 1997
61% A074637 001 Apr 03, 1997
IOPAMIDOL-370
COOK IMAGING 76% A074881 004 Jul 28, 2000
FRESENIUS KABI USA 76% A074679 003 Apr 02, 1997
HOSPIRA 76% A074898 004 Dec 30, 1997
76% A075005 003 Feb 24, 1998
IOPAMIDOL-370 IN PLASTIC CONTAINER
HOSPIRA 76% A074636 004 Dec 30, 1997
ISOVUE-128
BRACCO 26% N018735 005 Oct 21, 1986
ISOVUE-200
BRACCO 41% N020327 001 Oct 12, 1994
SCANLUX-300
SANOCHEMIA CORP USA 61% A090394 001 Jun 18, 2010
SCANLUX-370
SANOCHEMIA CORP USA 76% A090394 002 Jun 18, 2010
IOPANOIC ACID
TABLET;ORAL
TELEPAQUE
GE HEALTHCARE 500MG N008032 001
IOPHENDYLATE
INJECTABLE;INJECTION
PANTOPAQUE
ALCON 100% N005319 001
IOPROMIDE
INJECTABLE;INJECTION
ULTRAVIST (PHARMACY BULK)
+ BAYER HLTHCARE 49.9% N021425 003 Mar 12, 2004
ULTRAVIST 150
+ BAYER HLTHCARE 31.2% N020220 004 May 10, 1995
ULTRAVIST 240
+ BAYER HLTHCARE 49.9% N020220 003 May 10, 1995
ULTRAVIST 300 IN PLASTIC CONTAINER
+ BAYER HLTHCARE 62.3% N020220 005 Nov 18, 2008
IOTHALAMATE MEGLUMINE
INJECTABLE;INJECTION
CONRAY 30
+ LIEBEL-FLARSHEIM 30% N016983 001
CONRAY 43
+ LIEBEL-FLARSHEIM 43% N013295 002
IOTHALAMATE MEGLUMINE; IOTHALAMATE SODIUM
INJECTABLE;INJECTION
VASCORAY
MALLINCKRODT 52%;26% N016783 001
IOTHALAMATE SODIUM
INJECTABLE;INJECTION
ANGIO-CONRAY
MALLINCKRODT 80% N013319 001
CONRAY 325
MALLINCKRODT 54.3% N017685 001
CONRAY 400
MALLINCKRODT 66.8% N014295 001
IOTROLAN
INJECTABLE;INTRATHECAL
OSMOVIST 190
BAYER HLTHCARE 40.6% N019580 001 Dec 07, 1989
OSMOVIST 240
BAYER HLTHCARE 51.3% N019580 002 Dec 07, 1989

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-264(of 478)
** See List Footnote
IOVERSOL
INJECTABLE;INJECTION
OPTIRAY 160
LIEBEL-FLARSHEIM 34% N019710 003 Dec 30, 1988
OPTIRAY 240
+ LIEBEL-FLARSHEIM 51% N019710 002 Dec 30, 1988
51% N020923 001 May 28, 1998
IOXAGLATE MEGLUMINE; IOXAGLATE SODIUM
INJECTABLE;INJECTION
HEXABRIX
GUERBET 39.3%;19.6% N018905 002 Jul 26, 1985
IOXILAN
INJECTABLE;INJECTION
OXILAN-300
GUERBET 62% N020316 001 Dec 21, 1995
OXILAN-350
GUERBET 73% N020316 002 Dec 21, 1995
IPODATE CALCIUM
GRANULE;ORAL
ORAGRAFIN CALCIUM
BRACCO 3GM/PACKET N012968 001
IPODATE SODIUM
CAPSULE;ORAL
BILIVIST
BAYER HLTHCARE 500MG A087768 001 Aug 11, 1982
ORAGRAFIN SODIUM
BRACCO 500MG N012967 001
IPRATROPIUM BROMIDE
AEROSOL, METERED;INHALATION
ATROVENT
BOEHRINGER INGELHEIM 0.018MG/INH N019085 001 Dec 29, 1986
SOLUTION;INHALATION
ATROVENT
+ BOEHRINGER INGELHEIM 0.02% ** N020228 001 Sep 29, 1993
IPRATROPIUM BROMIDE
ACTAVIS MID ATLANTIC 0.02% A075111 001 Apr 22, 1999
APOTEX INC 0.02% A075441 001 Mar 28, 2001
BAUSCH 0.02% A075835 001 Oct 15, 2001
LANDELA PHARM 0.02% A077072 001 Jul 19, 2005
MYLAN SPECIALITY LP 0.02% A074755 001 Jan 10, 1997
ROXANE 0.02% A075867 001 Jul 22, 2002
TEVA PHARMS USA 0.02% A075313 001 Feb 07, 2000
WATSON LABS 0.02% A076291 001 May 09, 2005
ZENNOVA 0.02% A075507 001 Jan 19, 2001
SPRAY, METERED;NASAL
ATROVENT
+ BOEHRINGER INGELHEIM 0.021MG/SPRAY ** N020393 001 Oct 20, 1995
+ 0.042MG/SPRAY ** N020394 001 Oct 20, 1995
IPRATROPIUM BROMIDE
MYLAN SPECIALITY LP 0.021MG/SPRAY A075552 001 Mar 31, 2003
0.042MG/SPRAY A075553 001 Mar 31, 2003
IRBESARTAN
TABLET;ORAL
IRBESARTAN
AJANTA PHARMA LTD 75MG A203685 001 Dec 10, 2015
150MG A203685 002 Dec 10, 2015
300MG A203685 003 Dec 10, 2015
APOTEX INC 75MG A200832 001 Oct 15, 2012
150MG A200832 002 Oct 15, 2012
300MG A200832 003 Oct 15, 2012
APPCO 75MG A200461 001 Sep 27, 2012
150MG A200461 002 Sep 27, 2012
300MG A200461 003 Sep 27, 2012
HIKMA 75MG A090201 001 Oct 15, 2012
150MG A090201 002 Oct 15, 2012
300MG A090201 003 Oct 15, 2012

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-265(of 478)
** See List Footnote
IRBESARTAN
TABLET;ORAL
IRBESARTAN
PICKET PHARMS 75MG A203161 001 Sep 27, 2012
150MG A203161 002 Sep 27, 2012
300MG A203161 003 Sep 27, 2012
UNICHEM 75MG A203020 001 Dec 07, 2015
150MG A203020 002 Dec 07, 2015
300MG A203020 003 Dec 07, 2015
WATSON LABS INC 75MG A090720 001 Oct 12, 2012
150MG A090720 002 Oct 12, 2012
300MG A090720 003 Oct 12, 2012
IRINOTECAN HYDROCHLORIDE
INJECTABLE;INJECTION
IRINOTECAN HYDROCHLORIDE
CIPLA LTD 40MG/2ML (20MG/ML) A077219 001 Feb 20, 2008
100MG/5ML (20MG/ML) A077219 002 Feb 20, 2008
EMCURE PHARMS LTD 40MG/2ML (20MG/ML) A200771 001 Feb 14, 2012
100MG/5ML (20MG/ML) A200771 002 Feb 14, 2012
FRESENIUS KABI USA 40MG/2ML (20MG/ML) A078188 001 Feb 27, 2008
100MG/5ML (20MG/ML) A078188 002 Feb 27, 2008
PICKET PHARMS 40MG/2ML (20MG/ML) A078953 001 Apr 15, 2010
100MG/5ML (20MG/ML) A078953 002 Apr 15, 2010
PLIVA LACHEMA 40MG/2ML (20MG/ML) A078122 001 Oct 31, 2008
100MG/5ML (20MG/ML) A078122 002 Oct 31, 2008
SANDOZ 40MG/2ML (20MG/ML) A077994 001 Feb 27, 2008
100MG/5ML (20MG/ML) A077994 002 Feb 27, 2008
SANDOZ INC 40MG/2ML (20MG/ML) A090137 001 Nov 12, 2009
100MG/5ML (20MG/ML) A090137 002 Nov 12, 2009
SUN PHARMA GLOBAL 40MG/2ML (20MG/ML) A078805 001 Apr 21, 2008
100MG/5ML (20MG/ML) A078805 002 Apr 21, 2008
TEVA PHARMS USA 40MG/2ML (20MG/ML) A090101 002 Feb 27, 2008
100MG/5ML (20MG/ML) A090101 003 Feb 27, 2008
ISOETHARINE HYDROCHLORIDE
SOLUTION;INHALATION
BETA-2
NEPHRON 1% A086711 001
BRONKOSOL
SANOFI AVENTIS US 0.25% N012339 009
1% N012339 008
ISOETHARINE HYDROCHLORIDE
ALPHARMA US PHARMS 1% A087101 001
+ ASTRAZENECA 0.062% A087937 001 Nov 15, 1982
0.062% A089614 001 Jun 13, 1991
+ 0.125% A087938 001 Nov 15, 1982
0.125% A089615 001 Jun 13, 1991
+ 0.167% A088470 001 Mar 14, 1984
0.167% A089616 001 Jun 13, 1991
+ 0.2% A088471 001 Mar 14, 1984
0.2% A089617 001 Jun 13, 1991
+ 0.25% A088472 001 Mar 14, 1984
0.25% A089618 001 Jun 13, 1991
BAXTER HLTHCARE 0.08% A088144 001 Jul 29, 1983
0.14% A088145 001 Mar 26, 1984
0.25% A088146 001 Aug 01, 1983
DEY 0.08% A088187 001 Dec 03, 1982
0.1% A087389 001
0.17% A087390 001
0.25% A088188 001 Dec 03, 1982
+ 1% A086763 001
INTL MEDICATION 0.077% A086651 001
0.08% A086651 002
0.1% A086651 003
0.143% A086651 004
0.167% A086651 005
0.2% A086651 006
0.25% A086651 007
1% A086651 008

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-266(of 478)
** See List Footnote
ISOETHARINE HYDROCHLORIDE
SOLUTION;INHALATION
ISOETHARINE HYDROCHLORIDE
PARKE DAVIS 0.5% A085997 001
1% A085889 001
ROXANE 0.1% A087396 001
0.125% A087025 001
0.167% A088226 001 Sep 16, 1983
0.2% A087324 001
0.25% A088275 001 Jun 03, 1983
1% A086899 001
ISOETHARINE HYDROCHLORIDE S/F
DEY 0.08% A089817 001 Nov 22, 1988
0.1% A089818 001 Nov 22, 1988
0.17% A089819 001 Nov 22, 1988
0.25% A089820 001 Nov 22, 1988
1% A089252 001 Sep 15, 1986
ISOETHARINE MESYLATE
AEROSOL, METERED;INHALATION
BRONKOMETER
SANOFI AVENTIS US 0.34MG/INH N012339 007
ISOETHARINE MESYLATE
ALPHARMA US PHARMS 0.34MG/INH A087858 001 Aug 21, 1984
ISOFLURANE
LIQUID;INHALATION
ISOFLURANE
HOSPIRA 99.9% A074097 001 Jan 25, 1993
WATSON LABS INC 99.9% A074393 001 May 12, 1995
ISOFLUROPHATE
OINTMENT;OPHTHALMIC
FLOROPRYL
MERCK 0.025% N010656 001
ISONIAZID
INJECTABLE;INJECTION
NYDRAZID
SANDOZ 100MG/ML ** N008662 001
RIMIFON
ROCHE 25MG/ML N008420 002
100MG/ML N008420 003
SYRUP;ORAL
ISONIAZID
CHARTWELL RX 50MG/5ML A081118 001 Jul 21, 1997
LANIAZID
LANNETT 50MG/5ML A089243 001 Feb 03, 1986
RIMIFON
ROCHE 50MG/5ML N008420 001
TABLET;ORAL
DOW-ISONIAZID
DOW PHARM 300MG A080330 002
HYZYD
MEDPOINTE PHARM HLC 100MG A080134 003
300MG A080134 004
INH
NOVARTIS 300MG A080935 001
ISONIAZID
DURAMED PHARMS BARR 100MG A088231 001 Mar 17, 1983
300MG A088119 001 Mar 17, 1983
+ EPIC PHARMA LLC 100MG ** N008678 002
+ 300MG ** N008678 003
HALSEY 50MG A083632 001
HIKMA INTL PHARMS 100MG A080212 001
300MG A087425 001
IMPAX LABS 100MG A080153 001
IVAX SUB TEVA PHARMS 100MG A080270 001
300MG A083610 001
LILLY 100MG N008499 002
300MG N008499 003

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-267(of 478)
** See List Footnote
ISONIAZID
TABLET;ORAL
ISONIAZID
MK LABS 100MG A080941 001
NEXGEN PHARMA INC 100MG A084050 001
PANRAY 50MG N008428 001
100MG N008428 002
300MG N008428 003
PERRIGO 100MG A083060 001
PHARMAVITE 100MG A085091 001
PHOENIX LABS NY 50MG A080368 001
100MG A080368 002
PUREPAC PHARM 50MG A080132 003 Jul 14, 1982
100MG A080132 004 Jul 14, 1982
SUN PHARM INDUSTRIES 100MG A080136 001
300MG A083633 001
WATSON LABS 50MG A080522 001
100MG A080401 001
100MG A080523 001
100MG A085790 001
300MG A080521 001
300MG A083178 001
300MG A085784 001
WHITEWORTH TOWN PLSN 100MG A080120 002
LANIAZID
CHARTWELL MOLECULAR 300MG A089776 001 Jun 13, 1988
LANNETT 50MG A080140 001
100MG A080140 002
NYDRAZID
BRISTOL MYERS SQUIBB 100MG N008392 003
STANOZIDE
EVERYLIFE 100MG A080126 001
300MG A080126 002
ISONIAZID; PYRAZINAMIDE; RIFAMPIN
TABLET;ORAL
RIFATER
+ SANOFI AVENTIS US 50MG;300MG;120MG N050705 001 May 31, 1994
ISONIAZID; RIFAMPIN
CAPSULE;ORAL
RIFAMATE
SANOFI AVENTIS US 150MG;300MG A061884 001
RIFAMPIN AND ISONIAZID
HIKMA INTL PHARMS 150MG;300MG A065221 001 Jul 29, 2005
ISOPROPAMIDE IODIDE
TABLET;ORAL
DARBID
GLAXOSMITHKLINE EQ 5MG BASE N010744 001
ISOPROTERENOL HYDROCHLORIDE
AEROSOL, METERED;INHALATION
ISOPROTERENOL HYDROCHLORIDE
3M 0.12MG/INH N010375 004
ALPHARMA US PHARMS 0.12MG/INH A085904 001
ISUPREL
SANOFI AVENTIS US 0.103MG/INH N011178 001
DISC;INHALATION
NORISODRINE AEROTROL
ABBOTT 0.25% N016814 001
INJECTABLE;INJECTION
ISOPROTERENOL HYDROCHLORIDE
ABRAXIS PHARM 0.2MG/ML A083431 001
BAXTER HLTHCARE 0.2MG/ML A083486 001
CIPLA 0.2MG/ML A211738 001 Jun 28, 2019
HOSPIRA 0.02MG/ML A083283 001
0.2MG/ML A083346 001
INTL MEDICATION 0.2MG/ML A083724 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-268(of 478)
** See List Footnote
ISOPROTERENOL HYDROCHLORIDE
SOLUTION;INHALATION
AEROLONE
LILLY 0.25% N007245 001
ISOPROTERENOL HYDROCHLORIDE
ARMOUR PHARM 0.031% A087935 001 Nov 18, 1982
0.062% A087936 001 Nov 18, 1982
DEY 0.5% A086764 001 Jan 04, 1982
PARKE DAVIS 0.25% A085994 001
0.5% A085540 001
ISUPREL
SANOFI AVENTIS US 0.5% N006327 002
1% N006327 003
VAPO-ISO
FISONS 0.5% N016813 001
TABLET;RECTAL, SUBLINGUAL
ISUPREL
SANOFI AVENTIS US 10MG N006328 001
15MG N006328 002
ISOPROTERENOL HYDROCHLORIDE; PHENYLEPHRINE BITARTRATE
AEROSOL, METERED;INHALATION
DUO-MEDIHALER
3M 0.16MG/INH;0.24MG/INH N013296 001
ISOPROTERENOL SULFATE
AEROSOL, METERED;INHALATION
MEDIHALER-ISO
3M 0.08MG/INH N010375 003
POWDER;INHALATION
NORISODRINE
ABBVIE 10% N006905 003
25% N006905 002
ISOSORBIDE
SOLUTION;ORAL
ISMOTIC
ALCON 100GM/220ML N017063 001
ISOSORBIDE DINITRATE
CAPSULE, EXTENDED RELEASE;ORAL
DILATRATE-SR
+ AUXILIUM PHARMS LLC 40MG N019790 001 Sep 02, 1988
ISORDIL
WYETH AYERST 40MG N012882 002 Jul 29, 1988
TABLET;ORAL
ISORDIL
+ BAUSCH 10MG ** N012093 002 Jul 29, 1988
+ 20MG ** N012093 006 Jul 29, 1988
+ 30MG ** N012093 005 Jul 29, 1988
ISOSORBIDE DINITRATE
ANI PHARMS 10MG A086032 001 Jan 07, 1988
HIKMA INTL PHARMS 30MG A040591 001 Jan 10, 2007
SUN PHARM INDUSTRIES 5MG A086166 002 Sep 19, 1986
10MG A086169 001 Sep 19, 1986
20MG A086167 001 Sep 19, 1986
30MG A087564 001 Sep 18, 1986
SUPERPHARM 5MG A089190 001 Feb 17, 1987
10MG A089191 001 Feb 17, 1987
20MG A089192 001 Feb 17, 1987
WATSON LABS 5MG A086034 001 Jan 06, 1988
SORBITRATE
ASTRAZENECA 5MG N016192 001 Apr 01, 1996
10MG N016192 002 Apr 01, 1996
20MG A086405 002 Aug 21, 1990
30MG A088124 001 Aug 21, 1990
40MG A088125 001 Aug 21, 1990
TABLET;SUBLINGUAL
ISORDIL
+ BIOVAIL 2.5MG ** N012940 004 Jul 29, 1988
+ 5MG ** N012940 003 Jul 29, 1988

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-269(of 478)
** See List Footnote
ISOSORBIDE DINITRATE
TABLET;SUBLINGUAL
ISORDIL
+ 10MG ** N012940 005 Jul 29, 1988
ISOSORBIDE DINITRATE
HIKMA INTL PHARMS 2.5MG A086054 001 Oct 29, 1987
5MG A086055 001 Nov 02, 1987
SANDOZ 2.5MG A086225 001 Feb 19, 1988
5MG A086222 001 Feb 19, 1988
SUN PHARM INDUSTRIES 2.5MG A084204 001 Sep 18, 1986
5MG A086168 001 Sep 18, 1986
10MG A087545 001 Sep 18, 1986
WATSON LABS 2.5MG ** A086033 001 Feb 26, 1988
WATSON LABS TEVA 5MG ** A086031 001 Sep 29, 1987
SORBITRATE
ASTRAZENECA 2.5MG N016191 002 Apr 01, 1996
5MG N016191 001 Apr 01, 1996
TABLET, CHEWABLE;ORAL
SORBITRATE
ASTRAZENECA 5MG N016776 002 Apr 01, 1996
10MG N016776 003 Apr 01, 1996
TABLET, EXTENDED RELEASE;ORAL
ISORDIL
WYETH AYERST 40MG N012882 001 Jul 29, 1988
ISOSORBIDE DINITRATE
IMPAX LABS INC 40MG A040723 001 Mar 17, 2008
ISOSORBIDE MONONITRATE
TABLET;ORAL
ISMO
PROMIUS PHARMA 20MG N019091 001 Dec 30, 1991
ISOSORBIDE MONONITRATE
ANI PHARMS 20MG A075147 001 Nov 27, 1998
HIKMA PHARMS 20MG A075361 001 Oct 05, 2000
TABLET, EXTENDED RELEASE;ORAL
IMDUR
+ SCHERING PLOUGH 30MG ** N020225 001 Aug 12, 1993
+ 60MG ** N020225 002 Aug 12, 1993
+ 120MG ** N020225 003 Mar 30, 1995
ISOSORBIDE MONONITRATE
ACCORD HLTHCARE 30MG A209684 001 Oct 24, 2017
60MG A209684 002 Oct 24, 2017
120MG A209684 003 Oct 24, 2017
ACTAVIS ELIZABETH 30MG A075306 001 Dec 31, 1998
60MG A075306 002 Dec 31, 1998
ALKERMES GAINESVILLE 60MG A075041 001 Sep 22, 1998
HIKMA INTL PHARMS 30MG A076813 002 Mar 30, 2006
60MG A076813 001 Jan 07, 2005
IVAX SUB TEVA PHARMS 30MG A075448 002 Aug 07, 2001
60MG A075448 001 Jun 19, 2000
120MG A075448 003 Aug 07, 2001
SKYEPHARMA AG 60MG A075166 001 Oct 07, 1999
STRIDES PHARMA 30MG A090598 001 Aug 11, 2010
60MG A090598 002 Aug 11, 2010
120MG A090598 003 Aug 11, 2010
ISOSULFAN BLUE
INJECTABLE;INJECTION
ISOSULFAN BLUE
BELOTECA INC 1% A210714 001 Jan 16, 2019
EUGIA PHARMA 1% A206831 001 Feb 02, 2016
FRESENIUS KABI USA 1% A211869 001 Sep 08, 2022
SOMERSET THERAPS LLC 1% A210558 001 Jul 12, 2019
LYMPHAZURIN
+ COVIDIEN 1% ** N018310 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-270(of 478)
** See List Footnote
ISOTRETINOIN
CAPSULE;ORAL
ABSORICA LD
+ SUN PHARM 20MG N211913 003 Nov 05, 2019
+ 28MG N211913 005 Nov 05, 2019
ACCUTANE
+ HOFFMANN LA ROCHE 10MG ** N018662 002 May 07, 1982
+ 20MG ** N018662 004 Mar 28, 1983
+ 40MG ** N018662 003 May 07, 1982
SOTRET
SUN PHARM INDS LTD 10MG A076041 001 Dec 24, 2002
20MG A076041 002 Dec 24, 2002
30MG A076503 001 Jun 20, 2003
40MG A076041 003 Dec 24, 2002
ISRADIPINE
CAPSULE;ORAL
DYNACIRC
+ SMITHKLINE BEECHAM 2.5MG ** N019546 001 Dec 20, 1990
+ 5MG ** N019546 002 Dec 20, 1990
TABLET, EXTENDED RELEASE;ORAL
DYNACIRC CR
+ GLAXOSMITHKLINE LLC 5MG ** N020336 001 Jun 01, 1994
+ 10MG ** N020336 002 Jun 01, 1994
ISRADIPINE
MYLAN 5MG A201067 001 Nov 27, 2015
10MG A201067 002 Nov 27, 2015
ITRACONAZOLE
CAPSULE;ORAL
ITRACONAZOLE
JUBILANT GENERICS 100MG A203445 001 Feb 23, 2017
MYLAN PHARMS INC 100MG A200463 001 Jul 20, 2012
STRIDES PHARMA 100MG A206410 001 Jul 02, 2019
INJECTABLE;INJECTION
SPORANOX
JANSSEN PHARMS 10MG/ML N020966 001 Mar 30, 1999
SOLUTION;ORAL
ITRACONAZOLE
APOTEX 10MG/ML A208481 001 Aug 02, 2019
TABLET;ORAL
ONMEL
+ SEBELA IRELAND LTD 200MG N022484 001 Apr 29, 2010
IVABRADINE HYDROCHLORIDE
TABLET;ORAL
IVABRADINE HYDROCHLORIDE
INGENUS PHARMS LLC EQ 5MG BASE A214051 001 Dec 30, 2021
EQ 7.5MG BASE A214051 002 Dec 30, 2021
IVERMECTIN
CREAM;TOPICAL
IVERMECTIN
PADAGIS ISRAEL 1% A210225 001 Apr 13, 2020
LOTION;TOPICAL
IVERMECTIN
TEVA PHARMS USA 0.5% A212485 001 Mar 21, 2022
TABLET;ORAL
STROMECTOL
+ MERCK SHARP DOHME 6MG ** N050742 001 Nov 22, 1996
KANAMYCIN SULFATE
CAPSULE;ORAL
KANTREX
APOTHECON EQ 500MG BASE A060516 001
EQ 500MG BASE A061911 001
EQ 500MG BASE A062726 001 Mar 06, 1987
INJECTABLE;INJECTION
KANAMYCIN
HIKMA EQ 75MG BASE/2ML A062324 001
EQ 500MG BASE/2ML A062324 002
EQ 1GM BASE/3ML A062324 003

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-271(of 478)
** See List Footnote
KANAMYCIN SULFATE
INJECTABLE;INJECTION
KANAMYCIN SULFATE
ABRAXIS PHARM EQ 75MG BASE/2ML A062504 001 Apr 05, 1984
EQ 500MG BASE/2ML A062504 002 Apr 05, 1984
EQ 1GM BASE/3ML A062504 003 Apr 05, 1984
FRESENIUS KABI USA EQ 500MG BASE/2ML A065111 001 Dec 17, 2002
EQ 1GM BASE/3ML A065111 002 Dec 17, 2002
INTL MEDICATION EQ 500MG BASE/2ML A062466 001 Sep 30, 1983
EQ 1GM BASE/3ML A062466 002 Sep 30, 1983
LOCH EQ 75MG BASE/2ML A063021 001 Jul 31, 1992
EQ 500MG BASE/2ML A063022 001 Jul 31, 1992
EQ 1GM BASE/3ML A063025 001 Jul 31, 1992
PHARMAFAIR EQ 75MG BASE/2ML A062668 001 May 07, 1987
EQ 500MG BASE/2ML A062672 001 May 07, 1987
EQ 1GM BASE/3ML A062669 001 May 07, 1987
SOLOPAK EQ 75MG BASE/2ML A062605 003 Feb 26, 1986
EQ 500MG BASE/2ML A062605 001 Feb 26, 1986
EQ 1GM BASE/3ML A062605 002 Feb 26, 1986
WARNER CHILCOTT EQ 1GM BASE/3ML A063092 001 Oct 11, 1989
WATSON LABS EQ 1GM BASE/3ML A062520 003 May 09, 1985
KANTREX
APOTHECON EQ 75MG BASE/2ML A061655 003
EQ 75MG BASE/2ML A061901 003
EQ 75MG BASE/2ML A062564 001 Sep 21, 1984
EQ 500MG BASE/2ML A061655 001
EQ 500MG BASE/2ML A061901 001
EQ 500MG BASE/2ML A062564 002 Sep 21, 1984
EQ 1GM BASE/3ML A061655 002
EQ 1GM BASE/3ML A061901 002
EQ 1GM BASE/3ML A062564 003 Sep 21, 1984
KLEBCIL
KING PHARMS EQ 75MG BASE/2ML A062170 001
EQ 500MG BASE/2ML A062170 002
EQ 1GM BASE/3ML A062170 003
KETOCONAZOLE
CREAM;TOPICAL
NIZORAL
+ JANSSEN PHARMA 2% ** N019084 001 Dec 31, 1985
GEL;TOPICAL
XOLEGEL
+ ALMIRALL 2% N021946 001 Jul 28, 2006
SHAMPOO;TOPICAL
NIZORAL
+ JANSSEN PHARMS 2% ** N019927 001 Aug 31, 1990
SUSPENSION;ORAL
NIZORAL
JANSSEN PHARMA 100MG/5ML A070767 001 Nov 07, 1986
TABLET;ORAL
KETOCONAZOLE
AAIPHARMA LLC 200MG A075341 001 Jul 27, 1999
HERITAGE PHARMA 200MG A074971 001 Jun 15, 1999
200MG A075362 001 Jun 15, 1999
MYLAN 200MG A075597 001 Dec 23, 1999
SUN PHARM INDUSTRIES 200MG A075314 001 Jun 15, 1999
TEVA 200MG A075273 001 Jun 15, 1999
NIZORAL
+ JANSSEN PHARMS 200MG ** N018533 001
KETOPROFEN
CAPSULE;ORAL
KETOPROFEN
RISING 50MG A074024 001 Dec 29, 1995
50MG A074035 002 Dec 31, 1996
75MG A074024 002 Dec 29, 1995
75MG A074035 003 Dec 31, 1996
TEVA 25MG A073515 001 Dec 22, 1992
75MG A073517 001 Dec 22, 1992

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-272(of 478)
** See List Footnote
KETOPROFEN
CAPSULE;ORAL
ORUDIS
+ WYETH AYERST 25MG ** N018754 001 Jul 31, 1987
+ 50MG ** N018754 002 Jan 09, 1986
+ 75MG ** N018754 003 Jan 09, 1986
CAPSULE, EXTENDED RELEASE;ORAL
KETOPROFEN
ACTAVIS LABS FL INC 100MG A075270 002 Mar 24, 1999
150MG A075270 003 Mar 24, 1999
200MG A075270 001 Mar 24, 1999
ALKERMES GAINESVILLE 200MG A074879 001 Dec 10, 1997
MYLAN 100MG A075679 003 Feb 20, 2002
150MG A075679 002 Feb 20, 2002
ORUVAIL
+ WYETH PHARMS INC 100MG ** N019816 003 Feb 08, 1995
+ 150MG ** N019816 002 Feb 08, 1995
+ 200MG ** N019816 001 Sep 24, 1993
FILM;ORAL
NEXCEDE
NOVARTIS 12.5MG N022470 001 Nov 25, 2009
TABLET;ORAL
ACTRON
BAYER 12.5MG N020499 001 Oct 06, 1995
KETOPROFEN
PERRIGO 12.5MG A075364 001 Feb 07, 2002
ORUDIS KT
+ WYETH CONS 12.5MG ** N020429 001 Oct 06, 1995
KETOROLAC TROMETHAMINE
INJECTABLE;INJECTION
KETOROLAC TROMETHAMINE
AMPHASTAR PHARM 15MG/ML A076209 001 Jul 21, 2004
30MG/ML A076209 002 Jul 21, 2004
APOTEX INC 30MG/ML A075626 001 Jul 24, 2001
30MG/ML A077201 001 Oct 14, 2005
APOTHECON 15MG/ML A075348 001 Nov 28, 2000
30MG/ML A075348 002 Nov 28, 2000
BAXTER HLTHCARE CORP 15MG/ML A075631 002 Jun 29, 2001
30MG/ML A075631 001 Jun 29, 2001
BEDFORD 15MG/ML A075230 002 Oct 25, 1999
30MG/ML A075230 001 Oct 25, 1999
EUGIA PHARMA 15MG/ML A212939 001 Oct 20, 2020
30MG/ML A212939 002 Oct 20, 2020
GLAND PHARMA LTD 15MG/ML A076722 001 Jul 27, 2004
30MG/ML A076722 002 Jul 27, 2004
HIKMA 15MG/ML ** A075222 001 Apr 26, 1999
15MG/ML A075299 001 Nov 03, 1999
30MG/ML ** A075222 002 Apr 26, 1999
30MG/ML ** A075228 001 Apr 26, 1999
30MG/ML A075299 002 Nov 03, 1999
HOSPIRA 15MG/ML A074801 001 Jun 05, 1997
15MG/ML A074993 001 Jan 27, 1999
30MG/ML A074801 002 Jun 05, 1997
LUITPOLD 15MG/ML A078145 001 Jan 14, 2008
30MG/ML A078145 002 Jan 14, 2008
SANDOZ INC 15MG/ML A076271 001 Oct 06, 2004
STERISCIENCE 15MG/ML A078299 001 Jul 16, 2007
15MG/ML A201155 001 Aug 04, 2014
30MG/ML A078299 002 Jul 16, 2007
30MG/ML A201155 002 Aug 04, 2014
WOCKHARDT BIO AG 30MG/ML A077943 001 Mar 27, 2007
TORADOL
+ ROCHE PALO 15MG/ML ** N019698 001 Nov 30, 1989
+ 30MG/ML ** N019698 002 Nov 30, 1989
SOLUTION/DROPS;OPHTHALMIC
ACULAR PRESERVATIVE FREE
ALLERGAN 0.5% N020811 001 Nov 03, 1997

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-273(of 478)
** See List Footnote
KETOROLAC TROMETHAMINE
SOLUTION/DROPS;OPHTHALMIC
KETOROLAC TROMETHAMINE
AKORN 0.4% A078399 001 Nov 05, 2009
0.45% A203376 001 Feb 10, 2014
EUGIA PHARMA 0.4% A205191 001 Nov 15, 2018
0.5% A205190 001 Dec 03, 2020
SANDOZ INC 0.4% A078721 001 Nov 05, 2009
TABLET;ORAL
KETOROLAC TROMETHAMINE
CYCLE 10MG A074790 001 Jun 26, 1997
PLIVA 10MG A075284 001 Jun 23, 1999
WATSON LABS 10MG A074955 001 Sep 19, 1997
TORADOL
+ ROCHE PALO 10MG ** N019645 001 Dec 20, 1991
KETOTIFEN FUMARATE
SOLUTION/DROPS;OPHTHALMIC
ZADITOR
+ ALCON PHARMA EQ 0.025% BASE ** N021066 002 Oct 19, 2006
KRYPTON, KR-81M
GAS;INHALATION
MPI KRYPTON 81M GENERATOR
GE HEALTHCARE N/A N018088 001
L-GLUTAMINE
FOR SOLUTION;ORAL
NUTRESTORE
+ EMMAUS MEDCL 5GM/PACKET N021667 001 Jun 10, 2004
LABETALOL HYDROCHLORIDE
INJECTABLE;INJECTION
LABETALOL HYDROCHLORIDE
AKORN 5MG/ML A075524 001 Nov 29, 1999
APOTHECON 5MG/ML A075355 001 Nov 29, 1999
HOSPIRA 5MG/ML A075242 001 Sep 30, 1999
STERISCIENCE 5MG/ML A079134 001 Feb 03, 2010
NORMODYNE
+ SCHERING 5MG/ML ** N018686 001 Aug 01, 1984
TRANDATE
+ SEBELA IRELAND LTD 5MG/ML ** N019425 001 Dec 31, 1985
TABLET;ORAL
LABETALOL HYDROCHLORIDE
APOTHECON 100MG A075223 001 Nov 20, 1998
200MG A075223 002 Nov 20, 1998
300MG A075223 003 Nov 20, 1998
TEVA 100MG A074989 001 Sep 30, 1998
200MG A074989 002 Sep 30, 1998
300MG A074989 003 Sep 30, 1998
UNICHEM 100MG A212719 001 Aug 08, 2022
200MG A212719 002 Aug 08, 2022
300MG A212719 003 Aug 08, 2022
NORMODYNE
+ SCHERING 100MG ** N018687 001 Aug 31, 1987
+ 200MG ** N018687 002 Aug 01, 1984
+ 300MG ** N018687 003 Aug 01, 1984
+ 400MG ** N018687 004 Aug 01, 1984
TRANDATE
+ ALVOGEN 100MG N018716 001 May 24, 1985
+ 400MG ** N018716 004 Aug 01, 1984
LACTITOL
FOR SOLUTION;ORAL
PIZENSY
+ BRAINTREE LABS 10GM N211281 001 Feb 12, 2020

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-274(of 478)
** See List Footnote
LACTULOSE
SOLUTION;ORAL
CHRONULAC
+ SANOFI AVENTIS US 10GM/15ML ** N017884 001
CONSTILAC
ALRA 10GM/15ML A071054 001 Jul 26, 1988
CONSTULOSE
ACTAVIS MID ATLANTIC 10GM/15ML A070288 001 Aug 15, 1988
DUPHALAC
SOLVAY 10GM/15ML A072372 001 Mar 22, 1989
EVALOSE
TEVA PHARMS 10GM/15ML A073497 001 May 28, 1993
LACTULOSE
ANI PHARMS 10GM/15ML A078430 001 Nov 28, 2007
HIKMA 10GM/15ML A073591 001 May 29, 1992
MORTON GROVE 10GM/15ML A071841 001 Sep 22, 1988
PACO 10GM/15ML A073160 001 Aug 25, 1992
TORRENT 10GM/15ML A207786 001 Jun 11, 2018
XTTRIUM LABS INC 10GM/15ML A075911 001 Feb 21, 2002
LAXILOSE
NOSTRUM LABS 10GM/15ML A073686 001 May 28, 1993
SOLUTION;ORAL, RECTAL
ACILAC
NOSTRUM LABS 10GM/15ML A073685 001 May 28, 1993
CEPHULAC
+ SANOFI AVENTIS US 10GM/15ML ** N017657 001
CHOLAC
ALRA 10GM/15ML A071331 001 Jul 26, 1988
ENULOSE
ACTAVIS MID ATLANTIC 10GM/15ML A071548 001 Aug 15, 1988
GENERLAC
MORTON GROVE 10GM/15ML A071842 001 Sep 27, 1988
HEPTALAC
TEVA PHARMS 10GM/15ML A073504 001 May 28, 1993
LACTULOSE
ANI PHARMS 10GM/15ML A090426 001 Nov 21, 2008
BAJAJ 10GM/15ML A076645 001 Jul 28, 2003
PACO 10GM/15ML A072029 001 Aug 25, 1992
ROXANE 10GM/15ML A073590 001 May 29, 1992
SOLVAY 10GM/15ML N017906 001
TORRENT 10GM/15ML A203762 001 Mar 27, 2015
PORTALAC
SOLVAY 10GM/15ML A072374 001 Mar 22, 1989
LAMIVUDINE
TABLET;ORAL
LAMIVUDINE
AUROBINDO PHARMA LTD 150MG A202032 001 Nov 17, 2011
300MG A202032 002 Nov 17, 2011
MYLAN 100MG A204002 001 Dec 31, 2014
150MG A204528 001 Mar 04, 2016
300MG A204528 002 Mar 04, 2016
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
TABLET;ORAL
LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE
+ MICRO LABS 150MG;200MG;300MG N205626 001 Aug 13, 2018
LAMIVUDINE; RALTEGRAVIR POTASSIUM
TABLET;ORAL
DUTREBIS
MERCK SHARP DOHME 150MG;EQ 300MG BASE N206510 001 Feb 06, 2015
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
TABLET;ORAL
LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
+ AUROBINDO PHARMA LTD 300MG;300MG N022344 001 May 15, 2018
TEMIXYS
+ CELLTRION 300MG;300MG N211284 001 Nov 16, 2018

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-275(of 478)
** See List Footnote
LAMIVUDINE; ZIDOVUDINE
TABLET;ORAL
LAMIVUDINE AND ZIDOVUDINE
CHARTWELL RX 150MG;300MG A079081 001 May 25, 2011
MYLAN 150MG;300MG A204005 001 Aug 28, 2014
MYLAN LABS LTD 150MG;300MG A079079 001 Aug 12, 2019
PHARMACARE 150MG;300MG N022018 001 Mar 17, 2017
LAMOTRIGINE
TABLET;ORAL
LAMICTAL
+ GLAXOSMITHKLINE LLC 50MG ** N020241 006 Dec 27, 1994
+ 250MG ** N020241 004 Dec 27, 1994
LAMOTRIGINE
ACTAVIS TOTOWA 25MG A078669 001 Apr 08, 2011
100MG A078669 002 Apr 08, 2011
150MG A078669 003 Apr 08, 2011
200MG A078669 004 Apr 08, 2011
CIPLA 25MG A077783 001 Nov 01, 2010
100MG A077783 002 Nov 01, 2010
150MG A077783 003 Nov 01, 2010
200MG A077783 004 Nov 01, 2010
GRANULES 25MG A078982 001 Jan 27, 2009
100MG A078982 002 Jan 27, 2009
150MG A078982 003 Jan 27, 2009
200MG A078982 004 Jan 27, 2009
HIKMA PHARMS 25MG A078134 001 Apr 19, 2011
100MG A078134 002 Apr 19, 2011
150MG A078134 003 Apr 19, 2011
200MG A078134 004 Apr 19, 2011
MYLAN 25MG A077428 001 Jan 27, 2009
100MG A077428 002 Jan 27, 2009
150MG A077428 003 Jan 27, 2009
200MG A077428 004 Jan 27, 2009
MYLAN LABS LTD 25MG A078443 001 Feb 11, 2009
100MG A078443 002 Feb 11, 2009
150MG A078443 003 Feb 11, 2009
200MG A078443 004 Feb 11, 2009
RISING 25MG A077420 001 Jan 27, 2009
100MG A077420 002 Jan 27, 2009
150MG A077420 003 Jan 27, 2009
200MG A077420 004 Jan 27, 2009
ROXANE 25MG A077392 001 Jan 27, 2009
100MG A077392 002 Jan 27, 2009
150MG A077392 003 Jan 27, 2009
200MG A077392 004 Jan 27, 2009
SANDOZ 25MG A078645 001 Jan 27, 2009
100MG A078645 002 Jan 27, 2009
150MG A078645 003 Jan 27, 2009
200MG A078645 004 Jan 27, 2009
TEVA 25MG A076388 001 Aug 30, 2006
100MG A076388 002 Aug 30, 2006
150MG A076388 003 Aug 30, 2006
200MG A076388 004 Aug 30, 2006
ZENNOVA 25MG A078310 001 Feb 04, 2009
100MG A078310 002 Feb 04, 2009
150MG A078310 003 Feb 04, 2009
200MG A078310 004 Feb 04, 2009
TABLET, EXTENDED RELEASE;ORAL
LAMOTRIGINE
RUBICON 25MG A202887 001 Jun 17, 2013
50MG A202887 002 Jun 17, 2013
TORRENT 200MG A203370 004 Dec 23, 2013
TABLET, FOR SUSPENSION;ORAL
LAMICTAL CD
GLAXOSMITHKLINE LLC 100MG N020764 003 Aug 24, 1998
LAMOTRIGINE
JUBILANT GENERICS 5MG A200220 001 Feb 28, 2011
25MG A200220 002 Feb 28, 2011
MYLAN 5MG A076630 001 Jan 22, 2009

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-276(of 478)
** See List Footnote
LAMOTRIGINE
TABLET, FOR SUSPENSION;ORAL
LAMOTRIGINE
25MG A076630 002 Jan 22, 2009
SANDOZ 5MG A078409 002 Jan 22, 2009
25MG A078409 003 Jan 22, 2009
TEVA 5MG A076420 001 Jun 21, 2006
25MG A076420 002 Jun 21, 2006
TABLET, ORALLY DISINTEGRATING;ORAL
LAMOTRIGINE
IMPAX LABS INC 25MG A200828 001 Jul 15, 2013
50MG A200828 002 Jul 15, 2013
100MG A200828 003 Jul 15, 2013
200MG A200828 004 Jul 15, 2013
LANSOPRAZOLE
CAPSULE, DELAYED REL PELLETS;ORAL
LANSOPRAZOLE
AJANTA PHARMA LTD 15MG A203957 001 Oct 14, 2016
30MG A203957 002 Oct 14, 2016
BRECKENRIDGE 15MG A203964 001 Oct 17, 2018
30MG A203964 002 Oct 17, 2018
KRKA TOVARNA ZDRAVIL 15MG A091212 001 Sep 16, 2013
30MG A091212 002 Sep 16, 2013
LANNETT CO INC 15MG A207157 001 Sep 29, 2017
PREVACID
+ TAKEDA PHARMS USA 15MG N020406 001 May 10, 1995
FOR SUSPENSION, DELAYED RELEASE;ORAL
PREVACID
TAKEDA PHARMS NA 15MG/PACKET N021281 001 May 03, 2001
30MG/PACKET N021281 002 May 03, 2001
INJECTABLE;INTRAVENOUS
PREVACID IV
+ TAKEDA PHARMS NA 30MG/VIAL ** N021566 001 May 27, 2004
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
LANSOPRAZOLE
ANI PHARMS 15MG A078730 001 Oct 15, 2010
30MG A078730 002 Oct 15, 2010
LANSOPRAZOLE; NAPROXEN
CAPSULE, DELAYED REL PELLETS, TABLET;ORAL
PREVACID NAPRAPAC 250 (COPACKAGED)
+ TAKEDA PHARMS NA 15MG,N/A;N/A,250MG ** N021507 002 Nov 14, 2003
PREVACID NAPRAPAC 375 (COPACKAGED)
TAKEDA PHARMS NA 15MG,N/A;N/A,375MG N021507 003 Nov 14, 2003
PREVACID NAPRAPAC 500 (COPACKAGED)
TAKEDA PHARMS NA 15MG,N/A;N/A,500MG N021507 004 Nov 14, 2003
LANTHANUM CARBONATE
TABLET, CHEWABLE;ORAL
FOSRENOL
TAKEDA PHARMS USA EQ 250MG BASE N021468 001 Oct 26, 2004
LAPYRIUM CHLORIDE; UNDECOYLIUM CHLORIDE IODINE COMPLEX
SOLUTION;TOPICAL
VIRAC REX
CHESEBROUGH PONDS 0.5%;1.8% N011914 001
LASMIDITAN SUCCINATE
TABLET;ORAL
REYVOW
+ ELI LILLY AND CO EQ 200MG BASE N211280 003 Dec 18, 2020
LATANOPROST
SOLUTION/DROPS;OPHTHALMIC
LATANOPROST
APOTEX INC 0.005% A077697 001 Mar 22, 2011
EUGIA PHARMA 0.005% A206519 001 Sep 03, 2019

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-277(of 478)
** See List Footnote
LEFLUNOMIDE
TABLET;ORAL
LEFLUNOMIDE
BARR 10MG A077083 001 Sep 13, 2005
20MG A077083 002 Sep 13, 2005
SANDOZ 10MG A077085 001 Sep 13, 2005
20MG A077085 002 Sep 13, 2005
TEVA PHARMS 10MG A077084 001 Sep 13, 2005
20MG A077084 002 Sep 13, 2005
LESINURAD
TABLET;ORAL
ZURAMPIC
+ IRONWOOD PHARMS INC 200MG N207988 001 Dec 22, 2015
LETROZOLE
TABLET;ORAL
LETROZOLE
ACTAVIS TOTOWA 2.5MG A090292 001 Jul 13, 2011
APOTEX INC 2.5MG A091303 001 Apr 19, 2012
FRESENIUS KABI USA 2.5MG A090491 001 Jun 03, 2011
HENGRUI PHARMA 2.5MG A202716 001 May 16, 2013
HIKMA 2.5MG A090838 001 Jun 03, 2011
HIKMA PHARMS 2.5MG A203796 001 Jun 03, 2016
IMPAX LABS 2.5MG A091638 001 Jun 03, 2011
INDICUS PHARMA 2.5MG A201804 001 Jun 03, 2011
LANNETT CO INC 2.5MG A091098 001 Jun 03, 2011
2.5MG A202048 001 Oct 29, 2014
MYLAN 2.5MG A078190 001 Dec 24, 2008
STRIDES PHARMA 2.5MG A090789 001 Jun 03, 2011
SUN PHARM INDS LTD 2.5MG A091466 001 Jun 03, 2011
SYNTHON PHARMS 2.5MG A090196 001 Jun 03, 2011
LEUCOVORIN CALCIUM
FOR SOLUTION;ORAL
LEUCOVORIN CALCIUM
HOSPIRA EQ 60MG BASE/VIAL N008107 003 Jan 30, 1987
INJECTABLE;INJECTION
LEUCOVORIN CALCIUM
ABIC EQ 3MG BASE/ML A089352 001 Jun 01, 1988
EQ 50MG BASE/VIAL A089353 001 Jun 01, 1988
ABRAXIS PHARM EQ 50MG BASE/VIAL A088939 001 Dec 01, 1986
ELKINS SINN EQ 50MG BASE/VIAL A070480 001 Jan 02, 1987
EQ 100MG BASE/VIAL A081224 001 Jun 03, 1994
+ HOSPIRA EQ 3MG BASE/ML ** N008107 001
+ EQ 50MG BASE/VIAL ** N008107 002
+ EQ 100MG BASE/VIAL ** N008107 004 May 23, 1988
+ EQ 350MG BASE/VIAL ** N008107 005 Apr 05, 1989
NOVAST LABS EQ 10MG BASE/ML A210917 001 Nov 23, 2018
PHARMACHEMIE EQ 350MG BASE/VIAL A040262 001 Dec 15, 1999
PHARMACHEMIE USA EQ 50MG BASE/VIAL A089628 001 Apr 17, 1997
EQ 100MG BASE/VIAL A089915 001 Apr 17, 1997
TEVA PARENTERAL EQ 50MG BASE/VIAL A081278 001 Sep 28, 1993
LEUCOVORIN CALCIUM PRESERVATIVE FREE
AM REGENT EQ 50MG BASE/VIAL A040338 001 Jan 31, 2001
HOSPIRA EQ 10MG BASE/ML ** A040147 001 Jun 25, 1997
TEVA PARENTERAL EQ 10MG BASE/ML A040332 001 Jun 28, 1999
WELLCOVORIN
GLAXOSMITHKLINE EQ 5MG BASE/ML A087439 001 Oct 19, 1982
EQ 25MG BASE/VIAL A089833 001 Jan 23, 1989
EQ 50MG BASE/VIAL A089465 001 Jan 23, 1989
EQ 100MG BASE/VIAL A089834 001 Jan 23, 1989
TABLET;ORAL
LEUCOVORIN CALCIUM
ANI PHARMS EQ 15MG BASE A075327 001 Mar 24, 1999
PAR PHARM EQ 5MG BASE A071600 001 Oct 14, 1987
EQ 25MG BASE A071598 001 Oct 14, 1987
PHARMACHEMIE EQ 5MG BASE A073099 001 Mar 28, 1997
EQ 25MG BASE A073101 001 Mar 28, 1997
XANODYNE PHARM EQ 5MG BASE N018459 001 Jan 30, 1986
EQ 10MG BASE A071962 001 Nov 19, 1987

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-278(of 478)
** See List Footnote
LEUCOVORIN CALCIUM
TABLET;ORAL
LEUCOVORIN CALCIUM
EQ 15MG BASE A071104 001 Mar 04, 1987
WELLCOVORIN
+ GLAXOSMITHKLINE EQ 5MG BASE ** N018342 001 Jul 08, 1983
+ EQ 25MG BASE ** N018342 002 Jul 08, 1983
LEUPROLIDE ACETATE
IMPLANT;IMPLANTATION
VIADUR
ORTHO MCNEIL JANSSEN EQ 65MG BASE N021088 001 Mar 03, 2000
INJECTABLE;INJECTION
LEUPROLIDE ACETATE
GENZYME 1MG/0.2ML A075721 001 Nov 29, 2001
LUPRON
+ ABBVIE ENDOCRINE INC 1MG/0.2ML ** N019010 001 Apr 09, 1985
LUPRON DEPOT
+ ABBVIE ENDOCRINE INC 3.75MG/VIAL ** N020011 001 Oct 22, 1990
POWDER;INTRAMUSCULAR
LUPRON DEPOT-PED KIT
+ ABBVIE ENDOCRINE INC 3.75MG,7.5MG ** N020263 003 Apr 16, 1993
+ 7.5MG,7.5MG ** N020263 004 Apr 16, 1993
LEUPROLIDE ACETATE; NORETHINDRONE ACETATE
INJECTABLE, TABLET;INTRAMUSCULAR, ORAL
LUPANETA PACK
+ ABBVIE ENDOCRINE 3.75MG/VIAL,N/A;N/A,5MG N203696 001 Dec 14, 2012
+ 11.25MG/VIAL,N/A;N/A,5MG N203696 002 Dec 14, 2012
LEVALBUTEROL HYDROCHLORIDE
SOLUTION;INHALATION
LEVALBUTEROL HYDROCHLORIDE
MYLAN SPECIALITY LP EQ 0.0103% BASE A077800 001 Mar 15, 2013
EQ 0.021% BASE A077800 002 Mar 15, 2013
EQ 0.042% BASE A077800 003 Mar 15, 2013
LEVALLORPHAN TARTRATE
INJECTABLE;INJECTION
LORFAN
ROCHE 1MG/ML N010423 001
LEVAMISOLE HYDROCHLORIDE
TABLET;ORAL
ERGAMISOL
JANSSEN PHARMA EQ 50MG BASE N020035 001 Jun 18, 1990
LEVAMLODIPINE MALEATE
TABLET;ORAL
CONJUPRI
+ CSPC OUYI EQ 1.25MG BASE N212895 001 Dec 19, 2019
LEVETIRACETAM
INJECTABLE;INTRAVENOUS
LEVETIRACETAM
AKORN 500MG/5ML (100MG/ML) A209934 001 May 04, 2018
AM REGENT 500MG/5ML (100MG/ML) A202143 001 Jan 31, 2012
FRESENIUS KABI USA 500MG/5ML (100MG/ML) A090813 001 May 26, 2010
JUBILANT GENERICS 500MG/5ML (100MG/ML) A206838 001 Jun 02, 2016
SOLUTION;ORAL
LEVETIRACETAM
APOTEX INC 100MG/ML A090187 001 Aug 05, 2011
TOLMAR 100MG/ML A079107 001 Jan 15, 2009
WOCKHARDT BIO AG 100MG/ML A090028 001 Mar 03, 2010
TABLET;ORAL
LEVETIRACETAM
ACTAVIS LABS FL INC 250MG A077408 001 Mar 02, 2009
500MG A077408 002 Mar 02, 2009
750MG A077408 003 Mar 02, 2009
FOSUN PHARMA 250MG A077324 001 Jan 15, 2009
500MG A077324 002 Jan 15, 2009
750MG A077324 003 Jan 15, 2009
1GM A077324 004 Jan 15, 2009

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-279(of 478)
** See List Footnote
LEVETIRACETAM
TABLET;ORAL
LEVETIRACETAM
LOTUS PHARM CO LTD 250MG A090906 002 Oct 31, 2016
500MG A090906 001 Nov 05, 2010
750MG A090906 003 Oct 31, 2016
1GM A090906 004 Oct 31, 2016
MYLAN 250MG A078731 001 Feb 10, 2009
500MG A078731 002 Feb 10, 2009
750MG A078731 003 Feb 10, 2009
1GM A078731 004 Feb 10, 2009
NOSTRUM LABS INC 250MG A090511 001 Aug 18, 2011
500MG A090511 002 Aug 18, 2011
750MG A090511 003 Aug 18, 2011
1GM A090511 004 Aug 18, 2011
SECAN PHARMS 500MG A205102 004 Dec 16, 2015
1GM A205102 003 Dec 16, 2015
TEVA PHARMS 250MG A078101 001 Jan 15, 2009
500MG A078101 002 Jan 15, 2009
750MG A078101 003 Jan 15, 2009
1GM A078101 004 Jan 15, 2009
WATSON LABS INC 250MG A078797 002 Jan 15, 2009
500MG A078797 003 Jan 15, 2009
750MG A078797 004 Jan 15, 2009
1GM A078797 001 Jan 15, 2009
TABLET, EXTENDED RELEASE;ORAL
LEVETIRACETAM
ACTAVIS ELIZABETH 500MG A091557 001 Sep 12, 2011
750MG A091557 002 Sep 12, 2011
ANDA REPOSITORY 500MG A091291 001 Sep 12, 2011
750MG A091291 002 Sep 12, 2011
DEXCEL 500MG A202167 001 Sep 04, 2015
750MG A202167 002 Sep 04, 2015
LOTUS PHARM CO LTD 500MG A202095 002 Jun 06, 2016
750MG A202095 001 Jun 06, 2016
MYLAN PHARMS INC 500MG A200475 001 Dec 19, 2011
750MG A200475 002 Dec 19, 2011
1GM A200475 003 Dec 07, 2015
ROUSES POINT PHARMS 500MG A202524 001 Aug 27, 2012
750MG A202524 002 Aug 27, 2012
SANDOZ 500MG A091668 001 Nov 01, 2012
750MG A091668 002 Nov 01, 2012
SUN PHARM INDUSTRIES 500MG A091285 001 Sep 12, 2011
750MG A091285 002 Sep 12, 2011
TEVA PHARMS 500MG A091430 001 Sep 12, 2011
750MG A091430 002 Sep 12, 2011
TORRENT PHARMS LTD 500MG A091338 001 May 29, 2012
750MG A091338 002 May 29, 2012
LEVOBETAXOLOL HYDROCHLORIDE
SUSPENSION/DROPS;OPHTHALMIC
BETAXON
ALCON PHARMS LTD EQ 0.5% BASE N021114 001 Feb 23, 2000
LEVOBUNOLOL HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
AKBETA
AKORN 0.25% A074779 001 Oct 29, 1996
0.5% A074780 001 Oct 29, 1996
BETAGAN
+ ALLERGAN 0.25% ** N019814 001 Jun 28, 1989
LEVOBUNOLOL HYDROCHLORIDE
ALCON LABS INC 0.25% A074851 001 Oct 28, 1996
APOTEX INC 0.25% A075473 001 Aug 03, 2000
0.5% A075475 001 Aug 03, 2000
BAUSCH AND LOMB 0.25% A074307 001 Mar 04, 1994
SANDOZ INC 0.5% A074850 001 Oct 28, 1996

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-280(of 478)
** See List Footnote
LEVOBUPIVACAINE HYDROCHLORIDE
INJECTABLE;INJECTION
CHIROCAINE
PURDUE PHARMA LP EQ 2.5MG BASE/ML N020997 001 Aug 05, 1999
EQ 5MG BASE/ML N020997 002 Aug 05, 1999
EQ 7.5MG BASE/ML N020997 003 Aug 05, 1999
LEVOCABASTINE HYDROCHLORIDE
SUSPENSION/DROPS;OPHTHALMIC
LIVOSTIN
NOVARTIS EQ 0.05% BASE N020219 001 Nov 10, 1993
LEVOCARNITINE
INJECTABLE;INJECTION
LEVOCARNITINE
TEVA PHARMS USA 200MG/ML A075881 001 Mar 29, 2001
SOLUTION;ORAL
CARNITOR
LEADIANT BIOSCI INC 1GM/10ML N018948 002 Apr 27, 1988
LEVOCETIRIZINE DIHYDROCHLORIDE
SOLUTION;ORAL
LEVOCETIRIZINE DIHYDROCHLORIDE
APOTEX 2.5MG/5ML A202915 001 Aug 21, 2014
XYZAL
+ CHATTEM SANOFI 2.5MG/5ML ** N022157 001 Jan 28, 2008
TABLET;ORAL
LEVOCETIRIZINE DIHYDROCHLORIDE
APOTEX 5MG A203027 001 Feb 13, 2015
GRANULES 5MG A090486 001 Mar 26, 2013
SUN PHARM INDS LTD 5MG A201653 001 Jun 26, 2015
US ANTIBIOTICS 5MG A204323 001 Dec 20, 2016
XYZAL
+ CHATTEM SANOFI 5MG ** N022064 001 May 25, 2007
LEVODOPA
CAPSULE;ORAL
BENDOPA
VALEANT PHARM INTL 100MG N016948 003
250MG N016948 001
500MG N016948 002
DOPAR
SHIRE 100MG N016913 003
250MG N016913 001
500MG N016913 002
LARODOPA
ROCHE 100MG N016912 002
250MG N016912 001
500MG N016912 006
TABLET;ORAL
DOPAR
SHIRE 250MG N016913 004
500MG N016913 005
LARODOPA
ROCHE 100MG N016912 005
250MG N016912 003
500MG N016912 004
LEVOFLOXACIN
INJECTABLE;INJECTION
LEVAQUIN
+ JANSSEN PHARMS EQ 500MG/20ML (EQ 25MG/ML) ** N020635 001 Dec 20, 1996
+ EQ 750MG/30ML (EQ 25MG/ML) ** N020635 004 Dec 20, 1996
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
+ JANSSEN PHARMS EQ 250MG/50ML (EQ 5MG/ML) ** N020635 002 Dec 20, 1996
+ EQ 500MG/100ML (EQ 5MG/ML) ** N020635 003 Dec 20, 1996
+ EQ 750MG/150ML (EQ 5MG/ML) ** N020635 005 Dec 20, 1996
LEVOFLOXACIN
EMCURE PHARMS LTD EQ 500MG/20ML (EQ 25MG/ML) A202590 001 Jan 24, 2013
EQ 750MG/30ML (EQ 25MG/ML) A202590 002 Jan 24, 2013
EUGIA PHARMA EQ 500MG/20ML (EQ 25MG/ML) A202328 001 Jan 24, 2013
EQ 750MG/30ML (EQ 25MG/ML) A202328 002 Jan 24, 2013

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-281(of 478)
** See List Footnote
LEVOFLOXACIN
INJECTABLE;INJECTION
LEVOFLOXACIN
HOSPIRA EQ 500MG/20ML (EQ 25MG/ML) A078577 001 Aug 12, 2015
EQ 750MG/30ML (EQ 25MG/ML) A078577 002 Aug 12, 2015
MYLAN ASI EQ 500MG/20ML (EQ 25MG/ML) A200560 001 Jun 20, 2011
EQ 750MG/30ML (EQ 25MG/ML) A200560 002 Jun 20, 2011
ZYDUS PHARMS EQ 500MG/20ML (EQ 25MG/ML) A205968 001 Jun 01, 2017
EQ 750MG/30ML (EQ 25MG/ML) A205968 002 Jun 01, 2017
LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
EUGIA PHARMA EQ 250MG/50ML (EQ 5MG/ML) A206919 001 Feb 10, 2016
EQ 500MG/100ML (EQ 5MG/ML) A206919 002 Feb 10, 2016
EQ 750MG/150ML (EQ 5MG/ML) A206919 003 Feb 10, 2016
SOLUTION;ORAL
LEVAQUIN
+ JANSSEN PHARMS 250MG/10ML N021721 001 Oct 21, 2004
SOLUTION/DROPS;OPHTHALMIC
IQUIX
+ SANTEN 1.5% ** N021571 001 Mar 01, 2004
LEVOFLOXACIN
MYLAN LABS LTD 0.5% A204899 001 Dec 08, 2017
RUBICON 0.5% A078282 001 Dec 20, 2010
WATSON LABS TEVA 0.5% A076826 001 Feb 10, 2011
QUIXIN
+ SANTEN 0.5% ** N021199 001 Aug 18, 2000
TABLET;ORAL
LEVAQUIN
+ JANSSEN PHARMS 250MG ** N020634 001 Dec 20, 1996
+ 500MG ** N020634 002 Dec 20, 1996
+ 750MG ** N020634 003 Sep 08, 2000
LEVOFLOXACIN
JUBILANT GENERICS 250MG A203613 001 Jun 19, 2015
500MG A203613 002 Jun 19, 2015
MYLAN 250MG A076276 001 Jun 20, 2011
500MG A076276 002 Jun 20, 2011
750MG A077097 001 Jun 20, 2011
TORRENT PHARMS 250MG A090722 001 Jun 20, 2011
500MG A090722 002 Jun 20, 2011
750MG A090722 003 Jun 20, 2011
WATSON LABS INC 250MG A201484 001 Nov 22, 2013
500MG A201484 002 Nov 22, 2013
750MG A201484 003 Nov 22, 2013
LEVOLEUCOVORIN CALCIUM
POWDER;INTRAVENOUS
LEVOLEUCOVORIN CALCIUM
ACTAVIS LLC EQ 50MG BASE/VIAL A206516 001 Feb 13, 2017
+ EQ 175MG BASE/VIAL N208723 001 Sep 29, 2016
AMNEAL EQ 50MG BASE/VIAL A207547 001 Feb 13, 2017
HIKMA EQ 50MG BASE/VIAL A206263 001 Jun 16, 2016
SOLUTION;INTRAVENOUS
FUSILEV
+ ACROTECH BIOPHARMA EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) N020140 002 Apr 29, 2011
**
+ EQ 250MG BASE/25ML (EQ 10MG BASE/ML) ** N020140 003 Apr 29, 2011
LEVOLEUCOVORIN CALCIUM
MEITHEAL EQ 250MG BASE/25ML (EQ 10MG BASE/ML) A211002 002 Aug 16, 2019
MYLAN TEORANTA EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) A203576 001 Oct 20, 2015
EQ 250MG BASE/25ML (EQ 10MG BASE/ML) A203576 002 Oct 20, 2015
NOVAST LABS EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) A210623 001 May 03, 2018
EQ 250MG BASE/25ML (EQ 10MG BASE/ML) A210623 002 May 03, 2018
PRAXGEN EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) A213797 001 Nov 02, 2021
SANDOZ INC EQ 250MG BASE/25ML (EQ 10MG BASE/ML) A203563 002 Mar 09, 2015

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-282(of 478)
** See List Footnote
LEVOMEPROMAZINE
INJECTABLE;INJECTION
LEVOPROME
IMMUNEX 20MG/ML N015865 001
LEVOMETHADYL ACETATE HYDROCHLORIDE
CONCENTRATE;ORAL
ORLAAM
+ ROXANE 10MG/ML ** N020315 001 Jul 09, 1993
LEVOMILNACIPRAN HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
LEVOMILNACIPRAN HYDROCHLORIDE
AMNEAL PHARMS CO EQ 20MG BASE A210790 001 Feb 04, 2019
EQ 40MG BASE A210790 002 Feb 04, 2019
EQ 80MG BASE A210790 003 Feb 04, 2019
EQ 120MG BASE A210790 004 Feb 04, 2019
HIKMA EQ 20MG BASE A210732 001 Nov 05, 2020
EQ 40MG BASE A210732 002 Nov 05, 2020
EQ 80MG BASE A210732 003 Nov 05, 2020
EQ 120MG BASE A210732 004 Nov 05, 2020
LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
INJECTABLE;INJECTION
ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN
SOLVAY 0.05MG/ML;2% A085010 001
CARBOCAINE W/ NEO-COBEFRIN
EASTMAN KODAK 0.05MG/ML;2% N012125 002
ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN
SEPTODONT INC 0.05MG/ML;2% A084697 001
MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN
BELMORA LLC 0.05MG/ML;2% A084850 002 Oct 21, 1983
POLOCAINE W/ LEVONORDEFRIN
DENTSPLY PHARM 0.05MG/ML;2% A089517 001 Apr 14, 1988
LEVONORDEFRIN; PROCAINE HYDROCHLORIDE; PROPOXYCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN
EASTMAN KODAK 0.05MG/ML;2%;0.4% N008592 007
LEVONORGESTREL
IMPLANT;IMPLANTATION
JADELLE
+ POPULATION COUNCIL 75MG/IMPLANT ** N020544 001 Nov 01, 1996
LEVONORGESTREL
WYETH PHARMS INC 75MG/IMPLANT N020627 001 Aug 15, 1996
NORPLANT
POPULATION COUNCIL 36MG/IMPLANT N019897 001 Dec 10, 1990
NORPLANT SYSTEM IN PLASTIC CONTAINER
WYETH PHARMS INC 36MG/IMPLANT N020088 001 Dec 10, 1990
TABLET;ORAL
LEVONORGESTREL
ALVOGEN 1.5MG A202246 001 Jun 05, 2015
FDN CONSUMER 0.75MG ** A078665 001 Aug 28, 2009
1.5MG A200670 001 Jul 12, 2012
L PERRIGO CO 0.75MG A090740 001 Dec 30, 2010
LOTUS PHARM CO LTD 0.75MG A202684 001 Sep 02, 2016
LUPIN LTD 0.75MG A091328 001 Jan 23, 2013
MYLAN LABS LTD 0.75MG A202740 001 Sep 02, 2016
NAARI PTE LTD 1.5MG A207660 001 May 02, 2019
WATSON LABS 0.75MG A078666 001 Jun 24, 2009
PLAN B
+ FDN CONSUMER 0.75MG ** N021045 001 Jul 28, 1999
+ 0.75MG ** N021045 002 Aug 24, 2006
LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS
CAPSULE;ORAL
NOVRAD
LILLY EQ 50MG BASE N012928 006
EQ 100MG BASE N012928 004

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-283(of 478)
** See List Footnote
LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS
SUSPENSION;ORAL
NOVRAD
LILLY EQ 50MG BASE/5ML N012928 002
LEVORPHANOL TARTRATE
INJECTABLE;INJECTION
LEVO-DROMORAN
VALEANT PHARM INTL 2MG/ML N008719 001 Dec 19, 1991
TABLET;ORAL
LEVO-DROMORAN
+ VALEANT PHARM INTL 2MG ** N008720 001 Dec 19, 1991
LEVORPHANOL TARTRATE
HIKMA 1MG A074278 002 Jun 18, 2018
2MG A074278 001 Mar 31, 2000
3MG A074278 003 Jun 18, 2018
LEVOTHYROXINE SODIUM
CAPSULE;ORAL
LEVOTHYROXINE SODIUM
TEVA PHARMS USA INC 0.075MG A211369 001 Oct 28, 2020
0.088MG A213256 001 Jan 06, 2021
0.1MG A213256 002 Jan 06, 2021
0.112MG A211369 003 Apr 16, 2021
0.125MG A213256 003 Jan 06, 2021
0.15MG A211369 002 Oct 28, 2020
POWDER;INTRAVENOUS
LEVOTHYROXINE SODIUM
DR REDDYS 100MCG/VIAL A208837 001 Mar 27, 2020
PAR STERILE PRODUCTS 200MCG/VIAL A205366 001 Dec 07, 2015
TABLET;ORAL
EUTHYROX
PROVELL 0.3MG N021292 012 May 31, 2002
LEVOTHYROXINE SODIUM
AMNEAL 0.025MG A210831 001 Feb 19, 2019
0.05MG A210831 002 Feb 19, 2019
0.075MG A210831 003 Feb 19, 2019
0.088MG A210831 004 Feb 19, 2019
0.1MG A210831 005 Feb 19, 2019
0.112MG A210831 006 Feb 19, 2019
0.125MG A210831 007 Feb 19, 2019
0.137MG A210831 008 Feb 19, 2019
0.15MG A210831 009 Feb 19, 2019
0.175MG A210831 010 Feb 19, 2019
0.2MG A210831 011 Feb 19, 2019
0.3MG A210831 012 Feb 19, 2019
MERCK KGAA 0.025MG A076752 001 Jun 16, 2005
0.05MG A076752 002 Jun 16, 2005
0.075MG A076752 003 Jun 16, 2005
0.088MG A076752 004 Jun 16, 2005
0.1MG A076752 005 Jun 16, 2005
0.112MG A076752 006 Jun 16, 2005
0.125MG A076752 007 Jun 16, 2005
0.15MG A076752 008 Jun 16, 2005
0.175MG A076752 009 Jun 16, 2005
0.2MG A076752 010 Jun 16, 2005
0.3MG A076752 011 Jun 16, 2005
LEVOXYL
+ KING PHARMS 0.3MG ** N021301 012 May 25, 2001
LIDOCAINE
AEROSOL;ORAL
XYLOCAINE
ASTRAZENECA 10% N014394 001
FILM, EXTENDED RELEASE;BUCCAL
DENTIPATCH
NOVEN 23MG/PATCH N020575 001 May 21, 1996
OINTMENT;TOPICAL
ALPHACAINE
CARLISLE 5% A084944 001
5% A084946 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-284(of 478)
** See List Footnote
LIDOCAINE
OINTMENT;TOPICAL
ALPHACAINE
5% A084947 001
LIDOCAINE
BELMORA LLC 5% A080210 001
GENEYORK PHARMS 5% A212486 001 Oct 17, 2019
RISING 5% A208604 001 Sep 20, 2017
TEVA PHARMS USA 5% A210256 001 Jan 16, 2018
XYLOCAINE
+ ASTRAZENECA 5% ** N008048 001
PATCH;TOPICAL
DENTIPATCH
NOVEN 46.1MG/PATCH N020575 002 May 21, 1996
LIDOCAINE
NOVEN PHARMS INC 5% A203265 001 Dec 01, 2020
SOLUTION;TOPICAL
XYLOCAINE
ASTRAZENECA 5% N014127 001
SUPPOSITORY;RECTAL
XYLOCAINE
ASTRAZENECA 100MG N013077 001
LIDOCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
ALPHACAINE HYDROCHLORIDE
CARLISLE 2% A084721 001
LIDOCAINE HYDROCHLORIDE
ABBOTT 10% A087980 001 Feb 02, 1983
20% A089362 001 May 25, 1988
ABRAXIS PHARM 1% A080420 001
1% A086761 001
1.5% A080420 005
2% A080420 002
2% A080420 004
2% A086761 002
2% N017508 001
4% N017508 002
20% N017508 004
AKORN 1% A085037 001
2% A085037 002
AM REGENT 1% A080850 001
1% A091564 001 Aug 14, 2015
BEL MAR 1% A080710 001
2% A080760 001
BELMORA LLC 2% A080504 001
DELL LABS 1% A083387 001
2% A083388 001
ELKINS SINN 0.5% A085131 001
4% A084626 001
GD SEARLE LLC 1% A083135 001
2% A083135 002
HOSPIRA 1% A040013 001 Jun 23, 1995
1.5% A088330 001 May 17, 1984
2% A088331 001 May 17, 1984
20% A083158 003
INTL MEDICATION 1% N017701 002
2% N017701 001
1GM/VIAL N018543 001
2GM/VIAL N018543 002
LUITPOLD 2% A083198 001
LYPHOMED 1% A080390 001
2% A080390 002
MILES 1% A080414 001
2% A080414 002
RISING 0.5% A091056 001 Dec 08, 2010
0.5% A091058 001 Sep 30, 2010
1% A091056 002 Dec 08, 2010
1% A091058 002 Sep 30, 2010
2% A202242 001 Apr 11, 2014

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-285(of 478)
** See List Footnote
LIDOCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
LIDOCAINE HYDROCHLORIDE
WATSON LABS 1% A080377 001
1% A083627 001
2% A080377 002
2% A083627 002
WYETH AYERST 1% A083083 001
2% A083083 002
LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 100MG/100ML N018461 001
LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 200MG/100ML N018967 001 Mar 30, 1984
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5%
HOSPIRA 200MG/100ML A083158 005
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
ABBOTT 200MG/100ML N018954 001 Jul 09, 1985
HOSPIRA 200MG/100ML N018388 001
LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 400MG/100ML N018967 002 Mar 30, 1984
LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%
HOSPIRA 400MG/100ML A083158 006
LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER
HOSPIRA 400MG/100ML N018388 002
LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 800MG/100ML N018967 003 Mar 30, 1984
LIDOCAINE HYDROCHLORIDE 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER
HOSPIRA 800MG/100ML N018388 003 Nov 05, 1982
LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER
HOSPIRA 1.5% A088326 001 Jul 31, 1984
10% A088367 001 Jul 31, 1984
20% A088368 001 Jul 31, 1984
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
INTL MEDICATION 4% N017702 002
20% N017702 001
MYLAN LABS LTD 2% A090665 001 Sep 27, 2010
LIDOCATON
PHARMATON 2% A084727 001 Aug 17, 1983
LIDOPEN
MERIDIAN MEDCL TECHN 10% N017549 001
XYLOCAINE
ASTRAZENECA 1% N010418 005
1.5% N010418 009
2% N010418 007
XYLOCAINE 4% PRESERVATIVE FREE
+ FRESENIUS KABI USA 4% N010417 001
XYLOCAINE DENTAL
DENTSPLY PHARM 2% N021380 001
XYLOCAINE PRESERVATIVE FREE
+ FRESENIUS KABI USA 1% ** N016801 005 Jan 19, 1988
+ 2% ** N016801 001
+ 4% ** N016801 002
10% ** N016801 003
+ 20% ** N016801 004
INJECTABLE;SPINAL
XYLOCAINE 1.5% W/ DEXTROSE 7.5%
FRESENIUS KABI USA 1.5% N016297 001
XYLOCAINE 5% W/ GLUCOSE 7.5%
ASTRAZENECA 5% N010496 002 Jul 07, 1982
JELLY;TOPICAL
ANESTACON
BIONPHARMA INC 2% A080429 001
LIDOCAINE HYDROCHLORIDE
COSETTE 2% A081318 001 Apr 29, 1993
WATSON LABS INC 2% A040837 001 Mar 23, 2011
XYLOCAINE
+ AKORN 2% ** N008816 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-286(of 478)
** See List Footnote
LIDOCAINE HYDROCHLORIDE
SOLUTION;ORAL
LIDOCAINE HYDROCHLORIDE VISCOUS
ACTAVIS MID ATLANTIC 2% A086578 001
INTL MEDICATION 2% A086389 001 Feb 02, 1982
XYLOCAINE VISCOUS
+ FRESENIUS KABI USA 2% ** N009470 001
SOLUTION;TOPICAL
LARYNGOTRACHEAL ANESTHESIA KIT
KENDALL IL 4% A087931 001 Jun 10, 1983
LIDOCAINE HYDROCHLORIDE
PACO 4% A089688 001 Jun 30, 1989
LTA II KIT
HOSPIRA 4% A080409 001
4% A088542 001 Jul 31, 1984
PEDIATRIC LTA KIT
ABBOTT 2% A088572 001 Jul 31, 1984
HOSPIRA 2% A085995 001
XYLOCAINE 4% PRESERVATIVE FREE
+ FRESENIUS KABI USA 4% ** N010417 002
LIDOCAINE HYDROCHLORIDE; OXYTETRACYCLINE
INJECTABLE;INJECTION
TERRAMYCIN
PFIZER 2%;50MG/ML A060567 001
2%;125MG/ML A060567 002
LIDOCAINE; PRILOCAINE
CREAM;TOPICAL
EMLA
+ TEVA BRANDED PHARM 2.5%;2.5% N019941 001 Dec 30, 1992
LIDOCAINE AND PRILOCAINE
RHODES PHARMS 2.5%;2.5% A213253 001 Sep 21, 2020
DISC;TOPICAL
EMLA
ASTRAZENECA 2.5%;2.5% N020962 001 Feb 04, 1998
LIDOCAINE; TETRACAINE
PATCH;TOPICAL
SYNERA
+ GALEN SPECIALTY 70MG;70MG N021623 001 Jun 23, 2005
LINACLOTIDE
CAPSULE;ORAL
LINACLOTIDE
MYLAN 145MCG A209564 001 Feb 09, 2021
290MCG A209564 002 Feb 09, 2021
LINCOMYCIN HYDROCHLORIDE
CAPSULE;ORAL
LINCOCIN
PHARMACIA AND UPJOHN EQ 250MG BASE N050316 001
EQ 500MG BASE N050316 002
INJECTABLE;INJECTION
LINCOMYCIN HYDROCHLORIDE
ATHENEX INC EQ 300MG BASE/ML A212770 001 Mar 12, 2021
WATSON LABS EQ 300MG BASE/ML A063180 001 Apr 16, 1991
LINDANE
CREAM;TOPICAL
KWELL
REED AND CARNRICK 1% A084218 001
1% N006309 001
LOTION;TOPICAL
GAMENE
SOLA BARNES HIND 1% A084989 001
KWELL
REED AND CARNRICK 1% A084218 002
1% N006309 003
LINDANE
OLTA PHARMS 1% A087313 001
WOCKHARDT BIO AG 1% A088190 001 Aug 16, 1984

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-287(of 478)
** See List Footnote
LINDANE
LOTION;TOPICAL
SCABENE
STIEFEL 1% A086769 001
SHAMPOO;TOPICAL
GAMENE
SOLA BARNES HIND 1% A084988 001
KWELL
REED AND CARNRICK 1% A084219 001
1% N010718 001
LINDANE
OLTA PHARMS 1% A087266 001
WOCKHARDT BIO AG 1% A088191 001 Sep 18, 1984
SCABENE
STIEFEL 1% A087940 001 Apr 08, 1983
LINEZOLID
SOLUTION;INTRAVENOUS
LINEZOLID
HOSPIRA 600MG/300ML (2MG/ML) A205442 001 Jul 07, 2015
TEVA PHARMS 600MG/300ML (2MG/ML) A200222 001 Jun 27, 2012
ZYVOX
+ PFIZER 400MG/200ML (2MG/ML) ** N021131 002 Apr 18, 2000
TABLET;ORAL
LINEZOLID
AMNEAL PHARMS 600MG A204536 001 Dec 21, 2015
GATE PHARMS 600MG A091210 001 Feb 05, 2016
RISING 600MG A078845 001 Dec 21, 2015
TEVA PHARMS USA 600MG A078061 001 May 18, 2015
ZYVOX
+ PFIZER 400MG ** N021130 001 Apr 18, 2000
LIOTHYRONINE SODIUM
TABLET;ORAL
LIOTHYRONINE SODIUM
MYLAN EQ 0.005MG BASE A090326 001 Jul 14, 2009
EQ 0.025MG BASE A090326 002 Jul 14, 2009
EQ 0.05MG BASE A090326 003 Jul 14, 2009
WATSON LABS EQ 0.025MG BASE A085755 001 Jan 25, 1982
EQ 0.05MG BASE A085753 001 Feb 03, 1982
LIOTRIX (T4;T3)
TABLET;ORAL
EUTHROID-0.5
PARKE DAVIS 0.03MG;0.0075MG N016680 001
EUTHROID-1
PARKE DAVIS 0.06MG;0.015MG N016680 002
EUTHROID-2
PARKE DAVIS 0.12MG;0.03MG N016680 003
EUTHROID-3
PARKE DAVIS 0.18MG;0.045MG N016680 004
THYROLAR-0.25
+ ALLERGAN 0.0125MG;0.0031MG N016807 001
THYROLAR-0.5
+ ALLERGAN 0.025MG;0.0063MG N016807 005
THYROLAR-1
+ ALLERGAN 0.05MG;0.0125MG N016807 004
THYROLAR-2
+ ALLERGAN 0.1MG;0.025MG N016807 002
THYROLAR-3
+ ALLERGAN 0.15MG;0.0375MG N016807 003
THYROLAR-5
ALLERGAN 0.25MG;0.0625MG N016807 006
LISINOPRIL
TABLET;ORAL
LISINOPRIL
GRAVITI PHARMS 2.5MG A075999 001 Jul 01, 2002
5MG A075999 002 Jul 01, 2002
10MG A075999 003 Jul 01, 2002
20MG A075999 004 Jul 01, 2002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-288(of 478)
** See List Footnote
LISINOPRIL
TABLET;ORAL
LISINOPRIL
30MG A075999 005 Jul 01, 2002
40MG A075999 006 Jul 01, 2002
HERITAGE PHARMA 2.5MG A075752 001 Jul 01, 2002
5MG A075752 002 Jul 01, 2002
10MG A075752 003 Jul 01, 2002
20MG A075752 004 Jul 01, 2002
30MG A075752 005 Jul 01, 2002
40MG A075752 006 Jul 01, 2002
HIKMA INTL PHARMS 2.5MG A076063 001 Jul 01, 2002
5MG A076063 002 Jul 01, 2002
10MG A076063 003 Jul 01, 2002
20MG A076063 004 Jul 01, 2002
30MG A076063 006 Jun 27, 2003
40MG A076063 005 Jul 01, 2002
STRIDES PHARMA 2.5MG A076071 001 Jul 01, 2002
5MG A076071 002 Jul 01, 2002
10MG A076071 003 Jul 01, 2002
20MG A076071 004 Jul 01, 2002
30MG A076071 005 Jul 01, 2002
40MG A076071 006 Jul 01, 2002
TEVA 2.5MG A075783 001 Jul 01, 2002
5MG A075783 002 Jul 01, 2002
10MG A075783 003 Jul 01, 2002
20MG A075783 004 Jul 01, 2002
30MG A075783 005 Jul 01, 2002
40MG A075783 006 Jul 01, 2002
PRINIVIL
MERCK 2.5MG N019558 006 Jan 28, 1994
5MG N019558 001 Dec 29, 1987
10MG N019558 002 Dec 29, 1987
20MG N019558 003 Dec 29, 1987
40MG N019558 004 Oct 25, 1988
LITHIUM CARBONATE
CAPSULE;ORAL
ESKALITH
NOVEN THERAP 300MG N016860 001
LITHIUM CARBONATE
ABLE 150MG A076823 001 Jun 29, 2004
300MG A076121 001 Sep 27, 2001
300MG A076823 002 Jun 29, 2004
600MG A076823 003 Jun 29, 2004
APOTEX INC 300MG A076795 001 Nov 22, 2004
MYLAN 150MG A076243 002 Feb 24, 2003
300MG A076243 001 Jun 27, 2002
600MG A078763 001 Apr 15, 2008
USL PHARMA 300MG A072542 001 Feb 01, 1989
WATSON LABS 300MG A070407 001 Mar 19, 1987
LITHONATE
SOLVAY 300MG N016782 001
TABLET;ORAL
ESKALITH
JDS PHARMS 300MG N017971 001
LITHANE
BAYER PHARMS 300MG N018833 001 Jul 18, 1985
LITHIUM CARBONATE
HIKMA INTL PHARMS 300MG A078715 001 Dec 28, 2010
PFIZER 300MG N016834 001
LITHOTABS
SOLVAY 300MG N016980 001
TABLET, EXTENDED RELEASE;ORAL
ESKALITH CR
JDS PHARMS 450MG ** N018152 001 Mar 29, 1982
LITHIUM CARBONATE
ABLE 300MG A076382 001 Apr 21, 2003
ALEMBIC PHARMS 300MG A204445 001 Jun 10, 2015
HERITAGE PHARMA 300MG A076170 001 Jun 10, 2002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-289(of 478)
** See List Footnote
LITHIUM CARBONATE
TABLET, EXTENDED RELEASE;ORAL
LITHIUM CARBONATE
450MG A076366 001 Aug 21, 2003
HIKMA INTL PHARMS 450MG A076490 001 Jun 17, 2003
LITHIUM CITRATE
SYRUP;ORAL
LITHIUM CITRATE
+ HIKMA EQ 300MG CARBONATE/5ML N018421 001
LITHONATE
SOLVAY EQ 300MG CARBONATE/5ML N017672 001
LOMEFLOXACIN HYDROCHLORIDE
TABLET;ORAL
MAXAQUIN
PHARMACIA EQ 400MG BASE N020013 001 Feb 21, 1992
LOMITAPIDE MESYLATE
CAPSULE;ORAL
JUXTAPID
+ AMRYT EQ 40MG BASE N203858 005 Apr 23, 2015
+ EQ 60MG BASE N203858 006 Apr 23, 2015
LOMUSTINE
CAPSULE;ORAL
GLEOSTINE
+ CORDEN PHARMA 5MG N017588 004 Dec 19, 2014
LOPERAMIDE HYDROCHLORIDE
CAPSULE;ORAL
IMODIUM
J AND J CONSUMER INC 2MG ** N017690 001
+ 2MG ** N017694 001
LOPERAMIDE HYDROCHLORIDE
CHARTWELL RX 2MG A072993 001 Aug 28, 1992
ROXANE 2MG A073080 001 Nov 27, 1991
TEVA 2MG A073122 001 Aug 30, 1991
SOLUTION;ORAL
IMODIUM
JANSSEN PHARMS 1MG/5ML N019037 001 Jul 31, 1984
LOPERAMIDE HYDROCHLORIDE
AKORN 1MG/5ML A074352 001 Nov 17, 1995
ALLIED 1MG/5ML A073079 001 Apr 30, 1992
ALPHARMA US PHARMS 1MG/5ML A073187 001 Sep 15, 1992
DURAMED PHARMS BARR 1MG/5ML A074991 001 Dec 29, 1997
PERRIGO 1MG/5ML A073243 001 Jan 21, 1992
TEVA 1MG/5ML A073478 001 Jun 23, 1995
WATSON LABS 1MG/5ML A073062 001 May 28, 1993
TABLET;ORAL
LOPERAMIDE HYDROCHLORIDE
ABLE 2MG A073528 001 Nov 30, 1993
CONTRACT PHARMACAL 2MG A073254 001 Jul 30, 1993
PERRIGO 2MG A074194 001 Oct 30, 1992
TABLET, CHEWABLE;ORAL
IMODIUM A-D EZ CHEWS
+ J AND J CONSUMER INC 2MG N020448 001 Jul 24, 1997
LOPERAMIDE HYDROCHLORIDE; SIMETHICONE
TABLET, CHEWABLE;ORAL
IMODIUM MULTI-SYMPTOM RELIEF
+ J AND J CONSUMER INC 2MG;125MG N020606 001 Jun 26, 1996
LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE
PERRIGO 2MG;125MG A076029 001 Aug 30, 2002
LOPINAVIR; RITONAVIR
CAPSULE;ORAL
KALETRA
ABBVIE 133.3MG;33.3MG N021226 001 Sep 15, 2000

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-290(of 478)
** See List Footnote
LORACARBEF
CAPSULE;ORAL
LORABID
KING PHARMS 200MG N050668 001 Dec 31, 1991
400MG N050668 002 Apr 05, 1996
FOR SUSPENSION;ORAL
LORABID
KING PHARMS 100MG/5ML N050667 001 Dec 31, 1991
200MG/5ML N050667 002 Dec 31, 1991
LORATADINE
CAPSULE;ORAL
LORATADINE
STRIDES PHARMA 10MG A211926 001 Jan 15, 2020
SYRUP;ORAL
CLARITIN HIVES RELIEF
+ BAYER HEALTHCARE LLC 1MG/ML ** N020641 003 Nov 19, 2003
LORATADINE
PHARM ASSOC 1MG/ML A075565 001 Oct 05, 2004
RANBAXY LABS LTD 1MG/ML A076529 001 Aug 20, 2004
TEVA 1MG/ML A075505 001 Nov 07, 2003
TABLET;ORAL
LORATADINE
MYLAN 10MG A075790 001 Nov 07, 2008
10MG A078447 001 Aug 12, 2011
PERRIGO 10MG N021512 001 Jun 24, 2004
TABLET, ORALLY DISINTEGRATING;ORAL
LORATADINE
ACTAVIS LABS FL INC 10MG A075990 001 Nov 03, 2003
GLAXOSMITHKLINE 10MG A075822 001 Feb 10, 2003
LORATADINE; PSEUDOEPHEDRINE SULFATE
TABLET, EXTENDED RELEASE;ORAL
LORATADINE AND PSEUDOEPHEDRINE SULFATE
HERITAGE PHARMA 5MG;120MG A076208 001 Jan 28, 2004
LORAZEPAM
CONCENTRATE;ORAL
LORAZEPAM
CHARTWELL MOLECULAR 2MG/ML A079244 001 Apr 28, 2009
INJECTABLE;INJECTION
LORAZEPAM
AKORN 2MG/ML A074974 001 Jul 23, 1998
BEDFORD 2MG/ML A077076 001 Jul 13, 2005
4MG/ML A077076 002 Jul 13, 2005
DAVA PHARMS INC 2MG/ML A074793 001 Mar 16, 2000
4MG/ML A074793 002 Mar 16, 2000
DR REDDYS 1MG/0.5ML A074551 003 Sep 12, 1996
2MG/ML A074535 001 Sep 12, 1996
2MG/ML A074551 001 Sep 12, 1996
4MG/ML A074535 002 Sep 12, 1996
4MG/ML A074551 002 Sep 12, 1996
HIKMA 2MG/ML A074496 001 Sep 28, 1998
4MG/ML A074496 002 Sep 28, 1998
HOSPIRA 2MG/ML A074280 001 May 27, 1994
2MG/ML A074300 001 Apr 12, 1994
4MG/ML A074280 002 May 27, 1994
4MG/ML A074300 003 Mar 19, 1997
RISING 2MG/ML A200217 001 Apr 04, 2017
2MG/ML A200542 001 Apr 28, 2017
4MG/ML A200217 002 Apr 04, 2017
4MG/ML A200542 002 Apr 28, 2017
WATSON LABS 2MG/ML A074276 001 Apr 15, 1994
4MG/ML A074276 002 Apr 15, 1994
LORAZEPAM PRESERVATIVE FREE
BEDFORD LABS 2MG/ML A077074 001 Jul 13, 2005
4MG/ML A077074 002 Jul 13, 2005
SOLUTION;ORAL
LORAZEPAM
ROXANE 0.5MG/5ML A074648 001 Mar 18, 1997

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-291(of 478)
** See List Footnote
LORAZEPAM
TABLET;ORAL
LORAZ
QUANTUM PHARMICS 0.5MG A070200 001 Aug 09, 1985
1MG A070201 001 Aug 09, 1985
2MG A070202 001 Aug 09, 1985
LORAZEPAM
AM THERAP 0.5MG A070727 001 Mar 07, 1986
1MG A070728 001 Mar 07, 1986
2MG A070729 001 Mar 07, 1986
ANDA REPOSITORY 0.5MG A072555 002 Mar 29, 1991
1MG A072555 003 Mar 29, 1991
2MG A072555 001 Mar 29, 1991
ANI PHARMS 0.5MG A077396 001 Dec 13, 2006
1MG A077396 002 Dec 13, 2006
2MG A077396 003 Dec 13, 2006
HALSEY 0.5MG A071434 001 Sep 01, 1987
1MG A071435 001 Sep 01, 1987
2MG A071436 001 Sep 01, 1987
MUTUAL PHARM 0.5MG A070472 001 Dec 10, 1985
1MG A070473 001 Dec 10, 1985
2MG A070474 001 Dec 10, 1985
PAR PHARM 0.5MG A070675 001 Dec 01, 1986
1MG A070676 001 Dec 01, 1986
2MG A070677 001 Dec 01, 1986
RISING 0.5MG A077657 001 Mar 16, 2006
1MG A077657 002 Mar 16, 2006
2MG A077657 003 Mar 16, 2006
SANDOZ 0.5MG A071193 001 Apr 15, 1988
1MG A071194 001 Apr 15, 1988
2MG A071195 001 Apr 15, 1988
STRIDES PHARMA 0.5MG A071591 002 Oct 13, 1987
1MG A071591 003 Oct 13, 1987
2MG A071591 001 Oct 13, 1987
SUN PHARM INDS LTD 0.5MG A076045 001 Aug 29, 2001
1MG A076045 002 Aug 29, 2001
2MG A076045 003 Aug 29, 2001
SUPERPHARM 0.5MG A071245 001 Feb 09, 1987
1MG A071246 001 Feb 09, 1987
2MG A071247 001 Feb 09, 1987
USL PHARMA 1MG A070539 001 Dec 22, 1986
2MG A070540 001 Dec 22, 1986
WARNER CHILCOTT 1MG A071038 001 Jan 12, 1988
2MG A071039 001 Jan 12, 1988
WATSON LABS 0.5MG A071086 001 Mar 23, 1987
0.5MG A071117 001 Jul 24, 1986
1MG A071087 001 Mar 23, 1987
1MG A071118 001 Jul 24, 1986
2MG A071088 001 Mar 23, 1987
2MG A071110 001 Jul 24, 1986
LOSARTAN POTASSIUM
TABLET;ORAL
LOSARTAN POTASSIUM
APOTEX CORP 25MG A090790 001 Oct 06, 2010
50MG A090790 002 Oct 06, 2010
100MG A090790 003 Oct 06, 2010
HIKMA 25MG A077459 001 Oct 06, 2010
50MG A077459 002 Oct 06, 2010
100MG A077459 003 Oct 06, 2010
HISUN PHARM HANGZHOU 25MG A204795 001 Apr 04, 2019
50MG A204795 002 Apr 04, 2019
100MG A204795 003 Apr 04, 2019
MYLAN 25MG A091590 001 Oct 06, 2010
50MG A091590 002 Oct 06, 2010
100MG A091590 003 Oct 06, 2010
TEVA 25MG A076958 001 Apr 06, 2010
50MG A076958 002 Apr 06, 2010
100MG A076958 003 Apr 06, 2010
TORRENT PHARMS 25MG A090467 001 Oct 06, 2010

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-292(of 478)
** See List Footnote
LOSARTAN POTASSIUM
TABLET;ORAL
LOSARTAN POTASSIUM
50MG A090467 002 Oct 06, 2010
100MG A090467 003 Oct 06, 2010
UPSHER SMITH LABS 25MG A090544 001 Oct 06, 2010
50MG A090544 002 Oct 06, 2010
100MG A090544 003 Oct 06, 2010
LOTEPREDNOL ETABONATE
SUSPENSION/DROPS;OPHTHALMIC
LOTEMAX
PHARMOS 0.5% N020841 001 Mar 09, 1998
LOVASTATIN
TABLET;ORAL
LOVASTATIN
MYLAN 10MG A075451 001 Dec 17, 2001
10MG A075935 001 Dec 17, 2001
20MG A075451 002 Dec 17, 2001
20MG A075935 002 Dec 17, 2001
40MG A075451 003 Dec 17, 2001
40MG A075935 003 Dec 17, 2001
SUN PHARM INDUSTRIES 10MG A077520 001 Apr 14, 2006
20MG A077520 002 Apr 14, 2006
40MG A077520 003 Apr 14, 2006
MEVACOR
+ MERCK 10MG ** N019643 002 Mar 28, 1991
+ 20MG ** N019643 003 Aug 31, 1987
+ 40MG ** N019643 004 Dec 14, 1988
TABLET, EXTENDED RELEASE;ORAL
ALTOPREV
COVIS 10MG N021316 001 Jun 26, 2002
LOXAPINE HYDROCHLORIDE
CONCENTRATE;ORAL
LOXITANE C
TEVA BRANDED PHARM EQ 25MG BASE/ML N017658 001
INJECTABLE;INJECTION
LOXITANE IM
ACTAVIS LABS UT INC EQ 50MG BASE/ML N018039 001
LOXAPINE SUCCINATE
CAPSULE;ORAL
LOXAPINE SUCCINATE
RISING EQ 5MG BASE A076762 001 Nov 01, 2004
EQ 10MG BASE A076762 002 Nov 01, 2004
EQ 25MG BASE A076762 003 Nov 01, 2004
EQ 50MG BASE A076762 004 Nov 01, 2004
LOXITANE
+ TEVA BRANDED PHARM EQ 5MG BASE ** N017525 001
+ EQ 10MG BASE ** N017525 002
+ EQ 25MG BASE ** N017525 003
+ EQ 50MG BASE ** N017525 004
TABLET;ORAL
LOXITANE
+ TEVA BRANDED PHARM EQ 10MG BASE ** N017525 006
+ EQ 25MG BASE ** N017525 007
+ EQ 50MG BASE ** N017525 008
LUBIPROSTONE
CAPSULE;ORAL
LUBIPROSTONE
AMNEAL 8MCG A209450 001 Nov 30, 2021
24MCG A209450 002 Nov 30, 2021
ANCHEN PHARMS 8MCG A201442 001 Jun 27, 2022
24MCG A201442 002 Jun 27, 2022

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-293(of 478)
** See List Footnote
LUCINACTANT
SUSPENSION;INTRATRACHEAL
SURFAXIN
WINDTREE THERAP 8.5ML N021746 001 Mar 06, 2012
LURASIDONE HYDROCHLORIDE
TABLET;ORAL
LURASIDONE HYDROCHLORIDE
AMNEAL PHARMS CO 20MG A208002 001 Jan 03, 2019
40MG A208002 002 Jan 03, 2019
60MG A208002 003 Jan 03, 2019
80MG A208002 004 Jan 03, 2019
120MG A208002 005 Jan 03, 2019
EMCURE PHARMS LTD 20MG A208058 001 Sep 04, 2019
40MG A208058 002 Sep 04, 2019
60MG A208058 003 Sep 04, 2019
80MG A208058 004 Sep 04, 2019
LUPIN LTD 20MG A208031 001 Jan 03, 2019
40MG A208031 002 Jan 03, 2019
60MG A208031 003 Jan 03, 2019
80MG A208031 004 Jan 03, 2019
120MG A208031 005 Jan 03, 2019
PIRAMAL HLTHCARE UK 20MG A212091 001 Dec 28, 2020
40MG A212091 002 Dec 28, 2020
60MG A212091 003 Dec 28, 2020
80MG A212091 004 Dec 28, 2020
120MG A212091 005 Dec 28, 2020
TEVA PHARMS USA 20MG A208060 001 May 17, 2019
40MG A208060 002 May 17, 2019
60MG A208060 003 May 17, 2019
80MG A208060 004 May 17, 2019
120MG A208060 005 May 17, 2019
TORRENT 20MG A208055 001 Jan 03, 2019
40MG A208055 002 Jan 03, 2019
80MG A208055 003 Jan 03, 2019
120MG A208055 004 Jan 03, 2019
WATSON LABS TEVA 20MG A208016 001 Feb 02, 2021
40MG A208016 002 Feb 02, 2021
60MG A208016 003 Feb 02, 2021
80MG A208016 004 Feb 02, 2021
120MG A208016 005 Feb 02, 2021
LYPRESSIN
SOLUTION;NASAL
DIAPID
NOVARTIS 0.185MG/ML N016755 001
MACITENTAN
TABLET;ORAL
MACITENTAN
ZYDUS 10MG A211224 001 Apr 06, 2021
MAFENIDE ACETATE
FOR SOLUTION;TOPICAL
MAFENIDE ACETATE
PAR FORM 5% A201511 001 Feb 12, 2013
SULFAMYLON
+ MYLAN INSTITUTIONAL 5% N019832 003 Jun 05, 1998
MAGNESIUM ACETATE TETRAHYDRATE; POTASSIUM ACETATE; SODIUM CHLORIDE
INJECTABLE;INJECTION
PLASMA-LYTE 56 IN PLASTIC CONTAINER
BAXTER HLTHCARE 32MG/100ML;128MG/100ML;234MG/100ML N019047 001 Jun 15, 1984
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM
CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
INJECTABLE;INJECTION
ISOLYTE S PH 7.4 IN PLASTIC CONTAINER
B BRAUN 30MG/100ML;37MG/100ML;0.82MG/100ML;370M N019006 001 Apr 04, 1984
G/100ML;530MG/100ML;500MG/100ML;12MG/10
0ML

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-294(of 478)
** See List Footnote
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
INJECTABLE;INJECTION
ISOLYTE S IN PLASTIC CONTAINER
B BRAUN 30MG/100ML;37MG/100ML;370MG/100ML;530MG N018252 001
/100ML;500MG/100ML
MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5
FRESENIUS KABI USA 30MG/100ML;37MG/100ML;368MG/100ML;526MG A215370 001 Jun 29, 2022
/100ML;502MG/100ML
MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4
FRESENIUS KABI USA 30MG/100ML;37MG/100ML;368MG/100ML;526MG A215371 001 Jun 08, 2022
/100ML;502MG/100ML
SOLUTION;IRRIGATION
PHYSIOSOL IN PLASTIC CONTAINER
HOSPIRA INC 14MG/100ML;37MG/100ML;222MG/100ML;526MG N018406 001
/100ML;502MG/100ML
PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER
HOSPIRA INC 30MG/100ML;37MG/100ML;222MG/100ML;526MG N018406 002 Jul 08, 1982
/100ML;502MG/100ML
SYNOVALYTE IN PLASTIC CONTAINER
BAXTER HLTHCARE 30MG/100ML;37MG/100ML;368MG/100ML;526MG N019326 001 Jan 25, 1985
/100ML;502MG/100ML
MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE
TABLET;ORAL
MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATE
SANTARUS 343MG;20MG;750MG N022456 001 Dec 04, 2009
343MG;40MG;750MG N022456 002 Dec 04, 2009
TABLET, CHEWABLE;ORAL
ZEGERID
SANTARUS 700MG;20MG;600MG N021850 001 Mar 24, 2006
700MG;40MG;600MG N021850 002 Mar 24, 2006
MAGNESIUM SULFATE; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SODIUM
BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE
SOLUTION;ORAL
SUCLEAR
+ BRAINTREE LABS 1.6GM/BOT,3.13GM/BOT,17.5GM/BOT,N/A,N/A N203595 001 Jan 18, 2013
,N/A,N/A;N/A,N/A,N/A,210GM,0.74GM,2.86G
M,5.6GM **
MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE
POWDER;ORAL
COLPREP KIT
+ GATOR PHARMS 1.6GM/BOT;3.13GM/BOT;17.5GM/BOT N204553 001 Dec 27, 2016
MALATHION
LOTION;TOPICAL
MALATHION
MYLAN PHARMS INC 0.5% A078743 001 Mar 06, 2009
OVIDE
+ TARO PHARM INDS LTD 0.5% ** N018613 001 Aug 02, 1982
MANGAFODIPIR TRISODIUM
INJECTABLE;INJECTION
TESLASCAN
IC TARGETS 37.9MG/ML N020652 001 Nov 26, 1997
MANGANESE CHLORIDE TETRAHYDRATE
FOR SOLUTION;ORAL
LUMENHANCE
BRACCO 3.49MG/GM N020686 001 Dec 19, 1997
MANGANESE SULFATE
INJECTABLE;INJECTION
MANGANESE SULFATE
+ ABRAXIS PHARM EQ 0.1MG MANGANESE/ML ** N019228 001 May 05, 1987
MANNITOL
INJECTABLE;INJECTION
MANNITOL 10%
B BRAUN 10GM/100ML N016080 002
HOSPIRA 10GM/100ML N016269 002
MILES 10GM/100ML N016472 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-295(of 478)
** See List Footnote
MANNITOL
INJECTABLE;INJECTION
MANNITOL 10% IN PLASTIC CONTAINER
ICU MEDICAL INC 10GM/100ML N019603 002 Jan 08, 1987
MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
B BRAUN 10GM/100ML N016080 006
MANNITOL 15%
B BRAUN 15GM/100ML N016080 003
HOSPIRA 15GM/100ML N016269 003
MILES 15GM/100ML N016472 005
MANNITOL 15% IN PLASTIC CONTAINER
ICU MEDICAL INC 15GM/100ML N019603 003 Jan 08, 1990
MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%
B BRAUN 15GM/100ML N016080 005
MANNITOL 20%
B BRAUN 20GM/100ML N014738 001
20GM/100ML N016080 004
HOSPIRA 20GM/100ML N016269 004
MILES 20GM/100ML N016472 004
MANNITOL 25%
ABRAXIS PHARM 12.5GM/50ML A086754 001
HOSPIRA 12.5GM/50ML N016269 005
IGI LABS INC 12.5GM/50ML A089239 001 May 06, 1987
12.5GM/50ML A089240 001 May 06, 1987
INTL MEDICATION 12.5GM/50ML A083051 001
LUITPOLD 12.5GM/50ML A087409 001 Jan 21, 1982
MERCK 12.5GM/50ML N005620 001
WATSON LABS 12.5GM/50ML A087460 001 Jun 27, 1983
MANNITOL 5%
B BRAUN 5GM/100ML N016080 001
HOSPIRA 5GM/100ML N016269 001
MANNITOL 5% IN PLASTIC CONTAINER
ICU MEDICAL INC 5GM/100ML N019603 001 Jan 08, 1987
MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%
B BRAUN 5GM/100ML N016080 007
SOLUTION;IRRIGATION
RESECTISOL
B BRAUN 5GM/100ML N016704 002
RESECTISOL IN PLASTIC CONTAINER
B BRAUN 5GM/100ML N016772 002
MANNITOL; SORBITOL
SOLUTION;IRRIGATION
SORBITOL-MANNITOL
HOSPIRA 540MG/100ML;2.7GM/100ML A080224 001
SORBITOL-MANNITOL IN PLASTIC CONTAINER
HOSPIRA 540MG/100ML;2.7GM/100ML N017636 001
MAPROTILINE HYDROCHLORIDE
TABLET;ORAL
LUDIOMIL
NOVARTIS 25MG N017543 001
50MG N017543 002
75MG N017543 003 Sep 30, 1982
MAPROTILINE HYDROCHLORIDE
AM THERAP 25MG A072129 001 Jan 14, 1988
50MG A072130 001 Jan 14, 1988
75MG A072131 001 Jan 14, 1988
HERITAGE PHARMA 25MG A072162 001 Jun 01, 1988
50MG A072163 001 Jun 01, 1988
RISING 25MG A072285 002 Oct 03, 1988
50MG A072285 001 Oct 03, 1988
75MG A072285 003 Oct 03, 1988
WATSON LABS 25MG A071943 001 Dec 30, 1987
50MG A071944 001 Dec 30, 1987
75MG A071945 001 Dec 30, 1987
75MG A072164 001 Jun 01, 1988

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-296(of 478)
** See List Footnote
MASOPROCOL
CREAM;TOPICAL
ACTINEX
UNIV AZ CANCER CTR 10% N019940 001 Sep 04, 1992
MAZINDOL
TABLET;ORAL
MAZANOR
WYETH AYERST 1MG N017980 002
2MG N017980 001
SANOREX
+ NOVARTIS 1MG ** N017247 001
+ 2MG ** N017247 002
MEBENDAZOLE
TABLET, CHEWABLE;ORAL
VERMOX
+ JANSSEN PHARMS 100MG ** N017481 001
+ 500MG N208398 001 Oct 19, 2016
MEBUTAMATE
TABLET;ORAL
DORMATE
MEDPOINTE PHARM HLC 600MG N017374 001
MECAMYLAMINE HYDROCHLORIDE
TABLET;ORAL
INVERSINE
+ TARGACEPT 2.5MG ** N010251 001
MECHLORETHAMINE HYDROCHLORIDE
INJECTABLE;INJECTION
MUSTARGEN
+ RECORDATI RARE 10MG/VIAL N006695 001
MECLIZINE HYDROCHLORIDE
TABLET;ORAL
MECLIZINE HYDROCHLORIDE
ABC HOLDING 12.5MG A085253 001
25MG A085252 001
AMNEAL PHARMS 50MG A201451 003 Feb 23, 2011
ANABOLIC 25MG A085891 001
ANI PHARMS 12.5MG A085269 001
12.5MG A088732 001 Dec 11, 1985
25MG A085740 001
AUROBINDO PHARMA USA 12.5MG A202640 001 Sep 17, 2012
25MG A202640 002 Sep 17, 2012
50MG A202640 003 Sep 17, 2012
BUNDY 12.5MG A084382 001
25MG A084872 001
IVAX SUB TEVA PHARMS 12.5MG A083784 001
KV PHARM 12.5MG A085524 001
25MG A085523 001
PLIVA 25MG A088734 001 Dec 11, 1985
RISING 12.5MG A040179 001 Jan 30, 1997
25MG A040179 002 Jan 30, 1997
STRIDES PHARMA 50MG A089674 001 Mar 31, 1988
SUPERPHARM 12.5MG A089113 001 Aug 20, 1985
25MG A089114 001 Aug 20, 1985
UDL 12.5MG A088256 001 Jun 13, 1983
25MG A088257 001 Jun 13, 1983
VANGARD 12.5MG A087877 001 Apr 20, 1982
25MG A087620 001 Jan 04, 1982
WATSON LABS 12.5MG A085195 001
TABLET, CHEWABLE;ORAL
MECLIZINE HYDROCHLORIDE
IVAX SUB TEVA PHARMS 25MG A084976 001
NEXGEN PHARMA INC 25MG A086392 001
PLIVA 25MG A088733 001 Dec 11, 1985

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-297(of 478)
** See List Footnote
MECLOCYCLINE SULFOSALICYLATE
CREAM;TOPICAL
MECLAN
JOHNSON AND JOHNSON 1% N050518 001
MECLOFENAMATE SODIUM
CAPSULE;ORAL
MECLODIUM
QUANTUM PHARMICS EQ 50MG BASE A071380 001 Jul 14, 1987
EQ 100MG BASE A071381 001 Jul 14, 1987
MECLOFENAMATE SODIUM
AM THERAP EQ 50MG BASE A071362 001 Feb 10, 1987
EQ 100MG BASE A071363 001 Feb 10, 1987
ANI PHARMS EQ 50MG BASE A071469 002 Apr 15, 1987
EQ 100MG BASE A071469 001 Apr 15, 1987
BARR EQ 50MG BASE A072848 001 Mar 20, 1989
EQ 100MG BASE A072809 001 Mar 20, 1989
FOSUN PHARMA EQ 50MG BASE A072262 001 Nov 29, 1988
EQ 100MG BASE A072263 001 Nov 29, 1988
PAR PHARM EQ 50MG BASE A072077 001 Mar 10, 1988
EQ 100MG BASE A072078 001 Mar 10, 1988
USL PHARMA EQ 50MG BASE A071007 001 Mar 25, 1988
EQ 100MG BASE A071008 001 Mar 25, 1988
VITARINE EQ 50MG BASE A071710 001 Jun 15, 1988
EQ 100MG BASE A071684 001 Jun 15, 1988
WATSON LABS EQ 50MG BASE A070400 001 Nov 25, 1986
EQ 50MG BASE A071640 001 Aug 11, 1987
EQ 100MG BASE A070401 001 Nov 25, 1986
EQ 100MG BASE A071641 001 Aug 11, 1987
MECLOMEN
PARKE DAVIS EQ 50MG BASE N018006 001
EQ 100MG BASE N018006 002
MEDROXYPROGESTERONE ACETATE
INJECTABLE;INJECTION
DEPO-PROVERA
+ PFIZER 100MG/ML ** N012541 002
+ 400MG/ML N012541 003
MEDROXYPROGESTERONE ACETATE
CIPLA 150MG/ML A210335 001 Jan 25, 2019
SANDOZ INC 150MG/ML A078711 001 May 20, 2009
SUN PHARM 150MG/ML A210760 001 May 01, 2019
150MG/ML A210761 001 Apr 24, 2019
TEVA PHARMS USA 150MG/ML A076552 001 Oct 27, 2004
TABLET;ORAL
AMEN
AMARIN PHARMS 10MG A083242 001
CURRETAB
SOLVAY 10MG A085686 001
CYCRIN
ESI 2.5MG A081239 001 Oct 30, 1992
5MG A081240 001 Oct 30, 1992
10MG A089386 001 Sep 09, 1987
MEDROXYPROGESTERONE ACETATE
DURAMED PHARMS BARR 2.5MG A040311 001 Dec 01, 1999
5MG A040311 002 Dec 01, 1999
10MG A040311 003 Dec 01, 1999
UPSHER SMITH LABS 10MG A088484 001 Jul 26, 1984
MEDRYSONE
SUSPENSION;OPHTHALMIC
HMS
ALLERGAN 1% N016624 003
MEFENAMIC ACID
CAPSULE;ORAL
MEFENAMIC ACID
NOSTRUM LABS INC 250MG A090359 001 Feb 05, 2013
STRIDES PHARMA 250MG A209209 001 Sep 18, 2020

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-298(of 478)
** See List Footnote
MEFLOQUINE HYDROCHLORIDE
TABLET;ORAL
LARIAM
+ ROCHE 250MG ** N019591 001 May 02, 1989
MEFLOQUINE HYDROCHLORIDE
HIKMA INTL PHARMS 250MG A077699 001 Apr 21, 2010
SANDOZ 250MG A076175 001 Feb 20, 2002
US ARMY WALTER REED 250MG ** N019578 001 May 02, 1989
MEGESTROL ACETATE
SUSPENSION;ORAL
MEGACE
+ BRISTOL MYERS SQUIBB 40MG/ML ** N020264 001 Sep 10, 1993
MEGESTROL ACETATE
HIKMA 40MG/ML A075997 001 Feb 15, 2002
PHARM ASSOC 40MG/ML A077404 001 Feb 16, 2006
TEVA PHARMS 40MG/ML A075681 001 May 05, 2003
TABLET;ORAL
MEGACE
+ BRISTOL MYERS SQUIBB 20MG ** N016979 001
+ 40MG ** N016979 002
MEGESTROL ACETATE
HIKMA 20MG A074458 001 Sep 29, 1995
40MG A074458 002 Sep 29, 1995
TEVA 40MG A074745 001 Feb 27, 1998
USL PHARMA 20MG A070646 001 Oct 02, 1987
40MG A070647 001 Oct 02, 1987
MELOXICAM
CAPSULE;ORAL
VIVLODEX
+ ICEUTICA OPERATIONS 5MG ** N207233 001 Oct 22, 2015
+ 10MG ** N207233 002 Oct 22, 2015
SOLUTION;INTRAVENOUS
ANJESO
+ BAUDAX 30MG/ML (30MG/ML) N210583 001 Feb 20, 2020
TABLET;ORAL
MELOXICAM
AIPING PHARM INC 7.5MG A077920 001 Jul 19, 2006
15MG A077920 002 Jul 19, 2006
ANDA REPOSITORY 7.5MG A077935 001 Jul 19, 2006
15MG A077935 002 Jul 19, 2006
CR DOUBLE CRANE 7.5MG A078039 001 Dec 14, 2006
15MG A078039 002 Dec 14, 2006
HERITAGE PHARMA 7.5MG A077936 001 Jul 19, 2006
15MG A077936 002 Jul 19, 2006
IMPAX LABS INC 7.5MG A077930 001 Jul 19, 2006
15MG A077930 002 Jul 19, 2006
MYLAN 7.5MG A077923 001 Jul 19, 2006
7.5MG A077934 001 Jul 20, 2006
15MG A077923 002 Jul 19, 2006
15MG A077934 002 Jul 20, 2006
ROXANE 7.5MG A077925 001 Jul 19, 2006
15MG A077925 002 Jul 19, 2006
SUN PHARM INDS INC 7.5MG A077937 001 Jul 19, 2006
15MG A077937 002 Jul 19, 2006
YABAO PHARM 7.5MG A077933 001 Jul 19, 2006
15MG A077933 002 Jul 19, 2006
TABLET, ORALLY DISINTEGRATING;ORAL
QMIIZ ODT
+ TERSERA 7.5MG N211210 001 Oct 19, 2018
+ 15MG N211210 002 Oct 19, 2018
MELPHALAN
TABLET;ORAL
ALKERAN
+ APOTEX 2MG ** N014691 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-299(of 478)
** See List Footnote
MELPHALAN FLUFENAMIDE HYDROCHLORIDE
POWDER;INTRAVENOUS
PEPAXTO
+ ONCOPEPTIDES AB EQ 20MG BASE/VIAL N214383 001 Feb 26, 2021
MELPHALAN HYDROCHLORIDE
INJECTABLE;INJECTION
ALKERAN
+ APOTEX EQ 50MG BASE/VIAL ** N020207 001 Nov 18, 1992
MELPHALAN HYDROCHLORIDE
MYLAN INSTITUTIONAL EQ 50MG BASE/VIAL A090299 001 Oct 27, 2009
PAR STERILE PRODUCTS EQ 50MG BASE/VIAL A204773 001 Aug 22, 2016
USWM EQ 50MG BASE/VIAL A207032 001 May 03, 2019
POWDER;INTRAVENOUS
MELPHALAN HYDROCHLORIDE
ACTAVIS LLC EQ 50MG BASE/VIAL A209323 001 Mar 06, 2020
MEMANTINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
MEMANTINE HYDROCHLORIDE
ANCHEN PHARMS 7MG A205784 001 Jun 09, 2017
14MG A205784 002 Jun 09, 2017
21MG A205784 003 Jun 09, 2017
28MG A205784 004 Jun 09, 2017
ANI PHARMS 7MG A205365 001 Feb 28, 2020
14MG A205365 002 Feb 28, 2020
21MG A205365 003 Feb 28, 2020
RISING 7MG A206032 001 Sep 28, 2016
14MG A206032 002 Sep 28, 2016
21MG A206032 003 Sep 28, 2016
28MG A206032 004 Sep 28, 2016
SUN PHARM 7MG A205905 001 Sep 28, 2016
14MG A205905 002 Sep 28, 2016
21MG A205905 003 Sep 28, 2016
28MG A205905 004 Sep 28, 2016
SOLUTION;ORAL
MEMANTINE HYDROCHLORIDE
TORRENT 2MG/ML A205446 001 Dec 07, 2015
NAMENDA
+ ALLERGAN 2MG/ML N021627 001 Apr 18, 2005
TABLET;ORAL
MEMANTINE HYDROCHLORIDE
CHARTWELL 5MG A090244 001 Jul 11, 2018
10MG A090244 002 Jul 11, 2018
JUBILANT GENERICS 5MG A091585 001 Oct 13, 2015
10MG A091585 002 Oct 13, 2015
LANNETT CO INC 5MG A207236 001 Nov 10, 2016
10MG A207236 002 Nov 10, 2016
NINGBO 5MG A212947 001 Apr 03, 2020
10MG A212947 002 Apr 03, 2020
ORBION PHARMS 5MG A090044 001 Mar 12, 2012
10MG A090044 002 Mar 12, 2012
RISING 5MG A079225 001 Jan 30, 2015
10MG A079225 002 Jan 30, 2015
TEVA PHARMS 5MG A090052 001 Oct 25, 2011
10MG A090052 002 Oct 25, 2011
TORRENT 5MG A200155 001 Oct 13, 2015
10MG A200155 002 Oct 13, 2015
MENADIOL SODIUM DIPHOSPHATE
INJECTABLE;INJECTION
KAPPADIONE
LILLY 10MG/ML N005725 001
SYNKAYVITE
ROCHE 5MG/ML N003718 004
10MG/ML N003718 006
37.5MG/ML N003718 008
TABLET;ORAL
SYNKAYVITE
ROCHE 5MG N003718 010

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-300(of 478)
** See List Footnote
MENADIONE
TABLET;ORAL
MENADIONE
LILLY 5MG N002139 003
MEPENZOLATE BROMIDE
SOLUTION;ORAL
CANTIL
SANOFI AVENTIS US 25MG/5ML N010679 004
TABLET;ORAL
CANTIL
+ SANOFI AVENTIS US 25MG N010679 003
MEPERIDINE HYDROCHLORIDE
INJECTABLE;INJECTION
DEMEROL
VALIDUS PHARMS 25MG/ML N005010 007
50MG/ML N005010 002
75MG/ML N005010 009
100MG/ML N005010 003
MEPERIDINE HYDROCHLORIDE
ABBOTT 25MG/ML A080388 001
50MG/ML A080385 001
50MG/ML A080387 001
75MG/ML A080389 001
100MG/ML A080386 001
BAXTER HLTHCARE 25MG/ML A088279 001 Jun 15, 1984
50MG/ML A088280 001 Jun 15, 1984
75MG/ML A088281 001 Jun 15, 1984
100MG/ML A088282 001 Jun 15, 1984
IGI LABS INC 25MG/ML A089781 001 Mar 31, 1989
50MG/ML A089782 001 Mar 31, 1989
50MG/ML A089783 001 Mar 31, 1989
50MG/ML A089784 001 Mar 31, 1989
75MG/ML A089785 001 Mar 31, 1989
100MG/ML A089786 001 Mar 31, 1989
100MG/ML A089787 001 Mar 31, 1989
100MG/ML A089788 001 Mar 31, 1989
INTL MEDICATION 10MG/ML A086332 001
PARKE DAVIS 50MG/ML A080364 002
75MG/ML A080364 003
100MG/ML A080364 001
WATSON LABS 50MG/ML A073444 001 Mar 17, 1992
100MG/ML A073445 001 Mar 17, 1992
MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE
HOSPIRA 10MG/ML A040305 001 Mar 10, 1999
+ ICU MEDICAL INC 10MG/ML A088432 001 Aug 16, 1984
INTL MEDICATION 10MG/ML A081309 001 Aug 30, 1993
SPECGX LLC 10MG/ML A040163 001 May 12, 1997
WATSON LABS 10MG/ML A073443 001 Mar 17, 1992
SYRUP;ORAL
DEMEROL
VALIDUS PHARMS 50MG/5ML ** N005010 005
TABLET;ORAL
DEMEROL
+ VALIDUS PHARMS 50MG N005010 001
+ 100MG N005010 004
MEPERIDINE HYDROCHLORIDE
ANDA REPOSITORY 50MG A040893 001 Jun 24, 2009
75MG A040893 002 Jun 24, 2009
100MG A040893 003 Jun 24, 2009
150MG A040893 004 Jun 24, 2009
BARR 50MG A088639 001 Jul 02, 1984
100MG A088640 001 Sep 19, 1984
DURAMED PHARMS BARR 50MG A040318 001 Oct 05, 1999
100MG A040318 002 Oct 05, 1999
HIKMA 50MG A040110 001 Mar 12, 1997
100MG A040110 002 Mar 12, 1997
SPECGX LLC 50MG A040352 001 Jun 13, 2000
100MG A040352 002 Jun 13, 2000

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-301(of 478)
** See List Footnote
MEPERIDINE HYDROCHLORIDE
TABLET;ORAL
MEPERIDINE HYDROCHLORIDE
STRIDES PHARMA 50MG A040191 001 Dec 17, 1998
100MG A040191 002 Dec 17, 1998
SUN PHARM INDS INC 50MG A040446 001 Aug 08, 2002
100MG A040446 002 Aug 08, 2002
SUN PHARM INDUSTRIES 50MG A080448 001
100MG A080448 002
WATSON LABS 50MG A040186 001 Jun 30, 1997
100MG A040186 002 Jun 30, 1997
WYETH AYERST 50MG A080454 001
MEPERIDINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
INJECTABLE;INJECTION
MEPERGAN
HIKMA 25MG/ML;25MG/ML N011730 001
MEPHENTERMINE SULFATE
INJECTABLE;INJECTION
WYAMINE SULFATE
BAXTER HLTHCARE CORP EQ 15MG BASE/ML N008248 002
EQ 30MG BASE/ML N008248 001
MEPHENYTOIN
TABLET;ORAL
MESANTOIN
+ NOVARTIS 100MG ** N006008 001
MEPIVACAINE HYDROCHLORIDE
INJECTABLE;INJECTION
ARESTOCAINE HYDROCHLORIDE
SOLVAY 3% A084777 002 Apr 18, 1982
CARBOCAINE
+ EASTMAN KODAK 3% ** N012125 003
ISOCAINE HYDROCHLORIDE
SEPTODONT INC 3% A080925 001
MEPIVACAINE HYDROCHLORIDE
BELMORA LLC 3% A083559 001
HOSPIRA INC 3% A040806 001 Apr 28, 2008
INTL MEDICATION SYS 1% A087509 001 Oct 05, 1982
WATSON LABS 1% A088769 001 Nov 20, 1984
2% A088770 001 Nov 20, 1984
POLOCAINE
DENTSPLY PHARM 3% A088653 001 Aug 21, 1984
MEPREDNISONE
TABLET;ORAL
BETAPAR
SCHERING 4MG N016053 002
MEPROBAMATE
CAPSULE;ORAL
EQUANIL
WYETH AYERST 400MG N012455 002
CAPSULE, EXTENDED RELEASE;ORAL
MEPROSPAN
MEDPOINTE PHARM HLC 200MG N011284 001
400MG N011284 002
TABLET;ORAL
AMOSENE
FERNDALE LABS 400MG A084030 001
BAMATE
ALRA 200MG A080380 001
400MG A080380 002
EQUANIL
WYETH AYERST 200MG N010028 005
400MG N010028 004
MEPRIAM
TEVA 400MG N016069 001
MEPROBAMATE
ACELLA 400MG A084153 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-302(of 478)
** See List Footnote
MEPROBAMATE
TABLET;ORAL
MEPROBAMATE
BARR 600MG A084230 001
CHARTWELL MOLECULAR 200MG N014882 002
400MG N014882 001
ELKINS SINN 200MG N015426 002
400MG N015426 001
HEATHER 400MG N016928 003
600MG A084329 001
IMPAX LABS 200MG N014322 002
400MG N014322 001
IVAX SUB TEVA PHARMS 200MG N015438 001
400MG N015438 002
600MG A084181 001
LEDERLE 400MG A086299 001
LEE KM 400MG A089538 001 Nov 25, 1987
MALLARD 400MG N015072 002
MK LABS 200MG N014368 004
400MG N014368 002
MYLAN 400MG A083618 001
NEXGEN PHARMA INC 200MG A084220 001
400MG A084589 001
PARKE DAVIS 200MG A084744 001
400MG A084744 002
PERRIGO 200MG A084546 001
400MG A084547 001
PHARMAVITE 400MG A084438 001
PUREPAC PHARM 200MG A084804 001
400MG A084804 002
PVT FORM 400MG N014601 001
RISING 400MG A080655 001
ROXANE 600MG A084332 001
SANDOZ 200MG N014547 002
400MG N014547 001
SCHERER LABS 400MG A083343 001
SOLVAY 200MG A084435 001
STANLABS PHARM 200MG N014474 002
400MG N014474 004
SUN PHARM INDUSTRIES 200MG A080699 001
400MG A080699 002
TABLICAPS 400MG A083494 001
TARO 200MG A200998 001 May 23, 2011
400MG A200998 002 May 23, 2011
USL PHARMA 200MG A087825 001 Mar 18, 1982
400MG A087826 001 Mar 18, 1982
VALEANT PHARM INTL 200MG N015139 006
400MG N015139 005
VANGARD 400MG A088011 001 Jul 14, 1982
+ WATSON LABS 200MG A083304 001
200MG A085720 001
+ 400MG A083308 001
400MG A085721 001
600MG A084274 001
600MG A085719 001
WEST WARD 200MG N015417 003
400MG N015417 002
WHITEWORTH TOWN PLSN 200MG A083830 001
400MG A083442 001
MILTOWN
+ MEDPOINTE PHARM HLC 200MG ** N009698 004
+ 400MG ** N009698 002
600MG A083919 001
NEURAMATE
HALSEY 200MG N014359 002
400MG N014359 001
TRANMEP
SOLVAY 400MG A084369 001
400MG N016249 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-303(of 478)
** See List Footnote
MEQUINOL; TRETINOIN
SOLUTION;TOPICAL
SOLAGE
ALMIRALL 2%;0.01% N020922 001 Dec 10, 1999
MEROPENEM
INJECTABLE;INJECTION
MEROPENEM
HOSPIRA INC 500MG/VIAL A090940 001 Jun 22, 2010
1GM/VIAL A090940 002 Jun 22, 2010
SANDOZ 500MG/VIAL A091201 001 Mar 29, 2011
1GM/VIAL A091201 002 Mar 29, 2011
MERSALYL SODIUM; THEOPHYLLINE
INJECTABLE;INJECTION
MERSALYL-THEOPHYLLINE
WATSON LABS 100MG/ML;50MG/ML A084875 001
MESALAMINE
CAPSULE, EXTENDED RELEASE;ORAL
MESALAMINE
TEVA PHARMS USA 375MG A209970 001 May 06, 2022
ENEMA;RECTAL
MESALAMINE
G AND W LABS INC 4GM/60ML A076841 001 Sep 30, 2004
SUPPOSITORY;RECTAL
CANASA
ALLERGAN 500MG N021252 001 Jan 05, 2001
MESALAMINE
AMNEAL 1GM A210509 001 Jan 02, 2020
ROWASA
+ MEDA PHARMS 500MG ** N019919 001 Dec 18, 1990
TABLET, DELAYED RELEASE;ORAL
ASACOL
APIL 400MG N019651 001 Jan 31, 1992
ASACOL HD
+ APIL 800MG N021830 001 May 29, 2008
MESALAMINE
MYLAN 1.2GM A203574 001 Nov 20, 2018
MESNA
INJECTABLE;INTRAVENOUS
MESNA
MYLAN INSTITUTIONAL 100MG/ML A076488 001 Mar 08, 2012
MYLAN LABS LTD 100MG/ML A203364 001 Jul 18, 2014
TEVA PHARMS USA 100MG/ML A075764 001 Apr 27, 2001
MESORIDAZINE BESYLATE
CONCENTRATE;ORAL
SERENTIL
NOVARTIS EQ 25MG BASE/ML N016997 001
INJECTABLE;INJECTION
SERENTIL
NOVARTIS EQ 25MG BASE/ML N016775 001
TABLET;ORAL
SERENTIL
NOVARTIS EQ 10MG BASE ** N016774 001
EQ 25MG BASE ** N016774 002
EQ 50MG BASE ** N016774 003
EQ 100MG BASE ** N016774 004
MESTRANOL; NORETHINDRONE
TABLET;ORAL-20
NORINYL
ACTAVIS LABS UT INC 0.1MG;2MG N013625 004
TABLET;ORAL-21
NORETHIN 1/50M-21
HERITAGE PHARMA 0.05MG;1MG A071539 001 Apr 12, 1988
NORETHINDRONE AND MESTRANOL
WATSON LABS 0.05MG;1MG A070758 001 Jul 01, 1988
NORINYL 1+50 21-DAY
ACTAVIS LABS UT INC 0.05MG;1MG N013625 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-304(of 478)
** See List Footnote
MESTRANOL; NORETHINDRONE
TABLET;ORAL-21
NORINYL 1+80 21-DAY
GD SEARLE LLC 0.08MG;1MG N016724 001
ORTHO-NOVUM 1/50 21
ORTHO MCNEIL PHARM 0.05MG;1MG N012728 004
ORTHO-NOVUM 1/80 21
ORTHO MCNEIL PHARM 0.08MG;1MG N016715 001
ORTHO-NOVUM 10-21
ORTHO MCNEIL PHARM 0.06MG;10MG N012728 001
ORTHO-NOVUM 2-21
ORTHO MCNEIL PHARM 0.1MG;2MG N012728 005
TABLET;ORAL-28
NORETHIN 1/50M-28
HERITAGE PHARMA 0.05MG;1MG A071540 001 Apr 12, 1988
NORETHINDRONE AND MESTRANOL
WATSON LABS 0.05MG;1MG A070759 001 Jul 01, 1988
NORINYL 1+50 28-DAY
+ ACTAVIS LABS UT INC 0.05MG;1MG N016659 001
NORINYL 1+80 28-DAY
GD SEARLE LLC 0.08MG;1MG N016725 001
ORTHO-NOVUM 1/50 28
ORTHO MCNEIL JANSSEN 0.05MG;1MG N016709 001
ORTHO-NOVUM 1/80 28
ORTHO MCNEIL PHARM 0.08MG;1MG N016715 002
MESTRANOL; NORETHYNODREL
TABLET;ORAL
ENOVID
GD SEARLE LLC 0.075MG;5MG N010976 008
0.15MG;9.85MG N010976 005
TABLET;ORAL-20
ENOVID
GD SEARLE LLC 0.075MG;5MG N010976 004
ENOVID-E
GD SEARLE LLC 0.1MG;2.5MG N010976 006
TABLET;ORAL-21
ENOVID-E 21
GD SEARLE LLC 0.1MG;2.5MG N010976 007
METAPROTERENOL SULFATE
AEROSOL, METERED;INHALATION
ALUPENT
BOEHRINGER INGELHEIM 0.65MG/INH N016402 001
SOLUTION;INHALATION
ALUPENT
BOEHRINGER INGELHEIM 0.4% N018761 002 Oct 10, 1986
0.6% N018761 001 Jun 30, 1983
5% N017659 001
METAPROTERENOL SULFATE
APOTEX INC 0.4% A075402 001 Feb 28, 2001
0.6% A075403 001 Feb 28, 2001
ASTRAZENECA 0.4% A071275 001 Jul 27, 1988
0.6% A071018 001 Jul 27, 1988
DEY 0.33% A071806 001 Aug 05, 1988
0.5% A071805 001 Aug 05, 1988
5% A070805 001 Aug 17, 1987
MYLAN SPECIALITY LP 0.4% A071786 001 Aug 05, 1988
0.6% A070804 001 Aug 17, 1987
NEPHRON 0.4% A071855 001 Jul 14, 1988
0.6% A071726 001 Jul 14, 1988
WOCKHARDT 0.4% A075586 001 May 30, 2002
0.6% A075586 002 May 30, 2002
5% A072190 001 Jun 07, 1988
PROMETA
MURO 5% A073340 001 Mar 30, 1992
SYRUP;ORAL
ALUPENT
BOEHRINGER INGELHEIM 10MG/5ML N017571 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-305(of 478)
** See List Footnote
METAPROTERENOL SULFATE
SYRUP;ORAL
METAPROTERENOL SULFATE
APOTEX INC 10MG/5ML A075235 001 Jan 27, 2000
COSETTE 10MG/5ML A072761 001 Feb 27, 1992
G AND W LABS INC 10MG/5ML A073034 001 Aug 30, 1991
MORTON GROVE 10MG/5ML A071656 001 Oct 13, 1987
WOCKHARDT 10MG/5ML A074702 001 Mar 24, 1997
PROMETA
MURO 10MG/5ML A072023 001 Sep 15, 1988
TABLET;ORAL
ALUPENT
BOEHRINGER INGELHEIM 10MG N015874 002
20MG N015874 001
METAPROTERENOL SULFATE
AM THERAP 10MG A072054 001 Jun 23, 1988
20MG A072055 001 Jun 23, 1988
HERITAGE PHARMA 10MG A072519 001 Mar 30, 1990
20MG A072520 001 Mar 30, 1990
STRIDES PHARMA 10MG A072024 001 Jun 28, 1988
20MG A072025 001 Jun 28, 1988
USL PHARMA 10MG A071013 001 Jan 25, 1988
20MG A071014 001 Jan 25, 1988
WATSON LABS 10MG A073013 001 Jan 31, 1991
20MG A072795 001 Jan 31, 1991
METARAMINOL BITARTRATE
INJECTABLE;INJECTION
ARAMINE
+ MERCK EQ 10MG BASE/ML ** N009509 002 Dec 22, 1987
METARAMINOL BITARTRATE
ABRAXIS PHARM EQ 10MG BASE/ML A080431 001
ELKINS SINN EQ 10MG BASE/ML A083363 001
FRESENIUS KABI USA EQ 10MG BASE/ML A080722 001
GD SEARLE LLC EQ 10MG BASE/ML A086418 001
EQ 20MG BASE/ML A086418 002
METAXALONE
TABLET;ORAL
METAXALONE
INGENUS PHARMS LLC 800MG A213836 001 Oct 21, 2020
+ PRIMUS PHARMS 640MG ** N022503 001 Jun 01, 2015
SKELAXIN
+ KING PHARMS 400MG ** N013217 001
METFORMIN HYDROCHLORIDE
FOR SUSPENSION, EXTENDED RELEASE;ORAL
RIOMET ER
+ SUN PHARM 500MG/5ML N212595 001 Aug 29, 2019
SOLUTION;ORAL
RIOMET
+ RANBAXY 500MG/5ML N021591 001 Sep 11, 2003
TABLET;ORAL
GLUCOPHAGE
+ EMD SERONO INC 500MG ** N020357 001 Mar 03, 1995
+ 625MG ** N020357 003 Nov 05, 1998
+ 750MG ** N020357 004 Nov 05, 1998
+ 850MG ** N020357 002 Mar 03, 1995
+ 1GM ** N020357 005 Nov 05, 1998
METFORMIN HYDROCHLORIDE
BARR 500MG A075971 001 Jan 25, 2002
850MG A075971 002 Jan 25, 2002
1GM A075971 003 Jan 25, 2002
HERITAGE PHARMA 500MG A075978 001 Jan 25, 2002
850MG A075978 002 Jan 25, 2002
1GM A075978 003 Nov 05, 2002
INDICUS PHARMA 500MG A079148 001 Nov 25, 2008
850MG A079148 002 Nov 25, 2008
1GM A079148 003 Nov 25, 2008
IPCA LABS LTD 500MG A078422 001 Aug 06, 2007
850MG A078422 002 Aug 06, 2007

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-306(of 478)
** See List Footnote
METFORMIN HYDROCHLORIDE
TABLET;ORAL
METFORMIN HYDROCHLORIDE
1GM A078422 003 Aug 06, 2007
IVAX SUB TEVA PHARMS 500MG A075975 001 Jan 24, 2002
625MG A075975 004 Jan 24, 2002
750MG A075975 005 Jan 24, 2002
850MG A075975 002 Jan 24, 2002
1GM A075975 003 Jan 24, 2002
MACLEODS PHARMS LTD 500MG A205330 001 Oct 31, 2017
850MG A205330 002 Oct 31, 2017
1GM A205330 003 Oct 31, 2017
MYLAN 500MG A075976 001 Jan 24, 2002
850MG A075976 002 Jan 24, 2002
1GM A075976 003 Jan 24, 2002
MYLAN PHARMS INC 500MG A075969 001 Jan 29, 2002
850MG A075969 002 Jan 29, 2002
1GM A075969 003 Jan 29, 2002
PROVIDENT PHARM 500MG A077853 001 Jul 28, 2006
850MG A077853 002 Jul 28, 2006
1GM A077853 003 Jul 28, 2006
SANDOZ 500MG A075985 001 Jan 25, 2002
850MG A075985 002 Jan 25, 2002
1GM A075985 003 Jan 25, 2002
SUN PHARM INDUSTRIES 500MG A076038 001 Feb 21, 2002
850MG A076038 002 Feb 21, 2002
1GM A076038 003 Feb 21, 2002
SUNSHINE 500MG A208999 001 Oct 12, 2018
850MG A208999 002 Oct 12, 2018
1GM A208999 003 Oct 12, 2018
TEVA 500MG A076328 001 Dec 16, 2002
850MG A076328 002 Dec 16, 2002
1GM A076328 003 Dec 16, 2002
TORRENT PHARMS 500MG A077711 001 Jan 24, 2007
850MG A077711 002 Jan 24, 2007
1GM A077711 003 Jan 24, 2007
WATSON LABS 500MG A075979 001 Jan 24, 2002
850MG A075979 002 Jan 24, 2002
1GM A075979 003 Jan 24, 2002
WATSON LABS FLORIDA 500MG A075961 001 Jan 25, 2002
850MG A075961 002 Jan 25, 2002
1GM A075961 003 Jan 25, 2002
TABLET, EXTENDED RELEASE;ORAL
FORTAMET
+ ANDRX LABS LLC 500MG ** N021574 001 Apr 27, 2004
GLUCOPHAGE XR
+ EMD SERONO INC 500MG ** N021202 001 Oct 13, 2000
+ 750MG ** N021202 004 Apr 11, 2003
METFORMIN HYDROCHLORIDE
ACTAVIS ELIZABETH 500MG A076450 001 Oct 01, 2004
750MG A076878 001 Apr 13, 2005
ACTAVIS LABS FL INC 500MG A076172 001 Jun 16, 2004
AMTA 500MG A213394 001 Aug 03, 2021
1GM A213394 002 Aug 03, 2021
APOTEX 500MG A076706 001 Dec 14, 2004
750MG A076706 002 Dec 29, 2005
BARR 500MG A076496 001 Nov 25, 2005
750MG A076863 001 Oct 14, 2004
IMPAX LABS 500MG A076249 001 Jul 30, 2004
750MG A076985 001 Sep 13, 2005
IVAX SUB TEVA PHARMS 500MG A076545 001 Dec 01, 2003
MYLAN 500MG A076650 001 Sep 13, 2005
750MG A077113 001 Sep 08, 2005
RANBAXY LABS LTD 500MG A076413 001 Jun 18, 2004
750MG A077211 001 Jun 29, 2005
SANDOZ 500MG A076223 001 Dec 14, 2004
SUN PHARM INDUSTRIES 500MG A077124 001 Dec 21, 2005
TORRENT 500MG A090014 001 Dec 30, 2009
TORRENT PHARMS LTD 750MG A079226 001 Feb 18, 2010

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-307(of 478)
** See List Footnote
METFORMIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
METFORMIN HYDROCHLORIDE
WATSON LABS INC 500MG A076818 001 Dec 14, 2004
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
TABLET;ORAL
ACTOPLUS MET
+ TAKEDA PHARMS USA 500MG;EQ 15MG BASE N021842 001 Aug 29, 2005
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
MYLAN 500MG;EQ 15MG BASE A090406 001 Feb 25, 2011
850MG;EQ 15MG BASE A090406 002 Feb 25, 2011
SANDOZ 500MG;EQ 15MG BASE A091273 001 Apr 16, 2013
850MG;EQ 15MG BASE A091273 002 Apr 16, 2013
TORRENT PHARMS LTD 500MG;EQ 15MG BASE A202001 001 Feb 13, 2013
850MG;EQ 15MG BASE A202001 002 Feb 13, 2013
TABLET, EXTENDED RELEASE;ORAL
ACTOPLUS MET XR
+ TAKEDA PHARMS USA 1GM;EQ 15MG BASE N022024 001 May 12, 2009
+ 1GM;EQ 30MG BASE N022024 002 May 12, 2009
METFORMIN HYDROCHLORIDE; REPAGLINIDE
TABLET;ORAL
PRANDIMET
+ NOVO NORDISK INC 500MG;1MG N022386 001 Jun 23, 2008
+ 500MG;2MG N022386 002 Jun 23, 2008
REPAGLINIDE AND METFORMIN HYDROCHLORIDE
LUPIN LTD 500MG;1MG A200624 001 Jul 15, 2015
500MG;2MG A200624 002 Jul 15, 2015
METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE
TABLET;ORAL
AVANDAMET
+ SB PHARMCO 500MG;EQ 1MG BASE ** N021410 001 Oct 10, 2002
+ 500MG;EQ 2MG BASE ** N021410 002 Oct 10, 2002
+ 500MG;EQ 4MG BASE ** N021410 003 Oct 10, 2002
+ 1GM;EQ 2MG BASE ** N021410 004 Aug 25, 2003
+ 1GM;EQ 4MG BASE ** N021410 005 Aug 25, 2003
ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE
TEVA 500MG;EQ 2MG BASE A077337 001 May 07, 2014
500MG;EQ 1MG BASE A077337 005 May 19, 2017
500MG;EQ 4MG BASE A077337 002 May 07, 2014
1GM;EQ 4MG BASE A077337 004 May 07, 2014
1GM;EQ 2MG BASE A077337 003 May 07, 2014
METHACHOLINE CHLORIDE
FOR SOLUTION;INHALATION
PROVOCHOLINE
+ METHAPHARM 1600MG/VIAL N019193 002 Aug 29, 2016
METHACYCLINE HYDROCHLORIDE
CAPSULE;ORAL
RONDOMYCIN
MEDPOINTE PHARM HLC EQ 140MG BASE A060641 001
EQ 280MG BASE A060641 002
SYRUP;ORAL
RONDOMYCIN
MEDPOINTE PHARM HLC EQ 70MG BASE/5ML A060641 003
METHADONE HYDROCHLORIDE
CONCENTRATE;ORAL
METHADONE HYDROCHLORIDE
LANNETT CO INC 10MG/ML A212094 001 Mar 03, 2021
POWDER;FOR RX COMPOUNDING
METHADONE HYDROCHLORIDE
MALLINCKRODT INC 50GM/BOT N006383 002
100GM/BOT N006383 003
500GM/BOT N006383 004
SYRUP;ORAL
DOLOPHINE HYDROCHLORIDE
HIKMA 10MG/30ML N006134 004

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-308(of 478)
** See List Footnote
METHADONE HYDROCHLORIDE
TABLET;ORAL
DOLOPHINE HYDROCHLORIDE
+ HIKMA 5MG ** N006134 002
+ 10MG ** N006134 010
METHADONE HYDROCHLORIDE
NOSTRUM LABS INC 5MG A210484 001 Aug 02, 2018
10MG A210484 002 Aug 02, 2018
ROXANE 40MG A074081 001 Apr 28, 1995
VISTAPHARM 5MG A040241 001 May 29, 1998
METHADOSE
SPECGX LLC 5MG A040050 001 Apr 15, 1993
10MG A040050 002 Apr 15, 1993
TABLET, DISPERSIBLE;ORAL
WESTADONE
SANDOZ 2.5MG N017108 001
TABLET, EFFERVESCENT;ORAL
WESTADONE
SANDOZ 5MG N017108 002
10MG N017108 003
40MG N017108 004
METHAMPHETAMINE HYDROCHLORIDE
TABLET;ORAL
METHAMPEX
TEVA 10MG A083889 001
METHAMPHETAMINE HYDROCHLORIDE
ABLE 5MG A040529 001 Feb 25, 2004
REXAR 5MG A084931 001
10MG A084931 002
TEVA 5MG A086359 001
TABLET, EXTENDED RELEASE;ORAL
DESOXYN
KEY THERAP 5MG N005378 004
10MG N005378 003
15MG N005378 005
METHANTHELINE BROMIDE
TABLET;ORAL
BANTHINE
SHIRE 50MG N007390 001
METHARBITAL
TABLET;ORAL
GEMONIL
ABBVIE 100MG N008322 001
METHAZOLAMIDE
TABLET;ORAL
METHAZOLAMIDE
APPLIED ANAL 25MG A040011 001 Jul 17, 1997
50MG A040011 002 Jul 17, 1997
ATHEM 25MG A040102 001 Aug 28, 1996
50MG A040102 002 Aug 28, 1996
NEPTAZANE
+ LEDERLE 25MG ** N011721 002 Nov 25, 1991
+ 50MG ** N011721 001
METHDILAZINE
TABLET, CHEWABLE;ORAL
TACARYL
WESTWOOD SQUIBB 3.6MG N011950 009
METHDILAZINE HYDROCHLORIDE
SYRUP;ORAL
METHDILAZINE HYDROCHLORIDE
ALPHARMA US PHARMS 4MG/5ML A087122 001
TACARYL
WESTWOOD SQUIBB 4MG/5ML N011950 007
TABLET;ORAL
TACARYL
WESTWOOD SQUIBB 8MG N011950 006

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-309(of 478)
** See List Footnote
METHENAMINE HIPPURATE
TABLET;ORAL
METHENAMINE HIPPURATE
IMPAX LABS INC 1GM A076411 001 Jun 20, 2003
METHICILLIN SODIUM
INJECTABLE;INJECTION
STAPHCILLIN
APOTHECON EQ 900MG BASE/VIAL A061449 001
EQ 900MG BASE/VIAL N050117 001
EQ 3.6GM BASE/VIAL A061449 002
EQ 3.6GM BASE/VIAL N050117 002
EQ 5.4GM BASE/VIAL A061449 003
EQ 5.4GM BASE/VIAL N050117 003
METHIMAZOLE
TABLET;ORAL
METHIMAZOLE
AIPING LIFE SCI 20MG A040547 004 Feb 18, 2005
DISCOVERY THERAP 15MG A040619 003 Jul 12, 2005
MYLAN 20MG A040350 003 Jun 07, 2001
SUN PHARM INDS INC 5MG A040870 001 Sep 25, 2007
10MG A040870 002 Sep 25, 2007
TAPAZOLE
+ KING PHARMS 5MG ** N007517 002
+ 10MG ** N007517 004
KING PHARMS LLC 5MG A040320 001 Mar 31, 2000
10MG A040320 002 Mar 31, 2000
METHIXENE HYDROCHLORIDE
TABLET;ORAL
TREST
NOVARTIS 1MG N013420 001
METHOCARBAMOL
INJECTABLE;INJECTION
METHOCARBAMOL
DR REDDYS 100MG/ML A086459 001
MARSAM PHARMS LLC 100MG/ML A089849 001 Dec 27, 1991
SOLUTION;IM-IV
METHOCARBAMOL
MYLAN INSTITUTIONAL 1GM/10ML (100MG/ML) A204404 001 Dec 05, 2014
TABLET;ORAL
DELAXIN
FERNDALE LABS 500MG A085454 001
FORBAXIN
FOREST LABS 750MG A085136 001
METHOCARBAMOL
ABLE 500MG A040413 001 Mar 17, 2003
750MG A040413 002 Mar 17, 2003
AM THERAP 500MG A089417 001 Feb 11, 1987
750MG A089418 001 Feb 11, 1987
ANI PHARMS 500MG A084277 001
750MG A084276 002
ASCOT 500MG A087660 001 Oct 27, 1982
750MG A087661 001 Oct 27, 1982
AUROBINDO PHARMA LTD 750MG A213967 001 Aug 12, 2020
CHARTWELL MOLECULAR 500MG A084756 002 Mar 31, 2003
750MG A084756 001
CLONMEL HLTHCARE 500MG A085961 001
750MG A085963 001
FOSUN PHARMA 500MG A084616 001
750MG A084615 001
HEATHER 500MG A084675 001
750MG A084924 001
HIKMA INTL PHARMS 500MG A085159 001
750MG A085123 001
IMPAX LABS 500MG A084927 001
750MG A084928 001
INWOOD LABS 500MG A085137 001
IVAX SUB TEVA PHARMS 500MG A084648 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-310(of 478)
** See List Footnote
METHOCARBAMOL
TABLET;ORAL
METHOCARBAMOL
750MG A084649 001
KV PHARM 500MG A085660 001
750MG A085658 001
MYLAN 500MG A084259 001
750MG A084323 001
NYLOS 750MG A085033 001
PIONEER PHARMS 500MG A088731 001 Dec 13, 1985
750MG A089082 001 Dec 13, 1985
PURACAP PHARM 500MG A084231 002
750MG A084471 001
PUREPAC PHARM 500MG A085718 001
750MG A085718 002
ROXANE 500MG A088646 001 Feb 29, 1984
750MG A088647 001 Feb 29, 1984
SANDOZ 500MG A087283 001
750MG A087282 001
SOLVAY 500MG A084448 001
750MG A084449 001
SUN PHARM INDUSTRIES 500MG A084488 001
750MG A084486 001
SUPERPHARM 500MG A087589 001 Jan 22, 1982
750MG A087590 001 Jan 22, 1982
TABLICAPS 500MG A084846 001
UPSHER SMITH 500MG A087453 001
750MG A087454 001
WATSON LABS 500MG A083605 001
500MG A085180 001
750MG A083605 002
750MG A085192 001
ROBAXIN
+ AUXILIUM PHARMS LLC 500MG ** N011011 004
ROBAXIN-750
+ AUXILIUM PHARMS LLC 750MG ** N011011 006
METHOHEXITAL SODIUM
INJECTABLE;INJECTION
BREVITAL SODIUM
PAR STERILE PRODUCTS 200MG/VIAL N011559 004 Dec 21, 2012
+ 2.5GM/VIAL N011559 002
5GM/VIAL N011559 003
METHOTREXATE
SOLUTION;INTRAVENOUS
METHOTREXATE
+ ACCORD HLTHCARE 5GM/50ML (100MG/ML) N214121 001 Aug 24, 2020
SOLUTION;SUBCUTANEOUS
OTREXUP
+ OTTER PHARMS 7.5MG/0.4ML (7.5MG/0.4ML) N204824 005 Nov 07, 2014
OTREXUP PFS
+ OTTER PHARMS 10MG/0.4ML (10MG/0.4ML) N204824 009 May 31, 2017
+ 15MG/0.6ML (15MG/0.6ML) N204824 010 May 31, 2017
+ 17.5MG/0.7ML (17.5MG/0.7ML) N204824 011 May 31, 2017
+ 20MG/0.8ML (20MG/0.8ML) N204824 012 May 31, 2017
+ 22.5MG/0.9ML (22.5MG/0.9ML) N204824 013 May 31, 2017
+ 25MG/ML (25MG/ML) N204824 014 May 31, 2017
RASUVO
+ MEDEXUS 27.5MG/0.55ML (27.5MG/0.55ML) N205776 009 Jul 10, 2014
REDITREX
+ NORDIC GRP 7.5MG/0.3ML (7.5MG/0.3ML) N210737 001 Nov 27, 2019
+ 10MG/0.4ML (10MG/0.4ML) N210737 002 Nov 27, 2019
+ 12.5MG/0.5ML (12.5MG/0.5ML) N210737 003 Nov 27, 2019
+ 17.5MG/0.7ML (17.5MG/0.7ML) N210737 005 Nov 27, 2019
+ 22.5MG/ML (22.5MG/ML) N210737 007 Nov 27, 2019

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-311(of 478)
** See List Footnote
METHOTREXATE SODIUM
INJECTABLE;INJECTION
ABITREXATE
ABIC EQ 25MG BASE/ML A089161 001 Mar 10, 1987
EQ 50MG BASE/VIAL A089354 001 Jul 17, 1987
EQ 100MG BASE/VIAL A089355 001 Jul 17, 1987
EQ 250MG BASE/VIAL A089356 001 Jul 17, 1987
FOLEX
+ PHARMACIA AND UPJOHN EQ 25MG BASE/VIAL A087695 001 Apr 08, 1983
EQ 50MG BASE/VIAL A087695 002 Apr 08, 1983
+ EQ 100MG BASE/VIAL A087695 003 Apr 08, 1983
EQ 250MG BASE/VIAL A088954 001 Oct 24, 1985
FOLEX PFS
PHARMACIA AND UPJOHN EQ 25MG BASE/ML A081242 001 Aug 23, 1991
EQ 25MG BASE/ML A089180 001 Jan 03, 1986
METHOTREXATE LPF
+ HOSPIRA EQ 25MG BASE/ML N011719 007 Mar 31, 1982
METHOTREXATE PRESERVATIVE FREE
FRESENIUS KABI USA EQ 25MG BASE/ML A040265 001 Feb 26, 1999
+ HOSPIRA EQ 20MG BASE/2ML (EQ 10MG BASE/ML) N011719 014 Apr 13, 2005
+ EQ 500MG BASE/20ML (EQ 25MG BASE/ML) ** N011719 013 Apr 13, 2005
+ EQ 2.5GM BASE/100ML (EQ 25MG BASE/ML) N011719 011 Apr 13, 2005
METHOTREXATE SODIUM
ABRAXIS PHARM EQ 2.5MG BASE/ML A089323 001 Jun 13, 1986
EQ 20MG BASE/VIAL A088935 001 Oct 11, 1985
EQ 25MG BASE/ML A089263 001 Jun 13, 1986
EQ 25MG BASE/ML A089322 001 Jun 13, 1986
EQ 50MG BASE/VIAL A088936 001 Oct 11, 1985
EQ 100MG BASE/VIAL A088937 001 Oct 11, 1985
FRESENIUS KABI USA EQ 250MG BASE/10ML (EQ 25MG BASE/ML) A040263 002 Feb 26, 1999
+ HOSPIRA EQ 2.5MG BASE/ML N011719 004
+ EQ 20MG BASE/VIAL N011719 001
+ EQ 25MG BASE/ML N011719 005
+ EQ 50MG BASE/VIAL N011719 003
+ EQ 100MG BASE/VIAL N011719 006
NORBROOK EQ 25MG BASE/ML A088648 001 May 09, 1986
PHARMACHEMIE USA EQ 25MG BASE/ML A089158 001 Jul 08, 1988
METHOTREXATE SODIUM PRESERVATIVE FREE
EUGIA PHARMA SPECLTS EQ 50MG BASE/2ML (EQ 25MG BASE/ML) A201529 001 Mar 29, 2012
EQ 100MG BASE/4ML (EQ 25MG BASE/ML) A201529 002 Mar 29, 2012
EQ 200MG BASE/8ML (EQ 25MG BASE/ML) A201529 003 Mar 29, 2012
EQ 250MG BASE/10ML (EQ 25MG BASE/ML) A201529 004 Mar 29, 2012
+ HOSPIRA EQ 1GM BASE/VIAL N011719 009 Apr 07, 1988
MYLAN EQ 1GM BASE/40ML (EQ 25MG BASE/ML) A201530 001 Mar 29, 2012
MEXATE
+ BRISTOL EQ 20MG BASE/VIAL A086358 001
+ EQ 50MG BASE/VIAL A086358 002
+ EQ 100MG BASE/VIAL A086358 003
+ EQ 250MG BASE/VIAL A086358 004
MEXATE-AQ
+ BRISTOL MYERS EQ 25MG BASE/ML A088760 001 Feb 14, 1985
MEXATE-AQ PRESERVED
BRISTOL MYERS SQUIBB EQ 25MG BASE/ML A089887 001 Apr 14, 1989
TABLET;ORAL
METHOTREXATE SODIUM
DURAMED PHARMS BARR EQ 2.5MG BASE A040233 001 Jun 17, 1999
+ STRIDES PHARMA EQ 2.5MG BASE ** N008085 002
METHOXAMINE HYDROCHLORIDE
INJECTABLE;INJECTION
VASOXYL
GLAXOSMITHKLINE 10MG/ML N006772 002
20MG/ML N006772 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-312(of 478)
** See List Footnote
METHOXSALEN
CAPSULE;ORAL
8-MOP
+ VALEANT PHARM INTL 10MG N009048 001
METHOXSALEN
ACTAVIS INC 10MG A202603 001 Jun 09, 2015
ANI PHARMS 10MG A087781 001 Jun 08, 1982
LOTION;TOPICAL
OXSORALEN
+ VALEANT PHARM INTL 1% N009048 002
METHSCOPOLAMINE BROMIDE
TABLET;ORAL
METHSCOPOLAMINE BROMIDE
PVT FORM 2.5MG A080970 001
STRIDES PHARMA 2.5MG A040624 001 Dec 28, 2006
5MG A040624 002 Dec 28, 2006
PAMINE
FOUGERA PHARMS 2.5MG ** N008848 001
PAMINE FORTE
FOUGERA PHARMS 5MG ** N008848 002 Mar 25, 2003
METHSUXIMIDE
CAPSULE;ORAL
CELONTIN
+ PARKE DAVIS 150MG N010596 007
METHYCLOTHIAZIDE
TABLET;ORAL
AQUATENSEN
MEDPOINTE PHARM HLC 5MG N017364 001
ENDURON
+ ABBVIE 2.5MG ** N012524 001
+ 5MG ** N012524 004
METHYCLOTHIAZIDE
CHARTWELL RX 2.5MG A089835 001 Aug 18, 1988
5MG A089837 001 Aug 18, 1988
IVAX PHARMS 2.5MG A087913 001 Jun 03, 1982
5MG A087786 001 May 18, 1982
MYLAN 2.5MG A087671 001 Aug 17, 1982
MYLAN PHARMS INC 5MG A087672 001 Aug 17, 1982
PAR PHARM 2.5MG A089135 001 Feb 12, 1986
5MG A089136 001 Feb 12, 1986
USL PHARMA 5MG A088745 001 Mar 21, 1985
WATSON LABS 2.5MG A085487 001 Mar 11, 1982
2.5MG A088750 001 Sep 06, 1984
5MG A085476 001 Mar 11, 1982
5MG A088724 001 Sep 06, 1984
METHYCLOTHIAZIDE; PARGYLINE HYDROCHLORIDE
TABLET;ORAL
EUTRON
ABBOTT 5MG;25MG N016047 001
METHYCLOTHIAZIDE; RESERPINE
TABLET;ORAL
DIUTENSEN-R
MEDPOINTE PHARM HLC 2.5MG;0.1MG N012708 005
METHYL AMINOLEVULINATE HYDROCHLORIDE
CREAM;TOPICAL
METVIXIA
GALDERMA LABS LP EQ 16.8% BASE N021415 001 Jul 27, 2004
METHYLDOPA
SUSPENSION;ORAL
ALDOMET
MERCK 250MG/5ML N018389 001
TABLET;ORAL
ALDOMET
+ MERCK 125MG ** N013400 003
+ 250MG ** N013400 001
+ 500MG ** N013400 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-313(of 478)
** See List Footnote
METHYLDOPA
TABLET;ORAL
METHYLDOPA
ACCORD HLTHCARE 125MG A070070 003 Oct 15, 1985
250MG A070084 001 Oct 15, 1985
500MG A070085 001 Oct 15, 1985
CHARTWELL RX 125MG A071700 001 Mar 02, 1988
250MG N018934 001 Jun 29, 1984
500MG N018934 002 Jun 29, 1984
DURAMED PHARMS BARR 250MG A071006 001 Dec 16, 1986
500MG A071009 001 Dec 16, 1986
HALSEY 125MG A071751 001 Mar 28, 1988
250MG A071752 001 Mar 28, 1988
500MG A071753 001 Mar 28, 1988
HERITAGE PHARMA 250MG A070098 001 Feb 20, 1986
500MG A070343 001 Feb 20, 1986
PARKE DAVIS 125MG A070331 001 Apr 15, 1986
250MG A070332 001 Apr 15, 1986
500MG A070333 001 Apr 15, 1986
PLIVA 125MG A072126 001 Jul 07, 1988
250MG A072127 001 Jul 07, 1988
500MG A072128 001 Jul 07, 1988
PUREPAC PHARM 125MG A070749 001 Feb 07, 1986
250MG A070750 001 Feb 07, 1986
500MG A070452 001 Feb 07, 1986
RISING 250MG A070076 002 Apr 18, 1985
500MG A070076 001 Apr 18, 1985
ROXANE 125MG A070192 001 Apr 25, 1986
250MG A070193 001 Apr 25, 1986
500MG A070194 001 Apr 25, 1986
STRIDES PHARMA 125MG A070535 001 Jan 02, 1987
250MG A070536 001 Jan 02, 1987
500MG A070537 001 Jan 02, 1987
SUN PHARM INDUSTRIES 125MG A070073 001 Oct 09, 1986
250MG A070060 001 Oct 09, 1986
500MG A070074 001 Oct 09, 1986
SUPERPHARM 250MG A070669 001 Jun 23, 1989
500MG A070670 001 Jun 23, 1989
TEVA 125MG A071105 001 Dec 05, 1986
250MG A071106 001 Dec 05, 1986
500MG A071067 001 Dec 05, 1986
WATSON LABS 125MG A070245 001 Feb 25, 1986
125MG A070260 001 Jun 24, 1985
250MG A070246 001 Feb 25, 1986
250MG A070261 001 Jun 24, 1985
250MG A070703 001 Jun 06, 1986
500MG A070247 001 Feb 25, 1986
500MG A070262 001 Jun 24, 1985
500MG A070625 001 Jun 06, 1986
METHYLDOPATE HYDROCHLORIDE
INJECTABLE;INJECTION
ALDOMET
+ MERCK 50MG/ML ** N013401 001
METHYLDOPATE HYDROCHLORIDE
ABRAXIS PHARM 50MG/ML A070652 001 Jun 03, 1986
AM REGENT 50MG/ML A071279 001 Oct 02, 1987
BAXTER HLTHCARE 50MG/ML A070291 001 Jul 01, 1986
HOSPIRA 50MG/ML A070691 001 Jun 19, 1987
50MG/ML A070698 001 Jun 15, 1987
50MG/ML A070699 001 Jun 15, 1987
50MG/ML A070849 001 Jun 19, 1987
MARSAM PHARMS LLC 50MG/ML A071812 001 Dec 22, 1987
SMITH AND NEPHEW 50MG/ML A070841 001 Jan 02, 1987
TEVA PARENTERAL 50MG/ML A072974 001 Nov 22, 1991

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-314(of 478)
** See List Footnote
METHYLERGONOVINE MALEATE
TABLET;ORAL
METHERGINE
+ EDISON THERAPS LLC 0.2MG ** N006035 003
METHYLPHENIDATE
TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
METHYLPHENIDATE
ACTAVIS ELIZABETH 8.6MG A210924 001 Jun 19, 2020
17.3MG A210924 002 Jun 19, 2020
25.9MG A210924 003 Jun 19, 2020
METHYLPHENIDATE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
ADHANSIA XR
+ PURDUE PHARMA LP 25MG N212038 001 Feb 27, 2019
+ 35MG N212038 002 Feb 27, 2019
+ 45MG N212038 003 Feb 27, 2019
+ 55MG N212038 004 Feb 27, 2019
+ 70MG N212038 005 Feb 27, 2019
+ 85MG N212038 006 Feb 27, 2019
METHYLPHENIDATE HYDROCHLORIDE
BARR LABS INC 10MG A079031 004 Oct 15, 2014
20MG A079031 001 Jul 13, 2012
30MG A079031 002 Jul 13, 2012
40MG A079031 003 Jul 13, 2012
RITALIN LA
+ NOVARTIS 60MG ** N021284 005 Oct 27, 2014
SOLUTION;ORAL
METHYLPHENIDATE HYDROCHLORIDE
CHARTWELL MOLECULAR 5MG/5ML A207414 001 Dec 16, 2020
10MG/5ML A207414 002 Dec 16, 2020
TABLET;ORAL
METHYLPHENIDATE HYDROCHLORIDE
ABLE 5MG A040404 001 Mar 29, 2001
10MG A040404 002 Mar 29, 2001
20MG A040404 003 Mar 29, 2001
ACTAVIS ELIZABETH 5MG A040321 001 Feb 05, 2002
10MG A040321 002 Feb 05, 2002
20MG A040321 003 Feb 05, 2002
ALVOGEN 5MG A206840 001 Sep 15, 2016
10MG A206840 002 Sep 15, 2016
20MG A206840 003 Sep 15, 2016
AUROLIFE PHARMA LLC 5MG A209276 001 Oct 25, 2018
10MG A209276 002 Oct 25, 2018
20MG A209276 003 Oct 25, 2018
CEDIPROF INC 5MG A208737 001 Feb 01, 2019
10MG A208737 002 Feb 01, 2019
20MG A208737 003 Feb 01, 2019
LANNETT CO INC 5MG A086429 001
10MG A085799 001
20MG A086428 001
NOSTRUM LABS INC 5MG A207587 001 Mar 03, 2017
10MG A207587 002 Mar 03, 2017
20MG A207587 003 Mar 03, 2017
WATSON LABS 5MG A040220 001 Aug 29, 1997
10MG A040220 002 Aug 29, 1997
20MG A040220 003 Aug 29, 1997
TABLET, CHEWABLE;ORAL
METHYLIN
+ SPECGX LLC 2.5MG ** N021475 001 Apr 15, 2003
+ 5MG ** N021475 002 Apr 15, 2003
+ 10MG ** N021475 003 Apr 15, 2003
METHYLPHENIDATE HYDROCHLORIDE
NOSTRUM LABS INC 2.5MG A204954 001 Jan 26, 2017
5MG A204954 002 Jan 26, 2017
10MG A204954 003 Jan 26, 2017
NOVEL LABS INC 2.5MG A204115 001 Feb 25, 2015
5MG A204115 002 Feb 25, 2015
10MG A204115 003 Feb 25, 2015

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-315(of 478)
** See List Footnote
METHYLPHENIDATE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
METADATE ER
LANNETT CO INC 10MG A040306 001 Oct 20, 1999
20MG A089601 001 Jun 01, 1988
METHYLPHENIDATE HYDROCHLORIDE
ABLE 20MG A076032 001 May 09, 2001
ALVOGEN 10MG A204772 001 Feb 29, 2016
18MG A210818 001 Nov 30, 2018
20MG A204772 002 Feb 29, 2016
27MG A210818 002 Nov 30, 2018
36MG A210818 003 Nov 30, 2018
54MG A210818 004 Nov 30, 2018
ANI PHARMS 18MG A208607 001 Jul 14, 2017
27MG A208607 002 Jul 14, 2017
36MG A208607 003 Jul 14, 2017
54MG A208607 004 Jul 14, 2017
HERITAGE PHARMA 20MG A075450 001 Dec 21, 2001
RHODES PHARMS 18MG A214111 001 May 31, 2022
27MG A214111 002 May 31, 2022
36MG A214111 003 May 31, 2022
54MG A214111 004 May 31, 2022
STRIDES PHARMA 36MG A204659 001 Jul 15, 2019
54MG A204659 002 Jul 15, 2019
WATSON LABS 20MG A040410 001 Feb 09, 2001
RITALIN-SR
+ NOVARTIS 20MG ** N018029 001 Mar 30, 1982
METHYLPREDNISOLONE
TABLET;ORAL
MEDROL
PFIZER 24MG N011153 005
METHYLPREDNISOLONE
AMNEAL 4MG A207481 001 Sep 21, 2021
8MG A207481 002 Sep 21, 2021
16MG A207481 003 Sep 21, 2021
32MG A207481 004 Sep 21, 2021
DURAMED PHARMS BARR 4MG A088497 001 Feb 21, 1984
HEATHER 4MG A085650 001
INVATECH 4MG A087341 001
LUPIN LTD 2MG A209097 001 Feb 22, 2019
4MG A209097 002 Feb 22, 2019
8MG A209097 003 Feb 22, 2019
16MG A209097 004 Feb 22, 2019
32MG A209097 005 Feb 22, 2019
NOVAST LABS 4MG A210985 001 Jan 09, 2019
PAR PHARM 16MG A089207 001 Apr 25, 1988
24MG A089208 001 Apr 25, 1988
32MG A089209 001 Apr 25, 1988
WATSON LABS 4MG A086161 001 Feb 09, 1982
16MG A086159 001 Feb 09, 1982
METHYLPREDNISOLONE ACETATE
ENEMA;RECTAL
MEDROL
PHARMACIA AND UPJOHN 40MG/BOT N018102 001
INJECTABLE;INJECTION
M-PREDROL
BEL MAR 40MG/ML A086666 001
80MG/ML A087135 001
METHYLPREDNISOLONE ACETATE
AKORN 40MG/ML A086903 001 Oct 20, 1982
80MG/ML A086903 002 Oct 20, 1982
PAR STERILE PRODUCTS 40MG/ML A214297 001 Jan 21, 2022
SAGENT PHARMS INC 20MG/ML A201835 001 Jun 27, 2018
WATSON LABS 20MG/ML A085597 001
20MG/ML A087248 001
40MG/ML A085374 001
40MG/ML A085600 001
80MG/ML A085595 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-316(of 478)
** See List Footnote
METHYLPREDNISOLONE ACETATE
INJECTABLE;INJECTION
METHYLPREDNISOLONE ACETATE
80MG/ML A086507 001
OINTMENT;TOPICAL
MEDROL ACETATE
PHARMACIA AND UPJOHN 0.25% N012421 001
1% N012421 002
METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE
CREAM;TOPICAL
NEO-MEDROL ACETATE
PHARMACIA AND UPJOHN 0.25%;EQ 3.5MG BASE/GM A060611 002
1%;EQ 3.5MG BASE/GM A060611 001
METHYLPREDNISOLONE SODIUM SUCCINATE
INJECTABLE;INJECTION
A-METHAPRED
ABBOTT EQ 40MG BASE/VIAL A089573 001 Feb 22, 1991
EQ 125MG BASE/VIAL A089574 001 Feb 22, 1991
EQ 500MG BASE/VIAL A089575 001 Feb 22, 1991
EQ 1GM BASE/VIAL A089576 001 Feb 22, 1991
HOSPIRA EQ 40MG BASE/VIAL A040664 001 Dec 20, 2005
EQ 40MG BASE/VIAL A085853 001
EQ 125MG BASE/VIAL A040665 001 Dec 20, 2005
EQ 125MG BASE/VIAL A085855 001
EQ 500MG BASE/VIAL A085854 001
EQ 500MG BASE/VIAL A089173 001 Aug 18, 1987
EQ 1GM BASE/VIAL A085852 001
EQ 1GM BASE/VIAL A089174 001 Aug 18, 1987
HOSPIRA INC EQ 40MG BASE/VIAL A040793 001 Nov 25, 2008
EQ 125MG BASE/VIAL A040827 001 Nov 25, 2008
METHYLPREDNISOLONE
ELKINS SINN EQ 125MG BASE/VIAL A086906 002
EQ 500MG BASE/VIAL A086906 003
EQ 1GM BASE/VIAL A086906 004
ORGANON USA INC EQ 500MG BASE/VIAL A087535 001 Jun 25, 1982
EQ 1GM BASE/VIAL A087535 002 Jun 25, 1982
METHYLPREDNISOLONE SODIUM SUCCINATE
ABRAXIS PHARM EQ 40MG BASE/VIAL A088676 001 Jun 08, 1984
EQ 40MG BASE/VIAL A089143 001 Mar 28, 1986
EQ 125MG BASE/VIAL A088677 001 Jun 08, 1984
EQ 125MG BASE/VIAL A089144 001 Mar 28, 1986
EQ 500MG BASE/VIAL A088678 001 Jun 08, 1984
EQ 500MG BASE/VIAL A089186 001 Mar 28, 1986
EQ 500MG BASE/VIAL A089187 001 Mar 28, 1986
EQ 1GM BASE/VIAL A088679 001 Jun 08, 1984
EQ 1GM BASE/VIAL A089188 001 Mar 28, 1986
EQ 1GM BASE/VIAL A089189 001 Mar 28, 1986
BEDFORD LABS EQ 40MG BASE/VIAL A040662 001 Feb 21, 2007
EQ 125MG BASE/VIAL A040641 002 Feb 21, 2007
EQ 500MG BASE/VIAL A040641 003 Feb 21, 2007
EQ 500MG BASE/VIAL A040709 001 Feb 21, 2007
EQ 1GM BASE/VIAL A040641 004 Feb 21, 2007
EQ 1GM BASE/VIAL A040709 002 Feb 21, 2007
ELKINS SINN EQ 40MG BASE/VIAL A086906 001
EUGIA PHARMA EQ 40MG BASE/VIAL A207667 001 Dec 15, 2015
EQ 125MG BASE/VIAL A207667 002 Dec 15, 2015
EQ 500MG BASE/VIAL A207667 003 Dec 15, 2015
EQ 2GM BASE/VIAL A207667 004 Dec 15, 2015
INTL MEDICATION EQ 40MG BASE/VIAL A087812 001 Feb 09, 1983
EQ 125MG BASE/VIAL A087813 001 Feb 09, 1983
EQ 500MG BASE/VIAL A087851 001 Feb 09, 1983
EQ 1GM BASE/VIAL A087852 001 Feb 09, 1983
TEVA PARENTERAL EQ 125MG BASE/VIAL A081266 001 Nov 30, 1992
EQ 500MG BASE/VIAL A081267 001 Nov 30, 1992
EQ 1GM BASE/VIAL A081268 001 Nov 30, 1992
WATSON LABS EQ 40MG BASE/VIAL A086953 001 Jul 22, 1982
EQ 125MG BASE/VIAL A087030 001 Jul 22, 1982
EQ 500MG BASE/VIAL A088523 001 Jul 24, 1984

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-317(of 478)
** See List Footnote
METHYLPREDNISOLONE SODIUM SUCCINATE
INJECTABLE;INJECTION
METHYLPREDNISOLONE SODIUM SUCCINATE
EQ 1GM BASE/VIAL A088524 001 Jul 24, 1984
METHYLPREDNISOLONE; NEOMYCIN SULFATE
OINTMENT;OPHTHALMIC
NEO-MEDROL
PHARMACIA AND UPJOHN 0.1%;EQ 3.5MG BASE/GM A060645 001
METHYLTESTOSTERONE
CAPSULE;ORAL
METHYLTESTOSTERONE
HEATHER 10MG A084967 001
TESTRED
+ BAUSCH 10MG A083976 001
VIRILON
CHARTWELL 10MG A087750 001 Nov 24, 1982
TABLET;BUCCAL
ANDROID 5
VALEANT PHARM INTL 5MG A087222 001
ORETON
SCHERING 10MG A080281 001
TABLET;BUCCAL, SUBLINGUAL
METANDREN
NOVARTIS 5MG N003240 004
10MG N003240 001
10MG N003240 005
25MG N003240 003
METHYLTESTOSTERONE
IMPAX LABS 10MG A084287 001
LILLY 10MG A080256 001
25MG A080256 002
PUREPAC PHARM 10MG A080308 001
10MG A080475 001
10MG A080475 002
25MG A080475 003
PVT FORM 5MG A083836 001
TABLICAPS 10MG A085125 001
USL PHARMA 10MG A080271 001
TABLET;ORAL
ANDROID 10
VALEANT PHARMS NORTH 10MG A086450 001
METHYLTESTOSTERONE
IMPAX LABS 25MG A084310 001
INWOOD LABS 10MG A080839 001
25MG A080973 001
KV PHARM 10MG A084312 001
LANNETT 10MG A087092 001 Nov 05, 1982
25MG A087111 001 Jan 27, 1983
PARKE DAVIS 10MG A084244 001
25MG A084241 001
PUREPAC PHARM 10MG A080309 001
25MG A080310 001
PVT FORM 5MG A080214 001
10MG A080214 002
25MG A080214 003
TABLICAPS 10MG A080313 001
25MG A085270 001
WATSON LABS 10MG A080933 001
25MG A080931 001
WEST WARD 10MG A084331 001
25MG A084331 002
25MG A084642 001
ORETON METHYL
SCHERING 10MG N003158 001
25MG N003158 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-318(of 478)
** See List Footnote
METHYPRYLON
CAPSULE;ORAL
NOLUDAR
ROCHE 300MG N009660 008
ELIXIR;ORAL
NOLUDAR
ROCHE 50MG/5ML N009660 007
TABLET;ORAL
NOLUDAR
ROCHE 50MG N009660 002
200MG N009660 004
METHYSERGIDE MALEATE
TABLET;ORAL
SANSERT
NOVARTIS 2MG N012516 001
METIPRANOLOL HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
METIPRANOLOL
SANDOZ INC 0.3% A075720 001 Aug 06, 2001
OPTIPRANOLOL
+ BAUSCH AND LOMB 0.3% ** N019907 001 Dec 29, 1989
METOCLOPRAMIDE HYDROCHLORIDE
CONCENTRATE;ORAL
METOCLOPRAMIDE INTENSOL
ROXANE EQ 10MG BASE/ML A072995 001 Jan 30, 1992
INJECTABLE;INJECTION
METOCLOPRAMIDE HYDROCHLORIDE
BEDFORD EQ 5MG BASE/ML A072155 001 Mar 30, 1992
EQ 5MG BASE/ML A072244 001 Mar 30, 1992
EQ 5MG BASE/ML A072247 001 May 18, 1992
HOSPIRA EQ 5MG BASE/ML A070505 001 Jun 23, 1989
EQ 5MG BASE/ML A070506 001 Jun 22, 1989
EQ 5MG BASE/ML A070847 001 Nov 07, 1988
EQ 5MG BASE/ML A071291 001 Mar 03, 1989
EQ 5MG BASE/ML A071990 001 Jan 18, 1989
EQ 5MG BASE/ML A073117 001 Jan 17, 1991
EQ 5MG BASE/ML A074147 001 Aug 02, 1996
LYPHOMED EQ 10MG BASE/2ML A070293 001 Jan 24, 1986
NORBROOK EQ 10MG BASE/2ML A070892 001 Aug 26, 1988
SMITH AND NEPHEW EQ 5MG BASE/ML A070623 001 Mar 02, 1987
EQ 10MG BASE/2ML A070622 001 Mar 02, 1987
REGLAN
+ HIKMA EQ 5MG BASE/ML ** N017862 001
EQ 10MG BASE/ML ** N017862 004 May 28, 1987
SOLUTION;ORAL
METOCLOPRAMIDE HYDROCHLORIDE
ACTAVIS MID ATLANTIC EQ 5MG BASE/5ML A071340 001 Aug 18, 1988
CHARTWELL MOLECULAR EQ 5MG BASE/5ML A073680 001 Oct 27, 1992
MORTON GROVE EQ 5MG BASE/5ML A070949 001 Mar 06, 1987
PACO EQ 5MG BASE/5ML A071665 001 Dec 05, 1988
ROXANE EQ 5MG BASE/5ML A072038 001 Dec 05, 1988
TEVA EQ 5MG BASE/5ML A070819 001 Jul 10, 1987
EQ 5MG BASE/5ML A071315 001 Jun 30, 1993
REGLAN
+ ROBINS AH EQ 5MG BASE/5ML ** N018821 001 Mar 25, 1983
TABLET;ORAL
CLOPRA
QUANTUM PHARMICS EQ 5MG BASE A072384 001 Jun 02, 1988
EQ 10MG BASE A070294 001 Jul 29, 1985
CLOPRA-"YELLOW"
QUANTUM PHARMICS EQ 10MG BASE A070632 001 Oct 28, 1985
MAXOLON
KING PHARMS EQ 10MG BASE A070106 001 Mar 04, 1986
METOCLOPRAMIDE HYDROCHLORIDE
CHARTWELL RX EQ 5MG BASE A074478 001 Oct 05, 1995
EQ 10MG BASE A072215 001 Jan 30, 1990
EQ 10MG BASE A074478 002 Oct 05, 1995
CLONMEL EQ 10MG BASE A072639 001 May 09, 1991

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-319(of 478)
** See List Footnote
METOCLOPRAMIDE HYDROCHLORIDE
TABLET;ORAL
METOCLOPRAMIDE HYDROCHLORIDE
HALSEY EQ 10MG BASE A070906 001 Oct 28, 1986
INTERPHARM EQ 10MG BASE A071213 001 Sep 24, 1986
MUTUAL PHARM EQ 10MG BASE A070660 001 Feb 10, 1987
NORTHSTAR HLTHCARE EQ 5MG BASE A078374 001 Nov 30, 2007
EQ 10MG BASE A078374 002 Nov 30, 2007
PAR PHARM EQ 10MG BASE A070342 001 Mar 25, 1986
SANDOZ EQ 5MG BASE A072436 001 Jun 22, 1989
EQ 10MG BASE A070850 001 Feb 03, 1987
SCHERING EQ 10MG BASE A070598 001 Feb 02, 1987
SUN PHARM INDUSTRIES EQ 5MG BASE A071536 002 Jan 16, 1997
EQ 10MG BASE A071536 001 Apr 28, 1993
SUPERPHARM EQ 10MG BASE A070926 001 Jun 26, 1987
USL PHARMA EQ 10MG BASE A070339 001 Jul 29, 1985
WATSON LABS EQ 10MG BASE A070363 001 Mar 02, 1987
EQ 10MG BASE A070453 001 Jun 06, 1986
EQ 10MG BASE A070511 001 Jan 22, 1986
EQ 10MG BASE A070645 001 May 11, 1987
TABLET, ORALLY DISINTEGRATING;ORAL
METOZOLV ODT
+ SALIX PHARMS EQ 5MG BASE ** N022246 001 Sep 04, 2009
+ EQ 10MG BASE ** N022246 002 Sep 04, 2009
REGLAN ODT
MEDA PHARMS EQ 5MG BASE N021793 001 Jun 10, 2005
EQ 10MG BASE N021793 002 Jun 10, 2005
METOCURINE IODIDE
INJECTABLE;INJECTION
METUBINE IODIDE
LILLY 2MG/ML N006632 003
METOLAZONE
TABLET;ORAL
DIULO
GD SEARLE LLC 2.5MG N018535 001
5MG N018535 002
10MG N018535 003
METOLAZONE
ANI PHARMS 2.5MG A075543 001 Jan 06, 2004
5MG A075543 002 Mar 01, 2004
10MG A075543 003 Dec 24, 2003
ROXANE 10MG A076482 002 Apr 29, 2004
WATSON LABS 10MG A076891 001 Jul 21, 2004
MYKROX
LANNETT CO INC 0.5MG N019532 001 Oct 30, 1987
ZAROXOLYN
+ I3 PHARMS 2.5MG ** N017386 001
+ 5MG ** N017386 002
+ 10MG ** N017386 003
METOPROLOL FUMARATE
TABLET, EXTENDED RELEASE;ORAL
LOPRESSOR
NOVARTIS EQ 100MG TARTRATE N019786 001 Dec 27, 1989
EQ 200MG TARTRATE N019786 002 Dec 27, 1989
EQ 300MG TARTRATE N019786 003 Dec 27, 1989
EQ 400MG TARTRATE N019786 004 Dec 27, 1989
METOPROLOL SUCCINATE
TABLET, EXTENDED RELEASE;ORAL
METOPROLOL SUCCINATE
ACTAVIS LABS FL INC EQ 25MG TARTRATE A076862 002 Aug 03, 2009
EQ 100MG TARTRATE A077298 001 Apr 15, 2010
EQ 200MG TARTRATE A077298 002 Apr 15, 2010
NESHER PHARMS EQ 25MG TARTRATE A077779 001 Mar 20, 2008
EQ 50MG TARTRATE A077176 001 May 14, 2008
EQ 100MG TARTRATE A076640 002 May 18, 2007
EQ 200MG TARTRATE A076640 001 May 18, 2007
PRINSTON INC EQ 100MG TARTRATE A210597 001 Jan 04, 2022

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-320(of 478)
** See List Footnote
METOPROLOL SUCCINATE
TABLET, EXTENDED RELEASE;ORAL
METOPROLOL SUCCINATE
EQ 200MG TARTRATE A210597 002 Jan 04, 2022
SANDOZ EQ 25MG TARTRATE A076969 001 Jul 31, 2006
EQ 50MG TARTRATE A076969 002 May 18, 2007
EQ 100MG TARTRATE A076969 003 Mar 20, 2008
EQ 200MG TARTRATE A076969 004 Mar 20, 2008
METOPROLOL TARTRATE
INJECTABLE;INJECTION
LOPRESSOR
+ NOVARTIS 1MG/ML ** N018704 001 Mar 30, 1984
METOPROLOL TARTRATE
AM REGENT 1MG/ML A090386 001 Sep 30, 2009
LUITPOLD 1MG/ML A091307 001 Dec 29, 2010
STERISCIENCE 1MG/ML A090317 001 Apr 19, 2010
WATSON LABS 1MG/ML A074032 001 Dec 21, 1993
TABLET;ORAL
METOPROLOL TARTRATE
APOTHECON 50MG A074258 001 Jan 27, 1994
100MG A074258 002 Jan 27, 1994
CHARTWELL RX 50MG A073288 001 Mar 25, 1994
100MG A073289 001 Mar 25, 1994
HERITAGE PHARMA 50MG A074141 001 Jan 31, 1995
100MG A074141 002 Jan 31, 1995
MYLAN 50MG A073666 001 Dec 21, 1993
100MG A073666 002 Dec 21, 1993
PUREPAC PHARM 50MG A074380 001 Jul 29, 1994
100MG A074380 002 Jul 29, 1994
RENATA 50MG A074453 001 Apr 27, 1995
100MG A074453 002 Apr 27, 1995
SUN PHARM INDUSTRIES 25MG A073654 002 Jul 15, 2009
50MG A073654 003 Dec 21, 1993
100MG A073654 001 Dec 21, 1993
TEVA 50MG A074143 001 Sep 30, 1994
100MG A074143 002 Sep 30, 1994
TEVA PHARMS 50MG A074333 001 Jan 27, 1994
100MG A074333 002 Jan 27, 1994
WATSON LABS 50MG A074217 001 May 27, 1994
100MG A074217 002 May 27, 1994
METRIZAMIDE
INJECTABLE;INJECTION
AMIPAQUE
GE HEALTHCARE 2.5GM/VIAL N017982 003 Sep 12, 1983
3.75GM/VIAL N017982 001
6.75GM/VIAL N017982 002
13.5GM/VIAL N017982 004 Sep 12, 1983
METRONIDAZOLE
CAPSULE;ORAL
METRONIDAZOLE
ABLE 375MG A076505 001 Nov 13, 2003
GEL;VAGINAL
METRONIDAZOLE
TOLMAR 0.75% A077264 001 Oct 31, 2006
INJECTABLE;INJECTION
FLAGYL I.V. RTU IN PLASTIC CONTAINER
PFIZER 500MG/100ML N018353 002
METRO I.V.
B BRAUN 500MG/100ML N018674 001 Aug 31, 1982
METRONIDAZOLE
ABBOTT 500MG/100ML N018889 001 Nov 18, 1983
ABRAXIS PHARM 500MG/100ML A070071 001 Dec 03, 1984
HIKMA 500MG/100ML N018907 001 Mar 30, 1984
INTL MEDICATION 500MG/100ML A070004 001 May 08, 1985
WATSON LABS 500MG/100ML A070042 001 Dec 20, 1984
500MG/100ML A070170 001 Apr 01, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-321(of 478)
** See List Footnote
METRONIDAZOLE
INJECTABLE;INJECTION
METRONIDAZOLE IN PLASTIC CONTAINER
RISING 500MG/100ML A205531 001 May 09, 2017
TABLET;ORAL
METROMIDOL
LABS AF 250MG A074523 001 Oct 24, 1996
500MG A074523 002 Oct 24, 1996
METRONIDAZOLE
ABLE 250MG A076519 001 Jun 27, 2003
500MG A076519 002 Jun 27, 2003
CHARTWELL MOLECULES 250MG N018845 001 Aug 18, 1983
500MG N018930 001 Aug 18, 1983
FOSUN PHARMA 250MG N018620 001 Mar 04, 1982
250MG N018740 001 Oct 22, 1982
500MG N018620 002 Jun 02, 1983
500MG N018740 002 Oct 22, 1982
HALSEY 250MG A070021 001 Apr 02, 1985
500MG A070593 001 Feb 27, 1986
IVAX SUB TEVA PHARMS 250MG N018517 001
500MG N018517 002 May 05, 1982
LNK 250MG N019029 001 Apr 10, 1984
MUTUAL PHARM 250MG N018818 001 Feb 16, 1983
500MG N018818 002 Feb 16, 1983
SUPERPHARM 250MG A070008 001 Dec 11, 1984
500MG A070009 001 Dec 11, 1984
WATSON LABS 250MG N018599 001 Sep 17, 1982
250MG N018764 001 Sep 17, 1982
500MG N018599 002 Feb 13, 1984
500MG N018764 002 Dec 20, 1982
PROTOSTAT
ORTHO MCNEIL PHARM 250MG N018871 001 Mar 02, 1983
500MG N018871 002 Mar 02, 1983
SATRIC
SAVAGE LABS 250MG A070029 001 Mar 19, 1985
500MG A070731 001 Jun 08, 1987
TABLET, EXTENDED RELEASE;ORAL
FLAGYL ER
+ PFIZER 750MG N020868 001 Nov 26, 1997
METRONIDAZOLE
ABLE 750MG A076462 001 Jun 25, 2003
ALEMBIC PHARMS 750MG A090222 001 May 05, 2010
METRONIDAZOLE HYDROCHLORIDE
INJECTABLE;INJECTION
FLAGYL I.V.
PFIZER EQ 500MG BASE/VIAL ** N018353 001
METRONIDAZOLE HYDROCHLORIDE
ABRAXIS PHARM EQ 500MG BASE/VIAL A070295 001 Oct 15, 1985
METYRAPONE
TABLET;ORAL
METOPIRONE
HRA PHARMA 250MG N012911 001
MEXILETINE HYDROCHLORIDE
CAPSULE;ORAL
MEXILETINE HYDROCHLORIDE
WATSON LABS 150MG A074711 001 Feb 26, 1997
150MG A074865 001 Apr 13, 1998
200MG A074711 002 Feb 26, 1997
200MG A074865 002 Apr 13, 1998
250MG A074711 003 Feb 26, 1997
250MG A074865 003 Apr 13, 1998
MEXITIL
+ BOEHRINGER INGELHEIM 150MG N018873 002 Dec 30, 1985
+ 200MG N018873 003 Dec 30, 1985
+ 250MG N018873 004 Dec 30, 1985

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-322(of 478)
** See List Footnote
MEZLOCILLIN SODIUM MONOHYDRATE
INJECTABLE;INJECTION
MEZLIN
BAYER PHARMS EQ 1GM BASE/VIAL A062333 001
EQ 1GM BASE/VIAL A062372 005 Jan 13, 1983
EQ 1GM BASE/VIAL N050549 001
EQ 2GM BASE/VIAL A062333 002
EQ 2GM BASE/VIAL A062372 001 May 13, 1982
EQ 2GM BASE/VIAL N050549 002
EQ 3GM BASE/VIAL A062333 003
EQ 3GM BASE/VIAL A062372 002 May 13, 1982
EQ 3GM BASE/VIAL A062697 001 Jan 22, 1987
EQ 3GM BASE/VIAL N050549 003
EQ 4GM BASE/VIAL A062333 004
EQ 4GM BASE/VIAL A062372 003 May 13, 1982
EQ 4GM BASE/VIAL A062697 002 Jan 22, 1987
EQ 4GM BASE/VIAL N050549 004
EQ 20GM BASE/VIAL A062372 004 Mar 02, 1988
EQ 20GM BASE/VIAL N050549 005 Mar 02, 1988
MICAFUNGIN SODIUM
POWDER;INTRAVENOUS
MICAFUNGIN
+ TEVA PHARMS USA INC EQ 50MG BASE/VIAL N212125 001 Jul 30, 2021
+ EQ 100MG BASE/VIAL N212125 002 Jul 30, 2021
MICONAZOLE
INJECTABLE;INJECTION
MONISTAT
JANSSEN PHARMA 10MG/ML N018040 001
MICONAZOLE NITRATE
CREAM;TOPICAL
MONISTAT-DERM
INSIGHT PHARMS 2% N017494 001
CREAM;VAGINAL
MICONAZOLE NITRATE
TEVA 2% A074136 001 Jan 04, 1995
TEVA PHARMS 2% A074030 001 Oct 30, 1992
CREAM, SUPPOSITORY;TOPICAL, VAGINAL
M-ZOLE 7 DUAL PACK
ACTAVIS MID ATLANTIC 2%,100MG A074586 001 Jul 17, 1997
MICONAZOLE 7 COMBINATION PACK
COSETTE 2%,100MG A076585 001 Mar 26, 2004
LOTION;TOPICAL
MONISTAT-DERM
INSIGHT PHARMS 2% N017739 001
SUPPOSITORY;VAGINAL
MICONAZOLE NITRATE
PERRIGO 100MG A074395 001 Mar 20, 1997
TAMPON;VAGINAL
MONISTAT 5
PERSONAL PRODS 100MG N018592 001 Oct 27, 1989
MIDAZOLAM HYDROCHLORIDE
INJECTABLE;INJECTION
MIDAZOLAM HYDROCHLORIDE
AKORN EQ 5MG BASE/ML A075481 001 Jun 30, 2000
APOTHECON EQ 1MG BASE/ML A075620 001 Nov 01, 2000
EQ 5MG BASE/ML A075620 002 Nov 01, 2000
EQ 5MG BASE/ML A075641 001 Oct 19, 2000
BAXTER HLTHCARE CORP EQ 1MG BASE/ML A075637 001 Oct 31, 2000
EQ 5MG BASE/ML A075637 002 Oct 31, 2000
BEDFORD EQ 5MG BASE/ML A075249 001 Jun 23, 2000
BEN VENUE EQ 5MG BASE/ML A075455 001 Jun 20, 2000
HOSPIRA EQ 1MG BASE/ML A075396 001 Jun 20, 2000
EQ 1MG BASE/ML A075856 001 Jun 13, 2002
EQ 5MG BASE/ML A075396 002 Jun 20, 2000
EQ 5MG BASE/ML A075484 001 Jun 20, 2000
EQ 5MG BASE/ML A075856 002 Jun 13, 2002
HOSPIRA INC EQ 1MG BASE/ML A075409 002 Jun 20, 2000

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-323(of 478)
** See List Footnote
MIDAZOLAM HYDROCHLORIDE
INJECTABLE;INJECTION
MIDAZOLAM HYDROCHLORIDE
EQ 5MG BASE/ML A075409 001 Jun 20, 2000
IGI LABS INC EQ 5MG BASE/ML A075263 001 Jun 26, 2000
INTL MEDICATED EQ 1MG BASE/ML A076144 001 Jan 26, 2005
EQ 5MG BASE/ML A076144 002 Jan 26, 2005
INTL MEDICATION EQ 1MG BASE/ML A076020 001 Jul 16, 2004
EQ 5MG BASE/ML A076020 002 Jul 16, 2004
WOCKHARDT BIO AG EQ 1MG BASE/ML A078141 001 May 30, 2008
EQ 1MG BASE/ML A078511 001 Nov 10, 2008
EQ 5MG BASE/ML A078141 002 May 30, 2008
EQ 5MG BASE/ML A078511 002 Nov 10, 2008
MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE
STERISCIENCE EQ 1MG BASE/ML A090315 001 Nov 29, 2010
EQ 5MG BASE/ML A090315 002 Nov 29, 2010
MIDOZALAM HYDROCHLORIDE
STERISCIENCE EQ 1MG BASE/ML A090316 001 May 04, 2011
EQ 5MG BASE/ML A090316 002 May 04, 2011
VERSED
+ HLR EQ 1MG BASE/ML ** N018654 002 May 26, 1987
+ EQ 5MG BASE/ML ** N018654 001 Dec 20, 1985
SOLUTION;INTRAMUSCULAR
MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)
+ RAFA LABS LTD EQ 10MG BASE/0.7ML (EQ 10MG BASE/0.7ML) N216359 001 Aug 08, 2022
SYRUP;ORAL
MIDAZOLAM HYDROCHLORIDE
AKORN EQ 2MG BASE/ML A075958 001 Sep 04, 2003
PHARM ASSOC EQ 2MG BASE/ML A077115 001 Sep 09, 2005
SUN PHARM INDS LTD EQ 2MG BASE/ML A076058 001 Mar 15, 2002
VERSED
+ ROCHE EQ 2MG BASE/ML ** N020942 001 Oct 15, 1998
MIDODRINE HYDROCHLORIDE
TABLET;ORAL
MIDODRINE HYDROCHLORIDE
CHARTWELL RX 2.5MG A076514 001 Sep 11, 2003
5MG A076514 002 Sep 11, 2003
10MG A076514 003 Jul 02, 2004
PROAMATINE
+ TAKEDA PHARMS USA 2.5MG ** N019815 001 Sep 06, 1996
+ 5MG ** N019815 002 Sep 06, 1996
+ 10MG ** N019815 003 Mar 20, 2002
MILNACIPRAN HYDROCHLORIDE
TABLET;ORAL
MILNACIPRAN HYDROCHLORIDE
AMNEAL PHARMS 12.5MG A205081 001 Apr 22, 2016
25MG A205081 002 Apr 22, 2016
50MG A205081 003 Apr 22, 2016
100MG A205081 004 Apr 22, 2016
USPHARMA WINDLAS 12.5MG A205071 001 Jan 27, 2016
25MG A205071 002 Jan 27, 2016
50MG A205071 003 Jan 27, 2016
100MG A205071 004 Jan 27, 2016
MILRINONE LACTATE
INJECTABLE;INJECTION
MILRINONE LACTATE
BAXTER HLTHCARE CORP EQ 1MG BASE/ML A076427 001 Sep 21, 2004
GLAND PHARMA LTD EQ 1MG BASE/ML A077190 001 Oct 31, 2006
HIKMA EQ 1MG BASE/ML A075852 001 May 28, 2002
HOSPIRA EQ 1MG BASE/ML A075830 001 May 28, 2002
EQ 1MG BASE/ML A075884 001 May 28, 2002
INTL MEDICATED EQ 1MG BASE/ML A076013 001 Aug 02, 2002
MYLAN INSTITUTIONAL EQ 1MG BASE/ML A076428 001 Jun 16, 2003
MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) A076414 001 Aug 18, 2004
BAXTER HLTHCARE EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) A076259 001 Aug 08, 2002
HIKMA EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) A075510 001 May 28, 2002
WOODWARD EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) A077151 001 Jul 20, 2005

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-324(of 478)
** See List Footnote
MILRINONE LACTATE
INJECTABLE;INJECTION
PRIMACOR
+ SANOFI AVENTIS US EQ 1MG BASE/ML ** N019436 001 Dec 31, 1987
PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
+ SANOFI AVENTIS US EQ 10MG BASE/100ML ** N020343 001 Aug 09, 1994
+ EQ 15MG BASE/100ML ** N020343 002 Aug 09, 1994
+ EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) N020343 003 Aug 09, 1994
**
+ EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) N020343 004 Aug 09, 1994
**
MINOCYCLINE HYDROCHLORIDE
CAPSULE;ORAL
MINOCIN
+ BAUSCH EQ 75MG BASE ** N050649 003 Feb 12, 2001
TRIAX PHARMS EQ 50MG BASE N050315 002
EQ 100MG BASE N050315 001
CAPSULE, EXTENDED RELEASE;ORAL
XIMINO
JOURNEY EQ 67.5MG BASE N201922 002 Jul 11, 2012
EQ 112.5MG BASE N201922 004 Jul 11, 2012
INJECTABLE;INJECTION
MINOCIN
LEDERLE EQ 100MG BASE/VIAL A062139 001
SUSPENSION;ORAL
MINOCIN
BAUSCH EQ 50MG BASE/5ML N050445 001
TABLET;ORAL
MINOCYCLINE HYDROCHLORIDE
+ TRIAX PHARMS EQ 50MG BASE ** N050451 003 Aug 10, 1982
+ EQ 100MG BASE ** N050451 002 Aug 10, 1982
TABLET, EXTENDED RELEASE;ORAL
MINOCYCLINE HYDROCHLORIDE
BARR LABS INC EQ 45MG BASE A065485 001 Mar 17, 2009
EQ 65MG BASE A065485 004 May 18, 2012
EQ 80MG BASE A065485 007 Apr 26, 2017
EQ 90MG BASE A065485 002 Mar 17, 2009
EQ 105MG BASE A065485 008 Apr 26, 2017
EQ 115MG BASE A065485 005 May 18, 2012
EQ 135MG BASE A065485 003 Mar 17, 2009
IMPAX LABS INC EQ 45MG BASE A090024 001 Feb 03, 2009
EQ 90MG BASE A090024 002 Feb 03, 2009
EQ 135MG BASE A090024 003 Feb 03, 2009
MYLAN PHARMS INC EQ 45MG BASE A090911 001 Jul 20, 2010
EQ 90MG BASE A090911 002 Jul 20, 2010
EQ 135MG BASE A090911 003 Jul 20, 2010
RISING EQ 55MG BASE A203443 001 Aug 21, 2019
EQ 65MG BASE A201467 001 Jul 30, 2019
EQ 80MG BASE A203443 002 Aug 22, 2014
EQ 105MG BASE A203443 003 Aug 22, 2014
EQ 115MG BASE A201467 002 Jul 30, 2019
SOLODYN
+ BAUSCH EQ 45MG BASE ** N050808 001 May 08, 2006
+ EQ 90MG BASE ** N050808 002 May 08, 2006
+ EQ 135MG BASE ** N050808 003 May 08, 2006
MINOXIDIL
SOLUTION;TOPICAL
MINOXIDIL (FOR MEN)
AKORN 2% A074731 001 Dec 24, 1996
APOTEX INC 2% A074924 001 Apr 29, 1998
BAUSCH AND LOMB 2% A074643 001 Apr 09, 1996
COPLEY PHARM 2% A074500 001 May 23, 1996
SIGHT PHARMS 2% A074743 002 Oct 18, 1996
TEVA 2% A074589 001 Apr 05, 1996
MINOXIDIL (FOR WOMEN)
AKORN 2% A074731 002 May 11, 2005
APOTEX INC 2% A074924 002 Apr 29, 1998
SIGHT PHARMS 2% A074743 001 Oct 18, 1996

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-325(of 478)
** See List Footnote
MINOXIDIL
SOLUTION;TOPICAL
MINOXIDIL EXTRA STRENGTH (FOR MEN)
APOTEX INC 5% A075839 001 Oct 01, 2001
AVACOR PRODS 5% A075619 001 Nov 17, 2000
PERRIGO NEW YORK 5% A075737 001 Mar 15, 2002
TABLET;ORAL
LONITEN
+ PFIZER 2.5MG ** N018154 001
+ 10MG ** N018154 003
MINODYL
QUANTUM PHARMICS 2.5MG A072153 001 Jul 13, 1988
10MG A071534 001 Mar 19, 1987
MINOXIDIL
ROYCE LABS 2.5MG A071799 001 Nov 10, 1987
10MG A071796 001 Nov 10, 1987
USL PHARMA 2.5MG A071537 001 Dec 16, 1988
MIPOMERSEN SODIUM
SOLUTION;SUBCUTANEOUS
KYNAMRO
+ KASTLE THERAPS LLC 200MG/ML (200MG/ML) N203568 001 Jan 29, 2013
MIRABEGRON
TABLET, EXTENDED RELEASE;ORAL
MIRABEGRON
SAWAI USA 25MG A209446 001 Dec 27, 2019
MIRTAZAPINE
TABLET;ORAL
MIRTAZAPINE
ACTAVIS ELIZABETH 15MG A076241 001 Jun 25, 2003
15MG A076308 001 Jun 20, 2003
30MG A076241 002 Jun 25, 2003
30MG A076308 002 Jun 20, 2003
45MG A076241 003 Jun 25, 2003
45MG A076308 003 Jun 20, 2003
ACTAVIS LABS FL INC 15MG A076336 001 Jun 20, 2003
30MG A076336 002 Jun 20, 2003
45MG A076336 003 Jun 20, 2003
IVAX SUB TEVA PHARMS 15MG A076244 001 Dec 22, 2003
30MG A076244 002 Dec 22, 2003
45MG A076244 003 Dec 22, 2003
MYLAN PHARMS INC 15MG A076176 001 Jun 19, 2003
30MG A076176 002 Jun 19, 2003
45MG A076176 003 Jun 19, 2003
ROXANE 15MG A076270 001 Jun 19, 2003
30MG A076270 002 Jun 19, 2003
45MG A076270 003 Jun 19, 2003
UPSHER SMITH LABS 15MG A076189 001 Jun 19, 2003
30MG A076189 002 Jun 19, 2003
45MG A076189 003 Jun 19, 2003
WATSON LABS 15MG A076312 001 Jun 19, 2003
30MG A076312 002 Jun 19, 2003
45MG A076312 003 Jun 19, 2003
REMERON
+ ORGANON USA INC 45MG ** N020415 003 Mar 17, 1997
TABLET, ORALLY DISINTEGRATING;ORAL
MIRTAZAPINE
ACTAVIS ELIZABETH 15MG A076689 001 Aug 31, 2005
15MG A077959 001 Feb 14, 2011
30MG A076689 002 Aug 31, 2005
30MG A077959 002 Feb 14, 2011
45MG A076689 003 Aug 31, 2005
45MG A077959 003 Feb 14, 2011
ACTAVIS LABS FL INC 15MG A076307 001 Dec 17, 2003
30MG A076307 002 Dec 17, 2003
45MG A076307 003 Feb 28, 2006
IMPAX LABS INC 15MG A076901 001 Jun 28, 2005
30MG A076901 002 Jun 28, 2005
45MG A076901 003 Jun 28, 2005

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-326(of 478)
** See List Footnote
MISOPROSTOL
TABLET;ORAL
MISOPROSTOL
ACQ PHARMA 0.1MG A210201 001 Jul 02, 2019
0.2MG A210201 002 Jul 02, 2019
MITOMYCIN
INJECTABLE;INJECTION
MITOMYCIN
HIKMA 5MG/VIAL A064117 001 Apr 19, 1995
HOSPIRA 20MG/VIAL A064106 001 Nov 29, 1995
MITOZYTREX
+ SUPERGEN 5MG/VIAL ** N050763 001 Nov 14, 2002
MUTAMYCIN
+ BRISTOL 5MG/VIAL ** N050450 001
+ 20MG/VIAL ** N050450 002
BRISTOL MYERS 5MG/VIAL A062336 001
20MG/VIAL A062336 002
40MG/VIAL ** A062336 003 Mar 10, 1988
MITOXANTRONE HYDROCHLORIDE
INJECTABLE;INJECTION
MITOXANTRONE HYDROCHLORIDE
FRESENIUS KABI ONCOL EQ 20MG BASE/10ML (EQ 2MG BASE/ML) A078606 001 May 14, 2008
EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) A078606 002 May 14, 2008
EQ 30MG BASE/15ML (EQ 2MG BASE/ML) A078606 003 May 14, 2008
MYLAN LABS LTD EQ 20MG BASE/10ML (EQ 2MG BASE/ML) A201014 001 Dec 11, 2012
RISING EQ 20MG BASE/10ML (EQ 2MG BASE/ML) A078980 001 Apr 13, 2009
EQ 30MG BASE/15ML (EQ 2MG BASE/ML) A078980 002 Apr 13, 2009
NOVANTRONE
+ EMD SERONO EQ 20MG BASE/10ML (EQ 2MG BASE/ML) ** N019297 001 Dec 23, 1987
+ EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) ** N019297 002 Dec 23, 1987
+ EQ 30MG BASE/15ML (EQ 2MG BASE/ML) ** N019297 003 Dec 23, 1987
MIVACURIUM CHLORIDE
INJECTABLE;INJECTION
MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER
ABBVIE EQ 0.5MG BASE/ML N020098 002 Jan 22, 1992
EQ 50MG BASE/100ML N020098 003 Jan 22, 1992
MIVACURIUM CHLORIDE
RISING EQ 2MG BASE/ML A078562 001 Apr 30, 2009
SOLUTION;INTRAVENOUS
MIVACRON
+ ABBVIE EQ 2MG BASE/ML (EQ 2MG BASE/ML) ** N020098 001 Jan 22, 1992
+ EQ 10MG BASE/5ML (EQ 2MG BASE/ML) N020098 004 Jan 22, 1992
+ EQ 20MG BASE/10ML (EQ 2MG BASE/ML) N020098 005 Jan 22, 1992
MODAFINIL
TABLET;ORAL
MODAFINIL
HIKMA PHARMS 100MG A090543 001 Sep 26, 2012
200MG A090543 002 Sep 26, 2012
MYLAN PHARMS INC 100MG A076594 001 Jul 16, 2012
200MG A076594 002 Jul 16, 2012
MOEXIPRIL HYDROCHLORIDE
TABLET;ORAL
UNIVASC
UCB INC 7.5MG ** N020312 001 Apr 19, 1995
15MG ** N020312 002 Apr 19, 1995
MOLINDONE HYDROCHLORIDE
CAPSULE;ORAL
MOBAN
+ STRIDES PHARMA 5MG ** N017111 001
+ 10MG ** N017111 002
+ 25MG ** N017111 003
CONCENTRATE;ORAL
MOBAN
ENDO PHARMS 20MG/ML N017938 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-327(of 478)
** See List Footnote
MOLINDONE HYDROCHLORIDE
TABLET;ORAL
MOBAN
+ STRIDES PHARMA 5MG ** N017111 004
+ 10MG ** N017111 005
+ 25MG ** N017111 006
+ 50MG ** N017111 007
+ 100MG ** N017111 008
MOMETASONE FUROATE
CREAM;TOPICAL
ELOCON
ORGANON 0.1% ** N019625 001 May 06, 1987
+ 0.1% ** N019625 002 Apr 19, 2013
MOMETASONE FUROATE
ANDA REPOSITORY 0.1% A076591 001 Apr 18, 2007
FOUGERA PHARMS 0.1% A076171 001 Apr 08, 2005
LOTION;TOPICAL
MOMETASONE FUROATE
ENCUBE 0.1% A076499 001 Nov 21, 2007
OINTMENT;TOPICAL
ELOCON
+ ORGANON 0.1% N019543 001 Apr 30, 1987
MOMETASONE FUROATE
ENCUBE 0.1% A076481 001 Nov 14, 2003
TARO 0.1% A076624 001 Dec 03, 2004
TORRENT 0.1% A207899 001 Jul 13, 2018
SPRAY, METERED;NASAL
NASONEX
+ ORGANON LLC 0.05MG/SPRAY ** N020762 001 Oct 01, 1997
MONOBENZONE
CREAM;TOPICAL
BENOQUIN
VALEANT PHARM INTL 20% N008173 003
MONOCTANOIN
LIQUID;PERFUSION, BILIARY
MOCTANIN
ETHITEK 100% N019368 001 Oct 29, 1985
MONTELUKAST SODIUM
GRANULE;ORAL
MONTELUKAST SODIUM
MYLAN PHARMS INC EQ 4MG BASE/PACKET A202776 001 Dec 18, 2012
TABLET;ORAL
MONTELUKAST SODIUM
AJANTA PHARMA LTD EQ 10MG BASE A203432 001 Jul 31, 2015
APOTEX CORP EQ 10MG BASE A201294 001 Aug 03, 2012
BRECKENRIDGE EQ 10MG BASE A205319 001 Oct 30, 2020
HIKMA EQ 10MG BASE A090655 001 Aug 03, 2012
L PERRIGO CO EQ 10MG BASE A206112 001 Apr 26, 2017
MYLAN PHARMS INC EQ 10MG BASE A079103 001 Aug 03, 2012
STRIDES PHARMA EQ 10MG BASE A091576 001 Aug 03, 2012
TABLET, CHEWABLE;ORAL
MONTELUKAST SODIUM
AJANTA PHARMA LTD EQ 4MG BASE A203328 001 Jul 31, 2015
EQ 5MG BASE A203328 002 Jul 31, 2015
APOTEX INC EQ 4MG BASE A201508 001 Aug 03, 2012
EQ 5MG BASE A201508 002 Aug 03, 2012
HIKMA EQ 4MG BASE A091128 001 Aug 03, 2012
EQ 5MG BASE A091128 002 Aug 03, 2012
JUBILANT GENERICS EQ 4MG BASE A203795 001 Feb 27, 2015
EQ 5MG BASE A203795 002 Feb 27, 2015
MYLAN PHARMS INC EQ 4MG BASE A079142 001 Aug 03, 2012
EQ 5MG BASE A079142 002 Aug 03, 2012
STRIDES PHARMA EQ 4MG BASE A091588 001 Aug 03, 2012
EQ 5MG BASE A091588 002 Aug 03, 2012

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-328(of 478)
** See List Footnote
MORICIZINE HYDROCHLORIDE
TABLET;ORAL
ETHMOZINE
SHIRE 200MG N019753 001 Jun 19, 1990
250MG N019753 002 Jun 19, 1990
300MG N019753 003 Jun 19, 1990
MORPHINE SULFATE
CAPSULE, EXTENDED RELEASE;ORAL
AVINZA
KING PHARMS LLC 30MG N021260 001 Mar 20, 2002
45MG N021260 005 Dec 18, 2008
60MG N021260 002 Mar 20, 2002
75MG N021260 006 Dec 18, 2008
90MG N021260 003 Mar 20, 2002
120MG N021260 004 Mar 20, 2002
KADIAN
+ ALLERGAN 10MG N020616 008 Apr 20, 2007
+ 20MG N020616 001 Jul 03, 1996
+ 30MG N020616 004 Mar 09, 2001
+ 40MG N020616 009 Jul 09, 2012
+ 50MG N020616 002 Jul 03, 1996
+ 60MG N020616 005 Mar 09, 2001
+ 70MG N020616 010 Jul 09, 2012
+ 80MG N020616 006 Oct 27, 2006
+ 100MG N020616 003 Jul 03, 1996
+ 130MG N020616 011 Jul 09, 2012
+ 150MG N020616 012 Jul 09, 2012
+ 200MG N020616 007 Feb 27, 2007
MORPHINE SULFATE
IMPAX LABS INC 20MG A200411 001 Apr 12, 2016
30MG A200411 002 Apr 12, 2016
40MG A200411 007 Jul 25, 2018
50MG A200411 003 Apr 12, 2016
60MG A200411 004 Apr 12, 2016
80MG A200411 005 Apr 12, 2016
100MG A200411 006 Apr 12, 2016
NORTEC DEV ASSOC 20MG A203158 001 Aug 04, 2021
30MG A203158 002 Aug 04, 2021
50MG A203158 003 Aug 04, 2021
60MG A203158 004 Aug 04, 2021
80MG A203158 005 Aug 04, 2021
100MG A203158 006 Aug 04, 2021
STRIDES PHARMA 20MG A200812 001 Nov 10, 2011
30MG A200812 002 Nov 10, 2011
50MG A200812 003 Nov 10, 2011
60MG A200812 004 Nov 10, 2011
80MG A200812 005 Nov 10, 2011
100MG A200812 006 Nov 10, 2011
TEVA PHARMS USA 20MG A202718 001 Dec 29, 2014
30MG A202718 002 Dec 29, 2014
40MG A202718 007 Jun 03, 2015
50MG A202718 003 Dec 29, 2014
60MG A202718 004 Dec 29, 2014
70MG A202718 008 Jun 03, 2015
80MG A202718 005 Dec 29, 2014
100MG A202718 006 Dec 29, 2014
INJECTABLE;INJECTION
ASTRAMORPH PF
FRESENIUS KABI USA 0.5MG/ML A071050 001 Oct 07, 1986
0.5MG/ML A071051 001 Oct 07, 1986
1MG/ML A071052 001 Oct 07, 1986
1MG/ML A071053 001 Oct 07, 1986
MORPHINE SULFATE
HOSPIRA 1MG/ML A071850 001 May 11, 1988
+ HOSPIRA INC 15MG/ML N202515 005 Nov 14, 2011
ICU MEDICAL INC 0.5MG/ML N019917 001 Oct 30, 1992
+ 1MG/ML ** N019916 001 Oct 30, 1992
+ 5MG/ML ** N019916 002 Oct 27, 2006
SPECGX LLC 1MG/ML N020631 001 Jul 03, 1996

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-329(of 478)
** See List Footnote
MORPHINE SULFATE
INJECTABLE;INJECTION
MORPHINE SULFATE
2MG/ML N020631 002 Jul 03, 1996
WATSON LABS 0.5MG/ML A073373 001 Sep 30, 1991
0.5MG/ML A073375 001 Sep 30, 1991
1MG/ML A073374 001 Sep 30, 1991
1MG/ML A073376 001 Sep 30, 1991
INJECTABLE, LIPOSOMAL;EPIDURAL
DEPODUR
PACIRA PHARMS INC 10MG/ML (10MG/ML) N021671 001 May 18, 2004
15MG/1.5ML (10MG/ML) N021671 002 May 18, 2004
20MG/2ML (10MG/ML) N021671 003 May 18, 2004
SOLUTION;INTRAMUSCULAR
MORPHINE SULFATE (AUTOINJECTOR)
+ MERIDIAN MEDCL TECHN 10MG/0.7ML (10MG/0.7ML) N019999 001 Jul 12, 1990
SOLUTION;ORAL
MORPHINE SULFATE
ANI PHARMS 10MG/5ML A205509 001 Apr 17, 2018
20MG/5ML A205509 002 Apr 17, 2018
100MG/5ML A205509 003 Apr 17, 2018
CHARTWELL MOLECULAR 10MG/5ML A202309 001 Nov 25, 2015
20MG/5ML A202310 001 Oct 30, 2015
100MG/5ML N201517 001 Jun 23, 2011
NOSTRUM LABS INC 10MG/5ML A201011 001 Feb 05, 2014
20MG/5ML A201011 002 Feb 05, 2014
100MG/5ML A201011 003 Oct 06, 2016
TRIS PHARMA INC 20MG/5ML A203519 001 May 18, 2016
VISTAPHARM 10MG/5ML A201947 001 Jan 05, 2012
20MG/5ML A201947 002 Jan 05, 2012
WINDER LABS LLC 10MG/5ML A211454 001 Feb 12, 2021
20MG/5ML A211454 002 Feb 12, 2021
100MG/5ML A211454 003 Feb 12, 2021
TABLET;ORAL
MORPHINE SULFATE
INGENUS PHARMS NJ 15MG A215584 001 Feb 07, 2022
30MG A215584 002 Feb 07, 2022
TABLET, EXTENDED RELEASE;ORAL
ARYMO ER
+ ZYLA 15MG N208603 001 Jan 09, 2017
+ 30MG N208603 002 Jan 09, 2017
+ 60MG N208603 003 Jan 09, 2017
MORPHABOND ER
+ DAIICHI SANKYO INC 15MG N206544 001 Oct 02, 2015
+ 30MG N206544 002 Oct 02, 2015
+ 60MG N206544 003 Oct 02, 2015
+ 100MG N206544 004 Oct 02, 2015
MORPHINE SULFATE
EPIC PHARMA LLC 15MG A091357 001 Jun 23, 2016
30MG A091357 002 Jun 23, 2016
60MG A091357 003 Jun 23, 2016
100MG A091357 004 Jun 23, 2016
200MG A091357 005 Jun 23, 2016
NESHER PHARMS 15MG A076733 001 May 19, 2004
30MG A076720 002 Dec 23, 2005
60MG A076720 001 May 19, 2004
100MG A077855 001 Sep 27, 2007
200MG A077855 002 Sep 27, 2007
RISING 15MG A200824 001 Oct 18, 2011
30MG A200824 002 Oct 18, 2011
60MG A200824 003 Oct 18, 2011
100MG A200824 004 Oct 18, 2011
200MG A200824 005 Oct 18, 2011
SUN PHARM INDUSTRIES 15MG A205634 001 Aug 25, 2016
30MG A205634 002 Aug 25, 2016
60MG A205634 003 Aug 25, 2016
100MG A205634 004 Aug 25, 2016
200MG A205634 005 Aug 25, 2016
WATSON LABS 100MG A075656 001 Jan 30, 2001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-330(of 478)
** See List Footnote
MORPHINE SULFATE
TABLET, EXTENDED RELEASE;ORAL
ORAMORPH SR
XANODYNE PHARMS INC 15MG N019977 004 Nov 23, 1994
30MG N019977 001 Aug 15, 1991
60MG N019977 002 Aug 15, 1991
100MG N019977 003 Aug 15, 1991
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
EMBEDA
+ ALPHARMA PHARMS 20MG;0.8MG ** N022321 001 Aug 13, 2009
+ 30MG;1.2MG ** N022321 002 Aug 13, 2009
+ 50MG;2MG ** N022321 003 Aug 13, 2009
+ 60MG;2.4MG ** N022321 004 Aug 13, 2009
+ 80MG;3.2MG ** N022321 005 Aug 13, 2009
+ 100MG;4MG ** N022321 006 Aug 13, 2009
MOXALACTAM DISODIUM
INJECTABLE;INJECTION
MOXAM
LILLY EQ 250MG BASE/VIAL N050550 001
EQ 500MG BASE/VIAL N050550 002
EQ 1GM BASE/VIAL N050550 003
EQ 2GM BASE/VIAL N050550 004
EQ 10GM BASE/VIAL N050550 008
MOXIFLOXACIN HYDROCHLORIDE
SOLUTION;INTRAVENOUS
AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER
+ BAYER HLTHCARE 400MG/250ML (1.6MG/ML) ** N021277 001 Nov 30, 2001
TABLET;ORAL
AVELOX
+ BAYER HLTHCARE EQ 400MG BASE ** N021085 001 Dec 10, 1999
MOXIFLOXACIN HYDROCHLORIDE
MYLAN EQ 400MG BASE A204635 001 Aug 31, 2015
SUNSHINE EQ 400MG BASE A206295 001 Sep 28, 2018
MUPIROCIN
OINTMENT;TOPICAL
BACTROBAN
+ GLAXOSMITHKLINE 2% ** N050591 001 Dec 31, 1987
MUPIROCIN CALCIUM
CREAM;TOPICAL
BACTROBAN
+ GLAXOSMITHKLINE EQ 2% BASE ** N050746 001 Dec 11, 1997
OINTMENT;NASAL
BACTROBAN
+ GLAXOSMITHKLINE EQ 2% BASE N050703 001 Sep 18, 1995
MYCOPHENOLATE MOFETIL
CAPSULE;ORAL
MYCOPHENOLATE MOFETIL
APOTEX CORP 250MG A090419 001 Apr 22, 2009
DR REDDYS LABS LTD 250MG A091315 001 Oct 27, 2011
JUBILANT CADISTA 250MG A090762 001 Dec 15, 2014
STRIDES PHARMA 250MG A090111 001 Dec 22, 2009
ZYDUS PHARMS USA INC 250MG A065433 001 May 04, 2009
TABLET;ORAL
MYCOPHENOLATE MOFETIL
APOTEX 500MG A090499 001 Apr 22, 2009
DR REDDYS LABS LTD 500MG A090464 001 Sep 13, 2010
JUBILANT CADISTA 500MG A090661 001 Dec 15, 2014
TEVA PHARMS 500MG A065457 001 May 04, 2009
ZYDUS PHARMS USA INC 500MG A065477 001 May 04, 2009

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-331(of 478)
** See List Footnote
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
INJECTABLE;INJECTION
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
AMNEAL 500MG/VIAL A211374 001 Mar 05, 2021
MYCOPHENOLIC SODIUM
TABLET, DELAYED RELEASE;ORAL
MYCOPHENOLIC SODIUM
TEVA PHARMS USA EQ 180MG BASE A202720 001 Oct 30, 2014
EQ 360MG BASE A202720 002 Oct 30, 2014
NABUMETONE
TABLET;ORAL
NABUMETONE
COPLEY PHARM 750MG A075179 001 Jun 06, 2000
EPIC PHARMA 500MG A075590 001 Feb 25, 2002
750MG A075590 002 Feb 25, 2002
IMPAX LABS INC 500MG A075189 001 May 26, 2000
750MG A075189 002 Sep 24, 2001
MYLAN PHARMS INC 500MG A090516 001 Jul 12, 2010
750MG A090516 002 Jul 12, 2010
NOSTRUM LABS INC 500MG A090427 001 Dec 30, 2011
750MG A090427 002 Dec 30, 2011
OXFORD PHARMS 500MG A079093 001 Feb 27, 2009
750MG A079093 002 Feb 27, 2009
RELAFEN
+ SMITHKLINE BEECHAM 500MG ** N019583 001 Dec 24, 1991
+ 750MG ** N019583 002 Dec 24, 1991
NADOLOL
TABLET;ORAL
CORGARD
USWM 120MG N018063 003
160MG N018063 004
NADOLOL
HERITAGE PHARMA 120MG A074255 002 Jan 24, 1996
160MG A074255 003 Jan 24, 1996
NOVAST LABS 20MG A210786 001 Jun 01, 2018
40MG A210786 002 Jun 01, 2018
80MG A210786 003 Jun 01, 2018
TEVA PHARMS 80MG A074368 001 Aug 31, 1994
120MG A074368 002 Aug 31, 1994
160MG A074368 003 Aug 31, 1994
NAFCILLIN SODIUM
CAPSULE;ORAL
UNIPEN
WYETH AYERST EQ 250MG BASE N050111 001
FOR SOLUTION;ORAL
UNIPEN
WYETH AYERST EQ 250MG BASE/5ML N050199 001
INJECTABLE;INJECTION
NAFCILLIN SODIUM
APOTHECON EQ 500MG BASE/VIAL A061984 001
EQ 1GM BASE/VIAL A061984 002
EQ 2GM BASE/VIAL A061984 003
EQ 4GM BASE/VIAL A061984 005
FRESENIUS EQ 1GM BASE/VIAL A206682 001 Dec 10, 2019
EQ 2GM BASE/VIAL A206682 002 Dec 10, 2019
SANDOZ EQ 500MG BASE/VIAL A062527 001 Aug 02, 1984
STERISCIENCE EQ 1GM BASE/VIAL A200002 001 Apr 07, 2014
EQ 2GM BASE/VIAL A200002 002 Apr 07, 2014
WATSON LABS INC EQ 500MG BASE/VIAL A062844 001 Oct 26, 1988
EQ 1GM BASE/VIAL A062844 002 Oct 26, 1988
EQ 1.5GM BASE/VIAL A062844 003 Oct 26, 1988
EQ 2GM BASE/VIAL A062844 004 Oct 26, 1988
EQ 4GM BASE/VIAL A062844 005 Oct 26, 1988
EQ 10GM BASE/VIAL A063008 001 Sep 29, 1988
NALLPEN
GLAXOSMITHKLINE EQ 500MG BASE/VIAL A061999 001
EQ 1GM BASE/VIAL A061999 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-332(of 478)
** See List Footnote
NAFCILLIN SODIUM
INJECTABLE;INJECTION
NALLPEN
EQ 1GM BASE/VIAL A062755 001 Dec 19, 1986
EQ 2GM BASE/VIAL A061999 003
EQ 2GM BASE/VIAL A062755 002 Dec 19, 1986
EQ 10GM BASE/VIAL A061999 004
UNIPEN
WYETH AYERST EQ 500MG BASE/VIAL ** A062717 001 Dec 16, 1986
+ EQ 500MG BASE/VIAL ** N050320 001
EQ 1GM BASE/VIAL ** A062717 002 Dec 16, 1986
EQ 2GM BASE/VIAL ** A062717 004 Dec 16, 1986
+ EQ 2GM BASE/VIAL ** N050320 003
+ EQ 4GM BASE/VIAL ** N050320 004
+ EQ 10GM BASE/VIAL ** N050320 005
+ EQ 20GM BASE/VIAL ** N050320 006
UNIPEN IN PLASTIC CONTAINER
+ WYETH AYERST EQ 1GM BASE/VIAL ** N050320 002
TABLET;ORAL
UNIPEN
WYETH AYERST EQ 500MG BASE N050462 001
NAFTIFINE HYDROCHLORIDE
CREAM;TOPICAL
NAFTIN
+ SEBELA IRELAND LTD 1% ** N019599 001 Feb 29, 1988
GEL;TOPICAL
NAFTIFINE HYDROCHLORIDE
TARO 2% A208201 001 Apr 10, 2019
NALBUPHINE HYDROCHLORIDE
INJECTABLE;INJECTION
NALBUPHINE
ABRAXIS PHARM 10MG/ML A070751 001 Jul 02, 1986
20MG/ML A070752 001 Sep 24, 1986
NALBUPHINE HYDROCHLORIDE
ABBOTT 20MG/ML A070917 001 Feb 03, 1989
ABBVIE 1.5MG/ML N020200 001 Mar 12, 1993
DR REDDYS 10MG/ML A074471 001 Mar 19, 1998
20MG/ML A074471 002 Mar 19, 1998
IGI LABS INC 10MG/ML A072070 001 Apr 10, 1989
10MG/ML A072071 001 Apr 10, 1989
10MG/ML A072072 001 Apr 10, 1989
20MG/ML A072073 001 Apr 10, 1989
20MG/ML A072074 001 Apr 10, 1989
20MG/ML A072075 001 Apr 10, 1989
RISING 10MG/ML A206506 001 Feb 06, 2019
10MG/ML A207595 001 Jan 11, 2019
20MG/ML A206506 002 Feb 06, 2019
20MG/ML A207595 002 Jan 11, 2019
NUBAIN
+ PAR PHARM INC 10MG/ML ** N018024 001
+ 20MG/ML ** N018024 002 May 27, 1982
NALIDIXIC ACID
SUSPENSION;ORAL
NEGGRAM
SANOFI AVENTIS US 250MG/5ML N017430 001
TABLET;ORAL
NALIDIXIC ACID
SUN PHARM INDUSTRIES 250MG A070270 001 Jun 29, 1988
500MG A070271 001 Jun 29, 1988
1GM A070272 001 Jun 29, 1988
WATSON LABS 250MG A071936 001 Jun 29, 1988
500MG A072061 001 Jun 29, 1988
1GM A071919 001 Jun 29, 1988
NEGGRAM
SANOFI AVENTIS US 250MG N014214 002
500MG N014214 004
1GM N014214 005

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-333(of 478)
** See List Footnote
NALMEFENE HYDROCHLORIDE
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
REVEX
+ HIKMA EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) ** N020459 001 Apr 17, 1995
+ EQ 2MG BASE/2ML (EQ 1MG BASE/ML) ** N020459 002 Apr 17, 1995
NALOXONE HYDROCHLORIDE
INJECTABLE;INJECTION
NALOXONE
HIKMA 0.4MG/ML A070298 001 Sep 24, 1986
0.4MG/ML A070496 001 Sep 24, 1986
WYETH AYERST 0.02MG/ML A070188 001 Sep 24, 1986
0.02MG/ML A070189 001 Sep 24, 1986
0.4MG/ML A070190 001 Sep 24, 1986
0.4MG/ML A070191 001 Sep 24, 1986
NALOXONE HYDROCHLORIDE
ABRAXIS PHARM 0.02MG/ML A070648 001 Nov 17, 1986
0.02MG/ML A070661 001 Nov 17, 1986
0.4MG/ML A070649 001 Nov 17, 1986
1MG/ML A071604 001 Dec 16, 1988
ANDA REPOSITORY 0.4MG/ML A207846 001 Dec 17, 2018
ASTRAZENECA 0.02MG/ML A072081 001 Apr 11, 1989
HIKMA 0.02MG/ML A071272 001 May 24, 1988
1MG/ML A071273 001 May 24, 1988
1MG/ML A071274 001 May 24, 1988
1MG/ML A071287 001 May 24, 1988
HOSPIRA 0.02MG/ML A070171 001 Sep 24, 1986
0.02MG/ML A070252 001 Jan 16, 1987
0.02MG/ML A070253 001 Jan 16, 1987
0.4MG/ML A070254 001 Jan 07, 1987
0.4MG/ML A070255 001 Jan 07, 1987
IGI LABS INC 0.02MG/ML A072082 001 Apr 11, 1989
0.02MG/ML A072083 001 Apr 11, 1989
0.02MG/ML A072084 001 Apr 11, 1989
0.02MG/ML A072085 001 Apr 11, 1989
0.4MG/ML A072086 001 Apr 11, 1989
0.4MG/ML A072087 001 Apr 11, 1989
0.4MG/ML A072088 001 Apr 11, 1989
0.4MG/ML A072089 001 Apr 11, 1989
0.4MG/ML A072090 001 Apr 11, 1989
1MG/ML A072091 001 Apr 11, 1989
1MG/ML A072092 001 Apr 11, 1989
1MG/ML A072093 001 Apr 11, 1989
INTL MEDICATION 0.4MG/ML A070417 001 Sep 24, 1986
0.4MG/ML A070639 001 Sep 24, 1986
1MG/ML A072115 001 Apr 27, 1988
MARSAM PHARMS LLC 0.4MG/ML A071811 001 Jul 19, 1988
PAR STERILE PRODUCTS 0.4MG/ML A211286 001 Jan 17, 2020
SMITH AND NEPHEW 0.02MG/ML A071671 001 Nov 17, 1987
0.4MG/ML A071681 001 Nov 17, 1987
0.4MG/ML A071682 001 Nov 17, 1987
SOLOPAK 0.02MG/ML A071672 001 Nov 17, 1987
0.4MG/ML A071683 001 Nov 17, 1987
WATSON LABS 0.4MG/ML A071339 001 Nov 18, 1987
NARCAN
+ ADAPT 0.02MG/ML ** N016636 002
+ 0.4MG/ML ** N016636 001
+ 1MG/ML ** N016636 003 Jun 14, 1982
BRISTOL MYERS SQUIBB 0.4MG/ML A071083 001 Jul 28, 1988
1MG/ML A071084 001 Jul 28, 1988
1MG/ML A071311 001 Jul 28, 1988
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS
EVZIO
+ KALEO INC 0.4MG/0.4ML (0.4MG/0.4ML) N205787 001 Apr 03, 2014
EVZIO (AUTOINJECTOR)
+ KALEO INC 2MG/0.4ML (2MG/0.4ML) N209862 001 Oct 19, 2016
NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
+ KALEO INC 10MG/0.4ML (10MG/0.4ML) N215457 001 Feb 28, 2022

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-334(of 478)
** See List Footnote
NALOXONE HYDROCHLORIDE
SPRAY, METERED;NASAL
NARCAN
+ EMERGENT 2MG/SPRAY ** N208411 002 Jan 24, 2017
NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
TARGINIQ
+ PURDUE PHARMA LP 5MG;10MG N205777 001 Jul 23, 2014
+ 10MG;20MG N205777 002 Jul 23, 2014
+ 20MG;40MG N205777 003 Jul 23, 2014
NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE
TABLET;ORAL
TALWIN NX
SANOFI AVENTIS US EQ 0.5MG BASE;EQ 50MG BASE ** N018733 001 Dec 16, 1982
NALTREXONE HYDROCHLORIDE
TABLET;ORAL
NALTREXONE HYDROCHLORIDE
FOSUN PHARMA 50MG A075434 001 Mar 08, 2000
REVIA
+ TEVA WOMENS 50MG N018932 001 Nov 20, 1984
NALTREXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
TROXYCA ER
PFIZER 1.2MG;10MG N207621 001 Aug 19, 2016
2.4MG;20MG N207621 002 Aug 19, 2016
3.6MG;30MG N207621 003 Aug 19, 2016
4.8MG;40MG N207621 004 Aug 19, 2016
7.2MG;60MG N207621 005 Aug 19, 2016
9.6MG;80MG N207621 006 Aug 19, 2016
NANDROLONE DECANOATE
INJECTABLE;INJECTION
DECA-DURABOLIN
WOODWARD SPECL 50MG/ML N013132 001 Jun 12, 1986
100MG/ML N013132 002 Jun 12, 1986
+ 200MG/ML ** N013132 003 Jun 12, 1986
NANDROLONE DECANOATE
ABRAXIS PHARM 100MG/ML A088290 001 Oct 03, 1983
200MG/ML A088317 001 Oct 14, 1983
AKORN 100MG/ML A087519 001 Sep 28, 1983
AM REGENT 200MG/ML A091252 001 Aug 30, 2010
WATSON LABS 50MG/ML A086385 001 Jan 13, 1984
50MG/ML A087598 001 Oct 06, 1983
50MG/ML A088554 001 Feb 10, 1986
100MG/ML A086598 001 Jan 13, 1984
100MG/ML A087599 001 Oct 06, 1983
+ 200MG/ML A088128 001 Dec 05, 1983
NANDROLONE PHENPROPIONATE
INJECTABLE;INJECTION
DURABOLIN
ORGANON USA INC 25MG/ML N011891 001
50MG/ML N011891 002
NANDROLONE PHENPROPIONATE
WATSON LABS 25MG/ML A086386 001 Jun 17, 1983
50MG/ML A087488 001 Jun 17, 1983
NAPHAZOLINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
ALBALON
ALLERGAN 0.1% ** A080248 001
NAFAZAIR
BAUSCH AND LOMB 0.1% A040073 001 May 25, 1994
PHARMAFAIR 0.1% A088101 001 Apr 15, 1983
NAPHAZOLINE HYDROCHLORIDE
AKORN 0.1% A083590 001
NAPHCON FORTE
+ ALCON 0.1% A080229 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-335(of 478)
** See List Footnote
NAPHAZOLINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
OPCON
BAUSCH AND LOMB 0.1% A087506 001
VASOCON
NOVARTIS 0.1% A080235 002 Mar 24, 1983
NAPROXEN
TABLET;ORAL
NAPROSYN
+ ATNAHS PHARMA US 250MG N017581 002
+ 375MG N017581 003
NAPROXEN
CHARTWELL MOLECULES 250MG A074410 001 Apr 28, 1995
375MG A074410 002 Apr 28, 1995
500MG A074410 003 Apr 28, 1995
DAVA PHARMS INC 250MG A074105 001 Dec 21, 1993
375MG A074105 002 Dec 21, 1993
500MG A074105 003 Dec 21, 1993
HAMILTON PHARMS 250MG A074110 001 Oct 30, 1992
375MG A074110 002 Oct 30, 1992
500MG A074110 003 Oct 30, 1992
HIKMA INTL PHARMS 250MG A076494 001 Jan 14, 2004
375MG A076494 002 Jan 14, 2004
500MG A076494 003 Jan 14, 2004
IVAX SUB TEVA PHARMS 250MG A074111 001 Feb 28, 1995
375MG A074111 002 Feb 28, 1995
500MG A074111 003 Feb 28, 1995
L PERRIGO CO 250MG A077339 001 Apr 27, 2005
375MG A077339 002 Apr 27, 2005
500MG A077339 003 Apr 27, 2005
MYLAN 250MG A074121 001 Dec 21, 1993
375MG A074121 002 Dec 21, 1993
500MG A074121 003 Dec 21, 1993
PLIVA 250MG A074182 001 Jun 27, 1996
375MG A074182 002 Jun 27, 1996
500MG A074182 003 Jun 27, 1996
PUREPAC PHARM 250MG A074263 001 Dec 21, 1993
375MG A074263 002 Dec 21, 1993
500MG A074263 003 Dec 21, 1993
ROXANE 250MG A074211 001 Feb 28, 1994
375MG A074211 002 Feb 28, 1994
500MG A074211 003 Feb 28, 1994
TEVA 250MG A074129 001 Dec 21, 1993
250MG A074216 001 Apr 11, 1996
375MG A074129 002 Dec 21, 1993
375MG A074216 002 Apr 11, 1996
500MG A074129 003 Dec 21, 1993
500MG A074216 003 Apr 11, 1996
TEVA PHARMS 250MG A074207 001 Dec 21, 1993
375MG A074207 002 Dec 21, 1993
500MG A074207 003 Dec 21, 1993
WATSON LABS 250MG A074457 001 May 31, 1995
375MG A074457 002 May 31, 1995
500MG A074457 003 May 31, 1995
WATSON LABS TEVA 250MG A074163 001 Feb 10, 1995
375MG A074163 002 Feb 10, 1995
500MG A074163 003 Feb 10, 1995
TABLET, DELAYED RELEASE;ORAL
NAPROXEN
ACTAVIS ELIZABETH 375MG A074936 001 Feb 24, 1998
500MG A074936 002 Feb 24, 1998
FOSUN PHARMA 375MG A075061 001 Feb 18, 1998
500MG A075061 002 Feb 18, 1998
MYLAN PHARMS INC 375MG A075390 001 Apr 19, 2001
500MG A075390 002 Apr 19, 2001
PLIVA 375MG A075337 001 May 26, 1999
500MG A075337 002 May 26, 1999

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-336(of 478)
** See List Footnote
NAPROXEN SODIUM
TABLET;ORAL
ANAPROX
+ ATNAHS PHARMA US EQ 250MG BASE ** N018164 001
NAPROXEN SODIUM
ABLE EQ 250MG BASE A076544 001 Aug 22, 2003
EQ 500MG BASE A076544 002 Aug 22, 2003
CONTRACT PHARMACAL 220MG A074789 001 Feb 27, 1997
HAMILTON PHARMS EQ 250MG BASE A074106 001 Aug 31, 1993
EQ 500MG BASE A074106 002 Aug 31, 1993
HIKMA EQ 250MG BASE A074480 002 Feb 18, 1998
EQ 500MG BASE A074480 001 May 14, 1996
IVAX SUB TEVA PHARMS EQ 250MG BASE A074230 001 Mar 14, 1995
EQ 500MG BASE A074230 002 Mar 14, 1995
MYLAN EQ 250MG BASE A074367 001 Aug 31, 1994
EQ 500MG BASE A074367 002 Aug 31, 1994
PLD ACQUISITIONS LLC 220MG A074646 001 Jan 13, 1997
PLIVA EQ 250MG BASE A074242 001 Jun 20, 1996
EQ 500MG BASE A074242 002 Jun 20, 1996
PUREPAC PHARM EQ 250MG BASE A074319 001 Mar 20, 1995
EQ 500MG BASE A074319 002 Mar 20, 1995
ROXANE EQ 250MG BASE A074257 001 Dec 21, 1993
EQ 500MG BASE A074257 002 Dec 21, 1993
SANDOZ EQ 250MG BASE A074162 001 Dec 21, 1993
EQ 250MG BASE A074495 001 Dec 05, 1994
EQ 500MG BASE A074162 002 Dec 21, 1993
EQ 500MG BASE A074495 002 Dec 05, 1994
TEVA EQ 250MG BASE A074142 001 Dec 21, 1993
EQ 250MG BASE A074198 001 Dec 21, 1993
EQ 500MG BASE A074142 002 Dec 21, 1993
EQ 500MG BASE A074198 002 Dec 21, 1993
TEVA PHARMS EQ 250MG BASE A074289 001 Jan 27, 1994
EQ 500MG BASE A074289 002 Jan 27, 1994
WATSON LABS EQ 250MG BASE A074195 001 Dec 21, 1993
EQ 250MG BASE A074455 001 May 31, 1995
EQ 500MG BASE A074195 002 Dec 21, 1993
EQ 500MG BASE A074455 002 May 31, 1995
NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
ALEVE-D SINUS & COLD
+ BAYER 220MG;120MG N021076 001 Nov 29, 1999
NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE
AUROBINDO PHARMA 220MG;120MG A211360 001 Jun 01, 2022
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
TABLET;ORAL
TREXIMET
+ CURRAX 60MG;EQ 10MG BASE N021926 002 May 14, 2015
NARATRIPTAN HYDROCHLORIDE
TABLET;ORAL
NARATRIPTAN
ANI PHARMS EQ 1MG BASE A078751 001 Jul 07, 2010
EQ 2.5MG BASE A078751 002 Jul 07, 2010
APOTEX CORP EQ 1MG BASE A091373 001 Apr 22, 2011
EQ 2.5MG BASE A091373 002 Apr 22, 2011
CHARTWELL RX EQ 1MG BASE A090288 001 Jul 07, 2010
EQ 2.5MG BASE A090288 002 Jul 07, 2010
MYLAN PHARMS INC EQ 1MG BASE A202431 001 May 31, 2012
EQ 2.5MG BASE A202431 002 May 31, 2012
NATEGLINIDE
TABLET;ORAL
NATEGLINIDE
ALVOGEN 60MG A205055 001 Dec 11, 2015
120MG A205055 002 Dec 11, 2015
TEVA PHARMS 60MG A077467 001 Sep 09, 2009
120MG A077467 002 Sep 09, 2009
STARLIX
+ NOVARTIS 60MG ** N021204 001 Dec 22, 2000

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-337(of 478)
** See List Footnote
NATEGLINIDE
TABLET;ORAL
STARLIX
+ 120MG ** N021204 002 Dec 22, 2000
NEBIVOLOL HYDROCHLORIDE
TABLET;ORAL
NEBIVOLOL HYDROCHLORIDE
AJANTA PHARMA LTD EQ 2.5MG BASE A213349 001 Mar 31, 2022
EQ 5MG BASE A213349 002 Mar 31, 2022
EQ 10MG BASE A213349 003 Mar 31, 2022
EQ 20MG BASE A213349 004 Mar 31, 2022
ALKEM LABS LTD EQ 2.5MG BASE A203741 001 Jun 24, 2015
EQ 5MG BASE A203741 002 Jun 24, 2015
EQ 10MG BASE A203741 003 Jun 24, 2015
EQ 20MG BASE A203741 004 Jun 24, 2015
GLENMARK PHARMS LTD EQ 2.5MG BASE A203821 001 May 25, 2017
EQ 5MG BASE A203821 002 May 25, 2017
EQ 10MG BASE A203821 003 May 25, 2017
EQ 20MG BASE A203821 004 May 25, 2017
UNICHEM EQ 2.5MG BASE A213830 001 Mar 15, 2022
EQ 5MG BASE A213830 002 Mar 15, 2022
EQ 10MG BASE A213830 003 Mar 15, 2022
EQ 20MG BASE A213830 004 Mar 15, 2022
WATSON LABS INC EQ 2.5MG BASE A203683 001 Nov 27, 2015
EQ 5MG BASE A203683 002 Nov 27, 2015
EQ 10MG BASE A203683 003 Nov 27, 2015
EQ 20MG BASE A203683 004 Nov 27, 2015
NEBIVOLOL HYDROCHLORIDE; VALSARTAN
TABLET;ORAL
BYVALSON
+ ALLERGAN EQ 5MG BASE;80MG N206302 001 Jun 03, 2016
NEDOCROMIL SODIUM
AEROSOL, METERED;INHALATION
TILADE
KING PHARMS LLC 1.75MG/INH N019660 001 Dec 30, 1992
SOLUTION;INHALATION
TILADE
SANOFI AVENTIS US 0.5% N020750 001 Oct 01, 1997
SOLUTION/DROPS;OPHTHALMIC
ALOCRIL
+ ALLERGAN 2% N021009 001 Dec 08, 1999
NEDOCROMIL SODIUM
AKORN 2% A090638 001 Aug 22, 2012
NEFAZODONE HYDROCHLORIDE
TABLET;ORAL
NEFAZODONE HYDROCHLORIDE
ANI PHARMS 50MG A076072 001 Sep 16, 2003
100MG A076072 002 Sep 16, 2003
150MG A076072 003 Sep 16, 2003
200MG A076072 004 Sep 16, 2003
250MG A076072 005 Sep 16, 2003
DR REDDYS LABS INC 50MG A076309 001 Sep 16, 2003
100MG A076309 002 Sep 16, 2003
150MG A076309 003 Sep 16, 2003
200MG A076309 004 Sep 16, 2003
250MG A076309 005 Sep 16, 2003
FOSUN PHARMA 50MG A076302 001 Sep 16, 2003
100MG A076302 002 Sep 16, 2003
150MG A076302 003 Sep 16, 2003
200MG A076302 004 Sep 16, 2003
250MG A076302 005 Sep 16, 2003
IVAX SUB TEVA PHARMS 50MG A075763 001 Sep 16, 2003
100MG A075763 002 Sep 16, 2003
150MG A075763 003 Sep 16, 2003
200MG A075763 004 Sep 16, 2003
250MG A075763 005 Sep 16, 2003
MYLAN 100MG A076129 002 Sep 16, 2003

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-338(of 478)
** See List Footnote
NEFAZODONE HYDROCHLORIDE
TABLET;ORAL
NEFAZODONE HYDROCHLORIDE
150MG A076129 003 Sep 16, 2003
200MG A076129 004 Sep 16, 2003
250MG A076129 005 Sep 16, 2003
ROXANE 50MG A076196 001 Sep 16, 2003
100MG A076196 002 Sep 16, 2003
150MG A076196 003 Sep 16, 2003
200MG A076196 004 Sep 16, 2003
250MG A076196 005 Sep 16, 2003
SUN PHARM INDS LTD 50MG A076409 001 Sep 16, 2003
100MG A076409 002 Sep 16, 2003
150MG A076409 003 Sep 16, 2003
200MG A076409 004 Sep 16, 2003
250MG A076409 005 Sep 16, 2003
WATSON LABS 100MG A076073 002 Sep 16, 2003
150MG A076073 003 Sep 16, 2003
200MG A076073 004 Sep 16, 2003
250MG A076073 005 Sep 16, 2003
SERZONE
+ BRISTOL MYERS SQUIBB 50MG ** N020152 001 Dec 22, 1994
+ 100MG ** N020152 002 Dec 22, 1994
+ 150MG ** N020152 003 Dec 22, 1994
+ 200MG ** N020152 004 Dec 22, 1994
+ 250MG ** N020152 005 Dec 22, 1994
+ 300MG ** N020152 006 Dec 22, 1994
NELFINAVIR MESYLATE
POWDER;ORAL
VIRACEPT
AGOURON PHARMS EQ 50MG BASE/SCOOPFUL N020778 001 Mar 14, 1997
NEOMYCIN SULFATE
SOLUTION;ORAL
MYCIFRADIN
PHARMACIA AND UPJOHN EQ 87.5MG BASE/5ML N050285 001
NEO-FRADIN
X GEN PHARMS EQ 87.5MG BASE/5ML A065010 001 May 23, 2002
TABLET;ORAL
MYCIFRADIN
PHARMACIA AND UPJOHN EQ 350MG BASE A060520 001
NEOBIOTIC
PFIZER EQ 350MG BASE A060475 001
NEOMYCIN SULFATE
BRISTOL MYERS SQUIBB 500MG A060365 001
CHARTWELL MOLECULAR 500MG A204435 001 Jun 10, 2016
LANNETT 500MG A060607 001
LILLY 500MG A060385 001
NOSTRUM LABS INC 500MG A065468 001 Mar 29, 2010
ROXANE 500MG A062173 001
SANDOZ 500MG A061586 001
NEOMYCIN SULFATE; POLYMYXIN B SULFATE
CREAM;TOPICAL
NEOSPORIN
GLAXOSMITHKLINE EQ 3.5MG BASE/GM;10,000 UNITS/GM N050176 002 Jan 14, 1985
OINTMENT;OPHTHALMIC
STATROL
ALCON EQ 3.5MG BASE/GM;10,000 UNITS/GM N050344 002
SOLUTION/DROPS;OPHTHALMIC
STATROL
ALCON EQ 3.5MG BASE/ML;16,250 UNITS/ML A062339 001 Nov 30, 1984
EQ 3.5MG BASE/ML;16,250 UNITS/ML N050456 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-339(of 478)
** See List Footnote
NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE
SUSPENSION/DROPS;OPHTHALMIC
POLY-PRED
ALLERGAN EQ 0.35% BASE;10,000 UNITS/ML;0.5% N050081 002
NEOMYCIN SULFATE; PREDNISOLONE ACETATE
OINTMENT;OPHTHALMIC
NEO-DELTA-CORTEF
PHARMACIA AND UPJOHN EQ 3.5MG BASE/GM;0.25% A061039 002
EQ 3.5MG BASE/GM;0.5% A061039 001
SUSPENSION/DROPS;OPHTHALMIC
NEO-DELTA-CORTEF
PHARMACIA AND UPJOHN EQ 3.5MG BASE/ML;0.25% A061037 001
NEOMYCIN SULFATE; PREDNISOLONE SODIUM PHOSPHATE
OINTMENT;OPHTHALMIC
NEO-HYDELTRASOL
MERCK EQ 3.5MG BASE/GM;EQ 0.25% PHOSPHATE N050378 001
NEOMYCIN SULFATE; TRIAMCINOLONE ACETONIDE
CREAM;TOPICAL
MYTREX A
SAVAGE LABS EQ 3.5MG BASE/GM;0.1% A062598 001 Jul 21, 1986
NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE
FOUGERA EQ 3.5MG BASE/GM;0.1% A062600 001 Jul 21, 1986
PHARMADERM EQ 3.5MG BASE/GM;0.1% A062595 001 Jul 21, 1986
OINTMENT;TOPICAL
MYTREX A
SAVAGE LABS EQ 3.5MG BASE/GM;0.1% A062609 001 May 23, 1986
NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE
FOUGERA EQ 3.5MG BASE/GM;0.1% A062608 001 May 23, 1986
PHARMADERM EQ 3.5MG BASE/GM;0.1% A062607 001 May 23, 1986
NEOSTIGMINE METHYLSULFATE
SOLUTION;INTRAVENOUS
NEOSTIGMINE METHYLSULFATE
AM REGENT 5MG/10ML (0.5MG/ML) A209182 001 May 04, 2018
10MG/10ML (1MG/ML) A209182 002 May 04, 2018
NESIRITIDE RECOMBINANT
FOR SOLUTION;INTRAVENOUS
NATRECOR
+ SCIOS LLC 1.5MG/VIAL ** N020920 001 Aug 10, 2001
NETILMICIN SULFATE
INJECTABLE;INJECTION
NETROMYCIN
SCHERING EQ 10MG BASE/ML N050544 001 Feb 28, 1983
EQ 25MG BASE/ML N050544 002 Feb 28, 1983
EQ 100MG BASE/ML N050544 003 Feb 28, 1983
NEVIRAPINE
TABLET;ORAL
NEVIRAPINE
APOTEX INC 200MG A203021 001 May 22, 2012
MYLAN LABS 200MG A078864 001 May 22, 2012
PRINSTON INC 200MG A078644 001 May 22, 2012
TECH ORGANIZED 200MG A203176 001 May 22, 2012
VIRAMUNE
+ BOEHRINGER INGELHEIM 200MG N020636 001 Jun 21, 1996
TABLET, EXTENDED RELEASE;ORAL
NEVIRAPINE
ALVOGEN 100MG A204621 002 Nov 09, 2015
400MG A204621 001 Jul 10, 2015
APOTEX 400MG A205258 001 Apr 03, 2014
CIPLA 400MG A206448 001 Oct 15, 2015
MYLAN 100MG A206271 001 Nov 09, 2015
TECH ORGANIZED 100MG A207467 001 Jul 31, 2017
400MG A207467 002 Jul 31, 2017

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-340(of 478)
** See List Footnote
NIACIN
CAPSULE;ORAL
WAMPOCAP
MEDPOINTE PHARM HLC 500MG N011073 003
TABLET;ORAL
NIACIN
EVERYLIFE 500MG A083203 001
HALSEY 500MG A083453 001
HIKMA 500MG A083718 001
IMPAX LABS 500MG A083115 001
IVAX SUB TEVA PHARMS 500MG A083180 001
MK LABS 500MG A083525 001
PUREPAC PHARM 500MG A083271 001
SANDOZ 500MG A083306 001
TABLICAPS 500MG A084237 001
WATSON LABS 500MG A083136 001
500MG A083305 001
500MG A085172 001
WOCKHARDT 500MG A081134 001 Apr 28, 1992
NICOLAR
+ SANOFI AVENTIS US 500MG A083823 001
TABLET, EXTENDED RELEASE;ORAL
NIACIN
BEIJING 500MG A214428 001 Nov 22, 2021
1GM A214428 002 Nov 22, 2021
JUBILANT GENERICS 500MG A209156 001 May 14, 2018
750MG A209156 002 May 14, 2018
1GM A209156 003 May 14, 2018
RISING 500MG A203742 001 Feb 22, 2019
750MG A203742 002 Feb 22, 2019
1GM A203742 003 Feb 22, 2019
YICHANG HUMANWELL 500MG A212017 001 Jun 10, 2019
750MG A212017 002 Jun 10, 2019
1GM A212017 003 Jun 10, 2019
NIASPAN
ABBVIE 375MG N020381 001 Jul 28, 1997
+ 500MG ** N020381 002 Jul 28, 1997
+ 750MG ** N020381 003 Jul 28, 1997
+ 1GM ** N020381 004 Jul 28, 1997
NIASPAN TITRATION STARTER PACK
ABBVIE 375MG;500MG;750MG N020381 005 Jul 28, 1997
NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; TYROSINE
SUSPENSION;ORAL
TPN
INTL MINERALS 15MG/5ML;3.75MG/5ML;600MG/5ML N008378 003
NICARDIPINE HYDROCHLORIDE
CAPSULE;ORAL
CARDENE
+ CHIESI 20MG ** N019488 001 Dec 21, 1988
+ 30MG ** N019488 002 Dec 21, 1988
NICARDIPINE HYDROCHLORIDE
ANI PHARMS 20MG A074439 001 Dec 10, 1996
20MG A074540 001 Oct 28, 1996
30MG A074439 002 Dec 10, 1996
30MG A074540 002 Oct 28, 1996
MYLAN 20MG A074642 001 Jul 18, 1996
30MG A074642 002 Jul 18, 1996
CAPSULE, EXTENDED RELEASE;ORAL
CARDENE SR
+ CHIESI 30MG ** N020005 001 Feb 21, 1992
+ 45MG ** N020005 002 Feb 21, 1992
+ 60MG ** N020005 003 Feb 21, 1992
INJECTABLE;INJECTION
CARDENE
+ CHIESI 25MG/10ML (2.5MG/ML) ** N019734 001 Jan 30, 1992
NICARDIPINE HYDROCHLORIDE
NAVINTA LLC 25MG/10ML (2.5MG/ML) A090125 001 Nov 17, 2009
RK PHARMA 25MG/10ML (2.5MG/ML) A090664 001 Nov 17, 2009

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-341(of 478)
** See List Footnote
NICARDIPINE HYDROCHLORIDE
INJECTABLE;INJECTION
NICARDIPINE HYDROCHLORIDE
WEST-WARD PHARMS INT 25MG/10ML (2.5MG/ML) A078714 001 Dec 28, 2009
WOCKHARDT 25MG/10ML (2.5MG/ML) A090671 001 Nov 17, 2009
INJECTABLE;INTRAVENOUS
CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
+ CHIESI 40MG/200ML (0.2MG/ML) N019734 005 Nov 07, 2008
NICLOSAMIDE
TABLET, CHEWABLE;ORAL
NICLOCIDE
BAYER PHARMS 500MG N018669 001 May 14, 1982
NICOTINE
FILM, EXTENDED RELEASE;TRANSDERMAL
NICOTROL
MCNEIL CONS 15MG/16HR N020536 001 Jul 03, 1996
PROSTEP
AVEVA 11MG/24HR N019983 003 Dec 23, 1998
22MG/24HR N019983 004 Dec 23, 1998
NICOTINE POLACRILEX
GUM, CHEWING;BUCCAL
NICOTINE POLACRILEX
IVAX SUB TEVA PHARMS EQ 2MG BASE A076880 001 Feb 18, 2009
EQ 4MG BASE A077850 001 Feb 18, 2009
L PERRIGO CO EQ 2MG BASE A076776 001 Sep 16, 2004
EQ 4MG BASE A076778 001 Sep 16, 2004
PERRIGO R AND D EQ 2MG BASE A078967 001 Apr 23, 2008
EQ 4MG BASE A078968 001 Apr 23, 2008
THRIVE
GLAXOSMITHKLINE CONS EQ 2MG BASE A077658 001 Jun 19, 2007
EQ 4MG BASE A077656 001 Jun 19, 2007
NIFEDIPINE
CAPSULE;ORAL
ADALAT
BAYER PHARMS 10MG N019478 001 Nov 27, 1985
20MG N019478 002 Sep 17, 1986
NIFEDIPINE
CHASE LABS NJ 10MG A072409 001 Jul 04, 1990
20MG A073421 001 Jun 19, 1991
TEVA 10MG A072651 001 Feb 19, 1992
PROCARDIA
+ PFIZER 20MG ** N018482 002 Jul 24, 1986
TABLET, EXTENDED RELEASE;ORAL
ADALAT CC
+ NORWICH 30MG ** N020198 001 Apr 21, 1993
+ 60MG ** N020198 002 Apr 21, 1993
+ 90MG ** N020198 003 Apr 21, 1993
AFEDITAB CR
WATSON LABS 60MG A075659 001 Oct 26, 2001
WATSON LABS TEVA 30MG A075128 001 Mar 10, 2000
NIFEDIPINE
AUROBINDO PHARMA USA 30MG A090649 001 Jun 21, 2010
60MG A090649 002 Jun 21, 2010
90MG A090649 003 Jun 21, 2010
MARTEC USA LLC 90MG A075414 003 Mar 23, 2004
MYLAN 30MG A075108 001 Dec 17, 1999
PAR PHARM 30MG A077899 001 Dec 13, 2006
60MG A077899 002 Dec 13, 2006
90MG A077899 003 May 25, 2012
RISING 30MG A090602 001 Sep 13, 2010
30MG A201071 001 Dec 03, 2010
60MG A090602 002 Sep 13, 2010
60MG A201071 002 Dec 03, 2010
90MG A090602 003 Sep 13, 2010
90MG A201071 003 Dec 03, 2010

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-342(of 478)
** See List Footnote
NILUTAMIDE
TABLET;ORAL
NILANDRON
CONCORDIA 50MG N020169 001 Sep 19, 1996
NIMODIPINE
CAPSULE;ORAL
NIMODIPINE
SOFGEN PHARMS 30MG A201832 001 Jul 24, 2015
SUN PHARM INDS INC 30MG A077067 001 Apr 17, 2007
NIMOTOP
+ BAYER PHARMS 30MG ** N018869 001 Dec 28, 1988
SOLUTION;ORAL
NYMALIZE
+ AZURITY 3MG/ML ** N203340 001 May 10, 2013
NISOLDIPINE
TABLET, EXTENDED RELEASE;ORAL
SULAR
+ COVIS 10MG ** N020356 001 Feb 02, 1995
+ 20MG ** N020356 002 Feb 02, 1995
+ 25.5MG ** N020356 006 Jan 02, 2008
+ 30MG ** N020356 003 Feb 02, 1995
+ 40MG ** N020356 004 Feb 02, 1995
NITRIC OXIDE
GAS;INHALATION
INOMAX
+ MALLINCKRODT HOSP 100PPM ** N020845 002 Dec 23, 1999
NITROFURANTOIN
CAPSULE;ORAL
NITROFURANTOIN
WATSON LABS 50MG A084326 001
100MG A084326 002
SUSPENSION;ORAL
NITROFURANTOIN
AMNEAL PHARMS 25MG/5ML A201679 001 May 11, 2011
TABLET;ORAL
FURADANTIN
PROCTER AND GAMBLE 50MG N008693 001
100MG N008693 002
FURALAN
LANNETT 50MG A080017 001
100MG A080017 002
NITROFURANTOIN
ELKINS SINN 50MG A080003 001
100MG A080003 002
IVAX SUB TEVA PHARMS 50MG A080078 002
100MG A080078 001
SANDOZ 50MG A080043 001
100MG A080043 002
WATSON LABS 50MG A080447 001
50MG A085797 001
100MG A080447 002
100MG A085796 001
WHITEWORTH TOWN PLSN 100MG A084085 002
NITROFURANTOIN SODIUM
INJECTABLE;INJECTION
IVADANTIN
PROCTER AND GAMBLE EQ 180MG BASE/VIAL N012402 001
NITROFURANTOIN, MACROCRYSTALLINE
CAPSULE;ORAL
NITROFURANTOIN
ATHEM 25MG A074336 001 Jan 25, 1995
50MG A074336 002 Jan 25, 1995
100MG A074336 003 Jan 25, 1995
AUROBINDO PHARMA USA 50MG A074967 001 Jul 09, 1997
100MG A074967 002 Jul 09, 1997
100MG A077025 001 Aug 18, 2004

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-343(of 478)
** See List Footnote
NITROFURANTOIN, MACROCRYSTALLINE
CAPSULE;ORAL
NITROFURANTOIN
WATSON LABS 25MG A073696 001 Dec 31, 1992
50MG A073696 002 Dec 31, 1992
100MG A073696 003 Dec 31, 1992
NITROFURANTOIN MACROCRYSTALLINE
WATSON LABS 50MG A070248 001 Jun 24, 1988
100MG A070249 001 Jun 24, 1988
NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE
CAPSULE;ORAL
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
AUROBINDO PHARMA USA 75MG;25MG A076648 001 Mar 22, 2004
RANBAXY LABS LTD 75MG;25MG A076951 001 Mar 30, 2005
NITROFURAZONE
CREAM;TOPICAL
FURACIN
SHIRE 0.2% A083789 001
DRESSING;TOPICAL
ACTIN-N
SHERWOOD MEDCL 0.2% N017343 001
OINTMENT;TOPICAL
FURACIN
SHIRE 0.2% N005795 001
NITROFURAZONE
AMBIX 0.2% A086077 001
LANNETT 0.2% A084393 001
PERRIGO NEW YORK 0.2% A084968 001
TARO 0.2% A086156 001
WENDT 0.2% A086766 001
POWDER;TOPICAL
FURACIN
SHIRE 0.2% A083791 001
SOLUTION;TOPICAL
NITROFURAZONE
PERRIGO NEW YORK 0.2% A085130 001
WENDT 0.2% A087081 001
NITROGLYCERIN
AEROSOL;SUBLINGUAL
NITROLINGUAL
POHL BOSKAMP 0.4MG/SPRAY N018705 001 Oct 31, 1985
FILM, EXTENDED RELEASE;TRANSDERMAL
MINITRAN
BAUSCH 0.4MG/HR A089773 001 Aug 30, 1996
VALEANT PHARMS 0.1MG/HR A089771 001 Aug 30, 1996
0.6MG/HR A089774 001 Aug 30, 1996
VALEANT PHARMS NORTH 0.2MG/HR A089772 001 Aug 30, 1996
NITROGLYCERIN
LANNETT CO INC 0.2MG/HR A075115 001 Aug 10, 2004
0.4MG/HR A075115 002 Aug 10, 2004
MYLAN TECHNOLOGIES 0.1MG/HR A074992 004 Nov 12, 1999
0.2MG/HR A074992 003 Nov 12, 1999
0.4MG/HR A074992 002 Nov 12, 1999
0.6MG/HR A074992 001 Nov 12, 1999
TRANSDERM-NITRO
+ NOVARTIS 0.1MG/HR ** N020144 001 Feb 27, 1996
+ 0.2MG/HR ** N020144 002 Feb 27, 1996
+ 0.4MG/HR ** N020144 003 Feb 27, 1996
+ 0.6MG/HR ** N020144 004 Feb 27, 1996
+ 0.8MG/HR ** N020144 005 Feb 27, 1996
INJECTABLE;INJECTION
NITRO IV
POHL BOSKAMP 5MG/ML N018672 002 Aug 30, 1983
NITRO-BID
SANOFI AVENTIS US 5MG/ML N018621 001 Jan 05, 1982
10MG/ML A071159 001 Feb 28, 1990

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-344(of 478)
** See List Footnote
NITROGLYCERIN
INJECTABLE;INJECTION
NITROGLYCERIN
ABRAXIS PHARM 5MG/ML A070077 001 Dec 13, 1985
5MG/ML A071203 001 May 08, 1987
+ HOSPIRA 5MG/ML ** N018531 001
INTL MEDICATION 5MG/ML A070026 001 Sep 10, 1985
LUITPOLD 5MG/ML A071492 001 May 24, 1988
SMITH AND NEPHEW 5MG/ML A070633 001 Jun 19, 1986
5MG/ML A070634 001 Jun 19, 1986
NITROGLYCERIN IN DEXTROSE 5%
HOSPIRA 0.1MG/ML A074083 001 Oct 26, 1994
10MG/100ML A071846 001 Aug 31, 1990
20MG/100ML A071847 001 Aug 31, 1990
40MG/100ML A071848 001 Aug 31, 1990
NITROL
RORER 0.8MG/ML N018774 001 Jan 19, 1983
NITRONAL
POHL BOSKAMP 1MG/ML N018672 001 Aug 30, 1983
NITROSTAT
PARKE DAVIS 0.8MG/ML N018588 001
5MG/ML A070863 001 Jan 08, 1987
5MG/ML N018588 002 Dec 23, 1983
10MG/ML A070871 001 Jan 08, 1987
10MG/ML A070872 001 Jan 08, 1987
TRIDIL
HOSPIRA 0.5MG/ML N018537 002 Jun 16, 1983
5MG/ML N018537 001
POWDER;SUBLINGUAL
GONITRO
+ POHL BOSKAMP 0.4MG/PACKET N208424 001 Jun 08, 2016
TABLET;SUBLINGUAL
NITROGLYCERIN
ACTAVIS LABS FL INC 0.3MG A203693 001 Oct 16, 2017
0.4MG A203693 002 Oct 16, 2017
0.6MG A203693 003 Oct 16, 2017
SIGMAPHARM LABS LLC 0.3MG A207745 001 May 07, 2018
0.4MG A207745 002 May 07, 2018
0.6MG A207745 003 May 07, 2018
ZYDUS PHARMS 0.3MG A210153 001 Mar 08, 2022
0.4MG A210153 002 Mar 08, 2022
0.6MG A210153 003 Mar 08, 2022
NIZATIDINE
CAPSULE;ORAL
AXID
SMITHKLINE BEECHAM 150MG N019508 001 Apr 12, 1988
300MG N019508 002 Apr 12, 1988
NIZATIDINE
ANI PHARMS 150MG A075461 001 Jul 08, 2002
150MG A075668 001 Sep 12, 2002
300MG A075461 002 Jul 08, 2002
300MG A075668 002 Sep 12, 2002
APOTEX INC 150MG A076383 001 Jan 23, 2003
300MG A076383 002 Jan 23, 2003
MYLAN PHARMS INC 150MG A075806 001 Jul 05, 2002
150MG A075934 001 Jul 09, 2002
300MG A075806 002 Jul 05, 2002
300MG A075934 002 Jul 09, 2002
SOLUTION;ORAL
AXID
+ BRAINTREE 15MG/ML ** N021494 001 May 25, 2004
NIZATIDINE
AMNEAL PHARMS 15MG/ML A090576 001 Nov 18, 2009

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-345(of 478)
** See List Footnote
NONOXYNOL-9
AEROSOL;VAGINAL
DELFEN
PERSONAL PRODS 12.5% N014349 002
SPONGE;VAGINAL
TODAY
+ MAYER LABS INC 1GM N018683 001 Apr 01, 1983
NOREPINEPHRINE BITARTRATE
INJECTABLE;INJECTION
NOREPINEPHRINE BITARTRATE
METRICS PHARM EQ 1MG BASE/ML A040522 001 Sep 30, 2004
ZYDUS PHARMS EQ 1MG BASE/ML A216341 001 Jul 19, 2022
NOREPINEPHRINE BITARTRATE; PROCAINE HYDROCHLORIDE; PROPOXYCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
RAVOCAINE AND NOVOCAIN W/ LEVOPHED
EASTMAN KODAK EQ 0.033MG BASE/ML;2%;0.4% N008592 003
NORETHINDRONE
TABLET;ORAL
NORLUTIN
PARKE DAVIS 5MG N010895 002
TABLET;ORAL-28
MICRONOR
+ JANSSEN PHARMS 0.35MG ** N016954 001
NORETHINDRONE
AMNEAL PHARMS 0.35MG A202260 001 Aug 01, 2013
NORETHINDRONE ACETATE
TABLET;ORAL
AYGESTIN
+ DURAMED RES 5MG ** N018405 001 Apr 21, 1982
NORETHINDRONE ACETATE
AUROBINDO PHARMA LTD 5MG A204236 001 Jan 08, 2016
NORLUTATE
PARKE DAVIS 5MG N012184 002
NORFLOXACIN
SOLUTION/DROPS;OPHTHALMIC
CHIBROXIN
MERCK 0.3% N019757 001 Jun 17, 1991
TABLET;ORAL
NOROXIN
+ MERCK 400MG ** N019384 002 Oct 31, 1986
NORGESTREL
TABLET;ORAL
OPILL
+ LABORATOIRE HRA 0.075MG N017031 001
NORTRIPTYLINE HYDROCHLORIDE
CAPSULE;ORAL
AVENTYL HYDROCHLORIDE
LILLY EQ 10MG BASE N014684 001
EQ 25MG BASE N014684 002
NORTRIPTYLINE HYDROCHLORIDE
ANI PHARMS EQ 10MG BASE A074054 001 Dec 31, 1992
EQ 25MG BASE A074054 002 Dec 31, 1992
EQ 50MG BASE A074054 003 Dec 31, 1992
EQ 75MG BASE A074054 004 Dec 31, 1992
AUROBINDO PHARMA LTD EQ 10MG BASE A074835 001 Jun 30, 1997
EQ 25MG BASE A074835 002 Jun 30, 1997
EQ 50MG BASE A074835 003 Jun 30, 1997
EQ 75MG BASE A074835 004 Jun 30, 1997
MYLAN EQ 10MG BASE A074234 001 Jul 26, 1993
EQ 25MG BASE A074234 002 Jul 26, 1993
EQ 50MG BASE A074234 003 Jul 26, 1993
EQ 75MG BASE A074234 004 Jul 26, 1993
TEVA EQ 10MG BASE A073667 001 Apr 11, 1996
EQ 25MG BASE A073667 002 Apr 11, 1996
EQ 50MG BASE A073667 003 Apr 11, 1996
EQ 75MG BASE A073667 004 Apr 11, 1996

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-346(of 478)
** See List Footnote
NORTRIPTYLINE HYDROCHLORIDE
CAPSULE;ORAL
NORTRIPTYLINE HYDROCHLORIDE
ZYDUS EQ 10MG BASE A213441 001 Feb 24, 2021
EQ 25MG BASE A213441 002 Feb 24, 2021
EQ 50MG BASE A213441 003 Feb 24, 2021
EQ 75MG BASE A213441 004 Feb 24, 2021
SOLUTION;ORAL
AVENTYL
+ RANBAXY EQ 10MG BASE/5ML ** N014685 001
NORTRIPTYLINE HYDROCHLORIDE
TARO EQ 10MG BASE/5ML A077965 001 Jun 20, 2006
PAMELOR
SPECGX LLC EQ 10MG BASE/5ML N018012 001
NYSTATIN
CREAM;TOPICAL
CANDEX
BAYER PHARMS 100,000 UNITS/GM A061810 001
MYCOSTATIN
DELCOR ASSET CORP 100,000 UNITS/GM ** A060575 001
MYKINAC
ALPHARMA US PHARMS 100,000 UNITS/GM A062387 001 Jul 29, 1982
NILSTAT
LEDERLE 100,000 UNITS/GM A061445 001
NYSTATIN
STRIDES PHARMA 100,000 UNITS/GM A065315 001 May 31, 2006
TARO 100,000 UNITS/GM A062457 001 Jul 28, 1983
LOTION;TOPICAL
CANDEX
BAYER PHARMS 100,000 UNITS/ML N050233 001
OINTMENT;TOPICAL
MYCOSTATIN
DELCOR ASSET CORP 100,000 UNITS/GM ** A060571 001
MYKINAC
ALPHARMA US PHARMS 100,000 UNITS/GM A062731 001 Sep 22, 1986
NILSTAT
LEDERLE 100,000 UNITS/GM A061444 001
PASTILLE;ORAL
MYCOSTATIN
DELCOR ASSET CORP 200,000 UNITS N050619 001 Apr 09, 1987
POWDER;ORAL
BARSTATIN 100
BARLAN 100% A062489 001 Apr 27, 1988
NILSTAT
+ STRIDES PHARMA 100% ** N050576 001 Dec 22, 1983
NYSTATIN
PADDOCK LLC 100% A062613 001 Nov 26, 1985
POWDER;TOPICAL
MYCOSTATIN
DELCOR ASSET CORP 100,000 UNITS/GM ** A060578 001
NYSTATIN
NESHER PHARMS 100,000 UNITS/GM A065321 001 Aug 18, 2006
SUPPOSITORY;VAGINAL
NYSERT
WARNER CHILCOTT 100,000 UNITS N050478 001
SUSPENSION;ORAL
MYCOSTATIN
DELCOR ASSET CORP 100,000 UNITS/ML A061533 001
NILSTAT
+ GLENMARK PHARMS LTD 100,000 UNITS/ML ** N050299 001
NYSTATIN
AKORN 100,000 UNITS/ML A064042 001 Feb 28, 1994
ALPHARMA US PHARMS 100,000 UNITS/ML A062571 001 Oct 29, 1985
COSETTE 100,000 UNITS/ML A062776 001 Dec 17, 1987
G AND W LABS INC 100,000 UNITS/ML A062349 001 Jul 14, 1982
MORTON GROVE 100,000 UNITS/ML A062835 001 Nov 19, 1987
PHARMADERM 100,000 UNITS/ML A062518 001 Jul 06, 1984
PHARMAFAIR 100,000 UNITS/ML A062541 001 Jan 16, 1985
TEVA 100,000 UNITS/ML A062670 001 Jun 18, 1987

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-347(of 478)
** See List Footnote
NYSTATIN
SUSPENSION;ORAL
NYSTEX
SAVAGE LABS 100,000 UNITS/ML A062519 001 Jul 06, 1984
TABLET;ORAL
MYCOSTATIN
DELCOR ASSET CORP 500,000 UNITS A060574 001
NILSTAT
LEDERLE 500,000 UNITS A061151 001
NYSTATIN
CHARTWELL RX 500,000 UNITS A062524 001 Nov 26, 1985
QUANTUM PHARMICS 500,000 UNITS A062525 001 Oct 29, 1984
SANDOZ 500,000 UNITS A062065 001
WATSON LABS 500,000 UNITS A062402 001 Dec 16, 1982
TABLET;VAGINAL
KOROSTATIN
HOLLAND RANTOS 100,000 UNITS A061718 001
MYCOSTATIN
DELCOR ASSET CORP 100,000 UNITS A060577 001
NILSTAT
LEDERLE 100,000 UNITS A061325 001
NYSTATIN
FOUGERA 100,000 UNITS A062459 001 Nov 09, 1983
ODYSSEY PHARMS 100,000 UNITS A062615 001 Oct 17, 1985
PHARMADERM 100,000 UNITS A062460 001 Nov 09, 1983
QUANTUM PHARMICS 100,000 UNITS A062509 001 Apr 03, 1984
SANDOZ 100,000 UNITS A061965 001
TEVA 100,000 UNITS A062502 001 Dec 23, 1983
WATSON LABS 100,000 UNITS A062176 001
NYSTATIN; TRIAMCINOLONE ACETONIDE
CREAM;TOPICAL
MYCO-TRIACET II
TEVA 100,000 UNITS/GM;0.1% A061954 002 Sep 20, 1985
MYCOLOG-II
DELCOR ASSET CORP 100,000 UNITS/GM;0.1% ** A060576 002 May 01, 1985
MYLAN 100,000 UNITS/GM;0.1% ** A062606 001 May 15, 1985
MYTREX F
SAVAGE LABS 100,000 UNITS/GM;0.1% A062597 001 Oct 08, 1985
NYSTATIN AND TRIAMCINOLONE ACETONIDE
ALPHARMA US PHARMS 100,000 UNITS/GM;0.1% A063010 001 Dec 20, 1988
PERRIGO NEW YORK 100,000 UNITS/GM;0.1% A062186 002 Jun 06, 1985
PHARMAFAIR 100,000 UNITS/GM;0.1% A062657 001 Jul 30, 1986
TARO 100,000 UNITS/GM;0.1% A062347 001 Mar 30, 1987
NYSTATIN TRIAMCINOLONE ACETONIDE
PHARMADERM 100,000 UNITS/GM;0.1% A062596 001 Oct 08, 1985
OINTMENT;TOPICAL
MYCO-TRIACET II
TEVA 100,000 UNITS/GM;0.1% A062045 002 Nov 26, 1985
MYCOLOG-II
MYLAN 100,000 UNITS/GM;0.1% ** A060572 001 Jun 28, 1985
MYTREX F
SAVAGE LABS 100,000 UNITS/GM;0.1% A062601 001 Oct 09, 1985
NYSTATIN AND TRIAMCINOLONE ACETONIDE
CHARTWELL RX 100,000 UNITS/GM;0.1% A207316 001 Nov 18, 2019
CROWN LABS INC 100,000 UNITS/GM;0.1% A207731 001 Dec 26, 2017
PERRIGO NEW YORK 100,000 UNITS/GM;0.1% A062280 002 Oct 10, 1985
PHARMAFAIR 100,000 UNITS/GM;0.1% A062656 001 Jul 30, 1986
NYSTATIN-TRIAMCINOLONE ACETONIDE
PHARMADERM 100,000 UNITS/GM;0.1% A062603 001 Oct 09, 1985
OCTREOTIDE ACETATE
INJECTABLE;INJECTION
OCTREOTIDE ACETATE
SUN PHARM INDS EQ 0.05MG BASE/ML A077329 001 Mar 04, 2008
EQ 0.05MG BASE/ML A077372 001 Aug 14, 2007
EQ 0.1MG BASE/ML A077329 002 Mar 04, 2008
EQ 0.1MG BASE/ML A077372 002 Aug 14, 2007
EQ 0.2MG BASE/ML A077330 001 Mar 04, 2008
EQ 0.2MG BASE/ML A077373 001 Aug 14, 2007

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-348(of 478)
** See List Footnote
OCTREOTIDE ACETATE
INJECTABLE;INJECTION
OCTREOTIDE ACETATE
EQ 0.5MG BASE/ML A077329 003 Mar 04, 2008
EQ 0.5MG BASE/ML A077372 003 Aug 14, 2007
EQ 1MG BASE/ML A077331 001 Mar 04, 2008
EQ 1MG BASE/ML A077373 002 Aug 14, 2007
WOCKHARDT USA EQ 0.2MG BASE/ML A090986 001 May 11, 2011
EQ 1MG BASE/ML A090986 002 May 11, 2011
OCTREOTIDE ACETATE PRESERVATIVE FREE
WOCKHARDT USA EQ 0.05MG BASE/ML A090985 001 May 11, 2011
EQ 0.1MG BASE/ML A090985 002 May 11, 2011
EQ 0.5MG BASE/ML A090985 003 May 11, 2011
SANDOSTATIN
+ NOVARTIS EQ 0.2MG BASE/ML ** N019667 004 Jun 12, 1991
+ EQ 1MG BASE/ML ** N019667 005 Jun 12, 1991
OFLOXACIN
INJECTABLE;INJECTION
FLOXIN
ORTHO MCNEIL PHARM 20MG/ML N020087 002 Mar 31, 1992
40MG/ML N020087 003 Mar 31, 1992
FLOXIN IN DEXTROSE 5%
ORTHO MCNEIL PHARM 400MG/100ML N020087 001 Mar 31, 1992
FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
ORTHO MCNEIL PHARM 4MG/ML N020087 004 Mar 31, 1992
400MG/100ML N020087 005 Mar 31, 1992
OFLOXACIN
BEDFORD 40MG/ML A075762 001 Jan 16, 2002
SOLUTION/DROPS;OPHTHALMIC
OFLOXACIN
AKORN 0.3% A076615 001 May 14, 2004
ALVOGEN 0.3% A076830 001 Aug 31, 2004
SANDOZ 0.3% A076848 001 Nov 25, 2008
SANDOZ INC 0.3% A076231 001 May 14, 2004
SOLUTION/DROPS;OTIC
FLOXIN OTIC
+ DAIICHI 0.3% ** N020799 001 Dec 16, 1997
OFLOXACIN
ALVOGEN 0.3% A090395 001 Aug 11, 2009
FDC LTD 0.3% A215038 001 Jan 19, 2022
SANDOZ INC 0.3% A078222 001 Mar 17, 2008
TABLET;ORAL
FLOXIN
+ JANSSEN PHARMS 200MG ** N019735 001 Dec 28, 1990
+ 300MG ** N019735 002 Dec 28, 1990
+ 400MG ** N019735 003 Dec 28, 1990
OFLOXACIN
LARKEN LABS 200MG A076093 001 Sep 02, 2003
300MG A076093 002 Sep 02, 2003
RANBAXY LABS LTD 200MG A076220 001 Sep 02, 2003
300MG A076220 002 Sep 02, 2003
400MG A076220 003 Sep 02, 2003
OLANZAPINE
TABLET;ORAL
OLANZAPINE
AJANTA PHARMA LTD 2.5MG A206711 001 Aug 30, 2016
5MG A206711 002 Aug 30, 2016
7.5MG A206711 003 Aug 30, 2016
10MG A206711 004 Aug 30, 2016
15MG A206711 005 Aug 30, 2016
20MG A206711 006 Aug 30, 2016
HIKMA 2.5MG A204866 001 Jun 16, 2017
5MG A204866 002 Jun 16, 2017
7.5MG A204866 003 Jun 16, 2017
10MG A204866 004 Jun 16, 2017
15MG A204866 005 Jun 16, 2017
20MG A204866 006 Jun 16, 2017
HISUN PHARM HANGZHOU 2.5MG A206924 001 Dec 31, 2020

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-349(of 478)
** See List Footnote
OLANZAPINE
TABLET;ORAL
OLANZAPINE
5MG A206924 002 Dec 31, 2020
7.5MG A206924 003 Dec 31, 2020
10MG A206924 004 Dec 31, 2020
15MG A206924 005 Dec 31, 2020
20MG A206924 006 Dec 31, 2020
IVAX PHARMS INC 20MG A077301 001 Apr 29, 2015
JIANGSU HANSOH PHARM 2.5MG A209399 001 Sep 24, 2018
5MG A209399 002 Sep 24, 2018
10MG A209399 003 Sep 24, 2018
MYLAN 2.5MG A076866 001 Apr 23, 2012
5MG A076866 002 Apr 23, 2012
7.5MG A076866 003 Apr 23, 2012
10MG A076866 004 Apr 23, 2012
15MG A076866 005 Apr 23, 2012
20MG A076866 006 Apr 23, 2012
SUNSHINE 2.5MG A206238 001 Nov 19, 2018
5MG A206238 002 Nov 19, 2018
7.5MG A206238 003 Nov 19, 2018
10MG A206238 004 Nov 19, 2018
15MG A206238 005 Nov 19, 2018
20MG A206238 006 Nov 19, 2018
TEVA PHARMS 2.5MG A076000 001 Oct 24, 2011
5MG A076000 002 Oct 24, 2011
7.5MG A076000 003 Oct 24, 2011
10MG A076000 004 Oct 24, 2011
15MG A076000 005 Oct 24, 2011
TORRENT PHARMS LTD 2.5MG A091434 001 Apr 23, 2012
5MG A091434 002 Apr 23, 2012
7.5MG A091434 003 Apr 23, 2012
10MG A091434 004 Apr 23, 2012
15MG A091434 005 Apr 23, 2012
20MG A091434 006 Apr 23, 2012
TABLET, ORALLY DISINTEGRATING;ORAL
OLANZAPINE
AJANTA PHARMA LTD 5MG A204320 001 May 30, 2017
10MG A204320 002 May 30, 2017
15MG A204320 003 May 30, 2017
20MG A204320 004 May 30, 2017
HISUN PHARM HANGZHOU 5MG A206892 001 Dec 31, 2020
10MG A206892 002 Dec 31, 2020
15MG A206892 003 Dec 31, 2020
20MG A206892 004 Dec 31, 2020
OLAPARIB
CAPSULE;ORAL
LYNPARZA
+ ASTRAZENECA 50MG N206162 001 Dec 19, 2014
OLMESARTAN MEDOXOMIL
TABLET;ORAL
OLMESARTAN MEDOXOMIL
INVENTIA 5MG A208659 001 May 18, 2020
20MG A208659 002 May 18, 2020
40MG A208659 003 May 18, 2020
JUBILANT GENERICS 5MG A205482 001 Apr 24, 2017
20MG A205482 002 Apr 24, 2017
40MG A205482 003 Apr 24, 2017
LUPIN LTD 5MG A206631 001 Apr 27, 2017
20MG A206631 002 Apr 27, 2017
40MG A206631 003 Apr 27, 2017
RISING 5MG A078276 001 Oct 26, 2016
20MG A078276 002 Oct 26, 2016
40MG A078276 003 Oct 26, 2016
SANDOZ INC 5MG A090237 001 Apr 13, 2020
20MG A090237 002 Apr 13, 2020
40MG A090237 003 Apr 13, 2020
TEVA PHARMS USA 5MG A091079 001 Apr 24, 2017

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-350(of 478)
** See List Footnote
OLMESARTAN MEDOXOMIL
TABLET;ORAL
OLMESARTAN MEDOXOMIL
20MG A091079 002 Apr 24, 2017
40MG A091079 003 Apr 24, 2017
OLOPATADINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
OLOPATADINE HYDROCHLORIDE
BAUSCH AND LOMB INC EQ 0.1% BASE A206046 001 Jul 26, 2017
CIPLA EQ 0.2% BASE A206087 001 Dec 05, 2017
FDC LTD EQ 0.1% BASE A209282 001 Sep 26, 2019
GLENMARK PHARMS INC EQ 0.1% BASE A200810 001 Jun 28, 2017
RISING EQ 0.1% BASE A204392 001 Mar 21, 2018
EQ 0.2% BASE A204620 001 Jun 16, 2020
WATSON LABS INC EQ 0.7% BASE A208637 001 Feb 19, 2020
ZAMBON SPA EQ 0.1% BASE A204706 001 Dec 07, 2015
OMBITASVIR; PARITAPREVIR; RITONAVIR
TABLET;ORAL
TECHNIVIE
+ ABBVIE INC 12.5MG;75MG;50MG ** N207931 001 Jul 24, 2015
OMEGA-3-ACID ETHYL ESTERS
CAPSULE;ORAL
OMEGA-3-ACID ETHYL ESTERS
STRIDES PHARMA 1GM CONTAINS AT LEAST 900MG OF THE A091018 001 Jun 24, 2014
ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
ZYDUS 1GM CONTAINS AT LEAST 900MG OF THE A210107 001 Jun 14, 2019
ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
OMEGA-3-ACID ETHYL ESTERS TYPE A
CAPSULE;ORAL
OMTRYG
+ OSMOTICA PHARM US 1.2GM CONTAINS AT LEAST 900MG OF THE N204977 001 Apr 23, 2014
ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
OMEGA-3-CARBOXYLIC ACIDS
CAPSULE;ORAL
EPANOVA
+ ASTRAZENECA 1GM CONTAINS AT LEAST 850MG OF N205060 001 May 05, 2014
POLYUNSATURATED FATTY ACIDS
OMEPRAZOLE
CAPSULE, DELAYED REL PELLETS;ORAL
OMEPRAZOLE
LUPIN LTD 40MG A202384 001 Aug 25, 2015
MYLAN 10MG A205070 001 Jun 29, 2018
20MG A205070 002 Jun 29, 2018
40MG A205070 003 Jun 29, 2018
STRIDES PHARMA 10MG A075876 001 May 29, 2003
20MG A075876 002 May 29, 2003
40MG A075876 003 Jan 21, 2009
TEVA PHARMS USA 40MG A204661 002 Jun 13, 2017
PRILOSEC
+ ASTRAZENECA 10MG ** N019810 003 Oct 05, 1995
+ 20MG ** N019810 001 Sep 14, 1989
+ 40MG ** N019810 002 Jan 15, 1998
OMEPRAZOLE MAGNESIUM
TABLET, DELAYED RELEASE;ORAL
OMEPRAZOLE MAGNESIUM
PERRIGO R AND D EQ 20MG BASE A204152 001 Jul 30, 2015
OMEPRAZOLE; SODIUM BICARBONATE
CAPSULE;ORAL
OMEPRAZOLE AND SODIUM BICARBONATE
CHARTWELL RX 20MG;1.1GM A204137 001 Jul 15, 2016
STRIDES PHARMA 20MG;1.1GM A078966 001 May 25, 2010
20MG;1.1GM A201946 001 Jul 15, 2016
40MG;1.1GM A078966 002 May 25, 2010

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-351(of 478)
** See List Footnote
ONDANSETRON
FILM;ORAL
ZUPLENZ
+ AQUESTIVE 4MG N022524 001 Jul 02, 2010
+ 8MG N022524 002 Jul 02, 2010
TABLET, ORALLY DISINTEGRATING;ORAL
ONDANSETRON
BARR 4MG A076693 001 Jun 25, 2007
8MG A076693 002 Jun 25, 2007
NESHER PHARMS 4MG A077717 001 Jun 25, 2007
8MG A077717 002 Jun 25, 2007
TEVA 4MG A076810 001 Jun 25, 2007
8MG A076810 002 Jun 25, 2007
ZOFRAN ODT
+ NOVARTIS 4MG N020781 001 Jan 27, 1999
+ 8MG N020781 002 Jan 27, 1999
ONDANSETRON HYDROCHLORIDE
INJECTABLE;INJECTION
ONDANSETRON HYDROCHLORIDE
APOTEX INC EQ 2MG BASE/ML A077368 001 Dec 26, 2006
BAXTER HLTHCARE CORP EQ 2MG BASE/ML A078288 001 Feb 22, 2013
CHARTWELL MOLECULAR EQ 2MG BASE/ML A090116 001 Apr 14, 2010
EMCURE PHARMS EQ 2MG BASE/ML A090424 001 Apr 16, 2010
EUGIA PHARMA EQ 2MG BASE/ML A202599 001 Dec 21, 2012
HOSPIRA EQ 2MG BASE/ML A076695 001 Dec 26, 2006
EQ 2MG BASE/ML A077840 001 Jan 19, 2007
LANNETT CO INC EQ 2MG BASE/ML A090883 001 Aug 05, 2010
LUITPOLD EQ 2MG BASE/ML A077582 001 Dec 26, 2006
EQ 2MG BASE/ML A079039 001 Nov 18, 2008
PLIVA HRVATSKA DOO EQ 2MG BASE/ML A077544 001 Dec 26, 2006
RISING EQ 2MG BASE/ML A204906 001 Jul 31, 2017
SAGENT PHARMS EQ 2MG BASE/ML A078180 001 Mar 26, 2007
STERISCIENCE EQ 2MG BASE/ML A078257 001 Apr 23, 2008
SUN PHARM INDS (IN) EQ 2MG BASE/ML A077172 001 Dec 26, 2006
TEVA EQ 2MG BASE/ML A076876 001 Nov 22, 2006
ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER
HOSPIRA EQ 0.64MG BASE/ML A076978 001 Feb 26, 2007
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
AM REGENT EQ 2MG BASE/ML A079032 001 Nov 18, 2008
APOTEX INC EQ 2MG BASE/ML A077343 001 Dec 26, 2006
EMCURE PHARMS LTD EQ 2MG BASE/ML A078945 001 Jan 03, 2013
EUGIA PHARMA EQ 2MG BASE/ML A202600 001 Dec 21, 2012
HIKMA FARMACEUTICA EQ 2MG BASE/ML A076780 001 Dec 26, 2006
HOSPIRA EQ 2MG BASE/ML A076696 001 Dec 26, 2006
LUITPOLD EQ 2MG BASE/ML A077387 001 Dec 26, 2006
STERISCIENCE EQ 2MG BASE/ML A078244 001 Apr 23, 2008
SUN PHARM INDS LTD EQ 2MG BASE/ML A077173 001 Dec 26, 2006
TARO PHARMS IRELAND EQ 2MG BASE/ML A078014 001 Mar 21, 2008
TEVA EQ 2MG BASE/ML A076759 001 Nov 22, 2006
ZOFRAN
+ NOVARTIS EQ 2MG BASE/ML ** N020007 001 Jan 04, 1991
ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER
+ GLAXOSMITHKLINE EQ 0.64MG BASE/ML ** N020403 001 Jan 31, 1995
ZOFRAN PRESERVATIVE FREE
+ NOVARTIS EQ 2MG BASE/ML ** N020007 003 Dec 10, 1993
SOLUTION;ORAL
ZOFRAN
+ NOVARTIS EQ 4MG BASE/5ML N020605 001 Jan 24, 1997
TABLET;ORAL
ONDANSETRON HYDROCHLORIDE
AUROBINDO PHARMA EQ 24MG BASE A078539 003 Jul 31, 2007
CASI PHARMS INC EQ 24MG BASE A077517 003 Jun 25, 2007
DR REDDYS LABS LTD EQ 16MG BASE A076183 004 Dec 26, 2006
EQ 24MG BASE A076183 001 Dec 26, 2006
GLENMARK GENERICS EQ 24MG BASE A077535 003 Jun 25, 2007
HIKMA INTL PHARMS EQ 4MG BASE A077545 001 Sep 06, 2007
EQ 8MG BASE A077545 002 Sep 06, 2007
EQ 24MG BASE A077545 003 Sep 06, 2007
PLIVA HRVATSKA DOO EQ 4MG BASE A077112 001 Jun 25, 2007

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-352(of 478)
** See List Footnote
ONDANSETRON HYDROCHLORIDE
TABLET;ORAL
ONDANSETRON HYDROCHLORIDE
EQ 8MG BASE A077112 002 Jun 25, 2007
EQ 24MG BASE A077112 003 Jun 25, 2007
RISING EQ 4MG BASE A076930 001 Jun 25, 2007
EQ 8MG BASE A076930 002 Jun 25, 2007
EQ 24MG BASE A076930 004 Jun 25, 2007
TARO EQ 4MG BASE A077729 001 Mar 28, 2011
EQ 8MG BASE A077729 002 Mar 28, 2011
EQ 24MG BASE A077729 003 Mar 28, 2011
TEVA EQ 4MG BASE A076252 001 Jun 25, 2007
EQ 8MG BASE A076252 002 Jun 25, 2007
EQ 24MG BASE A076252 003 Jun 25, 2007
ZOFRAN
+ NOVARTIS EQ 4MG BASE N020103 001 Dec 31, 1992
+ EQ 8MG BASE N020103 002 Dec 31, 1992
+ EQ 24MG BASE N020103 003 Aug 27, 1999
ORPHENADRINE CITRATE
INJECTABLE;INJECTION
NORFLEX
+ PAI HOLDINGS PHARM 30MG/ML ** N013055 001
ORPHENADRINE CITRATE
WATSON LABS 30MG/ML A087062 001
TABLET, EXTENDED RELEASE;ORAL
NORFLEX
+ BAUSCH 100MG ** N012157 001
ORPHENADRINE CITRATE
ASCOT 100MG A088067 001 Apr 06, 1983
IMPAX PHARMS 100MG A040368 001 Jun 23, 2000
SANDOZ 100MG A085046 001
WATSON LABS 100MG A084303 001
ORPHENADRINE HYDROCHLORIDE
TABLET;ORAL
DISIPAL
3M 50MG N010653 001
OSELTAMIVIR PHOSPHATE
CAPSULE;ORAL
OSELTAMIVIR PHOSPHATE
RISING EQ 30MG BASE A210157 001 Jan 21, 2021
EQ 45MG BASE A210157 002 Jan 21, 2021
EQ 75MG BASE A210157 003 Jan 21, 2021
SUNSHINE EQ 30MG BASE A212739 001 Mar 04, 2020
EQ 45MG BASE A212739 002 Mar 04, 2020
EQ 75MG BASE A212739 003 Mar 04, 2020
FOR SUSPENSION;ORAL
OSELTAMIVIR PHOSPHATE
LEADING EQ 6MG BASE/ML A214949 001 Feb 28, 2022
TAMIFLU
ROCHE EQ 12MG BASE/ML N021246 001 Dec 14, 2000
OXACILLIN SODIUM
CAPSULE;ORAL
BACTOCILL
GLAXOSMITHKLINE EQ 250MG BASE A061336 001
EQ 250MG BASE A062241 001
EQ 500MG BASE A061336 002
EQ 500MG BASE A062241 002
OXACILLIN SODIUM
ANI PHARMS EQ 250MG BASE A062222 001
EQ 500MG BASE A062222 002
APOTHECON EQ 250MG BASE A061450 002
EQ 500MG BASE A061450 001
PROSTAPHLIN
APOTHECON EQ 500MG BASE N050118 002
FOR SOLUTION;ORAL
BACTOCILL
GLAXOSMITHKLINE EQ 250MG BASE/5ML A062321 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-353(of 478)
** See List Footnote
OXACILLIN SODIUM
FOR SOLUTION;ORAL
OXACILLIN SODIUM
APOTHECON EQ 250MG BASE/5ML A061457 001
TEVA EQ 250MG BASE/5ML A062252 001
PROSTAPHLIN
APOTHECON EQ 250MG BASE/5ML N050194 001
INJECTABLE;INJECTION
BACTOCILL
GLAXOSMITHKLINE EQ 500MG BASE/VIAL ** A061334 009 Mar 26, 1982
EQ 1GM BASE/VIAL ** A061334 006 Mar 26, 1982
EQ 1GM BASE/VIAL ** A062736 001 Dec 19, 1986
EQ 2GM BASE/VIAL ** A061334 007 Mar 26, 1982
EQ 2GM BASE/VIAL ** A062736 002 Dec 19, 1986
EQ 4GM BASE/VIAL ** A061334 008 Mar 26, 1982
EQ 10GM BASE/VIAL ** A061334 010
OXACILLIN SODIUM
+ APOTHECON EQ 250MG BASE/VIAL ** N050195 001
+ EQ 500MG BASE/VIAL ** N050195 002
+ EQ 1GM BASE/VIAL ** N050195 003
+ EQ 2GM BASE/VIAL ** N050195 004
+ EQ 4GM BASE/VIAL ** N050195 005
ELKINS SINN EQ 250MG BASE/VIAL A062711 001 Feb 03, 1989
EQ 500MG BASE/VIAL A062711 002 Feb 03, 1989
EQ 1GM BASE/VIAL A062711 003 Feb 03, 1989
EQ 2GM BASE/VIAL A062711 004 Feb 03, 1989
EQ 4GM BASE/VIAL A062711 005 Feb 03, 1989
EQ 10GM BASE/VIAL A062711 006 Feb 03, 1989
HOSPIRA EQ 1GM BASE/VIAL A203950 001 Dec 11, 2015
EQ 2GM BASE/VIAL A203950 002 Dec 11, 2015
ISTITUTO BIO ITA SPA EQ 125MG BASE/VIAL A062798 003 Dec 11, 1995
EQ 250MG BASE/VIAL A062798 004 Dec 11, 1995
EQ 500MG BASE/VIAL A062798 005 Dec 11, 1995
EQ 1GM BASE/VIAL A062798 001 Dec 11, 1995
EQ 2GM BASE/VIAL A062798 002 Dec 11, 1995
PIRAMAL CRITICAL EQ 1GM BASE/VIAL A206681 001 Sep 11, 2017
EQ 2GM BASE/VIAL A206681 002 Sep 11, 2017
SANDOZ EQ 250MG BASE/VIAL A061490 001
EQ 500MG BASE/VIAL A061490 002
EQ 1GM BASE/VIAL A061490 003
EQ 2GM BASE/VIAL A061490 004
EQ 10GM BASE/VIAL A061490 006 May 09, 1991
STERISCIENCE EQ 1GM BASE/VIAL A091486 001 Aug 25, 2014
WATSON LABS INC EQ 250MG BASE/VIAL A062856 001 Oct 26, 1988
EQ 500MG BASE/VIAL A062856 002 Oct 26, 1988
EQ 1GM BASE/VIAL A062856 003 Oct 26, 1988
EQ 2GM BASE/VIAL A062856 004 Oct 26, 1988
EQ 4GM BASE/VIAL A062856 005 Oct 26, 1988
EQ 10GM BASE/VIAL A062984 001 Sep 29, 1988
POWDER;INTRAVENOUS
OXACILLIN SODIUM
SANDOZ EQ 1GM BASE/VIAL A062737 001 Dec 23, 1986
EQ 2GM BASE/VIAL A062737 002 Dec 23, 1986
OXALIPLATIN
INJECTABLE;INTRAVENOUS
ELOXATIN
+ SANOFI AVENTIS US 50MG/VIAL ** N021492 001 Aug 09, 2002
+ 100MG/VIAL ** N021492 002 Aug 09, 2002
+ 200MG/40ML (5MG/ML) ** N021759 003 Nov 17, 2006
OXALIPLATIN
ACCORD HLTHCARE 200MG/40ML (5MG/ML) A207474 003 Mar 21, 2017
AM REGENT 50MG/10ML (5MG/ML) A204378 001 May 12, 2017
100MG/20ML (5MG/ML) A204378 002 May 12, 2017
CHARTWELL MOLECULAR 50MG/10ML (5MG/ML) A208523 001 Feb 10, 2017
100MG/20ML (5MG/ML) A208523 002 Feb 10, 2017
FRESENIUS KABI ONCOL 50MG/VIAL A078810 001 Aug 07, 2009
100MG/VIAL A078810 002 Aug 07, 2009
FRESENIUS KABI USA 200MG/40ML (5MG/ML) A090030 003 Jan 31, 2017
GLAND 200MG/40ML (5MG/ML) A207325 003 Oct 18, 2017

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-354(of 478)
** See List Footnote
OXALIPLATIN
INJECTABLE;INTRAVENOUS
OXALIPLATIN
HOSPIRA INC 50MG/VIAL A078815 001 Sep 30, 2009
100MG/VIAL A078815 002 Sep 30, 2009
MYLAN LABS LTD 50MG/VIAL A200979 001 Aug 08, 2012
100MG/VIAL A200979 002 Aug 08, 2012
200MG/40ML (5MG/ML) A091358 003 Nov 14, 2017
SANDOZ 50MG/VIAL A090849 001 Apr 28, 2011
100MG/VIAL A090849 002 Apr 28, 2011
SANDOZ INC 50MG/10ML (5MG/ML) A078812 001 Aug 07, 2009
100MG/20ML (5MG/ML) A078812 002 Aug 07, 2009
SUN PHARM 50MG/VIAL A078818 001 Aug 07, 2009
50MG/10ML (5MG/ML) A202922 001 Apr 08, 2014
100MG/VIAL A078818 002 Aug 07, 2009
100MG/20ML (5MG/ML) A202922 002 Apr 08, 2014
200MG/40ML (5MG/ML) A202922 003 Feb 15, 2019
OXAMNIQUINE
CAPSULE;ORAL
VANSIL
PFIZER 250MG N018069 001
OXANDROLONE
TABLET;ORAL
OXANDRIN
+ GEMINI LABS LLC 2.5MG N013718 001
+ 10MG N013718 002 Nov 05, 2001
OXANDROLONE
ROXANE 2.5MG A077249 001 Jul 10, 2007
10MG A077249 002 Jul 10, 2007
SANDOZ 2.5MG A076897 001 Dec 01, 2006
10MG A076897 002 Dec 01, 2006
OXAPROZIN
TABLET;ORAL
OXAPROZIN
ACTAVIS ELIZABETH 600MG A075843 001 Oct 03, 2001
BEXIMCO PHARMS USA 600MG A075842 001 Apr 12, 2001
IVAX SUB TEVA PHARMS 600MG A075846 001 May 13, 2002
MYLAN 600MG A075851 001 Aug 17, 2001
MYLAN PHARMS INC 600MG A075847 001 Feb 28, 2001
SANDOZ 600MG A075850 001 Apr 27, 2001
SUN PHARM INDS INC 600MG A075844 001 Jan 03, 2002
WATSON LABS 600MG A075848 001 Feb 09, 2001
OXAPROZIN POTASSIUM
TABLET;ORAL
DAYPRO ALTA
PFIZER 600MG N020776 001 Oct 17, 2002
OXAZEPAM
CAPSULE;ORAL
OXAZEPAM
AM THERAP 10MG A071955 001 Mar 03, 1988
15MG A071956 001 Mar 03, 1988
30MG A071957 001 Mar 03, 1988
IVAX SUB TEVA PHARMS 10MG A070943 001 Aug 03, 1987
15MG A070944 001 Aug 03, 1987
30MG A070945 001 Aug 03, 1987
MYLAN 10MG A071713 001 Oct 20, 1987
15MG A071714 001 Oct 20, 1987
30MG A071715 001 Oct 20, 1987
WATSON LABS 15MG A072953 001 Sep 28, 1990
30MG A072954 001 Sep 28, 1990
WATSON LABS TEVA 10MG A072952 001 Sep 28, 1990
SERAX
+ ALPHARMA US PHARMS 10MG ** N015539 002
+ 15MG ** N015539 004
+ 30MG ** N015539 006

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-355(of 478)
** See List Footnote
OXAZEPAM
CAPSULE;ORAL
ZAXOPAM
QUANTUM PHARMICS 10MG A070650 001 Mar 01, 1988
15MG A070640 001 Mar 01, 1988
30MG A070641 001 Mar 01, 1988
TABLET;ORAL
OXAZEPAM
PARKE DAVIS 15MG A071508 001 Feb 02, 1987
SUN PHARM INDUSTRIES 15MG A070683 001 Jan 16, 1987
WATSON LABS 15MG A071494 001 Apr 21, 1987
SERAX
ALPHARMA US PHARMS 15MG ** N015539 008
OXCARBAZEPINE
TABLET;ORAL
OXCARBAZEPINE
ANI PHARMS 150MG A078005 001 Dec 11, 2007
300MG A078005 002 Dec 11, 2007
600MG A078005 003 Dec 11, 2007
HIKMA 150MG A077795 001 Oct 09, 2007
300MG A077795 002 Oct 09, 2007
600MG A077795 003 Oct 09, 2007
JUBILANT CADISTA 150MG A090239 001 Jan 25, 2010
300MG A090239 002 Jan 25, 2010
600MG A090239 003 Jan 25, 2010
OXPRENOLOL HYDROCHLORIDE
CAPSULE;ORAL
TRASICOR
NOVARTIS 20MG N018166 001 Dec 28, 1983
40MG N018166 002 Dec 28, 1983
80MG N018166 003 Dec 28, 1983
160MG N018166 004 Dec 28, 1983
OXTRIPHYLLINE
SOLUTION;ORAL
CHOLEDYL
PARKE DAVIS 100MG/5ML N009268 012 Nov 27, 1984
OXTRIPHYLLINE
MORTON GROVE 100MG/5ML A088243 001 Dec 05, 1983
SYRUP;ORAL
CHOLEDYL
PARKE DAVIS 50MG/5ML N009268 011
OXTRIPHYLLINE PEDIATRIC
MORTON GROVE 50MG/5ML A088242 001 Dec 05, 1983
TABLET, DELAYED RELEASE;ORAL
CHOLEDYL
PARKE DAVIS 100MG N009268 003
200MG N009268 007
OXTRIPHYLLINE
WATSON LABS 100MG A087866 001 Aug 25, 1983
200MG A087835 001 Aug 25, 1983
TABLET, EXTENDED RELEASE;ORAL
CHOLEDYL SA
WARNER CHILCOTT LLC 400MG A087863 001 May 24, 1983
600MG A086742 001
OXYBUTYNIN
FILM, EXTENDED RELEASE;TRANSDERMAL
OXYBUTYNIN
BARR LABS DIV TEVA 3.9MG/24HR A090526 001 Mar 04, 2014
GEL, METERED;TRANSDERMAL
GELNIQUE 3%
+ ALLERGAN 3% N202513 001 Dec 07, 2011

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-356(of 478)
** See List Footnote
OXYBUTYNIN CHLORIDE
GEL;TRANSDERMAL
OXYBUTYNIN CHLORIDE
STRIDES PHARMA 10% (100MG/PACKET) A207329 001 May 31, 2018
SYRUP;ORAL
DITROPAN
+ ORTHO MCNEIL JANSSEN 5MG/5ML ** N018211 001
OXYBUTYNIN CHLORIDE
CHARTWELL RX 5MG/5ML A075039 001 Jan 29, 1999
LANNETT CO INC 5MG/5ML A076682 001 Dec 28, 2004
PHARM ASSOC 5MG/5ML A074997 001 Oct 15, 1997
WOCKHARDT BIO AG 5MG/5ML A074868 001 Feb 12, 1997
TABLET;ORAL
DITROPAN
+ JANSSEN PHARMS 5MG ** N017577 001
OXYBUTYNIN CHLORIDE
QUANTUM PHARMICS 5MG A072296 001 Dec 08, 1988
USL PHARMA 5MG A070746 001 Mar 10, 1988
WATSON LABS 5MG A072485 001 Apr 19, 1989
TABLET, EXTENDED RELEASE;ORAL
DITROPAN XL
+ JANSSEN PHARMS 15MG ** N020897 003 Jun 22, 1999
OXYBUTYNIN CHLORIDE
IMPAX PHARMS 5MG A076745 002 May 09, 2007
10MG A076745 003 May 09, 2007
15MG A076745 001 Nov 09, 2006
MYLAN 5MG A076702 001 Nov 09, 2006
MYLAN PHARMS INC 10MG A076644 001 Nov 09, 2006
15MG A076644 002 May 10, 2007
OXYCODONE HYDROCHLORIDE
CAPSULE;ORAL
OXYCODONE HYDROCHLORIDE
LANNETT CO INC 5MG A203823 001 Aug 01, 2014
SOLUTION;ORAL
OXYCODONE HYDROCHLORIDE
ANI PHARMS 100MG/5ML A203447 001 Aug 30, 2017
AUROLIFE PHARMA LLC 5MG/5ML A212429 001 Jan 27, 2020
100MG/5ML A212429 002 Jan 27, 2020
CHARTWELL MOLECULAR 100MG/5ML A204085 001 Sep 09, 2014
HIKMA 100MG/5ML A203208 001 Jul 12, 2013
NOVEL LABS INC 100MG/5ML A204603 001 Apr 29, 2015
RHODES PHARMS 100MG/5ML A205853 001 Apr 29, 2020
XTTRIUM LABS INC 5MG/5ML A206456 001 Jun 16, 2015
TABLET;ORAL
OXYCODONE HYDROCHLORIDE
ACTAVIS ELIZABETH 5MG A076636 003 Apr 07, 2015
15MG A076636 001 Feb 06, 2004
30MG A076636 002 Feb 06, 2004
MAYNE PHARMA INC 5MG A091313 001 Feb 18, 2011
10MG A091313 004 Apr 29, 2016
15MG A091313 002 Feb 18, 2011
20MG A091313 005 Apr 29, 2016
30MG A091313 003 Feb 18, 2011
NESHER PHARMS 5MG A077290 001 Dec 08, 2005
10MG A077290 002 Dec 08, 2005
15MG A077290 003 Dec 08, 2005
20MG A077290 004 Dec 08, 2005
30MG A077290 005 Dec 08, 2005
STRIDES PHARMA 5MG A077712 003 Mar 02, 2009
10MG A077712 004 Apr 13, 2015
15MG A077712 001 Jan 31, 2007
20MG A077712 005 Apr 13, 2015
30MG A077712 002 Jan 31, 2007
TABLET, EXTENDED RELEASE;ORAL
ROXICODONE
ROXANE 10MG N020932 001 Oct 26, 1998
30MG N020932 002 Oct 26, 1998

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-357(of 478)
** See List Footnote
OXYMETAZOLINE HYDROCHLORIDE
CREAM;TOPICAL
OXYMETAZOLINE HYDROCHLORIDE
TARO PHARMS 1% A213584 001 Oct 04, 2021
SOLUTION/DROPS;OPHTHALMIC
OCUCLEAR
BAYER HEALTHCARE LLC 0.025% N018471 001 May 30, 1986
OXYMETHOLONE
TABLET;ORAL
ANADROL-50
+ MYLAN SPECIALITY LP 50MG N016848 001
OXYMORPHONE HYDROCHLORIDE
INJECTABLE;INJECTION
OPANA
+ ENDO PHARMS 1MG/ML N011707 002
1.5MG/ML N011707 001
SUPPOSITORY;RECTAL
NUMORPHAN
ENDO PHARMS 5MG N011738 004
TABLET;ORAL
OPANA
+ ENDO PHARMS 5MG N021611 001 Jun 22, 2006
+ 10MG N021611 002 Jun 22, 2006
TABLET, EXTENDED RELEASE;ORAL
OPANA ER
+ ENDO PHARMS 5MG ** N021610 001 Jun 22, 2006
+ 5MG N201655 001 Dec 09, 2011
+ 7.5MG ** N021610 005 Feb 29, 2008
+ 7.5MG N201655 002 Dec 09, 2011
+ 10MG ** N021610 002 Jun 22, 2006
+ 10MG N201655 003 Dec 09, 2011
+ 15MG ** N021610 006 Feb 29, 2008
+ 15MG N201655 004 Dec 09, 2011
+ 20MG ** N021610 003 Jun 22, 2006
+ 20MG N201655 005 Dec 09, 2011
+ 30MG ** N021610 007 Feb 29, 2008
+ 30MG N201655 006 Dec 09, 2011
+ 40MG ** N021610 004 Jun 22, 2006
+ 40MG N201655 007 Dec 09, 2011
OXYMORPHONE HYDROCHLORIDE
ACTAVIS ELIZABETH 5MG A079046 003 Jul 11, 2013
7.5MG A079046 001 Dec 13, 2010
10MG A079046 004 Jul 11, 2013
15MG A079046 002 Dec 13, 2010
20MG A079046 005 Jul 11, 2013
30MG A079046 006 Jul 11, 2013
40MG A079046 007 Jul 11, 2013
HIKMA 5MG A200822 002 Jul 15, 2013
7.5MG A200822 003 Jul 15, 2013
10MG A200822 004 Jul 15, 2013
15MG A200822 005 Jul 15, 2013
20MG A200822 006 Jul 15, 2013
30MG A200822 007 Jul 15, 2013
40MG A200822 001 Jul 15, 2013
PAR PHARM 5MG A200792 001 Oct 24, 2014
7.5MG A200792 002 Oct 24, 2014
10MG A200792 003 Oct 24, 2014
15MG A200792 004 Oct 24, 2014
20MG A200792 005 Oct 24, 2014
30MG A200792 006 Oct 24, 2014
40MG A200792 007 Oct 24, 2014
SPECGX LLC 5MG A202946 001 Jun 27, 2014
7.5MG A202946 002 Jun 27, 2014
10MG A202946 003 Jun 27, 2014
15MG A202946 004 Jun 27, 2014
20MG A202946 005 Jun 27, 2014
30MG A202946 006 Jun 27, 2014
40MG A202946 007 Jun 27, 2014

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-358(of 478)
** See List Footnote
OXYMORPHONE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
OXYMORPHONE HYDROCHLORIDE
SUN PHARM INDS LTD 5MG A203506 001 Apr 24, 2015
7.5MG A203506 002 Apr 24, 2015
10MG A203506 003 Apr 24, 2015
15MG A203506 004 Apr 24, 2015
20MG A203506 005 Apr 24, 2015
30MG A203506 006 Apr 24, 2015
40MG A203506 007 Apr 24, 2015
OXYPHENBUTAZONE
TABLET;ORAL
OXYPHENBUTAZONE
WATSON LABS 100MG A088399 001 Sep 17, 1984
TANDEARIL
NOVARTIS 100MG N012542 004 Sep 03, 1982
OXYPHENCYCLIMINE HYDROCHLORIDE
TABLET;ORAL
DARICON
PFIZER 10MG N011612 001
OXYPHENONIUM BROMIDE
TABLET;ORAL
ANTRENYL
NOVARTIS 5MG N008492 002
OXYTETRACYCLINE
TABLET;ORAL
TERRAMYCIN
PFIZER 250MG N050287 001
OXYTETRACYCLINE CALCIUM
SYRUP;ORAL
TERRAMYCIN
PFIZER EQ 125MG BASE/5ML A060595 001
OXYTETRACYCLINE HYDROCHLORIDE
CAPSULE;ORAL
OXY-KESSO-TETRA
FERRANTE EQ 250MG BASE A060179 001
OXYTETRACYCLINE HYDROCHLORIDE
HIKMA EQ 250MG BASE A060770 001
IMPAX LABS EQ 250MG BASE A060760 001
PROTER EQ 250MG BASE A060869 001
PUREPAC PHARM EQ 250MG BASE A060634 001
TERRAMYCIN
PFIZER EQ 125MG BASE N050286 001
EQ 250MG BASE N050286 002
INJECTABLE;INJECTION
TERRAMYCIN
PFIZER EQ 250MG BASE/VIAL A060586 001
EQ 500MG BASE/VIAL A060586 002
OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
TERRAMYCIN W/ POLYMYXIN B SULFATE
CASPER PHARMA LLC EQ 5MG BASE/GM;10,000 UNITS/GM N061015 001
OINTMENT;OTIC
TERRAMYCIN W/ POLYMYXIN
PFIZER EQ 5MG BASE/GM;10,000 UNITS/GM A061841 001
TABLET;VAGINAL
TERRAMYCIN-POLYMYXIN
PFIZER EQ 100MG BASE;100,000 UNITS A061009 001
OXYTOCIN
INJECTABLE;INJECTION
OXYTOCIN
DR REDDYS 10USP UNITS/ML (10USP UNITS/ML) A077453 001 Jan 24, 2008
100USP UNITS/10ML (10USP UNITS/ML) A077453 002 Jan 24, 2008
OXYTOCIN 10 USP UNITS IN DEXTROSE 5%
+ ABBOTT 1USP UNITS/100ML ** N019185 004 Mar 29, 1985

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-359(of 478)
** See List Footnote
OXYTOCIN
INJECTABLE;INJECTION
OXYTOCIN 10 USP UNITS IN DEXTROSE 5%
+ 2USP UNITS/100ML ** N019185 003 Mar 29, 1985
OXYTOCIN 20 USP UNITS IN DEXTROSE 5%
+ ABBOTT 2USP UNITS/100ML ** N019185 002 Mar 29, 1985
OXYTOCIN 5 USP UNITS IN DEXTROSE 5%
+ ABBOTT 1USP UNITS/100ML ** N019185 001 Mar 29, 1985
SYNTOCINON
NOVARTIS 10USP UNITS/ML N018245 001
SOLUTION;NASAL
SYNTOCINON
RTRX 40USP UNITS/ML N012285 001
PACLITAXEL
INJECTABLE;INJECTION
PACLITAXEL
ACCORD HLTHCARE 6MG/ML A075436 001 Nov 12, 2004
HOSPIRA 6MG/ML A076233 001 Aug 01, 2002
MYLAN 6MG/ML A075278 001 Jan 25, 2002
MYLAN LABS LTD 6MG/ML A091540 001 Sep 29, 2011
PLIVA LACHEMA 6MG/ML A077413 001 Mar 12, 2008
SANDOZ INC 6MG/ML A078167 001 Dec 26, 2007
TEVA PHARMS USA 6MG/ML A075297 001 Jan 25, 2002
TAXOL
+ HQ SPCLT PHARMA 6MG/ML ** N020262 001 Dec 29, 1992
PALIPERIDONE
TABLET, EXTENDED RELEASE;ORAL
INVEGA
+ JANSSEN PHARMS 12MG ** N021999 004 Dec 19, 2006
PALIPERIDONE PALMITATE
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
PALIPERIDONE PALMITATE
TEVA PHARMS USA 39MG/0.25ML (39MG/0.25ML) A211149 001 Jul 06, 2021
78MG/0.5ML (78MG/0.5ML) A211149 002 Jul 06, 2021
117MG/0.75ML (117MG/0.75ML) A211149 003 Jul 06, 2021
156MG/ML (156MG/ML) A211149 004 Jul 06, 2021
234MG/1.5ML (156MG/ML) A211149 005 Jul 06, 2021
PALONOSETRON HYDROCHLORIDE
CAPSULE;ORAL
ALOXI
+ HELSINN HLTHCARE EQ 0.5MG BASE ** N022233 001 Aug 22, 2008
INJECTABLE;INTRAVENOUS
ALOXI
+ HELSINN HLTHCARE EQ 0.075MG BASE/1.5ML (EQ 0.05MG N021372 002 Feb 29, 2008
BASE/ML) **
+ EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) N021372 001 Jul 25, 2003
**
PALONOSETRON HYDROCHLORIDE
ACCORD HLTHCARE EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) A204615 001 Mar 15, 2021
DR REDDYS EQ 0.075MG BASE/1.5ML (EQ 0.05MG A201533 001 Apr 21, 2016
BASE/ML)
HOSPIRA EQ 0.075MG BASE/1.5ML (EQ 0.05MG A207005 002 Sep 19, 2018
BASE/ML)
QILU PHARM HAINAN EQ 0.075MG BASE/1.5ML (EQ 0.05MG A205648 002 Sep 19, 2018
BASE/ML)
TEVA PHARMS USA EQ 0.075MG BASE/1.5ML (EQ 0.05MG A090713 002 Mar 23, 2018
BASE/ML)
SOLUTION;INTRAVENOUS
PALONOSETRON HYDROCHLORIDE
DR REDDYS EQ 0.075MG BASE/1.5ML (EQ 0.05MG N203050 001 Mar 01, 2016
BASE/ML)
EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) N203050 002 Mar 01, 2016
+ FRESENIUS KABI USA EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) N208109 001 Nov 21, 2017

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-360(of 478)
** See List Footnote
PAMIDRONATE DISODIUM
INJECTABLE;INJECTION
AREDIA
+ NOVARTIS 30MG/VIAL ** N020036 001 Oct 31, 1991
60MG/VIAL N020036 003 May 06, 1993
90MG/VIAL N020036 004 May 06, 1993
PAMIDRONATE DISODIUM
AESGEN 30MG/VIAL A075594 001 May 06, 2002
90MG/VIAL A075594 002 May 06, 2002
AM REGENT 30MG/10ML (3MG/ML) A078942 001 Jul 25, 2008
90MG/10ML (9MG/ML) A078942 002 Jul 25, 2008
FRESENIUS KABI USA 30MG/VIAL A075773 001 May 06, 2002
30MG/10ML (3MG/ML) A076207 001 May 17, 2002
90MG/VIAL A075773 002 May 06, 2002
90MG/10ML (9MG/ML) A076207 002 May 17, 2002
MN PHARMS 30MG/VIAL A078300 001 Mar 10, 2009
90MG/VIAL A078300 002 Mar 10, 2009
SUN PHARMA GLOBAL 30MG/VIAL A077703 001 Dec 24, 2008
90MG/VIAL A077703 002 Dec 24, 2008
TEVA PHARMS USA 30MG/10ML (3MG/ML) A076153 001 Mar 27, 2002
90MG/10ML (9MG/ML) A076153 002 Mar 27, 2002
PANCURONIUM BROMIDE
INJECTABLE;INJECTION
PANCURONIUM BROMIDE
ELKINS SINN 1MG/ML A072058 001 Mar 23, 1988
2MG/ML A072059 001 Mar 23, 1988
2MG/ML A072060 001 Mar 23, 1988
HOSPIRA 2MG/ML A072321 001 Jan 19, 1989
IGI LABS INC 1MG/ML A072210 001 Mar 31, 1988
2MG/ML A072211 001 Mar 31, 1988
2MG/ML A072212 001 Mar 31, 1988
2MG/ML A072213 001 Mar 31, 1988
PAVULON
+ ORGANON USA INC 1MG/ML ** N017015 002
+ 2MG/ML ** N017015 001
PANOBINOSTAT LACTATE
CAPSULE;ORAL
FARYDAK
+ SECURA EQ 10MG BASE N205353 001 Feb 23, 2015
+ EQ 15MG BASE N205353 002 Feb 23, 2015
+ EQ 20MG BASE N205353 003 Feb 23, 2015
PANTOPRAZOLE SODIUM
INJECTABLE;INTRAVENOUS
PANTOPRAZOLE SODIUM
KNACK EQ 40MG BASE/VIAL A214680 001 May 19, 2022
MYLAN LABS LTD EQ 40MG BASE/VIAL A208580 001 May 04, 2018
TABLET, DELAYED RELEASE;ORAL
PANTOPRAZOLE SODIUM
JUBILANT GENERICS EQ 20MG BASE A090901 001 Aug 30, 2011
EQ 40MG BASE A090901 002 Aug 30, 2011
L PERRIGO CO EQ 20MG BASE A203024 001 May 07, 2014
MACLEODS PHARMS LTD EQ 20MG BASE A200821 001 Feb 16, 2012
EQ 40MG BASE A200821 002 Feb 16, 2012
SUN PHARM EQ 20MG BASE A077058 001 Sep 10, 2007
EQ 40MG BASE A077058 002 Sep 10, 2007
SUN PHARM INDS LTD EQ 20MG BASE A200794 001 May 02, 2012
EQ 40MG BASE A200794 002 May 02, 2012
TEVA EQ 20MG BASE A077056 001 Aug 02, 2007
EQ 40MG BASE A077056 002 Aug 02, 2007
PARAMETHADIONE
CAPSULE;ORAL
PARADIONE
ABBVIE 150MG N006800 003
300MG N006800 001
SOLUTION;ORAL
PARADIONE
ABBVIE 300MG/ML N006800 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-361(of 478)
** See List Footnote
PARAMETHASONE ACETATE
TABLET;ORAL
HALDRONE
LILLY 1MG N012772 005
2MG N012772 006
PARGYLINE HYDROCHLORIDE
TABLET;ORAL
EUTONYL
ABBOTT 10MG N013448 002
25MG N013448 003
50MG N013448 004
PARICALCITOL
CAPSULE;ORAL
PARICALCITOL
LOTUS PHARM CO LTD 1MCG A206710 001 Feb 24, 2016
2MCG A206710 002 Feb 24, 2016
4MCG A206710 003 Feb 24, 2016
ZEMPLAR
+ ABBVIE 4MCG ** N021606 003 May 26, 2005
SOLUTION;INTRAVENOUS
PARICALCITOL
AKORN 0.01MG/2ML (0.005MG/ML) A207692 001 Oct 16, 2017
RISING 0.002MG/ML (0.002MG/ML) A203897 001 Nov 02, 2017
PAROMOMYCIN SULFATE
CAPSULE;ORAL
HUMATIN
KING PFIZER EQ 250MG BASE A062310 001
PARKEDALE EQ 250MG BASE A060521 001
SYRUP;ORAL
HUMATIN
PARKE DAVIS EQ 125MG BASE/5ML A060522 001
PAROXETINE HYDROCHLORIDE
CAPSULE;ORAL
PAXIL
+ APOTEX EQ 10MG BASE ** N020885 001 Oct 09, 1998
+ EQ 20MG BASE ** N020885 002 Oct 09, 1998
+ EQ 30MG BASE ** N020885 003 Oct 09, 1998
+ EQ 40MG BASE ** N020885 004 Oct 09, 1998
SUSPENSION;ORAL
PAROXETINE HYDROCHLORIDE
APOTEX INC EQ 10MG BASE/5ML A077395 001 Dec 05, 2006
TABLET;ORAL
PAROXETINE HYDROCHLORIDE
JUBILANT GENERICS EQ 10MG BASE A205528 001 Nov 27, 2015
EQ 20MG BASE A205528 002 Nov 27, 2015
EQ 30MG BASE A205528 003 Nov 27, 2015
EQ 40MG BASE A205528 004 Nov 27, 2015
MYLAN PHARMS INC EQ 10MG BASE A075716 001 Mar 08, 2004
EQ 20MG BASE A075716 002 Mar 08, 2004
EQ 30MG BASE A075716 003 Mar 08, 2004
EQ 40MG BASE A075716 004 Mar 08, 2004
ROXANE EQ 10MG BASE A078026 001 Jun 29, 2007
EQ 20MG BASE A078026 002 Jun 29, 2007
EQ 30MG BASE A078026 003 Jun 29, 2007
EQ 40MG BASE A078026 004 Jun 29, 2007
SUN PHARM INDS INC EQ 10MG BASE A078194 001 Jun 29, 2007
EQ 20MG BASE A078194 002 Jun 29, 2007
EQ 30MG BASE A078194 003 Jun 29, 2007
EQ 40MG BASE A078194 004 Jun 29, 2007
TEVA PHARMS EQ 10MG BASE A077082 001 Jun 29, 2007
EQ 20MG BASE A077082 002 Jun 29, 2007
EQ 30MG BASE A077082 003 Jun 29, 2007
EQ 40MG BASE A077082 004 Jun 29, 2007
UPSHER SMITH LABS EQ 10MG BASE A075566 001 Mar 08, 2004
EQ 20MG BASE A075566 002 Mar 08, 2004
EQ 30MG BASE A075566 003 Mar 08, 2004
EQ 40MG BASE A075566 004 Mar 08, 2004

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-362(of 478)
** See List Footnote
PAROXETINE HYDROCHLORIDE
TABLET;ORAL
PAXIL
APOTEX EQ 50MG BASE N020031 004 Dec 29, 1992
TABLET, EXTENDED RELEASE;ORAL
PAROXETINE HYDROCHLORIDE
SINOTHERAPEUTICS INC EQ 12.5MG BASE A213612 001 Aug 11, 2021
EQ 25MG BASE A213612 002 Aug 11, 2021
EQ 37.5MG BASE A213612 003 May 26, 2022
PAROXETINE MESYLATE
TABLET;ORAL
PEXEVA
+ SEBELA IRELAND LTD EQ 40MG BASE N021299 004 Jul 03, 2003
PAZOPANIB HYDROCHLORIDE
TABLET;ORAL
VOTRIENT
+ NOVARTIS EQ 400MG BASE ** N022465 002 Oct 19, 2009
PEGAPTANIB SODIUM
INJECTABLE;INTRAVITREAL
MACUGEN
+ BAUSCH AND LOMB INC EQ 0.3MG ACID/0.09ML N021756 001 Dec 17, 2004
PEGINESATIDE ACETATE
SOLUTION;INTRAVENOUS, SUBCUTANEOUS
OMONTYS
TAKEDA PHARMS USA EQ 10MG BASE/ML (EQ 10MG BASE/ML) N202799 007 Mar 27, 2012
EQ 20MG BASE/2ML (EQ 10MG BASE/ML) N202799 008 Mar 27, 2012
OMONTYS PRESERVATIVE FREE
TAKEDA PHARMS USA EQ 1MG BASE/0.5ML (EQ 1MG BASE/0.5ML) N202799 001 Mar 27, 2012
EQ 2MG BASE/0.5ML (EQ 2MG BASE/0.5ML) N202799 002 Mar 27, 2012
EQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML) N202799 003 Mar 27, 2012
EQ 4MG BASE/0.5ML (EQ 4MG BASE/0.5ML) N202799 004 Mar 27, 2012
EQ 5MG BASE/0.5ML (EQ 5MG BASE/0.5ML) N202799 005 Mar 27, 2012
EQ 6MG BASE/0.5ML (EQ 6MG BASE/0.5ML) N202799 006 Mar 27, 2012
PEMETREXED DISODIUM
POWDER;INTRAVENOUS
PEMETREXED DISODIUM
BIOCON PHARMA EQ 1GM BASE/VIAL A211090 001 May 25, 2022
HOSPIRA EQ 100MG BASE/VIAL A202111 001 May 25, 2022
EQ 500MG BASE/VIAL A202111 002 May 25, 2022
EQ 1GM BASE/VIAL A202111 003 May 25, 2022
PEMETREXED DITROMETHAMINE
POWDER;INTRAVENOUS
PEMETREXED DITROMETHAMINE
+ HOSPIRA EQ 1GM BASE/VIAL N208746 003 Jun 10, 2022
PEMIROLAST POTASSIUM
SOLUTION/DROPS;OPHTHALMIC
ALAMAST
SANTEN 0.1% N021079 001 Sep 24, 1999
PEMOLINE
TABLET;ORAL
CYLERT
ABBOTT 18.75MG N016832 001
37.5MG N016832 002
75MG N016832 003
PEMOLINE
ACTAVIS ELIZABETH 18.75MG A075595 001 Feb 28, 2000
37.5MG A075595 002 Feb 28, 2000
75MG A075595 003 Feb 28, 2000
FOSUN PHARMA 18.75MG A075286 001 Dec 27, 1999
37.5MG A075286 002 Jun 30, 1999
75MG A075286 003 Jun 30, 1999
MALLINCKRODT 18.75MG A075726 003 Mar 30, 2001
37.5MG A075726 002 Mar 30, 2001
75MG A075726 001 Mar 30, 2001
TEVA PHARMS 18.75MG A075030 003 Feb 22, 2000

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-363(of 478)
** See List Footnote
PEMOLINE
TABLET;ORAL
PEMOLINE
37.5MG A075030 001 Jan 29, 1999
75MG A075030 002 Jan 29, 1999
VINTAGE PHARMS 18.75MG A075328 001 Apr 19, 2000
37.5MG A075328 002 Apr 19, 2000
75MG A075328 003 Apr 19, 2000
WATSON LABS 18.75MG A075287 001 Jun 13, 2001
37.5MG A075287 002 Sep 18, 2000
75MG A075287 003 Sep 18, 2000
TABLET, CHEWABLE;ORAL
CYLERT
ABBOTT 37.5MG N017703 001
PEMOLINE
ACTAVIS ELIZABETH 37.5MG A075678 001 Jul 26, 2000
TEVA PHARMS 37.5MG A075555 001 Feb 18, 2000
PENBUTOLOL SULFATE
TABLET;ORAL
LEVATOL
+ AUXILIUM PHARMS LLC 10MG ** N018976 001 Dec 30, 1987
+ 20MG ** N018976 004 Jan 05, 1989
PENICILLAMINE
CAPSULE;ORAL
CUPRIMINE
VALEANT PHARMS INTL 125MG N019853 002
TABLET;ORAL
PENICILLAMINE
TEVA PHARMS USA 250MG A211497 001 Feb 13, 2020
PENICILLIN G BENZATHINE
INJECTABLE;INJECTION
BICILLIN L-A
+ KING PHARMS LLC 300,000 UNITS/ML N050141 003
WYETH AYERST 300,000 UNITS/ML N050131 001
PERMAPEN
CASPER PHARMA LLC 600,000 UNITS/ML N060014 001
SUSPENSION;ORAL
BICILLIN
WYETH AYERST 300,000 UNITS/5ML N050126 002
TABLET;ORAL
BICILLIN
WYETH AYERST 200,000 UNITS N050128 001
PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE
INJECTABLE;INJECTION
BICILLIN C-R
+ KING PHARMS LLC 150,000 UNITS/ML;150,000 UNITS/ML N050138 002
PENICILLIN G POTASSIUM
FOR SOLUTION;ORAL
PENICILLIN
TEVA 200,000 UNITS/5ML A060307 002
400,000 UNITS/5ML A060307 004
PENICILLIN G POTASSIUM
MYLAN 200,000 UNITS/5ML A060752 003
250,000 UNITS/5ML A060752 002
400,000 UNITS/5ML A060752 001
PUREPAC PHARM 250,000 UNITS/5ML A061740 001
400,000 UNITS/5ML A061740 002
PENICILLIN-2
TEVA 250,000 UNITS/5ML A060307 003
PENTIDS '200'
APOTHECON 200,000 UNITS/5ML A062149 001
PENTIDS '400'
APOTHECON 400,000 UNITS/5ML A062149 002
PFIZERPEN G
PFIZER 400,000 UNITS/5ML A060587 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-364(of 478)
** See List Footnote
PENICILLIN G POTASSIUM
INJECTABLE;INJECTION
PENICILLIN G POTASSIUM
APOTHECON 1,000,000 UNITS/VIAL A060362 001
5,000,000 UNITS/VIAL A060362 003
10,000,000 UNITS/VIAL A060362 004
20,000,000 UNITS/VIAL A060362 002
CONSOLIDATED PHARM 500,000 UNITS/VIAL A060806 001
1,000,000 UNITS/VIAL A060806 002
5,000,000 UNITS/VIAL A060806 003
10,000,000 UNITS/VIAL A060806 004
LILLY 200,000 UNITS/VIAL A060384 004
500,000 UNITS/VIAL A060384 003
1,000,000 UNITS/VIAL A060384 002
5,000,000 UNITS/VIAL A060384 001
20,000,000 UNITS/VIAL A060384 005
20,000,000 UNITS/VIAL A060601 001
PARKE DAVIS 1,000,000 UNITS/VIAL A062003 001
5,000,000 UNITS/VIAL A062003 002
PFIZER 20,000,000 UNITS/VIAL A060074 003
SANDOZ 1,000,000 UNITS/VIAL ** A065079 001 Aug 30, 2002
WATSON LABS INC 1,000,000 UNITS/VIAL A062991 001 Sep 13, 1988
5,000,000 UNITS/VIAL A062991 002 Sep 13, 1988
10,000,000 UNITS/VIAL A062991 003 Sep 13, 1988
20,000,000 UNITS/VIAL A062991 004 Sep 13, 1988
PFIZERPEN
PFIZER 1,000,000 UNITS/VIAL ** A060657 001
TABLET;ORAL
PENICILLIN G POTASSIUM
APOTHECON 250,000 UNITS A060392 003
IVAX SUB TEVA PHARMS 400,000 UNITS A060073 004
LILLY 250,000 UNITS A060403 001
MYLAN 200,000 UNITS A060781 001
250,000 UNITS A060781 002
400,000 UNITS A060781 003
500,000 UNITS A060781 005
800,000 UNITS A060781 004
PUREPAC PHARM 200,000 UNITS A061588 001
250,000 UNITS A061588 002
400,000 UNITS A061588 003
TEVA 200,000 UNITS A060306 001
250,000 UNITS A060306 002
400,000 UNITS A060306 003
500,000 UNITS A060306 004
WYETH AYERST 200,000 UNITS A060413 001
250,000 UNITS A060413 002
400,000 UNITS A060413 003
PENTIDS '200'
APOTHECON 200,000 UNITS A062155 001
PENTIDS '250'
APOTHECON 250,000 UNITS A062155 002
PENTIDS '400'
APOTHECON 400,000 UNITS A060392 004
400,000 UNITS A062155 003
PENTIDS '800'
APOTHECON 800,000 UNITS A060392 005
800,000 UNITS A062155 004
PFIZERPEN G
PFIZER 50,000 UNITS A060075 001
100,000 UNITS A060075 002
200,000 UNITS A060075 003
250,000 UNITS A060075 004
400,000 UNITS A060075 005
800,000 UNITS A060075 006

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-365(of 478)
** See List Footnote
PENICILLIN G PROCAINE
INJECTABLE;INJECTION
DURACILLIN A.S.
LILLY 300,000 UNITS/ML A060093 001
PENICILLIN G PROCAINE
CONSOLIDATED PHARM 300,000 UNITS/ML A060800 001
600,000 UNITS/1.2ML A060800 002
PARKE DAVIS 300,000 UNITS/ML A062029 001
PFIZER 300,000 UNITS/VIAL A060099 001
1,500,000 UNITS/VIAL A060099 002
PFIZERPEN-AS
PFIZER 300,000 UNITS/ML A060286 001
600,000 UNITS/ML A060286 002
PENICILLIN G SODIUM
INJECTABLE;INJECTION
PENICILLIN G SODIUM
BRISTOL MYERS SQUIBB 5,000,000 UNITS/VIAL A061935 001
COPANOS 5,000,000 UNITS/VIAL A061051 001
PHARMACIA AND UPJOHN 1,000,000 UNITS/VIAL A061046 001
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS
PENICILLIN G SODIUM
WATSON LABS INC 5,000,000 UNITS/VIAL A063014 001 Sep 13, 1988
PENICILLIN V
FOR SUSPENSION;ORAL
V-CILLIN
LILLY 125MG/0.6ML A060002 001
PENICILLIN V POTASSIUM
FOR SOLUTION;ORAL
BEEPEN-VK
GLAXOSMITHKLINE EQ 125MG BASE/5ML A062270 001
EQ 250MG BASE/5ML A062270 002
BETAPEN-VK
APOTHECON EQ 125MG BASE/5ML A061149 001
EQ 250MG BASE/5ML A061149 002
LEDERCILLIN VK
LEDERLE EQ 125MG BASE/5ML A060136 001
EQ 250MG BASE/5ML A060136 002
PEN-VEE K
WYETH AYERST EQ 125MG BASE/5ML A060007 001
EQ 250MG BASE/5ML A060007 002
PENAPAR-VK
PARKE DAVIS EQ 125MG BASE/5ML A062002 001
EQ 250MG BASE/5ML A062002 002
PENICILLIN V POTASSIUM
BELCHER PHARMS EQ 125MG BASE/5ML A061529 001
EQ 250MG BASE/5ML A061529 002
MYLAN EQ 125MG BASE/5ML A061624 002
EQ 250MG BASE/5ML A061624 001
PUREPAC PHARM EQ 125MG BASE/5ML A061758 001
EQ 250MG BASE/5ML A061758 002
STRIDES PHARMA EQ 125MG BASE/5ML A062981 001 Feb 10, 1989
EQ 250MG BASE/5ML A062981 002 Feb 10, 1989
PFIZERPEN VK
PFIZER EQ 125MG BASE/5ML A061815 001
EQ 250MG BASE/5ML A061815 002
V-CILLIN K
LILLY EQ 125MG BASE/5ML A060004 001
EQ 250MG BASE/5ML A060004 002
VEETIDS
APOTHECON EQ 125MG BASE/5ML A061410 001
EQ 250MG BASE/5ML A061410 002
VEETIDS '125'
APOTHECON EQ 125MG BASE/5ML A061206 001
EQ 125MG BASE/5ML A062153 001
VEETIDS '250'
APOTHECON EQ 250MG BASE/5ML A061206 002
EQ 250MG BASE/5ML A062153 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-366(of 478)
** See List Footnote
PENICILLIN V POTASSIUM
TABLET;ORAL
BEEPEN-VK
GLAXOSMITHKLINE EQ 250MG BASE A062273 001
EQ 500MG BASE A062273 002
BETAPEN-VK
BRISTOL EQ 250MG BASE A061150 001
EQ 500MG BASE A061150 002
LEDERCILLIN VK
LEDERLE EQ 250MG BASE A060134 001
EQ 500MG BASE A060134 002
PEN-VEE K
WYETH AYERST EQ 125MG BASE A060006 001
EQ 250MG BASE A060006 002
EQ 500MG BASE A060006 003
PENAPAR-VK
PARKE DAVIS EQ 250MG BASE A062001 001
EQ 500MG BASE A062001 002
PENICILLIN V POTASSIUM
BELCHER PHARMS EQ 250MG BASE A061528 001
EQ 500MG BASE A061528 002
IVAX SUB TEVA PHARMS EQ 125MG BASE A060518 001
EQ 250MG BASE A060518 002
EQ 500MG BASE A060518 003
MYLAN EQ 250MG BASE A061530 001
EQ 500MG BASE A061530 002
PUREPAC PHARM EQ 125MG BASE A061571 001
EQ 250MG BASE A061571 002
EQ 500MG BASE A061571 003
PFIZERPEN VK
PFIZER EQ 250MG BASE A061836 001
EQ 500MG BASE A061836 002
UTICILLIN VK
PHARMACIA AND UPJOHN EQ 250MG BASE A061651 001
EQ 500MG BASE A061651 002
V-CILLIN K
LILLY EQ 125MG BASE ** A060003 001
EQ 250MG BASE ** A060003 002
EQ 500MG BASE ** A060003 003
VEETIDS
APOTHECON EQ 250MG BASE A061411 001
EQ 500MG BASE A061411 002
VEETIDS '250'
APOTHECON EQ 250MG BASE A061164 001
EQ 250MG BASE A062156 002
VEETIDS '500'
APOTHECON EQ 500MG BASE A061164 002
EQ 500MG BASE A062156 001
PENTAGASTRIN
INJECTABLE;INJECTION
PEPTAVLON
+ WYETH AYERST 0.25MG/ML ** N017048 001
PENTAMIDINE ISETHIONATE
FOR SOLUTION;INHALATION
NEBUPENT
FRESENIUS KABI USA 600MG/VIAL N019887 002 Mar 22, 1996
INJECTABLE;INJECTION
PENTACARINAT
ARMOUR PHARM 300MG/VIAL A073447 001 Apr 28, 1994
PENTAMIDINE ISETHIONATE
BAXTER HLTHCARE 300MG/VIAL A073617 001 Dec 18, 1995
HOSPIRA 300MG/VIAL A073479 001 Jun 30, 1992
WATSON LABS 300MG/VIAL A074303 001 Aug 17, 1995

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-367(of 478)
** See List Footnote
PENTAZOCINE HYDROCHLORIDE
TABLET;ORAL
TALWIN 50
SANOFI AVENTIS US EQ 50MG BASE N016732 001
PENTAZOCINE LACTATE
INJECTABLE;INJECTION
TALWIN
+ HOSPIRA EQ 30MG BASE/ML N016194 001
PENTETATE CALCIUM TRISODIUM
SOLUTION;INHALATION, INTRAVENOUS
PENTETATE CALCIUM TRISODIUM
+ HAMELN EQ 1GM BASE/5ML (EQ 200MG BASE/ML) ** N021749 001 Aug 11, 2004
PENTETATE CALCIUM TRISODIUM YB-169
INJECTABLE;INJECTION
YTTERBIUM YB 169 DTPA
3M 2mCi/ML N017518 001
PENTETATE ZINC TRISODIUM
SOLUTION;INHALATION, INTRAVENOUS
PENTETATE ZINC TRISODIUM
+ HAMELN PHARMA PLUS EQ 1GM BASE/5ML (EQ 200MG BASE/ML) ** N021751 001 Aug 11, 2004
PENTOBARBITAL
ELIXIR;ORAL
NEMBUTAL
AKORN 18.2MG/5ML A083244 001
PENTOBARBITAL SODIUM
CAPSULE;ORAL
NEMBUTAL SODIUM
AKORN 30MG A084095 001
50MG A084093 001
100MG A083245 001
PENTOBARBITAL SODIUM
LANNETT 50MG A085937 001
100MG A085915 001
VITARINE 100MG A083284 001
WHITEWORTH TOWN PLSN 100MG A083338 001
SODIUM PENTOBARBITAL
ANABOLIC 100MG A084590 001
ELKINS SINN 100MG A083368 001
EVERYLIFE 100MG A083259 001
HALSEY 100MG A084677 001
IVAX SUB TEVA PHARMS 50MG A083461 001
100MG A083461 002
PARKE DAVIS 100MG A084156 001
PERRIGO 100MG A084560 001
PUREPAC PHARM 100MG A083301 001
VALEANT PHARM INTL 100MG A083264 001
WATSON LABS 100MG A085791 001
WYETH AYERST 100MG A083239 001
INJECTABLE;INJECTION
PENTOBARBITAL SODIUM
ELKINS SINN 50MG/ML A083270 001
SODIUM PENTOBARBITAL
WYETH AYERST 50MG/ML A083261 001
SUPPOSITORY;RECTAL
NEMBUTAL
AKORN 30MG A083247 001 Jan 25, 1982
60MG A083247 002 Jan 25, 1982
120MG A083247 003 Jan 25, 1982
200MG A083247 004 Jan 25, 1982
TABLET;ORAL
PENTOBARBITAL SODIUM
VITARINE 100MG A083285 001
SODIUM PENTOBARBITAL
NEXGEN PHARMA INC 100MG A084238 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-368(of 478)
** See List Footnote
PENTOLINIUM TARTRATE
INJECTABLE;INJECTION
ANSOLYSEN
WYETH AYERST 10MG/ML N009372 001
PENTOSTATIN
INJECTABLE;INJECTION
PENTOSTATIN
RISING 10MG/VIAL A203554 001 Sep 19, 2014
PENTOXIFYLLINE
TABLET, EXTENDED RELEASE;ORAL
PENTOXIFYLLINE
ANI PHARMS 400MG A074878 001 Jul 09, 1997
400MG A075107 001 Sep 04, 1998
400MG A075199 001 Sep 03, 1999
HERITAGE PHARMS 400MG A074877 001 Jul 08, 1997
IMPAX LABS 400MG A075093 001 Aug 10, 1999
PLIVA 400MG A074874 001 May 25, 1999
RISING 400MG A074425 001 Jul 08, 1997
PENTOXIL
UPSHER SMITH LABS 400MG A074962 001 Mar 31, 1999
TRENTAL
+ VALIDUS PHARMS 400MG ** N018631 001 Aug 30, 1984
PERFLUBRON
LIQUID;ORAL
IMAGENT
ALLIANCE PHARM 100% N020091 001 Aug 13, 1993
PERFLUOROPOLYMETHYLISOPROPYL ETHER; POLYTETRAFLUOROETHYLENE
PASTE;TOPICAL
SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS
US ARMY 50%;50% N021084 001 Feb 17, 2000
PERGOLIDE MESYLATE
TABLET;ORAL
PERGOLIDE MESYLATE
IVAX SUB TEVA PHARMS EQ 0.05MG BASE A076094 001 Sep 04, 2003
EQ 0.25MG BASE A076094 002 Sep 04, 2003
EQ 1MG BASE A076094 003 Sep 04, 2003
STRIDES PHARMA EQ 0.05MG BASE A076061 001 Nov 27, 2002
EQ 0.25MG BASE A076061 002 Nov 27, 2002
EQ 1MG BASE A076061 003 Nov 27, 2002
PERMAX
VALEANT PHARM INTL EQ 0.05MG BASE N019385 001 Dec 30, 1988
EQ 0.25MG BASE N019385 002 Dec 30, 1988
EQ 1MG BASE N019385 003 Dec 30, 1988
PERINDOPRIL ERBUMINE
TABLET;ORAL
ACEON
+ SYMPLMED PHARMS LLC 2MG N020184 001 Dec 30, 1993
+ 4MG N020184 002 Dec 30, 1993
+ 8MG N020184 003 Dec 30, 1993
PERINDOPRIL ERBUMINE
ANI PHARMS 2MG A078138 001 Nov 10, 2009
4MG A078138 002 Nov 10, 2009
8MG A078138 003 Nov 10, 2009
APOTEX 2MG A090463 001 Aug 30, 2010
4MG A090463 002 Aug 30, 2010
8MG A090463 003 Aug 30, 2010
HIKMA 2MG A090072 001 Nov 10, 2009
4MG A090072 002 Nov 10, 2009
8MG A090072 003 Nov 10, 2009
LUPIN LTD 2MG A078263 001 Jan 27, 2010
4MG A078263 002 Jan 27, 2010
8MG A078263 003 Jan 27, 2010

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-369(of 478)
** See List Footnote
PERMETHRIN
CREAM;TOPICAL
ELIMITE
+ AUROBINDO PHARMA USA 5% N019855 001 Aug 25, 1989
LOTION;TOPICAL
NIX
GLAXOSMITHKLINE 1% ** N019435 001 Mar 31, 1986
PERPHENAZINE
CONCENTRATE;ORAL
PERPHENAZINE
PHARM ASSOC 16MG/5ML A040360 001 May 25, 2001
TRILAFON
SCHERING 16MG/5ML N011557 001
INJECTABLE;INJECTION
TRILAFON
SCHERING 5MG/ML N011213 002
SYRUP;ORAL
TRILAFON
SCHERING 2MG/5ML N011294 002
TABLET;ORAL
PERPHENAZINE
ANI PHARMS 2MG A089707 001 Sep 10, 1987
4MG A089708 001 Sep 10, 1987
8MG A089456 001 Sep 10, 1987
16MG A089457 001 Sep 10, 1987
MYLAN 2MG A206691 001 Apr 14, 2017
4MG A206691 002 Apr 14, 2017
8MG A206691 003 Apr 14, 2017
16MG A206691 004 Apr 14, 2017
TRILAFON
+ SCHERING 2MG ** N010775 001
+ 4MG ** N010775 002
+ 8MG ** N010775 003
+ 16MG ** N010775 004
TABLET, EXTENDED RELEASE;ORAL
TRILAFON
SCHERING 8MG N011361 002
PHENACEMIDE
TABLET;ORAL
PHENURONE
+ ABBVIE 500MG ** N007707 001
PHENAZOPYRIDINE HYDROCHLORIDE; SULFAMETHOXAZOLE
TABLET;ORAL
AZO GANTANOL
+ ROCHE 100MG;500MG ** N013294 001 Sep 10, 1987
PHENAZOPYRIDINE HYDROCHLORIDE; SULFAMETHOXAZOLE; TRIMETHOPRIM
TABLET;ORAL
SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE
ABLE 200MG,N/A,N/A;N/A,800MG,160MG N021105 001 Jun 26, 2001
PHENAZOPYRIDINE HYDROCHLORIDE; SULFISOXAZOLE
TABLET;ORAL
AZO GANTRISIN
+ ROCHE 50MG;500MG ** N019358 001 Aug 31, 1990
PHENDIMETRAZINE TARTRATE
CAPSULE;ORAL
PHENAZINE
MAST MM 35MG A086523 001
35MG A086524 001
35MG A086525 001
PHENDIMETRAZINE TARTRATE
SANDOZ 35MG A085633 001
35MG A085694 001
35MG A085702 001
VIRTUS PHARMS 35MG A085695 001
VITARINE 35MG A085634 001
35MG A085645 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-370(of 478)
** See List Footnote
PHENDIMETRAZINE TARTRATE
CAPSULE;ORAL
PHENDIMETRAZINE TARTRATE
35MG A085670 001
35MG A086403 001
35MG A086408 001
35MG A086410 001
35MG A087424 001
SPRX-3
SOLVAY 35MG A085897 001
STATOBEX
TEVA 35MG A085507 001
X-TROZINE
SHIRE RICHWOOD 35MG A087394 001 Sep 22, 1982
CAPSULE, EXTENDED RELEASE;ORAL
BONTRIL
VALEANT 105MG A088021 001 Sep 21, 1982
MELFIAT-105
NUMARK 105MG A087487 001 Oct 13, 1982
PHENDIMETRAZINE TARTRATE
GRAHAM DM 105MG A087214 001 May 26, 1982
105MG A088020 001 Aug 16, 1982
105MG A088028 001 Aug 16, 1982
105MG A088062 001 Sep 13, 1982
105MG A088063 001 Sep 10, 1982
105MG A088111 001 Oct 18, 1982
VIRTUS PHARMS 105MG A087378 001
SPRX-105
NUMARK 105MG A088024 001 Dec 22, 1982
X-TROZINE L.A.
SHIRE RICHWOOD 105MG A087371 001 Aug 24, 1982
TABLET;ORAL
ADPHEN
FERNDALE LABS 35MG A083655 001
ALPHAZINE
SANDOZ 35MG A085034 001
CAM-METRAZINE
ABC HOLDING 35MG A085511 001
CAMALL 35MG A085756 001
CHARTWELL RX 35MG A083922 001
35MG A085318 001
35MG A085320 001
35MG A085321 001
DI-METREX
PVT FORM 35MG A085698 001
MELFIAT
NUMARK 35MG A083790 002
METRA
FOREST PHARMS 35MG A083754 001
PHENAZINE
MAST MM 35MG A087305 001
PHENAZINE-35
ABC HOLDING 35MG A085512 001
PHENDIMETRAZINE TARTRATE
BARR 35MG A083644 001
35MG A083684 001
35MG A083686 001
35MG A083687 001
35MG A084831 001
35MG A084834 001
35MG A084835 001
CHARTWELL RX 35MG A085761 001
35MG A085941 001 Jun 27, 1983
FERNDALE LABS 35MG A086834 001 Sep 15, 1983
INWOOD LABS 35MG A084740 001
35MG A084741 001
35MG A084742 001
35MG A084743 001
IVAX PHARMS 35MG A085611 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-371(of 478)
** See List Footnote
PHENDIMETRAZINE TARTRATE
TABLET;ORAL
PHENDIMETRAZINE TARTRATE
35MG A085612 001
IVAX SUB TEVA PHARMS 35MG A083682 001
KV PHARM 35MG A084138 001
35MG A084141 001
35MG A085525 001
MFG CHEMISTS 35MG A085914 001
NEXGEN PHARMA INC 35MG A086020 001
NOSTRUM LABS INC 35MG A203600 001 Dec 27, 2017
NUMARK 35MG A083790 001
PVT FORM 35MG A085199 001
35MG A085697 001
SANDOZ 35MG A085402 001
35MG A085830 001
35MG A086370 001
SOLVAY 35MG A083993 001
UPSHER SMITH LABS 35MG A084399 001
USL PHARMA 35MG A083805 001
35MG A084398 001
VIRTUS PHARMS 35MG A085497 001
35MG A086365 001
VITARINE 35MG A085519 001
35MG A086005 001
35MG A086106 001
WATSON LABS 35MG A085767 001
35MG A085768 001
35MG A085770 001
35MG A085773 001
PLEGINE
WYETH AYERST 35MG ** N012248 001
STATOBEX
TEVA 35MG A086013 001
STATOBEX-G
TEVA 35MG A085095 001
X-TROZINE
SHIRE RICHWOOD 35MG A086550 001
35MG A086551 001
35MG A086552 001
35MG A086553 001
35MG A086554 001
PHENINDIONE
TABLET;ORAL
HEDULIN
SANOFI AVENTIS US 50MG N008767 002
PHENMETRAZINE HYDROCHLORIDE
TABLET;ORAL
PRELUDIN
BOEHRINGER INGELHEIM 25MG N010460 005
TABLET, EXTENDED RELEASE;ORAL
PRELUDIN
BOEHRINGER INGELHEIM 50MG N011752 004
75MG N011752 003
PHENPROCOUMON
TABLET;ORAL
LIQUAMAR
ORGANON USA INC 3MG N011228 001
PHENSUXIMIDE
CAPSULE;ORAL
MILONTIN
PARKE DAVIS 500MG N008855 004

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-372(of 478)
** See List Footnote
PHENTERMINE HYDROCHLORIDE
CAPSULE;ORAL
FASTIN
GLAXOSMITHKLINE 30MG ** N017352 001
OBESTIN-30
FERNDALE LABS 30MG A087144 001
OBY-TRIM
SHIRE RICHWOOD 30MG A087764 001 Mar 18, 1982
ONA-MAST
MAST MM 30MG A086511 001
30MG A086516 001
PHENTERMINE HYDROCHLORIDE
ABC HOLDING 30MG A085411 001
ABLE 15MG A040497 001 Mar 13, 2003
30MG A040403 001 Aug 30, 2001
30MG A040427 001 Aug 30, 2001
BARR 15MG A090591 001 Mar 18, 2010
30MG A090591 002 Mar 18, 2010
CAMALL 15MG A086735 001
30MG A087226 001
CHARTWELL RX 18.75MG A088576 001 May 23, 1984
30MG A085417 001
30MG A086732 002
30MG A087215 001
37.5MG A087915 001 Dec 22, 1983
37.5MG A087918 001 Dec 22, 1983
37.5MG A087930 001 Oct 14, 1983
37.5MG A088610 001 Jun 04, 1984
37.5MG A088611 001 Jun 04, 1984
37.5MG A088625 001 Aug 23, 1984
DURAMED PHARMS BARR 30MG A088948 001 Apr 25, 1986
ELITE LABS INC 15MG A040460 001 Jan 14, 2003
30MG A040227 001 Jun 18, 1997
30MG A040448 001 Jan 22, 2003
IVAX PHARMS 30MG A086329 001
LANNETT CO INC 30MG A091359 001 Jul 16, 2010
37.5MG A201961 001 Jul 20, 2011
SANDOZ 30MG A087208 001
30MG A087223 001
37.5MG A088414 001 Oct 19, 1983
SUN PHARM INDUSTRIES 37.5MG A040527 001 Oct 23, 2003
TEVA 30MG A086911 001
30MG A087126 001
30MG A087777 001 Nov 01, 1985
30MG A088612 001 Apr 04, 1984
30MG A088613 001 Apr 09, 1984
30MG A088614 001 Apr 09, 1984
TG UNITED INC 30MG A040083 001 Mar 07, 1997
UPSHER SMITH LABS 30MG A084487 001 Apr 09, 1982
30MG A088430 001 Mar 27, 1984
USL PHARMA 30MG A088797 001 Dec 10, 1984
VITARINE 30MG A087202 001
30MG A087235 001
WATSON LABS 30MG A086740 001 Mar 21, 1985
TABLET;ORAL
ONA-MAST
MAST MM 8MG A086260 001
PHENTERMINE HYDROCHLORIDE
ABLE 37.5MG A040402 001 Aug 30, 2001
ACTAVIS ELIZABETH 37.5MG A040276 001 Nov 25, 1998
BARR 37.5MG A090470 001 Aug 31, 2009
CHARTWELL RX 8MG A083923 001
8MG A085319 001
37.5MG A087805 001 Dec 06, 1982
37.5MG A088596 001 Apr 04, 1984
IVAX PHARMS 8MG A085553 001
LANNETT 37.5MG A040555 001 Apr 15, 2005
NOVAST LABS 37.5MG A091451 001 Sep 21, 2012
SANDOZ 8MG A085671 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-373(of 478)
** See List Footnote
PHENTERMINE HYDROCHLORIDE
TABLET;ORAL
PHENTERMINE HYDROCHLORIDE
8MG A085689 001
SANDOZ INC 30MG A088605 001 Sep 28, 1987
SUN PHARM INDS INC 37.5MG A040790 001 Aug 21, 2007
+ USL PHARMA 8MG A083804 001
37.5MG A088910 001 Jul 17, 1985
37.5MG A088917 001 Jul 17, 1985
VITARINE 8MG A086453 001
8MG A086456 001
WATSON LABS 8MG A085739 001
TORA
SOLVAY 8MG A084035 001
WILPO
+ SANDOZ 8MG ** N012737 001
TABLET, ORALLY DISINTEGRATING;ORAL
SUPRENZA
CITIUS PHARMS 15MG ** N202088 001 Jun 13, 2011
30MG ** N202088 002 Jun 13, 2011
37.5MG ** N202088 003 Mar 27, 2012
PHENTERMINE RESIN COMPLEX
CAPSULE, EXTENDED RELEASE;ORAL
IONAMIN
UCB INC EQ 15MG BASE ** N011613 004
EQ 30MG BASE ** N011613 002
PHENTERMINE RESIN 30
QUANTUM PHARMICS EQ 30MG BASE A089120 001 Feb 04, 1988
PHENTERMINE RESIN COMPLEX
LANNETT CO INC EQ 15MG BASE A040872 001 Jul 28, 2011
EQ 30MG BASE A040872 002 Jul 28, 2011
PHENTOLAMINE MESYLATE
INJECTABLE;INJECTION
REGITINE
+ NOVARTIS 5MG/VIAL ** N008278 003
PHENYL AMINOSALICYLATE
POWDER;ORAL
PHENY-PAS-TEBAMIN
PHARM RES ASSOC 50% N011695 002
TABLET;ORAL
PHENY-PAS-TEBAMIN
PHARM RES ASSOC 500MG N011695 003
PHENYLBUTAZONE
CAPSULE;ORAL
AZOLID
SANOFI AVENTIS US 100MG A087260 001
BUTAZOLIDIN
NOVARTIS 100MG N008319 009
PHENYLBUTAZONE
FOSUN PHARMA 100MG A087774 001 Jun 16, 1982
IVAX PHARMS 100MG A088218 001 Jun 24, 1983
SUN PHARM INDUSTRIES 100MG A088994 001 Dec 04, 1985
WATSON LABS 100MG A087756 001 Dec 17, 1982
TABLET;ORAL
AZOLID
SANOFI AVENTIS US 100MG A087091 001
BUTAZOLIDIN
NOVARTIS 100MG N008319 008
PHENYLBUTAZONE
FOSUN PHARMA 100MG A084339 001
SUN PHARM INDUSTRIES 100MG A088863 001 Dec 04, 1985
WATSON LABS 100MG A086151 001
100MG A087674 001 Apr 21, 1982

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-374(of 478)
** See List Footnote
PHENYLEPHRINE HYDROCHLORIDE
SOLUTION;INTRAVENOUS
BIORPHEN
+ DR REDDYS LABS SA 10MG/ML (10MG/ML) N212909 002 Mar 11, 2021
PHENYLEPHRINE HYDROCHLORIDE
PAR STERILE PRODUCTS 10MG/ML (10MG/ML) A210025 001 Dec 21, 2018
PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
SYRUP;ORAL
PHENERGAN VC
+ ANI PHARMS 5MG/5ML;6.25MG/5ML ** N008604 003 Apr 02, 1984
PHERAZINE VC
HALSEY 5MG/5ML;6.25MG/5ML A088868 001 Mar 02, 1987
PROMETH VC PLAIN
+ G AND W LABS INC 5MG/5ML;6.25MG/5ML A088761 001 Nov 08, 1984
PROMETHAZINE VC PLAIN
CENCI 5MG/5ML;6.25MG/5ML A088815 001 Nov 22, 1985
WOCKHARDT 5MG/5ML;6.25MG/5ML A088897 001 Jan 04, 1985
PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE
SOLUTION/DROPS;OPHTHALMIC
PREFRIN-A
ALLERGAN 0.12%;0.1% N007953 001
PHENYTOIN
SUSPENSION;ORAL
DILANTIN-30
VIATRIS 30MG/5ML N008762 002
PHENYTOIN
ACTAVIS MID ATLANTIC 125MG/5ML A089892 001 Sep 25, 1992
PHENYTOIN SODIUM
CAPSULE;ORAL
DIPHENYLAN SODIUM
LANNETT 30MG PROMPT A080857 001
100MG PROMPT A080857 002
EXTENDED PHENYTOIN SODIUM
ANI PHARMS 100MG EXTENDED A040435 001 Jun 20, 2003
100MG EXTENDED A089441 001 Dec 18, 1986
LUPIN LTD 100MG EXTENDED A211633 001 Sep 30, 2019
SUN PHARM INDS (IN) 100MG EXTENDED A040621 001 Dec 11, 2006
WOCKHARDT 30MG EXTENDED A040759 001 Dec 18, 2007
WOCKHARDT USA 100MG EXTENDED A040732 001 Jan 30, 2008
PHENYTEX
WATSON LABS 100MG EXTENDED A088711 001 Dec 21, 1984
PHENYTOIN SODIUM
PHARMERAL 100MG PROMPT A085435 001
WATSON LABS 100MG PROMPT A085894 001
PROMPT PHENYTOIN SODIUM
ANI PHARMS 100MG PROMPT A080259 001
WATSON LABS 100MG PROMPT A080905 001
INJECTABLE;INJECTION
DILANTIN
PARKE DAVIS 50MG/ML N010151 001
PHENYTOIN SODIUM
AM REGENT 50MG/ML A040781 001 Dec 04, 2007
FRESENIUS KABI USA 50MG/ML A089003 001 May 31, 1985
HOSPIRA 50MG/ML A089521 001 Mar 17, 1987
50MG/ML A089744 001 Dec 18, 1987
MARSAM PHARMS LLC 50MG/ML A089501 001 Oct 13, 1987
50MG/ML A089779 001 Nov 27, 1992
SMITH AND NEPHEW 50MG/ML A088519 001 Dec 19, 1984
50MG/ML A088521 001 Dec 18, 1984
SOLOPAK 50MG/ML A088520 001 Dec 17, 1984
WARNER CHILCOTT 50MG/ML A089900 001 Mar 30, 1990
WATSON LABS 50MG/ML A085434 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-375(of 478)
** See List Footnote
PHYTONADIONE
INJECTABLE;INJECTION
AQUAMEPHYTON
+ PAI HOLDINGS PHARM 1MG/0.5ML ** N012223 002
+ 10MG/ML ** N012223 001
KONAKION
ROCHE 1MG/0.5ML N011745 001
10MG/ML N011745 003
PHYTONADIONE
CIPLA 1MG/0.5ML A212424 001 Apr 22, 2022
10MG/ML A212424 002 Apr 22, 2022
GLAXOSMITHKLINE 1MG/0.5ML A084060 001
10MG/ML A084060 002
VITAMIN K1
HOSPIRA 10MG/ML A087956 001 Jul 25, 1983
PILOCARPINE
INSERT, EXTENDED RELEASE;OPHTHALMIC
OCUSERT PILO-20
AKORN 5MG N017431 001
OCUSERT PILO-40
AKORN 11MG N017548 001
PILOCARPINE HYDROCHLORIDE
GEL;OPHTHALMIC
PILOPINE HS
ALCON 4% N018796 001 Oct 01, 1984
PIMAVANSERIN TARTRATE
TABLET;ORAL
NUPLAZID
+ ACADIA PHARMS INC EQ 17MG BASE N207318 001 Apr 29, 2016
PIMOZIDE
TABLET;ORAL
ORAP
+ TEVA 1MG ** N017473 003 Aug 27, 1997
+ 2MG ** N017473 001 Jul 31, 1984
PINACIDIL
CAPSULE, EXTENDED RELEASE;ORAL
PINDAC
LEO PHARM 12.5MG N019456 001 Dec 28, 1989
25MG N019456 002 Dec 28, 1989
PINDOLOL
TABLET;ORAL
PINDOLOL
COSETTE 5MG A073661 001 Oct 31, 1993
5MG A073687 001 Feb 26, 1993
5MG A074123 001 Apr 17, 1997
10MG A073661 002 Oct 31, 1993
10MG A073687 002 Feb 26, 1993
10MG A074123 002 Apr 17, 1997
MYLAN PHARMS INC 5MG A074013 001 Sep 24, 1992
10MG A074018 001 Sep 24, 1992
NOSTRUM LABS 5MG A074474 001 Oct 28, 1996
10MG A074474 002 Oct 28, 1996
PUREPAC PHARM 5MG A074125 001 Apr 28, 1993
10MG A074125 002 Apr 28, 1993
WATSON LABS 5MG A074437 001 Feb 27, 1995
10MG A074437 002 Feb 27, 1995
ZYDUS PHARMS 5MG A209866 001 Aug 18, 2017
10MG A209866 002 Aug 18, 2017
VISKEN
+ NOVARTIS 5MG ** N018285 001 Sep 03, 1982
+ 10MG ** N018285 002 Sep 03, 1982

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-376(of 478)
** See List Footnote
PIOGLITAZONE HYDROCHLORIDE
TABLET;ORAL
PIOGLITAZONE HYDROCHLORIDE
MYLAN PHARMS INC EQ 15MG BASE A076801 001 Aug 17, 2012
EQ 30MG BASE A076801 002 Aug 17, 2012
EQ 45MG BASE A076801 003 Aug 17, 2012
NOSTRUM LABS INC EQ 15MG BASE A078472 001 Feb 13, 2013
EQ 30MG BASE A078472 002 Feb 13, 2013
EQ 45MG BASE A078472 003 Feb 13, 2013
PICKET PHARMS EQ 15MG BASE A078383 001 Mar 12, 2013
EQ 30MG BASE A078383 002 Mar 12, 2013
EQ 45MG BASE A078383 003 Mar 12, 2013
TORRENT PHARMS LTD EQ 15MG BASE A091298 001 Feb 13, 2013
EQ 30MG BASE A091298 002 Feb 13, 2013
EQ 45MG BASE A091298 003 Feb 13, 2013
PIPECURONIUM BROMIDE
INJECTABLE;INJECTION
ARDUAN
ORGANON USA INC 10MG/VIAL N019638 001 Jun 26, 1990
PIPERACETAZINE
TABLET;ORAL
QUIDE
DOW PHARM 10MG N013615 001
25MG N013615 002
PIPERACILLIN SODIUM
INJECTABLE;INJECTION
PIPRACIL
WYETH PHARMS INC EQ 2GM BASE/VIAL A062750 001 Oct 13, 1987
+ EQ 2GM BASE/VIAL ** N050545 002
EQ 3GM BASE/VIAL A062750 002 Oct 13, 1987
+ EQ 3GM BASE/VIAL ** N050545 003
EQ 4GM BASE/VIAL A062750 003 Oct 13, 1987
+ EQ 4GM BASE/VIAL ** N050545 004
+ EQ 40GM BASE/VIAL ** N050545 006 Sep 30, 1985
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
INJECTABLE;INJECTION
PIPERACILLIN AND TAZOBACTAM
HOSPIRA INC EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL A065386 001 Sep 15, 2009
EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL A065386 002 Sep 15, 2009
EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL A065386 003 Sep 15, 2009
EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL A065446 001 Sep 15, 2009
ZOSYN
+ WYETH PHARMS EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL ** N050684 001 Oct 22, 1993
+ EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL ** N050684 002 Oct 22, 1993
+ EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL ** N050684 003 Oct 22, 1993
+ EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL ** N050684 004 Oct 22, 1993
PIPERAZINE CITRATE
SYRUP;ORAL
ANTEPAR
GLAXOSMITHKLINE EQ 500MG BASE/5ML N009102 001
BRYREL
SANOFI AVENTIS US EQ 500MG BASE/5ML N017796 001
MULTIFUGE
BLULINE EQ 500MG BASE/5ML N009452 001
PIPERAZINE CITRATE
ALPHARMA US PHARMS EQ 500MG BASE/5ML A080774 001
LANNETT EQ 500MG BASE/5ML A080963 001
LUITPOLD EQ 500MG BASE/5ML A080671 001
VERMIDOL
SOLVAY EQ 500MG BASE/5ML A080992 001
TABLET;ORAL
ANTEPAR
GLAXOSMITHKLINE EQ 500MG BASE N009102 003
PIPERAZINE CITRATE
IMPAX LABS EQ 250MG BASE A080874 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-377(of 478)
** See List Footnote
PIPERONYL BUTOXIDE; PYRETHRINS
AEROSOL;TOPICAL
RID MOUSSE
BAYER HEALTHCARE LLC 4%;EQ 0.33% BASE N021043 001 Mar 07, 2000
PIPOBROMAN
TABLET;ORAL
VERCYTE
ABBOTT 10MG N016245 001
25MG N016245 002
PIRBUTEROL ACETATE
AEROSOL, METERED;INHALATION
MAXAIR
BAUSCH EQ 0.2MG BASE/INH N019009 001 Dec 30, 1986
EQ 0.2MG BASE/INH N020014 001 Nov 30, 1992
PIRFENIDONE
TABLET;ORAL
ESBRIET
+ GENENTECH INC 534MG ** N208780 002 Jan 11, 2017
PIROXICAM
CAPSULE;ORAL
PIROXICAM
BRECKENRIDGE 10MG A208991 001 Feb 21, 2018
20MG A208991 002 Feb 21, 2018
CYCLE 10MG A073651 001 Feb 26, 1993
20MG A073651 002 Feb 26, 1993
EGIS 10MG A074808 001 Jul 08, 1997
20MG A074808 002 Jul 08, 1997
IVAX SUB TEVA PHARMS 10MG A074148 001 Jun 03, 1996
20MG A074148 002 Jun 03, 1996
MYLAN 10MG A074043 001 Sep 22, 1992
10MG A074102 001 Jul 31, 1992
20MG A074043 002 Sep 22, 1992
20MG A074102 002 Jul 31, 1992
SCS 10MG A074036 001 May 29, 1992
20MG A074036 002 May 29, 1992
SUN PHARM INDUSTRIES 10MG A073536 002 Jan 23, 2008
20MG A073536 001 Mar 12, 1993
TEVA 10MG A073637 001 Jan 28, 1994
20MG A073638 001 Jan 28, 1994
TEVA PHARMS 10MG A074103 001 Aug 28, 1992
20MG A074103 002 Aug 28, 1992
WATSON LABS 10MG A074287 001 May 16, 1996
10MG A074460 001 Sep 29, 1995
20MG A074287 002 May 16, 1996
20MG A074460 002 Sep 29, 1995
PITAVASTATIN CALCIUM
TABLET;ORAL
PITAVASTATIN CALCIUM
MYLAN EQ 1MG BASE A206070 001 Apr 04, 2019
EQ 2MG BASE A206070 002 Apr 04, 2019
EQ 4MG BASE A206070 003 Apr 04, 2019
PITAVASTATIN MAGNESIUM
TABLET;ORAL
ZYPITAMAG
+ MEDICURE EQ 1MG BASE N208379 001 Jul 14, 2017
PITAVASTATIN SODIUM
TABLET;ORAL
NIKITA
+ LUPIN LTD EQ 1MG BASE N209875 001 Aug 04, 2017
+ EQ 2MG BASE N209875 002 Aug 04, 2017
+ EQ 4MG BASE N209875 003 Aug 04, 2017

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-378(of 478)
** See List Footnote
PLICAMYCIN
INJECTABLE;INJECTION
MITHRACIN
PFIZER 2.5MG/VIAL N050109 001
PODOFILOX
SOLUTION;TOPICAL
PODOFILOX
BAUSCH AND LOMB INC 0.5% A090184 001 Jul 21, 2010
POLIDOCANOL
SOLUTION;INTRAVENOUS
VARITHENA
+ PROVENSIS 77.5MG/7.75ML (10MG/ML) N205098 002 Dec 21, 2017
POLYESTRADIOL PHOSPHATE
INJECTABLE;INJECTION
ESTRADURIN
WYETH AYERST 40MG/AMP N010753 001
POLYETHYLENE GLYCOL 3350
FOR SOLUTION;ORAL
GLYCOLAX
LANNETT CO INC 17GM/SCOOPFUL A076652 001 Jul 02, 2004
17GM/PACKET A090600 001 Oct 06, 2009
17GM/SCOOPFUL A090600 002 Oct 06, 2009
POLYETHYLENE GLYCOL 3350
BRECKENRIDGE PHARM 17GM/SCOOPFUL A077736 001 May 26, 2006
NEXGEN PHARMA INC 17GM/SCOOPFUL A077706 001 Sep 27, 2006
PADDOCK LLC 17GM/SCOOPFUL A077893 001 May 26, 2006
17GM/SCOOPFUL A090567 001 Oct 15, 2009
TEVA PHARMS 17GM/SCOOPFUL A077445 001 May 04, 2006
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
FOR SOLUTION;ORAL
LAX-LYTE WITH FLAVOR PACKS
L PERRIGO CO 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/ A079232 001 Feb 25, 2010
BOT
PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE
MYLAN 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/ A090409 001 Apr 02, 2010
BOT
NOSTRUM LABS INC 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/ A202060 001 Mar 08, 2017
BOT
NOVEL LABS INC 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/ A090019 001 May 27, 2009
BOT
TRILYTE
AUROBINDO PHARMA USA 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/ A076491 001 Feb 05, 2004
BOT
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE
FOR SOLUTION;ORAL
CLENZ-LYTE
PADDOCK LLC 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ A090769 001 Jun 07, 2010
BOT;22.74GM/BOT
SOLUTION;ORAL
OCL
HOSPIRA 6GM/100ML;75MG/100ML;168MG/100ML;146MG/ N019284 001 Apr 30, 1986
100ML;1.29GM/100ML
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE
ANHYDROUS
FOR SOLUTION;ORAL
COLYTE
MYLAN SPECIALITY LP 120GM/PACKET;1.49GM/PACKET;3.36GM/PACKE N018983 005 Oct 26, 1984
T;2.92GM/PACKET;11.36GM/PACKET
227.1GM/PACKET;2.82GM/PACKET;6.36GM/PAC N018983 004 Oct 26, 1984
KET;5.53GM/PACKET;21.5GM/PACKET
227.1GM/BOT;2.82GM/BOT;6.36GM/BOT;5.53G N018983 010 Jan 31, 1989
M/BOT;21.5GM/BOT
240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ N018983 007 Jun 12, 1987
BOT;22.72GM/BOT
360GM/PACKET;4.47GM/PACKET;10.08GM/PACK N018983 006 Oct 26, 1984
ET;8.76GM/PACKET;34.08GM/PACKET
COLYTE-FLAVORED
MYLAN SPECIALITY LP 227.1GM/BOT;2.82GM/BOT;6.36GM/BOT;5.53 N018983 008 Nov 14, 1991

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-379(of 478)
** See List Footnote
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE
ANHYDROUS
FOR SOLUTION;ORAL
COLYTE-FLAVORED
GM/BOT;21.5GM/BOT
240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ N018983 009 Nov 14, 1991
BOT;22.72GM/BOT
GOLYTELY
+ BRAINTREE 227.1GM/PACKET;2.82GM/PACKET;6.36GM/PAC N019011 002 Jun 02, 1992
KET;5.53GM/PACKET;21.5GM/PACKET
PEG 3350 AND ELECTROLYTES
MYLAN 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ A090928 001 Jan 28, 2010
BOT;22.74GM/BOT
POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES
PADDOCK LLC 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ A090712 001 Feb 25, 2010
BOT;22.72GM/BOT
FOR SUSPENSION;ORAL
CO-LAV
VINTAGE PHARMS 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ A073428 001 Jan 28, 1992
BOT;22.72GM/BOT
COLOVAGE
DYNAPHARM 227.1GM/PACKET;2.82GM/PACKET;6.36GM/PAC A071320 001 Apr 20, 1988
KET;5.53GM/PACKET;21.5GM/PACKET
E-Z-EM PREP LYTE
E Z EM 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ A071278 001 Nov 21, 1988
BOT;22.74GM/BOT
GLYCOPREP
GOLDLINE 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ A072319 001 Dec 23, 1988
BOT;22.74GM/BOT
GO-EVAC
VINTAGE PHARMS 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ A073433 001 Apr 28, 1992
BOT;22.74GM/BOT
PEG-LYTE
SANDOZ 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ A073098 001 Aug 31, 1993
BOT;22.74GM/BOT
POLYMYXIN B SULFATE
INJECTABLE;INJECTION
AEROSPORIN
GLAXOSMITHKLINE EQ 500,000 UNITS BASE/VIAL A062036 001
POLYMYXIN B SULFATE
HIKMA EQ 500,000 UNITS BASE/VIAL A060716 001
RISING EQ 500,000 UNITS BASE/VIAL A090110 001 Jun 29, 2011
POWDER;FOR RX COMPOUNDING
POLY-RX
X GEN PHARMS 100,000,000 UNITS/BOT A061578 001
POLYMYXIN B SULFATE
PADDOCK LLC 100,000,000 UNITS/BOT A062455 001 Jul 27, 1983
POLYTHIAZIDE
TABLET;ORAL
RENESE
PFIZER 1MG N012845 001
2MG N012845 002
4MG N012845 003
POLYTHIAZIDE; PRAZOSIN HYDROCHLORIDE
CAPSULE;ORAL
MINIZIDE
PFIZER 0.5MG;EQ 1MG BASE N017986 001
0.5MG;EQ 2MG BASE N017986 002
0.5MG;EQ 5MG BASE N017986 003
POLYTHIAZIDE; RESERPINE
TABLET;ORAL
RENESE-R
PFIZER 2MG;0.25MG N013636 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-380(of 478)
** See List Footnote
POMALIDOMIDE
CAPSULE;ORAL
POMALIDOMIDE
BRECKENRIDGE 1MG A210111 001 Oct 30, 2020
2MG A210111 002 Oct 30, 2020
3MG A210111 003 Oct 30, 2020
4MG A210111 004 Oct 30, 2020
EUGIA PHARMA 1MG A210249 001 Oct 30, 2020
2MG A210249 002 Oct 30, 2020
3MG A210249 003 Oct 30, 2020
4MG A210249 004 Oct 30, 2020
MYLAN 1MG A210275 001 Jan 26, 2022
2MG A210275 002 Jan 26, 2022
3MG A210275 003 Jan 26, 2022
4MG A210275 004 Jan 26, 2022
TEVA PHARMS USA 1MG A209956 001 May 04, 2022
2MG A209956 002 May 04, 2022
3MG A209956 003 May 04, 2022
4MG A209956 004 May 04, 2022
POTASSIUM ACETATE
INJECTABLE;INJECTION
POTASSIUM ACETATE
EXELA PHARMA 2MEQ/ML A212692 001 Oct 20, 2021
POTASSIUM AMINOSALICYLATE
CAPSULE;ORAL
PASKALIUM
GLENWOOD 500MG N009395 004
POWDER;ORAL
POTASSIUM AMINOSALICYLATE
HEXCEL 100% A080098 001
TABLET;ORAL
PASKALIUM
GLENWOOD 1GM N009395 003
POTASSIUM CHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
K-LEASE
SAVAGE LABS 8MEQ A073398 001 Jan 28, 1992
10MEQ A072427 001 Mar 28, 1990
MICRO-K
+ NESHER PHARMS 8MEQ ** N018238 001
MICRO-K 10
+ NESHER PHARMS 10MEQ ** N018238 002 May 14, 1984
POTASSIUM CHLORIDE
LANNETT CO INC 8MEQ A204210 001 Mar 28, 2016
10MEQ A204210 002 Mar 28, 2016
NESHER PHARMS 10MEQ A070980 001 Feb 17, 1987
TEVA 8MEQ A073531 001 Apr 26, 1996
10MEQ A073532 001 Apr 26, 1996
TRIS PHARMA INC 8MEQ A201944 001 Mar 04, 2016
10MEQ A201944 002 Mar 04, 2016
FOR SOLUTION;ORAL
POTASSIUM CHLORIDE
GRANULES 20MEQ A213467 001 Jan 27, 2022
FOR SUSPENSION, EXTENDED RELEASE;ORAL
MICRO-K LS
+ KV PHARM 20MEQ/PACKET ** N019561 003 Aug 26, 1988
INJECTABLE;INJECTION
POTASSIUM CHLORIDE
+ ABRAXIS PHARM 2MEQ/ML A080204 001
2MEQ/ML A084290 001
2MEQ/ML A086713 001
2MEQ/ML A086714 001
2MEQ/ML A087787 001 Apr 20, 1982
2MEQ/ML A087885 001 Feb 03, 1983
AKORN 2MEQ/ML A088286 001 Sep 05, 1985
BAXTER HLTHCARE 2MEQ/ML A080203 001
2MEQ/ML A085499 001
+ FRESENIUS KABI USA 2MEQ/ML A080225 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-381(of 478)
** See List Footnote
POTASSIUM CHLORIDE
INJECTABLE;INJECTION
POTASSIUM CHLORIDE
2MEQ/ML A087817 001 Oct 20, 1982
3MEQ/ML A080225 003
GD SEARLE LLC 1MEQ/ML A086219 001
2MEQ/ML A086219 002
2MEQ/ML A086220 002
3MEQ/ML A086219 003
3MEQ/ML A086220 001
4MEQ/ML A086219 004
HOSPIRA 1MEQ/ML A080205 003
1MEQ/ML A083345 003
1.5MEQ/ML A083345 001
2MEQ/ML A083345 002
2.4MEQ/ML A080205 004
3.2MEQ/ML A080205 005
INTL MEDICATION 2MEQ/ML A083163 001
LILLY 2MEQ/ML N007865 002
LUITPOLD 2MEQ/ML A080221 001
2MEQ/ML A080736 001
2MEQ/ML A087584 001
2MEQ/ML A087585 001
MILES 1MEQ/ML A080195 002
2MEQ/ML A080195 001
3MEQ/ML A080195 003
4MEQ/ML A080195 004
PHARMA SERVE NY 2MEQ/ML A086297 001
2MEQ/ML A087362 001 Mar 08, 1983
WATSON LABS 2MEQ/ML A086208 001
2MEQ/ML A089163 001 Mar 10, 1988
2MEQ/ML A089421 001 Jan 02, 1987
3MEQ/ML A086210 001
POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER
+ ICU MEDICAL INC 2.24GM/100ML N020161 003 Aug 11, 1998
SOLUTION;ORAL
POTASSIUM CHLORIDE
TRIS PHARMA INC 20MEQ/15ML A214076 001 Jan 26, 2022
40MEQ/15ML A214076 002 Jan 26, 2022
TABLET, EXTENDED RELEASE;ORAL
K+10
FUTURE PAK 10MEQ A070999 001 Oct 22, 1987
K+8
FUTURE PAK 8MEQ A070998 001 Jan 25, 1993
K-TAB
+ ABBVIE 8MEQ N018279 002 Aug 01, 1988
KAON CL
SAVAGE LABS 6.7MEQ N017046 001
KAON CL-10
SAVAGE LABS 10MEQ N017046 002
KLOTRIX
APOTHECON 10MEQ N017850 001
POTASSIUM CHLORIDE
AMNEAL 15MEQ A212861 002 May 08, 2020
AUROBINDO PHARMA LTD 10MEQ A214728 001 Mar 31, 2021
15MEQ A214728 002 Mar 31, 2021
20MEQ A214728 003 Mar 31, 2021
BRECKENRIDGE 10MEQ A213588 001 Aug 21, 2020
20MEQ A213588 002 Aug 21, 2020
COPLEY PHARM 8MEQ A070618 001 Sep 09, 1987
NESHER PHARMS 20MEQ A076044 001 Apr 05, 2002
+ SCHERING 10MEQ ** N019439 002 Jun 13, 1986
+ 20MEQ ** N019439 001 Jun 13, 1986
SIGMAPHARM LABS LLC 8MEQ A207528 001 Aug 19, 2016
10MEQ A207528 002 Aug 19, 2016
STRIDES PHARMA 8MEQ A206881 001 Jan 22, 2019
10MEQ A206630 001 Mar 29, 2019
10MEQ A206881 002 Jan 22, 2019
10MEQ A210097 001 Jun 17, 2019

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-382(of 478)
** See List Footnote
POTASSIUM CHLORIDE
TABLET, EXTENDED RELEASE;ORAL
POTASSIUM CHLORIDE
15MEQ A206630 002 Mar 29, 2019
20MEQ A206630 003 Mar 29, 2019
20MEQ A210098 001 Apr 26, 2019
SLOW-K
NOVARTIS 8MEQ N017476 002
TEN-K
NOVARTIS 10MEQ N019381 001 Apr 16, 1986
POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE;INJECTION
POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 37MG/100ML;900MG/100ML N019708 001 Sep 29, 1989
POTASSIUM CHLORIDE 0.075% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 75MG/100ML;900MG/100ML N019708 002 Sep 29, 1989
POTASSIUM CHLORIDE 0.11% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 110MG/100ML;900MG/100ML N019708 003 Sep 29, 1989
POTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 220MG/100ML;900MG/100ML N019708 005 Sep 29, 1989
POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9%
+ BAXTER HLTHCARE 224MG/100ML;900MG/100ML N017648 003
POTASSIUM CHLORIDE 0.3% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
B BRAUN 300MG/100ML;900MG/100ML N019708 006 Sep 29, 1989
SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075%
BAXTER HLTHCARE 75MG/100ML;900MG/100ML N017648 004
SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER
B BRAUN 75MG/100ML;900MG/100ML N018722 001 Nov 09, 1982
SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER
B BRAUN 150MG/100ML;900MG/100ML N018722 002 Nov 09, 1982
SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER
B BRAUN 220MG/100ML;900MG/100ML N018722 003 Nov 09, 1982
SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
B BRAUN 300MG/100ML;900MG/100ML N018722 004 Nov 09, 1982
POTASSIUM CHLORIDE; SODIUM CHLORIDE; TROMETHAMINE
INJECTABLE;INJECTION
THAM-E
HOSPIRA 370MG/VIAL;1.75GM/VIAL;36GM/VIAL N013025 001
POTASSIUM CITRATE
FOR SOLUTION;ORAL
POTASSIUM CITRATE
+ UT SW MEDCTR 10MEQ/PACKET ** N019647 002 Oct 13, 1988
+ 20MEQ/PACKET ** N019647 001 Oct 13, 1988
POTASSIUM IODIDE
SOLUTION;ORAL
POTASSIUM IODIDE
+ ROXANE 1GM/ML ** N018551 001 Feb 19, 1982
THYROSHIELD
ARCO PHARMS LLC 65MG/ML A077218 001 Jan 12, 2005
TABLET;ORAL
THYRO-BLOCK
MEDA PHARMS 130MG N018307 001
POTASSIUM PERCHLORATE
CAPSULE;ORAL
PERCHLORACAP
MALLINCKRODT 200MG N017551 001
POVIDONE-IODINE
SOLUTION;TOPICAL
E-Z PREP
CLINIPAD 10% N019382 001 Jul 25, 1989
SPONGE;TOPICAL
E-Z PREP
CLINIPAD 5% N019382 002 Jul 25, 1989
E-Z PREP 220
CLINIPAD 5% N019382 003 Jul 25, 1989

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-383(of 478)
** See List Footnote
PRALIDOXIME CHLORIDE
INJECTABLE;INJECTION
PRALIDOXIME CHLORIDE
BAXTER HLTHCARE CORP 300MG/ML N018799 001 Dec 13, 1982
SOLUTION;INTRAMUSCULAR
PRALIDOXIME CHLORIDE (AUTOINJECTOR)
+ MERIDIAN MEDCL TECHN 600MG/2ML (300MG/ML) N018986 001 Apr 26, 1983
TABLET;ORAL
PROTOPAM CHLORIDE
WYETH AYERST 500MG N014122 002
PRAMIPEXOLE DIHYDROCHLORIDE
TABLET;ORAL
MIRAPEX
+ BOEHRINGER INGELHEIM 0.125MG N020667 001 Jul 01, 1997
+ 0.25MG N020667 002 Jul 01, 1997
+ 0.5MG N020667 006 Feb 12, 1998
+ 0.75MG N020667 007 Jul 30, 2007
+ 1MG N020667 003 Jul 01, 1997
1.25MG N020667 004 Jul 01, 1997
+ 1.5MG N020667 005 Jul 01, 1997
PRAMIPEXOLE DIHYDROCHLORIDE
ALEMBIC PHARMS 0.125MG A078894 001 Oct 08, 2010
0.25MG A078894 002 Oct 08, 2010
0.5MG A078894 003 Oct 08, 2010
1MG A078894 004 Oct 08, 2010
1.5MG A078894 005 Oct 08, 2010
HERITAGE PHARMA AVET 0.125MG A077724 001 Feb 19, 2008
0.125MG A078551 001 Oct 08, 2010
0.125MG A090241 001 Oct 08, 2010
0.125MG A091254 001 Nov 30, 2010
0.25MG A077724 002 Feb 19, 2008
0.25MG A078551 002 Oct 08, 2010
0.25MG A090241 002 Oct 08, 2010
0.25MG A091254 002 Nov 30, 2010
0.5MG A077724 003 Feb 19, 2008
0.5MG A078551 003 Oct 08, 2010
0.5MG A090241 003 Oct 08, 2010
0.5MG A091254 003 Nov 30, 2010
0.75MG A090241 004 Oct 08, 2010
0.75MG A091254 004 Nov 30, 2010
1MG A077724 004 Feb 19, 2008
1MG A078551 004 Oct 08, 2010
1MG A090241 005 Oct 08, 2010
1MG A091254 005 Nov 30, 2010
1.5MG A077724 005 Feb 19, 2008
1.5MG A078551 005 Oct 08, 2010
1.5MG A090241 006 Oct 08, 2010
1.5MG A091254 006 Nov 30, 2010
MACLEODS PHARMS LTD 0.125MG A202164 001 Sep 20, 2012
0.25MG A202164 002 Sep 20, 2012
0.5MG A202164 003 Sep 20, 2012
1MG A202164 004 Sep 20, 2012
1.5MG A202164 005 Sep 20, 2012
MYLAN 0.125MG A077854 001 Oct 08, 2010
0.25MG A077854 002 Oct 08, 2010
0.5MG A077854 003 Oct 08, 2010
0.75MG A090764 001 Apr 09, 2010
1MG A077854 004 Oct 08, 2010
1.5MG A077854 005 Oct 08, 2010
NOSTRUM LABS INC 0.125MG A091450 001 Oct 08, 2010
0.25MG A091450 002 Oct 08, 2010
0.5MG A091450 003 Oct 08, 2010
1MG A091450 004 Oct 08, 2010
1.5MG A091450 005 Oct 08, 2010
SANDOZ 0.125MG A090190 001 Jul 06, 2010
0.25MG A090190 002 Jul 06, 2010
0.5MG A090190 003 Jul 06, 2010
0.75MG A090190 006 Oct 08, 2010
1MG A090190 004 Jul 06, 2010

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-384(of 478)
** See List Footnote
PRAMIPEXOLE DIHYDROCHLORIDE
TABLET;ORAL
PRAMIPEXOLE DIHYDROCHLORIDE
1.5MG A090190 005 Jul 06, 2010
SUN PHARM INDS INC 0.125MG A091683 001 Mar 27, 2013
0.25MG A091683 002 Mar 27, 2013
0.5MG A091683 003 Mar 27, 2013
0.75MG A091683 004 Mar 27, 2013
1MG A091683 005 Mar 27, 2013
1.5MG A091683 006 Mar 27, 2013
UNICHEM 0.125MG A207011 001 Dec 19, 2018
0.25MG A207011 002 Dec 19, 2018
0.5MG A207011 003 Dec 19, 2018
0.75MG A207011 004 Dec 19, 2018
1MG A207011 005 Dec 19, 2018
1.5MG A207011 006 Dec 19, 2018
TABLET, EXTENDED RELEASE;ORAL
PRAMIPEXOLE DIHYDROCHLORIDE
ANCHEN PHARMS 0.375MG A202206 001 Feb 06, 2014
0.75MG A202206 002 Feb 06, 2014
1.5MG A202206 003 Feb 06, 2014
2.25MG A202206 004 Feb 06, 2014
3MG A202206 005 Feb 06, 2014
3.75MG A202206 006 Feb 06, 2014
4.5MG A202206 007 Feb 06, 2014
PRAMLINTIDE ACETATE
INJECTABLE;SUBCUTANEOUS
SYMLIN
ASTRAZENECA AB EQ 3MG BASE/5ML (EQ 600MCG BASE/ML) N021332 001 Mar 16, 2005
PRASUGREL HYDROCHLORIDE
TABLET;ORAL
PRASUGREL
CHARTWELL RX EQ 5MG BASE A205790 001 Oct 16, 2017
EQ 10MG BASE A205790 002 Oct 16, 2017
DR REDDYS EQ 5MG BASE A205926 001 Jul 07, 2020
EQ 10MG BASE A205926 002 Jul 07, 2020
PRAVASTATIN SODIUM
TABLET;ORAL
PRAVACHOL
+ BRISTOL MYERS SQUIBB 10MG ** N019898 002 Oct 31, 1991
+ 20MG N019898 003 Oct 31, 1991
+ 40MG N019898 004 Mar 22, 1993
+ 80MG N019898 008 Dec 18, 2001
PRAVASTATIN SODIUM
HISUN PHARM HANGZHOU 20MG A206061 001 Nov 23, 2018
40MG A206061 002 Nov 23, 2018
80MG A206061 003 Nov 23, 2018
MYLAN 10MG A077013 001 Oct 23, 2006
20MG A077013 002 Oct 23, 2006
40MG A077013 003 Oct 23, 2006
80MG A077013 004 Dec 28, 2007
MYLAN PHARMS INC 10MG A079187 001 May 27, 2010
20MG A079187 002 May 27, 2010
40MG A079187 003 May 27, 2010
80MG A079187 004 May 27, 2010
PLIVA HRVATSKA DOO 10MG A077730 001 Nov 21, 2006
20MG A077730 002 Nov 21, 2006
30MG A077730 003 Nov 21, 2006
40MG A077730 005 Nov 21, 2006
RANBAXY LABS LTD 10MG A076445 001 Apr 23, 2007
20MG A076445 002 Apr 23, 2007
40MG A076445 003 Apr 23, 2007
80MG A076445 004 Apr 23, 2007
ZYDUS PHARMS USA 10MG A077751 001 Apr 30, 2008

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-385(of 478)
** See List Footnote
PRAZEPAM
CAPSULE;ORAL
CENTRAX
PARKE DAVIS 5MG N018144 001
10MG N018144 002
20MG N018144 003 May 10, 1982
PRAZEPAM
USL PHARMA 5MG A070427 001 Nov 06, 1987
10MG A070428 001 Nov 06, 1987
TABLET;ORAL
CENTRAX
PARKE DAVIS 10MG N017415 001
PRAZOSIN HYDROCHLORIDE
CAPSULE;ORAL
PRAZOSIN HYDROCHLORIDE
AM THERAP EQ 1MG BASE A072782 001 May 16, 1989
EQ 2MG BASE A072783 001 May 16, 1989
EQ 5MG BASE A072784 001 May 16, 1989
ANI PHARMS EQ 1MG BASE A072577 002 May 16, 1989
EQ 2MG BASE A072577 001 May 16, 1989
EQ 5MG BASE A072577 003 May 16, 1989
DAVA PHARMS INC EQ 1MG BASE A072705 001 May 16, 1989
EQ 2MG BASE A072706 001 May 16, 1989
EQ 5MG BASE A072707 001 May 16, 1989
PUREPAC PHARM EQ 1MG BASE A072991 001 May 16, 1989
EQ 2MG BASE A072921 001 May 16, 1989
EQ 5MG BASE A072992 001 May 16, 1989
WATSON LABS EQ 1MG BASE A072352 001 May 16, 1989
EQ 2MG BASE A072333 001 May 16, 1989
EQ 5MG BASE A072609 001 May 16, 1989
TABLET, EXTENDED RELEASE;ORAL
MINIPRESS XL
PFIZER 2.5MG N019775 001 Jan 29, 1992
5MG N019775 002 Jan 29, 1992
PREDNICARBATE
CREAM;TOPICAL
DERMATOP E EMOLLIENT
+ VALEANT BERMUDA 0.1% N020279 001 Oct 29, 1993
PREDNICARBATE
FOUGERA PHARMS 0.1% A077287 001 Sep 19, 2006
OINTMENT;TOPICAL
DERMATOP
+ VALEANT PHARMS NORTH 0.1% ** N019568 001 Sep 23, 1991
PREDNISOLONE
CREAM;TOPICAL
METI-DERM
SCHERING 0.5% N010209 002
SYRUP;ORAL
PREDNISOLONE
IVAX SUB TEVA PHARMS 15MG/5ML A040287 001 May 28, 1999
NESHER PHARMS 5MG/5ML A040423 001 Oct 22, 2001
15MG/5ML A040364 001 Apr 10, 2002
PHARM ASSOC 5MG/5ML A040570 001 Aug 25, 2005
15MG/5ML A040571 001 Aug 25, 2005
TEVA PHARMS 15MG/5ML A040322 001 Jan 19, 2000
WE PHARMS 15MG/5ML A040192 001 May 28, 1998
PRELONE
MURO 5MG/5ML A089654 001 Jan 17, 1989
TABLET;ORAL
CORTALONE
HALSEY 1MG A080304 003
2.5MG A080304 002
5MG A080304 001
DELTA-CORTEF
PHARMACIA AND UPJOHN 5MG N009987 004
FERNISOLONE-P
FERNDALE LABS 5MG A083941 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-386(of 478)
** See List Footnote
PREDNISOLONE
TABLET;ORAL
PREDNISOLONE
BARR 5MG A084426 002
BUNDY 5MG A083675 001
CHARTWELL MOLECULAR 5MG A080531 002
CHARTWELL RX 5MG A084542 001
ELKINS SINN 5MG A080625 001
EVERYLIFE 1MG A084439 001
2.5MG A084439 002
5MG A084439 003
FERRANTE 2.5MG A080562 001
5MG A080562 002
FOSUN PHARMA 5MG A080339 001
HEATHER 5MG A080326 001
IMPAX LABS 5MG A080780 001
INWOOD LABS 5MG A080748 001
IVAX SUB TEVA PHARMS 5MG A080378 001
MARSHALL PHARMA 5MG A080307 001
PANRAY 1MG A080351 001
5MG A080351 002
PHOENIX LABS NY 5MG A080322 001
PUREPAC PHARM 5MG A080325 001
PVT FORM 5MG A080211 001
RISING 5MG A084773 001
ROXANE 5MG A080327 002
SPERTI 1MG A080358 001
2.5MG A080358 002
5MG A080358 003
SUPERPHARM 5MG A088892 001 Feb 26, 1985
TABLICAPS 5MG A085170 001
TEVA 5MG A080398 001
UDL 5MG A087987 001 Jan 18, 1983
VALEANT PHARM INTL 5MG A080236 001
VITARINE 5MG A080534 001
WATSON LABS 5MG A085085 002
5MG A085415 001
5MG A085416 001
WEST WARD 5MG A080324 001
WHITEWORTH TOWN PLSN 5MG A080342 001
STERANE
PFIZER 5MG N009996 001
PREDNISOLONE ACETATE
INJECTABLE;INJECTION
METICORTELONE
SCHERING 25MG/ML N010255 002
PREDNISOLONE ACETATE
AKORN 25MG/ML A083032 001
50MG/ML A084492 001
BEL MAR 25MG/ML A083738 001
50MG/ML A083738 002
CENT PHARMS 25MG/ML A084717 001
50MG/ML A084717 002
WATSON LABS 25MG/ML A083398 001
25MG/ML A083654 001
40MG/ML A083767 001
50MG/ML A083764 001
50MG/ML A085781 001
STERANE
PFIZER 25MG/ML N011446 001
SUSPENSION;ORAL
FLO-PRED
TARO EQ 5MG BASE/5ML N022067 001 Jan 17, 2008
EQ 15MG BASE/5ML N022067 002 Jan 17, 2008
SUSPENSION/DROPS;OPHTHALMIC
ECONOPRED
EYEVANCE 0.125% N017468 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-387(of 478)
** See List Footnote
PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
OINTMENT;OPHTHALMIC
BLEPHAMIDE S.O.P.
ALLERGAN 0.2%;10% A087748 001 Dec 03, 1986
CETAPRED
ALCON 0.25%;10% A087771 001 Aug 06, 1993
METIMYD
SCHERING 0.5%;10% N010210 002 Sep 09, 1984
PREDSULFAIR
PHARMAFAIR 0.5%;10% A088032 001 Apr 15, 1983
VASOCIDIN
NOVARTIS 0.5%;10% A088791 001 Oct 05, 1984
SUSPENSION;OPHTHALMIC
BLEPHAMIDE
+ ALLERGAN 0.2%;10% N012813 002
ISOPTO CETAPRED
ALCON 0.25%;10% A087547 001
SUSPENSION/DROPS;OPHTHALMIC
METIMYD
SCHERING 0.5%;10% N010210 001
PREDAMIDE
AKORN 0.5%;10% A088059 001 Jul 29, 1983
PREDSULFAIR
PHARMAFAIR 0.5%;10% A088007 001 Apr 19, 1983
PREDSULFAIR II
PHARMAFAIR 0.2%;10% A088837 001 Dec 24, 1985
SULPHRIN
BAUSCH AND LOMB 0.5%;10% A088089 001 Dec 28, 1982
PREDNISOLONE SODIUM PHOSPHATE
INJECTABLE;INJECTION
HYDELTRASOL
MERCK EQ 20MG PHOSPHATE/ML N011583 002
PREDNISOLONE SODIUM PHOSPHATE
WATSON LABS EQ 20MG PHOSPHATE/ML A080517 001
OINTMENT;OPHTHALMIC, OTIC
HYDELTRASOL
MERCK EQ 0.25% PHOSPHATE N011028 001
SOLUTION;ORAL
ORAPRED
CONCORDIA PHARMS INC EQ 15MG BASE/5ML ** A075117 001 Dec 14, 2000
PREDNISOLONE SODIUM PHOSPHATE
AMNEAL PHARMS EQ 15MG BASE/5ML A078345 001 Mar 10, 2009
BAUSCH EQ 15MG BASE/5ML A075250 001 Jul 12, 2002
NESHER PHARMS EQ 5MG BASE/5ML A076982 001 May 24, 2005
EQ 15MG BASE/5ML A076988 001 May 24, 2005
PHARM ASSOC EQ 5MG BASE/5ML A076123 001 Dec 23, 2002
VINTAGE EQ 15MG BASE/5ML A079010 001 May 26, 2009
VINTAGE PHARMS EQ 5MG BASE/5ML A078416 001 Oct 31, 2007
WE PHARMS EQ 5MG BASE/5ML A075181 001 Dec 23, 2002
SOLUTION/DROPS;OPHTHALMIC
INFLAMASE FORTE
+ NOVARTIS EQ 0.9% PHOSPHATE A080751 002
INFLAMASE MILD
+ NOVARTIS EQ 0.11% PHOSPHATE A080751 001
METRETON
SCHERING EQ 0.5% PHOSPHATE A083834 001
PREDAIR
PHARMAFAIR EQ 0.11% PHOSPHATE A088415 001 Feb 29, 1984
PREDAIR FORTE
PHARMAFAIR EQ 0.9% PHOSPHATE A088165 001 Mar 28, 1983
PREDNISOLONE SODIUM PHOSPHATE
AKORN EQ 0.11% PHOSPHATE A083358 001
EQ 0.9% PHOSPHATE A083358 002
ALCON PHARMS LTD EQ 0.11% PHOSPHATE A081043 001 Oct 24, 1991
EQ 0.9% PHOSPHATE A081044 001 Oct 24, 1991
BAUSCH AND LOMB EQ 0.11% PHOSPHATE A040065 001 Jul 29, 1994
SOLA BARNES HIND EQ 0.11% PHOSPHATE A084171 001
EQ 0.9% PHOSPHATE A084168 001
EQ 0.9% PHOSPHATE A084169 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-388(of 478)
** See List Footnote
PREDNISOLONE SODIUM PHOSPHATE
SOLUTION/DROPS;OPHTHALMIC
PREDNISOLONE SODIUM PHOSPHATE
EQ 0.9% PHOSPHATE A084172 001
TABLET, ORALLY DISINTEGRATING;ORAL
PREDNISOLONE SODIUM PHOSPHATE
RISING EQ 10MG BASE A202179 001 Apr 10, 2013
EQ 15MG BASE A202179 002 Apr 10, 2013
EQ 30MG BASE A202179 003 Apr 10, 2013
PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM
SOLUTION/DROPS;OPHTHALMIC
SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE
SANDOZ INC EQ 0.23% PHOSPHATE;10% A073630 001 May 27, 1993
SULSTER
AKORN EQ 0.23% PHOSPHATE;10% A074511 001 Jul 30, 1996
VASOCIDIN
+ NOVARTIS EQ 0.23% PHOSPHATE;10% ** N018988 001 Aug 26, 1988
PREDNISOLONE TEBUTATE
INJECTABLE;INJECTION
HYDELTRA-TBA
MERCK 20MG/ML N010562 001
PREDNISOLONE TEBUTATE
WATSON LABS 20MG/ML A083362 001 Feb 17, 1984
PREDNISONE
SOLUTION;ORAL
PREDNISONE
WOCKHARDT 5MG/5ML A089726 001 Aug 02, 1988
SYRUP;ORAL
LIQUID PRED
MURO 5MG/5ML A087611 002 Sep 07, 1982
TABLET;ORAL
CORTAN
HALSEY 20MG A087480 001
DELTA-DOME
BAYER PHARMS 5MG A080293 001
DELTASONE
+ PHARMACIA AND UPJOHN 2.5MG ** N009986 005
+ 5MG ** N009986 002
+ 10MG ** N009986 006
+ 20MG ** N009986 007
+ 50MG ** N009986 008
FERNISONE
FERNDALE LABS 5MG A083364 001
METICORTEN
+ SCHERING 1MG ** N009766 002
+ 5MG ** N009766 001
ORASONE
SOLVAY 1MG A083009 001
5MG A083009 002
10MG A083009 003
20MG A083009 004
50MG A085999 001
PARACORT
PARKE DAVIS 5MG N010962 002
PREDNICEN-M
SCHWARZ PHARMA 5MG A084655 001
PREDNISONE
AM THERAP 5MG A089387 001 Nov 06, 1986
10MG A089388 001 Nov 06, 1986
20MG A089389 001 Nov 06, 1986
AMNEAL PHARMS NY 5MG A089597 001 Oct 05, 1987
10MG A089598 001 Oct 05, 1987
20MG A089599 001 Oct 05, 1987
BUNDY 5MG A083676 001
CHARTWELL MOLECULAR 5MG A080514 001
20MG A084275 001
CHARTWELL RX 5MG A083059 001
CONTRACT PHARMACAL 5MG A080209 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-389(of 478)
** See List Footnote
PREDNISONE
TABLET;ORAL
PREDNISONE
DURAMED PHARMS BARR 5MG A088394 001 Oct 04, 1983
10MG A088395 001 Oct 04, 1983
20MG A088396 001 Oct 04, 1983
ELKINS SINN 5MG A080491 001
20MG A085811 001
EVERYLIFE 1MG A084440 001
2.5MG A084440 002
5MG A084440 003
FERRANTE 2.5MG A080563 001
5MG A080563 002
HALSEY 5MG A080300 001
HEATHER 5MG A080320 001
10MG A084341 001
20MG A084417 001
20MG A085543 001
50MG A086946 001
HIKMA PHARMS 1MG A040890 001 Nov 01, 2010
2.5MG A040538 001 Jan 08, 2004
50MG A088465 001 Jun 01, 1984
IMPAX LABS 5MG A080782 001
INWOOD LABS 1MG A080328 001
2.5MG A080306 001
5MG A080279 001
IVAX SUB TEVA PHARMS 5MG A080283 001
10MG A084133 001
20MG A084134 001
KV PHARM 5MG A084236 001
LEDERLE 5MG A086968 001
MARSHALL PHARMA 5MG A080301 001
MUTUAL PHARM 5MG A080701 001
10MG A086595 001
20MG A084634 001
NYLOS 5MG A085115 001
PANRAY 1MG A080350 001
2.5MG A080350 002
5MG A080350 003
PHARMAVITE 5MG A084662 002
PHOENIX LABS NY 5MG A080321 001
20MG A083807 001
PUREPAC PHARM 5MG A080353 001
10MG A086062 001
20MG A086061 001
PVT FORM 20MG A085151 001
REXALL 5MG A080232 001
RISING 5MG A084774 001
10MG A089983 001 Jan 12, 1989
20MG A085813 001
50MG A089984 001 Jan 12, 1989
ROXANE 20MG N017109 001
+ 25MG A087833 001 May 04, 1982
SANDOZ 5MG A080336 002
SCHERER LABS 5MG A080371 001
SPERTI 1MG A080359 001
2.5MG A080359 002
5MG A080359 003
SUN PHARM INDUSTRIES 50MG A086596 001
SUPERPHARM 5MG A088865 001 Oct 25, 1984
10MG A088866 001 Oct 25, 1984
20MG A088867 001 Oct 25, 1984
TEVA 5MG A080397 001
UDL 5MG A087984 001 Jan 18, 1983
10MG A087985 001 Jan 18, 1983
20MG A087986 001 Jan 18, 1983
UPSHER SMITH 5MG A087471 001
20MG A087470 001
VALEANT PHARM INTL 5MG A080237 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-390(of 478)
** See List Footnote
PREDNISONE
TABLET;ORAL
PREDNISONE
VANGARD 5MG A087682 001 Jan 15, 1982
20MG A087701 001 Jan 15, 1982
VITARINE 5MG A080334 001
5MG A080506 001
WATSON LABS 5MG A085084 002
10MG A087773 001 Jul 13, 1982
20MG A086813 001
50MG A086867 001
50MG A087772 001 Jul 13, 1982
WHITEWORTH TOWN PLSN 2.5MG A084913 001
5MG A080343 001
10MG A089028 001 Jul 24, 1986
20MG A084913 002
SERVISONE
LEDERLE 5MG A080223 001
PREGABALIN
CAPSULE;ORAL
PREGABALIN
LUPIN LTD 25MG A091040 001 May 03, 2022
50MG A091040 002 May 03, 2022
75MG A091040 003 May 03, 2022
100MG A091040 004 May 03, 2022
150MG A091040 005 May 03, 2022
200MG A091040 006 May 03, 2022
225MG A091040 007 May 03, 2022
300MG A091040 008 May 03, 2022
MYLAN 25MG A091228 001 Sep 20, 2019
50MG A091228 002 Sep 20, 2019
75MG A091228 003 Sep 20, 2019
100MG A091228 004 Sep 20, 2019
150MG A091228 005 Sep 20, 2019
200MG A091228 006 Sep 20, 2019
225MG A091228 007 Sep 20, 2019
300MG A091228 008 Sep 20, 2019
TABLET, EXTENDED RELEASE;ORAL
PREGABALIN
ALVOGEN 82.5MG A211687 001 Jul 06, 2021
165MG A211687 002 Jul 06, 2021
330MG A211687 003 Jul 06, 2021
MYLAN 82.5MG A211948 001 Apr 13, 2021
165MG A211967 001 Nov 04, 2021
330MG A211431 001 Jul 02, 2021
PRILOCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
CITANEST
+ ASTRAZENECA 1% ** N014763 004
+ 2% ** N014763 005
+ 3% ** N014763 003
CITANEST PLAIN
+ ASTRAZENECA 4% ** N014763 007
CITANEST PLAIN DENTAL
+ DENTSPLY PHARM 4% N021382 001
PRIMAQUINE PHOSPHATE
TABLET;ORAL
PRIMAQUINE PHOSPHATE
ALVOGEN EQ 15MG BASE A203924 001 Feb 03, 2014
PRIMIDONE
SUSPENSION;ORAL
MYSOLINE
+ NURO PHARMA 250MG/5ML N010401 001
TABLET;ORAL
PRIMIDONE
DR REDDYS LABS LTD 50MG A040862 001 Oct 03, 2008
250MG A040862 002 Oct 03, 2008

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-391(of 478)
** See List Footnote
PRIMIDONE
TABLET;ORAL
PRIMIDONE
HIKMA INTL PHARMS 50MG A040667 001 Jul 27, 2006
250MG A040667 002 Jul 27, 2006
IMPAX LABS 50MG A040717 001 Feb 12, 2008
250MG A040717 002 Feb 12, 2008
WATSON LABS 250MG A085052 001
PROBENECID
TABLET;ORAL
BENEMID
+ MERCK 500MG ** N007898 004
PROBENECID
AUROBINDO PHARMA USA 500MG A084211 002
IVAX SUB TEVA PHARMS 500MG A083740 001 May 09, 1984
LEDERLE 500MG A086917 001
WATSON LABS 500MG A086150 002 Apr 23, 1982
PROBUCOL
TABLET;ORAL
LORELCO
SANOFI AVENTIS US 250MG N017535 001
500MG N017535 002 Jul 06, 1988
PROCAINAMIDE HYDROCHLORIDE
CAPSULE;ORAL
PROCAINAMIDE HYDROCHLORIDE
ANI PHARMS 250MG A089219 001 Jul 01, 1986
375MG A089219 002 Jul 01, 1986
500MG A089219 003 Jul 01, 1986
ASCOT 250MG A087542 001 Jan 08, 1982
375MG A087697 001 Mar 01, 1983
500MG A087543 001 Jan 08, 1982
IVAX SUB TEVA PHARMS 250MG A084604 001
375MG A084595 001
500MG A084606 001
LANNETT 250MG A083693 001
500MG A084696 001
LEDERLE 250MG A086942 001
375MG A086952 001
500MG A086943 001
ROXANE 250MG A088989 001 Apr 26, 1985
500MG A088990 001 Apr 26, 1985
VANGARD 250MG A087643 001 Jun 01, 1982
500MG A087875 001 Jun 01, 1982
WATSON LABS 250MG A083287 001
250MG A083795 001
250MG A085167 001
375MG A084403 001
375MG A087020 001
500MG A084280 001
500MG A084357 001
500MG A087021 001
PROCAN
PARKE DAVIS 250MG A085804 001
375MG A087502 001
500MG A085079 001
PROCAPAN
PANRAY 250MG A083553 002
PRONESTYL
+ APOTHECON 250MG ** N007335 001
+ 375MG ** N007335 004
+ 500MG ** N007335 003
INJECTABLE;INJECTION
PROCAINAMIDE HYDROCHLORIDE
ABRAXIS PHARM 100MG/ML A089415 001 Nov 17, 1986
500MG/ML A089416 001 Nov 17, 1986
HOSPIRA 500MG/ML A089537 001 Aug 25, 1987
INTL MEDICATION 500MG/ML A088637 001 Jul 31, 1984
PHARMAFAIR 100MG/ML A088824 001 Nov 20, 1985

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-392(of 478)
** See List Footnote
PROCAINAMIDE HYDROCHLORIDE
INJECTABLE;INJECTION
PROCAINAMIDE HYDROCHLORIDE
500MG/ML A088830 001 Nov 20, 1985
SMITH AND NEPHEW 100MG/ML A088530 001 Mar 04, 1985
500MG/ML A088531 001 Mar 04, 1985
SOLOPAK 500MG/ML A088532 001 Mar 04, 1985
WARNER CHILCOTT 100MG/ML A089528 001 May 03, 1988
500MG/ML A089529 001 May 03, 1988
WATSON LABS 100MG/ML A087079 001
500MG/ML A087080 001
WEST-WARD PHARMS INT 100MG/ML A089029 001 Apr 17, 1986
500MG/ML A089030 001 Apr 17, 1986
PRONESTYL
+ APOTHECON 100MG/ML ** N007335 002
+ 500MG/ML ** N007335 005
TABLET;ORAL
PRONESTYL
APOTHECON 250MG N017371 001
375MG N017371 002
500MG N017371 003
TABLET, EXTENDED RELEASE;ORAL
PROCAINAMIDE HYDROCHLORIDE
ANI PHARMS 250MG A088958 001 Dec 02, 1985
250MG A089369 001 Aug 14, 1987
500MG A088959 001 Dec 02, 1985
500MG A088974 001 Jul 22, 1985
500MG A089369 002 Jan 09, 1987
750MG A089369 003 Aug 14, 1987
750MG A089438 001 Mar 23, 1987
1GM A040111 001 Dec 13, 1996
INWOOD LABS 500MG A089840 001 Mar 06, 1989
SANDOZ 500MG A089284 001 Jun 23, 1986
WATSON LABS 250MG A088533 001 Dec 03, 1984
250MG A089026 001 Oct 22, 1985
500MG A088534 001 Dec 03, 1984
500MG A089027 001 Oct 22, 1985
750MG A088535 001 Nov 03, 1984
750MG A089042 001 Oct 22, 1985
1GM A089520 001 Jan 15, 1987
PROCAN SR
+ PARKE DAVIS 250MG A086468 001
+ PARKEDALE 500MG A086065 001
+ 750MG A087510 001 Apr 01, 1982
1GM A088489 001 Jan 16, 1985
PROCANBID
KING PHARMS 500MG N020545 001 Jan 31, 1996
1GM N020545 002 Jan 31, 1996
PRONESTYL-SR
APOTHECON 500MG A087361 001
PROCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
NOVOCAIN
HOSPIRA 1% A085362 003
2% A085362 004
10% A086797 001
PROCAINE HYDROCHLORIDE
ABRAXIS PHARM 1% A080384 002
1% A080421 001
2% A080384 003
2% A080421 002
BEL MAR 1% A080711 001
2% A080756 001
ELKINS SINN 1% A083315 001
2% A083315 002
GD SEARLE LLC 1% A086202 001
2% A086202 002
HOSPIRA 1% A080416 001
2% A080416 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-393(of 478)
** See List Footnote
PROCAINE HYDROCHLORIDE
INJECTABLE;INJECTION
PROCAINE HYDROCHLORIDE
MILES 1% A080415 001
2% A080415 002
WATSON LABS 1% A080658 001
1% A083535 001
2% A080658 002
2% A083535 002
PROCAINE HYDROCHLORIDE; TETRACYCLINE HYDROCHLORIDE
INJECTABLE;INJECTION
ACHROMYCIN
LEDERLE 40MG/VIAL;100MG/VIAL N050276 001
40MG/VIAL;250MG/VIAL N050276 003
TETRACYN
PFIZER 40MG/VIAL;100MG/VIAL A060285 002
40MG/VIAL;250MG/VIAL A060285 003
PROCAINE MERETHOXYLLINE; THEOPHYLLINE
INJECTABLE;INJECTION
DICURIN PROCAINE
LILLY 100MG/ML;50MG/ML N008869 001
PROCHLORPERAZINE
SUPPOSITORY;RECTAL
COMPAZINE
GLAXOSMITHKLINE 2.5MG ** N011127 003
5MG ** N011127 001
25MG ** N011127 002
PROCHLORPERAZINE
ABLE 2.5MG A040407 001 Jul 11, 2001
5MG A040407 002 Jul 11, 2001
25MG A040407 003 Jul 11, 2001
PROCHLORPERAZINE EDISYLATE
CONCENTRATE;ORAL
COMPAZINE
+ GLAXOSMITHKLINE EQ 10MG BASE/ML N011276 001
PROCHLORPERAZINE
ALPHARMA US PHARMS EQ 10MG BASE/ML A087153 001 Jun 08, 1982
PROCHLORPERAZINE EDISYLATE
MORTON GROVE EQ 10MG BASE/ML A088598 001 Oct 25, 1984
INJECTABLE;INJECTION
COMPAZINE
+ GLAXOSMITHKLINE EQ 5MG BASE/ML ** N010742 002
PROCHLORPERAZINE
BAXTER HLTHCARE EQ 5MG BASE/ML A087759 001 Oct 01, 1982
PROCHLORPERAZINE EDISYLATE
HIKMA EQ 5MG BASE/ML A089523 001 May 03, 1988
HOSPIRA EQ 5MG BASE/ML A089703 001 Apr 07, 1988
MARSAM PHARMS LLC EQ 5MG BASE/ML A089675 001 Dec 05, 1988
SMITH AND NEPHEW EQ 5MG BASE/ML A089251 001 Dec 04, 1986
TEVA PARENTERAL EQ 5MG BASE/ML A040505 001 May 30, 2003
WATSON LABS EQ 5MG BASE/ML A089530 001 Jul 08, 1987
EQ 5MG BASE/ML A089605 001 Jul 08, 1987
EQ 5MG BASE/ML A089606 001 Jul 08, 1987
WYETH AYERST EQ 5MG BASE/ML A086348 001
SYRUP;ORAL
COMPAZINE
GLAXOSMITHKLINE EQ 5MG BASE/5ML N011188 001
PROCHLORPERAZINE EDISYLATE
ALPHARMA US PHARMS EQ 5MG BASE/5ML A087154 001 Sep 01, 1982
MORTON GROVE EQ 5MG BASE/5ML A088597 001 Oct 25, 1984
PROCHLORPERAZINE MALEATE
CAPSULE, EXTENDED RELEASE;ORAL
COMPAZINE
GLAXOSMITHKLINE EQ 10MG BASE N011000 001
EQ 10MG BASE N021019 001 Oct 06, 1999
EQ 15MG BASE N011000 002
EQ 15MG BASE N021019 002 Oct 06, 1999

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-394(of 478)
** See List Footnote
PROCHLORPERAZINE MALEATE
CAPSULE, EXTENDED RELEASE;ORAL
COMPAZINE
EQ 30MG BASE N011000 003
EQ 75MG BASE N011000 004
TABLET;ORAL
COMPAZINE
+ GLAXOSMITHKLINE EQ 5MG BASE ** N010571 001
+ EQ 10MG BASE ** N010571 002
+ EQ 25MG BASE ** N010571 003
PROCHLORPERAZINE
WATSON LABS EQ 5MG BASE A085580 001
EQ 10MG BASE A085178 001
EQ 25MG BASE A085579 001
PROCHLORPERAZINE MALEATE
CHARTWELL RX EQ 5MG BASE A040101 001 Jul 19, 1996
EQ 10MG BASE A040101 002 Jul 19, 1996
EQ 25MG BASE A040101 003 Jul 19, 1996
DURAMED PHARMS BARR EQ 5MG BASE A040207 001 May 01, 1997
EQ 5MG BASE A089484 001 Jan 20, 1987
EQ 10MG BASE A040207 002 May 01, 1997
EQ 10MG BASE A089485 001 Jan 20, 1987
EQ 25MG BASE A089486 001 Jan 20, 1987
IVAX SUB TEVA PHARMS EQ 5MG BASE A040162 001 Jan 20, 1998
EQ 10MG BASE A040162 002 Jan 20, 1998
MYLAN EQ 5MG BASE A040185 002 Oct 28, 1996
EQ 10MG BASE A040185 001 Oct 28, 1996
TEVA PHARMS EQ 5MG BASE A040120 001 Jul 11, 1996
EQ 10MG BASE A040120 002 Jul 11, 1996
PROCYCLIDINE HYDROCHLORIDE
TABLET;ORAL
KEMADRIN
MONARCH PHARMS 2MG N009818 005
5MG N009818 003
PROGESTERONE
CAPSULE;ORAL
PROGESTERONE
TEVA PHARMS 100MG A202121 001 Feb 29, 2012
200MG A202121 002 Feb 29, 2012
PROMETRIUM
VIRTUS PHARMS 300MG N019781 003 Oct 15, 1999
INJECTABLE;INJECTION
PROGESTERONE
+ ACTAVIS LABS UT INC 50MG/ML N017362 002
AM REGENT 50MG/ML A090845 001 Jun 22, 2009
LILLY 25MG/ML N009238 002
50MG/ML N009238 001
INSERT, EXTENDED RELEASE;INTRAUTERINE
PROGESTASERT
ALZA 38MG N017553 001
SYSTEM;VAGINAL
MILPROSA
+ FERRING PHARMS INC 1.78GM N201110 001 Apr 29, 2020
PROMAZINE HYDROCHLORIDE
CONCENTRATE;ORAL
SPARINE
WYETH AYERST 30MG/ML N010942 001
100MG/ML N010942 004
INJECTABLE;INJECTION
PROMAZINE HYDROCHLORIDE
WATSON LABS 25MG/ML A084510 001
50MG/ML A084517 001
SPARINE
HIKMA 25MG/ML N010349 008
50MG/ML N010349 006

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-395(of 478)
** See List Footnote
PROMAZINE HYDROCHLORIDE
SYRUP;ORAL
SPARINE
WYETH AYERST 10MG/5ML N010942 003
TABLET;ORAL
SPARINE
WYETH AYERST 10MG N010348 006
25MG N010348 001
50MG N010348 002
100MG N010348 003
200MG N010348 004
PROMETHAZINE HYDROCHLORIDE
INJECTABLE;INJECTION
PHENERGAN
WYETH AYERST 25MG/ML N008857 002
50MG/ML N008857 003
PROMETHAZINE HYDROCHLORIDE
ABBOTT 25MG/ML A084223 001
50MG/ML A084222 001
AKORN 25MG/ML A083955 002
50MG/ML A083955 001
AM REGENT 25MG/ML A040515 001 Mar 19, 2003
BEDFORD LABS 25MG/ML A040524 001 Mar 17, 2004
50MG/ML A040524 002 Mar 17, 2004
HOSPIRA 25MG/ML A040372 001 Jun 08, 2000
50MG/ML A040372 002 Jun 08, 2000
50MG/ML A083838 002
MARSAM PHARMS LLC 25MG/ML A089463 001 May 02, 1988
50MG/ML A089477 001 May 02, 1988
MYLAN INSTITUTIONAL 25MG/ML A040471 001 Nov 21, 2002
SANDOZ 25MG/ML A040593 001 Nov 08, 2006
50MG/ML A040593 002 Nov 08, 2006
TEVA PHARMS USA 25MG/ML ** A040454 001 Aug 22, 2002
50MG/ML ** A040454 002 Aug 22, 2002
WATSON LABS 25MG/ML A083532 001
25MG/ML A084591 001
50MG/ML A080629 002
50MG/ML A083532 002
WOCKHARDT 25MG/ML A040785 001 Sep 26, 2008
50MG/ML A040785 002 Sep 26, 2008
ZIPAN-25
ALTANA 25MG/ML A083997 001
ZIPAN-50
ALTANA 50MG/ML A083997 002
SUPPOSITORY;RECTAL
PHENERGAN
+ MYLAN 12.5MG ** N010926 002
+ 25MG ** N010926 001
+ 50MG ** N011689 001
PROMETHACON
POLYMEDICA 25MG A084901 001
50MG A084902 001
PROMETHAZINE HYDROCHLORIDE
ABLE 12.5MG A040504 001 Apr 11, 2003
25MG A040504 002 Apr 11, 2003
50MG A040449 001 Feb 27, 2003
WATSON LABS INC 12.5MG A040479 001 Jun 24, 2003
25MG A040479 002 Jun 24, 2003
SYRUP;ORAL
MYMETHAZINE FORTIS
USL PHARMA 25MG/5ML A087996 001 Jan 18, 1983
PROMETH FORTIS
ALPHARMA US PHARMS 25MG/5ML A084772 001
PROMETH PLAIN
ACTAVIS MID ATLANTIC 6.25MG/5ML A085953 001
PROMETHAZINE
CENCI 6.25MG/5ML A089013 001 Sep 20, 1985

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-396(of 478)
** See List Footnote
PROMETHAZINE HYDROCHLORIDE
SYRUP;ORAL
PROMETHAZINE HYDROCHLORIDE
KV PHARM 6.25MG/5ML A085388 001
25MG/5ML A085385 001
PHARM ASSOC 6.25MG/5ML A087518 001
WHITEWORTH TOWN PLSN 6.25MG/5ML A086395 001
PROMETHAZINE HYDROCHLORIDE PLAIN
+ ANI PHARMS 6.25MG/5ML ** N008381 004 Apr 18, 1984
+ 25MG/5ML ** N008381 003
TABLET;ORAL
PHENERGAN
+ DELCOR ASSET CORP 12.5MG ** N007935 002
+ 25MG ** N007935 003
+ 50MG ** N007935 004
PROMETHAZINE HYDROCHLORIDE
ABBOTT 12.5MG A084160 001
25MG A084166 001
50MG A084539 001
ABLE 12.5MG A040558 001 Jul 01, 2004
25MG A040558 002 Jul 01, 2004
50MG A040558 003 Jul 01, 2004
CHARTWELL MOLECULAR 12.5MG A080949 001
25MG A080949 002
50MG A080949 003
IMPAX LABS 12.5MG A040791 002 Feb 12, 2008
25MG A040791 003 Feb 12, 2008
25MG A084214 002 Jul 07, 1982
50MG A040791 001 May 20, 2008
INVATECH 12.5MG A084233 001
25MG A085146 001
50MG A085146 002
IVAX SUB TEVA PHARMS 12.5MG A083604 001
25MG A083603 001
50MG A083613 001
MYLAN 12.5MG A091054 001 Aug 30, 2011
25MG A091054 002 Aug 30, 2011
50MG A091054 003 Aug 30, 2011
PVT FORM 12.5MG A083214 001
25MG A083658 001
SANDOZ 12.5MG A084176 002 May 22, 2009
SUN PHARM INDUSTRIES 12.5MG A084555 001
25MG A084554 001
50MG A084557 001
TABLICAPS 12.5MG A084080 001
25MG A084027 001
TEVA 25MG A089109 001 Sep 10, 1985
WATSON LABS 12.5MG A083401 001
12.5MG A083712 001
12.5MG A085986 001
25MG A083204 001
25MG A085684 001
50MG A083403 001
50MG A085664 001
REMSED
BRISTOL MYERS SQUIBB 25MG A083176 002
50MG A083176 001
PROPAFENONE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
PROPAFENONE HYDROCHLORIDE
MYLAN 225MG A203803 001 Apr 29, 2016
325MG A203803 002 Apr 29, 2016
425MG A203803 003 Apr 29, 2016
TABLET;ORAL
PROPAFENONE HYDROCHLORIDE
NESHER PHARMS 150MG A076193 001 Feb 07, 2002
225MG A076193 002 Feb 07, 2002
300MG A076193 003 Feb 07, 2002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-397(of 478)
** See List Footnote
PROPAFENONE HYDROCHLORIDE
TABLET;ORAL
RYTHMOL
+ GLAXOSMITHKLINE LLC 150MG ** N019151 001 Nov 27, 1989
+ 225MG ** N019151 003 Nov 20, 1992
+ 300MG ** N019151 002 Nov 27, 1989
PROPANTHELINE BROMIDE
INJECTABLE;INJECTION
PRO-BANTHINE
GD SEARLE LLC 30MG/VIAL N008843 001
TABLET;ORAL
PRO-BANTHINE
+ SHIRE 7.5MG ** N008732 003
+ 15MG ** N008732 002
PROPANTHELINE BROMIDE
ASCOT 15MG A087663 001 Oct 25, 1982
HEATHER 15MG A085780 001
HIKMA 7.5MG A080927 001
15MG A080927 002
IMPAX LABS 15MG A084541 002
MYLAN 15MG A083706 001
PAR PHARM 15MG A088377 001 Dec 08, 1983
PVT FORM 15MG A080977 001
SANDOZ 15MG A080928 001
TABLICAPS 15MG A084428 001
WATSON LABS 15MG A083029 002
15MG A083151 001
PROPARACAINE HYDROCHLORIDE
SOLUTION/DROPS;OPHTHALMIC
KAINAIR
PHARMAFAIR 0.5% A088087 001 Jun 07, 1983
OPHTHAINE
+ APOTHECON 0.5% ** N008883 001
OPHTHETIC
+ ALLERGAN 0.5% ** N012583 001
PARACAINE
OPTOPICS 0.5% A087681 001 Aug 05, 1982
PROPARACAINE HYDROCHLORIDE
SOLA BARNES HIND 0.5% A084144 001
0.5% A084151 001
PROPIOLACTONE
SOLUTION;IRRIGATION
BETAPRONE
FOREST LABS N/A N011657 001
PROPIOMAZINE HYDROCHLORIDE
INJECTABLE;INJECTION
LARGON
HIKMA 20MG/ML N012382 002
PROPOFOL
INJECTABLE;INJECTION
DIPRIVAN
FRESENIUS KABI USA 10MG/ML N019627 001 Oct 02, 1989
PROPOFOL
TEVA PARENTERAL 10MG/ML A075392 001 Sep 19, 2000
PROPOXYPHENE HYDROCHLORIDE
CAPSULE;ORAL
DARVON
XANODYNE PHARM 32MG N010997 001
65MG N010997 003
DOLENE
HERITAGE PHARMS INC 65MG A080530 001
KESSO-GESIC
MK LABS 65MG A083544 001
PROPHENE 65
HALSEY 65MG A083538 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-398(of 478)
** See List Footnote
PROPOXYPHENE HYDROCHLORIDE
CAPSULE;ORAL
PROPOXYPHENE HYDROCHLORIDE
ALRA 65MG A083184 001
IMPAX LABS 65MG A083317 001
IVAX SUB TEVA PHARMS 32MG A083597 001
MUTUAL PHARM 65MG A083186 001
MYLAN 32MG A083528 001
65MG A040569 001 Dec 16, 2004
65MG A083299 001
NEXGEN PHARMA INC 65MG A083185 001
PAR PHARM 65MG A080269 001
PUREPAC PHARM 65MG A083278 001
PVT FORM 32MG A083464 001
65MG A083113 001
ROXANE 32MG A083089 001
65MG A083089 002
SANDOZ 32MG A084014 001
65MG A083125 002
65MG A083688 001
65MG A083870 002
65MG A086495 001
TEVA 65MG A088615 001 Oct 22, 1984
VALEANT PHARM INTL 65MG A080783 001
VINTAGE PHARMS 65MG A040908 001 Jul 17, 2009
WATSON LABS 65MG A080908 002
65MG A085190 001
WEST WARD 65MG A083501 001
WHITEWORTH TOWN PLSN 65MG A084551 001
PROPOXYPHENE HYDROCHLORIDE 65
WARNER CHILCOTT 65MG A083786 001
PROPOXYPHENE NAPSYLATE
SUSPENSION;ORAL
DARVON-N
AAIPHARMA LLC 50MG/5ML N016861 001
TABLET;ORAL
DARVON-N
XANODYNE PHARM 100MG N016862 002
PROPRANOLOL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
PROPRANOLOL HYDROCHLORIDE
INWOOD LABS 60MG A072499 001 Apr 11, 1989
80MG A072500 001 Apr 11, 1989
120MG A072501 001 Apr 11, 1989
160MG A072502 001 Apr 11, 1989
MYLAN 60MG A078022 001 Feb 15, 2007
80MG A078022 002 Feb 15, 2007
120MG A078022 003 Feb 15, 2007
160MG A078022 004 Feb 15, 2007
UPSHER SMITH LABS 60MG A078311 001 Mar 06, 2009
80MG A078311 002 Mar 06, 2009
120MG A078311 003 Mar 06, 2009
160MG A078311 004 Mar 06, 2009
CONCENTRATE;ORAL
PROPRANOLOL HYDROCHLORIDE INTENSOL
ROXANE 80MG/ML A071388 001 May 15, 1987
INJECTABLE;INJECTION
PROPRANOLOL HYDROCHLORIDE
+ BAXTER HLTHCARE CORP 1MG/ML ** N016419 001
CHARTWELL INJECTABLE 1MG/ML A075792 001 Aug 29, 2000
FOSUN PHARMA 1MG/ML A076400 001 Feb 26, 2003
SMITH AND NEPHEW 1MG/ML A070135 001 Apr 15, 1986
1MG/ML A070137 001 Apr 15, 1986
SOLOPAK 1MG/ML A070136 001 Apr 15, 1986
SOLUTION;ORAL
PROPRANOLOL HYDROCHLORIDE
PAI HOLDINGS PHARM 20MG/5ML A071984 001 Mar 03, 1989
40MG/5ML A071985 001 Mar 03, 1989

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-399(of 478)
** See List Footnote
PROPRANOLOL HYDROCHLORIDE
SUSPENSION;ORAL
INDERAL
WYETH AYERST 10MG/ML N019536 001 Dec 12, 1986
TABLET;ORAL
INDERAL
+ WYETH PHARMS 10MG ** N016418 001
+ 20MG ** N016418 003
+ 40MG ** N016418 002
+ 60MG ** N016418 009 Oct 18, 1982
+ 80MG ** N016418 004
+ 90MG ** N016418 010 Oct 18, 1982
PROPRANOLOL HYDROCHLORIDE
ANI PHARMS 60MG A071791 001 Jul 15, 1987
90MG A071977 001 Apr 06, 1988
CHARTWELL RX 10MG A070663 001 Jun 13, 1986
20MG A070664 001 Jun 13, 1986
40MG A070665 001 Jun 13, 1986
60MG A070666 001 Oct 10, 1986
80MG A070667 001 Jun 13, 1986
DAVA PHARMS INC 10MG A070125 001 Jul 30, 1985
20MG A070126 001 Jul 30, 1985
40MG A070127 001 Jul 30, 1985
60MG A071495 001 Dec 31, 1987
80MG A070128 001 Jul 30, 1985
90MG A071496 001 Dec 31, 1987
DURAMED PHARMS BARR 10MG A070306 001 Sep 09, 1985
20MG A070307 001 Sep 09, 1985
40MG A070308 001 Sep 09, 1985
60MG A070309 001 Oct 01, 1986
80MG A070310 001 Sep 09, 1985
90MG A071327 001 Oct 01, 1986
INTERPHARM 10MG A071368 001 May 05, 1987
20MG A071369 001 May 05, 1987
40MG A071370 001 May 05, 1987
80MG A071371 001 May 05, 1987
IVAX SUB TEVA PHARMS 10MG A072063 001 Jul 29, 1988
20MG A072066 001 Jul 29, 1988
40MG A072067 001 Jul 29, 1988
60MG A072068 001 Jul 29, 1988
80MG A072069 001 Jul 29, 1988
LEDERLE 10MG A072117 001 Jun 23, 1988
20MG A072118 001 Jun 23, 1988
40MG A072119 001 Jun 23, 1988
80MG A072120 001 Jun 23, 1988
MYLAN 60MG A072275 001 Jun 09, 1989
PUREPAC PHARM 10MG A070814 001 Nov 03, 1986
20MG A070815 001 Nov 03, 1986
40MG A070816 001 Nov 03, 1986
60MG A070817 001 Nov 03, 1986
80MG A070757 001 Nov 03, 1986
ROXANE 10MG A070516 001 Jul 07, 1986
20MG A070517 001 Jul 07, 1986
40MG A070518 001 Jul 07, 1986
60MG A070519 001 Sep 24, 1986
80MG A070520 001 Jul 07, 1986
90MG A070521 001 Sep 24, 1986
SANDOZ 10MG A071658 001 Jul 05, 1988
20MG A071687 001 Jul 05, 1988
40MG A071688 001 Jul 05, 1988
60MG A072197 001 Jul 05, 1988
80MG A071689 001 Jul 05, 1988
90MG A072198 001 Jul 05, 1988
SCHERING 10MG A070120 001 Aug 06, 1985
20MG A070121 001 Aug 06, 1985
40MG A070122 001 Aug 06, 1985
60MG A070123 001 Oct 29, 1986
80MG A070124 001 Aug 06, 1985
STRIDES PHARMA 90MG A071288 001 Oct 22, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-400(of 478)
** See List Footnote
PROPRANOLOL HYDROCHLORIDE
TABLET;ORAL
PROPRANOLOL HYDROCHLORIDE
SUPERPHARM 10MG A071515 001 Jun 08, 1988
20MG A071516 001 Jun 08, 1988
40MG A071517 001 Jun 08, 1988
80MG A071518 001 Jun 08, 1988
TEVA 10MG A070232 001 Oct 07, 1987
20MG A070233 001 Jun 23, 1986
40MG A070234 001 Jun 23, 1986
WARNER CHILCOTT 10MG A070438 001 Sep 15, 1986
20MG A070439 001 Sep 15, 1986
40MG A070440 001 Sep 15, 1986
60MG A070441 001 Sep 24, 1986
80MG A070442 001 Sep 15, 1986
WATSON LABS 10MG A070140 001 Jul 30, 1985
10MG A070378 001 Mar 19, 1987
20MG A070141 001 Jul 30, 1985
20MG A070379 001 Mar 19, 1987
40MG A070142 001 Jul 30, 1985
40MG A070380 001 Mar 19, 1987
60MG A070143 001 Jan 15, 1987
60MG A070178 002 Apr 23, 2018
60MG A070381 001 Mar 19, 1987
60MG A071098 001 Oct 06, 1986
80MG A070144 001 Jul 30, 1985
80MG A070382 001 Mar 19, 1987
80MG A070551 001 Jul 10, 1986
90MG A071183 001 Oct 06, 1986
90MG A071792 001 Jul 15, 1987
WATSON LABS TEVA 10MG A070548 001 Jul 10, 1986
20MG A070549 001 Apr 11, 1986
40MG A070550 001 Apr 11, 1986
PROPYLIODONE
SUSPENSION;INTRATRACHEAL
DIONOSIL AQUEOUS
GLAXOSMITHKLINE 50% N009309 001
DIONOSIL OILY
GLAXOSMITHKLINE 60% N009309 002
PROPYLTHIOURACIL
TABLET;ORAL
PROPYLTHIOURACIL
ABBOTT 50MG A084075 001
ANABOLIC 50MG A080285 001
ANI PHARMS 50MG A080215 001
CHARTWELL MOLECULAR 50MG A080016 001
CHARTWELL RX 50MG A084543 001
HALSEY 50MG A080015 001
IMPAX LABS 50MG A080159 001
LILLY 50MG N006213 001
SUN PHARM INDUSTRIES 50MG A083982 001
TABLICAPS 50MG A080840 001
WATSON LABS 50MG A080932 001
50MG A085201 001
PROTAMINE SULFATE
INJECTABLE;INJECTION
PROTAMINE SULFATE
HIKMA 10MG/ML A089474 001 Nov 05, 1986
10MG/ML A089475 001 Nov 05, 1986
+ LILLY 10MG/ML ** N006460 002
PHARMACIA AND UPJOHN 50MG/VIAL N007413 001
250MG/VIAL N007413 002 Aug 02, 1984

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-401(of 478)
** See List Footnote
PROTEIN HYDROLYSATE
INJECTABLE;INJECTION
AMINOSOL 5%
ABBVIE 5% N005932 012 Jan 31, 1985
HYPROTIGEN 5%
B BRAUN 5% N006170 003 Jan 10, 1984
PROTIRELIN
INJECTABLE;INJECTION
THYPINONE
ABBOTT 0.5MG/ML N017638 001
THYREL TRH
FERRING 0.5MG/ML N018087 001
PROTOKYLOL HYDROCHLORIDE
TABLET;ORAL
VENTAIRE
SANOFI AVENTIS US 2MG A083459 001
PROTRIPTYLINE HYDROCHLORIDE
TABLET;ORAL
VIVACTIL
HERITAGE PHARMA AVET 5MG A073644 001 Aug 24, 1995
10MG A073645 001 Aug 24, 1995
TEVA WOMENS 5MG ** N016012 001
10MG ** N016012 002
PSEUDOEPHEDRINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
NOVAFED
SANOFI AVENTIS US 120MG N017603 001
SUDAFED 12 HOUR
+ GLAXOSMITHKLINE 120MG ** N017941 002
TABLET, EXTENDED RELEASE;ORAL
SUDAFED 12 HOUR
MCNEIL CONS 120MG A073585 001 Oct 31, 1991
PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
ACTIFED
GLAXOSMITHKLINE 120MG;5MG N018996 001 Jun 17, 1985
TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES
KV PHARM 120MG;5MG A071798 001 Mar 16, 1989
SYRUP;ORAL
ACTAHIST
CENCI 30MG/5ML;1.25MG/5ML A088344 001 Feb 09, 1984
HISTAFED
CENCI 30MG/5ML;1.25MG/5ML A088283 001 Apr 20, 1984
MYFED
USL PHARMA 30MG/5ML;1.25MG/5ML A088116 001 Mar 04, 1983
TRILITRON
NEWTRON PHARMS 30MG/5ML;1.25MG/5ML A088474 001 Feb 12, 1985
TABLET;ORAL
ALLERFED
PVT FORM 60MG;2.5MG A088860 001 Jan 31, 1985
CORPHED
FOSUN PHARMA 60MG;2.5MG A088602 001 Apr 11, 1985
PSEUDOEPHEDRINE HYDROCHLORIDE AND TRIPROLIDINE HYDROCHLORIDE
SANDOZ 60MG;2.5MG A088193 001 May 17, 1983
TRILITRON
NEWTRON PHARMS 60MG;2.5MG A088515 001 Jan 09, 1985
TRIPHED
TEVA 60MG;2.5MG A088630 001 May 17, 1984
TRIPROLIDINE AND PSEUDOEPHEDRINE
WATSON LABS 60MG;2.5MG A088318 002 Jan 13, 1984
WEST WARD 60MG;2.5MG A088117 001 Apr 19, 1983
TRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
IVAX SUB TEVA PHARMS 60MG;2.5MG A085273 001 Dec 12, 1984
SUPERPHARM 60MG;2.5MG A088578 001 Feb 21, 1985

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-402(of 478)
** See List Footnote
PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES
KV PHARM 120MG;5MG A072758 001 Nov 25, 1991
PSEUDOEPHEDRINE POLISTIREX
SUSPENSION, EXTENDED RELEASE;ORAL
PSEUDO-12
UCB INC EQ 60MG HYDROCHLORIDE/5ML N019401 001 Jun 19, 1987
PSEUDOEPHEDRINE SULFATE
TABLET, EXTENDED RELEASE;ORAL
AFRINOL
+ SCHERING PLOUGH 120MG N018191 001
PYRIDOSTIGMINE BROMIDE
TABLET;ORAL
PYRIDOSTIGMINE BROMIDE
ANI PHARMS 30MG A040512 002 Jul 20, 2005
60MG A040512 001 Oct 08, 2003
IMPAX LABS INC 60MG A040457 001 Dec 26, 2002
SOLVAY 30MG A089572 001 Nov 27, 1990
US ARMY 30MG N020414 001 Feb 05, 2003
PYRIDOXINE HYDROCHLORIDE
INJECTABLE;INJECTION
HEXA-BETALIN
LILLY 100MG/ML A080854 001
PYRIDOXINE HYDROCHLORIDE
AKORN 100MG/ML A087967 001 Oct 01, 1982
BEL MAR 100MG/ML A080761 001
DELL LABS 50MG/ML A083771 001
100MG/ML A083772 001
DR REDDYS 100MG/ML A080572 001
ELKINS SINN 100MG/ML A080581 001
LUITPOLD 100MG/ML A080669 001
MYLAN INSTITUTIONAL 100MG/ML A204879 001 Jul 14, 2016
WATSON LABS 100MG/ML A083760 001
PYRILAMINE MALEATE
TABLET;ORAL
PYRILAMINE MALEATE
IMPAX LABS 25MG A080808 001
WATSON LABS 25MG A085231 001
PYRIMETHAMINE; SULFADOXINE
TABLET;ORAL
FANSIDAR
ROCHE 25MG;500MG N018557 001
PYRITHIONE ZINC
LOTION;TOPICAL
HEAD & SHOULDERS CONDITIONER
WARNER CHILCOTT 0.3% N019412 002 Mar 10, 1986
PYRVINIUM PAMOATE
SUSPENSION;ORAL
POVAN
PARKE DAVIS EQ 50MG BASE/5ML N011964 001
TABLET;ORAL
POVAN
PARKE DAVIS EQ 50MG BASE N012485 002
QUAZEPAM
TABLET;ORAL
DORAL
GALT PHARMS 7.5MG N018708 003 Feb 26, 1987

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-403(of 478)
** See List Footnote
QUETIAPINE FUMARATE
TABLET;ORAL
QUETIAPINE FUMARATE
ACTAVIS GRP PTC EQ 25MG BASE A201762 001 Feb 27, 2013
EQ 50MG BASE A201762 002 Feb 27, 2013
EQ 100MG BASE A201762 003 Feb 27, 2013
EQ 150MG BASE A201762 004 Feb 27, 2013
EQ 200MG BASE A201762 005 Feb 27, 2013
EQ 300MG BASE A201762 006 Feb 27, 2013
EQ 400MG BASE A201762 007 Feb 27, 2013
ALEMBIC PHARMS EQ 25MG BASE A203390 001 Oct 28, 2014
EQ 50MG BASE A203390 002 Oct 28, 2014
EQ 100MG BASE A203390 003 Oct 28, 2014
EQ 200MG BASE A203390 004 Oct 28, 2014
EQ 300MG BASE A203390 005 Oct 28, 2014
EQ 400MG BASE A203390 006 Oct 28, 2014
JUBILANT GENERICS EQ 25MG BASE A203150 001 Nov 26, 2013
MYLAN PHARMS INC EQ 25MG BASE A090323 001 Mar 27, 2012
TORRENT PHARMS LTD EQ 25MG BASE A200363 001 Mar 27, 2012
EQ 50MG BASE A200363 002 Mar 27, 2012
EQ 100MG BASE A200363 003 Mar 27, 2012
EQ 200MG BASE A200363 004 Mar 27, 2012
EQ 300MG BASE A200363 005 Mar 27, 2012
EQ 400MG BASE A200363 006 Mar 27, 2012
SEROQUEL
+ ASTRAZENECA EQ 150MG BASE ** N020639 004 Dec 20, 1998
TABLET, EXTENDED RELEASE;ORAL
QUETIAPINE FUMARATE
AMNEAL PHARMS EQ 400MG BASE A211405 001 Oct 26, 2018
ANCHEN PHARMS EQ 150MG BASE A090757 001 Dec 01, 2017
EQ 200MG BASE A090757 002 Dec 01, 2017
EQ 300MG BASE A090757 003 Dec 01, 2017
EQ 400MG BASE A090757 004 Dec 01, 2017
RISING EQ 50MG BASE A202228 001 Feb 02, 2021
EQ 150MG BASE A202228 002 Feb 02, 2021
EQ 200MG BASE A202228 003 Feb 02, 2021
EQ 300MG BASE A202228 004 Feb 02, 2021
EQ 400MG BASE A202228 005 Feb 02, 2021
QUINAPRIL HYDROCHLORIDE
TABLET;ORAL
ACCUPRIL
+ PFIZER PHARMS EQ 5MG BASE N019885 001 Nov 19, 1991
+ EQ 10MG BASE N019885 002 Nov 19, 1991
+ EQ 20MG BASE N019885 003 Nov 19, 1991
+ EQ 40MG BASE N019885 004 Nov 19, 1991
QUINAPRIL HYDROCHLORIDE
ACTAVIS ELIZABETH EQ 5MG BASE A076459 001 Dec 22, 2004
EQ 10MG BASE A076459 002 Dec 22, 2004
EQ 20MG BASE A076459 003 Dec 22, 2004
EQ 40MG BASE A076459 004 Dec 22, 2004
ACTAVIS LABS FL INC EQ 5MG BASE A076049 001 Jan 14, 2005
EQ 10MG BASE A076049 002 Jan 14, 2005
EQ 20MG BASE A076049 003 Jan 14, 2005
EQ 40MG BASE A076049 004 Jan 14, 2005
ANI PHARMS EQ 5MG BASE A075504 001 Aug 24, 2007
EQ 10MG BASE A075504 002 Aug 24, 2007
EQ 20MG BASE A075504 003 Aug 24, 2007
EQ 40MG BASE A075504 004 Aug 24, 2007
APOTEX INC EQ 5MG BASE A076240 001 Jan 26, 2006
EQ 10MG BASE A076240 002 Jan 26, 2006
EQ 20MG BASE A076240 003 Jan 26, 2006
EQ 40MG BASE A076240 004 Jan 26, 2006
CHARTWELL RX EQ 5MG BASE A076803 001 Mar 02, 2005
EQ 10MG BASE A076803 002 Mar 02, 2005
EQ 20MG BASE A076803 003 Mar 02, 2005
EQ 40MG BASE A076803 004 Mar 02, 2005
MYLAN EQ 5MG BASE A076036 001 Jan 28, 2005
EQ 5MG BASE A076694 001 Dec 23, 2004
EQ 10MG BASE A076036 002 Jan 28, 2005

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-404(of 478)
** See List Footnote
QUINAPRIL HYDROCHLORIDE
TABLET;ORAL
QUINAPRIL HYDROCHLORIDE
EQ 10MG BASE A076694 002 Dec 23, 2004
EQ 20MG BASE A076036 003 Jan 28, 2005
EQ 20MG BASE A076694 003 Dec 23, 2004
EQ 40MG BASE A076036 004 Jan 28, 2005
EQ 40MG BASE A076694 004 Dec 23, 2004
SUN PHARM INDS LTD EQ 5MG BASE A076607 001 Dec 15, 2004
EQ 5MG BASE A090800 001 Jun 18, 2009
EQ 10MG BASE A076607 002 Dec 15, 2004
EQ 10MG BASE A090800 002 Jun 18, 2009
EQ 20MG BASE A076607 003 Dec 15, 2004
EQ 20MG BASE A090800 003 Jun 18, 2009
EQ 40MG BASE A076607 004 Dec 15, 2004
EQ 40MG BASE A090800 004 Jun 18, 2009
QUINESTROL
TABLET;ORAL
ESTROVIS
PARKE DAVIS 0.1MG N016768 002
0.2MG N016768 003
QUINETHAZONE
TABLET;ORAL
HYDROMOX
LEDERLE 50MG N013264 001
QUINETHAZONE; RESERPINE
TABLET;ORAL
HYDROMOX R
LEDERLE 50MG;0.125MG N013927 001
QUINIDINE GLUCONATE
INJECTABLE;INJECTION
QUINIDINE GLUCONATE
+ LILLY 80MG/ML N007529 002 Feb 10, 1989
TABLET;ORAL
QUINACT
BAYER HLTHCARE 266MG A085978 001
400MG A086099 001
TABLET, EXTENDED RELEASE;ORAL
DURAQUIN
WARNER CHILCOTT 330MG N017917 001
QUINAGLUTE
+ BAYER HLTHCARE 324MG ** N016647 001
QUINALAN
CHARTWELL MOLECULAR 324MG A088081 001 Feb 10, 1986
QUINATIME
WATSON LABS 324MG A087448 001
QUINIDINE GLUCONATE
ANI PHARMS 324MG A087810 001 Sep 29, 1982
ASCOT 324MG A088582 001 Jun 17, 1985
CYCLE 324MG A088431 001 Jan 06, 1984
HALSEY 324MG A089476 001 Apr 10, 1987
RISING 324MG A089894 001 Dec 15, 1988
SUPERPHARM 324MG A089164 001 Nov 21, 1985
WATSON LABS 324MG A087785 001 Jan 24, 1983
QUINIDINE POLYGALACTURONATE
TABLET;ORAL
CARDIOQUIN
PHARM RES ASSOC 275MG N011642 002
QUINIDINE SULFATE
CAPSULE;ORAL
CIN-QUIN
SOLVAY 200MG A085296 001
300MG A085297 001
QUINIDINE SULFATE
LILLY 200MG A085103 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-405(of 478)
** See List Footnote
QUINIDINE SULFATE
TABLET;ORAL
CIN-QUIN
+ SOLVAY 100MG A085299 001
+ 200MG A084932 001
300MG A085298 001
QUINIDINE SULFATE
BARR 200MG A084177 001
CHARTWELL MOLECULAR 200MG A083743 001
CONTRACT PHARMACAL 200MG A083808 001
CYCLE 200MG A083640 001
300MG A085632 001
DAVA PHARMS INC 200MG A087011 001
ELKINS SINN 200MG A083622 001
EVERYLIFE 200MG A083439 001
HALSEY 200MG A083583 001
HIKMA 200MG A083862 001
IMPAX LABS 200MG A083347 001
IVAX SUB TEVA PHARMS 200MG A084549 001
KING PHARMS 200MG A085175 001
KV PHARM 200MG A085276 001
LEDERLE 200MG A086176 001
LILLY 200MG A085038 001
PERRIGO 200MG A085322 001
PHARMAVITE 200MG A084627 001
PUREPAC PHARM 200MG A084003 001
SANDOZ 200MG A084631 001
200MG A084914 001
300MG A089839 001 Sep 29, 1988
SCHERER LABS 200MG A085068 001
SUN PHARM INDUSTRIES 100MG A081029 001 Apr 14, 1989
200MG A081030 001 Apr 14, 1989
300MG A081031 001 Apr 14, 1989
SUPERPHARM 200MG A088973 001 Apr 10, 1985
USL PHARMA 200MG A087837 001 Apr 14, 1982
VALEANT PHARM INTL 200MG A083393 001
VANGARD 200MG A087909 001 Jul 13, 1982
VINTAGE PHARMS 200MG A083963 001
WARNER CHILCOTT 200MG A083879 001
WATSON LABS 100MG A085584 001
200MG A083288 001
200MG A085140 002
300MG A085583 001
WHITEWORTH TOWN PLSN 200MG A085444 001
QUINORA
KEY PHARMS 200MG A083576 001
+ SCHERING 300MG A085222 001
TABLET, EXTENDED RELEASE;ORAL
QUINIDEX
WYETH PHARMS INC 300MG N012796 002
QUINIDINE SULFATE
COSETTE 300MG A040045 001 Jun 30, 1994
QUININE SULFATE
CAPSULE;ORAL
QUININE SULFATE
MYLAN PHARMS INC 324MG A202581 001 Dec 14, 2012
RABEPRAZOLE SODIUM
CAPSULE, DELAYED RELEASE;ORAL
ACIPHEX SPRINKLE
+ AYTU 5MG N204736 001 Mar 26, 2013
+ 10MG N204736 002 Mar 26, 2013
TABLET, DELAYED RELEASE;ORAL
ACIPHEX
+ WOODWARD 10MG ** N020973 001 May 29, 2002
RABEPRAZOLE SODIUM
MYLAN 20MG A076885 001 Nov 08, 2013
TEVA PHARMS USA 20MG A076822 001 Nov 08, 2013

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-406(of 478)
** See List Footnote
RAMIPRIL
CAPSULE;ORAL
RAMIPRIL
ACTAVIS ELIZABETH 1.25MG A077513 001 Jun 18, 2008
2.5MG A077513 002 Jun 18, 2008
5MG A077513 003 Jun 18, 2008
10MG A077513 004 Jun 18, 2008
CHARTWELL RX 1.25MG A077514 001 Jun 18, 2008
2.5MG A077514 002 Jun 18, 2008
5MG A077514 003 Jun 18, 2008
10MG A077514 004 Jun 18, 2008
CIPLA 1.25MG A077004 001 Aug 07, 2008
2.5MG A077004 002 Aug 07, 2008
5MG A077004 003 Aug 07, 2008
10MG A077004 004 Aug 07, 2008
RANBAXY LABS LTD 5MG A078849 001 Mar 06, 2009
10MG A078849 002 Mar 06, 2009
TEVA PHARMS 1.25MG A077470 001 Jun 18, 2008
2.5MG A077470 002 Jun 18, 2008
5MG A077470 003 Jun 18, 2008
10MG A077470 004 Jun 18, 2008
WATSON LABS 5MG A076549 003 Oct 24, 2005
TABLET;ORAL
ALTACE
+ KING PFIZER 1.25MG ** N022021 001 Feb 27, 2007
+ 2.5MG ** N022021 002 Feb 27, 2007
+ 5MG ** N022021 003 Feb 27, 2007
+ 10MG ** N022021 004 Feb 27, 2007
RAMIPRIL
APOTEX 1.25MG A091069 001 Dec 02, 2015
2.5MG A091069 002 Dec 02, 2015
5MG A091069 003 Dec 02, 2015
10MG A091069 004 Dec 02, 2015
MYLAN PHARMS INC 1.25MG A090650 001 Jun 30, 2011
2.5MG A090650 002 Jun 30, 2011
5MG A090650 003 Jun 30, 2011
10MG A090650 004 Jun 30, 2011
ZYDUS PHARMS USA INC 1.25MG A090697 001 Sep 24, 2009
2.5MG A090697 002 Sep 24, 2009
5MG A090697 003 Sep 24, 2009
10MG A090697 004 Sep 24, 2009
RANITIDINE BISMUTH CITRATE
TABLET;ORAL
TRITEC
GLAXOSMITHKLINE 400MG N020559 001 Aug 08, 1996
RANITIDINE HYDROCHLORIDE
CAPSULE;ORAL
RANITIDINE HYDROCHLORIDE
AJANTA PHARMA LTD EQ 150MG BASE A209859 001 Sep 27, 2018
EQ 300MG BASE A209859 002 Sep 27, 2018
APPCO EQ 150MG BASE A211893 001 Apr 05, 2019
EQ 300MG BASE A211893 002 Apr 05, 2019
AUROBINDO PHARMA EQ 150MG BASE A211058 001 Jul 16, 2018
EQ 300MG BASE A211058 002 Jul 16, 2018
MYLAN EQ 150MG BASE A075564 001 Oct 27, 2000
EQ 300MG BASE A075564 002 Oct 27, 2000
NOVITIUM PHARMA EQ 150MG BASE A210681 001 Nov 23, 2018
EQ 300MG BASE A210681 002 Nov 23, 2018
TEVA EQ 150MG BASE A075557 001 Oct 31, 2003
EQ 300MG BASE A075557 002 Oct 31, 2003
ZANTAC 150
+ GLAXOSMITHKLINE EQ 150MG BASE ** N020095 001 Mar 08, 1994
ZANTAC 300
+ GLAXOSMITHKLINE EQ 300MG BASE ** N020095 002 Mar 08, 1994
GRANULE, EFFERVESCENT;ORAL
ZANTAC 150
GLAXO GRP LTD EQ 150MG BASE/PACKET N020251 002 Mar 31, 1994

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-407(of 478)
** See List Footnote
RANITIDINE HYDROCHLORIDE
INJECTABLE;INJECTION
RANITIDINE HYDROCHLORIDE
BEDFORD EQ 25MG BASE/ML A074764 001 Nov 19, 2004
MYLAN LABS LTD EQ 25MG BASE/ML A079076 001 Jun 09, 2016
ZANTAC IN PLASTIC CONTAINER
PAI HOLDINGS PHARM EQ 1MG BASE/ML N019593 002 Sep 27, 1991
EQ 50MG BASE/100ML N019593 001 Dec 17, 1986
SYRUP;ORAL
RANITIDINE HYDROCHLORIDE
ACTAVIS MID ATLANTIC EQ 15MG BASE/ML A076124 001 Feb 21, 2007
AKORN EQ 15MG BASE/ML A091078 001 Mar 22, 2011
AMNEAL PHARMS EQ 15MG BASE/ML A078312 001 Sep 02, 2008
APOTEX INC EQ 15MG BASE/ML A077602 001 Sep 17, 2007
AUROBINDO PHARMA EQ 15MG BASE/ML A090623 001 Jul 28, 2010
LANNETT CO INC EQ 15MG BASE/ML A078890 001 Jul 01, 2010
NOSTRUM LABS INC EQ 15MG BASE/ML A078684 001 Aug 27, 2009
EQ 15MG BASE/ML A091091 001 Sep 20, 2011
RANBAXY EQ 15MG BASE/ML A078448 001 Dec 13, 2007
TARO EQ 15MG BASE/ML A077476 001 Jun 13, 2011
TOLMAR EQ 15MG BASE/ML A090054 001 Nov 15, 2010
TORRENT EQ 15MG BASE/ML A090102 001 May 26, 2009
WOCKHARDT EQ 15MG BASE/ML A079211 001 May 26, 2009
EQ 15MG BASE/ML A079212 001 Feb 23, 2009
ZANTAC
+ GLAXO GRP LTD EQ 15MG BASE/ML N019675 001 Dec 30, 1988
TABLET;ORAL
RANITIDINE HYDROCHLORIDE
AMNEAL PHARMS NY EQ 150MG BASE A077824 001 Oct 13, 2006
EQ 300MG BASE A077824 002 Oct 13, 2006
ANI PHARMS EQ 75MG BASE A075212 001 Jan 14, 2000
EQ 75MG BASE A075296 001 Jan 14, 2000
EQ 150MG BASE A074488 001 Jul 31, 1997
EQ 150MG BASE A077426 001 Dec 19, 2005
EQ 300MG BASE A074488 002 Jul 31, 1997
EQ 300MG BASE A077426 002 Dec 19, 2005
APOTEX INC EQ 75MG BASE A075167 001 May 04, 2000
EQ 150MG BASE A200172 001 May 31, 2012
AUROBINDO PHARMA EQ 75MG BASE A207579 001 Nov 13, 2017
EQ 150MG BASE A207578 001 Nov 13, 2017
BOEHRINGER INGELHEIM EQ 150MG BASE A074662 001 Aug 29, 1997
EQ 300MG BASE A074662 002 Aug 29, 1997
CONTRACT PHARMACAL EQ 75MG BASE A075094 001 Jun 21, 1999
GRANULES EQ 150MG BASE A210243 001 Aug 20, 2018
EQ 150MG BASE A210243 002 Aug 20, 2018
HERITAGE PHARMA AVET EQ 150MG BASE A075165 001 Sep 30, 1998
EQ 300MG BASE A075165 002 Sep 30, 1998
MYLAN EQ 75MG BASE A075497 001 Jan 14, 2000
EQ 150MG BASE A074023 001 Aug 22, 1997
EQ 150MG BASE A074552 001 Jul 30, 1998
EQ 300MG BASE A074023 002 Aug 22, 1997
EQ 300MG BASE A074552 002 Jul 30, 1998
NOSTRUM LABS INC EQ 150MG BASE A203694 001 Nov 30, 2017
EQ 300MG BASE A203694 002 Nov 30, 2017
PERRIGO EQ 75MG BASE A076195 001 Aug 30, 2002
PERRIGO R AND D EQ 150MG BASE A091429 001 May 11, 2011
EQ 150MG BASE A091429 002 May 11, 2011
RANBAXY EQ 75MG BASE A075254 001 Jan 14, 2000
EQ 150MG BASE A075000 001 Jan 30, 1998
EQ 300MG BASE A075000 002 Jan 30, 1998
SANDOZ EQ 75MG BASE A075519 001 Sep 26, 2002
STRIDES PHARMA EQ 75MG BASE A201745 001 Feb 29, 2012
EQ 75MG BASE A209160 001 Mar 05, 2018
EQ 150MG BASE A200536 001 Jun 28, 2011
EQ 150MG BASE A205512 001 Aug 22, 2016
EQ 150MG BASE A209161 001 Feb 22, 2018
EQ 150MG BASE A210010 001 Aug 01, 2018
EQ 300MG BASE A205512 002 Aug 22, 2016
EQ 300MG BASE A210010 002 Aug 01, 2018

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-408(of 478)
** See List Footnote
RANITIDINE HYDROCHLORIDE
TABLET;ORAL
RANITIDINE HYDROCHLORIDE
SUN PHARM INDS LTD EQ 75MG BASE A075132 001 Jan 14, 2000
EQ 150MG BASE A075439 001 Apr 19, 2000
EQ 300MG BASE A075439 002 Apr 19, 2000
WATSON LABS EQ 150MG BASE A074864 001 Oct 20, 1997
EQ 300MG BASE A074864 002 Oct 20, 1997
WOCKHARDT EQ 75MG BASE A076760 001 Feb 24, 2006
EQ 75MG BASE A078884 001 Jul 31, 2008
EQ 150MG BASE A078653 001 Nov 26, 2007
EQ 150MG BASE A078701 001 Nov 12, 2009
EQ 300MG BASE A078701 002 Dec 11, 2009
WOCKHARDT LTD EQ 150MG BASE A075208 001 Dec 17, 1998
EQ 300MG BASE A075208 002 Dec 17, 1998
ZANTAC 150
+ CHATTEM SANOFI EQ 150MG BASE N021698 001 Aug 31, 2004
+ EQ 150MG BASE N021698 002 Mar 13, 2007
+ GLAXO GRP LTD EQ 150MG BASE ** N018703 001 Jun 09, 1983
ZANTAC 300
+ GLAXO GRP LTD EQ 300MG BASE ** N018703 002 Dec 09, 1985
ZANTAC 75
+ CHATTEM SANOFI EQ 75MG BASE N020520 001 Dec 19, 1995
TABLET, EFFERVESCENT;ORAL
ZANTAC 150
GLAXO GRP LTD EQ 150MG BASE N020251 001 Mar 31, 1994
ZANTAC 25
GLAXO GRP LTD EQ 25MG BASE N020251 003 Apr 01, 2004
ZANTAC 75
+ CHATTEM SANOFI EQ 75MG BASE ** N020745 001 Feb 26, 1998
RANOLAZINE
TABLET, EXTENDED RELEASE;ORAL
RANOLAZINE
ACCORD HLTHCARE 500MG A212930 001 May 18, 2021
1GM A212930 002 May 18, 2021
AMNEAL 500MG A207690 001 Mar 11, 2021
1GM A207690 002 Mar 11, 2021
ANI PHARMS 500MG A210482 001 Oct 29, 2019
1GM A210482 002 Oct 29, 2019
CIPLA 500MG A211291 001 May 28, 2019
1GM A211291 002 May 28, 2019
RAPACURONIUM BROMIDE
INJECTABLE;INJECTION
RAPLON
ORGANON USA INC 100MG/VIAL N020984 001 Aug 18, 1999
200MG/VIAL N020984 002 Aug 18, 1999
RASAGILINE MESYLATE
TABLET;ORAL
RASAGILINE MESYLATE
APOTEX INC EQ 0.5MG BASE A201950 001 Sep 12, 2013
EQ 1MG BASE A201950 002 Sep 12, 2013
DR REDDYS EQ 0.5MG BASE A201942 001 Nov 18, 2021
EQ 1MG BASE A201942 002 Nov 18, 2021
WATSON LABS INC EQ 0.5MG BASE A201823 001 Jul 01, 2013
EQ 1MG BASE A201823 002 Jul 01, 2013
RAUWOLFIA SERPENTINA ROOT
TABLET;ORAL
HIWOLFIA
BOWMAN PHARMS 50MG N009276 003
50MG N009276 005
100MG N009276 004
HYSERPIN
PHYS PRODS VA 50MG N010581 001
KOGLUCOID
PANRAY 50MG N009278 001
100MG N009278 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-409(of 478)
** See List Footnote
RAUWOLFIA SERPENTINA ROOT
TABLET;ORAL
RAUDIXIN
APOTHECON 50MG N008842 001
100MG N008842 002
RAUSERPIN
FERNDALE LABS 50MG N009926 002
100MG N009926 004
RAUVAL
PAL PAK 50MG N009108 002
100MG N009108 004
RAUWOLFIA SERPENTINA
BUNDY 50MG N009477 001
100MG N009477 002
HALSEY 50MG A080498 001
100MG A080498 002
IMPAX LABS 50MG N009273 001
100MG N009273 002
IVAX SUB TEVA PHARMS 50MG N011521 001
100MG N011521 002
PUREPAC PHARM 50MG A080842 001
100MG A080842 002
PVT FORM 50MG A080583 001
100MG A080583 002
SOLVAY 50MG A080500 001
100MG A080500 002
TABLICAPS 50MG A083867 001
100MG A083444 001
VALEANT PHARM INTL 50MG N009668 001
100MG N009668 002
WATSON LABS 50MG A080907 001
100MG A080914 001
WOLFINA
FOREST PHARMS 50MG N009255 008
100MG N009255 006
REGADENOSON
SOLUTION;INTRAVENOUS
REGADENOSON
IMS LTD 0.4MG/5ML (0.08MG/ML) A214252 001 May 23, 2022
REPAGLINIDE
TABLET;ORAL
PRANDIN
+ GEMINI LABS LLC 0.5MG ** N020741 001 Dec 22, 1997
+ 1MG ** N020741 002 Dec 22, 1997
+ 2MG ** N020741 003 Dec 22, 1997
REPAGLINIDE
ACTAVIS TOTOWA 0.5MG A090008 001 Jan 22, 2014
1MG A090008 002 Jan 22, 2014
2MG A090008 003 Jan 22, 2014
BOSCOGEN 0.5MG A091517 001 Apr 24, 2015
1MG A091517 002 Apr 24, 2015
2MG A091517 003 Apr 24, 2015
MYLAN 0.5MG A090252 001 Aug 23, 2013
1MG A090252 002 Jan 22, 2014
2MG A090252 003 Jan 22, 2014
RESCINNAMINE
CAPSULE;ORAL
CINNASIL
PANRAY 0.5MG A084736 001
TABLET;ORAL
MODERIL
PFIZER 0.25MG N010686 003
0.5MG N010686 006

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-410(of 478)
** See List Footnote
RESERPINE
ELIXIR;ORAL
SERPASIL
NOVARTIS 0.2MG/4ML N009115 005
INJECTABLE;INJECTION
SANDRIL
LILLY 2.5MG/ML N010012 001
SERPASIL
NOVARTIS 2.5MG/ML N009434 002
TABLET;ORAL
HISERPIA
BOWMAN PHARMS 0.1MG N009631 002
0.25MG N009631 004
RAU-SED
BRISTOL MYERS SQUIBB 0.1MG N009357 001
0.25MG N009357 004
0.5MG N009357 006
1MG N009357 008
RESERPINE
BARR 0.25MG A080721 002
BELL PHARMA 0.1MG A083058 001
0.25MG A083058 002
BUNDY 0.1MG N009663 001
0.25MG N009663 003
CYCLE 0.1MG N009859 001
0.25MG N009859 002
ELKINS SINN 0.1MG A083145 001
0.25MG A083145 002
EVERYLIFE 0.1MG N010441 001
0.25MG N010441 002
0.5MG N010441 003
1MG N010441 004
HALSEY 0.1MG A080457 002
0.25MG A080457 001
1MG A080457 003
HIKMA INTL PHARMS 0.1MG A080975 001
0.25MG A080975 002
1MG A080975 003
IMPAX LABS 0.1MG N009627 001
0.25MG N009627 002
IVAX SUB TEVA PHARMS 0.1MG N011185 001
0.25MG N011185 002
MARSHALL PHARMA 0.1MG A080492 001
0.25MG A080492 002
MK LABS 0.1MG A080525 002
0.25MG A080525 001
MYLAN 1MG A084974 001
PHARMAVITE 0.25MG A084663 001
PUREPAC PHARM 0.1MG A080753 002
0.25MG A080753 001
PVT FORM 0.1MG A086117 001
0.25MG A080582 001
0.25MG A085775 001
1MG A080582 002
REXALL 0.25MG A080637 001
+ SANDOZ 0.1MG N009838 001
+ 0.25MG N009838 002
SOLVAY 0.25MG A080446 001
TABLICAPS 0.25MG A085207 001
TEVA 0.1MG A089020 001 Mar 07, 1985
0.25MG A089019 001 Mar 07, 1985
VALEANT PHARM INTL 0.1MG N009667 001
0.25MG N009667 002
WATSON LABS 0.1MG A080679 001
0.25MG A080393 001
0.25MG A085401 001
1MG A080749 001
WHITEWORTH TOWN PLSN 0.1MG A080723 001
0.25MG A080723 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-411(of 478)
** See List Footnote
RESERPINE
TABLET;ORAL
RESERPINE
1MG A080723 003
SANDRIL
LILLY 0.1MG N009376 004
0.25MG N009376 001
SERPALAN
LANNETT 0.1MG N010124 001
0.25MG N010124 002
SERPANRAY
PANRAY 0.1MG N009391 001
0.25MG N009391 002
1MG N009391 004
SERPASIL
NOVARTIS 0.1MG N009115 001
0.25MG N009115 003
1MG N009115 004
SERPATE
VALE 0.1MG N009453 001
0.25MG N009453 002
SERPIVITE
VITARINE 0.25MG N009645 002
RESERPINE; TRICHLORMETHIAZIDE
TABLET;ORAL
METATENSIN #2
SANOFI AVENTIS US 0.1MG;2MG N012972 001
METATENSIN #4
SANOFI AVENTIS US 0.1MG;4MG N012972 002
NAQUIVAL
SCHERING 0.1MG;4MG N012265 003
TRICHLORMETHIAZIDE W/ RESERPINE
WATSON LABS 0.1MG;4MG A085248 001
RIBAVIRIN
CAPSULE;ORAL
REBETOL
MERCK SHARP DOHME 200MG**Indicated for use and comarketed N020903 001 Jun 03, 1998
with Interferon ALFA-2B, Recombinant
(INTRON A), as Rebetron Combination
Therapy**
+ 200MG N020903 002 Jul 25, 2001
RIBASPHERE
CHARTWELL RX 200MG A076203 001 Apr 06, 2004
RIBAVIRIN
CHARTWELL RX 200MG A076192 001 Apr 06, 2004
TEVA 200MG A076277 001 Oct 04, 2004
SOLUTION;ORAL
REBETOL
+ SCHERING 40MG/ML N021546 001 Jul 29, 2003
TABLET;ORAL
COPEGUS
+ ROCHE 200MG ** N021511 001 Dec 03, 2002
+ 400MG ** N021511 002 Jun 21, 2005
RIBAVIRIN
BEXIMCO PHARMS USA 200MG A202546 001 Aug 12, 2014
400MG A202546 002 Aug 12, 2014
500MG A202546 003 Aug 12, 2014
600MG A202546 004 Aug 12, 2014
CHARTWELL RX 200MG A077456 001 Dec 05, 2005
400MG A077456 002 Dec 05, 2005
600MG A077456 003 Dec 05, 2005
HERITAGE PHARMA AVET 200MG A077053 001 Dec 05, 2005
ZYDUS PHARMS USA 400MG A077094 002 Mar 16, 2007
500MG A077094 004 Apr 18, 2008
600MG A077094 003 Mar 16, 2007

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-412(of 478)
** See List Footnote
RIFAMPIN
CAPSULE;ORAL
RIFADIN
SANOFI AVENTIS US 150MG A062303 001
+ 300MG N050420 001
INJECTABLE;INJECTION
RIFAMPIN
EMCURE PHARMS LTD 600MG/VIAL A204101 001 Aug 18, 2014
WATSON PHARMS TEVA 600MG/VIAL A206736 001 Jan 19, 2016
RILUZOLE
TABLET;ORAL
RILUZOLE
APOTEX CORP 50MG A091300 001 Jun 18, 2013
DAITO PHARMS CO LTD 50MG A204430 001 Oct 16, 2018
RIMANTADINE HYDROCHLORIDE
SYRUP;ORAL
FLUMADINE
FOREST LABS 50MG/5ML N019650 001 Sep 17, 1993
TABLET;ORAL
RIMANTADINE HYDROCHLORIDE
HERITAGE PHARMA AVET 100MG A076375 001 Jan 14, 2003
IMPAX LABS INC 100MG A075916 001 Nov 02, 2001
RIMEXOLONE
SUSPENSION/DROPS;OPHTHALMIC
VEXOL
EYEVANCE 1% N020474 001 Dec 30, 1994
RISEDRONATE SODIUM
TABLET;ORAL
ACTONEL
+ APIL 5MG N020835 002 Apr 14, 2000
+ 30MG N020835 001 Mar 27, 1998
+ 75MG ** N020835 004 Apr 16, 2007
RISEDRONATE SODIUM
HANGZHOU BINJIANG 35MG A207516 001 Feb 15, 2019
MYLAN 5MG A200477 001 Nov 30, 2015
30MG A200477 002 Nov 30, 2015
35MG A200477 003 Nov 30, 2015
75MG A200477 004 Jun 10, 2014
150MG A200477 005 Jun 10, 2014
TABLET, DELAYED RELEASE;ORAL
RISEDRONATE SODIUM
IMPAX LABS INC 35MG A205066 001 Jun 29, 2018
ZYDUS PHARMS 35MG A203822 001 Sep 11, 2018
RISPERIDONE
SOLUTION;ORAL
RISPERIDONE
ANI PHARMS 1MG/ML A076440 001 Jan 30, 2009
PRECISION DOSE 1MG/ML A076797 001 Jun 28, 2010
TORRENT 1MG/ML A078909 001 Jul 29, 2009
WOCKHARDT 1MG/ML A078744 001 Oct 08, 2009
TABLET;ORAL
RISPERDAL
JANSSEN PHARMS 5MG N020272 005 Dec 29, 1993
RISPERIDONE
HERITAGE PHARMA AVET 0.25MG A076228 001 Jun 30, 2008
0.25MG A077769 001 Oct 16, 2008
0.5MG A076228 002 Jun 30, 2008
0.5MG A077769 002 Oct 16, 2008
1MG A076228 003 Jun 30, 2008
1MG A077769 003 Oct 16, 2008
2MG A076228 004 Jun 30, 2008
2MG A077769 004 Oct 16, 2008
3MG A076228 005 Jun 30, 2008
3MG A077769 005 Oct 16, 2008
4MG A076228 006 Jun 30, 2008
4MG A077769 006 Oct 16, 2008
JUBILANT CADISTA 0.25MG A078828 001 Mar 23, 2009

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-413(of 478)
** See List Footnote
RISPERIDONE
TABLET;ORAL
RISPERIDONE
0.5MG A078828 002 Mar 23, 2009
1MG A078828 003 Mar 23, 2009
2MG A078828 004 Mar 23, 2009
3MG A078828 005 Mar 23, 2009
4MG A078828 006 Mar 23, 2009
MYLAN 0.25MG A076288 001 Sep 15, 2008
0.5MG A076288 002 Sep 15, 2008
1MG A076288 003 Sep 15, 2008
2MG A076288 004 Sep 15, 2008
3MG A076288 005 Sep 15, 2008
4MG A076288 006 Sep 15, 2008
RATIOPHARM 0.25MG A077784 001 Jun 08, 2010
0.5MG A077784 002 Jun 08, 2010
1MG A077784 003 Jun 08, 2010
2MG A077784 004 Jun 08, 2010
3MG A077784 005 Jun 08, 2010
4MG A077784 006 Jun 08, 2010
SUN PHARM INDS INC 0.25MG A078036 001 Mar 10, 2014
0.5MG A078036 002 Mar 10, 2014
1MG A078036 003 Mar 10, 2014
2MG A078036 004 Mar 10, 2014
3MG A078036 005 Mar 10, 2014
4MG A078036 006 Mar 10, 2014
SYNTHON PHARMS 0.25MG A078187 001 Oct 22, 2009
0.5MG A078187 002 Oct 22, 2009
1MG A078187 003 Oct 22, 2009
2MG A078187 004 Oct 22, 2009
3MG A078187 005 Oct 22, 2009
4MG A078187 006 Oct 22, 2009
WATSON LABS 0.25MG A077860 001 Dec 05, 2008
0.5MG A077860 002 Dec 05, 2008
1MG A077860 003 Dec 05, 2008
2MG A077860 004 Dec 05, 2008
3MG A077860 005 Dec 05, 2008
4MG A077860 006 Dec 05, 2008
WEST WARD PHARMS 0.25MG A078740 001 May 29, 2009
0.5MG A078740 002 May 29, 2009
1MG A078740 003 May 29, 2009
2MG A078740 004 May 29, 2009
3MG A078740 005 May 29, 2009
4MG A078740 006 May 29, 2009
TABLET, ORALLY DISINTEGRATING;ORAL
RISPERDAL
+ JANSSEN PHARMS 0.5MG ** N021444 001 Apr 02, 2003
+ 1MG ** N021444 002 Apr 02, 2003
+ 2MG ** N021444 003 Apr 02, 2003
+ 3MG ** N021444 004 Dec 23, 2004
+ 4MG ** N021444 005 Dec 23, 2004
RISPERIDONE
ACTAVIS LABS FL INC 0.5MG A076996 001 Apr 19, 2011
1MG A076996 002 Apr 19, 2011
2MG A076996 003 Apr 19, 2011
3MG A076996 004 Apr 19, 2011
4MG A076996 005 Apr 19, 2011
HERITAGE PHARMA AVET 0.5MG A076908 001 Mar 12, 2012
1MG A076908 002 Mar 12, 2012
2MG A076908 003 Mar 12, 2012
MYLAN PHARMS INC 0.25MG A091537 006 Feb 12, 2013
0.5MG A091537 001 Mar 30, 2011
1MG A091537 002 Mar 30, 2011
2MG A091537 003 Mar 30, 2011
3MG A091537 004 Mar 30, 2011
4MG A091537 005 Mar 30, 2011

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-414(of 478)
** See List Footnote
RITODRINE HYDROCHLORIDE
INJECTABLE;INJECTION
RITODRINE HYDROCHLORIDE
ABRAXIS PHARM 10MG/ML A071188 001 Jul 23, 1987
15MG/ML A071189 001 Jul 23, 1987
HOSPIRA 10MG/ML A071618 001 Feb 28, 1991
15MG/ML A071619 001 Feb 28, 1991
RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
HOSPIRA 30MG/100ML A071438 001 Jan 22, 1991
YUTOPAR
ASTRAZENECA 10MG/ML N018580 001
15MG/ML N018580 002 Sep 27, 1984
TABLET;ORAL
YUTOPAR
ASTRAZENECA 10MG N018555 001
RITONAVIR
CAPSULE;ORAL
NORVIR
ABBOTT 100MG N020680 001 Mar 01, 1996
+ ABBVIE 100MG ** N020945 001 Jun 29, 1999
RITONAVIR
HIKMA 100MG A205801 001 Dec 03, 2020
RIVASTIGMINE TARTRATE
CAPSULE;ORAL
EXELON
+ NOVARTIS EQ 1.5MG BASE ** N020823 003 Apr 21, 2000
+ EQ 3MG BASE ** N020823 004 Apr 21, 2000
+ EQ 4.5MG BASE ** N020823 005 Apr 21, 2000
+ EQ 6MG BASE ** N020823 006 Apr 21, 2000
RIVASTIGMINE TARTRATE
APOTEX INC EQ 1.5MG BASE A091072 001 May 16, 2013
EQ 3MG BASE A091072 002 May 16, 2013
EQ 4.5MG BASE A091072 003 May 16, 2013
EQ 6MG BASE A091072 004 May 16, 2013
SOLUTION;ORAL
EXELON
NOVARTIS EQ 2MG BASE/ML N021025 001 Apr 21, 2000
RIZATRIPTAN BENZOATE
TABLET;ORAL
MAXALT
+ ORGANON LLC EQ 5MG BASE ** N020864 001 Jun 29, 1998
RIZATRIPTAN BENZOATE
APOTEX INC EQ 5MG BASE A202244 001 Dec 31, 2012
EQ 10MG BASE A202244 002 Dec 31, 2012
EMCURE PHARMS LTD EQ 5MG BASE A204090 001 Nov 26, 2013
EQ 10MG BASE A204090 002 Nov 26, 2013
JUBILANT GENERICS EQ 5MG BASE A203252 001 Dec 31, 2014
EQ 10MG BASE A203252 002 Dec 31, 2014
SANDOZ EQ 5MG BASE A079230 001 Dec 31, 2012
EQ 10MG BASE A079230 002 Dec 31, 2012
UNICHEM EQ 5MG BASE A207836 001 Mar 07, 2017
EQ 10MG BASE A207836 002 Mar 07, 2017
TABLET, ORALLY DISINTEGRATING;ORAL
MAXALT-MLT
+ ORGANON EQ 5MG BASE ** N020865 001 Jun 29, 1998
RIZATRIPTAN BENZOATE
APOTEX INC EQ 5MG BASE A202477 001 Jul 01, 2013
EQ 10MG BASE A202477 002 Jul 01, 2013
JUBILANT GENERICS EQ 5MG BASE A203334 001 Oct 16, 2015
EQ 10MG BASE A203334 002 Oct 16, 2015
MYLAN PHARMS INC EQ 5MG BASE A078173 001 Dec 31, 2012
EQ 10MG BASE A078173 002 Dec 31, 2012
SANDOZ EQ 5MG BASE A078739 001 Jul 01, 2013
EQ 10MG BASE A078739 002 Jul 01, 2013

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-415(of 478)
** See List Footnote
ROCURONIUM BROMIDE
INJECTABLE;INJECTION
ROCURONIUM BROMIDE
TEVA PHARMS 50MG/5ML (10MG/ML) A078717 001 Nov 26, 2008
100MG/10ML (10MG/ML) A078717 002 Nov 26, 2008
ZEMURON
+ ORGANON USA INC 50MG/5ML (10MG/ML) ** N020214 001 Mar 17, 1994
+ 10MG/ML (10MG/ML) ** N020214 002 Mar 17, 1994
+ 100MG/10ML (10MG/ML) ** N020214 003 Mar 17, 1994
ROFECOXIB
SUSPENSION;ORAL
VIOXX
MERCK 12.5MG/5ML N021052 001 May 20, 1999
25MG/5ML N021052 002 May 20, 1999
TABLET;ORAL
VIOXX
MERCK 12.5MG N021042 001 May 20, 1999
25MG N021042 002 May 20, 1999
50MG N021042 003 Feb 25, 2000
ROFLUMILAST
TABLET;ORAL
ROFLUMILAST
BRECKENRIDGE 500MCG A208236 001 Oct 03, 2018
ROLAPITANT HYDROCHLORIDE
EMULSION;INTRAVENOUS
VARUBI
+ TERSERA EQ 166.5MG BASE/92.5ML (EQ 1.8MG N208399 001 Oct 25, 2017
BASE/ML)
ROMIDEPSIN
SOLUTION;INTRAVENOUS
ROMIDEPSIN
+ TEVA PHARMS USA INC 10MG/2ML (5MG/ML) N208574 001 Mar 13, 2020
+ 27.5MG/5.5ML (5MG/ML) N208574 002 Mar 13, 2020
ROPINIROLE HYDROCHLORIDE
TABLET;ORAL
REQUIP
+ GLAXOSMITHKLINE LLC EQ 0.25MG BASE N020658 001 Sep 19, 1997
+ EQ 0.5MG BASE N020658 002 Sep 19, 1997
+ EQ 1MG BASE N020658 003 Sep 19, 1997
+ EQ 2MG BASE N020658 004 Sep 19, 1997
+ EQ 3MG BASE N020658 006 Jan 27, 1999
+ EQ 4MG BASE N020658 007 Jan 27, 1999
+ EQ 5MG BASE N020658 005 Sep 19, 1997
ROPINIROLE HYDROCHLORIDE
COSETTE EQ 0.25MG BASE A077460 001 May 05, 2008
EQ 0.5MG BASE A077460 002 May 05, 2008
EQ 1MG BASE A077460 003 May 05, 2008
EQ 2MG BASE A077460 004 May 05, 2008
EQ 3MG BASE A077460 005 May 05, 2008
EQ 4MG BASE A077460 006 May 05, 2008
EQ 5MG BASE A077460 007 May 19, 2008
EPIC PHARMA LLC EQ 0.25MG BASE A078230 001 May 20, 2008
EQ 0.5MG BASE A078230 002 May 20, 2008
EQ 1MG BASE A078230 003 May 20, 2008
EQ 2MG BASE A078230 004 May 20, 2008
EQ 3MG BASE A078230 005 May 20, 2008
EQ 4MG BASE A078230 006 May 20, 2008
EQ 5MG BASE A078230 007 May 20, 2008
HIKMA EQ 0.25MG BASE A077852 001 May 05, 2008
EQ 0.5MG BASE A077852 002 May 05, 2008
EQ 1MG BASE A077852 003 May 05, 2008
EQ 2MG BASE A077852 004 May 05, 2008
EQ 3MG BASE A077852 005 May 05, 2008
EQ 4MG BASE A077852 006 May 05, 2008
EQ 5MG BASE A077852 007 May 19, 2008

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-416(of 478)
** See List Footnote
ROPINIROLE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
REQUIP XL
+ GLAXOSMITHKLINE LLC EQ 2MG BASE ** N022008 001 Jun 13, 2008
+ EQ 3MG BASE ** N022008 002 Jun 13, 2008
+ EQ 4MG BASE ** N022008 003 Jun 13, 2008
+ EQ 6MG BASE ** N022008 006 Apr 10, 2009
+ EQ 8MG BASE ** N022008 004 Jun 13, 2008
+ EQ 12MG BASE ** N022008 005 Oct 31, 2008
ROPINIROLE HYDROCHLORIDE
MYLAN PHARMS INC EQ 2MG BASE A200462 001 Oct 15, 2012
EQ 3MG BASE A200462 002 Oct 15, 2012
EQ 4MG BASE A200462 003 Oct 15, 2012
EQ 6MG BASE A200462 004 Oct 15, 2012
EQ 8MG BASE A200462 005 Oct 15, 2012
EQ 12MG BASE A200462 006 Oct 15, 2012
WATSON LABS INC EQ 2MG BASE A200431 001 Jun 06, 2012
EQ 4MG BASE A200431 002 Jun 06, 2012
EQ 6MG BASE A200431 003 Jun 06, 2012
EQ 8MG BASE A200431 004 Jun 06, 2012
EQ 12MG BASE A200431 005 Jun 06, 2012
ROPIVACAINE HYDROCHLORIDE
SOLUTION;INJECTION
NAROPIN
+ FRESENIUS KABI USA 50MG/10ML (5MG/ML) N020533 013 May 01, 1998
+ 75MG/10ML (7.5MG/ML) N020533 012 Sep 24, 1996
ROPIVACAINE HYDROCHLORIDE
RISING 40MG/20ML (2MG/ML) A090318 001 Sep 23, 2014
150MG/30ML (5MG/ML) A090318 002 Sep 23, 2014
150MG/20ML (7.5MG/ML) A090318 003 Sep 23, 2014
200MG/20ML (10MG/ML) A090318 004 Sep 23, 2014
ROSE BENGAL SODIUM I-131
INJECTABLE;INJECTION
ROBENGATOPE
BRACCO 0.5mCi/VIAL N016224 001
1mCi/VIAL N016224 002
2mCi/VIAL N016224 003
SODIUM ROSE BENGAL I 131
SORIN 0.5mCi/ML N017318 001
ROSIGLITAZONE MALEATE
TABLET;ORAL
AVANDIA
+ WOODWARD EQ 8MG BASE ** N021071 004 May 25, 1999
ROSIGLITAZONE MALEATE
ANI PHARMS EQ 2MG BASE A076747 001 Jan 25, 2013
EQ 4MG BASE A076747 002 Jan 25, 2013
EQ 8MG BASE A076747 003 Jan 25, 2013
ROSUVASTATIN CALCIUM
TABLET;ORAL
ROSUVASTATIN CALCIUM
AMNEAL PHARMS CO EQ 5MG BASE A208850 001 Oct 16, 2018
EQ 10MG BASE A208850 002 Oct 16, 2018
EQ 20MG BASE A208850 003 Oct 16, 2018
EQ 40MG BASE A208850 004 Oct 16, 2018
APOTEX INC EQ 5MG BASE A079145 001 Jul 19, 2016
EQ 10MG BASE A079145 002 Jul 19, 2016
EQ 20MG BASE A079145 003 Jul 19, 2016
EQ 40MG BASE A079145 004 Jul 19, 2016
INVENTIA EQ 5MG BASE A207653 001 Feb 05, 2021
EQ 10MG BASE A207653 002 Feb 05, 2021
EQ 20MG BASE A207653 003 Feb 05, 2021
EQ 40MG BASE A207653 004 Feb 05, 2021
STRIDES PHARMA EQ 5MG BASE A079161 001 Jul 19, 2016
EQ 10MG BASE A079161 002 Jul 19, 2016
EQ 20MG BASE A079161 003 Jul 19, 2016
EQ 40MG BASE A079161 004 Jul 19, 2016
SUNSHINE EQ 5MG BASE A210667 001 Apr 01, 2020

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-417(of 478)
** See List Footnote
ROSUVASTATIN CALCIUM
TABLET;ORAL
ROSUVASTATIN CALCIUM
EQ 10MG BASE A210667 002 Apr 01, 2020
EQ 20MG BASE A210667 003 Apr 01, 2020
EQ 40MG BASE A210667 004 Apr 01, 2020
TEVA PHARMS USA EQ 5MG BASE A079166 001 Jul 19, 2016
EQ 10MG BASE A079166 002 Jul 19, 2016
EQ 20MG BASE A079166 003 Jul 19, 2016
EQ 40MG BASE A079166 004 Jul 19, 2016
UMEDICA LABS PVT LTD EQ 5MG BASE A207626 001 Apr 09, 2019
EQ 10MG BASE A207626 002 Apr 09, 2019
EQ 20MG BASE A207626 003 Apr 09, 2019
EQ 40MG BASE A207626 004 Apr 09, 2019
ZHEJIANG JINGXIN EQ 5MG BASE A206513 001 Mar 01, 2019
EQ 10MG BASE A206513 002 Mar 01, 2019
EQ 20MG BASE A206513 003 Mar 01, 2019
EQ 40MG BASE A206513 004 Mar 01, 2019
RUFINAMIDE
TABLET;ORAL
BANZEL
+ EISAI INC 100MG ** N021911 001 Nov 14, 2008
SAFFLOWER OIL
INJECTABLE;INJECTION
LIPOSYN 10%
ABBOTT 10% (10GM/100ML) N018203 001
LIPOSYN 20%
ABBOTT 20% (20GM/100ML) N018614 001
SAFFLOWER OIL; SOYBEAN OIL
INJECTABLE;INJECTION
LIPOSYN II 10%
HOSPIRA 5%;5% (5GM/100ML) N018997 001 Aug 27, 1984
LIPOSYN II 20%
HOSPIRA 10%;10% (10GM/100ML) N018991 001 Aug 27, 1984
SALMETEROL XINAFOATE
AEROSOL, METERED;INHALATION
SEREVENT
GLAXOSMITHKLINE EQ 0.021MG BASE/INH N020236 001 Feb 04, 1994
SAMARIUM SM-153 LEXIDRONAM PENTASODIUM
INJECTABLE;INJECTION
QUADRAMET
+ LANTHEUS MEDICAL 50mCi/ML N020570 001 Mar 28, 1997
SAQUINAVIR
CAPSULE;ORAL
FORTOVASE
+ HOFFMANN LA ROCHE 200MG ** N020828 001 Nov 07, 1997
SAQUINAVIR MESYLATE
CAPSULE;ORAL
INVIRASE
+ HOFFMANN LA ROCHE EQ 200MG BASE N020628 001 Dec 06, 1995
TABLET;ORAL
INVIRASE
+ HOFFMANN-LA ROCHE EQ 500MG BASE N021785 001 Dec 17, 2004
SARALASIN ACETATE
INJECTABLE;INJECTION
SARENIN
PROCTER AND GAMBLE EQ 0.6MG BASE/ML N018009 001
SECOBARBITAL SODIUM
CAPSULE;ORAL
SECOBARBITAL SODIUM
ANABOLIC 100MG A084422 001
BARR 100MG A084225 001
EVERYLIFE 100MG A085895 001
HALSEY 100MG A084676 001
IVAX PHARMS 100MG A085869 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-418(of 478)
** See List Footnote
SECOBARBITAL SODIUM
CAPSULE;ORAL
SECOBARBITAL SODIUM
KV PHARM 100MG A085285 001
LANNETT 50MG A085909 001
100MG A085903 001
PARKE DAVIS 100MG A084762 001
PERRIGO 100MG A084561 001
PUREPAC PHARM 100MG A085867 001
VALEANT PHARM INTL 100MG A085477 001
VITARINE 100MG A085898 001
100MG A086273 001
WATSON LABS 100MG A085792 001
WEST WARD 100MG A084926 001
WHITEWORTH TOWN PLSN 100MG A085798 001
WYETH AYERST 100MG A086390 001
SECONAL SODIUM
VALEANT PHARMS NORTH 50MG A086101 001 Oct 03, 1983
100MG A086101 002 Oct 03, 1983
INJECTABLE;INJECTION
SECOBARBITAL SODIUM
ELKINS SINN 100MG/VIAL A083281 001
WYETH AYERST 50MG/ML A083262 001
SECONAL SODIUM
LILLY 50MG/ML ** N007392 002
SUPPOSITORY;RECTAL
SECONAL SODIUM
LILLY 30MG A086530 001
60MG A086530 002
120MG A086530 003
200MG A086530 004
SECRETIN
INJECTABLE;INJECTION
SECRETIN-FERRING
FERRING 75CU/VIAL N018290 001
SECRETIN SYNTHETIC PORCINE
FOR SOLUTION;INTRAVENOUS
SECREFLO
CHIRHOCLIN 16MCG/VIAL N021136 001 Apr 04, 2002
SELEGILINE HYDROCHLORIDE
CAPSULE;ORAL
ELDEPRYL
+ SOMERSET 5MG ** N020647 001 May 15, 1996
SELEGILINE HYDROCHLORIDE
LANNETT CO INC 5MG A075145 001 Sep 15, 2003
TABLET;ORAL
SELEGILINE HYDROCHLORIDE
BOSCOGEN 5MG A074912 001 Apr 30, 1998
CHARTWELL MOLECULES 5MG A074565 001 Aug 02, 1996
5MG A074641 001 Aug 02, 1996
COSETTE 5MG A074744 001 Jan 27, 1997
5MG A074756 001 Nov 25, 1998
G AND W LABS INC 5MG A074537 001 Aug 02, 1996
MYLAN 5MG A074866 001 Nov 26, 1997
+ SOMERSET 5MG ** N019334 001 Jun 05, 1989
SELENIUM SULFIDE
LOTION/SHAMPOO;TOPICAL
EXSEL
ALLERGAN HERBERT 2.5% A083892 001
SELENIUM SULFIDE
ACTAVIS MID ATLANTIC 2.5% A084394 001
COSETTE 2.5% A086209 001
IVAX PHARMS 2.5% A085777 001
WOCKHARDT BIO AG 2.5% A088228 001 Sep 01, 1983
SELSUN
+ CHATTEM 2.5% ** N007936 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-419(of 478)
** See List Footnote
SELENOMETHIONINE SE-75
INJECTABLE;INJECTION
SELENOMETHIONINE SE 75
GE HEALTHCARE 250uCi/ML N017257 001
MALLINCKRODT 100uCi/ML N017098 001
PHARMALUCENCE 500uCi/ML N017322 001
SETHOTOPE
BRACCO 85-550uCi/ML N017047 001
SERMORELIN ACETATE
INJECTABLE;INJECTION
GEREF
+ EMD SERONO EQ 0.05MG BASE/AMP ** N019863 001 Dec 28, 1990
+ EMD SERONO INC EQ 0.5MG BASE/VIAL ** N020443 001 Sep 26, 1997
+ EQ 1MG BASE/VIAL ** N020443 002 Sep 26, 1997
SERTRALINE HYDROCHLORIDE
CONCENTRATE;ORAL
SERTRALINE HYDROCHLORIDE
RANBAXY LABS LTD EQ 20MG BASE/ML A078053 001 Feb 05, 2007
TABLET;ORAL
SERTRALINE HYDROCHLORIDE
ANDA REPOSITORY EQ 25MG BASE A077818 001 Feb 06, 2007
EQ 50MG BASE A077818 002 Feb 06, 2007
EQ 100MG BASE A077818 003 Feb 06, 2007
CADILA EQ 25MG BASE A077106 001 Feb 06, 2007
EQ 50MG BASE A077106 002 Feb 06, 2007
EQ 100MG BASE A077106 003 Feb 06, 2007
CHARTWELL MOLECULAR EQ 25MG BASE A077162 001 Feb 06, 2007
EQ 50MG BASE A077162 002 Feb 06, 2007
EQ 100MG BASE A077162 003 Feb 06, 2007
FOSUN PHARMA EQ 25MG BASE A077713 001 Feb 06, 2007
EQ 50MG BASE A077713 002 Feb 06, 2007
EQ 100MG BASE A077713 003 Feb 06, 2007
HERITAGE PHARMA AVET EQ 25MG BASE A076465 001 Aug 11, 2006
EQ 25MG BASE A077299 001 Feb 06, 2007
EQ 25MG BASE A077345 001 Feb 06, 2007
EQ 25MG BASE A077663 001 Feb 06, 2007
EQ 50MG BASE A076465 002 Aug 11, 2006
EQ 50MG BASE A077299 002 Feb 06, 2007
EQ 50MG BASE A077345 002 Feb 06, 2007
EQ 50MG BASE A077663 002 Feb 06, 2007
EQ 100MG BASE A076465 003 Aug 11, 2006
EQ 100MG BASE A077299 003 Feb 06, 2007
EQ 100MG BASE A077345 003 Feb 06, 2007
EQ 100MG BASE A077663 003 Feb 06, 2007
HIKMA PHARMS EQ 25MG BASE A077864 001 Aug 10, 2009
EQ 50MG BASE A077864 002 Aug 10, 2009
EQ 100MG BASE A077864 003 Aug 10, 2009
IVAX SUB TEVA PHARMS EQ 25MG BASE A075719 003 Jun 30, 2006
EQ 50MG BASE A075719 001 Jun 30, 2006
EQ 100MG BASE A075719 002 Jun 30, 2006
MYLAN EQ 25MG BASE A076671 001 Feb 06, 2007
EQ 50MG BASE A076671 002 Feb 06, 2007
EQ 100MG BASE A076671 003 Feb 06, 2007
MYLAN PHARMS INC EQ 25MG BASE A076540 001 Mar 20, 2007
EQ 25MG BASE A078626 001 Jan 31, 2008
EQ 50MG BASE A076540 002 Mar 20, 2007
EQ 50MG BASE A078626 002 Jan 31, 2008
EQ 100MG BASE A076540 003 Mar 20, 2007
EQ 100MG BASE A078626 003 Jan 31, 2008
SUN PHARM INDS (IN) EQ 25MG BASE A078108 001 Feb 06, 2007
EQ 50MG BASE A078108 002 Feb 06, 2007
EQ 100MG BASE A078108 003 Feb 06, 2007
SUN PHARM INDS LTD EQ 25MG BASE A077977 001 Feb 06, 2007
EQ 50MG BASE A077977 002 Feb 06, 2007
EQ 100MG BASE A077977 003 Feb 06, 2007
EQ 150MG BASE A077977 004 Feb 06, 2007
EQ 200MG BASE A077977 005 Feb 06, 2007
TORRENT PHARMS EQ 25MG BASE A077765 001 Feb 06, 2007

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-420(of 478)
** See List Footnote
SERTRALINE HYDROCHLORIDE
TABLET;ORAL
SERTRALINE HYDROCHLORIDE
EQ 50MG BASE A077765 002 Feb 06, 2007
EQ 100MG BASE A077765 003 Feb 06, 2007
ZOLOFT
+ VIATRIS EQ 150MG BASE ** N019839 003 Dec 30, 1991
+ EQ 200MG BASE ** N019839 004 Dec 30, 1991
SEVELAMER CARBONATE
FOR SUSPENSION;ORAL
SEVELAMER CARBONATE
LUPIN LTD 800MG/PACKET A201513 001 Dec 23, 2021
2.4GM/PACKET A201513 002 Dec 23, 2021
TABLET;ORAL
SEVELAMER CARBONATE
IMPAX LABS INC 800MG A090975 001 Oct 23, 2017
LUPIN LTD 800MG A204600 001 Jan 14, 2021
STRIDES PHARMA 800MG A201069 001 Aug 05, 2020
SEVELAMER HYDROCHLORIDE
CAPSULE;ORAL
RENAGEL
GENZYME 403MG N020926 001 Oct 30, 1998
TABLET;ORAL
SEVELAMER HYDROCHLORIDE
RISING 400MG A201068 001 Dec 14, 2020
800MG A201068 002 Dec 14, 2020
SIBUTRAMINE HYDROCHLORIDE
CAPSULE;ORAL
MERIDIA
ABBOTT 5MG N020632 001 Nov 22, 1997
10MG N020632 002 Nov 22, 1997
15MG N020632 003 Nov 22, 1997
SILDENAFIL CITRATE
FOR SUSPENSION;ORAL
SILDENAFIL CITRATE
TRIS PHARMA INC EQ 10MG BASE/ML A212312 001 Nov 17, 2021
TABLET;ORAL
SILDENAFIL CITRATE
ACTAVIS GRP PTC EQ 20MG BASE A200149 001 Feb 25, 2013
APOTEX CORP EQ 20MG BASE A091379 001 Nov 06, 2012
PERRIGO R AND D EQ 25MG BASE A205791 001 Apr 23, 2020
EQ 50MG BASE A205791 002 Apr 23, 2020
WATSON LABS INC EQ 25MG BASE A202506 001 Nov 25, 2020
EQ 50MG BASE A202506 002 Nov 25, 2020
EQ 100MG BASE A202506 003 Nov 25, 2020
SILODOSIN
CAPSULE;ORAL
SILODOSIN
ALEMBIC PHARMS 4MG A211731 001 Nov 22, 2019
8MG A211731 002 Nov 22, 2019
UPSHER SMITH LABS 4MG A213230 001 Jan 03, 2022
8MG A213230 002 Jan 03, 2022
SILVER SULFADIAZINE
CREAM;TOPICAL
SSD AF
DR REDDYS LA 1% N018578 003 Jul 11, 1990
DRESSING;TOPICAL
SILDAFLO
FRANKLIN PHARMS 1% N019608 001 Nov 30, 1989
SIMEPREVIR SODIUM
CAPSULE;ORAL
OLYSIO
+ JANSSEN PRODS EQ 150MG BASE N205123 001 Nov 22, 2013

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-421(of 478)
** See List Footnote
SIMETHICONE-CELLULOSE
SUSPENSION;ORAL
SONORX
BRACCO 7.5MG/ML N020773 001 Oct 29, 1998
SIMVASTATIN
TABLET;ORAL
SIMVASTATIN
CHARTWELL RX 5MG A077766 001 Dec 20, 2006
10MG A077766 002 Dec 20, 2006
20MG A077766 003 Dec 20, 2006
40MG A077766 004 Dec 20, 2006
80MG A077766 005 Dec 20, 2006
IVAX SUB TEVA PHARMS 5MG A076052 001 Jun 23, 2006
10MG A076052 002 Jun 23, 2006
20MG A076052 003 Jun 23, 2006
40MG A076052 004 Jun 23, 2006
80MG A076052 005 Dec 20, 2006
MYLAN PHARMS INC 5MG A090868 001 Jun 08, 2010
10MG A090868 002 Jun 08, 2010
20MG A090868 003 Jun 08, 2010
40MG A090868 004 Jun 08, 2010
80MG A090868 005 Jun 08, 2010
SUN PHARM INDS LTD 5MG A076285 001 Dec 20, 2006
10MG A076285 002 Dec 20, 2006
20MG A076285 003 Dec 20, 2006
40MG A076285 004 Dec 20, 2006
80MG A076285 005 Jun 23, 2006
ZOCOR
+ ORGANON 80MG ** N019766 005 Jul 10, 1998
TABLET, ORALLY DISINTEGRATING;ORAL
SIMVASTATIN
+ SYNTHON PHARMS 10MG N021961 001 Oct 09, 2007
+ 20MG N021961 002 Oct 09, 2007
+ 40MG N021961 003 Oct 09, 2007
+ 80MG N021961 004 Oct 09, 2007
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
TABLET;ORAL
JUVISYNC
+ MERCK SHARP DOHME 10MG;EQ 50MG BASE ** N202343 004 Sep 18, 2012
+ 10MG;EQ 100MG BASE ** N202343 001 Oct 07, 2011
+ 20MG;EQ 50MG BASE ** N202343 005 Sep 18, 2012
+ 20MG;EQ 100MG BASE ** N202343 002 Oct 07, 2011
+ 40MG;EQ 50MG BASE ** N202343 006 Sep 18, 2012
+ 40MG;EQ 100MG BASE ** N202343 003 Oct 07, 2011
SIROLIMUS
SOLUTION;ORAL
SIROLIMUS
TORRENT 1MG/ML A215016 001 Dec 27, 2021
TABLET;ORAL
RAPAMUNE
+ PF PRISM CV 5MG ** N021110 003 Feb 23, 2004
SODIUM BENZOATE; SODIUM PHENYLACETATE
SOLUTION;ORAL
UCEPHAN
B BRAUN 100MG/ML;100MG/ML N019530 001 Dec 23, 1987
SODIUM BICARBONATE
INJECTABLE;INJECTION
SODIUM BICARBONATE
HOSPIRA 0.9MEQ/ML A077394 001 Nov 09, 2005
1MEQ/ML A077394 002 Nov 09, 2005
SODIUM BICARBONATE IN PLASTIC CONTAINER
+ ABBOTT 0.9MEQ/ML ** N019443 001 Jun 03, 1986
+ 1MEQ/ML ** N019443 002 Jun 03, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-422(of 478)
** See List Footnote
SODIUM BICARBONATE; TARTARIC ACID
GRANULE, EFFERVESCENT;ORAL
BAROS
MALLINCKRODT INC 460MG/GM;420MG/GM N018509 001 Aug 07, 1985
SODIUM CHLORIDE
AEROSOL, METERED;INHALATION
BRONCHO SALINE
+ BLAIREX 0.9% N019912 001 Sep 03, 1992
INJECTABLE;INJECTION
BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
ABRAXIS PHARM 9MG/ML A088909 001 Feb 07, 1985
SODIUM CHLORIDE
ABBOTT 20GM/100ML N017013 001
B BRAUN 20GM/100ML N017038 001
SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
B BRAUN 450MG/100ML N018184 001
MILES 450MG/100ML N018503 001
SODIUM CHLORIDE 0.9%
+ MEDEFIL INC 9MG/ML (9MG/ML) N202832 001 Jan 06, 2012
+ 18MG/2ML (9MG/ML) N202832 002 Jan 06, 2012
+ 22.5MG/2.5ML (9MG/ML) N202832 003 Jan 06, 2012
+ 27MG/3ML (9MG/ML) N202832 004 Jan 06, 2012
+ 45MG/5ML (9MG/ML) N202832 005 Jan 06, 2012
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
ABBOTT 9MG/ML N019218 001 Jul 13, 1984
+ ICU MEDICAL INC 9MG/ML N019217 001 Jul 13, 1984
JUBILANT CADISTA 9MG/ML A203352 001 May 18, 2016
+ LIEBEL-FLARSHEIM 405MG/50ML (9MG/ML) N021569 001 Jul 27, 2006
MILES 900MG/100ML N018502 001
SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER
+ ABRAXIS PHARM 234MG/ML ** N019329 001 Apr 22, 1987
SOLUTION;INTRAVENOUS
SODIUM CHLORIDE 14.6%
+ HOSPIRA 50MEQ/20ML (2.5MEQ/ML) ** N018897 001 Jul 20, 1984
SOLUTION;IRRIGATION
SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
BAXTER HLTHCARE 450MG/100ML N017864 001
450MG/100ML N018497 001 Feb 19, 1982
HOSPIRA 450MG/100ML N017670 001
450MG/100ML N018380 001
SODIUM CHLORIDE IN PLASTIC CONTAINER
MILES 900MG/100ML N018247 001
SODIUM CHROMATE CR-51
INJECTABLE;INJECTION
CHROMITOPE SODIUM
BRACCO 2mCi/VIAL N013993 002
200uCi/ML N013993 001
SODIUM CHROMATE CR 51
CURIUM 100uCi/ML N016708 001
SODIUM FLUORIDE F-18
INJECTABLE;INTRAVENOUS
FLUORINE F-18
+ GE HEALTHCARE 2mCi/ML ** N017042 001
SODIUM FLUORIDE F 18
+ NIH NCI DCTD 10-200mCi/ML ** N022494 001 Jan 26, 2011
SODIUM FLUORIDE F-18
DECATUR 10-200mCi/ML A204464 001 Oct 21, 2014
UCSF RODIOPHARM 10-200mCi/ML A204437 001 Mar 13, 2014
UIHC PET IMAGING 10-200mCi/ML A204462 001 Nov 17, 2015
UNIV TX MD ANDERSON 10-200mCi/ML A203247 001 Dec 23, 2013
SODIUM FLUORIDE; TRICLOSAN
PASTE;DENTAL
COLGATE TOTAL
+ COLGATE PALMOLIVE 0.24%;0.3% N020231 001 Jul 11, 1997

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-423(of 478)
** See List Footnote
SODIUM IODIDE I-123
CAPSULE;ORAL
SODIUM IODIDE I 123
CARDINAL HEALTH 418 400uCi N018671 003 May 27, 1982
GE HEALTHCARE 100uCi N017630 001
200uCi N017630 003 Jan 08, 1993
SOLUTION;ORAL
SODIUM IODIDE I 123
GE HEALTHCARE 2mCi/ML ** N017630 002
SODIUM IODIDE I-131
CAPSULE;ORAL
IODOTOPE
BRACCO 1-130mCi N010929 001
1-150mCi N010929 003
SODIUM IODIDE I 131
CIS 50uCi N017316 001
100uCi N017316 002
CURIUM 0.8-100mCi N016515 002
+ 0.8-100mCi N016517 001
15-100uCi N016517 002
JUBILANT 2-200mCi N021305 004 Nov 18, 2004
SOLUTION;ORAL
HICON
JUBILANT 1-250mCi/0.25ML N021305 002 Jan 24, 2003
1-500mCi/0.5ML N021305 003 Jan 24, 2003
1-1000mCi/ML N021305 005 Apr 04, 2006
IODOTOPE
BRACCO 7-106mCi/BOT N010929 002
SODIUM IODIDE I 131
CIS 50mCi/ML N017315 001
+ CURIUM 3.5-150mCi/VIAL N016515 001
SODIUM LACTATE
INJECTABLE;INJECTION
SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER
B BRAUN 1.87GM/100ML N018186 001
BAXTER HLTHCARE 1.87GM/100ML N016692 001
HOSPIRA 1.87GM/100ML N018249 001
SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER
B BRAUN 1.87GM/100ML N020004 001 Apr 21, 1992
SODIUM LACTATE IN PLASTIC CONTAINER
+ HOSPIRA 5MEQ/ML N018947 001 Sep 05, 1984
SODIUM MONOFLUOROPHOSPHATE
GEL;DENTAL
EXTRA-STRENGTH AIM
CHESEBROUGH PONDS 1.2% N019518 002 Aug 06, 1986
PASTE;DENTAL
EXTRA-STRENGTH AIM
CHESEBROUGH PONDS 1.2% N019518 001 Jun 03, 1987
SODIUM NITROPRUSSIDE
INJECTABLE;INJECTION
NIPRIDE
ROCHE 50MG/VIAL N017546 001
NITROPRESS
ABBOTT 50MG/VIAL A071555 001 Nov 16, 1987
+ ABBVIE 50MG/VIAL ** N018450 001
HOSPIRA 50MG/VIAL A070566 001 Jun 09, 1986
VPNA 25MG/ML A071961 001 Aug 01, 1988
SODIUM NITROPRUSSIDE
ABRAXIS PHARM 50MG/VIAL A070031 001 Jan 17, 1985
AKORN 25MG/ML A208635 001 May 04, 2017
AMPHASTAR PHARMS INC 25MG/ML A209832 001 Dec 18, 2017
ANDA REPOSITORY 25MG/ML A209834 001 Jun 26, 2018
AVET LIFESCIENCES 25MG/ML A208923 001 Nov 08, 2022
+ BAXTER HLTHCARE 50MG/VIAL ** N018581 001 Jul 28, 1982
CIPLA 25MG/ML A210855 001 Jul 16, 2018
EUGIA PHARMA 25MG/ML A211934 001 Dec 10, 2020
SUN PHARM 25MG/ML A210467 001 Nov 26, 2018

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-424(of 478)
** See List Footnote
SODIUM NITROPRUSSIDE
INJECTABLE;INJECTION
SODIUM NITROPRUSSIDE
TEVA PARENTERAL 25MG/ML A073465 001 Mar 30, 1992
SOLUTION;INTRAVENOUS
NIPRIDE RTU IN SODIUM CHLORIDE 0.9%
+ EXELA PHARMA 10MG/50ML (0.2MG/ML) ** N209387 002 Dec 07, 2017
SODIUM OXYBATE
SOLUTION;ORAL
SODIUM OXYBATE
HIKMA 0.5GM/ML A202090 001 Jan 17, 2017
SODIUM PHENYLBUTYRATE
TABLET;ORAL
SODIUM PHENYLBUTYRATE
ALVOGEN 500MG A090910 001 Nov 18, 2011
SODIUM PHOSPHATE P-32
SOLUTION;INJECTION, ORAL
PHOSPHOTOPE
BRACCO 1-8mCi/VIAL N010927 001
SODIUM PHOSPHATE P 32
MALLINCKRODT 0.67mCi/ML N011777 001
1.5mCi/VIAL N011777 002
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
TABLET;ORAL
VISICOL
SALIX PHARMS 0.398GM;1.102GM N021097 001 Sep 21, 2000
SODIUM POLYSTYRENE SULFONATE
POWDER;ORAL, RECTAL
KAYEXALATE
+ CONCORDIA 453.6GM/BOT ** N011287 001
SODIUM POLYSTYRENE SULFONATE
CITRUSPHRMA 454GM/BOT A040909 001 Dec 03, 2008
+ PAI HOLDINGS PHARM 453.6GM/BOT A088786 001 Sep 11, 1984
SUSPENSION;ORAL, RECTAL
SODIUM POLYSTYRENE SULFONATE
ANI PHARMS 15GM/60ML A090590 001 May 13, 2011
HIKMA 15GM/60ML A089049 001 Nov 17, 1986
MORTON GROVE 15GM/60ML A088717 001 Sep 11, 1984
ROXANE 15GM/60ML A088453 001 Nov 17, 1983
SODIUM SUCCINATE
INJECTABLE;INJECTION
SODIUM SUCCINATE
ELKINS SINN 30% A080516 001
SODIUM TETRADECYL SULFATE
INJECTABLE;INJECTION
SOTRADECOL
+ ELKINS SINN 1% ** N005970 004
+ 3% ** N005970 005
SODIUM THIOSULFATE
INJECTABLE;INJECTION
SODIUM THIOSULFATE
+ US ARMY 250MG/ML N020166 001 Feb 14, 1992
SOFOSBUVIR
TABLET;ORAL
SOFOSBUVIR
TEVA PHARMS USA INC 400MG A211353 001 Jan 27, 2022
SOLIFENACIN SUCCINATE
TABLET;ORAL
SOLIFENACIN SUCCINATE
ACCORD HLTHCARE 5MG A207477 001 Jan 04, 2022
10MG A207477 002 Jan 04, 2022
AJANTA PHARMA LTD 5MG A205483 001 May 20, 2019
10MG A205483 002 May 20, 2019
AMNEAL PHARMS CO 5MG A209719 001 May 20, 2019

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-425(of 478)
** See List Footnote
SOLIFENACIN SUCCINATE
TABLET;ORAL
SOLIFENACIN SUCCINATE
10MG A209719 002 May 20, 2019
BRECKENRIDGE 5MG A209818 001 May 20, 2019
10MG A209818 002 May 20, 2019
SUNSHINE 5MG A213346 001 Apr 13, 2020
10MG A213346 002 Apr 13, 2020
ZYDUS PHARMS 5MG A207721 001 Oct 19, 2020
10MG A207721 002 Oct 19, 2020
SORBITOL
SOLUTION;IRRIGATION
SORBITOL 3% IN PLASTIC CONTAINER
BAXTER HLTHCARE 3GM/100ML N018512 001 May 27, 1982
SOTALOL HYDROCHLORIDE
TABLET;ORAL
BETAPACE
LEGACY PHARMA 320MG N019865 004 Oct 30, 1992
BETAPACE AF
LEGACY PHARMA 40MG N021151 006 Apr 02, 2003
60MG N021151 007 Apr 02, 2003
100MG N021151 005 Mar 14, 2003
SOTALOL HYDROCHLORIDE
AUROBINDO PHARMA USA 80MG A077616 001 Feb 07, 2007
120MG A077616 002 Feb 07, 2007
160MG A077616 003 Feb 07, 2007
IMPAX PHARMS 80MG A075663 001 Nov 07, 2000
120MG A075663 002 Nov 07, 2000
160MG A075663 003 Nov 07, 2000
240MG A075663 004 Nov 07, 2000
MYLAN 80MG A075237 001 May 01, 2000
80MG A075725 001 Dec 19, 2000
120MG A075237 002 May 01, 2000
120MG A075725 002 Dec 19, 2000
160MG A075237 003 May 01, 2000
160MG A075725 003 Dec 19, 2000
240MG A075237 004 May 01, 2000
240MG A075725 004 Dec 19, 2000
SUN PHARM INDUSTRIES 80MG A075515 001 Oct 15, 2001
80MG A076576 001 Apr 08, 2004
120MG A075515 004 Oct 15, 2001
120MG A076576 002 Apr 08, 2004
160MG A075515 002 Oct 15, 2001
160MG A076576 003 Apr 08, 2004
240MG A075515 003 Oct 15, 2001
TEVA 80MG A076883 001 Jul 26, 2004
120MG A076883 002 Jul 26, 2004
160MG A076883 003 Jul 26, 2004
UPSHER SMITH LABS 80MG A075366 001 May 01, 2000
120MG A075366 002 May 01, 2000
160MG A075366 003 May 01, 2000
240MG A075366 004 May 01, 2000
WATSON LABS 80MG A075238 001 Jul 13, 2000
120MG A075238 002 Jul 13, 2000
160MG A075238 003 Jul 13, 2000
240MG A075238 004 Jul 13, 2000
SOYBEAN OIL
INJECTABLE;INJECTION
LIPOSYN III 10%
HOSPIRA 10% N018969 001 Sep 24, 1984
LIPOSYN III 20%
HOSPIRA 20% N018970 001 Sep 25, 1984
LIPOSYN III 30%
HOSPIRA 30% N020181 001 Jan 13, 1998
SOYACAL 10%
ALPHA THERA 10% N018465 001 Jun 29, 1983

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-426(of 478)
** See List Footnote
SOYBEAN OIL
INJECTABLE;INJECTION
SOYACAL 20%
ALPHA THERA 20% N018786 001 Jun 29, 1983
TRAVAMULSION 10%
BAXTER HLTHCARE 10% N018660 001 Feb 26, 1982
TRAVAMULSION 20%
BAXTER HLTHCARE 20% N018758 001 Feb 15, 1983
SPARFLOXACIN
TABLET;ORAL
ZAGAM
MYLAN 200MG N020677 001 Dec 19, 1996
SPECTINOMYCIN HYDROCHLORIDE
INJECTABLE;INJECTION
TROBICIN
PFIZER EQ 2GM BASE/VIAL N050347 001
EQ 4GM BASE/VIAL N050347 002
SPIRAPRIL HYDROCHLORIDE
TABLET;ORAL
RENORMAX
SCHERING 3MG N020240 001 Dec 29, 1994
6MG N020240 002 Dec 29, 1994
12MG N020240 003 Dec 29, 1994
24MG N020240 004 Dec 29, 1994
SPIRONOLACTONE
TABLET;ORAL
SPIRONOLACTONE
ACTAVIS ELIZABETH 25MG A040353 003 Mar 15, 2006
50MG A040353 001 Jul 29, 1999
100MG A040353 002 Jul 29, 1999
ASCOT 25MG A087687 001 Oct 20, 1982
CHARTWELL RX 25MG A086809 001
IVAX PHARMS 25MG A087108 001
LEDERLE 25MG A087634 001
MUTUAL PHARM 25MG A087265 001
MYLAN 25MG A087086 001
PUREPAC PHARM 25MG A087998 001 Oct 14, 1983
25MG A088053 001 Aug 25, 1983
SUPERPHARM 25MG A089364 001 Nov 07, 1986
UPSHER SMITH 25MG A087554 001
VANGARD 25MG A087648 001 Feb 01, 1982
WARNER CHILCOTT 25MG A087952 001 Nov 18, 1982
WATSON LABS 25MG A086898 002 Mar 02, 1982
25MG A087078 001
STANOZOLOL
TABLET;ORAL
WINSTROL
+ LUNDBECK INC 2MG N012885 001 May 14, 1984
STAVUDINE
CAPSULE;ORAL
STAVUDINE
AUROBINDO PHARMA 15MG A077672 003 Dec 29, 2008
20MG A077672 004 Dec 29, 2008
30MG A077672 001 Dec 29, 2008
40MG A077672 002 Dec 29, 2008
HETERO LABS LTD III 15MG A078957 001 Dec 29, 2008
20MG A078957 002 Dec 29, 2008
30MG A078957 003 Dec 29, 2008
40MG A078957 004 Dec 29, 2008
MYLAN 15MG A079069 001 Dec 29, 2008
20MG A079069 002 Dec 29, 2008
30MG A079069 003 Dec 29, 2008
40MG A079069 004 Dec 29, 2008
MYLAN LABS LTD 30MG A078775 001 Jan 05, 2009
40MG A078775 002 Jan 05, 2009

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-427(of 478)
** See List Footnote
STAVUDINE
CAPSULE;ORAL
ZERIT
BRISTOL 5MG N020412 001 Jun 24, 1994
+ 15MG ** N020412 002 Jun 24, 1994
+ 20MG ** N020412 003 Jun 24, 1994
+ 30MG ** N020412 004 Jun 24, 1994
+ 40MG ** N020412 005 Jun 24, 1994
CAPSULE, EXTENDED RELEASE;ORAL
ZERIT XR
BRISTOL MYERS SQUIBB 37.5MG N021453 001 Dec 31, 2002
50MG N021453 002 Dec 31, 2002
75MG N021453 003 Dec 31, 2002
100MG N021453 004 Dec 31, 2002
FOR SOLUTION;ORAL
STAVUDINE
AUROBINDO PHARMA 1MG/ML A077774 001 Dec 29, 2008
CIPLA LTD 1MG/ML A078030 001 Mar 20, 2009
ZERIT
+ BRISTOL 1MG/ML ** N020413 001 Sep 06, 1996
STERILE WATER FOR INJECTION
LIQUID;N/A
BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER
ABRAXIS PHARM 100% A089099 001 Dec 29, 1987
100% A089100 001 Dec 29, 1987
STERILE WATER FOR INJECTION
HIKMA 100% (20ML) A206369 002 Sep 02, 2015
+ HOSPIRA 100% (1ML) N018801 001 Oct 27, 1982
STERILE WATER FOR INJECTION IN PLASTIC CONTAINER
B BRAUN 100% N019077 001 Mar 02, 1984
STERILE WATER FOR IRRIGATION
LIQUID;IRRIGATION
STERILE WATER IN PLASTIC CONTAINER
MILES 100% N018246 001
STREPTOMYCIN SULFATE
INJECTABLE;INJECTION
STREPTOMYCIN SULFATE
COPANOS EQ 500MG BASE/ML A060684 001
LILLY EQ 1GM BASE/VIAL A060107 001
EQ 1GM BASE/2ML A060404 001
EQ 5GM BASE/VIAL A060107 002
PFIZER EQ 1GM BASE/VIAL ** A060076 001
EQ 1GM BASE/2.5ML A060111 001
EQ 5GM BASE/VIAL ** A060076 002
SUCCINYLCHOLINE CHLORIDE
INJECTABLE;INJECTION
ANECTINE
SANDOZ INC 50MG/ML N008453 003
500MG/VIAL N008453 001
1GM/VIAL N008453 004
QUELICIN PRESERVATIVE FREE
+ HOSPIRA 20MG/ML ** N008845 001
+ 50MG/ML ** N008845 002
+ 100MG/ML ** N008845 004
SUCCINYLCHOLINE CHLORIDE
AMPHASTAR PHARMS INC 20MG/ML A213432 001 Jun 08, 2020
BE PHARMS 20MG/ML A216003 001 Feb 07, 2022
INTL MEDICATION 100MG/VIAL A085400 001 Feb 04, 1982
ORGANON USA INC 20MG/ML A080997 001
SUCOSTRIN
+ APOTHECON 20MG/ML N008847 001
+ 100MG/ML N008847 003

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-428(of 478)
** See List Footnote
SUFENTANIL CITRATE
INJECTABLE;INJECTION
SUFENTANIL CITRATE
WATSON LABS EQ 0.05MG BASE/ML A074406 001 Dec 15, 1995
SULFACETAMIDE SODIUM
OINTMENT;OPHTHALMIC
BLEPH-10
ALLERGAN 10% A084015 001
CETAMIDE
ALCON 10% A080021 001
SODIUM SULAMYD
+ SCHERING 10% ** N005963 002
SULFAIR 10
PHARMAFAIR 10% A088000 001 Dec 22, 1982
SOLUTION/DROPS;OPHTHALMIC
BLEPH-30
ALLERGAN 30% A080028 002
ISOPTO CETAMIDE
ALCON 15% A080020 002
OCUSULF-10
MIZA PHARMS USA 10% A080660 001
OCUSULF-30
MIZA PHARMS USA 30% A080660 002
SODIUM SULAMYD
+ SCHERING 10% ** N005963 001
+ 30% ** N005963 003
SODIUM SULFACETAMIDE
AKORN 10% A083021 001
15% A083021 002
30% A083021 003
SOLA BARNES HIND 10% A084143 001
10% A084145 001
30% A084146 001
30% A084147 001
SULF-10
NOVARTIS 10% A080025 001
SULF-15
NOVARTIS 15% A089047 001 Oct 31, 1995
SULFACEL-15
OPTOPICS 15% A080024 001
SULFACETAMIDE SODIUM
AKORN 30% A040216 001 May 25, 1999
ALCON PHARMS LTD 30% A089068 001 May 05, 1987
PHARMAFAIR 10% A088947 001 May 17, 1985
SULFAIR 10
PHARMAFAIR 10% A087949 001 Dec 13, 1982
SULFAIR FORTE
PHARMAFAIR 30% A088385 001 Oct 13, 1983
SULFAIR-15
PHARMAFAIR 15% A088186 001 May 25, 1983
SULTEN-10
BAUSCH AND LOMB 10% A087818 001 Feb 03, 1983
SULFACYTINE
TABLET;ORAL
RENOQUID
GLENWOOD 250MG N017569 001
SULFADIAZINE
TABLET;ORAL
SULFADIAZINE
ABBVIE 300MG N004125 005
EVERYLIFE 500MG A080088 001
+ IMPAX LABS 500MG A080081 001
LANNETT 500MG A080084 001
LEDERLE 500MG N004054 001
+ LILLY 500MG N004122 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-429(of 478)
** See List Footnote
SULFADIAZINE SODIUM
INJECTABLE;INJECTION
SULFADIAZINE SODIUM
LEDERLE 250MG/ML N004054 002
SULFADIAZINE; SULFAMERAZINE
SUSPENSION;ORAL
SULFONAMIDES DUPLEX
LILLY 250MG/5ML;250MG/5ML N006317 007
SULFAMETER
TABLET;ORAL
SULLA
BAYER HLTHCARE 500MG N016000 002
SULFAMETHIZOLE
TABLET;ORAL
MICROSUL
FOREST PHARMS 1GM A086012 001
PROKLAR
FOREST PHARMS 500MG A080273 001
THIOSULFIL
WYETH AYERST 250MG N008565 001
500MG N008565 004
SULFAMETHOXAZOLE
SUSPENSION;ORAL
GANTANOL
ROCHE 500MG/5ML N013664 002
TABLET;ORAL
GANTANOL
ROCHE 500MG N012715 002
GANTANOL-DS
ROCHE 1GM N012715 003
SULFAMETHOXAZOLE
ASCOT 500MG A087662 001 Oct 20, 1982
BARR 500MG A087189 001 Jul 25, 1983
HEATHER 500MG A086163 001
RISING 500MG A085844 001
WATSON LABS 500MG A085053 001
1GM A086000 001
UROBAK
SHIONOGI 500MG A087307 001
SULFAMETHOXAZOLE; TRIMETHOPRIM
INJECTABLE;INJECTION
BACTRIM
+ SUN PHARM INDS INC 80MG/ML;16MG/ML ** N018374 001
SEPTRA
MONARCH PHARMS 80MG/ML;16MG/ML ** N018452 001
SULFAMETHOXAZOLE AND TRIMETHOPRIM
ABRAXIS PHARM 80MG/ML;16MG/ML A070223 001 Dec 29, 1987
BEDFORD 80MG/ML;16MG/ML A072383 001 Apr 29, 1992
HIKMA 80MG/ML;16MG/ML A070627 001 Dec 29, 1987
80MG/ML;16MG/ML A070628 001 Dec 29, 1987
HOSPIRA 80MG/ML;16MG/ML A073199 001 Sep 11, 1992
WATSON LABS 80MG/ML;16MG/ML A071556 001 Dec 29, 1987
SUSPENSION;ORAL
BACTRIM
+ SUN PHARM INDUSTRIES 200MG/5ML;40MG/5ML ** N017560 001
BACTRIM PEDIATRIC
SUN PHARM INDUSTRIES 200MG/5ML;40MG/5ML ** N017560 002
SEPTRA
MONARCH PHARMS 200MG/5ML;40MG/5ML ** N017598 001
SEPTRA GRAPE
MONARCH PHARMS 200MG/5ML;40MG/5ML ** N017598 002 Feb 12, 1986
SULFAMETHOXAZOLE AND TRIMETHOPRIM
ANI PHARMS 200MG/5ML;40MG/5ML A070028 001 Jun 02, 1987
LUPIN LTD 200MG/5ML;40MG/5ML A212699 001 Jan 05, 2021
TEVA 200MG/5ML;40MG/5ML N018812 001 Jan 28, 1983
200MG/5ML;40MG/5ML N018812 002 Jun 10, 1983

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-430(of 478)
** See List Footnote
SULFAMETHOXAZOLE; TRIMETHOPRIM
SUSPENSION;ORAL
SULFATRIM
PHARM ASSOC 200MG/5ML;40MG/5ML N018615 002 Jan 07, 1983
SULMEPRIM
USL PHARMA 200MG/5ML;40MG/5ML A070063 001 Aug 01, 1986
SULMEPRIM PEDIATRIC
USL PHARMA 200MG/5ML;40MG/5ML A070064 001 Aug 01, 1986
TRIMETH/SULFA
ALPHARMA US PHARMS 200MG/5ML;40MG/5ML A072289 001 May 23, 1988
200MG/5ML;40MG/5ML A072398 001 May 23, 1988
NASKA 200MG/5ML;40MG/5ML A072399 001 May 23, 1988
TABLET;ORAL
COTRIM
TEVA 400MG;80MG A070034 001 May 16, 1985
COTRIM D.S.
TEVA 800MG;160MG A070048 001 Mar 18, 1985
SULFAMETHOPRIM
NOVEL LABS INC 400MG;80MG A070022 001 Feb 15, 1985
SULFAMETHOPRIM-DS
NOVEL LABS INC 800MG;160MG A070032 001 Feb 15, 1985
SULFAMETHOXAZOLE AND TRIMETHOPRIM
FOSUN PHARMA 400MG;80MG A070889 001 Nov 13, 1986
400MG;80MG N018598 003 May 19, 1982
800MG;160MG A070890 001 Nov 13, 1986
HEATHER 400MG;80MG N018946 001 Aug 10, 1984
800MG;160MG N018946 002 Aug 10, 1984
INTERPHARM 400MG;80MG A071299 001 Oct 27, 1987
800MG;160MG A071300 001 Oct 27, 1987
MARTEC USA LLC 400MG;80MG A072408 001 Dec 07, 1988
MUTUAL PHARM 400MG;80MG A070006 001 Nov 14, 1984
PLIVA 400MG;80MG A070215 001 Sep 10, 1985
800MG;160MG A070216 001 Sep 10, 1985
ROXANE 400MG;80MG A072768 001 Aug 30, 1991
TEVA 400MG;80MG N018242 001
800MG;160MG N018242 002
USL PHARMA 400MG;80MG A070203 001 Nov 08, 1985
800MG;160MG A070204 001 Nov 08, 1985
WATSON LABS 400MG;80MG A070002 001 Nov 07, 1984
400MG;80MG N018852 001 May 09, 1983
800MG;160MG A070000 001 Nov 07, 1984
SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH
FOSUN PHARMA 800MG;160MG N018598 004 May 19, 1982
HERITAGE PHARMA AVET 800MG;160MG A070037 001 Jun 02, 1987
MARTEC USA LLC 800MG;160MG A072417 001 Dec 07, 1988
MUTUAL PHARM 800MG;160MG A070007 001 Nov 14, 1984
ROXANE 800MG;160MG A072769 001 Aug 30, 1991
WATSON LABS 800MG;160MG N018854 001 May 09, 1983
SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH
HERITAGE PHARMA AVET 400MG;80MG A070030 001 Jun 02, 1987
SULFATRIM-DS
SUPERPHARM 800MG;160MG A070066 001 Jun 24, 1985
SULFATRIM-SS
SUPERPHARM 400MG;80MG A070065 002 Jun 24, 1985
UROPLUS DS
SHIONOGI 800MG;160MG A071816 001 Sep 28, 1987
UROPLUS SS
SHIONOGI 400MG;80MG A071815 001 Sep 28, 1987
SULFANILAMIDE
CREAM;VAGINAL
AVC
+ MYLAN SPECIALITY LP 15% ** N006530 003 Jan 27, 1987
SULFANILAMIDE
COSETTE 15% A088718 001 Sep 19, 1985
SUPPOSITORY;VAGINAL
AVC
MYLAN SPECIALITY LP 1.05GM N006530 004 Jan 27, 1987

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-431(of 478)
** See List Footnote
SULFAPHENAZOLE
SUSPENSION;ORAL
SULFABID
PHARM RES ASSOC 500MG/5ML N013093 001
TABLET;ORAL
SULFABID
PURDUE FREDERICK 500MG N013092 002
SULFAPYRIDINE
TABLET;ORAL
SULFAPYRIDINE
LILLY 500MG N000159 001
SULFASALAZINE
SUSPENSION;ORAL
AZULFIDINE
PHARMACIA AND UPJOHN 250MG/5ML N018605 001
TABLET;ORAL
S.A.S.-500
SOLVAY 500MG A083450 001
SULFASALAZINE
EPIC PHARMA 500MG A086184 001
SUN PHARM INDUSTRIES 500MG A089590 001 Oct 19, 1987
SUPERPHARM 500MG A089339 001 Oct 26, 1987
WATSON LABS 500MG A084964 001
500MG A087197 001
TABLET, DELAYED RELEASE;ORAL
SULFASALAZINE
WATSON LABS 500MG A088052 001 May 24, 1983
SULFINPYRAZONE
CAPSULE;ORAL
ANTURANE
+ NOVARTIS 200MG ** N011556 004
SULFINPYRAZONE
BARR 200MG A087666 001 Sep 17, 1982
IVAX PHARMS 200MG A087770 001 Nov 19, 1982
PAR PHARM 200MG A088934 001 Sep 06, 1985
VANGARD 200MG A088666 001 Feb 17, 1984
TABLET;ORAL
ANTURANE
NOVARTIS 100MG ** N011556 003
SULFINPYRAZONE
BARR 100MG A087665 001 Sep 17, 1982
IVAX PHARMS 100MG A087769 001 Jun 01, 1982
PAR PHARM 100MG A088933 001 Sep 06, 1985
WATSON LABS 100MG A087667 001 May 26, 1982
SULFISOXAZOLE
TABLET;ORAL
GANTRISIN
ROCHE 500MG N006525 001
SOSOL
MK LABS 500MG A080036 001
SOXAZOLE
ALRA 500MG A080366 001
SULFALAR
PARKE DAVIS 500MG A084955 001
SULFISOXAZOLE
ANI PHARMS 500MG A080142 001
BARR 500MG A084031 001
HEATHER 500MG A080189 001
IMPAX LABS 500MG A080109 001
LANNETT 500MG A080085 001
LEDERLE 500MG A087649 001
PHARMERAL 500MG A084385 001
PUREPAC PHARM 500MG A080087 001
RISING 500MG A085628 001
ROXANE 500MG A080082 001
VALEANT PHARM INTL 500MG A080268 002
VITARINE 500MG A087332 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-432(of 478)
** See List Footnote
SULFISOXAZOLE
TABLET;ORAL
SULFISOXAZOLE
WATSON LABS 500MG A085534 001
WEST WARD 500MG A080379 001
SULSOXIN
SOLVAY 500MG A080040 001
SULFISOXAZOLE ACETYL
EMULSION;ORAL
LIPO GANTRISIN
ROCHE EQ 1GM BASE/5ML N009182 009
SUSPENSION;ORAL
GANTRISIN PEDIATRIC
ROCHE EQ 500MG BASE/5ML N009182 004
SYRUP;ORAL
GANTRISIN
ROCHE EQ 500MG BASE/5ML N009182 002
SULFISOXAZOLE DIOLAMINE
INJECTABLE;INJECTION
GANTRISIN
ROCHE EQ 400MG BASE/ML N006917 001
OINTMENT;OPHTHALMIC
GANTRISIN
ROCHE EQ 4% BASE N008414 002
SOLUTION/DROPS;OPHTHALMIC
GANTRISIN
ROCHE EQ 4% BASE N007757 002
SULFISOXAZOLE DIOLAMINE
SOLA BARNES HIND EQ 4% BASE A084148 001
SULFOXONE SODIUM
TABLET, DELAYED RELEASE;ORAL
DIASONE SODIUM
ABBVIE 165MG N006044 003
SULFUR
POWDER;TOPICAL
BENSULFOID
POYTHRESS 33.32% N002918 001
SULINDAC
TABLET;ORAL
CLINORIL
+ MERCK 150MG ** N017911 001
+ 200MG ** N017911 002
SULINDAC
ANI PHARMS 150MG A072973 002 Feb 28, 1992
200MG A072973 001 Feb 28, 1992
EPIC PHARMA LLC 150MG A073262 002 Sep 06, 1991
200MG A073262 001 Sep 06, 1991
FOSUN PHARMA 150MG A072712 001 Aug 30, 1991
200MG A072713 001 Aug 30, 1991
RISING 150MG A073039 002 Jun 22, 1993
200MG A073039 001 Jun 22, 1993
SUMATRIPTAN
SPRAY;NASAL
IMITREX
GLAXOSMITHKLINE 10MG/SPRAY N020626 002 Aug 26, 1997
SUMATRIPTAN SUCCINATE
INJECTABLE;SUBCUTANEOUS
ALSUMA
MERIDIAN MEDCL EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) N022377 001 Jun 29, 2010
SUMATRIPTAN SUCCINATE
FRESENIUS KABI USA EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A079240 002 Sep 18, 2009
EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) A079240 001 Sep 18, 2009
MYLAN LABS LTD EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A203322 001 Apr 14, 2014
PAR STERILE PRODUCTS EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A077871 001 Jul 09, 2009
SANDOZ INC EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) A078067 002 Feb 06, 2009
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A078067 001 Feb 06, 2009

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-433(of 478)
** See List Footnote
SUMATRIPTAN SUCCINATE
INJECTABLE;SUBCUTANEOUS
SUMATRIPTAN SUCCINATE
STERISCIENCE EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A090314 001 Jun 10, 2010
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A090641 001 Jul 28, 2010
TEVA PARENTERAL EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) A078318 001 Feb 06, 2009
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A078318 002 Feb 06, 2009
TEVA PHARMS USA EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A077907 001 Feb 06, 2009
ZYDUS EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) A090310 001 Aug 11, 2010
SUMAVEL DOSEPRO
+ ENDO VENTURES LTD EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) N022239 002 Nov 26, 2013
+ EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) N022239 001 Jul 15, 2009
SYSTEM;IONTOPHORESIS
ZECUITY
+ TEVA BRANDED PHARM EQ 6.5MG BASE/4HR N202278 001 Jan 17, 2013
TABLET;ORAL
SUMATRIPTAN SUCCINATE
FOSUN PHARMA EQ 25MG BASE A076976 001 Aug 10, 2009
EQ 50MG BASE A076976 002 Aug 10, 2009
EQ 100MG BASE A076976 003 Aug 10, 2009
HIKMA PHARMS EQ 25MG BASE A078298 001 May 21, 2013
EQ 50MG BASE A078298 002 May 21, 2013
EQ 100MG BASE A078298 003 May 21, 2013
MYLAN EQ 25MG BASE A077163 001 Nov 02, 2009
EQ 50MG BASE A077163 002 Nov 02, 2009
EQ 100MG BASE A077163 003 Nov 02, 2009
ROXANE EQ 25MG BASE A078241 001 Aug 10, 2009
EQ 50MG BASE A078241 002 Aug 10, 2009
EQ 100MG BASE A078241 003 Aug 10, 2009
TEVA EQ 25MG BASE A076840 001 Feb 09, 2009
EQ 50MG BASE A076840 002 Feb 09, 2009
EQ 100MG BASE A076840 003 Feb 09, 2009
SUPROFEN
SOLUTION/DROPS;OPHTHALMIC
PROFENAL
ALCON 1% N019387 001 Dec 23, 1988
TACRINE HYDROCHLORIDE
CAPSULE;ORAL
COGNEX
SHIONOGI INC EQ 10MG BASE N020070 001 Sep 09, 1993
EQ 20MG BASE N020070 002 Sep 09, 1993
EQ 30MG BASE N020070 003 Sep 09, 1993
EQ 40MG BASE N020070 004 Sep 09, 1993
TACROLIMUS
CAPSULE;ORAL
TACROLIMUS
CONCORD BIOTECH LTD EQ 0.5MG BASE A213112 001 Nov 10, 2020
HERITAGE PHARMA AVET EQ 5MG BASE A090402 001 Jul 01, 2010
INJECTABLE;INJECTION
TACROLIMUS
HOSPIRA EQ 5MG BASE/ML A203900 001 Aug 25, 2017
TADALAFIL
TABLET;ORAL
TADALAFIL
CHARTWELL RX 2.5MG A210716 001 Dec 29, 2020
5MG A210716 002 Dec 29, 2020
10MG A210716 003 Dec 29, 2020
20MG A210716 004 Dec 29, 2020
MYLAN 5MG A206957 001 Apr 29, 2019
20MG A200630 001 Aug 03, 2018
RISING 2.5MG A206956 001 Apr 29, 2019
10MG A206956 002 Apr 29, 2019
20MG A206956 003 Apr 29, 2019
WATSON LABS INC 2.5MG A205885 001 Mar 29, 2019
5MG A205885 002 Mar 29, 2019
10MG A205885 003 Mar 29, 2019
20MG A205885 004 Mar 29, 2019

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-434(of 478)
** See List Footnote
TALBUTAL
TABLET;ORAL
LOTUSATE
SANOFI AVENTIS US 120MG N009410 005
TAMOXIFEN CITRATE
TABLET;ORAL
NOLVADEX
+ ASTRAZENECA EQ 10MG BASE ** N017970 001
+ EQ 20MG BASE ** N017970 002 Mar 21, 1994
TAMOXIFEN CITRATE
ACTAVIS LABS FL INC EQ 10MG BASE A076179 001 Feb 20, 2003
EQ 20MG BASE A076179 002 Feb 20, 2003
AEGIS PHARMS EQ 10MG BASE A076398 001 Mar 31, 2003
EQ 20MG BASE A076398 002 Mar 31, 2003
IVAX SUB TEVA PHARMS EQ 10MG BASE A075740 001 Feb 20, 2003
EQ 20MG BASE A075740 002 Feb 20, 2003
PHARMACHEMIE EQ 10MG BASE A074539 001 Mar 31, 2003
ROXANE EQ 10MG BASE A076027 001 Feb 20, 2003
EQ 20MG BASE A076027 002 Feb 20, 2003
TEVA EQ 10MG BASE A074504 001 Apr 28, 2003
EQ 20MG BASE A074504 002 Apr 28, 2003
TAMSULOSIN HYDROCHLORIDE
CAPSULE;ORAL
TAMSULOSIN HYDROCHLORIDE
ACME LABS 0.4MG A214730 001 May 04, 2022
ANCHEN PHARMS 0.4MG A202010 001 Jan 04, 2013
MYLAN 0.4MG A090408 001 Apr 27, 2010
TAPENTADOL HYDROCHLORIDE
SOLUTION;ORAL
NUCYNTA
+ COLLEGIUM PHARM INC EQ 20MG BASE/ML N203794 001 Oct 15, 2012
TAZAROTENE
CREAM;TOPICAL
TAZAROTENE
FOUGERA PHARMS INC 0.1% A211175 001 Jan 28, 2019
TECHNETIUM TC-99M APCITIDE
INJECTABLE;INJECTION
ACUTECT
CIS BIO INTL SA N/A N020887 001 Sep 14, 1998
TECHNETIUM TC-99M DEPREOTIDE
INJECTABLE;INJECTION
NEO TECT KIT
CIS BIO INTL SA N/A ** N021012 001 Aug 03, 1999
TECHNETIUM TC-99M DISOFENIN KIT
INJECTABLE;INJECTION
HEPATOLITE
SUN PHARM INDS INC N/A N018467 001 Mar 16, 1982
TECHNETIUM TC-99M ETIDRONATE KIT
INJECTABLE;INJECTION
CINTICHEM TECHNETIUM 99M HEDSPA
GE HEALTHCARE N/A N017653 001
MPI STANNOUS DIPHOSPHONATE
GE HEALTHCARE N/A N017667 001
OSTEOSCAN
MALLINCKRODT N/A N017454 001
TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT
GE HEALTHCARE N/A N017562 001
TECHNETIUM TC-99M FERPENTETATE KIT
INJECTABLE;INJECTION
RENOTEC
BRACCO N/A N017045 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-435(of 478)
** See List Footnote
TECHNETIUM TC-99M GLUCEPTATE KIT
INJECTABLE;INJECTION
GLUCOSCAN
BRISTOL MYERS SQUIBB N/A N017907 001
TECHNESCAN GLUCEPTATE
DRAXIMAGE N/A N018272 001 Jan 27, 1982
TECHNETIUM TC-99M LIDOFENIN KIT
INJECTABLE;INJECTION
TECHNESCAN HIDA
DRAXIMAGE N/A N018489 001 Oct 31, 1986
TECHNETIUM TC-99M MEDRONATE
INJECTABLE;INJECTION
DRAXIMAGE MDP-10
JUBILANT N/A N018035 001
TECHNETIUM TC-99M MEDRONATE KIT
INJECTABLE;INJECTION
AMERSCAN MDP KIT
GE HEALTHCARE N/A N018335 001 Aug 05, 1982
OSTEOLITE
PHARMALUCENCE N/A N017972 001
TECHNETIUM TC 99M MPI MDP
GE HEALTHCARE N/A N018141 001
N/A N018141 002 Jun 12, 1989
TECHNETIUM TC-99M PENTETATE KIT
INJECTABLE;INJECTION
AN-DTPA
JUBILANT DRAXIMAGE N/A N017714 001
MPI DTPA KIT - CHELATE
GE HEALTHCARE N/A N017255 001
TECHNETIUM TC-99M PENTETATE KIT
GE HEALTHCARE N/A N017264 002
TECHNETIUM TC-99M POLYPHOSPHATE KIT
INJECTABLE;INJECTION
SODIUM POLYPHOSPHATE-TIN KIT
GE HEALTHCARE N/A N017664 001
TECHNETIUM TC-99M PYRO/TRIMETA PHOSPHATES KIT
INJECTABLE;INJECTION
PYROLITE
PHARMALUCENCE N/A N017684 001
TECHNETIUM TC-99M PYROPHOSPHATE KIT
INJECTABLE;INJECTION
PHOSPHOTEC
BRACCO N/A N017680 001
TECHNETIUM TC-99M RED BLOOD CELL KIT
INJECTABLE;INJECTION
RBC-SCAN
CADEMA N/A N020063 001 Jun 11, 1992
TECHNETIUM TC-99M SESTAMIBI KIT
INJECTABLE;INJECTION
MIRALUMA
LANTHEUS MEDCL N/A N019785 003 May 23, 1997
TECHNETIUM TC-99M SODIUM PERTECHNETATE
SOLUTION;INJECTION, ORAL
SODIUM PERTECHNETATE TC 99M
+ GE HEALTHCARE 2-100mCi/ML ** N017471 001
+ MALLINCKRODT 10-60mCi/ML ** N017725 001
PHARMALUCENCE 12mCi/ML N017321 001
24mCi/ML N017321 002
48mCi/ML N017321 003

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-436(of 478)
** See List Footnote
TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR
SOLUTION;INJECTION, ORAL
MINITEC
BRACCO 0.22-2.22 CI/GENERATOR N017339 001
SOLUTION;INTRAVENOUS
TECHNELITE
LANTHEUS MEDCL 0.0083-2.7 CI/GENERATOR N017771 001
ULTRA-TECHNEKOW FM
CURIUM 0.25-3 CI/GENERATOR N017243 002
SOLUTION;INTRAVENOUS, ORAL
TECHNETIUM TC 99M GENERATOR
+ GE HEALTHCARE 68-2703mCi/GENERATOR N017693 002 Dec 13, 2013
830-16600mCi/GENERATOR N017693 001
TECHNETIUM TC-99M SUCCIMER KIT
INJECTABLE;INJECTION
MPI DMSA KIDNEY REAGENT
+ GE HEALTHCARE N/A ** N017944 001 May 18, 1982
TECHNETIUM TC-99M SULFUR COLLOID
SOLUTION;INJECTION, ORAL
TECHNETIUM TC 99M SULFUR COLLOID
GE HEALTHCARE 4mCi/ML N017456 001
SOLUTION;ORAL
TECHNETIUM TC 99M SULFUR COLLOID
MALLINCKRODT 3mCi/ML N017724 001
TECHNETIUM TC-99M SULFUR COLLOID KIT
SOLUTION;INJECTION, ORAL
TECHNECOLL
MALLINCKRODT N/A N017059 001
TECHNETIUM TC 99M TSC
GE HEALTHCARE N/A N017784 001
TESULOID
BRACCO N/A N016923 001
TECHNETIUM TC-99M TEBOROXIME KIT
INJECTABLE;INJECTION
CARDIOTEC
BRACCO N/A N019928 001 Dec 19, 1990
TEGASEROD MALEATE
TABLET;ORAL
ZELNORM
+ ALFASIGMA EQ 2MG BASE N021200 001 Jul 24, 2002
+ EQ 6MG BASE N021200 002 Jul 24, 2002
TELAPREVIR
TABLET;ORAL
INCIVEK
VERTEX PHARMS 375MG N201917 001 May 23, 2011
TELAVANCIN HYDROCHLORIDE
POWDER;INTRAVENOUS
VIBATIV
+ CUMBERLAND PHARMS EQ 250MG BASE/VIAL N022110 001 Sep 11, 2009
TELBIVUDINE
SOLUTION;ORAL
TYZEKA
NOVARTIS 100MG/5ML N022154 001 Apr 28, 2009
TABLET;ORAL
TYZEKA
+ NOVARTIS 600MG N022011 001 Oct 25, 2006
TELITHROMYCIN
TABLET;ORAL
KETEK
SANOFI AVENTIS US 300MG N021144 002 Feb 09, 2005
400MG N021144 001 Apr 01, 2004

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-437(of 478)
** See List Footnote
TELMISARTAN
TABLET;ORAL
TELMISARTAN
HISUN PHARM HANGZHOU 20MG A207843 001 Feb 19, 2019
40MG A207843 002 Feb 19, 2019
80MG A207843 003 Feb 19, 2019
JUBILANT GENERICS 20MG A204164 001 Aug 22, 2016
40MG A204164 002 Aug 22, 2016
80MG A204164 003 Aug 22, 2016
TORRENT 20MG A203171 001 Jul 07, 2014
40MG A203171 002 Jul 07, 2014
80MG A203171 003 Jul 07, 2014
TEMAZEPAM
CAPSULE;ORAL
TEMAZ
QUANTUM PHARMICS 15MG A070564 001 Oct 15, 1985
30MG A070547 001 Oct 15, 1985
TEMAZEPAM
AUROBINDO PHARMA USA 7.5MG A070920 002 May 21, 2010
15MG A070920 004 Jul 07, 1986
22.5MG A070920 003 Jun 12, 2009
30MG A070920 001 Jul 10, 1986
DURAMED PHARMS BARR 15MG A071708 001 Sep 29, 1988
30MG A071709 001 Sep 29, 1988
SUN PHARM INDUSTRIES 15MG A071174 001 Jul 10, 1986
30MG A071175 001 Jul 10, 1986
USL PHARMA 15MG A070489 001 Jul 07, 1986
30MG A070490 001 Jul 07, 1986
WATSON LABS 15MG A070383 001 Mar 23, 1987
15MG A071446 001 May 21, 1993
30MG A070384 001 Mar 23, 1987
30MG A071447 001 May 21, 1993
TEMOZOLOMIDE
CAPSULE;ORAL
TEMODAR
+ MERCK SHARP DOHME 5MG N021029 001 Aug 11, 1999
+ 20MG N021029 002 Aug 11, 1999
+ 100MG N021029 003 Aug 11, 1999
+ 140MG N021029 005 Oct 19, 2006
+ 180MG N021029 006 Oct 19, 2006
+ 250MG N021029 004 Aug 11, 1999
TEMOZOLOMIDE
ANI PHARMS 5MG A203490 001 Jul 13, 2016
20MG A203490 002 Jul 13, 2016
100MG A203490 003 Jul 13, 2016
140MG A203490 004 Jul 13, 2016
180MG A203490 005 Jul 13, 2016
250MG A203490 006 Jul 13, 2016
APOTEX INC 5MG A204159 001 Jul 05, 2018
20MG A204159 002 Jul 05, 2018
100MG A204159 003 Jul 05, 2018
140MG A204159 004 Jul 05, 2018
180MG A204159 005 Jul 05, 2018
250MG A204159 006 Jul 05, 2018
LANNETT CO INC 5MG A203898 001 Feb 10, 2016
20MG A203898 002 Feb 10, 2016
100MG A203898 003 Feb 10, 2016
140MG A203898 004 Feb 10, 2016
180MG A203898 005 Feb 10, 2016
250MG A203898 006 Feb 10, 2016
MYLAN 5MG A205227 001 Jun 29, 2016
20MG A205227 002 Jun 29, 2016
100MG A205227 003 Jun 29, 2016
140MG A205227 004 Jun 29, 2016
180MG A205227 005 Jun 29, 2016
250MG A205227 006 Jun 29, 2016
WATSON LABS TEVA 5MG A203959 001 Apr 18, 2017
20MG A203959 002 Apr 18, 2017

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-438(of 478)
** See List Footnote
TEMOZOLOMIDE
CAPSULE;ORAL
TEMOZOLOMIDE
100MG A203959 003 Apr 18, 2017
140MG A203959 004 Apr 18, 2017
250MG A203959 005 Apr 18, 2017
TENIPOSIDE
INJECTABLE;INJECTION
VUMON
+ HQ SPECLT PHARMA 10MG/ML N020119 001 Jul 14, 1992
TENOFOVIR DISOPROXIL FUMARATE
TABLET;ORAL
TENOFOVIR DISOPROXIL FUMARATE
MYLAN 150MG A206569 001 Nov 27, 2018
200MG A206569 002 Nov 27, 2018
250MG A206569 003 Nov 27, 2018
300MG A206569 004 Nov 27, 2018
TERAZOSIN HYDROCHLORIDE
CAPSULE;ORAL
HYTRIN
+ ABBOTT EQ 1MG BASE ** N020347 001 Dec 14, 1994
+ EQ 2MG BASE ** N020347 002 Dec 14, 1994
+ EQ 5MG BASE ** N020347 003 Dec 14, 1994
+ EQ 10MG BASE ** N020347 004 Dec 14, 1994
TERAZOSIN HYDROCHLORIDE
BEXIMCO PHARMS USA EQ 1MG BASE A075667 001 Jul 28, 2000
EQ 2MG BASE A075667 002 Jul 28, 2000
EQ 5MG BASE A075667 003 Jul 28, 2000
EQ 10MG BASE A075667 004 Jul 28, 2000
HIKMA EQ 1MG BASE A075498 001 Apr 12, 2001
EQ 2MG BASE A075498 002 Apr 12, 2001
EQ 5MG BASE A075498 003 Apr 12, 2001
EQ 10MG BASE A075498 004 Apr 12, 2001
MYLAN EQ 1MG BASE A075140 002 Feb 11, 2000
EQ 2MG BASE A075140 003 Feb 11, 2000
EQ 5MG BASE A075140 001 Feb 11, 2000
EQ 10MG BASE A075140 004 Feb 11, 2000
MYLAN TECHNOLOGIES EQ 1MG BASE A075384 001 Dec 01, 2000
EQ 2MG BASE A075384 002 Dec 01, 2000
EQ 5MG BASE A075384 003 Dec 01, 2000
EQ 10MG BASE A075384 004 Dec 01, 2000
RANBAXY LABS LTD EQ 1MG BASE A076021 001 Aug 22, 2002
EQ 2MG BASE A076021 002 Aug 22, 2002
EQ 5MG BASE A076021 003 Aug 22, 2002
EQ 10MG BASE A076021 004 Aug 22, 2002
TABLET;ORAL
HYTRIN
ABBOTT EQ 1MG BASE N019057 001 Aug 07, 1987
EQ 2MG BASE N019057 002 Aug 07, 1987
EQ 5MG BASE N019057 003 Aug 07, 1987
EQ 10MG BASE N019057 004 Aug 07, 1987
TERAZOSIN HYDROCHLORIDE
IVAX SUB TEVA PHARMS EQ 1MG BASE A074530 001 Apr 21, 2000
EQ 2MG BASE A074530 002 Apr 21, 2000
EQ 5MG BASE A074530 003 Apr 21, 2000
EQ 10MG BASE A074530 004 Apr 21, 2000
SANDOZ EQ 1MG BASE A074315 001 Dec 31, 1998
EQ 1MG BASE A074657 001 Apr 28, 2000
EQ 2MG BASE A074315 002 Dec 31, 1998
EQ 2MG BASE A074657 002 Apr 28, 2000
EQ 5MG BASE A074315 003 Dec 31, 1998
EQ 5MG BASE A074657 003 Apr 28, 2000
EQ 10MG BASE A074315 004 Dec 31, 1998
EQ 10MG BASE A074657 004 Apr 28, 2000
TEVA EQ 1MG BASE A074446 001 May 18, 2000
EQ 2MG BASE A074446 002 May 18, 2000
EQ 5MG BASE A074446 003 May 18, 2000
EQ 10MG BASE A074446 004 May 18, 2000

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-439(of 478)
** See List Footnote
TERBINAFINE
GEL;TOPICAL
LAMISIL
GLAXOSMITHKLINE CONS 1% N020846 001 Apr 29, 1998
TERBINAFINE HYDROCHLORIDE
CREAM;TOPICAL
LAMISIL
NOVARTIS 1% ** N020192 001 Dec 30, 1992
GRANULE;ORAL
LAMISIL
+ NOVARTIS EQ 125MG BASE/PACKET N022071 001 Sep 28, 2007
+ EQ 187.5MG BASE/PACKET N022071 002 Sep 28, 2007
SOLUTION;TOPICAL
LAMISIL
GLAXOSMITHKLINE CONS 1% N020749 001 Oct 17, 1997
TABLET;ORAL
LAMISIL
+ NOVARTIS EQ 250MG BASE ** N020539 001 May 10, 1996
TERBINAFINE HYDROCHLORIDE
GEDEON RICHTER USA EQ 250MG BASE A077065 001 Jul 02, 2007
HERITAGE PHARMA AVET EQ 250MG BASE A076377 001 Jul 02, 2007
MYLAN EQ 250MG BASE A077136 001 Jul 02, 2007
EQ 250MG BASE A077195 001 Jul 02, 2007
ROXANE EQ 250MG BASE A077223 001 Jul 02, 2007
WOCKHARDT EQ 250MG BASE A078229 001 Jul 02, 2007
TERBUTALINE SULFATE
AEROSOL, METERED;INHALATION
BRETHAIRE
NOVARTIS 0.2MG/INH N018762 001 Aug 17, 1984
BRICANYL
SANOFI AVENTIS US 0.2MG/INH N018000 001 Mar 19, 1985
INJECTABLE;INJECTION
BRETHINE
+ PHARMACARE 1MG/ML ** N018571 001
BRICANYL
SANOFI AVENTIS US 1MG/ML N017466 001
TERBUTALINE SULFATE
AKORN 1MG/ML A078151 001 Jan 07, 2008
DR REDDYS 1MG/ML A076853 001 Jul 20, 2004
TABLET;ORAL
BRICANYL
SANOFI AVENTIS US 2.5MG N017618 001
5MG N017618 002
TERCONAZOLE
CREAM;VAGINAL
TERAZOL 3
+ JANSSEN PHARMS 0.8% ** N019964 001 Feb 21, 1991
TERAZOL 7
+ JANSSEN PHARMS 0.4% ** N019579 001 Dec 31, 1987
SUPPOSITORY;VAGINAL
TERAZOL 3
+ JANSSEN PHARMS 80MG N019641 001 May 24, 1988
TERCONAZOLE
FOUGERA PHARMS 80MG A076850 001 Jul 12, 2006
TERIFLUNOMIDE
TABLET;ORAL
TERIFLUNOMIDE
AMNEAL PHARMS CO 7MG A209613 001 Sep 28, 2018
14MG A209613 002 Sep 28, 2018
APOTEX 7MG A209601 001 Nov 02, 2018
14MG A209601 002 Nov 02, 2018
AUROBINDO PHARMA 7MG A209638 001 Oct 26, 2018
14MG A209638 002 Oct 26, 2018
BRECKENRIDGE 7MG A209583 001 Sep 24, 2021
14MG A209583 002 Sep 24, 2021
MSN 7MG A209623 001 Apr 24, 2019
14MG A209623 002 Apr 24, 2019

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-440(of 478)
** See List Footnote
TERIFLUNOMIDE
TABLET;ORAL
TERIFLUNOMIDE
MYLAN 7MG A209702 001 Feb 28, 2020
14MG A209702 002 Feb 28, 2020
SOLA PHARMS 14MG A209677 001 Jun 17, 2020
TEVA PHARMS USA 7MG A209700 001 Sep 04, 2018
14MG A209700 002 Sep 04, 2018
WATSON LABS TEVA 7MG A209549 001 Jul 27, 2018
14MG A209549 002 Jul 27, 2018
ZYDUS PHARMS 7MG A209668 001 Nov 30, 2018
14MG A209668 002 Nov 30, 2018
TERIPARATIDE
SOLUTION;SUBCUTANEOUS
FORTEO
LILLY 0.75MG/3ML (0.25MG/ML) N021318 001 Nov 26, 2002
TERIPARATIDE ACETATE
INJECTABLE;INJECTION
PARATHAR
SANOFI AVENTIS US 200 UNITS/VIAL N019498 001 Dec 23, 1987
TESTOLACTONE
INJECTABLE;INJECTION
TESLAC
BRISTOL MYERS SQUIBB 100MG/ML N016119 001
TABLET;ORAL
TESLAC
BRISTOL MYERS SQUIBB 50MG N016118 001
250MG N016118 002
TESTOSTERONE
FILM, EXTENDED RELEASE;TRANSDERMAL
ANDRODERM
ALLERGAN 2.5MG/24HR N020489 001 Sep 29, 1995
5MG/24HR N020489 002 May 02, 1997
TESTODERM
ALZA 4MG/24HR N019762 001 Oct 12, 1993
6MG/24HR N019762 002 Oct 12, 1993
TESTODERM TTS
ALZA 5MG/24HR N020791 001 Dec 18, 1997
GEL;TRANSDERMAL
ANDROGEL
+ ABBVIE 1.62% (20.25MG/1.25GM PACKET) N022309 002 Sep 07, 2012
+ 1.62% (40.5MG/2.5GM PACKET) N022309 003 Sep 07, 2012
+ 25MG/2.5GM PACKET N021015 001 Feb 28, 2000
+ 50MG/5GM PACKET N021015 002 Feb 28, 2000
TESTOSTERONE
ANI PHARMS 25MG/2.5GM PACKET N202763 001 Feb 14, 2012
50MG/5GM PACKET N202763 002 Feb 14, 2012
PERRIGO ISRAEL 25MG/2.5GM PACKET N203098 002 Jan 31, 2013
50MG/5GM PACKET N203098 003 Jan 31, 2013
GEL, METERED;TRANSDERMAL
ANDROGEL
+ ABBVIE 12.5MG/1.25GM ACTUATION ** N021015 003 Sep 26, 2003
TESTOSTERONE
ALEOR DERMACEUTICALS 1.62% (20.25MG/1.25GM ACTUATION) A213922 001 Mar 03, 2021
PERRIGO ISRAEL 12.5MG/1.25GM ACTUATION N203098 001 Jan 31, 2013
INJECTABLE;INJECTION
TESTOSTERONE
DR REDDYS 100MG/ML A086417 001 Jul 07, 1983
WATSON LABS 25MG/ML A086420 001 May 10, 1983
50MG/ML A086419 001 Aug 23, 1983
SOLUTION, METERED;TRANSDERMAL
AXIRON
+ ELI LILLY AND CO 30MG/1.5ML ACTUATION ** N022504 001 Nov 23, 2010
TESTOSTERONE
ALEOR DERMACEUTICALS 30MG/1.5ML ACTUATION A212882 001 Jun 14, 2021
APOTEX 30MG/1.5ML ACTUATION A209181 001 Nov 25, 2020

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-441(of 478)
** See List Footnote
TESTOSTERONE
TABLET, EXTENDED RELEASE;BUCCAL
STRIANT
+ AUXILIUM PHARMS LLC 30MG N021543 001 Jun 19, 2003
TESTOSTERONE CYPIONATE
INJECTABLE;INJECTION
DEPO-TESTOSTERONE
PFIZER 50MG/ML A085635 001
TESTOSTERONE CYPIONATE
RISING 200MG/ML A040652 001 Dec 11, 2006
WATSON LABS 100MG/ML A084401 001
100MG/ML A086029 001
200MG/ML A084401 002
SOLUTION;INTRAMUSCULAR
TESTOSTERONE CYPIONATE
+ SLAYBACK PHARMA LLC 200MG/ML (200MG/ML) N216318 001 Jun 02, 2022
TESTOSTERONE ENANTHATE
INJECTABLE;INJECTION
DELATESTRYL
ENDO PHARMS 200MG/ML N009165 001
+ 200MG/ML N009165 003
TESTOSTERONE ENANTHATE
RISING 200MG/ML A040647 001 Oct 05, 2009
WATSON LABS 100MG/ML A083667 001
100MG/ML A085599 001
200MG/ML A083667 002
TESTOSTERONE PROPIONATE
INJECTABLE;INJECTION
TESTOSTERONE PROPIONATE
BEL MAR 25MG/ML A080741 001
50MG/ML A080742 001
100MG/ML A080743 001
ELKINS SINN 25MG/ML A080276 001
LILLY 50MG/ML A080254 002
WATSON LABS 25MG/ML A080188 001
25MG/ML A085490 001
50MG/ML A080188 002
50MG/ML A085490 002
100MG/ML A080188 003
100MG/ML A083595 003
TETRABENAZINE
TABLET;ORAL
TETRABENAZINE
AJANTA PHARMA LTD 12.5MG A213621 001 Dec 04, 2020
25MG A213621 002 Dec 04, 2020
HIKMA 12.5MG A209739 001 Apr 08, 2019
25MG A209739 002 Apr 08, 2019
TETRACYCLINE HYDROCHLORIDE
CAPSULE;ORAL
BRISTACYCLINE
BRISTOL 250MG A061658 001
250MG A061888 001
500MG A061658 002
500MG A061888 002
CYCLOPAR
WARNER CHILCOTT 250MG A061725 001
250MG A062175 001
250MG A062332 001
500MG A061725 002
500MG A062332 002
PANMYCIN
PHARMACIA AND UPJOHN 250MG A060347 001
RETET
SOLVAY 250MG A061443 001
500MG A061443 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-442(of 478)
** See List Footnote
TETRACYCLINE HYDROCHLORIDE
CAPSULE;ORAL
ROBITET
WYETH AYERST 250MG A061734 001
500MG A061734 002
SUMYCIN
APOTHECON 100MG A060429 002
125MG A060429 004
250MG A060429 001
500MG A060429 003
TETRACHEL
ANGUS 250MG A060343 001
500MG A060343 003
TETRACYCLINE HYDROCHLORIDE
ABBOTT 250MG A061802 001
500MG A061802 002
ANI PHARMS 250MG A061471 001
ELKINS SINN 250MG A060059 001
FERRANTE 125MG A060173 001
250MG A060173 002
HEATHER 250MG A061148 001
500MG A061148 002
HIKMA 250MG A060768 001
500MG A060768 002
IMPAX LABS 100MG A060469 002
250MG A060469 001
500MG A060469 003
IVAX SUB TEVA PHARMS 250MG A060704 001
500MG A060704 002
MAST MM 250MG A062085 001
MYLAN 250MG A060783 001
500MG A060783 002
PUREPAC PHARM 250MG A060290 001
500MG A060290 002
PVT FORM 250MG A062686 001 Jul 24, 1986
500MG A062686 002 Jul 24, 1986
ROXANE 500MG A061214 002
SUN PHARM INDUSTRIES 250MG A060736 001
500MG A060736 002
SUPERPHARM 250MG A062540 001 Mar 21, 1985
500MG A062540 002 Mar 21, 1985
VALEANT PHARM INTL 250MG A060471 001
500MG A060471 002
WARNER CHILCOTT 250MG A062300 001
500MG A062300 002
WATSON LABS 250MG A062103 001
250MG A062343 001
500MG A062103 002
500MG A062343 002
WYETH AYERST 250MG A061685 001
500MG A061685 002
TETRACYN
PFIPHARMECS 250MG A060082 003
500MG A060082 004
FIBER, EXTENDED RELEASE;PERIODONTAL
ACTISITE
SCHIFF AND CO 12.7MG/FIBER N050653 001 Mar 25, 1994
FOR SOLUTION;TOPICAL
TOPICYCLINE
SHIRE 2.2MG/ML N050493 001
INJECTABLE;INJECTION
ACHROMYCIN
LEDERLE 250MG/VIAL N050273 002
500MG/VIAL N050273 003
TETRACYN
PFIZER 250MG/VIAL A060096 001
500MG/VIAL A060096 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-443(of 478)
** See List Footnote
TETRACYCLINE HYDROCHLORIDE
OINTMENT;OPHTHALMIC
ACHROMYCIN
STORZ 10MG/GM N050266 001
SUSPENSION;ORAL
ACHROMYCIN V
LEDERLE 125MG/5ML N050263 002
SUMYCIN
PAR PHARM 125MG/5ML A060400 001
TETRACYCLINE HYDROCHLORIDE
ALPHARMA US PHARMS 125MG/5ML A060633 001
FERRANTE 125MG/5ML A060174 001
PROTER 125MG/5ML A060446 001
PUREPAC PHARM 125MG/5ML A060291 001
TETRACYN
PFIPHARMECS 125MG/5ML A060095 001
TETRAMED
IVAX SUB TEVA PHARMS 125MG/5ML A061468 001
SUSPENSION/DROPS;OPHTHALMIC
ACHROMYCIN
STORZ 1% N050268 001
TABLET;ORAL
PANMYCIN
PHARMACIA AND UPJOHN 250MG A061705 001
500MG A061705 002
SUMYCIN
STRIDES PHARMA 50MG A061147 003
100MG A061147 002
250MG A061147 001
500MG A061147 004
TETRACYCLINE PHOSPHATE COMPLEX
CAPSULE;ORAL
TETREX
BRISTOL EQ 100MG HYDROCHLORIDE A061653 001
EQ 250MG HYDROCHLORIDE A061653 002
EQ 250MG HYDROCHLORIDE A061889 002
EQ 250MG HYDROCHLORIDE N050212 002
EQ 500MG HYDROCHLORIDE A061653 003
EQ 500MG HYDROCHLORIDE A061889 001
EQ 500MG HYDROCHLORIDE N050212 003
THALLOUS CHLORIDE TL-201
INJECTABLE;INJECTION
THALLOUS CHLORIDE TL 201
BRACCO 1mCi/ML N018548 001 Dec 30, 1982
+ GE HEALTHCARE 1mCi/ML N018110 002 Feb 27, 1996
TRACE LIFE 1mCi/ML A075569 001 Nov 21, 2001
INJECTABLE;INTRAVENOUS
THALLOUS CHLORIDE TL 201
CURIUM 2mCi/ML A077698 001 Nov 09, 2006
+ LANTHEUS MEDCL 2mCi/ML N017806 002 Oct 09, 1998
THEOPHYLLINE
CAPSULE;ORAL
BRONKODYL
SANOFI AVENTIS US 100MG A085264 001
200MG A085264 002
ELIXOPHYLLIN
FOREST LABS 100MG A085545 001 Jul 31, 1984
200MG A083921 001 Jul 31, 1984
SOMOPHYLLIN-T
FISONS 100MG A087155 001 Feb 25, 1985
200MG A087155 002 Feb 25, 1985
250MG A087155 003 Feb 25, 1985
THEOPHYLLINE
KV PHARM 100MG A085263 001
200MG A085263 002
SCHERER RP 100MG A084731 002 Nov 07, 1986
200MG A084731 001 Nov 07, 1986
250MG A084731 003 Nov 07, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-444(of 478)
** See List Footnote
THEOPHYLLINE
CAPSULE, EXTENDED RELEASE;ORAL
AEROLATE III
FLEMING PHARMS 65MG A085075 003 Nov 24, 1986
AEROLATE JR
FLEMING PHARMS 130MG A085075 002 Nov 24, 1986
AEROLATE SR
FLEMING PHARMS 260MG A085075 001 Nov 24, 1986
ELIXOPHYLLIN SR
FOREST LABS 125MG A086826 001 Jan 29, 1985
250MG A086826 002 Jan 29, 1985
SLO-BID
SANOFI AVENTIS US 50MG A088269 001 Jan 31, 1985
75MG A089539 001 May 10, 1989
100MG A087892 001 Jan 31, 1985
125MG A089540 001 May 10, 1989
200MG A087893 001 Jan 31, 1985
300MG A087894 001 Jan 31, 1985
SLO-PHYLLIN
SANOFI AVENTIS US 60MG A085206 001 May 24, 1982
+ 125MG A085203 001 May 24, 1982
250MG A085205 001 May 24, 1982
SOMOPHYLLIN-CRT
GRAHAM DM 50MG A087763 001 Feb 27, 1985
100MG A087194 001
200MG A088382 001 Feb 27, 1985
+ 250MG A087193 001
300MG A088383 001 Feb 27, 1985
THEO-DUR
SCHERING 50MG A088022 001 Sep 10, 1985
75MG A088015 001 Sep 10, 1985
125MG A088016 001 Sep 10, 1985
200MG A087995 001 Sep 10, 1985
THEOBID
WHITBY 260MG A085983 001 Mar 20, 1985
THEOBID JR.
WHITBY 130MG A087854 001 Mar 20, 1985
THEOCLEAR L.A.-130
SCHWARZ PHARMA 130MG A086569 001 May 27, 1982
THEOCLEAR L.A.-260
SCHWARZ PHARMA 260MG A086569 002 May 27, 1982
THEOPHYL-SR
ORTHO MCNEIL PHARM 125MG A086480 001 Feb 08, 1985
250MG A086471 001 Feb 08, 1985
THEOPHYLLINE
CENT PHARMS 125MG A088654 001 Feb 12, 1985
250MG A088689 001 Feb 12, 1985
HOSPIRA 100MG A089976 001 Jan 04, 1995
200MG A089977 001 Jan 04, 1995
300MG A089932 001 Jan 04, 1995
INWOOD LABS 100MG A040052 001 Feb 14, 1994
125MG A040052 002 Feb 14, 1994
200MG A040052 003 Feb 14, 1994
300MG A040052 004 Feb 14, 1994
SANDOZ 260MG A087462 001 May 11, 1982
THEOPHYLLINE-SR
SCHERER RP 300MG A088255 001 Jun 12, 1986
THEOVENT
SCHERING 125MG A087010 001 Jan 31, 1985
250MG A087910 001 Jan 31, 1985
ELIXIR;ORAL
ELIXOMIN
CENCI 80MG/15ML A088303 001 Jan 25, 1984
LANOPHYLLIN
LANNETT 80MG/15ML A084578 001
THEOLIXIR
PANRAY 80MG/15ML A084559 001
THEOPHYL-225
ORTHO MCNEIL PHARM 112.5MG/15ML A086485 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-445(of 478)
** See List Footnote
THEOPHYLLINE
ELIXIR;ORAL
THEOPHYLLINE
ALPHARMA US PHARMS 80MG/15ML A089223 001 May 27, 1988
CENCI 80MG/15ML A087679 001 Apr 15, 1982
CHARTWELL RX 80MG/15ML A085952 001
HALSEY 80MG/15ML A085169 001
PHARM ASSOC 80MG/15ML A086720 001
+ PRECISION DOSE 80MG/15ML A085863 001
ROXANE 80MG/15ML A084739 001
TARO 80MG/15ML A089626 001 Oct 28, 1988
WOCKHARDT 80MG/15ML A086748 001
INJECTABLE;INJECTION
THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 40MG/100ML N019083 001 Nov 07, 1984
THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 80MG/100ML N019083 002 Nov 07, 1984
THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 160MG/100ML N019083 003 Nov 07, 1984
THEOPHYLLINE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 200MG/100ML N019212 001 Nov 07, 1984
200MG/100ML N019826 004 Aug 14, 1992
THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
B BRAUN 4MG/ML N019212 003 Nov 07, 1984
400MG/100ML N019212 002 Nov 07, 1984
400MG/100ML N019826 005 Aug 14, 1992
THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 4MG/ML N018649 007 Jul 26, 1982
40MG/100ML N018649 001 Jul 26, 1982
80MG/100ML N018649 002 Jul 26, 1982
160MG/100ML N018649 003 Jul 26, 1982
200MG/100ML N018649 004 Jul 26, 1982
320MG/100ML N018649 006 Nov 13, 1985
400MG/100ML N018649 005 Jul 26, 1982
THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER
+ HOSPIRA INC 4MG/ML N019211 007 Dec 14, 1984
+ 40MG/100ML N019211 001 Dec 14, 1984
80MG/100ML N019211 002 Dec 14, 1984
+ 160MG/100ML N019211 003 Dec 14, 1984
200MG/100ML N019211 004 Dec 14, 1984
+ 320MG/100ML N019211 006 Jan 20, 1988
400MG/100ML N019211 005 Dec 14, 1984
SOLUTION;ORAL
AEROLATE
FLEMING PHARMS 150MG/15ML A089141 001 Dec 03, 1986
THEOLAIR
3M 80MG/15ML A086107 001
THEOPHYLLINE
+ ROXANE 80MG/15ML A087449 001 Sep 15, 1983
SUSPENSION;ORAL
ELIXICON
FOREST LABS 100MG/5ML A085502 001
SYRUP;ORAL
ACCURBRON
SANOFI AVENTIS US 150MG/15ML A088746 001 Nov 22, 1985
AQUAPHYLLIN
FERNDALE LABS 80MG/15ML A087917 001 Jan 18, 1983
SLO-PHYLLIN
SANOFI AVENTIS US 80MG/15ML A085187 001
THEOCLEAR-80
CENT PHARMS 80MG/15ML A087095 001 Mar 01, 1982
THEOPHYLLINE
ALPHARMA US PHARMS 80MG/15ML A086001 001
+ 150MG/15ML A086545 001
TABLET;ORAL
QUIBRON-T
MONARCH PHARMS 300MG A088656 001 Aug 22, 1985
SLO-PHYLLIN
SANOFI AVENTIS US 100MG A085202 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-446(of 478)
** See List Footnote
THEOPHYLLINE
TABLET;ORAL
SLO-PHYLLIN
200MG A085204 001
THEOCLEAR-100
CENT PHARMS 100MG A085353 002
THEOCLEAR-200
CENT PHARMS 200MG A085353 001
THEOLAIR
MEDICIS 125MG A086399 001
250MG A086399 002
THEOPHYL-225
ORTHO MCNEIL PHARM 225MG A084726 001
TABLET, CHEWABLE;ORAL
THEOPHYL
ORTHO MCNEIL PHARM 100MG A086506 001 Sep 12, 1985
TABLET, EXTENDED RELEASE;ORAL
DURAPHYL
FOREST LABS 100MG A088503 001 Apr 03, 1985
200MG A088504 001 Apr 03, 1985
300MG A088505 001 Apr 03, 1985
LABID
WARNER CHILCOTT 250MG A087225 001
QUIBRON-T/SR
MONARCH PHARMS 300MG A087563 001 Jun 21, 1983
SUSTAIRE
ROERIG 100MG A085665 001
300MG A085665 002
T-PHYL
PHARM RES ASSOC 200MG A088253 001 Aug 17, 1983
THEO-DUR
SCHERING 100MG ** A085328 001
+ 200MG A086998 001
+ 300MG ** A085328 002
450MG A089131 001 Jun 25, 1986
THEOCHRON
NOSTRUM PHARMS LLC 100MG A087400 003 Feb 21, 1985
200MG A087400 004 Feb 21, 1985
300MG A087400 002 Jan 11, 1983
THEOLAIR-SR
3M 200MG A088369 001 Jul 16, 1987
250MG A086363 002 Jul 16, 1987
300MG A088364 001 Jul 16, 1987
500MG A089132 001 Jul 16, 1987
THEOPHYLLINE
ABLE 300MG A040548 001 Apr 30, 2004
400MG A040543 001 Apr 27, 2004
450MG A040546 001 Apr 30, 2004
600MG A040539 001 Apr 27, 2004
HERITAGE PHARMA AVET 100MG A089807 001 Apr 30, 1990
200MG A089808 001 Apr 30, 1990
INWOOD LABS 450MG A040034 001 Apr 28, 1995
UNI-DUR
SCHERING 400MG A089822 001 Jan 04, 1995
600MG A089823 001 Jan 04, 1995
THEOPHYLLINE SODIUM GLYCINATE
ELIXIR;ORAL
SYNOPHYLATE
CENT PHARMS EQ 165MG BASE/15ML N006333 008
TABLET;ORAL
ASBRON
NOVARTIS EQ 150MG BASE A085148 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-447(of 478)
** See List Footnote
THIABENDAZOLE
SUSPENSION;ORAL
MINTEZOL
MERCK SHARP DOHME 500MG/5ML N016097 001
TABLET, CHEWABLE;ORAL
MINTEZOL
MERCK SHARP DOHME 500MG N016096 001
THIAMINE HYDROCHLORIDE
INJECTABLE;INJECTION
BETALIN S
+ LILLY 100MG/ML A080853 001
THIAMINE HYDROCHLORIDE
ABRAXIS PHARM 100MG/ML A080509 001
AKORN 100MG/ML A087968 001 Oct 01, 1982
BEL MAR 100MG/ML A080718 001
200MG/ML A080712 001
DELL LABS 100MG/ML A083775 001
DR REDDYS 100MG/ML A080571 001
200MG/ML A080571 002
HOSPIRA 100MG/ML A040079 001 May 03, 1996
LUITPOLD 100MG/ML A080667 001
PARKE DAVIS 100MG/ML A080770 001
WATSON LABS 100MG/ML A083534 001
200MG/ML A083534 002
WYETH AYERST 100MG/ML A080553 001
THIAMYLAL SODIUM
INJECTABLE;INJECTION
SURITAL
PARKEDALE 1GM/VIAL N007600 003
5GM/VIAL N007600 005
10GM/VIAL N007600 009
THIETHYLPERAZINE MALATE
INJECTABLE;INJECTION
TORECAN
NOVARTIS 5MG/ML N012754 002
THIETHYLPERAZINE MALEATE
SUPPOSITORY;RECTAL
TORECAN
NOVARTIS 10MG N013247 001
TABLET;ORAL
TORECAN
NOVARTIS 10MG N012753 001
THIOPENTAL SODIUM
SUSPENSION;RECTAL
PENTOTHAL
ABBOTT 400MG/GM N011679 001
THIORIDAZINE
SUSPENSION;ORAL
MELLARIL-S
NOVARTIS EQ 25MG HYDROCHLORIDE/5ML ** N017923 001
EQ 100MG HYDROCHLORIDE/5ML ** N017923 002
THIORIDAZINE HYDROCHLORIDE
CONCENTRATE;ORAL
MELLARIL
NOVARTIS 30MG/ML ** N011808 012
100MG/ML ** N011808 018
THIORIDAZINE HYDROCHLORIDE
ACTAVIS MID ATLANTIC 100MG/ML A088229 001 Aug 23, 1983
AKORN 30MG/ML A040125 001 Aug 16, 1996
100MG/ML A040126 001 Aug 16, 1996
ALPHARMA US PHARMS 30MG/ML A087766 001 Apr 26, 1983
ANI PHARMS 30MG/ML A089602 001 Nov 09, 1987
100MG/ML A089603 001 Nov 09, 1987
PHARM ASSOC 30MG/ML A040187 001 Aug 28, 1997
100MG/ML A040213 001 May 29, 1998
SANDOZ 30MG/ML A088307 001 Nov 23, 1983

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-448(of 478)
** See List Footnote
THIORIDAZINE HYDROCHLORIDE
CONCENTRATE;ORAL
THIORIDAZINE HYDROCHLORIDE
100MG/ML A088308 001 Nov 23, 1983
WOCKHARDT 30MG/ML A088258 001 Jul 25, 1983
100MG/ML A088227 001 Jul 05, 1983
THIORIDAZINE HYDROCHLORIDE INTENSOL
ROXANE 30MG/ML A088941 001 Dec 16, 1985
100MG/ML A088942 001 Dec 16, 1985
TABLET;ORAL
MELLARIL
+ NOVARTIS 10MG ** N011808 003
+ 15MG ** N011808 016
+ 25MG ** N011808 006
+ 50MG ** N011808 011
+ 100MG ** N011808 009
+ 150MG ** N011808 017
+ 200MG ** N011808 015
THIORIDAZINE HYDROCHLORIDE
ANI PHARMS 10MG A088270 001 Apr 14, 1983
10MG A088493 001 May 17, 1985
15MG A088271 001 Apr 14, 1983
25MG A088272 001 Apr 14, 1983
50MG A088194 001 Apr 14, 1983
100MG A088273 001 Oct 03, 1983
100MG A088456 001 May 17, 1985
FOSUN PHARMA 10MG A088131 001 Aug 30, 1983
15MG A088132 001 Aug 30, 1983
25MG A088133 001 Aug 30, 1983
50MG A088134 001 Aug 30, 1983
100MG A088135 001 Nov 20, 1984
150MG A088136 001 Sep 17, 1986
200MG A088137 001 Sep 17, 1986
HERITAGE PHARMA AVET 10MG A088476 001 Nov 08, 1983
25MG A088478 001 Nov 08, 1983
50MG A088479 001 Nov 08, 1983
100MG A088736 001 Jul 24, 1984
MUTUAL PHARM 10MG A088375 001 Nov 18, 1983
25MG A087264 001 Nov 18, 1983
50MG A088370 001 Nov 18, 1983
100MG A088379 001 Nov 16, 1983
MYLAN 10MG A088332 001 Jun 27, 1983
25MG A088333 001 Jun 27, 1983
50MG A088334 001 Jun 27, 1983
100MG A088335 001 Nov 18, 1983
PAR PHARM 10MG A088351 001 Dec 05, 1983
15MG A088352 001 Dec 05, 1983
25MG A088336 001 Dec 05, 1983
50MG A088322 001 Dec 05, 1983
100MG A088480 001 Dec 29, 1983
150MG A089764 001 Feb 09, 1988
200MG A089765 001 Feb 09, 1988
ROXANE 10MG A088663 001 Mar 15, 1984
25MG A088664 001 Mar 15, 1984
50MG A088665 001 Mar 15, 1984
100MG A089048 001 Feb 26, 1985
SUN PHARM INDUSTRIES 10MG A089953 004 Aug 01, 1986
15MG A088461 001 Nov 18, 1983
25MG A089953 003 Aug 01, 1986
50MG A089953 002 Aug 01, 1986
100MG A089953 001 Oct 07, 1988
150MG A088737 001 Sep 26, 1984
200MG A088738 001 Oct 16, 1984
SUPERPHARM 10MG A089103 001 Jul 02, 1985
25MG A089104 001 Jul 02, 1985
50MG A089105 001 Jul 02, 1985
WATSON LABS 10MG A088412 001 Sep 12, 1983
10MG A088561 001 May 11, 1984
15MG A088345 001 Jul 28, 1983

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-449(of 478)
** See List Footnote
THIORIDAZINE HYDROCHLORIDE
TABLET;ORAL
THIORIDAZINE HYDROCHLORIDE
15MG A088562 001 May 11, 1984
25MG A088296 001 Jul 28, 1983
25MG A088755 001 Jul 24, 1984
50MG A088323 001 Jul 28, 1983
50MG A088563 001 May 11, 1984
100MG A088284 001 Aug 25, 1983
100MG A088564 001 May 11, 1984
150MG A088410 001 Mar 05, 1984
150MG A088869 001 Jun 28, 1985
200MG A088381 001 Mar 14, 1984
WATSON LABS TEVA 15MG A088477 001 Nov 08, 1983
25MG A088567 001 May 11, 1984
200MG A088872 001 Apr 26, 1985
WEST WARD 10MG A088658 001 Mar 26, 1984
15MG A088659 001 Mar 26, 1984
25MG A088660 001 Mar 26, 1984
50MG A088661 001 Mar 26, 1984
THIOTEPA
INJECTABLE;INJECTION
THIOPLEX
+ IMMUNEX 15MG/VIAL ** N020058 001 Dec 22, 1994
THIOTEPA
FRESENIUS KABI USA 15MG/VIAL A075698 001 Sep 20, 2001
IMMUNEX 15MG/VIAL N011683 001
TEVA PARENTERAL 15MG/VIAL ** A075730 001 Apr 20, 2001
30MG/VIAL ** A075730 002 Apr 20, 2001
THIOTHIXENE
CAPSULE;ORAL
NAVANE
+ PFIZER 1MG ** N016584 001
+ 2MG ** N016584 002
+ 5MG ** N016584 003
+ 10MG ** N016584 004
+ 20MG ** N016584 005
THIOTHIXENE
AM THERAP 1MG A071884 001 Aug 12, 1987
2MG A071885 001 Aug 12, 1987
5MG A071886 001 Aug 12, 1987
10MG A071887 001 Aug 12, 1987
20MG A072200 001 Dec 17, 1987
EPIC PHARMA 1MG A071529 002 Jun 24, 1987
2MG A071529 003 Jun 24, 1987
5MG A071529 001 Jun 24, 1987
10MG A071529 004 Jun 24, 1987
HERITAGE PHARMA AVET 1MG A070600 001 Jun 05, 1987
2MG A070601 001 Jun 05, 1987
5MG A070602 001 Jun 05, 1987
10MG A070603 001 Jun 05, 1987
WATSON LABS 2MG A071626 001 Jun 25, 1987
5MG A071627 001 Jun 25, 1987
10MG A071628 001 Jun 25, 1987
THIOTHIXENE HYDROCHLORIDE
CONCENTRATE;ORAL
NAVANE
+ PFIZER EQ 5MG BASE/ML N016758 001
THIOTHIXENE HYDROCHLORIDE
ALPHARMA US PHARMS EQ 5MG BASE/ML A070969 001 Oct 16, 1987
PACO EQ 1MG BASE/ML A071917 001 Sep 20, 1989
EQ 5MG BASE/ML A071939 001 Dec 16, 1988
TEVA EQ 5MG BASE/ML A071184 001 Jun 22, 1987
TEVA PHARMS EQ 5MG BASE/ML A071554 001 Oct 16, 1987
THIOTHIXENE HYDROCHLORIDE INTENSOL
HIKMA EQ 5MG BASE/ML A073494 001 Jun 30, 1992

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-450(of 478)
** See List Footnote
THIOTHIXENE HYDROCHLORIDE
INJECTABLE;INJECTION
NAVANE
PFIZER EQ 2MG BASE/ML N016904 001
EQ 10MG BASE/VIAL N016904 002
TIAGABINE HYDROCHLORIDE
TABLET;ORAL
GABITRIL
CEPHALON 6MG N020646 006 Nov 29, 2005
8MG N020646 007 Nov 29, 2005
10MG N020646 008 Nov 29, 2005
20MG N020646 004 Sep 30, 1997
TIAGABINE HYDROCHLORIDE
AMNEAL PHARMS CO 2MG A208181 001 Dec 08, 2017
4MG A208181 002 Dec 08, 2017
12MG A208181 003 Dec 08, 2017
16MG A208181 004 Dec 08, 2017
WILSHIRE PHARMS INC 2MG A206857 001 Oct 13, 2017
4MG A206857 002 Oct 13, 2017
12MG A206857 003 Oct 13, 2017
16MG A206857 004 Oct 13, 2017
TICAGRELOR
TABLET;ORAL
TICAGRELOR
AMNEAL 90MG A208531 001 Jan 23, 2019
MYLAN 60MG A208597 001 Jul 09, 2021
90MG A208597 002 Jul 09, 2021
SIGMAPHARM LABS LLC 90MG A208596 001 Apr 07, 2020
SUNSHINE 90MG A208508 001 Apr 06, 2020
WATSON LABS INC 60MG A208390 001 Sep 04, 2018
90MG A208390 002 Sep 04, 2018
TICARCILLIN DISODIUM
INJECTABLE;INJECTION
TICAR
GLAXOSMITHKLINE EQ 1GM BASE/VIAL N050497 001
EQ 3GM BASE/VIAL A062690 001 Dec 19, 1986
EQ 3GM BASE/VIAL N050497 002
EQ 6GM BASE/VIAL N050497 003
EQ 20GM BASE/VIAL N050497 004
EQ 30GM BASE/VIAL N050497 005 Apr 04, 1984
TICLOPIDINE HYDROCHLORIDE
TABLET;ORAL
TICLID
ROCHE PALO 125MG N019979 001 Mar 24, 1993
250MG N019979 002 Oct 31, 1991
TICLOPIDINE HYDROCHLORIDE
ACTAVIS ELIZABETH 250MG A075253 001 Aug 20, 1999
CHARTWELL RX 250MG A075318 001 Aug 20, 1999
250MG A075326 001 Aug 20, 1999
MYLAN 250MG A075161 001 Sep 13, 1999
250MG A075316 001 Nov 02, 1999
SUN PHARM INDS INC 250MG A075526 001 Sep 26, 2002
WATSON LABS 250MG A075309 001 Apr 26, 2000
TIGECYCLINE
POWDER;INTRAVENOUS
TIGECYCLINE
XELLIA PHARMS APS 50MG/VIAL A205722 001 Oct 18, 2019
TILUDRONATE DISODIUM
TABLET;ORAL
SKELID
+ SANOFI AVENTIS US EQ 200MG BASE ** N020707 001 Mar 07, 1997

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-451(of 478)
** See List Footnote
TIMOLOL MALEATE
SOLUTION/DROPS;OPHTHALMIC
TIMOLOL MALEATE
AKORN EQ 0.25% BASE A074465 001 Mar 25, 1997
EQ 0.25% BASE A074515 001 Mar 25, 1997
EQ 0.5% BASE A074516 001 Mar 25, 1997
EQ 0.5% BASE A075163 001 Sep 10, 2002
APOTEX INC EQ 0.25% BASE A075411 001 Sep 08, 2000
EQ 0.5% BASE A075412 001 Sep 08, 2000
FOUGERA EQ 0.25% BASE A074667 001 Mar 25, 1997
EQ 0.5% BASE A074668 001 Mar 25, 1997
TABLET;ORAL
BLOCADREN
+ MERCK 5MG ** N018017 001
+ 10MG ** N018017 002
+ 20MG ** N018017 004
TIMOLOL MALEATE
ANI PHARMS 5MG A072917 001 Jul 31, 1991
10MG A072918 001 Jul 31, 1991
20MG A072919 001 Jul 31, 1991
CHARTWELL RX 5MG A072550 001 Apr 13, 1989
10MG A072551 001 Apr 13, 1989
20MG A072552 001 Apr 13, 1989
QUANTUM PHARMICS 5MG A072466 001 May 19, 1989
10MG A072467 001 May 19, 1989
20MG A072468 001 May 19, 1989
TEVA 5MG A072648 001 Jun 16, 1993
10MG A072649 001 Jun 16, 1993
20MG A072650 001 Jun 16, 1993
USL PHARMA 5MG A072001 001 Apr 11, 1989
10MG A072002 001 Apr 11, 1989
20MG A072003 001 Apr 11, 1989
WATSON LABS 5MG A072269 001 Apr 11, 1989
10MG A072270 001 Apr 11, 1989
20MG A072271 001 Apr 11, 1989
TINIDAZOLE
TABLET;ORAL
TINIDAZOLE
HIKMA 250MG A201172 001 Apr 30, 2012
500MG A201172 002 Apr 30, 2012
TINZAPARIN SODIUM
INJECTABLE;INJECTION
INNOHEP
LEO PHARMA AS 20,000 IU/ML N020484 001 Jul 14, 2000
TIOCONAZOLE
CREAM;TOPICAL
TZ-3
PFIZER 1% N018682 001 Feb 18, 1983
TIPRANAVIR
SOLUTION;ORAL
APTIVUS
+ BOEHRINGER INGELHEIM 100MG/ML N022292 001 Jun 23, 2008
TIROFIBAN HYDROCHLORIDE
INJECTABLE;INJECTION
AGGRASTAT
MEDICURE EQ 12.5MG BASE/50ML (EQ 0.25MG BASE/ML) N020912 001 May 14, 1998
SOLUTION;INTRAVENOUS
AGGRASTAT
MEDICURE EQ 25MG BASE/500ML (EQ 0.05MG BASE/ML) N020913 001 May 14, 1998
TIZANIDINE HYDROCHLORIDE
CAPSULE;ORAL
TIZANIDINE HYDROCHLORIDE
MYLAN PHARMS INC EQ 2MG BASE A091502 001 Nov 09, 2012
EQ 4MG BASE A091502 002 Nov 09, 2012
EQ 6MG BASE A091502 003 Nov 09, 2012
PAR PHARM INC EQ 2MG BASE A207199 001 Mar 14, 2017

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-452(of 478)
** See List Footnote
TIZANIDINE HYDROCHLORIDE
CAPSULE;ORAL
TIZANIDINE HYDROCHLORIDE
EQ 4MG BASE A207199 002 Mar 14, 2017
EQ 6MG BASE A207199 003 Mar 14, 2017
TABLET;ORAL
TIZANIDINE HYDROCHLORIDE
ANI PHARMS EQ 2MG BASE A076283 001 Jul 12, 2002
EQ 2MG BASE A076284 001 Jul 03, 2002
EQ 2MG BASE A076321 001 Sep 30, 2004
EQ 2MG BASE A076371 001 Apr 09, 2003
EQ 4MG BASE A076283 002 Jul 12, 2002
EQ 4MG BASE A076284 002 Jul 03, 2002
EQ 4MG BASE A076321 002 Sep 30, 2004
EQ 4MG BASE A076371 002 Apr 09, 2003
MYLAN PHARMS INC EQ 2MG BASE A076282 001 Dec 16, 2003
EQ 4MG BASE A076282 002 Dec 16, 2003
PAR PHARM INC EQ 2MG BASE A207170 001 Jan 26, 2017
EQ 4MG BASE A207170 002 Jan 26, 2017
RISING EQ 2MG BASE A076354 001 Mar 28, 2003
EQ 4MG BASE A076354 002 Mar 28, 2003
ZANAFLEX
+ LEGACY PHARMA EQ 2MG BASE ** N020397 002 Feb 04, 2000
TOBRAMYCIN
SOLUTION;INHALATION
TOBRAMYCIN
LUOXIN AUROVITAS 300MG/5ML A210871 001 Jan 22, 2021
MYLAN 300MG/5ML A209554 001 Oct 13, 2017
SOLUTION/DROPS;OPHTHALMIC
TOBRAMYCIN
ALCON PHARMS LTD 0.3% A063176 001 May 25, 1994
APOTEX INC 0.3% A065087 001 Feb 25, 2002
TOBRAMYCIN SULFATE
INJECTABLE;INJECTION
NEBCIN
LILLY EQ 10MG BASE/ML A062008 004
EQ 10MG BASE/ML A062707 001 Apr 29, 1987
+ EQ 10MG BASE/ML ** N050477 005
EQ 40MG BASE/ML A062008 001
+ EQ 1.2GM BASE/VIAL ** N050519 001
TOBRAMYCIN SULFATE
AKORN EQ 40MG BASE/ML A205179 001 Sep 16, 2014
APOTHECON EQ 10MG BASE/ML A064021 001 May 31, 1994
EQ 40MG BASE/ML A064021 002 May 31, 1994
EQ 40MG BASE/ML A064026 001 May 31, 1994
HIKMA EQ 10MG BASE/ML A063113 001 Apr 26, 1991
EQ 10MG BASE/ML A063128 001 Nov 27, 1991
EQ 40MG BASE/ML A063118 001 Jul 29, 1991
EQ 40MG BASE/ML A063127 001 Nov 27, 1991
HOSPIRA EQ 10MG BASE/ML A063080 001 Apr 30, 1991
EQ 40MG BASE/ML A063161 001 May 29, 1991
IGI LABS INC EQ 10MG BASE/ML A063119 001 Oct 31, 1994
EQ 40MG BASE/ML A063120 001 Oct 31, 1994
EQ 40MG BASE/ML A063121 001 Oct 31, 1994
EQ 40MG BASE/ML A063122 001 Oct 31, 1994
TEVA PHARMS USA EQ 40MG BASE/ML A063100 001 Jan 30, 1992
WATSON LABS INC EQ 10MG BASE/ML A062945 001 Aug 09, 1989
EQ 40MG BASE/ML A062945 002 Aug 09, 1989
TOBRAMYCIN SULFATE (PHARMACY BULK)
HOSPIRA EQ 40MG BASE/ML ** A063116 001 May 18, 1992
TOCAINIDE HYDROCHLORIDE
TABLET;ORAL
TONOCARD
ASTRAZENECA 400MG N018257 001 Nov 09, 1984
600MG N018257 002 Nov 09, 1984

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-453(of 478)
** See List Footnote
TOFACITINIB CITRATE
TABLET;ORAL
TOFACITINIB CITRATE
AJANTA PHARMA LTD EQ 10MG BASE A212943 001 Jun 01, 2021
TABLET, EXTENDED RELEASE;ORAL
TOFACITINIB
ZYDUS PHARMS EQ 11MG BASE A214264 001 Aug 19, 2021
EQ 22MG BASE A214264 002 Aug 19, 2021
TOLAZAMIDE
TABLET;ORAL
TOLAZAMIDE
BARR 100MG A070162 001 Jan 14, 1986
250MG A070163 001 Jan 14, 1986
500MG A070164 001 Jan 14, 1986
CHARTWELL RX 100MG A071633 001 Dec 09, 1987
250MG A070289 001 Mar 13, 1986
500MG A070290 001 Mar 13, 1986
COSETTE 100MG N018894 001 Nov 02, 1984
250MG N018894 002 Nov 02, 1984
500MG N018894 003 Nov 02, 1984
DURAMED PHARMS BARR 100MG A070165 001 Jan 10, 1986
250MG A070166 001 Jan 10, 1986
500MG A070167 001 Jan 10, 1986
INTERPHARM 250MG A071270 001 Sep 23, 1986
500MG A071271 001 Sep 23, 1986
MYLAN PHARMS INC 250MG A070259 001 Jan 02, 1986
500MG A070259 003 Mar 17, 1986
PAR PHARM 100MG A070159 001 Jan 06, 1986
250MG A070160 001 Jan 06, 1986
500MG A070161 001 Jan 06, 1986
SUN PHARM INDUSTRIES 100MG A071357 001 Jul 16, 1987
250MG A071358 001 Jul 16, 1987
500MG A071359 001 Jul 16, 1987
SUPERPHARM 250MG A070763 001 Jun 16, 1986
500MG A070764 001 Jun 16, 1986
USL PHARMA 100MG A071355 001 Jan 11, 1988
250MG A070168 001 Apr 02, 1986
500MG A070169 001 Apr 02, 1986
WATSON LABS 100MG A070242 001 Aug 01, 1986
100MG A070513 001 Jan 09, 1986
250MG A070243 001 Aug 01, 1986
250MG A070514 001 Jan 09, 1986
500MG A070244 001 Aug 01, 1986
500MG A070515 001 Jan 09, 1986
TOLINASE
+ PHARMACIA AND UPJOHN 100MG ** N015500 002
+ 250MG ** N015500 004
+ 500MG ** N015500 005
TOLAZOLINE HYDROCHLORIDE
INJECTABLE;INJECTION
PRISCOLINE
NOVARTIS 25MG/ML N006403 005 Feb 22, 1985
TOLBUTAMIDE
TABLET;ORAL
ORINASE
PHARMACIA AND UPJOHN 250MG ** N010670 002
500MG ** N010670 001
TOLBUTAMIDE
ALRA 500MG A086141 001
ANI PHARMS 500MG A087093 001
ASCOT 500MG A087541 001 Mar 01, 1983
BARR 500MG A087121 001
CHARTWELL RX 500MG A086574 001
DAVA PHARMS INC 500MG A086926 001
MYLAN PHARMS INC 500MG A086445 001
PARKE DAVIS 500MG A086047 001
PUREPAC PHARM 500MG A088950 001 Jun 17, 1985
SANDOZ 500MG N012678 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-454(of 478)
** See List Footnote
TOLBUTAMIDE
TABLET;ORAL
TOLBUTAMIDE
SUPERPHARM 500MG A088893 001 Nov 19, 1984
VANGARD 500MG A087876 001 Apr 20, 1982
WATSON LABS 250MG A089110 001 May 29, 1987
500MG A086109 001
500MG A087318 001
500MG A089111 001 May 29, 1987
TOLBUTAMIDE SODIUM
INJECTABLE;INJECTION
ORINASE DIAGNOSTIC
PHARMACIA AND UPJOHN EQ 1GM BASE/VIAL N012095 001
TOLCAPONE
TABLET;ORAL
TASMAR
BAUSCH 200MG N020697 002 Jan 29, 1998
TOLCAPONE
ALVOGEN 100MG A207729 001 Jul 29, 2020
MAYNE PHARMA 100MG A210095 001 Aug 01, 2019
TOLMETIN SODIUM
CAPSULE;ORAL
TOLECTIN DS
+ ORTHO MCNEIL JANSSEN EQ 400MG BASE N018084 001
TOLMETIN SODIUM
ANI PHARMS EQ 400MG BASE A073308 001 Jan 24, 1992
EQ 400MG BASE A073392 001 Jan 24, 1992
EQ 400MG BASE A073519 001 May 29, 1992
FOSUN PHARMA EQ 400MG BASE A073462 001 Apr 30, 1992
RISING EQ 400MG BASE A073393 001 May 27, 1993
SUN PHARM INDUSTRIES EQ 400MG BASE A073311 001 Nov 27, 1991
TEVA EQ 400MG BASE A073290 001 Nov 27, 1991
TABLET;ORAL
TOLECTIN
+ ORTHO MCNEIL JANSSEN EQ 200MG BASE N017628 001
TOLECTIN 600
+ ORTHO MCNEIL JANSSEN EQ 600MG BASE N017628 002 Mar 08, 1989
TOLMETIN SODIUM
ANI PHARMS EQ 600MG BASE A073527 001 Jun 30, 1992
COSETTE EQ 600MG BASE A074399 001 Mar 28, 1996
EQ 600MG BASE A074729 001 Feb 27, 1997
FOSUN PHARMA EQ 200MG BASE A073588 001 Jul 31, 1992
EQ 600MG BASE A074002 001 Sep 27, 1993
RISING EQ 600MG BASE A074473 001 Aug 30, 1994
SUN PHARM INDUSTRIES EQ 200MG BASE A073310 001 Nov 27, 1991
TOLTERODINE TARTRATE
CAPSULE, EXTENDED RELEASE;ORAL
TOLTERODINE TARTRATE
AUROBINDO PHARMA USA 2MG A201486 001 Oct 31, 2013
4MG A201486 002 Oct 31, 2013
TABLET;ORAL
TOLTERODINE TARTRATE
APOTEX CORP 1MG A200164 001 Sep 25, 2012
2MG A200164 002 Sep 25, 2012
MYLAN PHARMS INC 1MG A202641 001 Nov 27, 2012
2MG A202641 002 Nov 27, 2012
TOLVAPTAN
TABLET;ORAL
SAMSCA
+ OTSUKA 60MG ** N022275 003 May 19, 2009

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-455(of 478)
** See List Footnote
TOPIRAMATE
CAPSULE;ORAL
TOPAMAX SPRINKLE
JANSSEN PHARMS 50MG N020844 003 Oct 26, 1998
TOPIRAMATE
BARR 15MG A076448 001 Apr 15, 2009
25MG A076448 002 Apr 15, 2009
FOSUN PHARMA 15MG A079206 001 Oct 14, 2009
25MG A079206 002 Oct 14, 2009
STRIDES PHARMA 15MG A078418 001 Oct 14, 2009
25MG A078418 002 Oct 14, 2009
TABLET;ORAL
TOPAMAX
JANSSEN PHARMS 300MG N020505 003 Dec 24, 1996
400MG N020505 006 Dec 24, 1996
TOPIRAMATE
ACTAVIS TOTOWA 25MG A078637 001 Feb 27, 2013
50MG A078637 002 Feb 27, 2013
100MG A078637 003 Feb 27, 2013
200MG A078637 004 Feb 27, 2013
BARR 25MG A076315 001 Mar 27, 2009
100MG A076315 002 Mar 27, 2009
200MG A076315 003 Mar 27, 2009
CHARTWELL 25MG A078410 001 Sep 11, 2013
50MG A078410 002 Sep 11, 2013
100MG A078410 003 Sep 11, 2013
200MG A078410 004 Sep 11, 2013
HIKMA PHARMS 25MG A091185 001 Nov 25, 2013
50MG A091185 002 Nov 25, 2013
100MG A091185 003 Nov 25, 2013
200MG A091185 004 Nov 25, 2013
MYLAN 25MG A076314 001 Mar 27, 2009
50MG A076314 002 Mar 27, 2009
100MG A076314 003 Mar 27, 2009
200MG A076314 004 Mar 27, 2009
PLIVA HRVATSKA DOO 25MG A077905 001 Mar 30, 2009
50MG A077905 002 Mar 30, 2009
100MG A077905 003 Mar 30, 2009
200MG A077905 004 Mar 30, 2009
ROXANE 25MG A076306 001 Mar 27, 2009
50MG A076306 002 Mar 27, 2009
100MG A076306 003 Mar 27, 2009
200MG A076306 004 Mar 27, 2009
TORRENT PHARMS 25MG A079153 001 Mar 27, 2009
50MG A079153 002 Mar 27, 2009
100MG A079153 003 Mar 27, 2009
200MG A079153 004 Mar 27, 2009
UPSHER SMITH LABS 25MG A078499 001 Jan 07, 2010
50MG A078499 002 Jan 07, 2010
100MG A078499 003 Jan 07, 2010
200MG A078499 004 Jan 07, 2010
WATSON LABS 25MG A077643 001 Mar 27, 2009
50MG A077643 002 Mar 27, 2009
100MG A077643 003 Mar 27, 2009
200MG A077643 004 Mar 27, 2009
WOCKHARDT 25MG A090353 001 Sep 01, 2010
50MG A090353 002 Sep 01, 2010
100MG A090353 003 Sep 01, 2010
200MG A090353 004 Sep 01, 2010
TOPOTECAN HYDROCHLORIDE
INJECTABLE;INJECTION
TOPOTECAN HYDROCHLORIDE
FRESENIUS KABI USA EQ 4MG BASE/VIAL A091376 001 Nov 29, 2010
MEITHEAL EQ 4MG BASE/VIAL A201166 001 Aug 08, 2012
MYLAN LABS LTD EQ 4MG BASE/VIAL A091542 001 Aug 28, 2012
SUN PHARM INDS LTD EQ 4MG BASE/VIAL A202203 001 Aug 29, 2013

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-456(of 478)
** See List Footnote
TOPOTECAN HYDROCHLORIDE
SOLUTION;INTRAVENOUS
TOPOTECAN
+ SANDOZ INC EQ 1MG BASE/ML (EQ 1MG BASE/ML) ** N200199 001 Feb 25, 2011
+ EQ 3MG BASE/3ML (EQ 1MG BASE/ML) ** N200199 002 Feb 25, 2011
+ EQ 4MG BASE/4ML (EQ 1MG BASE/ML) ** N200199 003 Feb 25, 2011
TOPOTECAN HYDROCHLORIDE
MYLAN LABS LTD EQ 4MG BASE/4ML (EQ 1MG BASE/ML) A206074 001 Nov 24, 2017
TORSEMIDE
INJECTABLE;INJECTION
DEMADEX
+ ROCHE 50MG/5ML (10MG/ML) ** N020137 002 Aug 23, 1993
+ 20MG/2ML (10MG/ML) ** N020137 001 Aug 23, 1993
TORSEMIDE
AM REGENT 20MG/2ML (10MG/ML) A090656 001 Apr 21, 2010
50MG/5ML (10MG/ML) A090656 002 Apr 21, 2010
WEST-WARD PHARMS INT 20MG/2ML (10MG/ML) A078007 001 Jun 11, 2008
50MG/5ML (10MG/ML) A078007 002 Jun 11, 2008
TABLET;ORAL
DEMADEX
+ MYLAN SPECIALITY LP 5MG ** N020136 001 Aug 23, 1993
+ 10MG ** N020136 002 Aug 23, 1993
+ 20MG ** N020136 003 Aug 23, 1993
+ 100MG ** N020136 004 Aug 23, 1993
TORSEMIDE
SUN PHARM INDS 5MG A078478 001 Feb 26, 2008
10MG A078478 002 Feb 26, 2008
20MG A078478 003 Feb 26, 2008
100MG A078478 004 Feb 26, 2008
TRAMADOL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
CONZIP
+ CIPHER PHARMS INC 150MG N022370 004 Aug 01, 2011
TABLET;ORAL
TRAMADOL HYDROCHLORIDE
ACCORD HLTHCARE 50MG A202390 001 May 16, 2013
ACTAVIS ELIZABETH 50MG A075960 001 Jun 19, 2002
ASTA 50MG A075974 001 Jul 12, 2002
GRAVITI PHARMS 50MG A075968 001 Jun 25, 2002
IVAX SUB TEVA PHARMS 50MG A075963 001 Jul 03, 2002
MACLEODS PHARMS LTD 50MG A205702 001 Sep 25, 2015
MYLAN 50MG A075986 001 Jun 21, 2002
MYLAN PHARMS INC 50MG A075980 001 Nov 21, 2002
NORTHSTAR HLTHCARE 50MG A078935 001 May 26, 2010
SPECGX LLC 50MG A075983 001 Jun 25, 2002
SUN PHARM INDUSTRIES 50MG A076100 001 Jun 20, 2002
WATSON LABS 50MG A075962 001 Jun 24, 2002
ULTRAM
+ JANSSEN PHARMS 50MG N020281 002 Mar 03, 1995
+ 100MG ** N020281 001 Mar 03, 1995
TABLET, EXTENDED RELEASE;ORAL
RYZOLT
+ PURDUE PHARMA 100MG ** N021745 001 Dec 30, 2008
+ 200MG ** N021745 002 Dec 30, 2008
+ 300MG ** N021745 003 Dec 30, 2008
TRAMADOL HYDROCHLORIDE
ANCHEN PHARMS 100MG A200491 001 Jun 27, 2012
200MG A200491 002 Jun 27, 2012
300MG A200491 003 Jun 27, 2012
AUROBINDO PHARMA LTD 100MG A204421 001 Oct 20, 2015
200MG A204421 002 Oct 20, 2015
300MG A204421 003 Oct 20, 2015
MYLAN 100MG A205257 001 Dec 22, 2015
200MG A205257 002 Dec 22, 2015
300MG A205257 003 Dec 22, 2015
STRIDES PHARMA 100MG A078783 001 Nov 13, 2009
200MG A078783 002 Nov 13, 2009
300MG A078783 003 Sep 20, 2011

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-457(of 478)
** See List Footnote
TRAMADOL HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
ULTRAM ER
+ VALEANT PHARMS 100MG ** N021692 001 Sep 08, 2005
+ 200MG ** N021692 002 Sep 08, 2005
+ 300MG ** N021692 003 Sep 08, 2005
TABLET, ORALLY DISINTEGRATING;ORAL
RYBIX ODT
SHIONOGI INC 50MG N021693 001 May 05, 2005
TRAMETINIB DIMETHYL SULFOXIDE
TABLET;ORAL
MEKINIST
+ NOVARTIS EQ 1MG N204114 002 May 29, 2013
TRANDOLAPRIL
TABLET;ORAL
MAVIK
+ ABBVIE 1MG ** N020528 001 Apr 26, 1996
+ 2MG ** N020528 002 Apr 26, 1996
+ 4MG ** N020528 003 Apr 26, 1996
TRANDOLAPRIL
CHARTWELL MOLECULAR 1MG A077307 002 Jun 12, 2007
2MG A077307 001 Jun 12, 2007
4MG A077307 003 Jun 12, 2007
DR REDDYS LABS LTD 1MG A078493 001 Aug 25, 2008
2MG A078493 002 Aug 25, 2008
4MG A078493 003 Aug 25, 2008
EPIC PHARMA LLC 1MG A077256 001 Jun 12, 2007
2MG A077256 002 Jun 12, 2007
4MG A077256 003 Jun 12, 2007
INVAGEN PHARMS 1MG A078320 001 Jun 12, 2007
2MG A078320 002 Jun 12, 2007
4MG A078320 003 Jun 12, 2007
MYLAN 1MG A078346 001 Apr 28, 2008
2MG A078346 002 Apr 28, 2008
4MG A078346 003 Apr 28, 2008
WATSON LABS 1MG A077805 001 Jun 12, 2007
2MG A077805 002 Jun 12, 2007
4MG A077805 003 Jun 12, 2007
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
TARKA
+ ABBVIE 1MG;240MG ** N020591 003 Oct 22, 1996
+ 2MG;180MG N020591 001 Oct 22, 1996
+ 2MG;240MG N020591 004 Oct 22, 1996
+ 4MG;240MG N020591 002 Oct 22, 1996
TRANEXAMIC ACID
INJECTABLE;INJECTION
TRANEXAMIC ACID
AKORN 100MG/ML A206594 001 Sep 28, 2017
100MG/ML A206634 001 Jun 09, 2016
ANDA REPOSITORY 100MG/ML A202755 001 Feb 25, 2016
ZYDUS PHARMS 100MG/ML A205228 001 Jul 17, 2017
TABLET;ORAL
CYKLOKAPRON
PHARMACIA AND UPJOHN 500MG N019280 001 Dec 30, 1986
TRANEXAMIC ACID
APOTEX INC 650MG A202286 001 Jan 27, 2014
AUROBINDO PHARMA USA 650MG A205133 001 Sep 21, 2015
TRAVOPROST
SOLUTION/DROPS;OPHTHALMIC
IZBA
+ NOVARTIS 0.003% ** N204822 001 May 15, 2014
TRAVATAN
+ ALCON PHARMS LTD 0.004% ** N021257 001 Mar 16, 2001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-458(of 478)
** See List Footnote
TRAZODONE HYDROCHLORIDE
TABLET;ORAL
DESYREL
+ PRAGMA 50MG ** N018207 001
+ 100MG ** N018207 002
+ 150MG ** N018207 003 Mar 25, 1985
+ 300MG ** N018207 004 Nov 07, 1988
TRAZODONE HYDROCHLORIDE
ALVOGEN 50MG A071636 001 Apr 18, 1988
100MG A071514 001 Apr 18, 1988
AM THERAP 50MG A071139 001 Oct 29, 1986
100MG A071140 001 Oct 29, 1986
FOSUN PHARMA 100MG A072483 001 Apr 30, 1990
MYLAN 50MG A071405 001 Feb 27, 1991
100MG A071406 001 Feb 27, 1991
MYLAN PHARMS INC 50MG A090514 001 Jun 02, 2009
100MG A090514 002 Jun 02, 2009
150MG A090514 003 Jun 02, 2009
300MG A090514 004 Jun 02, 2009
QUANTUM PHARMICS 100MG A070921 001 Dec 01, 1986
RISING 50MG A072484 001 Apr 30, 1990
TEVA 150MG A074357 001 Apr 30, 1997
USL PHARMA 50MG A070491 001 Apr 29, 1987
100MG A070492 001 Apr 29, 1987
WATSON LABS 50MG A070857 001 Oct 10, 1986
50MG A071112 001 Nov 17, 1986
100MG A070858 001 Oct 10, 1986
100MG A071113 001 Nov 17, 1986
TRIALODINE
QUANTUM PHARMICS 50MG A070942 001 Dec 01, 1986
TABLET, EXTENDED RELEASE;ORAL
OLEPTRO
+ ANGELINI PHARMA 150MG ** N022411 001 Feb 02, 2010
+ 300MG ** N022411 002 Feb 02, 2010
TREPROSTINIL
INJECTABLE;IV (INFUSION), SUBCUTANEOUS
TREPROSTINIL
DR REDDYS 1MG/ML A210214 001 May 22, 2020
2.5MG/ML A210214 002 May 22, 2020
5MG/ML A210214 003 May 22, 2020
10MG/ML A210214 004 May 22, 2020
SOLUTION;INTRAVENOUS, SUBCUTANEOUS
REMODULIN
UNITED THERAP 20MG/20ML (1MG/ML) N208276 001 Jul 30, 2018
50MG/20ML (2.5MG/ML) N208276 002 Jul 30, 2018
100MG/20ML (5MG/ML) N208276 003 Jul 30, 2018
200MG/20ML (10MG/ML) N208276 004 Jul 30, 2018
TRETINOIN
CAPSULE;ORAL
VESANOID
+ CHEPLAPHARM 10MG ** N020438 001 Nov 22, 1995
CREAM;TOPICAL
RENOVA
+ VALEANT PHARMS NORTH 0.05% N019963 001 Dec 29, 1995
TRETINOIN
ALLERGAN 0.0375% A090098 001 Mar 22, 2010
0.075% A202209 001 Oct 11, 2012
ZO SKIN HEALTH 0.05% A076498 001 Sep 15, 2005
GEL;TOPICAL
TRETINOIN
MYLAN 0.04% A202567 001 Jul 17, 2013
0.1% A202026 001 Jul 17, 2013
SOLUTION;TOPICAL
RETIN-A
+ VALEANT INTL 0.05% N016921 001
TRETINOIN
TEVA PHARMS 0.05% A074873 001 Jun 19, 1998
WOCKHARDT 0.05% A075260 001 Jan 25, 1999

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-459(of 478)
** See List Footnote
TRETINOIN
SWAB;TOPICAL
RETIN-A
VALEANT INTL 0.05% N016921 002
TRIAMCINOLONE
TABLET;ORAL
ARISTOCORT
ASTELLAS 1MG N011161 009
2MG N011161 004
4MG N011161 007
8MG N011161 011
16MG N011161 010
KENACORT
DELCOR ASSET CORP 1MG N011283 003
2MG N011283 008
4MG N011283 006
8MG N011283 010
TRIAMCINOLONE
BARR 2MG A084286 001
2MG A084318 001
4MG A084267 001
4MG A084319 001
8MG A084268 001
8MG A084320 001
IMPAX LABS 4MG A084340 001
IVAX SUB TEVA PHARMS 4MG A083750 001
MYLAN 2MG A084406 001
PUREPAC PHARM 2MG A084020 002
4MG A084020 003
ROXANE 2MG A084708 001
4MG A084709 001
8MG A084707 001
SANDOZ 4MG A085601 001
TEVA 4MG A084775 001
WATSON LABS 4MG A084270 001
4MG A085834 001
TRIAMCINOLONE ACETONIDE
AEROSOL, METERED;INHALATION
AZMACORT
ABBVIE 0.1MG/INH N018117 001 Apr 23, 1982
AEROSOL, METERED;NASAL
NASACORT
CHATTEM SANOFI 0.055MG/INH N019798 001 Jul 11, 1991
CREAM;TOPICAL
ARISTOCORT
ASTELLAS 0.025% A083017 003
0.1% A083016 004
+ 0.5% A083015 002
ARISTOCORT A
ASTELLAS 0.025% A083017 004
0.025% A088818 001 Oct 16, 1984
0.1% A083016 005
0.1% A088819 001 Oct 16, 1984
0.5% A083015 003
0.5% A088820 001 Oct 16, 1984
FLUTEX
IVAX PHARMS 0.025% A085539 001
0.1% A085539 002
0.5% A085539 003
KENALOG
+ DELCOR ASSET CORP 0.5% A083943 001
KENALOG-H
DELCOR ASSET CORP 0.1% A086240 001
TRIACET
TEVA 0.025% A084908 001
0.1% A084908 002
0.5% A084908 003

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-460(of 478)
** See List Footnote
TRIAMCINOLONE ACETONIDE
CREAM;TOPICAL
TRIACORT
SOLVAY 0.1% A087113 001
TRIAMCINOLONE ACETONIDE
ACTAVIS MID ATLANTIC 0.1% A087798 001 Jun 04, 1982
ALPHARMA US PHARMS 0.025% A087797 001 Jun 07, 1982
AMBIX 0.025% A087932 001 May 09, 1983
MORTON GROVE 0.025% A088094 001 Sep 01, 1983
0.1% A088095 001 Sep 01, 1983
0.5% A088096 001 Sep 01, 1983
+ MYLAN 0.025% ** N011601 003
+ 0.1% ** N011601 006
PHARMADERM 0.025% A087990 001 Jul 07, 1983
0.1% A087991 001 Jul 07, 1983
0.5% A087992 001 Jul 07, 1983
PHARMAFAIR 0.025% A087921 001 Aug 10, 1982
0.1% A087912 001 Aug 10, 1982
0.5% A087922 001 Aug 10, 1982
TARO 0.025% A040038 001 Oct 26, 1994
0.025% A086277 001
0.1% A086276 001
0.5% A086275 001
TOPIDERM 0.025% A089274 001 Feb 21, 1989
0.1% A089275 001 Feb 21, 1989
0.5% A089276 001 Feb 21, 1989
TRIATEX
IVAX PHARMS 0.025% A087430 001 Nov 01, 1988
0.1% A087429 001 Nov 01, 1988
0.5% A087428 001 Nov 01, 1988
TRYMEX
SAVAGE LABS 0.025% A088196 001 Mar 25, 1983
0.1% A088197 001 Mar 25, 1983
0.5% A088198 001 Mar 25, 1983
GEL;TOPICAL
ARISTOGEL
ASTELLAS 0.1% A083380 001
INJECTABLE;INJECTION
TRIAMCINOLONE ACETONIDE
PARNELL 3MG/ML N019503 001 Oct 16, 1987
SANDOZ INC 10MG/ML A090166 001 May 27, 2009
40MG/ML A090164 001 Jun 01, 2009
WATSON LABS 40MG/ML A085825 001
INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
TRIVARIS
+ ALLERGAN 8MG/0.1ML (8MG/0.1ML) ** N022220 001 Jun 16, 2008
LOTION;TOPICAL
KENALOG
DELCOR ASSET CORP 0.025% ** A084343 001
+ 0.025% ** N011602 003
0.1% ** A084343 002
+ 0.1% ** N011602 001
TRIAMCINOLONE ACETONIDE
ALPHARMA US PHARMS 0.025% A087191 001 Sep 08, 1982
0.1% A087192 001 Sep 08, 1982
OINTMENT;TOPICAL
ARISTOCORT
ASTELLAS 0.1% A080750 004
+ 0.5% ** A080745 002
ARISTOCORT A
ASTELLAS 0.1% A080750 003
0.1% A088780 001 Oct 01, 1984
+ 0.5% ** A080745 003
0.5% A088781 001 Oct 05, 1984
FLUTEX
IVAX PHARMS 0.025% A087375 001 Nov 01, 1988
0.1% A087377 001 Nov 01, 1988
0.5% A087376 001 Nov 01, 1988

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-461(of 478)
** See List Footnote
TRIAMCINOLONE ACETONIDE
OINTMENT;TOPICAL
KENALOG
+ DELCOR ASSET CORP 0.5% ** A083944 001
TRIAMCINOLONE ACETONIDE
ACTAVIS MID ATLANTIC 0.1% A087799 001 Jun 07, 1982
ALPHARMA US PHARMS 0.5% A089913 001 Dec 23, 1988
MORTON GROVE 0.025% A088090 001 Sep 01, 1983
0.1% A088091 001 Sep 01, 1983
0.5% A088092 001 Sep 01, 1983
+ MYLAN 0.025% ** N011600 003
+ 0.1% ** N011600 001
PHARMADERM 0.025% A088692 001 Aug 02, 1984
0.1% A088690 001 Aug 02, 1984
STRIDES PHARMA 0.1% A211315 001 Mar 18, 2020
0.5% A211315 002 Mar 18, 2020
TARO 0.025% A040040 001 Sep 30, 1994
0.025% A040374 001 Jun 05, 2001
0.1% A087902 001 Dec 27, 1982
0.5% A040386 001 Jun 05, 2001
TRYMEX
SAVAGE LABS 0.025% A088693 001 Aug 02, 1984
0.1% A088691 001 Aug 02, 1984
PASTE;DENTAL
KENALOG IN ORABASE
+ DELCOR ASSET CORP 0.1% ** N012097 001
ORALONE
TARO 0.1% A071383 001 Jul 06, 1987
SPRAY, METERED;NASAL
ALLERNAZE
LUPIN ATLANTIS 0.05MG/SPRAY N020120 001 Feb 04, 2000
NASACORT HFA
SANOFI AVENTIS US 0.055MG/SPRAY N020784 001 Apr 07, 2004
TRIAMCINOLONE ACETONIDE
PERRIGO PHARMA INTL 0.055MG/SPRAY A078104 001 Jul 30, 2009
TRIAMCINOLONE DIACETATE
INJECTABLE;INJECTION
ARISTOCORT
FOSUN PHARMA 25MG/ML N011685 003
+ 40MG/ML ** N012802 001
TRIAMCINOLONE DIACETATE
AKORN 25MG/ML A085122 001
40MG/ML A086394 001
WATSON LABS 40MG/ML A084072 001
40MG/ML A085529 001
SYRUP;ORAL
ARISTOCORT
ASTELLAS 2MG/5ML N011960 004
KENACORT
DELCOR ASSET CORP EQ 4MG BASE/5ML N012515 001
TRIAMCINOLONE HEXACETONIDE
INJECTABLE;INJECTION
ARISTOSPAN
+ SANDOZ INC 5MG/ML N016466 001
+ 20MG/ML N016466 002
TRIAZOLAM
TABLET;ORAL
HALCION
PFIZER 0.5MG N017892 002 Nov 15, 1982
TRIAZOLAM
MYLAN PHARMS INC 0.125MG A074031 001 Mar 25, 1994
0.25MG A074031 002 Mar 25, 1994
WATSON LABS 0.125MG A074445 001 Oct 20, 1995
0.25MG A074445 002 Oct 20, 1995

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-462(of 478)
** See List Footnote
TRICHLORMETHIAZIDE
TABLET;ORAL
METAHYDRIN
SANOFI AVENTIS US 2MG N012594 001 Jun 16, 1988
4MG N012594 002 Jun 16, 1988
NAQUA
SCHERING 2MG N012265 001
4MG N012265 002
TRICHLOREX
LANNETT 4MG A083436 001
4MG A085630 001
TRICHLORMAS
MAST MM 4MG A086259 001
TRICHLORMETHIAZIDE
CHARTWELL RX 4MG A085568 001
IMPAX LABS 4MG A083967 001
PAR PHARM 2MG A087007 001
4MG A087005 001
SANDOZ 4MG A086171 001
WATSON LABS 2MG A083847 001
2MG A086458 001
4MG A083462 001
4MG A083855 001
4MG A085962 001
TRICLOFOS SODIUM
SOLUTION;ORAL
TRICLOS
SANOFI AVENTIS US 1.5GM/15ML N016830 001
TABLET;ORAL
TRICLOS
SANOFI AVENTIS US 750MG N016809 002
TRIDIHEXETHYL CHLORIDE
INJECTABLE;INJECTION
PATHILON
LEDERLE 10MG/ML N009729 001
TABLET;ORAL
PATHILON
LEDERLE 25MG N009489 005
TRIENTINE HYDROCHLORIDE
CAPSULE;ORAL
CLOVIQUE
CHARTWELL RX 250MG A209731 001 Oct 21, 2019
TRIENTINE HYDROCHLORIDE
ACCORD HLTHCARE 250MG A212929 001 Aug 30, 2021
AMNEAL 250MG A210619 001 Feb 08, 2019
CHARTWELL RX 250MG A209415 001 Sep 16, 2019
LUPIN LTD 250MG A211637 001 May 21, 2020
TRIFLUOPERAZINE HYDROCHLORIDE
CONCENTRATE;ORAL
STELAZINE
+ GLAXOSMITHKLINE EQ 10MG BASE/ML ** N011552 006
TRIFLUOPERAZINE HYDROCHLORIDE
FOSUN PHARMA EQ 10MG BASE/ML A085787 001 Apr 15, 1982
WOCKHARDT EQ 10MG BASE/ML A088143 001 Jul 26, 1983
INJECTABLE;INJECTION
STELAZINE
+ GLAXOSMITHKLINE EQ 2MG BASE/ML ** N011552 005
TABLET;ORAL
STELAZINE
+ GLAXOSMITHKLINE EQ 1MG BASE ** N011552 001
+ EQ 2MG BASE ** N011552 002
+ EQ 5MG BASE ** N011552 003
+ EQ 10MG BASE ** N011552 004
TRIFLUOPERAZINE HYDROCHLORIDE
ATHEM EQ 1MG BASE A040153 001 Oct 25, 1996
EQ 2MG BASE A040153 002 Oct 25, 1996
EQ 5MG BASE A040153 003 Oct 25, 1996

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-463(of 478)
** See List Footnote
TRIFLUOPERAZINE HYDROCHLORIDE
TABLET;ORAL
TRIFLUOPERAZINE HYDROCHLORIDE
EQ 10MG BASE A040153 004 Oct 25, 1996
DURAMED PHARMS BARR EQ 1MG BASE A088967 001 Apr 23, 1985
EQ 2MG BASE A088968 001 Apr 23, 1985
EQ 5MG BASE A088969 001 Apr 23, 1985
EQ 10MG BASE A088970 001 Apr 23, 1985
IVAX PHARMS EQ 1MG BASE A087612 001 Nov 19, 1982
EQ 2MG BASE A087613 001 Nov 19, 1982
EQ 5MG BASE A087328 001 Nov 19, 1982
EQ 10MG BASE A087614 001 Nov 19, 1982
WATSON LABS EQ 1MG BASE A085975 001 Jun 23, 1988
EQ 2MG BASE A085976 001 Jun 23, 1988
EQ 5MG BASE A085973 001 Jun 23, 1988
EQ 10MG BASE A088710 001 Jun 23, 1988
TRIFLUPROMAZINE
SUSPENSION;ORAL
VESPRIN
APOTHECON EQ 50MG HYDROCHLORIDE/5ML N011491 004
TRIFLUPROMAZINE HYDROCHLORIDE
INJECTABLE;INJECTION
VESPRIN
APOTHECON 3MG/ML N011325 005
10MG/ML N011325 004
20MG/ML N011325 001
TABLET;ORAL
VESPRIN
BRISTOL MYERS SQUIBB 10MG N011123 001
25MG N011123 002
50MG N011123 003
TRIFLURIDINE
SOLUTION/DROPS;OPHTHALMIC
TRIFLURIDINE
AKORN 1% A205438 001 Jul 28, 2017
TRIHEXYPHENIDYL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
ARTANE
LEDERLE 5MG N006773 010
5MG N012947 001
ELIXIR;ORAL
ARTANE
LEDERLE 2MG/5ML N006773 009
TRIHEXYPHENIDYL HYDROCHLORIDE
PHARM VENTURES 2MG/5ML A089514 001 Apr 07, 1989
TABLET;ORAL
ARTANE
+ LEDERLE 2MG ** N006773 005
+ 5MG ** N006773 003
TREMIN
SCHERING 2MG A080381 001
5MG A080381 003
TRIHEXYPHENIDYL HYDROCHLORIDE
HIKMA 2MG A040337 002 Feb 16, 2000
5MG A040337 001 Feb 16, 2000
NYLOS 5MG A085622 001
VANGARD 2MG A088035 001 Jul 30, 1982
WATSON LABS 2MG A040184 001 Feb 06, 1998
2MG A085117 001
5MG A040184 002 Feb 06, 1998
5MG A085105 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-464(of 478)
** See List Footnote
TRILOSTANE
CAPSULE;ORAL
MODRASTANE
BIOENVISION 30MG N018719 002 Dec 31, 1984
60MG N018719 001 Dec 31, 1984
TRIMEPRAZINE TARTRATE
CAPSULE, EXTENDED RELEASE;ORAL
TEMARIL
ALLERGAN HERBERT EQ 5MG BASE N011316 004
SYRUP;ORAL
TEMARIL
ALLERGAN HERBERT EQ 2.5MG BASE/5ML N011316 003
TRIMEPRAZINE TARTRATE
ALPHARMA US PHARMS EQ 2.5MG BASE/5ML A085015 001 Feb 18, 1982
MORTON GROVE EQ 2.5MG BASE/5ML A088285 001 Apr 11, 1985
TABLET;ORAL
TEMARIL
ALLERGAN HERBERT EQ 2.5MG BASE N011316 001
TRIMETHADIONE
CAPSULE;ORAL
TRIDIONE
ABBVIE 300MG N005856 005
SOLUTION;ORAL
TRIDIONE
ABBVIE 200MG/5ML N005856 002
TABLET;ORAL
TRIDIONE
+ ABBVIE 150MG N005856 009
TRIMETHAPHAN CAMSYLATE
INJECTABLE;INJECTION
ARFONAD
ROCHE 50MG/ML N008983 001
TRIMETHOBENZAMIDE HYDROCHLORIDE
CAPSULE;ORAL
TIGAN
+ KING PHARMS LLC 300MG ** N017531 006 Dec 13, 2001
INJECTABLE;INJECTION
TRIMETHOBENZAMIDE HYDROCHLORIDE
AM REGENT 100MG/ML A091330 001 Mar 08, 2011
HOSPIRA 100MG/ML A088804 001 Apr 03, 1987
SMITH AND NEPHEW 100MG/ML A088960 001 Apr 04, 1986
100MG/ML A089043 001 Apr 04, 1986
SOLOPAK 100MG/ML A089094 001 Apr 04, 1986
WATSON LABS 100MG/ML A086577 001 Oct 19, 1982
100MG/ML A087939 001 Dec 28, 1982
TRIMETHOBENZAMIDE HYDROCHLORIDE PRESERVATIVE FREE
AM REGENT 100MG/ML A091329 001 Mar 08, 2011
TRIMETHOPRIM
TABLET;ORAL
PROLOPRIM
MONARCH PHARMS 100MG N017943 001
200MG N017943 003 Jul 14, 1982
TRIMETHOPRIM
SUN PHARM INDUSTRIES 100MG A070494 001 Jan 22, 1986
200MG A070495 001 Sep 24, 1986
TEVA 200MG ** A071259 001 Jun 18, 1987
TRIMPEX
ROCHE 100MG N017952 001
TRIMPEX 200
ROCHE 200MG N017952 002 Nov 09, 1982

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-465(of 478)
** See List Footnote
TRIMETHOPRIM HYDROCHLORIDE
SOLUTION;ORAL
PRIMSOL
ALLEGIS EQ 25MG BASE/5ML N074374 001 Jun 23, 1995
+ EQ 50MG BASE/5ML N074973 001 Jan 24, 2000
TRIMETREXATE GLUCURONATE
INJECTABLE;INJECTION
NEUTREXIN
MEDIMMUNE ONCOLOGY EQ 25MG BASE/VIAL N020326 001 Dec 17, 1993
EQ 200MG BASE/VIAL N020326 002 Jul 31, 1998
TRIMIPRAMINE MALEATE
CAPSULE;ORAL
SURMONTIL
+ ODYSSEY PHARMS EQ 25MG BASE ** N016792 001
+ EQ 50MG BASE ** N016792 002
+ EQ 100MG BASE ** N016792 003 Sep 15, 1982
TRIMIPRAMINE MALEATE
USL PHARMA EQ 25MG BASE A071283 001 Dec 08, 1987
EQ 50MG BASE A071284 001 Dec 08, 1987
EQ 100MG BASE A071285 001 Dec 08, 1987
TRIOXSALEN
TABLET;ORAL
TRISORALEN
VALEANT PHARM INTL 5MG N012697 001
TRIPELENNAMINE CITRATE
ELIXIR;ORAL
PBZ
NOVARTIS EQ 25MG HYDROCHLORIDE/5ML N005914 004
TRIPELENNAMINE HYDROCHLORIDE
TABLET;ORAL
PBZ
NOVARTIS 25MG A083149 001
50MG N005914 002
TRIPELENNAMINE HYDROCHLORIDE
ANABOLIC 50MG A083037 001
BARR 50MG A080744 001
HEATHER 50MG A083989 001
IMPAX LABS 50MG A080785 001
LANNETT 50MG A083557 001
NYLOS 50MG A085412 001
PARKE DAVIS 25MG A083625 001
50MG A083626 001
WATSON LABS 50MG A080713 001
50MG A080790 001
50MG A085188 001
TABLET, EXTENDED RELEASE;ORAL
PBZ-SR
NOVARTIS 50MG N010533 002
100MG N010533 001
TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)
CREAM;VAGINAL
GYNE-SULF
COSETTE 3.7%;2.86%;3.42% A088607 001 Jun 09, 1986
SULTRIN
ORTHO MCNEIL PHARM 3.7%;2.86%;3.42% N005794 001
TRIPLE SULFA
ALPHARMA US PHARMS 3.7%;2.86%;3.42% A087864 001 Sep 01, 1982
FOUGERA 3.7%;2.86%;3.42% A086424 001
PADAGIS US 3.7%;2.86%;3.42% A087285 001 Nov 15, 1982
TRYSUL
SAVAGE LABS 3.7%;2.86%;3.42% A087887 001 Jul 23, 1982
VAGILIA
COSETTE 3.7%;2.86%;3.42% A088821 001 Nov 09, 1987
TABLET;VAGINAL
SULTRIN
ORTHO MCNEIL PHARM 184MG;143.75MG;172.5MG N005794 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-466(of 478)
** See List Footnote
TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)
TABLET;VAGINAL
TRIPLE SULFA
FOUGERA 184MG;143.75MG;172.5MG A088463 001 Jan 03, 1985
PHARMADERM 184MG;143.75MG;172.5MG A088462 001 Jan 03, 1985
TRIPROLIDINE HYDROCHLORIDE
SYRUP;ORAL
ACTIDIL
GLAXOSMITHKLINE 1.25MG/5ML N011496 002 Jul 01, 1983
MYIDYL
USL PHARMA 1.25MG/5ML A087963 001 Jan 18, 1983
TRIPROLIDINE HYDROCHLORIDE
ALPHARMA US PHARMS 1.25MG/5ML A085940 001
HALSEY 1.25MG/5ML A088735 001 Jan 17, 1985
PHARM ASSOC 1.25MG/5ML A087514 001 Feb 10, 1982
TABLET;ORAL
ACTIDIL
GLAXOSMITHKLINE 2.5MG N011110 002 Jul 01, 1983
TRIPROLIDINE HYDROCHLORIDE
VITARINE 2.5MG A085610 001
WATSON LABS 2.5MG A085094 001
TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)
SUSPENSION;ORAL
LANTRISUL
LANNETT 167MG/5ML;167MG/5ML;167MG/5ML A080123 002
NEOTRIZINE
LILLY 167MG/5ML;167MG/5ML;167MG/5ML N006317 012
SULFALOID
FOREST PHARMS 167MG/5ML;167MG/5ML;167MG/5ML A080100 001
SULFOSE
WYETH AYERST 167MG/5ML;167MG/5ML;167MG/5ML A080013 002
TERFONYL
BRISTOL MYERS SQUIBB 167MG/5ML;167MG/5ML;167MG/5ML N006904 002
TRIPLE SULFA
ALPHARMA US PHARMS 167MG/5ML;167MG/5ML;167MG/5ML A080280 001
TRIPLE SULFAS
LEDERLE 167MG/5ML;167MG/5ML;167MG/5ML N006920 003
TABLET;ORAL
NEOTRIZINE
LILLY 167MG;167MG;167MG N006317 011
SULFA-TRIPLE #2
IMPAX LABS 167MG;167MG;167MG A080079 001
SULFALOID
FOREST PHARMS 167MG;167MG;167MG A080099 001
SULFOSE
WYETH AYERST 167MG;167MG;167MG A080013 001
TERFONYL
BRISTOL MYERS SQUIBB 167MG;167MG;167MG N006904 001
TRIPLE SULFA
PUREPAC PHARM 167MG;167MG;167MG A080086 001
TRIPLE SULFAS
LEDERLE 167MG;167MG;167MG N006920 002
TRIPLE SULFOID
PAL PAK 167MG;167MG;167MG A080094 001
TROGLITAZONE
TABLET;ORAL
PRELAY
SANKYO 200MG N020719 001 Jan 29, 1997
300MG N020719 003 Aug 04, 1997
400MG N020719 002 Jan 29, 1997
REZULIN
PFIZER PHARMS 200MG N020720 001 Jan 29, 1997
300MG N020720 003 Aug 04, 1997
400MG N020720 002 Jan 29, 1997

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-467(of 478)
** See List Footnote
TROLAMINE POLYPEPTIDE OLEATE CONDENSATE
SOLUTION/DROPS;OTIC
CERUMENEX
PHARM RES ASSOC 10% N011340 002
TROLEANDOMYCIN
CAPSULE;ORAL
TAO
PFIZER EQ 250MG BASE N050336 002
SUSPENSION;ORAL
TAO
PFIZER EQ 125MG BASE/5ML N050332 001
TROPICAMIDE
SOLUTION/DROPS;OPHTHALMIC
MYDRIACYL
ALCON 0.5% ** N012111 002
1% ** N012111 004
MYDRIAFAIR
PHARMAFAIR 0.5% A088274 001 Sep 16, 1983
1% A088230 001 Sep 16, 1983
TROPICAMIDE
AKORN 1% A088447 001 Aug 28, 1985
ALCON PHARMS LTD 1% A089172 001 Dec 28, 1990
MIZA PHARMS USA 0.5% A087636 001 Jul 30, 1982
1% A087637 001 Aug 09, 1982
WATSON LABS 0.5% A089171 001 Dec 28, 1990
TROSPIUM CHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
SANCTURA XR
+ ALLERGAN 60MG ** N022103 001 Aug 03, 2007
TROSPIUM CHLORIDE
UPSHER SMITH LABS 60MG A091635 001 Apr 29, 2015
TABLET;ORAL
SANCTURA
+ ALLERGAN 20MG ** N021595 001 May 28, 2004
TROVAFLOXACIN MESYLATE
TABLET;ORAL
TROVAN
PFIZER EQ 100MG BASE N020759 001 Dec 18, 1997
EQ 200MG BASE N020759 002 Dec 18, 1997
TRYPAN BLUE
SOLUTION;OPHTHALMIC
MEMBRANEBLUE
+ DORC 0.15% N022278 001 Feb 20, 2009
TUBOCURARINE CHLORIDE
INJECTABLE;INJECTION
TUBOCURARINE CHLORIDE
BRISTOL MYERS SQUIBB 3MG/ML N005657 001
HOSPIRA 3MG/ML N006095 001
LILLY 3MG/ML N006325 001
TYROPANOATE SODIUM
CAPSULE;ORAL
BILOPAQUE
GE HEALTHCARE 750MG N013731 001
UMBRALISIB TOSYLATE
TABLET;ORAL
UKONIQ
+ TG THERAPS EQ 200MG BASE N213176 001 Feb 05, 2021
UNOPROSTONE ISOPROPYL
SOLUTION/DROPS;OPHTHALMIC
RESCULA
+ SUCAMPO PHARMA LLC 0.15% ** N021214 001 Aug 03, 2000

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-468(of 478)
** See List Footnote
URACIL MUSTARD
CAPSULE;ORAL
URACIL MUSTARD
SHIRE 1MG N012892 001
UREA
INJECTABLE;INJECTION
STERILE UREA
HOSPIRA 40GM/VIAL N017698 001
UREAPHIL
HOSPIRA 40GM/VIAL N012154 001
UREA C-13
FOR SOLUTION;ORAL
BREATHTEK UBT FOR H-PYLORI
OTSUKA AMERICA EQ 75MG/POUCH N020586 002 May 10, 2001
HELICOSOL
METABOLIC SOLUTIONS 125MG/VIAL N021092 001 Dec 17, 1999
MERETEK UBT KIT (W/ PRANACTIN)
OTSUKA AMERICA 125MG/VIAL N020586 001 Sep 17, 1996
PYLORI-CHEK BREATH TEST
DXS DEVICES 100MG/VIAL N020900 001 Feb 04, 1999
URSODIOL
CAPSULE;ORAL
ACTIGALL
TEVA BRANDED PHARM 150MG N019594 001 Dec 31, 1987
URSODIOL
IMPAX LABS INC 300MG A077895 001 Jul 27, 2006
VGYAAN 300MG A214329 001 Jul 28, 2021
TABLET;ORAL
URSODIOL
IMPAX LABS INC 250MG A200826 001 Dec 23, 2011
500MG A200826 002 Dec 23, 2011
TEVA PHARMS USA 250MG A079184 001 May 13, 2009
500MG A079184 002 May 13, 2009
VALACYCLOVIR HYDROCHLORIDE
TABLET;ORAL
VALACYCLOVIR HYDROCHLORIDE
HIKMA EQ 500MG BASE A078656 001 May 24, 2010
EQ 1GM BASE A078656 002 May 24, 2010
MYLAN EQ 500MG BASE A078070 001 May 24, 2010
EQ 1GM BASE A078070 002 May 24, 2010
TEVA PHARMS EQ 500MG BASE A077655 001 May 24, 2010
EQ 1GM BASE A077655 002 May 24, 2010
WATSON LABS INC EQ 500MG BASE A090370 001 Mar 16, 2011
EQ 1GM BASE A090370 002 Mar 16, 2011
VALDECOXIB
TABLET;ORAL
BEXTRA
GD SEARLE 10MG N021341 002 Nov 16, 2001
20MG N021341 003 Nov 16, 2001
VALGANCICLOVIR HYDROCHLORIDE
TABLET;ORAL
VALGANCICLOVIR HYDROCHLORIDE
MYLAN EQ 450MG BASE A205151 001 Mar 03, 2021
VALPROATE SODIUM
INJECTABLE;INJECTION
DEPACON
+ ABBVIE EQ 100MG BASE/ML ** N020593 001 Dec 30, 1996
VALPROATE SODIUM
MYLAN EQ 100MG BASE/ML A208120 001 Dec 22, 2021

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-469(of 478)
** See List Footnote
VALPROIC ACID
CAPSULE;ORAL
DEPAKENE
+ ABBVIE 250MG ** N018081 001
VALPROIC ACID
PAR PHARM 250MG A070431 001 Feb 28, 1986
SCHERER RP 250MG A070195 001 Jul 02, 1987
UPSHER SMITH LABS 250MG A070631 001 Jun 11, 1987
CAPSULE, DELAYED RELEASE;ORAL
STAVZOR
+ BIONPHARMA INC 125MG ** N022152 001 Jul 29, 2008
+ 250MG ** N022152 002 Jul 29, 2008
+ 500MG ** N022152 003 Jul 29, 2008
SYRUP;ORAL
DEPAKENE
+ ABBVIE 250MG/5ML ** N018082 001
VALPROIC ACID
ANI PHARMS 250MG/5ML A073178 001 Aug 25, 1992
LANNETT CO INC 250MG/5ML A077960 001 Oct 13, 2006
NOSTRUM LABS INC 250MG/5ML A077105 001 Jul 29, 2005
WOCKHARDT BIO AG 250MG/5ML A070868 001 Jul 01, 1986
VALSARTAN
CAPSULE;ORAL
DIOVAN
NOVARTIS 80MG N020665 001 Dec 23, 1996
160MG N020665 002 Dec 23, 1996
SOLUTION;ORAL
PREXXARTAN
+ CARMEL BIOSCIENCES 20MG/5ML N209139 001 Dec 19, 2017
+ 80MG/20ML N209139 002 Dec 19, 2017
TABLET;ORAL
VALSARTAN
TORRENT 40MG A202728 001 Jan 05, 2015
80MG A202728 002 Jan 05, 2015
160MG A202728 003 Jan 05, 2015
320MG A202728 004 Jan 05, 2015
UNICHEM 40MG A209261 001 May 04, 2018
80MG A209261 002 May 04, 2018
160MG A209261 003 May 04, 2018
320MG A209261 004 May 04, 2018
WATSON LABS INC 40MG A090642 001 Jan 05, 2015
80MG A090642 002 Jan 05, 2015
160MG A090642 003 Jan 05, 2015
320MG A090642 004 Jan 05, 2015
VANCOMYCIN HYDROCHLORIDE
CAPSULE;ORAL
VANCOMYCIN HYDROCHLORIDE
FRESENIUS KABI USA EQ 125MG BASE A065453 001 Jun 18, 2012
EQ 250MG BASE A065453 002 Jun 18, 2012
FOR SOLUTION;ORAL
VANCOCIN HYDROCHLORIDE
ANI PHARMS EQ 500MG BASE/6ML A061667 001
VANCOLED
LEDERLE EQ 250MG BASE/5ML A063321 002 Oct 15, 1993
EQ 500MG BASE/6ML A063321 003 Oct 15, 1993
INJECTABLE;INJECTION
VANCOCIN HYDROCHLORIDE
STERISCIENCE EQ 500MG BASE/VIAL ** A060180 001
EQ 500MG BASE/VIAL A062476 001 Mar 15, 1984
EQ 500MG BASE/VIAL A062716 001 Mar 13, 1987
EQ 500MG BASE/VIAL ** A062812 001 Nov 17, 1987
EQ 1GM BASE/VIAL ** A060180 002 Mar 21, 1986
EQ 1GM BASE/VIAL A062476 002 Mar 21, 1986
EQ 1GM BASE/VIAL A062716 002 Mar 13, 1987
EQ 1GM BASE/VIAL ** A062812 002 Nov 17, 1987
EQ 10GM BASE/VIAL ** A062812 003 Nov 17, 1987
VANCOLED
HIKMA EQ 500MG BASE/VIAL ** A062682 001 Jul 22, 1986

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-470(of 478)
** See List Footnote
VANCOMYCIN HYDROCHLORIDE
INJECTABLE;INJECTION
VANCOLED
EQ 1GM BASE/VIAL ** A062682 002 Mar 30, 1988
EQ 2GM BASE/VIAL ** A062682 003 May 11, 1988
EQ 5GM BASE/VIAL ** A062682 004 May 11, 1988
EQ 10GM BASE/VIAL ** A062682 005 May 11, 1988
VANCOMYCIN HYDROCHLORIDE
EMCURE PHARMS LTD EQ 500MG BASE/VIAL A202275 001 Oct 31, 2013
EQ 1GM BASE/VIAL A202275 002 Oct 31, 2013
EQ 10GM BASE/VIAL A202464 001 Oct 09, 2013
EQ 5GM BASE/VIAL A202274 001 Oct 31, 2013
HIKMA EQ 1GM BASE/VIAL A203300 002 Aug 11, 2020
EQ 500MG BASE/VIAL A062879 001 Aug 02, 1988
EQ 500MG BASE/VIAL A203300 001 Aug 11, 2020
EQ 1GM BASE/VIAL A062879 002 Aug 02, 1988
KNACK EQ 500MG BASE/VIAL A213059 001 Feb 15, 2022
EQ 750MG BASE/VIAL A213059 002 Feb 15, 2022
EQ 1GM BASE/VIAL A213059 003 Feb 15, 2022
MYLAN LABS LTD EQ 10GM BASE/VIAL A091469 001 Jul 01, 2011
SANDOZ EQ 500MG BASE/VIAL A090250 001 Apr 27, 2010
EQ 1GM BASE/VIAL A090250 002 Apr 27, 2010
TEVA PHARMS USA EQ 500MG BASE/VIAL A201251 001 Dec 23, 2015
EQ 1GM BASE/VIAL A201251 002 Dec 23, 2015
EQ 5GM BASE/VIAL A201250 001 Dec 23, 2015
EQ 10GM BASE/VIAL A201250 002 Dec 23, 2015
XELLIA PHARMS APS EQ 500MG BASE/VIAL A091377 001 Sep 09, 2015
EQ 1GM BASE/VIAL A091377 002 Sep 09, 2015
EQ 5GM BASE/VIAL A206243 001 Dec 23, 2015
EQ 10GM BASE/VIAL A206243 002 Dec 23, 2015
VANCOR
PHARMACIA AND UPJOHN EQ 500MG BASE/VIAL A062956 001 Aug 01, 1988
EQ 1GM BASE/VIAL A062956 002 Aug 01, 1988
POWDER;INTRAVENOUS
VANCOMYCIN HYDROCHLORIDE
+ MYLAN LABS LTD EQ 250MG BASE/VIAL N209481 001 Jul 10, 2018
VARDENAFIL HYDROCHLORIDE
TABLET;ORAL
LEVITRA
+ BAYER HLTHCARE EQ 2.5MG BASE ** N021400 003 Aug 19, 2003
+ EQ 5MG BASE N021400 001 Aug 19, 2003
+ EQ 10MG BASE N021400 002 Aug 19, 2003
+ EQ 20MG BASE N021400 004 Aug 19, 2003
VARDENAFIL HYDROCHLORIDE
AMNEAL PHARMS CO EQ 5MG BASE A210738 001 Oct 31, 2018
EQ 10MG BASE A210738 002 Oct 31, 2018
EQ 20MG BASE A210738 003 Oct 31, 2018
TABLET, ORALLY DISINTEGRATING;ORAL
STAXYN
+ BAYER HLTHCARE 10MG N200179 001 Jun 17, 2010
VARENICLINE TARTRATE
TABLET;ORAL
CHANTIX
+ PF PRISM CV EQ 0.5MG BASE N021928 001 May 10, 2006
+ EQ 1MG BASE N021928 002 May 10, 2006
VASOPRESSIN TANNATE
INJECTABLE;INJECTION
PITRESSIN TANNATE
+ PARKE DAVIS 5PRESSOR UNITS/ML ** N003402 001
VECURONIUM BROMIDE
INJECTABLE;INJECTION
NORCURON
+ ORGANON USA INC 10MG/VIAL ** N018776 002 Apr 30, 1984
+ 20MG/VIAL ** N018776 003 Jan 03, 1992
VECURONIUM BROMIDE
HIKMA 10MG/VIAL A075218 001 Aug 23, 1999
20MG/VIAL A075218 002 Aug 23, 1999

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-471(of 478)
** See List Footnote
VECURONIUM BROMIDE
INJECTABLE;INJECTION
VECURONIUM BROMIDE
HOSPIRA 4MG/VIAL A075558 001 Sep 11, 2001
WATSON LABS 10MG/VIAL A074334 001 Aug 31, 1995
20MG/VIAL A074334 002 Aug 31, 1995
VENLAFAXINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
EFFEXOR XR
UPJOHN EQ 100MG BASE N020699 003 Oct 20, 1997
VENLAFAXINE HYDROCHLORIDE
ANCHEN PHARMS EQ 37.5MG BASE A078087 001 Mar 16, 2012
EQ 75MG BASE A078087 002 Mar 16, 2012
EQ 150MG BASE A078087 003 Mar 16, 2012
MYLAN EQ 37.5MG BASE A078789 001 Jun 01, 2011
EQ 75MG BASE A078789 002 Jun 01, 2011
EQ 150MG BASE A078789 003 Jun 01, 2011
TABLET;ORAL
EFFEXOR
+ WYETH PHARMS INC EQ 12.5MG BASE ** N020151 001 Dec 28, 1993
+ EQ 25MG BASE ** N020151 002 Dec 28, 1993
+ EQ 37.5MG BASE ** N020151 006 Dec 28, 1993
+ EQ 50MG BASE ** N020151 003 Dec 28, 1993
+ EQ 75MG BASE ** N020151 004 Dec 28, 1993
+ EQ 100MG BASE ** N020151 005 Dec 28, 1993
VENLAFAXINE HYDROCHLORIDE
FOSUN PHARMA EQ 25MG BASE A077515 001 Jun 13, 2008
EQ 37.5MG BASE A077515 002 Jun 13, 2008
EQ 50MG BASE A077515 003 Jun 13, 2008
EQ 75MG BASE A077515 004 Jun 13, 2008
EQ 100MG BASE A077515 005 Jun 13, 2008
MYLAN EQ 25MG BASE A077166 001 Jun 13, 2008
EQ 37.5MG BASE A077166 002 Jun 13, 2008
EQ 50MG BASE A077166 003 Jun 13, 2008
EQ 75MG BASE A077166 004 Jun 13, 2008
EQ 100MG BASE A077166 005 Jun 13, 2008
PLIVA HRVATSKA DOO EQ 25MG BASE A078517 001 Jun 13, 2008
EQ 37.5MG BASE A078517 002 Jun 13, 2008
EQ 50MG BASE A078517 003 Jun 13, 2008
EQ 75MG BASE A078517 004 Jun 13, 2008
EQ 100MG BASE A078517 005 Jun 13, 2008
PRINSTON INC EQ 25MG BASE A090027 001 Aug 04, 2010
EQ 37.5MG BASE A090027 002 Aug 04, 2010
EQ 50MG BASE A090027 003 Aug 04, 2010
EQ 75MG BASE A090027 004 Aug 04, 2010
EQ 100MG BASE A090027 005 Aug 04, 2010
TABLET, EXTENDED RELEASE;ORAL
VENLAFAXINE HYDROCHLORIDE
SUNNY EQ 75MG BASE A214423 001 Jan 04, 2022
EQ 150MG BASE A214423 002 Jan 04, 2022
VERAPAMIL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE;ORAL
VERAPAMIL HYDROCHLORIDE
RISING 100MG A078306 001 Aug 09, 2007
200MG A078306 002 Aug 09, 2007
300MG A078306 003 Aug 09, 2007
INJECTABLE;INJECTION
CALAN
GD SEARLE LLC 2.5MG/ML N019038 001 Mar 30, 1984
ISOPTIN
+ MT ADAMS 2.5MG/ML ** N018485 001
VERAPAMIL HYDROCHLORIDE
ABRAXIS PHARM 2.5MG/ML A070348 001 May 01, 1986
BEDFORD 2.5MG/ML A072888 001 Jul 28, 1995
HOSPIRA 2.5MG/ML A070577 001 Feb 02, 1987
2.5MG/ML A070739 001 May 06, 1987
2.5MG/ML A070740 001 May 06, 1987
INTL MEDICATION 2.5MG/ML A070451 001 Dec 16, 1985

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-472(of 478)
** See List Footnote
VERAPAMIL HYDROCHLORIDE
INJECTABLE;INJECTION
VERAPAMIL HYDROCHLORIDE
LUITPOLD 2.5MG/ML A070225 001 Nov 12, 1985
2.5MG/ML A070617 001 Nov 12, 1985
MARSAM PHARMS LLC 2.5MG/ML A072233 001 Feb 26, 1993
2.5MG/ML A073485 001 Sep 27, 1993
SMITH AND NEPHEW 2.5MG/ML A070696 001 Jul 31, 1987
2.5MG/ML A070697 001 Jul 31, 1987
SOLOPAK 2.5MG/ML A070695 001 Jul 31, 1987
SOLUTION;INTRAVENOUS
VERAPAMIL HYDROCHLORIDE
EXELA PHARMA 10MG/4ML (2.5MG/ML) N018925 002 Apr 05, 2018
TABLET;ORAL
CALAN
PFIZER 40MG ** N018817 003 Feb 23, 1988
+ 80MG ** N018817 001 Sep 10, 1984
+ 120MG ** N018817 002 Sep 10, 1984
160MG ** N018817 004 Feb 23, 1988
ISOPTIN
+ MT ADAMS 40MG ** N018593 003 Nov 23, 1987
+ 80MG ** N018593 001 Mar 08, 1982
+ 120MG ** N018593 002 Mar 08, 1982
VERAPAMIL HYDROCHLORIDE
ACTAVIS ELIZABETH 80MG A071019 001 Sep 24, 1986
120MG A070468 001 Sep 24, 1986
CHARTWELL RX 40MG A073168 001 Jul 31, 1992
80MG A071423 001 May 24, 1988
120MG A071424 001 May 25, 1988
MUTUAL PHARM 80MG A070482 001 Sep 24, 1986
120MG A070483 001 Sep 24, 1986
PLIVA 40MG A072751 001 Feb 23, 1996
80MG A072124 001 Jan 26, 1989
120MG A072125 001 Jan 26, 1989
RISING 80MG A071483 002 Feb 15, 1989
120MG A071483 001 Feb 15, 1989
SUN PHARM INDUSTRIES 80MG A071489 002 Jan 13, 1988
120MG A071489 001 Jan 13, 1988
WARNER CHILCOTT 80MG A070340 001 Sep 24, 1986
120MG A070341 001 Sep 24, 1986
WATSON LABS 40MG A072799 001 Apr 28, 1989
40MG A072923 001 Jun 29, 1993
80MG A070855 001 Sep 24, 1986
80MG A071366 001 Oct 01, 1986
120MG A070856 001 Sep 24, 1986
120MG A071367 001 Oct 01, 1986
TABLET, EXTENDED RELEASE;ORAL
CALAN SR
+ PFIZER 180MG ** N019152 002 Dec 15, 1989
COVERA-HS
PFIZER 180MG N020552 001 Feb 26, 1996
240MG N020552 002 Feb 26, 1996
VERAPAMIL HYDROCHLORIDE
APOTEX CORP 120MG A200878 001 Apr 20, 2012
180MG A200878 002 Apr 20, 2012
240MG A200878 003 Apr 20, 2012
PLIVA 240MG A072922 001 Mar 01, 1996
RISING 120MG A074587 002 Feb 21, 1997
180MG A074587 003 Sep 09, 1997
240MG A074587 001 Mar 23, 1996
VERATRUM VIRIDE ROOT
TABLET;ORAL
VERTAVIS
MEDPOINTE PHARM HLC 130CSR UNIT N005691 002

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-473(of 478)
** See List Footnote
VIDARABINE
INJECTABLE;INJECTION
VIRA-A
PARKEDALE EQ 187.4MG BASE/ML N050523 001
OINTMENT;OPHTHALMIC
VIRA-A
PARKEDALE 3% N050486 001
VIGABATRIN
FOR SOLUTION;ORAL
VIGABATRIN
GRANULES 500MG/PACKET A213469 001 Apr 24, 2020
LUPIN LTD 500MG/PACKET A211790 001 Mar 10, 2022
SPECGX LLC 500MG/PACKET A212626 001 Jul 28, 2021
VINBLASTINE SULFATE
INJECTABLE;INJECTION
VELBAN
+ LILLY 10MG/VIAL ** N012665 001
VINBLASTINE SULFATE
ABRAXIS PHARM 10MG/VIAL A089011 001 Nov 18, 1985
HOSPIRA 10MG/VIAL A089565 001 Aug 18, 1987
VINCRISTINE SULFATE
INJECTABLE;INJECTION
ONCOVIN
+ LILLY 1MG/VIAL ** N014103 001
+ 1MG/ML ** N014103 003 Mar 07, 1984
+ 5MG/VIAL ** N014103 002
VINCASAR PFS
TEVA PARENTERAL 1MG/ML A071426 001 Jul 17, 1987
VINCREX
BRISTOL MYERS SQUIBB 5MG/VIAL A070867 001 Jul 12, 1988
VINCRISTINE SULFATE
ABIC 1MG/ML A070873 001 Feb 19, 1987
ABRAXIS PHARM 1MG/ML A070411 001 Sep 10, 1986
FRESENIUS KABI USA 1MG/ML A076296 001 Dec 20, 2002
1MG/ML A076401 001 Oct 28, 2003
HOSPIRA 1MG/VIAL A071559 001 Apr 11, 1988
2MG/VIAL A071560 001 Apr 11, 1988
5MG/VIAL A071561 001 Apr 11, 1988
INJECTABLE, LIPOSOMAL;INTRAVENOUS
MARQIBO KIT
+ ACROTECH 5MG/5ML (1MG/ML) N202497 001 Aug 09, 2012
VINORELBINE TARTRATE
INJECTABLE;INJECTION
NAVELBINE
+ PIERRE FABRE EQ 10MG BASE/ML ** N020388 001 Dec 23, 1994
VINORELBINE TARTRATE
EBEWE PHARMA EQ 10MG BASE/ML A078408 001 Feb 13, 2008
FRESENIUS KABI USA EQ 10MG BASE/ML A076849 001 Apr 18, 2005
HOSPIRA EQ 10MG BASE/ML A076827 001 Jun 02, 2005
MYLAN LABS LTD EQ 10MG BASE/ML A200148 001 Aug 31, 2012
NOVAST LABS EQ 10MG BASE/ML A208997 001 Aug 05, 2019
TEVA PHARMS USA EQ 10MG BASE/ML A076028 001 Feb 03, 2003
VIOMYCIN SULFATE
INJECTABLE;INJECTION
VIOCIN SULFATE
PFIZER EQ 1GM BASE/VIAL A061086 001
EQ 5GM BASE/VIAL A061086 002
VITAMIN A
CAPSULE;ORAL
AQUASOL A
ASTRAZENECA 25,000USP UNITS A083080 002
50,000USP UNITS A083080 001
VITAMIN A
BANNER PHARMACAPS 50,000USP UNITS A083973 001
CHASE CHEM 50,000 IU A083351 001
EVERYLIFE 50,000 IU A083134 001

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-474(of 478)
** See List Footnote
VITAMIN A
CAPSULE;ORAL
VITAMIN A
IMPAX LABS 50,000USP UNITS A080952 001
WEST WARD 50,000USP UNITS A080985 001
VITAMIN A PALMITATE
CAPSULE;ORAL
AFAXIN
STERLING WINTHROP EQ 50,000 UNITS BASE A083187 001
ALPHALIN
LILLY EQ 50,000 UNITS BASE A080883 001
DEL-VI-A
DEL RAY LABS EQ 50,000 UNITS BASE A080830 001
VI-DOM-A
BAYER PHARMS EQ 50,000 UNITS BASE A080972 001
VITAMIN A
BANNER PHARMACAPS EQ 50,000 UNITS BASE A080702 001
BRISTOL MYERS SQUIBBEQ 50,000 UNITS BASE A080860 001
CHASE CHEM EQ 50,000 UNITS BASE A080746 001
EQ 50,000 UNITS BASE A083207 001
ELKINS SINN EQ 50,000 UNITS BASE A085479 001
EVERYLIFE EQ 50,000 UNITS BASE A080943 001
EQ 50,000 UNITS BASE A083114 001
IMPAX LABS EQ 50,000 UNITS BASE A080953 001
EQ 50,000 UNITS BASE A080955 001
IVAX SUB TEVA PHARMS EQ 50,000 UNITS BASE A083035 001
EQ 50,000 UNITS BASE A083190 001
MK LABS EQ 25,000 UNITS BASE A083457 002
EQ 50,000 UNITS BASE A083457 001
WEST WARD EQ 50,000 UNITS BASE A080967 001
WHARTON LABS EQ 50,000 UNITS BASE A083665 001
VITAMIN A PALMITATE
ARCUM EQ 50,000 UNITS BASE A083311 001
EQ 50,000 UNITS BASE A083321 001
BANNER PHARMACAPS EQ 50,000 UNITS BASE A083948 001
EQ 50,000 UNITS BASE A083981 001
VITAMIN A SOLUBILIZED
TEVA EQ 50,000 UNITS BASE A080921 001
INJECTABLE;INJECTION
VITAMIN A PALMITATE
BEL MAR EQ 50,000 UNITS BASE/ML A080819 001
VORICONAZOLE
FOR SUSPENSION;ORAL
VORICONAZOLE
RISING 200MG/5ML A202361 001 May 28, 2013
INJECTABLE;INTRAVENOUS
VORICONAZOLE
MYLAN LABS LTD 200MG/VIAL A210849 001 Oct 11, 2022
TABLET;ORAL
VORICONAZOLE
TEVA PHARMS 50MG A091658 001 Apr 06, 2012
200MG A091658 002 Apr 06, 2012
VORTIOXETINE HYDROBROMIDE
TABLET;ORAL
TRINTELLIX
+ TAKEDA PHARMS USA EQ 15MG BASE ** N204447 003 Sep 30, 2013
VORTIOXETINE HYDROBROMIDE
ZYDUS PHARMS EQ 5MG BASE A211146 001 Sep 17, 2021
EQ 10MG BASE A211146 002 Sep 17, 2021
EQ 20MG BASE A211146 003 Sep 17, 2021
WARFARIN POTASSIUM
TABLET;ORAL
ATHROMBIN-K
PHARM RES ASSOC 2MG N011771 007
5MG N011771 004
10MG N011771 005
25MG N011771 006

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-475(of 478)
** See List Footnote
WARFARIN SODIUM
INJECTABLE;INJECTION
COUMADIN
BRISTOL MYERS SQUIBB 5MG/VIAL N009218 024 Feb 07, 1995
50MG/VIAL N009218 020
75MG/VIAL N009218 012
TABLET;ORAL
ATHROMBIN
PHARM RES ASSOC 5MG N011771 003
10MG N011771 002
25MG N011771 001
COUMADIN
+ BRISTOL MYERS SQUIBB 1MG ** N009218 022 Mar 01, 1990
+ 2MG N009218 013
+ 2.5MG N009218 018
+ 3MG N009218 025 Nov 18, 1996
+ 4MG N009218 023 Aug 24, 1993
+ 5MG N009218 007
+ 6MG N009218 026 Nov 18, 1996
+ 7.5MG N009218 016
+ 10MG N009218 005
PANWARFIN
ABBOTT 2MG N017020 001
2.5MG N017020 002
5MG N017020 003
7.5MG N017020 004
10MG N017020 005
WARFARIN SODIUM
CHARTWELL RX 1MG A040196 001 Sep 30, 1997
2MG A040196 002 Sep 30, 1997
2.5MG A040196 003 Sep 30, 1997
3MG A040196 008 Jul 26, 2000
4MG A040196 004 Sep 30, 1997
5MG A040196 005 Sep 30, 1997
6MG A040196 009 Jul 26, 2000
7.5MG A040196 006 Sep 30, 1997
10MG A040196 007 Sep 30, 1997
MYLAN 1MG A040415 001 Sep 27, 2004
2MG A040415 002 Sep 27, 2004
2.5MG A040415 003 Sep 29, 2004
3MG A040415 004 Sep 27, 2004
4MG A040415 005 Sep 27, 2004
5MG A040415 006 Sep 27, 2004
6MG A040415 007 Sep 27, 2004
7.5MG A040415 008 Sep 27, 2004
10MG A040415 009 Sep 27, 2004
USL PHARMA 2MG A088719 001 Jun 27, 1985
2.5MG A088720 001 Aug 06, 1985
5MG A088721 001 Jul 02, 1985
WATSON LABS 2MG A086123 001 Aug 17, 1982
2.5MG A086120 001 Aug 17, 1982
5MG A086119 001 Aug 17, 1982
7.5MG A086118 001 Aug 17, 1982
10MG A086122 001 Aug 17, 1982
XENON XE-127
GAS;INHALATION
XENON XE 127
MALLINCKRODT 5mCi/VIAL N018536 001 Oct 01, 1982
10mCi/VIAL N018536 002 Oct 01, 1982
XENON XE-133
GAS;INHALATION
XENON XE 133
GE HEALTHCARE 1 CI/AMP N017256 002
10mCi/VIAL N017687 002
20mCi/VIAL N017687 003
GEN ELECTRIC 5-100 CI/CYLINDER N017550 001
0.25-5 CI/AMP N017550 003

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-476(of 478)
** See List Footnote
XENON XE-133
GAS;INHALATION
XENON XE 133-V.S.S.
GE HEALTHCARE 10mCi/VIAL N017687 001
INJECTABLE;INJECTION
XENON XE 133
GE HEALTHCARE 1.3-1.7 CI/AMP N017256 001
LANTHEUS MEDCL 6.3mCi/ML N017283 001
SOLUTION;INHALATION, INJECTION
XENEISOL
MALLINCKRODT 18-25mCi/AMP N017262 002
XYLOSE
POWDER;ORAL
XYLO-PFAN
SAVAGE LABS 25GM/BOT N017605 001
XYLOSE
LYNE 25GM/BOT N018856 001 Mar 26, 1987
ZALCITABINE
TABLET;ORAL
HIVID
ROCHE 0.375MG N020199 001 Jun 19, 1992
0.75MG N020199 002 Jun 19, 1992
ZALEPLON
CAPSULE;ORAL
ZALEPLON
HIKMA PHARMS 5MG A078147 001 Nov 25, 2008
10MG A078147 002 Nov 25, 2008
MYLAN 5MG A077238 001 Jun 06, 2008
10MG A077238 002 Jun 06, 2008
TEVA PHARMS 5MG A077239 001 Jun 06, 2008
10MG A077239 002 Jun 06, 2008
UPSHER SMITH LABS 5MG A078095 001 Jun 06, 2008
5MG A078706 001 Jun 06, 2008
10MG A078095 002 Jun 06, 2008
10MG A078706 002 Jun 06, 2008
ZICONOTIDE ACETATE
INJECTABLE;INTRATHECAL
PRIALT
TERSERA 200MCG/2ML (100MCG/ML) N021060 003 Dec 28, 2004
ZIDOVUDINE
INJECTABLE;INJECTION
ZIDOVUDINE
AM REGENT 10MG/ML A091457 001 May 06, 2010
LIAONING CHENGDA 10MG/ML A204538 001 Nov 26, 2013
TABLET;ORAL
RETROVIR
VIIV HLTHCARE 200MG N020518 001 Dec 19, 1995
+ 300MG ** N020518 002 Oct 04, 1996
ZIDOVUDINE
AUROBINDO PHARMA 60MG N022294 001 Jul 23, 2009
HEC PHARM 300MG A202058 001 Oct 07, 2011
HIKMA 300MG A076844 001 Sep 19, 2005
MYLAN LABS LTD 100MG N200732 001 Feb 23, 2011
RANBAXY LABS LTD 300MG A077327 001 Sep 19, 2005
ZILEUTON
TABLET;ORAL
ZYFLO
CHIESI 300MG N020471 001 Dec 09, 1996
TABLET, EXTENDED RELEASE;ORAL
ZILEUTON
TEVA PHARMS USA 600MG A211043 001 May 03, 2022

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-477(of 478)
** See List Footnote
ZINC SULFATE
INJECTABLE;INJECTION
ZINC SULFATE
ABRAXIS PHARM EQ 1MG ZINC/ML N019229 002 May 05, 1987
ZIPRASIDONE HYDROCHLORIDE
CAPSULE;ORAL
ZIPRASIDONE HYDROCHLORIDE
MYLAN EQ 20MG BASE A202395 001 Oct 10, 2013
EQ 40MG BASE A202395 002 Oct 10, 2013
EQ 60MG BASE A202395 003 Oct 10, 2013
EQ 80MG BASE A202395 004 Oct 10, 2013
SUSPENSION;ORAL
GEODON
PFIZER INC EQ 10MG BASE/ML N021483 001 Mar 29, 2006
ZOLEDRONIC ACID
INJECTABLE;INTRAVENOUS
ZOLEDRONIC ACID
ACTAVIS INC EQ 4MG BASE/5ML A202472 001 Mar 04, 2013
DR REDDYS EQ 4MG BASE/100ML A204344 001 Nov 19, 2018
EMCURE PHARMS LTD EQ 4MG BASE/5ML A201783 001 Mar 12, 2013
EQ 5MG BASE/100ML A201801 001 Mar 29, 2013
EUGIA PHARMA EQ 4MG BASE/5ML A207751 001 Sep 26, 2016
EQ 5MG BASE/100ML A209125 001 Dec 08, 2017
SHILPA EQ 4MG BASE/5ML A208513 001 May 15, 2019
SUN PHARMA GLOBAL EQ 4MG BASE/VIAL A090018 001 Mar 04, 2013
EQ 4MG BASE/5ML A202746 001 Mar 04, 2013
ZOMETA
+ NOVARTIS EQ 4MG BASE/VIAL ** N021223 001 Aug 20, 2001
ZOLMITRIPTAN
TABLET;ORAL
ZOLMITRIPTAN
ANI PHARMS 2.5MG A090861 001 Mar 04, 2014
5MG A090861 002 Mar 04, 2014
APOTEX INC 2.5MG A202078 001 May 14, 2013
5MG A202078 002 May 14, 2013
MACLEODS PHARMS LTD 2.5MG A203772 001 Sep 30, 2015
5MG A203772 002 Sep 30, 2015
MYLAN PHARMS INC 2.5MG A203186 001 May 14, 2013
5MG A203186 002 May 14, 2013
SUN PHARMA GLOBAL 2.5MG A203476 001 Nov 13, 2014
5MG A203476 002 Nov 13, 2014
TABLET, ORALLY DISINTEGRATING;ORAL
ZOLMITRIPTAN
APOTEX INC 2.5MG A202476 001 May 14, 2013
5MG A202476 002 May 14, 2013
MACLEODS PHARMS LTD 2.5MG A204336 001 Oct 22, 2015
5MG A204336 002 Oct 22, 2015
RISING 2.5MG A202855 001 Sep 20, 2019
5MG A202855 002 Sep 20, 2019
ZOLPIDEM TARTRATE
SPRAY, METERED;ORAL
ZOLPIMIST
+ AYTU 5MG/SPRAY N022196 001 Dec 19, 2008
TABLET;ORAL
ZOLPIDEM TARTRATE
DR REDDYS LABS LTD 5MG A077985 001 Apr 23, 2007
10MG A077985 002 Apr 23, 2007
HIKMA 5MG A078129 001 Apr 30, 2008
10MG A078129 002 Apr 30, 2008
MYLAN PHARMS INC 5MG A078016 001 Apr 23, 2007
10MG A078016 002 Apr 23, 2007
RISING 5MG A076578 001 Apr 23, 2007
10MG A076578 002 Apr 23, 2007
STRIDES PHARMA 5MG A076062 001 Apr 23, 2007
5MG A078616 001 Nov 21, 2008
10MG A076062 002 Apr 23, 2007
10MG A078616 002 Nov 21, 2008

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST
DISCONTINUED DRUG PRODUCT LIST 6-478(of 478)
** See List Footnote
ZOLPIDEM TARTRATE
TABLET;ORAL
ZOLPIDEM TARTRATE
SUN PHARM INDS INC 5MG A077359 001 Apr 23, 2007
10MG A077359 002 Apr 23, 2007
SUN PHARM INDS LTD 5MG A078055 001 Apr 23, 2007
10MG A078055 002 Apr 23, 2007
SUN PHARM INDUSTRIES 5MG A077288 001 Apr 23, 2007
10MG A077288 002 Apr 23, 2007
SYNTHON PHARMS 5MG A077540 001 Apr 23, 2007
10MG A077540 002 Apr 23, 2007
WATSON LABS 5MG A077773 001 Apr 23, 2007
10MG A077773 002 Apr 23, 2007
WOCKHARDT 5MG A078426 001 May 15, 2007
10MG A078426 002 May 15, 2007
YUNG SHIN PHARM 5MG A077990 001 Apr 23, 2007
10MG A077990 002 Apr 23, 2007
TABLET;SUBLINGUAL
INTERMEZZO
+ PURDUE PHARMA 1.75MG N022328 001 Nov 23, 2011
+ 3.5MG N022328 002 Nov 23, 2011
ZOLPIDEM TARTRATE
MYLAN 5MG A202657 001 Aug 08, 2016
10MG A202657 002 Aug 08, 2016
TABLET, EXTENDED RELEASE;ORAL
ZOLPIDEM TARTRATE
ACTAVIS ELIZABETH 6.25MG A078179 002 Oct 13, 2010
12.5MG A078179 001 Jun 06, 2011
SYNTHON PHARMS 6.25MG A078483 001 Apr 12, 2011
12.5MG A078483 002 Jun 06, 2011
TABLET, ORALLY DISINTEGRATING;ORAL
TOVALT ODT
+ BIOVAIL LABS INTL 5MG N021412 001 Apr 25, 2007
+ 10MG N021412 002 Apr 25, 2007
ZONISAMIDE
CAPSULE;ORAL
ZONEGRAN
+ CONCORDIA 50MG ** N020789 002 Aug 22, 2003
ZONISAMIDE
ANI PHARMS 25MG A077639 001 Dec 22, 2005
25MG A077641 003 Dec 22, 2005
50MG A077639 002 Dec 22, 2005
50MG A077641 002 Dec 22, 2005
100MG A077639 003 Dec 22, 2005
100MG A077641 001 Dec 22, 2005
EPIC PHARMA LLC 25MG A077876 001 Feb 21, 2007
50MG A077876 002 Feb 21, 2007
100MG A077876 003 Feb 21, 2007
HERITAGE PHARMA AVET 25MG A077650 001 Apr 20, 2006
50MG A077650 002 Apr 20, 2006
100MG A077650 003 Apr 20, 2006
MYLAN PHARMS INC 25MG A077647 001 Dec 22, 2005
50MG A077647 002 Dec 22, 2005
100MG A077647 003 Dec 22, 2005
RISING 25MG A077637 001 Dec 22, 2005
50MG A077637 002 Dec 22, 2005
100MG A077637 003 Dec 22, 2005
ROXANE 25MG A077648 001 Dec 22, 2005
50MG A077648 002 Dec 22, 2005
100MG A077648 003 Dec 22, 2005
SUN PHARM INDUSTRIES 25MG A077635 001 Dec 22, 2005
50MG A077635 002 Dec 22, 2005
100MG A077635 003 Dec 22, 2005
UPSHER SMITH LABS 25MG A077644 001 Dec 22, 2005
50MG A077644 002 Dec 22, 2005
100MG A077644 003 Dec 22, 2005

**Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness
reasons**
43RD EDITION – 2023 - APPROVED DRUG PRODUCTS LIST
7-1

ORPHAN PRODUCTS DESIGNATIONS AND APPROVALS LIST

The list of Orphan Designations and Approvals is available at:

http://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/de
fault.htm
43RD EDITION - 2023 - APPROVED DRUG PRODUCTS LIST
8-1

DRUG PRODUCTS WHICH MUST DEMONSTRATE IN VIVO BIOAVAILABILITY


ONLY IF PRODUCT FAILS TO ACHIEVE ADEQUATE DISSOLUTION

ACETAMINOPHEN;ASPIRIN;BUTALBITAL ASPIRIN;CAFFEINE;CARISOPRODOL;
CAPSULE OR TABLET; ORAL CODEINE PHOSPHATE
160-165MG;160-165MG;50MG TABLET; ORAL
325MG;325MG;50MG 160MG;32MG;200MG;16MG

ACETAMINOPHEN;ASPIRIN;BUTALBITAL; ASPIRIN;CARISOPRODOL
CAFFEINE TABLET; ORAL
CAPSULE OR TABLET; ORAL 325MG;200MG
160-165MG;160-165MG;50MG;40MG
325MG;325MG;50MG;40MG
ASPIRIN;CARISOPRODOL;
CODEINE PHOSPHATE
ACETAMINOPHEN;BUTALBITAL TABLET; ORAL
CAPSULE OR TABLET; ORAL 325MG;200MG;16MG
325MG;50MG

ASPIRIN;MEPROBAMATE
ACETAMINOPHEN;BUTALBITAL;CAFFEINE TABLET; ORAL
CAPSULE OR TABLET; ORAL 325MG;200MG
325MG;50MG;40MG

ASPIRIN;METHOCARBAMOL
AMINOPHYLLINE TABLET; ORAL
TABLET; ORAL 325MG;400MG
100MG;200MG

CHLOROTHIAZIDE
ASPIRIN;BUTALBITAL TABLET; ORAL
CAPSULE OR TABLET; ORAL 250MG
325MG;50MG
650MG;50MG
HYDROXYZINE HYDROCHLORIDE
TABLET; ORAL
ASPIRIN;BUTALBITAL;CAFFEINE 10MG;25MG;
CAPSULE OR TABLET; ORAL 50MG;100MG
325MG;50MG;40MG
650MG;50MG;40MG
PREDNISONE
TABLET; ORAL
ASPIRIN;CAFFEINE;CARISOPRODOL 1MG;2.5MG;5MG;10MG;
TABLET; ORAL 20MG;25MG;50MG
160MG;32MG;200MG
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST A - 1

APPENDIX A - PRODUCT NAME INDEX


** A **
ABACAVIR SULFATE, ABACAVIR SULFATE
ABACAVIR SULFATE AND LAMIVUDINE, ABACAVIR SULFATE
ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE, ABACAVIR SULFATE
ABELCET, AMPHOTERICIN B
ABILIFY, ARIPIPRAZOLE
ABILIFY MAINTENA KIT, ARIPIPRAZOLE
ABILIFY MYCITE KIT, ARIPIPRAZOLE
ABIRATERONE ACETATE, ABIRATERONE ACETATE
ABLYSINOL, ALCOHOL
ABRAXANE, PACLITAXEL
ABREVA, DOCOSANOL (OTC)
ABSORICA, ISOTRETINOIN
ABSORICA LD, ISOTRETINOIN
ACAMPROSATE CALCIUM, ACAMPROSATE CALCIUM
ACANYA, BENZOYL PEROXIDE
ACARBOSE, ACARBOSE
ACCOLATE, ZAFIRLUKAST
ACCRUFER, FERRIC MALTOL
ACCUNEB, ALBUTEROL SULFATE
ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE
ACEPHEN, ACETAMINOPHEN (OTC)
ACETADOTE, ACETYLCYSTEINE
ACETAMINOPHEN, ACETAMINOPHEN (OTC)
ACETAMINOPHEN, ACETAMINOPHEN
ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN
ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC)
ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE, ACETAMINOPHEN
ACETAZOLAMIDE, ACETAZOLAMIDE
ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE SODIUM
ACETIC ACID, ACETIC ACID, GLACIAL
ACETIC ACID 0.25% IN PLASTIC CONTAINER, ACETIC ACID, GLACIAL
ACETYLCYSTEINE, ACETYLCYSTEINE
ACHROMYCIN V, TETRACYCLINE HYDROCHLORIDE
ACIPHEX, RABEPRAZOLE SODIUM
ACITRETIN, ACITRETIN
ACTHAR GEL, CORTICOTROPIN
ACTICLATE, DOXYCYCLINE HYCLATE
ACTIGALL, URSODIOL
ACTIQ, FENTANYL CITRATE
ACTIVELLA, ESTRADIOL
ACTONEL, RISEDRONATE SODIUM
ACTOPLUS MET, METFORMIN HYDROCHLORIDE
ACTOS, PIOGLITAZONE HYDROCHLORIDE
ACULAR, KETOROLAC TROMETHAMINE
ACULAR LS, KETOROLAC TROMETHAMINE
ACUVAIL, KETOROLAC TROMETHAMINE
ACUVUE THERAVISION WITH KETOTIFEN, KETOTIFEN FUMARATE
ACYCLOVIR, ACYCLOVIR
ACYCLOVIR SODIUM, ACYCLOVIR SODIUM
ACZONE, DAPSONE
ADAPALENE, ADAPALENE (OTC)
ADAPALENE, ADAPALENE
ADAPALENE AND BENZOYL PEROXIDE, ADAPALENE
ADASUVE, LOXAPINE
ADCIRCA, TADALAFIL
ADDERALL XR 10, AMPHETAMINE ASPARTATE
ADDERALL XR 15, AMPHETAMINE ASPARTATE
ADDERALL XR 20, AMPHETAMINE ASPARTATE
ADDERALL XR 25, AMPHETAMINE ASPARTATE
ADDERALL XR 30, AMPHETAMINE ASPARTATE
ADDERALL XR 5, AMPHETAMINE ASPARTATE
ADDYI, FLIBANSERIN
ADEFOVIR DIPIVOXIL, ADEFOVIR DIPIVOXIL
ADEMPAS, RIOCIGUAT
ADENOSINE, ADENOSINE
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST A - 2

APPENDIX A - PRODUCT NAME INDEX


** A **
ADIPEX-P, PHENTERMINE HYDROCHLORIDE
ADLARITY, DONEPEZIL HYDROCHLORIDE
ADRENACLICK, EPINEPHRINE
ADRENALIN, EPINEPHRINE
ADREVIEW, IOBENGUANE SULFATE I-123
ADVAIR DISKUS 100/50, FLUTICASONE PROPIONATE
ADVAIR DISKUS 250/50, FLUTICASONE PROPIONATE
ADVAIR DISKUS 500/50, FLUTICASONE PROPIONATE
ADVAIR HFA, FLUTICASONE PROPIONATE
ADVIL, IBUPROFEN (OTC)
ADVIL, IBUPROFEN SODIUM (OTC)
ADVIL ALLERGY AND CONGESTION RELIEF, CHLORPHENIRAMINE MALEATE (OTC)
ADVIL ALLERGY SINUS, CHLORPHENIRAMINE MALEATE (OTC)
ADVIL COLD AND SINUS, IBUPROFEN (OTC)
ADVIL CONGESTION RELIEF, IBUPROFEN (OTC)
ADVIL DUAL ACTION WITH ACETAMINOPHEN, ACETAMINOPHEN (OTC)
ADVIL LIQUI-GELS, IBUPROFEN (OTC)
ADVIL MIGRAINE LIQUI-GELS, IBUPROFEN (OTC)
ADVIL MULTI-SYMPTOM COLD & FLU, CHLORPHENIRAMINE MALEATE (OTC)
ADVIL PM, DIPHENHYDRAMINE CITRATE (OTC)
ADVIL PM, DIPHENHYDRAMINE HYDROCHLORIDE (OTC)
ADZENYS XR-ODT, AMPHETAMINE
AEMCOLO, RIFAMYCIN SODIUM
AFINITOR, EVEROLIMUS
AFINITOR DISPERZ, EVEROLIMUS
AFIRMELLE, ETHINYL ESTRADIOL
AGGRASTAT, TIROFIBAN HYDROCHLORIDE
AGRYLIN, ANAGRELIDE HYDROCHLORIDE
AIRDUO DIGIHALER, FLUTICASONE PROPIONATE
AIRDUO RESPICLICK, FLUTICASONE PROPIONATE
AK-FLUOR 10%, FLUORESCEIN SODIUM
AK-FLUOR 25%, FLUORESCEIN SODIUM
AKLIEF, TRIFAROTENE
AKOVAZ, EPHEDRINE SULFATE
AKPENTOLATE, CYCLOPENTOLATE HYDROCHLORIDE
AKTEN, LIDOCAINE HYDROCHLORIDE
AKTOB, TOBRAMYCIN
AKYNZEO, FOSNETUPITANT CHLORIDE HYDROCHLORIDE
AKYNZEO, NETUPITANT
ALA-CORT, HYDROCORTISONE
ALA-SCALP, HYDROCORTISONE
ALAVERT, LORATADINE (OTC)
ALAWAY, KETOTIFEN FUMARATE (OTC)
ALBENDAZOLE, ALBENDAZOLE
ALBUTEROL SULFATE, ALBUTEROL SULFATE
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE
ALCAINE, PROPARACAINE HYDROCHLORIDE
ALCLOMETASONE DIPROPIONATE, ALCLOMETASONE DIPROPIONATE
ALDACTAZIDE, HYDROCHLOROTHIAZIDE
ALDACTONE, SPIRONOLACTONE
ALDARA, IMIQUIMOD
ALECENSA, ALECTINIB HYDROCHLORIDE
ALENDRONATE SODIUM, ALENDRONATE SODIUM
ALEVE, NAPROXEN SODIUM (OTC)
ALEVE PM, DIPHENHYDRAMINE HYDROCHLORIDE (OTC)
ALFENTA, ALFENTANIL HYDROCHLORIDE
ALFENTANIL, ALFENTANIL HYDROCHLORIDE
ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE
ALIMTA, PEMETREXED DISODIUM
ALINIA, NITAZOXANIDE
ALIQOPA, COPANLISIB DIHYDROCHLORIDE
ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE
ALKINDI SPRINKLE, HYDROCORTISONE
ALLEGRA ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC)
ALLEGRA HIVES, FEXOFENADINE HYDROCHLORIDE (OTC)
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST A - 3

APPENDIX A - PRODUCT NAME INDEX


** A **
ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION, FEXOFENADINE HYDROCHLORIDE (OTC)
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION, FEXOFENADINE HYDROCHLORIDE (OTC)
ALLI, ORLISTAT (OTC)
ALLOPURINOL, ALLOPURINOL
ALLOPURINOL SODIUM, ALLOPURINOL SODIUM
ALLZITAL, ACETAMINOPHEN
ALMOTRIPTAN MALATE, ALMOTRIPTAN MALATE
ALOMIDE, LODOXAMIDE TROMETHAMINE
ALOPRIM, ALLOPURINOL SODIUM
ALOSETRON HYDROCHLORIDE, ALOSETRON HYDROCHLORIDE
ALPHAGAN P, BRIMONIDINE TARTRATE
ALPRAZOLAM, ALPRAZOLAM
ALPROSTADIL, ALPROSTADIL
ALREX, LOTEPREDNOL ETABONATE
ALTABAX, RETAPAMULIN
ALTACE, RAMIPRIL
ALTAFLUOR BENOX, BENOXINATE HYDROCHLORIDE
ALTAVERA, ETHINYL ESTRADIOL
ALTOPREV, LOVASTATIN
ALTRENO, TRETINOIN
ALUNBRIG, BRIGATINIB
ALVESCO, CICLESONIDE
ALVIMOPAN, ALVIMOPAN
ALYACEN 1/35, ETHINYL ESTRADIOL
ALYACEN 7/7/7, ETHINYL ESTRADIOL
ALYQ, TADALAFIL
AMABELZ, ESTRADIOL
AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE
AMARYL, GLIMEPIRIDE
AMBIEN, ZOLPIDEM TARTRATE
AMBIEN CR, ZOLPIDEM TARTRATE
AMBISOME, AMPHOTERICIN B
AMBRISENTAN, AMBRISENTAN
AMCINONIDE, AMCINONIDE
AMELUZ, AMINOLEVULINIC ACID HYDROCHLORIDE
AMERGE, NARATRIPTAN HYDROCHLORIDE
AMICAR, AMINOCAPROIC ACID
AMIDATE, ETOMIDATE
AMIFOSTINE, AMIFOSTINE
AMIKACIN SULFATE, AMIKACIN SULFATE
AMILORIDE HYDROCHLORIDE, AMILORIDE HYDROCHLORIDE
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE
AMINO ACIDS, AMINO ACIDS
AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER, GLYCINE
AMINOCAPROIC ACID, AMINOCAPROIC ACID
AMINOCAPROIC ACID IN PLASTIC CONTAINER, AMINOCAPROIC ACID
AMINOPHYLLINE, AMINOPHYLLINE
AMINOSYN II 10% IN PLASTIC CONTAINER, AMINO ACIDS
AMINOSYN II 15% IN PLASTIC CONTAINER, AMINO ACIDS
AMINOSYN-PF 10%, AMINO ACIDS
AMINOSYN-PF 7%, AMINO ACIDS
AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE
AMITIZA, LUBIPROSTONE
AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE
AMLODIPINE AND OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE
AMLODIPINE BESYLATE, AMLODIPINE BESYLATE
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM, AMLODIPINE BESYLATE
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE
AMLODIPINE BESYLATE AND VALSARTAN, AMLODIPINE BESYLATE
AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE, AMLODIPINE BESYLATE
AMMONIA N 13, AMMONIA N-13
AMMONIUM CHLORIDE IN PLASTIC CONTAINER, AMMONIUM CHLORIDE
AMMONIUM LACTATE, AMMONIUM LACTATE
AMMONUL, SODIUM BENZOATE
AMNESTEEM, ISOTRETINOIN
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST A - 4

APPENDIX A - PRODUCT NAME INDEX


** A **
AMONDYS 45, CASIMERSEN
AMOXAPINE, AMOXAPINE
AMOXICILLIN, AMOXICILLIN
AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN
AMOXICILLIN PEDIATRIC, AMOXICILLIN
AMOXIL, AMOXICILLIN
AMPHETAMINE SULFATE, AMPHETAMINE SULFATE
AMPHOTERICIN B, AMPHOTERICIN B
AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM
AMPICILLIN SODIUM, AMPICILLIN SODIUM
AMPICILLIN TRIHYDRATE, AMPICILLIN/AMPICILLIN TRIHYDRATE
AMPYRA, DALFAMPRIDINE
AMRINONE LACTATE, INAMRINONE LACTATE
AMRIX, CYCLOBENZAPRINE HYDROCHLORIDE
AMVUTTRA, VUTRISIRAN
AMYVID, FLORBETAPIR F-18
AMZEEQ, MINOCYCLINE HYDROCHLORIDE
AN-SULFUR COLLOID, TECHNETIUM TC-99M SULFUR COLLOID KIT
ANAFRANIL, CLOMIPRAMINE HYDROCHLORIDE
ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE
ANAPROX DS, NAPROXEN SODIUM
ANASTROZOLE, ANASTROZOLE
ANCEF IN PLASTIC CONTAINER, CEFAZOLIN SODIUM
ANCOBON, FLUCYTOSINE
ANDRODERM, TESTOSTERONE
ANDROGEL, TESTOSTERONE
ANDROID 25, METHYLTESTOSTERONE
ANECTINE, SUCCINYLCHOLINE CHLORIDE
ANEXSIA 5/325, ACETAMINOPHEN
ANEXSIA 7.5/325, ACETAMINOPHEN
ANGELIQ, DROSPIRENONE
ANGIOMAX, BIVALIRUDIN
ANGIOMAX RTU, BIVALIRUDIN
ANNOVERA, ETHINYL ESTRADIOL
ANORO ELLIPTA, UMECLIDINIUM BROMIDE
ANTARA (MICRONIZED), FENOFIBRATE
ANTHELIOS 20, AVOBENZONE (OTC)
ANTHELIOS 40, AVOBENZONE (OTC)
ANTHELIOS SX, AVOBENZONE (OTC)
ANTIVERT, MECLIZINE HYDROCHLORIDE
ANUSOL HC, HYDROCORTISONE
ANZEMET, DOLASETRON MESYLATE
APADAZ, ACETAMINOPHEN
APIXABAN, APIXABAN
APLENZIN, BUPROPION HYDROBROMIDE
APOKYN, APOMORPHINE HYDROCHLORIDE
APOMORPHINE HYDROCHLORIDE, APOMORPHINE HYDROCHLORIDE
APONVIE, APREPITANT
APRACLONIDINE HYDROCHLORIDE, APRACLONIDINE HYDROCHLORIDE
APREMILAST, APREMILAST
APREPITANT, APREPITANT
APRETUDE, CABOTEGRAVIR
APRISO, MESALAMINE
APTENSIO XR, METHYLPHENIDATE HYDROCHLORIDE
APTIOM, ESLICARBAZEPINE ACETATE
APTIVUS, TIPRANAVIR
AQUASOL A, VITAMIN A PALMITATE
ARAKODA, TAFENOQUINE SUCCINATE
ARANELLE, ETHINYL ESTRADIOL
ARAVA, LEFLUNOMIDE
ARAZLO, TAZAROTENE
ARESTIN, MINOCYCLINE HYDROCHLORIDE
ARFORMOTEROL TARTRATE, ARFORMOTEROL TARTRATE
ARGATROBAN, ARGATROBAN
ARGATROBAN IN SODIUM CHLORIDE, ARGATROBAN
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST A - 5

APPENDIX A - PRODUCT NAME INDEX


** A **
ARICEPT, DONEPEZIL HYDROCHLORIDE
ARIDOL KIT, MANNITOL
ARIKAYCE KIT, AMIKACIN SULFATE
ARIMIDEX, ANASTROZOLE
ARIPIPRAZOLE, ARIPIPRAZOLE
ARISTADA, ARIPIPRAZOLE LAUROXIL
ARISTADA INITIO KIT, ARIPIPRAZOLE LAUROXIL
ARIXTRA, FONDAPARINUX SODIUM
ARMODAFINIL, ARMODAFINIL
ARMONAIR DIGIHALER, FLUTICASONE PROPIONATE
ARNUITY ELLIPTA, FLUTICASONE FUROATE
AROMASIN, EXEMESTANE
ARRANON, NELARABINE
ARSENIC TRIOXIDE, ARSENIC TRIOXIDE
ARTESUNATE, ARTESUNATE
ARTHROTEC, DICLOFENAC SODIUM
ASCLERA, POLIDOCANOL
ASCOR, ASCORBIC ACID
ASENAPINE MALEATE, ASENAPINE MALEATE
ASHLYNA, ETHINYL ESTRADIOL
ASMANEX HFA, MOMETASONE FUROATE
ASMANEX TWISTHALER, MOMETASONE FUROATE
ASPIRIN AND DIPYRIDAMOLE, ASPIRIN
ASPRUZYO SPRINKLE, RANOLAZINE
ASTAGRAF XL, TACROLIMUS
ASTEPRO ALLERGY, AZELASTINE HYDROCHLORIDE (OTC)
ATACAND, CANDESARTAN CILEXETIL
ATACAND HCT, CANDESARTAN CILEXETIL
ATAZANAVIR SULFATE, ATAZANAVIR SULFATE
ATELVIA, RISEDRONATE SODIUM
ATENOLOL, ATENOLOL
ATENOLOL AND CHLORTHALIDONE, ATENOLOL
ATHENTIA NEXT, LEVONORGESTREL (OTC)
ATIVAN, LORAZEPAM
ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE
ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM
ATOVAQUONE, ATOVAQUONE
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, ATOVAQUONE
ATRACURIUM BESYLATE, ATRACURIUM BESYLATE
ATRACURIUM BESYLATE PRESERVATIVE FREE, ATRACURIUM BESYLATE
ATRALIN, TRETINOIN
ATRIPLA, EFAVIRENZ
ATROPEN, ATROPINE
ATROPINE SULFATE, ATROPINE SULFATE
ATROVENT HFA, IPRATROPIUM BROMIDE
AUBAGIO, TERIFLUNOMIDE
AUGMENTIN '125', AMOXICILLIN
AUGMENTIN '250', AMOXICILLIN
AUGMENTIN '875', AMOXICILLIN
AUGMENTIN ES-600, AMOXICILLIN
AUROVELA 1.5/30, ETHINYL ESTRADIOL
AUROVELA 1/20, ETHINYL ESTRADIOL
AUROVELA 24 FE, ETHINYL ESTRADIOL
AUROVELA FE 1.5/30, ETHINYL ESTRADIOL
AUROVELA FE 1/20, ETHINYL ESTRADIOL
AURYXIA, FERRIC CITRATE
AUSTEDO, DEUTETRABENAZINE
AUVELITY, BUPROPION HYDROCHLORIDE
AUVI-Q, EPINEPHRINE
AVAGARD, ALCOHOL (OTC)
AVAGE, TAZAROTENE
AVALIDE, HYDROCHLOROTHIAZIDE
AVANDIA, ROSIGLITAZONE MALEATE
AVAPRO, IRBESARTAN
AVEED, TESTOSTERONE UNDECANOATE
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST A - 6

APPENDIX A - PRODUCT NAME INDEX


** A **
AVIANE-28, ETHINYL ESTRADIOL
AVITA, TRETINOIN
AVODART, DUTASTERIDE
AVYCAZ, AVIBACTAM SODIUM
AXID AR, NIZATIDINE (OTC)
AXUMIN, FLUCICLOVINE F-18
AYUNA, ETHINYL ESTRADIOL
AYVAKIT, AVAPRITINIB
AZACITIDINE, AZACITIDINE
AZACTAM, AZTREONAM
AZASAN, AZATHIOPRINE
AZASITE, AZITHROMYCIN
AZATHIOPRINE, AZATHIOPRINE
AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM
AZEDRA, IOBENGUANE I-131
AZELAIC ACID, AZELAIC ACID
AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, AZELASTINE HYDROCHLORIDE
AZELEX, AZELAIC ACID
AZILECT, RASAGILINE MESYLATE
AZITHROMYCIN, AZITHROMYCIN
AZOPT, BRINZOLAMIDE
AZOR, AMLODIPINE BESYLATE
AZSTARYS, DEXMETHYLPHENIDATE HYDROCHLORIDE
AZTREONAM, AZTREONAM
AZULFIDINE, SULFASALAZINE
AZULFIDINE EN-TABS, SULFASALAZINE
** B **
BACITRACIN, BACITRACIN
BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC
BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE, BACITRACIN ZINC
BACLOFEN, BACLOFEN
BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE
BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION
BACTOCILL IN PLASTIC CONTAINER, OXACILLIN SODIUM
BACTRIM, SULFAMETHOXAZOLE
BACTRIM DS, SULFAMETHOXAZOLE
BAFIERTAM, MONOMETHYL FUMARATE
BAL, DIMERCAPROL
BALANCED SALT, CALCIUM CHLORIDE
BALCOLTRA, ETHINYL ESTRADIOL
BALSALAZIDE DISODIUM, BALSALAZIDE DISODIUM
BALVERSA, ERDAFITINIB
BALZIVA-28, ETHINYL ESTRADIOL
BANZEL, RUFINAMIDE
BAQSIMI, GLUCAGON
BARACLUDE, ENTECAVIR
BARHEMSYS, AMISULPRIDE
BAXDELA, DELAFLOXACIN MEGLUMINE
BECONASE AQ, BECLOMETHASONE DIPROPIONATE MONOHYDRATE
BEKYREE, DESOGESTREL
BELBUCA, BUPRENORPHINE HYDROCHLORIDE
BELEODAQ, BELINOSTAT
BELRAPZO, BENDAMUSTINE HYDROCHLORIDE
BELSOMRA, SUVOREXANT
BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE
BENDAMUSTINE HYDROCHLORIDE, BENDAMUSTINE HYDROCHLORIDE
BENDEKA, BENDAMUSTINE HYDROCHLORIDE
BENICAR, OLMESARTAN MEDOXOMIL
BENICAR HCT, HYDROCHLOROTHIAZIDE
BENTYL, DICYCLOMINE HYDROCHLORIDE
BENTYL PRESERVATIVE FREE, DICYCLOMINE HYDROCHLORIDE
BENZACLIN, BENZOYL PEROXIDE
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST A - 7

APPENDIX A - PRODUCT NAME INDEX


** B **
BENZAMYCIN, BENZOYL PEROXIDE
BENZNIDAZOLE, BENZNIDAZOLE
BENZONATATE, BENZONATATE
BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE
BENZTROPINE MESYLATE, BENZTROPINE MESYLATE
BEPOTASTINE BESILATE, BEPOTASTINE BESILATE
BEPREVE, BEPOTASTINE BESILATE
BESIVANCE, BESIFLOXACIN HYDROCHLORIDE
BETA-VAL, BETAMETHASONE VALERATE
BETADINE, POVIDONE-IODINE
BETAGAN, LEVOBUNOLOL HYDROCHLORIDE
BETAINE, BETAINE
BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE, BETAMETHASONE ACETATE
BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE
BETAMETHASONE VALERATE, BETAMETHASONE VALERATE
BETAPACE, SOTALOL HYDROCHLORIDE
BETAPACE AF, SOTALOL HYDROCHLORIDE
BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE
BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE
BETHKIS, TOBRAMYCIN
BETIMOL, TIMOLOL
BETOPTIC, BETAXOLOL HYDROCHLORIDE
BETOPTIC S, BETAXOLOL HYDROCHLORIDE
BEVESPI AEROSPHERE, FORMOTEROL FUMARATE
BEXAROTENE, BEXAROTENE
BEYAZ, DROSPIRENONE
BICALUTAMIDE, BICALUTAMIDE
BICILLIN C-R, PENICILLIN G BENZATHINE
BICILLIN C-R 900/300, PENICILLIN G BENZATHINE
BICILLIN L-A, PENICILLIN G BENZATHINE
BICNU, CARMUSTINE
BIDIL, HYDRALAZINE HYDROCHLORIDE
BIJUVA, ESTRADIOL
BIKTARVY, BICTEGRAVIR SODIUM
BILTRICIDE, PRAZIQUANTEL
BIMATOPROST, BIMATOPROST
BINOSTO, ALENDRONATE SODIUM
BIORPHEN, PHENYLEPHRINE HYDROCHLORIDE
BIOSCRUB, CHLORHEXIDINE GLUCONATE (OTC)
BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE, BISMUTH SUBSALICYLATE
BISOPROLOL FUMARATE, BISOPROLOL FUMARATE
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE
BIVALIRUDIN, BIVALIRUDIN
BLEOMYCIN SULFATE, BLEOMYCIN SULFATE
BLEPH-10, SULFACETAMIDE SODIUM
BLISOVI 24 FE, ETHINYL ESTRADIOL
BLISOVI FE 1.5/30, ETHINYL ESTRADIOL
BLISOVI FE 1/20, ETHINYL ESTRADIOL
BLOXIVERZ, NEOSTIGMINE METHYLSULFATE
BLUDIGO, INDIGOTINDISULFONATE SODIUM
BONJESTA, DOXYLAMINE SUCCINATE
BONSITY, TERIPARATIDE
BONTRIL PDM, PHENDIMETRAZINE TARTRATE
BORTEZOMIB, BORTEZOMIB
BOSENTAN, BOSENTAN
BOSULIF, BOSUTINIB MONOHYDRATE
BRAFTOVI, ENCORAFENIB
BREO ELLIPTA, FLUTICASONE FUROATE
BRETHINE, TERBUTALINE SULFATE
BRETYLIUM TOSYLATE, BRETYLIUM TOSYLATE
BREVIBLOC, ESMOLOL HYDROCHLORIDE
BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE
BREVIBLOC IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE
BREVITAL SODIUM, METHOHEXITAL SODIUM
BREXAFEMME, IBREXAFUNGERP CITRATE
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST A - 8

APPENDIX A - PRODUCT NAME INDEX


** B **
BREXPIPRAZOLE, BREXPIPRAZOLE
BREYNA, BUDESONIDE
BREZTRI AEROSPHERE, BUDESONIDE
BRIDION, SUGAMMADEX SODIUM
BRIELLYN, ETHINYL ESTRADIOL
BRILINTA, TICAGRELOR
BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE, BRIMONIDINE TARTRATE
BRINZOLAMIDE, BRINZOLAMIDE
BRISDELLE, PAROXETINE MESYLATE
BRIVARACETAM, BRIVARACETAM
BRIVIACT, BRIVARACETAM
BROMFED-DM, BROMPHENIRAMINE MALEATE
BROMFENAC SODIUM, BROMFENAC SODIUM
BROMOCRIPTINE MESYLATE, BROMOCRIPTINE MESYLATE
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE,
BROMSITE, BROMFENAC SODIUM
BRONCHITOL, MANNITOL
BROVANA, ARFORMOTEROL TARTRATE
BRUKINSA, ZANUBRUTINIB
BRYHALI, HALOBETASOL PROPIONATE
BSS, CALCIUM CHLORIDE
BSS PLUS, CALCIUM CHLORIDE
BUDESONIDE, BUDESONIDE (OTC)
BUDESONIDE, BUDESONIDE
BUMETANIDE, BUMETANIDE
BUMEX, BUMETANIDE
BUPHENYL, SODIUM PHENYLBUTYRATE
BUPIVACAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE
BUPRENEX, BUPRENORPHINE HYDROCHLORIDE
BUPRENORPHINE, BUPRENORPHINE
BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE
BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE
BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE
BUSULFAN, BUSULFAN
BUSULFEX, BUSULFAN
BUTALBITAL AND ACETAMINOPHEN, ACETAMINOPHEN
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE, ACETAMINOPHEN
BUTALBITAL, ASPIRIN AND CAFFEINE, ASPIRIN
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE, ASPIRIN
BUTAPAP, ACETAMINOPHEN
BUTENAFINE HYDROCHLORIDE, BUTENAFINE HYDROCHLORIDE (OTC)
BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE
BUTORPHANOL TARTRATE PRESERVATIVE FREE, BUTORPHANOL TARTRATE
BUTRANS, BUPRENORPHINE
BYDUREON BCISE, EXENATIDE SYNTHETIC
BYETTA, EXENATIDE SYNTHETIC
BYFAVO, REMIMAZOLAM BESYLATE
BYLVAY, ODEVIXIBAT
BYSTOLIC, NEBIVOLOL HYDROCHLORIDE
** C **
CABAZITAXEL, CABAZITAXEL
CABENUVA KIT, CABOTEGRAVIR
CABERGOLINE, CABERGOLINE
CABOMETYX, CABOZANTINIB S-MALATE
CADUET, AMLODIPINE BESYLATE
CAFCIT, CAFFEINE CITRATE
CAFFEINE CITRATE, CAFFEINE CITRATE
CALAN SR, VERAPAMIL HYDROCHLORIDE
CALCIPOTRIENE, CALCIPOTRIENE
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST A - 9

APPENDIX A - PRODUCT NAME INDEX


** C **
CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE
CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE
CALCITONIN-SALMON, CALCITONIN SALMON
CALCITRIOL, CALCITRIOL
CALCIUM ACETATE, CALCIUM ACETATE
CALCIUM CHLORIDE 10%, CALCIUM CHLORIDE
CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER, CALCIUM CHLORIDE
CALCIUM DISODIUM VERSENATE, EDETATE CALCIUM DISODIUM
CALCIUM GLUCONATE, CALCIUM GLUCONATE
CALCIUM GLUCONATE IN SODIUM CHLORIDE, CALCIUM GLUCONATE
CALDOLOR, IBUPROFEN
CALQUENCE, ACALABRUTINIB
CALQUENCE, ACALABRUTINIB MALEATE
CAMBIA, DICLOFENAC POTASSIUM
CAMCEVI KIT, LEUPROLIDE MESYLATE
CAMILA, NORETHINDRONE
CAMPTOSAR, IRINOTECAN HYDROCHLORIDE
CAMZYOS, MAVACAMTEN
CANASA, MESALAMINE
CANCIDAS, CASPOFUNGIN ACETATE
CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL
CAPECITABINE, CAPECITABINE
CAPEX, FLUOCINOLONE ACETONIDE
CAPITAL SOLEIL 15, AVOBENZONE (OTC)
CAPLYTA, LUMATEPERONE TOSYLATE
CAPRELSA, VANDETANIB
CAPTOPRIL, CAPTOPRIL
CARAC, FLUOROURACIL
CARAFATE, SUCRALFATE
CARBAGLU, CARGLUMIC ACID
CARBAMAZEPINE, CARBAMAZEPINE
CARBATROL, CARBAMAZEPINE
CARBIDOPA, CARBIDOPA
CARBIDOPA AND LEVODOPA, CARBIDOPA
CARBIDOPA, LEVODOPA AND ENTACAPONE, CARBIDOPA
CARBINOXAMINE MALEATE, CARBINOXAMINE MALEATE
CARBOCAINE, MEPIVACAINE HYDROCHLORIDE
CARBOPLATIN, CARBOPLATIN
CARBOPROST TROMETHAMINE, CARBOPROST TROMETHAMINE
CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE
CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE
CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE
CARDIOGEN-82, RUBIDIUM CHLORIDE RB-82
CARDIOLITE, TECHNETIUM TC-99M SESTAMIBI KIT
CARDIOPLEGIC IN PLASTIC CONTAINER, CALCIUM CHLORIDE
CARDIZEM, DILTIAZEM HYDROCHLORIDE
CARDIZEM CD, DILTIAZEM HYDROCHLORIDE
CARDIZEM LA, DILTIAZEM HYDROCHLORIDE
CARDURA, DOXAZOSIN MESYLATE
CARDURA XL, DOXAZOSIN MESYLATE
CARFILZOMIB, CARFILZOMIB
CARGLUMIC ACID, CARGLUMIC ACID
CARISOPRODOL, CARISOPRODOL
CARMUSTINE, CARMUSTINE
CARNITOR, LEVOCARNITINE
CARNITOR SF, LEVOCARNITINE
CAROSPIR, SPIRONOLACTONE
CARTEOLOL HYDROCHLORIDE, CARTEOLOL HYDROCHLORIDE
CARTIA XT, DILTIAZEM HYDROCHLORIDE
CARVEDILOL, CARVEDILOL
CARVEDILOL PHOSPHATE, CARVEDILOL PHOSPHATE
CASODEX, BICALUTAMIDE
CASPOFUNGIN ACETATE, CASPOFUNGIN ACETATE
CASPORYN HC, HYDROCORTISONE
43RD EDITION - 2023 - APPROVED DRUG PRODUCT LIST A - 10

APPENDIX A - PRODUCT NAME INDEX


** C **
CATAFLAM, DICLOFENAC POTASSIUM
CATAPRES-TTS-1, CLONIDINE
CATAPRES-TTS-2, CLONIDINE
CATAPRES-TTS-3, CLONIDINE
CAVERJECT, ALPROSTADIL
CAVERJECT IMPULSE, ALPROSTADIL
CAYSTON, AZTREONAM
CEFACLOR, CEFACLOR
CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE
CEFAZOLIN AND DEXTROSE, CEFAZOLIN SODIUM
CEFAZOLIN IN PLASTIC CONTAINER, CEFAZOLIN SODIUM
CEFAZOLIN SODIUM, CEFAZOLIN SODIUM
CEFDINIR, CEFDINIR
CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER, CEFEPIME HYDROCHLORIDE
CEFEPIME HYDROCHLORIDE, CEFEPIME HYDROCHLORIDE
CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER, CEFEPIME HYDROCHLORIDE
CEFEPIME IN PLASTIC CONTAINER, CEFEPIME HYDROCHLORIDE
CEFIXIME, CEFIXIME
CEFOTAN, CEFOTETAN DISODIUM
CEFOTAXIME, CEFOTAXIME SODIUM
CEFOTETAN, CEFOTETAN DISODIUM
CEFOXITIN, CEFOXITIN SODIUM
CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER, CEFOXITIN SODIUM
CEFOXITIN IN PLASTIC CONTAINER, CEFOXITIN SODIUM
CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL
CEFPROZIL, CEFPROZIL
CEFTAZIDIME, CEFTAZIDIME
CEFTRIAXONE, CEFTRIAXONE SODIUM
CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER, CEFTRIAXONE SODIUM
CEFTRIAXONE IN PLASTIC CONTAINER, CEFTRIAXONE SODIUM
CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM
CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER, CEFUROXIME SODIUM
CEFUROXIME AXETIL, CEFUROXIME AXETIL
CEFUROXIME

You might also like